Psyllid ID: psy7889

---

Local Sequence Feature Prediction

Residue Number Marker
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300-------310-------320-------330-------340-------350-------360-------370-------380-------390-------400-------410-------420-------430---
Protein Sequence
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVF
Secondary Structure (PSIPRED)
cccccccHHHHHHHHHHHHccccccccccEEEEccccccccccccEEEEEccHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHcccccccccccccccccccccEEEccccccccccccccccccccccccccccccccccccccccccccHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHccccccccccccccccccccccccccccccHHHHcccccccHHHHHHHHHHHHccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHHHHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccc
Secondary Structure Prediction (SSPRO)
cccccHHHHHHHHHHHHHHcccccEEEHHHccccccccHHHccccEEEEEHHHHHHHHHHHHcccccccHHHHHHHHHHHHHHHHHHHHcccccccccHHHEEEcccccEEEccccccccccHHHccccEccccccccHHHcccHHHHcEcccccHHHHHHHHHHHHHHHHcccccccccccHHHHHHHHHHccccHHHcccHHHccccHHccccccccccHHHHcccccccHHHHHHHHHHHcccccccccHHHHHcccHHcccccccccccccccccccHHHccccHHHHHHHHHHHHHHHccccccccccccccccccccccccccccccccccHHcccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccccHcccccccccccccc
Coil and Loop (DISEMBL)
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKAnqynryrsTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARafsqtkngqvnrytnrvvtlwyrppelllgdrnygppvdlwgagcimaemwtrspimqgntEQQQITLISQLcgsitpeswpgvetldlynkmelpkaQKRKVKERLkpyvkdqygcdlldklllldpskrfdsdaalnhdffwtdpmpsdlSKMLAQHTQSMFeylapprrpghmrahhhhhhagapgaagpaagrattetgyhdrvkerlkpyvkdqygcdlldklllldpskrfdsdaalnhdffwtdpmpsdlSKMLAQHTQSMFeylapprrpghmrahhhhhhagapgaagpaagrattetgyhdrvf
Flexible Loop (DISEMBL)
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARafsqtkngqvnrytnrvVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMElpkaqkrkvkerlkpyvkdqygcDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVF
Low Complexity Region (SEG)
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCdlldklllldPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLapprrpghmrahhhhhhagapgaagpaagraTTETGYHDRVKERLKPYVKDQYGCdlldklllldPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLapprrpghmrahhhhhhagapgaagpaagraTTETGYHDRVF
Disordered region (IsUnstruct)
**GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL*******VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD*************************************************************VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD***************************************************************
Disordered Region (DISOPRED)
**GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDL*************************************AAGPAAGRATTETGYHDRVKERLKPYVKDQYGCD*****************************************************************************************VF
Disordered Region (DISEMBL)
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRP*******************************HDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRP************************************
Disordered Region (DISPRO)
**GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHH***********************************************************************************************************************************
Transmembrane Helix (TMHMM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (HMMTOP)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Transmembrane Helix (MEMSAT)
iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiihhhhhhhhhhhhhhhhhhhoooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
TM Helix, Signal Peptide (MEMSAT_SVM)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooohhhhhhhhhhhhhhhhiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii
TM Helix, Signal Peptide (Phobius)
ooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooooo
Signal Peptide (SignalP HMM Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Signal Peptide (SignalP NN Mode)
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
Coiled Coils (COILS)
MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETGYHDRVF
Positional Conservation
no confident homologs detected

---

Close Homologs for Annotation Transfer

Close Homologs in SWISS-PROT Database Detected by BLAST

Original result of BLAST against SWISS-PROT Database

ID	Length	Definition	RBH(Q2H)	RBH(H2Q)	Q cover	H cover	Identity	E-value
Query	433	2.2.26 [Sep-21-2011]
Q6GLD8	376	Cyclin-dependent kinase 9	yes	N/A	0.722	0.832	0.757	1e-142
Q5ZKN1	372	Cyclin-dependent kinase 9	yes	N/A	0.722	0.841	0.757	1e-141
Q4V862	376	Cyclin-dependent kinase 9	N/A	N/A	0.706	0.813	0.764	1e-140
P50750	372	Cyclin-dependent kinase 9	yes	N/A	0.685	0.798	0.751	1e-139
Q641Z4	372	Cyclin-dependent kinase 9	yes	N/A	0.685	0.798	0.748	1e-138
Q99J95	372	Cyclin-dependent kinase 9	yes	N/A	0.685	0.798	0.748	1e-138
Q5EAB2	372	Cyclin-dependent kinase 9	yes	N/A	0.685	0.798	0.748	1e-138
Q7ZX42	376	Cyclin-dependent kinase 9	N/A	N/A	0.706	0.813	0.767	1e-134
Q9TVL3	478	Probable cyclin-dependent	yes	N/A	0.713	0.646	0.481	1e-79
Q5JK68	513	Cyclin-dependent kinase C	yes	N/A	0.618	0.522	0.477	4e-72

>sp|Q6GLD8|CDK9_XENTR Cyclin-dependent kinase 9 OS=Xenopus tropicalis GN=cdk9 PE=2 SV=1

 Score =  504 bits (1298), Expect = e-142,   Method: Compositional matrix adjust.
 Identities = 247/326 (75%), Positives = 268/326 (82%), Gaps = 13/326 (3%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTK----ANQYNRYRSTFYLVFDFCEHDLAGLL 61
           FPITALREIKILQLLKHENVV+LIEICRTK    ANQYNR + T +LVFDFCEHDLAGLL
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKISPTANQYNRCKGTIFLVFDFCEHDLAGLL 118

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           SN HVKF+L EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAF
Sbjct: 119 SNAHVKFTLSEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 178

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  KN Q N+YTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTE
Sbjct: 179 SLAKNSQPNKYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 238

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
           Q Q+TLISQLCGSITPE WP V+  +LY K+ELPK QKRKVKERLK YVKD Y  DL+DK
Sbjct: 239 QHQLTLISQLCGSITPEVWPNVDKYELYQKLELPKGQKRKVKERLKAYVKDLYALDLIDK 298

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHH 301
           LL+LDP++R DSD ALNHDFFW+DPMPSDL  ML+ H QSMFEYLAPPRR G      H 
Sbjct: 299 LLVLDPAQRIDSDDALNHDFFWSDPMPSDLKNMLSTHNQSMFEYLAPPRRRG-----GHM 353

Query: 302 HHAGAPGAAGPAAGRATTETGYHDRV 327
               A  A  PAA    T     DRV
Sbjct: 354 PQQPANQARNPAA----TNQSEFDRV 375

Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) and SUPT5H.
Xenopus tropicalis (taxid: 8364)
EC: 2EC: .EC: 7EC: .EC: 1EC: 1EC: .EC: 2EC: 3

>sp|Q5ZKN1|CDK9_CHICK Cyclin-dependent kinase 9 OS=Gallus gallus GN=CDK9 PE=2 SV=1

 Score =  501 bits (1289), Expect = e-141,   Method: Compositional matrix adjust.
 Identities = 244/322 (75%), Positives = 268/322 (83%), Gaps = 9/322 (2%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN H
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNTH 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWG GCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGGGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           TLISQLCGSITPE WP V+  +LY K+ELPK QKRKVK+RLK YVKD Y  DL+DKLL+L
Sbjct: 239 TLISQLCGSITPEVWPNVDKYELYQKLELPKGQKRKVKDRLKAYVKDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H QSMFEYLAPPRR G      H     
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKNMLSTHNQSMFEYLAPPRRRG-----GHMPQQP 353

Query: 306 APGAAGPAAGRATTETGYHDRV 327
           A     PA   AT +T + DRV
Sbjct: 354 ANQGRNPA---ATNQTEF-DRV 371

Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II), SUPT5H and RDBP. The CDK9/cyclin-K complex has also a kinase activity toward CTD of RNAP II and can substitute for P-TEFb in vitro.

Gallus gallus (taxid: 9031)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q4V862|CDK9A_XENLA Cyclin-dependent kinase 9-A OS=Xenopus laevis GN=cdk9-a PE=2 SV=1

 Score =  498 bits (1283), Expect = e-140,   Method: Compositional matrix adjust.
 Identities = 237/310 (76%), Positives = 262/310 (84%), Gaps = 4/310 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTK----ANQYNRYRSTFYLVFDFCEHDLAGLL 61
           FPITALREIKILQLLKHENVV+LIEICRTK    ANQYNR + T +LVFDFCEHDLAGLL
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKVSPTANQYNRCKGTIFLVFDFCEHDLAGLL 118

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           SN HVKF+L EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAF
Sbjct: 119 SNAHVKFTLSEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 178

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  KN Q N+YTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTE
Sbjct: 179 SLAKNSQPNKYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 238

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
           Q Q+TLISQLCGSITPE WP V+  +LY K+ELPK QKRKVK+RLK YVKD +  DL+DK
Sbjct: 239 QHQLTLISQLCGSITPEVWPNVDKYELYQKLELPKGQKRKVKDRLKAYVKDPHALDLIDK 298

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHH 301
           LL+LDP++R DSD ALN+DFFW+DPMPSDL  ML+ H QSMFEYLAPPRR G        
Sbjct: 299 LLVLDPTQRLDSDDALNNDFFWSDPMPSDLKNMLSTHNQSMFEYLAPPRRRGGHMPQQPA 358

Query: 302 HHAGAPGAAG 311
           + A  P A  
Sbjct: 359 NQARNPAATN 368

Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) and SUPT5H.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|P50750|CDK9_HUMAN Cyclin-dependent kinase 9 OS=Homo sapiens GN=CDK9 PE=1 SV=3

 Score =  494 bits (1272), Expect = e-139,   Method: Compositional matrix adjust.
 Identities = 230/306 (75%), Positives = 257/306 (83%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYLAPPRR G        + + 
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSR 358

Query: 306 APGAAG 311
            P    
Sbjct: 359 NPATTN 364

Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in co-transcriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation.

Homo sapiens (taxid: 9606)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q641Z4|CDK9_RAT Cyclin-dependent kinase 9 OS=Rattus norvegicus GN=Cdk9 PE=2 SV=1

 Score =  492 bits (1267), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 229/306 (74%), Positives = 257/306 (83%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 239 ALISQLCGSITPEVWPNVDKYELFEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYLAPPRR G        + + 
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSR 358

Query: 306 APGAAG 311
            P    
Sbjct: 359 NPATTN 364

Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in co-transcriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation.

Rattus norvegicus (taxid: 10116)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q99J95|CDK9_MOUSE Cyclin-dependent kinase 9 OS=Mus musculus GN=Cdk9 PE=1 SV=1

 Score =  492 bits (1267), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 229/306 (74%), Positives = 257/306 (83%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 239 ALISQLCGSITPEVWPNVDKYELFEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYLAPPRR G        + + 
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSR 358

Query: 306 APGAAG 311
            P    
Sbjct: 359 NPATTN 364

Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in co-transcriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation.

Mus musculus (taxid: 10090)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q5EAB2|CDK9_BOVIN Cyclin-dependent kinase 9 OS=Bos taurus GN=CDK9 PE=2 SV=1

 Score =  492 bits (1266), Expect = e-138,   Method: Compositional matrix adjust.
 Identities = 229/306 (74%), Positives = 257/306 (83%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 239 ALISQLCGSITPEVWPNVDKYELFEKVELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYLAPPRR G        + + 
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKGSQITQQSTNQSR 358

Query: 306 APGAAG 311
            P    
Sbjct: 359 NPATTN 364

Protein kinase involved in the regulation of transcription. Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor b (P-TEFb), which facilitates the transition from abortive to productive elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) POLR2A, SUPT5H and RDBP. This complex is inactive when in the 7SK snRNP complex form. Phosphorylates EP300, MYOD1, RPB1/POLR2A and AR, and the negative elongation factors DSIF and NELF. Regulates cytokine inducible transcription networks by facilitating promoter recognition of target transcription factors (e.g. TNF-inducible RELA/p65 activation and IL-6-inducible STAT3 signaling). Promotes RNA synthesis in genetic programs for cell growth, differentiation and viral pathogenesis. P-TEFb is also involved in co-transcriptional histone modification, mRNA processing and mRNA export. Modulates a complex network of chromatin modifications including histone H2B monoubiquitination (H2Bub1), H3 lysine 4 trimethylation (H3K4me3) and H3K36me3; integrates phosphorylation during transcription with chromatin modifications to control co-transcriptional histone mRNA processing. The CDK9/cyclin-K complex has also a kinase activity towards CTD of RNAP II and can substitute for CDK9/cyclin-T P-TEFb in vitro. Replication stress response protein; the CDK9/cyclin-K complex is required for genome integrity maintenance, by promoting cell cycle recovery from replication arrest and limiting single-stranded DNA amount in response to replication stress, thus reducing the breakdown of stalled replication forks and avoiding DNA damage. In addition, probable function in DNA repair of isoform 2 via interaction with KU70/XRCC6. Promotes cardiac myocyte enlargement. RPB1/POLR2A phosphorylation on 'Ser-2' in CTD activates transcription. AR phosphorylation modulates AR transcription factor promoter selectivity and cell growth. DSIF and NELF phosphorylation promotes transcription by inhibiting their negative effect. The phosphorylation of MYOD1 enhances its transcriptional activity and thus promotes muscle differentiation.

Bos taurus (taxid: 9913)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q7ZX42|CDK9B_XENLA Cyclin-dependent kinase 9-B OS=Xenopus laevis GN=cdk9-b PE=2 SV=1

 Score =  479 bits (1232), Expect = e-134,   Method: Compositional matrix adjust.
 Identities = 238/310 (76%), Positives = 260/310 (83%), Gaps = 4/310 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTK----ANQYNRYRSTFYLVFDFCEHDLAGLL 61
           FPITALREIKILQLLKHENVVHLIEICR K    ANQYNR + T +LVFDFCEHDLAGLL
Sbjct: 59  FPITALREIKILQLLKHENVVHLIEICRNKISPTANQYNRCKGTIFLVFDFCEHDLAGLL 118

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           SN HVKF++ EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAF
Sbjct: 119 SNAHVKFTVAEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAF 178

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  KN Q N+YTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTE
Sbjct: 179 SLAKNSQPNKYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTE 238

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
           Q Q+TLISQLCGSITPE WP V+  +LY K+ELPK QKRKVKERLK YVKD    DL+DK
Sbjct: 239 QHQLTLISQLCGSITPEVWPNVDKYELYQKLELPKGQKRKVKERLKAYVKDVCALDLIDK 298

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHH 301
           LL+LDP++R DSD ALNHDFFW+DPMPSDL  ML+ H QSMFEYLAPPRR G        
Sbjct: 299 LLILDPAQRTDSDEALNHDFFWSDPMPSDLKNMLSTHNQSMFEYLAPPRRRGGHMPQQPA 358

Query: 302 HHAGAPGAAG 311
           + A  P A  
Sbjct: 359 NQARNPAATN 368

Member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) and SUPT5H.

Xenopus laevis (taxid: 8355)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q9TVL3|CDK9_CAEEL Probable cyclin-dependent kinase 9 OS=Caenorhabditis elegans GN=cdk-9 PE=3 SV=2

 Score =  296 bits (759), Expect = 1e-79,   Method: Compositional matrix adjust.
 Identities = 167/347 (48%), Positives = 216/347 (62%), Gaps = 38/347 (10%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSN 63
           FPITALRE+K+L+ LKH N+  LIE+C  K+     ++ R+TFYLV   C HDLAGLLSN
Sbjct: 125 FPITALREVKMLEQLKHPNITDLIEVCSAKSTGTTGSKDRATFYLVMALCAHDLAGLLSN 184

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
             ++ SL  IK +++ L++GL  +H +KILHRDMKAANVLI+K GILKLADFGLAR F Q
Sbjct: 185 PKIRMSLVHIKTMMKHLMSGLNKLHRSKILHRDMKAANVLISKDGILKLADFGLARPFVQ 244

Query: 124 TKNGQVNR--YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
            +NG   R  YTNRVVTLWYRPPELLLGDR YG  +D+WGAGCIMAEMWTR PIMQG+TE
Sbjct: 245 RENGAGPRPLYTNRVVTLWYRPPELLLGDRQYGTKIDVWGAGCIMAEMWTRQPIMQGDTE 304

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKME------LPKAQKRKVKERLKPYVK---- 231
           Q+Q+ LIS LCGSI  + WP    + L++ M       LP+ + R +  ++K  +K    
Sbjct: 305 QKQLQLISGLCGSINKDVWPNCVNMPLWSAMSSEPNSALPQGKYRILPNKMKNLMKFDAP 364

Query: 232 ----DQYGCD--------------LLDKLLLLDPSKRFDSDAALNHDFFWTDPMP-SDLS 272
               D +G +              LL+ LL +DP KR  SD A +  +F+ DP+P +++ 
Sbjct: 365 DSKTDPFGKNVKQHDSATDDDALHLLEILLAIDPDKRPTSDEAEDDIWFFKDPVPMANVQ 424

Query: 273 KMLAQHTQSMFEYL----APPRRPGHMRAHHHHHHAGA-PGAAGPAA 314
            ++     S FEY     A   R  H  A    +   A P  A PA 
Sbjct: 425 DLMDTIPNSQFEYTVGKGAHANRGRHQNAQQRPNQQQARPSNAIPAG 471

Essential member of the cyclin-dependent kinase pair (CDK9/cyclin-T) complex, also called positive transcription elongation factor B (P-TEFb), which is proposed to facilitate the transition from abortive to production elongation by phosphorylating the CTD (C-terminal domain) of the large subunit of RNA polymerase II (RNAP II) and spt-5.

Caenorhabditis elegans (taxid: 6239)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

>sp|Q5JK68|CDKC2_ORYSJ Cyclin-dependent kinase C-2 OS=Oryza sativa subsp. japonica GN=CDKC-2 PE=2 SV=1

 Score =  272 bits (695), Expect = 4e-72,   Method: Compositional matrix adjust.
 Identities = 136/285 (47%), Positives = 187/285 (65%), Gaps = 17/285 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRT---------KANQYNRYRSTFYLVFDFCEHD 56
           FPITA+REIKIL+ L H+NV+ L EI  +         K  + N+Y+ + Y+VF++ +HD
Sbjct: 65  FPITAIREIKILKKLHHQNVIQLKEIVTSPGPERDEQGKPIEGNKYKGSIYMVFEYMDHD 124

Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           L GL     ++F++ +IK  ++QLL GL+Y H N++LHRD+K +N+LI   G LKLADFG
Sbjct: 125 LTGLADRPGMRFTVPQIKCYMRQLLTGLHYCHVNQVLHRDIKGSNLLIDNEGNLKLADFG 184

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
           LAR+FS   NG +   TNRV+TLWYRPPELLLG   YGP VD+W  GCI AE+    PI+
Sbjct: 185 LARSFSSDHNGNL---TNRVITLWYRPPELLLGSTRYGPAVDMWSVGCIFAELLNGKPIL 241

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC 236
            G  E +Q++ I +LCG+     WPGV  +  YN  +  +  KR+VKE  K +  DQ+  
Sbjct: 242 TGKNEPEQLSKIFELCGTPDELIWPGVTKMPWYNNFKPQRPMKRRVKESFKHF--DQHAL 299

Query: 237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD---LSKMLAQH 278
           DLL+K+L LDPS+R  +  AL+ ++FWTDP+P D   L K  A H
Sbjct: 300 DLLEKMLTLDPSQRISAKDALDAEYFWTDPLPCDPKSLPKYEASH 344

Oryza sativa subsp. japonica (taxid: 39947)

EC: 2

EC: .

EC: 7

EC: .

EC: 1

EC: 1

EC: .

EC: 2

EC: 3

Close Homologs in the Non-Redundant Database Detected by BLAST

Original result of BLAST against Nonredundant Database

GI	Length	Definition	Q cover	H cover	Identity	E-value
Query	433
350420587	382	PREDICTED: cyclin-dependent kinase 9-lik	0.732	0.829	0.854	1e-156
340716915	382	PREDICTED: cyclin-dependent kinase 9-lik	0.732	0.829	0.854	1e-155
242020760	382	mitogen-activated protein kinase ERK-A,	0.732	0.829	0.844	1e-155
383853023	382	PREDICTED: cyclin-dependent kinase 9-lik	0.732	0.829	0.847	1e-155
66550153	382	PREDICTED: cyclin-dependent kinase 9 [Ap	0.732	0.829	0.850	1e-154
322795202	381	hypothetical protein SINV_08323 [Solenop	0.729	0.829	0.850	1e-152
332029713	381	Cell division protein kinase 9 [Acromyrm	0.729	0.829	0.847	1e-152
345479695	365	PREDICTED: cyclin-dependent kinase 9-lik	0.729	0.865	0.832	1e-152
156544917	381	PREDICTED: cyclin-dependent kinase 9-lik	0.729	0.829	0.832	1e-151
307202831	382	Cell division protein kinase 9 [Harpegna	0.729	0.827	0.842	1e-151

>gi|350420587|ref|XP_003492557.1| PREDICTED: cyclin-dependent kinase 9-like [Bombus impatiens]

 Score =  556 bits (1432), Expect = e-156,   Method: Compositional matrix adjust.
 Identities = 275/322 (85%), Positives = 295/322 (91%), Gaps = 5/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLKHENVV+LIEICRT+A QYNRYRSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIRILQLLKHENVVNLIEICRTRATQYNRYRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSANK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NGQ NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 185 NGQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE L+L+NKM+LPK QKRKVK+RLKPY+KD Y CDLLD+LL+L
Sbjct: 245 ILISQLCGSITTEVWPGVENLELFNKMDLPKGQKRKVKDRLKPYLKDPYACDLLDRLLIL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKRFDSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGH+R H HH   G
Sbjct: 305 DPSKRFDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHIR-HPHHQVPG 363

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 364 GP--AKPSSSMA--DSGYQDRV 381

Source: Bombus impatiens

Species: Bombus impatiens

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|340716915|ref|XP_003396936.1| PREDICTED: cyclin-dependent kinase 9-like isoform 1 [Bombus terrestris] gi|340716917|ref|XP_003396937.1| PREDICTED: cyclin-dependent kinase 9-like isoform 2 [Bombus terrestris]

 Score =  555 bits (1431), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 275/322 (85%), Positives = 295/322 (91%), Gaps = 5/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLKHENVV+LIEICRT+A QYNRYRSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIRILQLLKHENVVNLIEICRTRATQYNRYRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSANK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NGQ NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 185 NGQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE L+L+NKM+LPK QKRKVK+RLKPY+KD Y CDLLD+LL+L
Sbjct: 245 ILISQLCGSITTEVWPGVENLELFNKMDLPKGQKRKVKDRLKPYLKDPYACDLLDRLLIL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKRFDSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGH+R H HH   G
Sbjct: 305 DPSKRFDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHIR-HPHHQVPG 363

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 364 GP--AKPSSSMA--DSGYQDRV 381

Source: Bombus terrestris

Species: Bombus terrestris

Genus: Bombus

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|242020760|ref|XP_002430819.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis] gi|212516022|gb|EEB18081.1| mitogen-activated protein kinase ERK-A, putative [Pediculus humanus corporis]

 Score =  553 bits (1426), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 272/322 (84%), Positives = 294/322 (91%), Gaps = 5/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA   NRYRSTFYLVF+FCEHDLAGLLSN++
Sbjct: 65  FPITALREIKILQLLKHENVVNLIEICRTKATLTNRYRSTFYLVFEFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLY+IHSN+ILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYFIHSNRILHRDMKAANVLITKLGILKLADFGLARAFSANK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           +G   RYTNRVVTLWYRPPELLLGDR YGPPVDLWGAGCIMAEMWTRSPIMQG+TEQQQ+
Sbjct: 185 SGLAQRYTNRVVTLWYRPPELLLGDRCYGPPVDLWGAGCIMAEMWTRSPIMQGSTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           TLISQLCGSITPE WPGVE L+LYNKM+LPK QKRKVK+RLKPYVK+ Y CDLLDKLL+L
Sbjct: 245 TLISQLCGSITPEVWPGVENLELYNKMDLPKGQKRKVKDRLKPYVKEMYACDLLDKLLVL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKR DSD+ALNHDFFW+DPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMR HHHH  AG
Sbjct: 305 DPSKRLDSDSALNHDFFWSDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRPHHHHQAAG 364

Query: 306 APGAAGPAAGRATTETGYHDRV 327
           +  AA P+    + ++GY DRV
Sbjct: 365 S--AAKPS---TSMDSGYQDRV 381

Source: Pediculus humanus corporis

Species: Pediculus humanus

Genus: Pediculus

Family: Pediculidae

Order: Phthiraptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|383853023|ref|XP_003702024.1| PREDICTED: cyclin-dependent kinase 9-like [Megachile rotundata]

 Score =  553 bits (1425), Expect = e-155,   Method: Compositional matrix adjust.
 Identities = 273/322 (84%), Positives = 296/322 (91%), Gaps = 5/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLKHENVV+LIEICRT+A QYNRYRSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIRILQLLKHENVVNLIEICRTRATQYNRYRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+LGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFNLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSANK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NGQ NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 185 NGQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE L+L+NKM+LPK QKRKVK+RLKPY++D Y CDLLDKLL+L
Sbjct: 245 ILISQLCGSITTEVWPGVENLELFNKMDLPKGQKRKVKDRLKPYLRDPYACDLLDKLLIL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKR+DSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGH+R H HH  +G
Sbjct: 305 DPSKRYDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHIR-HPHHQVSG 363

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 364 GP--AKPSSSMA--DSGYQDRV 381

Source: Megachile rotundata

Species: Megachile rotundata

Genus: Megachile

Family: Megachilidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|66550153|ref|XP_396015.2| PREDICTED: cyclin-dependent kinase 9 [Apis mellifera] gi|380022922|ref|XP_003695282.1| PREDICTED: cyclin-dependent kinase 9-like [Apis florea]

 Score =  551 bits (1421), Expect = e-154,   Method: Compositional matrix adjust.
 Identities = 274/322 (85%), Positives = 295/322 (91%), Gaps = 5/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLKH+NVV+LIEICRTKA QYNRYRSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIRILQLLKHDNVVNLIEICRTKATQYNRYRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+LGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFNLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSVNK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NGQ NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 185 NGQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE L+L+NKM+LPK QKRKVK+RLKPY+KD Y CDLLDKLL+L
Sbjct: 245 ILISQLCGSITTEVWPGVENLELFNKMDLPKGQKRKVKDRLKPYLKDPYACDLLDKLLIL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKRFD+D+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGH+R H HH   G
Sbjct: 305 DPSKRFDADSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHIR-HPHHQVPG 363

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 364 GP--AKPSSSMA--DSGYQDRV 381

Source: Apis mellifera

Species: Apis mellifera

Genus: Apis

Family: Apidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|322795202|gb|EFZ18024.1| hypothetical protein SINV_08323 [Solenopsis invicta]

 Score =  545 bits (1405), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 274/322 (85%), Positives = 292/322 (90%), Gaps = 6/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRT+A QYNR+RSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIKILQLLKHENVVNLIEICRTRATQYNRHRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK G+LKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGVLKLADFGLARAFS-AK 183

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NG  NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 184 NGHSNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 243

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE LDL+ KM+LPK QKRKVK+RLKPY+KD Y CDLLDKLL+L
Sbjct: 244 ILISQLCGSITTEVWPGVENLDLFTKMDLPKGQKRKVKDRLKPYLKDAYACDLLDKLLIL 303

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKR DSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGHMR H HH   G
Sbjct: 304 DPSKRCDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHMR-HPHHQVPG 362

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 363 GP--AKPSSSMA--DSGYQDRV 380

Source: Solenopsis invicta

Species: Solenopsis invicta

Genus: Solenopsis

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|332029713|gb|EGI69592.1| Cell division protein kinase 9 [Acromyrmex echinatior]

 Score =  545 bits (1403), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 273/322 (84%), Positives = 292/322 (90%), Gaps = 6/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRT+A QYNRYRSTFYL+FDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIKILQLLKHENVVNLIEICRTRATQYNRYRSTFYLIFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK G+LKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGVLKLADFGLARAFS-AK 183

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           NG  NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG+TEQQQ+
Sbjct: 184 NGHSNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGSTEQQQL 243

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSIT E WPGVE LDL+ KM+LPK QKRKVK+RLKPY+KD Y CDLLDKLL+L
Sbjct: 244 ILISQLCGSITTEVWPGVENLDLFTKMDLPKGQKRKVKDRLKPYLKDPYACDLLDKLLIL 303

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPSKR DSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGHMR H HH   G
Sbjct: 304 DPSKRCDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHMR-HPHHQVPG 362

Query: 306 APGAAGPAAGRATTETGYHDRV 327
            P  A P++  A  ++GY DRV
Sbjct: 363 GP--AKPSSSMA--DSGYQDRV 380

Source: Acromyrmex echinatior

Species: Acromyrmex echinatior

Genus: Acromyrmex

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|345479695|ref|XP_003424012.1| PREDICTED: cyclin-dependent kinase 9-like isoform 2 [Nasonia vitripennis]

 Score =  543 bits (1398), Expect = e-152,   Method: Compositional matrix adjust.
 Identities = 268/322 (83%), Positives = 291/322 (90%), Gaps = 6/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLK+EN+V+LIEICRTKANQ N+YRSTFYL+FDFCEHDLAGLLSN++
Sbjct: 49  FPITALREIRILQLLKNENIVNLIEICRTKANQNNKYRSTFYLIFDFCEHDLAGLLSNVN 108

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 109 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSANK 168

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             Q NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 169 KDQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 228

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           TLISQLCGSITP+ WPGV+ L+L+NKMEL + QKRKVK+RL+PYVKD Y CDLLDKLL+L
Sbjct: 229 TLISQLCGSITPDVWPGVDALELFNKMELIQGQKRKVKDRLRPYVKDPYACDLLDKLLIL 288

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPS+RFDSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGHMR    H H  
Sbjct: 289 DPSRRFDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHMR----HPHQV 344

Query: 306 APGAAGPAAGRATTETGYHDRV 327
             G A P++  A  +T Y DRV
Sbjct: 345 PGGQAKPSSSVA--DTSYQDRV 364

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|156544917|ref|XP_001601866.1| PREDICTED: cyclin-dependent kinase 9-like isoform 1 [Nasonia vitripennis]

 Score =  542 bits (1396), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 268/322 (83%), Positives = 291/322 (90%), Gaps = 6/322 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREI+ILQLLK+EN+V+LIEICRTKANQ N+YRSTFYL+FDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIRILQLLKNENIVNLIEICRTKANQNNKYRSTFYLIFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAFSANK 184

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             Q NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct: 185 KDQPNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQL 244

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           TLISQLCGSITP+ WPGV+ L+L+NKMEL + QKRKVK+RL+PYVKD Y CDLLDKLL+L
Sbjct: 245 TLISQLCGSITPDVWPGVDALELFNKMELIQGQKRKVKDRLRPYVKDPYACDLLDKLLIL 304

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAG 305
           DPS+RFDSD+ALNHDFFWTDPMP DLSKMLAQHTQSMFEYLAPPRRPGHMR    H H  
Sbjct: 305 DPSRRFDSDSALNHDFFWTDPMPCDLSKMLAQHTQSMFEYLAPPRRPGHMR----HPHQV 360

Query: 306 APGAAGPAAGRATTETGYHDRV 327
             G A P++  A  +T Y DRV
Sbjct: 361 PGGQAKPSSSVA--DTSYQDRV 380

Source: Nasonia vitripennis

Species: Nasonia vitripennis

Genus: Nasonia

Family: Pteromalidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

>gi|307202831|gb|EFN82091.1| Cell division protein kinase 9 [Harpegnathos saltator]

 Score =  540 bits (1391), Expect = e-151,   Method: Compositional matrix adjust.
 Identities = 272/323 (84%), Positives = 292/323 (90%), Gaps = 7/323 (2%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRT+A QYNR+RSTFYLVFDFCEHDLAGLLSN++
Sbjct: 65  FPITALREIKILQLLKHENVVNLIEICRTRATQYNRFRSTFYLVFDFCEHDLAGLLSNVN 124

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARA+S +K
Sbjct: 125 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKNGILKLADFGLARAYS-SK 183

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQ 184
           NG  NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR SPIMQGNTEQQQ
Sbjct: 184 NGHSNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRQSPIMQGNTEQQQ 243

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           + LISQLCGSIT + WPGVE+LDL+NKM+LPK QKRKVK+RLKPY+KD Y CDLLDKLL+
Sbjct: 244 LILISQLCGSITTDIWPGVESLDLFNKMDLPKGQKRKVKDRLKPYLKDPYACDLLDKLLI 303

Query: 245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHA 304
           LDP+KR DSD+ALNHDFFWTDPMP DLSKMLAQH+QSMFEYLAPPRRPGHMR   H HH 
Sbjct: 304 LDPNKRCDSDSALNHDFFWTDPMPCDLSKMLAQHSQSMFEYLAPPRRPGHMR---HPHHQ 360

Query: 305 GAPGAAGPAAGRATTETGYHDRV 327
              GA  P    A  E+GY DRV
Sbjct: 361 VPGGATKPTTTMA--ESGYQDRV 381

Source: Harpegnathos saltator

Species: Harpegnathos saltator

Genus: Harpegnathos

Family: Formicidae

Order: Hymenoptera

Class: Insecta

Phylum: Arthropoda

Superkingdom: Eukaryota

---

Prediction of Gene Ontology (GO) Terms

Close Homologs with Gene Ontology terms Detected by BLAST

Original result of BLAST against Gene Ontology (AMIGO)

ID	Length	Definition	Q cover	H cover	Identity	E-value
Query	433
FB|FBgn0019949	404	Cdk9 "Cyclin-dependent kinase	0.648	0.695	0.836	5.3e-127
UNIPROTKB|Q5ZKN1	372	CDK9 "Cyclin-dependent kinase	0.648	0.755	0.782	4.1e-120
ZFIN|ZDB-GENE-030131-321	393	cdk9 "cyclin-dependent kinase	0.648	0.715	0.783	8.5e-120
UNIPROTKB|P50750	372	CDK9 "Cyclin-dependent kinase	0.648	0.755	0.765	7.9e-117
UNIPROTKB|J9NWT0	489	CDK9 "Uncharacterized protein"	0.648	0.574	0.761	2.7e-116
UNIPROTKB|C9E1C9	372	CDK9 "Uncharacterized protein"	0.648	0.755	0.761	2.7e-116
MGI|MGI:1328368	372	Cdk9 "cyclin-dependent kinase	0.648	0.755	0.761	2.7e-116
RGD|1359638	372	Cdk9 "cyclin-dependent kinase	0.648	0.755	0.761	2.7e-116
UNIPROTKB|Q5EAB2	372	CDK9 "Cyclin-dependent kinase	0.648	0.755	0.761	3.4e-116
WB|WBGene00000410	478	cdk-9 [Caenorhabditis elegans	0.521	0.472	0.580	7.6e-72

FB|FBgn0019949 Cdk9 "Cyclin-dependent kinase 9" [Drosophila melanogaster (taxid:7227)]

 Score = 1247 (444.0 bits), Expect = 5.3e-127, P = 5.3e-127
 Identities = 235/281 (83%), Positives = 249/281 (88%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREI+ILQLLKHENVV+LIEICRTKA   N YRSTFYLVFDFCEHDLAGLLSN++
Sbjct:    91 FPITALREIRILQLLKHENVVNLIEICRTKATATNGYRSTFYLVFDFCEHDLAGLLSNMN 150

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKFSLGEIKKV+QQLLNGLYYIHSNKILHRDMKAANVLITK GILKLADFGLARAFS  K
Sbjct:   151 VKFSLGEIKKVMQQLLNGLYYIHSNKILHRDMKAANVLITKHGILKLADFGLARAFSIPK 210

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N   NRYTNRVVTLWYRPPELLLGDRNYGPPVD+WGAGCIMAEMWTRSPIMQGNTEQQQ+
Sbjct:   211 NESKNRYTNRVVTLWYRPPELLLGDRNYGPPVDMWGAGCIMAEMWTRSPIMQGNTEQQQL 270

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             T ISQLCGS TP+ WPGVE L+LY  +ELPK QKR+VKERL+PYVKDQ GC         
Sbjct:   271 TFISQLCGSFTPDVWPGVEELELYKSIELPKNQKRRVKERLRPYVKDQTGCDLLDKLLTL 330

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P KR D+D ALNHDFFWTDPMPSDLSKML+QH QSMFEYL
Sbjct:   331 DPKKRIDADTALNHDFFWTDPMPSDLSKMLSQHLQSMFEYL 371

GO:0006368 "transcription elongation from RNA polymerase II promoter" evidence=IDA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA;TAS

GO:0005634 "nucleus" evidence=IDA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=ISS;IDA

GO:0004674 "protein serine/threonine kinase activity" evidence=NAS

GO:0009408 "response to heat" evidence=IDA

GO:0006351 "transcription, DNA-dependent" evidence=IDA

GO:0005700 "polytene chromosome" evidence=IDA

GO:0005703 "polytene chromosome puff" evidence=IDA

GO:0008024 "positive transcription elongation factor complex b" evidence=TAS

GO:0006468 "protein phosphorylation" evidence=IEA;NAS

GO:0007155 "cell adhesion" evidence=IMP

GO:0008360 "regulation of cell shape" evidence=IMP

GO:0007049 "cell cycle" evidence=IMP

GO:0005524 "ATP binding" evidence=IEA

GO:0022008 "neurogenesis" evidence=IMP

GO:0032783 "ELL-EAF complex" evidence=IPI

UNIPROTKB|Q5ZKN1 CDK9 "Cyclin-dependent kinase 9" [Gallus gallus (taxid:9031)]

 Score = 1182 (421.1 bits), Expect = 4.1e-120, P = 4.1e-120
 Identities = 220/281 (78%), Positives = 240/281 (85%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN H
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNTH 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWG GCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGGGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             TLISQLCGSITPE WP V+  +LY K+ELPK QKRKVK+RLK YVKD Y           
Sbjct:   239 TLISQLCGSITPEVWPNVDKYELYQKLELPKGQKRKVKDRLKAYVKDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H QSMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKNMLSTHNQSMFEYL 339

GO:0005524 "ATP binding" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0006282 "regulation of DNA repair" evidence=IEA

GO:0016605 "PML body" evidence=IEA

GO:0017069 "snRNA binding" evidence=IEA

GO:0031056 "regulation of histone modification" evidence=IEA

GO:0043111 "replication fork arrest" evidence=IEA

GO:0044212 "transcription regulatory region DNA binding" evidence=IEA

GO:0071157 "negative regulation of cell cycle arrest" evidence=IEA

GO:0071345 "cellular response to cytokine stimulus" evidence=IEA

ZFIN|ZDB-GENE-030131-321 cdk9 "cyclin-dependent kinase 9 (CDC2-related kinase)" [Danio rerio (taxid:7955)]

 Score = 1179 (420.1 bits), Expect = 8.5e-120, P = 8.5e-120
 Identities = 221/282 (78%), Positives = 242/282 (85%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA Q+NRY+ + YLVFDFCEHDLAGLLSN +
Sbjct:    80 FPITALREIKILQLLKHENVVNLIEICRTKATQFNRYKGSIYLVFDFCEHDLAGLLSNAN 139

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   140 VKFTLAEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 199

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   200 NSQGNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 259

Query:   186 TLISQLCGSITPESWPGVET-LDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXX 244
             TLISQLCGSITPE WPGV+   +LY KMELPK QKRKVK+RLK YVKD Y          
Sbjct:   260 TLISQLCGSITPEVWPGVDKKYELYQKMELPKGQKRKVKDRLKAYVKDPYALDLIDKLLV 319

Query:   245 XXPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
               P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   320 LDPAQRIDSDDALNHDFFWSDPMPSDLKNMLSTHNTSMFEYL 361

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0000166 "nucleotide binding" evidence=IEA

UNIPROTKB|P50750 CDK9 "Cyclin-dependent kinase 9" [Homo sapiens (taxid:9606)]

 Score = 1151 (410.2 bits), Expect = 7.9e-117, P = 7.9e-117
 Identities = 215/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y           
Sbjct:   239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

GO:0005524 "ATP binding" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0017069 "snRNA binding" evidence=IEA

GO:0044212 "transcription regulatory region DNA binding" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IDA

GO:0071345 "cellular response to cytokine stimulus" evidence=IDA

GO:0031056 "regulation of histone modification" evidence=IDA

GO:0071157 "negative regulation of cell cycle arrest" evidence=IDA

GO:0043111 "replication fork arrest" evidence=IDA

GO:0006282 "regulation of DNA repair" evidence=IDA

GO:0016605 "PML body" evidence=IDA

GO:0008024 "positive transcription elongation factor complex b" evidence=IDA

GO:0004672 "protein kinase activity" evidence=TAS

GO:0008023 "transcription elongation factor complex" evidence=TAS

GO:0008283 "cell proliferation" evidence=TAS

GO:0003677 "DNA binding" evidence=IDA

GO:0006468 "protein phosphorylation" evidence=IDA

GO:0005654 "nucleoplasm" evidence=TAS

GO:0006351 "transcription, DNA-dependent" evidence=TAS

GO:0006366 "transcription from RNA polymerase II promoter" evidence=TAS

GO:0006367 "transcription initiation from RNA polymerase II promoter" evidence=TAS

GO:0006368 "transcription elongation from RNA polymerase II promoter" evidence=TAS

GO:0007179 "transforming growth factor beta receptor signaling pathway" evidence=TAS

GO:0010467 "gene expression" evidence=TAS

GO:0016032 "viral reproduction" evidence=TAS

GO:0045944 "positive regulation of transcription from RNA polymerase II promoter" evidence=TAS

GO:0050434 "positive regulation of viral transcription" evidence=TAS

GO:0007049 "cell cycle" evidence=TAS

GO:0005634 "nucleus" evidence=IDA

GO:0005730 "nucleolus" evidence=IDA

GO:0043231 "intracellular membrane-bounded organelle" evidence=IDA

UNIPROTKB|J9NWT0 CDK9 "Uncharacterized protein" [Canis lupus familiaris (taxid:9615)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 214/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:   176 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 235

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIKKV+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   236 VKFTLSEIKKVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 295

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   296 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 355

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +L+ K++L K QKRKVK+RLK YV+D Y           
Sbjct:   356 ALISQLCGSITPEVWPNVDKYELFEKLDLVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 415

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   416 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 456

GO:0005524 "ATP binding" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

UNIPROTKB|C9E1C9 CDK9 "Uncharacterized protein" [Sus scrofa (taxid:9823)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 214/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y           
Sbjct:   239 ALISQLCGSITPEVWPNVDKYELFEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

GO:0071345 "cellular response to cytokine stimulus" evidence=IEA

GO:0071157 "negative regulation of cell cycle arrest" evidence=IEA

GO:0044212 "transcription regulatory region DNA binding" evidence=IEA

GO:0043111 "replication fork arrest" evidence=IEA

GO:0031056 "regulation of histone modification" evidence=IEA

GO:0017069 "snRNA binding" evidence=IEA

GO:0016605 "PML body" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0006282 "regulation of DNA repair" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

MGI|MGI:1328368 Cdk9 "cyclin-dependent kinase 9 (CDC2-related kinase)" [Mus musculus (taxid:10090)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 214/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y           
Sbjct:   239 ALISQLCGSITPEVWPNVDKYELFEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

GO:0000166 "nucleotide binding" evidence=IEA

GO:0003677 "DNA binding" evidence=ISO

GO:0003682 "chromatin binding" evidence=IDA

GO:0004672 "protein kinase activity" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005515 "protein binding" evidence=IPI

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=IDA

GO:0005737 "cytoplasm" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0006282 "regulation of DNA repair" evidence=ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA;ISO

GO:0006974 "response to DNA damage stimulus" evidence=IEA

GO:0008024 "positive transcription elongation factor complex b" evidence=ISO;TAS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=ISO

GO:0016301 "kinase activity" evidence=IEA

GO:0016310 "phosphorylation" evidence=IEA

GO:0016605 "PML body" evidence=ISO

GO:0016740 "transferase activity" evidence=IEA

GO:0016772 "transferase activity, transferring phosphorus-containing groups" evidence=IEA

GO:0017069 "snRNA binding" evidence=IDA

GO:0031056 "regulation of histone modification" evidence=ISO

GO:0043111 "replication fork arrest" evidence=ISO

GO:0044212 "transcription regulatory region DNA binding" evidence=IDA

GO:0071157 "negative regulation of cell cycle arrest" evidence=ISO

GO:0071345 "cellular response to cytokine stimulus" evidence=ISO

RGD|1359638 Cdk9 "cyclin-dependent kinase 9" [Rattus norvegicus (taxid:10116)]

 Score = 1146 (408.5 bits), Expect = 2.7e-116, P = 2.7e-116
 Identities = 214/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y           
Sbjct:   239 ALISQLCGSITPEVWPNVDKYELFEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

GO:0003677 "DNA binding" evidence=ISO

GO:0003682 "chromatin binding" evidence=ISO

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0005634 "nucleus" evidence=ISO

GO:0005737 "cytoplasm" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0006282 "regulation of DNA repair" evidence=IEA;ISO

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=ISO

GO:0008024 "positive transcription elongation factor complex b" evidence=ISO;ISS

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA;ISO

GO:0016605 "PML body" evidence=IEA;ISO

GO:0017069 "snRNA binding" evidence=IEA;ISO

GO:0031056 "regulation of histone modification" evidence=IEA;ISO

GO:0043111 "replication fork arrest" evidence=IEA;ISO

GO:0043231 "intracellular membrane-bounded organelle" evidence=ISO

GO:0044212 "transcription regulatory region DNA binding" evidence=IEA;ISO

GO:0071157 "negative regulation of cell cycle arrest" evidence=IEA;ISO

GO:0071345 "cellular response to cytokine stimulus" evidence=IEA;ISO

GO:0005730 "nucleolus" evidence=ISO

UNIPROTKB|Q5EAB2 CDK9 "Cyclin-dependent kinase 9" [Bos taurus (taxid:9913)]

 Score = 1145 (408.1 bits), Expect = 3.4e-116, P = 3.4e-116
 Identities = 214/281 (76%), Positives = 238/281 (84%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct:    59 FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query:    66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct:   119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query:   126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct:   179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query:   186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
              LISQLCGSITPE WP V+  +L+ K+EL K QKRKVK+RLK YV+D Y           
Sbjct:   239 ALISQLCGSITPEVWPNVDKYELFEKVELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query:   246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
              P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct:   299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

GO:0008024 "positive transcription elongation factor complex b" evidence=ISS

GO:0016605 "PML body" evidence=IEA

GO:0005737 "cytoplasm" evidence=IEA

GO:0071345 "cellular response to cytokine stimulus" evidence=IEA

GO:0071157 "negative regulation of cell cycle arrest" evidence=IEA

GO:0044212 "transcription regulatory region DNA binding" evidence=IEA

GO:0043111 "replication fork arrest" evidence=IEA

GO:0031056 "regulation of histone modification" evidence=IEA

GO:0017069 "snRNA binding" evidence=IEA

GO:0006282 "regulation of DNA repair" evidence=IEA

GO:0008353 "RNA polymerase II carboxy-terminal domain kinase activity" evidence=IEA

GO:0004693 "cyclin-dependent protein serine/threonine kinase activity" evidence=IEA

GO:0006355 "regulation of transcription, DNA-dependent" evidence=IEA

GO:0006351 "transcription, DNA-dependent" evidence=IEA

GO:0006281 "DNA repair" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

WB|WBGene00000410 cdk-9 [Caenorhabditis elegans (taxid:6239)]

 Score = 686 (246.5 bits), Expect = 7.6e-72, Sum P(2) = 7.6e-72
 Identities = 137/236 (58%), Positives = 172/236 (72%)

Query:     6 FPITALREIKILQLLKHENVVHLIEICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSN 63
             FPITALRE+K+L+ LKH N+  LIE+C  K+     ++ R+TFYLV   C HDLAGLLSN
Sbjct:   125 FPITALREVKMLEQLKHPNITDLIEVCSAKSTGTTGSKDRATFYLVMALCAHDLAGLLSN 184

Query:    64 IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
               ++ SL  IK +++ L++GL  +H +KILHRDMKAANVLI+K GILKLADFGLAR F Q
Sbjct:   185 PKIRMSLVHIKTMMKHLMSGLNKLHRSKILHRDMKAANVLISKDGILKLADFGLARPFVQ 244

Query:   124 TKNGQVNR--YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
              +NG   R  YTNRVVTLWYRPPELLLGDR YG  +D+WGAGCIMAEMWTR PIMQG+TE
Sbjct:   245 RENGAGPRPLYTNRVVTLWYRPPELLLGDRQYGTKIDVWGAGCIMAEMWTRQPIMQGDTE 304

Query:   182 QQQITLISQLCGSITPESWPGVETLDLYNKME------LPKAQKRKVKERLKPYVK 231
             Q+Q+ LIS LCGSI  + WP    + L++ M       LP+ + R +  ++K  +K
Sbjct:   305 QKQLQLISGLCGSINKDVWPNCVNMPLWSAMSSEPNSALPQGKYRILPNKMKNLMK 360

GO:0004672 "protein kinase activity" evidence=IEA

GO:0005524 "ATP binding" evidence=IEA

GO:0006468 "protein phosphorylation" evidence=IEA

GO:0004674 "protein serine/threonine kinase activity" evidence=IEA

GO:0004713 "protein tyrosine kinase activity" evidence=IEA

GO:0009792 "embryo development ending in birth or egg hatching" evidence=IMP

GO:0040007 "growth" evidence=IMP

GO:0002119 "nematode larval development" evidence=IMP

GO:0040011 "locomotion" evidence=IMP

GO:0040010 "positive regulation of growth rate" evidence=IMP

GO:0006479 "protein methylation" evidence=IMP

---

Prediction of Enzyme Commission (EC) Number

EC Number Prediction by Annotation Transfer from SWISS-PROT Entries

Original result of BLAST against SWISS-PROT

ID	Name	Annotated EC number	Identity	Query coverage	Hit coverage	RBH(Q2H)	RBH(H2Q)
Q6GLD8	CDK9_XENTR	2, ., 7, ., 1, 1, ., 2, 3	0.7576	0.7228	0.8324	yes	N/A
Q7ZX42	CDK9B_XENLA	2, ., 7, ., 1, 1, ., 2, 3	0.7677	0.7066	0.8138	N/A	N/A
Q4V862	CDK9A_XENLA	2, ., 7, ., 1, 1, ., 2, 3	0.7645	0.7066	0.8138	N/A	N/A
P50750	CDK9_HUMAN	2, ., 7, ., 1, 1, ., 2, 3	0.7516	0.6859	0.7983	yes	N/A
Q641Z4	CDK9_RAT	2, ., 7, ., 1, 1, ., 2, 3	0.7483	0.6859	0.7983	yes	N/A
Q99J95	CDK9_MOUSE	2, ., 7, ., 1, 1, ., 2, 3	0.7483	0.6859	0.7983	yes	N/A
Q9TVL3	CDK9_CAEEL	2, ., 7, ., 1, 1, ., 2, 3	0.4812	0.7136	0.6464	yes	N/A
Q5ZKN1	CDK9_CHICK	2, ., 7, ., 1, 1, ., 2, 3	0.7577	0.7228	0.8413	yes	N/A
Q5EAB2	CDK9_BOVIN	2, ., 7, ., 1, 1, ., 2, 3	0.7483	0.6859	0.7983	yes	N/A

EC Number Prediction by EFICAz Software

Prediction Level	EC number	Confidence of Prediction
4th Layer	2.7.11.22	0.946
4th Layer	2.7.11.1	LOW CONFIDENCE prediction!
3rd Layer	2.7.11	0.963

---

Conserved Domains and Related Protein Families

Conserved Domains Detected by RPS-BLAST

Original result of RPS-BLAST against CDD database

ID	Length	Definition	E-value
Query	433
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	0.0
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	1e-130
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	1e-114
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-104
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	4e-90
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	6e-90
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	3e-84
cd07845	309	cd07845, STKc_CDK10, Catalytic domain of the Serin	7e-80
cd07832	286	cd07832, STKc_CCRK, Catalytic domain of the Serine	5e-78
cd05118	283	cd05118, STKc_CMGC, Catalytic domain of CMGC famil	1e-77
cd07835	283	cd07835, STKc_CDK1_like, Catalytic domain of Cycli	6e-73
cd07833	288	cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dep	7e-70
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	5e-69
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	2e-68
cd07834	330	cd07834, STKc_MAPK, Catalytic domain of the Serine	8e-67
smart00220	254	smart00220, S_TKc, Serine/Threonine protein kinase	2e-66
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	6e-66
cd07844	291	cd07844, STKc_PCTAIRE_like, Catalytic domain of PC	3e-65
cd07836	284	cd07836, STKc_Pho85, Catalytic domain of the Serin	8e-65
pfam00069	260	pfam00069, Pkinase, Protein kinase domain	2e-64
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-62
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	8e-62
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	8e-61
cd07871	288	cd07871, STKc_PCTAIRE3, Catalytic domain of the Se	2e-60
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	8e-60
cd07837	295	cd07837, STKc_CdkB_plant, Catalytic domain of the	1e-59
cd07830	283	cd07830, STKc_MAK_like, Catalytic domain of Male g	1e-58
cd07847	286	cd07847, STKc_CDKL1_4, Catalytic domain of the Ser	2e-58
cd07846	286	cd07846, STKc_CDKL2_3, Catalytic domain of the Ser	2e-58
cd07873	301	cd07873, STKc_PCTAIRE1, Catalytic domain of the Se	1e-56
cd07852	337	cd07852, STKc_MAPK15, Catalytic domain of the Seri	1e-55
cd07872	309	cd07872, STKc_PCTAIRE2, Catalytic domain of the Se	2e-54
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	1e-51
cd07870	291	cd07870, STKc_PFTAIRE2, Catalytic domain of the Se	1e-48
cd07863	288	cd07863, STKc_CDK4, Catalytic domain of the Serine	2e-48
cd07858	337	cd07858, STKc_TEY_MAPK_plant, Catalytic domain of	2e-48
cd07857	332	cd07857, STKc_MPK1, Catalytic domain of the Serine	3e-48
cd07849	336	cd07849, STKc_ERK1_2_like, Catalytic domain of Ext	9e-48
cd00180	215	cd00180, PKc, Catalytic domain of Protein Kinases	2e-47
cd07869	303	cd07869, STKc_PFTAIRE1, Catalytic domain of the Se	6e-47
cd07851	343	cd07851, STKc_p38, Catalytic domain of the Serine/	2e-46
cd07848	287	cd07848, STKc_CDKL5, Catalytic domain of the Serin	9e-46
cd07880	343	cd07880, STKc_p38gamma_MAPK12, Catalytic domain of	3e-45
cd07862	290	cd07862, STKc_CDK6, Catalytic domain of the Serine	3e-45
cd07879	342	cd07879, STKc_p38delta_MAPK13, Catalytic domain of	3e-42
cd07854	342	cd07854, STKc_MAPK4_6, Catalytic domain of the Ser	4e-42
cd07831	282	cd07831, STKc_MOK, Catalytic domain of the Serine/	5e-42
cd07856	328	cd07856, STKc_Sty1_Hog1, Catalytic domain of the S	4e-39
cd07853	372	cd07853, STKc_NLK, Catalytic domain of the Serine/	1e-36
cd07868	317	cd07868, STKc_CDK8, Catalytic domain of the Serine	2e-36
cd07867	317	cd07867, STKc_CDC2L6, Catalytic domain of Serine/T	3e-35
cd07878	343	cd07878, STKc_p38beta_MAPK11, Catalytic domain of	3e-35
cd08215	258	cd08215, STKc_Nek, Catalytic domain of the Protein	9e-35
cd07877	345	cd07877, STKc_p38alpha_MAPK14, Catalytic domain of	1e-34
cd06606	260	cd06606, STKc_MAPKKK, Catalytic domain of the Prot	1e-34
cd07859	338	cd07859, STKc_TDY_MAPK_plant, Catalytic domain of	4e-34
cd05579	265	cd05579, STKc_MAST_like, Catalytic domain of Micro	7e-33
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	2e-32
COG0515	384	COG0515, SPS1, Serine/threonine protein kinase [Ge	2e-31
cd05122	253	cd05122, PKc_STE, Catalytic domain of STE family P	2e-30
cd07850	353	cd07850, STKc_JNK, Catalytic domain of the Serine/	2e-29
cd05581	280	cd05581, STKc_PDK1, Catalytic domain of the Protei	2e-27
cd06627	254	cd06627, STKc_Cdc7_like, Catalytic domain of Cell	3e-27
cd08217	265	cd08217, STKc_Nek2, Catalytic domain of the Protei	9e-27
cd07874	355	cd07874, STKc_JNK3, Catalytic domain of the Serine	1e-26
cd06626	264	cd06626, STKc_MEKK4, Catalytic domain of the Prote	9e-26
cd06632	258	cd06632, STKc_MEKK1_plant, Catalytic domain of the	2e-25
cd07875	364	cd07875, STKc_JNK1, Catalytic domain of the Serine	2e-25
cd06614	286	cd06614, STKc_PAK, Catalytic domain of the Protein	2e-25
cd05123	250	cd05123, STKc_AGC, Catalytic domain of AGC family	3e-25
PTZ00036	440	PTZ00036, PTZ00036, glycogen synthase kinase; Prov	5e-25
smart00219	257	smart00219, TyrKc, Tyrosine kinase, catalytic doma	1e-23
smart00221	258	smart00221, STYKc, Protein kinase; unclassified sp	3e-23
cd00192	262	cd00192, PTKc, Catalytic domain of Protein Tyrosin	2e-22
cd06630	268	cd06630, STKc_MEKK1, Catalytic domain of the Prote	7e-22
cd06612	256	cd06612, STKc_MST1_2, Catalytic domain of the Prot	1e-21
cd06629	272	cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain o	6e-21
cd08218	256	cd08218, STKc_Nek1, Catalytic domain of the Protei	8e-21
cd06623	264	cd06623, PKc_MAPKK_plant_like, Catalytic domain of	2e-20
cd08224	267	cd08224, STKc_Nek6_Nek7, Catalytic domain of the P	3e-20
pfam07714	258	pfam07714, Pkinase_Tyr, Protein tyrosine kinase	3e-20
cd06624	268	cd06624, STKc_ASK, Catalytic domain of the Protein	2e-19
cd06611	280	cd06611, STKc_SLK_like, Catalytic domain of Ste20-	3e-19
cd06628	267	cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain o	5e-19
cd06917	277	cd06917, STKc_NAK1_like, Catalytic domain of Funga	9e-19
cd05578	258	cd05578, STKc_Yank1, Catalytic domain of the Prote	1e-18
cd07865	310	cd07865, STKc_CDK9, Catalytic domain of the Serine	2e-18
cd05580	290	cd05580, STKc_PKA, Catalytic domain of the Protein	2e-18
cd08221	256	cd08221, STKc_Nek9, Catalytic domain of the Protei	2e-18
cd05611	260	cd05611, STKc_Rim15_like, Catalytic domain of fung	4e-18
cd06657	292	cd06657, STKc_PAK4, Catalytic domain of the Protei	6e-18
PHA03212	391	PHA03212, PHA03212, serine/threonine kinase US3; P	9e-18
cd06625	263	cd06625, STKc_MEKK3_like, Catalytic domain of MAP/	3e-17
PHA03210	501	PHA03210, PHA03210, serine/threonine kinase US3; P	4e-17
cd06610	267	cd06610, STKc_OSR1_SPAK, Catalytic domain of the P	4e-17
cd08530	256	cd08530, STKc_CNK2-like, Catalytic domain of the P	4e-17
cd06643	282	cd06643, STKc_SLK, Catalytic domain of the Protein	5e-17
cd08225	257	cd08225, STKc_Nek5, Catalytic domain of the Protei	6e-17
cd06633	313	cd06633, STKc_TAO3, Catalytic domain of the Protei	7e-17
cd06607	307	cd06607, STKc_TAO, Catalytic domain of the Protein	8e-17
cd06648	285	cd06648, STKc_PAK_II, Catalytic domain of the Prot	9e-17
cd06609	274	cd06609, STKc_MST3_like, Catalytic domain of Mamma	2e-16
cd06613	262	cd06613, STKc_MAP4K3_like, Catalytic domain of Mit	3e-16
cd06631	265	cd06631, STKc_YSK4, Catalytic domain of the Protei	4e-16
cd05572	262	cd05572, STKc_cGK_PKG, Catalytic domain of the Pro	5e-16
cd06654	296	cd06654, STKc_PAK1, Catalytic domain of the Protei	6e-16
cd08529	256	cd08529, STKc_FA2-like, Catalytic domain of the Pr	6e-16
cd06658	292	cd06658, STKc_PAK5, Catalytic domain of the Protei	8e-16
cd06621	287	cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of	1e-15
cd08528	269	cd08528, STKc_Nek10, Catalytic domain of the Prote	2e-15
cd06655	296	cd06655, STKc_PAK2, Catalytic domain of the Protei	2e-15
cd06647	293	cd06647, STKc_PAK_I, Catalytic domain of the Prote	2e-15
cd06634	308	cd06634, STKc_TAO2, Catalytic domain of the Protei	3e-15
cd08219	255	cd08219, STKc_Nek3, Catalytic domain of the Protei	4e-15
cd06635	317	cd06635, STKc_TAO1, Catalytic domain of the Protei	4e-15
cd06656	297	cd06656, STKc_PAK3, Catalytic domain of the Protei	5e-15
cd06651	266	cd06651, STKc_MEKK3, Catalytic domain of the Prote	6e-15
cd05573	350	cd05573, STKc_ROCK_NDR_like, Catalytic domain of R	6e-15
cd06652	265	cd06652, STKc_MEKK2, Catalytic domain of the Prote	7e-15
cd05059	256	cd05059, PTKc_Tec_like, Catalytic domain of Tec-li	8e-15
cd08223	257	cd08223, STKc_Nek4, Catalytic domain of the Protei	2e-14
PHA03209	357	PHA03209, PHA03209, serine/threonine kinase US3; P	2e-14
cd06644	292	cd06644, STKc_STK10_LOK, Catalytic domain of the P	2e-14
cd05600	333	cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fun	2e-14
cd06645	267	cd06645, STKc_MAP4K3, Catalytic domain of the Prot	3e-14
cd06653	264	cd06653, STKc_MEKK3_like_1, Catalytic domain of MA	4e-14
cd08228	267	cd08228, STKc_Nek6, Catalytic domain of the Protei	5e-14
cd05038	284	cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domai	5e-14
PTZ00266	1021	PTZ00266, PTZ00266, NIMA-related protein kinase; P	6e-14
cd06659	297	cd06659, STKc_PAK6, Catalytic domain of the Protei	9e-14
cd08229	267	cd08229, STKc_Nek7, Catalytic domain of the Protei	1e-13
cd05586	330	cd05586, STKc_Sck1_like, Catalytic domain of Suppr	1e-13
cd08222	260	cd08222, STKc_Nek11, Catalytic domain of the Prote	1e-13
cd05040	257	cd05040, PTKc_Ack_like, Catalytic domain of the Pr	2e-13
cd05571	323	cd05571, STKc_PKB, Catalytic domain of the Protein	4e-13
cd05101	304	cd05101, PTKc_FGFR2, Catalytic domain of the Prote	4e-13
cd06640	277	cd06640, STKc_MST4, Catalytic domain of the Protei	4e-13
cd05084	252	cd05084, PTKc_Fes, Catalytic domain of the Protein	5e-13
cd05081	284	cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2)	7e-13
cd05601	330	cd05601, STKc_CRIK, Catalytic domain of the Protei	8e-13
cd06646	267	cd06646, STKc_MAP4K5, Catalytic domain of the Prot	9e-13
PLN00034	353	PLN00034, PLN00034, mitogen-activated protein kina	2e-12
cd05583	288	cd05583, STKc_MSK_N, N-terminal catalytic domain o	2e-12
cd06642	277	cd06642, STKc_STK25-YSK1, Catalytic domain of the	3e-12
cd06641	277	cd06641, STKc_MST3, Catalytic domain of the Protei	3e-12
cd05609	305	cd05609, STKc_MAST, Catalytic domain of the Protei	4e-12
cd05570	318	cd05570, STKc_PKC, Catalytic domain of the Protein	4e-12
cd05079	284	cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) doma	4e-12
cd05114	256	cd05114, PTKc_Tec_Rlk, Catalytic domain of the Pro	4e-12
cd05112	256	cd05112, PTKc_Itk, Catalytic domain of the Protein	5e-12
cd06636	282	cd06636, STKc_MAP4K4_6, Catalytic domain of the Pr	5e-12
cd05113	256	cd05113, PTKc_Btk_Bmx, Catalytic domain of the Pro	5e-12
cd05605	285	cd05605, STKc_GRK4_like, Catalytic domain of G pro	6e-12
cd05099	314	cd05099, PTKc_FGFR4, Catalytic domain of the Prote	7e-12
cd06608	275	cd06608, STKc_myosinIII_like, Catalytic domain of	7e-12
cd06637	272	cd06637, STKc_TNIK, Catalytic domain of the Protei	1e-11
cd05055	302	cd05055, PTKc_PDGFR, Catalytic domain of the Prote	1e-11
cd05593	328	cd05593, STKc_PKB_gamma, Catalytic domain of the P	1e-11
cd05080	283	cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) doma	1e-11
cd05098	307	cd05098, PTKc_FGFR1, Catalytic domain of the Prote	1e-11
PTZ00267	478	PTZ00267, PTZ00267, NIMA-related protein kinase; P	1e-11
cd05100	334	cd05100, PTKc_FGFR3, Catalytic domain of the Prote	2e-11
cd05596	370	cd05596, STKc_ROCK, Catalytic domain of the Protei	2e-11
cd06605	265	cd06605, PKc_MAPKK, Catalytic domain of the dual-s	2e-11
cd05574	316	cd05574, STKc_phototropin_like, Catalytic domain o	3e-11
cd05607	277	cd05607, STKc_GRK7, Catalytic domain of the Protei	4e-11
cd05034	261	cd05034, PTKc_Src_like, Catalytic domain of Src ki	4e-11
cd05072	261	cd05072, PTKc_Lyn, Catalytic domain of the Protein	5e-11
cd05116	257	cd05116, PTKc_Syk, Catalytic domain of the Protein	5e-11
cd05095	296	cd05095, PTKc_DDR2, Catalytic domain of the Protei	5e-11
cd05577	277	cd05577, STKc_GRK, Catalytic domain of the Protein	6e-11
cd05071	262	cd05071, PTKc_Src, Catalytic domain of the Protein	7e-11
cd05595	323	cd05595, STKc_PKB_beta, Catalytic domain of the Pr	9e-11
cd05060	257	cd05060, PTKc_Syk_like, Catalytic domain of Spleen	9e-11
cd05589	324	cd05589, STKc_PKN, Catalytic domain of the Protein	1e-10
cd05619	316	cd05619, STKc_nPKC_theta, Catalytic domain of the	1e-10
cd05585	312	cd05585, STKc_YPK1_like, Catalytic domain of Yeast	1e-10
cd05053	293	cd05053, PTKc_FGFR, Catalytic domain of the Protei	1e-10
cd05039	256	cd05039, PTKc_Csk_like, Catalytic domain of C-term	1e-10
cd05073	260	cd05073, PTKc_Hck, Catalytic domain of the Protein	2e-10
cd05592	316	cd05592, STKc_nPKC_theta_delta, Catalytic domain o	2e-10
PTZ00283	496	PTZ00283, PTZ00283, serine/threonine protein kinas	2e-10
cd05085	250	cd05085, PTKc_Fer, Catalytic domain of the Protein	2e-10
cd05582	318	cd05582, STKc_RSK_N, N-terminal catalytic domain o	2e-10
cd05093	288	cd05093, PTKc_TrkB, Catalytic domain of the Protei	2e-10
cd05613	290	cd05613, STKc_MSK1_N, N-terminal catalytic domain	3e-10
cd05069	260	cd05069, PTKc_Yes, Catalytic domain of the Protein	3e-10
cd05033	266	cd05033, PTKc_EphR, Catalytic domain of Ephrin Rec	3e-10
cd08220	256	cd08220, STKc_Nek8, Catalytic domain of the Protei	3e-10
cd06615	308	cd06615, PKc_MEK, Catalytic domain of the dual-spe	4e-10
cd05622	371	cd05622, STKc_ROCK1, Catalytic domain of the Prote	5e-10
cd05067	260	cd05067, PTKc_Lck_Blk, Catalytic domain of the Pro	9e-10
TIGR03903	1266	TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclas	1e-09
cd05620	316	cd05620, STKc_nPKC_delta, Catalytic domain of the	1e-09
cd06619	279	cd06619, PKc_MKK5, Catalytic domain of the dual-sp	1e-09
cd05070	260	cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Pro	1e-09
cd08216	314	cd08216, PK_STRAD, Pseudokinase domain of STE20-re	1e-09
cd05092	280	cd05092, PTKc_TrkA, Catalytic domain of the Protei	1e-09
cd05591	321	cd05591, STKc_nPKC_epsilon, Catalytic domain of th	2e-09
cd05045	290	cd05045, PTKc_RET, Catalytic domain of the Protein	2e-09
cd05612	291	cd05612, STKc_PRKX_like, Catalytic domain of PRKX-	2e-09
cd05632	285	cd05632, STKc_GRK5, Catalytic domain of the Protei	2e-09
cd05049	280	cd05049, PTKc_Trk, Catalytic domain of the Protein	2e-09
cd05068	261	cd05068, PTKc_Frk_like, Catalytic domain of Fyn-re	2e-09
cd05057	279	cd05057, PTKc_EGFR_like, Catalytic domain of Epide	2e-09
cd05621	370	cd05621, STKc_ROCK2, Catalytic domain of the Prote	2e-09
PHA03207	392	PHA03207, PHA03207, serine/threonine kinase US3; P	2e-09
cd05094	291	cd05094, PTKc_TrkC, Catalytic domain of the Protei	2e-09
cd05587	324	cd05587, STKc_cPKC, Catalytic domain of the Protei	3e-09
cd05052	263	cd05052, PTKc_Abl, Catalytic domain of the Protein	3e-09
cd06638	286	cd06638, STKc_myosinIIIA, Catalytic domain of the	3e-09
cd06639	291	cd06639, STKc_myosinIIIB, Catalytic domain of the	3e-09
cd05624	331	cd05624, STKc_MRCK_beta, Catalytic domain of the P	4e-09
cd05041	251	cd05041, PTKc_Fes_like, Catalytic domain of Fes-li	4e-09
cd05148	261	cd05148, PTKc_Srm_Brk, Catalytic domain of the Pro	5e-09
cd05046	275	cd05046, PTK_CCK4, Pseudokinase domain of the Prot	5e-09
cd05584	323	cd05584, STKc_p70S6K, Catalytic domain of the Prot	5e-09
cd05588	329	cd05588, STKc_aPKC, Catalytic domain of the Protei	6e-09
PHA03211	461	PHA03211, PHA03211, serine/threonine kinase US3; P	7e-09
cd05614	332	cd05614, STKc_MSK2_N, N-terminal catalytic domain	8e-09
cd05594	325	cd05594, STKc_PKB_alpha, Catalytic domain of the P	8e-09
cd05631	285	cd05631, STKc_GRK4, Catalytic domain of the Protei	9e-09
cd05097	295	cd05097, PTKc_DDR_like, Catalytic domain of Discoi	9e-09
cd05615	323	cd05615, STKc_cPKC_alpha, Catalytic domain of the	1e-08
cd05056	270	cd05056, PTKc_FAK, Catalytic domain of the Protein	1e-08
cd05633	279	cd05633, STKc_GRK3, Catalytic domain of the Protei	2e-08
cd05597	331	cd05597, STKc_DMPK_like, Catalytic domain of Myoto	2e-08
cd05082	256	cd05082, PTKc_Csk, Catalytic domain of the Protein	2e-08
cd05083	254	cd05083, PTKc_Chk, Catalytic domain of the Protein	3e-08
cd05103	343	cd05103, PTKc_VEGFR2, Catalytic domain of the Prot	3e-08
cd05630	285	cd05630, STKc_GRK6, Catalytic domain of the Protei	3e-08
cd05590	320	cd05590, STKc_nPKC_eta, Catalytic domain of the Pr	4e-08
cd05115	257	cd05115, PTKc_Zap-70, Catalytic domain of the Prot	5e-08
cd05050	288	cd05050, PTKc_Musk, Catalytic domain of the Protei	5e-08
cd05608	280	cd05608, STKc_GRK1, Catalytic domain of the Protei	6e-08
cd05606	278	cd05606, STKc_beta_ARK, Catalytic domain of the Pr	6e-08
cd05102	338	cd05102, PTKc_VEGFR3, Catalytic domain of the Prot	6e-08
cd07840	287	cd07840, STKc_CDK9_like, Catalytic domain of Cycli	2e-07
cd05616	323	cd05616, STKc_cPKC_beta, Catalytic domain of the P	2e-07
cd06650	333	cd06650, PKc_MEK1, Catalytic domain of the dual-sp	2e-07
cd05032	277	cd05032, PTKc_InsR_like, Catalytic domain of Insul	2e-07
cd05618	329	cd05618, STKc_aPKC_iota, Catalytic domain of the P	2e-07
cd06617	283	cd06617, PKc_MKK3_6, Catalytic domain of the dual-	3e-07
cd05048	283	cd05048, PTKc_Ror, Catalytic Domain of the Protein	3e-07
cd05623	332	cd05623, STKc_MRCK_alpha, Catalytic domain of the	3e-07
cd05075	272	cd05075, PTKc_Axl, Catalytic domain of the Protein	4e-07
cd05054	337	cd05054, PTKc_VEGFR, Catalytic domain of the Prote	5e-07
cd05066	267	cd05066, PTKc_EphR_A, Catalytic domain of the Prot	5e-07
PTZ00263	329	PTZ00263, PTZ00263, protein kinase A catalytic sub	5e-07
cd05062	277	cd05062, PTKc_IGF-1R, Catalytic domain of the Prot	6e-07
cd05042	269	cd05042, PTKc_Aatyk, Catalytic domain of the Prote	7e-07
cd05599	364	cd05599, STKc_NDR_like, Catalytic domain of Nuclea	7e-07
cd05051	296	cd05051, PTKc_DDR, Catalytic domain of the Protein	7e-07
cd05617	327	cd05617, STKc_aPKC_zeta, Catalytic domain of the P	7e-07
PHA03390	267	PHA03390, pk1, serine/threonine-protein kinase 1;	9e-07
cd08226	328	cd08226, PK_STRAD_beta, Pseudokinase domain of STE	1e-06
cd05106	374	cd05106, PTKc_CSF-1R, Catalytic domain of the Prot	1e-06
cd05044	269	cd05044, PTKc_c-ros, Catalytic domain of the Prote	1e-06
cd05105	400	cd05105, PTKc_PDGFR_alpha, Catalytic domain of the	1e-06
cd05088	303	cd05088, PTKc_Tie2, Catalytic domain of the Protei	2e-06
cd05036	277	cd05036, PTKc_ALK_LTK, Catalytic domain of the Pro	2e-06
cd06649	331	cd06649, PKc_MEK2, Catalytic domain of the dual-sp	2e-06
cd05058	262	cd05058, PTKc_Met_Ron, Catalytic domain of the Pro	3e-06
cd06620	284	cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of	3e-06
cd05107	401	cd05107, PTKc_PDGFR_beta, Catalytic domain of the	3e-06
cd05063	268	cd05063, PTKc_EphR_A2, Catalytic domain of the Pro	3e-06
PLN03224	507	PLN03224, PLN03224, probable serine/threonine prot	5e-06
cd05629	377	cd05629, STKc_NDR_like_fungal, Catalytic domain of	6e-06
cd05610	669	cd05610, STKc_MASTL, Catalytic domain of the Prote	7e-06
PTZ00426	340	PTZ00426, PTZ00426, cAMP-dependent protein kinase	7e-06
cd05035	273	cd05035, PTKc_Axl_like, Catalytic Domain of Axl-li	8e-06
cd05604	325	cd05604, STKc_SGK3, Catalytic domain of the Protei	8e-06
cd05089	297	cd05089, PTKc_Tie1, Catalytic domain of the Protei	9e-06
cd07866	311	cd07866, STKc_BUR1, Catalytic domain of the Serine	1e-05
cd05575	323	cd05575, STKc_SGK, Catalytic domain of the Protein	1e-05
cd07843	293	cd07843, STKc_CDC2L1, Catalytic domain of the Seri	2e-05
PTZ00024	335	PTZ00024, PTZ00024, cyclin-dependent protein kinas	2e-05
cd05104	375	cd05104, PTKc_Kit, Catalytic domain of the Protein	2e-05
cd05090	283	cd05090, PTKc_Ror1, Catalytic domain of the Protei	2e-05
cd05602	325	cd05602, STKc_SGK1, Catalytic domain of the Protei	2e-05
cd05065	269	cd05065, PTKc_EphR_B, Catalytic domain of the Prot	2e-05
cd05096	304	cd05096, PTKc_DDR1, Catalytic domain of the Protei	3e-05
PTZ00284	467	PTZ00284, PTZ00284, protein kinase; Provisional	3e-05
PRK13184	932	PRK13184, pknD, serine/threonine-protein kinase; R	3e-05
cd05086	268	cd05086, PTKc_Aatyk2, Catalytic domain of the Prot	4e-05
cd05047	270	cd05047, PTKc_Tie, Catalytic domain of Tie Protein	5e-05
cd07841	298	cd07841, STKc_CDK7, Catalytic domain of the Serine	7e-05
cd05061	288	cd05061, PTKc_InsR, Catalytic domain of the Protei	7e-05
cd06616	288	cd06616, PKc_MKK4, Catalytic domain of the dual-sp	1e-04
cd05598	376	cd05598, STKc_LATS, Catalytic domain of the Protei	1e-04
cd05108	316	cd05108, PTKc_EGFR, Catalytic domain of the Protei	1e-04
cd07829	282	cd07829, STKc_CDK_like, Catalytic domain of Cyclin	2e-04
cd05603	321	cd05603, STKc_SGK2, Catalytic domain of the Protei	2e-04
cd05087	269	cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of t	2e-04
cd05109	279	cd05109, PTKc_HER2, Catalytic domain of the Protei	2e-04
cd05110	303	cd05110, PTKc_HER4, Catalytic domain of the Protei	2e-04
cd08227	327	cd08227, PK_STRAD_alpha, Pseudokinase domain of ST	2e-04
cd05626	381	cd05626, STKc_LATS2, Catalytic domain of the Prote	2e-04
cd05625	382	cd05625, STKc_LATS1, Catalytic domain of the Prote	5e-04
cd06618	296	cd06618, PKc_MKK7, Catalytic domain of the dual-sp	6e-04
cd05074	273	cd05074, PTKc_Tyro3, Catalytic domain of the Prote	6e-04
cd07839	284	cd07839, STKc_CDK5, Catalytic domain of the Serine	7e-04
cd05111	279	cd05111, PTK_HER3, Pseudokinase domain of the Prot	7e-04
cd07860	284	cd07860, STKc_CDK2_3, Catalytic domain of the Seri	0.001
PLN00009	294	PLN00009, PLN00009, cyclin-dependent kinase A; Pro	0.001
PLN03225	566	PLN03225, PLN03225, Serine/threonine-protein kinas	0.001
cd05628	363	cd05628, STKc_NDR1, Catalytic domain of the Protei	0.001
cd07855	334	cd07855, STKc_ERK5, Catalytic domain of the Serine	0.002
cd07838	287	cd07838, STKc_CDK4_6_like, Catalytic domain of Cyc	0.003
cd07842	316	cd07842, STKc_CDK8_like, Catalytic domain of Cycli	0.003
cd07864	302	cd07864, STKc_CDK12, Catalytic domain of the Serin	0.004
cd07861	285	cd07861, STKc_CDK1_euk, Catalytic domain of the Se	0.004
cd07876	359	cd07876, STKc_JNK2, Catalytic domain of the Serine	0.004
cd05091	283	cd05091, PTKc_Ror2, Catalytic domain of the Protei	0.004
cd05627	360	cd05627, STKc_NDR2, Catalytic domain of the Protei	0.004

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score =  550 bits (1419), Expect = 0.0
 Identities = 211/257 (82%), Positives = 236/257 (91%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA  YNRY+ +FYLVF+FCEHDLAGLLSN +
Sbjct: 54  FPITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKN 113

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIKKV++ LLNGLYYIH NKILHRDMKAAN+LITK GILKLADFGLARAFS +K
Sbjct: 114 VKFTLSEIKKVMKMLLNGLYYIHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSK 173

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N + NRYTNRVVTLWYRPPELLLG+R+YGPP+D+WGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 174 NSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIMAEMWTRSPIMQGNTEQHQL 233

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           TLISQLCGSITPE WPGV+ L+L+ KMELP+ QKRKVKERLKPYVKD +  DL+DKLL+L
Sbjct: 234 TLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVL 293

Query: 246 DPSKRFDSDAALNHDFF 262
           DP+KR D+D ALNHDFF
Sbjct: 294 DPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score =  377 bits (971), Expect = e-130
 Identities = 132/257 (51%), Positives = 178/257 (69%), Gaps = 10/257 (3%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITA+REIK+LQ L+H N+V L EI  +K       + + Y+VF++ +HDL GLL +  
Sbjct: 41  FPITAIREIKLLQKLRHPNIVRLKEIVTSKG------KGSIYMVFEYMDHDLTGLLDSPE 94

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+  +IK  ++QLL GL Y+HSN ILHRD+K +N+LI   G+LKLADFGLAR +++  
Sbjct: 95  VKFTESQIKCYMKQLLEGLQYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRN 154

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           +     YTNRV+TLWYRPPELLLG   YGP VD+W  GCI+AE++   PI QG+TE +Q+
Sbjct: 155 SA---DYTNRVITLWYRPPELLLGATRYGPEVDMWSVGCILAELFLGKPIFQGSTELEQL 211

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I +LCGS T E+WPGV  L  +  ++  K  KR+++E  K ++ D    DLLDKLL L
Sbjct: 212 EKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFK-HLIDPSALDLLDKLLTL 270

Query: 246 DPSKRFDSDAALNHDFF 262
           DP KR  +D AL H++F
Sbjct: 271 DPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score =  337 bits (866), Expect = e-114
 Identities = 114/257 (44%), Positives = 153/257 (59%), Gaps = 15/257 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TALREI +L+ LKH N+V L+++  T+           YLVF++C+ DL   L    
Sbjct: 41  IPSTALREISLLKELKHPNIVKLLDVIHTE--------RKLYLVFEYCDMDLKKYLDKRP 92

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
              S   IK ++ QLL GL Y HS++ILHRD+K  N+LI + G+LKLADFGLARAF    
Sbjct: 93  GPLSPNLIKSIMYQLLRGLAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGI-- 150

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              +  YT+ VVTLWYR PE+LLG ++Y   VD+W  GCI AEM T  P+  G++E  Q+
Sbjct: 151 --PLRTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVGCIFAEMITGKPLFPGDSEIDQL 208

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I Q+ G+ T ESWPGV  L  Y     PK   + +++ L     D  G DLL K+L  
Sbjct: 209 FKIFQILGTPTEESWPGVTKLPDYKP-TFPKFPPKDLEKVLPRL--DPEGIDLLSKMLQY 265

Query: 246 DPSKRFDSDAALNHDFF 262
           +P+KR  +  AL H +F
Sbjct: 266 NPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score =  310 bits (796), Expect = e-104
 Identities = 130/264 (49%), Positives = 169/264 (64%), Gaps = 9/264 (3%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKIL+ LKH NVV LI++   + ++  R R + Y+V  + +HDL+GLL N  
Sbjct: 50  FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPS 109

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF---- 121
           VK +  +IK  + QLL G+ Y+H N ILHRD+KAAN+LI   GILK+ADFGLAR +    
Sbjct: 110 VKLTESQIKCYMLQLLEGINYLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPP 169

Query: 122 --SQTKNGQVNR-YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
              +   G   R YTN VVT WYRPPELLLG+R Y   VD+WG GC+ AEM+TR PI+QG
Sbjct: 170 PNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVDIWGIGCVFAEMFTRRPILQG 229

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
            ++  Q+ LI +LCG+ T E+WPG  +L     +       R ++ER      +  G DL
Sbjct: 230 KSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFGKLGPE--GLDL 287

Query: 239 LDKLLLLDPSKRFDSDAALNHDFF 262
           L KLL LDP KR  +  AL H +F
Sbjct: 288 LSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score =  275 bits (704), Expect = 4e-90
 Identities = 123/258 (47%), Positives = 165/258 (63%), Gaps = 7/258 (2%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTK--ANQYNRYRSTFYLVFDFCEHDLAGLLSN 63
           FPITA+REIKIL+ L H N+V+L EI   K  A  + + +  FYLVF++ +HDL GLL +
Sbjct: 49  FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLES 108

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
             V FS   IK  ++QLL GL Y H    LHRD+K +N+L+   G +KLADFGLAR ++ 
Sbjct: 109 GLVHFSEDHIKSFMKQLLEGLNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNS 168

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
               +   YTN+V+TLWYRPPELLLG+  YGP +D+W  GCI+ E++T+ PI Q N E  
Sbjct: 169 ---EESRPYTNKVITLWYRPPELLLGEERYGPAIDVWSCGCILGELFTKKPIFQANQELA 225

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           Q+ LIS+LCGS  P  WP V  L  +N M+  K  +R+++E            DLLD +L
Sbjct: 226 QLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFSFIPTP--ALDLLDHML 283

Query: 244 LLDPSKRFDSDAALNHDF 261
            LDPSKR  ++ ALN  +
Sbjct: 284 TLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score =  274 bits (702), Expect = 6e-90
 Identities = 101/258 (39%), Positives = 150/258 (58%), Gaps = 12/258 (4%)

Query: 6   FPITALREIKILQLLKHENVVHLIEIC-RTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
           FPIT+LREI IL  L+H N+V + E+   +  ++        Y+V ++ EHDL  L+  +
Sbjct: 47  FPITSLREINILLKLQHPNIVTVKEVVVGSNLDK-------IYMVMEYVEHDLKSLMETM 99

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              F   E+K ++ QLL+G+ ++H N ILHRD+K +N+L+   GILK+ DFGLAR +   
Sbjct: 100 KQPFLQSEVKCLMLQLLSGVAHLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYG-- 157

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               +  YT  VVTLWYR PELLLG + Y   +D+W  GCI AE+ T+ P+  G +E  Q
Sbjct: 158 --SPLKPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCIFAELLTKKPLFPGKSEIDQ 215

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I +L G+ T + WPG   L    K    K    +++++         G DLL++LL 
Sbjct: 216 LNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLT 275

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP+KR  ++ AL H +F
Sbjct: 276 YDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score =  259 bits (665), Expect = 3e-84
 Identities = 111/271 (40%), Positives = 157/271 (57%), Gaps = 18/271 (6%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           GI F  TALREIK+LQ LKH N++ L+++   K+N          LVF+F E DL  ++ 
Sbjct: 44  GINF--TALREIKLLQELKHPNIIGLLDVFGHKSN--------INLVFEFMETDLEKVIK 93

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           +  +  +  +IK  +   L GL Y+HSN ILHRD+K  N+LI   G+LKLADFGLAR+F 
Sbjct: 94  DKSIVLTPADIKSYMLMTLRGLEYLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFG 153

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                   + T++VVT WYR PELL G R+YG  VD+W  GCI AE+  R P + G+++ 
Sbjct: 154 SPNR----KMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCIFAELLLRVPFLPGDSDI 209

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
            Q+  I +  G+ T E+WPGV +L  Y + +        +K+            DLL +L
Sbjct: 210 DQLGKIFEALGTPTEENWPGVTSLPDYVEFK--PFPPTPLKQIFP--AASDDALDLLQRL 265

Query: 243 LLLDPSKRFDSDAALNHDFFWTDPMPSDLSK 273
           L L+P+KR  +  AL H +F  DP P+  S+
Sbjct: 266 LTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|173742 cd07845, STKc_CDK10, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

 Score =  248 bits (636), Expect = 7e-80
 Identities = 111/268 (41%), Positives = 155/268 (57%), Gaps = 12/268 (4%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           PI++LREI +L  L+H N+V L E+            S F LV ++CE DLA LL N+  
Sbjct: 50  PISSLREITLLLNLRHPNIVELKEVV-----VGKHLDSIF-LVMEYCEQDLASLLDNMPT 103

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            FS  ++K ++ QLL GL Y+H N I+HRD+K +N+L+T  G LK+ADFGLAR +     
Sbjct: 104 PFSESQVKCLMLQLLRGLQYLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLP-- 161

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                 T +VVTLWYR PELLLG   Y   +D+W  GCI+AE+    P++ G +E +Q+ 
Sbjct: 162 --AKPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCILAELLAHKPLLPGKSEIEQLD 219

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
           LI QL G+     WPG   L L  K  LPK     +K +  P++  + G  LL+ LL+ D
Sbjct: 220 LIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF-PWLS-EAGLRLLNFLLMYD 277

Query: 247 PSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           P KR  ++ AL   +F   P+P +   M
Sbjct: 278 PKKRATAEEALESSYFKEKPLPCEPEMM 305

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing increases the transcription of c-RAF and the activation of the p42/p44 MAPK pathway, which leads to antiestrogen resistance. Patients who express low levels of CDK10 relapse early on tamoxifen. Length = 309

>gnl|CDD|173736 cd07832, STKc_CCRK, Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

 Score =  243 bits (622), Expect = 5e-78
 Identities = 102/257 (39%), Positives = 148/257 (57%), Gaps = 13/257 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P  ALREIK LQ  +H  VV L+++          + S F LV ++   DL+ +L +  
Sbjct: 42  IPNQALREIKALQACQHPYVVKLLDV--------FPHGSGFVLVMEYMPSDLSEVLRDEE 93

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                 ++K  ++ LL G+ Y+H+N I+HRD+K AN+LI+  G+LK+ADFGLAR FS   
Sbjct: 94  RPLPEAQVKSYMRMLLKGVAYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFS--- 150

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
             +   Y+++V T WYR PELL G R Y P VDLW  GCI AE+   SP+  G  + +Q+
Sbjct: 151 EEEPRLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGCIFAELLNGSPLFPGENDIEQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            ++ +  G+   E+WPG+ +L  YNK+  P+  K    E + P    +   DLL  LL+ 
Sbjct: 211 AIVFRTLGTPNEETWPGLTSLPDYNKITFPE-SKPIPLEEIFPDASPE-ALDLLKGLLVY 268

Query: 246 DPSKRFDSDAALNHDFF 262
           DPSKR  +  AL H +F
Sbjct: 269 DPSKRLSAAEALRHPYF 285

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of heart failure. Length = 286

>gnl|CDD|143333 cd05118, STKc_CMGC, Catalytic domain of CMGC family Serine/Threonine Kinases

 Score =  242 bits (619), Expect = 1e-77
 Identities = 109/257 (42%), Positives = 146/257 (56%), Gaps = 14/257 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TALREIK+L+ L H N++ L+++ R K +         YLVF+F + DL  L+ +  
Sbjct: 41  IPKTALREIKLLKELNHPNIIKLLDVFRHKGD--------LYLVFEFMDTDLYKLIKDRQ 92

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  IK  + QLL GL + HS+ ILHRD+K  N+LI   G+LKLADFGLAR+F    
Sbjct: 93  RGLPESLIKSYLYQLLQGLAFCHSHGILHRDLKPENLLINTEGVLKLADFGLARSFG--- 149

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVT WYR PELLLGD+ Y  PVD+W  GCI AE+ +R P+  G +E  Q+
Sbjct: 150 -SPVRPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIFAELLSRRPLFPGKSEIDQL 208

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I +  G+  PE WP   +L    K   PK +      +L P    Q   DLL ++L  
Sbjct: 209 FKIFRTLGTPDPEVWPKFTSLARNYKFSFPK-KAGMPLPKLFPNASPQ-ALDLLSQMLHY 266

Query: 246 DPSKRFDSDAALNHDFF 262
           DP KR  ++ AL H +F
Sbjct: 267 DPHKRITAEQALAHPYF 283

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Length = 283

>gnl|CDD|173738 cd07835, STKc_CDK1_like, Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

 Score =  230 bits (588), Expect = 6e-73
 Identities = 109/258 (42%), Positives = 152/258 (58%), Gaps = 18/258 (6%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+REI +L+ L H N+V L+++  ++           YLVF+F + DL   + +   
Sbjct: 42  PSTAIREISLLKELNHPNIVRLLDVVHSENK--------LYLVFEFLDLDLKKYMDSSP- 92

Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              L    IK  + QLL G+ Y HS+++LHRD+K  N+LI + G LKLADFGLARAF   
Sbjct: 93  LTGLDPPLIKSYLYQLLQGIAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVP 152

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               V  YT+ VVTLWYR PE+LLG R Y  PVD+W  GCI AEM  R P+  G++E  Q
Sbjct: 153 ----VRTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIGCIFAEMVNRRPLFPGDSEIDQ 208

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I +  G+   + WPGV +L  Y K   PK  ++ + + +     D+ G DLL K+L+
Sbjct: 209 LFRIFRTLGTPDEDVWPGVTSLPDY-KPTFPKWARQDLSKVVPNL--DEDGLDLLSKMLV 265

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP+KR  + AAL H +F
Sbjct: 266 YDPAKRISAKAALQHPYF 283

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression while the CDK1/cyclin B complex is critical for G2 to M phase transition. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. Studies in knockout mice revealed that CDK1 can compensate for the loss of the cdk2 gene as it can also bind cyclin E and drive G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 283

>gnl|CDD|143338 cd07833, STKc_CDKL, Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

 Score =  222 bits (568), Expect = 7e-70
 Identities = 95/254 (37%), Positives = 136/254 (53%), Gaps = 11/254 (4%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           TALRE+K+L+ L+HEN+V+L E  R K     R     YLVF++ E  L  LL       
Sbjct: 46  TALREVKVLRQLRHENIVNLKEAFRRK----GRL----YLVFEYVERTLLELLEASPGGL 97

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               ++  I QLL  + Y HS+ I+HRD+K  N+L++++G+LKL DFG ARA        
Sbjct: 98  PPDAVRSYIWQLLQAIAYCHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA-- 155

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
            +  T+ V T WYR PELL+GD NYG PVD+W  GCIMAE+    P+  G+++  Q+ LI
Sbjct: 156 -SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIMAELLDGEPLFPGDSDIDQLYLI 214

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
            +  G + P       +   +  +  P+  + +  ER  P        D L   L +DP 
Sbjct: 215 QKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLERRYPGKVSSPALDFLKACLRMDPK 274

Query: 249 KRFDSDAALNHDFF 262
           +R   D  L H +F
Sbjct: 275 ERLTCDELLQHPYF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning and memory. Length = 288

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score =  219 bits (561), Expect = 5e-69
 Identities = 107/258 (41%), Positives = 155/258 (60%), Gaps = 17/258 (6%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+REI +L+ L+H N+V L ++      Q +R     YL+F+F   DL   L ++  
Sbjct: 43  PSTAIREISLLKELQHPNIVCLQDVLM----QESR----LYLIFEFLSMDLKKYLDSLPK 94

Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              +    +K  + Q+L G+ + HS ++LHRD+K  N+LI   G++KLADFGLARAF   
Sbjct: 95  GQYMDAELVKSYLYQILQGILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIP 154

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               V  YT+ VVTLWYR PE+LLG   Y  PVD+W  G I AEM T+ P+  G++E  Q
Sbjct: 155 ----VRVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIGTIFAEMATKKPLFHGDSEIDQ 210

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I ++ G+ T + WPGV +L  Y K   PK +K  ++  +K    D+ G DLL+K+L+
Sbjct: 211 LFRIFRILGTPTEDVWPGVTSLPDY-KNTFPKWKKGSLRSAVKNL--DEDGLDLLEKMLI 267

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP+KR  +  ALNH +F
Sbjct: 268 YDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score =  218 bits (558), Expect = 2e-68
 Identities = 98/261 (37%), Positives = 146/261 (55%), Gaps = 20/261 (7%)

Query: 7   PITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN 63
           P++ LREI +L+ L+   H N+V L+++C     + +R      LVF+  + DLA  LS 
Sbjct: 42  PLSTLREIALLKQLESFEHPNIVRLLDVCHGP--RTDRE-LKLTLVFEHVDQDLATYLSK 98

Query: 64  IHVKFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
              K  L    IK +++QLL G+ ++HS++I+HRD+K  N+L+T  G +K+ADFGLAR +
Sbjct: 99  -CPKPGLPPETIKDLMRQLLRGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIY 157

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T+ VVTLWYR PE+LL   +Y  PVD+W  GCI AE++ R P+ +G +E
Sbjct: 158 SFEM-----ALTSVVVTLWYRAPEVLLQS-SYATPVDMWSVGCIFAELFRRRPLFRGTSE 211

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
             Q+  I  + G  + E WP   +L    +   P    R  K  +      + G DLL K
Sbjct: 212 ADQLDKIFDVIGLPSEEEWPRNVSL---PRSSFPSYTPRSFKSFVPEI--CEEGLDLLKK 266

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
           +L  +P KR  +  AL H +F
Sbjct: 267 MLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173737 cd07834, STKc_MAPK, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

 Score =  215 bits (551), Expect = 8e-67
 Identities = 88/260 (33%), Positives = 139/260 (53%), Gaps = 20/260 (7%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL------LSN 63
            LREIK+L+ L+HEN++ L++I R        +    Y+V +  E DL  +      L++
Sbjct: 46  ILREIKLLRHLRHENIIGLLDILR--PPSPEDFN-DVYIVTELMETDLHKVIKSPQPLTD 102

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            H+++        + Q+L GL Y+HS  ++HRD+K +N+L+     LK+ DFGLAR    
Sbjct: 103 DHIQY-------FLYQILRGLKYLHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDP 155

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            ++ +    T  VVT WYR PELLL    Y   +D+W  GCI AE+ TR P+  G     
Sbjct: 156 DEDEKGF-LTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIFAELLTRKPLFPGRDYID 214

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           Q+ LI ++ G+ + E    + +    N ++ LPK  K+ + +       +    DLL+K+
Sbjct: 215 QLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLFPGASPE--AIDLLEKM 272

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L+ DP KR  +D AL H + 
Sbjct: 273 LVFDPKKRITADEALAHPYL 292

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPK kinase (MAP2K or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAP3K or MKKK). Each cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. There are three main typical MAPK subfamilies: Extracellular signal-Regulated Kinase (ERK), c-Jun N-terminal Kinase (JNK), and p38. Some MAPKs are atypical in that they are not regulated by MAP2Ks. These include MAPK4, MAPK6, NLK, and ERK7. Length = 330

>gnl|CDD|214567 smart00220, S_TKc, Serine/Threonine protein kinases, catalytic domain

 Score =  212 bits (542), Expect = 2e-66
 Identities = 84/258 (32%), Positives = 119/258 (46%), Gaps = 44/258 (17%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI 64
                LREIKIL+ LKH N+V L ++   +           YLV ++CE  DL  LL   
Sbjct: 40  DRERILREIKILKKLKHPNIVRLYDVFEDE--------DKLYLVMEYCEGGDLFDLLKK- 90

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
             + S  E +  ++Q+L+ L Y+HS  I+HRD+K  N+L+ + G +KLADFGLAR     
Sbjct: 91  RGRLSEDEARFYLRQILSALEYLHSKGIVHRDLKPENILLDEDGHVKLADFGLARQLDPG 150

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                 + T  V T  Y  PE+LLG   YG  VD+W  G I+ E+ T  P   G+ +  +
Sbjct: 151 -----EKLTTFVGTPEYMAPEVLLGKG-YGKAVDIWSLGVILYELLTGKPPFPGDDQLLE 204

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
              + +  G   P   P    +                              DL+ KLL+
Sbjct: 205 ---LFKKIGKPKPPFPPPEWDI-------------------------SPEAKDLIRKLLV 236

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP KR  ++ AL H FF
Sbjct: 237 KDPEKRLTAEEALQHPFF 254

Phosphotransferases. Serine or threonine-specific kinase subfamily. Length = 254

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score =  212 bits (541), Expect = 6e-66
 Identities = 108/257 (42%), Positives = 147/257 (57%), Gaps = 16/257 (6%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+REI +L+ L H N+V L+++  T+           YLVF+F   DL   +    +
Sbjct: 43  PSTAIREISLLKELNHPNIVKLLDVIHTENK--------LYLVFEFLHQDLKKFMDASPL 94

Query: 67  K-FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 95  SGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 153

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 154 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I +  G+     WPGV +L  Y K   PK  ++   + + P   D+ G DLL ++L  
Sbjct: 211 FRIFRTLGTPDEVVWPGVTSLPDY-KPSFPKWARQDFSKVVPPL--DEDGRDLLSQMLHY 267

Query: 246 DPSKRFDSDAALNHDFF 262
           DP+KR  + AAL H FF
Sbjct: 268 DPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|143349 cd07844, STKc_PCTAIRE_like, Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

 Score =  210 bits (537), Expect = 3e-65
 Identities = 98/257 (38%), Positives = 143/257 (55%), Gaps = 13/257 (5%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE  +L+ LKH N+V L +I  TK         T  LVF++ + DL   + +   
Sbjct: 47  PFTAIREASLLKDLKHANIVTLHDIIHTK--------KTLTLVFEYLDTDLKQYMDDCGG 98

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S+  ++  + QLL GL Y H  ++LHRD+K  N+LI++ G LKLADFGLARA    K+
Sbjct: 99  GLSMHNVRLFLFQLLRGLAYCHQRRVLHRDLKPQNLLISERGELKLADFGLARA----KS 154

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE-QQQI 185
                Y+N VVTLWYRPP++LLG   Y   +D+WG GCI  EM T  P+  G+T+ + Q+
Sbjct: 155 VPSKTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIFYEMATGRPLFPGSTDVEDQL 214

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I ++ G+ T E+WPGV +   +     P    R +        +  +G +L  K L  
Sbjct: 215 HKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY 274

Query: 246 DPSKRFDSDAALNHDFF 262
           +P KR  +  A+ H +F
Sbjct: 275 EPKKRISAAEAMKHPYF 291

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the membrane-associated cyclin Y. PCTAIRE-like proteins show unusual expression patterns with high levels in post-mitotic tissues, suggesting that they may be involved in regulating post-mitotic cellular events. Length = 291

>gnl|CDD|143341 cd07836, STKc_Pho85, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

 Score =  209 bits (533), Expect = 8e-65
 Identities = 103/259 (39%), Positives = 148/259 (57%), Gaps = 19/259 (7%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+REI +++ LKHEN+V L ++  T+        +   LVF++ + DL   + + H 
Sbjct: 42  PSTAIREISLMKELKHENIVRLHDVIHTE--------NKLMLVFEYMDKDLKKYM-DTHG 92

Query: 67  K---FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
                    +K    QLL G+ + H N++LHRD+K  N+LI K G LKLADFGLARAF  
Sbjct: 93  VRGALDPNTVKSFTYQLLKGIAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGI 152

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                VN ++N VVTLWYR P++LLG R Y   +D+W  GCIMAEM T  P+  G   + 
Sbjct: 153 P----VNTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVGCIMAEMITGRPLFPGTNNED 208

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           Q+  I ++ G+ T  +WPG+  L  Y     P+   + +++ L P+  D  G DLL +LL
Sbjct: 209 QLLKIFRIMGTPTESTWPGISQLPEYKP-TFPRYPPQDLQQ-LFPHA-DPLGIDLLHRLL 265

Query: 244 LLDPSKRFDSDAALNHDFF 262
            L+P  R  +  AL H +F
Sbjct: 266 QLNPELRISAHDALQHPWF 284

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment. It is not essential for yeast viability and is the functional homolog of mammalian CDK5, which plays a role in central nervous system development. Length = 284

>gnl|CDD|215690 pfam00069, Pkinase, Protein kinase domain

 Score =  207 bits (529), Expect = 2e-64
 Identities = 91/258 (35%), Positives = 123/258 (47%), Gaps = 39/258 (15%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI 64
              TA REI+IL+ L H N+V LI+    K +         YLV ++CE  DL   LS  
Sbjct: 41  KDQTARREIRILRRLSHPNIVRLIDAFEDKDH--------LYLVMEYCEGGDLFDYLSR- 91

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
               S  E KK+  Q+L GL Y+HSN I+HRD+K  N+L+ + G++K+ADFGLA+     
Sbjct: 92  GGPLSEDEAKKIALQILRGLEYLHSNGIIHRDLKPENILLDENGVVKIADFGLAKKL--L 149

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           K+      T  V T WY  PE+LLG   YGP VD+W  G I+ E+ T  P   G     Q
Sbjct: 150 KSSS--SLTTFVGTPWYMAPEVLLGGNGYGPKVDVWSLGVILYELLTGKPPFSGENILDQ 207

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           + LI ++ G       P                         K     +   DL+ K L 
Sbjct: 208 LQLIRRILGPPLEFDEP-------------------------KWSSGSEEAKDLIKKCLN 242

Query: 245 LDPSKRFDSDAALNHDFF 262
            DPSKR  ++  L H +F
Sbjct: 243 KDPSKRPTAEEILQHPWF 260

Length = 260

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score =  204 bits (522), Expect = 2e-62
 Identities = 100/286 (34%), Positives = 151/286 (52%), Gaps = 29/286 (10%)

Query: 1   MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFY--LVFDFCEHDLA 58
           M GI F  T LRE+KI+  +KHEN++ L+++          Y    +  LV D    DL 
Sbjct: 60  MCGIHF--TTLRELKIMNEIKHENIMGLVDV----------YVEGDFINLVMDIMASDLK 107

Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
            ++    ++ +  ++K ++ Q+LNGL  +H    +HRD+  AN+ I   GI K+ADFGLA
Sbjct: 108 KVVDR-KIRLTESQVKCILLQILNGLNVLHKWYFMHRDLSPANIFINSKGICKIADFGLA 166

Query: 119 RAF---------SQTKNGQVNR-YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
           R +         S+ +  Q     T++VVTLWYR PELL+G   Y   VD+W  GCI AE
Sbjct: 167 RRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAVDMWSVGCIFAE 226

Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP 228
           + T  P+  G  E  Q+  I +L G+   ++WP  + L LY   E    + + +K     
Sbjct: 227 LLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLY--TEFTPRKPKDLKTIFP- 283

Query: 229 YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
                   DLL  LL L+P +R  +  AL H++F +DP+P D S++
Sbjct: 284 -NASDDAIDLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQL 328

Length = 335

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score =  201 bits (513), Expect = 8e-62
 Identities = 101/257 (39%), Positives = 141/257 (54%), Gaps = 16/257 (6%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P +ALREI +L+ LKH+N+V L ++  +             LVF++C+ DL     + + 
Sbjct: 43  PSSALREICLLKELKHKNIVRLYDVLHSD--------KKLTLVFEYCDQDLKKYFDSCNG 94

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 +K  + QLL GL + HS+ +LHRD+K  N+LI K G LKLADFGLARAF     
Sbjct: 95  DIDPEIVKSFMFQLLKGLAFCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIP-- 152

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQI 185
             V  Y+  VVTLWYRPP++L G + Y   +D+W AGCI AE+     P+  GN    Q+
Sbjct: 153 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I +L G+ T ESWPGV  L  Y     P          + P + +  G DLL  LL+ 
Sbjct: 211 KRIFRLLGTPTEESWPGVSKLPDYK--PYPMYPATTSLVNVVPKL-NSTGRDLLQNLLVC 267

Query: 246 DPSKRFDSDAALNHDFF 262
           +P +R  ++ AL H +F
Sbjct: 268 NPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score =  199 bits (509), Expect = 8e-61
 Identities = 99/285 (34%), Positives = 152/285 (53%), Gaps = 41/285 (14%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL---- 61
              +A REI +L+ LKHENVV L+E+    A++      + YL+FD+ EHDL  ++    
Sbjct: 45  ISQSACREIALLRELKHENVVSLVEVFLEHADK------SVYLLFDYAEHDLWQIIKFHR 98

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGL 117
               V      +K ++ Q+LNG++Y+HSN +LHRD+K AN+L+     + G++K+ D GL
Sbjct: 99  QAKRVSIPPSMVKSLLWQILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGL 158

Query: 118 ARAFSQ------TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           AR F+         +  V       VT+WYR PELLLG R+Y   +D+W  GCI AE+ T
Sbjct: 159 ARLFNAPLKPLADLDPVV-------VTIWYRAPELLLGARHYTKAIDIWAIGCIFAELLT 211

Query: 172 RSPIMQGNTEQ---------QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV 222
             PI +G   +          Q+  I ++ G+ T + WP ++ +  Y+ +      K   
Sbjct: 212 LEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYP 271

Query: 223 KERLKPYVK-----DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
              L  +++     D  G DLL KLL  DP+KR  ++ AL H +F
Sbjct: 272 SNSLAKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|143376 cd07871, STKc_PCTAIRE3, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

 Score =  198 bits (504), Expect = 2e-60
 Identities = 106/256 (41%), Positives = 151/256 (58%), Gaps = 14/256 (5%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE+ +L+ LKH N+V L +I  T+            LVF++ + DL   L N   
Sbjct: 47  PCTAIREVSLLKNLKHANIVTLHDIIHTE--------RCLTLVFEYLDSDLKQYLDNCGN 98

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S+  +K  + QLL GL Y H  KILHRD+K  N+LI + G LKLADFGLARA    K+
Sbjct: 99  LMSMHNVKIFMFQLLRGLSYCHKRKILHRDLKPQNLLINEKGELKLADFGLARA----KS 154

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                Y+N VVTLWYRPP++LLG   Y  P+D+WG GCI+ EM T  P+  G+T ++++ 
Sbjct: 155 VPTKTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCILYEMATGRPMFPGSTVKEELH 214

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
           LI +L G+ T E+WPG+ + + +     P+ + + +     P + D  G DLL  LLL +
Sbjct: 215 LIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINHA-PRL-DTDGIDLLSSLLLYE 272

Query: 247 PSKRFDSDAALNHDFF 262
              R  ++AAL H +F
Sbjct: 273 TKSRISAEAALRHSYF 288

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filaments (PHFs) and stimulate Tau phosphorylation. As AD progresses, phosphorylated Tau aggregates and forms PHFs, which leads to the formation of neurofibrillary tangles (NFTs). In human glioma cells, PCTAIRE-3 induces cell cycle arrest and cell death. Length = 288

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score =  196 bits (500), Expect = 8e-60
 Identities = 107/258 (41%), Positives = 157/258 (60%), Gaps = 17/258 (6%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ ++H N+V L ++       ++  R   YLVF++ + DL   + S+  
Sbjct: 45  PSTAIREISLLKEMQHGNIVRLQDVV------HSEKR--LYLVFEYLDLDLKKHMDSSPD 96

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQT 124
              +   IK  + Q+L G+ Y HS+++LHRD+K  N+LI + T  LKLADFGLARAF   
Sbjct: 97  FAKNPRLIKTYLYQILRGIAYCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIP 156

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               V  +T+ VVTLWYR PE+LLG R+Y  PVD+W  GCI AEM  + P+  G++E  +
Sbjct: 157 ----VRTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGCIFAEMVNQKPLFPGDSEIDE 212

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I ++ G+   E+WPGV +L  Y K   PK   + +   + P + +  G DLL K+L 
Sbjct: 213 LFKIFRILGTPNEETWPGVTSLPDY-KSAFPKWPPKDL-ATVVPTL-EPAGVDLLSKMLR 269

Query: 245 LDPSKRFDSDAALNHDFF 262
           LDPSKR  + AAL H++F
Sbjct: 270 LDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|143342 cd07837, STKc_CdkB_plant, Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

 Score =  196 bits (499), Expect = 1e-59
 Identities = 101/262 (38%), Positives = 149/262 (56%), Gaps = 17/262 (6%)

Query: 7   PITALREIKILQLLKHEN-VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           P TALREI +LQ+L     +V L+++   +       + + YLVF++ + DL   + +  
Sbjct: 44  PPTALREISLLQMLSESIYIVRLLDVEHVEEKNG---KPSLYLVFEYLDSDLKKFMDSNG 100

Query: 66  VKFSLGEIKKVIQ----QLLNGLYYIHSNKILHRDMKAANVLITKT-GILKLADFGLARA 120
                    K I+    QLL G+ + H + ++HRD+K  N+L+ K  G+LK+AD GL RA
Sbjct: 101 RGPGRPLPAKTIKSFMYQLLKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRA 160

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
           FS      V  YT+ +VTLWYR PE+LLG  +Y  PVD+W  GCI AEM  + P+  G++
Sbjct: 161 FSIP----VKSYTHEIVTLWYRAPEVLLGSTHYSTPVDIWSVGCIFAEMSRKQPLFPGDS 216

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD 240
           E QQ+  I +L G+ T + WPGV    L +  E P+ + + +  R  P +    G DLL 
Sbjct: 217 ELQQLLHIFKLLGTPTEQVWPGV--SKLRDWHEFPQWKPQDLS-RAVPDL-SPEGLDLLQ 272

Query: 241 KLLLLDPSKRFDSDAALNHDFF 262
           K+L  DP+KR  + AAL H +F
Sbjct: 273 KMLRYDPAKRISAKAALTHPYF 294

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developmental pathways, such as stomata and leaf development. CdkB has been shown to associate with both cyclin B, which controls G2/M transition, and cyclin D, which acts as a mediator in linking extracellular signals to the cell cycle. Length = 295

>gnl|CDD|173734 cd07830, STKc_MAK_like, Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

 Score =  193 bits (492), Expect = 1e-58
 Identities = 89/258 (34%), Positives = 136/258 (52%), Gaps = 21/258 (8%)

Query: 9   TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIHV 66
             LRE+K L+ L  H N+V L E+ R             Y VF++ E +L  L+      
Sbjct: 43  MNLREVKSLRKLNEHPNIVKLKEVFR--------ENDELYFVFEYMEGNLYQLMKDRKGK 94

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            FS   I+ +I Q+L GL +IH +   HRD+K  N+L++   ++K+ADFGLAR   + ++
Sbjct: 95  PFSESVIRSIIYQILQGLAHIHKHGFFHRDLKPENLLVSGPEVVKIADFGLAR---EIRS 151

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                YT+ V T WYR PE+LL   +Y  PVD+W  GCIMAE++T  P+  G++E  Q+ 
Sbjct: 152 --RPPYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIMAELYTLRPLFPGSSEIDQLY 209

Query: 187 LISQLCGSITPESWPGVETLDLYNKME--LPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
            I  + G+ T + WP  E   L +K+    P+     + + +     +    DL+  +L 
Sbjct: 210 KICSVLGTPTKQDWP--EGYKLASKLGFRFPQFAPTSLHQLIPNASPE--AIDLIKDMLR 265

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP KR  +  AL H +F
Sbjct: 266 WDPKKRPTASQALQHPYF 283

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertility. It functions as a coactivator of the androgen receptor in prostate cells. MRK, also called Intestinal Cell Kinase (ICK), is expressed ubiquitously, with highest expression in the ovary and uterus. A missense mutation in MRK causes endocrine-cerebro-osteodysplasia (ECO), suggesting that this protein plays an important role in the development of many organs. MAK and MRK may be involved in regulating cell cycle and cell fate. Ime2p is a meiosis-specific kinase that is important during meiotic initiation and during the later stages of meiosis. Mde3 functions downstream of the transcription factor Mei-4 which is essential for meiotic prophase I. Length = 283

>gnl|CDD|173744 cd07847, STKc_CDKL1_4, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

 Score =  192 bits (490), Expect = 2e-58
 Identities = 92/253 (36%), Positives = 135/253 (53%), Gaps = 13/253 (5%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           ALREI++L+ LKH N+V+LIE+ R K           +LVF++C+H +   L        
Sbjct: 47  ALREIRMLKQLKHPNLVNLIEVFRRK--------RKLHLVFEYCDHTVLNELEKNPRGVP 98

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              IKK+I Q L  + + H +  +HRD+K  N+LITK G +KL DFG AR       G  
Sbjct: 99  EHLIKKIIWQTLQAVNFCHKHNCIHRDVKPENILITKQGQIKLCDFGFARIL----TGPG 154

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           + YT+ V T WYR PELL+GD  YGPPVD+W  GC+ AE+ T  P+  G ++  Q+ LI 
Sbjct: 155 DDYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVFAELLTGQPLWPGKSDVDQLYLIR 214

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
           +  G + P       T   +  + +P+ + R+  E   P +        L   L +DP++
Sbjct: 215 KTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFPNISSP-ALSFLKGCLQMDPTE 273

Query: 250 RFDSDAALNHDFF 262
           R   +  L H +F
Sbjct: 274 RLSCEELLEHPYF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The function of CDKL4 is unknown. Length = 286

>gnl|CDD|173743 cd07846, STKc_CDKL2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

 Score =  192 bits (490), Expect = 2e-58
 Identities = 90/253 (35%), Positives = 142/253 (56%), Gaps = 13/253 (5%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A+REI++L+ L+HEN+V+LIE+ R K           YLVF+F +H +   L        
Sbjct: 47  AMREIRMLKQLRHENLVNLIEVFRRKKR--------LYLVFEFVDHTVLDDLEKYPNGLD 98

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              ++K + Q+L G+ + HS+ I+HRD+K  N+L++++G++KL DFG AR    T     
Sbjct: 99  ESRVRKYLFQILRGIEFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFAR----TLAAPG 154

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
             YT+ V T WYR PELL+GD  YG  VD+W  GC++ EM T  P+  G+++  Q+  I 
Sbjct: 155 EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLVTEMLTGEPLFPGDSDIDQLYHII 214

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
           +  G++ P      +   L+  M LP+ ++ +  E+  P +      DL  + L +DP  
Sbjct: 215 KCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKRFPKL-SGLVLDLAKQCLRIDPDD 273

Query: 250 RFDSDAALNHDFF 262
           R  S   L+H+FF
Sbjct: 274 RPSSSQLLHHEFF 286

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKIAMRE (NKIATRE in rat), by translocation is associated with mild mental retardation. It has been reported that CDKL3 is lost in leukemic cells having a chromosome arm 5q deletion, and may contribute to the transformed phenotype. Length = 286

>gnl|CDD|143378 cd07873, STKc_PCTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

 Score =  188 bits (479), Expect = 1e-56
 Identities = 99/256 (38%), Positives = 147/256 (57%), Gaps = 14/256 (5%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE+ +L+ LKH N+V L +I  T+         +  LVF++ + DL   L +   
Sbjct: 48  PCTAIREVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDKDLKQYLDDCGN 99

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             ++  +K  + QLL GL Y H  K+LHRD+K  N+LI + G LKLADFGLARA    K+
Sbjct: 100 SINMHNVKLFLFQLLRGLNYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA----KS 155

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                Y+N VVTLWYRPP++LLG  +Y   +D+WG GCI  EM T  P+  G+T ++Q+ 
Sbjct: 156 IPTKTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMSTGRPLFPGSTVEEQLH 215

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            I ++ G+ T E+WPG+ + + +     PK +   +         D  G +LL KLL  +
Sbjct: 216 FIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHNHAPRL--DSDGAELLSKLLQFE 273

Query: 247 PSKRFDSDAALNHDFF 262
             KR  ++ A+ H +F
Sbjct: 274 GRKRISAEEAMKHPYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may play a role in regulating neurite outgrowth. It can also associate with Trap (Tudor repeat associator with PCTAIRE-2), a physiological partner of PCTAIRE-2; with p11, a small dimeric protein with similarity to S100; and with 14-3-3 proteins, mediators of phosphorylation-dependent interactions in many different proteins. Length = 301

>gnl|CDD|173747 cd07852, STKc_MAPK15, Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

 Score =  187 bits (476), Expect = 1e-55
 Identities = 90/262 (34%), Positives = 138/262 (52%), Gaps = 29/262 (11%)

Query: 12  REIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSNIH 65
           REI  LQ L  H N+V L+ + + + ++        YLVF++ E DL     A +L ++H
Sbjct: 55  REIMFLQELGDHPNIVKLLNVIKAENDK------DIYLVFEYMETDLHAVIRANILEDVH 108

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            ++       ++ QLL  L YIHS  ++HRD+K +N+L+     +KLADFGLAR+ S+ +
Sbjct: 109 KRY-------IMYQLLKALKYIHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELE 161

Query: 126 NGQVNR-YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               N   T+ V T WYR PE+LLG   Y   VD+W  GCI+ EM    P+  G +   Q
Sbjct: 162 ENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCILGEMLLGKPLFPGTSTLNQ 221

Query: 185 ITLISQLCGSITPESWPGVETL--DLYNKM--ELPKAQKRKVKERLKPYVKDQYGCDLLD 240
           +  I ++ G  + E    +E++       M   LP   ++ + E L     D    DLL 
Sbjct: 222 LEKIIEVIGPPSAED---IESIKSPFAATMLDSLPSRPRKPLDELLPKASDDA--LDLLK 276

Query: 241 KLLLLDPSKRFDSDAALNHDFF 262
           KLL+ +P+KR  ++ AL H + 
Sbjct: 277 KLLVFNPNKRLTAEEALEHPYV 298

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimuli whereas ERK8 shows low basal activity and is activated by DNA-damaging agents. ERK7 and ERK8 also have different substrate profiles. Genome analysis shows that they are orthologs with similar gene structures. ERK7 and ERK 8 may be involved in the signaling of some nuclear receptor transcription factors. ERK7 regulates hormone-dependent degradation of estrogen receptor alpha while ERK8 down-regulates the transcriptional co-activation androgen and glucocorticoid receptors. Length = 337

>gnl|CDD|143377 cd07872, STKc_PCTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

 Score =  182 bits (464), Expect = 2e-54
 Identities = 99/261 (37%), Positives = 146/261 (55%), Gaps = 24/261 (9%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE+ +L+ LKH N+V L +I  T          +  LVF++ + DL   + +   
Sbjct: 48  PCTAIREVSLLKDLKHANIVTLHDIVHTD--------KSLTLVFEYLDKDLKQYMDDCGN 99

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S+  +K  + Q+L GL Y H  K+LHRD+K  N+LI + G LKLADFGLARA    K+
Sbjct: 100 IMSMHNVKIFLYQILRGLAYCHRRKVLHRDLKPQNLLINERGELKLADFGLARA----KS 155

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                Y+N VVTLWYRPP++LLG   Y   +D+WG GCI  EM +  P+  G+T + ++ 
Sbjct: 156 VPTKTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIFFEMASGRPLFPGSTVEDELH 215

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK-----DQYGCDLLDK 241
           LI +L G+ T E+WPG+ + D +     PK +        +P +      D  G +LL K
Sbjct: 216 LIFRLLGTPTEETWPGISSNDEFKNYNFPKYKP-------QPLINHAPRLDTEGIELLTK 268

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
            L  +  KR  ++ A+ H +F
Sbjct: 269 FLQYESKKRISAEEAMKHAYF 289

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play a role in regulating mitochondrial function in neurons. Length = 309

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score =  176 bits (448), Expect = 1e-51
 Identities = 89/274 (32%), Positives = 132/274 (48%), Gaps = 23/274 (8%)

Query: 7   PITA---LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL--- 60
           P  A   LRE+KIL+  KH+N++ + +I R     +       Y+V D  E DL  +   
Sbjct: 45  PTLAKRTLRELKILRHFKHDNIIAIRDILRPPGADFK----DVYVVMDLMESDLHHIIHS 100

Query: 61  ---LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
              L+  H+++ L        QLL GL YIHS  ++HRD+K +N+L+ +   L++ DFG+
Sbjct: 101 DQPLTEEHIRYFLY-------QLLRGLKYIHSANVIHRDLKPSNLLVNEDCELRIGDFGM 153

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
           AR  S +        T  V T WYR PELLL    Y   +D+W  GCI AEM  R  +  
Sbjct: 154 ARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIFAEMLGRRQLFP 213

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGC 236
           G     Q+ LI  + GS + E    + +  +   ++ LP+ Q     + + P        
Sbjct: 214 GKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSK-IFPK-ASPEAL 271

Query: 237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 270
           DLL ++L  DP +R   + AL H F      P D
Sbjct: 272 DLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|143375 cd07870, STKc_PFTAIRE2, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

 Score =  167 bits (424), Expect = 1e-48
 Identities = 102/261 (39%), Positives = 141/261 (54%), Gaps = 21/261 (8%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE  +L+ LKH N+V L +I  TK         T   VF++   DLA  +     
Sbjct: 47  PFTAIREASLLKGLKHANIVLLHDIIHTK--------ETLTFVFEYMHTDLAQYMIQHPG 98

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 ++  + QLL GL YIH   ILHRD+K  N+LI+  G LKLADFGLARA    K+
Sbjct: 99  GLHPYNVRLFMFQLLRGLAYIHGQHILHRDLKPQNLLISYLGELKLADFGLARA----KS 154

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ-QQI 185
                Y++ VVTLWYRPP++LLG  +Y   +D+WGAGCI  EM    P   G ++  +Q+
Sbjct: 155 IPSQTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCIFIEMLQGQPAFPGVSDVFEQL 214

Query: 186 TLISQLCGSITPESWPGVETLDLYNK--MELPKAQK-RKVKERL-KPYVKDQYGCDLLDK 241
             I  + G  T ++WPGV  L  Y        K Q+ R V +RL +P   +    DL  +
Sbjct: 215 EKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAE----DLASQ 270

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
           +L++ P  R  +  AL H +F
Sbjct: 271 MLMMFPKDRISAQDALLHPYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recessive form of juvenile ALS. The function of PFTAIRE-2 is not yet known. Length = 291

>gnl|CDD|143368 cd07863, STKc_CDK4, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

 Score =  166 bits (422), Expect = 2e-48
 Identities = 95/261 (36%), Positives = 138/261 (52%), Gaps = 18/261 (6%)

Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            P++ +RE+ +L+ L+   H N+V L+++C   A       +   LVF+  + DL   L 
Sbjct: 42  LPLSTVREVALLKRLEAFDHPNIVRLMDVC---ATSRTDRETKVTLVFEHVDQDLRTYLD 98

Query: 63  NIHVK-FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            +         IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 99  KVPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIY 158

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T  VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+E
Sbjct: 159 SCQM-----ALTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 212

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
             Q+  I  L G    + WP   TL             R V + + P + ++ G  LL +
Sbjct: 213 ADQLGKIFDLIGLPPEDDWPRDVTLPRGA---FSPRGPRPV-QSVVPEI-EESGAQLLLE 267

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
           +L  +P KR  +  AL H FF
Sbjct: 268 MLTFNPHKRISAFRALQHPFF 288

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the nucleus. CDK4 also shows kinase activity towards Smad3, a signal transducer of transforming growth factor (TGF)-beta signaling which modulates transcription and plays a role in cell proliferation and apoptosis. CDK4 is inhibited by the p21 inhibitor and is specifically mutated in human melanoma. Length = 288

>gnl|CDD|143363 cd07858, STKc_TEY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

 Score =  167 bits (426), Expect = 2e-48
 Identities = 96/271 (35%), Positives = 135/271 (49%), Gaps = 47/271 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF---YLVFDFCEHDL------AGLL 61
           LREIK+L+ L HENV+ + +I           R  F   Y+V++  + DL      +  L
Sbjct: 52  LREIKLLRHLDHENVIAIKDIMPPPH------REAFNDVYIVYELMDTDLHQIIRSSQTL 105

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           S+ H ++ L        QLL GL YIHS  +LHRD+K +N+L+     LK+ DFGLAR  
Sbjct: 106 SDDHCQYFL-------YQLLRGLKYIHSANVLHRDLKPSNLLLNANCDLKICDFGLAR-- 156

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
             T + + +  T  VVT WYR PELLL    Y   +D+W  GCI AE+  R P+  G   
Sbjct: 157 --TTSEKGDFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFAELLGRKPLFPGKDY 214

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG------ 235
             Q+ LI++L GS      P  E L         KA +R ++  L    +  +       
Sbjct: 215 VHQLKLITELLGS------PSEEDLGFIRN---EKA-RRYIRS-LPYTPRQSFARLFPHA 263

Query: 236 ----CDLLDKLLLLDPSKRFDSDAALNHDFF 262
                DLL+K+L+ DPSKR   + AL H + 
Sbjct: 264 NPLAIDLLEKMLVFDPSKRITVEEALAHPYL 294

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. This subfamily represents the TEY subtype and is further subdivided into three groups (A, B, and C). Group A is represented by AtMPK3, AtMPK6, Nicotiana tabacum BTF4 (NtNTF4), among others. They are mostly involved in environmental and hormonal responses. AtMPK3 and AtMPK6 are also key regulators for stomatal development and patterning. Group B is represented by AtMPK4, AtMPK13, and NtNTF6, among others. They may be involved in both cell division and environmental stress response. AtMPK4 also participates in regulating innate immunity. Group C is represented by AtMPK1, AtMPK2, NtNTF3, Oryza sativa MAPK4 (OsMAPK4), among others. They may also be involved in stress responses. AtMPK1 and AtMPK2 are activated following mechanical injury and in the presence of stress chemicals such as jasmonic acid, hydrogen peroxide and abscisic acid. OsMAPK4 is also called OsMSRMK3 for Multiple Stress-Responsive MAPK3. Length = 337

>gnl|CDD|173750 cd07857, STKc_MPK1, Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

 Score =  167 bits (425), Expect = 3e-48
 Identities = 90/267 (33%), Positives = 134/267 (50%), Gaps = 23/267 (8%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL------LS 62
           ALRE+K+L+  + H+N+  L ++       +N      YL  +  E DL  +      L+
Sbjct: 48  ALRELKLLRHFRGHKNITCLYDMDIVFPGNFNE----LYLYEELMEADLHQIIRSGQPLT 103

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           + H +         I Q+L GL YIHS  +LHRD+K  N+L+     LK+ DFGLAR FS
Sbjct: 104 DAHFQS-------FIYQILCGLKYIHSANVLHRDLKPGNLLVNADCELKICDFGLARGFS 156

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +         T  V T WYR PE++L  ++Y   +D+W  GCI+AE+  R P+ +G    
Sbjct: 157 ENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCILAELLGRKPVFKGKDYV 216

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
            Q+  I Q+ G+   E+   + +    N +  LP   K+   E + P        DLL+K
Sbjct: 217 DQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPF-ESIFPNANPL-ALDLLEK 274

Query: 242 LLLLDPSKRFDSDAALNHDFF--WTDP 266
           LL  DP+KR   + AL H +   W DP
Sbjct: 275 LLAFDPTKRISVEEALEHPYLAIWHDP 301

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall construction, morphogenesis, and ion homeostasis. MPK1 is activated in response to cell wall stress including heat stimulation, osmotic shock, UV irradiation, and any agents that interfere with cell wall biogenesis such as chitin antagonists, caffeine, or zymolase. MPK1 is regulated by the MAP2Ks Mkk1/2, which are regulated by the MAP3K Bck1. Pmk1 is also activated by multiple stresses including elevated temperatures, hyper- or hypotonic stress, glucose deprivation, exposure to cell-wall damaging compounds, and oxidative stress. It is regulated by the MAP2K Pek1, which is regulated by the MAP3K Mkh1. Length = 332

>gnl|CDD|143354 cd07849, STKc_ERK1_2_like, Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

 Score =  166 bits (422), Expect = 9e-48
 Identities = 97/288 (33%), Positives = 143/288 (49%), Gaps = 23/288 (7%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL----- 60
           F    LREIKIL+  KHEN++ +++I R     +  +    Y+V +  E DL  L     
Sbjct: 46  FCQRTLREIKILRRFKHENIIGILDIIR--PPSFESFNDV-YIVQELMETDLYKLIKTQH 102

Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR- 119
           LSN H+++        + Q+L GL YIHS  +LHRD+K +N+L+     LK+ DFGLAR 
Sbjct: 103 LSNDHIQY-------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTNCDLKICDFGLARI 155

Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           A  +  +      T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  P+  G 
Sbjct: 156 ADPEHDHTGF--LTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCILAEMLSNRPLFPGK 213

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVK-ERLKPYVKDQYGCD 237
               Q+ LI  + G+ + E    + +L   N ++ LP   K KV   +L P    +   D
Sbjct: 214 DYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLP--FKPKVPWNKLFPNADPK-ALD 270

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEY 285
           LLDK+L  +P KR   + AL H +      PSD              +
Sbjct: 271 LLDKMLTFNPHKRITVEEALAHPYLEQYHDPSDEPVAEEPFPFDFELF 318

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase kinase from the Raf family. ERK1/2 have numerous substrates, many of which are nuclear and participate in transcriptional regulation of many cellular processes. They regulate cell growth, cell proliferation, and cell cycle progression from G1 to S phase. Although the distinct roles of ERK1 and ERK2 have not been fully determined, it is known that ERK2 can maintain most functions in the absence of ERK1, and that the deletion of ERK2 is embryonically lethal. The MAPK, Fus3, regulates yeast mating processes including mating-specific gene expression, G1 arrest, mating projection, and cell fusion. Length = 336

>gnl|CDD|173623 cd00180, PKc, Catalytic domain of Protein Kinases

 Score =  161 bits (410), Expect = 2e-47
 Identities = 61/162 (37%), Positives = 87/162 (53%), Gaps = 14/162 (8%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
            LREI+IL+ L H N+V L  +   +        +  YLV ++CE   L  LL     K 
Sbjct: 38  LLREIEILKKLNHPNIVKLYGVFEDE--------NHLYLVMEYCEGGSLKDLLKENEGKL 89

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNG 127
           S  EI +++ Q+L GL Y+HSN I+HRD+K  N+L+    G +KLADFGL++  +  K  
Sbjct: 90  SEDEILRILLQILEGLEYLHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDK-- 147

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             +     V T  Y  PE+LLG   Y    D+W  G I+ E+
Sbjct: 148 --SLLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVILYEL 187

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which one kinase activates a second kinase, which in turn, may act on other kinases; this sequential action transmits a signal from the cell surface to target proteins, which results in cellular responses. The PK family is one of the largest known protein families with more than 100 homologous yeast enzymes and 550 human proteins. A fraction of PK family members are pseudokinases that lack crucial residues for catalytic activity. The mutiplicity of kinases allows for specific regulation according to substrate, tissue distribution, and cellular localization. PKs regulate many cellular processes including proliferation, division, differentiation, motility, survival, metabolism, cell-cycle progression, cytoskeletal rearrangement, immunity, and neuronal functions. Many kinases are implicated in the development of various human diseases including different types of cancer. Length = 215

>gnl|CDD|143374 cd07869, STKc_PFTAIRE1, Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

 Score =  163 bits (413), Expect = 6e-47
 Identities = 98/257 (38%), Positives = 135/257 (52%), Gaps = 13/257 (5%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE  +L+ LKH N+V L +I  TK         T  LVF++   DL   +     
Sbjct: 47  PFTAIREASLLKGLKHANIVLLHDIIHTK--------ETLTLVFEYVHTDLCQYMDKHPG 98

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 +K  + QLL GL YIH   ILHRD+K  N+LI+ TG LKLADFGLARA    K+
Sbjct: 99  GLHPENVKLFLFQLLRGLSYIHQRYILHRDLKPQNLLISDTGELKLADFGLARA----KS 154

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE-QQQI 185
              + Y+N VVTLWYRPP++LLG   Y   +D+WG GCI  EM        G  + Q Q+
Sbjct: 155 VPSHTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIFVEMIQGVAAFPGMKDIQDQL 214

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I  + G+   ++WPGV +L  +          + +++         +  DL  KLL  
Sbjct: 215 ERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQC 274

Query: 246 DPSKRFDSDAALNHDFF 262
            P  R  + AAL+H++F
Sbjct: 275 FPKNRLSAQAALSHEYF 291

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 and is inhibited by the p21 cell cycle inhibitor. It has also been shown to interact with the membrane-associated cyclin Y, which recruits the protein to the plasma membrane. Length = 303

>gnl|CDD|143356 cd07851, STKc_p38, Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

 Score =  162 bits (413), Expect = 2e-46
 Identities = 86/252 (34%), Positives = 133/252 (52%), Gaps = 14/252 (5%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+++L+ + HENV+ L+++  T A+    ++   YLV      DL  ++     K S  
Sbjct: 63  RELRLLKHMDHENVIGLLDVF-TPASSLEDFQ-DVYLVTHLMGADLNNIVK--CQKLSDD 118

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
            I+ ++ Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR    T +     
Sbjct: 119 HIQFLVYQILRGLKYIHSAGIIHRDLKPSNIAVNEDCELKILDFGLAR---HTDD----E 171

Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL 191
            T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G+    Q+  I  L
Sbjct: 172 MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGKTLFPGSDHIDQLKRIMNL 231

Query: 192 CGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
            G+   E    + +    N ++ LP+  K+  KE       +    DLL+K+L+LDP KR
Sbjct: 232 VGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVFSGA--NPLAIDLLEKMLVLDPDKR 289

Query: 251 FDSDAALNHDFF 262
             +  AL H + 
Sbjct: 290 ITAAEALAHPYL 301

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. p38 substrates include other protein kinases and factors that regulate transcription, nuclear export, mRNA stability and translation. p38 kinases are drug targets for the inflammatory diseases psoriasis, rheumatoid arthritis, and chronic pulmonary disease. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta, which show varying substrate specificity and expression patterns. p38alpha and p38beta are ubiquitously expressed, p38gamma is predominantly found in skeletal muscle, and p38delta is found in the heart, lung, testis, pancreas, and small intestine. Length = 343

>gnl|CDD|173745 cd07848, STKc_CDKL5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

 Score =  159 bits (404), Expect = 9e-46
 Identities = 88/254 (34%), Positives = 131/254 (51%), Gaps = 12/254 (4%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           T LRE+K+L+ LK EN+V L E  R         R   YLVF++ E ++  LL  +    
Sbjct: 46  TTLRELKMLRTLKQENIVELKEAFRR--------RGKLYLVFEYVEKNMLELLEEMPNGV 97

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +++  I QL+  +++ H N I+HRD+K  N+LI+   +LKL DFG AR  S+  N  
Sbjct: 98  PPEKVRSYIYQLIKAIHWCHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSNAN 157

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
              YT  V T WYR PELLLG   YG  VD+W  GCI+ E+    P+  G +E  Q+  I
Sbjct: 158 ---YTEYVATRWYRSPELLLG-APYGKAVDMWSVGCILGELSDGQPLFPGESEIDQLFTI 213

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
            ++ G +  E      +   ++ +  P     +  ER    +      DL+  LL L+P+
Sbjct: 214 QKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLNPT 273

Query: 249 KRFDSDAALNHDFF 262
            R+ ++  LNH  F
Sbjct: 274 DRYLTEQCLNHPAF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes cause a phenotype similar to Rett syndrome (RTT), a progressive neurodevelopmental disorder. These pathogenic mutations are located in the N-terminal portion of the protein within the kinase domain. Length = 287

>gnl|CDD|143385 cd07880, STKc_p38gamma_MAPK12, Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

 Score =  160 bits (405), Expect = 3e-45
 Identities = 93/259 (35%), Positives = 145/259 (55%), Gaps = 14/259 (5%)

Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F   A RE+++L+ +KHENV+ L+++  T     +R+   FYLV  F   DL  L+   
Sbjct: 56  LFAKRAYRELRLLKHMKHENVIGLLDVF-TPDLSLDRF-HDFYLVMPFMGTDLGKLMK-- 111

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H K S   I+ ++ Q+L GL YIH+  I+HRD+K  N+ + +   LK+ DFGLAR   QT
Sbjct: 112 HEKLSEDRIQFLVYQMLKGLKYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLAR---QT 168

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
            +      T  VVT WYR PE++L   +Y   VD+W  GCIMAEM T  P+ +G+    Q
Sbjct: 169 DS----EMTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMAEMLTGKPLFKGHDHLDQ 224

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           +  I ++ G+ + E    +++ D  N ++ LP+ +K+  +  L P        ++L+K+L
Sbjct: 225 LMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSLL-PNANPL-AVNVLEKML 282

Query: 244 LLDPSKRFDSDAALNHDFF 262
           +LD   R  +  AL H +F
Sbjct: 283 VLDAESRITAAEALAHPYF 301

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12, is predominantly expressed in skeletal muscle. Unlike p38alpha and p38beta, p38gamma is insensitive to pyridinylimidazoles. It displays an antagonizing function compared to p38alpha. p38gamma inhibits, while p38alpha stimulates, c-Jun phosphorylation and AP-1 mediated transcription. p38gamma also plays a role in the signaling between Ras and the estrogen receptor and has been implicated to increase cell invasion and breast cancer progression. In Xenopus, p38gamma is critical in the meiotic maturation of oocytes. Length = 343

>gnl|CDD|143367 cd07862, STKc_CDK6, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

 Score =  158 bits (400), Expect = 3e-45
 Identities = 97/265 (36%), Positives = 151/265 (56%), Gaps = 28/265 (10%)

Query: 7   PITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN 63
           P++ +RE+ +L+ L+   H NVV L ++C    ++ +R  +   LVF+  + DL   L  
Sbjct: 45  PLSTIREVAVLRHLETFEHPNVVRLFDVC--TVSRTDR-ETKLTLVFEHVDQDLTTYLDK 101

Query: 64  IHVKFSLGE-IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           +       E IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +S
Sbjct: 102 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 161

Query: 123 -QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
            Q     V      VVTLWYR PE+LL   +Y  PVDLW  GCI AEM+ R P+ +G+++
Sbjct: 162 FQMALTSV------VVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 214

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPK----AQKRKVKERLKPYVKDQYGCD 237
             Q+  I  + G    E WP          + LP+    ++  +  E+    + D+ G D
Sbjct: 215 VDQLGKILDVIGLPGEEDWP--------RDVALPRQAFHSKSAQPIEKFVTDI-DELGKD 265

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFF 262
           LL K L  +P+KR  + +AL+H +F
Sbjct: 266 LLLKCLTFNPAKRISAYSALSHPYF 290

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytoplasm. It is also present in the ruffling edge of spreading fibroblasts and may play a role in cell spreading. It binds to the p21 inhibitor without any effect on its own activity and it is overexpressed in squamous cell carcinomas and neuroblastomas. CDK6 has also been shown to inhibit cell differentiation in many cell types. Length = 290

>gnl|CDD|143384 cd07879, STKc_p38delta_MAPK13, Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

 Score =  151 bits (383), Expect = 3e-42
 Identities = 94/276 (34%), Positives = 143/276 (51%), Gaps = 23/276 (8%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           F   A RE+ +L+ ++HENV+ L+++  T A   + ++  FYLV  + + DL  ++ +  
Sbjct: 57  FAKRAYRELTLLKHMQHENVIGLLDV-FTSAVSGDEFQD-FYLVMPYMQTDLQKIMGH-- 112

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
              S  +++ ++ Q+L GL YIHS  I+HRD+K  N+ + +   LK+ DFGLAR      
Sbjct: 113 -PLSEDKVQYLVYQMLCGLKYIHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADAEM 171

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G V       VT WYR PE++L   +Y   VD+W  GCIMAEM T   + +G     Q+
Sbjct: 172 TGYV-------VTRWYRAPEVILNWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 224

Query: 186 TLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           T I ++ G   PE    +E     + ++ LPK  ++     L P    Q   DLL+K+L 
Sbjct: 225 TQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFST-LFPKASPQ-AVDLLEKMLE 282

Query: 245 LDPSKRFDSDAALNHDFF--------WTDPMPSDLS 272
           LD  KR  +  AL H +F         T+  P D S
Sbjct: 283 LDVDKRLTATEALEHPYFDSFRDADEETEQQPYDDS 318

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13, is found in skeletal muscle, heart, lung, testis, pancreas, and small intestine. It regulates microtubule function by phosphorylating Tau. It activates the c-jun promoter and plays a role in G2 cell cycle arrest. It also controls the degration of c-Myb, which is associated with myeloid leukemia and poor prognosis in colorectal cancer. p38delta is the main isoform involved in regulating the differentiation and apoptosis of keratinocytes. Length = 342

>gnl|CDD|143359 cd07854, STKc_MAPK4_6, Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

 Score =  151 bits (383), Expect = 4e-42
 Identities = 92/275 (33%), Positives = 135/275 (49%), Gaps = 26/275 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRS------TFYLVFDFCEHDLA----- 58
           ALREIKI++ L H+N+V + E+     +             + Y+V ++ E DLA     
Sbjct: 49  ALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ 108

Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGL 117
           G LS  H +         + QLL GL YIHS  +LHRD+K ANV I T+  +LK+ DFGL
Sbjct: 109 GPLSEEHARL-------FMYQLLRGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGL 161

Query: 118 ARAFSQ--TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           AR      +  G +   +  +VT WYR P LLL   NY   +D+W AGCI AEM T  P+
Sbjct: 162 ARIVDPHYSHKGYL---SEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKPL 218

Query: 176 MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG 235
             G  E +Q+ LI +    +  E    +  +            +R +++ L P V  +  
Sbjct: 219 FAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL-PGVNPE-A 276

Query: 236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 270
            D L+++L  +P  R  ++ AL H +      P D
Sbjct: 277 LDFLEQILTFNPMDRLTAEEALMHPYMSCYSCPFD 311

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progression in certain conditions. It may also play a role in glucose-induced insulin secretion. MAPK6 and MAPK4 cooperate to regulate the activity of MAPK-activated protein kinase 5 (MK5), leading to its relocation to the cytoplasm and exclusion from the nucleus. The MAPK6/MK5 and MAPK4/MK5 pathways may play critical roles in embryonic and post-natal development. Length = 342

>gnl|CDD|173735 cd07831, STKc_MOK, Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

 Score =  149 bits (378), Expect = 5e-42
 Identities = 89/261 (34%), Positives = 122/261 (46%), Gaps = 26/261 (9%)

Query: 8   ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           +  LREI+ L+ L  H N++ LIE+       ++R      LVF+  + +L  L+     
Sbjct: 42  VNNLREIQALRRLSPHPNILRLIEVL------FDRKTGRLALVFELMDMNLYELIKGRKR 95

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 +K  + QLL  L ++H N I HRD+K  N+LI K  ILKLADFG  R       
Sbjct: 96  PLPEKRVKSYMYQLLKSLDHMHRNGIFHRDIKPENILI-KDDILKLADFGSCRGIYSKPP 154

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                YT  + T WYR PE LL D  YGP +D+W  GC+  E+ +  P+  G  E  QI 
Sbjct: 155 -----YTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFFEILSLFPLFPGTNELDQIA 209

Query: 187 LISQLCGSITPESWPGVETLDL---YNKMELPKAQKRKVK--ERLKPYVKDQYGCDLLDK 241
            I  + G+      P  E L        M       +K     +L P    + G DLL K
Sbjct: 210 KIHDVLGT------PDAEVLKKFRKSRHMNY-NFPSKKGTGLRKLLPNASAE-GLDLLKK 261

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
           LL  DP +R  +  AL H +F
Sbjct: 262 LLAYDPDERITAKQALRHPYF 282

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation. Length = 282

>gnl|CDD|143361 cd07856, STKc_Sty1_Hog1, Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

 Score =  143 bits (361), Expect = 4e-39
 Identities = 89/267 (33%), Positives = 135/267 (50%), Gaps = 33/267 (12%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+K+L+ L+HEN++ L +I       +       Y V +    DL  LL++  ++    
Sbjct: 58  RELKLLKHLRHENIISLSDI-------FISPLEDIYFVTELLGTDLHRLLTSRPLE---- 106

Query: 72  EIKKVIQ----QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
             K+ IQ    Q+L GL Y+HS  ++HRD+K +N+LI +   LK+ DFGLAR        
Sbjct: 107 --KQFIQYFLYQILRGLKYVHSAGVVHRDLKPSNILINENCDLKICDFGLARI------- 157

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           Q  + T  V T +YR PE++L  + Y   VD+W AGCI AEM    P+  G     Q ++
Sbjct: 158 QDPQMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIFAEMLEGKPLFPGKDHVNQFSI 217

Query: 188 ISQLCGSITPESWPGVETLDLYNKME----LPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           I+ L G+   +    + T+   N +     LPK +     E+ K    D    DLL+K+L
Sbjct: 218 ITDLLGTPPDDV---INTICSENTLRFVQSLPKREPVPFSEKFKN--ADPSAIDLLEKML 272

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSD 270
           + DP KR  +  AL H +      P+D
Sbjct: 273 VFDPQKRISAAEALAHPYLAPYHDPTD 299

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and UV radiation. Sty1 is regulated by the MAP2K Wis1, which is activated by the MAP3Ks Wis4 and Win1, which receive signals of the stress condition from membrane-spanning histidine kinases Mak1-3. Activated Sty1 stabilizes the Atf1 transcription factor and induces transcription of Atf1-dependent genes of the core environmetal stress response (CESR). Hog1 is the key element in the high osmolarity glycerol (HOG) pathway and is activated upon hyperosmotic stress. Activated Hog1 accumulates in the nucleus and regulates stress-induced transcription. The HOG pathway is mediated by two transmembrane osmosensors, Sln1 and Sho1. Length = 328

>gnl|CDD|173748 cd07853, STKc_NLK, Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

 Score =  137 bits (347), Expect = 1e-36
 Identities = 88/266 (33%), Positives = 131/266 (49%), Gaps = 39/266 (14%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL------LSN 63
             RE+K+L   KH+NV+  ++I +             Y+V +  + DL  +      LS+
Sbjct: 46  VFRELKMLCFFKHDNVLSALDILQPPHIDPFEE---IYVVTELMQSDLHKIIVSPQPLSS 102

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA--F 121
            HVK  L        Q+L GL Y+HS  ILHRD+K  N+L+    +LK+ DFGLAR    
Sbjct: 103 DHVKVFL-------YQILRGLKYLHSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEP 155

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
            ++K+      T  VVT +YR PE+L+G R+Y   VD+W  GCI AE+  R  + Q  + 
Sbjct: 156 DESKH-----MTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFAELLGRRILFQAQSP 210

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ--KRKVKERLKP---YVKDQY-- 234
            QQ+ LI+ L G+      P +E   + +  E  +A   +   K    P    +  Q   
Sbjct: 211 IQQLDLITDLLGT------PSLE--AMRSACEGARAHILRGPHKPPSLPVLYTLSSQATH 262

Query: 235 -GCDLLDKLLLLDPSKRFDSDAALNH 259
               LL ++L+ DP KR  +  AL H
Sbjct: 263 EAVHLLCRMLVFDPDKRISAADALAH 288

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription factors from the TCF/LEF family, inhibiting their ability to activate the transcription of target genes. In prostate cancer cells, NLK is involved in regulating androgen receptor-mediated transcription and its expression is altered during cancer progression. Length = 372

>gnl|CDD|143373 cd07868, STKc_CDK8, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

 Score =  135 bits (341), Expect = 2e-36
 Identities = 94/293 (32%), Positives = 145/293 (49%), Gaps = 46/293 (15%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL----- 57
           G    ++A REI +L+ LKH NV+ L ++  + A++        +L+FD+ EHDL     
Sbjct: 38  GTGISMSACREIALLRELKHPNVISLQKVFLSHADR------KVWLLFDYAEHDLWHIIK 91

Query: 58  ---AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGIL 110
              A   +   V+   G +K ++ Q+L+G++Y+H+N +LHRD+K AN+L+     + G +
Sbjct: 92  FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151

Query: 111 KLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW 170
           K+AD G AR F+       +     VVT WYR PELLLG R+Y   +D+W  GCI AE+ 
Sbjct: 152 KIADMGFARLFNSPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 171 TRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETL------------DLY 209
           T  PI     E           Q+  I  + G    + W  ++ +            + Y
Sbjct: 211 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 270

Query: 210 NKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
               L K  +   K ++KP   D     LL KLL +DP KR  S+ A+   +F
Sbjct: 271 TNCSLIKYME---KHKVKP---DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF 317

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDK8 phosphorylates cyclin H, a subunit of the general transcription factor TFIIH, which results in the inhibition of TFIIH-dependent phosphorylation of the C-terminal domain (CTD) of RNAP II, facilitating the inhibition of transcription. It has also been shown to promote transcription by a mechanism that is likely to involve RNAP II phosphorylation. CDK8 also functions as a stimulus-specific positive coregulator of p53 transcriptional responses. Length = 317

>gnl|CDD|143372 cd07867, STKc_CDC2L6, Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

 Score =  132 bits (333), Expect = 3e-35
 Identities = 91/294 (30%), Positives = 145/294 (49%), Gaps = 48/294 (16%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL----- 57
           G    ++A REI +L+ LKH NV+ L ++  + +++        +L+FD+ EHDL     
Sbjct: 38  GTGISMSACREIALLRELKHPNVIALQKVFLSHSDR------KVWLLFDYAEHDLWHIIK 91

Query: 58  ---AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGIL 110
              A   +   ++     +K ++ Q+L+G++Y+H+N +LHRD+K AN+L+     + G +
Sbjct: 92  FHRASKANKKPMQLPRSMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 151

Query: 111 KLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW 170
           K+AD G AR F+       +     VVT WYR PELLLG R+Y   +D+W  GCI AE+ 
Sbjct: 152 KIADMGFARLFNSPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 210

Query: 171 TRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKME-------- 213
           T  PI     E           Q+  I  + G    + W  +  +  Y  ++        
Sbjct: 211 TSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTY 270

Query: 214 -----LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                +   +K KVK   K ++       LL KLL +DP+KR  S+ AL   +F
Sbjct: 271 ANSSLIKYMEKHKVKPDSKVFL-------LLQKLLTMDPTKRITSEQALQDPYF 317

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as the caspase-processed CDK11(p46). CDK11(p110), CDK11(p58), and CDK11(p46)do not belong to this subfamily. CDC2L6 is an associated protein of Mediator, a multiprotein complex that provides a platform to connect transcriptional and chromatin regulators and cofactors, in order to activate and mediate RNA polymerase II transcription. CDC2L6 is localized mainly in the nucleus amd exerts an opposing effect to CDK8 in VP16-dependent transcriptional activation by being a negative regulator. Length = 317

>gnl|CDD|143383 cd07878, STKc_p38beta_MAPK11, Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

 Score =  133 bits (335), Expect = 3e-35
 Identities = 90/263 (34%), Positives = 141/263 (53%), Gaps = 26/263 (9%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     + +  YLV +    DL  +     LS+ HV
Sbjct: 63  RELRLLKHMKHENVIGLLDVF-TPATSIENF-NEVYLVTNLMGADLNNIVKCQKLSDEHV 120

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I QLL GL YIHS  I+HRD+K +NV + +   L++ DFGLAR   Q  +
Sbjct: 121 QF-------LIYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLAR---QADD 170

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                 T  V T WYR PE++L   +Y   VD+W  GCIMAE+     +  GN    Q+ 
Sbjct: 171 ----EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLKGKALFPGNDYIDQLK 226

Query: 187 LISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            I ++ G+ +PE    + +      ++ LP   ++ +K+  +    +    DLL+K+L+L
Sbjct: 227 RIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIFRG--ANPLAIDLLEKMLVL 284

Query: 246 DPSKRFDSDAALNHDFF--WTDP 266
           D  KR  +  AL H +F  + DP
Sbjct: 285 DSDKRISASEALAHPYFSQYHDP 307

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is widely expressed in tissues and shows more similarity with p38alpha than with the other isoforms. Both are sensitive to pyridinylimidazoles and share some common substrates such as MAPK activated protein kinase 2 (MK2) and the transcription factors ATF2, c-Fos and, ELK-1. p38beta is involved in regulating the activation of the cyclooxygenase-2 promoter and the expression of TGFbeta-induced alpha-smooth muscle cell actin. Length = 343

>gnl|CDD|173755 cd08215, STKc_Nek, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

 Score =  129 bits (327), Expect = 9e-35
 Identities = 66/258 (25%), Positives = 102/258 (39%), Gaps = 50/258 (19%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IH 65
           AL E+KIL+ L H N++   E    +            +V ++ +  DL+  +       
Sbjct: 46  ALNEVKILKKLNHPNIIKYYE--SFEEKGK------LCIVMEYADGGDLSQKIKKQKKEG 97

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             F   +I     QL   L Y+HS KILHRD+K  N+ +T  G++KL DFG+++  S T 
Sbjct: 98  KPFPEEQILDWFVQLCLALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV 157

Query: 126 NGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           +         VV T +Y  PEL      Y    D+W  GC++ E+ T     +G    + 
Sbjct: 158 D-----LAKTVVGTPYYLSPELCQNKP-YNYKSDIWSLGCVLYELCTLKHPFEGENLLEL 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
              I +  G   P                +P     +    L+         +L+  LL 
Sbjct: 212 ALKILK--GQYPP----------------IP----SQYSSELR---------NLVSSLLQ 240

Query: 245 LDPSKRFDSDAALNHDFF 262
            DP +R      L   F 
Sbjct: 241 KDPEERPSIAQILQSPFI 258

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Length = 258

>gnl|CDD|143382 cd07877, STKc_p38alpha_MAPK14, Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

 Score =  131 bits (331), Expect = 1e-34
 Identities = 88/263 (33%), Positives = 132/263 (50%), Gaps = 26/263 (9%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 65  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 122

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 123 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMT 175

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 176 GYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 228

Query: 187 LISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           LI +L G+   E    + +    N ++ L +  K            +    DLL+K+L+L
Sbjct: 229 LILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVL 286

Query: 246 DPSKRFDSDAALNHDFF--WTDP 266
           D  KR  +  AL H +F  + DP
Sbjct: 287 DSDKRITAAQALAHAYFAQYHDP 309

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14, is expressed in most tissues and is the major isoform involved in the immune and inflammatory response. It is the central p38 MAPK involved in myogenesis. It plays a role in regulating cell cycle check-point transition and promoting cell differentiation. p38alpha also regulates cell proliferation and death through crosstalk with the JNK pathway. Its substrates include MAPK activated protein kinase 2 (MK2), MK5, and the transcription factors ATF2 and Mitf. Length = 345

>gnl|CDD|173724 cd06606, STKc_MAPKKK, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

 Score =  129 bits (326), Expect = 1e-34
 Identities = 75/254 (29%), Positives = 106/254 (41%), Gaps = 42/254 (16%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
            REI+IL  L+H N+V      R +            +  ++     L+ LL     K  
Sbjct: 47  EREIRILSSLQHPNIVRYYGSERDEEKNT------LNIFLEYVSGGSLSSLLKKFG-KLP 99

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I+K  +Q+L GL Y+HSN I+HRD+K AN+L+   G++KLADFG A+   +  + + 
Sbjct: 100 EPVIRKYTRQILEGLAYLHSNGIVHRDIKGANILVDSDGVVKLADFGCAK---RLGDIET 156

Query: 130 NRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
              T  V  T ++  PE++ G+  YG   D+W  GC + EM T  P            L 
Sbjct: 157 GEGTGSVRGTPYWMAPEVIRGE-EYGRAADIWSLGCTVIEMATGKPP-WSELGNPMAALY 214

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
                   P               E+P        E L    K     D L K L  DP 
Sbjct: 215 KIGSSGEPP---------------EIP--------EHLSEEAK-----DFLRKCLRRDPK 246

Query: 249 KRFDSDAALNHDFF 262
           KR  +D  L H F 
Sbjct: 247 KRPTADELLQHPFL 260

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKKK5) and ASK2 (or MAPKKK6), MEKK1, MEKK2, MEKK3, MEKK4, as well as plant and fungal MAPKKKs. Also included in this subfamily are the cell division control proteins Schizosaccharomyces pombe Cdc7 and Saccharomyces cerevisiae Cdc15. Length = 260

>gnl|CDD|143364 cd07859, STKc_TDY_MAPK_plant, Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

 Score =  129 bits (327), Expect = 4e-34
 Identities = 93/269 (34%), Positives = 127/269 (47%), Gaps = 39/269 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL------LSNI 64
           LREIK+L+LL+H ++V   EI         R     Y+VF+  E DL  +      L+  
Sbjct: 47  LREIKLLRLLRHPDIV---EIKHIMLPPSRREFKDIYVVFELMESDLHQVIKANDDLTPE 103

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR-AFSQ 123
           H +F L        QLL  L YIH+  + HRD+K  N+L      LK+ DFGLAR AF+ 
Sbjct: 104 HHQFFL-------YQLLRALKYIHTANVFHRDLKPKNILANADCKLKICDFGLARVAFND 156

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           T       +T+ V T WYR PE L G     Y P +D+W  GCI AE+ T  P+  G   
Sbjct: 157 TPTAIF--WTDYVATRWYRAPE-LCGSFFSKYTPAIDIWSIGCIFAEVLTGKPLFPGKNV 213

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK--------DQ 233
             Q+ LI+ L G+ +PE+   V            KA++     R K  V         D 
Sbjct: 214 VHQLDLITDLLGTPSPETISRVRN---------EKARRYLSSMRKKQPVPFSQKFPNADP 264

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
               LL++LL  DP  R  ++ AL   +F
Sbjct: 265 LALRLLERLLAFDPKDRPTAEEALADPYF 293

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activation loop, TEY and TDY. Arabidopsis thaliana contains more TEY-type MAPKs than TDY-type, whereas the reverse is true for Oryza sativa. This subfamily represents the TDY subtype and is composed of Group D plant MAPKs including Arabidopsis thaliana MPK18 (AtMPK18), Oryza sativa Blast- and Wound-induced MAPK1 (OsBWMK1), OsWJUMK1 (Wound- and JA-Uninducible MAPK1), Zea mays MPK6, and the Medicago sativa TDY1 gene product. OsBWMK1 enhances resistance to pathogenic infections. It mediates stress-activated defense responses by activating a transcription factor that affects the expression of stress-related genes. AtMPK18 is involved in microtubule-related functions. Length = 338

>gnl|CDD|173670 cd05579, STKc_MAST_like, Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

 Score =  124 bits (314), Expect = 7e-33
 Identities = 79/262 (30%), Positives = 109/262 (41%), Gaps = 48/262 (18%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
             L E  IL   +   VV L    + K N         YLV ++    DLA LL N+   
Sbjct: 39  QVLTERDILSQAQSPYVVKLYYSFQGKKN--------LYLVMEYLPGGDLASLLENVGS- 89

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS---QT 124
                 +  I +++  L Y+HSN I+HRD+K  N+LI   G LKL DFGL++      Q 
Sbjct: 90  LDEDVARIYIAEIVLALEYLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQI 149

Query: 125 KNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                 +   R+V T  Y  PE++LG + +   VD W  GCI+ E     P   G T ++
Sbjct: 150 NLNDDEKEDKRIVGTPDYIAPEVILG-QGHSKTVDWWSLGCILYEFLVGIPPFHGETPEE 208

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
               I  L G I    WP          +E+                      DL+ KLL
Sbjct: 209 IFQNI--LNGKI---EWP--------EDVEVSDEAI-----------------DLISKLL 238

Query: 244 LLDPSKRFDSDAA---LNHDFF 262
           + DP KR  + +     NH FF
Sbjct: 239 VPDPEKRLGAKSIEEIKNHPFF 260

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert relative to other kinases. The fungal kinases in this subfamily harbor other domains in addition to a central catalytic domain, which also contains an insert relative to MAST kinases like MASTL. Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. The fungal proteins Rim15 and cek1 are involved in the regulation of meiosis and mitosis, respectively. Length = 265

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score =  125 bits (315), Expect = 2e-32
 Identities = 83/280 (29%), Positives = 135/280 (48%), Gaps = 37/280 (13%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +L+ + H+N++ L+ +  T       ++   YLV +  +   A L   IH++  
Sbjct: 67  AYRELVLLKCVNHKNIISLLNVF-TPQKSLEEFQD-VYLVMELMD---ANLCQVIHMELD 121

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR  +   N  +
Sbjct: 122 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMM 179

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
             Y   VVT +YR PE++LG   Y   VD+W  GCIM E+   S I QG     Q   + 
Sbjct: 180 TPY---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 235

Query: 190 QLCGSITPE-----------------SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
           +  G+ + E                  +PG+   +L+     P   +R         +K 
Sbjct: 236 EQLGTPSAEFMNRLQPTVRNYVENRPQYPGISFEELFPDWIFPSESERD-------KLKT 288

Query: 233 QYGCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDPMPSD 270
               DLL K+L++DP KR   D AL H +   W DP  ++
Sbjct: 289 SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|223589 COG0515, SPS1, Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

 Score =  123 bits (309), Expect = 2e-31
 Identities = 76/289 (26%), Positives = 112/289 (38%), Gaps = 40/289 (13%)

Query: 6   FPITALREIKILQLLKHE-NVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN 63
                LREI+IL  L H  N+V L +  + + +         YLV ++ +   L  LL  
Sbjct: 40  EVERFLREIQILASLNHPPNIVKLYDFFQDEGS--------LYLVMEYVDGGSLEDLLKK 91

Query: 64  IH--VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARA 120
           I      S  E   ++ Q+L+ L Y+HS  I+HRD+K  N+L+ + G ++KL DFGLA+ 
Sbjct: 92  IGRKGPLSESEALFILAQILSALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKL 151

Query: 121 F--SQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSPIM 176
                + +      +  V T  Y  PE+LLG          D+W  G  + E+       
Sbjct: 152 LPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSSDIWSLGITLYEL------- 204

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM--ELPKAQKRKVKERLKPYVKDQY 234
                         L G    E            K+  ELP            P +  + 
Sbjct: 205 --------------LTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNPELISKA 250

Query: 235 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMF 283
             DLL KLL  DP  R  S + L+HD      +       L +   S  
Sbjct: 251 ASDLLKKLLAKDPKNRLSSSSDLSHDLLAHLKLKESDLSDLLKPDDSAP 299

Length = 384

>gnl|CDD|173659 cd05122, PKc_STE, Catalytic domain of STE family Protein Kinases

 Score =  117 bits (296), Expect = 2e-30
 Identities = 56/168 (33%), Positives = 84/168 (50%), Gaps = 21/168 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNR---YRSTFYLVFDFCEH-DLAGLLSNIHV 66
           + EI+IL+  KH N+V           +Y      +   ++V +FC    L  LL + + 
Sbjct: 45  INEIQILKKCKHPNIV-----------KYYGSYLKKDELWIVMEFCSGGSLKDLLKSTNQ 93

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             +  +I  V ++LL GL Y+HSN I+HRD+KAAN+L+T  G +KL DFGL+   S TK 
Sbjct: 94  TLTESQIAYVCKELLKGLEYLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA 153

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                    V T ++  PE++ G   Y    D+W  G    E+    P
Sbjct: 154 RN-----TMVGTPYWMAPEVINGKP-YDYKADIWSLGITAIELAEGKP 195

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and activated by a MAPKK, which itself is phosphorylated and activated by a MAPKKK. Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAPKKK to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. Other STE family members include p21-activated kinases (PAKs) and class III myosins, among others. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain, which can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, as well as autophosphorylate the C-terminal motor domain. They play an important role in maintaining the structural integrity of photoreceptor cell microvilli. Length = 253

>gnl|CDD|173746 cd07850, STKc_JNK, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

 Score =  117 bits (294), Expect = 2e-29
 Identities = 79/274 (28%), Positives = 126/274 (45%), Gaps = 32/274 (11%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++L+ H+N++ L+    T       ++   YLV +  + +L  +   I +   
Sbjct: 62  AYRELVLMKLVNHKNIIGLLN-VFTPQKSLEEFQDV-YLVMELMDANLCQV---IQMDLD 116

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 117 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR-----TAGTS 171

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM   + +  G     Q   I 
Sbjct: 172 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIRGTVLFPGTDHIDQWNKII 230

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---------------RLKPYVKDQY 234
           +  G+ + E    ++          PK      +E               +LK       
Sbjct: 231 EQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR-- 288

Query: 235 GCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
             DLL K+L++DP KR   D AL H +   W DP
Sbjct: 289 --DLLSKMLVIDPEKRISVDDALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3) that are alternatively spliced to produce at least 10 isoforms. JNKs are specifically activated by the MAPK kinases MKK4 and MKK7, which are in turn activated by upstream MAPK kinase kinases as a result of different stimuli including stresses such as ultraviolet (UV) irradiation, hyperosmolarity, heat shock, or cytokines. JNKs activate a large number of different substrates based on specific stimulus, cell type, and cellular condition, and may be implicated in seemingly contradictory functions. Length = 353

>gnl|CDD|173672 cd05581, STKc_PDK1, Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

 Score =  109 bits (276), Expect = 2e-27
 Identities = 69/281 (24%), Positives = 105/281 (37%), Gaps = 76/281 (27%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DLAGLL 61
              E ++L  L  H  ++ L                TF      Y V ++  + +L   +
Sbjct: 48  VKIEKEVLTRLNGHPGIIKLY--------------YTFQDEENLYFVLEYAPNGELLQYI 93

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
              +        +    ++L  L Y+HS  I+HRD+K  N+L+ K   +K+ DFG A+  
Sbjct: 94  -RKYGSLDEKCTRFYAAEILLALEYLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVL 152

Query: 122 SQTKNGQVN----------------RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
               + + N                R+ + V T  Y  PELL      G   DLW  GCI
Sbjct: 153 DPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNEKP-AGKSSDLWALGCI 211

Query: 166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKER 225
           + +M T  P  +G+ E      I +L  S  P ++P             P A+       
Sbjct: 212 IYQMLTGKPPFRGSNEYLTFQKILKLEYSF-PPNFP-------------PDAK------- 250

Query: 226 LKPYVKDQYGCDLLDKLLLLDPSKR----FDSDAALNHDFF 262
                      DL++KLL+LDP  R       D    H FF
Sbjct: 251 -----------DLIEKLLVLDPQDRLGVNEGYDELKAHPFF 280

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to autophosphorylate and is constitutively active in mammalian cells. PDK1 is essential for normal embryo development and is important in regulating cell volume. Length = 280

>gnl|CDD|173731 cd06627, STKc_Cdc7_like, Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

 Score =  108 bits (273), Expect = 3e-27
 Identities = 58/169 (34%), Positives = 89/169 (52%), Gaps = 25/169 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF-SL 70
           +EI +L+ LKH N+V  I    T          + Y++ ++ E+   G L  I  KF   
Sbjct: 48  QEIDLLKNLKHPNIVKYIGSIETS--------DSLYIILEYAEN---GSLRQIIKKFGPF 96

Query: 71  GE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            E  +   + Q+L GL Y+H   ++HRD+KAAN+L TK G++KLADFG+A     TK   
Sbjct: 97  PESLVAVYVYQVLQGLAYLHEQGVIHRDIKAANILTTKDGVVKLADFGVA-----TKLND 151

Query: 129 VNRYTNRVV-TLWYRPPELLLGDRNYGPPV--DLWGAGCIMAEMWTRSP 174
           V++    VV T ++  PE++      G     D+W  GC + E+ T +P
Sbjct: 152 VSKDDASVVGTPYWMAPEVIEMS---GASTASDIWSLGCTVIELLTGNP 197

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Cdc7 is essential for cell division by playing a key role in the initiation of septum formation and cytokinesis. Budding yeast Cdc15 functions to coordinate mitotic exit with cytokinesis. Arabidopsis MAPKKK epsilon is required for pollen development in the plasma membrane. Length = 254

>gnl|CDD|173757 cd08217, STKc_Nek2, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

 Score =  107 bits (270), Expect = 9e-27
 Identities = 60/193 (31%), Positives = 92/193 (47%), Gaps = 32/193 (16%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN-IHVKFSL 70
           E+ IL+ LKH N+V   +    ++NQ      T Y+V ++CE  DLA L+      +  +
Sbjct: 49  EVNILRELKHPNIVRYYDRIIDRSNQ------TLYIVMEYCEGGDLAQLIQKCKKERKYI 102

Query: 71  GE--IKKVIQQLLNGLYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLAR---- 119
            E  I +++ QLL  LY  H      N +LHRD+K AN+ +     +KL DFGLA+    
Sbjct: 103 EEEFIWRILTQLLLALYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGH 162

Query: 120 --AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
             +F++T  G          T +Y  PE L     Y    D+W  GC++ E+   SP   
Sbjct: 163 DSSFAKTYVG----------TPYYMSPEQLNHMS-YDEKSDIWSLGCLIYELCALSPPFT 211

Query: 178 GNTEQQQITLISQ 190
              + Q  + I +
Sbjct: 212 ARNQLQLASKIKE 224

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exit. NIMA is involved in nuclear membrane fission. Vertebrate Nek2 is a cell cycle-regulated STK, localized in centrosomes and kinetochores, that regulates centrosome splitting at the G2/M phase. It also interacts with other mitotic kinases such as Polo-like kinase 1 and may play a role in spindle checkpoint. An increase in the expression of the human NEK2 gene is strongly associated with the progression of non-Hodgkin lymphoma. Length = 265

>gnl|CDD|143379 cd07874, STKc_JNK3, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

 Score =  109 bits (273), Expect = 1e-26
 Identities = 80/269 (29%), Positives = 127/269 (47%), Gaps = 23/269 (8%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVF-TPQKSLEEFQDV-YLVMELMD---ANLCQVIQMELD 117

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 172

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKV--KERLKPYVKDQYGCDLL 239
           +  G+  PE            VE    Y  +  PK     +   +     +K     DLL
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 240 DKLLLLDPSKRFDSDAALNHDFF--WTDP 266
            K+L++DP+KR   D AL H +   W DP
Sbjct: 292 SKMLVIDPAKRISVDEALQHPYINVWYDP 320

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, stroke, sciatic axotomy neural death, and neuronal death due to NGF deprivation, oxidative stress, or exposure to beta-amyloid peptide. This suggests that JNK3 may play roles in the pathogenesis of these diseases. Length = 355

>gnl|CDD|132957 cd06626, STKc_MEKK4, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

 Score =  105 bits (263), Expect = 9e-26
 Identities = 56/167 (33%), Positives = 84/167 (50%), Gaps = 14/167 (8%)

Query: 12  REIKILQLLKHENVV--HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            E+K+L+LLKH N+V  + +E+ R K   +  Y S   L  +  EH   G + + HV   
Sbjct: 48  DEMKVLELLKHPNLVKYYGVEVHREKVYIFMEYCSGGTL-EELLEH---GRILDEHV--- 100

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I+    QLL GL Y+HS+ I+HRD+K AN+ +   G++KL DFG A           
Sbjct: 101 ---IRVYTLQLLEGLAYLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMG 157

Query: 130 NRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSP 174
               +   T  Y  PE++ G +   +G   D+W  GC++ EM T   
Sbjct: 158 EEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLGCVVLEMATGKR 204

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. MEKK4 also plays roles in the re-polarization of the actin cytoskeleton in response to osmotic stress, in the proper closure of the neural tube, in cardiovascular development, and in immune responses. Length = 264

>gnl|CDD|132963 cd06632, STKc_MEKK1_plant, Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

 Score =  104 bits (260), Expect = 2e-25
 Identities = 70/256 (27%), Positives = 109/256 (42%), Gaps = 55/256 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF-SL 70
           +EI +L  L+H N+V  +   R + N Y            F E    G L+ +  K+ S 
Sbjct: 51  QEIALLSKLQHPNIVQYLGTEREEDNLY-----------IFLELVPGGSLAKLLKKYGSF 99

Query: 71  GE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR---AFSQTK 125
            E  I+   +Q+L GL Y+H    +HRD+K AN+L+   G++KLADFG+A+    FS  K
Sbjct: 100 PEPVIRLYTRQILLGLEYLHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFSFAK 159

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           + + + Y        +  PE++     YG   D+W  GC + EM T  P     ++ + +
Sbjct: 160 SFKGSPY--------WMAPEVIAQQGGYGLAADIWSLGCTVLEMATGKPPW---SQLEGV 208

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             +                   +    ELP      + + L    K     D + K L  
Sbjct: 209 AAV-----------------FKIGRSKELP-----PIPDHLSDEAK-----DFILKCLQR 241

Query: 246 DPSKRFDSDAALNHDF 261
           DPS R  +   L H F
Sbjct: 242 DPSLRPTAAELLEHPF 257

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidopsis thaliana MEKK1 activates MPK4, a MAPK that regulates systemic acquired resistance. MEKK1 also participates in the regulation of temperature-sensitive and tissue-specific cell death. Length = 258

>gnl|CDD|143380 cd07875, STKc_JNK1, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

 Score =  106 bits (265), Expect = 2e-25
 Identities = 82/275 (29%), Positives = 132/275 (48%), Gaps = 27/275 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQD-VYIVMELMD---ANLCQVIQMELD 124

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238

Query: 190 QLCGSITPESWPGVE-TLDLYNKMELPKAQKRKVKERLKPYV-----------KDQYGCD 237
           +  G+  PE    ++ T+  Y +   PK       E+L P V           K     D
Sbjct: 239 EQLGTPCPEFMKKLQPTVRTYVENR-PKYAGYSF-EKLFPDVLFPADSEHNKLKASQARD 296

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFF--WTDPMPSD 270
           LL K+L++D SKR   D AL H +   W DP  ++
Sbjct: 297 LLSKMLVIDASKRISVDEALQHPYINVWYDPSEAE 331

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK1 specifically binds with JAMP (JNK1-associated membrane protein), which regulates the duration of JNK1 activity in response to stimuli. Specific JNK1 substrates include Itch and SG10, which are implicated in Th2 responses and airway inflammation, and microtubule dynamics and axodendritic length, respectively. Mice deficient in Jnk1 are protected against arthritis, obesity, type 2 diabetes, cardiac cell death, and non-alcoholic liver disease, suggesting that JNK1 may play roles in the pathogenesis of these diseases. Length = 364

>gnl|CDD|173728 cd06614, STKc_PAK, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

 Score =  104 bits (262), Expect = 2e-25
 Identities = 72/271 (26%), Positives = 121/271 (44%), Gaps = 53/271 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + EI I++  KH N+V   +        Y       ++V ++ +   L  +++   V+ +
Sbjct: 63  INEILIMKDCKHPNIVDYYD-------SY-LVGDELWVVMEYMDGGSLTDIITQNFVRMN 114

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             +I  V +++L GL Y+HS  ++HRD+K+ N+L++K G +KLADFG A   +Q    + 
Sbjct: 115 EPQIAYVCREVLQGLEYLHSQNVIHRDIKSDNILLSKDGSVKLADFGFA---AQLTKEKS 171

Query: 130 NRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQQITL 187
            R  N VV T ++  PE++   ++YGP VD+W  G IM  EM       +G         
Sbjct: 172 KR--NSVVGTPYWMAPEVIKR-KDYGPKVDIWSLG-IMCIEM------AEGE-------- 213

Query: 188 ISQLCGSITPE--SWPGVETLDLYNKMELPKAQ-KRKVKERLKPYVKDQYGCDLLDKLLL 244
                    P     P +  L L     +P  +   K     K         D L+K L+
Sbjct: 214 ---------PPYLREPPLRALFLITTKGIPPLKNPEKWSPEFK---------DFLNKCLV 255

Query: 245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKML 275
            DP KR  ++  L H F        + + ++
Sbjct: 256 KDPEKRPSAEELLQHPFLKKACPKEEFAPLI 286

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). Group II PAKs contain a PBD and a catalytic domain, but lack other motifs found in group I PAKs. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. Group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX; no such binding has been demonstrated for group II PAKs. Length = 286

>gnl|CDD|173660 cd05123, STKc_AGC, Catalytic domain of AGC family Protein Serine/Threonine Kinases

 Score =  103 bits (259), Expect = 3e-25
 Identities = 71/259 (27%), Positives = 103/259 (39%), Gaps = 52/259 (20%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
             L E  IL  + H  +V L       A Q        YLV ++    +L   LS    +
Sbjct: 39  HTLTERNILSRINHPFIVKLH-----YAFQTEEK---LYLVLEYAPGGELFSHLSKEG-R 89

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FS    +    +++  L Y+HS  I++RD+K  N+L+   G +KL DFGLA+  S   + 
Sbjct: 90  FSEERARFYAAEIVLALEYLHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEGS- 148

Query: 128 QVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                TN    T  Y  PE+LLG + YG  VD W  G ++ EM T  P       ++   
Sbjct: 149 ----RTNTFCGTPEYLAPEVLLG-KGYGKAVDWWSLGVLLYEMLTGKPPFYAEDRKEIYE 203

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            I                   L + +  P+     +    +         DL+  LL  D
Sbjct: 204 KI-------------------LKDPLRFPE----FLSPEAR---------DLISGLLQKD 231

Query: 247 PSKRFDSDAA---LNHDFF 262
           P+KR  S  A     H FF
Sbjct: 232 PTKRLGSGGAEEIKAHPFF 250

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the turn motif. Phosphorylation at the A-loop is required of most AGC kinases, which results in a disorder-to-order transition of the A-loop. The ordered conformation results in the access of substrates and ATP to the active site. A subset of AGC kinases with C-terminal extensions containing the HM also requires phosphorylation at this site. Phosphorylation at the HM allows the C-terminal extension to form an ordered structure that packs into the hydrophobic pocket of the catalytic domain, which then reconfigures the kinase into an active bi-lobed state. In addition, growth factor-activated AGC kinases such as PKB, p70S6K, RSK, MSK, PKC, and SGK, require phosphorylation at the turn motif (also called tail or zipper site), located N-terminal to the HM at the C-terminal extension. AGC kinases regulate many cellular processes including division, growth, survival, metabolism, motility, and differentiation. Many are implicated in the development of various human diseases. Length = 250

>gnl|CDD|173333 PTZ00036, PTZ00036, glycogen synthase kinase; Provisional

 Score =  106 bits (265), Expect = 5e-25
 Identities = 79/255 (30%), Positives = 119/255 (46%), Gaps = 12/255 (4%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE+ I++ L H N++ L +   T+  + N       +V +F     H      +  +   
Sbjct: 108 RELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHAL 167

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNG 127
            L  +K    QL   L YIHS  I HRD+K  N+LI   T  LKL DFG A+       G
Sbjct: 168 PLFLVKLYSYQLCRALAYIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLL---AG 224

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           Q  R  + + + +YR PEL+LG  NY   +DLW  GCI+AEM    PI  G +   Q+  
Sbjct: 225 Q--RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGCIIAEMILGYPIFSGQSSVDQLVR 282

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I Q+ G+ T +     E    Y  ++ P  + + +K ++ P        + + + L  +P
Sbjct: 283 IIQVLGTPTEDQLK--EMNPNYADIKFPDVKPKDLK-KVFPKGTPDDAINFISQFLKYEP 339

Query: 248 SKRFDSDAALNHDFF 262
            KR +   AL   FF
Sbjct: 340 LKRLNPIEALADPFF 354

Length = 440

>gnl|CDD|197581 smart00219, TyrKc, Tyrosine kinase, catalytic domain

 Score = 99.1 bits (248), Expect = 1e-23
 Identities = 46/164 (28%), Positives = 79/164 (48%), Gaps = 15/164 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           LRE +I++ L H NVV L+ +C  +           Y+V ++ E  DL   L     K S
Sbjct: 49  LREARIMRKLDHPNVVKLLGVCTEEEP--------LYIVMEYMEGGDLLSYLRKNRPKLS 100

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L ++     Q+  G+ Y+ S   +HRD+ A N L+ +  ++K++DFGL+R      +   
Sbjct: 101 LSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDDY 157

Query: 130 NRYTNRVVTL-WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
            R     + + W   PE L  +  +    D+W  G ++ E++T 
Sbjct: 158 YRKRGGKLPIRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFTL 199

Phosphotransferases. Tyrosine-specific kinase subfamily. Length = 257

>gnl|CDD|214568 smart00221, STYKc, Protein kinase; unclassified specificity

 Score = 97.6 bits (244), Expect = 3e-23
 Identities = 42/165 (25%), Positives = 78/165 (47%), Gaps = 16/165 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAG-LLSNIHVKF 68
           LRE +I++ L H N+V L+ +C  +            +V ++    DL   L  N   + 
Sbjct: 49  LREARIMRKLDHPNIVKLLGVCTEEEP--------LMIVMEYMPGGDLLDYLRKNRPKEL 100

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           SL ++     Q+  G+ Y+ S   +HRD+ A N L+ +  ++K++DFGL+R      +  
Sbjct: 101 SLSDLLSFALQIARGMEYLESKNFIHRDLAARNCLVGENLVVKISDFGLSRD---LYDDD 157

Query: 129 VNRYTNRVVTL-WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
             +     + + W   PE L  +  +    D+W  G ++ E++T 
Sbjct: 158 YYKVKGGKLPIRWM-APESLK-EGKFTSKSDVWSFGVLLWEIFTL 200

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase. Length = 258

>gnl|CDD|173624 cd00192, PTKc, Catalytic domain of Protein Tyrosine Kinases

 Score = 95.7 bits (239), Expect = 2e-22
 Identities = 46/171 (26%), Positives = 79/171 (46%), Gaps = 20/171 (11%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E ++++ L H NVV L+ +C  +           YLV ++ E  DL   L      F 
Sbjct: 44  LKEARVMKKLGHPNVVRLLGVCTEE--------EPLYLVLEYMEGGDLLDYLRKSRPVFP 95

Query: 70  LGEIKKV-IQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
             E   + ++ LL        G+ Y+ S K +HRD+ A N L+ +  ++K++DFGL+R  
Sbjct: 96  SPEKSTLSLKDLLSFAIQIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDV 155

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                 +      ++   W   PE L  D  +    D+W  G ++ E++T 
Sbjct: 156 YDDDYYRKKT-GGKLPIRWM-APESLK-DGIFTSKSDVWSFGVLLWEIFTL 203

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain, leading to intracellular signaling. Some RTKs are orphan receptors with no known ligands. Non-receptor (or cytoplasmic) tyr kinases are distributed in different intracellular compartments and are usually multi-domain proteins containing a catalytic tyr kinase domain as well as various regulatory domains such as SH3 and SH2. PTKs are usually autoinhibited and require a mechanism for activation. In many PTKs, the phosphorylation of tyr residues in the activation loop is essential for optimal activity. Aberrant expression of PTKs is associated with many development abnormalities and cancers. Length = 262

>gnl|CDD|132961 cd06630, STKc_MEKK1, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

 Score = 94.2 bits (234), Expect = 7e-22
 Identities = 58/198 (29%), Positives = 94/198 (47%), Gaps = 18/198 (9%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNI 64
              +EI+++  L H +++ ++      ++ +N           F E      ++ LLS  
Sbjct: 49  ALRKEIRLMARLNHPHIIRMLGATCEDSH-FNL----------FVEWMAGGSVSHLLSK- 96

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQ 123
           +  F    I    +QLL GL Y+H N+I+HRD+K AN+LI  TG  L++ADFG A   + 
Sbjct: 97  YGAFKEAVIINYTEQLLRGLSYLHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAA 156

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
              G        + T+ +  PE+L G+  YG   D+W  GC++ EM T  P         
Sbjct: 157 KGTGAGEFQGQLLGTIAFMAPEVLRGE-QYGRSCDVWSVGCVIIEMATAKPPWNAEKHSN 215

Query: 184 QITLISQLCGSITPESWP 201
            + LI ++  + T  S P
Sbjct: 216 HLALIFKIASATTAPSIP 233

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their respective MAPKKs, MEK1/2 and MKK4/MKK7, respectively. MEKK1 is important in regulating cell survival and apoptosis. MEKK1 also plays a role in cell migration, tissue maintenance and homeostasis, and wound healing. Length = 268

>gnl|CDD|132943 cd06612, STKc_MST1_2, Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

 Score = 93.5 bits (233), Expect = 1e-21
 Identities = 53/168 (31%), Positives = 82/168 (48%), Gaps = 31/168 (18%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYR--STFYLVFDFCEHDLAGLLSNIHVK-- 67
           +EI IL+      +V            Y  Y   +  ++V ++C    AG +S+I +K  
Sbjct: 47  KEISILKQCDSPYIVKY----------YGSYFKNTDLWIVMEYCG---AGSVSDI-MKIT 92

Query: 68  ---FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
               +  EI  ++ Q L GL Y+HSNK +HRD+KA N+L+ + G  KLADFG++   + T
Sbjct: 93  NKTLTEEEIAAILYQTLKGLEYLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDT 152

Query: 125 KNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAG--CI-MAE 168
                    N V+ T ++  PE++     Y    D+W  G   I MAE
Sbjct: 153 -----MAKRNTVIGTPFWMAPEVIQE-IGYNNKADIWSLGITAIEMAE 194

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a MAPK kinase) and MEKK1 (a MAPK kinase kinase) by acting as a MAPK kinase kinase kinase (MAPKKKK). Activation of JNK by MST1 leads to caspase activation and apoptosis. MST1 has also been implicated in cell proliferation and differentiation. Krs1 may regulate cell growth arrest and apoptosis in response to cellular stress. Length = 256

>gnl|CDD|132960 cd06629, STKc_MAPKKK_Bck1_like, Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

 Score = 91.8 bits (228), Expect = 6e-21
 Identities = 52/174 (29%), Positives = 87/174 (50%), Gaps = 21/174 (12%)

Query: 8   ITALR-EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-- 64
           + ALR EI+ L+ L H N+V           QY  + +T   +  F E+   G + +   
Sbjct: 52  VKALRSEIETLKDLDHLNIV-----------QYLGFETTEEYLSIFLEYVPGGSIGSCLR 100

Query: 65  -HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            + +F    ++   +Q+L GL Y+HS  ILHRD+KA N+L+   GI K++DFG+++   +
Sbjct: 101 TYGRFEEQLVRFFTEQVLEGLAYLHSKGILHRDLKADNLLVDADGICKISDFGISK---K 157

Query: 124 TKNGQVNRYTN--RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + +   N      +    W  P  +    + Y   VD+W  GC++ EM+  R P
Sbjct: 158 SDDIYDNDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVVLEMFAGRRP 211

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell integrity MAPK pathway, which is activated by stresses and aggressions to the cell wall. The MAPKKK Bck1, MAPKKs Mkk1 and Mkk2, and the MAPK Slt2 make up the cascade that is important in the maintenance of cell wall homeostasis. Fission yeast Mkh1 is involved in MAPK cascades regulating cell morphology, cell wall integrity, salt resistance, and filamentous growth in response to stress. Length = 272

>gnl|CDD|173758 cd08218, STKc_Nek1, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

 Score = 91.0 bits (226), Expect = 8e-21
 Identities = 61/199 (30%), Positives = 96/199 (48%), Gaps = 31/199 (15%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DLAGLLS 62
           + +E+ +L  +KH N+V              +Y+ +F      Y+V D+CE  DL   ++
Sbjct: 46  SRKEVAVLSNMKHPNIV--------------QYQESFEENGNLYIVMDYCEGGDLYKKIN 91

Query: 63  NIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
               V F   +I     Q+   L ++H  KILHRD+K+ N+ +TK G +KL DFG+AR  
Sbjct: 92  AQRGVLFPEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVL 151

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNT 180
           + T    V      + T +Y  PE +  +R Y    D+W  GC++ EM T +     GN 
Sbjct: 152 NST----VELARTCIGTPYYLSPE-ICENRPYNNKSDIWALGCVLYEMCTLKHAFEAGNM 206

Query: 181 EQQQITLISQLCGSITPES 199
           +   + +I    GS  P S
Sbjct: 207 KNLVLKIIR---GSYPPVS 222

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycystic kidney disease, which is characterized by benign polycystic tumors formed by abnormal overgrowth of renal epithelial cells. It appears also to be involved in DNA damage response, and may be important for both correct DNA damage checkpoint activation and DNA repair. Length = 256

>gnl|CDD|132954 cd06623, PKc_MAPKK_plant_like, Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

 Score = 90.3 bits (225), Expect = 2e-20
 Identities = 58/260 (22%), Positives = 98/260 (37%), Gaps = 53/260 (20%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI-- 64
             LRE+K L+  +   VV            Y  +       +V ++ +    G L+++  
Sbjct: 45  QLLRELKTLRSCESPYVVKC----------YGAFYKEGEISIVLEYMD---GGSLADLLK 91

Query: 65  -HVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFS 122
              K     +  + +Q+L GL Y+H+   I+HRD+K +N+LI   G +K+ADFG+++   
Sbjct: 92  KVGKIPEPVLAYIARQILKGLDYLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLE 151

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTE 181
            T        T  V T+ Y  PE + G+ +Y    D+W  G  + E    + P      +
Sbjct: 152 NT---LDQCNTF-VGTVTYMSPERIQGE-SYSYAADIWSLGLTLLECALGKFPF-LPPGQ 205

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
                L+  +C                      P     +     +         D +  
Sbjct: 206 PSFFELMQAICDG------------------PPPSLPAEEFSPEFR---------DFISA 238

Query: 242 LLLLDPSKRFDSDAALNHDF 261
            L  DP KR  +   L H F
Sbjct: 239 CLQKDPKKRPSAAELLQHPF 258

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include MAPKKs from plants, kinetoplastids, alveolates, and mycetozoa. The MAPKK, LmxPK4, from Leishmania mexicana, is important in differentiation and virulence. Dictyostelium discoideum MEK1 is required for proper chemotaxis. MEK1 null mutants display severe defects in cell polarization and directional movement. Plants contain multiple MAPKKs like other eukaryotes. The Arabidopsis genome encodes for 10 MAPKKs while poplar and rice contain 13 MAPKKs each. The functions of these proteins have not been fully elucidated. There is evidence to suggest that MAPK cascades are involved in plant stress responses. In Arabidopsis, MKK3 plays a role in pathogen signaling, MKK2 is involved in cold and salt stress signaling, MKK4/MKK5 participates in innate immunity, and MKK7 regulates basal and systemic acquired resistance. Length = 264

>gnl|CDD|173764 cd08224, STKc_Nek6_Nek7, Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

 Score = 89.8 bits (223), Expect = 3e-20
 Identities = 69/231 (29%), Positives = 105/231 (45%), Gaps = 49/231 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFY------LVFDFCEHDLAGLLSNI 64
           L+EI +L+ L H NV+              +Y ++F       +V +  +   AG LS +
Sbjct: 50  LKEIDLLKQLDHPNVI--------------KYLASFIENNELNIVLELAD---AGDLSRM 92

Query: 65  HVKFSLGE-------IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
              F   +       I K   QL + L ++HS +I+HRD+K ANV IT TG++KL D GL
Sbjct: 93  IKHFKKQKRLIPERTIWKYFVQLCSALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGL 152

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIM 176
            R FS     +     + V T +Y  PE +  +  Y    D+W  GC++ EM   +SP  
Sbjct: 153 GRFFSS----KTTAAHSLVGTPYYMSPERIHEN-GYNFKSDIWSLGCLLYEMAALQSPF- 206

Query: 177 QGNTEQQQITLISQLCGSITPESWPGV-------ETLDLYNKMELPKAQKR 220
                  ++ L S LC  I    +P +       E  DL ++   P  +KR
Sbjct: 207 ----YGDKMNLYS-LCKKIEKCDYPPLPADHYSEELRDLVSRCINPDPEKR 252

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may also be regulators of the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|219530 pfam07714, Pkinase_Tyr, Protein tyrosine kinase

 Score = 89.5 bits (223), Expect = 3e-20
 Identities = 45/170 (26%), Positives = 79/170 (46%), Gaps = 26/170 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNIHV--- 66
           L E  I++ L H N+V L+ +C              Y+V ++      G LL  +     
Sbjct: 49  LEEASIMKKLSHPNIVRLLGVCTQGE--------PLYIVTEYMPG---GDLLDFLRKHGE 97

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           K +L ++ ++  Q+  G+ Y+ S   +HRD+ A N L+T+  ++K++DFGL+R   +   
Sbjct: 98  KLTLKDLLQMALQIAKGMEYLESKNFVHRDLAARNCLVTENLVVKISDFGLSRDIYED-- 155

Query: 127 GQVNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
              + Y  R        W   PE L  D  +    D+W  G ++ E++T 
Sbjct: 156 ---DYYRKRGGGKLPIKWM-APESLK-DGKFTSKSDVWSFGVLLWEIFTL 200

Length = 258

>gnl|CDD|173730 cd06624, STKc_ASK, Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

 Score = 87.2 bits (216), Expect = 2e-19
 Identities = 56/170 (32%), Positives = 85/170 (50%), Gaps = 23/170 (13%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI------HV 66
           EI +   LKH N+V  +              + F+ +F   E    G LS +       +
Sbjct: 55  EIALHSYLKHRNIVQYLGSDSE---------NGFFKIF--MEQVPGGSLSALLRSKWGPL 103

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTK 125
           K +   I    +Q+L GL Y+H N+I+HRD+K  NVL+ T +G++K++DFG ++  +   
Sbjct: 104 KDNEQTIIFYTKQILEGLKYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGI- 162

Query: 126 NGQVNRYTNRVVTLWYRPPELL-LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           N     +T    TL Y  PE++  G R YG P D+W  GC + EM T  P
Sbjct: 163 NPCTETFTG---TLQYMAPEVIDKGPRGYGAPADIWSLGCTIVEMATGKP 209

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4/MKK7 and MKK3/MKK6. It plays important roles in cytokine and stress responses, as well as in reactive oxygen species (ROS)-mediated cellular responses. ASK1 is implicated in various diseases mediated by oxidative stress including inschemic heart disease, hypertension, vessel injury, brain ischemia, Fanconi anemia, asthma, and pulmonary edema, among others. ASK2 (also called MAPKKK6) functions only in a heteromeric complex with ASK1, and can activate ASK1 by direct phosphorylation. The function of MAPKKK15 is still unknown. Length = 268

>gnl|CDD|132942 cd06611, STKc_SLK_like, Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

 Score = 87.1 bits (216), Expect = 3e-19
 Identities = 50/170 (29%), Positives = 85/170 (50%), Gaps = 23/170 (13%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----F 68
           EI IL   KH N+V L E           Y +  +++ +FC+    G L +I ++     
Sbjct: 52  EIDILSECKHPNIVGLYEAYF--------YENKLWILIEFCD---GGALDSIMLELERGL 100

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I+ V +Q+L  L ++HS+K++HRD+KA N+L+T  G +KLADFG++     T    
Sbjct: 101 TEPQIRYVCRQMLEALNFLHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL--- 157

Query: 129 VNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSP 174
             +    + T ++  PE++      D  Y    D+W  G  + E+    P
Sbjct: 158 -QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSLGITLIELAQMEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. SmSLK is capable of activating the MAPK Jun N-terminal kinase (JNK) pathway in human embryonic kidney (HEK) cells as well as in Xenopus oocytes. It may participate in regulating MAPK cascades during host-parasite interactions. Length = 280

>gnl|CDD|173732 cd06628, STKc_MAPKKK_Byr2_like, Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

 Score = 86.0 bits (213), Expect = 5e-19
 Identities = 59/201 (29%), Positives = 96/201 (47%), Gaps = 26/201 (12%)

Query: 8   ITAL-REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH----DLAGLLS 62
           + AL REI +L+ L+HEN+V  +      A+  N           F E+     +A LL+
Sbjct: 50  LDALAREIALLKELQHENIVQYLG-SSLDADHLNI----------FLEYVPGGSVAALLN 98

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL----- 117
           N +  F    ++  ++Q+L GL Y+H+  I+HRD+K AN+L+   G +K++DFG+     
Sbjct: 99  N-YGAFEETLVRNFVRQILKGLNYLHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLE 157

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
           A + S   NG   R + +    W  P   ++   +Y    D+W  GC++ EM T      
Sbjct: 158 ANSLSTKTNG--ARPSLQGSVFWMAPE--VVKQTSYTRKADIWSLGCLVVEMLTGKHPFP 213

Query: 178 GNTEQQQITLISQLCGSITPE 198
             T+ Q I  I +      P 
Sbjct: 214 DCTQLQAIFKIGENASPEIPS 234

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast Byr2 is regulated by Ras1. It responds to pheromone signaling and controls mating through the MAPK pathway. Budding yeast Ste11 functions in MAPK cascades that regulate mating, high osmolarity glycerol, and filamentous growth responses. Length = 267

>gnl|CDD|132991 cd06917, STKc_NAK1_like, Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

 Score = 85.6 bits (212), Expect = 9e-19
 Identities = 47/181 (25%), Positives = 86/181 (47%), Gaps = 18/181 (9%)

Query: 12  REIKILQLLKHENVVHLIEI--CRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           RE+ +L  L+     ++ +      K           +++ ++ E    G +  +     
Sbjct: 48  REVALLSQLRQSQPPNITKYYGSYLKG-------PRLWIIMEYAE---GGSVRTLMKAGP 97

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           + E  I  +I+++L  L YIH   ++HRD+KAAN+L+T TG +KL DFG+A   +Q    
Sbjct: 98  IAEKYISVIIREVLVALKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS-- 155

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
             ++ +  V T ++  PE++   + Y    D+W  G  + EM T +P        + + L
Sbjct: 156 --SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLGITIYEMATGNPPYSDVDAFRAMML 213

Query: 188 I 188
           I
Sbjct: 214 I 214

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of centrin, and phosphorylates substrates in a Cdc31p-dependent manner. Length = 277

>gnl|CDD|173669 cd05578, STKc_Yank1, Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

 Score = 84.7 bits (210), Expect = 1e-18
 Identities = 65/223 (29%), Positives = 93/223 (41%), Gaps = 39/223 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNI 64
           L E +ILQ L H  +V+L                +F      YLV D     L G L   
Sbjct: 48  LNERRILQELNHPFLVNL--------------WYSFQDEENMYLVVDLL---LGGDL-RY 89

Query: 65  H----VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
           H    VKFS  ++K  I +++  L Y+HS  I+HRD+K  N+L+ + G + + DF +A  
Sbjct: 90  HLSQKVKFSEEQVKFWICEIVLALEYLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATK 149

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPI-MQG 178
            +          T+   T  Y  PE+L   + Y   VD W  G    E    + P     
Sbjct: 150 VTPDTLT-----TSTSGTPGYMAPEVLCR-QGYSVAVDWWSLGVTAYECLRGKRPYRGHS 203

Query: 179 NTEQQQITLISQLCGSIT-PESWPGVETLDLYNKMELPKAQKR 220
            T + QI    Q    +  P +W   E +D  NK+     QKR
Sbjct: 204 RTIRDQI-RAKQETADVLYPATWS-TEAIDAINKLLERDPQKR 244

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A. Length = 258

>gnl|CDD|173754 cd07865, STKc_CDK9, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

 Score = 85.5 bits (212), Expect = 2e-18
 Identities = 32/47 (68%), Positives = 38/47 (80%)

Query: 321 TGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
            G   +VKERLKPYVKD +  DL+DKLL+LDP+KR D+D ALNHDFF
Sbjct: 264 QGQKRKVKERLKPYVKDPHALDLIDKLLVLDPAKRIDADTALNHDFF 310

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multiple steps of gene expression including transcription elongation, mRNA synthesis, processing, export, and translation. It also plays a role in mediating cytokine induced transcription networks such as IL6-induced STAT3 signaling. In addition, the CDK9/cyclin T2a complex promotes muscle differentiation and enhances the function of some myogenic regulatory factors. Length = 310

>gnl|CDD|173671 cd05580, STKc_PKA, Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

 Score = 84.9 bits (211), Expect = 2e-18
 Identities = 66/269 (24%), Positives = 103/269 (38%), Gaps = 77/269 (28%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFS 69
           L E +ILQ ++H  +V+L       + Q +      YLV ++    +L   L     +F 
Sbjct: 49  LNEKRILQSIRHPFLVNLY-----GSFQDDSN---LYLVMEYVPGGELFSHLRKSG-RFP 99

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
               +    Q++  L Y+HS  I++RD+K  N+L+   G +K+ DFG A+          
Sbjct: 100 EPVARFYAAQVVLALEYLHSLDIVYRDLKPENLLLDSDGYIKITDFGFAK---------- 149

Query: 130 NRYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEM-------WTRSPIMQG 178
            R   R  TL     Y  PE++L  + YG  VD W  G ++ EM       +  +PI   
Sbjct: 150 -RVKGRTYTLCGTPEYLAPEIILS-KGYGKAVDWWALGILIYEMLAGYPPFFDDNPI--- 204

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
                      Q+   I            L  K+  P           K         DL
Sbjct: 205 -----------QIYEKI------------LEGKVRFPS----FFSPDAK---------DL 228

Query: 239 LDKLLLLDPSKRFDSDAA-----LNHDFF 262
           +  LL +D +KR  +         NH +F
Sbjct: 229 IRNLLQVDLTKRLGNLKNGVNDIKNHPWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubiquitously in cells and interacts with many different downstream targets. It plays a role in the regulation of diverse processes such as growth, development, memory, metabolism, gene expression, immunity, and lipolysis. Length = 290

>gnl|CDD|173761 cd08221, STKc_Nek9, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

 Score = 84.0 bits (208), Expect = 2e-18
 Identities = 50/169 (29%), Positives = 80/169 (47%), Gaps = 25/169 (14%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVK 67
           AL EI IL LL+H N++            YN +   +T  +  ++      G L +  V+
Sbjct: 46  ALNEIVILSLLQHPNII----------AYYNHFMDDNTLLIEMEYAN---GGTLYDKIVR 92

Query: 68  -----FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
                F    +   + Q+++ + YIH   ILHRD+K  N+ +TK G++KL DFG+++   
Sbjct: 93  QKGQLFEEEMVLWYLFQIVSAVSYIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILG 152

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
              +         V T +Y  PEL  G   Y    D+W  GC++ E+ T
Sbjct: 153 SEYSMA----ETVVGTPYYMSPELCQG-VKYNFKSDIWALGCVLYELLT 196

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associates with FACT (FAcilitates Chromatin Transcription) and modulates interphase progression. It also interacts with Nek6, and Nek7, during mitosis, resulting in their activation. Length = 256

>gnl|CDD|173702 cd05611, STKc_Rim15_like, Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

 Score = 83.3 bits (206), Expect = 4e-18
 Identities = 65/220 (29%), Positives = 94/220 (42%), Gaps = 42/220 (19%)

Query: 47  YLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT 105
           YLV ++    D A L+  +         K+ I +++ G+  +H   I+HRD+K  N+LI 
Sbjct: 73  YLVMEYLNGGDCASLIKTLGG-LPEDWAKQYIAEVVLGVEDLHQRGIIHRDIKPENLLID 131

Query: 106 KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           +TG LKL DFGL+R      NG  N+    V T  Y  PE +LG        D W  GC+
Sbjct: 132 QTGHLKLTDFGLSR------NGLENK--KFVGTPDYLAPETILG-VGDDKMSDWWSLGCV 182

Query: 166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKER 225
           + E     P     T       I  L   I   +WP                   +VKE 
Sbjct: 183 IFEFLFGYPPFHAETPDAVFDNI--LSRRI---NWP------------------EEVKEF 219

Query: 226 LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL---NHDFF 262
             P        DL+++LL +DP+KR  ++      +H FF
Sbjct: 220 CSPEAV-----DLINRLLCMDPAKRLGANGYQEIKSHPFF 254

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a downstream effector of PKA and regulates entry into stationary phase (G0). Thus, it plays a crucial role in regulating yeast proliferation, differentiation, and aging. Cek1 may facilitate progression of mitotic anaphase. Length = 260

>gnl|CDD|132988 cd06657, STKc_PAK4, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

 Score = 83.5 bits (206), Expect = 6e-18
 Identities = 72/270 (26%), Positives = 122/270 (45%), Gaps = 51/270 (18%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYR--STFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 67  EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 113

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG    F    + +
Sbjct: 114 NEEQIAAVCLAVLKALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFG----FCAQVSKE 169

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V R  + V T ++  PE L+    YGP VD+W  G ++ EM    P        + + +I
Sbjct: 170 VPRRKSLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEPPYFNEPPLKAMKMI 228

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
                                 +  LP   K K   ++ P +K       LD+LL+ DP+
Sbjct: 229 ----------------------RDNLPP--KLKNLHKVSPSLK-----GFLDRLLVRDPA 259

Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
           +R  +   L H F      PS +  ++ Q+
Sbjct: 260 QRATAAELLKHPFLAKAGPPSCIVPLMRQN 289

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell morphology and cytoskeletal organization. It is essential for embryonic viability and proper neural development. Mice lacking PAK4 die due to defects in the fetal heart. In addition, their spinal cord motor neurons showed failure to differentiate and migrate. PAK4 also plays a role in cell survival and tumorigenesis. It is overexpressed in many primary tumors including colon, esophageal, and mammary tumors. PAK4 has also been implicated in viral and bacterial infection pathways. Length = 292

>gnl|CDD|165478 PHA03212, PHA03212, serine/threonine kinase US3; Provisional

 Score = 84.3 bits (208), Expect = 9e-18
 Identities = 76/271 (28%), Positives = 124/271 (45%), Gaps = 29/271 (10%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           E  IL+ + H +++ L          YN++     L+    + DL   L+      ++ +
Sbjct: 133 EAHILRAINHPSIIQLK-----GTFTYNKFTC---LILPRYKTDLYCYLAA-KRNIAICD 183

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           I  + + +L  + Y+H N+I+HRD+KA N+ I   G + L DFG A  F    N   N+Y
Sbjct: 184 ILAIERSVLRAIQYLHENRIIHRDIKAENIFINHPGDVCLGDFG-AACFPVDINA--NKY 240

Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT------RSPIMQGNTE-QQQI 185
                T+    PELL  D  YGP VD+W AG ++ EM T          + G+ +  +QI
Sbjct: 241 YGWAGTIATNAPELLARD-PYGPAVDIWSAGIVLFEMATCHDSLFEKDGLDGDCDSDRQI 299

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD-----LLD 240
            LI +  G   P  +P     +L +++ +  A+K   K   +P   + Y        L+ 
Sbjct: 300 KLIIRRSG-THPNEFPIDAQANL-DEIYIGLAKKSSRKPGSRPLWTNLYELPIDLEYLIC 357

Query: 241 KLLLLDPSKRFDSDAALNHDFFWT--DPMPS 269
           K+L  D   R  ++A L+   F    DP P+
Sbjct: 358 KMLAFDAHHRPSAEALLDFAAFQDIPDPYPN 388

Length = 391

>gnl|CDD|132956 cd06625, STKc_MEKK3_like, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 81.0 bits (200), Expect = 3e-17
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 2/101 (1%)

Query: 74  KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT 133
           +K  +Q+L G+ Y+HSN I+HRD+K AN+L    G +KL DFG ++   QT         
Sbjct: 107 RKYTRQILEGVEYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-QTICSSGTGMK 165

Query: 134 NRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +   T ++  PE++ G+  YG   D+W  GC + EM T  P
Sbjct: 166 SVTGTPYWMSPEVISGE-GYGRKADVWSVGCTVVEMLTEKP 205

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 263

>gnl|CDD|165476 PHA03210, PHA03210, serine/threonine kinase US3; Provisional

 Score = 82.8 bits (204), Expect = 4e-17
 Identities = 56/194 (28%), Positives = 92/194 (47%), Gaps = 16/194 (8%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSLG 71
           EI  L  L HEN++ + EI R++AN Y   +   + ++ F  +         +     L 
Sbjct: 213 EILALGRLNHENILKIEEILRSEANTYMITQKYDFDLYSFMYDEAFDWKDRPL-----LK 267

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + + +++QLL  + YIH  K++HRD+K  N+ +   G + L DFG A  F   +  +   
Sbjct: 268 QTRAIMKQLLCAVEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPF---EKEREAF 324

Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS--PIMQG--NTEQQQITL 187
               V T+    PE+L GD  Y    D+W  G I+ +M +    PI  G     +Q + +
Sbjct: 325 DYGWVGTVATNSPEILAGD-GYCEITDIWSCGLILLDMLSHDFCPIGDGGGKPGKQLLKI 383

Query: 188 ISQLCGSITPESWP 201
           I  L  S+  E +P
Sbjct: 384 IDSL--SVCDEEFP 395

Length = 501

>gnl|CDD|173726 cd06610, STKc_OSR1_SPAK, Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

 Score = 80.5 bits (199), Expect = 4e-17
 Identities = 63/261 (24%), Positives = 104/261 (39%), Gaps = 47/261 (18%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAG-LLSNIHV 66
             +E++ +    H NVV            Y  +      +LV  +      G LL  +  
Sbjct: 46  LRKEVQAMSQCNHPNVVK----------YYTSFVVGDELWLVMPYLS---GGSLLDIMKS 92

Query: 67  KFSLG-----EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            +  G      I  V++++L GL Y+HSN  +HRD+KA N+L+ + G +K+ADFG++ + 
Sbjct: 93  SYPRGGLDEAIIATVLKEVLKGLEYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASL 152

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           +   +         V T  +  PE++     Y    D+W  G                  
Sbjct: 153 ADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFG------------------ 194

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
              IT I    G+     +P ++ L L  + + P  +        K Y K      ++  
Sbjct: 195 ---ITAIELATGAAPYSKYPPMKVLMLTLQNDPPSLE---TGADYKKYSKSFR--KMISL 246

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
            L  DPSKR  ++  L H FF
Sbjct: 247 CLQKDPSKRPTAEELLKHKFF 267

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1 and SPAK contain a conserved C-terminal (CCT) domain, which recognizes a unique motif ([RK]FX[VI]) present in their activating kinases (WNK1/WNK4) and their substrates. Length = 267

>gnl|CDD|173772 cd08530, STKc_CNK2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

 Score = 80.2 bits (198), Expect = 4e-17
 Identities = 51/185 (27%), Positives = 84/185 (45%), Gaps = 33/185 (17%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCE-HDLAGLLS 62
           A+ EI+IL  + H N++               Y+  F       +V ++    DL+  +S
Sbjct: 46  AVNEIRILASVNHPNII--------------SYKEAFLDGNKLCIVMEYAPFGDLSKAIS 91

Query: 63  NIHVK---FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
               K       EI ++  QLL GL  +H  KILHRD+K+AN+L+    ++K+ D G+++
Sbjct: 92  KRKKKRKLIPEQEIWRIFIQLLRGLQALHEQKILHRDLKSANILLVANDLVKIGDLGISK 151

Query: 120 AFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
              +             + T  Y  PE+  G R Y    D+W  GC++ EM T +P  + 
Sbjct: 152 VLKK-------NMAKTQIGTPHYMAPEVWKG-RPYSYKSDIWSLGCLLYEMATFAPPFEA 203

Query: 179 NTEQQ 183
            + Q 
Sbjct: 204 RSMQD 208

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, and it regulates cell size, through influencing the size threshold at which cells commit to mitosis. Length = 256

>gnl|CDD|132974 cd06643, STKc_SLK, Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

 Score = 80.4 bits (198), Expect = 5e-17
 Identities = 50/167 (29%), Positives = 85/167 (50%), Gaps = 17/167 (10%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           EI IL    H N+V L++           Y +  +++ +FC    +  ++  +    +  
Sbjct: 52  EIDILASCDHPNIVKLLDAFY--------YENNLWILIEFCAGGAVDAVMLELERPLTEP 103

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I+ V +Q L  L Y+H NKI+HRD+KA N+L T  G +KLADFG++   ++T    + R
Sbjct: 104 QIRVVCKQTLEALNYLHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----IQR 159

Query: 132 YTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSP 174
             + + T ++  PE+++     DR Y    D+W  G  + EM    P
Sbjct: 160 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAQIEP 206

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration. Length = 282

>gnl|CDD|173765 cd08225, STKc_Nek5, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

 Score = 80.0 bits (197), Expect = 6e-17
 Identities = 59/195 (30%), Positives = 93/195 (47%), Gaps = 26/195 (13%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRST--FYLVFDFCEHDLAGLLSNIH---- 65
           +E+ +L  +KH N+V            +  ++     ++V ++C  D   L+  I+    
Sbjct: 48  KEVILLAKMKHPNIVTF----------FASFQENGRLFIVMEYC--DGGDLMKRINRQRG 95

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQT 124
           V FS  +I     Q+  GL +IH  KILHRD+K+ N+ ++K G + KL DFG+AR     
Sbjct: 96  VLFSEDQILSWFVQISLGLKHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIAR----Q 151

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
            N  +      V T +Y  PE +  +R Y    D+W  GC++ E+ T     +GN   Q 
Sbjct: 152 LNDSMELAYTCVGTPYYLSPE-ICQNRPYNNKTDIWSLGCVLYELCTLKHPFEGNNLHQL 210

Query: 185 ITLISQLCGSITPES 199
           +  I Q  G   P S
Sbjct: 211 VLKICQ--GYFAPIS 223

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown. Length = 257

>gnl|CDD|132964 cd06633, STKc_TAO3, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

 Score = 80.5 bits (198), Expect = 7e-17
 Identities = 74/277 (26%), Positives = 119/277 (42%), Gaps = 50/277 (18%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FS 69
           ++E+K LQ LKH N +   + C  K +       T +LV ++C    + LL  +H K   
Sbjct: 69  IKEVKFLQQLKHPNTIEY-KGCYLKEH-------TAWLVMEYCLGSASDLLE-VHKKPLQ 119

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             EI  +    L GL Y+HS+ ++HRD+KA N+L+T+ G +KLADFG     S +K+   
Sbjct: 120 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFG-----SASKSSPA 174

Query: 130 NRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           N +   V T ++  PE++L   +  Y   VD+W  G    E+  R P +        +  
Sbjct: 175 NSF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 231

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I+Q                      + P  Q  +  +  + +V         D  L   P
Sbjct: 232 IAQ---------------------NDSPTLQSNEWTDSFRGFV---------DYCLQKIP 261

Query: 248 SKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
            +R  S   L HDF   D     L  ++ +   ++ E
Sbjct: 262 QERPASAELLRHDFVRRDRPARVLIDLIQRTKDAVRE 298

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a component of the RAM (regulation of Ace2p activity and cellular morphogenesis) signaling pathway. TAO3 is upregulated in retinal ganglion cells after axotomy, and may play a role in apoptosis. Length = 313

>gnl|CDD|132938 cd06607, STKc_TAO, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

 Score = 80.2 bits (198), Expect = 8e-17
 Identities = 68/276 (24%), Positives = 112/276 (40%), Gaps = 53/276 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FS 69
           ++E++ LQ L+H N +   + C  +         T +LV ++C    + +L  +H K   
Sbjct: 63  IKEVRFLQQLRHPNTIEY-KGCYLR-------EHTAWLVMEYCLGSASDIL-EVHKKPLQ 113

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             EI  +    L GL Y+HS++ +HRD+KA N+L+T+ G +KLADFG A          V
Sbjct: 114 EVEIAAICHGALQGLAYLHSHERIHRDIKAGNILLTEPGTVKLADFGSA--------SLV 165

Query: 130 NRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           +   + V T ++  PE++L   +  Y   VD+W  G    E+  R P +        +  
Sbjct: 166 SPANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225

Query: 188 ISQ-LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
           I+Q    +++   W                                 Y  + +D  L   
Sbjct: 226 IAQNDSPTLSSNDW-------------------------------SDYFRNFVDSCLQKI 254

Query: 247 PSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 282
           P  R  S+  L H F      P  +   L Q T+  
Sbjct: 255 PQDRPSSEELLKHRFV-LRERPPTVIIDLIQRTKDA 289

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily members, named TAO1, TAO2, and TAO3. Length = 307

>gnl|CDD|132979 cd06648, STKc_PAK_II, Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

 Score = 79.8 bits (197), Expect = 9e-17
 Identities = 67/268 (25%), Positives = 117/268 (43%), Gaps = 53/268 (19%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +H N+V +          Y+ Y      ++V +F E    G L++I  H + 
Sbjct: 66  EVVIMRDYQHPNIVEM----------YSSYLVGDELWVVMEFLE---GGALTDIVTHTRM 112

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L ++H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 113 NEEQIATVCLAVLKALSFLHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSK----E 168

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V R  + V T ++  PE ++    YG  VD+W  G ++ EM    P        Q +  I
Sbjct: 169 VPRRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMVDGEPPYFNEPPLQAMKRI 227

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQK-RKVKERLKPYVKDQYGCDLLDKLLLLDP 247
                                     PK +   KV  RL+           LD++L+ DP
Sbjct: 228 RD---------------------NLPPKLKNLHKVSPRLR---------SFLDRMLVRDP 257

Query: 248 SKRFDSDAALNHDFFWTDPMPSDLSKML 275
           ++R  +   LNH F      PS +  ++
Sbjct: 258 AQRATAAELLNHPFLAKAGPPSSIVPLM 285

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs found in group I PAKs, such as an AID (autoinhibitory domain) and SH3 binding sites. Since group II PAKs do not contain an obvious AID, they may be regulated differently from group I PAKs. While group I PAKs interact with the SH3 containing proteins Nck, Grb2 and PIX, no such binding has been demonstrated for group II PAKs. Some known substrates of group II PAKs are also substrates of group I PAKs such as Raf, BAD, LIMK and GEFH1. Unique group II substrates include MARK/Par-1 and PDZ-RhoGEF. Group II PAKs play important roles in filopodia formation, neuron extension, cytoskeletal organization, and cell survival. Length = 285

>gnl|CDD|132940 cd06609, STKc_MST3_like, Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

 Score = 78.8 bits (195), Expect = 2e-16
 Identities = 57/251 (22%), Positives = 96/251 (38%), Gaps = 46/251 (18%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           +EI+ L   +   +         K        S  +++ ++C       LL     K   
Sbjct: 48  QEIQFLSQCRSPYITKYYG-SFLK-------GSKLWIIMEYCGGGSCLDLLKPG--KLDE 97

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             I  +++++L GL Y+H    +HRD+KAAN+L+++ G +KLADFG++    Q  +    
Sbjct: 98  TYIAFILREVLLGLEYLHEEGKIHRDIKAANILLSEEGDVKLADFGVS---GQLTSTMSK 154

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
           R T  V T ++  PE++     Y    D+W  G    E+    P +      + + LI  
Sbjct: 155 RNT-FVGTPFWMAPEVIKQS-GYDEKADIWSLGITAIELAKGEPPLSDLHPMRVLFLIP- 211

Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
                               K   P  +  K  +  K         D +   L  DP +R
Sbjct: 212 --------------------KNNPPSLEGNKFSKPFK---------DFVSLCLNKDPKER 242

Query: 251 FDSDAALNHDF 261
             +   L H F
Sbjct: 243 PSAKELLKHKF 253

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN) signaling pathway, and plays a role in cytokinesis. SPS1 plays a role in regulating proteins required for spore wall formation. MST4 plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. STK25 may play a role in the regulation of cell migration and polarization. Length = 274

>gnl|CDD|173727 cd06613, STKc_MAP4K3_like, Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 51/167 (30%), Positives = 85/167 (50%), Gaps = 24/167 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HV-KFS 69
           +EI +L+  +H N+V            Y R R   ++V ++C     G L +I  V +  
Sbjct: 49  QEISMLKECRHPNIVAYF-------GSYLR-RDKLWIVMEYCG---GGSLQDIYQVTRGP 97

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L E  I  V ++ L GL Y+H    +HRD+K AN+L+T+ G +KLADFG++   + T   
Sbjct: 98  LSELQIAYVCRETLKGLAYLHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTAT--- 154

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAG--CI-MAEM 169
            + +  + + T ++  PE+   +R   Y    D+W  G   I +AE+
Sbjct: 155 -IAKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGITAIELAEL 200

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K1, also called haematopoietic progenitor kinase 1 (HPK1), is a hematopoietic-specific STK involved in many cellular signaling cascades including MAPK, antigen receptor, apoptosis, growth factor, and cytokine signaling. It participates in the regulation of T cell receptor signaling and T cell-mediated immune responses. MAP4K2 was referred to as germinal center (GC) kinase because of its preferred location in GC B cells. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. It is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). Length = 262

>gnl|CDD|132962 cd06631, STKc_YSK4, Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

 Score = 77.6 bits (191), Expect = 4e-16
 Identities = 53/167 (31%), Positives = 83/167 (49%), Gaps = 17/167 (10%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF-SLG 71
           E+ +L+ LKH N+V  +  C                +  F E    G +S+I  +F  L 
Sbjct: 52  EVDLLKSLKHVNIVQYLGTCLDDN-----------TISIFMEFVPGGSISSILNRFGPLP 100

Query: 72  EI--KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR--AFSQTKNG 127
           E    K  +Q+L+G+ Y+H+N ++HRD+K  NV++   GI+KL DFG AR  A+      
Sbjct: 101 EPVFCKYTKQILDGVAYLHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGT 160

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             N   +   T ++  PE ++ +  YG   D+W  GC + EM T  P
Sbjct: 161 HSNMLKSMHGTPYWMAPE-VINESGYGRKSDIWSIGCTVFEMATGKP 206

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Length = 265

>gnl|CDD|173663 cd05572, STKc_cGK_PKG, Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

 Score = 77.3 bits (191), Expect = 5e-16
 Identities = 62/251 (24%), Positives = 100/251 (39%), Gaps = 64/251 (25%)

Query: 11  LREIKILQLLKHENVVHLIEICRT-KANQYNRYRSTFYLVFDFCE--------HDLAGLL 61
             E +IL+   H  +V L    RT K  +Y       Y++ ++C          D  GL 
Sbjct: 41  FSEKEILEECNHPFIVKLY---RTFKDKKY------IYMLMEYCLGGELWTILRD-RGLF 90

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                +F +         ++    Y+H+  I++RD+K  N+L+   G +KL DFG A+  
Sbjct: 91  DEYTARFYIA-------CVVLAFEYLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAK-- 141

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
            + K+GQ   +T    T  Y  PE++L  + Y   VD W  G ++ E+ T  P    + E
Sbjct: 142 -KLKSGQ-KTWT-FCGTPEYVAPEIILN-KGYDFSVDYWSLGILLYELLTGRPPFGEDDE 197

Query: 182 QQQIT--LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
                   I                 L    K+E P             Y+ D+   DL+
Sbjct: 198 DPMEIYNDI-----------------LKGNGKLEFPN------------YI-DKAAKDLI 227

Query: 240 DKLLLLDPSKR 250
            +LL  +P +R
Sbjct: 228 KQLLRRNPEER 238

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowing autophosphorylation and activation of the kinase. cGKI is a soluble protein expressed in all smooth muscles, platelets, cerebellum, and kidney. It is also expressed at lower concentrations in other tissues. cGKII is a membrane-bound protein that is most abundantly expressed in the intestine. It is also present in the brain nuclei, adrenal cortex, kidney, lung, and prostate. cGKI is involved in the regulation of smooth muscle tone, smooth cell proliferation, and platelet activation. cGKII plays a role in the regulation of secretion, such as renin secretion by the kidney and aldosterone secretion by the adrenal. It also regulates bone growth and the circadian rhythm. Length = 262

>gnl|CDD|132985 cd06654, STKc_PAK1, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

 Score = 77.8 bits (191), Expect = 6e-16
 Identities = 72/273 (26%), Positives = 123/273 (45%), Gaps = 40/273 (14%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNIH 65
           A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++ 
Sbjct: 49  AIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 108

Query: 66  VKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG     +Q
Sbjct: 109 TETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQ 165

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
               Q  R +  V T ++  PE++   + YGP VD+W  G +  EM    P        +
Sbjct: 166 ITPEQSKR-STMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEPPYLNENPLR 223

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            + LI+    + TPE             ++ P        E+L    +     D L++ L
Sbjct: 224 ALYLIAT---NGTPE-------------LQNP--------EKLSAIFR-----DFLNRCL 254

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 276
            +D  KR  +   L H F       S L+ ++A
Sbjct: 255 DMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK1 is important in the regulation of many cellular processes including cytoskeletal dynamics, cell motility, growth, and proliferation. Although PAK1 has been regarded mainly as a cytosolic protein, recent reports indicate that PAK1 also exists in significant amounts in the nucleus, where it is involved in transcription modulation and in cell cycle regulatory events. PAK1 is also involved in transformation and tumorigenesis. Its overexpression, hyperactivation and increased nuclear accumulation is correlated to breast cancer invasiveness and progression. Nuclear accumulation is also linked to tamoxifen resistance in breast cancer cells. Length = 296

>gnl|CDD|173771 cd08529, STKc_FA2-like, Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

 Score = 76.8 bits (189), Expect = 6e-16
 Identities = 46/173 (26%), Positives = 76/173 (43%), Gaps = 33/173 (19%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCE----HDLAG 59
           A+ E ++L  L    ++              RY  +F       +V ++ E    H L  
Sbjct: 46  AIDEARVLAKLDSSYII--------------RYYESFLDKGKLNIVMEYAENGDLHKL-- 89

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           L           ++ +   Q+L GL ++HS KILHRD+K+ N+ +     +K+ D G+A+
Sbjct: 90  LKMQRGRPLPEDQVWRFFIQILLGLAHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAK 149

Query: 120 AFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             S   N     + N +V T +Y  PE L  D+ Y    D+W  G ++ E  T
Sbjct: 150 LLSDNTN-----FANTIVGTPYYLSPE-LCEDKPYNEKSDVWALGVVLYECCT 196

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cycle progression. No cellular function has yet been ascribed to CNK4. Length = 256

>gnl|CDD|132989 cd06658, STKc_PAK5, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

 Score = 77.4 bits (190), Expect = 8e-16
 Identities = 71/275 (25%), Positives = 121/275 (44%), Gaps = 61/275 (22%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYR--STFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++   HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 69  EVVIMRDYHHENVVDM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 115

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L Y+H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 116 NEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK----E 171

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V +  + V T ++  PE ++    YG  VD+W  G ++ EM    P              
Sbjct: 172 VPKRKSLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEP-------------- 216

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD-----LLDKLL 243
                               +N  E P    R++++ L P VKD +         LD +L
Sbjct: 217 ------------------PYFN--EPPLQAMRRIRDNLPPRVKDSHKVSSVLRGFLDLML 256

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
           + +PS+R  +   L H F      PS +  ++ Q+
Sbjct: 257 VREPSQRATAQELLQHPFLKLAGPPSCIVPLMRQY 291

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly expressed in the brain. It is not required for viability, but together with PAK6, it is required for normal levels of locomotion and activity, and for learning and memory. PAK5 cooperates with Inca (induced in neural crest by AP2) in the regulation of cell adhesion and cytoskeletal organization in the embryo and in neural crest cells during craniofacial development. PAK5 may also play a role in controlling the signaling of Raf-1, an effector of Ras, at the mitochondria. Length = 292

>gnl|CDD|132952 cd06621, PKc_MAPKK_Pek1_like, Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

 Score = 76.7 bits (189), Expect = 1e-15
 Identities = 71/288 (24%), Positives = 119/288 (41%), Gaps = 70/288 (24%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS- 69
           LRE++I +  K         I +      +   S+  +  ++CE    G L +I+ K   
Sbjct: 47  LRELEINKSCKSPY------IVKYYGAFLDESSSSIGIAMEYCE---GGSLDSIYKKVKK 97

Query: 70  ----LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG----LAR 119
               +GE  + K+ + +L GL Y+HS KI+HRD+K +N+L+T+ G +KL DFG    L  
Sbjct: 98  RGGRIGEKVLGKIAESVLKGLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVN 157

Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           + + T  G          T +Y  PE + G + Y    D+W  G  + E           
Sbjct: 158 SLAGTFTG----------TSFYMAPERIQG-KPYSITSDVWSLGLTLLE----------- 195

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYN---KMELPKAQ-----KRKVKERLKPYVK 231
                   ++Q      PE  P +  ++L +    M  P+ +       K  E  K    
Sbjct: 196 --------VAQNRFPFPPEGEPPLGPIELLSYIVNMPNPELKDEPGNGIKWSEEFK---- 243

Query: 232 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM--PSDLSKMLAQ 277
                D + + L  DP++R      L H  +    M    +++K +AQ
Sbjct: 244 -----DFIKQCLEKDPTRRPTPWDMLEHP-WIKAQMKKKVNMAKFVAQ 285

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Pek1/Skh1 from Schizosaccharomyces pombe and MKK2 from Saccharomyces cerevisiae, and related proteins. Both fission yeast Pek1 and baker's yeast MKK2 are components of the cell integrity MAPK pathway. In fission yeast, Pek1 phosphorylates and activates the MAPK Pmk1/Spm1 and is regulated by the MAPKKK Mkh1. In baker's yeast, the pathway involves the MAPK Slt2, the MAPKKs MKK1 and MKK2, and the MAPKKK Bck1. The cell integrity MAPK cascade is activated by multiple stress conditions, and is essential in cell wall construction, morphogenesis, cytokinesis, and ion homeostasis. Length = 287

>gnl|CDD|173770 cd08528, STKc_Nek10, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

 Score = 76.0 bits (187), Expect = 2e-15
 Identities = 54/223 (24%), Positives = 95/223 (42%), Gaps = 52/223 (23%)

Query: 13  EIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCE----HDLAGLL 61
           E+ I+ + L+H N+V              RY  TF      Y+V D  E     +    L
Sbjct: 58  EVTIIKEQLRHPNIV--------------RYYKTFLENDRLYIVMDLIEGAPLGEHFNSL 103

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARA 120
                +F+   I  +  Q++  L Y+H  K I+HRD+   N+++ +   + + DFGLA+ 
Sbjct: 104 KEKKQRFTEERIWNIFVQMVLALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAK- 162

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP------ 174
               +    ++ T+ V T+ Y  PE++  +  YG   D+W  GCI+ +M T  P      
Sbjct: 163 ----QKQPESKLTSVVGTILYSCPEIVKNE-PYGEKADVWAFGCILYQMCTLQPPFYSTN 217

Query: 175 -------IMQGNTE-------QQQITLISQLCGSITPESWPGV 203
                  I++   E        + +T +   C +   E+ P +
Sbjct: 218 MLSLATKIVEAVYEPLPEGMYSEDVTDVITSCLTPDAEARPDI 260

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24. Length = 269

>gnl|CDD|132986 cd06655, STKc_PAK2, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

 Score = 76.3 bits (187), Expect = 2e-15
 Identities = 71/278 (25%), Positives = 124/278 (44%), Gaps = 55/278 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLV----FDFCEHDLAGLLSNIHV 66
           + EI +++ LK+ N+V+ ++                +LV    F   E+   G L+++  
Sbjct: 64  INEILVMKELKNPNIVNFLDS---------------FLVGDELFVVMEYLAGGSLTDVVT 108

Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           +  + E  I  V ++ L  L ++H+N+++HRD+K+ NVL+   G +KL DFG     +Q 
Sbjct: 109 ETCMDEAQIAAVCRECLQALEFLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFC---AQI 165

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
              Q  R T  V T ++  PE++   + YGP VD+W  G +  EM    P        + 
Sbjct: 166 TPEQSKRST-MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           + LI+    + TPE             ++ P        E+L P  +     D L++ L 
Sbjct: 224 LYLIAT---NGTPE-------------LQNP--------EKLSPIFR-----DFLNRCLE 254

Query: 245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 282
           +D  KR  +   L H F       S L+ ++    ++M
Sbjct: 255 MDVEKRGSAKELLQHPFLKLAKPLSSLTPLILAAKEAM 292

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK2 plays a role in pro-apoptotic signaling. It is cleaved and activated by caspases leading to morphological changes during apoptosis. PAK2 is also activated in response to a variety of stresses including DNA damage, hyperosmolarity, serum starvation, and contact inhibition, and may play a role in coordinating the stress response. PAK2 also contributes to cancer cell invasion through a mechanism distinct from that of PAK1. Length = 296

>gnl|CDD|132978 cd06647, STKc_PAK_I, Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

 Score = 76.1 bits (187), Expect = 2e-15
 Identities = 65/258 (25%), Positives = 113/258 (43%), Gaps = 55/258 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNIHV 66
           + EI +++  KH N+V+ ++                YLV D      E+   G L+++  
Sbjct: 64  INEILVMRENKHPNIVNYLDS---------------YLVGDELWVVMEYLAGGSLTDVVT 108

Query: 67  KFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG    F   
Sbjct: 109 ETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----FCAQ 164

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
              + ++ +  V T ++  PE++   + YGP VD+W  G +  EM    P        + 
Sbjct: 165 ITPEQSKRSTMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLRA 223

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           + LI+    + TP               EL         E+L    +     D L++ L 
Sbjct: 224 LYLIAT---NGTP---------------ELQN------PEKLSAIFR-----DFLNRCLE 254

Query: 245 LDPSKRFDSDAALNHDFF 262
           +D  KR  +   L H F 
Sbjct: 255 MDVEKRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group I PAKs, also called conventional PAKs, include PAK1, PAK2, and PAK3. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). They interact with the SH3 domain containing proteins Nck, Grb2 and PIX. Binding of group I PAKs to activated GTPases leads to conformational changes that destabilize the AID, allowing autophosphorylation and full activation of the kinase domain. Known group I PAK substrates include MLCK, Bad, Raf, MEK1, LIMK, Merlin, Vimentin, Myc, Stat5a, and Aurora A, among others. Length = 293

>gnl|CDD|132965 cd06634, STKc_TAO2, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

 Score = 75.9 bits (186), Expect = 3e-15
 Identities = 66/255 (25%), Positives = 104/255 (40%), Gaps = 50/255 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FS 69
           ++E++ LQ L+H N +     C  + +       T +LV ++C    + LL  +H K   
Sbjct: 63  IKEVRFLQKLRHPNTIQY-RGCYLREH-------TAWLVMEYCLGSASDLLE-VHKKPLQ 113

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             EI  V    L GL Y+HS+ ++HRD+KA N+L+++ G++KL DFG A   +       
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168

Query: 130 NRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
                 V T ++  PE++L   +  Y   VD+W  G    E+  R P +        +  
Sbjct: 169 ---NXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I+Q                      E P  Q     E  + +V         D  L   P
Sbjct: 226 IAQ---------------------NESPALQSGHWSEYFRNFV---------DSCLQKIP 255

Query: 248 SKRFDSDAALNHDFF 262
             R  S+  L H F 
Sbjct: 256 QDRPTSEVLLKHRFV 270

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. TAO2 contains a long C-terminal extension with autoinhibitory segments. It is activated by the release of this inhibition and the phosphorylation of its activation loop serine. TAO2 functions as a regulator of actin cytoskeletal and microtubule organization. In addition, it regulates the transforming growth factor-activated kinase 1 (TAK1), which is a MAPKKK that plays an essential role in the signaling pathways of tumor necrosis factor (TNF), interleukin 1 (IL-1), and Toll-like receptor (TLR). Length = 308

>gnl|CDD|173759 cd08219, STKc_Nek3, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

 Score = 74.6 bits (183), Expect = 4e-15
 Identities = 55/193 (28%), Positives = 89/193 (46%), Gaps = 21/193 (10%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK- 67
            + +E  +L  +KH N+V   E      +         Y+V ++C  D   L+  I ++ 
Sbjct: 44  DSRKEAVLLAKMKHPNIVAFKESFEADGH--------LYIVMEYC--DGGDLMQKIKLQR 93

Query: 68  ---FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              F    I +   Q+  G+ +IH  ++LHRD+K+ N+ +T+ G +KL DFG AR  +  
Sbjct: 94  GKLFPEDTILQWFVQMCLGVQHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSP 153

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                      V T +Y PPE +  +  Y    D+W  GCI+ E+ T     Q N+ +  
Sbjct: 154 ----GAYACTYVGTPYYVPPE-IWENMPYNNKSDIWSLGCILYELCTLKHPFQANSWKNL 208

Query: 185 ITLISQLCGSITP 197
           I  + Q  GS  P
Sbjct: 209 ILKVCQ--GSYKP 219

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activation of Vav2 and contributes to prolactin-mediated motility of breast cancer cells. Length = 255

>gnl|CDD|132966 cd06635, STKc_TAO1, Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

 Score = 75.5 bits (185), Expect = 4e-15
 Identities = 54/167 (32%), Positives = 85/167 (50%), Gaps = 20/167 (11%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FS 69
           ++E+K LQ +KH N +   + C  + +       T +LV ++C    + LL  +H K   
Sbjct: 73  IKEVKFLQRIKHPNSIEY-KGCYLREH-------TAWLVMEYCLGSASDLLE-VHKKPLQ 123

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             EI  +    L GL Y+HS+ ++HRD+KA N+L+T+ G +KLADFG A   S       
Sbjct: 124 EVEIAAITHGALQGLAYLHSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASPA----- 178

Query: 130 NRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSP 174
               + V T ++  PE++L   +  Y   VD+W  G    E+  R P
Sbjct: 179 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 222

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuronal apoptosis. TAO1 interacts with the checkpoint proteins BubR1 and Mad2, and plays an important role in regulating mitotic progression, which is required for both chromosome congression and checkpoint-induced anaphase delay. TAO1 may play a role in protecting genomic stability. Length = 317

>gnl|CDD|132987 cd06656, STKc_PAK3, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

 Score = 75.1 bits (184), Expect = 5e-15
 Identities = 69/259 (26%), Positives = 117/259 (45%), Gaps = 40/259 (15%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNIH 65
           A++++ + Q  K E +++ I + R   N         YLV D      E+   G L+++ 
Sbjct: 48  AIKQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDVV 107

Query: 66  VKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG     +Q
Sbjct: 108 TETCMDEGQIAAVCRECLQALDFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQ 164

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
               Q  R T  V T ++  PE++   + YGP VD+W  G +  EM    P        +
Sbjct: 165 ITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMVEGEPPYLNENPLR 222

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            + LI+    + TPE             ++ P        ERL    +     D L++ L
Sbjct: 223 ALYLIAT---NGTPE-------------LQNP--------ERLSAVFR-----DFLNRCL 253

Query: 244 LLDPSKRFDSDAALNHDFF 262
            +D  +R  +   L H F 
Sbjct: 254 EMDVDRRGSAKELLQHPFL 272

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding site for PIX (PAK-interacting exchange factor). PAK3 is highly expressed in the brain. It is implicated in neuronal plasticity, synapse formation, dendritic spine morphogenesis, cell cycle progression, neuronal migration, and apoptosis. Inactivating mutations in the PAK3 gene cause X-linked non-syndromic mental retardation, the severity of which depends on the site of the mutation. Length = 297

>gnl|CDD|132982 cd06651, STKc_MEKK3, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

 Score = 74.3 bits (182), Expect = 6e-15
 Identities = 55/171 (32%), Positives = 89/171 (52%), Gaps = 15/171 (8%)

Query: 8   ITALR-EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN-IH 65
           ++AL  EI++L+ L+HE +V      R +A +      T  +   F E+   G + + + 
Sbjct: 48  VSALECEIQLLKNLQHERIVQYYGCLRDRAEK------TLTI---FMEYMPGGSVKDQLK 98

Query: 66  VKFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
              +L E   +K  +Q+L G+ Y+HSN I+HRD+K AN+L    G +KL DFG ++   Q
Sbjct: 99  AYGALTESVTRKYTRQILEGMSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRL-Q 157

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           T         +   T ++  PE++ G+  YG   D+W  GC + EM T  P
Sbjct: 158 TICMSGTGIRSVTGTPYWMSPEVISGE-GYGRKADVWSLGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. In addition, MEKK3 is involved in interleukin-1 receptor and Toll-like receptor 4 signaling. It is also a specific regulator of the proinflammatory cytokines IL-6 and GM-CSF in some immune cells. MEKK3 also regulates calcineurin, which plays a critical role in T cell activation, apoptosis, skeletal myocyte differentiation, and cardiac hypertrophy. Length = 266

>gnl|CDD|173664 cd05573, STKc_ROCK_NDR_like, Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

 Score = 75.4 bits (186), Expect = 6e-15
 Identities = 46/149 (30%), Positives = 62/149 (41%), Gaps = 28/149 (18%)

Query: 47  YLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT 105
           YLV ++    DL  LL    V F     +  I +L+  L  +H    +HRD+K  N+LI 
Sbjct: 77  YLVMEYMPGGDLMNLLIRKDV-FPEETARFYIAELVLALDSVHKLGFIHRDIKPDNILID 135

Query: 106 KTGILKLADFGLARAFSQTKNG------------------------QVNRYTNRVV-TLW 140
             G +KLADFGL +  ++ K+                         Q     N  V T  
Sbjct: 136 ADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD 195

Query: 141 YRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           Y  PE+L G   YG   D W  G I+ EM
Sbjct: 196 YIAPEVLRG-TPYGLECDWWSLGVILYEM 223

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Proteins in this subfamily are involved in regulating many cellular functions including contraction, motility, division, proliferation, apoptosis, morphogenesis, and cytokinesis. Length = 350

>gnl|CDD|132983 cd06652, STKc_MEKK2, Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

 Score = 73.9 bits (181), Expect = 7e-15
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 2/101 (1%)

Query: 74  KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT 133
           +K  +Q+L G+ Y+HSN I+HRD+K AN+L    G +KL DFG ++   QT         
Sbjct: 109 RKYTRQILEGVSYLHSNMIVHRDIKGANILRDSVGNVKLGDFGASKRL-QTICLSGTGMK 167

Query: 134 NRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +   T ++  PE++ G+  YG   D+W  GC + EM T  P
Sbjct: 168 SVTGTPYWMSPEVISGE-GYGRKADIWSVGCTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their respective MAPKKs MEK1/2, JNK-activating kinase 2 (JNKK2), and MKK3/6. MEKK2 plays roles in T cell receptor signaling, immune synapse formation, cytokine gene expression, as well as in EGF and FGF receptor signaling. Length = 265

>gnl|CDD|173637 cd05059, PTKc_Tec_like, Catalytic domain of Tec-like Protein Tyrosine Kinases

 Score = 73.6 bits (181), Expect = 8e-15
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 19/163 (11%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           E K++  L H N+V L  +C        + R   ++V ++  +  L   L     K    
Sbjct: 49  EAKVMMKLSHPNLVQLYGVC-------TKQRP-IFIVTEYMANGCLLNYLRERKGKLGTE 100

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
            +  +   +   + Y+ SN  +HRD+ A N L+ +  ++K++DFGLAR          ++
Sbjct: 101 WLLDMCSDVCEAMEYLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLD------DQ 154

Query: 132 YTNRVVTLW---YRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           YT+   T +   + PPE+    R +    D+W  G +M E+++
Sbjct: 155 YTSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVLMWEVFS 196

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, some members contain the Tec homology (TH) domain, which contains proline-rich and zinc-binding regions. Tec kinases form the second largest subfamily of nRTKs and are expressed mainly by haematopoietic cells, although Tec and Bmx are also found in endothelial cells. B-cells express Btk and Tec, while T-cells express Itk, Txk, and Tec. Collectively, Tec kinases are expressed in a variety of myeloid cells such as mast cells, platelets, macrophages, and dendritic cells. Each Tec kinase shows a distinct cell-type pattern of expression. The function of Tec kinases in lymphoid cells have been studied extensively. They play important roles in the development, differentiation, maturation, regulation, survival, and function of B-cells and T-cells. Mutations in Btk cause the severe B-cell immunodeficiency, X-linked agammaglobulinaemia (XLA). Length = 256

>gnl|CDD|173763 cd08223, STKc_Nek4, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

 Score = 72.7 bits (178), Expect = 2e-14
 Identities = 52/164 (31%), Positives = 77/164 (46%), Gaps = 14/164 (8%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           A +E ++L  LKH N+V   E    +           Y+V  FCE  DL   L     K 
Sbjct: 46  AEQEAQLLSQLKHPNIVAYRESWEGEDGL-------LYIVMGFCEGGDLYHKLKEQKGKL 98

Query: 69  SL-GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
               ++ +   Q+   L Y+H   ILHRD+K  NV +T+T I+K+ D G+AR        
Sbjct: 99  LPENQVVEWFVQIAMALQYLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLEN---- 154

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           Q +  +  + T +Y  PE L  ++ Y    D+W  GC + EM T
Sbjct: 155 QCDMASTLIGTPYYMSPE-LFSNKPYNYKSDVWALGCCVYEMAT 197

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown. Length = 257

>gnl|CDD|177557 PHA03209, PHA03209, serine/threonine kinase US3; Provisional

 Score = 73.8 bits (181), Expect = 2e-14
 Identities = 63/279 (22%), Positives = 108/279 (38%), Gaps = 52/279 (18%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQ---YNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           T L E  +LQ + H +V+ + +   + A        Y S           DL   L+   
Sbjct: 103 TTLIEAMLLQNVNHPSVIRMKDTLVSGAITCMVLPHYSS-----------DLYTYLTKRS 151

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               + +   + +Q+L GL Y+H+ +I+HRD+K  N+ I     + + D G A+      
Sbjct: 152 RPLPIDQALIIEKQILEGLRYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVAP 211

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQG------ 178
                 +     T+    PE+L  D+ Y    D+W AG ++ EM    S I +       
Sbjct: 212 A-----FLGLAGTVETNAPEVLARDK-YNSKADIWSAGIVLFEMLAYPSTIFEDPPSTPE 265

Query: 179 ----NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY 234
               +     + +IS L   + PE +P      L        + +R      +PY   +Y
Sbjct: 266 EYVKSCHSHLLKIISTL--KVHPEEFPRDPGSRLVRGFIEYASLER------QPYT--RY 315

Query: 235 GCD-----------LLDKLLLLDPSKRFDSDAALNHDFF 262
            C            L+ K+L  D + R  ++  LN+  F
Sbjct: 316 PCFQRVNLPIDGEFLVHKMLTFDAAMRPSAEEILNYPMF 354

Length = 357

>gnl|CDD|132975 cd06644, STKc_STK10_LOK, Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

 Score = 73.1 bits (179), Expect = 2e-14
 Identities = 50/170 (29%), Positives = 84/170 (49%), Gaps = 23/170 (13%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG- 71
           EI+IL    H  +V L+            +    +++ +FC     G +  I ++   G 
Sbjct: 59  EIEILATCNHPYIVKLLGAFY--------WDGKLWIMIEFCP---GGAVDAIMLELDRGL 107

Query: 72  ---EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I+ + +Q+L  L Y+HS KI+HRD+KA NVL+T  G +KLADFG++    +T    
Sbjct: 108 TEPQIQVICRQMLEALQYLHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKT---- 163

Query: 129 VNRYTNRVVTLWYRPPELL----LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           + R  + + T ++  PE++    + D  Y    D+W  G  + EM    P
Sbjct: 164 LQRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 213

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types. Length = 292

>gnl|CDD|173691 cd05600, STKc_Sid2p_Dbf2p, Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

 Score = 73.2 bits (180), Expect = 2e-14
 Identities = 60/205 (29%), Positives = 90/205 (43%), Gaps = 41/205 (20%)

Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G+LS  H +F + E+ + +  L       H    +HRD+K  N LI  +G +KL DFGL+
Sbjct: 96  GVLSEDHARFYMAEMFEAVDAL-------HELGYIHRDLKPENFLIDASGHIKLTDFGLS 148

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
           +         V    + V +  Y  PE+L G + Y   VD W  GC++ E     P    
Sbjct: 149 KGI-------VTYANSVVGSPDYMAPEVLRG-KGYDFTVDYWSLGCMLYEFLCGFP---- 196

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
                         GS   E+W   E L  + +       +R V +  +  + D+   DL
Sbjct: 197 -----------PFSGSTPNETW---ENLKYWKET-----LQRPVYDDPRFNLSDE-AWDL 236

Query: 239 LDKLLLLDPSKRFDS-DAALNHDFF 262
           + K L+ DPS+RF S +   NH FF
Sbjct: 237 ITK-LINDPSRRFGSLEDIKNHPFF 260

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis. Dbf2p is important in regulating the mitotic exit network (MEN) and in cytokinesis. Length = 333

>gnl|CDD|132976 cd06645, STKc_MAP4K3, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

 Score = 72.0 bits (176), Expect = 3e-14
 Identities = 54/170 (31%), Positives = 84/170 (49%), Gaps = 20/170 (11%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSL 70
           +EI +++  KH N+V            Y R R   ++  +FC     G L +I HV   L
Sbjct: 55  QEIIMMKDCKHSNIVAYF-------GSYLR-RDKLWICMEFCG---GGSLQDIYHVTGPL 103

Query: 71  GE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            E  I  V ++ L GLYY+HS   +HRD+K AN+L+T  G +KLADFG++   + T    
Sbjct: 104 SESQIAYVSRETLQGLYYLHSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITAT---- 159

Query: 129 VNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIM 176
           + +  + + T ++  PE+   +R   Y    D+W  G    E+    P M
Sbjct: 160 IAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K3 plays a role in the nutrient-responsive pathway of mTOR (mammalian target of rapamycin) signaling. MAP4K3 is required in the activation of S6 kinase by amino acids and for the phosphorylation of the mTOR-regulated inhibitor of eukaryotic initiation factor 4E. mTOR regulates ribosome biogenesis and protein translation, and is frequently deregulated in cancer. Length = 267

>gnl|CDD|132984 cd06653, STKc_MEKK3_like_1, Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

 Score = 71.6 bits (175), Expect = 4e-14
 Identities = 48/165 (29%), Positives = 81/165 (49%), Gaps = 14/165 (8%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN-IHVKFSLG 71
           EI++L+ L+H+ +V      R    +          +  F E+   G + + +    +L 
Sbjct: 54  EIQLLKNLRHDRIVQYYGCLRDPEEKK---------LSIFVEYMPGGSIKDQLKAYGALT 104

Query: 72  E--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           E   ++  +Q+L G+ Y+HSN I+HRD+K AN+L    G +KL DFG ++   QT     
Sbjct: 105 ENVTRRYTRQILQGVSYLHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRI-QTICMSG 163

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
               +   T ++  PE++ G+  YG   D+W   C + EM T  P
Sbjct: 164 TGIKSVTGTPYWMSPEVISGE-GYGRKADVWSVACTVVEMLTEKP 207

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK2 and MEKK3 activate MEK5 (also called MKK5), which activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development. MEKK2 and MEKK3 can also activate the MAPKs, c-Jun N-terminal kinase (JNK) and p38, through their respective MAPKKs. Length = 264

>gnl|CDD|173768 cd08228, STKc_Nek6, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

 Score = 71.6 bits (175), Expect = 5e-14
 Identities = 58/198 (29%), Positives = 95/198 (47%), Gaps = 28/198 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           ++EI +L+ L H NV+  ++    + N+ N       +V +  +   AG LS +   F  
Sbjct: 50  VKEIDLLKQLNHPNVIKYLD-SFIEDNELN-------IVLELAD---AGDLSQMIKYFKK 98

Query: 71  GE-------IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            +       + K   QL + + ++HS +++HRD+K ANV IT TG++KL D GL R FS 
Sbjct: 99  QKRLIPERTVWKYFVQLCSAVEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSS 158

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
               +     + V T +Y  PE  + +  Y    D+W  GC++ EM      +Q      
Sbjct: 159 ----KTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM----AALQSPFYGD 209

Query: 184 QITLISQLCGSITPESWP 201
           ++ L S LC  I    +P
Sbjct: 210 KMNLFS-LCQKIEQCDYP 226

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase and anaphase, and to the midbody during cytokinesis. Length = 267

>gnl|CDD|173628 cd05038, PTKc_Jak_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

 Score = 71.7 bits (176), Expect = 5e-14
 Identities = 48/185 (25%), Positives = 81/185 (43%), Gaps = 19/185 (10%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L HEN+V    +C            +  L+ ++     L   L     + +L
Sbjct: 55  REIEILRTLDHENIVKYKGVC------EKPGGRSLRLIMEYLPSGSLRDYLQRHRDQINL 108

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+ S + +HRD+ A N+L+    ++K++DFGLA+   + K+    
Sbjct: 109 KRLLLFSSQICKGMDYLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDYYYV 168

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-----SPI-----MQGNT 180
           +        WY  PE L   +      D+W  G  + E++T      SP      M G  
Sbjct: 169 KEPGESPIFWY-APECLRTSKFSSAS-DVWSFGVTLYELFTYGDPSQSPPAEFLRMIGIA 226

Query: 181 EQQQI 185
           + Q I
Sbjct: 227 QGQMI 231

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jaks are also involved in regulating the surface expression of some cytokine receptors. The Jak-STAT pathway is involved in many biological processes including hematopoiesis, immunoregulation, host defense, fertility, lactation, growth, and embryogenesis. Length = 284

>gnl|CDD|173502 PTZ00266, PTZ00266, NIMA-related protein kinase; Provisional

 Score = 73.6 bits (180), Expect = 6e-14
 Identities = 64/213 (30%), Positives = 105/213 (49%), Gaps = 52/213 (24%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL-G 71
           E+ +++ LKH+N+V  I+    KANQ        Y++ +FC  D   L  NI   + + G
Sbjct: 62  EVNVMRELKHKNIVRYIDRFLNKANQ------KLYILMEFC--DAGDLSRNIQKCYKMFG 113

Query: 72  EIKK-----VIQQLLNGLYYIHS-------NKILHRDMKAANVLITKTG----------- 108
           +I++     + +QLL+ L Y H+        ++LHRD+K  N+ ++ TG           
Sbjct: 114 KIEEHAIVDITRQLLHALAYCHNLKDGPNGERVLHRDLKPQNIFLS-TGIRHIGKITAQA 172

Query: 109 -------ILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGD-RNYGPPVDL 159
                  I K+ DFGL      +KN  +    +  V T +Y  PELLL + ++Y    D+
Sbjct: 173 NNLNGRPIAKIGDFGL------SKNIGIESMAHSCVGTPYYWSPELLLHETKSYDDKSDM 226

Query: 160 WGAGCIMAEMWT-RSPIMQGNTEQQQITLISQL 191
           W  GCI+ E+ + ++P  + N   Q   LIS+L
Sbjct: 227 WALGCIIYELCSGKTPFHKANNFSQ---LISEL 256

Length = 1021

>gnl|CDD|132990 cd06659, STKc_PAK6, Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

 Score = 71.2 bits (174), Expect = 9e-14
 Identities = 68/272 (25%), Positives = 121/272 (44%), Gaps = 55/272 (20%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNIHVKF 68
           E+ I++  +H+NVV +             Y+S  YLV +      E    G L++I  + 
Sbjct: 68  EVVIMRDYQHQNVVEM-------------YKS--YLVGEELWVLMEFLQGGALTDIVSQT 112

Query: 69  SLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            L E  I  V + +L  L Y+HS  ++HRD+K+ ++L+T  G +KL+DFG     S+   
Sbjct: 113 RLNEEQIATVCESVLQALCYLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK--- 169

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
             V +  + V T ++  PE ++    YG  VD+W  G ++ EM    P    ++    + 
Sbjct: 170 -DVPKRKSLVGTPYWMAPE-VISRTPYGTEVDIWSLGIMVIEMVDGEPPYFSDSP---VQ 224

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            + +L  S  P                     K K   ++ P ++     D L+++L  +
Sbjct: 225 AMKRLRDSPPP---------------------KLKNAHKISPVLR-----DFLERMLTRE 258

Query: 247 PSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
           P +R  +   L+H F     +P  L  ++ Q+
Sbjct: 259 PQERATAQELLDHPFLLQTGLPECLVPLIQQY 290

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role in stress responses through its activation by the mitogen-activated protein kinase (MAPK) p38 and MAPK kinase 6 (MKK6) pathway. PAK6 is highly expressed in the brain. It is not required for viability, but together with PAK5, it is required for normal levels of locomotion and activity, and for learning and memory. Increased expression of PAK6 is found in primary and metastatic prostate cancer. PAK6 may play a role in the regulation of motility. Length = 297

>gnl|CDD|173769 cd08229, STKc_Nek7, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

 Score = 70.8 bits (173), Expect = 1e-13
 Identities = 50/169 (29%), Positives = 84/169 (49%), Gaps = 29/169 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFY------LVFDFCEH-DLAGLLSN 63
           ++EI +L+ L H NV+              +Y ++F       +V +  +  DL+ ++ +
Sbjct: 50  IKEIDLLKQLNHPNVI--------------KYYASFIEDNELNIVLELADAGDLSRMIKH 95

Query: 64  IHVKFSL---GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
              +  L     + K   QL + L ++HS +++HRD+K ANV IT TG++KL D GL R 
Sbjct: 96  FKKQKRLIPEKTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRF 155

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           FS     +     + V T +Y  PE  + +  Y    D+W  GC++ EM
Sbjct: 156 FSS----KTTAAHSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEM 199

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase. Length = 267

>gnl|CDD|173677 cd05586, STKc_Sck1_like, Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

 Score = 71.5 bits (175), Expect = 1e-13
 Identities = 42/119 (35%), Positives = 64/119 (53%), Gaps = 9/119 (7%)

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +FS    K  I +L+  L ++H   I++RD+K  N+L+  TG + L DFGL++A + T N
Sbjct: 92  RFSEDRAKFYIAELVLALEHLHKYDIVYRDLKPENILLDATGHIALCDFGLSKA-NLTDN 150

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM---WTRSPIMQGNTEQ 182
              N +     T  Y  PE+LL ++ Y   VD W  G ++ EM   W  SP    +T+Q
Sbjct: 151 KTTNTFCG---TTEYLAPEVLLDEKGYTKHVDFWSLGVLVFEMCCGW--SPFYAEDTQQ 204

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of yeast to environmental changes. Length = 330

>gnl|CDD|173762 cd08222, STKc_Nek11, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

 Score = 70.0 bits (171), Expect = 1e-13
 Identities = 44/131 (33%), Positives = 68/131 (51%), Gaps = 10/131 (7%)

Query: 43  RSTFYLVFDFCE-HDLAGLLSNIH---VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMK 98
           R  F ++ ++CE  DL   L  +       S  ++ +   QLL G++Y+H  +ILHRD+K
Sbjct: 74  RDAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLGVHYMHQRRILHRDLK 133

Query: 99  AANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD 158
           A N+ + K  +LK+ DFG++R       G  +  T    T +Y  PE  L  + Y    D
Sbjct: 134 AKNIFL-KNNLLKIGDFGVSRLLM----GSCDLATTFTGTPYYMSPE-ALKHQGYDSKSD 187

Query: 159 LWGAGCIMAEM 169
           +W  GCI+ EM
Sbjct: 188 IWSLGCILYEM 198

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M checkpoint. Nek11 may also play a role in the S-phase checkpoint as well as in DNA replication and genotoxic stress responses. Length = 260

>gnl|CDD|133172 cd05040, PTKc_Ack_like, Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

 Score = 69.7 bits (171), Expect = 2e-13
 Identities = 45/165 (27%), Positives = 73/165 (44%), Gaps = 17/165 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--- 67
           L+E  I+  L HEN++ L  +  T             +V +     L  LL  +      
Sbjct: 44  LKEAAIMHSLDHENLIRLYGVVLTHP---------LMMVTELAP--LGSLLDRLRKDALG 92

Query: 68  -FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            F +  +     Q+ NG+ Y+ S + +HRD+ A N+L+     +K+ DFGL RA  Q ++
Sbjct: 93  HFLISTLCDYAVQIANGMRYLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED 152

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             V    +  V   +  PE  L  R +    D+W  G  + EM+T
Sbjct: 153 HYVMEE-HLKVPFAWCAPE-SLRTRTFSHASDVWMFGVTLWEMFT 195

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with androgen-independent prostate cancer progression. Tnk1 regulates TNFalpha signaling and may play an important role in cell death. Length = 257

>gnl|CDD|173662 cd05571, STKc_PKB, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

 Score = 69.8 bits (171), Expect = 4e-13
 Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 60/203 (29%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 103 EIVSALGYLHSCDVVYRDLKLENLMLDKDGHIKITDFGLC------KEGISDGATMKTFC 156

Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSIT 196
            T  Y  PE +L D +YG  VD WG G +M EM                     +CG   
Sbjct: 157 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM---------------------MCGR-- 192

Query: 197 PESWPGVETLDLYNK-----MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF 251
                    L  YN+      EL   ++ +    L P  K      LL  LL  DP +R 
Sbjct: 193 ---------LPFYNQDHEKLFELILMEEIRFPRTLSPEAK-----SLLAGLLKKDPKQRL 238

Query: 252 -----DSDAALNHDFF----WTD 265
                D+   + H FF    W D
Sbjct: 239 GGGPEDAKEIMEHRFFASINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having been implicated in tumor initiation, progression, and metastasis. Length = 323

>gnl|CDD|133232 cd05101, PTKc_FGFR2, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

 Score = 69.3 bits (169), Expect = 4e-13
 Identities = 50/180 (27%), Positives = 90/180 (50%), Gaps = 36/180 (20%)

Query: 13  EIKILQLL-KHENVVHLIEICR------------TKAN--QYNRYRSTFYLVFDFCEHDL 57
           E+++++++ KH+N+++L+  C             +K N  +Y R R    + + +   D+
Sbjct: 70  EMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY---DI 126

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
           A +      + +  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGL
Sbjct: 127 ARVPDE---QMTFKDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGL 183

Query: 118 ARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           AR       + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 184 ARDVNNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. There are many splice variants of FGFR2 which show differential expression and binding to FGF ligands. Disruption of either FGFR2 or FGFR2b is lethal in mice, due to defects in the placenta or severe impairment of tissue development including lung, limb, and thyroid, respectively. Disruption of FGFR2c in mice results in defective bone and skull development. Genetic alterations of FGFR2 are associated with many human skeletal disorders including Apert syndrome, Crouzon syndrome, Jackson-Weiss syndrome, and Pfeiffer syndrome. Length = 304

>gnl|CDD|132971 cd06640, STKc_MST4, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

 Score = 68.9 bits (168), Expect = 4e-13
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 102 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 158

Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 159 NTFVGTPFWMAPE--VIQQSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by interacting with the Golgi matrix protein GM130 and may play a role in cell migration. Length = 277

>gnl|CDD|173645 cd05084, PTKc_Fes, Catalytic domain of the Protein Tyrosine Kinase, Fes

 Score = 68.5 bits (167), Expect = 5e-13
 Identities = 55/207 (26%), Positives = 96/207 (46%), Gaps = 21/207 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E +IL+   H N+V LI +C  K           Y+V +  +  D    L     +  
Sbjct: 41  LQEARILKQYSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTEGPRLK 92

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + E+ ++++    G+ Y+ S   +HRD+ A N L+T+  +LK++DFG++R   + ++G V
Sbjct: 93  VKELIQMVENAAAGMEYLESKHCIHRDLAARNCLVTEKNVLKISDFGMSR---EEEDG-V 148

Query: 130 NRYTN--RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN-TEQQQIT 186
              T   + + + +  PE L   R Y    D+W  G ++ E ++   +   N + QQ   
Sbjct: 149 YASTGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILLWEAFSLGAVPYANLSNQQTRE 207

Query: 187 LISQLCGSITPESWPGVETLDLYNKME 213
            I Q      PE  P      +Y  ME
Sbjct: 208 AIEQGVRLPCPELCPD----AVYRLME 230

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular endothelial, epithelial, and neuronal cells. It plays important roles in cell growth and differentiation, angiogenesis, inflammation and immunity, and cytoskeletal regulation. A recent study implicates Fes kinase as a tumor suppressor in colorectal cancer. Length = 252

>gnl|CDD|133212 cd05081, PTKc_Jak2_Jak3_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

 Score = 68.3 bits (167), Expect = 7e-13
 Identities = 48/184 (26%), Positives = 80/184 (43%), Gaps = 19/184 (10%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    LV ++  +  L   L     +   
Sbjct: 54  REIEILKSLQHDNIVKYKGVC------YSAGRRNLRLVMEYLPYGSLRDYLQKHRERLDH 107

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++     Q+  G+ Y+ S + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 108 RKLLLYASQICKGMEYLGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEYYKV 167

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI----------MQGNT 180
           R        WY P    L +  +    D+W  G ++ E++T S            M GN 
Sbjct: 168 REPGESPIFWYAPES--LTESKFSVASDVWSFGVVLYELFTYSDKSCSPPAEFMRMMGND 225

Query: 181 EQQQ 184
           +Q Q
Sbjct: 226 KQGQ 229

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak2 is widely expressed in many tissues while Jak3 is expressed only in hematopoietic cells. Jak2 is essential for the signaling of hormone-like cytokines such as growth hormone, erythropoietin, thrombopoietin, and prolactin, as well as some IFNs and cytokines that signal through the IL-3 and gp130 receptors. Jak3 binds the shared receptor subunit common gamma chain and thus, is essential in the signaling of cytokines that use it such as IL-2, IL-4, IL-7, IL-9, IL-15, and IL-21. Disruption of Jak2 in mice results in an embryonic lethal phenotype with multiple defects including erythropoietic and cardiac abnormalities. It is the only Jak gene that results in a lethal phenotype when disrupted in mice. A mutation in the pseudokinase domain of Jak2, V617F, is present in many myeloproliferative diseases, including almost all patients with polycythemia vera, and 50% of patients with essential thrombocytosis and myelofibrosis. Jak3 is important in lymphoid development and myeloid cell differentiation. Inactivating mutations in Jak3 have been reported in humans with severe combined immunodeficiency (SCID). Length = 284

>gnl|CDD|173692 cd05601, STKc_CRIK, Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

 Score = 68.7 bits (168), Expect = 8e-13
 Identities = 77/272 (28%), Positives = 110/272 (40%), Gaps = 50/272 (18%)

Query: 8   ITALREIKILQLLKHENVVHLIE---ICRTKAN------QYN-RYRSTFYLVFDFCEH-D 56
           I A++ +K   LL  E V    E   I     +      QY  + +   YLV ++    D
Sbjct: 28  IYAMKVMKKSVLLAQETVSFFEEERDILSISNSPWIPQLQYAFQDKDNLYLVMEYQPGGD 87

Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           L  LL+    +F     +  + +L+  ++ +H    +HRD+K  NVLI +TG +KLADFG
Sbjct: 88  LLSLLNRYEDQFDEDMAQFYLAELVLAIHSVHQMGYVHRDIKPENVLIDRTGHIKLADFG 147

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDRN--YGPPVDLWGAGCIMAEM-W 170
            A     T N  VN     V T  Y  PE+L    GD    YG   D W  G I  EM +
Sbjct: 148 SAARL--TANKMVNS-KLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWSLGVIAYEMIY 204

Query: 171 TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV 230
            RSP  +G +                       +T   YN +      +R +K    P V
Sbjct: 205 GRSPFHEGTS----------------------AKT---YNNI---MNFQRFLKFPEDPKV 236

Query: 231 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
              +  DL+   LL    +R   +    H FF
Sbjct: 237 SSDF-LDLIQS-LLCGQKERLGYEGLCCHPFF 266

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnormal cytokinesis and massive apoptosis in neuronal precursors. A Down syndrome critical region protein TTC3 interacts with CRIK and inhibits CRIK-dependent neuronal differentiation and neurite extension. Length = 330

>gnl|CDD|132977 cd06646, STKc_MAP4K5, Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

 Score = 67.8 bits (165), Expect = 9e-13
 Identities = 52/172 (30%), Positives = 84/172 (48%), Gaps = 24/172 (13%)

Query: 12  REIKILQLLKHENVVHLI--EICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKF 68
           +EI +++  KH N+V      + R K           ++  ++C     G L +I HV  
Sbjct: 55  QEIFMVKECKHCNIVAYFGSYLSREK----------LWICMEYCG---GGSLQDIYHVTG 101

Query: 69  SLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            L E  I  V ++ L GL Y+HS   +HRD+K AN+L+T  G +KLADFG+A   + T  
Sbjct: 102 PLSELQIAYVCRETLQGLAYLHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITAT-- 159

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIM 176
             + +  + + T ++  PE+   ++N  Y    D+W  G    E+    P M
Sbjct: 160 --IAKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGITAIELAELQPPM 209

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K5, also called germinal center kinase-related enzyme (GCKR), has been shown to activate the MAPK c-Jun N-terminal kinase (JNK). MAP4K5 also facilitates Wnt signaling in B cells, and may therefore be implicated in the control of cell fate, proliferation, and polarity. Length = 267

>gnl|CDD|215036 PLN00034, PLN00034, mitogen-activated protein kinase kinase; Provisional

 Score = 67.9 bits (166), Expect = 2e-12
 Identities = 56/193 (29%), Positives = 95/193 (49%), Gaps = 22/193 (11%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI+IL+ + H NVV        K +    +     ++ +F +    G L   H+     
Sbjct: 121 REIEILRDVNHPNVV--------KCHDMFDHNGEIQVLLEFMD---GGSLEGTHIA-DEQ 168

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
            +  V +Q+L+G+ Y+H   I+HRD+K +N+LI     +K+ADFG++R  +QT    ++ 
Sbjct: 169 FLADVARQILSGIAYLHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQT----MDP 224

Query: 132 YTNRVVTLWYRPPELLLGDRNYGP----PVDLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
             + V T+ Y  PE +  D N+G       D+W  G  + E +  R P   G  +    +
Sbjct: 225 CNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSLGVSILEFYLGRFPFGVGR-QGDWAS 283

Query: 187 LISQLCGSITPES 199
           L+  +C S  PE+
Sbjct: 284 LMCAICMSQPPEA 296

Length = 353

>gnl|CDD|173674 cd05583, STKc_MSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

 Score = 67.1 bits (164), Expect = 2e-12
 Identities = 52/207 (25%), Positives = 87/207 (42%), Gaps = 39/207 (18%)

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
            F+  E++  I +++  L ++H   I++RD+K  N+L+   G + L DFGL++ F   + 
Sbjct: 101 HFTESEVRVYIAEIVLALDHLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEE 160

Query: 127 GQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            +   +     T+ Y  PE++  G   +   VD W  G +  E+ T +     + EQ   
Sbjct: 161 ERAYSFCG---TIEYMAPEVIRGGSGGHDKAVDWWSLGVLTFELLTGASPFTVDGEQNSQ 217

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           + IS+    I     P  +T+         +A+                  D + KLL  
Sbjct: 218 SEISR---RILKSKPPFPKTMS-------AEAR------------------DFIQKLLEK 249

Query: 246 DPSKRF---DSDAALNHDFF----WTD 265
           DP KR     +D   NH FF    W D
Sbjct: 250 DPKKRLGANGADEIKNHPFFQGIDWDD 276

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines. This triggers phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) in the C-terminal extension of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSKs are predominantly nuclear proteins. They are widely expressed in many tissues including heart, brain, lung, liver, kidney, and pancreas. There are two isoforms of MSK, called MSK1 and MSK2. Length = 288

>gnl|CDD|132973 cd06642, STKc_STK25-YSK1, Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

 Score = 66.2 bits (161), Expect = 3e-12
 Identities = 36/102 (35%), Positives = 56/102 (54%), Gaps = 5/102 (4%)

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           I  +++++L GL Y+HS + +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R 
Sbjct: 103 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRN 159

Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 160 TFVGTPFWMAPE--VIKQSAYDFKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25 is a candidate gene responsible for pseudopseudohypoparathyroidism (PPHP), a disease that shares features with the Albright hereditary osteodystrophy (AHO) phenotype. Length = 277

>gnl|CDD|132972 cd06641, STKc_MST3, Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

 Score = 66.3 bits (161), Expect = 3e-12
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 102 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 158

Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 159 NTFVGTPFWMAPE--VIKQSAYDSKADIWSLGITAIELAKGEP 199

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and intrauterine growth retardation. Length = 277

>gnl|CDD|173700 cd05609, STKc_MAST, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

 Score = 66.3 bits (162), Expect = 4e-12
 Identities = 61/201 (30%), Positives = 87/201 (43%), Gaps = 52/201 (25%)

Query: 84  LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA--FSQTKN---GQVNRYTNRVV- 137
           L Y+H+  I+HRD+K  N+LIT  G +KL DFGL++    S T N   G + + T   + 
Sbjct: 114 LEYLHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLD 173

Query: 138 -----TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLC 192
                T  Y  PE++L  + YG PVD W  G I+ E         G+T ++   L  Q+ 
Sbjct: 174 KQVCGTPEYIAPEVIL-RQGYGKPVDWWAMGIILYEFLVGCVPFFGDTPEE---LFGQV- 228

Query: 193 GSITPE-SWP-GVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
             I+ +  WP G E L          AQ                  DL+ +LL  +P +R
Sbjct: 229 --ISDDIEWPEGDEALP-------ADAQ------------------DLISRLLRQNPLER 261

Query: 251 FDSDAALN---HDFF----WT 264
             +  A     H FF    W 
Sbjct: 262 LGTGGAFEVKQHRFFLGLDWN 282

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that are also expressed at neuromuscular junctions and postsynaptic densities. MAST1, MAST2, and MAST3 bind and phosphorylate the tumor suppressor PTEN, and may contribute to the regulation and stabilization of PTEN. MAST2 is involved in the regulation of the Fc-gamma receptor of the innate immune response in macrophages, and may also be involved in the regulation of the Na+/H+ exchanger NHE3. Length = 305

>gnl|CDD|173661 cd05570, STKc_PKC, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

 Score = 66.6 bits (163), Expect = 4e-12
 Identities = 35/103 (33%), Positives = 51/103 (49%), Gaps = 9/103 (8%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLW 140
           GL ++H   I++RD+K  NVL+   G +K+ADFG+       K G +   T      T  
Sbjct: 108 GLQFLHERGIIYRDLKLDNVLLDSEGHIKIADFGMC------KEGILGGVTTSTFCGTPD 161

Query: 141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           Y  PE+L     YGP VD W  G ++ EM       +G+ E +
Sbjct: 162 YIAPEILSYQ-PYGPAVDWWALGVLLYEMLAGQSPFEGDDEDE 203

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only require PS. PKCs phosphorylate and modify the activities of a wide variety of cellular proteins including receptors, enzymes, cytoskeletal proteins, transcription factors, and other kinases. They play a central role in signal transduction pathways that regulate cell migration and polarity, proliferation, differentiation, and apoptosis. Also included in this subfamily are the PKC-like proteins, called PKNs. Length = 318

>gnl|CDD|173644 cd05079, PTKc_Jak1_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

 Score = 66.1 bits (161), Expect = 4e-12
 Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 9/161 (5%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           +EI+IL+ L HEN+V    IC           +   L+ +F     L   L     K +L
Sbjct: 55  KEIEILRNLYHENIVKYKGICTEDGG------NGIKLIMEFLPSGSLKEYLPRNKNKINL 108

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            +  K   Q+  G+ Y+ S + +HRD+ A NVL+     +K+ DFGL +A    K     
Sbjct: 109 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEYYTV 168

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        WY  PE L+  + Y    D+W  G  + E+ T
Sbjct: 169 KDDLDSPVFWY-APECLIQSKFYIAS-DVWSFGVTLYELLT 207

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Jak1 is widely expressed in many tissues. Many cytokines are dependent on Jak1 for signaling, including those that use the shared receptor subunits common gamma chain (IL-2, IL-4, IL-7, IL-9, IL-15, IL-21) and gp130 (IL-6, IL-11, oncostatin M, G-CSF, and IFNs, among others). The many varied interactions of Jak1 and its ubiquitous expression suggest many biological roles. Jak1 is important in neurological development, as well as in lymphoid development and function. It also plays a role in the pathophysiology of cardiac hypertrophy and heart failure. A mutation in the ATP-binding site of Jak1 was identified in a human uterine leiomyosarcoma cell line, resulting in defective cytokine induction and antigen presentation, thus allowing the tumor to evade the immune system. Length = 284

>gnl|CDD|173658 cd05114, PTKc_Tec_Rlk, Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

 Score = 65.6 bits (160), Expect = 4e-12
 Identities = 44/182 (24%), Positives = 85/182 (46%), Gaps = 14/182 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E K++  L H  +V L  +C          +   Y+V +F E+  L   L     K S
Sbjct: 47  IEEAKVMMKLSHPKLVQLYGVCTQ--------QKPLYIVTEFMENGCLLNYLRQRQGKLS 98

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  + Q +  G+ Y+  N  +HRD+ A N L++ TG++K++DFG+ R      + + 
Sbjct: 99  KDMLLSMCQDVCEGMEYLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTR---YVLDDEY 155

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITLI 188
              +     + + PPE+    + Y    D+W  G +M E++T   +  +  +  + + +I
Sbjct: 156 TSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVLMWEVFTEGKMPFEKKSNYEVVEMI 214

Query: 189 SQ 190
           S+
Sbjct: 215 SR 216

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. Instead of PH, Rlk contains an N-terminal cysteine-rich region. In addition to PH, Tec also contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Tec is more widely-expressed than other Tec subfamily kinases. It is found in endothelial cells, both B- and T-cells, and a variety of myeloid cells including mast cells, erythroid cells, platelets, macrophages and neutrophils. Rlk is expressed in T-cells and mast cell lines. Tec and Rlk are both key components of T-cell receptor (TCR) signaling. They are important in TCR-stimulated proliferation, IL-2 production and phopholipase C-gamma1 activation. Length = 256

>gnl|CDD|133243 cd05112, PTKc_Itk, Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

 Score = 65.4 bits (159), Expect = 5e-12
 Identities = 45/178 (25%), Positives = 78/178 (43%), Gaps = 21/178 (11%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           E +++  L H  +V L  +C          RS   LVF+F EH  L+  L     KFS  
Sbjct: 49  EAQVMMKLSHPKLVQLYGVCTE--------RSPICLVFEFMEHGCLSDYLRAQRGKFSQE 100

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
            +  +   +  G+ Y+ S+ ++HRD+ A N L+ +  ++K++DFG+ R          ++
Sbjct: 101 TLLGMCLDVCEGMAYLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLD------DQ 154

Query: 132 YTNRVVT----LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           YT+   T     W  P         Y    D+W  G +M E+++       N    ++
Sbjct: 155 YTSSTGTKFPVKWSSPEVFSFS--KYSSKSDVWSFGVLMWEVFSEGKTPYENRSNSEV 210

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Itk contains the Tec homology (TH) domain containing one proline-rich region and a zinc-binding region. Tec kinases are expressed mainly by haematopoietic cells. Itk is expressed in T-cells and mast cells, and is important in their development and differentiation. Of the three Tec kinases expressed in T-cells, Itk plays the predominant role in T-cell receptor (TCR) signaling. It is activated by phosphorylation upon TCR crosslinking and is involved in the pathway resulting in phospholipase C-gamma1 activation and actin polymerization. It also plays a role in the downstream signaling of the T-cell costimulatory receptor CD28, the T-cell surface receptor CD2, and the chemokine receptor CXCR4. In addition, Itk is crucial for the development of T-helper(Th)2 effector responses. Length = 256

>gnl|CDD|132967 cd06636, STKc_MAP4K4_6, Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

 Score = 65.8 bits (160), Expect = 5e-12
 Identities = 53/190 (27%), Positives = 92/190 (48%), Gaps = 34/190 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFY----------------LVFDFCE 54
           L  IK++ + + E     +EI   K   ++R  +T+Y                LV +FC 
Sbjct: 43  LAAIKVMDVTEDEEEEIKLEINMLKKYSHHRNIATYYGAFIKKSPPGHDDQLWLVMEFCG 102

Query: 55  HDLAGLLSNIHVKFSLGE------IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG 108
              AG ++++ VK + G       I  + +++L GL ++H++K++HRD+K  NVL+T+  
Sbjct: 103 ---AGSVTDL-VKNTKGNALKEDWIAYICREILRGLAHLHAHKVIHRDIKGQNVLLTENA 158

Query: 109 ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----YGPPVDLWGAGC 164
            +KL DFG++    +T    V R    + T ++  PE++  D N    Y    D+W  G 
Sbjct: 159 EVKLVDFGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIWSLGI 214

Query: 165 IMAEMWTRSP 174
              EM   +P
Sbjct: 215 TAIEMAEGAP 224

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAP4K4 is also called Nck Interacting kinase (NIK). It facilitates the activation of the MAPKs, extracellular signal-regulated kinase (ERK) 1, ERK2, and c-Jun N-terminal kinase (JNK), by phosphorylating and activating MEKK1. MAP4K4 plays a role in tumor necrosis factor (TNF) alpha-induced insulin resistance. MAP4K4 silencing in skeletal muscle cells from type II diabetic patients restores insulin-mediated glucose uptake. MAP4K4, through JNK, also plays a broad role in cell motility, which impacts inflammation, homeostasis, as well as the invasion and spread of cancer. MAP4K4 is found to be highly expressed in most tumor cell lines relative to normal tissue. MAP4K6 (also called MINK for Misshapen/NIKs-related kinase) is activated after Ras induction and mediates activation of p38 MAPK. MAP4K6 plays a role in cell cycle arrest, cytoskeleton organization, cell adhesion, and cell motility. Length = 282

>gnl|CDD|173657 cd05113, PTKc_Btk_Bmx, Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

 Score = 65.3 bits (159), Expect = 5e-12
 Identities = 45/164 (27%), Positives = 82/164 (50%), Gaps = 17/164 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C     Q   Y  T Y+  + C   L   L     +F  
Sbjct: 47  IEEAKVMMKLSHEKLVQLYGVCTK---QRPIYIVTEYMS-NGC---LLNYLREHGKRFQP 99

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +  G+ Y+ S + +HRD+ A N L+   G +K++DFGL+R          +
Sbjct: 100 SQLLEMCKDVCEGMAYLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLD------D 153

Query: 131 RYTNRVVTLW---YRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V + +   + PPE+LL  + +    D+W  G +M E+++
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVLMWEVYS 196

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activation. In addition, Btk contains the Tec homology (TH) domain with proline-rich and zinc-binding regions. Tec kinases are expressed mainly by haematopoietic cells. Btk is expressed in B-cells, and a variety of myeloid cells including mast cells, platelets, neutrophils, and dendrictic cells. It interacts with a variety of partners, from cytosolic proteins to nuclear transcription factors, suggesting a diversity of functions. Stimulation of a diverse array of cell surface receptors, including antigen engagement of the B-cell receptor (BCR), leads to PH-mediated membrane translocation of Btk and subsequent phosphorylation by Src kinase and activation. Btk plays an important role in the life cycle of B-cells including their development, differentiation, proliferation, survival, and apoptosis. Mutations in Btk cause the primary immunodeficiency disease, X-linked agammaglobulinaemia (XLA) in humans. Bmx is primarily expressed in bone marrow and the arterial endothelium, and plays an important role in ischemia-induced angiogenesis. It facilitates arterial growth, capillary formation, vessel maturation, and bone marrow-derived endothelial progenitor cell mobilization. Length = 256

>gnl|CDD|173696 cd05605, STKc_GRK4_like, Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

 Score = 65.6 bits (160), Expect = 6e-12
 Identities = 31/91 (34%), Positives = 52/91 (57%), Gaps = 6/91 (6%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++  GL  +H  +I++RD+K  N+L+   G ++++D GLA    +   G+  R   RV T
Sbjct: 110 EITCGLEDLHRERIVYRDLKPENILLDDYGHIRISDLGLA---VEIPEGETIR--GRVGT 164

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + Y  PE++  +R Y    D WG GC++ EM
Sbjct: 165 VGYMAPEVVKNER-YTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5, GRK6, and similar GRKs. GRKs in this group contain an N-terminal RGS homology (RH) domain and a catalytic domain, but lack a G protein betagamma-subunit binding domain. They are localized to the plasma membrane through post-translational lipid modification or direct binding to PIP2. Length = 285

>gnl|CDD|133230 cd05099, PTKc_FGFR4, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

 Score = 65.8 bits (160), Expect = 7e-12
 Identities = 51/184 (27%), Positives = 87/184 (47%), Gaps = 40/184 (21%)

Query: 11  LREIKILQLL-KHENVVHLIEICR------------TKAN--QYNRYRS--TFYLVFDFC 53
           + E+++++L+ KH+N+++L+ +C              K N  ++ R R        FD  
Sbjct: 65  ISEMELMKLIGKHKNIINLLGVCTQEGPLYVIVEYAAKGNLREFLRARRPPGPDYTFDIT 124

Query: 54  EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
           +     L        S  ++     Q+  G+ Y+ S + +HRD+ A NVL+T+  ++K+A
Sbjct: 125 KVPEEQL--------SFKDLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIA 176

Query: 114 DFGLARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA 167
           DFGLAR       + +T NG       R+   W  P  L   DR Y    D+W  G +M 
Sbjct: 177 DFGLARGVHDIDYYKKTSNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGILMW 227

Query: 168 EMWT 171
           E++T
Sbjct: 228 EIFT 231

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Unlike other FGFRs, there is only one splice form of FGFR4. It binds FGF1, FGF2, FGF6, FGF19, and FGF23. FGF19 is a selective ligand for FGFR4. Although disruption of FGFR4 in mice causes no obvious phenotype, in vivo inhibition of FGFR4 in cultured skeletal muscle cells resulted in an arrest of muscle progenitor differentiation. FGF6 and FGFR4 are uniquely expressed in myofibers and satellite cells. FGF6/FGFR4 signaling appears to play a key role in the regulation of muscle regeneration. A polymorphism in FGFR4 is found in head and neck squamous cell carcinoma. Length = 314

>gnl|CDD|173725 cd06608, STKc_myosinIII_like, Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

 Score = 65.4 bits (160), Expect = 7e-12
 Identities = 45/166 (27%), Positives = 73/166 (43%), Gaps = 15/166 (9%)

Query: 13  EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH----DLAGLLSNIHVK 67
           E  IL+    H N+         K N         +LV + C      DL   L     +
Sbjct: 52  EYNILRKYSNHPNIATFYG-AFIKKNPPGN-DDQLWLVMELCGGGSVTDLVKGLRKKGKR 109

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
                I  ++++ L GL Y+H NK++HRD+K  N+L+TK   +KL DFG++     +  G
Sbjct: 110 LKEEWIAYILRETLRGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQ-LDSTLG 168

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRN----YGPPVDLWGAGCIMAEM 169
           + N +   + T ++  PE++  D      Y    D+W  G    E+
Sbjct: 169 RRNTF---IGTPYWMAPEVIACDEQPDASYDARSDVWSLGITAIEL 211

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin III may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. It may also function as a cargo carrier during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. The Drosophila class III myosin, called NinaC (Neither inactivation nor afterpotential protein C), is critical in normal adaptation and termination of photoresponse. Vertebrates contain two isoforms of class III myosin, IIIA and IIIB. This subfamily also includes mammalian NIK-like embryo-specific kinase (NESK), Traf2- and Nck-interacting kinase (TNIK), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6). MAP4Ks are involved in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated either by a small GTP-binding protein or by an adaptor protein, which transmits the signal either directly to a MAP3K to start the triple kinase core cascade or indirectly through a mediator kinase, a MAP4K. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Length = 275

>gnl|CDD|132968 cd06637, STKc_TNIK, Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

 Score = 64.7 bits (157), Expect = 1e-11
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 18/139 (12%)

Query: 46  FYLVFDFCEHDLAGLLSNIHVKFSLGE------IKKVIQQLLNGLYYIHSNKILHRDMKA 99
            +LV +FC    AG ++++ +K + G       I  + +++L GL ++H +K++HRD+K 
Sbjct: 84  LWLVMEFCG---AGSVTDL-IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 139

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----YGP 155
            NVL+T+   +KL DFG++    +T    V R    + T ++  PE++  D N    Y  
Sbjct: 140 QNVLLTENAEVKLVDFGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDF 195

Query: 156 PVDLWGAGCIMAEMWTRSP 174
             DLW  G    EM   +P
Sbjct: 196 KSDLWSLGITAIEMAEGAP 214

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activates the c-Jun N-terminal kinase (JNK) pathway and plays a role in regulating the actin cytoskeleton. Length = 272

>gnl|CDD|133186 cd05055, PTKc_PDGFR, Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 45/164 (27%), Positives = 78/164 (47%), Gaps = 14/164 (8%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVK 67
           + E+KI+  L  HEN+V+L+  C T             ++ ++C + DL   L       
Sbjct: 86  MSELKIMSHLGNHENIVNLLGAC-TIG-------GPILVITEYCCYGDLLNFLRRKRESF 137

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            +L ++     Q+  G+ ++ S   +HRD+ A NVL+T   I+K+ DFGLAR      N 
Sbjct: 138 LTLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSN- 196

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            V +   R+   W  P  +   +  Y    D+W  G ++ E+++
Sbjct: 197 YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGILLWEIFS 238

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR subfamily receptors are important in the development of a variety of cells. PDGFRs are expressed in a many cells including fibroblasts, neurons, endometrial cells, mammary epithelial cells, and vascular smooth muscle cells. PDGFR signaling is critical in normal embryonic development, angiogenesis, and wound healing. PDGFRs transduce mitogenic signals for connective tissue cells and are important for cell shape and motility. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. Mammalian FLT3 plays an important role in the survival, proliferation, and differentiation of stem cells. Length = 302

>gnl|CDD|173684 cd05593, STKc_PKB_gamma, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

 Score = 65.1 bits (158), Expect = 1e-11
 Identities = 57/199 (28%), Positives = 85/199 (42%), Gaps = 52/199 (26%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS KI++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 103 EIVSALDYLHSGKIVYRDLKLENLMLDKDGHIKITDFGLC------KEGITDAATMKTFC 156

Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSI 195
            T  Y  PE +L D +YG  VD WG G +M EM   R P    + E+             
Sbjct: 157 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEMMCGRLPFYNQDHEK------------- 202

Query: 196 TPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---- 251
                  +  L L   ++ P+      K              LL  LL+ DP+KR     
Sbjct: 203 -------LFELILMEDIKFPRTLSADAKS-------------LLSGLLIKDPNKRLGGGP 242

Query: 252 -DSDAALNHDFF----WTD 265
            D+   + H FF    W D
Sbjct: 243 DDAKEIMRHSFFTGVNWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulated in estrogen-deficient breast cancer cells, androgen-independent prostate cancer cells, and primary ovarian tumors. It acts as a key mediator in the genesis of ovarian cancer. Length = 328

>gnl|CDD|133211 cd05080, PTKc_Tyk2_rpt2, Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

 Score = 64.5 bits (157), Expect = 1e-11
 Identities = 44/162 (27%), Positives = 72/162 (44%), Gaps = 11/162 (6%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSL 70
           +EI IL+ L HEN+V     C  +  +         L+ ++    L  L   +   K +L
Sbjct: 55  KEINILKTLYHENIVKYKGCCSEQGGK------GLQLIMEYVP--LGSLRDYLPKHKLNL 106

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++    QQ+  G+ Y+HS   +HRD+ A NVL+    ++K+ DFGLA+A  +       
Sbjct: 107 AQLLLFAQQICEGMAYLHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYRV 166

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           R        WY      L +  +    D+W  G  + E+ T 
Sbjct: 167 REDGDSPVFWYAVE--CLKENKFSYASDVWSFGVTLYELLTH 206

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers and activators of transcription (STATs). Tyk2 is widely expressed in many tissues. It is involved in signaling via the cytokine receptors IFN-alphabeta, IL-6, IL-10, IL-12, IL-13, and IL-23. It mediates cell surface urokinase receptor (uPAR) signaling and plays a role in modulating vascular smooth muscle cell (VSMC) functional behavior in response to injury. Tyk2 is also important in dendritic cell function and T helper (Th)1 cell differentiation. A homozygous mutation of Tyk2 was found in a patient with hyper-IgE syndrome (HIES), a primary immunodeficiency characterized by recurrent skin abscesses, pneumonia, and elevated serum IgE. This suggests that Tyk2 may play important roles in multiple cytokine signaling involved in innate and adaptive immunity. Length = 283

>gnl|CDD|133229 cd05098, PTKc_FGFR1, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

 Score = 64.6 bits (157), Expect = 1e-11
 Identities = 47/180 (26%), Positives = 86/180 (47%), Gaps = 32/180 (17%)

Query: 11  LREIKILQLL-KHENVVHLIEICR------------TKANQYNRYRSTFYLVFDFCEHDL 57
           + E+++++++ KH+N+++L+  C             +K N     R+      ++C +  
Sbjct: 71  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYCYNPT 130

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
                 +  K    ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGL
Sbjct: 131 QVPEEQLSFK----DLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGL 186

Query: 118 ARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           AR       + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 187 ARDIHHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 237

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Alternative splicing of FGFR1 transcripts produces a variety of isoforms, which are differentially expressed in cells. FGFR1 binds the ligands, FGF1 and FGF2, with high affinity and has also been reported to bind FGF4, FGF6, and FGF9. FGFR1 signaling is critical in the control of cell migration during embryo development. It promotes cell proliferation in fibroblasts. Nuclear FGFR1 plays a role in the regulation of transcription. Mutations, insertions or deletions of FGFR1 have been identified in patients with Kallman's syndrome (KS), an inherited disorder characterized by hypogonadotropic hypogonadism and loss of olfaction. Aberrant FGFR1 expression has been found in some human cancers including 8P11 myeloproliferative syndrome (EMS), breast cancer, and pancreatic adenocarcinoma. Length = 307

>gnl|CDD|140293 PTZ00267, PTZ00267, NIMA-related protein kinase; Provisional

 Score = 65.8 bits (160), Expect = 1e-11
 Identities = 38/119 (31%), Positives = 67/119 (56%), Gaps = 3/119 (2%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H+ F   E+  +  Q++  L  +HS K++HRD+K+AN+ +  TGI+KL DFG ++ +S +
Sbjct: 163 HLPFQEYEVGLLFYQIVLALDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDS 222

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            +  V   ++   T +Y  PEL    R Y    D+W  G I+ E+ T     +G ++++
Sbjct: 223 VSLDVA--SSFCGTPYYLAPELWERKR-YSKKADMWSLGVILYELLTLHRPFKGPSQRE 278

Length = 478

>gnl|CDD|173652 cd05100, PTKc_FGFR3, Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

 Score = 64.7 bits (157), Expect = 2e-11
 Identities = 52/185 (28%), Positives = 88/185 (47%), Gaps = 40/185 (21%)

Query: 13  EIKILQLL-KHENVVHLIEICR------------TKAN--QYNRYRST--FYLVFDFCEH 55
           E+++++++ KH+N+++L+  C             +K N  +Y R R        FD C+ 
Sbjct: 67  EMEMMKMIGKHKNIINLLGACTQDGPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCK- 125

Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                L    + F   ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADF
Sbjct: 126 -----LPEEQLTFK--DLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADF 178

Query: 116 GLARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           GLAR       + +T NG       R+   W  P  L   DR Y    D+W  G ++ E+
Sbjct: 179 GLARDVHNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEI 229

Query: 170 WTRSP 174
           +T   
Sbjct: 230 FTLGG 234

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. Many FGFR3 splice variants have been reported with the IIIb and IIIc isoforms being the predominant forms. FGFR3 IIIc is the isoform expressed in chondrocytes, the cells affected in dwarfism, while IIIb is expressed in epithelial cells. FGFR3 ligands include FGF1, FGF2, FGF4, FGF8, FGF9, and FGF23. It is a negative regulator of long bone growth. In the cochlear duct and in the lens, FGFR3 is involved in differentiation while it appears to have a role in cell proliferation in epithelial cells. Germline mutations in FGFR3 are associated with skeletal disorders including several forms of dwarfism. Some missense mutations are associated with multiple myeloma and carcinomas of the bladder and cervix. Overexpression of FGFR3 is found in thyroid carcinoma. Length = 334

>gnl|CDD|173687 cd05596, STKc_ROCK, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

 Score = 64.8 bits (158), Expect = 2e-11
 Identities = 50/143 (34%), Positives = 67/143 (46%), Gaps = 22/143 (15%)

Query: 36  ANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-----KFSLGEIKKVIQQLLNGLYYIHS 89
           A Q ++Y    Y+V ++    DL  L+SN  +     +F   E+       +  L  IHS
Sbjct: 111 AFQDDKY---LYMVMEYMPGGDLVNLMSNYDIPEKWARFYTAEV-------VLALDAIHS 160

Query: 90  NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL- 148
              +HRD+K  N+L+ K+G LKLADFG         NG V R    V T  Y  PE+L  
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMDANGMV-RCDTAVGTPDYISPEVLKS 217

Query: 149 --GDRNYGPPVDLWGAGCIMAEM 169
             GD  YG   D W  G  + EM
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via interaction with Rho GTPases and is involved in many cellular functions including contraction, adhesion, migration, motility, proliferation, and apoptosis. The ROCK subfamily consists of two isoforms, ROCK1 and ROCK2, which may be functionally redundant in some systems, but exhibit different tissue distributions. Both isoforms are ubiquitously expressed in most tissues, but ROCK2 is more prominent in brain and skeletal muscle while ROCK1 is more pronounced in the liver, testes, and kidney. Studies in knockout mice result in different phenotypes, suggesting that the two isoforms do not compensate for each other during embryonic development. Length = 370

>gnl|CDD|173723 cd06605, PKc_MAPKK, Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

 Score = 63.5 bits (155), Expect = 2e-11
 Identities = 53/200 (26%), Positives = 77/200 (38%), Gaps = 51/200 (25%)

Query: 73  IKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFG--------LARAFSQ 123
           + K+   +L GL Y+H   KI+HRD+K +N+L+   G +KL DFG        LA+ F  
Sbjct: 102 LGKIAVAVLKGLTYLHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLAKTFVG 161

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQ 182
           T +              Y  PE + G+ +Y    D+W  G  + E+ T R P      E 
Sbjct: 162 TSS--------------YMAPERIQGN-DYSVKSDIWSLGLSLIELATGRFPYPP---EN 203

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
                I +L   I  E  P            LP             +  D    D ++  
Sbjct: 204 DPPDGIFELLQYIVNEPPP-----------RLPS----------GKFSPDF--QDFVNLC 240

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L+ DP +R      L H F 
Sbjct: 241 LIKDPRERPSYKELLEHPFI 260

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity PKs that phosphorylate their downstream targets, MAPKs, at specific threonine and tyrosine residues. There are three MAPK subfamilies: extracellular signal-regulated kinase (ERK), c-Jun N-terminal kinase (JNK), and p38. In mammalian cells, there are seven MAPKKs (named MKK1-7) and 20 MAPKKKs. Each MAPK subfamily can be activated by at least two cognate MAPKKs and by multiple MAPKKKs. Length = 265

>gnl|CDD|173665 cd05574, STKc_phototropin_like, Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

 Score = 63.8 bits (156), Expect = 3e-11
 Identities = 71/295 (24%), Positives = 108/295 (36%), Gaps = 92/295 (31%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVF--DFCE-HDLAGLL----- 61
            L E +IL  L H  +  L          Y  +++  YL    D+C   +L  LL     
Sbjct: 48  VLTEQEILATLDHPFLPTL----------YASFQTETYLCLVMDYCPGGELFRLLQRQPG 97

Query: 62  ---SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
              S    +F   E+       L  L Y+H   I++RD+K  N+L+ ++G + L+DF L+
Sbjct: 98  KCLSEEVARFYAAEV-------LLALEYLHLLGIVYRDLKPENILLHESGHIMLSDFDLS 150

Query: 119 ------------RAFSQTKNGQVNRYTNRVV-------------TLWYRPPELLLGDRNY 153
                            ++   VN   +                T  Y  PE++ GD  +
Sbjct: 151 KQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEEYIAPEVISGD-GH 209

Query: 154 GPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGSIT-PESWPGVETLDLYNK 211
           G  VD W  G ++ EM +  +P    N ++   T  + L   +T P S P          
Sbjct: 210 GSAVDWWTLGILLYEMLYGTTPFKGSNRDE---TFSNILKKEVTFPGSPP---------- 256

Query: 212 MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN----HDFF 262
                     V    +         DL+ KLL+ DPSKR  S         H FF
Sbjct: 257 ----------VSSSAR---------DLIRKLLVKDPSKRLGSKRGAAEIKQHPFF 292

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-terminal photosensory domain and a C-terminal catalytic domain. The N-terminal domain contains two LOV (Light, Oxygen or Voltage) domains that binds FMN. Photoexcitation of the LOV domains results in autophosphorylation at multiple sites and activation of the catalytic domain. Neurospora crassa nrc-2 plays a role in growth and development by controlling entry into the conidiation program. Length = 316

>gnl|CDD|173698 cd05607, STKc_GRK7, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

 Score = 63.0 bits (153), Expect = 4e-11
 Identities = 38/101 (37%), Positives = 57/101 (56%), Gaps = 9/101 (8%)

Query: 72  EIKKVI---QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           E+++VI    Q+  G+ ++HS  I++RDMK  NVL+   G  +L+D GLA    + K+G+
Sbjct: 93  EMERVIHYSAQITCGILHLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLA---VELKDGK 149

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
               T R  T  Y  PE+L  +  Y  PVD +  GC + EM
Sbjct: 150 T--ITQRAGTNGYMAPEILK-EEPYSYPVDWFAMGCSIYEM 187

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual group of GRKs. It is primarily found in the retina and plays a role in the regulation of opsin light receptors. GRK7 is located in retinal cone outer segments and plays an important role in regulating photoresponse of the cones. Length = 277

>gnl|CDD|173626 cd05034, PTKc_Src_like, Catalytic domain of Src kinase-like Protein Tyrosine Kinases

 Score = 62.7 bits (153), Expect = 4e-11
 Identities = 46/172 (26%), Positives = 77/172 (44%), Gaps = 24/172 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L+E +I++ L+H+ +V L  +C              Y+V ++      L  L S    K 
Sbjct: 49  LQEAQIMKKLRHDKLVQLYAVCSE--------EEPIYIVTEYMSKGSLLDFLKSGEGKKL 100

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++  +  Q+  G+ Y+ S   +HRD+ A N+L+ +  + K+ADFGLAR        +
Sbjct: 101 RLPQLVDMAAQIAEGMAYLESRNYIHRDLAARNILVGENLVCKIADFGLARLI------E 154

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
            + YT R        W  P     G   +    D+W  G ++ E+ T  R P
Sbjct: 155 DDEYTAREGAKFPIKWTAPEAANYG--RFTIKSDVWSFGILLTEIVTYGRVP 204

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. They were identified as the first proto-oncogene products, and they regulate cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Src kinases are overexpressed in a variety of human cancers, making them attractive targets for therapy. They are also implicated in acute inflammatory responses and osteoclast function. Src, Fyn, Yes, and Yrk are widely expressed, while Blk, Lck, Hck, Fgr, and Lyn show a limited expression pattern. Length = 261

>gnl|CDD|173641 cd05072, PTKc_Lyn, Catalytic domain of the Protein Tyrosine Kinase, Lyn

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 59/231 (25%), Positives = 103/231 (44%), Gaps = 28/231 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +   +   Y    Y +   L+ DF + D  G       K 
Sbjct: 49  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEYMAKGSLL-DFLKSDEGG-------KV 100

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ YI     +HRD++AANVL++++ + K+ADFGLAR         
Sbjct: 101 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED----- 155

Query: 129 VNRYTNR---VVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-MQGNTE 181
            N YT R      + +  PE +    N+G      D+W  G ++ E+ T   I   G + 
Sbjct: 156 -NEYTAREGAKFPIKWTAPEAI----NFGSFTIKSDVWSFGILLYEIVTYGKIPYPGMSN 210

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
              ++ + +       E+ P  E  D+       KA++R   + L+  + D
Sbjct: 211 SDVMSALQRGYRMPRMENCP-DELYDIMKTCWKEKAEERPTFDYLQSVLDD 260

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lyn is expressed in B lymphocytes and myeloid cells. It exhibits both positive and negative regulatory roles in B cell receptor (BCR) signaling. Lyn, as well as Fyn and Blk, promotes B cell activation by phosphorylating ITAMs (immunoreceptor tyr activation motifs) in CD19 and in Ig components of BCR. It negatively regulates signaling by its unique ability to phosphorylate ITIMs (immunoreceptor tyr inhibition motifs) in cell surface receptors like CD22 and CD5. Lyn also plays an important role in G-CSF receptor signaling by phosphorylating a variety of adaptor molecules. Length = 261

>gnl|CDD|133247 cd05116, PTKc_Syk, Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

 Score = 62.3 bits (151), Expect = 5e-11
 Identities = 58/231 (25%), Positives = 98/231 (42%), Gaps = 31/231 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIHV 66
           LRE  ++Q L +  +V +I IC  ++         + LV +  E    +    L  N HV
Sbjct: 44  LREANVMQQLDNPYIVRMIGICEAES---------WMLVMELAELGPLNKF--LQKNKHV 92

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 I +++ Q+  G+ Y+     +HRD+ A NVL+      K++DFGL++A    +N
Sbjct: 93  TEK--NITELVHQVSMGMKYLEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADEN 150

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSPI--MQGNTEQ 182
               +   +    WY P    +    +    D+W  G +M E ++  + P   M+GN   
Sbjct: 151 YYKAKTHGKWPVKWYAPE--CMNYYKFSSKSDVWSFGVLMWEAFSYGQKPYKGMKGNEVT 208

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK----VKERLKPY 229
           Q I    ++     P+  P  E  DL          +R     V+ RL+ Y
Sbjct: 209 QMIESGERME---CPQRCP-PEMYDLMKLCWTYGVDERPGFAVVELRLRNY 255

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. More recently, Syk expression has been detected in other cell types (including epithelial cells, vascular endothelial cells, neurons, hepatocytes, and melanocytes), suggesting a variety of biological functions in non-immune cells. Syk plays a critical role in maintaining vascular integrity and in wound healing during embryogenesis. It also regulates Vav3, which is important in osteoclast function including bone development. In breast epithelial cells, where Syk acts as a negative regulator for epidermal growth factor receptor (EGFR) signaling, loss of Syk expression is associated with abnormal proliferation during cancer development suggesting a potential role as a tumor suppressor. In mice, Syk has been shown to inhibit malignant transformation of mammary epithelial cells induced with murine mammary tumor virus (MMTV). Length = 257

>gnl|CDD|173651 cd05095, PTKc_DDR2, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

 Score = 63.0 bits (153), Expect = 5e-11
 Identities = 49/180 (27%), Positives = 75/180 (41%), Gaps = 13/180 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKAN--QYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           L+EIKI+  LK  N++ L+ +C T         Y     L      H+         V  
Sbjct: 67  LKEIKIMSRLKDPNIIRLLAVCITSDPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVT 126

Query: 69  -SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            S   +  +  Q+ +G+ Y+ S   +HRD+   N L+ K   +K+ADFG++R       G
Sbjct: 127 ISYSTLIFMATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYS---G 183

Query: 128 QVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT---RSPIMQGNTEQ 182
              R   R V    W     +LLG   +    D+W  G  + E+ T     P  Q + EQ
Sbjct: 184 DYYRIQGRAVLPIRWMSWESILLG--KFTTASDVWAFGVTLWEILTLCKEQPYSQLSDEQ 241

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues with the highest levels found in skeletal muscle, skin, kidney and lung. It is important in cell proliferation and development. Mice, with a deletion of DDR2, suffer from dwarfism and delayed healing of epidermal wounds. DDR2 also contributes to collagen (type I) regulation by inhibiting fibrillogenesis and altering the morphology of collagen fibers. It is also expressed in immature dendritic cells (DCs), where it plays a role in DC activation and function. Length = 296

>gnl|CDD|173668 cd05577, STKc_GRK, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

 Score = 62.5 bits (152), Expect = 6e-11
 Identities = 35/100 (35%), Positives = 53/100 (53%), Gaps = 7/100 (7%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++ GL ++H  +I++RD+K  NVL+   G ++++D GLA      K     +   R  T
Sbjct: 103 QIICGLEHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGGK-----KIKGRAGT 157

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQ 177
             Y  PE+L G+  Y   VD +  GC + EM   RSP  Q
Sbjct: 158 PGYMAPEVLQGEV-YDFSVDWFALGCTLYEMIAGRSPFRQ 196

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of G protein signaling) homology (RH) domain and several motifs. The C-terminus diverges among different groups of GRKs. There are seven types of GRKs, named GRK1 to GRK7. They are subdivided into three main groups: visual (GRK1/7); beta-adrenergic receptor kinases (GRK2/3); and GRK4-like (GRK4/5/6). Expression of GRK2/3/5/6 is widespread while GRK1/4/7 show a limited tissue distribution. The substrate spectrum of the widely expressed GRKs partially overlaps. GRKs play important roles in the cardiovascular, immune, respiratory, skeletal, and nervous systems. Length = 277

>gnl|CDD|133202 cd05071, PTKc_Src, Catalytic domain of the Protein Tyrosine Kinase, Src

 Score = 62.0 bits (150), Expect = 7e-11
 Identities = 58/245 (23%), Positives = 105/245 (42%), Gaps = 37/245 (15%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++       LL 
Sbjct: 41  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVTEYM--SKGSLLD 89

Query: 63  NIHVKFS----LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
            +  +      L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 90  FLKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 149

Query: 119 RAFSQTKNGQVNRYTNR----VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS- 173
           R          N YT R        W  P   L G   +    D+W  G ++ E+ T+  
Sbjct: 150 RLIED------NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGR 201

Query: 174 ---PIMQGNTEQQQITLISQL-CGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
              P M       Q+    ++ C    PES       DL  +    + ++R   E L+ +
Sbjct: 202 VPYPGMVNREVLDQVERGYRMPCPPECPESLH-----DLMCQCWRKEPEERPTFEYLQAF 256

Query: 230 VKDQY 234
           ++D +
Sbjct: 257 LEDYF 261

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Src also play a role in regulating cell adhesion, invasion, and motility in cancer cells and tumor vasculature, contributing to cancer progression and metastasis. Elevated levels of Src kinase activity have been reported in a variety of human cancers. Several inhibitors of Src have been developed as anti-cancer drugs. Src is also implicated in acute inflammatory responses and osteoclast function. Length = 262

>gnl|CDD|173686 cd05595, STKc_PKB_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

 Score = 62.3 bits (151), Expect = 9e-11
 Identities = 57/203 (28%), Positives = 84/203 (41%), Gaps = 60/203 (29%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 103 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKTFC 156

Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSIT 196
            T  Y  PE +L D +YG  VD WG G +M EM                     +CG   
Sbjct: 157 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM---------------------MCGR-- 192

Query: 197 PESWPGVETLDLYNK-----MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF 251
                    L  YN+      EL   ++ +    L P  K      LL  LL  DP +R 
Sbjct: 193 ---------LPFYNQDHERLFELILMEEIRFPRTLSPEAK-----SLLAGLLKKDPKQRL 238

Query: 252 -----DSDAALNHDFF----WTD 265
                D+   + H FF    W D
Sbjct: 239 GGGPSDAKEVMEHRFFLSINWQD 261

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in PKB-beta display normal growth weights but exhibit severe insulin resistance and diabetes, accompanied by lipoatrophy and B-cell failure. Length = 323

>gnl|CDD|133191 cd05060, PTKc_Syk_like, Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

 Score = 61.6 bits (150), Expect = 9e-11
 Identities = 42/169 (24%), Positives = 70/169 (41%), Gaps = 25/169 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIHV 66
           LRE  ++  L H  +V LI +C+ +            LV +            L     +
Sbjct: 44  LREASVMAQLDHPCIVRLIGVCKGEP---------LMLVMELAPLGPLLKY--LKKRREI 92

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S  ++K++  Q+  G+ Y+ S   +HRD+ A NVL+      K++DFG++RA     +
Sbjct: 93  PVS--DLKELAHQVAMGMAYLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSD 150

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYG---PPVDLWGAGCIMAEMWTR 172
                   R    WY P  +     NYG      D+W  G  + E ++ 
Sbjct: 151 YYRATTAGRWPLKWYAPECI-----NYGKFSSKSDVWSYGVTLWEAFSY 194

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, migration, and phagocytosis. Syk is important in B-cell receptor (BCR) signaling, while Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Syk also plays a central role in Fc receptor-mediated phagocytosis in the adaptive immune system. Shark is exclusively expressed in ectodermally derived epithelia, and is localized preferentially to the apical surface of the epithelial cells, it may play a role in a signaling pathway for epithelial cell polarity. Length = 257

>gnl|CDD|173680 cd05589, STKc_PKN, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

 Score = 62.0 bits (151), Expect = 1e-10
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 13/105 (12%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL Y+H NKI++RD+K  N+L+   G +K+ADFGL       K G    + +R  T    
Sbjct: 113 GLQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLC------KEGM--GFGDRTSTFCGT 164

Query: 143 P----PELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           P    PE+L  + +Y   VD WG G ++ EM        G+ E++
Sbjct: 165 PEFLAPEVLT-ETSYTRAVDWWGLGVLIYEMLVGESPFPGDDEEE 208

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved in many biological processes including cytokeletal regulation, cell adhesion, vesicle transport, glucose transport, regulation of meiotic maturation and embryonic cell cycles, signaling to the nucleus, and tumorigenesis. Length = 324

>gnl|CDD|173709 cd05619, STKc_nPKC_theta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 69/295 (23%), Positives = 120/295 (40%), Gaps = 55/295 (18%)

Query: 3   GIFFPITALR---------------EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTF 46
             FF I AL+               E ++L L  +H  + HL    +TK N        F
Sbjct: 20  NQFFAIKALKKDVVLMDDDVECTMVEKRVLSLAWEHPFLTHLYCTFQTKEN-------LF 72

Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           +++      DL   + + H KF L        +++ GL ++HS  I++RD+K  N+L+  
Sbjct: 73  FVMEYLNGGDLMFHIQSCH-KFDLPRATFYAAEIICGLQFLHSKGIVYRDLKLDNILLDT 131

Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
            G +K+ADFG+ +  +   + +   +     T  Y  PE+LLG + Y   VD W  G ++
Sbjct: 132 DGHIKIADFGMCKE-NMLGDAKTCTFCG---TPDYIAPEILLGQK-YNTSVDWWSFGVLL 186

Query: 167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDL------------------ 208
            EM        G+ E++    I ++     P  W   E  D+                  
Sbjct: 187 YEMLIGQSPFHGHDEEELFQSI-RMDNPCYPR-WLTREAKDILVKLFVREPERRLGVKGD 244

Query: 209 ------YNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL 257
                 + +++    ++R+++   KP VK    C   DK  L +  +   +D  L
Sbjct: 245 IRQHPFFREIDWSALEEREIEPPFKPKVKSANDCSNFDKEFLNEKPRLSVTDRML 299

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. Although T-cells also express other PKC isoforms, PKC-theta is unique in that upon antigen stimulation, it is translocated to the plasma membrane at the immunological synapse, where it mediates signals essential for T-cell activation. It is essential for TCR-induced proliferation, cytokine production, T-cell survival, and the differentiation and effector function of T-helper (Th) cells, particularly Th2 and Th17. PKC-theta is being developed as a therapeutic target for Th2-mediated allergic inflammation and Th17-mediated autoimmune diseases. Length = 316

>gnl|CDD|173676 cd05585, STKc_YPK1_like, Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

 Score = 61.9 bits (150), Expect = 1e-10
 Identities = 59/230 (25%), Positives = 92/230 (40%), Gaps = 53/230 (23%)

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F L   +    +LL  L  +H   +++RD+K  N+L+   G + L DFGL +  +   +
Sbjct: 89  RFDLSRARFYTAELLCALENLHKFNVIYRDLKPENILLDYQGHIALCDFGLCK-LNMKDD 147

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
            + N +     T  Y  PELLLG   Y   VD W  G ++ EM T  P            
Sbjct: 148 DKTNTFCG---TPEYLAPELLLG-HGYTKAVDWWTLGVLLYEMLTGLP------------ 191

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK-PYVKDQYGCDLLDKLLLL 245
                     P           +    + +  ++ ++E L+ P   D+   DLL  LL  
Sbjct: 192 ----------P-----------FYDENVNEMYRKILQEPLRFPDGFDRDAKDLLIGLLSR 230

Query: 246 DPSKRFDSDAA---LNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRP 292
           DP++R   + A    NH FF          K+L +  Q       PP +P
Sbjct: 231 DPTRRLGYNGAQEIKNHPFF----SQLSWKKLLMKGIQ-------PPFKP 269

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It plays a role in cell growth and sexual development. Length = 312

>gnl|CDD|173634 cd05053, PTKc_FGFR, Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

 Score = 61.7 bits (150), Expect = 1e-10
 Identities = 43/173 (24%), Positives = 76/173 (43%), Gaps = 39/173 (22%)

Query: 21  KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH---------------DLAGLLSNIH 65
           KH+N+++L+ +C  +           Y+V ++  H                 +       
Sbjct: 74  KHKNIINLLGVCTQEG--------PLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPP 125

Query: 66  V-KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA---- 120
               +  ++     Q+  G+ ++ S K +HRD+ A NVL+T+  ++K+ADFGLAR     
Sbjct: 126 EETLTQKDLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHI 185

Query: 121 --FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 186 DYYRKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLLWEIFT 229

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation, and intracellular signaling. There are at least 23 FGFs and four types of FGFRs. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to more that one type of receptor. FGF/FGFR signaling is important in the regulation of embryonic development, homeostasis, and regenerative processes. Depending on the cell type and stage, FGFR signaling produces diverse cellular responses including proliferation, growth arrest, differentiation, and apoptosis. Aberrant signaling leads to many human diseases such as skeletal, olfactory, and metabolic disorders, as well as cancer. Length = 293

>gnl|CDD|133171 cd05039, PTKc_Csk_like, Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

 Score = 60.9 bits (148), Expect = 1e-10
 Identities = 32/125 (25%), Positives = 55/125 (44%), Gaps = 22/125 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  ++  L+H N+V L+ +               Y+V ++     L   L       S
Sbjct: 48  LAEASVMTTLRHPNLVQLLGVVLQGNP--------LYIVTEYMAKGSLVDYLR------S 93

Query: 70  LGEIKKVIQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
            G     + Q L        G+ Y+     +HRD+ A NVL+++  + K++DFGLA+  S
Sbjct: 94  RGRAVITLAQQLGFALDVCEGMEYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEAS 153

Query: 123 QTKNG 127
           Q ++ 
Sbjct: 154 QGQDS 158

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As negative regulators of Src kinases, Csk and Chk play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Length = 256

>gnl|CDD|133204 cd05073, PTKc_Hck, Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

 Score = 61.2 bits (148), Expect = 2e-10
 Identities = 44/171 (25%), Positives = 77/171 (45%), Gaps = 23/171 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +           +   Y++ +F      L  L S+   K 
Sbjct: 49  LAEANVMKTLQHDKLVKLHAVVT---------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 99

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ +I     +HRD++AAN+L++ + + K+ADFGLAR      N  
Sbjct: 100 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEY 157

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWT--RSP 174
             R   +    W  P  +     N+G      D+W  G ++ E+ T  R P
Sbjct: 158 TAREGAKFPIKWTAPEAI-----NFGSFTIKSDVWSFGILLMEIVTYGRIP 203

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Hck is present in myeloid and lymphoid cells that play a role in the development of cancer. It may be important in the oncogenic signaling of the protein Tel-Abl, which induces a chronic myelogenous leukemia (CML)-like disease. Hck also acts as a negative regulator of granulocyte colony-stimulating factor (G-CSF)-induced proliferation of granulocytic precursors, suggesting a possible role in the development of acute myeloid leukemia (AML). In addition, Hck is essential in regulating the degranulation of polymorphonuclear leukocytes (PMNs). Genetic polymorphisms affect the expression level of Hck, which affects PMN mediator release and influences the development of chronic obstructive pulmonary disease (COPD). Length = 260

>gnl|CDD|173683 cd05592, STKc_nPKC_theta_delta, Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

 Score = 61.7 bits (150), Expect = 2e-10
 Identities = 52/197 (26%), Positives = 80/197 (40%), Gaps = 38/197 (19%)

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F     +    +++ GL ++H   I++RD+K  NVL+ K G +K+ADFG+ +  +    
Sbjct: 92  RFDEARARFYAAEIICGLQFLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKE-NMNGE 150

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G+ + +     T  Y  PE+L G + Y   VD W  G ++ EM        G  E     
Sbjct: 151 GKASTFCG---TPDYIAPEILKGQK-YNESVDWWSFGVLLYEMLIGQSPFHGEDED---- 202

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
              +L  SI                 + P   +   KE            D L KL   D
Sbjct: 203 ---ELFDSI---------------LNDRPHFPRWISKE----------AKDCLSKLFERD 234

Query: 247 PSKRFDSDAAL-NHDFF 262
           P+KR   D  +  H FF
Sbjct: 235 PTKRLGVDGDIRQHPFF 251

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in several aspects of T-cell biology. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. Length = 316

>gnl|CDD|240344 PTZ00283, PTZ00283, serine/threonine protein kinase; Provisional

 Score = 62.2 bits (151), Expect = 2e-10
 Identities = 50/160 (31%), Positives = 80/160 (50%), Gaps = 24/160 (15%)

Query: 52  FCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILK 111
           F EH+ AGLL               IQ LL  ++++HS  ++HRD+K+AN+L+   G++K
Sbjct: 140 FREHE-AGLL--------------FIQVLL-AVHHVHSKHMIHRDIKSANILLCSNGLVK 183

Query: 112 LADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           L DFG ++ ++ T +  V R      T +Y  PE+    + Y    D++  G ++ E+ T
Sbjct: 184 LGDFGFSKMYAATVSDDVGR--TFCGTPYYVAPEIWR-RKPYSKKADMFSLGVLLYELLT 240

Query: 172 -RSPIMQGNTEQ-QQITLISQ---LCGSITPESWPGVETL 206
            + P    N E+    TL  +   L  SI+PE    V  L
Sbjct: 241 LKRPFDGENMEEVMHKTLAGRYDPLPPSISPEMQEIVTAL 280

Length = 496

>gnl|CDD|133216 cd05085, PTKc_Fer, Catalytic domain of the Protein Tyrosine Kinase, Fer

 Score = 60.8 bits (147), Expect = 2e-10
 Identities = 46/183 (25%), Positives = 80/183 (43%), Gaps = 17/183 (9%)

Query: 8   ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV 66
           I  L E +IL+   H N+V LI +C          R   Y+V +     D    L     
Sbjct: 37  IKFLSEARILKQYDHPNIVKLIGVCTQ--------RQPIYIVMELVPGGDFLSFLRKKKD 88

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +    ++ K       G+ Y+ S   +HRD+ A N L+ +  +LK++DFG++R   Q  +
Sbjct: 89  ELKTKQLVKFALDAAAGMAYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR---QEDD 145

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS----PIMQGNTEQ 182
           G  +    + + + +  PE L   R Y    D+W  G ++ E ++      P M     +
Sbjct: 146 GIYSSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILLWETFSLGVCPYPGMTNQQAR 204

Query: 183 QQI 185
           +Q+
Sbjct: 205 EQV 207

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-cell interactions mediated by adherens junctions and focal adhesions. Fer kinase also regulates cell cycle progression in malignant cells. Length = 250

>gnl|CDD|173673 cd05582, STKc_RSK_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

 Score = 61.4 bits (149), Expect = 2e-10
 Identities = 46/143 (32%), Positives = 73/143 (51%), Gaps = 7/143 (4%)

Query: 47  YLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT 105
           YL+ DF    DL   LS   V F+  ++K  + +L   L ++HS  I++RD+K  N+L+ 
Sbjct: 74  YLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILLD 132

Query: 106 KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           + G +KL DFGL    S+       +  +   T+ Y  PE ++  R +    D W  G +
Sbjct: 133 EEGHIKLTDFGL----SKESIDHEKKAYSFCGTVEYMAPE-VVNRRGHTQSADWWSFGVL 187

Query: 166 MAEMWTRSPIMQGNTEQQQITLI 188
           M EM T S   QG   ++ +T+I
Sbjct: 188 MFEMLTGSLPFQGKDRKETMTMI 210

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylates all known RSK substrates. RSKs act as downstream effectors of mitogen-activated protein kinase (MAPK) and play key roles in mitogen-activated cell growth, differentiation, and survival. Mammals possess four RSK isoforms (RSK1-4) from distinct genes. RSK proteins are also referred to as MAP kinase-activated protein kinases (MAPKAPKs), p90-RSKs, or p90S6Ks. Length = 318

>gnl|CDD|173649 cd05093, PTKc_TrkB, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

 Score = 60.9 bits (147), Expect = 2e-10
 Identities = 42/173 (24%), Positives = 83/173 (47%), Gaps = 24/173 (13%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL--------- 61
           RE ++L  L+HE++V    +C               +VF++ +H DL   L         
Sbjct: 56  REAELLTNLQHEHIVKFYGVCVEG--------DPLIMVFEYMKHGDLNKFLRAHGPDAVL 107

Query: 62  ---SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
               N   + +  ++  + QQ+  G+ Y+ S   +HRD+   N L+ +  ++K+ DFG++
Sbjct: 108 MAEGNRPAELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 167

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R    T   +V  +T  ++ + + PPE ++  R +    D+W  G ++ E++T
Sbjct: 168 RDVYSTDYYRVGGHT--MLPIRWMPPESIMY-RKFTTESDVWSLGVVLWEIFT 217

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly expressed in the nervous system and in some non-neural tissues. It plays important roles in cell proliferation, differentiation, and survival. BDNF/Trk signaling plays a key role in regulating activity-dependent synaptic plasticity. TrkB also contributes to protection against gp120-induced neuronal cell death. TrkB overexpression is associated with poor prognosis in neuroblastoma (NB) and other human cancers. It acts as a suppressor of anoikis (detachment-induced apoptosis) and contributes to tumor metastasis. Length = 288

>gnl|CDD|173704 cd05613, STKc_MSK1_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

 Score = 60.4 bits (146), Expect = 3e-10
 Identities = 49/212 (23%), Positives = 89/212 (41%), Gaps = 45/212 (21%)

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            +F   E++    +++  L ++H   I++RD+K  N+L+   G + L DFGL++ F + +
Sbjct: 100 ERFKEQEVQIYSGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDE 159

Query: 126 NGQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
             +   +     T+ Y  P+++  GD  +   VD W  G +M E+ T +     + E+  
Sbjct: 160 VERAYSFCG---TIEYMAPDIVRGGDGGHDKAVDWWSMGVLMYELLTGASPFTVDGEKNS 216

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC--DLLDKL 242
              IS                              R++ +   PY ++      D++ +L
Sbjct: 217 QAEIS------------------------------RRILKSEPPYPQEMSALAKDIIQRL 246

Query: 243 LLLDPSKRF-----DSDAALNHDFF----WTD 265
           L+ DP KR      D+D    H FF    W D
Sbjct: 247 LMKDPKKRLGCGPSDADEIKKHPFFQKINWDD 278

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK1 plays a role in the regulation of translational control and transcriptional activation. It phosphorylates the transcription factors, CREB and NFkappaB. It also phosphorylates the nucleosomal proteins H3 and HMG-14. Increased phosphorylation of MEK1 is associated with the development of cerebral ischemic/hypoxic preconditioning. Length = 290

>gnl|CDD|133200 cd05069, PTKc_Yes, Catalytic domain of the Protein Tyrosine Kinase, Yes

 Score = 60.1 bits (145), Expect = 3e-10
 Identities = 46/175 (26%), Positives = 80/175 (45%), Gaps = 15/175 (8%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLL 61
           G   P   L+E +I++ L+H+ +V L  +   +           Y+V +F  +  L   L
Sbjct: 41  GTMMPEAFLQEAQIMKKLRHDKLVPLYAVVSEEP---------IYIVTEFMGKGSLLDFL 91

Query: 62  SNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                K+  L ++  +  Q+ +G+ YI     +HRD++AAN+L+    + K+ADFGLAR 
Sbjct: 92  KEGDGKYLKLPQLVDMAAQIADGMAYIERMNYIHRDLRAANILVGDNLVCKIADFGLARL 151

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 152 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRV 202

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. c-Yes kinase is the cellular homolog of the oncogenic protein (v-Yes) encoded by the Yamaguchi 73 and Esh sarcoma viruses. It displays functional overlap with other Src subfamily members, particularly Src. It also shows some unique functions such as binding to occludins, transmembrane proteins that regulate extracellular interactions in tight junctions. Yes also associates with a number of proteins in different cell types that Src does not interact with, like JAK2 and gp130 in pre-adipocytes, and Pyk2 in treated pulmonary vein endothelial cells. Although the biological function of Yes remains unclear, it appears to have a role in regulating cell-cell interactions and vesicle trafficking in polarized cells. Length = 260

>gnl|CDD|133165 cd05033, PTKc_EphR, Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

 Score = 60.0 bits (146), Expect = 3e-10
 Identities = 36/159 (22%), Positives = 71/159 (44%), Gaps = 12/159 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +  TK            ++ ++ E+  L   L     KF+
Sbjct: 53  LTEASIMGQFDHPNIIRLEGVV-TK-------SRPVMIITEYMENGSLDKFLRENDGKFT 104

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +G++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFGL+R   +      
Sbjct: 105 VGQLVGMLRGIASGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSR-RLEDSEATY 163

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
                ++   W  P    +  R +    D+W  G +M E
Sbjct: 164 TTKGGKIPIRWTAPEA--IAYRKFTSASDVWSFGIVMWE 200

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. This allows ephrin/EphR dimers to form, leading to the activation of the intracellular tyr kinase domain. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). The main effect of ephrin/EphR interaction is cell-cell repulsion or adhesion. Ephrin/EphR signaling is important in neural development and plasticity, cell morphogenesis and proliferation, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. Length = 266

>gnl|CDD|173760 cd08220, STKc_Nek8, Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

 Score = 59.9 bits (145), Expect = 3e-10
 Identities = 47/170 (27%), Positives = 77/170 (45%), Gaps = 29/170 (17%)

Query: 9   TALREIKILQLLKHENVVHLIE-ICRTKA----NQYNRYRSTFYLVFDFCEHDLAGLLSN 63
            A  E ++L+LL H N++   E     KA     +Y    +    +   C          
Sbjct: 45  AAQNECQVLKLLSHPNIIEYYENFLEDKALMIVMEYAPGGTLAEYIQKRCN--------- 95

Query: 64  IHVKFSLGEIKKVIQ---QLLNGLYYIHSNKILHRDMKAANVLITK-TGILKLADFGLAR 119
                SL +   ++    Q+L  L+++H+  ILHRD+K  N+L+ K   ++K+ DFG+++
Sbjct: 96  -----SLLDEDTILHFFVQILLALHHVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISK 150

Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             S         YT  V T  Y  PEL  G + Y    D+W  GC++ E+
Sbjct: 151 ILSSKSKA----YT-VVGTPCYISPELCEG-KPYNQKSDIWALGCVLYEL 194

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with a rare form of juvenile renal cystic disease, nephronophthisis type 9. It has been suggested that a defect in the ciliary localization of Nek8 contributes to the development of cysts manifested by these diseases. Length = 256

>gnl|CDD|132946 cd06615, PKc_MEK, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

 Score = 60.1 bits (146), Expect = 4e-10
 Identities = 56/209 (26%), Positives = 80/209 (38%), Gaps = 35/209 (16%)

Query: 70  LGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           LG+I   +   L GL Y+    KI+HRD+K +N+L+   G +KL DFG++    Q  +  
Sbjct: 101 LGKISIAV---LRGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSM 154

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITL 187
            N +   V T  Y  PE L G   Y    D+W  G  + EM   R PI   + ++ +   
Sbjct: 155 ANSF---VGTRSYMSPERLQGTH-YTVQSDIWSLGLSLVEMAIGRYPIPPPDAKELEAMF 210

Query: 188 ISQLCGSITPESWPGV--------------ETLDLYNKMELPKAQKRKVKERLKPYVKDQ 233
              +      ES   V              E LD       PK       +         
Sbjct: 211 GRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEF------- 263

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
              D +DK L  +P +R D      H F 
Sbjct: 264 --QDFVDKCLKKNPKERADLKELTKHPFI 290

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the downstream targets, ERK(extracellular signal-regulated kinase) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1/2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. This cascade has also been implicated in synaptic plasticity, migration, morphological determination, and stress response immunological reactions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1/2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 308

>gnl|CDD|173712 cd05622, STKc_ROCK1, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

 Score = 60.4 bits (146), Expect = 5e-10
 Identities = 52/143 (36%), Positives = 67/143 (46%), Gaps = 22/143 (15%)

Query: 36  ANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-----KFSLGEIKKVIQQLLNGLYYIHS 89
           A Q +RY    Y+V ++    DL  L+SN  V     +F   E+       +  L  IHS
Sbjct: 111 AFQDDRY---LYMVMEYMPGGDLVNLMSNYDVPEKWARFYTAEV-------VLALDAIHS 160

Query: 90  NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL- 148
              +HRD+K  N+L+ K+G LKLADFG        K G V R    V T  Y  PE+L  
Sbjct: 161 MGFIHRDVKPDNMLLDKSGHLKLADFG--TCMKMNKEGMV-RCDTAVGTPDYISPEVLKS 217

Query: 149 --GDRNYGPPVDLWGAGCIMAEM 169
             GD  YG   D W  G  + EM
Sbjct: 218 QGGDGYYGRECDWWSVGVFLYEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, and kidney. It mediates signaling from Rho to the actin cytoskeleton. It is implicated in the development of cardiac fibrosis, cardiomyocyte apoptosis, and hyperglycemia. Mice deficient with ROCK1 display eyelids open at birth (EOB) and omphalocele phenotypes due to the disorganization of actin filaments in the eyelids and the umbilical ring. Length = 371

>gnl|CDD|173640 cd05067, PTKc_Lck_Blk, Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

 Score = 58.7 bits (142), Expect = 9e-10
 Identities = 60/242 (24%), Positives = 110/242 (45%), Gaps = 35/242 (14%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L E  +++ L+H  +V L  +           +   Y++ ++ E+   +  L
Sbjct: 41  GSMSPEAFLAEANLMKQLQHPRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 91

Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L+++T   K+ADFGLAR 
Sbjct: 92  KTPEGIKLTINKLIDMAAQIAEGMAFIERKNYIHRDLRAANILVSETLCCKIADFGLARL 151

Query: 121 FSQTKNGQVNRYTNR---VVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSP 174
                  + N YT R      + +  PE +    NYG      D+W  G ++ E+ T   
Sbjct: 152 I------EDNEYTAREGAKFPIKWTAPEAI----NYGTFTIKSDVWSFGILLTEIVTYGR 201

Query: 175 I-MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL---PKAQKRKVKERLKPYV 230
           I   G T  + I  + +      P++ P     +LY  M L    K ++R   E L+  +
Sbjct: 202 IPYPGMTNPEVIQNLERGYRMPRPDNCPE----ELYELMRLCWKEKPEERPTFEYLRSVL 257

Query: 231 KD 232
           +D
Sbjct: 258 ED 259

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Lck is expressed in T-cells and natural killer (NK) cells. It plays a critical role in T-cell maturation, activation, and T-cell receptor (TCR) signaling. Lck phosphorylates ITAM (immunoreceptor tyr activation motif) sequences on several subunits of TCRs, leading to the activation of different second messenger cascades. Phosphorylated ITAMs serve as binding sites for other signaling factor such as Syk and ZAP-70, leading to their activation and propagation of downstream events. In addition, Lck regulates drug-induced apoptosis by interfering with the mitochondrial death pathway. The apototic role of Lck is independent of its primary function in T-cell signaling. Blk is expressed specifically in B-cells. It is involved in pre-BCR (B-cell receptor) signaling. Length = 260

>gnl|CDD|234389 TIGR03903, TOMM_kin_cyc, TOMM system kinase/cyclase fusion protein

 Score = 60.6 bits (147), Expect = 1e-09
 Identities = 47/182 (25%), Positives = 83/182 (45%), Gaps = 22/182 (12%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSL 70
           RE  +   L H N+V L++    +A          + VF++     L  +L+        
Sbjct: 27  RETALCARLYHPNIVALLD--SGEAPP-----GLLFAVFEYVPGRTLREVLAADGA-LPA 78

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNG 127
           GE  +++ Q+L+ L   H+  I+HRD+K  N+++++TG+    K+ DFG+       ++ 
Sbjct: 79  GETGRLMLQVLDALACAHNQGIVHRDLKPQNIMVSQTGVRPHAKVLDFGIGTLLPGVRDA 138

Query: 128 ---QVNRYTNRVVTLWYRPPELLLGDRNYGPPV---DLWGAGCIMAEMWTRSPIMQGNTE 181
               + R T  + T  Y  PE L G+    P     DL+  G I  E  T   ++QG + 
Sbjct: 139 DVATLTRTTEVLGTPTYCAPEQLRGE----PVTPNSDLYAWGLIFLECLTGQRVVQGASV 194

Query: 182 QQ 183
            +
Sbjct: 195 AE 196

This model represents proteins of 1350 in length, in multiple species of Burkholderia, in Acidovorax avenae subsp. citrulli AAC00-1 and Delftia acidovorans SPH-1, and in multiple copies in Sorangium cellulosum, in genomic neighborhoods that include a cyclodehydratase/docking scaffold fusion protein (TIGR03882) and a member of the thiazole/oxazole modified metabolite (TOMM) precursor family TIGR03795. It has a kinase domain in the N-terminal 300 amino acids, followed by a cyclase homology domain, followed by regions without named domain definitions. It is a probable bacteriocin-like metabolite biosynthesis protein [Cellular processes, Toxin production and resistance]. Length = 1266

>gnl|CDD|173710 cd05620, STKc_nPKC_delta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

 Score = 59.2 bits (143), Expect = 1e-09
 Identities = 41/136 (30%), Positives = 67/136 (49%), Gaps = 11/136 (8%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           +++ GL ++HS  I++RD+K  NV++ + G +K+ADFG+ +   +   G  NR +    T
Sbjct: 104 EIVCGLQFLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCK---ENVFGD-NRASTFCGT 159

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPE 198
             Y  PE+L G + Y   VD W  G ++ EM        G+ E +    I       TP 
Sbjct: 160 PDYIAPEILQGLK-YTFSVDWWSFGVLLYEMLIGQSPFHGDDEDELFESIRV----DTPH 214

Query: 199 --SWPGVETLDLYNKM 212
              W   E+ D+  K+
Sbjct: 215 YPRWITKESKDILEKL 230

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. It slows down cell proliferation, inducing cell cycle arrest and enhancing cell differentiation. PKC-delta is also involved in the regulation of transcription as well as immune and inflammatory responses. It plays a central role in the genotoxic stress response that leads to DNA damaged-induced apoptosis. Length = 316

>gnl|CDD|132950 cd06619, PKc_MKK5, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

 Score = 58.7 bits (142), Expect = 1e-09
 Identities = 37/103 (35%), Positives = 53/103 (51%), Gaps = 10/103 (9%)

Query: 80  LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
           ++ GL Y+ S KILHRD+K +N+L+   G +KL DFG++    Q  N     Y   V T 
Sbjct: 104 VVKGLTYLWSLKILHRDVKPSNMLVNTRGQVKLCDFGVST---QLVNSIAKTY---VGTN 157

Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS---PIMQGN 179
            Y  PE + G++ YG   D+W  G    E+       P +Q N
Sbjct: 158 AYMAPERISGEQ-YGIHSDVWSLGISFMELALGRFPYPQIQKN 199

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that phosphorylates its downstream target, extracellular signal-regulated kinase 5 (ERK5), on specific threonine and tyrosine residues. MKK5 is activated by MEKK2 and MEKK3 in response to mitogenic and stress stimuli. The ERK5 cascade promotes cell proliferation, differentiation, neuronal survival, and neuroprotection. This cascade plays an essential role in heart development. Mice deficient in either ERK5 or MKK5 die around embryonic day 10 due to cardiovascular defects including underdevelopment of the myocardium. In addition, MKK5 is associated with metastasis and unfavorable prognosis in prostate cancer. Length = 279

>gnl|CDD|133201 cd05070, PTKc_Fyn_Yrk, Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 43/172 (25%), Positives = 75/172 (43%), Gaps = 15/172 (8%)

Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P + L E +I++ L+H+ +V L  +               Y+V ++     L   L
Sbjct: 41  GTMSPESFLEEAQIMKKLRHDKLVQLYAVVS---------EEPIYIVTEYMSKGSLLDFL 91

Query: 62  SNIHVK-FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +   L  +  +  Q+  G+ YI     +HRD+++AN+L+    + K+ADFGLAR 
Sbjct: 92  KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGDGLVCKIADFGLARL 151

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+
Sbjct: 152 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTK 199

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Fyn, together with Lck, plays a critical role in T-cell signal transduction by phosphorylating ITAM (immunoreceptor tyr activation motif) sequences on T-cell receptors, ultimately leading to the proliferation and differentiation of T-cells. In addition, Fyn is involved in the myelination of neurons, and is implicated in Alzheimer's and Parkinson's diseases. Yrk has been detected only in chickens. It is primarily found in neuronal and epithelial cells and in macrophages. It may play a role in inflammation and in response to injury. Length = 260

>gnl|CDD|173756 cd08216, PK_STRAD, Pseudokinase domain of STE20-related kinase adapter protein

 Score = 58.9 bits (143), Expect = 1e-09
 Identities = 43/171 (25%), Positives = 74/171 (43%), Gaps = 30/171 (17%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNIHV 66
           EI   + L+H N+                Y ++F      Y+V     +     L   H 
Sbjct: 49  EIITSRQLQHPNI--------------LPYVTSFIVDSELYVVSPLMAYGSCEDLLKTHF 94

Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              L E  I  +++ +LN L YIHS   +HR +KA+++L++  G + L+  GL  + S  
Sbjct: 95  PEGLPELAIAFILKDVLNALDYIHSKGFIHRSVKASHILLSGDGKVVLS--GLRYSVSMI 152

Query: 125 KNGQVNRY-----TNRVVTLWYRPPELLLGD-RNYGPPVDLWGAGCIMAEM 169
           K+G+  R       + V  L +  PE+L  + + Y    D++  G    E+
Sbjct: 153 KHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYSVGITACEL 203

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha stabilized through ATP and MO25 may be needed to activate LKB1. Length = 314

>gnl|CDD|173648 cd05092, PTKc_TrkA, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

 Score = 58.5 bits (141), Expect = 1e-09
 Identities = 50/197 (25%), Positives = 95/197 (48%), Gaps = 31/197 (15%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS----NIHV 66
           RE ++L +L+H+++V    +C               +VF++  H DL   L     +  +
Sbjct: 56  REAELLTVLQHQHIVRFYGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKI 107

Query: 67  ----------KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
                     + +LG++  +  Q+ +G+ Y+ S   +HRD+   N L+ +  ++K+ DFG
Sbjct: 108 LAGGEDVAPGQLTLGQMLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFG 167

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
           ++R    T   +V   T  ++ + + PPE +L  R +    D+W  G ++ E++T  + P
Sbjct: 168 MSRDIYSTDYYRVGGRT--MLPIRWMPPESILY-RKFTTESDIWSFGVVLWEIFTYGKQP 224

Query: 175 IMQ-GNTEQQQITLISQ 190
             Q  NTE   I  I+Q
Sbjct: 225 WYQLSNTE--AIECITQ 239

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory and sympathetic neurons of the peripheral nervous system, and in basal forebrain cholinergic neurons of the central nervous system. It is critical for neuronal growth, differentiation and survival. Alternative TrkA splicing has been implicated as a pivotal regulator of neuroblastoma (NB) behavior. Normal TrkA expression is associated with better NB prognosis, while the hypoxia-regulated TrkAIII splice variant promotes NB pathogenesis and progression. Aberrant TrkA expression has also been demonstrated in non-neural tumors including prostate, breast, lung, and pancreatic cancers. Length = 280

>gnl|CDD|173682 cd05591, STKc_nPKC_epsilon, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 35/100 (35%), Positives = 51/100 (51%), Gaps = 9/100 (9%)

Query: 84  LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLWY 141
           L ++H + +++RD+K  N+L+   G  KLADFG+       K G +N  T      T  Y
Sbjct: 109 LMFLHRHGVIYRDLKLDNILLDAEGHCKLADFGMC------KEGILNGVTTTTFCGTPDY 162

Query: 142 RPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
             PE +L +  YGP VD W  G +M EM    P  + + E
Sbjct: 163 IAPE-ILQELEYGPSVDWWALGVLMYEMMAGQPPFEADNE 201

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to neoplastic transformation depending on the cell type. It contributes to oncogenesis by inducing disordered cell growth and inhibiting cell death. It also plays a role in tumor invasion and metastasis. PKC-epsilon has also been found to confer cardioprotection against ischemia and reperfusion-mediated damage. Other cellular functions include the regulation of gene expression, cell adhesion, and cell motility. Length = 321

>gnl|CDD|173631 cd05045, PTKc_RET, Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

 Score = 58.4 bits (141), Expect = 2e-09
 Identities = 43/177 (24%), Positives = 79/177 (44%), Gaps = 19/177 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKAN-----QYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           L E  +L+ + H +V+ L   C          +Y +Y S    + +  +   + L S+ +
Sbjct: 51  LSEFNLLKQVNHPHVIKLYGACSQDGPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGN 110

Query: 66  VKFS-----------LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
              S           +G++     Q+  G+ Y+   K++HRD+ A NVL+ +   +K++D
Sbjct: 111 RNSSYLDNPDERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISD 170

Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           FGL+R   + ++  V R   R+   W     L   D  Y    D+W  G ++ E+ T
Sbjct: 171 FGLSRDVYE-EDSYVKRSKGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 224

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leading to autophosphorylation, activation, and intracellular signaling. RET is essential for the development of the sympathetic, parasympathetic and enteric nervous systems, and the kidney. RET disruption by germline mutations causes diseases in humans including congenital aganglionosis of the gastrointestinal tract (Hirschsprung's disease) and three related inherited cancers: multiple endocrine neoplasia type 2A (MEN2A), MEN2B, and familial medullary thyroid carcinoma (FMTC). Length = 290

>gnl|CDD|173703 cd05612, STKc_PRKX_like, Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 61/262 (23%), Positives = 104/262 (39%), Gaps = 67/262 (25%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CEHDL------AGLLSNIH 65
           E ++L+ + H  ++ L     T+ +Q        Y++ ++    +L      +G  SN  
Sbjct: 51  EKRVLKEVSHPFIIRLFW---TEHDQRF-----LYMLMEYVPGGELFSYLRNSGRFSNST 102

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             F   EI   ++       Y+HS +I++RD+K  N+L+ K G +KL DFG A+      
Sbjct: 103 GLFYASEIVCALE-------YLHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKL---- 151

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
               +R      T  Y  PE ++  + +   VD W  G ++ EM    P    +      
Sbjct: 152 ---RDRTWTLCGTPEYLAPE-VIQSKGHNKAVDWWALGILIYEMLVGYPPFFDDN----- 202

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
                                 +Y K+    A K +    L  Y K     DL+ KLL++
Sbjct: 203 -------------------PFGIYEKI---LAGKLEFPRHLDLYAK-----DLIKKLLVV 235

Query: 246 DPSKRF-----DSDAALNHDFF 262
           D ++R       +D   NH +F
Sbjct: 236 DRTRRLGNMKNGADDVKNHRWF 257

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyte/macrophage lineage differentiation, renal cell epithelial migration, and tubular morphogenesis in the developing kidney. Length = 291

>gnl|CDD|173721 cd05632, STKc_GRK5, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

 Score = 58.1 bits (140), Expect = 2e-09
 Identities = 32/91 (35%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++L GL  +H    ++RD+K  N+L+   G ++++D GLA    +   G+  R   RV T
Sbjct: 110 EILCGLEDLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPE---GESIR--GRVGT 164

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + Y  PE+L   R Y    D WG GC++ EM
Sbjct: 165 VGYMAPEVLNNQR-YTLSPDYWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with the membrane though an N-terminal PIP2 binding domain and also binds phospholipids via its C-terminus. GRK5 deficiency is associated with early Alzheimer's disease in humans and mouse models. GRK5 also plays a crucial role in the pathogenesis of sporadic Parkinson's disease. It participates in the regulation and desensitization of PDGFRbeta, a receptor tyrosine kinase involved in a variety of downstream cellular effects including cell growth, chemotaxis, apoptosis, and angiogenesis. GRK5 also regulates Toll-like receptor 4, which is involved in innate and adaptive immunity. Length = 285

>gnl|CDD|133180 cd05049, PTKc_Trk, Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

 Score = 58.2 bits (141), Expect = 2e-09
 Identities = 45/187 (24%), Positives = 89/187 (47%), Gaps = 28/187 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL--------- 61
           RE ++L   +HEN+V    +C T+ +          +VF++ EH DL   L         
Sbjct: 57  REAELLTNFQHENIVKFYGVC-TEGDPP-------IMVFEYMEHGDLNKFLRSHGPDAAF 108

Query: 62  ----SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
                +   + +L ++ ++  Q+ +G+ Y+ S   +HRD+   N L+    ++K+ DFG+
Sbjct: 109 LKSPDSPMGELTLSQLLQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGM 168

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSPI 175
           +R    T   +V    + ++ + + PPE ++  R +    D+W  G ++ E++T  + P 
Sbjct: 169 SRDVYTTDYYRVG--GHTMLPIRWMPPESIMY-RKFTTESDVWSFGVVLWEIFTYGKQPW 225

Query: 176 MQ-GNTE 181
               N E
Sbjct: 226 YGLSNEE 232

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalytic domain. Trk receptors are mainly expressed in the peripheral and central nervous systems. They play important roles in cell fate determination, neuronal survival and differentiation, as well as in the regulation of synaptic plasticity. Altered expression of Trk receptors is associated with many human diseases. Length = 280

>gnl|CDD|133199 cd05068, PTKc_Frk_like, Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 42/169 (24%), Positives = 78/169 (46%), Gaps = 26/169 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQY-----NRYRSTFYLVFDFCEHDLAGLLSNIH 65
           L E +I++ L+H  ++ L  +C  +   Y      +Y S    + ++ +      L    
Sbjct: 49  LAEAQIMKKLRHPKLIQLYAVCTLEEPIYIVTELMKYGS----LLEYLQGGAGRALK--- 101

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L ++  +  Q+ +G+ Y+ +   +HRD+ A NVL+ +  I K+ADFGLAR   +  
Sbjct: 102 ----LPQLIDMAAQVASGMAYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKE-- 155

Query: 126 NGQVNRYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               + Y  R      + +  PE  L +R +    D+W  G ++ E+ T
Sbjct: 156 ----DIYEAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGILLTEIVT 199

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Frk, also known as Rak, is specifically expressed in liver, lung, kidney, intestine, mammary glands, and the islets of Langerhans. Rodent homologs were previously referred to as GTK (gastrointestinal tyr kinase), BSK (beta-cell Src-like kinase), or IYK (intestinal tyr kinase). Studies in mice reveal that Frk is not essential for viability. It plays a role in the signaling that leads to cytokine-induced beta-cell death in Type I diabetes. It also regulates beta-cell number during embryogenesis and early in life. Length = 261

>gnl|CDD|173636 cd05057, PTKc_EGFR_like, Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 44/168 (26%), Positives = 70/168 (41%), Gaps = 25/168 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E  ++  + H +VV L+ IC +         S   L+       L  LL   +V+   
Sbjct: 57  LDEAYVMASVDHPHVVRLLGICLS---------SQVQLITQLMP--LGCLLD--YVRNHK 103

Query: 71  GEIKKVIQQLLN-------GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
             I    Q LLN       G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+    
Sbjct: 104 DNIGS--QYLLNWCVQIAKGMSYLEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLD- 160

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               + +    +V   W     +L   R Y    D+W  G  + E+ T
Sbjct: 161 VDEKEYHAEGGKVPIKWMALESILH--RIYTHKSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, resulting in the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Collectively, they can recognize a variety of ligands including EGF, TGFalpha, and neuregulins, among others. All four subfamily members can form homo- or heterodimers. HER3 contains an impaired kinase domain and depends on its heterodimerization partner for activation. EGFR subfamily members are involved in signaling pathways leading to a broad range of cellular responses including cell proliferation, differentiation, migration, growth inhibition, and apoptosis. Gain of function alterations, through their overexpression, deletions, or point mutations in their kinase domains, have been implicated in various cancers. These receptors are targets of many small molecule inhibitors and monoclonal antibodies used in cancer therapy. Length = 279

>gnl|CDD|173711 cd05621, STKc_ROCK2, Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

 Score = 58.5 bits (141), Expect = 2e-09
 Identities = 49/133 (36%), Positives = 63/133 (47%), Gaps = 19/133 (14%)

Query: 46  FYLVFDFCEH-DLAGLLSNIHV-----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
            Y+V ++    DL  L+SN  V     KF   E+       +  L  IHS  ++HRD+K 
Sbjct: 118 LYMVMEYMPGGDLVNLMSNYDVPEKWAKFYTAEV-------VLALDAIHSMGLIHRDVKP 170

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDRNYGPP 156
            N+L+ K G LKLADFG      +T  G V R    V T  Y  PE+L    GD  YG  
Sbjct: 171 DNMLLDKHGHLKLADFGTCMKMDET--GMV-RCDTAVGTPDYISPEVLKSQGGDGYYGRE 227

Query: 157 VDLWGAGCIMAEM 169
            D W  G  + EM
Sbjct: 228 CDWWSVGVFLFEM 240

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found to play a role in stress fiber and focal adhesion formation. It is prominently expressed in the brain, heart, and skeletal muscles. It is implicated in vascular and neurological disorders, such as hypertension and vasospasm of the coronary and cerebral arteries. ROCK2 is also activated by caspase-2 cleavage, resulting in thrombin-induced microparticle generation in response to cell activation. Mice deficient in ROCK2 show intrauterine growth retardation and embryonic lethality because of placental dysfunction. Length = 370

>gnl|CDD|165473 PHA03207, PHA03207, serine/threonine kinase US3; Provisional

 Score = 58.7 bits (142), Expect = 2e-09
 Identities = 46/164 (28%), Positives = 73/164 (44%), Gaps = 24/164 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI IL+ + H  +++LI   R K        ST  +V    + DL   + +      L 
Sbjct: 135 REIDILKTISHRAIINLIHAYRWK--------STVCMVMPKYKCDLFTYV-DRSGPLPLE 185

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +   + ++LL  L Y+H   I+HRD+K  N+ + +     L DFG A         +++ 
Sbjct: 186 QAITIQRRLLEALAYLHGRGIIHRDVKTENIFLDEPENAVLGDFGAA--------CKLDA 237

Query: 132 YTNR------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + +         TL    PELL  D  Y    D+W AG ++ EM
Sbjct: 238 HPDTPQCYGWSGTLETNSPELLALD-PYCAKTDIWSAGLVLFEM 280

Length = 392

>gnl|CDD|173650 cd05094, PTKc_TrkC, Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

 Score = 57.7 bits (139), Expect = 2e-09
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 30/189 (15%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS-------- 62
           RE ++L  L+HE++V    +C               +VF++ +H DL   L         
Sbjct: 56  REAELLTNLQHEHIVKFYGVCGDG--------DPLIMVFEYMKHGDLNKFLRAHGPDAMI 107

Query: 63  -------NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                      +  L ++  +  Q+ +G+ Y+ S   +HRD+   N L+    ++K+ DF
Sbjct: 108 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 167

Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RS 173
           G++R    T   +V  +T  ++ + + PPE ++  R +    D+W  G I+ E++T  + 
Sbjct: 168 GMSRDVYSTDYYRVGGHT--MLPIRWMPPESIMY-RKFTTESDVWSFGVILWEIFTYGKQ 224

Query: 174 PIMQ-GNTE 181
           P  Q  NTE
Sbjct: 225 PWFQLSNTE 233

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some non-neural tissues including the developing heart. NT3/TrkC signaling plays an important role in the innervation of the cardiac conducting system and the development of smooth muscle cells. Mice deficient with NT3 and TrkC have multiple heart defects. NT3/TrkC signaling is also critical for the development and maintenance of enteric neurons that are important for the control of gut peristalsis. Length = 291

>gnl|CDD|173678 cd05587, STKc_cPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

 Score = 57.9 bits (140), Expect = 3e-09
 Identities = 35/110 (31%), Positives = 53/110 (48%), Gaps = 9/110 (8%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLW 140
           GL+++HS  I++RD+K  NV++   G +K+ADFG+       K       T R    T  
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMC------KENIFGGKTTRTFCGTPD 166

Query: 141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
           Y  PE++   + YG  VD W  G ++ EM    P   G  E +    I +
Sbjct: 167 YIAPEIIA-YQPYGKSVDWWAFGVLLYEMLAGQPPFDGEDEDELFQSIME 215

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory domain. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. cPKCs are potent kinases for histones, myelin basic protein, and protamine. PKC-gamma is mainly expressed in neuronal tissues. It plays a role in protection from ischemia. Length = 324

>gnl|CDD|173633 cd05052, PTKc_Abl, Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

 Score = 57.2 bits (138), Expect = 3e-09
 Identities = 28/111 (25%), Positives = 57/111 (51%), Gaps = 10/111 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   L  L      + 
Sbjct: 50  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTYGNLLDYLRECNRQEV 101

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +   +  +  Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R
Sbjct: 102 NAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSR 152

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays a role in cell proliferation and survival. In response to DNA damage or oxidative stress, Abl is transported to the nucleus where it induces apoptosis. In chronic myelogenous leukemia (CML) patients, an aberrant translocation results in the replacement of the first exon of Abl with the BCR (breakpoint cluster region) gene. The resulting BCR-Abl fusion protein is constitutively active and associates into tetramers, resulting in a hyperactive kinase sending a continuous signal. This leads to uncontrolled proliferation, morphological transformation and anti-apoptotic effects. BCR-Abl is the target of selective inhibitors, such as imatinib (Gleevec), used in the treatment of CML. Abl2, also known as ARG (Abelson-related gene), is thought to play a cooperative role with Abl in the proper development of the nervous system. The Tel-ARG fusion protein, resulting from reciprocal translocation between chromosomes 1 and 12, is associated with acute myeloid leukemia (AML). The TEL gene is a frequent fusion partner of other tyr kinase oncogenes, including Tel/Abl, Tel/PDGFRbeta, and Tel/Jak2, found in patients with leukemia and myeloproliferative disorders. Length = 263

>gnl|CDD|132969 cd06638, STKc_myosinIIIA, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 33/106 (31%), Positives = 53/106 (50%), Gaps = 8/106 (7%)

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           I  ++ + L GL ++H NK +HRD+K  N+L+T  G +KL DFG++   + T+     R 
Sbjct: 126 IAYILHEALMGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR----LRR 181

Query: 133 TNRVVTLWYRPPELLLG----DRNYGPPVDLWGAGCIMAEMWTRSP 174
              V T ++  PE++      D  Y    D+W  G    E+    P
Sbjct: 182 NTSVGTPFWMAPEVIACEQQLDSTYDARCDVWSLGITAIELGDGDP 227

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear hair cells. It is localized to the distal ends of actin-bundled structures. Mutations in human myosin IIIA are responsible for progressive nonsyndromic hearing loss. Human myosin IIIA possesses ATPase and kinase activities, and the ability to move actin filaments in a motility assay. It may function as a cellular transporter capable of moving along actin bundles in sensory cells. Length = 286

>gnl|CDD|132970 cd06639, STKc_myosinIIIB, Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

 Score = 57.3 bits (138), Expect = 3e-09
 Identities = 50/172 (29%), Positives = 79/172 (45%), Gaps = 18/172 (10%)

Query: 13  EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-----LAGLLSNIHV 66
           E  ILQ L  H NVV    +   KA++        +LV + C        + GLL     
Sbjct: 68  EYNILQSLPNHPNVVKFYGMF-YKADKLVG--GQLWLVLELCNGGSVTELVKGLLICGQ- 123

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +     I  ++   L GL ++H+N+I+HRD+K  N+L+T  G +KL DFG++   + T+ 
Sbjct: 124 RLDEAMISYILYGALLGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR- 182

Query: 127 GQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGAGCIMAEMWTRSP 174
               R    V T ++  PE++      D +Y    D+W  G    E+    P
Sbjct: 183 ---LRRNTSVGTPFWMAPEVIACEQQYDYSYDARCDVWSLGITAIELGDGDP 231

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also present in the brain and testis. The human class IIIB myosin gene maps to a region that overlaps the locus for Bardet-Biedl syndrome, which is characterized by dysmorphic extremities, retinal dystrophy, obesity, male hypogenitalism, and renal abnormalities. Length = 291

>gnl|CDD|173713 cd05624, STKc_MRCK_beta, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

 Score = 57.7 bits (139), Expect = 4e-09
 Identities = 43/129 (33%), Positives = 61/129 (47%), Gaps = 8/129 (6%)

Query: 46  FYLVFDF-CEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YLV D+    DL  LLS    +      +  I +++  ++ IH    +HRD+K  NVL+
Sbjct: 76  LYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHSIHQLHYVHRDIKPDNVLL 135

Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLW 160
              G ++LADFG        ++G V + +  V T  Y  PE+L     G   YGP  D W
Sbjct: 136 DMNGHIRLADFG--SCLKMNQDGTV-QSSVAVGTPDYISPEILQAMEDGMGKYGPECDWW 192

Query: 161 GAGCIMAEM 169
             G  M EM
Sbjct: 193 SLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues. Length = 331

>gnl|CDD|173629 cd05041, PTKc_Fes_like, Catalytic domain of Fes-like Protein Tyrosine Kinases

 Score = 56.7 bits (137), Expect = 4e-09
 Identities = 47/168 (27%), Positives = 82/168 (48%), Gaps = 24/168 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L+E +IL+   H N+V LI +C  K           Y+V +     + G  LL+ +  K 
Sbjct: 40  LQEAEILKQYDHPNIVKLIGVCVQK--------QPIYIVMEL----VPGGSLLTFLRKKK 87

Query: 69  SLGEIKKVIQQLL---NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           +   +KK++Q  L    G+ Y+ S   +HRD+ A N L+ +  +LK++DFG++R   + +
Sbjct: 88  NRLTVKKLLQMSLDAAAGMEYLESKNCIHRDLAARNCLVGENNVLKISDFGMSR---EEE 144

Query: 126 NG--QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            G   V+    ++   W  P  L  G   Y    D+W  G ++ E ++
Sbjct: 145 GGIYTVSDGLKQIPIKWTAPEALNYG--RYTSESDVWSYGILLWETFS 190

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes and Fer kinases play roles in haematopoiesis, inflammation and immunity, growth factor signaling, cytoskeletal regulation, cell migration and adhesion, and the regulation of cell-cell interactions. Fes and Fer show redundancy in their biological functions. Length = 251

>gnl|CDD|133248 cd05148, PTKc_Srm_Brk, Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 38/180 (21%), Positives = 79/180 (43%), Gaps = 16/180 (8%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK-FS 69
           +E++ L+ L+H++++ L  +C              Y++ +  E   L   L +   +   
Sbjct: 51  KEVQALKRLRHKHLISLFAVCSVG--------EPVYIITELMEKGSLLAFLRSPEGQVLP 102

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  +  +  Q+  G+ Y+     +HRD+ A N+L+ +  + K+ADFGLAR   +     V
Sbjct: 103 VASLIDMACQVAEGMAYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKED----V 158

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITLI 188
              +++ +   +  PE       +    D+W  G ++ EM+T   +   G    +    I
Sbjct: 159 YLSSDKKIPYKWTAPE-AASHGTFSTKSDVWSFGILLYEMFTYGQVPYPGMNNHEVYDQI 217

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Srm and Brk however, lack the N-terminal myristylation sites. Src proteins are involved in signaling pathways that regulate cytokine and growth factor responses, cytoskeleton dynamics, cell proliferation, survival, and differentiation. Brk has been found to be overexpressed in a majority of breast tumors. Length = 261

>gnl|CDD|133178 cd05046, PTK_CCK4, Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

 Score = 56.7 bits (137), Expect = 5e-09
 Identities = 37/169 (21%), Positives = 77/169 (45%), Gaps = 21/169 (12%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLL--------S 62
           RE+ + + L H+NVV L+ +CR             Y++ ++ +  DL   L         
Sbjct: 57  RELDMFRKLSHKNVVRLLGLCREA--------EPHYMILEYTDLGDLKQFLRATKSKDEK 108

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
                 S  +   +  Q+  G+ ++ + + +HRD+ A N L++    +K++   L++   
Sbjct: 109 LKPPPLSTKQKVALCTQIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSK--- 165

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
              N +  +  N ++ L +  PE +  D ++    D+W  G +M E++T
Sbjct: 166 DVYNSEYYKLRNALIPLRWLAPEAVQED-DFSTKSDVWSFGVLMWEVFT 213

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is still unknown. Other pseudokinases such as HER3 rely on the activity of partner RTKs. Length = 275

>gnl|CDD|173675 cd05584, STKc_p70S6K, Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

 Score = 57.1 bits (138), Expect = 5e-09
 Identities = 71/269 (26%), Positives = 103/269 (38%), Gaps = 68/269 (25%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD-------FCEHDLAGLLSNIH 65
           E  IL+ +KH  +V LI   +T            YL+ +       F   +  G+     
Sbjct: 50  ERNILEAVKHPFIVDLIYAFQTGGK--------LYLILEYLSGGELFMHLEREGIFMEDT 101

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             F L EI   ++ L       H   I++RD+K  N+L+   G +KL DFGL +      
Sbjct: 102 ACFYLSEISLALEHL-------HQQGIIYRDLKPENILLDAQGHVKLTDFGLCK--ESIH 152

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G V        T+ Y  PE+L+    +G  VD W  G +M +M T +P       ++ I
Sbjct: 153 EGTVTH--TFCGTIEYMAPEILM-RSGHGKAVDWWSLGALMYDMLTGAPPFTAENRKKTI 209

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I                   L  K+ LP            PY+  +   DLL KLL  
Sbjct: 210 DKI-------------------LKGKLNLP------------PYLTPE-ARDLLKKLLKR 237

Query: 246 DPSKRF-----DSDAALNHDFF----WTD 265
           +PS R      D+    +H FF    W D
Sbjct: 238 NPSSRLGAGPGDAAEVQSHPFFRHVNWDD 266

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the insulin receptor substrate IRS-1, among others. Mammals contain two isoforms of p70S6K, named S6K1 and S6K2 (or S6K-beta). Length = 323

>gnl|CDD|173679 cd05588, STKc_aPKC, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

 Score = 56.8 bits (137), Expect = 6e-09
 Identities = 41/133 (30%), Positives = 57/133 (42%), Gaps = 37/133 (27%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR----- 119
           H +F   EI          L ++H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 97  HARFYSAEI-------SLALNFLHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRP 149

Query: 120 -----AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RS 173
                 F  T N              Y  PE+L G+ +YG  VD W  G +M EM   RS
Sbjct: 150 GDTTSTFCGTPN--------------YIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRS 194

Query: 174 PI----MQGNTEQ 182
           P     M  N +Q
Sbjct: 195 PFDIVGMSDNPDQ 207

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions including proliferation, migration, apoptosis, polarity maintenance and cytoskeletal regulation. They also play a critical role in the regulation of glucose metabolism and in the pathogenesis of type 2 diabetes. Length = 329

>gnl|CDD|223009 PHA03211, PHA03211, serine/threonine kinase US3; Provisional

 Score = 57.2 bits (138), Expect = 7e-09
 Identities = 40/113 (35%), Positives = 56/113 (49%), Gaps = 3/113 (2%)

Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
           DL   L        L ++  V +QLL+ + YIH   I+HRD+K  NVL+     + L DF
Sbjct: 245 DLYTYLGARLRPLGLAQVTAVARQLLSAIDYIHGEGIIHRDIKTENVLVNGPEDICLGDF 304

Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
           G A  F++        Y     T+    PE+L GD  Y P VD+W AG ++ E
Sbjct: 305 G-AACFARGSWSTPFHY-GIAGTVDTNAPEVLAGD-PYTPSVDIWSAGLVIFE 354

Length = 461

>gnl|CDD|173705 cd05614, STKc_MSK2_N, N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

 Score = 56.5 bits (136), Expect = 8e-09
 Identities = 52/202 (25%), Positives = 85/202 (42%), Gaps = 40/202 (19%)

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FS  E++    +++  L ++H   I++RD+K  N+L+   G + L DFGL++ F   +  
Sbjct: 102 FSEDEVRFYSGEIILALEHLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEKE 161

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPI-MQGNTEQQQI 185
           +   +     T+ Y  PE++ G   +G  VD W  G ++ E+ T  SP  ++G    Q  
Sbjct: 162 RTYSFCG---TIEYMAPEIIRGKGGHGKAVDWWSLGILIFELLTGASPFTLEGERNTQ-- 216

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
              S++   I               K + P          + P  +     DLL KLL  
Sbjct: 217 ---SEVSRRIL--------------KCDPP------FPSFIGPEAQ-----DLLHKLLRK 248

Query: 246 DPSKRFDS-----DAALNHDFF 262
           DP KR  +          H FF
Sbjct: 249 DPKKRLGAGPQGASEIKEHPFF 270

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydrophobic motif (HM) of NTD, which facilitates the phosphorylation of the A-loop and activates the NTD, which in turn phosphorylates downstream targets. MSK2 and MSK1 play nonredundant roles in activating histone H3 kinases, which play pivotal roles in compaction of the chromatin fiber. MSK2 is the required H3 kinase in response to stress stimuli and activation of the p38 MAPK pathway. MSK2 also plays a role in the pathogenesis of psoriasis. Length = 332

>gnl|CDD|173685 cd05594, STKc_PKB_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

 Score = 56.6 bits (136), Expect = 8e-09
 Identities = 58/209 (27%), Positives = 86/209 (41%), Gaps = 57/209 (27%)

Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 103 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK--TFCG 158

Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PE +L D +YG  VD WG G +M EM                     +CG    
Sbjct: 159 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM---------------------MCGR--- 193

Query: 198 ESWPGVETLDLYNK-----MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF- 251
                   L  YN+      EL   ++ +    L P  K      LL  LL  DP +R  
Sbjct: 194 --------LPFYNQDHEKLFELILMEEIRFPRTLSPEAK-----SLLSGLLKKDPKQRLG 240

Query: 252 ----DSDAALNHDFF----WTDPMPSDLS 272
               D+   + H FF    W D     L 
Sbjct: 241 GGPDDAKEIMQHKFFAGIVWQDVYEKKLV 269

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficient in PKB-alpha exhibit perinatal morbidity, growth retardation, reduction in body weight accompanied by reduced sizes of multiple organs, and enhanced apoptosis in some cell types. PKB-alpha activity has been reported to be frequently elevated in breast and prostate cancers. In some cancer cells, PKB-alpha may act as a suppressor of metastasis. Length = 325

>gnl|CDD|173720 cd05631, STKc_GRK4, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

 Score = 56.2 bits (135), Expect = 9e-09
 Identities = 31/91 (34%), Positives = 50/91 (54%), Gaps = 6/91 (6%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           +L  GL  +   +I++RD+K  N+L+   G ++++D GLA    Q   G+  R   RV T
Sbjct: 110 ELCCGLEDLQRERIVYRDLKPENILLDDRGHIRISDLGLA---VQIPEGETVR--GRVGT 164

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + Y  PE ++ +  Y    D WG GC++ EM
Sbjct: 165 VGYMAPE-VINNEKYTFSPDWWGLGCLIYEM 194

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found in the testis, but is also present in the cerebellum and kidney. It is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK4 polymorphisms are associated with hypertension and salt sensitivity, as they cause hyperphosphorylation, desensitization, and internalization of the dopamine 1 (D1) receptor while increasing the expression of the angiotensin II type 1 receptor. GRK4 plays a crucial role in the D1 receptor regulation of sodium excretion and blood pressure. Length = 285

>gnl|CDD|133228 cd05097, PTKc_DDR_like, Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

 Score = 56.1 bits (135), Expect = 9e-09
 Identities = 47/175 (26%), Positives = 80/175 (45%), Gaps = 27/175 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN--IHVK 67
           L+EIKI+  LK+ N++ L+ +C +             ++ ++ E+ DL   LS   I   
Sbjct: 65  LKEIKIMSRLKNPNIIRLLGVCVSD--------DPLCMITEYMENGDLNQFLSQREIEST 116

Query: 68  F---------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           F         S+  +  +  Q+ +G+ Y+ S   +HRD+   N L+     +K+ADFG++
Sbjct: 117 FTHANNIPSVSIANLLYMAVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMS 176

Query: 119 RAFSQTKNGQVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R      +G   R   R V    W     +LLG   +    D+W  G  + EM+T
Sbjct: 177 RNLY---SGDYYRIQGRAVLPIRWMAWESILLG--KFTTASDVWAFGVTLWEMFT 226

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 295

>gnl|CDD|173706 cd05615, STKc_cPKC_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

 Score = 55.8 bits (134), Expect = 1e-08
 Identities = 34/103 (33%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLW 140
           GL+++H   I++RD+K  NV++   G +K+ADFG+       K   V+  T R    T  
Sbjct: 113 GLFFLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMC------KEHMVDGVTTRTFCGTPD 166

Query: 141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           Y  PE ++  + YG  VD W  G ++ EM    P   G  E +
Sbjct: 167 YIAPE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. PKC-alpha is expressed in many tissues and is associated with cell proliferation, apoptosis, and cell motility. It plays a role in the signaling of the growth factors PDGF, VEGF, EGF, and FGF. Abnormal levels of PKC-alpha have been detected in many transformed cell lines and several human tumors. In addition, PKC-alpha is required for HER2 dependent breast cancer invasion. Length = 323

>gnl|CDD|133187 cd05056, PTKc_FAK, Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 30/113 (26%), Positives = 50/113 (44%), Gaps = 10/113 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E  I++   H ++V LI +            +  ++V +     +L   L        
Sbjct: 55  LQEAYIMRQFDHPHIVKLIGVITE---------NPVWIVMELAPLGELRSYLQVNKYSLD 105

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           L  +     QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R   
Sbjct: 106 LASLILYSYQLSTALAYLESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLE 158

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions and at growth factor receptors. Through diverse molecular interactions, FAK functions as a biosensor or integrator to control cell motility. It is a key regulator of cell survival, proliferation, migration and invasion, and thus plays an important role in the development and progression of cancer. Src binds to autophosphorylated FAK forming the FAK-Src dual kinase complex, which is activated in a wide variety of tumor cells and generates signals promoting growth and metastasis. FAK is being developed as a target for cancer therapy. Length = 270

>gnl|CDD|173722 cd05633, STKc_GRK3, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

 Score = 55.0 bits (132), Expect = 2e-08
 Identities = 40/141 (28%), Positives = 72/141 (51%), Gaps = 13/141 (9%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  E++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 91  HGVFSEKEMRFYATEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 151 KPHA------SVGTHGYMAPEVLQKGTAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Query: 184 Q------ITLISQLCGSITPE 198
                  +T+  +L  S +PE
Sbjct: 205 HEIDRMTLTVNVELPDSFSPE 225

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is widely expressed in many tissues. GRK3-deficient mice show a lack of olfactory receptor desensitization and altered regulation of the M2 muscarinic airway. GRK3 is involved in modulating the cholinergic response of airway smooth muscles. It also plays a role in dopamine receptor regulation. GRK3 promoter polymorphisms may be associated with bipolar disorder. Length = 279

>gnl|CDD|173688 cd05597, STKc_DMPK_like, Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

 Score = 55.6 bits (134), Expect = 2e-08
 Identities = 46/135 (34%), Positives = 58/135 (42%), Gaps = 22/135 (16%)

Query: 47  YLVFDF-CEHDLAGLLSNIH-------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMK 98
           YLV D+    DL  LLS           +F L E+   I         +H    +HRD+K
Sbjct: 77  YLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS-------VHQLGYVHRDIK 129

Query: 99  AANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYG 154
             NVL+ K G ++LADFG         +G V +    V T  Y  PE+L     G   YG
Sbjct: 130 PDNVLLDKNGHIRLADFG--SCLRLLADGTV-QSNVAVGTPDYISPEILQAMEDGKGRYG 186

Query: 155 PPVDLWGAGCIMAEM 169
           P  D W  G  M EM
Sbjct: 187 PECDWWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy, and cardiac conduction defects. The genetic basis for DM1 is the mutational expansion of a CTG repeat in the 3'-UTR of DMPK. DMPK is expressed in skeletal and cardiac muscles, and in central nervous tissues. The functional role of DMPK is not fully understood. It may play a role in the signal transduction and homeostasis of calcium. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKgamma is expressed in heart and skeletal muscles, unlike MRCKalpha and MRCKbeta, which are expressed ubiquitously. Length = 331

>gnl|CDD|133213 cd05082, PTKc_Csk, Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

 Score = 54.6 bits (131), Expect = 2e-08
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 19/164 (11%)

Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVK 67
           L E  ++  L+H N+V L+  I   K   Y    Y +   LV        + L  +  +K
Sbjct: 47  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FSL         +   + Y+ +N  +HRD+ A NVL+++  + K++DFGL +  S T++ 
Sbjct: 107 FSL--------DVCEAMEYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                T ++   W  P  L   ++ +    D+W  G ++ E+++
Sbjct: 158 -----TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYS 194

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, resulting in their inactivation. Csk is expressed in a wide variety of tissues. As a negative regulator of Src, Csk plays a role in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. In addition, Csk also shows Src-independent functions. It is a critical component in G-protein signaling, and plays a role in cytoskeletal reorganization and cell migration. Length = 256

>gnl|CDD|133214 cd05083, PTKc_Chk, Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

 Score = 54.2 bits (130), Expect = 3e-08
 Identities = 45/179 (25%), Positives = 81/179 (45%), Gaps = 43/179 (24%)

Query: 11  LREIKILQLLKHENVVHLIEIC-----------RTKANQYN--RYRSTFYLVFDFCEHDL 57
           L E  ++  L H+N+V L+ +             +K N  N  R R    +        +
Sbjct: 47  LEETAVMTKLHHKNLVRLLGVILHNGLYIVMELMSKGNLVNFLRTRGRALV-------SV 99

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
             LL     +FSL         +  G+ Y+ S K++HRD+ A N+L+++ G+ K++DFGL
Sbjct: 100 IQLL-----QFSL--------DVAEGMEYLESKKLVHRDLAARNILVSEDGVAKVSDFGL 146

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
           AR  S   +       +++   W  P    L  + +    D+W  G ++ E+++  R+P
Sbjct: 147 ARVGSMGVD------NSKLPVKWTAPEA--LKHKKFSSKSDVWSYGVLLWEVFSYGRAP 197

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src kinases using a noncatalytic mechanism by simply binding to them. As a negative regulator of Src kinases, Chk may play important roles in cell proliferation, survival, and differentiation, and consequently, in cancer development and progression. Chk is expressed in brain and hematopoietic cells. Studies in mice reveal that Chk is not functionally redundant with Csk and that it plays an important role as a regulator of immune responses. Chk also plays a role in neural differentiation in a manner independent of Src by enhancing Mapk activation via Ras-mediated signaling. Length = 254

>gnl|CDD|133234 cd05103, PTKc_VEGFR2, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

 Score = 54.6 bits (131), Expect = 3e-08
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 187 QVAKGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 245

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 246 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 276

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosphorylation and activation. VEGFR2 binds the ligands VEGFA, VEGFC, VEGFD and VEGFE. VEGFR2 signaling is implicated in all aspects of normal and pathological vascular endothelial cell biology. It induces a variety of cellular effects including migration, survival, and proliferation. It is critical in regulating embryonic vascular development and angiogenesis. VEGFR2 is the major signal transducer in pathological angiogenesis including cancer and diabetic retinopathy, and is a target for inhibition in cancer therapy. Length = 343

>gnl|CDD|173719 cd05630, STKc_GRK6, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

 Score = 54.3 bits (130), Expect = 3e-08
 Identities = 33/96 (34%), Positives = 52/96 (54%), Gaps = 7/96 (7%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL  +H  +I++RD+K  N+L+   G ++++D GLA        GQ  +   RV T+ Y 
Sbjct: 114 GLEDLHQERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIK--GRVGTVGYM 168

Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQ 177
            PE++  +R    P D W  GC++ EM   +SP  Q
Sbjct: 169 APEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQQ 203

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as multiple splice variants with different domain architectures. It is post-translationally palmitoylated and localized in the membrane. GRK6 plays important roles in the regulation of dopamine, M3 muscarinic, opioid, and chemokine receptor signaling. It also plays maladaptive roles in addiction and Parkinson's disease. GRK6-deficient mice exhibit altered dopamine receptor regulation, decreased lymphocyte chemotaxis, and increased acute inflammation and neutrophil chemotaxis. Length = 285

>gnl|CDD|173681 cd05590, STKc_nPKC_eta, Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

 Score = 54.5 bits (131), Expect = 4e-08
 Identities = 34/93 (36%), Positives = 48/93 (51%), Gaps = 9/93 (9%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++ + L ++H   I++RD+K  NVL+   G  KLADFG+       K G  N  T     
Sbjct: 104 EITSALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC------KEGIFNGKTTSTFC 157

Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L +  YGP VD W  G ++ EM
Sbjct: 158 GTPDYIAPE-ILQEMLYGPSVDWWAMGVLLYEM 189

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signaling of cell-type specific differentiation. It is also expressed in pro-B cells and early-stage thymocytes, and acts as a key regulator in early B-cell development. PKC-eta increases glioblastoma multiforme (GBM) proliferation and resistance to radiation, and is being developed as a therapeutic target for the management of GBM. Length = 320

>gnl|CDD|133246 cd05115, PTKc_Zap-70, Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

 Score = 53.4 bits (128), Expect = 5e-08
 Identities = 39/159 (24%), Positives = 70/159 (44%), Gaps = 12/159 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           +RE +I+  L +  +V +I +C  +A           LV +      L   LS    + +
Sbjct: 43  MREAEIMHQLDNPYIVRMIGVCEAEA---------LMLVMEMASGGPLNKFLSGKKDEIT 93

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HRD+ A NVL+      K++DFGL++A     +   
Sbjct: 94  VSNVVELMHQVSMGMKYLEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSYYK 153

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            R   +    WY P  +    R +    D+W  G  M E
Sbjct: 154 ARSAGKWPLKWYAPECINF--RKFSSRSDVWSYGITMWE 190

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its phosphorylation and activation. It then phosphorylates target proteins, which propagate the signals to downstream pathways. Zap-70 is hardly detected in normal peripheral B-cells, but is present in some B-cell malignancies. It is used as a diagnostic marker for chronic lymphocytic leukemia (CLL) as it is associated with the more aggressive subtype of the disease. Length = 257

>gnl|CDD|133181 cd05050, PTKc_Musk, Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

 Score = 53.7 bits (129), Expect = 5e-08
 Identities = 53/222 (23%), Positives = 96/222 (43%), Gaps = 30/222 (13%)

Query: 12  REIKILQLLKHENVVHLIEICRTKA--------------NQYNRYRSTFYLVFDFCEHDL 57
           RE  ++    H N+V L+ +C                  N++ R+RS             
Sbjct: 57  REAALMAEFDHPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSS 116

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
           A       +  S  E   + +Q+  G+ Y+   K +HRD+   N L+ +  ++K+ADFGL
Sbjct: 117 ARKCGLNPLPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGL 176

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
           +R        + +   N  + + + PPE +  +R Y    D+W  G ++ E+++    MQ
Sbjct: 177 SRNIYSADYYKASE--NDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYG--MQ 231

Query: 178 ---GNTEQQQITLISQLCGSI--TPESWPGVETLDLYNKMEL 214
              G   ++ I  +    G++   P++ P    L+LYN M L
Sbjct: 232 PYYGMAHEEVIYYVRD--GNVLSCPDNCP----LELYNLMRL 267

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates Musk autophosphorylation and activation, leading to the clustering of acetylcholine receptors (AChRs). To date, there is no evidence to suggest that agrin binds directly to Musk. Mutations in AChR, Musk and other partners are responsible for diseases of the NMJ, such as the autoimmune syndrome myasthenia gravis. Length = 288

>gnl|CDD|173699 cd05608, STKc_GRK1, Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

 Score = 53.7 bits (129), Expect = 6e-08
 Identities = 31/91 (34%), Positives = 53/91 (58%), Gaps = 5/91 (5%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+++GL ++H  +I++RD+K  NVL+   G ++++D GLA    + K+GQ ++      T
Sbjct: 105 QIISGLEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLA---VELKDGQ-SKTKGYAGT 160

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             +  PELL G+  Y   VD +  G  + EM
Sbjct: 161 PGFMAPELLQGEE-YDFSVDYFALGVTLYEM 190

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual group of GRKs and is expressed in retinal cells. It phosphorylates rhodopsin in rod cells, which leads to termination of the phototransduction cascade. Mutations in GRK1 are associated to a recessively inherited form of stationary nightblindness called Oguchi disease. Length = 280

>gnl|CDD|173697 cd05606, STKc_beta_ARK, Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

 Score = 53.4 bits (128), Expect = 6e-08
 Identities = 44/163 (26%), Positives = 81/163 (49%), Gaps = 12/163 (7%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  E++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 91  HGVFSEAEMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 150

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 151 KPHA------SVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 204

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL 226
               I ++  ++  E  P   + +L + +E     +R V  RL
Sbjct: 205 H--EIDRMTLTMAVE-LPDSFSPELRSLLE--GLLQRDVNRRL 242

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is composed of GRK2, GRK3, and similar proteins. GRK2 and GRK3 are both widely expressed in many tissues, although GRK2 is present at higher levels. They contain an N-terminal RGS homology (RH) domain, a central catalytic domain, and C-terminal pleckstrin homology (PH) domain that mediates PIP2 and G protein betagamma-subunit translocation to the membrane. GRK2 (also called beta-ARK or beta-ARK1) is important in regulating several cardiac receptor responses. It plays a role in cardiac development and in hypertension. Deletion of GRK2 in mice results in embryonic lethality, caused by hypoplasia of the ventricular myocardium. GRK2 also plays important roles in the liver (as a regulator of portal blood pressure), in immune cells, and in the nervous system. Altered GRK2 expression has been reported in several disorders including major depression, schizophrenia, bipolar disorder, and Parkinsonism. Length = 278

>gnl|CDD|133233 cd05102, PTKc_VEGFR3, Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

 Score = 53.9 bits (129), Expect = 6e-08
 Identities = 27/93 (29%), Positives = 53/93 (56%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V + + R+  
Sbjct: 182 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGSARLPL 240

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   D+ Y    D+W  G ++ E+++
Sbjct: 241 KWMAPESIF--DKVYTTQSDVWSFGVLLWEIFS 271

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. VEGFR3 preferentially binds the ligands VEGFC and VEGFD. VEGFR3 is essential for lymphatic endothelial cell (EC) development and function. It has been shown to regulate adaptive immunity during corneal transplantation. VEGFR3 is upregulated on blood vascular ECs in pathological conditions such as vascular tumors and the periphery of solid tumors. It plays a role in cancer progression and lymph node metastasis. Missense mutations in the VEGFR3 gene are associated with primary human lymphedema. Length = 338

>gnl|CDD|143345 cd07840, STKc_CDK9_like, Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

 Score = 51.8 bits (125), Expect = 2e-07
 Identities = 22/45 (48%), Positives = 29/45 (64%), Gaps = 1/45 (2%)

Query: 323 YHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           Y  R++E  K ++ D    DLLDKLL LDP KR  +D AL H++F
Sbjct: 244 YKRRLREFFK-HLIDPSALDLLDKLLTLDPKKRISADQALQHEYF 287

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA polymerase II and participate in regulating mutliple steps of gene expression including transcription elongation and RNA processing. CDK9 and CdkC associate with T-type cyclins while BUR1 associates with the cyclin BUR2. CDK12 is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 interacts with cyclins L1 and L2, and participates in regulating transcription and alternative splicing. Length = 287

>gnl|CDD|173707 cd05616, STKc_cPKC_beta, Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

 Score = 52.3 bits (125), Expect = 2e-07
 Identities = 32/103 (31%), Positives = 52/103 (50%), Gaps = 9/103 (8%)

Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLW 140
           GL+++HS  I++RD+K  NV++   G +K+ADFG+       K    +  T +    T  
Sbjct: 113 GLFFLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMC------KENMWDGVTTKTFCGTPD 166

Query: 141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           Y  PE ++  + YG  VD W  G ++ EM       +G  E +
Sbjct: 167 YIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 208

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and gamma. The PKC beta isoforms (I and II), generated by alternative splicing of a single gene, are preferentially activated by hyperglycemia-induced DAG in retinal tissues. This is implicated in diabetic microangiopathy such as ischemia, neovascularization, and abnormal vasodilator function. PKC-beta also plays an important role in VEGF signaling. In addition, glucose regulates proliferation in retinal endothelial cells via PKC-betaI. PKC-beta is also being explored as a therapeutic target in cancer. It contributes to tumor formation and is involved in the tumor host mechanisms of inflammation and angiogenesis. Length = 323

>gnl|CDD|132981 cd06650, PKc_MEK1, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 54/202 (26%), Positives = 90/202 (44%), Gaps = 22/202 (10%)

Query: 75  KVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT 133
           KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N + 
Sbjct: 107 KVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF- 162

Query: 134 NRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLC 192
             V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++     + 
Sbjct: 163 --VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAIGRYPIPPPDAKELELMFGCPVE 219

Query: 193 G-----SITPESWPGVETLDLYNKMELPKAQKRKVKERL--KPYVKDQYGC------DLL 239
           G       +P   P    L  Y     P     ++ + +  +P  K   G       D +
Sbjct: 220 GDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVFGAEFQDFV 279

Query: 240 DKLLLLDPSKRFDSDAALNHDF 261
           +K L+ +P++R D    + H F
Sbjct: 280 NKCLIKNPAERADLKQLMVHAF 301

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK1, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK1, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. MEK1 also plays a role in cell cycle control. Length = 333

>gnl|CDD|173625 cd05032, PTKc_InsR_like, Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

 Score = 51.6 bits (124), Expect = 2e-07
 Identities = 26/97 (26%), Positives = 50/97 (51%), Gaps = 11/97 (11%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT----KNGQVNRYTN 134
           ++ +G+ Y+ + K +HRD+ A N ++ +   +K+ DFG+ R   +T    K G+      
Sbjct: 127 EIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDYYRKGGK------ 180

Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            ++ + +  PE L  D  +    D+W  G ++ EM T
Sbjct: 181 GLLPVRWMAPESLK-DGVFTTKSDVWSFGVVLWEMAT 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR and IGF-1R, which share 84% sequence identity in their kinase domains, display physiologically distinct yet overlapping functions in cell growth, differentiation, and metabolism. InsR activation leads primarily to metabolic effects while IGF-1R activation stimulates mitogenic pathways. In cells expressing both receptors, InsR/IGF-1R hybrids are found together with classical receptors. Both receptors can interact with common adaptor molecules such as IRS-1 and IRS-2. Length = 277

>gnl|CDD|88519 cd05618, STKc_aPKC_iota, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

 Score = 52.0 bits (124), Expect = 2e-07
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 13/111 (11%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L Y+H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 97  HARFYSAEISL-------ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGL 147

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + G     +    T  Y  PE+L G+ +YG  VD W  G +M EM   RSP
Sbjct: 148 RPGDTT--STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target of tumor-specific gene amplification in many human cancers, and has been identified as a human oncogene. In addition to its role in transformed growth, PKC-iota also promotes invasion, chemoresistance, and tumor cell survival. Expression profiling of PKC-iota is a prognostic marker of poor clinical outcome in several human cancers. PKC-iota also plays a role in establishing cell polarity, and has critical embryonic functions. Length = 329

>gnl|CDD|173729 cd06617, PKc_MKK3_6, Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 40/126 (31%), Positives = 58/126 (46%), Gaps = 21/126 (16%)

Query: 70  LGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFG----LARAFSQT 124
           LG+I   I   +  L Y+HS   ++HRD+K +NVLI + G +KL DFG    L  + ++T
Sbjct: 105 LGKIAVSI---VKALEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSVAKT 161

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRN---YGPPVDLWGAGCIMAEMWT-RSPIMQGNT 180
            +     Y           PE +  + N   Y    D+W  G  M E+ T R P     T
Sbjct: 162 IDAGCKPYM---------APERINPELNQKGYDVKSDVWSLGITMIELATGRFPYDSWKT 212

Query: 181 EQQQIT 186
             QQ+ 
Sbjct: 213 PFQQLK 218

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs that phosphorylate and activate their downstream target, p38 MAPK, on specific threonine and tyrosine residues. MKK3/6 plays roles in the regulation of cell cycle progression, cytokine- and stress-induced apoptosis, oncogenic transformation, and adult tissue regeneration. In addition, MKK6 plays a critical role in osteoclast survival in inflammatory disease while MKK3 is associated with tumor invasion, progression, and poor patient survival in glioma. Length = 283

>gnl|CDD|133179 cd05048, PTKc_Ror, Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

 Score = 51.3 bits (123), Expect = 3e-07
 Identities = 41/176 (23%), Positives = 85/176 (48%), Gaps = 27/176 (15%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL------SNI 64
           +E +++  L+H N+V L+ +C TK            ++F++  H DL   L      S++
Sbjct: 57  QEAELMSDLQHPNIVCLLGVC-TKEQPTC-------MLFEYLAHGDLHEFLVRNSPHSDV 108

Query: 65  HVKFSLGEIKK---------VIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
             +     +K          +  Q+  G+ Y+ S+  +HRD+ A N L+ +   +K++DF
Sbjct: 109 GAESGDETVKSSLDCSDFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDF 168

Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           GL+R        +V   +  ++ + + PPE +L  + +    D+W  G ++ E+++
Sbjct: 169 GLSRDIYSADYYRVQ--SKSLLPVRWMPPEAILYGK-FTTESDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. They play important roles in bone and heart formation. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Drosophila Ror is expressed only in the developing nervous system during neurite outgrowth and neuronal differentiation, suggesting a role for Drosophila Ror in neural development. More recently, mouse Ror1 and Ror2 have also been found to play an important role in regulating neurite growth in central neurons. Ror1 and Ror2 are believed to have some overlapping and redundant functions. Length = 283

>gnl|CDD|88524 cd05623, STKc_MRCK_alpha, Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

 Score = 51.6 bits (123), Expect = 3e-07
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 8/131 (6%)

Query: 44  STFYLVFDF-CEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANV 102
           +  YLV D+    DL  LLS    +      +  + +++  +  +H    +HRD+K  N+
Sbjct: 74  NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 133

Query: 103 LITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVD 158
           L+   G ++LADFG        ++G V + +  V T  Y  PE+L     G   YGP  D
Sbjct: 134 LMDMNGHIRLADFG--SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEDGKGKYGPECD 190

Query: 159 LWGAGCIMAEM 169
            W  G  M EM
Sbjct: 191 WWSLGVCMYEM 201

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathway. Length = 332

>gnl|CDD|173642 cd05075, PTKc_Axl, Catalytic domain of the Protein Tyrosine Kinase, Axl

 Score = 50.8 bits (121), Expect = 4e-07
 Identities = 58/229 (25%), Positives = 98/229 (42%), Gaps = 45/229 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E   ++   H NV+ LI +C  +  +   Y S   ++  F +H   G L +  +   L
Sbjct: 48  LSEAVCMKEFDHPNVMRLIGVC-LQTVESEGYPSPV-VILPFMKH---GDLHSFLLYSRL 102

Query: 71  GE---------IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           G+         + K +  + +G+ Y+ S   +HRD+ A N ++ +   + +ADFGL++  
Sbjct: 103 GDCPQYLPTQMLVKFMTDIASGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSK-- 160

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELL----LGDRNYGPPVDLWGAGCIMAEMWTR--SP- 174
            +  NG   R   R+  +   P + +    L DR Y    D+W  G  M E+ TR  +P 
Sbjct: 161 -KIYNGDYYR-QGRIAKM---PVKWIAIESLADRVYTTKSDVWSFGVTMWEIATRGQTPY 215

Query: 175 -----------IMQGNTEQQQITLISQL------CGSITPESWPGVETL 206
                      + QGN  +Q    +  L      C  + P+  P  ETL
Sbjct: 216 PGVENSEIYDYLRQGNRLKQPPDCLDGLYSLMSSCWLLNPKDRPSFETL 264

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transformed cells. Axl signaling is important in many cellular functions such as survival, anti-apoptosis, proliferation, migration, and adhesion. Axl was originally isolated from patients with chronic myelogenous leukemia and a chronic myeloproliferative disorder. Axl is overexpressed in many human cancers including colon, squamous cell, thyroid, breast, and lung carcinomas. Length = 272

>gnl|CDD|173635 cd05054, PTKc_VEGFR, Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 181 QVARGMEFLASRKCIHRDLAARNILLSENNVVKICDFGLARDIYKDPD-YVRKGDARLPL 239

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   D+ Y    D+W  G ++ E+++
Sbjct: 240 KWMAPESIF--DKVYTTQSDVWSFGVLLWEIFS 270

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. There are five VEGF ligands in mammals, which bind, in an overlapping pattern to the three VEGFRs, which can form homo or heterodimers. VEGFRs regulate the cardiovascular system. They are critical for vascular development during embryogenesis and blood vessel formation in adults. They induce cellular functions common to other growth factor receptors such as cell migration, survival, and proliferation. VEGFR1 binds VEGFA, VEGFB, and placenta growth factor (PLGF). It regulates monocyte and macrophage migration, vascular permeability, haematopoiesis, and the recruitment of haematopietic progenitor cells from the bone marrow. Length = 337

>gnl|CDD|173639 cd05066, PTKc_EphR_A, Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

 Score = 50.3 bits (120), Expect = 5e-07
 Identities = 37/160 (23%), Positives = 72/160 (45%), Gaps = 11/160 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK+           +V ++ E+  L   L     +F+
Sbjct: 53  LSEASIMGQFDHPNIIHL-EGVVTKSK-------PVMIVTEYMENGSLDAFLRKHDGQFT 104

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFGL+R          
Sbjct: 105 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAAY 164

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G +M E+
Sbjct: 165 TTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEV 202

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. EphARs and ephrin-A ligands are expressed in multiple areas of the developing brain, especially in the retina and tectum. They are part of a system controlling retinotectal mapping. Length = 267

>gnl|CDD|140289 PTZ00263, PTZ00263, protein kinase A catalytic subunit; Provisional

 Score = 51.0 bits (122), Expect = 5e-07
 Identities = 27/88 (30%), Positives = 44/88 (50%), Gaps = 16/88 (18%)

Query: 86  YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLW----Y 141
           Y+HS  I++RD+K  N+L+   G +K+ DFG A+           +  +R  TL     Y
Sbjct: 133 YLHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAK-----------KVPDRTFTLCGTPEY 181

Query: 142 RPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             PE ++  + +G  VD W  G ++ E 
Sbjct: 182 LAPE-VIQSKGHGKAVDWWTMGVLLYEF 208

Length = 329

>gnl|CDD|133193 cd05062, PTKc_IGF-1R, Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

 Score = 50.4 bits (120), Expect = 6e-07
 Identities = 34/131 (25%), Positives = 65/131 (49%), Gaps = 17/131 (12%)

Query: 69  SLGEIKKVIQ---QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT- 124
           +   +KK+IQ   ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T 
Sbjct: 114 APPSLKKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETD 173

Query: 125 ---KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSPIMQGN 179
              K G+       +   W  P    L D  +    D+W  G ++ E+ T    P  QG 
Sbjct: 174 YYRKGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIATLAEQP-YQGM 225

Query: 180 TEQQQITLISQ 190
           + +Q +  + +
Sbjct: 226 SNEQVLRFVME 236

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, where it is frequently overexpressed, IGF-1R is implicated in proliferation, the suppression of apoptosis, invasion, and metastasis. IGF-1R is being developed as a therapeutic target in cancer treatment. Length = 277

>gnl|CDD|133174 cd05042, PTKc_Aatyk, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

 Score = 50.3 bits (120), Expect = 7e-07
 Identities = 44/176 (25%), Positives = 71/176 (40%), Gaps = 23/176 (13%)

Query: 8   ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL-VFDFCEH-DLAGLLSNIH 65
           +  L+E++  + L H NV+  +  C           S  YL V +FC   DL   L +  
Sbjct: 40  LLFLQEVQPYRELNHPNVLQCLGQC---------IESIPYLLVLEFCPLGDLKNYLRSNR 90

Query: 66  VKFSLGEIKKVIQQL----LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
              +    K V+Q++     +GL ++H    +H D+   N  +T    +K+ D+GL  A 
Sbjct: 91  GMVAQMAQKDVLQRMACEVASGLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGL--AL 148

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD------LWGAGCIMAEMWT 171
            Q             V L +  PEL+        P D      +W  G  M E++T
Sbjct: 149 EQYPEDYYITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKKSNIWSLGVTMWELFT 204

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kinases based on overall sequence similarity and the phylogenetic tree. However, analysis of catalytic residues suggests that Aatyk proteins may be multispecific kinases, functioning also as serine/threonine kinases. They are involved in neural differentiation, nerve growth factor (NGF) signaling, apoptosis, and spermatogenesis. Length = 269

>gnl|CDD|173690 cd05599, STKc_NDR_like, Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 50.8 bits (122), Expect = 7e-07
 Identities = 32/118 (27%), Positives = 44/118 (37%), Gaps = 37/118 (31%)

Query: 87  IHSNKILHRDMKAANVLITKTGILKLADFGL----------------------------- 117
           IH    +HRD+K  N+L+   G +KL+DFGL                             
Sbjct: 117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFIS 176

Query: 118 ------ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                  +A +  +N +   Y+  V T  Y  PE+ L    Y    D W  G IM EM
Sbjct: 177 KPMSSKRKAETWKRNRRALAYST-VGTPDYIAPEVFLQT-GYNKECDWWSLGVIMYEM 232

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplication. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. This subfamily also contains fungal NDR-like kinases. Length = 364

>gnl|CDD|173632 cd05051, PTKc_DDR, Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

 Score = 50.4 bits (121), Expect = 7e-07
 Identities = 42/180 (23%), Positives = 75/180 (41%), Gaps = 38/180 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS------- 62
           L+E+KIL  L   N+  L+ +C               ++ ++ E+ DL   L        
Sbjct: 67  LKEVKILSRLSDPNIARLLGVCTVD--------PPLCMIMEYMENGDLNQFLQKHVAETS 118

Query: 63  --NIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
               + K  S   +  +  Q+ +G+ Y+ S   +HRD+   N L+ K   +K+ADFG++R
Sbjct: 119 GLACNSKSLSFSTLLYMATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSR 178

Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPP--------ELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                     N Y++    +  R P        E +L  + +    D+W  G  + E+ T
Sbjct: 179 ----------NLYSSDYYRVQGRAPLPIRWMAWESVLLGK-FTTKSDVWAFGVTLWEILT 227

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including breast, colon, ovarian, brain, and lung. There is no evidence showing that DDRs act as transforming oncogenes. They are more likely to play a role in the regulation of tumor growth and metastasis. Length = 296

>gnl|CDD|173708 cd05617, STKc_aPKC_zeta, Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

 Score = 50.4 bits (120), Expect = 7e-07
 Identities = 37/111 (33%), Positives = 53/111 (47%), Gaps = 13/111 (11%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L ++H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 97  HARFYAAEI-------CIALNFLHERGIIYRDLKLDNVLLDADGHIKLTDYGMCK----E 145

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
             G  +  +    T  Y  PE+L G+  YG  VD W  G +M EM   RSP
Sbjct: 146 GLGPGDTTSTFCGTPNYIAPEILRGE-EYGFSVDWWALGVLMFEMMAGRSP 195

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways. PKC-zeta also plays a central role in maintaining cell polarity in yeast and mammalian cells. In addition, it affects actin remodeling in muscle cells. Length = 327

>gnl|CDD|223069 PHA03390, pk1, serine/threonine-protein kinase 1; Provisional

 Score = 49.9 bits (120), Expect = 9e-07
 Identities = 42/129 (32%), Positives = 60/129 (46%), Gaps = 12/129 (9%)

Query: 45  TFYLVFDFC-EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL 103
              L+ D+  + DL  LL     K S  E+KK+I+QL+  L  +H + I+H D+K  NVL
Sbjct: 83  GHVLIMDYIKDGDLFDLLKK-EGKLSEAEVKKIIRQLVEALNDLHKHNIIHNDIKLENVL 141

Query: 104 IT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA 162
                  + L D+GL +       G  + Y     TL Y  PE + G  NY    D W  
Sbjct: 142 YDRAKDRIYLCDYGLCKII-----GTPSCYDG---TLDYFSPEKIKG-HNYDVSFDWWAV 192

Query: 163 GCIMAEMWT 171
           G +  E+ T
Sbjct: 193 GVLTYELLT 201

Length = 267

>gnl|CDD|173766 cd08226, PK_STRAD_beta, Pseudokinase domain of STE20-related kinase adapter protein beta

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 61/241 (25%), Positives = 96/241 (39%), Gaps = 39/241 (16%)

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           I  ++   L GL Y+H N  +HR++KA+++LI+  G++ L+  GL+  +S  +NGQ  + 
Sbjct: 103 IGNILFGALRGLNYLHQNGYIHRNIKASHILISGDGLVSLS--GLSHLYSLVRNGQKAKV 160

Query: 133 T------NRVVTLWYRPPELLLGD-RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ- 183
                  +  V  W   PELL  D   Y    D++  G    E+ T R P       Q  
Sbjct: 161 VYDFPQFSTSVLPWLS-PELLRQDLYGYNVKSDIYSVGITACELATGRVPFQDMLRTQML 219

Query: 184 ------------QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK 231
                        IT       S    S  GV++  +   +      +    ERL+    
Sbjct: 220 LQKLKGPPYSPLDITTFPC-EESRMKNSQSGVDS-GIGESVVAAGMTQTMTSERLRTPSS 277

Query: 232 DQYGCD---LLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAP 288
             +      L++  L  DP KR  + + L+H FF          K + + TQ     L P
Sbjct: 278 KTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFF----------KQVKEQTQGSILSLLP 327

Query: 289 P 289
           P
Sbjct: 328 P 328

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. STRAD-beta is also referred to as ALS2CR2 (Amyotrophic lateral sclerosis 2 chromosomal region candidate gene 2 protein), since the human gene encoding it is located within the juvenile ALS2 critical region on chromosome 2q33-q34. It is not linked to the development of ALS2. Length = 328

>gnl|CDD|133237 cd05106, PTKc_CSF-1R, Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

 Score = 49.8 bits (119), Expect = 1e-06
 Identities = 31/98 (31%), Positives = 50/98 (51%), Gaps = 5/98 (5%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DFGLAR      N  V +   R+  
Sbjct: 220 QVAQGMDFLASKNCIHRDVAARNVLLTDGRVAKICDFGLARDIMNDSN-YVVKGNARLPV 278

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
            W  P  +   D  Y    D+W  G ++ E+++  +SP
Sbjct: 279 KWMAPESIF--DCVYTVQSDVWSYGILLWEIFSLGKSP 314

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is critical in the regulation of macrophages and osteoclasts. It leads to increases in gene transcription and protein translation, and induces cytoskeletal remodeling. CSF-1R signaling leads to a variety of cellular responses including survival, proliferation, and differentiation of target cells. It plays an important role in innate immunity, tissue development and function, and the pathogenesis of some diseases including atherosclerosis and cancer. CSF-1R signaling is also implicated in mammary gland development during pregnancy and lactation. Aberrant CSF-1/CSF-1R expression correlates with tumor cell invasiveness, poor clinical prognosis, and bone metastasis in breast cancer. Although the structure of the human CSF-1R catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 374

>gnl|CDD|173630 cd05044, PTKc_c-ros, Catalytic domain of the Protein Tyrosine Kinase, C-ros

 Score = 49.5 bits (118), Expect = 1e-06
 Identities = 44/173 (25%), Positives = 78/173 (45%), Gaps = 23/173 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK-- 67
           L+E  ++    H N+V L+ +C     QY        ++ +  E  DL   L +  V+  
Sbjct: 47  LKEAHLMSNFNHPNIVKLLGVCLLNEPQY--------IIMELMEGGDLLSYLRDARVERF 98

Query: 68  ----FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG-----ILKLADFGLA 118
                +L E+  +   +  G  Y+     +HRD+ A N L+++ G     ++K+ DFGLA
Sbjct: 99  GPPLLTLKELLDICLDVAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLA 158

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R     K+    +    ++ + +  PE LL D  +    D+W  G +M E+ T
Sbjct: 159 RDI--YKSDYYRKEGEGLLPVRWMAPESLL-DGKFTTQSDVWSFGVLMWEILT 208

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male mice bearing inactive mutations of c-ros lack the initial segment of the epididymis and are infertile. The Drosophila protein, Sevenless, is required for the specification of the R7 photoreceptor cell during eye development. Length = 269

>gnl|CDD|173653 cd05105, PTKc_PDGFR_alpha, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

 Score = 50.0 bits (119), Expect = 1e-06
 Identities = 28/93 (30%), Positives = 49/93 (52%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S   +HRD+ A NVL+ +  I+K+ DFGLAR      N  V++ +  +  
Sbjct: 245 QVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN-YVSKGSTFLPV 303

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 304 KWMAPESIF--DNLYTTLSDVWSYGILLWEIFS 334

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-AB, and PDGF-CC induce PDGFR alpha homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR alpha signaling is important in the formation of lung alveoli, intestinal villi, mesenchymal dermis, and hair follicles, as well as in the development of oligodendrocytes, retinal astrocytes, neural crest cells, and testicular cells. Aberrant PDGFR alpha expression is associated with some human cancers. Mutations in PDGFR alpha have been found within a subset of gastrointestinal stromal tumors (GISTs). An active fusion protein FIP1L1-PDGFR alpha, derived from interstitial deletion, is associated with idiopathic hypereosinophilic syndrome (HES) and chronic eosinophilic leukemia (CEL). Length = 400

>gnl|CDD|133219 cd05088, PTKc_Tie2, Catalytic domain of the Protein Tyrosine Kinase, Tie2

 Score = 48.8 bits (116), Expect = 2e-06
 Identities = 43/174 (24%), Positives = 76/174 (43%), Gaps = 31/174 (17%)

Query: 13  EIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV---- 66
           E+++L +L  H N+++L+  C         +R   YL  ++  H +L   L    V    
Sbjct: 57  ELEVLCKLGHHPNIINLLGACE--------HRGYLYLAIEYAPHGNLLDFLRKSRVLETD 108

Query: 67  -KFSLGEIKKVI---QQLLN-------GLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
             F++          QQLL+       G+ Y+   + +HRD+ A N+L+ +  + K+ADF
Sbjct: 109 PAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADF 168

Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           GL+R     +   V +   R+   W       L    Y    D+W  G ++ E+
Sbjct: 169 GLSRG----QEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEI 216

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. Tie2 signaling plays key regulatory roles in vascular integrity and quiescence, and in inflammation. Length = 303

>gnl|CDD|133168 cd05036, PTKc_ALK_LTK, Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

 Score = 48.6 bits (116), Expect = 2e-06
 Identities = 43/175 (24%), Positives = 75/175 (42%), Gaps = 29/175 (16%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL----SNIH 65
           L E  I+    H+N+V LI +           R   +++ +     DL   L        
Sbjct: 57  LMEALIMSKFNHQNIVRLIGVSFE--------RLPRFILLELMAGGDLKSFLRENRPRPE 108

Query: 66  VKFSLG--EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARA 120
              SL   ++    + +  G  Y+  N  +HRD+ A N L+T  G   + K+ADFG+AR 
Sbjct: 109 RPSSLTMKDLLFCARDVAKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARD 168

Query: 121 FSQT----KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +     K G+       ++ + + PPE  L D  +    D+W  G ++ E+++
Sbjct: 169 IYRASYYRKGGRA------MLPIKWMPPEAFL-DGIFTSKTDVWSFGVLLWEIFS 216

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well as visceral muscle differentiation in Drosophila. ALK is aberrantly expressed as fusion proteins, due to chromosomal translocations, in about 60% of anaplastic large cell lymphomas (ALCLs). ALK fusion proteins are also found in rare cases of diffuse large B cell lymphomas (DLBCLs). LTK is mainly expressed in B lymphocytes and neuronal tissues. It is important in cell proliferation and survival. Transgenic mice expressing TLK display retarded growth and high mortality rate. In addition, a polymorphism in mouse and human LTK is implicated in the pathogenesis of systemic lupus erythematosus. Length = 277

>gnl|CDD|132980 cd06649, PKc_MEK2, Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

 Score = 48.9 bits (116), Expect = 2e-06
 Identities = 36/103 (34%), Positives = 54/103 (52%), Gaps = 9/103 (8%)

Query: 75  KVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT 133
           KV   +L GL Y+   ++I+HRD+K +N+L+   G +KL DFG++    Q  +   N + 
Sbjct: 107 KVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANSF- 162

Query: 134 NRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPI 175
             V T  Y  PE L G  +Y    D+W  G  + E+   R PI
Sbjct: 163 --VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVELAIGRYPI 202

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downstream targets, extracellular signal-regulated kinase (ERK) 1 and ERK2, on specific threonine and tyrosine residues. The ERK cascade starts with extracellular signals including growth factors, hormones, and neurotransmitters, which act through receptors and ion channels to initiate intracellular signaling that leads to the activation at the MAPKKK (Raf-1 or MOS) level, which leads to the transmission of signals to MEK2, and finally to ERK1/2. The ERK cascade plays an important role in cell proliferation, differentiation, oncogenic transformation, and cell cycle control, as well as in apoptosis and cell survival under certain conditions. Gain-of-function mutations in genes encoding ERK cascade proteins, including MEK2, cause cardiofaciocutaneous (CFC) syndrome, a condition leading to multiple congenital anomalies and mental retardation in patients. Length = 331

>gnl|CDD|133189 cd05058, PTKc_Met_Ron, Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

 Score = 48.2 bits (115), Expect = 3e-06
 Identities = 41/163 (25%), Positives = 79/163 (48%), Gaps = 9/163 (5%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E  I++   H NV+ L+ IC            +  +V  + +H DL   + +     +
Sbjct: 44  LKEGIIMKDFSHPNVLSLLGICLPS-------EGSPLVVLPYMKHGDLRNFIRSETHNPT 96

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ ++  +K+ADFGLAR     +   V
Sbjct: 97  VKDLIGFGLQVAKGMEYLASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSV 156

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           + +T   + + +   E L   + +    D+W  G ++ E+ TR
Sbjct: 157 HNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTR 198

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also called the HGF receptor. HGF/Met signaling plays a role in growth, transformation, cell motility, invasion, metastasis, angiogenesis, wound healing, and tissue regeneration. Aberrant expression of Met through mutations or gene amplification is associated with many human cancers including hereditary papillary renal and gastric carcinomas. The ligand for Ron is macrophage stimulating protein (MSP). Ron signaling is important in regulating cell motility, adhesion, proliferation, and apoptosis. Aberrant Ron expression is implicated in tumorigenesis and metastasis. Length = 262

>gnl|CDD|132951 cd06620, PKc_MAPKK_Byr1_like, Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

 Score = 48.3 bits (115), Expect = 3e-06
 Identities = 33/102 (32%), Positives = 53/102 (51%), Gaps = 13/102 (12%)

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ- 128
           LG+I   + + L  LY +H  +I+HRD+K +N+L+   G +KL DFG++        G+ 
Sbjct: 105 LGKIAVAVVEGLTYLYNVH--RIMHRDIKPSNILVNSRGQIKLCDFGVS--------GEL 154

Query: 129 VNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           +N   +  V T  Y  PE + G   Y    D+W  G  + E+
Sbjct: 155 INSIADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGISIIEL 195

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include the MAPKKs Byr1 from Schizosaccharomyces pombe, FUZ7 from Ustilago maydis, and related proteins. Byr1 phosphorylates its downstream target, the MAPK Spk1, and is regulated by the MAPKKK Byr2. The Spk1 cascade is pheromone-responsive and is essential for sporulation and sexual differentiation in fission yeast. FUZ7 phosphorylates and activates its target, the MAPK Crk1, which is required in mating and virulence in U. maydis. Length = 284

>gnl|CDD|133238 cd05107, PTKc_PDGFR_beta, Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

 Score = 48.9 bits (116), Expect = 3e-06
 Identities = 28/93 (30%), Positives = 51/93 (54%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+ NG+ ++ S   +HRD+ A NVLI +  ++K+ DFGLAR   +  N  +++ +  +  
Sbjct: 247 QVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSN-YISKGSTFLPL 305

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   +  Y    D+W  G ++ E++T
Sbjct: 306 KWMAPESIF--NNLYTTLSDVWSFGILLWEIFT 336

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-DD induce PDGFR beta homodimerization. PDGFR signaling plays many roles in normal embryonic development and adult physiology. PDGFR beta signaling leads to a variety of cellular effects including the stimulation of cell growth and chemotaxis, as well as the inhibition of apoptosis and GAP junctional communication. It is critical in normal angiogenesis as it is involved in the recruitment of pericytes and smooth muscle cells essential for vessel stability. Aberrant PDGFR beta expression is associated with some human cancers. The continuously-active fusion proteins of PDGFR beta with COL1A1 and TEL are associated with dermatofibrosarcoma protuberans (DFSP) and a subset of chronic myelomonocytic leukemia (CMML), respectively. Length = 401

>gnl|CDD|133194 cd05063, PTKc_EphR_A2, Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

 Score = 48.0 bits (114), Expect = 3e-06
 Identities = 25/105 (23%), Positives = 49/105 (46%), Gaps = 2/105 (1%)

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +FS  ++  +++ +  G+ Y+     +HRD+ A N+L+      K++DFGL+R       
Sbjct: 103 EFSSYQLVGMLRGIAAGMKYLSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPE 162

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           G       ++   W  P  +    R +    D+W  G +M E+ +
Sbjct: 163 GTYTTSGGKIPIRWTAPEAIAY--RKFTSASDVWSFGIVMWEVMS 205

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion, making it important in neural development and plasticity, cell morphogenesis, cell-fate determination, embryonic development, tissue patterning, and angiogenesis. The EphA2 receptor is overexpressed in tumor cells and tumor blood vessels in a variety of cancers including breast, prostate, lung, and colon. As a result, it is an attractive target for drug design since its inhibition could affect several aspects of tumor progression. Length = 268

>gnl|CDD|178763 PLN03224, PLN03224, probable serine/threonine protein kinase; Provisional

 Score = 48.5 bits (115), Expect = 5e-06
 Identities = 33/102 (32%), Positives = 49/102 (48%), Gaps = 20/102 (19%)

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           IK V++Q+L GL  +H   I+HRD+K  N+L+T  G +K+ DFG A       N      
Sbjct: 311 IKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN------ 364

Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                   + P   +L D  Y PP +L     +M +   R+P
Sbjct: 365 --------FNPLYGML-DPRYSPPEEL-----VMPQSCPRAP 392

Length = 507

>gnl|CDD|173718 cd05629, STKc_NDR_like_fungal, Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

 Score = 47.5 bits (113), Expect = 6e-06
 Identities = 33/125 (26%), Positives = 47/125 (37%), Gaps = 44/125 (35%)

Query: 87  IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---------------KNGQVNR 131
           +H    +HRD+K  N+LI + G +KL+DFGL+  F +                KN   NR
Sbjct: 117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNR 176

Query: 132 YTNRVVTLW----------------------------YRPPELLLGDRNYGPPVDLWGAG 163
            +  V ++                             Y  PE+ L  + YG   D W  G
Sbjct: 177 NSVAVDSINLTMSSKDQIATWKKNRRLMAYSTVGTPDYIAPEIFLQ-QGYGQECDWWSLG 235

Query: 164 CIMAE 168
            IM E
Sbjct: 236 AIMFE 240

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of Ace2p activity and cellular morphogenesis) network. CBK1 and Orb6 play similar roles in coordinating cell morphology with cell cycle progression. Ukc1 is involved in morphogenesis, pathogenicity, and pigment formation. Cot1 plays a role in polar tip extension. Length = 377

>gnl|CDD|173701 cd05610, STKc_MASTL, Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

 Score = 47.9 bits (114), Expect = 7e-06
 Identities = 20/45 (44%), Positives = 31/45 (68%)

Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           K I ++   L Y+H + I+HRD+K  N+LI+  G +KL DFGL++
Sbjct: 108 KYISEVALALDYLHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK 152

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ14813 is associated with autosomal dominant thrombocytopenia. To date, the function of MASTL is unknown. Length = 669

>gnl|CDD|173616 PTZ00426, PTZ00426, cAMP-dependent protein kinase catalytic subunit; Provisional

 Score = 47.3 bits (112), Expect = 7e-06
 Identities = 29/94 (30%), Positives = 43/94 (45%), Gaps = 8/94 (8%)

Query: 86  YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPE 145
           Y+ S  I++RD+K  N+L+ K G +K+ DFG A+           R      T  Y  PE
Sbjct: 146 YLQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVD-------TRTYTLCGTPEYIAPE 198

Query: 146 LLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           +LL +  +G   D W  G  + E+    P    N
Sbjct: 199 ILL-NVGHGKAADWWTLGIFIYEILVGCPPFYAN 231

Length = 340

>gnl|CDD|133167 cd05035, PTKc_Axl_like, Catalytic Domain of Axl-like Protein Tyrosine Kinases

 Score = 47.1 bits (112), Expect = 8e-06
 Identities = 50/210 (23%), Positives = 87/210 (41%), Gaps = 42/210 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD------LAGLLSNI 64
           L E   ++   H NV+ LI +C   A+   +      ++  F +H       L   L  +
Sbjct: 49  LSEAACMKDFDHPNVMKLIGVCFE-ASSLQKIPKPM-VILPFMKHGDLHSFLLYSRLGGL 106

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
             K  L  + K +  +  G+ Y+ +   +HRD+ A N ++ +   + +ADFGL++   + 
Sbjct: 107 PEKLPLQTLLKFMVDIALGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSK---KI 163

Query: 125 KNGQVNRYTNRVVTLWYRPPELL----LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            +G   R   R+  +   P + +    L DR Y    D+W  G  M E+ TR        
Sbjct: 164 YSGDYYRQG-RIAKM---PVKWIAIESLADRVYTSKSDVWAFGVTMWEIATR-------- 211

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYN 210
                          TP  +PGVE  ++Y+
Sbjct: 212 -------------GQTP--YPGVENHEIYD 226

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellular effects including survival, proliferation, migration, and phagocytosis. They are also associated with several types of cancer as well as inflammatory, autoimmune, vascular, and kidney diseases. Mer is named after its original reported expression pattern (monocytes, epithelial, and reproductive tissues). It is required for the ingestion of apoptotic cells by phagocytes such as macrophages, retinal pigment epithelial cells, and dendritic cells. Mer is also important in maintaining immune homeostasis. Length = 273

>gnl|CDD|173695 cd05604, STKc_SGK3, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

 Score = 47.3 bits (112), Expect = 8e-06
 Identities = 31/95 (32%), Positives = 47/95 (49%), Gaps = 9/95 (9%)

Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG--QVNRYTN 134
             ++ + L Y+HS  I++RD+K  N+L+   G + L DFGL       K G  Q +  T 
Sbjct: 102 AAEIASALGYLHSINIVYRDLKPENILLDSQGHVVLTDFGLC------KEGIAQSDTTTT 155

Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
              T  Y  PE++   + Y   VD W  G ++ EM
Sbjct: 156 FCGTPEYLAPEVIR-KQPYDNTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels, and receptors. It plays a critical role in hair follicle morphogenesis and hair cycling. Length = 325

>gnl|CDD|133220 cd05089, PTKc_Tie1, Catalytic domain of the Protein Tyrosine Kinase, Tie1

 Score = 46.9 bits (111), Expect = 9e-06
 Identities = 53/237 (22%), Positives = 94/237 (39%), Gaps = 46/237 (19%)

Query: 13  EIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFY-LVFDFC--------------EHD 56
           E+++L +L  H N+++L+  C  +   Y       Y  + DF               EH 
Sbjct: 52  ELEVLCKLGHHPNIINLLGACENRGYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHG 111

Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
            A  L++        ++ +    +  G+ Y+   + +HRD+ A NVL+ +    K+ADFG
Sbjct: 112 TASTLTS-------QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFG 164

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
           L+R     +   V +   R+   W       L    Y    D+W  G ++ E+     + 
Sbjct: 165 LSRG----EEVYVKKTMGRLPVRWMAIES--LNYSVYTTKSDVWSFGVLLWEI-----VS 213

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ 233
            G T           CG    E +   E L    +ME P+    +V E ++   +D+
Sbjct: 214 LGGTP---------YCGMTCAELY---EKLPQGYRMEKPRNCDDEVYELMRQCWRDR 258

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations. In vivo studies of Tie1 show that it is critical in vascular development. Length = 297

>gnl|CDD|143371 cd07866, STKc_BUR1, Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

 Score = 46.5 bits (111), Expect = 1e-05
 Identities = 21/56 (37%), Positives = 27/56 (48%), Gaps = 2/56 (3%)

Query: 312 PAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           P      + T Y   ++ER      +  G DLL KLL LDP KR  +  AL H +F
Sbjct: 258 PGCEGVHSFTNYPRTLEERFGKLGPE--GLDLLSKLLSLDPYKRLTASDALEHPYF 311

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic screen as factors involved in general transcription. The BUR1/BUR2 complex phosphorylates the C-terminal domain of RNA polymerase II. In addition, this complex regulates histone modification by phosporylating Rad6 and mediating the association of the Paf1 complex with chromatin. Length = 311

>gnl|CDD|173666 cd05575, STKc_SGK, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

 Score = 46.3 bits (110), Expect = 1e-05
 Identities = 28/85 (32%), Positives = 45/85 (52%), Gaps = 7/85 (8%)

Query: 86  YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPP 144
           Y+HS  I++RD+K  N+L+   G + L DFGL +     +  + ++ T+    T  Y  P
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGLCK-----EGIEHSKTTSTFCGTPEYLAP 165

Query: 145 ELLLGDRNYGPPVDLWGAGCIMAEM 169
           E+L   + Y   VD W  G ++ EM
Sbjct: 166 EVLR-KQPYDRTVDWWCLGAVLYEM 189

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell proliferation, and apoptosis. Length = 323

>gnl|CDD|173741 cd07843, STKc_CDC2L1, Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

 Score = 45.7 bits (109), Expect = 2e-05
 Identities = 17/56 (30%), Positives = 31/56 (55%)

Query: 312 PAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           P A + T     +++++++         G DLL++LL  DP+KR  ++ AL H +F
Sbjct: 238 PGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTYDPAKRISAEDALKHPYF 293

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the major isoform, associates with cyclin L and is expressed throughout the cell cycle. It is involved in RNA processing and the regulation of transcription. CDK11(p58) associates with cyclin D3 and is expressed during the G2/M phase of the cell cycle. It plays roles in spindle morphogenesis, centrosome maturation, sister chromatid cohesion, and the completion of mitosis. CDK11(p46) is formed from the larger isoforms by caspases during TNFalpha- and Fas-induced apoptosis. It functions as a downstream effector kinase in apoptotic signaling pathways and interacts with eukaryotic initiation factor 3f (eIF3f), p21-activated kinase (PAK1), and Ran-binding protein (RanBPM). Length = 293

>gnl|CDD|240233 PTZ00024, PTZ00024, cyclin-dependent protein kinase; Provisional

 Score = 45.9 bits (109), Expect = 2e-05
 Identities = 17/38 (44%), Positives = 26/38 (68%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
           DLL  LL L+P +R  +  AL H++F +DP+P D S++
Sbjct: 291 DLLQSLLKLNPLERISAKEALKHEYFKSDPLPCDPSQL 328

Length = 335

>gnl|CDD|133235 cd05104, PTKc_Kit, Catalytic domain of the Protein Tyrosine Kinase, Kit

 Score = 46.4 bits (110), Expect = 2e-05
 Identities = 28/93 (30%), Positives = 47/93 (50%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S   +HRD+ A N+L+T   I K+ DFGLAR      N  V +   R+  
Sbjct: 222 QVAKGMSFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIRNDSN-YVVKGNARLPV 280

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   +  Y    D+W  G ++ E+++
Sbjct: 281 KWMAPESIF--NCVYTFESDVWSYGILLWEIFS 311

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem cells, the interstitial cells of Cajal, and the pacemaker cells of the GI tract. Kit signaling is involved in major cellular functions including cell survival, proliferation, differentiation, adhesion, and chemotaxis. Mutations in Kit, which result in constitutive ligand-independent activation, are found in human cancers such as gastrointestinal stromal tumor (GIST) and testicular germ cell tumor (TGCT). The aberrant expression of Kit and/or SCF is associated with other tumor types such as systemic mastocytosis and cancers of the breast, neurons, lung, prostate, colon, and rectum. Although the structure of the human Kit catalytic domain is known, it is excluded from this specific alignment model because it contains a deletion in its sequence. Length = 375

>gnl|CDD|133221 cd05090, PTKc_Ror1, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

 Score = 46.2 bits (109), Expect = 2e-05
 Identities = 28/108 (25%), Positives = 58/108 (53%), Gaps = 5/108 (4%)

Query: 66  VKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
           VK SL  G+   +  Q+  G+ Y+ S+  +H+D+ A N+LI +   +K++D GL+R    
Sbjct: 117 VKSSLDHGDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYS 176

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               +V      ++ + + PPE ++  + +    D+W  G ++ E+++
Sbjct: 177 ADYYRVQ--PKSLLPIRWMPPEAIMYGK-FSSDSDIWSFGVVLWEIFS 221

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror kinases are expressed in many tissues during development. Avian Ror1 was found to be involved in late limb development. Studies in mice reveal that Ror1 is important in the regulation of neurite growth in central neurons, as well as in respiratory development. Loss of Ror1 also enhances the heart and skeletal abnormalities found in Ror2-deficient mice. Length = 283

>gnl|CDD|173693 cd05602, STKc_SGK1, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

 Score = 45.8 bits (108), Expect = 2e-05
 Identities = 33/105 (31%), Positives = 53/105 (50%), Gaps = 6/105 (5%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++ + L Y+HS  I++RD+K  N+L+   G + L DFGL +  +   NG  + +     T
Sbjct: 104 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKE-NIEHNGTTSTFCG---T 159

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQ 182
             Y  PE +L  + Y   VD W  G ++ EM +   P    NT +
Sbjct: 160 PEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAE 203

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt sensitivity, memory consolidation, and cardiac repolarization. A common SGK1 variant is associated with increased blood pressure and body weight. SGK1 may also contribute to tumor growth, neurodegeneration, fibrosing disease, and ischemia. Length = 325

>gnl|CDD|173638 cd05065, PTKc_EphR_B, Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

 Score = 45.2 bits (107), Expect = 2e-05
 Identities = 39/164 (23%), Positives = 75/164 (45%), Gaps = 17/164 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK+           ++ +F E+  L   L     +F+
Sbjct: 53  LSEASIMGQFDHPNIIHL-EGVVTKS-------RPVMIITEFMENGALDSFLRQNDGQFT 104

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A N+L+    + K++DFGL+R      +   
Sbjct: 105 VIQLVGMLRGIAAGMKYLSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 164

Query: 130 NRYTN----RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             YT+    ++   W  P  +    R +    D+W  G +M E+
Sbjct: 165 --YTSSLGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEV 204

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored to the plasma membrane. The resulting downstream signals occur bidirectionally in both EphR-expressing cells (forward signaling) and ephrin-expressing cells (reverse signaling). Ephrin/EphR interaction mainly results in cell-cell repulsion or adhesion. EphBRs play important roles in synapse formation and plasticity, spine morphogenesis, axon guidance, and angiogenesis. In the intestinal epithelium, EphBRs are Wnt signaling target genes that control cell compartmentalization. They function as suppressors of color cancer progression. Length = 269

>gnl|CDD|133227 cd05096, PTKc_DDR1, Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

 Score = 45.3 bits (107), Expect = 3e-05
 Identities = 42/172 (24%), Positives = 75/172 (43%), Gaps = 18/172 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRT-----------KANQYNRYRSTFYLVFDFCEHDLAG 59
           L+E+KIL  LK  N++ L+ +C             +    N++ S+ +L       + A 
Sbjct: 67  LKEVKILSRLKDPNIIRLLGVCVDEDPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAV 126

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
             ++     S   +  V  Q+ +G+ Y+ S   +HRD+   N L+ +   +K+ADFG++R
Sbjct: 127 PPAHCLPAISYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSR 186

Query: 120 AFSQTKNGQVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                  G   R   R V    W     +L+G   +    D+W  G  + E+
Sbjct: 187 NLYA---GDYYRIQGRAVLPIRWMAWECILMG--KFTTASDVWAFGVTLWEI 233

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in keratinocytes, colonic mucosa epithelium, lung epithelium, thyroid follicles, and the islets of Langerhans. During embryonic development, it is found in the developing neuroectoderm. DDR1 is a key regulator of cell morphogenesis, differentiation and proliferation. It is important in the development of the mammary gland, the vasculator and the kidney. DDR1 is also found in human leukocytes, where it facilitates cell adhesion, migration, maturation, and cytokine production. Length = 304

>gnl|CDD|140307 PTZ00284, PTZ00284, protein kinase; Provisional

 Score = 45.7 bits (108), Expect = 3e-05
 Identities = 56/228 (24%), Positives = 95/228 (41%), Gaps = 43/228 (18%)

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLI--TKTGI------------ 109
           H  FS   + ++I Q    L Y H+   ++H D+K  N+L+  + T +            
Sbjct: 225 HGPFSHRHLAQIIFQTGVALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDP 284

Query: 110 --LKLADFGLARAFSQTKNGQVNRYTNR---VVTLWYRPPELLLGDRNYGPPVDLWGAGC 164
             +++ D G          G  +   +R   V T  YR PE++LG   +    D+W  GC
Sbjct: 285 CRVRICDLG----------GCCDERHSRTAIVSTRHYRSPEVVLG-LGWMYSTDMWSMGC 333

Query: 165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPG----VETLDLYNKMEL------ 214
           I+ E++T   +   +   + + L+ +  G + P  W G     E   LYN          
Sbjct: 334 IIYELYTGKLLYDTHDNLEHLHLMEKTLGRL-PSEWAGRCGTEEARLLYNSAGQLRPCTD 392

Query: 215 PKAQKRKVKER-LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDF 261
           PK   R  + R ++  ++D   CDL+  LL  D  KR ++     H +
Sbjct: 393 PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPY 440

Length = 467

>gnl|CDD|183880 PRK13184, pknD, serine/threonine-protein kinase; Reviewed

 Score = 45.9 bits (109), Expect = 3e-05
 Identities = 47/188 (25%), Positives = 77/188 (40%), Gaps = 34/188 (18%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI----- 64
           LRE KI   L H  +V +  IC              Y    + E + L  LL ++     
Sbjct: 50  LREAKIAADLIHPGIVPVYSICSDG--------DPVYYTMPYIEGYTLKSLLKSVWQKES 101

Query: 65  -----HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
                  K S+G    +  ++   + Y+HS  +LHRD+K  N+L+   G + + D+G A 
Sbjct: 102 LSKELAEKTSVGAFLSIFHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAI 161

Query: 120 AFSQTKNGQVN--------RYTN-----RVV-TLWYRPPELLLGDRNYGPPVDLWGAGCI 165
                +   ++         Y++     ++V T  Y  PE LLG        D++  G I
Sbjct: 162 FKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYMAPERLLGVPA-SESTDIYALGVI 220

Query: 166 MAEMWTRS 173
           + +M T S
Sbjct: 221 LYQMLTLS 228

Length = 932

>gnl|CDD|133217 cd05086, PTKc_Aatyk2, Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

 Score = 44.9 bits (106), Expect = 4e-05
 Identities = 36/163 (22%), Positives = 74/163 (45%), Gaps = 22/163 (13%)

Query: 19  LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEI---K 74
           +L+H N++  +  C             + LVF++CE  DL   LS         ++   +
Sbjct: 51  ILQHPNILQCLGQCVEAI--------PYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQ 102

Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           ++  ++  G+ ++H +  LH D+   N  +T    +K+ D+G+    S+ K   +    +
Sbjct: 103 RMACEIAAGVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGI--GPSRYKEDYIETEDD 160

Query: 135 RVVTLWYRPPELLLGDRNYG-------PPVDLWGAGCIMAEMW 170
           + V L +  PE L+G+ + G        P ++W  G  + E++
Sbjct: 161 KCVPLRWLAPE-LVGEFHGGLITAEQTKPSNVWALGVTLWELF 202

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage spermatogenesis. Although it is classified as a tyr kinase based on sequence similarity and the phylogenetic tree, Aatyk2 has been characterized as a serine/threonine kinase. Length = 268

>gnl|CDD|88330 cd05047, PTKc_Tie, Catalytic domain of Tie Protein Tyrosine Kinases

 Score = 44.3 bits (104), Expect = 5e-05
 Identities = 37/173 (21%), Positives = 71/173 (41%), Gaps = 29/173 (16%)

Query: 13  EIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFY-LVFDFC--------------EHD 56
           E+++L +L  H N+++L+  C  +   Y       +  + DF                + 
Sbjct: 45  ELEVLCKLGHHPNIINLLGACEHRGYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANS 104

Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
            A  LS+        ++      +  G+ Y+   + +HRD+ A N+L+ +  + K+ADFG
Sbjct: 105 TASTLSS-------QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFG 157

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           L+R     +   V +   R+   W       L    Y    D+W  G ++ E+
Sbjct: 158 LSRG----QEVYVKKTMGRLPVRWMAIES--LNYSVYTTNSDVWSYGVLLWEI 204

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific ligand has been identified for Tie1. The binding of Ang-1 to Tie2 leads to receptor autophosphorylation and activation, promoting cell migration and survival. In contrast, Ang-2 binding to Tie2 does not result in the same response, suggesting that Ang-2 may function as an antagonist. In vivo studies of Tie1 show that it is critical in vascular development. Length = 270

>gnl|CDD|143346 cd07841, STKc_CDK7, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

 Score = 44.1 bits (105), Expect = 7e-05
 Identities = 17/42 (40%), Positives = 24/42 (57%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSK 378
                DLL +LL L+P+KR  +  AL H +F  DP P+  S+
Sbjct: 255 SDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPSQ 296

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is also a component of the general transcription factor TFIIH, which phosphorylates the C-terminal domain (CTD) of RNA polymerase II when it is bound with unphosphorylated DNA, as present in the pre-initiation complex. Following phosphorylation, the CTD dissociates from the DNA which allows transcription initiation. Length = 298

>gnl|CDD|133192 cd05061, PTKc_InsR, Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

 Score = 44.2 bits (104), Expect = 7e-05
 Identities = 26/107 (24%), Positives = 53/107 (49%), Gaps = 11/107 (10%)

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           +L E+ ++  ++ +G+ Y+++ K +HRD+ A N ++     +K+ DFG+ R   +T    
Sbjct: 117 TLQEMIQMAAEIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYYR 176

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ +
Sbjct: 177 KGGK-----GLLPVRWMAPES--LKDGVFTTSSDMWSFGVVLWEITS 216

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein metabolism, ion and amino acid transport, cell cycle and proliferation, cell differentiation, gene transcription, and nitric oxide synthesis. Insulin resistance, caused by abnormalities in InsR signaling, has been described in diabetes, hypertension, cardiovascular disease, metabolic syndrome, heart failure, and female infertility. Length = 288

>gnl|CDD|132947 cd06616, PKc_MKK4, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 33/120 (27%), Positives = 56/120 (46%), Gaps = 17/120 (14%)

Query: 75  KVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFG----LARAFSQTKNGQV 129
           K+    +  L Y+    KI+HRD+K +N+L+ + G +KL DFG    L  + ++T++   
Sbjct: 111 KIAVATVKALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSIAKTRDAGC 170

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPV--DLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
             Y           PE +      G  V  D+W  G  + E+ T + P  + N+   Q+T
Sbjct: 171 RPYM---------APERIDPSARDGYDVRSDVWSLGITLYEVATGKFPYPKWNSVFDQLT 221

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates the downstream targets, c-Jun N-terminal kinase (JNK) and p38 MAPK, on specific threonine and tyrosine residues. JNK and p38 are collectively known as stress-activated MAPKs, as they are activated in response to a variety of environmental stresses and pro-inflammatory cytokines. Their activation is associated with the induction of cell death. Mice deficient in MKK4 die during embryogenesis and display anemia, severe liver hemorrhage, and abnormal hepatogenesis. MKK4 may also play roles in the immune system and in cardiac hypertrophy. It plays a major role in cancer as a tumor and metastasis suppressor. Under certain conditions, MKK4 is pro-oncogenic. Length = 288

>gnl|CDD|173689 cd05598, STKc_LATS, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

 Score = 43.3 bits (102), Expect = 1e-04
 Identities = 19/50 (38%), Positives = 28/50 (56%)

Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           I +L   +  +H    +HRD+K  N+LI + G +KL DFGL   F  T +
Sbjct: 107 IAELTCAIESVHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHD 156

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Length = 376

>gnl|CDD|173654 cd05108, PTKc_EGFR, Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

 Score = 43.1 bits (101), Expect = 1e-04
 Identities = 37/161 (22%), Positives = 68/161 (42%), Gaps = 11/161 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E  ++  + + +V  L+ IC T   Q       F  + D+       + S   + + +
Sbjct: 57  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCV 116

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
                   Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + +
Sbjct: 117 --------QIAKGMNYLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEK-EYH 167

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               +V   W     +L   R Y    D+W  G  + E+ T
Sbjct: 168 AEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands for EGFR include EGF, heparin binding EGF-like growth factor (HBEGF), epiregulin, amphiregulin, TGFalpha, and betacellulin. Upon ligand binding, EGFR can form homo- or heterodimers with other EGFR subfamily members. The EGFR signaling pathway is one of the most important pathways regulating cell proliferation, differentiation, survival, and growth. Overexpression and mutation in the kinase domain of EGFR have been implicated in the development and progression of a variety of cancers. A number of monoclonal antibodies and small molecule inhibitors have been developed that target EGFR, including the antibodies Cetuximab and Panitumumab, which are used in combination with other therapies for the treatment of colorectal cancer and non-small cell lung carcinoma (NSCLC). The small molecule inhibitors Gefitinib (Iressa) and Erlotinib (Tarceva), already used for NSCLC, are undergoing clinical trials for other types of cancer including gastrointestinal, breast, head and neck, and bladder. Length = 316

>gnl|CDD|173733 cd07829, STKc_CDK_like, Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

 Score = 42.9 bits (102), Expect = 2e-04
 Identities = 14/32 (43%), Positives = 19/32 (59%)

Query: 336 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
            D  G DLL K+L  +P+KR  +  AL H +F
Sbjct: 251 LDPEGIDLLSKMLQYNPAKRISAKEALKHPYF 282

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the early G1 phase by CDK4 or CDK6, the G1/S phase transition by CDK2, or the entry of mitosis by CDK1. They also exhibit overlapping cyclin specificity and functions in certain conditions. Knockout mice with a single CDK deleted remain viable with specific phenotypes, showing that some CDKs can compensate for each other. For example, CDK4 can compensate for the loss of CDK6, however, double knockout mice with both CDK4 and CDK6 deleted die in utero. CDK8 and CDK9 are mainly involved in transcription while CDK5 is implicated in neuronal function. CDK7 plays essential roles in both the cell cycle as a CDK-Activating Kinase (CAK) and in transcription as a component of the general transcription factor TFIIH. Length = 282

>gnl|CDD|173694 cd05603, STKc_SGK2, Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 53/190 (27%), Positives = 71/190 (37%), Gaps = 49/190 (25%)

Query: 86  YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLWYRP 143
           Y+HS  I++RD+K  N+L+   G + L DFGL       K G     T      T  Y  
Sbjct: 111 YLHSLNIIYRDLKPENILLDSQGHVVLTDFGLC------KEGVEPEETTSTFCGTPEYLA 164

Query: 144 PELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGV 203
           PE +L    Y   VD W  G ++ EM    P             +SQ+  +I        
Sbjct: 165 PE-VLRKEPYDRTVDWWCLGAVLYEMLYGLPPFYSRD-------VSQMYDNI-------- 208

Query: 204 ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL----NH 259
               L+  ++LP               K    CDLL  LL  D  +R  + A      NH
Sbjct: 209 ----LHKPLQLPGG-------------KTVAACDLLVGLLHKDQRRRLGAKADFLEIKNH 251

Query: 260 DFF----WTD 265
            FF    W D
Sbjct: 252 VFFSPINWDD 261

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1. Length = 321

>gnl|CDD|173646 cd05087, PTKc_Aatyk1_Aatyk3, Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

 Score = 43.0 bits (101), Expect = 2e-04
 Identities = 28/113 (24%), Positives = 51/113 (45%), Gaps = 13/113 (11%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFS 69
           L E +  + L+H N++  +  C           + + LV +FC   DL G L +      
Sbjct: 43  LEEAQPYRSLQHSNLLQCLGQCTEV--------TPYLLVMEFCPLGDLKGYLRSCRKAEL 94

Query: 70  LGEIKKVIQQL----LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           +      +Q++      GL ++H N  +H D+   N L+T    +K+ D+GL+
Sbjct: 95  MTPDPTTLQRMACEIALGLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLS 147

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells. Aatyk1 has been implicated in neural differentiation, and is a regulator of the Na-K-2Cl cotransporter, a membrane protein involved in cell proliferation and survival, epithelial transport, and blood pressure control. The function of Aatyk3 is still unknown. Length = 269

>gnl|CDD|133240 cd05109, PTKc_HER2, Catalytic domain of the Protein Tyrosine Kinase, HER2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 26/93 (27%), Positives = 45/93 (48%), Gaps = 3/93 (3%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLAR     +  + +    +V  
Sbjct: 117 QIAKGMSYLEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDET-EYHADGGKVPI 175

Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W     +L   R +    D+W  G  + E+ T
Sbjct: 176 KWMALESIL--HRRFTHQSDVWSYGVTVWELMT 206

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER2 does not bind to any known EGFR subfamily ligands, but contributes to the kinase activity of all possible heterodimers. It acts as the preferred partner with other ligand-bound EGFR proteins and functions as a signal amplifier, with the HER2-HER3 heterodimer being the most potent pair in mitogenic signaling. HER2 plays an important role in cell development, proliferation, survival and motility. Overexpression of HER2 results in its activation and downstream signaling, even in the absence of ligand. HER2 overexpression, mainly due to gene amplification, has been shown in a variety of human cancers. Its role in breast cancer is especially well-documented. HER2 is up-regulated in about 25% of breast tumors and is associated with increases in tumor aggressiveness, recurrence and mortality. HER2 is a target for monoclonal antibodies and small molecule inhibitors, which are being developed as treatments for cancer. The first humanized antibody approved for clinical use is Trastuzumab (Herceptin), which is being used in combination with other therapies to improve the survival rates of patients with HER2-overexpressing breast cancer. Length = 279

>gnl|CDD|173655 cd05110, PTKc_HER4, Catalytic domain of the Protein Tyrosine Kinase, HER4

 Score = 42.7 bits (100), Expect = 2e-04
 Identities = 32/112 (28%), Positives = 54/112 (48%), Gaps = 14/112 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           + E  I+  + H ++V L+ +C +          T  LV     H    LL  +H  K +
Sbjct: 57  MDEALIMASMDHPHLVRLLGVCLS---------PTIQLVTQLMPH--GCLLDYVHEHKDN 105

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +G   +     Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLAR
Sbjct: 106 IGSQLLLNWCVQIAKGMMYLEERRLVHRDLAARNVLVKSPNHVKITDFGLAR 157

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. Ligands that bind HER4 fall into two groups, the neuregulins (or heregulins) and some EGFR (HER1) ligands including betacellulin, HBEGF, and epiregulin. All four neuregulins (NRG1-4) interact with HER4. Upon ligand binding, HER4 forms homo- or heterodimers with other HER proteins. HER4 is essential in embryonic development. It is implicated in mammary gland, cardiac, and neural development. As a postsynaptic receptor of NRG1, HER4 plays an important role in synaptic plasticity and maturation. The impairment of NRG1/HER4 signaling may contribute to schizophrenia. Length = 303

>gnl|CDD|173767 cd08227, PK_STRAD_alpha, Pseudokinase domain of STE20-related kinase adapter protein alpha

 Score = 42.6 bits (100), Expect = 2e-04
 Identities = 61/279 (21%), Positives = 105/279 (37%), Gaps = 46/279 (16%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNIHV 66
           E+ + +L  H N+V               YR+TF      ++V  F  +  A  L   H 
Sbjct: 49  ELHVSKLFNHPNIV--------------PYRATFIADNELWVVTSFMAYGSAKDLICTHF 94

Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E  I  ++Q +L  L YIH    +HR +KA+++LI+  G + L+  GL    S  
Sbjct: 95  MDGMSELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLS--GLRSNLSMI 152

Query: 125 KNGQ-------VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM------WT 171
            +GQ         +Y+ +V+  W  P  L    + Y    D++  G    E+      + 
Sbjct: 153 NHGQRLRVVHDFPKYSVKVLP-WLSPEVLQQNLQGYDAKSDIYSVGITACELANGHVPFK 211

Query: 172 RSPIMQGNTEQQQITLISQLCGSITPESWPGVET------LDLYNKMELPKAQKRKVKER 225
             P  Q   E+   T+   L  +  P     ++         L     +   +    +  
Sbjct: 212 DMPATQMLLEKLNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESS 271

Query: 226 LKPYVKDQYGC--DLLDKLLLLDPSKRFDSDAALNHDFF 262
             PY +         +++ L  +P  R  +   LNH FF
Sbjct: 272 SHPYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF 310

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buccal mucosa. There are two forms of STRAD, alpha and beta, that complex with LKB1 and MO25. The structure of STRAD-alpha is available and shows that this protein binds ATP, has an ordered activation loop, and adopts a closed conformation typical of fully active protein kinases. It does not possess activity due to nonconservative substitutions of essential catalytic residues. ATP binding enhances the affinity of STRAD for MO25. The conformation of STRAD-alpha, stabilized through ATP and MO25, may be needed to activate LKB1. A mutation which results in a truncation of a C-terminal part of the human STRAD-alpha pseudokinase domain and disrupts its association with LKB1, leads to PMSE (polyhydramnios, megalencephaly, symptomatic epilepsy) syndrome. Several splice variants of STRAD-alpha exist which exhibit different effects on the localization and activation of LKB1. Length = 327

>gnl|CDD|173715 cd05626, STKc_LATS2, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

 Score = 43.1 bits (101), Expect = 2e-04
 Identities = 28/101 (27%), Positives = 45/101 (44%), Gaps = 14/101 (13%)

Query: 43  RSTFYLVFDFCEH-DLAGLLSNIHV------KFSLGEIKKVIQQLLNGLYYIHSNKILHR 95
           +   Y V D+    D+  LL  + V      +F + E+   I+        +H    +HR
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLIRMEVFPEVLARFYIAELTLAIES-------VHKMGFIHR 125

Query: 96  DMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRV 136
           D+K  N+LI   G +KL DFGL   F  T N +  +  + +
Sbjct: 126 DIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHI 166

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with poor prognosis in acute lymphoblastic leukemia and breast cancer. Length = 381

>gnl|CDD|173714 cd05625, STKc_LATS1, Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

 Score = 41.9 bits (98), Expect = 5e-04
 Identities = 52/215 (24%), Positives = 76/215 (35%), Gaps = 46/215 (21%)

Query: 43  RSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAAN 101
           +   Y V D+    D+  LL  + + F     +  I +L   +  +H    +HRD+K  N
Sbjct: 73  KDNLYFVMDYIPGGDMMSLLIRMGI-FPEDLARFYIAELTCAVESVHKMGFIHRDIKPDN 131

Query: 102 VLITKTGILKLADFGLARAFSQTKNGQVNRYTNRV-------VTLWYRPPELLLGDR--- 151
           +LI + G +KL DFGL   F  T + +  +  + V          W  P     GDR   
Sbjct: 132 ILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKP 191

Query: 152 ---------------------NYGPP-----------VDLWGAGCIMAEMWTRSP--IMQ 177
                                NY  P            D W  G I+ EM    P  + Q
Sbjct: 192 LERRAARQHQRCLAHSLVGTPNYIAPEVLLRTGYTQLCDWWSVGVILYEMLVGQPPFLAQ 251

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKM 212
              E Q   +  Q    I P++    E  DL  K+
Sbjct: 252 TPLETQMKVINWQTSLHIPPQAKLSPEASDLIIKL 286

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype and poor prognosis. LATS1 induces G2 arrest and promotes cytokinesis. It may be a component of the mitotic exit network in higher eukaryotes. Length = 382

>gnl|CDD|132949 cd06618, PKc_MKK7, Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

 Score = 41.2 bits (97), Expect = 6e-04
 Identities = 15/45 (33%), Positives = 30/45 (66%), Gaps = 1/45 (2%)

Query: 75  KVIQQLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLA 118
           K+   ++  L+Y+     ++HRD+K +N+L+  +G +KL DFG++
Sbjct: 118 KMTVAIVKALHYLKEKHGVIHRDVKPSNILLDASGNVKLCDFGIS 162

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates its downstream target, c-Jun N-terminal kinase (JNK), on specific threonine and tyrosine residues. Although MKK7 is capable of dual phosphorylation, it prefers to phosphorylate the threonine residue of JNK. Thus, optimal activation of JNK requires both MKK4 (not included in this subfamily) and MKK7. MKK7 is primarily activated by cytokines. MKK7 is essential for liver formation during embryogenesis. It plays roles in G2/M cell cycle arrest and cell growth. In addition, it is involved in the control of programmed cell death, which is crucial in oncogenesis, cancer chemoresistance, and antagonism to TNFalpha-induced killing, through its inhibition by Gadd45beta and the subsequent suppression of the JNK cascade. Length = 296

>gnl|CDD|133205 cd05074, PTKc_Tyro3, Catalytic domain of the Protein Tyrosine Kinase, Tyro3

 Score = 41.1 bits (96), Expect = 6e-04
 Identities = 47/186 (25%), Positives = 80/186 (43%), Gaps = 21/186 (11%)

Query: 11  LREIKILQLLKHENVVHLIEIC-RTKANQYNRYRSTFYLV-FDFCEH-DLAG--LLSNIH 65
           LRE   ++   H NV+ LI +  R++A      R    +V   F +H DL    L+S I 
Sbjct: 49  LREAACMKEFDHPNVIKLIGVSLRSRAKG----RLPIPMVILPFMKHGDLHTFLLMSRIG 104

Query: 66  ---VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF- 121
                  L  + + +  + +G+ Y+ S   +HRD+ A N ++ +   + +ADFGL++   
Sbjct: 105 EEPFTLPLQTLVRFMIDIASGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIY 164

Query: 122 --SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
                + G  ++   + + L        L D  Y    D+W  G  M E+ TR       
Sbjct: 165 SGDYYRQGCASKLPVKWLALES------LADNVYTTHSDVWAFGVTMWEIMTRGQTPYAG 218

Query: 180 TEQQQI 185
            E  +I
Sbjct: 219 VENSEI 224

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic factor. It is also expressed in osteoclasts and has a role in bone resorption. Length = 273

>gnl|CDD|143344 cd07839, STKc_CDK5, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

 Score = 40.9 bits (96), Expect = 7e-04
 Identities = 12/28 (42%), Positives = 18/28 (64%)

Query: 340 GCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           G DLL  LL+ +P +R  ++ AL H +F
Sbjct: 257 GRDLLQNLLVCNPVQRISAEEALQHPYF 284

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also important in synaptic plasticity and learning. CDK5 also participates in protecting against cell death and promoting angiogenesis. Impaired CDK5 activity is implicated in Alzheimer's disease, amyotrophic lateral sclerosis, Parkinson's disease, Huntington's disease and acute neuronal injury. Length = 284

>gnl|CDD|173656 cd05111, PTK_HER3, Pseudokinase domain of the Protein Tyrosine Kinase, HER3

 Score = 40.7 bits (95), Expect = 7e-04
 Identities = 15/40 (37%), Positives = 30/40 (75%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           Q+  G+YY+  ++++HR++ A N+L+    I+++ADFG+A
Sbjct: 117 QIAKGMYYLEEHRMVHRNLAARNILLKSDSIVQIADFGVA 156

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as binding sites for downstream signaling molecules. HER3 binds the neuregulin ligands, NRG1 and NRG2. HER3 contains an impaired tyr kinase domain and relies on its heterodimerization partners for activity following ligand binding. The HER2-HER3 heterodimer constitutes a high affinity co-receptor capable of potent mitogenic signaling. HER3 participates in a signaling pathway involved in the proliferation, survival, adhesion, and motility of tumor cells. Length = 279

>gnl|CDD|173751 cd07860, STKc_CDK2_3, Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

 Score = 39.8 bits (93), Expect = 0.001
 Identities = 16/31 (51%), Positives = 21/31 (67%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           D+ G DLL ++L  DP+KR  + AAL H FF
Sbjct: 254 DEDGRDLLSQMLHYDPNKRISAKAALAHPFF 284

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex plays a role in regulating DNA replication. CDK2, together with CDK4, also regulates embryonic cell proliferation. Despite these important roles, mice deleted for the cdk2 gene are viable and normal except for being sterile. This may be due to compensation provided by CDK1 (also called Cdc2), which can also bind cyclin E and drive the G1 to S phase transition. CDK3 is regulated by cyclin C and it phosphorylates pRB specifically during the G0/G1 transition. This phosphorylation is required for cells to exit G0 efficiently and enter the G1 phase. Length = 284

>gnl|CDD|177649 PLN00009, PLN00009, cyclin-dependent kinase A; Provisional

 Score = 40.2 bits (94), Expect = 0.001
 Identities = 17/31 (54%), Positives = 22/31 (70%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           +  G DLL K+L LDPSKR  + AAL H++F
Sbjct: 257 EPAGVDLLSKMLRLDPSKRITARAALEHEYF 287

Length = 294

>gnl|CDD|215638 PLN03225, PLN03225, Serine/threonine-protein kinase SNT7; Provisional

 Score = 40.9 bits (96), Expect = 0.001
 Identities = 25/84 (29%), Positives = 40/84 (47%), Gaps = 15/84 (17%)

Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNR 131
           I+ +++Q+L  L  +HS  I+HRD+K  N++ +  +G  K+ D G A             
Sbjct: 257 IQTIMRQILFALDGLHSTGIVHRDVKPQNIIFSEGSGSFKIIDLGAA------------- 303

Query: 132 YTNRVVTLWYRPPELLLGDRNYGP 155
             +  V + Y P E LL  R   P
Sbjct: 304 -ADLRVGINYIPKEFLLDPRYAAP 326

Length = 566

>gnl|CDD|173717 cd05628, STKc_NDR1, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

 Score = 40.4 bits (94), Expect = 0.001
 Identities = 33/128 (25%), Positives = 44/128 (34%), Gaps = 32/128 (25%)

Query: 87  IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN------------ 134
           IH    +HRD+K  N+L+   G +KL+DFGL     +    +  R  N            
Sbjct: 117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNM 176

Query: 135 ---RVVTLWYR----------------PPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
              R    W R                 PE+ +    Y    D W  G IM EM    P 
Sbjct: 177 NSKRKAETWKRNRRQLAFSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 176 MQGNTEQQ 183
               T Q+
Sbjct: 236 FCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, muscle, lung and spleen. It is not an essential protein because mice deficient of NDR1 remain viable and fertile. However, these mice develop T-cell lymphomas and appear to be hypersenstive to carcinogenic treatment. NDR1 appears to act as a tumor suppressor. NDR1 is also called STK38. Length = 363

>gnl|CDD|173749 cd07855, STKc_ERK5, Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

 Score = 40.0 bits (94), Expect = 0.002
 Identities = 13/40 (32%), Positives = 17/40 (42%)

Query: 336 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 375
                 DLL ++L  DP +R   + AL H F      P D
Sbjct: 266 ASPEALDLLSQMLQFDPEERITVEQALQHPFLAQYHDPDD 305

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the MAP2K MEK5, which in turn is regulated by the MAP3Ks MEKK2 and MEKK3. Activated ERK5 phosphorylates its targets including myocyte enhancer factor 2 (MEF2), Sap1a, c-Myc, and RSK. It plays a role in EGF-induced cell proliferation during the G1/S phase transition. Studies on knockout mice revealed that ERK5 is essential for cardiovascular development and plays an important role in angiogenesis. It is also critical for neural differentiation and survival. The ERK5 pathway has been implicated in the pathogenesis of many diseases including cancer, cardiac hypertrophy, and atherosclerosis. Length = 334

>gnl|CDD|173739 cd07838, STKc_CDK4_6_like, Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 13/31 (41%), Positives = 18/31 (58%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
            + G DLL K+L  +P KR  +  AL H +F
Sbjct: 257 CEEGLDLLKKMLTFNPHKRISAFEALQHPYF 287

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both expressed ubiquitously, associate with all three D cyclins (D1, D2 and D3), and phosphorylate the retinoblastoma (pRb) protein. They are also regulated by the INK4 family of inhibitors which associate with either the CDK alone or the CDK/cyclin complex. CDK4 and CDK6 show differences in subcellular localization, sensitivity to some inhibitors, timing in activation, tumor selectivity, and possibly substrate profiles. Although CDK4 and CDK6 seem to show some redundancy, they also have discrete, nonoverlapping functions. CDK6 plays an important role in cell differentiation. Length = 287

>gnl|CDD|173740 cd07842, STKc_CDK8_like, Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

 Score = 38.8 bits (91), Expect = 0.003
 Identities = 15/70 (21%), Positives = 23/70 (32%), Gaps = 7/70 (10%)

Query: 298 HHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD 357
               +               +         K   + +       DLL KLL  DP+KR  
Sbjct: 254 KMPEYDTLMKDFKTKTYPSNSLAKWMEKHKKPDSQGF-------DLLRKLLEYDPTKRIT 306

Query: 358 SDAALNHDFF 367
           ++ AL H +F
Sbjct: 307 AEEALEHPYF 316

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA polymerase II (RNAP II)-dependent transcription. CDC2L6 also associates with Mediator in complexes lacking CDK8. In VP16-dependent transcriptional activation, CDK8 and CDC2L6 exerts opposing effects by positive and negative regulation, respectively, in similar conditions. Length = 316

>gnl|CDD|173753 cd07864, STKc_CDK12, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 14/25 (56%), Positives = 18/25 (72%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDF 366
           DLLD +L LDPSKR  ++ ALN  +
Sbjct: 277 DLLDHMLTLDPSKRCTAEEALNSPW 301

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely expressed in tissues. It interacts with cyclins L1 and L2, and plays roles in regulating transcription and alternative splicing. Length = 302

>gnl|CDD|173752 cd07861, STKc_CDK1_euk, Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

 Score = 38.6 bits (90), Expect = 0.004
 Identities = 20/42 (47%), Positives = 28/42 (66%), Gaps = 2/42 (4%)

Query: 328 KERLKPYVK--DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           K  L+  VK  D+ G DLL+K+L+ DP+KR  +  ALNH +F
Sbjct: 244 KGSLRSAVKNLDEDGLDLLEKMLIYDPAKRISAKKALNHPYF 285

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2 phase entry and progression. CDK1/cyclin A2 has also been implicated as an important regulator of S phase events. The CDK1/cyclin B complex is critical for G2 to M phase transition. It induces mitosis by activating nuclear enzymes that regulate chromatin condensation, nuclear membrane degradation, mitosis-specific microtubule and cytoskeletal reorganization. CDK1 also associates with cyclin E and plays a role in the entry into S phase. CDK1 transcription is stable throughout the cell cycle but is modulated in some pathological conditions. It may play a role in regulating apoptosis under these conditions. In breast cancer cells, HER2 can mediate apoptosis by inactivating CDK1. Activation of CDK1 may contribute to HIV-1 induced apoptosis and neuronal apoptosis in neurodegenerative diseases. Length = 285

>gnl|CDD|143381 cd07876, STKc_JNK2, Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 17/43 (39%), Positives = 24/43 (55%), Gaps = 2/43 (4%)

Query: 335 VKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDPMPSD 375
           +K     DLL K+L++DP KR   D AL H +   W DP  ++
Sbjct: 286 LKTSQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 328

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jnk1 or Jnk2) could survive but disruption of both genes resulted in lethality. However, recent studies have shown that JNK1 and JNK2 perform distinct functions through specific binding partners and substrates. JNK2 is specifically translocated to the mitochondria during dopaminergic cell death. Specific substrates include the microtubule-associated proteins DCX and Tau, as well as TIF-IA which is involved in ribosomal RNA synthesis regulation. Mice deficient in Jnk2 show protection against arthritis, type 1 diabetes, atherosclerosis, abdominal aortic aneurysm, cardiac cell death, TNF-induced liver damage, and tumor growth, indicating that JNK2 may play roles in the pathogenesis of these diseases. Length = 359

>gnl|CDD|173647 cd05091, PTKc_Ror2, Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

 Score = 38.5 bits (89), Expect = 0.004
 Identities = 47/234 (20%), Positives = 101/234 (43%), Gaps = 39/234 (16%)

Query: 20  LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--------------DLAGLLSNIH 65
           L+H N+V L+ +  TK    +       ++F +C H              D+     +  
Sbjct: 65  LQHPNIVCLLGVV-TKEQPLS-------MIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKT 116

Query: 66  VKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
           VK +L   +   ++ Q+  G+ ++ S+ ++H+D+   NVL+     +K++D GL R    
Sbjct: 117 VKSTLEPADFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYA 176

Query: 124 TKNGQVNRYTNRVVTL-WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ---GN 179
               ++    N ++ + W  P  ++ G   +    D+W  G ++ E+++    +Q   G 
Sbjct: 177 ADYYKL--MGNSLLPIRWMSPEAIMYG--KFSIDSDIWSYGVVLWEVFSYG--LQPYCGY 230

Query: 180 TEQQQITLISQ----LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + Q  I +I       C    P +W     L+ +N+    + + + +  RL+ +
Sbjct: 231 SNQDVIEMIRNRQVLPCPDDCP-AWVYTLMLECWNEFPSRRPRFKDIHSRLRTW 283

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. Ror2 plays important roles in skeletal and heart formation. Ror2-deficient mice show widespread bone abnormalities, ventricular defects in the heart, and respiratory dysfunction. Mutations in human Ror2 result in two different bone development genetic disorders, recessive Robinow syndrome and brachydactyly type B. Ror2 is also implicated in neural development. Length = 283

>gnl|CDD|173716 cd05627, STKc_NDR2, Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

 Score = 38.9 bits (90), Expect = 0.004
 Identities = 32/128 (25%), Positives = 44/128 (34%), Gaps = 32/128 (25%)

Query: 87  IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV---------------NR 131
           IH    +HRD+K  N+L+   G +KL+DFGL     +    +                N 
Sbjct: 117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNM 176

Query: 132 YTNRVVTLW----------------YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
            + R    W                Y  PE+ +    Y    D W  G IM EM    P 
Sbjct: 177 NSKRKAETWKKNRRQLAYSTVGTPDYIAPEVFM-QTGYNKLCDWWSLGVIMYEMLIGYPP 235

Query: 176 MQGNTEQQ 183
               T Q+
Sbjct: 236 FCSETPQE 243

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regulating neuronal growth and differentiation, as well as in facilitating neurite outgrowth. It is also implicated in fear conditioning as it contributes to the coupling of neuronal morphological changes with fear-memory consolidation. NDR2 is also referred to as STK38-like. Length = 360

Conserved Domains Detected by HHsearch

Original result of HHsearch against CDD database

ID	Length	Definition	Probability
Query	433
KOG0663|consensus	419		100.0
KOG0600|consensus	560		100.0
KOG0669|consensus	376		100.0
KOG0659|consensus	318		100.0
KOG0661|consensus	538		100.0
KOG0593|consensus	396		100.0
KOG0660|consensus	359		100.0
KOG0615|consensus	475		100.0
KOG0594|consensus	323		100.0
KOG0575|consensus	592		100.0
KOG0581|consensus	364		100.0
KOG0658|consensus	364		100.0
KOG0666|consensus	438		100.0
KOG0662|consensus	292		100.0
KOG0598|consensus	357		100.0
KOG0592|consensus	604		100.0
KOG0033|consensus	355		100.0
KOG0583|consensus	370		100.0
KOG0616|consensus	355		100.0
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	100.0
KOG0588|consensus	786		100.0
KOG0599|consensus	411		100.0
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	100.0
KOG0578|consensus	550		100.0
KOG0667|consensus	586		100.0
KOG0198|consensus	313		100.0
KOG0595|consensus	429		100.0
KOG0582|consensus	516		100.0
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	100.0
KOG0585|consensus	576		100.0
KOG0591|consensus	375		100.0
KOG0605|consensus	550		100.0
KOG0597|consensus	808		100.0
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	100.0
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	100.0
PTZ00036	440	glycogen synthase kinase; Provisional	100.0
cd07865	310	STKc_CDK9 Catalytic domain of the Serine/Threonine	100.0
KOG0610|consensus	459		100.0
KOG4717|consensus	864		100.0
KOG0604|consensus	400		100.0
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	100.0
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	100.0
cd07859	338	STKc_TDY_MAPK_plant Catalytic domain of the Serine	100.0
KOG0032|consensus	382		100.0
PHA03212	391	serine/threonine kinase US3; Provisional	100.0
KOG0694|consensus	694		100.0
KOG0580|consensus	281		100.0
cd07853	372	STKc_NLK Catalytic domain of the Serine/Threonine	100.0
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	100.0
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	100.0
KOG0611|consensus	668		100.0
cd05571	323	STKc_PKB Catalytic domain of the Protein Serine/Th	100.0
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	100.0
cd07844	291	STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like	100.0
KOG0665|consensus	369		100.0
cd07861	285	STKc_CDK1_euk Catalytic domain of the Serine/Threo	100.0
cd07843	293	STKc_CDC2L1 Catalytic domain of the Serine/Threoni	100.0
cd07839	284	STKc_CDK5 Catalytic domain of the Serine/Threonine	100.0
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	100.0
cd07832	286	STKc_CCRK Catalytic domain of the Serine/Threonine	100.0
cd07876	359	STKc_JNK2 Catalytic domain of the Serine/Threonine	100.0
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	100.0
PHA03207	392	serine/threonine kinase US3; Provisional	100.0
PTZ00426	340	cAMP-dependent protein kinase catalytic subunit; P	100.0
PTZ00263	329	protein kinase A catalytic subunit; Provisional	100.0
PHA03209	357	serine/threonine kinase US3; Provisional	100.0
cd05612	291	STKc_PRKX_like Catalytic domain of PRKX-like Prote	100.0
KOG0589|consensus	426		100.0
cd05585	312	STKc_YPK1_like Catalytic domain of Yeast Protein K	100.0
cd07874	355	STKc_JNK3 Catalytic domain of the Serine/Threonine	100.0
cd05593	328	STKc_PKB_gamma Catalytic domain of the Protein Ser	100.0
KOG0579|consensus	1187		100.0
cd05595	323	STKc_PKB_beta Catalytic domain of the Protein Seri	100.0
cd07870	291	STKc_PFTAIRE2 Catalytic domain of the Serine/Threo	100.0
PTZ00284	467	protein kinase; Provisional	100.0
cd07866	311	STKc_BUR1 Catalytic domain of the Serine/Threonine	100.0
cd05584	323	STKc_p70S6K Catalytic domain of the Protein Serine	100.0
PHA03211	461	serine/threonine kinase US3; Provisional	100.0
cd05600	333	STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p-	100.0
cd05631	285	STKc_GRK4 Catalytic domain of the Protein Serine/T	100.0
cd07860	284	STKc_CDK2_3 Catalytic domain of the Serine/Threoni	100.0
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	100.0
KOG0192|consensus	362		100.0
KOG0668|consensus	338		100.0
cd05625	382	STKc_LATS1 Catalytic domain of the Protein Serine/	100.0
cd05594	325	STKc_PKB_alpha Catalytic domain of the Protein Ser	100.0
cd05590	320	STKc_nPKC_eta Catalytic domain of the Protein Seri	100.0
cd06649	331	PKc_MEK2 Catalytic domain of the dual-specificity	100.0
PHA03210	501	serine/threonine kinase US3; Provisional	100.0
cd05628	363	STKc_NDR1 Catalytic domain of the Protein Serine/T	100.0
cd07847	286	STKc_CDKL1_4 Catalytic domain of the Serine/Threon	100.0
cd05599	364	STKc_NDR_like Catalytic domain of Nuclear Dbf2-Rel	100.0
cd05626	381	STKc_LATS2 Catalytic domain of the Protein Serine/	100.0
cd05596	370	STKc_ROCK Catalytic domain of the Protein Serine/T	100.0
KOG0201|consensus	467		100.0
KOG0671|consensus	415		100.0
cd05629	377	STKc_NDR_like_fungal Catalytic domain of Fungal Nu	100.0
cd07842	316	STKc_CDK8_like Catalytic domain of Cyclin-Dependen	100.0
cd07833	288	STKc_CDKL Catalytic domain of Cyclin-Dependent pro	100.0
cd05614	332	STKc_MSK2_N N-terminal catalytic domain of the Pro	100.0
KOG0577|consensus	948		100.0
cd05591	321	STKc_nPKC_epsilon Catalytic domain of the Protein	100.0
cd07840	287	STKc_CDK9_like Catalytic domain of Cyclin-Dependen	100.0
cd07855	334	STKc_ERK5 Catalytic domain of the Serine/Threonine	100.0
cd05621	370	STKc_ROCK2 Catalytic domain of the Protein Serine/	100.0
cd05608	280	STKc_GRK1 Catalytic domain of the Protein Serine/T	100.0
cd07864	302	STKc_CDK12 Catalytic domain of the Serine/Threonin	100.0
cd05620	316	STKc_nPKC_delta Catalytic domain of the Protein Se	100.0
cd05582	318	STKc_RSK_N N-terminal catalytic domain of the Prot	100.0
cd07836	284	STKc_Pho85 Catalytic domain of the Serine/Threonin	100.0
cd05601	330	STKc_CRIK Catalytic domain of the Protein Serine/T	100.0
cd05586	330	STKc_Sck1_like Catalytic domain of Suppressor of l	100.0
KOG0574|consensus	502		100.0
PTZ00024	335	cyclin-dependent protein kinase; Provisional	100.0
cd05573	350	STKc_ROCK_NDR_like Catalytic domain of ROCK- and N	100.0
KOG0197|consensus	468		100.0
cd05598	376	STKc_LATS Catalytic domain of the Protein Serine/T	100.0
cd05570	318	STKc_PKC Catalytic domain of the Protein Serine/Th	100.0
cd05575	323	STKc_SGK Catalytic domain of the Protein Serine/Th	100.0
cd07831	282	STKc_MOK Catalytic domain of the Serine/Threonine	100.0
cd05592	316	STKc_nPKC_theta_delta Catalytic domain of the Prot	100.0
cd07837	295	STKc_CdkB_plant Catalytic domain of the Serine/Thr	100.0
cd07849	336	STKc_ERK1_2_like Catalytic domain of Extracellular	100.0
PTZ00267	478	NIMA-related protein kinase; Provisional	100.0
PLN00009	294	cyclin-dependent kinase A; Provisional	100.0
cd05588	329	STKc_aPKC Catalytic domain of the Protein Serine/T	100.0
cd07835	283	STKc_CDK1_like Catalytic domain of Cyclin-Dependen	100.0
cd05118	283	STKc_CMGC Catalytic domain of CMGC family Serine/T	100.0
cd05589	324	STKc_PKN Catalytic domain of the Protein Serine/Th	100.0
PLN00034	353	mitogen-activated protein kinase kinase; Provision	100.0
cd05619	316	STKc_nPKC_theta Catalytic domain of the Protein Se	100.0
cd05627	360	STKc_NDR2 Catalytic domain of the Protein Serine/T	100.0
cd05587	324	STKc_cPKC Catalytic domain of the Protein Serine/T	100.0
cd07829	282	STKc_CDK_like Catalytic domain of Cyclin-Dependent	100.0
cd05618	329	STKc_aPKC_iota Catalytic domain of the Protein Ser	100.0
cd05622	371	STKc_ROCK1 Catalytic domain of the Protein Serine/	100.0
cd07850	353	STKc_JNK Catalytic domain of the Serine/Threonine	100.0
cd06650	333	PKc_MEK1 Catalytic domain of the dual-specificity	100.0
cd07846	286	STKc_CDKL2_3 Catalytic domain of the Serine/Threon	100.0
KOG0664|consensus	449		100.0
KOG0596|consensus	677		100.0
cd05604	325	STKc_SGK3 Catalytic domain of the Protein Serine/T	100.0
cd05602	325	STKc_SGK1 Catalytic domain of the Protein Serine/T	100.0
cd05603	321	STKc_SGK2 Catalytic domain of the Protein Serine/T	100.0
cd05616	323	STKc_cPKC_beta Catalytic domain of the Protein Ser	100.0
cd05605	285	STKc_GRK4_like Catalytic domain of G protein-coupl	100.0
KOG0607|consensus	463		100.0
cd07858	337	STKc_TEY_MAPK_plant Catalytic domain of the Serine	100.0
cd07857	332	STKc_MPK1 Catalytic domain of the Serine/Threonine	100.0
cd05597	331	STKc_DMPK_like Catalytic domain of Myotonic Dystro	100.0
cd05607	277	STKc_GRK7 Catalytic domain of the Protein Serine/T	100.0
KOG4279|consensus	1226		100.0
cd07834	330	STKc_MAPK Catalytic domain of the Serine/Threonine	100.0
cd06643	282	STKc_SLK Catalytic domain of the Protein Serine/Th	100.0
cd05617	327	STKc_aPKC_zeta Catalytic domain of the Protein Ser	100.0
cd05615	323	STKc_cPKC_alpha Catalytic domain of the Protein Se	100.0
cd05623	332	STKc_MRCK_alpha Catalytic domain of the Protein Se	100.0
cd07830	283	STKc_MAK_like Catalytic domain of Male germ cell-A	100.0
cd08227	327	PK_STRAD_alpha Pseudokinase domain of STE20-relate	100.0
cd06625	263	STKc_MEKK3_like Catalytic domain of MAP/ERK kinase	100.0
cd06615	308	PKc_MEK Catalytic domain of the dual-specificity P	100.0
KOG0983|consensus	391		100.0
cd07852	337	STKc_MAPK15 Catalytic domain of the Serine/Threoni	100.0
cd06644	292	STKc_STK10_LOK Catalytic domain of the Protein Ser	100.0
cd07851	343	STKc_p38 Catalytic domain of the Serine/Threonine	100.0
KOG1290|consensus	590		100.0
cd05630	285	STKc_GRK6 Catalytic domain of the Protein Serine/T	100.0
cd06611	280	STKc_SLK_like Catalytic domain of Ste20-like kinas	100.0
cd07879	342	STKc_p38delta_MAPK13 Catalytic domain of the Serin	100.0
cd06658	292	STKc_PAK5 Catalytic domain of the Protein Serine/T	100.0
cd08529	256	STKc_FA2-like Catalytic domain of the Protein Seri	100.0
PF00069	260	Pkinase: Protein kinase domain Protein kinase; unc	100.0
cd08223	257	STKc_Nek4 Catalytic domain of the Protein Serine/T	100.0
cd08216	314	PK_STRAD Pseudokinase domain of STE20-related kina	100.0
KOG0603|consensus	612		100.0
cd06607	307	STKc_TAO Catalytic domain of the Protein Serine/Th	100.0
PTZ00283	496	serine/threonine protein kinase; Provisional	100.0
cd05102	338	PTKc_VEGFR3 Catalytic domain of the Protein Tyrosi	100.0
cd07877	345	STKc_p38alpha_MAPK14 Catalytic domain of the Serin	100.0
cd06628	267	STKc_MAPKKK_Byr2_like Catalytic domain of fungal B	100.0
cd05580	290	STKc_PKA Catalytic domain of the Protein Serine/Th	100.0
cd07854	342	STKc_MAPK4_6 Catalytic domain of the Serine/Threon	100.0
KOG0612|consensus	1317		100.0
cd06612	256	STKc_MST1_2 Catalytic domain of the Protein Serine	100.0
cd06637	272	STKc_TNIK Catalytic domain of the Protein Serine/T	100.0
cd06630	268	STKc_MEKK1 Catalytic domain of the Protein Serine/	100.0
KOG4236|consensus	888		100.0
PHA02988	283	hypothetical protein; Provisional	100.0
cd05624	331	STKc_MRCK_beta Catalytic domain of the Protein Ser	100.0
KOG0670|consensus	752		100.0
cd06645	267	STKc_MAP4K3 Catalytic domain of the Protein Serine	100.0
PTZ00266	1021	NIMA-related protein kinase; Provisional	100.0
cd06619	279	PKc_MKK5 Catalytic domain of the dual-specificity	100.0
cd06648	285	STKc_PAK_II Catalytic domain of the Protein Serine	100.0
cd05632	285	STKc_GRK5 Catalytic domain of the Protein Serine/T	100.0
cd05574	316	STKc_phototropin_like Catalytic domain of Phototro	100.0
cd06631	265	STKc_YSK4 Catalytic domain of the Protein Serine/T	100.0
cd07856	328	STKc_Sty1_Hog1 Catalytic domain of the Serine/Thre	100.0
cd07838	287	STKc_CDK4_6_like Catalytic domain of Cyclin-Depend	100.0
cd06609	274	STKc_MST3_like Catalytic domain of Mammalian Ste20	100.0
KOG0586|consensus	596		100.0
cd06613	262	STKc_MAP4K3_like Catalytic domain of Mitogen-activ	100.0
cd06622	286	PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS	100.0
cd06610	267	STKc_OSR1_SPAK Catalytic domain of the Protein Ser	100.0
KOG0986|consensus	591		100.0
KOG0690|consensus	516		100.0
KOG0614|consensus	732		100.0
cd07880	343	STKc_p38gamma_MAPK12 Catalytic domain of the Serin	100.0
cd06651	266	STKc_MEKK3 Catalytic domain of the Protein Serine/	100.0
KOG4721|consensus	904		100.0
cd08221	256	STKc_Nek9 Catalytic domain of the Protein Serine/T	100.0
cd06654	296	STKc_PAK1 Catalytic domain of the Protein Serine/T	100.0
cd06659	297	STKc_PAK6 Catalytic domain of the Protein Serine/T	100.0
KOG0584|consensus	632		100.0
cd06655	296	STKc_PAK2 Catalytic domain of the Protein Serine/T	100.0
cd06608	275	STKc_myosinIII_like Catalytic domain of Class III	100.0
cd06633	313	STKc_TAO3 Catalytic domain of the Protein Serine/T	100.0
cd06636	282	STKc_MAP4K4_6 Catalytic domain of the Protein Seri	100.0
cd06639	291	STKc_myosinIIIB Catalytic domain of the Protein Se	100.0
cd06635	317	STKc_TAO1 Catalytic domain of the Protein Serine/T	100.0
cd08218	256	STKc_Nek1 Catalytic domain of the Protein Serine/T	100.0
cd06634	308	STKc_TAO2 Catalytic domain of the Protein Serine/T	100.0
cd06624	268	STKc_ASK Catalytic domain of the Protein Serine/Th	100.0
cd06605	265	PKc_MAPKK Catalytic domain of the dual-specificity	100.0
cd08217	265	STKc_Nek2 Catalytic domain of the Protein Serine/T	100.0
cd05572	262	STKc_cGK_PKG Catalytic domain of the Protein Serin	100.0
cd05609	305	STKc_MAST Catalytic domain of the Protein Serine/T	100.0
cd05064	266	PTKc_EphR_A10 Catalytic domain of the Protein Tyro	100.0
cd06646	267	STKc_MAP4K5 Catalytic domain of the Protein Serine	100.0
cd06616	288	PKc_MKK4 Catalytic domain of the dual-specificity	100.0
cd05114	256	PTKc_Tec_Rlk Catalytic domain of the Protein Tyros	100.0
KOG4645|consensus	1509		100.0
cd08226	328	PK_STRAD_beta Pseudokinase domain of STE20-related	100.0
cd06656	297	STKc_PAK3 Catalytic domain of the Protein Serine/T	100.0
cd06621	287	PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek	100.0
cd08220	256	STKc_Nek8 Catalytic domain of the Protein Serine/T	100.0
cd05577	277	STKc_GRK Catalytic domain of the Protein Serine/Th	100.0
cd05096	304	PTKc_DDR1 Catalytic domain of the Protein Tyrosine	100.0
cd05048	283	PTKc_Ror Catalytic Domain of the Protein Tyrosine	100.0
cd06617	283	PKc_MKK3_6 Catalytic domain of the dual-specificit	100.0
PHA03390	267	pk1 serine/threonine-protein kinase 1; Provisional	100.0
cd05106	374	PTKc_CSF-1R Catalytic domain of the Protein Tyrosi	100.0
cd06657	292	STKc_PAK4 Catalytic domain of the Protein Serine/T	100.0
cd05606	278	STKc_beta_ARK Catalytic domain of the Protein Seri	100.0
cd06638	286	STKc_myosinIIIA Catalytic domain of the Protein Se	100.0
cd05084	252	PTKc_Fes Catalytic domain of the Protein Tyrosine	100.0
cd06652	265	STKc_MEKK2 Catalytic domain of the Protein Serine/	100.0
cd05093	288	PTKc_TrkB Catalytic domain of the Protein Tyrosine	100.0
cd05113	256	PTKc_Btk_Bmx Catalytic domain of the Protein Tyros	100.0
cd00192	262	PTKc Catalytic domain of Protein Tyrosine Kinases.	100.0
cd05059	256	PTKc_Tec_like Catalytic domain of Tec-like Protein	100.0
cd05049	280	PTKc_Trk Catalytic domain of the Protein Tyrosine	100.0
cd06614	286	STKc_PAK Catalytic domain of the Protein Serine/Th	100.0
cd06629	272	STKc_MAPKKK_Bck1_like Catalytic domain of fungal B	100.0
cd06642	277	STKc_STK25-YSK1 Catalytic domain of the Protein Se	100.0
cd06640	277	STKc_MST4 Catalytic domain of the Protein Serine/T	100.0
cd06917	277	STKc_NAK1_like Catalytic domain of Fungal Nak1-lik	100.0
cd05077	262	PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd06632	258	STKc_MEKK1_plant Catalytic domain of the Protein S	100.0
cd05633	279	STKc_GRK3 Catalytic domain of the Protein Serine/T	100.0
cd05104	375	PTKc_Kit Catalytic domain of the Protein Tyrosine	100.0
cd05579	265	STKc_MAST_like Catalytic domain of Microtubule-ass	100.0
cd05052	263	PTKc_Abl Catalytic domain of the Protein Tyrosine	100.0
cd06620	284	PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr	100.0
KOG0696|consensus	683		100.0
cd06626	264	STKc_MEKK4 Catalytic domain of the Protein Serine/	100.0
cd05094	291	PTKc_TrkC Catalytic domain of the Protein Tyrosine	100.0
cd05578	258	STKc_Yank1 Catalytic domain of the Protein Serine/	100.0
cd08219	255	STKc_Nek3 Catalytic domain of the Protein Serine/T	100.0
KOG1989|consensus	738		100.0
KOG0608|consensus	1034		100.0
cd08225	257	STKc_Nek5 Catalytic domain of the Protein Serine/T	100.0
cd05122	253	PKc_STE Catalytic domain of STE family Protein Kin	100.0
cd05062	277	PTKc_IGF-1R Catalytic domain of the Protein Tyrosi	100.0
cd05068	261	PTKc_Frk_like Catalytic domain of Fyn-related kina	100.0
cd05058	262	PTKc_Met_Ron Catalytic domain of the Protein Tyros	100.0
cd05036	277	PTKc_ALK_LTK Catalytic domain of the Protein Tyros	100.0
cd05115	257	PTKc_Zap-70 Catalytic domain of the Protein Tyrosi	100.0
cd05054	337	PTKc_VEGFR Catalytic domain of the Protein Tyrosin	100.0
cd05116	257	PTKc_Syk Catalytic domain of the Protein Tyrosine	100.0
cd08215	258	STKc_Nek Catalytic domain of the Protein Serine/Th	100.0
cd05108	316	PTKc_EGFR Catalytic domain of the Protein Tyrosine	100.0
cd05033	266	PTKc_EphR Catalytic domain of Ephrin Receptor Prot	100.0
cd05089	297	PTKc_Tie1 Catalytic domain of the Protein Tyrosine	100.0
cd05581	280	STKc_PDK1 Catalytic domain of the Protein Serine/T	100.0
cd05076	274	PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of th	100.0
cd05053	293	PTKc_FGFR Catalytic domain of the Protein Tyrosine	100.0
cd05611	260	STKc_Rim15_like Catalytic domain of fungal Rim15-l	100.0
cd05061	288	PTKc_InsR Catalytic domain of the Protein Tyrosine	100.0
cd05072	261	PTKc_Lyn Catalytic domain of the Protein Tyrosine	100.0
cd05078	258	PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain	100.0
cd06647	293	STKc_PAK_I Catalytic domain of the Protein Serine/	100.0
cd06653	264	STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kina	100.0
cd06641	277	STKc_MST3 Catalytic domain of the Protein Serine/T	100.0
cd05060	257	PTKc_Syk_like Catalytic domain of Spleen Tyrosine	100.0
cd06623	264	PKc_MAPKK_plant_like Catalytic domain of Plant dua	100.0
cd05090	283	PTKc_Ror1 Catalytic domain of the Protein Tyrosine	100.0
cd05123	250	STKc_AGC Catalytic domain of AGC family Protein Se	100.0
cd05055	302	PTKc_PDGFR Catalytic domain of the Protein Tyrosin	100.0
cd05091	283	PTKc_Ror2 Catalytic domain of the Protein Tyrosine	100.0
cd05063	268	PTKc_EphR_A2 Catalytic domain of the Protein Tyros	100.0
cd05082	256	PTKc_Csk Catalytic domain of the Protein Tyrosine	100.0
cd05088	303	PTKc_Tie2 Catalytic domain of the Protein Tyrosine	100.0
cd06618	296	PKc_MKK7 Catalytic domain of the dual-specificity	100.0
cd05092	280	PTKc_TrkA Catalytic domain of the Protein Tyrosine	100.0
cd05085	250	PTKc_Fer Catalytic domain of the Protein Tyrosine	100.0
cd05042	269	PTKc_Aatyk Catalytic domain of the Protein Tyrosin	100.0
cd06627	254	STKc_Cdc7_like Catalytic domain of Cell division c	100.0
cd05066	267	PTKc_EphR_A Catalytic domain of the Protein Tyrosi	100.0
cd05148	261	PTKc_Srm_Brk Catalytic domain of the Protein Tyros	100.0
cd05045	290	PTKc_RET Catalytic domain of the Protein Tyrosine	100.0
cd05070	260	PTKc_Fyn_Yrk Catalytic domain of the Protein Tyros	100.0
cd05041	251	PTKc_Fes_like Catalytic domain of Fes-like Protein	100.0
KOG2345|consensus	302		100.0
cd05056	270	PTKc_FAK Catalytic domain of the Protein Tyrosine	100.0
cd05032	277	PTKc_InsR_like Catalytic domain of Insulin Recepto	100.0
cd05051	296	PTKc_DDR Catalytic domain of the Protein Tyrosine	100.0
cd05075	272	PTKc_Axl Catalytic domain of the Protein Tyrosine	100.0
cd05069	260	PTKc_Yes Catalytic domain of the Protein Tyrosine	100.0
cd05040	257	PTKc_Ack_like Catalytic domain of the Protein Tyro	100.0
cd05101	304	PTKc_FGFR2 Catalytic domain of the Protein Tyrosin	100.0
cd08222	260	STKc_Nek11 Catalytic domain of the Protein Serine/	100.0
cd05111	279	PTK_HER3 Pseudokinase domain of the Protein Tyrosi	100.0
cd05035	273	PTKc_Axl_like Catalytic Domain of Axl-like Protein	100.0
cd05047	270	PTKc_Tie Catalytic domain of Tie Protein Tyrosine	100.0
cd06606	260	STKc_MAPKKK Catalytic domain of the Protein Serine	100.0
cd05099	314	PTKc_FGFR4 Catalytic domain of the Protein Tyrosin	100.0
cd05613	290	STKc_MSK1_N N-terminal catalytic domain of the Pro	100.0
cd05112	256	PTKc_Itk Catalytic domain of the Protein Tyrosine	100.0
cd05109	279	PTKc_HER2 Catalytic domain of the Protein Tyrosine	100.0
cd08530	256	STKc_CNK2-like Catalytic domain of the Protein Ser	100.0
cd05098	307	PTKc_FGFR1 Catalytic domain of the Protein Tyrosin	100.0
cd05097	295	PTKc_DDR_like Catalytic domain of Discoidin Domain	100.0
cd05044	269	PTKc_c-ros Catalytic domain of the Protein Tyrosin	100.0
PF07714	259	Pkinase_Tyr: Protein tyrosine kinase Protein kinas	100.0
cd05105	400	PTKc_PDGFR_alpha Catalytic domain of the Protein T	100.0
cd05034	261	PTKc_Src_like Catalytic domain of Src kinase-like	100.0
cd05065	269	PTKc_EphR_B Catalytic domain of the Protein Tyrosi	99.98
cd05071	262	PTKc_Src Catalytic domain of the Protein Tyrosine	99.98
cd05067	260	PTKc_Lck_Blk Catalytic domain of the Protein Tyros	99.98
cd05039	256	PTKc_Csk_like Catalytic domain of C-terminal Src k	99.98
cd08229	267	STKc_Nek7 Catalytic domain of the Protein Serine/T	99.98
cd05576	237	STKc_RPK118_like Catalytic domain of the Protein S	99.98
smart00219	258	TyrKc Tyrosine kinase, catalytic domain. Phosphotr	99.98
cd05079	284	PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05080	283	PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the	99.98
cd05050	288	PTKc_Musk Catalytic domain of the Protein Tyrosine	99.98
cd05087	269	PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein	99.98
cd08228	267	STKc_Nek6 Catalytic domain of the Protein Serine/T	99.98
cd05100	334	PTKc_FGFR3 Catalytic domain of the Protein Tyrosin	99.98
cd05095	296	PTKc_DDR2 Catalytic domain of the Protein Tyrosine	99.98
KOG1027|consensus	903		99.98
cd05086	268	PTKc_Aatyk2 Catalytic domain of the Protein Tyrosi	99.98
KOG0587|consensus	953		99.98
cd05037	259	PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the	99.98
cd05083	254	PTKc_Chk Catalytic domain of the Protein Tyrosine	99.98
cd05046	275	PTK_CCK4 Pseudokinase domain of the Protein Tyrosi	99.97
cd05057	279	PTKc_EGFR_like Catalytic domain of Epidermal Growt	99.97
cd08224	267	STKc_Nek6_Nek7 Catalytic domain of the Protein Ser	99.97
cd05043	280	PTK_Ryk Pseudokinase domain of Ryk (Receptor relat	99.97
cd05583	288	STKc_MSK_N N-terminal catalytic domain of the Prot	99.97
cd05073	260	PTKc_Hck Catalytic domain of the Protein Tyrosine	99.97
KOG1151|consensus	775		99.97
PRK13184	932	pknD serine/threonine-protein kinase; Reviewed	99.97
KOG1035|consensus	1351		99.97
cd05081	284	PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of	99.97
cd05110	303	PTKc_HER4 Catalytic domain of the Protein Tyrosine	99.97
cd05103	343	PTKc_VEGFR2 Catalytic domain of the Protein Tyrosi	99.97
KOG1167|consensus	418		99.97
KOG0695|consensus	593		99.97
KOG0193|consensus	678		99.97
KOG1026|consensus	774		99.97
KOG1187|consensus	361		99.97
cd05610	669	STKc_MASTL Catalytic domain of the Protein Serine/	99.97
cd08528	269	STKc_Nek10 Catalytic domain of the Protein Serine/	99.97
KOG1006|consensus	361		99.97
cd05107	401	PTKc_PDGFR_beta Catalytic domain of the Protein Ty	99.97
PHA02882	294	putative serine/threonine kinase; Provisional	99.97
KOG0194|consensus	474		99.97
cd05038	284	PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the P	99.97
KOG4257|consensus	974		99.97
cd05074	273	PTKc_Tyro3 Catalytic domain of the Protein Tyrosin	99.97
smart00220	244	S_TKc Serine/Threonine protein kinases, catalytic	99.97
PLN00181	793	protein SPA1-RELATED; Provisional	99.97
KOG1095|consensus	1025		99.97
KOG4250|consensus	732		99.97
KOG4278|consensus	1157		99.96
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	99.96
KOG0196|consensus	996		99.96
KOG1094|consensus	807		99.96
PLN03224	507	probable serine/threonine protein kinase; Provisio	99.96
KOG0984|consensus	282		99.96
KOG0199|consensus	1039		99.95
KOG0576|consensus	829		99.94
smart00750	176	KIND kinase non-catalytic C-lobe domain. It is an	99.94
KOG1152|consensus	772		99.94
KOG0200|consensus	609		99.94
PLN00113	968	leucine-rich repeat receptor-like protein kinase;	99.94
cd00180	215	PKc Catalytic domain of Protein Kinases. Protein K	99.93
KOG0590|consensus	601		99.93
KOG1025|consensus	1177		99.92
KOG3653|consensus	534		99.92
KOG2052|consensus	513		99.91
smart00221	225	STYKc Protein kinase; unclassified specificity. Ph	99.9
KOG1024|consensus	563		99.89
KOG1345|consensus	378		99.89
KOG0603|consensus	612		99.87
COG0515	384	SPS1 Serine/threonine protein kinase [General func	99.85
KOG1240|consensus	1431		99.83
KOG4158|consensus	598		99.82
KOG0606|consensus	1205		99.78
KOG1164|consensus	322		99.77
PRK09188	365	serine/threonine protein kinase; Provisional	99.76
PRK10359	232	lipopolysaccharide core biosynthesis protein; Prov	99.74
KOG1033|consensus	516		99.73
KOG1023|consensus	484		99.72
KOG1163|consensus	341		99.71
PRK12274	218	serine/threonine protein kinase; Provisional	99.71
KOG1165|consensus	449		99.69
PF14531	288	Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_	99.69
PRK10345	210	hypothetical protein; Provisional	99.68
cd05147	190	RIO1_euk RIO kinase family; eukaryotic RIO1, catal	99.65
cd05145	190	RIO1_like RIO kinase family; RIO1, RIO3 and simila	99.62
KOG0590|consensus	601		99.6
KOG0195|consensus	448		99.59
KOG1266|consensus	458		99.52
PRK01723	239	3-deoxy-D-manno-octulosonic-acid kinase; Reviewed	99.45
PRK14879	211	serine/threonine protein kinase; Provisional	99.43
smart00090	237	RIO RIO-like kinase.	99.43
KOG0601|consensus	524		99.41
TIGR03724	199	arch_bud32 Kae1-associated kinase Bud32. Members o	99.4
PRK09605	535	bifunctional UGMP family protein/serine/threonine	99.4
KOG1166|consensus	974		99.38
KOG0606|consensus	1205		99.33
KOG1243|consensus	690		99.3
cd05144	198	RIO2_C RIO kinase family; RIO2, C-terminal catalyt	99.27
cd05120	155	APH_ChoK_like Aminoglycoside 3'-phosphotransferase	99.17
KOG0669|consensus	376		99.11
cd05146	197	RIO3_euk RIO kinase family; eukaryotic RIO3, catal	99.11
cd05119	187	RIO RIO kinase family, catalytic domain. The RIO k	99.11
COG3642	204	Mn2+-dependent serine/threonine protein kinase [Si	98.95
KOG3741|consensus	655		98.94
KOG2137|consensus	700		98.93
KOG3087|consensus	229		98.91
KOG0601|consensus	524		98.86
PRK15123	268	lipopolysaccharide core heptose(I) kinase RfaP; Pr	98.85
PF06293	206	Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family;	98.85
cd05151	170	ChoK Choline Kinase (ChoK). The ChoK subfamily is	98.82
PF01163	188	RIO1: RIO1 family; InterPro: IPR018934 Protein pho	98.76
TIGR01982	437	UbiB 2-polyprenylphenol 6-hydroxylase. This model	98.73
KOG0660|consensus	359		98.59
COG4248	637	Uncharacterized protein with protein kinase and he	98.57
PRK04750	537	ubiB putative ubiquinone biosynthesis protein UbiB	98.53
PRK09902	216	hypothetical protein; Provisional	98.5
KOG0033|consensus	355		98.47
KOG0659|consensus	318		98.44
KOG0663|consensus	419		98.38
cd05154	223	ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 an	98.3
PF06176	229	WaaY: Lipopolysaccharide core biosynthesis protein	98.23
KOG0666|consensus	438		98.18
COG0478	304	RIO-like serine/threonine protein kinase fused to	98.14
KOG0576|consensus	829		98.13
KOG1035|consensus	1351		98.04
KOG0615|consensus	475		97.94
KOG0661|consensus	538		97.89
PF12260	188	PIP49_C: Protein-kinase domain of FAM69; InterPro:	97.82
cd07868	317	STKc_CDK8 Catalytic domain of the Serine/Threonine	97.64
COG1718	268	RIO1 Serine/threonine protein kinase involved in c	97.62
cd07871	288	STKc_PCTAIRE3 Catalytic domain of the Serine/Threo	97.6
KOG0671|consensus	415		97.57
KOG1167|consensus	418		97.53
cd07845	309	STKc_CDK10 Catalytic domain of the Serine/Threonin	97.53
KOG0668|consensus	338		97.52
KOG0662|consensus	292		97.47
cd07869	303	STKc_PFTAIRE1 Catalytic domain of the Serine/Threo	97.46
KOG0599|consensus	411		97.46
KOG1093|consensus	725		97.45
cd05150	244	APH Aminoglycoside 3'-phosphotransferase (APH). Th	97.44
TIGR02172	226	Fb_sc_TIGR02172 Fibrobacter succinogenes paralogou	97.38
PTZ00284	467	protein kinase; Provisional	97.36
PF10707	199	YrbL-PhoP_reg: PhoP regulatory network protein Yrb	97.35
cd07848	287	STKc_CDKL5 Catalytic domain of the Serine/Threonin	97.35
PHA03209	357	serine/threonine kinase US3; Provisional	97.34
KOG0594|consensus	323		97.31
cd07867	317	STKc_CDC2L6 Catalytic domain of Serine/Threonine K	97.3
KOG0593|consensus	396		97.27
PHA03212	391	serine/threonine kinase US3; Provisional	97.26
cd07863	288	STKc_CDK4 Catalytic domain of the Serine/Threonine	97.25
KOG0032|consensus	382		97.23
cd07862	290	STKc_CDK6 Catalytic domain of the Serine/Threonine	97.2
cd07872	309	STKc_PCTAIRE2 Catalytic domain of the Serine/Threo	97.14
KOG0665|consensus	369		97.11
PTZ00036	440	glycogen synthase kinase; Provisional	97.11
KOG1826|consensus	2724		97.09
PLN03225	566	Serine/threonine-protein kinase SNT7; Provisional	97.09
cd07878	343	STKc_p38beta_MAPK11 Catalytic domain of the Serine	97.08
cd07875	364	STKc_JNK1 Catalytic domain of the Serine/Threonine	97.05
PHA03211	461	serine/threonine kinase US3; Provisional	97.04
cd07841	298	STKc_CDK7 Catalytic domain of the Serine/Threonine	97.01
cd07873	301	STKc_PCTAIRE1 Catalytic domain of the Serine/Threo	97.0

>KOG0663|consensus

Probab=100.00  E-value=1.2e-56  Score=403.95  Aligned_cols=259  Identities=41%  Similarity=0.760  Sum_probs=240.0

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      ++|++.+.+|||++|.+++|||||.+.++.....-      +.+|||||||+.||.+++.+...+|...+++.++.|++.
T Consensus       115 k~GFPItsLREIniLl~~~H~NIV~vkEVVvG~~~------d~iy~VMe~~EhDLksl~d~m~q~F~~~evK~L~~QlL~  188 (419)
T KOG0663|consen  115 KEGFPITSLREINILLKARHPNIVEVKEVVVGSNM------DKIYIVMEYVEHDLKSLMETMKQPFLPGEVKTLMLQLLR  188 (419)
T ss_pred             cCCCcchhHHHHHHHHhcCCCCeeeeEEEEecccc------ceeeeeHHHHHhhHHHHHHhccCCCchHHHHHHHHHHHH
Confidence            58999999999999999999999999999987644      779999999999999999998888999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||+|||.++|+||||||+|+|+++.|.+||+|||+|+.++.+    ...++..+.|+||+|||++.|.+.|++++||||+
T Consensus       189 glk~lH~~wilHRDLK~SNLLm~~~G~lKiaDFGLAR~ygsp----~k~~T~lVVTLWYRaPELLLG~~tyst~iDMWSv  264 (419)
T KOG0663|consen  189 GLKHLHDNWILHRDLKTSNLLLSHKGILKIADFGLAREYGSP----LKPYTPLVVTLWYRAPELLLGAKTYSTAVDMWSV  264 (419)
T ss_pred             HHHHHhhceeEecccchhheeeccCCcEEecccchhhhhcCC----cccCcceEEEeeecCHHHhcCCcccCcchhhhhH
Confidence            999999999999999999999999999999999999998754    3567888999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |||++||+.++|.|+|.++.+++.+|.+.+|.+....|+++...+...++.++......+...+.....+..+.+|+.++
T Consensus       265 GCI~aE~l~~kPlf~G~sE~dQl~~If~llGtPte~iwpg~~~lp~~k~~~f~~~pyn~lr~kF~~~~lse~g~~Lln~l  344 (419)
T KOG0663|consen  265 GCIFAELLTQKPLFPGKSEIDQLDKIFKLLGTPSEAIWPGYSELPAVKKMTFSEHPYNNLRKKFGALSLSEQGFDLLNKL  344 (419)
T ss_pred             HHHHHHHHhcCCCCCCCchHHHHHHHHHHhCCCccccCCCccccchhhccccCCCCchhhhhhccccccchhHHHHHHHH
Confidence            99999999999999999999999999999999999999999998887777777766666666666656789999999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCCCchh
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPMPSDL  271 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~~~~~  271 (433)
                      |.+||.+|.||+|+|+|.||.+.|.+..+
T Consensus       345 lt~dP~kR~tA~~~L~h~~F~e~P~p~~P  373 (419)
T KOG0663|consen  345 LTYDPGKRITAEDGLKHEYFRETPLPIDP  373 (419)
T ss_pred             hccCccccccHHHhhcccccccCCCCCCh
Confidence            99999999999999999999998877653

>KOG0600|consensus

Probab=100.00  E-value=1.6e-56  Score=423.07  Aligned_cols=279  Identities=47%  Similarity=0.795  Sum_probs=241.9

Q ss_pred             CCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      .++|.+.+..|||.||++|+|||||+|.+.......      +.+|+|+|||+.||..++.....+|++.+|+.+++||+
T Consensus       155 ~~~~~~~t~~REI~ILr~l~HpNIikL~eivt~~~~------~siYlVFeYMdhDL~GLl~~p~vkft~~qIKc~mkQLl  228 (560)
T KOG0600|consen  155 EKEGFPITAIREIKILRRLDHPNIIKLEEIVTSKLS------GSIYLVFEYMDHDLSGLLSSPGVKFTEPQIKCYMKQLL  228 (560)
T ss_pred             CCCcchHHHHHHHHHHHhcCCCcccceeeEEEecCC------ceEEEEEecccchhhhhhcCCCcccChHHHHHHHHHHH
Confidence            367899999999999999999999999999988633      67999999999999999999888899999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||+|||++||+|||||.+|||||++|.+||+|||+|+++.....   ..++..+.|+||+|||+++|...|+.++|+||
T Consensus       229 ~Gl~~cH~~gvlHRDIK~SNiLidn~G~LKiaDFGLAr~y~~~~~---~~~T~rVvTLWYRpPELLLG~t~Yg~aVDlWS  305 (560)
T KOG0600|consen  229 EGLEYCHSRGVLHRDIKGSNILIDNNGVLKIADFGLARFYTPSGS---APYTSRVVTLWYRPPELLLGATSYGTAVDLWS  305 (560)
T ss_pred             HHHHHHhhcCeeeccccccceEEcCCCCEEeccccceeeccCCCC---cccccceEEeeccChHHhcCCcccccceeehh
Confidence            999999999999999999999999999999999999998864432   34788899999999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +|||+.||+.|+|.|+|.++.+++..|.+++|.+..+.|+ ....                                   
T Consensus       306 ~GCIl~El~~gkPI~~G~tEveQl~kIfklcGSP~e~~W~-~~kL-----------------------------------  349 (560)
T KOG0600|consen  306 VGCILAELFLGKPILQGRTEVEQLHKIFKLCGSPTEDYWP-VSKL-----------------------------------  349 (560)
T ss_pred             hhHHHHHHHcCCCCcCCccHHHHHHHHHHHhCCCChhccc-cccC-----------------------------------
Confidence            9999999999999999999999999999999999988886 2211                                   


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCCCchhHHHHhhhccccccccCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCccc
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTET  321 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  321 (433)
                                        ||+..                                                    ..+..
T Consensus       350 ------------------P~~~~----------------------------------------------------~kp~~  359 (560)
T KOG0600|consen  350 ------------------PHATI----------------------------------------------------FKPQQ  359 (560)
T ss_pred             ------------------Ccccc----------------------------------------------------cCCCC
Confidence                              11100                                                    00122


Q ss_pred             CcccccccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhhhhhhhhhhcCCCCCCCc
Q psy7889         322 GYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGH  399 (433)
Q Consensus       322 ~~~~~l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (433)
                      .+.+.+.+.|..+  ++.|++|++.||.+||.+|+||++||+|+||+..|.++++..  .+.+...+++.++.++...
T Consensus       360 ~y~r~l~E~~~~~--~~~~l~Ll~~lL~ldP~kR~tA~~aL~seyF~t~p~~~~p~~--Lp~y~~s~E~~~K~r~e~~  433 (560)
T KOG0600|consen  360 PYKRRLRETFKDF--PASALDLLEKLLSLDPDKRGTASSALQSEYFTTEPLPCDPSS--LPKYPPSHELDAKRRREQK  433 (560)
T ss_pred             cccchHHHHhccC--CHHHHHHHHHHhccCccccccHHHHhcCcccccCCCCCCccc--CCCCCcchhHHHHHHHHHh
Confidence            3445566677777  999999999999999999999999999999999999999887  4457788888765554433

>KOG0669|consensus

Probab=100.00  E-value=4.1e-56  Score=386.36  Aligned_cols=293  Identities=78%  Similarity=1.252  Sum_probs=278.5

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      ++|++.+.++||.+|+.|+|+|++.++++|......+.+.+..+|+||++|+.||..++.+...+|+..+++.++.+++.
T Consensus        56 KeGfpitalreikiL~~lkHenv~nliEic~tk~Tp~~r~r~t~ylVf~~cehDLaGlLsn~~vr~sls~Ikk~Mk~Lm~  135 (376)
T KOG0669|consen   56 KEGFPITALREIKILQLLKHENVVNLIEICRTKATPTNRDRATFYLVFDFCEHDLAGLLSNRKVRFSLSEIKKVMKGLMN  135 (376)
T ss_pred             ccCCcHHHHHHHHHHHHhcchhHHHHHHHHhhccCCcccccceeeeeHHHhhhhHHHHhcCccccccHHHHHHHHHHHHH
Confidence            78999999999999999999999999999999887777788999999999999999999998889999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|+|+..|+|||+|+.|+||+.+|.+||+|||+++.++..++.....++.++.|+||++||.+.|.+.|+++.|||..
T Consensus       136 GL~~iHr~kilHRDmKaaNvLIt~dgilklADFGlar~fs~~~n~~kprytnrvvTLwYrppEllLG~r~yg~~iDiWgA  215 (376)
T KOG0669|consen  136 GLYYIHRNKILHRDMKAANVLITKDGILKLADFGLARAFSTSKNVVKPRYTNRVVTLWYRPPELLLGDREYGPPIDIWGA  215 (376)
T ss_pred             HHHHHHHhhHHhhcccHhhEEEcCCceEEeeccccccceecccccCCCCcccceeeeecCCHHHhhcccccCCcchhHhH
Confidence            99999999999999999999999999999999999999988887777788889999999999999999999999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc---cchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME---LPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||+.||++|.|.|.+.++..++..|..++|...++-|++....+++..++   .++...+.++..++++..++++.||+
T Consensus       216 gCimaeMwtrspimqgnteqqql~~Is~LcGs~tkevWP~~d~lpL~~sie~ePl~~~~~rkv~n~~kp~~kd~~a~dLl  295 (376)
T KOG0669|consen  216 GCIMAEMWTRSPIMQGNTEQQQLHLISQLCGSITKEVWPNVDNLPLYQSIELEPLPKGQKRKVKNRLKPYVKDDEALDLL  295 (376)
T ss_pred             HHHHHHHHccCccccCChHHHHHHHHHHHhccCCcccCCCcccchHHHhccCCCCCcchhhhhhhhcccccCChhHHHHH
Confidence            999999999999999999999999999999999999999999999998883   66778888999999999999999999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCCCCC-chhHHHHhhhccccccccCCCCCCCCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTDPMP-SDLSKMLAQHTQSMFEYLAPPRRPGHM  295 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (433)
                      .+||..||.+|++++++|+|.||+.++.+ +..+.+++++.+++|+|.++++.....
T Consensus       296 e~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml~t~~~s~fey~~~~~~~~~~  352 (376)
T KOG0669|consen  296 EKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDMLSTHLQSMFEYLAQPRRSNQM  352 (376)
T ss_pred             HHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHHHHhHHHHHHHhcCcchhhhh
Confidence            99999999999999999999999999999 777889999999999999999876543

>KOG0659|consensus

Probab=100.00  E-value=2e-54  Score=378.79  Aligned_cols=255  Identities=42%  Similarity=0.706  Sum_probs=227.0

Q ss_pred             CCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      .++|+.-+++|||++|+.++|+|||.|+|+|-+.        +.+.||+||++.||...++.....++...++.|+.+++
T Consensus        40 ~kdGi~~talREIK~Lqel~h~nIi~LiD~F~~~--------~~l~lVfEfm~tdLe~vIkd~~i~l~pa~iK~y~~m~L  111 (318)
T KOG0659|consen   40 AKDGINRTALREIKLLQELKHPNIIELIDVFPHK--------SNLSLVFEFMPTDLEVVIKDKNIILSPADIKSYMLMTL  111 (318)
T ss_pred             cccCccHHHHHHHHHHHHccCcchhhhhhhccCC--------CceEEEEEeccccHHHHhcccccccCHHHHHHHHHHHH
Confidence            4789999999999999999999999999999887        45899999999999999999888899999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      +||+|||++.|+||||||.|+||+.+|.+||+|||+++.+.....    .....+.|+||+|||.+.|.+.|+..+||||
T Consensus       112 kGl~y~H~~~IlHRDlKPnNLLis~~g~lKiADFGLAr~f~~p~~----~~~~~V~TRWYRAPELLfGsr~Yg~~VDmWa  187 (318)
T KOG0659|consen  112 KGLAYCHSKWILHRDLKPNNLLISSDGQLKIADFGLARFFGSPNR----IQTHQVVTRWYRAPELLFGSRQYGTGVDMWA  187 (318)
T ss_pred             HHHHHHHhhhhhcccCCccceEEcCCCcEEeecccchhccCCCCc----ccccceeeeeccChHHhccchhcCCcchhhh
Confidence            999999999999999999999999999999999999999875432    2333478999999999999999999999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      +|||++||+.|.|.|+|.++.+++..|.+.+|.+.++.|++......|.++. +|......   .+.  ..+.++.||+.
T Consensus       188 vGCI~AELllr~P~fpG~sDidQL~~If~~LGTP~~~~WP~~~~lpdY~~~~~~P~~~~~~---lf~--aas~d~ldLl~  262 (318)
T KOG0659|consen  188 VGCIFAELLLRVPFFPGDSDIDQLSKIFRALGTPTPDQWPEMTSLPDYVKIQQFPKPPLNN---LFP--AASSDALDLLS  262 (318)
T ss_pred             HHHHHHHHHccCCCCCCCchHHHHHHHHHHcCCCCcccCccccccccHHHHhcCCCCcccc---ccc--cccHHHHHHHH
Confidence            9999999999999999999999999999999999999999999998888776 22221111   111  24677899999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCCCCchhHH
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSK  273 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~  273 (433)
                      +||.+||.+|+|+.|+|.|+||.+.|.+....+
T Consensus       263 ~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~  295 (318)
T KOG0659|consen  263 KMLTYNPKKRITASQALKHPYFKSLPLPTPPSK  295 (318)
T ss_pred             hhhccCchhcccHHHHhcchhhhcCCCCCChhh
Confidence            999999999999999999999998887765443

>KOG0661|consensus

Probab=100.00  E-value=2.9e-53  Score=398.29  Aligned_cols=244  Identities=36%  Similarity=0.674  Sum_probs=222.3

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..-+|||.-|++|+ |||||+|++++.+.       ...+|+|||||+++|+++++.++..|+++.++.|+.||++||+|
T Consensus        53 ~~nLREvksL~kln~hpniikL~Evi~d~-------~~~L~fVfE~Md~NLYqLmK~R~r~fse~~irnim~QilqGL~h  125 (538)
T KOG0661|consen   53 CMNLREVKSLRKLNPHPNIIKLKEVIRDN-------DRILYFVFEFMDCNLYQLMKDRNRLFSESDIRNIMYQILQGLAH  125 (538)
T ss_pred             HHHHHHHHHHHhcCCCCcchhhHHHhhcc-------CceEeeeHHhhhhhHHHHHhhcCCcCCHHHHHHHHHHHHHHHHH
Confidence            35689999999998 99999999999986       23799999999999999999988789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      +|++|+.|||+||+|||++....|||+|||+|+.....     .+++.++.|+||+|||+++....|+.++||||+|||+
T Consensus       126 iHk~GfFHRDlKPENiLi~~~~~iKiaDFGLARev~Sk-----pPYTeYVSTRWYRAPEvLLrs~~Ys~pvD~wA~GcI~  200 (538)
T KOG0661|consen  126 IHKHGFFHRDLKPENILISGNDVIKIADFGLAREVRSK-----PPYTEYVSTRWYRAPEVLLRSGYYSSPVDMWAVGCIM  200 (538)
T ss_pred             HHhcCcccccCChhheEecccceeEecccccccccccC-----CCcchhhhcccccchHHhhhccccCCchHHHHHHHHH
Confidence            99999999999999999999899999999999987533     4678889999999999999888899999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|+.+-+|+|+|.++.+++.+|+.++|.+....|+........-++.++......+...+..  .+.++.++|.+||.+|
T Consensus       201 aEl~sLrPLFPG~sE~Dqi~KIc~VLGtP~~~~~~eg~~La~~mnf~~P~~~~~~l~~L~p~--~s~~~~~li~~ll~WD  278 (538)
T KOG0661|consen  201 AELYSLRPLFPGASEIDQIYKICEVLGTPDKDSWPEGYNLASAMNFRFPQVKPSPLKDLLPN--ASSEAASLIERLLAWD  278 (538)
T ss_pred             HHHHHhcccCCCCcHHHHHHHHHHHhCCCccccchhHHHHHHHhccCCCcCCCCChHHhCcc--cCHHHHHHHHHHhcCC
Confidence            99999999999999999999999999999999998865555555667777777777766665  7899999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+||||+|+|+||||+..
T Consensus       279 P~kRpTA~~al~~pffq~~  297 (538)
T KOG0661|consen  279 PDKRPTASQALQHPFFQVG  297 (538)
T ss_pred             CccCccHHHHhcCcccccc
Confidence            9999999999999999754

>KOG0593|consensus

Probab=100.00  E-value=6.7e-54  Score=381.62  Aligned_cols=244  Identities=37%  Similarity=0.695  Sum_probs=220.1

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +...++|||.+|++|+|||+|.|+++|...        ..++||+|||+.++++.+......++.+.++.+++|++.|+.
T Consensus        44 VkKIAlREIrmLKqLkH~NLVnLiEVFrrk--------rklhLVFE~~dhTvL~eLe~~p~G~~~~~vk~~l~Q~l~ai~  115 (396)
T KOG0593|consen   44 VKKIALREIRMLKQLKHENLVNLIEVFRRK--------RKLHLVFEYCDHTVLHELERYPNGVPSELVKKYLYQLLKAIH  115 (396)
T ss_pred             HHHHHHHHHHHHHhcccchHHHHHHHHHhc--------ceeEEEeeecchHHHHHHHhccCCCCHHHHHHHHHHHHHHhh
Confidence            457899999999999999999999999886        679999999999999999988888999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++++|||||||+||||+.+|.+||||||+|+.+..+.    ..|+.++.|+||+|||.+.|...|+.++||||+||+
T Consensus       116 ~cHk~n~IHRDIKPENILit~~gvvKLCDFGFAR~L~~pg----d~YTDYVATRWYRaPELLvGDtqYG~pVDiWAiGCv  191 (396)
T KOG0593|consen  116 FCHKNNCIHRDIKPENILITQNGVVKLCDFGFARTLSAPG----DNYTDYVATRWYRAPELLVGDTQYGKPVDIWAIGCV  191 (396)
T ss_pred             hhhhcCeecccCChhheEEecCCcEEeccchhhHhhcCCc----chhhhhhhhhhccChhhhcccCcCCCcccchhhhHH
Confidence            9999999999999999999999999999999999887432    457788999999999999999999999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhh-HHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK-VKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +.||++|.|.|+|.++.+++..|...+|...+....-+.....|..+.+|...... ++..+.  ..+.-..||+.+||.
T Consensus       192 ~aEl~~G~pL~PG~SDiDQLy~I~ktLG~L~prhq~iF~~N~~F~Gv~lP~~~~~epLe~k~p--~~s~~~ld~~k~cL~  269 (396)
T KOG0593|consen  192 FAELLTGEPLWPGRSDIDQLYLIRKTLGNLIPRHQSIFSSNPFFHGVRLPEPEHPEPLERKYP--KISNVLLDLLKKCLK  269 (396)
T ss_pred             HHHHhcCCcCCCCcchHHHHHHHHHHHcccCHHHHHHhccCCceeeeecCCCCCccchhhhcc--cchHHHHHHHHHHhc
Confidence            99999999999999999999999999999999888777788888877777654433 333332  245678899999999


Q ss_pred             cCCCCCCCHHHhhcCCCcc
Q psy7889         245 LDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~  263 (433)
                      .||.+|++.+|+|.|+||.
T Consensus       270 ~dP~~R~sc~qll~H~yFd  288 (396)
T KOG0593|consen  270 MDPDDRLSCEQLLHHPYFD  288 (396)
T ss_pred             CCccccccHHHHhcChHHH
Confidence            9999999999999999993

>KOG0660|consensus

Probab=100.00  E-value=3.4e-51  Score=374.01  Aligned_cols=255  Identities=34%  Similarity=0.600  Sum_probs=216.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      -...+||+.+|+.++|+|||.+++++..+..   .....+|+|+|+|+.||.+.++..+ .++++.+..+++||+.||+|
T Consensus        65 akRtlRElklLr~~~HeNIi~l~di~~p~~~---~~f~DvYiV~elMetDL~~iik~~~-~L~d~H~q~f~YQiLrgLKy  140 (359)
T KOG0660|consen   65 AKRTLRELKLLRHLRHENIIGLLDIFRPPSR---DKFNDVYLVFELMETDLHQIIKSQQ-DLTDDHAQYFLYQILRGLKY  140 (359)
T ss_pred             HHHHHHHHHHHHHhcCCCcceEEeecccccc---cccceeEEehhHHhhHHHHHHHcCc-cccHHHHHHHHHHHHHhcch
Confidence            4578999999999999999999999987311   1247799999999999999988743 59999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      +|+.||+|||+||+|+|++.++.+||||||+|+.....  .....++..+.|+||+|||++.....|+.++||||+|||+
T Consensus       141 iHSAnViHRDLKPsNll~n~~c~lKI~DFGLAR~~~~~--~~~~~mTeYVaTRWYRAPElll~~~~Yt~aiDiWSvGCI~  218 (359)
T KOG0660|consen  141 IHSANVIHRDLKPSNLLLNADCDLKICDFGLARYLDKF--FEDGFMTEYVATRWYRAPELLLNSSEYTKAIDIWSVGCIL  218 (359)
T ss_pred             hhcccccccccchhheeeccCCCEEeccccceeecccc--CcccchhcceeeeeecCHHHHhccccccchhhhhhhhHHH
Confidence            99999999999999999999999999999999988654  3334567889999999999998888899999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +||++|++.|+|.+..+++..|..++|.++++.+..+.+......+. .+...+......+.  ..++.++||+.+||.+
T Consensus       219 AEmL~gkplFpG~d~v~Ql~lI~~~lGtP~~e~l~~i~s~~ar~yi~slp~~p~~~f~~~fp--~a~p~AidLlekmL~f  296 (359)
T KOG0660|consen  219 AEMLTGKPLFPGKDYVHQLQLILELLGTPSEEDLQKIRSEKARPYIKSLPQIPKQPFSSIFP--NANPLAIDLLEKMLVF  296 (359)
T ss_pred             HHHHcCCCCCCCCchHHHHHHHHHhcCCCCHHHHHHhccHHHHHHHHhCCCCCCCCHHHHcC--CCCHHHHHHHHHHhcc
Confidence            99999999999999999999999999999887766665443333332 33333333444444  4789999999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      ||.+|+|++|+|+|||+..-.++.
T Consensus       297 dP~kRita~eAL~hPYl~~~hdp~  320 (359)
T KOG0660|consen  297 DPKKRITAEEALAHPYLAPYHDPE  320 (359)
T ss_pred             CccccCCHHHHhcChhhhhhcCCc
Confidence            999999999999999997655544

>KOG0615|consensus

Probab=100.00  E-value=1.3e-51  Score=380.97  Aligned_cols=220  Identities=28%  Similarity=0.466  Sum_probs=185.8

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|++||++|+|||||+++++|+..        +..|+||||++ |+|.+.+.. ++.+.+...+.+++||+.||.||
T Consensus       222 ~v~~EieILkkL~HP~IV~~~d~f~~~--------ds~YmVlE~v~GGeLfd~vv~-nk~l~ed~~K~~f~Qll~avkYL  292 (475)
T KOG0615|consen  222 DVQNEIEILKKLSHPNIVRIKDFFEVP--------DSSYMVLEYVEGGELFDKVVA-NKYLREDLGKLLFKQLLTAVKYL  292 (475)
T ss_pred             hhHHHHHHHHhcCCCCEEEEeeeeecC--------CceEEEEEEecCccHHHHHHh-ccccccchhHHHHHHHHHHHHHH
Confidence            367999999999999999999999987        55899999997 478888876 44689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecC---CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC--CCCCcchhhhH
Q psy7889          88 HSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR--NYGPPVDLWGA  162 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~---~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSl  162 (433)
                      |++||+||||||+|||++.+   ..+||+|||+|++....     ..+.+.|||+.|.|||++.+..  .+..++||||+
T Consensus       293 H~~GI~HRDiKPeNILl~~~~e~~llKItDFGlAK~~g~~-----sfm~TlCGTpsYvAPEVl~~kg~~~~~~kVDiWSl  367 (475)
T KOG0615|consen  293 HSQGIIHRDIKPENILLSNDAEDCLLKITDFGLAKVSGEG-----SFMKTLCGTPSYVAPEVLASKGVEYYPSKVDIWSL  367 (475)
T ss_pred             HHcCcccccCCcceEEeccCCcceEEEecccchhhccccc-----eehhhhcCCccccChhheecCCeecccchheeeec
Confidence            99999999999999999876   68999999999987532     4678899999999999997542  35568999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++|.+++|.+||.+..... ...+|.+......+..|.                            ..|.++++||.+
T Consensus       368 GcvLfvcLsG~pPFS~~~~~~sl~eQI~~G~y~f~p~~w~----------------------------~Iseea~dlI~~  419 (475)
T KOG0615|consen  368 GCVLFVCLSGYPPFSEEYTDPSLKEQILKGRYAFGPLQWD----------------------------RISEEALDLINW  419 (475)
T ss_pred             cceEEEEeccCCCcccccCCccHHHHHhcCcccccChhhh----------------------------hhhHHHHHHHHH
Confidence            999999999999999876554 555555433333333332                            257788899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      ||..||++|||++|+|+||||+..+..+.
T Consensus       420 mL~VdP~~R~s~~eaL~hpW~~~~~~~s~  448 (475)
T KOG0615|consen  420 MLVVDPENRPSADEALNHPWFKDAPCLSK  448 (475)
T ss_pred             hhEeCcccCcCHHHHhcChhhhcccccch
Confidence            99999999999999999999988776653

>KOG0594|consensus

Probab=100.00  E-value=4e-49  Score=361.59  Aligned_cols=257  Identities=43%  Similarity=0.724  Sum_probs=221.3

Q ss_pred             CCCchhHHHHHHHHHhCCCCC-ccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC---CCCCHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHEN-VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH---VKFSLGEIKKVIQQ   79 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~---~~l~~~~~~~i~~q   79 (433)
                      +|.+.++.|||.+|+.|+|+| ||.|++++.+..+  ......+++||||+..||..++....   ..++...++.+++|
T Consensus        51 EG~P~taiREisllk~L~~~~~iv~L~dv~~~~~~--~~~~~~l~lvfe~~d~DL~~ymd~~~~~~~g~~~~~ik~~m~Q  128 (323)
T KOG0594|consen   51 EGVPSTAIREISLLKRLSHANHIVRLHDVIHTSNN--HRGIGKLYLVFEFLDRDLKKYMDSLPKKPQGLPPRLIKSFMRQ  128 (323)
T ss_pred             cCCCchhhHHHHHHHHhCCCcceEEEEeeeeeccc--ccccceEEEEEEeecccHHHHHHhccccccCCCHHHHHHHHHH
Confidence            689999999999999999999 9999999998742  11235799999999999999998876   35788899999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |+.||+|||++||+||||||.||||+.+|.+||+|||+|+...-+    ...++..++|.||+|||++.+...|++.+||
T Consensus       129 ll~gl~~~H~~~IlHRDLKPQNlLi~~~G~lKlaDFGlAra~~ip----~~~yt~evvTlWYRaPEvLlGs~~Ys~~vDi  204 (323)
T KOG0594|consen  129 LLRGLAFLHSHGILHRDLKPQNLLISSSGVLKLADFGLARAFSIP----MRTYTPEVVTLWYRAPEVLLGSTSYSTSVDI  204 (323)
T ss_pred             HHHHHHHHHhCCeecccCCcceEEECCCCcEeeeccchHHHhcCC----cccccccEEEeeccCHHHhcCCCcCCCCcch
Confidence            999999999999999999999999999999999999999865532    2347778999999999999999889999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||+|||++||+++++.|+|.++.+++..|.+++|.+....|++......+............+....+.  .++++.+++
T Consensus       205 Ws~GcIfaEm~~~~~LFpG~se~~ql~~If~~lGtP~e~~Wp~v~~~~~~k~~f~~~~~~~~l~~~~~~--~~~~~~dll  282 (323)
T KOG0594|consen  205 WSLGCIFAEMFTRRPLFPGDSEIDQLFRIFRLLGTPNEKDWPGVSSLPDYKAPFPKWPGPKDLSSILPK--LDPDGIELL  282 (323)
T ss_pred             HhHHHHHHHHHhCCCCCCCCcHHHHHHHHHHHcCCCCccCCCCccccccccccCcCCCCccchHHhccc--cCccHHHHH
Confidence            999999999999999999999999999999999999999999999877665422211113333322222  347899999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      .+||+.+|.+|+|++.+|+||||...+..
T Consensus       283 ~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  283 SKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             HHHhccCcccCcCHHHHhcChhhcccccc
Confidence            99999999999999999999999876544

>KOG0575|consensus

Probab=100.00  E-value=4.5e-48  Score=374.37  Aligned_cols=218  Identities=29%  Similarity=0.444  Sum_probs=191.7

Q ss_pred             CCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQL   80 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~ql   80 (433)
                      ++.+--+.+.+||+|.+.|+|||||+++++|+++        ..+|||+|+|.. +|..+++ .+..++|.+++.+++||
T Consensus        57 ~k~~~reKv~~EIeIHr~L~HpnIV~f~~~FEDs--------~nVYivLELC~~~sL~el~K-rrk~ltEpEary~l~QI  127 (592)
T KOG0575|consen   57 KKPKQREKVLNEIEIHRSLKHPNIVQFYHFFEDS--------NNVYIVLELCHRGSLMELLK-RRKPLTEPEARYFLRQI  127 (592)
T ss_pred             cCcchHHHHHHHHHHHHhcCCCcEEeeeeEeecC--------CceEEEEEecCCccHHHHHH-hcCCCCcHHHHHHHHHH
Confidence            4556678899999999999999999999999998        459999999985 5555555 67789999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.||.|||+++|+|||||..|++++.+-+|||+|||+|..+....    .+-.+.|||+.|+||||+.... .+..+|||
T Consensus       128 v~GlkYLH~~~IiHRDLKLGNlfL~~~~~VKIgDFGLAt~le~~~----Erk~TlCGTPNYIAPEVl~k~g-HsfEvDiW  202 (592)
T KOG0575|consen  128 VEGLKYLHSLGIIHRDLKLGNLFLNENMNVKIGDFGLATQLEYDG----ERKKTLCGTPNYIAPEVLNKSG-HSFEVDIW  202 (592)
T ss_pred             HHHHHHHHhcCceecccchhheeecCcCcEEecccceeeeecCcc----cccceecCCCcccChhHhccCC-CCCchhhh
Confidence            999999999999999999999999999999999999999887432    3456789999999999998655 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+|||+|.||.|+|||...+-.++...|...-...                                |...|.++++||.
T Consensus       203 SlGcvmYtLL~G~PPFetk~vkety~~Ik~~~Y~~--------------------------------P~~ls~~A~dLI~  250 (592)
T KOG0575|consen  203 SLGCVMYTLLVGRPPFETKTVKETYNKIKLNEYSM--------------------------------PSHLSAEAKDLIR  250 (592)
T ss_pred             hhhhHHHhhhhCCCCcccchHHHHHHHHHhcCccc--------------------------------ccccCHHHHHHHH
Confidence            99999999999999999999888888886533322                                2246889999999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||+.||.+|||++++|.|+||...
T Consensus       251 ~lL~~~P~~Rpsl~~vL~h~Ff~~g  275 (592)
T KOG0575|consen  251 KLLRPNPSERPSLDEVLDHPFFKSG  275 (592)
T ss_pred             HHhcCCcccCCCHHHHhcCHhhhCC
Confidence            9999999999999999999999544

>KOG0581|consensus

Probab=100.00  E-value=1.8e-47  Score=351.05  Aligned_cols=221  Identities=23%  Similarity=0.343  Sum_probs=183.7

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...++++|+++++.++|||||++|+.|....       ..++|+||||++ +|-.++.. -++++|..+..++.++++||
T Consensus       120 ~~~Qi~rEl~il~~~~spyIV~~ygaF~~~~-------~~isI~mEYMDgGSLd~~~k~-~g~i~E~~L~~ia~~VL~GL  191 (364)
T KOG0581|consen  120 LQKQILRELEILRSCQSPYIVGFYGAFYSNG-------EEISICMEYMDGGSLDDILKR-VGRIPEPVLGKIARAVLRGL  191 (364)
T ss_pred             HHHHHHHHHHHHhhCCCCCeeeEeEEEEeCC-------ceEEeehhhcCCCCHHHHHhh-cCCCCHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999999862       259999999986 56655554 46799999999999999999


Q ss_pred             HHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          85 YYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        85 ~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      .|||+ ++||||||||+|||++..|.|||||||.+..+.+.      ...+++||..|||||.+.+.. |+.++||||||
T Consensus       192 ~YLh~~~~IIHRDIKPsNlLvNskGeVKicDFGVS~~lvnS------~a~tfvGT~~YMsPERi~g~~-Ys~~sDIWSLG  264 (364)
T KOG0581|consen  192 SYLHEERKIIHRDIKPSNLLVNSKGEVKICDFGVSGILVNS------IANTFVGTSAYMSPERISGES-YSVKSDIWSLG  264 (364)
T ss_pred             HHHhhccCeeeccCCHHHeeeccCCCEEeccccccHHhhhh------hcccccccccccChhhhcCCc-CCcccceeccc
Confidence            99995 99999999999999999999999999999887643      456789999999999999876 89999999999


Q ss_pred             HHHHHHHhcCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         164 CIMAEMWTRSPIMQGN--TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       164 vil~ell~g~~pf~~~--~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ++++|+++|+.||...  ...+....+..++..+++.                           +..-..|+++++||..
T Consensus       265 LsllE~a~GrfP~~~~~~~~~~~~~Ll~~Iv~~ppP~---------------------------lP~~~fS~ef~~FV~~  317 (364)
T KOG0581|consen  265 LSLLELAIGRFPYPPPNPPYLDIFELLCAIVDEPPPR---------------------------LPEGEFSPEFRSFVSC  317 (364)
T ss_pred             HHHHHHhhCCCCCCCcCCCCCCHHHHHHHHhcCCCCC---------------------------CCcccCCHHHHHHHHH
Confidence            9999999999999874  1222333333333333222                           1111478899999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ||++||.+|+++.|+|+|||+......
T Consensus       318 CL~Kdp~~R~s~~qLl~Hpfi~~~~~~  344 (364)
T KOG0581|consen  318 CLRKDPSERPSAKQLLQHPFIKKFEDP  344 (364)
T ss_pred             HhcCCcccCCCHHHHhcCHHHhhcccc
Confidence            999999999999999999999865543

>KOG0658|consensus

Probab=100.00  E-value=2.3e-48  Score=356.02  Aligned_cols=247  Identities=30%  Similarity=0.528  Sum_probs=204.8

Q ss_pred             HHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHH
Q psy7889          11 LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI---HVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus        11 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      -+|+++|+.++|||||+|..+|......   ..-...+||||++.+|...++..   +.+++.-.++-+..||+.||.||
T Consensus        65 nrEl~im~~l~HpNIV~L~~~f~~~~~~---d~~~lnlVleymP~tL~~~~r~~~~~~~~mp~~~iKLYt~Qlfrgl~yL  141 (364)
T KOG0658|consen   65 NRELQIMRKLDHPNIVRLLYFFSSSTES---DEVYLNLVLEYMPETLYRVIRHYTRANQRMPLLEIKLYTYQLFRGLAYL  141 (364)
T ss_pred             cHHHHHHHhcCCcCeeeEEEEEEecCCC---chhHHHHHHHhchHHHHHHHHHHhhcCCCCceeeeHHHHHHHHHHHHHH
Confidence            4799999999999999999999887442   12356699999999999999852   55688899999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      |+.||+||||||.|+|+|.+ |.+||||||.|+.+..+..     ..+..+|++|+|||.+.|...|+.++||||.|||+
T Consensus       142 h~~~IcHRDIKPqNlLvD~~tg~LKicDFGSAK~L~~~ep-----niSYicSRyYRaPELifga~~Yt~~IDiWSaGCV~  216 (364)
T KOG0658|consen  142 HSHGICHRDIKPQNLLVDPDTGVLKICDFGSAKVLVKGEP-----NISYICSRYYRAPELIFGATEYTTSIDIWSAGCVM  216 (364)
T ss_pred             HhcCcccCCCChheEEEcCCCCeEEeccCCcceeeccCCC-----ceeEEEeccccCHHHHcCccccCceeEEhhhhHHH
Confidence            99999999999999999965 8999999999999875542     24567799999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +||+.|.|.|+|.+..+++..|.+++|.++.+.+......-  ....+++........ +-....++++.+|+.++|.++
T Consensus       217 aELl~g~plFpG~s~~dQL~eIik~lG~Pt~e~I~~mn~~y--~~~~~p~ik~~~~~~-~~~~~~~~d~~dll~~~L~Y~  293 (364)
T KOG0658|consen  217 AELLKGQPLFPGDSSVDQLVEIIKVLGTPTREDIKSMNPNY--TEFKFPQIKAHPWHK-VFFKRLPPDALDLLSKLLQYS  293 (364)
T ss_pred             HHHhcCCcccCCCCHHHHHHHHHHHhCCCCHHHHhhcCccc--ccccCccccccccee-ecccCCCHHHHHHHHHHhccC
Confidence            99999999999999999999999999999887665443321  122223322222211 122346889999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      |.+|.++.|+|.||||.+...+
T Consensus       294 P~~R~~~~~~l~h~fFdelr~~  315 (364)
T KOG0658|consen  294 PSKRLSALEALAHPFFDELRDP  315 (364)
T ss_pred             hhhcCCHHHHhcchhhHHhhCc
Confidence            9999999999999999765544

>KOG0666|consensus

Probab=100.00  E-value=1.1e-46  Score=336.63  Aligned_cols=259  Identities=37%  Similarity=0.696  Sum_probs=214.2

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCC----CCCHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV----KFSLGEIKKVIQ   78 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~----~l~~~~~~~i~~   78 (433)
                      .+|++.++-|||.+++.|+|||||.|..+|...       +..+++++||.+.||+..+.-.+.    .++...++.++.
T Consensus        67 ~tGiS~SAcREiaL~REl~h~nvi~Lv~Vfl~~-------d~~v~l~fdYAEhDL~~II~fHr~~~~~~lp~~mvKsilw  139 (438)
T KOG0666|consen   67 GTGISMSACREIALLRELKHPNVISLVKVFLSH-------DKKVWLLFDYAEHDLWHIIKFHRASKAKQLPRSMVKSILW  139 (438)
T ss_pred             CCCcCHHHHHHHHHHHHhcCCcchhHHHHHhcc-------CceEEEEehhhhhhHHHHHHHhccchhccCCHHHHHHHHH
Confidence            358999999999999999999999999999874       377999999999999999965332    389999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecC----CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCC
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKT----GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG  154 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~----~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (433)
                      ||+.|+.|||++.|+||||||.|||+..+    |.|||+|||+++.+..+-. ........+.|.||+|||.+.|.+.|+
T Consensus       140 Qil~Gv~YLH~NWvlHRDLKPaNIlvmgdgperG~VKIaDlGlaR~~~~plk-pl~s~d~VVVTiWYRAPELLLGa~hYT  218 (438)
T KOG0666|consen  140 QILDGVHYLHSNWVLHRDLKPANILVMGDGPERGRVKIADLGLARLFNNPLK-PLASLDPVVVTIWYRAPELLLGARHYT  218 (438)
T ss_pred             HHHhhhHHHhhhheeeccCCcceEEEeccCCccCeeEeecccHHHHhhcccc-ccccCCceEEEEEecChHHhccccccc
Confidence            99999999999999999999999999988    8999999999998865321 222334567799999999999999999


Q ss_pred             CcchhhhHHHHHHHHHhcCCCCCCCC---------hHHHHHHHHHHhCCCCCCCCCcccchhhhhccc--cchHHHhh--
Q psy7889         155 PPVDLWGAGCIMAEMWTRSPIMQGNT---------EQQQITLISQLCGSITPESWPGVETLDLYNKME--LPKAQKRK--  221 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~g~~pf~~~~---------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--  221 (433)
                      .++||||+|||++||++-.|.|.+.+         ..+++.+|..++|.+....|+.....+.+...-  ++......  
T Consensus       219 ~AiDvWAiGCIfaElLtl~PlF~g~E~k~~~~~Pfq~dQl~rIf~vLG~Pt~~~Wp~lkk~Pe~q~~ls~f~~~~~~n~s  298 (438)
T KOG0666|consen  219 KAIDVWAIGCIFAELLTLEPLFKGREEKIKTKNPFQHDQLDRIFEVLGTPTDKDWPDLKKMPEYQTLLSDFRRHYYDNVS  298 (438)
T ss_pred             chhhhHHHHHHHHHHHccCccccchhhhcccCCCchHHHHHHHHHHcCCCccccchhhhhCcchHHHHHHhHHhhcCcch
Confidence            99999999999999999999998753         347899999999999999999988776652221  11111100  


Q ss_pred             HHhhhCC-ccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         222 VKERLKP-YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       222 ~~~~~~~-~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +...+.. -+.++.+.+|+.+||++||-+|+|++|+|+|+||.+.+.++
T Consensus       299 L~~~~~~~k~k~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lpp  347 (438)
T KOG0666|consen  299 LHKYYHKHKVKDPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLPP  347 (438)
T ss_pred             HHHHHHHhcCCCchHHHHHHHHhccCchhhccHHHHhcccccccCCCCC
Confidence            1112211 12466699999999999999999999999999998887663

>KOG0662|consensus

Probab=100.00  E-value=2.3e-46  Score=310.31  Aligned_cols=246  Identities=39%  Similarity=0.712  Sum_probs=217.6

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      ++|.+..++|||-+|+.|+|.|||+++++...+        ..+.+|+|||..+|..++...++.+..+.++.++.|++.
T Consensus        41 degvpssalreicllkelkhknivrl~dvlhsd--------kkltlvfe~cdqdlkkyfdslng~~d~~~~rsfmlqllr  112 (292)
T KOG0662|consen   41 DEGVPSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSLNGDLDPEIVRSFMLQLLR  112 (292)
T ss_pred             CCCCcHHHHHHHHHHHHhhhcceeehhhhhccC--------ceeEEeHHHhhHHHHHHHHhcCCcCCHHHHHHHHHHHHh
Confidence            478899999999999999999999999999876        669999999999999999999999999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|+|++++.|||+||.|.||+.+|.+||+|||+++.+.-+    ...++..+.|+||++|.++.|.+.|++++|+||.
T Consensus       113 gl~fchshnvlhrdlkpqnllin~ngelkladfglarafgip----vrcysaevvtlwyrppdvlfgakly~tsidmwsa  188 (292)
T KOG0662|consen  113 GLGFCHSHNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP----VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSA  188 (292)
T ss_pred             hhhhhhhhhhhhccCCcceEEeccCCcEEecccchhhhcCCc----eEeeeceeeeeeccCcceeeeeehhccchHhhhc
Confidence            999999999999999999999999999999999999887632    3456677889999999999999999999999999


Q ss_pred             HHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHH--HhhHHhhhCCccCChhHHHHH
Q psy7889         163 GCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ--KRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       163 Gvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||++|+.. |.|.|+|.+-.+++.+|..++|.+..+.|+.+...+.+..+..-...  ......     ..+..++|++
T Consensus       189 gcifaelanagrplfpg~dvddqlkrif~~lg~p~ed~wps~t~lpdyk~yp~ypattswsqivp-----~lns~grdll  263 (292)
T KOG0662|consen  189 GCIFAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEDQWPSMTKLPDYKPYPIYPATTSWSQIVP-----KLNSTGRDLL  263 (292)
T ss_pred             chHHHHHhhcCCCCCCCCcHHHHHHHHHHHhCCCccccCCccccCCCCcccCCccccchHHHHhh-----hhcchhHHHH
Confidence            999999985 89999999999999999999999999999998877666544322111  111111     2456789999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +++|..+|..|++++++|+||||...
T Consensus       264 qkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  264 QKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             HHHhccCcccccCHHHHhcCcccccc
Confidence            99999999999999999999999653

>KOG0598|consensus

Probab=100.00  E-value=1e-44  Score=332.72  Aligned_cols=216  Identities=31%  Similarity=0.422  Sum_probs=187.5

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      .+.-..+..|.+||.+++||+||+++..|++.        +.+|+|+||+.| .|...+.+ .+.|++..++.|+.+|+.
T Consensus        66 ~~e~~~~~~Er~IL~~v~hPFiv~l~ysFQt~--------~kLylVld~~~GGeLf~hL~~-eg~F~E~~arfYlaEi~l  136 (357)
T KOG0598|consen   66 KKEVRHTKAERNILSKIKHPFIVKLIYSFQTE--------EKLYLVLDYLNGGELFYHLQR-EGRFSEDRARFYLAEIVL  136 (357)
T ss_pred             hhhHHHHHHHHHHHHhCCCCcEeeeEEecccC--------CeEEEEEeccCCccHHHHHHh-cCCcchhHHHHHHHHHHH
Confidence            34456788999999999999999999999997        669999999986 77777765 457999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|||+.|||||||||+|||++.+|+++|+|||+|+......    ....+.|||+.|+|||++.+.. |+.++|+|||
T Consensus       137 AL~~LH~~gIiyRDlKPENILLd~~GHi~LtDFgL~k~~~~~~----~~t~tfcGT~eYmAPEil~~~g-y~~~vDWWsL  211 (357)
T KOG0598|consen  137 ALGYLHSKGIIYRDLKPENILLDEQGHIKLTDFGLCKEDLKDG----DATRTFCGTPEYMAPEILLGKG-YDKAVDWWSL  211 (357)
T ss_pred             HHHHHHhCCeeeccCCHHHeeecCCCcEEEeccccchhcccCC----CccccccCCccccChHHHhcCC-CCcccchHhH
Confidence            9999999999999999999999999999999999998654322    2345689999999999998875 8999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+.......|.+....                               ..+...+.++++||.++
T Consensus       212 GillYeML~G~pPF~~~~~~~~~~~I~~~k~~-------------------------------~~p~~ls~~ardll~~L  260 (357)
T KOG0598|consen  212 GILLYEMLTGKPPFYAEDVKKMYDKILKGKLP-------------------------------LPPGYLSEEARDLLKKL  260 (357)
T ss_pred             HHHHHHHhhCCCCCcCccHHHHHHHHhcCcCC-------------------------------CCCccCCHHHHHHHHHH
Confidence            99999999999999999988888887653311                               12234688899999999


Q ss_pred             cccCCCCCC----CHHHhhcCCCccC
Q psy7889         243 LLLDPSKRF----DSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~----t~~e~L~h~~~~~  264 (433)
                      |+.||.+|.    .+.++-+||||..
T Consensus       261 L~rdp~~RLg~~~d~~~ik~HpfF~~  286 (357)
T KOG0598|consen  261 LKRDPRQRLGGPGDAEEIKRHPFFKG  286 (357)
T ss_pred             hccCHHHhcCCCCChHHhhcCccccc
Confidence            999999996    6899999999954

>KOG0592|consensus

Probab=100.00  E-value=2.9e-44  Score=342.64  Aligned_cols=216  Identities=31%  Similarity=0.487  Sum_probs=189.1

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      -.=+.+|-++|.+| +||.||+|+..|+++        ..+|+|+||++ |+|++++.+. +.|++..++.++.||+.||
T Consensus       117 vkYV~~Ek~~l~~L~~hPgivkLy~TFQD~--------~sLYFvLe~A~nGdll~~i~K~-Gsfde~caR~YAAeIldAl  187 (604)
T KOG0592|consen  117 VKYVTREKEALTQLSGHPGIVKLYFTFQDE--------ESLYFVLEYAPNGDLLDLIKKY-GSFDETCARFYAAEILDAL  187 (604)
T ss_pred             cchhhHHHHHHHHhhCCCCeEEEEEEeecc--------cceEEEEEecCCCcHHHHHHHh-CcchHHHHHHHHHHHHHHH
Confidence            34467899999999 899999999999997        45999999997 6899999885 5899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC---------ccccccCCcccccccCcccccCCCCCCC
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG---------QVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~---------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      +|||++|||||||||+|||++.++++||+|||.|+.+......         .......++||..|.+||++.... .++
T Consensus       188 eylH~~GIIHRDlKPENILLd~dmhikITDFGsAK~l~~~~~~~~~~~~~~~a~s~~~SFVGTAeYVSPElL~~~~-~~~  266 (604)
T KOG0592|consen  188 EYLHSNGIIHRDLKPENILLDKDGHIKITDFGSAKILSPSQKSQENPVDPNQASSRRSSFVGTAEYVSPELLNDSP-AGP  266 (604)
T ss_pred             HHHHhcCceeccCChhheeEcCCCcEEEeeccccccCChhhccccCccCcccccCcccceeeeecccCHHHhcCCC-CCc
Confidence            9999999999999999999999999999999999888653222         111225689999999999998765 699


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|||+||||+|.|+.|.|||.+.++--...+|..+....++.                                .++.+
T Consensus       267 ~sDiWAlGCilyQmlaG~PPFra~NeyliFqkI~~l~y~fp~~--------------------------------fp~~a  314 (604)
T KOG0592|consen  267 SSDLWALGCILYQMLAGQPPFRAANEYLIFQKIQALDYEFPEG--------------------------------FPEDA  314 (604)
T ss_pred             ccchHHHHHHHHHHhcCCCCCccccHHHHHHHHHHhcccCCCC--------------------------------CCHHH
Confidence            9999999999999999999999999999999988866544432                                35677


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +|||.++|..||++|+|++|+-+||||..
T Consensus       315 ~dLv~KLLv~dp~~Rlt~~qIk~HpFF~~  343 (604)
T KOG0592|consen  315 RDLIKKLLVRDPSDRLTSQQIKAHPFFEG  343 (604)
T ss_pred             HHHHHHHHccCccccccHHHHhhCccccc
Confidence            89999999999999999999999999954

>KOG0033|consensus

Probab=100.00  E-value=2.4e-44  Score=311.79  Aligned_cols=217  Identities=30%  Similarity=0.456  Sum_probs=189.5

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .-+.+.+|+.|.+.|+|||||+|++.+...        +..|||+|++.| +|...+.++ .-++|..+..+++||+.||
T Consensus        53 ~~e~l~rEarIC~~LqHP~IvrL~~ti~~~--------~~~ylvFe~m~G~dl~~eIV~R-~~ySEa~aSH~~rQiLeal  123 (355)
T KOG0033|consen   53 DFQKLEREARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILEAL  123 (355)
T ss_pred             cHHHHHHHHHHHHhcCCCcEeehhhhhccc--------ceeEEEEecccchHHHHHHHHH-HHHHHHHHHHHHHHHHHHH
Confidence            346788999999999999999999998776        668999999986 677766654 3478999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecC---CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~---~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .|||.+||||||+||+|+++-..   .-+||+|||+|..++.+     .....++||+.|+|||++...+ |+..+|||+
T Consensus       124 ~yCH~n~IvHRDvkP~nllLASK~~~A~vKL~~FGvAi~l~~g-----~~~~G~~GtP~fmaPEvvrkdp-y~kpvDiW~  197 (355)
T KOG0033|consen  124 AYCHSNGIVHRDLKPENLLLASKAKGAAVKLADFGLAIEVNDG-----EAWHGFAGTPGYLSPEVLKKDP-YSKPVDIWA  197 (355)
T ss_pred             HHHHhcCceeccCChhheeeeeccCCCceeecccceEEEeCCc-----cccccccCCCcccCHHHhhcCC-CCCcchhhh
Confidence            99999999999999999999643   36999999999988732     2456789999999999998776 899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      .|||+|-|+.|.+||.+.+.......|...-...++..|+.                            .++++++||++
T Consensus       198 cGViLfiLL~G~~PF~~~~~~rlye~I~~g~yd~~~~~w~~----------------------------is~~Ak~Lvrr  249 (355)
T KOG0033|consen  198 CGVILYILLVGYPPFWDEDQHRLYEQIKAGAYDYPSPEWDT----------------------------VTPEAKSLIRR  249 (355)
T ss_pred             hhHHHHHHHhCCCCCCCccHHHHHHHHhccccCCCCcccCc----------------------------CCHHHHHHHHH
Confidence            99999999999999999999999999988776666666653                            45678899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||..||.+|+|+.|+|+|||+.+.
T Consensus       250 ML~~dP~kRIta~EAL~HpWi~~r  273 (355)
T KOG0033|consen  250 MLTVNPKKRITADEALKHPWICNR  273 (355)
T ss_pred             HhccChhhhccHHHHhCCchhcch
Confidence            999999999999999999999653

>KOG0583|consensus

Probab=100.00  E-value=1.5e-43  Score=342.88  Aligned_cols=214  Identities=29%  Similarity=0.474  Sum_probs=187.2

Q ss_pred             CchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ....+.+||.+|+.++ ||||+++++++...        ..+|+|||||.| +|++.+.+ .+++.|.+++.++.||+.|
T Consensus        62 ~~~~i~rEi~~~~~~~~HpnI~~l~ev~~t~--------~~~~ivmEy~~gGdL~~~i~~-~g~l~E~~ar~~F~Qlisa  132 (370)
T KOG0583|consen   62 LDELIKREISILRRLRSHPNIIRLLEVFATP--------TKIYIVMEYCSGGDLFDYIVN-KGRLKEDEARKYFRQLISA  132 (370)
T ss_pred             cchhhHHHHHHHHHhccCCCEeEEEEEEecC--------CeEEEEEEecCCccHHHHHHH-cCCCChHHHHHHHHHHHHH
Confidence            4667779999999998 99999999999987        569999999985 99999998 7789999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchhhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDLWG  161 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwS  161 (433)
                      |+|||++||+||||||+|||++.+ +.+||+|||++....    .......+.+||+.|+|||++.+.. .-+.++||||
T Consensus       133 v~y~H~~gi~HRDLK~ENilld~~~~~~Kl~DFG~s~~~~----~~~~~l~t~cGsp~Y~aPEvl~~~~~Y~g~~aDvWS  208 (370)
T KOG0583|consen  133 VAYCHSRGIVHRDLKPENILLDGNEGNLKLSDFGLSAISP----GEDGLLKTFCGSPAYAAPEVLSGKGTYSGKAADVWS  208 (370)
T ss_pred             HHHHHhCCEeeCCCCHHHEEecCCCCCEEEeccccccccC----CCCCcccCCCCCcccCCHHHhCCCCCcCCchhhhhh
Confidence            999999999999999999999999 999999999998763    1224567889999999999998876 4478999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC-ChhHHHHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK-DQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-s~~~~~li~  240 (433)
                      +||++|.|++|..||...+.......|.......                                +... |.++++||.
T Consensus       209 ~GViLy~ml~G~~PF~d~~~~~l~~ki~~~~~~~--------------------------------p~~~~S~~~~~Li~  256 (370)
T KOG0583|consen  209 LGVILYVLLCGRLPFDDSNVPNLYRKIRKGEFKI--------------------------------PSYLLSPEARSLIE  256 (370)
T ss_pred             hHHHHHHHHhCCCCCCCccHHHHHHHHhcCCccC--------------------------------CCCcCCHHHHHHHH
Confidence            9999999999999999977777666654321111                                1123 788899999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +||..||.+|+|+.+++.||||+.
T Consensus       257 ~mL~~~P~~R~t~~~i~~h~w~~~  280 (370)
T KOG0583|consen  257 KMLVPDPSTRITLLEILEHPWFQK  280 (370)
T ss_pred             HHcCCCcccCCCHHHHhhChhhcc
Confidence            999999999999999999999987

>KOG0616|consensus

Probab=100.00  E-value=8e-44  Score=316.56  Aligned_cols=208  Identities=27%  Similarity=0.403  Sum_probs=184.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|..+|+.+.||++|+|++.|.+.        +.+|+||||++| .|.+++++.+ +|+++.++.++.||+.||+|
T Consensus        89 eH~~nEk~vL~~v~~PFlv~l~~t~~d~--------~~lymvmeyv~GGElFS~Lrk~~-rF~e~~arFYAAeivlAley  159 (355)
T KOG0616|consen   89 EHTHNEKRVLKAVSHPFLVKLYGTFKDN--------SNLYMVMEYVPGGELFSYLRKSG-RFSEPHARFYAAEIVLALEY  159 (355)
T ss_pred             HHHhhHHHHHhhccCceeEEEEEeeccC--------CeEEEEEeccCCccHHHHHHhcC-CCCchhHHHHHHHHHHHHHH
Confidence            4677899999999999999999999886        669999999985 6888888754 79999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+++|++||+||+|||++.+|.+||+|||+|+.+..       ...+.|||+.|+|||++.... |+.++|+|||||++
T Consensus       160 lH~~~iiYRDLKPENiLlD~~G~iKitDFGFAK~v~~-------rT~TlCGTPeYLAPEii~sk~-ynkavDWWalGVLI  231 (355)
T KOG0616|consen  160 LHSLDIIYRDLKPENLLLDQNGHIKITDFGFAKRVSG-------RTWTLCGTPEYLAPEIIQSKG-YNKAVDWWALGVLI  231 (355)
T ss_pred             HHhcCeeeccCChHHeeeccCCcEEEEeccceEEecC-------cEEEecCCccccChHHhhcCC-CCcchhHHHHHHHH
Confidence            9999999999999999999999999999999988763       356789999999999998766 89999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |||+.|.+||...+......+|...--..                                |...+.+++|||.++|+.|
T Consensus       232 YEMlaG~pPF~~~~~~~iY~KI~~~~v~f--------------------------------P~~fs~~~kdLl~~LL~vD  279 (355)
T KOG0616|consen  232 YEMLAGYPPFYDDNPIQIYEKILEGKVKF--------------------------------PSYFSSDAKDLLKKLLQVD  279 (355)
T ss_pred             HHHHcCCCCCcCCChHHHHHHHHhCcccC--------------------------------CcccCHHHHHHHHHHHhhh
Confidence            99999999999999988888876522111                                2346788999999999999


Q ss_pred             CCCC-----CCHHHhhcCCCccC
Q psy7889         247 PSKR-----FDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R-----~t~~e~L~h~~~~~  264 (433)
                      -.+|     ....++.+||||..
T Consensus       280 ~t~R~gnlknG~~dIk~H~wF~~  302 (355)
T KOG0616|consen  280 LTKRFGNLKNGVEDIKNHPWFKG  302 (355)
T ss_pred             hHhhhcCcCCCccccccCccccc
Confidence            9999     36689999999964

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=100.00  E-value=3.1e-43  Score=333.90  Aligned_cols=243  Identities=43%  Similarity=0.765  Sum_probs=203.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.+++.++||||+++++++.+.        +.+|+||||+.++|.+.+......+++..++.++.||+.||+
T Consensus        46 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~  117 (288)
T cd07871          46 APCTAIREVSLLKNLKHANIVTLHDIIHTE--------RCLTLVFEYLDSDLKQYLDNCGNLMSMHNVKIFMFQLLRGLS  117 (288)
T ss_pred             cchhHHHHHHHHHhCCCCCEeeEEEEEcCC--------CeEEEEEeCCCcCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            345778999999999999999999999875        569999999999999988776656899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......++..|+|||++.+...++.++||||+||+
T Consensus       118 ~LH~~~ivH~dlkp~Nil~~~~~~~kl~DfG~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~~  193 (288)
T cd07871         118 YCHKRKILHRDLKPQNLLINEKGELKLADFGLARAKSVPT----KTYSNEVVTLWYRPPDVLLGSTEYSTPIDMWGVGCI  193 (288)
T ss_pred             HHHhCCcccCCCCHHHEEECCCCCEEECcCcceeeccCCC----ccccCceecccccChHHhcCCcccCcHHHHHHHHHH
Confidence            9999999999999999999999999999999987643221    122345678999999998776568999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+....+.+..+.|+.......+.....+..........  ....+.++++||.+||++
T Consensus       194 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~dll~~mL~~  271 (288)
T cd07871         194 LYEMATGRPMFPGSTVKEELHLIFRLLGTPTEETWPGITSNEEFRSYLFPQYRAQPLINH--APRLDTDGIDLLSSLLLY  271 (288)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhccccchhhhccccCccCCCchHHh--CCCCCHHHHHHHHHhcCc
Confidence            999999999999999999999999999999999888876655444433333211111111  123578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      ||.+|||++|+|+||||
T Consensus       272 dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         272 ETKSRISAEAALRHSYF  288 (288)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0588|consensus

Probab=100.00  E-value=8.9e-44  Score=345.97  Aligned_cols=221  Identities=26%  Similarity=0.417  Sum_probs=193.7

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      .+..+..+-+||-||+.+.||||+++||++++.        .++|+|.||++ |.|++++.. ++.+++.+++.+++||+
T Consensus        52 s~s~~~~IerEIviMkLi~HpnVl~LydVwe~~--------~~lylvlEyv~gGELFdylv~-kG~l~e~eaa~ff~QIi  122 (786)
T KOG0588|consen   52 SSSQPAGIEREIVIMKLIEHPNVLRLYDVWENK--------QHLYLVLEYVPGGELFDYLVR-KGPLPEREAAHFFRQIL  122 (786)
T ss_pred             ccccccchhhhhHHHHHhcCCCeeeeeeeeccC--------ceEEEEEEecCCchhHHHHHh-hCCCCCHHHHHHHHHHH
Confidence            345577889999999999999999999999986        67999999997 479998877 55799999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .|+.|||..+|+|||+||+|+|++..+.|||+|||.|..-..++     -..+.||+++|.|||++.|.++.+.++||||
T Consensus       123 ~gv~yCH~~~icHRDLKpENlLLd~~~nIKIADFGMAsLe~~gk-----lLeTSCGSPHYA~PEIV~G~pYdG~~sDVWS  197 (786)
T KOG0588|consen  123 DGVSYCHAFNICHRDLKPENLLLDVKNNIKIADFGMASLEVPGK-----LLETSCGSPHYAAPEIVSGRPYDGRPSDVWS  197 (786)
T ss_pred             HHHHHHhhhcceeccCCchhhhhhcccCEeeeccceeecccCCc-----cccccCCCcccCCchhhcCCCCCCCccccch
Confidence            99999999999999999999999999999999999997754432     3456799999999999999998899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +|||+|.||+|+.||.+.+-...+.++.+....++                                ...+.++++||.+
T Consensus       198 CGVILfALLtG~LPFdDdNir~LLlKV~~G~f~MP--------------------------------s~Is~eaQdLLr~  245 (786)
T KOG0588|consen  198 CGVILFALLTGKLPFDDDNIRVLLLKVQRGVFEMP--------------------------------SNISSEAQDLLRR  245 (786)
T ss_pred             hHHHHHHHHhCCCCCCCccHHHHHHHHHcCcccCC--------------------------------CcCCHHHHHHHHH
Confidence            99999999999999998877777777665443332                                3478899999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      ||..||.+|+|.+|++.|||+.......
T Consensus       246 ml~VDp~~RiT~~eI~kHP~l~g~~~~~  273 (786)
T KOG0588|consen  246 MLDVDPSTRITTEEILKHPFLSGYTSLP  273 (786)
T ss_pred             HhccCccccccHHHHhhCchhhcCCCCC
Confidence            9999999999999999999998765443

>KOG0599|consensus

Probab=100.00  E-value=2.3e-44  Score=316.33  Aligned_cols=214  Identities=28%  Similarity=0.503  Sum_probs=189.9

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +...+|+.||+++ .||+|+++.|+|+.+        ..+++|+|.|+ |.|++++.. ...+++...+.+++||+.|++
T Consensus        67 EaT~~Ev~ILRqv~GHP~II~l~D~yes~--------sF~FlVFdl~prGELFDyLts-~VtlSEK~tR~iMrqlfegVe  137 (411)
T KOG0599|consen   67 EATRQEISILRQVMGHPYIIDLQDVYESD--------AFVFLVFDLMPRGELFDYLTS-KVTLSEKETRRIMRQLFEGVE  137 (411)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEeeeeccCc--------chhhhhhhhcccchHHHHhhh-heeecHHHHHHHHHHHHHHHH
Confidence            3567899999999 699999999999987        66899999998 678888865 446899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-----CCCCCcchhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-----RNYGPPVDLW  160 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Diw  160 (433)
                      |||.++|+|||+||+|||++++-.++|+|||++..+..+.     .....|||+.|+|||.+.+.     +.|+..+|+|
T Consensus       138 ylHa~~IVHRDLKpENILlddn~~i~isDFGFa~~l~~Ge-----kLrelCGTPgYLAPEtikC~m~e~~pGYs~EVD~W  212 (411)
T KOG0599|consen  138 YLHARNIVHRDLKPENILLDDNMNIKISDFGFACQLEPGE-----KLRELCGTPGYLAPETIKCSMYENHPGYSKEVDEW  212 (411)
T ss_pred             HHHHhhhhhcccChhheeeccccceEEeccceeeccCCch-----hHHHhcCCCcccChhheeeecccCCCCccchhhHH
Confidence            9999999999999999999999999999999999887653     45678999999999998653     4588999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ++|||+|.|+.|.|||.-....-.+..|.........+.|.++                            |...+|||.
T Consensus       213 a~GVImyTLLaGcpPFwHRkQmlMLR~ImeGkyqF~speWadi----------------------------s~~~KdLIs  264 (411)
T KOG0599|consen  213 ACGVIMYTLLAGCPPFWHRKQMLMLRMIMEGKYQFRSPEWADI----------------------------SATVKDLIS  264 (411)
T ss_pred             HHHHHHHHHHcCCCchhHHHHHHHHHHHHhcccccCCcchhhc----------------------------cccHHHHHH
Confidence            9999999999999999998888888888887777777777654                            345669999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCcc
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +||+.||.+|+|++|+|.||||.
T Consensus       265 rlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  265 RLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             HHHeeCchhcccHHHHhcChHHH
Confidence            99999999999999999999993

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=100.00  E-value=8e-43  Score=333.48  Aligned_cols=248  Identities=40%  Similarity=0.672  Sum_probs=199.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+.+++.++||||+++++++.+.        ..+|+||||+.++|.+.+......++++.++.++.||+.||+|
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~~  118 (303)
T cd07869          47 PFTAIREASLLKGLKHANIVLLHDIIHTK--------ETLTLVFEYVHTDLCQYMDKHPGGLHPENVKLFLFQLLRGLSY  118 (303)
T ss_pred             chhHHHHHHHHhhCCCCCcCeEEEEEecC--------CeEEEEEECCCcCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999875        5699999999999999988766779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    .......+|+.|+|||++.+...++.++||||+||++
T Consensus       119 lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il  194 (303)
T cd07869         119 IHQRYILHRDLKPQNLLISDTGELKLADFGLARAKSVPS----HTYSNEVVTLWYRPPDVLLGSTEYSTCLDMWGVGCIF  194 (303)
T ss_pred             HHHCCeecCCCCHHHEEECCCCCEEECCCCcceeccCCC----ccCCCCcccCCCCChHHHcCCCCCCcHHHHHHHHHHH
Confidence            999999999999999999999999999999986543211    2234456799999999987766688999999999999


Q ss_pred             HHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|.+||.+..+ .+.+..+....+.+....|+.......+......................+.++.+||.+||+.
T Consensus       195 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~  274 (303)
T cd07869         195 VEMIQGVAAFPGMKDIQDQLERIFLVLGTPNEDTWPGVHSLPHFKPERFTLYSPKNLRQAWNKLSYVNHAEDLASKLLQC  274 (303)
T ss_pred             HHHHhCCCCCCCCccHHHHHHHHHHHhCCCChhhccchhhccccccccccccCCccHHHHhhccCCChHHHHHHHHHhcc
Confidence            999999999988544 4566677777787777777665543322211111111222222233334567889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||++|||++|+|+||||...+
T Consensus       275 dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         275 FPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             CchhccCHHHHhcCcccccCC
Confidence            999999999999999997653

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0578|consensus

Probab=100.00  E-value=9.6e-44  Score=341.69  Aligned_cols=231  Identities=26%  Similarity=0.476  Sum_probs=194.1

Q ss_pred             CCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      ++...+-+++||.+|+..+|+|||++++.|...        +.+++||||++| +|.+.+...  .++|.++..|+++++
T Consensus       310 ~Q~~keLilnEi~Vm~~~~H~NiVnfl~Sylv~--------deLWVVMEym~ggsLTDvVt~~--~~~E~qIA~Icre~l  379 (550)
T KOG0578|consen  310 KQPKKELLLNEILVMRDLHHPNIVNFLDSYLVG--------DELWVVMEYMEGGSLTDVVTKT--RMTEGQIAAICREIL  379 (550)
T ss_pred             cCCchhhhHHHHHHHHhccchHHHHHHHHhccc--------ceeEEEEeecCCCchhhhhhcc--cccHHHHHHHHHHHH
Confidence            345567889999999999999999999999876        669999999985 666666553  489999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      +||+|||.+||+|||||.+|||++.+|.+||+|||+|..+.....    ...+-+||++|||||++.... |++++||||
T Consensus       380 ~aL~fLH~~gIiHrDIKSDnILL~~~g~vKltDFGFcaqi~~~~~----KR~TmVGTPYWMAPEVvtrk~-YG~KVDIWS  454 (550)
T KOG0578|consen  380 QGLKFLHARGIIHRDIKSDNILLTMDGSVKLTDFGFCAQISEEQS----KRSTMVGTPYWMAPEVVTRKP-YGPKVDIWS  454 (550)
T ss_pred             HHHHHHHhcceeeeccccceeEeccCCcEEEeeeeeeeccccccC----ccccccCCCCccchhhhhhcc-cCccccchh
Confidence            999999999999999999999999999999999999988764332    445679999999999997655 899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++++||+.|.|||-.......+..|.. -|.+.-.                            .+...|+.++|||++
T Consensus       455 LGIMaIEMveGEPPYlnE~PlrAlyLIa~-ng~P~lk----------------------------~~~klS~~~kdFL~~  505 (550)
T KOG0578|consen  455 LGIMAIEMVEGEPPYLNENPLRALYLIAT-NGTPKLK----------------------------NPEKLSPELKDFLDR  505 (550)
T ss_pred             hhhHHHHHhcCCCCccCCChHHHHHHHhh-cCCCCcC----------------------------CccccCHHHHHHHHH
Confidence            99999999999999998888877777654 2222111                            123468899999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCCCchhHHHHhh
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ  277 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~  277 (433)
                      ||+.|+.+|++|.|+|+||||..+.-.+....++..
T Consensus       506 cL~~dv~~RasA~eLL~HpFl~~a~p~ssL~pLi~~  541 (550)
T KOG0578|consen  506 CLVVDVEQRASAKELLEHPFLKMAKPESSLNPLILA  541 (550)
T ss_pred             HhhcchhcCCCHHHHhcChhhhhcCCHHHhHHHHHH
Confidence            999999999999999999999766555554444443

>KOG0667|consensus

Probab=100.00  E-value=2.3e-43  Score=345.24  Aligned_cols=242  Identities=31%  Similarity=0.540  Sum_probs=191.6

Q ss_pred             hhHHHHHHHHHhCC-CC-----CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCC-CCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HE-----NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hp-----nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~-l~~~~~~~i~~ql   80 (433)
                      .+.+.||.||..|+ |.     |||+++|+|...        .++|||+|.++.+|++++++++.. |+...++.++.||
T Consensus       227 ~Q~~~Ei~iL~~ln~~d~~~~~n~Vrm~d~F~fr--------~HlciVfELL~~NLYellK~n~f~Glsl~~ir~~~~Qi  298 (586)
T KOG0667|consen  227 RQAQIEIRILELLNKHDPDDKYNIVRMLDYFYFR--------NHLCIVFELLSTNLYELLKNNKFRGLSLPLVRKFAQQI  298 (586)
T ss_pred             HHHHHHHHHHHHHhccCCCCCeeEEEeeeccccc--------cceeeeehhhhhhHHHHHHhcCCCCCCHHHHHHHHHHH
Confidence            46778999999996 43     999999999875        779999999999999999876544 8999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecC--CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKT--GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~--~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      +.||.+||+.||||+||||||||+..-  ..|||+|||.|....+       ...+.+.+++|+|||||+|.+ |+.++|
T Consensus       299 l~~L~~L~~l~IIHcDLKPENILL~~~~r~~vKVIDFGSSc~~~q-------~vytYiQSRfYRAPEVILGlp-Y~~~ID  370 (586)
T KOG0667|consen  299 LTALLFLHELGIIHCDLKPENILLKDPKRSRIKVIDFGSSCFESQ-------RVYTYIQSRFYRAPEVILGLP-YDTAID  370 (586)
T ss_pred             HHHHHHHHhCCeeeccCChhheeeccCCcCceeEEecccccccCC-------cceeeeeccccccchhhccCC-CCCccc
Confidence            999999999999999999999999854  4799999999977653       223678899999999999987 899999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccc-hhhhhc-------cccch--------HHHhh-
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVET-LDLYNK-------MELPK--------AQKRK-  221 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~-~~~~~~-------~~~~~--------~~~~~-  221 (433)
                      |||||||++||++|.|+|+|.++.+++..|..++|.++......... ..++..       +....        ..... 
T Consensus       371 mWSLGCIlAEL~tG~PLfpG~ne~DQl~~I~e~lG~Pp~~mL~~~~~~~kff~~~~~~~~~~~~~~~~~~~k~~~~~~~~  450 (586)
T KOG0667|consen  371 MWSLGCILAELFTGEPLFPGDNEYDQLARIIEVLGLPPPKMLDTAKKAHKFFTSLKGFPRLCVETSAPRGTKSPEVRKYY  450 (586)
T ss_pred             eeehhhhHHhHhcCccccCCCCHHHHHHHHHHHhCCCCHHHHHhccccceehhccCCceeeeeeecccccccchhhhhhh
Confidence            99999999999999999999999999999999999877632211100 111111       00000        00000 


Q ss_pred             ---HHhhhCC-----------ccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         222 ---VKERLKP-----------YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       222 ---~~~~~~~-----------~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                         ......|           ......+.|||.+||.+||.+|+|+.|+|+||||...
T Consensus       451 ~~~~~~~~~P~~~~~l~~~~~~~~~~~F~dflk~~L~~dP~~R~tp~qal~Hpfl~~~  508 (586)
T KOG0667|consen  451 RKARLERRGPPGSRSLESGLPKADDKLFIDFLKRCLEWDPAERITPAQALNHPFLTGT  508 (586)
T ss_pred             hhhcccccCCCCCcccchhcccccHHHHHHHHHHHhccCchhcCCHHHHhcCcccccc
Confidence               0000011           0123567899999999999999999999999999743

>KOG0198|consensus

Probab=100.00  E-value=1.5e-42  Score=323.53  Aligned_cols=222  Identities=28%  Similarity=0.453  Sum_probs=177.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+|.+|+|||||++++.....+.      ..++|+|||++ |+|.+++.+..+.++++.++.+.+||++||+|
T Consensus        59 ~~l~~Ei~iL~~l~~p~IV~~~G~~~~~~~------~~~~i~mEy~~~GsL~~~~~~~g~~l~E~~v~~ytr~iL~GL~y  132 (313)
T KOG0198|consen   59 ESLEREIRILSRLNHPNIVQYYGSSSSREN------DEYNIFMEYAPGGSLSDLIKRYGGKLPEPLVRRYTRQILEGLAY  132 (313)
T ss_pred             HHHHHHHHHHHhCCCCCEEeeCCccccccC------eeeEeeeeccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999997555421      36899999998 48888888766589999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++||+||||||+|||++. ++.+||+|||++..... ............||+.|+|||++........++|||||||+
T Consensus       133 lHs~g~vH~DiK~~NiLl~~~~~~~KlaDFG~a~~~~~-~~~~~~~~~~~~Gtp~~maPEvi~~g~~~~~~sDiWSlGCt  211 (313)
T KOG0198|consen  133 LHSKGIVHCDIKPANILLDPSNGDVKLADFGLAKKLES-KGTKSDSELSVQGTPNYMAPEVIRNGEVARRESDIWSLGCT  211 (313)
T ss_pred             HHhCCEeccCcccceEEEeCCCCeEEeccCcccccccc-ccccccccccccCCccccCchhhcCCCcCCccchhhhcCCE
Confidence            99999999999999999999 79999999999987653 11122234457899999999999853223459999999999


Q ss_pred             HHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +.||+||.+||... ...+.+..+..  .. ....+                           +...|.++++||.+||.
T Consensus       212 VvEM~Tg~~PW~~~~~~~~~~~~ig~--~~-~~P~i---------------------------p~~ls~~a~~Fl~~C~~  261 (313)
T KOG0198|consen  212 VVEMLTGKPPWSEFFEEAEALLLIGR--ED-SLPEI---------------------------PDSLSDEAKDFLRKCFK  261 (313)
T ss_pred             EEeccCCCCcchhhcchHHHHHHHhc--cC-CCCCC---------------------------CcccCHHHHHHHHHHhh
Confidence            99999999999873 33333333221  11 00011                           22367889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .||.+||||+++|+|||.....
T Consensus       262 ~~p~~Rpta~eLL~hpf~~~~~  283 (313)
T KOG0198|consen  262 RDPEKRPTAEELLEHPFLKQNS  283 (313)
T ss_pred             cCcccCcCHHHHhhChhhhccc
Confidence            9999999999999999996543

>KOG0595|consensus

Probab=100.00  E-value=2.8e-42  Score=319.41  Aligned_cols=215  Identities=29%  Similarity=0.510  Sum_probs=184.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +-+..||.||+.++|||||.++|+++++        +.+|||||||. |||..++.+. +.+++..++.++.||+.||++
T Consensus        54 e~L~~Ei~iLkel~H~nIV~l~d~~~~~--------~~i~lVMEyC~gGDLs~yi~~~-~~l~e~t~r~Fm~QLA~alq~  124 (429)
T KOG0595|consen   54 ELLLSEIKILKELKHPNIVRLLDCIEDD--------DFIYLVMEYCNGGDLSDYIRRR-GRLPEATARHFMQQLASALQF  124 (429)
T ss_pred             HHHHHHHHHHHhcCCcceeeEEEEEecC--------CeEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999987        67999999998 6888888774 479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecC------CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          87 IHSNKILHRDMKAANVLITKT------GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~------~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      ||+++||||||||.|||++..      -.+||+|||+|+.+...     ....+.||++.|||||++.... |+.++|+|
T Consensus       125 L~~~~IiHRDLKPQNiLLs~~~~~~~~~~LKIADFGfAR~L~~~-----~~a~tlcGSplYMAPEV~~~~~-YdAKADLW  198 (429)
T KOG0595|consen  125 LHENNIIHRDLKPQNILLSTTARNDTSPVLKIADFGFARFLQPG-----SMAETLCGSPLYMAPEVIMSQQ-YDAKADLW  198 (429)
T ss_pred             HHHCCeeeccCCcceEEeccCCCCCCCceEEecccchhhhCCch-----hHHHHhhCCccccCHHHHHhcc-ccchhhHH
Confidence            999999999999999999865      46899999999998743     2346789999999999997655 89999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+|+|+|+|++|++||...+..+....+.+.....+.                             .+...+....+++.
T Consensus       199 SiG~Ilyq~l~g~~Pf~a~t~~eL~~~~~k~~~~~~~-----------------------------~~~~~s~~~~~Ll~  249 (429)
T KOG0595|consen  199 SIGTILYQCLTGKPPFDAETPKELLLYIKKGNEIVPV-----------------------------LPAELSNPLRELLI  249 (429)
T ss_pred             HHHHHHHHHHhCCCCccccCHHHHHHHHhccccccCc-----------------------------hhhhccCchhhhhh
Confidence            9999999999999999999988877766542221110                             11234566679999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ..|..+|..|.+..+.+.|++++..+
T Consensus       250 ~ll~~~~~~~~~~~~~~~~~~l~~~p  275 (429)
T KOG0595|consen  250 SLLQRNPKDRISFEDFFDHPFLAANP  275 (429)
T ss_pred             HHHhcCccccCchHHhhhhhhcccCc
Confidence            99999999999999999999998766

>KOG0582|consensus

Probab=100.00  E-value=7.7e-42  Score=319.10  Aligned_cols=231  Identities=24%  Similarity=0.370  Sum_probs=191.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+..|+.++|||||.++..|..+        ..+++||.||. |++.++++.. ...++|..|..|++++++||.
T Consensus        69 d~l~kE~~~msl~~HPNIv~~~~sFvv~--------~~LWvVmpfMa~GS~ldIik~~~~~Gl~E~~Ia~iLre~LkaL~  140 (516)
T KOG0582|consen   69 DALRKEVQTMSLIDHPNIVTYHCSFVVD--------SELWVVMPFMAGGSLLDIIKTYYPDGLEEASIATILREVLKALD  140 (516)
T ss_pred             HHHHHHHHHhhhcCCCCcceEEEEEEec--------ceeEEeehhhcCCcHHHHHHHHccccccHHHHHHHHHHHHHHHH
Confidence            5788999999999999999999999987        67999999997 5788888654 334999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc-CCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwSlGv  164 (433)
                      |||.+|.||||||+.||||+.+|.|||+|||.+..+..+......++.+.+||++|+|||++. .-..|+.++||||||+
T Consensus       141 YLH~~G~IHRdvKAgnILi~~dG~VkLadFgvsa~l~~~G~R~~~rf~tfvgtp~wmAPEvl~q~~~GYdfKaDIwSfGI  220 (516)
T KOG0582|consen  141 YLHQNGHIHRDVKAGNILIDSDGTVKLADFGVSASLFDSGDRQVTRFNTFVGTPCWMAPEVLMQQLHGYDFKADIWSFGI  220 (516)
T ss_pred             HHHhcCceecccccccEEEcCCCcEEEcCceeeeeecccCceeeEeeccccCcccccChHHhhhcccCccchhhhhhhhH
Confidence            999999999999999999999999999999999888766655555557789999999999954 4456999999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +..||++|..||....+...+-  .++-+.++.........           .+.         ..++..++++|..||+
T Consensus       221 TA~ELA~G~aPf~k~pPmkvLl--~tLqn~pp~~~t~~~~~-----------d~~---------k~~~ksf~e~i~~CL~  278 (516)
T KOG0582|consen  221 TACELAHGHAPFSKYPPMKVLL--LTLQNDPPTLLTSGLDK-----------DED---------KKFSKSFREMIALCLV  278 (516)
T ss_pred             HHHHHhcCCCCcccCChHHHHH--HHhcCCCCCcccccCCh-----------HHh---------hhhcHHHHHHHHHHhh
Confidence            9999999999999988877543  34445544322111111           000         1245578899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      .||.+||||+++|.|+||+.....
T Consensus       279 kDP~kRptAskLlkh~FFk~~k~~  302 (516)
T KOG0582|consen  279 KDPSKRPTASKLLKHAFFKKAKSK  302 (516)
T ss_pred             cCcccCCCHHHHhccHHHhhccch
Confidence            999999999999999999865443

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=100.00  E-value=1.1e-41  Score=322.93  Aligned_cols=244  Identities=36%  Similarity=0.641  Sum_probs=191.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++..+        +.+|+||||+.+++...+......+++..++.++.||+.||.|
T Consensus        44 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~L~~  115 (287)
T cd07848          44 KETTLRELKMLRTLKQENIVELKEAFRRR--------GKLYLVFEYVEKNMLELLEEMPNGVPPEKVRSYIYQLIKAIHW  115 (287)
T ss_pred             hhhHHHHHHHHHhCCCccccchhhhEecC--------CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999875        6699999999998888777666679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||+||+++.++.+||+|||++........   .......|+..|+|||++.+.. ++.++||||+||++
T Consensus       116 lH~~~i~H~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGvil  191 (287)
T cd07848         116 CHKNDIVHRDIKPENLLISHNDVLKLCDFGFARNLSEGSN---ANYTEYVATRWYRSPELLLGAP-YGKAVDMWSVGCIL  191 (287)
T ss_pred             HHHCCeecCCCCHHHEEEcCCCcEEEeeccCccccccccc---ccccccccccccCCcHHHcCCC-CCCchhHHhHHHHH
Confidence            9999999999999999999999999999999987643221   1223456899999999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+....+..+...+........+.....+................+.++++||.+||++|
T Consensus       192 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~dll~~~L~~~  271 (287)
T cd07848         192 GELSDGQPLFPGESEIDQLFTIQKVLGPLPAEQMKLFYSNPRFHGLRFPAVNHPQSLERRYLGILSGVLLDLMKNLLKLN  271 (287)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhhCCCCHHHHHhhhccchhcccccCcccCcccHHHhhhcccCHHHHHHHHHHccCC
Confidence            99999999999998888888887777766544332211111111111111000000000001235788999999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+|||++|+|+||||
T Consensus       272 P~~R~s~~~~l~hp~f  287 (287)
T cd07848         272 PTDRYLTEQCLNHPAF  287 (287)
T ss_pred             cccCCCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>KOG0585|consensus

Probab=100.00  E-value=3.3e-42  Score=323.49  Aligned_cols=223  Identities=26%  Similarity=0.390  Sum_probs=181.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      -+.+.+||.||++|+|||||+|+++..+...      +.+|||+|||..+-..........+++.+++.|++.++.||+|
T Consensus       152 ~ekv~~EIailKkl~H~nVV~LiEvLDDP~s------~~~YlVley~s~G~v~w~p~d~~els~~~Ar~ylrDvv~GLEY  225 (576)
T KOG0585|consen  152 IEKVRREIAILKKLHHPNVVKLIEVLDDPES------DKLYLVLEYCSKGEVKWCPPDKPELSEQQARKYLRDVVLGLEY  225 (576)
T ss_pred             HHHHHHHHHHHHhcCCcCeeEEEEeecCccc------CceEEEEEeccCCccccCCCCcccccHHHHHHHHHHHHHHHHH
Confidence            3689999999999999999999999988754      8899999999853222222222238999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC-ccccccCCcccccccCcccccCC---CCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG-QVNRYTNRVVTLWYRPPELLLGD---RNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~DiwSl  162 (433)
                      ||.+|||||||||+|+|++.+|++||+|||.+.....+... ........+||+.|+|||.+.+.   ...+.+.||||+
T Consensus       226 LH~QgiiHRDIKPsNLLl~~~g~VKIsDFGVs~~~~~~~~~~~d~~L~~tvGTPAF~APE~c~~~~~~~~~g~a~DiWal  305 (576)
T KOG0585|consen  226 LHYQGIIHRDIKPSNLLLSSDGTVKISDFGVSNEFPQGSDEGSDDQLSRTVGTPAFFAPELCSGGNSFSYSGFALDIWAL  305 (576)
T ss_pred             HHhcCeeccccchhheEEcCCCcEEeeccceeeecccCCccccHHHHhhcCCCccccchHhhcCCCCccccchhhhhhhh
Confidence            99999999999999999999999999999999776433111 11123346899999999999873   335789999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||+||.|+.|+.||.+....+...+|....-..+..                              -...+.++|||.+|
T Consensus       306 GVTLYCllfG~~PF~~~~~~~l~~KIvn~pL~fP~~------------------------------pe~~e~~kDli~~l  355 (576)
T KOG0585|consen  306 GVTLYCLLFGQLPFFDDFELELFDKIVNDPLEFPEN------------------------------PEINEDLKDLIKRL  355 (576)
T ss_pred             hhhHHHhhhccCCcccchHHHHHHHHhcCcccCCCc------------------------------ccccHHHHHHHHHH
Confidence            999999999999999999888888876522111110                              02466788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+||..|++..++-.|||....
T Consensus       356 L~KdP~~Ri~l~~ik~Hpwvt~~  378 (576)
T KOG0585|consen  356 LEKDPEQRITLPDIKLHPWVTRD  378 (576)
T ss_pred             hhcChhheeehhhheecceeccC
Confidence            99999999999999999999754

>KOG0591|consensus

Probab=100.00  E-value=6.1e-43  Score=308.73  Aligned_cols=206  Identities=27%  Similarity=0.427  Sum_probs=172.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc---cCCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN---IHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qll~   82 (433)
                      .+....||.+|++|+|||||+++++-....      ...++||||||. |||.++++.   .+..++|..+|.++.||+.
T Consensus        62 rq~~v~Ei~lLkQL~HpNIVqYy~~~f~~~------~evlnivmE~c~~GDLsqmIk~~K~qkr~ipE~~Vwk~f~QL~~  135 (375)
T KOG0591|consen   62 RQDCVKEISLLKQLNHPNIVQYYAHSFIED------NEVLNIVMELCDAGDLSQMIKHFKKQKRLIPEKTVWKYFVQLCR  135 (375)
T ss_pred             HHHHHHHHHHHHhcCCchHHHHHHHhhhcc------chhhHHHHHhhcccCHHHHHHHHHhccccCchHHHHHHHHHHHH
Confidence            456788999999999999999998333321      245899999997 688888754   3445999999999999999


Q ss_pred             HHHHHHh--CC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          83 GLYYIHS--NK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        83 aL~~LH~--~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      ||..||+  .+  |+||||||.||+++.+|.+||+|||+++.+...    .....+.+||++||+||++.+.+ |+.++|
T Consensus       136 AL~~cH~~~~r~~VmHRDIKPaNIFl~~~gvvKLGDfGL~r~l~s~----~tfA~S~VGTPyYMSPE~i~~~~-Y~~kSD  210 (375)
T KOG0591|consen  136 ALYHCHSKIPRGTVMHRDIKPANIFLTANGVVKLGDFGLGRFLSSK----TTFAHSLVGTPYYMSPERIHESG-YNFKSD  210 (375)
T ss_pred             HHHHHhccccccceeeccCcchheEEcCCCceeeccchhHhHhcch----hHHHHhhcCCCcccCHHHHhcCC-CCcchh
Confidence            9999998  45  999999999999999999999999999988643    23456789999999999998876 899999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |||+||++|||+.-.+||.|.+-...-.+|.+.-.++.+                              ...+|.+...+
T Consensus       211 iWslGCllyEMcaL~~PF~g~n~~~L~~KI~qgd~~~~p------------------------------~~~YS~~l~~l  260 (375)
T KOG0591|consen  211 IWSLGCLLYEMCALQSPFYGDNLLSLCKKIEQGDYPPLP------------------------------DEHYSTDLREL  260 (375)
T ss_pred             HHHHHHHHHHHHhcCCCcccccHHHHHHHHHcCCCCCCc------------------------------HHHhhhHHHHH
Confidence            999999999999999999999877777777653221111                              12467888899


Q ss_pred             HHhhcccCCCCCCCH
Q psy7889         239 LDKLLLLDPSKRFDS  253 (433)
Q Consensus       239 i~~~L~~dP~~R~t~  253 (433)
                      |..|+..||..||+.
T Consensus       261 i~~ci~vd~~~RP~t  275 (375)
T KOG0591|consen  261 INMCIAVDPEQRPDT  275 (375)
T ss_pred             HHHHccCCcccCCCc
Confidence            999999999999987

>KOG0605|consensus

Probab=100.00  E-value=9.2e-42  Score=325.68  Aligned_cols=222  Identities=28%  Similarity=0.405  Sum_probs=184.4

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      -+--..++.|-+||...++|+||+||..|++.        ..+||||||++| |+..++.+.+ .|++..++.++.+++.
T Consensus       182 ~~Qv~hV~aERdiL~~~ds~~vVKLyYsFQD~--------~~LYLiMEylPGGD~mTLL~~~~-~L~e~~arfYiaE~vl  252 (550)
T KOG0605|consen  182 KNQVEHVRAERDILAEVDSPWVVKLYYSFQDK--------EYLYLIMEYLPGGDMMTLLMRKD-TLTEDWARFYIAETVL  252 (550)
T ss_pred             hhhHHHHHHHHHHhhhcCCCcEEEEEEEecCC--------CeeEEEEEecCCccHHHHHHhcC-cCchHHHHHHHHHHHH
Confidence            34456788999999999999999999999997        559999999985 7888887744 7999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccC-------------------cCCccc-------------
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT-------------------KNGQVN-------------  130 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~-------------------~~~~~~-------------  130 (433)
                      ||+.||+.|+|||||||+|+||+..|++||+||||+.-+...                   ......             
T Consensus       253 AI~~iH~~gyIHRDIKPdNlLiD~~GHiKLSDFGLs~gl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  332 (550)
T KOG0605|consen  253 AIESIHQLGYIHRDIKPDNLLIDAKGHIKLSDFGLSTGLDKKHRIESYRLDEQMQINLSEAKPSDFPKFNTPRSTMSRRE  332 (550)
T ss_pred             HHHHHHHcCcccccCChhheeecCCCCEeeccccccchhhhhhhhhhhcchhhhhhhhccCCCccccccccccchhhHHH
Confidence            999999999999999999999999999999999999543210                   000000             


Q ss_pred             -----------cccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCC
Q psy7889         131 -----------RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPES  199 (433)
Q Consensus       131 -----------~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~  199 (433)
                                 .....+||+.|+||||+.+.. |+..+|+||||||+||||.|.|||.+.+..++...|...--.+.   
T Consensus       333 ~~~~w~~nrr~~a~StVGTPDYiAPEVll~kg-Y~~~cDwWSLG~ImyEmLvGyPPF~s~tp~~T~rkI~nwr~~l~---  408 (550)
T KOG0605|consen  333 QLQTWKRNRRQLAYSTVGTPDYIAPEVLLGKG-YGKECDWWSLGCIMYEMLVGYPPFCSETPQETYRKIVNWRETLK---  408 (550)
T ss_pred             HHHHHHhhhhhhhhcccCCccccchHHHhcCC-CCccccHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhhhcc---
Confidence                       012468999999999999876 89999999999999999999999999999999988875322111   


Q ss_pred             CCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCC---HHHhhcCCCccC
Q psy7889         200 WPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD---SDAALNHDFFWT  264 (433)
Q Consensus       200 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~L~h~~~~~  264 (433)
                                    +|.           ....+.+++|||.+||. ||.+|..   ++|+-.||||..
T Consensus       409 --------------fP~-----------~~~~s~eA~DLI~rll~-d~~~RLG~~G~~EIK~HPfF~~  450 (550)
T KOG0605|consen  409 --------------FPE-----------EVDLSDEAKDLITRLLC-DPENRLGSKGAEEIKKHPFFKG  450 (550)
T ss_pred             --------------CCC-----------cCcccHHHHHHHHHHhc-CHHHhcCcccHHHHhcCCcccc
Confidence                          111           11256889999999999 9999985   899999999965

>KOG0597|consensus

Probab=100.00  E-value=3.5e-42  Score=328.88  Aligned_cols=210  Identities=34%  Similarity=0.550  Sum_probs=185.0

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      .+.+|++|++.|+|||||.+++.|+++        .++++|+|||.|+|..++.. ++.++|+.++.++.+++.||.|||
T Consensus        47 ~l~~ev~i~r~lkHpniv~m~esfEt~--------~~~~vVte~a~g~L~~il~~-d~~lpEe~v~~~a~~LVsaL~yLh  117 (808)
T KOG0597|consen   47 NLRQEVRILRSLKHPNIVEMLESFETS--------AHLWVVTEYAVGDLFTILEQ-DGKLPEEQVRAIAYDLVSALYYLH  117 (808)
T ss_pred             HHHHHHHHHHhcCCcchhhHHHhhccc--------ceEEEEehhhhhhHHHHHHh-ccCCCHHHHHHHHHHHHHHHHHHH
Confidence            488999999999999999999999987        67999999999999998876 668999999999999999999999


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHH
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE  168 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  168 (433)
                      +.+|+|||+||.|||+...|.+|+||||+|+.++...    ...+...||+.|+|||+..+.. |+..+|+||||||+||
T Consensus       118 s~rilhrd~kPqniLl~~~~~~KlcdFg~Ar~m~~~t----~vltsikGtPlYmAPElv~e~p-yd~~sDlWslGcilYE  192 (808)
T KOG0597|consen  118 SNRILHRDMKPQNILLEKGGTLKLCDFGLARAMSTNT----SVLTSIKGTPLYMAPELVEEQP-YDHTSDLWSLGCILYE  192 (808)
T ss_pred             hcCcccccCCcceeeecCCCceeechhhhhhhcccCc----eeeeeccCcccccCHHHHcCCC-ccchhhHHHHHHHHHH
Confidence            9999999999999999999999999999999987533    3345678999999999998765 8999999999999999


Q ss_pred             HHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCC
Q psy7889         169 MWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS  248 (433)
Q Consensus       169 ll~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  248 (433)
                      |++|+|||...+-...+..|..-.-     .|                           +...|.+++.||..+|.+||.
T Consensus       193 ~~~G~PPF~a~si~~Lv~~I~~d~v-----~~---------------------------p~~~S~~f~nfl~gLL~kdP~  240 (808)
T KOG0597|consen  193 LYVGQPPFYARSITQLVKSILKDPV-----KP---------------------------PSTASSSFVNFLQGLLIKDPA  240 (808)
T ss_pred             HhcCCCCchHHHHHHHHHHHhcCCC-----CC---------------------------cccccHHHHHHHHHHhhcChh
Confidence            9999999998877766666543111     11                           123678888999999999999


Q ss_pred             CCCCHHHhhcCCCccC
Q psy7889         249 KRFDSDAALNHDFFWT  264 (433)
Q Consensus       249 ~R~t~~e~L~h~~~~~  264 (433)
                      .|+|-.+++.|||++.
T Consensus       241 ~RltW~~Ll~HpF~k~  256 (808)
T KOG0597|consen  241 QRLTWTDLLGHPFWKG  256 (808)
T ss_pred             hcccHHHHhcChHHhh
Confidence            9999999999999963

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=100.00  E-value=8.1e-41  Score=320.51  Aligned_cols=246  Identities=40%  Similarity=0.736  Sum_probs=203.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|++++++++||||+++++++..+        +..|+||||++++|.+.+......+++..++.++.||+.||+|
T Consensus        48 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~  119 (309)
T cd07872          48 PCTAIREVSLLKDLKHANIVTLHDIVHTD--------KSLTLVFEYLDKDLKQYMDDCGNIMSMHNVKIFLYQILRGLAY  119 (309)
T ss_pred             chhHHHHHHHHHhCCCCCcceEEEEEeeC--------CeEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999875        5699999999999999887766668999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    .......++..|+|||++.+...++.++||||+||++
T Consensus       120 lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il  195 (309)
T cd07872         120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSVPT----KTYSNEVVTLWYRPPDVLLGSSEYSTQIDMWGVGCIF  195 (309)
T ss_pred             HHHCCeecCCCCHHHEEECCCCCEEECccccceecCCCc----cccccccccccccCCHHHhCCCCCCcHHHHHHHHHHH
Confidence            999999999999999999999999999999987643221    1223346788999999987765689999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||.+.+..+.+..+....+.+..+.|+.......+.....+..........  ....+.++++||.+||..|
T Consensus       196 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~d  273 (309)
T cd07872         196 FEMASGRPLFPGSTVEDELHLIFRLLGTPTEETWPGISSNDEFKNYNFPKYKPQPLINH--APRLDTEGIELLTKFLQYE  273 (309)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhhcchhhhhhhhcCccCCCchhhh--ccCCCHHHHHHHHHhccCC
Confidence            99999999999999999999999999988888887766554443333332211111111  1135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       274 p~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         274 SKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             hhhCCCHHHHhcChhhhhcc
Confidence            99999999999999997543

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=100.00  E-value=1.2e-40  Score=320.42  Aligned_cols=251  Identities=34%  Similarity=0.627  Sum_probs=189.2

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc--------CCCCCHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--------HVKFSLGEIKKV   76 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~--------~~~l~~~~~~~i   76 (433)
                      +....+.+|+.+|++++||||+++++++.....      ..+|+||||++++|..++...        ...+++..++.+
T Consensus        40 ~~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i  113 (317)
T cd07868          40 GISMSACREIALLRELKHPNVISLQKVFLSHAD------RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKSL  113 (317)
T ss_pred             CCcHHHHHHHHHHHhcCCCCCcceeeeEecCCC------cEEEEEEeccCCCHHHHHHhcccccccCCcccCCHHHHHHH
Confidence            345568899999999999999999999976432      678999999999998887532        124899999999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEe----cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN  152 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~----~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (433)
                      +.||+.||+|||++||+||||||+|||++    .++.+||+|||++........ .........+|+.|+|||++.+...
T Consensus       114 ~~qi~~al~~LH~~~ivHrDlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~  192 (317)
T cd07868         114 LYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARH  192 (317)
T ss_pred             HHHHHHHHHHHHhCCEEcCCCCHHHEEEecCCCCcCcEEEeecCceeccCCCCc-cccccCCccccccccCCHHHcCCCC
Confidence            99999999999999999999999999994    557899999999977643211 1122345678999999999987666


Q ss_pred             CCCcchhhhHHHHHHHHHhcCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCcccchhhhhccc----cchHHH
Q psy7889         153 YGPPVDLWGAGCIMAEMWTRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKME----LPKAQK  219 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~g~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~~~  219 (433)
                      ++.++||||+||++++|++|.+||.+...         ..++..+....|.+....|.............    ......
T Consensus       193 ~~~~~DiwslG~il~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  272 (317)
T cd07868         193 YTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTN  272 (317)
T ss_pred             cCchhhHHHHHHHHHHHHhCCCCccCCcccccccccccHHHHHHHHHhcCCCChHHhHHHhhccchhhhhhhhhccccCc
Confidence            89999999999999999999999986543         35667777888877766665443221110000    000000


Q ss_pred             hhHHh--hhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         220 RKVKE--RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       220 ~~~~~--~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      .....  .......+..+++||.+||++||.+|||++|+|+||||
T Consensus       273 ~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         273 CSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ccccchHHhcCCCCChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            00000  00112346678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>PTZ00036 glycogen synthase kinase; Provisional

Probab=100.00  E-value=8.4e-41  Score=334.86  Aligned_cols=248  Identities=30%  Similarity=0.487  Sum_probs=192.7

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+|+.+|+.++|||||+++++|.............+++||||+++++..++..   ....+++..++.++.||+.||+
T Consensus       105 ~~~~Ei~il~~l~h~niv~l~~~~~~~~~~~~~~~~~l~lvmE~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~gL~  184 (440)
T PTZ00036        105 YKNRELLIMKNLNHINIIFLKDYYYTECFKKNEKNIFLNVVMEFIPQTVHKYMKHYARNNHALPLFLVKLYSYQLCRALA  184 (440)
T ss_pred             hHHHHHHHHHhcCCCCCcceeeeEeecccccCCCceEEEEEEecCCccHHHHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            4568999999999999999999886542211111245789999999998877653   3456899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||++||+||||||+|||++.++ .+||+|||+++.+....     ......||+.|+|||++.+...|+.++||||+||
T Consensus       185 yLH~~~IiHrDLKp~NILl~~~~~~vkL~DFGla~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGv  259 (440)
T PTZ00036        185 YIHSKFICHRDLKPQNLLIDPNTHTLKLCDFGSAKNLLAGQ-----RSVSYICSRFYRAPELMLGATNYTTHIDLWSLGC  259 (440)
T ss_pred             HHHHCCEecCCcCHHHEEEcCCCCceeeeccccchhccCCC-----CcccCCCCcCccCHHHhcCCCCCCcHHHHHHHHH
Confidence            99999999999999999998665 79999999998764322     1234567999999999887666899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+.+..+.+.+|.+..+.+....  ..+..+.++......+...+ +...+.++++||.+||+
T Consensus       260 il~elltG~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~--~~~~~~~~~~~~~~~l~~~~-p~~~~~~~~~li~~~L~  336 (440)
T PTZ00036        260 IIAEMILGYPIFSGQSSVDQLVRIIQVLGTPTEDQLKEMN--PNYADIKFPDVKPKDLKKVF-PKGTPDDAINFISQFLK  336 (440)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhc--hhhhcccCCccCchhHHHHh-ccCCCHHHHHHHHHHCC
Confidence            9999999999999999999999999888876554332211  11122222222222222211 23457889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccC
Q psy7889         245 LDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +||.+|||+.|+|+||||..
T Consensus       337 ~dP~~R~ta~e~l~hp~f~~  356 (440)
T PTZ00036        337 YEPLKRLNPIEALADPFFDD  356 (440)
T ss_pred             CChhHCcCHHHHhCChhHHh
Confidence            99999999999999999954

>cd07865 STKc_CDK9 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 9

Probab=100.00  E-value=4.5e-40  Score=315.00  Aligned_cols=256  Identities=82%  Similarity=1.349  Sum_probs=214.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++++.++||||+++++++......+.......|+||||+.+++.+.+.+....+++.+++.++.||+.||.|
T Consensus        55 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~al~~  134 (310)
T cd07865          55 PITALREIKILQLLKHENVVNLIEICRTKATPYNRYKGSFYLVFEFCEHDLAGLLSNKNVKFTLSEIKKVMKMLLNGLYY  134 (310)
T ss_pred             hhHHHHHHHHHHhCCCCCccceEEEEecccccccCCCceEEEEEcCCCcCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            44567899999999999999999999876543344457789999999999999887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.+||+|||++..+...............++..|+|||.+.+...++.++||||+||++
T Consensus       135 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l  214 (310)
T cd07865         135 IHRNKILHRDMKAANILITKDGILKLADFGLARAFSLSKNSKPNRYTNRVVTLWYRPPELLLGERDYGPPIDMWGAGCIM  214 (310)
T ss_pred             HHHCCeeccCCCHHHEEECCCCcEEECcCCCcccccCCcccCCCCccCcccCccccCcHHhcCCcccCchhhhHHHHHHH
Confidence            99999999999999999999999999999999876543322222233456788899999987765578899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+....|..+++.++.......+.....+..........+.+...+..+++||.+||..|
T Consensus       215 ~el~t~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~dli~~~l~~~  294 (310)
T cd07865         215 AEMWTRSPIMQGNTEQHQLTLISQLCGSITPEVWPGVDKLELFKKMELPQGQKRKVKERLKPYVKDPHALDLIDKLLVLD  294 (310)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhcccccchhhhhhccCCCccchhhHHhcccccCCHHHHHHHHHHhcCC
Confidence            99999999999999888888999999988888877776655555555555555555555566667888999999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+|||++++|+||||
T Consensus       295 P~~R~t~~e~l~h~~f  310 (310)
T cd07865         295 PAKRIDADTALNHDFF  310 (310)
T ss_pred             hhhccCHHHHhcCCCC
Confidence            9999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK9 together with a cyclin partner (cyclin T1, T2a, T2b, or K) is the main component of distinct positive transcription elongation factors (P-TEFb), which function as Ser2 C-terminal domain kinases of RNA polymerase II. P-TEFb participates in multipl

>KOG0610|consensus

Probab=100.00  E-value=2e-40  Score=307.22  Aligned_cols=219  Identities=28%  Similarity=0.391  Sum_probs=181.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      -.+++.|-+||+.++||.++.||..|+.+        +.+|+|||||+| +|..++.+.. ..|+++.++.++.+++.||
T Consensus       121 l~Ra~tE~eIL~~lDHPFlPTLYa~fet~--------~~~cl~meyCpGGdL~~LrqkQp~~~fse~~aRFYaAEvl~AL  192 (459)
T KOG0610|consen  121 LKRAQTEREILSLLDHPFLPTLYASFETD--------KYSCLVMEYCPGGDLHSLRQKQPGKRFSESAARFYAAEVLLAL  192 (459)
T ss_pred             HHHHHHHHHHHHhcCCCccchhhheeecc--------ceeEEEEecCCCccHHHHHhhCCCCccchhhHHHHHHHHHHHH
Confidence            35678899999999999999999999987        669999999985 7777776544 3499999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccC--------------------------------cCC-----
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT--------------------------------KNG-----  127 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~--------------------------------~~~-----  127 (433)
                      +|||-+|||+|||||+||||..+|+|.|+||.++......                                ...     
T Consensus       193 EYLHmlGivYRDLKPENILvredGHIMLsDFDLS~~~~~~Pt~~~s~~~~~~~~~~~~~~~~~s~f~~r~~~~~~~~~k~  272 (459)
T KOG0610|consen  193 EYLHMLGIVYRDLKPENILVREDGHIMLSDFDLSLRCPVSPTLVKSSSPRSSGSQPSCRSRQPSCFSPRCLSSSKKRKKK  272 (459)
T ss_pred             HHHHhhceeeccCCcceeEEecCCcEEeeeccccccCCCCCeeeccCCCCCCCCCcccccccccccccchhccccccccc
Confidence            9999999999999999999999999999999988543210                                000     


Q ss_pred             ---------------ccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy7889         128 ---------------QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLC  192 (433)
Q Consensus       128 ---------------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~  192 (433)
                                     ...+...++||-.|+|||+|.|.. -+.++|+|+|||++|||+.|..||.|.+..+++..|..  
T Consensus       273 ~~~~~~~~p~~~aep~~~RSnSFVGThEYlAPEvI~G~G-HgsAVDWWtfGIflYEmLyG~TPFKG~~~~~Tl~NIv~--  349 (459)
T KOG0610|consen  273 DESASRSLPELVAEPTGARSNSFVGTHEYLAPEVIRGEG-HGSAVDWWTFGIFLYEMLYGTTPFKGSNNKETLRNIVG--  349 (459)
T ss_pred             cccccccchhhhcCCCCccccccccccccccceeeecCC-CCchhhHHHHHHHHHHHHhCCCCcCCCCchhhHHHHhc--
Confidence                           001123578999999999999987 49999999999999999999999999998888776643  


Q ss_pred             CCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCC----HHHhhcCCCccC
Q psy7889         193 GSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD----SDAALNHDFFWT  264 (433)
Q Consensus       193 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~e~L~h~~~~~  264 (433)
                       .+.  .+++.                         -..+..++|||+++|.+||++|+.    |.|+-+||||..
T Consensus       350 -~~l--~Fp~~-------------------------~~vs~~akDLIr~LLvKdP~kRlg~~rGA~eIK~HpFF~g  397 (459)
T KOG0610|consen  350 -QPL--KFPEE-------------------------PEVSSAAKDLIRKLLVKDPSKRLGSKRGAAEIKRHPFFEG  397 (459)
T ss_pred             -CCC--cCCCC-------------------------CcchhHHHHHHHHHhccChhhhhccccchHHhhcCccccC
Confidence             211  01100                         035678899999999999999998    999999999965

>KOG4717|consensus

Probab=100.00  E-value=7.6e-41  Score=316.43  Aligned_cols=218  Identities=28%  Similarity=0.509  Sum_probs=195.2

Q ss_pred             CCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQL   80 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~ql   80 (433)
                      |++.....+.+|+.+|+.++|||||+||+++.+.        +.+|||+|.-.+ ||++++.+....+.|+.++.|+.||
T Consensus        56 lD~~st~hlfqEVRCMKLVQHpNiVRLYEViDTQ--------TKlyLiLELGD~GDl~DyImKHe~Gl~E~La~kYF~QI  127 (864)
T KOG4717|consen   56 LDTLSTGHLFQEVRCMKLVQHPNIVRLYEVIDTQ--------TKLYLILELGDGGDLFDYIMKHEEGLNEDLAKKYFAQI  127 (864)
T ss_pred             cchhhhhHHHHHHHHHHHhcCcCeeeeeehhccc--------ceEEEEEEecCCchHHHHHHhhhccccHHHHHHHHHHH
Confidence            3445567889999999999999999999999875        779999999875 9999999988889999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEE-ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll-~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      +.||.|||+..+|||||||+||.+ ..-|.|||.|||++..+..++     ...+.||++.|-|||++.|..+.-+++||
T Consensus       128 ~~AI~YCHqLHVVHRDLKPENVVFFEKlGlVKLTDFGFSNkf~PG~-----kL~TsCGSLAYSAPEILLGDsYDAPAVDi  202 (864)
T KOG4717|consen  128 VHAISYCHQLHVVHRDLKPENVVFFEKLGLVKLTDFGFSNKFQPGK-----KLTTSCGSLAYSAPEILLGDSYDAPAVDI  202 (864)
T ss_pred             HHHHHHHhhhhhhcccCCcceeEEeeecCceEeeeccccccCCCcc-----hhhcccchhhccCchhhhcCccCCcchhh
Confidence            999999999999999999999876 567899999999998877653     45678999999999999998866789999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||||||+|.|++|++||...++.+++..|+......                                |...|.++++||
T Consensus       203 WSLGVILyMLVCGq~PFqeANDSETLTmImDCKYtv--------------------------------PshvS~eCrdLI  250 (864)
T KOG4717|consen  203 WSLGVILYMLVCGQPPFQEANDSETLTMIMDCKYTV--------------------------------PSHVSKECRDLI  250 (864)
T ss_pred             hHHHHHHHHHHhCCCccccccchhhhhhhhcccccC--------------------------------chhhhHHHHHHH
Confidence            999999999999999999999999999987644332                                224688999999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||..||++|.+.+++..|+|++.
T Consensus       251 ~sMLvRdPkkRAslEeI~s~~Wlq~  275 (864)
T KOG4717|consen  251 QSMLVRDPKKRASLEEIVSTSWLQA  275 (864)
T ss_pred             HHHHhcCchhhccHHHHhccccccC
Confidence            9999999999999999999999974

>KOG0604|consensus

Probab=100.00  E-value=7.3e-41  Score=297.87  Aligned_cols=222  Identities=25%  Similarity=0.402  Sum_probs=181.8

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~a   83 (433)
                      .+.+.||+++.-.. .|||||.++|+|.+..+    +...+.+|||+++| .|++.+.... ..|+|.++..|++||..|
T Consensus        98 s~KARrEVeLHw~~s~h~~iV~IidVyeNs~~----~rkcLLiVmE~meGGeLfsriq~~g~~afTErea~eI~~qI~~A  173 (400)
T KOG0604|consen   98 SPKARREVELHWMASGHPHIVSIIDVYENSYQ----GRKCLLIVMECMEGGELFSRIQDRGDQAFTEREASEIMKQIGLA  173 (400)
T ss_pred             CHHHHhHhhhhhhhcCCCceEEeehhhhhhcc----CceeeEeeeecccchHHHHHHHHcccccchHHHHHHHHHHHHHH
Confidence            56788999988877 59999999999987633    36889999999985 7888886643 349999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecC---CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~---~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.|||+.+|.||||||+|+|.+.+   ..+||+|||+|+.-..+     ....+.+.|++|.|||++-..+ |+..+|+|
T Consensus       174 v~~lH~~nIAHRDlKpENLLyt~t~~na~lKLtDfGFAK~t~~~-----~~L~TPc~TPyYvaPevlg~eK-ydkscdmw  247 (400)
T KOG0604|consen  174 VRYLHSMNIAHRDLKPENLLYTTTSPNAPLKLTDFGFAKETQEP-----GDLMTPCFTPYYVAPEVLGPEK-YDKSCDMW  247 (400)
T ss_pred             HHHHHhcchhhccCChhheeeecCCCCcceEecccccccccCCC-----ccccCCcccccccCHHHhCchh-cCCCCCcc
Confidence            999999999999999999999854   47999999999875532     3455678899999999986555 89999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChH----HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQ----QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~----~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |+||++|-|++|.|||......    ....+|...-...+.++|.                   .         .|+.++
T Consensus       248 SlgVimYIlLCGyPPFYS~hg~aispgMk~rI~~gqy~FP~pEWs-------------------~---------VSe~aK  299 (400)
T KOG0604|consen  248 SLGVIMYILLCGYPPFYSNHGLAISPGMKRRIRTGQYEFPEPEWS-------------------C---------VSEAAK  299 (400)
T ss_pred             chhHHHHHhhcCCCcccccCCccCChhHHhHhhccCccCCChhHh-------------------H---------HHHHHH
Confidence            9999999999999999876543    3344444433334444443                   2         356677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |+|+++|..+|.+|+|.+++++|||+...+
T Consensus       300 dlIR~LLkt~PteRlTI~~~m~hpwi~~~~  329 (400)
T KOG0604|consen  300 DLIRKLLKTEPTERLTIEEVMDHPWINQYE  329 (400)
T ss_pred             HHHHHHhcCCchhheeHHHhhcCchhcccc
Confidence            999999999999999999999999996543

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=100.00  E-value=1e-39  Score=311.67  Aligned_cols=244  Identities=41%  Similarity=0.747  Sum_probs=199.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+|+||||+.++|.+.+......+++..++.++.||+.||.|
T Consensus        48 ~~~~~~E~~~l~~l~h~nI~~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~aL~~  119 (301)
T cd07873          48 PCTAIREVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDKDLKQYLDDCGNSINMHNVKLFLFQLLRGLNY  119 (301)
T ss_pred             hhHHHHHHHHHHhcCCCCcceEEEEEecC--------CeEEEEEeccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999875        5699999999999999988766678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++|||||||++
T Consensus       120 lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~~l  195 (301)
T cd07873         120 CHRRKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT----KTYSNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIF  195 (301)
T ss_pred             HHhCCeeCCCCCHHHEEECCCCcEEECcCcchhccCCCC----CcccccceeecccCcHHHhCCCCCccHHHHHHHHHHH
Confidence            999999999999999999999999999999987643221    1123345688999999987766678999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+.+..+....+.+....|+.......+.....+.........  .....++++.+||.+||+.|
T Consensus       196 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~ml~~d  273 (301)
T cd07873         196 YEMSTGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKSYNYPKYRADCLHN--HAPRLDSDGAELLSKLLQFE  273 (301)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCChhhchhhhccccccccccCccccccHHh--hcCCCCHHHHHHHHHHhcCC
Confidence            9999999999999988888888888888888777665443333222222211111110  11235778899999999999


Q ss_pred             CCCCCCHHHhhcCCCccC
Q psy7889         247 PSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~  264 (433)
                      |.+|||++|+|+||||..
T Consensus       274 p~~R~t~~eil~h~~f~~  291 (301)
T cd07873         274 GRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             cccCcCHHHHhcCccccc
Confidence            999999999999999954

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=100.00  E-value=1.2e-39  Score=309.36  Aligned_cols=243  Identities=38%  Similarity=0.711  Sum_probs=192.4

Q ss_pred             CchhHHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLL   81 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll   81 (433)
                      ......+|+++++.+   +||||+++++++.....   .....+++||||+.++|.+++.... ..+++..++.++.||+
T Consensus        44 ~~~~~~~e~~~l~~l~~~~hpniv~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  120 (290)
T cd07862          44 MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT---DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQLL  120 (290)
T ss_pred             chHHHHHHHHHHHhhcccCCCCcceEEEEEecccC---CCCCcEEEEEccCCCCHHHHHHhCCCCCCCHHHHHHHHHHHH
Confidence            345677899988877   59999999999864321   1135689999999999999887543 3489999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||.|||++||+||||||+|||++.++.+||+|||++......     .......||..|+|||++.+.. ++.++||||
T Consensus       121 ~aL~~lH~~~iiH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws  194 (290)
T cd07862         121 RGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSS-YATPVDLWS  194 (290)
T ss_pred             HHHHHHHHCCeeeCCCCHHHEEEcCCCCEEEccccceEeccCC-----cccccccccccccChHHHhCCC-CCCccchHH
Confidence            9999999999999999999999999999999999999765432     1233456799999999987654 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|.+||.+..+.+.+..+....+.+.+..|+.........   +.............  ..+..+++||.+
T Consensus       195 lG~il~el~~g~~~f~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~--~~~~~~~~li~~  269 (290)
T cd07862         195 VGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQA---FHSKSAQPIEKFVT--DIDELGKDLLLK  269 (290)
T ss_pred             HHHHHHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhchhhhcccchh---ccCCCCCCHHHHcc--CCCHHHHHHHHH
Confidence            9999999999999999999999999999888877777665433211110   00000111111111  257788899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCc
Q psy7889         242 LLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ||+.||++|||+.|+|+||||
T Consensus       270 ~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         270 CLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             HhccCchhcCCHHHHhcCCCC
Confidence            999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07859 STKc_TDY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TDY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=4.5e-40  Score=319.19  Aligned_cols=251  Identities=32%  Similarity=0.541  Sum_probs=190.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++||||+++++++.....   .....+|+|||||+++|.+.+... ..+++..++.++.||+.||.||
T Consensus        44 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~L  119 (338)
T cd07859          44 TRILREIKLLRLLRHPDIVEIKHIMLPPSR---REFKDIYVVFELMESDLHQVIKAN-DDLTPEHHQFFLYQLLRALKYI  119 (338)
T ss_pred             HHHHHHHHHHHhCCCCCEeeecceEeccCC---CCCceEEEEEecCCCCHHHHHHhc-ccCCHHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999875422   112468999999999999888653 3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGAGCIM  166 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil  166 (433)
                      |++||+||||||+|||++.++.+||+|||++......... ........||..|+|||++.+. ..++.++||||+||++
T Consensus       120 H~~~ivH~dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~~~~~~~~DvwSlGvvl  198 (338)
T cd07859         120 HTANVFHRDLKPKNILANADCKLKICDFGLARVAFNDTPT-AIFWTDYVATRWYRAPELCGSFFSKYTPAIDIWSIGCIF  198 (338)
T ss_pred             HHCCeecCCCCHHHeEECCCCcEEEccCccccccccccCc-cccccCCCCCCCcCCHHHHhccccccCchhHHHHHHHHH
Confidence            9999999999999999999999999999999765322111 1122345789999999998652 3478999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|++||.+.+....+..+....|.+....+..+.......... ............+.  ..++.+.++|.+||..
T Consensus       199 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~  276 (338)
T cd07859         199 AEVLTGKPLFPGKNVVHQLDLITDLLGTPSPETISRVRNEKARRYLSSMRKKQPVPFSQKFP--NADPLALRLLERLLAF  276 (338)
T ss_pred             HHHHcCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhhcccCCCchHHhcC--CCChHHHHHHHHHcCc
Confidence            99999999999998888888888888776554333222111000000 00000000011111  2467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||++|||++|+|+||||...
T Consensus       277 ~P~~Rpt~~e~l~hp~f~~~  296 (338)
T cd07859         277 DPKDRPTAEEALADPYFKGL  296 (338)
T ss_pred             CcccCCCHHHHhcCchhhhc
Confidence            99999999999999999653

Serine/Threonine Kinases (STKs), Plant TDY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TDY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. Oryza sativa contains at least 17 MAPKs. There are two subtypes of plant MAPKs based on the conserved phos

>KOG0032|consensus

Probab=100.00  E-value=1.4e-39  Score=315.16  Aligned_cols=214  Identities=33%  Similarity=0.533  Sum_probs=187.7

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.||+++. |||||.++++|++.        ..+++|||+|. |.|++.+...  .+++..+..++.|++.|++
T Consensus        80 ~~v~~Ev~il~~l~~hpniv~l~~~~e~~--------~~~~lvmEL~~GGeLfd~i~~~--~~sE~da~~~~~~il~av~  149 (382)
T KOG0032|consen   80 EDVRREVAILQQLSGHPNIVQLKDAFEDP--------DSVYLVMELCEGGELFDRIVKK--HYSERDAAGIIRQILEAVK  149 (382)
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEEcC--------CeEEEEEEecCCchHHHHHHHc--cCCHHHHHHHHHHHHHHHH
Confidence            57899999999998 99999999999987        56999999998 5788888776  3999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecC----CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKT----GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~----~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||+.||+|||+||+|+|+...    +.+|++|||++.....+     ......+||+.|+|||++.... |+..+||||
T Consensus       150 ~lH~~gvvHrDlKpEN~L~~~~~~~~~~ik~~DFGla~~~~~~-----~~~~~~~Gtp~y~APEvl~~~~-y~~~~DiWS  223 (382)
T KOG0032|consen  150 YLHSLGVVHRDLKPENLLLASKDEGSGRIKLIDFGLAKFIKPG-----ERLHTIVGTPEYVAPEVLGGRP-YGDEVDVWS  223 (382)
T ss_pred             HHHhCCceeccCCHHHeeeccccCCCCcEEEeeCCCceEccCC-----ceEeeecCCccccCchhhcCCC-CCcccchhH
Confidence            9999999999999999999643    47999999999887642     3466789999999999997655 899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|.|++|.+||.+.+.......|...-.....+.|..                            ++..+++||.+
T Consensus       224 ~Gvi~yiLL~G~~PF~~~~~~~~~~~i~~~~~~f~~~~w~~----------------------------is~~akd~i~~  275 (382)
T KOG0032|consen  224 IGVILYILLSGVPPFWGETEFEIFLAILRGDFDFTSEPWDD----------------------------ISESAKDFIRK  275 (382)
T ss_pred             HHHHHHHHhhCCCCCcCCChhHHHHHHHcCCCCCCCCCccc----------------------------cCHHHHHHHHH
Confidence            99999999999999999998888887766555455555543                            35677899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||..||.+|+|+.++|+|||+...
T Consensus       276 ll~~dp~~R~ta~~~L~HpWi~~~  299 (382)
T KOG0032|consen  276 LLEFDPRKRLTAAQALQHPWIKSI  299 (382)
T ss_pred             hcccCcccCCCHHHHhcCccccCC
Confidence            999999999999999999999754

>PHA03212 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=7.4e-40  Score=323.11  Aligned_cols=250  Identities=26%  Similarity=0.348  Sum_probs=185.1

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+++|++|+|||||+++++|...        ...++|||++.++|...+... ..+++..++.++.||+.||+
T Consensus       126 ~~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~  196 (391)
T PHA03212        126 QRGGTATEAHILRAINHPSIIQLKGTFTYN--------KFTCLILPRYKTDLYCYLAAK-RNIAICDILAIERSVLRAIQ  196 (391)
T ss_pred             hhhhhHHHHHHHHhCCCCCCCCEeEEEEEC--------CeeEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999875        668999999999998888664 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......   .......+||+.|+|||++.+.. ++.++||||+||+
T Consensus       197 ylH~~~IvHrDiKP~NIll~~~~~vkL~DFG~a~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi  272 (391)
T PHA03212        197 YLHENRIIHRDIKAENIFINHPGDVCLGDFGAACFPVDIN---ANKYYGWAGTIATNAPELLARDP-YGPAVDIWSAGIV  272 (391)
T ss_pred             HHHhCCcccCCCChHhEEEcCCCCEEEEeCCccccccccc---ccccccccCccCCCChhhhcCCC-CCcHHHHHHHHHH
Confidence            9999999999999999999999999999999986543211   12234567899999999997755 7999999999999


Q ss_pred             HHHHHhcCCCCCCC-------ChHHHHHHHHHHhCCCCCCCCCcccc--hhhh-hccccchHHHhhHHhhhCCccCChhH
Q psy7889         166 MAEMWTRSPIMQGN-------TEQQQITLISQLCGSITPESWPGVET--LDLY-NKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       166 l~ell~g~~pf~~~-------~~~~~~~~i~~~~g~~~~~~~~~~~~--~~~~-~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      +|+|++|..||.+.       ....++..+....|..+.+.......  ...+ ......................+.++
T Consensus       273 l~elltg~~p~~~~~~~~~~~~~~~~l~~i~~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  352 (391)
T PHA03212        273 LFEMATCHDSLFEKDGLDGDCDSDRQIKLIIRRSGTHPNEFPIDAQANLDEIYIGLAKKSSRKPGSRPLWTNLYELPIDL  352 (391)
T ss_pred             HHHHHHCCCCcCCcccccccCchhHHHHHHHHHhcCChhhcCcchhHHHHHHHHHHHhccCCCCCCCCCHHHHhhhhhhH
Confidence            99999998766543       23456666777777654432211100  0000 00000000000000000001235678


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      .+||.+||++||.+|||++|+|+||||...+.+
T Consensus       353 ~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        353 EYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             HHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            899999999999999999999999999775433

>KOG0694|consensus

Probab=100.00  E-value=2.3e-40  Score=324.44  Aligned_cols=217  Identities=25%  Similarity=0.380  Sum_probs=186.4

Q ss_pred             CCCCCchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQL   80 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~ql   80 (433)
                      |.+..-+..+.|..|+... +||++++|+.+|++.        +++|+||||+.|+.. +.......|++..++.|+.+|
T Consensus       407 l~~d~Ve~~~~EkrI~~la~~HPFL~~L~~~fQT~--------~~l~fvmey~~Ggdm-~~~~~~~~F~e~rarfyaAev  477 (694)
T KOG0694|consen  407 LQRDEVESLMCEKRIFELANRHPFLVNLFSCFQTK--------EHLFFVMEYVAGGDL-MHHIHTDVFSEPRARFYAAEV  477 (694)
T ss_pred             eccccHHHHHHHHHHHHHhccCCeEeecccccccC--------CeEEEEEEecCCCcE-EEEEecccccHHHHHHHHHHH
Confidence            4555667889999999988 599999999999997        779999999987552 122233579999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.||+|||++||||||||.+|||+|.+|.+||+|||+++......    ...+++|||+.|+|||++.+.. |+.++|+|
T Consensus       478 ~l~L~fLH~~~IIYRDlKLdNiLLD~eGh~kiADFGlcKe~m~~g----~~TsTfCGTpey~aPEil~e~~-Yt~aVDWW  552 (694)
T KOG0694|consen  478 VLGLQFLHENGIIYRDLKLDNLLLDTEGHVKIADFGLCKEGMGQG----DRTSTFCGTPEFLAPEVLTEQS-YTRAVDWW  552 (694)
T ss_pred             HHHHHHHHhcCceeeecchhheEEcccCcEEecccccccccCCCC----CccccccCChhhcChhhhccCc-ccchhhHH
Confidence            999999999999999999999999999999999999998765332    3567899999999999998876 89999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||+|||||.|.+||+|.++++....|..--                                ..-|...|.++..+++
T Consensus       553 ~lGVLlyeML~Gq~PF~gddEee~FdsI~~d~--------------------------------~~yP~~ls~ea~~il~  600 (694)
T KOG0694|consen  553 GLGVLLYEMLVGESPFPGDDEEEVFDSIVNDE--------------------------------VRYPRFLSKEAIAIMR  600 (694)
T ss_pred             HHHHHHHHHHcCCCCCCCCCHHHHHHHHhcCC--------------------------------CCCCCcccHHHHHHHH
Confidence            99999999999999999999998877775411                                1123346889999999


Q ss_pred             hhcccCCCCCCCH-----HHhhcCCCccC
Q psy7889         241 KLLLLDPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       241 ~~L~~dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      ++|..+|.+|..+     +++..||||.+
T Consensus       601 ~ll~k~p~kRLG~~e~d~~~i~~hpFFr~  629 (694)
T KOG0694|consen  601 RLLRKNPEKRLGSGERDAEDIKKHPFFRS  629 (694)
T ss_pred             HHhccCcccccCCCCCCchhhhhCCcccc
Confidence            9999999999875     88999999965

>KOG0580|consensus

Probab=100.00  E-value=9e-41  Score=288.92  Aligned_cols=216  Identities=27%  Similarity=0.435  Sum_probs=190.4

Q ss_pred             CCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc-cCCCCCHHHHHHHHHH
Q psy7889           2 LGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN-IHVKFSLGEIKKVIQQ   79 (433)
Q Consensus         2 ~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~q   79 (433)
                      ++.+.++++.|||+|...|+||||+++|++|.++        ..+||++||.. |.++..+.. ...++++...+.+++|
T Consensus        61 ~~~~v~~qlrREiEIqs~L~hpnilrlY~~fhd~--------~riyLilEya~~gel~k~L~~~~~~~f~e~~~a~Yi~q  132 (281)
T KOG0580|consen   61 LKTQVEHQLRREIEIQSHLRHPNILRLYGYFHDS--------KRIYLILEYAPRGELYKDLQEGRMKRFDEQRAATYIKQ  132 (281)
T ss_pred             HHhcchhhhhheeEeecccCCccHHhhhhheecc--------ceeEEEEEecCCchHHHHHHhcccccccccchhHHHHH
Confidence            4567899999999999999999999999999987        66999999987 678888873 3446999999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ++.||.|||..+++||||||+|+|++.+|.+|++|||.+.....      ....+.|||..|.+||...+.. ++..+|+
T Consensus       133 ~A~Al~y~h~k~VIhRdiKpenlLlg~~~~lkiAdfGwsV~~p~------~kR~tlcgt~dyl~pEmv~~~~-hd~~Vd~  205 (281)
T KOG0580|consen  133 LANALLYCHLKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPS------NKRKTLCGTLDYLPPEMVEGRG-HDKFVDL  205 (281)
T ss_pred             HHHHHHHhccCCcccCCCCHHHhccCCCCCeeccCCCceeecCC------CCceeeecccccCCHhhcCCCC-ccchhhH
Confidence            99999999999999999999999999999999999998866432      3446789999999999988766 6999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |++|++.||++.|.+||...+..+...+|.++--..                                |...+.++.|+|
T Consensus       206 w~lgvl~yeflvg~ppFes~~~~etYkrI~k~~~~~--------------------------------p~~is~~a~dlI  253 (281)
T KOG0580|consen  206 WSLGVLCYEFLVGLPPFESQSHSETYKRIRKVDLKF--------------------------------PSTISGGAADLI  253 (281)
T ss_pred             HHHHHHHHHHHhcCCchhhhhhHHHHHHHHHccccC--------------------------------CcccChhHHHHH
Confidence            999999999999999999999888888887643322                                224678889999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||.++|.+|++..|++.|||+..
T Consensus       254 ~~ll~~~p~~r~~l~~v~~hpwI~a  278 (281)
T KOG0580|consen  254 SRLLVKNPIERLALTEVMDHPWIVA  278 (281)
T ss_pred             HHHhccCccccccHHHHhhhHHHHh
Confidence            9999999999999999999999854

>cd07853 STKc_NLK Catalytic domain of the Serine/Threonine Kinase, Nemo-Like Kinase

Probab=100.00  E-value=7.2e-40  Score=322.08  Aligned_cols=251  Identities=31%  Similarity=0.524  Sum_probs=193.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++.....   .....+|+||||+.++|...+.. ...+++..++.++.||+.||+||
T Consensus        44 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L  119 (372)
T cd07853          44 KRVFRELKMLCFFKHDNVLSALDILQPPHI---DPFEEIYVVTELMQSDLHKIIVS-PQPLSSDHVKVFLYQILRGLKYL  119 (372)
T ss_pred             HHHHHHHHHHHhCCCCCcCCHhheecCCCc---cccceEEEEeeccccCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999987532   11246899999999999888765 34689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++........   .......++..|+|||++.+...++.++||||+||++|
T Consensus       120 H~~~ivH~dlkp~Nili~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  196 (372)
T cd07853         120 HSAGILHRDIKPGNLLVNSNCVLKICDFGLARVEEPDES---KHMTQEVVTQYYRAPEILMGSRHYTSAVDIWSVGCIFA  196 (372)
T ss_pred             HhCCeeCCCCChHHEEECCCCCEEeccccceeecccCcc---ccCCCCCcCCCcCCHHHHcCCCCCCcHHHHHhHHHHHH
Confidence            999999999999999999999999999999976542211   12334567899999999987666899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhh-hCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKER-LKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|++||.+.+..+.+..+...+|.+..+.+..............+.. ....... ......+.++.+||.+||..|
T Consensus       197 el~~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~li~~mL~~d  275 (372)
T cd07853         197 ELLGRRILFQAQSPIQQLDLITDLLGTPSLEAMRSACEGARAHILRGPHK-PPSLPVLYTLSSQATHEAVHLLCRMLVFD  275 (372)
T ss_pred             HHHcCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhHHHHHHHHhCCCC-CCchHHhcccCCCCCHHHHHHHHHhCCCC
Confidence            99999999999999999999999888765533221111000000000000 0000000 011234788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       276 P~~R~t~~e~l~hp~~~~~~  295 (372)
T cd07853         276 PDKRISAADALAHPYLDEGR  295 (372)
T ss_pred             hhhCcCHHHHhcCHhhCCCc
Confidence            99999999999999997643

Serine/Threonine Kinases (STKs), Nemo-Like Kinase (NLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mitogen-activated protein kinases (MAPKs) are important mediators of cellular responses to extracellular signals. NLK is an atypical MAPK that is not regulated by a MAPK kinase. It functions downstream of the MAPK kinase kinase Tak1, which also plays a role in activating the JNK and p38 MAPKs. The Tak1/NLK pathways are regulated by Wnts, a family of secreted proteins that is critical in the control of asymmetric division and cell polarity. NLK can phosphorylate transcription

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=100.00  E-value=2.5e-39  Score=311.07  Aligned_cols=250  Identities=34%  Similarity=0.636  Sum_probs=188.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc--------CCCCCHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--------HVKFSLGEIKKVI   77 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~--------~~~l~~~~~~~i~   77 (433)
                      ....+.+|+++|+.++||||+++++++....      ...+|+||||++++|.+.+...        ...+++..++.++
T Consensus        41 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~i~  114 (317)
T cd07867          41 ISMSACREIALLRELKHPNVIALQKVFLSHS------DRKVWLLFDYAEHDLWHIIKFHRASKANKKPMQLPRSMVKSLL  114 (317)
T ss_pred             CcHHHHHHHHHHHhCCCCCeeeEEEEEeccC------CCeEEEEEeeeCCcHHHHHHhhhccccCCCCccCCHHHHHHHH
Confidence            3456889999999999999999999987543      2678999999999988887532        1248899999999


Q ss_pred             HHHHHHHHHHHhCCeeccCCCCCcEEE----ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCC
Q psy7889          78 QQLLNGLYYIHSNKILHRDMKAANVLI----TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNY  153 (433)
Q Consensus        78 ~qll~aL~~LH~~~iiH~dikp~NIll----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (433)
                      .||+.||.|||++||+||||||+||++    +.++.+||+|||+++....... .........+|..|+|||++.+...+
T Consensus       115 ~qi~~aL~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~~t~~y~aPE~~~~~~~~  193 (317)
T cd07867         115 YQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGARHY  193 (317)
T ss_pred             HHHHHHHHHHHhCCEEcCCCCHHHEEEccCCCCCCcEEEeeccceeccCCCcc-cccccCcceecccccCcHHhcCCCcc
Confidence            999999999999999999999999999    4567899999999987643221 11223445779999999999876668


Q ss_pred             CCcchhhhHHHHHHHHHhcCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCcccchhhhhccccc----hHHHh
Q psy7889         154 GPPVDLWGAGCIMAEMWTRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKMELP----KAQKR  220 (433)
Q Consensus       154 ~~~~DiwSlGvil~ell~g~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~----~~~~~  220 (433)
                      +.++||||+||++|+|++|.+||.....         ...+..+...+|.+....|........+......    .....
T Consensus       194 ~~~~DiwSlG~il~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (317)
T cd07867         194 TKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPFHHDQLDRIFSVMGFPADKDWEDIRKMPEYPTLQKDFRRTTYANS  273 (317)
T ss_pred             CcHHHHHhHHHHHHHHHhCCCCcccccccccccccccHHHHHHHHHhcCCCChhhhhhhhhcccchhhhhhhcccccCCc
Confidence            9999999999999999999999986443         3456677777887777766554332211110000    00000


Q ss_pred             hHHhhh--CCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         221 KVKERL--KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       221 ~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ......  .....+..+++||.+||+.||.+|||++|+|+||||
T Consensus       274 ~~~~~~~~~~~~~~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         274 SLIKYMEKHKVKPDSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             hhhhhhhcccCCCChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            000001  112346678899999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=100.00  E-value=6.9e-39  Score=307.10  Aligned_cols=251  Identities=43%  Similarity=0.790  Sum_probs=202.4

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.++++++|+||+++++++....      .+.+|+||||+.++|.+++......+++..++.++.||+.||+
T Consensus        49 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~~l~  122 (309)
T cd07845          49 IPISSLREITLLLNLRHPNIVELKEVVVGKH------LDSIFLVMEYCEQDLASLLDNMPTPFSESQVKCLMLQLLRGLQ  122 (309)
T ss_pred             CcchhhHHHHHHHhCCCCCCcceEEEEecCC------CCeEEEEEecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            3456778999999999999999999997642      2568999999999999988876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||+||+
T Consensus       123 ~lH~~~i~H~dl~p~nil~~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~i  198 (309)
T cd07845         123 YLHENFIIHRDLKVSNLLLTDKGCLKIADFGLARTYGLPA----KPMTPKVVTLWYRAPELLLGCTTYTTAIDMWAVGCI  198 (309)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEECccceeeecCCcc----CCCCcccccccccChhhhcCCCCcCchHHHHHHHHH
Confidence            9999999999999999999999999999999997765322    122233457889999998776667999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+....+.+....|+........................+  ...+.++.+||.+||.+
T Consensus       199 l~el~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~ml~~  276 (309)
T cd07845         199 LAELLAHKPLLPGKSEIEQLDLIIQLLGTPNESIWPGFSDLPLVGKFTLPKQPYNNLKHKF--PWLSEAGLRLLNFLLMY  276 (309)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChhhchhhhcccccccccccCCCCCchHHhc--cccCHHHHHHHHHHhcC
Confidence            9999999999999999999999999888887777765544433332222111111111111  12478889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ||++|||++++++||||...+-+
T Consensus       277 dp~~R~t~~~il~h~~f~~~~~~  299 (309)
T cd07845         277 DPKKRATAEEALESSYFKEKPLP  299 (309)
T ss_pred             ChhhCcCHHHHhcChhhccCCCC
Confidence            99999999999999999765544

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0611|consensus

Probab=100.00  E-value=1.1e-39  Score=300.84  Aligned_cols=209  Identities=23%  Similarity=0.438  Sum_probs=185.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.|||+||..|+||||+.+|++|+++        +.+.|||||.. |.|++++... ..+++.+++.+++||..|+.|
T Consensus        98 vhIRREIeIMSsLNHPhII~IyEVFENk--------dKIvivMEYaS~GeLYDYiSer-~~LsErEaRhfFRQIvSAVhY  168 (668)
T KOG0611|consen   98 VHIRREIEIMSSLNHPHIIQIYEVFENK--------DKIVIVMEYASGGELYDYISER-GSLSEREARHFFRQIVSAVHY  168 (668)
T ss_pred             HHHHHHHHHHhhcCCCceeehhhhhcCC--------ceEEEEEEecCCccHHHHHHHh-ccccHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999987        67999999997 5899999874 479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+++++|||||.+|||++.++.+||+|||++..+...+     ...++||++.|.+||++.|.++-++.+|.|||||++
T Consensus       169 CHknrVvHRDLKLENILLD~N~NiKIADFGLSNly~~~k-----fLqTFCGSPLYASPEIvNG~PY~GPEVDsWsLGvLL  243 (668)
T KOG0611|consen  169 CHKNRVVHRDLKLENILLDQNNNIKIADFGLSNLYADKK-----FLQTFCGSPLYASPEIVNGTPYKGPEVDSWSLGVLL  243 (668)
T ss_pred             HhhccceecccchhheeecCCCCeeeeccchhhhhcccc-----HHHHhcCCcccCCccccCCCCCCCCccchhhHHHHH
Confidence            999999999999999999999999999999998876543     456789999999999999988778999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |.|+.|..||.|.+....+.+|......-++                                 .+..+.-||+.||..|
T Consensus       244 YtLVyGtMPFDG~Dhk~lvrQIs~GaYrEP~---------------------------------~PSdA~gLIRwmLmVN  290 (668)
T KOG0611|consen  244 YTLVYGTMPFDGRDHKRLVRQISRGAYREPE---------------------------------TPSDASGLIRWMLMVN  290 (668)
T ss_pred             HHHhhcccccCCchHHHHHHHhhcccccCCC---------------------------------CCchHHHHHHHHHhcC
Confidence            9999999999999999888888663332211                                 2345568999999999


Q ss_pred             CCCCCCHHHhhcCCCcc
Q psy7889         247 PSKRFDSDAALNHDFFW  263 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~  263 (433)
                      |.+|-|.+++-.|=|+.
T Consensus       291 P~RRATieDiAsHWWvN  307 (668)
T KOG0611|consen  291 PERRATIEDIASHWWVN  307 (668)
T ss_pred             cccchhHHHHhhhheee
Confidence            99999999999998884

>cd05571 STKc_PKB Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B

Probab=100.00  E-value=3.3e-39  Score=311.30  Aligned_cols=212  Identities=27%  Similarity=0.395  Sum_probs=175.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++...        +.+||||||+.+ +|...+.. ...+++..++.++.||+.||+|
T Consensus        40 ~~~~~e~~~l~~l~hp~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~  110 (323)
T cd05571          40 AHTLTESRVLQNTRHPFLTALKYSFQTH--------DRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALGY  110 (323)
T ss_pred             HHHHHHHHHHHhCCCCCCCCEEEEEEcC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        669999999975 67777655 4468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       111 lH~~~ivHrDlkp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  185 (323)
T cd05571         111 LHSCDVVYRDLKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVM  185 (323)
T ss_pred             HHhCCeEeCCCCHHHEEECCCCCEEEeeCCCCcccccCC----CcccceecCccccChhhhcCCC-CCccccCcccchhh
Confidence            999999999999999999999999999999987532211    1233457899999999997755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+...  ..                 .             .+...+.++.+||.+||..|
T Consensus       186 ~elltg~~Pf~~~~~~~~~~~~~~~--~~-----------------~-------------~p~~~~~~~~~li~~~L~~d  233 (323)
T cd05571         186 YEMMCGRLPFYNQDHEKLFELILME--EI-----------------R-------------FPRTLSPEAKSLLAGLLKKD  233 (323)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHcC--CC-----------------C-------------CCCCCCHHHHHHHHHHccCC
Confidence            9999999999887766554443221  00                 0             01135677889999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccCC
Q psy7889         247 PSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~~  265 (433)
                      |++||     ++.++++||||...
T Consensus       234 P~~R~~~~~~~~~~ll~h~~f~~~  257 (323)
T cd05571         234 PKQRLGGGPEDAKEIMEHRFFASI  257 (323)
T ss_pred             HHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99999     89999999999663

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. It is activated downstream of PI3K and plays important roles in diverse cellular functions including cell survival, growth, proliferation, angiogenesis, motility, and migration. PKB also has a central role in a variety of human cancers, having be

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=100.00  E-value=1.3e-38  Score=301.86  Aligned_cols=244  Identities=39%  Similarity=0.691  Sum_probs=191.6

Q ss_pred             CCchhHHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQL   80 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql   80 (433)
                      +....+.+|+.+++.+   +||||+++++++.....   .....+++||||+.++|.+++.... ..+++..++.++.||
T Consensus        41 ~~~~~~~~e~~~l~~l~~~~h~ni~~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi  117 (288)
T cd07863          41 GLPLSTVREVALLKRLEAFDHPNIVRLMDVCATSRT---DRETKVTLVFEHVDQDLRTYLDKVPPPGLPAETIKDLMRQF  117 (288)
T ss_pred             CCchHHHHHHHHHHHhhhcCCCCeeeeeeeeccccC---CCCceEEEEEcccccCHHHHHHhcCCCCCCHHHHHHHHHHH
Confidence            4455678899988877   69999999999875421   1236689999999999998887643 348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.||+|||++||+||||||+||+++.++.+||+|||++.......     ......+|..|+|||++.+.. ++.++|||
T Consensus       118 ~~al~~lH~~~ivH~dikp~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Diw  191 (288)
T cd07863         118 LRGLDFLHANCIVHRDLKPENILVTSGGQVKLADFGLARIYSCQM-----ALTPVVVTLWYRAPEVLLQST-YATPVDMW  191 (288)
T ss_pred             HHHHHHHHhCCeecCCCCHHHEEECCCCCEEECccCccccccCcc-----cCCCccccccccCchHhhCCC-CCCcchhh
Confidence            999999999999999999999999999999999999997664321     123346788999999997655 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+||++|+|++|.+||.+....+.+..+....+.+....|+.........   .............  -..+..+.++|.
T Consensus       192 slG~~l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~li~  266 (288)
T cd07863         192 SVGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVTLPRGA---FSPRGPRPVQSVV--PEIEESGAQLLL  266 (288)
T ss_pred             hHHHHHHHHHhCCcCcCCCCHHHHHHHHHHHhCCCChhhCcccccccccc---cCCCCCCchHHhC--cCcCHHHHHHHH
Confidence            99999999999999999999888888888888877666665432211100   0000000111111  125677889999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCc
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      +||+.||.+|||+.|++.||||
T Consensus       267 ~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         267 EMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             HHhccCcccCCCHHHHhcCCCC
Confidence            9999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>cd07844 STKc_PCTAIRE_like Catalytic domain of PCTAIRE-like Serine/Threonine Kinases

Probab=100.00  E-value=1.3e-38  Score=302.33  Aligned_cols=244  Identities=40%  Similarity=0.710  Sum_probs=195.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+++++.++||||+++++++.+.        ...|+||||+.++|.+.+......+++..++.++.|++.||.|
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~~~ql~~al~~  118 (291)
T cd07844          47 PFTAIREASLLKDLKHANIVTLHDIIHTK--------KTLTLVFEYLDTDLKQYMDDCGGGLSMHNVRLFLFQLLRGLAY  118 (291)
T ss_pred             chhHHHHHHHHhhCCCcceeeEEEEEecC--------CeEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999875        6699999999999999887766678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||+||++
T Consensus       119 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG~il  194 (291)
T cd07844         119 CHQRRVLHRDLKPQNLLISERGELKLADFGLARAKSVPS----KTYSNEVVTLWYRPPDVLLGSTEYSTSLDMWGVGCIF  194 (291)
T ss_pred             HHhCCeecccCCHHHEEEcCCCCEEECccccccccCCCC----ccccccccccccCCcHHhhcCcccCcHHHHHHHHHHH
Confidence            999999999999999999999999999999986543211    1112234578899999987765678999999999999


Q ss_pred             HHHHhcCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNT-EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|.+||.+.. ..+.+..+....+.+.+..|+.......+........................++.++|.+||..
T Consensus       195 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~  274 (291)
T cd07844         195 YEMATGRPLFPGSTDVEDQLHKIFRVLGTPTEETWPGVSSNPEFKPYSFPFYPPRPLINHAPRLDRIPHGEELALKFLQY  274 (291)
T ss_pred             HHHHhCCCCCCCCccHHHHHHHHHHhcCCCChhhhhhhhhccccccccccccCChhHHHhCcCCCCchhHHHHHHHHhcc
Confidence            99999999998766 55667777788888877777666544333333322222222222222222347888999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|.+|||+.++++||||
T Consensus       275 ~p~~Rps~~e~l~~~~f  291 (291)
T cd07844         275 EPKKRISAAEAMKHPYF  291 (291)
T ss_pred             CcccccCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily share sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. The association of PCTAIRE-like proteins with cyclins has not been widely studied, although PFTAIRE-1 has been shown to function as a CDK which is regulated by cyclin D3 as well as the

>KOG0665|consensus

Probab=100.00  E-value=2.2e-40  Score=297.65  Aligned_cols=246  Identities=29%  Similarity=0.491  Sum_probs=199.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|..+|..++|+|||+++.+|.-...  -.....+|+|||++..+|.+.+.   ..+.-+.+..++.|++.|++|
T Consensus        59 akra~rel~l~~~v~~~nii~l~n~ftP~~~--l~~~~e~y~v~e~m~~nl~~vi~---~elDH~tis~i~yq~~~~ik~  133 (369)
T KOG0665|consen   59 AKRAYRELKLMKCVNHKNIISLLNVFTPQKT--LEEFQEVYLVMELMDANLCQVIL---MELDHETISYILYQMLCGIKH  133 (369)
T ss_pred             chhhhhhhhhhhhhcccceeeeeeccCcccc--HHHHHhHHHHHHhhhhHHHHHHH---HhcchHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999976522  11235589999999999998887   357888999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||+||+++.++.+||.|||+++.....     -..+..+.|++|+|||++.+.. |...+||||+||++
T Consensus       134 lhs~~IihRdLkPsnivv~~~~~lKi~dfg~ar~e~~~-----~~mtpyVvtRyyrapevil~~~-~ke~vdiwSvGci~  207 (369)
T KOG0665|consen  134 LHSAGIIHRDLKPSNIVVNSDCTLKILDFGLARTEDTD-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM  207 (369)
T ss_pred             HHhcceeecccCcccceecchhheeeccchhhcccCcc-----cccCchhheeeccCchheeccC-CcccchhhhhhhHH
Confidence            99999999999999999999999999999999764321     3567788999999999999877 89999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC----------ccCChhHH
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP----------YVKDQYGC  236 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~s~~~~  236 (433)
                      .||++|+..|+|.+..++..++...+|.+.+............--...++.........++.          ...+..++
T Consensus       208 gEli~~~Vlf~g~d~idQ~~ki~~~lgtpd~~F~~qL~~~~r~yv~~~~~y~~~~f~~~fpD~~f~~~~e~~~~~~~~ar  287 (369)
T KOG0665|consen  208 GELILGTVLFPGKDHIDQWNKIIEQLGTPDPSFMKQLQPTVRNYVENRPQYQAISFSELFPDSLFPVVLEGSKLDCSLAR  287 (369)
T ss_pred             HHHhhceEEecCchHHHHHHHHHHHhcCCCHHHHHHhhHHHHHHhhcChHhhccchhhhCCcccccccccCCccchHHHH
Confidence            99999999999999999999999999998876543333221110012222222222222221          12356789


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      |++.+||..||++|++++++|+|||+.
T Consensus       288 dll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  288 DLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             HHHHHhhccChhhcccHHHHhcCCeee
Confidence            999999999999999999999999995

>cd07861 STKc_CDK1_euk Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 1 from higher eukaryotes-like

Probab=100.00  E-value=1.7e-38  Score=300.57  Aligned_cols=242  Identities=43%  Similarity=0.774  Sum_probs=193.8

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC--CCCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~--~~l~~~~~~~i~~qll~a   83 (433)
                      ....+.+|+.+++.++||||+++++++.++        ..+|+||||+.++|.+.+....  ..+++..++.++.||+.|
T Consensus        42 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~  113 (285)
T cd07861          42 VPSTAIREISLLKELQHPNIVCLQDVLMQE--------SRLYLIFEFLSMDLKKYLDSLPKGQYMDAELVKSYLYQILQG  113 (285)
T ss_pred             chHHHHHHHHHHHhcCCCCEeeeEEEEeeC--------CeEEEEEecCCCCHHHHHhcCCCCCcCCHHHHHHHHHHHHHH
Confidence            346788999999999999999999999875        5699999999999988886543  458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||||
T Consensus       114 L~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  189 (285)
T cd07861         114 ILFCHSRRVLHRDLKPQNLLIDNKGVIKLADFGLARAFGIPV----RVYTHEVVTLWYRAPEVLLGSPRYSTPVDIWSIG  189 (285)
T ss_pred             HHHHHhCCeeecCCCHHHEEEcCCCcEEECcccceeecCCCc----ccccCCcccccccChHHhcCCCCcCcHHHHHHHH
Confidence            999999999999999999999999999999999987653221    1223345688999999987765578999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|.+||.+....+....+....+.+....|+.......+... .+..........  ....+.+++++|.+||
T Consensus       190 ~il~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~--~~~~~~~~~~li~~~l  266 (285)
T cd07861         190 TIFAEMATKKPLFHGDSEIDQLFRIFRILGTPTEDVWPGVTSLPDYKNT-FPKWKKGSLRSA--VKNLDEDGLDLLEKML  266 (285)
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhcchhhHHHHhh-ccccCcchhHHh--cCCCCHHHHHHHHHHh
Confidence            9999999999999999888888877777777766666554433222111 000000001111  1236788999999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..||.+|||+.++++||||
T Consensus       267 ~~dP~~Rpt~~~ll~~~~~  285 (285)
T cd07861         267 IYDPAKRISAKKALNHPYF  285 (285)
T ss_pred             cCChhhCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyclin A complex controls G2

>cd07843 STKc_CDC2L1 Catalytic domain of the Serine/Threonine Kinase, Cell Division Cycle 2-like 1

Probab=100.00  E-value=1.3e-38  Score=302.69  Aligned_cols=247  Identities=41%  Similarity=0.763  Sum_probs=201.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+++++.++||||+++++++....      ....|+||||+.++|.+++......+++..++.++.||+.||+
T Consensus        47 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~~------~~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~  120 (293)
T cd07843          47 FPITSLREINILLKLQHPNIVTVKEVVVGSN------LDKIYMVMEYVEHDLKSLMETMKQPFLQSEVKCLMLQLLSGVA  120 (293)
T ss_pred             chhhHHHHHHHHHhcCCCCEEEEEEEEEecC------CCcEEEEehhcCcCHHHHHHhccCCCCHHHHHHHHHHHHHHHH
Confidence            3446789999999999999999999987652      2669999999999999988776657999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+...++.++||||+||+
T Consensus       121 ~LH~~~i~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~~  196 (293)
T cd07843         121 HLHDNWILHRDLKTSNLLLNNRGILKICDFGLAREYGSPL----KPYTQLVVTLWYRAPELLLGAKEYSTAIDMWSVGCI  196 (293)
T ss_pred             HHHHCCeeeccCCHHHEEECCCCcEEEeecCceeeccCCc----cccccccccccccCchhhcCCccccchhhHHHHHHH
Confidence            9999999999999999999999999999999987765432    122344568889999998776557899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||.+.+..+....+...++.+....|+........................+.....+..+.++|.+||+.
T Consensus       197 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~l~~  276 (293)
T cd07843         197 FAELLTKKPLFPGKSEIDQLNKIFKLLGTPTEKIWPGFSELPGAKKKTFTKYPYNQLRKKFPALSLSDNGFDLLNRLLTY  276 (293)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCchHHHHHhhccchhcccccccccchhhhccccccCCChHHHHHHHHHhcc
Confidence            99999999999999999988888888888777766655443333322222222222233333333578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|++|||+.|+|.|+||
T Consensus       277 ~p~~R~t~~ell~~~~f  293 (293)
T cd07843         277 DPAKRISAEDALKHPYF  293 (293)
T ss_pred             CccccCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 1 (CDC2L1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L1, also called PITSLRE, exists in different isoforms which are named using the alias CDK11(p). The CDC2L1 gene produces two protein products, CDK11(p110) and CDK11(p58). CDC2L1 is also represented by the caspase-processed CDK11(p46). CDK11(p110), the

>cd07839 STKc_CDK5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 5

Probab=100.00  E-value=6.2e-39  Score=303.45  Aligned_cols=242  Identities=40%  Similarity=0.721  Sum_probs=192.1

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.+++.++||||+++++++.+.        ..+|+|+||++++|.+.+......+++..++.++.||+.||.
T Consensus        42 ~~~~~~~ei~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~al~  113 (284)
T cd07839          42 VPSSALREICLLKELKHKNIVRLYDVLHSD--------KKLTLVFEYCDQDLKKYFDSCNGDIDPEIVKSFMFQLLKGLA  113 (284)
T ss_pred             CccchhHHHHHHHhcCCCCeeeHHHHhccC--------CceEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            345678899999999999999999999875        569999999999999988776667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||+||+
T Consensus       114 ~LH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~i  189 (284)
T cd07839         114 FCHSHNVLHRDLKPQNLLINKNGELKLADFGLARAFGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCI  189 (284)
T ss_pred             HHHHCCEecCCCCHHHEEEcCCCcEEECccchhhccCCCC----CCcCCCccccCCcChHHHhCCcccCcHHHHHHHHHH
Confidence            9999999999999999999999999999999987654321    122344668899999998776667899999999999


Q ss_pred             HHHHHhcCCC-CCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPI-MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++|..| |.+.+..+.+..+....+......|+.......+........... ....  ....+.++++||.+||.
T Consensus       190 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~--~~~~~~~~~~li~~~l~  266 (284)
T cd07839         190 FAELANAGRPLFPGNDVDDQLKRIFRLLGTPTEESWPGVSKLPDYKPYPMYPATTS-LVNV--VPKLNSTGRDLLQNLLV  266 (284)
T ss_pred             HHHHHhcCCCCcCCCCHHHHHHHHHHHhCCCChHHhHHhhhcccccccCCCCCcch-hhhh--cccCCHHHHHHHHHHhc
Confidence            9999997655 677777778888888777776665554433222211111000000 0000  11357888999999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .||.+|||+++++.||||
T Consensus       267 ~~P~~R~t~~~il~h~~f  284 (284)
T cd07839         267 CNPVQRISAEEALQHPYF  284 (284)
T ss_pred             CChhhcCCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 5 (CDK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK5 is unusual in that it is regulated by non-cyclin proteins, p35 and p39. It is highly expressed in the nervous system and is critical in normal neural development and function. It plays a role in neuronal migration and differentiation, and is also

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=100.00  E-value=8.8e-39  Score=313.49  Aligned_cols=247  Identities=28%  Similarity=0.478  Sum_probs=187.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++.....  ......+|+||||+++++...+..   .+++..++.++.|++.||+|
T Consensus        67 ~~~~~~E~~~l~~l~h~~ii~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~aL~~  141 (364)
T cd07875          67 AKRAYRELVLMKCVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH  141 (364)
T ss_pred             HHHHHHHHHHHHhcCCCCccccceeeccccc--ccccCeEEEEEeCCCCCHHHHHHh---cCCHHHHHHHHHHHHHHHHH
Confidence            3567889999999999999999999875421  111256899999999998887753   47899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++......     ......+|..|+|||++.+.. ++.++|||||||++
T Consensus       142 LH~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il  215 (364)
T cd07875         142 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM  215 (364)
T ss_pred             HhhCCeecCCCCHHHEEECCCCcEEEEeCCCccccCCCC-----cccCCcccCCcCCHHHHhCCC-CCchhhHHhHHHHH
Confidence            999999999999999999999999999999997654321     223457799999999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhh----------CCccCChhHH
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL----------KPYVKDQYGC  236 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~~  236 (433)
                      |+|++|..||.+.+..+....+....+.+.++.+..............+...........          .....+.+++
T Consensus       216 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  295 (364)
T cd07875         216 GEMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQAR  295 (364)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhhHHHHHHHhhCCCcCCCChHhhCccccccccccccccccHHHH
Confidence            999999999999999888888888777665443222211100000000000000000000          0112356789


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +||.+||+.||++|||++|+|+||||..
T Consensus       296 dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         296 DLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             HHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            9999999999999999999999999954

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07832 STKc_CCRK Catalytic domain of the Serine/Threonine Kinase, Cell Cycle-Related Kinase

Probab=100.00  E-value=2e-38  Score=300.02  Aligned_cols=246  Identities=41%  Similarity=0.741  Sum_probs=203.0

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      +....+.+|+.+++.++||||+++++++...        ..+|+||||++++|.+.+......+++..++.++.||+.||
T Consensus        41 ~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l  112 (286)
T cd07832          41 GIPNQALREIKALQACQHPYVVKLLDVFPHG--------SGFVLVMEYMPSDLSEVLRDEERPLPEAQVKSYMRMLLKGV  112 (286)
T ss_pred             hhhHHHHHHHHHHHhCCCCCCcceeeEEecC--------CeeEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999999875        66899999998899999877666799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||.+.+...++.++||||+||
T Consensus       113 ~~lH~~~i~H~dl~p~ni~~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~  189 (286)
T cd07832         113 AYMHANGIMHRDLKPANLLISADGVLKIADFGLARLFSEEEP---RLYSHQVATRWYRAPELLYGARKYDPGVDLWAVGC  189 (286)
T ss_pred             HHHHHCCeecCCcCHHHEEEcCCCcEEEeeeeecccccCCCC---CccccccCcccccCceeeeccccCCchhHHHHHHH
Confidence            999999999999999999999999999999999877653221   12334567889999999877666789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.++|.+..+......+....+.+....|+.......+..+..+............  ..+..+.++|.+||.
T Consensus       190 ~l~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~  267 (286)
T cd07832         190 IFAELLNGSPLFPGENDIEQLAIVFRTLGTPNEETWPGLTSLPDYNKITFPESKPIPLEEIFP--DASPEALDLLKGLLV  267 (286)
T ss_pred             HHHHHHcCCcCcCCCCHHHHHHHHHHHcCCCChHHHhhccCcchhhcccCCCCCcchHHHhCC--CccHHHHHHHHHHhc
Confidence            999999999999999988888888888888877777665554444444333332222222221  235788899999999


Q ss_pred             cCCCCCCCHHHhhcCCCcc
Q psy7889         245 LDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~  263 (433)
                      .+|.+|||++++|+||||.
T Consensus       268 ~~p~~R~~~~~~l~h~~~~  286 (286)
T cd07832         268 YDPSKRLSAAEALRHPYFT  286 (286)
T ss_pred             cChhhCCCHHHHhhCcCcC
Confidence            9999999999999999983

Serine/Threonine Kinases (STKs), Cell Cycle-Related Kinase (CCRK) p42 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CCRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CCRK was previously called p42. It is a Cyclin-Dependent Kinase (CDK)-Activating Kinase (CAK) which is essential for the activation of CDK2. It is indispensable for cell growth and has been implicated in the progression of glioblastoma multiforme. In the heart, a splice variant of CCRK with a different C-terminal half is expressed, this variant promotes cardiac cell growth and survival and is significantly down-regulated during the development of hea

>cd07876 STKc_JNK2 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 2

Probab=100.00  E-value=1.1e-38  Score=312.33  Aligned_cols=246  Identities=30%  Similarity=0.509  Sum_probs=185.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++.....  ......+|+||||+++++...+..   .+++..+..++.||+.||+|
T Consensus        64 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~~~~qi~~~L~~  138 (359)
T cd07876          64 AKRAYRELVLLKCVNHKNIISLLNVFTPQKS--LEEFQDVYLVMELMDANLCQVIHM---ELDHERMSYLLYQMLCGIKH  138 (359)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeeccCCC--ccccceeEEEEeCCCcCHHHHHhc---cCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999975422  111245899999999988877643   57899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.+|.+||+|||++......     .......+|..|+|||++.+.. ++.++|||||||++
T Consensus       139 LH~~~ivHrDlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il  212 (359)
T cd07876         139 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTACTN-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM  212 (359)
T ss_pred             HHhCCcccCCCCHHHEEECCCCCEEEecCCCccccccC-----ccCCCCcccCCCCCchhccCCC-CCcchhhHHHHHHH
Confidence            99999999999999999999999999999998764321     1223457799999999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh-hhhccccchHHHhhHHhhh----------CCccCChhH
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD-LYNKMELPKAQKRKVKERL----------KPYVKDQYG  235 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~----------~~~~~s~~~  235 (433)
                      |+|++|.+||.+.+..+....+....+.+..+.+....... .+.. ..+..........+          .....+.++
T Consensus       213 ~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (359)
T cd07876         213 GELVKGSVIFQGTDHIDQWNKVIEQLGTPSAEFMNRLQPTVRNYVE-NRPQYPGISFEELFPDWIFPSESERDKLKTSQA  291 (359)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCcHHHHHHHHHHHHHHHh-hCCCCCCcchhhhccccccccccccccccchhH
Confidence            99999999999998888777777766655432211110000 0000 00000000000000          112346788


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ++||.+||..||++|||+.|+|+||||..
T Consensus       292 ~~li~~mL~~dP~~R~t~~e~l~hp~~~~  320 (359)
T cd07876         292 RDLLSKMLVIDPDKRISVDEALRHPYITV  320 (359)
T ss_pred             HHHHHHHhccCcccCCCHHHHhcCchhhh
Confidence            99999999999999999999999999964

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 2 (JNK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.5e-38  Score=309.39  Aligned_cols=246  Identities=33%  Similarity=0.578  Sum_probs=189.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++.....  ......+|+++++++++|...+..  ..+++..++.++.||+.||+||
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~aL~~L  134 (343)
T cd07878          59 RRTYRELRLLKHMKHENVIGLLDVFTPATS--IENFNEVYLVTNLMGADLNNIVKC--QKLSDEHVQFLIYQLLRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHhcCCCchhhhhhhhccccc--ccccCcEEEEeecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999875422  112356899999999998877653  3589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++......       .....+|+.|+|||++.+...++.++||||+||++|
T Consensus       135 H~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  207 (343)
T cd07878         135 HSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  207 (343)
T ss_pred             HHCCeecccCChhhEEECCCCCEEEcCCccceecCCC-------cCCccccccccCchHhcCCccCCchhhhHhHHHHHH
Confidence            9999999999999999999999999999999765421       234578999999999987656899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+....+.+..+....+.+..+.+..+.......... .+..........+  ...++.+.+||.+||..|
T Consensus       208 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~mL~~d  285 (343)
T cd07878         208 ELLKGKALFPGNDYIDQLKRIMEVVGTPSPEVLKKISSEHARKYIQSLPHMPQQDLKKIF--RGANPLAIDLLEKMLVLD  285 (343)
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhcchhhHHHHhhccccccchhHHHhc--cCCCHHHHHHHHHHcCCC
Confidence            9999999999998888888888877766544332222111000000 0000000011111  124567889999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||+.|+|+||||....
T Consensus       286 p~~R~s~~ell~hp~~~~~~  305 (343)
T cd07878         286 SDKRISASEALAHPYFSQYH  305 (343)
T ss_pred             hhhCCCHHHHhcCcchhccC
Confidence            99999999999999997543

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>PHA03207 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.1e-38  Score=313.69  Aligned_cols=247  Identities=25%  Similarity=0.330  Sum_probs=187.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ....+|+++|+.++|||||++++++...        ..+|+|||++.++|..++.. ...+++..++.++.||+.||.||
T Consensus       131 ~~~~~E~~il~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~-~~~l~~~~~~~i~~ql~~aL~~L  201 (392)
T PHA03207        131 KTPGREIDILKTISHRAIINLIHAYRWK--------STVCMVMPKYKCDLFTYVDR-SGPLPLEQAITIQRRLLEALAYL  201 (392)
T ss_pred             ccHHHHHHHHHhcCCCCccceeeeEeeC--------CEEEEEehhcCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            3457899999999999999999999875        56999999999999998843 45799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.++|+|||++........  ........||..|+|||++.+.. ++.++|||||||++|
T Consensus       202 H~~givHrDlkp~Nill~~~~~~~l~DfG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil~  278 (392)
T PHA03207        202 HGRGIIHRDVKTENIFLDEPENAVLGDFGAACKLDAHPD--TPQCYGWSGTLETNSPELLALDP-YCAKTDIWSAGLVLF  278 (392)
T ss_pred             HHCCccccCCCHHHEEEcCCCCEEEccCccccccCcccc--cccccccccccCccCHhHhcCCC-CCchhhHHHHHHHHH
Confidence            999999999999999999999999999999976653221  11223457899999999997765 799999999999999


Q ss_pred             HHHhcCCCCCCCC---hHHHHHHHHHHhCCCCCCCCCcccc--hhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         168 EMWTRSPIMQGNT---EQQQITLISQLCGSITPESWPGVET--LDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       168 ell~g~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      +|++|..||.+..   ....+..+...++..+.+.......  ...+................+.....+.++.+||.+|
T Consensus       279 el~~g~~pf~~~~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~m  358 (392)
T PHA03207        279 EMSVKNVTLFGKQVKSSSSQLRSIIRCMQVHPLEFPQNGSTNLCKHFKQYAIVLRPPYTIPPVIRKYGMHMDVEYLIAKM  358 (392)
T ss_pred             HHHHCCCCCCCCCCCCcHHHHHHHHHHhccCccccCCccchhHHHHHHhhcccccCCccccchhhccCcchhHHHHHHHH
Confidence            9999999997653   3455666666665443322111100  0011111111100111112222334567888999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|||+.|+|.||||...+
T Consensus       359 l~~dp~~Rpsa~e~l~~p~f~~~~  382 (392)
T PHA03207        359 LTFDQEFRPSAQDILSLPLFTKEP  382 (392)
T ss_pred             hccChhhCCCHHHHhhCchhhccc
Confidence            999999999999999999997654

>PTZ00426 cAMP-dependent protein kinase catalytic subunit; Provisional

Probab=100.00  E-value=1.3e-38  Score=308.88  Aligned_cols=209  Identities=26%  Similarity=0.350  Sum_probs=175.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|||||++++++.+.        +.+|+||||+. ++|.+++.. ...+++..+..++.||+.||.|
T Consensus        76 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--------~~~~lv~Ey~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~aL~~  146 (340)
T PTZ00426         76 DHVFSERKILNYINHPFCVNLYGSFKDE--------SYLYLVLEFVIGGEFFTFLRR-NKRFPNDVGCFYAAQIVLIFEY  146 (340)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEeC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        66999999996 578877765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++......       .....||+.|+|||++.+.. ++.++||||+||++
T Consensus       147 LH~~~ivHrDLkp~NILl~~~~~ikL~DFG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil  218 (340)
T PTZ00426        147 LQSLNIVYRDLKPENLLLDKDGFIKMTDFGFAKVVDTR-------TYTLCGTPEYIAPEILLNVG-HGKAADWWTLGIFI  218 (340)
T ss_pred             HHHCCeEccCCCHHHEEECCCCCEEEecCCCCeecCCC-------cceecCChhhcCHHHHhCCC-CCccccccchhhHH
Confidence            99999999999999999999999999999999765321       23457899999999997755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+.......                                +...+..+.++|.+||+.|
T Consensus       219 ~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~~l~~d  266 (340)
T PTZ00426        219 YEILVGCPPFYANEPLLIYQKILEGIIYF--------------------------------PKFLDNNCKHLMKKLLSHD  266 (340)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHhcCCCCC--------------------------------CCCCCHHHHHHHHHHcccC
Confidence            99999999999887766555543211100                                1124567789999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccCC
Q psy7889         247 PSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~~  265 (433)
                      |.+|+     +++++++||||...
T Consensus       267 p~~R~~~~~~~~~~~~~hp~f~~~  290 (340)
T PTZ00426        267 LTKRYGNLKKGAQNVKEHPWFGNI  290 (340)
T ss_pred             HHHcCCCCCCCHHHHHcCCCcCCC
Confidence            99995     89999999999653

>PTZ00263 protein kinase A catalytic subunit; Provisional

Probab=100.00  E-value=1.5e-38  Score=307.45  Aligned_cols=209  Identities=26%  Similarity=0.381  Sum_probs=175.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        +.+|+||||+.+ +|.+.+.+ ...+++..++.++.||+.||+|
T Consensus        63 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~  133 (329)
T PTZ00263         63 QHVAQEKSILMELSHPFIVNMMCSFQDE--------NRVYFLLEFVVGGELFTHLRK-AGRFPNDVAKFYHAELVLAFEY  133 (329)
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEcC--------CEEEEEEcCCCCChHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999876        669999999975 78777765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++......       .....||+.|+|||++.+.. ++.++|||||||++
T Consensus       134 LH~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  205 (329)
T PTZ00263        134 LHSKDIIYRDLKPENLLLDNKGHVKVTDFGFAKKVPDR-------TFTLCGTPEYLAPEVIQSKG-HGKAVDWWTMGVLL  205 (329)
T ss_pred             HHHCCeeecCCCHHHEEECCCCCEEEeeccCceEcCCC-------cceecCChhhcCHHHHcCCC-CCCcceeechHHHH
Confidence            99999999999999999999999999999999765421       12357899999999998765 69999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+..  +...                              .+...+..+++||.+||+.|
T Consensus       206 ~elltg~~pf~~~~~~~~~~~i~~--~~~~------------------------------~p~~~~~~~~~li~~~L~~d  253 (329)
T PTZ00263        206 YEFIAGYPPFFDDTPFRIYEKILA--GRLK------------------------------FPNWFDGRARDLVKGLLQTD  253 (329)
T ss_pred             HHHHcCCCCCCCCCHHHHHHHHhc--CCcC------------------------------CCCCCCHHHHHHHHHHhhcC
Confidence            999999999998876655554432  1110                              01124566789999999999


Q ss_pred             CCCCCC-----HHHhhcCCCccCC
Q psy7889         247 PSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t-----~~e~L~h~~~~~~  265 (433)
                      |.+|++     ++++++||||...
T Consensus       254 P~~R~~~~~~~~~~ll~hp~f~~~  277 (329)
T PTZ00263        254 HTKRLGTLKGGVADVKNHPYFHGA  277 (329)
T ss_pred             HHHcCCCCCCCHHHHhcCCccCCC
Confidence            999997     7999999999653

>PHA03209 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2e-38  Score=309.93  Aligned_cols=245  Identities=23%  Similarity=0.308  Sum_probs=180.2

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      +.......|+.+++.++|||||++++++...        ...|+|||++.++|.+++.+....+++..++.++.||+.||
T Consensus        99 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~aL  170 (357)
T PHA03209         99 GQKGTTLIEAMLLQNVNHPSVIRMKDTLVSG--------AITCMVLPHYSSDLYTYLTKRSRPLPIDQALIIEKQILEGL  170 (357)
T ss_pred             CCccccHHHHHHHHhCCCCCCcChhheEEeC--------CeeEEEEEccCCcHHHHHHhccCCCCHHHHHHHHHHHHHHH
Confidence            3445667899999999999999999999875        56899999999999999987777799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++||+||||||+|||++.++.+||+|||++......     .......||..|+|||++.+.. ++.++|||||||
T Consensus       171 ~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGv  244 (357)
T PHA03209        171 RYLHAQRIIHRDVKTENIFINDVDQVCIGDLGAAQFPVVA-----PAFLGLAGTVETNAPEVLARDK-YNSKADIWSAGI  244 (357)
T ss_pred             HHHHHCCeecCCCCHHHEEECCCCCEEEecCccccccccC-----cccccccccccccCCeecCCCC-CCchhhHHHHHH
Confidence            9999999999999999999999999999999998753321     1223456899999999997765 799999999999


Q ss_pred             HHHHHHhc-CCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCcccchhhhh-ccccchH--HHhhHHhhhCCccC
Q psy7889         165 IMAEMWTR-SPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYN-KMELPKA--QKRKVKERLKPYVK  231 (433)
Q Consensus       165 il~ell~g-~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~-~~~~~~~--~~~~~~~~~~~~~~  231 (433)
                      ++|+|+++ .++|.....         ...+..+...++..+.. ++......... .+.....  .+......+.....
T Consensus       245 vl~ell~~~~~~f~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  323 (357)
T PHA03209        245 VLFEMLAYPSTIFEDPPSTPEEYVKSCHSHLLKIISTLKVHPEE-FPRDPGSRLVRGFIEYASLERQPYTRYPCFQRVNL  323 (357)
T ss_pred             HHHHHHHcCCccccCCCCcHHHHHHHHHHHHHHHHHHhccChhh-cCCCCccHHHHHHHhhcccCCCcccccHHHhccCC
Confidence            99999985 455544221         12333444444433322 22111000000 0000000  00000011222345


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +.++.+||.+||++||.+|||+.|+|+||||++
T Consensus       324 ~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        324 PIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            678889999999999999999999999999964

>cd05612 STKc_PRKX_like Catalytic domain of PRKX-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-38  Score=302.89  Aligned_cols=208  Identities=26%  Similarity=0.409  Sum_probs=174.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++||||+++++++.+.        ..+|+||||+. ++|.+++.+. ..+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~qi~~~l~~  116 (291)
T cd05612          46 QHVHNEKRVLKEVSHPFIIRLFWTEHDQ--------RFLYMLMEYVPGGELFSYLRNS-GRFSNSTGLFYASEIVCALEY  116 (291)
T ss_pred             HHHHHHHHHHHhCCCCcHhhhHhhhccC--------CeEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999988765        66999999997 4788887653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||++......       ....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       117 lH~~~i~H~dlkp~NIli~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  188 (291)
T cd05612         117 LHSKEIVYRDLKPENILLDKEGHIKLTDFGFAKKLRDR-------TWTLCGTPEYLAPEVIQSKG-HNKAVDWWALGILI  188 (291)
T ss_pred             HHHCCeeecCCCHHHeEECCCCCEEEEecCcchhccCC-------cccccCChhhcCHHHHcCCC-CCchhhHHHHHHHH
Confidence            99999999999999999999999999999998765421       22346899999999987755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.+.......+....  ..                 +             +...+..+++||.+||+.|
T Consensus       189 ~~l~~g~~pf~~~~~~~~~~~i~~~~--~~-----------------~-------------~~~~~~~~~~li~~~l~~d  236 (291)
T cd05612         189 YEMLVGYPPFFDDNPFGIYEKILAGK--LE-----------------F-------------PRHLDLYAKDLIKKLLVVD  236 (291)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCC--cC-----------------C-------------CccCCHHHHHHHHHHcCCC
Confidence            99999999999887766555543211  00                 0             1123667889999999999


Q ss_pred             CCCCCC-----HHHhhcCCCccC
Q psy7889         247 PSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t-----~~e~L~h~~~~~  264 (433)
                      |.+|++     ++++++||||..
T Consensus       237 p~~R~~~~~~~~~~~l~h~~~~~  259 (291)
T cd05612         237 RTRRLGNMKNGADDVKNHRWFKS  259 (291)
T ss_pred             HHHccCCccCCHHHHhcCccccC
Confidence            999995     999999999965

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, PRKX-like kinases, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include human PRKX (X chromosome-encoded protein kinase), Drosophila DC2, and similar proteins. PRKX is present in many tissues including fetal and adult brain, kidney, and lung. The PRKX gene is located in the Xp22.3 subregion and has a homolog called PRKY on the Y chromosome. An abnormal interchange between PRKX aand PRKY leads to the sex reversal disorder of XX males and XY females. PRKX is implicated in granulocyt

>KOG0589|consensus

Probab=100.00  E-value=5.3e-39  Score=307.14  Aligned_cols=213  Identities=30%  Similarity=0.465  Sum_probs=189.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.++++++|||||.+++.|..+       +..+||||+||+| ++.+.+...+ ..|+++.+..|+.|++.|+.
T Consensus        48 ~~A~~E~~lis~~~hP~iv~y~ds~~~~-------~~~l~Ivm~Y~eGg~l~~~i~~~k~~~f~E~~i~~~~~Q~~~av~  120 (426)
T KOG0589|consen   48 RSAIQEMDLLSKLLHPNIVEYKDSFEED-------GQLLCIVMEYCEGGDLAQLIKEQKGVLFPEERILKWFVQILLAVN  120 (426)
T ss_pred             HHHHHHHHHHHhccCCCeeeeccchhcC-------CceEEEEEeecCCCCHHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            3678999999999999999999999987       2349999999985 8888887766 45899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+++|+|||||+.||+++.++.|+|+|||+|+.+....    ....+.+||+.|+.||++.+.+ |+.++|||||||+
T Consensus       121 ylH~~~iLHRDlK~~Nifltk~~~VkLgDfGlaK~l~~~~----~~a~tvvGTp~YmcPEil~d~p-Yn~KSDiWsLGC~  195 (426)
T KOG0589|consen  121 YLHENRVLHRDLKCANIFLTKDKKVKLGDFGLAKILNPED----SLASTVVGTPYYMCPEILSDIP-YNEKSDIWSLGCC  195 (426)
T ss_pred             HHHhhhhhcccchhhhhhccccCceeecchhhhhhcCCch----hhhheecCCCcccCHHHhCCCC-CCccCcchhhcch
Confidence            9999999999999999999999999999999999987542    2456789999999999998876 8999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|||++-++.|.+.+....+.+|.+....+.+.                               .++.+++.+|..||..
T Consensus       196 ~yEm~~lk~aF~a~~m~~Li~ki~~~~~~Plp~-------------------------------~ys~el~~lv~~~l~~  244 (426)
T KOG0589|consen  196 LYEMCTLKPAFKASNMSELILKINRGLYSPLPS-------------------------------MYSSELRSLVKSMLRK  244 (426)
T ss_pred             HHHHHhcccccCccchHHHHHHHhhccCCCCCc-------------------------------cccHHHHHHHHHHhhc
Confidence            999999999999999999999998876554433                               3577788999999999


Q ss_pred             CCCCCCCHHHhhcCCCcc
Q psy7889         246 DPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~  263 (433)
                      +|..||++.++|.+|.+.
T Consensus       245 ~P~~RPsa~~LL~~P~l~  262 (426)
T KOG0589|consen  245 NPEHRPSALELLRRPHLL  262 (426)
T ss_pred             CCccCCCHHHHhhChhhh
Confidence            999999999999998774

>cd05585 STKc_YPK1_like Catalytic domain of Yeast Protein Kinase 1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-38  Score=303.37  Aligned_cols=212  Identities=29%  Similarity=0.399  Sum_probs=174.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++...        +.+|+||||+.+ +|...+.. ...+++..++.++.||+.||.|
T Consensus        38 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~  108 (312)
T cd05585          38 THTLAERTVLAQVNCPFIVPLKFSFQSP--------EKLYLVLAFINGGELFHHLQR-EGRFDLSRARFYTAELLCALEN  108 (312)
T ss_pred             HHHHHHHHHHHhCCCCcEeceeeEEecC--------CeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999875        669999999975 77777765 4468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.++|+|||++.......    ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       109 lH~~~i~HrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslGvil  183 (312)
T cd05585         109 LHKFNVIYRDLKPENILLDYQGHIALCDFGLCKLNMKDD----DKTNTFCGTPEYLAPELLLGHG-YTKAVDWWTLGVLL  183 (312)
T ss_pred             HHhCCeEeCCCCHHHeEECCCCcEEEEECcccccCccCC----CccccccCCcccCCHHHHcCCC-CCCccceechhHHH
Confidence            999999999999999999999999999999987543211    1223457899999999997755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+...  ..   .                           .+...+.++.+||.+||..|
T Consensus       184 ~el~tg~~pf~~~~~~~~~~~~~~~--~~---~---------------------------~~~~~~~~~~~li~~~L~~d  231 (312)
T cd05585         184 YEMLTGLPPFYDENVNEMYRKILQE--PL---R---------------------------FPDGFDRDAKDLLIGLLSRD  231 (312)
T ss_pred             HHHHhCCCCcCCCCHHHHHHHHHcC--CC---C---------------------------CCCcCCHHHHHHHHHHcCCC
Confidence            9999999999987766554443221  00   0                           01124677889999999999


Q ss_pred             CCCCC---CHHHhhcCCCccCC
Q psy7889         247 PSKRF---DSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~---t~~e~L~h~~~~~~  265 (433)
                      |.+||   ++.++|.||||...
T Consensus       232 p~~R~~~~~~~e~l~hp~~~~~  253 (312)
T cd05585         232 PTRRLGYNGAQEIKNHPFFSQL  253 (312)
T ss_pred             HHHcCCCCCHHHHHcCCCcCCC
Confidence            99997   58999999999764

Serine/Threonine Kinases (STKs), Yeast protein kinase 1 (YPK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YPK1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the AGC STKs, Saccharomyces cerevisiae YPK1 and Schizosaccharomyces pombe Gad8p. YPK1 is required for cell growth and acts as a downstream kinase in the sphingolipid-mediated signaling pathway of yeast. It also plays a role in efficient endocytosis and in the maintenance of cell wall integrity. Gad8p is a downstream target of Tor1p, the fission yeast homolog of mTOR. It pl

>cd07874 STKc_JNK3 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 3

Probab=100.00  E-value=2.1e-38  Score=309.71  Aligned_cols=246  Identities=29%  Similarity=0.508  Sum_probs=186.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++.....  ......+|+||||+++++.+.+..   .+++..++.++.|++.||+||
T Consensus        61 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~qi~~aL~~L  135 (355)
T cd07874          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKS--LEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHL  135 (355)
T ss_pred             HHHHHHHHHHHHhCCCchhceeeeeecccc--ccccceeEEEhhhhcccHHHHHhh---cCCHHHHHHHHHHHHHHHHHH
Confidence            467789999999999999999999876422  111356899999999988877753   588999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||+++.....     .......+|..|+|||++.+.. ++.++|||||||++|
T Consensus       136 H~~givHrDikp~Nill~~~~~~kl~Dfg~~~~~~~~-----~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwslG~il~  209 (355)
T cd07874         136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMG  209 (355)
T ss_pred             HhCCcccCCCChHHEEECCCCCEEEeeCcccccCCCc-----cccCCccccCCccCHHHHcCCC-CCchhhHHHHHHHHH
Confidence            9999999999999999999999999999999765422     1223457899999999997755 799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh--------hhhccccchHHHhhHH--hhhCCccCChhHHH
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD--------LYNKMELPKAQKRKVK--ERLKPYVKDQYGCD  237 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~--------~~~~~~~~~~~~~~~~--~~~~~~~~s~~~~~  237 (433)
                      +|++|..||.+.+..+....+....+.+.++.+.......        .+.....+........  ....+...+.++++
T Consensus       210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  289 (355)
T cd07874         210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD  289 (355)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhcHHHHHHHhcCCccccccchhhccccccccccccccccchHHHH
Confidence            9999999999998888887777777765543322211100        0000000000000000  00011224567889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||.+||..||++|||+.|+|+||||..
T Consensus       290 li~~mL~~dP~~Rps~~ell~hp~~~~  316 (355)
T cd07874         290 LLSKMLVIDPAKRISVDEALQHPYINV  316 (355)
T ss_pred             HHHHHhcCCchhcCCHHHHhcCcchhc
Confidence            999999999999999999999999954

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 3 (JNK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK3 is expressed primarily in the brain, and to a lesser extent in the heart and testis. Mice deficient in Jnk3 are protected against kainic acid-induced seizures, strok

>cd05593 STKc_PKB_gamma Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B gamma

Probab=100.00  E-value=3.3e-38  Score=304.88  Aligned_cols=211  Identities=29%  Similarity=0.431  Sum_probs=173.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++...        +.+|+||||+++ +|...+.. ...+++..++.++.||+.||+|
T Consensus        40 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~Ey~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~  110 (328)
T cd05593          40 AHTLTESRVLKNTRHPFLTSLKYSFQTK--------DRLCFVMEYVNGGELFFHLSR-ERVFSEDRTRFYGAEIVSALDY  110 (328)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcC--------CEEEEEEeCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999875        669999999975 67666654 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       111 LH~~~ivHrDikp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil  185 (328)
T cd05593         111 LHSGKIVYRDLKLENLMLDKDGHIKITDFGLCKEGITDA----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVM  185 (328)
T ss_pred             HHhCCeEecccCHHHeEECCCCcEEEecCcCCccCCCcc----cccccccCCcCccChhhhcCCC-CCccCCccccchHH
Confidence            999999999999999999999999999999987532211    1233457899999999997655 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.+.......+..  +..                 .             .+...+.++.+||.+||..|
T Consensus       186 ~elltG~~Pf~~~~~~~~~~~~~~--~~~-----------------~-------------~p~~~~~~~~~li~~~L~~d  233 (328)
T cd05593         186 YEMMCGRLPFYNQDHEKLFELILM--EDI-----------------K-------------FPRTLSADAKSLLSGLLIKD  233 (328)
T ss_pred             HHHhhCCCCCCCCCHHHHHHHhcc--CCc-----------------c-------------CCCCCCHHHHHHHHHHcCCC
Confidence            999999999988776554443321  000                 0             01135677889999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccC
Q psy7889         247 PSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~  264 (433)
                      |++|+     ++.++++|+||..
T Consensus       234 P~~R~~~~~~~~~~il~h~~~~~  256 (328)
T cd05593         234 PNKRLGGGPDDAKEIMRHSFFTG  256 (328)
T ss_pred             HHHcCCCCCCCHHHHhcCCCcCC
Confidence            99997     8999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, gamma (or Akt3) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-gamma is predominantly expressed in neuronal tissues. Mice deficient in PKB-gamma show a reduction in brain weight due to the decreases in cell size and cell number. PKB-gamma has also been shown to be upregulate

>KOG0579|consensus

Probab=100.00  E-value=6.1e-39  Score=309.74  Aligned_cols=228  Identities=25%  Similarity=0.406  Sum_probs=189.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHH-HhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-LSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~-l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.++-||+||..++||+||+|++.|..+        +.++|.+|||+|+-.+. +......|++.+|..+++|+|.||.|
T Consensus        74 EDylVEIeILa~CdHP~ivkLl~ayy~e--------nkLwiliEFC~GGAVDaimlEL~r~LtE~QIqvvc~q~ldALn~  145 (1187)
T KOG0579|consen   74 EDYLVEIEILAECDHPVIVKLLSAYYFE--------NKLWILIEFCGGGAVDAIMLELGRVLTEDQIQVVCYQVLDALNW  145 (1187)
T ss_pred             hhhhhhhhhhhcCCChHHHHHHHHHhcc--------CceEEEEeecCCchHhHHHHHhccccchHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999988765        56999999999865544 45666679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSl  162 (433)
                      ||+++|||||||..|||++-+|.|+|+|||.+.....    ......+++||++|||||+..+.    ..|+.++|||||
T Consensus       146 LHs~~iIHRDLKAGNiL~TldGdirLADFGVSAKn~~----t~qkRDsFIGTPYWMAPEVvmCET~KD~PYDykaDiWSl  221 (1187)
T KOG0579|consen  146 LHSQNIIHRDLKAGNILLTLDGDIRLADFGVSAKNKS----TRQKRDSFIGTPYWMAPEVVMCETFKDQPYDYKADIWSL  221 (1187)
T ss_pred             HhhcchhhhhccccceEEEecCcEeeecccccccchh----HHhhhccccCCcccccchheeeccccCCCchhhhhHHhh
Confidence            9999999999999999999999999999999865432    22344678999999999998653    348999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |+++.||.-+.||...-+.+..+-+|.+--                             .+.++.|...+..+.||+.+|
T Consensus       222 GITLIEMAqiEPPHhelnpMRVllKiaKSe-----------------------------PPTLlqPS~Ws~~F~DfLk~c  272 (1187)
T KOG0579|consen  222 GITLIEMAQIEPPHHELNPMRVLLKIAKSE-----------------------------PPTLLQPSHWSRSFSDFLKRC  272 (1187)
T ss_pred             hhHHHHHhccCCCccccchHHHHHHHhhcC-----------------------------CCcccCcchhhhHHHHHHHHH
Confidence            999999999999999888887776665411                             122334445567788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCCCchhHHHHh
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLA  276 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~  276 (433)
                      |.+||..||++.++|.||||++.+.......+++
T Consensus       273 L~Knp~~Rp~aaqll~Hpfv~~~~SnK~ireLlA  306 (1187)
T KOG0579|consen  273 LVKNPRNRPPAAQLLKHPFVQNAPSNKMIRELLA  306 (1187)
T ss_pred             HhcCCccCCCHHHHhhCcccccCCcchHHHHHHH
Confidence            9999999999999999999987776544444444

>cd05595 STKc_PKB_beta Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B beta

Probab=100.00  E-value=5.4e-38  Score=302.79  Aligned_cols=211  Identities=26%  Similarity=0.385  Sum_probs=173.9

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||++++++|...        +.+||||||+++ +|...+.. ...+++..++.++.||+.||+||
T Consensus        41 ~~~~E~~~l~~l~hp~i~~~~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~L  111 (323)
T cd05595          41 HTVTESRVLQNTRHPFLTALKYAFQTH--------DRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALEYL  111 (323)
T ss_pred             HHHHHHHHHHhCCCCCCcceeeEEecC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            456899999999999999999999875        669999999975 67666654 34689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||||++|
T Consensus       112 H~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~  186 (323)
T cd05595         112 HSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMY  186 (323)
T ss_pred             HHCCeEecCCCHHHEEEcCCCCEEecccHHhccccCCC----CccccccCCcCcCCcccccCCC-CCchhchhhhHHHHH
Confidence            99999999999999999999999999999986532211    1223457899999999997665 799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|..||.+.+.......+......                                .+...++++.+||.+||..||
T Consensus       187 ell~g~~Pf~~~~~~~~~~~~~~~~~~--------------------------------~p~~~~~~~~~li~~~L~~dP  234 (323)
T cd05595         187 EMMCGRLPFYNQDHERLFELILMEEIR--------------------------------FPRTLSPEAKSLLAGLLKKDP  234 (323)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHhcCCCC--------------------------------CCCCCCHHHHHHHHHHccCCH
Confidence            999999999887766555444221100                                011356778899999999999


Q ss_pred             CCCC-----CHHHhhcCCCccCC
Q psy7889         248 SKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       248 ~~R~-----t~~e~L~h~~~~~~  265 (433)
                      .+|+     ++.++++|+||...
T Consensus       235 ~~R~~~~~~~~~~~l~h~~~~~~  257 (323)
T cd05595         235 KQRLGGGPSDAKEVMEHRFFLSI  257 (323)
T ss_pred             HHhCCCCCCCHHHHHcCCCcCCC
Confidence            9998     89999999999653

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, beta (or Akt2) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-beta is the predominant PKB isoform expressed in insulin-responsive tissues. It plays a critical role in the regulation of glucose homeostasis. It is also implicated in muscle cell differentiation. Mice deficient in

>cd07870 STKc_PFTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-2 kinase

Probab=100.00  E-value=1.8e-37  Score=294.58  Aligned_cols=245  Identities=39%  Similarity=0.672  Sum_probs=188.2

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+++|+++++.++|+||+++++++...        ...|+||||+.+++.+.+......+++..++.++.|++.||.
T Consensus        46 ~~~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~  117 (291)
T cd07870          46 VPFTAIREASLLKGLKHANIVLLHDIIHTK--------ETLTFVFEYMHTDLAQYMIQHPGGLHPYNVRLFMFQLLRGLA  117 (291)
T ss_pred             CcHHHHHHHHHHHhcCCCCEeEEEEEEecC--------CeEEEEEecccCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999999865        568999999999998888765566889999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+...++.++|||||||+
T Consensus       118 ~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~  193 (291)
T cd07870         118 YIHGQHILHRDLKPQNLLISYLGELKLADFGLARAKSIPS----QTYSSEVVTLWYRPPDVLLGATDYSSALDIWGAGCI  193 (291)
T ss_pred             HHHhCCcccCCCChHHEEEcCCCcEEEeccccccccCCCC----CCCCCccccccccCCceeecCCCCCcHHHHHHHHHH
Confidence            9999999999999999999999999999999987543211    112234568899999998765557889999999999


Q ss_pred             HHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++|++|.+||.+... .+.+..+....|.+....++.......+......................+..+.+++.+||.
T Consensus       194 l~~l~~g~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~ll~~~l~  273 (291)
T cd07870         194 FIEMLQGQPAFPGVSDVFEQLEKIWTVLGVPTEDTWPGVSKLPNYKPEWFLPCKPQQLRVVWKRLSRPPKAEDLASQMLM  273 (291)
T ss_pred             HHHHHhCCCCCCCchhHHHHHHHHHHHcCCCChhhhhhhhhcccccchhccccCCcchhhhccccCCChHHHHHHHHHhC
Confidence            9999999999987654 345555556666665555444332222211111111111122222223346778899999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .||++|||++|++.||||
T Consensus       274 ~dp~~R~t~~~~l~h~~~  291 (291)
T cd07870         274 MFPKDRISAQDALLHPYF  291 (291)
T ss_pred             cCcccCcCHHHHhcCCCC
Confidence            999999999999999998

Serine/Threonine Kinases (STKs), PFTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-2 is also referred to as ALS2CR7 (amyotrophic lateral sclerosis 2 (juvenile) chromosome region candidate 7). It may be associated with amyotrophic lateral sclerosis 2 (ALS2), an autosomal recess

>PTZ00284 protein kinase; Provisional

Probab=100.00  E-value=3.8e-38  Score=318.71  Aligned_cols=240  Identities=22%  Similarity=0.379  Sum_probs=182.6

Q ss_pred             hhHHHHHHHHHhCCCC------CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hp------nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      .....|+.+++.++|.      +|++++++|...       ..++|||||+++++|.+.+.+. ..+++..++.++.||+
T Consensus       170 ~~~~~e~~~l~~l~~~~~~~~~~i~~i~~~~~~~-------~~~~~iv~~~~g~~l~~~l~~~-~~l~~~~~~~i~~qi~  241 (467)
T PTZ00284        170 RDAKIEIQFMEKVRQADPADRFPLMKIQRYFQNE-------TGHMCIVMPKYGPCLLDWIMKH-GPFSHRHLAQIIFQTG  241 (467)
T ss_pred             HHHHHHHHHHHHHhhcCcccCcceeeeEEEEEcC-------CceEEEEEeccCCCHHHHHHHc-CCCCHHHHHHHHHHHH
Confidence            3456788888887544      588999988764       3679999999999999888764 4689999999999999


Q ss_pred             HHHHHHHh-CCeeccCCCCCcEEEecCC----------------cEEEeecCCccccccCcCCccccccCCcccccccCc
Q psy7889          82 NGLYYIHS-NKILHRDMKAANVLITKTG----------------ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPP  144 (433)
Q Consensus        82 ~aL~~LH~-~~iiH~dikp~NIll~~~~----------------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aP  144 (433)
                      .||+|||+ .||+||||||+|||++.++                .+||+|||.+.....       .....+||+.|+||
T Consensus       242 ~aL~yLH~~~gIiHrDlKP~NILl~~~~~~~~~~~~~~~~~~~~~vkl~DfG~~~~~~~-------~~~~~~gt~~Y~AP  314 (467)
T PTZ00284        242 VALDYFHTELHLMHTDLKPENILMETSDTVVDPVTNRALPPDPCRVRICDLGGCCDERH-------SRTAIVSTRHYRSP  314 (467)
T ss_pred             HHHHHHHhcCCeecCCCCHHHEEEecCCcccccccccccCCCCceEEECCCCccccCcc-------ccccccCCccccCc
Confidence            99999997 5999999999999998765                499999998754321       22346789999999


Q ss_pred             ccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccch----hhhhcccc--chHH
Q psy7889         145 ELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETL----DLYNKMEL--PKAQ  218 (433)
Q Consensus       145 E~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~----~~~~~~~~--~~~~  218 (433)
                      |++.+.. |+.++|||||||++|||++|++||.+.+..+.+..+...+|.++.... .....    ..+.....  +...
T Consensus       315 E~~~~~~-~~~~~DiwSlGvil~elltG~~pf~~~~~~~~~~~i~~~~g~~p~~~~-~~~~~~~~~~~~~~~~~~~~~~~  392 (467)
T PTZ00284        315 EVVLGLG-WMYSTDMWSMGCIIYELYTGKLLYDTHDNLEHLHLMEKTLGRLPSEWA-GRCGTEEARLLYNSAGQLRPCTD  392 (467)
T ss_pred             HHhhcCC-CCcHHHHHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHcCCCCHHHH-hhccchhHHHHhhhcccccccCC
Confidence            9998765 899999999999999999999999999999999999998887754322 11100    01100000  0000


Q ss_pred             HhhHHh-----hhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         219 KRKVKE-----RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       219 ~~~~~~-----~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ......     .......+..+.|||.+||++||.+|||++|+|+||||..
T Consensus       393 ~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~  443 (467)
T PTZ00284        393 PKHLARIARARPVREVIRDDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLK  443 (467)
T ss_pred             HHHHHhhhcccchhhhhchHHHHHHHHHhCCcChhhCCCHHHHhcCccccc
Confidence            000000     0111234567889999999999999999999999999965

>cd07866 STKc_BUR1 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Bypass UAS Requirement 1 and similar proteins

Probab=100.00  E-value=1.4e-37  Score=297.87  Aligned_cols=255  Identities=50%  Similarity=0.862  Sum_probs=199.1

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+++++.++||||+++++++.............+|+||||+.+++...+......+++..++.++.||++||.
T Consensus        50 ~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~lv~~~~~~~l~~~~~~~~~~~~~~~~~~i~~~l~~al~  129 (311)
T cd07866          50 FPITALREIKILKKLKHPNVVPLIDMAVERPDKSKRKRGSVYMVTPYMDHDLSGLLENPSVKLTESQIKCYMLQLLEGIN  129 (311)
T ss_pred             cchhHHHHHHHHHhcCCCCccchhhheecccccccccCceEEEEEecCCcCHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence            34567899999999999999999998876543222234678999999999998888766667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-------cccccCCcccccccCcccccCCCCCCCcch
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-------VNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |||++||+|+||||+||+++.++.++|+|||++..........       ...+....++..|+|||.+.+...++.++|
T Consensus       130 ~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~D  209 (311)
T cd07866         130 YLHENHILHRDIKAANILIDNQGILKIADFGLARPYDGPPPNPKGGGGGGTRKYTNLVVTRWYRPPELLLGERRYTTAVD  209 (311)
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEECcCccchhccCCCcccccCCcccccccccceeccCcCChHHhhCCCccCchhH
Confidence            9999999999999999999999999999999997654322111       112233466888999999876655789999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |||+||++|+|++|.+||.+.+.......+....+.+.+..|+........................+.  ..+..+.+|
T Consensus       210 v~slG~il~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~  287 (311)
T cd07866         210 IWGIGCVFAEMFTRRPILQGKSDIDQLHLIFKLCGTPTEETWPGWRSLPGCEGVHSFTNYPRTLEERFG--KLGPEGLDL  287 (311)
T ss_pred             hHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhchhhhhcccccccccCCCCCccHHHHcc--cCChhHHHH
Confidence            999999999999999999999999888888888887777666544333222211111111111111111  245778899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      |.+||..||.+|||+.+++.||||
T Consensus       288 i~~~l~~~p~~R~t~~ell~~~~f  311 (311)
T cd07866         288 LSKLLSLDPYKRLTASDALEHPYF  311 (311)
T ss_pred             HHHHcccCcccCcCHHHHhcCCCC
Confidence            999999999999999999999998

Serine/Threonine Kinases (STKs), Bypass UAS Requirement 1 (BUR1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The BUR1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. BUR1, also called SGV1, is a yeast Cyclin-Dependent protein Kinase (CDK) that is functionally equivalent to mammalian CDK9. It associates with the cyclin BUR2. BUR genes were orginally identified in a genetic

>cd05584 STKc_p70S6K Catalytic domain of the Protein Serine/Threonine Kinase, 70 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=9e-38  Score=301.29  Aligned_cols=212  Identities=28%  Similarity=0.390  Sum_probs=175.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||++++++|..+        +.+|+||||+.+ +|...+.+ ...+++..+..++.||+.||+|
T Consensus        45 ~~~~~E~~il~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~  115 (323)
T cd05584          45 AHTKAERNILEAVKHPFIVDLIYAFQTG--------GKLYLILEYLSGGELFMHLER-EGIFMEDTACFYLSEISLALEH  115 (323)
T ss_pred             HHHHHHHHHHHhCCCCchhceeeEEecC--------CeEEEEEeCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        569999999985 67777655 4468899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||||++
T Consensus       116 lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  190 (323)
T cd05584         116 LHQQGIIYRDLKPENILLDAQGHVKLTDFGLCKESIHEG----TVTHTFCGTIEYMAPEILMRSG-HGKAVDWWSLGALM  190 (323)
T ss_pred             HHHCCeecCCCCHHHeEECCCCCEEEeeCcCCeecccCC----CcccccCCCccccChhhccCCC-CCCcceecccHHHH
Confidence            999999999999999999999999999999986543211    1123456899999999997755 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+......                                .+...+.++.+||.+||..|
T Consensus       191 ~ell~G~~pf~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~  238 (323)
T cd05584         191 YDMLTGAPPFTAENRKKTIDKILKGKLN--------------------------------LPPYLTPEARDLLKKLLKRN  238 (323)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHcCCCC--------------------------------CCCCCCHHHHHHHHHHcccC
Confidence            9999999999988776655554321100                                01124667789999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccCC
Q psy7889         247 PSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~~  265 (433)
                      |++||     +++++++||||...
T Consensus       239 p~~R~~~~~~~~~~l~~h~~~~~~  262 (323)
T cd05584         239 PSSRLGAGPGDAAEVQSHPFFRHV  262 (323)
T ss_pred             HhHcCCCCCCCHHHHhcCCCcCCC
Confidence            99999     89999999999653

Serine/Threonine Kinases (STKs), 70 kDa ribosomal protein S6 kinase (p70S6K) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p70S6K subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p70S6K (or S6K) contains only one catalytic kinase domain, unlike p90 ribosomal S6 kinases (RSKs). It acts as a downstream effector of the STK mTOR (mammalian Target of Rapamycin) and plays a role in the regulation of the translation machinery during protein synthesis. p70S6K also plays a pivotal role in regulating cell size and glucose homeostasis. Its targets include S6, the translation initiation factor eIF3, and the in

>PHA03211 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=9.7e-38  Score=312.22  Aligned_cols=248  Identities=24%  Similarity=0.305  Sum_probs=179.5

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      +....+.+|+.+|++|+|+|||++++++...        +..|+|||++.++|..++......+++..++.++.||+.||
T Consensus       202 ~~~~~~~~E~~iL~~L~HpnIv~l~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL  273 (461)
T PHA03211        202 GWYASSVHEARLLRRLSHPAVLALLDVRVVG--------GLTCLVLPKYRSDLYTYLGARLRPLGLAQVTAVARQLLSAI  273 (461)
T ss_pred             ccccCHHHHHHHHHHCCCCCCCcEEEEEEEC--------CEEEEEEEccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            3445678999999999999999999998875        56899999999999999877666799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++||+||||||+|||++.++.++|+|||+++........  .......||..|+|||++.+.. ++.++|||||||
T Consensus       274 ~yLH~~gIvHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~~--~~~~~~~GT~~Y~APE~~~~~~-~~~~sDvwSlGv  350 (461)
T PHA03211        274 DYIHGEGIIHRDIKTENVLVNGPEDICLGDFGAACFARGSWST--PFHYGIAGTVDTNAPEVLAGDP-YTPSVDIWSAGL  350 (461)
T ss_pred             HHHHHCCEEECcCCHHHEEECCCCCEEEcccCCceeccccccc--ccccccCCCcCCcCHHHHcCCC-CCchHHHHHHHH
Confidence            9999999999999999999999999999999999765432111  1122456899999999998765 799999999999


Q ss_pred             HHHHHHhcCCC-CCCCC------hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHH----hhHHhhhCCccCCh
Q psy7889         165 IMAEMWTRSPI-MQGNT------EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK----RKVKERLKPYVKDQ  233 (433)
Q Consensus       165 il~ell~g~~p-f~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~~~s~  233 (433)
                      ++|||++|..+ |....      ....+..+.+..+... ..++..........+.......    .....+..-...+.
T Consensus       351 iL~El~~g~~~lf~~~~~~~~~~~~~~l~~~i~~~~~~~-~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  429 (461)
T PHA03211        351 VIFEAAVHTASLFSASRGDERRPYDAQILRIIRQAQVHV-DEFPQHAGSRLVSQYRHRAARNRRPAYTRPAWTRYYKLDL  429 (461)
T ss_pred             HHHHHHHcCCCcccCCcccccCCcHHHHHHHHHhhcccc-ccCCCCcchHHHHHHHhhhhcccCCccCCcchhhhccccc
Confidence            99999997643 43321      1233444443333221 1122111111110000000000    00000011123567


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ++.+||.+||++||.+|||+.|+|+||||+.
T Consensus       430 ~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        430 DVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             hHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            8889999999999999999999999999954

>cd05600 STKc_Sid2p_Dbf2p Catalytic domain of Fungal Sid2p- and Dbf2p-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.1e-37  Score=302.02  Aligned_cols=217  Identities=25%  Similarity=0.373  Sum_probs=178.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++...        ..+||||||+++ +|.+++.. ...+++..++.++.||+.||.|
T Consensus        46 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~  116 (333)
T cd05600          46 RHVLTERDILTTTKSEWLVKLLYAFQDD--------EYLYLAMEYVPGGDFRTLLNN-LGVLSEDHARFYMAEMFEAVDA  116 (333)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEcC--------CEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        669999999974 78887765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.....       .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       117 lH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il  188 (333)
T cd05600         117 LHELGYIHRDLKPENFLIDASGHIKLTDFGLSKGIVT-------YANSVVGSPDYMAPEVLRGKG-YDFTVDYWSLGCML  188 (333)
T ss_pred             HHHCCccccCCCHHHEEECCCCCEEEEeCcCCccccc-------ccCCcccCccccChhHhcCCC-CCCccceecchHHH
Confidence            9999999999999999999999999999999876542       223457899999999998764 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+...........+..                        .....+.++.+||.+||..+
T Consensus       189 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~------------------------~~~~~s~~~~~li~~~l~~~  244 (333)
T cd05600         189 YEFLCGFPPFSGSTPNETWENLKYWKETLQRPVYDD------------------------PRFNLSDEAWDLITKLINDP  244 (333)
T ss_pred             hhhhhCCCCCCCCCHHHHHHHHHhccccccCCCCCc------------------------cccccCHHHHHHHHHHhhCh
Confidence            999999999998887766655543221111100000                        00235778889999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|++++++++||||...
T Consensus       245 ~~rr~s~~~ll~h~~~~~~  263 (333)
T cd05600         245 SRRFGSLEDIKNHPFFKEV  263 (333)
T ss_pred             hhhcCCHHHHHhCcccCCC
Confidence            9999999999999999653

Serine/Threonine Kinases (STKs), ROCK- and NDR-like subfamily, fungal Sid2p- and Dbf2p-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sid2p- and Dbf2p-like group is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group contains fungal kinases including Schizosaccharomyces pombe Sid2p and Saccharomyces cerevisiae Dbf2p. Group members show similarity to NDR kinases in that they contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Sid2p plays a crucial role in the septum initiation network (SIN) and in the initiation of cytokinesis.

>cd05631 STKc_GRK4 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 4

Probab=100.00  E-value=1.4e-37  Score=294.59  Aligned_cols=217  Identities=24%  Similarity=0.344  Sum_probs=174.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+.+|+.++|+||+++++++.+.        +.+++||||+.+ +|...+... ...+++..+..++.|++.||+
T Consensus        45 ~~~~~E~~il~~l~~~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  116 (285)
T cd05631          45 AMALNEKRILEKVNSRFVVSLAYAYETK--------DALCLVLTIMNGGDLKFHIYNMGNPGFDEQRAIFYAAELCCGLE  116 (285)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEccC--------CeEEEEEEecCCCcHHHHHHhhCCCCCCHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999875        569999999975 676666543 335899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.++|+|||++.......     ......||..|+|||++.+.. ++.++||||+||+
T Consensus       117 ~lH~~~iiH~dikp~Nill~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslGvi  190 (285)
T cd05631         117 DLQRERIVYRDLKPENILLDDRGHIRISDLGLAVQIPEGE-----TVRGRVGTVGYMAPEVINNEK-YTFSPDWWGLGCL  190 (285)
T ss_pred             HHHhCCEEeCCCCHHHEEECCCCCEEEeeCCCcEEcCCCC-----eecCCCCCCCccCHhhhcCCC-CCcccCchhHHHH
Confidence            9999999999999999999999999999999997754221     223457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.........+..........                            .+...+.++.+||.+||+.
T Consensus       191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~l~~  242 (285)
T cd05631         191 IYEMIQGQSPFRKRKERVKREEVDRRVKEDQEE----------------------------YSEKFSEDAKSICRMLLTK  242 (285)
T ss_pred             HHHHHhCCCCCCCCCcchhHHHHHHHhhccccc----------------------------CCccCCHHHHHHHHHHhhc
Confidence            999999999998765543333332211111000                            0112567788999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccCCC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~~~  266 (433)
                      ||.+||+     ++++++||||....
T Consensus       243 ~P~~R~~~~~~~~~~~~~h~~~~~~~  268 (285)
T cd05631         243 NPKERLGCRGNGAAGVKQHPIFKNIN  268 (285)
T ss_pred             CHHHhcCCCCCCHHHHhcCHhhcCCC
Confidence            9999997     89999999996643

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK4 has a limited tissue distribution. It is mainly found i

>cd07860 STKc_CDK2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase 2 and 3

Probab=100.00  E-value=2.6e-37  Score=292.32  Aligned_cols=241  Identities=44%  Similarity=0.759  Sum_probs=191.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|++++++++||||+++++++.+.        +..++||||+.++|.+.+... ...+++..++.++.|++.||+
T Consensus        43 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~l~~~~~~~~~~~l~~~~~~~~~~~i~~~l~  114 (284)
T cd07860          43 PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASPLSGIPLPLIKSYLFQLLQGLA  114 (284)
T ss_pred             chHHHHHHHHHHhcCCCCCcchhhhcccC--------CcEEEEeeccccCHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999765        568999999998888887653 345899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++|||||||+
T Consensus       115 ~lh~~~i~H~~l~p~nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i  190 (284)
T cd07860         115 FCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCI  190 (284)
T ss_pred             HHHHCCeecCCCCHHHEEECCCCCEEEeeccchhhcccCc----cccccccccccccCCeEEecCCCCCcHHHHHHHHHH
Confidence            9999999999999999999999999999999987654221    122334567889999998776656889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.++.+....+....+.+....|+.......+.. .++...........  ...+.+++++|.+||+.
T Consensus       191 l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  267 (284)
T cd07860         191 FAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSLPDYKP-SFPKWARQDFSKVV--PPLDEDGRDLLSQMLHY  267 (284)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHHHhCCCChhhhhhhhHHHHHHh-hcccccccCHHHHc--ccCCHHHHHHHHHhcCC
Confidence            9999999999999998888888888888776655554332221111 01111111111111  13567888999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      ||.+|||+++++.||||
T Consensus       268 ~P~~Rpt~~~~l~~~~f  284 (284)
T cd07860         268 DPNKRISAKAALAHPFF  284 (284)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 2 (CDK2) and CDK3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK2/3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK2 is regulated by cyclin E or cyclin A. Upon activation by cyclin E, it phosphorylates the retinoblastoma (pRb) protein which activates E2F mediated transcription and allows cells to move into S phase. The CDK2/cyclin A complex

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=100.00  E-value=1.8e-37  Score=295.50  Aligned_cols=248  Identities=43%  Similarity=0.752  Sum_probs=197.2

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+..|+++++.++|+||+++++++.+.        ..+|+||||+.++|.+++......+++..++.++.||+.||.
T Consensus        45 ~~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~L~~~i~~~~~~~~~~~~~~~~~qi~~al~  116 (298)
T cd07841          45 INFTALREIKLLQELKHPNIIGLLDVFGHK--------SNINLVFEFMETDLEKVIKDKSIVLTPADIKSYMLMTLRGLE  116 (298)
T ss_pred             hhHHHHHHHHHHhhcCCCCChhhhheeecC--------CEEEEEEcccCCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            345677899999999999999999999875        568999999988999988765446899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+...++.++|+||+||+
T Consensus       117 ~lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~i  192 (298)
T cd07841         117 YLHSNWILHRDLKPNNLLIASDGVLKLADFGLARSFGSPN----RKMTHQVVTRWYRAPELLFGARHYGVGVDMWSVGCI  192 (298)
T ss_pred             HHHhCCeeecCCChhhEEEcCCCCEEEccceeeeeccCCC----ccccccccceeeeCHHHHhCCCCCCcHHHHHHHHHH
Confidence            9999999999999999999999999999999997765322    122334567889999998765557899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.++|.+.++.+.+..+....+.+....|+.......+........  ......  ....+..+++||.+||..
T Consensus       193 l~e~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~--~~~~~~~~~~li~~~l~~  268 (298)
T cd07841         193 FAELLLRVPFLPGDSDIDQLGKIFEALGTPTEENWPGVTSLPDYVEFKPFPP--TPLKQI--FPAASDDALDLLQRLLTL  268 (298)
T ss_pred             HHHHHcCCccccCCccHHHHHHHHHHcCCCchhhhhhcccccccccccccCC--cchhhh--cccccHHHHHHHHHHhcC
Confidence            9999999999999888888888877777766666554333222111110000  000111  123467888999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      ||++|||+.|+++|+||.+.+.+.
T Consensus       269 ~P~~R~s~~e~l~~~~~~~~~~~~  292 (298)
T cd07841         269 NPNKRITARQALEHPYFSNDPAPT  292 (298)
T ss_pred             CcccCcCHHHHhhCccccCCCCCC
Confidence            999999999999999998876554

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>KOG0192|consensus

Probab=100.00  E-value=3.1e-37  Score=296.30  Aligned_cols=210  Identities=25%  Similarity=0.365  Sum_probs=173.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc-cCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN-IHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|.+++|||||++++++....       ..++|||||++ |+|..++.. ....++...+..++.||+.|+.
T Consensus        84 ~~f~~E~~il~~l~HpNIV~f~G~~~~~~-------~~~~iVtEy~~~GsL~~~l~~~~~~~l~~~~~l~~aldiArGm~  156 (362)
T KOG0192|consen   84 KAFRREASLLSRLRHPNIVQFYGACTSPP-------GSLCIVTEYMPGGSLSVLLHKKRKRKLPLKVRLRIALDIARGME  156 (362)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEcCCC-------CceEEEEEeCCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHH
Confidence            48999999999999999999999998762       25899999998 578888876 3667999999999999999999


Q ss_pred             HHHhCC-eeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhH
Q psy7889          86 YIHSNK-ILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~-iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSl  162 (433)
                      |||+++ ||||||||+|||++.++ ++||+|||+++......    ...+...||+.|+|||++.+. ..|+.++||||+
T Consensus       157 YLH~~~~iIHrDLK~~NiLv~~~~~~~KI~DFGlsr~~~~~~----~~~~~~~GT~~wMAPEv~~~~~~~~~~K~DvySF  232 (362)
T KOG0192|consen  157 YLHSEGPIIHRDLKSDNILVDLKGKTLKIADFGLSREKVISK----TSMTSVAGTYRWMAPEVLRGEKSPYTEKSDVYSF  232 (362)
T ss_pred             HHhcCCCeeecccChhhEEEcCCCCEEEECCCccceeecccc----ccccCCCCCccccChhhhcCCCCcCCccchhhhH
Confidence            999999 99999999999999998 99999999998865432    233446889999999999852 448999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |+++|||++|..||.+.........+......+...                              ....+....++.+|
T Consensus       233 gIvlWEl~t~~~Pf~~~~~~~~~~~v~~~~~Rp~~p------------------------------~~~~~~l~~l~~~C  282 (362)
T KOG0192|consen  233 GIVLWELLTGEIPFEDLAPVQVASAVVVGGLRPPIP------------------------------KECPPHLSSLMERC  282 (362)
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCCCC------------------------------ccCCHHHHHHHHHh
Confidence            999999999999999988854444443211111100                              11345566899999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      +..||.+||+..+++.
T Consensus       283 W~~dp~~RP~f~ei~~  298 (362)
T KOG0192|consen  283 WLVDPSRRPSFLEIVS  298 (362)
T ss_pred             CCCCCCcCCCHHHHHH
Confidence            9999999999999874

>KOG0668|consensus

Probab=100.00  E-value=6.7e-39  Score=275.39  Aligned_cols=246  Identities=28%  Similarity=0.471  Sum_probs=189.6

Q ss_pred             CCCCchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           3 GIFFPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         3 ~~~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      +-.....+.|||.||+.|. |||||+|+++..+...      ....||+||+...-+..+   ...++.-.++.++.||+
T Consensus        72 KPVkkkKIkREikIL~nL~gg~NIi~L~DiV~Dp~S------ktpaLiFE~v~n~Dfk~l---y~tl~d~dIryY~~elL  142 (338)
T KOG0668|consen   72 KPVKKKKIKREIKILQNLRGGPNIIKLLDIVKDPES------KTPSLIFEYVNNTDFKQL---YPTLTDYDIRYYIYELL  142 (338)
T ss_pred             chHHHHHHHHHHHHHHhccCCCCeeehhhhhcCccc------cCchhHhhhhccccHHHH---hhhhchhhHHHHHHHHH
Confidence            3344677899999999996 9999999999998755      667899999986433322   33578889999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +||.|||++||+|||+||.|++|+... .++|+|+|+|.++-.+.     .+.-++.+++|-.||.+.....|+.+.|+|
T Consensus       143 kALdyCHS~GImHRDVKPhNvmIdh~~rkLrlIDWGLAEFYHp~~-----eYnVRVASRyfKGPELLVdy~~YDYSLD~W  217 (338)
T KOG0668|consen  143 KALDYCHSMGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFKGPELLVDYQMYDYSLDMW  217 (338)
T ss_pred             HHHhHHHhcCcccccCCcceeeechhhceeeeeecchHhhcCCCc-----eeeeeeehhhcCCchheeechhccccHHHH
Confidence            999999999999999999999999654 79999999999886543     345567789999999999888899999999


Q ss_pred             hHHHHHHHHHhcC-CCCCCCChHHHHHHHHHHhCCCCCCCCCc---ccchhhhhccccchHHHhhHHhhh---CCccCCh
Q psy7889         161 GAGCIMAEMWTRS-PIMQGNTEQQQITLISQLCGSITPESWPG---VETLDLYNKMELPKAQKRKVKERL---KPYVKDQ  233 (433)
Q Consensus       161 SlGvil~ell~g~-~pf~~~~~~~~~~~i~~~~g~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~s~  233 (433)
                      ||||+++.|+..+ |+|.|.+..+++.+|.+++|...-..+-.   +...+.+..+. ....++......   .....++
T Consensus       218 S~GcmlA~miFrkepFFhG~dN~DQLVkIakVLGt~el~~Yl~KY~i~Ldp~~~~i~-~~~~rk~w~~Fi~~~n~hl~~p  296 (338)
T KOG0668|consen  218 SLGCMLASMIFRKEPFFHGHDNYDQLVKIAKVLGTDELYAYLNKYQIDLDPQFEDIL-GRHSRKPWSRFINSENQHLVSP  296 (338)
T ss_pred             HHHHHHHHHHhccCcccCCCCCHHHHHHHHHHhChHHHHHHHHHHccCCChhHhhHh-hccccccHHHhCCccccccCCh
Confidence            9999999999875 77889999999999999999642110000   00000000000 000011111111   1234589


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +++|||+++|.+|-++|+||.|++.||||.
T Consensus       297 eaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  297 EAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             HHHHHHHHHHhhccccccchHHHhcCchHH
Confidence            999999999999999999999999999994

>cd05625 STKc_LATS1 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 1

Probab=100.00  E-value=1.9e-37  Score=305.97  Aligned_cols=219  Identities=29%  Similarity=0.369  Sum_probs=174.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|||||++++++.+.        +.+|+|||||++ +|.+++.+. ..+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~il~~~~h~~iv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~al~~  116 (382)
T cd05625          46 AHVKAERDILAEADNEWVVRLYYSFQDK--------DNLYFVMDYIPGGDMMSLLIRM-GIFPEDLARFYIAELTCAVES  116 (382)
T ss_pred             HHHHHHHHHHHhCCCCcCCeEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999876        669999999975 788877653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC---------------------------------------
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG---------------------------------------  127 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~---------------------------------------  127 (433)
                      ||++||+||||||+|||++.+|.+||+|||++..+......                                       
T Consensus       117 lH~~~ivHrDlKp~NILl~~~g~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (382)
T cd05625         117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQSGDHVRQDSMDFSNEWGDPANCRCGDRLKPLERRA  196 (382)
T ss_pred             HHhCCeecCCCCHHHEEECCCCCEEEeECCCCccccccccccccccccccccccccccccccccccccccccccchhhhh
Confidence            99999999999999999999999999999997533110000                                       


Q ss_pred             ----ccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcc
Q psy7889         128 ----QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGV  203 (433)
Q Consensus       128 ----~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  203 (433)
                          ........+||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+..+....+..........     
T Consensus       197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p-----  270 (382)
T cd05625         197 ARQHQRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLAQTPLETQMKVINWQTSLHIP-----  270 (382)
T ss_pred             ccccccccccccccCcccCCHHHhcCCC-CCCeeeEEechHHHHHHHhCCCCCCCCCHHHHHHHHHccCCCcCCC-----
Confidence                000112347899999999997765 7999999999999999999999999887766655543311111000     


Q ss_pred             cchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCC---HHHhhcCCCccCC
Q psy7889         204 ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD---SDAALNHDFFWTD  265 (433)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~L~h~~~~~~  265 (433)
                                             .....+++++++|.+|+ .+|.+|++   ++++++||||...
T Consensus       271 -----------------------~~~~~s~~~~~li~~l~-~~p~~R~~~~~~~ei~~hp~f~~~  311 (382)
T cd05625         271 -----------------------PQAKLSPEASDLIIKLC-RGPEDRLGKNGADEIKAHPFFKTI  311 (382)
T ss_pred             -----------------------CcccCCHHHHHHHHHHc-cCHhHcCCCCCHHHHhcCCCcCCc
Confidence                                   01125778889999987 49999997   9999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. Promoter methylation, loss of heterozygosity, and missense mutations targeting the LATS1 gene have also been found in human sarcomas and ovarian cancers. In addition, decreased expression of LATS1 is associated with an aggressive phenotype an

>cd05594 STKc_PKB_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase B alpha

Probab=100.00  E-value=8.5e-38  Score=301.74  Aligned_cols=211  Identities=27%  Similarity=0.387  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+||||||+++ +|...+.. ...+++..++.++.||+.||+|
T Consensus        40 ~~~~~e~~~l~~~~hp~i~~~~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~  110 (325)
T cd05594          40 AHTLTENRVLQNSRHPFLTALKYSFQTH--------DRLCFVMEYANGGELFFHLSR-ERVFSEDRARFYGAEIVSALDY  110 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEEcC--------CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999875        669999999985 66666554 4468999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+ .||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||||+
T Consensus       111 lH~~~~ivHrDikp~NIll~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  185 (325)
T cd05594         111 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVV  185 (325)
T ss_pred             HHhcCCEEecCCCCCeEEECCCCCEEEecCCCCeecCCCC----cccccccCCcccCCHHHHccCC-CCCccccccccce
Confidence            997 799999999999999999999999999986532211    1223456899999999997755 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+.......+......                                .+...++++.+||.+||..
T Consensus       186 l~el~tG~~Pf~~~~~~~~~~~i~~~~~~--------------------------------~p~~~~~~~~~li~~~L~~  233 (325)
T cd05594         186 MYEMMCGRLPFYNQDHEKLFELILMEEIR--------------------------------FPRTLSPEAKSLLSGLLKK  233 (325)
T ss_pred             eeeeccCCCCCCCCCHHHHHHHHhcCCCC--------------------------------CCCCCCHHHHHHHHHHhhc
Confidence            99999999999887765554443211000                                0112467788999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      ||.+|+     ++.++++||||..
T Consensus       234 dP~~R~~~~~~~~~~il~h~~~~~  257 (325)
T cd05594         234 DPKQRLGGGPDDAKEIMQHKFFAG  257 (325)
T ss_pred             CHHHhCCCCCCCHHHHhcCCCcCC
Confidence            999997     9999999999965

Serine/Threonine Kinases (STKs), Protein Kinase B (PKB) or Akt subfamily, alpha (or Akt1) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three PKB isoforms from different genes, PKB-alpha (or Akt1), PKB-beta (or Akt2), and PKB-gamma (or Akt3). PKB contains an N-terminal pleckstrin homology (PH) domain and a C-terminal catalytic domain. PKB-alpha is predominantly expressed in endothelial cells. It is critical for the regulation of angiogenesis and the maintenance of vascular integrity. It also plays a role in adipocyte differentiation. Mice deficien

>cd05590 STKc_nPKC_eta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C eta

Probab=100.00  E-value=2e-37  Score=298.41  Aligned_cols=212  Identities=26%  Similarity=0.407  Sum_probs=174.3

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.+ +||||+++++++.+.        +.+|+||||+.+ +|...+.+ ...+++..++.++.||+.||+
T Consensus        40 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~--------~~~~iv~Ey~~~g~L~~~i~~-~~~l~~~~~~~~~~ql~~~L~  110 (320)
T cd05590          40 ECTMTEKRILSLARNHPFLTQLYCCFQTP--------DRLFFVMEFVNGGDLMFHIQK-SRRFDEARARFYAAEITSALM  110 (320)
T ss_pred             HHHHHHHHHHHhccCCCchhceeeEEEcC--------CEEEEEEcCCCCchHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            4567889999877 699999999999875        669999999985 67766655 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       111 ~lH~~~ivH~dlkp~NIli~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  185 (320)
T cd05590         111 FLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGIFNG----KTTSTFCGTPDYIAPEILQEML-YGPSVDWWAMGVL  185 (320)
T ss_pred             HHHHCCeEeCCCCHHHeEECCCCcEEEeeCCCCeecCcCC----CcccccccCccccCHHHHcCCC-CCCccchhhhHHH
Confidence            9999999999999999999999999999999986542211    1223457899999999987654 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+..+....+....  ..                              .+...+.++++||.+||+.
T Consensus       186 l~el~~g~~Pf~~~~~~~~~~~i~~~~--~~------------------------------~~~~~~~~~~~li~~~L~~  233 (320)
T cd05590         186 LYEMLCGHAPFEAENEDDLFEAILNDE--VV------------------------------YPTWLSQDAVDILKAFMTK  233 (320)
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHhcCC--CC------------------------------CCCCCCHHHHHHHHHHccc
Confidence            999999999999888776665553211  00                              0112466788999999999


Q ss_pred             CCCCCCCH------HHhhcCCCccCC
Q psy7889         246 DPSKRFDS------DAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~------~e~L~h~~~~~~  265 (433)
                      ||.+|+++      +++++||||...
T Consensus       234 dP~~R~~~~~~~~~~~~~~h~~f~~~  259 (320)
T cd05590         234 NPTMRLGSLTLGGEEAILRHPFFKEL  259 (320)
T ss_pred             CHHHCCCCCCCCCHHHHHcCCCcCCC
Confidence            99999998      999999999653

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), eta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-eta is predominantly expressed in squamous epithelia, where it plays a crucial role in the signal

>cd06649 PKc_MEK2 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 2

Probab=100.00  E-value=3.8e-37  Score=297.96  Aligned_cols=244  Identities=20%  Similarity=0.294  Sum_probs=177.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++||||+++++++...        +.+++||||+++ +|.+++.. ...+++..+..++.|++.||.|
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~~  118 (331)
T cd06649          48 NQIIRELQVLHECNSPYIVGFYGAFYSD--------GEISICMEHMDGGSLDQVLKE-AKRIPEEILGKVSIAVLRGLAY  118 (331)
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEEC--------CEEEEEeecCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999875        569999999985 78777765 3468999999999999999999


Q ss_pred             HHhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+. +|+||||||+|||++.++.++|+|||++......      ......|+..|+|||++.+.. ++.++|||||||+
T Consensus       119 lH~~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~i  191 (331)
T cd06649         119 LREKHQIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS  191 (331)
T ss_pred             HhhcCCEEcCCCChhhEEEcCCCcEEEccCccccccccc------ccccCCCCcCcCCHhHhcCCC-CCchHhHHHHHHH
Confidence            9986 6999999999999999999999999998765432      123446899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh-----hhhcc---ccchHHHhh-----H---HhhhCCc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD-----LYNKM---ELPKAQKRK-----V---KERLKPY  229 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-----~~~~~---~~~~~~~~~-----~---~~~~~~~  229 (433)
                      +|+|++|..||......+....+...........+.......     .....   ..+......     .   .......
T Consensus       192 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (331)
T cd06649         192 LVELAIGRYPIPPPDAKELEAIFGRPVVDGEEGEPHSISPRPRPPGRPVSGHGMDSRPAMAIFELLDYIVNEPPPKLPNG  271 (331)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhcccccccccCCccccCcccccccccccccccccccchhHHHHHHHHHhCCCcCCCCc
Confidence            999999999998776554332221111000000000000000     00000   000000000     0   0011112


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      ..+.++++||.+||++||++|||++++|+||||.....
T Consensus       272 ~~~~~l~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~~  309 (331)
T cd06649         272 VFTPDFQEFVNKCLIKNPAERADLKMLMNHTFIKRSEV  309 (331)
T ss_pred             cccHHHHHHHHHHccCCcccCCCHHHHhcChHHhhccc
Confidence            46788999999999999999999999999999976543

Protein kinases (PKs), MAP/ERK Kinase (MEK) 2 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK2 is a dual-specificity PK that phosphorylates and activates the downst

>PHA03210 serine/threonine kinase US3; Provisional

Probab=100.00  E-value=2.9e-37  Score=313.93  Aligned_cols=245  Identities=24%  Similarity=0.356  Sum_probs=180.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC----CCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH----VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~----~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|+.++|||||++++++...        +..|+|++++.+++..++....    .......++.++.||+.|
T Consensus       208 ~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~ql~~a  279 (501)
T PHA03210        208 IQLENEILALGRLNHENILKIEEILRSE--------ANTYMITQKYDFDLYSFMYDEAFDWKDRPLLKQTRAIMKQLLCA  279 (501)
T ss_pred             HHHHHHHHHHHhCCCCCcCcEeEEEEEC--------CeeEEEEeccccCHHHHHhhccccccccccHHHHHHHHHHHHHH
Confidence            4567899999999999999999999876        5689999999999888875432    223466788899999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.++.+||+|||++..+.....   .......||..|+|||++.+.. ++.++||||||
T Consensus       280 L~yLH~~gIiHrDLKP~NILl~~~~~vkL~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG  355 (501)
T PHA03210        280 VEYIHDKKLIHRDIKLENIFLNCDGKIVLGDFGTAMPFEKERE---AFDYGWVGTVATNSPEILAGDG-YCEITDIWSCG  355 (501)
T ss_pred             HHHHHhCCeecCCCCHHHEEECCCCCEEEEeCCCceecCcccc---cccccccCCcCCCCchhhcCCC-CCcHHHHHHHH
Confidence            9999999999999999999999999999999999987653221   1223457899999999998765 79999999999


Q ss_pred             HHHHHHHhcCCC-CCC--CChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccc--hHHHhhHHhhhCCccCChhHHHH
Q psy7889         164 CIMAEMWTRSPI-MQG--NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELP--KAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       164 vil~ell~g~~p-f~~--~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |++|||++|..+ +.+  ......+..+...++... +.++.... ..+..+...  ..........+.....+.++.++
T Consensus       356 vil~ell~~~~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~p~~~~-~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~l  433 (501)
T PHA03210        356 LILLDMLSHDFCPIGDGGGKPGKQLLKIIDSLSVCD-EEFPDPPC-KLFDYIDSAEIDHAGHSVPPLIRNLGLPADFEYP  433 (501)
T ss_pred             HHHHHHHHCCCCCccCCCCCHHHHHHHHHHhcccCh-hhcCCcHH-HHHHHhhhhhcccCccchhhHHHhcCCChHHHHH
Confidence            999999998754 432  234455555555444332 22322111 111111000  00111222233333456778899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+||++||.+|||+.|+|.||||....
T Consensus       434 i~kmL~~DP~~Rpsa~elL~hp~f~~~~  461 (501)
T PHA03210        434 LVKMLTFDWHLRPGAAELLALPLFSAEE  461 (501)
T ss_pred             HHHHhccCcccCcCHHHHhhChhhhcCC
Confidence            9999999999999999999999997654

>cd05628 STKc_NDR1 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 1

Probab=100.00  E-value=3.8e-37  Score=301.76  Aligned_cols=219  Identities=23%  Similarity=0.292  Sum_probs=174.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++.+.+.        ..+|+|||||++ +|.+.+.+ ...+++..++.++.|++.||+|
T Consensus        46 ~~~~~E~~il~~~~~~~iv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~  116 (363)
T cd05628          46 GHIRAERDILVEADSLWVVKMFYSFQDK--------LNLYLIMEFLPGGDMMTLLMK-KDTLTEEETQFYIAETVLAIDS  116 (363)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC--------CeEEEEEcCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999876        569999999975 78877765 3478999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-------------------------------cccccCC
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-------------------------------VNRYTNR  135 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-------------------------------~~~~~~~  135 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+.......                               .......
T Consensus       117 lH~~givHrDlKp~NILi~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (363)
T cd05628         117 IHQLGFIHRDIKPDNLLLDSKGHVKLSDFGLCTGLKKAHRTEFYRNLNHSLPSDFTFQNMNSKRKAETWKRNRRQLAFST  196 (363)
T ss_pred             HHhCCeEecCCCHHHeEECCCCCEEEeeccCcccccccccccccccccccccccccccccccccccchhhhccccccccc
Confidence            999999999999999999999999999999987653211000                               0011245


Q ss_pred             cccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccc
Q psy7889         136 VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELP  215 (433)
Q Consensus       136 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  215 (433)
                      +||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+....+....+........                 ++
T Consensus       197 ~Gt~~Y~aPE~~~~~~-~~~~~DvwSlGvil~ell~G~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~p  258 (363)
T cd05628         197 VGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYKKVMNWKETLI-----------------FP  258 (363)
T ss_pred             cCCccccCHHHHcCCC-CCCchhhhhhHHHHHHHHhCCCCCCCCCHHHHHHHHHcCcCccc-----------------CC
Confidence            7899999999997765 79999999999999999999999998887776666543211110                 00


Q ss_pred             hHHHhhHHhhhCCccCChhHHHHHHhhcccCCC---CCCCHHHhhcCCCccCC
Q psy7889         216 KAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS---KRFDSDAALNHDFFWTD  265 (433)
Q Consensus       216 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~---~R~t~~e~L~h~~~~~~  265 (433)
                      .           ....+.++++||.+|+. +|.   .||+++|+++||||...
T Consensus       259 ~-----------~~~~s~~~~~li~~l~~-~~~~r~~r~~~~ei~~hp~f~~~  299 (363)
T cd05628         259 P-----------EVPISEKAKDLILRFCC-EWEHRIGAPGVEEIKTNPFFEGV  299 (363)
T ss_pred             C-----------cCCCCHHHHHHHHHHcC-ChhhcCCCCCHHHHhCCCCCCCC
Confidence            0           01256778899999775 444   45899999999999654

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. NDR1 is highly expressed in thymus, mus

>cd07847 STKc_CDKL1_4 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 1 and 4

Probab=100.00  E-value=6.4e-37  Score=289.74  Aligned_cols=242  Identities=36%  Similarity=0.692  Sum_probs=186.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++++.++||||+++++++...        ..+++||||+++++...+......+++..++.++.||+.||.|
T Consensus        44 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~ql~~~l~~  115 (286)
T cd07847          44 KKIALREIRMLKQLKHPNLVNLIEVFRRK--------RKLHLVFEYCDHTVLNELEKNPRGVPEHLIKKIIWQTLQAVNF  115 (286)
T ss_pred             cHHHHHHHHHHHhCCCCCEeeeeeEEeeC--------CEEEEEEeccCccHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999999875        5689999999987777766555579999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.++|+|||++........    ......++..|+|||++.+...++.++||||+||++
T Consensus       116 LH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG~i~  191 (286)
T cd07847         116 CHKHNCIHRDVKPENILITKQGQIKLCDFGFARILTGPGD----DYTDYVATRWYRAPELLVGDTQYGPPVDVWAIGCVF  191 (286)
T ss_pred             HHHCCceecCCChhhEEEcCCCcEEECccccceecCCCcc----cccCcccccccCCHHHHhCCCCcCchhhhHHHHHHH
Confidence            9999999999999999999999999999999977653221    122345678899999987755578999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHH-hhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK-RKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|.+||.+.+..+.+..+....+...............+.....+.... ......+.  ..+..+.+||.+||..
T Consensus       192 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~  269 (286)
T cd07847         192 AELLTGQPLWPGKSDVDQLYLIRKTLGDLIPRHQQIFSTNQFFKGLSIPEPETREPLESKFP--NISSPALSFLKGCLQM  269 (286)
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcccccccccccCCCcccccCHHHHhc--cCCHHHHHHHHHHhcC
Confidence            99999999999988888777777666554332111111111111111111100 00111111  2477888999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|++||++.|++.||||
T Consensus       270 ~p~~Rp~~~eil~~~~f  286 (286)
T cd07847         270 DPTERLSCEELLEHPYF  286 (286)
T ss_pred             CccccCCHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 1 (CDKL1) and CDKL4 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL1 and CDKL4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL1, also called p42 KKIALRE, is a glial protein that is upregulated in gliosis. It is present in neuroblastoma and A431 human carcinoma cells, and may be implicated in neoplastic transformation. The functio

>cd05599 STKc_NDR_like Catalytic domain of Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3e-37  Score=302.67  Aligned_cols=219  Identities=25%  Similarity=0.366  Sum_probs=174.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        ..+|||||||.+ +|.+++.. ...+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~~  116 (364)
T cd05599          46 AHVRAERDILAEADNPWVVKLYYSFQDE--------NYLYLIMEYLPGGDMMTLLMK-KDTFTEEETRFYIAETILAIDS  116 (364)
T ss_pred             HHHHHHHHHHHhCCCCCCcceEEEEEcC--------CeEEEEECCCCCcHHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        679999999975 67777765 3469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcc----------------------------------ccc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV----------------------------------NRY  132 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~----------------------------------~~~  132 (433)
                      ||++||+||||||+|||++.+|.++|+|||++..+........                                  ...
T Consensus       117 lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (364)
T cd05599         117 IHKLGYIHRDIKPDNLLLDAKGHIKLSDFGLCTGLKKSHRTEFYRILSHALPSNFLDFISKPMSSKRKAETWKRNRRALA  196 (364)
T ss_pred             HHHCCeEeccCCHHHeEECCCCCEEEeecccceeccccccccccccccccccccccccccccccccccccchhhcccccc
Confidence            9999999999999999999999999999999876532110000                                  011


Q ss_pred             cCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc
Q psy7889         133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM  212 (433)
Q Consensus       133 ~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  212 (433)
                      ...+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+........                
T Consensus       197 ~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il~el~~G~~Pf~~~~~~~~~~~i~~~~~~~~----------------  259 (364)
T cd05599         197 YSTVGTPDYIAPEVFLQTG-YNKECDWWSLGVIMYEMLVGYPPFCSDNPQETYRKIINWKETLQ----------------  259 (364)
T ss_pred             cccccCccccCHHHHcCCC-CCCeeeeecchhHHHHhhcCCCCCCCCCHHHHHHHHHcCCCccC----------------
Confidence            1346899999999987654 79999999999999999999999998887665555432111000                


Q ss_pred             ccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCC---HHHhhcCCCccCC
Q psy7889         213 ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD---SDAALNHDFFWTD  265 (433)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t---~~e~L~h~~~~~~  265 (433)
                       .+           .....+.++++||.+||. +|.+|++   +++++.||||...
T Consensus       260 -~~-----------~~~~~s~~~~~li~~ll~-~p~~R~~~~~~~~ll~h~~~~~~  302 (364)
T cd05599         260 -FP-----------DEVPLSPEAKDLIKRLCC-EAERRLGNNGVNEIKSHPFFKGV  302 (364)
T ss_pred             -CC-----------CCCCCCHHHHHHHHHHcc-CHhhcCCCCCHHHHhcCCCcCCC
Confidence             00           011356788899999997 9999998   9999999999653

Serine/Threonine Kinases (STKs), Nuclear Dbf2-Related (NDR) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. NDR kinases regulate mitosis, cell growth, embryonic development, and neurological processes. They are also required for proper centrosome duplica

>cd05626 STKc_LATS2 Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor 2

Probab=100.00  E-value=4.2e-37  Score=303.32  Aligned_cols=220  Identities=27%  Similarity=0.338  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++|||||++++++.+.        +.+|+|||||++ +|.+++.+. ..+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL~~  116 (381)
T cd05626          46 AHVKAERDILAEADNEWVVKLYYSFQDK--------DNLYFVMDYIPGGDMMSLLIRM-EVFPEVLARFYIAELTLAIES  116 (381)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeEEEEecC--------CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999875        669999999975 787777653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc--------------------------------------
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ--------------------------------------  128 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~--------------------------------------  128 (433)
                      ||++||+||||||+|||++.++.+||+|||++..+.......                                      
T Consensus       117 LH~~givHrDlKp~Nili~~~~~~kL~DFGl~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (381)
T cd05626         117 VHKMGFIHRDIKPDNILIDLDGHIKLTDFGLCTGFRWTHNSKYYQKGSHIRQDSMEPSDLWDDVSNCRCGDRLKTLEQRA  196 (381)
T ss_pred             HHhCCeeecCCcHHHEEECCCCCEEEeeCcCCcccccccccccccccccccccccCcccccccccccccccccchhhccc
Confidence            999999999999999999999999999999975432100000                                      


Q ss_pred             -----cccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcc
Q psy7889         129 -----VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGV  203 (433)
Q Consensus       129 -----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  203 (433)
                           .......+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+..........     
T Consensus       197 ~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlG~il~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~~-----  270 (381)
T cd05626         197 TKQHQRCLAHSLVGTPNYIAPEVLLRKG-YTQLCDWWSVGVILFEMLVGQPPFLAPTPTETQLKVINWENTLHIP-----  270 (381)
T ss_pred             cccccccccccccCCccccCHHHHcCCC-CCCccceeehhhHHHHHHhCCCCCcCCCHHHHHHHHHccccccCCC-----
Confidence                 00012357899999999997755 7999999999999999999999999887665554443211111000     


Q ss_pred             cchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc--CCCCCCCHHHhhcCCCccCC
Q psy7889         204 ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL--DPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~--dP~~R~t~~e~L~h~~~~~~  265 (433)
                                             .....+.++++||.+||..  ++..|++++++++||||...
T Consensus       271 -----------------------~~~~~s~~~~dli~~ll~~~~~~~~R~~~~~~l~hp~f~~~  311 (381)
T cd05626         271 -----------------------PQVKLSPEAVDLITKLCCSAEERLGRNGADDIKAHPFFSEV  311 (381)
T ss_pred             -----------------------CCCCCCHHHHHHHHHHccCcccccCCCCHHHHhcCcccCCC
Confidence                                   0112577888999996654  45559999999999999653

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, LATS2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS functions as a tumor suppressor and is implicated in cell cycle regulation. LATS2 is an essential mitotic regulator responsible for coordinating accurate cytokinesis completion and governing the stabilization of other mitotic regulators. It is also critical in the maintenance of proper chromosome number, genomic stability, mitotic fidelity, and the integrity of centrosome duplication. Downregulation of LATS2 is associated with po

>cd05596 STKc_ROCK Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase

Probab=100.00  E-value=4.8e-37  Score=301.51  Aligned_cols=217  Identities=27%  Similarity=0.350  Sum_probs=176.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        ..+|+|||||+ ++|..++..  ..+++..+..++.||+.||+|
T Consensus        88 ~~~~~e~~il~~~~h~~iv~~~~~~~~~--------~~~~lv~Ey~~gg~L~~~l~~--~~l~~~~~~~~~~qi~~aL~~  157 (370)
T cd05596          88 AFFWEERDIMAHANSEWIVQLHYAFQDD--------KYLYMVMEYMPGGDLVNLMSN--YDIPEKWARFYTAEVVLALDA  157 (370)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC--------CEEEEEEcCCCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        66999999997 478877754  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC---CCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR---NYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   ......+||+.|+|||++.+..   .++.++||||||
T Consensus       158 LH~~~ivHrDLkp~NILl~~~~~~kL~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~DiwSlG  234 (370)
T cd05596         158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMDANGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  234 (370)
T ss_pred             HHHCCeeccCCCHHHEEEcCCCCEEEEeccceeeccCCCc---ccCCCCCCCcCeECHHHhccCCCCCCCCCceeeeehh
Confidence            9999999999999999999999999999999976542211   1223457899999999986532   378899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+.......+........   ++                         .....+.++++||.+||
T Consensus       235 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~---~~-------------------------~~~~~s~~~~~li~~~L  286 (370)
T cd05596         235 VFLYEMLVGDTPFYADSLVGTYSKIMDHKNSLT---FP-------------------------DDIEISKQAKDLICAFL  286 (370)
T ss_pred             HHHHHHHhCCCCcCCCCHHHHHHHHHcCCCcCC---CC-------------------------CcCCCCHHHHHHHHHHc
Confidence            999999999999999887666555533111110   00                         01135778889999999


Q ss_pred             ccCCCC--CCCHHHhhcCCCccCC
Q psy7889         244 LLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      +.+|.+  |++++++++||||+..
T Consensus       287 ~~~p~r~~R~s~~ell~h~~~~~~  310 (370)
T cd05596         287 TDREVRLGRNGVDEIKSHPFFKND  310 (370)
T ss_pred             cChhhccCCCCHHHHhcCcccCCC
Confidence            999998  9999999999999753

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK is also referred to as Rho-associated kinase or simply as Rho kinase. It contains an N-terminal extension, a catalytic kinase domain, and a long C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain. It is activated via in

>KOG0201|consensus

Probab=100.00  E-value=8.7e-39  Score=298.46  Aligned_cols=225  Identities=25%  Similarity=0.406  Sum_probs=183.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+||.+|..++++||.++|+.|...        ..++++||||.|+ +.+++. ....+.+.++..++++++.||.|
T Consensus        56 ediqqei~~Ls~~~~~~it~yygsyl~g--------~~LwiiMey~~gGsv~~lL~-~~~~~~E~~i~~ilre~l~~l~y  126 (467)
T KOG0201|consen   56 EDIQQEISVLSQCDSPNITEYYGSYLKG--------TKLWIIMEYCGGGSVLDLLK-SGNILDEFEIAVILREVLKGLDY  126 (467)
T ss_pred             HHHHHHHHHHHhcCcchHHhhhhheeec--------ccHHHHHHHhcCcchhhhhc-cCCCCccceeeeehHHHHHHhhh
Confidence            4678899999999999999999999886        6699999999864 555444 34456899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||.++.+|||||+.|||+..+|.+||+|||++..+....    ....+++||++||||||+.+. .|+.++||||||++.
T Consensus       127 lH~~~kiHrDIKaanil~s~~g~vkl~DfgVa~ql~~~~----~rr~tfvGTPfwMAPEVI~~~-~Y~~KADIWSLGITa  201 (467)
T KOG0201|consen  127 LHSEKKIHRDIKAANILLSESGDVKLADFGVAGQLTNTV----KRRKTFVGTPFWMAPEVIKQS-GYDTKADIWSLGITA  201 (467)
T ss_pred             hhhcceecccccccceeEeccCcEEEEecceeeeeechh----hccccccccccccchhhhccc-cccchhhhhhhhHHH
Confidence            999999999999999999999999999999998875432    233678999999999999864 489999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +||++|.||+....++..+..|       +...-|                       .+.. ..|+.+++||..||++|
T Consensus       202 iEla~GePP~s~~hPmrvlflI-------pk~~PP-----------------------~L~~-~~S~~~kEFV~~CL~k~  250 (467)
T KOG0201|consen  202 IELAKGEPPHSKLHPMRVLFLI-------PKSAPP-----------------------RLDG-DFSPPFKEFVEACLDKN  250 (467)
T ss_pred             HHHhcCCCCCcccCcceEEEec-------cCCCCC-----------------------cccc-ccCHHHHHHHHHHhhcC
Confidence            9999999999887764322222       111111                       1111 35778889999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCchhHHHHhh
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ  277 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~  277 (433)
                      |+.||+|.++|.|+|++.....+.....+..
T Consensus       251 P~~RpsA~~LLKh~FIk~a~k~s~L~~~i~r  281 (467)
T KOG0201|consen  251 PEFRPSAKELLKHKFIKRAKKTSELKELIDR  281 (467)
T ss_pred             cccCcCHHHHhhhHHHHhcCCchHHHHHHHH
Confidence            9999999999999999886655555544443

>KOG0671|consensus

Probab=100.00  E-value=3.7e-38  Score=289.53  Aligned_cols=243  Identities=26%  Similarity=0.480  Sum_probs=188.4

Q ss_pred             chhHHHHHHHHHhCC--CC----CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc-CCCCCHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK--HE----NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSLGEIKKVIQQ   79 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~--hp----nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~-~~~l~~~~~~~i~~q   79 (433)
                      -+.++-||++|+++.  -|    -+|.+.++|.-        .+++|||+|.++.++++++.++ ...++...++.+..|
T Consensus       129 reAa~iEi~vLqki~~~DP~g~~rcv~m~~wFdy--------rghiCivfellG~S~~dFlk~N~y~~fpi~~ir~m~~Q  200 (415)
T KOG0671|consen  129 REAALIEIEVLQKINESDPNGKFRCVQMRDWFDY--------RGHICIVFELLGLSTFDFLKENNYIPFPIDHIRHMGYQ  200 (415)
T ss_pred             hhHHHHHHHHHHHHHhcCCCCceEEEeeehhhhc--------cCceEEEEeccChhHHHHhccCCccccchHHHHHHHHH
Confidence            356788999999993  32    46888887764        4789999999999999999764 445999999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEec--------------------CCcEEEeecCCccccccCcCCccccccCCcccc
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITK--------------------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL  139 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~--------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~  139 (433)
                      |+.+++|||+.+++|.||||+|||+.+                    +..|+|+|||.|++-.+.       .++.+.|.
T Consensus       201 L~~sv~fLh~~kl~HTDLKPENILfvss~~~~~~~~k~~~~~~r~~ks~~I~vIDFGsAtf~~e~-------hs~iVsTR  273 (415)
T KOG0671|consen  201 LLESVAFLHDLKLTHTDLKPENILFVSSEYFKTYNPKKKVCFIRPLKSTAIKVIDFGSATFDHEH-------HSTIVSTR  273 (415)
T ss_pred             HHHHHHHHHhcceeecCCChheEEEeccceEEEeccCCccceeccCCCcceEEEecCCcceeccC-------cceeeecc
Confidence            999999999999999999999999842                    235899999999775432       24567799


Q ss_pred             cccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhh--hccccchH
Q psy7889         140 WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLY--NKMELPKA  217 (433)
Q Consensus       140 ~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~--~~~~~~~~  217 (433)
                      .|+|||++++-. ++.++||||+||||+||.+|..+|++.++.+.+..|..++|.++............+  ..++++..
T Consensus       274 HYRAPEViLgLG-wS~pCDvWSiGCIL~ElytG~~LFqtHen~EHLaMMerIlGp~P~~mi~r~~~~Kyf~~~rldw~e~  352 (415)
T KOG0671|consen  274 HYRAPEVILGLG-WSQPCDVWSIGCILVELYTGETLFQTHENLEHLAMMERILGPIPSRMIKKTRKEKYFRRGRLDWPEV  352 (415)
T ss_pred             ccCCchheeccC-cCCccCceeeeeEEEEeeccceecccCCcHHHHHHHHHhhCCCcHHHhhhhhhHhhhhcccccCccc
Confidence            999999999876 899999999999999999999999999999999999999997665433222111111  12222221


Q ss_pred             HH----hhHHhhhCC--------ccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         218 QK----RKVKERLKP--------YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       218 ~~----~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ..    +.+....++        .....++.|||.+||.+||.+|+|+.|+|.||||...
T Consensus       353 ~~~~~~k~v~~~ckpl~~~~~~~d~e~~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  353 SSKGKSKYVFEPCKPLKKYMLQDDLEHVQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             cccccchhhhcCCccHHHHhccCcHHHhHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            11    111111111        1123457799999999999999999999999999653

>cd05629 STKc_NDR_like_fungal Catalytic domain of Fungal Nuclear Dbf2-Related kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-37  Score=303.76  Aligned_cols=218  Identities=24%  Similarity=0.353  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++|||||+++++|.+.        ..+||||||++ ++|...+.. ...+++..++.++.|++.||+|
T Consensus        46 ~~~~~E~~il~~l~hp~iv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~-~~~~~~~~~~~~~~ql~~aL~~  116 (377)
T cd05629          46 AHVKAERDVLAESDSPWVVSLYYSFQDA--------QYLYLIMEFLPGGDLMTMLIK-YDTFSEDVTRFYMAECVLAIEA  116 (377)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcC--------CeeEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999875        66999999996 578887765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC-----------cc--------------------------
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG-----------QV--------------------------  129 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~-----------~~--------------------------  129 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+......           ..                          
T Consensus       117 LH~~givHrDlkp~NIll~~~~~~kl~DfGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (377)
T cd05629         117 VHKLGFIHRDIKPDNILIDRGGHIKLSDFGLSTGFHKQHDSAYYQKLLQGKSNKNRIDNRNSVAVDSINLTMSSKDQIAT  196 (377)
T ss_pred             HHhCCeeccCCCHHHEEECCCCCEEEeecccccccccccccccccccccccccccccccccccccccccccccchhhhhh
Confidence            99999999999999999999999999999998643211000           00                          


Q ss_pred             ------ccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcc
Q psy7889         130 ------NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGV  203 (433)
Q Consensus       130 ------~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~  203 (433)
                            ......+||+.|+|||++.+.. ++.++||||+||++|+|++|.+||.+.+..+....+........   +   
T Consensus       197 ~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~---~---  269 (377)
T cd05629         197 WKKNRRLMAYSTVGTPDYIAPEIFLQQG-YGQECDWWSLGAIMFECLIGWPPFCSENSHETYRKIINWRETLY---F---  269 (377)
T ss_pred             hhhcccccccccCCCccccCHHHHccCC-CCCceeeEecchhhhhhhcCCCCCCCCCHHHHHHHHHccCCccC---C---
Confidence                  0001246899999999997755 79999999999999999999999998877666555543111100   0   


Q ss_pred             cchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCC---CCHHHhhcCCCccC
Q psy7889         204 ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR---FDSDAALNHDFFWT  264 (433)
Q Consensus       204 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R---~t~~e~L~h~~~~~  264 (433)
                                 +           .....+.++.+||.+||. +|.+|   +++.+++.||||..
T Consensus       270 -----------p-----------~~~~~s~~~~dli~~lL~-~~~~r~~r~~~~~~l~hp~~~~  310 (377)
T cd05629         270 -----------P-----------DDIHLSVEAEDLIRRLIT-NAENRLGRGGAHEIKSHPFFRG  310 (377)
T ss_pred             -----------C-----------CCCCCCHHHHHHHHHHhc-CHhhcCCCCCHHHHhcCCCcCC
Confidence                       0           011246778899999998 67665   59999999999964

Serine/Threonine Kinases (STKs), NDR kinase subfamily, fungal NDR-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This group is composed of fungal NDR-like proteins including Saccharomyces cerevisiae CBK1 (or CBK1p), Schizosaccharomyces pombe Orb6 (or Orb6p), Ustilago maydis Ukc1 (or Ukc1p), and Neurospora crassa Cot1. Like NDR kinase, group members contain an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. CBK1 is an essential component in the RAM (regulation of

>cd07842 STKc_CDK8_like Catalytic domain of Cyclin-Dependent protein Kinase 8-like Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-37  Score=295.64  Aligned_cols=252  Identities=38%  Similarity=0.702  Sum_probs=188.0

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC----CCCCHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH----VKFSLGEIKKVIQQ   79 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~----~~l~~~~~~~i~~q   79 (433)
                      ++....+.+|+.+++.++||||+++++++.+..      ...+|+||||+++++.+.+....    ..+++..++.++.|
T Consensus        43 ~~~~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~q  116 (316)
T cd07842          43 TGISQSACREIALLRELKHENVVSLVEVFLEHA------DKSVYLLFDYAEHDLWQIIKFHRQAKRVSIPPSMVKSLLWQ  116 (316)
T ss_pred             cCccHHHHHHHHHHHhcCCCCccceEEEEeCCC------CceEEEEEeCCCcCHHHHHHhhccCCCcCcCHHHHHHHHHH
Confidence            344567889999999999999999999998753      26799999999998888775322    25899999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEec----CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITK----TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~----~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      |+.||+|||+.||+||||||+||+++.    ++.+||+|||++......... ........++..|+|||++.+...++.
T Consensus       117 i~~~l~~lH~~~i~h~dlkp~Nil~~~~~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~  195 (316)
T cd07842         117 ILNGVHYLHSNWVLHRDLKPANILVMGEGPERGVVKIGDLGLARLFNAPLKP-LADLDPVVVTIWYRAPELLLGARHYTK  195 (316)
T ss_pred             HHHHHHHHHhCCEeeCCCCHHHEEEcCCCCccceEEECCCccccccCCCccc-ccccCCccccccccCHHHHhCCCCCCc
Confidence            999999999999999999999999999    899999999999876433211 112234467889999999877666789


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChH---------HHHHHHHHHhCCCCCCCCCcccchhhhhcc----ccchHHHhhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQ---------QQITLISQLCGSITPESWPGVETLDLYNKM----ELPKAQKRKV  222 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~---------~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~----~~~~~~~~~~  222 (433)
                      ++|||||||++++|++|.+||.+....         ..+..+...++.+.+..|........+...    ..........
T Consensus       196 ~~Dv~slG~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (316)
T cd07842         196 AIDIWAIGCIFAELLTLEPIFKGREAKIKKSNPFQRDQLERIFEVLGTPTEKDWPDIKKMPEYDTLMKDFKTKTYPSNSL  275 (316)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCcCCcccccccchhHHHHHHHHHHHhCCCchhHHHHHhhcccchhhhhhccCCCCCCccH
Confidence            999999999999999999999876543         345556666665555444322222111110    0000000000


Q ss_pred             HhhhC-CccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         223 KERLK-PYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       223 ~~~~~-~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..... ....+..+.++|.+||+.||++|||+.|+++||||
T Consensus       276 ~~~~~~~~~~~~~~~~~i~~~l~~~P~~Rps~~eil~~~~f  316 (316)
T cd07842         276 AKWMEKHKKPDSQGFDLLRKLLEYDPTKRITAEEALEHPYF  316 (316)
T ss_pred             HHHHHhccCCCHHHHHHHHHHhcCCcccCcCHHHHhcCCCC
Confidence            11110 02467788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK8, CDC2L6, and similar proteins. CDK8 functions as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the

>cd07833 STKc_CDKL Catalytic domain of Cyclin-Dependent protein Kinase Like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=288.29  Aligned_cols=244  Identities=38%  Similarity=0.684  Sum_probs=194.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++++.++|+||+++++++...        +..++||||+++++...+......+++..++.++.||+.||.|
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~  115 (288)
T cd07833          44 KKTALREVKVLRQLRHENIVNLKEAFRRK--------GRLYLVFEYVERTLLELLEASPGGLPPDAVRSYIWQLLQAIAY  115 (288)
T ss_pred             hhHHHHHHHHHHhcCCCCeeehhheEEEC--------CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999875        6699999999998887776655669999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++........   .......++..|+|||++.+...++.++||||+||++
T Consensus       116 LH~~~i~H~dl~~~ni~~~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~~~~PE~~~~~~~~~~~~Dv~slG~~l  192 (288)
T cd07833         116 CHSHNIIHRDIKPENILVSESGVLKLCDFGFARALRARPA---SPLTDYVATRWYRAPELLVGDTNYGKPVDVWAIGCIM  192 (288)
T ss_pred             HHHCCeecCCCCHHHeEECCCCCEEEEeeecccccCCCcc---ccccCcccccCCcCCchhcCCCCcCchhhHHHHHHHH
Confidence            9999999999999999999999999999999877654321   1233456788999999998774579999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHH-HhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ-KRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|.+||.+....+.+..+....+...+..+........+.....+... ...... ..+...+.++++||.+||..
T Consensus       193 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~li~~~l~~  271 (288)
T cd07833         193 AELLDGEPLFPGDSDIDQLYLIQKCLGPLPPSHQELFSSNPRFAGVAFPEPSQPESLER-RYPGKVSSPALDFLKACLRM  271 (288)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHhhhcccCccccccccCCCCCcHHHHH-hcCCccchHHHHHHHHHhcc
Confidence            9999999999998888888888887777665433333222222211111111 111111 11223578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|++||++++++.||||
T Consensus       272 ~p~~Rps~~~il~~~~f  288 (288)
T cd07833         272 DPKERLTCDELLQHPYF  288 (288)
T ss_pred             CchhcccHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like (CDKL) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDKL1-5 and similar proteins. Some CDKLs, like CDKL1 and CDKL3, may be implicated in transformation and others, like CDKL3 and CDKL5, are associated with mental retardation when impaired. CDKL2 plays a role in learning

>cd05614 STKc_MSK2_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 2

Probab=100.00  E-value=3.2e-37  Score=298.59  Aligned_cols=218  Identities=26%  Similarity=0.368  Sum_probs=172.0

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.+ +||||+++++++...        +.+|+||||+.+ +|...+.. +..+++..++.++.||+.||+
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~  119 (332)
T cd05614          49 EHTRTERNVLEHVRQSPFLVTLHYAFQTE--------AKLHLILDYVSGGEMFTHLYQ-RDNFSEDEVRFYSGEIILALE  119 (332)
T ss_pred             HHHHHHHHHHHhccCCCCcccEEEEEecC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            4567899999999 599999999999875        669999999975 78777765 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++........   ......+||+.|+|||++.+...++.++|||||||+
T Consensus       120 ~lH~~~ivHrDlkp~Nili~~~~~~kl~DfG~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  196 (332)
T cd05614         120 HLHKLGIVYRDIKLENILLDSEGHVVLTDFGLSKEFLSEEK---ERTYSFCGTIEYMAPEIIRGKGGHGKAVDWWSLGIL  196 (332)
T ss_pred             HHHHCCcEecCCCHHHeEECCCCCEEEeeCcCCccccccCC---CccccccCCccccCHHHhcCCCCCCCccccccchhh
Confidence            99999999999999999999999999999999976543211   122345789999999999876557899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||...........+........+.                            .+...+..+.++|.+||..
T Consensus       197 l~elltg~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~  248 (332)
T cd05614         197 IFELLTGASPFTLEGERNTQSEVSRRILKCDPP----------------------------FPSFIGPEAQDLLHKLLRK  248 (332)
T ss_pred             hhhhhcCCCCCCCCCCCCCHHHHHHHHhcCCCC----------------------------CCCCCCHHHHHHHHHHcCC
Confidence            999999999997543221111111111000000                            0113567788999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||++||     +++++++||||...
T Consensus       249 dp~~R~~~~~~~~~~~l~h~~~~~~  273 (332)
T cd05614         249 DPKKRLGAGPQGASEIKEHPFFKGL  273 (332)
T ss_pred             CHHHcCCCCCCCHHHHHcCCCcCCC
Confidence            999999     88999999999653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK2, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>KOG0577|consensus

Probab=100.00  E-value=3.9e-38  Score=302.33  Aligned_cols=215  Identities=28%  Similarity=0.451  Sum_probs=184.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      +.+++||..|++|+|||+|.+.++|..+        .+.+||||||-|+-.+++.-....+-+-+|..|+.+.+.||+||
T Consensus        71 qDIlKEVrFL~~l~HPntieYkgCyLre--------~TaWLVMEYClGSAsDlleVhkKplqEvEIAAi~~gaL~gLaYL  142 (948)
T KOG0577|consen   71 QDILKEVRFLRQLRHPNTIEYKGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL  142 (948)
T ss_pred             HHHHHHHHHHHhccCCCcccccceeecc--------chHHHHHHHHhccHHHHHHHHhccchHHHHHHHHHHHHHHHHHH
Confidence            4589999999999999999999999876        67899999999977777766666899999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvi  165 (433)
                      |+.+.||||||..|||++..|.|||+|||.|..+.        +..+++||++|||||||...  ..|+-++||||||++
T Consensus       143 HS~~~IHRDiKAGNILLse~g~VKLaDFGSAsi~~--------PAnsFvGTPywMAPEVILAMDEGqYdgkvDvWSLGIT  214 (948)
T KOG0577|consen  143 HSHNRIHRDIKAGNILLSEPGLVKLADFGSASIMA--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  214 (948)
T ss_pred             HHhhHHhhhccccceEecCCCeeeeccccchhhcC--------chhcccCCccccchhHheeccccccCCccceeeccch
Confidence            99999999999999999999999999999886653        44678999999999999753  458999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ..||..++||....+-+..+..|.+.-.+.                              +.....|.+++.||++||++
T Consensus       215 CIELAERkPPlFnMNAMSALYHIAQNesPt------------------------------Lqs~eWS~~F~~Fvd~CLqK  264 (948)
T KOG0577|consen  215 CIELAERKPPLFNMNAMSALYHIAQNESPT------------------------------LQSNEWSDYFRNFVDSCLQK  264 (948)
T ss_pred             hhhhhhcCCCccCchHHHHHHHHHhcCCCC------------------------------CCCchhHHHHHHHHHHHHhh
Confidence            999999999988888777777776533211                              11122467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      -|.+|||++++|.|+|+....-+
T Consensus       265 ipqeRptse~ll~H~fv~R~Rp~  287 (948)
T KOG0577|consen  265 IPQERPTSEELLKHRFVLRERPP  287 (948)
T ss_pred             CcccCCcHHHHhhcchhccCCCc
Confidence            99999999999999999665433

>cd05591 STKc_nPKC_epsilon Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C epsilon

Probab=100.00  E-value=4.7e-37  Score=296.06  Aligned_cols=211  Identities=27%  Similarity=0.403  Sum_probs=174.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+..|+.+++.+ +||||+++++++...        +.+|+||||+++ +|...+.+ ...+++..++.++.||+.||.
T Consensus        40 ~~~~~e~~il~~~~~hp~i~~~~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~  110 (321)
T cd05591          40 DCTMTEKRILALAAKHPFLTALHCCFQTK--------DRLFFVMEYVNGGDLMFQIQR-SRKFDEPRSRFYAAEVTLALM  110 (321)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcC--------CeEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            3467899999876 799999999999875        569999999975 77766655 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++||||+||+
T Consensus       111 ~LH~~~ivHrDikp~Nill~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~i  185 (321)
T cd05591         111 FLHRHGVIYRDLKLDNILLDAEGHCKLADFGMCKEGILNG----VTTTTFCGTPDYIAPEILQELE-YGPSVDWWALGVL  185 (321)
T ss_pred             HHHHCCeeccCCCHHHeEECCCCCEEEeecccceecccCC----ccccccccCccccCHHHHcCCC-CCCccceechhHH
Confidence            9999999999999999999999999999999987543211    1223456899999999987655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+....+....  ..                              .+...+.++.++|.+||..
T Consensus       186 l~el~tg~~Pf~~~~~~~~~~~i~~~~--~~------------------------------~p~~~~~~~~~ll~~~L~~  233 (321)
T cd05591         186 MYEMMAGQPPFEADNEDDLFESILHDD--VL------------------------------YPVWLSKEAVSILKAFMTK  233 (321)
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCC--CC------------------------------CCCCCCHHHHHHHHHHhcc
Confidence            999999999999988777666553311  00                              0112467788999999999


Q ss_pred             CCCCCC-------CHHHhhcCCCccC
Q psy7889         246 DPSKRF-------DSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~-------t~~e~L~h~~~~~  264 (433)
                      ||++|+       +++++++||||..
T Consensus       234 dp~~R~~~~~~~~~~~~~~~hp~~~~  259 (321)
T cd05591         234 NPNKRLGCVASQGGEDAIKQHPFFKE  259 (321)
T ss_pred             CHHHcCCCCCCCCCHHHHhcCCccCC
Confidence            999999       9999999999954

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), epsilon isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-epsilon has been shown to behave as an oncoprotein. Its overexpression contributes to

>cd07840 STKc_CDK9_like Catalytic domain of Cyclin-Dependent protein Kinase 9-like Serine/Threonine Kinases

Probab=100.00  E-value=1.2e-36  Score=287.75  Aligned_cols=248  Identities=53%  Similarity=0.958  Sum_probs=202.1

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      +....+.+|+.+++.++||||+++++++....      .+..++||||++++|.+++......+++..++.++.||+.||
T Consensus        40 ~~~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~al  113 (287)
T cd07840          40 GFPITAIREIKLLQKLRHPNIVRLKEIVTSKG------KGSIYMVFEYMDHDLTGLLDSPEVKFTESQIKCYMKQLLEGL  113 (287)
T ss_pred             cchHHHHHHHHHHHhccCCCeeeheeeEecCC------CCcEEEEeccccccHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            34456889999999999999999999998652      256999999999999988877656799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||+.|++|+||+|+||+++.++.++|+|||++........   .......++..|+|||.+.+...++.++|||||||
T Consensus       114 ~~LH~~~~~h~dl~p~nil~~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~  190 (287)
T cd07840         114 QYLHSNGILHRDIKGSNILINNDGVLKLADFGLARPYTKRNS---ADYTNRVITLWYRPPELLLGATRYGPEVDMWSVGC  190 (287)
T ss_pred             HHHHHCCceeccCcHHHeEEcCCCCEEEccccceeeccCCCc---ccccccccccccCCceeeEccccCChHHHHHHHHH
Confidence            999999999999999999999999999999999987654321   12233456788999998876656789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.+||........+..+....+.+....|+........................+.. ..+..+.++|.+||.
T Consensus       191 ~l~el~t~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~i~~~l~  269 (287)
T cd07840         191 ILAELFLGKPIFQGSTELEQLEKIFELCGSPTDENWPGVSKLPWFENLKPKKPYKRRLREFFKH-LIDPSALDLLDKLLT  269 (287)
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCchhhccccccchhhhhccccccchhHHHHHhcc-cCCHHHHHHHHHHcC
Confidence            9999999999999999888888888888888888887665543333322222222222222222 247889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .+|.+||++++++.||||
T Consensus       270 ~~P~~Rp~~~~~l~~~~~  287 (287)
T cd07840         270 LDPKKRISADQALQHEYF  287 (287)
T ss_pred             CChhhCcCHHHHhhCcCC
Confidence            999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 9 (CDK9)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK9-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK9 and CDK12 from higher eukaryotes, yeast BUR1, C-type plant CDKs (CdkC), and similar proteins. CDK9, BUR1, and CdkC are functionally equivalent. They act as a kinase for the C-terminal domain of RNA po

>cd07855 STKc_ERK5 Catalytic domain of the Serine/Threonine Kinase, Extracellular signal-Regulated Kinase 5

Probab=100.00  E-value=2.9e-37  Score=299.14  Aligned_cols=256  Identities=32%  Similarity=0.550  Sum_probs=196.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+|+.++||||+++++++.....    ....+|+||||+.++|.+.+... ..+++..++.++.||+.||.|
T Consensus        48 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~~~~lv~e~~~~~l~~~~~~~-~~~~~~~~~~i~~qi~~aL~~  122 (334)
T cd07855          48 AKRTLRELKILRHFKHDNIIAIRDILRPPGA----DFKDVYVVMDLMESDLHHIIHSD-QPLTEEHIRYFLYQLLRGLKY  122 (334)
T ss_pred             hHHHHHHHHHHHhcCCCCccCHHHhccccCC----CCceEEEEEehhhhhHHHHhccC-CCCCHHHHHHHHHHHHHHHHH
Confidence            3457789999999999999999998876432    13678999999999888887653 458999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++..................++..|+|||++.+...++.++||||+||++
T Consensus       123 LH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG~~l  202 (334)
T cd07855         123 IHSANVIHRDLKPSNLLVNEDCELRIGDFGMARGLSSSPTEHKYFMTEYVATRWYRAPELLLSLPEYTTAIDMWSVGCIF  202 (334)
T ss_pred             HHHCCeecCCCCHHHEEEcCCCcEEecccccceeecccCcCCCcccccccccccccChHHhcCCcccccccchHHHHHHH
Confidence            99999999999999999999999999999999776433222222223457889999999987655579999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|.+||.+.+....+..+....|.++...+............. .+...........  ...+.++.++|.+||+.
T Consensus       203 ~el~~g~~pf~~~~~~~~~~~~~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  280 (334)
T cd07855         203 AEMLGRRQLFPGKNYVHQLKLILSVLGSPSEEVLNRIGSDRVRKYIQNLPRKQPVPWSKIF--PKASPEALDLLSQMLQF  280 (334)
T ss_pred             HHHHcCCCccCCCChHHHHHHHHHHhCCChhHhhhhhchhhHHHHHhhcccCCCCCHHHHc--ccCCHHHHHHHHHHccC
Confidence            99999999999998888888888888877665543333221111110 0000000000000  12478899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +|.+|||+++++.||||...+.+.
T Consensus       281 ~P~~Rpt~~~~l~~~~~~~~~~~~  304 (334)
T cd07855         281 DPEERITVEQALQHPFLAQYHDPD  304 (334)
T ss_pred             ChhhCcCHHHHHhChhhhhccCCc
Confidence            999999999999999997655443

Serine/Threonine Kinases (STKs), Extracellular signal-Regulated Kinase 5 (ERK5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ERK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. ERK5, also called Big MAPK1 (BMK1) or MAPK7, has a unique C-terminal extension, making it approximately twice as big as other MAPKs. This extension contains transcriptional activation capability which is inhibited by the N-terminal half. ERK5 is activated in response to growth factors and stress by a cascade that leads to its phosphorylation by the

>cd05621 STKc_ROCK2 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 2

Probab=100.00  E-value=5.2e-37  Score=301.04  Aligned_cols=217  Identities=26%  Similarity=0.355  Sum_probs=176.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ..+|+|||||+ ++|.+++...  .+++..++.++.||+.||+|
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~--------~~~~lv~Ey~~gg~L~~~l~~~--~~~~~~~~~~~~qil~aL~~  157 (370)
T cd05621          88 AFFWEERDIMAFANSPWVVQLFCAFQDD--------KYLYMVMEYMPGGDLVNLMSNY--DVPEKWAKFYTAEVVLALDA  157 (370)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcC--------CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        66999999997 5788877643  58999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC---CCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR---NYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......   .......+||+.|+|||++.+..   .++.++||||+|
T Consensus       158 LH~~~IvHrDLKp~NILl~~~~~~kL~DFG~a~~~~~~~---~~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~~DiwSlG  234 (370)
T cd05621         158 IHSMGLIHRDVKPDNMLLDKHGHLKLADFGTCMKMDETG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  234 (370)
T ss_pred             HHHCCeEecCCCHHHEEECCCCCEEEEecccceecccCC---ceecccCCCCcccCCHHHHhccCCCCCCCcccCEEeeh
Confidence            999999999999999999999999999999997764321   11234567899999999987542   368899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+.......+........   ++                         .....+..++++|.+||
T Consensus       235 ~ilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~p-------------------------~~~~~s~~~~~li~~~L  286 (370)
T cd05621         235 VFLFEMLVGDTPFYADSLVGTYSKIMDHKNSLN---FP-------------------------EDVEISKHAKNLICAFL  286 (370)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCcccC---CC-------------------------CcccCCHHHHHHHHHHc
Confidence            999999999999999887766665543221111   00                         01125677889999999


Q ss_pred             ccCCCC--CCCHHHhhcCCCccCC
Q psy7889         244 LLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      ..++.+  |++++|+++||||...
T Consensus       287 ~~~~~r~~R~~~~e~l~hp~~~~~  310 (370)
T cd05621         287 TDREVRLGRNGVEEIKQHPFFKND  310 (370)
T ss_pred             cCchhccCCCCHHHHhcCcccCCC
Confidence            866554  8999999999999763

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK2 (or ROK-alpha) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK2 was the first identified target of activated RhoA, and was found

>cd05608 STKc_GRK1 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 1

Probab=100.00  E-value=8.4e-37  Score=288.56  Aligned_cols=216  Identities=25%  Similarity=0.326  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+..|+.+|+.++||||+++++++...        ..+|+||||+++ +|...+..   ....+++..++.++.||+.|
T Consensus        38 ~~~~~E~~il~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~g~L~~~~~~~~~~~~~l~~~~~~~~~~qi~~~  109 (280)
T cd05608          38 EGAMVEKRILAKVHSRFIVSLAYAFQTK--------TDLCLVMTIMNGGDLRYHIYNVDEENPGFPEPRACFYTAQIISG  109 (280)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeeEEEcCC--------CeEEEEEeCCCCCCHHHHHHhccccCCCCCHHHHHHHHHHHHHH
Confidence            3467899999999999999999998875        569999999975 67666533   23458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+||||||+||+++.++.++|+|||++........    ......||+.|+|||++.+.. ++.++||||+|
T Consensus       110 l~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~g~~~y~aPE~~~~~~-~~~~~DvwslG  184 (280)
T cd05608         110 LEHLHQRRIIYRDLKPENVLLDNDGNVRISDLGLAVELKDGQS----KTKGYAGTPGFMAPELLQGEE-YDFSVDYFALG  184 (280)
T ss_pred             HHHHHHCCcccCCCCHHHEEECCCCCEEEeeCccceecCCCCc----cccccCCCcCccCHHHhcCCC-CCccccHHHHH
Confidence            9999999999999999999999999999999999876543221    123456789999999998765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|..||...........+.........                            ..+...+..+.+++.+||
T Consensus       185 ~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l  236 (280)
T cd05608         185 VTLYEMIAARGPFRARGEKVENKELKQRILNDSV----------------------------TYPDKFSPASKSFCEALL  236 (280)
T ss_pred             HHHHHHHhCCCCCCCCCcchhHHHHHHhhcccCC----------------------------CCcccCCHHHHHHHHHHh
Confidence            9999999999999875433222222111100000                            001125677889999999


Q ss_pred             ccCCCCCC-----CHHHhhcCCCccC
Q psy7889         244 LLDPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      +.||.+||     +++++++||||..
T Consensus       237 ~~~P~~R~~~~~~~~~~~l~h~~~~~  262 (280)
T cd05608         237 AKDPEKRLGFRDGNCDGLRTHPLFRD  262 (280)
T ss_pred             cCCHHHhcCCCCCCHHHHhcChhhhc
Confidence            99999999     8899999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK1, also called rhodopsin kinase, belongs to the visual g

>cd07864 STKc_CDK12 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 12

Probab=100.00  E-value=1.6e-36  Score=289.58  Aligned_cols=252  Identities=48%  Similarity=0.906  Sum_probs=199.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCc--cccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKAN--QYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~--~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ....+.+|+++++.++||||+++++++.+..+  .+......+|+|+||+++++...+......+++..++.++.|++.|
T Consensus        49 ~~~~~~~e~~~~~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~a  128 (302)
T cd07864          49 FPITAIREIKILRQLNHRNIVNLKEIVTDKQDALDFKKDKGAFYLVFEYMDHDLMGLLESGLVHFSEDHIKSFMKQLLEG  128 (302)
T ss_pred             chHHHHHHHHHHHhCCCCCeeeeeheecCcchhhhccccCCcEEEEEcccCccHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            34567889999999999999999999977531  0111134799999999999988887766679999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||+.||+|+||||+||+++.++.+||+|||++........   ..+....++..|+|||.+.+...++.++||||+|
T Consensus       129 L~~LH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~~~~~~~Di~slG  205 (302)
T cd07864         129 LNYCHKKNFLHRDIKCSNILLNNKGQIKLADFGLARLYNSEES---RPYTNKVITLWYRPPELLLGEERYGPAIDVWSCG  205 (302)
T ss_pred             HHHHHhCCeecCCCCHHHEEECCCCcEEeCcccccccccCCcc---cccccceeccCccChHHhcCCCCCCchhHHHHHH
Confidence            9999999999999999999999999999999999977643221   1222334577899999887655578999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|++||...+..+.+..+....+.+.+..|+.......+..................  ..+..+.++|.+||
T Consensus       206 ~~~~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l  283 (302)
T cd07864         206 CILGELFTKKPIFQANQELAQLELISRLCGSPCPAVWPDVIKLPYFNTMKPKKQYRRRLREEFS--FIPTPALDLLDHML  283 (302)
T ss_pred             HHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhcccccccccccccccccccccchhhhcC--CCCHHHHHHHHHHc
Confidence            9999999999999999999999999998888888777766544333222211111111111111  24778899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..||.+||++++++.||||
T Consensus       284 ~~~P~~Rp~~~~il~~~~~  302 (302)
T cd07864         284 TLDPSKRCTAEEALNSPWL  302 (302)
T ss_pred             cCChhhCCCHHHHhcCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 12 (CDK12) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK12 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK12 is also called Cdc2-related protein kinase 7 (CRK7) or Cdc2-related kinase arginine/serine-rich (CrkRS). It is a unique CDK that contains an arginine/serine-rich (RS) domain, which is predominantly found in splicing factors. CDK12 is widely

>cd05620 STKc_nPKC_delta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C delta

Probab=100.00  E-value=8.9e-37  Score=293.44  Aligned_cols=211  Identities=28%  Similarity=0.435  Sum_probs=171.9

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .....|+.++..+ +||||+++++++.+.        +.+|+||||+.+ +|...+.. ...+++..+..++.||+.||+
T Consensus        40 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--------~~~~lv~E~~~~g~L~~~i~~-~~~~~~~~~~~~~~qi~~~l~  110 (316)
T cd05620          40 ECTMVEKRVLALAWENPFLTHLYCTFQTK--------EHLFFVMEFLNGGDLMFHIQD-KGRFDLYRATFYAAEIVCGLQ  110 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccCeeEEEEeC--------CEEEEEECCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            4567788888765 899999999999875        679999999975 77777655 446899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.++|+|||++.......    ......+||..|+|||++.+.. ++.++||||+||+
T Consensus       111 ~lH~~~ivHrDlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvi  185 (316)
T cd05620         111 FLHSKGIIYRDLKLDNVMLDRDGHIKIADFGMCKENVFGD----NRASTFCGTPDYIAPEILQGLK-YTFSVDWWSFGVL  185 (316)
T ss_pred             HHHHCCeEecCCCHHHeEECCCCCEEeCccCCCeecccCC----CceeccCCCcCccCHHHHcCCC-CCcccchhhhHHH
Confidence            9999999999999999999999999999999986432111    1233457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+.......+...  .+.                              .+...+.++++||.+||..
T Consensus       186 l~el~~g~~Pf~~~~~~~~~~~~~~~--~~~------------------------------~~~~~~~~~~~li~~~l~~  233 (316)
T cd05620         186 LYEMLIGQSPFHGDDEDELFESIRVD--TPH------------------------------YPRWITKESKDILEKLFER  233 (316)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhC--CCC------------------------------CCCCCCHHHHHHHHHHccC
Confidence            99999999999988776555444221  100                              0112466778999999999


Q ss_pred             CCCCCCCH-HHhhcCCCccC
Q psy7889         246 DPSKRFDS-DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~-~e~L~h~~~~~  264 (433)
                      ||++|+++ +++++||||..
T Consensus       234 dP~~R~~~~~~~~~h~~f~~  253 (316)
T cd05620         234 DPTRRLGVVGNIRGHPFFKT  253 (316)
T ss_pred             CHHHcCCChHHHHcCCCcCC
Confidence            99999998 58889999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), delta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-delta plays a role in cell cycle regulation and programmed cell death in many cell types. I

>cd05582 STKc_RSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, 90 kDa ribosomal protein S6 kinase

Probab=100.00  E-value=2.6e-37  Score=297.50  Aligned_cols=212  Identities=29%  Similarity=0.408  Sum_probs=175.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|++++||||+++++++.+.        +.+|+||||+. ++|.+.+.+ ...+++..++.++.||+.||+|
T Consensus        43 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~l~~~~~~~~~~qi~~~l~~  113 (318)
T cd05582          43 VRTKMERDILAEVNHPFIVKLHYAFQTE--------GKLYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDH  113 (318)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcC--------CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        66999999997 578877765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    .......|+..|+|||++.+.. ++.++|||||||++
T Consensus       114 lH~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~il  188 (318)
T cd05582         114 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLM  188 (318)
T ss_pred             HHHCCEecCCCCHHHeEECCCCcEEEeeccCCcccCCCC----CceecccCChhhcCHHHHcCCC-CCCccceeccceEe
Confidence            999999999999999999999999999999987654321    1223457899999999987654 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.+..+....+.......                                +...+..+.+||.+||+.|
T Consensus       189 ~el~tg~~p~~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~~l~~~  236 (318)
T cd05582         189 FEMLTGSLPFQGKDRKETMTMILKAKLGM--------------------------------PQFLSPEAQSLLRALFKRN  236 (318)
T ss_pred             eeeccCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhhcC
Confidence            99999999999888776665553311100                                1124667789999999999


Q ss_pred             CCCCCC-----HHHhhcCCCccCC
Q psy7889         247 PSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t-----~~e~L~h~~~~~~  265 (433)
                      |.+||+     .++++.||||...
T Consensus       237 P~~R~~a~~~~~~~~~~~~~~~~~  260 (318)
T cd05582         237 PANRLGAGPDGVEEIKRHPFFSTI  260 (318)
T ss_pred             HhHcCCCCCCCHHHHhCCCCcCCC
Confidence            999999     6779999999653

Serine/Threonine Kinases (STKs), 90 kDa ribosomal protein S6 kinase (RSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. RSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family. They are activated by signaling inputs from extracellular regulated kinase (ERK) and phosphoinositide dependent kinase 1 (PDK1). ERK phosphorylates and activates the CTD of RSK, serving as a docking site for PDK1, which phosphorylates and activates the NTD, which in turn phosphorylate

>cd07836 STKc_Pho85 Catalytic domain of the Serine/Threonine Kinase, Fungal Cyclin-Dependent protein Kinase Pho85

Probab=100.00  E-value=1.5e-36  Score=287.12  Aligned_cols=242  Identities=41%  Similarity=0.769  Sum_probs=192.8

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC--CCCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~--~~l~~~~~~~i~~qll~a   83 (433)
                      ....+.+|+.+++.++||||+++++++.+.        +..++||||++++|.+++....  ..+++..+..++.|++.|
T Consensus        41 ~~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~qi~~~  112 (284)
T cd07836          41 TPSTAIREISLMKELKHENIVRLHDVIHTE--------NKLMLVFEYMDKDLKKYMDTHGVRGALDPNTVKSFTYQLLKG  112 (284)
T ss_pred             chHHHHHHHHHHHhhcCCCEeeeeeeEeeC--------CcEEEEEecCCccHHHHHHhcCCCCCcCHHHHHHHHHHHHHH
Confidence            346778999999999999999999999886        5589999999999988886543  458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||+.|++|+||||+||+++.++.++|+|||++.......    .......++..|++||++.+...++.++||||+|
T Consensus       113 l~~lH~~~i~h~dl~p~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG  188 (284)
T cd07836         113 IAFCHENRVLHRDLKPQNLLINKRGELKLADFGLARAFGIPV----NTFSNEVVTLWYRAPDVLLGSRTYSTSIDIWSVG  188 (284)
T ss_pred             HHHHHHCCeeeCCCCHHHEEECCCCcEEEeecchhhhhcCCc----cccccccccccccChHHhcCCCCCCcHHHHHHHH
Confidence            999999999999999999999999999999999987654221    1223345688899999987766678999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|.+||.+.+..+....+....+.+....|........+. ...+............  ..+..++++|.+||
T Consensus       189 ~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~--~~~~~~~~~i~~~l  265 (284)
T cd07836         189 CIMAEMITGRPLFPGTNNEDQLLKIFRIMGTPTESTWPGISQLPEYK-PTFPRYPPQDLQQLFP--HADPLGIDLLHRLL  265 (284)
T ss_pred             HHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhHHHHhcCchhc-ccccCCChHHHHHHhh--hcCcHHHHHHHHHh
Confidence            99999999999999998888888888877777666654444222111 1111111111111111  24788899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      +.||.+||++.++++||||
T Consensus       266 ~~~p~~R~~~~~~l~~~~f  284 (284)
T cd07836         266 QLNPELRISAHDALQHPWF  284 (284)
T ss_pred             cCCcccCCCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Pho85 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Pho85 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Pho85 is a multifunctional Cyclin-Dependent protein Kinase (CDK) in yeast. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Pho85 is regulated by 10 different cyclins (Pcls) and plays a role in G1 progression, cell polarity, phosphate and glycogen metabolism, gene expression, and in signaling changes in the environment.

>cd05601 STKc_CRIK Catalytic domain of the Protein Serine/Threonine Kinase, Citron Rho-interacting kinase

Probab=100.00  E-value=3.4e-37  Score=298.17  Aligned_cols=217  Identities=27%  Similarity=0.343  Sum_probs=177.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||++ ++|.+++.+....+++..++.++.||+.||+|
T Consensus        46 ~~~~~e~~i~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~~  117 (330)
T cd05601          46 SFFEEERDILSISNSPWIPQLQYAFQDK--------DNLYLVMEYQPGGDLLSLLNRYEDQFDEDMAQFYLAELVLAIHS  117 (330)
T ss_pred             HHHHHHHHHHHhCCCCCCcceeeEEecC--------CeEEEEECCCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        66999999996 58888887765679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC-----CCCCCCcchhhh
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG-----DRNYGPPVDLWG  161 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~DiwS  161 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   .......||+.|+|||++..     ...++.++||||
T Consensus       118 lH~~~i~H~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Diws  194 (330)
T cd05601         118 VHQMGYVHRDIKPENVLIDRTGHIKLADFGSAARLTANKM---VNSKLPVGTPDYIAPEVLTTMNGDGKGTYGVECDWWS  194 (330)
T ss_pred             HHHCCeEcccCchHheEECCCCCEEeccCCCCeECCCCCc---eeeecccCCccccCHHHhccccccccCCCCCcceeec
Confidence            9999999999999999999999999999999977643221   11223468999999999863     234688999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|..||.+.+.......+........   +              +           .....+.++++||.+
T Consensus       195 lG~il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~---~--------------~-----------~~~~~~~~~~~li~~  246 (330)
T cd05601         195 LGVIAYEMIYGRSPFHEGTSAKTYNNIMNFQRFLK---F--------------P-----------EDPKVSSDFLDLIQS  246 (330)
T ss_pred             ccceeeeeccCCCCCCCCCHHHHHHHHHcCCCccC---C--------------C-----------CCCCCCHHHHHHHHH
Confidence            99999999999999998877666555433211000   0              0           011256778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||. +|.+|||+++++.||||..
T Consensus       247 ll~-~p~~R~t~~~l~~h~~~~~  268 (330)
T cd05601         247 LLC-GQKERLGYEGLCCHPFFSK  268 (330)
T ss_pred             Hcc-ChhhCCCHHHHhCCCCcCC
Confidence            998 9999999999999999965

Serine/Threonine Kinases (STKs), Citron Rho-interacting kinase (CRIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CRIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CRIK is also called citron kinase. It contains a catalytic domain, a central coiled-coil domain, and a C-terminal region containing a Rho-binding domain (RBD), a zinc finger, and a pleckstrin homology (PH) domain, in addition to other motifs. CRIK, an effector of the small GTPase Rho, plays an important function during cytokinesis and affects its contractile process. CRIK-deficient mice show severe ataxia and epilepsy as a result of abnor

>cd05586 STKc_Sck1_like Catalytic domain of Suppressor of loss of cAMP-dependent protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-37  Score=297.03  Aligned_cols=212  Identities=28%  Similarity=0.352  Sum_probs=172.0

Q ss_pred             HHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus        10 ~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...|.+++..+   +||||+++++++.+.        ..+|+||||+.+ +|...+.+ ...+++..++.++.||+.||+
T Consensus        40 ~~~e~~~l~~~~~~~~p~i~~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qil~al~  110 (330)
T cd05586          40 TIGERNILVRTLLDESPFIVGLKFSFQTD--------SDLYLVTDYMSGGELFWHLQK-EGRFSEDRAKFYIAELVLALE  110 (330)
T ss_pred             HHHHHHHHHHhccCCCCcCcceEEEEecC--------CeEEEEEcCCCCChHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            45577777765   699999999999876        669999999975 67776655 456899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.++|+|||++.......    ......+||..|+|||++.+...++.++||||+||+
T Consensus       111 ~LH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DvwslGvi  186 (330)
T cd05586         111 HLHKYDIVYRDLKPENILLDATGHIALCDFGLSKANLTDN----KTTNTFCGTTEYLAPEVLLDEKGYTKHVDFWSLGVL  186 (330)
T ss_pred             HHHHCCeEeccCCHHHeEECCCCCEEEecCCcCcCCCCCC----CCccCccCCccccCHHHHcCCCCCCCccceeccccE
Confidence            9999999999999999999999999999999986543211    122345789999999999776668999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+..+....+......                               +.....+.++.+||.+||..
T Consensus       187 l~elltG~~Pf~~~~~~~~~~~i~~~~~~-------------------------------~~~~~~~~~~~~li~~~L~~  235 (330)
T cd05586         187 VFEMCCGWSPFYAEDTQQMYRNIAFGKVR-------------------------------FPKNVLSDEGRQFVKGLLNR  235 (330)
T ss_pred             EEEeccCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCccCCHHHHHHHHHHcCC
Confidence            99999999999987766555444221000                               01112567788999999999


Q ss_pred             CCCCCC----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~----t~~e~L~h~~~~~~  265 (433)
                      ||.+||    +++++++||||...
T Consensus       236 ~P~~R~~~~~~~~~ll~h~~~~~~  259 (330)
T cd05586         236 NPQHRLGAHRDAVELKEHPFFADI  259 (330)
T ss_pred             CHHHCCCCCCCHHHHhcCccccCC
Confidence            999998    79999999999753

Serine/Threonine Kinases (STKs), Fission yeast Suppressor of loss of cAMP-dependent protein kinase (Sck1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sck1-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of fungal proteins with similarity to the Schizosaccharomyces pombe STK Sck1. Sck1 plays a role in trehalase activation triggered by glucose and a nitrogen source. Trehalase catalyzes the cleavage of the disaccharide trehalose to glucose. Trehalose, as a carbohydrate reserve and stress metabolite, plays an important role in the response of

>KOG0574|consensus

Probab=100.00  E-value=5.8e-39  Score=285.81  Aligned_cols=229  Identities=26%  Similarity=0.388  Sum_probs=189.7

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .-+.+.+||.||++++.|++|++|+.|-..        ..++||||||+ |+..+.++-++..++++++..+++..++||
T Consensus        71 DLQEIIKEISIMQQC~S~yVVKYYGSYFK~--------sDLWIVMEYCGAGSiSDI~R~R~K~L~E~EIs~iL~~TLKGL  142 (502)
T KOG0574|consen   71 DLQEIIKEISIMQQCKSKYVVKYYGSYFKH--------SDLWIVMEYCGAGSISDIMRARRKPLSEQEISAVLRDTLKGL  142 (502)
T ss_pred             hHHHHHHHHHHHHHcCCchhhhhhhhhccC--------CceEeehhhcCCCcHHHHHHHhcCCccHHHHHHHHHHHHhHH
Confidence            457889999999999999999999988654        66999999998 678888888888899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||...-+|||||..|||++.+|+.||+|||.|..+.+..    ....+..||+.|+|||++..-. |+..+||||||+
T Consensus       143 ~YLH~~~KIHRDIKAGNILLNT~G~AKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVI~EIG-Y~~~ADIWSLGI  217 (502)
T KOG0574|consen  143 QYLHDLKKIHRDIKAGNILLNTDGIAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIEEIG-YDTKADIWSLGI  217 (502)
T ss_pred             HHHHHHHHHHhhcccccEEEcccchhhhhhccccchhhhhH----HhhCccccCcccccHHHHHHhc-cchhhhHhhhcc
Confidence            99999999999999999999999999999999997765322    2345678999999999997654 899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +..||..|+|||....+...+..|   .-.++ ..+                         -+|...|.++.|||++||.
T Consensus       218 TaIEMAEG~PPYsDIHPMRAIFMI---PT~PP-PTF-------------------------~KPE~WS~~F~DFi~~CLi  268 (502)
T KOG0574|consen  218 TAIEMAEGRPPYSDIHPMRAIFMI---PTKPP-PTF-------------------------KKPEEWSSEFNDFIRSCLI  268 (502)
T ss_pred             hhhhhhcCCCCcccccccceeEec---cCCCC-CCC-------------------------CChHhhhhHHHHHHHHHhc
Confidence            999999999999887766443332   11111 111                         1223457778899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCCchhHHHHh
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKMLA  276 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~  276 (433)
                      ++|+.|-||.++++|+|+++++..+-...++.
T Consensus       269 K~PE~R~TA~~L~~H~FiknA~g~~I~~~~I~  300 (502)
T KOG0574|consen  269 KKPEERKTALRLCEHTFIKNAPGCDIMQLMIQ  300 (502)
T ss_pred             CCHHHHHHHHHHhhhhhhcCCCcccHHHHHHH
Confidence            99999999999999999988876554444443

>PTZ00024 cyclin-dependent protein kinase; Provisional

Probab=100.00  E-value=3.2e-36  Score=291.96  Aligned_cols=248  Identities=37%  Similarity=0.686  Sum_probs=198.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+++++.++||||+++++++...        ..+|+||||+.++|.+.+.. ...++++.+..++.|++.||+||
T Consensus        65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~-~~~~~~~~~~~~~~ql~~aL~~L  135 (335)
T PTZ00024         65 FTTLRELKIMNEIKHENIMGLVDVYVEG--------DFINLVMDIMASDLKKVVDR-KIRLTESQVKCILLQILNGLNVL  135 (335)
T ss_pred             hhHHHHHHHHHhCCCcceeeeeEEEecC--------CcEEEEEeccccCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            3678999999999999999999999865        56999999999999988865 34689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC----------CccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN----------GQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      |+.||+|+||+|+||+++.++.++|+|||++........          ..........++..|+|||.+.+...++.++
T Consensus       136 H~~~i~H~dl~~~nill~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  215 (335)
T PTZ00024        136 HKWYFMHRDLSPANIFINSKGICKIADFGLARRYGYPPYSDTLSKDETMQRREEMTSKVVTLWYRAPELLMGAEKYHFAV  215 (335)
T ss_pred             HhCCeecccccHHHeEECCCCCEEECCccceeecccccccccccccccccccccccccccccCCCCChhcccCCCCCcHH
Confidence            999999999999999999999999999999976541110          0011222345678899999998766578999


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      |+|||||++++|++|.+||.+....+.+..+....+.+....|+.......+.......  +......  ....+.++.+
T Consensus       216 Dv~slG~~l~el~tg~~p~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~  291 (335)
T PTZ00024        216 DMWSVGCIFAELLTGKPLFPGENEIDQLGRIFELLGTPNEDNWPQAKKLPLYTEFTPRK--PKDLKTI--FPNASDDAID  291 (335)
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCchhhCcchhhcccccccCcCC--cccHHHh--CcCCChHHHH
Confidence            99999999999999999999999999898898888888777776554333222211110  0111111  1124678889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      +|.+||+.+|++|||++|+|.||||+..+..
T Consensus       292 li~~~l~~~P~~R~s~~~~l~~~~~~~~~~~  322 (335)
T PTZ00024        292 LLQSLLKLNPLERISAKEALKHEYFKSDPLP  322 (335)
T ss_pred             HHHHHcCCCchhccCHHHHhcCcccCCCCCC
Confidence            9999999999999999999999999876543

>cd05573 STKc_ROCK_NDR_like Catalytic domain of ROCK- and NDR kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=6.3e-37  Score=298.65  Aligned_cols=220  Identities=29%  Similarity=0.374  Sum_probs=178.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +.+|+||||+. ++|..++.+. ..+++..++.++.||+.||+
T Consensus        45 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~aL~  115 (350)
T cd05573          45 IAHVRAERDILADADSPWIVKLYYSFQDE--------EHLYLVMEYMPGGDLMNLLIRK-DVFPEETARFYIAELVLALD  115 (350)
T ss_pred             HHHHHHHHHHHHhcCCCCccchhhheecC--------CeEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            34578899999999999999999999875        66999999996 5888888764 57899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC-------------------------CccccccCCccccc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN-------------------------GQVNRYTNRVVTLW  140 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-------------------------~~~~~~~~~~gt~~  140 (433)
                      |||++||+||||||+|||++.++.+||+|||++........                         ..........||+.
T Consensus       116 ~LH~~giiH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~  195 (350)
T cd05573         116 SVHKLGFIHRDIKPDNILIDADGHIKLADFGLCKKMNKAKDREYYLNDSHNLLFRDNVLVRRRDHKQRRVRANSTVGTPD  195 (350)
T ss_pred             HHHHCCeeccCCCHHHeEECCCCCEEeecCCCCccCcccCcccccccccccccccccccccccccccccccccccccCcc
Confidence            99999999999999999999999999999999977653220                         00112234578999


Q ss_pred             ccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHh
Q psy7889         141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR  220 (433)
Q Consensus       141 y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (433)
                      |+|||++.+.. ++.++|||||||++|+|++|.+||.+.........+..........                 .    
T Consensus       196 y~aPE~~~~~~-~~~~~DiwSlG~il~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~~p-----------------~----  253 (350)
T cd05573         196 YIAPEVLRGTP-YGLECDWWSLGVILYEMLYGFPPFYSDTLQETYNKIINWKESLRFP-----------------P----  253 (350)
T ss_pred             ccCHHHHcCCC-CCCceeeEecchhhhhhccCCCCCCCCCHHHHHHHHhccCCcccCC-----------------C----
Confidence            99999998764 7999999999999999999999999888766655554321111000                 0    


Q ss_pred             hHHhhhCCccCChhHHHHHHhhcccCCCCCCC-HHHhhcCCCccCC
Q psy7889         221 KVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD-SDAALNHDFFWTD  265 (433)
Q Consensus       221 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t-~~e~L~h~~~~~~  265 (433)
                             ....+.++.+||.+||. ||.+|++ ++++|+||||...
T Consensus       254 -------~~~~~~~~~~li~~ll~-dp~~R~~s~~~ll~hp~~~~~  291 (350)
T cd05573         254 -------DPPVSPEAIDLICRLLC-DPEDRLGSFEEIKSHPFFKGI  291 (350)
T ss_pred             -------CCCCCHHHHHHHHHHcc-ChhhcCCCHHHHhcCCCcCCC
Confidence                   01146778899999998 9999999 9999999999653

Serine/Threonine Kinases (STKs), Rho-associated coiled-coil containing protein kinase (ROCK) and Nuclear Dbf2-Related (NDR)-like kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK- and NDR-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include ROCK and ROCK-like proteins such as DMPK, MRCK, and CRIK, as well as NDR and NDR-like proteins such as LATS, CBK1 and Sid2p. ROCK and CRIK are effectors of the small GTPase Rho, while MRCK is an effector of the small GTPase Cdc42. NDR and NDR-like kinases contain an N-terminal regulatory (NTR) domain and an insert within the

>KOG0197|consensus

Probab=100.00  E-value=6.2e-37  Score=293.95  Aligned_cols=211  Identities=23%  Similarity=0.415  Sum_probs=180.0

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc-cCCCCCHHHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN-IHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qll   81 (433)
                      ...++.+++|+++|++|+|+|||++++++..++        -+||||||+. |+|.+++.. ....+...+...++.||+
T Consensus       242 ~m~~~~f~~Ea~iMk~L~H~~lV~l~gV~~~~~--------piyIVtE~m~~GsLl~yLr~~~~~~l~~~~Ll~~a~qIa  313 (468)
T KOG0197|consen  242 SMSPEAFLREAQIMKKLRHEKLVKLYGVCTKQE--------PIYIVTEYMPKGSLLDYLRTREGGLLNLPQLLDFAAQIA  313 (468)
T ss_pred             ccChhHHHHHHHHHHhCcccCeEEEEEEEecCC--------ceEEEEEecccCcHHHHhhhcCCCccchHHHHHHHHHHH
Confidence            345789999999999999999999999999863        4999999997 689999987 555689999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      +|++||+++++|||||-..||||+.+..+||+|||+|+...+   ..........-...|.|||++.... |+.++||||
T Consensus       314 eGM~YLes~~~IHRDLAARNiLV~~~~~vKIsDFGLAr~~~d---~~Y~~~~~~kfPIkWtAPEa~~~~~-FS~kSDVWS  389 (468)
T KOG0197|consen  314 EGMAYLESKNYIHRDLAARNILVDEDLVVKISDFGLARLIGD---DEYTASEGGKFPIKWTAPEALNYGK-FSSKSDVWS  389 (468)
T ss_pred             HHHHHHHhCCccchhhhhhheeeccCceEEEcccccccccCC---CceeecCCCCCCceecCHHHHhhCC-cccccceee
Confidence            999999999999999999999999999999999999995432   1222222233356799999998776 899999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      +||+|+||+| |+.|+.+.+..+.+..+.+....+.|+.+                               +.+.-+++.
T Consensus       390 FGVlL~E~fT~G~~py~~msn~ev~~~le~GyRlp~P~~C-------------------------------P~~vY~lM~  438 (468)
T KOG0197|consen  390 FGVLLWELFTYGRVPYPGMSNEEVLELLERGYRLPRPEGC-------------------------------PDEVYELMK  438 (468)
T ss_pred             hhhhHHHHhccCCCCCCCCCHHHHHHHHhccCcCCCCCCC-------------------------------CHHHHHHHH
Confidence            9999999998 89999999999999999886666555543                               344458999


Q ss_pred             hhcccCCCCCCCHHHhh
Q psy7889         241 KLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L  257 (433)
                      .|+..+|++|||.+.+.
T Consensus       439 ~CW~~~P~~RPtF~~L~  455 (468)
T KOG0197|consen  439 SCWHEDPEDRPTFETLR  455 (468)
T ss_pred             HHhhCCcccCCCHHHHH
Confidence            99999999999998664

>cd05598 STKc_LATS Catalytic domain of the Protein Serine/Threonine Kinase, Large Tumor Suppressor

Probab=100.00  E-value=6.2e-37  Score=301.70  Aligned_cols=219  Identities=27%  Similarity=0.356  Sum_probs=173.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++.+.+.        +.+|+|||||+ ++|.+++.+. ..+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~il~~l~h~~iv~~~~~~~~~--------~~~~lv~E~~~~g~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~  116 (376)
T cd05598          46 AHVKAERDILAEADNEWVVKLYYSFQDK--------DNLYFVMDYIPGGDMMSLLIRL-GIFEEDLARFYIAELTCAIES  116 (376)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcC--------CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        67999999997 5788887663 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC---------------------------------------C
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN---------------------------------------G  127 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~---------------------------------------~  127 (433)
                      ||++||+||||||+|||++.++.+||+|||++..+.....                                       .
T Consensus       117 lH~~~ivHrDlkp~Nill~~~~~ikL~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (376)
T cd05598         117 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQKGDHHRQDSMEPSEEWSEIDRCRLKPLERRRKRQH  196 (376)
T ss_pred             HHHCCeEeCCCCHHHEEECCCCCEEEEeCCCCccccccccccccccccccccccccccccccccccccccchhhhhhhhc
Confidence            9999999999999999999999999999999753310000                                       0


Q ss_pred             ccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh
Q psy7889         128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD  207 (433)
Q Consensus       128 ~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~  207 (433)
                      ........+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+..........         
T Consensus       197 ~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~---------  266 (376)
T cd05598         197 QRCLAHSLVGTPNYIAPEVLLRTG-YTQLCDWWSVGVILYEMLVGQPPFLADTPAETQLKVINWETTLHIP---------  266 (376)
T ss_pred             ccccccccCCCccccCHHHHcCCC-CCcceeeeeccceeeehhhCCCCCCCCCHHHHHHHHhccCccccCC---------
Confidence            000112347899999999997755 7999999999999999999999999888766554443211110000         


Q ss_pred             hhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCC---CHHHhhcCCCccCC
Q psy7889         208 LYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---DSDAALNHDFFWTD  265 (433)
Q Consensus       208 ~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~L~h~~~~~~  265 (433)
                                         .....+.++.++|.+|+ .+|.+|+   ++.++++||||...
T Consensus       267 -------------------~~~~~s~~~~~li~~l~-~~p~~R~~~~t~~ell~h~~~~~~  307 (376)
T cd05598         267 -------------------SQAKLSREASDLILRLC-CGAEDRLGKNGADEIKAHPFFKGI  307 (376)
T ss_pred             -------------------CCCCCCHHHHHHHHHHh-cCHhhcCCCCCHHHHhCCCCcCCC
Confidence                               01124677889999977 5999999   99999999999753

Serine/Threonine Kinases (STKs), Large Tumor Suppressor (LATS) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The LATS subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. LATS was originally identified in Drosophila using a screen for genes whose inactivation led to overproliferation of cells. In tetrapods, there are two LATS isoforms, LATS1 and LATS2. Inactivation of LATS1 in mice results in the development of various tumors, including sarcomas and ovarian cancer. LATS functions as a tumor suppressor and is implicated in cell cycle regulation.

>cd05570 STKc_PKC Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase C

Probab=100.00  E-value=1.1e-36  Score=293.15  Aligned_cols=211  Identities=26%  Similarity=0.401  Sum_probs=173.1

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.+ +||||+++++++...        +.+|+||||+.+ +|...+.+ ...+++..+..++.||+.||.
T Consensus        40 ~~~~~e~~il~~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~  110 (318)
T cd05570          40 ECTMTEKRVLALAGKHPFLTQLHSCFQTK--------DRLFFVMEYVNGGDLMFHIQR-SGRFDEPRARFYAAEIVLGLQ  110 (318)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcC--------CEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            3467899999988 699999999999875        669999999975 67666654 346999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.++|+|||++.......    ......+|+..|+|||++.+.. ++.++||||+||+
T Consensus       111 ~LH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslGvi  185 (318)
T cd05570         111 FLHERGIIYRDLKLDNVLLDSEGHIKIADFGMCKEGILGG----VTTSTFCGTPDYIAPEILSYQP-YGPAVDWWALGVL  185 (318)
T ss_pred             HHHhCCeEccCCCHHHeEECCCCcEEecccCCCeecCcCC----CcccceecCccccCHHHhcCCC-CCcchhhhhHHHH
Confidence            9999999999999999999999999999999986532211    1223456899999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+.......+.....                                ..+...+.++.+||.+||..
T Consensus       186 l~~l~~G~~pf~~~~~~~~~~~i~~~~~--------------------------------~~~~~~~~~~~~li~~~l~~  233 (318)
T cd05570         186 LYEMLAGQSPFEGDDEDELFQSILEDEV--------------------------------RYPRWLSKEAKSILKSFLTK  233 (318)
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHcCCC--------------------------------CCCCcCCHHHHHHHHHHccC
Confidence            9999999999998876655544422100                                00112466778999999999


Q ss_pred             CCCCCCCH-----HHhhcCCCccC
Q psy7889         246 DPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      ||.+||++     .+++.||||..
T Consensus       234 dP~~R~s~~~~~~~~ll~~~~~~~  257 (318)
T cd05570         234 NPEKRLGCLPTGEQDIKGHPFFRE  257 (318)
T ss_pred             CHHHcCCCCCCCHHHHhcCCCcCC
Confidence            99999999     99999999965

Serine/Threonine Kinases (STKs), Protein Kinase C (PKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, classical PKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. Novel PKCs are calcium-independent, but require DAG and PS for activity, while atypical PKCs only re

>cd05575 STKc_SGK Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase

Probab=100.00  E-value=9.3e-37  Score=294.24  Aligned_cols=211  Identities=26%  Similarity=0.324  Sum_probs=170.4

Q ss_pred             hHHHHHH-HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIK-ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+++|.. +++.++||||+++++++...        ..+|+||||+.+ +|...+.+ ...+++..++.++.||+.||+|
T Consensus        41 ~~~~e~~~~~~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~~l~~  111 (323)
T cd05575          41 HIMAERNVLLKNVKHPFLVGLHYSFQTA--------DKLYFVLDYVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGY  111 (323)
T ss_pred             HHHHHHHHHHhhCCCCCCCCeeEEEEeC--------CEEEEEEcCCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3455655 45788999999999999875        669999999975 67776655 4468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       112 lH~~givH~dikp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il  186 (323)
T cd05575         112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGIEHS----KTTSTFCGTPEYLAPEVLRKQP-YDRTVDWWCLGAVL  186 (323)
T ss_pred             HHHCCeEeCCCCHHHeEECCCCcEEEeccCCCcccccCC----CccccccCChhhcChhhhcCCC-CCccccccccchhh
Confidence            999999999999999999999999999999986532211    1233457899999999987755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+.......                                +...+..+.++|.+||+.|
T Consensus       187 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~  234 (323)
T cd05575         187 YEMLYGLPPFYSRDTAEMYDNILNKPLRL--------------------------------KPNISVSARHLLEGLLQKD  234 (323)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhhcC
Confidence            99999999999877665554443210000                                0124667789999999999


Q ss_pred             CCCCCCH----HHhhcCCCccCC
Q psy7889         247 PSKRFDS----DAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~----~e~L~h~~~~~~  265 (433)
                      |.+||++    .++++||||...
T Consensus       235 p~~R~~~~~~~~~il~~~~~~~~  257 (323)
T cd05575         235 RTKRLGAKDDFLEIKNHVFFSSI  257 (323)
T ss_pred             HHhCCCCCCCHHHHHcCCCcCCC
Confidence            9999998    699999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGKs are activated by insulin and growth factors via phosphoinositide 3-kinase and PDK1. They activate ion channels, ion carriers, and the Na-K-ATPase, as well as regulate the activity of enzymes and transcription factors. SGKs play important roles in transport, hormone release, neuroexcitability, cell pr

>cd07831 STKc_MOK Catalytic domain of the Serine/Threonine Kinase, MAPK/MAK/MRK Overlapping Kinase

Probab=100.00  E-value=2.1e-36  Score=285.65  Aligned_cols=239  Identities=35%  Similarity=0.592  Sum_probs=185.4

Q ss_pred             hHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ...+|+.+++++. |+||+++++++.+...      +.+++||||+++++.+.+......+++..++.++.|++.||+||
T Consensus        43 ~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~L  116 (282)
T cd07831          43 NNLREIQALRRLSPHPNILRLIEVLFDRKT------GRLALVFELMDMNLYELIKGRKRPLPEKRVKSYMYQLLKSLDHM  116 (282)
T ss_pred             hHHHHHHHHhhcCCCCCccceEEEEecCCC------CcEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHHH
Confidence            4467999999995 9999999999987522      56899999999999998877666789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |+.|++|+||+|+||+++. +.+||+|||++.......     ......++..|+|||.+.....++.++||||+||+++
T Consensus       117 H~~~i~H~dl~p~ni~l~~-~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slGv~l~  190 (282)
T cd07831         117 HRNGIFHRDIKPENILIKD-DILKLADFGSCRGIYSKP-----PYTEYISTRWYRAPECLLTDGYYGPKMDIWAVGCVFF  190 (282)
T ss_pred             HHCCceecccCHHHEEEcC-CCeEEEecccccccccCC-----CcCCCCCCcccCChhHhhcCCCCCcchhHHHHHHHHH
Confidence            9999999999999999999 999999999997764322     1223456889999998765555788999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|.+||.+.+..+.+..+....+............. ......++...........  ...+..++++|.+||..+|
T Consensus       191 el~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~~P  267 (282)
T cd07831         191 EILSLFPLFPGTNELDQIAKIHDVLGTPDAEVLKKFRKS-RHMNYNFPSKKGTGLRKLL--PNASAEGLDLLKKLLAYDP  267 (282)
T ss_pred             HHHcCCcCCCCCCHHHHHHHHHHHcCCCCHHHHHhhccc-ccccccCcccccccHHHHc--ccccHHHHHHHHHHhccCc
Confidence            999999999999988888888777776544211000000 0000111111111111111  1347889999999999999


Q ss_pred             CCCCCHHHhhcCCCc
Q psy7889         248 SKRFDSDAALNHDFF  262 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~  262 (433)
                      ++|||++++++||||
T Consensus       268 ~~R~~~~~~l~~~~~  282 (282)
T cd07831         268 DERITAKQALRHPYF  282 (282)
T ss_pred             ccccCHHHHhhCCCC
Confidence            999999999999997

Serine/Threonine Kinases (STKs), MAPK/MAK/MRK Overlapping Kinase (MOK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MOK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MOK, also called Renal tumor antigen 1 (RAGE-1), is widely expressed and is enriched in testis, kidney, lung, and brain. It is expressed in approximately 50% of renal cell carcinomas (RCC) and is a potential target for immunotherapy. MOK is stabilized by its association with the HSP90 molecular chaperone. It is induced by the transcription factor Cdx2 and may be involved in regulating intestinal epithelial development and differentiation.

>cd05592 STKc_nPKC_theta_delta Catalytic domain of the Protein Serine/Threonine Kinases, Novel Protein Kinase C theta and delta

Probab=100.00  E-value=1.4e-36  Score=292.10  Aligned_cols=211  Identities=27%  Similarity=0.433  Sum_probs=171.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .....|..++..+ +||||+++++++...        +.+|+||||+++ +|...+.. ...+++..++.++.||+.||+
T Consensus        40 ~~~~~e~~~l~~~~~hp~i~~~~~~~~~~--------~~~~lv~e~~~gg~L~~~~~~-~~~~~~~~~~~~~~qi~~al~  110 (316)
T cd05592          40 ECTMVERRVLALAWEHPFLTHLFCTFQTK--------EHLFFVMEYLNGGDLMFHIQS-SGRFDEARARFYAAEIICGLQ  110 (316)
T ss_pred             HHHHHHHHHHHhccCCCCccceeeEEEcC--------CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            3456677777755 899999999999875        669999999974 77776655 446999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......    ......+||..|+|||++.+.. ++.++|||||||+
T Consensus       111 ~LH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~i  185 (316)
T cd05592         111 FLHKKGIIYRDLKLDNVLLDKDGHIKIADFGMCKENMNGE----GKASTFCGTPDYIAPEILKGQK-YNESVDWWSFGVL  185 (316)
T ss_pred             HHHHCCEEeCCCCHHHeEECCCCCEEEccCcCCeECCCCC----CccccccCCccccCHHHHcCCC-CCCcccchhHHHH
Confidence            9999999999999999999999999999999987643221    1233457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+..+....+......                                .+...+.++.+||.+||..
T Consensus       186 l~ell~G~~Pf~~~~~~~~~~~i~~~~~~--------------------------------~~~~~~~~~~~ll~~~l~~  233 (316)
T cd05592         186 LYEMLIGQSPFHGEDEDELFDSILNDRPH--------------------------------FPRWISKEAKDCLSKLFER  233 (316)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCCCC--------------------------------CCCCCCHHHHHHHHHHccC
Confidence            99999999999988876655544321100                                0112456778999999999


Q ss_pred             CCCCCCCH-HHhhcCCCccC
Q psy7889         246 DPSKRFDS-DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~-~e~L~h~~~~~  264 (433)
                      ||++|+++ .++++||||..
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~  253 (316)
T cd05592         234 DPTKRLGVDGDIRQHPFFRG  253 (316)
T ss_pred             CHHHcCCChHHHHcCcccCC
Confidence            99999986 58889999965

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta and delta-like isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an imp

>cd07837 STKc_CdkB_plant Catalytic domain of the Serine/Threonine Kinase, Plant B-type Cyclin-Dependent protein Kinase

Probab=100.00  E-value=3.8e-36  Score=285.91  Aligned_cols=247  Identities=39%  Similarity=0.726  Sum_probs=191.8

Q ss_pred             CchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC----CCCCHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH----VKFSLGEIKKVIQQL   80 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~----~~l~~~~~~~i~~ql   80 (433)
                      ....+.+|+.+++.+ +||||+++++++......   ....+|+||||++++|.+++....    ..+++..++.++.||
T Consensus        43 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~~---~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~qi  119 (295)
T cd07837          43 IPPTALREISLLQMLSESIYIVRLLDVEHVEEKN---GKPSLYLVFEYLDSDLKKFMDSNGRGPGRPLPAKTIKSFMYQL  119 (295)
T ss_pred             CchHHHHHHHHHHHccCCCCccceeeeEeecCCC---CCceEEEEeeccCcCHHHHHHHhcccCCCCCCHHHHHHHHHHH
Confidence            345688999999999 479999999999775321   123489999999999988886532    348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      +.||.|||++||+||||+|+||+++. ++.++|+|||++..+....    .......+++.|+|||++.+...++.++||
T Consensus       120 ~~~L~~LH~~~i~H~dl~~~nil~~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di  195 (295)
T cd07837         120 LKGVAHCHKHGVMHRDLKPQNLLVDKQKGLLKIADLGLGRAFSIPV----KSYTHEIVTLWYRAPEVLLGSTHYSTPVDI  195 (295)
T ss_pred             HHHHHHHHHCCeeecCCChHHEEEecCCCeEEEeecccceecCCCc----cccCCcccccCCCChHHhhCCCCCCchHHH
Confidence            99999999999999999999999998 8899999999987653221    122333567889999998765557999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||+||++|+|++|.+||.+.+.......+....+.+....|+...........  +...........  ...+..+.+||
T Consensus       196 ~slG~~l~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--~~~~~~~~~~i  271 (295)
T cd07837         196 WSVGCIFAEMSRKQPLFPGDSELQQLLHIFKLLGTPTEQVWPGVSKLRDWHEF--PQWKPQDLSRAV--PDLSPEGLDLL  271 (295)
T ss_pred             HHHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHhCCCChhhCcchhhccchhhc--CcccchhHHHhc--cccCHHHHHHH
Confidence            99999999999999999999988888888887777666666544332222111  111111111111  12577889999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      .+||..||.+||+++|+|.||||.
T Consensus       272 ~~~l~~~P~~R~~~~eil~~~~~~  295 (295)
T cd07837         272 QKMLRYDPAKRISAKAALTHPYFD  295 (295)
T ss_pred             HHHccCChhhcCCHHHHhcCCCcC
Confidence            999999999999999999999984

Serine/Threonine Kinases (STKs), Plant B-type Cyclin-Dependent protein Kinase (CdkB) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CdkB subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. The plant-specific B-type CDKs are expressed from the late S to the M phase of the cell cycle. They are characterized by the cyclin binding motif PPT[A/T]LRE. They play a role in controlling mitosis and integrating developm

>cd07849 STKc_ERK1_2_like Catalytic domain of Extracellular signal-Regulated Kinase 1 and 2-like Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-36  Score=294.61  Aligned_cols=254  Identities=35%  Similarity=0.589  Sum_probs=192.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+.+++.++||||+++++++.....   .....+|+|+||+.+++...+..  ..+++..++.++.|++.||+|
T Consensus        47 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~ql~~aL~~  121 (336)
T cd07849          47 CQRTLREIKILRRFKHENIIGILDIIRPPSF---ESFNDVYIVQELMETDLYKLIKT--QHLSNDHIQYFLYQILRGLKY  121 (336)
T ss_pred             HHHHHHHHHHHHhCCCCCcCchhheeecccc---cccceEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            3457789999999999999999998875421   11356899999999998887754  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||+||+++.++.++|+|||++......... ........++..|+|||++.+...++.++||||+||++
T Consensus       122 LH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGvil  200 (336)
T cd07849         122 IHSANVLHRDLKPSNLLLNTNCDLKICDFGLARIADPEHDH-TGFLTEYVATRWYRAPEIMLNSKGYTKAIDIWSVGCIL  200 (336)
T ss_pred             HHhCCeeccCCCHHHEEECCCCCEEECcccceeeccccccc-cCCcCCcCcCCCccChHHhhCCCCCCcHHHHHHHHHHH
Confidence            99999999999999999999999999999998765432211 11223356789999999886655578999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|++||.+.........+...++.+..+.+..+.......... .+........... + ..+.++.+||.+||+.
T Consensus       201 ~el~~G~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~li~~~l~~  278 (336)
T cd07849         201 AEMLSNRPLFPGKDYLHQLNLILGVLGTPSQEDLNCIISLRARNYIKSLPFKPKVPWNKLF-P-NADPKALDLLDKMLTF  278 (336)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHHhhchhhhhHHhhcCcCCcccHHHHh-c-ccCcHHHHHHHHHcCC
Confidence            99999999999988888888888888776655443322211110000 0000000001111 1 2477889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      +|.+|||+.|+++||||....++
T Consensus       279 dP~~Rpt~~e~l~hp~~~~~~~~  301 (336)
T cd07849         279 NPHKRITVEEALAHPYLEQYHDP  301 (336)
T ss_pred             ChhhCcCHHHHhcCccccccCCC
Confidence            99999999999999999765443

Serine/Threonine Kinases (STKs), Extracellular signal-regulated kinases 1 and 2 (ERK1/2) and Fus3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. This ERK1/2-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the mitogen-activated protein kinases (MAPKs) ERK1, ERK2, baker's yeast Fus3, and similar proteins. MAPK pathways are important mediators of cellular responses to extracellular signals. ERK1/2 activation is preferentially by mitogenic factors, differentiation stimuli, and cytokines, through a kinase cascade involving the MAPK kinases MEK1/2 and a MAPK kinase

>PTZ00267 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=2e-36  Score=306.58  Aligned_cols=215  Identities=27%  Similarity=0.443  Sum_probs=176.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|+.++|||||++++++...        +.+||||||+. ++|.+.+...   ...+++..+..++.||+.|
T Consensus       110 ~~~~~E~~~l~~l~Hpniv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~~~~l~~~~~~~i~~qi~~a  181 (478)
T PTZ00267        110 AYARSELHCLAACDHFGIVKHFDDFKSD--------DKLLLIMEYGSGGDLNKQIKQRLKEHLPFQEYEVGLLFYQIVLA  181 (478)
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEEEEC--------CEEEEEEECCCCCCHHHHHHHHHhccCCCCHHHHHHHHHHHHHH
Confidence            3567899999999999999999999876        66999999997 5787776532   3458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.++.+||+|||++..+.....  .......+||+.|+|||++.+.. ++.++||||+|
T Consensus       182 L~~lH~~~ivHrDlkp~NIll~~~~~~kL~DFgla~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG  258 (478)
T PTZ00267        182 LDEVHSRKMMHRDLKSANIFLMPTGIIKLGDFGFSKQYSDSVS--LDVASSFCGTPYYLAPELWERKR-YSKKADMWSLG  258 (478)
T ss_pred             HHHHHhCCEEECCcCHHhEEECCCCcEEEEeCcCceecCCccc--cccccccCCCccccCHhHhCCCC-CCcHHhHHHHH
Confidence            9999999999999999999999999999999999987653221  11233457899999999987754 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|..||.+.+..+.+..+..  +...+                             .+...+.++.+||.+||
T Consensus       259 ~~l~el~tg~~Pf~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~s~~~~~li~~~L  307 (478)
T PTZ00267        259 VILYELLTLHRPFKGPSQREIMQQVLY--GKYDP-----------------------------FPCPVSSGMKALLDPLL  307 (478)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHh--CCCCC-----------------------------CCccCCHHHHHHHHHHh
Confidence            999999999999998877665554432  11100                             01124567789999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||.+||++++++.|+|+..
T Consensus       308 ~~dP~~Rps~~~~l~~~~~~~  328 (478)
T PTZ00267        308 SKNPALRPTTQQLLHTEFLKY  328 (478)
T ss_pred             ccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999853

>PLN00009 cyclin-dependent kinase A; Provisional

Probab=100.00  E-value=3.6e-36  Score=286.10  Aligned_cols=244  Identities=42%  Similarity=0.739  Sum_probs=192.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCC-CCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~-~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++.+.        ...|+||||+++++...+..... .+++..++.++.||+.||+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~aL~  116 (294)
T PLN00009         45 PSTAIREISLLKEMQHGNIVRLQDVVHSE--------KRLYLVFEYLDLDLKKHMDSSPDFAKNPRLIKTYLYQILRGIA  116 (294)
T ss_pred             hHHHHHHHHHHHhccCCCEeeEEEEEecC--------CeEEEEEecccccHHHHHHhCCCCCcCHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999875        56999999999998888765433 3688899999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||++|++|+||+|+||+++. ++.+||+|||++.......    .......++..|+|||++.+...++.++||||+||
T Consensus       117 ~LH~~~i~H~dl~p~nill~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~Dv~slG~  192 (294)
T PLN00009        117 YCHSHRVLHRDLKPQNLLIDRRTNALKLADFGLARAFGIPV----RTFTHEVVTLWYRAPEILLGSRHYSTPVDIWSVGC  192 (294)
T ss_pred             HHHhCCeeCCCCCcceEEEECCCCEEEEcccccccccCCCc----cccccCceeecccCHHHHhCCCCCCcHHHHHHHHH
Confidence            999999999999999999985 4579999999997653211    12233456889999999877656789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+.+..+....+.+....|........+... .+....  ..........+.+++++|.+||+
T Consensus       193 i~~~l~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~--~~~~~~~~~~~~~~~~~i~~~l~  269 (294)
T PLN00009        193 IFAEMVNQKPLFPGDSEIDELFKIFRILGTPNEETWPGVTSLPDYKSA-FPKWPP--KDLATVVPTLEPAGVDLLSKMLR  269 (294)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccccccchhhhhh-cccCCC--CCHHHhCcCCChHHHHHHHHHcc
Confidence            999999999999999888888888888888777777654433222110 000000  00001112357788999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+|.+||++.++++||||.+.
T Consensus       270 ~~P~~Rps~~~~l~~~~~~~~  290 (294)
T PLN00009        270 LDPSKRITARAALEHEYFKDL  290 (294)
T ss_pred             CChhhCcCHHHHhcCchHhHH
Confidence            999999999999999999653

>cd05588 STKc_aPKC Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C

Probab=100.00  E-value=1.7e-36  Score=293.20  Aligned_cols=213  Identities=23%  Similarity=0.335  Sum_probs=167.6

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+|+.+++.+ +||||++++++|.+.        ..+|+|||||++ +|...+.+ ...+++..++.++.||+.||.|
T Consensus        41 ~~~~e~~il~~~~~hp~Iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~~~~-~~~l~~~~~~~~~~qi~~~l~~  111 (329)
T cd05588          41 WVQTEKHVFETASNHPFLVGLHSCFQTE--------SRLFFVIEFVSGGDLMFHMQR-QRKLPEEHARFYSAEISLALNF  111 (329)
T ss_pred             HHHHHHHHHHhccCCCCCCceEEEEEcC--------CEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            467899999998 799999999999875        669999999975 77766654 3579999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++||||+||++
T Consensus       112 lH~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~~l  186 (329)
T cd05588         112 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGIRPG----DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLM  186 (329)
T ss_pred             HHHCCeEecCCCHHHeEECCCCCEEECcCccccccccCC----CccccccCCccccCHHHHcCCC-CCCccceechHHHH
Confidence            999999999999999999999999999999986532111    1233457899999999998755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHH-----HHHHHHH-HhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         167 AEMWTRSPIMQGNTEQQ-----QITLISQ-LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~-----~~~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+|++|..||......+     ....+.+ .....                             .-.+...+..+.++|.
T Consensus       187 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~p~~~~~~~~~li~  237 (329)
T cd05588         187 FEMMAGRSPFDIVGMSDNPDQNTEDYLFQVILEKQ-----------------------------IRIPRSLSVKASSVLK  237 (329)
T ss_pred             HHHHHCCCCcccccccccccccchHHHHHHHHcCC-----------------------------CCCCCCCCHHHHHHHH
Confidence            99999999996421100     0000000 00000                             0011235677889999


Q ss_pred             hhcccCCCCCCC------HHHhhcCCCccC
Q psy7889         241 KLLLLDPSKRFD------SDAALNHDFFWT  264 (433)
Q Consensus       241 ~~L~~dP~~R~t------~~e~L~h~~~~~  264 (433)
                      +||..||.+|++      ++++++||||..
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~~~~  267 (329)
T cd05588         238 GFLNKDPKERLGCHPQTGFRDIKSHPFFRN  267 (329)
T ss_pred             HHhccCHHHcCCCCCCCCHHHHhcCCCCCC
Confidence            999999999997      789999999954

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. They contain a C2-like region, instead of a calcium-binding (C2) region found in classical PKCs, in their regulatory domain. There are two aPKC isoforms, zeta and iota. aPKCs are involved in many cellular functions incl

>cd07835 STKc_CDK1_like Catalytic domain of Cyclin-Dependent protein Kinase 1-like Serine/Threonine Kinases

Probab=100.00  E-value=3.3e-36  Score=284.62  Aligned_cols=243  Identities=44%  Similarity=0.781  Sum_probs=191.8

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll~a   83 (433)
                      +....+.+|+++++.++||||+++++++.+.        +..|+||||++++|.+++.... ..+++..+..++.|++.|
T Consensus        40 ~~~~~~~~E~~~l~~l~~~~iv~~~~~~~~~--------~~~~iv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~~  111 (283)
T cd07835          40 GVPSTAIREISLLKELNHPNIVRLLDVVHSE--------NKLYLVFEFLDLDLKKYMDSSPLTGLDPPLIKSYLYQLLQG  111 (283)
T ss_pred             cchhHHHHHHHHHHhcCCCCccCHhheeccC--------CeEEEEEeccCcCHHHHHhhCCCCCCCHHHHHHHHHHHHHH
Confidence            3456788999999999999999999999865        6699999999989998886644 358999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||+|
T Consensus       112 L~~lH~~~~~H~dl~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~slG  187 (283)
T cd07835         112 IAYCHSHRVLHRDLKPQNLLIDREGALKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGSRQYSTPVDIWSIG  187 (283)
T ss_pred             HHHHHHCCeeCCCCCHHHEEEcCCCcEEEeecccccccCCCc----cccCccccccCCCCCceeecCcccCcHHHHHHHH
Confidence            999999999999999999999999999999999987654221    1122335578899999987655578899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+....+..+.+..+.+....|+.......+... .+........  ......+..+.++|.+||
T Consensus       188 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~--~~~~~~~~~~~~li~~~l  264 (283)
T cd07835         188 CIFAEMVNRRPLFPGDSEIDQLFRIFRTLGTPDEDVWPGVTSLPDYKPT-FPKWARQDLS--KVVPNLDEDGLDLLSKML  264 (283)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChHHhhhhhhchhhhhh-cccccccchh--hhcCCCCHHHHHHHHHHh
Confidence            9999999999999999888888888887777766555443322211100 0000000000  011235678899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      +.+|.+|||++|++.||||
T Consensus       265 ~~~P~~Rpt~~~il~~~~~  283 (283)
T cd07835         265 VYDPAKRISAKAALQHPYF  283 (283)
T ss_pred             cCChhhCcCHHHHhcCCCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 1 (CDK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. This subfamily is composed of CDK1 from higher eukaryotes, plants, and yeasts, as well as CDK2 and CDK3. CDK1 is also called Cell division control protein 2 (Cdc2) or p34 protein kinase, and is regulated by cyclins A, B, and E. The CDK1/cyc

>cd05118 STKc_CMGC Catalytic domain of CMGC family Serine/Threonine Kinases

Probab=100.00  E-value=1.5e-36  Score=286.74  Aligned_cols=242  Identities=43%  Similarity=0.769  Sum_probs=198.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++|+||+++++++...        ..+++||||+++++.+.+......+++..+..++.||+.||.|
T Consensus        42 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~i~~~l~~  113 (283)
T cd05118          42 PKTALREIKLLKELNHPNIIKLLDVFRHK--------GDLYLVFEFMDTDLYKLIKDRQRGLPESLIKSYLYQLLQGLAF  113 (283)
T ss_pred             HHHHHHHHHHHHHhcCCCcchHHHhhccC--------CCEEEEEeccCCCHHHHHHhhcccCCHHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        5699999999999999887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+|+||||+||+++.++.++|+|||.+.......    .......++..|+|||.+.+...++.++|+||+||++
T Consensus       114 LH~~~i~H~dl~p~nili~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~~~~~~~Di~slG~~l  189 (283)
T cd05118         114 CHSHGILHRDLKPENLLINTEGVLKLADFGLARSFGSPV----RPYTHYVVTRWYRAPELLLGDKGYSTPVDIWSVGCIF  189 (283)
T ss_pred             HHHCCeeecCcCHHHEEECCCCcEEEeeeeeeEecCCCc----ccccCccCcccccCcHHHhcCCCCCchhHHHHHHHHH
Confidence            999999999999999999999999999999987765332    1223345688899999988764579999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.++|.+.+..+.+..+....+.+.+..|...........+..+...........  ...+.++++||.+||..|
T Consensus       190 ~~l~tg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~i~~~l~~~  267 (283)
T cd05118         190 AELLSRRPLFPGKSEIDQLFKIFRTLGTPDPEVWPKFTSLARNYKFSFPKKAGMPLPKLF--PNASPQALDLLSQMLHYD  267 (283)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHcCCCchHhcccchhhhhhhhhhhccccccCHHHhh--hhhCHHHHHHHHHHhccC
Confidence            999999999999999888888888888877776666554322222222221111111111  124788899999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||++++++.||||
T Consensus       268 P~~Rp~~~~ll~~~~~  283 (283)
T cd05118         268 PHKRITAEQALAHPYF  283 (283)
T ss_pred             cccCcCHHHHhhCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), CMGC family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CMGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The CMGC family consists of Cyclin-Dependent protein Kinases (CDKs), Mitogen-activated protein kinases (MAPKs) such as Extracellular signal-regulated kinase (ERKs), c-Jun N-terminal kinases (JNKs), and p38, and similar proteins. CDKs belong to a large subfamily of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. MAPKs serve as important mediators of cellular responses to extracellular signals. They

>cd05589 STKc_PKN Catalytic domain of the Protein Serine/Threonine Kinase, Protein Kinase N

Probab=100.00  E-value=2.2e-36  Score=291.72  Aligned_cols=211  Identities=26%  Similarity=0.390  Sum_probs=170.4

Q ss_pred             hhHHHHHHHH---HhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKIL---QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il---~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.++   +.++||||+++++++.+.        ..+|+||||+.+ +|...+..  ..+++..++.++.||+.|
T Consensus        44 ~~l~~e~~~~~~~~~l~hp~i~~~~~~~~~~--------~~~~lv~E~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~a  113 (324)
T cd05589          44 ESLMCEKRIFETANSERHPFLVNLFACFQTE--------DHVCFVMEYAAGGDLMMHIHT--DVFSEPRAVFYAACVVLG  113 (324)
T ss_pred             HHHHHHHHHHHhccccCCCChhceeeEEEcC--------CEEEEEEcCCCCCcHHHHhhc--CCCCHHHHHHHHHHHHHH
Confidence            3456676665   456799999999999875        669999999986 66655543  468999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+||||||+||+++.++.+||+|||++.......    ......+|++.|+|||++.+.. ++.++||||||
T Consensus       114 l~~lH~~~ivHrdlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG  188 (324)
T cd05589         114 LQYLHENKIVYRDLKLDNLLLDTEGFVKIADFGLCKEGMGFG----DRTSTFCGTPEFLAPEVLTETS-YTRAVDWWGLG  188 (324)
T ss_pred             HHHHHhCCeEecCCCHHHeEECCCCcEEeCcccCCccCCCCC----CcccccccCccccCHhHhcCCC-CCcccchhhHH
Confidence            999999999999999999999999999999999986532211    1223457899999999987755 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....+......                                .+...+..+.++|.+||
T Consensus       189 ~il~el~~G~~pf~~~~~~~~~~~i~~~~~~--------------------------------~p~~~~~~~~~li~~~L  236 (324)
T cd05589         189 VLIYEMLVGESPFPGDDEEEVFDSIVNDEVR--------------------------------YPRFLSREAISIMRRLL  236 (324)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCC--------------------------------CCCCCCHHHHHHHHHHh
Confidence            9999999999999988777665554331110                                01124667789999999


Q ss_pred             ccCCCCCC-----CHHHhhcCCCccCC
Q psy7889         244 LLDPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      +.||.+||     ++.++++||||...
T Consensus       237 ~~dP~~R~~~~~~~~~~l~~~~~f~~~  263 (324)
T cd05589         237 RRNPERRLGSGEKDAEDVKKQPFFRDI  263 (324)
T ss_pred             hcCHhHcCCCCCCCHHHHhhCCCcCCC
Confidence            99999999     79999999999653

Serine/Threonine Kinases (STKs), Protein Kinase N (PKN) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKN subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKN has a C-terminal catalytic domain that is highly homologous to PKCs. Its unique N-terminal regulatory region contains antiparallel coiled-coil (ACC) domains. In mammals, there are three PKN isoforms from different genes (designated PKN-alpha, beta, and gamma), which show different enzymatic properties, tissue distribution, and varied functions. PKN can be activated by the small GTPase Rho, and by fatty acids such as arachidonic and linoleic acids. It is involved

>PLN00034 mitogen-activated protein kinase kinase; Provisional

Probab=100.00  E-value=2.6e-36  Score=294.74  Aligned_cols=215  Identities=27%  Similarity=0.426  Sum_probs=166.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++|+||+++++++...        +.+|+||||+.+ +|..     .....+..+..++.||+.||+|
T Consensus       117 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~-----~~~~~~~~~~~i~~qi~~aL~~  183 (353)
T PLN00034        117 RQICREIEILRDVNHPNVVKCHDMFDHN--------GEIQVLLEFMDGGSLEG-----THIADEQFLADVARQILSGIAY  183 (353)
T ss_pred             HHHHHHHHHHHhCCCCCcceeeeEeccC--------CeEEEEEecCCCCcccc-----cccCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999775        669999999986 4422     2235778889999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSl  162 (433)
                      ||++||+||||||+|||++.++.+||+|||++..+....    .......||..|+|||++...    ...+.++|||||
T Consensus       184 LH~~~ivHrDlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Dvwsl  259 (353)
T PLN00034        184 LHRRHIVHRDIKPSNLLINSAKNVKIADFGVSRILAQTM----DPCNSSVGTIAYMSPERINTDLNHGAYDGYAGDIWSL  259 (353)
T ss_pred             HHHCCEeecCCCHHHEEEcCCCCEEEcccccceeccccc----ccccccccCccccCccccccccccCcCCCcchhHHHH
Confidence            999999999999999999999999999999997764321    122345789999999987432    224568999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|+.||......+....+..........                            .+...+.++++||.+|
T Consensus       260 Gvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~l~~li~~~  311 (353)
T PLN00034        260 GVSILEFYLGRFPFGVGRQGDWASLMCAICMSQPPE----------------------------APATASREFRHFISCC  311 (353)
T ss_pred             HHHHHHHHhCCCCCCCCCCccHHHHHHHHhccCCCC----------------------------CCCccCHHHHHHHHHH
Confidence            999999999999997443322222221111100000                            1123467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      |..||++|||+.|+|+||||.....
T Consensus       312 l~~~P~~Rpt~~ell~hp~~~~~~~  336 (353)
T PLN00034        312 LQREPAKRWSAMQLLQHPFILRAQP  336 (353)
T ss_pred             ccCChhhCcCHHHHhcCcccccCCc
Confidence            9999999999999999999977543

>cd05619 STKc_nPKC_theta Catalytic domain of the Protein Serine/Threonine Kinase, Novel Protein Kinase C theta

Probab=100.00  E-value=2.9e-36  Score=289.79  Aligned_cols=212  Identities=27%  Similarity=0.438  Sum_probs=172.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .....|+.+++.+ +||||+++++++.+.        +.+|+||||++ ++|...+.. ...+++..+..++.|++.||+
T Consensus        40 ~~~~~e~~~l~~~~~hp~iv~~~~~~~~~--------~~~~lv~ey~~~g~L~~~l~~-~~~~~~~~~~~~~~qi~~al~  110 (316)
T cd05619          40 ECTMVEKRVLSLAWEHPFLTHLYCTFQTK--------ENLFFVMEYLNGGDLMFHIQS-CHKFDLPRATFYAAEIICGLQ  110 (316)
T ss_pred             HHHHHHHHHHHhccCCCcCcceEEEEEeC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            4567788888865 899999999999876        66999999997 578777765 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++||||+||+
T Consensus       111 ~LH~~~ivHrdikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~i  185 (316)
T cd05619         111 FLHSKGIVYRDLKLDNILLDTDGHIKIADFGMCKENMLGD----AKTCTFCGTPDYIAPEILLGQK-YNTSVDWWSFGVL  185 (316)
T ss_pred             HHHhCCeEeCCCCHHHEEECCCCCEEEccCCcceECCCCC----CceeeecCCccccCHHHHcCCC-CCchhhhhhHHHH
Confidence            9999999999999999999999999999999986532211    1223456899999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+..+....+...  .+.                              .+...+.++++||.+||..
T Consensus       186 l~el~~G~~pf~~~~~~~~~~~i~~~--~~~------------------------------~~~~~~~~~~~li~~~l~~  233 (316)
T cd05619         186 LYEMLIGQSPFHGHDEEELFQSIRMD--NPC------------------------------YPRWLTREAKDILVKLFVR  233 (316)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhC--CCC------------------------------CCccCCHHHHHHHHHHhcc
Confidence            99999999999987766554443221  000                              0112456778999999999


Q ss_pred             CCCCCCCHH-HhhcCCCccCC
Q psy7889         246 DPSKRFDSD-AALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~~-e~L~h~~~~~~  265 (433)
                      ||++|+++. ++++||||...
T Consensus       234 ~P~~R~~~~~~l~~h~~~~~~  254 (316)
T cd05619         234 EPERRLGVKGDIRQHPFFREI  254 (316)
T ss_pred             CHhhcCCChHHHHcCcccCCC
Confidence            999999996 89999999663

Serine/Threonine Kinases (STKs), Novel Protein Kinase C (nPKC), theta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The nPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. nPKCs are calcium-independent, but require DAG (1,2-diacylglycerol) and phosphatidylserine (PS) for activity. There are four nPKC isoforms, delta, epsilon, eta, and theta. PKC-theta is selectively expressed in T-cells and plays an important and non-redundant role in

>cd05627 STKc_NDR2 Catalytic domain of the Protein Serine/Threonine Kinase, Nuclear Dbf2-Related kinase 2

Probab=100.00  E-value=1.4e-36  Score=297.38  Aligned_cols=219  Identities=24%  Similarity=0.333  Sum_probs=174.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.++..++||||+++++.+.+.        +.+|||||||++ +|.+++.+ ...+++..++.++.|++.||+|
T Consensus        46 ~~~~~e~~~l~~l~~~~iv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~~L~~  116 (360)
T cd05627          46 AHIRAERDILVEADGAWVVKMFYSFQDK--------RNLYLIMEFLPGGDMMTLLMK-KDTLSEEATQFYIAETVLAIDA  116 (360)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcC--------CEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999999875        669999999975 78777765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-------------------------------cccccCC
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-------------------------------VNRYTNR  135 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-------------------------------~~~~~~~  135 (433)
                      ||++||+||||||+|||++.+|.++|+|||++..........                               .......
T Consensus       117 lH~~givHrDLkp~NIli~~~~~vkL~DfG~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  196 (360)
T cd05627         117 IHQLGFIHRDIKPDNLLLDAKGHVKLSDFGLCTGLKKAHRTEFYRNLTHNPPSDFSFQNMNSKRKAETWKKNRRQLAYST  196 (360)
T ss_pred             HHHCCeEccCCCHHHEEECCCCCEEEeeccCCcccccccccccccccccCCccccccccccccccccccccccccccccc
Confidence            999999999999999999999999999999987543211000                               0011235


Q ss_pred             cccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccc
Q psy7889         136 VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELP  215 (433)
Q Consensus       136 ~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  215 (433)
                      +||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+.......+.......                 .++
T Consensus       197 ~gt~~Y~APE~~~~~~-~~~~~DiwSlGvilyel~tG~~Pf~~~~~~~~~~~i~~~~~~~-----------------~~p  258 (360)
T cd05627         197 VGTPDYIAPEVFMQTG-YNKLCDWWSLGVIMYEMLIGYPPFCSETPQETYRKVMNWKETL-----------------VFP  258 (360)
T ss_pred             CCCccccCHHHHcCCC-CCCcceeccccceeeecccCCCCCCCCCHHHHHHHHHcCCCce-----------------ecC
Confidence            7899999999997765 7999999999999999999999999888776655553211100                 000


Q ss_pred             hHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCC---CHHHhhcCCCccCC
Q psy7889         216 KAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---DSDAALNHDFFWTD  265 (433)
Q Consensus       216 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~L~h~~~~~~  265 (433)
                                 .....+.++++||.+|+. ||.+|+   +++++++||||...
T Consensus       259 -----------~~~~~s~~~~~li~~l~~-~p~~R~~~~~~~ei~~hp~f~~~  299 (360)
T cd05627         259 -----------PEVPISEKAKDLILRFCT-DSENRIGSNGVEEIKSHPFFEGV  299 (360)
T ss_pred             -----------CCCCCCHHHHHHHHHhcc-ChhhcCCCCCHHHHhcCCCCCCC
Confidence                       011256788899999875 999998   47999999999753

Serine/Threonine Kinases (STKs), NDR kinase subfamily, NDR2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The NDR subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. NDR kinase contains an N-terminal regulatory (NTR) domain and an insert within the catalytic domain that contains an auto-inhibitory sequence. Like many other AGC kinases, NDR kinase requires phosphorylation at two sites, the activation loop (A-loop) and the hydrophobic motif (HM), for activity. Higher eukaryotes contain two NDR isoforms, NDR1 and NDR2. Both isoforms play a role in proper centrosome duplication. In addition, NDR2 plays a role in regul

>cd05587 STKc_cPKC Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C

Probab=100.00  E-value=3e-36  Score=290.83  Aligned_cols=212  Identities=25%  Similarity=0.383  Sum_probs=173.0

Q ss_pred             chhHHHHHHHHHhCCC-CCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...++.|+.++..++| ++|+++++++...        +.+|+||||+.+ +|...+.. ...+++..++.++.||+.||
T Consensus        44 ~~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--------~~~~lv~E~~~~g~L~~~~~~-~~~~~~~~~~~~~~qi~~al  114 (324)
T cd05587          44 VECTMVEKRVLALPGKPPFLTQLHSCFQTM--------DRLYFVMEYVNGGDLMYHIQQ-VGKFKEPHAVFYAAEIAIGL  114 (324)
T ss_pred             HHHHHHHHHHHHhcCCCCceeeeEEEEEcC--------CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHH
Confidence            3467789999999975 5688899988765        569999999974 77777655 34689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++||||+||
T Consensus       115 ~~lH~~~ivH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGv  189 (324)
T cd05587         115 FFLHSKGIIYRDLKLDNVMLDAEGHIKIADFGMCKENIFGG----KTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV  189 (324)
T ss_pred             HHHHHCCeEecCCCHHHeEEcCCCCEEEeecCcceecCCCC----CceeeecCCccccChhhhcCCC-CCcccchhhhHH
Confidence            99999999999999999999999999999999986532111    1223457899999999998765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+....+.......                                +...+.++.++|.+||.
T Consensus       190 il~elltG~~pf~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~~~~~li~~~l~  237 (324)
T cd05587         190 LLYEMLAGQPPFDGEDEDELFQSIMEHNVSY--------------------------------PKSLSKEAVSICKGLLT  237 (324)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhh
Confidence            9999999999999888776665553311100                                11246678899999999


Q ss_pred             cCCCCCCCH-----HHhhcCCCccC
Q psy7889         245 LDPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      .||.+|++.     +++++||||..
T Consensus       238 ~~P~~R~~~~~~~~~~~~~hp~~~~  262 (324)
T cd05587         238 KHPAKRLGCGPTGERDIREHAFFRR  262 (324)
T ss_pred             cCHHHcCCCCCCCHHHHhcCCCcCC
Confidence            999999986     89999999965

Serine/Threonine Kinases (STKs), Classical (or Conventional) Protein Kinase C (cPKC) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. cPKCs contain a calcium-binding C2 region in their regulatory

>cd07829 STKc_CDK_like Catalytic domain of Cyclin-Dependent protein Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-36  Score=284.70  Aligned_cols=244  Identities=47%  Similarity=0.806  Sum_probs=197.5

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      +.....+.+|+.+++.++|+||+++++++...        ...++||||++++|.+++.+....+++..++.++.|++.|
T Consensus        39 ~~~~~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~  110 (282)
T cd07829          39 EGIPSTALREISLLKELKHPNIVKLLDVIHTE--------RKLYLVFEYCDMDLKKYLDKRPGPLSPNLIKSIMYQLLRG  110 (282)
T ss_pred             ccccHHHHHHHHHHHhcCCCCHHHHHhhhhcC--------CceEEEecCcCcCHHHHHHhhccCCCHHHHHHHHHHHHHH
Confidence            34456778999999999999999999999875        5699999999999999998765579999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+...++.++||||+|
T Consensus       111 l~~LH~~~i~H~~l~~~ni~~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~~~~~~~Dv~slG  186 (282)
T cd07829         111 LAYCHSHRILHRDLKPQNILINRDGVLKLADFGLARAFGIPL----RTYTHEVVTLWYRAPEILLGSKHYSTAVDIWSVG  186 (282)
T ss_pred             HHHHHHCCcccCCCChheEEEcCCCCEEEecCCcccccCCCc----cccCccccCcCcCChHHhcCCcCCCccccHHHHH
Confidence            999999999999999999999999999999999987654321    1233345577899999987764579999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|.+||.+.+..+.+..+....+.+.+..|....... ......+..........+..  .+..+.++|.+||
T Consensus       187 ~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~--~~~~~~~~i~~~l  263 (282)
T cd07829         187 CIFAEMITGKPLFPGDSEIDQLFKIFQILGTPTEESWPGVTKLP-DYKPTFPKFPPKDLEKVLPR--LDPEGIDLLSKML  263 (282)
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHHHHhCCCcHHHHHhhcccc-cccccccccCccchHHhccc--ccHHHHHHHHHhh
Confidence            99999999999999999998888888888887777665554433 11111111111111111111  3678899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..||++||+++++++||||
T Consensus       264 ~~~P~~Rp~~~~~l~~p~~  282 (282)
T cd07829         264 QYNPAKRISAKEALKHPYF  282 (282)
T ss_pred             ccCcccCCCHHHHhhCcCC
Confidence            9999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase (CDK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKs are partly regulated by their subcellular localization, which defines substrate phosphorylation and the resulting specific function. CDK1, CDK2, CDK4, and CDK6 have well-defined functions in the cell cycle, such as the regulation of the

>cd05618 STKc_aPKC_iota Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C iota

Probab=100.00  E-value=2.8e-36  Score=291.51  Aligned_cols=214  Identities=24%  Similarity=0.341  Sum_probs=166.6

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+|+.++..+ +||||+++++++...        +.+|+||||+.+ +|...+.. ...+++..++.++.||+.||+|
T Consensus        41 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~--------~~~~lv~E~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~~l~~  111 (329)
T cd05618          41 WVQTEKHVFEQASNHPFLVGLHSCFQTE--------SRLFFVIEYVNGGDLMFHMQR-QRKLPEEHARFYSAEISLALNY  111 (329)
T ss_pred             HHHHHHHHHHhcCCCCcCCceeeEEEeC--------CEEEEEEeCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            467899998877 899999999999875        669999999985 67666554 4469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++||||+||++
T Consensus       112 lH~~~ivH~Dikp~Nili~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  186 (329)
T cd05618         112 LHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVLM  186 (329)
T ss_pred             HHHCCeeeCCCCHHHEEECCCCCEEEeeCCccccccCCC----CccccccCCccccCHHHHcCCC-CCCccceecccHHH
Confidence            999999999999999999999999999999987532211    1223457899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCCh-----HHHHHHHHH-HhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         167 AEMWTRSPIMQGNTE-----QQQITLISQ-LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       167 ~ell~g~~pf~~~~~-----~~~~~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+|++|..||.....     ......+.. .....                             .-.+...+..+.++|.
T Consensus       187 ~el~~g~~Pf~~~~~~~~~~~~~~~~~~~~i~~~~-----------------------------~~~p~~~~~~~~~ll~  237 (329)
T cd05618         187 FEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILEKQ-----------------------------IRIPRSLSVKAASVLK  237 (329)
T ss_pred             HHHhhCCCCCccCCCcCCcccccHHHHHHHHhcCC-----------------------------CCCCCCCCHHHHHHHH
Confidence            999999999953110     000000000 00000                             0011235677889999


Q ss_pred             hhcccCCCCCCC------HHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFD------SDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t------~~e~L~h~~~~~~  265 (433)
                      +||..||.+|++      ..++++||||...
T Consensus       238 ~~L~~dP~~R~~~~~~~~~~~i~~hp~f~~~  268 (329)
T cd05618         238 SFLNKDPKERLGCHPQTGFADIQGHPFFRNV  268 (329)
T ss_pred             HHhcCCHHHcCCCCCCCCHHHHhcCCCCCCC
Confidence            999999999998      4799999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, iota isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-iota is directly implicated in carcinogenesis. It is critical to oncogenic signaling mediated by Ras and Bcr-Abl. The PKC-iota gene is the target o

>cd05622 STKc_ROCK1 Catalytic domain of the Protein Serine/Threonine Kinase, Rho-associated coiled-coil containing protein kinase 1

Probab=100.00  E-value=4.9e-36  Score=294.37  Aligned_cols=218  Identities=26%  Similarity=0.337  Sum_probs=174.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ..+|+|||||+ ++|..++...  .+++..++.++.||+.||+|
T Consensus        88 ~~~~~e~~i~~~~~hp~iv~~~~~~~~~--------~~~~lv~Ey~~gg~L~~~~~~~--~~~~~~~~~~~~qi~~aL~~  157 (371)
T cd05622          88 AFFWEERDIMAFANSPWVVQLFYAFQDD--------RYLYMVMEYMPGGDLVNLMSNY--DVPEKWARFYTAEVVLALDA  157 (371)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcC--------CEEEEEEcCCCCCcHHHHHHhc--CCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        66999999997 5788777643  58999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC---CCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR---NYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   ......+||+.|+|||++.+..   .++.++||||||
T Consensus       158 LH~~~ivHrDLkp~NIll~~~~~ikL~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~~~~~~~~~~DiwSlG  234 (371)
T cd05622         158 IHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEGM---VRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWSVG  234 (371)
T ss_pred             HHHCCEEeCCCCHHHEEECCCCCEEEEeCCceeEcCcCCc---ccccCcccCccccCHHHHhccCCCccCCCccceeehh
Confidence            9999999999999999999999999999999977643211   1223567899999999986542   378899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+.......|........   ++                         .....+..++++|.+||
T Consensus       235 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~---~~-------------------------~~~~~s~~~~~li~~~L  286 (371)
T cd05622         235 VFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLT---FP-------------------------DDNDISKEAKNLICAFL  286 (371)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHcCCCccc---CC-------------------------CcCCCCHHHHHHHHHHc
Confidence            999999999999999887666555543211110   00                         01125677889999999


Q ss_pred             ccCCCC--CCCHHHhhcCCCccCCC
Q psy7889         244 LLDPSK--RFDSDAALNHDFFWTDP  266 (433)
Q Consensus       244 ~~dP~~--R~t~~e~L~h~~~~~~~  266 (433)
                      ..++.+  |++++++++|+||....
T Consensus       287 ~~~~~r~~r~~~~ei~~h~~~~~~~  311 (371)
T cd05622         287 TDREVRLGRNGVEEIKRHLFFKNDQ  311 (371)
T ss_pred             CChhhhcCCCCHHHHhcCcccCCCC
Confidence            854443  78999999999997643

Serine/Threonine Kinases (STKs), ROCK subfamily, ROCK1 (or ROK-beta) isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ROCK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. ROCK contains an N-terminal extension, a catalytic kinase domain, and a C-terminal extension, which contains a coiled-coil region encompassing a Rho-binding domain (RBD) and a pleckstrin homology (PH) domain. ROCK is auto-inhibited by the RBD and PH domain interacting with the catalytic domain, and is activated via interaction with Rho GTPases. ROCK1 is preferentially expressed in the liver, lung, spleen, testes, an

>cd07850 STKc_JNK Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase

Probab=100.00  E-value=2.7e-36  Score=294.59  Aligned_cols=245  Identities=29%  Similarity=0.494  Sum_probs=184.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||++++++|.....  .......|+||||+.++|...+..   .+++..+..++.|++.||+||
T Consensus        60 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~---~l~~~~~~~~~~ql~~aL~~L  134 (353)
T cd07850          60 KRAYRELVLMKLVNHKNIIGLLNVFTPQKS--LEEFQDVYLVMELMDANLCQVIQM---DLDHERMSYLLYQMLCGIKHL  134 (353)
T ss_pred             HHHHHHHHHHHhcCCCCCcceeeeeccCCC--ccccCcEEEEEeccCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999999875422  111245899999999998888764   289999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++.......     ......++..|+|||.+.+.. ++.++||||+||+++
T Consensus       135 H~~gi~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~  208 (353)
T cd07850         135 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF-----MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMG  208 (353)
T ss_pred             HhCCeeeCCCCHHHEEECCCCCEEEccCccceeCCCCC-----CCCCCcccccccCHHHHhCCC-CCCchhhHhHHHHHH
Confidence            99999999999999999999999999999997654321     123346788999999997755 799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhC-----------CccCChhHH
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK-----------PYVKDQYGC  236 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~s~~~~  236 (433)
                      +|++|..||.+.+.......+...+|.+..+.+..............+............           ....+..++
T Consensus       209 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  288 (353)
T cd07850         209 EMIRGTVLFPGTDHIDQWNKIIEQLGTPSDEFMSRLQPTVRNYVENRPKYAGYSFEELFPDVLFPPDSESHNKLKASQAR  288 (353)
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhhhhHHhhcCCCCCCcchhhhCcccccCcccccccccchhHHH
Confidence            999999999998888888888777776544321111100000000000000000000000           113456788


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +||.+||+.||++|||+.|+|.||||.
T Consensus       289 ~li~~~L~~dP~~R~t~~eiL~~~~~~  315 (353)
T cd07850         289 DLLSKMLVIDPEKRISVDDALQHPYIN  315 (353)
T ss_pred             HHHHHHcCCChhhCcCHHHHhcChhHh
Confidence            999999999999999999999999985

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase (JNK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. They are also essential regulators of physiological and pathological processes and are involved in the pathogenesis of several diseases such as diabetes, atherosclerosis, stroke, Parkinson's and Alzheimer's. Vetebrates harbor three different JNK

>cd06650 PKc_MEK1 Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase 1

Probab=100.00  E-value=4.3e-36  Score=290.74  Aligned_cols=243  Identities=21%  Similarity=0.300  Sum_probs=176.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++|||||+++++|...        +.+|+||||+.+ +|.+++.+. ..+++..++.++.|++.||.|
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~  118 (333)
T cd06650          48 NQIIRELQVLHECNSPYIVGFYGAFYSD--------GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY  118 (333)
T ss_pred             HHHHHHHHHHHHCCCCcccceeEEEEEC--------CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999876        669999999974 888887653 468999999999999999999


Q ss_pred             HHhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+. +|+|+||||+|||++.++.+||+|||++......      ......|+..|+|||++.+.. ++.++||||+||+
T Consensus       119 lH~~~~ivH~dlkp~Nili~~~~~~kL~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~i  191 (333)
T cd06650         119 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS  191 (333)
T ss_pred             HHhcCCEEecCCChhhEEEcCCCCEEEeeCCcchhhhhh------ccccCCCCccccCHHHhcCCC-CCcHHHHHHHHHH
Confidence            9975 7999999999999999999999999998765322      122346789999999997754 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHH-HhCCCCCCCCCcccch-----hhhhccccchHHH----hh----HHhhhCCccC
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQ-LCGSITPESWPGVETL-----DLYNKMELPKAQK----RK----VKERLKPYVK  231 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~-~~g~~~~~~~~~~~~~-----~~~~~~~~~~~~~----~~----~~~~~~~~~~  231 (433)
                      +|+|++|..||......+....+.. ..+.............     ..+..-..+....    ..    ..........
T Consensus       192 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  271 (333)
T cd06650         192 LVEMAIGRYPIPPPDAKELELMFGCPVEGDPAESETSPRPRPPGRPLSSYGPDSRPPMAIFELLDYIVNEPPPKLPSGVF  271 (333)
T ss_pred             HHHHHHCCCCCCCcchhHHHHHhcCcccCCccccccCcccCCccchhhhhcccccccccHHHHHHHHhcCCCccCCCCCc
Confidence            9999999999987665433222211 1111111000000000     0000000000000    00    0001111235


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +.++++||.+||++||++|||++|++.|+||+...
T Consensus       272 ~~~~~~li~~~L~~~P~~Rpt~~ell~h~~~~~~~  306 (333)
T cd06650         272 GAEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSE  306 (333)
T ss_pred             CHHHHHHHHHhccCCcccCcCHHHHhhCHHHhcCc
Confidence            67889999999999999999999999999997653

Protein kinases (PKs), MAP/ERK kinase (MEK) 1 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 is a dual-specificity PK that phosphorylates and activates the downst

>cd07846 STKc_CDKL2_3 Catalytic domain of the Serine/Threonine Kinases, Cyclin-Dependent protein Kinase Like 2 and 3

Probab=100.00  E-value=4e-36  Score=284.38  Aligned_cols=242  Identities=36%  Similarity=0.691  Sum_probs=185.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++++.++||||+++++++...        ..+|+||||+.+++...+......+++..++.++.||+.||.|
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~i~~~l~~  115 (286)
T cd07846          44 KKIAMREIRMLKQLRHENLVNLIEVFRRK--------KRLYLVFEFVDHTVLDDLEKYPNGLDESRVRKYLFQILRGIEF  115 (286)
T ss_pred             hHHHHHHHHHHHhcCCcchhhHHHhcccC--------CeEEEEEecCCccHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999765        6699999999987666665545568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++.+...++.++||||+||++
T Consensus       116 LH~~~i~h~~l~p~ni~~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~~l  191 (286)
T cd07846         116 CHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----EVYTDYVATRWYRAPELLVGDTKYGRAVDIWAVGCLV  191 (286)
T ss_pred             HHHCCccccCCCHHHEEECCCCcEEEEeeeeeeeccCCc----cccCcccceeeccCcHHhccccccCchHhHHHHHHHH
Confidence            999999999999999999999999999999987654322    1223456788999999987655578899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHH-hhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK-RKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|.+||.+....+....+....+.....................+.... ......  .-..+..+.+|+.+||..
T Consensus       192 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~  269 (286)
T cd07846         192 TEMLTGEPLFPGDSDIDQLYHIIKCLGNLIPRHQEIFQKNPLFAGMRLPEVKEIEPLEKR--FPKLSGLVLDLAKQCLRI  269 (286)
T ss_pred             HHHHcCCCCCCCCchHHHHHHHHHHhCCCchhhHHHhccchHhhccccccccCcchHHHh--CCCcCHHHHHHHHHHhcC
Confidence            99999999999888877777777666654322111111111111111111000 000000  113567888999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|.+||++.++++||||
T Consensus       270 ~P~~Rp~~~~il~~~~~  286 (286)
T cd07846         270 DPDDRPSSSQLLHHEFF  286 (286)
T ss_pred             CcccchhHHHHhcCCCC
Confidence            99999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 2 (CDKL2) and CDKL3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL2 and CDKL3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDKL2, also called p56 KKIAMRE, is expressed in testis, kidney, lung, and brain. It functions mainly in mature neurons and plays an important role in learning and memory. Inactivation of CDKL3, also called NKI

>KOG0664|consensus

Probab=100.00  E-value=1.2e-38  Score=280.32  Aligned_cols=252  Identities=32%  Similarity=0.558  Sum_probs=200.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++|..++|.|++..+|+..-..-   .|...+|+|+|.+..||...+..-. .++...++-+++||+.||+|
T Consensus        96 ~krvFre~kmLcfFkHdNVLSaLDILQPph~---dfFqEiYV~TELmQSDLHKIIVSPQ-~Ls~DHvKVFlYQILRGLKY  171 (449)
T KOG0664|consen   96 CKRVFREIKMLSSFRHDNVLSLLDILQPANP---SFFQELYVLTELMQSDLHKIIVSPQ-ALTPDHVKVFVYQILRGLKY  171 (449)
T ss_pred             HHHHHHHHHHHHhhccccHHHHHHhcCCCCc---hHHHHHHHHHHHHHhhhhheeccCC-CCCcchhhhhHHHHHhhhHH
Confidence            4568899999999999999999999876533   3346689999999999988887633 58999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||.|.|++.+..+||||||+++.+...   ....++..+.|.+|+|||++.|...|+.++||||+|||+
T Consensus       172 LHsA~ILHRDIKPGNLLVNSNCvLKICDFGLARvee~d---~~~hMTqEVVTQYYRAPEiLMGaRhYs~AvDiWSVGCIF  248 (449)
T KOG0664|consen  172 LHTANILHRDIKPGNLLVNSNCILKICDFGLARTWDQR---DRLNMTHEVVTQYYRAPELLMGARRYTGAVDIWSVGCIF  248 (449)
T ss_pred             HhhcchhhccCCCccEEeccCceEEecccccccccchh---hhhhhHHHHHHHHhccHHHhhcchhhcCccceehhhHHH
Confidence            99999999999999999999999999999999987643   234566778899999999999999999999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHh--hHHhhhCCccCChhHHHHHHhhcc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR--KVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      .||+.++.+|....+.+++..|..++|.+..+..........-.-+.-+...+.  .+.....+.....+..+++.+||.
T Consensus       249 aELLgRrILFQAq~PiqQL~lItdLLGTPs~EaMr~ACEGAk~H~LR~~~k~Ps~~vLYtlsS~~~~~heav~~~~~~l~  328 (449)
T KOG0664|consen  249 AELLQRKILFQAAGPIEQLQMIIDLLGTPSQEAMKYACEGAKNHVLRAGLRAPDTQRLYKIASPDDKNHEAVDLLQKLLH  328 (449)
T ss_pred             HHHHhhhhhhhccChHHHHHHHHHHhCCCcHHHHHHHhhhhHHHhhccCCCCCCccceeeecCCcccchHHHHHHHHHhC
Confidence            999999999999999999999999999987664332221100000000000000  000000111234567899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||++|++.++++.|+|..+.
T Consensus       329 ~d~dkris~~~A~~~~~~~e~  349 (449)
T KOG0664|consen  329 FDPDKRISVEEALQHRYLEEG  349 (449)
T ss_pred             CCCcccccHhhhccccccccc
Confidence            999999999999999998553

>KOG0596|consensus

Probab=100.00  E-value=6.5e-36  Score=285.72  Aligned_cols=223  Identities=27%  Similarity=0.386  Sum_probs=174.5

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+||++|.+|+ |.+||+|+||=.++        +.+|+||||-+.||...+.+.....+.-+++.|..|+|+|+++
T Consensus       404 ~gy~nEI~lL~KLkg~~~IIqL~DYEv~d--------~~lYmvmE~Gd~DL~kiL~k~~~~~~~~~lk~ywkqML~aV~~  475 (677)
T KOG0596|consen  404 DGYRNEIALLNKLKGHDKIIQLYDYEVTD--------GYLYMVMECGDIDLNKILKKKKSIDPDWFLKFYWKQMLLAVKT  475 (677)
T ss_pred             HHHHHHHHHHHHhcCCceEEEEeeeeccC--------ceEEEEeecccccHHHHHHhccCCCchHHHHHHHHHHHHHHHH
Confidence            45789999999995 99999999998876        7799999999999999998866556656999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC----------CCCc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----------YGPP  156 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----------~~~~  156 (433)
                      +|..||||.||||.|+|+- .|.+||+|||+|..+....  ...-....+||+.||+||.+.....          .+.+
T Consensus       476 IH~~gIVHSDLKPANFLlV-kG~LKLIDFGIA~aI~~DT--TsI~kdsQvGT~NYMsPEAl~~~~s~~~~~~~k~Ki~r~  552 (677)
T KOG0596|consen  476 IHQHGIVHSDLKPANFLLV-KGRLKLIDFGIANAIQPDT--TSIVKDSQVGTVNYMSPEALTDMSSSRENGKSKIKISRK  552 (677)
T ss_pred             HHHhceeecCCCcccEEEE-eeeEEeeeechhcccCccc--cceeeccccCcccccCHHHHhhccccccCCCcceeecCc
Confidence            9999999999999999986 5789999999998876432  1222345789999999999864321          4678


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      +||||||||+|+|+.|++||....  ..+.++..+......-.++...                          ...+++
T Consensus       553 SDvWSLGCILYqMvYgktPf~~~~--n~~aKl~aI~~P~~~Iefp~~~--------------------------~~~~li  604 (677)
T KOG0596|consen  553 SDVWSLGCILYQMVYGKTPFGQII--NQIAKLHAITDPNHEIEFPDIP--------------------------ENDELI  604 (677)
T ss_pred             cchhhhhhHHHHHHhcCCchHHHH--HHHHHHHhhcCCCccccccCCC--------------------------CchHHH
Confidence            999999999999999999997543  1222332222111111111111                          122377


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +++..||..||++|+|..++|+|||++--+.+.
T Consensus       605 ~~mK~CL~rdPkkR~si~eLLqhpFl~~~~i~~  637 (677)
T KOG0596|consen  605 DVMKCCLARDPKKRWSIPELLQHPFLQIQPIPV  637 (677)
T ss_pred             HHHHHHHhcCcccCCCcHHHhcCcccccccccc
Confidence            999999999999999999999999997755544

>cd05604 STKc_SGK3 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 3

Probab=100.00  E-value=2.7e-36  Score=291.22  Aligned_cols=211  Identities=25%  Similarity=0.308  Sum_probs=169.4

Q ss_pred             hHHHHHH-HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIK-ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+++|.. +++.++||||+++++++...        +.+|+||||+.+ +|...+.+ ...+++..++.++.||+.||+|
T Consensus        41 ~~~~e~~~~l~~~~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~al~~  111 (325)
T cd05604          41 HIMAERNVLLKNVKHPFLVGLHYSFQTT--------EKLYFVLDFVNGGELFFHLQR-ERSFPEPRARFYAAEIASALGY  111 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEecC--------CEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4455655 46778999999999999875        669999999985 67666654 4468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||..|+|||++.+.. ++.++||||+||++
T Consensus       112 lH~~givH~Dlkp~NIll~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DvwslG~il  186 (325)
T cd05604         112 LHSINIVYRDLKPENILLDSQGHVVLTDFGLCKEGIAQS----DTTTTFCGTPEYLAPEVIRKQP-YDNTVDWWCLGAVL  186 (325)
T ss_pred             HHHCCeeecCCCHHHeEECCCCCEEEeecCCcccCCCCC----CCcccccCChhhCCHHHHcCCC-CCCcCcccccccee
Confidence            999999999999999999999999999999986532211    1223457899999999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+....-.                                .+...+..+.++|.+||..+
T Consensus       187 ~el~~G~~pf~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~ll~~ll~~~  234 (325)
T cd05604         187 YEMLYGLPPFYCRDVAEMYDNILHKPLV--------------------------------LRPGASLTAWSILEELLEKD  234 (325)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHHcCCcc--------------------------------CCCCCCHHHHHHHHHHhccC
Confidence            9999999999987766554444321000                                00124566779999999999


Q ss_pred             CCCCCCH----HHhhcCCCccCC
Q psy7889         247 PSKRFDS----DAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~----~e~L~h~~~~~~  265 (433)
                      |.+||++    .+++.||||...
T Consensus       235 p~~R~~~~~~~~~i~~h~~f~~~  257 (325)
T cd05604         235 RQRRLGAKEDFLEIQEHPFFESL  257 (325)
T ss_pred             HHhcCCCCCCHHHHhcCCCcCCC
Confidence            9999987    599999999653

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3 (also called cytokine-independent survival kinase CISK). SGK3 is expressed in most tissues and is most abundant in the embryo and adult heart and spleen. It was originally discovered in a screen for antiapoptotic genes. It phosphorylates and inhibits the proapoptotic proteins, Bad and FKHRL1. SGK3 also regulates many transporters, ion channels,

>cd05602 STKc_SGK1 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 1

Probab=100.00  E-value=4.2e-36  Score=289.95  Aligned_cols=210  Identities=26%  Similarity=0.334  Sum_probs=169.6

Q ss_pred             hHHHHHH-HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIK-ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+++|.. +++.++||||+++++++...        +.+|+||||+.+ +|...+.. ...+++..++.++.||+.||+|
T Consensus        41 ~~~~e~~~~l~~~~h~~Iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~L~~  111 (325)
T cd05602          41 HIMSERNVLLKNVKHPFLVGLHFSFQTA--------DKLYFVLDYINGGELFYHLQR-ERCFLEPRARFYAAEIASALGY  111 (325)
T ss_pred             HHHHHHHHHHHhCCCCCCCceeEEEEcC--------CeEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3444544 46778999999999999875        669999999986 67777655 4468899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       112 lH~~giiHrDlkp~Nili~~~~~~kl~DfG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  186 (325)
T cd05602         112 LHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----GTTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGAVL  186 (325)
T ss_pred             HHHCCeEecCCCHHHeEECCCCCEEEccCCCCcccccCC----CCcccccCCccccCHHHHcCCC-CCCccccccccHHH
Confidence            999999999999999999999999999999987543211    1233457899999999997755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+.......                                +...+..+.++|.+||+.|
T Consensus       187 ~el~~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~~  234 (325)
T cd05602         187 YEMLYGLPPFYSRNTAEMYDNILNKPLQL--------------------------------KPNITNSARHLLEGLLQKD  234 (325)
T ss_pred             HHHhcCCCCCCCCCHHHHHHHHHhCCcCC--------------------------------CCCCCHHHHHHHHHHcccC
Confidence            99999999999887766555443211000                                0124667789999999999


Q ss_pred             CCCCCCHH----HhhcCCCccC
Q psy7889         247 PSKRFDSD----AALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~----e~L~h~~~~~  264 (433)
                      |.+|+++.    ++++|+||..
T Consensus       235 p~~R~~~~~~~~~i~~~~~~~~  256 (325)
T cd05602         235 RTKRLGAKDDFMEIKNHIFFSP  256 (325)
T ss_pred             HHHCCCCCCCHHHHhcCcccCC
Confidence            99999886    8999999954

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK1 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK1 is ubiquitously expressed and is under transcriptional control of numerous stimuli including cell stress (cell shrinkage), serum, hormones (gluco- and mineralocorticoids), gonadotropins, growth factors, interleukin-6, and other cytokines. It plays roles in sodium retention and potassium elimination in the kidney, nutrient transport, salt

>cd05603 STKc_SGK2 Catalytic domain of the Protein Serine/Threonine Kinase, Serum- and Glucocorticoid-induced Kinase 2

Probab=100.00  E-value=4.3e-36  Score=289.36  Aligned_cols=210  Identities=28%  Similarity=0.363  Sum_probs=167.9

Q ss_pred             hHHHHHH-HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIK-ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+++|+. +++.++||||+++++++.+.        +.+|+||||+++ +|...+.. ...+++..++.++.||+.||+|
T Consensus        41 ~~~~e~~~~l~~~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~  111 (321)
T cd05603          41 HIMAERNVLLKNLKHPFLVGLHYSFQTA--------EKLYFVLDYVNGGELFFHLQR-ERCFLEPRARFYAAEVASAIGY  111 (321)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcC--------CEEEEEEcCCCCCCHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3455554 57888999999999999875        669999999985 67666654 4468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.+|.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       112 lH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  186 (321)
T cd05603         112 LHSLNIIYRDLKPENILLDSQGHVVLTDFGLCKEGVEPE----ETTSTFCGTPEYLAPEVLRKEP-YDRTVDWWCLGAVL  186 (321)
T ss_pred             HHHCCeEeccCCHHHeEECCCCCEEEccCCCCccCCCCC----CccccccCCcccCCHHHhcCCC-CCCcCcccccchhh
Confidence            999999999999999999999999999999987532211    1223457899999999987655 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+..   ...  .                           .+...+..+.++|.+||+.|
T Consensus       187 ~el~~g~~pf~~~~~~~~~~~i~~---~~~--~---------------------------~~~~~~~~~~~li~~~l~~~  234 (321)
T cd05603         187 YEMLYGLPPFYSRDVSQMYDNILH---KPL--Q---------------------------LPGGKTVAACDLLVGLLHKD  234 (321)
T ss_pred             hhhhcCCCCCCCCCHHHHHHHHhc---CCC--C---------------------------CCCCCCHHHHHHHHHHccCC
Confidence            999999999998776554444321   100  0                           01124566779999999999


Q ss_pred             CCCCCCH----HHhhcCCCccC
Q psy7889         247 PSKRFDS----DAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~----~e~L~h~~~~~  264 (433)
                      |.+|+++    .++++|+||..
T Consensus       235 p~~R~~~~~~~~~~~~~~~~~~  256 (321)
T cd05603         235 QRRRLGAKADFLEIKNHVFFSP  256 (321)
T ss_pred             HhhcCCCCCCHHHHhCCCCcCC
Confidence            9999976    59999999954

Serine/Threonine Kinases (STKs), Serum- and Glucocorticoid-induced Kinase (SGK) subfamily, SGK2 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. There are three isoforms of SGK, named SGK1, SGK2, and SGK3. SGK2 shows a more restricted distribution that SGK1 and is most abundantly expressed in epithelial tissues including kidney, liver, pancreas, and the choroid plexus of the brain. In vitro cellular assays show that SGK2 can stimulate the activity of ion channels, the glutamate transporter EEAT4, and the glutamate receptors, GluR6 and GLUR1.

>cd05616 STKc_cPKC_beta Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C beta

Probab=100.00  E-value=6.3e-36  Score=288.46  Aligned_cols=211  Identities=24%  Similarity=0.381  Sum_probs=173.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .....|+.++..+ +|++|+++++++...        +.+|+||||++ ++|...+... ..+++..+..++.||+.||+
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--------~~~~lv~E~~~~g~L~~~~~~~-~~~~~~~~~~~~~qi~~aL~  115 (323)
T cd05616          45 ECTMVEKRVLALSGKPPFLTQLHSCFQTM--------DRLYFVMEYVNGGDLMYQIQQV-GRFKEPHAVFYAAEIAIGLF  115 (323)
T ss_pred             HHHHHHHHHHHhccCCCeEeeEEEEEecC--------CEEEEEEcCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            3467788888877 589999999999875        66999999997 5787777553 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++||||+||+
T Consensus       116 ~LH~~~ivHrDlkp~Nill~~~~~~kL~DfG~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi  190 (323)
T cd05616         116 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENMWDG----VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL  190 (323)
T ss_pred             HHHHCCEEecCCCHHHeEECCCCcEEEccCCCceecCCCC----CccccCCCChhhcCHHHhcCCC-CCCccchhchhHH
Confidence            9999999999999999999999999999999986543211    1223457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+.......                                +...+.++.+++.+||+.
T Consensus       191 l~elltg~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~l~~  238 (323)
T cd05616         191 LYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------------------------------PKSMSKEAVAICKGLMTK  238 (323)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CCcCCHHHHHHHHHHccc
Confidence            999999999999888776666554311100                                112467788999999999


Q ss_pred             CCCCCCCH-----HHhhcCCCccC
Q psy7889         246 DPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      ||.+|+++     .++++|+||..
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~~~~  262 (323)
T cd05616         239 HPGKRLGCGPEGERDIKEHAFFRY  262 (323)
T ss_pred             CHHhcCCCCCCCHHHHhcCCCcCC
Confidence            99999984     89999999965

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, beta isoforms, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, and

>cd05605 STKc_GRK4_like Catalytic domain of G protein-coupled Receptor Kinase 4-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=9.3e-36  Score=282.17  Aligned_cols=216  Identities=26%  Similarity=0.381  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+.+++.++||||+++++++...        +.+|+||||+.+ +|...+... ...+++..+..++.|++.||.
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l~  116 (285)
T cd05605          45 AMALNEKQILEKVNSRFVVSLAYAYETK--------DALCLVLTLMNGGDLKFHIYNMGNPGFDEERAVFYAAEITCGLE  116 (285)
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeeeecCC--------CeEEEEEeccCCCcHHHHHHhcCcCCCCHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999775        569999999974 677666543 345899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+||||||+||+++.++.++|+|||++.......     ......|+..|+|||++.+.. ++.++||||+||+
T Consensus       117 ~lH~~~ivH~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Diws~G~~  190 (285)
T cd05605         117 DLHRERIVYRDLKPENILLDDYGHIRISDLGLAVEIPEGE-----TIRGRVGTVGYMAPEVVKNER-YTFSPDWWGLGCL  190 (285)
T ss_pred             HHHHCCcEecCCCHHHEEECCCCCEEEeeCCCceecCCCC-----ccccccCCCCccCcHHhcCCC-CCccccchhHHHH
Confidence            9999999999999999999999999999999987654221     123446889999999997655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.........+..........                            .+..++..+.+||.+||..
T Consensus       191 l~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~li~~~l~~  242 (285)
T cd05605         191 IYEMIEGKSPFRQRKEKVKREEVERRVKEDQEE----------------------------YSEKFSEAARSICRQLLTK  242 (285)
T ss_pred             HHHHHHCCCCCCCCchhhHHHHHHHHhhhcccc----------------------------cCcccCHHHHHHHHHHccC
Confidence            999999999999876544433332221110000                            0112466677999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||.+||     +++++++||||...
T Consensus       243 ~P~~R~~~~~~~~~~l~~~~~~~~~  267 (285)
T cd05605         243 DPGFRLGCRGEGAEEVKAHPFFRTA  267 (285)
T ss_pred             CHHHhcCCCCCCHHHHhcCcCccCC
Confidence            999999     99999999999653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK4-like group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. Members of the GRK4-like group include GRK4, GRK5,

>KOG0607|consensus

Probab=100.00  E-value=1.2e-36  Score=273.06  Aligned_cols=231  Identities=25%  Similarity=0.421  Sum_probs=176.0

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      -..+.||++++...+ |+||++|+++|+++        +.+|||||-+.| .|++-+.+. ..|++.++..+++.|+.||
T Consensus       119 R~RvfREVe~f~~Cqgh~nilqLiefFEdd--------~~FYLVfEKm~GGplLshI~~~-~~F~E~EAs~vvkdia~aL  189 (463)
T KOG0607|consen  119 RSRVFREVETFYQCQGHKNILQLIEFFEDD--------TRFYLVFEKMRGGPLLSHIQKR-KHFNEREASRVVKDIASAL  189 (463)
T ss_pred             HHHHHHHHHHHHHhcCCccHHHHHHHhccc--------ceEEEEEecccCchHHHHHHHh-hhccHHHHHHHHHHHHHHH
Confidence            357899999999995 99999999999987        669999999975 677777663 3699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCc---cccccCCcccccccCccccc---C-CCCCC
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQ---VNRYTNRVVTLWYRPPELLL---G-DRNYG  154 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~---~-~~~~~  154 (433)
                      +|||.+||.|||+||+|||-.+..   -||||||.+..-.....+..   .....+.+|+..|||||+..   + ...|+
T Consensus       190 dFlH~kgIAHRDlKPENiLC~~pn~vsPvKiCDfDLgSg~k~~~~~spastP~L~tPvGSAEfMAPEVVd~fv~qA~~YD  269 (463)
T KOG0607|consen  190 DFLHTKGIAHRDLKPENILCESPNKVSPVKICDFDLGSGIKLNNDCSPASTPELLTPVGSAEFMAPEVVDVFVDQATFYD  269 (463)
T ss_pred             HHHhhcCcccccCCccceeecCCCCcCceeeeccccccccccCCCCCCCCCccccCcccchhhcchhHHhhhcccccccc
Confidence            999999999999999999987654   58999999875543221111   11234678899999999863   2 23489


Q ss_pred             CcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhh-----hccccchHHHhhHHhhhCCc
Q psy7889         155 PPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLY-----NKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~~  229 (433)
                      .++|.||||||+|-||+|.+||.|....+        +|= ............+|     .++++|+..+..        
T Consensus       270 KrCDlwSLGvIlYImLsGYpPFvG~Cg~d--------CGW-drGe~Cr~CQ~~LFesIQEGkYeFPdkdWah--------  332 (463)
T KOG0607|consen  270 KRCDLWSLGVILYIMLSGYPPFVGHCGAD--------CGW-DRGEVCRVCQNKLFESIQEGKYEFPDKDWAH--------  332 (463)
T ss_pred             ccccHHHHHHHHHHHHhCCCCccCccCCc--------CCc-cCCCccHHHHHHHHHHHhccCCcCChhhhHH--------
Confidence            99999999999999999999999865432        110 00000011111111     234455544433        


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                       .|.+++|+|+.+|..|+..|.++.++++|||+..
T Consensus       333 -IS~eakdlisnLlvrda~~rlsa~~vlnhPw~~~  366 (463)
T KOG0607|consen  333 -ISSEAKDLISNLLVRDAKQRLSAAQVLNHPWVQR  366 (463)
T ss_pred             -hhHHHHHHHHHHHhccHHhhhhhhhccCCccccc
Confidence             4677889999999999999999999999999954

>cd07858 STKc_TEY_MAPK_plant Catalytic domain of the Serine/Threonine Kinases, TEY Mitogen-Activated Protein Kinases from Plants

Probab=100.00  E-value=6.1e-36  Score=290.29  Aligned_cols=250  Identities=35%  Similarity=0.576  Sum_probs=193.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++......   ....+|+||||++++|.+.+... ..+++..++.++.|++.||.||
T Consensus        49 ~~~~~E~~~l~~l~h~ni~~~~~~~~~~~~~---~~~~~~lv~e~~~~~L~~~~~~~-~~l~~~~~~~i~~qi~~aL~~L  124 (337)
T cd07858          49 KRTLREIKLLRHLDHENVIAIKDIMPPPHRE---AFNDVYIVYELMDTDLHQIIRSS-QTLSDDHCQYFLYQLLRGLKYI  124 (337)
T ss_pred             HHHHHHHHHHHhcCCCCccchHHheeccccc---ccCcEEEEEeCCCCCHHHHHhcC-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4567899999999999999999988754210   12458999999999998888653 4699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++|++|+||||+||+++.++.+||+|||++.......    .......++..|+|||.+.....++.++||||+||++|
T Consensus       125 H~~~i~H~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~DiwslG~il~  200 (337)
T cd07858         125 HSANVLHRDLKPSNLLLNANCDLKICDFGLARTTSEKG----DFMTEYVVTRWYRAPELLLNCSEYTTAIDVWSVGCIFA  200 (337)
T ss_pred             HhCCEecCCCCHHHEEEcCCCCEEECcCccccccCCCc----ccccccccccCccChHHHhcCCCCCCcccHHHHHHHHH
Confidence            99999999999999999999999999999997654321    12234467889999999876445799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+.......+....|.+..+.+............. .+..........  .-..+.++++||.+||+.+
T Consensus       201 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~~  278 (337)
T cd07858         201 ELLGRKPLFPGKDYVHQLKLITELLGSPSEEDLGFIRNEKARRYIRSLPYTPRQSFARL--FPHANPLAIDLLEKMLVFD  278 (337)
T ss_pred             HHHcCCCCCCCCChHHHHHHHHHHhCCCChHHhhhcCchhhhHHHHhcCcccccCHHHH--cccCCHHHHHHHHHHhcCC
Confidence            9999999999998888888888888877665553322221111000 000000000111  1135788899999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~  267 (433)
                      |++|||++++|+||||.....
T Consensus       279 P~~Rps~~ell~h~~~~~~~~  299 (337)
T cd07858         279 PSKRITVEEALAHPYLASLHD  299 (337)
T ss_pred             hhhccCHHHHHcCcchhhhcC
Confidence            999999999999999965443

Serine/Threonine Kinases (STKs), Plant TEY Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TEY MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. In plants, MAPKs are associated with physiological, developmental, hormonal, and stress responses. Some plants show numerous gene duplications of MAPKs. Arabidopsis thaliana harbors at least 20 MAPKs, named AtMPK1-20. There are two subtypes of plant MAPKs based on the conserved phosphorylation motif present in the activati

>cd07857 STKc_MPK1 Catalytic domain of the Serine/Threonine Kinase, Fungal Mitogen-Activated Protein Kinase MPK1

Probab=100.00  E-value=7.1e-36  Score=289.20  Aligned_cols=253  Identities=32%  Similarity=0.552  Sum_probs=191.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+++++ +||||+++++.+.....    ....+|++++|++++|.+.+.. ...+++..++.++.||+.||+|
T Consensus        46 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~~~----~~~~~~~~~e~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~aL~~  120 (332)
T cd07857          46 KRALRELKLLRHFRGHKNITCLYDMDIVFPG----NFNELYLYEELMEADLHQIIRS-GQPLTDAHFQSFIYQILCGLKY  120 (332)
T ss_pred             HHHHHHHHHHHHhcCCCChheeeeeeeeccc----cCCcEEEEEecccCCHHHHHhc-CCCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999 59999999997654311    1256899999999999888865 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||+||+++.++.++|+|||++..................|+..|+|||++.+...++.++||||+||++
T Consensus       121 LH~~givH~dlkp~Nili~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~Di~slGv~l  200 (332)
T cd07857         121 IHSANVLHRDLKPGNLLVNADCELKICDFGLARGFSENPGENAGFMTEYVATRWYRAPEIMLSFQSYTKAIDVWSVGCIL  200 (332)
T ss_pred             HHhCCcccCCCCHHHeEEcCCCCEEeCcCCCceecccccccccccccCcccCccccCcHHHhCCCCCCcHHHHHHHHHHH
Confidence            99999999999999999999999999999999876543222112223457899999999887655578999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-ccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|.+||.+.+....+..+...+|.+..+.+............ ..............  ...+..+.+||.+||+.
T Consensus       201 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  278 (332)
T cd07857         201 AELLGRKPVFKGKDYVDQLNQILQVLGTPDEETLSRIGSPKAQNYIRSLPNIPKKPFESIF--PNANPLALDLLEKLLAF  278 (332)
T ss_pred             HHHHhCCcCCCCCCHHHHHHHHHHHhCCCCHHHHHhhhhhhHHHHHHhccccCCcchHhhC--CCCCHHHHHHHHHHccC
Confidence            9999999999999988888888888887654332222111100000 00000000011111  12367889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      ||.+|||+.+++.||||.+...
T Consensus       279 ~P~~R~t~~~ll~~~~~~~~~~  300 (332)
T cd07857         279 DPTKRISVEEALEHPYLAIWHD  300 (332)
T ss_pred             CcccCCCHHHHhcChhhhhhcC
Confidence            9999999999999999965443

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) MPK1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MPK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs MPK1 from Saccharomyces cerevisiae, Pmk1 from Schizosaccharomyces pombe, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. MPK1 (also called Slt2) and Pmk1 (also called Spm1) are stress-activated MAPKs that regulate the cell wall integrity (CWI) pathway, and are therefore important in the maintainance of cell shape, cell wall co

>cd05597 STKc_DMPK_like Catalytic domain of Myotonic Dystrophy protein kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.4e-35  Score=286.92  Aligned_cols=220  Identities=23%  Similarity=0.302  Sum_probs=174.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|+||+++++++.+.        +.+|+||||+. ++|.+++.+....+++..++.++.||+.||+|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  117 (331)
T cd05597          46 ACFREERDVLVNGDRRWITNLHYAFQDE--------NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVLAIDS  117 (331)
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecC--------CeEEEEEecCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4477899999999999999999999875        66999999996 58888887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSl  162 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   .......||+.|+|||++.+    ...++.++||||+
T Consensus       118 lH~~~ivH~dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~Diwsl  194 (331)
T cd05597         118 VHQLGYVHRDIKPDNVLLDKNGHIRLADFGSCLRLLADGT---VQSNVAVGTPDYISPEILQAMEDGKGRYGPECDWWSL  194 (331)
T ss_pred             HHhCCeEECCCCHHHEEECCCCCEEEEECCceeecCCCCC---ccccceeccccccCHHHHhhccccccCCCCcceeehh
Confidence            9999999999999999999999999999999876543221   11223468999999999863    2346889999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|..||.+.+..+....+........                 .+.          .....+..+++||.+|
T Consensus       195 G~~l~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~~~----------~~~~~~~~~~~li~~l  247 (331)
T cd05597         195 GVCMYEMLYGETPFYAESLVETYGKIMNHKEHFQ-----------------FPP----------DVTDVSEEAKDLIRRL  247 (331)
T ss_pred             hhHHHHHhhCCCCCCCCCHHHHHHHHHcCCCccc-----------------CCC----------ccCCCCHHHHHHHHHH
Confidence            9999999999999998876665555432111000                 000          0012567788999999


Q ss_pred             cccCCCC--CCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      |..++++  |++++++++||||...
T Consensus       248 l~~~~~r~~r~~~~~~l~hp~~~~~  272 (331)
T cd05597         248 ICSPETRLGRNGLQDFKDHPFFEGI  272 (331)
T ss_pred             ccCcccccCCCCHHHHhcCCCCCCC
Confidence            9765544  7899999999999653

Serine/Threonine Kinases (STKs), Myotonic Dystrophy protein kinase (DMPK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The DMPK-like subfamily is composed of DMPK and DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK). Three isoforms of MRCK are known, named alpha, beta and gamma. The DMPK gene is implicated in myotonic dystrophy 1 (DM1), an inherited multisystemic disorder with symptoms that include muscle hyperexcitability, progressive muscle weakness and wasting, cataract development, testicular atrophy,

>cd05607 STKc_GRK7 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 7

Probab=100.00  E-value=1.1e-35  Score=280.49  Aligned_cols=216  Identities=27%  Similarity=0.371  Sum_probs=169.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+..|+++++.++||||+++++++...        ..+|+||||+.+ +|...+.... ..+++..+..++.|++.||+
T Consensus        38 ~~~~~E~~il~~l~hp~i~~~~~~~~~~--------~~~~lv~e~~~g~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al~  109 (277)
T cd05607          38 KMALLEKEILEKVNSPFIVNLAYAFESK--------THLCLVMSLMNGGDLKYHIYNVGERGLEMERVIHYSAQITCGIL  109 (277)
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEecC--------CeEEEEEecCCCCCHHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence            3456799999999999999999999875        669999999974 7776665432 34888999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+||||||+||+++.++.++|+|||++.......     ......|+..|+|||++.+.. ++.++||||+||+
T Consensus       110 ~lH~~~ivH~dikp~Nili~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslGv~  183 (277)
T cd05607         110 HLHSMDIVYRDMKPENVLLDDQGNCRLSDLGLAVELKDGK-----TITQRAGTNGYMAPEILKEEP-YSYPVDWFAMGCS  183 (277)
T ss_pred             HHHHCCEEEccCChHhEEEcCCCCEEEeeceeeeecCCCc-----eeeccCCCCCccCHHHHccCC-CCCchhHHHHHHH
Confidence            9999999999999999999999999999999987764321     122346788999999998766 8999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.........+....-.   ...                        .......+.++++||.+||+.
T Consensus       184 l~el~~g~~p~~~~~~~~~~~~~~~~~~~---~~~------------------------~~~~~~~~~~~~~li~~~L~~  236 (277)
T cd05607         184 IYEMVAGRTPFKDHKEKVAKEELKRRTLE---DEV------------------------KFEHQNFTEESKDICRLFLAK  236 (277)
T ss_pred             HHHHHhCCCCCCCCcchhhHHHHHHHhhc---ccc------------------------ccccccCCHHHHHHHHHHhcc
Confidence            99999999999865432221111111000   000                        000112567788999999999


Q ss_pred             CCCCCCCH----HHhhcCCCccC
Q psy7889         246 DPSKRFDS----DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~----~e~L~h~~~~~  264 (433)
                      ||.+||++    ++++.|+||..
T Consensus       237 ~P~~R~~~~~~~~~~~~h~~f~~  259 (277)
T cd05607         237 KPEDRLGSREKNDDPRKHEFFKT  259 (277)
T ss_pred             CHhhCCCCccchhhhhcChhhcC
Confidence            99999999    77889999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK7 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK7, also called iodopsin kinase, belongs to the visual gr

>KOG4279|consensus

Probab=100.00  E-value=1e-36  Score=297.18  Aligned_cols=219  Identities=26%  Similarity=0.404  Sum_probs=178.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCC--CHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF--SLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l--~~~~~~~i~~qll~a   83 (433)
                      .+....||.+.+.|+|.|||++++.+...        +.+-|.||-++| +|.+++...-+.+  +|..+..+.+||++|
T Consensus       616 ~QPLhEEIaLH~~LrHkNIVrYLGs~sen--------Gf~kIFMEqVPGGSLSsLLrskWGPlKDNEstm~fYtkQILeG  687 (1226)
T KOG4279|consen  616 VQPLHEEIALHSTLRHKNIVRYLGSVSEN--------GFFKIFMEQVPGGSLSSLLRSKWGPLKDNESTMNFYTKQILEG  687 (1226)
T ss_pred             hccHHHHHHHHHHHhhHhHHHHhhccCCC--------CeEEEEeecCCCCcHHHHHHhccCCCccchhHHHHHHHHHHHH
Confidence            46678899999999999999999987654        678899999975 7888887766677  899999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc-CCCCCCCcchhhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWG  161 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~~~~~~~~~DiwS  161 (433)
                      |+|||++.|||||||-+||||+ -.|.+||+|||-++.+..-.    ....++.||+.|||||+|- |...|+.++||||
T Consensus       688 LkYLHen~IVHRDIKGDNVLvNTySGvlKISDFGTsKRLAgin----P~TETFTGTLQYMAPEvIDqG~RGYG~aADIWS  763 (1226)
T KOG4279|consen  688 LKYLHENKIVHRDIKGDNVLVNTYSGVLKISDFGTSKRLAGIN----PCTETFTGTLQYMAPEVIDQGPRGYGKAADIWS  763 (1226)
T ss_pred             hhhhhhcceeeccccCCcEEEeeccceEEecccccchhhccCC----ccccccccchhhhChHhhccCCcCCCchhhhhh
Confidence            9999999999999999999998 46899999999998876432    2234678999999999995 4567999999999


Q ss_pred             HHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |||++.||+||+|||..- +....+.++....-.+                              -.|...|.+++.||.
T Consensus       764 ~GCT~vEMATGrPPF~ElgspqAAMFkVGmyKvHP------------------------------~iPeelsaeak~Fil  813 (1226)
T KOG4279|consen  764 FGCTMVEMATGRPPFVELGSPQAAMFKVGMYKVHP------------------------------PIPEELSAEAKNFIL  813 (1226)
T ss_pred             ccceeEeeccCCCCeeecCChhHhhhhhcceecCC------------------------------CCcHHHHHHHHHHHH
Confidence            999999999999999753 2222222221111000                              012236788999999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      +|+.+||.+||+|.++|..||++..+.
T Consensus       814 rcFepd~~~R~sA~~LL~DpFlq~~~k  840 (1226)
T KOG4279|consen  814 RCFEPDPCDRPSAKDLLQDPFLQHNNK  840 (1226)
T ss_pred             HHcCCCcccCccHHHhccCcccccCCC
Confidence            999999999999999999999986643

>cd07834 STKc_MAPK Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase

Probab=100.00  E-value=6.5e-36  Score=289.13  Aligned_cols=253  Identities=34%  Similarity=0.602  Sum_probs=197.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++.....   .....+|+||||++++|.+.+.... .+++..++.++.||+.||+|
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~l~~~~-~l~~~~~~~i~~~l~~~l~~  118 (330)
T cd07834          43 AKRILREIKLLRHLRHENIIGLLDILRPPSP---EDFNDVYIVTELMETDLHKVIKSPQ-PLTDDHIQYFLYQILRGLKY  118 (330)
T ss_pred             hhhHHHHHHHHHhcCCcchhhhhhhhcccCc---ccccceEEEecchhhhHHHHHhCCC-CCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999987631   1124689999999998888886644 79999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++......... ........++..|+|||++.+...++.++|+||+||++
T Consensus       119 LH~~gi~H~dlkp~nili~~~~~~~L~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~il  197 (330)
T cd07834         119 LHSANVIHRDLKPSNILVNSNCDLKICDFGLARGVDPDEDE-KGFLTEYVVTRWYRAPELLLSSSRYTKAIDIWSVGCIF  197 (330)
T ss_pred             HHhCCeecCCCCHHHEEEcCCCCEEEcccCceEeecccccc-cccccccccccCcCCceeeecccCCCcchhHHHHHHHH
Confidence            99999999999999999999999999999999876543211 11233456788999999998774579999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|.+||.+.+..+....+....+.+.+..+...........+. .............  ...+.++.+||.+||++
T Consensus       198 ~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~l~~  275 (330)
T cd07834         198 AELLTRKPLFPGRDYIDQLNLIVEVLGTPSEEDLKFITSEKARNYLKSLPKKPKKPLSKLF--PGASPEAIDLLEKMLVF  275 (330)
T ss_pred             HHHHcCCCCcCCCCHHHHHHHHHHhcCCCChhHhhhccccchhhHHhhcccCCcchhHHhc--ccCCHHHHHHHHHHccC
Confidence            99999999999999999888888888877766544222111111110 0000001111111  12577889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +|.+|||+++++.||||....
T Consensus       276 ~P~~Rpt~~~ll~~~~~~~~~  296 (330)
T cd07834         276 DPKKRITADEALAHPYLAQLH  296 (330)
T ss_pred             ChhhCCCHHHHHhCccHHhhc
Confidence            999999999999999996544

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase (MAPK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs serve as important mediators of cellular responses to extracellular signals. They control critical cellular functions including differentiation, proliferation, migration, and apoptosis. They are also implicated in the pathogenesis of many diseases including multiple types of cancer, stroke, diabetes, and chronic inflammation. Typical MAPK pathways involve a triple kinase core cascade comprising of the MAPK, which is phosphorylated and

>cd06643 STKc_SLK Catalytic domain of the Protein Serine/Threonine Kinase, Ste20-like kinase

Probab=100.00  E-value=6.2e-35  Score=275.92  Aligned_cols=218  Identities=27%  Similarity=0.432  Sum_probs=174.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++...        ...|+||||+++ +|...+.+....+++..+..++.|++.||.|
T Consensus        47 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~--------~~~~~v~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~~L~~  118 (282)
T cd06643          47 EDYMVEIDILASCDHPNIVKLLDAFYYE--------NNLWILIEFCAGGAVDAVMLELERPLTEPQIRVVCKQTLEALNY  118 (282)
T ss_pred             HHHHHHHHHHHHCCCCCeeeEEEEEeeC--------CEEEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        568999999986 5555555545578999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSl  162 (433)
                      ||+.|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||++..    ...++.++||||+
T Consensus       119 LH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  194 (282)
T cd06643         119 LHENKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSL  194 (282)
T ss_pred             HHHCCeeecCCCcccEEEccCCCEEEccccccccccccc----cccccccccccccCHhhccccCCCCCCCCccchhhhH
Confidence            999999999999999999999999999999987653221    12233467889999999842    2336789999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||...+..+....+........                             ..+...+.++.+||.+|
T Consensus       195 Gvil~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~  245 (282)
T cd06643         195 GITLIEMAQIEPPHHELNPMRVLLKIAKSEPPTL-----------------------------AQPSRWSSEFKDFLKKC  245 (282)
T ss_pred             HHHHHHHccCCCCccccCHHHHHHHHhhcCCCCC-----------------------------CCccccCHHHHHHHHHH
Confidence            9999999999999988776655544433211000                             01112456778999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+||+++++++||||....
T Consensus       246 l~~~p~~Rp~~~~il~~~~~~~~~  269 (282)
T cd06643         246 LEKNVDARWTTTQLLQHPFVTVNS  269 (282)
T ss_pred             ccCChhhCcCHHHHhcCCCEeccC
Confidence            999999999999999999997654

Serine/threonine kinases (STKs), Ste20-like kinase (SLK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It acts as a MAPK kinase kinase (MAPKKK) by phosphorylating ASK1, resulting in the phosphorylation of p38. SLK also plays a role in mediating actin reorganization. It is part of a microtubule-associated complex that is targeted at adhesion sites, and is required in focal adhesion turnover and in regulating cell migration.

>cd05617 STKc_aPKC_zeta Catalytic domain of the Protein Serine/Threonine Kinase, Atypical Protein Kinase C zeta

Probab=100.00  E-value=1.5e-35  Score=286.23  Aligned_cols=215  Identities=23%  Similarity=0.328  Sum_probs=167.7

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+|+.++.++ +||||+++++++.+.        ..+|+||||+++ +|...+.. ...+++..++.++.||+.||+|
T Consensus        41 ~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~al~~  111 (327)
T cd05617          41 WVQTEKHVFEQASSNPFLVGLHSCFQTT--------SRLFLVIEYVNGGDLMFHMQR-QRKLPEEHARFYAAEICIALNF  111 (327)
T ss_pred             HHHHHHHHHHhhcCCCCEeeEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHHH
Confidence            467899999888 699999999999875        669999999975 67666654 3469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||++
T Consensus       112 lH~~~ivHrDlkp~Nili~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvil  186 (327)
T cd05617         112 LHERGIIYRDLKLDNVLLDADGHIKLTDYGMCKEGLGPG----DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLM  186 (327)
T ss_pred             HHHCCeeccCCCHHHEEEeCCCCEEEeccccceeccCCC----CceecccCCcccCCHHHHCCCC-CCchheeehhHHHH
Confidence            999999999999999999999999999999987532211    1223457899999999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChH---HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         167 AEMWTRSPIMQGNTEQ---QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |+|++|.+||......   .....+.......+                            .-.+...+..+.++|.+||
T Consensus       187 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~p~~~~~~~~~li~~~L  238 (327)
T cd05617         187 FEMMAGRSPFDIITDNPDMNTEDYLFQVILEKP----------------------------IRIPRFLSVKASHVLKGFL  238 (327)
T ss_pred             HHHHhCCCCCCccCCCcccccHHHHHHHHHhCC----------------------------CCCCCCCCHHHHHHHHHHh
Confidence            9999999999643211   00011111000000                            0012235677889999999


Q ss_pred             ccCCCCCCC------HHHhhcCCCccCC
Q psy7889         244 LLDPSKRFD------SDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t------~~e~L~h~~~~~~  265 (433)
                      ..||.+|++      .+++++||||...
T Consensus       239 ~~dP~~R~~~~~~~~~~~i~~h~~f~~~  266 (327)
T cd05617         239 NKDPKERLGCQPQTGFSDIKSHTFFRSI  266 (327)
T ss_pred             ccCHHHcCCCCCCCCHHHHHcCCCCCCC
Confidence            999999998      4799999999653

Serine/Threonine Kinases (STKs), Atypical Protein Kinase C (aPKC) subfamily, zeta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The aPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. aPKCs only require phosphatidylserine (PS) for activation. There are two aPKC isoforms, zeta and iota. PKC-zeta plays a critical role in activating the glucose transport response. It is activated by glucose, insulin, and exercise through diverse pathways

>cd05615 STKc_cPKC_alpha Catalytic domain of the Protein Serine/Threonine Kinase, Classical Protein Kinase C alpha

Probab=100.00  E-value=2.2e-35  Score=284.68  Aligned_cols=212  Identities=25%  Similarity=0.382  Sum_probs=172.5

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+..|+.+++.+. |++|+++++++.+.        +.+|+||||+++ +|...+.. ...+++..++.++.||+.||+
T Consensus        45 ~~~~~e~~~l~~~~~~~~i~~~~~~~~~~--------~~~~lv~Ey~~~g~L~~~i~~-~~~l~~~~~~~i~~qi~~al~  115 (323)
T cd05615          45 ECTMVEKRVLALQDKPPFLTQLHSCFQTV--------DRLYFVMEYVNGGDLMYHIQQ-VGKFKEPQAVFYAAEISVGLF  115 (323)
T ss_pred             HHHHHHHHHHHhccCCCchhheeeEEecC--------CEEEEEEcCCCCCcHHHHHHH-cCCCCHHHHHHHHHHHHHHHH
Confidence            45678999998885 67888999998875        569999999974 77777654 346999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++||||+||+
T Consensus       116 ~lH~~~ivHrDikp~Nill~~~~~ikL~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslGvi  190 (323)
T cd05615         116 FLHRRGIIYRDLKLDNVMLDSEGHIKIADFGMCKEHMVDG----VTTRTFCGTPDYIAPEIIAYQP-YGKSVDWWAYGVL  190 (323)
T ss_pred             HHHHCCeeccCCCHHHeEECCCCCEEEeccccccccCCCC----ccccCccCCccccCHHHHcCCC-CCCccchhhhHHH
Confidence            9999999999999999999999999999999987543211    1123456899999999997755 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.........+.......                                +...+.++.+++.+||..
T Consensus       191 l~elltG~~pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~~l~~  238 (323)
T cd05615         191 LYEMLAGQPPFDGEDEDELFQSIMEHNVSY--------------------------------PKSLSKEAVSICKGLMTK  238 (323)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CccCCHHHHHHHHHHccc
Confidence            999999999999888766655554311100                                112456778999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccCC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~~  265 (433)
                      +|.+|++     .+++++||||...
T Consensus       239 ~p~~R~~~~~~~~~~i~~h~~f~~~  263 (323)
T cd05615         239 HPSKRLGCGPEGERDIREHAFFRRI  263 (323)
T ss_pred             CHhhCCCCCCCCHHHHhcCcccCCC
Confidence            9999997     4799999999653

Serine/Threonine Kinases (STKs), Classical Protein Kinase C (cPKC) subfamily, alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cPKC subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PKCs are classified into three groups (classical, atypical, and novel) depending on their mode of activation and the structural characteristics of their regulatory domain. PKCs undergo three phosphorylations in order to take mature forms. In addition, cPKCs depend on calcium, DAG (1,2-diacylglycerol), and in most cases, phosphatidylserine (PS) for activation. There are four cPKC isoforms, named alpha, betaI, betaII, a

>cd05623 STKc_MRCK_alpha Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase alpha

Probab=100.00  E-value=2.3e-35  Score=285.65  Aligned_cols=219  Identities=22%  Similarity=0.307  Sum_probs=175.2

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.++..++|+||+++++++.+.        +.+|+||||+. ++|.+++.+....+++..++.++.||+.||+||
T Consensus        47 ~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~ey~~~g~L~~~l~~~~~~l~~~~~~~~~~qi~~al~~l  118 (332)
T cd05623          47 CFREERDVLVNGDNQWITTLHYAFQDE--------NNLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYLAEMVIAIDSV  118 (332)
T ss_pred             HHHHHHHHHhhCCCCCEeeEEEEEecC--------CEEEEEEeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999875        66999999996 589888877666799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGAG  163 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlG  163 (433)
                      |++||+||||||+|||++.++.+||+|||++........   ......+||+.|+|||++.+    ...++.++||||+|
T Consensus       119 H~~~iiHrDlkp~Nili~~~~~~kL~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DvwSlG  195 (332)
T cd05623         119 HQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEDGKGKYGPECDWWSLG  195 (332)
T ss_pred             HHCCeEecCCCHHHEEECCCCCEEEeecchheecccCCc---ceecccccCccccCHHHHhccccCCCCCCCcCCEEeeH
Confidence            999999999999999999999999999999876532211   12233578999999999863    33478899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....+.......   .++              .          .....+.++++||.+||
T Consensus       196 vil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~---~~p--------------~----------~~~~~s~~~~~li~~ll  248 (332)
T cd05623         196 VCMYEMLYGETPFYAESLVETYGKIMNHKERF---QFP--------------A----------QVTDVSEDAKDLIRRLI  248 (332)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhCCCccc---cCC--------------C----------ccccCCHHHHHHHHHHc
Confidence            99999999999999887776665553211100   000              0          00124678889999999


Q ss_pred             ccCCCC--CCCHHHhhcCCCccCC
Q psy7889         244 LLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      ..++.+  |++++++++||||...
T Consensus       249 ~~~~~r~~r~~~~~~~~h~~f~~~  272 (332)
T cd05623         249 CSREHRLGQNGIEDFKQHPFFTGI  272 (332)
T ss_pred             cChhhhcCCCCHHHHhCCCCcCCC
Confidence            765554  6899999999999653

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) alpha isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKalpha is expressed ubiquitously in many tissues. It plays a role in the regulation of peripheral actin reorganization and neurite outgrowth. It may also play a role in the transferrin iron uptake pathw

>cd07830 STKc_MAK_like Catalytic domain of Male germ cell-Associated Kinase-like Serine/Threonine Kinases

Probab=100.00  E-value=2.5e-35  Score=278.50  Aligned_cols=239  Identities=37%  Similarity=0.676  Sum_probs=192.1

Q ss_pred             hHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+|+..+++++ ||||+++++++...        +..|+||||+.++|.+.+.... ..+++..+..++.|++.+|.|
T Consensus        43 ~~~~e~~~l~~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  114 (283)
T cd07830          43 MNLREVKSLRKLNEHPNIVKLKEVFREN--------DELYFVFEYMEGNLYQLMKDRKGKPFSESVIRSIIYQILQGLAH  114 (283)
T ss_pred             HHHHHHHHHHhccCCCCchhHHHHhhcC--------CcEEEEEecCCCCHHHHHHhcccccCCHHHHHHHHHHHHHHHHH
Confidence            4567999999998 99999999999875        6689999999999999887654 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||+|+||+++.++.++|+|||++.......     ......++..|+|||++.+...++.++|+||+||++
T Consensus       115 Lh~~~i~H~dl~~~ni~i~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~aPE~~~~~~~~~~~~Di~s~G~~l  189 (283)
T cd07830         115 IHKHGFFHRDLKPENLLVSGPEVVKIADFGLAREIRSRP-----PYTDYVSTRWYRAPEILLRSTSYSSPVDIWALGCIM  189 (283)
T ss_pred             HHHCCcccCCCChhhEEEcCCCCEEEeecccceeccCCC-----CcCCCCCcccccCceeeecCcCcCCccchhhHHHHH
Confidence            999999999999999999999999999999997664321     223346788999999987655678999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||.+....+....+....+.+....|..............+........... +. .+..+++||.+||+.+
T Consensus       190 ~el~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~-~~~~~~~li~~cl~~~  267 (283)
T cd07830         190 AELYTLRPLFPGSSEIDQLYKICSVLGTPTKQDWPEGYKLASKLGFRFPQFAPTSLHQLI-PN-ASPEAIDLIKDMLRWD  267 (283)
T ss_pred             HHHHhCCCccCCCChHHHHHHHHHhcCCCChhhhhhHhhhhccccccccccccccHHHHc-cc-CCHHHHHHHHHhcccC
Confidence            999999999999999999988888888877766644332221111111111111111111 11 2678899999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |++|||++|++.||||
T Consensus       268 p~~Rpt~~ei~~~~~~  283 (283)
T cd07830         268 PKKRPTASQALQHPYF  283 (283)
T ss_pred             cccCCCHHHHhhCCCC
Confidence            9999999999999997

Serine/Threonine Kinases (STKs), Male germ cell-Associated Kinase (MAK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of human MAK and MAK-related kinase (MRK), Saccharomyces cerevisiae Ime2p, Schizosaccharomyces pombe Mei4-dependent protein 3 (Mde3) and Pit1, Caenorhabditis elegans dyf-5, Arabidopsis thaliana MHK, and similar proteins. These proteins play important roles during meiosis. MAK is highly expressed in testicular cells specifically in the meiotic phase, but is not essential for spermatogenesis and fertili

>cd08227 PK_STRAD_alpha Pseudokinase domain of STE20-related kinase adapter protein alpha

Probab=100.00  E-value=2.9e-35  Score=284.34  Aligned_cols=247  Identities=19%  Similarity=0.227  Sum_probs=172.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++|||||++++++..+        +..|+||||++ ++|.+++... ...+++..++.++.|++.||+
T Consensus        44 ~~~~~e~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~l~~~~~~~i~~qi~~~L~  115 (327)
T cd08227          44 TFLQGELHVSKLFNHPNIVPYRATFIAD--------NELWVVTSFMAYGSAKDLICTHFMDGMSELAIAYILQGVLKALD  115 (327)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEEC--------CEEEEEEeccCCCcHHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999876        66899999998 4777777653 335899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc---cccccCCcccccccCcccccCC-CCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ---VNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.++.++++||+.+..........   ........++..|+|||++.+. ..++.++||||
T Consensus       116 ~LH~~~iiH~dlkp~Nil~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws  195 (327)
T cd08227         116 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMINHGQRLRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS  195 (327)
T ss_pred             HHHHCCEecCCCChhhEEEecCCcEEEcccchhhccccccccccccccccccccceecccChHHhhcccCCCCchhhHHH
Confidence            9999999999999999999999999999998654432111000   0011223457789999998754 34789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCC---------CCCCccc-----chhhhhccccchHHHhhHHhhh-
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP---------ESWPGVE-----TLDLYNKMELPKAQKRKVKERL-  226 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~---------~~~~~~~-----~~~~~~~~~~~~~~~~~~~~~~-  226 (433)
                      +||++++|++|.+||............  ..+..+.         +......     ...................... 
T Consensus       196 lG~il~el~~g~~pf~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (327)
T cd08227         196 VGITACELANGHVPFKDMPATQMLLEK--LNGTVPCLLDTTTIPAEELTMKPSRSGANSGLGESTTVSTPRPSNGESSSH  273 (327)
T ss_pred             HHHHHHHHHHCCCCCCCcchhHHHHHH--hcCCccccccccchhhhhcccCCcccCCcCCCCcccccCCcCccccCCccc
Confidence            999999999999999876554432222  1121110         0000000     0000000000000000000000 


Q ss_pred             -CCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         227 -KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       227 -~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                       .....++++.+||.+||+.||++|||++|+++||||.+
T Consensus       274 ~~~~~~~~~~~~li~~~l~~dP~~Rpt~~ell~~p~f~~  312 (327)
T cd08227         274 PYNRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQ  312 (327)
T ss_pred             ccccccCHHHHHHHHHHHhhCchhcCCHHHHhcChhhhh
Confidence             11234678899999999999999999999999999965

Protein Kinase family, STE20-related kinase adapter protein (STRAD) alpha subfamily, pseudokinase domain. The STRAD alpha subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hype

>cd06625 STKc_MEKK3_like Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.9e-35  Score=273.41  Aligned_cols=213  Identities=26%  Similarity=0.422  Sum_probs=171.7

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|++++++++||||+++++++...        ..+++||||+++ +|.+.+... ..+++..++.++.|++.||.||
T Consensus        50 ~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~l~~~l~~l  120 (263)
T cd06625          50 ALECEIQLLKNLQHERIVQYYGCLRDD--------ETLSIFMEYMPGGSVKDQLKAY-GALTETVTRKYTRQILEGVEYL  120 (263)
T ss_pred             HHHHHHHHHHhCCCCCeeeeEEEEccC--------CeEEEEEEECCCCcHHHHHHHh-CCCCHHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999876        569999999975 777777653 4589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |+.||+|+||+|+||+++.++.++|+|||++........ .........++..|+|||++.+.. ++.++||||+||++|
T Consensus       121 H~~~i~H~dl~p~nilv~~~~~~~l~dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il~  198 (263)
T cd06625         121 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICS-SGTGMKSVTGTPYWMSPEVISGEG-YGRKADVWSVGCTVV  198 (263)
T ss_pred             HhCCeecCCCCHHHEEEcCCCCEEEeecccceecccccc-ccccccCCCcCccccCcceeccCC-CCchhhhHHHHHHHH
Confidence            999999999999999999999999999999876542211 111113345788999999998765 799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|++||...+.......+......   ..                           .+...+..+.++|.+||..+|
T Consensus       199 el~~g~~p~~~~~~~~~~~~~~~~~~~---~~---------------------------~~~~~~~~~~~li~~~l~~~p  248 (263)
T cd06625         199 EMLTEKPPWAEFEAMAAIFKIATQPTN---PQ---------------------------LPSHVSPDARNFLRRTFVENA  248 (263)
T ss_pred             HHHhCCCCccccchHHHHHHHhccCCC---CC---------------------------CCccCCHHHHHHHHHHhhcCc
Confidence            999999999876655444333211100   00                           011245667799999999999


Q ss_pred             CCCCCHHHhhcCCCc
Q psy7889         248 SKRFDSDAALNHDFF  262 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~  262 (433)
                      .+|||+.++|+|+||
T Consensus       249 ~~Rpt~~~ll~~~~~  263 (263)
T cd06625         249 KKRPSAEELLRHFFV  263 (263)
T ss_pred             ccCCCHHHHhhCCCC
Confidence            999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades t

>cd06615 PKc_MEK Catalytic domain of the dual-specificity Protein Kinase, MAP/ERK Kinase

Probab=100.00  E-value=3.8e-35  Score=281.10  Aligned_cols=243  Identities=21%  Similarity=0.288  Sum_probs=175.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|++++++++||||+++++++.++        +.+|+||||+++ +|.+++.+. ..+++..+..++.|++.||.|
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~ey~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~  114 (308)
T cd06615          44 NQIIRELKVLHECNSPYIVGFYGAFYSD--------GEISICMEHMDGGSLDQVLKKA-GRIPENILGKISIAVLRGLTY  114 (308)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeC--------CEEEEEeeccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999876        669999999975 788777654 568999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+ ++++|+||||+||+++.++.++|+|||++......      ......++..|+|||++.+.. ++.++|+||+||+
T Consensus       115 lH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~~~aPE~~~~~~-~~~~~DiwslG~~  187 (308)
T cd06615         115 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH-YTVQSDIWSLGLS  187 (308)
T ss_pred             HHhhCCEEECCCChHHEEEecCCcEEEccCCCccccccc------ccccCCCCcCccChhHhcCCC-CCccchHHHHHHH
Confidence            997 69999999999999999999999999998665322      123456788999999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcc---cchhhhhccccchHHHh---hHHhhhCCccCChhHHHHH
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGV---ETLDLYNKMELPKAQKR---KVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~---~~~~~~~~~~~~~~~~~---~~~~~~~~~~~s~~~~~li  239 (433)
                      +++|++|..||...+.......+...............   .................   ...........+.++.+|+
T Consensus       188 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li  267 (308)
T cd06615         188 LVEMAIGRYPIPPPDAKELEAMFGRPVSEGEAKESHRPVSGHPPDSPRPMAIFELLDYIVNEPPPKLPSGAFSDEFQDFV  267 (308)
T ss_pred             HHHHHhCCCCCCCcchhhHHHhhcCccccccccCCcccccCCCCCccchhhHHHHHHHHhcCCCccCcCcccCHHHHHHH
Confidence            99999999999876644332222111111100000000   00000000000000000   0000111123577899999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+||..+|++|||+.++++||||....
T Consensus       268 ~~~l~~~P~~Rpt~~~ll~~~~~~~~~  294 (308)
T cd06615         268 DKCLKKNPKERADLKELTKHPFIKRAE  294 (308)
T ss_pred             HHHccCChhhCcCHHHHhcChhhhhcc
Confidence            999999999999999999999996643

Protein kinases (PKs), MAP/ERK kinase (MEK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MEK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MEK1 and MEK2 are dual-specificity PKs that phosphorylate and activate the down

>KOG0983|consensus

Probab=100.00  E-value=3.6e-36  Score=264.89  Aligned_cols=215  Identities=20%  Similarity=0.310  Sum_probs=177.3

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+++..+.++...+ +|+||+.+++|..+        ..++|.||.|..-.-.+++...+.++|..+-.+...+++||.|
T Consensus       135 kRILmDldvv~~s~dcpyIV~c~GyFi~n--------~dV~IcMelMs~C~ekLlkrik~piPE~ilGk~tva~v~AL~Y  206 (391)
T KOG0983|consen  135 KRILMDLDVVLKSHDCPYIVQCFGYFITN--------TDVFICMELMSTCAEKLLKRIKGPIPERILGKMTVAIVKALYY  206 (391)
T ss_pred             HHHHHhhhHHhhccCCCeeeeeeeEEeeC--------chHHHHHHHHHHHHHHHHHHhcCCchHHhhhhhHHHHHHHHHH
Confidence            35666777777664 99999999999986        5589999999876666777777789999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlG  163 (433)
                      |.+ +||+|||+||+|||++..|.+||||||++.++-+++.     .+...|.+.|+|||.+.-  ...|+.++||||||
T Consensus       207 LKeKH~viHRDvKPSNILlDe~GniKlCDFGIsGrlvdSkA-----htrsAGC~~YMaPERidp~~~~kYDiRaDVWSlG  281 (391)
T KOG0983|consen  207 LKEKHGVIHRDVKPSNILLDERGNIKLCDFGISGRLVDSKA-----HTRSAGCAAYMAPERIDPPDKPKYDIRADVWSLG  281 (391)
T ss_pred             HHHhcceeecccCccceEEccCCCEEeecccccceeecccc-----cccccCCccccCccccCCCCCCccchhhhhhhhc
Confidence            995 7999999999999999999999999999988865542     234567889999999853  34589999999999


Q ss_pred             HHHHHHHhcCCCCCC-CChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWTRSPIMQG-NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~g~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ++++||+||..||.+ ..+.+.+.++.+-.....++                             ...+|+++++|+..|
T Consensus       282 ITlveLaTg~yPy~~c~tdFe~ltkvln~ePP~L~~-----------------------------~~gFSp~F~~fv~~C  332 (391)
T KOG0983|consen  282 ITLVELATGQYPYKGCKTDFEVLTKVLNEEPPLLPG-----------------------------HMGFSPDFQSFVKDC  332 (391)
T ss_pred             cchhhhhcccCCCCCCCccHHHHHHHHhcCCCCCCc-----------------------------ccCcCHHHHHHHHHH
Confidence            999999999999998 46777777775522111000                             012688899999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |++|+.+||.-.++|+|||+..
T Consensus       333 L~kd~r~RP~Y~~Ll~h~Fi~~  354 (391)
T KOG0983|consen  333 LTKDHRKRPKYNKLLEHPFIKR  354 (391)
T ss_pred             hhcCcccCcchHHHhcCcceee
Confidence            9999999999999999999964

>cd07852 STKc_MAPK15 Catalytic domain of the Serine/Threonine Kinase, Mitogen-Activated Protein Kinase 15

Probab=100.00  E-value=2.6e-35  Score=285.85  Aligned_cols=248  Identities=33%  Similarity=0.599  Sum_probs=188.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++++ +||||+++++++....      ...+|+||||+.++|...+...  .+++..++.++.||+.||+|
T Consensus        51 ~~~~~E~~~l~~l~~h~ni~~~~~~~~~~~------~~~~~lv~e~~~~~L~~~~~~~--~~~~~~~~~i~~qi~~~L~~  122 (337)
T cd07852          51 QRTFREIMFLQELGDHPNIVKLLNVIKAEN------DKDIYLVFEYMETDLHAVIRAN--ILEDVHKRYIMYQLLKALKY  122 (337)
T ss_pred             hhhhHHHHHHHHhcCCCCccceeeeeccCC------CceEEEEecccccCHHHHHhcC--CCCHHHHHHHHHHHHHHHHH
Confidence            3466899999999 9999999999986542      2568999999999998888653  67888999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-cccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+.||+|+||||+||+++.++.+||+|||++.......... ........++..|+|||++.+...++.++||||+||+
T Consensus       123 LH~~~i~H~dl~p~nill~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~sDi~slG~~  202 (337)
T cd07852         123 IHSGNVIHRDLKPSNILLNSDCRVKLADFGLARSLSELEENPENPVLTDYVATRWYRAPEILLGSTRYTKGVDMWSVGCI  202 (337)
T ss_pred             HHHCCeecCCCCHHHEEEcCCCcEEEeeccchhccccccccccCcchhcccccccccCceeeeccccccccchHHHHHHH
Confidence            999999999999999999999999999999997764322110 0122334678899999998766567899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-ccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++|.+||.+....+....+....+....+.+...........+ ................  .+.++.++|.+||+
T Consensus       203 l~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~l~~li~~~l~  280 (337)
T cd07852         203 LGEMLLGKPLFPGTSTLNQLEKIIEVIGPPSAEDIESIKSPFAATMLDSLPSRPRKPLDELLPK--ASDDALDLLKKLLV  280 (337)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHHHhhhHHHhhhhcccccccchhhhccC--CCHHHHHHHHHhcc
Confidence            99999999999999888888888777665543322111100000000 0000011111111111  57888999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .||++|||+.++++||||...
T Consensus       281 ~~P~~Rps~~~il~~~~~~~~  301 (337)
T cd07852         281 FNPNKRLTAEEALEHPYVAQF  301 (337)
T ss_pred             CCcccccCHHHHhhChhhhhh
Confidence            999999999999999999653

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 15 (MAPK15) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK15 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. Human MAPK15 is also called Extracellular signal Regulated Kinase 8 (ERK8) while the rat protein is called ERK7. ERK7 and ERK8 display both similar and different biochemical properties. They autophosphorylate and activate themselves and do not require upstream activating kinases. ERK7 is constitutively active and is not affected by extracellular stimul

>cd06644 STKc_STK10_LOK Catalytic domain of the Protein Serine/Threonine Kinase, STK10 or Lymphocyte-oriented kinase

Probab=100.00  E-value=9e-35  Score=276.28  Aligned_cols=218  Identities=27%  Similarity=0.417  Sum_probs=172.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..+        +.+|+||||+++ +|...+.+....+++..++.++.|++.||.|
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~  125 (292)
T cd06644          54 EDYMVEIEILATCNHPYIVKLLGAFYWD--------GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVICRQMLEALQY  125 (292)
T ss_pred             HHHHHHHHHHHhCCCCcEeeeEEEEEeC--------CeEEEEEecCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        569999999986 5655665555568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSl  162 (433)
                      ||++|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+    ...++.++|+|||
T Consensus       126 lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Dv~sl  201 (292)
T cd06644         126 LHSMKIIHRDLKAGNVLLTLDGDIKLADFGVSAKNVKTL----QRRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  201 (292)
T ss_pred             HhcCCeeecCCCcceEEEcCCCCEEEccCccceeccccc----cccceecCCccccCceeeccccccCCCCCchhhhHhH
Confidence            999999999999999999999999999999886543211    12234467889999999853    2336789999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||...+.......+..   ...+. .                         ..+...+.++.++|.+|
T Consensus       202 G~il~el~~g~~p~~~~~~~~~~~~~~~---~~~~~-~-------------------------~~~~~~~~~~~~li~~~  252 (292)
T cd06644         202 GITLIEMAQIEPPHHELNPMRVLLKIAK---SEPPT-L-------------------------SQPSKWSMEFRDFLKTA  252 (292)
T ss_pred             HHHHHHHhcCCCCCccccHHHHHHHHhc---CCCcc-C-------------------------CCCcccCHHHHHHHHHH
Confidence            9999999999999987765444333321   11000 0                         00112455677999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..+|++||+++++++||||....
T Consensus       253 l~~~p~~Rp~~~~il~~~~~~~~~  276 (292)
T cd06644         253 LDKHPETRPSAAQLLEHPFVSSVT  276 (292)
T ss_pred             hcCCcccCcCHHHHhcCccccccc
Confidence            999999999999999999996543

Serine/threonine kinases (STKs), STK10 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Other names for STK10 include lymphocyte-oriented kinase (LOK) and Xenopus polo-like kinase kinase 1 (xPlkk1). STK10 is highly expressed in lymphocytes and is responsible in regulating leukocyte function associated antigen (LFA-1)-mediated lymphocyte adhesion. It plays a role in regulating the CD28 responsive element in T cells, and may also function as a regulator of polo-like kinase 1 (Plk1), a protein which is overexpressed in multiple tumor types.

>cd07851 STKc_p38 Catalytic domain of the Serine/Threonine Kinase, p38 Mitogen-Activated Protein Kinase

Probab=100.00  E-value=1.4e-35  Score=288.38  Aligned_cols=247  Identities=34%  Similarity=0.565  Sum_probs=189.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++.....  ......+|+|+||++++|.+++..  ..+++..++.++.||+.||.||
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~ql~~aL~~L  134 (343)
T cd07851          59 KRTYRELRLLKHMDHENVIGLLDVFTPASS--LEDFQDVYLVTHLMGADLNNIVKC--QKLSDDHIQFLVYQILRGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHhccCCCHHHHHHHhhcccc--ccccccEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999998866422  112345899999999999888865  3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |+.||+|+||||+||+++.++.++|+|||++......       .....++..|+|||++.+...++.++|||||||+++
T Consensus       135 H~~gi~H~dlkp~Nill~~~~~~kL~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslGv~l~  207 (343)
T cd07851         135 HSAGIIHRDLKPSNIAVNEDCELKILDFGLARHTDDE-------MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  207 (343)
T ss_pred             HHCCeecCCCCHHHeEECCCCCEEEcccccccccccc-------ccCCcccccccCHHHHhCCCCCCchHhHHHHHHHHH
Confidence            9999999999999999999999999999998765422       233466888999999876545789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+....+.+..+....+.+.+..+............. .+...........  ...+..+.+||.+||..+
T Consensus       208 elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~l~dli~~~l~~~  285 (343)
T cd07851         208 ELLTGKTLFPGSDHIDQLKRIMNLVGTPDEELLQKISSESARNYIQSLPQMPKKDFKEVF--SGANPLAIDLLEKMLVLD  285 (343)
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHhcCCCCHHHHhhccchhHHHHHHhccccCCCCHHHHh--ccCCHHHHHHHHHhCCCC
Confidence            9999999999988888888888777665543332222111000000 0000000011111  124788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~  267 (433)
                      |.+|||+.++++||||.....
T Consensus       286 P~~Rpt~~ell~h~~~~~~~~  306 (343)
T cd07851         286 PDKRITAAEALAHPYLAEYHD  306 (343)
T ss_pred             hhhCCCHHHHhcCCCccccCC
Confidence            999999999999999976443

Serine/Threonine Kinases (STKs), p38 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They function in the regulation of the cell cycle, cell development, cell differentiation, senescence, tumorigenesis, apoptosis, pain development and pain progression, and immune responses. p38 kinases are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK

>KOG1290|consensus

Probab=100.00  E-value=2.1e-35  Score=278.39  Aligned_cols=250  Identities=29%  Similarity=0.472  Sum_probs=190.0

Q ss_pred             chhHHHHHHHHHhCC-----C---CCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-----H---ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVI   77 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-----h---pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~   77 (433)
                      .++++.||++|++++     |   .+||+|+|.|...+.    ++.++|+|+|+++.+|+.++...+ ..++...|+.|+
T Consensus       118 tEaAlDEIklL~~v~~~Dp~~~~~~~VV~LlD~FkhsGp----NG~HVCMVfEvLGdnLLklI~~s~YrGlpl~~VK~I~  193 (590)
T KOG1290|consen  118 TEAALDEIKLLQQVREGDPNDPGKKCVVQLLDHFKHSGP----NGQHVCMVFEVLGDNLLKLIKYSNYRGLPLSCVKEIC  193 (590)
T ss_pred             HHHHHHHHHHHHHHHhcCCCCCCCceeeeeeccceecCC----CCcEEEEEehhhhhHHHHHHHHhCCCCCcHHHHHHHH
Confidence            578899999999983     2   389999999999755    489999999999999999997654 449999999999


Q ss_pred             HHHHHHHHHHHh-CCeeccCCCCCcEEEec--------------------------------------------------
Q psy7889          78 QQLLNGLYYIHS-NKILHRDMKAANVLITK--------------------------------------------------  106 (433)
Q Consensus        78 ~qll~aL~~LH~-~~iiH~dikp~NIll~~--------------------------------------------------  106 (433)
                      +|||.||.|||+ .||||.||||+|||+..                                                  
T Consensus       194 ~qvL~GLdYLH~ecgIIHTDlKPENvLl~~~e~~~~~~~~~a~e~~~~~p~~s~s~~~t~~d~~~~~~~~~~s~~~~k~~  273 (590)
T KOG1290|consen  194 RQVLTGLDYLHRECGIIHTDLKPENVLLCSTEIDPAKDAREAGEATTSLPKMSPSAVSTRPDALQRMAAEPMSKSKFKKM  273 (590)
T ss_pred             HHHHHHHHHHHHhcCccccCCCcceeeeeccccchhhhhhhhccccccCCCCCcccccccccccchhhccccchhhHHHH
Confidence            999999999995 79999999999999742                                                  


Q ss_pred             --------------------------------------------------------------------------------
Q psy7889         107 --------------------------------------------------------------------------------  106 (433)
Q Consensus       107 --------------------------------------------------------------------------------  106 (433)
                                                                                                      
T Consensus       274 ~kk~~r~~~~~~~~l~~~~~~~~~~~~~s~n~~~~~n~~~~~v~~~~~~~~~~~~~~~~n~~~k~~e~~~~~~~sl~~~~  353 (590)
T KOG1290|consen  274 KKKLKRQAKKLEASLAGLEGIEEEPNQESYNNEPRINGNESTVERSTLEEDSNENGNRENLPIKSPENFRGNNTSLPESQ  353 (590)
T ss_pred             HHHHhhhhhhhhhhhcccccccccccccccccccCCCccccchhhcccccccccccCCccccccCccccccccccccchh
Confidence                                                                                            


Q ss_pred             ------------------------------------CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889         107 ------------------------------------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus       107 ------------------------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                                                          +-.|||.|||.|.++.       ..++.-+.|+.|+||||+.|.
T Consensus       354 ~~~~~t~~~~~~~s~~s~~~~~~n~~v~p~~~~~~~di~vKIaDlGNACW~~-------khFT~DIQTRQYRapEVllGs  426 (590)
T KOG1290|consen  354 LRDSATPSDGSLSSPSSPGTIASNPLVNPDIPLPECDIRVKIADLGNACWVH-------KHFTEDIQTRQYRAPEVLLGS  426 (590)
T ss_pred             cccccccccccccCcCCccccccccccCCCCCCCccceeEEEeeccchhhhh-------hhhchhhhhhhccCcceeecC
Confidence                                                0035677777665543       234455679999999999998


Q ss_pred             CCCCCcchhhhHHHHHHHHHhcCCCCCC------CChHHHHHHHHHHhCCCCCCCCC-cccchhhhhcc----ccchHHH
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWTRSPIMQG------NTEQQQITLISQLCGSITPESWP-GVETLDLYNKM----ELPKAQK  219 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~g~~pf~~------~~~~~~~~~i~~~~g~~~~~~~~-~~~~~~~~~~~----~~~~~~~  219 (433)
                      . |++.+||||++|+++||+||..+|..      ..+++.++.|+.++|.++..... +.....+|+.-    .+.....
T Consensus       427 g-Y~~~ADiWS~AC~~FELaTGDyLFePhsG~~Y~rDEDHiA~i~ELLG~iPr~ia~~Gk~SRdFFnr~G~LrhI~~LK~  505 (590)
T KOG1290|consen  427 G-YSTSADIWSTACMAFELATGDYLFEPHSGENYSRDEDHIALIMELLGKIPRKIALGGKYSRDFFNRRGELRHIRRLKP  505 (590)
T ss_pred             C-CCCchhHHHHHHHHHHhhcCceeecCCCCCCCCccHHHHHHHHHHHhhccHHHHhcCcchHhhhccccceecccccCC
Confidence            7 89999999999999999999998864      34778999999999988764322 22222222111    0111111


Q ss_pred             hhHHhhh-CCc----cCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         220 RKVKERL-KPY----VKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       220 ~~~~~~~-~~~----~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ..+...+ ..+    ....++-+||.-||+++|.+|+||.++|+|||+...+.+
T Consensus       506 WpL~~VL~eKY~~s~e~A~~fsdFL~PmLef~PeKR~tA~~cl~hPwLn~~~~~  559 (590)
T KOG1290|consen  506 WPLYEVLIEKYEWSEEDAQQFSDFLSPMLEFDPEKRPTAAQCLKHPWLNPVAGP  559 (590)
T ss_pred             CcHHHHHHHHhCCCHHHHHHHHHHHHHHHhcCccccccHHHHhcCccccCCCCC
Confidence            1111111 111    224567799999999999999999999999999876654

>cd05630 STKc_GRK6 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 6

Probab=100.00  E-value=3.5e-35  Score=278.21  Aligned_cols=215  Identities=25%  Similarity=0.372  Sum_probs=170.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+.+++.++|+||+.+++.+.+.        +.+|+||||+. ++|...+.... ..+++..+..++.|++.||.
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~l~  116 (285)
T cd05630          45 SMALNEKQILEKVNSRFVVSLAYAYETK--------DALCLVLTLMNGGDLKFHIYHMGEAGFEEGRAVFYAAEICCGLE  116 (285)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeEEEecC--------CEEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999875        56999999997 47777775432 35899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+||||||+||+++.++.++|+|||++.......     ......|+..|+|||++.+.. ++.++||||+||+
T Consensus       117 ~lH~~~iiH~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~g~~~y~aPE~~~~~~-~~~~~DiwslG~~  190 (285)
T cd05630         117 DLHQERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-----TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCL  190 (285)
T ss_pred             HHHhCCEEeCCCCHHHEEECCCCCEEEeeccceeecCCCc-----cccCCCCCccccChHHHcCCC-CCCccccHHHHHH
Confidence            9999999999999999999999999999999987654221     123346899999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+...................                            ..+...+.++.+||.+||+.
T Consensus       191 l~~l~~g~~Pf~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~  242 (285)
T cd05630         191 LYEMIAGQSPFQQRKKKIKREEVERLVKEVQE----------------------------EYSEKFSPDARSLCKMLLCK  242 (285)
T ss_pred             HHHHHhCCCCCCCCCccchHHHHHhhhhhhhh----------------------------hcCccCCHHHHHHHHHHhhc
Confidence            99999999999875432211111111100000                            00112466788999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~  264 (433)
                      ||.+|||     ++|+++||||.+
T Consensus       243 ~p~~R~s~~~~~~~~~~~h~~~~~  266 (285)
T cd05630         243 DPKERLGCQGGGAREVKEHPLFKQ  266 (285)
T ss_pred             CHHHccCCCCCchHHHHcChhhhc
Confidence            9999999     999999999965

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK6 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK6 is widely expressed in many tissues. t is expressed as

>cd06611 STKc_SLK_like Catalytic domain of Ste20-like kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5e-35  Score=276.23  Aligned_cols=218  Identities=27%  Similarity=0.429  Sum_probs=174.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++...        ..+|+||||+++ +|..++.+....+++..++.++.|++.||.|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~l~~~~~~~~~~ql~~~l~~  118 (280)
T cd06611          47 EDFMVEIDILSECKHPNIVGLYEAYFYE--------NKLWILIEFCDGGALDSIMLELERGLTEPQIRYVCRQMLEALNF  118 (280)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEecC--------CeEEEEeeccCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        568999999986 7777776656679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSl  162 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||++..    ...++.++|+||+
T Consensus       119 lh~~~i~h~dl~p~nili~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~~sDi~sl  194 (280)
T cd06611         119 LHSHKVIHRDLKAGNILLTLDGDVKLADFGVSAKNKSTL----QKRDTFIGTPYWMAPEVVACETFKDNPYDYKADIWSL  194 (280)
T ss_pred             HHHCCcccCCCChhhEEECCCCCEEEccCccchhhcccc----cccceeecchhhcCHHHHhhcccCCCCCCccccHHHH
Confidence            999999999999999999999999999999886653221    12233467889999999752    2236779999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+....+..+..  +..+.     .                      ..+...+.++.++|.+|
T Consensus       195 G~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~~~-----~----------------------~~~~~~~~~~~~li~~~  245 (280)
T cd06611         195 GITLIELAQMEPPHHELNPMRVLLKILK--SEPPT-----L----------------------DQPSKWSSSFNDFLKSC  245 (280)
T ss_pred             HHHHHHHHhCCCCcccCCHHHHHHHHhc--CCCCC-----c----------------------CCcccCCHHHHHHHHHH
Confidence            9999999999999988765554433321  11000     0                      00112456677999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..+|.+||+++++|+|+||....
T Consensus       246 l~~~p~~Rps~~~il~~~~~~~~~  269 (280)
T cd06611         246 LVKDPDDRPTAAELLKHPFVSDQS  269 (280)
T ss_pred             hccChhhCcCHHHHhcChhhcccc
Confidence            999999999999999999997653

Serine/threonine kinases (STKs), Ste20-like kinase (SLK)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The SLK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of the subfamily include SLK, STK10 (also called LOK for lymphocyte-oriented kinase), SmSLK (Schistosoma mansoni SLK), and related proteins. SLK promotes apoptosis through apoptosis signal-regulating kinase 1 (ASK1) and the mitogen-activated protein kinase (MAPK) p38. It also plays a role in mediating actin reorganization. STK10 is responsible in regulating the CD28 responsive element in T cells, as well as leukocyte function associated anti

>cd07879 STKc_p38delta_MAPK13 Catalytic domain of the Serine/Threonine Kinase, p38delta Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.3e-35  Score=285.73  Aligned_cols=246  Identities=34%  Similarity=0.573  Sum_probs=185.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++.....  ......+|+|+||+..++.....   ..++++.++.++.|++.||+|
T Consensus        58 ~~~~~~e~~~l~~l~h~niv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~~~~qi~~aL~~  132 (342)
T cd07879          58 AKRAYRELTLLKHMQHENVIGLLDVFTSAVS--GDEFQDFYLVMPYMQTDLQKIMG---HPLSEDKVQYLVYQMLCGLKY  132 (342)
T ss_pred             hhHHHHHHHHHHhcCCCCccchhheeccccc--CCCCceEEEEecccccCHHHHHc---CCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999876522  11234579999999987766542   358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.++|+|||++.....       ......++..|+|||++.+...++.++||||+||++
T Consensus       133 LH~~~i~H~dlkp~NIll~~~~~~kL~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slGvil  205 (342)
T cd07879         133 IHSAGIIHRDLKPGNLAVNEDCELKILDFGLARHADA-------EMTGYVVTRWYRAPEVILNWMHYNQTVDIWSVGCIM  205 (342)
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEeeCCCCcCCCC-------CCCCceeeecccChhhhcCccccCchHHHHHHHHHH
Confidence            9999999999999999999999999999999876432       122346688899999987655578999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|+.||.+.+....+..+....|.+.+..+............. .+...+........  ..+..+++||.+||+.
T Consensus       206 ~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~li~~~l~~  283 (342)
T cd07879         206 AEMLTGKTLFKGKDYLDQLTQILKVTGVPGPEFVQKLEDKAAKSYIKSLPKYPRKDFSTLFP--KASPQAVDLLEKMLEL  283 (342)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhcccchHHHHhhcCCcccchHHHHhc--CCCHHHHHHHHHHcCC
Confidence            99999999999988888777777776655433222211110000000 00000000111111  2467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+||++++++.||||....
T Consensus       284 dP~~R~~~~e~l~h~~f~~~~  304 (342)
T cd07879         284 DVDKRLTATEALEHPYFDSFR  304 (342)
T ss_pred             ChhhCcCHHHHhcCcchhhcc
Confidence            999999999999999996643

Serine/Threonine Kinases (STKs), p38delta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38delta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38delta, also called MAPK13

>cd06658 STKc_PAK5 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 5

Probab=100.00  E-value=3.8e-35  Score=278.95  Aligned_cols=224  Identities=25%  Similarity=0.422  Sum_probs=178.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++.+...        +..|+||||+++ +|..++..  ..+++..++.++.||+.||.|
T Consensus        64 ~~~~~e~~~l~~l~h~~ii~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~l~~  133 (292)
T cd06658          64 ELLFNEVVIMRDYHHENVVDMYNSYLVG--------DELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLSVLRALSY  133 (292)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHheecC--------CeEEEEEeCCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999998875        568999999986 56555533  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+||++
T Consensus       134 LH~~~ivH~dlkp~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvil  208 (292)
T cd06658         134 LHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSKEV----PKRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMV  208 (292)
T ss_pred             HHHCCEeecCCCHHHEEEcCCCCEEEccCcchhhccccc----ccCceeecCccccCHHHHccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999986553221    1123346788999999987654 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||.+.+....+..+.........                             .....+....++|.+||..|
T Consensus       209 ~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~~l~~~  259 (292)
T cd06658         209 IEMIDGEPPYFNEPPLQAMRRIRDNLPPRVK-----------------------------DSHKVSSVLRGFLDLMLVRE  259 (292)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhcCCCccc-----------------------------cccccCHHHHHHHHHHccCC
Confidence            9999999999887766554443321111000                             01124566779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCchhHHHH
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPSDLSKML  275 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~~~~~~~  275 (433)
                      |.+|||++++++||||...+.++.....+
T Consensus       260 P~~Rpt~~~il~~~~~~~~~~~~~~~~~~  288 (292)
T cd06658         260 PSQRATAQELLQHPFLKLAGPPSCIVPLM  288 (292)
T ss_pred             hhHCcCHHHHhhChhhhccCCccccchhh
Confidence            99999999999999998777666544433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 5, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK5 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK5 is mainly express

>cd08529 STKc_FA2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii FA2 and similar domains

Probab=100.00  E-value=1.1e-34  Score=269.87  Aligned_cols=212  Identities=26%  Similarity=0.342  Sum_probs=174.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++||||+++++++...        +..|+||||+. ++|.+++... ...+++..++.++.|++.||
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~~l~~al  114 (256)
T cd08529          43 REEAIDEARVLAKLDSSYIIRYYESFLDK--------GKLNIVMEYAENGDLHKLLKMQRGRPLPEDQVWRFFIQILLGL  114 (256)
T ss_pred             HHHHHHHHHHHHhcCCCCeehheeeeccC--------CEEEEEEEeCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999875        66999999996 5888888664 44689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++|+||||+||+++.++.++|+|||++........    ......++..|+|||++.+.. ++.++|+|||||
T Consensus       115 ~~lH~~~i~h~dl~~~nili~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  189 (256)
T cd08529         115 AHLHSKKILHRDIKSLNLFLDAYDNVKIGDLGVAKLLSDNTN----FANTIVGTPYYLSPELCEDKP-YNEKSDVWALGV  189 (256)
T ss_pred             HHHHHCCcccCCCCcceEEEeCCCCEEEcccccceeccCccc----hhhccccCccccCHHHhcCCC-CCCccchHHHHH
Confidence            999999999999999999999999999999999877653221    122346788999999987765 789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||...+.......+........                               +...+..+.++|.+||+
T Consensus       190 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~i~~~l~  238 (256)
T cd08529         190 VLYECCTGKHPFDANNQGALILKIIRGVFPPV-------------------------------SQMYSQQLAQLIDQCLT  238 (256)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------ccccCHHHHHHHHHHcc
Confidence            99999999999988876554444322110000                               01245667799999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .+|++||++.++++|||+
T Consensus       239 ~~p~~Rp~~~~ll~~~~~  256 (256)
T cd08529         239 KDYRQRPDTFQLLRNPSL  256 (256)
T ss_pred             CCcccCcCHHHHhhCCCC
Confidence            999999999999999995

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii FA2-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii FA2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes FA2 and CNK4. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii FA2 was discovered in a genetic screen for deflagellation-defective mutants. It is essential for basal-body/centriole-associated microtubule severing, and plays a role in cell cyc

>PF00069 Pkinase: Protein kinase domain Protein kinase; unclassified specificity

Probab=100.00  E-value=6.1e-35  Score=272.07  Aligned_cols=215  Identities=31%  Similarity=0.547  Sum_probs=172.9

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ..+|+.++++++||||+++++++.+.        ..+++||||+.+ +|..++.+ ...+++..+..++.||+.||++||
T Consensus        45 ~~~e~~~~~~l~~~~i~~~~~~~~~~--------~~~~~v~~~~~~~~L~~~l~~-~~~~~~~~~~~~~~qi~~~L~~Lh  115 (260)
T PF00069_consen   45 NIREIKILRRLRHPNIVQILDVFQDD--------NYLYIVMEYCPGGSLQDYLQK-NKPLSEEEILKIAYQILEALAYLH  115 (260)
T ss_dssp             HHHHHHHHHHHTBTTBCHEEEEEEES--------SEEEEEEEEETTEBHHHHHHH-HSSBBHHHHHHHHHHHHHHHHHHH
T ss_pred             hhhhhhcccccccccccccccccccc--------ccccccccccccccccccccc-cccccccccccccccccccccccc
Confidence            34599999999999999999999985        668999999998 88888873 346899999999999999999999


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHH
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE  168 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  168 (433)
                      ++||+|+||||+||+++.++.++|+|||.+.....    .........++..|+|||++.....++.++||||||+++++
T Consensus       116 ~~~i~H~dikp~NIl~~~~~~~~l~Dfg~~~~~~~----~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~~  191 (260)
T PF00069_consen  116 SKGIVHRDIKPENILLDENGEVKLIDFGSSVKLSE----NNENFNPFVGTPEYMAPEVLQQGKKYTRKSDIWSLGIILYE  191 (260)
T ss_dssp             HTTEEESSBSGGGEEESTTSEEEESSGTTTEESTS----TTSEBSSSSSSGGGSCHHHHTTTSSBSTHHHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccc----ccccccccccccccccccccccccccccccccccccccccc
Confidence            99999999999999999999999999999876411    11234456779999999998733447999999999999999


Q ss_pred             HHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCC
Q psy7889         169 MWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS  248 (433)
Q Consensus       169 ll~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  248 (433)
                      |++|..||......+....+.........                         .........+..+.++|.+||+.||+
T Consensus       192 l~~~~~p~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~~~~~~~~l~~li~~~l~~~p~  246 (260)
T PF00069_consen  192 LLTGKLPFEESNSDDQLEIIEKILKRPLP-------------------------SSSQQSREKSEELRDLIKKMLSKDPE  246 (260)
T ss_dssp             HHHSSSSSTTSSHHHHHHHHHHHHHTHHH-------------------------HHTTSHTTSHHHHHHHHHHHSSSSGG
T ss_pred             ccccccccccccchhhhhhhhhccccccc-------------------------ccccccchhHHHHHHHHHHHccCChh
Confidence            99999999987545444444332221000                         00000001126778999999999999


Q ss_pred             CCCCHHHhhcCCCc
Q psy7889         249 KRFDSDAALNHDFF  262 (433)
Q Consensus       249 ~R~t~~e~L~h~~~  262 (433)
                      +||+++++++||||
T Consensus       247 ~R~~~~~l~~~~~~  260 (260)
T PF00069_consen  247 QRPSAEELLKHPWF  260 (260)
T ss_dssp             GSTTHHHHHTSGGG
T ss_pred             HCcCHHHHhcCCCC
Confidence            99999999999998

Serine/Threonine protein kinases, catalytic domain Tyrosine kinase, catalytic domain; InterPro: IPR017442 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Eukaryotic protein kinases [, , , , ] are enzymes that belong to a very extensive family of proteins which share a conserved catalytic core common with both serine/threonine and tyrosine protein kinases. There are a number of conserved regions in the catalytic domain of protein kinases. In the N-terminal extremity of the catalytic domain there is a glycine-rich stretch of residues in the vicinity of a lysine residue, which has been shown to be involved in ATP binding. In the central part of the catalytic domain there is a conserved aspartic acid residue which is important for the catalytic activity of the enzyme []. This entry includes protein kinases from eukaryotes and viruses and may include some bacterial hits too.; GO: 0004672 protein kinase activity, 0005524 ATP binding, 0006468 protein phosphorylation; PDB: 3GC7_A 3ZYA_A 3MPT_A 3NEW_A 3MVM_A 1R3C_A 2FST_X 3E93_A 3HV5_B 3OCG_A ....

>cd08223 STKc_Nek4 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 4

Probab=100.00  E-value=1.6e-34  Score=269.01  Aligned_cols=212  Identities=28%  Similarity=0.458  Sum_probs=171.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|++++++++|+||+++++.+...       ...+|+||||++ ++|.+.+... ...+++.+++.++.|++.||+
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------~~~~~lv~e~~~~~~l~~~l~~~~~~~l~~~~~~~~~~~l~~~l~  116 (257)
T cd08223          44 KAAEQEAQLLSQLKHPNIVAYRESWEGE-------DGLLYIVMGFCEGGDLYHKLKEQKGKLLPENQVVEWFVQIAMALQ  116 (257)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeecCC-------CCEEEEEecccCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999987643       246899999997 4788777653 335899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      +||+.|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+.. ++.++|+||+||+
T Consensus       117 ~lH~~~i~H~di~p~nil~~~~~~~~l~df~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  191 (257)
T cd08223         117 YLHEKHILHRDLKTQNVFLTRTNIIKVGDLGIARVLENQC----DMASTLIGTPYYMSPELFSNKP-YNYKSDVWALGCC  191 (257)
T ss_pred             HHHhCCeeccCCCchhEEEecCCcEEEecccceEEecccC----CccccccCCcCccChhHhcCCC-CCchhhhHHHHHH
Confidence            9999999999999999999999999999999987764322    1223456788999999987754 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||.+.+.......+..  +..+.                             .+...+.++.+||.+||..
T Consensus       192 l~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~li~~~l~~  240 (257)
T cd08223         192 VYEMATLKHAFNAKDMNSLVYRIIE--GKLPP-----------------------------MPKDYSPELGELIATMLSK  240 (257)
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHh--cCCCC-----------------------------CccccCHHHHHHHHHHhcc
Confidence            9999999999987765544433322  11100                             0112456778999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      ||.+|||+.++++||||
T Consensus       241 ~p~~Rp~~~~~l~~~~~  257 (257)
T cd08223         241 RPEKRPSVKSILRQPYI  257 (257)
T ss_pred             CcccCCCHHHHhcCCCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 4 (Nek4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek4 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. Nek4 is highly abundant in the testis. Its specific function is unknown.

>cd08216 PK_STRAD Pseudokinase domain of STE20-related kinase adapter protein

Probab=100.00  E-value=9.7e-35  Score=278.90  Aligned_cols=249  Identities=19%  Similarity=0.256  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+++++.++||||+++++++...        ...|++|||++ ++|.+++.+. ...+++..++.++.|++.||.
T Consensus        44 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~--------~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~l~~~L~  115 (314)
T cd08216          44 KLLQQEIITSRQLQHPNILPYVTSFIVD--------SELYVVSPLMAYGSCEDLLKTHFPEGLPELAIAFILKDVLNALD  115 (314)
T ss_pred             HHHHHHHHHHHhcCCcchhhhhheeecC--------CeEEEEEeccCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999875        56899999998 4677777653 345899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC---ccccccCCcccccccCcccccCC-CCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG---QVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS  161 (433)
                      |||++||+|+||||+||+++.++.++|+|||.+..+......   .........++..|+|||++.+. ..++.++||||
T Consensus       116 ~LH~~~ivH~dlk~~Nili~~~~~~kl~d~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws  195 (314)
T cd08216         116 YIHSKGFIHRSVKASHILLSGDGKVVLSGLRYSVSMIKHGKRQRVVHDFPKSSVKNLPWLSPEVLQQNLQGYNEKSDIYS  195 (314)
T ss_pred             HHHHCCeecCCCCcceEEEecCCceEEecCccceeeccccccccccccccccccccccccCHHHhcCCCCCCCcchhHHH
Confidence            999999999999999999999999999999988655322110   11112234567789999998654 34789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC----CCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPE----SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~----~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      +||++++|++|.+||..........  ....+.....    .++..............................+.++.+
T Consensus       196 ~G~il~el~~g~~pf~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  273 (314)
T cd08216         196 VGITACELANGHVPFKDMPATQMLL--EKVRGTVPCLLDKSTYPLYEDSMSQSRSSNEHPNNRDSVDHPYTRTFSEHFHQ  273 (314)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHH--HHHhccCccccccCchhhhcCCcCcccccccccchhhhhhcchhhHHHHHHHH
Confidence            9999999999999998766544322  2222222110    000000000000000000000000011111224567889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |+.+||..||++|||++++|+||||....
T Consensus       274 li~~~l~~~P~~Rpt~~~ll~~p~~~~~~  302 (314)
T cd08216         274 FVELCLQRDPESRPSASQLLNHSFFKQCK  302 (314)
T ss_pred             HHHHHhhcCCCcCcCHHHHhcCchHhhhc
Confidence            99999999999999999999999997543

Protein Kinase family, STE20-related kinase adapter protein (STRAD) subfamily, pseudokinase domain. The STRAD subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpigmentation of the buc

>KOG0603|consensus

Probab=100.00  E-value=2.1e-35  Score=288.08  Aligned_cols=205  Identities=25%  Similarity=0.408  Sum_probs=165.0

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+|+.++... +||||+++++++.+.        .++|+|||.+.+. +...+.. . +....++..|+.+|+.|+.|
T Consensus       361 ~~~~e~~~~~~~~~h~niv~~~~v~~~~--------~~~~~v~e~l~g~ell~ri~~-~-~~~~~e~~~w~~~lv~Av~~  430 (612)
T KOG0603|consen  361 DNQDEIPISLLVRDHPNIVKSHDVYEDG--------KEIYLVMELLDGGELLRRIRS-K-PEFCSEASQWAAELVSAVDY  430 (612)
T ss_pred             ccccccchhhhhcCCCcceeecceecCC--------ceeeeeehhccccHHHHHHHh-c-chhHHHHHHHHHHHHHHHHH
Confidence            466788777766 799999999999886        6699999999874 3333332 2 22337888899999999999


Q ss_pred             HHhCCeeccCCCCCcEEE-ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll-~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++|++|||+||+|||+ +..|+++|+|||.++.....       +.+.+-|..|.|||++... .|+.++||||||++
T Consensus       431 LH~~gvvhRDLkp~NIL~~~~~g~lrltyFG~a~~~~~~-------~~tp~~t~~y~APEvl~~~-~yt~acD~WSLGvl  502 (612)
T KOG0603|consen  431 LHEQGVVHRDLKPGNILLDGSAGHLRLTYFGFWSELERS-------CDTPALTLQYVAPEVLAIQ-EYTEACDWWSLGVL  502 (612)
T ss_pred             HHhcCeeecCCChhheeecCCCCcEEEEEechhhhCchh-------hcccchhhcccChhhhccC-CCCcchhhHHHHHH
Confidence            999999999999999999 68899999999999776533       3344668999999999854 48999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+||+|..||.......   .|..-++.+...                              ...|.+++|||++||+.
T Consensus       503 Ly~ML~G~tp~~~~P~~~---ei~~~i~~~~~s------------------------------~~vS~~AKdLl~~LL~~  549 (612)
T KOG0603|consen  503 LYEMLTGRTLFAAHPAGI---EIHTRIQMPKFS------------------------------ECVSDEAKDLLQQLLQV  549 (612)
T ss_pred             HHHHHhCCCccccCCchH---HHHHhhcCCccc------------------------------cccCHHHHHHHHHhccC
Confidence            999999999999776552   122222222111                              23688999999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||.+|+++.+++.||||.+
T Consensus       550 dP~~Rl~~~~i~~h~w~~~  568 (612)
T KOG0603|consen  550 DPALRLGADEIGAHPWFLS  568 (612)
T ss_pred             ChhhCcChhhhccCcchhc
Confidence            9999999999999999933

>cd06607 STKc_TAO Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids proteins

Probab=100.00  E-value=1.8e-34  Score=276.27  Aligned_cols=216  Identities=29%  Similarity=0.468  Sum_probs=176.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+++++.++||||+++++++.+.        +..|+||||+.+++.+.+......+++..+..++.||+.||.||
T Consensus        60 ~~~~~Ei~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~~~~ql~~~L~~L  131 (307)
T cd06607          60 QDIIKEVRFLQQLRHPNTIEYKGCYLRE--------HTAWLVMEYCLGSASDILEVHKKPLQEVEIAAICHGALQGLAYL  131 (307)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEEeC--------CeEEEEHHhhCCCHHHHHHHcccCCCHHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999875        55899999999999888876556789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |+.||+|+||+|+||+++.++.++|+|||++......        ....++..|+|||++.+  ...++.++||||+||+
T Consensus       132 H~~~i~H~dl~p~nIl~~~~~~~kL~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~s~G~i  203 (307)
T cd06607         132 HSHERIHRDIKAGNILLTEPGTVKLADFGSASLVSPA--------NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (307)
T ss_pred             HHCCceecCCCcccEEECCCCCEEEeecCcceecCCC--------CCccCCccccCceeeeccCCCCCCcccchHHHHHH
Confidence            9999999999999999999999999999988654321        23456788999998852  2347889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+...  .. +.                           ..+...+..+.++|.+||..
T Consensus       204 l~el~tg~~p~~~~~~~~~~~~~~~~--~~-~~---------------------------~~~~~~~~~~~~li~~~l~~  253 (307)
T cd06607         204 CIELAERKPPLFNMNAMSALYHIAQN--DS-PT---------------------------LSSNDWSDYFRNFVDSCLQK  253 (307)
T ss_pred             HHHHHcCCCCCCCccHHHHHHHHhcC--CC-CC---------------------------CCchhhCHHHHHHHHHHhcC
Confidence            99999999999887665544433210  00 00                           00011355677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +|++||++.+++.||||.....+.
T Consensus       254 ~p~~Rp~~~~il~~~~~~~~~~~~  277 (307)
T cd06607         254 IPQDRPSSEELLKHRFVLRERPPT  277 (307)
T ss_pred             ChhhCcCHHHHhcChhhcccCCcH
Confidence            999999999999999998765443

Serine/threonine kinases (STKs), thousand-and-one amino acids (TAO) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. They activate the MAPKs, p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activating the respective MAP/ERK kinases (MEKs, also known as MKKs or MAPKKs), MEK3/MEK6 and MKK4/MKK7. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Vertebrates contain three TAO subfamily

>PTZ00283 serine/threonine protein kinase; Provisional

Probab=100.00  E-value=7.5e-35  Score=295.47  Aligned_cols=223  Identities=23%  Similarity=0.316  Sum_probs=176.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.++..++|+||+++++.+.............+++||||+. ++|.+.+...   ...+++..++.++.|++.|
T Consensus        76 ~~~~~Ei~~l~~~~h~~iv~~~~~~~~~~~~~~~~~~~i~lV~Ey~~~gsL~~~l~~~~~~~~~l~e~~~~~i~~qll~a  155 (496)
T PTZ00283         76 NRAQAEVCCLLNCDFFSIVKCHEDFAKKDPRNPENVLMIALVLDYANAGDLRQEIKSRAKTNRTFREHEAGLLFIQVLLA  155 (496)
T ss_pred             HHHHHHHHHHhcCCCCcEEEeecceecccccCcccceEEEEEEeCCCCCcHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            45778999999999999999998886543221112235789999997 5888877543   2358999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.++.+||+|||+++.+......  ......+||+.|+|||++.+.. ++.++||||||
T Consensus       156 L~~lH~~~IiHrDLKP~NILl~~~~~vkL~DFGls~~~~~~~~~--~~~~~~~Gt~~Y~aPE~~~~~~-~s~k~DVwSlG  232 (496)
T PTZ00283        156 VHHVHSKHMIHRDIKSANILLCSNGLVKLGDFGFSKMYAATVSD--DVGRTFCGTPYYVAPEIWRRKP-YSKKADMFSLG  232 (496)
T ss_pred             HHHHHhCCEecCCCCHHHEEEeCCCCEEEEecccCeeccccccc--cccccccCCcceeCHHHhCCCC-CCcHHHHHHHH
Confidence            99999999999999999999999999999999999776432211  1223457899999999998755 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|..||.+.+..+.+..+..  +...+                             .+...++++.++|.+||
T Consensus       233 vilyeLltG~~Pf~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~l~~li~~~L  281 (496)
T PTZ00283        233 VLLYELLTLKRPFDGENMEEVMHKTLA--GRYDP-----------------------------LPPSISPEMQEIVTALL  281 (496)
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHhc--CCCCC-----------------------------CCCCCCHHHHHHHHHHc
Confidence            999999999999998776655444322  11000                             01124667889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||.+||++.++++|||++.
T Consensus       282 ~~dP~~RPs~~ell~~p~~~~  302 (496)
T PTZ00283        282 SSDPKRRPSSSKLLNMPICKL  302 (496)
T ss_pred             ccChhhCcCHHHHHhCHHHHH
Confidence            999999999999999999853

>cd05102 PTKc_VEGFR3 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 3

Probab=100.00  E-value=1.3e-34  Score=281.10  Aligned_cols=211  Identities=22%  Similarity=0.399  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      ..+++|+.+|+.+ +|||||++++++...       ...+++||||++ |+|.+++....                    
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~-------~~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  127 (338)
T cd05102          55 KALMSELKILIHIGNHLNVVNLLGACTKP-------NGPLMVIVEFCKYGNLSNFLRAKREFFSPYREKSPKQRGRFRAM  127 (338)
T ss_pred             HHHHHHHHHHHHhccCcceeeEEeEecCC-------CCceEEEEecCCCCcHHHHHHhcchhcccccccchhhhhhhhhh
Confidence            4588999999999 899999999988754       245899999997 57887775421                    


Q ss_pred             -----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEE
Q psy7889          66 -----------------------------------------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI  104 (433)
Q Consensus        66 -----------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll  104 (433)
                                                               ..+++..+..++.||+.||+|||++||+||||||+|||+
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~LH~~~ivHrDiKp~Nil~  207 (338)
T cd05102         128 VEQSRVDRRIEAGQASVLFSRFQPSTSGSTNPPQETDDLWKSPLTMEDLICYSFQVARGMEFLASRKCIHRDLAARNILL  207 (338)
T ss_pred             hhhhccccccccccCCccccccccccCcccccchhccccccCCCCHHHHHHHHHHHHHHHHHHHHCCEECCCCccceEEE
Confidence                                                     237788899999999999999999999999999999999


Q ss_pred             ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHH
Q psy7889         105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ  183 (433)
Q Consensus       105 ~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~  183 (433)
                      +.++.+||+|||+++.......  ........++..|+|||++.+.. ++.++||||+||++|||++ |.+||.+.....
T Consensus       208 ~~~~~~kl~DfG~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDiwslG~il~el~~~g~~pf~~~~~~~  284 (338)
T cd05102         208 SENNVVKICDFGLARDIYKDPD--YVRKGSARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQINE  284 (338)
T ss_pred             cCCCcEEEeecccccccccCcc--hhcccCCCCCccccCcHHhhcCC-CCcccCHHHHHHHHHHHHhCCCCCCCCCCccH
Confidence            9999999999999976542211  11122334567899999987655 7999999999999999997 999998765433


Q ss_pred             HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       184 ~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ....... .+...                             ..+...+..+.+++.+||..||.+|||+.++++
T Consensus       285 ~~~~~~~-~~~~~-----------------------------~~~~~~~~~l~~li~~cl~~dp~~RPs~~el~~  329 (338)
T cd05102         285 EFCQRLK-DGTRM-----------------------------RAPENATPEIYRIMLACWQGDPKERPTFSALVE  329 (338)
T ss_pred             HHHHHHh-cCCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            2222111 01000                             001124567789999999999999999999985

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 3 (VEGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR3 (or Flt4) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. V

>cd07877 STKc_p38alpha_MAPK14 Catalytic domain of the Serine/Threonine Kinase, p38alpha Mitogen-Activated Protein Kinase

Probab=100.00  E-value=8.9e-35  Score=282.99  Aligned_cols=246  Identities=33%  Similarity=0.549  Sum_probs=186.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|++++++++||||+++++++.....  ......+|+++++++++|...+..  ..+++..++.++.|++.||+||
T Consensus        61 ~~~~~Ei~~l~~l~h~~iv~~~~~~~~~~~--~~~~~~~~lv~~~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L  136 (345)
T cd07877          61 KRTYRELRLLKHMKHENVIGLLDVFTPARS--LEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI  136 (345)
T ss_pred             HHHHHHHHHHHHcCCCcccceeeeeeeccc--ccccccEEEEehhcccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            457789999999999999999999875422  111245899999998888877654  2589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.++|+|||++.....       ......++..|+|||++.+...++.++||||+||+++
T Consensus       137 H~~~ivH~dlkp~NIll~~~~~~kl~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~DvwslG~il~  209 (345)
T cd07877         137 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  209 (345)
T ss_pred             HHCCeeecCCChHHEEEcCCCCEEEecccccccccc-------cccccccCCCccCHHHHhCccCCCchhhHHHHHHHHH
Confidence            999999999999999999999999999999876432       1233467889999999876555789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.........+....+...+..+............. .+..........  ....++++++||.+||+.|
T Consensus       210 el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~d  287 (345)
T cd07877         210 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV--FIGANPLAVDLLEKMLVLD  287 (345)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHhhcccHhHHHHHHHhcccCCcchhhh--cCCCCHHHHHHHHHHcCCC
Confidence            9999999999888877777777766655544333222211100000 000000000000  0135778899999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|+++.++++||||.+..
T Consensus       288 p~~R~t~~e~l~h~~f~~~~  307 (345)
T cd07877         288 SDKRITAAQALAHAYFAQYH  307 (345)
T ss_pred             hhhcCCHHHHhcChhhhhcC
Confidence            99999999999999997644

Serine/Threonine Kinases (STKs), p38alpha subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38alpha subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38alpha, also called MAPK14

>cd06628 STKc_MAPKKK_Byr2_like Catalytic domain of fungal Byr2-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=1.4e-34  Score=271.05  Aligned_cols=214  Identities=28%  Similarity=0.495  Sum_probs=171.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        ...++||||+++ +|.+++... ..+++..+..++.|++.||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~~  121 (267)
T cd06628          51 DALAREIALLKELQHENIVQYLGSSLDA--------DHLNIFLEYVPGGSVAALLNNY-GAFEETLVRNFVRQILKGLNY  121 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEEeC--------CccEEEEEecCCCCHHHHHHhc-cCccHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999875        568999999975 777777653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC--ccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG--QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~--~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++.........  .........++..|+|||.+.+.. ++.++|+||+||
T Consensus       122 lH~~~ivH~di~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~  200 (267)
T cd06628         122 LHNRGIIHRDIKGANILVDNKGGIKISDFGISKKLEANSLSTKTNGARPSLQGSVFWMAPEVVKQTS-YTRKADIWSLGC  200 (267)
T ss_pred             HHhcCcccccCCHHHEEEcCCCCEEecccCCCcccccccccCCccccccccCCCcCccChhHhccCC-CCchhhhHHHHH
Confidence            99999999999999999999999999999998776521110  001112345788899999987654 688999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||.+......+..+.....   +.                            .+...+..+.++|.+||+
T Consensus       201 il~~l~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------------------~~~~~~~~~~~li~~~l~  249 (267)
T cd06628         201 LVVEMLTGKHPFPDCTQLQAIFKIGENAS---PE----------------------------IPSNISSEAIDFLEKTFE  249 (267)
T ss_pred             HHHHHhhCCCCCCCccHHHHHHHHhccCC---Cc----------------------------CCcccCHHHHHHHHHHcc
Confidence            99999999999987665544433322100   00                            011245677799999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .||.+||++.++++||||
T Consensus       250 ~~p~~Rp~~~~il~~~~~  267 (267)
T cd06628         250 IDHNKRPTAAELLKHPFL  267 (267)
T ss_pred             CCchhCcCHHHHhhCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Byr2-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Schizosaccharomyces pombe Byr2, Saccharomyces cerevisiae and Cryptococcus neoformans Ste11, and related proteins. They contain an N-terminal SAM (sterile alpha-motif) domain, which mediates protein-protein interaction, and a C-terminal catalytic domain. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate

>cd05580 STKc_PKA Catalytic domain of the Protein Serine/Threonine Kinase, cAMP-dependent protein kinase

Probab=100.00  E-value=2.1e-34  Score=273.48  Aligned_cols=209  Identities=29%  Similarity=0.428  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecC-cCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|++++||||+++++++...        ..+|+||||+ .++|.+.+... ..+++..+..++.||+.||+|
T Consensus        46 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~qil~~l~~  116 (290)
T cd05580          46 EHVLNEKRILQSIRHPFLVNLYGSFQDD--------SNLYLVMEYVPGGELFSHLRKS-GRFPEPVARFYAAQVVLALEY  116 (290)
T ss_pred             HHHHHHHHHHHhCCCCCccceeeEEEcC--------CeEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        5699999999 56888887664 478999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+|+||+|.||+++.++.+||+|||++......       .....++..|+|||.+.+.. ++.++||||||+++
T Consensus       117 lH~~~i~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  188 (290)
T cd05580         117 LHSLDIVYRDLKPENLLLDSDGYIKITDFGFAKRVKGR-------TYTLCGTPEYLAPEIILSKG-YGKAVDWWALGILI  188 (290)
T ss_pred             HHHCCEecCCCCHHHEEECCCCCEEEeeCCCccccCCC-------CCCCCCCccccChhhhcCCC-CCccccHHHHHHHH
Confidence            99999999999999999999999999999998776432       23346788999999987654 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||...+.......+..  +...                              .+...+..+.++|.+||..|
T Consensus       189 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------------------------------~~~~~~~~l~~li~~~l~~~  236 (290)
T cd05580         189 YEMLAGYPPFFDDNPIQIYEKILE--GKVR------------------------------FPSFFSPDAKDLIRNLLQVD  236 (290)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhc--CCcc------------------------------CCccCCHHHHHHHHHHccCC
Confidence            999999999988775544444321  1100                              01123566779999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccCC
Q psy7889         247 PSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~~  265 (433)
                      |.+|+     +++++++||||...
T Consensus       237 p~~R~~~~~~~~~~l~~~~~~~~~  260 (290)
T cd05580         237 LTKRLGNLKNGVNDIKNHPWFAGI  260 (290)
T ss_pred             HHHccCcccCCHHHHHcCcccccC
Confidence            99999     99999999999654

Serine/Threonine Kinases (STKs), cAMP-dependent protein kinase (PKA) subfamily, catalytic (c) subunit. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PKA subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This subfamily is composed of the cAMP-dependent proteins kinases, PKA and PRKX. The inactive PKA holoenzyme is a heterotetramer composed of two phosphorylated and active catalytic (C) subunits with a dimer of regulatory (R) subunits. Activation is achieved through the binding of the important second messenger cAMP to the R subunits, which leads to the dissociation of PKA into the R dimer and two active C subunits. PKA is present ubi

>cd07854 STKc_MAPK4_6 Catalytic domain of the Serine/Threonine Kinases, Mitogen-Activated Protein Kinases 4 and 6

Probab=100.00  E-value=9.1e-35  Score=282.61  Aligned_cols=253  Identities=33%  Similarity=0.534  Sum_probs=180.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccc------cccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQY------NRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~------~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+++++.++||||+++++++.......      ......+|+||||++++|...+..  ..+++..++.++.||+
T Consensus        47 ~~~~~Ei~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~  124 (342)
T cd07854          47 KHALREIKIIRRLDHDNIVKVYEVLGPSGSDLTEDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLSEEHARLFMYQLL  124 (342)
T ss_pred             HHHHHHHHHHHhcCCCcchhhHhhhcccccccccccccccccceEEEEeecccccHHHHHHc--CCCCHHHHHHHHHHHH
Confidence            45788999999999999999999887653210      011245899999999988887754  3589999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      .||.|||++||+||||||+||+++. ++.++|+|||++......... ........++..|+|||++.+...++.++|||
T Consensus       125 ~aL~~LH~~givH~dikp~Nili~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Diw  203 (342)
T cd07854         125 RGLKYIHSANVLHRDLKPANVFINTEDLVLKIGDFGLARIVDPHYSH-KGYLSEGLVTKWYRSPRLLLSPNNYTKAIDMW  203 (342)
T ss_pred             HHHHHHHhCCcccCCCCHHHEEEcCCCceEEECCcccceecCCcccc-ccccccccccccccCHHHHhCccccCchhhHH
Confidence            9999999999999999999999985 457899999998765322111 11122345688999999876655578999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|..||.+....+....+...........+..........................  ...+.++++||.
T Consensus       204 SlGvil~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~  281 (342)
T cd07854         204 AAGCIFAEMLTGKPLFAGAHELEQMQLILESVPVVREEDRNELLNVIPSFVRNDGGEPRRPLRDLL--PGVNPEALDFLE  281 (342)
T ss_pred             HHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcccccCCCHHHHc--cCCCHHHHHHHH
Confidence            999999999999999998887776665544333222211111000000000000000000011111  135778899999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||+.||.+|||++++|.||||...
T Consensus       282 ~~L~~dP~~R~t~~ell~h~~~~~~  306 (342)
T cd07854         282 QILTFNPMDRLTAEEALMHPYMSCY  306 (342)
T ss_pred             HHhCCCchhccCHHHHhCCCccccc
Confidence            9999999999999999999999643

Serine/Threonine Kinases (STKs), Mitogen-Activated Protein Kinase 4 (MAPK4) and MAPK6 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPK4/6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKs are important mediators of cellular responses to extracellular signals. MAPK4 is also called ERK4 or p63MAPK, while MAPK6 is also called ERK3 or p97MAPK. MAPK4 and MAPK6 are atypical MAPKs that are not regulated by MAP2Ks. MAPK6 is expressed ubiquitously with highest amounts in brain and skeletal muscle. It may be involved in the control of cell differentiation by negatively regulating cell cycle progressi

>KOG0612|consensus

Probab=100.00  E-value=1.4e-35  Score=303.36  Aligned_cols=223  Identities=28%  Similarity=0.348  Sum_probs=191.8

Q ss_pred             CCCCCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHH
Q psy7889           1 MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQ   79 (433)
Q Consensus         1 ~~~~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~q   79 (433)
                      |++.+...-|..|-.||..-+.+-||.++..|++.        .++|+||||++ |||..++.+.. ++++..++.|+..
T Consensus       113 MlKr~~tA~F~EERDimv~~ns~Wiv~LhyAFQD~--------~~LYlVMdY~pGGDlltLlSk~~-~~pE~~ArFY~aE  183 (1317)
T KOG0612|consen  113 MLKRAETACFREERDIMVFGNSEWIVQLHYAFQDE--------RYLYLVMDYMPGGDLLTLLSKFD-RLPEDWARFYTAE  183 (1317)
T ss_pred             HhhchhHHHHHHHhHHHHcCCcHHHHHHHHHhcCc--------cceEEEEecccCchHHHHHhhcC-CChHHHHHHHHHH
Confidence            46677788899999999999999999999999997        66999999987 58999999977 8999999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCC
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGP  155 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~  155 (433)
                      |+.||.-||+.|+|||||||+|||++..|+|||+|||.|-.+...+  . ......+|||.|++||++...    ..|+.
T Consensus       184 iVlAldslH~mgyVHRDiKPDNvLld~~GHikLADFGsClkm~~dG--~-V~s~~aVGTPDYISPEvLqs~~~~~g~yG~  260 (1317)
T KOG0612|consen  184 IVLALDSLHSMGYVHRDIKPDNVLLDKSGHIKLADFGSCLKMDADG--T-VRSSVAVGTPDYISPEVLQSQGDGKGEYGR  260 (1317)
T ss_pred             HHHHHHHHHhccceeccCCcceeEecccCcEeeccchhHHhcCCCC--c-EEeccccCCCCccCHHHHHhhcCCccccCC
Confidence            9999999999999999999999999999999999999998876322  2 345667999999999998532    34899


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      .+|+||+||++|||+.|..||...+-.++..+|......+                 .+|           .....|.++
T Consensus       261 ecDwWSlGV~~YEMlyG~TPFYadslveTY~KIm~hk~~l-----------------~FP-----------~~~~VSeea  312 (1317)
T KOG0612|consen  261 ECDWWSLGVFMYEMLYGETPFYADSLVETYGKIMNHKESL-----------------SFP-----------DETDVSEEA  312 (1317)
T ss_pred             ccchhhhHHHHHHHHcCCCcchHHHHHHHHHHHhchhhhc-----------------CCC-----------cccccCHHH
Confidence            9999999999999999999999999999999887642111                 111           012368899


Q ss_pred             HHHHHhhcccCCCCCCC---HHHhhcCCCccC
Q psy7889         236 CDLLDKLLLLDPSKRFD---SDAALNHDFFWT  264 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t---~~e~L~h~~~~~  264 (433)
                      ++||.+++. +|..|..   ++++-.||||.+
T Consensus       313 kdLI~~ll~-~~e~RLgrngiedik~HpFF~g  343 (1317)
T KOG0612|consen  313 KDLIEALLC-DREVRLGRNGIEDIKNHPFFEG  343 (1317)
T ss_pred             HHHHHHHhc-ChhhhcccccHHHHHhCccccC
Confidence            999999887 7889998   999999999964

>cd06612 STKc_MST1_2 Catalytic domain of the Protein Serine/Threonine Kinases, Mammalian Ste20-like protein kinase 1 and 2

Probab=100.00  E-value=1e-34  Score=270.10  Aligned_cols=214  Identities=26%  Similarity=0.441  Sum_probs=173.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+++.++||||+++++++...        ..+|+++||+++ +|.+.+......+++..++.++.|++.||.
T Consensus        42 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------~~~~l~~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~~l~  113 (256)
T cd06612          42 LQEIIKEISILKQCDSPYIVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIMKITNKTLTEEEIAAILYQTLKGLE  113 (256)
T ss_pred             HHHHHHHHHHHHhCCCCcEeeeeeeeecC--------CcEEEEEecCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH
Confidence            35788999999999999999999999876        569999999985 788887766667899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||++.+.. ++.++||||+||+
T Consensus       114 ~lh~~~i~H~dl~~~ni~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~s~G~i  188 (256)
T cd06612         114 YLHSNKKIHRDIKAGNILLNEEGQAKLADFGVSGQLTDTMA----KRNTVIGTPFWMAPEVIQEIG-YNNKADIWSLGIT  188 (256)
T ss_pred             HHHHCCcccCCCCcceEEECCCCcEEEcccccchhcccCcc----ccccccCCccccCHHHHhcCC-CCchhhHHHHHHH
Confidence            99999999999999999999999999999999877653221    122345688899999987764 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...........+..    .....+.                         .+...+.++.++|.+||+.
T Consensus       189 l~~l~~g~~p~~~~~~~~~~~~~~~----~~~~~~~-------------------------~~~~~~~~~~~~i~~~l~~  239 (256)
T cd06612         189 AIEMAEGKPPYSDIHPMRAIFMIPN----KPPPTLS-------------------------DPEKWSPEFNDFVKKCLVK  239 (256)
T ss_pred             HHHHHhCCCCCCCcchhhhhhhhcc----CCCCCCC-------------------------chhhcCHHHHHHHHHHHhc
Confidence            9999999999987655433222111    0000000                         0112456778999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      ||++|||++|+|.||||
T Consensus       240 ~P~~Rps~~~il~~~~~  256 (256)
T cd06612         240 DPEERPSAIQLLQHPFI  256 (256)
T ss_pred             ChhhCcCHHHHhcCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 1 (MST1) and MST2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST1/2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST1, MST2, and related proteins including Drosophila Hippo and Dictyostelium discoideum Krs1 (kinase responsive to stress 1). MST1/2 and Hippo are involved in a conserved pathway that governs cell contact inhibition, organ size control, and tumor development. MST1 activates the mitogen-activated protein kinases (MAPKs) p38 and c-Jun N-terminal kinase (JNK) through MKK7 (a

>cd06637 STKc_TNIK Catalytic domain of the Protein Serine/Threonine Kinase, Traf2- and Nck-interacting kinase

Probab=100.00  E-value=2.6e-34  Score=270.01  Aligned_cols=220  Identities=25%  Similarity=0.404  Sum_probs=172.5

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.+++.+ +||||+++++++.....  ......+|+||||+.+ +|.+++... ...+++..+..++.|++.|
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~--~~~~~~~~iv~e~~~~~~L~~~l~~~~~~~l~~~~~~~~~~qi~~~  123 (272)
T cd06637          46 EEEIKQEINMLKKYSHHRNIATYYGAFIKKNP--PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILRG  123 (272)
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEeeEEeecCC--CCCCcEEEEEEEcCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence            45688999999999 79999999999976532  1123578999999975 788877653 3458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcchh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~Di  159 (433)
                      |+|||++||+|+||||+||+++.++.++|+|||++.......    .......|+..|+|||++.+.    ..++.++||
T Consensus       124 l~~LH~~~ivh~dl~~~nili~~~~~~~l~Dfg~~~~~~~~~----~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~Dv  199 (272)
T cd06637         124 LSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSDL  199 (272)
T ss_pred             HHHHHHCCCccCCCCHHHEEECCCCCEEEccCCCceeccccc----ccCCcccccccccCHhHhccccCcCCCCCchhhH
Confidence            999999999999999999999999999999999987653221    122345678899999998632    237889999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||+||++|+|++|..||...........+...   ..                           ........+..+.+||
T Consensus       200 ~slGv~l~el~~g~~p~~~~~~~~~~~~~~~~---~~---------------------------~~~~~~~~~~~~~~li  249 (272)
T cd06637         200 WSLGITAIEMAEGAPPLCDMHPMRALFLIPRN---PA---------------------------PRLKSKKWSKKFQSFI  249 (272)
T ss_pred             HHHHHHHHHHHhCCCCccccCHHHHHHHHhcC---CC---------------------------CCCCCCCcCHHHHHHH
Confidence            99999999999999999766544433322110   00                           0001112456778999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCc
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      .+||..+|.+|||+.+++.||||
T Consensus       250 ~~~l~~~p~~Rpt~~~il~~~~~  272 (272)
T cd06637         250 ESCLVKNHSQRPTTEQLMKHPFI  272 (272)
T ss_pred             HHHcCCChhhCCCHHHHhhCCCC
Confidence            99999999999999999999997

Serine/threonine kinases (STKs), Traf2- and Nck-interacting kinase (TNIK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TNIK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to mitogen-activated protein kinase (MAPK), kinase kinase kinase 4 (MAP4K4), and MAP4K6. MAP4Ks participate in some MAPK signaling pathways by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). TNIK is an effector of Rap2, a small GTP-binding protein from the Ras family. TNIK specifically activ

>cd06630 STKc_MEKK1 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 1

Probab=100.00  E-value=1.4e-34  Score=271.08  Aligned_cols=219  Identities=31%  Similarity=0.493  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|+||+++++++.+.        +.+++||||+.+ +|.+++.+ ...+++..++.++.||+.||+|
T Consensus        48 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~ql~~al~~  118 (268)
T cd06630          48 EALRKEIRLMARLNHPHIIRMLGATCED--------SHFNLFVEWMAGGSVSHLLSK-YGAFKEAVIINYTEQLLRGLSY  118 (268)
T ss_pred             HHHHHHHHHHHHcCCCceehhhceeccC--------CeEEEEEeccCCCcHHHHHHH-hCCCCHHHHHHHHHHHHHHHHH
Confidence            5678899999999999999999999875        569999999985 77777765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++|++|+||+|+||+++.++ .++|+|||.+..+...............++..|+|||.+.+.. ++.++|+||+||+
T Consensus       119 LH~~~i~H~~i~~~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~~  197 (268)
T cd06630         119 LHENQIIHRDVKGANLLIDSTGQRLRIADFGAAARLAAKGTGAGEFQGQLLGTIAFMAPEVLRGEQ-YGRSCDVWSVGCV  197 (268)
T ss_pred             HHhCCeecCCCCHHHEEEcCCCCEEEEcccccccccccccccCCccccccccccceeCHhHhccCC-CCcccchHHHHHH
Confidence            9999999999999999998776 6999999999776543211111122346788999999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||...........+....-......                           .+...+.++.+++.+||..
T Consensus       198 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~i~~~l~~  250 (268)
T cd06630         198 IIEMATAKPPWNAEKHSNHLALIFKIASATTAPS---------------------------IPEHLSPGLRDVTLRCLEL  250 (268)
T ss_pred             HHHHHhCCCCCCCCCCcchHHHHHHHhccCCCCC---------------------------CchhhCHHHHHHHHHHcCC
Confidence            9999999999976543333322222111000000                           0112466778999999999


Q ss_pred             CCCCCCCHHHhhcCCCcc
Q psy7889         246 DPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~  263 (433)
                      +|.+||++.++++||||.
T Consensus       251 ~p~~R~~~~~ll~~~~~~  268 (268)
T cd06630         251 QPEDRPPSRELLKHPVFR  268 (268)
T ss_pred             CcccCcCHHHHhcCcccC
Confidence            999999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 1 (MEKK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK1 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK1 activates the extracellular signal-regulated kinase 1/2 (ERK1/2) and c-Jun N-terminal kinase (JNK) pathways by activating their

>KOG4236|consensus

Probab=100.00  E-value=3.3e-36  Score=285.68  Aligned_cols=215  Identities=25%  Similarity=0.395  Sum_probs=183.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHh-ccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS-NIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~-~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +.+...|+.||+.++||.||.+--.|++.        +.+++|||-+.||++..+. ...+++++..-+.++.||+-||+
T Consensus       607 esqlR~EVaILq~l~HPGiV~le~M~ET~--------ervFVVMEKl~GDMLEMILSsEkgRL~er~TkFlvtQIL~ALr  678 (888)
T KOG4236|consen  607 ESQLRNEVAILQNLHHPGIVNLECMFETP--------ERVFVVMEKLHGDMLEMILSSEKGRLPERITKFLVTQILVALR  678 (888)
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEeecCC--------ceEEEEehhhcchHHHHHHHhhcccchHHHHHHHHHHHHHHHH
Confidence            46788999999999999999999999887        6699999999999888774 55778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||-+||+|+||||+|||+....   ++||||||+|+.....     ......+||+.|+|||++..+. |+.+.||||+
T Consensus       679 ~LH~knIvHCDLKPENVLLas~~~FPQvKlCDFGfARiIgEk-----sFRrsVVGTPAYLaPEVLrnkG-yNrSLDMWSV  752 (888)
T KOG4236|consen  679 YLHFKNIVHCDLKPENVLLASASPFPQVKLCDFGFARIIGEK-----SFRRSVVGTPAYLAPEVLRNKG-YNRSLDMWSV  752 (888)
T ss_pred             HhhhcceeeccCCchheeeccCCCCCceeeccccceeecchh-----hhhhhhcCCccccCHHHHhhcc-ccccccceee
Confidence            99999999999999999997553   7999999999988642     2334678999999999998765 8999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |||+|.-++|..||...++.  -.+|.+.....+++.|..                            .+.+++|||..+
T Consensus       753 GVIiYVsLSGTFPFNEdEdI--ndQIQNAaFMyPp~PW~e----------------------------is~~AidlIn~L  802 (888)
T KOG4236|consen  753 GVIIYVSLSGTFPFNEDEDI--NDQIQNAAFMYPPNPWSE----------------------------ISPEAIDLINNL  802 (888)
T ss_pred             eEEEEEEecccccCCCccch--hHHhhccccccCCCchhh----------------------------cCHHHHHHHHHH
Confidence            99999999999999865544  334444444455555543                            467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |+..-++|.+.++.|.|||+++-
T Consensus       803 LqVkm~kRysvdk~lsh~Wlq~y  825 (888)
T KOG4236|consen  803 LQVKMRKRYSVDKSLSHPWLQDY  825 (888)
T ss_pred             HHHHHHHhcchHhhccchhhhcc
Confidence            99999999999999999999764

>PHA02988 hypothetical protein; Provisional

Probab=100.00  E-value=1.7e-34  Score=273.25  Aligned_cols=209  Identities=18%  Similarity=0.203  Sum_probs=167.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|++++|||||++++++.+...    ....+++||||+.+ +|.+++.+. ..+++.....++.|++.||.|
T Consensus        63 ~~~~~E~~~l~~l~h~nIv~~~g~~~~~~~----~~~~~~lv~Ey~~~g~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~  137 (283)
T PHA02988         63 DITENEIKNLRRIDSNNILKIYGFIIDIVD----DLPRLSLILEYCTRGYLREVLDKE-KDLSFKTKLDMAIDCCKGLYN  137 (283)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEeeeEEeccc----CCCceEEEEEeCCCCcHHHHHhhC-CCCChhHHHHHHHHHHHHHHH
Confidence            455699999999999999999999976211    02568999999985 688887663 468899999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhHHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv  164 (433)
                      ||+ .+++||||||+||+++.++.+||+|||++..+...       .....++..|+|||++.+. ..++.++|||||||
T Consensus       138 lH~~~~~~Hrdlkp~nill~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~k~Di~SlGv  210 (283)
T PHA02988        138 LYKYTNKPYKNLTSVSFLVTENYKLKIICHGLEKILSSP-------PFKNVNFMVYFSYKMLNDIFSEYTIKDDIYSLGV  210 (283)
T ss_pred             HHhcCCCCCCcCChhhEEECCCCcEEEcccchHhhhccc-------cccccCcccccCHHHhhhccccccchhhhhHHHH
Confidence            998 59999999999999999999999999998765422       1234678899999998652 34799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|..||.+.+..+....+......+.                              .+...+.++.+|+.+||+
T Consensus       211 il~el~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~  260 (283)
T PHA02988        211 VLWEIFTGKIPFENLTTKEIYDLIINKNNSLK------------------------------LPLDCPLEIKCIVEACTS  260 (283)
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHhcCCCCC------------------------------CCCcCcHHHHHHHHHHhc
Confidence            99999999999998876655544432111110                              011235667799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||++|||++++++
T Consensus       261 ~dp~~Rps~~ell~  274 (283)
T PHA02988        261 HDSIKRPNIKEILY  274 (283)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999985

>cd05624 STKc_MRCK_beta Catalytic domain of the Protein Serine/Threonine Kinase, DMPK-related cell division control protein 42 binding kinase beta

Probab=100.00  E-value=1.1e-34  Score=280.59  Aligned_cols=219  Identities=24%  Similarity=0.304  Sum_probs=174.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.++..++|+||+++++++.+.        +.+|+||||+. ++|.+++.+....+++..++.++.|++.||+|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~l~~~~~~~--------~~~~lv~Ey~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~~L~~  117 (331)
T cd05624          46 ACFREERNVLVNGDCQWITTLHYAFQDE--------NYLYLVMDYYVGGDLLTLLSKFEDRLPEDMARFYIAEMVLAIHS  117 (331)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcC--------CEEEEEEeCCCCCcHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        66999999996 58888887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~DiwSl  162 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   .......||+.|+|||++.+.    ..++.++||||+
T Consensus       118 lH~~~iiHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~DiwSl  194 (331)
T cd05624         118 IHQLHYVHRDIKPDNVLLDMNGHIRLADFGSCLKMNQDGT---VQSSVAVGTPDYISPEILQAMEDGMGKYGPECDWWSL  194 (331)
T ss_pred             HHHCCeeeccCchHHEEEcCCCCEEEEeccceeeccCCCc---eeeccccCCcccCCHHHHhccccCCCCCCCcccEEee
Confidence            9999999999999999999999999999999976543211   112235689999999998652    236889999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|..||.+.+..+....+........   ++..                        ....+.+++++|.+|
T Consensus       195 Gvil~ell~g~~Pf~~~~~~~~~~~i~~~~~~~~---~p~~------------------------~~~~~~~~~~li~~l  247 (331)
T cd05624         195 GVCMYEMLYGETPFYAESLVETYGKIMNHEERFQ---FPSH------------------------ITDVSEEAKDLIQRL  247 (331)
T ss_pred             ehhhhhhhhCCCCccCCCHHHHHHHHHcCCCccc---CCCc------------------------cccCCHHHHHHHHHH
Confidence            9999999999999998877665555432111100   0000                        012467788999999


Q ss_pred             cccCCCC--CCCHHHhhcCCCccC
Q psy7889         243 LLLDPSK--RFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~--R~t~~e~L~h~~~~~  264 (433)
                      |..++.+  |++++++++|+||..
T Consensus       248 l~~~~~~~~~~~~~~~~~h~~f~~  271 (331)
T cd05624         248 ICSRERRLGQNGIEDFKKHAFFEG  271 (331)
T ss_pred             ccCchhhcCCCCHHHHhcCCCcCC
Confidence            9976655  579999999999964

Serine/Threonine Kinases (STKs), DMPK-like subfamily, DMPK-related cell division control protein 42 (Cdc42) binding kinase (MRCK) beta isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The DMPK-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MRCK is activated via interaction with the small GTPase Cdc42. MRCK/Cdc42 signaling mediates myosin-dependent cell motility. MRCKbeta is expressed ubiquitously in many tissues.

>KOG0670|consensus

Probab=100.00  E-value=1.9e-36  Score=286.97  Aligned_cols=243  Identities=30%  Similarity=0.492  Sum_probs=191.1

Q ss_pred             chhHHHHHHHHHhCC------CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCC--CCHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK------HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSLGEIKKVIQ   78 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~--l~~~~~~~i~~   78 (433)
                      ..+=++|++||++|+      --|+++|+..|...        .++|||||.+.-+|..++++....  |....++.|+.
T Consensus       472 ~KtGl~EleiLkKL~~AD~Edk~Hclrl~r~F~hk--------nHLClVFE~LslNLRevLKKyG~nvGL~ikaVRsYaq  543 (752)
T KOG0670|consen  472 HKTGLKELEILKKLNDADPEDKFHCLRLFRHFKHK--------NHLCLVFEPLSLNLREVLKKYGRNVGLHIKAVRSYAQ  543 (752)
T ss_pred             hhhhhHHHHHHHHhhccCchhhhHHHHHHHHhhhc--------ceeEEEehhhhchHHHHHHHhCcccceeehHHHHHHH
Confidence            345688999999995      33899999999876        779999999999999999986544  67789999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      ||+.||..|..+||+|.||||+|||++.. ..+||||||.|......      ..+.+..+..|+|||+|+|-+ |+...
T Consensus       544 QLflALklLK~c~vlHaDIKPDNiLVNE~k~iLKLCDfGSA~~~~en------eitPYLVSRFYRaPEIiLG~~-yd~~i  616 (752)
T KOG0670|consen  544 QLFLALKLLKKCGVLHADIKPDNILVNESKNILKLCDFGSASFASEN------EITPYLVSRFYRAPEIILGLP-YDYPI  616 (752)
T ss_pred             HHHHHHHHHHhcCeeecccCccceEeccCcceeeeccCccccccccc------cccHHHHHHhccCcceeecCc-ccCCc
Confidence            99999999999999999999999999965 57899999999887653      345567788999999999987 89999


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhh---------hhccc-cchH---------H
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDL---------YNKME-LPKA---------Q  218 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~---------~~~~~-~~~~---------~  218 (433)
                      |+||+||+||||.||+..|+|.+...++...+.+.|..+......-.+...         +..++ +...         .
T Consensus       617 D~WSvgctLYElYtGkIlFpG~TNN~MLrl~me~KGk~p~KmlRKgqF~dqHFD~d~nf~~~e~D~vT~r~~~~vm~~vk  696 (752)
T KOG0670|consen  617 DTWSVGCTLYELYTGKILFPGRTNNQMLRLFMELKGKFPNKMLRKGQFKDQHFDQDLNFLYIEVDKVTEREKRTVMVNVK  696 (752)
T ss_pred             cceeeceeeEEeeccceecCCCCcHHHHHHHHHhcCCCcHHHhhhcchhhhhcccccceEEEeccccccceeEEEecccC
Confidence            999999999999999999999999999999999999877643322111110         00000 0000         0


Q ss_pred             H-hhHHhhhCC--------ccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         219 K-RKVKERLKP--------YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       219 ~-~~~~~~~~~--------~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      + +.+...+..        ...-.++++||.+||..||.+|+|..|+|.||||+.
T Consensus       697 Ptkdl~s~l~~~q~~~deq~~~~~~~rdLLdkml~LdP~KRit~nqAL~HpFi~~  751 (752)
T KOG0670|consen  697 PTKDLGSELIAVQRLPDEQPKIVQQLRDLLDKMLILDPEKRITVNQALKHPFITE  751 (752)
T ss_pred             cchhHHHHHhccCCCCchhHHHHHHHHHHHHHHhccChhhcCCHHHHhcCCcccC
Confidence            0 111111111        011256889999999999999999999999999964

>cd06645 STKc_MAP4K3 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 3

Probab=100.00  E-value=2.4e-34  Score=269.58  Aligned_cols=213  Identities=25%  Similarity=0.431  Sum_probs=167.9

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||+++++++...        +.+|+||||+++ +|.+++.. ...+++..++.++.|++.||.||
T Consensus        52 ~~~~e~~~~~~l~h~~ii~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~~l  122 (267)
T cd06645          52 VVQQEIIMMKDCKHSNIVAYFGSYLRR--------DKLWICMEFCGGGSLQDIYHV-TGPLSESQIAYVSRETLQGLYYL  122 (267)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEEeC--------CEEEEEEeccCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999875        668999999985 77777655 44789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |++|++|+||||+||+++.++.++|+|||++.......    .......|+..|+|||++..  ...++.++|+||+||+
T Consensus       123 H~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~DvwSlG~i  198 (267)
T cd06645         123 HSKGKMHRDIKGANILLTDNGHVKLADFGVSAQITATI----AKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWAVGIT  198 (267)
T ss_pred             HHCCeecCCCCHHHEEECCCCCEEECcceeeeEccCcc----cccccccCcccccChhhhccccCCCCCchhhhHHHHHH
Confidence            99999999999999999999999999999987654221    12234567899999998742  2336889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||........+..+..  ....+..+.                         .....+..+.++|.+||..
T Consensus       199 l~~l~~~~~p~~~~~~~~~~~~~~~--~~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~~  251 (267)
T cd06645         199 AIELAELQPPMFDLHPMRALFLMTK--SNFQPPKLK-------------------------DKMKWSNSFHHFVKMALTK  251 (267)
T ss_pred             HHHHhcCCCCcccccchhhHHhhhc--cCCCCCccc-------------------------ccCCCCHHHHHHHHHHccC
Confidence            9999999999876554333322211  111111000                         0012355677999999999


Q ss_pred             CCCCCCCHHHhhcCCC
Q psy7889         246 DPSKRFDSDAALNHDF  261 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~  261 (433)
                      +|++||+++++++|||
T Consensus       252 ~P~~R~~~~~ll~~~~  267 (267)
T cd06645         252 NPKKRPTAEKLLQHPF  267 (267)
T ss_pred             CchhCcCHHHHhcCCC
Confidence            9999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>PTZ00266 NIMA-related protein kinase; Provisional

Probab=100.00  E-value=1.2e-34  Score=304.14  Aligned_cols=216  Identities=27%  Similarity=0.444  Sum_probs=170.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+.+|+.|+|||||+++++|.+...      ..+|||||||. ++|..++...   ...+++..++.|+.||+.
T Consensus        56 ~~~~~~EI~IL~~L~HPNIVrl~d~f~de~~------~~lyIVMEY~~gGSL~~lL~k~~~~~g~L~E~~Il~Ia~QIL~  129 (1021)
T PTZ00266         56 KSQLVIEVNVMRELKHKNIVRYIDRFLNKAN------QKLYILMEFCDAGDLSRNIQKCYKMFGKIEEHAIVDITRQLLH  129 (1021)
T ss_pred             HHHHHHHHHHHHHcCCCCcCeEEEEEEecCC------CEEEEEEeCCCCCcHHHHHHHHhhccCCCCHHHHHHHHHHHHH
Confidence            3467889999999999999999999976533      57999999997 4888887653   346899999999999999


Q ss_pred             HHHHHHhC-------CeeccCCCCCcEEEec-----------------CCcEEEeecCCccccccCcCCccccccCCccc
Q psy7889          83 GLYYIHSN-------KILHRDMKAANVLITK-----------------TGILKLADFGLARAFSQTKNGQVNRYTNRVVT  138 (433)
Q Consensus        83 aL~~LH~~-------~iiH~dikp~NIll~~-----------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt  138 (433)
                      ||.|||+.       +|+||||||+||||+.                 .+.+||+|||++..+....     .....+||
T Consensus       130 ALaYLHs~g~~~~~k~IVHRDLKPeNILL~s~~~~lg~i~~~~~n~ng~~iVKLsDFGlAr~l~~~s-----~~~s~vGT  204 (1021)
T PTZ00266        130 ALAYCHNLKDGPNGERVLHRDLKPQNIFLSTGIRHIGKITAQANNLNGRPIAKIGDFGLSKNIGIES-----MAHSCVGT  204 (1021)
T ss_pred             HHHHHHhcccccccCCceeccCcHHHeEeecCccccccccccccccCCCCceEEccCCccccccccc-----cccccCCC
Confidence            99999984       4999999999999964                 2358999999997654221     12345789


Q ss_pred             ccccCcccccCC-CCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchH
Q psy7889         139 LWYRPPELLLGD-RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKA  217 (433)
Q Consensus       139 ~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~  217 (433)
                      +.|+|||++.+. ..++.++||||||||+|+|++|.+||........+......  .+.                     
T Consensus       205 p~YmAPEvL~ge~~~~s~KSDVWSLG~ILYELLTGk~PF~~~~~~~qli~~lk~--~p~---------------------  261 (1021)
T PTZ00266        205 PYYWSPELLLHETKSYDDKSDMWALGCIIYELCSGKTPFHKANNFSQLISELKR--GPD---------------------  261 (1021)
T ss_pred             ccccCHHHHhccCCCCCchhHHHHHHHHHHHHHHCCCCCCcCCcHHHHHHHHhc--CCC---------------------
Confidence            999999998643 34789999999999999999999999876554433322111  000                     


Q ss_pred             HHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         218 QKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       218 ~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                              +.....+.++.+||..||..+|.+||++.|+|.|+|+..
T Consensus       262 --------lpi~~~S~eL~dLI~~~L~~dPeeRPSa~QlL~h~~ik~  300 (1021)
T PTZ00266        262 --------LPIKGKSKELNILIKNLLNLSAKERPSALQCLGYQIIKN  300 (1021)
T ss_pred             --------CCcCCCCHHHHHHHHHHhcCChhHCcCHHHHhccHHHhh
Confidence                    000123567789999999999999999999999999964

>cd06619 PKc_MKK5 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 5

Probab=100.00  E-value=1.3e-34  Score=273.38  Aligned_cols=215  Identities=20%  Similarity=0.279  Sum_probs=168.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|++++++++||||+++++++...        ...++||||+++......    ..+++..+..++.|++.||.||
T Consensus        44 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~----~~~~~~~~~~~~~qi~~~l~~l  111 (279)
T cd06619          44 KQIMSELEILYKCDSPYIIGFYGAFFVE--------NRISICTEFMDGGSLDVY----RKIPEHVLGRIAVAVVKGLTYL  111 (279)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEEC--------CEEEEEEecCCCCChHHh----hcCCHHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999886        568999999987544332    2478899999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |+.||+|+||||+||+++.++.++|+|||++......      ......++..|+|||++.+.. ++.++|+||+||++|
T Consensus       112 H~~~i~H~dlkp~Nill~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~~l~  184 (279)
T cd06619         112 WSLKILHRDVKPSNMLVNTRGQVKLCDFGVSTQLVNS------IAKTYVGTNAYMAPERISGEQ-YGIHSDVWSLGISFM  184 (279)
T ss_pred             HHCCEeeCCCCHHHEEECCCCCEEEeeCCcceecccc------cccCCCCChhhcCceeecCCC-CCCcchHHHHHHHHH
Confidence            9999999999999999999999999999999765432      123457789999999998765 799999999999999


Q ss_pred             HHHhcCCCCCCCChHHH---HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         168 EMWTRSPIMQGNTEQQQ---ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|++|..||........   .............                          ........+.++++||.+||.
T Consensus       185 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~li~~~l~  238 (279)
T cd06619         185 ELALGRFPYPQIQKNQGSLMPLQLLQCIVDEDP--------------------------PVLPVGQFSEKFVHFITQCMR  238 (279)
T ss_pred             HHHhCCCCchhhcccccccchHHHHHHHhccCC--------------------------CCCCCCcCCHHHHHHHHHHhh
Confidence            99999999975322110   0011111100000                          001112356678899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      .+|.+||++++++.||||.....
T Consensus       239 ~~P~~Rp~~~eil~~~~~~~~~~  261 (279)
T cd06619         239 KQPKERPAPENLMDHPFIVQYND  261 (279)
T ss_pred             CChhhCCCHHHHhcCcccccccC
Confidence            99999999999999999976543

Protein kinases (PKs), MAP kinase kinase 5 (MKK5) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK5, also referred to as MEK5, is a dual-specificity PK that p

>cd06648 STKc_PAK_II Catalytic domain of the Protein Serine/Threonine Kinase, Group II p21-activated kinase

Probab=100.00  E-value=3.7e-34  Score=271.23  Aligned_cols=218  Identities=25%  Similarity=0.431  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +..|+|+||+.+ +|.+.+..  .++++..+..++.|++.||+|
T Consensus        61 ~~~~~e~~~l~~~~h~~vv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~  130 (285)
T cd06648          61 ELLFNEVVIMRDYQHPNIVEMYSSYLVG--------DELWVVMEFLEGGALTDIVTH--TRMNEEQIATVCLAVLKALSF  130 (285)
T ss_pred             HHHHHHHHHHHHcCCCChheEEEEEEcC--------CeEEEEEeccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999998865        568999999964 78777765  468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||+|+||+++.++.++|+|||++.......    .......|+..|+|||.+.+.. ++.++||||+||++
T Consensus       131 lH~~~i~H~dl~p~Nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGv~l  205 (285)
T cd06648         131 LHAQGVIHRDIKSDSILLTSDGRVKLSDFGFCAQVSKEV----PRRKSLVGTPYWMAPEVISRLP-YGTEVDIWSLGIMV  205 (285)
T ss_pred             HHhCCeecCCCChhhEEEcCCCcEEEcccccchhhccCC----cccccccCCccccCHHHhcCCC-CCCcccHHHHHHHH
Confidence            999999999999999999999999999999876543221    1122346788999999987755 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||...+.......+....   . ....                         .+...+..+.+||.+||..+
T Consensus       206 ~ell~g~~p~~~~~~~~~~~~~~~~~---~-~~~~-------------------------~~~~~~~~l~~li~~~l~~~  256 (285)
T cd06648         206 IEMVDGEPPYFNEPPLQAMKRIRDNL---P-PKLK-------------------------NLHKVSPRLRSFLDRMLVRD  256 (285)
T ss_pred             HHHHhCCCCCcCCCHHHHHHHHHhcC---C-CCCc-------------------------ccccCCHHHHHHHHHHcccC
Confidence            99999999998876655554433211   0 0000                         01124566779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCc
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |++||++.++++|+||.....+.
T Consensus       257 p~~Rpt~~~il~~~~~~~~~~~~  279 (285)
T cd06648         257 PAQRATAAELLNHPFLAKAGPPS  279 (285)
T ss_pred             hhhCcCHHHHccCcccccCCCcc
Confidence            99999999999999998766443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group II, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. Group II PAKs, also called non-conventional PAKs, include PAK4, PAK5, and PAK6. Group II PAKs contain PBD (p21-binding domain) and catalytic domains, but lack other motifs foun

>cd05632 STKc_GRK5 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 5

Probab=100.00  E-value=3.2e-34  Score=271.64  Aligned_cols=217  Identities=26%  Similarity=0.374  Sum_probs=174.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+++|+.++|+||+.+++++...        +.+|+||||+.+ +|...+... ...+++..+..++.|++.||.
T Consensus        45 ~~~~~E~~il~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~ql~~~l~  116 (285)
T cd05632          45 SMALNEKQILEKVNSQFVVNLAYAYETK--------DALCLVLTIMNGGDLKFHIYNMGNPGFEEERALFYAAEILCGLE  116 (285)
T ss_pred             HHHHHHHHHHHHcCCcCceeEEEEEecC--------CEEEEEEEeccCccHHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        669999999985 676666543 335899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+||||||+||+++.++.++|+|||++.......     ......|+..|+|||++.+.. ++.++|+||+||+
T Consensus       117 ~lH~~~iiH~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~g~~~~~aPE~~~~~~-~~~~~Di~slG~~  190 (285)
T cd05632         117 DLHRENTVYRDLKPENILLDDYGHIRISDLGLAVKIPEGE-----SIRGRVGTVGYMAPEVLNNQR-YTLSPDYWGLGCL  190 (285)
T ss_pred             HHHhCCeeecCCCHHHEEECCCCCEEEecCCcceecCCCC-----cccCCCCCcCccChHHhcCCC-CCcccchHHHHHH
Confidence            9999999999999999999999999999999987653221     123456899999999997755 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||.+.........+...........                            +...+..+.+|+.+||+.
T Consensus       191 l~~l~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~l~~  242 (285)
T cd05632         191 IYEMIEGQSPFRGRKEKVKREEVDRRVLETEEVY----------------------------SAKFSEEAKSICKMLLTK  242 (285)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHhhhcccccc----------------------------CccCCHHHHHHHHHHccC
Confidence            9999999999988766554444433221111000                            112455677999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccCCC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~~~  266 (433)
                      ||.+||+     +.+++.|+||....
T Consensus       243 ~P~~R~~~~~~~~~~l~~~~~~~~~~  268 (285)
T cd05632         243 DPKQRLGCQEEGAGEVKRHPFFRNMN  268 (285)
T ss_pred             CHhHcCCCcccChHHHHcChhhhcCC
Confidence            9999999     89999999997653

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK5 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK5 is widely expressed in many tissues. It associates with

>cd05574 STKc_phototropin_like Catalytic domain of Phototropin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.8e-34  Score=276.05  Aligned_cols=219  Identities=28%  Similarity=0.389  Sum_probs=175.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+++++.++||||+++++.+.+.        ...|+||||+.+ +|.+++... ...+++..++.++.|++.||+
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~qi~~~l~  117 (316)
T cd05574          46 KRVLTEQEILATLDHPFLPTLYASFQTE--------TYLCLVMDYCPGGELFRLLQRQPGKCLSEEVARFYAAEVLLALE  117 (316)
T ss_pred             HHHHHHHHHHHhCCCCCchhheeeeecC--------CEEEEEEEecCCCCHHHHHHhCCCCccCHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999775        669999999975 888887653 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcc-------------------------ccccCCccccc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV-------------------------NRYTNRVVTLW  140 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~-------------------------~~~~~~~gt~~  140 (433)
                      |||++|++|+||||+||+++.++.++|+|||++...........                         .......|+..
T Consensus       118 ~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~g~~~  197 (316)
T cd05574         118 YLHLLGIVYRDLKPENILLHESGHIMLSDFDLSKQSDVEPPPVSKALRKGSRRSSVNSIPSETFSEEPSFRSNSFVGTEE  197 (316)
T ss_pred             HHHHCCeeccCCChHHeEEcCCCCEEEeecchhhcccccccccccccccccccccccccchhhhcccccCCCCCCcCccC
Confidence            99999999999999999999999999999999876532211000                         01123467889


Q ss_pred             ccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHh
Q psy7889         141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR  220 (433)
Q Consensus       141 y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (433)
                      |+|||++.+.. ++.++|||||||++|+|++|..||.+.+.......+.....     .++                   
T Consensus       198 y~aPE~~~~~~-~~~~~Di~slG~ll~~l~~g~~pf~~~~~~~~~~~~~~~~~-----~~~-------------------  252 (316)
T cd05574         198 YIAPEVISGDG-HGSAVDWWTLGILLYEMLYGTTPFKGSNRDETFSNILKKEV-----TFP-------------------  252 (316)
T ss_pred             CcCHHHHcCCC-CCchHHHHHHHHHHHHHhhCCCCCCCCchHHHHHHHhcCCc-----cCC-------------------
Confidence            99999997765 78999999999999999999999998876655544321100     000                   


Q ss_pred             hHHhhhCCccCChhHHHHHHhhcccCCCCCCC----HHHhhcCCCccCC
Q psy7889         221 KVKERLKPYVKDQYGCDLLDKLLLLDPSKRFD----SDAALNHDFFWTD  265 (433)
Q Consensus       221 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t----~~e~L~h~~~~~~  265 (433)
                            .....+.+++++|.+||..||.+|||    ++++|+||||...
T Consensus       253 ------~~~~~~~~~~~li~~~l~~~p~~R~s~~~~~~~ll~~~~~~~~  295 (316)
T cd05574         253 ------GSPPVSSSARDLIRKLLVKDPSKRLGSKRGAAEIKQHPFFRGV  295 (316)
T ss_pred             ------CccccCHHHHHHHHHHccCCHhHCCCchhhHHHHHcCchhhcC
Confidence                  00114677889999999999999999    9999999999653

Serine/Threonine Kinases (STKs), Phototropin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The phototropin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Included in this subfamily are plant phototropins and predominantly uncharacterized fungal STKs whose catalytic domains resemble the phototropin kinase domain. One protein from Neurospora crassa is called nrc-2. Phototropins are blue-light receptors that control responses such as phototropism, stromatal opening, and chloroplast movement in order to optimize the photosynthetic efficiency of plants. They are light-activated STKs that contain an N-termin

>cd06631 STKc_YSK4 Catalytic domain of the Protein Serine/Threonine Kinase, Yeast Sps1/Ste20-related kinase 4

Probab=100.00  E-value=3.6e-34  Score=268.03  Aligned_cols=216  Identities=27%  Similarity=0.447  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++|+||+++++++...        ..+++||||+.+ +|.+++.+. ..+++..+..++.|++.||+|
T Consensus        47 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~  117 (265)
T cd06631          47 EKLQEEVDLLKSLKHVNIVQYLGTCLDD--------NTISIFMEFVPGGSISSILNRF-GPLPEPVFCKYTKQILDGVAY  117 (265)
T ss_pred             HHHHHHHHHHHhcCCCCEeeEeeEeecC--------CeEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999875        669999999975 777777553 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC--CccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN--GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      ||+.||+|+||+|+||+++.++.++|+|||++........  ..........++..|+|||++.+.. ++.++|+|||||
T Consensus       118 lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~  196 (265)
T cd06631         118 LHNNCVVHRDIKGNNVMLMPNGIIKLIDFGCARRLAWVGLHGTHSNMLKSMHGTPYWMAPEVINESG-YGRKSDIWSIGC  196 (265)
T ss_pred             HHhCCcccCCcCHHhEEECCCCeEEeccchhhHhhhhccccccccccccccCCCccccChhhhcCCC-CcchhhHHHHHH
Confidence            9999999999999999999999999999999876532111  0111223446788999999987655 789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.+||...+.......+....+..+.                             .+...+.++.+||.+||.
T Consensus       197 ~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~i~~~l~  247 (265)
T cd06631         197 TVFEMATGKPPLASMDRLAAMFYIGAHRGLMPR-----------------------------LPDSFSAAAIDFVTSCLT  247 (265)
T ss_pred             HHHHHHhCCCccccCChHHHHHHhhhccCCCCC-----------------------------CCCCCCHHHHHHHHHHhc
Confidence            999999999999876655443333221111100                             011246677899999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .+|.+||++.++|.||||
T Consensus       248 ~~p~~Rp~~~~~l~~~~~  265 (265)
T cd06631         248 RDQHERPSALQLLRHDFL  265 (265)
T ss_pred             CCcccCCCHHHHhcCCCC
Confidence            999999999999999997

Serine/threonine kinases (STKs), yeast Sps1/Ste20-related kinase 4 (YSK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The YSK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. YSK4 is a putative MAPKKK, whose mammalian gene has been isolated. MAPKKKs (MKKKs or MAP3Ks) phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals.

>cd07856 STKc_Sty1_Hog1 Catalytic domain of the Serine/Threonine Kinases, Fungal Mitogen-Activated Protein Kinases Sty1 and Hog1

Probab=100.00  E-value=2.9e-34  Score=277.40  Aligned_cols=242  Identities=33%  Similarity=0.569  Sum_probs=186.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||++++++|...       ....|+||||++++|...+..  ..+++..+..++.|++.||+|
T Consensus        53 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~-------~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~aL~~  123 (328)
T cd07856          53 AKRTYRELKLLKHLRHENIISLSDIFISP-------LEDIYFVTELLGTDLHRLLTS--RPLEKQFIQYFLYQILRGLKY  123 (328)
T ss_pred             hHHHHHHHHHHHhcCCCCeeeEeeeEecC-------CCcEEEEeehhccCHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            45677899999999999999999998754       245899999999998887764  357888999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+|+||+|+||+++.++.++|+|||++.....       ......++..|+|||++.+...++.++||||+||++
T Consensus       124 LH~~~iiH~dl~p~Nili~~~~~~~l~dfg~~~~~~~-------~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG~il  196 (328)
T cd07856         124 VHSAGVVHRDLKPSNILINENCDLKICDFGLARIQDP-------QMTGYVSTRYYRAPEIMLTWQKYDVEVDIWSAGCIF  196 (328)
T ss_pred             HHhCCcccCCCCHHHEeECCCCCEEeCccccccccCC-------CcCCCcccccccCceeeeccCCcCcHHHHHHHHHHH
Confidence            9999999999999999999999999999999875432       112345678899999987645579999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh---hhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD---LYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|++|.+||.+.........+...+|.++.+.+.......   ......  ...........  ...+..+.++|.+||
T Consensus       197 ~el~tg~~~f~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~--~~~~~~~~~li~~~l  272 (328)
T cd07856         197 AEMLEGKPLFPGKDHVNQFSIITDLLGTPPDDVINTICSENTLRFVQSLP--KREPVPFSEKF--KNADPSAIDLLEKML  272 (328)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhccchhhHHHHhhcc--ccCCCcHHHHc--CCCCHHHHHHHHHHc
Confidence            99999999999988887777777777776543322111110   000000  00000000111  124678899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      +.+|++|||+++++.|+||.....+
T Consensus       273 ~~~P~~R~t~~ell~~~~~~~~~~~  297 (328)
T cd07856         273 VFDPQKRISAAEALAHPYLAPYHDP  297 (328)
T ss_pred             CCChhhCCCHHHHhcCCccccccCC
Confidence            9999999999999999999655433

Serine/Threonine Kinases (STKs), Fungal Mitogen-Activated Protein Kinase (MAPK) Sty1/Hog1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Sty1/Hog1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of the MAPKs Sty1 from Schizosaccharomyces pombe, Hog1 from Saccharomyces cerevisiae, and similar proteins. MAPKs are important mediators of cellular responses to extracellular signals. Sty1 and Hog1 are stress-activated MAPKs that partipate in transcriptional regulation in response to stress. Sty1 is activated in response to oxidative stress, osmotic stress, and U

>cd07838 STKc_CDK4_6_like Catalytic domain of Cyclin-Dependent protein Kinase 4 and 6-like Serine/Threonine Kinases

Probab=100.00  E-value=5.2e-34  Score=269.87  Aligned_cols=243  Identities=39%  Similarity=0.718  Sum_probs=185.7

Q ss_pred             CchhHHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLL   81 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll   81 (433)
                      ....+.+|+.+++++   +||||+++++++......   ....++++|||+.++|.+++.... ..+++..++.++.|++
T Consensus        41 ~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~~---~~~~~~l~~e~~~~~l~~~l~~~~~~~l~~~~~~~~~~~i~  117 (287)
T cd07838          41 IPLSTLREIALLKQLESFEHPNIVRLLDVCHGPRTD---RELKLTLVFEHVDQDLATYLSKCPKPGLPPETIKDLMRQLL  117 (287)
T ss_pred             hhhhHHHHHHHHHHhhccCCCCcceEEEEEeeccCC---CCceeEEEehhcccCHHHHHHHccCCCCCHHHHHHHHHHHH
Confidence            345677899888877   599999999999876321   123589999999999988886643 3589999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||.|||+.|++|+||+|+||+++.++.++|+|||++..+....     ......++..|+|||++.+.. ++.++|+||
T Consensus       118 ~al~~LH~~~i~h~~l~~~nili~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~s  191 (287)
T cd07838         118 RGVDFLHSHRIVHRDLKPQNILVTSDGQVKIADFGLARIYSFEM-----ALTSVVVTLWYRAPEVLLQSS-YATPVDMWS  191 (287)
T ss_pred             HHHHHHHHCCeeeccCChhhEEEccCCCEEEeccCcceeccCCc-----ccccccccccccChHHhccCC-CCCcchhhh
Confidence            99999999999999999999999999999999999987764321     122335688899999997765 789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++++|++|.+||.+.+..+.+..+....+......|+.........   .+...........  ...+..+.++|.+
T Consensus       192 ~G~~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~--~~~~~~~~~li~~  266 (287)
T cd07838         192 VGCIFAELFRRRPLFRGTSEADQLDKIFDVIGLPSEEEWPRNVSLPRSS---FPSYTPRSFKSFV--PEICEEGLDLLKK  266 (287)
T ss_pred             HHHHHHHHHhCCCcccCCChHHHHHHHHHHcCCCChHhcCCCcccchhh---cccccccchhhhh--hhhhHHHHHHHHH
Confidence            9999999999999999999888888887766655444333222110000   0000000000000  1235778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCc
Q psy7889         242 LLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ||..||.+||++++++.||||
T Consensus       267 ~l~~dp~~Rp~~~~il~~~~~  287 (287)
T cd07838         267 MLTFNPHKRISAFEALQHPYF  287 (287)
T ss_pred             HhccCCccCCCHHHHhcCcCC
Confidence            999999999999999999997

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) and CDK6-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4/6-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 and CDK6 partner with D-type cyclins to regulate the early G1 phase of the cell cycle. They are the first kinase activated by mitogenic signals to release cells from the G0 arrested state. CDK4 and CDK6 are both

>cd06609 STKc_MST3_like Catalytic domain of Mammalian Ste20-like protein kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.3e-34  Score=268.35  Aligned_cols=217  Identities=24%  Similarity=0.365  Sum_probs=176.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|+||+++++++.+.        ..+|+|+||+.+ +|.+.+...  .+++..++.++.|++.||.|
T Consensus        44 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~--~~~~~~~~~~~~ql~~~l~~  113 (274)
T cd06609          44 EDIQQEIQFLSQCRSPYITKYYGSFLKG--------SKLWIIMEYCGGGSCLDLLKPG--KLDETYIAFILREVLLGLEY  113 (274)
T ss_pred             HHHHHHHHHHHHcCCCCeeeeeEEEEEC--------CeEEEEEEeeCCCcHHHHHhhc--CCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        569999999975 787777653  68999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++||||+||++
T Consensus       114 lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~-~~~~sDv~slG~il  188 (274)
T cd06609         114 LHEEGKIHRDIKAANILLSEEGDVKLADFGVSGQLTSTM----SKRNTFVGTPFWMAPEVIKQSG-YDEKADIWSLGITA  188 (274)
T ss_pred             HHhCCcccCCCCHHHEEECCCCCEEEcccccceeecccc----cccccccCCccccChhhhccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999998765332    1223456788899999998766 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||...+.......+......    ..                          .....+.++.++|.+||..+
T Consensus       189 ~~l~tg~~p~~~~~~~~~~~~~~~~~~~----~~--------------------------~~~~~~~~~~~~l~~~l~~~  238 (274)
T cd06609         189 IELAKGEPPLSDLHPMRVLFLIPKNNPP----SL--------------------------EGNKFSKPFKDFVSLCLNKD  238 (274)
T ss_pred             HHHHhCCCCcccCchHHHHHHhhhcCCC----CC--------------------------cccccCHHHHHHHHHHhhCC
Confidence            9999999999876654443333221100    00                          00014556779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCc
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |++|||++++++||||.......
T Consensus       239 p~~Rpt~~~il~~~~~~~~~~~~  261 (274)
T cd06609         239 PKERPSAKELLKHKFIKKAKKTS  261 (274)
T ss_pred             hhhCcCHHHHhhChhhcCCCccc
Confidence            99999999999999998765543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of MST3, MST4, STK25, Schizosaccharomyces pombe Nak1 and Sid1, Saccharomyces cerevisiae sporulation-specific protein 1 (SPS1), and related proteins. Nak1 is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Sid1 is a component in the septation initiation network (SIN)

>KOG0586|consensus

Probab=100.00  E-value=2.1e-35  Score=286.67  Aligned_cols=211  Identities=29%  Similarity=0.464  Sum_probs=180.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +..-+|+++|+.|+|||||+++.++...        ..+|+||||+. |.+.+++.+. +++.+.+++.++.|++.|++|
T Consensus       100 ~k~~rev~imk~l~HPnIvkl~~v~~t~--------~~lylV~eya~~ge~~~yl~~~-gr~~e~~ar~~F~q~vsaveY  170 (596)
T KOG0586|consen  100 QKLGREVDIMKSLNHPNIVKLFSVIETE--------ATLYLVMEYASGGELFDYLVKH-GRMKEKEARAKFRQIVSAVEY  170 (596)
T ss_pred             HHHHHHHHHHHhcCCcceeeeeeeeeec--------ceeEEEEEeccCchhHHHHHhc-ccchhhhhhhhhHHHHHHHHH
Confidence            3468999999999999999999999987        66999999996 5788888874 477889999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+++|+|||||.+|||++.+-.+||+|||++.++..+     ....+.||++.|.|||++.+....++.+|+||+|+++
T Consensus       171 cH~k~ivHrdLk~eNilL~~~mnikIaDfgfS~~~~~~-----~~lqt~cgsppyAaPEl~~g~~y~gpe~D~Wslgvvl  245 (596)
T KOG0586|consen  171 CHSKNIVHRDLKAENILLDENMNIKIADFGFSTFFDYG-----LMLQTFCGSPPYAAPELFNGKKYDGPEVDIWSLGVVL  245 (596)
T ss_pred             Hhhcceeccccchhhcccccccceeeeccccceeeccc-----ccccccCCCCCccChHhhcCcccCCcceehhhhhhhh
Confidence            99999999999999999999999999999999988643     2356789999999999999988789999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |.|++|..||.|.+-.+.....                   ...++.             .++.++.++.++|+++|..+
T Consensus       246 y~LV~GsLPFDG~~lk~Lr~rv-------------------l~gk~r-------------Ip~~ms~dce~lLrk~lvl~  293 (596)
T KOG0586|consen  246 YALVEGSLPFDGQNLKELRPRV-------------------LRGKYR-------------IPFYMSCDCEDLLRKFLVLN  293 (596)
T ss_pred             eeeeecccccCCcccccccchh-------------------eeeeec-------------ccceeechhHHHHHHhhccC
Confidence            9999999999986533211111                   111111             23457888999999999999


Q ss_pred             CCCCCCHHHhhcCCCccC
Q psy7889         247 PSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~  264 (433)
                      |.+|++.++++.|.|...
T Consensus       294 Pskr~~~dqim~~~W~n~  311 (596)
T KOG0586|consen  294 PSKRGPCDQIMKDRWRND  311 (596)
T ss_pred             ccccCCHHHhhhhcccch
Confidence            999999999999999853

>cd06613 STKc_MAP4K3_like Catalytic domain of Mitogen-activated protein kinase kinase kinase kinase-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.8e-34  Score=266.45  Aligned_cols=215  Identities=27%  Similarity=0.411  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++...        ..+|+||||+++ +|..++......+++..++.++.|++.||.|
T Consensus        45 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~l~~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~  116 (262)
T cd06613          45 EIIQQEISMLKECRHPNIVAYFGSYLRR--------DKLWIVMEYCGGGSLQDIYQVTRGPLSELQIAYVCRETLKGLAY  116 (262)
T ss_pred             HHHHHHHHHHHhCCCCChhceEEEEEeC--------CEEEEEEeCCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHH
Confidence            5688999999999999999999998775        669999999986 6777776654679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv  164 (433)
                      ||++||+|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.  ..++.++|+||+||
T Consensus       117 lh~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~y~~Pe~~~~~~~~~~~~~~Di~slG~  192 (262)
T cd06613         117 LHETGKIHRDIKGANILLTEDGDVKLADFGVSAQLTATI----AKRKSFIGTPYWMAPEVAAVERKGGYDGKCDIWALGI  192 (262)
T ss_pred             HHhCCceecCCChhhEEECCCCCEEECccccchhhhhhh----hccccccCCccccCchhhcccccCCcCchhhhHHHHH
Confidence            999999999999999999999999999999987654321    112334678889999998665  13688999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.+||.+.+.......+....  ..+....                         .....+.++.+||.+||.
T Consensus       193 ~l~~~~tg~~p~~~~~~~~~~~~~~~~~--~~~~~~~-------------------------~~~~~~~~~~~li~~~l~  245 (262)
T cd06613         193 TAIELAELQPPMFDLHPMRALFLISKSN--FPPPKLK-------------------------DKEKWSPVFHDFIKKCLT  245 (262)
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhcc--CCCcccc-------------------------chhhhhHHHHHHHHHHcC
Confidence            9999999999999877665544433210  0000000                         001134567799999999


Q ss_pred             cCCCCCCCHHHhhcCCC
Q psy7889         245 LDPSKRFDSDAALNHDF  261 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~  261 (433)
                      .+|..|||+++++.|+|
T Consensus       246 ~~p~~Rpt~~~il~~~~  262 (262)
T cd06613         246 KDPKKRPTATKLLQHPF  262 (262)
T ss_pred             CChhhCCCHHHHhcCCC
Confidence            99999999999999998

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 3 (MAPKKKK3 or MAP4K3)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily includes MAP4K3, MAP4K1, MAP4K2, MAP4K5, and related proteins. Vertebrate members contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activ

>cd06622 PKc_MAPKK_PBS2_like Catalytic domain of fungal PBS2-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=4.4e-34  Score=270.60  Aligned_cols=217  Identities=20%  Similarity=0.307  Sum_probs=172.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc--CCCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI--HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~--~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+|++++++++||||+++++.+...        +.+|+||||+++ +|..++...  ...+++..+..++.|++.||
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~i~~~l  115 (286)
T cd06622          44 NQIIMELDILHKAVSPYIVDFYGAFFIE--------GAVYMCMEYMDAGSLDKLYAGGVATEGIPEDVLRRITYAVVKGL  115 (286)
T ss_pred             HHHHHHHHHHHhcCCCcHHhhhhheecC--------CeEEEEEeecCCCCHHHHHHhccccCCCCHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999875        669999999986 676666543  23689999999999999999


Q ss_pred             HHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-----CCCCcch
Q psy7889          85 YYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-----NYGPPVD  158 (433)
Q Consensus        85 ~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~D  158 (433)
                      .|||+ .||+|+||||+||+++.++.++|+|||++..+...      ......++..|+|||.+.+..     .++.++|
T Consensus       116 ~~LH~~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~D  189 (286)
T cd06622         116 KFLKEEHNIIHRDVKPTNVLVNGNGQVKLCDFGVSGNLVAS------LAKTNIGCQSYMAPERIKSGGPNQNPTYTVQSD  189 (286)
T ss_pred             HHHHhcCCEeeCCCCHHHEEECCCCCEEEeecCCcccccCC------ccccCCCccCccCcchhcCCCCCccCCCCcccc
Confidence            99996 59999999999999999999999999998765322      122345788899999985432     2578999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |||+||++|+|++|..||...........+........+..                            +...+.++.+|
T Consensus       190 iwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~l  241 (286)
T cd06622         190 VWSLGLSILEMALGRYPYPPETYANIFAQLSAIVDGDPPTL----------------------------PSGYSDDAQDF  241 (286)
T ss_pred             hHhHHHHHHHHHhCCCCCCCcchhhHHHHHHHHhhcCCCCC----------------------------CcccCHHHHHH
Confidence            99999999999999999987654443333333222111110                            11246677899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+||..+|++||+++++++||||....
T Consensus       242 i~~~l~~~p~~Rp~~~~l~~~~~~~~~~  269 (286)
T cd06622         242 VAKCLNKIPNRRPTYAQLLEHPWLVKYK  269 (286)
T ss_pred             HHHHcccCcccCCCHHHHhcChhhhhcc
Confidence            9999999999999999999999996654

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal PBS2-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd06610 STKc_OSR1_SPAK Catalytic domain of the Protein Serine/Threonine Kinases, Oxidative stress response kinase and Ste20-related proline alanine-rich kinase

Probab=100.00  E-value=4.3e-34  Score=267.42  Aligned_cols=221  Identities=24%  Similarity=0.348  Sum_probs=175.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC--CCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH--VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~--~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+|+++++.++|+||+++++.+...        ..+|+|||++.+ +|.+++....  ..+++..++.++.|++.||
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~iv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~ql~~al  115 (267)
T cd06610          44 DELRKEVQAMSQCNHPNVVKYYTSFVVG--------DELWLVMPYLSGGSLLDIMKSSYPRGGLDEAIIATVLKEVLKGL  115 (267)
T ss_pred             HHHHHHHHHHHhcCCCCEEEEEEEEeeC--------CEEEEEEeccCCCcHHHHHHHhcccCCCCHHHHHHHHHHHHHHH
Confidence            5678999999999999999999998875        668999999975 7777776542  3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++|++|+||+|+||+++.++.++|+|||++..+...............++..|+|||++.....++.++|+||+||
T Consensus       116 ~~lh~~~i~h~~l~p~ni~~~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~y~~Pe~~~~~~~~~~~~Dv~slG~  195 (267)
T cd06610         116 EYLHSNGQIHRDIKAGNILLGEDGSVKIADFGVSASLADGGDRTRKVRKTFVGTPCWMAPEVMEQVHGYDFKADIWSFGI  195 (267)
T ss_pred             HHHHhCCeecCCCCHHhEEEcCCCCEEEcccchHHHhccCccccccccccccCChhhcChHHHccccCcCcccchHhHhH
Confidence            99999999999999999999999999999999997765433221112234467889999999877645789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||...+.......+..   ...+ .+....                      .....+...++++.+||.
T Consensus       196 i~~~l~~g~~p~~~~~~~~~~~~~~~---~~~~-~~~~~~----------------------~~~~~~~~~~~li~~~l~  249 (267)
T cd06610         196 TAIELATGAAPYSKYPPMKVLMLTLQ---NDPP-SLETGA----------------------DYKKYSKSFRKMISLCLQ  249 (267)
T ss_pred             HHHHHHhCCCCccccChhhhHHHHhc---CCCC-CcCCcc----------------------ccccccHHHHHHHHHHcC
Confidence            99999999999987665543333222   1110 000000                      001245677899999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .||.+||++++++.||||
T Consensus       250 ~~p~~Rp~~~~ll~~p~~  267 (267)
T cd06610         250 KDPSKRPTAEELLKHKFF  267 (267)
T ss_pred             CChhhCcCHHHHhhCCCC
Confidence            999999999999999998

Serine/threonine kinases (STKs), oxidative stress response kinase (OSR1) and Ste20-related proline alanine-rich kinase (SPAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The OSR1 and SPAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. SPAK is also referred to as STK39 or PASK (proline-alanine-rich STE20-related kinase). OSR1 and SPAK regulate the activity of cation-chloride cotransporters through direct interaction and phosphorylation. They are also implicated in cytoskeletal rearrangement, cell differentiation, transformation and proliferation. OSR1

>KOG0986|consensus

Probab=100.00  E-value=4.9e-35  Score=273.70  Aligned_cols=217  Identities=25%  Similarity=0.346  Sum_probs=178.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      +.-++.|-.||.+++.++||.|-..|+++        +.+|+||..|.| ||.--+.+.. ..|+++.+..++.+|+.||
T Consensus       229 e~maLnEk~iL~kV~s~FiVslaYAfeTk--------d~LClVLtlMNGGDLkfHiyn~g~~gF~e~ra~FYAAEi~cGL  300 (591)
T KOG0986|consen  229 ETMALNEKQILEKVSSPFIVSLAYAFETK--------DALCLVLTLMNGGDLKFHIYNHGNPGFDEQRARFYAAEIICGL  300 (591)
T ss_pred             hHHhhHHHHHHHHhccCcEEEEeeeecCC--------CceEEEEEeecCCceeEEeeccCCCCCchHHHHHHHHHHHhhH
Confidence            45678999999999999999999999987        669999999985 6655555543 3599999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      ++||+++||+||+||+|||+|+.|+++|+|+|+|..+..++     +...++||..|||||++.+.. |+.++|+|||||
T Consensus       301 ehlH~~~iVYRDLKPeNILLDd~GhvRISDLGLAvei~~g~-----~~~~rvGT~GYMAPEvl~ne~-Y~~s~Dwf~lGC  374 (591)
T KOG0986|consen  301 EHLHRRRIVYRDLKPENILLDDHGHVRISDLGLAVEIPEGK-----PIRGRVGTVGYMAPEVLQNEV-YDFSPDWFSLGC  374 (591)
T ss_pred             HHHHhcceeeccCChhheeeccCCCeEeeccceEEecCCCC-----ccccccCcccccCHHHHcCCc-ccCCccHHHHHh
Confidence            99999999999999999999999999999999999887654     345669999999999999887 999999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||+.|..||.....-.....+.+..-..                           ...+ +..+|+++++|...+|.
T Consensus       375 llYemi~G~sPFr~~KeKvk~eEvdrr~~~~---------------------------~~ey-~~kFS~eakslc~~LL~  426 (591)
T KOG0986|consen  375 LLYEMIAGHSPFRQRKEKVKREEVDRRTLED---------------------------PEEY-SDKFSEEAKSLCEGLLT  426 (591)
T ss_pred             HHHHHHcccCchhhhhhhhhHHHHHHHHhcc---------------------------hhhc-ccccCHHHHHHHHHHHc
Confidence            9999999999998654332222222111000                           0001 13478999999999999


Q ss_pred             cCCCCCC-----CHHHhhcCCCccCC
Q psy7889         245 LDPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      .||.+|.     +++++-+||||+..
T Consensus       427 Kdp~~RLGcrg~ga~evk~HpfFk~l  452 (591)
T KOG0986|consen  427 KDPEKRLGCRGEGAQEVKEHPFFKDL  452 (591)
T ss_pred             cCHHHhccCCCcCcchhhhCcccccC
Confidence            9999997     45799999999763

>KOG0690|consensus

Probab=100.00  E-value=2.2e-35  Score=265.52  Aligned_cols=211  Identities=28%  Similarity=0.392  Sum_probs=177.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.|-.+|+..+||.+..|...|+..        +++|+||||..| .|+--+.. ...|++...+.+-.+|+.||.|
T Consensus       213 AHTlTE~RVL~~~~HPFLt~LKYsFQt~--------drlCFVMeyanGGeLf~HLsr-er~FsE~RtRFYGaEIvsAL~Y  283 (516)
T KOG0690|consen  213 AHTLTENRVLQNCRHPFLTSLKYSFQTQ--------DRLCFVMEYANGGELFFHLSR-ERVFSEDRTRFYGAEIVSALGY  283 (516)
T ss_pred             hhhhhHHHHHHhccCcHHHHhhhhhccC--------ceEEEEEEEccCceEeeehhh-hhcccchhhhhhhHHHHHHhhh
Confidence            4567899999999999999999999886        789999999976 45544443 3358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+++||+||+|.+|+|++.+|++||.|||+++.--.    .-....++|||+.|+|||++-.. .|+.++|+|-+||++
T Consensus       284 LHs~~ivYRDlKLENLlLDkDGHIKitDFGLCKE~I~----~g~t~kTFCGTPEYLAPEVleDn-DYgraVDWWG~GVVM  358 (516)
T KOG0690|consen  284 LHSRNIVYRDLKLENLLLDKDGHIKITDFGLCKEEIK----YGDTTKTFCGTPEYLAPEVLEDN-DYGRAVDWWGVGVVM  358 (516)
T ss_pred             hhhCCeeeeechhhhheeccCCceEeeecccchhccc----ccceeccccCChhhcCchhhccc-cccceeehhhhhHHH
Confidence            9999999999999999999999999999999976321    12346789999999999998654 589999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |||++|+.||...+.......|...-                                .--|...+++++.|+..+|.+|
T Consensus       359 YEMmCGRLPFyn~dh~kLFeLIl~ed--------------------------------~kFPr~ls~eAktLLsGLL~kd  406 (516)
T KOG0690|consen  359 YEMMCGRLPFYNKDHEKLFELILMED--------------------------------LKFPRTLSPEAKTLLSGLLKKD  406 (516)
T ss_pred             HHHHhccCcccccchhHHHHHHHhhh--------------------------------ccCCccCCHHHHHHHHHHhhcC
Confidence            99999999999988777666553311                                0113347899999999999999


Q ss_pred             CCCCCC-----HHHhhcCCCccC
Q psy7889         247 PSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t-----~~e~L~h~~~~~  264 (433)
                      |.+|..     +.|+.+|+||..
T Consensus       407 P~kRLGgGpdDakEi~~h~FF~~  429 (516)
T KOG0690|consen  407 PKKRLGGGPDDAKEIMRHRFFAS  429 (516)
T ss_pred             hHhhcCCCchhHHHHHhhhhhcc
Confidence            999974     699999999964

>KOG0614|consensus

Probab=100.00  E-value=1.2e-35  Score=280.83  Aligned_cols=213  Identities=25%  Similarity=0.406  Sum_probs=186.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+..|-+||..++.|+||+||..|.++        ..+|++||-|- |.++..++. ++.|.+..++.++..+++|++
T Consensus       464 qeHv~sEr~Im~~~~s~fIvrLYrTfrd~--------kyvYmLmEaClGGElWTiLrd-Rg~Fdd~tarF~~acv~EAfe  534 (732)
T KOG0614|consen  464 QEHVFSERNIMMECRSDFIVRLYRTFRDS--------KYVYMLMEACLGGELWTILRD-RGSFDDYTARFYVACVLEAFE  534 (732)
T ss_pred             HHHHHhHHHHHHhcCchHHHHHHHHhccc--------hhhhhhHHhhcCchhhhhhhh-cCCcccchhhhhHHHHHHHHH
Confidence            45677899999999999999999999987        66999999985 589998887 457999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|||+|||||+|++++.+|-+||.|||+|+.+..+.     ...++|||+.|.|||++..+. .+.++|.||||++
T Consensus       535 YLH~k~iIYRDLKPENllLd~~Gy~KLVDFGFAKki~~g~-----KTwTFcGTpEYVAPEIILnKG-HD~avDyWaLGIl  608 (732)
T KOG0614|consen  535 YLHRKGIIYRDLKPENLLLDNRGYLKLVDFGFAKKIGSGR-----KTWTFCGTPEYVAPEIILNKG-HDRAVDYWALGIL  608 (732)
T ss_pred             HHHhcCceeccCChhheeeccCCceEEeehhhHHHhccCC-----ceeeecCCcccccchhhhccC-cchhhHHHHHHHH
Confidence            9999999999999999999999999999999999987553     456889999999999999876 5999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|||++|.|||.+.+++.+...|.+.+..                 +.+|             ...+..+.+||.++...
T Consensus       609 i~ELL~G~pPFs~~dpmktYn~ILkGid~-----------------i~~P-------------r~I~k~a~~Lik~LCr~  658 (732)
T KOG0614|consen  609 IYELLTGSPPFSGVDPMKTYNLILKGIDK-----------------IEFP-------------RRITKTATDLIKKLCRD  658 (732)
T ss_pred             HHHHHcCCCCCCCCchHHHHHHHHhhhhh-----------------hhcc-------------cccchhHHHHHHHHHhc
Confidence            99999999999999999999888664321                 1111             12445667999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~  264 (433)
                      +|.+|..     ..++-.|.||..
T Consensus       659 ~P~ERLG~~~~gI~DIkkH~Wf~g  682 (732)
T KOG0614|consen  659 NPTERLGYQKGGINDIKKHRWFEG  682 (732)
T ss_pred             CcHhhhccccCChHHHHhhhhhhc
Confidence            9999986     799999999954

>cd07880 STKc_p38gamma_MAPK12 Catalytic domain of the Serine/Threonine Kinase, p38gamma Mitogen-Activated Protein Kinase

Probab=100.00  E-value=3.1e-34  Score=278.91  Aligned_cols=245  Identities=35%  Similarity=0.594  Sum_probs=184.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++..+...  .....+++||||++++|...+..  ..+++..++.++.||+.||+||
T Consensus        59 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~i~~qi~~al~~L  134 (343)
T cd07880          59 KRAYRELRLLKHMKHENVIGLLDVFTPDLSL--DRFHDFYLVMPFMGTDLGKLMKH--EKLSEDRIQFLVYQMLKGLKYI  134 (343)
T ss_pred             HHHHHHHHHHHhcCCCCccceeeeecCCccc--cccceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999765321  11245799999998888877754  3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.++|+|||++......       .....++..|+|||.+.+...++.++|+||+||+++
T Consensus       135 H~~gi~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~ll~  207 (343)
T cd07880         135 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQTDSE-------MTGYVVTRWYRAPEVILNWMHYTQTVDIWSVGCIMA  207 (343)
T ss_pred             HhCCeecCCCCHHHEEEcCCCCEEEeecccccccccC-------ccccccCCcccCHHHHhCCCCCCcHHHHHHHHHHHH
Confidence            9999999999999999999999999999998765321       123456888999999876445789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-ccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.........+....+..+.+.+............ ..+..........  ....+.++.++|.+||..|
T Consensus       208 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~l~~d  285 (343)
T cd07880         208 EMLTGKPLFKGHDHLDQLMEIMKVTGTPSKEFVQKLQSEDAKNYVKKLPRFRKKDFRSL--LPNANPLAVNVLEKMLVLD  285 (343)
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhhcchhHHHHHHhccccCcchHHHh--ccCCChHHHHHHHHHcCCC
Confidence            999999999988887777777665554432221111111000000 0000000000000  1135677889999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |++|||+.+++.||||...
T Consensus       286 P~~R~t~~~~l~~~~~~~~  304 (343)
T cd07880         286 AESRITAAEALAHPYFEEF  304 (343)
T ss_pred             hhhCCCHHHHhcCccHhhh
Confidence            9999999999999999654

Serine/Threonine Kinases (STKs), p38gamma subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38gamma subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38gamma, also called MAPK12

>cd06651 STKc_MEKK3 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 3

Probab=100.00  E-value=5.9e-34  Score=266.92  Aligned_cols=215  Identities=27%  Similarity=0.437  Sum_probs=167.9

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||+++++++.+..      ...+++||||+++ +|.+.+... ..+++..++.++.|++.||.||
T Consensus        50 ~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~~l~~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~L  122 (266)
T cd06651          50 ALECEIQLLKNLQHERIVQYYGCLRDRA------EKTLTIFMEYMPGGSVKDQLKAY-GALTESVTRKYTRQILEGMSYL  122 (266)
T ss_pred             HHHHHHHHHHHcCCCCeeeEEEEEEcCC------CCEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999987642      2568999999975 788777653 3589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+|+||+|+||+++.++.++|+|||++......... ........++..|+|||.+.+.. ++.++||||+||++|
T Consensus       123 H~~~i~H~~l~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i~~  200 (266)
T cd06651         123 HSNMIVHRDIKGANILRDSAGNVKLGDFGASKRLQTICMS-GTGIRSVTGTPYWMSPEVISGEG-YGRKADVWSLGCTVV  200 (266)
T ss_pred             HhCCeeeCCCCHHHEEECCCCCEEEccCCCcccccccccc-CCccccCCccccccCHHHhCCCC-CCchhhhHHHHHHHH
Confidence            9999999999999999999999999999998765421111 11122345788899999987754 789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|.+||........+..+.   .......+                           +...+..+.++| +||..+|
T Consensus       201 el~~g~~pf~~~~~~~~~~~~~---~~~~~~~~---------------------------~~~~~~~~~~li-~~~~~~p  249 (266)
T cd06651         201 EMLTEKPPWAEYEAMAAIFKIA---TQPTNPQL---------------------------PSHISEHARDFL-GCIFVEA  249 (266)
T ss_pred             HHHHCCCCccccchHHHHHHHh---cCCCCCCC---------------------------chhcCHHHHHHH-HHhcCCh
Confidence            9999999998765444333221   11110000                           112455667888 5677899


Q ss_pred             CCCCCHHHhhcCCCcc
Q psy7889         248 SKRFDSDAALNHDFFW  263 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~~  263 (433)
                      ++||+++|+++||||.
T Consensus       250 ~~Rp~~~eil~hp~~~  265 (266)
T cd06651         250 RHRPSAEELLRHPFAQ  265 (266)
T ss_pred             hhCcCHHHHhcCcccc
Confidence            9999999999999994

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK3 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK3 plays an essential role in embryonic angiogenesis and early heart development

>KOG4721|consensus

Probab=100.00  E-value=2.1e-35  Score=282.58  Aligned_cols=207  Identities=24%  Similarity=0.357  Sum_probs=168.5

Q ss_pred             HHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7889          11 LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHS   89 (433)
Q Consensus        11 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~   89 (433)
                      -.+|+.|++|+|||||.+.++|...        ..+|||||||. |.|..+++..+ .++......|..+|+.|+.|||.
T Consensus       160 ETdIKHLRkLkH~NII~FkGVCtqs--------PcyCIiMEfCa~GqL~~VLka~~-~itp~llv~Wsk~IA~GM~YLH~  230 (904)
T KOG4721|consen  160 ETDIKHLRKLKHPNIITFKGVCTQS--------PCYCIIMEFCAQGQLYEVLKAGR-PITPSLLVDWSKGIAGGMNYLHL  230 (904)
T ss_pred             hhhHHHHHhccCcceeeEeeeecCC--------ceeEEeeeccccccHHHHHhccC-ccCHHHHHHHHHHhhhhhHHHHH
Confidence            3578999999999999999999986        77999999997 67888887754 67888899999999999999999


Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHH
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM  169 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el  169 (433)
                      +.|||||||.-||||+.+..|||+|||-++.+..-     ...-.++||..|||||+|...+ .+.++||||+|||||||
T Consensus       231 hKIIHRDLKSPNiLIs~~d~VKIsDFGTS~e~~~~-----STkMSFaGTVaWMAPEvIrneP-csEKVDIwSfGVVLWEm  304 (904)
T KOG4721|consen  231 HKIIHRDLKSPNILISYDDVVKISDFGTSKELSDK-----STKMSFAGTVAWMAPEVIRNEP-CSEKVDIWSFGVVLWEM  304 (904)
T ss_pred             hhHhhhccCCCceEeeccceEEeccccchHhhhhh-----hhhhhhhhhHhhhCHHHhhcCC-cccccceehhHHHHHHH
Confidence            99999999999999999999999999999876532     2334679999999999999877 69999999999999999


Q ss_pred             HhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCC
Q psy7889         170 WTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK  249 (433)
Q Consensus       170 l~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  249 (433)
                      |||..||...+...    |....|....                          .+.-|..-+..++-||..|++-.|..
T Consensus       305 LT~EiPYkdVdssA----IIwGVGsNsL--------------------------~LpvPstcP~GfklL~Kqcw~sKpRN  354 (904)
T KOG4721|consen  305 LTGEIPYKDVDSSA----IIWGVGSNSL--------------------------HLPVPSTCPDGFKLLLKQCWNSKPRN  354 (904)
T ss_pred             HhcCCCccccchhe----eEEeccCCcc--------------------------cccCcccCchHHHHHHHHHHhcCCCC
Confidence            99999998765432    2111221100                          00011112344557899999999999


Q ss_pred             CCCHHHhhcCCCc
Q psy7889         250 RFDSDAALNHDFF  262 (433)
Q Consensus       250 R~t~~e~L~h~~~  262 (433)
                      ||+..++|.|--+
T Consensus       355 RPSFrqil~HldI  367 (904)
T KOG4721|consen  355 RPSFRQILLHLDI  367 (904)
T ss_pred             CccHHHHHHHHhh
Confidence            9999999999544

>cd08221 STKc_Nek9 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 9

Probab=100.00  E-value=1.1e-33  Score=263.40  Aligned_cols=211  Identities=29%  Similarity=0.469  Sum_probs=175.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.++++++|+||+++++++...        ..+++||||+. ++|.+.+... ...+++..+..++.|++.||.
T Consensus        44 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~~~~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  115 (256)
T cd08221          44 RDALNEIVILSLLQHPNIIAYYNHFMDD--------NTLLIEMEYANGGTLYDKIVRQKGQLFEEEMVLWYLFQIVSAVS  115 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEeEEecC--------CeEEEEEEecCCCcHHHHHHhccccCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875        66999999997 5888888664 345899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||+|+||+++.++.+||+|||++........    ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       116 ~lh~~~i~h~dl~p~ni~~~~~~~~kl~d~~~~~~~~~~~~----~~~~~~~~~~y~ape~~~~~~-~~~~~Dv~slG~i  190 (256)
T cd08221         116 YIHKAGILHRDIKTLNIFLTKAGLIKLGDFGISKILGSEYS----MAETVVGTPYYMSPELCQGVK-YNFKSDIWALGCV  190 (256)
T ss_pred             HHHhCCccccCCChHhEEEeCCCCEEECcCcceEEcccccc----cccccCCCccccCHhhcCCCC-CCCcchhHHHHHH
Confidence            99999999999999999999999999999999876643221    223456789999999987655 7889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||.+....+....+..  +...+.                             +...+.++.++|.+||..
T Consensus       191 ~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~~-----------------------------~~~~~~~~~~~i~~~l~~  239 (256)
T cd08221         191 LYELLTLKRTFDATNPLNLVVKIVQ--GNYTPV-----------------------------VSVYSSELISLVHSLLQQ  239 (256)
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHc--CCCCCC-----------------------------ccccCHHHHHHHHHHccc
Confidence            9999999999988776665555432  111110                             012456677999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|.+||+++++|+|+|+
T Consensus       240 ~p~~R~s~~~ll~~~~l  256 (256)
T cd08221         240 DPEKRPTADEVLDQPLL  256 (256)
T ss_pred             CcccCCCHHHHhhCcCC
Confidence            99999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 9 (Nek9) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek9 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek9, also called Nercc1, is primarily a cytoplasmic protein but can also localize in the nucleus. It is involved in modulating chromosome alignment and splitting during mitosis. It interacts with the gamma-tubulin ring complex and the Ran GTPase, and is implicated in microtubule organization. Nek9 associa

>cd06654 STKc_PAK1 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 1

Probab=100.00  E-value=9.2e-34  Score=269.98  Aligned_cols=215  Identities=25%  Similarity=0.461  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++.+...        ...|+||||+.+ +|..++.+  ..+++.++..++.|++.||.|
T Consensus        62 ~~~~~e~~~l~~~~h~~v~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~ql~~aL~~  131 (296)
T cd06654          62 ELIINEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALEF  131 (296)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEeC--------CEEEEeecccCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHHH
Confidence            5678899999999999999999999875        569999999974 78877754  357899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+|+||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++||||+||++
T Consensus       132 LH~~gi~H~dLkp~Nill~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~s~Gvil  206 (296)
T cd06654         132 LHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMA  206 (296)
T ss_pred             HHHCCcccCCCCHHHEEEcCCCCEEECccccchhccccc----cccCcccCCccccCHHHHcCCC-CCccchHHHHHHHH
Confidence            999999999999999999999999999999987654221    1122346788999999987654 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||...........+.. .+.+...                            .+...+..+.++|.+||..+
T Consensus       207 ~~l~~g~~pf~~~~~~~~~~~~~~-~~~~~~~----------------------------~~~~~~~~l~~li~~~l~~~  257 (296)
T cd06654         207 IEMIEGEPPYLNENPLRALYLIAT-NGTPELQ----------------------------NPEKLSAIFRDFLNRCLDMD  257 (296)
T ss_pred             HHHHhCCCCCCCCCHHHhHHHHhc-CCCCCCC----------------------------CccccCHHHHHHHHHHCcCC
Confidence            999999999987765443332211 1110000                            01123456779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||+.++++|+||....
T Consensus       258 p~~Rpt~~eil~~~~~~~~~  277 (296)
T cd06654         258 VEKRGSAKELLQHQFLKIAK  277 (296)
T ss_pred             cccCcCHHHHhhChhhhccC
Confidence            99999999999999997643

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 1, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK1 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06659 STKc_PAK6 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 6

Probab=100.00  E-value=4.1e-34  Score=272.55  Aligned_cols=220  Identities=25%  Similarity=0.463  Sum_probs=176.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        +..|+||||+++ +|...+..  ..+++..++.++.|++.||.
T Consensus        62 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--------~~~~iv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~  131 (297)
T cd06659          62 RELLFNEVVIMRDYQHQNVVEMYKSYLVG--------EELWVLMEFLQGGALTDIVSQ--TRLNEEQIATVCESVLQALC  131 (297)
T ss_pred             HHHHHHHHHHHHhCCCCchhhhhhheeeC--------CeEEEEEecCCCCCHHHHHhh--cCCCHHHHHHHHHHHHHHHH
Confidence            34678899999999999999999999875        568999999985 66665543  35899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||++.+.. ++.++||||+||+
T Consensus       132 ~LH~~~ivH~dl~p~Nill~~~~~~kL~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  206 (297)
T cd06659         132 YLHSQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----PKRKSLVGTPYWMAPEVISRTP-YGTEVDIWSLGIM  206 (297)
T ss_pred             HHHhCCeecCCCCHHHeEEccCCcEEEeechhHhhccccc----ccccceecCccccCHHHHccCC-CCchhhHHHHHHH
Confidence            9999999999999999999999999999999986553221    1123356788999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||......+.+..+..   .. ...+.                         .....+..+.++|.+||+.
T Consensus       207 l~el~~g~~p~~~~~~~~~~~~~~~---~~-~~~~~-------------------------~~~~~~~~l~~~i~~~l~~  257 (297)
T cd06659         207 VIEMVDGEPPYFSDSPVQAMKRLRD---SP-PPKLK-------------------------NAHKISPVLRDFLERMLTR  257 (297)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhc---cC-CCCcc-------------------------ccCCCCHHHHHHHHHHhcC
Confidence            9999999999987776655443321   11 01000                         0112455677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      +|.+||+++++++||||.+...+.-
T Consensus       258 ~P~~Rps~~~ll~~~~~~~~~~~~~  282 (297)
T cd06659         258 EPQERATAQELLDHPFLLQTGLPEC  282 (297)
T ss_pred             CcccCcCHHHHhhChhhccCCCccc
Confidence            9999999999999999987765544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 6, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK6 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK6 may play a role i

>KOG0584|consensus

Probab=100.00  E-value=1.1e-34  Score=282.13  Aligned_cols=213  Identities=27%  Similarity=0.416  Sum_probs=177.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+..|+.+|+.|+|||||++|+.+.+..+      ..+-+|+|.+. |+|..++++. .+++...++.|++|||+||.|
T Consensus        86 eR~~~Ev~lLKsL~H~NIirfy~SW~d~~n------~~in~iTEL~TSGtLr~Y~kk~-~~vn~kaik~W~RQILkGL~y  158 (632)
T KOG0584|consen   86 ERLYSEVHLLKSLKHPNIIRFYDSWVDTDN------KTINFITELFTSGTLREYRKKH-RRVNIKAIKSWCRQILKGLVY  158 (632)
T ss_pred             HHHHHHHHHHccCCCCceeeeeeheecCCC------ceeeeeeecccCCcHHHHHHHh-ccCCHHHHHHHHHHHHHHhhh
Confidence            678889999999999999999999998754      77899999996 7888888774 478999999999999999999


Q ss_pred             HHhCC--eeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNK--ILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~--iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++.  |||||||=+||+|+. .|.|||+|+|+|......      .....+||+.|||||+.-  ..|+..+||||||
T Consensus       159 LHs~~PPIIHRDLKCDNIFinG~~G~VKIGDLGLAtl~r~s------~aksvIGTPEFMAPEmYE--E~YnE~VDVYaFG  230 (632)
T KOG0584|consen  159 LHSQDPPIIHRDLKCDNIFVNGNLGEVKIGDLGLATLLRKS------HAKSVIGTPEFMAPEMYE--ENYNELVDVYAFG  230 (632)
T ss_pred             hhcCCCCccccccccceEEEcCCcCceeecchhHHHHhhcc------ccceeccCccccChHHHh--hhcchhhhhhhhh
Confidence            99986  999999999999985 589999999999887532      234478999999999875  3589999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      .+++||+|+..||..-....++.+  ++.....|..+                           ..+.+++.++||.+||
T Consensus       231 MCmLEMvT~eYPYsEC~n~AQIYK--KV~SGiKP~sl---------------------------~kV~dPevr~fIekCl  281 (632)
T KOG0584|consen  231 MCMLEMVTSEYPYSECTNPAQIYK--KVTSGIKPAAL---------------------------SKVKDPEVREFIEKCL  281 (632)
T ss_pred             HHHHHHHhccCChhhhCCHHHHHH--HHHcCCCHHHh---------------------------hccCCHHHHHHHHHHh
Confidence            999999999999986544444332  22222222111                           1235788899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .. .+.|+|+.|+|.|+||..+
T Consensus       282 ~~-~~~R~sa~eLL~d~Ff~~d  302 (632)
T KOG0584|consen  282 AT-KSERLSAKELLKDPFFDED  302 (632)
T ss_pred             cC-chhccCHHHHhhChhhccc
Confidence            99 9999999999999999875

>cd06655 STKc_PAK2 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 2

Probab=100.00  E-value=6.9e-34  Score=270.85  Aligned_cols=216  Identities=25%  Similarity=0.457  Sum_probs=174.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+|+|+||+.+ +|..++..  ..+++.++..++.|++.||.
T Consensus        60 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~  129 (296)
T cd06655          60 KELIINEILVMKELKNPNIVNFLDSFLVG--------DELFVVMEYLAGGSLTDVVTE--TCMDEAQIAAVCRECLQALE  129 (296)
T ss_pred             HHHHHHHHHHHHhcCCCceeeeeeeEecC--------ceEEEEEEecCCCcHHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999875        669999999975 66666653  35899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||||+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       130 ~LH~~~i~H~dL~p~Nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slGvi  204 (296)
T cd06655         130 FLHANQVIHRDIKSDNVLLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  204 (296)
T ss_pred             HHHHCCcccCCCCHHHEEECCCCCEEEccCccchhcccccc----cCCCcCCCccccCcchhcCCC-CCchhhHHHHHHH
Confidence            99999999999999999999999999999999876543211    122346788999999987655 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+... +.....                            .+...++.+.+||.+||..
T Consensus       205 l~~lltg~~pf~~~~~~~~~~~~~~~-~~~~~~----------------------------~~~~~~~~~~~li~~~l~~  255 (296)
T cd06655         205 AIEMVEGEPPYLNENPLRALYLIATN-GTPELQ----------------------------NPEKLSPIFRDFLNRCLEM  255 (296)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhc-CCcccC----------------------------CcccCCHHHHHHHHHHhhc
Confidence            99999999999988766554443221 110000                            0112456777999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+||++.+++.||||....
T Consensus       256 dp~~Rpt~~~il~~~~~~~~~  276 (296)
T cd06655         256 DVEKRGSAKELLQHPFLKLAK  276 (296)
T ss_pred             ChhhCCCHHHHhhChHhhhcc
Confidence            999999999999999996543

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 2, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK2 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06608 STKc_myosinIII_like Catalytic domain of Class III myosin-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=3.8e-34  Score=268.82  Aligned_cols=221  Identities=24%  Similarity=0.393  Sum_probs=172.6

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll   81 (433)
                      ...+.+|+.+++++ +|+||+++++++......  .....+|+||||+.+ +|.+++...   +..+++..++.++.|++
T Consensus        46 ~~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~~--~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~ql~  123 (275)
T cd06608          46 EEEIKEEYNILRKYSNHPNIATFYGAFIKKNPP--GNDDQLWLVMELCGGGSVTDLVKGLRKKGKRLKEEWIAYILRETL  123 (275)
T ss_pred             HHHHHHHHHHHHHhcCCCChheEEEEEEecCCC--CcceEEEEEEEcCCCCcHHHHHHHHhhcCCCCCHHHHHHHHHHHH
Confidence            35688999999999 799999999999875320  113668999999985 676666542   35689999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPV  157 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~  157 (433)
                      .||.|||++|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++.+.    ..++.++
T Consensus       124 ~al~~lH~~~i~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  199 (275)
T cd06608         124 RGLAYLHENKVIHRDIKGQNILLTKNAEVKLVDFGVSAQLDSTL----GRRNTFIGTPYWMAPEVIACDEQPDASYDARS  199 (275)
T ss_pred             HHHHHHhcCCcccCCCCHHHEEEccCCeEEECCCccceecccch----hhhcCccccccccCHhHhcccccccCCccccc
Confidence            99999999999999999999999999999999999987654321    122345678899999987542    3467899


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||+||++++|++|.+||........+..+...   ..+ .+                         ..+...+.++++
T Consensus       200 Dv~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~---~~~-~~-------------------------~~~~~~~~~~~~  250 (275)
T cd06608         200 DVWSLGITAIELADGKPPLCDMHPMRALFKIPRN---PPP-TL-------------------------KSPENWSKKFND  250 (275)
T ss_pred             cHHHhHHHHHHHHhCCCCccccchHHHHHHhhcc---CCC-CC-------------------------CchhhcCHHHHH
Confidence            9999999999999999999876555444433211   000 00                         001124567789


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ||.+||..||++|||+.+++.|||+
T Consensus       251 li~~~l~~dp~~Rpt~~~ll~~~~~  275 (275)
T cd06608         251 FISECLIKNYEQRPFMEELLEHPFI  275 (275)
T ss_pred             HHHHHhhcChhhCcCHHHHhcCCCC
Confidence            9999999999999999999999996

Serine/threonine kinases (STKs), Class III myosin-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins with an N-terminal kinase catalytic domain and a C-terminal actin-binding motor domain. Class III myosins are present in the photoreceptors of invertebrates and vertebrates and in the auditory hair cells of mammals. The kinase domain of myosin III can phosphorylate several cytoskeletal proteins, conventional myosin regulatory light chains, and can autophosphorylate the C-terminal motor domain. Myosin I

>cd06633 STKc_TAO3 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 3

Probab=100.00  E-value=2.4e-33  Score=269.27  Aligned_cols=213  Identities=30%  Similarity=0.428  Sum_probs=175.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+++++.++||||+++++++.+.        ...|+||||+.+++.+.+......+++..+..++.||+.||.||
T Consensus        66 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~l~~~~~~~~~~qi~~al~~L  137 (313)
T cd06633          66 QDIIKEVKFLQQLKHPNTIEYKGCYLKE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL  137 (313)
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEEeC--------CEEEEEEecCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999876        56899999999999988877666789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |++|++|+||+|+||+++.++.++|+|||++....        ......++..|+|||++..  ...++.++||||+||+
T Consensus       138 H~~gi~H~dl~p~nili~~~~~~kL~dfg~~~~~~--------~~~~~~~~~~y~aPE~~~~~~~~~~~~~sDv~slGvi  209 (313)
T cd06633         138 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASKSS--------PANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  209 (313)
T ss_pred             HHCCeecCCCChhhEEECCCCCEEEeecCCCcccC--------CCCCccccccccChhhccccCCCCCCchhhHHHHHHH
Confidence            99999999999999999999999999999875432        1223467889999999853  2347889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...+....+..+...  ..+..                            .....+....+|+.+||+.
T Consensus       210 l~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~~l~~li~~~l~~  259 (313)
T cd06633         210 CIELAERKPPLFNMNAMSALYHIAQN--DSPTL----------------------------QSNEWTDSFRGFVDYCLQK  259 (313)
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhc--CCCCC----------------------------CccccCHHHHHHHHHHccC
Confidence            99999999999887766555544321  10000                            0011345567999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +|.+||++.+++.||||...+
T Consensus       260 ~P~~Rp~~~~~l~~~~~~~~~  280 (313)
T cd06633         260 IPQERPASAELLRHDFVRRDR  280 (313)
T ss_pred             ChhhCcCHHHHhcCcccCCCc
Confidence            999999999999999997654

Serine/threonine kinases (STKs), thousand-and-one amino acids 3 (TAO3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO3 is also known as JIK (JNK inhibitory kinase) or KFC (kinase from chicken). It specifically activates c-Jun N-terminal kinase (JNK), presumably by phosphorylating and activating MKK4/MKK7. In Saccharomyces cerevisiae, TAO3 is a co

>cd06636 STKc_MAP4K4_6 Catalytic domain of the Protein Serine/Threonine Kinases, Mitogen-Activated Protein Kinase Kinase Kinase Kinase 4 and 6

Probab=100.00  E-value=7.4e-34  Score=268.49  Aligned_cols=219  Identities=25%  Similarity=0.414  Sum_probs=170.6

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+..|+.+++++ +||||+++++++.....  ......+|+||||+++ +|.+++.... ..+++..++.++.||+.||
T Consensus        57 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~~~--~~~~~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~al  134 (282)
T cd06636          57 EEIKLEINMLKKYSHHRNIATYYGAFIKKSP--PGHDDQLWLVMEFCGAGSVTDLVKNTKGNALKEDWIAYICREILRGL  134 (282)
T ss_pred             HHHHHHHHHHHHhcCCCcEEEEeeehhcccc--cCCCCEEEEEEEeCCCCcHHHHHHHccCCCCCHHHHHHHHHHHHHHH
Confidence            4677899999998 79999999999865321  1124679999999985 7888776533 3488999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLW  160 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~Diw  160 (433)
                      +|||++||+|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++..    ...++.++|+|
T Consensus       135 ~~LH~~~ivH~dl~~~nili~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~l~~~~~~~~~~~~~~Dvw  210 (282)
T cd06636         135 AHLHAHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDYRSDIW  210 (282)
T ss_pred             HHHHHCCcccCCCCHHHEEECCCCCEEEeeCcchhhhhccc----cCCCcccccccccCHhhcCcccCcCcCCCcccchh
Confidence            99999999999999999999999999999999987653221    12234567889999999863    23368899999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||........+..+..   ....                           .......+.++.+||.
T Consensus       211 slG~~l~el~~g~~p~~~~~~~~~~~~~~~---~~~~---------------------------~~~~~~~~~~~~~li~  260 (282)
T cd06636         211 SLGITAIEMAEGAPPLCDMHPMRALFLIPR---NPPP---------------------------KLKSKKWSKKFIDFIE  260 (282)
T ss_pred             HHHHHHHHHHhCCCCccccCHHhhhhhHhh---CCCC---------------------------CCcccccCHHHHHHHH
Confidence            999999999999999987654443332211   0000                           0011124667889999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCc
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      +||+.||.+||++.|+|+||||
T Consensus       261 ~cl~~~p~~Rp~~~ell~~~~~  282 (282)
T cd06636         261 GCLVKNYLSRPSTEQLLKHPFI  282 (282)
T ss_pred             HHhCCChhhCcCHHHHhcCCCC
Confidence            9999999999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 4 (MAPKKKK4 or MAP4K4) and MAPKKKK6 (or MAP4K6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K4/MAP4K6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain. MAP4Ks (or MAPKKKKs) are involved in MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Ea

>cd06639 STKc_myosinIIIB Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIB myosin

Probab=100.00  E-value=9.8e-34  Score=268.95  Aligned_cols=221  Identities=25%  Similarity=0.387  Sum_probs=171.8

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll   81 (433)
                      ...+.+|+.+++++ +||||+++++++.....   .....+|+||||+++ +|.+++..   ....+++..++.++.|++
T Consensus        62 ~~~~~~e~~~l~~l~~h~ni~~~~~~~~~~~~---~~~~~~~lv~ey~~~~sL~~~~~~~~~~~~~~~~~~~~~~~~qi~  138 (291)
T cd06639          62 DEEIEAEYNILQSLPNHPNVVKFYGMFYKADK---LVGGQLWLVLELCNGGSVTELVKGLLICGQRLDEAMISYILYGAL  138 (291)
T ss_pred             HHHHHHHHHHHHHhcCCCCeEEEEEEEEeccc---cCCCeeEEEEEECCCCcHHHHHHHhhhcCCCCCHHHHHHHHHHHH
Confidence            45677899999999 89999999999976421   113568999999975 77776653   234689999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC----CCCCcc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR----NYGPPV  157 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~  157 (433)
                      .||+|||+.|++|+||||+||+++.++.++|+|||++........    ......++..|+|||++....    .++.++
T Consensus       139 ~al~~lH~~~ivH~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  214 (291)
T cd06639         139 LGLQHLHNNRIIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTRL----RRNTSVGTPFWMAPEVIACEQQYDYSYDARC  214 (291)
T ss_pred             HHHHHHHhCCeeccCCCHHHEEEcCCCCEEEeecccchhcccccc----cccCccCCccccChhhhcCCCCcccccCCcc
Confidence            999999999999999999999999999999999999876543211    112345788899999975432    257899


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||+||++|+|++|++||........+..+...   ..+ .+                         ..+...+..+.+
T Consensus       215 Di~slGvi~~el~~g~~p~~~~~~~~~~~~~~~~---~~~-~~-------------------------~~~~~~~~~l~~  265 (291)
T cd06639         215 DVWSLGITAIELGDGDPPLFDMHPVKTLFKIPRN---PPP-TL-------------------------LHPEKWCRSFNH  265 (291)
T ss_pred             chHHHHHHHHHHhhCCCCCCCCcHHHHHHHHhcC---CCC-CC-------------------------CcccccCHHHHH
Confidence            9999999999999999999887665554443221   000 00                         001113455779


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +|.+||+.+|.+||++.++++||||+
T Consensus       266 li~~~l~~~p~~Rps~~~il~~~~~~  291 (291)
T cd06639         266 FISQCLIKDFEARPSVTHLLEHPFIK  291 (291)
T ss_pred             HHHHHhhcChhhCcCHHHHhcCcccC
Confidence            99999999999999999999999984

Serine/threonine kinases (STKs), class IIIB myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. They may also function as cargo carriers during light-dependent translocation, in photoreceptor cells, of proteins such as transducin and arrestin. Class IIIB myosin is expressed highly in retina. It is also pre

>cd06635 STKc_TAO1 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 1

Probab=100.00  E-value=2.9e-33  Score=269.23  Aligned_cols=214  Identities=29%  Similarity=0.440  Sum_probs=175.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+++++.++||||+++++++..+        ...|+||||+.+++.+.+......+++..+..++.|++.||.||
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~g~l~~~~~~~~~~l~~~~~~~i~~~i~~~l~~l  141 (317)
T cd06635          70 QDIIKEVKFLQRIKHPNSIEYKGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAITHGALQGLAYL  141 (317)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeeC--------CeEEEEEeCCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999875        55899999999999888876666789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |++||+|+||+|+||+++.++.++|+|||++.....        .....++..|+|||.+..  ...++.++||||+||+
T Consensus       142 H~~~i~H~dL~p~Nil~~~~~~~kl~dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Dv~slGvi  213 (317)
T cd06635         142 HSHNMIHRDIKAGNILLTEPGQVKLADFGSASIASP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  213 (317)
T ss_pred             HHCCcccCCCCcccEEECCCCCEEEecCCCccccCC--------cccccCCccccChhhhhcCCCCCCCccccHHHHHHH
Confidence            999999999999999999999999999998865432        123457888999999742  2347889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...........+.......                              ......+..++++|.+||+.
T Consensus       214 l~el~~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~  263 (317)
T cd06635         214 CIELAERKPPLFNMNAMSALYHIAQNESPT------------------------------LQSNEWSDYFRNFVDSCLQK  263 (317)
T ss_pred             HHHHHhCCCCCCCccHHHHHHHHHhccCCC------------------------------CCCccccHHHHHHHHHHccC
Confidence            999999999998776555554443311100                              00112455677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      +|.+||++.++++|+|+.....
T Consensus       264 ~p~~Rpt~~~il~~~~~~~~~~  285 (317)
T cd06635         264 IPQDRPTSEELLKHMFVLRERP  285 (317)
T ss_pred             CcccCcCHHHHHhChhhhccCc
Confidence            9999999999999999965543

Serine/threonine kinases (STKs), thousand-and-one amino acids 1 (TAO1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. TAO1 is sometimes referred to as prostate-derived sterile 20-like kinase 2 (PSK2). TAO1 activates the p38 MAPK through direct interaction with and activation of MEK3. TAO1 is highly expressed in the brain and may play a role in neuron

>cd08218 STKc_Nek1 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 1

Probab=100.00  E-value=1.3e-33  Score=262.76  Aligned_cols=211  Identities=29%  Similarity=0.490  Sum_probs=172.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++||||+++++++...        +..|+||||+.+ +|.+.+.... ..+++..+..++.|++.||.
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~l~~~l~  115 (256)
T cd08218          44 EESRKEVAVLSNMKHPNIVQYQESFEEN--------GNLYIVMDYCEGGDLYKKINAQRGVLFPEDQILDWFVQICLALK  115 (256)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEeeecCC--------CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999765        669999999974 8888876533 35789999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||++.+.. ++.++|+||+||+
T Consensus       116 ~lh~~~i~h~~l~~~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG~i  190 (256)
T cd08218         116 HVHDRKILHRDIKSQNIFLTKDGTIKLGDFGIARVLNSTVE----LARTCIGTPYYLSPEICENRP-YNNKSDIWALGCV  190 (256)
T ss_pred             HHHhCCEecCCCCHHHEEEcCCCCEEEeeccceeecCcchh----hhhhccCCccccCHHHhCCCC-CCCccchhHHHHH
Confidence            99999999999999999999999999999999876543211    112345688899999987765 6889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||......+....+..  +..+.                             .+...+.++.++|.+||+.
T Consensus       191 ~~~l~~g~~~~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~li~~~l~~  239 (256)
T cd08218         191 LYEMCTLKHAFEAGNMKNLVLKIIR--GSYPP-----------------------------VSSHYSYDLRNLVSQLFKR  239 (256)
T ss_pred             HHHHHcCCCCccCCCHHHHHHHHhc--CCCCC-----------------------------CcccCCHHHHHHHHHHhhC
Confidence            9999999999987766555444322  11110                             0112456677999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|.+||++.++++||||
T Consensus       240 ~p~~Rp~~~~vl~~~~~  256 (256)
T cd08218         240 NPRDRPSVNSILEKNFI  256 (256)
T ss_pred             ChhhCcCHHHHhhCcCC
Confidence            99999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 1 (Nek1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek1 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek1 is associated with centrosomes throughout the cell cycle. It is involved in the formation of primary cilium and in the maintenance of centrosomes. It cycles through the nucleus and may be capable of relaying signals between the cilium and the nucleus. Nek1 is implicated in the development of polycysti

>cd06634 STKc_TAO2 Catalytic domain of the Protein Serine/Threonine Kinase, Thousand-and-one amino acids 2

Probab=100.00  E-value=2.4e-33  Score=268.66  Aligned_cols=216  Identities=28%  Similarity=0.458  Sum_probs=174.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+++++.++|+||+++++++...        ...++||||+.+++...+......+++..+..++.|++.||.||
T Consensus        60 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~~l~~~l~~L  131 (308)
T cd06634          60 QDIIKEVRFLQKLRHPNTIQYRGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL  131 (308)
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEEcC--------CeeEEEEEccCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999875        56899999999998888766566689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |++|++|+||+|+||+++.++.++|+|||++.....        .....++..|+|||.+.+  ...++.++|||||||+
T Consensus       132 H~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di~slG~i  203 (308)
T cd06634         132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANXFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (308)
T ss_pred             HhCCcccCCCCHHhEEECCCCcEEECCcccceeecC--------cccccCCccccCHHHHhhcccCCCCcccchHHHHHH
Confidence            999999999999999999999999999998866432        123456888999999753  2336889999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||........+..+.....  +                            .......+..+.+||.+||..
T Consensus       204 l~el~~g~~p~~~~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~~~~~~li~~cl~~  253 (308)
T cd06634         204 CIELAERKPPLFNMNAMSALYHIAQNES--P----------------------------ALQSGHWSEYFRNFVDSCLQK  253 (308)
T ss_pred             HHHHHcCCCCCccccHHHHHHHHhhcCC--C----------------------------CcCcccccHHHHHHHHHHhhC
Confidence            9999999999877655444433322110  0                            001112456677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +|.+||+++++++|+|+.....+.
T Consensus       254 ~P~~Rp~~~~ll~~~~~~~~~~~~  277 (308)
T cd06634         254 IPQDRPTSEVLLKHRFVLRERPPT  277 (308)
T ss_pred             CcccCCCHHHHhhCccccccCChh
Confidence            999999999999999997765443

Serine/threonine kinases (STKs), thousand-and-one amino acids 2 (TAO2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The TAO subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. TAO proteins possess mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MAP3K or MKKK) activity. MAPK signaling cascades are important in mediating cellular responses to extracellular signals. Human TAO2 is also known as prostate-derived Ste20-like kinase (PSK) and was identified in a screen for overexpressed RNAs in prostate cancer. TAO2 activates both p38 and c-Jun N-terminal kinase (JNK), by phosphorylating and activatin

>cd06624 STKc_ASK Catalytic domain of the Protein Serine/Threonine Kinase, Apoptosis signal-regulating kinase

Probab=100.00  E-value=2e-33  Score=263.61  Aligned_cols=214  Identities=27%  Similarity=0.424  Sum_probs=166.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCC--CHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKF--SLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l--~~~~~~~i~~qll~aL   84 (433)
                      +.+.+|+.+++.++|+||+++++++...        +.+++|+||+. ++|...+......+  ++..+..++.||+.||
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~al  121 (268)
T cd06624          50 QPLHEEIALHSYLKHRNIVQYLGSDSEN--------GFFKIFMEQVPGGSLSALLRSKWGPLKDNEQTIIFYTKQILEGL  121 (268)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeeeeccC--------CEEEEEEecCCCCCHHHHHHHhcccCCCcHHHHHHHHHHHHHHH
Confidence            4678999999999999999999998875        66999999997 58888887644445  7888999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhH
Q psy7889          85 YYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGA  162 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSl  162 (433)
                      .|||++||+|+||||+||+++. .+.++|+|||++........    ......++..|+|||++.+. ..++.++|+||+
T Consensus       122 ~~lH~~~i~h~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~~~~~~~~Dv~sl  197 (268)
T cd06624         122 KYLHDNQIVHRDIKGDNVLVNTYSGVVKISDFGTSKRLAGINP----CTETFTGTLQYMAPEVIDKGPRGYGAPADIWSL  197 (268)
T ss_pred             HHHHHCCEeecCCCHHHEEEcCCCCeEEEecchhheecccCCC----ccccCCCCccccChhhhccccccCCchhhhHHH
Confidence            9999999999999999999976 67999999999876542211    12233568899999998653 337889999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++++|++|.+||...................                             ...+...+.++++|+.+|
T Consensus       198 Gvvl~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~~li~~~  248 (268)
T cd06624         198 GCTIVEMATGKPPFIELGEPQAAMFKVGMFKIH-----------------------------PEIPESLSAEAKNFILRC  248 (268)
T ss_pred             HHHHHHHHhCCCCCccccChhhhHhhhhhhccC-----------------------------CCCCcccCHHHHHHHHHH
Confidence            999999999999997543221111000000000                             000112456778999999


Q ss_pred             cccCCCCCCCHHHhhcCCCc
Q psy7889         243 LLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~  262 (433)
                      |..+|.+|||+.+++.||||
T Consensus       249 l~~~p~~Rpt~~~ll~~~~~  268 (268)
T cd06624         249 FEPDPDKRASAHDLLQDPFL  268 (268)
T ss_pred             cCCCchhCCCHHHHHhCCCC
Confidence            99999999999999999997

Serine/threonine kinases (STKs), Apoptosis signal-regulating kinase (ASK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The ASK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Subfamily members are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) and include ASK1, ASK2, and MAPKKK15. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. ASK1 (also called MAPKKK5) functions in the c-Jun N-terminal kina

>cd06605 PKc_MAPKK Catalytic domain of the dual-specificity Protein Kinase, Mitogen-Activated Protein Kinase Kinase

Probab=100.00  E-value=7.9e-34  Score=265.57  Aligned_cols=215  Identities=24%  Similarity=0.389  Sum_probs=172.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++++.++||||+++++++...        ..+++|+||++ ++|.+++......+++..++.++.|++.||+|
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  115 (265)
T cd06605          44 KQILRELDILHKCNSPYIVGFYGAFYNN--------GDISICMEYMDGGSLDKILKEVQGRIPERILGKIAVAVLKGLTY  115 (265)
T ss_pred             HHHHHHHHHHHHCCCCchhhhheeeecC--------CEEEEEEEecCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999876        66999999999 68888887655679999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+ .|++|+||||+||+++.++.++|+|||.+........      ....++..|+|||.+.+.. ++.++||||+||+
T Consensus       116 lH~~~~i~H~dl~~~ni~~~~~~~~~l~d~g~~~~~~~~~~------~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~  188 (265)
T cd06605         116 LHEKHKIIHRDVKPSNILVNSRGQIKLCDFGVSGQLVNSLA------KTFVGTSSYMAPERIQGND-YSVKSDIWSLGLS  188 (265)
T ss_pred             HcCCCCeecCCCCHHHEEECCCCCEEEeecccchhhHHHHh------hcccCChhccCHHHHcCCC-CCchhhHHHHHHH
Confidence            999 9999999999999999999999999999876543211      1156788899999987764 7999999999999


Q ss_pred             HHHHHhcCCCCCCCCh--HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         166 MAEMWTRSPIMQGNTE--QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       166 l~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +++|++|..||.....  ......+........+.                           +.....+.+++++|.+||
T Consensus       189 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~li~~~l  241 (265)
T cd06605         189 LIELATGRFPYPPENDPPDGIFELLQYIVNEPPPR---------------------------LPSGKFSPDFQDFVNLCL  241 (265)
T ss_pred             HHHHHhCCCCCCccccccccHHHHHHHHhcCCCCC---------------------------CChhhcCHHHHHHHHHHc
Confidence            9999999999876421  11111122211111100                           000114667889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||.+|||+.+++.||||+.
T Consensus       242 ~~~p~~Rpt~~~ll~~~~~~~  262 (265)
T cd06605         242 IKDPRERPSYKELLEHPFIKK  262 (265)
T ss_pred             CCCchhCcCHHHHhhCchhhc
Confidence            999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK or MAP2K), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK or MAP3K). MAPKKs are dual-specificity

>cd08217 STKc_Nek2 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 2

Probab=100.00  E-value=1.8e-33  Score=262.56  Aligned_cols=213  Identities=30%  Similarity=0.482  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      +.+.+|+++++.++||||+++++++....      +..+|++|||+++ +|.+++...   ...+++..++.++.||+.|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~~~~~~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~~~~~i~~~  117 (265)
T cd08217          44 QQLVSEVNILRELKHPNIVRYYDRIIDRS------NQTLYIVMEYCEGGDLAQLIQKCKKERKYIEEEFIWRILTQLLLA  117 (265)
T ss_pred             HHHHHHHHHHHhcCCCccceeeeeeecCC------CCEEEEEehhccCCCHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            45778999999999999999999887542      2568999999974 788777653   4568999999999999999


Q ss_pred             HHHHH-----hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          84 LYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        84 L~~LH-----~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |.|||     +.+++|+||+|+||+++.++.++|+|||++........    ......++..|+|||++.+.. ++.++|
T Consensus       118 l~~lH~~~~~~~~i~h~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~----~~~~~~~~~~~~~pE~~~~~~-~~~~~D  192 (265)
T cd08217         118 LYECHNRSDPGNTVLHRDLKPANIFLDANNNVKLGDFGLAKILGHDSS----FAKTYVGTPYYMSPEQLNHMS-YDEKSD  192 (265)
T ss_pred             HHHHhcCccccCcceecCCCHHHEEEecCCCEEEecccccccccCCcc----cccccccCCCccChhhhcCCC-CCchhH
Confidence            99999     89999999999999999999999999999987653221    123346788999999987755 789999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      +|||||++++|++|..||...+.......+......    .                           .+...+..+.++
T Consensus       193 v~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~---------------------------~~~~~~~~~~~l  241 (265)
T cd08217         193 IWSLGCLIYELCALSPPFTARNQLQLASKIKEGKFR----R---------------------------IPYRYSSELNEV  241 (265)
T ss_pred             HHHHHHHHHHHHHCCCcccCcCHHHHHHHHhcCCCC----C---------------------------CccccCHHHHHH
Confidence            999999999999999999987754444333221100    0                           011245667799


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      +.+||..+|.+||++.++++|||+
T Consensus       242 ~~~~l~~~p~~Rp~~~~il~~~~~  265 (265)
T cd08217         242 IKSMLNVDPDKRPSTEELLQLPLI  265 (265)
T ss_pred             HHHHccCCcccCCCHHHHhhCCCC
Confidence            999999999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 2 (Nek2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek2 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek2 subfamily includes Aspergillus nidulans NIMA kinase, the founding member of the Nek family, which was identified in a screen for cell cycle mutants prevented from entering mitosis. NIMA is essential for mitotic entry and progression through mitosis, and its degradation is essential for mitotic exi

>cd05572 STKc_cGK_PKG Catalytic domain of the Protein Serine/Threonine Kinase, cGMP-dependent protein kinase

Probab=100.00  E-value=1.3e-33  Score=263.84  Aligned_cols=213  Identities=25%  Similarity=0.404  Sum_probs=172.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++.+.+.        ..+|+||||++ ++|.+.+.+. ..+++..+..++.||+.||+
T Consensus        37 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~  107 (262)
T cd05572          37 QEHIFSEKEILEECNHPFIVKLYRTFKDK--------KYIYMLMEYCLGGELWTILRDR-GLFDEYTARFYIACVVLAFE  107 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeeeeeEEcC--------CccEEEEecCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHHHH
Confidence            35688899999999999999999998765        56899999987 5888887664 35899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||+|+||+++.++.++|+|||++.......     ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       108 ~lH~~~~~h~dl~~~nilv~~~~~~~l~df~~~~~~~~~~-----~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~i  181 (262)
T cd05572         108 YLHNRGIIYRDLKPENLLLDSNGYVKLVDFGFAKKLKSGQ-----KTWTFCGTPEYVAPEIILNKG-YDFSVDYWSLGIL  181 (262)
T ss_pred             HHhhCCcccCCCCHHHEEEcCCCCEEEeeCCcccccCccc-----ccccccCCcCccChhHhcCCC-CCChhhhhhhHHH
Confidence            9999999999999999999999999999999998765321     122346788899999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCC--hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         166 MAEMWTRSPIMQGNT--EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       166 l~ell~g~~pf~~~~--~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +|+|++|..||....  ..+....+........                              .+...+.+++++|.+||
T Consensus       182 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~i~~~l  231 (262)
T cd05572         182 LYELLTGRPPFGEDDEDPMEIYNDILKGNGKLE------------------------------FPNYIDKAAKDLIKQLL  231 (262)
T ss_pred             HHHHHhCCCCcCCCCCCHHHHHHHHhccCCCCC------------------------------CCcccCHHHHHHHHHHc
Confidence            999999999998766  3333332221000000                              01112567789999999


Q ss_pred             ccCCCCCCC-----HHHhhcCCCccC
Q psy7889         244 LLDPSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t-----~~e~L~h~~~~~  264 (433)
                      ..+|.+|++     ++|+++||||.+
T Consensus       232 ~~~p~~R~~~~~~~~~~l~~~~~~~~  257 (262)
T cd05572         232 RRNPEERLGNLKGGIKDIKKHKWFNG  257 (262)
T ss_pred             cCChhhCcCCcccCHHHHhcChhhhC
Confidence            999999999     999999999965

Serine/Threonine Kinases (STKs), cGMP-dependent protein kinase (cGK or PKG) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The cGK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Mammals have two cGK isoforms from different genes, cGKI and cGKII. cGKI exists as two splice variants, cGKI-alpha and cGKI-beta. cGK consists of an N-terminal regulatory domain containing a dimerization and an autoinhibitory pseudosubstrate region, two cGMP-binding domains, and a C-terminal catalytic domain. Binding of cGMP to both binding sites releases the inhibition of the catalytic center by the pseudosubstrate region, allowi

>cd05609 STKc_MAST Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine kinase

Probab=100.00  E-value=2.7e-33  Score=267.94  Aligned_cols=220  Identities=27%  Similarity=0.356  Sum_probs=172.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++.+...        +.+|+||||+++ +|.+++... ..+++..+..++.|++.||.|
T Consensus        46 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~~  116 (305)
T cd05609          46 QQVFVERDILTFAENPFVVSMFCSFETK--------RHLCMVMEYVEGGDCATLLKNI-GALPVDMARMYFAETVLALEY  116 (305)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeEEEEecC--------CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999875        669999999975 777777654 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC-----------ccccccCCcccccccCcccccCCCCCCC
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG-----------QVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~-----------~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      ||++|++|+||||+||+++.++.++|+|||+++........           .........++..|+|||.+.+.. ++.
T Consensus       117 lH~~~i~H~dl~p~NIll~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~  195 (305)
T cd05609         117 LHNYGIVHRDLKPDNLLITSMGHIKLTDFGLSKIGLMSLTTNLYEGHIEKDTREFLDKQVCGTPEYIAPEVILRQG-YGK  195 (305)
T ss_pred             HHHCCccccCCchHHEEECCCCCEEEeeCCCccccCcCccccccccccccchhhccccCCccCccccCchhccCCC-CCc
Confidence            99999999999999999999999999999988642110000           000111235678899999987755 799


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|+||+||++|+|++|..||.+....+....+.......+..                             ....+.++
T Consensus       196 ~~Di~slG~vl~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~  246 (305)
T cd05609         196 PVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEG-----------------------------DEALPADA  246 (305)
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCCCCc-----------------------------cccCCHHH
Confidence            9999999999999999999998877655444433211110000                             01245667


Q ss_pred             HHHHHhhcccCCCCCCC---HHHhhcCCCccCCC
Q psy7889         236 CDLLDKLLLLDPSKRFD---SDAALNHDFFWTDP  266 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t---~~e~L~h~~~~~~~  266 (433)
                      .++|.+||..||.+||+   +.++|+||||....
T Consensus       247 ~~li~~~l~~~P~~R~~~~~~~~ll~~~~~~~~~  280 (305)
T cd05609         247 QDLISRLLRQNPLERLGTGGAFEVKQHRFFLGLD  280 (305)
T ss_pred             HHHHHHHhccChhhccCccCHHHHHhCccccCCC
Confidence            89999999999999998   79999999996543

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. There are four mammalian MAST kinases, named MAST1-MAST4. MAST1 is also referred to as syntrophin-associated STK (SAST), while MAST2 is also called MAST205. MAST kinases are cytoskeletal associated kinases of unknown function that a

>cd05064 PTKc_EphR_A10 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A10

Probab=100.00  E-value=1.6e-33  Score=264.15  Aligned_cols=208  Identities=16%  Similarity=0.218  Sum_probs=166.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+|+||||+++ +|.+++......+++..++.++.||+.||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~i~~al~~  122 (266)
T cd05064          51 RGFLAEALTLGQFDHSNIVRLEGVITRG--------NTMMIVTEYMSNGALDSFLRKHEGQLVAGQLMGMLPGLASGMKY  122 (266)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEecC--------CCcEEEEEeCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999765        568999999986 6777776655678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++||||||+||+++.++.++++|||.+.......   ........++..|+|||++.+.. ++.++||||+||++
T Consensus       123 lH~~~iiH~dikp~nili~~~~~~~l~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  198 (266)
T cd05064         123 LSEMGYVHKGLAAHKVLVNSDLVCKISGFRRLQEDKSEA---IYTTMSGKSPVLWAAPEAIQYHH-FSSASDVWSFGIVM  198 (266)
T ss_pred             HHHCCEeeccccHhhEEEcCCCcEEECCCcccccccccc---hhcccCCCCceeecCHHHHhhCC-ccchhHHHHHHHHH
Confidence            999999999999999999999999999999875542211   11111234467899999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |++++ |.+||.+.+..+.+..+......+.                               +...+..+.+++.+||..
T Consensus       199 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~c~~~  247 (266)
T cd05064         199 WEVMSYGERPYWDMSGQDVIKAVEDGFRLPA-------------------------------PRNCPNLLHQLMLDCWQK  247 (266)
T ss_pred             HHHhcCCCCCcCcCCHHHHHHHHHCCCCCCC-------------------------------CCCCCHHHHHHHHHHcCC
Confidence            99775 9999998877765555432211110                               112345566999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+||+++++++
T Consensus       248 ~p~~RP~~~~i~~  260 (266)
T cd05064         248 ERGERPRFSQIHS  260 (266)
T ss_pred             CchhCCCHHHHHH
Confidence            9999999999875

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA10 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchor

>cd06646 STKc_MAP4K5 Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-activated protein kinase kinase kinase kinase 5

Probab=100.00  E-value=1.1e-33  Score=265.12  Aligned_cols=214  Identities=25%  Similarity=0.384  Sum_probs=166.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        ..+|+||||+++ +|.+.+.. ...+++..+..++.|++.||.|
T Consensus        51 ~~~~~e~~~l~~~~h~~ii~~~~~~~~~--------~~~~iv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~  121 (267)
T cd06646          51 SLIQQEIFMVKECKHCNIVAYFGSYLSR--------EKLWICMEYCGGGSLQDIYHV-TGPLSELQIAYVCRETLQGLAY  121 (267)
T ss_pred             HHHHHHHHHHHhcCCCCeeeeeEEEEeC--------CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999875        568999999985 67776654 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv  164 (433)
                      ||+.||+|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+  ...++.++|+||+||
T Consensus       122 lH~~~i~H~dl~p~nill~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~~~~~~~~~Dvws~G~  197 (267)
T cd06646         122 LHSKGKMHRDIKGANILLTDNGDVKLADFGVAAKITATI----AKRKSFIGTPYWMAPEVAAVEKNGGYNQLCDIWAVGI  197 (267)
T ss_pred             HHHCCccccCCCHHHEEECCCCCEEECcCccceeecccc----cccCccccCccccCHhHcccccCCCCcchhhHHHHHH
Confidence            999999999999999999999999999999997664221    11233467889999998753  233678999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.+||...........+...  ...+..+.                         .....+..+.+||.+||.
T Consensus       198 il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~~~~~-------------------------~~~~~~~~~~~li~~~l~  250 (267)
T cd06646         198 TAIELAELQPPMFDLHPMRALFLMSKS--NFQPPKLK-------------------------DKTKWSSTFHNFVKISLT  250 (267)
T ss_pred             HHHHHHhCCCCccccchhhhheeeecC--CCCCCCCc-------------------------cccccCHHHHHHHHHHhh
Confidence            999999999998655433222211110  00000000                         011245678899999999


Q ss_pred             cCCCCCCCHHHhhcCCC
Q psy7889         245 LDPSKRFDSDAALNHDF  261 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~  261 (433)
                      .+|.+|||++++|+|+|
T Consensus       251 ~~P~~Rp~~~~il~~l~  267 (267)
T cd06646         251 KNPKKRPTAERLLTHLF  267 (267)
T ss_pred             CChhhCcCHHHHhcCCC
Confidence            99999999999999987

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase kinase 5 (MAPKKKK5 or MAP4K5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAP4K5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily contain an N-terminal catalytic domain and a C-terminal citron homology (CNH) regulatory domain, similar to MAP4K4/6. MAP4Ks are involved in some MAPK signaling pathways that are important in mediating cellular responses to extracellular signals by activating a MAPK kinase kinase (MAPKKK or MAP3K or MKKK). Each MAPK cascade is activated

>cd06616 PKc_MKK4 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 4

Probab=100.00  E-value=1.5e-33  Score=267.26  Aligned_cols=219  Identities=18%  Similarity=0.244  Sum_probs=169.1

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHh----ccCCCCCHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS----NIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~----~~~~~l~~~~~~~i~~qll~   82 (433)
                      ..+++|+.++.++. ||||+++++++..+        +..+++|||+..++.++..    .....+++..+..++.|++.
T Consensus        47 ~~~~~e~~~l~~~~~~~~iv~~~~~~~~~--------~~~~~~~e~~~~~l~~l~~~~~~~~~~~l~~~~~~~i~~~i~~  118 (288)
T cd06616          47 KRLLMDLDVVMRSSDCPYIVKFYGALFRE--------GDCWICMELMDISLDKFYKYVYEVLKSVIPEEILGKIAVATVK  118 (288)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeEEecC--------CcEEEEEecccCCHHHHHHHHHHhhcCCCCHHHHHHHHHHHHH
Confidence            45788999999996 99999999998765        5589999999877655432    22356899999999999999


Q ss_pred             HHHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchh
Q psy7889          83 GLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDL  159 (433)
Q Consensus        83 aL~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~Di  159 (433)
                      ||+|||+ .|++||||||+||+++.++.++|+|||++.......     ......++..|+|||++.+.  ..++.++||
T Consensus       119 ~l~~lh~~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~Di  193 (288)
T cd06616         119 ALNYLKEELKIIHRDVKPSNILLDRNGNIKLCDFGISGQLVDSI-----AKTRDAGCRPYMAPERIDPSARDGYDVRSDV  193 (288)
T ss_pred             HHHHHhhcCCeeccCCCHHHEEEccCCcEEEeecchhHHhccCC-----ccccccCccCccCHHHhccccccCCcchhhh
Confidence            9999997 599999999999999999999999999987654321     11233568889999998765  357899999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||+||++++|++|.+||.....  ....+........+....                        ..+...+.++.+||
T Consensus       194 ~slG~il~el~~g~~p~~~~~~--~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~l~~li  247 (288)
T cd06616         194 WSLGITLYEVATGKFPYPKWNS--VFDQLTQVVKGDPPILSN------------------------SEEREFSPSFVNFI  247 (288)
T ss_pred             hHHHHHHHHHHhCCCCchhcch--HHHHHhhhcCCCCCcCCC------------------------cCCCccCHHHHHHH
Confidence            9999999999999999976542  222222222111110000                        00112566788999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+||+.+|++|||+++++.||||...
T Consensus       248 ~~~l~~~p~~Rpt~~~i~~~~~~~~~  273 (288)
T cd06616         248 NLCLIKDESKRPKYKELLEHPFIKDY  273 (288)
T ss_pred             HHHccCChhhCcCHHHHhcChhhhch
Confidence            99999999999999999999999653

Protein kinases (PKs), MAP kinase kinase 4 (MKK4) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK4 is a dual-specificity PK that phosphorylates and activates

>cd05114 PTKc_Tec_Rlk Catalytic domain of the Protein Tyrosine Kinases, Tyrosine kinase expressed in hepatocellular carcinoma and Resting lymphocyte kinase

Probab=100.00  E-value=2.7e-33  Score=260.83  Aligned_cols=209  Identities=23%  Similarity=0.405  Sum_probs=169.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++|++++||||+++++++...        ..+++||||++ ++|.+.+......+++..++.++.|++.||+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~  114 (256)
T cd05114          43 EEDFIEEAKVMMKLSHPKLVQLYGVCTQQ--------KPLYIVTEFMENGCLLNYLRQRQGKLSKDMLLSMCQDVCEGME  114 (256)
T ss_pred             HHHHHHHHHHHHHCCCCCceeEEEEEccC--------CCEEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999998765        55899999997 5788888765557899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.++|+|||.+........   .......++..|+|||++.+.. ++.++||||+||+
T Consensus       115 ~lH~~~i~H~dl~p~ni~i~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s~G~~  190 (256)
T cd05114         115 YLERNSFIHRDLAARNCLVSSTGVVKVSDFGMTRYVLDDEY---TSSSGAKFPVKWSPPEVFNFSK-YSSKSDVWSFGVL  190 (256)
T ss_pred             HHHHCCccccccCcceEEEcCCCeEEECCCCCccccCCCce---eccCCCCCchhhCChhhcccCc-cchhhhhHHHHHH
Confidence            99999999999999999999999999999999876542211   1112223456799999987654 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||...+..+....+.......                               .+...+..+.+++.+||.
T Consensus       191 l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~~~~li~~c~~  239 (256)
T cd05114         191 MWEVFTEGKMPFEKKSNYEVVEMISRGFRLY-------------------------------RPKLASMTVYEVMYSCWH  239 (256)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHCCCCCC-------------------------------CCCCCCHHHHHHHHHHcc
Confidence            999999 899998887766666554311100                               011234567799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .+|.+||+++++++
T Consensus       240 ~~p~~Rps~~~l~~  253 (256)
T cd05114         240 EKPEGRPTFAELLR  253 (256)
T ss_pred             CCcccCcCHHHHHH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) and Resting lymphocyte kinase (Rlk); catalytic (c) domain. The PTKc family is part of a larger superfamily, that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec and Rlk (also named Txk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin h

>KOG4645|consensus

Probab=100.00  E-value=1.5e-35  Score=306.87  Aligned_cols=220  Identities=28%  Similarity=0.432  Sum_probs=175.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|.+++..++|||||++|++=.+.        ..++|.||||.+ +|.+++.. ....++-..+.+..|++.|+.|
T Consensus      1279 ~~i~eEm~vlE~lnHpNlV~YyGVEvHR--------ekv~IFMEyC~~GsLa~ll~~-gri~dE~vt~vyt~qll~gla~ 1349 (1509)
T KOG4645|consen 1279 KLIAEEMKVLEGLNHPNLVRYYGVEVHR--------EKVYIFMEYCEGGSLASLLEH-GRIEDEMVTRVYTKQLLEGLAY 1349 (1509)
T ss_pred             cchHHHHHHHHhccCccccccCceeecH--------HHHHHHHHHhccCcHHHHHHh-cchhhhhHHHHHHHHHHHHHHH
Confidence            3467899999999999999999988775        558999999985 56665554 4346777788899999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC--CCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR--NYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGv  164 (433)
                      ||++|||||||||.||+++.+|.+|++|||.|..+..+............||+.|||||+|.+..  .-+-+.|||||||
T Consensus      1350 LH~~gIVHRDIK~aNI~Ld~~g~iK~~DFGsa~ki~~~~~~~~~el~~~~GT~~YMAPEvit~t~~kG~~~A~DiWslGC 1429 (1509)
T KOG4645|consen 1350 LHEHGIVHRDIKPANILLDFNGLIKYGDFGSAVKIKNNAQTMPGELQSMMGTPMYMAPEVITGTKGKGHGGAADIWSLGC 1429 (1509)
T ss_pred             HHhcCceecCCCccceeeecCCcEEeecccceeEecCchhcCCHHHHhhcCCchhcCchhhcccccCCCCcchhhhcccc
Confidence            99999999999999999999999999999999888765322233445678999999999998754  2466999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHH-HHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQI-TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |+.||+||+-||...+..=++ ..+  ..|..+.                             .|...|++++|||..||
T Consensus      1430 VVlEM~tGkrPW~~~dne~aIMy~V--~~gh~Pq-----------------------------~P~~ls~~g~dFle~Cl 1478 (1509)
T KOG4645|consen 1430 VVLEMATGKRPWAELDNEWAIMYHV--AAGHKPQ-----------------------------IPERLSSEGRDFLEHCL 1478 (1509)
T ss_pred             eEEEeecCCCchhhccchhHHHhHH--hccCCCC-----------------------------CchhhhHhHHHHHHHHH
Confidence            999999999999865443222 222  1222111                             01226889999999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      ..||++|.++.|+|+|.|-....+
T Consensus      1479 ~~dP~~Rw~~~qlle~~f~~~~~d 1502 (1509)
T KOG4645|consen 1479 EQDPKMRWTASQLLEHAFGKSCTD 1502 (1509)
T ss_pred             hcCchhhhHHHHHHHhhccccccc
Confidence            999999999999999999765443

>cd08226 PK_STRAD_beta Pseudokinase domain of STE20-related kinase adapter protein beta

Probab=100.00  E-value=1.1e-33  Score=273.43  Aligned_cols=249  Identities=20%  Similarity=0.246  Sum_probs=171.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++||||++++++|...        +.+|+||||+.+ ++.+++.+.. ..+++..+..++.||+.||+
T Consensus        44 ~~~~~e~~~~~~l~h~niv~~~~~~~~~--------~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi~~aL~  115 (328)
T cd08226          44 KALQNEVVLSHFFRHPNIMTSWTVFTTG--------SWLWVISPFMAYGSANSLLKTYFPEGMSEALIGNILFGALRGLN  115 (328)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeeeEecC--------CceEEEEecccCCCHHHHHHhhcccCCCHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        568999999985 7888776543 34899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcccc---ccCCcccccccCcccccCC-CCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR---YTNRVVTLWYRPPELLLGD-RNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~---~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS  161 (433)
                      |||++||+||||||+||+++.++.++++||+.+.............   .....++..|+|||++.+. ..++.++||||
T Consensus       116 ~lH~~~ivHrDlkp~Nill~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Diws  195 (328)
T cd08226         116 YLHQNGYIHRNIKASHILISGDGLVSLSGLSHLYSLVRNGQKAKVVYDFPQFSTSVLPWLSPELLRQDLYGYNVKSDIYS  195 (328)
T ss_pred             HHHhCCeecCCCCHHHEEEeCCCcEEEechHHHhhhhccCccccccccccccccCccCccChhhhcCCCCCCCchhhHHH
Confidence            9999999999999999999999999999998654332211100000   0112345679999998764 34789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCC--CCCcccchhhhh--ccc--cch---------HHHhhHHhhh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPE--SWPGVETLDLYN--KME--LPK---------AQKRKVKERL  226 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~--~~~~~~~~~~~~--~~~--~~~---------~~~~~~~~~~  226 (433)
                      +||++++|++|.+||.+.........+.......+..  .++.........  ...  ...         ..........
T Consensus       196 lG~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  275 (328)
T cd08226         196 VGITACELATGRVPFQDMLRTQMLLQKLKGPPYSPLDITTFPCEESRMKNSQSGVDSGIGESVVAAGMTQTMTSERLRTP  275 (328)
T ss_pred             HHHHHHHHHhCCCCCCCcChHHHHHHHhcCCCCCCccccccchhhhhhccchhhhhcccccchhccccccccccccccch
Confidence            9999999999999998876554433332211110000  000000000000  000  000         0000000000


Q ss_pred             CCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         227 KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       227 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .....+..+++||.+||..||.+|||++|+|+|+||..
T Consensus       276 ~~~~~~~~~~~li~~~l~~dP~~Rpta~e~l~~~~~~~  313 (328)
T cd08226         276 SSKTFSPAFQNLVELCLQQDPEKRPSASSLLSHAFFKQ  313 (328)
T ss_pred             hhhhhhHHHHHHHHHHccCCcccCCCHHHHhhCHHHHH
Confidence            01234677889999999999999999999999999954

Protein Kinase family, STE20-related kinase adapter protein (STRAD) beta subfamily, pseudokinase domain. The STRAD-beta subfamily is part of a larger superfamily that includes the catalytic domains of serine/threonine kinases (STKs), protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The pseudokinase domain shows similarity to protein kinases but lacks crucial residues for catalytic activity. STRAD forms a complex with the scaffolding protein MO25, and the STK, LKB1, resulting in the activation of the kinase. In the complex, LKB1 phosphorylates and activates adenosine monophosphate-activated protein kinases (AMPKs), which regulate cell energy metabolism and cell polarity. LKB1 is a tumor suppressor linked to the rare inherited disease, Peutz-Jeghers syndrome, which is characterized by a predisposition to benign polyps and hyperpig

>cd06656 STKc_PAK3 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 3

Probab=100.00  E-value=1.1e-33  Score=269.54  Aligned_cols=216  Identities=25%  Similarity=0.448  Sum_probs=171.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        +..|+||||+++ +|.+++.+  ..+++..+..++.|++.||.
T Consensus        60 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~l~~~L~  129 (297)
T cd06656          60 KELIINEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALD  129 (297)
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecC--------CEEEEeecccCCCCHHHHHHh--CCCCHHHHHHHHHHHHHHHH
Confidence            35678899999999999999999999875        669999999975 77777654  35789999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       130 ~LH~~~i~H~dL~p~Nili~~~~~~~l~Dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slGvi  204 (297)
T cd06656         130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  204 (297)
T ss_pred             HHHHCCcccCCCCHHHEEECCCCCEEECcCccceEccCCcc----CcCcccCCccccCHHHHcCCC-CCcHHHHHHHHHH
Confidence            99999999999999999999999999999999876542211    122346788999999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+.. .+.+..                            ..+...+...++||.+||..
T Consensus       205 l~~l~tg~~pf~~~~~~~~~~~~~~-~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~  255 (297)
T cd06656         205 AIEMVEGEPPYLNENPLRALYLIAT-NGTPEL----------------------------QNPERLSAVFRDFLNRCLEM  255 (297)
T ss_pred             HHHHHhCCCCCCCCCcchheeeecc-CCCCCC----------------------------CCccccCHHHHHHHHHHccC
Confidence            9999999999987654332221111 011000                            00112456677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +|.+||+++++++||||....
T Consensus       256 ~p~~Rps~~~il~~~~~~~~~  276 (297)
T cd06656         256 DVDRRGSAKELLQHPFLKLAK  276 (297)
T ss_pred             ChhhCcCHHHHhcCchhcccc
Confidence            999999999999999997544

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 3, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK3 belongs to group I. Group I PAKs contain a PBD (p21-binding domain) overlapping with an AID (autoinhibitory domain), a C-terminal catalytic domain, SH3 binding sites and a non-classical SH3 binding

>cd06621 PKc_MAPKK_Pek1_like Catalytic domain of fungal Pek1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=3.7e-33  Score=264.58  Aligned_cols=225  Identities=24%  Similarity=0.352  Sum_probs=169.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+++++.++||||++++++|.....      +.+|+||||+++ +|.+++..   ....+++..+..++.||+.
T Consensus        43 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~l~~~~~~~i~~~i~~  116 (287)
T cd06621          43 QKQILRELEINKSCKSPYIVKYYGAFLDESS------SSIGIAMEYCEGGSLDSIYKKVKKRGGRIGEKVLGKIAESVLK  116 (287)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeEEEccCC------CeEEEEEEecCCCCHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            3568899999999999999999999976532      568999999975 77666542   2345899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|||+.|++|+||+|+||+++.++.++|+|||++.......      .....++..|+|||.+.+.. ++.++|||||
T Consensus       117 ~L~~lH~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~sl  189 (287)
T cd06621         117 GLSYLHSRKIIHRDIKPSNILLTRKGQVKLCDFGVSGELVNSL------AGTFTGTSFYMAPERIQGKP-YSITSDVWSL  189 (287)
T ss_pred             HHHHHHHCCcccCCCCHHHEEEecCCeEEEeeccccccccccc------cccccCCccccCHHHhcCCC-CCchhhHHHH
Confidence            9999999999999999999999999999999999986654221      11334678899999987654 7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCCh--HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         163 GCIMAEMWTRSPIMQGNTE--QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||++|+|++|..||.....  ............... ......                     .......+..+.+||.
T Consensus       190 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~---------------------~~~~~~~~~~~~~li~  247 (287)
T cd06621         190 GLTLLEVAQNRFPFPPEGEPPLGPIELLSYIVNMPN-PELKDE---------------------PGNGIKWSEEFKDFIK  247 (287)
T ss_pred             HHHHHHHHhCCCCCCcccCCCCChHHHHHHHhcCCc-hhhccC---------------------CCCCCchHHHHHHHHH
Confidence            9999999999999986522  011111111111000 000000                     0000113456779999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||..+|++|||+.|++.||||....
T Consensus       248 ~~l~~~p~~Rpt~~eil~~~~~~~~~  273 (287)
T cd06621         248 QCLEKDPTRRPTPWDMLEHPWIKAQM  273 (287)
T ss_pred             HHcCCCcccCCCHHHHHhCccccccc
Confidence            99999999999999999999996544

Protein kinases (PKs), MAP kinase kinase(MAPKK) subfamily, fungal Pek1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>cd08220 STKc_Nek8 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 8

Probab=100.00  E-value=3.5e-33  Score=259.69  Aligned_cols=210  Identities=25%  Similarity=0.369  Sum_probs=170.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+++++.++||||+++++.+...        +.+++||||+++ +|.+++.... ..+++..++.++.|++.||+
T Consensus        44 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l~  115 (256)
T cd08220          44 LAAQNECQVLKLLSHPNIIEYYENFLED--------KALMIVMEYAPGGTLAEYIQKRCNSLLDEDTILHFFVQILLALH  115 (256)
T ss_pred             HHHHHHHHHHhhCCCCchhheeeeEecC--------CEEEEEEecCCCCCHHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999998765        669999999975 7888887643 34899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||++|++|+||+|+||+++.+ +.++|+|||++.......     ......++..|+|||.+.+.. ++.++||||+||
T Consensus       116 ~lh~~~i~h~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~  189 (256)
T cd08220         116 HVHTKLILHRDLKTQNILLDKHKMVVKIGDFGISKILSSKS-----KAYTVVGTPCYISPELCEGKP-YNQKSDIWALGC  189 (256)
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCCEEEEccCCCceecCCCc-----cccccccCCcccCchhccCCC-CCcccchHHHHH
Confidence            9999999999999999999855 468999999997764321     122345788999999987654 689999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||.+.+.......+.......                               .+...+.++.++|.+||.
T Consensus       190 ~l~~l~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~  238 (256)
T cd08220         190 VLYELASLKRAFEAANLPALVLKIMSGTFAP-------------------------------ISDRYSPDLRQLILSMLN  238 (256)
T ss_pred             HHHHHHhCCCCcccCchHHHHHHHHhcCCCC-------------------------------CCCCcCHHHHHHHHHHcc
Confidence            9999999999998876555444332211000                               011245667799999999


Q ss_pred             cCCCCCCCHHHhhcCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~  262 (433)
                      .+|.+|||+.|+++||||
T Consensus       239 ~~p~~Rpt~~~ll~~p~~  256 (256)
T cd08220         239 LDPSKRPQLSQIMAQPIC  256 (256)
T ss_pred             CChhhCCCHHHHhhCCCC
Confidence            999999999999999996

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 8 (Nek8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek8 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek8 contains an N-terminal kinase catalytic domain and a C-terminal RCC1 (regulator of chromosome condensation) domain. A double point mutation in Nek8 causes cystic kidney disease in mice that genetically resembles human autosomal recessive polycystic kidney disease (ARPKD). Nek8 is also associated with

>cd05577 STKc_GRK Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase

Probab=100.00  E-value=1.4e-33  Score=266.05  Aligned_cols=216  Identities=27%  Similarity=0.369  Sum_probs=171.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...++.|+++|+.++||||+++++++...        +.+|+||||+. ++|.+.+.+.. ..+++..+..++.|++.||
T Consensus        37 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~ql~~~l  108 (277)
T cd05577          37 EQMALNEKKILEKVSSRFIVSLAYAFETK--------DDLCLVMTLMNGGDLKYHIYNVGEPGFPEARAIFYAAQIICGL  108 (277)
T ss_pred             hHHHHHHHHHHHhCCCCCEeeeeeEEecC--------CeEEEEEecCCCCcHHHHHHHcCcCCCCHHHHHHHHHHHHHHH
Confidence            34567899999999999999999999875        66999999998 47887776543 3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++|+||+|+||+++.++.++|+|||++......     .......++..|+|||++.+.. ++.++||||+||
T Consensus       109 ~~lH~~~i~H~di~p~Nil~~~~~~~~l~dfg~~~~~~~~-----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~  182 (277)
T cd05577         109 EHLHQRRIVYRDLKPENVLLDDHGNVRISDLGLAVELKGG-----KKIKGRAGTPGYMAPEVLQGEV-YDFSVDWFALGC  182 (277)
T ss_pred             HHHHhCCcccCCCCHHHEEECCCCCEEEccCcchhhhccC-----CccccccCCCCcCCHHHhcCCC-CCchhhhHHHHH
Confidence            9999999999999999999999999999999998765431     1123345678899999987765 789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||...........+....-...                            ...+...++.+.++|.+||+
T Consensus       183 il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~~li~~~l~  234 (277)
T cd05577         183 TLYEMIAGRSPFRQRKEKVEKEELKRRTLEMA----------------------------VEYPDKFSPEAKDLCEALLQ  234 (277)
T ss_pred             HHHHHhhCCCCCCCCcccccHHHHHhcccccc----------------------------ccCCccCCHHHHHHHHHHcc
Confidence            99999999999987654222222211100000                            00011246778899999999


Q ss_pred             cCCCCCC-----CHHHhhcCCCccC
Q psy7889         245 LDPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      .||.+||     ++.++++||||..
T Consensus       235 ~~p~~R~~~~~~~~~~ll~h~~~~~  259 (277)
T cd05577         235 KDPEKRLGCRGGSADEVREHPLFKD  259 (277)
T ss_pred             CChhHccCCCcccHHHHHhChhhhc
Confidence            9999999     8999999999964

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors, which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. GRKs contain a central catalytic domain, flanked by N- and C-terminal extensions. The N-terminus contains an RGS (regulator of

>cd05096 PTKc_DDR1 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 1

Probab=100.00  E-value=2.6e-33  Score=267.84  Aligned_cols=215  Identities=22%  Similarity=0.346  Sum_probs=164.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC------------------CCC
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH------------------VKF   68 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~------------------~~l   68 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        +..++||||+.+ +|.+++....                  ..+
T Consensus        64 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  135 (304)
T cd05096          64 NDFLKEVKILSRLKDPNIIRLLGVCVDE--------DPLCMITEYMENGDLNQFLSSHHLDDKEENGNDAVPPAHCLPAI  135 (304)
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEecC--------CceEEEEecCCCCcHHHHHHhccccccccccccccccccccccc
Confidence            3578999999999999999999999875        558999999974 7888775422                  236


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc
Q psy7889          69 SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL  148 (433)
Q Consensus        69 ~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (433)
                      +...+..++.||+.||.|||+.||+||||||+|||++.++.+||+|||++..+.....  ........++..|+|||++.
T Consensus       136 ~~~~~~~i~~~i~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~DfG~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  213 (304)
T cd05096         136 SYSSLLHVALQIASGMKYLSSLNFVHRDLATRNCLVGENLTIKIADFGMSRNLYAGDY--YRIQGRAVLPIRWMAWECIL  213 (304)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHCCccccCcchhheEEcCCccEEECCCccceecccCce--eEecCcCCCCccccCHHHHh
Confidence            7788999999999999999999999999999999999999999999999976543221  11112334577899999987


Q ss_pred             CCCCCCCcchhhhHHHHHHHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhh
Q psy7889         149 GDRNYGPPVDLWGAGCIMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL  226 (433)
Q Consensus       149 ~~~~~~~~~DiwSlGvil~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (433)
                      +.. ++.++|||||||++|+|++  +..||.+.+..+.+..+...........+                        ..
T Consensus       214 ~~~-~~~~~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~  268 (304)
T cd05096         214 MGK-FTTASDVWAFGVTLWEILMLCKEQPYGELTDEQVIENAGEFFRDQGRQVY------------------------LF  268 (304)
T ss_pred             cCC-CCchhhhHHHHHHHHHHHHccCCCCCCcCCHHHHHHHHHHHhhhcccccc------------------------cc
Confidence            655 7999999999999999986  56788877666555444332211100000                        00


Q ss_pred             CCccCChhHHHHHHhhcccCCCCCCCHHHhh
Q psy7889         227 KPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       227 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L  257 (433)
                      .+...+..+.+|+.+||..||.+|||++++.
T Consensus       269 ~~~~~~~~~~~li~~cl~~~p~~RPs~~~i~  299 (304)
T cd05096         269 RPPPCPQGLYELMLQCWSRDCRERPSFSDIH  299 (304)
T ss_pred             CCCCCCHHHHHHHHHHccCCchhCcCHHHHH
Confidence            1112356678999999999999999999995

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 1 (DDR1) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR1 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR1 binds to all collagens tested to date (types I-IV). It is widely expressed in many tissues. It is abundant in the brain and is also found in k

>cd05048 PTKc_Ror Catalytic Domain of the Protein Tyrosine Kinases, Receptor tyrosine kinase-like Orphan Receptors

Probab=100.00  E-value=2.6e-33  Score=264.85  Aligned_cols=210  Identities=20%  Similarity=0.342  Sum_probs=168.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSLG   71 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~~   71 (433)
                      ..+.+|+.+++.++||||+++++++...        ...|++|||+. ++|.+++....               ..+++.
T Consensus        53 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~--------~~~~~~~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~  124 (283)
T cd05048          53 QEFRQEAELMSDLQHPNIVCLLGVCTKE--------QPTCMLFEYLAHGDLHEFLVRNSPHSDVGAESGDETVKSSLDCS  124 (283)
T ss_pred             HHHHHHHHHHHhcCCcccceEEEEEcCC--------CceEEEEecCCCCcHHHHHHhcCCCcccccccccccccCCCCHH
Confidence            4578899999999999999999999865        45899999997 58888876531               347889


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .++.++.|++.||.|||++|++|+||||+||+++.++.++|+|||++........  ........+++.|+|||.+.+..
T Consensus       125 ~~~~~~~~l~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~L~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05048         125 DFLHIAIQIAAGMEYLSSHHFVHRDLAARNCLVGEGLTVKISDFGLSRDIYSADY--YRVQSKSLLPVRWMPPEAILYGK  202 (283)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeccccccceEEEcCCCcEEECCCcceeecccccc--ccccCCCcccccccCHHHhccCc
Confidence            9999999999999999999999999999999999999999999999876532211  11123345678899999987655


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       ++.++|||||||++|+|++ |..||.+.+..+....+.......                               .+..
T Consensus       203 -~~~~sDv~slG~il~el~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~  250 (283)
T cd05048         203 -FTTESDIWSFGVVLWEIFSYGLQPYYGFSNQEVIEMIRSRQLLP-------------------------------CPED  250 (283)
T ss_pred             -CchhhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCC-------------------------------Cccc
Confidence             7999999999999999998 999998877665554443211000                               0112


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .+.++.+|+.+||+.||.+||++.+++++
T Consensus       251 ~~~~~~~l~~~c~~~~p~~Rp~~~~i~~~  279 (283)
T cd05048         251 CPARVYALMIECWNEIPARRPRFKDIHTR  279 (283)
T ss_pred             CCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            46777899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor (Ror) subfamily; catalytic (c) domain. The Ror subfamily consists of Ror1, Ror2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimer

>cd06617 PKc_MKK3_6 Catalytic domain of the dual-specificity Protein Kinases, MAP kinase kinases 3 and 6

Probab=100.00  E-value=3e-33  Score=264.27  Aligned_cols=217  Identities=22%  Similarity=0.318  Sum_probs=168.6

Q ss_pred             hhHHHHHHH-HHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKI-LQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+..|+.+ ++.++||||+++++++..+        +.+|+||||++++|.+++...   ...+++..++.++.||+.|
T Consensus        44 ~~~~~e~~~~~~~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~qi~~~  115 (283)
T cd06617          44 KRLLMDLDISMRSVDCPYTVTFYGALFRE--------GDVWICMEVMDTSLDKFYKKVYDKGLTIPEDILGKIAVSIVKA  115 (283)
T ss_pred             HHHHHHHHHHHHHcCCCCeeeeeEEEecC--------CcEEEEhhhhcccHHHHHHHhccCCCCCCHHHHHHHHHHHHHH
Confidence            356667775 5666899999999999865        559999999999888877542   3458999999999999999


Q ss_pred             HHHHHhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC---CCCCCcchh
Q psy7889          84 LYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD---RNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Di  159 (433)
                      |+|||++ +++||||||+||+++.++.+||+|||++.......     ......++..|+|||.+.+.   ..++.++|+
T Consensus       116 l~~lH~~~~i~h~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di  190 (283)
T cd06617         116 LEYLHSKLSVIHRDVKPSNVLINRNGQVKLCDFGISGYLVDSV-----AKTIDAGCKPYMAPERINPELNQKGYDVKSDV  190 (283)
T ss_pred             HHHHhhcCCeecCCCCHHHEEECCCCCEEEeeccccccccccc-----ccccccCCccccChhhcCCcccccccCccccc
Confidence            9999997 99999999999999999999999999987654221     11234578889999988652   236889999


Q ss_pred             hhHHHHHHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||+||++|+|++|..||... ...+.+..+..  + ..+.                           +.....+.++.+|
T Consensus       191 ~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~--~-~~~~---------------------------~~~~~~~~~l~~l  240 (283)
T cd06617         191 WSLGITMIELATGRFPYDSWKTPFQQLKQVVE--E-PSPQ---------------------------LPAEKFSPEFQDF  240 (283)
T ss_pred             hhhHHHHHHHHhCCCCCCccccCHHHHHHHHh--c-CCCC---------------------------CCccccCHHHHHH
Confidence            99999999999999999643 22232222211  1 0000                           0001246678899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      |.+||..+|.+||+++++++||||.....
T Consensus       241 i~~~l~~~p~~Rp~~~~il~~~~~~~~~~  269 (283)
T cd06617         241 VNKCLKKNYKERPNYPELLQHPFFELHLS  269 (283)
T ss_pred             HHHHccCChhhCcCHHHHhcCchhhhccc
Confidence            99999999999999999999999977653

Protein kinases (PKs), MAP kinase kinase 3 (MKK3) and MKK6 subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK3 and MKK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK3 and MKK6 are dual-specificity PKs

>PHA03390 pk1 serine/threonine-protein kinase 1; Provisional

Probab=100.00  E-value=3.5e-33  Score=262.00  Aligned_cols=204  Identities=25%  Similarity=0.371  Sum_probs=161.5

Q ss_pred             HHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7889          13 EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN   90 (433)
Q Consensus        13 Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~   90 (433)
                      |+.+...+ +||||+++++.|...        +.+|+||||++ ++|.+++.... .++++.++.++.|++.||.|||+.
T Consensus        58 e~~~~~~~~~h~~iv~~~~~~~~~--------~~~~iv~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~lH~~  128 (267)
T PHA03390         58 EPMVHQLMKDNPNFIKLYYSVTTL--------KGHVLIMDYIKDGDLFDLLKKEG-KLSEAEVKKIIRQLVEALNDLHKH  128 (267)
T ss_pred             hHHHHHHhhcCCCEEEEEEEEecC--------CeeEEEEEcCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHHHhC
Confidence            44444433 799999999999875        56999999997 58888887643 789999999999999999999999


Q ss_pred             CeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHH
Q psy7889          91 KILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM  169 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el  169 (433)
                      |++||||||+||+++.++ .++|+|||++......        ....++..|+|||++.+.. ++.++||||+||++++|
T Consensus       129 ~i~H~dl~p~nil~~~~~~~~~l~dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~~l  199 (267)
T PHA03390        129 NIIHNDIKLENVLYDRAKDRIYLCDYGLCKIIGTP--------SCYDGTLDYFSPEKIKGHN-YDVSFDWWAVGVLTYEL  199 (267)
T ss_pred             CeeeCCCCHHHEEEeCCCCeEEEecCccceecCCC--------ccCCCCCcccChhhhcCCC-CCchhhHHHHHHHHHHH
Confidence            999999999999999988 9999999998765421        1235688999999997655 78999999999999999


Q ss_pred             HhcCCCCCCCChHHH-HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCC
Q psy7889         170 WTRSPIMQGNTEQQQ-ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS  248 (433)
Q Consensus       170 l~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  248 (433)
                      ++|..||........ ...+..... ....                            .....++.+.+||.+||+.+|.
T Consensus       200 ~~g~~p~~~~~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~~~~~~~li~~~l~~~p~  250 (267)
T PHA03390        200 LTGKHPFKEDEDEELDLESLLKRQQ-KKLP----------------------------FIKNVSKNANDFVQSMLKYNIN  250 (267)
T ss_pred             HHCCCCCCCCCcchhhHHHHHHhhc-ccCC----------------------------cccccCHHHHHHHHHHhccChh
Confidence            999999986543321 111111110 0000                            0013577888999999999999


Q ss_pred             CCCC-HHHhhcCCCcc
Q psy7889         249 KRFD-SDAALNHDFFW  263 (433)
Q Consensus       249 ~R~t-~~e~L~h~~~~  263 (433)
                      +|++ .+++|+||||.
T Consensus       251 ~R~~~~~~~l~h~~~~  266 (267)
T PHA03390        251 YRLTNYNEIIKHPFLK  266 (267)
T ss_pred             hCCchHHHHhcCCccc
Confidence            9996 59999999995

>cd05106 PTKc_CSF-1R Catalytic domain of the Protein Tyrosine Kinase, Colony-Stimulating Factor-1 Receptor

Probab=100.00  E-value=1.9e-33  Score=276.35  Aligned_cols=210  Identities=22%  Similarity=0.383  Sum_probs=163.1

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      ..+++|+++|+.+ +|+|||++++++...        +.+|+|||||. ++|.+++....                    
T Consensus        86 ~~~~~E~~il~~l~~h~nIv~~~~~~~~~--------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  157 (374)
T cd05106          86 EALMSELKILSHLGQHKNIVNLLGACTHG--------GPVLVITEYCCYGDLLNFLRKKAETFLNFVMALPEISETSSDY  157 (374)
T ss_pred             HHHHHHHHHHHhhccCCceeeEeeEecCC--------CCeEEeHhhccCCcHHHHHHhhhhhhccccccccccccccccc
Confidence            3578999999999 899999999999875        56899999997 57887774321                    


Q ss_pred             -------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccC
Q psy7889          66 -------------------------------------------------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRD   96 (433)
Q Consensus        66 -------------------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~iiH~d   96 (433)
                                                                       ..+++..++.++.||+.||.|||++||+|||
T Consensus       158 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~aL~yLH~~giiHrD  237 (374)
T cd05106         158 KNITLEKKYIRSDSGFSSQGSDTYVEMRPVSSSSSQSSDSKDEEDTEDSWPLDLDDLLRFSSQVAQGMDFLASKNCIHRD  237 (374)
T ss_pred             cccchhcccccccccccccccccccccCCccccccccccccchhccCCCCCcCHHHHHHHHHHHHHHHHHHHHCCEEecc
Confidence                                                             2377888999999999999999999999999


Q ss_pred             CCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh-cCCC
Q psy7889          97 MKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPI  175 (433)
Q Consensus        97 ikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~p  175 (433)
                      |||+|||++.++.+||+|||++.........  .......++..|+|||++.+.. ++.++||||+||++|+|++ |.+|
T Consensus       238 Lkp~Nil~~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlGvil~ellt~G~~P  314 (374)
T cd05106         238 VAARNVLLTDGRVAKICDFGLARDIMNDSNY--VVKGNARLPVKWMAPESIFDCV-YTVQSDVWSYGILLWEIFSLGKSP  314 (374)
T ss_pred             CchheEEEeCCCeEEEeeceeeeeccCCcce--eeccCCCCccceeCHHHhcCCC-CCccccHHHHHHHHHHHHhCCCCC
Confidence            9999999999999999999999765432211  1111223456799999987655 7999999999999999997 9999


Q ss_pred             CCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHH
Q psy7889         176 MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDA  255 (433)
Q Consensus       176 f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e  255 (433)
                      |...........+........                              .+...+.++.++|.+||..||.+|||+++
T Consensus       315 f~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~cl~~dp~~RPs~~~  364 (374)
T cd05106         315 YPGILVNSKFYKMVKRGYQMS------------------------------RPDFAPPEIYSIMKMCWNLEPTERPTFSQ  364 (374)
T ss_pred             CccccccHHHHHHHHcccCcc------------------------------CCCCCCHHHHHHHHHHcCCChhhCcCHHH
Confidence            987654333322221100000                              01124567789999999999999999999


Q ss_pred             hhc
Q psy7889         256 ALN  258 (433)
Q Consensus       256 ~L~  258 (433)
                      +++
T Consensus       365 l~~  367 (374)
T cd05106         365 ISQ  367 (374)
T ss_pred             HHH
Confidence            975

Protein Tyrosine Kinase (PTK) family; Colony-Stimulating Factor-1 Receptor (CSF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CSF-1R, also called c-Fms, is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of CSF-1R to its ligand, CSF-1, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. CSF-1R signaling is criti

>cd06657 STKc_PAK4 Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase 4

Probab=100.00  E-value=4.8e-33  Score=264.54  Aligned_cols=218  Identities=27%  Similarity=0.443  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|+||+++++++...        +..|+||||+++ +|.+.+..  ..+++..++.++.|++.||+|
T Consensus        62 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~ql~~~l~~  131 (292)
T cd06657          62 ELLFNEVVIMRDYQHENVVEMYNSYLVG--------DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLKALSV  131 (292)
T ss_pred             HHHHHHHHHHHhcCCcchhheeeEEEeC--------CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999875        669999999986 56665533  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+||++
T Consensus       132 lH~~givH~dl~p~Nilv~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slGvil  206 (292)
T cd06657         132 LHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGIMV  206 (292)
T ss_pred             HHHCCeecCCCCHHHEEECCCCCEEEcccccceeccccc----ccccccccCccccCHHHhcCCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999886654221    1123346788999999886654 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||.+......+..+.....    ..+..                         ....+..+.+++.+||..+
T Consensus       207 ~el~tg~~p~~~~~~~~~~~~~~~~~~----~~~~~-------------------------~~~~~~~l~~li~~~l~~~  257 (292)
T cd06657         207 IEMVDGEPPYFNEPPLKAMKMIRDNLP----PKLKN-------------------------LHKVSPSLKGFLDRLLVRD  257 (292)
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhhCC----cccCC-------------------------cccCCHHHHHHHHHHHhCC
Confidence            999999999988776655444332111    00000                         0123556779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCc
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |.+||++.+++.||||.....++
T Consensus       258 P~~R~~~~~ll~~~~~~~~~~~~  280 (292)
T cd06657         258 PAQRATAAELLKHPFLAKAGPPS  280 (292)
T ss_pred             cccCcCHHHHhcChHHhccCCCc
Confidence            99999999999999997765443

Serine/threonine kinases (STKs), p21-activated kinase (PAK) 4, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs from higher eukaryotes are classified into two groups (I and II), according to their biochemical and structural features. PAK4 belongs to group II. Group II PAKs contain a PBD (p21-binding domain) and a C-terminal catalytic domain, but do not harbor an AID (autoinhibitory domain) or SH3 binding sites. PAK4 regulates cell mo

>cd05606 STKc_beta_ARK Catalytic domain of the Protein Serine/Threonine Kinase, beta-adrenergic receptor kinase

Probab=100.00  E-value=3.1e-33  Score=263.94  Aligned_cols=206  Identities=23%  Similarity=0.334  Sum_probs=161.8

Q ss_pred             HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeec
Q psy7889          16 ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILH   94 (433)
Q Consensus        16 il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH   94 (433)
                      +++..+||||+++++++...        +.+|+||||+.+ +|...+.. ...+++..++.++.|++.||+|||+.+|+|
T Consensus        50 ~~~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~g~~L~~~l~~-~~~l~~~~~~~~~~ql~~~l~~lH~~~i~H  120 (278)
T cd05606          50 LVSTGDCPFIVCMSYAFHTP--------DKLSFILDLMNGGDLHYHLSQ-HGVFSEAEMRFYAAEIILGLEHMHNRFVVY  120 (278)
T ss_pred             HHHhCCCCcEeeeeeeeecC--------CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHHHHHCCEEc
Confidence            34445799999999999875        669999999975 66665554 456999999999999999999999999999


Q ss_pred             cCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCC
Q psy7889          95 RDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP  174 (433)
Q Consensus        95 ~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~  174 (433)
                      +||||+||+++.++.++|+|||++......      ......|+..|+|||++.+...++.++||||+||++++|++|..
T Consensus       121 ~di~p~nili~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~s~G~~l~~l~~g~~  194 (278)
T cd05606         121 RDLKPANILLDEHGHVRISDLGLACDFSKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHS  194 (278)
T ss_pred             CCCCHHHEEECCCCCEEEccCcCccccCcc------CCcCcCCCcCCcCcHHhcCCCCCCcccchHhHHHHHHHHHhCCC
Confidence            999999999999999999999998755321      11234689999999998765457899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCC---
Q psy7889         175 IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---  251 (433)
Q Consensus       175 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---  251 (433)
                      ||.+............... ...                            ..+...+.++.++|.+||..+|.+|+   
T Consensus       195 p~~~~~~~~~~~~~~~~~~-~~~----------------------------~~~~~~s~~~~~li~~~l~~~p~~R~~~~  245 (278)
T cd05606         195 PFRQHKTKDKHEIDRMTLT-MAV----------------------------ELPDSFSPELRSLLEGLLQRDVNRRLGCL  245 (278)
T ss_pred             CCCCCCccchHHHHHHhhc-cCC----------------------------CCCCcCCHHHHHHHHHHhhcCHHhccCCC
Confidence            9987632221111111000 000                            00112467788999999999999999   


Q ss_pred             --CHHHhhcCCCccCC
Q psy7889         252 --DSDAALNHDFFWTD  265 (433)
Q Consensus       252 --t~~e~L~h~~~~~~  265 (433)
                        ++.++++||||...
T Consensus       246 ~~~~~~ll~~~~~~~~  261 (278)
T cd05606         246 GRGAQEVKEHPFFRSL  261 (278)
T ss_pred             CCCHHHHHhCccccCC
Confidence              99999999999664

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, beta-adrenergic receptor kinase (beta-ARK) group, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. The beta-ARK group is co

>cd06638 STKc_myosinIIIA Catalytic domain of the Protein Serine/Threonine Kinase, Class IIIA myosin

Probab=100.00  E-value=2.5e-33  Score=265.37  Aligned_cols=220  Identities=26%  Similarity=0.403  Sum_probs=169.2

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll   81 (433)
                      ...+.+|+.+++.+ +||||+++++++.....   ..+..+|+||||+++ +|.+++..   ....+++..++.++.|++
T Consensus        58 ~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~  134 (286)
T cd06638          58 DEEIEAEYNILKALSDHPNVVKFYGMYYKKDV---KNGDQLWLVLELCNGGSVTDLVKGFLKRGERMEEPIIAYILHEAL  134 (286)
T ss_pred             HHHHHHHHHHHHHHhcCCCeeeeeeeeeeccc---CCCCeEEEEEeecCCCCHHHHHHHhhccCccccHHHHHHHHHHHH
Confidence            35677899999999 69999999998864321   113679999999975 77776643   234588999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----CCCCCcc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----RNYGPPV  157 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----~~~~~~~  157 (433)
                      .||.|||+++|+||||||+||+++.++.++|+|||++.......    .......|+..|+|||++...    ..++.++
T Consensus       135 ~~l~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~  210 (286)
T cd06638         135 MGLQHLHVNKTIHRDVKGNNILLTTEGGVKLVDFGVSAQLTSTR----LRRNTSVGTPFWMAPEVIACEQQLDSTYDARC  210 (286)
T ss_pred             HHHHHHHhCCccccCCCHHhEEECCCCCEEEccCCceeecccCC----CccccccCCCcccChhhhchhhhccccccchh
Confidence            99999999999999999999999999999999999987654321    112334678999999988532    2368899


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||+||++|+|++|.+||........+..+..   ....                          ....+...+..+.+
T Consensus       211 Dv~slGvi~~el~~g~~p~~~~~~~~~~~~~~~---~~~~--------------------------~~~~~~~~~~~~~~  261 (286)
T cd06638         211 DVWSLGITAIELGDGDPPLADLHPMRALFKIPR---NPPP--------------------------TLHQPELWSNEFND  261 (286)
T ss_pred             hhhhHHHHHHHHhcCCCCCCCCchhHHHhhccc---cCCC--------------------------cccCCCCcCHHHHH
Confidence            999999999999999999987654433322111   0000                          00011123556789


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      +|.+||+.||++|||+.|+++|+||
T Consensus       262 li~~~l~~~p~~Rps~~ell~~~~~  286 (286)
T cd06638         262 FIRKCLTKDYEKRPTVSDLLQHVFI  286 (286)
T ss_pred             HHHHHccCCcccCCCHHHHhhcccC
Confidence            9999999999999999999999997

Serine/threonine kinases (STKs), class IIIA myosin subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The class III myosin subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Class III myosins are motor proteins containing an N-terminal kinase catalytic domain and a C-terminal actin-binding domain. Class III myosins may play an important role in maintaining the structural integrity of photoreceptor cell microvilli. In photoreceptor cells, they may also function as cargo carriers during light-dependent translocation of proteins such as transducin and arrestin. Class IIIA myosin is highly expressed in retina and in inner ear

>cd05084 PTKc_Fes Catalytic domain of the Protein Tyrosine Kinase, Fes

Probab=100.00  E-value=4e-33  Score=258.96  Aligned_cols=209  Identities=24%  Similarity=0.406  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++...        ..+|+||||+.+ +|.+++......+++..++.++.|++.||.|
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~qi~~~L~~  109 (252)
T cd05084          38 AKFLQEARILKQYSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTEGPRLKVKELIQMVENAAAGMEY  109 (252)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcCC--------CCeEEEEeeccCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999775        568999999974 7888876655568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.+||+|||++.........  ........+..|+|||.+.+.. ++.++|||||||++
T Consensus       110 lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il  186 (252)
T cd05084         110 LESKHCIHRDLAARNCLVTEKNVLKISDFGMSREEEDGVYA--STGGMKQIPVKWTAPEALNYGR-YSSESDVWSFGILL  186 (252)
T ss_pred             HHhCCccccccchheEEEcCCCcEEECccccCccccccccc--ccCCCCCCceeecCchhhcCCC-CChHHHHHHHHHHH
Confidence            99999999999999999999999999999998765422110  0011112245699999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||...........+.......                               .+...+..+.+|+.+||..
T Consensus       187 ~e~~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~  235 (252)
T cd05084         187 WEAFSLGAVPYANLSNQQTREAIEQGVRLP-------------------------------CPELCPDAVYRLMERCWEY  235 (252)
T ss_pred             HHHHhCCCCCccccCHHHHHHHHHcCCCCC-------------------------------CcccCCHHHHHHHHHHcCC
Confidence            99998 889997766544333332211000                               0112355677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|++|||+.++++
T Consensus       236 ~p~~Rps~~~~~~  248 (252)
T cd05084         236 DPGQRPSFSTVHQ  248 (252)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999974

Protein Tyrosine Kinase (PTK) family; Fes (or Fps) kinase subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr kinase activity. Fes kinase is expressed in myeloid, vascular

>cd06652 STKc_MEKK2 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 2

Probab=100.00  E-value=4.4e-33  Score=260.74  Aligned_cols=214  Identities=27%  Similarity=0.423  Sum_probs=169.1

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||+++++++.+...      ..+++||||+++ +|.+++.+. ..+++..+..++.|++.||.||
T Consensus        50 ~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~~~~v~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~l~~~l~~l  122 (265)
T cd06652          50 ALECEIQLLKNLLHERIVQYYGCLRDPME------RTLSIFMEHMPGGSIKDQLKSY-GALTENVTRKYTRQILEGVSYL  122 (265)
T ss_pred             HHHHHHHHHHhcCCCCeeeEEeEeccCCC------ceEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            56779999999999999999998876432      568899999975 788777653 4588999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++|++|+||||+||+++.++.++|+|||++........ .........++..|+|||++.+.. ++.++|+|||||++|
T Consensus       123 H~~~i~H~dl~p~nil~~~~~~~~l~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il~  200 (265)
T cd06652         123 HSNMIVHRDIKGANILRDSVGNVKLGDFGASKRLQTICL-SGTGMKSVTGTPYWMSPEVISGEG-YGRKADIWSVGCTVV  200 (265)
T ss_pred             HhCCEecCCCCHHHEEecCCCCEEECcCccccccccccc-cccccccCCCCccccChhhhcCCC-CCcchhHHHHHHHHH
Confidence            999999999999999999999999999999876542211 111223346788999999987754 789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|.+||........+..+   ........                           .+...+..+.++|.+|+. +|
T Consensus       201 el~~g~~p~~~~~~~~~~~~~---~~~~~~~~---------------------------~~~~~~~~~~~~i~~~l~-~p  249 (265)
T cd06652         201 EMLTEKPPWAEFEAMAAIFKI---ATQPTNPV---------------------------LPPHVSDHCRDFLKRIFV-EA  249 (265)
T ss_pred             HHhhCCCCCCccchHHHHHHH---hcCCCCCC---------------------------CchhhCHHHHHHHHHHhc-Ch
Confidence            999999999876555443332   21111000                           011245667799999995 99


Q ss_pred             CCCCCHHHhhcCCCc
Q psy7889         248 SKRFDSDAALNHDFF  262 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~  262 (433)
                      ..||+++++++|||+
T Consensus       250 ~~Rp~~~~il~~~~~  264 (265)
T cd06652         250 KLRPSADELLRHTFV  264 (265)
T ss_pred             hhCCCHHHHhcCccc
Confidence            999999999999997

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 2 (MEKK2) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK2 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates the MAPK kinase MEK5 (or MKK5), which in turn phosphorylates and activates extracellular signal-regulated kinase 5 (ERK5). The ERK5 cascade plays roles in promoting cell proliferation, differentiation, neuronal survival, and neuroprotection. MEKK2 also activates ERK1/2, c-Jun N-terminal kinase (JNK) and p38 through their re

>cd05093 PTKc_TrkB Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase B

Probab=100.00  E-value=4.4e-33  Score=264.16  Aligned_cols=209  Identities=22%  Similarity=0.404  Sum_probs=167.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC------------CCCCHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH------------VKFSLGEIK   74 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~------------~~l~~~~~~   74 (433)
                      ..+.+|++++++++||||+++++++...        +.+++||||+. ++|.+++....            ..+++..++
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~l~~~~~~  123 (288)
T cd05093          52 KDFHREAELLTNLQHEHIVKFYGVCVEG--------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNRPAELTQSQML  123 (288)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC--------CccEEEEEcCCCCCHHHHHHHcCCccccccccCCCCCCCHHHHH
Confidence            4578999999999999999999999865        56899999997 58888876432            248999999


Q ss_pred             HHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCC
Q psy7889          75 KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG  154 (433)
Q Consensus        75 ~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (433)
                      .++.|++.||+|||++|++||||||+||+++.++.++|+|||++........  ........++..|+|||.+.+.. ++
T Consensus       124 ~~~~ql~~aL~~lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~  200 (288)
T cd05093         124 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRK-FT  200 (288)
T ss_pred             HHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEeccCCccccccCCce--eecCCCCCccccccCHHHhccCC-CC
Confidence            9999999999999999999999999999999999999999999876542211  11122334567899999987654 79


Q ss_pred             CcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         155 PPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      .++|||||||++++|++ |.+||.+....+....+....  ...                             .+...+.
T Consensus       201 ~~sDiwslG~il~~l~t~g~~p~~~~~~~~~~~~i~~~~--~~~-----------------------------~~~~~~~  249 (288)
T cd05093         201 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGR--VLQ-----------------------------RPRTCPK  249 (288)
T ss_pred             chhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCC--cCC-----------------------------CCCCCCH
Confidence            99999999999999998 999998887666555543211  100                             0112456


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++.+|+.+||+.||.+|||+.+++.
T Consensus       250 ~l~~li~~~l~~~p~~Rpt~~~v~~  274 (288)
T cd05093         250 EVYDLMLGCWQREPHMRLNIKEIHS  274 (288)
T ss_pred             HHHHHHHHHccCChhhCCCHHHHHH
Confidence            6789999999999999999999964

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase B (TrkB); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkB is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkB to its ligands, brain-derived neurotrophic factor (BDNF) or neurotrophin 4 (NT4), results in receptor oligomerization and activation of the catalytic domain. TrkB is broadly

>cd05113 PTKc_Btk_Bmx Catalytic domain of the Protein Tyrosine Kinases, Bruton's tyrosine kinase and Bone marrow kinase on the X chromosome

Probab=100.00  E-value=4.2e-33  Score=259.71  Aligned_cols=210  Identities=21%  Similarity=0.393  Sum_probs=168.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        ..+++||||+. ++|.+++......+++..++.++.|++.||+
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~i~~~~~~~~~~~~~~~~~~i~~~l~  114 (256)
T cd05113          43 EDEFIEEAKVMMKLSHEKLVQLYGVCTKQ--------RPIYIVTEYMSNGCLLNYLREHGKRFQPSQLLEMCKDVCEGMA  114 (256)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccC--------CCcEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999998764        45899999997 4788888765557899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.+||+|||++........   .......++..|+|||.+.+.. ++.++|||||||+
T Consensus       115 ~lH~~~i~H~dl~p~nili~~~~~~kl~d~g~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~~  190 (256)
T cd05113         115 YLESKQFIHRDLAARNCLVDDQGCVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLLYSK-FSSKSDVWAFGVL  190 (256)
T ss_pred             HHHhCCeeccccCcceEEEcCCCCEEECCCccceecCCCce---eecCCCccChhhCCHHHHhcCc-ccchhHHHHHHHH
Confidence            99999999999999999999999999999999876543211   1111233467799999987655 7899999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |..||......+....+.......                               .+...+..+++++.+||.
T Consensus       191 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~cl~  239 (256)
T cd05113         191 MWEVYSLGKMPYERFNNSETVEKVSQGLRLY-------------------------------RPHLASEKVYAIMYSCWH  239 (256)
T ss_pred             HHHHhcCCCCCcCcCCHHHHHHHHhcCCCCC-------------------------------CCCCCCHHHHHHHHHHcC
Confidence            999998 999998777655444443211110                               011235667799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .+|.+||++.+++.+
T Consensus       240 ~~p~~Rp~~~~ll~~  254 (256)
T cd05113         240 EKAEERPTFQQLLSS  254 (256)
T ss_pred             CCcccCCCHHHHHHh
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Bruton's tyrosine kinase (Btk) and Bone marrow kinase on the X chromosome (Bmx); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Btk and Bmx (also named Etk) are members of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds

>cd00192 PTKc Catalytic domain of Protein Tyrosine Kinases

Probab=100.00  E-value=4.8e-33  Score=259.16  Aligned_cols=210  Identities=24%  Similarity=0.424  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecC-cCCHHHHHhcc--------CCCCCHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNI--------HVKFSLGEIKKVIQ   78 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~--------~~~l~~~~~~~i~~   78 (433)
                      ..+.+|+.+++.++|+||+++++++.+.        ..+++||||+ +++|.+.+...        ...+++..++.++.
T Consensus        41 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  112 (262)
T cd00192          41 KDFLKEARVMKKLGHPNVVRLLGVCTEE--------EPLYLVLEYMEGGDLLDYLRKSRPVFPSPEKSTLSLKDLLSFAI  112 (262)
T ss_pred             HHHHHHHHHHhhcCCCChheeeeeecCC--------CceEEEEEeccCCcHHHHHhhccccccccccccCCHHHHHHHHH
Confidence            5678899999999999999999999874        6699999999 57899988775        36789999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |++.||+|||++|++|+||+|+||+++.++.++|+|||.+........  ........++..|+|||.+.... ++.++|
T Consensus       113 ~l~~al~~lH~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  189 (262)
T cd00192         113 QIAKGMEYLASKKFVHRDLAARNCLVGEDLVVKISDFGLSRDVYDDDY--YRKKTGGKLPIRWMAPESLKDGI-FTSKSD  189 (262)
T ss_pred             HHHHHHHHHHcCCcccCccCcceEEECCCCcEEEcccccccccccccc--cccccCCCcCccccCHHHhccCC-cchhhc
Confidence            999999999999999999999999999999999999999987653321  11223445678899999987654 799999


Q ss_pred             hhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||||++++|++ |..||......+....+......                               ..+...+.++.+
T Consensus       190 i~slG~il~~l~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~  238 (262)
T cd00192         190 VWSFGVLLWEIFTLGATPYPGLSNEEVLEYLRKGYRL-------------------------------PKPEYCPDELYE  238 (262)
T ss_pred             cHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------------------CCCccCChHHHH
Confidence            9999999999999 69999988766655544331000                               001123677889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ++.+||..+|++|||+++++++
T Consensus       239 li~~~l~~~p~~Rps~~~l~~~  260 (262)
T cd00192         239 LMLSCWQLDPEDRPTFSELVER  260 (262)
T ss_pred             HHHHHccCCcccCcCHHHHHHh
Confidence            9999999999999999999875

Protein Tyrosine Kinase (PTK) family, catalytic domain. This PTKc family is part of a larger superfamily that includes the catalytic domains of protein serine/threonine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. They can be classified into receptor and non-receptor tyr kinases. PTKs play important roles in many cellular processes including, lymphocyte activation, epithelium growth and maintenance, metabolism control, organogenesis regulation, survival, proliferation, differentiation, migration, adhesion, motility, and morphogenesis. Receptor tyr kinases (RTKs) are integral membrane proteins which contain an extracellular ligand-binding region, a transmembrane segment, and an intracellular tyr kinase domain. RTKs are usually activated through ligan

>cd05059 PTKc_Tec_like Catalytic domain of Tec-like Protein Tyrosine Kinases

Probab=100.00  E-value=4.6e-33  Score=259.37  Aligned_cols=210  Identities=20%  Similarity=0.342  Sum_probs=168.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++...        +..|+||||++ ++|.+++......+++..+..++.|++.||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~  114 (256)
T cd05059          43 EDDFIEEAKVMMKLSHPNLVQLYGVCTKQ--------RPIFIVTEYMANGCLLNYLRERKGKLGTEWLLDMCSDVCEAME  114 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEcCC--------CceEEEEecCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999998765        55899999996 4788888765557899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++||||||+||+++.++.+||+|||+++.......   .......++..|+|||.+.+.. ++.++||||+||+
T Consensus       115 ~lH~~~i~H~dl~p~ni~i~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~i  190 (256)
T cd05059         115 YLESNGFIHRDLAARNCLVGEDNVVKVSDFGLARYVLDDQY---TSSQGTKFPVKWAPPEVFDYSR-FSSKSDVWSFGVL  190 (256)
T ss_pred             HHHHCCcccccccHhhEEECCCCcEEECCcccceecccccc---cccCCCCCCccccCHHHhccCC-CCchhhHHHHHHH
Confidence            99999999999999999999999999999999876542211   1111122345799999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+.......                               .+...+....+++.+||.
T Consensus       191 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~cl~  239 (256)
T cd05059         191 MWEVFSEGKMPYERFSNSEVVESVSAGYRLY-------------------------------RPKLAPTEVYTIMYSCWH  239 (256)
T ss_pred             HHHHhccCCCCCCCCCHHHHHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHhc
Confidence            999998 899998877665554443211100                               011246677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .+|++|||+.++++.
T Consensus       240 ~~p~~Rpt~~~~l~~  254 (256)
T cd05059         240 EKPEDRPAFKKLLSQ  254 (256)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase expressed in hepatocellular carcinoma (Tec) subfamily; catalytic (c) domain. The Tec subfamily is composed of Tec, Btk, Bmx (Etk), Itk (Tsk, Emt), Rlk (Txk), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tec kinases are cytoplasmic (or nonreceptor) tyr kinases (nRTKs) with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows

>cd05049 PTKc_Trk Catalytic domain of the Protein Tyrosine Kinases, Tropomyosin Related Kinases

Probab=100.00  E-value=5.6e-33  Score=262.05  Aligned_cols=209  Identities=22%  Similarity=0.386  Sum_probs=167.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-------------CCCCHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-------------VKFSLGEI   73 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-------------~~l~~~~~   73 (433)
                      +.+.+|+++|+.++||||+++++++...        ...++||||+. ++|.+++....             ..+++..+
T Consensus        53 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~l~~~~~  124 (280)
T cd05049          53 KDFEREAELLTNFQHENIVKFYGVCTEG--------DPPIMVFEYMEHGDLNKFLRSHGPDAAFLKSPDSPMGELTLSQL  124 (280)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeEEecC--------CCeEEEEecCCCCCHHHHHHhcCCchhhhcccccccccccHHHH
Confidence            5788999999999999999999999875        56899999997 57888876532             24788899


Q ss_pred             HHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCC
Q psy7889          74 KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNY  153 (433)
Q Consensus        74 ~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~  153 (433)
                      ..++.|++.||.|||++|++|+||||+||+++.++.++|+|||++.........  .......++..|+|||++.+.. +
T Consensus       125 ~~~~~~i~~~l~~lH~~~i~h~dlkp~nili~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~  201 (280)
T cd05049         125 LQIAVQIASGMVYLASQHFVHRDLATRNCLVGYDLVVKIGDFGMSRDVYTTDYY--RVGGHTMLPIRWMPPESIMYRK-F  201 (280)
T ss_pred             HHHHHHHHHHHHHHhhCCeeccccccceEEEcCCCeEEECCcccceecccCcce--ecCCCCcccceecChhhhccCC-c
Confidence            999999999999999999999999999999999999999999998764322110  1112234567899999997765 7


Q ss_pred             CCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCC
Q psy7889         154 GPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD  232 (433)
Q Consensus       154 ~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  232 (433)
                      +.++|||||||++|+|++ |..||.+....+....+........                               +...+
T Consensus       202 ~~~~Di~slG~il~e~~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~  250 (280)
T cd05049         202 TTESDVWSFGVVLWEIFTYGKQPWYGLSNEEVIECITQGRLLQR-------------------------------PRTCP  250 (280)
T ss_pred             chhhhHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCcCCC-------------------------------CCCCC
Confidence            999999999999999998 9999988776665554432111000                               11245


Q ss_pred             hhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         233 QYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       233 ~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+.+++.+||..||.+||++.|+++
T Consensus       251 ~~~~~li~~~l~~~p~~Rp~~~eil~  276 (280)
T cd05049         251 SEVYDIMLGCWKRDPQQRINIKDIHE  276 (280)
T ss_pred             HHHHHHHHHHcCCCcccCCCHHHHHH
Confidence            66779999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase (Trk) subfamily; catalytic (c) domain. The Trk subfamily consists of TrkA, TrkB, TrkC, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Trk subfamily members are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, the nerve growth factor (NGF) family of neutrotrophins, leads to Trk receptor oligomerization and activation of the catalyt

>cd06614 STKc_PAK Catalytic domain of the Protein Serine/Threonine Kinase, p21-activated kinase

Probab=100.00  E-value=4.2e-33  Score=263.94  Aligned_cols=218  Identities=30%  Similarity=0.517  Sum_probs=176.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++|+||+++++.+...        ...|+|+||+. ++|.+++......++...+..++.|++.||.
T Consensus        59 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~i~~~i~~~L~  130 (286)
T cd06614          59 KELIINEILIMKDCKHPNIVDYYDSYLVG--------DELWVVMEYMDGGSLTDIITQNFVRMNEPQIAYVCREVLQGLE  130 (286)
T ss_pred             HHHHHHHHHHHHHCCCCCeeEEEEEEEEC--------CEEEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        66999999998 6898888775547899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       131 ~lH~~gi~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slGvi  205 (286)
T cd06614         131 YLHSQNVIHRDIKSDNILLSKDGSVKLADFGFAAQLTKEKS----KRNSVVGTPYWMAPEVIKRKD-YGPKVDIWSLGIM  205 (286)
T ss_pred             HHHhCCeeeCCCChhhEEEcCCCCEEECccchhhhhccchh----hhccccCCcccCCHhHhcCCC-CCCccccHHHHHH
Confidence            99999999999999999999999999999998866543211    122335678899999987655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||...........+... + ...  ..                         .+...+.++.+||.+||+.
T Consensus       206 l~~l~~g~~p~~~~~~~~~~~~~~~~-~-~~~--~~-------------------------~~~~~~~~l~~li~~~l~~  256 (286)
T cd06614         206 CIEMAEGEPPYLREPPLRALFLITTK-G-IPP--LK-------------------------NPEKWSPEFKDFLNKCLVK  256 (286)
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhc-C-CCC--Cc-------------------------chhhCCHHHHHHHHHHhcc
Confidence            99999999999887666544443221 0 000  00                         0011345677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +|.+||++.++++|+||....
T Consensus       257 ~p~~Rpt~~~il~~~~~~~~~  277 (286)
T cd06614         257 DPEKRPSAEELLQHPFLKKAC  277 (286)
T ss_pred             ChhhCcCHHHHhhChHhhccC
Confidence            999999999999999997743

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAK deregulation is associated with tumor development. PAKs from higher eukaryotes are classified into two grou

>cd06629 STKc_MAPKKK_Bck1_like Catalytic domain of fungal Bck1-like MAP Kinase Kinase Kinases

Probab=100.00  E-value=7.7e-33  Score=260.07  Aligned_cols=217  Identities=23%  Similarity=0.442  Sum_probs=169.4

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||+++++++...        ..+++||||+.+ +|.+.+.+. ..+++..++.++.|++.||.||
T Consensus        54 ~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~~l~~l  124 (272)
T cd06629          54 ALRSEIETLKDLDHLNIVQYLGFETTE--------EYLSIFLEYVPGGSIGSCLRTY-GRFEEQLVRFFTEQVLEGLAYL  124 (272)
T ss_pred             HHHHHHHHHHhcCCCCcceEEEEeccC--------CceEEEEecCCCCcHHHHHhhc-cCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999998765        568999999974 788877664 4789999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchhhhHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDLWGAGCIM  166 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGvil  166 (433)
                      |++|++|+||+|+||+++.++.++|+|||++........  ........++..|+|||++.+.. .++.++|+||+||++
T Consensus       125 H~~~i~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~~--~~~~~~~~~~~~y~~PE~~~~~~~~~~~~~Dv~slG~~l  202 (272)
T cd06629         125 HSKGILHRDLKADNLLVDADGICKISDFGISKKSDDIYD--NDQNMSMQGSVFWMAPEVIHSYSQGYSAKVDIWSLGCVV  202 (272)
T ss_pred             hhCCeeecCCChhhEEEcCCCeEEEeecccccccccccc--ccccccccCCccccCHHHhccccCCCCccchhHHHHHHH
Confidence            999999999999999999999999999999876542111  11123345788999999987643 368899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||...........+..   ......++.                      .. ....+.++.++|.+||..+
T Consensus       203 ~~l~~g~~p~~~~~~~~~~~~~~~---~~~~~~~~~----------------------~~-~~~~~~~~~~li~~~l~~~  256 (272)
T cd06629         203 LEMFAGRRPWSDEEAIAAMFKLGN---KRSAPPIPP----------------------DV-SMNLSPVALDFLNACFTIN  256 (272)
T ss_pred             HHHHhCCCCCcCcchHHHHHHhhc---cccCCcCCc----------------------cc-cccCCHHHHHHHHHHhcCC
Confidence            999999999976554433322211   100000000                      00 0124667889999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||+++++|+||||
T Consensus       257 p~~Rps~~~il~~~~~  272 (272)
T cd06629         257 PDNRPTARELLQHPFI  272 (272)
T ss_pred             hhhCCCHHHHhhCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, fungal Bck1-like proteins, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include the MAPKKKs Saccharomyces cerevisiae Bck1 and Schizosaccharomyces pombe Mkh1, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Budding yeast Bck1 is part of the cell inte

>cd06642 STKc_STK25-YSK1 Catalytic domain of the Protein Serine/Threonine Kinase, STK25 or Yeast Sps1/Ste20-related kinase 1

Probab=100.00  E-value=1.9e-33  Score=265.13  Aligned_cols=213  Identities=24%  Similarity=0.365  Sum_probs=169.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        ...|+||||+++ +|.+.+..  ..+++..++.++.|++.||.|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~~i~~~l~~  116 (277)
T cd06642          47 EDIQQEITVLSQCDSPYITRYYGSYLKG--------TKLWIIMEYLGGGSALDLLKP--GPLEETYIATILREILKGLDY  116 (277)
T ss_pred             HHHHHHHHHHHcCCCCccHhhhcccccC--------CceEEEEEccCCCcHHHHhhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999865        568999999985 67666643  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+||++
T Consensus       117 lH~~~ivH~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~il  191 (277)
T cd06642         117 LHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSA-YDFKADIWSLGITA  191 (277)
T ss_pred             HhcCCeeccCCChheEEEeCCCCEEEccccccccccCcc----hhhhcccCcccccCHHHhCcCC-CchhhhHHHHHHHH
Confidence            999999999999999999999999999999987664321    1122345788899999987754 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||...........+..  +.  ...                           .+...+.++.++|.+||..+
T Consensus       192 ~el~tg~~p~~~~~~~~~~~~~~~--~~--~~~---------------------------~~~~~~~~~~~li~~~l~~~  240 (277)
T cd06642         192 IELAKGEPPNSDLHPMRVLFLIPK--NS--PPT---------------------------LEGQYSKPFKEFVEACLNKD  240 (277)
T ss_pred             HHHHhCCCCCcccchhhHHhhhhc--CC--CCC---------------------------CCcccCHHHHHHHHHHccCC
Confidence            999999999976554433222110  00  000                           00123456779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+||++.++++||||....
T Consensus       241 p~~Rp~~~~il~~~~~~~~~  260 (277)
T cd06642         241 PRFRPTAKELLKHKFITRYT  260 (277)
T ss_pred             cccCcCHHHHHHhHHHHHHh
Confidence            99999999999999996543

Serine/threonine kinases (STKs), STK25 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The STK25 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. STK25 is also called Ste20/oxidant stress response kinase 1 (SOK1) or yeast Sps1/Ste20-related kinase 1 (YSK1). STK25 is localized in the Golgi apparatus through its interaction with the Golgi matrix protein GM130. It may play a role in the regulation of cell migration and polarization. STK25 binds and phosphorylates CCM3 (cerebral cavernous malformation 3), also called PCD10 (programmed cell death 10), and may play a role in apoptosis. Human STK25

>cd06640 STKc_MST4 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 4

Probab=100.00  E-value=5.8e-33  Score=261.82  Aligned_cols=215  Identities=26%  Similarity=0.398  Sum_probs=172.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ...|+||||+++ +|.+.+..  ..+++..+..++.|++.||+|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~--~~l~~~~~~~~~~~l~~~l~~  116 (277)
T cd06640          47 EDIQQEITVLSQCDSPYVTKYYGSYLKG--------TKLWIIMEYLGGGSALDLLRA--GPFDEFQIATMLKEILKGLDY  116 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC--------CEEEEEEecCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        669999999975 77777754  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.+++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||++.+.. ++.++|+||+||++
T Consensus       117 lh~~~ivH~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~apE~~~~~~-~~~~~Dv~slG~il  191 (277)
T cd06640         117 LHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIQQSA-YDSKADIWSLGITA  191 (277)
T ss_pred             HHhCCccCcCCChhhEEEcCCCCEEEcccccceeccCCc----cccccccCcccccCHhHhccCC-CccHHHHHHHHHHH
Confidence            999999999999999999999999999999987654321    1122345688899999987655 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.........+..  +. .+.               .             ....+..+.++|.+||..+
T Consensus       192 ~el~tg~~p~~~~~~~~~~~~~~~--~~-~~~---------------~-------------~~~~~~~~~~li~~~l~~~  240 (277)
T cd06640         192 IELAKGEPPNSDMHPMRVLFLIPK--NN-PPT---------------L-------------TGEFSKPFKEFIDACLNKD  240 (277)
T ss_pred             HHHHHCCCCCCCcChHhHhhhhhc--CC-CCC---------------C-------------chhhhHHHHHHHHHHcccC
Confidence            999999999987665543332211  00 000               0             0012345669999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      |.+||++++++.|+||......
T Consensus       241 p~~Rp~~~~il~~~~~~~~~~~  262 (277)
T cd06640         241 PSFRPTAKELLKHKFIVKNAKK  262 (277)
T ss_pred             cccCcCHHHHHhChHhhhcchh
Confidence            9999999999999999766543

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 4 (MST4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST4 is sometimes referred to as MASK (MST3 and SOK1-related kinase). It plays a role in mitogen-activated protein kinase (MAPK) signaling during cytoskeletal rearrangement, morphogenesis, and apoptosis. It influences cell growth and transformation by modulating the extracellular signal-regulated kinase (ERK) pathway. MST4 may also play a role in tumor formation and progression. It localizes in the Golgi apparatus by inter

>cd06917 STKc_NAK1_like Catalytic domain of Fungal Nak1-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.2e-33  Score=262.54  Aligned_cols=215  Identities=24%  Similarity=0.422  Sum_probs=172.5

Q ss_pred             hhHHHHHHHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+++++.++   ||||+++++++...        ...|+||||+.+ +|.+++..  ..+++..++.++.|++.|
T Consensus        44 ~~~~~e~~~l~~l~~~~~~~vi~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~i~~~  113 (277)
T cd06917          44 SDIQREVALLSQLRQSQPPNITKYYGSYLKG--------PRLWIIMEYAEGGSVRTLMKA--GPIAEKYISVIIREVLVA  113 (277)
T ss_pred             HHHHHHHHHHHHhccCCCCCeeeEeeeeeeC--------CEEEEEEecCCCCcHHHHHHc--cCCCHHHHHHHHHHHHHH
Confidence            45788999999996   99999999998765        668999999975 67776654  368999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||+.||+|+||+|+||+++.++.++|+|||++.......    .......|+..|+|||.+.+...++.++|+||+|
T Consensus       114 l~~lh~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Dv~slG  189 (277)
T cd06917         114 LKYIHKVGVIHRDIKAANILVTNTGNVKLCDFGVAALLNQNS----SKRSTFVGTPYWMAPEVITEGKYYDTKADIWSLG  189 (277)
T ss_pred             HHHHHhCCcccCCcCHHHEEEcCCCCEEEccCCceeecCCCc----cccccccCCcceeCHHHhccCCccccchhHHHHH
Confidence            999999999999999999999999999999999997765432    1123346788999999987655578999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.........+..    ..+..                          +.....+.++.+++.+||
T Consensus       190 ~~l~~ll~g~~p~~~~~~~~~~~~~~~----~~~~~--------------------------~~~~~~~~~~~~~i~~~l  239 (277)
T cd06917         190 ITIYEMATGNPPYSDVDAFRAMMLIPK----SKPPR--------------------------LEDNGYSKLLREFVAACL  239 (277)
T ss_pred             HHHHHHHhCCCCCCCCChhhhhhcccc----CCCCC--------------------------CCcccCCHHHHHHHHHHc
Confidence            999999999999987654433221111    00000                          001114566779999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +.||++||++.+++.|+||.+..
T Consensus       240 ~~~p~~R~~~~~il~~~~~~~~~  262 (277)
T cd06917         240 DEEPKERLSAEELLKSKWIKAHS  262 (277)
T ss_pred             CCCcccCcCHHHHhhChHhhccc
Confidence            99999999999999999997654

Serine/threonine kinases (STKs), Nak1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nak1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of Schizosaccharomyces pombe Nak1, Saccharomyces cerevisiae Kic1p (kinase that interacts with Cdc31p) and related proteins. Nak1 (also known as N-rich kinase 1), is required by fission yeast for polarizing the tips of actin cytoskeleton and is involved in cell growth, cell separation, cell morphology and cell-cycle progression. Kic1p is required by budding yeast for cell integrity and morphogenesis. Kic1p interacts with Cdc31p, the yeast homologue of cent

>cd05077 PTK_Jak1_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=100.00  E-value=5e-33  Score=260.20  Aligned_cols=203  Identities=19%  Similarity=0.272  Sum_probs=158.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..+        ...++||||+++ +|..++......+++..++.++.||+.||+|
T Consensus        49 ~~~~~~~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  120 (262)
T cd05077          49 LAFFETASMMRQVSHKHIVLLYGVCVRD--------VENIMVEEFVEFGPLDLFMHRKSDVLTTPWKFKVAKQLASALSY  120 (262)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecC--------CCCEEEEecccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4677889999999999999999999875        457999999985 5555555545568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCc-------EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          87 IHSNKILHRDMKAANVLITKTGI-------LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~-------~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ||++||+||||||+|||++.++.       ++++|||++......        ....++..|+|||++.....++.++||
T Consensus       121 lH~~~ivH~dlkp~Nill~~~~~~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~Di  192 (262)
T cd05077         121 LEDKDLVHGNVCTKNILLAREGIDGECGPFIKLSDPGIPITVLSR--------QECVERIPWIAPECVEDSKNLSIAADK  192 (262)
T ss_pred             hhhCCeECCCCCcccEEEecCCccCCCCceeEeCCCCCCccccCc--------ccccccccccChhhhcCCCCCCchhHH
Confidence            99999999999999999987664       899999988654321        223567889999998755568999999


Q ss_pred             hhHHHHHHHHH-hcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMW-TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||+||++|+|+ .|.+||......+.......   .. .                             .....+.++.+|
T Consensus       193 wslG~~l~el~~~~~~p~~~~~~~~~~~~~~~---~~-~-----------------------------~~~~~~~~~~~l  239 (262)
T cd05077         193 WSFGTTLWEICYNGEIPLKDKTLAEKERFYEG---QC-M-----------------------------LVTPSCKELADL  239 (262)
T ss_pred             HHHHHHHHHHHhCCCCCCCCcchhHHHHHHhc---Cc-c-----------------------------CCCCChHHHHHH
Confidence            99999999998 58888876554332211110   00 0                             000123456799


Q ss_pred             HHhhcccCCCCCCCHHHhhcC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h  259 (433)
                      |.+||+.||.+||+..+++++
T Consensus       240 i~~cl~~dp~~Rp~~~~il~~  260 (262)
T cd05077         240 MTHCMNYDPNQRPFFRAIMRD  260 (262)
T ss_pred             HHHHcCCChhhCcCHHHHHHh
Confidence            999999999999999999875

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalytic dom

>cd06632 STKc_MEKK1_plant Catalytic domain of the Protein Serine/Threonine Kinase, Plant MAP/ERK kinase kinase 1

Probab=100.00  E-value=6.9e-33  Score=257.92  Aligned_cols=211  Identities=28%  Similarity=0.441  Sum_probs=170.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|+||+++++++...        ..+|+||||+++ +|.+++.+. ..+++..+..++.||+.||+|
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~~i~~~l~~  117 (258)
T cd06632          47 KQLEQEIALLSKLQHPNIVQYLGTEREE--------DNLYIFLELVPGGSLAKLLKKY-GSFPEPVIRLYTRQILLGLEY  117 (258)
T ss_pred             HHHHHHHHHHHhcCCCCchheeeeEecC--------CeEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999998765        568999999975 787777653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.+||+|||++.......     ......++..|+|||.+.....++.++|+||+||++
T Consensus       118 lH~~~i~H~dl~~~ni~~~~~~~~kl~d~~~~~~~~~~~-----~~~~~~~~~~y~~pe~~~~~~~~~~~~D~~slG~~l  192 (258)
T cd06632         118 LHDRNTVHRDIKGANILVDTNGVVKLADFGMAKQVVEFS-----FAKSFKGSPYWMAPEVIAQQGGYGLAADIWSLGCTV  192 (258)
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEccCccceeccccc-----cccccCCCcceeCHHHhcCCCCCCchhhhHHHHHHH
Confidence            999999999999999999999999999999987754321     123456788899999986544478999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||...........+......   ..                           .+...+..+.+++.+||..+
T Consensus       193 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~---~~---------------------------~~~~~~~~~~~li~~~l~~~  242 (258)
T cd06632         193 LEMATGKPPWSQLEGVAAVFKIGRSKEL---PP---------------------------IPDHLSDEAKDFILKCLQRD  242 (258)
T ss_pred             HHHHhCCCCcccCcHHHHHHHHHhcccC---CC---------------------------cCCCcCHHHHHHHHHHhhcC
Confidence            9999999999876644433332210000   00                           01124566779999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||++.+++.|||+
T Consensus       243 p~~Rp~~~~~l~~~~~  258 (258)
T cd06632         243 PSLRPTAAELLEHPFV  258 (258)
T ss_pred             cccCcCHHHHhcCCCC
Confidence            9999999999999996

Serine/threonine kinases (STKs), plant MAP/ERK kinase kinase 1 (MEKK1)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The plant MEKK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily is composed of plant mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks) including Arabidopsis thaliana MEKK1 and MAPKKK3. MEKK1 is a MAPKKK that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Arabidops

>cd05633 STKc_GRK3 Catalytic domain of the Protein Serine/Threonine Kinase, G protein-coupled Receptor Kinase 3

Probab=100.00  E-value=3.5e-33  Score=263.67  Aligned_cols=212  Identities=26%  Similarity=0.367  Sum_probs=163.6

Q ss_pred             HHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus        10 ~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .++|..+++.+   +||||+.+++++...        +..|+||||+.+ +|...+.. ...+++..+..++.|++.||.
T Consensus        41 ~~~~~~~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~-~~~l~~~~~~~i~~qi~~al~  111 (279)
T cd05633          41 ALNERIMLSLVSTGDCPFIVCMTYAFHTP--------DKLCFILDLMNGGDLHYHLSQ-HGVFSEKEMRFYATEIILGLE  111 (279)
T ss_pred             HHHHHHHHHHHhhCCCCcEeEEEEEEecC--------CeEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            45565555544   799999999999875        568999999985 67666654 346999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.||+|+||||+||+++.++.++|+|||++.......      .....|+..|+|||.+.+...++.++||||+||+
T Consensus       112 ~lH~~~ivH~dikp~Nil~~~~~~~~l~dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~  185 (279)
T cd05633         112 HMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK------PHASVGTHGYMAPEVLQKGTAYDSSADWFSLGCM  185 (279)
T ss_pred             HHHHCCcCCCCCCHHHEEECCCCCEEEccCCcceeccccC------ccCcCCCcCccCHHHhcCCCCCCchhhhHHHHHH
Confidence            9999999999999999999999999999999986553221      1234678999999998654457899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||.+....... .+.........                            ..+...+.++.++|.+||..
T Consensus       186 l~~l~~g~~pf~~~~~~~~~-~~~~~~~~~~~----------------------------~~~~~~~~~~~~li~~~l~~  236 (279)
T cd05633         186 LFKLLRGHSPFRQHKTKDKH-EIDRMTLTVNV----------------------------ELPDSFSPELKSLLEGLLQR  236 (279)
T ss_pred             HHHHHhCCCCcCCCCCcCHH-HHHHHhhcCCc----------------------------CCccccCHHHHHHHHHHhcC
Confidence            99999999999764322111 11111100000                            00112466778999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||.+|+     +++++++||||...
T Consensus       237 ~p~~R~~~~~~~~~~~~~h~~~~~~  261 (279)
T cd05633         237 DVSKRLGCLGRGAQEVKEHVFFKGI  261 (279)
T ss_pred             CHHHhcCCCCCCHHHHHhCccccCC
Confidence            999999     69999999999763

Serine/Threonine Kinases (STKs), G protein-coupled Receptor Kinase (GRK) subfamily, GRK3 isoform, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The GRK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. GRKs phosphorylate and regulate G protein-coupled receptors (GPCRs), the largest superfamily of cell surface receptors which regulate some part of nearly all physiological functions. Phosphorylated GPCRs bind to arrestins, which prevents further G protein signaling despite the presence of activating ligand. There are seven types of GRKs, named GRK1 to GRK7. GRK3 (also known as beta-adrenergic receptor kinase 2) is wi

>cd05104 PTKc_Kit Catalytic domain of the Protein Tyrosine Kinase, Kit

Probab=100.00  E-value=5.7e-33  Score=273.11  Aligned_cols=211  Identities=24%  Similarity=0.382  Sum_probs=163.3

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      +.+++|+.+|+.+ +|||||++++++...        +..++|||||+ |+|.+++....                    
T Consensus        83 ~~~~~Ei~il~~l~~HpnIv~l~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  154 (375)
T cd05104          83 EALMSELKVLSYLGNHINIVNLLGACTVG--------GPTLVITEYCCYGDLLNFLRRKRDSFICPKHEDHAEAALYKNL  154 (375)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeeeeeccC--------CcceeeehhccCCcHHHHHHhcccccccccccchhhhHHHHhh
Confidence            4678999999999 899999999999875        55899999997 57887775422                    


Q ss_pred             ------------------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCC
Q psy7889          66 ------------------------------------------------------VKFSLGEIKKVIQQLLNGLYYIHSNK   91 (433)
Q Consensus        66 ------------------------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~   91 (433)
                                                                            ..++++.+..++.||+.||+|||++|
T Consensus       155 ~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~~l~~lH~~~  234 (375)
T cd05104         155 LHQREMSCDSLNEYMDMKPGVSYVVPTKADKRRSVRSGSYIDQDVTSEILEEDELALDTEDLLSFSYQVAKGMSFLASKN  234 (375)
T ss_pred             hhhhcccchhhhhhhhcCCCcccccccccccccccccceecccccHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHHCC
Confidence                                                                  13678889999999999999999999


Q ss_pred             eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh
Q psy7889          92 ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT  171 (433)
Q Consensus        92 iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~  171 (433)
                      |+||||||+|||++.++.+||+|||++.........  .......++..|+|||++.+.. ++.++|||||||++|+|++
T Consensus       235 ivH~Dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~sDi~slG~~l~ellt  311 (375)
T cd05104         235 CIHRDLAARNILLTHGRITKICDFGLARDIRNDSNY--VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGILLWEIFS  311 (375)
T ss_pred             eeccCCchhhEEEECCCcEEEecCccceeccCcccc--cccCCCCCCcceeChhHhcCCC-CCCCCCHHHHHHHHHHHHh
Confidence            999999999999999999999999999766432211  1111223456799999997765 7999999999999999998


Q ss_pred             -cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCC
Q psy7889         172 -RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR  250 (433)
Q Consensus       172 -g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  250 (433)
                       |.+||.+.........+... +.. .                            ..+...+.++.+||.+||+.||++|
T Consensus       312 ~g~~p~~~~~~~~~~~~~~~~-~~~-~----------------------------~~~~~~~~~l~~li~~cl~~dP~~R  361 (375)
T cd05104         312 LGSSPYPGMPVDSKFYKMIKE-GYR-M----------------------------LSPECAPSEMYDIMKSCWDADPLKR  361 (375)
T ss_pred             cCCCCCCCCCchHHHHHHHHh-Ccc-C----------------------------CCCCCCCHHHHHHHHHHccCChhHC
Confidence             88999876544332222110 000 0                            0011235677899999999999999


Q ss_pred             CCHHHhhcC
Q psy7889         251 FDSDAALNH  259 (433)
Q Consensus       251 ~t~~e~L~h  259 (433)
                      |++.++++.
T Consensus       362 Ps~~eil~~  370 (375)
T cd05104         362 PTFKQIVQL  370 (375)
T ss_pred             cCHHHHHHH
Confidence            999999863

Protein Tyrosine Kinase (PTK) family; Kit (or c-Kit); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Kit is a member of the Platelet Derived Growth Factor Receptor (PDGFR) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of Kit to its ligand, the stem-cell factor (SCF), leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. Kit is important in the development of melanocytes, germ cells, mast cells, hematopoietic stem ce

>cd05579 STKc_MAST_like Catalytic domain of Microtubule-associated serine/threonine kinase-like proteins

Probab=100.00  E-value=4e-33  Score=260.25  Aligned_cols=218  Identities=34%  Similarity=0.520  Sum_probs=174.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++.+...        ..+|+||||+.+ +|.+++.+.. .+++..+..++.||+.||.
T Consensus        37 ~~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~~L~  107 (265)
T cd05579          37 VDQVLTERDILSQAQSPYVVKLYYSFQGK--------KNLYLVMEYLPGGDLASLLENVG-SLDEDVARIYIAEIVLALE  107 (265)
T ss_pred             HHHHHHHHHHHHhCCCcchhHHHHheecC--------cEEEEEEecCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHH
Confidence            34678899999999999999999998765        669999999975 8888877644 7899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc----cccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ----VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~----~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++|++|+||+|+||+++.++.++|+|||++..........    ........++..|+|||.+.+.. ++.++|+||
T Consensus       108 ~lH~~~i~H~di~~~nil~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~s  186 (265)
T cd05579         108 YLHSNGIIHRDLKPDNILIDSNGHLKLTDFGLSKVGLVRRQINLNDDEKEDKRIVGTPDYIAPEVILGQG-HSKTVDWWS  186 (265)
T ss_pred             HHHHcCeecCCCCHHHeEEcCCCCEEEEecccchhcccCcccccccccccccCcccCccccCHHHhcCCC-CCcchhhHH
Confidence            9999999999999999999999999999999987654321100    01122345678899999987765 789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++++|++|..||......+....+..  +...   ++.                         ....+..+.+||.+
T Consensus       187 lG~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~---~~~-------------------------~~~~~~~~~~~i~~  236 (265)
T cd05579         187 LGCILYEFLVGIPPFHGETPEEIFQNILN--GKIE---WPE-------------------------DVEVSDEAIDLISK  236 (265)
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHhc--CCcC---CCc-------------------------cccCCHHHHHHHHH
Confidence            99999999999999988776655444332  1110   000                         00135677899999


Q ss_pred             hcccCCCCCCCH---HHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDS---DAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~---~e~L~h~~~~~  264 (433)
                      ||+.+|.+|||+   .++|+||||..
T Consensus       237 ~l~~~p~~Rpt~~~~~~~l~~~~~~~  262 (265)
T cd05579         237 LLVPDPEKRLGAKSIEEIKNHPFFKG  262 (265)
T ss_pred             HhcCCHhhcCCCccHHHHhcCccccC
Confidence            999999999999   99999999953

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MAST kinase subfamily includes MAST kinases, MAST-like (MASTL) kinases, and fungal kinases with similarity to Saccharomyces cerevisiae Rim15 and Schizosaccharomyces pombe cek1. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. MASTL kinases carry only a catalytic domain which contains a long insert re

>cd05052 PTKc_Abl Catalytic domain of the Protein Tyrosine Kinase, Abelson kinase

Probab=100.00  E-value=9.5e-33  Score=258.29  Aligned_cols=208  Identities=22%  Similarity=0.366  Sum_probs=165.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+++++.++||||+++++++..+        +.+++||||++ ++|.+++.... ..+++..++.++.|++.||+
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~l~~~~~~~~~~ql~~~l~  118 (263)
T cd05052          47 EEFLKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTYGNLLDYLRECNRQEVNAVVLLYMATQISSAME  118 (263)
T ss_pred             HHHHHHHHHHHhCCCCChhheEEEEcCC--------CCcEEEEEeCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999998765        55899999996 57888876533 35899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||||+||+++.++.+||+|||++........   .......++..|+|||.+.+.. ++.++|||||||+
T Consensus       119 ~lH~~~i~H~dlkp~nil~~~~~~~kl~df~~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~i  194 (263)
T cd05052         119 YLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVL  194 (263)
T ss_pred             HHHhCCEeecccCcceEEEcCCCcEEeCCCcccccccccee---eccCCCCCccccCCHHHhccCC-CCchhHHHHHHHH
Confidence            99999999999999999999999999999999977643211   1111223356799999887655 7899999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+.....   .+                            .+...+.++.++|.+||.
T Consensus       195 l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~----------------------------~~~~~~~~~~~li~~cl~  243 (263)
T cd05052         195 LWEIATYGMSPYPGIDLSQVYELLEKGYR---ME----------------------------RPEGCPPKVYELMRACWQ  243 (263)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHHCCCC---CC----------------------------CCCCCCHHHHHHHHHHcc
Confidence            999998 9999988776554444322110   00                            011245677899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||++|||+.++++
T Consensus       244 ~~p~~Rp~~~~l~~  257 (263)
T cd05052         244 WNPSDRPSFAEIHQ  257 (263)
T ss_pred             CCcccCCCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Abelson (Abl) kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Abl (or c-Abl) is a ubiquitously-expressed cytoplasmic (or nonreceptor) tyr kinase that contains SH3, SH2, and tyr kinase domains in its N-terminal region, as well as nuclear localization motifs, a putative DNA-binding domain, and F- and G-actin binding domains in its C-terminal tail. It also contains a short autoinhibitory cap region in its N-terminus. Abl is normally inactive and requires phosphorylation and myristoylation for activation. Abl function depends on its subcellular localization. In the cytoplasm, Abl plays

>cd06620 PKc_MAPKK_Byr1_like Catalytic domain of fungal Byr1-like dual-specificity MAP kinase kinases

Probab=100.00  E-value=5.6e-33  Score=262.90  Aligned_cols=217  Identities=22%  Similarity=0.350  Sum_probs=169.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+++++.++||||+++++++...        ..+|+||||+++ +|...+.+ ...+++..++.++.+++.||.
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~~i~~~l~  117 (284)
T cd06620          47 RKQILRELQIMHECRSPYIVSFYGAFLNE--------NNICMCMEFMDCGSLDRIYKK-GGPIPVEILGKIAVAVVEGLT  117 (284)
T ss_pred             HHHHHHHHHHHHHcCCCCcceEeeeEecC--------CEEEEEEecCCCCCHHHHHHh-ccCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        569999999986 66666554 446899999999999999999


Q ss_pred             HHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||+ .|++|+||+|+||+++.++.++|+|||++.......      .....++..|+|||++.+. .++.++||||+||
T Consensus       118 ~LH~~~~i~H~dl~p~nil~~~~~~~~l~d~gl~~~~~~~~------~~~~~~~~~~~aPE~~~~~-~~~~~~Di~slG~  190 (284)
T cd06620         118 YLYNVHRIMHRDIKPSNILVNSRGQIKLCDFGVSGELINSI------ADTFVGTSTYMSPERIQGG-KYTVKSDVWSLGI  190 (284)
T ss_pred             HHHHhcCeeccCCCHHHEEECCCCcEEEccCCcccchhhhc------cCccccCcccCCHHHHccC-CCCccchHHHHHH
Confidence            9997 699999999999999999999999999986553221      1234678999999998765 4789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHH--------HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQ--------ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~--------~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      ++++|++|..||........        ...+........+                           .+.....+..+.
T Consensus       191 ~l~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~~~~~  243 (284)
T cd06620         191 SIIELALGKFPFAFSNIDDDGQDDPMGILDLLQQIVQEPPP---------------------------RLPSSDFPEDLR  243 (284)
T ss_pred             HHHHHHhCCCCCcccchhhhhhhhhhHHHHHHHHHhhccCC---------------------------CCCchhcCHHHH
Confidence            99999999999986544210        1111111100000                           000011345677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||.+||..||.+|||++|+++|+||.+..
T Consensus       244 ~li~~~l~~dp~~Rpt~~e~~~~~~~~~~~  273 (284)
T cd06620         244 DFVDACLLKDPTERPTPQQLCAMPPFIQAL  273 (284)
T ss_pred             HHHHHHhcCCcccCcCHHHHhcCccccccc
Confidence            999999999999999999999999996643

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, fungal Byr1-like proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of this group include

>KOG0696|consensus

Probab=100.00  E-value=5.7e-34  Score=263.59  Aligned_cols=211  Identities=26%  Similarity=0.386  Sum_probs=177.0

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +-.+.|-.+|... +-|.+++|+.+|++-        +.+|+||||+.| +|.--+. .-++|.++.+..++.+|+.||-
T Consensus       394 ectm~EKrvLAL~~kppFL~qlHScFQTm--------DRLyFVMEyvnGGDLMyhiQ-Q~GkFKEp~AvFYAaEiaigLF  464 (683)
T KOG0696|consen  394 ECTMVEKRVLALPGKPPFLVQLHSCFQTM--------DRLYFVMEYVNGGDLMYHIQ-QVGKFKEPVAVFYAAEIAIGLF  464 (683)
T ss_pred             cceehhhhheecCCCCchHHHHHHHhhhh--------hheeeEEEEecCchhhhHHH-HhcccCCchhhhhhHHHHHHhh
Confidence            3446677777766 588999999999986        779999999986 5554444 4568999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||++||||.+||+++.+|++||.|||+++.---..    ....+++||+.|+|||++...+ |+.++|+||+||+
T Consensus       465 FLh~kgIiYRDLKLDNvmLd~eGHiKi~DFGmcKEni~~~----~TTkTFCGTPdYiAPEIi~YqP-YgksvDWWa~GVL  539 (683)
T KOG0696|consen  465 FLHSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIFDG----VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGVL  539 (683)
T ss_pred             hhhcCCeeeeeccccceEeccCCceEeeecccccccccCC----cceeeecCCCcccccceEEecc-cccchhHHHHHHH
Confidence            9999999999999999999999999999999997632211    2346789999999999998766 8999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|||+.|++||.|.++.+..+.|..-.-..                                |-..|.++.+++..+|.+
T Consensus       540 LyEmlaGQpPFdGeDE~elF~aI~ehnvsy--------------------------------PKslSkEAv~ickg~ltK  587 (683)
T KOG0696|consen  540 LYEMLAGQPPFDGEDEDELFQAIMEHNVSY--------------------------------PKSLSKEAVAICKGLLTK  587 (683)
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHHccCcC--------------------------------cccccHHHHHHHHHHhhc
Confidence            999999999999999998888876522111                                123678899999999999


Q ss_pred             CCCCCCCH-----HHhhcCCCccC
Q psy7889         246 DPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      .|.+|..+     .++-.||||..
T Consensus       588 ~P~kRLGcg~~ge~di~~H~FFR~  611 (683)
T KOG0696|consen  588 HPGKRLGCGPEGERDIREHPFFRR  611 (683)
T ss_pred             CCccccCCCCccccchhhCcchhh
Confidence            99999865     78899999953

>cd06626 STKc_MEKK4 Catalytic domain of the Protein Serine/Threonine Kinase, MAP/ERK kinase kinase 4

Probab=100.00  E-value=1.5e-32  Score=256.69  Aligned_cols=219  Identities=30%  Similarity=0.486  Sum_probs=170.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++|+||+++++++...        +.+++|+||+.+ +|.+.+.+ ...+++..++.++.|++.||.
T Consensus        43 ~~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~~i~~~l~  113 (264)
T cd06626          43 IKEIADEMKVLELLKHPNLVKYYGVEVHR--------EKVYIFMEYCSGGTLEELLEH-GRILDEHVIRVYTLQLLEGLA  113 (264)
T ss_pred             HHHHHHHHHHHHhCCCCChhheeeeEecC--------CEEEEEEecCCCCcHHHHHhh-cCCCChHHHHHHHHHHHHHHH
Confidence            35678999999999999999999988764        669999999974 67777665 335889999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC--CCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR--NYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlG  163 (433)
                      |||+.||+|+||+|+||+++.++.+||+|||++..................++..|+|||++.+..  .++.++||||+|
T Consensus       114 ~lh~~~i~H~dl~~~nil~~~~~~~kl~d~g~~~~~~~~~~~~~~~~~~~~~~~~~~~PE~~~~~~~~~~~~~~Dv~s~G  193 (264)
T cd06626         114 YLHSHGIVHRDIKPANIFLDHNGVIKLGDFGCAVKLKNNTTTMGEEVQSLAGTPAYMAPEVITGGKGKGHGRAADIWSLG  193 (264)
T ss_pred             HHHHCCcccCCCCHHHEEECCCCCEEEcccccccccCCCCCcccccccCCcCCcCccChhhccCCCCCCCCcccchHHHH
Confidence            999999999999999999999999999999999876543221111122346688899999987643  268899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|..||.+............ .+..  ...+.                         ....+....+||.+||
T Consensus       194 ~il~~l~~g~~pf~~~~~~~~~~~~~~-~~~~--~~~~~-------------------------~~~~~~~~~~li~~~l  245 (264)
T cd06626         194 CVVLEMATGKRPWSELDNEFQIMFHVG-AGHK--PPIPD-------------------------SLQLSPEGKDFLDRCL  245 (264)
T ss_pred             HHHHHHHhCCCCccCCcchHHHHHHHh-cCCC--CCCCc-------------------------ccccCHHHHHHHHHHc
Confidence            999999999999976543322221111 1110  00000                         0113566779999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      +.+|.+|||+.+++.|||+
T Consensus       246 ~~~p~~R~~~~~i~~~~~~  264 (264)
T cd06626         246 ESDPKKRPTASELLQHPFV  264 (264)
T ss_pred             cCCcccCCCHHHHhcCCCC
Confidence            9999999999999999996

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 4 (MEKK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MEKK4 is a mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK or MKKK or MAP3K), that phosphorylates and activates MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. MEKK4 activates the c-Jun N-terminal kinase (JNK) and p38 MAPK signaling pathways by directly activating their respective MAPKKs, MKK4

>cd05094 PTKc_TrkC Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase C

Probab=100.00  E-value=1e-32  Score=262.00  Aligned_cols=209  Identities=22%  Similarity=0.432  Sum_probs=166.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSLG   71 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~~   71 (433)
                      ..+.+|+.+++.++||||+++++++...        +..++||||++ ++|.+++....               ..+++.
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~~  123 (291)
T cd05094          52 KDFQREAELLTNLQHEHIVKFYGVCGDG--------DPLIMVFEYMKHGDLNKFLRAHGPDAMILVDGQPRQAKGELGLS  123 (291)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccC--------CceEEEEecCCCCcHHHHHHhcCcccccccccccccCcCCCCHH
Confidence            4688999999999999999999999765        56899999996 58888876432               347899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .++.++.||+.||+|||++||+||||||+||+++.++.++|+|||++........  ........++..|+|||.+.+..
T Consensus       124 ~~~~i~~~i~~al~~lH~~~i~H~dlkp~Nil~~~~~~~~l~dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~  201 (291)
T cd05094         124 QMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRK  201 (291)
T ss_pred             HHHHHHHHHHHHHHHHHhCCeeecccCcceEEEccCCcEEECCCCcccccCCCce--eecCCCCCcceeecChHHhccCC
Confidence            9999999999999999999999999999999999999999999999876543211  11122345578899999987755


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       ++.++||||+||++|+|++ |.+||......+....+..  +....                             .+..
T Consensus       202 -~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~  249 (291)
T cd05094         202 -FTTESDVWSFGVILWEIFTYGKQPWFQLSNTEVIECITQ--GRVLE-----------------------------RPRV  249 (291)
T ss_pred             -CCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhC--CCCCC-----------------------------CCcc
Confidence             7899999999999999998 9999988776654443321  11000                             0112


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .+..+.+++.+||..+|++|||+.++++
T Consensus       250 ~~~~~~~li~~~l~~~P~~Rpt~~~v~~  277 (291)
T cd05094         250 CPKEVYDIMLGCWQREPQQRLNIKEIYK  277 (291)
T ss_pred             CCHHHHHHHHHHcccChhhCcCHHHHHH
Confidence            3556779999999999999999999975

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase C (TrkC); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkC is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkC to its ligand, neurotrophin 3 (NT3), results in receptor oligomerization and activation of the catalytic domain. TrkC is broadly expressed in the nervous system and in some n

>cd05578 STKc_Yank1 Catalytic domain of the Protein Serine/Threonine Kinase, Yank1

Probab=100.00  E-value=2.7e-33  Score=261.12  Aligned_cols=212  Identities=31%  Similarity=0.412  Sum_probs=170.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|++++++++||||+++++.+...        ..+|+|+||+.+ +|...+... ..+++..+..++.||+.||.
T Consensus        44 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~i~~~l~  114 (258)
T cd05578          44 VRNVLNERRILQELNHPFLVNLWYSFQDE--------ENMYLVVDLLLGGDLRYHLSQK-VKFSEEQVKFWICEIVLALE  114 (258)
T ss_pred             HHHHHHHHHHHHhCCCCChHHHHHhhcCC--------CeEEEEEeCCCCCCHHHHHHhc-CCcCHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999765        669999999975 777777654 57899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||+|+||+++.++.++|+|||++.......     ......++..|+|||++.+.. ++.++|+||+||+
T Consensus       115 ~lh~~~i~h~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~  188 (258)
T cd05578         115 YLHSKGIIHRDIKPDNILLDEQGHVHITDFNIATKVTPDT-----LTTSTSGTPGYMAPEVLCRQG-YSVAVDWWSLGVT  188 (258)
T ss_pred             HHHhCCeeccCCCHHHeEEcCCCCEEEeecccccccCCCc-----cccccCCChhhcCHHHHcccC-CCCcccchhhHHH
Confidence            9999999999999999999999999999999987654321     123345788899999987655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||......... .+.........                            ..+...+.++.++|.+||..
T Consensus       189 l~~l~~g~~p~~~~~~~~~~-~~~~~~~~~~~----------------------------~~~~~~~~~~~~~i~~~l~~  239 (258)
T cd05578         189 AYECLRGKRPYRGHSRTIRD-QIRAKQETADV----------------------------LYPATWSTEAIDAINKLLER  239 (258)
T ss_pred             HHHHHhCCCCCCCCCccHHH-HHHHHhccccc----------------------------cCcccCcHHHHHHHHHHccC
Confidence            99999999999876642111 11111110000                            01112356777999999999


Q ss_pred             CCCCCCCH--HHhhcCCCc
Q psy7889         246 DPSKRFDS--DAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~--~e~L~h~~~  262 (433)
                      ||.+||++  +|+++||||
T Consensus       240 ~p~~R~~~~~~~l~~~~~~  258 (258)
T cd05578         240 DPQKRLGDNLKDLKNHPYF  258 (258)
T ss_pred             ChhHcCCccHHHHhcCCCC
Confidence            99999999  999999998

Serine/Threonine Kinases (STKs), Yank1 or STK32A subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Yank1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. This subfamily contains uncharacterized STKs with similarity to the human protein designated Yank1 or STK32A.

>cd08219 STKc_Nek3 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 3

Probab=100.00  E-value=7.3e-33  Score=257.68  Aligned_cols=209  Identities=27%  Similarity=0.415  Sum_probs=169.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+.+|+.+++.++||||+++++.+.+.        +.+|+||||++ ++|.+.+... ...++++.++.++.|++.||
T Consensus        42 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~al  113 (255)
T cd08219          42 VEDSRKEAVLLAKMKHPNIVAFKESFEAD--------GHLYIVMEYCDGGDLMQKIKLQRGKLFPEDTILQWFVQMCLGV  113 (255)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEEC--------CEEEEEEeeCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            35678899999999999999999999876        66999999997 4788877653 33589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++||+|+||||+||+++.++.++|+|||.+........    ......++..|+|||++.+.. ++.++|+||+|+
T Consensus       114 ~~lH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~aPE~~~~~~-~~~~~Dv~slG~  188 (255)
T cd08219         114 QHIHEKRVLHRDIKSKNIFLTQNGKVKLGDFGSARLLTSPGA----YACTYVGTPYYVPPEIWENMP-YNNKSDIWSLGC  188 (255)
T ss_pred             HHHhhCCcccCCCCcceEEECCCCcEEEcccCcceeeccccc----ccccccCCccccCHHHHccCC-cCchhhhhhhch
Confidence            999999999999999999999999999999999876543211    122346788899999987655 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|.+||...+.......+........                               +...+..+.+||.+||.
T Consensus       189 i~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~  237 (255)
T cd08219         189 ILYELCTLKHPFQANSWKNLILKVCQGSYKPL-------------------------------PSHYSYELRSLIKQMFK  237 (255)
T ss_pred             hheehhhccCCCCCCCHHHHHHHHhcCCCCCC-------------------------------CcccCHHHHHHHHHHHh
Confidence            99999999999988776555444332111000                               01234567799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+||++.++++-
T Consensus       238 ~~P~~Rp~~~~il~~  252 (255)
T cd08219         238 RNPRSRPSATTILSR  252 (255)
T ss_pred             CCcccCCCHHHHhhc
Confidence            999999999999864

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 3 (Nek3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek3 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek3 is primarily localized in the cytoplasm and shows no cell cycle-dependent changes in its activity. It is present in the axons of neurons and affects morphogenesis and polarity through its regulation of microtubule acetylation. Nek3 modulates the signaling of the prolactin receptor through its activati

>KOG1989|consensus

Probab=100.00  E-value=4.6e-34  Score=288.36  Aligned_cols=217  Identities=24%  Similarity=0.392  Sum_probs=163.2

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeee-EEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEI-CRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~-~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+||++|+.|+ |+|||.++|. ......+  ...-.++|.||||. ++|.+++.++ ..+|++.+|..|+.++++|
T Consensus        79 ~~v~~EI~~MK~L~gh~nIV~yidss~~~~~~~--~~~~EvllLmEyC~gg~Lvd~mn~Rlq~~lte~eVLkIf~dv~~A  156 (738)
T KOG1989|consen   79 NAVKREIDIMKLLSGHKNIVSYIDSSAINRSSN--NGVWEVLLLMEYCKGGSLVDFMNTRLQTRLTEDEVLKIFYDVCEA  156 (738)
T ss_pred             HHHHHHHHHHHHhcCCCceeeEeccccccccCC--CceeEEEeehhhccCCcHHHHHHHHHhccCChHHHHHHHHHHHHH
Confidence            46788999999996 9999999993 3322111  01356899999999 6999999743 4459999999999999999


Q ss_pred             HHHHHhCC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-cccc----cCCcccccccCccccc--CCCCCC
Q psy7889          84 LYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-VNRY----TNRVVTLWYRPPELLL--GDRNYG  154 (433)
Q Consensus        84 L~~LH~~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-~~~~----~~~~gt~~y~aPE~~~--~~~~~~  154 (433)
                      +.+||.+.  |||||||-|||||+.+|.+||||||.+.-........ ...+    -....|+.|||||+|-  .....+
T Consensus       157 Va~mH~~~pPiIHRDLKiENvLls~~g~~KLCDFGSatt~~~~~~~~~e~~~ve~eI~k~TTp~YRsPEMIDlysg~pI~  236 (738)
T KOG1989|consen  157 VAAMHYLKPPIIHRDLKIENVLLSADGNYKLCDFGSATTKILSPTSAQEVNYVEEEIEKYTTPQYRSPEMIDLYSGLPIG  236 (738)
T ss_pred             HHHHhcCCCccchhhhhhhheEEcCCCCEEeCcccccccccCCCccHHHHHHHHHHHHhhCCccccChHHHhhhcCCCCc
Confidence            99999988  9999999999999999999999999885533221100 0000    0123489999999973  223378


Q ss_pred             CcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         155 PPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      .++|||+|||+||-|+....||...-...    |...                   ++.+|..           -.++..
T Consensus       237 eKsDIWALGclLYkLCy~t~PFe~sg~la----Ilng-------------------~Y~~P~~-----------p~ys~~  282 (738)
T KOG1989|consen  237 EKSDIWALGCLLYKLCYFTTPFEESGKLA----ILNG-------------------NYSFPPF-----------PNYSDR  282 (738)
T ss_pred             chhHHHHHHHHHHHHHHhCCCcCcCccee----EEec-------------------cccCCCC-----------ccHHHH
Confidence            99999999999999999999998653221    1111                   1111111           125677


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHD  260 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~  260 (433)
                      +.+||..||+.||.+||++.|++.+-
T Consensus       283 l~~LI~~mL~~nP~~RPnI~Qv~~~~  308 (738)
T KOG1989|consen  283 LKDLIRTMLQPNPDERPNIYQVLEEI  308 (738)
T ss_pred             HHHHHHHHhccCcccCCCHHHHHHHH
Confidence            78999999999999999999998654

>KOG0608|consensus

Probab=100.00  E-value=8.1e-34  Score=274.53  Aligned_cols=218  Identities=27%  Similarity=0.379  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+..|-.||...+.+-||+||..|+++        +.+|+||||++| |+.+++.+.. -|.|..++.++.+|..|+++
T Consensus       674 aHVKAERDILAEADn~WVVrLyySFQDk--------dnLYFVMdYIPGGDmMSLLIrmg-IFeE~LARFYIAEltcAies  744 (1034)
T KOG0608|consen  674 AHVKAERDILAEADNEWVVRLYYSFQDK--------DNLYFVMDYIPGGDMMSLLIRMG-IFEEDLARFYIAELTCAIES  744 (1034)
T ss_pred             hhhhhhhhhHhhcCCcceEEEEEEeccC--------CceEEEEeccCCccHHHHHHHhc-cCHHHHHHHHHHHHHHHHHH
Confidence            3567799999999999999999999998        559999999974 8888888754 68999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCcccccc--------CcC------------------------------Cc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ--------TKN------------------------------GQ  128 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~--------~~~------------------------------~~  128 (433)
                      .|+.|+|||||||+|||||.+|+|||+|||||.-+-.        ..+                              .+
T Consensus       745 VHkmGFIHRDiKPDNILIDrdGHIKLTDFGLCTGfRWTHdskYYq~gdH~RqDSmep~~e~~d~~~~lkvL~~ra~~~h~  824 (1034)
T KOG0608|consen  745 VHKMGFIHRDIKPDNILIDRDGHIKLTDFGLCTGFRWTHDSKYYQEGDHHRQDSMEPSPEWADISKCLKVLERRAMRQHQ  824 (1034)
T ss_pred             HHhccceecccCccceEEccCCceeeeeccccccceeccccccccCCCccccccCCCchhhccccccchHHHHHHHhhhh
Confidence            9999999999999999999999999999999943211        000                              00


Q ss_pred             cccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhh
Q psy7889         129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDL  208 (433)
Q Consensus       129 ~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~  208 (433)
                      .......+||..|+|||++... .|+..+|+||+|||||||+.|++||...+..++..++..         |........
T Consensus       825 r~~ahslvgt~nyiapevl~r~-g~~q~cdwws~gvil~em~~g~~pf~~~tp~~tq~kv~n---------w~~~l~~~~  894 (1034)
T KOG0608|consen  825 RILAHSLVGTPNYIAPEVLART-GYTQLCDWWSVGVILYEMLVGQPPFLADTPGETQYKVIN---------WRNFLHIPY  894 (1034)
T ss_pred             hhhhhhhcCCCcccChHHhccc-CccccchhhHhhHHHHHHhhCCCCccCCCCCcceeeeee---------hhhcccccc
Confidence            1112346899999999999764 489999999999999999999999998876655444422         221111111


Q ss_pred             hhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCC---CHHHhhcCCCccC
Q psy7889         209 YNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---DSDAALNHDFFWT  264 (433)
Q Consensus       209 ~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~---t~~e~L~h~~~~~  264 (433)
                                         --.+|.++.++|.++.. ++++|+   .++|+-.||||+.
T Consensus       895 -------------------~~~ls~e~~~li~kLc~-sad~RLGkng~d~vKaHpfFkg  933 (1034)
T KOG0608|consen  895 -------------------QGNLSKEALDLIQKLCC-SADSRLGKNGADQVKAHPFFKG  933 (1034)
T ss_pred             -------------------ccccCHHHHHHHHHHhc-ChhhhhcccchhhhhcCccccc
Confidence                               12368899999998764 778886   4678999999964

>cd08225 STKc_Nek5 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 5

Probab=100.00  E-value=7.7e-33  Score=257.56  Aligned_cols=212  Identities=28%  Similarity=0.483  Sum_probs=170.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-CCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+++++.++|+||+++++.+...        ...|+|+||+.+ +|.+.+..... .+++..+..++.|++.||
T Consensus        43 ~~~~~~E~~~l~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~~l  114 (257)
T cd08225          43 KEASKKEVILLAKMKHPNIVTFFASFQEN--------GRLFIVMEYCDGGDLMKRINRQRGVLFSEDQILSWFVQISLGL  114 (257)
T ss_pred             hHHHHHHHHHHHhCCCCChhhhhheeccC--------CeEEEEEecCCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            45678999999999999999999998765        669999999964 88887765433 478999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      .|||+.+++|+||||+||+++.++ .++|+|||.+........    ......|+..|+|||++.+.. ++.++|+||+|
T Consensus       115 ~~lh~~~i~H~dl~~~nil~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG  189 (257)
T cd08225         115 KHIHDRKILHRDIKSQNIFLSKNGMVAKLGDFGIARQLNDSME----LAYTCVGTPYYLSPEICQNRP-YNNKTDIWSLG  189 (257)
T ss_pred             HHHHHCCcccccCCHHHEEEcCCCCeEEecccccchhccCCcc----cccccCCCccccCHHHHcCCC-CCchhhHHHHH
Confidence            999999999999999999999876 569999999877643221    122345788999999887654 78999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|..||......+....+..  +..     ...                        .-..+.++.++|.+||
T Consensus       190 ~il~~l~~g~~p~~~~~~~~~~~~~~~--~~~-----~~~------------------------~~~~~~~~~~~i~~~l  238 (257)
T cd08225         190 CVLYELCTLKHPFEGNNLHQLVLKICQ--GYF-----API------------------------SPNFSRDLRSLISQLF  238 (257)
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHhc--ccC-----CCC------------------------CCCCCHHHHHHHHHHh
Confidence            999999999999987765554433221  100     000                        0124566789999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..+|++|||+.+++.||||
T Consensus       239 ~~~p~~Rpt~~~ll~~~~~  257 (257)
T cd08225         239 KVSPRDRPSITSILKRPFL  257 (257)
T ss_pred             ccChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 5 (Nek5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek5 subfamily is one of a family of 11 different Neks (Nek1-11). The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Neks are involved in the regulation of downstream processes following the activation of Cdc2, and many of their functions are cell cycle-related. They play critical roles in microtubule dynamics during ciliogenesis and mitosis. The specific function of Nek5 is unknown.

>cd05122 PKc_STE Catalytic domain of STE family Protein Kinases

Probab=100.00  E-value=1.8e-32  Score=253.55  Aligned_cols=212  Identities=33%  Similarity=0.496  Sum_probs=174.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++|+||+++++++..+        ...++++||++ ++|.+++......+++..+..++.|++.||.
T Consensus        41 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~l~~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~  112 (253)
T cd05122          41 KEKIINEIQILKKCKHPNIVKYYGSYLKK--------DELWIVMEFCSGGSLKDLLKSTNQTLTESQIAYVCKELLKGLE  112 (253)
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecC--------CeEEEEEecCCCCcHHHHHhhcCCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999876        55899999998 6888888765567899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      +||+.|++|+||+|+||+++.++.++|+|||.+........     .....++..|+|||.+.+.. ++.++|+||+||+
T Consensus       113 ~lh~~~i~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~-----~~~~~~~~~~~~PE~~~~~~-~~~~~Dv~slG~i  186 (253)
T cd05122         113 YLHSNGIIHRDIKAANILLTSDGEVKLIDFGLSAQLSDTKA-----RNTMVGTPYWMAPEVINGKP-YDYKADIWSLGIT  186 (253)
T ss_pred             HhhcCCEecCCCCHHHEEEccCCeEEEeecccccccccccc-----ccceecCCcccCHHHHcCCC-CCccccHHHHHHH
Confidence            99999999999999999999999999999999877653321     23446688899999987765 6899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...+....+..+.....   + ..                         ..+...+..+.++|.+||+.
T Consensus       187 l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-~~-------------------------~~~~~~~~~~~~~i~~~l~~  237 (253)
T cd05122         187 AIELAEGKPPYSELPPMKALFKIATNGP---P-GL-------------------------RNPEKWSDEFKDFLKKCLQK  237 (253)
T ss_pred             HHHHHhCCCCCCCCchHHHHHHHHhcCC---C-Cc-------------------------CcccccCHHHHHHHHHHccC
Confidence            9999999999987765554443332100   0 00                         00111356778999999999


Q ss_pred             CCCCCCCHHHhhcCCC
Q psy7889         246 DPSKRFDSDAALNHDF  261 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~  261 (433)
                      ||++|||+.++|.|||
T Consensus       238 ~p~~R~t~~~~l~~~~  253 (253)
T cd05122         238 NPEKRPTAEQLLKHPF  253 (253)
T ss_pred             ChhhCCCHHHHhcCCC
Confidence            9999999999999998

Protein Kinases (PKs), STE family, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The STE family is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases (STKs), protein tyrosine kinases (PTKs), RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). This family is composed of STKs, and some dual-specificity PKs that phosphorylate both threonine and tyrosine residues of target proteins. Most members are kinases involved in mitogen-activated protein kinase (MAPK) signaling cascades, acting as MAPK kinases (MAPKKs), MAPK kinase kinases (MAPKKKs), or MAPK kinase kinase kinases (MAP4Ks). The MAPK signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core

>cd05062 PTKc_IGF-1R Catalytic domain of the Protein Tyrosine Kinase, Insulin-like Growth Factor-1 Receptor

Probab=100.00  E-value=1e-32  Score=260.12  Aligned_cols=209  Identities=20%  Similarity=0.339  Sum_probs=163.9

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC---------CCCHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV---------KFSLGEIKKVIQ   78 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~---------~l~~~~~~~i~~   78 (433)
                      .+.+|+.+++.++||||+++++++...        ...++||||++ ++|.+++.+...         .++...+..++.
T Consensus        55 ~~~~e~~~l~~l~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (277)
T cd05062          55 EFLNEASVMKEFNCHHVVRLLGVVSQG--------QPTLVIMELMTRGDLKSYLRSLRPEMENNPVQAPPSLKKMIQMAG  126 (277)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCC--------CCeEEEEecCCCCCHHHHHHHcCccccccccccCCCHHHHHHHHH
Confidence            477899999999999999999998764        56899999997 478888765322         256778899999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |++.||+|||+.|++|+||||+||+++.++.++|+|||++.........  .......++..|+|||++.+.. ++.++|
T Consensus       127 ~l~~~l~~lH~~~~vH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  203 (277)
T cd05062         127 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMSPESLKDGV-FTTYSD  203 (277)
T ss_pred             HHHHHHHHHHHCCcccCCcchheEEEcCCCCEEECCCCCccccCCccee--ecCCCCccCHhhcChhHhhcCC-cCchhH
Confidence            9999999999999999999999999999999999999998765422111  1112234567899999987655 799999


Q ss_pred             hhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||||++|+|++ |.+||.+.........+....  ...                             .+...+..+.+
T Consensus       204 i~slG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~--~~~-----------------------------~~~~~~~~~~~  252 (277)
T cd05062         204 VWSFGVVLWEIATLAEQPYQGMSNEQVLRFVMEGG--LLD-----------------------------KPDNCPDMLFE  252 (277)
T ss_pred             HHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC--cCC-----------------------------CCCCCCHHHHH
Confidence            9999999999998 789998877665554432211  000                             00113456779


Q ss_pred             HHHhhcccCCCCCCCHHHhhcC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ++.+||+.||++|||+.|++++
T Consensus       253 li~~~l~~~p~~Rps~~e~l~~  274 (277)
T cd05062         253 LMRMCWQYNPKMRPSFLEIISS  274 (277)
T ss_pred             HHHHHcCCChhhCcCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Insulin-like Growth Factor-1 Receptor (IGF-1R); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. IGF-1R is a receptor tyr kinases (RTK) that is composed of two alphabeta heterodimers. Binding of the ligand (IGF-1 or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, which stimulates downstream kinase activities and biological function. IGF-1R signaling is important in the differentiation, growth, and survival of normal cells. In cancer cells, wh

>cd05068 PTKc_Frk_like Catalytic domain of Fyn-related kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=2.1e-32  Score=255.61  Aligned_cols=209  Identities=23%  Similarity=0.362  Sum_probs=167.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecC-cCCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.++++++||||+++++++...        ..+|+||||+ .++|.+++.... ..+++..+..++.|++.||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l  116 (261)
T cd05068          45 PKDFLAEAQIMKKLRHPKLIQLYAVCTLE--------EPIYIVTELMKYGSLLEYLQGGAGRALKLPQLIDMAAQVASGM  116 (261)
T ss_pred             HHHHHHHHHHHHHCCCCCccceeEEEecC--------CCeeeeeecccCCcHHHHHhccCCCCCCHHHHHHHHHHHHHHH
Confidence            45688999999999999999999998765        5589999999 568988886643 4589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.||+|+||||+||+++.++.++|+|||++........   ........+..|+|||++.+.. ++.++|||||||
T Consensus       117 ~~lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  192 (261)
T cd05068         117 AYLEAQNYIHRDLAARNVLVGENNICKVADFGLARVIKEDIY---EAREGAKFPIKWTAPEAALYNR-FSIKSDVWSFGI  192 (261)
T ss_pred             HHHHhCCeeeccCCcceEEEcCCCCEEECCcceEEEccCCcc---cccCCCcCceeccCccccccCC-CCchhhHHHHHH
Confidence            999999999999999999999999999999999987652211   1111122245799999987654 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |.+||.+.........+......+.                               +...+..+.+++.+||
T Consensus       193 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l  241 (261)
T cd05068         193 LLTEIVTYGRMPYPGMTNAEVLQQVDQGYRMPC-------------------------------PPGCPKELYDIMLDCW  241 (261)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCcCCHHHHHHHHHHh
Confidence            9999999 9999998776655554432111000                               1123456779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      +.+|.+||++++++.
T Consensus       242 ~~~P~~Rp~~~~l~~  256 (261)
T cd05068         242 KEDPDDRPTFETLQW  256 (261)
T ss_pred             hcCcccCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Human Fyn-related kinase (Frk) and similar proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Frk and Srk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins a

>cd05058 PTKc_Met_Ron Catalytic domain of the Protein Tyrosine Kinases, Met and Ron

Probab=100.00  E-value=1.5e-32  Score=256.60  Aligned_cols=212  Identities=21%  Similarity=0.303  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...       .+..++||||+. ++|.+++.+....+++..+..++.|++.||.|
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  113 (262)
T cd05058          41 EQFLKEGIIMKDFSHPNVLSLLGICLPS-------EGSPLVVLPYMKHGDLRNFIRSETHNPTVKDLIGFGLQVAKGMEY  113 (262)
T ss_pred             HHHHHHHHHHccCCCCCcceEEEEeecC-------CCCcEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4677899999999999999999977643       245789999997 58888887655567788888999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++||||||+|||++.++.+||+|||++..................++..|+|||.+.+.. ++.++|||||||++
T Consensus       114 lH~~~i~H~dlk~~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  192 (262)
T cd05058         114 LASKKFVHRDLAARNCMLDESFTVKVADFGLARDIYDKEYYSVHNHTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  192 (262)
T ss_pred             HHhCCccccccCcceEEEcCCCcEEECCccccccccCCcceeecccccCcCCccccChhHhccCc-cchHHHHHHHHHHH
Confidence            99999999999999999999999999999998765322111111112334567899999987654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||...+..+....+..  +....                             .+...+..+.+++.+||..
T Consensus       193 ~el~~~~~~~~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~li~~cl~~  241 (262)
T cd05058         193 WELMTRGAPPYPDVDSFDITVYLLQ--GRRLL-----------------------------QPEYCPDPLYEVMLSCWHP  241 (262)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHhc--CCCCC-----------------------------CCCcCCHHHHHHHHHHcCC
Confidence            99999 5778877665544433321  10000                             0111345677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|++||++.+++.
T Consensus       242 ~p~~Rp~~~~il~  254 (262)
T cd05058         242 KPEMRPTFSELVS  254 (262)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Met and Ron; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Met and Ron are receptor tyr kinases (RTKs) composed of an alpha-beta heterodimer. The extracellular alpha chain is disulfide linked to the beta chain, which contains an extracellular ligand-binding region with a sema domain, a PSI domain and four IPT repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Met binds to the ligand, hepatocyte growth factor/scatter factor (HGF/SF), and is also ca

>cd05036 PTKc_ALK_LTK Catalytic domain of the Protein Tyrosine Kinases, Anaplastic Lymphoma Kinase and Leukocyte Tyrosine Kinase

Probab=100.00  E-value=1.3e-32  Score=259.47  Aligned_cols=210  Identities=21%  Similarity=0.371  Sum_probs=164.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC------CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH------VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~------~~l~~~~~~~i~~ql   80 (433)
                      ..+++|+.+++.++|+||+++++++...        ...++||||+. ++|.+++....      ..+++..+..++.||
T Consensus        54 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~g~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~qi  125 (277)
T cd05036          54 SDFLMEALIMSKFNHQNIVRLIGVSFER--------LPRFILLELMAGGDLKSFLRENRPRPERPSSLTMKDLLFCARDV  125 (277)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEccC--------CCcEEEEecCCCCCHHHHHHHhCCCCCCCCCCCHHHHHHHHHHH
Confidence            4588999999999999999999988765        44799999996 58888886543      248899999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      +.||+|||++|++|+||||+||+++.++   .+||+|||++........  .........+..|+|||++.+.. ++.++
T Consensus       126 ~~~l~~LH~~~ivH~dlkp~nil~~~~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  202 (277)
T cd05036         126 AKGCKYLEENHFIHRDIAARNCLLTCKGPGRVAKIADFGMARDIYRASY--YRKGGRAMLPIKWMPPEAFLDGI-FTSKT  202 (277)
T ss_pred             HHHHHHHHHCCEeecccchheEEEeccCCCcceEeccCccccccCCccc--eecCCCCCccHhhCCHHHHhcCC-cCchh
Confidence            9999999999999999999999998655   599999999977632111  01111223356799999997765 79999


Q ss_pred             hhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++|+|++ |..||.+....+....+...   ... .                           .+...+..+.
T Consensus       203 DiwslG~il~el~~~g~~pf~~~~~~~~~~~~~~~---~~~-~---------------------------~~~~~~~~~~  251 (277)
T cd05036         203 DVWSFGVLLWEIFSLGYMPYPGRTNQEVMEFVTGG---GRL-D---------------------------PPKGCPGPVY  251 (277)
T ss_pred             HHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcC---CcC-C---------------------------CCCCCCHHHH
Confidence            99999999999996 99999987766544433211   000 0                           0112355677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +++.+||+.+|++||++.++++|
T Consensus       252 ~~i~~cl~~~p~~Rps~~~vl~~  274 (277)
T cd05036         252 RIMTDCWQHTPEDRPNFATILER  274 (277)
T ss_pred             HHHHHHcCCCcccCcCHHHHHHH
Confidence            99999999999999999999976

Protein Tyrosine Kinase (PTK) family; Anaplastic Lymphoma Kinase (ALK) and Leukocyte Tyrosine (tyr) Kinase (LTK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyr residues in protein substrates. ALK and LTK are orphan receptor tyr kinases (RTKs) whose ligands are not yet well-defined. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. They are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. ALK appears to play an important role in mammalian neural development as well

>cd05115 PTKc_Zap-70 Catalytic domain of the Protein Tyrosine Kinase, Zeta-chain-associated protein of 70kDa

Probab=100.00  E-value=1.4e-32  Score=256.34  Aligned_cols=209  Identities=20%  Similarity=0.320  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+++.++||||+++++++..         ..+++||||++ ++|.+++......+++..++.++.|++.||+|
T Consensus        40 ~~~~~E~~~l~~l~h~~ii~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~  110 (257)
T cd05115          40 DEMMREAEIMHQLDNPYIVRMIGVCEA---------EALMLVMEMASGGPLNKFLSGKKDEITVSNVVELMHQVSMGMKY  110 (257)
T ss_pred             HHHHHHHHHHHhcCCCCeEEEEEEEcC---------CCeEEEEEeCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999998753         34799999997 57888887656679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.+||+|||++......... ........++..|+|||.+.+.. ++.++|||||||++
T Consensus       111 lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  188 (257)
T cd05115         111 LEGKNFVHRDLAARNVLLVNQHYAKISDFGLSKALGADDSY-YKARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGITM  188 (257)
T ss_pred             HHhcCeeecccchheEEEcCCCcEEeccCCccccccCCccc-eeccCCCCCCcccCCHHHHccCC-CCchhhHHHHHHHH
Confidence            99999999999999999999999999999999765432211 11112223356899999987655 78999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||.+....+....+......    .                           .+...+.++.++|.+||..
T Consensus       189 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~----~---------------------------~~~~~~~~l~~li~~c~~~  237 (257)
T cd05115         189 WEAFSYGQKPYKKMKGPEVMSFIEQGKRL----D---------------------------CPAECPPEMYALMKDCWIY  237 (257)
T ss_pred             HHHhcCCCCCcCcCCHHHHHHHHHCCCCC----C---------------------------CCCCCCHHHHHHHHHHcCC
Confidence            99996 99999887766554443221100    0                           0112356777999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|++||++.++++
T Consensus       238 ~~~~Rp~~~~i~~  250 (257)
T cd05115         238 KWEDRPNFAKVEE  250 (257)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999864

Protein Tyrosine Kinase (PTK) family; Zeta-chain-associated protein of 70kDa (Zap-70); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Zap-70 is a member of the Syk subfamily of kinases, which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Zap-70 is primarily expressed in T-cells and NK cells, and is a crucial component in T-cell receptor (TCR) signaling. Zap-70 binds the phosphorylated ITAM (immunoreceptor tyr activation motif) sequences of the activated TCR zeta-chain through its SH2 domains, leading to its pho

>cd05054 PTKc_VEGFR Catalytic domain of the Protein Tyrosine Kinases, Vascular Endothelial Growth Factor Receptors

Probab=100.00  E-value=1.6e-32  Score=266.11  Aligned_cols=212  Identities=21%  Similarity=0.389  Sum_probs=163.9

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~--------------------   65 (433)
                      ..+++|+++++++ +|+||+++++++...       ...+++||||+++ +|.+++....                    
T Consensus        55 ~~~~~E~~~~~~l~~h~niv~~~~~~~~~-------~~~~~~v~ey~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~  127 (337)
T cd05054          55 KALMTELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEYCKFGNLSNYLRSKRECFSPYRNKSTRKREMKQKE  127 (337)
T ss_pred             HHHHHHHHHHHhhccCcchhheeeeEecC-------CCCEEEEEecCCCCCHHHHHHhcccccccccccccccccccccc
Confidence            3567899999999 899999999988755       3568999999975 7777764321                    


Q ss_pred             ----------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEe
Q psy7889          66 ----------------------------------------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT  105 (433)
Q Consensus        66 ----------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~  105 (433)
                                                              ..++++.+..++.||+.||+|||++||+||||||+||+++
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~lH~~~ivHrDikp~Nill~  207 (337)
T cd05054         128 GKKQRLDSVSSSQSSASSGFIEDKSLSDVEEDEEGDELYKEPLTLEDLISYSFQVARGMEFLASRKCIHRDLAARNILLS  207 (337)
T ss_pred             ccccccccCCccccccccccccCcchhhcccchhhhHHhhcCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEEe
Confidence                                                    2578899999999999999999999999999999999999


Q ss_pred             cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHH
Q psy7889         106 KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQ  184 (433)
Q Consensus       106 ~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~  184 (433)
                      .++.++|+|||++..+......  .......++..|+|||++.+.. ++.++||||+||++++|++ |.+||.+....+.
T Consensus       208 ~~~~vkL~DfG~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~SlGv~l~el~t~g~~p~~~~~~~~~  284 (337)
T cd05054         208 ENNVVKICDFGLARDIYKDPDY--VRKGDARLPLKWMAPESIFDKV-YTTQSDVWSFGVLLWEIFSLGASPYPGVQIDEE  284 (337)
T ss_pred             CCCcEEEeccccchhcccCcch--hhccCCCCCccccCcHHhcCCC-CCccccHHHHHHHHHHHHHcCCCCCCCCCccHH
Confidence            9999999999999876432211  1122334567899999987765 7999999999999999998 9999987543332


Q ss_pred             HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       185 ~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ...... .+...                             ..+...+.++.+++.+||+.+|.+||+++|+++|
T Consensus       285 ~~~~~~-~~~~~-----------------------------~~~~~~~~~~~~l~~~cl~~~p~~RPs~~ell~~  329 (337)
T cd05054         285 FCRRLK-EGTRM-----------------------------RAPEYATPEIYSIMLDCWHNNPEDRPTFSELVEI  329 (337)
T ss_pred             HHHHHh-ccCCC-----------------------------CCCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            222111 00000                             0011245667899999999999999999999874

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor (VEGFR) subfamily; catalytic (c) domain. The VEGFR subfamily consists of VEGFR1 (Flt1), VEGFR2 (Flk1), VEGFR3 (Flt4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. In VEGFR3, the fifth Ig-like domain is replaced by a disulfide bridge. The binding of VEGFRs to their ligands, the VEGFs, leads to recepto

>cd05116 PTKc_Syk Catalytic domain of the Protein Tyrosine Kinase, Spleen tyrosine kinase

Probab=100.00  E-value=1.8e-32  Score=255.51  Aligned_cols=208  Identities=22%  Similarity=0.334  Sum_probs=165.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..         ...++||||+++ +|.+++.. ...+++..+..++.|++.||+|
T Consensus        41 ~~~~~e~~~l~~l~h~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~~  110 (257)
T cd05116          41 DELLREANVMQQLDNPYIVRMIGICEA---------ESWMLVMELAELGPLNKFLQK-NKHVTEKNITELVHQVSMGMKY  110 (257)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEcC---------CCcEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            467889999999999999999998753         347899999984 68777765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||.||+++.++.++|+|||++..+....... .......++..|+|||.+.... ++.++|||||||++
T Consensus       111 lH~~~i~H~dlkp~nill~~~~~~kl~Dfg~~~~~~~~~~~~-~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  188 (257)
T cd05116         111 LEETNFVHRDLAARNVLLVTQHYAKISDFGLSKALGADENYY-KAKTHGKWPVKWYAPECMNYYK-FSSKSDVWSFGVLM  188 (257)
T ss_pred             HHHCCEeecccchhhEEEcCCCeEEECCCccccccCCCCCee-eecCCCCCCccccCHhHhccCC-cCchhHHHHHHHHH
Confidence            999999999999999999999999999999997764332111 1112223457899999886554 78899999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+....+....+.......                               .+...+.++.++|.+||+.
T Consensus       189 ~el~t~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~li~~~~~~  237 (257)
T cd05116         189 WEAFSYGQKPYKGMKGNEVTQMIESGERME-------------------------------CPQRCPPEMYDLMKLCWTY  237 (257)
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHCCCCCC-------------------------------CCCCCCHHHHHHHHHHhcc
Confidence            99998 999998877666555543211100                               0112466778999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||++||+++++..
T Consensus       238 ~p~~Rp~~~~i~~  250 (257)
T cd05116         238 GVDERPGFAVVEL  250 (257)
T ss_pred             CchhCcCHHHHHH
Confidence            9999999998864

Protein Tyrosine Kinase (PTK) family; Spleen tyrosine kinase (Syk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk, together with Zap-70, form the Syk subfamily of kinases which are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. Syk was first cloned from the spleen, and its function in hematopoietic cells is well-established. Syk is involved in the signaling downstream of activated receptors (including B-cell and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferatio

>cd08215 STKc_Nek Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase

Probab=100.00  E-value=2.1e-32  Score=254.21  Aligned_cols=212  Identities=30%  Similarity=0.448  Sum_probs=173.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---CCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+++++.++|||++++++.+...        ..+++|+||+++ +|...+....   ..+++..+..++.+++.
T Consensus        43 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~  114 (258)
T cd08215          43 REDALNEVKILKKLNHPNIIKYYESFEEK--------GKLCIVMEYADGGDLSQKIKKQKKEGKPFPEEQILDWFVQLCL  114 (258)
T ss_pred             HHHHHHHHHHHHhcCCCChhheEEEEecC--------CEEEEEEEecCCCcHHHHHHHhhccCCCcCHHHHHHHHHHHHH
Confidence            34678899999999999999999999875        669999999985 7888887653   56999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|||++|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+
T Consensus       115 ~l~~lh~~~~~H~dl~~~nil~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~sl  189 (258)
T cd08215         115 ALKYLHSRKILHRDIKPQNIFLTSNGLVKLGDFGISKVLSSTV----DLAKTVVGTPYYLSPELCQNKP-YNYKSDIWSL  189 (258)
T ss_pred             HHHHHHhCCEecccCChHHeEEcCCCcEEECCccceeecccCc----ceecceeeeecccChhHhccCC-CCccccHHHH
Confidence            9999999999999999999999999999999999987754322    1223346788899999987655 7899999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |+++++|++|..||...+.......+.......                               .+...+.++.+++.+|
T Consensus       190 G~~~~~l~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~i~~~  238 (258)
T cd08215         190 GCVLYELCTLKHPFEGENLLELALKILKGQYPP-------------------------------IPSQYSSELRNLVSSL  238 (258)
T ss_pred             HHHHHHHHcCCCCCCCCcHHHHHHHHhcCCCCC-------------------------------CCCCCCHHHHHHHHHH
Confidence            999999999999998776444333322111000                               0112456777999999


Q ss_pred             cccCCCCCCCHHHhhcCCCc
Q psy7889         243 LLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~  262 (433)
                      |..+|++|||+.++|+||||
T Consensus       239 l~~~p~~Rp~~~~ll~~~~~  258 (258)
T cd08215         239 LQKDPEERPSIAQILQSPFI  258 (258)
T ss_pred             cCCChhhCcCHHHHhcCCCC
Confidence            99999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase (Nek) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The Nek family is composed of 11 different mammalian members (Nek1-11) with similarity to the catalytic domain of Aspergillus nidulans NIMA kinase, the founding member of the Nek family which was identified in a screen for cell cycle mutants that were prevented from entering mitosis. Neks contain a conserved N-terminal catalytic domain and a more divergent C-terminal regulatory region of various sizes and structures. They

>cd05108 PTKc_EGFR Catalytic domain of the Protein Tyrosine Kinase, Epidermal Growth Factor Receptor

Probab=100.00  E-value=1.3e-32  Score=264.58  Aligned_cols=210  Identities=20%  Similarity=0.286  Sum_probs=165.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+++.++||||+++++++...         ..++|++|+. ++|.+.+......++...+..++.||+.||+
T Consensus        53 ~~~~~~e~~~l~~l~h~niv~~~g~~~~~---------~~~~v~e~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~  123 (316)
T cd05108          53 NKEILDEAYVMASVDNPHVCRLLGICLTS---------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN  123 (316)
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEcCC---------CceeeeecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHH
Confidence            35678899999999999999999998753         3579999987 5788888876667899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+++.+......  .......++..|+|||.+.+.. ++.++|||||||+
T Consensus       124 ~LH~~~iiH~dlkp~Nill~~~~~~kl~DfG~a~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slGv~  200 (316)
T cd05108         124 YLEERRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGADEKE--YHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  200 (316)
T ss_pred             HHHhcCeeccccchhheEecCCCcEEEccccccccccCCCcc--eeccCCccceeecChHHhccCC-CCchhhhHHHHHH
Confidence            999999999999999999999999999999999876532211  1112233466899999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+.... ..+.                              +...+....+++.+||.
T Consensus       201 l~el~t~g~~p~~~~~~~~~~~~~~~~~-~~~~------------------------------~~~~~~~~~~li~~cl~  249 (316)
T cd05108         201 VWELMTFGSKPYDGIPASEISSILEKGE-RLPQ------------------------------PPICTIDVYMIMVKCWM  249 (316)
T ss_pred             HHHHHcCCCCCCCCCCHHHHHHHHhCCC-CCCC------------------------------CCCCCHHHHHHHHHHcc
Confidence            999997 999998876554332221100 0000                              01134456799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .+|.+||++.+++.+
T Consensus       250 ~~p~~Rps~~~l~~~  264 (316)
T cd05108         250 IDADSRPKFRELIIE  264 (316)
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999976

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EGFR (HER1, ErbB1) is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphor

>cd05033 PTKc_EphR Catalytic domain of Ephrin Receptor Protein Tyrosine Kinases

Probab=100.00  E-value=2.3e-32  Score=256.03  Aligned_cols=210  Identities=19%  Similarity=0.334  Sum_probs=168.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++.+...        ...++||||+.+ +|.+++......+++..+..++.|++.||.|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~iv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  121 (266)
T cd05033          50 LDFLTEASIMGQFDHPNIIRLEGVVTKS--------RPVMIITEYMENGSLDKFLRENDGKFTVGQLVGMLRGIASGMKY  121 (266)
T ss_pred             HHHHHHHHHHHhCCCCCcceEeEEEecC--------CceEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999998765        558999999975 8888887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++..........  ......++..|+|||.+.+.. ++.++|||||||++
T Consensus       122 Lh~~~i~H~di~p~nili~~~~~~~l~dfg~~~~~~~~~~~~--~~~~~~~~~~y~~Pe~~~~~~-~~~~~Dv~slG~~l  198 (266)
T cd05033         122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRRLEDSEATY--TTKGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVM  198 (266)
T ss_pred             HHhCCcccCCCCcceEEEcCCCCEEECccchhhcccccccce--eccCCCCCccccChhhhccCC-CccccchHHHHHHH
Confidence            999999999999999999999999999999998775221111  111223466899999987654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||...........+......+.                               +...+..+.+++.+||+.
T Consensus       199 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~cl~~  247 (266)
T cd05033         199 WEVMSYGERPYWDMSNQDVIKAVEDGYRLPP-------------------------------PMDCPSALYQLMLDCWQK  247 (266)
T ss_pred             HHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHcCC
Confidence            99997 9999987766655544432111100                               112356677999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      +|++||++++++++
T Consensus       248 ~p~~Rp~~~ei~~~  261 (266)
T cd05033         248 DRNERPTFSQIVST  261 (266)
T ss_pred             CcccCcCHHHHHHH
Confidence            99999999999864

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). They can be classified into two classes (EphA and EphB), according to their extracellular sequences, which largely correspond to binding preferences for either GPI-anchored ephrin-A ligands or transmembrane ephrin-B ligands. Vertebrates have ten EphA and six EhpB receptors, which display promiscuous ligand interactions within each class. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment

>cd05089 PTKc_Tie1 Catalytic domain of the Protein Tyrosine Kinase, Tie1

Probab=100.00  E-value=2e-32  Score=260.93  Aligned_cols=207  Identities=21%  Similarity=0.307  Sum_probs=163.6

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      +.+.+|++++.++ +||||+++++++...        ..+|+||||++ ++|.+++....               ..+++
T Consensus        47 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  118 (297)
T cd05089          47 RDFAGELEVLCKLGHHPNIINLLGACENR--------GYLYIAIEYAPYGNLLDFLRKSRVLETDPAFAKEHGTASTLTS  118 (297)
T ss_pred             HHHHHHHHHHHhhcCCCchhheEEEEccC--------CcceEEEEecCCCcHHHHHHhccccccccccccccCccCCCCH
Confidence            4678899999999 799999999998765        55899999997 58888886532               24788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.|++.||+|||++||+||||||+|||++.++.+||+|||++.......     .......+..|+|||++.+.
T Consensus       119 ~~~~~i~~qi~~al~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~  193 (297)
T cd05089         119 QQLLQFASDVATGMQYLSEKQFIHRDLAARNVLVGENLASKIADFGLSRGEEVYV-----KKTMGRLPVRWMAIESLNYS  193 (297)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccCcCCcceEEECCCCeEEECCcCCCcccccee-----ccCCCCcCccccCchhhccC
Confidence            9999999999999999999999999999999999999999999999986432110     11112234569999998765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |.+||.+....+....+.......                               .+.
T Consensus       194 ~-~~~~~DvwSlG~il~el~t~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------------~~~  241 (297)
T cd05089         194 V-YTTKSDVWSFGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRME-------------------------------KPR  241 (297)
T ss_pred             C-CCchhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-------------------------------CCC
Confidence            5 7999999999999999997 999998877665444432211000                               011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+..+.+||.+||..+|.+||+++++++.
T Consensus       242 ~~~~~~~~li~~~l~~~p~~Rp~~~~i~~~  271 (297)
T cd05089         242 NCDDEVYELMRQCWRDRPYERPPFAQISVQ  271 (297)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            245677899999999999999999999754

Protein Tyrosine Kinase (PTK) family; Tie1; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie1 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. No specific ligand has been identified for Tie1, although the angiopoietin, Ang-1, binds to Tie1 through integrins at high concentrations.

>cd05581 STKc_PDK1 Catalytic domain of the Protein Serine/Threonine Kinase, Phosphoinositide-dependent kinase 1

Probab=100.00  E-value=1.1e-32  Score=259.70  Aligned_cols=213  Identities=30%  Similarity=0.479  Sum_probs=174.0

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecC-cCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+++++.++ ||||+++++++.+.        +.+++||||+ .++|.+++.+.. .+++..++.++.|++.||.
T Consensus        46 ~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~-~l~~~~~~~i~~ql~~~l~  116 (280)
T cd05581          46 KYVKIEKEVLTRLNGHPGIIKLYYTFQDE--------ENLYFVLEYAPNGELLQYIRKYG-SLDEKCTRFYAAEILLALE  116 (280)
T ss_pred             HHHHHHHHHHHhcccCCCchhHHHHhcCC--------ceEEEEEcCCCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHH
Confidence            56788999999998 99999999999765        5699999999 568888887643 6999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc----------------cccccCCcccccccCcccccC
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ----------------VNRYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~----------------~~~~~~~~gt~~y~aPE~~~~  149 (433)
                      |||+.|++|+||+|+||+++.++.++|+|||++..........                ........++..|+|||++.+
T Consensus       117 ~Lh~~~~~H~dl~~~ni~i~~~~~~~l~df~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~Pe~~~~  196 (280)
T cd05581         117 YLHSKGIIHRDLKPENILLDKDMHIKITDFGTAKVLDPNSSPESNKGDATNIDSQIEKNRRRFASFVGTAEYVSPELLNE  196 (280)
T ss_pred             HHHHCCeeecCCCHHHeEECCCCCEEecCCccccccCCccccccCCCCCccccccccccccccccccCCccccCHHHhCC
Confidence            9999999999999999999999999999999987765322110                012233456888999998876


Q ss_pred             CCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      .. ++.++|+|||||+++++++|..||...........+.......                                +.
T Consensus       197 ~~-~~~~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------~~  243 (280)
T cd05581         197 KP-AGKSSDLWALGCIIYQMLTGKPPFRGSNEYLTFQKILKLEYSF--------------------------------PP  243 (280)
T ss_pred             CC-CChhhhHHHHHHHHHHHHhCCCCCCCccHHHHHHHHHhcCCCC--------------------------------CC
Confidence            54 6889999999999999999999999887655444443211110                                11


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCH----HHhhcCCCc
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDS----DAALNHDFF  262 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~----~e~L~h~~~  262 (433)
                      ..+....+||.+||+.+|++||++    +++++||||
T Consensus       244 ~~~~~~~~li~~~l~~~p~~R~~~~~~~~~ll~~~~~  280 (280)
T cd05581         244 NFPPDAKDLIEKLLVLDPQDRLGVNEGYDELKAHPFF  280 (280)
T ss_pred             ccCHHHHHHHHHHhcCCHhhCCCcccCHHHHhcCCCC
Confidence            235667799999999999999999    999999998

Serine/Threonine Kinases (STKs), Phosphoinositide-dependent kinase 1 (PDK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PDK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). PDK1 carries an N-terminal catalytic domain and a C-terminal pleckstrin homology (PH) domain that binds phosphoinositides. It phosphorylates the activation loop of AGC kinases that are regulated by PI3K such as PKB, SGK, and PKC, among others, and is crucial for their activation. Thus, it contributes in regulating many processes including metabolism, growth, proliferation, and survival. PDK1 also has the ability to auto

>cd05076 PTK_Tyk2_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=100.00  E-value=2.8e-32  Score=256.85  Aligned_cols=203  Identities=20%  Similarity=0.310  Sum_probs=159.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        ...++||||+++ +|..++......+++..+..++.||+.||+|
T Consensus        61 ~~~~~~~~~~~~l~h~niv~~~~~~~~~--------~~~~lv~ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~~  132 (274)
T cd05076          61 LAFFETASLMSQVSHIHLAFVHGVCVRG--------SENIMVEEFVEHGPLDVCLRKEKGRVPVAWKITVAQQLASALSY  132 (274)
T ss_pred             HHHHHHHHHHhcCCCCCeeeEEEEEEeC--------CceEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4567889999999999999999999875        558999999986 5666665556678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCC-------cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          87 IHSNKILHRDMKAANVLITKTG-------ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~-------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ||++||+||||||+||+++..+       .++++|||++......        ....++..|+|||.+.+...++.++||
T Consensus       133 lH~~~iiH~dlkp~Nill~~~~~~~~~~~~~kl~d~g~~~~~~~~--------~~~~~~~~~~aPe~~~~~~~~~~~~Dv  204 (274)
T cd05076         133 LEDKNLVHGNVCAKNILLARLGLAEGTSPFIKLSDPGVSFTALSR--------EERVERIPWIAPECVPGGNSLSTAADK  204 (274)
T ss_pred             HHcCCccCCCCCcccEEEeccCcccCccceeeecCCccccccccc--------cccccCCcccCchhhcCCCCCCcHHHH
Confidence            9999999999999999998644       4899999987543211        123457789999998765557999999


Q ss_pred             hhHHHHHHHHH-hcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMW-TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |||||++|+|+ +|.+||.+....+....+.....                                 .+...+..+.++
T Consensus       205 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---------------------------------~~~~~~~~~~~l  251 (274)
T cd05076         205 WSFGTTLLEICFDGEVPLKERTPSEKERFYEKKHR---------------------------------LPEPSCKELATL  251 (274)
T ss_pred             HHHHHHHHHHHhCCCCCccccChHHHHHHHHhccC---------------------------------CCCCCChHHHHH
Confidence            99999999985 68999987655443222111000                                 001123456799


Q ss_pred             HHhhcccCCCCCCCHHHhhcC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h  259 (433)
                      |.+||..+|++||++.++|++
T Consensus       252 i~~cl~~~p~~Rps~~~il~~  272 (274)
T cd05076         252 ISQCLTYEPTQRPSFRTILRD  272 (274)
T ss_pred             HHHHcccChhhCcCHHHHHHh
Confidence            999999999999999999864

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity of the C-terminal catalyt

>cd05053 PTKc_FGFR Catalytic domain of the Protein Tyrosine Kinases, Fibroblast Growth Factor Receptors

Probab=100.00  E-value=1.7e-32  Score=260.73  Aligned_cols=209  Identities=24%  Similarity=0.436  Sum_probs=165.3

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---------------CCCCCHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---------------HVKFSLG   71 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---------------~~~l~~~   71 (433)
                      .+.+|+++++.+ +|+||+++++++...        +.+++||||+. ++|..++...               ...+++.
T Consensus        61 ~~~~E~~~l~~l~~h~~i~~~~~~~~~~--------~~~~li~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~~  132 (293)
T cd05053          61 DLVSEMEMMKMIGKHKNIINLLGVCTQE--------GPLYVVVEYAAHGNLRDFLRARRPPGEYASPDDPRPPEETLTQK  132 (293)
T ss_pred             HHHHHHHHHHhhcCCCCeeeEEEEEcCC--------CCeEEEEEeCCCCcHHHHHHhcCCCccccccccccccccccCHH
Confidence            477899999999 899999999999765        55899999997 5788887532               2358899


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .+..++.|++.||+|||+.||+|+||||+||+++.++.+||+|||++..+.....  ........++..|+|||++.+..
T Consensus       133 ~~~~i~~qi~~al~~LH~~~ivH~dlkp~Nil~~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~  210 (293)
T cd05053         133 DLVSFAYQVARGMEFLASKKCIHRDLAARNVLVTEDHVMKIADFGLARDIHHIDY--YRKTTNGRLPVKWMAPEALFDRV  210 (293)
T ss_pred             HHHHHHHHHHHHHHHHHHCCccccccceeeEEEcCCCeEEeCccccccccccccc--eeccCCCCCCccccCHHHhccCC
Confidence            9999999999999999999999999999999999999999999999987643221  11112233456799999987654


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       ++.++|||||||++|+|++ |..||.+....+....+.....   .                            ..+..
T Consensus       211 -~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~----------------------------~~~~~  258 (293)
T cd05053         211 -YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGYR---M----------------------------EKPQN  258 (293)
T ss_pred             -cCcccceeehhhHHHHHhcCCCCCCCCCCHHHHHHHHHcCCc---C----------------------------CCCCC
Confidence             7999999999999999997 8999988766554443321100   0                            01122


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .+..+.+|+.+||..||.+|||+.+++++
T Consensus       259 ~~~~~~~li~~~l~~~p~~Rps~~eil~~  287 (293)
T cd05053         259 CTQELYHLMRDCWHEVPSQRPTFKQLVED  287 (293)
T ss_pred             CCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            45667799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor (FGFR) subfamily; catalytic (c) domain. The FGFR subfamily consists of FGFR1, FGFR2, FGFR3, FGFR4, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K).PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, and to heparin/heparan sulfate (HS) results in the formation of a ternary complex, which leads to receptor dimerization and activation,

>cd05611 STKc_Rim15_like Catalytic domain of fungal Rim15-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=1.9e-32  Score=255.59  Aligned_cols=209  Identities=29%  Similarity=0.398  Sum_probs=165.2

Q ss_pred             HHHHHHHHH-hCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus        10 ~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ...|..++. .++|+||+++++++...        +.+|+||||+.+ +|.+++... ..+++..+..++.|++.||.||
T Consensus        43 ~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~~l  113 (260)
T cd05611          43 VKAERAIMMIQGESPYVAKLYYSFQSK--------DYLYLVMEYLNGGDCASLIKTL-GGLPEDWAKQYIAEVVLGVEDL  113 (260)
T ss_pred             HHHHHHHHhhcCCCCCeeeeeeeEEcC--------CeEEEEEeccCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHH
Confidence            344555444 44899999999999865        569999999975 777777653 4689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |+.|++|+||+|+||+++.++.++|+|||++.....        .....++..|+|||.+.+.. ++.++||||+|+++|
T Consensus       114 H~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~--------~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~il~  184 (260)
T cd05611         114 HQRGIIHRDIKPENLLIDQTGHLKLTDFGLSRNGLE--------NKKFVGTPDYLAPETILGVG-DDKMSDWWSLGCVIF  184 (260)
T ss_pred             HHCCeecCCCCHHHeEECCCCcEEEeecccceeccc--------cccCCCCcCccChhhhcCCC-CcchhhhHHHHHHHH
Confidence            999999999999999999999999999998865432        12335678899999987765 789999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|.+||.+.+.......+..........                            .....+..+.++|.+||+.+|
T Consensus       185 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~~i~~~l~~~p  236 (260)
T cd05611         185 EFLFGYPPFHAETPDAVFDNILSRRINWPEE----------------------------VKEFCSPEAVDLINRLLCMDP  236 (260)
T ss_pred             HHHHCCCCCCCCCHHHHHHHHHhcccCCCCc----------------------------ccccCCHHHHHHHHHHccCCH
Confidence            9999999998877665444432211000000                            001246778899999999999


Q ss_pred             CCCCCH---HHhhcCCCccC
Q psy7889         248 SKRFDS---DAALNHDFFWT  264 (433)
Q Consensus       248 ~~R~t~---~e~L~h~~~~~  264 (433)
                      ++||++   +|+|.||||..
T Consensus       237 ~~R~~~~~~~~~l~~~~~~~  256 (260)
T cd05611         237 AKRLGANGYQEIKSHPFFKS  256 (260)
T ss_pred             HHccCCCcHHHHHcChHhhc
Confidence            999955   79999999954

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, fungal Rim15-like kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this group include Saccharomyces cerevisiae Rim15, Schizosaccharomyces pombe cek1, and similar fungal proteins. They contain a central catalytic domain, which contains an insert relative to MAST kinases. In addition, Rim15 contains a C-terminal signal receiver (REC) domain while cek1 contains an N-terminal PAS domain. Rim15 (or Rim15p) functions as a regulator of meiosis. It acts as a do

>cd05061 PTKc_InsR Catalytic domain of the Protein Tyrosine Kinase, Insulin Receptor

Probab=100.00  E-value=2.9e-32  Score=258.53  Aligned_cols=214  Identities=21%  Similarity=0.360  Sum_probs=167.8

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------CCCCHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------VKFSLGEIKKVIQ   78 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------~~l~~~~~~~i~~   78 (433)
                      .+++|+.+++.++||||+++++++...        ...|+||||+. ++|.+++....         ..++...+..++.
T Consensus        55 ~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (288)
T cd05061          55 EFLNEASVMKGFTCHHVVRLLGVVSKG--------QPTLVVMELMAHGDLKSYLRSLRPEAENNPGRPPPTLQEMIQMAA  126 (288)
T ss_pred             HHHHHHHHHHhCCCCCeeeEEEEEcCC--------CCcEEEEeCCCCCCHHHHHHHhccccccCCCCCCCCHHHHHHHHH
Confidence            567899999999999999999998765        45899999997 58888886532         2246678899999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      ||+.||.|||++||+||||||+||+++.++.++|+|||+++........  .......++..|+|||.+.+.. ++.++|
T Consensus       127 ~l~~~l~~lH~~~i~H~dikp~nili~~~~~~~L~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~-~~~~~D  203 (288)
T cd05061         127 EIADGMAYLNAKKFVHRDLAARNCMVAHDFTVKIGDFGMTRDIYETDYY--RKGGKGLLPVRWMAPESLKDGV-FTTSSD  203 (288)
T ss_pred             HHHHHHHHHHhCCCcCCCCChheEEEcCCCcEEECcCCccccccccccc--cccCCCcccccccCHHHhccCC-CChHhH
Confidence            9999999999999999999999999999999999999998765432211  1112234467799999987655 799999


Q ss_pred             hhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      +||+||++++|++ |.+||.+....+....+..  +....                             .+...+..+.+
T Consensus       204 vwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~  252 (288)
T cd05061         204 MWSFGVVLWEITSLAEQPYQGLSNEQVLKFVMD--GGYLD-----------------------------QPDNCPERVTD  252 (288)
T ss_pred             HHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHc--CCCCC-----------------------------CCCCCCHHHHH
Confidence            9999999999998 7889988776654443321  10000                             00113456779


Q ss_pred             HHHhhcccCCCCCCCHHHhhc------CCCccC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALN------HDFFWT  264 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~------h~~~~~  264 (433)
                      ++.+||+.||++|||+.++++      ||||..
T Consensus       253 li~~~l~~~p~~Rps~~~ll~~l~~~~~~~~~~  285 (288)
T cd05061         253 LMRMCWQFNPKMRPTFLEIVNLLKDDLHPSFPE  285 (288)
T ss_pred             HHHHHcCCChhHCcCHHHHHHHHHhhcCCCCCC
Confidence            999999999999999999987      888854

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR is a receptor tyr kinase (RTK) that is composed of two alphabeta heterodimers. Binding of the insulin ligand to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological function. InsR signaling plays an important role in many cellular processes including glucose homeostasis, glycogen synthesis, lipid and protein meta

>cd05072 PTKc_Lyn Catalytic domain of the Protein Tyrosine Kinase, Lyn

Probab=100.00  E-value=2.3e-32  Score=255.24  Aligned_cols=209  Identities=20%  Similarity=0.308  Sum_probs=167.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+.+|+.+++.++|+||+++++++...        ...++||||+. ++|.+++... ...++...+..++.|++.||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~l~~~l  116 (261)
T cd05072          45 VQAFLEEANLMKTLQHDKLVRLYAVVTKE--------EPIYIITEYMAKGSLLDFLKSDEGGKVLLPKLIDFSAQIAEGM  116 (261)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcCC--------CCcEEEEecCCCCcHHHHHHHhcCCCCCHHHHHHHHHHHHHHH
Confidence            35678899999999999999999998765        55899999996 5888887653 34588899999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||.+.+.. ++.++|||||||
T Consensus       117 ~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  192 (261)
T cd05072         117 AYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGI  192 (261)
T ss_pred             HHHHHCCeeccccchhhEEecCCCcEEECCCccceecCCCce---eccCCCccceecCCHHHhccCC-CChhhhhhhhHH
Confidence            999999999999999999999999999999999977643211   1112233466799999987654 788999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |..||.+.........+......+.                               ....+.++.+++.+||
T Consensus       193 ~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l  241 (261)
T cd05072         193 LLYEIVTYGKIPYPGMSNSDVMSALQRGYRMPR-------------------------------MENCPDELYDIMKTCW  241 (261)
T ss_pred             HHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999998 9999988776665555432111000                               0123456779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++||+++++++
T Consensus       242 ~~~p~~Rp~~~~i~~  256 (261)
T cd05072         242 KEKAEERPTFDYLQS  256 (261)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999864

Protein Tyrosine Kinase (PTK) family; Lyn kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lyn is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine and growth fa

>cd05078 PTK_Jak2_Jak3_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=100.00  E-value=2e-32  Score=255.36  Aligned_cols=203  Identities=17%  Similarity=0.254  Sum_probs=161.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+..|+.+++.++|||||++++++...        ...++||||+.+ +|..++......+++..+..++.||+.||+|
T Consensus        44 ~~~~~e~~~l~~~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  115 (258)
T cd05078          44 ESFFEAASMMSQLSHKHLVLNYGVCVCG--------DESIMVQEYVKFGSLDTYLKKNKNLINISWKLEVAKQLAWALHF  115 (258)
T ss_pred             HHHHHHHHHHHhCCCCChhheeeEEEeC--------CCcEEEEecCCCCcHHHHHhcCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        458999999975 7888887666568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCc--------EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          87 IHSNKILHRDMKAANVLITKTGI--------LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~--------~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      ||+.||+||||||+||+++.++.        ++++|||++......        ....++..|+|||++.+...++.++|
T Consensus       116 lH~~~iiH~dlkp~nili~~~~~~~~~~~~~~~l~d~g~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~D  187 (258)
T cd05078         116 LEDKGLTHGNVCAKNVLLIREEDRKTGNPPFIKLSDPGISITVLPK--------EILLERIPWVPPECIENPQNLSLAAD  187 (258)
T ss_pred             HHHCCeecCCCccceEEEecccccccCCCceEEecccccccccCCc--------hhccccCCccCchhccCCCCCCchhh
Confidence            99999999999999999987664        699999988654321        22456788999999977555789999


Q ss_pred             hhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      |||+||++|+|++| .+||...+.......... ...                                .+...+.+..+
T Consensus       188 iwslG~~l~~l~~g~~~~~~~~~~~~~~~~~~~-~~~--------------------------------~~~~~~~~~~~  234 (258)
T cd05078         188 KWSFGTTLWEIFSGGDKPLSALDSQKKLQFYED-RHQ--------------------------------LPAPKWTELAN  234 (258)
T ss_pred             HHHHHHHHHHHHcCCCCChhhccHHHHHHHHHc-ccc--------------------------------CCCCCcHHHHH
Confidence            99999999999998 567766554433222110 000                                01112345679


Q ss_pred             HHHhhcccCCCCCCCHHHhhcC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +|.+||+.||++|||++++++.
T Consensus       235 li~~~l~~~p~~Rps~~~il~~  256 (258)
T cd05078         235 LINQCMDYEPDFRPSFRAIIRD  256 (258)
T ss_pred             HHHHHhccChhhCCCHHHHHHh
Confidence            9999999999999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; pseudokinase domain (repeat 1). The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the kinase activity

>cd06647 STKc_PAK_I Catalytic domain of the Protein Serine/Threonine Kinase, Group I p21-activated kinase

Probab=100.00  E-value=1.1e-32  Score=262.12  Aligned_cols=219  Identities=26%  Similarity=0.451  Sum_probs=173.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+++.++||||+++++++...        ...|+|+||+.+ +|.+++.+  ..+++..+..++.|++.||.
T Consensus        60 ~~~~~~e~~~l~~l~hp~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~l~~~~~~~i~~~l~~al~  129 (293)
T cd06647          60 KELIINEILVMRENKHPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALE  129 (293)
T ss_pred             HHHHHHHHHHHhhcCCCCeeehhheeeeC--------CcEEEEEecCCCCcHHHHHhh--cCCCHHHHHHHHHHHHHHHH
Confidence            35678899999999999999999999875        558999999975 77777754  24789999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+||+
T Consensus       130 ~LH~~gi~H~dL~p~Nili~~~~~~kL~dfg~~~~~~~~~~----~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~l  204 (293)
T cd06647         130 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS----KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  204 (293)
T ss_pred             HHHhCCEeeccCCHHHEEEcCCCCEEEccCcceeccccccc----ccccccCChhhcCchhhccCC-CCchhhHHHHHHH
Confidence            99999999999999999999999999999998876543221    112345788899999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||........+..+.. .+.+   .+                         ..+...+....++|.+||..
T Consensus       205 l~~ll~g~~pf~~~~~~~~~~~~~~-~~~~---~~-------------------------~~~~~~~~~l~~li~~~l~~  255 (293)
T cd06647         205 AIEMVEGEPPYLNENPLRALYLIAT-NGTP---EL-------------------------QNPEKLSAIFRDFLNRCLEM  255 (293)
T ss_pred             HHHHHhCCCCCCCCChhhheeehhc-CCCC---CC-------------------------CCccccCHHHHHHHHHHccC
Confidence            9999999999987665443322211 0000   00                         00112345677999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      +|.+||++.+++.|+||.......
T Consensus       256 ~p~~Rp~~~~il~h~~~~~~~~~~  279 (293)
T cd06647         256 DVEKRGSAKELLQHPFLKIAKPLS  279 (293)
T ss_pred             ChhhCcCHHHHhcCHHHhcCcccc
Confidence            999999999999999997665433

Serine/threonine kinases (STKs), p21-activated kinase (PAK) subfamily, Group I, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PAK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PAKs are Rho family GTPase-regulated kinases that serve as important mediators in the function of Cdc42 (cell division cycle 42) and Rac. PAKs are implicated in the regulation of many cellular processes including growth factor receptor-mediated proliferation, cell polarity, cell motility, cell death and survival, and actin cytoskeleton organization. PAKs from higher eukaryotes are classified into two groups (I and II), according to their bi

>cd06653 STKc_MEKK3_like_1 Catalytic domain of MAP/ERK kinase kinase 3-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=4.3e-32  Score=253.97  Aligned_cols=215  Identities=24%  Similarity=0.408  Sum_probs=170.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++|+||+++++++.+..      ...+++||||+++ +|.+.+... ..+++..++.++.|++.||.|
T Consensus        49 ~~~~~ei~~l~~l~h~~i~~~~~~~~~~~------~~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~al~~  121 (264)
T cd06653          49 NALECEIQLLKNLRHDRIVQYYGCLRDPE------EKKLSIFVEYMPGGSIKDQLKAY-GALTENVTRRYTRQILQGVSY  121 (264)
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEEcCC------CCEEEEEEEeCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            36778999999999999999999987642      2568999999975 787777653 358899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.++|+|||++......... ........++..|+|||.+.+.. ++.++|+||+||++
T Consensus       122 LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  199 (264)
T cd06653         122 LHSNMIVHRDIKGANILRDSAGNVKLGDFGASKRIQTICMS-GTGIKSVTGTPYWMSPEVISGEG-YGRKADVWSVACTV  199 (264)
T ss_pred             HHhCCEecCCCCHHHEEEcCCCCEEECcccccccccccccc-CccccccCCcccccCHhhhcCCC-CCccccHHHHHHHH
Confidence            99999999999999999999999999999999765422111 11122346788999999987755 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||........+..+   ...+....                           .+...+.++.++|.+||+ +
T Consensus       200 ~~l~~g~~p~~~~~~~~~~~~~---~~~~~~~~---------------------------~p~~~~~~~~~~i~~~l~-~  248 (264)
T cd06653         200 VEMLTEKPPWAEYEAMAAIFKI---ATQPTKPM---------------------------LPDGVSDACRDFLKQIFV-E  248 (264)
T ss_pred             HHHHhCCCCCCccCHHHHHHHH---HcCCCCCC---------------------------CCcccCHHHHHHHHHHhc-C
Confidence            9999999999876555443332   22211111                           112356677899999999 5


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||++.++++|||.
T Consensus       249 ~~~r~~~~~~~~~~~~  264 (264)
T cd06653         249 EKRRPTAEFLLRHPFV  264 (264)
T ss_pred             cccCccHHHHhcCCCC
Confidence            7999999999999984

Serine/threonine kinases (STKs), MAP/ERK kinase kinase 3 (MEKK3)-like subfamily, catalytic (c) domain, functionally uncharacterized subgroup 1. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MEKK3-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The MEKK3-like subfamily is composed of MEKK3, MEKK2, and related proteins, all containing an N-terminal PB1 domain, which mediates oligomerization, and a C-terminal catalytic domain. MEKK2 and MEKK3 are mitogen-activated protein kinase (MAPK) kinase kinases (MAPKKKs or MKKKs or MAP3Ks), proteins that phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phospho

>cd06641 STKc_MST3 Catalytic domain of the Protein Serine/Threonine Kinase, Mammalian Ste20-like protein kinase 3

Probab=100.00  E-value=3e-32  Score=256.93  Aligned_cols=215  Identities=24%  Similarity=0.375  Sum_probs=172.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +..|+||||+++ +|...+..  ..+++..+..++.|++.|+.|
T Consensus        47 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~i~~--~~~~~~~~~~~~~~l~~~l~~  116 (277)
T cd06641          47 EDIQQEITVLSQCDSPYVTKYYGSYLKD--------TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLDY  116 (277)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEEeC--------CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            3577899999999999999999999875        568999999985 67766654  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+||++
T Consensus       117 lh~~~i~h~dl~p~Ni~i~~~~~~~l~dfg~~~~~~~~~----~~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~~l  191 (277)
T cd06641         117 LHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGITA  191 (277)
T ss_pred             HccCCeecCCCCHHhEEECCCCCEEEeecccceecccch----hhhccccCCccccChhhhccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999987654321    1122346788899999987654 68899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||...........+..  +.  ...                           .+...+.++.++|.+||..+
T Consensus       192 ~~l~~g~~p~~~~~~~~~~~~~~~--~~--~~~---------------------------~~~~~~~~~~~~i~~~l~~~  240 (277)
T cd06641         192 IELAKGEPPHSELHPMKVLFLIPK--NN--PPT---------------------------LEGNYSKPLKEFVEACLNKE  240 (277)
T ss_pred             HHHHcCCCCCCccchHHHHHHHhc--CC--CCC---------------------------CCcccCHHHHHHHHHHccCC
Confidence            999999999987665443333211  00  000                           01124566779999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      |.+||++.++++||||.+....
T Consensus       241 p~~Rp~~~~~l~~~~~~~~~~~  262 (277)
T cd06641         241 PSFRPTAKELLKHKFIVRFAKK  262 (277)
T ss_pred             hhhCcCHHHHHhCHHHhhhhhc
Confidence            9999999999999999775443

Serine/threonine kinases (STKs), mammalian Ste20-like protein kinase 3 (MST3) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MST3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MST3 phosphorylates the STK NDR and may play a role in cell cycle progression and cell morphology. It may also regulate paxillin and consequently, cell migration. MST3 is present in human placenta, where it plays an essential role in the oxidative stress-induced apoptosis of trophoblasts in normal spontaneous delivery. Dysregulation of trophoblast apoptosis may result in pregnancy complications such as preeclampsia and int

>cd05060 PTKc_Syk_like Catalytic domain of Spleen Tyrosine Kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=3.4e-32  Score=253.56  Aligned_cols=209  Identities=21%  Similarity=0.329  Sum_probs=165.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++|||||++++++..         ..+++||||+. ++|.+++.+.. .+++..+..++.|++.||+
T Consensus        40 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~~~~~v~e~~~~~~L~~~l~~~~-~~~~~~~~~~~~qi~~~l~  109 (257)
T cd05060          40 KKEFLREASVMAQLDHPCIVRLIGVCKG---------EPLMLVMELAPLGPLLKYLKKRR-EIPVSDLKELAHQVAMGMA  109 (257)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEcC---------CceEEEEEeCCCCcHHHHHHhCC-CCCHHHHHHHHHHHHHHHH
Confidence            3467889999999999999999998753         34799999987 58888887644 6899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||||+||+++.++.++|+|||++......... ........++..|+|||.+.+.. ++.++|||||||+
T Consensus       110 ~lh~~~i~H~di~p~nili~~~~~~kl~df~~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  187 (257)
T cd05060         110 YLESKHFVHRDLAARNVLLVNRHQAKISDFGMSRALGAGSDY-YRATTAGRWPLKWYAPECINYGK-FSSKSDVWSYGVT  187 (257)
T ss_pred             HHhhcCeeccCcccceEEEcCCCcEEeccccccceeecCCcc-cccccCccccccccCHHHhcCCC-CCccchHHHHHHH
Confidence            999999999999999999999999999999999776432211 11111222356799999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||......+....+.......                               .+...+..++++|.+||.
T Consensus       188 l~~~~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~cl~  236 (257)
T cd05060         188 LWEAFSYGAKPYGEMKGAEVIAMLESGERLP-------------------------------RPEECPQEIYSIMLSCWK  236 (257)
T ss_pred             HHHHHcCCCCCcccCCHHHHHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHhc
Confidence            999998 999998877655544443211000                               111245667799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .+|++||++.+++.
T Consensus       237 ~~p~~Rp~~~~l~~  250 (257)
T cd05060         237 YRPEDRPTFSELES  250 (257)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999874

Protein Tyrosine Kinase (PTK) family; Spleen Tyrosine Kinase (Syk) subfamily; catalytic (c) domain. The Syk subfamily is composed of Syk, ZAP-70, Shark, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Syk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing two Src homology 2 (SH2) domains N-terminal to the catalytic tyr kinase domain. They are involved in the signaling downstream of activated receptors (including B-cell, T-cell, and Fc receptors) that contain ITAMs (immunoreceptor tyr activation motifs), leading to processes such as cell proliferation, differentiation, survival, adhesion, mi

>cd06623 PKc_MAPKK_plant_like Catalytic domain of Plant dual-specificity MAP kinase kinases and similar proteins

Probab=100.00  E-value=2.1e-32  Score=255.50  Aligned_cols=216  Identities=27%  Similarity=0.428  Sum_probs=173.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++|+||+++++++...        ...++||||++ ++|.+.+... ..+++..++.++.|++.||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~~l~~~l~  113 (264)
T cd06623          43 RKQLLRELKTLRSCESPYVVKCYGAFYKE--------GEISIVLEYMDGGSLADLLKKV-GKIPEPVLAYIARQILKGLD  113 (264)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEccC--------CeEEEEEEecCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        66999999998 6788887654 56899999999999999999


Q ss_pred             HHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||+ .|++|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+. .++.++|+||||+
T Consensus       114 ~lh~~~~~~H~~l~~~ni~~~~~~~~~l~df~~~~~~~~~~~----~~~~~~~~~~y~~pE~~~~~-~~~~~~Dv~slG~  188 (264)
T cd06623         114 YLHTKRHIIHRDIKPSNLLINSKGEVKIADFGISKVLENTLD----QCNTFVGTVTYMSPERIQGE-SYSYAADIWSLGL  188 (264)
T ss_pred             HHhccCCCccCCCCHHHEEECCCCCEEEccCccceecccCCC----cccceeecccccCHhhhCCC-CCCchhhHHHHHH
Confidence            9999 9999999999999999999999999999877643221    11234568889999998766 4789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc-CChhHHHHHHhhc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV-KDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L  243 (433)
                      ++|+|++|.+||...........+..........                            .+.. .+..+.++|.+||
T Consensus       189 il~~l~tg~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~l~~li~~~l  240 (264)
T cd06623         189 TLLECALGKFPFLPPGQPSFFELMQAICDGPPPS----------------------------LPAEEFSPEFRDFISACL  240 (264)
T ss_pred             HHHHHHhCCCCCccccccCHHHHHHHHhcCCCCC----------------------------CCcccCCHHHHHHHHHHc
Confidence            9999999999998764211111122222111100                            0111 4567779999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..+|++||++.++++||||+.
T Consensus       241 ~~~p~~R~~~~~ll~~~~~~~  261 (264)
T cd06623         241 QKDPKKRPSAAELLQHPFIKK  261 (264)
T ss_pred             cCChhhCCCHHHHHhCHHHHh
Confidence            999999999999999999964

Protein kinases (PKs), MAP kinase kinase (MAPKK) subfamily, Plant MAPKKs and similar proteins, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MAPKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising of the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). Members of

>cd05090 PTKc_Ror1 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 1

Probab=100.00  E-value=3.1e-32  Score=257.60  Aligned_cols=210  Identities=19%  Similarity=0.335  Sum_probs=165.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc----------------CCCCCH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI----------------HVKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~----------------~~~l~~   70 (433)
                      ..+.+|+.+++.++||||+++++++...        ...|+||||+. ++|.+++...                ...+++
T Consensus        52 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  123 (283)
T cd05090          52 GEFQQEASLMAELHHPNIVCLLGVVTQE--------QPVCMLFEYLNQGDLHEFLIMRSPHSDVGCSSDEDGTVKSSLDH  123 (283)
T ss_pred             HHHHHHHHHHhhCCCCCeeeEEEEEecC--------CceEEEEEcCCCCcHHHHHHhcCCCCccccccccccccccccCH
Confidence            3578899999999999999999998875        55899999997 4788877432                123788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.|++.||.|||++||+|+||||+||+++.++.+||+|||++.........  .......++..|+|||.+.+.
T Consensus       124 ~~~~~i~~~i~~al~~lH~~~i~H~dlkp~nili~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  201 (283)
T cd05090         124 GDFLHIAIQIAAGMEYLSSHFFVHKDLAARNILIGEQLHVKISDLGLSREIYSADYY--RVQPKSLLPIRWMPPEAIMYG  201 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHhcCeehhccccceEEEcCCCcEEeccccccccccCCcce--ecccCCCccceecChHHhccC
Confidence            889999999999999999999999999999999999999999999999776432211  112233446779999998765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++++|++ |.+||.+.........+.... .+  .                            .+.
T Consensus       202 ~-~~~~~Dv~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~--~----------------------------~~~  249 (283)
T cd05090         202 K-FSSDSDIWSFGVVLWEIFSFGLQPYYGFSNQEVIEMVRKRQ-LL--P----------------------------CSE  249 (283)
T ss_pred             C-CCchhhhHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCC-cC--C----------------------------CCC
Confidence            5 7999999999999999998 999998876654444332211 00  0                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+..+.+++.+||+.||.+||++.+++++
T Consensus       250 ~~~~~~~~li~~cl~~~p~~Rp~~~~i~~~  279 (283)
T cd05090         250 DCPPRMYSLMTECWQEGPSRRPRFKDIHTR  279 (283)
T ss_pred             CCCHHHHHHHHHHcccCcccCcCHHHHHHH
Confidence            235567799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 1 (Ror1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05123 STKc_AGC Catalytic domain of AGC family Protein Serine/Threonine Kinases

Probab=100.00  E-value=2.3e-32  Score=253.33  Aligned_cols=209  Identities=32%  Similarity=0.493  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecC-cCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~-~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++.+...        ...|+||||+ .++|.+.+.... .+++..+..++.|++.||.|
T Consensus        38 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~-~l~~~~~~~~~~qi~~~l~~  108 (250)
T cd05123          38 EHTLTERNILSRINHPFIVKLHYAFQTE--------EKLYLVLEYAPGGELFSHLSKEG-RFSEERARFYAAEIVLALEY  108 (250)
T ss_pred             HHHHHHHHHHHHcCCCcHHHHHHHeecC--------CeeEEEEecCCCCcHHHHHHhcC-CCCHHHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999765        6699999999 568888887643 58999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. .+.++|+|||||++
T Consensus       109 lh~~~~~H~~l~p~ni~~~~~~~~~l~d~~~~~~~~~~~----~~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG~~~  183 (250)
T cd05123         109 LHSLGIIYRDLKPENILLDADGHIKLTDFGLAKELSSEG----SRTNTFCGTPEYLAPEVLLGKG-YGKAVDWWSLGVLL  183 (250)
T ss_pred             HHHCCceecCCCcceEEEcCCCcEEEeecCcceecccCC----CcccCCcCCccccChHHhCCCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999987754321    1223446688899999987655 68899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||...+.......+..  +...                              .+...+....++|.+||..|
T Consensus       184 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~------------------------------~~~~~~~~l~~~i~~~l~~~  231 (250)
T cd05123         184 YEMLTGKPPFYAEDRKEIYEKILK--DPLR------------------------------FPEFLSPEARDLISGLLQKD  231 (250)
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHhc--CCCC------------------------------CCCCCCHHHHHHHHHHhcCC
Confidence            999999999987776444443322  1000                              01123566779999999999


Q ss_pred             CCCCCCH---HHhhcCCCc
Q psy7889         247 PSKRFDS---DAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~---~e~L~h~~~  262 (433)
                      |++||++   +++++||||
T Consensus       232 p~~R~~~~~~~~l~~~~~f  250 (250)
T cd05123         232 PTKRLGSGGAEEIKAHPFF  250 (250)
T ss_pred             HhhCCCcccHHHHHhCCCC
Confidence            9999999   999999998

Serine/Threonine Kinases (STKs), AGC (Protein Kinases A, G and C) family, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The AGC family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and Phosphoinositide 3-Kinase (PI3K). Members of this family include cAMP-dependent Protein Kinase (PKA), cGMP-dependent Protein Kinase (PKG), Protein Kinase C (PKC), Protein Kinase B (PKB), G protein-coupled Receptor Kinase (GRK), Serum- and Glucocorticoid-induced Kinase (SGK), and 70 kDa ribosomal Protein S6 Kinase (p70S6K or S6K), among others. AGC kinases share an activation mechanism based on the phosphorylation of up to three sites: the activation loop (A-loop), the hydrophobic motif (HM) and the

>cd05055 PTKc_PDGFR Catalytic domain of the Protein Tyrosine Kinases, Platelet Derived Growth Factor Receptors

Probab=100.00  E-value=3.9e-32  Score=259.52  Aligned_cols=210  Identities=25%  Similarity=0.387  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC-CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV-KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qll~aL   84 (433)
                      +.+.+|+++++++ +||||+++++++...        +..|+||||+. ++|.+++..... .+++..+..++.|++.||
T Consensus        83 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~l~~~~~~~i~~~i~~~l  154 (302)
T cd05055          83 EALMSELKIMSHLGNHENIVNLLGACTIG--------GPILVITEYCCYGDLLNFLRRKRESFLTLEDLLSFSYQVAKGM  154 (302)
T ss_pred             HHHHHHHHHHHhccCCCCcceEEEEEecC--------CceEEEEEcCCCCcHHHHHHhCCCCCCCHHHHHHHHHHHHHHH
Confidence            3578899999999 799999999999775        55899999997 588888865433 389999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++||+|+||||+||+++.++.++|+|||++.........  .......++..|+|||.+.+.. ++.++||||+||
T Consensus       155 ~~lH~~~ivH~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~~DiwslGv  231 (302)
T cd05055         155 AFLASKNCIHRDLAARNVLLTHGKIVKICDFGLARDIMNDSNY--VVKGNARLPVKWMAPESIFNCV-YTFESDVWSYGI  231 (302)
T ss_pred             HHHHHCCeehhhhccceEEEcCCCeEEECCCcccccccCCCce--eecCCCCcccccCCHhhhccCC-CCcHhHHHHHHH
Confidence            9999999999999999999999999999999999766432211  1112234567899999987765 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+....+........ +.. .                            ..+...+..+.+|+.+||
T Consensus       232 il~el~t~g~~p~~~~~~~~~~~~~~~~-~~~-~----------------------------~~~~~~~~~~~~li~~cl  281 (302)
T cd05055         232 LLWEIFSLGSNPYPGMPVDSKFYKLIKE-GYR-M----------------------------AQPEHAPAEIYDIMKTCW  281 (302)
T ss_pred             HHHHHHhCCCCCcCCCCchHHHHHHHHc-CCc-C----------------------------CCCCCCCHHHHHHHHHHc
Confidence            9999998 99999876654433332210 000 0                            001124567789999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++|||+.+++.
T Consensus       282 ~~~p~~Rpt~~ell~  296 (302)
T cd05055         282 DADPLKRPTFKQIVQ  296 (302)
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) subfamily; catalytic (c) domain. The PDGFR subfamily consists of PDGFR alpha, PDGFR beta, KIT, CSF-1R, the mammalian FLT3, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. PDGFR kinase domains are autoinhibited by their juxtamembrane regions containing tyr residues. The binding to their ligands leads to recept

>cd05091 PTKc_Ror2 Catalytic domain of the Protein Tyrosine Kinase, Receptor tyrosine kinase-like Orphan Receptor 2

Probab=100.00  E-value=2.5e-32  Score=258.13  Aligned_cols=210  Identities=19%  Similarity=0.328  Sum_probs=166.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---------------CCCCCHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---------------HVKFSLG   71 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---------------~~~l~~~   71 (433)
                      ..+.+|+.+++.++||||+++++++...        ...++++||+. ++|..++...               ...++..
T Consensus        53 ~~~~~e~~~~~~l~h~~iv~~~~~~~~~--------~~~~~~~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  124 (283)
T cd05091          53 EEFKHEAMMRSRLQHPNIVCLLGVVTKE--------QPLSMIFSYCSHSDLHEFLVMRSPHSDVGSTDDDKTVKSTLEPA  124 (283)
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcCC--------CceEEEEEcCCCCcHHHHHHhcCCCccccccccccccccccCHH
Confidence            4577899999999999999999999876        55899999997 4677776421               2247888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++.......  ........++..|+|||.+.+..
T Consensus       125 ~~~~~~~ql~~aL~~lH~~gi~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~  202 (283)
T cd05091         125 DFVHIVTQIAAGMEFLSSHHVVHKDLATRNVLVFDKLNVKISDLGLFREVYAADY--YKLMGNSLLPIRWMSPEAIMYGK  202 (283)
T ss_pred             HHHHHHHHHHHHHHHHHHcCccccccchhheEecCCCceEecccccccccccchh--eeeccCccCCccccCHHHHhcCC
Confidence            8999999999999999999999999999999999999999999999876643221  11122334577899999987655


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       ++.++|||||||++|||++ |.+||.+....+....+......+.                               +..
T Consensus       203 -~~~~~Dv~slG~~l~el~~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~  250 (283)
T cd05091         203 -FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVIEMIRNRQVLPC-------------------------------PDD  250 (283)
T ss_pred             -CCcchhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCcCCC-------------------------------CCC
Confidence             7999999999999999998 8899988777665555443211100                               012


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .+.+..+|+.+||+.+|.+||++++++..
T Consensus       251 ~~~~~~~li~~cl~~~p~~RP~~~~i~~~  279 (283)
T cd05091         251 CPAWVYTLMLECWNEFPSRRPRFKDIHSR  279 (283)
T ss_pred             CCHHHHHHHHHHhCCCcccCCCHHHHHHH
Confidence            34556799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Receptor tyrosine kinase-like Orphan Receptor 2 (Ror2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ror proteins are orphan receptor tyr kinases (RTKs) containing an extracellular region with immunoglobulin-like, cysteine-rich, and kringle domains, a transmembrane segment, and an intracellular catalytic domain. Ror RTKs are unrelated to the nuclear receptor subfamily called retinoid-related orphan receptors (RORs). RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase cataly

>cd05063 PTKc_EphR_A2 Catalytic domain of the Protein Tyrosine Kinase, Ephrin Receptor A2

Probab=100.00  E-value=4.1e-32  Score=254.55  Aligned_cols=210  Identities=19%  Similarity=0.300  Sum_probs=167.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+++++.++||||+++++++.+.        +..|+||||+++ +|..++......+++..+..++.|++.||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~al~~  122 (268)
T cd05063          51 QDFLSEASIMGQFSHHNIIRLEGVVTKF--------KPAMIITEYMENGALDKYLRDHDGEFSSYQLVGMLRGIAAGMKY  122 (268)
T ss_pred             HHHHHHHHHHhcCCCCCeeEEEEEEccC--------CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4578899999999999999999999875        558999999985 7877776655678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||||+||+++.++.++|+|||++........... .......+..|+|||++.+.. ++.++||||+||++
T Consensus       123 lH~~~i~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~~~~~-~~~~~~~~~~y~~PE~~~~~~-~~~~~Dv~slG~il  200 (268)
T cd05063         123 LSDMNYVHRDLAARNILVNSNLECKVSDFGLSRVLEDDPEGTY-TTSGGKIPIRWTAPEAIAYRK-FTSASDVWSFGIVM  200 (268)
T ss_pred             HHHCCeeccccchhhEEEcCCCcEEECCCccceecccccccce-eccCCCcCceecCHHHhhcCC-cChHhHHHHHHHHH
Confidence            9999999999999999999999999999999876643221111 111122345799999987654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||...+..+....+......+.                               +...+....+++.+||..
T Consensus       201 ~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~~~~li~~c~~~  249 (268)
T cd05063         201 WEVMSFGERPYWDMSNHEVMKAINDGFRLPA-------------------------------PMDCPSAVYQLMLQCWQQ  249 (268)
T ss_pred             HHHHhCCCCCCCcCCHHHHHHHHhcCCCCCC-------------------------------CCCCCHHHHHHHHHHcCC
Confidence            99997 9999988777665555543211100                               011345667999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|++||++.++++
T Consensus       250 ~p~~Rp~~~~i~~  262 (268)
T cd05063         250 DRARRPRFVDIVN  262 (268)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; EphA2 receptor; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. EphRs contain an ephrin binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephrin ligand to EphR requires cell-cell contact since both are anchored

>cd05082 PTKc_Csk Catalytic domain of the Protein Tyrosine Kinase, C-terminal Src kinase

Probab=100.00  E-value=4.1e-32  Score=252.89  Aligned_cols=206  Identities=19%  Similarity=0.328  Sum_probs=164.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC-CCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV-KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++|+||+++++++...       ....|+||||++ ++|.+++.+... .+++..+..++.|++.||
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~~l  115 (256)
T cd05082          43 AQAFLAEASVMTQLRHSNLVQLLGVIVEE-------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEAM  115 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEEcC-------CCceEEEEECCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            34678999999999999999999987544       255899999997 488888876443 478999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++|++||||||+||+++.++.+||+|||++.......       ....++..|+|||++.+.. ++.++||||+||
T Consensus       116 ~~lH~~~i~H~dlkp~nil~~~~~~~kl~dfg~~~~~~~~~-------~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~  187 (256)
T cd05082         116 EYLEANNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ-------DTGKLPVKWTAPEALREKK-FSTKSDVWSFGI  187 (256)
T ss_pred             HHHHhCCEeccccchheEEEcCCCcEEecCCccceeccccC-------CCCccceeecCHHHHccCC-CCchhhhHHHHH
Confidence            99999999999999999999999999999999987653221       1223356799999987654 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||......+....+.....   ..                            .+...+....+++.+||
T Consensus       188 i~~~l~~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------------------~~~~~~~~~~~li~~~l  236 (256)
T cd05082         188 LLWEIYSFGRVPYPRIPLKDVVPRVEKGYK---MD----------------------------APDGCPPVVYDVMKQCW  236 (256)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHhcCCC---CC----------------------------CCCCCCHHHHHHHHHHh
Confidence            9999997 9999987665554444322100   00                            00123566779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++|||+.++++
T Consensus       237 ~~~p~~Rpt~~~l~~  251 (256)
T cd05082         237 HLDAATRPSFLQLRE  251 (256)
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999975

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk catalyzes the tyr phosphorylation of the regulatory C-terminal tail of Src kinases, re

>cd05088 PTKc_Tie2 Catalytic domain of the Protein Tyrosine Kinase, Tie2

Probab=100.00  E-value=1.6e-32  Score=262.39  Aligned_cols=207  Identities=23%  Similarity=0.350  Sum_probs=163.0

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|++++.++ +||||+++++++...        +.+|+||||++ ++|.+++....               ..+++
T Consensus        52 ~~~~~Ei~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  123 (303)
T cd05088          52 RDFAGELEVLCKLGHHPNIINLLGACEHR--------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS  123 (303)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEECCC--------CCceEEEEeCCCCcHHHHHHhcccccccccccccccccCcCCH
Confidence            3567899999999 899999999999765        55899999997 58888886432               24789


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.......     ......++..|+|||.+.+.
T Consensus       124 ~~~~~~~~qi~~al~~LH~~gi~H~dlkp~Nili~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~  198 (303)
T cd05088         124 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYS  198 (303)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCccccccchheEEecCCCcEEeCccccCcccchhh-----hcccCCCcccccCHHHHhcc
Confidence            9999999999999999999999999999999999999999999999985432110     11112235679999988665


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++||||+||++++|++ |.+||.+.+..+....+..   .....                            .+.
T Consensus       199 ~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~---~~~~~----------------------------~~~  246 (303)
T cd05088         199 V-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQ---GYRLE----------------------------KPL  246 (303)
T ss_pred             C-CcccccchhhhhHHHHHHhcCCCCcccCChHHHHHHHhc---CCcCC----------------------------CCC
Confidence            4 7899999999999999998 9999987765544333211   00000                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+||.+||..+|++||+++++|.+
T Consensus       247 ~~~~~~~~li~~~l~~~p~~Rp~~~~il~~  276 (303)
T cd05088         247 NCDDEVYDLMRQCWREKPYERPSFAQILVS  276 (303)
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            235667799999999999999999999976

Protein Tyrosine Kinase (PTK) family; Tie2; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie2 is a receptor tyr kinase (RTK) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie2 is expressed mainly in endothelial cells and hematopoietic stem cells. It is also found in a subset of tumor-associated monocytes and eosinophils. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2. The binding of A

>cd06618 PKc_MKK7 Catalytic domain of the dual-specificity Protein Kinase, MAP kinase kinase 7

Probab=100.00  E-value=3.7e-32  Score=258.85  Aligned_cols=217  Identities=22%  Similarity=0.304  Sum_probs=169.4

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.++..+. ||||+++++++.+.        ..+|+||||+++++..++......+++..+..++.|++.||+|
T Consensus        58 ~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~l~~l~~~~~~~l~~~~~~~i~~~i~~~l~~  129 (296)
T cd06618          58 KRILMDLDVVLKSHDCPYIVKCYGYFITD--------SDVFICMELMSTCLDKLLKRIQGPIPEDILGKMTVAIVKALHY  129 (296)
T ss_pred             HHHHHHHHHHHhccCCCchHhhheeeecC--------CeEEEEeeccCcCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34677888777774 99999999999876        5599999999988888887766679999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC---CCCCcchhhhH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR---NYGPPVDLWGA  162 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---~~~~~~DiwSl  162 (433)
                      ||+ .||+||||+|+||+++.++.++|+|||++..+....     ......++..|+|||.+.+..   .++.++||||+
T Consensus       130 lH~~~~i~H~dl~p~nill~~~~~~kL~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~Di~sl  204 (296)
T cd06618         130 LKEKHGVIHRDVKPSNILLDASGNVKLCDFGISGRLVDSK-----AKTRSAGCAAYMAPERIDPPDPNPKYDIRADVWSL  204 (296)
T ss_pred             HHhhCCEecCCCcHHHEEEcCCCCEEECccccchhccCCC-----cccCCCCCccccCHhhcCCCCCccccccchhHHHH
Confidence            997 699999999999999999999999999987654321     112234678899999986542   36889999999


Q ss_pred             HHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         163 GCIMAEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++|+|++|+.||..... .+.+..+   ...... .++.                         ....+.++.+||.+
T Consensus       205 G~il~el~~g~~p~~~~~~~~~~~~~~---~~~~~~-~~~~-------------------------~~~~~~~l~~li~~  255 (296)
T cd06618         205 GISLVELATGQFPYKNCKTEFEVLTKI---LQEEPP-SLPP-------------------------NEGFSPDFCSFVDL  255 (296)
T ss_pred             HHHHHHHHhCCCCCCcchhHHHHHHHH---hcCCCC-CCCC-------------------------CCCCCHHHHHHHHH
Confidence            9999999999999976432 2222222   211100 0000                         00135567799999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||..||.+||+++++++|+||....
T Consensus       256 ~l~~~p~~Rp~~~~il~~~~~~~~~  280 (296)
T cd06618         256 CLTKDHRKRPKYRELLQHPFIRRYE  280 (296)
T ss_pred             HccCChhhCCCHHHHhcChhhhccc
Confidence            9999999999999999999997643

Protein kinases (PKs), MAP kinase kinase 7 (MKK7) subfamily, catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The MKK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein serine/threonine kinases, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. The mitogen-activated protein (MAP) kinase signaling pathways are important mediators of cellular responses to extracellular signals. The pathways involve a triple kinase core cascade comprising the MAP kinase (MAPK), which is phosphorylated and activated by a MAPK kinase (MAPKK or MKK), which itself is phosphorylated and activated by a MAPK kinase kinase (MAPKKK or MKKK). MKK7 is a dual-specificity PK that phosphorylates and activates it

>cd05092 PTKc_TrkA Catalytic domain of the Protein Tyrosine Kinase, Tropomyosin Related Kinase A

Probab=100.00  E-value=4e-32  Score=256.57  Aligned_cols=209  Identities=21%  Similarity=0.398  Sum_probs=165.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------CCCCHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------VKFSLGE   72 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------~~l~~~~   72 (433)
                      ..+.+|+++++.++|+||+++++++.+.        +..++||||+. ++|.+++....              ..+++..
T Consensus        52 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~l~~~~  123 (280)
T cd05092          52 QDFQREAELLTVLQHQHIVRFYGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKILAGGEDVAPGQLTLGQ  123 (280)
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEEEecC--------CceEEEEecCCCCCHHHHHHhcCcchhhhcccccCCccccCHHH
Confidence            4688899999999999999999998875        55899999997 57888876542              2478899


Q ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC
Q psy7889          73 IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN  152 (433)
Q Consensus        73 ~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (433)
                      +..++.||+.||+|||++|++|+||||+||+++.++.++|+|||++........  ........++..|+|||.+.+.. 
T Consensus       124 ~~~~~~qi~~al~~LH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-  200 (280)
T cd05092         124 MLAIASQIASGMVYLASLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRK-  200 (280)
T ss_pred             HHHHHHHHHHHHHHHHHCCeecccccHhhEEEcCCCCEEECCCCceeEcCCCce--eecCCCccccccccCHHHhccCC-
Confidence            999999999999999999999999999999999999999999999876542211  01112233467899999987765 


Q ss_pred             CCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC
Q psy7889         153 YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK  231 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (433)
                      ++.++|||||||++|+|++ |.+||......+....+.......                               .+...
T Consensus       201 ~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~  249 (280)
T cd05092         201 FTTESDIWSFGVVLWEIFTYGKQPWYQLSNTEAIECITQGRELE-------------------------------RPRTC  249 (280)
T ss_pred             cCchhhHHHHHHHHHHHHcCCCCCCccCCHHHHHHHHHcCccCC-------------------------------CCCCC
Confidence            7999999999999999998 899998776655444432211000                               01123


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +....++|.+||+.||.+||++++++.
T Consensus       250 ~~~~~~li~~cl~~~P~~Rp~~~~l~~  276 (280)
T cd05092         250 PPEVYAIMQGCWQREPQQRMVIKDIHS  276 (280)
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            556779999999999999999999974

Protein Tyrosine Kinase (PTK) family; Tropomyosin Related Kinase A (TrkA); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. TrkA is a member of the Trk subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular region with arrays of leucine-rich motifs flanked by two cysteine-rich clusters followed by two immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. Binding of TrkA to its ligand, nerve growth factor (NGF), results in receptor oligomerization and activation of the catalytic domain. TrkA is expressed mainly in neural-crest-derived sensory

>cd05085 PTKc_Fer Catalytic domain of the Protein Tyrosine Kinase, Fer

Probab=100.00  E-value=6e-32  Score=250.70  Aligned_cols=208  Identities=23%  Similarity=0.378  Sum_probs=165.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++...        +..++||||++ ++|..++......+++..+..++.|++.||.|
T Consensus        37 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  108 (250)
T cd05085          37 IKFLSEARILKQYDHPNIVKLIGVCTQR--------QPIYIVMELVPGGDFLSFLRKKKDELKTKQLVKFALDAAAGMAY  108 (250)
T ss_pred             HHHHHHHHHHHhCCCCCcCeEEEEEecC--------CccEEEEECCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            3578899999999999999999999765        55899999997 57888776655668999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.++|+|||++........   .......++..|+|||++.+.. ++.++||||+||++
T Consensus       109 lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~ll  184 (250)
T cd05085         109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSRQEDDGIY---SSSGLKQIPIKWTAPEALNYGR-YSSESDVWSYGILL  184 (250)
T ss_pred             HHhCCeeecccChheEEEcCCCeEEECCCccceecccccc---ccCCCCCCcccccCHHHhccCC-CCchhHHHHHHHHH
Confidence            9999999999999999999999999999999865432211   1111223356799999987654 78999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |++++ |..||.+.........+......   .                            .+...+..+.+++.+||..
T Consensus       185 ~~~~~~g~~p~~~~~~~~~~~~~~~~~~~---~----------------------------~~~~~~~~~~~li~~~l~~  233 (250)
T cd05085         185 WETFSLGVCPYPGMTNQQAREQVEKGYRM---S----------------------------CPQKCPDDVYKVMQRCWDY  233 (250)
T ss_pred             HHHhcCCCCCCCCCCHHHHHHHHHcCCCC---C----------------------------CCCCCCHHHHHHHHHHccc
Confidence            99998 99999887666544443221100   0                            0112356677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|++||++.++++
T Consensus       234 ~p~~Rp~~~~l~~  246 (250)
T cd05085         234 KPENRPKFSELQK  246 (250)
T ss_pred             CcccCCCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; Fer kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fer kinase is a member of the Fes subfamily of proteins which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. Fer kinase is expressed in a wide variety of tissues, and is found to reside in both the cytoplasm and the nucleus. It plays important roles in neuronal polarization and neurite development, cytoskeletal reorganization, cell migration, growth factor signaling, and the regulation of cell-c

>cd05042 PTKc_Aatyk Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases

Probab=100.00  E-value=4e-32  Score=254.81  Aligned_cols=214  Identities=20%  Similarity=0.318  Sum_probs=160.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC----CCCHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV----KFSLGEIKKVIQQLLN   82 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~----~l~~~~~~~i~~qll~   82 (433)
                      ..+++|+.+++.++||||+++++.+.+.        ..+|+||||+. ++|.+++.....    .+++..+..++.||+.
T Consensus        40 ~~~~~e~~~~~~l~h~nii~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~  111 (269)
T cd05042          40 LLFLQEVQPYRELNHPNVLQCLGQCIES--------IPYLLVLEFCPLGDLKNYLRSNRGMVAQMAQKDVLQRMACEVAS  111 (269)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEECCC--------CceEEEEEeCCCCcHHHHHHhccccccccccHHHHHHHHHHHHH
Confidence            3578899999999999999999999865        55899999997 488888865432    2467788999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC------CCCCCCc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG------DRNYGPP  156 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~  156 (433)
                      ||+|||++||+||||||+||+++.++.+||+|||++........  ........++..|+|||++..      ...++.+
T Consensus       112 ~l~~lH~~~ivH~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~  189 (269)
T cd05042         112 GLLWLHQADFIHSDLALRNCQLTADLSVKIGDYGLALEQYPEDY--YITKDCHAVPLRWLAPELVEIRGQDLLPKDQTKK  189 (269)
T ss_pred             HHHHHHhcCEecccccHhheEecCCCcEEEeccccccccccchh--eeccCCCCCcccccCHHHHhhccccccccccchh
Confidence            99999999999999999999999999999999999865432110  011122345677999998743      2236789


Q ss_pred             chhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         157 VDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       157 ~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      +||||+||++|+|++ |.+||....+.+.+..+........+..                          ..+...+...
T Consensus       190 ~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~  243 (269)
T cd05042         190 SNIWSLGVTMWELFTAADQPYPDLSDEQVLKQVVREQDIKLPKP--------------------------QLDLKYSDRW  243 (269)
T ss_pred             hHHHHHHHHHHHHHhCCCCCCCcCCHHHHHHHHhhccCccCCCC--------------------------cccccCCHHH
Confidence            999999999999999 7889988776655444432111100000                          0011245566


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhc
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .+++..|+ .||++|||++++++
T Consensus       244 ~~~~~~~~-~dp~~Rpt~~~v~~  265 (269)
T cd05042         244 YEVMQFCW-LDPETRPTAEEVHE  265 (269)
T ss_pred             HHHHHHHh-cCcccccCHHHHHH
Confidence            68888888 59999999999985

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase (Aatyk) subfamily; catalytic (c) domain. The Aatyk subfamily is also referred to as the lemur tyrosine kinase (Lmtk) subfamily. It consists of Aatyk1 (Lmtk1), Aatyk2 (Lmtk2, Brek), Aatyk3 (Lmtk3), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk proteins are mostly receptor tyr kinases (RTKs) containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 does not contain a transmembrane segment and is a cytoplasmic (or nonreceptor) kinase. Aatyk proteins are classified as tyr kina

>cd06627 STKc_Cdc7_like Catalytic domain of Cell division control protein 7-like Protein Serine/Threonine Kinases

Probab=100.00  E-value=5.9e-32  Score=250.88  Aligned_cols=210  Identities=28%  Similarity=0.470  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|++++++++||||+++++++.+.        ...++||||+.+ +|.+.+... ..+++..++.++.|++.||.|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~-~~l~~~~~~~~~~~i~~~l~~  114 (254)
T cd06627          44 KSIMQEIDLLKNLKHPNIVKYIGSIETS--------DSLYIILEYAENGSLRQIIKKF-GPFPESLVAVYVYQVLQGLAY  114 (254)
T ss_pred             HHHHHHHHHHHhCCCCCccEEEEEEEeC--------CEEEEEEecCCCCcHHHHHHhc-cCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999875        568999999975 777777654 578999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+|+++
T Consensus       115 lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~~lG~~l  189 (254)
T cd06627         115 LHEQGVIHRDIKAANILTTKDGVVKLADFGVATKLNDVSK----DDASVVGTPYWMAPEVIEMSG-ASTASDIWSLGCTV  189 (254)
T ss_pred             HhhCCcccCCCCHHHEEECCCCCEEEeccccceecCCCcc----cccccccchhhcCHhhhcCCC-CCcchhHHHHHHHH
Confidence            9999999999999999999999999999999987654321    123346688899999987655 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||...........+..  ....  .                           .+...+..+.+++.+||..+
T Consensus       190 ~~l~~g~~p~~~~~~~~~~~~~~~--~~~~--~---------------------------~~~~~~~~~~~~i~~~l~~~  238 (254)
T cd06627         190 IELLTGNPPYYDLNPMAALFRIVQ--DDHP--P---------------------------LPEGISPELKDFLMQCFQKD  238 (254)
T ss_pred             HHHHhCCCCCCCccHHHHHHHHhc--cCCC--C---------------------------CCCCCCHHHHHHHHHHHhCC
Confidence            999999999987665443333221  0000  0                           01124567789999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |++|||+.+++.||||
T Consensus       239 p~~R~~~~~~l~~~~~  254 (254)
T cd06627         239 PNLRPTAKQLLKHPWI  254 (254)
T ss_pred             hhhCcCHHHHhcCCCC
Confidence            9999999999999997

Serine/threonine kinases (STKs), (Cdc7)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Cdc7-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily include Schizosaccharomyces pombe Cdc7, Saccharomyces cerevisiae Cdc15, Arabidopsis thaliana mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) epsilon, and related proteins. MAPKKKs phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. Fission yeast

>cd05066 PTKc_EphR_A Catalytic domain of the Protein Tyrosine Kinases, Class EphA Ephrin Receptors

Probab=100.00  E-value=4.5e-32  Score=254.27  Aligned_cols=210  Identities=19%  Similarity=0.321  Sum_probs=167.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +..|+||||+++ +|.+++......++...+..++.|++.||.|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~~  121 (267)
T cd05066          50 RDFLSEASIMGQFDHPNIIHLEGVVTKS--------KPVMIVTEYMENGSLDAFLRKHDGQFTVIQLVGMLRGIASGMKY  121 (267)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC--------CccEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            3678899999999999999999999765        568999999974 7888887766678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.++|+|||++..+....... .......++..|+|||.+.+.. ++.++|+||+||++
T Consensus       122 lH~~~i~h~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~~l  199 (267)
T cd05066         122 LSDMGYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAA-YTTRGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIVM  199 (267)
T ss_pred             HHHCCEeehhhchhcEEECCCCeEEeCCCCccccccccccee-eecCCCccceeecCHhHhccCc-cCchhhhHHHHHHH
Confidence            999999999999999999999999999999998765332111 1112223356799999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++++ |..||.+....+....+......+.                               +...+..+.+++.+||+.
T Consensus       200 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~~  248 (267)
T cd05066         200 WEVMSYGERPYWEMSNQDVIKAIEEGYRLPA-------------------------------PMDCPAALHQLMLDCWQK  248 (267)
T ss_pred             HHHhcCCCCCcccCCHHHHHHHHhCCCcCCC-------------------------------CCCCCHHHHHHHHHHccc
Confidence            99886 9999987766555444432111000                               112345677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+||++.++++
T Consensus       249 ~p~~Rp~~~~i~~  261 (267)
T cd05066         249 DRNERPKFEQIVS  261 (267)
T ss_pred             CchhCCCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; most class EphA receptors including EphA3, EphA4, EphA5, and EphA7, but excluding EphA1, EphA2 and EphA10; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). In general, class EphA receptors bind GPI-anchored ephrin-A ligands. There are ten vertebrate EphA receptors (EphA1-10), which display promiscuous interactions with six ephrin-A ligands. One exception is EphA4, which also binds ephrins-B2/B3. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellul

>cd05148 PTKc_Srm_Brk Catalytic domain of the Protein Tyrosine Kinases, Srm and Brk

Probab=100.00  E-value=5.2e-32  Score=252.76  Aligned_cols=208  Identities=20%  Similarity=0.350  Sum_probs=168.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++||||+++++++.+.        ..+++||||+++ +|.+++.+.. ..+++..+..++.||+.||
T Consensus        46 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~i~~al  117 (261)
T cd05148          46 QQDFQKEVQALKRLRHKHLISLFAVCSVG--------EPVYIITELMEKGSLLAFLRSPEGQVLPVASLIDMACQVAEGM  117 (261)
T ss_pred             HHHHHHHHHHHhcCCCcchhheeeeEecC--------CCeEEEEeecccCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHH
Confidence            34678899999999999999999999875        568999999975 8988887643 3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++||+|+||||+||+++.++.+||+|||.+.......    .......++..|+|||.+.+.. ++.++|||||||
T Consensus       118 ~~lH~~~i~h~dl~~~nilv~~~~~~kl~d~g~~~~~~~~~----~~~~~~~~~~~~~~PE~~~~~~-~~~~~DiwslG~  192 (261)
T cd05148         118 AYLEEQNSIHRDLAARNILVGEDLVCKVADFGLARLIKEDV----YLSSDKKIPYKWTAPEAASHGT-FSTKSDVWSFGI  192 (261)
T ss_pred             HHHHHCCeeccccCcceEEEcCCceEEEccccchhhcCCcc----ccccCCCCceEecCHHHHccCC-CCchhhHHHHHH
Confidence            99999999999999999999999999999999997654321    1112334567899999987654 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |..||.+.+..+....+......+                               .+...+..+.+++.+||
T Consensus       193 ~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~i~~~l  241 (261)
T cd05148         193 LLYEMFTYGQVPYPGMNNHEVYDQITAGYRMP-------------------------------CPAKCPQEIYKIMLECW  241 (261)
T ss_pred             HHHHHHcCCCCCCCcCCHHHHHHHHHhCCcCC-------------------------------CCCCCCHHHHHHHHHHc
Confidence            9999998 899998877666555544211100                               01124566779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      +.||.+|||+.++++
T Consensus       242 ~~~p~~Rpt~~~l~~  256 (261)
T cd05148         242 AAEPEDRPSFKALRE  256 (261)
T ss_pred             CCCchhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites (Srm) and breast tumor kinase (Brk, also called protein tyrosine kinase 6); catalytic (c) domains. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Srm and Brk are a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases in general contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr; they are activated by autophosphorylation at the tyr kinase dom

>cd05045 PTKc_RET Catalytic domain of the Protein Tyrosine Kinase, REarranged during Transfection protein

Probab=100.00  E-value=4.1e-32  Score=257.77  Aligned_cols=209  Identities=21%  Similarity=0.359  Sum_probs=164.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------------   65 (433)
                      ..+.+|+++++.++||||+++++.+...        +..++||||+. ++|.+++....                     
T Consensus        48 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  119 (290)
T cd05045          48 RDLLSEFNLLKQVNHPHVIKLYGACSQD--------GPLLLIVEYAKYGSLRSFLRESRKVGPSYLGSDGNRNSSYLDNP  119 (290)
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEEecC--------CCcEEEEEecCCCCHHHHHHhcCCccccccccccccccccccCc
Confidence            3577899999999999999999998765        55899999998 57877765421                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccC
Q psy7889          66 --VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRP  143 (433)
Q Consensus        66 --~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~a  143 (433)
                        ..+++..+..++.|++.||+|||+.||+||||||+||+++.++.++|+|||++.........  .......++..|+|
T Consensus       120 ~~~~l~~~~~~~i~~~i~~~l~~LH~~~ivH~dikp~nill~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~y~a  197 (290)
T cd05045         120 DERALTMGDLISFAWQISRGMQYLAEMKLVHRDLAARNVLVAEGRKMKISDFGLSRDVYEEDSY--VKRSKGRIPVKWMA  197 (290)
T ss_pred             cccccCHHHHHHHHHHHHHHHHHHHHCCeehhhhhhheEEEcCCCcEEeccccccccccCccch--hcccCCCCCccccC
Confidence              23788899999999999999999999999999999999999999999999998765432211  11122344678999


Q ss_pred             cccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         144 PELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       144 PE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      ||.+.+.. ++.++|||||||++++|++ |.+||.+.........+.......                           
T Consensus       198 pE~~~~~~-~~~~~Di~slG~~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------  249 (290)
T cd05045         198 IESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIAPERLFNLLKTGYRME---------------------------  249 (290)
T ss_pred             HHHHccCC-cchHhHHHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC---------------------------
Confidence            99887654 7999999999999999998 999998877655443332111000                           


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                          .+...+..+++|+.+||+.+|.+||++.+++.
T Consensus       250 ----~~~~~~~~~~~~i~~cl~~~P~~Rp~~~~i~~  281 (290)
T cd05045         250 ----RPENCSEEMYNLMLTCWKQEPDKRPTFADISK  281 (290)
T ss_pred             ----CCCCCCHHHHHHHHHHccCCcccCCCHHHHHH
Confidence                01124567789999999999999999999974

Protein Tyrosine Kinase (PTK) family; RET (REarranged during Transfection) protein; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. RET is a receptor tyr kinase (RTK) containing an extracellular region with four cadherin-like repeats, a calcium-binding site, and a cysteine-rich domain, a transmembrane segment, and an intracellular catalytic domain. It is part of a multisubunit complex that binds glial-derived neurotropic factor (GDNF) family ligands (GFLs) including GDNF, neurturin, artemin, and persephin. GFLs bind RET along with four GPI-anchored coreceptors, bringing two RET molecules together, leadi

>cd05070 PTKc_Fyn_Yrk Catalytic domain of the Protein Tyrosine Kinases, Fyn and Yrk

Probab=100.00  E-value=5.3e-32  Score=252.74  Aligned_cols=208  Identities=22%  Similarity=0.353  Sum_probs=165.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+.+|+.+++.++|+||+++++++..         ...|+||||+. ++|.+++.... ..++++.++.++.|++.||
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al  115 (260)
T cd05070          45 PESFLEEAQIMKKLRHDKLVQLYAVVSE---------EPIYIVTEYMSKGSLLDFLKDGEGRALKLPNLVDMAAQVAAGM  115 (260)
T ss_pred             HHHHHHHHHHHHhcCCCceEEEEeEECC---------CCcEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            4678899999999999999999998743         34789999997 48888876533 3489999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+|+||||+||+++.++.++|+|||++..+......   ......++..|+|||.+.+.. ++.++|||||||
T Consensus       116 ~~lH~~~i~H~di~p~Nili~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  191 (260)
T cd05070         116 AYIERMNYIHRDLRSANILVGDGLVCKIADFGLARLIEDNEYT---ARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  191 (260)
T ss_pred             HHHHHCCcccCCCccceEEEeCCceEEeCCceeeeeccCcccc---cccCCCCCccccChHHHhcCC-CcchhhhHHHHH
Confidence            9999999999999999999999999999999999775432211   111223456799999987655 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+.+..+....+.......                               .+...+..+.+|+.+||
T Consensus       192 ~l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l  240 (260)
T cd05070         192 LLTELVTKGRVPYPGMNNREVLEQVERGYRMP-------------------------------CPQDCPISLHELMLQCW  240 (260)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCcCCHHHHHHHHHHc
Confidence            9999999 899998877666555543211000                               01123556779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++|||+.++++
T Consensus       241 ~~~p~~Rpt~~~l~~  255 (260)
T cd05070         241 KKDPEERPTFEYLQS  255 (260)
T ss_pred             ccCcccCcCHHHHHH
Confidence            999999999998863

Protein Tyrosine Kinase (PTK) family; Fyn and Yrk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fyn and Yrk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that r

>cd05041 PTKc_Fes_like Catalytic domain of Fes-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.6e-32  Score=250.56  Aligned_cols=209  Identities=23%  Similarity=0.372  Sum_probs=165.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++|+||+++++++.+.        ...++||||+. ++|.+.+.+....+++..+..++.+++.||+|
T Consensus        37 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~l~~  108 (251)
T cd05041          37 RKFLQEAEILKQYDHPNIVKLIGVCVQK--------QPIYIVMELVPGGSLLTFLRKKKNRLTVKKLLQMSLDAAAGMEY  108 (251)
T ss_pred             HHHHHHHHHHHhCCCCCeEEEEEEEecC--------CCeEEEEEcCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999876        55899999996 57888886655568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++||||||+||+++.++.++|+|||++.........  ........+..|+|||.+.+.. ++.++|+|||||++
T Consensus       109 lH~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~i~  185 (251)
T cd05041         109 LESKNCIHRDLAARNCLVGENNVLKISDFGMSREEEGGIYT--VSDGLKQIPIKWTAPEALNYGR-YTSESDVWSYGILL  185 (251)
T ss_pred             HHhCCEehhhcCcceEEEcCCCcEEEeeccccccccCCcce--eccccCcceeccCChHhhccCC-CCcchhHHHHHHHH
Confidence            99999999999999999999999999999998765421110  0011122356799999987654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++ |..||.+.........+.......                               .+...+.+..+++.+||..
T Consensus       186 ~~l~t~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~  234 (251)
T cd05041         186 WETFSLGDTPYPGMSNQQTRERIESGYRMP-------------------------------APQLCPEEIYRLMLQCWAY  234 (251)
T ss_pred             HHHHhccCCCCccCCHHHHHHHHhcCCCCC-------------------------------CCccCCHHHHHHHHHHhcc
Confidence            99999 889998876554444332211100                               0112355677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+|||+.|+++
T Consensus       235 ~p~~Rp~~~ell~  247 (251)
T cd05041         235 DPENRPSFSEIYN  247 (251)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Fes subfamily; catalytic (c) domain. Fes subfamily members include Fes (or Fps), Fer, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Fes subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal region with FCH (Fes/Fer/CIP4 homology) and coiled-coil domains, followed by a SH2 domain, and a C-terminal catalytic domain. The genes for Fes (feline sarcoma) and Fps (Fujinami poultry sarcoma) were first isolated from tumor-causing retroviruses. The viral oncogenes encode chimeric Fes proteins consisting of Gag sequences at the N-termini, resulting in unregulated tyr k

>KOG2345|consensus

Probab=100.00  E-value=2.3e-33  Score=244.08  Aligned_cols=222  Identities=22%  Similarity=0.350  Sum_probs=166.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC---CCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV---KFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~---~l~~~~~~~i~~qll~   82 (433)
                      .+.+++||+..++++||||++++++...+..+   -....||+++|.. |+|++.+.....   .+++.++..|+.+|++
T Consensus        62 ~e~~~rEid~~rkf~s~~vl~l~dh~l~~~~D---~~~~~yll~Pyy~~Gsl~d~i~~~k~kg~~~sE~~iL~if~gic~  138 (302)
T KOG2345|consen   62 IEEALREIDNHRKFNSPNVLRLVDHQLREEKD---GKHEAYLLLPYYKRGSLLDEIERLKIKGNFVSEAQILWIFLGICR  138 (302)
T ss_pred             HHHHHHHHHHHHhhCCcchHHHHHHHHHhhcc---CceeEEEEeehhccccHHHHHHHHhhcCCccCHHHHHHHHHHHHH
Confidence            35689999999999999999999998776442   2367899999986 679988865432   4899999999999999


Q ss_pred             HHHHHHhCC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcc-----ccccCCcccccccCcccccCCC--CC
Q psy7889          83 GLYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV-----NRYTNRVVTLWYRPPELLLGDR--NY  153 (433)
Q Consensus        83 aL~~LH~~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~--~~  153 (433)
                      ||++||+..  +.||||||.|||+++.+.++|.|||.+....-.-....     ........|..|+|||.+....  ..
T Consensus       139 gL~~lH~~~~~yAH~DiKP~NILls~~~~~vl~D~GS~~~a~i~i~~~~~a~~lQe~a~e~Ct~pyRAPELf~vk~~~ti  218 (302)
T KOG2345|consen  139 GLEALHEKEPPYAHRDIKPANILLSDSGLPVLMDLGSATQAPIQIEGSRQALRLQEWAEERCTIPYRAPELFNVKSHCTI  218 (302)
T ss_pred             HHHHHhccCCcccccCCCcceeEecCCCceEEEeccCccccceEeechHHHHHHHHHHHHhCCCcccCchheecccCccc
Confidence            999999998  99999999999999999999999999876542111110     0111234588899999986443  25


Q ss_pred             CCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         154 GPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       154 ~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      +.++|||||||++|.|+.|..||......          |.       .+.....-.++.+|.           ...+|+
T Consensus       219 ~ertDIWSLGCtLYa~mf~~sPfe~~~~~----------Gg-------SlaLAv~n~q~s~P~-----------~~~yse  270 (302)
T KOG2345|consen  219 TERTDIWSLGCTLYAMMFGESPFERIYQQ----------GG-------SLALAVQNAQISIPN-----------SSRYSE  270 (302)
T ss_pred             ccccchhhhhHHHHHHHHcCCcchHHhhc----------CC-------eEEEeeeccccccCC-----------CCCccH
Confidence            78999999999999999999999642211          10       000000000111111           112677


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ....+|.+||+.||.+||++.+++.+
T Consensus       271 ~l~~lik~mlqvdP~qRP~i~~ll~~  296 (302)
T KOG2345|consen  271 ALHQLIKSMLQVDPNQRPTIPELLSK  296 (302)
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHHHH
Confidence            88899999999999999999999864

>cd05056 PTKc_FAK Catalytic domain of the Protein Tyrosine Kinase, Focal Adhesion Kinase

Probab=100.00  E-value=5.8e-32  Score=253.88  Aligned_cols=207  Identities=24%  Similarity=0.325  Sum_probs=166.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+++.++||||+++++++.+         ...|+||||+. ++|.+++.+....+++..+..++.|++.||+|
T Consensus        52 ~~~~~e~~~l~~~~h~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~  122 (270)
T cd05056          52 EKFLQEAYIMRQFDHPHIVKLIGVITE---------NPVWIVMELAPLGELRSYLQVNKYSLDLASLILYSYQLSTALAY  122 (270)
T ss_pred             HHHHHHHHHHHhCCCCchhceeEEEcC---------CCcEEEEEcCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            467889999999999999999998864         33689999997 58888887655568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||.+.+.. ++.++|||||||++
T Consensus       123 lH~~~~~H~dl~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  198 (270)
T cd05056         123 LESKRFVHRDIAARNVLVSSPDCVKLGDFGLSRYLEDESY---YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  198 (270)
T ss_pred             HHhCCeeccccChheEEEecCCCeEEccCceeeecccccc---eecCCCCccccccChhhhccCC-CCchhhhHHHHHHH
Confidence            9999999999999999999999999999999876543211   1111223356799999886654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++ |.+||.+.+..+....+.......                               .+...+....++|.+|+..
T Consensus       199 ~el~~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~  247 (270)
T cd05056         199 WEILMLGVKPFQGVKNNDVIGRIENGERLP-------------------------------MPPNCPPTLYSLMTKCWAY  247 (270)
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHcCCcCC-------------------------------CCCCCCHHHHHHHHHHcCC
Confidence            99986 999998887666554443211100                               0112356677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+|||+.+++.
T Consensus       248 ~P~~Rpt~~~~~~  260 (270)
T cd05056         248 DPSKRPRFTELKA  260 (270)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999885

Protein Tyrosine Kinase (PTK) family; Focal Adhesion Kinase (FAK); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FAK is a cytoplasmic (or nonreceptor) tyr kinase that contains an autophosphorylation site and a FERM domain at the N-terminus, a central tyr kinase domain, proline-rich regions, and a C-terminal FAT (focal adhesion targeting) domain. FAK activity is dependent on integrin-mediated cell adhesion, which facilitates N-terminal autophosphorylation. Full activation is achieved by the phosphorylation of its two adjacent A-loop tyrosines. FAK is important in mediating signaling initiated at sites of cell adhesions

>cd05032 PTKc_InsR_like Catalytic domain of Insulin Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=6.2e-32  Score=254.50  Aligned_cols=209  Identities=20%  Similarity=0.337  Sum_probs=166.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------CCCCHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------VKFSLGEIKKVI   77 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------~~l~~~~~~~i~   77 (433)
                      ..+.+|+.+|+.++||||+++++++...        ...|+||||++ ++|.+++....         ..+++..+..++
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  125 (277)
T cd05032          54 IEFLNEASVMKEFNCHHVVRLLGVVSTG--------QPTLVVMELMAKGDLKSYLRSRRPEAENNPGLGPPTLQKFIQMA  125 (277)
T ss_pred             HHHHHHHHHHHhCCCCceeEEEEEEcCC--------CCcEEEEecCCCCCHHHHHHhcccchhhccCCCCCCHHHHHHHH
Confidence            3578999999999999999999999875        55899999996 58888876432         236788899999


Q ss_pred             HHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          78 QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        78 ~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      .|++.||.|||+.||+|+||||+||+++.++.+||+|||+++.+.....  ........++..|+|||.+.+.. ++.++
T Consensus       126 ~~i~~~l~~lH~~~i~H~di~p~nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  202 (277)
T cd05032         126 AEIADGMAYLAAKKFVHRDLAARNCMVAEDLTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMAPESLKDGV-FTTKS  202 (277)
T ss_pred             HHHHHHHHHHHhCCccccccChheEEEcCCCCEEECCcccchhhccCcc--cccCCCCCccccccCHHHHhcCC-CCccc
Confidence            9999999999999999999999999999999999999999876543221  11122345577899999987655 79999


Q ss_pred             hhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++|+|++ |.+||.+.+.......+..  +....                             .+...+.++.
T Consensus       203 Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~  251 (277)
T cd05032         203 DVWSFGVVLWEMATLAEQPYQGLSNEEVLKFVID--GGHLD-----------------------------LPENCPDKLL  251 (277)
T ss_pred             chHHHHHHHHHhhccCCCCCccCCHHHHHHHHhc--CCCCC-----------------------------CCCCCCHHHH
Confidence            99999999999998 9999988776655544431  11000                             0111355677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++|.+||..+|++|||+.++++
T Consensus       252 ~li~~~l~~~p~~Rpt~~~l~~  273 (277)
T cd05032         252 ELMRMCWQYNPKMRPTFLEIVS  273 (277)
T ss_pred             HHHHHHcCCChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Insulin Receptor (InsR) subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The InsR subfamily is composed of InsR, Insulin-like Growth Factor-1 Receptor (IGF-1R), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. InsR and IGF-1R are receptor tyr kinases (RTKs) composed of two alphabeta heterodimers. Binding of the ligand (insulin, IGF-1, or IGF-2) to the extracellular alpha subunit activates the intracellular tyr kinase domain of the transmembrane beta subunit. Receptor activation leads to autophosphorylation, stimulating downstream kinase activities, which initiate signaling cascades and biological

>cd05051 PTKc_DDR Catalytic domain of the Protein Tyrosine Kinases, Discoidin Domain Receptors

Probab=100.00  E-value=7.4e-32  Score=256.56  Aligned_cols=216  Identities=21%  Similarity=0.314  Sum_probs=166.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC----------CCCCHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH----------VKFSLGEIKKV   76 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~----------~~l~~~~~~~i   76 (433)
                      ..+.+|+++++.++||||+++++++..+        ..+++||||+. ++|.+++....          ..+++..++.+
T Consensus        64 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  135 (296)
T cd05051          64 EDFLKEVKILSRLSDPNIARLLGVCTVD--------PPLCMIMEYMENGDLNQFLQKHVAETSGLACNSKSLSFSTLLYM  135 (296)
T ss_pred             HHHHHHHHHHHhcCCCCEeEEEEEEecC--------CCcEEEEecCCCCCHHHHHHhcccccccccccCCCCCHHHHHHH
Confidence            4677899999999999999999999875        56899999997 57888876543          25899999999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +.|++.||+|||++||+|+||||+||+++.++.++|+|||++.........  .......++..|+|||.+.+.. ++.+
T Consensus       136 ~~~i~~al~~LH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~~~  212 (296)
T cd05051         136 ATQIASGMRYLESLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSSDYY--RVQGRAPLPIRWMAWESVLLGK-FTTK  212 (296)
T ss_pred             HHHHHHHHHHHHHcCccccccchhceeecCCCceEEccccceeecccCcce--eecCcCCCCceecCHHHhhcCC-CCcc
Confidence            999999999999999999999999999999999999999998765322111  1122334577899999987655 7999


Q ss_pred             chhhhHHHHHHHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         157 VDLWGAGCIMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       157 ~DiwSlGvil~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      +||||+||++|+|++  +..||........+..+............                        ...+...+.+
T Consensus       213 ~Dv~slG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~  268 (296)
T cd05051         213 SDVWAFGVTLWEILTLCREQPYEHLTDQQVIENAGHFFRDDGRQIY------------------------LPRPPNCPKD  268 (296)
T ss_pred             chhhhhHHHHHHHHhcCCCCCCCCcChHHHHHHHHhcccccccccc------------------------CCCccCCCHH
Confidence            999999999999998  67888776665554444332111000000                        0001124567


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +.+++.+||+.||.+|||+.++++
T Consensus       269 l~~li~~cl~~~p~~Rpt~~el~~  292 (296)
T cd05051         269 IYELMLECWRRDEEDRPTFREIHL  292 (296)
T ss_pred             HHHHHHHHhccChhcCCCHHHHHH
Confidence            889999999999999999999964

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR) subfamily; catalytic (c) domain. The DDR subfamily consists of homologs of mammalian DDR1, DDR2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR subfamily members are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linke

>cd05075 PTKc_Axl Catalytic domain of the Protein Tyrosine Kinase, Axl

Probab=100.00  E-value=7.6e-32  Score=253.19  Aligned_cols=216  Identities=20%  Similarity=0.253  Sum_probs=164.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-----CCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-----HVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-----~~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.++||||+++++++......  ......++||||+. ++|.+.+...     ...+++..+..++.|++
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~  122 (272)
T cd05075          45 EDFLSEAVCMKEFDHPNVMRLIGVCLQTVES--EGYPSPVVILPFMKHGDLHSFLLYSRLGDCPQYLPTQMLVKFMTDIA  122 (272)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEccCCcc--cCCCCcEEEEEeCCCCcHHHHHHHhcccCCcccCCHHHHHHHHHHHH
Confidence            4578899999999999999999987543221  11235799999997 5777766321     23478999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||.|||++||+||||||+|||++.++.++|+|||++..+......  .......++..|+|||.+.+.. ++.++||||
T Consensus       123 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~-~~~~~Di~s  199 (272)
T cd05075         123 SGMEYLSSKSFIHRDLAARNCMLNENMNVCVADFGLSKKIYNGDYY--RQGRIAKMPVKWIAIESLADRV-YTTKSDVWS  199 (272)
T ss_pred             HHHHHHHHCCeeccccchhheEEcCCCCEEECCCCcccccCcccce--ecCCcccCCcccCCHHHccCCC-cChHHHHHH
Confidence            9999999999999999999999999999999999999876532211  1112234467899999987654 799999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      +||++|+|++ |.+||.+.........+.....  ..                             .+...+..+.++|.
T Consensus       200 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~--~~-----------------------------~~~~~~~~~~~li~  248 (272)
T cd05075         200 FGVTMWEIATRGQTPYPGVENSEIYDYLRQGNR--LK-----------------------------QPPDCLDGLYSLMS  248 (272)
T ss_pred             HHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCC--CC-----------------------------CCCCCCHHHHHHHH
Confidence            9999999999 8999988766554444322110  00                             00113455679999


Q ss_pred             hhcccCCCCCCCHHHhhcC
Q psy7889         241 KLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h  259 (433)
                      +||..||.+|||+.+++++
T Consensus       249 ~~l~~~p~~Rps~~~l~~~  267 (272)
T cd05075         249 SCWLLNPKDRPSFETLRCE  267 (272)
T ss_pred             HHcCCCcccCcCHHHHHHH
Confidence            9999999999999999863

Protein Tyrosine Kinase (PTK) family; Axl; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl is widely expressed in a variety of organs and cells including epithelial, mesenchymal, hematopoietic, as well as non-transfor

>cd05069 PTKc_Yes Catalytic domain of the Protein Tyrosine Kinase, Yes

Probab=100.00  E-value=8.3e-32  Score=251.45  Aligned_cols=208  Identities=23%  Similarity=0.377  Sum_probs=165.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+.+|+.+++.++||||+++++++..         +..|+||||+.+ +|.+++.... ..+++..+..++.|++.||
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~al  115 (260)
T cd05069          45 PEAFLQEAQIMKKLRHDKLVPLYAVVSE---------EPIYIVTEFMGKGSLLDFLKEGDGKYLKLPQLVDMAAQIADGM  115 (260)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEcC---------CCcEEEEEcCCCCCHHHHHhhCCCCCCCHHHHHHHHHHHHHHH
Confidence            4567899999999999999999988743         347899999985 8988886543 3478999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||.+.+.. ++.++|||||||
T Consensus       116 ~~lH~~~i~H~dl~~~Nill~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~~Pe~~~~~~-~~~~~Di~slG~  191 (260)
T cd05069         116 AYIERMNYIHRDLRAANILVGDNLVCKIADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  191 (260)
T ss_pred             HHHHhCCEeecccCcceEEEcCCCeEEECCCccceEccCCcc---cccCCCccchhhCCHHHhccCC-cChHHHHHHHHH
Confidence            999999999999999999999999999999999976543211   1111223467799999887655 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+....+....+.....   ...                            +...+..+.+++.+||
T Consensus       192 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~---~~~----------------------------~~~~~~~~~~li~~~l  240 (260)
T cd05069         192 LLTELVTKGRVPYPGMVNREVLEQVERGYR---MPC----------------------------PQGCPESLHELMKLCW  240 (260)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CCC----------------------------CcccCHHHHHHHHHHc
Confidence            9999999 8999998776665554432110   000                            0113456779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+||+++++++
T Consensus       241 ~~~p~~Rp~~~~i~~  255 (260)
T cd05069         241 KKDPDERPTFEYIQS  255 (260)
T ss_pred             cCCcccCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Yes kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Yes (or c-Yes) is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pathways that regulate cytokine an

>cd05040 PTKc_Ack_like Catalytic domain of the Protein Tyrosine Kinase, Activated Cdc42-associated kinase

Probab=100.00  E-value=1e-31  Score=250.11  Aligned_cols=210  Identities=24%  Similarity=0.341  Sum_probs=168.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.++++++||||+++++++..         ..+++||||+. ++|.+.+.+.. ..+++..++.++.|++.||.
T Consensus        41 ~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~L~  111 (257)
T cd05040          41 DDFLKEAAIMHSLDHENLIRLYGVVLT---------HPLMMVTELAPLGSLLDRLRKDALGHFLISTLCDYAVQIANGMR  111 (257)
T ss_pred             HHHHHHHHHHhhcCCCCccceeEEEcC---------CeEEEEEEecCCCcHHHHHHhcccccCcHHHHHHHHHHHHHHHH
Confidence            467889999999999999999999875         34899999996 68998887754 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|++|+||||+||+++.++.+||+|||++..+..... .........++..|+|||.+.+.. ++.++|||||||+
T Consensus       112 ~lH~~~i~H~di~p~nil~~~~~~~kl~dfg~~~~~~~~~~-~~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Di~slG~~  189 (257)
T cd05040         112 YLESKRFIHRDLAARNILLASDDKVKIGDFGLMRALPQNED-HYVMEEHLKVPFAWCAPESLRTRT-FSHASDVWMFGVT  189 (257)
T ss_pred             HHHhCCccccccCcccEEEecCCEEEecccccccccccccc-ceecccCCCCCceecCHHHhcccC-cCchhhhHHHHHH
Confidence            99999999999999999999999999999999987654221 111112345677899999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++|++ |.+||...+..+....+.....     .+.                         .+...+....+++.+||.
T Consensus       190 l~el~t~g~~p~~~~~~~~~~~~~~~~~~-----~~~-------------------------~~~~~~~~~~~li~~~l~  239 (257)
T cd05040         190 LWEMFTYGEEPWAGLSGSQILKKIDKEGE-----RLE-------------------------RPEACPQDIYNVMLQCWA  239 (257)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHhcCC-----cCC-------------------------CCccCCHHHHHHHHHHCC
Confidence            999998 9999987776665554432110     000                         011234567799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .+|.+||++.++++
T Consensus       240 ~~p~~Rps~~~~~~  253 (257)
T cd05040         240 HNPADRPTFAALRE  253 (257)
T ss_pred             CCcccCCCHHHHHH
Confidence            99999999999975

Protein Tyrosine Kinase (PTK) family; Activated Cdc42-associated kinase (Ack) subfamily; catalytic (c) domain. Ack subfamily members include Ack1, thirty-eight-negative kinase 1 (Tnk1), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ack subfamily members are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal catalytic domain, an SH3 domain, a Cdc42-binding CRIB domain, and a proline-rich region. They are mainly expressed in brain and skeletal tissues and are involved in the regulation of cell adhesion and growth, receptor degradation, and axonal guidance. Ack1 is also associated with and

>cd05101 PTKc_FGFR2 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 2

Probab=100.00  E-value=8.3e-32  Score=257.46  Aligned_cols=210  Identities=23%  Similarity=0.422  Sum_probs=166.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+.+++.+ +||||+++++++...        ..+|+||||+.+ +|.+++.+..               ..++.
T Consensus        65 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  136 (304)
T cd05101          65 SDLVSEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDIARVPDEQMTF  136 (304)
T ss_pred             HHHHHHHHHHHhhccCCCchheeEEEecC--------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCCcccccH
Confidence            4578899999999 899999999999875        568999999974 8888886532               24778


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.||+.||.|||++||+||||||+||+++.++.+||+|||++.........  .......++..|+|||++.+.
T Consensus       137 ~~~~~~~~qi~~al~~LH~~givH~dlkp~Nili~~~~~~kl~D~g~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  214 (304)
T cd05101         137 KDLVSCTYQVARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDVNNIDYY--KKTTNGRLPVKWMAPEALFDR  214 (304)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeecccccceEEEcCCCcEEECCCccceeccccccc--ccccCCCCCceeeCchhhccC
Confidence            889999999999999999999999999999999999999999999999776432111  112223456789999998775


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |..||.+.+..+....+......                               ..+.
T Consensus       215 ~-~~~~~Di~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------~~~~  262 (304)
T cd05101         215 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRM-------------------------------DKPA  262 (304)
T ss_pred             C-CCchhhHHHHHHHHHHHHcCCCCCcccCCHHHHHHHHHcCCcC-------------------------------CCCC
Confidence            5 7999999999999999998 78899887766554443211000                               0011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+||.+||..+|.+||++.++++.
T Consensus       263 ~~~~~~~~li~~cl~~~p~~Rps~~e~l~~  292 (304)
T cd05101         263 NCTNELYMMMRDCWHAIPSHRPTFKQLVED  292 (304)
T ss_pred             CCCHHHHHHHHHHcccChhhCCCHHHHHHH
Confidence            245677899999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 2 (FGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR2 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd08222 STKc_Nek11 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 11

Probab=100.00  E-value=3e-32  Score=254.35  Aligned_cols=210  Identities=28%  Similarity=0.472  Sum_probs=166.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ...++||||+.+ +|...+..   ....+++..++.++.|++.|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~l~~~  118 (260)
T cd08222          47 VQANQEAQLLSKLDHPAIVKFHASFLER--------DAFCIITEYCEGRDLDCKLEELKHTGKTLSENQVCEWFIQLLLG  118 (260)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHHHHhcC--------CceEEEEEeCCCCCHHHHHHHHhhcccccCHHHHHHHHHHHHHH
Confidence            3567899999999999999999998765        558999999975 67666643   23468999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||+.|++|+||+|+||+++. +.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       119 l~~lH~~~i~h~~l~~~nili~~-~~~~l~d~g~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~slG  192 (260)
T cd08222         119 VHYMHQRRILHRDLKAKNIFLKN-NLLKIGDFGVSRLLMGSCD----LATTFTGTPYYMSPEALKHQG-YDSKSDIWSLG  192 (260)
T ss_pred             HHHHHHcCccccCCChhheEeec-CCEeecccCceeecCCCcc----cccCCCCCcCccCHHHHccCC-CCchhhHHHHH
Confidence            99999999999999999999975 5699999999876543221    122345688899999886544 68899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +++++|++|..||.+.........+..  +..+ .                            .+...+.++.++|.+||
T Consensus       193 ~~~~~l~~~~~~~~~~~~~~~~~~~~~--~~~~-~----------------------------~~~~~~~~~~~li~~~l  241 (260)
T cd08222         193 CILYEMCCLAHAFEGQNFLSVVLRIVE--GPTP-S----------------------------LPETYSRQLNSIMQSML  241 (260)
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHHc--CCCC-C----------------------------CcchhcHHHHHHHHHHh
Confidence            999999999999987665444433321  1100 0                            01124566779999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..+|++||++.++++||||
T Consensus       242 ~~~p~~Rp~~~~il~~~~~  260 (260)
T cd08222         242 NKDPSLRPSAAEILRNPFI  260 (260)
T ss_pred             cCChhhCcCHHHHhhCCCC
Confidence            9999999999999999997

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 11 (Nek11) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek11 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek11 is involved, through direct phosphorylation, in regulating the degradation of Cdc25A (Cell Division Cycle 25 homolog A), which plays a role in cell cycle progression and in activating cyclin dependent kinases. Nek11 is activated by CHK1 (CHeckpoint Kinase 1) and may be involved in the G2/M check

>cd05111 PTK_HER3 Pseudokinase domain of the Protein Tyrosine Kinase, HER3

Probab=100.00  E-value=9.2e-32  Score=253.96  Aligned_cols=208  Identities=20%  Similarity=0.335  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+..|+.+++.++||||+++++++..         ...++|+||+. ++|.+++......+++..+..++.||+.||.|
T Consensus        54 ~~~~~~~~~l~~l~h~~iv~~~~~~~~---------~~~~~i~e~~~~gsL~~~l~~~~~~~~~~~~~~i~~qi~~~l~~  124 (279)
T cd05111          54 QEITDHMLAMGSLDHAYIVRLLGICPG---------ASLQLVTQLSPLGSLLDHVRQHRDSLDPQRLLNWCVQIAKGMYY  124 (279)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEECC---------CccEEEEEeCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            356667888899999999999998743         33688999987 68999987766678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++|+||||+||+++.++.+||+|||+++.......  ........++..|+|||.+.+.. ++.++|||||||++
T Consensus       125 lH~~~iiH~dlkp~nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~il  201 (279)
T cd05111         125 LEEHRMVHRNLAARNILLKSDSIVQIADFGVADLLYPDDK--KYFYSEHKTPIKWMALESILFGR-YTHQSDVWSYGVTV  201 (279)
T ss_pred             HHHCCEeccccCcceEEEcCCCcEEEcCCccceeccCCCc--ccccCCCCCcccccCHHHhccCC-cCchhhHHHHHHHH
Confidence            9999999999999999999999999999999976543211  11223345677899999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |..||.+.........+..  +....                             .+...+....+++.+|+..
T Consensus       202 ~el~t~g~~p~~~~~~~~~~~~~~~--~~~~~-----------------------------~~~~~~~~~~~li~~c~~~  250 (279)
T cd05111         202 WEMMSYGAEPYAGMRPHEVPDLLEK--GERLA-----------------------------QPQICTIDVYMVMVKCWMI  250 (279)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHC--CCcCC-----------------------------CCCCCCHHHHHHHHHHcCC
Confidence            99998 9999988765543333221  11000                             0011234456899999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||+.|+++
T Consensus       251 ~p~~Rps~~el~~  263 (279)
T cd05111         251 DENVRPTFKELAN  263 (279)
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999975

Protein Tyrosine Kinase (PTK) family; HER3 (ErbB3); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER3 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr r

>cd05035 PTKc_Axl_like Catalytic Domain of Axl-like Protein Tyrosine Kinases

Probab=100.00  E-value=7.1e-32  Score=253.35  Aligned_cols=216  Identities=20%  Similarity=0.247  Sum_probs=165.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-----CCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-----HVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-----~~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.++||||+++++++......  ......++||||+. ++|..++...     ...+++..++.++.|++
T Consensus        46 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~--~~~~~~~~v~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~~~i~  123 (273)
T cd05035          46 EEFLSEAACMKDFDHPNVMKLIGVCFEASSL--QKIPKPMVILPFMKHGDLHSFLLYSRLGGLPEKLPLQTLLKFMVDIA  123 (273)
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEeeeccCCcc--ccCcccEEEEeccCCCCHHHHHHHhhccCCcccCCHHHHHHHHHHHH
Confidence            3578899999999999999999988654210  01245799999997 4777776432     23589999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||.|||++|++||||||+||+++.++.+||+|||+++.+......  .......++..|+|||.+.+.. ++.++||||
T Consensus       124 ~aL~~lH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~-~~~~~Dv~S  200 (273)
T cd05035         124 LGMEYLSNRNFIHRDLAARNCMLREDMTVCVADFGLSKKIYSGDYY--RQGRIAKMPVKWIAIESLADRV-YTSKSDVWA  200 (273)
T ss_pred             HHHHHHHhCCeeccccchheEEECCCCeEEECCccceeeccccccc--cccccccCCccccCHhhcccCC-CCcccchHH
Confidence            9999999999999999999999999999999999999776432211  1111223466799999986654 799999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      +||++|||++ |.+||.+....+....+...  ....                             .+...+..+.+++.
T Consensus       201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~--~~~~-----------------------------~~~~~~~~~~~li~  249 (273)
T cd05035         201 FGVTMWEIATRGQTPYPGVENHEIYDYLRHG--NRLK-----------------------------QPEDCLDELYDLMY  249 (273)
T ss_pred             HHHHHHHHHhCCCCCCCCCCHHHHHHHHHcC--CCCC-----------------------------CCcCCCHHHHHHHH
Confidence            9999999999 89999887765544433221  0000                             01124566779999


Q ss_pred             hhcccCCCCCCCHHHhhcC
Q psy7889         241 KLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h  259 (433)
                      +||..||++|||+.+++.+
T Consensus       250 ~~l~~~p~~Rp~~~e~~~~  268 (273)
T cd05035         250 SCWRADPKDRPTFTKLREV  268 (273)
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999999864

Protein Tyrosine Kinase (PTK) family; Axl subfamily; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). The Axl subfamily consists of Axl, Tyro3 (or Sky), Mer (or Mertk), and similar proteins. PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Axl subfamily members are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Axl subfamily members are implicated in a variety of cellu

>cd05047 PTKc_Tie Catalytic domain of Tie Protein Tyrosine Kinases

Probab=100.00  E-value=6e-32  Score=253.89  Aligned_cols=206  Identities=23%  Similarity=0.345  Sum_probs=161.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+++++++ +||||+++++++...        ..+|+||||+. ++|.+++....               ..+++
T Consensus        40 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~  111 (270)
T cd05047          40 RDFAGELEVLCKLGHHPNIINLLGACEHR--------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLSS  111 (270)
T ss_pred             HHHHHHHHHHHhhccCCCeeeEEEEEecC--------CCceEEEEeCCCCcHHHHHHhccccccccccccccCCcCCCCH
Confidence            4677899999999 899999999999875        45899999997 58888886532               24788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      +.++.++.|++.||+|||+.|++|+||||+||+++.++.+||+|||++.......     .......+..|+|||++.+.
T Consensus       112 ~~~~~~~~~i~~al~~lH~~~i~H~dikp~nili~~~~~~kl~dfgl~~~~~~~~-----~~~~~~~~~~y~apE~~~~~  186 (270)
T cd05047         112 QQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNYS  186 (270)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCEeecccccceEEEcCCCeEEECCCCCccccchhh-----hccCCCCccccCChHHHccC
Confidence            9999999999999999999999999999999999999999999999985322110     11112235679999998665


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++++|++ |..||.+.+..+....+....   ..+                            .+.
T Consensus       187 ~-~~~~~Di~slG~il~el~~~g~~pf~~~~~~~~~~~~~~~~---~~~----------------------------~~~  234 (270)
T cd05047         187 V-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGY---RLE----------------------------KPL  234 (270)
T ss_pred             C-CCchhhHHHHHHHHHHHHcCCCCCccccCHHHHHHHHhCCC---CCC----------------------------CCC
Confidence            4 7999999999999999997 999998766555444331100   000                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+.++.+++.+||..+|.+|||+.+++.
T Consensus       235 ~~~~~~~~li~~~l~~~p~~Rps~~~il~  263 (270)
T cd05047         235 NCDDEVYDLMRQCWREKPYERPSFAQILV  263 (270)
T ss_pred             cCCHHHHHHHHHHcccChhhCCCHHHHHH
Confidence            23556779999999999999999999985

Protein Tyrosine Kinase (PTK) family; Tie subfamily; catalytic (c) domain. The Tie subfamily consists of Tie1 and Tie2. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tie proteins are receptor tyr kinases (RTKs) containing an extracellular region, a transmembrane segment, and an intracellular catalytic domain. The extracellular region contains an immunoglobulin (Ig)-like domain, three epidermal growth factor (EGF)-like domains, a second Ig-like domain, and three fibronectin type III repeats. Tie receptors are specifically expressed in endothelial cells and hematopoietic stem cells. The angiopoietins (Ang-1 to Ang-4) serve as ligands for Tie2, while no specific l

>cd06606 STKc_MAPKKK Catalytic domain of the Protein Serine/Threonine Kinase, Mitogen-Activated Protein Kinase Kinase Kinase

Probab=100.00  E-value=1.3e-31  Score=248.84  Aligned_cols=217  Identities=33%  Similarity=0.535  Sum_probs=172.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|++++++++||||+++++.+....      ...+++|+||+. ++|.+++.+.. .+++..++.++.|++.||.
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~~------~~~~~lv~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~  115 (260)
T cd06606          43 LEALEREIRILSSLQHPNIVRYYGSERDEE------KNTLNIFLEYVSGGSLSSLLKKFG-KLPEPVIRKYTRQILEGLA  115 (260)
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEecCC------CCeEEEEEEecCCCcHHHHHHHcC-CCCHHHHHHHHHHHHHHHH
Confidence            356788999999999999999999998752      256899999995 57888877654 7899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||+|+||+++.++.++|+|||.+.........  .......++..|+|||.+.+.. ++.++|||||||+
T Consensus       116 ~lh~~~~~h~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~~--~~~~~~~~~~~y~~pE~~~~~~-~~~~~Dv~slG~i  192 (260)
T cd06606         116 YLHSNGIVHRDIKGANILVDSDGVVKLADFGCAKRLGDIETG--EGTGSVRGTPYWMAPEVIRGEE-YGRAADIWSLGCT  192 (260)
T ss_pred             HHHHCCccccCCCHHHEEEcCCCCEEEcccccEEeccccccc--ccccCCCCCccccCHhhhcCCC-CCchhhHHHHHHH
Confidence            999999999999999999999999999999998876543211  0123346788899999987765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||.......  ..+...........                           .+...+....+||.+||..
T Consensus       193 l~~l~~g~~p~~~~~~~~--~~~~~~~~~~~~~~---------------------------~~~~~~~~l~~~i~~~l~~  243 (260)
T cd06606         193 VIEMATGKPPWSELGNPM--AALYKIGSSGEPPE---------------------------IPEHLSEEAKDFLRKCLRR  243 (260)
T ss_pred             HHHHHhCCCCCCCCCchH--HHHHhccccCCCcC---------------------------CCcccCHHHHHHHHHhCcC
Confidence            999999999998766221  11111110000000                           0112356778999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|++||++.+++.||||
T Consensus       244 ~p~~Rp~~~~ll~~~~~  260 (260)
T cd06606         244 DPKKRPTADELLQHPFL  260 (260)
T ss_pred             ChhhCCCHHHHhhCCCC
Confidence            99999999999999997

Serine/threonine kinases (STKs), mitogen-activated protein kinase (MAPK) kinase kinase (MAPKKK) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAPKKK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAPKKKs (MKKKs or MAP3Ks) are also called MAP/ERK kinase kinases (MEKKs) in some cases. They phosphorylate and activate MAPK kinases (MAPKKs or MKKs or MAP2Ks), which in turn phosphorylate and activate MAPKs during signaling cascades that are important in mediating cellular responses to extracellular signals. This subfamily is composed of the Apoptosis Signal-regulating Kinases ASK1 (or MAPKK

>cd05099 PTKc_FGFR4 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 4

Probab=100.00  E-value=1.1e-31  Score=257.75  Aligned_cols=208  Identities=24%  Similarity=0.452  Sum_probs=163.9

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSLG   71 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~~   71 (433)
                      .+.+|+++++.+ +||||+++++++...        +.+|+||||+. ++|.+++....               ..++..
T Consensus        63 ~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~~  134 (314)
T cd05099          63 DLISEMELMKLIGKHKNIINLLGVCTQE--------GPLYVIVEYAAKGNLREFLRARRPPGPDYTFDITKVPEEQLSFK  134 (314)
T ss_pred             HHHHHHHHHHhccCCCCeeeEEEEEccC--------CceEEEEecCCCCcHHHHHHhcCCCcccccccccCCcccccCHH
Confidence            577899999999 699999999999765        55899999997 58888886532               247888


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .+..++.||+.||.|||++||+|+||||+||+++.++.+||+|||+++........  .......++..|+|||++.+..
T Consensus       135 ~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~  212 (314)
T cd05099         135 DLVSCAYQVARGMEYLESRRCIHRDLAARNVLVTEDNVMKIADFGLARGVHDIDYY--KKTSNGRLPVKWMAPEALFDRV  212 (314)
T ss_pred             HHHHHHHHHHHHHHHHHHCCeeeccccceeEEEcCCCcEEEccccccccccccccc--cccccCCCCccccCHHHHccCC
Confidence            99999999999999999999999999999999999999999999999765432111  0111223346799999987654


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       ++.++|||||||++|+|++ |..||.+....+....+.....   ..                            .+..
T Consensus       213 -~~~~~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------------------~~~~  260 (314)
T cd05099         213 -YTHQSDVWSFGILMWEIFTLGGSPYPGIPVEELFKLLREGHR---MD----------------------------KPSN  260 (314)
T ss_pred             -cCccchhhHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCC---CC----------------------------CCCC
Confidence             7999999999999999999 8899988776655544432100   00                            0112


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .+.+.+++|.+||..+|.+|||+.++++
T Consensus       261 ~~~~l~~li~~cl~~~p~~Rps~~~ll~  288 (314)
T cd05099         261 CTHELYMLMRECWHAVPTQRPTFKQLVE  288 (314)
T ss_pred             CCHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            3456779999999999999999999985

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 4 (FGFR4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR4 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05613 STKc_MSK1_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase 1

Probab=100.00  E-value=8.6e-32  Score=255.48  Aligned_cols=219  Identities=26%  Similarity=0.390  Sum_probs=170.4

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.+ +|+||+++++++...        ..+|+||||+++ +|.+.+... ..+++..+..++.|++.||.
T Consensus        49 ~~~~~e~~~l~~l~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~  119 (290)
T cd05613          49 EHTRTERQVLEHIRQSPFLVTLHYAFQTD--------TKLHLILDYINGGELFTHLSQR-ERFKEQEVQIYSGEIVLALE  119 (290)
T ss_pred             HHHHHHHHHHHhcccCCChhceeeEeecC--------CeEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            4567899999999 699999999999875        568999999985 788777653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGv  164 (433)
                      |||+.|++||||+|+||+++.++.++|+|||++........   .......++..|+|||.+.+. ..++.++||||+||
T Consensus       120 ~lH~~~i~H~dl~p~nil~~~~~~~kl~dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~  196 (290)
T cd05613         120 HLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFHEDEV---ERAYSFCGTIEYMAPDIVRGGDGGHDKAVDWWSMGV  196 (290)
T ss_pred             HHHhCCeeccCCCHHHeEECCCCCEEEeeCccceecccccc---cccccccCCcccCChhhccCCCCCCCccccHHHHHH
Confidence            99999999999999999999999999999999876543211   122345678899999998653 23678999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|..||...........+..........                            .+...+..+.+++.+||.
T Consensus       197 ~l~~ll~g~~p~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~~ll~~~l~  248 (290)
T cd05613         197 LMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----------------------------YPQEMSALAKDIIQRLLM  248 (290)
T ss_pred             HHHHHhcCCCCCCcCCccccHHHHHHHhhccCCC----------------------------CCccCCHHHHHHHHHHhc
Confidence            9999999999997543322222222211100000                            011245667799999999


Q ss_pred             cCCCCCC-----CHHHhhcCCCccCCC
Q psy7889         245 LDPSKRF-----DSDAALNHDFFWTDP  266 (433)
Q Consensus       245 ~dP~~R~-----t~~e~L~h~~~~~~~  266 (433)
                      .||.+|+     ++++++.||||....
T Consensus       249 ~~p~~R~~~~~~~~~~l~~~~~~~~~~  275 (290)
T cd05613         249 KDPKKRLGCGPSDADEIKKHPFFQKIN  275 (290)
T ss_pred             CCHHHhcCCCCCCHHHHHcCcccccCC
Confidence            9999997     899999999997654

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, MSK1, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, which trigger phosphorylation in the activation loop (A-loop) of the CTD of MSK. The active CTD phosphorylates the hydroph

>cd05112 PTKc_Itk Catalytic domain of the Protein Tyrosine Kinase, Interleukin-2-inducible T-cell Kinase

Probab=100.00  E-value=1e-31  Score=250.06  Aligned_cols=210  Identities=23%  Similarity=0.418  Sum_probs=167.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++...        ..+++||||+.+ +|.+.+......++++.++.++.|++.||+
T Consensus        43 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~  114 (256)
T cd05112          43 EEDFIEEAQVMMKLSHPKLVQLYGVCTER--------SPICLVFEFMEHGCLSDYLRAQRGKFSQETLLGMCLDVCEGMA  114 (256)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeEEEEEccC--------CceEEEEEcCCCCcHHHHHHhCccCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999998765        558999999975 677777665566899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++.......   ........++..|+|||.+.+.. ++.++||||+||+
T Consensus       115 ~lH~~~i~h~dl~p~ni~i~~~~~~~l~d~g~~~~~~~~~---~~~~~~~~~~~~~~aPe~~~~~~-~~~~~Dv~slG~~  190 (256)
T cd05112         115 YLESSNVIHRDLAARNCLVGENQVVKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWSSPEVFSFSK-YSSKSDVWSFGVL  190 (256)
T ss_pred             HHHHCCccccccccceEEEcCCCeEEECCCcceeecccCc---ccccCCCccchhhcCHhHhccCC-cChHHHHHHHHHH
Confidence            9999999999999999999999999999999987653221   11112223456899999987654 7899999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||...........+......                               ..+...+..+.+|+.+||.
T Consensus       191 l~el~~~g~~p~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~l~~~~l~  239 (256)
T cd05112         191 MWEVFSEGKTPYENRSNSEVVETINAGFRL-------------------------------YKPRLASQSVYELMQHCWK  239 (256)
T ss_pred             HHHHHcCCCCCCCcCCHHHHHHHHhCCCCC-------------------------------CCCCCCCHHHHHHHHHHcc
Confidence            999998 99999877765555443221000                               0111245667799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .+|.+|||+.++++.
T Consensus       240 ~~p~~Rp~~~~~l~~  254 (256)
T cd05112         240 ERPEDRPSFSLLLHQ  254 (256)
T ss_pred             cChhhCCCHHHHHHh
Confidence            999999999999863

Protein Tyrosine Kinase (PTK) family; Interleukin-2 (IL-2)-inducible T-cell kinase (Itk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Itk (also known as Tsk or Emt) is a member of the Tec subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases with similarity to Src kinases in that they contain Src homology protein interaction domains (SH3, SH2) N-terminal to the catalytic tyr kinase domain. Unlike Src kinases, most Tec subfamily members (except Rlk) also contain an N-terminal pleckstrin homology (PH) domain, which binds the products of PI3K and allows membrane recruitment and activ

>cd05109 PTKc_HER2 Catalytic domain of the Protein Tyrosine Kinase, HER2

Probab=100.00  E-value=1e-31  Score=253.54  Aligned_cols=208  Identities=21%  Similarity=0.295  Sum_probs=164.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...         ..+++++|++ ++|.+.+......+++..+..++.|++.||.|
T Consensus        54 ~~~~~e~~~l~~~~~~~i~~~~~~~~~~---------~~~l~~~~~~~g~l~~~l~~~~~~~~~~~~~~~~~qi~~~L~~  124 (279)
T cd05109          54 KEILDEAYVMAGVGSPYVCRLLGICLTS---------TVQLVTQLMPYGCLLDYVRENKDRIGSQDLLNWCVQIAKGMSY  124 (279)
T ss_pred             HHHHHHHHHHHhcCCCCCceEEEEEcCC---------CcEEEEEcCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999988643         3679999997 58888887666679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||+++++.+||+|||+++.+......  .......++..|+|||.+.+.. ++.++|||||||++
T Consensus       125 lH~~~iiH~dlkp~Nil~~~~~~~kL~dfG~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l  201 (279)
T cd05109         125 LEEVRLVHRDLAARNVLVKSPNHVKITDFGLARLLDIDETE--YHADGGKVPIKWMALESILHRR-FTHQSDVWSYGVTV  201 (279)
T ss_pred             HHHCCeeccccccceEEEcCCCcEEECCCCceeecccccce--eecCCCccchhhCCHHHhccCC-CCchhHHHHHHHHH
Confidence            99999999999999999999999999999999876532211  1112223466799999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||...........+... ...+.                              +...+.++.+++.+||..
T Consensus       202 ~el~t~g~~p~~~~~~~~~~~~~~~~-~~~~~------------------------------~~~~~~~~~~li~~~l~~  250 (279)
T cd05109         202 WELMTFGAKPYDGIPAREIPDLLEKG-ERLPQ------------------------------PPICTIDVYMIMVKCWMI  250 (279)
T ss_pred             HHHHcCCCCCCCCCCHHHHHHHHHCC-CcCCC------------------------------CccCCHHHHHHHHHHcCC
Confidence            99998 89999876654433332211 00000                              012345667999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||..||++.+++.
T Consensus       251 dp~~Rp~~~~l~~  263 (279)
T cd05109         251 DSECRPRFRELVD  263 (279)
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999984

Protein Tyrosine Kinase (PTK) family; HER2 (ErbB2, HER2/neu); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER2 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve

>cd08530 STKc_CNK2-like Catalytic domain of the Protein Serine/Threonine Kinase, Chlamydomonas reinhardtii CNK2, and similar domains

Probab=100.00  E-value=7.9e-32  Score=250.48  Aligned_cols=209  Identities=27%  Similarity=0.455  Sum_probs=170.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++|+||+++++++...        ...|+||||+++ +|...+.+.   ...++++.++.++.|++.|
T Consensus        44 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~l~~a  115 (256)
T cd08530          44 EDAVNEIRILASVNHPNIISYKEAFLDG--------NKLCIVMEYAPFGDLSKAISKRKKKRKLIPEQEIWRIFIQLLRG  115 (256)
T ss_pred             HHHHHHHHHHHhCCCCCchhhhhhhccC--------CEEEEEehhcCCCCHHHHHHHHHhhcCCCCHHHHHHHHHHHHHH
Confidence            4667899999999999999999999875        669999999964 787777552   2458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||+.|++|+||+|+||+++.++.++|+|||++......      ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       116 l~~lh~~~i~h~~l~~~ni~~~~~~~~kl~d~g~~~~~~~~------~~~~~~~~~~~~~Pe~~~~~~-~~~~~D~~slG  188 (256)
T cd08530         116 LQALHEQKILHRDLKSANILLVANDLVKIGDLGISKVLKKN------MAKTQIGTPHYMAPEVWKGRP-YSYKSDIWSLG  188 (256)
T ss_pred             HHHHhhCCcccCCCCcceEEEecCCcEEEeeccchhhhccC------CcccccCCccccCHHHHCCCC-CCchhhHHHHH
Confidence            99999999999999999999999999999999999776532      112345688899999987755 78899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +++++|++|..||...+.......+..  +..+     .                        .+...+.+++++|.+||
T Consensus       189 ~~~~~l~~g~~p~~~~~~~~~~~~~~~--~~~~-----~------------------------~~~~~~~~~~~li~~~l  237 (256)
T cd08530         189 CLLYEMATFAPPFEARSMQDLRYKVQR--GKYP-----P------------------------IPPIYSQDLQNFIRSML  237 (256)
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHhc--CCCC-----C------------------------CchhhCHHHHHHHHHHc
Confidence            999999999999988776544333321  1000     0                        00124566789999999


Q ss_pred             ccCCCCCCCHHHhhcCCCc
Q psy7889         244 LLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~  262 (433)
                      ..+|.+||++.++++||++
T Consensus       238 ~~~p~~Rp~~~~~l~~p~~  256 (256)
T cd08530         238 QVKPKLRPNCDKILASPAV  256 (256)
T ss_pred             CCCcccCCCHHHHhcCCCC
Confidence            9999999999999999974

Serine/Threonine Kinases (STKs), Chlamydomonas reinhardtii Never In Mitosis gene A (NIMA)-related kinase 1 (CNK2)-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Chlamydomonas reinhardtii CNK2-like subfamily belongs to the (NIMA)-related kinase (Nek) family. The Nek family includes seven different Chlamydomonas Neks (CNKs 1-6 and Fa2). This subfamily includes CNK1, and -2. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Chlamydomonas reinhardtii CNK2 has both cilliary and cell cycle functions. It influences flagellar length through promoting flagellar disassembly, an

>cd05098 PTKc_FGFR1 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 1

Probab=100.00  E-value=8e-32  Score=257.96  Aligned_cols=210  Identities=23%  Similarity=0.434  Sum_probs=164.5

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+++++.+ +||||+++++++...        +.+|+||||++ ++|.+++....               ..++.
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~~~l~~  139 (307)
T cd05098          68 SDLISEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLRARRPPGMEYCYNPTQVPEEQLSF  139 (307)
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEecC--------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCH
Confidence            3577899999999 799999999999775        56899999997 48888886532               23788


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.|++.||+|||++|++|+||||+||+++.++.++|+|||++.........  .......++..|+|||++.+.
T Consensus       140 ~~~~~~~~qi~~aL~~lH~~gi~H~dlkp~Nill~~~~~~kL~dfg~a~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  217 (307)
T cd05098         140 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDYY--KKTTNGRLPVKWMAPEALFDR  217 (307)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCcccccccHHheEEcCCCcEEECCCcccccccccchh--hccccCCCccceeChHHhccC
Confidence            899999999999999999999999999999999999999999999998765422110  111122335679999998765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++||||+||++|+|++ |.+||.+....+....+....   ..+                            .+.
T Consensus       218 ~-~~~~~DvwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~----------------------------~~~  265 (307)
T cd05098         218 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGH---RMD----------------------------KPS  265 (307)
T ss_pred             C-CCcHHHHHHHHHHHHHHHcCCCCCCCcCCHHHHHHHHHcCC---CCC----------------------------CCC
Confidence            4 7999999999999999998 889998766544443332110   000                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+||.+||..+|++||++.+++++
T Consensus       266 ~~~~~~~~li~~~l~~~p~~Rps~~evl~~  295 (307)
T cd05098         266 NCTNELYMMMRDCWHAVPSQRPTFKQLVED  295 (307)
T ss_pred             cCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            235677799999999999999999999864

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 1 (FGFR1); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR1 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05097 PTKc_DDR_like Catalytic domain of Discoidin Domain Receptor-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.5e-31  Score=254.51  Aligned_cols=215  Identities=21%  Similarity=0.335  Sum_probs=164.6

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-----------CCCCHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-----------VKFSLGEIKKV   76 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-----------~~l~~~~~~~i   76 (433)
                      .+.+|+++|+.++||||+++++++...        ...++||||+.+ +|.+++....           ..+++..+..+
T Consensus        63 ~~~~ei~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~i  134 (295)
T cd05097          63 DFLKEIKIMSRLKNPNIIRLLGVCVSD--------DPLCMITEYMENGDLNQFLSQREIESTFTHANNIPSVSIANLLYM  134 (295)
T ss_pred             HHHHHHHHHHhCCCCCcCeEEEEEcCC--------CccEEEEecCCCCcHHHHHHhccccccccccccCCcccHHHHHHH
Confidence            577899999999999999999999765        558999999975 7877775421           13678889999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +.|++.||+|||++|++|+||||+||+++.++.+||+|||++..+.....  ........++..|+|||++.+.. ++.+
T Consensus       135 ~~~i~~al~~lH~~~i~H~dlkp~Nill~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~  211 (295)
T cd05097         135 AVQIASGMKYLASLNFVHRDLATRNCLVGNHYTIKIADFGMSRNLYSGDY--YRIQGRAVLPIRWMAWESILLGK-FTTA  211 (295)
T ss_pred             HHHHHHHHHHHHhcCeeccccChhhEEEcCCCcEEecccccccccccCcc--eeccCcCcCceeecChhhhccCC-cCch
Confidence            99999999999999999999999999999999999999999876532211  11112234467899999987765 7999


Q ss_pred             chhhhHHHHHHHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         157 VDLWGAGCIMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       157 ~DiwSlGvil~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      +|||||||++++|++  +..||...+..+.+..+...........+                        ...+...+..
T Consensus       212 ~DvwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~  267 (295)
T cd05097         212 SDVWAFGVTLWEMFTLCKEQPYSLLSDEQVIENTGEFFRNQGRQIY------------------------LSQTPLCPSP  267 (295)
T ss_pred             hhHHHHHHHHHHHHHcCCCCCCcccChHHHHHHHHHhhhhcccccc------------------------CCCCCCCCHH
Confidence            999999999999988  66788877766555444332211100000                        0001124567


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +.+|+.+||..||.+||+++++++
T Consensus       268 l~~li~~~l~~~p~~RPs~~~i~~  291 (295)
T cd05097         268 VFKLMMRCWSRDIKDRPTFNKIHH  291 (295)
T ss_pred             HHHHHHHHcCCCchhCcCHHHHHH
Confidence            789999999999999999999974

Protein Tyrosine Kinase (PTK) family; Discoidin Domain Receptor (DDR)-like proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR-like proteins are members of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDRs regulate cell adhesion, proliferation, and extracellular matrix remodeling. They have been linked to a variety of human cancers including

>cd05044 PTKc_c-ros Catalytic domain of the Protein Tyrosine Kinase, C-ros

Probab=100.00  E-value=1.4e-31  Score=251.03  Aligned_cols=210  Identities=23%  Similarity=0.414  Sum_probs=164.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc------CCCCCHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI------HVKFSLGEIKKVIQQ   79 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~------~~~l~~~~~~~i~~q   79 (433)
                      ...+.+|+++++.++||||+++++++...        ...++||||++ ++|.+++...      ...+++..+..++.|
T Consensus        43 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  114 (269)
T cd05044          43 KKEFLKEAHLMSNFNHPNIVKLLGVCLLN--------EPQYIIMELMEGGDLLSYLRDARVERFGPPLLTLKELLDICLD  114 (269)
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEeeeecCC--------CCeEEEEeccCCCcHHHHHHHhhhcccCCccccHHHHHHHHHH
Confidence            34678999999999999999999998765        55899999997 5888887642      223788999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCC-----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCC
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTG-----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG  154 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~-----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (433)
                      ++.||+|||+.+++|+||||+||+++.++     .++|+|||++.........  .......++..|+|||++.+.. ++
T Consensus       115 l~~~l~~lH~~~i~H~dl~p~nil~~~~~~~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~~-~~  191 (269)
T cd05044         115 VAKGCVYLEQMHFIHRDLAARNCLVSEKGYDADRVVKIGDFGLARDIYKSDYY--RKEGEGLLPVRWMAPESLLDGK-FT  191 (269)
T ss_pred             HHHHHHHHHhCCcccCCCChheEEEecCCCCCCcceEECCccccccccccccc--ccCcccCCCccccCHHHHccCC-cc
Confidence            99999999999999999999999999877     8999999998765432111  1112234467899999987665 79


Q ss_pred             CcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         155 PPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      .++|||||||++|+|++ |..||......+....+.... .+                              ..+...+.
T Consensus       192 ~~~Dv~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~-~~------------------------------~~~~~~~~  240 (269)
T cd05044         192 TQSDVWSFGVLMWEILTLGQQPYPALNNQEVLQHVTAGG-RL------------------------------QKPENCPD  240 (269)
T ss_pred             cchhHHHHHHHHHHHHHcCCCCCcccCHHHHHHHHhcCC-cc------------------------------CCcccchH
Confidence            99999999999999998 999998776655444332100 00                              00112345


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .+.++|.+||..+|.+||+++++++
T Consensus       241 ~~~~li~~~l~~~p~~Rp~~~~i~~  265 (269)
T cd05044         241 KIYQLMTNCWAQDPSERPTFDRIQE  265 (269)
T ss_pred             HHHHHHHHHcCCCcccCCCHHHHHH
Confidence            6779999999999999999999875

Protein Tyrosine Kinases (PTK) family; C-ros and Drosophila Sevenless proteins; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The proto-oncogene c-ros encodes an orphan receptor tyr kinase (RTK) with an unknown ligand. RTKs contain an extracellular ligand-binding domain, a transmembrane region, and an intracellular tyr kinase domain. RTKs are usually activated through ligand binding, which causes dimerization and autophosphorylation of the intracellular tyr kinase catalytic domain. C-ros is expressed in embryonic cells of the kidney, intestine and lung, but disappears soon after birth. It persists only in the adult epididymis. Male

>PF07714 Pkinase_Tyr: Protein tyrosine kinase Protein kinase; unclassified specificity

Probab=100.00  E-value=2.2e-32  Score=255.37  Aligned_cols=209  Identities=26%  Similarity=0.418  Sum_probs=162.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|++++++++||||+++++++...        +.+++|||||. ++|.+++... ...+++..+..++.||+.||.
T Consensus        46 ~~~~~e~~~l~~l~h~ni~~~~g~~~~~--------~~~~lv~e~~~~g~L~~~L~~~~~~~~~~~~~~~i~~~i~~~l~  117 (259)
T PF07714_consen   46 EEFLNEIQILRKLRHPNIVKLYGFCIEN--------EPLFLVMEYCPGGSLDDYLKSKNKEPLSEQQRLSIAIQIAEALS  117 (259)
T ss_dssp             HHHHHHHHHHHTHSBTTBE-EEEEEESS--------SSEEEEEE--TTEBHHHHHHHTCTTTSBHHHHHHHHHHHHHHHH
T ss_pred             eeeeeccccccccccccccccccccccc--------cccccccccccccccccccccccccccccccccccccccccccc
Confidence            5789999999999999999999999954        44899999997 6899999876 556899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+++++|++|+++||+++.++.+||+|||++........  ............|+|||++.+.. ++.++||||||++
T Consensus       118 ~Lh~~~iiH~~l~~~nill~~~~~~Kl~~f~~~~~~~~~~~--~~~~~~~~~~~~~~aPE~~~~~~-~~~ksDVysfG~~  194 (259)
T PF07714_consen  118 YLHSNNIIHGNLSPSNILLDSNGQVKLSDFGLSRPISEKSK--YKNDSSQQLPLRYLAPEVLKDGE-YTKKSDVYSFGML  194 (259)
T ss_dssp             HHHHTTEEEST-SGGGEEEETTTEEEEESTTTGEETTTSSS--EEESTTSESGGGGS-HHHHHHSE-ESHHHHHHHHHHH
T ss_pred             ccccccccccccccccccccccccccccccccccccccccc--ccccccccccccccccccccccc-ccccccccccccc
Confidence            99999999999999999999999999999999977632211  11222334577899999987765 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++||++ |..||......+....+.......                               .+...+....++|..||.
T Consensus       195 l~ei~~~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~C~~  243 (259)
T PF07714_consen  195 LYEILTLGKFPFSDYDNEEIIEKLKQGQRLP-------------------------------IPDNCPKDIYSLIQQCWS  243 (259)
T ss_dssp             HHHHHTTSSGTTTTSCHHHHHHHHHTTEETT-------------------------------SBTTSBHHHHHHHHHHT-
T ss_pred             cccccccccccccccccccccccccccccce-------------------------------eccchhHHHHHHHHHHcC
Confidence            999999 789998887766555552211100                               011235566799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+|||+.++++
T Consensus       244 ~~p~~RPs~~~i~~  257 (259)
T PF07714_consen  244 HDPEKRPSFQEILQ  257 (259)
T ss_dssp             SSGGGS--HHHHHH
T ss_pred             CChhhCcCHHHHHh
Confidence            99999999999974

Tyrosine kinase, catalytic domain; InterPro: IPR001245 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases. Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. Tyrosine-protein kinases can transfer a phosphate group from ATP to a tyrosine residue in a protein. These enzymes can be divided into two main groups []: Receptor tyrosine kinases (RTK), which are transmembrane proteins involved in signal transduction; they play key roles in growth, differentiation, metabolism, adhesion, motility, death and oncogenesis []. RTKs are composed of 3 domains: an extracellular domain (binds ligand), a transmembrane (TM) domain, and an intracellular catalytic domain (phosphorylates substrate). The TM domain plays an important role in the dimerisation process necessary for signal transduction []. Cytoplasmic / non-receptor tyrosine kinases, which act as regulatory proteins, playing key roles in cell differentiation, motility, proliferation, and survival. For example, the Src-family of protein-tyrosine kinases []. ; GO: 0004672 protein kinase activity, 0006468 protein phosphorylation; PDB: 2HYY_C 1OPL_A 2V7A_A 2G2H_B 2G1T_A 3PYY_A 3CS9_D 2HZI_A 2E2B_A 2HIW_A ....

>cd05105 PTKc_PDGFR_alpha Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor alpha

Probab=100.00  E-value=1.2e-31  Score=265.04  Aligned_cols=210  Identities=23%  Similarity=0.381  Sum_probs=161.6

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      +.+++|+++|+.++ |||||++++++...        ..+|||||||. ++|.+++.+..                    
T Consensus        85 ~~~~~Ei~~l~~l~~HpnIv~l~~~~~~~--------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  156 (400)
T cd05105          85 QALMSELKIMTHLGPHLNIVNLLGACTKS--------GPIYIITEYCFYGDLVNYLHKNRDNFLSRHPEKPKKDLDIFGI  156 (400)
T ss_pred             HHHHHHHHHHHhcCCCCCeeeEEEEEccC--------CceEEEEEecCCCcHHHHHHHhhhhhhccccccccccccccCC
Confidence            56889999999996 99999999999765        56899999997 57877765421                    


Q ss_pred             ---------------------------------------------------------------------------CCCCH
Q psy7889          66 ---------------------------------------------------------------------------VKFSL   70 (433)
Q Consensus        66 ---------------------------------------------------------------------------~~l~~   70 (433)
                                                                                                 ..+++
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~~  236 (400)
T cd05105         157 NPADESTRSYVILSFENKGDYMDMKQADTTQYVPMLEIKEASKYSDIQRSNYDRPASYKGSNDSEVKNLLSDDGSEGLTT  236 (400)
T ss_pred             CcccccccchhhhhhcccccccccccccccccchhhhhhhhhhhhhcccCcccccccccCcchhhHHHHHHhcccCCCCH
Confidence                                                                                       13677


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.||+.||+|||+.||+|+||||+|||++.++.+||+|||++........  ........++..|+|||++.+.
T Consensus       237 ~~~~~~~~qi~~aL~~LH~~~ivH~dikp~Nill~~~~~~kL~DfGla~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~  314 (400)
T cd05105         237 LDLLSFTYQVARGMEFLASKNCVHRDLAARNVLLAQGKIVKICDFGLARDIMHDSN--YVSKGSTFLPVKWMAPESIFDN  314 (400)
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeCCCCChHhEEEeCCCEEEEEeCCcceecccccc--ccccCCcCCCcceEChhhhcCC
Confidence            88899999999999999999999999999999999999999999999976543211  1112233456789999998765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |..||..............  ......                            .+.
T Consensus       315 ~-~~~~~DiwSlGvil~ellt~g~~P~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~  363 (400)
T cd05105         315 L-YTTLSDVWSYGILLWEIFSLGGTPYPGMIVDSTFYNKIK--SGYRMA----------------------------KPD  363 (400)
T ss_pred             C-CCchhhHHHHHHHHHHHHHCCCCCCcccchhHHHHHHHh--cCCCCC----------------------------CCc
Confidence            5 7999999999999999997 8889887543332222111  100000                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+.++.+++.+||..||++||++.++.+
T Consensus       364 ~~~~~l~~li~~cl~~dP~~RPt~~~l~~  392 (400)
T cd05105         364 HATQEVYDIMVKCWNSEPEKRPSFLHLSD  392 (400)
T ss_pred             cCCHHHHHHHHHHCccCHhHCcCHHHHHH
Confidence            24566779999999999999999988875

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) alpha; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR alpha is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR alpha forms homodimers or heterodimers with PDGFR beta, depending on the nature of the PDGF ligand. PDGF-AA, PDGF-

>cd05034 PTKc_Src_like Catalytic domain of Src kinase-like Protein Tyrosine Kinases

Probab=100.00  E-value=1.4e-31  Score=249.91  Aligned_cols=209  Identities=23%  Similarity=0.387  Sum_probs=167.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+++++.++|+||+++++++...        ...++||||+.+ +|.+++.... ..++...+..++.|++.||
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~i~~~~~~~~~~~~~~~~~~~i~~al  116 (261)
T cd05034          45 PEAFLQEAQIMKKLRHDKLVQLYAVCSEE--------EPIYIVTEYMSKGSLLDFLKSGEGKKLRLPQLVDMAAQIAEGM  116 (261)
T ss_pred             HHHHHHHHHHHhhCCCCCEeeeeeeeecC--------CceEEEEeccCCCCHHHHHhccccCCCCHHHHHHHHHHHHHHH
Confidence            45788999999999999999999998765        558999999974 8888887643 3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++|++|+||||+||+++.++.++|+|||++........   .......++..|+|||.+.+.. ++.++||||+||
T Consensus       117 ~~lh~~~i~h~di~p~nili~~~~~~~l~d~g~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~  192 (261)
T cd05034         117 AYLESRNYIHRDLAARNILVGENLVCKIADFGLARLIEDDEY---TAREGAKFPIKWTAPEAANYGR-FTIKSDVWSFGI  192 (261)
T ss_pred             HHHHhCCcccCCcchheEEEcCCCCEEECccccceeccchhh---hhhhccCCCccccCHHHhccCC-cCchhHHHHHHH
Confidence            999999999999999999999999999999999876643110   1111222356799999987655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |..||.+.........+........                               +...+..+.+++.+||
T Consensus       193 il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~i~~~l  241 (261)
T cd05034         193 LLTEIVTYGRVPYPGMTNREVLEQVERGYRMPR-------------------------------PPNCPEELYDLMLQCW  241 (261)
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999998 9999988776666555433211110                               0112456679999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++||+++++++
T Consensus       242 ~~~p~~Rp~~~~l~~  256 (261)
T cd05034         242 DKDPEERPTFEYLQS  256 (261)
T ss_pred             ccCcccCCCHHHHHH
Confidence            999999999999874

Protein Tyrosine Kinase (PTK) family; Src kinase subfamily; catalytic (c) domain. Src subfamily members include Src, Lck, Hck, Blk, Lyn, Fgr, Fyn, Yrk, and Yes. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) proteins are cytoplasmic (or non-receptor) tyr kinases which are anchored to the plasma membrane. They contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-t

>cd05065 PTKc_EphR_B Catalytic domain of the Protein Tyrosine Kinases, Class EphB Ephrin Receptors

Probab=99.98  E-value=1.5e-31  Score=250.87  Aligned_cols=211  Identities=19%  Similarity=0.312  Sum_probs=165.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+..|+.+++.++||||+++++++.++        ..+++||||+++ +|.+++......+++..++.++.|++.||.|
T Consensus        50 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~l~~al~~  121 (269)
T cd05065          50 RDFLSEASIMGQFDHPNIIHLEGVVTKS--------RPVMIITEFMENGALDSFLRQNDGQFTVIQLVGMLRGIAAGMKY  121 (269)
T ss_pred             HHHHHHHHHHHhCCCcCcceEEEEECCC--------CceEEEEecCCCCcHHHHHhhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999998765        558999999975 7888877656678999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccc-cccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN-RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~-~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++|++|+||||+||+++.++.++|+|||++............ .......+..|+|||.+.+.. ++.++||||+||+
T Consensus       122 lH~~g~~H~dl~p~nili~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~~  200 (269)
T cd05065         122 LSEMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSSLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGIV  200 (269)
T ss_pred             HHHCCEeecccChheEEEcCCCcEEECCCccccccccCccccccccccCCCcceeecCHhHhccCc-ccchhhhhhhHHH
Confidence            99999999999999999999999999999998766432211100 001111245799999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|||++ |..||...+..+....+......+.                               +...+..+.+++.+||.
T Consensus       201 l~e~l~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~  249 (269)
T cd05065         201 MWEVMSYGERPYWDMSNQDVINAIEQDYRLPP-------------------------------PMDCPTALHQLMLDCWQ  249 (269)
T ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHHcCCcCCC-------------------------------cccCCHHHHHHHHHHcC
Confidence            999886 9999988776655554432111000                               01134556699999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .+|.+||++++++.
T Consensus       250 ~~p~~Rp~~~~i~~  263 (269)
T cd05065         250 KDRNARPKFGQIVS  263 (269)
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999985

Protein Tyrosine Kinase (PTK) family; Ephrin Receptor (EphR) subfamily; class EphB receptors; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. EphRs comprise the largest subfamily of receptor tyr kinases (RTKs). Class EphB receptors bind to transmembrane ephrin-B ligands. There are six vertebrate EhpB receptors (EphB1-6), which display promiscuous interactions with three ephrin-B ligands. One exception is EphB2, which also interacts with ephrin A5. EphRs contain an ephrin-binding domain and two fibronectin repeats extracellularly, a transmembrane segment, and a cytoplasmic tyr kinase domain. Binding of the ephr

>cd05071 PTKc_Src Catalytic domain of the Protein Tyrosine Kinase, Src

Probab=99.98  E-value=1.7e-31  Score=249.80  Aligned_cols=208  Identities=22%  Similarity=0.362  Sum_probs=164.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+++++.++||||+++++.+..         ...|+||||+.+ +|.+++.+.. ..+++..+..++.|++.||
T Consensus        45 ~~~~~~E~~~l~~l~~~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL  115 (262)
T cd05071          45 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------EPIYIVTEYMSKGSLLDFLKGEMGKYLRLPQLVDMAAQIASGM  115 (262)
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEECC---------CCcEEEEEcCCCCcHHHHHhhccccCCCHHHHHHHHHHHHHHH
Confidence            4568899999999999999999988743         347999999974 8888886533 3478999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||+.|++|+||||+||+++.++.++|+|||.+..+.....   .......++..|+|||...+.. ++.++|||||||
T Consensus       116 ~~lH~~~i~H~dl~p~Nill~~~~~~~L~dfg~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~DvwslG~  191 (262)
T cd05071         116 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  191 (262)
T ss_pred             HHHHHCCccccccCcccEEEcCCCcEEeccCCceeecccccc---ccccCCcccceecCHhHhccCC-CCchhhHHHHHH
Confidence            999999999999999999999999999999999976643221   1112234567899999886655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+.........+......+                               .+...+..+.+++.+||
T Consensus       192 ~l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l  240 (262)
T cd05071         192 LLTELTTKGRVPYPGMVNREVLDQVERGYRMP-------------------------------CPPECPESLHDLMCQCW  240 (262)
T ss_pred             HHHHHHcCCCCCCCCCChHHHHHHHhcCCCCC-------------------------------CccccCHHHHHHHHHHc
Confidence            9999999 889998876655544432210000                               00113456679999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      +.+|.+||++.++++
T Consensus       241 ~~~p~~Rp~~~~~~~  255 (262)
T cd05071         241 RKEPEERPTFEYLQA  255 (262)
T ss_pred             cCCcccCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Src kinase; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Src (or c-Src) is a cytoplasmic (or non-receptor) tyr kinase, containing an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region with a conserved tyr. It is activated by autophosphorylation at the tyr kinase domain, and is negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). c-Src is the vertebrate homolog of the oncogenic protein (v-Src) from Rous sarcoma virus. Together with other Src subfamily proteins, it is invo

>cd05067 PTKc_Lck_Blk Catalytic domain of the Protein Tyrosine Kinases, Lymphocyte-specific kinase and Blk

Probab=99.98  E-value=1.8e-31  Score=249.20  Aligned_cols=208  Identities=22%  Similarity=0.359  Sum_probs=165.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++|+||+++++++..         ...++||||+. ++|.+.+... ...+++..+..++.|++.||
T Consensus        45 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~al  115 (260)
T cd05067          45 PEAFLAEANLMKQLQHPRLVRLYAVVTQ---------EPIYIITEYMENGSLVDFLKTPEGIKLTINKLIDMAAQIAEGM  115 (260)
T ss_pred             HHHHHHHHHHHHhcCCcCeeeEEEEEcc---------CCcEEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            4578899999999999999999998743         34799999996 5888887653 34589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||++.+.. ++.++||||+||
T Consensus       116 ~~LH~~~i~H~dl~p~ni~i~~~~~~~l~dfg~~~~~~~~~~---~~~~~~~~~~~y~~pe~~~~~~-~~~~~Di~slG~  191 (260)
T cd05067         116 AFIERKNYIHRDLRAANILVSETLCCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGI  191 (260)
T ss_pred             HHHhcCCeecccccHHhEEEcCCCCEEEccCcceeecCCCCc---ccccCCcccccccCHHHhccCC-cCcccchHHHHH
Confidence            999999999999999999999999999999999876542211   1111223466899999987655 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |.+||.+.+..+....+........                               +...+.+..++|.+||
T Consensus       192 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l  240 (260)
T cd05067         192 LLTEIVTYGRIPYPGMTNPEVIQNLERGYRMPR-------------------------------PDNCPEELYELMRLCW  240 (260)
T ss_pred             HHHHHHhCCCCCCCCCChHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999998 9999998776665554432211100                               1123456779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++|||++++++
T Consensus       241 ~~~p~~Rp~~~~l~~  255 (260)
T cd05067         241 KEKPEERPTFEYLRS  255 (260)
T ss_pred             cCChhhCCCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Lck and Blk kinases; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Lck (lymphocyte-specific kinase) and Blk are members of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Sr

>cd05039 PTKc_Csk_like Catalytic domain of C-terminal Src kinase-like Protein Tyrosine Kinases

Probab=99.98  E-value=1.9e-31  Score=248.37  Aligned_cols=205  Identities=20%  Similarity=0.341  Sum_probs=165.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC-CCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV-KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qll~aL   84 (433)
                      ..++.+|+.+++.++|+||+++++++.+.        +..++||||++ ++|.+++..... .+++..++.++.|++.||
T Consensus        44 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~qi~~~l  115 (256)
T cd05039          44 AQAFLAEASVMTTLRHPNLVQLLGVVLQG--------NPLYIVTEYMAKGSLVDYLRSRGRAVITLAQQLGFALDVCEGM  115 (256)
T ss_pred             HHHHHHHHHHHHhcCCcceeeeEEEEcCC--------CCeEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            35688999999999999999999998764        56899999998 588888866443 589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||++|++|+||||+||+++.++.++|+|||.+.......       .....+..|+|||.+.+.. ++.++||||+||
T Consensus       116 ~~lh~~~i~H~di~p~Nili~~~~~~~l~d~g~~~~~~~~~-------~~~~~~~~~~ape~~~~~~-~~~~~Di~slG~  187 (256)
T cd05039         116 EYLEEKNFVHRDLAARNVLVSEDLVAKVSDFGLAKEASQGQ-------DSGKLPVKWTAPEALREKK-FSTKSDVWSFGI  187 (256)
T ss_pred             HHHHhCCccchhcccceEEEeCCCCEEEccccccccccccc-------ccCCCcccccCchhhcCCc-CCcHHHHHHHHH
Confidence            99999999999999999999999999999999997763221       1223356799999987654 788999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |..||......+....+....   .. .                           .+...++.+.++|.+||
T Consensus       188 il~~l~~~g~~p~~~~~~~~~~~~~~~~~---~~-~---------------------------~~~~~~~~~~~li~~~l  236 (256)
T cd05039         188 LLWEIYSFGRVPYPRIPLKDVVPHVEKGY---RM-E---------------------------APEGCPPEVYKVMKDCW  236 (256)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhcCC---CC-C---------------------------CccCCCHHHHHHHHHHh
Confidence            9999997 999998776555443332100   00 0                           01124567789999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++||++++++.
T Consensus       237 ~~~p~~Rp~~~~l~~  251 (256)
T cd05039         237 ELDPAKRPTFKQLRE  251 (256)
T ss_pred             ccChhhCcCHHHHHH
Confidence            999999999999985

Protein Tyrosine Kinase (PTK) family; C-terminal Src kinase (Csk) subfamily; catalytic (c) domain. The Csk subfamily is composed of Csk, Chk, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. To inhibit Src kinases, Csk and Chk are translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Csk

>cd08229 STKc_Nek7 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 7

Probab=99.98  E-value=1.3e-31  Score=250.84  Aligned_cols=208  Identities=28%  Similarity=0.432  Sum_probs=163.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+++||||+.+ +|.+++..   ....+++..++.++.||+.|
T Consensus        47 ~~~~~e~~~l~~~~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  118 (267)
T cd08229          47 ADCIKEIDLLKQLNHPNVIKYYASFIED--------NELNIVLELADAGDLSRMIKHFKKQKRLIPEKTVWKYFVQLCSA  118 (267)
T ss_pred             HHHHHHHHHHHHccCCchhhhhheeEeC--------CeEEEEEEecCCCCHHHHHHHhhccCCCCCHHHHHHHHHHHHHH
Confidence            4678899999999999999999999875        568999999985 78777653   23458999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++|++|+||||+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+|
T Consensus       119 l~~LH~~~i~H~dl~p~nili~~~~~~~l~dfg~~~~~~~~~~----~~~~~~~~~~~~ape~~~~~~-~~~~~Dv~slG  193 (267)
T cd08229         119 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENG-YNFKSDIWSLG  193 (267)
T ss_pred             HHHHHHCCeecCCCCHHHEEEcCCCCEEECcchhhhccccCCc----ccccccCCcCccCHHHhcCCC-ccchhhHHHHH
Confidence            9999999999999999999999999999999999876543221    122346788999999987655 78999999999


Q ss_pred             HHHHHHHhcCCCCCCCChH--HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         164 CIMAEMWTRSPIMQGNTEQ--QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |++++|++|..||.+....  .....+..  +..++                            ......+..+.++|.+
T Consensus       194 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~~~~~~li~~  243 (267)
T cd08229         194 CLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP----------------------------LPSDHYSEELRQLVNM  243 (267)
T ss_pred             HHHHHHHhCCCCcccccchHHHHhhhhhc--CCCCC----------------------------CCcccccHHHHHHHHH
Confidence            9999999999999764322  11111110  00000                            0011245677899999


Q ss_pred             hcccCCCCCCCHHHhhc
Q psy7889         242 LLLLDPSKRFDSDAALN  258 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~  258 (433)
                      ||..||.+|||++++++
T Consensus       244 ~l~~~p~~Rpt~~~i~~  260 (267)
T cd08229         244 CINPDPEKRPDITYVYD  260 (267)
T ss_pred             hcCCCcccCCCHHHHHH
Confidence            99999999999998764

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 7 (Nek7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek7 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek7 is required for mitotic spindle formation and cytokinesis. It is enriched in the centrosome and is critical for microtubule nucleation. Nek7 is activated by Nek9 during mitosis, and may regulate the p70 ribosomal S6 kinase.

>cd05576 STKc_RPK118_like Catalytic domain of the Protein Serine/Threonine Kinases, RPK118 and similar proteins

Probab=99.98  E-value=3.7e-32  Score=250.47  Aligned_cols=200  Identities=21%  Similarity=0.315  Sum_probs=158.0

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ..+|...+....||||+++++++...        ..+|+||||+.+ +|.+.+.+. ..+++..+..++.|++.||+|||
T Consensus        32 ~~~~~~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~ql~~~l~~lH  102 (237)
T cd05576          32 YSRERLTIIPHCVPNMVCLHKYIVSE--------DSVFLVLQHAEGGKLWSHISKF-LNIPEECVKRWAAEMVVALDALH  102 (237)
T ss_pred             hhhHHHHHHhcCCCceeehhhheecC--------CeEEEEEecCCCCCHHHHHHHh-cCCCHHHHHHHHHHHHHHHHHHH
Confidence            44565666666799999999999875        568999999985 788877653 35899999999999999999999


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHH
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE  168 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  168 (433)
                      ++||+||||||+||+++.++.++++|||.+......       .....++..|+|||.+.+.. ++.++|+||+||++|+
T Consensus       103 ~~~i~H~dlkp~Nil~~~~~~~~l~df~~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il~e  174 (237)
T cd05576         103 REGIVCRDLNPNNILLDDRGHIQLTYFSRWSEVEDS-------CDGEAVENMYCAPEVGGISE-ETEACDWWSLGAILFE  174 (237)
T ss_pred             hCCeeccCCCHHHEEEcCCCCEEEecccchhccccc-------cccCCcCccccCCcccCCCC-CCchhhHHHHHHHHHH
Confidence            999999999999999999999999999987665432       12234467799999886654 6899999999999999


Q ss_pred             HHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCC
Q psy7889         169 MWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS  248 (433)
Q Consensus       169 ll~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~  248 (433)
                      |++|..+|.......         ..        .      ....             .+...+..+.++|.+||+.||+
T Consensus       175 l~~g~~~~~~~~~~~---------~~--------~------~~~~-------------~~~~~~~~~~~li~~~l~~dp~  218 (237)
T cd05576         175 LLTGKTLVECHPSGI---------NT--------H------TTLN-------------IPEWVSEEARSLLQQLLQFNPT  218 (237)
T ss_pred             HHHCcchhhcCchhc---------cc--------c------cccC-------------CcccCCHHHHHHHHHHccCCHH
Confidence            999998775322100         00        0      0000             1112466788999999999999


Q ss_pred             CCCCH-----HHhhcCCCc
Q psy7889         249 KRFDS-----DAALNHDFF  262 (433)
Q Consensus       249 ~R~t~-----~e~L~h~~~  262 (433)
                      +|+++     +++++||||
T Consensus       219 ~R~~~~~~~~~~~~~h~~~  237 (237)
T cd05576         219 ERLGAGVAGVEDIKSHPFF  237 (237)
T ss_pred             HhcCCCccchHHHHcCCCC
Confidence            99996     999999997

Serine/Threonine Kinases (STKs), RPK118-like subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The RPK118-like subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Members of this subfamily show similarity to human RPK118, which contains an N-terminal Phox homology (PX) domain, a Microtubule Interacting and Trafficking (MIT) domain, and a kinase domain containing a long insert. Also included in the family is human RPK60 (or ribosomal protein S6 kinase-like 1), which also contains MIT and kinase domains but lacks a PX domain. RPK118 binds sphingosine kinase, a key enzyme in the synthesis of sphingosine 1-phospha

>smart00219 TyrKc Tyrosine kinase, catalytic domain

Probab=99.98  E-value=2.2e-31  Score=247.59  Aligned_cols=208  Identities=24%  Similarity=0.413  Sum_probs=167.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCC-CCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK-FSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~-l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++|+||+++++++.+.        +..|+||||+.+ +|.+.+...... +++..++.++.|++.||+
T Consensus        46 ~~~~~e~~~l~~l~~~~i~~~~~~~~~~--------~~~~~i~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~ql~~~l~  117 (258)
T smart00219       46 EEFLREARIMRKLDHPNIVKLLGVCTEE--------EPLMIVMEYMEGGDLLDYLRKNRPKELSLSDLLSFALQIARGME  117 (258)
T ss_pred             HHHHHHHHHHHhcCCCchheEEEEEcCC--------CeeEEEEeccCCCCHHHHHHhhhhccCCHHHHHHHHHHHHHHHH
Confidence            4788899999999999999999999876        558999999974 888888665444 899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++.........   ......++..|+|||.+.+. .++.++||||+||+
T Consensus       118 ~lh~~~~~h~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~~Pe~~~~~-~~~~~~Di~slG~i  193 (258)
T smart00219      118 YLESKNFIHRDLAARNCLVGENLVVKISDFGLSRDLYDDDYY---KKKGGKLPIRWMAPESLKDG-KFTSKSDVWSFGVL  193 (258)
T ss_pred             HHhcCCeeecccccceEEEccCCeEEEcccCCceeccccccc---ccccCCCcccccChHHhccC-CCCcchhHHHHHHH
Confidence            999999999999999999999999999999999776543111   11122357789999998554 47999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++|++ |.+||.+.+.......+.......                               .+...+.++.+++.+||.
T Consensus       194 ~~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~i~~~l~  242 (258)
T smart00219      194 LWEIFTLGESPYPGMSNEEVLEYLKKGYRLP-------------------------------KPENCPPEIYKLMLQCWA  242 (258)
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHhcCCCCC-------------------------------CCCcCCHHHHHHHHHHCc
Confidence            999998 889998876655554443211000                               011245677799999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||++|||+.++++
T Consensus       243 ~~p~~Rpt~~~ll~  256 (258)
T smart00219      243 EDPEDRPTFSELVE  256 (258)
T ss_pred             CChhhCcCHHHHHh
Confidence            99999999999985

Phosphotransferases. Tyrosine-specific kinase subfamily.

>cd05079 PTKc_Jak1_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Janus kinase 1

Probab=99.98  E-value=1.6e-31  Score=252.87  Aligned_cols=228  Identities=24%  Similarity=0.341  Sum_probs=164.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.....      ..+++||||++ ++|.+++.+....+++..+..++.|++.||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~~i~~aL~~  124 (284)
T cd05079          51 ADLKKEIEILRNLYHENIVKYKGICTEDGG------NGIKLIMEFLPSGSLKEYLPRNKNKINLKQQLKYAVQICKGMDY  124 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCC------CceEEEEEccCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            467889999999999999999999876522      45899999996 57888876655568999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++|++||||||+||+++.++.++|+|||++......... ........++..|+|||++.+.. ++.++||||+||++
T Consensus       125 lH~~gi~H~dlkp~Nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~apE~~~~~~-~~~~~Di~slG~il  202 (284)
T cd05079         125 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-YTVKDDLDSPVFWYAPECLIQSK-FYIASDVWSFGVTL  202 (284)
T ss_pred             HHHCCeeecccchheEEEcCCCCEEECCCccccccccCccc-eeecCCCCCCccccCHHHhccCC-CCccccchhhhhhh
Confidence            99999999999999999999999999999999876533211 11112345567899999987654 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|+++..++......     .....+....+....    .......       .......+...+..+.+||.+||+.+
T Consensus       203 ~ellt~~~~~~~~~~~-----~~~~~~~~~~~~~~~----~~~~~~~-------~~~~~~~~~~~~~~~~~li~~~l~~~  266 (284)
T cd05079         203 YELLTYCDSESSPMTL-----FLKMIGPTHGQMTVT----RLVRVLE-------EGKRLPRPPNCPEEVYQLMRKCWEFQ  266 (284)
T ss_pred             hhhhcCCCCCccccch-----hhhhcccccccccHH----HHHHHHH-------cCccCCCCCCCCHHHHHHHHHHccCC
Confidence            9999987654332110     111111111000000    0000000       00000011235678889999999999


Q ss_pred             CCCCCCHHHhhcC
Q psy7889         247 PSKRFDSDAALNH  259 (433)
Q Consensus       247 P~~R~t~~e~L~h  259 (433)
                      |.+|||+++++++
T Consensus       267 p~~Rpt~~~il~~  279 (284)
T cd05079         267 PSKRTTFQNLIEG  279 (284)
T ss_pred             cccCcCHHHHHHH
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; Janus kinase 1 (Jak1); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak1 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of signal transducers a

>cd05080 PTKc_Tyk2_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinase, Tyrosine kinase 2

Probab=99.98  E-value=2.4e-31  Score=251.48  Aligned_cols=225  Identities=23%  Similarity=0.345  Sum_probs=162.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++||||+++++++.....      ..+++||||+.+ +|.+++..  ..+++..++.++.|++.||+|
T Consensus        51 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~~--~~l~~~~~~~i~~~l~~~l~~  122 (283)
T cd05080          51 SGWKKEINILKTLYHENIVKYKGCCSEQGG------KGLQLIMEYVPLGSLRDYLPK--HKLNLAQLLLFAQQICEGMAY  122 (283)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCC------ceEEEEecCCCCCCHHHHHHH--cCCCHHHHHHHHHHHHHHHHH
Confidence            456789999999999999999998876422      568999999985 67777754  358999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.......... .......++..|+|||.+.+.. ++.++|||||||++
T Consensus       123 lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~~-~~~~~~~~~~~~~~PE~~~~~~-~~~~~Di~slG~~l  200 (283)
T cd05080         123 LHSQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYY-RVREDGDSPVFWYAVECLKENK-FSYASDVWSFGVTL  200 (283)
T ss_pred             HHHCCeeccccChheEEEcCCCcEEEeecccccccCCcchhh-ccCCCCCCCceeeCHhHhcccC-CCcccccHHHHHHH
Confidence            999999999999999999999999999999998765322110 1112234466799999987654 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||......- ...+....+..        ..........      .. ...-.+...+.++.+++.+||..+
T Consensus       201 ~el~tg~~p~~~~~~~~-~~~~~~~~~~~--------~~~~~~~~~~------~~-~~~~~~~~~~~~~~~li~~cl~~~  264 (283)
T cd05080         201 YELLTHCDSKQSPPKKF-EEMIGPKQGQM--------TVVRLIELLE------RG-MRLPCPKNCPQEVYILMKNCWETE  264 (283)
T ss_pred             HHHHhCCCCCCCCcchh-hhhhccccccc--------chhhhhhhhh------cC-CCCCCCCCCCHHHHHHHHHHhccC
Confidence            99999999886543210 00000000000        0000000000      00 000012235678889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |++|||++++++
T Consensus       265 p~~Rps~~~i~~  276 (283)
T cd05080         265 AKFRPTFRSLIP  276 (283)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999985

Protein Tyrosine Kinase (PTK) family; Tyrosine kinase 2 (Tyk2); catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyk2 is a member of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as the phosphorylation of sign

>cd05050 PTKc_Musk Catalytic domain of the Protein Tyrosine Kinase, Muscle-specific kinase

Probab=99.98  E-value=2e-31  Score=252.72  Aligned_cols=209  Identities=23%  Similarity=0.402  Sum_probs=163.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------------   65 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ...|+||||+++ +|.+++....                     
T Consensus        53 ~~~~~ei~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  124 (288)
T cd05050          53 ADFQREAALMAEFDHPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRHRSPRAQCSLSHSTSSARKCGLNP  124 (288)
T ss_pred             HHHHHHHHHHHhcCCCchheEEEEEcCC--------CccEEEEecCCCCCHHHHHHHcCccccccccccccccccccccc
Confidence            4577899999999999999999998865        458999999984 8888876421                     


Q ss_pred             CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcc
Q psy7889          66 VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPE  145 (433)
Q Consensus        66 ~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (433)
                      ..+++..++.++.|++.||+|||++|++||||||+||+++.++.++|+|||++..+.....  .........+..|+|||
T Consensus       125 ~~l~~~~~~~~~~~i~~aL~~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE  202 (288)
T cd05050         125 LPLSCTEQLCIAKQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY--YKASENDAIPIRWMPPE  202 (288)
T ss_pred             cccCHHHHHHHHHHHHHHHHHHHhCCeecccccHhheEecCCCceEECccccceecccCcc--ccccCCCccChhhcCHH
Confidence            2377888999999999999999999999999999999999999999999999876532211  01112223456799999


Q ss_pred             cccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHh
Q psy7889         146 LLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE  224 (433)
Q Consensus       146 ~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (433)
                      .+.+.. ++.++|||||||++|+|++ |..||.+....+....+..  +...+                           
T Consensus       203 ~~~~~~-~~~~~Dv~slG~il~el~~~~~~p~~~~~~~~~~~~~~~--~~~~~---------------------------  252 (288)
T cd05050         203 SIFYNR-YTTESDVWAYGVVLWEIFSYGMQPYYGMAHEEVIYYVRD--GNVLS---------------------------  252 (288)
T ss_pred             HHhcCC-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHhc--CCCCC---------------------------
Confidence            987655 7999999999999999997 8888887766655444322  11000                           


Q ss_pred             hhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         225 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       225 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                        .+...+.++.+||.+||+.+|.+|||+.|+++
T Consensus       253 --~~~~~~~~l~~li~~~l~~~p~~Rpt~~el~~  284 (288)
T cd05050         253 --CPDNCPLELYNLMRLCWSKLPSDRPSFASINR  284 (288)
T ss_pred             --CCCCCCHHHHHHHHHHcccCcccCCCHHHHHH
Confidence              00113456779999999999999999999874

Protein Tyrosine Kinase (PTK) family; Muscle-specific kinase (Musk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Musk is a receptor tyr kinase (RTK) containing an extracellular region with four immunoglobulin-like domains and a cysteine-rich cluster, a transmembrane segment, and an intracellular catalytic domain. Musk is expressed and concentrated in the postsynaptic membrane in skeletal muscle. It is essential for the establishment of the neuromuscular junction (NMJ), a peripheral synapse that conveys signals from motor neurons to muscle cells. Agrin, a large proteoglycan released from motor neurons, stimulates M

>cd05087 PTKc_Aatyk1_Aatyk3 Catalytic domain of the Protein Tyrosine Kinases, Apoptosis-associated tyrosine kinases 1 and 3

Probab=99.98  E-value=3.9e-31  Score=248.21  Aligned_cols=214  Identities=20%  Similarity=0.317  Sum_probs=159.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC----CCCCHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH----VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~----~~l~~~~~~~i~~qll~   82 (433)
                      ..+.+|+.+++.++||||+++++++.+.        ..+++||||++ ++|.+++....    ...++..+..++.|++.
T Consensus        40 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~qi~~  111 (269)
T cd05087          40 MKFLEEAQPYRSLQHSNLLQCLGQCTEV--------TPYLLVMEFCPLGDLKGYLRSCRKAELMTPDPTTLQRMACEIAL  111 (269)
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcCC--------CCcEEEEECCCCCcHHHHHHHhhhcccccccHHHHHHHHHHHHH
Confidence            3678899999999999999999998765        45899999998 57888875432    23566788899999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC------CCCCc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR------NYGPP  156 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~------~~~~~  156 (433)
                      ||+|||+.|++|+||||+||+++.++.++|+|||++........  ........++..|+|||++.+..      .++.+
T Consensus       112 al~~lH~~~i~H~dlkp~nil~~~~~~~kL~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~  189 (269)
T cd05087         112 GLLHLHKNNFIHSDLALRNCLLTADLTVKIGDYGLSHNKYKEDY--YVTPDQLWVPLRWIAPELVDEVHGNLLVVDQTKE  189 (269)
T ss_pred             HHHHHHHCCEeccccCcceEEEcCCCcEEECCccccccccCcce--eecCCCcCCcccccCHhHhccccccccccCCCcc
Confidence            99999999999999999999999999999999999865432111  11112345677899999985421      25789


Q ss_pred             chhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         157 VDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       157 ~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      +||||+||++++|++ |.+||......+.............+.                          .......+...
T Consensus       190 ~DiwslG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~  243 (269)
T cd05087         190 SNVWSLGVTIWELFELGSQPYRHLSDEQVLTYTVREQQLKLPK--------------------------PRLKLPLSDRW  243 (269)
T ss_pred             chhHHHHHHHHHHHhCCCCCCCCCChHHHHHHHhhcccCCCCC--------------------------CccCCCCChHH
Confidence            999999999999996 999998766554433221110000000                          00011234566


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhc
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .+++.+|+ .+|++|||+++++.
T Consensus       244 ~~l~~~c~-~~P~~Rpt~~~l~~  265 (269)
T cd05087         244 YEVMQFCW-LQPEQRPSAEEVHL  265 (269)
T ss_pred             HHHHHHHh-cCcccCCCHHHHHH
Confidence            78999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 1 (Aatyk1) and Aatyk3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk1 and Aatyk3 are members of the Aatyk subfamily of proteins. Aatyk3 is a receptor kinase containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk1 has a similar domain arrangement but without the transmembrane segment and is thus, a cytoplasmic (or nonreceptor) kinase. The expression of Aatyk1 (also referred simply as Aatyk) is upregulated during growth arrest and apoptosis in myeloid cells

>cd08228 STKc_Nek6 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 6

Probab=99.98  E-value=1.8e-31  Score=249.96  Aligned_cols=209  Identities=25%  Similarity=0.407  Sum_probs=162.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +..++||||+++ +|.+++..   ....++++.+..++.|++.|
T Consensus        47 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~~~i~~~  118 (267)
T cd08228          47 QDCVKEIDLLKQLNHPNVIKYLDSFIED--------NELNIVLELADAGDLSQMIKYFKKQKRLIPERTVWKYFVQLCSA  118 (267)
T ss_pred             HHHHHHHHHHHhCCCcceeeeeeeEEEC--------CeEEEEEEecCCCcHHHHHHHhhhccCCCCHHHHHHHHHHHHHH
Confidence            3568899999999999999999999875        568999999985 77776643   23348999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++|++|+||||+||+++.++.++|+|||++.......    .......++..|+|||.+.+.. ++.++|+||+|
T Consensus       119 l~~LH~~~i~H~dl~~~nil~~~~~~~~l~d~g~~~~~~~~~----~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~slG  193 (267)
T cd08228         119 VEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLG  193 (267)
T ss_pred             HHHHhhCCeeCCCCCHHHEEEcCCCCEEECccccceeccchh----HHHhcCCCCccccChhhhccCC-CCchhhHHHHH
Confidence            999999999999999999999999999999999987764321    1122345788899999987655 68999999999


Q ss_pred             HHHHHHHhcCCCCCCCChH-HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWTRSPIMQGNTEQ-QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |++++|++|..||...... ..........+.++.                             .....+....++|.+|
T Consensus       194 ~~l~el~~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~li~~c  244 (267)
T cd08228         194 CLLYEMAALQSPFYGDKMNLFSLCQKIEQCDYPPL-----------------------------PTEHYSEKLRELVSMC  244 (267)
T ss_pred             HHHHHHhcCCCCCccccccHHHHHHHHhcCCCCCC-----------------------------ChhhcCHHHHHHHHHH
Confidence            9999999999998654321 111111111111000                             0012345677999999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      |..+|++||++.++++
T Consensus       245 l~~~p~~Rp~~~~vl~  260 (267)
T cd08228         245 IYPDPDQRPDIGYVHQ  260 (267)
T ss_pred             CCCCcccCcCHHHHHH
Confidence            9999999999999986

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 is required for the transition from metaphase to anaphase. It also plays important roles in mitotic spindle formation and cytokinesis. Activated by Nek9 during mitosis, Nek6 phosphorylates Eg5, a kinesin that is important for spindle bipolarity. Nek6 localizes to spindle microtubules during metaphase

>cd05100 PTKc_FGFR3 Catalytic domain of the Protein Tyrosine Kinase, Fibroblast Growth Factor Receptor 3

Probab=99.98  E-value=2.2e-31  Score=257.98  Aligned_cols=210  Identities=23%  Similarity=0.429  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+++++++ +||||+++++++...        +.+++||||+++ +|.+++....               ..++.
T Consensus        62 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  133 (334)
T cd05100          62 SDLVSEMEMMKMIGKHKNIINLLGACTQD--------GPLYVLVEYASKGNLREYLRARRPPGMDYSFDTCKLPEEQLTF  133 (334)
T ss_pred             HHHHHHHHHHHhhcCCCCeeeeeEEEccC--------CceEEEEecCCCCcHHHHHHhcCCcccccccccccCccccCCH
Confidence            4678899999999 799999999999765        558999999974 8888886532               23677


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.|++.||.|||++||+||||||+||+++.++.+||+|||+++........  .......++..|+|||++.+.
T Consensus       134 ~~~~~~~~qi~~al~~LH~~givH~dlkp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~aPE~~~~~  211 (334)
T cd05100         134 KDLVSCAYQVARGMEYLASQKCIHRDLAARNVLVTEDNVMKIADFGLARDVHNIDYY--KKTTNGRLPVKWMAPEALFDR  211 (334)
T ss_pred             HHHHHHHHHHHHHHHHHHHCCeeccccccceEEEcCCCcEEECCcccceeccccccc--ccccCCCcCceEcCHHHhccC
Confidence            888999999999999999999999999999999999999999999998765432111  111223335679999999775


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |.+||.+.+..+....+.....   ..                            .+.
T Consensus       212 ~-~~~~~Di~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~---~~----------------------------~~~  259 (334)
T cd05100         212 V-YTHQSDVWSFGVLLWEIFTLGGSPYPGIPVEELFKLLKEGHR---MD----------------------------KPA  259 (334)
T ss_pred             C-cCchhhhHHHHHHHHHHHhcCCCCCCCCCHHHHHHHHHcCCC---CC----------------------------CCC
Confidence            5 7899999999999999998 8899988776655444322100   00                            011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+++.+||..+|.+||++.+++++
T Consensus       260 ~~~~~l~~li~~cl~~~p~~Rps~~ell~~  289 (334)
T cd05100         260 NCTHELYMIMRECWHAVPSQRPTFKQLVED  289 (334)
T ss_pred             CCCHHHHHHHHHHcccChhhCcCHHHHHHH
Confidence            235567799999999999999999999975

Protein Tyrosine Kinase (PTK) family; Fibroblast Growth Factor Receptor 3 (FGFR3); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. FGFR3 is part of the FGFR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with three immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of FGFRs to their ligands, the FGFs, results in receptor dimerization and activation, and intracellular signaling. The binding of FGFs to FGFRs is promiscuous, in that a receptor may be activated by several ligands and a ligand may bind to

>cd05095 PTKc_DDR2 Catalytic domain of the Protein Tyrosine Kinase, Discoidin Domain Receptor 2

Probab=99.98  E-value=4.2e-31  Score=251.57  Aligned_cols=216  Identities=22%  Similarity=0.326  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC----------CCCCHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH----------VKFSLGEIKKV   76 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~----------~~l~~~~~~~i   76 (433)
                      ..+.+|+++|+.++|+||+++++++...        +..++||||+. ++|.+++....          ..+++..+..+
T Consensus        64 ~~~~~E~~~l~~l~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  135 (296)
T cd05095          64 NDFLKEIKIMSRLKDPNIIRLLAVCITS--------DPLCMITEYMENGDLNQFLSRHEPQEAAEKADVVTISYSTLIFM  135 (296)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEecC--------CccEEEEEeCCCCcHHHHHHhcCcccccccccccccCHHHHHHH
Confidence            4678999999999999999999999875        55899999997 58888876532          13677889999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +.|++.||+|||++|++|+||||+||+++.++.++|+|||++..+......  .......++..|+|||+..+.. ++.+
T Consensus       136 ~~~i~~al~~lH~~~i~H~dlkp~Nili~~~~~~~l~dfg~~~~~~~~~~~--~~~~~~~~~~~~~~pe~~~~~~-~~~~  212 (296)
T cd05095         136 ATQIASGMKYLSSLNFVHRDLATRNCLVGKNYTIKIADFGMSRNLYSGDYY--RIQGRAVLPIRWMSWESILLGK-FTTA  212 (296)
T ss_pred             HHHHHHHHHHHHHCCeecccCChheEEEcCCCCEEeccCcccccccCCcce--eccCcCcCccccCCHHHHhcCC-ccch
Confidence            999999999999999999999999999999999999999998765432110  1111223356799999887655 7999


Q ss_pred             chhhhHHHHHHHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         157 VDLWGAGCIMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       157 ~DiwSlGvil~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      +||||+||++|||++  |..||...+..+.+..............                        ....+...+..
T Consensus       213 ~DiwSlG~~l~el~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~------------------------~~~~~~~~~~~  268 (296)
T cd05095         213 SDVWAFGVTLWEILTLCKEQPYSQLSDEQVIENTGEFFRDQGRQV------------------------YLPKPALCPDS  268 (296)
T ss_pred             hhhhHHHHHHHHHHHhCCCCCccccChHHHHHHHHHHHhhccccc------------------------cCCCCCCCCHH
Confidence            999999999999998  6788877665554433222110000000                        00001123456


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +.+|+.+||+.||.+||++.++++
T Consensus       269 ~~~li~~cl~~~p~~Rp~~~~i~~  292 (296)
T cd05095         269 LYKLMLSCWRRNAKERPSFQEIHA  292 (296)
T ss_pred             HHHHHHHHcCCCcccCCCHHHHHH
Confidence            779999999999999999999874

Protein Tyrosine Kinase (PTK) family; mammalian Discoidin Domain Receptor 2 (DDR2) and homologs; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. DDR2 is a member of the DDR subfamily, which are receptor tyr kinases (RTKs) containing an extracellular discoidin homology domain, a transmembrane segment, an extended juxtamembrane region, and an intracellular catalytic domain. The binding of the ligand, collagen, to DDRs results in a slow but sustained receptor activation. DDR2 binds mostly to fibrillar collagens. More recently, it has been reported to also bind collagen X. DDR2 is widely expressed in many tissues wit

>KOG1027|consensus

Probab=99.98  E-value=8.2e-33  Score=275.91  Aligned_cols=223  Identities=31%  Similarity=0.475  Sum_probs=172.6

Q ss_pred             CCchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCC--CCH-HHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL-GEIKKVIQQL   80 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~--l~~-~~~~~i~~ql   80 (433)
                      +...-+.|||.+|+.- +|||||++|..=.+.        ...||..|.|..+|.+++......  ... -..+.++.|+
T Consensus       544 e~~~~A~rEi~lL~eSD~H~NviRyyc~E~d~--------qF~YIalELC~~sL~dlie~~~~d~~~~~~i~~~~~l~q~  615 (903)
T KOG1027|consen  544 EFFDFAQREIQLLQESDEHPNVIRYYCSEQDR--------QFLYIALELCACSLQDLIESSGLDVEMQSDIDPISVLSQI  615 (903)
T ss_pred             HhHHHHHHHHHHHHhccCCCceEEEEeeccCC--------ceEEEEehHhhhhHHHHHhccccchhhcccccHHHHHHHH
Confidence            3455689999999988 599999998766554        679999999999999999874111  111 3567889999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEec---CC--cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITK---TG--ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~---~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      ++||++||+.+||||||||.||||+.   ++  .++|+|||+++.+..++.. ........||-.|+|||.+..... +.
T Consensus       616 ~~GlaHLHsl~iVHRDLkPQNILI~~~~~~~~~ra~iSDfglsKkl~~~~sS-~~r~s~~sGt~GW~APE~L~~~~~-~~  693 (903)
T KOG1027|consen  616 ASGLAHLHSLKIVHRDLKPQNILISVPSADGTLRAKISDFGLSKKLAGGKSS-FSRLSGGSGTSGWQAPEQLREDRK-TQ  693 (903)
T ss_pred             HHHHHHHHhcccccccCCCceEEEEccCCCcceeEEecccccccccCCCcch-hhcccCCCCcccccCHHHHhcccc-Cc
Confidence            99999999999999999999999986   33  6899999999999866543 334667889999999999988774 78


Q ss_pred             cchhhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         156 PVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      ++||+|+||++|..++| ..||......+.  .|.  .|...-     .                     .+.+. ...+
T Consensus       694 avDiFslGCvfyYvltgG~HpFGd~~~R~~--NIl--~~~~~L-----~---------------------~L~~~-~d~e  742 (903)
T KOG1027|consen  694 AVDIFSLGCVFYYVLTGGSHPFGDSLERQA--NIL--TGNYTL-----V---------------------HLEPL-PDCE  742 (903)
T ss_pred             ccchhhcCceEEEEecCCccCCCchHHhhh--hhh--cCccce-----e---------------------eeccC-chHH
Confidence            99999999999998886 899986543321  111  111000     0                     00000 1116


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      +.|||.+||.++|..||+|.++|.||+||...+.
T Consensus       743 A~dLI~~ml~~dP~~RPsa~~VL~HPlFW~~ekr  776 (903)
T KOG1027|consen  743 AKDLISRMLNPDPQLRPSATDVLNHPLFWDSEKR  776 (903)
T ss_pred             HHHHHHHhcCCCcccCCCHHHHhCCCccCChHHH
Confidence            7899999999999999999999999999986543

>cd05086 PTKc_Aatyk2 Catalytic domain of the Protein Tyrosine Kinase, Apoptosis-associated tyrosine kinase 2

Probab=99.98  E-value=6.1e-31  Score=246.82  Aligned_cols=214  Identities=18%  Similarity=0.325  Sum_probs=161.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---CCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---~~l~~~~~~~i~~qll~   82 (433)
                      ...+++|+.+++.++||||+++++.+...        ...|+||||+. ++|.+++.+..   ..+++..++.++.||+.
T Consensus        39 ~~~~~~e~~~~~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~  110 (268)
T cd05086          39 QNEFLQQGDPYRILQHPNILQCLGQCVEA--------IPYLLVFEYCELGDLKSYLSQEQWHRRNSQLLLLQRMACEIAA  110 (268)
T ss_pred             HHHHHHHHHHHhccCCcchhheEEEecCC--------CccEEEEecCCCCcHHHHHHhhhcccccccHHHHHHHHHHHHH
Confidence            35789999999999999999999999875        55899999998 48888886532   23567788899999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC------CCCCCc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD------RNYGPP  156 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~------~~~~~~  156 (433)
                      ||+|||+.+++||||||+|||++.++.++|+|||++.......  .........++..|+|||++...      ..++.+
T Consensus       111 al~~lH~~~i~H~dikp~nil~~~~~~~~l~Dfg~~~~~~~~~--~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~  188 (268)
T cd05086         111 GVTHMHKHNFLHSDLALRNCFLTSDLTVKVGDYGIGPSRYKED--YIETEDDKCVPLRWLAPELVGEFHGGLITAEQTKP  188 (268)
T ss_pred             HHHHHHHCCeeccCCccceEEEcCCccEEecccccccccCcch--hhhcccCCcCcccccCchhcccccCccccCCCCCc
Confidence            9999999999999999999999999999999999875432110  11112234668889999987431      125778


Q ss_pred             chhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCC-CCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         157 VDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGS-ITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       157 ~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      +||||+||++|+|++ |.+||...++.+.+..+...... .....                           ....++..
T Consensus       189 ~DiwslG~~l~el~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~---------------------------~~~~~~~~  241 (268)
T cd05086         189 SNVWALGVTLWELFENAAQPYSHLSDREVLNHVIKDQQVKLFKPQ---------------------------LELPYSER  241 (268)
T ss_pred             chhHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhhcccccCCCc---------------------------cCCCCcHH
Confidence            999999999999997 57788877766655544321110 00000                           01124556


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+++..|+ .+|.+||+++++++
T Consensus       242 ~~~l~~~c~-~~P~~Rp~~~~i~~  264 (268)
T cd05086         242 WYEVLQFCW-LSPEKRATAEEVHR  264 (268)
T ss_pred             HHHHHHHHh-hCcccCCCHHHHHH
Confidence            678999998 68999999999974

Protein Tyrosine Kinase (PTK) family; Apoptosis-associated tyrosine kinase 2 (Aatyk2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Aatyk2 is a member of the Aatyk subfamily of proteins, which are receptor kinases containing a transmembrane segment and a long C-terminal cytoplasmic tail with a catalytic domain. Aatyk2 is also called lemur tyrosine kinase 2 (Lmtk2) or brain-enriched kinase (Brek). It is expressed at high levels in early postnatal brain, and has been shown to play a role in nerve growth factor (NGF) signaling. Studies with knockout mice reveal that Aatyk2 is essential for late stage

>KOG0587|consensus

Probab=99.98  E-value=4.4e-32  Score=271.96  Aligned_cols=225  Identities=26%  Similarity=0.408  Sum_probs=184.3

Q ss_pred             CchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~   82 (433)
                      ..+.+.-|.+||+.+ +|||++.+|++|.....   ..++.++||||||++ +..+++++.. .++.|+.+.+|++.++.
T Consensus        58 ~deEiE~eynil~~~~~hpnv~~fyg~~~k~~~---~~~DqLWLVMEfC~gGSVTDLVKn~~g~rl~E~~IaYI~re~lr  134 (953)
T KOG0587|consen   58 EEEEIELEYNMLKKYSHHPNVATFYGAFIKKDP---GNGDQLWLVMEFCGGGSVTDLVKNTKGNRLKEEWIAYILREILR  134 (953)
T ss_pred             ccHHHHHHHHHHHhccCCCCcceEEEEEEEecC---CCCCeEEEEeeccCCccHHHHHhhhcccchhhHHHHHHHHHHHH
Confidence            356777889999988 69999999999976644   346999999999985 6666666543 35899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC----CCCcch
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----YGPPVD  158 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----~~~~~D  158 (433)
                      |+.+||.+.++|||||-.|||++.+|.|||+|||++..+..    ...+..+.+||+.|||||++.+...    |+..+|
T Consensus       135 gl~HLH~nkviHRDikG~NiLLT~e~~VKLvDFGvSaQlds----T~grRnT~iGtP~WMAPEViac~e~~d~tyd~R~D  210 (953)
T KOG0587|consen  135 GLAHLHNNKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDS----TVGRRNTFIGTPYWMAPEVIACDESPDATYDYRSD  210 (953)
T ss_pred             HHHHHhhcceeeecccCceEEEeccCcEEEeeeeeeeeeec----ccccccCcCCCcccccceeeecccCCCCCcccccc
Confidence            99999999999999999999999999999999999977653    3345567899999999999976543    677999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      +||||++..||..|.||+-...+...+..|   ...+++.                          ...+...++++.||
T Consensus       211 ~WsLGITaIEladG~PPl~DmHPmraLF~I---pRNPPPk--------------------------Lkrp~kWs~~FndF  261 (953)
T KOG0587|consen  211 LWSLGITAIEMAEGAPPLCDMHPMRALFLI---PRNPPPK--------------------------LKRPKKWSKKFNDF  261 (953)
T ss_pred             hhhccceeehhcCCCCCccCcchhhhhccC---CCCCCcc--------------------------ccchhhHHHHHHHH
Confidence            999999999999999999887776554433   2222211                          11233456788899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|-.+||+..++|.|||+.+.+
T Consensus       262 Is~cL~Kd~e~RP~~~~ll~hpFi~e~~  289 (953)
T KOG0587|consen  262 ISTCLVKDYEQRPSTEELLKHPFITEQP  289 (953)
T ss_pred             HHHHHhhccccCcchhhhccCCcccccc
Confidence            9999999999999999999999998655

>cd05037 PTK_Jak_rpt1 Pseudokinase (repeat 1) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.98  E-value=3.3e-31  Score=246.85  Aligned_cols=202  Identities=20%  Similarity=0.312  Sum_probs=159.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.. .        ..++||||+.+ +|.+++......++...+..++.||+.||+
T Consensus        45 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~-~--------~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~  115 (259)
T cd05037          45 SLAFFETASLMSQLSHKHLVKLYGVCVR-D--------ENIMVEEYVKFGPLDVFLHREKNNVSLHWKLDVAKQLASALH  115 (259)
T ss_pred             HHHHHHHHHHHHcCCCcchhheeeEEec-C--------CcEEEEEcCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999998876 2        25899999975 777777665547899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC-------cEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG-------ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPV  157 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~-------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~  157 (433)
                      |||++||+|+||||+||+++.++       .++|+|||++.....        .....++..|+|||++.+. ..++.++
T Consensus       116 ~LH~~~i~H~dlkp~Nill~~~~~~~~~~~~~kl~Dfg~a~~~~~--------~~~~~~~~~y~aPE~~~~~~~~~~~~~  187 (259)
T cd05037         116 YLEDKKLVHGNVCGKNILVARYGLNEGYVPFIKLSDPGIPITVLS--------REERVERIPWIAPECIRNGQASLTIAA  187 (259)
T ss_pred             HHhhCCeecccCccceEEEecCccccCCceeEEeCCCCccccccc--------ccccccCCCccChhhhcCCCCCcchhh
Confidence            99999999999999999999887       799999999876543        1123456679999998765 3478999


Q ss_pred             hhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      ||||+||++++|++ |.+||.............. ..     .                           .+......+.
T Consensus       188 Di~slG~~~~~l~~~~~~p~~~~~~~~~~~~~~~-~~-----~---------------------------~~~~~~~~~~  234 (259)
T cd05037         188 DKWSFGTTLLEICSNGEEPLSTLSSSEKERFYQD-QH-----R---------------------------LPMPDCAELA  234 (259)
T ss_pred             HHHHHHHHHHHHHhCCCCCcccCCchhHHHHHhc-CC-----C---------------------------CCCCCchHHH
Confidence            99999999999999 5777776543322221110 00     0                           0011124567


Q ss_pred             HHHHhhcccCCCCCCCHHHhhc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++|.+||..+|.+|||+.++++
T Consensus       235 ~li~~~l~~~p~~Rpt~~~il~  256 (259)
T cd05037         235 NLINQCWTYDPTKRPSFRAILR  256 (259)
T ss_pred             HHHHHHhccChhhCCCHHHHHH
Confidence            9999999999999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; pseudokinase domain (repeat1). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. The pseudokinase domain shows similarity to tyr kinases but lacks crucial residues for catalytic activity and ATP binding. It modulates the ki

>cd05083 PTKc_Chk Catalytic domain of the Protein Tyrosine Kinase, Csk homologous kinase

Probab=99.98  E-value=4.2e-31  Score=245.75  Aligned_cols=204  Identities=22%  Similarity=0.346  Sum_probs=163.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++||||+++++++...         ..++||||+. ++|.+++.... ..+++..+..++.|++.||
T Consensus        43 ~~~~~~e~~~l~~~~~~~i~~~~~~~~~~---------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~al  113 (254)
T cd05083          43 AQAFLEETAVMTKLHHKNLVRLLGVILHN---------GLYIVMELMSKGNLVNFLRTRGRALVSVIQLLQFSLDVAEGM  113 (254)
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEcCC---------CcEEEEECCCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHH
Confidence            35688999999999999999999988643         3699999997 58988887543 3488999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++||||||+||+++.++.++|+|||++.......       .....+..|+|||.+.+.. ++.++|+|||||
T Consensus       114 ~~lH~~~~~H~dl~p~nili~~~~~~kl~Dfg~~~~~~~~~-------~~~~~~~~y~~pe~~~~~~-~~~~~Dv~slG~  185 (254)
T cd05083         114 EYLESKKLVHRDLAARNILVSEDGVAKVSDFGLARVGSMGV-------DNSKLPVKWTAPEALKHKK-FSSKSDVWSYGV  185 (254)
T ss_pred             HHHHhCCeeccccCcceEEEcCCCcEEECCCccceeccccC-------CCCCCCceecCHHHhccCC-cCchhhHHHHHH
Confidence            99999999999999999999999999999999986643211       1223356799999887654 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |.+||.+.+..+....+.+.....                               .+...+..+.+++.+||
T Consensus       186 ~l~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l  234 (254)
T cd05083         186 LLWEVFSYGRAPYPKMSLKEVKECVEKGYRME-------------------------------PPEGCPADVYVLMTSCW  234 (254)
T ss_pred             HHHHHHhCCCCCCccCCHHHHHHHHhCCCCCC-------------------------------CCCcCCHHHHHHHHHHc
Confidence            9999998 999998877655443332210000                               01124566779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|.+||++++++.
T Consensus       235 ~~~p~~Rp~~~~l~~  249 (254)
T cd05083         235 ETEPKKRPSFHKLRE  249 (254)
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999875

Protein Tyrosine Kinase (PTK) family; Csk homologous kinase (Chk); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Csk subfamily kinases are cytoplasmic (or nonreceptor) tyr kinases containing the Src homology domains, SH3 and SH2, N-terminal to the catalytic tyr kinase domain. They negatively regulate the activity of Src kinases that are anchored to the plasma membrane. Chk is also referred to as megakaryocyte-associated tyrosine kinase (Matk). To inhibit Src kinases, Chk is translocated to the membrane via binding to specific transmembrane proteins, G-proteins, or adaptor proteins near the membrane. Chk inhibit Src ki

>cd05046 PTK_CCK4 Pseudokinase domain of the Protein Tyrosine Kinase, Colon Carcinoma Kinase 4

Probab=99.97  E-value=4e-31  Score=248.81  Aligned_cols=210  Identities=20%  Similarity=0.402  Sum_probs=166.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------CCCCHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------VKFSLGEIKKVIQ   78 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------~~l~~~~~~~i~~   78 (433)
                      ..+.+|+.++++++|+||+++++++.+.        ...|+||||++ ++|.+++....        ..+++..+..++.
T Consensus        53 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~i~~~~~~~~~~~~~~l~~~~~~~~~~  124 (275)
T cd05046          53 SEFRRELDMFRKLSHKNVVRLLGLCREA--------EPHYMILEYTDLGDLKQFLRATKSKDEKLKPPPLSTKQKVALCT  124 (275)
T ss_pred             HHHHHHHHHHHhcCCcceeeeEEEECCC--------CcceEEEEecCCCcHHHHHHhcccccccccccCCCHHHHHHHHH
Confidence            4688999999999999999999998765        55899999998 58888886543        1589999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      ||+.||+|||+.||+|+||||+||+++.++.++++|||++.......   ........++..|+|||.+.+.. ++.++|
T Consensus       125 ~l~~~l~~LH~~~i~H~dlkp~Nili~~~~~~~l~~~~~~~~~~~~~---~~~~~~~~~~~~y~~PE~~~~~~-~~~~~D  200 (275)
T cd05046         125 QIALGMDHLSNARFVHRDLAARNCLVSSQREVKVSLLSLSKDVYNSE---YYKLRNALIPLRWLAPEAVQEDD-FSTKSD  200 (275)
T ss_pred             HHHHHHHHhhhcCcccCcCccceEEEeCCCcEEEcccccccccCccc---ccccCCceeEEeecChhhhccCC-CCchhh
Confidence            99999999999999999999999999999999999999886543211   12233345577899999987654 688999


Q ss_pred             hhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||||++++|++ |.+||........+..+..  +...   |.                         .+...+..+.+
T Consensus       201 i~slG~~l~~l~~~~~~p~~~~~~~~~~~~~~~--~~~~---~~-------------------------~~~~~~~~l~~  250 (275)
T cd05046         201 VWSFGVLMWEVFTQGELPFYGLSDEEVLNRLQA--GKLE---LP-------------------------VPEGCPSRLYK  250 (275)
T ss_pred             HHHHHHHHHHHHhCCCCCccccchHHHHHHHHc--CCcC---CC-------------------------CCCCCCHHHHH
Confidence            9999999999998 7889987665544443321  1100   00                         01124566779


Q ss_pred             HHHhhcccCCCCCCCHHHhhcC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ++.+||+.+|.+||++.+++..
T Consensus       251 ~i~~~l~~~p~~Rp~~~~~l~~  272 (275)
T cd05046         251 LMTRCWAVNPKDRPSFSELVSA  272 (275)
T ss_pred             HHHHHcCCCcccCCCHHHHHHH
Confidence            9999999999999999999864

Protein Tyrosine Kinase (PTK) family; Colon Carcinoma Kinase 4 (CCK4); pseudokinase domain. The PTKc (catalytic domain) family, to which this subfamily belongs, includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. CCK4, also called protein tyrosine kinase 7 (PTK7), is an orphan receptor tyr kinase (RTK) containing an extracellular region with seven immunoglobulin domains, a transmembrane segment, and an intracellular inactive pseudokinase domain. Studies in mice reveal that CCK4 is essential for neural development. Mouse embryos containing a truncated CCK4 die perinatally and display craniorachischisis, a severe form of neural tube defect. The mechanism of action of the CCK4 pseudokinase is s

>cd05057 PTKc_EGFR_like Catalytic domain of Epidermal Growth Factor Receptor-like Protein Tyrosine Kinases

Probab=99.97  E-value=6.1e-31  Score=248.20  Aligned_cols=208  Identities=22%  Similarity=0.297  Sum_probs=165.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..         ...++||||+. ++|.+.+.+....+++..+..++.|++.||+|
T Consensus        54 ~~~~~e~~~l~~l~h~~i~~~~~~~~~---------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  124 (279)
T cd05057          54 KEILDEAYVMASVDHPHVVRLLGICLS---------SQVQLITQLMPLGCLLDYVRNHKDNIGSQYLLNWCVQIAKGMSY  124 (279)
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEec---------CceEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            467789999999999999999999875         34799999997 58888887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.........  .......++..|+|||.+.... ++.++|+||+||++
T Consensus       125 LH~~~i~H~di~p~nil~~~~~~~kL~dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~~l  201 (279)
T cd05057         125 LEEKRLVHRDLAARNVLVKTPQHVKITDFGLAKLLDVDEKE--YHAEGGKVPIKWMALESILHRI-YTHKSDVWSYGVTV  201 (279)
T ss_pred             HHhCCEEecccCcceEEEcCCCeEEECCCcccccccCcccc--eecCCCcccccccCHHHhhcCC-cCchhhHHHHHHHH
Confidence            99999999999999999999999999999999776532211  1111223356799999886544 78999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++++ |.+||.+....+....+.......                               .+...+..+.+++.+||..
T Consensus       202 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~~~~~l~~  250 (279)
T cd05057         202 WELMTFGAKPYEGIPAVEIPDLLEKGERLP-------------------------------QPPICTIDVYMVLVKCWMI  250 (279)
T ss_pred             HHHhcCCCCCCCCCCHHHHHHHHhCCCCCC-------------------------------CCCCCCHHHHHHHHHHcCC
Confidence            99998 999998877655444433210000                               0112345567999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+||++.++++
T Consensus       251 ~p~~Rp~~~~l~~  263 (279)
T cd05057         251 DAESRPTFKELIN  263 (279)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999874

Protein Tyrosine Kinase (PTK) family; Epidermal Growth Factor Receptor (EGFR) subfamily; catalytic (c) domain. EGFR (HER, ErbB) subfamily members include EGFR (HER1, ErbB1), HER2 (ErbB2), HER3 (ErbB3), HER4 (ErbB4), and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. The EGFR proteins are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instea

>cd08224 STKc_Nek6_Nek7 Catalytic domain of the Protein Serine/Threonine Kinases, Never In Mitosis gene A-related kinase 6 and 7

Probab=99.97  E-value=6e-31  Score=246.24  Aligned_cols=209  Identities=30%  Similarity=0.455  Sum_probs=163.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|++++++++|+||+++++++...        +..++||||+++ +|..++...   ...+++..++.++.|++.
T Consensus        46 ~~~~~~ei~~l~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  117 (267)
T cd08224          46 RQDCLKEIDLLKQLDHPNVIKYLASFIEN--------NELNIVLELADAGDLSRMIKHFKKQKRLIPERTIWKYFVQLCS  117 (267)
T ss_pred             HHHHHHHHHHHHhCCCCCeeeeeeeeecC--------CeEEEEEecCCCCCHHHHHHHhcccCCCcCHHHHHHHHHHHHH
Confidence            45688999999999999999999999875        568999999974 888877542   344899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|||+.||+|+||+|+||+++.++.++|+|||++........    ......++..|+|||.+.+.. ++.++|+||+
T Consensus       118 ~l~~lh~~~i~h~dl~p~nil~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~y~apE~~~~~~-~~~~~Di~sl  192 (267)
T cd08224         118 ALEHMHSKRIMHRDIKPANVFITATGVVKLGDLGLGRFFSSKTT----AAHSLVGTPYYMSPERIHENG-YNFKSDIWSL  192 (267)
T ss_pred             HHHHHHhCCEecCCcChhhEEECCCCcEEEeccceeeeccCCCc----ccceecCCccccCHHHhccCC-CCchhcHHHH
Confidence            99999999999999999999999999999999999876543221    122345788899999987655 7899999999


Q ss_pred             HHHHHHHHhcCCCCCCCChH--HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQ--QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~--~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||++++|++|..||......  +....+..  +...+                            ......+....++|.
T Consensus       193 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~~~~~~~i~  242 (267)
T cd08224         193 GCLLYEMAALQSPFYGDKMNLYSLCKKIEK--CDYPP----------------------------LPADHYSEELRDLVS  242 (267)
T ss_pred             HHHHHHHHHCCCCcccCCccHHHHHhhhhc--CCCCC----------------------------CChhhcCHHHHHHHH
Confidence            99999999999998654311  11111111  00000                            000124556779999


Q ss_pred             hhcccCCCCCCCHHHhhc
Q psy7889         241 KLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~  258 (433)
                      +||..+|++|||+.++++
T Consensus       243 ~cl~~~p~~Rp~~~~il~  260 (267)
T cd08224         243 RCINPDPEKRPDISYVLQ  260 (267)
T ss_pred             HHcCCCcccCCCHHHHHH
Confidence            999999999999999874

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 6 (Nek6) and Nek7 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek6/7 subfamily is part of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. Nek6 and Nek7 are the shortest Neks, consisting only of the catalytic domain and a very short N-terminal extension. They show distinct expression patterns and both appear to be downstream substrates of Nek9. They are required for mitotic spindle formation and cytokinesis. They may a

>cd05043 PTK_Ryk Pseudokinase domain of Ryk (Receptor related to tyrosine kinase)

Probab=99.97  E-value=5e-31  Score=248.85  Aligned_cols=210  Identities=18%  Similarity=0.274  Sum_probs=164.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-------CCCCHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-------VKFSLGEIKKVIQQ   79 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-------~~l~~~~~~~i~~q   79 (433)
                      ..+.+|+.+|+.++||||+++++++...       ....+++++|+. ++|..++....       ..+++..++.++.|
T Consensus        53 ~~~~~e~~~l~~l~h~ni~~~~~~~~~~-------~~~~~~~~~~~~~~~L~~~l~~~~~~~~~~~~~l~~~~~~~i~~~  125 (280)
T cd05043          53 TLLLQESCLLYGLSHQNILPILHVCIED-------GEPPFVLYPYMNWGNLKLFLQQCRLGEANNPQALSTQQLVHMAIQ  125 (280)
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecC-------CCCCEEEEEcCCCCcHHHHHHhccccccccccCCCHHHHHHHHHH
Confidence            4578899999999999999999987764       245799999997 57888775532       34889999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ++.||+|||++|++|+||||+||+++.++.+||+|||+++.+......  .......++..|+|||++.+.. ++.++||
T Consensus       126 i~~~l~~LH~~~i~H~di~p~nil~~~~~~~kl~d~g~~~~~~~~~~~--~~~~~~~~~~~y~apE~~~~~~-~~~~~Di  202 (280)
T cd05043         126 IACGMSYLHKRGVIHKDIAARNCVIDEELQVKITDNALSRDLFPMDYH--CLGDNENRPVKWMALESLVNKE-YSSASDV  202 (280)
T ss_pred             HHHHHHHHHHCCEeecccCHhhEEEcCCCcEEECCCCCcccccCCceE--EeCCCCCcchhccCHHHHhcCC-CCchhhH
Confidence            999999999999999999999999999999999999999765432111  1112234567799999987655 7999999


Q ss_pred             hhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||+||+++++++ |.+||......+....+....   ...                            .+...+.++.++
T Consensus       203 ~slG~~l~el~~~g~~p~~~~~~~~~~~~~~~~~---~~~----------------------------~~~~~~~~~~~l  251 (280)
T cd05043         203 WSFGVLLWELMTLGQTPYVEIDPFEMAAYLKDGY---RLA----------------------------QPINCPDELFAV  251 (280)
T ss_pred             HHhHHHHHHHhcCCCCCcCcCCHHHHHHHHHcCC---CCC----------------------------CCCcCCHHHHHH
Confidence            999999999998 999998876655433332210   000                            011234567799


Q ss_pred             HHhhcccCCCCCCCHHHhhc
Q psy7889         239 LDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~  258 (433)
                      +.+||..||++|||+.++++
T Consensus       252 i~~~l~~~p~~Rps~~~~~~  271 (280)
T cd05043         252 MACCWALDPEERPSFSQLVQ  271 (280)
T ss_pred             HHHHcCCChhhCCCHHHHHH
Confidence            99999999999999999984

Protein Tyrosine Kinase (PTK) family; Receptor related to tyrosine kinase (Ryk); pseudokinase domain. The PTKc (catalytic domain) family to which this subfamily belongs, is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Ryk is a receptor tyr kinase (RTK) containing an extracellular region with two leucine-rich motifs, a transmembrane segment, and an intracellular inactive pseudokinase domain. The extracellular region of Ryk shows homology to the N-terminal domain of Wnt inhibitory factor-1 (WIF) and serves as the ligand (Wnt) binding domain of Ryk. Ryk is expressed in many different tissues both during development and in adults, suggesting a widespread function. It

>cd05583 STKc_MSK_N N-terminal catalytic domain of the Protein Serine/Threonine Kinase, Mitogen and stress-activated kinase

Probab=99.97  E-value=3.4e-31  Score=251.11  Aligned_cols=217  Identities=27%  Similarity=0.373  Sum_probs=167.3

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++++ +||||+++++.+...        ..+|+||||+.+ +|...+... ..+++..++.++.|++.||.
T Consensus        49 ~~~~~E~~~l~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~~~~ql~~~l~  119 (288)
T cd05583          49 EHTRTERQVLEAVRRCPFLVTLHYAFQTD--------TKLHLILDYVNGGELFTHLYQR-EHFTESEVRVYIAEIVLALD  119 (288)
T ss_pred             HHHHHHHHHHHhccCCcchhhhheeeecC--------CEEEEEEecCCCCcHHHHHhhc-CCcCHHHHHHHHHHHHHHHH
Confidence            3467899999999 699999999998765        568999999975 787777653 36899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv  164 (433)
                      |||+.|++|+||+|+||+++.++.++|+|||++.........   ......++..|+|||.+.+.. ..+.++|+||+|+
T Consensus       120 ~lH~~~~~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~---~~~~~~~~~~y~aPE~~~~~~~~~~~~~Dv~slG~  196 (288)
T cd05583         120 HLHQLGIIYRDIKLENILLDSEGHVVLTDFGLSKEFLAEEEE---RAYSFCGTIEYMAPEVIRGGSGGHDKAVDWWSLGV  196 (288)
T ss_pred             HHHHCCeeccCCCHHHeEECCCCCEEEEECcccccccccccc---ccccccCCccccCHHHhcCCCCCCcchhhhHHHHH
Confidence            999999999999999999999999999999998765432211   112345788999999986543 3578999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHH-hCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQL-CGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++|..||...........+.+. .....                             ..+...+..+.++|.+||
T Consensus       197 il~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~l~~li~~~l  247 (288)
T cd05583         197 LTFELLTGASPFTVDGEQNSQSEISRRILKSKP-----------------------------PFPKTMSAEARDFIQKLL  247 (288)
T ss_pred             HHHHHHhCCCCcccCcccchHHHHHHHHHccCC-----------------------------CCCcccCHHHHHHHHHHh
Confidence            999999999999754322222222111 11000                             001124566789999999


Q ss_pred             ccCCCCCCC---HHHhhcCCCccCC
Q psy7889         244 LLDPSKRFD---SDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t---~~e~L~h~~~~~~  265 (433)
                      +.||++|||   +.++|+||||+..
T Consensus       248 ~~~p~~R~t~~~~~~~l~~~~~~~~  272 (288)
T cd05583         248 EKDPKKRLGANGADEIKNHPFFQGI  272 (288)
T ss_pred             cCCHhhccCcchHHHHhcCcccccC
Confidence            999999998   5777999999653

Serine/Threonine Kinases (STKs), Mitogen and stress-activated kinase (MSK) subfamily, N-terminal catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MSK subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MSKs contain an N-terminal kinase domain (NTD) from the AGC family and a C-terminal kinase domain (CTD) from the CAMK family, similar to 90 kDa ribosomal protein S6 kinases (RSKs). MSKs are activated by two major signaling cascades, the Ras-MAPK and p38 stress kinase pathways, in response to various stimuli such as growth factors, hormones, neurotransmitters, cellular stress, and pro-inflammatory cytokines

>cd05073 PTKc_Hck Catalytic domain of the Protein Tyrosine Kinase, Hematopoietic cell kinase

Probab=99.97  E-value=7.6e-31  Score=244.98  Aligned_cols=208  Identities=20%  Similarity=0.329  Sum_probs=164.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+.+|+.+++.++|+||+++++++..         ...++||||++ ++|.+++.+. ...++...+..++.|++.||
T Consensus        45 ~~~~~~e~~~l~~l~~~~i~~~~~~~~~---------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~~l~~aL  115 (260)
T cd05073          45 VEAFLAEANVMKTLQHDKLVKLHAVVTK---------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM  115 (260)
T ss_pred             HHHHHHHHHHHHhcCCCCcceEEEEEcC---------CCeEEEEEeCCCCcHHHHHHhCCccccCHHHHHHHHHHHHHHH
Confidence            3567899999999999999999998865         33799999997 5898888653 34578889999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .|||+.|++|+||||+||+++.++.++|+|||++........   .......++..|+|||++.+.. ++.++|+|||||
T Consensus       116 ~~lH~~~i~H~dl~p~ni~i~~~~~~~l~d~~~~~~~~~~~~---~~~~~~~~~~~y~~PE~~~~~~-~~~~~Di~slG~  191 (260)
T cd05073         116 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNEY---TAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGI  191 (260)
T ss_pred             HHHHhCCccccccCcceEEEcCCCcEEECCCcceeeccCCCc---ccccCCcccccccCHhHhccCC-cCccccchHHHH
Confidence            999999999999999999999999999999999876543211   1111223456799999987654 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|++++ |.+||.+.+.......+.......                               .+...+.++.+++.+||
T Consensus       192 ~l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~~i~~~l  240 (260)
T cd05073         192 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMP-------------------------------RPENCPEELYNIMMRCW  240 (260)
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHhCCCCCC-------------------------------CcccCCHHHHHHHHHHc
Confidence            9999998 999999877665554443211100                               00124566779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..+|++||++.+++.
T Consensus       241 ~~~p~~Rp~~~~l~~  255 (260)
T cd05073         241 KNRPEERPTFEYIQS  255 (260)
T ss_pred             ccCcccCcCHHHHHH
Confidence            999999999988864

Protein Tyrosine Kinase (PTK) family; Hematopoietic cell kinase (Hck); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Hck is a member of the Src subfamily of proteins, which are cytoplasmic (or non-receptor) tyr kinases. Src kinases contain an N-terminal SH4 domain with a myristoylation site, followed by SH3 and SH2 domains, a tyr kinase domain, and a regulatory C-terminal region containing a conserved tyr. They are activated by autophosphorylation at the tyr kinase domain, but are negatively regulated by phosphorylation at the C-terminal tyr by Csk (C-terminal Src Kinase). Src proteins are involved in signaling pa

>KOG1151|consensus

Probab=99.97  E-value=8.1e-32  Score=251.33  Aligned_cols=225  Identities=24%  Similarity=0.415  Sum_probs=178.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.||..|.+.|+||.||++||+|..+       .+.+|-|+|||+|+-+++..+.+..+++.+++.|+.||+.||.|
T Consensus       511 hKHAcREyrIHKeLDHpRIVKlYDyfslD-------tdsFCTVLEYceGNDLDFYLKQhklmSEKEARSIiMQiVnAL~Y  583 (775)
T KOG1151|consen  511 HKHACREYRIHKELDHPRIVKLYDYFSLD-------TDSFCTVLEYCEGNDLDFYLKQHKLMSEKEARSIIMQIVNALKY  583 (775)
T ss_pred             HHHHHHHHhhhhccCcceeeeeeeeeeec-------cccceeeeeecCCCchhHHHHhhhhhhHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999887       46799999999997777777767779999999999999999999


Q ss_pred             HHhC--CeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCC---CCCCC
Q psy7889          87 IHSN--KILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGD---RNYGP  155 (433)
Q Consensus        87 LH~~--~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~---~~~~~  155 (433)
                      |.+.  -|||-||||.|||+.+   .|.+||+|||+++.+........   .-.+...||.||++||.+.-.   +..+.
T Consensus       584 LNEikpPIIHYDLKPgNILLv~GtacGeIKITDFGLSKIMdddSy~~vdGmeLTSQgAGTYWYLPPEcFvVgkePPKIsn  663 (775)
T KOG1151|consen  584 LNEIKPPIIHYDLKPGNILLVNGTACGEIKITDFGLSKIMDDDSYNSVDGMELTSQGAGTYWYLPPECFVVGKEPPKISN  663 (775)
T ss_pred             HhccCCCeeeeccCCccEEEecCcccceeEeeecchhhhccCCccCcccceeeecccCceeeecCcceeecCCCCCcccc
Confidence            9965  5999999999999853   47899999999998865332211   223567899999999998533   44788


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++||||+|||+|..+.|+-||........+-....++-.               ..+.+|.          + -..+.++
T Consensus       664 KVDVWSvGVIFyQClYGrKPFGhnqsQQdILqeNTIlkA---------------tEVqFP~----------K-PvVsseA  717 (775)
T KOG1151|consen  664 KVDVWSVGVIFYQCLYGRKPFGHNQSQQDILQENTILKA---------------TEVQFPP----------K-PVVSSEA  717 (775)
T ss_pred             ceeeEeeehhhhhhhccCCCCCCchhHHHHHhhhchhcc---------------eeccCCC----------C-CccCHHH
Confidence            999999999999999999999865433322211111100               0011111          1 1467889


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ++||++||.+--.+|....++-.||||..
T Consensus       718 kaFIRRCLaYRKeDR~DV~qLA~dpyllP  746 (775)
T KOG1151|consen  718 KAFIRRCLAYRKEDRIDVQQLACDPYLLP  746 (775)
T ss_pred             HHHHHHHHHhhhhhhhhHHHHccCccccc
Confidence            99999999999999999999999999954

>PRK13184 pknD serine/threonine-protein kinase; Reviewed

Probab=99.97  E-value=3.7e-31  Score=276.94  Aligned_cols=214  Identities=25%  Similarity=0.318  Sum_probs=161.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc----------CCCCCHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI----------HVKFSLGEIKKV   76 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~----------~~~l~~~~~~~i   76 (433)
                      ..+++|+.+++.++||||+++++++.+.        +..|+||||++| +|.+++...          ...++...+..+
T Consensus        47 ~rflrEi~ILs~L~HPNIVkl~~v~~d~--------~~lyLVMEY~eGGSL~~lL~s~~~~~~l~e~~~~~lsv~~iL~I  118 (932)
T PRK13184         47 KRFLREAKIAADLIHPGIVPVYSICSDG--------DPVYYTMPYIEGYTLKSLLKSVWQKESLSKELAEKTSVGAFLSI  118 (932)
T ss_pred             HHHHHHHHHHHhCCCcCcCeEEEEEeeC--------CEEEEEEEcCCCCCHHHHHHHhhhccccchhhhcccCHHHHHHH
Confidence            4688999999999999999999999875        568999999975 787777532          123556678899


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC--------------ccccccCCccccccc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG--------------QVNRYTNRVVTLWYR  142 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~--------------~~~~~~~~~gt~~y~  142 (433)
                      +.||+.||+|||++||+||||||+||+++.+|.++|+|||++.........              ........+||+.|+
T Consensus       119 ~~QIa~AL~yLHs~GIIHRDLKPeNILLd~dg~vKLiDFGLAk~i~~~~~~~~~l~~~~~~s~~s~~t~~g~~vGT~~Ym  198 (932)
T PRK13184        119 FHKICATIEYVHSKGVLHRDLKPDNILLGLFGEVVILDWGAAIFKKLEEEDLLDIDVDERNICYSSMTIPGKIVGTPDYM  198 (932)
T ss_pred             HHHHHHHHHHHHHCCccccCCchheEEEcCCCCEEEEecCcceecccccccccccccccccccccccccCCCCCCCCCCC
Confidence            999999999999999999999999999999999999999999766211100              001112346899999


Q ss_pred             CcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         143 PPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       143 aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      |||++.+.. ++.++||||+||++++|++|.+||.+.........  .....+  ...                      
T Consensus       199 APE~l~g~~-~S~kSDIWSLGVILyELLTG~~PF~~~~~~ki~~~--~~i~~P--~~~----------------------  251 (932)
T PRK13184        199 APERLLGVP-ASESTDIYALGVILYQMLTLSFPYRRKKGRKISYR--DVILSP--IEV----------------------  251 (932)
T ss_pred             CHHHhcCCC-CCcHhHHHHHHHHHHHHHHCCCCCCCcchhhhhhh--hhccCh--hhc----------------------
Confidence            999988765 79999999999999999999999987543322111  000000  000                      


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                         ......+..+.+++.+||..||++|++..+.+.+
T Consensus       252 ---~p~~~iP~~L~~LI~rcL~~DP~kR~ss~eeLl~  285 (932)
T PRK13184        252 ---APYREIPPFLSQIAMKALAVDPAERYSSVQELKQ  285 (932)
T ss_pred             ---cccccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence               0001245667799999999999999887666643

>KOG1035|consensus

Probab=99.97  E-value=1.5e-31  Score=275.92  Aligned_cols=189  Identities=26%  Similarity=0.443  Sum_probs=140.6

Q ss_pred             ceEEEEeecCcCCHHHHHhccCCCC-CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          44 STFYLVFDFCEHDLAGLLSNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        44 ~~~~lV~e~~~~~L~~~l~~~~~~l-~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      ..+||=||||+.+++..+...+... ....+|.+++||+.||.|+|++|||||||||.||+++.++.|||+|||+|....
T Consensus       669 ~~LYIQMEyCE~~ll~~iI~~N~~~~~~d~~wrLFreIlEGLaYIH~~giIHRDLKP~NIFLd~~~~VKIGDFGLAt~~~  748 (1351)
T KOG1035|consen  669 LILYIQMEYCEKTLLRDIIRRNHFNSQRDEAWRLFREILEGLAYIHDQGIIHRDLKPRNIFLDSRNSVKIGDFGLATDLK  748 (1351)
T ss_pred             eEEEEEHhhhhhhHHHHHHHhcccchhhHHHHHHHHHHHHHHHHHHhCceeeccCCcceeEEcCCCCeeecccccchhhh
Confidence            4679999999988777776655433 367899999999999999999999999999999999999999999999998722


Q ss_pred             --------------cCcCCccccccCCcccccccCcccccCCC--CCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHH
Q psy7889         123 --------------QTKNGQVNRYTNRVVTLWYRPPELLLGDR--NYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT  186 (433)
Q Consensus       123 --------------~~~~~~~~~~~~~~gt~~y~aPE~~~~~~--~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~  186 (433)
                                    ..........++.+||..|+|||++.+..  .|+.++||||||||++||+-   ||..  .++...
T Consensus       749 ~~~~~~d~~~~~~~~~~g~~~~~~Ts~VGTalYvAPEll~~~~~~~Yn~KiDmYSLGIVlFEM~y---PF~T--sMERa~  823 (1351)
T KOG1035|consen  749 ENLESIDQDLSFSTNRAGSNDGDLTSQVGTALYVAPELLSDTSSNKYNSKIDMYSLGIVLFEMLY---PFGT--SMERAS  823 (1351)
T ss_pred             hhhhhHhhccCccccccCCCCcccccccceeeeecHHHhcccccccccchhhhHHHHHHHHHHhc---cCCc--hHHHHH
Confidence                          01111122345679999999999997766  59999999999999999963   3543  233333


Q ss_pred             HHHHHh-CCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         187 LISQLC-GSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       187 ~i~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      .+..+- |.++.+  ++...                        ..-+.-..+|.+||+.||++||||.|+|++.||-
T Consensus       824 iL~~LR~g~iP~~--~~f~~------------------------~~~~~e~slI~~Ll~hdP~kRPtA~eLL~s~llp  875 (1351)
T KOG1035|consen  824 ILTNLRKGSIPEP--ADFFD------------------------PEHPEEASLIRWLLSHDPSKRPTATELLNSELLP  875 (1351)
T ss_pred             HHHhcccCCCCCC--ccccc------------------------ccchHHHHHHHHHhcCCCccCCCHHHHhhccCCC
Confidence            333222 222211  11100                        0112234799999999999999999999999995

>cd05081 PTKc_Jak2_Jak3_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases 2 and 3

Probab=99.97  E-value=9.2e-31  Score=247.59  Aligned_cols=228  Identities=21%  Similarity=0.336  Sum_probs=162.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++....      ...+++||||++ ++|.+++.+....+++..++.++.|++.||.|
T Consensus        50 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~l~~~~~~~~~~~l~~aL~~  123 (284)
T cd05081          50 RDFEREIEILKSLQHDNIVKYKGVCYSAG------RRNLRLVMEYLPYGSLRDYLQKHRERLDHRKLLLYASQICKGMEY  123 (284)
T ss_pred             HHHHHHHHHHHhCCCCCeeEEEEEEccCC------CCceEEEEEecCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHHH
Confidence            35788999999999999999999876542      245899999996 58988887655668999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++......... ........++..|+|||++.+.. ++.++||||+||++
T Consensus       124 LH~~~i~H~dlkp~nili~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  201 (284)
T cd05081         124 LGSKRYVHRDLATRNILVESENRVKIGDFGLTKVLPQDKEY-YKVREPGESPIFWYAPESLTESK-FSVASDVWSFGVVL  201 (284)
T ss_pred             HHHCCceeccCCHhhEEECCCCeEEECCCcccccccCCCcc-eeecCCCCCceEeeCHHHhccCC-cChHHHHHHHHHHH
Confidence            99999999999999999999999999999999876432211 00111122345699999987654 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +||++|..++......     .....+......   .........+      .. ......+...+.++.+||.+||..+
T Consensus       202 ~el~~~~~~~~~~~~~-----~~~~~~~~~~~~---~~~~~~~~~~------~~-~~~~~~~~~~~~~~~~li~~cl~~~  266 (284)
T cd05081         202 YELFTYSDKSCSPPAE-----FMRMMGNDKQGQ---MIVYHLIELL------KN-NGRLPAPPGCPAEIYAIMKECWNND  266 (284)
T ss_pred             HHHhhcCCcCCCcchh-----hhhhcccccccc---cchHHHHHHH------hc-CCcCCCCCCCCHHHHHHHHHHccCC
Confidence            9999987765443211     011111110000   0000000000      00 0000011234567889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |++|||+.+++.
T Consensus       267 p~~Rpt~~ei~~  278 (284)
T cd05081         267 PSQRPSFSELAL  278 (284)
T ss_pred             hhhCCCHHHHHH
Confidence            999999999975

Protein Tyrosine Kinase (PTK) family; Janus kinase 2 (Jak2) and Jak3; catalytic (c) domain (repeat 2). The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak2 and Jak3 are members of the Janus kinase (Jak) subfamily of proteins, which are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal catalytic tyr kinase domain. Jaks are crucial for cytokine receptor signaling. They are activated by autophosphorylation upon cytokine-induced receptor aggregation, and subsequently trigger downstream signaling events such as th

>cd05110 PTKc_HER4 Catalytic domain of the Protein Tyrosine Kinase, HER4

Probab=99.97  E-value=6.2e-31  Score=251.33  Aligned_cols=208  Identities=19%  Similarity=0.297  Sum_probs=163.4

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+++.++||||+++++++...         ..++|+||++ ++|.+.+......+++..+..++.|++.||.||
T Consensus        55 ~~~~e~~~~~~l~h~niv~~~~~~~~~---------~~~~v~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~qi~~~L~~L  125 (303)
T cd05110          55 EFMDEALIMASMDHPHLVRLLGVCLSP---------TIQLVTQLMPHGCLLDYVHEHKDNIGSQLLLNWCVQIAKGMMYL  125 (303)
T ss_pred             HHHHHHHHHHhCCCCCcccEEEEEcCC---------CceeeehhcCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            578899999999999999999988643         2579999997 578888876655689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+|+||||+||+++.++.+||+|||++.........  .......++..|+|||.+.+.. ++.++|||||||++|
T Consensus       126 H~~~ivH~dikp~Nill~~~~~~kL~Dfg~~~~~~~~~~~--~~~~~~~~~~~y~~PE~~~~~~-~~~~~DiwslG~~l~  202 (303)
T cd05110         126 EERRLVHRDLAARNVLVKSPNHVKITDFGLARLLEGDEKE--YNADGGKMPIKWMALECIHYRK-FTHQSDVWSYGVTIW  202 (303)
T ss_pred             hhcCeeccccccceeeecCCCceEEccccccccccCcccc--cccCCCccccccCCHHHhccCC-CChHHHHHHHHHHHH
Confidence            9999999999999999999999999999999876432211  1122234567899999987655 799999999999999


Q ss_pred             HHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++ |..||.+.........+.. ....+.                              +...+..+.+++.+|+..+
T Consensus       203 el~t~g~~p~~~~~~~~~~~~~~~-~~~~~~------------------------------~~~~~~~~~~li~~c~~~~  251 (303)
T cd05110         203 ELMTFGGKPYDGIPTREIPDLLEK-GERLPQ------------------------------PPICTIDVYMVMVKCWMID  251 (303)
T ss_pred             HHHhCCCCCCCCCCHHHHHHHHHC-CCCCCC------------------------------CCCCCHHHHHHHHHHcCCC
Confidence            9997 8899987665443332221 000000                              0113445679999999999


Q ss_pred             CCCCCCHHHhhcC
Q psy7889         247 PSKRFDSDAALNH  259 (433)
Q Consensus       247 P~~R~t~~e~L~h  259 (433)
                      |.+||++.+++..
T Consensus       252 p~~Rp~~~~l~~~  264 (303)
T cd05110         252 ADSRPKFKELAAE  264 (303)
T ss_pred             hhhCcCHHHHHHH
Confidence            9999999999863

Protein Tyrosine Kinase (PTK) family; HER4 (ErbB4); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. HER4 is a member of the EGFR (HER, ErbB) subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular EGF-related ligand-binding region, a transmembrane helix, and a cytoplasmic region with a tyr kinase domain and a regulatory C-terminal tail. Unlike other tyr kinases, phosphorylation of the activation loop of EGFR proteins is not critical to their activation. Instead, they are activated by ligand-induced dimerization, leading to the phosphorylation of tyr residues in the C-terminal tail, which serve as bindin

>cd05103 PTKc_VEGFR2 Catalytic domain of the Protein Tyrosine Kinase, Vascular Endothelial Growth Factor Receptor 2

Probab=99.97  E-value=7.3e-31  Score=255.26  Aligned_cols=212  Identities=23%  Similarity=0.397  Sum_probs=160.1

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      ..+++|+.+|+++ +|||||++++++...       ...+++|||||+ ++|.+++....                    
T Consensus        55 ~~~~~E~~~l~~l~~h~niv~~~~~~~~~-------~~~~~lv~ey~~~g~L~~~i~~~~~~~~~~~~~~~~~~~~~~~~  127 (343)
T cd05103          55 RALMSELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEFCKFGNLSNYLRSKRGEFVPYKTKDARFRQGKSGY  127 (343)
T ss_pred             HHHHHHHHHHHhccCCccHhhhcceeecC-------CCceEEEEeccCCCcHHHHHHhcCCccccccccccccccccccc
Confidence            3577899999999 689999999988654       245899999997 47877775421                    


Q ss_pred             ----------------------------------------------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCC
Q psy7889          66 ----------------------------------------------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA   99 (433)
Q Consensus        66 ----------------------------------------------~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp   99 (433)
                                                                    ..++...+..++.|++.||+|||++||+||||||
T Consensus       128 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~qi~~al~~lH~~~i~H~dikp  207 (343)
T cd05103         128 GDISEDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAEQEDLYKKVLTLEDLICYSFQVAKGMEFLASRKCIHRDLAA  207 (343)
T ss_pred             cchhhhhhhhccccccccccccccccCCCccccchhhhhhhhhhhhccCCHHHHHHHHHHHHHHHHHHHhCCeecCCCcc
Confidence                                                          1357778889999999999999999999999999


Q ss_pred             CcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCC
Q psy7889         100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQG  178 (433)
Q Consensus       100 ~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~  178 (433)
                      +||+++.++.+||+|||++........  ........++..|+|||++.+.. ++.++||||+||++++|++ |..||.+
T Consensus       208 ~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l~el~~~g~~p~~~  284 (343)
T cd05103         208 RNILLSENNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPG  284 (343)
T ss_pred             CeEEEcCCCcEEEEecccccccccCcc--hhhcCCCCCCcceECcHHhcCCC-CCchhhHHHHHHHHHHHHHCCCCCCCC
Confidence            999999999999999999876532211  11112233466799999987654 7999999999999999997 8999876


Q ss_pred             CChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       179 ~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ............ .+...                             ..+...++.+.+++.+||..||.+|||+.++++
T Consensus       285 ~~~~~~~~~~~~-~~~~~-----------------------------~~~~~~~~~~~~~~~~cl~~~p~~Rps~~eil~  334 (343)
T cd05103         285 VKIDEEFCRRLK-EGTRM-----------------------------RAPDYTTPEMYQTMLDCWHGEPSQRPTFSELVE  334 (343)
T ss_pred             ccccHHHHHHHh-ccCCC-----------------------------CCCCCCCHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            543322211111 01000                             001123456779999999999999999999997


Q ss_pred             C
Q psy7889         259 H  259 (433)
Q Consensus       259 h  259 (433)
                      |
T Consensus       335 ~  335 (343)
T cd05103         335 H  335 (343)
T ss_pred             H
Confidence            5

Protein Tyrosine Kinase (PTK) family; Vascular Endothelial Growth Factor Receptor 2 (VEGFR2); catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. VEGFR2 (or Flk1) is a member of the VEGFR subfamily of proteins, which are receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with seven immunoglobulin (Ig)-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding of VEGFRs to their ligands, the VEGFs, leads to receptor dimerization, activation, and intracellular signaling. The carboxyl terminus of VEGFR2 plays an important role in its autophosp

>KOG1167|consensus

Probab=99.97  E-value=4.8e-32  Score=252.55  Aligned_cols=250  Identities=28%  Similarity=0.409  Sum_probs=181.7

Q ss_pred             CCchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+..+..|+++|..+ .+.||+++.+++...        +...+||||++.+-...+..   .++..+++.+++.++.|
T Consensus        76 s~p~ri~~El~~L~~~gG~~ni~~~~~~~rnn--------d~v~ivlp~~~H~~f~~l~~---~l~~~~i~~Yl~~ll~A  144 (418)
T KOG1167|consen   76 SSPSRILNELEMLYRLGGSDNIIKLNGCFRNN--------DQVAIVLPYFEHDRFRDLYR---SLSLAEIRWYLRNLLKA  144 (418)
T ss_pred             cCchHHHHHHHHHHHhccchhhhcchhhhccC--------CeeEEEecccCccCHHHHHh---cCCHHHHHHHHHHHHHH
Confidence            3578899999999999 599999999988764        78999999999743333332   46789999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCc-------------------------------------
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTK-------------------------------------  125 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~-------------------------------------  125 (433)
                      |.++|.+|||||||||+|+|.+. .+.-.|+|||+|.......                                     
T Consensus       145 l~~~h~~GIvHRDiKpsNFL~n~~t~rg~LvDFgLA~~~d~~~~~~~s~~~~~~~~~~~~g~~~~~~~~~~~~~p~g~~~  224 (418)
T KOG1167|consen  145 LAHLHKNGIVHRDIKPSNFLYNRRTQRGVLVDFGLAQRYDGYQQTEHSRSYSGRHATPAMGKDVHCQSVATASKPAGYYR  224 (418)
T ss_pred             hhhhhccCccccCCCccccccccccCCceEEechhHHHHHhhhhhhhhhhhhcccCCccccCcccccccccccCCCCcee
Confidence            99999999999999999999984 5678999999997322100                                     


Q ss_pred             ---CCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCC-CCCCChHHHHHHHHHHhCCCCCCCCC
Q psy7889         126 ---NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITLISQLCGSITPESWP  201 (433)
Q Consensus       126 ---~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~  201 (433)
                         ...........||+.|+|||++.....-++++||||.|||+..++++..| |...++.+.+.+|..+.|........
T Consensus       225 ~~~~~r~~~~anrAGT~GfRaPEvL~k~~~QttaiDiws~GVI~Lslls~~~PFf~a~dd~~al~ei~tifG~~~mrk~A  304 (418)
T KOG1167|consen  225 RCNDGRPSERANRAGTPGFRAPEVLFRCPRQTTAIDIWSAGVILLSLLSRRYPFFKAKDDADALAEIATIFGSAEMRKCA  304 (418)
T ss_pred             ccCCCccceecccCCCCCCCchHHHhhccCcCCccceeeccceeehhhccccccccCccccchHHHHHHHhChHHHHHHh
Confidence               00000112357899999999998887789999999999999999998655 56778888888888877764322211


Q ss_pred             cccch--hhh-hccccchHHHhh----------------HHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         202 GVETL--DLY-NKMELPKAQKRK----------------VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       202 ~~~~~--~~~-~~~~~~~~~~~~----------------~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      .....  .+. .++.........                ..........+..+.||+++||..||.+|+||+++|.||||
T Consensus       305 ~l~g~~~l~~ksn~~~~~e~~~~f~s~~~~~~~~~~q~n~~~~~~~d~~~~~~~dlLdk~le~np~kRitAEeALkHpFF  384 (418)
T KOG1167|consen  305 ALPGRILLWQKSNIPTIPELRVNFETLHIESIYKSRQPNTEREIGSDVFPALLLDLLDKCLELNPQKRITAEDALKHPFF  384 (418)
T ss_pred             hcCCceeeeccccccccHHHHhchhccChhhcccccccceeeccccccccHHHHHHHHHHccCChhhcccHHHHhcCcCC
Confidence            11111  000 000000000000                01111112345678999999999999999999999999999


Q ss_pred             cCC
Q psy7889         263 WTD  265 (433)
Q Consensus       263 ~~~  265 (433)
                      ...
T Consensus       385 ~~~  387 (418)
T KOG1167|consen  385 DEA  387 (418)
T ss_pred             cch
Confidence            743

>KOG0695|consensus

Probab=99.97  E-value=1.4e-31  Score=241.97  Aligned_cols=258  Identities=21%  Similarity=0.338  Sum_probs=193.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..++.|..+..+. +||.+|.|+.+|+++        ..+++|.||++|+-+-+-.+.+.+++++.++.+..+|+.||.|
T Consensus       295 dwvqtek~vfe~asn~pflvglhscfqte--------srlffvieyv~ggdlmfhmqrqrklpeeharfys~ei~lal~f  366 (593)
T KOG0695|consen  295 DWVQTEKHVFEQASNNPFLVGLHSCFQTE--------SRLFFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEICLALNF  366 (593)
T ss_pred             hhHHhhHHHHHhccCCCeEEehhhhhccc--------ceEEEEEEEecCcceeeehhhhhcCcHHHhhhhhHHHHHHHHH
Confidence            4577888888877 799999999999986        7799999999864333334445579999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||++||+|.+|||++..|++||+|+|.++.--...    ...+++|||+.|+|||++.+.. |++++|+|+|||++
T Consensus       367 lh~rgiiyrdlkldnvlldaeghikltdygmcke~l~~g----d~tstfcgtpnyiapeilrgee-ygfsvdwwalgvlm  441 (593)
T KOG0695|consen  367 LHERGIIYRDLKLDNVLLDAEGHIKLTDYGMCKEGLGPG----DTTSTFCGTPNYIAPEILRGEE-YGFSVDWWALGVLM  441 (593)
T ss_pred             HhhcCeeeeeccccceEEccCCceeecccchhhcCCCCC----cccccccCCCcccchhhhcccc-cCceehHHHHHHHH
Confidence            999999999999999999999999999999997643322    3456889999999999999876 89999999999999


Q ss_pred             HHHHhcCCCCCC----CCh---HHHHHHHHH----------------------------HhCCCCCCCCCcccchhhhhc
Q psy7889         167 AEMWTRSPIMQG----NTE---QQQITLISQ----------------------------LCGSITPESWPGVETLDLYNK  211 (433)
Q Consensus       167 ~ell~g~~pf~~----~~~---~~~~~~i~~----------------------------~~g~~~~~~~~~~~~~~~~~~  211 (433)
                      +||+.|+.||.-    +.+   ++.+.++.-                            .+|-.+...+..+..+.++..
T Consensus       442 femmagrspfdivgm~n~d~ntedylfqvilekqiriprslsvkas~vlkgflnkdp~erlgc~~~~g~~dik~h~ffr~  521 (593)
T KOG0695|consen  442 FEMMAGRSPFDIVGMDNPDMNTEDYLFQVILEKQIRIPRSLSVKASHVLKGFLNKDPKERLGCRPQTGFSDIKSHAFFRS  521 (593)
T ss_pred             HHHHcCCCCcceecCCCcccchhHHHHHHHhhhcccccceeehhhHHHHHHhhcCCcHHhcCCCcccchhhhhcchhhhh
Confidence            999999999962    122   222222110                            011112234455566666666


Q ss_pred             cccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCCCCchhHHHHhhhccccccccCCCCC
Q psy7889         212 MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRR  291 (433)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (433)
                      +++.....+.+...+.|.+.+..+.+-.+.-+.-.+              .+-.|+.......+.|.+...|+|.+|...
T Consensus       522 idwd~leqk~v~ppf~p~i~~d~~l~~fd~qft~e~--------------~qltpdd~d~i~ridqsefegfeyinpl~m  587 (593)
T KOG0695|consen  522 IDWDLLEQKQVLPPFQPQITDDYGLDNFDTQFTSEP--------------VQLTPDDEDAIKRIDQSEFEGFEYINPLLM  587 (593)
T ss_pred             CCHHHHhhcccCCCCCCccccccCccccccccccCC--------------cccCCCCHHHHHhcchhhcCcceecchhhc
Confidence            777666666666666666666555544443333322              234566677778889999999999998754


Q ss_pred             C
Q psy7889         292 P  292 (433)
Q Consensus       292 ~  292 (433)
                      .
T Consensus       588 s  588 (593)
T KOG0695|consen  588 S  588 (593)
T ss_pred             c
Confidence            3

>KOG0193|consensus

Probab=99.97  E-value=4.1e-32  Score=262.65  Aligned_cols=212  Identities=21%  Similarity=0.295  Sum_probs=169.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.|.+|+.++++-+|.||+-+.+++..+         .+.||+-+|+| +|+..+.-...+|..-..+.|++||++|+.|
T Consensus       433 qaFKnEVa~lkkTRH~NIlLFMG~~~~p---------~~AIiTqwCeGsSLY~hlHv~etkfdm~~~idIAqQiaqGM~Y  503 (678)
T KOG0193|consen  433 QAFKNEVAVLKKTRHENILLFMGACMNP---------PLAIITQWCEGSSLYTHLHVQETKFDMNTTIDIAQQIAQGMDY  503 (678)
T ss_pred             HHHHHHHHHHhhcchhhheeeehhhcCC---------ceeeeehhccCchhhhhccchhhhhhHHHHHHHHHHHHHhhhh
Confidence            5789999999999999999999999865         24999999997 7888887777789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv  164 (433)
                      ||.++|||||||..||++.+++.|||+|||++..-..-  ..........|...|+|||++...  -.|++.+||||+||
T Consensus       504 LHAK~IIHrDLKSnNIFl~~~~kVkIgDFGLatvk~~w--~g~~q~~qp~gsilwmAPEvIRmqd~nPfS~qSDVYaFGi  581 (678)
T KOG0193|consen  504 LHAKNIIHRDLKSNNIFLHEDLKVKIGDFGLATVKTRW--SGEQQLEQPHGSLLWMAPEVIRMQDDNPFSFQSDVYAFGI  581 (678)
T ss_pred             hhhhhhhhhhccccceEEccCCcEEEecccceeeeeee--ccccccCCCccchhhhcHHHHhhcccCCCCcccchhhhhH
Confidence            99999999999999999999999999999999653221  111234455678899999999643  24899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc-CChhHHHHHHhhc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV-KDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~s~~~~~li~~~L  243 (433)
                      |+|||++|..||........+..+-+..+.+..                            .+... -..+.++|+..|+
T Consensus       582 V~YELltg~lPysi~~~dqIifmVGrG~l~pd~----------------------------s~~~s~~pk~mk~Ll~~C~  633 (678)
T KOG0193|consen  582 VWYELLTGELPYSIQNRDQIIFMVGRGYLMPDL----------------------------SKIRSNCPKAMKRLLSDCW  633 (678)
T ss_pred             HHHHHHhCcCCcCCCChhheEEEecccccCccc----------------------------hhhhccCHHHHHHHHHHHH
Confidence            999999999999965554444333222211110                            01111 1246779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      .+++++||+..++|.
T Consensus       634 ~~~~~eRP~F~~il~  648 (678)
T KOG0193|consen  634 KFDREERPLFPQLLS  648 (678)
T ss_pred             hcCcccCccHHHHHH
Confidence            999999999999985

>KOG1026|consensus

Probab=99.97  E-value=2e-31  Score=268.22  Aligned_cols=208  Identities=24%  Similarity=0.410  Sum_probs=172.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC-------------CCCHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV-------------KFSLGE   72 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~-------------~l~~~~   72 (433)
                      .+.|.||+++|..|+|||||+|+++|..+        +-+|+|+|||. |||.+++.....             .++..+
T Consensus       533 ~~dF~REaeLla~l~H~nIVrLlGVC~~~--------~P~~MvFEYm~~GDL~eFLra~sP~a~~~~~g~~~~~~L~~~q  604 (774)
T KOG1026|consen  533 RQDFRREAELLAELQHPNIVRLLGVCREG--------DPLCMVFEYMDHGDLHEFLRARSPKADKLASGQDTPPPLSTSQ  604 (774)
T ss_pred             HHHHHHHHHHHHhccCCCeEEEEEEEccC--------CeeEEEEEecccccHHHHHHhhCCccccccCCCCCCCCCCHHH
Confidence            35799999999999999999999999987        44999999997 799999976421             278889


Q ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcccccc-CCcccccccCcccccCCC
Q psy7889          73 IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT-NRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        73 ~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~  151 (433)
                      ...|+.||+.|++||-++.+|||||-..|+||+.+-.|||+|||+++..-..   .+.+.. ...-...|||||.|...+
T Consensus       605 ~L~iA~QIAaGM~YLs~~~FVHRDLATRNCLVge~l~VKIsDfGLsRdiYss---DYYk~~~~t~lPIRWMppEsIly~k  681 (774)
T KOG1026|consen  605 FLHIATQIAAGMEYLSSHHFVHRDLATRNCLVGENLVVKISDFGLSRDIYSS---DYYKVRGNTLLPIRWMPPESILYGK  681 (774)
T ss_pred             HHHHHHHHHHHHHHHHhCcccccchhhhhceeccceEEEecccccchhhhhh---hhhcccCCceeeeecCCHHHhhcCc
Confidence            9999999999999999999999999999999999999999999999765422   111111 112255799999999877


Q ss_pred             CCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       |++++||||+||++||+++ |.-|+.|.+..+.+..|...---.-++                               .
T Consensus       682 -FTteSDVWs~GVvLWEIFsyG~QPy~glSn~EVIe~i~~g~lL~~Pe-------------------------------~  729 (774)
T KOG1026|consen  682 -FTTESDVWSFGVVLWEIFSYGKQPYYGLSNQEVIECIRAGQLLSCPE-------------------------------N  729 (774)
T ss_pred             -ccchhhhhhhhhhhhhhhccccCcccccchHHHHHHHHcCCcccCCC-------------------------------C
Confidence             8999999999999999998 899999999999998886522211111                               2


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhh
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L  257 (433)
                      -+.+..+|+..|++.+|++||+.+|+-
T Consensus       730 CP~~vY~LM~~CW~~~P~~RPsF~eI~  756 (774)
T KOG1026|consen  730 CPTEVYSLMLECWNENPKRRPSFKEIH  756 (774)
T ss_pred             CCHHHHHHHHHHhhcCcccCCCHHHHH
Confidence            345556999999999999999999884

>KOG1187|consensus

Probab=99.97  E-value=3.9e-31  Score=255.77  Aligned_cols=160  Identities=26%  Similarity=0.400  Sum_probs=136.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCc-eEEEEeecCc-CCHHHHHhccCC-CCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRS-TFYLVFDFCE-HDLAGLLSNIHV-KFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~-~~~lV~e~~~-~~L~~~l~~~~~-~l~~~~~~~i~~qll~a   83 (433)
                      ..++.+||++|.+++|||+|+|+++|.+.        + +.+||+||+. |+|.+.+..... .+++.....|+.++++|
T Consensus       115 ~~eF~~Ei~~ls~l~H~Nlv~LlGyC~e~--------~~~~~LVYEym~nGsL~d~L~~~~~~~L~W~~R~kIa~g~A~g  186 (361)
T KOG1187|consen  115 EREFLNEVEILSRLRHPNLVKLLGYCLEG--------GEHRLLVYEYMPNGSLEDHLHGKKGEPLDWETRLKIALGAARG  186 (361)
T ss_pred             hhHHHHHHHHHhcCCCcCcccEEEEEecC--------CceEEEEEEccCCCCHHHHhCCCCCCCCCHHHHHHHHHHHHHH
Confidence            35699999999999999999999999876        3 5899999998 588888877655 78999999999999999


Q ss_pred             HHHHHhCC---eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCC-cccccccCcccccCCCCCCCcchh
Q psy7889          84 LYYIHSNK---ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNR-VVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~~~---iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |+|||+..   |+||||||+|||+|.+...||+|||+|+..... .   ...... .||..|+|||.+.... .+.++||
T Consensus       187 L~yLH~~~~~~iiHrDiKssNILLD~~~~aKlsDFGLa~~~~~~-~---~~~~~~~~gt~gY~~PEy~~~g~-lt~KsDV  261 (361)
T KOG1187|consen  187 LAYLHEGCPPPIIHRDIKSSNILLDEDFNAKLSDFGLAKLGPEG-D---TSVSTTVMGTFGYLAPEYASTGK-LTEKSDV  261 (361)
T ss_pred             HHHHccCCCCCEecCCCCHHHeeECCCCCEEccCccCcccCCcc-c---cceeeecCCCCccCChhhhccCC-cCccccc
Confidence            99999754   999999999999999999999999999654321 1   111222 7899999999987644 6999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCC
Q psy7889         160 WGAGCIMAEMWTRSPIMQGN  179 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~  179 (433)
                      ||+||+++||++|+.+....
T Consensus       262 ySFGVvllElitgr~~~d~~  281 (361)
T KOG1187|consen  262 YSFGVVLLELITGRKAVDQS  281 (361)
T ss_pred             ccchHHHHHHHhCCcccCCC
Confidence            99999999999999877643

>cd05610 STKc_MASTL Catalytic domain of the Protein Serine/Threonine Kinase, Microtubule-associated serine/threonine-like kinase

Probab=99.97  E-value=1.3e-30  Score=273.34  Aligned_cols=103  Identities=33%  Similarity=0.480  Sum_probs=93.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        ..+||||||+. ++|..++... ..+++..++.++.||+.||+|
T Consensus        49 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--------~~~~lVmEy~~g~~L~~li~~~-~~l~~~~~~~i~~qil~aL~y  119 (669)
T cd05610          49 HQVQAERDALALSKSPFIVHLYYSLQSA--------NNVYLVMEYLIGGDVKSLLHIY-GYFDEEMAVKYISEVALALDY  119 (669)
T ss_pred             HHHHHHHHHHHhcCCCCcCeEEEEEEEC--------CEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            5688899999999999999999998875        66999999996 5788877653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      ||++||+||||||+|||++.++.+||+|||+++
T Consensus       120 LH~~gIiHrDLKP~NILl~~~g~vkL~DFGls~  152 (669)
T cd05610         120 LHRHGIIHRDLKPDNMLISNEGHIKLTDFGLSK  152 (669)
T ss_pred             HHhCCEEeCCccHHHEEEcCCCCEEEEeCCCCc
Confidence            999999999999999999999999999999985

Serine/Threonine Kinases (STKs), Microtubule-associated serine/threonine (MAST) kinase subfamily, MAST-like (MASTL) kinases, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The MAST kinase subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. MAST kinases contain an N-terminal domain of unknown function, a central catalytic domain, and a C-terminal PDZ domain that mediates protein-protein interactions. The MASTL kinases in this group carry only a catalytic domain, which contains a long insertion relative to MAST kinases. The human MASTL gene has also been labelled FLJ14813. A missense mutation in FLJ1481

>cd08528 STKc_Nek10 Catalytic domain of the Protein Serine/Threonine Kinase, Never In Mitosis gene A-related kinase 10

Probab=99.97  E-value=2.2e-30  Score=242.99  Aligned_cols=208  Identities=24%  Similarity=0.395  Sum_probs=165.3

Q ss_pred             hhHHHHHHHHHh-CCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQL-LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         8 ~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~   82 (433)
                      ..+.+|+.++.+ ++||||+++++++...        +..++||||+.+ +|.+++..   ....+++..++.++.|++.
T Consensus        53 ~~~~~e~~~l~~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~~~~l~~  124 (269)
T cd08528          53 GDIVSEVTIIKEQLRHPNIVRYYKTFLEN--------DRLYIVMDLIEGAPLGEHFNSLKEKKQRFTEERIWNIFVQMVL  124 (269)
T ss_pred             HHHHHHHHHHhhcCCCCCeeeEEeeEccC--------CeEEEEEecCCCCcHHHHHHHHHhccCCCCHHHHHHHHHHHHH
Confidence            346778888875 6999999999999875        669999999975 77766633   3446899999999999999


Q ss_pred             HHHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          83 GLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        83 aL~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      ||.|||+ .|++|+||+|+||+++.++.++|+|||++.......     ......++..|+|||.+.+.. ++.++|+||
T Consensus       125 ~l~~lh~~~~i~H~dl~~~nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~~~~Pe~~~~~~-~~~~~Dv~s  198 (269)
T cd08528         125 ALRYLHKEKRIVHRDLTPNNIMLGEDDKVTITDFGLAKQKQPES-----KLTSVVGTILYSCPEIVKNEP-YGEKADVWA  198 (269)
T ss_pred             HHHHhccCCceeecCCCHHHEEECCCCcEEEecccceeeccccc-----ccccccCcccCcChhhhcCCC-CchHHHHHH
Confidence            9999996 789999999999999999999999999997754322     233456788999999998755 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||...........+......+.                              .....+..+.++|.+
T Consensus       199 lG~ll~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~  248 (269)
T cd08528         199 FGCILYQMCTLQPPFYSTNMLSLATKIVEAVYEPL------------------------------PEGMYSEDVTDVITS  248 (269)
T ss_pred             HHHHHHHHHhCCCcccccCHHHHHHHHhhccCCcC------------------------------CcccCCHHHHHHHHH
Confidence            99999999999999987665544443332111100                              001245677799999


Q ss_pred             hcccCCCCCCCHHHhhcC
Q psy7889         242 LLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h  259 (433)
                      ||+.||++||++.|+..+
T Consensus       249 cl~~~p~~Rp~~~e~~~~  266 (269)
T cd08528         249 CLTPDAEARPDIIQVSAM  266 (269)
T ss_pred             HCCCCCccCCCHHHHHHH
Confidence            999999999999998753

Serine/Threonine Kinases (STKs), Never In Mitosis gene A (NIMA)-related kinase 10 (Nek10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The Nek10 subfamily is one of a family of 11 different Neks (Nek1-11) that are involved in cell cycle control. The Nek family is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. No function has yet been ascribed to Nek10. The gene encoding Nek10 is a putative causative gene for breast cancer; it is located within a breast cancer susceptibility loci on chromosome 3p24.

>KOG1006|consensus

Probab=99.97  E-value=2.3e-32  Score=240.00  Aligned_cols=218  Identities=18%  Similarity=0.234  Sum_probs=171.2

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc----cCCCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN----IHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~----~~~~l~~~~~~~i~~qll   81 (433)
                      ..+++.|.+...+- ++||||++|++.-.+        +..+|.||.|.-++-.+.+.    .+..++|.-+..|....+
T Consensus       106 q~rll~e~d~~mks~~cp~IVkfyGa~F~E--------GdcWiCMELMd~SlDklYk~vy~vq~~~ipE~Ilg~ItvatV  177 (361)
T KOG1006|consen  106 QKRLLMEHDTVMKSSNCPNIVKFYGALFSE--------GDCWICMELMDISLDKLYKRVYSVQKSRIPENILGHITVATV  177 (361)
T ss_pred             HHHHHHHHHHHHhhcCCcHHHHHhhhhhcC--------CceeeeHHHHhhhHHHHHHHHHHHHhccCcHhhhhheeeeeh
Confidence            35677888766655 799999999998776        55899999999765444322    244689999999999999


Q ss_pred             HHHHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchh
Q psy7889          82 NGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDL  159 (433)
Q Consensus        82 ~aL~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~Di  159 (433)
                      .||.||.+ ..||||||||+|||++..|.+||||||++..+..+-     ..+...|...|+|||.+-... .|+.++|+
T Consensus       178 ~AL~yLK~~lkiIHRDvKPSNILldr~G~vKLCDFGIcGqLv~Si-----AkT~daGCrpYmAPERi~p~~~gyDiRSDv  252 (361)
T KOG1006|consen  178 DALDYLKEELKIIHRDVKPSNILLDRHGDVKLCDFGICGQLVDSI-----AKTVDAGCRPYMAPERIDPSDKGYDIRSDV  252 (361)
T ss_pred             hHHHHHHHHhhhhhccCChhheEEecCCCEeeecccchHhHHHHH-----HhhhccCCccccChhccCCccCCcchhhhh
Confidence            99999995 689999999999999999999999999997775432     223346788899999986544 38999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh-CCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLC-GSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~-g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||||++++|+++|..|+.+.+.  ...++.++. |.++.- ...                       .....++..++.|
T Consensus       253 WSLGITL~EvAtG~fPyr~w~s--vfeql~~Vv~gdpp~l-~~~-----------------------~~~~~~s~~~~~f  306 (361)
T KOG1006|consen  253 WSLGITLYEVATGNFPYRKWDS--VFEQLCQVVIGDPPIL-LFD-----------------------KECVHYSFSMVRF  306 (361)
T ss_pred             hhhcceEeeeecCCCCcchHHH--HHHHHHHHHcCCCCee-cCc-----------------------ccccccCHHHHHH
Confidence            9999999999999999998765  344444433 332211 100                       0113367788899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      |.-||.+|-+.||...+++.+||+.
T Consensus       307 intCl~Kd~~~Rpky~~Lk~~~fyr  331 (361)
T KOG1006|consen  307 INTCLIKDRSDRPKYDDLKKFPFYR  331 (361)
T ss_pred             HHHHhhcccccCcchhhhhcCchhh
Confidence            9999999999999999999999995

>cd05107 PTKc_PDGFR_beta Catalytic domain of the Protein Tyrosine Kinase, Platelet Derived Growth Factor Receptor beta

Probab=99.97  E-value=2.5e-30  Score=255.55  Aligned_cols=211  Identities=24%  Similarity=0.369  Sum_probs=163.7

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------------
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------------   65 (433)
                      +.+++|+.+|.++. |||||++++++...        +.+|+|||||. ++|.+++....                    
T Consensus        85 ~~~~~E~~~l~~l~~H~niv~~~~~~~~~--------~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  156 (401)
T cd05107          85 QALMSELKIMSHLGPHLNIVNLLGACTKG--------GPIYIITEYCRYGDLVDYLHRNKHTFLQYYLDKNRDDGSLISG  156 (401)
T ss_pred             HHHHHHHHHHHhcCCCCCeEEEEEEEccC--------CCcEEEEeccCCCcHHHHHHhccccchhhhccccccccccccc
Confidence            46889999999997 99999999999775        56899999997 58888875421                    


Q ss_pred             -----------------------------------------------------------------------------CCC
Q psy7889          66 -----------------------------------------------------------------------------VKF   68 (433)
Q Consensus        66 -----------------------------------------------------------------------------~~l   68 (433)
                                                                                                   ..+
T Consensus       157 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  236 (401)
T cd05107         157 GSTPLSQRKSHVSLGSESDGGYMDMSKDESADYVPMQDMKGTVKYADIESSNYESPYDQYLPSAPERTRRDTLINESPAL  236 (401)
T ss_pred             ccccccccccchhhhhccCccccccCCccccCccchhcchhhhhhhhhhccCcCCchhhhhcccCCCcchhhhhcCCCCC
Confidence                                                                                         125


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc
Q psy7889          69 SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL  148 (433)
Q Consensus        69 ~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (433)
                      +...+..++.||+.||+|||+.||+||||||+|||++.++.+||+|||+++........  .......++..|+|||.+.
T Consensus       237 ~~~~~~~~~~qi~~aL~~LH~~~ivHrdlkp~NiLl~~~~~~kL~DfGla~~~~~~~~~--~~~~~~~~~~~y~aPE~~~  314 (401)
T cd05107         237 SYMDLVGFSYQVANGMEFLASKNCVHRDLAARNVLICEGKLVKICDFGLARDIMRDSNY--ISKGSTFLPLKWMAPESIF  314 (401)
T ss_pred             CHHHHHHHHHHHHHHHHHHhcCCcCcccCCcceEEEeCCCEEEEEecCcceeccccccc--ccCCCcCCCCceeChHHhc
Confidence            66778899999999999999999999999999999999999999999999765322111  1112335678899999987


Q ss_pred             CCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhC
Q psy7889         149 GDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK  227 (433)
Q Consensus       149 ~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (433)
                      +.. ++.++||||+||+++||++ |..||......+.......  +.....                            .
T Consensus       315 ~~~-~~~~~DvwslGvil~e~l~~g~~P~~~~~~~~~~~~~~~--~~~~~~----------------------------~  363 (401)
T cd05107         315 NNL-YTTLSDVWSFGILLWEIFTLGGTPYPELPMNEQFYNAIK--RGYRMA----------------------------K  363 (401)
T ss_pred             CCC-CCcHhHHHHHHHHHHHHHHcCCCCCCCCCchHHHHHHHH--cCCCCC----------------------------C
Confidence            655 7899999999999999998 8889877654443322211  110000                            0


Q ss_pred             CccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         228 PYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       228 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +...+.++.+|+.+|+..+|.+||++.++++.
T Consensus       364 p~~~~~~l~~li~~cl~~~P~~RPs~~ell~~  395 (401)
T cd05107         364 PAHASDEIYEIMQKCWEEKFEIRPDFSQLVHL  395 (401)
T ss_pred             CCCCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            11245677899999999999999999999863

Protein Tyrosine Kinase (PTK) family; Platelet Derived Growth Factor Receptor (PDGFR) beta; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. PDGFR beta is a receptor tyr kinase (RTK) containing an extracellular ligand-binding region with five immunoglobulin-like domains, a transmembrane segment, and an intracellular catalytic domain. The binding to its ligands, the PDGFs, leads to receptor dimerization, trans phosphorylation and activation, and intracellular signaling. PDGFR beta forms homodimers or heterodimers with PDGFR alpha, depending on the nature of the PDGF ligand. PDGF-BB and PDGF-D

>PHA02882 putative serine/threonine kinase; Provisional

Probab=99.97  E-value=3.6e-30  Score=245.03  Aligned_cols=214  Identities=16%  Similarity=0.178  Sum_probs=157.2

Q ss_pred             HHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe
Q psy7889          13 EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKI   92 (433)
Q Consensus        13 Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~i   92 (433)
                      +...+..++|+||++++++.......    ....+++++++..++...+... ...++..++.++.|++.||+|||+.||
T Consensus        73 ~~~~~~~~~h~~i~~~~~~~~~~~~~----~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~i~~qi~~~l~~lH~~~i  147 (294)
T PHA02882         73 LWKNIHNIDHLGIPKYYGCGSFKRCR----MYYRFILLEKLVENTKEIFKRI-KCKNKKLIKNIMKDMLTTLEYIHEHGI  147 (294)
T ss_pred             HHHHhccCCCCCCCcEEEeeeEecCC----ceEEEEEEehhccCHHHHHHhh-ccCCHHHHHHHHHHHHHHHHHHHhCCe
Confidence            33445567899999999977654221    1245789999888877776653 346888999999999999999999999


Q ss_pred             eccCCCCCcEEEecCCcEEEeecCCccccccCcCCc---cccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHH
Q psy7889          93 LHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ---VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM  169 (433)
Q Consensus        93 iH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el  169 (433)
                      +||||||+|||++.++.++|+|||+++.+.......   ........||+.|+|||++.+.. ++.++||||+||++++|
T Consensus       148 iHrDiKp~Nill~~~~~~~l~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~y~ape~~~~~~-~~~~~DiwSlG~~l~el  226 (294)
T PHA02882        148 SHGDIKPENIMVDGNNRGYIIDYGIASHFIIHGKHIEYSKEQKDLHRGTLYYAGLDAHNGAC-VTRRGDLESLGYCMLKW  226 (294)
T ss_pred             ecCCCCHHHEEEcCCCcEEEEEcCCceeeccCCcccccccccccccCCCccccCHHHhCCCC-CCcHHHHHHHHHHHHHH
Confidence            999999999999999999999999997764321110   01122346899999999988765 79999999999999999


Q ss_pred             HhcCCCCCCCChHHHHHHHHH--HhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         170 WTRSPIMQGNTEQQQITLISQ--LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       170 l~g~~pf~~~~~~~~~~~i~~--~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      ++|.+||.+............  ....+..                          ........+.++.+++..|+..+|
T Consensus       227 ~~g~~P~~~~~~~~~~~~~~~~~~~~~~~~--------------------------~~~~~~~~~~~~~~~~~~~~~~~~  280 (294)
T PHA02882        227 AGIKLPWKGFGHNGNLIHAAKCDFIKRLHE--------------------------GKIKIKNANKFIYDFIECVTKLSY  280 (294)
T ss_pred             HhCCCCCCccccchHHHHHhHHHHHHHhhh--------------------------hhhccCCCCHHHHHHHHHHHhCCC
Confidence            999999987743322211111  1100000                          000111235677899999999999


Q ss_pred             CCCCCHHHhhc
Q psy7889         248 SKRFDSDAALN  258 (433)
Q Consensus       248 ~~R~t~~e~L~  258 (433)
                      ++||+.+++++
T Consensus       281 ~~rp~~~~l~~  291 (294)
T PHA02882        281 EEKPDYDALIK  291 (294)
T ss_pred             CCCCCHHHHHH
Confidence            99999999874

>KOG0194|consensus

Probab=99.97  E-value=4.5e-31  Score=257.38  Aligned_cols=207  Identities=22%  Similarity=0.335  Sum_probs=171.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|..+|+.++|||||++|++......        +|||||+|.| +|.+++.+....++..+...++.+.+.||+|
T Consensus       206 ~e~m~EArvMr~l~H~NVVr~yGVa~~~~P--------l~ivmEl~~gGsL~~~L~k~~~~v~~~ek~~~~~~AA~Gl~Y  277 (474)
T KOG0194|consen  206 KEFMKEARVMRQLNHPNVVRFYGVAVLEEP--------LMLVMELCNGGSLDDYLKKNKKSLPTLEKLRFCYDAARGLEY  277 (474)
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEcCCCc--------cEEEEEecCCCcHHHHHHhCCCCCCHHHHHHHHHHHHhHHHH
Confidence            468899999999999999999999998855        9999999985 8999999877779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcccccc-CCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT-NRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+++++||||-.+|+|++.++.+||+|||+++....-     .... ...-...|+|||.+... .|+.++||||+||+
T Consensus       278 Lh~k~~IHRDIAARNcL~~~~~~vKISDFGLs~~~~~~-----~~~~~~~klPirWLAPEtl~~~-~~s~kTDV~sfGV~  351 (474)
T KOG0194|consen  278 LHSKNCIHRDIAARNCLYSKKGVVKISDFGLSRAGSQY-----VMKKFLKKLPIRWLAPETLNTG-IFSFKTDVWSFGVL  351 (474)
T ss_pred             HHHCCCcchhHhHHHheecCCCeEEeCccccccCCcce-----eeccccccCcceecChhhhccC-ccccccchhheeee
Confidence            99999999999999999999999999999998764311     1111 11235679999999876 58999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +||+++ |..||.+....+....|...-...+..                              ...+.+...++.+|+.
T Consensus       352 ~~Eif~~g~~Py~g~~~~~v~~kI~~~~~r~~~~------------------------------~~~p~~~~~~~~~c~~  401 (474)
T KOG0194|consen  352 LWEIFENGAEPYPGMKNYEVKAKIVKNGYRMPIP------------------------------SKTPKELAKVMKQCWK  401 (474)
T ss_pred             EEeeeccCCCCCCCCCHHHHHHHHHhcCccCCCC------------------------------CCCHHHHHHHHHHhcc
Confidence            999998 788999999888877774322211111                              1133455588899999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .+|+.|+++.++.+
T Consensus       402 ~~p~~R~tm~~i~~  415 (474)
T KOG0194|consen  402 KDPEDRPTMSTIKK  415 (474)
T ss_pred             CChhhccCHHHHHH
Confidence            99999999998875

>cd05038 PTKc_Jak_rpt2 Catalytic (repeat 2) domain of the Protein Tyrosine Kinases, Janus kinases

Probab=99.97  E-value=3.2e-30  Score=243.53  Aligned_cols=228  Identities=21%  Similarity=0.346  Sum_probs=165.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++....      ....++||||++ ++|.+++......+++..+..++.||+.||+
T Consensus        50 ~~~~~~ei~~l~~l~~~~i~~~~~~~~~~~------~~~~~lv~e~~~~~~l~~~l~~~~~~~~~~~~~~~~~~l~~aL~  123 (284)
T cd05038          50 RSDFEREIEILRTLDHENIVKYKGVCEKPG------GRSLRLIMEYLPSGSLRDYLQRHRDQINLKRLLLFSSQICKGMD  123 (284)
T ss_pred             HHHHHHHHHHHHhCCCCChheEEeeeecCC------CCceEEEEecCCCCCHHHHHHhCccccCHHHHHHHHHHHHHHHH
Confidence            356889999999999999999999887642      256899999996 5898888776657899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.|++|+||||+||+++.++.++|+|||++......... ........++..|+|||.+.+.. ++.++|||||||+
T Consensus       124 ~lH~~~i~H~dl~p~nil~~~~~~~~l~dfg~~~~~~~~~~~-~~~~~~~~~~~~~~~Pe~~~~~~-~~~~~Di~slG~~  201 (284)
T cd05038         124 YLGSQRYIHRDLAARNILVESEDLVKISDFGLAKVLPEDKDY-YYVKEPGESPIFWYAPECLRTSK-FSSASDVWSFGVT  201 (284)
T ss_pred             HHHhCCeecCCCCHHhEEEcCCCCEEEcccccccccccCCcc-eeccCCCCCcccccCcHHHccCC-CCcccchHHHhhh
Confidence            999999999999999999999999999999999876532211 01111223456799999987654 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|..||........     ...+......+    .......+..       ......+...+.++.+++.+||..
T Consensus       202 l~el~tg~~p~~~~~~~~~-----~~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~~~li~~cl~~  265 (284)
T cd05038         202 LYELFTYGDPSQSPPAEFL-----RMIGIAQGQMI----VTRLLELLKE-------GERLPRPPSCPDEVYDLMKLCWEA  265 (284)
T ss_pred             hheeeccCCCcccccchhc-----ccccccccccc----HHHHHHHHHc-------CCcCCCCccCCHHHHHHHHHHhcc
Confidence            9999999988865432110     00110000000    0000000000       000000112346678999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      +|.+|||+.|+++
T Consensus       266 ~p~~Rpt~~ei~~  278 (284)
T cd05038         266 EPQDRPSFADLIL  278 (284)
T ss_pred             ChhhCCCHHHHHH
Confidence            9999999999985

Protein Tyrosine Kinase (PTK) family; Janus kinase (Jak) subfamily; catalytic (c) domain (repeat 2). The Jak subfamily is composed of Jak1, Jak2, Jak3, TYK2, and similar proteins. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Jak subfamily proteins are cytoplasmic (or nonreceptor) tyr kinases containing an N-terminal FERM domain, followed by a Src homology 2 (SH2) domain, a pseudokinase domain, and a C-terminal tyr kinase catalytic domain. Most Jaks are expressed in a wide variety of tissues, except for Jak3, which is expressed only in hematopoietic cells. Jaks are crucial for cytokine receptor signaling. They are activated by aut

>KOG4257|consensus

Probab=99.97  E-value=3.5e-31  Score=256.06  Aligned_cols=207  Identities=24%  Similarity=0.375  Sum_probs=173.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.++.|..+|+.++|||||+|++++.+.         -++||||.++ |.|..++......++......++.||+.||.
T Consensus       435 tekflqEa~iMrnfdHphIikLIGv~~e~---------P~WivmEL~~~GELr~yLq~nk~sL~l~tL~ly~~Qi~tala  505 (974)
T KOG4257|consen  435 TEKFLQEASIMRNFDHPHIIKLIGVCVEQ---------PMWIVMELAPLGELREYLQQNKDSLPLRTLTLYCYQICTALA  505 (974)
T ss_pred             HHHHHHHHHHHHhCCCcchhheeeeeecc---------ceeEEEecccchhHHHHHHhccccchHHHHHHHHHHHHHHHH
Confidence            56799999999999999999999999864         3799999997 7899999988888999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+.+.|||||-..|||+.....+||+|||+++.+....   +...+...-...|+|||.+.-.. ++.++|||.|||+
T Consensus       506 YLeSkrfVHRDIAaRNiLVsSp~CVKLaDFGLSR~~ed~~---yYkaS~~kLPIKWmaPESINfRr-FTtASDVWMFgVC  581 (974)
T KOG4257|consen  506 YLESKRFVHRDIAARNILVSSPQCVKLADFGLSRYLEDDA---YYKASRGKLPIKWMAPESINFRR-FTTASDVWMFGVC  581 (974)
T ss_pred             HHHhhchhhhhhhhhheeecCcceeeecccchhhhccccc---hhhccccccceeecCccccchhc-ccchhhHHHHHHH
Confidence            9999999999999999999999999999999999987532   22222223355799999986655 8999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +||++. |.-||.|-...+.+..|.+....+.++.++                               +.+..|+.+|+.
T Consensus       582 mWEIl~lGvkPfqgvkNsDVI~~iEnGeRlP~P~nCP-------------------------------p~LYslmskcWa  630 (974)
T KOG4257|consen  582 MWEILSLGVKPFQGVKNSDVIGHIENGERLPCPPNCP-------------------------------PALYSLMSKCWA  630 (974)
T ss_pred             HHHHHHhcCCccccccccceEEEecCCCCCCCCCCCC-------------------------------hHHHHHHHHHhc
Confidence            999875 889999987777776666555444444332                               233379999999


Q ss_pred             cCCCCCCCHHHhh
Q psy7889         245 LDPSKRFDSDAAL  257 (433)
Q Consensus       245 ~dP~~R~t~~e~L  257 (433)
                      ++|.+||+..++.
T Consensus       631 yeP~kRPrftei~  643 (974)
T KOG4257|consen  631 YEPSKRPRFTEIK  643 (974)
T ss_pred             cCcccCCcHHHHH
Confidence            9999999997764

>cd05074 PTKc_Tyro3 Catalytic domain of the Protein Tyrosine Kinase, Tyro3

Probab=99.97  E-value=7.1e-30  Score=239.96  Aligned_cols=215  Identities=19%  Similarity=0.263  Sum_probs=162.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-----CCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-----HVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-----~~~l~~~~~~~i~~qll   81 (433)
                      +.+++|+++|+.++||||+++++++......  ......+++++|+. ++|..++...     ...++...++.++.|++
T Consensus        46 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~l~~~~~~~~~~~i~  123 (273)
T cd05074          46 EEFLREAACMKEFDHPNVIKLIGVSLRSRAK--GRLPIPMVILPFMKHGDLHTFLLMSRIGEEPFTLPLQTLVRFMIDIA  123 (273)
T ss_pred             HHHHHHHHHHhcCCCCCcceEEEEEccCCCC--CcccceEEEEecCCCCcHHHHHHHhcccCCCCCCCHHHHHHHHHHHH
Confidence            3578999999999999999999998765321  11234578999987 5676665322     12478899999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||+|||+.||+|+||||+||+++.++.+||+|||++........  ........++..|++||.+.... ++.++||||
T Consensus       124 ~~l~~lH~~~i~H~dikp~nili~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~~~~pe~~~~~~-~~~~sDi~s  200 (273)
T cd05074         124 SGMEYLSSKNFIHRDLAARNCMLNENMTVCVADFGLSKKIYSGDY--YRQGCASKLPVKWLALESLADNV-YTTHSDVWA  200 (273)
T ss_pred             HHHHHHHhCCEeecccchhhEEEcCCCCEEECcccccccccCCcc--eecCCCccCchhhcCHhHHhcCc-cchhhhhHH
Confidence            999999999999999999999999999999999999876543211  11112234466799999887654 688999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |||++|+|++ |.+||.+....+....+.... ...                              .+...+..+.+++.
T Consensus       201 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~-~~~------------------------------~~~~~~~~~~~l~~  249 (273)
T cd05074         201 FGVTMWEIMTRGQTPYAGVENSEIYNYLIKGN-RLK------------------------------QPPDCLEDVYELMC  249 (273)
T ss_pred             HHHHHHHHhhCCCCCCCCCCHHHHHHHHHcCC-cCC------------------------------CCCCCCHHHHHHHH
Confidence            9999999999 899998776654443332210 000                              00123456779999


Q ss_pred             hhcccCCCCCCCHHHhhc
Q psy7889         241 KLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~  258 (433)
                      +||..+|++||++.+++.
T Consensus       250 ~~l~~~p~~Rps~~~~~~  267 (273)
T cd05074         250 QCWSPEPKCRPSFQHLRD  267 (273)
T ss_pred             HHcCCChhhCcCHHHHHH
Confidence            999999999999999985

Protein Tyrosine Kinase (PTK) family; Tyro3; catalytic (c) domain. The PTKc family is part of a larger superfamily that includes the catalytic domains of other kinases such as protein serine/threonine kinases, RIO kinases, and phosphoinositide 3-kinase (PI3K). PTKs catalyze the transfer of the gamma-phosphoryl group from ATP to tyrosine (tyr) residues in protein substrates. Tyro3 (or Sky) is a member of the Axl subfamily, which is composed of receptor tyr kinases (RTKs) containing an extracellular ligand-binding region with two immunoglobulin-like domains followed by two fibronectin type III repeats, a transmembrane segment, and an intracellular catalytic domain. Binding to their ligands, Gas6 and protein S, leads to receptor dimerization, autophosphorylation, activation, and intracellular signaling. Tyro3 is predominantly expressed in the central nervous system and the brain, and functions as a neurotrophic fac

>smart00220 S_TKc Serine/Threonine protein kinases, catalytic domain

Probab=99.97  E-value=8.9e-30  Score=233.82  Aligned_cols=211  Identities=39%  Similarity=0.632  Sum_probs=170.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+..+++++|+||+++++.+...        ...++||||+++ +|..++.... .++...++.++.+++.++.+
T Consensus        32 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------~~~~l~~e~~~~~~L~~~~~~~~-~~~~~~~~~~~~~l~~~l~~  102 (244)
T smart00220       32 ERILREISILKKLKHPNIVRLYDVFEDE--------DKLYLVMEYCDGGDLFDLLKKRG-RLSEDEARFYARQILSALEY  102 (244)
T ss_pred             HHHHHHHHHHHhCCCCcHHHHHhheeeC--------CEEEEEEeCCCCCCHHHHHHhcc-CCCHHHHHHHHHHHHHHHHH
Confidence            6788999999999999999999999875        568999999987 8888876644 38899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.|++|+||+|.||+++.++.++|+|||.+.......     ......++..|++||.+.+.. ++.++||||+|+++
T Consensus       103 lh~~~i~h~~i~~~ni~~~~~~~~~l~d~~~~~~~~~~~-----~~~~~~~~~~~~~pE~~~~~~-~~~~~Di~slG~~l  176 (244)
T smart00220      103 LHSNGIIHRDLKPENILLDEDGHVKLADFGLARQLDPGG-----LLTTFVGTPEYMAPEVLLGKG-YGKAVDVWSLGVIL  176 (244)
T ss_pred             HHHcCeecCCcCHHHeEECCCCcEEEccccceeeecccc-----ccccccCCcCCCCHHHHccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999998765431     223456688899999987554 68899999999999


Q ss_pred             HHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++|..||... ........+.......... +                            ...+.++.+++.+||..
T Consensus       177 ~~l~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~i~~~l~~  227 (244)
T smart00220      177 YELLTGKPPFPGDDQLLELFKKIGKPKPPFPPP-E----------------------------WKISPEAKDLIRKLLVK  227 (244)
T ss_pred             HHHHhCCCCCCCCCcHHHHHHHHhccCCCCccc-c----------------------------ccCCHHHHHHHHHHccC
Confidence            9999999999873 3332222221111100000 0                            00345677999999999


Q ss_pred             CCCCCCCHHHhhcCCCc
Q psy7889         246 DPSKRFDSDAALNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~  262 (433)
                      +|++||++.++++||||
T Consensus       228 ~p~~Rp~~~~~~~~~~~  244 (244)
T smart00220      228 DPEKRLTAEEALQHPFF  244 (244)
T ss_pred             CchhccCHHHHhhCCCC
Confidence            99999999999999997

Phosphotransferases. Serine or threonine-specific kinase subfamily.

>PLN00181 protein SPA1-RELATED; Provisional

Probab=99.97  E-value=8.8e-31  Score=280.77  Aligned_cols=213  Identities=15%  Similarity=0.172  Sum_probs=151.0

Q ss_pred             HHhCCC-CCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeecc
Q psy7889          17 LQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHR   95 (433)
Q Consensus        17 l~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~   95 (433)
                      .+.++| +||++++++|..... .......++++|||++++|.+.+......+++.+++.++.||+.||+|||++||+||
T Consensus        26 ~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~lH~~gIvHr  104 (793)
T PLN00181         26 SKSLSHIDYVRSLLGSHKEGNL-DGLDDDSIVRALECEDVSLRQWLDNPDRSVDAFECFHVFRQIVEIVNAAHSQGIVVH  104 (793)
T ss_pred             cchhhHHHHHHHhhcccCCccc-cccccchhhhhhccCCccHHHHHhcccccccHHHHHHHHHHHHHHHHHHHhCCeeec
Confidence            445567 799999999844321 111135688999999999999997655569999999999999999999999999999


Q ss_pred             CCCCCcEEEecCCc-------------------EEEeecCCccccccCcCCc------------cccccCCcccccccCc
Q psy7889          96 DMKAANVLITKTGI-------------------LKLADFGLARAFSQTKNGQ------------VNRYTNRVVTLWYRPP  144 (433)
Q Consensus        96 dikp~NIll~~~~~-------------------~kl~DFg~a~~~~~~~~~~------------~~~~~~~~gt~~y~aP  144 (433)
                      ||||+||||+..|.                   +|++|||+++.........            .......+||++|+||
T Consensus       105 DlKP~NiLl~~~~~~k~~d~~~~~~~~~~~~~~~ki~DfG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~AP  184 (793)
T PLN00181        105 NVRPSCFVMSSFNHVSFIESASCSDSGSDEDATTKSREIGSSRREEILSERRIEKLEEVKKQPFPMKQILAMEMSWYTSP  184 (793)
T ss_pred             cCCchhEEEcccCcEEEeeccccCcccccccCcccccccccccccccccccchhhhhccccCCCcccccccCCCcceECh
Confidence            99999999965444                   5555555554321100000            0001124678999999


Q ss_pred             ccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHh
Q psy7889         145 ELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE  224 (433)
Q Consensus       145 E~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (433)
                      |++.+.. |+.++|||||||++|||++|.+|+....  ..+..+....  .++. +                        
T Consensus       185 E~~~~~~-~~~~sDVwSlGviL~ELl~~~~~~~~~~--~~~~~~~~~~--~~~~-~------------------------  234 (793)
T PLN00181        185 EEDNGSS-SNCASDVYRLGVLLFELFCPVSSREEKS--RTMSSLRHRV--LPPQ-I------------------------  234 (793)
T ss_pred             hhhccCC-CCchhhhhhHHHHHHHHhhCCCchhhHH--HHHHHHHHhh--cChh-h------------------------
Confidence            9998765 7999999999999999999988765322  1111111100  0000 0                        


Q ss_pred             hhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         225 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       225 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                          ........+++.+||..+|.+||++.|+|+||||.+
T Consensus       235 ----~~~~~~~~~~~~~~L~~~P~~Rps~~eil~h~~~~~  270 (793)
T PLN00181        235 ----LLNWPKEASFCLWLLHPEPSCRPSMSELLQSEFINE  270 (793)
T ss_pred             ----hhcCHHHHHHHHHhCCCChhhCcChHHHhhchhhhh
Confidence                001233458899999999999999999999999965

>KOG1095|consensus

Probab=99.97  E-value=4.2e-30  Score=267.46  Aligned_cols=212  Identities=21%  Similarity=0.355  Sum_probs=172.5

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc------CCCCCHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI------HVKFSLGEIKKV   76 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~------~~~l~~~~~~~i   76 (433)
                      ++....+++|..+|+.++|||||++++++.+.        ...+|++|||. |||.+++++.      ...++......+
T Consensus       736 ~~~~~~Fl~Ea~~m~~f~HpNiv~liGv~l~~--------~~~~i~leyM~gGDL~sflr~~r~~~~~~~~L~~~dLl~~  807 (1025)
T KOG1095|consen  736 EQEVSDFLKEALLMSKFDHPNIVSLIGVCLDS--------GPPLILLEYMEGGDLLSFLRESRPAPFQPSNLSMRDLLAF  807 (1025)
T ss_pred             HHHHHHHHHHHHHHhcCCCcceeeEEEeecCC--------CCcEEEehhcccCcHHHHHHhcccccCCCCCCCHHHHHHH
Confidence            34467899999999999999999999999986        44899999997 6999999987      445899999999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCC-cccccccCcccccCCCCCCC
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNR-VVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~-~gt~~y~aPE~~~~~~~~~~  155 (433)
                      +.+|++|++||++++.|||||-..|+|++....+||+|||+|+-+...   .+.+.... .-...|||||.+.... |+.
T Consensus       808 a~dvA~G~~YLe~~~fvHRDLAaRNCLL~~~r~VKIaDFGlArDiy~~---~yyr~~~~a~lPvkWm~PEsl~d~i-Fts  883 (1025)
T KOG1095|consen  808 ALDVAKGMNYLESKHFVHRDLAARNCLLDERRVVKIADFGLARDIYDK---DYYRKHGEAMLPVKWMPPESLKDGI-FTS  883 (1025)
T ss_pred             HHHHhhhhHHHHhCCCcCcchhhhheeecccCcEEEcccchhHhhhhc---hheeccCccccceecCCHHHHhhcc-ccc
Confidence            999999999999999999999999999999999999999999844322   11111122 2245799999998754 899


Q ss_pred             cchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         156 PVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       156 ~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      ++|||||||++||++| |..||.+.+..+.+......-...++..+                               +..
T Consensus       884 kSDvWsFGVllWEifslG~~PY~~~~n~~v~~~~~~ggRL~~P~~C-------------------------------P~~  932 (1025)
T KOG1095|consen  884 KSDVWSFGVLLWEIFSLGATPYPSRSNFEVLLDVLEGGRLDPPSYC-------------------------------PEK  932 (1025)
T ss_pred             ccchhhhHHHHHHHHhCCCCCCCCcchHHHHHHHHhCCccCCCCCC-------------------------------ChH
Confidence            9999999999999998 79999999888777644432222222222                               122


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+++..|++.+|.+||+...+++
T Consensus       933 ly~lM~~CW~~~pe~RP~F~~i~~  956 (1025)
T KOG1095|consen  933 LYQLMLQCWKHDPEDRPSFRTIVE  956 (1025)
T ss_pred             HHHHHHHHccCChhhCccHHHHHh
Confidence            338999999999999999999997

>KOG4250|consensus

Probab=99.97  E-value=1.9e-30  Score=255.53  Aligned_cols=165  Identities=32%  Similarity=0.456  Sum_probs=139.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc--CCCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI--HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qll~aL   84 (433)
                      +.-.+|+++|++|+|||||+++++=++...  +.-...-.+|||||. |+|...+..-  ...|++.++..++..+..||
T Consensus        56 e~~~~EieilkKLnh~NIVk~f~iee~~~~--~~~~~~~vlvmEyC~gGsL~~~L~~PEN~~GLpE~e~l~lL~d~~~al  133 (732)
T KOG4250|consen   56 ERWCREIEILKKLNHPNIVKLFDIEETKFL--GLVTRLPVLVMEYCSGGSLRKVLNSPENAYGLPESEFLDLLSDLVSAL  133 (732)
T ss_pred             HHHHHHHHHHHHcCchhhhhhcccCCcccc--CcccccceEEEeecCCCcHHHHhcCcccccCCCHHHHHHHHHHHHHHH
Confidence            345689999999999999999998776642  223466789999997 5888888652  23499999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEe--cCC--cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          85 YYIHSNKILHRDMKAANVLIT--KTG--ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~--~~~--~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      .|||++||+||||||.||++-  .+|  ..||+|||.|+.++++     ..+.+.+||+.|.+||+.-..+.|+..+|.|
T Consensus       134 ~~LrEn~IvHRDlKP~NIvl~~Gedgq~IyKLtDfG~Arel~d~-----s~~~S~vGT~~YLhPel~E~q~~y~~tVDLW  208 (732)
T KOG4250|consen  134 RHLRENGIVHRDLKPGNIVLQIGEDGQSIYKLTDFGAARELDDN-----SLFTSLVGTEEYLHPELYERQKKYTATVDLW  208 (732)
T ss_pred             HHHHHcCceeccCCCCcEEEeecCCCceEEeeecccccccCCCC-----CeeeeecCchhhcChHHHhhccCcCceeehh
Confidence            999999999999999999974  334  5799999999998754     3577889999999999886556689999999


Q ss_pred             hHHHHHHHHHhcCCCCCCC
Q psy7889         161 GAGCIMAEMWTRSPIMQGN  179 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~  179 (433)
                      |+||++|+++||..||-..
T Consensus       209 S~GvtlY~caTG~lPF~p~  227 (732)
T KOG4250|consen  209 SFGVTLYECATGELPFIPF  227 (732)
T ss_pred             hhhhHHHHHhccCCCCCcC
Confidence            9999999999999988653

>KOG4278|consensus

Probab=99.96  E-value=1.1e-29  Score=245.38  Aligned_cols=210  Identities=22%  Similarity=0.339  Sum_probs=171.5

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCC-CCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVK-FSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~-l~~~~~~~i~~qll~a   83 (433)
                      --+.|+.|..+|+.++|||+|+|+++|..+        .-+|||+|||. |+|+++++..+.. ++.-...+++.||..|
T Consensus       306 eveEFLkEAAvMKeikHpNLVqLLGVCT~E--------pPFYIiTEfM~yGNLLdYLRecnr~ev~avvLlyMAtQIsSa  377 (1157)
T KOG4278|consen  306 EVEEFLKEAAVMKEIKHPNLVQLLGVCTHE--------PPFYIITEFMCYGNLLDYLRECNRSEVPAVVLLYMATQISSA  377 (1157)
T ss_pred             hHHHHHHHHHHHHhhcCccHHHHhhhhccC--------CCeEEEEecccCccHHHHHHHhchhhcchhHHHHHHHHHHHH
Confidence            357899999999999999999999999987        44999999986 7999999886654 5666778899999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ++||..+++|||||-..|+|+..+..||++|||+++.+....   +...........|.|||.+-... ++.++|||+||
T Consensus       378 MeYLEkknFIHRDLAARNCLVgEnhiVKvADFGLsRlMtgDT---YTAHAGAKFPIKWTAPEsLAyNt-FSiKSDVWAFG  453 (1157)
T KOG4278|consen  378 MEYLEKKNFIHRDLAARNCLVGENHIVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNT-FSIKSDVWAFG  453 (1157)
T ss_pred             HHHHHHhhhhhhhhhhhhccccccceEEeeccchhhhhcCCc---eecccCccCcccccCcccccccc-cccchhhHHHH
Confidence            999999999999999999999999999999999999986321   11111222356799999986655 79999999999


Q ss_pred             HHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |+|||+.| |-.||+|.+.......+.+......++.+                               ++...+|+..|
T Consensus       454 VLLWEIATYGMsPYPGidlSqVY~LLEkgyRM~~PeGC-------------------------------PpkVYeLMraC  502 (1157)
T KOG4278|consen  454 VLLWEIATYGMSPYPGIDLSQVYGLLEKGYRMDGPEGC-------------------------------PPKVYELMRAC  502 (1157)
T ss_pred             HHHHHHHhcCCCCCCCccHHHHHHHHhccccccCCCCC-------------------------------CHHHHHHHHHH
Confidence            99999998 88999999887777766654433333322                               12234899999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      ++++|.+||+..|+-+
T Consensus       503 W~WsPsDRPsFaeiHq  518 (1157)
T KOG4278|consen  503 WNWSPSDRPSFAEIHQ  518 (1157)
T ss_pred             hcCCcccCccHHHHHH
Confidence            9999999999988743

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=99.96  E-value=3e-29  Score=256.96  Aligned_cols=207  Identities=21%  Similarity=0.330  Sum_probs=136.6

Q ss_pred             CceEEEEeecCcC-CHHHHHhccCCC-------------------CCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcE
Q psy7889          43 RSTFYLVFDFCEH-DLAGLLSNIHVK-------------------FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANV  102 (433)
Q Consensus        43 ~~~~~lV~e~~~~-~L~~~l~~~~~~-------------------l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NI  102 (433)
                      ...++|||||+++ +|.+++......                   .....++.++.||+.||+|||++||+||||||+||
T Consensus       207 ~~~~~LV~ey~~~gsL~~~l~~~~~~~~v~~~l~~~~~~l~~~~~r~~~~i~~i~~qll~aL~yLH~~gIiHRDLKP~NI  286 (566)
T PLN03225        207 EDEYWLVWRYEGESTLADLMQSKEFPYNVEPYLLGKVQDLPKGLERENKIIQTIMRQILFALDGLHSTGIVHRDVKPQNI  286 (566)
T ss_pred             CCceEEEEEecCCCcHHHHHHhcCCchhHHHHhccchhhccccchhhHHHHHHHHHHHHHHHHHHHHCCEEeCcCCHHHE
Confidence            4679999999985 677777543211                   12345678999999999999999999999999999


Q ss_pred             EEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC---------------------CCCCcchhh
Q psy7889         103 LITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR---------------------NYGPPVDLW  160 (433)
Q Consensus       103 ll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~---------------------~~~~~~Diw  160 (433)
                      |++. ++.+||+|||+++.+.....   ......++++.|+|||.+....                     .++.++|||
T Consensus       287 Ll~~~~~~~KL~DFGlA~~l~~~~~---~~~~~~~~t~~Y~APE~~~~~~~~~~~~~~~~~~~~sp~l~~~~~~~k~DVw  363 (566)
T PLN03225        287 IFSEGSGSFKIIDLGAAADLRVGIN---YIPKEFLLDPRYAAPEQYIMSTQTPSAPSAPVATALSPVLWQLNLPDRFDIY  363 (566)
T ss_pred             EEeCCCCcEEEEeCCCccccccccc---cCCcccccCCCccChHHhhccCCCCCCccccccccccchhccccCCCCcccH
Confidence            9985 57999999999976543221   1223467789999999764321                     134467999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC-ccCChhHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP-YVKDQYGCDLL  239 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~s~~~~~li  239 (433)
                      |+||++|||+++..+  ..+.......+....+.. ...|.        ......  ........+.. ...+..+++||
T Consensus       364 SlGviL~el~~~~~~--~~~~~~~~~~~l~~~~~~-~~~~~--------~~~~~~--~~~~~~~~~~~~d~~~~~~~dLi  430 (566)
T PLN03225        364 SAGLIFLQMAFPNLR--SDSNLIQFNRQLKRNDYD-LVAWR--------KLVEPR--ASPDLRRGFEVLDLDGGAGWELL  430 (566)
T ss_pred             HHHHHHHHHHhCcCC--CchHHHHHHHHHHhcCCc-HHHHH--------Hhhccc--cchhhhhhhhhccccchHHHHHH
Confidence            999999999986544  333333333332222211 00110        000000  00000000000 11244567999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+||++||++|||++|+|+||||...
T Consensus       431 ~~mL~~dP~kR~ta~e~L~Hpff~~~  456 (566)
T PLN03225        431 KSMMRFKGRQRISAKAALAHPYFDRE  456 (566)
T ss_pred             HHHccCCcccCCCHHHHhCCcCcCCC
Confidence            99999999999999999999999653

>KOG0196|consensus

Probab=99.96  E-value=2.8e-30  Score=255.75  Aligned_cols=209  Identities=20%  Similarity=0.338  Sum_probs=182.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..||.|..||-+++||||++|-++....        .-+.||+|||+ |.|-.++++.+++|+.-++..+++.|+.|++|
T Consensus       675 rdFL~EAsIMGQFdHPNIIrLEGVVTks--------~PvMIiTEyMENGsLDsFLR~~DGqftviQLVgMLrGIAsGMkY  746 (996)
T KOG0196|consen  675 RDFLSEASIMGQFDHPNIIRLEGVVTKS--------KPVMIITEYMENGSLDSFLRQNDGQFTVIQLVGMLRGIASGMKY  746 (996)
T ss_pred             hhhhhhhhhcccCCCCcEEEEEEEEecC--------ceeEEEhhhhhCCcHHHHHhhcCCceEeehHHHHHHHHHHHhHH
Confidence            4688899999999999999999999876        45999999997 68999999999999999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcc--cccccCcccccCCCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~g--t~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |-++|+|||||-..|||++.+-.+|++|||+++++++...   ..+++..|  ...|.|||.|...+ ++.++||||+||
T Consensus       747 Lsdm~YVHRDLAARNILVNsnLvCKVsDFGLSRvledd~~---~~ytt~GGKIPiRWTAPEAIa~RK-FTsASDVWSyGI  822 (996)
T KOG0196|consen  747 LSDMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE---AAYTTLGGKIPIRWTAPEAIAYRK-FTSASDVWSYGI  822 (996)
T ss_pred             HhhcCchhhhhhhhheeeccceEEEeccccceeecccCCC---ccccccCCccceeecChhHhhhcc-cCchhhccccce
Confidence            9999999999999999999999999999999998865432   22333333  56899999997766 899999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +|||.++ |.-||...+..+.+..|.+....+++-..+.                               .+-.|+..|+
T Consensus       823 VmWEVmSyGERPYWdmSNQdVIkaIe~gyRLPpPmDCP~-------------------------------aL~qLMldCW  871 (996)
T KOG0196|consen  823 VMWEVMSYGERPYWDMSNQDVIKAIEQGYRLPPPMDCPA-------------------------------ALYQLMLDCW  871 (996)
T ss_pred             EEEEecccCCCcccccchHHHHHHHHhccCCCCCCCCcH-------------------------------HHHHHHHHHH
Confidence            9999886 8999999999999999999888777665432                               2237899999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      ++|-.+||+..|++.+
T Consensus       872 qkdR~~RP~F~qiV~~  887 (996)
T KOG0196|consen  872 QKDRNRRPKFAQIVST  887 (996)
T ss_pred             HHHhhcCCCHHHHHHH
Confidence            9999999999999863

>KOG1094|consensus

Probab=99.96  E-value=5.6e-29  Score=239.43  Aligned_cols=215  Identities=22%  Similarity=0.331  Sum_probs=169.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCC-CHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKF-SLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l-~~~~~~~i~~qll~aL~   85 (433)
                      ..+++||++|.+|+|||||+|+++|..+        +-+++|+||++ |+|.+++....... ..+....|+.||+.|++
T Consensus       580 ~~F~kEIkiLsqLkhPNIveLvGVC~~D--------ePicmI~EYmEnGDLnqFl~aheapt~~t~~~vsi~tqiasgma  651 (807)
T KOG1094|consen  580 NDFLKEIKILSRLKHPNIVELLGVCVQD--------DPLCMITEYMENGDLNQFLSAHELPTAETAPGVSICTQIASGMA  651 (807)
T ss_pred             HHHHHHHHHHhccCCCCeeEEEeeeecC--------CchHHHHHHHhcCcHHHHHHhccCcccccchhHHHHHHHHHHHH
Confidence            4689999999999999999999999987        44999999997 69999998764332 44556679999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcccccc-CCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYT-NRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      ||.+.++||||+.+.|+|++.++++||+|||.++.+-.+.-   .... ..+-...|+|+|.+.-.+ +++++|+|++|+
T Consensus       652 YLes~nfVHrd~a~rNcLv~~e~~iKiadfgmsR~lysg~y---y~vqgr~vlpiRwmawEsillgk-FttaSDvWafgv  727 (807)
T KOG1094|consen  652 YLESLNFVHRDLATRNCLVDGEFTIKIADFGMSRNLYSGDY---YRVQGRAVLPIRWMAWESILLGK-FTTASDVWAFGV  727 (807)
T ss_pred             HHHhhchhhccccccceeecCcccEEecCcccccccccCCc---eeeecceeeeeeehhHHHHHhcc-ccchhhhhhhHH
Confidence            99999999999999999999999999999999986543321   1111 223356899999998776 899999999999


Q ss_pred             HHHHHHh--cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         165 IMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       165 il~ell~--g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ++||+++  ..-||...++++.+.....++.........                        ..|..-+....+++.+|
T Consensus       728 TlwE~~~~C~e~Py~~lt~e~vven~~~~~~~~~~~~~l------------------------~~P~~cp~~lyelml~C  783 (807)
T KOG1094|consen  728 TLWEVFMLCREQPYSQLTDEQVVENAGEFFRDQGRQVVL------------------------SRPPACPQGLYELMLRC  783 (807)
T ss_pred             HHHHHHHHHhhCchhhhhHHHHHHhhhhhcCCCCcceec------------------------cCCCcCcHHHHHHHHHH
Confidence            9999764  678888888777666655544433322111                        11223345566999999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      +..+..+||+.+++-.
T Consensus       784 w~~es~~RPsFe~lh~  799 (807)
T KOG1094|consen  784 WRRESEQRPSFEQLHL  799 (807)
T ss_pred             hchhhhcCCCHHHHHH
Confidence            9999999999999853

>PLN03224 probable serine/threonine protein kinase; Provisional

Probab=99.96  E-value=8e-28  Score=240.88  Aligned_cols=236  Identities=24%  Similarity=0.314  Sum_probs=155.8

Q ss_pred             CchhHHHHHHHHHhCCCCCc-----cceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC--------------
Q psy7889           6 FPITALREIKILQLLKHENV-----VHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH--------------   65 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnI-----v~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~--------------   65 (433)
                      ..+....|+.++.+++|.++     ++++++|.....+.....+..+|||||+++ +|.+++....              
T Consensus       215 ~~e~~~vE~~~l~~l~~~~l~~~~~~~~lg~~~~~~~~g~~~~~~~~LV~Ey~~~gsL~~~L~~~~~~~~~~L~e~l~~g  294 (507)
T PLN03224        215 SAETGMVEAYMCAKIKRNPIAAASCAEYLGYFTSNTADGAFTKGSQWLVWKFESDATLGDALDGKLGPFPGCLEEFMMAG  294 (507)
T ss_pred             ccchhHHHHHHHHHhhcccchhhhhhhhhhhcccccccccccCCceEEEEEcCCCCcHHHHHhhccCCCcchHHHHHhcC
Confidence            44556678888888876654     677777765322111123568999999985 7777665321              


Q ss_pred             ---------CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCc
Q psy7889          66 ---------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRV  136 (433)
Q Consensus        66 ---------~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  136 (433)
                               ..+++..++.++.|++.||.|||+++|+||||||+|||++.++.+||+|||++..+.....   .......
T Consensus       295 ~~l~~~~~~~~~~~~~~~~i~~ql~~aL~~lH~~~ivHrDLKp~NILl~~~~~~kL~DFGla~~~~~~~~---~~~~~g~  371 (507)
T PLN03224        295 KKIPDNMPQDKRDINVIKGVMRQVLTGLRKLHRIGIVHRDIKPENLLVTVDGQVKIIDFGAAVDMCTGIN---FNPLYGM  371 (507)
T ss_pred             CchhhhcccccCCHHHHHHHHHHHHHHHHHHHHCCeecCCCchHhEEECCCCcEEEEeCcCccccccCCc---cCccccC
Confidence                     1245677889999999999999999999999999999999999999999999976543211   1111234


Q ss_pred             ccccccCcccccCCCC-------------------CC--CcchhhhHHHHHHHHHhcCC-CCCCCChHHHHHHHHHHhCC
Q psy7889         137 VTLWYRPPELLLGDRN-------------------YG--PPVDLWGAGCIMAEMWTRSP-IMQGNTEQQQITLISQLCGS  194 (433)
Q Consensus       137 gt~~y~aPE~~~~~~~-------------------~~--~~~DiwSlGvil~ell~g~~-pf~~~~~~~~~~~i~~~~g~  194 (433)
                      +++.|+|||++.....                   |+  ...||||+||++++|+++.. ||.+.........  . .. 
T Consensus       372 ~tp~Y~aPE~l~~~~~~~~~~~~~~~~~l~~~~~~yg~~~~~DvwSlGvil~em~~~~l~p~~~~~~f~~~~~--~-~~-  447 (507)
T PLN03224        372 LDPRYSPPEELVMPQSCPRAPAPAMAALLSPFAWLYGRPDLFDSYTAGVLLMQMCVPELRPVANIRLFNTELR--Q-YD-  447 (507)
T ss_pred             CCcceeChhhhcCCCCCCccchhhhhhhhhhhHHhcCCCCccchhhHHHHHHHHHhCCCCCccchhhhhhHHh--h-cc-
Confidence            4789999998753211                   12  24799999999999999875 6654322111000  0 00 


Q ss_pred             CCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC---CCCCCHHHhhcCCCcc
Q psy7889         195 ITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP---SKRFDSDAALNHDFFW  263 (433)
Q Consensus       195 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP---~~R~t~~e~L~h~~~~  263 (433)
                      .....|......    .+.++           .....+..++||+.+||..+|   .+|+|++|+|+||||.
T Consensus       448 ~~~~~~r~~~~~----~~~~~-----------~~d~~s~~~~dLi~~LL~~~~~~~~~RlSa~eaL~Hp~f~  504 (507)
T PLN03224        448 NDLNRWRMYKGQ----KYDFS-----------LLDRNKEAGWDLACKLITKRDQANRGRLSVGQALSHRFFL  504 (507)
T ss_pred             chHHHHHhhccc----CCCcc-----------cccccChHHHHHHHHHhccCCCCcccCCCHHHHhCCCCcC
Confidence            000001000000    00000           011247889999999999876   6899999999999994

>KOG0984|consensus

Probab=99.96  E-value=1.2e-28  Score=209.22  Aligned_cols=170  Identities=21%  Similarity=0.325  Sum_probs=140.3

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      .+.++|+++..+. .||++|.+|+.+...        ..++|.||.|..+|-.+..+   ....++|..+-.|+..++.|
T Consensus        89 ~r~L~dldi~~r~~~CPf~V~FyGa~~re--------gdvwIcME~M~tSldkfy~~v~~~g~~ipE~vlGkIa~Svv~a  160 (282)
T KOG0984|consen   89 KRLLMDLDIIMRTVDCPFTVHFYGALFRE--------GDVWICMELMDTSLDKFYRKVLKKGGTIPEDVLGKIAVSVVHA  160 (282)
T ss_pred             HHHHHhhhhhccCCCCCeEEEeehhhhcc--------ccEEEeHHHhhhhHHHHHHHHHhcCCcCchHHhhHhHHHHHHH
Confidence            4667888887766 799999999988776        55999999999887666543   35569999999999999999


Q ss_pred             HHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC---CCCCCcchh
Q psy7889          84 LYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD---RNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---~~~~~~~Di  159 (433)
                      |.|||+ ..++|||+||+||||+..|++|+||||.+..+.++-     ..+...|...|+|||.+...   ..|+.++||
T Consensus       161 l~~L~~kL~vIHRDvKPsNiLIn~~GqVKiCDFGIsG~L~dSi-----Akt~daGCkpYmaPEri~~e~n~~gY~vksDv  235 (282)
T KOG0984|consen  161 LEFLHSKLSVIHRDVKPSNILINYDGQVKICDFGISGYLVDSI-----AKTMDAGCKPYMAPERINPELNQKGYSVKSDV  235 (282)
T ss_pred             HHHHHHHhhhhhccCCcceEEEccCCcEEEcccccceeehhhh-----HHHHhcCCCccCChhhcCcccCcccceeehhh
Confidence            999996 589999999999999999999999999998876432     12224566789999998532   358999999


Q ss_pred             hhHHHHHHHHHhcCCCCCC-CChHHHHHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQG-NTEQQQITLISQ  190 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~-~~~~~~~~~i~~  190 (433)
                      ||||+++.||++++.||.. .++.+++.++..
T Consensus       236 WSLGItmiElA~lr~PY~~w~tpF~qLkqvVe  267 (282)
T KOG0984|consen  236 WSLGITMIEMAILRFPYESWGTPFQQLKQVVE  267 (282)
T ss_pred             hhhhhhhhhhhhccccccccCCHHHHHHHHhc
Confidence            9999999999999999885 467777766654

>KOG0199|consensus

Probab=99.95  E-value=3.1e-28  Score=238.48  Aligned_cols=215  Identities=20%  Similarity=0.282  Sum_probs=175.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc-cCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN-IHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~-~~~~l~~~~~~~i~~qll~aL   84 (433)
                      -..|++|+.+|.+|+|||+|+||++..+.         -+.+|||.+. |+|++.+.+ ....|.......|+.||+.|+
T Consensus       155 mddflrEas~M~~L~H~hliRLyGvVl~q---------p~mMV~ELaplGSLldrLrka~~~~llv~~Lcdya~QiA~aM  225 (1039)
T KOG0199|consen  155 MDDFLREASHMLKLQHPHLIRLYGVVLDQ---------PAMMVFELAPLGSLLDRLRKAKKAILLVSRLCDYAMQIAKAM  225 (1039)
T ss_pred             HHHHHHHHHHHHhccCcceeEEeeeeccc---------hhhHHhhhcccchHHHHHhhccccceeHHHHHHHHHHHHHHH
Confidence            45799999999999999999999999863         2689999998 689998887 444588899999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      .||.++++|||||-..|+|+-....|||+|||+.+.+..+... +...........|.|||.+...+ ++.++|+|++||
T Consensus       226 ~YLeskrlvHRDLAARNlllasprtVKI~DFGLmRaLg~ned~-Yvm~p~rkvPfAWCaPEsLrh~k-FShaSDvWmyGV  303 (1039)
T KOG0199|consen  226 QYLESKRLVHRDLAARNLLLASPRTVKICDFGLMRALGENEDM-YVMAPQRKVPFAWCAPESLRHRK-FSHASDVWMYGV  303 (1039)
T ss_pred             HHHhhhhhhhhhhhhhhheecccceeeeecccceeccCCCCcc-eEecCCCcCcccccCHhHhcccc-ccccchhhhhhh
Confidence            9999999999999999999999999999999999998765432 12222234466799999998776 899999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |..||.|-.....+..|......+.+                               -.-+....+++..|+
T Consensus       304 TiWEMFtyGEePW~G~~g~qIL~~iD~~erLpRP-------------------------------k~csedIY~imk~cW  352 (1039)
T KOG0199|consen  304 TIWEMFTYGEEPWVGCRGIQILKNIDAGERLPRP-------------------------------KYCSEDIYQIMKNCW  352 (1039)
T ss_pred             hHHhhhccCCCCCCCCCHHHHHHhccccccCCCC-------------------------------CCChHHHHHHHHHhc
Confidence            9999998 68999999888877776522111111                               112445558999999


Q ss_pred             ccCCCCCCCHHHhhcCCCcc
Q psy7889         244 LLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~  263 (433)
                      ..+|.+|||...+.+.-+..
T Consensus       353 ah~paDRptFsair~~~~l~  372 (1039)
T KOG0199|consen  353 AHNPADRPTFSAIREDLVLA  372 (1039)
T ss_pred             cCCccccccHHHHHHhHHHH
Confidence            99999999999886554443

>KOG0576|consensus

Probab=99.94  E-value=4.2e-28  Score=236.76  Aligned_cols=230  Identities=21%  Similarity=0.330  Sum_probs=185.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++||-+++..+|||||.+++.|.-.        ..++|+||||+++..+.+....+.+++.++.+++++.++||+||
T Consensus        57 ~~iqqei~~~~dc~h~nivay~gsylr~--------dklwicMEycgggslQdiy~~TgplselqiayvcRetl~gl~yl  128 (829)
T KOG0576|consen   57 SGIQQEIGMLRDCRHPNIVAYFGSYLRR--------DKLWICMEYCGGGSLQDIYHVTGPLSELQIAYVCRETLQGLKYL  128 (829)
T ss_pred             cccccceeeeecCCCcChHHHHhhhhhh--------cCcEEEEEecCCCcccceeeecccchhHHHHHHHhhhhccchhh
Confidence            4577899999999999999999988765        56999999999876666777677899999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc--CCCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL--GDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwSlGvi  165 (433)
                      |++|-+|||||-.|||+++.|.+|+.|||.+..+..    .......+.||++|+|||+-.  ....|+..+|||++|++
T Consensus       129 hs~gk~hRdiKGanilltd~gDvklaDfgvsaqita----ti~KrksfiGtpywmapEvaaverkggynqlcdiwa~git  204 (829)
T KOG0576|consen  129 HSQGKIHRDIKGANILLTDEGDVKLADFGVSAQITA----TIAKRKSFIGTPYWMAPEVAAVERKGGYNQLCDIWALGIT  204 (829)
T ss_pred             hcCCcccccccccceeecccCceeecccCchhhhhh----hhhhhhcccCCccccchhHHHHHhcccccccccccccccc
Confidence            999999999999999999999999999999877653    234456789999999999862  12348999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ..||..-++|.....++..+..+.+-...++.-.                           .+...++.+-+|+..+|.+
T Consensus       205 Aiel~eLqpplfdlhpmr~l~LmTkS~~qpp~lk---------------------------Dk~kws~~fh~fvK~altk  257 (829)
T KOG0576|consen  205 AIELGELQPPLFDLHPMRALFLMTKSGFQPPTLK---------------------------DKTKWSEFFHNFVKGALTK  257 (829)
T ss_pred             hhhhhhcCCcccccchHHHHHHhhccCCCCCccc---------------------------CCccchHHHHHHHHHHhcC
Confidence            9999998988877777777766654322221110                           0112355666999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCchhHHHHh
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLA  276 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~  276 (433)
                      +|++|||++.+|.|||............++.
T Consensus       258 npKkRptaeklL~h~fvs~~l~~rl~~eLLd  288 (829)
T KOG0576|consen  258 NPKKRPTAEKLLQHPFVSQTLSRRLAIELLD  288 (829)
T ss_pred             CCccCCChhhheeceeeccchhhHHHHHHHH
Confidence            9999999999999999977633333333333

>smart00750 KIND kinase non-catalytic C-lobe domain

Probab=99.94  E-value=4.5e-27  Score=206.27  Aligned_cols=166  Identities=20%  Similarity=0.204  Sum_probs=126.9

Q ss_pred             CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccC
Q psy7889          55 HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN  134 (433)
Q Consensus        55 ~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~  134 (433)
                      |+|.+++......+++.+++.++.|++.||+|||+++      ||+|||++.++.+++  ||++......         .
T Consensus         1 GsL~~~l~~~~~~l~~~~~~~i~~qi~~~L~~lH~~~------kp~Nil~~~~~~~~~--fG~~~~~~~~---------~   63 (176)
T smart00750        1 VSLADILEVRGRPLNEEEIWAVCLQCLRALRELHRQA------KSGNILLTWDGLLKL--DGSVAFKTPE---------Q   63 (176)
T ss_pred             CcHHHHHHHhCCCCCHHHHHHHHHHHHHHHHHHHhcC------CcccEeEcCccceee--ccceEeeccc---------c
Confidence            5788888776667999999999999999999999998      999999999999999  9998765421         1


Q ss_pred             CcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCCCcccchhhhhccc
Q psy7889         135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPESWPGVETLDLYNKME  213 (433)
Q Consensus       135 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~  213 (433)
                      ..||+.|+|||++.+.. ++.++||||+||++|||++|.+||....... .+..+.....   ..........       
T Consensus        64 ~~g~~~y~aPE~~~~~~-~~~~~DiwSlG~il~elltg~~p~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-------  132 (176)
T smart00750       64 SRVDPYFMAPEVIQGQS-YTEKADIYSLGITLYEALDYELPYNEERELSAILEILLNGMP---ADDPRDRSNL-------  132 (176)
T ss_pred             CCCcccccChHHhcCCC-CcchhhHHHHHHHHHHHHhCCCCccccchhcHHHHHHHHHhc---cCCccccccH-------
Confidence            25789999999998765 7999999999999999999999997654332 2222221111   1100000000       


Q ss_pred             cchHHHhhHHhhhCCccCC--hhHHHHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         214 LPKAQKRKVKERLKPYVKD--QYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       214 ~~~~~~~~~~~~~~~~~~s--~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                                     ...+  .++.++|.+||..+|.+||++.|+++|+|+.
T Consensus       133 ---------------~~~~~~~~~~~~i~~cl~~~p~~Rp~~~~ll~~~~~~  169 (176)
T smart00750      133 ---------------ESVSAARSFADFMRVCASRLPQRREAANHYLAHCRAL  169 (176)
T ss_pred             ---------------HHHHhhhhHHHHHHHHHhcccccccCHHHHHHHHHHH
Confidence                           0011  2567999999999999999999999999984

It is an interaction domain identified as being similar to the C-terminal protein kinase catalytic fold (C lobe). Its presence at the N terminus of signalling proteins and the absence of the active-site residues in the catalytic and activation loops suggest that it folds independently and is likely to be non-catalytic. The occurrence of KIND only in metazoa implies that it has evolved from the catalytic protein kinase domain into an interaction domain possibly by keeping the substrate-binding features

>KOG1152|consensus

Probab=99.94  E-value=1.3e-27  Score=229.86  Aligned_cols=160  Identities=28%  Similarity=0.458  Sum_probs=142.0

Q ss_pred             CCCchhHHHHHHHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccCCCCCHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVKFSLGEIKKVIQ   78 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~~~l~~~~~~~i~~   78 (433)
                      |-.-.++--||+||..|+   |+||++++++|+++        +.+||+||.-+.  ||++++.- +.+++|.+++.|++
T Consensus       607 DrkLGtVp~EIqIla~l~~~sH~NIlKlLdfFEdd--------d~yyl~te~hg~gIDLFd~IE~-kp~m~E~eAk~IFk  677 (772)
T KOG1152|consen  607 DRKLGTVPSEIQILATLNKHSHENILKLLDFFEDD--------DYYYLETEVHGEGIDLFDFIEF-KPRMDEPEAKLIFK  677 (772)
T ss_pred             ccccCccchhHHHHHHhhhcCccchhhhhheeecC--------CeeEEEecCCCCCcchhhhhhc-cCccchHHHHHHHH
Confidence            344456677999999997   99999999999987        669999999864  78888865 55799999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |++.|+++||++||||||||-+||.++.+|.+||+|||.+.....      .++..++||..|.|||++.|.+..+...|
T Consensus       678 QV~agi~hlh~~~ivhrdikdenvivd~~g~~klidfgsaa~~ks------gpfd~f~gtv~~aapevl~g~~y~gk~qd  751 (772)
T KOG1152|consen  678 QVVAGIKHLHDQGIVHRDIKDENVIVDSNGFVKLIDFGSAAYTKS------GPFDVFVGTVDYAAPEVLGGEKYLGKPQD  751 (772)
T ss_pred             HHHhccccccccCceecccccccEEEecCCeEEEeeccchhhhcC------CCcceeeeeccccchhhhCCCccCCCcch
Confidence            999999999999999999999999999999999999999877643      35677899999999999999988899999


Q ss_pred             hhhHHHHHHHHHhcCCCCCC
Q psy7889         159 LWGAGCIMAEMWTRSPIMQG  178 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~  178 (433)
                      ||+||+++|.++....||..
T Consensus       752 iwalgillytivykenpyyn  771 (772)
T KOG1152|consen  752 IWALGILLYTIVYKENPYYN  771 (772)
T ss_pred             hhhhhheeeEEEeccCCCcC
Confidence            99999999999888877753

>KOG0200|consensus

Probab=99.94  E-value=3.8e-26  Score=236.32  Aligned_cols=208  Identities=25%  Similarity=0.431  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+..|+++|+.+ +|+|||.+++++...        +.+++|+|||. |+|..++++.+               ..++.
T Consensus       346 ~~~~~El~~m~~~g~H~niv~llG~~t~~--------~~~~~v~Ey~~~G~L~~~Lr~~r~~~~~~~~~~~~~~~~~L~~  417 (609)
T KOG0200|consen  346 KDLMSELNVLKELGKHPNIVNLLGACTQD--------GPLYVIVEYAEHGDLLEFLRKKRVTESIDGSGVFPNERDALTT  417 (609)
T ss_pred             HHHHHHHHHHHHhcCCcchhhheeeeccC--------CceEEEEEeccCCcHHHHHHhccccccccccCCCccccCCcCH
Confidence            5788999999999 699999999999885        55999999997 79999998766               34888


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCc--ccccccCccccc
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRV--VTLWYRPPELLL  148 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~--gt~~y~aPE~~~  148 (433)
                      .....++.||+.|++||++.+++||||-..|||++.+..+||+|||+|+........   ......  -...|+|||.+.
T Consensus       418 ~dLlsfa~QIa~GMe~L~~~~~vHRDLAaRNVLi~~~~~~kIaDFGlar~~~~~~~y---~~~~~~~~LP~kWmApEsl~  494 (609)
T KOG0200|consen  418 KDLLSFAYQIANGMEYLASVPCVHRDLAARNVLITKNKVIKIADFGLARDHYNKDYY---RTKSSAGTLPVKWMAPESLF  494 (609)
T ss_pred             HHHHHHHHHHHHHHHHHhhCCccchhhhhhhEEecCCCEEEEccccceeccCCCCce---EecCCCCccceeecCHHHhc
Confidence            999999999999999999999999999999999999999999999999865432211   111112  234599999998


Q ss_pred             CCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCC-hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhh
Q psy7889         149 GDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNT-EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL  226 (433)
Q Consensus       149 ~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~-~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  226 (433)
                      .. .|+.++||||+||++||+++ |..|+++.. ..+....+......                               -
T Consensus       495 ~~-~ft~kSDVWSfGI~L~EifsLG~~PYp~~~~~~~l~~~l~~G~r~-------------------------------~  542 (609)
T KOG0200|consen  495 DR-VFTSKSDVWSFGILLWEIFTLGGTPYPGIPPTEELLEFLKEGNRM-------------------------------E  542 (609)
T ss_pred             cC-cccccchhhHHHHHHHHHhhCCCCCCCCCCcHHHHHHHHhcCCCC-------------------------------C
Confidence            84 48999999999999999998 789998854 33333323221110                               1


Q ss_pred             CCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         227 KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       227 ~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +|..-+.++.+++..|++.+|++||+..++.+
T Consensus       543 ~P~~c~~eiY~iM~~CW~~~p~~RP~F~~~~~  574 (609)
T KOG0200|consen  543 QPEHCSDEIYDLMKSCWNADPEDRPTFSECVE  574 (609)
T ss_pred             CCCCCCHHHHHHHHHHhCCCcccCCCHHHHHH
Confidence            12233566679999999999999999999875

>PLN00113 leucine-rich repeat receptor-like protein kinase; Provisional

Probab=99.94  E-value=1.9e-26  Score=253.48  Aligned_cols=212  Identities=19%  Similarity=0.300  Sum_probs=150.4

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ...|+++|++++|||||++++++.+.        ...|+||||++ ++|.+++.    .+++..+..++.|++.||+|||
T Consensus       730 ~~~~~~~l~~l~HpnIv~~~~~~~~~--------~~~~lv~Ey~~~g~L~~~l~----~l~~~~~~~i~~~ia~~L~yLH  797 (968)
T PLN00113        730 PSSEIADMGKLQHPNIVKLIGLCRSE--------KGAYLIHEYIEGKNLSEVLR----NLSWERRRKIAIGIAKALRFLH  797 (968)
T ss_pred             cHHHHHHHhhCCCCCcceEEEEEEcC--------CCCEEEEeCCCCCcHHHHHh----cCCHHHHHHHHHHHHHHHHHhc
Confidence            35679999999999999999999876        45899999997 57887775    3788999999999999999999


Q ss_pred             ---hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          89 ---SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        89 ---~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                         +.+|+||||||+||+++.++..++. ||.......        .....+|..|+|||++.+.. ++.++||||+||+
T Consensus       798 ~~~~~~iiH~dlkp~Nil~~~~~~~~~~-~~~~~~~~~--------~~~~~~t~~y~aPE~~~~~~-~~~~sDv~S~Gvv  867 (968)
T PLN00113        798 CRCSPAVVVGNLSPEKIIIDGKDEPHLR-LSLPGLLCT--------DTKCFISSAYVAPETRETKD-ITEKSDIYGFGLI  867 (968)
T ss_pred             cCCCCCeecCCCCHHhEEECCCCceEEE-ecccccccc--------CCCccccccccCcccccCCC-CCcccchhhHHHH
Confidence               6699999999999999988887775 555433211        12236788999999987655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChH-HHHHHHHHHhC-CCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         166 MAEMWTRSPIMQGNTEQ-QQITLISQLCG-SITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~-~~~~~i~~~~g-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      +|||++|+.||...... ..+........ ......|..   ..........             .....+..+++.+|+
T Consensus       868 l~el~tg~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~-------------~~~~~~~~~l~~~Cl  931 (968)
T PLN00113        868 LIELLTGKSPADAEFGVHGSIVEWARYCYSDCHLDMWID---PSIRGDVSVN-------------QNEIVEVMNLALHCT  931 (968)
T ss_pred             HHHHHhCCCCCCcccCCCCcHHHHHHHhcCccchhheeC---ccccCCCCcc-------------HHHHHHHHHHHHhhC
Confidence            99999999998542211 11111111110 000000000   0000000000             001124568999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      +.||++|||+.|+++.
T Consensus       932 ~~~P~~RPt~~evl~~  947 (968)
T PLN00113        932 ATDPTARPCANDVLKT  947 (968)
T ss_pred             cCCchhCcCHHHHHHH
Confidence            9999999999999864

>cd00180 PKc Catalytic domain of Protein Kinases

Probab=99.93  E-value=9.3e-25  Score=195.48  Aligned_cols=178  Identities=40%  Similarity=0.650  Sum_probs=152.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++|++|+++++++...        ...++|||++. ++|.+++......++...++.++.+++.++++
T Consensus        36 ~~~~~e~~~~~~l~~~~i~~~~~~~~~~--------~~~~~~~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~l~~~l~~  107 (215)
T cd00180          36 EELLREIEILKKLNHPNIVKLYGVFEDE--------NHLYLVMEYCEGGSLKDLLKENEGKLSEDEILRILLQILEGLEY  107 (215)
T ss_pred             HHHHHHHHHHHhcCCCCeeeEeeeeecC--------CeEEEEEecCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            5689999999999999999999999875        56899999999 68888887654468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+.|++|+||+|.||+++. ++.++|+|||.+........    ......+...|.+||.+.....++.+.|+|++|++
T Consensus       108 lh~~~~~H~dl~~~ni~~~~~~~~~~l~d~~~~~~~~~~~~----~~~~~~~~~~~~~pe~~~~~~~~~~~~D~~~lg~~  183 (215)
T cd00180         108 LHSNGIIHRDLKPENILLDSDNGKVKLADFGLSKLLTSDKS----LLKTIVGTPAYMAPEVLLGKGYYSEKSDIWSLGVI  183 (215)
T ss_pred             HHhCCeeccCCCHhhEEEeCCCCcEEEecCCceEEccCCcc----hhhcccCCCCccChhHhcccCCCCchhhhHHHHHH
Confidence            99999999999999999999 89999999999877643221    12234557789999998765346899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|                                                               ....+++.+||..
T Consensus       184 ~~~l---------------------------------------------------------------~~~~~~l~~~l~~  200 (215)
T cd00180         184 LYEL---------------------------------------------------------------PELKDLIRKMLQK  200 (215)
T ss_pred             HHHH---------------------------------------------------------------HHHHHHHHHHhhC
Confidence            9998                                                               1223899999999


Q ss_pred             CCCCCCCHHHhhcCC
Q psy7889         246 DPSKRFDSDAALNHD  260 (433)
Q Consensus       246 dP~~R~t~~e~L~h~  260 (433)
                      +|++||++.++++|+
T Consensus       201 ~p~~R~~~~~l~~~~  215 (215)
T cd00180         201 DPEKRPSAKEILEHL  215 (215)
T ss_pred             CcccCcCHHHHhhCC
Confidence            999999999999874

Protein Kinases (PKs), catalytic (c) domain. PKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine or tyrosine residues on protein substrates. The PK family is part of a larger superfamily that includes the catalytic domains of RIO kinases, aminoglycoside phosphotransferase, choline kinase, phosphoinositide 3-kinase (PI3K), and actin-fragmin kinase. PKs make up a large family of serine/threonine kinases, protein tyrosine kinases (PTKs), and dual-specificity PKs that phosphorylate both serine/threonine and tyrosine residues of target proteins. Majority of protein phosphorylation, about 95%, occurs on serine residues while only 1% occurs on tyrosine residues. Protein phosphorylation is a mechanism by which a wide variety of cellular proteins, such as enzymes and membrane channels, are reversibly regulated in response to certain stimuli. PKs often function as components of signal transduction pathways in which

>KOG0590|consensus

Probab=99.93  E-value=1.3e-26  Score=236.93  Aligned_cols=224  Identities=25%  Similarity=0.353  Sum_probs=171.2

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHS   89 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~   89 (433)
                      +..|.-+=..++||||+...+.+.+.        ...+-+||||++||+.++... ..++..++-.+++||+.||+|||+
T Consensus       368 i~sE~~i~~~l~h~~~~e~l~~~~~~--------~~~~~~mE~~~~Dlf~~~~~~-~~~~~~e~~c~fKqL~~Gv~y~h~  438 (601)
T KOG0590|consen  368 ITSEFCIGSSLSHPNIIETLDIVQEI--------DGILQSMEYCPYDLFSLVMSN-GKLTPLEADCFFKQLLRGVKYLHS  438 (601)
T ss_pred             hhhheeecccccCCchhhhHHHHhhc--------ccchhhhhcccHHHHHHHhcc-cccchhhhhHHHHHHHHHHHHHHh
Confidence            34455556677999998888877765        334455999999888888764 468999999999999999999999


Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHH
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM  169 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~el  169 (433)
                      +||.|||+|++|++++..|.+||+|||.+.................+|+..|+|||++.+.......+||||.|+++..|
T Consensus       439 ~GiahrdlK~enll~~~~g~lki~Dfg~~~vf~~~~e~~~~~~~g~~gS~pY~apE~~~~~~ydpr~vDiwS~~ii~~~m  518 (601)
T KOG0590|consen  439 MGLAHRDLKLENLLVTENGILKIIDFGAASVFRYPWEKNIHESSGIVGSDPYLAPEVLTGKEYDPRAVDVWSCGIIYICM  518 (601)
T ss_pred             cCceeccCccccEEEecCCceEEeecCcceeeccCcchhhhhhcCcccCCcCcCcccccccccCcchhhhhhccceEEEE
Confidence            99999999999999999999999999999887655444334556788999999999998877556689999999999999


Q ss_pred             HhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCC
Q psy7889         170 WTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK  249 (433)
Q Consensus       170 l~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  249 (433)
                      ++|+.||......+....-      .....+....        ..+    ..+.     ...+...+.+|.+||+.||.+
T Consensus       519 ~~~~~~Wk~a~~~~~~~~~------~~~~~~~~~~--------~~~----~~~~-----~~lp~~~~~~~~~~l~~~P~~  575 (601)
T KOG0590|consen  519 ILGRFPWKVAKKSDNSFKT------NNYSDQRNIF--------EGP----NRLL-----SLLPRETRIIIYRMLQLDPTK  575 (601)
T ss_pred             ecCCCccccccccccchhh------hccccccccc--------cCh----HHHH-----HhchhhHHHHHHHHccCChhh
Confidence            9999999876544332100      0000110000        000    0111     123556779999999999999


Q ss_pred             CCCHHHhhcCCCccCC
Q psy7889         250 RFDSDAALNHDFFWTD  265 (433)
Q Consensus       250 R~t~~e~L~h~~~~~~  265 (433)
                      |.|++++++.+||+.-
T Consensus       576 R~ti~~i~~d~W~~~i  591 (601)
T KOG0590|consen  576 RITIEQILNDEWIRSI  591 (601)
T ss_pred             eecHHHHhhChHhhhc
Confidence            9999999999999653

>KOG1025|consensus

Probab=99.92  E-value=3.4e-25  Score=220.64  Aligned_cols=209  Identities=20%  Similarity=0.292  Sum_probs=169.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...++.|.-+|.+|+|||+++|++++..+         .+.||++|++ |.|+++++..+..+..+....|..||++|+.
T Consensus       742 s~e~LdeAl~masldHpnl~RLLgvc~~s---------~~qlvtq~mP~G~LlDyvr~hr~~igsq~lLnw~~QIAkgM~  812 (1177)
T KOG1025|consen  742 SIELLDEALRMASLDHPNLLRLLGVCMLS---------TLQLVTQLMPLGCLLDYVREHRDNIGSQDLLNWCYQIAKGMK  812 (1177)
T ss_pred             hHHHHHHHHHHhcCCCchHHHHhhhcccc---------hHHHHHHhcccchHHHHHHHhhccccHHHHHHHHHHHHHHHH
Confidence            57899999999999999999999999874         3789999998 6899999998888999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||+++++||||-..|||+..-..+|+.|||+++.......+  ...........|+|-|.+.... |+.++||||+||+
T Consensus       813 YLe~qrlVHrdLaaRNVLVksP~hvkitdfgla~ll~~d~~e--y~~~~gK~pikwmale~i~~~~-~thqSDVWsfGVt  889 (1177)
T KOG1025|consen  813 YLEEQRLVHRDLAARNVLVKSPNHVKITDFGLAKLLAPDEKE--YSAPGGKVPIKWMALESIRIRK-YTHQSDVWSFGVT  889 (1177)
T ss_pred             HHHhcchhhhhhhhhheeecCCCeEEEEecchhhccCccccc--ccccccccCcHHHHHHHhhccC-CCchhhhhhhhhh
Confidence            999999999999999999999999999999999887643321  2222333356799999987765 8999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +||++| |.-|+.+..-.+.-..+.....    -                           .+|-+=+-+..-++.+|+.
T Consensus       890 iWElmTFGa~Py~gi~~~eI~dlle~geR----L---------------------------sqPpiCtiDVy~~mvkCwm  938 (1177)
T KOG1025|consen  890 IWELMTFGAKPYDGIPAEEIPDLLEKGER----L---------------------------SQPPICTIDVYMVMVKCWM  938 (1177)
T ss_pred             HHHHHhcCCCccCCCCHHHhhHHHhcccc----C---------------------------CCCCCccHHHHHHHHHHhc
Confidence            999997 8888888776554433322111    1                           1111223344578999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .|+..||+++++..
T Consensus       939 id~~~rp~fkel~~  952 (1177)
T KOG1025|consen  939 IDADSRPTFKELAE  952 (1177)
T ss_pred             cCcccCccHHHHHH
Confidence            99999999988753

>KOG3653|consensus

Probab=99.92  E-value=5.6e-25  Score=207.69  Aligned_cols=232  Identities=24%  Similarity=0.355  Sum_probs=160.8

Q ss_pred             chhHHHHHHHHHhC--CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL--KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .+.++.|-+|.+..  +|+||++++.+=.....    -+..+.||++|.+ |+|.+++...  .+++.....++..+++|
T Consensus       246 kqs~~~Ek~Iy~lp~m~h~nIl~Fi~~ekr~t~----~~~eywLVt~fh~kGsL~dyL~~n--tisw~~~cria~SmarG  319 (534)
T KOG3653|consen  246 KQSFQNEKNIYSLPGMKHENILQFIGAEKRGTA----DRMEYWLVTEFHPKGSLCDYLKAN--TISWNSLCRIAESMARG  319 (534)
T ss_pred             HHHHHhHHHHHhccCccchhHHHhhchhccCCc----cccceeEEeeeccCCcHHHHHHhc--cccHHHHHHHHHHHHHH
Confidence            46788898988865  79999999986654321    1457999999987 7899999863  57999999999999999


Q ss_pred             HHHHHhC---------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCC
Q psy7889          84 LYYIHSN---------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG  154 (433)
Q Consensus        84 L~~LH~~---------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (433)
                      |+|||+.         .|+|||||..||||..++.+.|+|||+|..+......  ......+||..|||||++-+..++.
T Consensus       320 La~LHee~p~~d~~Kp~IaHRDlkSkNVLvK~DlTccIaDFGLAl~~~p~~~~--~d~~~qVGT~RYMAPEvLEgainl~  397 (534)
T KOG3653|consen  320 LAHLHEELPRGDHHKPPIAHRDLKSKNVLVKNDLTCCIADFGLALRLEPGKPQ--GDTHGQVGTRRYMAPEVLEGAINLQ  397 (534)
T ss_pred             HHHhcccCCcCCCCCCccccccccccceEEccCCcEEeeccceeEEecCCCCC--cchhhhhhhhhhcCHHHHhhhcccc
Confidence            9999953         4999999999999999999999999999888754432  2334479999999999998766655


Q ss_pred             -----CcchhhhHHHHHHHHHhcCCCCC-CCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC
Q psy7889         155 -----PPVDLWGAGCIMAEMWTRSPIMQ-GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP  228 (433)
Q Consensus       155 -----~~~DiwSlGvil~ell~g~~pf~-~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (433)
                           .+.||||+|.|+|||+++...+. +..+.-++. ....+|..+.        .............+.........
T Consensus       398 d~~Afkr~DvYamgLVLWEi~SRC~~~~~~~vp~Yqlp-fe~evG~hPt--------~e~mq~~VV~kK~RP~~p~~W~~  468 (534)
T KOG3653|consen  398 DRDAFKRIDVYAMGLVLWEIASRCTDADPGPVPEYQLP-FEAEVGNHPT--------LEEMQELVVRKKQRPKIPDAWRK  468 (534)
T ss_pred             cHHHHHHHHHHHHHHHHHHHHhhcccccCCCCCcccCc-hhHHhcCCCC--------HHHHHHHHHhhccCCCChhhhhc
Confidence                 36899999999999999755442 221111000 0111121110        00000000111111111111112


Q ss_pred             ccCChhHHHHHHhhcccCCCCCCCHHH
Q psy7889         229 YVKDQYGCDLLDKLLLLDPSKRFDSDA  255 (433)
Q Consensus       229 ~~~s~~~~~li~~~L~~dP~~R~t~~e  255 (433)
                      ...-..+++.+..|+..||+.|+||.=
T Consensus       469 h~~~~~l~et~EeCWDhDaeARLTA~C  495 (534)
T KOG3653|consen  469 HAGMAVLCETIEECWDHDAEARLTAGC  495 (534)
T ss_pred             CccHHHHHHHHHHHcCCchhhhhhhHH
Confidence            223455679999999999999999953

>KOG2052|consensus

Probab=99.91  E-value=2.6e-24  Score=201.80  Aligned_cols=218  Identities=23%  Similarity=0.321  Sum_probs=163.7

Q ss_pred             chhHHHHHHHHHhC--CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL--KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      +....||.+|.+.+  +|+||+.+++.--.+.    ..-+.++||++|-+ |+|++++..  ..++.+...+++..++.|
T Consensus       247 E~SWfrEtEIYqTvmLRHENILgFIaaD~~~~----gs~TQLwLvTdYHe~GSL~DyL~r--~tv~~~~ml~LalS~AsG  320 (513)
T KOG2052|consen  247 ERSWFRETEIYQTVMLRHENILGFIAADNKDN----GSWTQLWLVTDYHEHGSLYDYLNR--NTVTTEGMLKLALSIASG  320 (513)
T ss_pred             hhhhhhHHHHHHHHHhccchhhhhhhccccCC----CceEEEEEeeecccCCcHHHHHhh--ccCCHHHHHHHHHHHhhh
Confidence            55678899999966  9999999998655442    34688999999997 789999976  368899999999999999


Q ss_pred             HHHHHhC--------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCC--
Q psy7889          84 LYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNY--  153 (433)
Q Consensus        84 L~~LH~~--------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--  153 (433)
                      |++||..        .|.|||||..|||+.++|.+.|+|+|+|.......+.-.......+||..|||||++...-+.  
T Consensus       321 LaHLH~eI~GTqgKPaIAHRDlKSKNILVKkn~~C~IADLGLAv~h~~~t~~idi~~N~rVGTKRYMAPEvLdetin~~~  400 (513)
T KOG2052|consen  321 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSDTDTIDIPPNPRVGTKRYMAPEVLDETINMKH  400 (513)
T ss_pred             HHHHHHHHhcCCCCchhhccccccccEEEccCCcEEEeeceeeEEecccCCcccCCCCCccceeeccChHHhhhhcChhh
Confidence            9999943        399999999999999999999999999988776555555667789999999999999654321  


Q ss_pred             -C--CcchhhhHHHHHHHHHhc----------CCCCCCCC----hHHHHHHHH--HHhCCCCCCCCCcccchhhhhcccc
Q psy7889         154 -G--PPVDLWGAGCIMAEMWTR----------SPIMQGNT----EQQQITLIS--QLCGSITPESWPGVETLDLYNKMEL  214 (433)
Q Consensus       154 -~--~~~DiwSlGvil~ell~g----------~~pf~~~~----~~~~~~~i~--~~~g~~~~~~~~~~~~~~~~~~~~~  214 (433)
                       .  ..+||||+|.|+||++.+          .+||.+..    ..+.+..+.  +-+....+..|......        
T Consensus       401 Fesyk~ADIYafgLVlWEiarRc~~ggi~eey~~Pyyd~Vp~DPs~eeMrkVVCv~~~RP~ipnrW~s~~~l--------  472 (513)
T KOG2052|consen  401 FESYKRADIYAFGLVLWEIARRCESGGIVEEYQLPYYDVVPSDPSFEEMRKVVCVQKLRPNIPNRWKSDPAL--------  472 (513)
T ss_pred             hhhhhHHHHHHHHHHHHHHHHHhhcCCEehhhcCCcccCCCCCCCHHHHhcceeecccCCCCCcccccCHHH--------
Confidence             1  268999999999999842          46766422    122222221  22333344444333221        


Q ss_pred             chHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHh
Q psy7889         215 PKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAA  256 (433)
Q Consensus       215 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~  256 (433)
                                        ..+-.++..|+..||..|.||--+
T Consensus       473 ------------------~~m~klMkeCW~~Np~aRltALri  496 (513)
T KOG2052|consen  473 ------------------RVMAKLMKECWYANPAARLTALRI  496 (513)
T ss_pred             ------------------HHHHHHHHHhhcCCchhhhHHHHH
Confidence                              122378999999999999988544

>smart00221 STYKc Protein kinase; unclassified specificity

Probab=99.90  E-value=6e-23  Score=186.53  Aligned_cols=165  Identities=38%  Similarity=0.610  Sum_probs=138.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|++.++.++|+||+++++++...        ...++++|++.+ +|.+.+......+++..++.++.+++.+|.
T Consensus        41 ~~~~~~e~~~~~~~~~~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~l~~~l~  112 (225)
T smart00221       41 REEFLREIRILKKLKHPNIVKLYGVFEDP--------EPLYLVMEYCEGGDLFDYLRKKGGKLSEEEARFYLRQILEALE  112 (225)
T ss_pred             HHHHHHHHHHHHhCCCCChhhheeeeecC--------CceEEEEeccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            35778899999999999999999998765        568999999987 888888765433889999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      +||+++++|+||+|.||+++.++.++|+|||.+.........   ......++..|++||.+.+...++.++|+|++|++
T Consensus       113 ~lh~~~i~h~di~~~ni~v~~~~~~~l~d~g~~~~~~~~~~~---~~~~~~~~~~~~~pe~~~~~~~~~~~~Dv~~lG~~  189 (225)
T smart00221      113 YLHSLGIVHRDLKPENILLGMDGLVKLADFGLARFIHRDLAA---LLKTVKGTPFYLAPEVLLGGKGYGEAVDIWSLGVI  189 (225)
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCCEEEeeCceeeEecCcccc---cccceeccCCcCCHhHhcCCCCCCchhhHHHHHHH
Confidence            999999999999999999999999999999998776543200   12334567789999988433346789999999999


Q ss_pred             HHHHHhcCCCCCC-CChH
Q psy7889         166 MAEMWTRSPIMQG-NTEQ  182 (433)
Q Consensus       166 l~ell~g~~pf~~-~~~~  182 (433)
                      +++|++|++||.+ .+..
T Consensus       190 ~~~l~~g~~pf~~~~~~~  207 (225)
T smart00221      190 LYELLWGPEPFSGEGEFT  207 (225)
T ss_pred             HHHHHHCCCCccccchhH
Confidence            9999999999977 3433

Phosphotransferases. The specificity of this class of kinases can not be predicted. Possible dual-specificity Ser/Thr/Tyr kinase.

>KOG1024|consensus

Probab=99.89  E-value=2.3e-22  Score=185.78  Aligned_cols=208  Identities=16%  Similarity=0.196  Sum_probs=165.6

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC-------CCCHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV-------KFSLGEIKKVIQQL   80 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~-------~l~~~~~~~i~~ql   80 (433)
                      -+++|--++..+.|||+....++...+       ...-++++.+++ ++|..++...++       .++..++..++.|+
T Consensus       333 ~~L~es~lly~~sH~nll~V~~V~ie~-------~~~P~V~y~~~~~gNLK~FL~~Cr~~~~~~aqtvtt~qlV~masQl  405 (563)
T KOG1024|consen  333 LLLQESMLLYGASHPNLLSVLGVSIED-------YATPFVLYPATGVGNLKSFLQICRGDDPSYAQTVTTIQLVLMASQL  405 (563)
T ss_pred             HHHHHHHHHhcCcCCCccceeEEEeec-------cCcceEEEeccCcchHHHHHHHhccCCCccccchhHHHHHHHHHHH
Confidence            357788888889999999999998775       355788899988 689988873221       26667788899999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.|++|||++|+||.||-..|++|++.-++||+|=.+++-+-...-....  ...-....|++||.+.... |+.++|+|
T Consensus       406 a~am~hlh~~~ViHkDiAaRNCvIdd~LqVkltDsaLSRDLFP~DYhcLG--DnEnRPvkWMslEal~n~~-yssasDvW  482 (563)
T KOG1024|consen  406 AMAMEHLHNHGVIHKDIAARNCVIDDQLQVKLTDSALSRDLFPGDYHCLG--DNENRPVKWMSLEALQNSH-YSSASDVW  482 (563)
T ss_pred             HHHHHHHHhcCcccchhhhhcceehhheeEEeccchhccccCcccccccC--CCCCCcccccCHHHHhhhh-hcchhhhH
Confidence            99999999999999999999999999999999999888766532211100  0112255799999998765 89999999


Q ss_pred             hHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         161 GAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       161 SlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||||++|||++ |+.|+-..++.+....+.....                               ..+|+.-+.++..++
T Consensus       483 sfGVllWELmtlg~~PyaeIDPfEm~~ylkdGyR-------------------------------laQP~NCPDeLf~vM  531 (563)
T KOG1024|consen  483 SFGVLLWELMTLGKLPYAEIDPFEMEHYLKDGYR-------------------------------LAQPFNCPDELFTVM  531 (563)
T ss_pred             HHHHHHHHHHhcCCCCccccCHHHHHHHHhccce-------------------------------ecCCCCCcHHHHHHH
Confidence            99999999997 8999999888887777654322                               223444566777999


Q ss_pred             HhhcccCCCCCCCHHHhh
Q psy7889         240 DKLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L  257 (433)
                      ..|+...|.+||+.+|+.
T Consensus       532 acCWallpeeRPsf~Qlv  549 (563)
T KOG1024|consen  532 ACCWALLPEERPSFSQLV  549 (563)
T ss_pred             HHHHhcCcccCCCHHHHH
Confidence            999999999999999985

>KOG1345|consensus

Probab=99.89  E-value=7.1e-24  Score=187.23  Aligned_cols=213  Identities=23%  Similarity=0.293  Sum_probs=148.4

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+|...=-.| .|.|||.-|++.-..       -+.+++++||++ |||.+.+..  ..+.|...+.++.|+++||.|
T Consensus        66 dF~rEfhY~~~Ls~H~hIi~tY~vaFqt-------~d~YvF~qE~aP~gdL~snv~~--~GigE~~~K~v~~ql~SAi~f  136 (378)
T KOG1345|consen   66 DFVREFHYSFFLSPHQHIIDTYEVAFQT-------SDAYVFVQEFAPRGDLRSNVEA--AGIGEANTKKVFAQLLSAIEF  136 (378)
T ss_pred             HHHHHhccceeeccchhhhHHHHHHhhc-------CceEEEeeccCccchhhhhcCc--ccccHHHHHHHHHHHHHHHHH
Confidence            355565554455 499999988865433       256889999998 688877654  347888999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec--CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC----CCCCcchhh
Q psy7889          87 IHSNKILHRDMKAANVLITK--TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR----NYGPPVDLW  160 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~~~~~~Diw  160 (433)
                      ||+.++||||||.+||||-.  ...|||||||+.+..+..       ....--+..|.+||++....    ...+..|+|
T Consensus       137 MHsknlVHRdlK~eNiLif~~df~rvKlcDFG~t~k~g~t-------V~~~~~~~~y~~pe~~~~~~ne~~~~~ps~D~W  209 (378)
T KOG1345|consen  137 MHSKNLVHRDLKAENILIFDADFYRVKLCDFGLTRKVGTT-------VKYLEYVNNYHAPELCDTVVNEKLVVNPSTDIW  209 (378)
T ss_pred             hhccchhhcccccceEEEecCCccEEEeeecccccccCce-------ehhhhhhcccCCcHHHhhccccceEecccccch
Confidence            99999999999999999953  348999999998765421       11112255689999864322    246789999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      .+|+++|.+++|.+||+...-.+ ......+..+...+                       .++..+.  ..++.+..+.
T Consensus       210 qfGIi~f~cltG~~PWQka~~~d~~Y~~~~~w~~rk~~-----------------------~~P~~F~--~fs~~a~r~F  264 (378)
T KOG1345|consen  210 QFGIIFFYCLTGKFPWQKASIMDKPYWEWEQWLKRKNP-----------------------ALPKKFN--PFSEKALRLF  264 (378)
T ss_pred             heeeeeeeeecCCCcchhhhccCchHHHHHHHhcccCc-----------------------cCchhhc--ccCHHHHHHH
Confidence            99999999999999998533222 12222222221111                       1111122  2577788999


Q ss_pred             HhhcccCCCCC---CCHHHhhcCCCc
Q psy7889         240 DKLLLLDPSKR---FDSDAALNHDFF  262 (433)
Q Consensus       240 ~~~L~~dP~~R---~t~~e~L~h~~~  262 (433)
                      .+-|..++++|   -++..-....|.
T Consensus       265 kk~lt~~~~drcki~~~kk~rk~~w~  290 (378)
T KOG1345|consen  265 KKSLTPRFKDRCKIWTAKKMRKCLWK  290 (378)
T ss_pred             HHhcCCcccccchhHHHHHHHHHHHH
Confidence            99999999999   444444444554

>KOG0603|consensus

Probab=99.87  E-value=1.2e-22  Score=199.07  Aligned_cols=203  Identities=27%  Similarity=0.350  Sum_probs=167.0

Q ss_pred             CCchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      +.......|-.++..++ ||.+|+++..|+.+        +..++++++..+ ++...+.+.. .+.+..++.+...++.
T Consensus        38 ~~~~~t~~er~il~~~~~~~f~v~lhyafqt~--------~kl~l~ld~~rgg~lft~l~~~~-~f~~~~~~~~~aelaL  108 (612)
T KOG0603|consen   38 RDRTHTKQERIILAFVHNTPFLVKLHYAFQTD--------GKLYLILDFLRGGDLFTRLSKEV-MFDELDVAFYLAELAL  108 (612)
T ss_pred             ccccccccHHHHHhhccCCCceeeeeeeeccc--------cchhHhhhhcccchhhhccccCC-chHHHHHHHHHHHHHH
Confidence            33335667888999886 99999999999987        568999999976 6666665533 5788889999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |++++|+.+|+|||+|++||+++.+|++++.|||+++..-..+.        .|||..|||||++.+   ...++|+||+
T Consensus       109 ald~lh~l~iiyrd~k~enilld~~Ghi~~tdfglske~v~~~~--------~cgt~eymApEI~~g---h~~a~D~ws~  177 (612)
T KOG0603|consen  109 ALDHLHKLGIAYRDYKLENVLLLLEGHIKLTDFGLSKEAVKEKI--------ACGTYEYRAPEIING---HLSAADWWSF  177 (612)
T ss_pred             HHhhcchhHHHHhcccccceeecccCccccCCchhhhHhHhhhh--------cccchhhhhhHhhhc---cCCcccchhh
Confidence            99999999999999999999999999999999999977654321        288999999999973   5789999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |+++++|++|..||.+    +....|.+..-..                                |...+.++++++..+
T Consensus       178 gvl~felltg~~pf~~----~~~~~Il~~~~~~--------------------------------p~~l~~~a~~~~~~l  221 (612)
T KOG0603|consen  178 GVLAFELLTGTLPFGG----DTMKRILKAELEM--------------------------------PRELSAEARSLFRQL  221 (612)
T ss_pred             hhhHHHHhhCCCCCch----HHHHHHhhhccCC--------------------------------chhhhHHHHHHHHHH
Confidence            9999999999999998    4444443321111                                223567788999999


Q ss_pred             cccCCCCCCCH-----HHhhcCCCcc
Q psy7889         243 LLLDPSKRFDS-----DAALNHDFFW  263 (433)
Q Consensus       243 L~~dP~~R~t~-----~e~L~h~~~~  263 (433)
                      +..+|..|..+     .|+++|+||+
T Consensus       222 ~~r~p~nrLg~~~~~~~eik~h~f~~  247 (612)
T KOG0603|consen  222 FKRNPENRLGAGPDGVDEIKQHEFFQ  247 (612)
T ss_pred             HhhCHHHHhccCcchhHHHhccchhe
Confidence            99999999765     8999999996

>COG0515 SPS1 Serine/threonine protein kinase [General function prediction only / Signal transduction mechanisms / Transcription / DNA replication, recombination, and repair]

Probab=99.85  E-value=7.7e-20  Score=174.66  Aligned_cols=227  Identities=31%  Similarity=0.484  Sum_probs=169.6

Q ss_pred             chhHHHHHHHHHhCCCC-CccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC--CCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHE-NVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH--VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hp-nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~--~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+.+++.+.|+ +|+++++++...        ...+++++++.+ ++...+....  ..++...+..++.|++.
T Consensus        41 ~~~~~~e~~~~~~~~~~~~i~~~~~~~~~~--------~~~~~~~~~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  112 (384)
T COG0515          41 VERFLREIQILASLNHPPNIVKLYDFFQDE--------GSLYLVMEYVDGGSLEDLLKKIGRKGPLSESEALFILAQILS  112 (384)
T ss_pred             HHHHHHHHHHHHHccCCcceeeEEEEEecC--------CEEEEEEecCCCCcHHHHHHhcccccCCCHHHHHHHHHHHHH
Confidence            45688999999999888 799999999554        448999999986 5664554433  26899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCcc--ccccCCcccccccCcccccCC--CCCCCcc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQV--NRYTNRVVTLWYRPPELLLGD--RNYGPPV  157 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~--~~~~~~~gt~~y~aPE~~~~~--~~~~~~~  157 (433)
                      ++.|+|+.|++|||+||+||+++..+ .++++|||.+...........  .......|+..|+|||.+.+.  ..++...
T Consensus       113 ~l~~~H~~~~~hrd~kp~nil~~~~~~~~~l~dfg~~~~~~~~~~~~~~~~~~~~~~~t~~~~~pe~~~~~~~~~~~~~~  192 (384)
T COG0515         113 ALEYLHSKGIIHRDIKPENILLDRDGRVVKLIDFGLAKLLPDPGSTSSIPALPSTSVGTPGYMAPEVLLGLSLAYASSSS  192 (384)
T ss_pred             HHHHHHhCCeeccCCCHHHeeecCCCCeEEEeccCcceecCCCCccccccccccccccccccCCHHHhcCCCCCCCCchH
Confidence            99999999999999999999999988 799999999976543322111  134567889999999999874  3578999


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCCh---HHHHHHHHHHhCCC-CCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTE---QQQITLISQLCGSI-TPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~---~~~~~~i~~~~g~~-~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      |+||+|++++++++|..||.....   .............. ..........                       .....
T Consensus       193 D~~s~g~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----------------------~~~~~  249 (384)
T COG0515         193 DIWSLGITLYELLTGLPPFEGEKNSSATSQTLKIILELPTPSLASPLSPSNP-----------------------ELISK  249 (384)
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCccccHHHHHHHHHhcCCcccccccCcccc-----------------------chhhH
Confidence            999999999999999999887764   22222222222211 0000000000                       01123


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ...+++.+++..+|..|.+..+...++|...
T Consensus       250 ~~~~~~~~~~~~~~~~r~~~~~~~~~~~~~~  280 (384)
T COG0515         250 AASDLLKKLLAKDPKNRLSSSSDLSHDLLAH  280 (384)
T ss_pred             HHHHHHHHHHhcCchhcCCHHHHhhchHhhC
Confidence            5669999999999999999999999866643

>KOG1240|consensus

Probab=99.83  E-value=3.6e-21  Score=197.79  Aligned_cols=208  Identities=27%  Similarity=0.384  Sum_probs=149.9

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHS   89 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~   89 (433)
                      -++|++ ....++||.+.+.-+...+        ...|||-+|+..+|++.+..+ .-+..-+.+.|+.||+.||.-+|+
T Consensus        69 rL~~ik-~~l~~~pn~lPfqk~~~t~--------kAAylvRqyvkhnLyDRlSTR-PFL~~iEKkWiaFQLL~al~qcH~  138 (1431)
T KOG1240|consen   69 RLEEIK-FALMKAPNCLPFQKVLVTD--------KAAYLVRQYVKHNLYDRLSTR-PFLVLIEKKWIAFQLLKALSQCHK  138 (1431)
T ss_pred             HHHHHH-HHhhcCCcccchHHHHHhh--------HHHHHHHHHHhhhhhhhhccc-hHHHHHHHHHHHHHHHHHHHHHHH
Confidence            345555 4555899999998876665        567999999999999998774 347778899999999999999999


Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccc----cCCcccccccCcccccCCC----------CCCC
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY----TNRVVTLWYRPPELLLGDR----------NYGP  155 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~----~~~~gt~~y~aPE~~~~~~----------~~~~  155 (433)
                      .||+|||||.+||||+.-.++-|+||...+..--+. .....+    .+...-..|+|||.+....          ..++
T Consensus       139 ~gVcHGDIKsENILiTSWNW~~LtDFAsFKPtYLPe-DNPadf~fFFDTSrRRtCYiAPERFv~~~~~~~~~q~~~~L~p  217 (1431)
T KOG1240|consen  139 LGVCHGDIKSENILITSWNWLYLTDFASFKPTYLPE-DNPADFTFFFDTSRRRTCYIAPERFVSALGKTSVGQDAPLLTP  217 (1431)
T ss_pred             cCccccccccceEEEeeechhhhhcccccCCccCCC-CCcccceEEEecCCceeeecChHhhhccccccccCCcccccCh
Confidence            999999999999999999999999998664322111 111112    2222344699999986421          1467


Q ss_pred             cchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         156 PVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       156 ~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      +-||||+||+++||++ |.|+|.-..    +-....  |    +     .               ... +.....+.+..
T Consensus       218 aMDIFS~GCViaELf~Eg~PlF~LSQ----L~aYr~--~----~-----~---------------~~~-e~~Le~Ied~~  266 (1431)
T KOG1240|consen  218 AMDIFSAGCVIAELFLEGRPLFTLSQ----LLAYRS--G----N-----A---------------DDP-EQLLEKIEDVS  266 (1431)
T ss_pred             hhhhhhhhHHHHHHHhcCCCcccHHH----HHhHhc--c----C-----c---------------cCH-HHHHHhCcCcc
Confidence            8899999999999987 799996321    111100  0    0     0               000 00111234556


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .+.+|..|++.||++|.+|++.|+-
T Consensus       267 ~Rnlil~Mi~rdPs~RlSAedyL~~  291 (1431)
T KOG1240|consen  267 LRNLILSMIQRDPSKRLSAEDYLQK  291 (1431)
T ss_pred             HHHHHHHHHccCchhccCHHHHHHh
Confidence            7799999999999999999999986

>KOG4158|consensus

Probab=99.82  E-value=1.7e-19  Score=167.54  Aligned_cols=202  Identities=25%  Similarity=0.280  Sum_probs=142.8

Q ss_pred             CCCCccceeeeEEecCccc-------------------cccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889          21 KHENVVHLIEICRTKANQY-------------------NRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus        21 ~hpnIv~l~~~~~~~~~~~-------------------~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      +|||||++..+|.++....                   .....++|+||.....+|.+++...+  .+....+-++.|++
T Consensus       274 ~HPNIvri~~aF~dsv~~lPda~~~YPdalp~R~~p~g~g~~~tlylvMkrY~~tLr~yl~~~~--~s~r~~~~~laQlL  351 (598)
T KOG4158|consen  274 KHPNIVRIQTAFIDSVKVLPDAIERYPDALPARWYPSGAGEPKTLYLVMKRYRQTLREYLWTRH--RSYRTGRVILAQLL  351 (598)
T ss_pred             CCCCEEeehhhhhhhhccCCchhhhCcccccceecccccCCCceEEEehhcchhhHHHHHhcCC--CchHHHHHHHHHHH
Confidence            6999999999997763211                   11247899999999999999998754  46778888999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEe--cCC--cEEEeecCCccccccCcC--CccccccCCcccccccCcccccCCCCC--
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLIT--KTG--ILKLADFGLARAFSQTKN--GQVNRYTNRVVTLWYRPPELLLGDRNY--  153 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~--~~~--~~kl~DFg~a~~~~~~~~--~~~~~~~~~~gt~~y~aPE~~~~~~~~--  153 (433)
                      +|+.|||++||.|||+|.+|||+.  +++  .+.|+|||++-.-....-  .-.+..-...|.-..+|||+....+..  
T Consensus       352 Eav~hL~~hgvAhRDlKSDNiL~ElddD~~P~LVvaDFGCcLAd~~hGlqlpy~S~~Vd~GGNa~lmAPEi~ta~PGp~a  431 (598)
T KOG4158|consen  352 EAVTHLHKHGVAHRDLKSDNILLELDDDEIPQLVVADFGCCLADDNHGLQLPYESDEVDLGGNAKLMAPEIATAVPGPNA  431 (598)
T ss_pred             HHHHHHHHccchhhcccccceEEEecCCCCcEEEEcccceeeeccccccccccccccccCCCcceecchhhhhcCCCCce
Confidence            999999999999999999999985  333  689999998844322110  001112234556678999998654421  


Q ss_pred             ---CCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         154 ---GPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       154 ---~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                         -.++|.|+.|.+.||++....||.+.-+...-                    ...|..-+.|          ..+..
T Consensus       432 vvny~kAD~WA~GalaYEIfg~~NPFY~rGem~L~--------------------~r~Yqe~qLP----------alp~~  481 (598)
T KOG4158|consen  432 VVNYEKADTWAAGALAYEIFGRSNPFYKRGEMLLD--------------------TRTYQESQLP----------ALPSR  481 (598)
T ss_pred             eeccchhhhhhhhhhHHHHhccCCcccccchheec--------------------hhhhhhhhCC----------CCccc
Confidence               13789999999999999999999873221100                    0001110111          11223


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHH
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSD  254 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~  254 (433)
                      .++.+++++..+|+.||++|+++.
T Consensus       482 vpp~~rqlV~~lL~r~pskRvsp~  505 (598)
T KOG4158|consen  482 VPPVARQLVFDLLKRDPSKRVSPN  505 (598)
T ss_pred             CChHHHHHHHHHhcCCccccCCcc
Confidence            467788999999999999999874

>KOG0606|consensus

Probab=99.78  E-value=2.7e-19  Score=184.01  Aligned_cols=156  Identities=29%  Similarity=0.423  Sum_probs=125.2

Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCc-----CCccc------cccCCcccccccCcccccC
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK-----NGQVN------RYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~-----~~~~~------~~~~~~gt~~y~aPE~~~~  149 (433)
                      +.+++|||+-||+|||+||+|.+|+.-|++|++|||+++.....-     .+.+.      ...+.+||+.|+||||+.-
T Consensus       153 vla~Eylh~ygivhrdlkpdnllIT~mGhiKlTDfgLsk~GLms~atnl~eg~I~k~t~Ef~dKqvcgTPeyiaPeVilr  232 (1205)
T KOG0606|consen  153 VLAVEYLHSYGIVHRDLKPDNLLITSMGHIKLTDFGLSKKGLMSLATNLKEGHIEKDTHEFQDKQVCGTPEYIAPEVILR  232 (1205)
T ss_pred             hHHhHhhccCCeecCCCCCCcceeeecccccccchhhhhhhhhhccchhhhcchHHHHHHhhhccccCCccccChhhhhh
Confidence            779999999999999999999999999999999999986533211     01111      1235689999999999976


Q ss_pred             CCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      .. |+..+|+|++|+|+|+.+-|..||.|.+.++.+..........+++.+                             
T Consensus       233 qg-ygkpvdwwamGiIlyeFLVgcvpffGdtpeelfg~visd~i~wpE~de-----------------------------  282 (1205)
T KOG0606|consen  233 QG-YGKPVDWWAMGIILYEFLVGCVPFFGDTPEELFGQVISDDIEWPEEDE-----------------------------  282 (1205)
T ss_pred             hc-cCCCccHHHHHHHHHHHheeeeeccCCCHHHHHhhhhhhhccccccCc-----------------------------
Confidence            54 899999999999999999999999999999887776654443333222                             


Q ss_pred             cCChhHHHHHHhhcccCCCCCC---CHHHhhcCCCccCCC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRF---DSDAALNHDFFWTDP  266 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~---t~~e~L~h~~~~~~~  266 (433)
                      ...++++++|.++|+.+|..|.   .+-++.+|.||+...
T Consensus       283 a~p~Ea~dli~~LL~qnp~~Rlgt~ga~evk~h~ff~~LD  322 (1205)
T KOG0606|consen  283 ALPPEAQDLIEQLLRQNPLCRLGTGGALEVKQHGFFQLLD  322 (1205)
T ss_pred             CCCHHHHHHHHHHHHhChHhhcccchhhhhhhccceeecc
Confidence            2567888999999999999995   567888999997543

>KOG1164|consensus

Probab=99.77  E-value=1.8e-17  Score=159.60  Aligned_cols=171  Identities=25%  Similarity=0.277  Sum_probs=139.0

Q ss_pred             hHHHHHHHHHhCC----CCCccceeeeEE-ecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK----HENVVHLIEICR-TKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         9 ~~~~Ei~il~~l~----hpnIv~l~~~~~-~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll~   82 (433)
                      .+..|+.+|..+.    .+++..+++... ..        ..-||||+.++.+|.++..... .+|+...+..++.|++.
T Consensus        62 ~l~~E~~vl~~l~~~~~~~~~~~~~~~G~~~~--------~~~~iVM~l~G~sL~dl~~~~~~~~fs~~T~l~ia~q~l~  133 (322)
T KOG1164|consen   62 VLKIEIQVLKKLEKKNGPSHFPKLLDHGRSTE--------DFNFIVMSLLGPSLEDLRKRNPPGRFSRKTVLRIAIQNLN  133 (322)
T ss_pred             cchhHHHHHHHHhhhcCCCCCCEEEEeccCCC--------ceeEEEEeccCccHHHHHHhCCCCCcCHhHHHHHHHHHHH
Confidence            6888999999996    368999999885 32        5679999999999999886655 67999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecC-----CcEEEeecCCcc--ccccCcCC---cccc-ccCCcccccccCcccccCCC
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKT-----GILKLADFGLAR--AFSQTKNG---QVNR-YTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~-----~~~kl~DFg~a~--~~~~~~~~---~~~~-~~~~~gt~~y~aPE~~~~~~  151 (433)
                      +|++||+.|++||||||.|+++...     ..+.|.|||+++  .+......   .... .....||..|.++.+..+..
T Consensus       134 ~l~~lH~~G~iHRDiKp~N~~~g~~~~~~~~~~~llDfGlar~~~~~~~~~~~~~~~r~~~~~~rGT~ry~S~~~H~~~e  213 (322)
T KOG1164|consen  134 ALEDLHSKGFIHRDIKPENFVVGQSSRSEVRTLYLLDFGLARRFKYVGDSGGNLRPPRPQKGLFRGTLRYASINVHLGIE  213 (322)
T ss_pred             HHHHHHhcCcccCCcCHHHeeecCCCCcccceEEEEecCCCccccccCCCCcccccCCCCccCCCCccccccHHHhCCCc
Confidence            9999999999999999999999865     368999999998  43222211   1111 23456999999999988876


Q ss_pred             CCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHH
Q psy7889         152 NYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI  188 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i  188 (433)
                       .+.+.|+||++.++.+|+.|..||.+.........+
T Consensus       214 -~~r~DDles~~Y~l~el~~g~LPW~~~~~~~~~~~~  249 (322)
T KOG1164|consen  214 -QGRRDDLESLFYMLLELLKGSLPWEALEMTDLKSKF  249 (322)
T ss_pred             -cCCchhhhhHHHHHHHHhcCCCCCccccccchHHHH
Confidence             599999999999999999999999876654444433

>PRK09188 serine/threonine protein kinase; Provisional

Probab=99.76  E-value=2.3e-18  Score=165.87  Aligned_cols=124  Identities=23%  Similarity=0.193  Sum_probs=92.9

Q ss_pred             hhHHHHHHHHHhCCCCCccc-eeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVH-LIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~-l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++|+|||. +++ +           +..|||||||+|..+.....    ..   ...++.|++.||.|
T Consensus        66 ~~~~~E~~iL~~L~h~~iv~~l~~-~-----------~~~~LVmE~~~G~~L~~~~~----~~---~~~~~~~i~~aL~~  126 (365)
T PRK09188         66 HLAAREIRALKTVRGIGVVPQLLA-T-----------GKDGLVRGWTEGVPLHLARP----HG---DPAWFRSAHRALRD  126 (365)
T ss_pred             HHHHHHHHHHHhccCCCCCcEEEE-c-----------CCcEEEEEccCCCCHHHhCc----cc---hHHHHHHHHHHHHH
Confidence            45889999999999999985 443 1           23699999998643332211    11   14678999999999


Q ss_pred             HHhCCeeccCC-CCCcEEEecCCcEEEeecCCccccccCcCCcc----ccccCCcccccccCcccccCC
Q psy7889          87 IHSNKILHRDM-KAANVLITKTGILKLADFGLARAFSQTKNGQV----NRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        87 LH~~~iiH~di-kp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ||++||+|||| ||+|||++.++.++|+|||+|+.+........    .......++..|.|||.+...
T Consensus       127 lH~~gIiHrDL~KP~NILv~~~~~ikLiDFGlA~~~~~~~~~~~~~~~~d~~~~~~~~~~~~pe~~~~~  195 (365)
T PRK09188        127 LHRAGITHNDLAKPQNWLMGPDGEAAVIDFQLASVFRRRGALYRIAAYEDLRHLLKHKRTYAPDALTPR  195 (365)
T ss_pred             HHHCCCeeCCCCCcceEEEcCCCCEEEEECccceecccCcchhhhhhhhhhhhhhccCccCCcccCChh
Confidence            99999999999 99999999999999999999987754321111    112345678889999988543

>PRK10359 lipopolysaccharide core biosynthesis protein; Provisional

Probab=99.74  E-value=4.1e-18  Score=152.98  Aligned_cols=134  Identities=18%  Similarity=0.282  Sum_probs=101.9

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      +.+|+..+.++.|++|..+.+++.+....+..+.+..+|||||++| +|.+..     .+++    ....+++.+|..||
T Consensus        82 ~e~Ea~~l~rL~~~GI~~~~d~~~~~~~~~~~~~~~~~lvmEyi~G~tL~~~~-----~~~~----~~~~~i~~~l~~lH  152 (232)
T PRK10359         82 YENLIVQTDRVRSEGLASLNDFYLLAERKTLRYAHTYIMLIEYIEGVELNDMP-----EISE----DVKAKIKASIESLH  152 (232)
T ss_pred             HHHHHHHHHHHHHCCCCcceEeeeecccccccccCCeEEEEEEECCccHHHhh-----hccH----HHHHHHHHHHHHHH
Confidence            5789999999999999999999887644333345678999999997 565542     2333    24569999999999


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHH
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE  168 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~e  168 (433)
                      +.|++|+|+||+||+++.+| ++|+|||.........                 |-+.+.-...|+.++|+||||+++..
T Consensus       153 ~~gi~H~Dikp~Nili~~~g-i~liDfg~~~~~~e~~-----------------a~d~~vler~y~~~~di~~lg~~~~~  214 (232)
T PRK10359        153 QHGMVSGDPHKGNFIVSKNG-LRIIDLSGKRCTAQRK-----------------AKDRIDLERHYGIKNEIKDLGYYLLI  214 (232)
T ss_pred             HcCCccCCCChHHEEEeCCC-EEEEECCCcccccchh-----------------hHHHHHHHhHhcccccccceeEeehH
Confidence            99999999999999999988 9999999875543211                 11112222336789999999999876


Q ss_pred             HH
Q psy7889         169 MW  170 (433)
Q Consensus       169 ll  170 (433)
                      +.
T Consensus       215 ~~  216 (232)
T PRK10359        215 YK  216 (232)
T ss_pred             HH
Confidence            53

>KOG1033|consensus

Probab=99.73  E-value=8e-19  Score=169.23  Aligned_cols=182  Identities=27%  Similarity=0.481  Sum_probs=132.3

Q ss_pred             CceEEEEeecCcC-CHHHHHhccC--CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          43 RSTFYLVFDFCEH-DLAGLLSNIH--VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        43 ~~~~~lV~e~~~~-~L~~~l~~~~--~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      ..++||.|+.|.. +|.+.+....  ...+......++.|+..|++|   +|.+|+|+||.||++..++.+||+|||+..
T Consensus       328 ~~~lyI~Mn~c~~~tledWl~rr~~~e~~s~s~~~~~~~q~~~~~~y---k~~ihrdlkp~nif~~~d~q~kIgDFgl~t  404 (516)
T KOG1033|consen  328 KVYLYIQMNLCEKETLEDWLRRRRTGEERSLSLMLDIFKQIAPAVEY---KGLIHRDLKPSNIFFSDDDQLKIGDFGLVT  404 (516)
T ss_pred             ccchhhhhhhhhhhhHHHHhhCCCcccccchhHHHHHHHhhccchhh---ccchhhhccccccccccchhhhhhhhhhee
Confidence            4578999999984 6666665332  235667889999999999999   999999999999999999999999999987


Q ss_pred             ccccCc--CCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHH-hCCCC
Q psy7889         120 AFSQTK--NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL-CGSIT  196 (433)
Q Consensus       120 ~~~~~~--~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~-~g~~~  196 (433)
                      ......  .......+..+||.+|++||.+.+.. |+.++||||||++++||+.-   |.  +..+....+..+ -|.++
T Consensus       405 s~~~~~~~~~~~a~~t~~~gt~~YmsPEQi~g~~-y~~kvdIyaLGlil~EL~~~---f~--T~~er~~t~~d~r~g~ip  478 (516)
T KOG1033|consen  405 SQDKDETVAPAAASHTQQVGTLLYMSPEQIRGQQ-YSEKVDIYALGLILAELLIQ---FS--TQFERIATLTDIRDGIIP  478 (516)
T ss_pred             ecccCCcccchhhhhhhcccccccCCHHHHhhhh-hhhhcchhhHHHHHHHHHHH---hc--cHHHHHHhhhhhhcCCCC
Confidence            765332  11122456788999999999999875 89999999999999999872   11  112222221111 11122


Q ss_pred             CCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         197 PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       197 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      +..|.                             -.++-.+|+.+||...|.+||++.+.-.|+|.
T Consensus       479 ~~~~~-----------------------------d~p~e~~ll~~lls~~p~~RP~~~~~~~~~~~  515 (516)
T KOG1033|consen  479 PEFLQ-----------------------------DYPEEYTLLQQLLSPSPEERPSAIEVALHEFL  515 (516)
T ss_pred             hHHhh-----------------------------cCcHHHHHHHHhcCCCcccCchHHHHhhhhhc
Confidence            11111                             11233489999999999999988887777765

>KOG1023|consensus

Probab=99.72  E-value=3.3e-17  Score=160.92  Aligned_cols=207  Identities=25%  Similarity=0.339  Sum_probs=153.6

Q ss_pred             HHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCe-ec
Q psy7889          17 LQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKI-LH   94 (433)
Q Consensus        17 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~i-iH   94 (433)
                      |+.+.|.|+.++++.+.+.        ..+++|.+||. |+|.+.+.+....++.-+...+++.|+.||.|+|+--| .|
T Consensus         1 l~~l~h~n~~~f~g~~~~~--------~~~~~i~~~c~rGsl~D~i~~~~~~~d~~F~~s~~rdi~~Gl~ylh~s~i~~h   72 (484)
T KOG1023|consen    1 LRQLDHDNLNKFIGASVDG--------PEMIVIWEYCSRGSLLDILSNEDIKLDYFFILSFIRDISKGLAYLHNSPIGYH   72 (484)
T ss_pred             CcccchhhhhhheeeEecC--------CceEEEEeeecCccHHhHHhccccCccHHHHHHHHHHHHHHHHHHhcCcceee
Confidence            4678999999999999986        66999999997 78999998877788999999999999999999997765 99


Q ss_pred             cCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC------CCCcchhhhHHHHHHH
Q psy7889          95 RDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN------YGPPVDLWGAGCIMAE  168 (433)
Q Consensus        95 ~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~------~~~~~DiwSlGvil~e  168 (433)
                      +.++..|++++....+||.|||+.......  ..........-...|.|||.+.+...      .+.+.||||+|++++|
T Consensus        73 g~l~s~nClvd~~w~lklt~~Gl~~~~~~~--~~~~~~~~~~~~~lw~aPellr~~~~~~~~~~~~~~gdiYs~~ii~~e  150 (484)
T KOG1023|consen   73 GALKSSNCLVDSRWVLKLTDFGLNSLLEET--AEPEAHHPIRKALLWTAPELLRGALSQSLESALTQKGDIYSFGIIMYE  150 (484)
T ss_pred             eeeccccceeeeeEEEEechhhhccccccc--ccccccchhHHHHhccCHHHhcccccccccccccccCCeehHHHHHHH
Confidence            999999999999999999999998776421  01111112223557999999976421      3667999999999999


Q ss_pred             HHhcCCCCCCCChH----HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         169 MWTRSPIMQGNTEQ----QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       169 ll~g~~pf~~~~~~----~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++...||......    +.+..+..   ......-+.+....                      ...++...++..|+.
T Consensus       151 i~~r~~~~~~~~~~~~~~eii~~~~~---~~~~~~rP~i~~~~----------------------e~~~~l~~l~~~cw~  205 (484)
T KOG1023|consen  151 ILFRSGPFDLRNLVEDPDEIILRVKK---GGSNPFRPSIELLN----------------------ELPPELLLLVARCWE  205 (484)
T ss_pred             HHhccCccccccccCChHHHHHHHHh---cCCCCcCcchhhhh----------------------hcchHHHHHHHHhcc
Confidence            99999999863222    22222222   11111111111000                      122356689999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      -+|..||+.+++-.
T Consensus       206 e~P~~rPs~~~i~~  219 (484)
T KOG1023|consen  206 EIPEKRPSIEQIRS  219 (484)
T ss_pred             cChhhCccHHHHHh
Confidence            99999999988853

>KOG1163|consensus

Probab=99.71  E-value=5.6e-17  Score=141.54  Aligned_cols=175  Identities=23%  Similarity=0.303  Sum_probs=141.5

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+.|..+.+.|+ ...|..+..+....        .+-.+|||.++.+|.+++.-....|+..++.-++-|++.-++
T Consensus        54 hpqL~yEskvY~iL~~g~GiP~i~~y~~e~--------~ynvlVMdLLGPsLEdLfnfC~R~ftmkTvLMLaDQml~RiE  125 (341)
T KOG1163|consen   54 HPQLLYESKVYRILQGGVGIPHIRHYGTEK--------DYNVLVMDLLGPSLEDLFNFCSRRFTMKTVLMLADQMLSRIE  125 (341)
T ss_pred             CcchhHHHHHHHHhccCCCCchhhhhcccc--------ccceeeeeccCccHHHHHHHHhhhhhHHhHHHHHHHHHHHHH
Confidence            456788999999995 66777777666654        456899999998877777665667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCcccccc---CCcccccccCcccccCCCCCCCcchh
Q psy7889          86 YIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYT---NRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |+|.++.+||||||+|+|..-   ...+-|+|||+|+.+-+.......++.   ...||..|.+-....+.. .+...|+
T Consensus       126 yvH~r~fiHRDIKPdNFLMGlgrh~~kl~LIDFGLaKky~d~~t~~HIpyre~r~ltGTaRYASinAh~g~e-qSRRDDm  204 (341)
T KOG1163|consen  126 YVHLRNFIHRDIKPDNFLMGLGRHCNKLYLIDFGLAKKYRDIRTRQHIPYREDRNLTGTARYASINAHLGIE-QSRRDDM  204 (341)
T ss_pred             HHHhhccccccCCccceeeccccccceEEEEeccchhhhccccccccCccccCCccceeeeehhhhhhhhhh-hhhhhhh
Confidence            999999999999999999863   457899999999998776655555544   357899999887776655 4788999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQ  190 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~  190 (433)
                      =|+|.++..+.-|..||+|.......++..+
T Consensus       205 eSvgYvLmYfnrG~LPWQglka~tk~QKyEk  235 (341)
T KOG1163|consen  205 ESVGYVLMYFNRGSLPWQGLKAATKKQKYEK  235 (341)
T ss_pred             hhhcceeeeeecCCCcccccchhhHHHHHHH
Confidence            9999999999999999999765554444433

>PRK12274 serine/threonine protein kinase; Provisional

Probab=99.71  E-value=5.9e-17  Score=142.51  Aligned_cols=151  Identities=17%  Similarity=0.062  Sum_probs=106.9

Q ss_pred             hHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      -+.+|+++|++|+ |++|++++++.            ..|++|||+.|. |.....       .. ...++.|++.+|++
T Consensus        47 l~~rE~~iL~~L~~~~~vP~ll~~~------------~~~lvmeyI~G~~L~~~~~-------~~-~~~~~~qi~~~L~~  106 (218)
T PRK12274         47 LARREALALRQLDGLPRTPRLLHWD------------GRHLDRSYLAGAAMYQRPP-------RG-DLAYFRAARRLLQQ  106 (218)
T ss_pred             HHHHHHHHHHhcCCCCCCCEEEEEc------------CEEEEEeeecCccHHhhhh-------hh-hHHHHHHHHHHHHH
Confidence            3789999999995 68899998851            158999999874 433211       11 23577899999999


Q ss_pred             HHhCCeeccCC-CCCcEEEecCCcEEEeecCCccccccCcCC-------cccc--ccCCcccccccCcccccCCCCCC-C
Q psy7889          87 IHSNKILHRDM-KAANVLITKTGILKLADFGLARAFSQTKNG-------QVNR--YTNRVVTLWYRPPELLLGDRNYG-P  155 (433)
Q Consensus        87 LH~~~iiH~di-kp~NIll~~~~~~kl~DFg~a~~~~~~~~~-------~~~~--~~~~~gt~~y~aPE~~~~~~~~~-~  155 (433)
                      +|++||+|||| ||+|||++.+|.++|+|||++........-       ....  ..-...++.|+.|+...--...+ .
T Consensus       107 lH~~GIvHrDL~kp~NILv~~~g~i~LIDFG~A~~~~~~~~~~r~L~~rDl~~llk~~~~y~~~~l~~~~~~~l~~~~~~  186 (218)
T PRK12274        107 LHRCGVAHNDLAKEANWLVQEDGSPAVIDFQLAVRGNPRARWMRLLAREDLRHLLKHKRMYCPAALTPVERRVLKRTSWI  186 (218)
T ss_pred             HHHCcCccCCCCCcceEEEcCCCCEEEEECCCceecCCcchHHHHHHHHHHHHHHHHHHhcCCCCCCHHHHhhhccchhH
Confidence            99999999999 799999999999999999999754422100       0000  00012356677776432211122 4


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCC
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGN  179 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~  179 (433)
                      +.++++.|+-+|.++|+..++.+.
T Consensus       187 ~~~w~~~g~~~~~~~~~~~~~~~~  210 (218)
T PRK12274        187 RELWFATGKPVYRFVTRRVLHWED  210 (218)
T ss_pred             HHHHHHhcchHHHHHhccCCcccc
Confidence            678899999999999998877654

>KOG1165|consensus

Probab=99.69  E-value=1.8e-16  Score=144.32  Aligned_cols=166  Identities=23%  Similarity=0.333  Sum_probs=142.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      -++.-|....+.| ..+.|...|.+-...        .+-.||||.++.+|.+++.-...+|+...+..++.|++.-++|
T Consensus        68 PQLrdEYr~YKlL~g~~GIP~vYYFGqeG--------~~NiLVidLLGPSLEDLFD~CgR~FSvKTV~miA~Qmi~rie~  139 (449)
T KOG1165|consen   68 PQLRDEYRTYKLLGGTEGIPQVYYFGQEG--------KYNILVIDLLGPSLEDLFDLCGRRFSVKTVAMIAKQMITRIEY  139 (449)
T ss_pred             chHHHHHHHHHHHcCCCCCCceeeecccc--------chhhhhhhhhCcCHHHHHHHhcCcccHHhHHHHHHHHHHHHHH
Confidence            3566788888888 589999888766543        4457999999999999998888899999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCC-----cEEEeecCCccccccCcCCcccccc---CCcccccccCcccccCCCCCCCcch
Q psy7889          87 IHSNKILHRDMKAANVLITKTG-----ILKLADFGLARAFSQTKNGQVNRYT---NRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~-----~~kl~DFg~a~~~~~~~~~~~~~~~---~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      +|++.+|+|||||+|+||...+     .|.++|||+|+.+-+++..++.++.   ...||..||+-...+|.. -+...|
T Consensus       140 vH~k~LIYRDIKPdNFLIGrp~~k~~n~IhiiDFGmAK~YrDp~TkqHIPYrE~KSLsGTARYMSINTHlGrE-QSRRDD  218 (449)
T KOG1165|consen  140 VHEKDLIYRDIKPDNFLIGRPGTKDANVIHIIDFGMAKEYRDPKTKQHIPYREHKSLSGTARYMSINTHLGRE-QSRRDD  218 (449)
T ss_pred             HHhcceeecccCccceeecCCCCCCCceEEEEeccchhhhcCccccccCccccccccccceeeeEeeccccch-hhhhhh
Confidence            9999999999999999997543     6899999999999887766666654   467899999988888877 488999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQ  182 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~  182 (433)
                      +=|||-++...|-|..||.|-.-.
T Consensus       219 LEaLGHvFmYFLRGsLPWQGLKA~  242 (449)
T KOG1165|consen  219 LEALGHVFMYFLRGSLPWQGLKAD  242 (449)
T ss_pred             HHHhhhhhhhhccCCCccccccCc
Confidence            999999999999999999985433

>PF14531 Kinase-like: Kinase-like; PDB: 3DZO_A 2W1Z_A 3BYV_A 3Q5Z_A 3Q60_A

Probab=99.69  E-value=5.5e-18  Score=156.66  Aligned_cols=162  Identities=19%  Similarity=0.258  Sum_probs=103.8

Q ss_pred             EEEEeecCcCCHHHHHhcc---CCC-CCHHH-H-HHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          46 FYLVFDFCEHDLAGLLSNI---HVK-FSLGE-I-KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        46 ~~lV~e~~~~~L~~~l~~~---~~~-l~~~~-~-~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .+++|+-+.+||..++.-.   ... ..... + ..+..|+++.+++||+.|++|+||+|+|++++.+|.+.|+||+...
T Consensus       114 ~~~l~P~~~~dL~~~~~~l~~~~~~~~~l~~~arl~lT~Q~I~lvA~Lh~~GlVHgdi~~~nfll~~~G~v~Lg~F~~~~  193 (288)
T PF14531_consen  114 RFLLMPRAQGDLQDLVEALFSRAQTHSPLAFAARLSLTVQMIRLVANLHSYGLVHGDIKPENFLLDQDGGVFLGDFSSLV  193 (288)
T ss_dssp             EEEEEE--SEEHHHHHHHHHHHTTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEEEST-SGGGEEE-TTS-EEE--GGGEE
T ss_pred             hhhccchhhhcHHHHHHHHhhcccccchhHHHHHHHHHHHHHHHHHHHhhcceEecccceeeEEEcCCCCEEEcChHHHe
Confidence            4789999999888776432   111 11222 2 3455899999999999999999999999999999999999998776


Q ss_pred             ccccCcCCccccccCCcccccccCcccccCC-------CCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHh
Q psy7889         120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-------RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLC  192 (433)
Q Consensus       120 ~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~  192 (433)
                      ......       .....+..|.+||.....       ..++.+.|.|+||+++|.|+++..||..........      
T Consensus       194 r~g~~~-------~~~~~~~~~~PPe~~~~~~~~~~~~~~~t~~~DaW~LG~~ly~lWC~~lPf~~~~~~~~~~------  260 (288)
T PF14531_consen  194 RAGTRY-------RCSEFPVAFTPPELESCAGQFGQNNAPYTFATDAWQLGITLYSLWCGRLPFGLSSPEADPE------  260 (288)
T ss_dssp             ETTEEE-------EGGGS-TTTS-HHHHHHHTSCHHSEEEE-HHHHHHHHHHHHHHHHHSS-STCCCGGGSTSG------
T ss_pred             ecCcee-------eccCCCcccCChhhhhhhcccCcccceeeeccCHHHHHHHHHHHHHccCCCCCCCcccccc------
Confidence            654211       112335678999976432       236889999999999999999999998654321000      


Q ss_pred             CCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCC
Q psy7889         193 GSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR  250 (433)
Q Consensus       193 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R  250 (433)
                                .    .+..+              .  .++...++||.++|+.||.+|
T Consensus       261 ----------~----~f~~C--------------~--~~Pe~v~~LI~~lL~~~~~~R  288 (288)
T PF14531_consen  261 ----------W----DFSRC--------------R--DMPEPVQFLIRGLLQRNPEDR  288 (288)
T ss_dssp             ----------G----GGTTS--------------S-----HHHHHHHHHHT-SSGGGS
T ss_pred             ----------c----cchhc--------------C--CcCHHHHHHHHHHccCCcccC
Confidence                      0    11111              1  345667799999999999887

>PRK10345 hypothetical protein; Provisional

Probab=99.68  E-value=2.6e-16  Score=140.75  Aligned_cols=104  Identities=20%  Similarity=0.252  Sum_probs=83.0

Q ss_pred             CchhHHHHHHHHHhC-----CCCCccceeeeEEecCccccccCceEE-EEeecCc---CCHHHHHhccCCCCCHHHHHHH
Q psy7889           6 FPITALREIKILQLL-----KHENVVHLIEICRTKANQYNRYRSTFY-LVFDFCE---HDLAGLLSNIHVKFSLGEIKKV   76 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l-----~hpnIv~l~~~~~~~~~~~~~~~~~~~-lV~e~~~---~~L~~~l~~~~~~l~~~~~~~i   76 (433)
                      ....+.+|+.+++.+     +||||+++++++.++..     .+.++ +|+||++   ++|.+++.+.  .+++.  ..+
T Consensus        39 ~~~~~~rEi~~l~~L~~~~~~h~nIvr~yg~~et~~g-----~g~v~~~I~e~~G~~~~tL~~~l~~~--~~~e~--~~~  109 (210)
T PRK10345         39 GDKEIRRELKYYAHLSRRLIDWSGIPRYYGTVETDCG-----TGYVYDVIADFDGKPSITLTEFAEQC--RYEED--VAQ  109 (210)
T ss_pred             hHHHHHHHHHHHHHhhccCCCCcccceeeEEEEeCCC-----CeEEEEEEecCCCCcchhHHHHHHcc--cccHh--HHH
Confidence            346789999999999     57999999999998732     13434 8999955   5999999663  46665  356


Q ss_pred             HHHHHHHH-HHHHhCCeeccCCCCCcEEEecC----CcEEEeecCCc
Q psy7889          77 IQQLLNGL-YYIHSNKILHRDMKAANVLITKT----GILKLADFGLA  118 (433)
Q Consensus        77 ~~qll~aL-~~LH~~~iiH~dikp~NIll~~~----~~~kl~DFg~a  118 (433)
                      +.|++.++ +|||+++|+||||||+|||++..    +.++|+||+.+
T Consensus       110 ~~~~L~~l~~yLh~~~IvhrDlKp~NILl~~~~~~~~~~~LiDg~G~  156 (210)
T PRK10345        110 LRQLLKKLKRYLLDNRIVTMELKPQNILCQRISESEVIPVVCDNIGE  156 (210)
T ss_pred             HHHHHHHHHHHHHHCCEeecCCCHHHEEEeccCCCCCcEEEEECCCC
Confidence            78888887 99999999999999999999743    37999995433

>cd05147 RIO1_euk RIO kinase family; eukaryotic RIO1, catalytic domain

Probab=99.65  E-value=2.9e-16  Score=139.00  Aligned_cols=100  Identities=18%  Similarity=0.223  Sum_probs=79.2

Q ss_pred             HHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHH-HHHhccCCCCCHHHHHHHHHHHHHHHHHH-H
Q psy7889          11 LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLA-GLLSNIHVKFSLGEIKKVIQQLLNGLYYI-H   88 (433)
Q Consensus        11 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~-~~l~~~~~~l~~~~~~~i~~qll~aL~~L-H   88 (433)
                      .+|+.+|+++.+++|.....+...         . .+|||||++++.. ....+ ...++.+.+..++.|++.+|.++ |
T Consensus        67 ~~E~~~l~~l~~~~v~~p~~~~~~---------~-~~iVmE~i~g~~l~~~~~~-~~~~~~~~~~~i~~qi~~~L~~l~H  135 (190)
T cd05147          67 EKEMRNLKRLVTAGIPCPEPILLK---------S-HVLVMEFIGDDGWAAPRLK-DAPLSESKARELYLQVIQIMRILYQ  135 (190)
T ss_pred             HHHHHHHHHHHHCCCCCCcEEEec---------C-CEEEEEEeCCCCCcchhhh-cCCCCHHHHHHHHHHHHHHHHHHHH
Confidence            459999999998887554433221         1 3899999997433 22222 34689999999999999999999 7


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      +.||+||||||+|||++ ++.++|+|||+|....
T Consensus       136 ~~giiHrDlkP~NIli~-~~~v~LiDFG~a~~~~  168 (190)
T cd05147         136 DCRLVHADLSEYNLLYH-DGKLYIIDVSQSVEHD  168 (190)
T ss_pred             hCCcccCCCCHHHEEEE-CCcEEEEEccccccCC
Confidence            99999999999999998 5789999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. This subfamily is composed of RIO1 proteins from eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle progression and c

>cd05145 RIO1_like RIO kinase family; RIO1, RIO3 and similar proteins, catalytic domain

Probab=99.62  E-value=2e-15  Score=134.01  Aligned_cols=101  Identities=21%  Similarity=0.230  Sum_probs=82.0

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ..+|+..+.++.|++|.....+....          .||||||+++. +...... ...++...+..++.|++.++.+||
T Consensus        66 ~~~E~~~l~~l~~~~i~~p~~~~~~~----------~~lVmE~~~g~~~~~~~l~-~~~~~~~~~~~i~~~l~~~l~~lH  134 (190)
T cd05145          66 AEKEFRNLKRLYEAGVPVPEPILLKK----------NVLVMEFIGDDGSPAPRLK-DVPLEEEEAEELYEQVVEQMRRLY  134 (190)
T ss_pred             HHHHHHHHHHHHhCCCCCceEEEecC----------CEEEEEEecCCCchhhhhh-hccCCHHHHHHHHHHHHHHHHHHH
Confidence            35799999999999986665554321          38999999874 3222222 345788899999999999999999


Q ss_pred             h-CCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          89 S-NKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        89 ~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      + +||+||||||+||+++ ++.++|+|||++....
T Consensus       135 ~~~givHrDlkP~NIll~-~~~~~liDFG~a~~~~  168 (190)
T cd05145         135 QEAGLVHGDLSEYNILYH-DGKPYIIDVSQAVELD  168 (190)
T ss_pred             HhCCEecCCCChhhEEEE-CCCEEEEEcccceecC
Confidence            9 9999999999999999 8899999999997654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO1 is present in archaea, bacteria and eukaryotes. In addition, RIO3 is present in multicellular eukaryotes. RIO1 is essential for survival and is required for 18S rRNA processing, proper cell cycle pro

>KOG0590|consensus

Probab=99.60  E-value=6.8e-17  Score=165.77  Aligned_cols=221  Identities=29%  Similarity=0.431  Sum_probs=167.5

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-~l~~~~~~~i~~qll~aL   84 (433)
                      ..+..|+.+-+.+. |.|++++++.....        ...+++++|..+ ++...+..... ..+...+..++.|+..++
T Consensus        65 ~~i~~e~~~~~~~s~h~n~~~~~~~~~~~--------~~~~~~~~~s~g~~~f~~i~~~~~~~~~~~~~~~~~~ql~s~l  136 (601)
T KOG0590|consen   65 EHIDTETDIQKKLSKHSNTVHMIEPSSSP--------RSYLLSLSYSDGGSLFSKISHPDSTGTSSSSASRYLPQLNSGL  136 (601)
T ss_pred             hhcCccccccccccccccccccCCccCCC--------cccccccCcccccccccccccCCccCCCCcchhhhhhhhccCc
Confidence            34455777888886 99999999988775        558899999765 55555523333 577788999999999999


Q ss_pred             HHHH-hCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcc-cccccCcccccCCCCCCCcchhhh
Q psy7889          85 YYIH-SNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        85 ~~LH-~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~g-t~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .|+| ..++.|+|+||+|.+++..+ .+++.|||+|..+..- .+........+| ++.|.|||...+....+...|+||
T Consensus       137 ~~~H~~~~~~h~~ikP~n~~l~~s~~~l~~~df~~At~~~~~-~g~~~~~~~~~g~s~~y~a~E~~~~~~~~~~~~d~~S  215 (601)
T KOG0590|consen  137 SYLHPENGVTHRDIKPSNSLLDESGSALKIADFGLATAYRNK-NGAERSLKDRCGSSPPYGAPEHLSGKAYRGPSVDVWS  215 (601)
T ss_pred             cccCcccccccCCCCCccchhccCCCcccCCCchhhcccccc-CCcceeeecccCCCCCCCCcccccchhhcCCCccccc
Confidence            9999 99999999999999999999 9999999999887651 222334455677 999999999988656789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      .|+++.-+++|..|+......+...           ..|.......                ........+....+++.+
T Consensus       216 ~g~~l~~~~~g~~p~~~~~~~~~~~-----------~~~~~~~~~~----------------~~~~~~~~~~~~~~~l~k  268 (601)
T KOG0590|consen  216 LGIVLSAMLTGELPWDFPSRKDGRY-----------SSWKSNKGRF----------------TQLPWNSISDQAHDLLHK  268 (601)
T ss_pred             ccccccccccCCCCccccccccccc-----------eeeccccccc----------------ccCccccCChhhhhcccc
Confidence            9999999999999887655433110           0111110000                000001235556689999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +|..+|+.|.+.+++-.++|+..
T Consensus       269 ~l~~~~~~r~s~~~~~~d~~~~~  291 (601)
T KOG0590|consen  269 ILKENPSNRLSIEELKLDNWLSS  291 (601)
T ss_pred             cccCCchhccccccccccccccc
Confidence            99999999999999999999977

>KOG0195|consensus

Probab=99.59  E-value=3.8e-15  Score=132.29  Aligned_cols=202  Identities=16%  Similarity=0.221  Sum_probs=147.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCC-CCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVK-FSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~-l~~~~~~~i~~qll~aL   84 (433)
                      +..+..|.--|+-+.||||..+++.|...        ..+.++..|++ ++|++++.....- .+..++..++..++.|+
T Consensus       231 srdfneefp~lrifshpnilpvlgacnsp--------pnlv~isq~mp~gslynvlhe~t~vvvd~sqav~faldiargm  302 (448)
T KOG0195|consen  231 SRDFNEEFPALRIFSHPNILPVLGACNSP--------PNLVIISQYMPFGSLYNVLHEQTSVVVDHSQAVRFALDIARGM  302 (448)
T ss_pred             cchhhhhCcceeeecCCchhhhhhhccCC--------CCceEeeeeccchHHHHHHhcCccEEEecchHHHHHHHHHhhH
Confidence            45567788888888999999999999876        45899999998 6888888764332 57788999999999999


Q ss_pred             HHHHhCC--eeccCCCCCcEEEecCCcEEE--eecCCccccccCcCCccccccCCcccccccCcccccCCCCC--CCcch
Q psy7889          85 YYIHSNK--ILHRDMKAANVLITKTGILKL--ADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNY--GPPVD  158 (433)
Q Consensus        85 ~~LH~~~--iiH~dikp~NIll~~~~~~kl--~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~--~~~~D  158 (433)
                      .|||+..  |.---+....|+|+.+-..+|  +|--++...           ....-.+.|++||.+...+..  -.++|
T Consensus       303 aflhslep~ipr~~lns~hvmidedltarismad~kfsfqe-----------~gr~y~pawmspealqrkped~n~raad  371 (448)
T KOG0195|consen  303 AFLHSLEPMIPRFYLNSKHVMIDEDLTARISMADTKFSFQE-----------VGRAYSPAWMSPEALQRKPEDLNIRAAD  371 (448)
T ss_pred             HHHhhcchhhhhhhcccceEEecchhhhheecccceeeeec-----------cccccCcccCCHHHHhcCchhcchhhhh
Confidence            9999864  444458888999998765444  443222111           112237789999999765432  34799


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      +||+++++|||-|+..||...++.+.-.+|.- .|.-                ..+|.             -.+.....|
T Consensus       372 mwsfaillwel~trevpfadlspmecgmkial-eglr----------------v~ipp-------------gis~hm~kl  421 (448)
T KOG0195|consen  372 MWSFAILLWELNTREVPFADLSPMECGMKIAL-EGLR----------------VHIPP-------------GISRHMNKL  421 (448)
T ss_pred             HHHHHHHHHHhhccccccccCCchhhhhhhhh-cccc----------------ccCCC-------------CccHHHHHH
Confidence            99999999999999999999888775544421 1100                00111             134555689


Q ss_pred             HHhhcccCCCCCCCHHHhh
Q psy7889         239 LDKLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L  257 (433)
                      +.-|+.-||.+||..+.++
T Consensus       422 m~icmnedpgkrpkfdmiv  440 (448)
T KOG0195|consen  422 MNICMNEDPGKRPKFDMIV  440 (448)
T ss_pred             HHHHhcCCCCcCCCcceeh
Confidence            9999999999999987664

>KOG1266|consensus

Probab=99.52  E-value=1.3e-14  Score=132.18  Aligned_cols=212  Identities=17%  Similarity=0.216  Sum_probs=144.1

Q ss_pred             HHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHHHHHHHHhCC-
Q psy7889          17 LQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLNGLYYIHSNK-   91 (433)
Q Consensus        17 l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~aL~~LH~~~-   91 (433)
                      |-.+.|.|||+.+.++.+...   .......+++||+. +++.+++++.   ...+.....++|+-||+.||.|||+.. 
T Consensus       121 llqlvHsnlvkfH~yw~d~K~---~e~~rviFiteymssgs~~~fLkrt~~~~~a~~~~~wkkw~tqIlsal~yLhs~~P  197 (458)
T KOG1266|consen  121 LLQLVHSNLVKFHKYWTDKKY---EEKPRVIFITEYMSSGSLKQFLKRTKKNQKALFQKAWKKWCTQILSALSYLHSCDP  197 (458)
T ss_pred             HHHHHHHHHHHHHHhhccccc---ccccceEEEEecccchhHHHHHHHHHHhhhhhhHHHHHHHHHHHHhhhhhhhccCC
Confidence            334569999999999987633   12467889999997 5788888654   334888899999999999999999875 


Q ss_pred             -eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHH
Q psy7889          92 -ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW  170 (433)
Q Consensus        92 -iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell  170 (433)
                       |+|++++-+.|++..+|.||++--........-............+-++|.|||.=.. .+.+.++|||++|....+|.
T Consensus       198 piihgnlTc~tifiq~ngLIkig~~ap~s~h~s~~~~~~~Ek~~~~~~~g~~a~~sg~~-tn~~~a~dIy~fgmcAlema  276 (458)
T KOG1266|consen  198 PIIHGNLTCDTIFIQHNGLIKIGSVAPDSTHPSVNSTREAEKSVNTSLPGFSAPESGTT-TNTTGASDIYKFGMCALEMA  276 (458)
T ss_pred             ccccCCcchhheeecCCceEEecccCccccchhhhhhhHhhhhccccCCccccCCcCcc-cccccchhhhhhhHHHHHHH
Confidence             9999999999999999999987422111110000000001112344667889985432 23577999999999999998


Q ss_pred             hcCCC-CCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCC
Q psy7889         171 TRSPI-MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK  249 (433)
Q Consensus       171 ~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~  249 (433)
                      .+..- -.+.+.......|..+.-..                                   ...-.++++.+||+-.|..
T Consensus       277 ilEiq~tnseS~~~~ee~ia~~i~~l-----------------------------------en~lqr~~i~kcl~~eP~~  321 (458)
T KOG1266|consen  277 ILEIQSTNSESKVEVEENIANVIIGL-----------------------------------ENGLQRGSITKCLEGEPNG  321 (458)
T ss_pred             HheeccCCCcceeehhhhhhhheeec-----------------------------------cCccccCcCcccccCCCCC
Confidence            76532 22222222222222211110                                   1122237899999999999


Q ss_pred             CCCHHHhhcCCCccCCCC
Q psy7889         250 RFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       250 R~t~~e~L~h~~~~~~~~  267 (433)
                      ||++.++|.||-+.+.+.
T Consensus       322 rp~ar~llfHpllfeVhs  339 (458)
T KOG1266|consen  322 RPDARLLLFHPLLFEVHS  339 (458)
T ss_pred             CcchhhhhcCceeeecch
Confidence            999999999999877653

>PRK01723 3-deoxy-D-manno-octulosonic-acid kinase; Reviewed

Probab=99.45  E-value=4.2e-13  Score=123.17  Aligned_cols=104  Identities=21%  Similarity=0.258  Sum_probs=81.3

Q ss_pred             chhHHHHHHHHHhCCCCCc--cceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENV--VHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnI--v~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|++++..|.|++|  ++.+++......    .....++|||++++  +|..++..  ..+++..    +.||+.
T Consensus        84 ~~r~~rE~~ll~~L~~~gi~vP~pl~~~~~~~~----~~~~~~lV~e~l~G~~~L~~~l~~--~~l~~~~----~~~i~~  153 (239)
T PRK01723         84 RTRAFAEFRLLAQLYEAGLPVPRPIAARVVRHG----LFYRADILIERIEGARDLVALLQE--APLSEEQ----WQAIGQ  153 (239)
T ss_pred             hhHHHHHHHHHHHHHhCCCCCceeEeeeeeecC----cceeeeEEEEecCCCCCHHHHHhc--CCCCHHH----HHHHHH
Confidence            3568899999999998875  677776544311    11234699999985  77777654  2455543    578999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      +|.+||+.||+|+||||.|||++.++.++|+|||.+..
T Consensus       154 ~l~~lH~~GI~HrDlkp~NILv~~~~~v~LIDfg~~~~  191 (239)
T PRK01723        154 LIARFHDAGVYHADLNAHNILLDPDGKFWLIDFDRGEL  191 (239)
T ss_pred             HHHHHHHCCCCCCCCCchhEEEcCCCCEEEEECCCccc
Confidence            99999999999999999999999889999999998755

>PRK14879 serine/threonine protein kinase; Provisional

Probab=99.43  E-value=6.1e-13  Score=120.04  Aligned_cols=98  Identities=23%  Similarity=0.362  Sum_probs=83.2

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.++..+.|++|.....++.+.        +..++||||++| +|.+.+....    . ....++.+++.+|.+|
T Consensus        45 ~~~~E~~~l~~l~~~~i~~p~~~~~~~--------~~~~lv~e~~~G~~L~~~~~~~~----~-~~~~i~~~i~~~l~~l  111 (211)
T PRK14879         45 RTRREARIMSRARKAGVNVPAVYFVDP--------ENFIIVMEYIEGEPLKDLINSNG----M-EELELSREIGRLVGKL  111 (211)
T ss_pred             HHHHHHHHHHHHHHCCCCCCeEEEEeC--------CCCEEEEEEeCCcCHHHHHHhcc----H-HHHHHHHHHHHHHHHH
Confidence            577899999999999998877776654        447899999976 6777765422    2 7888999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      |+.|++|+|++|.||+++ ++.++|+|||++..
T Consensus       112 H~~~i~H~Dl~p~Nil~~-~~~~~liDf~~a~~  143 (211)
T PRK14879        112 HSAGIIHGDLTTSNMILS-GGKIYLIDFGLAEF  143 (211)
T ss_pred             HhCCcccCCCCcccEEEE-CCCEEEEECCcccC
Confidence            999999999999999999 78899999998865

>smart00090 RIO RIO-like kinase

Probab=99.43  E-value=3.6e-13  Score=123.35  Aligned_cols=101  Identities=20%  Similarity=0.229  Sum_probs=76.4

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      +.+|+.+++++.+. ++....++...         ..+|||||+++. +...... ...+....+..++.|++.+|.+||
T Consensus        97 ~~~E~~~L~~L~~~-~i~~p~~~~~~---------~~~lV~E~~~g~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~LH  165 (237)
T smart00090       97 AEKEFRNLQRLYEA-GVPVPKPIAWR---------RNVLVMEFIGGDGLPAPRLK-DVEPEEEEEFELYDDILEEMRKLY  165 (237)
T ss_pred             HHHHHHHHHHHHhc-CCCCCeeeEec---------CceEEEEEecCCcccccccc-cCCcchHHHHHHHHHHHHHHHHHH
Confidence            56899999999753 33333333221         148999999984 3333222 334566678899999999999999


Q ss_pred             hCC-eeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          89 SNK-ILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        89 ~~~-iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      +.| |+|+||||+||+++ ++.++|+|||.+....
T Consensus       166 ~~g~iiH~Dikp~NIli~-~~~i~LiDFg~a~~~~  199 (237)
T smart00090      166 KEGELVHGDLSEYNILVH-DGKVVIIDVSQSVELD  199 (237)
T ss_pred             hcCCEEeCCCChhhEEEE-CCCEEEEEChhhhccC
Confidence            999 99999999999999 8899999999886543

>KOG0601|consensus

Probab=99.41  E-value=1.7e-13  Score=135.00  Aligned_cols=213  Identities=22%  Similarity=0.249  Sum_probs=160.2

Q ss_pred             HHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHH----HH
Q psy7889          10 ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLN----GL   84 (433)
Q Consensus        10 ~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~----aL   84 (433)
                      -++|+.....++ |+|.|+.+..+...        +..|+-+|+|+.+|.++.......++...++.++.+...    ||
T Consensus       164 k~~~~~s~~~i~~~~~~v~~~~~~e~~--------~~lfiqtE~~~~sl~~~~~~~~~~~p~~~l~~~~~~~~~~~~~al  235 (524)
T KOG0601|consen  164 KLREFLSHHKIDSHENPVRDSPAWEGS--------GILFIQTELCGESLQSYCHTPCNFLPDNLLWNSLRDWLSRDVTAL  235 (524)
T ss_pred             ccchhhcccccCccccccccCcccccC--------CcceeeeccccchhHHhhhcccccCCchhhhhHHhhhhhcccccc
Confidence            356666667774 99999988888775        679999999999999999887777899999999999999    99


Q ss_pred             HHHHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCcccccc-CCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYT-NRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~-~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ..+|+.+|+|.|+||.||+...+ ..++++|||+...+..+......... ...|..-|++||++.+  .++.+.|++++
T Consensus       236 ~~~hs~~~~~~~~kp~~i~~~~~~~s~~~~df~~v~~i~~~~~~~~~~~~~r~~~~~~Y~~ke~~~~--l~~~~~di~sl  313 (524)
T KOG0601|consen  236 SHLHSNNIVHDDLKPANIFTTSDWTSCKLTDFGLVSKISDGNFSSVFKVSKRPEGDCIYAAKELLNG--LATFASDIFSL  313 (524)
T ss_pred             cccCCCcccccccchhheecccccceeecCCcceeEEccCCccccceeeeecCCCCceEeChhhhcc--ccchHhhhcch
Confidence            99999999999999999999999 78999999999888765432222222 2255667999999866  36999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |.++.+-.++..++....                ...|......-.      +.       +.+  ...+......+..|
T Consensus       314 ~ev~l~~~l~~~~~~~g~----------------~~~W~~~r~~~i------p~-------e~~--~~~s~~l~~~~~~~  362 (524)
T KOG0601|consen  314 GEVILEAILGSHLPSVGK----------------NSSWSQLRQGYI------PL-------EFC--EGGSSSLRSVTSQM  362 (524)
T ss_pred             hhhhHhhHhhcccccCCC----------------CCCccccccccC------ch-------hhh--cCcchhhhhHHHHh
Confidence            999999988865543320                011111111000      00       000  01223334578899


Q ss_pred             cccCCCCCCCHHHhhcCCCcc
Q psy7889         243 LLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      ++.+|..|++++.+++|+++.
T Consensus       363 ~d~~~~~~~~~q~~~~l~~i~  383 (524)
T KOG0601|consen  363 LDEDPRLRLTAQILTALNVIH  383 (524)
T ss_pred             cCcchhhhhHHHHHhcccccc
Confidence            999999999999999999985

>TIGR03724 arch_bud32 Kae1-associated kinase Bud32

Probab=99.40  E-value=1.1e-12  Score=117.38  Aligned_cols=97  Identities=18%  Similarity=0.286  Sum_probs=77.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .++.+|+++++.+.|++|....-++...        ...++||||++| +|.+.+....     .   .++.+++.+|.+
T Consensus        42 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--------~~~~lv~e~~~g~~l~~~~~~~~-----~---~~~~~i~~~l~~  105 (199)
T TIGR03724        42 ERTRNEARLLSRARKAGVNTPVVYDVDP--------DNKTIVMEYIEGKPLKDVIEEGN-----D---ELLREIGRLVGK  105 (199)
T ss_pred             HHHHHHHHHHHHHHHCCCCCCEEEEEEC--------CCCEEEEEEECCccHHHHHhhcH-----H---HHHHHHHHHHHH
Confidence            4466899999999988765555544443        346899999976 5665553311     1   788999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      ||+.|++|+|++|.||+++ ++.++++|||++...
T Consensus       106 lH~~gi~H~Dl~~~Nil~~-~~~~~liDfg~a~~~  139 (199)
T TIGR03724       106 LHKAGIVHGDLTTSNIIVR-DDKLYLIDFGLGKYS  139 (199)
T ss_pred             HHHCCeecCCCCcceEEEE-CCcEEEEECCCCcCC
Confidence            9999999999999999999 789999999988653

Members of this protein family are the Bud32 protein associated with Kae1 (kinase-associated endopeptidase 1) in the Archaea. In many Archaeal genomes, Kae1 and Bud32 are fused. The complex is homologous to the Kae1 and Bud32 subunits of the eukaryotic KEOPS complex, an apparently ancient protein kinase-containing molecular machine.

>PRK09605 bifunctional UGMP family protein/serine/threonine protein kinase; Validated

Probab=99.40  E-value=1e-12  Score=135.07  Aligned_cols=96  Identities=19%  Similarity=0.283  Sum_probs=81.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++|++|+..+.++.+.        ...++||||+++ +|.+.+.         ....++.+++.+|.+
T Consensus       381 ~~~~~E~~~l~~l~~~~i~~p~~~~~~~--------~~~~lv~E~~~g~~L~~~l~---------~~~~~~~~i~~~L~~  443 (535)
T PRK09605        381 ERTRAEARLLSEARRAGVPTPVIYDVDP--------EEKTIVMEYIGGKDLKDVLE---------GNPELVRKVGEIVAK  443 (535)
T ss_pred             HHHHHHHHHHHhhcccCCCeeEEEEEeC--------CCCEEEEEecCCCcHHHHHH---------HHHHHHHHHHHHHHH
Confidence            4578899999999999999887766654        336899999976 6666554         346788999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      ||+.|++||||||+|||+ .++.++|+|||+++..
T Consensus       444 lH~~giiHrDlkp~NILl-~~~~~~liDFGla~~~  477 (535)
T PRK09605        444 LHKAGIVHGDLTTSNFIV-RDDRLYLIDFGLGKYS  477 (535)
T ss_pred             HHhCCCccCCCChHHEEE-ECCcEEEEeCcccccC
Confidence            999999999999999999 6788999999998663

>KOG1166|consensus

Probab=99.38  E-value=9.1e-13  Score=138.67  Aligned_cols=147  Identities=19%  Similarity=0.251  Sum_probs=116.3

Q ss_pred             HHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7889          15 KILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN   90 (433)
Q Consensus        15 ~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~   90 (433)
                      +++.+|+   -+.|.++..++.-        .+.-+||+||.+ |+|++++. ....+++..+..++.|++.-|+.||..
T Consensus       743 q~~~RLk~~~~~~~~~~~~a~~~--------~~~S~lv~ey~~~Gtlld~~N-~~~~m~e~lv~~~~~qml~ive~lH~~  813 (974)
T KOG1166|consen  743 QVMERLKPQMLPSIMHISSAHVF--------QNASVLVSEYSPYGTLLDLIN-TNKVMDEYLVMFFSCQMLRIVEHLHAM  813 (974)
T ss_pred             HHHHhhchhhhcchHHHHHHHcc--------CCcceeeeeccccccHHHhhc-cCCCCCchhhhHHHHHHHHHHHHHHhc
Confidence            4556666   2344444444433        355789999997 68888877 344689999999999999999999999


Q ss_pred             CeeccCCCCCcEEEec-------CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          91 KILHRDMKAANVLITK-------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        91 ~iiH~dikp~NIll~~-------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      +|||+||||+|+||..       .--++|+|||.+.-+.--.+.  ..+...++|-.+-.+|...|.+ |+..+|-|-|+
T Consensus       814 ~IIHgDiKPDNfll~~~~~~~~~~~~l~lIDfG~siDm~lfp~~--~~F~~~~~td~f~C~EM~~grp-WtYq~DyfGlA  890 (974)
T KOG1166|consen  814 GIIHGDIKPDNFLLRREICADSDSKGLYLIDFGRSIDMKLFPDG--TKFKAVWHTDLFDCIEMREGRP-WTYQIDYFGLA  890 (974)
T ss_pred             ceecccCCcceeEeecccCCCCcccceEEEecccceeeeEcCCC--cEEeeeeccccchhHHHhcCCC-CchhhhhHHHH
Confidence            9999999999999963       235999999999776543333  3456677788899999887765 99999999999


Q ss_pred             HHHHHHHhcC
Q psy7889         164 CIMAEMWTRS  173 (433)
Q Consensus       164 vil~ell~g~  173 (433)
                      .+++.||.|+
T Consensus       891 a~~h~mLFG~  900 (974)
T KOG1166|consen  891 ATVHVMLFGK  900 (974)
T ss_pred             HHHHHHHHHH
Confidence            9999999995

>KOG0606|consensus

Probab=99.33  E-value=8.1e-13  Score=136.90  Aligned_cols=192  Identities=30%  Similarity=0.405  Sum_probs=146.7

Q ss_pred             CceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          43 RSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        43 ~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      +.-.+||++|+.+ ++...+.+.. ..+.+-.+.++..+.+++++||...+.|+|++|.|+++..+|..++.|||.....
T Consensus       876 rsP~~L~~~~~~~~~~~Skl~~~~-~~saepaRs~i~~~vqs~e~L~s~~r~h~~~~p~~~l~~~~gh~~l~~~~t~~~v  954 (1205)
T KOG0606|consen  876 RSPLPLVGHYLNGGDLPSKLHNSG-CLSAEPARSPILERVQSLESLHSSLRKHRDLKPDSLLIAYDGHRPLTDFGTLSKV  954 (1205)
T ss_pred             CCCcchhhHHhccCCchhhhhcCC-CcccccccchhHHHHhhhhccccchhhcccccccchhhcccCCcccCcccccccc
Confidence            3558999999964 7777776644 4677778888889999999999999999999999999999999999999843322


Q ss_pred             ccC--------c-----------CC--------ccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCC
Q psy7889         122 SQT--------K-----------NG--------QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP  174 (433)
Q Consensus       122 ~~~--------~-----------~~--------~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~  174 (433)
                      ..-        .           ..        ....-....+|..|.+||.+.+.. -+.++|+|++|+++++.++|.+
T Consensus       955 g~~~p~~~~sg~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~t~~~laPe~~lg~~-hgs~ad~~~~g~~l~e~l~g~p 1033 (1205)
T KOG0606|consen  955 GLIPPTTDLSGPSSSGTPRRLSRSERRPQLSADEARRKHAVVGTPDYLAPEILLGRR-HGSAADWWSSGVCLFEVLTGIP 1033 (1205)
T ss_pred             ccccCcCCcccccccCccccccccccccccccchhhccccccCCCcccCCccccccc-CCCcchhhhhhhhhhhhhcCCC
Confidence            110        0           00        001123457899999999999877 4899999999999999999999


Q ss_pred             CCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHH
Q psy7889         175 IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSD  254 (433)
Q Consensus       175 pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~  254 (433)
                      ||...........|..  +.   ..|+..                        +...+.++.+++..+|..+|.+|..+.
T Consensus      1034 p~na~tpq~~f~ni~~--~~---~~~p~g------------------------~~~~s~~aq~~~~~ll~~~~~qr~~a~ 1084 (1205)
T KOG0606|consen 1034 PFNAETPQQIFENILN--RD---IPWPEG------------------------PEEGSYEAQDLINRLLTEEPTQRLGAK 1084 (1205)
T ss_pred             CCCCcchhhhhhcccc--CC---CCCCCC------------------------ccccChhhhhhhhhhhccCchhccCcc
Confidence            9999887765543321  11   112211                        234677888999999999999999987


Q ss_pred             ---HhhcCCCccCC
Q psy7889         255 ---AALNHDFFWTD  265 (433)
Q Consensus       255 ---e~L~h~~~~~~  265 (433)
                         ++-.|+||+..
T Consensus      1085 ~~~e~k~~~~~~~~ 1098 (1205)
T KOG0606|consen 1085 GAAEVKGHPFFQDV 1098 (1205)
T ss_pred             cccccccCCccCCC
Confidence               89999999653

>KOG1243|consensus

Probab=99.30  E-value=1.2e-11  Score=123.41  Aligned_cols=145  Identities=22%  Similarity=0.393  Sum_probs=112.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      +.+.+-++-|+.++||||+++++.++.+        +++|||+|.+.. |..++++    ++...+..-+.||+.||.||
T Consensus        54 ~~~~~A~k~lKtlRHP~Il~yL~t~e~~--------~~~ylvTErV~P-l~~~lk~----l~~~~v~~Gl~qIl~AL~FL  120 (690)
T KOG1243|consen   54 ELAKRAVKRLKTLRHPNILSYLDTTEEE--------GTLYLVTERVRP-LETVLKE----LGKEEVCLGLFQILAALSFL  120 (690)
T ss_pred             HHHHHHHHHhhhccCchhhhhhhhhccc--------CceEEEeecccc-HHHHHHH----hHHHHHHHHHHHHHHHHHHH
Confidence            4577888999999999999999999887        679999999873 4444544    34778888999999999999


Q ss_pred             H-hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          88 H-SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        88 H-~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      | +.+++|++|.-..|+|+..|..||++|.++........  .....  .---.|..|+.+...   +-..|.|-|||++
T Consensus       121 ~~d~~lvHgNv~~~SVfVn~~GeWkLggle~v~~~~~~~~--~~~~~--~~~~s~~~P~~~~~s---~~s~D~~~Lg~li  193 (690)
T KOG1243|consen  121 NDDCNLVHGNVCKDSVFVNESGEWKLGGLELVSKASGFNA--PAKSL--YLIESFDDPEEIDPS---EWSIDSWGLGCLI  193 (690)
T ss_pred             hccCCeeeccEeeeeEEEcCCCcEEEeeeEEEeccccCCc--ccccc--hhhhcccChhhcCcc---ccchhhhhHHHHH
Confidence            8 67899999999999999999999999988765442211  00111  112236677654321   2468999999999


Q ss_pred             HHHHhc
Q psy7889         167 AEMWTR  172 (433)
Q Consensus       167 ~ell~g  172 (433)
                      ++++.|
T Consensus       194 ~el~ng  199 (690)
T KOG1243|consen  194 EELFNG  199 (690)
T ss_pred             HHHhCc
Confidence            999998

>cd05144 RIO2_C RIO kinase family; RIO2, C-terminal catalytic domain

Probab=99.27  E-value=1.1e-11  Score=110.85  Aligned_cols=96  Identities=18%  Similarity=0.258  Sum_probs=74.3

Q ss_pred             hHHHHHHHHHhCCCCC--ccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHEN--VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+|+.++..+.|++  +...++.            ...++||||+++.....+..      ......++.+++.++.+
T Consensus        79 ~~~~E~~~l~~l~~~~i~v~~~~~~------------~~~~lv~e~~~g~~L~~~~~------~~~~~~~~~~i~~~l~~  140 (198)
T cd05144          79 AAQKEFAALKALYEEGFPVPKPIDW------------NRHAVVMEYIDGVELYRVRV------LEDPEEVLDEILEEIVK  140 (198)
T ss_pred             HHHHHHHHHHHHHHcCCCCCceeec------------CCceEEEEEeCCcchhhccc------cccHHHHHHHHHHHHHH
Confidence            4678999999998874  4444431            22589999998743222211      13456788999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      +|+.||+|+||||+||+++.++.++|+|||.+....
T Consensus       141 lh~~gi~H~Dl~p~Nill~~~~~~~liDfg~~~~~~  176 (198)
T cd05144         141 AYKHGIIHGDLSEFNILVDDDEKIYIIDWPQMVSTD  176 (198)
T ss_pred             HHHCCCCcCCCCcccEEEcCCCcEEEEECCccccCC
Confidence            999999999999999999999999999999986543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO2 is present in archaea and eukaryotes. It contains an N-terminal winged helix (wHTH) domain and a C-terminal RIO kinase catalytic domain. The wHTH domain is primarily seen in DNA-binding proteins, although some wHTH dom

>cd05120 APH_ChoK_like Aminoglycoside 3'-phosphotransferase (APH) and Choline Kinase (ChoK) family

Probab=99.17  E-value=9.4e-11  Score=99.11  Aligned_cols=98  Identities=26%  Similarity=0.336  Sum_probs=81.1

Q ss_pred             hhHHHHHHHHHhCCC--CCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++|  .++.+++.++...        +..+++|||+.+.....+       +......++.+++.+++
T Consensus        36 ~~~~~e~~~~~~l~~~~~~~p~~~~~~~~~--------~~~~~v~e~~~g~~~~~~-------~~~~~~~~~~~~~~~l~  100 (155)
T cd05120          36 ADREREVAILQLLARKGLPVPKVLASGESD--------GWSYLLMEWIEGETLDEV-------SEEEKEDIAEQLAELLA  100 (155)
T ss_pred             hHHHHHHHHHHHHHHcCCCCCeEEEEcCCC--------CccEEEEEecCCeecccC-------CHHHHHHHHHHHHHHHH
Confidence            468999999999976  5899988877654        558999999986422211       45667778899999999


Q ss_pred             HHHhC---CeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          86 YIHSN---KILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        86 ~LH~~---~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      +||..   +++|+|++|.||+++..+.++++|||.+..
T Consensus       101 ~lh~~~~~~i~H~Dl~~~Nil~~~~~~~~l~Df~~~~~  138 (155)
T cd05120         101 KLHQLPLLVLCHGDLHPGNILVDDGKILGIIDWEYAGY  138 (155)
T ss_pred             HHhCCCceEEEecCCCcceEEEECCcEEEEEecccccC
Confidence            99985   799999999999999989999999998754

The APH/ChoK family is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). The family is composed of APH, ChoK, ethanolamine kinase (ETNK), macrolide 2'-phosphotransferase (MPH2'), an unusual homoserine kinase, and uncharacterized proteins with similarity to the N-terminal domain of acyl-CoA dehydrogenase 10 (ACAD10). The members of this family catalyze the transfer of the gamma-phosphoryl group from ATP (or CTP) to small molecule substrates such as aminoglycosides, macrolides, choline, ethanolamine, and homoserine. Phosphorylation of the antibiotics, aminoglycosides and macrolides, leads to their inactivation and to bacterial antibiotic resistance. Phosphorylation of choline, ethanolamine, and homoserine serves

>KOG0669|consensus

Probab=99.11  E-value=6.2e-11  Score=104.68  Aligned_cols=82  Identities=65%  Similarity=1.095  Sum_probs=71.2

Q ss_pred             ccCcccccccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC-CChhHHhhhhhhhhhhhcCCCCCCC
Q psy7889         320 ETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP-SDLSKMLAQHTQSMFEYLAPPRRPG  398 (433)
Q Consensus       320 ~~~~~~~l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~~~~~  398 (433)
                      ..+.+++++...+.+..+++|.|||++||.+||.||++|++||+|.||+.+|.| .+...+++...+++++|.+..++..
T Consensus       271 ~~~~~rkv~n~~kp~~kd~~a~dLle~ll~~DP~kR~~ad~alnh~~F~kdp~pqanl~~ml~t~~~s~fey~~~~~~~~  350 (376)
T KOG0669|consen  271 PKGQKRKVKNRLKPYVKDDEALDLLEKLLKLDPTKRIDADQALNHDFFWKDPMPQANLQDMLSTHLQSMFEYLAQPRRSN  350 (376)
T ss_pred             CcchhhhhhhhcccccCChhHHHHHHHHhccCcccCcchHhhhchhhhhcCCcchhhHHHHHHHhHHHHHHHhcCcchhh
Confidence            456677788888888889999999999999999999999999999999999999 6777888999999999998666554


Q ss_pred             ccc
Q psy7889         399 HMR  401 (433)
Q Consensus       399 ~~~  401 (433)
                      .+.
T Consensus       351 ~~~  353 (376)
T KOG0669|consen  351 QMR  353 (376)
T ss_pred             hhh
Confidence            443

>cd05146 RIO3_euk RIO kinase family; eukaryotic RIO3, catalytic domain

Probab=99.11  E-value=3.4e-10  Score=99.66  Aligned_cols=99  Identities=19%  Similarity=0.267  Sum_probs=75.1

Q ss_pred             hHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcCC-HHH-HHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAG-LLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         9 ~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~-~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+|+..|+++.  .-++.+++++..            -+|||||++++ +.. .+..  ..++++.+..+..+++.+|
T Consensus        72 wa~kE~r~L~rl~~~Gv~vP~pi~~~~------------~~lvME~Ig~~~~~~~~Lkd--~~~~~~~~~~i~~~i~~~l  137 (197)
T cd05146          72 WAEKEMHNLKRMQKAGIPCPEVVVLKK------------HVLVMSFIGDDQVPAPKLKD--AKLNDEEMKNAYYQVLSMM  137 (197)
T ss_pred             HHHHHHHHHHHHHHcCCCCCeEEEecC------------CEEEEEEcCCCCccchhhhc--cccCHHHHHHHHHHHHHHH
Confidence            4558999999995  456667766421            37999999864 211 1222  2356667778889999999


Q ss_pred             HHH-HhCCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          85 YYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        85 ~~L-H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      ..| |+.||+|+|+++.||++. ++.+.|+|||.+....
T Consensus       138 ~~l~H~~glVHGDLs~~NIL~~-~~~v~iIDF~qav~~~  175 (197)
T cd05146         138 KQLYKECNLVHADLSEYNMLWH-DGKVWFIDVSQSVEPT  175 (197)
T ss_pred             HHHHHhCCeecCCCCHHHEEEE-CCcEEEEECCCceeCC
Confidence            999 899999999999999997 4689999999876543

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases containing a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. RIO3 is present only in multicellular eukaryotes. Its function is still unknown.

>cd05119 RIO RIO kinase family, catalytic domain

Probab=99.11  E-value=2.4e-10  Score=101.01  Aligned_cols=96  Identities=21%  Similarity=0.352  Sum_probs=68.9

Q ss_pred             HHHHHHHHhCCCCC--ccceeeeEEecCccccccCceEEEEeecCcCC-HH-HHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889          11 LREIKILQLLKHEN--VVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LA-GLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus        11 ~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~-~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..|...+..+.+..  +.+++.+            ...++||||++++ +. ..+....  . ...+..++.+++.++.+
T Consensus        65 ~~e~~~l~~l~~~~~~~~~~~~~------------~~~~lv~e~~~g~~~~~~~l~~~~--~-~~~~~~~~~~~~~~l~~  129 (187)
T cd05119          65 EKEFRNLKRLYEAGVPVPKPIDL------------NRHVLVMEFIGGDGIPAPRLKDVR--L-LEDPEELYDQILELMRK  129 (187)
T ss_pred             HHHHHHHHHHHHcCCCCCceEec------------CCCEEEEEEeCCCCccChhhhhhh--h-cccHHHHHHHHHHHHHH
Confidence            35666666664433  4444432            1258999999972 11 1111111  1 16788899999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      +|. .||+|+||||+||+++ ++.++|+|||.+....
T Consensus       130 lh~~~~ivH~Dl~p~Nili~-~~~~~liDfg~a~~~~  165 (187)
T cd05119         130 LYREAGLVHGDLSEYNILVD-DGKVYIIDVPQAVEID  165 (187)
T ss_pred             HhhccCcCcCCCChhhEEEE-CCcEEEEECccccccc
Confidence            999 9999999999999999 8899999999986654

The RIO kinase catalytic domain family is part of a larger superfamily, that includes the catalytic domains of other kinases such as the typical serine/threonine/tyrosine protein kinases (PKs), aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase (PI3K). RIO kinases are atypical protein serine kinases present in archaea, bacteria and eukaryotes. Serine kinases catalyze the transfer of the gamma-phosphoryl group from ATP to serine residues in protein substrates. RIO kinases contain a kinase catalytic signature, but otherwise show very little sequence similarity to typical PKs. The RIO catalytic domain is truncated compared to the catalytic domains of typical PKs, with deletions of the loops responsible for substrate binding. Most organisms contain at least two RIO kinases, RIO1 and RIO2. A third protein, RIO3, is present in multicellular eukaryotes. In yeast, RIO1 and RIO2 are essential for survival. They funct

>COG3642 Mn2+-dependent serine/threonine protein kinase [Signal transduction mechanisms]

Probab=98.95  E-value=4.3e-09  Score=89.85  Aligned_cols=96  Identities=20%  Similarity=0.287  Sum_probs=70.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHH-HHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~-~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ....+|..+|.+++--.|--.+-++.+.        +...|+|||++|.+.. .+...        ...+++.+-.-+.-
T Consensus        44 ~Rt~~Earil~~a~~~GV~~P~v~dvD~--------~~~~I~me~I~G~~lkd~l~~~--------~~~~~r~vG~~vg~  107 (204)
T COG3642          44 ERTRREARILAKAREAGVPVPIVYDVDP--------DNGLIVMEYIEGELLKDALEEA--------RPDLLREVGRLVGK  107 (204)
T ss_pred             HHHHHHHHHHHHHHHcCCCCCeEEEEcC--------CCCEEEEEEeCChhHHHHHHhc--------chHHHHHHHHHHHH
Confidence            4567899999998644443333333333        3367999999986555 55442        14556677777889


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      ||..||+|+|++++||+++..+ +.++|||++.+
T Consensus       108 lH~~givHGDLTtsNiIl~~~~-i~~IDfGLg~~  140 (204)
T COG3642         108 LHKAGIVHGDLTTSNIILSGGR-IYFIDFGLGEF  140 (204)
T ss_pred             HHhcCeecCCCccceEEEeCCc-EEEEECCcccc
Confidence            9999999999999999998765 99999999864

>KOG3741|consensus

Probab=98.94  E-value=1.3e-08  Score=98.97  Aligned_cols=182  Identities=20%  Similarity=0.212  Sum_probs=131.0

Q ss_pred             HHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhcc--------------CCCCCHHHHHH
Q psy7889          12 REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNI--------------HVKFSLGEIKK   75 (433)
Q Consensus        12 ~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~--------------~~~l~~~~~~~   75 (433)
                      .=+++++++.|+|||.+.++|.+....    ...+++|++|.++  +|.++.-..              +.+.+|..+|.
T Consensus       322 ~lve~wkkl~h~NvV~frevf~t~tF~----D~SlvlvYDYyP~s~TL~d~~F~~~~~t~~~n~~~~~~~~~~~e~~lW~  397 (655)
T KOG3741|consen  322 SLVEAWKKLCHTNVVPFREVFLTYTFG----DLSLVLVYDYYPSSPTLYDLYFANPPFTKRTNSFYPSQNLKAPEEVLWS  397 (655)
T ss_pred             HHHHHHHHhccCceeehhhhhhhhccC----cceEEEEEecCCCCchHHHHHccCCccccccccccccCCCCchHHHHHH
Confidence            347899999999999999999854321    4678999999985  677765321              22378899999


Q ss_pred             HHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC
Q psy7889          76 VIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        76 i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      ++.||..||.++|+.|+.-+-|.|.+|+++++-+++|..-|....+....                .  |-+.    -..
T Consensus       398 y~~QLtaaL~sIHssGLAck~L~~~kIlv~G~~RIriS~C~i~Dvl~~d~----------------~--~~le----~~Q  455 (655)
T KOG3741|consen  398 YISQLTAALYSIHSSGLACKTLDLKKILVTGKMRIRISGCGIMDVLQEDP----------------T--EPLE----SQQ  455 (655)
T ss_pred             HHHHHHHHHHHHHhcCceeecccHhHeEeeCcceEEEecccceeeecCCC----------------C--cchh----HHh
Confidence            99999999999999999999999999999998888888666554443211                0  1121    134


Q ss_pred             cchhhhHHHHHHHHHhcCCCCC-CCChHHH-HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQ-GNTEQQQ-ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~-~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      +-|.=.||.+++.|.+|..--. ....... +..|.                                       ..+|.
T Consensus       456 q~D~~~lG~ll~aLAt~~~ns~~~d~~~~s~~~~I~---------------------------------------~~yS~  496 (655)
T KOG3741|consen  456 QNDLRDLGLLLLALATGTENSNRTDSTQSSHLTRIT---------------------------------------TTYST  496 (655)
T ss_pred             hhhHHHHHHHHHHHhhcccccccccchHHHHHHHhh---------------------------------------hhhhH
Confidence            6799999999999999853211 1111111 11111                                       13567


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +++++|.-+...++++ -+.++++.+
T Consensus       497 D~rn~v~yl~s~~~~~-ksI~~llp~  521 (655)
T KOG3741|consen  497 DLRNVVEYLESLNFRE-KSIQDLLPM  521 (655)
T ss_pred             HHHHHHHHHHhcCccc-ccHHHHHHH
Confidence            7778888888888876 678888766

>KOG2137|consensus

Probab=98.93  E-value=5.5e-10  Score=112.05  Aligned_cols=159  Identities=21%  Similarity=0.275  Sum_probs=111.3

Q ss_pred             HHHHHHHHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccC-----CcccccccCcccccCCC
Q psy7889          78 QQLLNGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN-----RVVTLWYRPPELLLGDR  151 (433)
Q Consensus        78 ~qll~aL~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~-----~~gt~~y~aPE~~~~~~  151 (433)
                      .++..|+.|+|. .++||++|.|++|.++..|..||+.|+++.....+.......+..     ......|.|||++.+..
T Consensus       106 ~~v~dgl~flh~sAk~VH~ni~p~~i~~na~~~wkl~Gf~f~v~~~~~~~~p~~~yd~~lp~~~~~~~~f~apE~~~~~~  185 (700)
T KOG2137|consen  106 GNVADGLAFLHRSAKVVHGNIQPEAIVVNANGDWKLAGFSFCVNANGPTEYPFSEYDPPLPLLLQPHLNFLAPEYLLGTT  185 (700)
T ss_pred             hcccchhhhhccCcceeecccchhheeeccCcceeeccchhhhccCCCCccccccCCCCCChhhccCcccccchhhcccc
Confidence            345589999995 589999999999999999999999999876554322211122222     12356799999998855


Q ss_pred             CCCCcchhhhHHHHHHHHH-hcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMW-TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell-~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                       .+.++|++|+||++|.+. .|+..+.+......... ....+....                           ...+..
T Consensus       186 -~~~~sd~fSlG~li~~i~~~gk~i~~a~~~~~~~~~-~~~~~~~~~---------------------------~~~s~~  236 (700)
T KOG2137|consen  186 -NTPASDVFSLGVLIYTIYNGGKSIIAANGGLLSYSF-SRNLLNAGA---------------------------FGYSNN  236 (700)
T ss_pred             -ccccccceeeeeEEEEEecCCcchhhccCCcchhhh-hhccccccc---------------------------cccccc
Confidence             589999999999999988 67776655432211111 000000000                           000123


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+.+.++=|.++|..++..||++.+++..+||...
T Consensus       237 ~p~el~~~l~k~l~~~~~~rp~~~~l~~~~ff~D~  271 (700)
T KOG2137|consen  237 LPSELRESLKKLLNGDSAVRPTLDLLLSIPFFSDP  271 (700)
T ss_pred             CcHHHHHHHHHHhcCCcccCcchhhhhcccccCCc
Confidence            56778889999999999999999999999999753

>KOG3087|consensus

Probab=98.91  E-value=8.6e-09  Score=87.64  Aligned_cols=106  Identities=16%  Similarity=0.229  Sum_probs=79.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccCCC-CCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVK-FSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~~~-l~~~~~~~i~~qll~a   83 (433)
                      ....++|+.+|.++.--.|.-..-+|.+...        -+|+|||++|  ++.+++...... ...+....++..|-..
T Consensus        54 r~Rt~~Ear~l~k~~~~GI~~P~l~~~D~~~--------~~i~ME~~~g~~~vk~~i~~~~~~~~~d~~~~~~~~~iG~~  125 (229)
T KOG3087|consen   54 RKRTKQEARLLAKCRALGIPAPRLIFIDTYG--------GQIYMEFIDGASTVKDFILSTMEDESEDEGLAELARRIGEL  125 (229)
T ss_pred             HHHHHHHHHHHHHHHHhCCCCceEEEEecCC--------CeEEEEeccchhHHHHHHHHHccCcccchhHHHHHHHHHHH
Confidence            3467889999999865555555555555422        3799999998  777777654333 2333347888999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccc
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARA  120 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~  120 (433)
                      |.-||..+|+|+||+.+||++...|   .+.++|||++..
T Consensus       126 igklH~ndiiHGDLTTSNill~~~~~~~~~~lIdfgls~~  165 (229)
T KOG3087|consen  126 IGKLHDNDIIHGDLTTSNILLRSDGNQITPILIDFGLSSV  165 (229)
T ss_pred             HHHhhhCCeecccccccceEEecCCCcCceEEEeecchhc
Confidence            9999999999999999999998665   358999998754

>KOG0601|consensus

Probab=98.86  E-value=7.6e-10  Score=109.47  Aligned_cols=206  Identities=24%  Similarity=0.258  Sum_probs=142.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .-.+.|+.+...+ -|.+++.++..+...        ...||=.|||.+....+-......+.+...+.+..|++.++.+
T Consensus       310 i~sl~ev~l~~~l~~~~~~~g~~~~W~~~--------r~~~ip~e~~~~~s~~l~~~~~~~~d~~~~~~~~~q~~~~l~~  381 (524)
T KOG0601|consen  310 IFSLGEVILEAILGSHLPSVGKNSSWSQL--------RQGYIPLEFCEGGSSSLRSVTSQMLDEDPRLRLTAQILTALNV  381 (524)
T ss_pred             hcchhhhhHhhHhhcccccCCCCCCcccc--------ccccCchhhhcCcchhhhhHHHHhcCcchhhhhHHHHHhcccc
Confidence            3446678888777 499999988877654        4577999999763333322222246788899999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCccccccc-CcccccCCCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR-PPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~-aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|+..++|+|++|+||++.++ +..+++|||+...+.-.      . ......-.+. ..|++.....+..++|++|||.
T Consensus       382 i~s~~~~~~d~~psni~i~~~~~~~~~~~~~~~t~~~~~------~-~~~~~~~r~~p~~~~~~e~~~~~~~~~~~sl~~  454 (524)
T KOG0601|consen  382 IHSKLFVHLDVKPSNILISNDGFFSKLGDFGCWTRLAFS------S-GVFHHIDRLYPIAEILLEDYPHLSKADIFSLGL  454 (524)
T ss_pred             ccchhhhcccccccceeeccchhhhhcccccccccccee------c-ccccccccccccchhhccccccccccccccccc
Confidence            999999999999999999886 78899999988642210      0 0011122333 4666766667899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      .+.+.+++.+.-........+.   .  |..     +..                        +. ...++..+...++.
T Consensus       455 ~~~e~~~~~~ls~~~~~~~~i~---~--~~~-----p~~------------------------~~-~~~~~q~~~kv~~~  499 (524)
T KOG0601|consen  455 SVDEAITGSPLSESGVQSLTIR---S--GDT-----PNL------------------------PG-LKLQLQVLLKVMIN  499 (524)
T ss_pred             cccccccCcccCcccccceeee---c--ccc-----cCC------------------------Cc-hHHhhhhhhhhhcC
Confidence            9999999876543322111110   0  000     000                        00 11445578888999


Q ss_pred             cCCCCCCCHHHhhcCCCcc
Q psy7889         245 LDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~  263 (433)
                      .++..|+.+.++..|.-|-
T Consensus       500 ~~~~~~~l~~~l~~~~~~~  518 (524)
T KOG0601|consen  500 PDRKRRPSAVELSLHSEFY  518 (524)
T ss_pred             Cccccchhhhhhcccchhh
Confidence            9999999999998887663

>PRK15123 lipopolysaccharide core heptose(I) kinase RfaP; Provisional

Probab=98.85  E-value=3.7e-08  Score=91.60  Aligned_cols=108  Identities=16%  Similarity=0.132  Sum_probs=81.2

Q ss_pred             hHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhcc-CCCCCHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNI-HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         9 ~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~-~~~l~~~~~~~i~~qll~a   83 (433)
                      .+.+|...+.+|.  .-....++.+.....+   ......+||||++++  +|.+++... ....+......++.+++..
T Consensus        74 ~a~rE~~~l~~L~~~GIptP~pVa~~e~~~~---~~~~~s~LVte~l~~~~sL~~~~~~~~~~~~~~~~~~~ll~~la~~  150 (268)
T PRK15123         74 GADREWRAIHRLHEVGVDTMTGVAFGERGSN---PATRTSFIITEDLAPTISLEDYCADWATNPPDPRLKRMLIKRVATM  150 (268)
T ss_pred             HHHHHHHHHHHHHHcCCCCCCeeEEEEecCC---CccceeEEEEeeCCCCccHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            5889999999984  3334455555543211   112346899999997  577777532 2345667788999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec-------CCcEEEeecCCcc
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK-------TGILKLADFGLAR  119 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~-------~~~~kl~DFg~a~  119 (433)
                      +.-||+.||+|+|+++.|||++.       ++.+.|+||+.+.
T Consensus       151 i~~LH~~Gi~HgDL~~~NiLl~~~~~~~~~~~~~~LIDl~r~~  193 (268)
T PRK15123        151 VRDMHAAGINHRDCYICHFLLHLPFPGREEDLKLSVIDLHRAQ  193 (268)
T ss_pred             HHHHHHCcCccCCCChhhEEEeccccCCCCCceEEEEECCccc
Confidence            99999999999999999999975       4579999999764

>PF06293 Kdo: Lipopolysaccharide kinase (Kdo/WaaP) family; InterPro: IPR010440 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.85  E-value=3.3e-08  Score=88.76  Aligned_cols=110  Identities=20%  Similarity=0.236  Sum_probs=87.4

Q ss_pred             CchhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      ...++.+|...+..|.  .-.+.+.+.+......   . ....+||+|++++  +|.+++..... .+......++.+++
T Consensus        54 ~~~ra~~E~~~~~~L~~~Gi~tP~pva~~~~r~~---~-~~~s~lite~l~~~~~L~~~~~~~~~-~~~~~~~~ll~~l~  128 (206)
T PF06293_consen   54 RRSRAKREWRNLQRLREAGIPTPEPVAYGERRKG---G-GYRSYLITEALPGAQDLRDLLQQWEQ-LDPSQRRELLRALA  128 (206)
T ss_pred             cchHHHHHHHHHHHHHHcCCCCCcEEEEEEEcCC---C-ceeEEEEEEeCCCcccHHHHHHhhcc-cchhhHHHHHHHHH
Confidence            3567899999999885  4445677776665422   1 1456899999986  67777766333 66778889999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARA  120 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~  120 (433)
                      ..++-||+.||+|+|+++.|||++.++   .+.++||+.+..
T Consensus       129 ~~i~~lH~~gi~H~Dl~~~NILv~~~~~~~~~~lIDld~~~~  170 (206)
T PF06293_consen  129 RLIAKLHDAGIYHGDLNPSNILVDPDDGQYRFYLIDLDRMRF  170 (206)
T ss_pred             HHHHHHHHCcCCCCCCCcccEEEeCCCCceeEEEEcchhcee
Confidence            999999999999999999999999887   899999997654

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents lipopolysaccharide kinases which are related to protein kinases IPR000719 from INTERPRO. This family includes waaP (rfaP) gene product is required for the addition of phosphate to O-4 of the first heptose residue of the lipopolysaccharide (LPS) inner core region. It has previously been shown that WaaP is necessary for resistance to hydrophobic and polycationic antimicrobials in E. coli and that it is required for virulence in invasive strains of Salmonella enterica [].; GO: 0005524 ATP binding, 0016773 phosphotransferase activity, alcohol group as acceptor, 0009103 lipopolysaccharide biosynthetic process, 0016020 membrane

>cd05151 ChoK Choline Kinase (ChoK)

Probab=98.82  E-value=9.6e-09  Score=89.06  Aligned_cols=93  Identities=22%  Similarity=0.164  Sum_probs=67.3

Q ss_pred             hhHHHHHHHHHhCCCCCcc-ceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVV-HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv-~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ....+|+.+++.+.+.+++ +++.+..          ..-++||||++|......        ......++.+++.+|+.
T Consensus        37 ~~~~~E~~~l~~l~~~~~~P~~~~~~~----------~~~~lv~e~i~G~~l~~~--------~~~~~~~~~~l~~~l~~   98 (170)
T cd05151          37 INRENEAENSKLAAEAGIGPKLYYFDP----------ETGVLITEFIEGSELLTE--------DFSDPENLEKIAKLLKK   98 (170)
T ss_pred             cCHHHHHHHHHHHHHhCCCCceEEEeC----------CCCeEEEEecCCCccccc--------cccCHHHHHHHHHHHHH
Confidence            3468899999999655554 4444322          124799999997322110        11123456889999999


Q ss_pred             HHhCCe-----eccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          87 IHSNKI-----LHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        87 LH~~~i-----iH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      ||+.++     +|+|++|.||+++ ++.++++|||.+.
T Consensus        99 LH~~~~~~~~~~HgD~~~~Nil~~-~~~~~liDf~~a~  135 (170)
T cd05151          99 LHSSPLPDLVPCHNDLLPGNFLLD-DGRLWLIDWEYAG  135 (170)
T ss_pred             HhCCCCCCceeecCCCCcCcEEEE-CCeEEEEeccccc
Confidence            999885     9999999999999 6789999999764

The ChoK subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). It is composed of bacterial and eukaryotic choline kinases, as well as eukaryotic ethanolamine kinase. ChoK catalyzes the transfer of the gamma-phosphoryl group from ATP (or CTP) to its substrate, choline, producing phosphorylcholine (PCho), a precursor to the biosynthesis of two major membrane phospholipids, phosphatidylcholine (PC), and sphingomyelin (SM). Although choline is the preferred substrate, ChoK also shows substantial activity towards ethanolamine and its N-methylated derivatives. Bacterial ChoK is also referred to as licA protein. ETNK catalyzes the transfer of the gamma-phosphoryl group from CTP to ethanolamine (Etn), the first step in the CDP-Etn pathway for the formation of the major ph

>PF01163 RIO1: RIO1 family; InterPro: IPR018934 Protein phosphorylation, which plays a key role in most cellular activities, is a reversible process mediated by protein kinases and phosphoprotein phosphatases

Probab=98.76  E-value=1.5e-08  Score=88.87  Aligned_cols=100  Identities=22%  Similarity=0.298  Sum_probs=66.1

Q ss_pred             chhHHHHHHHHHhCCCC--CccceeeeEEecCccccccCceEEEEeecCc--CCHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHE--NVVHLIEICRTKANQYNRYRSTFYLVFDFCE--HDLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~--~~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|...|.++..-  ++.+++++-.            -+|||||++  |.....+....  ++.+....++.+++.
T Consensus        52 ~~~~~~E~~~L~~l~~~Gv~vP~p~~~~~------------~~ivME~I~~~G~~~~~l~~~~--~~~~~~~~~~~~il~  117 (188)
T PF01163_consen   52 REWAKKEFRNLKRLYEAGVPVPKPYDYNR------------NVIVMEYIGEDGVPLPRLKDVD--LSPEEPKELLEEILE  117 (188)
T ss_dssp             HHHHHHHHHHHHHCCCTT-SS--EEEEET------------TEEEEE--EETTEEGGCHHHCG--GGGSTHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHCCccCCcEEEEeC------------CEEEEEecCCCccchhhHHhcc--ccchhHHHHHHHHHH
Confidence            35678999999999755  5666665431            279999999  63222232211  223456677788888


Q ss_pred             HHHH-HHhCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          83 GLYY-IHSNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        83 aL~~-LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      .+.. +|+.||+|+|+.+.||+++.+ .+.++|||.+...
T Consensus       118 ~~~~~~~~~givHGDLs~~NIlv~~~-~~~iIDf~qav~~  156 (188)
T PF01163_consen  118 EIIKMLHKAGIVHGDLSEYNILVDDG-KVYIIDFGQAVDS  156 (188)
T ss_dssp             HHHHHHHCTTEEESS-STTSEEEETT-CEEE--GTTEEET
T ss_pred             HHHHHHHhcCceecCCChhhEEeecc-eEEEEecCcceec
Confidence            5555 579999999999999999877 8999999977553

Protein kinases catalyse the transfer of the gamma phosphate from nucleotide triphosphates (often ATP) to one or more amino acid residues in a protein substrate side chain, resulting in a conformational change affecting protein function. Phosphoprotein phosphatases catalyse the reverse process. Protein kinases fall into three broad classes, characterised with respect to substrate specificity []: Serine/threonine-protein kinases Tyrosine-protein kinases Dual specific protein kinases (e.g. MEK - phosphorylates both Thr and Tyr on target proteins) Protein kinase function has been evolutionarily conserved from Escherichia coli to human []. Protein kinases play a role in a multitude of cellular processes, including division, proliferation, apoptosis, and differentiation []. Phosphorylation usually results in a functional change of the target protein by changing enzyme activity, cellular location, or association with other proteins. The catalytic subunits of protein kinases are highly conserved, and several structures have been solved [], leading to large screens to develop kinase-specific inhibitors for the treatments of a number of diseases []. This entry represents RIO kinase, they exhibit little sequence similarity with eukaryotic protein kinases, and are classified as atypical protein kinases []. The conformation of ATP when bound to the RIO kinases is unique when compared with ePKs, such as serine/threonine kinases or the insulin receptor tyrosine kinase, suggesting that the detailed mechanism by which the catalytic aspartate of RIO kinases participates in phosphoryl transfer may not be identical to that employed in known serine/threonine ePKs. Representatives of the RIO family are present in organisms varying from Archaea to humans, although the RIO3 proteins have only been identified in multicellular eukaryotes, to date. Yeast Rio1 and Rio2 proteins are required for proper cell cycle progression and chromosome maintenance, and are necessary for survival of the cells. These proteins are involved in the processing of 20 S pre-rRNA via late 18 S rRNA processing. ; GO: 0003824 catalytic activity, 0005524 ATP binding; PDB: 1TQP_A 1ZAR_A 1TQI_A 1ZAO_A 1TQM_A 3RE4_A 1ZTH_B 1ZP9_A 1ZTF_A.

>TIGR01982 UbiB 2-polyprenylphenol 6-hydroxylase

Probab=98.73  E-value=3.1e-08  Score=98.93  Aligned_cols=104  Identities=19%  Similarity=0.264  Sum_probs=67.6

Q ss_pred             hHHHHHHHHHhCC----CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHH-
Q psy7889           9 TALREIKILQLLK----HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLN-   82 (433)
Q Consensus         9 ~~~~Ei~il~~l~----hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~-   82 (433)
                      .+.+|...+.++.    |.+-|.+-.++.+-       .+.-+|||||++| ++.+..........   ...++.+++. 
T Consensus       199 df~~Ea~n~~~~~~~~~~~~~v~vP~v~~~~-------~~~~vLvmE~i~G~~L~~~~~~~~~~~~---~~~ia~~~~~~  268 (437)
T TIGR01982       199 DLRREAANASELGENFKNDPGVYVPEVYWDR-------TSERVLTMEWIDGIPLSDIAALDEAGLD---RKALAENLARS  268 (437)
T ss_pred             CHHHHHHHHHHHHHhcCCCCCEEeCCEehhh-------cCCceEEEEeECCcccccHHHHHhcCCC---HHHHHHHHHHH
Confidence            3566777666662    33233333333221       2336899999987 44444322111222   2334455554 


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      .+..+|..|++|+|++|.||+++.+|.++++|||++..+.
T Consensus       269 ~l~ql~~~g~~H~D~hPgNilv~~~g~i~liDfG~~~~l~  308 (437)
T TIGR01982       269 FLNQVLRDGFFHADLHPGNIFVLKDGKIIALDFGIVGRLS  308 (437)
T ss_pred             HHHHHHhCCceeCCCCcccEEECCCCcEEEEeCCCeeECC
Confidence            4788999999999999999999999999999999987664

This model represents the enzyme (UbiB) which catalyzes the first hydroxylation step in the ubiquinone biosynthetic pathway in bacteria. It is believed that the reaction is 2-polyprenylphenol - 6-hydroxy-2-polyprenylphenol. This model finds hits primarily in the proteobacteria. The gene is also known as AarF in certain species.

>KOG0660|consensus

Probab=98.59  E-value=2.7e-08  Score=92.59  Aligned_cols=50  Identities=28%  Similarity=0.463  Sum_probs=42.3

Q ss_pred             ccccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChh
Q psy7889         326 RVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLS  377 (433)
Q Consensus       326 ~l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~  377 (433)
                      .+...|+..  ++.|+|||++||++||.||+||+|||.||||.....|.+.+
T Consensus       274 ~f~~~fp~a--~p~AidLlekmL~fdP~kRita~eAL~hPYl~~~hdp~dEP  323 (359)
T KOG0660|consen  274 PFSSIFPNA--NPLAIDLLEKMLVFDPKKRITAEEALAHPYLAPYHDPEDEP  323 (359)
T ss_pred             CHHHHcCCC--CHHHHHHHHHHhccCccccCCHHHHhcChhhhhhcCCccCC
Confidence            345556656  89999999999999999999999999999998877765544

>COG4248 Uncharacterized protein with protein kinase and helix-hairpin-helix DNA-binding domains [General function prediction only]

Probab=98.57  E-value=5.2e-07  Score=86.03  Aligned_cols=131  Identities=13%  Similarity=0.115  Sum_probs=98.2

Q ss_pred             ceEEEEeecCcC--CHHHHHhcc-----CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecC
Q psy7889          44 STFYLVFDFCEH--DLAGLLSNI-----HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG  116 (433)
Q Consensus        44 ~~~~lV~e~~~~--~L~~~l~~~-----~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg  116 (433)
                      ..+.+.|+.+.+  ....++.-.     ...+.++++..+.+.|+.+.+.||..|.+-+|+.++|+|+++++.+.|.|-.
T Consensus        83 ~~iGflmP~v~g~~pI~~~y~p~tRRqs~P~~~w~fllrvaRnlA~aFA~lH~~Gh~vGDVn~~~~lVsd~~~V~LVdsD  162 (637)
T COG4248          83 KVIGFLMPKVSGKEPIHMIYSPATRRQSYPHCAWDFLLRVARNLASAFATLHEHGHVVGDVNQNSFLVSDDSKVVLVDSD  162 (637)
T ss_pred             ceeEEecccCCCccchhhhcCchhhcccCCccccHHHHHHHHHHHHHHHHHHhcCCcccccCccceeeecCceEEEEccc
Confidence            337899999886  344443221     1226788999999999999999999999999999999999999999999854


Q ss_pred             CccccccCcCCccccccCCcccccccCccccc-C---CCCCCCcchhhhHHHHHHHHHhc-CCCCCCC
Q psy7889         117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLL-G---DRNYGPPVDLWGAGCIMAEMWTR-SPIMQGN  179 (433)
Q Consensus       117 ~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-~---~~~~~~~~DiwSlGvil~ell~g-~~pf~~~  179 (433)
                      .......   +  ..+...+|...|.+||.=. +   ...-+...|.|-||+++++|+.| +.||.|.
T Consensus       163 sfqi~~n---g--~~~~cpVg~~eftPPElQ~~~sf~g~~r~~~hD~FGLavLiF~lL~ggrHPysGI  225 (637)
T COG4248         163 SFQINAN---G--TLHLCPVGVSEFTPPELQTLPSFVGFERTANHDNFGLAVLIFHLLFGGRHPYSGI  225 (637)
T ss_pred             ceeeccC---C--ceEecccCccccCCHHHhccccccccCCCccccchhHHHHHHHHHhcCCCCCCcc
Confidence            3222111   1  2344567899999999632 1   11135678999999999999886 9999874

>PRK04750 ubiB putative ubiquinone biosynthesis protein UbiB; Reviewed

Probab=98.53  E-value=5.4e-08  Score=98.65  Aligned_cols=73  Identities=15%  Similarity=0.282  Sum_probs=52.2

Q ss_pred             ceEEEEeecCcC-CHHHH--HhccCC---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCC----cEEEe
Q psy7889          44 STFYLVFDFCEH-DLAGL--LSNIHV---KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG----ILKLA  113 (433)
Q Consensus        44 ~~~~lV~e~~~~-~L~~~--l~~~~~---~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~----~~kl~  113 (433)
                      +.-+|||||+.| .+.+.  +.....   .+.+..+..++.|++       ..|++|+|++|.||+++.+|    .++++
T Consensus       234 t~~VLvmE~i~G~~l~d~~~l~~~g~d~~~la~~~v~~~~~Qif-------~~GffHaDpHPGNIlv~~~g~~~~~i~ll  306 (537)
T PRK04750        234 SETVMVMERMYGIPVSDVAALRAAGTDMKLLAERGVEVFFTQVF-------RDGFFHADMHPGNIFVSYDPPENPRYIAL  306 (537)
T ss_pred             CCceEEEeeecCccHHhHHHHHhcCCCHHHHHHHHHHHHHHHHH-------hCCeeeCCCChHHeEEecCCCCCCeEEEE
Confidence            446799999987 44332  222111   244444555555554       58999999999999999888    99999


Q ss_pred             ecCCcccccc
Q psy7889         114 DFGLARAFSQ  123 (433)
Q Consensus       114 DFg~a~~~~~  123 (433)
                      |||++..+..
T Consensus       307 DFGivg~l~~  316 (537)
T PRK04750        307 DFGIVGSLNK  316 (537)
T ss_pred             ecceEEECCH
Confidence            9999877653

>PRK09902 hypothetical protein; Provisional

Probab=98.50  E-value=1.5e-06  Score=76.88  Aligned_cols=110  Identities=14%  Similarity=0.112  Sum_probs=82.9

Q ss_pred             chhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccC-CCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIH-VKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~-~~l~~~~~~~i~~qll   81 (433)
                      ..++.+|+..|+.|.  .-.+.++. ++.....   ...-..+||+|-+++  +|.+.+.+.. .+.++.+...++.+++
T Consensus        63 ~ptf~rE~~~L~~L~~~GvPVP~pv-f~~~~k~---~~~~rA~LVTe~L~g~~~L~~~l~~~~~~~~~~~~k~~il~~va  138 (216)
T PRK09902         63 RPTIVREVAVIKELERAGVIVPKIV-FGEAVKI---EGEWRALLVTEDMAGFISIADWYAQHAVSPYSDEVRQAMLKAVA  138 (216)
T ss_pred             chHHHHHHHHHHHHHHcCCCCCccc-eeeeecc---CCceEEEEEEEeCCCCccHHHHHhcCCcCCcchHHHHHHHHHHH
Confidence            468999999999995  33355555 3321111   113457899999884  7887775532 2467777889999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCc--EEEeecCCccc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA  120 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~--~kl~DFg~a~~  120 (433)
                      .+|+-||+.|+.|+|+.+.||+++.+|.  ++++||.-++.
T Consensus       139 ~~ia~LH~~Gv~Hgdly~khIll~~~g~~~v~lIDlEk~r~  179 (216)
T PRK09902        139 LAFKKMHSVNRQHGCCYVRHIYVKTEGKAEAGFLDLEKSRR  179 (216)
T ss_pred             HHHHHHHHCCCcCCCCCHhheeecCCCCeeEEEEEhhccch
Confidence            9999999999999999999999987776  99999986543

>KOG0033|consensus

Probab=98.47  E-value=2.7e-08  Score=87.90  Aligned_cols=62  Identities=18%  Similarity=0.304  Sum_probs=46.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhhhhhhhhhhcCCCCCCCc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGH  399 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  399 (433)
                      +++|+||+++||..||+|||||.|||+|||..+...-..... .......++.|++++|...+
T Consensus       240 s~~Ak~LvrrML~~dP~kRIta~EAL~HpWi~~r~~~As~~H-~~dtvd~lrkfNarRKLKga  301 (355)
T KOG0033|consen  240 TPEAKSLIRRMLTVNPKKRITADEALKHPWICNRERVASAIH-RQDTVDCLKKFNARRKLKGA  301 (355)
T ss_pred             CHHHHHHHHHHhccChhhhccHHHHhCCchhcchHHHHHHhh-hHHHHHHHHHhhHHHHHHHH
Confidence            789999999999999999999999999999976432211111 23345567778877776654

>KOG0659|consensus

Probab=98.44  E-value=1.1e-07  Score=85.03  Aligned_cols=51  Identities=31%  Similarity=0.499  Sum_probs=44.9

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhh
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ  382 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~  382 (433)
                      .|...  +.+++|||.+||+|||.+|+||.|||+|+||.+.|.|+.+..++.+
T Consensus       249 lf~aa--s~d~ldLl~~m~~ynP~~Rita~qaL~~~yf~~~P~pt~~~~lp~p  299 (318)
T KOG0659|consen  249 LFPAA--SSDALDLLSKMLTYNPKKRITASQALKHPYFKSLPLPTPPSKLPIP  299 (318)
T ss_pred             ccccc--cHHHHHHHHhhhccCchhcccHHHHhcchhhhcCCCCCChhhCcCC
Confidence            44444  8889999999999999999999999999999999999998876544

>KOG0663|consensus

Probab=98.38  E-value=3.8e-07  Score=84.20  Aligned_cols=53  Identities=34%  Similarity=0.680  Sum_probs=44.0

Q ss_pred             cccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHH
Q psy7889         327 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM  379 (433)
Q Consensus       327 l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~  379 (433)
                      +...|...--++.|.|||..||.|||.+|+||+++|+|.||.+.|.|++|..+
T Consensus       324 lr~kF~~~~lse~g~~Lln~llt~dP~kR~tA~~~L~h~~F~e~P~p~~P~~~  376 (419)
T KOG0663|consen  324 LRKKFGALSLSEQGFDLLNKLLTYDPGKRITAEDGLKHEYFRETPLPIDPSMF  376 (419)
T ss_pred             hhhhccccccchhHHHHHHHHhccCccccccHHHhhcccccccCCCCCChhhc
Confidence            33444443115899999999999999999999999999999999999988763

>cd05154 ACAD10_11_like Acyl-CoA dehydrogenase (ACAD) 10 and 11, N-terminal domain, and similar proteins

Probab=98.30  E-value=2.6e-06  Score=77.07  Aligned_cols=107  Identities=22%  Similarity=0.341  Sum_probs=74.7

Q ss_pred             chhHHHHHHHHHhCCC--CCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+++++.+.+  .++.+++.+.....     ..+..++||||++|. +...+..  ..++++....++.+++.+
T Consensus        39 ~~~~~~E~~~~~~l~~~~~~vp~~~~~~~~~~-----~~~~~~~v~e~i~G~~l~~~~~~--~~~~~~~~~~i~~~i~~~  111 (223)
T cd05154          39 AHDVAREYRVLRALAGTGVPVPKVLALCEDPS-----VLGTPFYVMERVDGRVLRDRLLR--PELSPEERRALARALADT  111 (223)
T ss_pred             cccHHHHHHHHHHhhCCCCCCCCEEEECCCCC-----ccCCceEEEEEeCCEecCCCCCC--CCCCHHHHHHHHHHHHHH
Confidence            4578999999999975  44577776655431     113568999999873 3222211  235666666667777777


Q ss_pred             HHHHHh--------------------------------------------------------CCeeccCCCCCcEEEec-
Q psy7889          84 LYYIHS--------------------------------------------------------NKILHRDMKAANVLITK-  106 (433)
Q Consensus        84 L~~LH~--------------------------------------------------------~~iiH~dikp~NIll~~-  106 (433)
                      |..||+                                                        ..++|+|+.|.||+++. 
T Consensus       112 l~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~HgD~~~~Nil~~~~  191 (223)
T cd05154         112 LAALHSVDPAAVGLGDLGRPGGYLERQVARWRRQYDASRTDEPPAMERLLRWLEAHLPADSRPGLVHGDYRLGNVLFHPD  191 (223)
T ss_pred             HHHHhCCChhhcCCcccCCCCchHHHHHHHHHHHHHhhcccccHHHHHHHHHHHhhCCCCCCcEEEECCCCcccEEEcCC
Confidence            777763                                                        24699999999999998 


Q ss_pred             -CCcEEEeecCCccc
Q psy7889         107 -TGILKLADFGLARA  120 (433)
Q Consensus       107 -~~~~kl~DFg~a~~  120 (433)
                       ++.+.|+||+.+..
T Consensus       192 ~~~~~~iID~e~~~~  206 (223)
T cd05154         192 EPRVVAVLDWELATL  206 (223)
T ss_pred             CCcEEEEEecccccc
Confidence             66789999997754

This subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). This subfamily is composed of bacterial and eukaryotic proteins with similarity to the N-terminal domains of vertebrate ACAD10 and ACAD11. ACADs are a family of flavoproteins that are involved in the beta-oxidation of fatty acyl-CoA derivatives. ACAD deficiency can cause metabolic disorders including muscle fatigue, hypoglycemia, and hepatic lipidosis, among them. There are at least 11 distinct ACADs, some of which show distinct substrate specificities to either straight-chain or branched-chain fatty acids. ACAD10 is widely expressed in human tissues and is highly expressed in liver, kidney, pancreas, and spleen. ACAD10 and ACAD11 contain

>PF06176 WaaY: Lipopolysaccharide core biosynthesis protein (WaaY); InterPro: IPR009330 This family consists of several bacterial lipopolysaccharide core biosynthesis proteins (WaaY or RfaY)

Probab=98.23  E-value=3.2e-06  Score=75.16  Aligned_cols=97  Identities=18%  Similarity=0.297  Sum_probs=62.7

Q ss_pred             HHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus        10 ~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++..+.++   ..-.++.++-+..-..   ..+....++||||++|- |.+..     .+++    .+...+.+++.
T Consensus        82 ~~~l~~~~~~i~~~g~~~~~~~yl~~ekk~---~~~~~~~~ll~EYIeG~~l~d~~-----~i~e----~~~~ki~~~ik  149 (229)
T PF06176_consen   82 YSRLINNTDKIRNEGFTEPADPYLAAEKKI---FRYTSSYVLLMEYIEGVELNDIE-----DIDE----DLAEKIVEAIK  149 (229)
T ss_pred             HHHHHHHHHHHHHcCccccccceeeeeeee---ccceeEEEEEEEEecCeecccch-----hcCH----HHHHHHHHHHH
Confidence            34455555555   3444455444444332   22345667999999982 22211     1222    23456677899


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      -||+.|+.|+|..|.|++++.++ ++++||+..+
T Consensus       150 qlH~~G~~HGD~hpgNFlv~~~~-i~iID~~~k~  182 (229)
T PF06176_consen  150 QLHKHGFYHGDPHPGNFLVSNNG-IRIIDTQGKR  182 (229)
T ss_pred             HHHHcCCccCCCCcCcEEEECCc-EEEEECcccc
Confidence            99999999999999999998655 9999997543

The waaY, waaQ, and waaP genes are located in the central operon of the waa (formerly rfa) locus on the chromosome of Escherichia coli. This locus contains genes whose products are involved in the assembly of the core region of the lipopolysaccharide molecule. WaaY is the enzyme that phosphorylates HepII in this system [].; GO: 0009244 lipopolysaccharide core region biosynthetic process

>KOG0666|consensus

Probab=98.18  E-value=1.1e-06  Score=80.40  Aligned_cols=37  Identities=49%  Similarity=0.828  Sum_probs=34.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++.|.+||.+||+|||.||+||+|||+|+||..++.|
T Consensus       310 ~~~a~~LL~klL~yDP~kRIta~qAleh~yF~~d~lp  346 (438)
T KOG0666|consen  310 DPSALDLLQKLLTYDPIKRITAEQALEHPYFTEDPLP  346 (438)
T ss_pred             CchHHHHHHHHhccCchhhccHHHHhcccccccCCCC
Confidence            5669999999999999999999999999999998766

>COG0478 RIO-like serine/threonine protein kinase fused to N-terminal HTH domain [Signal transduction mechanisms]

Probab=98.14  E-value=8.7e-06  Score=73.99  Aligned_cols=95  Identities=22%  Similarity=0.297  Sum_probs=71.7

Q ss_pred             hhHHHHHHHHHhCCCC--CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHE--NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hp--nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|.++|+.|.-.  .|.+.+++=            .-.+|||++.|-.+..     .+++.+....++..|+.-+.
T Consensus       154 l~A~rEf~~L~~L~~~G~~VP~P~~~n------------RHaVvMe~ieG~eL~~-----~r~~~en~~~il~~il~~~~  216 (304)
T COG0478         154 LAAEREFEALQRLYPEGVKVPKPIAWN------------RHAVVMEYIEGVELYR-----LRLDVENPDEILDKILEEVR  216 (304)
T ss_pred             HHHHHHHHHHHHhhhcCCCCCCccccc------------cceeeeehcccceeec-----ccCcccCHHHHHHHHHHHHH
Confidence            4578999999999644  777877643            3479999999832211     12234556666667777677


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      -+-..||||+|+.+-||+++.+|.+.++||--+.
T Consensus       217 ~~~~~GiVHGDlSefNIlV~~dg~~~vIDwPQ~v  250 (304)
T COG0478         217 KAYRRGIVHGDLSEFNILVTEDGDIVVIDWPQAV  250 (304)
T ss_pred             HHHHcCccccCCchheEEEecCCCEEEEeCcccc
Confidence            6669999999999999999999999999996443

>KOG0576|consensus

Probab=98.13  E-value=3.8e-07  Score=91.10  Aligned_cols=210  Identities=17%  Similarity=0.155  Sum_probs=136.0

Q ss_pred             hHHHHHHHHHhCCCCC-ccceeeeEEecCccccccCceEEEEeecCcCC--HHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHEN-VVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpn-Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~--L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...-++++|.+++||| .+..++-++.        .+...++++++++.  ...........+.+-+...+++.-+++++
T Consensus       279 ~~rl~~eLLdK~n~P~~~v~~~~d~~~--------E~~~~i~~~i~s~~rs~~~~~~~se~~~~~~~~~~~~r~et~~l~  350 (829)
T KOG0576|consen  279 SRRLAIELLDKVNNPNPVVRYLEDYDG--------EDYLWIPMRICSTGRSSALEMTVSEIALEQYQFAYPLRKETRPLA  350 (829)
T ss_pred             hhHHHHHHHHHccCCCCcccccccCCc--------ccccchhhhhhcCCccccccCChhhHhhhhhhhhhhhhhhccccc
Confidence            3455899999999999 5555444433        37789999999864  11111111112444455666777788999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ++|+.--+|+|    ||+... +..++.||+....+....     ...+..+++.++|||+..... +....|.|++|+-
T Consensus       351 ~l~~~~~~~~d----~~l~s~-~~~~~~~~~v~~~L~~~~-----~~~t~~~~~~~~~pev~~~~~-~~~~p~~~~~~~~  419 (829)
T KOG0576|consen  351 ELHSSYKVHRD----NILGSE-EEVKLLDFAVPPQLTRTM-----KPRTAIGTPEPLAPEVIQENT-IDGCPDSGSLAVS  419 (829)
T ss_pred             ccccccccCcc----cccccc-cccccccccCCcccCccc-----ccccCCCCCCCCCchhhcccc-cccCCCccCCCcc
Confidence            99998778888    777654 678999999887665321     234567899999999988776 6889999999998


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ..++.-|.+|-......  ...    .|..+  .-+...     .+     ..+           ...+-.++...|+..
T Consensus       420 ~~~~ap~~pPr~~P~~~--~~~----~g~~p--~s~~L~-----~~-----~aw-----------~~~~~~~~~~~~~~g  470 (829)
T KOG0576|consen  420 AIQMAPGLPPRSSPPAV--LPM----IGNGP--NSPMLT-----DK-----SAW-----------SPVFHRDFPAPCLNG  470 (829)
T ss_pred             hhhcCCCCCCCCCCccc--cCC----CCCCC--Cccccc-----hh-----hhc-----------CcccccCCcccccCC
Confidence            77887777765541100  000    01000  000000     00     000           000111577889999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .|..|++.-+++-|++|...+
T Consensus       471 ~P~~pkv~mgacfsKvfngCp  491 (829)
T KOG0576|consen  471 LPPTPKVHMGACFSKVFNGCP  491 (829)
T ss_pred             CCCCCcchhhHHHHHHhccCc
Confidence            999999999999999996543

>KOG1035|consensus

Probab=98.04  E-value=1.6e-05  Score=84.96  Aligned_cols=201  Identities=20%  Similarity=0.301  Sum_probs=130.8

Q ss_pred             HHHHHHHhCCCCCccceeeeEEecCccccccCc-eEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7889          12 REIKILQLLKHENVVHLIEICRTKANQYNRYRS-TFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHS   89 (433)
Q Consensus        12 ~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~-~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~   89 (433)
                      .|++.+..+.|+|++.++.+-.....     .+ .+.+..++|.. ++.+.+... ...+...++.+..+++.|++|+|+
T Consensus       231 ~e~~~l~k~~~~n~~~~~~~~le~~~-----~g~~~~v~~~~~s~~~~~~~~q~v-~~i~~~~~r~~~~~~~~GL~~~h~  304 (1351)
T KOG1035|consen  231 IELESLSKIAHDNLGGYFVYGLERLF-----RGIVLDVLQEICSKVELRSLLQSV-GSIPLETLRILHQKLLEGLAYLHS  304 (1351)
T ss_pred             HHHHHHHhhccccccceeEEeehhhc-----chHHHHHHHhhcCccchHHHHhhc-cccCHHHHHHHHHHHhhhHHHHHH
Confidence            46667777789999999988776533     12 23344566664 556555543 357889999999999999999999


Q ss_pred             CCeeccCCCCC---cEEEecCCcEEEe--ecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC--cchhhhH
Q psy7889          90 NKILHRDMKAA---NVLITKTGILKLA--DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP--PVDLWGA  162 (433)
Q Consensus        90 ~~iiH~dikp~---NIll~~~~~~kl~--DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~--~~DiwSl  162 (433)
                      ....|.-+..+   +.-++.++.+.++  ||+.+..+.....+     .....+.-+.++|...... +..  ..|+|.+
T Consensus       305 ~~l~~v~L~~s~~~~~~~~~e~~~~~sl~~~~ss~~l~d~~~~-----~~~~~~~~~~~~e~~~~~~-~~~~r~~dL~~l  378 (1351)
T KOG1035|consen  305 LSLEHVVLSASSSKESTVDGEGVVAISLSDFDSSKPLPDNEKS-----FSDLLAEIRNADEDLKENT-AKKSRLTDLWCL  378 (1351)
T ss_pred             hccceeEEecccccccccCccceeecchhhhcccccCCCcccc-----hhhcCcccccccccccccc-chhhhhhHHHHH
Confidence            86555544444   3334455566666  88877766543221     1223345577888765443 233  4699999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |.....+..|..+-....      .+..+++                                  ....+ ...+++.+|
T Consensus       379 gll~~~~~~~~~i~~~~~------~~~~~l~----------------------------------~~~~~-~~~d~~~~~  417 (1351)
T KOG1035|consen  379 GLLLLQLSQGEDISEKSA------VPVSLLD----------------------------------VLSTS-ELLDALPKC  417 (1351)
T ss_pred             HHHHhhhhhcCccccccc------chhhhhc----------------------------------cccch-hhhhhhhhh
Confidence            999998877754321110      0001111                                  00011 455889999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +.-++++|+.+.+++.|+|....
T Consensus       418 ~~~~~~~Rl~~~~ll~~~f~~~~  440 (1351)
T KOG1035|consen  418 LDEDSEERLSALELLTHPFLRFP  440 (1351)
T ss_pred             cchhhhhccchhhhhhchhcccc
Confidence            99999999999999999998543

>KOG0615|consensus

Probab=97.94  E-value=4.8e-06  Score=79.09  Aligned_cols=38  Identities=37%  Similarity=0.601  Sum_probs=34.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      +++|+|||+.||+.||++|+|+++||+||||...+.-+
T Consensus       410 seea~dlI~~mL~VdP~~R~s~~eaL~hpW~~~~~~~s  447 (475)
T KOG0615|consen  410 SEEALDLINWMLVVDPENRPSADEALNHPWFKDAPCLS  447 (475)
T ss_pred             hHHHHHHHHHhhEeCcccCcCHHHHhcChhhhcccccc
Confidence            78899999999999999999999999999998766543

>KOG0661|consensus

Probab=97.89  E-value=8.9e-06  Score=78.61  Aligned_cols=39  Identities=33%  Similarity=0.519  Sum_probs=34.5

Q ss_pred             cccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         329 ERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       329 ~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ..+++.  +++|++||..||.|||.+||||+|||+||||+.
T Consensus       258 ~L~p~~--s~~~~~li~~ll~WDP~kRpTA~~al~~pffq~  296 (538)
T KOG0661|consen  258 DLLPNA--SSEAASLIERLLAWDPDKRPTASQALQHPFFQV  296 (538)
T ss_pred             HhCccc--CHHHHHHHHHHhcCCCccCccHHHHhcCccccc
Confidence            344444  899999999999999999999999999999975

>PF12260 PIP49_C: Protein-kinase domain of FAM69; InterPro: IPR022049 Family with sequence similarity 69 has three members (A, B and C)

Probab=97.82  E-value=8e-05  Score=65.60  Aligned_cols=98  Identities=26%  Similarity=0.307  Sum_probs=77.6

Q ss_pred             HHHHHHHHhCCC-CCccceeeeEEecCccccccCceEEEEeecCcC-CHHHH---HhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889          11 LREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGL---LSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus        11 ~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~---l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..|.-+|+.+.+ +++.+++++|-.            ++|.||.+. .+...   +.+. ..-++....+++.+++..++
T Consensus         7 ~~E~lll~~l~~~~~~pk~lG~CG~------------~~v~E~~~~~~~~~~~~~l~~~-~~~~w~~R~~iA~~lL~~l~   73 (188)
T PF12260_consen    7 NNEPLLLQLLQGSEPFPKLLGSCGR------------FYVVEYVGAGSLYGIYRPLSQF-LQSPWEQRAKIALQLLELLE   73 (188)
T ss_pred             ccHHHHHHHcCCCCCCCCeeeECCC------------EEEEEeecCccccccccccccc-cccCHHHHHHHHHHHHHHHH
Confidence            458889999965 699999999842            578999884 33211   1111 13578899999999999999


Q ss_pred             HHHh---CCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          86 YIHS---NKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        86 ~LH~---~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      +|+.   ..+.-.|++++|+-++.+|.+|++|...+...
T Consensus        74 ~l~~~~~~~~~lcDv~~~nfgv~~~~~lk~iDld~v~~~  112 (188)
T PF12260_consen   74 ELDHGPLGFFYLCDVSPDNFGVNDDGRLKLIDLDDVFVE  112 (188)
T ss_pred             HHhcCCCCcEEEeecchHHeEEeCCCcEEEEechhcchh
Confidence            9997   45889999999999999999999999877554

Proteins in this uncharacterised family are described as transmembrane proteins.

>cd07868 STKc_CDK8 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 8

Probab=97.64  E-value=3.4e-05  Score=73.95  Aligned_cols=31  Identities=42%  Similarity=0.713  Sum_probs=29.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      +..++|||.+||.+||.+|+||+|+|+||||
T Consensus       287 ~~~~~dli~~mL~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07868         287 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYF  317 (317)
T ss_pred             ChHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            6779999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 8 (CDK8) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK8 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK8 can act as a negative or positive regulator of transcription, depending on the scenario. Together with its regulator, cyclin C, it reversibly associates with the multi-subunit core Mediator complex, a cofactor that is involved in regulating RNA p

>COG1718 RIO1 Serine/threonine protein kinase involved in cell cycle control [Signal transduction mechanisms / Cell division and chromosome partitioning]

Probab=97.62  E-value=0.0002  Score=64.58  Aligned_cols=102  Identities=19%  Similarity=0.205  Sum_probs=75.0

Q ss_pred             chhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc-cCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN-IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~-~~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.-|+++.  +-.+.+.+.+...            .|||||++.. ..---. ....+..+++..+..++++.
T Consensus       112 ~~W~~kEf~NL~R~~eAGVrvP~Pi~~~~n------------VLvMEfIg~~-g~pAP~LkDv~~e~~e~~~~~~~~v~~  178 (268)
T COG1718         112 FAWARKEFRNLKRAYEAGVRVPEPIAFRNN------------VLVMEFIGDD-GLPAPRLKDVPLELEEAEGLYEDVVEY  178 (268)
T ss_pred             HHHHHHHHHHHHHHHHcCCCCCCceeecCC------------eEEEEeccCC-CCCCCCcccCCcCchhHHHHHHHHHHH
Confidence            345678999999884  5666777776653            5999999854 100000 01123344677788888998


Q ss_pred             HHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccc
Q psy7889          84 LYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFS  122 (433)
Q Consensus        84 L~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~  122 (433)
                      +.-|-. .|+||+||..-|||+. ++.+.++|||-|....
T Consensus       179 ~~~l~~~a~LVHgDLSEyNiL~~-~~~p~iID~~QaV~~~  217 (268)
T COG1718         179 MRRLYKEAGLVHGDLSEYNILVH-DGEPYIIDVSQAVTID  217 (268)
T ss_pred             HHHHHHhcCcccccchhhheEEE-CCeEEEEECccccccC
Confidence            888887 8999999999999999 8899999999876544

>cd07871 STKc_PCTAIRE3 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-3 kinase

Probab=97.60  E-value=4.2e-05  Score=72.27  Aligned_cols=31  Identities=45%  Similarity=0.789  Sum_probs=30.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      +.+++|||++||.+||.+|+||+|+|+||||
T Consensus       258 ~~~~~dll~~mL~~dp~~R~t~~~~l~hp~f  288 (288)
T cd07871         258 DTDGIDLLSSLLLYETKSRISAEAALRHSYF  288 (288)
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCCCC
Confidence            7889999999999999999999999999998

Serine/Threonine Kinases (STKs), PCTAIRE-3 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-3 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-3 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-3 shows a restricted pattern of expression and is present in brain, kidney, and intestine. It is elevated in Alzheimer's disease (AD) and has been shown to associate with paired helical filament

>KOG0671|consensus

Probab=97.57  E-value=4e-05  Score=72.31  Aligned_cols=33  Identities=36%  Similarity=0.515  Sum_probs=30.1

Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         338 QYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       338 ~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ....|||++||.|||.+|+|+.|||.||||...
T Consensus       380 ~~LfDLl~~mL~fDP~~RiTl~EAL~HpFF~~~  412 (415)
T KOG0671|consen  380 VQLFDLLRRMLEFDPARRITLREALSHPFFARL  412 (415)
T ss_pred             hHHHHHHHHHHccCccccccHHHHhcCHHhhcC
Confidence            457899999999999999999999999999754

>KOG1167|consensus

Probab=97.53  E-value=5.3e-05  Score=72.28  Aligned_cols=33  Identities=45%  Similarity=0.618  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +..++|||+++|..||.||+||++||+||||..
T Consensus       354 ~~~~~dlLdk~le~np~kRitAEeALkHpFF~~  386 (418)
T KOG1167|consen  354 PALLLDLLDKCLELNPQKRITAEDALKHPFFDE  386 (418)
T ss_pred             cHHHHHHHHHHccCChhhcccHHHHhcCcCCcc
Confidence            668999999999999999999999999999984

>cd07845 STKc_CDK10 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 10

Probab=97.53  E-value=7.5e-05  Score=71.28  Aligned_cols=42  Identities=33%  Similarity=0.621  Sum_probs=38.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhH
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSK  378 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~  378 (433)
                      ++.+.|||.+||.+||.+|+|++++|.||||...+.|+.+..
T Consensus       263 ~~~~~~li~~ml~~dp~~R~t~~~il~h~~f~~~~~~~~~~~  304 (309)
T cd07845         263 SEAGLRLLNFLLMYDPKKRATAEEALESSYFKEKPLPCEPEM  304 (309)
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHhcChhhccCCCCCCCCc
Confidence            788999999999999999999999999999998888876543

Serine/Threonine Kinases (STKs), Cyclin-dependent protein Kinase 10 (CDK10) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK10 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK10, also called PISSLRE, is essential for cell growth and proliferation, and acts through the G2/M phase of the cell cycle. CDK10 has also been identified as an important factor in endocrine therapy resistance in breast cancer. CDK10 silencing

>KOG0668|consensus

Probab=97.52  E-value=5e-05  Score=66.94  Aligned_cols=32  Identities=38%  Similarity=0.578  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +++|+|||+++|.||.+.|+||.||+.||||.
T Consensus       295 ~peaiDlldklLrYDHqeRlTakEam~HpyF~  326 (338)
T KOG0668|consen  295 SPEAIDLLDKLLRYDHQERLTAKEAMAHPYFA  326 (338)
T ss_pred             ChHHHHHHHHHHhhccccccchHHHhcCchHH
Confidence            78999999999999999999999999999996

>KOG0662|consensus

Probab=97.47  E-value=8.2e-05  Score=63.08  Aligned_cols=39  Identities=36%  Similarity=0.563  Sum_probs=33.9

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ..+.+  +.-+.||++++|..+|..|++|++||+||||.+.
T Consensus       251 ivp~l--ns~grdllqkll~cnp~qrisaeaalqhpyf~d~  289 (292)
T KOG0662|consen  251 IVPKL--NSTGRDLLQKLLKCNPAQRISAEAALQHPYFSDF  289 (292)
T ss_pred             Hhhhh--cchhHHHHHHHhccCcccccCHHHHhcCcccccc
Confidence            34445  6779999999999999999999999999999764

>cd07869 STKc_PFTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PFTAIRE-1 kinase

Probab=97.46  E-value=8.2e-05  Score=70.81  Aligned_cols=35  Identities=37%  Similarity=0.507  Sum_probs=32.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ...+.|||++||.+||.+|+||.++|+||||.+.+
T Consensus       261 ~~~~~dli~~mL~~dp~~R~s~~~~l~h~~f~~~~  295 (303)
T cd07869         261 VNHAEDLASKLLQCFPKNRLSAQAALSHEYFSDLP  295 (303)
T ss_pred             ChHHHHHHHHHhccCchhccCHHHHhcCcccccCC
Confidence            57899999999999999999999999999998643

Serine/Threonine Kinases (STKs), PFTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PFTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PFTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PFTAIRE-1 is widely expressed except in the spleen and thymus. It is highly expressed in the brain, heart, pancreas, testis, and ovary, and is localized in the cytoplasm. It is regulated by cyclin D3 an

>KOG0599|consensus

Probab=97.46  E-value=4.8e-05  Score=68.70  Aligned_cols=32  Identities=41%  Similarity=0.658  Sum_probs=30.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +..++|||.++|+.||.+|+||+|+|.||||.
T Consensus       256 s~~~KdLIsrlLqVdp~~Ritake~LaHpff~  287 (411)
T KOG0599|consen  256 SATVKDLISRLLQVDPTKRITAKEALAHPFFI  287 (411)
T ss_pred             cccHHHHHHHHHeeCchhcccHHHHhcChHHH
Confidence            67799999999999999999999999999993

>KOG1093|consensus

Probab=97.45  E-value=0.00059  Score=67.46  Aligned_cols=175  Identities=23%  Similarity=0.342  Sum_probs=111.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++--..+++.+.|+|...++++-+.+.       ....+|||++..++.+.+......  ..       +++     
T Consensus        26 s~~ilgr~~~lktl~~~~l~~yl~~~r~~~-------~r~IVV~e~~~~Sled~~~~~~l~--~~-------s~~-----   84 (725)
T KOG1093|consen   26 SIQILGRFQYLKSLQHDNLCQYLDFSRGKH-------ERVIVVMEHYTMSLEDILKTGNLK--DE-------SLL-----   84 (725)
T ss_pred             HHHHhhhhHHHHhhcCccceeeEeeecCcc-------ceEEEEehhhccchHHHHHhcccc--hh-------hhc-----
Confidence            345666778899999999999999888763       448899999999998888764311  11       111     


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                        .+|+.|-     |       .++.+| -++..                    |  |-.      .++++||||+|.++
T Consensus        85 --~~~~~~~-----~-------~~~~td-~~~t~--------------------~--~~~------~~pKsdVwsl~~i~  121 (725)
T KOG1093|consen   85 --AHGVLHL-----N-------IIYITD-HFLTK--------------------Y--PSP------IGPKSDVWSLGFII  121 (725)
T ss_pred             --cccccee-----h-------hhhccc-ccccc--------------------C--CCC------CCcchhhhhHHHHH
Confidence              1222221     1       223333 11100                    0  111      23599999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      .++..|...+......+....|.++........ .                   ...+...-...++-.+.++.+|+...
T Consensus       122 ~el~L~~~l~~~~~~s~~l~~i~k~~~~d~~~~-~-------------------~a~e~~~~~~~d~~~~~~~~~c~~~~  181 (725)
T KOG1093|consen  122 LELYLGISLEAELTESEYLEILLKYYTDDQELL-S-------------------TAMEHLIQLLADKKRLPLLKKCLWLE  181 (725)
T ss_pred             HHHHHhhHHHHHHHHHHHHHHHHHhccCchhHH-H-------------------HHHHHHHHHhhhHhHHHHhccCCccc
Confidence            999999988888777777776655433221110 0                   00000111123455668999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |..||...++..++-|.+.
T Consensus       182 ~~ir~l~~~~~k~~i~~ev  200 (725)
T KOG1093|consen  182 PIIRPLPMELSKRCSFTEV  200 (725)
T ss_pred             cccccchhHHhcCccHHHH
Confidence            9999999999999998653

>cd05150 APH Aminoglycoside 3'-phosphotransferase (APH)

Probab=97.44  E-value=0.00081  Score=61.91  Aligned_cols=29  Identities=17%  Similarity=0.269  Sum_probs=25.7

Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .++|+|+.|.||+++.++.+.|+||+.+.
T Consensus       164 ~l~HgD~~~~Nil~~~~~~~~iIDwe~a~  192 (244)
T cd05150         164 VVTHGDACLPNIIVDPGKFSGFIDLGRLG  192 (244)
T ss_pred             EEECCCCCCccEEEeCCcEEEEEEccccc
Confidence            48999999999999998778899998663

The APH subfamily is part of a larger superfamily that includes the catalytic domains of other kinases, such as the typical serine/threonine/tyrosine protein kinases (PKs), RIO kinases, actin-fragmin kinase (AFK), and phosphoinositide 3-kinase (PI3K). APH catalyzes the transfer of the gamma-phosphoryl group from ATP to aminoglycoside antibiotics such as kanamycin, streptomycin, neomycin, and gentamicin, among others. The aminoglycoside antibiotics target the 30S ribosome and promote miscoding, leading to the production of defective proteins which insert into the bacterial membrane, resulting in membrane damage and the ultimate demise of the bacterium. Phosphorylation of the aminoglycoside antibiotics results in their inactivation, leading to bacterial antibiotic resistance. The APH gene is found on transposons and plasmids and is thought to have originated as a self-defense mechanism used by microorganisms that produce the antibio

>TIGR02172 Fb_sc_TIGR02172 Fibrobacter succinogenes paralogous family TIGR02172

Probab=97.38  E-value=0.0014  Score=59.65  Aligned_cols=28  Identities=25%  Similarity=0.376  Sum_probs=25.0

Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .++|+|+.|.||+++.++ +.++||+.+.
T Consensus       154 ~~~HgD~~~~Nii~~~~~-~~iIDwe~a~  181 (226)
T TIGR02172       154 TCLHGDFQIGNLITSGKG-TYWIDLGDFG  181 (226)
T ss_pred             ceEecCCCCCcEEEcCCC-cEEEechhcC
Confidence            478999999999999888 9999998764

This model describes a paralogous family of five proteins, likely to be enzymes, in the rumen bacterium Fibrobacter succinogenes S85. Members show homology to proteins described by PFAM model pfam01636, a phosphotransferase enzyme family associated with resistance to aminoglycoside antibiotics. However, members of this family score below the current trusted and noise cutoffs for pfam01636.

>PTZ00284 protein kinase; Provisional

Probab=97.36  E-value=0.00013  Score=74.22  Aligned_cols=34  Identities=29%  Similarity=0.478  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++.++|||.+||.+||.+|+||+|+|+||||...
T Consensus       411 ~~~~~dli~~mL~~dP~~R~ta~e~L~Hp~~~~~  444 (467)
T PTZ00284        411 DDLLCDLIYGLLHYDRQKRLNARQMTTHPYVLKY  444 (467)
T ss_pred             hHHHHHHHHHhCCcChhhCCCHHHHhcCcccccc
Confidence            5678899999999999999999999999999764

>PF10707 YrbL-PhoP_reg: PhoP regulatory network protein YrbL; InterPro: IPR019647 This entry represents proteins that are activated by the protein PhoP

Probab=97.35  E-value=0.0026  Score=56.43  Aligned_cols=99  Identities=18%  Similarity=0.271  Sum_probs=72.9

Q ss_pred             CCchhHHHHHHHHHhCC------CCCccceeeeEEecCccccccCceEEEEeecCc---C----CHHHHHhccCCCCCHH
Q psy7889           5 FFPITALREIKILQLLK------HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---H----DLAGLLSNIHVKFSLG   71 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~------hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~---~----~L~~~l~~~~~~l~~~   71 (433)
                      +...+.++|+.-...+.      +.+|.+++++.+++..        ..+|+|.+.   |    +|.+++.+  ..+++ 
T Consensus        53 ~~~~~~~~E~~~y~~l~~~~~~~~~~i~r~~G~veT~~G--------~Glv~e~I~d~dG~~s~TL~~~l~~--~~~~~-  121 (199)
T PF10707_consen   53 SRYRQNRRELRYYKQLSLRRGVDWSHIPRFYGFVETNLG--------LGLVVELIRDADGNISPTLEDYLKE--GGLTE-  121 (199)
T ss_pred             chhHHHHHHHHHHHHHhhccCCcccccccEeEEEecCCc--------eEEEEEEEECCCCCcCccHHHHHHc--CCccH-
Confidence            34567888988888876      8899999999999844        678888764   2    68877754  23555 


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCC----cEEEee-cCC
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG----ILKLAD-FGL  117 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~----~~kl~D-Fg~  117 (433)
                      .+...+   -.-.+||-+.+|+.+|++|.||++...+    .+.|+| ||.
T Consensus       122 ~~~~~L---~~f~~~l~~~~Iv~~dl~~~NIv~~~~~~~~~~lvlIDG~G~  169 (199)
T PF10707_consen  122 ELRQAL---DEFKRYLLDHHIVIRDLNPHNIVVQRRDSGEFRLVLIDGLGE  169 (199)
T ss_pred             HHHHHH---HHHHHHHHHcCCeecCCCcccEEEEecCCCceEEEEEeCCCC
Confidence            333333   3445688899999999999999997432    588888 553

PhoP controls the expression of a large number of genes that mediate adaptation to low Mg2+ environments and/or virulence in several bacterial species. YbrL is proposed to be acting in a loop activity with PhoP and PrmA analogous to the multi-component loop in Salmonella sp., where the PhoP-dependent PmrD protein activates the regulatory protein PmrA, and the activated PmrA then represses transcription from the PmrD promoter which harbours binding sites for both the PhoP and PmrA proteins. Expression of YrbL is induced in low Mg2+ in a PhoP-dependent fashion and repressed by Fe3+ in a PmrA-dependent manner [].

>cd07848 STKc_CDKL5 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase Like 5

Probab=97.35  E-value=0.00014  Score=68.55  Aligned_cols=31  Identities=35%  Similarity=0.593  Sum_probs=30.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      +.+++|||++||.+||.+|+|++++|+||||
T Consensus       257 s~~~~dll~~~L~~~P~~R~s~~~~l~hp~f  287 (287)
T cd07848         257 SGVLLDLMKNLLKLNPTDRYLTEQCLNHPAF  287 (287)
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcCCCC
Confidence            7789999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase like 5 (CDKL5) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDKL5 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. Mutations in the gene encoding CDKL5, previously called STK9, are associated with early onset epilepsy and severe mental retardation [X-linked infantile spasm syndrome (ISSX) or West syndrome]. In addition, CDKL5 mutations also sometimes

>PHA03209 serine/threonine kinase US3; Provisional

Probab=97.34  E-value=0.00012  Score=71.71  Aligned_cols=33  Identities=27%  Similarity=0.300  Sum_probs=31.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.++.+||.+||.+||.+||||.|+|+||||++
T Consensus       324 ~~~~~~li~~mL~~dP~~Rpta~e~l~hp~f~~  356 (357)
T PHA03209        324 PIDGEFLVHKMLTFDAAMRPSAEEILNYPMFAQ  356 (357)
T ss_pred             CchHHHHHHHHHcCCcccCcCHHHHhcCchhcc
Confidence            667889999999999999999999999999974

>KOG0594|consensus

Probab=97.31  E-value=0.00016  Score=67.75  Aligned_cols=45  Identities=38%  Similarity=0.573  Sum_probs=37.7

Q ss_pred             cccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         327 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       327 l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +...++..  ++++.||+.+||.|||.+|+||..||.||||...+.+
T Consensus       267 l~~~~~~~--~~~~~dll~~~L~y~p~~R~Sa~~al~h~yf~~~~~~  311 (323)
T KOG0594|consen  267 LSSILPKL--DPDGIELLSKLLQYDPAKRISAKGALTHPYFSELPEK  311 (323)
T ss_pred             hHHhcccc--CccHHHHHHHHhccCcccCcCHHHHhcChhhcccccc
Confidence            33344444  6899999999999999999999999999999877654

>cd07867 STKc_CDC2L6 Catalytic domain of Serine/Threonine Kinase, Cell Division Cycle 2-like 6

Probab=97.30  E-value=0.00017  Score=68.95  Aligned_cols=31  Identities=45%  Similarity=0.673  Sum_probs=29.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      +..+++||.+||..||.+|+||+|+|+||||
T Consensus       287 ~~~~~~ll~~~l~~dP~~R~t~~e~l~hp~f  317 (317)
T cd07867         287 DSKVFLLLQKLLTMDPTKRITSEQALQDPYF  317 (317)
T ss_pred             ChHHHHHHHHHhccCcccccCHHHHhcCCCC
Confidence            5678999999999999999999999999998

Serine/Threonine Kinases (STKs), Cell Division Cycle 2-like 6 (CDC2L6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDC2L6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDC2L6 is also called CDK8-like and was previously referred to as CDK11. However, this is a confusing nomenclature as CDC2L6 is distinct from CDC2L1, which is represented by the two protein products from its gene, called CDK11(p110) and CDK11(p58), as well as

>KOG0593|consensus

Probab=97.27  E-value=0.00018  Score=66.10  Aligned_cols=46  Identities=24%  Similarity=0.392  Sum_probs=39.2

Q ss_pred             CcccccccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         322 GYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       322 ~~~~~l~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +-+..+...++..  +..++||+++||.+||.+|++++|+|.|+||..
T Consensus       244 ~~~epLe~k~p~~--s~~~ld~~k~cL~~dP~~R~sc~qll~H~yFd~  289 (396)
T KOG0593|consen  244 EHPEPLERKYPKI--SNVLLDLLKKCLKMDPDDRLSCEQLLHHPYFDG  289 (396)
T ss_pred             CCccchhhhcccc--hHHHHHHHHHHhcCCccccccHHHHhcChHHHH
Confidence            3445566667777  789999999999999999999999999999943

>PHA03212 serine/threonine kinase US3; Provisional

Probab=97.26  E-value=0.00017  Score=71.52  Aligned_cols=37  Identities=27%  Similarity=0.243  Sum_probs=33.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +.+..+||.+||.+||.+|+||+|+|+||||...+.|
T Consensus       349 ~~~l~~Li~~mL~~dP~~Rpta~elL~hp~f~~~~~~  385 (391)
T PHA03212        349 PIDLEYLICKMLAFDAHHRPSAEALLDFAAFQDIPDP  385 (391)
T ss_pred             hhhHHHHHHHHhcCChhhCCCHHHHhcChhhccCCCC
Confidence            5678899999999999999999999999999875554

>cd07863 STKc_CDK4 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 4

Probab=97.25  E-value=0.00022  Score=67.09  Aligned_cols=31  Identities=39%  Similarity=0.695  Sum_probs=29.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      +..+.|||.+||.+||.+|+|+.++|.||||
T Consensus       258 ~~~~~~li~~~L~~dP~~R~t~~~~l~hp~f  288 (288)
T cd07863         258 EESGAQLLLEMLTFNPHKRISAFRALQHPFF  288 (288)
T ss_pred             CHHHHHHHHHHhccCcccCCCHHHHhcCCCC
Confidence            7788999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 4 (CDK4) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK4 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK4 partners with all three D-type cyclins (D1, D2, and D3) and is also regulated by INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein and plays a role in regulating the early G1 phase of the cell cycle. It is expressed ubiquitou

>KOG0032|consensus

Probab=97.23  E-value=0.00025  Score=69.55  Aligned_cols=35  Identities=31%  Similarity=0.475  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +..|+||++.||..||.+|+||.++|+|||+....
T Consensus       266 s~~akd~i~~ll~~dp~~R~ta~~~L~HpWi~~~~  300 (382)
T KOG0032|consen  266 SESAKDFIRKLLEFDPRKRLTAAQALQHPWIKSIG  300 (382)
T ss_pred             CHHHHHHHHHhcccCcccCCCHHHHhcCccccCCc
Confidence            78899999999999999999999999999998753

>cd07862 STKc_CDK6 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 6

Probab=97.20  E-value=0.00026  Score=66.78  Aligned_cols=31  Identities=45%  Similarity=0.749  Sum_probs=30.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      ++.+.+||.+||..||++|+|+.++|+||||
T Consensus       260 ~~~~~~li~~~l~~~P~~R~s~~~~l~hp~f  290 (290)
T cd07862         260 DELGKDLLLKCLTFNPAKRISAYSALSHPYF  290 (290)
T ss_pred             CHHHHHHHHHHhccCchhcCCHHHHhcCCCC
Confidence            7889999999999999999999999999998

Serine/Threonine Kinases (STKs), Cyclin-dependent protein kinase 6 (CDK6) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK6 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK6 is regulated by D-type cyclins and INK4 inhibitors. It is active towards the retinoblastoma (pRb) protein, implicating it to function in regulating the early G1 phase of the cell cycle. It is expressed ubiquitously and is localized in the cytopla

>cd07872 STKc_PCTAIRE2 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-2 kinase

Probab=97.14  E-value=0.0003  Score=67.14  Aligned_cols=35  Identities=31%  Similarity=0.575  Sum_probs=32.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++++|||.+||.+||.+|+|+.++|.||||...+
T Consensus       259 ~~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~  293 (309)
T cd07872         259 DTEGIELLTKFLQYESKKRISAEEAMKHAYFRSLG  293 (309)
T ss_pred             CHHHHHHHHHhccCChhhCCCHHHHhcChhhhhcc
Confidence            78899999999999999999999999999998644

Serine/Threonine Kinases (STKs), PCTAIRE-2 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-2 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-2 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-2 is specifically expressed in neurons in the central nervous system, mainly in terminally differentiated neurons. It associates with Trap (Tudor repeat associator with PCTAIRE-2) and could play

>KOG0665|consensus

Probab=97.11  E-value=0.00028  Score=65.28  Aligned_cols=32  Identities=41%  Similarity=0.657  Sum_probs=30.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +..|.||+.+||..||++|+++.+||.||||.
T Consensus       283 ~~~ardll~~MLvi~pe~Risv~daL~HPY~~  314 (369)
T KOG0665|consen  283 CSLARDLLSKMLVIDPEKRISVDDALRHPYIK  314 (369)
T ss_pred             hHHHHHHHHHhhccChhhcccHHHHhcCCeee
Confidence            56799999999999999999999999999995

>PTZ00036 glycogen synthase kinase; Provisional

Probab=97.11  E-value=0.00023  Score=71.74  Aligned_cols=34  Identities=24%  Similarity=0.366  Sum_probs=31.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +.++++||.+||.+||.+|+||.++|+||||...
T Consensus       324 ~~~~~~li~~~L~~dP~~R~ta~e~l~hp~f~~~  357 (440)
T PTZ00036        324 PDDAINFISQFLKYEPLKRLNPIEALADPFFDDL  357 (440)
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhCChhHHhh
Confidence            6789999999999999999999999999999753

>KOG1826|consensus

Probab=97.09  E-value=0.00013  Score=80.12  Aligned_cols=156  Identities=12%  Similarity=-0.006  Sum_probs=114.7

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCC---CCHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVK---FSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~---l~~~~~~~i~~qll~aL~   85 (433)
                      .+.|.+-++...|++++..+.-.....+      ...+++++||. |++++.+.+.-.+   +.+..+.....+.+.+..
T Consensus      1276 ll~e~de~~~~~h~~~~~~p~rI~ps~s------~ee~~r~~~~~~g~~f~iIikg~ee~~~ld~~~v~~~~kvsvl~~~ 1349 (2724)
T KOG1826|consen 1276 LLSERDELREAKHYLTEVDPLRIPPSES------TEEYIRSLYVEFGKLFSIIIKGLEESPDLDRSPVHLRHKVSVLNRN 1349 (2724)
T ss_pred             hhhhhhhhhhhhceeeecccccCCCCCC------hHHHHHHHHHHHhHHHHHHHhccccCCcchhchHHHHHHHHHhccc
Confidence            3445555666789999988877765543      66789999997 5788888654332   444455555555577788


Q ss_pred             HHHhCC-----eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          86 YIHSNK-----ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        86 ~LH~~~-----iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      -+|++.     .+|+++|+-|.+|..+-.++++++|+.+...    .........++++.|+.|++...-. ++.++|+|
T Consensus      1350 ~~ls~tnlg~T~v~~~Lkf~lpmIVtny~v~~gk~gLdKIkn----p~~sf~Gl~l~sp~~v~qli~N~ik-~t~rsdil 1424 (2724)
T KOG1826|consen 1350 VILSLTNLGNTNVSKSLKFTLPMIVTNYNVKLGKGGLDKIKN----PVLSFFGLELCSPIYVLQLIKNEIK-FTKRSDIL 1424 (2724)
T ss_pred             hhhhcccCCccchhhhhhhhccceecCCcccccccccccccC----chHhhhhhhhCCHHHHHHHHHHHHh-hhhHHHHH
Confidence            877542     7899999999999999999999999987221    1223345567788899999876544 68789999


Q ss_pred             hHHHHHHHHHhcCCCC
Q psy7889         161 GAGCIMAEMWTRSPIM  176 (433)
Q Consensus       161 SlGvil~ell~g~~pf  176 (433)
                      ..|+-+|.+-.|.++|
T Consensus      1425 r~s~~ly~rs~~n~~f 1440 (2724)
T KOG1826|consen 1425 RRSLSLYLRSDGNAYF 1440 (2724)
T ss_pred             HHHHHHHHHhcccHHH
Confidence            9999999987776655

>PLN03225 Serine/threonine-protein kinase SNT7; Provisional

Probab=97.09  E-value=0.00039  Score=72.06  Aligned_cols=35  Identities=26%  Similarity=0.466  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +..+.|||++||.+||.+|+||.++|+||||....
T Consensus       423 ~~~~~dLi~~mL~~dP~kR~ta~e~L~Hpff~~~~  457 (566)
T PLN03225        423 GGAGWELLKSMMRFKGRQRISAKAALAHPYFDREG  457 (566)
T ss_pred             chHHHHHHHHHccCCcccCCCHHHHhCCcCcCCCC
Confidence            44577999999999999999999999999997643

>cd07878 STKc_p38beta_MAPK11 Catalytic domain of the Serine/Threonine Kinase, p38beta Mitogen-Activated Protein Kinase

Probab=97.08  E-value=0.00039  Score=67.41  Aligned_cols=37  Identities=38%  Similarity=0.632  Sum_probs=33.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++.++|||.+||..||.+|+||.++|.||||.....+
T Consensus       271 ~~~~~~li~~mL~~dp~~R~s~~ell~hp~~~~~~~~  307 (343)
T cd07878         271 NPLAIDLLEKMLVLDSDKRISASEALAHPYFSQYHDP  307 (343)
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcchhccCCC
Confidence            6778999999999999999999999999999865443

Serine/Threonine Kinases (STKs), p38beta subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The p38beta subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. p38 kinases are mitogen-activated protein kinases (MAPKs), serving as important mediators of cellular responses to extracellular signals. They are activated by the MAPK kinases MKK3 and MKK6, which in turn are activated by upstream MAPK kinase kinases including TAK1, ASK1, and MLK3, in response to cellular stresses or inflammatory cytokines. Vertebrates contain four isoforms of p38, named alpha, beta, gamma, and delta. p38beta, also called MAPK11, is

>cd07875 STKc_JNK1 Catalytic domain of the Serine/Threonine Kinase, c-Jun N-terminal Kinase 1

Probab=97.05  E-value=0.00048  Score=67.45  Aligned_cols=33  Identities=39%  Similarity=0.602  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +..++|||.+||.+||.+|+|+.++|+||||..
T Consensus       291 ~~~~~dll~~mL~~dP~~R~t~~e~L~hp~~~~  323 (364)
T cd07875         291 ASQARDLLSKMLVIDASKRISVDEALQHPYINV  323 (364)
T ss_pred             cHHHHHHHHHhcCcCcccCCCHHHHhcCccccc
Confidence            567899999999999999999999999999965

Serine/Threonine Kinases (STKs), c-Jun N-terminal kinase 1 (JNK1) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The JNK1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. JNKs are mitogen-activated protein kinases (MAPKs) that are involved in many stress-activated responses including those during inflammation, neurodegeneration, apoptosis, and persistent pain sensitization, among others. Vetebrates harbor three different JNK genes (Jnk1, Jnk2, and Jnk3). JNK1, like JNK2, is expressed in every cell and tissue type. Initially it was thought that JNK1 and JNK2 were functionally redundant as mice deficient in either genes (Jn

>PHA03211 serine/threonine kinase US3; Provisional

Probab=97.04  E-value=0.00038  Score=70.30  Aligned_cols=33  Identities=21%  Similarity=0.178  Sum_probs=31.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.++.+||.+||.+||.+|+||.|+|+||||+.
T Consensus       428 ~~~~~dli~~mL~~DP~~RPsa~elL~hp~f~~  460 (461)
T PHA03211        428 DLDVEYLVCRALTFDGARRPSAAELLRLPLFQS  460 (461)
T ss_pred             cchHHHHHHHHcccChhhCcCHHHHhhCcccCC
Confidence            668999999999999999999999999999964

>cd07841 STKc_CDK7 Catalytic domain of the Serine/Threonine Kinase, Cyclin-Dependent protein Kinase 7

Probab=97.01  E-value=0.00054  Score=64.87  Aligned_cols=41  Identities=41%  Similarity=0.704  Sum_probs=37.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChh
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLS  377 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~  377 (433)
                      +...++||.+||..||.+|+|+.++|.|+||.+.+.|+.+.
T Consensus       255 ~~~~~~li~~~l~~~P~~R~s~~e~l~~~~~~~~~~~~~~~  295 (298)
T cd07841         255 SDDALDLLQRLLTLNPNKRITARQALEHPYFSNDPAPTPPS  295 (298)
T ss_pred             cHHHHHHHHHHhcCCcccCcCHHHHhhCccccCCCCCCCCC
Confidence            67899999999999999999999999999999988876543

Serine/Threonine Kinases (STKs), Cyclin-Dependent protein Kinase 7 (CDK7) subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The CDK7 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. CDKs belong to a large family of STKs that are regulated by their cognate cyclins. Together, they are involved in the control of cell-cycle progression, transcription, and neuronal function. CDK7 plays essential roles in the cell cycle and in transcription. It associates with cyclin H and MAT1 and acts as a CDK-Activating Kinase (CAK) by phosphorylating and activating cell cycle CDKs (CDK1/2/4/6). In the brain, it activates CDK5. CDK7 is

>cd07873 STKc_PCTAIRE1 Catalytic domain of the Serine/Threonine Kinase, PCTAIRE-1 kinase

Probab=97.00  E-value=0.00048  Score=65.43  Aligned_cols=33  Identities=36%  Similarity=0.689  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.++.|||.+||.+||.+|+|++++|+||||..
T Consensus       259 ~~~~~~li~~ml~~dp~~R~t~~eil~h~~f~~  291 (301)
T cd07873         259 DSDGAELLSKLLQFEGRKRISAEEAMKHPYFHC  291 (301)
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHhcCccccc
Confidence            678999999999999999999999999999965

Serine/Threonine Kinases (STKs), PCTAIRE-1 subfamily, catalytic (c) domain. STKs catalyze the transfer of the gamma-phosphoryl group from ATP to serine/threonine residues on protein substrates. The PCTAIRE-1 subfamily is part of a larger superfamily that includes the catalytic domains of other protein STKs, protein tyrosine kinases, RIO kinases, aminoglycoside phosphotransferase, choline kinase, and phosphoinositide 3-kinase. PCTAIRE-1 shares sequence similarity with Cyclin-Dependent Kinases (CDKs), which belong to a large family of STKs that are regulated by their cognate cyclins. Together, CDKs and cyclins are involved in the control of cell-cycle progression, transcription, and neuronal function. PCTAIRE-1 is expressed ubiquitously and is localized in the cytoplasm. Its kinase activity is cell cycle dependent and peaks at the S and G2 phases. PCTAIRE-1 is highly expressed in the brain and may pl

---

Homologous Structure Templates

Structure Templates Detected by BLAST

Original result of BLAST against Protein Data Bank

ID	Length	Definition	E-value
Query	433
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		1e-129
4ec8_A	373	Structure Of Full Length Cdk9 In Complex With Cycli		5e-17
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		1e-128
3mi9_A	351	Crystal Structure Of Hiv-1 Tat Complexed With Human		5e-17
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		1e-124
4bcf_A	331	Structure Of Cdk9 In Complex With Cyclin T And A 2-		9e-13
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		1e-124
3blh_A	331	Crystal Structure Of Human Cdk9CYCLINT1 Length = 33		9e-13
4erw_A	306	Cdk2 In Complex With Staurosporine Length = 306		2e-44
1gz8_A	299	Human Cyclin Dependent Kinase 2 Complexed With The		2e-44
1pf8_A	298	Crystal Structure Of Human Cyclin-dependent Kinase		4e-44
2w17_A	299	Cdk2 In Complex With The Imidazole Pyrimidine Amide		4e-44
1fin_A	298	Cyclin A-Cyclin-Dependent Kinase 2 Complex Length =		4e-44
3ezr_A	300	Cdk-2 With Indazole Inhibitor 17 Bound At Its Activ		4e-44
1oit_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-44
3pxf_A	306	Cdk2 In Complex With Two Molecules Of 8-Anilino-1-N		5e-44
1oir_A	299	Imidazopyridines: A Potent And Selective Class Of C		5e-44
1h01_A	298	Cdk2 In Complex With A Disubstituted 2, 4-Bis Anili		5e-44
3pj8_A	299	Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]		5e-44
1vyw_A	309	Structure Of Cdk2CYCLIN A WITH PNU-292137 Length =		5e-44
4eoi_A	299	Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyc		1e-43
1qmz_A	299	Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Com		2e-43
1w98_A	298	The Structural Basis Of Cdk2 Activation By Cyclin E		2e-43
4eoo_A	299	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-43
1e9h_A	297	Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex		2e-43
4eop_A	300	Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3		2e-43
3bht_A	300	Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN		2e-43
4eoq_A	301	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-43
4bcq_A	301	Structure Of Cdk2 In Complex With Cyclin A And A 2-		2e-43
3qhr_A	298	Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic		2e-43
1jst_A	298	Phosphorylated Cyclin-Dependent Kinase-2 Bound To C		2e-43
2iw6_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A Com		2e-43
4eos_A	300	Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Co		2e-43
1ogu_A	302	Structure Of Human Thr160-phospho Cdk2/cyclin A Com		2e-43
4i3z_A	296	Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNES		2e-43
1h1p_A	303	Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMP		2e-43
4eom_A	301	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		2e-43
4eon_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Hum		3e-43
4eok_A	300	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-43
4eoj_A	302	Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Huma		3e-43
1gii_A	298	Human Cyclin Dependent Kinase 2 Complexed With The		3e-43
2jgz_A	289	Crystal Structure Of Phospho-Cdk2 In Complex With C		6e-43
2pk9_A	317	Structure Of The Pho85-pho80 Cdk-cyclin Complex Of		6e-43
3niz_A	311	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-43
2qkr_A	313	Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5		8e-43
2iw8_A	302	Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82		9e-43
3mtl_A	324	Crystal Structure Of The Pctaire1 Kinase In Complex		2e-42
1v0b_A	288	Crystal Structure Of The T198a Mutant Of Pfpk5 Leng		3e-40
1v0o_A	288	Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulpho		3e-40
1ob3_A	288	Structure Of P. Falciparum Pfpk5 Length = 288		4e-40
4aaa_A	331	Crystal Structure Of The Human Cdkl2 Kinase Domain		5e-40
1ua2_A	346	Crystal Structure Of Human Cdk7 Length = 346		1e-39
1h4l_A	292	Structure And Regulation Of The Cdk5-P25(Nck5a) Com		3e-38
3gbz_A	329	Structure Of The Cmgc Cdk Kinase From Giardia Lambl		7e-38
1ung_A	292	Structural Mechanism For The Inhibition Of Cdk5-P25		1e-37
4agu_A	311	Crystal Structure Of The Human Cdkl1 Kinase Domain		4e-36
3nup_A	307	Cdk6 (Monomeric) In Complex With Inhibitor Length =		5e-36
1jow_B	308	Crystal Structure Of A Complex Of Human Cdk6 And A		5e-36
1bi8_A	326	Mechanism Of G1 Cyclin Dependent Kinase Inhibition		5e-36
3g33_A	308	Crystal Structure Of Cdk4CYCLIN D3 Length = 308		4e-35
2w99_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		1e-34
2w96_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-34
2w9f_B	306	Crystal Structure Of Cdk4 In Complex With A D-Type		2e-34
3rgf_A	405	Crystal Structure Of Human Cdk8CYCC Length = 405		3e-32
3tei_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		1e-31
4fv7_A	360	Crystal Structure Of The Erk2 Complexed With E94 Le		2e-31
3sa0_A	360	Complex Of Erk2 With Norathyriol Length = 360		2e-31
4fux_A	360	Crystal Structure Of The Erk2 Complexed With E75 Le		2e-31
4fv6_A	360	Crystal Structure Of The Erk2 Complexed With E57 Le		2e-31
4gsb_A	364	Monoclinic Crystal Form Of The Apo-Erk2 Length = 36		2e-31
2y9q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		2e-31
3qyw_A	364	Crystal Structure Of Erk2 In Complex With An Inhibi		2e-31
3o71_A	358	Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length		2e-31
2ojg_A	380	Crystal Structure Of Erk2 In Complex With N,n-dimet		3e-31
1gol_A	364	Coordinates Of Rat Map Kinase Erk2 With An Arginine		3e-31
1wzy_A	368	Crystal Structure Of Human Erk2 Complexed With A Py		3e-31
1tvo_A	368	The Structure Of Erk2 In Complex With A Small Molec		3e-31
3zu7_A	365	Crystal Structure Of A Designed Selected Ankyrin Re		3e-31
2z7l_A	366	Unphosphorylated Mitogen Activated Protein Kinase E		3e-31
3c9w_A	357	Crystal Structure Of Erk-2 With Hypothemycin Covale		3e-31
2fys_B	364	Crystal Structure Of Erk2 Complex With Kim Peptide		3e-31
4b99_A	398	Crystal Structure Of Mapk7 (Erk5) With Inhibitor Le		4e-31
4h3q_A	362	Crystal Structure Of Human Erk2 Complexed With A Ma		4e-31
3r63_A	358	Structure Of Erk2 (Spe) Mutant (S246e) Length = 358		5e-31
2gph_A	364	Docking Motif Interactions In The Map Kinase Erk2 L		5e-31
4ic7_A	442	Crystal Structure Of The Erk5 Kinase Domain In Comp		6e-31
2zoq_A	382	Structural Dissection Of Human Mitogen-Activated Ki		6e-31
3zuv_A	364	Crystal Structure Of A Designed Selected Ankyrin Re		8e-31
2erk_A	365	Phosphorylated Map Kinase Erk2 Length = 365		8e-31
1pme_A	380	Structure Of Penta Mutant Human Erk2 Map Kinase Com		4e-30
3coi_A	353	Crystal Structure Of P38delta Kinase Length = 353		1e-29
2f9g_A	353	Crystal Structure Of Fus3 Phosphorylated On Tyr182		2e-29
2b9f_A	353	Crystal Structure Of Non-Phosphorylated Fus3 Length		2e-29
4exu_A	371	Mapk13, Inactive Form Length = 371		4e-29
2b9h_A	353	Crystal Structure Of Fus3 With A Docking Motif From		1e-28
1cm8_A	367	Phosphorylated Map Kinase P38-Gamma Length = 367		2e-28
2i6l_A	320	Crystal Structure Of Human Mitogen Activated Protei		4e-28
3oz6_A	388	Crystal Structure Of Mapk From Cryptosporidium Parv		4e-27
3gc9_A	370	The Structure Of P38beta C119s, C162s In Complex Wi		7e-27
3gc8_A	370	The Structure Of P38beta C162s In Complex With A Di		8e-27
4e5a_X	360	The W197a Mutant Of P38a Map Kinase Length = 360		1e-26
3gp0_A	348	Crystal Structure Of Human Mitogen Activated Protei		2e-26
1ove_A	366	The Structure Of P38 Alpha In Complex With A Dihydr		2e-26
2y8o_A	362	Crystal Structure Of Human P38alpha Complexed With		2e-26
3d83_A	360	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
2fst_X	367	Mitogen Activated Protein Kinase P38alpha (d176a+f3		3e-26
2fso_X	367	Mitogen Activated Protein Kinase P38alpha (D176a) A		3e-26
2bal_A	365	P38alpha Map Kinase Bound To Pyrazoloamine Length =		3e-26
2fsl_X	367	Mitogen Activated Protein Kinase P38alpha (D176a+f3		3e-26
2baq_A	365	P38alpha Bound To Ro3201195 Length = 365		3e-26
3e92_A	371	Crystal Structure Of P38 Kinase In Complex With A B		3e-26
3nnx_A	354	Crystal Structure Of Phosphorylated P38 Alpha In Co		3e-26
3d7z_A	360	Crystal Structure Of P38 Kinase In Complex With A B		4e-26
1ian_A	366	Human P38 Map Kinase Inhibitor Complex Length = 366		4e-26
1lew_A	360	Crystal Structure Of Map Kinase P38 Complexed To Th		4e-26
1m7q_A	366	Crystal Structure Of P38 Map Kinase In Complex With		4e-26
1di9_A	360	The Structure Of P38 Mitogen-Activated Protein Kina		4e-26
3oef_X	360	Crystal Structure Of Y323f Inactive Mutant Of P38al		4e-26
3od6_X	360	Crystal Structure Of P38alpha Y323t Active Mutant L		4e-26
2baj_A	365	P38alpha Bound To Pyrazolourea Length = 365		4e-26
3odz_X	360	Crystal Structure Of P38alpha Y323r Active Mutant L		4e-26
3p4k_A	370	The Third Conformation Of P38a Map Kinase Observed		4e-26
3hrb_A	359	P38 Kinase Crystal Structure In Complex With Small		4e-26
2oza_B	366	Structure Of P38alpha Complex Length = 366		4e-26
3ody_X	360	Crystal Structure Of P38alpha Y323q Active Mutant L		4e-26
2npq_A	367	A Novel Lipid Binding Site In The P38 Alpha Map Kin		4e-26
3dt1_A	383	P38 Complexed With A Quinazoline Inhibitor Length =		4e-26
2lgc_A	359	Joint Nmr And X-Ray Refinement Reveals The Structur		4e-26
3tg1_A	380	Crystal Structure Of P38alpha In Complex With A Map		4e-26
3kq7_A	380	Structure Of Human P38alpha With N-[4-Methyl-3-(6-{		4e-26
3gcu_A	360	Human P38 Map Kinase In Complex With Rl48 Length =		4e-26
3zsg_A	362	X-Ray Structure Of P38alpha Bound To Tak-715 Length		4e-26
3fi4_A	372	P38 Kinase Crystal Structure In Complex With Ro4499		4e-26
1oz1_A	372	P38 Mitogen-Activated Kinase In Complex With 4-Azai		5e-26
3s3i_A	349	P38 Kinase Crystal Structure In Complex With Small		5e-26
2gfs_A	372	P38 Kinase Crystal Structure In Complex With Ro3201		5e-26
3mpt_A	371	Crystal Structure Of P38 Kinase In Complex With A P		5e-26
3hvc_A	362	Crystal Structure Of Human P38alpha Map Kinase Leng		5e-26
1zzl_A	351	Crystal Structure Of P38 With Triazolopyridine Leng		5e-26
2puu_A	348	Crystal Structure Of P38 Complex With 1-(5-Tert-But		5e-26
3nnu_A	354	Crystal Structure Of P38 Alpha In Complex With Dp13		5e-26
3k3j_A	362	P38alpha Bound To Novel Dfg-Out Compound Pf-0041612		5e-26
1bl6_A	379	The Complex Structure Of The Map Kinase P38SB216995		5e-26
1bmk_A	379	The Complex Structure Of The Map Kinase P38SB218655		5e-26
3hec_A	348	P38 In Complex With Imatinib Length = 348		5e-26
2gtm_A	348	Mutated Mouse P38 Map Kinase Domain In Complex With		5e-26
3k3i_A	350	P38alpha Bound To Novel Dgf-Out Compound Pf-0021595		5e-26
3py3_A	380	Crystal Structure Of Phosphorylated P38alpha Map Ki		5e-26
4ewq_A	383	Human P38 Alpha Mapk In Complex With A Pyridazine B		7e-26
3gcp_A	360	Human P38 Map Kinase In Complex With Sb203580 Lengt		7e-26
1yw2_A	360	Mutated Mus Musculus P38 Kinase (Mp38) Length = 360		8e-26
1ywr_A	360	Crystal Structure Analysis Of Inactive P38 Kinase D		8e-26
3mh2_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		1e-25
2ghl_A	348	Mutant Mus Musculus P38 Kinase Domain In Complex Wi		1e-25
3o8p_A	360	Conformational Plasticity Of P38 Map Kinase Dfg Mot		3e-25
3mh0_A	360	Mutagenesis Of P38 Map Kinase Eshtablishes Key Role		4e-25
3gi3_A	360	Crystal Structure Of A N-Phenyl-N'-Naphthylurea Ana		5e-25
3mh3_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-25
3mh1_A	360	Mutagenesis Of P38 Map Kinase Establishes Key Roles		5e-25
3oht_A	389	Crystal Structure Of Salmo Salar P38alpha Length =		6e-25
3e7o_A	360	Crystal Structure Of Jnk2 Length = 360		2e-23
3rp9_A	458	Crystal Structure Of The Apo Mapk From Toxoplasma G		3e-23
3uib_A	362	Map Kinase Lmampk10 From Leishmania Major In Comple		4e-23
3pg1_A	362	Map Kinase Lmampk10 From Leishmania Major (1.95 Ang		4e-23
3npc_A	364	Crystal Structure Of Jnk2 Complexed With Birb796 Le		7e-23
3n9x_A	432	Crystal Structure Of Map Kinase From Plasmodium Ber		2e-21
4e7w_A	394	Structure Of Gsk3 From Ustilago Maydis Length = 394		1e-20
3vuk_A	370	Crystal Structure Of A Cysteine-deficient Mutant M5		4e-20
3vui_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		4e-20
3fi3_A	364	Crystal Structure Of Jnk3 With Indazole Inhibitor,		6e-20
3kvx_A	364	Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Le		6e-20
2r9s_A	356	C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Qu		6e-20
3f7z_A	350	X-ray Co-crystal Structure Of Glycogen Synthase Kin		7e-20
2ow3_A	352	Glycogen Synthase Kinase-3 Beta In Complex With Bis		7e-20
3vuh_A	370	Crystal Structure Of A Cysteine-deficient Mutant M3		8e-20
3zdi_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		8e-20
3gb2_A	353	Gsk3beta Inhibitor Complex Length = 353		8e-20
2o0u_A	364	Crystal Structure Of Human Jnk3 Complexed With N-{3		9e-20
3zrk_A	371	Identification Of 2-(4-Pyridyl)thienopyridinones As		9e-20
3fv8_A	355	Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Le		9e-20
1gng_A	378	Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With		9e-20
4afj_A	367	5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selec		1e-19
3oxi_A	362	Design And Synthesis Of Disubstituted Thiophene And		1e-19
3sd0_A	350	Identification Of A Glycogen Synthase Kinase-3b Inh		1e-19
2o5k_A	372	Crystal Structure Of Gsk3beta In Complex With A Ben		1e-19
2ok1_A	365	Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3		1e-19
1pmn_A	364	Crystal Structure Of Jnk3 In Complex With An Imidaz		1e-19
3f88_A	349	Glycogen Synthase Kinase 3beta Inhibitor Complex Le		1e-19
1uv5_A	350	Glycogen Synthase Kinase 3 Beta Complexed With 6-Br		1e-19
4dit_A	382	Crystal Structure Of Gsk3beta In Complex With A Imi		1e-19
3ptg_A	363	Design And Synthesis Of A Novel, Orally Efficacious		1e-19
3ttj_A	464	Crystal Structure Of Jnk3 Complexed With Cc-359, A		1e-19
2b1p_A	355	Inhibitor Complex Of Jnk3 Length = 355		1e-19
2exc_X	356	Inhibitor Complex Of Jnk3 Length = 356		1e-19
3say_A	430	Crystal Structure Of Human Glycogen Synthase Kinase		1e-19
1jnk_A	423	The C-Jun N-Terminal Kinase (Jnk3s) Complexed With		1e-19
1o9u_A	350	Glycogen Synthase Kinase 3 Beta Complexed With Axin		1e-19
4h36_A	356	Crystal Structure Of Jnk3 In Complex With Atf2 Pept		1e-19
1r0e_A	391	Glycogen Synthase Kinase-3 Beta In Complex With 3-I		1e-19
1q5k_A	414	Crystal Structure Of Glycogen Synthase Kinase 3 In		1e-19
1h8f_A	352	Glycogen Synthase Kinase 3 Beta. Length = 352		1e-19
1i09_A	420	Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Len		1e-19
1pyx_A	422	Gsk-3 Beta Complexed With Amp-Pnp Length = 422		1e-19
4acc_A	465	Gsk3b In Complex With Inhibitor Length = 465		2e-19
3vug_A	370	Crystal Structure Of A Cysteine-deficient Mutant M2		2e-19
3vud_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		2e-19
1q3d_A	424	Gsk-3 Beta Complexed With Staurosporine Length = 42		2e-19
3v3v_A	379	Structural And Functional Analysis Of Quercetagetin		2e-19
3pze_A	358	Jnk1 In Complex With Inhibitor Length = 358		2e-19
3elj_A	369	Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine		3e-19
2xrw_A	371	Linear Binding Motifs For Jnk And For Calcineurin A		3e-19
1ukh_A	369	Structural Basis For The Selective Inhibition Of Jn		3e-19
3fi2_A	353	Crystal Structure Of Jnk3 With Amino-Pyrazole Inhib		3e-19
3vum_A	370	Crystal Structure Of A Cysteine-deficient Mutant M7		4e-19
3vul_A	370	Crystal Structure Of A Cysteine-deficient Mutant M1		4e-19
2g01_A	370	Pyrazoloquinolones As Novel, Selective Jnk1 Inhibit		6e-19
3nie_A	429	Crystal Structure Of Pf11_0147 Length = 429		1e-18
3kvw_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		1e-18
4azf_A	417	Human Dyrk2 In Complex With Leucettine L41 Length =		2e-18
2xs0_A	386	Linear Binding Motifs For Jnk And For Calcineurin A		2e-18
3k2l_A	429	Crystal Structure Of Dual-Specificity Tyrosine Phos		2e-18
3o17_A	370	Crystal Structure Of Jnk1-Alpha1 Isoform Length = 3		4e-18
3e3p_A	360	Glycogen Synthase Kinase From Leishmania Major Leng		6e-18
3igo_A	486	Crystal Structure Of Cryptosporidium Parvum Cdpk1,		3e-17
3eb0_A	383	Crystal Structure Of Cgd4_240 From Cryptosporidium		4e-17
2wei_A	287	Crystal Structure Of The Kinase Domain Of Cryptospo		5e-17
2wtk_C	305	Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo2		5e-17
3dfa_A	286	Crystal Structure Of Kinase Domain Of Calcium-depen		5e-17
2j51_A	325	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2uv2_A	287	Crystal Structure Of Human Ste20-Like Kinase Bound		2e-16
2qnj_A	328	Kinase And Ubiquitin-Associated Domains Of Mark3PAR		3e-16
3i79_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		3e-16
3lij_A	494	Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820)		4e-16
3ku2_A	507	Crystal Structure Of Inactivated Form Of Cdpk1 From		4e-16
3hx4_A	508	Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tg		4e-16
3ma6_A	298	Crystal Structure Of Kinase Domain Of Tgcdpk1 In Pr		4e-16
3fe3_A	328	Crystal Structure Of The Kinase Mark3PAR-1: T211a-S		5e-16
2jfm_A	325	Crystal Structure Of Human Ste20-Like Kinase (Unlig		5e-16
3i7c_A	484	Calcium-Dependent Protein Kinase 1 From Toxoplasma		6e-16
2jfl_A	325	Crystal Structure Of Human Ste20-Like Kinase ( Diph		1e-15
4apc_A	350	Crystal Structure Of Human Nima-Related Kinase 1 (N		1e-15
2clq_A	295	Structure Of Mitogen-Activated Protein Kinase Kinas		1e-15
3vw6_A	269	Crystal Structure Of Human Apoptosis Signal-Regulat		2e-15
2hak_A	328	Catalytic And Ubiqutin-Associated Domains Of Mark1P		2e-15
1zmu_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
1zmv_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-15
2r0i_A	327	Crystal Structure Of A Kinase Mark2PAR-1 Mutant Len		2e-15
2vx3_A	382	Crystal Structure Of The Human Dual Specificity Tyr		2e-15
3anq_A	368	Human Dyrk1aINHIBITOR COMPLEX Length = 368		3e-15
3q5i_A	504	Crystal Structure Of Pbanka_031420 Length = 504		3e-15
4aze_A	382	Human Dyrk1a In Complex With Leucettine L41 Length		4e-15
2wzj_A	327	Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82		5e-15
3hzt_A	467	Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme4		5e-15
3dxn_A	287	Crystal Structure Of The Calcium-dependent Kinase F		6e-15
1zmw_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		8e-15
2c6e_A	283	Aurora A Kinase Activated Mutant (T287d) In Complex		8e-15
2j4z_A	306	Structure Of Aurora-2 In Complex With Pha-680626 Le		9e-15
3fdn_A	279	Structure-Based Drug Design Of Novel Aurora Kinase		9e-15
3lau_A	287	Crystal Structure Of Aurora2 Kinase In Complex With		1e-14
2c6d_A	275	Aurora A Kinase Activated Mutant (T287d) In Complex		1e-14
2wtw_A	285	Aurora-A Inhibitor Structure (2nd Crystal Form) Len		1e-14
4dgm_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-14
1muo_A	297	Crystal Structure Of Aurora-2, An Oncogenic Serine-		1e-14
2qc6_A	332	Protein Kinase Ck2 In Complex With Dbc Length = 332		1e-14
4fie_A	423	Full-Length Human Pak4 Length = 423		1e-14
4dgn_A	326	Crystal Structure Of Maize Ck2 In Complex With The		1e-14
1u5q_A	348	Crystal Structure Of The Tao2 Kinase Domain: Activa		1e-14
3pvg_A	331	Crystal Structure Of Z. Mays Ck2 Alpha Subunit In C		1e-14
3kxg_A	327	Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subun		1e-14
1daw_A	327	Crystal Structure Of A Binary Complex Of Protein Ki		1e-14
2x6d_A	285	Aurora-A Bound To An Inhibitor Length = 285		1e-14
2xru_A	280	Aurora-A T288e Complexed With Pha-828300 Length = 2		1e-14
2xng_A	283	Structure Of Aurora-A Bound To A Selective Imidazop		1e-14
1m2p_A	325	Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- Anthra		1e-14
2pvh_A	352	Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]tri		1e-14
1ds5_A	332	Dimeric Crystal Structure Of The Alpha Subunit In C		1e-14
2j50_A	280	Structure Of Aurora-2 In Complex With Pha-739358 Le		1e-14
4anm_A	335	Complex Of Ck2 With A Cdc7 Inhibitor Length = 335		1e-14
1f3m_C	297	Crystal Structure Of Human SerineTHREONINE KINASE P		2e-14
2gcd_A	309	Tao2 Kinase Domain-Staurosporine Structure Length =		2e-14
2w1d_A	275	Structure Determination Of Aurora Kinase In Complex		2e-14
3o50_A	267	Crystal Structure Of Benzamide 9 Bound To Auroraa L		2e-14
2dwb_A	285	Aurora-A Kinase Complexed With Amppnp Length = 285		2e-14
3iec_A	319	Helicobacter Pylori Caga Inhibits Par1MARK FAMILY K		2e-14
2q0n_A	301	Structure Of Human P21 Activating Kinase 4 (Pak4) I		2e-14
2cdz_A	303	Crystal Structure Of The Human P21-Activated Kinase		2e-14
3ofm_A	350	Structure Of A Human Ck2alpha Prime, The Paralog Is		2e-14
3e3b_X	339	Crystal Structure Of Catalytic Subunit Of Human Pro		2e-14
1mq4_A	272	Crystal Structure Of Aurora-A Protein Kinase Length		2e-14
2bva_A	292	Crystal Structure Of The Human P21-Activated Kinase		2e-14
1na7_A	329	Crystal Structure Of The Catalytic Subunit Of Human		2e-14
1yhv_A	297	Crystal Structure Of Pak1 Kinase Domain With Two Po		2e-14
2x4z_A	296	Crystal Structure Of The Human P21-Activated Kinase		2e-14
4fif_A	346	Catalytic Domain Of Human Pak4 With Rpkplvdp Peptid		2e-14
1y8g_A	327	Catalytic And Ubiqutin-Associated Domains Of Mark2P		2e-14
3qbn_A	281	Structure Of Human Aurora A In Complex With A Diami		2e-14
3e5a_A	268	Crystal Structure Of Aurora A In Complex With Vx-68		2e-14
2wqe_A	262	Structure Of S155r Aurora-A Somatic Mutant Length =		2e-14
2wel_A	327	Crystal Structure Of Su6656-Bound CalciumCALMODULIN		3e-14
3q52_A	306	Structure Of Phosphorylated Pak1 Kinase Domain Leng		3e-14
3fxz_A	297	Crystal Structure Of Pak1 Kinase Domain With Ruthen		3e-14
2bmc_A	306	Aurora-2 T287d T288d Complexed With Pha-680632 Leng		3e-14
2vn9_A	301	Crystal Structure Of Human Calcium Calmodulin Depen		3e-14
2vz6_A	313	Structure Of Human Calcium Calmodulin Dependent Pro		4e-14
3mn3_A	271	An Inhibited Conformation For The Protein Kinase Do		4e-14
4eqm_A	294	Structural Analysis Of Staphylococcus Aureus Serine		5e-14
1ol6_A	282	Structure Of Unphosphorylated D274n Mutant Of Auror		5e-14
3r21_A	271	Design, Synthesis, And Biological Evaluation Of Pyr		5e-14
3dae_A	283	Crystal Structure Of Phosphorylated Snf1 Kinase Dom		5e-14
2fh9_A	274	Structure And Dimerization Of The Kinase Domain Fro		5e-14
3hyh_A	275	Crystal Structure Of The Protein Kinase Domain Of Y		6e-14
4fsy_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
3unz_A	279	Aurora A In Complex With Rpm1679 Length = 279		6e-14
2hog_A	322	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
2xne_A	272	Structure Of Aurora-A Bound To An Imidazopyrazine I		6e-14
4fsz_A	279	Crystal Structure Of The Chk1 Length = 279		6e-14
2ydj_A	276	Discovery Of Checkpoint Kinase Inhibitor Azd7762 By		6e-14
2r0u_A	323	Crystal Structure Of Chek1 In Complex With Inhibito		6e-14
3nrm_A	283	Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibito		6e-14
2wtv_A	285	Aurora-A Inhibitor Structure Length = 285		7e-14
3coh_A	268	Crystal Structure Of Aurora-A In Complex With A Pen		7e-14
1ol5_A	282	Structure Of Aurora-A 122-403, Phosphorylated On Th		7e-14
3q4z_A	306	Structure Of Unphosphorylated Pak1 Kinase Domain Le		7e-14
3h0y_A	268	Aurora A In Complex With A Bisanilinopyrimidine Len		7e-14
2br1_A	297	Structure-Based Design Of Novel Chk1 Inhibitors: In		9e-14
1ia8_A	289	The 1.7 A Crystal Structure Of Human Cell Cycle Che		9e-14
1zlt_A	295	Crystal Structure Of Chk1 Complexed With A Hymenald		9e-14
4fsn_A	278	Crystal Structure Of The Chk1 Length = 278		9e-14
1zyc_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
4fsm_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsu_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
1zy4_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-13
3ot3_A	273	X-Ray Crystal Structure Of Compound 22k Bound To Hu		1e-13
2w1c_A	275	Structure Determination Of Aurora Kinase In Complex		1e-13
2e9v_A	268	Structure Of H-Chk1 Complexed With A859017 Length =		1e-13
2x8e_A	276	Discovery Of A Novel Class Of Triazolones As Checkp		1e-13
2ayp_A	269	Crystal Structure Of Chk1 With An Indol Inhibitor L		1e-13
2ghg_A	269	H-Chk1 Complexed With A431994 Length = 269		1e-13
3jvr_A	271	Characterization Of The Chk1 Allosteric Inhibitor B		1e-13
3ha6_A	268	Crystal Structure Of Aurora A In Complex With Tpx2		1e-13
4ft3_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
4fsw_A	279	Crystal Structure Of The Chk1 Length = 279		1e-13
3soa_A	444	Full-Length Human Camkii Length = 444		1e-13
4fst_A	269	Crystal Structure Of The Chk1 Length = 269		1e-13
1zys_A	273	Co-Crystal Structure Of Checkpoint Kinase Chk1 With		2e-13
2v7o_A	336	Crystal Structure Of Human Calcium-Calmodulin-Depen		2e-13
3lm0_A	327	Crystal Structure Of Human SerineTHREONINE KINASE 1		3e-13
3d14_A	272	Crystal Structure Of Mouse Aurora A (Asn186->gly, L		3e-13
3mfr_A	351	Cask-4m Cam Kinase Domain, Native Length = 351		3e-13
2bdw_A	362	Crystal Structure Of The Auto-Inhibited Kinase Doma		5e-13
3juh_A	335	Crystal Structure Of A Mutant Of Human Protein Kina		5e-13
3is5_A	285	Crystal Structure Of Cdpk Kinase Domain From Toxopl		5e-13
2wqm_A	310	Structure Of Apo Human Nek7 Length = 310		6e-13
3kk8_A	284	Camkii Substrate Complex A Length = 284		7e-13
3kl8_A	269	Camkiintide Inhibitor Complex Length = 269		7e-13
3kk9_A	282	Camkii Substrate Complex B Length = 282		7e-13
3cok_A	278	Crystal Structure Of Plk4 Kinase Length = 278		7e-13
3nga_A	333	Human Ck2 Catalytic Domain In Complex With Cx-4945		7e-13
3q04_A	328	Crystal Structure Of The Apo-Form Of Human Ck2 Alph		7e-13
3mb6_A	331	Human Ck2 Catalytic Domain In Complex With A Difura		7e-13
3nsz_A	330	Human Ck2 Catalytic Domain In Complex With Amppn Le		8e-13
3h30_A	334	Crystal Structure Of The Catalytic Subunit Of Human		8e-13
2r7i_A	335	Crystal Structure Of Catalytic Subunit Of Protein K		8e-13
1jwh_A	337	Crystal Structure Of Human Protein Kinase Ck2 Holoe		8e-13
3uiu_A	306	Crystal Structure Of Apo-Pkr Kinase Domain Length =		9e-13
3q9w_A	336	Crystal Structure Of Human Ck2 Alpha In Complex Wit		9e-13
2a19_B	284	Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Leng		9e-13
3bqc_A	335	High Ph-Value Crystal Structure Of Emodin In Comple		9e-13
1pjk_A	334	Crystal Structure Of A C-terminal Deletion Mutant O		9e-13
4dgl_C	335	Crystal Structure Of The Ck2 Tetrameric Holoenzyme		9e-13
3u87_A	349	Structure Of A Chimeric Construct Of Human Ck2alpha		1e-12
2zjw_A	340	Crystal Structure Of Human Ck2 Alpha Complexed With		1e-12
2zv2_A	298	Crystal Structure Of Human CalciumCALMODULIN-Depend		1e-12
2y94_A	476	Structure Of An Active Form Of Mammalian Ampk Lengt		1e-12
3f69_A	311	Crystal Structure Of The Mycobacterium Tuberculosis		1e-12
3daj_A	272	Crystal Structure Of Aurora A Complexed With An Inh		1e-12
3zhp_C	294	Human Mst3 (stk24) In Complex With Mo25beta Length		1e-12
3ckw_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		2e-12
2f57_A	317	Crystal Structure Of The Human P21-activated Kinase		2e-12
3bhh_A	295	Crystal Structure Of Human Calcium/calmodulin-depen		2e-12
3ggf_A	301	Crystal Structure Of Human SerineTHREONINE-Protein		2e-12
2pwl_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-12
4e6d_A	298	Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex W		2e-12
3f61_A	311	Crystal Structure Of M. Tuberculosis Pknb Leu33aspV		2e-12
3hko_A	345	Crystal Structure Of A Cdpk Kinase Domain From Cryp		2e-12
3ori_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain L33d		3e-12
1mru_A	311	Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycob		3e-12
3orm_A	311	Mycobacterium Tuberculosis Pknb Kinase Domain D76a		3e-12
2w1i_A	326	Structure Determination Of Aurora Kinase In Complex		4e-12
1o6y_A	299	Catalytic Domain Of Pknb Kinase From Mycobacterium		4e-12
2x7f_A	326	Crystal Structure Of The Kinase Domain Of Human Tra		4e-12
2yza_A	276	Crystal Structure Of Kinase Domain Of Human 5'-Amp-		4e-12
4hge_A	300	Jak2 Kinase (Jh1 Domain) In Complex With Compound 8		4e-12
4aqc_A	301	Triazolopyridine-Based Inhibitor Of Janus Kinase 2		4e-12
3tjc_A	298	Co-Crystal Structure Of Jak2 With Thienopyridine 8		4e-12
4e4m_A	302	Jak2 Kinase (Jh1 Domain) In Complex With Compound 3		4e-12
2bfx_B	284	Mechanism Of Aurora-B Activation By Incenp And Inhi		4e-12
2b7a_A	293	The Structural Basis Of Janus Kinase 2 Inhibition B		4e-12
3rvg_A	303	Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido		4e-12
2j7t_A	302	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
3e62_A	293	Fragment Based Discovery Of Jak-2 Inhibitors Length		5e-12
2bfy_A	284	Complex Of Aurora-B With Incenp And Hesperidin. Len		5e-12
4bc6_A	293	Crystal Structure Of Human Serine Threonine Kinase-		5e-12
2vrx_A	285	Structure Of Aurora B Kinase In Complex With Zm4474		5e-12
2h6d_A	276	Protein Kinase Domain Of The Human 5'-Amp-Activated		5e-12
3q32_A	301	Structure Of Janus Kinase 2 With A Pyrrolotriazine		5e-12
2pvf_A	334	Crystal Structure Of Tyrosine Phosphorylated Activa		5e-12
2qg5_A	294	Cryptosporidium Parvum Calcium Dependent Protein Ki		5e-12
3f3z_A	277	Crystal Structure Of Cryptosporidium Parvum Calcium		5e-12
3lpb_A	295	Crystal Structure Of Jak2 Complexed With A Potent 2		5e-12
1rjb_A	344	Crystal Structure Of Flt3 Length = 344		6e-12
3jy9_A	311	Janus Kinase 2 Inhibitors Length = 311		6e-12
3a7f_A	303	Human Mst3 Kinase Length = 303		6e-12
3ckx_A	304	Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3		7e-12
3io7_A	313	2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Sel		7e-12
2xa4_A	298	Inhibitors Of Jak2 Kinase Domain Length = 298		7e-12
3p08_A	267	Crystal Structure Of The Human Btk Kinase Domain Le		7e-12
3gqi_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		7e-12
3gen_A	283	The 1.6 A Crystal Structure Of Human Bruton's Tyros		8e-12
3cly_A	334	Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase		8e-12
1k2p_A	263	Crystal Structure Of Bruton's Tyrosine Kinase Domai		8e-12
1yvj_A	290	Crystal Structure Of The Jak3 Kinase Domain In Comp		8e-12
4hvd_A	314	Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h		9e-12
3h4j_B	336	Crystal Structure Of Pombe Ampk Kdaid Fragment Leng		9e-12
3pix_A	274	Crystal Structure Of Btk Kinase Domain Complexed Wi		9e-12
3ocs_A	271	Crystal Structure Of Bruton's Tyrosine Kinase In Co		9e-12
2jed_A	352	The Crystal Structure Of The Kinase Domain Of The P		9e-12
3pjc_A	315	Crystal Structure Of Jak3 Complexed With A Potent A		1e-11
3lxk_A	327	Structural And Thermodynamic Characterization Of Th		1e-11
2pvy_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1zxe_A	303	Crystal Structure Of Eif2alpha Protein Kinase Gcn2:		1e-11
2pzp_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
1xjd_A	345	Crystal Structure Of Pkc-Theta Complexed With Staur		1e-11
2psq_A	370	Crystal Structure Of Unphosphorylated Unactivated W		1e-11
1gjo_A	316	The Fgfr2 Tyrosine Kinase Domain Length = 316		1e-11
3ri1_A	313	Crystal Structure Of The Catalytic Domain Of Fgfr2		1e-11
3k54_A	283	Structures Of Human Bruton's Tyrosine Kinase In Act		1e-11
2q0b_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3b2t_A	311	Structure Of Phosphotransferase Length = 311		1e-11
2py3_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		1e-11
3kxx_A	317	Structure Of The Mutant Fibroblast Growth Factor Re		1e-11
3ugc_A	295	Structural Basis Of Jak2 Inhibition By The Type Ii		2e-11
2o8y_A	298	Apo Irak4 Kinase Domain Length = 298		2e-11
2nry_A	307	Crystal Structure Of Irak-4 Length = 307		2e-11
2pz5_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
2pzr_A	324	Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase D		2e-11
3ll6_A	337	Crystal Structure Of The Human Cyclin G Associated		2e-11
3oct_A	265	Crystal Structure Of Bruton's Tyrosine Kinase Mutan		2e-11
2z7q_A	321	Crystal Structure Of The N-Terminal Kinase Domain O		3e-11
3a4o_X	286	Lyn Kinase Domain Length = 286		3e-11
3tac_A	361	Crystal Structure Of The Liprin-AlphaCASK COMPLEX L		3e-11
3c0g_A	351	Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Len		3e-11
2w5a_A	279	Human Nek2 Kinase Adp-Bound Length = 279		3e-11
2xik_A	294	Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related K		3e-11
3rhx_B	306	Crystal Structure Of The Catalytic Domain Of Fgfr1		3e-11
2nru_A	307	Crystal Structure Of Irak-4 Length = 307		3e-11
1fgk_A	310	Crystal Structure Of The Tyrosine Kinase Domain Of		3e-11
3js2_A	317	Crystal Structure Of Minimal Kinase Domain Of Fibro		3e-11
4f63_A	309	Crystal Structure Of Human Fibroblast Growth Factor		4e-11
4a4x_A	279	Nek2-Ede Bound To Cct248662 Length = 279		4e-11
3tt0_A	382	Co-Structure Of Fibroblast Growth Factor Receptor 1		4e-11
4bbe_A	298	Aminoalkylpyrimidine Inhibitor Complexes With Jak2		4e-11
3gql_A	326	Crystal Structure Of Activated Receptor Tyrosine Ki		4e-11
3c4f_A	302	Fgfr Tyrosine Kinase Domain In Complex With 3-(3- M		4e-11
2jav_A	279	Human Kinase With Pyrrole-Indolinone Ligand Length		4e-11
2oib_A	301	Crystal Structure Of Irak4 Kinase Domain Apo Form L		5e-11
1u54_A	291	Crystal Structures Of The Phosphorylated And Unphos		5e-11
1p4f_A	293	Death Associated Protein Kinase Catalytic Domain Wi		5e-11
3f5u_A	295	Crystal Structure Of The Death Associated Protein K		5e-11
1ig1_A	294	1.8a X-Ray Structure Of Ternary Complex Of A Cataly		5e-11
3dfc_B	295	Crystal Structure Of A Glycine-Rich Loop Mutant Of		5e-11
3gu4_A	295	Crystal Structure Of Dapkq23v-Amppnp Length = 295		5e-11
2yak_A	285	Structure Of Death-Associated Protein Kinase 1 (Dap		5e-11
4ewh_B	275	Co-Crystal Structure Of Ack1 With Inhibitor Length		5e-11
3omv_A	307	Crystal Structure Of C-Raf (Raf-1) Length = 307		6e-11
2w4j_A	277	X-Ray Structure Of A Dap-Kinase 2-277 Length = 277		6e-11
2w4k_A	302	X-Ray Structure Of A Dap-Kinase 2-302 Length = 302		6e-11
1wvw_A	278	Crystal Structures Of Kinase Domain Of Dap Kinase I		6e-11
2y0a_A	326	Structure Of Dapk1 Construct Residues 1-304 Length		7e-11
3d7u_B	277	Structural Basis For The Recognition Of C-Src By It		7e-11
1u46_A	291	Crystal Structure Of The Unphosphorylated Kinase Do		7e-11
2xuu_A	334	Crystal Structure Of A Dap-Kinase 1 Mutant Length =		8e-11
2oiq_A	286	Crystal Structure Of Chicken C-Src Kinase Domain In		8e-11
2hwo_A	286	Crystal Structure Of Src Kinase Domain In Complex W		8e-11
2h8h_A	535	Src Kinase In Complex With A Quinazoline Inhibitor		8e-11
3dqw_A	286	C-Src Kinase Domain Thr338ile Mutant In Complex Wit		8e-11
3u4w_A	275	Src In Complex With Dna-Templated Macrocyclic Inhib		8e-11
3svv_A	286	Crystal Structure Of T338c C-Src Covalently Bound T		8e-11
2x0g_A	334	X-ray Structure Of A Dap-kinase Calmodulin Complex		8e-11
3eqp_B	276	Crystal Structure Of Ack1 With Compound T95 Length		8e-11
2xzs_A	312	Death Associated Protein Kinase 1 Residues 1-312 Le		9e-11
4hzr_A	277	Crystal Structure Of Ack1 Kinase Domain Length = 27		9e-11
4id7_A	273	Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-		9e-11
1yrp_A	278	Catalytic Domain Of Human Zip Kinase Phosphorylated		9e-11
3gu8_A	295	Crystal Structure Of Dapkl93g With N6-Cyclopentylad		1e-10
4hzs_A	341	Crystal Structure Of Ack1 Kinase Domain With C-term		1e-10
3s95_A	310	Crystal Structure Of The Human Limk1 Kinase Domain		1e-10
1y57_A	452	Structure Of Unphosphorylated C-Src In Complex With		1e-10
4a07_A	311	Human Pdk1 Kinase Domain In Complex With Allosteric		1e-10
1fmk_A	452	Crystal Structure Of Human Tyrosine-Protein Kinase		1e-10
3g6h_A	286	Src Thr338ile Inhibited In The Dfg-Asp-Out Conforma		1e-10
2j90_A	304	Crystal Structure Of Human Zip Kinase In Complex Wi		1e-10
3pwy_A	311	Crystal Structure Of An Extender (Spd28345)-Modifie		1e-10
3g51_A	325	Structural Diversity Of The Active Conformation Of		1e-10
4e4l_A	302	Jak1 Kinase (Jh1 Domain) In Complex With Compound 3		1e-10
2qq7_A	286	Crystal Structure Of Drug Resistant Src Kinase Doma		1e-10
3bhy_A	283	Crystal Structure Of Human Death Associated Protein		1e-10
3oez_A	286	Crystal Structure Of The L317i Mutant Of The Chicke		1e-10
1ksw_A	452	Structure Of Human C-Src Tyrosine Kinase (Thr338gly		1e-10
3cd3_A	377	Crystal Structure Of Phosphorylated Human Feline Sa		1e-10
3eyg_A	290	Crystal Structures Of Jak1 And Jak2 Inhibitor Compl		1e-10
2vwi_A	303	Structure Of The Osr1 Kinase, A Hypertension Drug T		1e-10
3hrc_A	311	Crystal Structure Of A Mutant Of Human Pdk1 Kinase		1e-10
3nun_A	292	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lea		1e-10
3nax_A	311	Pdk1 In Complex With Inhibitor Mp7 Length = 311		1e-10
3lxn_A	318	Structural And Thermodynamic Characterization Of Th		1e-10
3nay_A	311	Pdk1 In Complex With Inhibitor Mp6 Length = 311		2e-10
3geq_A	286	Structural Basis For The Chemical Rescue Of Src Kin		2e-10
3dak_A	290	Crystal Structure Of Domain-Swapped Osr1 Kinase Dom		2e-10
3og7_A	289	B-Raf Kinase V600e Oncogenic Mutant In Complex With		2e-10
3bkb_A	377	Crystal Structure Of Human Feline Sarcoma Viral Onc		2e-10
2bdf_A	279	Src Kinase In Complex With Inhibitor Ap23451 Length		2e-10
3ubd_A	304	Structure Of N-Terminal Domain Of Rsk2 Kinase In Co		2e-10
4el9_A	305	Structure Of N-Terminal Kinase Domain Of Rsk2 With		2e-10
3com_A	314	Crystal Structure Of Mst1 Kinase Length = 314		2e-10
3orx_A	316	Pdk1 Mutant Bound To Allosteric Disulfide Fragment		2e-10
2xck_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
2xch_A	309	Crystal Structure Of Pdk1 In Complex With A Pyrazol		2e-10
1z5m_A	286	Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrr		2e-10
3rwp_A	311	Discovery Of A Novel, Potent And Selective Inhibito		2e-10
1yi6_A	276	C-Term Tail Segment Of Human Tyrosine Kinase (258-5		2e-10
2r7b_A	312	Crystal Structure Of The Phosphoinositide-Dependent		2e-10
1uwh_A	276	The Complex Of Wild Type B-Raf And Bay439006 Length		2e-10
3nus_A	286	Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fra		2e-10
1uu3_A	310	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
2biy_A	310	Structure Of Pdk1-S241a Mutant Kinase Domain Length		2e-10
3sc1_A	311	Novel Isoquinolone Pdk1 Inhibitors Discovered Throu		2e-10
3p23_A	432	Crystal Structure Of The Human Kinase And Rnase Dom		2e-10
3nyx_A	302	Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-T		2e-10
2c30_A	321	Crystal Structure Of The Human P21-Activated Kinase		2e-10
3h9o_A	311	Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1)		2e-10
1uu9_A	286	Structure Of Human Pdk1 Kinase Domain In Complex Wi		2e-10
3iop_A	312	Pdk-1 In Complex With The Inhibitor Compound-8i Len		2e-10
3c4c_A	280	B-Raf Kinase In Complex With Plx4720 Length = 280		2e-10
1h1w_A	289	High Resolution Crystal Structure Of The Human Pdk1		3e-10
3qc4_A	314	Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length =		3e-10
2y7j_A	365	Structure Of Human Phosphorylase Kinase, Gamma 2 Le		3e-10
2phk_A	277	The Crystal Structure Of A Phosphorylase Kinase Pep		3e-10
1yoj_A	283	Crystal Structure Of Src Kinase Domain Length = 283		3e-10
1yol_A	283	Crystal Structure Of Src Kinase Domain In Complex W		3e-10
1ql6_A	298	The Catalytic Mechanism Of Phosphorylase Kinase Pro		3e-10
1phk_A	298	Two Structures Of The Catalytic Domain Of Phosphory		3e-10
2ptk_A	453	Chicken Src Tyrosine Kinase Length = 453		3e-10
4fk3_A	292	B-Raf Kinase V600e Oncogenic Mutant In Complex With		3e-10
3zgw_A	347	Crystal Structure Of Maternal Embryonic Leucine Zip		3e-10
2zm1_A	285	Crystal Structure Of Imidazo Pyrazin 1 Bound To The		3e-10
2eu9_A	355	Crystal Structure Of Clk3 Length = 355		3e-10
2exe_A	357	Crystal Structure Of The Phosphorylated Clk3 Length		3e-10
3kxz_A	287	The Complex Crystal Structure Of Lck With A Probe M		3e-10
2wu6_A	381	Crystal Structure Of The Human Clk3 In Complex With		4e-10
4g31_A	299	Crystal Structure Of Gsk6414 Bound To Perk (R587-R1		4e-10
3q96_A	282	B-Raf Kinase Domain In Complex With A Tetrahydronap		4e-10
3kmm_A	288	Structure Of Human Lck Kinase With A Small Molecule		4e-10
2fb8_A	281	Structure Of The B-Raf Kinase Domain Bound To Sb-59		4e-10
4dbn_A	284	Crystal Structure Of The Kinase Domain Of Human B-R		4e-10
1qpe_A	279	Structural Analysis Of The Lymphocyte-Specific Kina		4e-10
4h58_A	275	Braf In Complex With Compound 3 Length = 275		4e-10
3nz0_A	302	Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 3		4e-10
3bym_A	272	X-Ray Co-Crystal Structure Aminobenzimidazole Triaz		4e-10
2ofu_A	273	X-Ray Crystal Structure Of 2-Aminopyrimidine Carbam		4e-10
3d4q_A	307	Pyrazole-Based Inhibitors Of B-Raf Kinase Length =		5e-10
3ii5_A	306	The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimi		5e-10
2pl0_A	289	Lck Bound To Imatinib Length = 289		5e-10
3lck_A	271	The Kinase Domain Of Human Lymphocyte Kinase (Lck),		5e-10
3bys_A	277	Co-Crystal Structure Of Lck And Aminopyrimidine Ami		5e-10
2ofv_A	277	Crystal Structure Of Aminoquinazoline 1 Bound To Lc		5e-10
3miy_A	266	X-Ray Crystal Structure Of Itk Complexed With Sunit		5e-10
4aoj_A	329	Human Trka In Complex With The Inhibitor Az-23 Leng		5e-10
1uwj_A	276	The Complex Of Mutant V599e B-raf And Bay439006 Len		5e-10
4f0i_A	300	Crystal Structure Of Apo Trka Length = 300		5e-10
2og8_A	265	Crystal Structure Of Aminoquinazoline 36 Bound To L		6e-10
4gt5_A	306	Crystal Structure Of The Inactive Trka Kinase Domai		6e-10
3idp_A	300	B-Raf V600e Kinase Domain In Complex With An Aminoi		6e-10
4g9r_A	307	B-Raf V600e Kinase Domain Bound To A Type Ii Dihydr		6e-10
2zv7_A	279	Lyn Tyrosine Kinase Domain, Apo Form Length = 279		6e-10
2of2_A	271	Crystal Structure Of Furanopyrimidine 8 Bound To Lc		6e-10
4e1z_A	291	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
4e20_A	290	Structure Of Mouse Tyk-2 Complexed To A 3-Aminoinda		8e-10
4asz_A	299	Crystal Structure Of Apo Trkb Kinase Domain Length		8e-10
1zws_A	288	Crystal Structure Of The Catalytic Domain Of Human		9e-10
3v5j_A	266	Crystal Structure Of Interleukin-2 Inducible T-Cell		9e-10
1qpd_A	279	Structural Analysis Of The Lymphocyte-specific Kina		9e-10
4hct_A	269	Crystal Structure Of Itk In Complex With Compound 5		1e-09
2pml_X	348	Crystal Structure Of Pfpk7 In Complex With An Atp A		1e-09
1sm2_A	264	Crystal Structure Of The Phosphorylated Interleukin		1e-09
2a27_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
3qgw_A	286	Crystal Structure Of Itk Kinase Bound To An Inhibit		1e-09
1z9x_A	321	Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal		1e-09
2a2a_A	321	High-resolution Crystallographic Analysis Of The Au		1e-09
1wmk_A	321	Human Death-Associated Kinase Drp-1, Mutant S308d D		1e-09
1mrv_A	339	Crystal Structure Of An Inactive Akt2 Kinase Domain		2e-09
2dq7_X	283	Crystal Structure Of Fyn Kinase Domain Complexed Wi		2e-09
1gzn_A	335	Structure Of Pkb Kinase Domain Length = 335		2e-09
1o6l_A	337	Crystal Structure Of An Activated Akt/protein Kinas		2e-09
3r1n_A	317	Mk3 Kinase Bound To Compound 5b Length = 317		2e-09
3fhr_A	336	High Resolution Crystal Structure Of Mitogen-Activa		2e-09
2jdo_A	342	Structure Of Pkb-Beta (Akt2) Complexed With Isoquin		2e-09
1gzk_A	315	Molecular Mechanism For The Regulation Of Protein K		2e-09
1o6k_A	336	Structure Of Activated Form Of Pkb Kinase Domain S4		2e-09
3e87_A	335	Crystal Structures Of The Kinase Domain Of Akt2 In		2e-09
2w4o_A	349	Crystal Structure Of Human Camk4 In Complex With 4-		2e-09
3mpm_A	267	Lck Complexed With A Pyrazolopyrimidine Length = 26		2e-09
1qcf_A	454	Crystal Structure Of Hck In Complex With A Src Fami		2e-09
1u59_A	287	Crystal Structure Of The Zap-70 Kinase Domain In Co		3e-09
2jam_A	304	Crystal Structure Of Human Calmodulin-Dependent Pro		3e-09
2hk5_A	270	Hck Kinase In Complex With Lck Targetted Inhibitor		3e-09
2v55_A	406	Mechanism Of Multi-site Phosphorylation From A Rock		4e-09
3v8s_A	410	Human Rho-Associated Protein Kinase 1 (Rock 1) In C		4e-09
2ya9_A	361	Crystal Structure Of The Autoinhibited Form Of Mous		4e-09
2esm_A	415	Crystal Structure Of Rock 1 Bound To Fasudil Length		4e-09
3v5q_A	297	Discovery Of A Selective Trk Inhibitor With Efficac		4e-09
3udb_A	317	Crystal Structure Of Snrk2.6 Length = 317		4e-09
3rzf_A	677	Crystal Structure Of Inhibitor Of Kappab Kinase Bet		4e-09
3qa8_A	676	Crystal Structure Of Inhibitor Of Kappa B Kinase Be		4e-09
1z57_A	339	Crystal Structure Of Human Clk1 In Complex With 10z		5e-09
3nr9_A	368	Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length		5e-09
1k9a_A	450	Crystal Structure Analysis Of Full-Length Carboxyl-		5e-09
2ozo_A	613	Autoinhibited Intact Human Zap-70 Length = 613		5e-09
1byg_A	278	Kinase Domain Of Human C-Terminal Src Kinase (Csk)		6e-09
3cik_A	689	Human Grk2 In Complex With Gbetagamma Subunits Leng		6e-09
3krw_A	688	Human Grk2 In Complex With Gbetgamma Subunits And B		6e-09
1omw_A	689	Crystal Structure Of The Complex Between G Protein-		6e-09
3psc_A	695	Bovine Grk2 In Complex With Gbetagamma Subunits Len		6e-09
3d7u_A	263	Structural Basis For The Recognition Of C-Src By It		6e-09
3i6w_A	443	Structure And Activation Mechanism Of The Chk2 Dna-		7e-09
1luf_A	343	Crystal Structure Of The Musk Tyrosine Kinase: Insi		7e-09
3i6u_A	419	Structure And Activation Mechanism Of The Chk2 Dna-		7e-09
3c7q_A	316	Structure Of Vegfr2 Kinase Domain In Complex With B		7e-09
4gv1_A	340	Pkb Alpha In Complex With Azd5363 Length = 340		7e-09
4fl3_A	635	Structural And Biophysical Characterization Of The		7e-09
3cqu_A	342	Crystal Structure Of Akt-1 Complexed With Substrate		7e-09
4fl2_A	636	Structural And Biophysical Characterization Of The		7e-09
3sls_A	304	Crystal Structure Of Human Mek-1 Kinase In Complex		7e-09
3ocb_A	341	Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor		8e-09
2p3g_X	327	Crystal Structure Of A Pyrrolopyridine Inhibitor Bo		8e-09
3tub_A	293	Crystal Structure Of Syk Kinase Domain With 1-(5-(6		8e-09
3vf8_A	299	Crystal Structure Of Spleen Tyrosine Kinase Syk Cat		8e-09
3srv_A	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		8e-09
2xk9_A	322	Structural Analysis Of Checkpoint Kinase 2 (Chk2) I		8e-09
3fpm_A	325	Crystal Structure Of A Squarate Inhibitor Bound To		8e-09
3hmn_A	342	Crystal Structure Of Human Mps1 Catalytic Domain In		8e-09
2w0j_A	323	Crystal Structure Of Chk2 In Complex With Nsc 10955		8e-09
3r2y_A	319	Mk2 Kinase Bound To Compound 1 Length = 319		8e-09
2pzy_A	324	Structure Of Mk2 Complexed With Compound 76 Length		8e-09
2jbo_A	326	Protein Kinase Mk2 In Complex With An Inhibitor (Cr		8e-09
3o96_A	446	Crystal Structure Of Human Akt1 With An Allosteric		8e-09
3gok_A	334	Binding Site Mapping Of Protein Ligands Length = 33		9e-09
4ejn_A	446	Crystal Structure Of Autoinhibited Form Of Akt1 In		9e-09
2ycf_A	322	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-09
3ka0_A	320	Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4		9e-09
3db6_A	301	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
2onl_C	406	Crystal Structure Of The P38a-Mapkap Kinase 2 Heter		9e-09
3emg_A	291	Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylami		9e-09
2oh4_A	316	Crystal Structure Of Vegfr2 With A Benzimidazole-Ur		9e-09
1kwp_A	400	Crystal Structure Of Mapkap2 Length = 400		9e-09
2oza_A	356	Structure Of P38alpha Complex Length = 356		9e-09
2ycr_A	323	Crystal Structure Of Checkpoint Kinase 2 In Complex		9e-09
2zmc_A	390	Crystal Structure Of Human Mitotic Checkpoint Kinas		9e-09
3r2b_A	318	Mk2 Kinase Bound To Compound 5b Length = 318		9e-09
3d5v_A	317	Crystal Structure Of An Activated (Thr->asp) Polo-L		9e-09
2cn5_A	329	Crystal Structure Of Human Chk2 In Complex With Adp		9e-09
3hng_A	360	Crystal Structure Of Vegfr1 In Complex With N-(4-ch		1e-08
3uc3_A	361	The Crystal Structure Of Snf1-Related Kinase 2.3 Le		1e-08
3t9t_A	267	Crystal Structure Of Btk Mutant (F435t,K596r) Compl		1e-08
1q8y_A	373	The Structure Of The Yeast Sr Protein Kinase, Sky1p		1e-08
1how_A	373	The X-Ray Crystal Structure Of Sky1p, An Sr Protein		1e-08
3a60_A	327	Crystal Structure Of Unphosphorylated P70s6k1 (Form		1e-08
3cek_A	313	Crystal Structure Of Human Dual Specificity Protein		1e-08
3a62_A	327	Crystal Structure Of Phosphorylated P70s6k1 Length		1e-08
3cjf_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		1e-08
2jc6_A	334	Crystal Structure Of Human Calmodulin-Dependent Pro		1e-08
3srv_B	277	Crystal Structure Of Spleen Tyrosine Kinase (Syk) I		1e-08
3dbq_A	343	Crystal Structure Of Ttk Kinase Domain Length = 343		1e-08
1xba_A	291	Crystal Structure Of Apo Syk Tyrosine Kinase Domain		1e-08
4f4p_A	273	Syk In Complex With Ligand Lasw836 Length = 273		1e-08
4dfl_A	274	Crystal Structure Of Spleen Tyrosine Kinase Complex		1e-08
3kb7_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
2yac_A	311	Crystal Structure Of Polo-Like Kinase 1 In Complex		1e-08
3d5u_A	317	Crystal Structure Of A Wildtype Polo-Like Kinase 1		1e-08
2v5q_A	315	Crystal Structure Of Wild-type Plk-1 Kinase Domain		1e-08
2x9e_A	317	Human Mps1 In Complex With Nms-P715 Length = 317		2e-08
3vqu_A	320	Crystal Structure Of Human Mps1 Catalytic Domain In		2e-08
2vag_A	339	Crystal Structure Of Di-Phosphorylated Human Clk1 I		2e-08
1ywn_A	316	Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]p		2e-08
3cjg_A	309	Crystal Structure Of Vegfr2 In Complex With A 3,4,5		2e-08
3lcd_A	329	Inhibitor Bound To A Dfg-In Structure Of The Kinase		2e-08
3h9f_A	313	Crystal Structure Of Human Dual Specificity Protein		2e-08
3d5w_A	317	Crystal Structure Of A Phosphorylated Polo-Like Kin		2e-08
4af3_A	292	Human Aurora B Kinase In Complex With Incenp And Vx		2e-08
3d7t_A	269	Structural Basis For The Recognition Of C-Src By It		2e-08
2ogv_A	317	Crystal Structure Of The Autoinhibited Human C-Fms		2e-08
2p2h_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2p2i_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		2e-08
2rei_A	318	Kinase Domain Of Human Ephrin Type-a Receptor 7 (ep		2e-08
3iw4_A	360	Crystal Structure Of Pkc Alpha In Complex With Nvp-		2e-08
1vzo_A	355	The Structure Of The N-Terminal Kinase Domain Of Ms		2e-08
3dls_A	335	Crystal Structure Of Human Pas Kinase Bound To Adp		2e-08
3p1a_A	311	Structure Of Human Membrane-Associated Tyrosine- An		2e-08
2f2u_A	402	Crystal Structure Of The Rho-Kinase Kinase Domain L		2e-08
1vr2_A	316	Human Vascular Endothelial Growth Factor Receptor 2		3e-08
3q6w_A	307	Structure Of Dually-phosphorylated Met Receptor Kin		3e-08
2rku_A	294	Structure Of Plk1 In Complex With Bi2536 Length = 2		3e-08
2ou7_A	335	Structure Of The Catalytic Domain Of Human Polo-Lik		3e-08
3thb_A	333	Structure Of Plk1 Kinase Domain In Complex With A B		3e-08
2r2p_A	295	Kinase Domain Of Human Ephrin Type-A Receptor 5 (Ep		3e-08
3qd2_B	332	Crsytal Structure Of Mouse Perk Kinase Domain Lengt		3e-08
2zmd_A	390	Crystal Structure Of Human Mps1 Catalytic Domain T6		3e-08
2hel_A	306	Crystal Structure Of A Mutant Epha4 Kinase Domain (		3e-08
3txo_A	353	Pkc Eta Kinase In Complex With A Naphthyridine Leng		3e-08
3bea_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A P		3e-08
1y6a_A	366	Crystal Structure Of Vegfr2 In Complex With A 2-Ani		3e-08
2i0v_A	335	C-Fms Tyrosine Kinase In Complex With A Quinolone I		3e-08
2v7a_A	286	Crystal Structure Of The T315i Abl Mutant In Comple		3e-08
3dk7_A	277	Crystal Structure Of Mutant Abl Kinase Domain In Co		4e-08
3vhk_A	368	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3vhe_A	359	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
2xir_A	316	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3vnt_A	318	Crystal Structure Of The Kinase Domain Of Human Veg		4e-08
3vid_A	356	Crystal Structure Of Human Vegfr2 Kinase Domain Wit		4e-08
3qrj_A	277	The Crystal Structure Of Human Abl1 Kinase Domain T		4e-08
3u6j_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		4e-08
3oy3_A	284	Crystal Structure Of Abl T315i Mutant Kinase Domain		5e-08
3ewh_A	314	Crystal Structure Of The Vegfr2 Kinase Domain In Co		5e-08
3uc4_A	362	The Crystal Structure Of Snf1-Related Kinase 2.6 Le		5e-08
2z60_A	288	Crystal Structure Of The T315i Mutant Of Abl Kinase		5e-08
3qfv_A	415	Mrck Beta In Complex With Tpca-1 Length = 415		5e-08
3ujg_A	361	Crystal Structure Of Snrk2.6 In Complex With Hab1 L		5e-08
4agc_A	353	Crystal Structure Of Vegfr2 (Juxtamembrane And Kina		5e-08
2i1m_A	333	Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An		5e-08
2gqg_A	278	X-Ray Crystal Structure Of Dasatinib (Bms-354825) B		5e-08
2qok_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		5e-08
3tku_A	433	Mrck Beta In Complex With Fasudil Length = 433		5e-08
2xyu_A	285	Crystal Structure Of Epha4 Kinase Domain In Complex		5e-08
2y6m_A	291	Crystal Structure Of Epha4 Kinase Domain Length = 2		6e-08
3lco_A	324	Inhibitor Bound To A Dfg-Out Structure Of The Kinas		6e-08
3dk6_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		6e-08
2g15_A	318	Structural Characterization Of Autoinhibited C-Met		6e-08
3q6u_A	308	Structure Of The Apo Met Receptor Kinase In The Dua		6e-08
1fpu_A	293	Crystal Structure Of Abl Kinase Domain In Complex W		7e-08
3f66_A	298	Human C-Met Kinase In Complex With Quinoxaline Inhi		7e-08
3i5n_A	309	Crystal Structure Of C-Met With Triazolopyridazine		7e-08
2rfn_A	310	X-ray Structure Of C-met With Inhibitor. Length = 3		7e-08
3lq8_A	302	Structure Of The Kinase Domain Of C-Met Bound To Xl		7e-08
2wd1_A	292	Human C-Met Kinase In Complex With Azaindole Inhibi		7e-08
1ad5_A	438	Src Family Kinase Hck-Amp-Pnp Complex Length = 438		7e-08
2wgj_A	306	X-Ray Structure Of Pf-02341066 Bound To The Kinase		7e-08
3qri_A	277	The Crystal Structure Of Human Abl1 Kinase Domain I		7e-08
2qoo_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		7e-08
4gg5_A	319	Crystal Structure Of Cmet In Complex With Novel Inh		8e-08
2hiw_A	287	Crystal Structure Of Inactive Conformation Abl Kina		8e-08
2hzi_A	277	Abl Kinase Domain In Complex With Pd180970 Length =		8e-08
2e2b_A	293	Crystal Structure Of The C-Abl Kinase Domain In Com		8e-08
4g3d_A	371	Crystal Structure Of Human Nf-kappab Inducing Kinas		8e-08
3oxz_A	284	Crystal Structure Of Abl Kinase Domain Bound With A		8e-08
3nyn_A	576	Crystal Structure Of G Protein-Coupled Receptor Kin		8e-08
2qoh_A	288	Crystal Structure Of Abl Kinase Bound With Ppy-a Le		8e-08
2j0k_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		8e-08
2acx_A	576	Crystal Structure Of G Protein Coupled Receptor Kin		9e-08
2g1t_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		9e-08
2jkk_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-08
2hyy_A	273	Human Abl Kinase Domain In Complex With Imatinib (S		1e-07
3pyy_A	298	Discovery And Characterization Of A Cell-Permeable,		1e-07
4dn5_A	356	Crystal Structure Of Nf-kb-inducing Kinase (nik) Le		1e-07
1mqb_A	333	Crystal Structure Of Ephrin A2 (Epha2) Receptor Pro		1e-07
2gsf_A	373	The Human Epha3 Receptor Tyrosine Kinase And Juxtam		1e-07
2qof_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f		1e-07
2qod_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y602f		1e-07
3fxx_A	371	Human Epha3 Kinase And Juxtamembrane Region Bound T		1e-07
2qoi_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		1e-07
2rio_A	434	Structure Of The Dual Enzyme Ire1 Reveals The Basis		1e-07
3dk3_A	293	Crystal Structure Of Mutant Abl Kinase Domain In Co		1e-07
3eqc_A	360	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2hz0_A	270	Abl Kinase Domain In Complex With Nvp-Aeg082 Length		1e-07
1s9j_A	341	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
3mbl_A	328	Crystal Structure Of The Human Mitogen-Activated Pr		1e-07
3dv3_A	322	Mek1 With Pf-04622664 Bound Length = 322		1e-07
2y4i_C	395	Ksr2-Mek1 Heterodimer Length = 395		1e-07
2g2f_A	287	A Src-Like Inactive Conformation In The Abl Tyrosin		1e-07
3qti_A	314	C-Met Kinase In Complex With Nvp-Bvu972 Length = 31		1e-07
3gvu_A	292	The Crystal Structure Of Human Abl2 In Complex With		1e-07
2p55_A	333	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-07
2f4j_A	287	Structure Of The Kinase Domain Of An Imatinib-Resis		1e-07
2qol_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596:y		1e-07
3fbv_A	448	Crystal Structure Of The Oligomer Formed By The Kin		1e-07
3c1x_A	373	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
2j0l_A	276	Crystal Structure Of A The Active Conformation Of T		1e-07
3a4p_A	319	Human C-Met Kinase Domain Complexed With 6-Benzylox		1e-07
2qoc_A	344	Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp		1e-07
3sdj_A	448	Structure Of Rnase-Inactive Point Mutant Of Oligome		1e-07
3dkc_A	317	Sgx Clone 5698a65kfg1h1 Length = 317		1e-07
3cth_A	314	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
1r0p_A	312	Crystal Structure Of The Tyrosine Kinase Domain Of		1e-07
3dkg_A	317	Sgx Clone 5698a109kfg1h1 Length = 317		1e-07
3dzq_A	361	Human Epha3 Kinase Domain In Complex With Inhibitor		2e-07
3kul_B	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
2ivt_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		2e-07
1t46_A	313	Structural Basis For The Autoinhibition And Sti-571		2e-07
4fr4_A	384	Crystal Structure Of Human SerineTHREONINE-Protein		2e-07
3mdy_A	337	Crystal Structure Of The Cytoplasmic Domain Of The		2e-07
3ama_A	351	Protein Kinase A Sixfold Mutant Model Of Aurora B W		2e-07
3kul_A	325	Kinase Domain Of Human Ephrin Type-A Receptor 8 (Ep		2e-07
4aw2_A	437	Crystal Structure Of Cdc42 Binding Protein Kinase A		2e-07
2gnf_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
2gnj_A	350	Pka Three Fold Mutant Model Of Rho-Kinase With Y-27		2e-07
2gng_A	350	Protein Kinase A Fivefold Mutant Model Of Rho-Kinas		2e-07
3g0e_A	336	Kit Kinase Domain In Complex With Sunitinib Length		2e-07
1jpa_A	312	Crystal Structure Of Unphosphorylated Ephb2 Recepto		2e-07
1t45_A	331	Structural Basis For The Autoinhibition And Sti-571		2e-07
4dc2_A	396	Structure Of Pkc In Complex With A Substrate Peptid		2e-07
2qlu_A	314	Crystal Structure Of Activin Receptor Type Ii Kinas		2e-07
3g0f_A	336	Kit Kinase Domain Mutant D816h In Complex With Suni		2e-07
2ivs_A	314	Crystal Structure Of Non-Phosphorylated Ret Tyrosin		2e-07
1pkg_A	329	Structure Of A C-kit Kinase Product Complex Length		2e-07
1zrz_A	364	Crystal Structure Of The Catalytic Domain Of Atypic		2e-07
1opk_A	495	Structural Basis For The Auto-Inhibition Of C-Abl T		2e-07
3zh8_A	349	A Novel Small Molecule Apkc Inhibitor Length = 349		3e-07
1opl_A	537	Structural Basis For The Auto-Inhibition Of C-Abl T		3e-07
2qon_A	373	Human Epha3 Kinase And Juxtamembrane Region, Y596f:		3e-07
2j0j_A	656	Crystal Structure Of A Fragment Of Focal Adhesion K		3e-07
3zuu_A	362	The Structure Of Ost1 (D160a, S175d) Kinase In Comp		3e-07
1nxk_A	400	Crystal Structure Of Staurosporine Bound To Map Kap		3e-07
3a8w_A	345	Crystal Structure Of Pkciota Kinase Domain Length =		3e-07
2fo0_A	495	Organization Of The Sh3-Sh2 Unit In Active And Inac		3e-07
3t8o_A	543	Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolu		3e-07
3zut_A	362	The Structure Of Ost1 (D160a) Kinase Length = 362		3e-07
3qc9_A	543	Crystal Structure Of Cross-Linked Bovine Grk1 T8cN4		3e-07
3c4x_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
2qo7_A	373	Human Epha3 Kinase And Juxtamembrane Region, Dephos		3e-07
3h9r_A	330	Crystal Structure Of The Kinase Domain Of Type I Ac		3e-07
3c4w_A	543	Crystal Structure Of G Protein Coupled Receptor Kin		3e-07
3orn_A	307	Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In		4e-07
3lj0_A	434	Ire1 Complexed With Adp And Quercetin Length = 434		4e-07
1koa_A	491	Twitchin Kinase Fragment (C.Elegans), Autoregulated		4e-07
4dym_A	301	Crystal Structure Of The Acvr1 Kinase Domain In Com		4e-07
3mtf_A	301	Crystal Structure Of The Acvr1 Kinase In Complex Wi		4e-07
2qob_A	344	Human Epha3 Kinase Domain, Base Structure Length =		4e-07
4eut_A	396	Structure Of Bx-795 Complexed With Unphosphorylated		4e-07
1xh9_A	350	Crystal Structures Of Protein Kinase B Selective In		4e-07
2ivv_A	314	Crystal Structure Of Phosphorylated Ret Tyrosine Ki		5e-07
3uto_A	573	Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-		5e-07
2uzt_A	336	Pka Structures Of Akt, Indazole-Pyridine Inhibitors		6e-07
2f7e_E	351	Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoqu		6e-07
4euu_A	319	Structure Of Bx-795 Complexed With Human Tbk1 Kinas		7e-07
4f99_A	361	Human Cdc7 Kinase In Complex With Dbf4 And Nucleoti		7e-07
4ebw_A	304	Structure Of Focal Adhesion Kinase Catalytic Domain		7e-07
3pxk_A	282	Focal Adhesion Kinase Catalytic Domain In Complex W		8e-07
3hgk_A	327	Crystal Structure Of Effect Protein Avrptob Complex		8e-07
2etm_A	281	Crystal Structure Of Focal Adhesion Kinase Domain C		8e-07
3fhi_A	350	Crystal Structure Of A Complex Between The Catalyti		8e-07
4an2_A	301	Crystal Structures Of Human Mek1 With Carboxamide-B		9e-07
3dtc_A	271	Crystal Structure Of Mixed-Lineage Kinase Mlk1 Comp		9e-07
2jkm_A	276	Focal Adhesion Kinase Catalytic Domain In Complex W		9e-07
1mp8_A	281	Crystal Structure Of Focal Adhesion Kinase (Fak) Le		9e-07
3bz3_A	276	Crystal Structure Analysis Of Focal Adhesion Kinase		9e-07
3pls_A	298	Ron In Complex With Ligand Amp-Pnp Length = 298		9e-07
1wbp_A	397	Srpk1 Bound To 9mer Docking Motif Peptide Length =		1e-06
2j0m_B	276	Crystal Structure A Two-Chain Complex Between The F		1e-06
2jdt_A	351	Structure Of Pka-Pkb Chimera Complexed With Isoquin		1e-06
1s9i_A	354	X-Ray Structure Of The Human Mitogen-Activated Prot		1e-06
1j3h_A	350	Crystal Structure Of Apoenzyme Camp-Dependent Prote		1e-06
1q61_A	350	Pka Triple Mutant Model Of Pkb Length = 350		1e-06
2vo0_A	351	Structure Of Pka-Pkb Chimera Complexed With C-(4-(4		1e-06
3l9m_A	351	Crystal Structure Of Pkab3 (Pka Triple Mutant V123a		1e-06
1smh_A	350	Protein Kinase A Variant Complex With Completely Or		1e-06
2qur_A	350	Crystal Structure Of F327aK285P MUTANT OF CAMP-Depe		1e-06
1ydt_E	350	Structure Of Camp-Dependent Protein Kinase, Alpha-C		1e-06
1bkx_A	350	A Binary Complex Of The Catalytic Subunit Of Camp-D		1e-06
3qal_E	350	Crystal Structure Of Arg280ala Mutant Of Catalytic		1e-06
2erz_E	351	Crystal Structure Of C-amp Dependent Kinase (pka) B		1e-06
1fmo_E	350	Crystal Structure Of A Polyhistidine-Tagged Recombi		1e-06
3llt_A	360	Crystal Structure Of Pf14_0431, Kinase Domain Lengt		1e-06
1jbp_E	350	Crystal Structure Of The Catalytic Subunit Of Camp-		1e-06
2i0e_A	353	Structure Of Catalytic Domain Of Human Protein Kina		1e-06
3q4t_A	322	Crystal Structure Of Activin Receptor Type-Iia (Acv		1e-06
2gu8_A	337	Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel		1e-06
3beg_A	381	Crystal Structure Of Sr Protein Kinase 1 Complexed		1e-06
1cmk_E	350	Crystal Structures Of The Myristylated Catalytic Su		1e-06
3dnd_A	350	Camp-Dependent Protein Kinase Pka Catalytic Subunit		1e-06
4ae6_A	343	Structure And Function Of The Human Sperm-specific		2e-06
1cdk_A	350	Camp-Dependent Protein Kinase Catalytic Subunit (E.		2e-06
3nx8_A	351	Human Camp Dependent Protein Kinase In Complex With		2e-06
1svh_A	350	Crystal Structure Of Protein Kinase A In Complex Wi		2e-06
3agl_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
3agm_A	351	Complex Of Pka With The Bisubstrate Protein Kinase		2e-06
1ctp_E	350	Structure Of The Mammalian Catalytic Subunit Of Cam		2e-06
1stc_E	350	Camp-Dependent Protein Kinase, Alpha-Catalytic Subu		2e-06
2c1a_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		2e-06
1b6c_B	342	Crystal Structure Of The Cytoplasmic Domain Of The		2e-06
3pfq_A	674	Crystal Structure And Allosteric Activation Of Prot		2e-06
3mvj_A	371	Human Cyclic Amp-Dependent Protein Kinase Pka Inhib		2e-06
2uvy_A	351	Structure Of Pka-pkb Chimera Complexed With Methyl-		2e-06
1szm_A	350	Dual Binding Mode Of Bisindolylmaleimide 2 To Prote		2e-06
1rdq_E	350	Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of		2e-06
2hen_A	286	Crystal Structure Of The Ephb2 Receptor Kinase Doma		2e-06
3kn5_A	325	Crystal Structure Of The C-Terminal Kinase Domain O		2e-06
1py5_A	326	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		2e-06
2vwu_A	302	Ephb4 Kinase Domain Inhibitor Complex Length = 302		2e-06
3pvb_A	345	Crystal Structure Of (73-244)ria:c Holoenzyme Of Ca		2e-06
1apm_E	350	2.0 Angstrom Refined Crystal Structure Of The Catal		2e-06
4dfx_E	350	Crystal Structure Of Myristoylated K7c Catalytic Su		2e-06
1rw8_A	301	Crystal Structure Of Tgf-Beta Receptor I Kinase Wit		3e-06
1l3r_E	350	Crystal Structure Of A Transition State Mimic Of Th		3e-06
2qcs_A	350	A Complex Structure Between The Catalytic And Regul		3e-06
4ae9_A	343	Structure And Function Of The Human Sperm-specific		3e-06
4dfy_A	371	Crystal Structure Of R194a Mutant Of Camp-Dependent		3e-06
1q24_A	350	Pka Double Mutant Model Of Pkb In Complex With Mgat		3e-06
1vjy_A	303	Crystal Structure Of A Naphthyridine Inhibitor Of H		3e-06
2jds_A	351	Structure Of Camp-Dependent Protein Kinase Complexe		3e-06
1syk_A	350	Crystal Structure Of E230q Mutant Of Camp-Dependent		3e-06
1q8w_A	350	The Catalytic Subunit Of Camp-Dependent Protein Kin		3e-06
2wot_A	306	Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)		3e-06
3tzm_A	309	Tgf-Beta Receptor Type 1 In Complex With Sb431542 L		3e-06
4dg3_E	371	Crystal Structure Of R336a Mutant Of Camp-dependent		3e-06
1xh7_A	350	Crystal Structures Of Protein Kinase B Selective In		3e-06
2qkw_B	321	Structural Basis For Activation Of Plant Immunity B		3e-06
1yhs_A	273	Crystal Structure Of Pim-1 Bound To Staurosporine L		4e-06
2zm3_A	308	Complex Structure Of Insulin-Like Growth Factor Rec		4e-06
1yxs_A	293	Crystal Structure Of Kinase Pim1 With P123m Mutatio		4e-06
3o7l_B	350	Crystal Structure Of Phospholamban (1-19):pka C-Sub		4e-06
1ywv_A	293	Crystal Structures Of Proto-Oncogene Kinase Pim1: A		4e-06
4dtk_A	276	Novel And Selective Pan-Pim Kinase Inhibitor Length		4e-06
3c4e_A	273	Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7		4e-06
3jxw_A	294	Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-		4e-06
4alu_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		4e-06
3uix_A	298	Crystal Structure Of Pim1 Kinase In Complex With Sm		4e-06
1k3a_A	299	Structure Of The Insulin-Like Growth Factor 1 Recep		4e-06
4aw5_A	291	Complex Of The Ephb4 Kinase Domain With An Oxindole		4e-06
3r00_A	299	The Discovery Of Novel Benzofuran-2-Carboxylic Acid		5e-06
4g3f_A	336	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
4as0_A	273	Cyclometalated Phthalimides As Protein Kinase Inhib		5e-06
4g3c_A	352	Crystal Structure Of Apo Murine Nf-kappab Inducing		5e-06
1xqz_A	300	Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolut		5e-06
4g3g_A	350	Crystal Structure Of Murine Nf-kappab Inducing Kina		5e-06
3f2a_A	300	Crystal Structure Of Human Pim-1 In Complex With Da		5e-06
2xj0_A	301	Protein Kinase Pim-1 In Complex With Fragment-4 Fro		5e-06
2xiy_A	301	Protein Kinase Pim-1 In Complex With Fragment-2 Fro		5e-06
2y4i_B	319	Ksr2-Mek1 Heterodimer Length = 319		5e-06
1a06_A	332	Calmodulin-Dependent Protein Kinase From Rat Length		5e-06
4fg7_A	293	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
1m7n_A	322	Crystal Structure Of Unactivated Apo Insulin-Like G		5e-06
1xws_A	313	Crystal Structure Of The Human Pim1 Kinase Domain L		5e-06
4a7c_A	308	Crystal Structure Of Pim1 Kinase With Etp46546 Leng		5e-06
4fg8_A	315	Crystal Structure Of Human Calcium/calmodulin-depen		5e-06
4alv_A	328	Benzofuropyrimidinone Inhibitors Of Pim-1 Length =		5e-06
3cxw_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		5e-06
2xix_A	301	Protein Kinase Pim-1 In Complex With Fragment-1 Fro		5e-06
1p4o_A	322	Structure Of Apo Unactivated Igf-1r Kinase Domain A		5e-06
3o23_A	305	Human Unphosphorylated Igf1-R Kinase Domain In Comp		5e-06
3jpv_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
3dcv_A	328	Crystal Structure Of Human Pim1 Kinase Complexed Wi		6e-06
1jqh_A	308	Igf-1 Receptor Kinase Domain Length = 308		6e-06
2bil_B	313	The Human Protein Kinase Pim1 In Complex With Its C		6e-06
2bik_B	313	Human Pim1 Phosphorylated On Ser261 Length = 313		6e-06
3ma3_A	313	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
3cy3_A	314	Crystal Structure Of Human Proto-Oncogene Serine Th		6e-06
2oj9_A	307	Structure Of Igf-1r Kinase Domain Complexed With A		6e-06
2j2i_B	312	Crystal Structure Of The Humab Pim1 In Complex With		6e-06
3a99_A	320	Structure Of Pim-1 Kinase Crystallized In The Prese		6e-06
3qam_E	350	Crystal Structure Of Glu208ala Mutant Of Catalytic		6e-06
1xkk_A	352	Egfr Kinase Domain Complexed With A Quinazoline Inh		6e-06
3i81_A	315	Crystal Structure Of Insulin-Like Growth Factor 1 R		6e-06
4fg9_A	320	Crystal Structure Of Human Calcium/calmodulin-depen		6e-06
3lvp_A	336	Crystal Structure Of Bisphosphorylated Igf1-R Kinas		6e-06
3lw0_A	304	Igf-1rk In Complex With Ligand Msc1609119a-1 Length		6e-06
2x4f_A	373	The Crystal Structure Of The Human Myosin Light Cha		6e-06
3qqu_A	301	Cocrystal Structure Of Unphosphorylated Igf With Py		6e-06
1m14_A	333	Tyrosine Kinase Domain From Epidermal Growth Factor		6e-06
2obj_A	333	Crystal Structure Of Human Pim-1 Kinase In Complex		6e-06
2rfd_A	324	Crystal Structure Of The Complex Between The Egfr K		7e-06
4i23_A	329	Crystal Structure Of The Wild-type Egfr Kinase Doma		7e-06
4hjo_A	337	Crystal Structure Of The Inactive Egfr Tyrosine Kin		7e-06
3ika_A	331	Crystal Structure Of Egfr 696-1022 T790m Mutant Cov		7e-06
2jiu_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
3bel_A	315	X-Ray Structure Of Egfr In Complex With Oxime Inhib		7e-06
1fot_A	318	Structure Of The Unliganded Camp-Dependent Protein		7e-06
2itn_A	327	Crystal Structure Of Egfr Kinase Domain G719s Mutat		7e-06
2j5f_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		7e-06
2gs7_A	330	Crystal Structure Of The Inactive Egfr Kinase Domai		7e-06
4g5j_A	330	Crystal Structure Of Egfr Kinase In Complex With Bi		7e-06
4i24_A	329	Structure Of T790m Egfr Kinase Domain Co-crystalliz		7e-06
2jit_A	327	Crystal Structure Of Egfr Kinase Domain T790m Mutat		7e-06
2gs2_A	330	Crystal Structure Of The Active Egfr Kinase Domain		7e-06
4g5p_A	330	Crystal Structure Of Egfr Kinase T790m In Complex W		8e-06
2eb2_A	334	Crystal Structure Of Mutated Egfr Kinase Domain (G7		8e-06
2j5e_A	327	Crystal Structure Of Egfr Kinase Domain In Complex		8e-06
3vjo_A	334	Crystal Structure Of The Wild-Type Egfr Kinase Doma		8e-06
3ug1_A	334	Crystal Structure Of The Mutated Egfr Kinase Domain		8e-06
2jiv_A	328	Crystal Structure Of Egfr Kinase Domain T790m Mutat		8e-06
2h34_A	309	Apoenzyme Crystal Structure Of The Tuberculosis Ser		8e-06
2r5t_A	373	Crystal Structure Of Inactive Serum And Glucocortic		9e-06
3lzb_A	327	Egfr Kinase Domain Complexed With An Imidazo[2,1-B]		1e-05
3gop_A	361	Crystal Structure Of The Egf Receptor Juxtamembrane		1e-05
1tki_A	321	Autoinhibited Serine Kinase Domain Of The Giant Mus		1e-05
3d94_A	301	Crystal Structure Of The Insulin-Like Growth Factor		1e-05

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score =  456 bits (1174), Expect = e-129,   Method: Compositional matrix adjust.
 Identities = 214/281 (76%), Positives = 237/281 (84%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 60  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 119
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRY NRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y           
Sbjct: 240 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 299
Query: 246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
            P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct: 300 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 340

>pdb|4EC8|A Chain A, Structure Of Full Length Cdk9 In Complex With Cyclint And Drb Length = 373

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 39/70 (55%), Positives = 46/70 (65%)
Query: 322 GYHDRVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 381
           G   +VK+RLK YV+D Y            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 271 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 330
Query: 382 QHTQSMFEYL 391
            H  SMFEYL
Sbjct: 331 THLTSMFEYL 340

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score =  456 bits (1173), Expect = e-128,   Method: Compositional matrix adjust.
 Identities = 214/281 (76%), Positives = 237/281 (84%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRY NRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y           
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298
Query: 246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL 286
            P++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYL
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYL 339

>pdb|3MI9|A Chain A, Crystal Structure Of Hiv-1 Tat Complexed With Human P-Tefb Length = 351

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 39/70 (55%), Positives = 46/70 (65%)
Query: 322 GYHDRVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 381
           G   +VK+RLK YV+D Y            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 270 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 329
Query: 382 QHTQSMFEYL 391
            H  SMFEYL
Sbjct: 330 THLTSMFEYL 339

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score =  442 bits (1138), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 207/271 (76%), Positives = 231/271 (85%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR +++ YLVFDFCEHDLAGLLSN+ 
Sbjct: 60  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKASIYLVFDFCEHDLAGLLSNVL 119
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRY NRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y           
Sbjct: 240 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 299
Query: 246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 276
            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 300 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 330

>pdb|4BCF|A Chain A, Structure Of Cdk9 In Complex With Cyclin T And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 32/60 (53%), Positives = 39/60 (65%)
Query: 322 GYHDRVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 381
           G   +VK+RLK YV+D Y            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 271 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 330

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score =  442 bits (1136), Expect = e-124,   Method: Compositional matrix adjust.
 Identities = 207/271 (76%), Positives = 230/271 (84%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 60  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 119
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 120 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 179
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRY NRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 180 NSQPNRYXNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 239
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y           
Sbjct: 240 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 299
Query: 246 XPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 276
            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 300 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 330

>pdb|3BLH|A Chain A, Crystal Structure Of Human Cdk9CYCLINT1 Length = 331

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 32/60 (53%), Positives = 39/60 (65%)
Query: 322 GYHDRVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 381
           G   +VK+RLK YV+D Y            P++R DSD ALNHDFFW+DPMPSDL  ML+
Sbjct: 271 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLS 330

>pdb|4ERW|A Chain A, Cdk2 In Complex With Staurosporine Length = 306

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 53  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 104
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 164 ---VRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 221 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 277
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 278 DPNKRISAKAALAHPFFQDVTKPVP 302

>pdb|1GZ8|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Inhibitor 2-Amino-6-(3'-Methyl-2'-Oxo)butoxypurine Length = 299

Iteration: 1
 Score =  176 bits (446), Expect = 2e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYTHEVVTLWYRAPEILLGXKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1PF8|A Chain A, Crystal Structure Of Human Cyclin-dependent Kinase 2 Complexed With A Nucleoside Inhibitor Length = 298

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|2W17|A Chain A, Cdk2 In Complex With The Imidazole Pyrimidine Amide, Compound (S)-8b Length = 299

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1FIN|A Chain A, Cyclin A-Cyclin-Dependent Kinase 2 Complex Length = 298

Iteration: 1
 Score =  175 bits (444), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|3EZR|A Chain A, Cdk-2 With Indazole Inhibitor 17 Bound At Its Active Site Length = 300

Iteration: 1
 Score =  175 bits (443), Expect = 4e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 98
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 157
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 158 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 215 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 271
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 272 DPNKRISAKAALAHPFFQDVTKPVP 296

>pdb|1OIT|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-dependent Kinase Inhibitors Identified Through Structure-based Hybridisation Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLSFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|3PXF|A Chain A, Cdk2 In Complex With Two Molecules Of 8-Anilino-1-Naphthalene Sulfonate Length = 306

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 53  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 104
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 105 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 164 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 220
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 221 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 277
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 278 DPNKRISAKAALAHPFFQDVTKPVP 302

>pdb|1OIR|A Chain A, Imidazopyridines: A Potent And Selective Class Of Cyclin-Dependent Kinase Inhibitors Identified Through Structure-Based Hybridisation Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1H01|A Chain A, Cdk2 In Complex With A Disubstituted 2, 4-Bis Anilino Pyrimidine Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|3PJ8|A Chain A, Structure Of Cdk2 In Complex With A Pyrazolo[4,3-D]pyrimidine Bioisostere Of Roscovitine Length = 299

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1VYW|A Chain A, Structure Of Cdk2CYCLIN A WITH PNU-292137 Length = 309

Iteration: 1
 Score =  175 bits (443), Expect = 5e-44,   Method: Compositional matrix adjust.
 Identities = 105/265 (39%), Positives = 146/265 (55%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 50  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 101
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 160
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 161 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 218 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 274
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 275 DPNKRISAKAALAHPFFQDVTKPVP 299

>pdb|4EOI|A Chain A, Thr 160 Phosphorylated Cdk2 K89d, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 299

Iteration: 1
 Score =  173 bits (439), Expect = 1e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKDFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1QMZ|A Chain A, Phosphorylated Cdk2-Cyclyin A-Substrate Peptide Complex Length = 299

Iteration: 1
 Score =  173 bits (439), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|1W98|A Chain A, The Structural Basis Of Cdk2 Activation By Cyclin E Length = 298

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|4EOO|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With Atp Length = 299

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 98
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP- 157
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 158 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 215 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 271
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 272 DPNKRISAKAALAHPFFQDVTKPVP 296

>pdb|1E9H|A Chain A, Thr 160 Phosphorylated Cdk2-Human Cyclin A3 Complex With The Inhibitor Indirubin-5-Sulphonate Bound Length = 297

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 271 DPNKRISAKAALAHPFFQDVTKPVP 295

>pdb|4EOP|A Chain A, Thr 160 Phosphorylated Cdk2 Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 48  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 99
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP- 158
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 159 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 216 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 272
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 273 DPNKRISAKAALAHPFFQDVTKPVP 297

>pdb|3BHT|A Chain A, Structure Of Phosphorylated Thr160 Cdk2CYCLIN A IN COMPLEX WITH THE Inhibitor Meriolin 3 Length = 300

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 98
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 157
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 158 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 215 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 271
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 272 DPNKRISAKAALAHPFFQDVTKPVP 296

>pdb|4EOQ|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|4BCQ|A Chain A, Structure Of Cdk2 In Complex With Cyclin A And A 2-amino-4- Heteroaryl-pyrimidine Inhibitor Length = 301

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 48  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 99
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 158
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 159 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 216 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 272
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 273 DPNKRISAKAALAHPFFQDVTKPVP 297

>pdb|3QHR|A Chain A, Structure Of A Pcdk2CYCLINA TRANSITION-State Mimic Length = 298

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 98
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 157
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 158 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 215 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 271
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 272 DPNKRISAKAALAHPFFQDVTKPVP 296

>pdb|1JST|A Chain A, Phosphorylated Cyclin-Dependent Kinase-2 Bound To Cyclin A Length = 298

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|2IW6|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A Complexed With A Bisanilinopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKTFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|4EOS|A Chain A, Thr 160 Phosphorylated Cdk2 Wt - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 48  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 99
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 158
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 159 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 216 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 272
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 273 DPNKRISAKAALAHPFFQDVTKPVP 297

>pdb|1OGU|A Chain A, Structure Of Human Thr160-phospho Cdk2/cyclin A Complexed With A 2-arylamino-4-cyclohexylmethyl-5-nitroso-6- aminopyrimidine Inhibitor Length = 302

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|4I3Z|A Chain A, Structure Of Pcdk2CYCLINA BOUND TO ADP AND 2 MAGNESIUM IONS Length = 296

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|1H1P|A Chain A, Structure Of Human Thr160-Phospho Cdk2CYCLIN A COMPLEXED With The Inhibitor Nu2058 Length = 303

Iteration: 1
 Score =  173 bits (438), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 50  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 101
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 102 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 160
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 161 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 217
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 218 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 274
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 275 DPNKRISAKAALAHPFFQDVTKPVP 299

>pdb|4EOM|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With Atp Length = 301

Iteration: 1
 Score =  172 bits (437), Expect = 2e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLSMDLKKFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|4EON|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, Q131e - Human Cyclin A3 Complex With The Inhibitor Ro3306 Length = 300

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 47  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLSMDLKKFMDASAL 98
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 99  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPENLLINTEGAIKLADFGLARAFGVP- 157
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 158 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 214
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 215 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 271
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 272 DPNKRISAKAALAHPFFQDVTKPVP 296

>pdb|4EOK|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With The Inhibitor Nu6102 Length = 300

Iteration: 1
 Score =  172 bits (437), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 48  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLSMDLKDFMDASAL 99
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 100 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 158
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 159 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 215
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 216 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 272
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 273 DPNKRISAKAALAHPFFQDVTKPVP 297

>pdb|4EOJ|A Chain A, Thr 160 Phosphorylated Cdk2 H84s, Q85m, K89d - Human Cyclin A3 Complex With Atp Length = 302

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLSMDLKDFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|1GII|A Chain A, Human Cyclin Dependent Kinase 2 Complexed With The Cdk4 Inhibitor Length = 298

Iteration: 1
 Score =  172 bits (436), Expect = 3e-43,   Method: Compositional matrix adjust.
 Identities = 104/265 (39%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+    DL   + ++  
Sbjct: 45  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEHVHQDLKTFMDASAL 96
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 97  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 155
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 156 ---VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 213 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 269
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 270 DPNKRISAKAALAHPFFQDVTKPVP 294

>pdb|2JGZ|A Chain A, Crystal Structure Of Phospho-Cdk2 In Complex With Cyclin B Length = 289

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 101/257 (39%), Positives = 141/257 (54%), Gaps = 16/257 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++  
Sbjct: 46  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASAL 97
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 98  TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 156
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 157 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 213
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 214 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 270
Query: 246 XPSKRFDSDAALNHDFF 262
            P+KR  + AAL H FF
Sbjct: 271 DPNKRISAKAALAHPFF 287

>pdb|2PK9|A Chain A, Structure Of The Pho85-pho80 Cdk-cyclin Complex Of The Phosphate-responsive Signal Transduction Pathway Length = 317

Iteration: 1
 Score =  171 bits (434), Expect = 6e-43,   Method: Compositional matrix adjust.
 Identities = 101/267 (37%), Positives = 144/267 (53%), Gaps = 27/267 (10%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLL 61
           P TA+REI +++ LKHEN+V L ++  T+        +   LVF+F ++DL     +  +
Sbjct: 47  PSTAIREISLMKELKHENIVRLYDVIHTE--------NKLTLVFEFMDNDLKKYMDSRTV 98
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            N      L  +K    QLL GL + H NKILHRD+K  N+LI K G LKL DFGLARAF
Sbjct: 99  GNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAF 158
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                  VN +++ VVTLWYR P++L+G R Y   +D+W  GCI+AEM T  P+  G  +
Sbjct: 159 GIP----VNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTND 214
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK---RKVKERLKPYVK---DQYG 235
           ++Q+ LI  + G+     WP V  L  YN    P  Q+   R +++ L+P+ K   D   
Sbjct: 215 EEQLKLIFDIMGTPNESLWPSVTKLPKYN----PNIQQRPPRDLRQVLQPHTKEPLDGNL 270
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF 262
                      P  R  +  AL+H +F
Sbjct: 271 MDFLHGLLQLNPDMRLSAKQALHHPWF 297

>pdb|3NIZ|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Adp Bound Length = 311

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 96/257 (37%), Positives = 136/257 (52%), Gaps = 14/257 (5%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+REI +L+ L H N+V LI++  ++            LVF+F E DL  +L    
Sbjct: 62  IPSTAIREISLLKELHHPNIVSLIDVIHSE--------RCLTLVFEFMEKDLKKVLDENK 113
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                 +IK  + QLL G+ + H ++ILHRD+K  N+LI   G LKLADFGLARAF    
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR P++L+G + Y   VD+W  GCI AEM T  P+  G T+  Q+
Sbjct: 173 ---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I  + G+  P  WP V+ L L+ +      +K+     +  +   Q G          
Sbjct: 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC--QEGIDLLSNMLCF 287
Query: 246 XPSKRFDSDAALNHDFF 262
            P+KR  +  A+NH +F
Sbjct: 288 DPNKRISARDAMNHPYF 304

>pdb|2QKR|A Chain A, Cryptosporidium Parvum Cyclin-Dependent Kinase Cgd5_2510 With Indirubin 3'-Monoxime Bound Length = 313

Iteration: 1
 Score =  171 bits (433), Expect = 8e-43,   Method: Compositional matrix adjust.
 Identities = 96/257 (37%), Positives = 136/257 (52%), Gaps = 14/257 (5%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+REI +L+ L H N+V LI++  ++            LVF+F E DL  +L    
Sbjct: 62  IPSTAIREISLLKELHHPNIVSLIDVIHSE--------RCLTLVFEFMEKDLKKVLDENK 113
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                 +IK  + QLL G+ + H ++ILHRD+K  N+LI   G LKLADFGLARAF    
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIP- 172
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR P++L+G + Y   VD+W  GCI AEM T  P+  G T+  Q+
Sbjct: 173 ---VRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I  + G+  P  WP V+ L L+ +      +K+     +  +   Q G          
Sbjct: 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGFC--QEGIDLLSNMLCF 287
Query: 246 XPSKRFDSDAALNHDFF 262
            P+KR  +  A+NH +F
Sbjct: 288 DPNKRISARDAMNHPYF 304

>pdb|2IW8|A Chain A, Structure Of Human Thr160-Phospho Cdk2-Cyclin A F82h-L83v- H84d Mutant With An O6-Cyclohexylmethylguanine Inhibitor Length = 302

Iteration: 1
 Score =  171 bits (432), Expect = 9e-43,   Method: Compositional matrix adjust.
 Identities = 103/265 (38%), Positives = 145/265 (54%), Gaps = 18/265 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNIH 65
           P TA+REI +L+ L H N+V L+++  T+        +  YLVF+  + DL   + ++  
Sbjct: 49  PSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEHVDQDLKKFMDASAL 100
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF    
Sbjct: 101 TGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP- 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  Y + VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q+
Sbjct: 160 ---VRTYXHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQL 216
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +  G+     WPGV ++  Y K   PK  ++   + + P   D+ G          
Sbjct: 217 FRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPL--DEDGRSLLSQMLHY 273
Query: 246 XPSKRFDSDAALNHDFFW--TDPMP 268
            P+KR  + AAL H FF   T P+P
Sbjct: 274 DPNKRISAKAALAHPFFQDVTKPVP 298

>pdb|3MTL|A Chain A, Crystal Structure Of The Pctaire1 Kinase In Complex With Ind E804 Length = 324

Iteration: 1
 Score =  169 bits (429), Expect = 2e-42,   Method: Compositional matrix adjust.
 Identities = 95/258 (36%), Positives = 141/258 (54%), Gaps = 14/258 (5%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE+ +L+ LKH N+V L +I  T+         +  LVF++ + DL   L +   
Sbjct: 44  PCTAIREVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDKDLKQYLDDCGN 95
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             ++  +K  + QLL GL Y H  K+LHRD+K  N+LI + G LKLADFGLARA    K+
Sbjct: 96  IINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARA----KS 151
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                Y N VVTLWYRPP++LLG  +Y   +D+WG GCI  EM T  P+  G+T ++Q+ 
Sbjct: 152 IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQLH 211
Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXX 246
            I ++ G+ T E+WPG+ + + +     PK +   +     P + D  G           
Sbjct: 212 FIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH-APRL-DSDGADLLTKLLQFE 269
Query: 247 PSKRFDSDAALNHDFFWT 264
              R  ++ A+ H FF +
Sbjct: 270 GRNRISAEDAMKHPFFLS 287

>pdb|1V0B|A Chain A, Crystal Structure Of The T198a Mutant Of Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/262 (37%), Positives = 137/262 (52%), Gaps = 25/262 (9%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P T +REI IL+ LKH N+V L ++  TK            LVF+  + DL  LL    
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKR--------LVLVFEHLDQDLKKLLDVCE 94
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   K  + QLLNG+ Y H  ++LHRD+K  N+LI + G LK+ADFGLARAF    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V +YT+ VVTLWYR P++L+G + Y   +D+W  GCI AEM   +P+  G +E  Q+
Sbjct: 154 ---VRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGAPLFPGVSEADQL 210
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKR-KVKERL--KPYVK--DQYGCXXXX 240
             I ++ G+   ++WP V         ELPK      V E L  + ++K  D+ G     
Sbjct: 211 MRIFRILGTPNSKNWPNV--------TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 241 XXXXXXPSKRFDSDAALNHDFF 262
                 P++R  +  AL H +F
Sbjct: 263 KMLKLDPNQRITAKQALEHAYF 284

>pdb|1V0O|A Chain A, Structure Of P. Falciparum Pfpk5-Indirubin-5-Sulphonate Ligand Complex Length = 288

Iteration: 1
 Score =  162 bits (411), Expect = 3e-40,   Method: Compositional matrix adjust.
 Identities = 97/262 (37%), Positives = 137/262 (52%), Gaps = 25/262 (9%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P T +REI IL+ LKH N+V L ++  TK            LVF+  + DL  LL    
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKR--------LVLVFEHLDQDLKKLLDVCE 94
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   K  + QLLNG+ Y H  ++LHRD+K  N+LI + G LK+ADFGLARAF    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V +YT+ VVTLWYR P++L+G + Y   +D+W  GCI AEM   +P+  G +E  Q+
Sbjct: 154 ---VRKYTHEVVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKR-KVKERL--KPYVK--DQYGCXXXX 240
             I ++ G+   ++WP V         ELPK      V E L  + ++K  D+ G     
Sbjct: 211 MRIFRILGTPNSKNWPNV--------TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 241 XXXXXXPSKRFDSDAALNHDFF 262
                 P++R  +  AL H +F
Sbjct: 263 KMLKLDPNQRITAKQALEHAYF 284

>pdb|1OB3|A Chain A, Structure Of P. Falciparum Pfpk5 Length = 288

Iteration: 1
 Score =  162 bits (409), Expect = 4e-40,   Method: Compositional matrix adjust.
 Identities = 96/262 (36%), Positives = 137/262 (52%), Gaps = 25/262 (9%)
Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P T +REI IL+ LKH N+V L ++  TK            LVF+  + DL  LL    
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKR--------LVLVFEHLDQDLKKLLDVCE 94
Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   K  + QLLNG+ Y H  ++LHRD+K  N+LI + G LK+ADFGLARAF    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V +YT+ +VTLWYR P++L+G + Y   +D+W  GCI AEM   +P+  G +E  Q+
Sbjct: 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKR-KVKERL--KPYVK--DQYGCXXXX 240
             I ++ G+   ++WP V         ELPK      V E L  + ++K  D+ G     
Sbjct: 211 MRIFRILGTPNSKNWPNV--------TELPKYDPNFTVYEPLPWESFLKGLDESGIDLLS 262
Query: 241 XXXXXXPSKRFDSDAALNHDFF 262
                 P++R  +  AL H +F
Sbjct: 263 KMLKLDPNQRITAKQALEHAYF 284

>pdb|4AAA|A Chain A, Crystal Structure Of The Human Cdkl2 Kinase Domain Length = 331

Iteration: 1
 Score =  162 bits (409), Expect = 5e-40,   Method: Compositional matrix adjust.
 Identities = 90/272 (33%), Positives = 146/272 (53%), Gaps = 13/272 (4%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            A+REIK+L+ L+HEN+V+L+E+C+ K          +YLVF+F +H +   L       
Sbjct: 70  IAMREIKLLKQLRHENLVNLLEVCKKK--------KRWYLVFEFVDHTILDDLELFPNGL 121
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               ++K + Q++NG+ + HS+ I+HRD+K  N+L++++G++KL DFG AR  +    G+
Sbjct: 122 DYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAP--GE 179
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V  Y + V T WYR PELL+GD  YG  VD+W  GC++ EM+   P+  G+++  Q+  I
Sbjct: 180 V--YDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQLYHI 237
Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
               G++ P          ++  + LP+ ++R+  ER  P + +              P 
Sbjct: 238 MMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKLSEVV-IDLAKKCLHIDPD 296
Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQ 280
           KR      L+HDFF  D      S+ L    Q
Sbjct: 297 KRPFCAELLHHDFFQMDGFAERFSQELQLKVQ 328

>pdb|1UA2|A Chain A, Crystal Structure Of Human Cdk7 Length = 346

Iteration: 1
 Score =  160 bits (406), Expect = 1e-39,   Method: Compositional matrix adjust.
 Identities = 88/202 (43%), Positives = 123/202 (60%), Gaps = 14/202 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           TALREIK+LQ L H N++ L++    K+N          LVFDF E DL  ++ +  +  
Sbjct: 58  TALREIKLLQELSHPNIIGLLDAFGHKSN--------ISLVFDFMETDLEVIIKDNSLVL 109
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +   IK  +   L GL Y+H + ILHRD+K  N+L+ + G+LKLADFGLA++F     G 
Sbjct: 110 TPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSF-----GS 164
Query: 129 VNR-YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
            NR Y ++VVT WYR PELL G R YG  VD+W  GCI+AE+  R P + G+++  Q+T 
Sbjct: 165 PNRAYXHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQLTR 224
Query: 188 ISQLCGSITPESWPGVETLDLY 209
           I +  G+ T E WP + +L  Y
Sbjct: 225 IFETLGTPTEEQWPDMCSLPDY 246

>pdb|1H4L|A Chain A, Structure And Regulation Of The Cdk5-P25(Nck5a) Complex Length = 292

Iteration: 1
 Score =  156 bits (394), Expect = 3e-38,   Method: Compositional matrix adjust.
 Identities = 94/257 (36%), Positives = 132/257 (51%), Gaps = 16/257 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P +ALREI +L+ LKH+N+V L ++  +             LVF+FC+ DL     + + 
Sbjct: 45  PSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCNG 96
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 +K  + QLL GL + HS  +LHRD+K  N+LI + G LKLADFGLARAF     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLADFGLARAFGIP-- 154
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS-PIMQGNTEQQQI 185
             V  Y+  VVTLWYRPP++L G + Y   +D+W AGCI AE+   + P+  GN    Q+
Sbjct: 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAARPLFPGNDVDDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +L G+ T E WP +  L  Y    +  A    V    K    +  G          
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK---LNATGRDLLQNLLKC 269
Query: 246 XPSKRFDSDAALNHDFF 262
            P +R  ++ AL H +F
Sbjct: 270 NPVQRISAEEALQHPYF 286

>pdb|3GBZ|A Chain A, Structure Of The Cmgc Cdk Kinase From Giardia Lamblia Length = 329

Iteration: 1
 Score =  154 bits (390), Expect = 7e-38,   Method: Compositional matrix adjust.
 Identities = 91/261 (34%), Positives = 148/261 (56%), Gaps = 20/261 (7%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P TA+RE+ +L+ L+H N++ L      K+  ++ +R   +L+F++ E+DL   +   + 
Sbjct: 77  PGTAIREVSLLKELQHRNIIEL------KSVIHHNHR--LHLIFEYAENDLKKYMDK-NP 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-----KTGILKLADFGLARAF 121
             S+  IK  + QL+NG+ + HS + LHRD+K  N+L++     +T +LK+ DFGLARAF
Sbjct: 128 DVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAF 187
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                  + ++T+ ++TLWYRPPE+LLG R+Y   VD+W   CI AEM  ++P+  G++E
Sbjct: 188 GIP----IRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDSE 243
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXX 241
             Q+  I ++ G     +WPGV  L  + K   PK + + +K R+   + D  G      
Sbjct: 244 IDQLFKIFEVLGLPDDTTWPGVTALPDW-KQSFPKFRGKTLK-RVLGALLDDEGLDLLTA 301
Query: 242 XXXXXPSKRFDSDAALNHDFF 262
                P KR  +  AL H +F
Sbjct: 302 MLEMDPVKRISAKNALEHPYF 322

>pdb|1UNG|A Chain A, Structural Mechanism For The Inhibition Of Cdk5-P25 By Roscovitine, Aloisine And Indirubin. Length = 292

Iteration: 1
 Score =  154 bits (388), Expect = 1e-37,   Method: Compositional matrix adjust.
 Identities = 93/257 (36%), Positives = 131/257 (50%), Gaps = 16/257 (6%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P +ALREI +L+ LKH+N+V L ++  +             LVF+FC+ DL     + + 
Sbjct: 45  PSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCNG 96
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 +K  + QLL GL + HS  +LHRD+K  N+LI + G LKLA+FGLARAF     
Sbjct: 97  DLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP-- 154
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS-PIMQGNTEQQQI 185
             V  Y+  VVTLWYRPP++L G + Y   +D+W AGCI AE+     P+  GN    Q+
Sbjct: 155 --VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQL 212
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I +L G+ T E WP +  L  Y    +  A    V    K    +  G          
Sbjct: 213 KRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK---LNATGRDLLQNLLKC 269
Query: 246 XPSKRFDSDAALNHDFF 262
            P +R  ++ AL H +F
Sbjct: 270 NPVQRISAEEALQHPYF 286

>pdb|4AGU|A Chain A, Crystal Structure Of The Human Cdkl1 Kinase Domain Length = 311

Iteration: 1
 Score =  148 bits (374), Expect = 4e-36,   Method: Compositional matrix adjust.
 Identities = 86/279 (30%), Positives = 141/279 (50%), Gaps = 23/279 (8%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           ALREI++L+ LKH N+V+L+E+ R K           +LVF++C+H +   L        
Sbjct: 49  ALREIRMLKQLKHPNLVNLLEVFRRKRR--------LHLVFEYCDHTVLHELDRYQRGVP 100
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +K +  Q L  + + H +  +HRD+K  N+LITK  ++KL DFG AR  +    G  
Sbjct: 101 EHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT----GPS 156
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           + Y + V T WYR PELL+GD  YGPPVD+W  GC+ AE+ +  P+  G ++  Q+ LI 
Sbjct: 157 DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQLYLIR 216
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY-----GCXXXXXXXX 244
           +  G + P       T   ++ +++P  +  +  E   P +         GC        
Sbjct: 217 KTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNISYPALGLLKGC------LH 270
Query: 245 XXPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMF 283
             P++R   +  L+H +F       DL+K   +  ++++
Sbjct: 271 MDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLY 309

>pdb|3NUP|A Chain A, Cdk6 (Monomeric) In Complex With Inhibitor Length = 307

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 145/263 (55%), Gaps = 24/263 (9%)
Query: 7   PITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN 63
           P++ +RE+ +L+ L+   H NVV L ++C    ++ +R  +   LVF+  + DL   L  
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVC--TVSRTDR-ETKLTLVFEHVDQDLTTYLDK 111
Query: 64  I-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           +         IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +S
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                     T+ VVTLWYR PE+LL   +Y  PVDLW  GCI AEM+ R P+ +G+++ 
Sbjct: 172 FQMA-----LTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225
Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPK-AQKRKVKERLKPYVK--DQYGCXXX 239
            Q+  I  + G    E WP          + LP+ A   K  + ++ +V   D+ G    
Sbjct: 226 DQLGKILDVIGLPGEEDWP--------RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 240 XXXXXXXPSKRFDSDAALNHDFF 262
                  P+KR  + +AL+H +F
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYF 300

>pdb|1JOW|B Chain B, Crystal Structure Of A Complex Of Human Cdk6 And A Viral Cyclin Length = 308

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/263 (34%), Positives = 145/263 (55%), Gaps = 24/263 (9%)
Query: 7   PITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN 63
           P++ +RE+ +L+ L+   H NVV L ++C    ++ +R  +   LVF+  + DL   L  
Sbjct: 55  PLSTIREVAVLRHLETFEHPNVVRLFDVC--TVSRTDR-ETKLTLVFEHVDQDLTTYLDK 111
Query: 64  I-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
           +         IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +S
Sbjct: 112 VPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYS 171
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                     T+ VVTLWYR PE+LL   +Y  PVDLW  GCI AEM+ R P+ +G+++ 
Sbjct: 172 FQMA-----LTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSDV 225
Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPK-AQKRKVKERLKPYVK--DQYGCXXX 239
            Q+  I  + G    E WP          + LP+ A   K  + ++ +V   D+ G    
Sbjct: 226 DQLGKILDVIGLPGEEDWP--------RDVALPRQAFHSKSAQPIEKFVTDIDELGKDLL 277
Query: 240 XXXXXXXPSKRFDSDAALNHDFF 262
                  P+KR  + +AL+H +F
Sbjct: 278 LKCLTFNPAKRISAYSALSHPYF 300

>pdb|1BI8|A Chain A, Mechanism Of G1 Cyclin Dependent Kinase Inhibition From The Structures Cdk6-P19ink4d Inhibitor Complex Length = 326

Iteration: 1
 Score =  148 bits (374), Expect = 5e-36,   Method: Compositional matrix adjust.
 Identities = 92/264 (34%), Positives = 145/264 (54%), Gaps = 24/264 (9%)
Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            P++ +RE+ +L+ L+   H NVV L ++C    ++ +R  +   LVF+  + DL   L 
Sbjct: 54  MPLSTIREVAVLRHLETFEHPNVVRLFDVC--TVSRTDR-ETKLTLVFEHVDQDLTTYLD 110
Query: 63  NI-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            +         IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T+ VVTLWYR PE+LL   +Y  PVDLW  GCI AEM+ R P+ +G+++
Sbjct: 171 SFQMA-----LTSVVVTLWYRAPEVLL-QSSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 224
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPK-AQKRKVKERLKPYVK--DQYGCXX 238
             Q+  I  + G    E WP          + LP+ A   K  + ++ +V   D+ G   
Sbjct: 225 VDQLGKILDVIGLPGEEDWP--------RDVALPRQAFHSKSAQPIEKFVTDIDELGKDL 276
Query: 239 XXXXXXXXPSKRFDSDAALNHDFF 262
                   P+KR  + +AL+H +F
Sbjct: 277 LLKCLTFNPAKRISAYSALSHPYF 300

>pdb|3G33|A Chain A, Crystal Structure Of Cdk4CYCLIN D3 Length = 308

Iteration: 1
 Score =  145 bits (366), Expect = 4e-35,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 131/264 (49%), Gaps = 18/264 (6%)
Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            PI+ +RE+ +L+ L+   H NVV L+++C T             LVF+  + DL   L 
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQDLRTYLD 110
Query: 63  NIHVKFSLGE-IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                    E IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 170
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T  VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+E
Sbjct: 171 SYQMA-----LTPVVVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 224
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXX 241
             Q+  I  L G    + WP   +L    +   P    R V+  +     ++ G      
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEM--EESGAQLLLE 279
Query: 242 XXXXXPSKRFDSDAALNHDFFWTD 265
                P KR  +  AL H +   D
Sbjct: 280 MLTFNPHKRISAFRALQHSYLHKD 303

>pdb|2W99|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  144 bits (363), Expect = 1e-34,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 132/265 (49%), Gaps = 20/265 (7%)
Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            PI+ +RE+ +L+ L+   H NVV L+++C T             LVF+  + DL   L 
Sbjct: 46  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQDLRTYLD 102
Query: 63  NIHVKFSLGE-IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                    E IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 122 S-QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
           S Q     V      VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+
Sbjct: 163 SYQMALAPV------VVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215
Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXX 240
           E  Q+  I  L G    + WP   +L    +   P    R V+  +     ++ G     
Sbjct: 216 EADQLGKIFDLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEM--EESGAQLLL 270
Query: 241 XXXXXXPSKRFDSDAALNHDFFWTD 265
                 P KR  +  AL H +   D
Sbjct: 271 EMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|2W96|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  143 bits (361), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 94/265 (35%), Positives = 132/265 (49%), Gaps = 20/265 (7%)
Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            PI+ +RE+ +L+ L+   H NVV L+++C T             LVF+  + DL   L 
Sbjct: 46  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQDLRTYLD 102
Query: 63  NIHVKFSLGE-IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                    E IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 122 S-QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
           S Q     V      VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+
Sbjct: 163 SYQMALDPV------VVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNS 215
Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXX 240
           E  Q+  I  L G    + WP   +L    +   P    R V+  +     ++ G     
Sbjct: 216 EADQLGKIFDLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEM--EESGAQLLL 270
Query: 241 XXXXXXPSKRFDSDAALNHDFFWTD 265
                 P KR  +  AL H +   D
Sbjct: 271 EMLTFNPHKRISAFRALQHSYLHKD 295

>pdb|2W9F|B Chain B, Crystal Structure Of Cdk4 In Complex With A D-Type Cyclin Length = 306

Iteration: 1
 Score =  143 bits (360), Expect = 2e-34,   Method: Compositional matrix adjust.
 Identities = 93/264 (35%), Positives = 133/264 (50%), Gaps = 18/264 (6%)
Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            PI+ +RE+ +L+ L+   H NVV L+++C T             LVF+  + DL   L 
Sbjct: 46  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDRE---IKVTLVFEHVDQDLRTYLD 102
Query: 63  NIHVKFSLGE-IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                    E IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 103 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 162
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S     Q+  +   VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+E
Sbjct: 163 SY----QMALFPV-VVTLWYRAPEVLL-QSTYATPVDMWSVGCIFAEMFRRKPLFCGNSE 216
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXX 241
             Q+  I  L G    + WP   +L    +   P    R V+  +     ++ G      
Sbjct: 217 ADQLGKIFDLIGLPPEDDWPRDVSLP---RGAFPPRGPRPVQSVVPEM--EESGAQLLLE 271
Query: 242 XXXXXPSKRFDSDAALNHDFFWTD 265
                P KR  +  AL H +   D
Sbjct: 272 MLTFNPHKRISAFRALQHSYLHKD 295

>pdb|3RGF|A Chain A, Crystal Structure Of Human Cdk8CYCC Length = 405

Iteration: 1
 Score =  135 bits (341), Expect = 3e-32,   Method: Compositional matrix adjust.
 Identities = 91/300 (30%), Positives = 143/300 (47%), Gaps = 46/300 (15%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL----- 57
           G    ++A REI +L+ LKH NV+ L ++  + A++        +L+FD+ EHDL     
Sbjct: 58  GTGISMSACREIALLRELKHPNVISLQKVFLSHADR------KVWLLFDYAEHDLWHIIK 111
Query: 58  ---AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGIL 110
              A   +   V+   G +K ++ Q+L+G++Y+H+N +LHRD+K AN+L+     + G +
Sbjct: 112 FHRASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRV 171
Query: 111 KLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW 170
           K+AD G AR F+       +     VVT WYR PELLLG R+Y   +D+W  GCI AE+ 
Sbjct: 172 KIADMGFARLFNSPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELL 230
Query: 171 TRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETL------------DLY 209
           T  PI     E           Q+  I  + G    + W  ++ +            + Y
Sbjct: 231 TSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTY 290
Query: 210 NKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPS 269
               L K  +   K ++KP   D              P KR  S+ A+   +F  DP+P+
Sbjct: 291 TNCSLIKYME---KHKVKP---DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPT 344

>pdb|3TEI|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  133 bits (335), Expect = 1e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 70  TLREIKILLAFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 183
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 184 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 244 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 301
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 302 KRIEVEQALAHPYLAQYYDPSD 323

>pdb|4FV7|A Chain A, Crystal Structure Of The Erk2 Complexed With E94 Length = 360

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHT 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 242 GILGSPSQEDLNXIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 299
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 300 KRIEVEQALAHPYLEQYYDPSD 321

>pdb|3SA0|A Chain A, Complex Of Erk2 With Norathyriol Length = 360

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKIXDFGLARV-ADPDHDHT 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 242 GILGSPSQEDLNXIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 299
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 300 KRIEVEQALAHPYLEQYYDPSD 321

>pdb|4FUX|A Chain A, Crystal Structure Of The Erk2 Complexed With E75 Length = 360

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHT 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 242 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 299
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 300 KRIEVEQALAHPYLEQYYDPSD 321

>pdb|4FV6|A Chain A, Crystal Structure Of The Erk2 Complexed With E57 Length = 360

Iteration: 1
 Score =  133 bits (335), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 242 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 299
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 300 KRIEVEQALAHPYLEQYYDPSD 321

>pdb|4GSB|A Chain A, Monoclinic Crystal Form Of The Apo-Erk2 Length = 364

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|2Y9Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 70  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 125 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 183
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 184 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 243
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 244 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 301
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 302 KRIEVEQALAHPYLEQYYDPSD 323

>pdb|3QYW|A Chain A, Crystal Structure Of Erk2 In Complex With An Inhibitor Length = 364

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|3O71|A Chain A, Crystal Structure Of Erk2DCC PEPTIDE COMPLEX Length = 358

Iteration: 1
 Score =  133 bits (334), Expect = 2e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 66  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 120
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 121 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 240 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 297
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 298 KRIEVEQALAHPYLEQYYDPSD 319

>pdb|2OJG|A Chain A, Crystal Structure Of Erk2 In Complex With N,n-dimethyl-4-(4- Phenyl-1h-pyrazol-3-yl)-1h-pyrrole-2-carboxamide Length = 380

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 142
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 143 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 201
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 202 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 262 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 319
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 320 KRIEVEQALAHPYLEQYYDPSD 341

>pdb|1GOL|A Chain A, Coordinates Of Rat Map Kinase Erk2 With An Arginine Mutation At Position 52 Length = 364

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|1WZY|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Pyrazolopyridazine Derivative Length = 368

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 76  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 130
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 131 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 189
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 190 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 249
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 250 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 307
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 308 KRIEVEQALAHPYLEQYYDPSD 329

>pdb|1TVO|A Chain A, The Structure Of Erk2 In Complex With A Small Molecule Inhibitor Length = 368

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 68  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 123 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 182 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 241
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 242 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 299
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 300 KRIEVEQALAHPYLEQYYDPSD 321

>pdb|3ZU7|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 73  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 127
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 128 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 186
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 187 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 247 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 304
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 305 KRIEVEQALAHPYLEQYYDPSD 326

>pdb|2Z7L|A Chain A, Unphosphorylated Mitogen Activated Protein Kinase Erk2 In Complex With (4-{[5-Carbamoyl-4-(3-Methylanilino)pyrimidin 2-Yl]amino}phenyl)acetic Acid Length = 366

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 74  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 128
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 129 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 187
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 188 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 247
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 248 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 305
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 306 KRIEVEQALAHPYLEQYYDPSD 327

>pdb|3C9W|A Chain A, Crystal Structure Of Erk-2 With Hypothemycin Covalently Bound Length = 357

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 65  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 120 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 178
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 179 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 238
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 239 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 296
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 297 KRIEVEQALAHPYLEQYYDPSD 318

>pdb|2FYS|B Chain B, Crystal Structure Of Erk2 Complex With Kim Peptide Derived From Mkp3 Length = 364

Iteration: 1
 Score =  132 bits (333), Expect = 3e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|4B99|A Chain A, Crystal Structure Of Mapk7 (Erk5) With Inhibitor Length = 398

Iteration: 1
 Score =  132 bits (332), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 128/260 (49%), Gaps = 10/260 (3%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           LRE+KIL+  KH+N++ + +I R     Y  ++S  Y+V D  E DL  ++ +     +L
Sbjct: 101 LRELKILKHFKHDNIIAIKDILRPTV-PYGEFKSV-YVVLDLMESDLHQIIHSSQ-PLTL 157
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             ++  + QLL GL Y+HS +++HRD+K +N+L+ +   LK+ DFG+AR    +      
Sbjct: 158 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 217
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
             T  V T WYR PEL+L    Y   +DLW  GCI  EM  R  +  G     Q+ LI  
Sbjct: 218 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 277
Query: 191 LCGSITPE--SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
           + G+ +P      G E +  Y +  LP  Q     E + P   D+             PS
Sbjct: 278 VLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPW-ETVYPGA-DRQALSLLGRMLRFEPS 334
Query: 249 KRFDSDAALNHDFF--WTDP 266
            R  + AAL H F   + DP
Sbjct: 335 ARISAAAALRHPFLAKYHDP 354

>pdb|4H3Q|A Chain A, Crystal Structure Of Human Erk2 Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  132 bits (331), Expect = 4e-31,   Method: Compositional matrix adjust.
 Identities = 92/261 (35%), Positives = 125/261 (47%), Gaps = 9/261 (3%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S 
Sbjct: 71  LREIKILLAFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--SN 125
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +    
Sbjct: 126 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTSDLKICDFGLARV-ADPDHDHTG 184
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
             T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I  
Sbjct: 185 FLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 244
Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPSK 249
           + GS + E       L   N + L    K KV   RL P   D              P K
Sbjct: 245 ILGSPSQEDLNCGINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPHK 302
Query: 250 RFDSDAALNHDFFWTDPMPSD 270
           R + + AL H +      PSD
Sbjct: 303 RIEVEQALAHPYLAQYYDPSD 323

>pdb|3R63|A Chain A, Structure Of Erk2 (Spe) Mutant (S246e) Length = 358

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 125/262 (47%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 66  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 120
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 121 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 180 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 239
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS   E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 240 GILGSPEQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 297
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 298 KRIEVEQALAHPYLEQYYDPSD 319

>pdb|2GPH|A Chain A, Docking Motif Interactions In The Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  132 bits (331), Expect = 5e-31,   Method: Compositional matrix adjust.
 Identities = 92/262 (35%), Positives = 126/262 (48%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKCQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|4IC7|A Chain A, Crystal Structure Of The Erk5 Kinase Domain In Complex With An Mkk5 Binding Fragment Length = 442

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/260 (33%), Positives = 128/260 (49%), Gaps = 10/260 (3%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           LRE+KIL+  KH+N++ + +I R     Y  ++S  Y+V D  E DL  ++ +     +L
Sbjct: 102 LRELKILKHFKHDNIIAIKDILRPTV-PYGEFKSV-YVVLDLMESDLHQIIHSSQ-PLTL 158
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             ++  + QLL GL Y+HS +++HRD+K +N+L+ +   LK+ DFG+AR    +      
Sbjct: 159 EHVRYFLYQLLRGLKYMHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQY 218
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
             T  V T WYR PEL+L    Y   +DLW  GCI  EM  R  +  G     Q+ LI  
Sbjct: 219 FMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIFGEMLARRQLFPGKNYVHQLQLIMM 278
Query: 191 LCGSITPE--SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
           + G+ +P      G E +  Y +  LP  Q     E + P   D+             PS
Sbjct: 279 VLGTPSPAVIQAVGAERVRAYIQ-SLPPRQPVPW-ETVYPGA-DRQALSLLGRMLRFEPS 335
Query: 249 KRFDSDAALNHDFF--WTDP 266
            R  + AAL H F   + DP
Sbjct: 336 ARISAAAALRHPFLAKYHDP 355

>pdb|2ZOQ|A Chain A, Structural Dissection Of Human Mitogen-Activated Kinase Erk1 Length = 382

Iteration: 1
 Score =  131 bits (330), Expect = 6e-31,   Method: Compositional matrix adjust.
 Identities = 86/258 (33%), Positives = 127/258 (49%), Gaps = 9/258 (3%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           LREI+IL   +HENV+ + +I R    +  R     Y+V D  E DL  LL +   + S 
Sbjct: 89  LREIQILLRFRHENVIGIRDILRASTLEAMR---DVYIVQDLMETDLYKLLKS--QQLSN 143
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             I   + Q+L GL YIHS  +LHRD+K +N+LI  T  LK+ DFGLAR  +  ++    
Sbjct: 144 DHICYFLYQILRGLKYIHSANVLHRDLKPSNLLINTTCDLKICDFGLAR-IADPEHDHTG 202
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
             T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I  
Sbjct: 203 FLTEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHILG 262
Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKR 250
           + GS + E    +  +   N ++   ++ +    +L P   D              P+KR
Sbjct: 263 ILGSPSQEDLNCIINMKARNYLQSLPSKTKVAWAKLFPK-SDSKALDLLDRMLTFNPNKR 321
Query: 251 FDSDAALNHDFF--WTDP 266
              + AL H +   + DP
Sbjct: 322 ITVEEALAHPYLEQYYDP 339

>pdb|3ZUV|A Chain A, Crystal Structure Of A Designed Selected Ankyrin Repeat Protein In Complex With The Phosphorylated Map Kinase Erk2 Length = 364

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 125/262 (47%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 72  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 127 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 185
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                 V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 186 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 245
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 246 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 303
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 304 KRIEVEQALAHPYLEQYYDPSD 325

>pdb|2ERK|A Chain A, Phosphorylated Map Kinase Erk2 Length = 365

Iteration: 1
 Score =  131 bits (329), Expect = 8e-31,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 125/262 (47%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     Y+V D  E DL  LL   H+  S
Sbjct: 73  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYIVQDLMETDLYKLLKTQHL--S 127
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 128 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARV-ADPDHDHT 186
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                 V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 187 GFLXEXVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 246
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 247 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 304
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 305 KRIEVEQALAHPYLEQYYDPSD 326

>pdb|1PME|A Chain A, Structure Of Penta Mutant Human Erk2 Map Kinase Complexed With A Specific Inhibitor Of Human P38 Map Kinase Length = 380

Iteration: 1
 Score =  129 bits (324), Expect = 4e-30,   Method: Compositional matrix adjust.
 Identities = 91/262 (34%), Positives = 124/262 (47%), Gaps = 9/262 (3%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     YLV      DL  LL   H+  S
Sbjct: 88  TLREIKILLRFRHENIIGINDIIRAPTIEQMK---DVYLVTHLMGADLYKLLKTQHL--S 142
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR  +   +   
Sbjct: 143 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTXDLKICDFGLARV-ADPDHDHT 201
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 202 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 261
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVK-ERLKPYVKDQYGCXXXXXXXXXXPS 248
            + GS + E    +  L   N + L    K KV   RL P   D              P 
Sbjct: 262 GILGSPSQEDLNCIINLKARNYL-LSLPHKNKVPWNRLFPNA-DSKALDLLDKMLTFNPH 319
Query: 249 KRFDSDAALNHDFFWTDPMPSD 270
           KR + + AL H +      PSD
Sbjct: 320 KRIEVEQALAHPYLEQYYDPSD 341

>pdb|3COI|A Chain A, Crystal Structure Of P38delta Kinase Length = 353

Iteration: 1
 Score =  127 bits (319), Expect = 1e-29,   Method: Compositional matrix adjust.
 Identities = 91/271 (33%), Positives = 132/271 (48%), Gaps = 29/271 (10%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F   A RE+ +L+ ++HENV+ L+++    ++  N Y   FYLV  F + DL  ++   
Sbjct: 65  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY--DFYLVMPFMQTDLQKIMG-- 120
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
            +KFS  +I+ ++ Q+L GL YIHS  ++HRD+K  N+ + +   LK+ DFGLAR     
Sbjct: 121 -LKFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 179
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
             G        VVT WYR PE++L   +Y   VD+W  GCIMAEM T   + +G     Q
Sbjct: 180 MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 232
Query: 185 ITLISQLCGSITPESWPGVETLDLYNK-------MELPKAQKRKVKERLKPYVKDQYGCX 237
           +T I ++ G       PG E +   N          LP+   RK   +L P    Q    
Sbjct: 233 LTQILKVTGV------PGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQ-AAD 284
Query: 238 XXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      KR  +  AL H FF  + DP
Sbjct: 285 LLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

>pdb|2F9G|A Chain A, Crystal Structure Of Fus3 Phosphorylated On Tyr182 Length = 353

Iteration: 1
 Score =  127 bits (318), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F +  LREIKIL+  KHEN++ +  I R   + +  +    Y++ +  + DL  ++S  
Sbjct: 51  LFALRTLREIKILKHFKHENIITIFNIQR--PDSFENFNEV-YIIQELMQTDLHRVIST- 106
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
               S   I+  I Q L  +  +H + ++HRD+K +N+LI     LK+ DFGLAR   ++
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 125 K------NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                   GQ +  T  V T WYR PE++L    Y   +D+W  GCI+AE++ R PI  G
Sbjct: 166 AADNSEPTGQQSGMTEXVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225
Query: 179 NTEQQQITLISQLCGSI----------TPESWPGVETLDLYNKMELPKAQKRKVKERLKP 228
              + Q+ LI  + G+           +P +   +++L +Y     P A   K+  R+ P
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-----PAAPLEKMFPRVNP 280
Query: 229 YVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSD 270
                 G           P+KR  +  AL H +  T   P+D
Sbjct: 281 -----KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317

>pdb|2B9F|A Chain A, Crystal Structure Of Non-Phosphorylated Fus3 Length = 353

Iteration: 1
 Score =  126 bits (317), Expect = 2e-29,   Method: Compositional matrix adjust.
 Identities = 84/282 (29%), Positives = 134/282 (47%), Gaps = 31/282 (10%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F +  LREIKIL+  KHEN++ +  I R   + +  +    Y++ +  + DL  ++S  
Sbjct: 51  LFALRTLREIKILKHFKHENIITIFNIQR--PDSFENFNEV-YIIQELMQTDLHRVIST- 106
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
               S   I+  I Q L  +  +H + ++HRD+K +N+LI     LK+ DFGLAR   ++
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 125 K------NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                   GQ +  T  V T WYR PE++L    Y   +D+W  GCI+AE++ R PI  G
Sbjct: 166 AADNSEPTGQQSGMTEYVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225
Query: 179 NTEQQQITLISQLCGSI----------TPESWPGVETLDLYNKMELPKAQKRKVKERLKP 228
              + Q+ LI  + G+           +P +   +++L +Y     P A   K+  R+ P
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-----PAAPLEKMFPRVNP 280
Query: 229 YVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSD 270
                 G           P+KR  +  AL H +  T   P+D
Sbjct: 281 -----KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317

>pdb|4EXU|A Chain A, Mapk13, Inactive Form Length = 371

Iteration: 1
 Score =  125 bits (315), Expect = 4e-29,   Method: Compositional matrix adjust.
 Identities = 90/271 (33%), Positives = 132/271 (48%), Gaps = 29/271 (10%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F   A RE+ +L+ ++HENV+ L+++    ++  N Y   FYLV  F + DL  ++   
Sbjct: 83  IFAKRAYRELLLLKHMQHENVIGLLDVFTPASSLRNFY--DFYLVMPFMQTDLQKIMG-- 138
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
            ++FS  +I+ ++ Q+L GL YIHS  ++HRD+K  N+ + +   LK+ DFGLAR     
Sbjct: 139 -MEFSEEKIQYLVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE 197
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
             G        VVT WYR PE++L   +Y   VD+W  GCIMAEM T   + +G     Q
Sbjct: 198 MTG-------YVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQ 250
Query: 185 ITLISQLCGSITPESWPGVETLDLYNK-------MELPKAQKRKVKERLKPYVKDQYGCX 237
           +T I ++ G       PG E +   N          LP+   RK   +L P    Q    
Sbjct: 251 LTQILKVTGV------PGTEFVQKLNDKAAKSYIQSLPQT-PRKDFTQLFPRASPQ-AAD 302
Query: 238 XXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      KR  +  AL H FF  + DP
Sbjct: 303 LLEKMLELDVDKRLTAAQALTHPFFEPFRDP 333

>pdb|2B9H|A Chain A, Crystal Structure Of Fus3 With A Docking Motif From Ste7 Length = 353

Iteration: 1
 Score =  124 bits (311), Expect = 1e-28,   Method: Compositional matrix adjust.
 Identities = 83/282 (29%), Positives = 133/282 (47%), Gaps = 31/282 (10%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F +  LREIKIL+  KHEN++ +  I R   + +  +    Y++ +  + DL  ++S  
Sbjct: 51  LFALRTLREIKILKHFKHENIITIFNIQR--PDSFENFNEV-YIIQELMQTDLHRVIST- 106
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
               S   I+  I Q L  +  +H + ++HRD+K +N+LI     LK+ DFGLAR   ++
Sbjct: 107 -QMLSDDHIQYFIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165
Query: 125 K------NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                   GQ +     V T WYR PE++L    Y   +D+W  GCI+AE++ R PI  G
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225
Query: 179 NTEQQQITLISQLCGSI----------TPESWPGVETLDLYNKMELPKAQKRKVKERLKP 228
              + Q+ LI  + G+           +P +   +++L +Y     P A   K+  R+ P
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMY-----PAAPLEKMFPRVNP 280
Query: 229 YVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSD 270
                 G           P+KR  +  AL H +  T   P+D
Sbjct: 281 -----KGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPND 317

>pdb|1CM8|A Chain A, Phosphorylated Map Kinase P38-Gamma Length = 367

Iteration: 1
 Score =  123 bits (308), Expect = 2e-28,   Method: Compositional matrix adjust.
 Identities = 75/217 (34%), Positives = 118/217 (54%), Gaps = 12/217 (5%)
Query: 5   FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
            F   A RE+++L+ ++HENV+ L+++  T     + + + FYLV  F   DL  L+   
Sbjct: 66  LFAKRAYRELRLLKHMRHENVIGLLDVF-TPDETLDDF-TDFYLVMPFMGTDLGKLMK-- 121
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H K     I+ ++ Q+L GL YIH+  I+HRD+K  N+ + +   LK+ DFGLAR     
Sbjct: 122 HEKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
             G V       VT WYR PE++L    Y   VD+W  GCIMAEM T   + +G+    Q
Sbjct: 182 MXGXV-------VTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234
Query: 185 ITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKR 220
           +  I ++ G+   E    +++ +  N M+ LP+ +K+
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKK 271

>pdb|2I6L|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 6 (Mapk6) Length = 320

Iteration: 1
 Score =  122 bits (306), Expect = 4e-28,   Method: Compositional matrix adjust.
 Identities = 91/275 (33%), Positives = 131/275 (47%), Gaps = 26/275 (9%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYN------RYRSTFYLVFDFCEHDLAGLLSN 63
           ALREIKI++ L H+N+V + EI     +Q           ++ Y+V ++ E DLA +L  
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114
Query: 64  IHVKFSLGEIKKVIQ-QLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAF 121
             +   L E  ++   QLL GL YIHS  +LHRD+K AN+ I T+  +LK+ DFGLAR  
Sbjct: 115 GPL---LEEHARLFMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIM 171
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
               + +    +  +VT WYR P LLL   NY   +D+W AGCI AEM T   +  G  E
Sbjct: 172 DPHYSHK-GHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFAGAHE 230
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVK-----DQYG 235
            +Q+ LI         ES P V   D    +  +P   +  + E  KP  +      +  
Sbjct: 231 LEQMQLIL--------ESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLLPGISREA 282
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFFWTDPMPSD 270
                      P  R  ++ AL+H +      P D
Sbjct: 283 VDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD 317

>pdb|3OZ6|A Chain A, Crystal Structure Of Mapk From Cryptosporidium Parvum, Cgd2_1960 Length = 388

Iteration: 1
 Score =  119 bits (298), Expect = 4e-27,   Method: Compositional matrix adjust.
 Identities = 87/293 (29%), Positives = 137/293 (46%), Gaps = 57/293 (19%)
Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSN 63
             REI IL +L  HEN+V+L+ + R   ++        YLVFD+ E DL     A +L  
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDR------DVYLVFDYMETDLHAVIRANILEP 108
Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
           +H ++       V+ QL+  + Y+HS  +LHRDMK +N+L+     +K+ADFGL+R+F  
Sbjct: 109 VHKQY-------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161
Query: 124 TK----------NGQVNRY-------TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
            +          N     +       T+ V T WYR PE+LLG   Y   +D+W  GCI+
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221
Query: 167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETL----------DLYNKMELPK 216
            E+    PI  G++   Q   + ++ G I   S   VE++           L  K+E+ +
Sbjct: 222 GEILCGKPIFPGSSTMNQ---LERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQ 278
Query: 217 AQKRKVKERLKPY---VKDQYGCXXXX-----XXXXXXPSKRFDSDAALNHDF 261
           + KR +  + K     +  +  C               P+KR  ++ AL H F
Sbjct: 279 SNKRDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPF 331

>pdb|3GC9|A Chain A, The Structure Of P38beta C119s, C162s In Complex With A Dihydroquinazolinone Inhibitor Length = 370

Iteration: 1
 Score =  118 bits (295), Expect = 7e-27,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 105/192 (54%), Gaps = 21/192 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ LKHENV+ L+++  T A     + S  YLV      DL  +     LS+ HV
Sbjct: 76  RELRLLKHLKHENVIGLLDVF-TPATSIEDF-SEVYLVTTLMGADLNNIVKSQALSDEHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       ++ QLL GL YIHS  I+HRD+K +NV + +   L++ DFGLAR   +   
Sbjct: 134 QF-------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT 186
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+     +  G+    Q+ 
Sbjct: 187 GYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 239
Query: 187 LISQLCGSITPE 198
            I ++ G+ +PE
Sbjct: 240 RIMEVVGTPSPE 251

>pdb|3GC8|A Chain A, The Structure Of P38beta C162s In Complex With A Dihydroquinazolinone Length = 370

Iteration: 1
 Score =  118 bits (295), Expect = 8e-27,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 105/192 (54%), Gaps = 21/192 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ LKHENV+ L+++  T A     + S  YLV      DL  +     LS+ HV
Sbjct: 76  RELRLLKHLKHENVIGLLDVF-TPATSIEDF-SEVYLVTTLMGADLNNIVKCQALSDEHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       ++ QLL GL YIHS  I+HRD+K +NV + +   L++ DFGLAR   +   
Sbjct: 134 QF-------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDSELRILDFGLARQADEEMT 186
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+     +  G+    Q+ 
Sbjct: 187 GYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 239
Query: 187 LISQLCGSITPE 198
            I ++ G+ +PE
Sbjct: 240 RIMEVVGTPSPE 251

>pdb|4E5A|X Chain X, The W197a Mutant Of P38a Map Kinase Length = 360

Iteration: 1
 Score =  117 bits (292), Expect = 1e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNAMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3GP0|A Chain A, Crystal Structure Of Human Mitogen Activated Protein Kinase 11 (p38 Beta) In Complex With Nilotinib Length = 348

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 71/192 (36%), Positives = 105/192 (54%), Gaps = 21/192 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ LKHENV+ L+++  T A     + S  YLV      DL  +     LS+ HV
Sbjct: 68  RELRLLKHLKHENVIGLLDVF-TPATSIEDF-SEVYLVTTLMGADLNNIVKCQALSDEHV 125
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       ++ QLL GL YIHS  I+HRD+K +NV + +   L++ DFGLAR   +   
Sbjct: 126 QF-------LVYQLLRGLKYIHSAGIIHRDLKPSNVAVNEDCELRILDFGLARQADEEMT 178
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+     +  G+    Q+ 
Sbjct: 179 GYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLQGKALFPGSDYIDQLK 231
Query: 187 LISQLCGSITPE 198
            I ++ G+ +PE
Sbjct: 232 RIMEVVGTPSPE 243

>pdb|1OVE|A Chain A, The Structure Of P38 Alpha In Complex With A Dihydroquinolinone Length = 366

Iteration: 1
 Score =  117 bits (292), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 76  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 134 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD---- 182
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 183 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 239
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 240 LILRLVGT------PGAELL 253

>pdb|2Y8O|A Chain A, Crystal Structure Of Human P38alpha Complexed With A Mapk Docking Peptide Length = 362

Iteration: 1
 Score =  116 bits (291), Expect = 2e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 72  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 129
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 130 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLARHTD---- 178
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 179 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 235
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 236 LILRLVGT------PGAELL 249

>pdb|3D83|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKXQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|2FST|X Chain X, Mitogen Activated Protein Kinase P38alpha (d176a+f327l) Activating Mutant Length = 367

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 107/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 77  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR  +    
Sbjct: 135 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---- 183
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 184 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 241 LILRLVGT------PGAELL 254

>pdb|2FSO|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a) Activating Mutant Length = 367

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 107/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 77  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR  +    
Sbjct: 135 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---- 183
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 184 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 241 LILRLVGT------PGAELL 254

>pdb|2BAL|A Chain A, P38alpha Map Kinase Bound To Pyrazoloamine Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 75  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 132
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 133 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---- 181
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 182 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 238
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 239 LILRLVGT------PGAELL 252

>pdb|2FSL|X Chain X, Mitogen Activated Protein Kinase P38alpha (D176a+f327s) Activating Mutant Form-A Length = 367

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 107/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 77  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR  +    
Sbjct: 135 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTA---- 183
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 184 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 241 LILRLVGT------PGAELL 254

>pdb|2BAQ|A Chain A, P38alpha Bound To Ro3201195 Length = 365

Iteration: 1
 Score =  116 bits (290), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 75  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 132
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 133 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---- 181
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 182 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 238
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 239 LILRLVGT------PGAELL 252

>pdb|3E92|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biaryl Amide Inhibitor Length = 371

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 81  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 138
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 139 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDXELKILDFGLARHTD---- 187
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 188 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 244
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 245 LILRLVGT------PGAELL 258

>pdb|3NNX|A Chain A, Crystal Structure Of Phosphorylated P38 Alpha In Complex With Dp802 Length = 354

Iteration: 1
 Score =  115 bits (289), Expect = 3e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGXVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3D7Z|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Biphenyl Amide Inhibitor Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKXQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|1IAN|A Chain A, Human P38 Map Kinase Inhibitor Complex Length = 366

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 76  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 134 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 182
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 183 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 239
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 240 LILRLVGT------PGAELL 253

>pdb|1LEW|A Chain A, Crystal Structure Of Map Kinase P38 Complexed To The Docking Site On Its Nuclear Substrate Mef2a Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|1M7Q|A Chain A, Crystal Structure Of P38 Map Kinase In Complex With A Dihydroquinazolinone Inhibitor Length = 366

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 76  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 134 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 182
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 183 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 239
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 240 LILRLVGT------PGAELL 253

>pdb|1DI9|A Chain A, The Structure Of P38 Mitogen-Activated Protein Kinase In Complex With 4-[3-Methylsulfanylanilino]-6,7- Dimethoxyquinazoline Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3OEF|X Chain X, Crystal Structure Of Y323f Inactive Mutant Of P38alpha Map Kinase Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3OD6|X Chain X, Crystal Structure Of P38alpha Y323t Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|2BAJ|A Chain A, P38alpha Bound To Pyrazolourea Length = 365

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 75  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 132
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 133 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 181
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 182 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 238
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 239 LILRLVGT------PGAELL 252

>pdb|3ODZ|X Chain X, Crystal Structure Of P38alpha Y323r Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3P4K|A Chain A, The Third Conformation Of P38a Map Kinase Observed In Phosphorylated P38a And In Solution Length = 370

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 80  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 137
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 138 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 186
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 187 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 243
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 244 LILRLVGT------PGAELL 257

>pdb|3HRB|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 359

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 69  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 126
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 127 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 175
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 176 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 232
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 233 LILRLVGT------PGAELL 246

>pdb|2OZA|B Chain B, Structure Of P38alpha Complex Length = 366

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 76  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 134 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 182
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 183 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 239
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 240 LILRLVGT------PGAELL 253

>pdb|3ODY|X Chain X, Crystal Structure Of P38alpha Y323q Active Mutant Length = 360

Iteration: 1
 Score =  115 bits (289), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|2NPQ|A Chain A, A Novel Lipid Binding Site In The P38 Alpha Map Kinase Length = 367

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 77  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 134
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 135 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 183
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 184 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 240
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 241 LILRLVGT------PGAELL 254

>pdb|3DT1|A Chain A, P38 Complexed With A Quinazoline Inhibitor Length = 383

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 93  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 150
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 151 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 199
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 200 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 256
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 257 LILRLVGT------PGAELL 270

>pdb|2LGC|A Chain A, Joint Nmr And X-Ray Refinement Reveals The Structure Of A Novel Dibenzo[a,D]cycloheptenone InhibitorP38 MAP KINASE COMPLEX IN Solution Length = 359

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 75  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 132
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 133 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 181
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 182 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 238
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 239 LILRLVGT------PGAELL 252

>pdb|3TG1|A Chain A, Crystal Structure Of P38alpha In Complex With A Mapk Docking Partner Length = 380

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 90  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 147
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 148 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 196
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 197 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 253
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 254 LILRLVGT------PGAELL 267

>pdb|3KQ7|A Chain A, Structure Of Human P38alpha With N-[4-Methyl-3-(6-{[2-(1- Methylpyrrolidin-2-Yl)ethyl]amino}pyridine-3- Amido)phenyl]- 2-(Morpholin-4-Yl)pyridine-4-Carboxamide Length = 380

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 90  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 147
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 148 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 196
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 197 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 253
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 254 LILRLVGT------PGAELL 267

>pdb|3GCU|A Chain A, Human P38 Map Kinase In Complex With Rl48 Length = 360

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3ZSG|A Chain A, X-Ray Structure Of P38alpha Bound To Tak-715 Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 72  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 129
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 130 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 178
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 179 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 235
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 236 LILRLVGT------PGAELL 249

>pdb|3FI4|A Chain A, P38 Kinase Crystal Structure In Complex With Ro4499 Length = 372

Iteration: 1
 Score =  115 bits (288), Expect = 4e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 82  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 139
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 140 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 188
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 189 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 245
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 246 LILRLVGT------PGAELL 259

>pdb|1OZ1|A Chain A, P38 Mitogen-Activated Kinase In Complex With 4-Azaindole Inhibitor Length = 372

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 82  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 139
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 140 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 188
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 189 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 245
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 246 LILRLVGT------PGAELL 259

>pdb|3S3I|A Chain A, P38 Kinase Crystal Structure In Complex With Small Molecule Inhibitor Length = 349

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 67  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 124
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 125 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 173
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 174 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 230
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 231 LILRLVGT------PGAELL 244

>pdb|2GFS|A Chain A, P38 Kinase Crystal Structure In Complex With Ro3201195 Length = 372

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 82  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 139
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 140 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 188
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 189 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 245
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 246 LILRLVGT------PGAELL 259

>pdb|3MPT|A Chain A, Crystal Structure Of P38 Kinase In Complex With A Pyrrole-2- Carboxamide Inhibitor Length = 371

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 81  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 138
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 139 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 187
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 188 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 244
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 245 LILRLVGT------PGAELL 258

>pdb|3HVC|A Chain A, Crystal Structure Of Human P38alpha Map Kinase Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 72  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 129
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 130 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 178
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 179 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 235
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 236 LILRLVGT------PGAELL 249

>pdb|1ZZL|A Chain A, Crystal Structure Of P38 With Triazolopyridine Length = 351

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 67  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 124
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 125 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 173
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 174 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 230
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 231 LILRLVGT------PGAELL 244

>pdb|2PUU|A Chain A, Crystal Structure Of P38 Complex With 1-(5-Tert-Butyl-2-P- Tolyl-2h-Pyrazol-3-Yl)-3-[4-(6-Morpholin-4-Ylmethyl- Pyridin-3-Yl)naphthalen-1-Yl]urea Length = 348

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 66  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCAKLTDDHV 123
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 124 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 230 LILRLVGT------PGAELL 243

>pdb|3NNU|A Chain A, Crystal Structure Of P38 Alpha In Complex With Dp1376 Length = 354

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3K3J|A Chain A, P38alpha Bound To Novel Dfg-Out Compound Pf-00416121 Length = 362

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 72  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 129
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 130 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 178
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 179 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 235
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 236 LILRLVGT------PGAELL 249

>pdb|1BL6|A Chain A, The Complex Structure Of The Map Kinase P38SB216995 Length = 379

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 89  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 146
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 147 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 195
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 196 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 252
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 253 LILRLVGT------PGAELL 266

>pdb|1BMK|A Chain A, The Complex Structure Of The Map Kinase P38SB218655 Length = 379

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 89  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 146
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 147 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 195
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 196 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 252
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 253 LILRLVGT------PGAELL 266

>pdb|3HEC|A Chain A, P38 In Complex With Imatinib Length = 348

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 66  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 124 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 230 LILRLVGT------PGAELL 243

>pdb|2GTM|A Chain A, Mutated Mouse P38 Map Kinase Domain In Complex With Inhibitor Pg-892579 Length = 348

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 66  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 124 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 172
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 173 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 230 LILRLVGT------PGAELL 243

>pdb|3K3I|A Chain A, P38alpha Bound To Novel Dgf-Out Compound Pf-00215955 Length = 350

Iteration: 1
 Score =  115 bits (288), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 68  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 125
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 126 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 174
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 175 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 231
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 232 LILRLVGT------PGAELL 245

>pdb|3PY3|A Chain A, Crystal Structure Of Phosphorylated P38alpha Map Kinase Length = 380

Iteration: 1
 Score =  115 bits (287), Expect = 5e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 90  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 147
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 148 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX 200
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 201 GXV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 253
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 254 LILRLVGT------PGAELL 267

>pdb|4EWQ|A Chain A, Human P38 Alpha Mapk In Complex With A Pyridazine Based Inhibitor Length = 383

Iteration: 1
 Score =  115 bits (287), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 93  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 150
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 151 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMX 203
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G V        T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 204 GYV-------ATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 256
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 257 LILRLVGT------PGAELL 270

>pdb|3GCP|A Chain A, Human P38 Map Kinase In Complex With Sb203580 Length = 360

Iteration: 1
 Score =  114 bits (286), Expect = 7e-26,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKSQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGL R       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDSELKILDFGLCRHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|1YW2|A Chain A, Mutated Mus Musculus P38 Kinase (Mp38) Length = 360

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA 180
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G        V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 181 G-------FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|1YWR|A Chain A, Crystal Structure Analysis Of Inactive P38 Kinase Domain In Complex With A Monocyclic Pyrazolone Inhibitor Length = 360

Iteration: 1
 Score =  114 bits (286), Expect = 8e-26,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA 180
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G        V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 181 G-------FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3MH2|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 106/200 (53%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ D+GLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDYGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|2GHL|A Chain A, Mutant Mus Musculus P38 Kinase Domain In Complex With Inhibitor Pg-874743 Length = 348

Iteration: 1
 Score =  114 bits (285), Expect = 1e-25,   Method: Compositional matrix adjust.
 Identities = 73/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 66  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 123
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 124 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDEMA 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G        V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 G-------FVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 229
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 230 LILRLVGT------PGAELL 243

>pdb|3O8P|A Chain A, Conformational Plasticity Of P38 Map Kinase Dfg Motif Mutants In Response To Inhibitor Binding Length = 360

Iteration: 1
 Score =  112 bits (281), Expect = 3e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+  FGLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILGFGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3MH0|A Chain A, Mutagenesis Of P38 Map Kinase Eshtablishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  112 bits (280), Expect = 4e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ D GLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDAGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3GI3|A Chain A, Crystal Structure Of A N-Phenyl-N'-Naphthylurea Analog In Complex With P38 Map Kinase Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DF LAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFYLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3MH3|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ D GLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDRGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3MH1|A Chain A, Mutagenesis Of P38 Map Kinase Establishes Key Roles Of Phe169 In Function And Structural Dynamics And Reveals A Novel Dfg-Out State Length = 360

Iteration: 1
 Score =  112 bits (279), Expect = 5e-25,   Method: Compositional matrix adjust.
 Identities = 72/200 (36%), Positives = 105/200 (52%), Gaps = 27/200 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 70  RELRLLKHMKHENVIGLLDVF-TPARSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ D GLAR       
Sbjct: 128 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDGGLARHTD---- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 177 ---DEMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLK 233
Query: 187 LISQLCGSITPESWPGVETL 206
           LI +L G+      PG E L
Sbjct: 234 LILRLVGT------PGAELL 247

>pdb|3OHT|A Chain A, Crystal Structure Of Salmo Salar P38alpha Length = 389

Iteration: 1
 Score =  112 bits (279), Expect = 6e-25,   Method: Compositional matrix adjust.
 Identities = 86/267 (32%), Positives = 126/267 (47%), Gaps = 34/267 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL-----LSNIHV 66
           RE+++L+ +KHENV+ L+++  T A     +    YLV      DL  +     L++ HV
Sbjct: 99  RELRLLKHMKHENVIGLLDVF-TPATSLEEFNDV-YLVTHLMGADLNNIVKCQKLTDDHV 156
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR       
Sbjct: 157 QF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTD---- 205
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              +  T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ 
Sbjct: 206 ---DEMTGYVATRWYRAPEIMLNWMHYNMTVDIWSVGCIMAELLTGRTLFPGTDHINQLQ 262
Query: 187 LISQLCGSITPES----WPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCXXXXX 241
            I +L G+  P S     P  E  +  N + ++PK     V     P   D         
Sbjct: 263 QIMRLTGT-PPASVISRMPSHEARNYINSLPQMPKRNFADVFIGANPLAVD-----LLEK 316
Query: 242 XXXXXPSKRFDSDAALNHDFF--WTDP 266
                  KR  +  AL H +F  + DP
Sbjct: 317 MLVLDTDKRITASEALAHPYFSQYHDP 343

>pdb|3E7O|A Chain A, Crystal Structure Of Jnk2 Length = 360

Iteration: 1
 Score =  107 bits (266), Expect = 2e-23,   Method: Compositional matrix adjust.
 Identities = 78/280 (27%), Positives = 127/280 (45%), Gaps = 37/280 (13%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +L+ + H+N++ L+ +  T       ++   YLV +  +   A L   IH++  
Sbjct: 68  AYRELVLLKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIHMELD 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR  S   N  +
Sbjct: 123 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAS--TNFMM 180
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
             Y   VVT +YR PE++LG   Y   VD+W  GCIM E+   S I QG     Q   + 
Sbjct: 181 TPY---VVTRYYRAPEVILG-MGYKENVDIWSVGCIMGELVKGSVIFQGTDHIDQWNKVI 236
Query: 190 QLCGSITPE-----------------SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
           +  G+ + E                 ++PG+   +L+     P   +R         +K 
Sbjct: 237 EQLGTPSAEFMAALQPTVRNYVENRPAYPGIAFEELFPDWIFPSESERD-------KIKT 289
Query: 233 QYGCXXXXXXXXXXPSKRFDSDAALNHDFF--WTDPMPSD 270
                         P KR   D AL H +   W DP  ++
Sbjct: 290 SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 329

>pdb|3RP9|A Chain A, Crystal Structure Of The Apo Mapk From Toxoplasma Gondii, 25.M01780 Or Tgme49_007820 Length = 458

Iteration: 1
 Score =  106 bits (264), Expect = 3e-23,   Method: Compositional matrix adjust.
 Identities = 84/308 (27%), Positives = 127/308 (41%), Gaps = 63/308 (20%)
Query: 11  LREIKILQLLKHENVVHLIEICRTK-ANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           LREI IL  L H++VV +++I   K   +++      Y+V +  + D   L     V  +
Sbjct: 100 LREIAILNRLNHDHVVKVLDIVIPKDVEKFDE----LYVVLEIADSDFKKLFRTP-VYLT 154
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              IK ++  LL G+ Y+HS  ILHRD+K AN L+ +   +K+ DFGLAR     +NG  
Sbjct: 155 ELHIKTLLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNS 214
Query: 130 N-----------------------RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
                                   + T  VVT WYR PEL+L   NY   +D+W  GCI 
Sbjct: 215 QLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEAIDVWSIGCIF 274
Query: 167 AEMWT-----------RSPIMQGNT--------------------EQQQITLISQLCGSI 195
           AE+             R P+  G++                     + Q+ +I  + G+ 
Sbjct: 275 AELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILGTP 334
Query: 196 TPESWPGVETLDLYNKMEL-PKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSD 254
           + E    +E  D    + + PK +   + ER      D              P+KR   +
Sbjct: 335 SEEDIEALEKEDAKRYIRIFPKREGTDLAERFPASSAD--AIHLLKRMLVFNPNKRITIN 392
Query: 255 AALNHDFF 262
             L H FF
Sbjct: 393 ECLAHPFF 400

>pdb|3UIB|A Chain A, Map Kinase Lmampk10 From Leishmania Major In Complex With Sb203580 Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 26/277 (9%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREI++L    H N++ L +I     +         YLV +    DLA ++ +  +  S
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIF---VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I+  +  +L GL+ +H   ++HRD+   N+L+     + + DF LAR  +   N   
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T+ V   WYR PEL++  + +   VD+W AGC+MAEM+ R  + +G+T   Q+  I 
Sbjct: 191 ---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQK------RKVKERLKPYV---KDQYGCXXXX 240
           ++ G+      P +E + +++    P A+         V  R    V    D        
Sbjct: 248 EVVGT------PKIEDVVMFSS---PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
Query: 241 XXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 277
                 P +R  ++ AL H +F +   P DL++ L++
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE 335

>pdb|3PG1|A Chain A, Map Kinase Lmampk10 From Leishmania Major (1.95 Angs Resolution) Length = 362

Iteration: 1
 Score =  105 bits (263), Expect = 4e-23,   Method: Compositional matrix adjust.
 Identities = 74/277 (26%), Positives = 128/277 (46%), Gaps = 26/277 (9%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREI++L    H N++ L +I     +         YLV +    DLA ++ +  +  S
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIF---VHFEEPAMHKLYLVTELMRTDLAQVIHDQRIVIS 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I+  +  +L GL+ +H   ++HRD+   N+L+     + + DF LAR  +   N   
Sbjct: 133 PQHIQYFMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADANK-- 190
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T+ V   WYR PEL++  + +   VD+W AGC+MAEM+ R  + +G+T   Q+  I 
Sbjct: 191 ---THYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFYNQLNKIV 247
Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQK------RKVKERLKPYV---KDQYGCXXXX 240
           ++ G+      P +E + +++    P A+         V  R    V    D        
Sbjct: 248 EVVGT------PKIEDVVMFSS---PSARDYLRNSLSNVPARAWTAVVPTADPVALDLIA 298
Query: 241 XXXXXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 277
                 P +R  ++ AL H +F +   P DL++ L++
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDPLDLTEGLSE 335

>pdb|3NPC|A Chain A, Crystal Structure Of Jnk2 Complexed With Birb796 Length = 364

Iteration: 1
 Score =  105 bits (261), Expect = 7e-23,   Method: Compositional matrix adjust.
 Identities = 76/280 (27%), Positives = 126/280 (45%), Gaps = 37/280 (13%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +L+ + H+N++ L+ +  T       ++   YLV +  +   A L   IH++  
Sbjct: 70  AYRELVLLKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIHMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR  +   N  +
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLAR--TACTNFMM 182
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
             Y   VVT +YR PE++LG   Y   VD+W  GCIM E+     I QG     Q   + 
Sbjct: 183 TPY---VVTRYYRAPEVILG-MGYAANVDIWSVGCIMGELVKGCVIFQGTDHIDQWNKVI 238
Query: 190 QLCGSITPE-----------------SWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
           +  G+ + E                  +PG++  +L+     P   +R         +K 
Sbjct: 239 EQLGTPSAEFMAALQPTVRNYVENRPKYPGIKFEELFPDWIFPSESERD-------KIKT 291
Query: 233 QYGCXXXXXXXXXXPSKRFDSDAALNHDFF--WTDPMPSD 270
                         P KR   D AL H +   W DP  ++
Sbjct: 292 SQARDLLSKMLVIDPDKRISVDEALRHPYITVWYDPAEAE 331

>pdb|3N9X|A Chain A, Crystal Structure Of Map Kinase From Plasmodium Berghei, Pb000659.00.0 Length = 432

Iteration: 1
 Score =  100 bits (248), Expect = 2e-21,   Method: Compositional matrix adjust.
 Identities = 78/300 (26%), Positives = 131/300 (43%), Gaps = 55/300 (18%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           LREI IL  LK + ++ L + I      +++      Y+V +  + DL  L     +  +
Sbjct: 73  LREITILNRLKSDYIIRLYDLIIPDDLLKFDE----LYIVLEIADSDLKKLFKT-PIFLT 127
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              IK ++  LL G  +IH + I+HRD+K AN L+ +   +K+ DFGLAR  +  K+  +
Sbjct: 128 EEHIKTILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNI 187
Query: 130 ------------------NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW- 170
                              + T+ VVT WYR PEL+L   NY   +D+W  GCI AE+  
Sbjct: 188 VNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCIFAELLN 247
Query: 171 ----------TRSPIMQGN-----------------TEQQQITLISQLCGSITPESWPGV 203
                      R P+  G+                 + + Q+ +I  + G+ T +    +
Sbjct: 248 MLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLKNI 307
Query: 204 ETLDLYNKMEL-PKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNHDFF 262
              ++   ++L P  +   +K++  P + D  G           P+KR   D AL+H + 
Sbjct: 308 NKPEVIKYIKLFPHRKPINLKQKY-PSISDD-GINLLESMLKFNPNKRITIDQALDHPYL 365

>pdb|4E7W|A Chain A, Structure Of Gsk3 From Ustilago Maydis Length = 394

Iteration: 1
 Score = 97.4 bits (241), Expect = 1e-20,   Method: Compositional matrix adjust.
 Identities = 71/256 (27%), Positives = 123/256 (48%), Gaps = 16/256 (6%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL---AGLLSNIHVKF 68
           RE++I++++KH NVV L     +  ++ +       LV ++    +   +   + +    
Sbjct: 81  RELQIMRIVKHPNVVDLKAFFYSNGDKKDEV--FLNLVLEYVPETVYRASRHYAKLKQTM 138
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  IK  + QLL  L YIHS  I HRD+K  N+L+   +G+LKL DFG A+       G
Sbjct: 139 PMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIA---G 195
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  NY   +D+W  GC+MAE+    P+  G +   Q+  
Sbjct: 196 EPN--VSXICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLVE 253
Query: 188 ISQLCGSITPESWPGVETLDL-YNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXX 246
           I ++ G+ + E    ++T++  Y + + P+ +     +  +P                  
Sbjct: 254 IIKVLGTPSREQ---IKTMNPNYMEHKFPQIRPHPFSKVFRPRTPPD-AIDLISRLLEYT 309
Query: 247 PSKRFDSDAALNHDFF 262
           PS R  +  AL H FF
Sbjct: 310 PSARLTAIEALCHPFF 325

>pdb|3VUK|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M5 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++++ H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|3VUI|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 95.9 bits (237), Expect = 4e-20,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 100/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++++ H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|3FI3|A Chain A, Crystal Structure Of Jnk3 With Indazole Inhibitor, Sr-3737 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLXQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 239 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 294
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|3KVX|A Chain A, Jnk3 Bound To Aminopyrimidine Inhibitor, Sr-3562 Length = 364

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLXQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 239 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 294
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|2R9S|A Chain A, C-Jun N-Terminal Kinase 3 With 3,5-Disubstituted Quinoline Inhibitor Length = 356

Iteration: 1
 Score = 95.1 bits (235), Expect = 6e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLXQVIQMELD 117
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 118 HERMSYLLYQMLXGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-----AGTS 172
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 287
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 288 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320

>pdb|3F7Z|A Chain A, X-ray Co-crystal Structure Of Glycogen Synthase Kinase 3beta In Complex With An Inhibitor Length = 350

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 63  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 120
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 121 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 177
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 178 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 235
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 236 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 292
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 293 TARLTPLEACAHSFF 307

>pdb|2OW3|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With Bis- (Indole)maleimide Pyridinophane Inhibitor Length = 352

Iteration: 1
 Score = 95.1 bits (235), Expect = 7e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|3VUH|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M3 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|3ZDI|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide And Inhibitor 7d Length = 350

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|3GB2|A Chain A, Gsk3beta Inhibitor Complex Length = 353

Iteration: 1
 Score = 94.7 bits (234), Expect = 8e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 66  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 123
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 124 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 180
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 181 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 238
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 239 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 295
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 296 TARLTPLEACAHSFF 310

>pdb|2O0U|A Chain A, Crystal Structure Of Human Jnk3 Complexed With N-{3-Cyano-6-[3-(1- Piperidinyl)propanoyl]-4,5,6,7-Tetrahydrothieno[2, 3-C]pyridin-2-Yl}- 1-Naphthalenecarboxamide Length = 364

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 239 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 294
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|3ZRK|A Chain A, Identification Of 2-(4-Pyridyl)thienopyridinones As Gsk-3beta Inhibitors Length = 371

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 188
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 189 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 247 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 303
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 304 TARLTPLEACAHSFF 318

>pdb|3FV8|A Chain A, Jnk3 Bound To Piperazine Amide Inhibitor, Sr2774 Length = 355

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLXQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 239 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 294
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|1GNG|A Chain A, Glycogen Synthase Kinase-3 Beta (Gsk3) Complex With Frattide Peptide Length = 378

Iteration: 1
 Score = 94.7 bits (234), Expect = 9e-20,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 81  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 138
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 139 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 195
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 196 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 253
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 254 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 310
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 311 TARLTPLEACAHSFF 325

>pdb|4AFJ|A Chain A, 5-Aryl-4-Carboxamide-1,3-Oxazoles: Potent And Selective Gsk-3 Inhibitors Length = 367

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 70  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 127
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 128 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 184
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 185 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 242
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 243 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 299
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 300 TARLTPLEACAHSFF 314

>pdb|3OXI|A Chain A, Design And Synthesis Of Disubstituted Thiophene And Thiazole Based Inhibitors Of Jnk For The Treatment Of Neurodegenerative Diseases Length = 362

Iteration: 1
 Score = 94.7 bits (234), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 69  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 123
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 124 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 178
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 179 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 237
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 238 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 293
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 294 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 326

>pdb|3SD0|A Chain A, Identification Of A Glycogen Synthase Kinase-3b Inhibitor That Attenuates Hyperactivity In Clock Mutant Mice Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|2O5K|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Benzoimidazol Inhibitor Length = 372

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 75  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 132
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 133 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 189
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 190 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 247
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 248 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 304
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 305 TARLTPLEACAHSFF 319

>pdb|2OK1|A Chain A, Crystal Structure Of Jnk3 Bound To N-Benzyl-4-(4-(3- Chlorophenyl)-1h-Pyrazol-3-Yl)-1h-Pyrrole-2-Carboxamide Length = 365

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 125
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 180
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 240 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 295
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 296 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 328

>pdb|1PMN|A Chain A, Crystal Structure Of Jnk3 In Complex With An Imidazole- Pyrimidine Inhibitor Length = 364

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 71  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 125
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 180
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 239
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 240 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 295
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 296 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 328

>pdb|3F88|A Chain A, Glycogen Synthase Kinase 3beta Inhibitor Complex Length = 349

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 72/257 (28%), Positives = 117/257 (45%), Gaps = 18/257 (7%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL--VFDFCE---HDLAGLLSNIHV 66
           RE++I++ L H N+V L     +   +    +   YL  V D+     + +A   S    
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEK----KDVVYLNLVLDYVPETVYRVARHYSRAKQ 117
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTK 125
              +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q  
Sbjct: 118 TLPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLV 174
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G+ N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+
Sbjct: 175 RGEPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQL 232
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             I ++ G+ T E     E    Y + + P+ +     +  +P    +            
Sbjct: 233 VEIIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEY 289
Query: 246 XPSKRFDSDAALNHDFF 262
            P+ R     A  H FF
Sbjct: 290 TPTARLTPLEACAHSFF 306

>pdb|1UV5|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With 6-Bromoindirubin-3'-Oxime Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|4DIT|A Chain A, Crystal Structure Of Gsk3beta In Complex With A Imidazopyridine Inhibitor Length = 382

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 74  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 131
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 132 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 188
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 189 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 246
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 247 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 303
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 304 TARLTPLEACAHSFF 318

>pdb|3PTG|A Chain A, Design And Synthesis Of A Novel, Orally Efficacious Tri-Substituted Thiophene Based Jnk Inhibitor Length = 363

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 239 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 294
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 295 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 327

>pdb|3TTJ|A Chain A, Crystal Structure Of Jnk3 Complexed With Cc-359, A Jnk Inhibitor For The Prevention Of Ischemia-Reperfusion Injury Length = 464

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 162
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 217
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 332
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 333 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365

>pdb|2B1P|A Chain A, Inhibitor Complex Of Jnk3 Length = 355

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 117
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 172
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 173 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 287
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 288 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 320

>pdb|2EXC|X Chain X, Inhibitor Complex Of Jnk3 Length = 356

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 118
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 173
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 174 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 233 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 288
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 289 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 321

>pdb|3SAY|A Chain A, Crystal Structure Of Human Glycogen Synthase Kinase 3 Beta (Gsk3b) In Complex With Inhibitor 142 Length = 430

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 210
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 211 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 269 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 325
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 326 TARLTPLEACAHSFF 340

>pdb|1JNK|A Chain A, The C-Jun N-Terminal Kinase (Jnk3s) Complexed With Mgamp-Pnp Length = 423

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 162
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 163 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 217
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 218 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 276
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 277 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 332
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 333 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365

>pdb|1O9U|A Chain A, Glycogen Synthase Kinase 3 Beta Complexed With Axin Peptide Length = 350

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPATVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSXICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y +   P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFAFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|4H36|A Chain A, Crystal Structure Of Jnk3 In Complex With Atf2 Peptide Length = 356

Iteration: 1
 Score = 94.4 bits (233), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 76/273 (27%), Positives = 119/273 (43%), Gaps = 31/273 (11%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 64  AYRELVLMKCVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 118
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 173
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 174 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 232
Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPY------VKDQYG 235
           +  G+  PE            VE    Y  +  PK       + L P       +K    
Sbjct: 233 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKL----FPDSLFPADSEHNKLKASQA 288
Query: 236 CXXXXXXXXXXPSKRFDSDAALNHDFF--WTDP 266
                      P+KR   D AL H +   W DP
Sbjct: 289 RDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 321

>pdb|1R0E|A Chain A, Glycogen Synthase Kinase-3 Beta In Complex With 3-Indolyl-4- Arylmaleimide Inhibitor Length = 391

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 67  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 124
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 125 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 181
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 182 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 239
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 240 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 296
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 297 TARLTPLEACAHSFF 311

>pdb|1Q5K|A Chain A, Crystal Structure Of Glycogen Synthase Kinase 3 In Complexed With Inhibitor Length = 414

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 90  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 147
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 148 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 204
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 205 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 262
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 263 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 319
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 320 TARLTPLEACAHSFF 334

>pdb|1H8F|A Chain A, Glycogen Synthase Kinase 3 Beta. Length = 352

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 115/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEV--YLNLVLDYVPETVYRVARHYSRAKQTL 119
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y +   P+ +     +  +P    +             P
Sbjct: 235 IIKVLGTPTREQI--REMNPNYTEFAFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>pdb|1I09|A Chain A, Structure Of Glycogen Synthase Kinase-3 (Gsk3b) Length = 420

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 96  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 153
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 154 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 210
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 211 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 268
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 269 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 325
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 326 TARLTPLEACAHSFF 340

>pdb|1PYX|A Chain A, Gsk-3 Beta Complexed With Amp-Pnp Length = 422

Iteration: 1
 Score = 94.0 bits (232), Expect = 1e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 98  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 155
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 156 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 212
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 213 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 270
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 271 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 327
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 328 TARLTPLEACAHSFF 342

>pdb|4ACC|A Chain A, Gsk3b In Complex With Inhibitor Length = 465

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 141 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 198
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 199 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 255
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 256 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 313
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 314 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 370
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 371 TARLTPLEACAHSFF 385

>pdb|3VUG|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M2 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 94.0 bits (232), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|3VUD|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 97/189 (51%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|1Q3D|A Chain A, Gsk-3 Beta Complexed With Staurosporine Length = 424

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 71/255 (27%), Positives = 116/255 (45%), Gaps = 14/255 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE---HDLAGLLSNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+     + +A   S      
Sbjct: 100 RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 157
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   Q   G
Sbjct: 158 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAK---QLVRG 214
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
           + N   + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 215 EPN--VSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 272
Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +             P
Sbjct: 273 IIKVLGTPTREQI--REMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 329
Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 330 TARLTPLEACAHSFF 344

>pdb|3V3V|A Chain A, Structural And Functional Analysis Of Quercetagetin, A Natural Jnk1 Inhibitor Length = 379

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPEVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 239 EQLGTPCPE 247

>pdb|3PZE|A Chain A, Jnk1 In Complex With Inhibitor Length = 358

Iteration: 1
 Score = 93.6 bits (231), Expect = 2e-19,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 64  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 118
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 119 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 173
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VDLW  GCIM EM     +  G     Q   + 
Sbjct: 174 FMMTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 232
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 233 EQLGTPCPE 241

>pdb|3ELJ|A Chain A, Jnk1 Complexed With A Bis-Anilino-Pyrrolopyrimidine Inhibitor Length = 369

Iteration: 1
 Score = 93.2 bits (230), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 75  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 130 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 184
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VDLW  GCIM EM     +  G     Q   + 
Sbjct: 185 FMMTPYVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 243
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 244 EQLGTPCPE 252

>pdb|2XRW|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 371

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 125
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 126 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 180
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 181 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 239
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 240 EQLGTPCPE 248

>pdb|1UKH|A Chain A, Structural Basis For The Selective Inhibition Of Jnk1 By The Scaffolding Protein Jip1 And Sp600125 Length = 369

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 239 EQLGTPCPE 247

>pdb|3FI2|A Chain A, Crystal Structure Of Jnk3 With Amino-Pyrazole Inhibitor, Sr- 3451 Length = 353

Iteration: 1
 Score = 92.8 bits (229), Expect = 3e-19,   Method: Compositional matrix adjust.
 Identities = 58/189 (30%), Positives = 96/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   YLV +  +   A L   I ++  
Sbjct: 70  AYRELVLMKXVNHKNIISLLNVF-TPQKTLEEFQDV-YLVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDXTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 239 EQLGTPCPE 247

>pdb|3VUM|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M7 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++++ H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  G IM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|3VUL|A Chain A, Crystal Structure Of A Cysteine-deficient Mutant M1 In Map Kinase Jnk1 Length = 370

Iteration: 1
 Score = 92.4 bits (228), Expect = 4e-19,   Method: Compositional matrix adjust.
 Identities = 55/189 (29%), Positives = 99/189 (52%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++++ H+N++ L+ +  T       ++   Y+V +  + +L+ +   I ++  
Sbjct: 70  AYRELVLMKVVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMDANLSQV---IQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLVGIKHLHSAGIIHRDLKPSNIVVKSDATLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  G IM EM     +  G     Q   + 
Sbjct: 180 FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGVIMGEMIKGGVLFPGTDHIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+ +PE
Sbjct: 239 EQLGTPSPE 247

>pdb|2G01|A Chain A, Pyrazoloquinolones As Novel, Selective Jnk1 Inhibitors Length = 370

Iteration: 1
 Score = 92.0 bits (227), Expect = 6e-19,   Method: Compositional matrix adjust.
 Identities = 57/189 (30%), Positives = 95/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                 VVT +YR PE++LG   Y   VDLW  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMEPEVVTRYYRAPEVILG-MGYKENVDLWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 239 EQLGTPCPE 247

>pdb|3NIE|A Chain A, Crystal Structure Of Pf11_0147 Length = 429

Iteration: 1
 Score = 90.9 bits (224), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 57/181 (31%), Positives = 89/181 (49%), Gaps = 27/181 (14%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           LREI IL  LK + ++ L + I      +++      Y+V +  + DL  L     +  +
Sbjct: 75  LREITILNRLKSDYIIRLHDLIIPEDLLKFDE----LYIVLEIADSDLKKLFKT-PIFLT 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +K ++  LL G  +IH + I+HRD+K AN L+ +   +K+ DFGLAR  +  K+  +
Sbjct: 130 EQHVKTILYNLLLGEKFIHESGIIHRDLKPANCLLNQDCSVKICDFGLARTINSDKDIHI 189
Query: 130 ---------------------NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
                                 + T+ VVT WYR PEL+L   NY   +D+W  GCI AE
Sbjct: 190 VNDLEEKEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTNSIDIWSTGCIFAE 249
Query: 169 M 169
           +
Sbjct: 250 L 250

>pdb|3KVW|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) In Complex With An Indirubin Ligand Length = 429

Iteration: 1
 Score = 90.5 bits (223), Expect = 1e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 6   FPITALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG 59
           F   A  EI+IL+ L+ +      NV+H++E           +R+   + F+    +L  
Sbjct: 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--------NFTFRNHICMTFELLSMNLYE 187
Query: 60  LLS-NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFG 116
           L+  N    FSL  ++K    +L  L  +H N+I+H D+K  N+L+ + G   +K+ DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
            +    Q       R    + + +YR PE++LG R YG P+D+W  GCI+AE+ T  P++
Sbjct: 248 SSCYEHQ-------RVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLL 299
Query: 177 QGNTEQQQITLISQLCG 193
            G  E  Q+  + +L G
Sbjct: 300 PGEDEGDQLACMIELLG 316

>pdb|4AZF|A Chain A, Human Dyrk2 In Complex With Leucettine L41 Length = 417

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 6   FPITALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG 59
           F   A  EI+IL+ L+ +      NV+H++E           +R+   + F+    +L  
Sbjct: 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--------NFTFRNHICMTFELLSMNLYE 187
Query: 60  LLS-NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFG 116
           L+  N    FSL  ++K    +L  L  +H N+I+H D+K  N+L+ + G   +K+ DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
            +    Q       R    + + +YR PE++LG R YG P+D+W  GCI+AE+ T  P++
Sbjct: 248 SSCYEHQ-------RVYTXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLL 299
Query: 177 QGNTEQQQITLISQLCG 193
            G  E  Q+  + +L G
Sbjct: 300 PGEDEGDQLACMIELLG 316

>pdb|2XS0|A Chain A, Linear Binding Motifs For Jnk And For Calcineurin Antagonistically Control The Nuclear Shuttling Of Nfat4 Length = 386

Iteration: 1
 Score = 90.5 bits (223), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 56/189 (29%), Positives = 95/189 (50%), Gaps = 11/189 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 72  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 127 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                 VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 182 FMMVPFVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQWNKVI 240
Query: 190 QLCGSITPE 198
           +  G+  PE
Sbjct: 241 EQLGTPCPE 249

>pdb|3K2L|A Chain A, Crystal Structure Of Dual-Specificity Tyrosine Phosphorylation Regulated Kinase 2 (Dyrk2) Length = 429

Iteration: 1
 Score = 90.1 bits (222), Expect = 2e-18,   Method: Compositional matrix adjust.
 Identities = 61/197 (30%), Positives = 101/197 (51%), Gaps = 25/197 (12%)
Query: 6   FPITALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG 59
           F   A  EI+IL+ L+ +      NV+H++E           +R+   + F+    +L  
Sbjct: 136 FHRQAAEEIRILEHLRKQDKDNTMNVIHMLE--------NFTFRNHICMTFELLSMNLYE 187
Query: 60  LLS-NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFG 116
           L+  N    FSL  ++K    +L  L  +H N+I+H D+K  N+L+ + G   +K+ DFG
Sbjct: 188 LIKKNKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFG 247
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
            +    Q       R    + + +YR PE++LG R YG P+D+W  GCI+AE+ T  P++
Sbjct: 248 SSCYEHQ-------RVYXXIQSRFYRAPEVILGAR-YGMPIDMWSLGCILAELLTGYPLL 299
Query: 177 QGNTEQQQITLISQLCG 193
            G  E  Q+  + +L G
Sbjct: 300 PGEDEGDQLACMIELLG 316

>pdb|3O17|A Chain A, Crystal Structure Of Jnk1-Alpha1 Isoform Length = 370

Iteration: 1
 Score = 89.4 bits (220), Expect = 4e-18,   Method: Compositional matrix adjust.
 Identities = 55/188 (29%), Positives = 94/188 (50%), Gaps = 11/188 (5%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +  T       ++   Y+V +  +   A L   I ++  
Sbjct: 70  AYRELVLMKCVNHKNIIGLLNVF-TPQKSLEEFQDV-YIVMELMD---ANLCQVIQMELD 124
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR       G  
Sbjct: 125 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLART-----AGTS 179
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                 VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 180 FMMEPEVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVCHKILFPGRDYIDQWNKVI 238
Query: 190 QLCGSITP 197
           +  G+  P
Sbjct: 239 EQLGTPCP 246

>pdb|3E3P|A Chain A, Glycogen Synthase Kinase From Leishmania Major Length = 360

Iteration: 1
 Score = 88.6 bits (218), Expect = 6e-18,   Method: Compositional matrix adjust.
 Identities = 68/219 (31%), Positives = 104/219 (47%), Gaps = 23/219 (10%)
Query: 12  REIKILQ---LLKHENVVHLIEICRTKANQYNRYRSTFYL--VFDFCEHDLAGLLSNIHV 66
           RE++I+Q   +L H N+V L     T      R R   YL  V ++    L     N + 
Sbjct: 65  RELQIMQDLAVLHHPNIVQLQSYFYTLGE---RDRRDIYLNVVMEYVPDTLHRCCRNYYR 121
Query: 67  KFSLGE---IKKVIQQLLNGLYYIH--SNKILHRDMKAANVLITKT-GILKLADFGLARA 120
           +        IK  + QL+  +  +H  S  + HRD+K  NVL+ +  G LKL DFG A+ 
Sbjct: 122 RQVAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKK 181
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            S ++          + + +YR PEL+ G+++Y   VD+W  GCI AEM    PI +G+ 
Sbjct: 182 LSPSEPN-----VAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDN 236
Query: 181 EQQQITLISQLCGSITPESW----PGVETLDLYNKMELP 215
              Q+  I ++ G  + E      P    +DLYN   +P
Sbjct: 237 SAGQLHEIVRVLGCPSREVLRKLNPSHTDVDLYNSKGIP 275

>pdb|3IGO|A Chain A, Crystal Structure Of Cryptosporidium Parvum Cdpk1, Cgd3_920 Length = 486

Iteration: 1
 Score = 86.3 bits (212), Expect = 3e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 22/178 (12%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HV 66
           T LRE+++L+ L H N++ L EI            S+FY+V +   +    L   I    
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDS--------SSFYIVGEL--YTGGELFDEIIKRK 116
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+ +G+ Y+H + I+HRD+K  N+L+    K   +K+ DFGL+  F Q
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                  +  +R+ T +Y  PE+L G   Y    D+W AG I+  + + +P   G  E
Sbjct: 177 N-----TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|3EB0|A Chain A, Crystal Structure Of Cgd4_240 From Cryptosporidium Parvum In Complex With Indirubin E804 Length = 383

Iteration: 1
 Score = 85.9 bits (211), Expect = 4e-17,   Method: Compositional matrix adjust.
 Identities = 55/187 (29%), Positives = 84/187 (44%), Gaps = 9/187 (4%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           I QL   + +IHS  I HRD+K  N+L+ +K   LKL DFG A+    ++          
Sbjct: 147 IYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEPS-----VAX 201
Query: 136 VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSI 195
           + + +YR PEL+LG   Y P +DLW  GC+  E+    P+  G T   Q+  I Q+ G+ 
Sbjct: 202 ICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTP 261
Query: 196 TPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDA 255
           T E    +     Y ++  P  + +  ++ L P                  P  R +   
Sbjct: 262 TKEQM--IRMNPHYTEVRFPTLKAKDWRKIL-PEGTPSLAIDLLEQILRYEPDLRINPYE 318
Query: 256 ALNHDFF 262
           A+ H FF
Sbjct: 319 AMAHPFF 325

>pdb|2WEI|A Chain A, Crystal Structure Of The Kinase Domain Of Cryptosporidium Parvum Calcium Dependent Protein Kinase In Complex With 3- Mb-Pp1 Length = 287

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 22/178 (12%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HV 66
           T LRE+++L+ L H N++ L EI            S+FY+V +   +    L   I    
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDS--------SSFYIVGEL--YTGGELFDEIIKRK 116
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+ +G+ Y+H + I+HRD+K  N+L+    K   +K+ DFGL+  F Q
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                  +  +R+ T +Y  PE+L G   Y    D+W AG I+  + + +P   G  E
Sbjct: 177 N-----TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2WTK|C Chain C, Structure Of The Heterotrimeric Lkb1-Stradalpha-Mo25alpha Complex Length = 305

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 49/162 (30%), Positives = 88/162 (54%), Gaps = 10/162 (6%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FSL 70
           +EI++L+ L+H+NV+ L+++       YN  +   Y+V ++C   +  +L ++  K F +
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVL------YNEEKQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            +      QL++GL Y+HS  I+H+D+K  N+L+T  G LK++  G+A A          
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168
Query: 131 RYTNRVVTLWYRPPELLLG-DRNYGPPVDLWGAGCIMAEMWT 171
           R +    +  ++PPE+  G D   G  VD+W AG  +  + T
Sbjct: 169 RTSQG--SPAFQPPEIANGLDTFSGFKVDIWSAGVTLYNITT 208

>pdb|3DFA|A Chain A, Crystal Structure Of Kinase Domain Of Calcium-dependent Protein Kinase Cgd3_920 From Cryptosporidium Parvum Length = 286

Iteration: 1
 Score = 85.5 bits (210), Expect = 5e-17,   Method: Compositional matrix adjust.
 Identities = 55/178 (30%), Positives = 92/178 (51%), Gaps = 22/178 (12%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HV 66
           T LRE+++L+ L H N++ L EI            S+FY+V +   +    L   I    
Sbjct: 67  TILREVELLKKLDHPNIMKLFEILEDS--------SSFYIVGEL--YTGGELFDEIIKRK 116
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+ +G+ Y+H + I+HRD+K  N+L+    K   +K+ DFGL+  F Q
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                  +  +R+ T +Y  PE+L G   Y    D+W AG I+  + + +P   G  E
Sbjct: 177 N-----TKMKDRIGTAYYIAPEVLRG--TYDEKCDVWSAGVILYILLSGTPPFYGKNE 227

>pdb|2J51|A Chain A, Crystal Structure Of Human Ste20-Like Kinase Bound To 5- Amino-3-((4-(Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2,4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 83.6 bits (205), Expect = 2e-16,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 86/167 (51%), Gaps = 17/167 (10%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           EI IL    H N+V L++           Y +  +++ +FC    +  ++  +    +  
Sbjct: 84  EIDILASCDHPNIVKLLDAFY--------YENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I+ V +Q L+ L Y+H NKI+HRD+KA N+L T  G +KLADFG++   ++T    + R
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----IQR 191
Query: 132 YTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSP 174
             + + T ++  PE+++     DR Y    D+W  G  + EM    P
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|2QNJ|A Chain A, Kinase And Ubiquitin-Associated Domains Of Mark3PAR-1 Length = 328

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 83/163 (50%), Gaps = 13/163 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YL+ ++            H +   
Sbjct: 59  FREVRIMKILNHPNIVKLFEVIETE--------KTLYLIMEYASGGEVFDYLVAHGRMKE 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H  +I+HRD+KA N+L+     +K+ADFG +  F  T  G+++
Sbjct: 111 KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLD 168
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            +     +  Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 169 TFCG---SPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 208

>pdb|3I79|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) Length = 484

Iteration: 1
 Score = 82.8 bits (203), Expect = 3e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 50/259 (19%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           LRE+++L+ L H N++ L E    K          FYLV +   +    L   I    +F
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKG--------YFYLVGEV--YTGGELFDEIISRKRF 123
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           S  +  ++I+Q+L+G+ Y+H NKI+HRD+K  N+L+   +K   +++ DFGL+  F  +K
Sbjct: 124 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                +  +++ T +Y  PE+L G   Y    D+W  G I+  + +  P   G  E   +
Sbjct: 184 -----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             + +  G  T                ELP  Q +KV E  K  ++              
Sbjct: 237 KKVEK--GKYT---------------FELP--QWKKVSESAKDLIR---------KMLTY 268
Query: 246 XPSKRFDSDAALNHDFFWT 264
            PS R  +  AL+H++  T
Sbjct: 269 VPSMRISARDALDHEWIQT 287

>pdb|3LIJ|A Chain A, Crystal Structure Of Full Length Cpcdpk3 (Cgd5_820) In Complex With Ca2+ And Amppnp Length = 494

Iteration: 1
 Score = 82.8 bits (203), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 61/216 (28%), Positives = 104/216 (48%), Gaps = 22/216 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFS 69
           L E+ +L+LL H N++ L +    K N        +YLV + C          IH +KF+
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRN--------YYLVME-CYKGGELFDEIIHRMKFN 134
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +   +I+Q+L+G+ Y+H + I+HRD+K  N+L+    K  ++K+ DFGL+  F   K 
Sbjct: 135 EVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK- 193
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
               +   R+ T +Y  PE+L   + Y    D+W  G I+  +    P   G T+Q+ + 
Sbjct: 194 ----KMKERLGTAYYIAPEVLR--KKYDEKCDVWSIGVILFILLAGYPPFGGQTDQEILR 247
Query: 187 LISQLCGSITPESWPGVE--TLDLYNKMELPKAQKR 220
            + +   +     W  V     DL  +M    +Q+R
Sbjct: 248 KVEKGKYTFDSPEWKNVSEGAKDLIKQMLQFDSQRR 283

>pdb|3KU2|A Chain A, Crystal Structure Of Inactivated Form Of Cdpk1 From Toxoplasma Gondii, Tgme49.101440 Length = 507

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 50/259 (19%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           LRE+++L+ L H N++ L E    K          FYLV +   +    L   I    +F
Sbjct: 97  LREVQLLKQLDHPNIMKLYEFFEDKG--------YFYLVGEV--YTGGELFDEIISRKRF 146
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           S  +  ++I+Q+L+G+ Y+H NKI+HRD+K  N+L+   +K   +++ DFGL+  F  +K
Sbjct: 147 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 206
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                +  +++ T +Y  PE+L G   Y    D+W  G I+  + +  P   G  E   +
Sbjct: 207 -----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 259
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             + +  G  T                ELP  Q +KV E  K  ++              
Sbjct: 260 KKVEK--GKYT---------------FELP--QWKKVSESAKDLIR---------KMLTY 291
Query: 246 XPSKRFDSDAALNHDFFWT 264
            PS R  +  AL+H++  T
Sbjct: 292 VPSMRISARDALDHEWIQT 310

>pdb|3HX4|A Chain A, Crystal Structure Of Cdpk1 Of Toxoplasma Gondii, Tgme49_101440, In Presence Of Calcium Length = 508

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/259 (27%), Positives = 118/259 (45%), Gaps = 50/259 (19%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           LRE+++L+ L H N++ L E    K          FYLV +   +    L   I    +F
Sbjct: 98  LREVQLLKQLDHPNIMKLYEFFEDKG--------YFYLVGEV--YTGGELFDEIISRKRF 147
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           S  +  ++I+Q+L+G+ Y+H NKI+HRD+K  N+L+   +K   +++ DFGL+  F  +K
Sbjct: 148 SEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 207
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                +  +++ T +Y  PE+L G   Y    D+W  G I+  + +  P   G  E   +
Sbjct: 208 -----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 260
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             + +  G  T                ELP  Q +KV E  K  ++              
Sbjct: 261 KKVEK--GKYT---------------FELP--QWKKVSESAKDLIR---------KMLTY 292
Query: 246 XPSKRFDSDAALNHDFFWT 264
            PS R  +  AL+H++  T
Sbjct: 293 VPSMRISARDALDHEWIQT 311

>pdb|3MA6|A Chain A, Crystal Structure Of Kinase Domain Of Tgcdpk1 In Presence Of 3brb-Pp1 Length = 298

Iteration: 1
 Score = 82.4 bits (202), Expect = 4e-16,   Method: Compositional matrix adjust.
 Identities = 71/261 (27%), Positives = 119/261 (45%), Gaps = 50/261 (19%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HV 66
           + LRE+++L+ L H N++ L E    K          FYLV +   +    L   I    
Sbjct: 78  SLLREVQLLKQLDHPNIMKLYEFFEDKG--------YFYLVGEV--YTGGELFDEIISRK 127
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+L+G+ Y+H NKI+HRD+K  N+L+   +K   +++ DFGL+  F  
Sbjct: 128 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 187
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           +K     +  +++ T +Y  PE+L G   Y    D+W  G I+  + +  P   G  E  
Sbjct: 188 SK-----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYD 240
Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXX 243
            +  + +  G  T                ELP  Q +KV E  K  ++            
Sbjct: 241 ILKKVEK--GKYT---------------FELP--QWKKVSESAKDLIR---------KML 272
Query: 244 XXXPSKRFDSDAALNHDFFWT 264
              PS R  +  AL+H++  T
Sbjct: 273 TYVPSMRISARDALDHEWIQT 293

>pdb|3FE3|A Chain A, Crystal Structure Of The Kinase Mark3PAR-1: T211a-S215a Double Mutant Length = 328

Iteration: 1
 Score = 82.4 bits (202), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 82/163 (50%), Gaps = 13/163 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YL+ ++            H +   
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETE--------KTLYLIMEYASGGEVFDYLVAHGRMKE 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H  +I+HRD+KA N+L+     +K+ADFG +  F  T  G+++
Sbjct: 114 KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEF--TVGGKLD 171
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            +        Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 172 AFCG---APPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>pdb|2JFM|A Chain A, Crystal Structure Of Human Ste20-Like Kinase (Unliganded Form) Length = 325

Iteration: 1
 Score = 82.0 bits (201), Expect = 5e-16,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 83/167 (49%), Gaps = 17/167 (10%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           EI IL    H N+V L++           Y +  +++ +FC    +  ++  +    +  
Sbjct: 84  EIDILASCDHPNIVKLLDAFY--------YENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I+ V +Q L+ L Y+H NKI+HRD+KA N+L T  G +KLADFG+    S      + R
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQR 191
Query: 132 YTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSP 174
             + + T ++  PE+++     DR Y    D+W  G  + EM    P
Sbjct: 192 RDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|3I7C|A Chain A, Calcium-Dependent Protein Kinase 1 From Toxoplasma Gondii (Tgcdpk1) In Complex With Bumped Kinase Inhibitor Na-Pp2 Length = 484

Iteration: 1
 Score = 82.0 bits (201), Expect = 6e-16,   Method: Compositional matrix adjust.
 Identities = 72/259 (27%), Positives = 117/259 (45%), Gaps = 50/259 (19%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           LRE+++L+ L H N+  L E    K          FYLV +   +    L   I    +F
Sbjct: 74  LREVQLLKQLDHPNIXKLYEFFEDKG--------YFYLVGEV--YTGGELFDEIISRKRF 123
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           S  +  ++I+Q+L+G+ Y H NKI+HRD+K  N+L+   +K   +++ DFGL+  F  +K
Sbjct: 124 SEVDAARIIRQVLSGITYXHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK 183
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                +  +++ T +Y  PE+L G   Y    D+W  G I+  + +  P   G  E   +
Sbjct: 184 -----KXKDKIGTAYYIAPEVLHG--TYDEKCDVWSTGVILYILLSGCPPFNGANEYDIL 236
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             + +  G  T                ELP  Q +KV E  K  ++              
Sbjct: 237 KKVEK--GKYT---------------FELP--QWKKVSESAKDLIR---------KXLTY 268
Query: 246 XPSKRFDSDAALNHDFFWT 264
            PS R  +  AL+H++  T
Sbjct: 269 VPSXRISARDALDHEWIQT 287

>pdb|2JFL|A Chain A, Crystal Structure Of Human Ste20-Like Kinase ( Diphosphorylated Form) Bound To 5- Amino-3-((4-( Aminosulfonyl)phenyl)amino)-N-(2,6- Difluorophenyl)-1h-1,2, 4-Triazole-1-Carbothioamide Length = 325

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 50/167 (29%), Positives = 82/167 (49%), Gaps = 17/167 (10%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLG 71
           EI IL    H N+V L++           Y +  +++ +FC    +  ++  +    +  
Sbjct: 84  EIDILASCDHPNIVKLLDAFY--------YENNLWILIEFCAGGAVDAVMLELERPLTES 135
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I+ V +Q L+ L Y+H NKI+HRD+KA N+L T  G +KLADFG+    S      + R
Sbjct: 136 QIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGV----SAKNTRXIQR 191
Query: 132 YTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSP 174
               + T ++  PE+++     DR Y    D+W  G  + EM    P
Sbjct: 192 RDXFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEP 238

>pdb|4APC|A Chain A, Crystal Structure Of Human Nima-Related Kinase 1 (Nek1) Length = 350

Iteration: 1
 Score = 81.3 bits (199), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 58/198 (29%), Positives = 92/198 (46%), Gaps = 33/198 (16%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNIH 65
           RE+ +L  +KH N+V               YR +F      Y+V D+CE     L   I+
Sbjct: 72  REVAVLANMKHPNIVQ--------------YRESFEENGSLYIVMDYCEG--GDLFKRIN 115
Query: 66  ----VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
               V F   +I     Q+   L ++H  KILHRD+K+ N+ +TK G ++L DFG+AR  
Sbjct: 116 AQKGVLFQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVL 175
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           + T    V      + T +Y  PE +  ++ Y    D+W  GC++ E+ T     +  + 
Sbjct: 176 NST----VELARACIGTPYYLSPE-ICENKPYNNKSDIWALGCVLYELCTLKHAFEAGSM 230
Query: 182 QQQITLISQLCGSITPES 199
           +  +  I  + GS  P S
Sbjct: 231 KNLVLKI--ISGSFPPVS 246

>pdb|2CLQ|A Chain A, Structure Of Mitogen-Activated Protein Kinase Kinase Kinase 5 Length = 295

Iteration: 1
 Score = 80.9 bits (198), Expect = 1e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 25/172 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
            EI + + LKH+N+V           QY    S    +  F E    G LS + ++   G
Sbjct: 68  EEIALHKHLKHKNIV-----------QYLGSFSENGFIKIFMEQVPGGSLSAL-LRSKWG 115
Query: 72  EIKKVIQ-------QLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQ 123
            +K   Q       Q+L GL Y+H N+I+HRD+K  NVLI T +G+LK++DFG ++  + 
Sbjct: 116 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 175
Query: 124 TKNGQVNRYTNRVVTLWYRPPELL-LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             N     +T    TL Y  PE++  G R YG   D+W  GC + EM T  P
Sbjct: 176 I-NPCTETFTG---TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>pdb|3VW6|A Chain A, Crystal Structure Of Human Apoptosis Signal-Regulating Kinase 1 (Ask1) With Imidazopyridine Inhibitor Length = 269

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 60/172 (34%), Positives = 86/172 (50%), Gaps = 25/172 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
            EI + + LKH+N+V           QY    S    +  F E    G LS + ++   G
Sbjct: 54  EEIALHKHLKHKNIV-----------QYLGSFSENGFIKIFMEQVPGGSLSAL-LRSKWG 101
Query: 72  EIKKVIQ-------QLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQ 123
            +K   Q       Q+L GL Y+H N+I+HRD+K  NVLI T +G+LK++DFG ++  + 
Sbjct: 102 PLKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAG 161
Query: 124 TKNGQVNRYTNRVVTLWYRPPELL-LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             N     +T    TL Y  PE++  G R YG   D+W  GC + EM T  P
Sbjct: 162 I-NPCTETFTG---TLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 209

>pdb|2HAK|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark1PAR-1 Length = 328

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 62  FREVRIMKILNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+       N
Sbjct: 114 KEARAKFRQIVSAVQYCHQKYIVHRDLKAENLLLDGDMNIKIADFGFSNEFTVG-----N 168
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +      +  Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 169 KLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 211

>pdb|1ZMU|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Wild Type Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------- 164
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            + N++ T      Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 165 -FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|1ZMV|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: K82r Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------- 164
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            + N++ T      Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 165 -FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2R0I|A Chain A, Crystal Structure Of A Kinase Mark2PAR-1 Mutant Length = 327

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 81/167 (48%), Gaps = 21/167 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------- 164
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            + N++ T      Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 165 -FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2VX3|A Chain A, Crystal Structure Of The Human Dual Specificity Tyrosine- Phosphorylation-Regulated Kinase 1a Length = 382

Iteration: 1
 Score = 80.1 bits (196), Expect = 2e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 13  EIKILQLL-KHEN-----VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           E+++L+L+ KH+      +VHL         ++  +R+   LVF+   ++L  LL N + 
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHL--------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 151
Query: 67  K-FSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT--KTGILKLADFGLARAF 121
           +  SL   +K  QQ+   L ++ + +  I+H D+K  N+L+   K   +K+ DFG     
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----- 206
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  + GQ  R    + + +YR PE+LLG   Y   +D+W  GCI+ EM T  P+  G  E
Sbjct: 207 SSCQLGQ--RIYQXIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK 219
             Q+  I ++ G       P    LD     + PKA+K
Sbjct: 264 VDQMNKIVEVLG------IPPAHILD-----QAPKARK 290

>pdb|3ANQ|A Chain A, Human Dyrk1aINHIBITOR COMPLEX Length = 368

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 13  EIKILQLL-KHEN-----VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           E+++L+L+ KH+      +VHL         ++  +R+   LVF+   ++L  LL N + 
Sbjct: 81  EVRLLELMNKHDTEMKYYIVHL--------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 132
Query: 67  K-FSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT--KTGILKLADFGLARAF 121
           +  SL   +K  QQ+   L ++ + +  I+H D+K  N+L+   K   +K+ DFG     
Sbjct: 133 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFG----- 187
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  + GQ  R    + + +YR PE+LLG   Y   +D+W  GCI+ EM T  P+  G  E
Sbjct: 188 SSCQLGQ--RIYQXIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 244
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK 219
             Q+  I ++ G       P    LD     + PKA+K
Sbjct: 245 VDQMNKIVEVLG------IPPAHILD-----QAPKARK 271

>pdb|3Q5I|A Chain A, Crystal Structure Of Pbanka_031420 Length = 504

Iteration: 1
 Score = 79.7 bits (195), Expect = 3e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 91/182 (50%), Gaps = 20/182 (10%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLG 71
           EI +L+ L H N++ L ++   K          FYLV +F E  +L   + N H KF   
Sbjct: 96  EISLLKSLDHPNIIKLFDVFEDK--------KYFYLVTEFYEGGELFEQIINRH-KFDEC 146
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGIL---KLADFGLARAFSQTKNGQ 128
           +   +++Q+L+G+ Y+H + I+HRD+K  N+L+     L   K+ DFGL+  FS+     
Sbjct: 147 DAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKDY--- 203
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
             +  +R+ T +Y  PE+L   + Y    D+W  G IM  +    P   G  +Q  I  +
Sbjct: 204 --KLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQDIIKKV 259
Query: 189 SQ 190
            +
Sbjct: 260 EK 261

>pdb|4AZE|A Chain A, Human Dyrk1a In Complex With Leucettine L41 Length = 382

Iteration: 1
 Score = 79.3 bits (194), Expect = 4e-15,   Method: Compositional matrix adjust.
 Identities = 66/218 (30%), Positives = 108/218 (49%), Gaps = 38/218 (17%)
Query: 13  EIKILQLL-KHEN-----VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           E+++L+L+ KH+      +VHL         ++  +R+   LVF+   ++L  LL N + 
Sbjct: 100 EVRLLELMNKHDTEMKYYIVHL--------KRHFMFRNHLCLVFEMLSYNLYDLLRNTNF 151
Query: 67  K-FSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT--KTGILKLADFGLARAF 121
           +  SL   +K  QQ+   L ++ + +  I+H D+K  N+L+   K   +K+ DFG     
Sbjct: 152 RGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRXAIKIVDFG----- 206
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S  + GQ  R    + + +YR PE+LLG   Y   +D+W  GCI+ EM T  P+  G  E
Sbjct: 207 SSCQLGQ--RIYQXIQSRFYRSPEVLLG-MPYDLAIDMWSLGCILVEMHTGEPLFSGANE 263
Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQK 219
             Q+  I ++ G       P    LD     + PKA+K
Sbjct: 264 VDQMNKIVEVLG------IPPAHILD-----QAPKARK 290

>pdb|2WZJ|A Chain A, Catalytic And Uba Domain Of Kinase Mark2(PAR-1) K82r, T208e Double Mutant Length = 327

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 79/163 (48%), Gaps = 13/163 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+       N
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFTFG-----N 167
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +      +  Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 168 KLDEFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|3HZT|A Chain A, Crystal Structure Of Toxoplasma Gondii Cdpk3, Tgme49_105860 Length = 467

Iteration: 1
 Score = 79.0 bits (193), Expect = 5e-15,   Method: Compositional matrix adjust.
 Identities = 66/255 (25%), Positives = 110/255 (43%), Gaps = 52/255 (20%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVK 67
           L E+ +L+ L H N++ L E    K N        +YLV +       G L +   +  K
Sbjct: 52  LDEVAVLKQLDHPNIMKLYEFFEDKRN--------YYLVMEVYR---GGELFDEIILRQK 100
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQT 124
           FS  +   +++Q+L+G  Y+H + I+HRD+K  N+L+   ++  ++K+ DFGL+  F   
Sbjct: 101 FSEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG 160
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                 +   R+ T +Y  PE+L   + Y    D+W  G I+  +    P   G T+Q+ 
Sbjct: 161 -----GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEI 213
Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXX 244
           +  + +   S  P  W                    +V +  K  VK             
Sbjct: 214 LKRVEKGKFSFDPPDWT-------------------QVSDEAKQLVK---------LMLT 245
Query: 245 XXPSKRFDSDAALNH 259
             PSKR  ++ ALNH
Sbjct: 246 YEPSKRISAEEALNH 260

>pdb|3DXN|A Chain A, Crystal Structure Of The Calcium-dependent Kinase From Toxoplasma Gondii, 541.m00134, Kinase Domain Length = 287

Iteration: 1
 Score = 78.6 bits (192), Expect = 6e-15,   Method: Compositional matrix adjust.
 Identities = 66/254 (25%), Positives = 110/254 (43%), Gaps = 50/254 (19%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV--KF 68
           L E+ +L+ L H N++ L E    K N        +YLV +   +    L   I +  KF
Sbjct: 69  LDEVAVLKQLDHPNIMKLYEFFEDKRN--------YYLVMEV--YRGGELFDEIILRQKF 118
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           S  +   +++Q+L+G  Y+H + I+HRD+K  N+L+   ++  ++K+ DFGL+  F    
Sbjct: 119 SEVDAAVIMKQVLSGTTYLHKHNIVHRDLKPENLLLESKSRDALIKIVDFGLSAHFEVG- 177
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                +   R+ T +Y  PE+L   + Y    D+W  G I+  +    P   G T+Q+ +
Sbjct: 178 ----GKMKERLGTAYYIAPEVL--RKKYDEKCDVWSCGVILYILLCGYPPFGGQTDQEIL 231
Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXX 245
             + +   S  P  W                    +V +  K  VK              
Sbjct: 232 KRVEKGKFSFDPPDWT-------------------QVSDEAKQLVK---------LMLTY 263
Query: 246 XPSKRFDSDAALNH 259
            PSKR  ++ ALNH
Sbjct: 264 EPSKRISAEEALNH 277

>pdb|1ZMW|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: T208aS212A INACTIVE DOUBLE MUTANT Length = 327

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGRMKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------- 164
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            + N++        Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 165 -FGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 210

>pdb|2C6E|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With A 5-Aminopyrimidinyl Quinazoline Inhibitor Length = 283

Iteration: 1
 Score = 78.2 bits (191), Expect = 8e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 62  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 111
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 165
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T+   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 166 SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 224
Query: 190 QL 191
           ++
Sbjct: 225 RV 226

>pdb|2J4Z|A Chain A, Structure Of Aurora-2 In Complex With Pha-680626 Length = 306

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 83  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 186
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 187 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 245
Query: 190 QL 191
           ++
Sbjct: 246 RV 247

>pdb|3FDN|A Chain A, Structure-Based Drug Design Of Novel Aurora Kinase A Inhibitors: Structure Basis For Potency And Specificity Length = 279

Iteration: 1
 Score = 78.2 bits (191), Expect = 9e-15,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 58  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 107
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 161
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T+   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 162 SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 190 QL 191
           ++
Sbjct: 221 RV 222

>pdb|3LAU|A Chain A, Crystal Structure Of Aurora2 Kinase In Complex With A Gsk3beta Inhibitor Length = 287

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T+   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|2C6D|A Chain A, Aurora A Kinase Activated Mutant (T287d) In Complex With Adpnp Length = 275

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 86/182 (47%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T+   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRTDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|2WTW|A Chain A, Aurora-A Inhibitor Structure (2nd Crystal Form) Length = 285

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 54/180 (30%), Positives = 82/180 (45%), Gaps = 15/180 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE++I   L+H N++ L          Y    +  YL+ ++              KF   
Sbjct: 62  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
                I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   +R
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSR 167
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL 191
            T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS++
Sbjct: 168 RTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|4DGM|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Apigenin Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/178 (29%), Positives = 93/178 (52%), Gaps = 16/178 (8%)
Query: 19  LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQ 78
           L+   N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I 
Sbjct: 82  LMGGPNIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIY 132
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           +LL  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV 
Sbjct: 133 ELLKALDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVA 187
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
           + +++ PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 188 SRYFKGPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|1MUO|A Chain A, Crystal Structure Of Aurora-2, An Oncogenic Serine- Threonine Kinase Length = 297

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 74  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 123
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 124 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 177
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 178 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 236
Query: 190 QL 191
           ++
Sbjct: 237 RV 238

>pdb|2QC6|A Chain A, Protein Kinase Ck2 In Complex With Dbc Length = 332

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 88  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 138
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 139 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 193
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 194 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|4FIE|A Chain A, Full-Length Human Pak4 Length = 423

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 198 EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 244
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 245 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 300
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 301 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 345

>pdb|4DGN|A Chain A, Crystal Structure Of Maize Ck2 In Complex With The Inhibitor Luteolin Length = 326

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 87  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 137
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 192
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|1U5Q|A Chain A, Crystal Structure Of The Tao2 Kinase Domain: Activation And Specifity Of A Ste20p Map3k Length = 348

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           ++E++ LQ L+H N +     C  + +       T +LV ++C    + LL         
Sbjct: 102 IKEVRFLQKLRHPNTIQY-RGCYLREH-------TAWLVMEYCLGSASDLLEVHKKPLQE 153
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            EI  V    L GL Y+HS+ ++HRD+KA N+L+++ G++KL DFG A   +       N
Sbjct: 154 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 208
Query: 131 RYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSP 174
            +   V T ++  PE++L   +  Y   VD+W  G    E+  R P
Sbjct: 209 XF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 251

>pdb|3PVG|A Chain A, Crystal Structure Of Z. Mays Ck2 Alpha Subunit In Complex With The Inhibitor 4,5,6,7-Tetrabromo-1-Carboxymethylbenzimidazole (K68) Length = 331

Iteration: 1
 Score = 77.8 bits (190), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 87  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 137
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 192
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|3KXG|A Chain A, Crystal Structure Of Z. Mays Ck2 Kinase Alpha Subunit In Complex With The Inhibitor 3,4,5,6,7-Pentabromo-1h-Indazole (K64) Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 87  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 137
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 192
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|1DAW|A Chain A, Crystal Structure Of A Binary Complex Of Protein Kinase Ck2 (Alpha-Subunit) And Mg-Amppnp Length = 327

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 87  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 137
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 192
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2X6D|A Chain A, Aurora-A Bound To An Inhibitor Length = 285

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 62  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 111
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 165
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 166 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 224
Query: 190 QL 191
           ++
Sbjct: 225 RV 226

>pdb|2XRU|A Chain A, Aurora-A T288e Complexed With Pha-828300 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRTELCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|2XNG|A Chain A, Structure Of Aurora-A Bound To A Selective Imidazopyrazine Inhibitor Length = 283

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|1M2P|A Chain A, Crystal Structure Of 1,8-Di-Hydroxy-4-Nitro- AnthraquinoneCK2 KINASE COMPLEX Length = 325

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 87  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 137
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 138 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 192
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 193 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 245

>pdb|2PVH|A Chain A, Structure-Based Design Of Pyrazolo[1,5-A][1,3,5]triazine Derivatives As Potent Inhibitors Of Protein Kinase Ck2 Length = 352

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 108 NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 158
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 159 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 213
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 214 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 266

>pdb|1DS5|A Chain A, Dimeric Crystal Structure Of The Alpha Subunit In Complex With Two Beta Peptides Mimicking The Architecture Of The Tetrameric Protein Kinase Ck2 Holoenzyme. Length = 332

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 88  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 138
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 139 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 193
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 194 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 246

>pdb|2J50|A Chain A, Structure Of Aurora-2 In Complex With Pha-739358 Length = 280

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|4ANM|A Chain A, Complex Of Ck2 With A Cdc7 Inhibitor Length = 335

Iteration: 1
 Score = 77.4 bits (189), Expect = 1e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 91/173 (52%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N+V L++I R      +++  T  L+F++  +    +L      +   +I+  I +LL  
Sbjct: 89  NIVKLLDIVR------DQHSKTPSLIFEYVNNTDFKVLYPTLTDY---DIRYYIYELLKA 139
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   K      Y  RV + +++
Sbjct: 140 LDYCHSQGIMHRDVKPHNVMIDHELRKLRLIDWGLAEFYHPGK-----EYNVRVASRYFK 194
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  ++Y   +D+W  GC+ A M + + P   G+    Q+  I+++ G+
Sbjct: 195 GPELLVDLQDYDYSLDMWSLGCMFAGMIFRKEPFFYGHDNHDQLVKIAKVLGT 247

>pdb|1F3M|C Chain C, Crystal Structure Of Human SerineTHREONINE KINASE PAK1 Length = 297

Iteration: 1
 Score = 77.4 bits (189), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 53/172 (30%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNI 64
            A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 65  HVKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG     +
Sbjct: 108 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---A 164
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           Q    Q  R T  V T ++  PE++   + YGP VD+W  G +  EM    P
Sbjct: 165 QITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2GCD|A Chain A, Tao2 Kinase Domain-Staurosporine Structure Length = 309

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/166 (30%), Positives = 82/166 (49%), Gaps = 18/166 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           ++E++ LQ L+H N +     C  + +       T +LV ++C    + LL         
Sbjct: 63  IKEVRFLQKLRHPNTIQY-RGCYLREH-------TAWLVMEYCLGSASDLLEVHKKPLQE 114
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            EI  V    L GL Y+HS+ ++HRD+KA N+L+++ G++KL DFG A   +       N
Sbjct: 115 VEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA-----N 169
Query: 131 RYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCIMAEMWTRSP 174
            +   V T ++  PE++L   +  Y   VD+W  G    E+  R P
Sbjct: 170 XF---VGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKP 212

>pdb|2W1D|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|3O50|A Chain A, Crystal Structure Of Benzamide 9 Bound To Auroraa Length = 267

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 56  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 105
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 106 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 159
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 160 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 218
Query: 190 QL 191
           ++
Sbjct: 219 RV 220

>pdb|2DWB|A Chain A, Aurora-A Kinase Complexed With Amppnp Length = 285

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 62  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 111
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 112 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 165
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE + G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 166 SRRTTLCGTLDYLPPEXIEG-RXHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 224
Query: 190 QL 191
           ++
Sbjct: 225 RV 226

>pdb|3IEC|A Chain A, Helicobacter Pylori Caga Inhibits Par1MARK FAMILY KINASES BY Mimicking Host Substrates Length = 319

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/167 (28%), Positives = 80/167 (47%), Gaps = 21/167 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I+++L H N+V L E+  T+         T YLV ++            H     
Sbjct: 54  FREVRIMKVLNHPNIVKLFEVIETE--------KTLYLVMEYASGGEVFDYLVAHGWMKE 105
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 106 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADMNIKIADFGFSNEFT-------- 157
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
            + N++ T      Y  PEL  G +  GP VD+W  G I+  + + S
Sbjct: 158 -FGNKLDTFCGSPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGS 203

>pdb|2Q0N|A Chain A, Structure Of Human P21 Activating Kinase 4 (Pak4) In Complex With A Consensus Peptide Length = 301

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 76  EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 122
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 123 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 178
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 179 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 223

>pdb|2CDZ|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Cgp74514a Length = 303

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 78  EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 124
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 125 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 180
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 181 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 225

>pdb|3OFM|A Chain A, Structure Of A Human Ck2alpha Prime, The Paralog Isoform Of The Catalytic Subunit Of Protein Kinase Ck2 From Homo Sapiens Length = 350

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N++ LI+  +   ++      T  LVF++  +     L  I   F   +I+  + +LL  
Sbjct: 94  NIIKLIDTVKDPVSK------TPALVFEYINNTDFKQLYQILTDF---DIRFYMYELLKA 144
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++
Sbjct: 145 LDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-----YNVRVASRYFK 199
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  + Y   +D+W  GC++A M + R P   G     Q+  I+++ G+
Sbjct: 200 GPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT 252

>pdb|3E3B|X Chain X, Crystal Structure Of Catalytic Subunit Of Human Protein Kinase Ck2alpha Prime With A Potent Indazole-Derivative Inhibitor Length = 339

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 51/173 (29%), Positives = 88/173 (50%), Gaps = 16/173 (9%)
Query: 24  NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG 83
           N++ LI+  +   ++      T  LVF++  +     L  I   F   +I+  + +LL  
Sbjct: 99  NIIKLIDTVKDPVSK------TPALVFEYINNTDFKQLYQILTDF---DIRFYMYELLKA 149
Query: 84  LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   +      Y  RV + +++
Sbjct: 150 LDYCHSKGIMHRDVKPHNVMIDHQQKKLRLIDWGLAEFYHPAQE-----YNVRVASRYFK 204
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLISQLCGS 194
            PELL+  + Y   +D+W  GC++A M + R P   G     Q+  I+++ G+
Sbjct: 205 GPELLVDYQMYDYSLDMWSLGCMLASMIFRREPFFHGQDNYDQLVRIAKVLGT 257

>pdb|1MQ4|A Chain A, Crystal Structure Of Aurora-A Protein Kinase Length = 272

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 61  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 110
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 164
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 165 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 223
Query: 190 QL 191
           ++
Sbjct: 224 RV 225

>pdb|2BVA|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 Length = 292

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 67  EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 113
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 114 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 169
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 170 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 214

>pdb|1NA7|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 Length = 329

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 59/190 (31%), Positives = 99/190 (52%), Gaps = 25/190 (13%)
Query: 12  REIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH----DLAGLLSNIHV 66
           REIKIL+ L+   N++ L +I +   ++      T  LVF+   +     L   L++  +
Sbjct: 80  REIKILENLRGGPNIITLADIVKDPVSR------TPALVFEHVNNTDFKQLYQTLTDYDI 133
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTK 125
           +F + EI       L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +    
Sbjct: 134 RFYMYEI-------LKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP-- 184
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQ 184
            GQ   Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q
Sbjct: 185 -GQ--EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQ 241
Query: 185 ITLISQLCGS 194
           +  I+++ G+
Sbjct: 242 LVRIAKVLGT 251

>pdb|1YHV|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Two Point Mutations (K299r, T423e) Length = 297

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNI 64
            A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 65  HVKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG    F 
Sbjct: 108 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----FC 163
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                + ++ +  V T ++  PE++   + YGP VD+W  G +  EM    P
Sbjct: 164 AQITPEQSKRSEMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2X4Z|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 4 In Complex With Pf-03758309 Length = 296

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 71  EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 117
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 118 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 173
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 174 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 218

>pdb|4FIF|A Chain A, Catalytic Domain Of Human Pak4 With Rpkplvdp Peptide Length = 346

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 52/166 (31%), Positives = 85/166 (51%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +HENVV +          YN Y      ++V +F E    G L++I  H + 
Sbjct: 121 EVVIMRDYQHENVVEM----------YNSYLVGDELWVVMEFLE---GGALTDIVTHTRM 167
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L  +H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 168 NEEQIAAVCLAVLQALSVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSK----E 223
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V R    V T ++  PE L+    YGP VD+W  G ++ EM    P
Sbjct: 224 VPRRKXLVGTPYWMAPE-LISRLPYGPEVDIWSLGIMVIEMVDGEP 268

>pdb|1Y8G|A Chain A, Catalytic And Ubiqutin-Associated Domains Of Mark2PAR-1: Inactive Double Mutant With Selenomethionine Length = 327

Iteration: 1
 Score = 77.0 bits (188), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 48/172 (27%), Positives = 80/172 (46%), Gaps = 21/172 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE++I ++L H N+V L E+  T+         T YLV ++            H +   
Sbjct: 61  FREVRIXKVLNHPNIVKLFEVIETE--------KTLYLVXEYASGGEVFDYLVAHGRXKE 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +   +Q+++ + Y H   I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 113 KEARAKFRQIVSAVQYCHQKFIVHRDLKAENLLLDADXNIKIADFGFSNEFT-------- 164
Query: 131 RYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
            + N++        Y  PEL  G +  GP VD+W  G I+  + + S    G
Sbjct: 165 -FGNKLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVILYTLVSGSLPFDG 215

>pdb|3QBN|A Chain A, Structure Of Human Aurora A In Complex With A Diaminopyrimidine Length = 281

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 58  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 107
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SCHAPS 161
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 162 SRRTTLSGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 190 QL 191
           ++
Sbjct: 221 RV 222

>pdb|3E5A|A Chain A, Crystal Structure Of Aurora A In Complex With Vx-680 And Tpx2 Length = 268

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRTXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|2WQE|A Chain A, Structure Of S155r Aurora-A Somatic Mutant Length = 262

Iteration: 1
 Score = 76.6 bits (187), Expect = 2e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 54  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 103
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 104 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 157
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 158 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 216
Query: 190 QL 191
           ++
Sbjct: 217 RV 218

>pdb|2WEL|A Chain A, Crystal Structure Of Su6656-Bound CalciumCALMODULIN- Dependent Protein Kinase Ii Delta In Complex With Calmodulin Length = 327

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    +   Y        LVFD        L  +I  +  +S
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHY--------LVFDLVTG--GELFEDIVAREYYS 101
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + + H N I+HRD+K  N+L+   +K   +KLADFGLA        
Sbjct: 102 EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV----Q 157
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G    +     T  Y  PE+L  D  YG PVD+W  G I+  +    P      + +   
Sbjct: 158 GDQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQ 216
Query: 187 LISQLCGSITPESWPGV--ETLDLYNKM-ELPKAQKRKVKERLK-PYV 230
            I           W  V  E  DL NKM  +  A++    E LK P++
Sbjct: 217 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|3Q52|A Chain A, Structure Of Phosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNI 64
            A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 65  HVKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG    F 
Sbjct: 109 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----FC 164
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                + ++ +  V T ++  PE++   + YGP VD+W  G +  EM    P
Sbjct: 165 AQITPEQSKRSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3FXZ|A Chain A, Crystal Structure Of Pak1 Kinase Domain With Ruthenium Complex Lambda-Fl172 Length = 297

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 50/172 (29%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNI 64
            A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++
Sbjct: 48  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 107
Query: 65  HVKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             +  +  G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG    F 
Sbjct: 108 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFG----FC 163
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                + ++ +  V T ++  PE++   + YGP VD+W  G +  EM    P
Sbjct: 164 AQITPEQSKRSXMVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEP 214

>pdb|2BMC|A Chain A, Aurora-2 T287d T288d Complexed With Pha-680632 Length = 306

Iteration: 1
 Score = 76.6 bits (187), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 83  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 133 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 186
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R  +   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 187 SRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 245
Query: 190 QL 191
           ++
Sbjct: 246 RV 247

>pdb|2VN9|A Chain A, Crystal Structure Of Human Calcium Calmodulin Dependent Protein Kinase Ii Delta Isoform 1, Camkd Length = 301

Iteration: 1
 Score = 76.3 bits (186), Expect = 3e-14,   Method: Compositional matrix adjust.
 Identities = 70/228 (30%), Positives = 100/228 (43%), Gaps = 24/228 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    +   Y        LVFD        L  +I  +  +S
Sbjct: 52  REARICRLLKHPNIVRLHDSISEEGFHY--------LVFDLVTG--GELFEDIVAREYYS 101
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + + H N I+HRD+K  N+L+   +K   +KLADFGLA        
Sbjct: 102 EADASHCIQQILESVNHCHLNGIVHRDLKPENLLLASKSKGAAVKLADFGLAIEV----Q 157
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G    +     T  Y  PE+L  D  YG PVD+W  G I+  +    P      + +   
Sbjct: 158 GDQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDMWACGVILYILLVGYPPFWDEDQHRLYQ 216
Query: 187 LISQLCGSITPESWPGV--ETLDLYNKM-ELPKAQKRKVKERLK-PYV 230
            I           W  V  E  DL NKM  +  A++    E LK P++
Sbjct: 217 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPAKRITASEALKHPWI 264

>pdb|2VZ6|A Chain A, Structure Of Human Calcium Calmodulin Dependent Protein Kinase Type Ii Alpha (Camk2a) In Complex With Indirubin E804 Length = 313

Iteration: 1
 Score = 76.3 bits (186), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 65/216 (30%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    + + Y        L+FD        L  +I  +  +S
Sbjct: 70  REARICRLLKHPNIVRLHDSISEEGHHY--------LIFDLVTG--GELFEDIVAREYYS 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + + H   ++HRD+K  N+L+    K   +KLADFGLA        
Sbjct: 120 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKLKGAAVKLADFGLAIEV----E 175
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G+   +     T  Y  PE+L  D  YG PVDLW  G I+  +    P      + +   
Sbjct: 176 GEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 234
Query: 187 LISQLCGSITPESWPGV--ETLDLYNKMELPKAQKR 220
            I           W  V  E  DL NKM      KR
Sbjct: 235 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKR 270

>pdb|3MN3|A Chain A, An Inhibited Conformation For The Protein Kinase Domain Of The Saccharomyces Cerevisiae Ampk Homolog Snf1 Length = 271

Iteration: 1
 Score = 75.9 bits (185), Expect = 4e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++ ++K            +V ++  ++L   +     K S  
Sbjct: 53  REISYLRLLRHPHIIKLYDVIKSK--------DEIIMVIEYAGNELFDYIVQ-RDKMSEQ 103
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA-----FSQTKN 126
           E ++  QQ+++ + Y H +KI+HRD+K  N+L+ +   +K+ADFGL+       F +T  
Sbjct: 104 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 163
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           G  N          Y  PE++ G    GP VD+W  G I+  M  R
Sbjct: 164 GSPN----------YAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 199

>pdb|4EQM|A Chain A, Structural Analysis Of Staphylococcus Aureus SerineTHREONINE KINASE Pknb Length = 294

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 48/169 (28%), Positives = 77/169 (45%), Gaps = 12/169 (7%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+     L H+N+V +I++        +     +YLV ++ E          H   S+ 
Sbjct: 60  REVHNSSQLSHQNIVSMIDV--------DEEDDCYYLVMEYIEGPTLSEYIESHGPLSVD 111
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
                  Q+L+G+ + H  +I+HRD+K  N+LI     LK+ DFG+A+A S+T   Q N 
Sbjct: 112 TAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQTNH 171
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
                 T+ Y  PE   G+       D++  G ++ EM    P   G T
Sbjct: 172 VLG---TVQYFSPEQAKGEAT-DECTDIYSIGIVLYEMLVGEPPFNGET 216

>pdb|1OL6|A Chain A, Structure Of Unphosphorylated D274n Mutant Of Aurora-a Length = 282

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 59  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 108
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+A+FG       + +   
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW------SVHAPS 162
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 163 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 221
Query: 190 QL 191
           ++
Sbjct: 222 RV 223

>pdb|3R21|A Chain A, Design, Synthesis, And Biological Evaluation Of Pyrazolopyridine- Sulfonamides As Potent Multiple-Mitotic Kinase (Mmk) Inhibitors (Part I) Length = 271

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R  +   TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRDDLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|3DAE|A Chain A, Crystal Structure Of Phosphorylated Snf1 Kinase Domain Length = 283

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++ ++K            +V ++  ++L   +     K S  
Sbjct: 63  REISYLRLLRHPHIIKLYDVIKSK--------DEIIMVIEYAGNELFDYIVQ-RDKMSEQ 113
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA-----FSQTKN 126
           E ++  QQ+++ + Y H +KI+HRD+K  N+L+ +   +K+ADFGL+       F +T  
Sbjct: 114 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 173
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           G  N          Y  PE++ G    GP VD+W  G I+  M  R
Sbjct: 174 GSPN----------YAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 209

>pdb|2FH9|A Chain A, Structure And Dimerization Of The Kinase Domain From Yeast Snf1 Length = 274

Iteration: 1
 Score = 75.5 bits (184), Expect = 5e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++ ++K            +V ++  ++L   +     K S  
Sbjct: 57  REISYLRLLRHPHIIKLYDVIKSK--------DEIIMVIEYAGNELFDYIVQ-RDKMSEQ 107
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA-----FSQTKN 126
           E ++  QQ+++ + Y H +KI+HRD+K  N+L+ +   +K+ADFGL+       F +T  
Sbjct: 108 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 167
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           G  N          Y  PE++ G    GP VD+W  G I+  M  R
Sbjct: 168 GSPN----------YAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 203

>pdb|3HYH|A Chain A, Crystal Structure Of The Protein Kinase Domain Of Yeast Amp-Activated Protein Kinase Snf1 Length = 275

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 49/166 (29%), Positives = 84/166 (50%), Gaps = 24/166 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++ ++K            +V ++  ++L   +     K S  
Sbjct: 62  REISYLRLLRHPHIIKLYDVIKSK--------DEIIMVIEYAGNELFDYIVQ-RDKMSEQ 112
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA-----FSQTKN 126
           E ++  QQ+++ + Y H +KI+HRD+K  N+L+ +   +K+ADFGL+       F +T  
Sbjct: 113 EARRFFQQIISAVEYCHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDGNFLKTSC 172
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           G  N          Y  PE++ G    GP VD+W  G I+  M  R
Sbjct: 173 GSPN----------YAAPEVISGKLYAGPEVDVWSCGVILYVMLCR 208

>pdb|4FSY|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEIXINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3UNZ|A Chain A, Aurora A In Complex With Rpm1679 Length = 279

Iteration: 1
 Score = 75.5 bits (184), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 58  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 107
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 108 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 161
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 162 SRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 220
Query: 190 QL 191
           ++
Sbjct: 221 RV 222

>pdb|2HOG|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 20 Length = 322

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2XNE|A Chain A, Structure Of Aurora-A Bound To An Imidazopyrazine Inhibitor Length = 272

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+A+FG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIANFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|4FSZ|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEIXINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2YDJ|A Chain A, Discovery Of Checkpoint Kinase Inhibitor Azd7762 By Structure Based Design And Optimization Of Thiophene Carboxamide Ureas Length = 276

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEIXINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2R0U|A Chain A, Crystal Structure Of Chek1 In Complex With Inhibitor 54 Length = 323

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|3NRM|A Chain A, Imidazo[1,2-A]pyrazine-Based Aurora Kinase Inhibitors Length = 283

Iteration: 1
 Score = 75.1 bits (183), Expect = 6e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|2WTV|A Chain A, Aurora-A Inhibitor Structure Length = 285

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 53/180 (29%), Positives = 81/180 (45%), Gaps = 15/180 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE++I   L+H N++ L          Y    +  YL+ ++              KF   
Sbjct: 62  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYAPRGEVYKELQKLSKFDEQ 113
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
                I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   +R
Sbjct: 114 RTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPSSR 167
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL 191
                 TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS++
Sbjct: 168 RXXLXGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRISRV 226

>pdb|3COH|A Chain A, Crystal Structure Of Aurora-A In Complex With A Pentacyclic Inhibitor Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 55/182 (30%), Positives = 83/182 (45%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDSTRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS K++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKKVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q     IS
Sbjct: 161 SRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQDTYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|1OL5|A Chain A, Structure Of Aurora-A 122-403, Phosphorylated On Thr287, Thr288 And Bound To Tpx2 1-43 Length = 282

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 59  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 108
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 109 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 162
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 163 SRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 221
Query: 190 QL 191
           ++
Sbjct: 222 RV 223

>pdb|3Q4Z|A Chain A, Structure Of Unphosphorylated Pak1 Kinase Domain Length = 306

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 52/172 (30%), Positives = 88/172 (51%), Gaps = 11/172 (6%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD----FCEHDLAGLLSNI 64
            A+R++ + Q  K E +++ I + R   N         YLV D      E+   G L+++
Sbjct: 49  VAIRQMNLQQQPKKELIINEILVMRENKNPNIVNYLDSYLVGDELWVVMEYLAGGSLTDV 108
Query: 65  HVKFSL--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             +  +  G+I  V ++ L  L ++HSN+++HR++K+ N+L+   G +KL DFG     +
Sbjct: 109 VTETCMDEGQIAAVCRECLQALEFLHSNQVIHRNIKSDNILLGMDGSVKLTDFGFC---A 165
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           Q    Q  R T  V T ++  PE++   + YGP VD+W  G +  EM    P
Sbjct: 166 QITPEQSKRST-MVGTPYWMAPEVVT-RKAYGPKVDIWSLGIMAIEMIEGEP 215

>pdb|3H0Y|A Chain A, Aurora A In Complex With A Bisanilinopyrimidine Length = 268

Iteration: 1
 Score = 75.1 bits (183), Expect = 7e-14,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRAALCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|2BR1|A Chain A, Structure-Based Design Of Novel Chk1 Inhibitors: Insights Into Hydrogen Bonding And Protein-Ligand Affinity Length = 297

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1IA8|A Chain A, The 1.7 A Crystal Structure Of Human Cell Cycle Checkpoint Kinase Chk1 Length = 289

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|1ZLT|A Chain A, Crystal Structure Of Chk1 Complexed With A Hymenaldisine Analog Length = 295

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|4FSN|A Chain A, Crystal Structure Of The Chk1 Length = 278

Iteration: 1
 Score = 74.7 bits (182), Expect = 9e-14,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 47  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 96
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 97  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 153
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 154 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 199

>pdb|1ZYC|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: Wild- Type In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYN-----RYRSTFYLVFDFCEH-DLAGLLS 62
           T L E+ +L  L H+ VV        + N        + +ST ++  ++CE+  L  L+ 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENRTLYDLIH 107
Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF- 121
           + ++     E  ++ +Q+L  L YIHS  I+HRD+K  N+ I ++  +K+ DFGLA+   
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 122 ---------SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                    SQ   G  +  T+ + T  Y   E+L G  +Y   +D++  G I  EM   
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--- 224
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPK 216
             I   +T  +++ ++ +L  S++ E  P  +     NKM++ K
Sbjct: 225 --IYPFSTGMERVNILKKL-RSVSIEFPPDFDD----NKMKVEK 261

>pdb|4FSM|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSU|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|1ZY4|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: R794g Hyperactivating Mutant In Apo Form. Length = 303

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 61/224 (27%), Positives = 108/224 (48%), Gaps = 26/224 (11%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYN-----RYRSTFYLVFDFCEHD-LAGLLS 62
           T L E+ +L  L H+ VV        + N        + +ST ++  ++CE+  L  L+ 
Sbjct: 48  TILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIH 107
Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF- 121
           + ++     E  ++ +Q+L  L YIHS  I+HRD+K  N+ I ++  +K+ DFGLA+   
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVH 167
Query: 122 ---------SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                    SQ   G  +  T+ + T  Y   E+L G  +Y   +D++  G I  EM   
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM--- 224
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPK 216
             I   +T  +++ ++ +L  S++ E  P  +     NKM++ K
Sbjct: 225 --IYPFSTGMERVNILKKL-RSVSIEFPPDFDD----NKMKVEK 261

>pdb|3OT3|A Chain A, X-Ray Crystal Structure Of Compound 22k Bound To Human Chk1 Kinase Domain Length = 273

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2W1C|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 275

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 60  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 109
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 110 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 163
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 164 SRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 222
Query: 190 QL 191
           ++
Sbjct: 223 RV 224

>pdb|2E9V|A Chain A, Structure Of H-Chk1 Complexed With A859017 Length = 268

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|2X8E|A Chain A, Discovery Of A Novel Class Of Triazolones As Checkpoint Kinase Inhibitors - Hit To Lead Exploration Length = 276

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2AYP|A Chain A, Crystal Structure Of Chk1 With An Indol Inhibitor Length = 269

Iteration: 1
 Score = 74.7 bits (182), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2GHG|A Chain A, H-Chk1 Complexed With A431994 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3JVR|A Chain A, Characterization Of The Chk1 Allosteric Inhibitor Binding Site Length = 271

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3HA6|A Chain A, Crystal Structure Of Aurora A In Complex With Tpx2 And Compound 10 Length = 268

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 54/182 (29%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    KF 
Sbjct: 57  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSKFD 106
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 107 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGW------SVHAPS 160
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + NT Q+    IS
Sbjct: 161 SRRXXLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGKPPFEANTYQETYKRIS 219
Query: 190 QL 191
           ++
Sbjct: 220 RV 221

>pdb|4FT3|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|4FSW|A Chain A, Crystal Structure Of The Chk1 Length = 279

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|3SOA|A Chain A, Full-Length Human Camkii Length = 444

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 64/216 (29%), Positives = 92/216 (42%), Gaps = 22/216 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    + + Y        L+FD        L  +I  +  +S
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGHHY--------LIFDLVTG--GELFEDIVAREYYS 108
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + + H   ++HR++K  N+L+    K   +KLADFGLA        
Sbjct: 109 EADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEV----E 164
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G+   +     T  Y  PE+L  D  YG PVDLW  G I+  +    P      + +   
Sbjct: 165 GEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDLWACGVILYILLVGYPPFWDEDQHRLYQ 223
Query: 187 LISQLCGSITPESWPGV--ETLDLYNKMELPKAQKR 220
            I           W  V  E  DL NKM      KR
Sbjct: 224 QIKAGAYDFPSPEWDTVTPEAKDLINKMLTINPSKR 259

>pdb|4FST|A Chain A, Crystal Structure Of The Chk1 Length = 269

Iteration: 1
 Score = 74.3 bits (181), Expect = 1e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 78/172 (45%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I ++L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 48  PENIKKEICINKMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 97
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 98  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 154
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 155 ------RYNNRERLLNKMXGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 200

>pdb|1ZYS|A Chain A, Co-Crystal Structure Of Checkpoint Kinase Chk1 With A Pyrrolo-Pyridine Inhibitor Length = 273

Iteration: 1
 Score = 73.9 bits (180), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 55/172 (31%), Positives = 77/172 (44%), Gaps = 28/172 (16%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           P    +EI I  +L HENVV        K   + R  +  YL  ++C      L   I  
Sbjct: 49  PENIKKEICINAMLNHENVV--------KFYGHRREGNIQYLFLEYCSG--GELFDRIEP 98
Query: 67  KFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
              + E   ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F   
Sbjct: 99  DIGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVF--- 155
Query: 125 KNGQVNRYTNR-------VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                 RY NR         TL Y  PELL     +  PVD+W  G ++  M
Sbjct: 156 ------RYNNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM 201

>pdb|2V7O|A Chain A, Crystal Structure Of Human Calcium-Calmodulin-Dependent Protein Kinase Ii Gamma Length = 336

Iteration: 1
 Score = 73.6 bits (179), Expect = 2e-13,   Method: Compositional matrix adjust.
 Identities = 54/160 (33%), Positives = 77/160 (48%), Gaps = 20/160 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    +   Y        LVFD        L  +I  +  +S
Sbjct: 79  REARICRLLKHPNIVRLHDSISEEGFHY--------LVFDLVTG--GELFEDIVAREYYS 128
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
             +    I Q+L  + +IH + I+HRD+K  N+L+    K   +KLADFGLA        
Sbjct: 129 EADASHCIHQILESVNHIHQHDIVHRDLKPENLLLASKCKGAAVKLADFGLAIEV----Q 184
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
           G+   +     T  Y  PE+L  D  YG PVD+W  G I+
Sbjct: 185 GEQQAWFGFAGTPGYLSPEVLRKD-PYGKPVDIWACGVIL 223

>pdb|3LM0|A Chain A, Crystal Structure Of Human SerineTHREONINE KINASE 17B (STK17B) Length = 327

Iteration: 1
 Score = 73.2 bits (178), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 62/233 (26%), Positives = 101/233 (43%), Gaps = 44/233 (18%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLV-----------FDFCEHDLAG 59
           L EI +L+L K          C    N +  Y +T  ++           F  C  +LA 
Sbjct: 76  LHEIAVLELAKS---------CPRVINLHEVYENTSEIILILEYAAGGEIFSLCLPELAE 126
Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKT---GILKLADFG 116
           ++S         ++ ++I+Q+L G+YY+H N I+H D+K  N+L++     G +K+ DFG
Sbjct: 127 MVSE-------NDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFG 179
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRS 173
           ++R     K G        + T  Y  PE+L    NY P     D+W  G I   + T +
Sbjct: 180 MSR-----KIGHACELREIMGTPEYLAPEIL----NYDPITTATDMWNIGIIAYMLLTHT 230
Query: 174 PIMQGNTEQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKRKVKE 224
               G   Q+    ISQ+    + E++  V  L  D    + +   +KR   E
Sbjct: 231 SPFVGEDNQETYLNISQVNVDYSEETFSSVSQLATDFIQSLLVKNPEKRPTAE 283

>pdb|3D14|A Chain A, Crystal Structure Of Mouse Aurora A (Asn186->gly, Lys240->arg, Met302- >leu) In Complex With 1-{5-[2-(Thieno[3,2-D]pyrimidin-4-Ylamino)- Ethyl]- Thiazol-2-Yl}-3-(3-Trifluoromethyl-Phenyl)-Urea Length = 272

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 53/182 (29%), Positives = 85/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    +F 
Sbjct: 61  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSRFD 110
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW------SVHAPS 164
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R T    TL Y PPE++ G R +   VDLW  G +  E     P  + +T Q+    IS
Sbjct: 165 SRRTTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 190 QL 191
           ++
Sbjct: 224 RV 225

>pdb|3MFR|A Chain A, Cask-4m Cam Kinase Domain, Native Length = 351

Iteration: 1
 Score = 72.8 bits (177), Expect = 3e-13,   Method: Compositional matrix adjust.
 Identities = 69/235 (29%), Positives = 110/235 (46%), Gaps = 29/235 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE  I  +LKH ++V L+E   +            Y+VF+F   D A L   I  +   G
Sbjct: 75  REASICHMLKHPHIVELLETYSSDG--------MLYMVFEFM--DGADLCFEIVKRADAG 124
Query: 72  EI------KKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFS 122
            +         ++Q+L  L Y H N I+HRD+K  NVL+     +  +KL DFG+A    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPENVLLASKENSAPVKLGDFGVAIQLG 184
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           ++  G V     RV T  +  PE++  +  YG PVD+WG G I+  + +      G T++
Sbjct: 185 ES--GLVA--GGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYG-TKE 238
Query: 183 QQITLISQLCGSITPESWPGV--ETLDLYNKM-ELPKAQKRKVKERLK-PYVKDQ 233
           +    I +    + P  W  +     DL  +M  L  A++  V E L  P++K++
Sbjct: 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>pdb|2BDW|A Chain A, Crystal Structure Of The Auto-Inhibited Kinase Domain Of CalciumCALMODULIN ACTIVATED KINASE II Length = 362

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I + L+H N+V L +  + +        S  YLVFD        L  +I  +  +S
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTG--GELFEDIVAREFYS 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA   + ++ 
Sbjct: 127 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 185
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
                +     T  Y  PE+L  D  Y  PVD+W  G I+
Sbjct: 186 ----AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVIL 220

>pdb|3JUH|A Chain A, Crystal Structure Of A Mutant Of Human Protein Kinase Ck2alpha With Altered Cosubstrate Specificity Length = 335

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 42/125 (33%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NVLI  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVLIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|3IS5|A Chain A, Crystal Structure Of Cdpk Kinase Domain From Toxoplasma Gondii, Tgme49_018720 Length = 285

Iteration: 1
 Score = 72.4 bits (176), Expect = 5e-13,   Method: Compositional matrix adjust.
 Identities = 46/161 (28%), Positives = 79/161 (49%), Gaps = 22/161 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK---F 68
           EI++L+ L H N++ + E+     N         Y+V + CE  +L   + +   +    
Sbjct: 70  EIEVLKSLDHPNIIKIFEVFEDYHN--------MYIVMETCEGGELLERIVSAQARGKAL 121
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTK 125
           S G + ++++Q++N L Y HS  ++H+D+K  N+L   T     +K+ DFGLA  F   +
Sbjct: 122 SEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE 181
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +      TN   T  Y  PE+   D  +    D+W AG +M
Sbjct: 182 HS-----TNAAGTALYMAPEVFKRDVTF--KCDIWSAGVVM 215

>pdb|2WQM|A Chain A, Structure Of Apo Human Nek7 Length = 310

Iteration: 1
 Score = 72.0 bits (175), Expect = 6e-13,   Method: Compositional matrix adjust.
 Identities = 57/202 (28%), Positives = 94/202 (46%), Gaps = 34/202 (16%)
Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFY------LVFDFCEH-DLAGLLS 62
            ++EI +L+ L H NV+              +Y ++F       +V +  +  DL+ ++ 
Sbjct: 79  CIKEIDLLKQLNHPNVI--------------KYYASFIEDNELNIVLELADAGDLSRMIK 124
Query: 63  NIHVKFSL---GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +   +  L     + K   QL + L ++HS +++HRD+K ANV IT TG++KL D GL R
Sbjct: 125 HFKKQKRLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGR 184
Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
            FS           + V T +Y  PE  + +  Y    D+W  GC++ EM        G+
Sbjct: 185 FFSSKTTAA----HSLVGTPYYMSPE-RIHENGYNFKSDIWSLGCLLYEMAALQSPFYGD 239
Query: 180 TEQQQITLISQLCGSITPESWP 201
               ++ L S LC  I    +P
Sbjct: 240 ----KMNLYS-LCKKIEQCDYP 256

>pdb|3KK8|A Chain A, Camkii Substrate Complex A Length = 284

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I + L+H N+V L +  + +        S  YLVFD        L  +I  +  +S
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTG--GELFEDIVAREFYS 103
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA   + ++ 
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 163
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
                +     T  Y  PE+L  D  Y  PVD+W  G I+
Sbjct: 164 -----WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVIL 197

>pdb|3KL8|A Chain A, Camkiintide Inhibitor Complex Length = 269

Iteration: 1
 Score = 72.0 bits (175), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I + L+H N+V L +  + +        S  YLVFD        L  +I  +  +S
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTG--GELFEDIVAREFYS 103
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA   + ++ 
Sbjct: 104 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE- 162
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
                +     T  Y  PE+L  D  Y  PVD+W  G I+
Sbjct: 163 ----AWHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVIL 197

>pdb|3KK9|A Chain A, Camkii Substrate Complex B Length = 282

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 53/160 (33%), Positives = 79/160 (49%), Gaps = 21/160 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I + L+H N+V L +  + +        S  YLVFD        L  +I  +  +S
Sbjct: 53  REARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTG--GELFEDIVAREFYS 102
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA   + ++ 
Sbjct: 103 EADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSEA 162
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
                +     T  Y  PE+L  D  Y  PVD+W  G I+
Sbjct: 163 -----WHGFAGTPGYLSPEVLKKD-PYSKPVDIWACGVIL 196

>pdb|3COK|A Chain A, Crystal Structure Of Plk4 Kinase Length = 278

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 59/203 (29%), Positives = 97/203 (47%), Gaps = 20/203 (9%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRST--FYLVFDFCEH-DLAGLLSNIHVKFS 69
           E+KI   LKH +++ L          YN +  +   YLV + C + ++   L N    FS
Sbjct: 61  EVKIHCQLKHPSILEL----------YNYFEDSNYVYLVLEMCHNGEMNRYLKNRVKPFS 110
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             E +  + Q++ G+ Y+HS+ ILHRD+  +N+L+T+   +K+ADFGLA   +Q K    
Sbjct: 111 ENEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA---TQLKMPHE 167
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
             YT    T  Y  PE+      +G   D+W  GC+   +    P    +T +   TL  
Sbjct: 168 KHYT-LCGTPNYISPEIATRSA-HGLESDVWSLGCMFYTLLIGRPPFDTDTVKN--TLNK 223
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
            +       S+  +E  DL +++
Sbjct: 224 VVLADYEMPSFLSIEAKDLIHQL 246

>pdb|3NGA|A Chain A, Human Ck2 Catalytic Domain In Complex With Cx-4945 Length = 333

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|3Q04|A Chain A, Crystal Structure Of The Apo-Form Of Human Ck2 Alpha At Ph 8.5 Length = 328

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 130 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 184
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 185 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 244
Query: 190 QLCGS 194
           ++ G+
Sbjct: 245 KVLGT 249

>pdb|3MB6|A Chain A, Human Ck2 Catalytic Domain In Complex With A Difurane Derivative Inhibitor (Cpa) Length = 331

Iteration: 1
 Score = 71.6 bits (174), Expect = 7e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|3NSZ|A Chain A, Human Ck2 Catalytic Domain In Complex With Amppn Length = 330

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 185
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 190 QLCGS 194
           ++ G+
Sbjct: 246 KVLGT 250

>pdb|3H30|A Chain A, Crystal Structure Of The Catalytic Subunit Of Human Protein Kinase Ck2 With 5,6-Dichloro-1-Beta-D- Ribofuranosylbenzimidazole Length = 334

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|2R7I|A Chain A, Crystal Structure Of Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|1JWH|A Chain A, Crystal Structure Of Human Protein Kinase Ck2 Holoenzyme Length = 337

Iteration: 1
 Score = 71.6 bits (174), Expect = 8e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|3UIU|A Chain A, Crystal Structure Of Apo-Pkr Kinase Domain Length = 306

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 65/238 (27%), Positives = 102/238 (42%), Gaps = 51/238 (21%)
Query: 10  ALREIKILQLLKHENVVH------------------LIEICRTKANQYNRYRS---TFYL 48
           A RE+K L  L H N+VH                  L        N  N  RS     ++
Sbjct: 52  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSDDSLESSDYDPENSKNSSRSKTKCLFI 111
Query: 49  VFDFCEHDLAGLLSNIHVKFSLGEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVL 103
             +FC+    G L     K    ++ KV+     +Q+  G+ YIHS K++HRD+K +N+ 
Sbjct: 112 QMEFCD---KGTLEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLIHRDLKPSNIF 168
Query: 104 ITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG 163
           +  T  +K+ DFGL  +     +G+  R      TL Y  PE  +  ++YG  VDL+  G
Sbjct: 169 LVDTKQVKIGDFGLVTSLKN--DGKRTRSKG---TLRYMSPE-QISSQDYGKEVDLYALG 222
Query: 164 CIMAEMW---------------TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETL 206
            I+AE+                 R  I+    ++++ TL+ +L  S  PE  P    +
Sbjct: 223 LILAELLHVCDTAFETSKFFTDLRDGIISDIFDKKEKTLLQKLL-SKKPEDRPNTSEI 279

>pdb|3Q9W|A Chain A, Crystal Structure Of Human Ck2 Alpha In Complex With Emodin At Ph 8.5 Length = 336

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|2A19|B Chain B, Pkr Kinase Domain- Eif2alpha- Amp-Pnp Complex. Length = 284

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 62/226 (27%), Positives = 104/226 (46%), Gaps = 40/226 (17%)
Query: 10  ALREIKILQLLKHENVVHLIEIC--------RTKANQYNRYRST-FYLVFDFCEHDLAGL 60
           A RE+K L  L H N+VH    C         T +   +R ++   ++  +FC+    G 
Sbjct: 51  AEREVKALAKLDHVNIVHY-NGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCD---KGT 106
Query: 61  LSNIHVKFSLGEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
           L     K    ++ KV+     +Q+  G+ YIHS K+++RD+K +N+ +  T  +K+ DF
Sbjct: 107 LEQWIEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDF 166
Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW----- 170
           GL  +     +G+  R      TL Y  PE  +  ++YG  VDL+  G I+AE+      
Sbjct: 167 GLVTSLKN--DGKRXRSKG---TLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCDT 220
Query: 171 ----------TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETL 206
                      R  I+    ++++ TL+ +L  S  PE  P    +
Sbjct: 221 AFETSKFFTDLRDGIISDIFDKKEKTLLQKLL-SKKPEDRPNTSEI 265

>pdb|3BQC|A Chain A, High Ph-Value Crystal Structure Of Emodin In Complex With The Catalytic Subunit Of Protein Kinase Ck2 Length = 335

Iteration: 1
 Score = 71.6 bits (174), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|1PJK|A Chain A, Crystal Structure Of A C-terminal Deletion Mutant Of Human Protein Kinase Ck2 Catalytic Subunit Length = 334

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 131 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 185
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 186 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 245
Query: 190 QLCGS 194
           ++ G+
Sbjct: 246 KVLGT 250

>pdb|4DGL|C Chain C, Crystal Structure Of The Ck2 Tetrameric Holoenzyme Length = 335

Iteration: 1
 Score = 71.2 bits (173), Expect = 9e-13,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|3U87|A Chain A, Structure Of A Chimeric Construct Of Human Ck2alpha And Human Ck2alpha' In Complex With A Non-hydrolysable Atp-analogue Length = 349

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 132 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 187 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 246
Query: 190 QLCGS 194
           ++ G+
Sbjct: 247 KVLGT 251

>pdb|2ZJW|A Chain A, Crystal Structure Of Human Ck2 Alpha Complexed With Ellagic Acid Length = 340

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 41/125 (32%), Positives = 71/125 (56%), Gaps = 7/125 (5%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVN 130
           +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +     GQ  
Sbjct: 137 DIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHP---GQ-- 191
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS 189
            Y  RV + +++ PELL+  + Y   +D+W  GC++A M + + P   G+    Q+  I+
Sbjct: 192 EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLVRIA 251
Query: 190 QLCGS 194
           ++ G+
Sbjct: 252 KVLGT 256

>pdb|2ZV2|A Chain A, Crystal Structure Of Human CalciumCALMODULIN-Dependent Protein Kinase Kinase 2, Beta, Camkk2 Kinase Domain In Complex With Sto-609 Length = 298

Iteration: 1
 Score = 71.2 bits (173), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/157 (29%), Positives = 76/157 (48%), Gaps = 13/157 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           +EI IL+ L H NVV L+E+       +       Y+VF+         +  +    S  
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPNEDH------LYMVFELVNQGPVMEVPTLK-PLSED 137
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + +   Q L+ G+ Y+H  KI+HRD+K +N+L+ + G +K+ADFG++  F     G    
Sbjct: 138 QARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEF----KGSDAL 193
Query: 132 YTNRVVTLWYRPPELLLGDRNY--GPPVDLWGAGCIM 166
            +N V T  +  PE L   R    G  +D+W  G  +
Sbjct: 194 LSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTL 230

>pdb|2Y94|A Chain A, Structure Of An Active Form Of Mammalian Ampk Length = 476

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 47/158 (29%), Positives = 82/158 (51%), Gaps = 19/158 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK---F 68
           REI+ L+L +H +++ L ++  T ++           +F   E+   G L +   K    
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTPSD-----------IFMVMEYVSGGELFDYICKNGRL 113
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              E +++ QQ+L+G+ Y H + ++HRD+K  NVL+      K+ADFGL+   S   +G+
Sbjct: 114 DEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGE 170
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             R +    +  Y  PE++ G    GP VD+W +G I+
Sbjct: 171 FLRXS--CGSPNYAAPEVISGRLYAGPEVDIWSSGVIL 206

>pdb|3F69|A Chain A, Crystal Structure Of The Mycobacterium Tuberculosis Pknb Mutant Kinase Domain In Complex With Kt5720 Length = 311

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/106 (34%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN+LI+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANILISATNAVKVVDFGIARAIADSGN-SVXQTAA 178
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 179 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3DAJ|A Chain A, Crystal Structure Of Aurora A Complexed With An Inhibitor Discovered Through Site-Directed Dynamic Tethering Length = 272

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 52/182 (28%), Positives = 84/182 (46%), Gaps = 19/182 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH--VKFS 69
           RE++I   L+H N++ L          Y    +  YL+ ++    L  +   +    +F 
Sbjct: 61  REVEIQSHLRHPNILRLY--------GYFHDATRVYLILEYA--PLGTVYRELQKLSRFD 110
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 111 EQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSNGELKIADFGW------SVHAPS 164
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +R      TL Y PPE++ G R +   VDLW  G +  E     P  + +T Q+    IS
Sbjct: 165 SRRDTLCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEFLVGMPPFEAHTYQETYRRIS 223
Query: 190 QL 191
           ++
Sbjct: 224 RV 225

>pdb|3ZHP|C Chain C, Human Mst3 (stk24) In Complex With Mo25beta Length = 294

Iteration: 1
 Score = 70.9 bits (172), Expect = 1e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 125 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 181
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 182 NTFVGTPFWMAPE--VIKQSAYDSKADIWSLGITAIELARGEP 222

>pdb|3CKW|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) Length = 304

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 105 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 161
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 162 NTFVGTPFWMAPE--VIKQSAYDSKADIWSLGITAIELARGEP 202

>pdb|2F57|A Chain A, Crystal Structure Of The Human P21-activated Kinase 5 Length = 317

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 66/275 (24%), Positives = 114/275 (41%), Gaps = 61/275 (22%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++   H+NVV          + Y+ Y      ++V +F E    G L++I  H + 
Sbjct: 92  EVVIMRDYHHDNVV----------DMYSSYLVGDELWVVMEFLE---GGALTDIVTHTRM 138
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V   +L  L Y+H+  ++HRD+K+ ++L+T  G +KL+DFG     S+    +
Sbjct: 139 NEEQIATVCLSVLRALSYLHNQGVIHRDIKSDSILLTSDGRIKLSDFGFCAQVSK----E 194
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V +    V T ++  PE ++    YG  VD+W  G ++ EM    P              
Sbjct: 195 VPKRKXLVGTPYWMAPE-VISRLPYGTEVDIWSLGIMVIEMIDGEP-------------- 239
Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXX-----XX 243
                               +N  E P    R++++ L P VKD +              
Sbjct: 240 ------------------PYFN--EPPLQAMRRIRDSLPPRVKDLHKVSSVLRGFLDLML 279
Query: 244 XXXPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
              PS+R  +   L H F      PS +  ++ Q+
Sbjct: 280 VREPSQRATAQELLGHPFLKLAGPPSCIVPLMRQY 314

>pdb|3BHH|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase Iib Isoform 1 (camk2b) Length = 295

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 52/160 (32%), Positives = 75/160 (46%), Gaps = 20/160 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FS 69
           RE +I +LLKH N+V L +    +   Y        LVFD        L  +I  +  +S
Sbjct: 52  REARICRLLKHSNIVRLHDSISEEGFHY--------LVFDLVTG--GELFEDIVAREYYS 101
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
             +    IQQ+L  + + H   ++HRD+K  N+L+    K   +KLADFGLA        
Sbjct: 102 EADASHCIQQILEAVLHCHQMGVVHRDLKPENLLLASKCKGAAVKLADFGLAIEV----Q 157
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
           G    +     T  Y  PE+L  +  YG PVD+W  G I+
Sbjct: 158 GDQQAWFGFAGTPGYLSPEVLRKE-AYGKPVDIWACGVIL 196

>pdb|3GGF|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase Mst4 In Complex With An Quinazolin Length = 301

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 37/103 (35%), Positives = 57/103 (55%), Gaps = 5/103 (4%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 121 QIATMLKEILKGLDYLHSEKKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKR 177
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            T      W  P   ++    Y    D+W  G    E+    P
Sbjct: 178 NTFVGTPFWMAPE--VIQQSAYDSKADIWSLGITAIELAKGEP 218

>pdb|2PWL|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549h Mutation Responsible For Crouzon Syndrome. Length = 324

Iteration: 1
 Score = 70.5 bits (171), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N++HL+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIIHLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 208 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|4E6D|A Chain A, Jak2 Kinase (Jh1 Domain) Triple Mutant In Complex With Compound 7 Length = 298

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 47/187 (25%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ +F  +  L   L     +   
Sbjct: 63  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEFLPYGSLREYLQKHKERIDH 116
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 117 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 177 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 235 KQGQMIV 241

>pdb|3F61|A Chain A, Crystal Structure Of M. Tuberculosis Pknb Leu33aspVAL222ASP DOUBLE MUTANT IN COMPLEX WITH ADP Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAA 178
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 179 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3HKO|A Chain A, Crystal Structure Of A Cdpk Kinase Domain From Cryptosporidium Parvum, Cgd7_40 Length = 345

Iteration: 1
 Score = 70.1 bits (170), Expect = 2e-12,   Method: Compositional matrix adjust.
 Identities = 34/97 (35%), Positives = 58/97 (59%), Gaps = 3/97 (3%)
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNGQVN 130
           I  +++Q+ + L+Y+H+  I HRD+K  N L +  K+  +KL DFGL++ F +  NG+  
Sbjct: 170 ISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYY 229
Query: 131 RYTNRVVTLWYRPPELL-LGDRNYGPPVDLWGAGCIM 166
             T +  T ++  PE+L   + +YGP  D W AG ++
Sbjct: 230 GMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLL 266

>pdb|3ORI|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain L33d Mutant (Crystal Form 1) Length = 311

Iteration: 1
 Score = 70.1 bits (170), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAA 178
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 179 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|1MRU|A Chain A, Intracellular SerTHR PROTEIN KINASE DOMAIN OF Mycobacterium Tuberculosis Pknb. Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAA 178
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 179 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|3ORM|A Chain A, Mycobacterium Tuberculosis Pknb Kinase Domain D76a Mutant Length = 311

Iteration: 1
 Score = 69.7 bits (169), Expect = 3e-12,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 120 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAA 178
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 179 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 223

>pdb|2W1I|A Chain A, Structure Determination Of Aurora Kinase In Complex With Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 91  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 144
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 145 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 204
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 205 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 262
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 263 KQGQMIV 269

>pdb|1O6Y|A Chain A, Catalytic Domain Of Pknb Kinase From Mycobacterium Tuberculosis Length = 299

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 36/106 (33%), Positives = 58/106 (54%), Gaps = 2/106 (1%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N  V +   
Sbjct: 137 EVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAA 195
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            + T  Y  PE   GD +     D++  GC++ E+ T  P   G++
Sbjct: 196 VIGTAQYLSPEQARGD-SVDARSDVYSLGCVLYEVLTGEPPFTGDS 240

>pdb|2X7F|A Chain A, Crystal Structure Of The Kinase Domain Of Human Traf2- And Nck-Interacting Kinase With Wee1chk1 Inhibitor Length = 326

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 43/139 (30%), Positives = 73/139 (52%), Gaps = 18/139 (12%)
Query: 46  FYLVFDFCEHDLAGLLSNIHVKFSLGE------IKKVIQQLLNGLYYIHSNKILHRDMKA 99
            +LV +FC    AG ++++ +K + G       I  + +++L GL ++H +K++HRD+K 
Sbjct: 102 LWLVMEFCG---AGSVTDL-IKNTKGNTLKEEWIAYICREILRGLSHLHQHKVIHRDIKG 157
Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----YGP 155
            NVL+T+   +KL DFG++    +T    V R    + T ++  PE++  D N    Y  
Sbjct: 158 QNVLLTENAEVKLVDFGVSAQLDRT----VGRRNTFIGTPYWMAPEVIACDENPDATYDF 213
Query: 156 PVDLWGAGCIMAEMWTRSP 174
             DLW  G    EM   +P
Sbjct: 214 KSDLWSLGITAIEMAEGAP 232

>pdb|2YZA|A Chain A, Crystal Structure Of Kinase Domain Of Human 5'-Amp-Activated Protein Kinase Alpha-2 Subunit Mutant (T172d) Length = 276

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/158 (29%), Positives = 82/158 (51%), Gaps = 19/158 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI---HVKF 68
           REI+ L+L +H +++ L ++  T  +        F++V ++      G L +    H + 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD--------FFMVMEYVS---GGELFDYICKHGRV 108
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              E +++ QQ+L+ + Y H + ++HRD+K  NVL+      K+ADFGL+   S   +G+
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMS---DGE 165
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             R  +   +  Y  PE++ G    GP VD+W  G I+
Sbjct: 166 FLR--DSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|4HGE|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 8 Length = 300

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 65  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 118
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 119 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 178
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 179 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 236
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 237 KQGQMIV 243

>pdb|4AQC|A Chain A, Triazolopyridine-Based Inhibitor Of Janus Kinase 2 Length = 301

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 66  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 119
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 120 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 179
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 180 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 237
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 238 KQGQMIV 244

>pdb|3TJC|A Chain A, Co-Crystal Structure Of Jak2 With Thienopyridine 8 Length = 298

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 63  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 116
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 117 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 177 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 235 KQGQMIV 241

>pdb|4E4M|A Chain A, Jak2 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 69.3 bits (168), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 67  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 120
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 121 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 180
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 181 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 238
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 239 KQGQMIV 245

>pdb|2B7A|A Chain A, The Structural Basis Of Janus Kinase 2 Inhibition By A Potent And Specific Pan-Janus Kinase Inhibitor Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 58  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 111
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 112 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 171
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 172 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 229
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 230 KQGQMIV 236

>pdb|3RVG|A Chain A, Crystals Structure Of Jak2 With A 1-Amino-5h-Pyrido[4,3-B]indol-4- Carboxamide Inhibitor Length = 303

Iteration: 1
 Score = 68.9 bits (167), Expect = 4e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 64  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 117
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 118 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 177
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 178 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 235
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 236 KQGQMIV 242

>pdb|2J7T|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Su11274 Length = 302

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG- 71
           EI+IL    H  +V L+         Y  +    +++ +FC     G +  I ++   G 
Sbjct: 66  EIEILATCDHPYIVKLL-------GAY-YHDGKLWIMIEFCP---GGAVDAIMLELDRGL 114
Query: 72  ---EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I+ V +Q+L  L ++HS +I+HRD+KA NVL+T  G ++LADFG++    +T    
Sbjct: 115 TEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---- 170
Query: 129 VNRYTNRVVTLWYRPPELL----LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           + +  + + T ++  PE++    + D  Y    D+W  G  + EM    P
Sbjct: 171 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 220

>pdb|3E62|A Chain A, Fragment Based Discovery Of Jak-2 Inhibitors Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 59  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 112
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 113 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 172
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 173 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 230
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 231 KQGQMIV 237

>pdb|2BFY|A Chain A, Complex Of Aurora-B With Incenp And Hesperidin. Length = 284

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI+I   L+H N++ +          YN +  R   YL+ +F            H +F 
Sbjct: 63  REIEIQSHLRHPNILRM----------YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 112
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  +++L + L+Y H  K++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 113 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW------SVHAPS 166
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            R      TL Y PPE++ G + +   VDLW AG +  E     P
Sbjct: 167 LRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMP 210

>pdb|4BC6|A Chain A, Crystal Structure Of Human Serine Threonine Kinase-10 Bound To Novel Bosutinib Isoform 1, Previously Thought To Be Bosutinib Length = 293

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 85/170 (50%), Gaps = 23/170 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG- 71
           EI+IL    H  +V L+         Y  +    +++ +FC     G +  I ++   G 
Sbjct: 58  EIEILATCDHPYIVKLL-------GAY-YHDGKLWIMIEFCP---GGAVDAIMLELDRGL 106
Query: 72  ---EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I+ V +Q+L  L ++HS +I+HRD+KA NVL+T  G ++LADFG++    +T    
Sbjct: 107 TEPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKT---- 162
Query: 129 VNRYTNRVVTLWYRPPELL----LGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           + +  + + T ++  PE++    + D  Y    D+W  G  + EM    P
Sbjct: 163 LQKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSLGITLIEMAQIEP 212

>pdb|2VRX|A Chain A, Structure Of Aurora B Kinase In Complex With Zm447439 Length = 285

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 76/165 (46%), Gaps = 19/165 (11%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI+I   L+H N++ +          YN +  R   YL+ +F            H +F 
Sbjct: 64  REIEIQSHLRHPNILRM----------YNYFHDRKRIYLMLEFAPRGELYKELQKHGRFD 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                  +++L + L+Y H  K++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 114 EQRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGW------SVHAPS 167
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            R      TL Y PPE++ G + +   VDLW AG +  E     P
Sbjct: 168 LRRRXMCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEFLVGMP 211

>pdb|2H6D|A Chain A, Protein Kinase Domain Of The Human 5'-Amp-Activated Protein Kinase Catalytic Subunit Alpha-2 (Ampk Alpha-2 Chain) Length = 276

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/163 (28%), Positives = 80/163 (49%), Gaps = 29/163 (17%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI---HVKF 68
           REI+ L+L +H +++ L ++  T  +        F++V ++      G L +    H + 
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTPTD--------FFMVMEYVS---GGELFDYICKHGRV 108
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-----Q 123
              E +++ QQ+L+ + Y H + ++HRD+K  NVL+      K+ADFGL+   S     +
Sbjct: 109 EEMEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLR 168
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
           T  G  N          Y  PE++ G    GP VD+W  G I+
Sbjct: 169 TSCGSPN----------YAAPEVISGRLYAGPEVDIWSCGVIL 201

>pdb|3Q32|A Chain A, Structure Of Janus Kinase 2 With A Pyrrolotriazine Inhibitor Length = 301

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 60  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 174 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 232 KQGQMIV 238

>pdb|2PVF|A Chain A, Crystal Structure Of Tyrosine Phosphorylated Activated Fgf Receptor 2 (Fgfr2) Kinase Domain In Complex With Atp Analog And Substrate Peptide Length = 334

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 12/170 (7%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEXSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +     +  + TN  + + +  PE L  DR Y    D+W  G +M E++T
Sbjct: 208 NNIDXXK--KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2QG5|A Chain A, Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 Length = 294

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN--IHVK-F 68
           +EI+I++ L H N++ L E      +         YLV + C     G L    +H + F
Sbjct: 72  QEIEIMKSLDHPNIIRLYETFEDNTD--------IYLVMELC---TGGELFERVVHKRVF 120
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
              +  ++++ +L+ + Y H   + HRD+K  N L    +    LKL DFGLA  F   K
Sbjct: 121 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---K 177
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G++ R   +V T +Y  P++L G   YGP  D W AG +M  +    P     T+ + +
Sbjct: 178 PGKMMR--TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 233
Query: 186 TLISQLCGSITPESW----PGVETL 206
             I +   +   + W    P  E+L
Sbjct: 234 LKIREGTFTFPEKDWLNVSPQAESL 258

>pdb|3F3Z|A Chain A, Crystal Structure Of Cryptosporidium Parvum Calcium Dependent Protein Kinase Cgd7_1840 In Presence Of Indirubin E804 Length = 277

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 58/205 (28%), Positives = 94/205 (45%), Gaps = 28/205 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN--IHVK-F 68
           +EI+I++ L H N++ L E      +         YLV + C     G L    +H + F
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTD--------IYLVMELC---TGGELFERVVHKRVF 103
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
              +  ++++ +L+ + Y H   + HRD+K  N L    +    LKL DFGLA  F   K
Sbjct: 104 RESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARF---K 160
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G++ R   +V T +Y  P++L G   YGP  D W AG +M  +    P     T+ + +
Sbjct: 161 PGKMMR--TKVGTPYYVSPQVLEG--LYGPECDEWSAGVMMYVLLCGYPPFSAPTDXEVM 216
Query: 186 TLISQLCGSITPESW----PGVETL 206
             I +   +   + W    P  E+L
Sbjct: 217 LKIREGTFTFPEKDWLNVSPQAESL 241

>pdb|3LPB|A Chain A, Crystal Structure Of Jak2 Complexed With A Potent 2,8-Diaryl Quinoxaline Inhibitor Length = 295

Iteration: 1
 Score = 68.9 bits (167), Expect = 5e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 60  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 173
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 174 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 232 KQGQMIV 238

>pdb|1RJB|A Chain A, Crystal Structure Of Flt3 Length = 344

Iteration: 1
 Score = 68.9 bits (167), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 53/185 (28%), Positives = 83/185 (44%), Gaps = 35/185 (18%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+K++ QL  HEN+V+L+  C              YL+F++C + DL   L +   KF
Sbjct: 96  MSELKMMTQLGSHENIVNLLGACTLSG--------PIYLIFEYCCYGDLLNYLRSKREKF 147
Query: 69  SLGEIKKVIQ----------------------QLLNGLYYIHSNKILHRDMKAANVLITK 106
           S  EI+   Q                      Q+  G+ ++     +HRD+ A NVL+T 
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             ++K+ DFGLAR      N  V R   R+   W  P  L  G   Y    D+W  G ++
Sbjct: 208 GKVVKICDFGLARDIMSDSN-YVVRGNARLPVKWMAPESLFEGI--YTIKSDVWSYGILL 264
Query: 167 AEMWT 171
            E+++
Sbjct: 265 WEIFS 269

>pdb|3JY9|A Chain A, Janus Kinase 2 Inhibitors Length = 311

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 78  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 131
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 132 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 192 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 250 KQGQMIV 256

>pdb|3A7F|A Chain A, Human Mst3 Kinase Length = 303

Iteration: 1
 Score = 68.6 bits (166), Expect = 6e-12,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 120 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 176
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                   W  P   ++    Y    D+W  G    E+    P
Sbjct: 177 NXFVGTPFWMAPE--VIKQSAYDSKADIWSLGITAIELARGEP 217

>pdb|3CKX|A Chain A, Crystal Structure Of Sterile 20-Like Kinase 3 (Mst3, Stk24) In Complex With Staurosporine Length = 304

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 36/103 (34%), Positives = 56/103 (54%), Gaps = 5/103 (4%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R
Sbjct: 105 QIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDT---QIKR 161
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                   W  P   ++    Y    D+W  G    E+    P
Sbjct: 162 NXFVGTPFWMAPE--VIKQSAYDSKADIWSLGITAIELARGEP 202

>pdb|3IO7|A Chain A, 2-Aminopyrazolo[1,5-A]pyrimidines As Potent And Selective Inhibitors Of Jak2 Length = 313

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 78  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 131
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 132 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 191
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 192 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 249
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 250 KQGQMIV 256

>pdb|2XA4|A Chain A, Inhibitors Of Jak2 Kinase Domain Length = 298

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 63  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQAHAERIDH 116
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 117 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEXXKV 176
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 177 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 234
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 235 KQGQMIV 241

>pdb|3P08|A Chain A, Crystal Structure Of The Human Btk Kinase Domain Length = 267

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 51  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 103
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          +
Sbjct: 104 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 157
Query: 131 RYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V +   + + PPE+L+  + +    D+W  G +M E+++
Sbjct: 158 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 200

>pdb|3GQI|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 68.6 bits (166), Expect = 7e-12,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 88/176 (50%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEIC------------RTKAN--QYNRYRSTFYLVFDFCEH 55
           + E+++++++ KH+N+++L+  C             +K N  +Y + R    L F F   
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEFSFNPS 140
Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                  N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADF
Sbjct: 141 ------HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADF 194
Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           GLAR        +  + TN  + + +  PE L  DR Y    D+W  G ++ E++T
Sbjct: 195 GLARDIHHIDXXK--KTTNGRLPVKWMAPEALF-DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3GEN|A Chain A, The 1.6 A Crystal Structure Of Human Bruton's Tyrosine Kinase Bound To A Pyrrolopyrimidine-Containing Compound Length = 283

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 173
Query: 131 RYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V +   + + PPE+L+  + +    D+W  G +M E+++
Sbjct: 174 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>pdb|3CLY|A Chain A, Crystal Structure Of Fgf Receptor 2 (Fgfr2) Kinase Domains Trapped In Trans-Phosphorylation Reaction Length = 334

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 86/170 (50%), Gaps = 12/170 (7%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +     +  + TN  + + +  PE L  DR Y    D+W  G +M E++T
Sbjct: 208 NNIDXXK--KTTNGRLPVKWMAPEALF-DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1K2P|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Domain Length = 263

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 99
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          +
Sbjct: 100 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 153
Query: 131 RYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V +   + + PPE+L+  + +    D+W  G +M E+++
Sbjct: 154 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 196

>pdb|1YVJ|A Chain A, Crystal Structure Of The Jak3 Kinase Domain In Complex With A Staurosporine Analogue Length = 290

Iteration: 1
 Score = 68.2 bits (165), Expect = 8e-12,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 72/161 (44%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSL 70
           REI+IL+ L  + +V      + +   Y   R    LV ++     L   L     +   
Sbjct: 57  REIQILKALHSDFIV------KYRGVSYGPGRPELRLVMEYLPSGCLRDFLQRHRARLDA 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+ S + +HRD+ A N+L+     +K+ADFGLA+     K+  V 
Sbjct: 111 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDXXVV 170
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R   +    WY P    L D  +    D+W  G ++ E++T
Sbjct: 171 REPGQSPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 209

>pdb|4HVD|A Chain A, Jak3 Kinase Domain In Complex With 2-cyclopropyl-5h-pyrrolo[2,3- B]pyrazine-7-carboxylic Acid ((s)-1,2,2-trimethyl-propyl)-amide Length = 314

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSL 70
           REI+IL+ L  + +V      + +   Y   R +  LV ++     L   L     +   
Sbjct: 60  REIQILKALHSDFIV------KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+ S + +HRD+ A N+L+     +K+ADFGLA+     K+  V 
Sbjct: 114 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 173
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R   +    WY P    L D  +    D+W  G ++ E++T
Sbjct: 174 REPGQSPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 212

>pdb|3H4J|B Chain B, Crystal Structure Of Pombe Ampk Kdaid Fragment Length = 336

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 45/165 (27%), Positives = 79/165 (47%), Gaps = 24/165 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++  T  +          +V ++   +L   +     + +  
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTPTD--------IVMVIEYAGGELFDYIVE-KKRMTED 108
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA-----FSQTKN 126
           E ++  QQ++  + Y H +KI+HRD+K  N+L+     +K+ADFGL+       F +T  
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           G  N          Y  PE++ G    GP VD+W  G ++  M  
Sbjct: 169 GSPN----------YAAPEVINGKLYAGPEVDVWSCGIVLYVMLV 203

>pdb|3PIX|A Chain A, Crystal Structure Of Btk Kinase Domain Complexed With 2-Isopropyl-7- (4-Methyl-Piperazin-1-Yl)-4-(5-Methyl-2h-Pyrazol-3- Ylamino)-2h- Phthalazin-1-One Length = 274

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 58  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          +
Sbjct: 111 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 164
Query: 131 RYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V +   + + PPE+L+  + +    D+W  G +M E+++
Sbjct: 165 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 207

>pdb|3OCS|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase In Complex With Inhibitor Cgi1746 Length = 271

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 41/164 (25%), Positives = 80/164 (48%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 104
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          +
Sbjct: 105 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------D 158
Query: 131 RYTNRVVT---LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            YT+ V +   + + PPE+L+  + +    D+W  G +M E+++
Sbjct: 159 EYTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 201

>pdb|2JED|A Chain A, The Crystal Structure Of The Kinase Domain Of The Protein Kinase C Theta In Complex With Nvp-Xaa228 At 2.32a Resolution. Length = 352

Iteration: 1
 Score = 68.2 bits (165), Expect = 9e-12,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 13  EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           E ++L L  +H  + H+    +TK N        F+++      DL   + + H KF L 
Sbjct: 68  EKRVLSLAWEHPFLTHMFCTFQTKEN-------LFFVMEYLNGGDLMYHIQSCH-KFDLS 119
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
                  +++ GL ++HS  I++RD+K  N+L+ K G +K+ADFG+ +  +   + + N 
Sbjct: 120 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNE 178
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL 191
           +     T  Y  PE+LLG + Y   VD W  G ++ EM        G  E++    I ++
Sbjct: 179 FCG---TPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RM 233
Query: 192 CGSITPESWPGVETLDLYNKMELPKAQKR 220
                P  W   E  DL  K+ + + +KR
Sbjct: 234 DNPFYP-RWLEKEAKDLLVKLFVREPEKR 261

>pdb|3PJC|A Chain A, Crystal Structure Of Jak3 Complexed With A Potent Atp Site Inhibitor Showing High Selectivity Within The Janus Kinase Family Length = 315

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSL 70
           REI+IL+ L  + +V      + +   Y   R +  LV ++     L   L     +   
Sbjct: 61  REIQILKALHSDFIV------KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 114
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+ S + +HRD+ A N+L+     +K+ADFGLA+     K+  V 
Sbjct: 115 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 174
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R   +    WY P    L D  +    D+W  G ++ E++T
Sbjct: 175 REPGQSPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 213

>pdb|3LXK|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 327

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 43/161 (26%), Positives = 73/161 (45%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSL 70
           REI+IL+ L  + +V      + +   Y   R +  LV ++     L   L     +   
Sbjct: 73  REIQILKALHSDFIV------KYRGVSYGPGRQSLRLVMEYLPSGCLRDFLQRHRARLDA 126
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+ S + +HRD+ A N+L+     +K+ADFGLA+     K+  V 
Sbjct: 127 SRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYVV 186
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R   +    WY P    L D  +    D+W  G ++ E++T
Sbjct: 187 REPGQSPIFWYAPES--LSDNIFSRQSDVWSFGVVLYELFT 225

>pdb|2PVY|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K659n Mutation Responsible For An Unclassified Craniosynostosis Syndrome. Length = 324

Iteration: 1
 Score = 68.2 bits (165), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 47/170 (27%), Positives = 83/170 (48%), Gaps = 12/170 (7%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +     + N    R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 208 NNIDYYK-NTTNGRLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1ZXE|A Chain A, Crystal Structure Of Eif2alpha Protein Kinase Gcn2: D835n Inactivating Mutant In Apo Form Length = 303

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 16/176 (9%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYN-----RYRSTFYLVFDFCEH-DLAGLLS 62
           T L E+ +L  L H+ VV        + N        + +ST ++  ++CE+  L  L+ 
Sbjct: 48  TILSEVXLLASLNHQYVVRYYAAWLERRNFVKPXTAVKKKSTLFIQXEYCENRTLYDLIH 107
Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF- 121
           + ++     E  ++ +Q+L  L YIHS  I+HR++K  N+ I ++  +K+ DFGLA+   
Sbjct: 108 SENLNQQRDEYWRLFRQILEALSYIHSQGIIHRNLKPXNIFIDESRNVKIGDFGLAKNVH 167
Query: 122 ---------SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
                    SQ   G  +  T+ + T  Y   E+L G  +Y   +D +  G I  E
Sbjct: 168 RSLDILKLDSQNLPGSSDNLTSAIGTAXYVATEVLDGTGHYNEKIDXYSLGIIFFE 223

>pdb|2PZP|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K526e Mutation Responsible For Crouzon Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 208 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|1XJD|A Chain A, Crystal Structure Of Pkc-Theta Complexed With Staurosporine At 2a Resolution Length = 345

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 58/209 (27%), Positives = 99/209 (47%), Gaps = 16/209 (7%)
Query: 13  EIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           E ++L L  +H  + H+    +TK N        F+++      DL   + + H KF L 
Sbjct: 67  EKRVLSLAWEHPFLTHMFCTFQTKEN-------LFFVMEYLNGGDLMYHIQSCH-KFDLS 118
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
                  +++ GL ++HS  I++RD+K  N+L+ K G +K+ADFG+ +  +   + + N 
Sbjct: 119 RATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKE-NMLGDAKTNX 177
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQL 191
           +     T  Y  PE+LLG + Y   VD W  G ++ EM        G  E++    I ++
Sbjct: 178 FCG---TPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHSI-RM 232
Query: 192 CGSITPESWPGVETLDLYNKMELPKAQKR 220
                P  W   E  DL  K+ + + +KR
Sbjct: 233 DNPFYPR-WLEKEAKDLLVKLFVREPEKR 260

>pdb|2PSQ|A Chain A, Crystal Structure Of Unphosphorylated Unactivated Wild Type Fgf Receptor 2 (Fgfr2) Kinase Domain Length = 370

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/182 (27%), Positives = 90/182 (49%), Gaps = 36/182 (19%)
Query: 11  LREIKILQLL-KHENVVHLIEIC------------RTKAN--QYNRYRSTFYLVFDFCEH 55
           + E+++++++ KH+N+++L+  C             +K N  +Y R R    + + +   
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSY--- 190
Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
           D+  +      + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADF
Sbjct: 191 DINRVPEE---QMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 247
Query: 116 GLARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           GLAR       + +T NG       R+   W  P  L   DR Y    D+W  G +M E+
Sbjct: 248 GLARDINNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEI 298
Query: 170 WT 171
           +T
Sbjct: 299 FT 300

>pdb|1GJO|A Chain A, The Fgfr2 Tyrosine Kinase Domain Length = 316

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 80  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 139
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 140 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 199
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 200 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 246

>pdb|3RI1|A Chain A, Crystal Structure Of The Catalytic Domain Of Fgfr2 Kinase In Complex With Arq 069 Length = 313

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 77  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 136
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 137 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 196
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 197 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 243

>pdb|3K54|A Chain A, Structures Of Human Bruton's Tyrosine Kinase In Active And Inactive Conformations Suggests A Mechanism Of Activation For Tec Family Kinases Length = 283

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 39/161 (24%), Positives = 78/161 (48%), Gaps = 11/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 119
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R      + + +
Sbjct: 120 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYV--LDDEETS 177
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
              ++    W  PPE+L+  + +    D+W  G +M E+++
Sbjct: 178 SVGSKFPVRW-SPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 216

>pdb|2Q0B|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565a Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.8 bits (164), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 36/182 (19%)
Query: 11  LREIKILQLL-KHENVVHLIEIC------------RTKAN--QYNRYRSTFYLVFDFCEH 55
           + E+++++++ KH+N+++L+  C             +K N  +Y R R    + + +  +
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVAYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
            +         + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADF
Sbjct: 148 RVP------EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 116 GLARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           GLAR       + +T NG       R+   W  P  L   DR Y    D+W  G +M E+
Sbjct: 202 GLARDINNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEI 252
Query: 170 WT 171
           +T
Sbjct: 253 FT 254

>pdb|3B2T|A Chain A, Structure Of Phosphotransferase Length = 311

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 75  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 134
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 135 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLTARNVLVTENNVMKIADFGLARDI 194
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 195 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 241

>pdb|2PY3|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic E565g Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 49/182 (26%), Positives = 89/182 (48%), Gaps = 36/182 (19%)
Query: 11  LREIKILQLL-KHENVVHLIEIC------------RTKAN--QYNRYRSTFYLVFDFCEH 55
           + E+++++++ KH+N+++L+  C             +K N  +Y R R    + + +  +
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVGYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 56  DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
            +         + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADF
Sbjct: 148 RVP------EEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADF 201
Query: 116 GLARA------FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           GLAR       + +T NG       R+   W  P  L   DR Y    D+W  G +M E+
Sbjct: 202 GLARDINNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEI 252
Query: 170 WT 171
           +T
Sbjct: 253 FT 254

>pdb|3KXX|A Chain A, Structure Of The Mutant Fibroblast Growth Factor Receptor 1 Length = 317

Iteration: 1
 Score = 67.4 bits (163), Expect = 1e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L       +  GL       
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQAREPPGLEYSYNPS 140
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 201 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3UGC|A Chain A, Structural Basis Of Jak2 Inhibition By The Type Ii Inhibtor Nvp-Bbt594 Length = 295

Iteration: 1
 Score = 67.4 bits (163), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 46/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 60  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K     
Sbjct: 114 IKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFKV 173
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 174 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 231
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 232 KQGQMIV 238

>pdb|2O8Y|A Chain A, Apo Irak4 Kinase Domain Length = 298

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           K+ Q   NG+ ++H N  +HRD+K+AN+L+ +    K++DFGLARA    K  Q    + 
Sbjct: 128 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQXVXXSR 185
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            V T  Y  PE L G+    P  D++  G ++ E+ T  P +  + E Q
Sbjct: 186 IVGTTAYXAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 232

>pdb|2NRY|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 59/109 (54%), Gaps = 4/109 (3%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           K+ Q   NG+ ++H N  +HRD+K+AN+L+ +    K++DFGLARA    K  Q    + 
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQTVMXSR 194
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            V T  Y  PE L G+    P  D++  G ++ E+ T  P +  + E Q
Sbjct: 195 IVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|2PZ5|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic N549t Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 67.0 bits (162), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 49/176 (27%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N++ L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIITLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDI 207
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 208 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|2PZR|A Chain A, Crystal Strucure Of Fgf Receptor 2 (Fgfr2) Kinase Domain Harboring The Pathogenic K641r Mutation Responsible For Pfeiffer Syndrome Length = 324

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 48/176 (27%), Positives = 85/176 (48%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHV- 66
           + E+++++++ KH+N+++L+  C      Y    Y S   L          G+  +  + 
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLRARRPPGMEYSYDIN 147
Query: 67  -----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
                + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++++ADFGLAR  
Sbjct: 148 RVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMRIADFGLARDI 207
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G +M E++T
Sbjct: 208 NNIDYYKKTTNG-------RLPVKWMAPEALF--DRVYTHQSDVWSFGVLMWEIFT 254

>pdb|3LL6|A Chain A, Crystal Structure Of The Human Cyclin G Associated Kinase (gak) Length = 337

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 43/163 (26%), Positives = 73/163 (44%), Gaps = 14/163 (8%)
Query: 18  QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSLGEIKK 75
           +L  H N+V           + +  ++ F L+ + C+  L   L  +  +   S   + K
Sbjct: 81  KLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLK 140
Query: 76  VIQQLLNGLYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLAR--------AFSQTK 125
           +  Q    + ++H  K  I+HRD+K  N+L++  G +KL DFG A         ++S  +
Sbjct: 141 IFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQR 200
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNY--GPPVDLWGAGCIM 166
              V     R  T  YR PE++    N+  G   D+W  GCI+
Sbjct: 201 RALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCIL 243

>pdb|3OCT|A Chain A, Crystal Structure Of Bruton's Tyrosine Kinase Mutant V555r In Complex With Dasatinib Length = 265

Iteration: 1
 Score = 66.6 bits (161), Expect = 2e-11,   Method: Compositional matrix adjust.
 Identities = 39/163 (23%), Positives = 80/163 (49%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           + E K++  L HE +V L  +C        + R  F +        L   L  +  +F  
Sbjct: 52  IEEAKVMMNLSHEKLVQLYGVC-------TKQRPIFIITEYMANGCLLNYLREMRHRFQT 104
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF--SQTKNGQ 128
            ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R     +  + +
Sbjct: 105 QQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEYTSSR 164
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            +++  R     + PPE+L+  + +    D+W  G +M E+++
Sbjct: 165 GSKFPVR-----WSPPEVLMYSK-FSSKSDIWAFGVLMWEIYS 201

>pdb|2Z7Q|A Chain A, Crystal Structure Of The N-Terminal Kinase Domain Of Human Rsk-1 Bound To Amp-Pcp Length = 321

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 55/177 (31%), Positives = 88/177 (49%), Gaps = 15/177 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLG 71
           E  IL  + H  VV L    +T+           YL+ DF    DL   LS   V F+  
Sbjct: 80  ERDILADVNHPFVVKLHYAFQTEGK--------LYLILDFLRGGDLFTRLSK-EVMFTEE 130
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           ++K  + +L  GL ++HS  I++RD+K  N+L+ + G +KL DFGL++   +  + +   
Sbjct: 131 DVKFYLAELALGLDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK---EAIDHEKKA 187
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           Y+    T+ Y  PE ++  + +    D W  G +M EM T S   QG   ++ +TLI
Sbjct: 188 YSF-CGTVEYMAPE-VVNRQGHSHSADWWSYGVLMFEMLTGSLPFQGKDRKETMTLI 242

>pdb|3A4O|X Chain X, Lyn Kinase Domain Length = 286

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 62/230 (26%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +   +   Y    Y +   L+ DF + D  G       K 
Sbjct: 56  LEEANLMKTLQHDKLVRLYAVVTREEPIYIITEYMAKGSLL-DFLKSDEGG-------KV 107
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ YI     +HRD++AANVL++++ + K+ADFGLAR      N  
Sbjct: 108 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEY 165
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITL 187
             R   +    W  P  +  G   +    D+W  G ++ E+ T   I   G T    +T 
Sbjct: 166 TAREGAKFPIKWTAPEAINFG--CFTIKSDVWSFGILLYEIVTYGKIPYPGRTNADVMTA 223
Query: 188 ISQLCGSITPESWPGVETLDLYNKMEL---PKAQKRKVKERLKPYVKDQY 234
           +SQ       E+ P     +LY+ M++    KA++R   + L+  + D Y
Sbjct: 224 LSQGYRMPRVENCPD----ELYDIMKMCWKEKAEERPTFDYLQSVLDDFY 269

>pdb|3TAC|A Chain A, Crystal Structure Of The Liprin-AlphaCASK COMPLEX Length = 361

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE  I  +LKH ++V L+E   +            Y+VF+F   D A L   I  +   G
Sbjct: 77  REASICHMLKHPHIVELLETYSSDG--------MLYMVFEFM--DGADLCFEIVKRADAG 126
Query: 72  EI------KKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFS 122
            +         ++Q+L  L Y H N I+HRD+K   VL+     +  +KL  FG+A    
Sbjct: 127 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 186
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           ++  G V     RV T  +  PE++  +  YG PVD+WG G I+  + +      G T++
Sbjct: 187 ES--GLVA--GGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYG-TKE 240
Query: 183 QQITLISQLCGSITPESWPGV--ETLDLYNKM-ELPKAQKRKVKERLK-PYVKDQ 233
           +    I +    + P  W  +     DL  +M  L  A++  V E L  P++K++
Sbjct: 241 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 295

>pdb|3C0G|A Chain A, Cask Cam-kinase Domain- 3'-amp Complex, P1 Form Length = 351

Iteration: 1
 Score = 66.6 bits (161), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 67/235 (28%), Positives = 108/235 (45%), Gaps = 29/235 (12%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE  I  +LKH ++V L+E   +            Y+VF+F   D A L   I  +   G
Sbjct: 75  REASICHMLKHPHIVELLETYSSDG--------MLYMVFEFM--DGADLCFEIVKRADAG 124
Query: 72  EI------KKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFS 122
            +         ++Q+L  L Y H N I+HRD+K   VL+     +  +KL  FG+A    
Sbjct: 125 FVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLG 184
Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           ++  G V     RV T  +  PE++  +  YG PVD+WG G I+  + +      G T++
Sbjct: 185 ES--GLVA--GGRVGTPHFMAPEVVKRE-PYGKPVDVWGCGVILFILLSGCLPFYG-TKE 238
Query: 183 QQITLISQLCGSITPESWPGV--ETLDLYNKM-ELPKAQKRKVKERLK-PYVKDQ 233
           +    I +    + P  W  +     DL  +M  L  A++  V E L  P++K++
Sbjct: 239 RLFEGIIKGKYKMNPRQWSHISESAKDLVRRMLMLDPAERITVYEALNHPWLKER 293

>pdb|2W5A|A Chain A, Human Nek2 Kinase Adp-Bound Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS-NIHVKFSL 70
           E+ +L+ LKH N+V      R      +R  +T Y+V ++CE  DLA +++     +  L
Sbjct: 55  EVNLLRELKHPNIV------RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 71  GE--IKKVIQQLLNGLYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            E  + +V+ QL   L   H      + +LHRD+K ANV +     +KL DFGLAR    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-- 166
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             N   +     V T +Y  PE  +   +Y    D+W  GC++ E+    P
Sbjct: 167 --NHDTSFAKTFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|2XIK|A Chain A, Structure Of Human Ysk1 (Yeast Sps1-Ste20-Related Kinase 1) Length = 294

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 35/102 (34%), Positives = 55/102 (53%), Gaps = 5/102 (4%)
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
           I  +++++L GL Y+HS + +HRD+KAANVL+++ G +KLADFG+A   + T   Q+ R 
Sbjct: 118 IATILREILKGLDYLHSERKIHRDIKAANVLLSEQGDVKLADFGVAGQLTDT---QIKRN 174
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                  W  P   ++    Y    D+W  G    E+    P
Sbjct: 175 XFVGTPFWMAPE--VIKQSAYDFKADIWSLGITAIELAKGEP 214

>pdb|3RHX|B Chain B, Crystal Structure Of The Catalytic Domain Of Fgfr1 Kinase In Complex With Arq 069 Length = 306

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 70  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 129
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 130 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 189
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 190 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 236

>pdb|2NRU|A Chain A, Crystal Structure Of Irak-4 Length = 307

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           K+ Q   NG+ ++H N  +HRD+K+AN+L+ +    K++DFGLARA    K  Q      
Sbjct: 137 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQTVMXXR 194
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            V T  Y  PE L G+    P  D++  G ++ E+ T  P +  + E Q
Sbjct: 195 IVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 241

>pdb|1FGK|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of Fibroblast Growth Factor Receptor 1 Length = 310

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 74  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 133
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 134 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 193
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 194 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 240

>pdb|3JS2|A Chain A, Crystal Structure Of Minimal Kinase Domain Of Fibroblast Growth Factor Receptor 1 In Complex With 5-(2-Thienyl) Nicotinic Acid Length = 317

Iteration: 1
 Score = 66.2 bits (160), Expect = 3e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 140
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 201 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|4F63|A Chain A, Crystal Structure Of Human Fibroblast Growth Factor Receptor 1 Kinase Domain In Complex With Compound 1 Length = 309

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 73  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 132
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 133 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 192
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 193 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 239

>pdb|4A4X|A Chain A, Nek2-Ede Bound To Cct248662 Length = 279

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 52/171 (30%), Positives = 83/171 (48%), Gaps = 20/171 (11%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS-NIHVKFSL 70
           E+ +L+ LKH N+V      R      +R  +T Y+V ++CE  DLA +++     +  L
Sbjct: 55  EVNLLRELKHPNIV------RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 71  GE--IKKVIQQLLNGLYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            E  + +V+ QL   L   H      + +LHRD+K ANV +     +KL DFGLAR  + 
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNH 168
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            ++         V T +Y  PE  +   +Y    D+W  GC++ E+    P
Sbjct: 169 DEDFA----KEFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|3TT0|A Chain A, Co-Structure Of Fibroblast Growth Factor Receptor 1 Kinase Domain With 3-(2,6-Dichloro-3, 5-Dimethoxy-Phenyl)-1-{6-[4-(4-Ethyl-Piperazin-1- Yl)-Phenylamino]-Pyrimidin-4-Yl}-1-Methyl-Urea (Bgj398) Length = 382

Iteration: 1
 Score = 66.2 bits (160), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYSYNPS 181
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 182 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 241
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 242 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 288

>pdb|4BBE|A Chain A, Aminoalkylpyrimidine Inhibitor Complexes With Jak2 Length = 298

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 45/187 (24%), Positives = 85/187 (45%), Gaps = 19/187 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +   
Sbjct: 61  REIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERIDH 114
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++ +   Q+  G+ Y+ + + +HR++   N+L+     +K+ DFGL +   Q K     
Sbjct: 115 IKLLQYTSQICKGMEYLGTKRYIHRNLATRNILVENENRVKIGDFGLTKVLPQDKEYYKV 174
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-----RSP-----IMQGNT 180
           +        WY P  L   +  +    D+W  G ++ E++T     +SP      M GN 
Sbjct: 175 KEPGESPIFWYAPESLT--ESKFSVASDVWSFGVVLYELFTYIEKSKSPPAEFMRMIGND 232
Query: 181 EQQQITL 187
           +Q Q+ +
Sbjct: 233 KQGQMIV 239

>pdb|3GQL|A Chain A, Crystal Structure Of Activated Receptor Tyrosine Kinase In Complex With Substrates Length = 326

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 81  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 140
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 141 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 200
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 201 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 247

>pdb|3C4F|A Chain A, Fgfr Tyrosine Kinase Domain In Complex With 3-(3- Methoxybenzyl)-7-Azaindole Length = 302

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 50/176 (28%), Positives = 84/176 (47%), Gaps = 24/176 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGL------L 61
           + E+++++++ KH+N+++L+  C      Y    Y S   L          GL       
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGPLYVIVEYASKGNLREYLQARRPPGLEYCYNPS 125
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA- 120
            N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+ADFGLAR  
Sbjct: 126 HNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDI 185
Query: 121 -----FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                + +T NG       R+   W  P  L   DR Y    D+W  G ++ E++T
Sbjct: 186 HHIDYYKKTTNG-------RLPVKWMAPEALF--DRIYTHQSDVWSFGVLLWEIFT 232

>pdb|2JAV|A Chain A, Human Kinase With Pyrrole-Indolinone Ligand Length = 279

Iteration: 1
 Score = 65.9 bits (159), Expect = 4e-11,   Method: Compositional matrix adjust.
 Identities = 53/171 (30%), Positives = 82/171 (47%), Gaps = 20/171 (11%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS-NIHVKFSL 70
           E+ +L+ LKH N+V      R      +R  +T Y+V ++CE  DLA +++     +  L
Sbjct: 55  EVNLLRELKHPNIV------RYYDRIIDRTNTTLYIVMEYCEGGDLASVITKGTKERQYL 108
Query: 71  GE--IKKVIQQLLNGLYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            E  + +V+ QL   L   H      + +LHRD+K ANV +     +KL DFGLAR    
Sbjct: 109 DEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARIL-- 166
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             N   +     V T +Y  PE  +   +Y    D+W  GC++ E+    P
Sbjct: 167 --NHDTSFAKAFVGTPYYMSPE-QMNRMSYNEKSDIWSLGCLLYELCALMP 214

>pdb|2OIB|A Chain A, Crystal Structure Of Irak4 Kinase Domain Apo Form Length = 301

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 38/109 (34%), Positives = 58/109 (53%), Gaps = 4/109 (3%)
Query: 75  KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN 134
           K+ Q   NG+ ++H N  +HRD+K+AN+L+ +    K++DFGLARA    K  Q      
Sbjct: 131 KIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARA--SEKFAQXVMXXR 188
Query: 135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            V T  Y  PE L G+    P  D++  G ++ E+ T  P +  + E Q
Sbjct: 189 IVGTTAYMAPEALRGE--ITPKSDIYSFGVVLLEIITGLPAVDEHREPQ 235

>pdb|1U54|A Chain A, Crystal Structures Of The Phosphorylated And Unphosphorylated Kinase Domains Of The Cdc42-Associated Tyrosine Kinase Ack1 Bound To Amp-Pcp Length = 291

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 120
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 180
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 181 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|1P4F|A Chain A, Death Associated Protein Kinase Catalytic Domain With Bound Inhibitor Fragment Length = 293

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 109
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 170 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3F5U|A Chain A, Crystal Structure Of The Death Associated Protein Kinase In Complex With Amppnp And Mg2+ Length = 295

Iteration: 1
 Score = 65.9 bits (159), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|1IG1|A Chain A, 1.8a X-Ray Structure Of Ternary Complex Of A Catalytic Domain Of Death-Associated Protein Kinase With Atp Analogue And Mn. Length = 294

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 62  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 109
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 110 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 169
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 170 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 220
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 221 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 275

>pdb|3DFC|B Chain B, Crystal Structure Of A Glycine-Rich Loop Mutant Of The Death Associated Protein Kinase Catalytic Domain With Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3GU4|A Chain A, Crystal Structure Of Dapkq23v-Amppnp Length = 295

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2YAK|A Chain A, Structure Of Death-Associated Protein Kinase 1 (Dapk1) In Complex With A Ruthenium Octasporine Ligand (Osv) Length = 285

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|4EWH|B Chain B, Co-Crystal Structure Of Ack1 With Inhibitor Length = 275

Iteration: 1
 Score = 65.5 bits (158), Expect = 5e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHXVM 170
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 171 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|3OMV|A Chain A, Crystal Structure Of C-Raf (Raf-1) Length = 307

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 62/221 (28%), Positives = 107/221 (48%), Gaps = 29/221 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV---KFS 69
           E+ +L+  +H N++ L     TK N          +V  +CE   + L  ++HV   KF 
Sbjct: 82  EVAVLRKTRHVNIL-LFMGYMTKDN--------LAIVTQWCEG--SSLYKHLHVQETKFQ 130
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQ 128
           + ++  + +Q   G+ Y+H+  I+HRDMK+ N+ + +   +K+ DFGLA   S+ + + Q
Sbjct: 131 MFQLIDIARQTAQGMDYLHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSGSQQ 190
Query: 129 VNRYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWTRS-PIMQGNTEQQQIT 186
           V + T  V  LW  P  + + D N +    D++  G ++ E+ T   P    N   Q I 
Sbjct: 191 VEQPTGSV--LWMAPEVIRMQDNNPFSFQSDVYSYGIVLYELMTGELPYSHINNRDQIIF 248
Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK 227
           ++ +  G  +P      +   LY     PKA KR V + +K
Sbjct: 249 MVGR--GYASP------DLSKLYK--NCPKAMKRLVADCVK 279

>pdb|2W4J|A Chain A, X-Ray Structure Of A Dap-Kinase 2-277 Length = 277

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2W4K|A Chain A, X-Ray Structure Of A Dap-Kinase 2-302 Length = 302

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 58/222 (26%), Positives = 102/222 (45%), Gaps = 34/222 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR 220
           +Q+ +  +S +      E +     L  D   ++ +   +KR
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKR 263

>pdb|1WVW|A Chain A, Crystal Structures Of Kinase Domain Of Dap Kinase In Complex With Small Molecular Inhibitors Length = 278

Iteration: 1
 Score = 65.5 bits (158), Expect = 6e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2Y0A|A Chain A, Structure Of Dapk1 Construct Residues 1-304 Length = 326

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3D7U|B Chain B, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 277

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 44  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 99
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 100 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 152
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 153 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 205

>pdb|1U46|A Chain A, Crystal Structure Of The Unphosphorylated Kinase Domain Of The Tyrosine Kinase Ack1 Length = 291

Iteration: 1
 Score = 65.1 bits (157), Expect = 7e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 120
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 121 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 180
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 181 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 219

>pdb|2XUU|A Chain A, Crystal Structure Of A Dap-Kinase 1 Mutant Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPAFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|2OIQ|A Chain A, Crystal Structure Of Chicken C-Src Kinase Domain In Complex With The Cancer Drug Imatinib. Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 108
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 109 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 161
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 162 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2HWO|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Covalent Inhibitor Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGCLLDFLKGEMG 108
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 109 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 161
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 162 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2H8H|A Chain A, Src Kinase In Complex With A Quinazoline Inhibitor Length = 535

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CEHDLAGLL 61
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++  +  L   L
Sbjct: 302 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVTEYMSKGSLLDFL 352
Query: 62  SNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                K+  L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 353 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 412
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 413 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 463

>pdb|3DQW|A Chain A, C-Src Kinase Domain Thr338ile Mutant In Complex With Atpgs Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++      L  L
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVIEYMSKGSLLDFL 103
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
              +     L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 104 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 163
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 164 IED--NEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3U4W|A Chain A, Src In Complex With Dna-Templated Macrocyclic Inhibitor Mc4b Length = 275

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 42  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 97
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 98  KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 150
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 151 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 203

>pdb|3SVV|A Chain A, Crystal Structure Of T338c C-Src Covalently Bound To Vinylsulfonamide- Pyrazolopyrimidine 9 Length = 286

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 45/179 (25%), Positives = 83/179 (46%), Gaps = 23/179 (12%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           G   P   L+E ++++ L+HE +V L  +   +             ++  CE+   G L 
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP------------IYIVCEYMSKGSLL 100
Query: 63  NIHVKFSLGEIKKVIQ------QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           +  +K  +G+  ++ Q      Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFG
Sbjct: 101 DF-LKGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFG 159
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           LAR      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 160 LARLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2X0G|A Chain A, X-ray Structure Of A Dap-kinase Calmodulin Complex Length = 334

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|3EQP|B Chain B, Crystal Structure Of Ack1 With Compound T95 Length = 276

Iteration: 1
 Score = 65.1 bits (157), Expect = 8e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 171 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|2XZS|A Chain A, Death Associated Protein Kinase 1 Residues 1-312 Length = 312

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 61/235 (25%), Positives = 111/235 (47%), Gaps = 36/235 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H NV+ L E+   K +          L+ +     +AG  L   +  K S
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD--------VILILEL----VAGGELFDFLAEKES 110
Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQ 123
           L E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA     
Sbjct: 111 LTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDF 170
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNT 180
                 N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T
Sbjct: 171 G-----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDT 221
Query: 181 EQQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           +Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 222 KQETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|4HZR|A Chain A, Crystal Structure Of Ack1 Kinase Domain Length = 277

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 114
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 115 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 175 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|4ID7|A Chain A, Ack1 Kinase In Complex With The Inhibitor Cis-3-[8-amino-1-(4- Phenoxyphenyl)imidazo[1,5-a]pyrazin-3-yl]cyclobutanol Length = 273

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 110
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 111 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 170
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 171 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 209

>pdb|1YRP|A Chain A, Catalytic Domain Of Human Zip Kinase Phosphorylated At Thr265 Length = 278

Iteration: 1
 Score = 64.7 bits (156), Expect = 9e-11,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL- 70
           RE+ IL+ ++H N++ L +I   K +          L+ +        L   +  K SL 
Sbjct: 64  REVNILREIRHPNIITLHDIFENKTD--------VVLILELVSG--GELFDFLAEKESLT 113
Query: 71  -GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
             E  + ++Q+L+G++Y+HS +I H D+K  N+++    +    +KL DFG+A       
Sbjct: 114 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 172
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
               N + N   T  +  PE++    NY P     D+W  G I   + + +    G T+Q
Sbjct: 173 ----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 224
Query: 183 QQITLISQL 191
           + +T IS +
Sbjct: 225 ETLTNISAV 233

>pdb|3GU8|A Chain A, Crystal Structure Of Dapkl93g With N6-Cyclopentyladenosine Length = 295

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 61/234 (26%), Positives = 108/234 (46%), Gaps = 34/234 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNIHVKFSL 70
           RE+ IL+ ++H NV+ L E+   K +           V    E    G L   +  K SL
Sbjct: 63  REVSILKEIQHPNVITLHEVYENKTD-----------VILIGELVAGGELFDFLAEKESL 111
Query: 71  GE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQT 124
            E    + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA      
Sbjct: 112 TEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG 171
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTE 181
                N + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+
Sbjct: 172 -----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTK 222
Query: 182 QQQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYVK 231
           Q+ +  +S +      E +     L  D   ++ +   +KR  +++ L+ P++K
Sbjct: 223 QETLANVSAVNYEFEDEYFSNTSALAKDFIRRLLVKDPKKRMTIQDSLQHPWIK 276

>pdb|4HZS|A Chain A, Crystal Structure Of Ack1 Kinase Domain With C-terminal Sh3 Domain Length = 341

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 42/161 (26%), Positives = 70/161 (43%), Gaps = 10/161 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           +RE+  +  L H N++ L  +  T   +     +    + D         L      F L
Sbjct: 63  IREVNAMHSLDHRNLIRLYGVVLTPPMKMVTELAPLGSLLD--------RLRKHQGHFLL 114
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
           G + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V 
Sbjct: 115 GTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYVM 174
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +   +V   W  P    L  R +    D W  G  + EM+T
Sbjct: 175 QEHRKVPFAWCAPES--LKTRTFSHASDTWMFGVTLWEMFT 213

>pdb|3S95|A Chain A, Crystal Structure Of The Human Limk1 Kinase Domain In Complex With Staurosporine Length = 310

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/175 (26%), Positives = 86/175 (49%), Gaps = 20/175 (11%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           T L+E+K+++ L+H NV+  I +       Y   R  F   +      L G++ ++  ++
Sbjct: 53  TFLKEVKVMRCLEHPNVLKFIGVL------YKDKRLNFITEY-IKGGTLRGIIKSMDSQY 105
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF------- 121
              +     + + +G+ Y+HS  I+HRD+ + N L+ +   + +ADFGLAR         
Sbjct: 106 PWSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQP 165
Query: 122 ----SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
               S  K  +  RYT  V   ++  PE++ G R+Y   VD++  G ++ E+  R
Sbjct: 166 EGLRSLKKPDRKKRYTV-VGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGR 218

>pdb|1Y57|A Chain A, Structure Of Unphosphorylated C-Src In Complex With An Inhibitor Length = 452

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CEHDLAGLL 61
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++  +  L   L
Sbjct: 219 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVTEYMSKGSLLDFL 269
Query: 62  SNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                K+  L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 330 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 380

>pdb|4A07|A Chain A, Human Pdk1 Kinase Domain In Complex With Allosteric Activator Ps171 Bound To The Pif-Pocket Length = 311

Iteration: 1
 Score = 64.7 bits (156), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSAXKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|1FMK|A Chain A, Crystal Structure Of Human Tyrosine-Protein Kinase C-Src Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CEHDLAGLL 61
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++  +  L   L
Sbjct: 219 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVTEYMSKGSLLDFL 269
Query: 62  SNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                K+  L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 330 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 380

>pdb|3G6H|A Chain A, Src Thr338ile Inhibited In The Dfg-Asp-Out Conformation Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++      L  L
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVIEYMSKGSLLDFL 103
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
              +     L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 104 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 163
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 164 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|2J90|A Chain A, Crystal Structure Of Human Zip Kinase In Complex With A Tetracyclic Pyridone Inhibitor (pyridone 6) Length = 304

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL- 70
           RE+ IL+ ++H N++ L +I   K +          L+ +        L   +  K SL 
Sbjct: 78  REVNILREIRHPNIITLHDIFENKTD--------VVLILELVSG--GELFDFLAEKESLT 127
Query: 71  -GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
             E  + ++Q+L+G++Y+HS +I H D+K  N+++    +    +KL DFG+A       
Sbjct: 128 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 186
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
               N + N   T  +  PE++    NY P     D+W  G I   + + +    G T+Q
Sbjct: 187 ----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 238
Query: 183 QQITLISQL 191
           + +T IS +
Sbjct: 239 ETLTNISAV 247

>pdb|3PWY|A Chain A, Crystal Structure Of An Extender (Spd28345)-Modified Human Pdk1 Complex 2 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSASKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3G51|A Chain A, Structural Diversity Of The Active Conformation Of The N- Terminal Kinase Domain Of P90 Ribosomal S6 Kinase 2 Length = 325

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 46  FYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YL+ DF    DL   LS   V F+  ++K  + +L   L ++HS  I++RD+K  N+L+
Sbjct: 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC 164
            + G +KL DFGL++   ++ + +   Y+    T+ Y  PE ++  R +    D W  G 
Sbjct: 160 DEEGHIKLTDFGLSK---ESIDHEKKAYSF-CGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 165 IMAEMWTRSPIMQGNTEQQQITLI 188
           +M EM T +   QG   ++ +T+I
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4E4L|A Chain A, Jak1 Kinase (Jh1 Domain) In Complex With Compound 30 Length = 302

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSL 70
           +EI+IL+ L HEN+V    IC           +   L+ +F     L   L     K +L
Sbjct: 72  KEIEILRNLYHENIVKYKGICTEDGG------NGIKLIMEFLPSGSLKEYLPKNKNKINL 125
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            +  K   Q+  G+ Y+ S + +HRD+ A NVL+     +K+ DFGL +A    K     
Sbjct: 126 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 185
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        WY  PE L+  + Y    D+W  G  + E+ T
Sbjct: 186 KDDRDSPVFWY-APECLMQSKFY-IASDVWSFGVTLHELLT 224

>pdb|2QQ7|A Chain A, Crystal Structure Of Drug Resistant Src Kinase Domain With Irreversible Inhibitor Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/175 (24%), Positives = 79/175 (45%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++      L  L
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVMEYMSKGCLLDFL 103
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
              +     L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 104 KGEMGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 163
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 164 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3BHY|A Chain A, Crystal Structure Of Human Death Associated Protein Kinase 3 (Dapk3) In Complex With A Beta-Carboline Ligand Length = 283

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 50/189 (26%), Positives = 89/189 (47%), Gaps = 28/189 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL- 70
           RE+ IL+ ++H N++ L +I   K +          L+ +        L   +  K SL 
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTD--------VVLILELVSG--GELFDFLAEKESLT 106
Query: 71  -GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
             E  + ++Q+L+G++Y+HS +I H D+K  N+++    +    +KL DFG+A       
Sbjct: 107 EDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAG- 165
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
               N + N   T  +  PE++    NY P     D+W  G I   + + +    G T+Q
Sbjct: 166 ----NEFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGETKQ 217
Query: 183 QQITLISQL 191
           + +T IS +
Sbjct: 218 ETLTNISAV 226

>pdb|3OEZ|A Chain A, Crystal Structure Of The L317i Mutant Of The Chicken C-Src Tyrosine Kinase Domain Complexed With Imatinib Length = 286

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 83/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ ++HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 53  GTMSPEAFLQEAQVMKKIRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 108
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 109 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 161
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 162 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|1KSW|A Chain A, Structure Of Human C-Src Tyrosine Kinase (Thr338gly Mutant) In Complex With N6-Benzyl Adp Length = 452

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 44/175 (25%), Positives = 81/175 (46%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CEHDLAGLL 61
           G   P   L+E ++++ L+HE +V L  +   +           Y+V ++  +  L   L
Sbjct: 219 GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEP---------IYIVGEYMSKGSLLDFL 269
Query: 62  SNIHVKF-SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                K+  L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR 
Sbjct: 270 KGETGKYLRLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARL 329
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 330 IED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 380

>pdb|3CD3|A Chain A, Crystal Structure Of Phosphorylated Human Feline Sarcoma Viral Oncogene Homologue (V-Fes) In Complex With Staurosporine And A Consensus Peptide Length = 377

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 48/193 (24%), Positives = 83/193 (43%), Gaps = 13/193 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E +IL+   H N+V LI +C  K           Y+V +  +  D    L     +  
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTEGARLR 211
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++     G+ Y+ S   +HRD+ A N L+T+  +LK++DFG++R  +       
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVXA-A 270
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W  P  L  G   Y    D+W  G ++ E ++       N   QQ     
Sbjct: 271 SGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTREFV 328
Query: 190 QLCGSI-TPESWP 201
           +  G +  PE  P
Sbjct: 329 EKGGRLPCPELCP 341

>pdb|3EYG|A Chain A, Crystal Structures Of Jak1 And Jak2 Inhibitor Complexes Length = 290

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 47/161 (29%), Positives = 72/161 (44%), Gaps = 9/161 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFSL 70
           +EI+IL+ L HEN+V    IC           +   L+ +F     L   L     K +L
Sbjct: 60  KEIEILRNLYHENIVKYKGICTEDGG------NGIKLIMEFLPSGSLKEYLPKNKNKINL 113
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            +  K   Q+  G+ Y+ S + +HRD+ A NVL+     +K+ DFGL +A    K     
Sbjct: 114 KQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEXXTV 173
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        WY  PE L+  + Y    D+W  G  + E+ T
Sbjct: 174 KDDRDSPVFWY-APECLMQSKFY-IASDVWSFGVTLHELLT 212

>pdb|2VWI|A Chain A, Structure Of The Osr1 Kinase, A Hypertension Drug Target Length = 303

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 49  VFDFCEHDLAGLLSNIHVKFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           V D  +H +A      H    L E  I  +++++L GL Y+H N  +HRD+KA N+L+ +
Sbjct: 100 VLDIIKHIVA---KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 156
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNR---VVTLWYRPPELLLGDRNYGPPVDLWGAG 163
            G +++ADFG++ AF  T  G + R   R   V T  +  PE++   R Y    D+W  G
Sbjct: 157 DGSVQIADFGVS-AFLAT-GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 214
Query: 164 CIMAEMWT 171
               E+ T
Sbjct: 215 ITAIELAT 222

>pdb|3HRC|A Chain A, Crystal Structure Of A Mutant Of Human Pdk1 Kinase Domain In Complex With Atp Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEGLIFAKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3NUN|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Lead Compound Length = 292

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 122 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 178
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 179 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 237
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 238 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 267

>pdb|3NAX|A Chain A, Pdk1 In Complex With Inhibitor Mp7 Length = 311

Iteration: 1
 Score = 64.3 bits (155), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VG 193
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 194 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 252
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 253 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|3LXN|A Chain A, Structural And Thermodynamic Characterization Of The Tyk2 And Jak3 Kinase Domains In Complex With Cp-690550 And Cmp-6 Length = 318

Iteration: 1
 Score = 63.9 bits (154), Expect = 1e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           +EI IL+ L HE+++     C           ++  LV ++      G L +   + S+G
Sbjct: 82  QEIDILRTLYHEHIIKYKGCCEDAGA------ASLQLVMEYVP---LGSLRDYLPRHSIG 132
Query: 72  EIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + ++  QQ+  G+ Y+H+   +HRD+ A NVL+    ++K+ DFGLA+A  +      
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEXYR 192
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY P    L +  +    D+W  G  + E+ T
Sbjct: 193 VREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYELLT 232

>pdb|3NAY|A Chain A, Pdk1 In Complex With Inhibitor Mp6 Length = 311

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 137 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 193
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 194 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 252
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 253 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 282

>pdb|3GEQ|A Chain A, Structural Basis For The Chemical Rescue Of Src Kinase Activity Length = 286

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 53  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 108
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD+ AAN+L+ +  + K+ADFGLA
Sbjct: 109 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLAAANILVGENLVCKVADFGLA 161
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 162 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 214

>pdb|3DAK|A Chain A, Crystal Structure Of Domain-Swapped Osr1 Kinase Domain Length = 290

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/128 (33%), Positives = 67/128 (52%), Gaps = 10/128 (7%)
Query: 49  VFDFCEHDLAGLLSNIHVKFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           V D  +H +A      H    L E  I  +++++L GL Y+H N  +HRD+KA N+L+ +
Sbjct: 95  VLDIIKHIVA---KGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGE 151
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNR---VVTLWYRPPELLLGDRNYGPPVDLWGAG 163
            G +++ADFG++ AF  T  G + R   R   V T  +  PE++   R Y    D+W  G
Sbjct: 152 DGSVQIADFGVS-AFLAT-GGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG 209
Query: 164 CIMAEMWT 171
               E+ T
Sbjct: 210 ITAIELAT 217

>pdb|3OG7|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx4032 Length = 289

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 60/222 (27%), Positives = 109/222 (49%), Gaps = 31/222 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           E+ +L+  +H N+  L+ +  + A Q         +V  +CE   + L  ++H   +  E
Sbjct: 70  EVGVLRKTRHVNI--LLFMGYSTAPQ-------LAIVTQWCEG--SSLYHHLHASETKFE 118
Query: 73  IKKVI---QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQ 128
           +KK+I   +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q
Sbjct: 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 129 VNRYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
             + +  +  LW  P  + + D N Y    D++  G ++ E+ T + P    N   Q I 
Sbjct: 179 FEQLSGSI--LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236
Query: 187 LISQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
           ++ +  GS++P         DL   +   PK  KR + E LK
Sbjct: 237 MVGR--GSLSP---------DLSKVRSNCPKRMKRLMAECLK 267

>pdb|3BKB|A Chain A, Crystal Structure Of Human Feline Sarcoma Viral Oncogene Homologue (V- Fes) Length = 377

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 49/195 (25%), Positives = 85/195 (43%), Gaps = 17/195 (8%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E +IL+   H N+V LI +C  K           Y+V +  +  D    L     +  
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTEGARLR 211
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG-- 127
           +  + +++     G+ Y+ S   +HRD+ A N L+T+  +LK++DFG++R   +  +G  
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR---EEADGVY 268
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
             +    +V   W  P  L  G   Y    D+W  G ++ E ++       N   QQ   
Sbjct: 269 AASGGLRQVPVKWTAPEALNYG--RYSSESDVWSFGILLWETFSLGASPYPNLSNQQTRE 326
Query: 188 ISQLCGSI-TPESWP 201
             +  G +  PE  P
Sbjct: 327 FVEKGGRLPCPELCP 341

>pdb|2BDF|A Chain A, Src Kinase In Complex With Inhibitor Ap23451 Length = 279

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + +  
Sbjct: 46  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGETG 101
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 102 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 154
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 155 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 207

>pdb|3UBD|A Chain A, Structure Of N-Terminal Domain Of Rsk2 Kinase In Complex With Flavonoid Glycoside Sl0101 Length = 304

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 46  FYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YL+ DF    DL   LS   V F+  ++K  + +L   L ++HS  I++RD+K  N+L+
Sbjct: 101 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 159
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC 164
            + G +KL DFGL++   ++ + +   Y+    T+ Y  PE ++  R +    D W  G 
Sbjct: 160 DEEGHIKLTDFGLSK---ESIDHEKKAYSF-CGTVEYMAPE-VVNRRGHTQSADWWSFGV 214
Query: 165 IMAEMWTRSPIMQGNTEQQQITLI 188
           +M EM T +   QG   ++ +T+I
Sbjct: 215 LMFEMLTGTLPFQGKDRKETMTMI 238

>pdb|4EL9|A Chain A, Structure Of N-Terminal Kinase Domain Of Rsk2 With Afzelin Length = 305

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/144 (31%), Positives = 77/144 (53%), Gaps = 7/144 (4%)
Query: 46  FYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YL+ DF    DL   LS   V F+  ++K  + +L   L ++HS  I++RD+K  N+L+
Sbjct: 102 LYLILDFLRGGDLFTRLSK-EVMFTEEDVKFYLAELALALDHLHSLGIIYRDLKPENILL 160
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC 164
            + G +KL DFGL++   ++ + +   Y+    T+ Y  PE ++  R +    D W  G 
Sbjct: 161 DEEGHIKLTDFGLSK---ESIDHEKKAYSF-CGTVEYMAPE-VVNRRGHTQSADWWSFGV 215
Query: 165 IMAEMWTRSPIMQGNTEQQQITLI 188
           +M EM T +   QG   ++ +T+I
Sbjct: 216 LMFEMLTGTLPFQGKDRKETMTMI 239

>pdb|3COM|A Chain A, Crystal Structure Of Mst1 Kinase Length = 314

Iteration: 1
 Score = 63.9 bits (154), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 48/170 (28%), Positives = 75/170 (44%), Gaps = 24/170 (14%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI---- 64
           ++EI I+Q     +VV            Y  Y   +  ++V ++C    AG +S+I    
Sbjct: 72  IKEISIMQQCDSPHVVKY----------YGSYFKNTDLWIVMEYCG---AGSVSDIIRLR 118
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           +   +  EI  ++Q  L GL Y+H  + +HRD+KA N+L+   G  KLADFG+A    Q 
Sbjct: 119 NKTLTEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQL 175
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            +    R        W  P   ++ +  Y    D+W  G    EM    P
Sbjct: 176 TDXMAKRNXVIGTPFWMAPE--VIQEIGYNCVADIWSLGITAIEMAEGKP 223

>pdb|3ORX|A Chain A, Pdk1 Mutant Bound To Allosteric Disulfide Fragment Inhibitor 1f8 Length = 316

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 145 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 201
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 202 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 260
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 261 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 290

>pdb|2XCK|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 194
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 195 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 254 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|2XCH|A Chain A, Crystal Structure Of Pdk1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 309

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 194
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 195 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 254 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|1Z5M|A Chain A, Crystal Structure Of N1-[3-[[5-bromo-2-[[3-[(1-pyrrolidinylcarbonyl) Amino]phenyl]amino]-4-pyrimidinyl]amino]propyl]-2,2- Dimethylpropanediamide Complexed With Human Pdk1 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 115 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 171
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 172 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 230
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 231 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 260

>pdb|3RWP|A Chain A, Discovery Of A Novel, Potent And Selective Inhibitor Of 3- Phosphoinositide Dependent Kinase (Pdk1) Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|1YI6|A Chain A, C-Term Tail Segment Of Human Tyrosine Kinase (258-533) Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/174 (25%), Positives = 80/174 (45%), Gaps = 13/174 (7%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQ-YNRYRSTFYLVFDFCEHDLAGLL 61
           G   P   L+E ++++ L+HE +V L  +   +       Y S   L+ DF + +    L
Sbjct: 43  GTMSPEAFLQEAQVMKKLRHEKLVQLYAVVSEEPIXIVTEYMSKGSLL-DFLKGETGKYL 101
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                   L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR  
Sbjct: 102 R-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI 154
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
               N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 155 ED--NEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 204

>pdb|2R7B|A Chain A, Crystal Structure Of The Phosphoinositide-Dependent Kinase- 1 (Pdk-1)catalytic Domain Bound To A Dibenzonaphthyridine Inhibitor Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANSF---VG 197
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 198 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 256
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 257 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 286

>pdb|1UWH|A Chain A, The Complex Of Wild Type B-Raf And Bay439006 Length = 276

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/220 (26%), Positives = 107/220 (48%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N+  L+ +  + A Q         +V  +CE   L   L  I  KF + 
Sbjct: 54  EVGVLRKTRHVNI--LLFMGYSTAPQ-------LAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 165 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 223 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 251

>pdb|3NUS|A Chain A, Phosphoinositide-Dependent Kinase-1 (Pdk1) With Fragment8 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 116 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 172
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 173 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 231
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 232 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 261

>pdb|1UU3|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Ly333531 Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 194
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 195 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 254 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|2BIY|A Chain A, Structure Of Pdk1-S241a Mutant Kinase Domain Length = 310

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 138 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANAF---VG 194
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 195 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 253
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 254 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 283

>pdb|3SC1|A Chain A, Novel Isoquinolone Pdk1 Inhibitors Discovered Through Fragment-Based Lead Discovery Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|3P23|A Chain A, Crystal Structure Of The Human Kinase And Rnase Domains In Complex With Adp Length = 432

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 59/221 (26%), Positives = 100/221 (45%), Gaps = 19/221 (8%)
Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           A RE+++L +  +H NV+     C  K  Q+       Y+  + C   L   +       
Sbjct: 64  ADREVQLLRESDEHPNVIRYF--CTEKDRQFQ------YIAIELCAATLQEYVEQKDFAH 115
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILK--LADFGLARAFSQ 123
              E   ++QQ  +GL ++HS  I+HRD+K  N+LI+     G +K  ++DFGL +  + 
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP--PVDLWGAGCIMAEMWTRSPIMQGNTE 181
            ++   +R +    T  +  PE+L  D    P   VD++ AGC+   + +      G + 
Sbjct: 176 GRHS-FSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234
Query: 182 QQQITLISQLCG--SITPESWPGVETLDLYNKMELPKAQKR 220
           Q+Q  ++   C    + PE    V   +L  KM     QKR
Sbjct: 235 QRQANILLGACSLDCLHPEKHEDVIARELIEKMIAMDPQKR 275

>pdb|3NYX|A Chain A, Non-Phosphorylated Tyk2 Jh1 Domain With Quinoline-Thiadiazole- Thiophene Inhibitor Length = 302

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           +EI IL+ L HE+++     C  +  +      +  LV ++      G L +   + S+G
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEK------SLQLVMEYVP---LGSLRDYLPRHSIG 115
Query: 72  EIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + ++  QQ+  G+ Y+HS   +HR++ A NVL+    ++K+ DFGLA+A  +      
Sbjct: 116 LAQLLLFAQQICEGMAYLHSQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY P    L +  +    D+W  G  + E+ T
Sbjct: 176 VREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|2C30|A Chain A, Crystal Structure Of The Human P21-Activated Kinase 6 Length = 321

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 45/166 (27%), Positives = 82/166 (49%), Gaps = 22/166 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVKF 68
           E+ I++  +H NVV +          Y  Y      +++ +F +    G L++I   V+ 
Sbjct: 92  EVVIMRDYQHFNVVEM----------YKSYLVGEELWVLMEFLQ---GGALTDIVSQVRL 138
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  +I  V + +L  L Y+H+  ++HRD+K+ ++L+T  G +KL+DFG     S+     
Sbjct: 139 NEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISK----D 194
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           V +    V T ++  PE ++    Y   VD+W  G ++ EM    P
Sbjct: 195 VPKRKXLVGTPYWMAPE-VISRSLYATEVDIWSLGIMVIEMVDGEP 239

>pdb|3H9O|A Chain A, Phosphoinositide-Dependent Protein Kinase 1 (Pdk-1) In Complex With Compound 9 Length = 311

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 140 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 196
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 197 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 255
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 256 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 285

>pdb|1UU9|A Chain A, Structure Of Human Pdk1 Kinase Domain In Complex With Bim-3 Length = 286

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 117 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 173
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 174 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 232
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 233 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 262

>pdb|3IOP|A Chain A, Pdk-1 In Complex With The Inhibitor Compound-8i Length = 312

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 141 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 197
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 198 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 256
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 257 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 286

>pdb|3C4C|A Chain A, B-Raf Kinase In Complex With Plx4720 Length = 280

Iteration: 1
 Score = 63.5 bits (153), Expect = 2e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           E+ +L+  +H N++  +             +    +V  +CE   + L  ++H   +  E
Sbjct: 58  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEG--SSLYHHLHASETKFE 106
Query: 73  IKKVI---QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQ 128
           +KK+I   +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q
Sbjct: 107 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATVKSRWSGSHQ 166
Query: 129 VNRYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
             + +  +  LW  P  + + D N Y    D++  G ++ E+ T + P    N   Q I 
Sbjct: 167 FEQLSGSI--LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 224
Query: 187 LISQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
           ++ +  GS++P         DL   +   PK  KR + E LK
Sbjct: 225 MVGR--GSLSP---------DLSKVRSNCPKRMKRLMAECLK 255

>pdb|1H1W|A Chain A, High Resolution Crystal Structure Of The Human Pdk1 Catalytic Domain Length = 289

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 43/152 (28%), Positives = 76/152 (50%), Gaps = 7/152 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 118 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 174
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITP 197
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E      I +L      
Sbjct: 175 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPE 233
Query: 198 ESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           + +P  +  DL  K+ +  A KR   E ++ Y
Sbjct: 234 KFFP--KARDLVEKLLVLDATKRLGCEEMEGY 263

>pdb|3QC4|A Chain A, Pdk1 In Complex With Dfg-Out Inhibitor Xxx Length = 314

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/156 (28%), Positives = 77/156 (49%), Gaps = 15/156 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS-QTKNGQVNRYTNRVV 137
           ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S ++K  + N +   V 
Sbjct: 143 EIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESKQARANXF---VG 199
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE----QQQITLISQLCG 193
           T  Y  PELL  +++     DLW  GCI+ ++    P  +   E    Q+ I L      
Sbjct: 200 TAQYVSPELLT-EKSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIKLEYDFPA 258
Query: 194 SITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY 229
           +  P++       DL  K+ +  A KR   E ++ Y
Sbjct: 259 AFFPKAR------DLVEKLLVLDATKRLGCEEMEGY 288

>pdb|2Y7J|A Chain A, Structure Of Human Phosphorylase Kinase, Gamma 2 Length = 365

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 49/170 (28%), Positives = 81/170 (47%), Gaps = 21/170 (12%)
Query: 12  REIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           RE  IL Q+  H +++ LI+   +         S  +LVFD     +L   L+   V  S
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESS--------SFMFLVFDLMRKGELFDYLTE-KVALS 198
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             E + +++ LL  + ++H+N I+HRD+K  N+L+     ++L+DFG +      + G+ 
Sbjct: 199 EKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFS---CHLEPGE- 254
Query: 130 NRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSP 174
            +      T  Y  PE+L    +     YG  VDLW  G I+  +   SP
Sbjct: 255 -KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILFTLLAGSP 303

>pdb|2PHK|A Chain A, The Crystal Structure Of A Phosphorylase Kinase Peptide Substrate Complex: Kinase Substrate Recognition Length = 277

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 21/173 (12%)
Query: 9   TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV 66
             L+E+ IL+ +  H N++ L +   T         + F+LVFD  +  +L   L+   V
Sbjct: 56  ATLKEVDILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTE-KV 106
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S  E +K+++ LL  +  +H   I+HRD+K  N+L+     +KL DFG +    Q   
Sbjct: 107 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDP 163
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSP 174
           G+  R      T  Y  PE++    N     YG  VD+W  G IM  +   SP
Sbjct: 164 GEKLREV--CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 214

>pdb|1YOJ|A Chain A, Crystal Structure Of Src Kinase Domain Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + +  
Sbjct: 50  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMNKGSLLDFLKGETG 105
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 106 KYLR-------LPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 158
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 159 RLIED--NEWTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 211

>pdb|1YOL|A Chain A, Crystal Structure Of Src Kinase Domain In Complex With Cgp77675 Length = 283

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + +  
Sbjct: 50  GTMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMNKGSLLDFLKGETG 105
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLA
Sbjct: 106 KYLR-------LPQLVDMSAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLA 158
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 159 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 211

>pdb|1QL6|A Chain A, The Catalytic Mechanism Of Phosphorylase Kinase Probed By Mutational Studies Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 82/173 (47%), Gaps = 21/173 (12%)
Query: 9   TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV 66
             L+E+ IL+ +  H N++ L +   T         + F+LVFD  +  +L   L+   V
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTE-KV 119
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S  E +K+++ LL  +  +H   I+HRD+K  N+L+     +KL DFG +    Q   
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDP 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSP 174
           G+  R  +   T  Y  PE++    N     YG  VD+W  G IM  +   SP
Sbjct: 177 GEKLR--SVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|1PHK|A Chain A, Two Structures Of The Catalytic Domain Of Phosphorylase, Kinase: An Active Protein Kinase Complexed With Nucleotide, Substrate-Analogue And Product Length = 298

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 52/173 (30%), Positives = 81/173 (46%), Gaps = 21/173 (12%)
Query: 9   TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV 66
             L+E+ IL+ +  H N++ L +   T         + F+LVFD  +  +L   L+   V
Sbjct: 69  ATLKEVDILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTE-KV 119
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S  E +K+++ LL  +  +H   I+HRD+K  N+L+     +KL DFG +    Q   
Sbjct: 120 TLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFS---CQLDP 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSP 174
           G+  R      T  Y  PE++    N     YG  VD+W  G IM  +   SP
Sbjct: 177 GEKLREV--CGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSP 227

>pdb|2PTK|A Chain A, Chicken Src Tyrosine Kinase Length = 453

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 44/177 (24%), Positives = 82/177 (46%), Gaps = 19/177 (10%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYL----VFDFCEHDLA 58
           G   P   L+E ++++ L+HE +V L  +     ++   Y  T Y+    + DF + ++ 
Sbjct: 220 GNMSPEAFLQEAQVMKKLRHEKLVQLYAV----VSEEPIYIVTEYMSKGSLLDFLKGEMG 275
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
             L        L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGL 
Sbjct: 276 KYLR-------LPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLG 328
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
           R      N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 329 RLIED--NEYTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELTTKGRV 381

>pdb|4FK3|A Chain A, B-Raf Kinase V600e Oncogenic Mutant In Complex With Plx3203 Length = 292

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 57/222 (25%), Positives = 106/222 (47%), Gaps = 31/222 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           E+ +L+  +H N++  +             +    +V  +CE   + L  ++H   +  E
Sbjct: 70  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEG--SSLYHHLHASETKFE 118
Query: 73  IKKVI---QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQ 128
           +KK+I   +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q
Sbjct: 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGSHQ 178
Query: 129 VNRYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
             + +  +  LW  P  + + D N Y    D++  G ++ E+ T + P    N   Q I 
Sbjct: 179 FEQLSGSI--LWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIE 236
Query: 187 LISQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
           ++ +  GS++P         DL   +   PK  KR + E LK
Sbjct: 237 MVGR--GSLSP---------DLSKVRSNCPKRMKRLMAECLK 267

>pdb|2ZM1|A Chain A, Crystal Structure Of Imidazo Pyrazin 1 Bound To The Kinase Domain Of Human Lck, (Auto-Phosphorylated On Tyr394) Length = 285

Iteration: 1
 Score = 63.2 bits (152), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+   +  L
Sbjct: 54  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 104
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 105 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 164
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 165 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 218 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 251

>pdb|2EU9|A Chain A, Crystal Structure Of Clk3 Length = 355

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 27/147 (18%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-------------------TKTG 108
           + L  ++ +  QL + L ++H N++ H D+K  N+L                     K  
Sbjct: 120 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 179
Query: 109 ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +++ADFG A  F          +T  V T  YRPPE++L +  +  P D+W  GCI+ E
Sbjct: 180 SIRVADFGSA-TFDH------EHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 231
Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSI 195
            +    + Q +  ++ + ++ ++ G I
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPI 258

>pdb|2EXE|A Chain A, Crystal Structure Of The Phosphorylated Clk3 Length = 357

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 27/147 (18%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-------------------TKTG 108
           + L  ++ +  QL + L ++H N++ H D+K  N+L                     K  
Sbjct: 129 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 188
Query: 109 ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +++ADFG A  F          +T  V T  YRPPE++L +  +  P D+W  GCI+ E
Sbjct: 189 SIRVADFGSA-TFDH------EHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 240
Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSI 195
            +    + Q +  ++ + ++ ++ G I
Sbjct: 241 YYRGFTLFQTHENREHLVMMEKILGPI 267

>pdb|3KXZ|A Chain A, The Complex Crystal Structure Of Lck With A Probe Molecule W259 Length = 287

Iteration: 1
 Score = 62.8 bits (151), Expect = 3e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+   +  L
Sbjct: 56  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 106
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 107 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 166
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 167 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 219
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 220 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 253

>pdb|2WU6|A Chain A, Crystal Structure Of The Human Clk3 In Complex With Dki Length = 381

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 37/147 (25%), Positives = 68/147 (46%), Gaps = 27/147 (18%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-------------------TKTG 108
           + L  ++ +  QL + L ++H N++ H D+K  N+L                     K  
Sbjct: 152 YPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNT 211
Query: 109 ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +++ADFG A  F          +T  V T  YRPPE++L +  +  P D+W  GCI+ E
Sbjct: 212 SIRVADFGSA-TFDH------EHHTTIVATRHYRPPEVIL-ELGWAQPCDVWSIGCILFE 263
Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSI 195
            +    + Q +  ++ + ++ ++ G I
Sbjct: 264 YYRGFTLFQTHENREHLVMMEKILGPI 290

>pdb|4G31|A Chain A, Crystal Structure Of Gsk6414 Bound To Perk (R587-R1092, Delete A660- T867) At 2.28 A Resolution Length = 299

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 85/177 (48%), Gaps = 20/177 (11%)
Query: 10  ALREIKILQLLKHENVVHL----IEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            +RE+K L  L+H  +V      +E   T+  Q +  +   Y+    C  +   L   ++
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKE--NLKDWMN 107
Query: 66  VKFSLGEIKK-----VIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            + ++ E ++     +  Q+   + ++HS  ++HRD+K +N+  T   ++K+ DFGL  A
Sbjct: 108 GRCTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTA 167
Query: 121 FSQTKNGQV--------NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             Q +  Q          R+T +V T  Y  PE + G+ +Y   VD++  G I+ E+
Sbjct: 168 MDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGN-SYSHKVDIFSLGLILFEL 223

>pdb|3Q96|A Chain A, B-Raf Kinase Domain In Complex With A Tetrahydronaphthalene Inhibitor Length = 282

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 56  EVGVLRKTRHVNILLFMGYST---------KPQLAIVTQWCEGSSLYHHLHIIETKFEMI 106
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 107 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 166
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 167 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 224
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 225 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 253

>pdb|3KMM|A Chain A, Structure Of Human Lck Kinase With A Small Molecule Inhibitor Length = 288

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 57  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 107
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 108 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 167
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 168 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 220
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 221 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 254

>pdb|2FB8|A Chain A, Structure Of The B-Raf Kinase Domain Bound To Sb-590885 Length = 281

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 59  EVGVLRKTRHVNILLFMGYST---------KPQLAIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 110 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 170 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 228 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 256

>pdb|4DBN|A Chain A, Crystal Structure Of The Kinase Domain Of Human B-Raf With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 284

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 59  EVGVLRKTRHVNILLFMGYST---------KPQLAIVTQWCEGSSLYHHLHIIETKFEMI 109
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 110 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 169
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 170 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 227
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 228 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 256

>pdb|1QPE|A Chain A, Structural Analysis Of The Lymphocyte-Specific Kinase Lck In Complex With Non-Selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 62.8 bits (151), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+   +  L
Sbjct: 48  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 98
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 159 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 245

>pdb|4H58|A Chain A, Braf In Complex With Compound 3 Length = 275

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 54  EVGVLRKTRHVNILLFMGYST---------KPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 164
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 165 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 223 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 251

>pdb|3NZ0|A Chain A, Non-Phosphorylated Tyk2 Kinase With Cmp6 Length = 302

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 76/162 (46%), Gaps = 13/162 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           +EI IL+ L HE+++     C  +  +      +  LV ++      G L +   + S+G
Sbjct: 65  QEIDILRTLYHEHIIKYKGCCEDQGEK------SLQLVMEYVP---LGSLRDYLPRHSIG 115
Query: 72  EIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + ++  QQ+  G+ Y+H+   +HR++ A NVL+    ++K+ DFGLA+A  +      
Sbjct: 116 LAQLLLFAQQICEGMAYLHAQHYIHRNLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 175
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY P    L +  +    D+W  G  + E+ T
Sbjct: 176 VREDGDSPVFWYAPE--CLKEYKFYYASDVWSFGVTLYELLT 215

>pdb|3BYM|A Chain A, X-Ray Co-Crystal Structure Aminobenzimidazole Triazine 1 Bound To Lck Length = 272

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 49  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 99
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 100 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 159
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 160 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 212
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 213 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 246

>pdb|2OFU|A Chain A, X-Ray Crystal Structure Of 2-Aminopyrimidine Carbamate 43 Bound To Lck Length = 273

Iteration: 1
 Score = 62.4 bits (150), Expect = 4e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 50  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 100
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 101 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 160
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 161 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 213
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 214 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 247

>pdb|3D4Q|A Chain A, Pyrazole-Based Inhibitors Of B-Raf Kinase Length = 307

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 133 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 192
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 193 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 251 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 279

>pdb|3II5|A Chain A, The Complex Of Wild-Type B-Raf With Pyrazolo Pyrimidine Inhibitor Length = 306

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 81  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 131
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 132 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSHQFE 191
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 192 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 249
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 250 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 278

>pdb|2PL0|A Chain A, Lck Bound To Imatinib Length = 289

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 97/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGL 60
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+   +  L
Sbjct: 58  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 108
Query: 61  LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 109 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 168
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 169 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 221
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 222 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 255

>pdb|3LCK|A Chain A, The Kinase Domain Of Human Lymphocyte Kinase (Lck), Activated Form (Auto-Phosphorylated On Tyr394) Length = 271

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 48  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 98
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 159 IED--NEXTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 245

>pdb|3BYS|A Chain A, Co-Crystal Structure Of Lck And Aminopyrimidine Amide 10b Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 54  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 104
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 105 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 164
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 165 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 217
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 218 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 251

>pdb|2OFV|A Chain A, Crystal Structure Of Aminoquinazoline 1 Bound To Lck Length = 277

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 53  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 103
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 104 KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 163
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 164 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 216
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 217 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 250

>pdb|3MIY|A Chain A, X-Ray Crystal Structure Of Itk Complexed With Sunitinib Length = 266

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LVF+F EH  L+  L      F+
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRGLFA 101
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 102 AETLLGMCLDVCEGMAYLEEASVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 158
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 159 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|4AOJ|A Chain A, Human Trka In Complex With The Inhibitor Az-23 Length = 329

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 42/175 (24%), Positives = 79/175 (45%), Gaps = 26/175 (14%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--------------- 56
           RE ++L +L+H+++V    +C               +VF++  H                
Sbjct: 92  REAELLTMLQHQHIVRFFGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKL 143
Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           LAG          LG++  V  Q+  G+ Y+     +HRD+   N L+ +  ++K+ DFG
Sbjct: 144 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 203
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           ++R    T   +V   T  ++ + + PPE +L  R +    D+W  G ++ E++T
Sbjct: 204 MSRDIYSTDYYRVGGRT--MLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFT 255

>pdb|1UWJ|A Chain A, The Complex Of Mutant V599e B-raf And Bay439006 Length = 276

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 54  EVGVLRKTRHVNILLFMGYST---------KPQLAIVTQWCEGSSLYHHLHIIETKFEMI 104
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 105 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 164
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 165 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 222
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 223 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 251

>pdb|4F0I|A Chain A, Crystal Structure Of Apo Trka Length = 300

Iteration: 1
 Score = 62.4 bits (150), Expect = 5e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--------------- 56
           RE ++L +L+H+++V    +C               +VF++  H                
Sbjct: 63  REAELLTMLQHQHIVRFFGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKL 114
Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           LAG          LG++  V  Q+  G+ Y+     +HRD+   N L+ +  ++K+ DFG
Sbjct: 115 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 174
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
           ++R    T   +V   T  ++ + + PPE +L  R +    D+W  G ++ E++T  + P
Sbjct: 175 MSRDIYSTDYYRVGGRT--MLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQP 231
Query: 175 IMQ-GNTEQQQITLISQ 190
             Q  NTE   I  I+Q
Sbjct: 232 WYQLSNTE--AIDCITQ 246

>pdb|2OG8|A Chain A, Crystal Structure Of Aminoquinazoline 36 Bound To Lck Length = 265

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 43  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 93
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 94  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 153
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 154 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 206
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 207 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 240

>pdb|4GT5|A Chain A, Crystal Structure Of The Inactive Trka Kinase Domain Length = 306

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 50/197 (25%), Positives = 89/197 (45%), Gaps = 31/197 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--------------- 56
           RE ++L +L+H+++V    +C               +VF++  H                
Sbjct: 69  REAELLTMLQHQHIVRFFGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKL 120
Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFG 116
           LAG          LG++  V  Q+  G+ Y+     +HRD+   N L+ +  ++K+ DFG
Sbjct: 121 LAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFG 180
Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
           ++R    T   +V   T  ++ + + PPE +L  R +    D+W  G ++ E++T  + P
Sbjct: 181 MSRDIYSTDYYRVGGRT--MLPIRWMPPESIL-YRKFTTESDVWSFGVVLWEIFTYGKQP 237
Query: 175 IMQ-GNTEQQQITLISQ 190
             Q  NTE   I  I+Q
Sbjct: 238 WYQLSNTE--AIDCITQ 252

>pdb|3IDP|A Chain A, B-Raf V600e Kinase Domain In Complex With An Aminoisoquinoline Inhibitor Length = 300

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 74  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 124
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 125 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 184
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 185 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 242
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 243 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 271

>pdb|4G9R|A Chain A, B-Raf V600e Kinase Domain Bound To A Type Ii Dihydroquinazoline Inhibitor Length = 307

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 56/220 (25%), Positives = 104/220 (47%), Gaps = 27/220 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E+ +L+  +H N++  +             +    +V  +CE   L   L  I  KF + 
Sbjct: 82  EVGVLRKTRHVNILLFMGYS---------TKPQLAIVTQWCEGSSLYHHLHIIETKFEMI 132
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQVN 130
           ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+ + + Q  
Sbjct: 133 KLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATEKSRWSGSHQFE 192
Query: 131 RYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLI 188
           + +  +  LW  P  + + D+N Y    D++  G ++ E+ T + P    N   Q I ++
Sbjct: 193 QLSGSI--LWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIFMV 250
Query: 189 SQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLK 227
            +  G ++P         DL   +   PKA KR + E LK
Sbjct: 251 GR--GYLSP---------DLSKVRSNCPKAMKRLMAECLK 279

>pdb|2ZV7|A Chain A, Lyn Tyrosine Kinase Domain, Apo Form Length = 279

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 59/230 (25%), Positives = 105/230 (45%), Gaps = 22/230 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +   +   Y    + +   L+ DF + D  G       K 
Sbjct: 55  LEEANLMKTLQHDKLVRLYAVVTKEEPIYIITEFMAKGSLL-DFLKSDEGG-------KV 106
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ YI     +HRD++AANVL++++ + K+ADFGLAR      N  
Sbjct: 107 LLPKLIDFSAQIAEGMAYIERKNYIHRDLRAANVLVSESLMCKIADFGLARVIED--NEY 164
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITL 187
             R   +    W  P  +  G   +    ++W  G ++ E+ T   I   G T    ++ 
Sbjct: 165 TAREGAKFPIKWTAPEAINFG--CFTIKSNVWSFGILLYEIVTYGKIPYPGRTNADVMSA 222
Query: 188 ISQLCGSITPESWPGVETLDLYNKMEL---PKAQKRKVKERLKPYVKDQY 234
           +SQ       E+ P     +LY+ M++    KA++R   + L+  + D Y
Sbjct: 223 LSQGYRMPRMENCPD----ELYDIMKMCWKEKAEERPTFDYLQSVLDDFY 268

>pdb|2OF2|A Chain A, Crystal Structure Of Furanopyrimidine 8 Bound To Lck Length = 271

Iteration: 1
 Score = 62.0 bits (149), Expect = 6e-10,   Method: Compositional matrix adjust.
 Identities = 54/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 48  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 98
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 159 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 245

>pdb|4E1Z|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 291

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI+IL+ L HE++V     C  +  +      +  LV ++      G L +   +  +G
Sbjct: 60  REIEILRTLYHEHIVKYKGCCEDQGEK------SVQLVMEYVP---LGSLRDYLPRHCVG 110
Query: 72  EIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + ++  QQ+  G+ Y+H+   +HR + A NVL+    ++K+ DFGLA+A  +      
Sbjct: 111 LAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 170
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY P    L +  +    D+W  G  + E+ T
Sbjct: 171 VREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYELLT 210

>pdb|4E20|A Chain A, Structure Of Mouse Tyk-2 Complexed To A 3-Aminoindazole Inhibitor Length = 290

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 13/162 (8%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI+IL+ L HE++V     C  +  +      +  LV ++      G L +   +  +G
Sbjct: 59  REIEILRTLYHEHIVKYKGCCEDQGEK------SVQLVMEYVP---LGSLRDYLPRHCVG 109
Query: 72  EIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + ++  QQ+  G+ Y+H+   +HR + A NVL+    ++K+ DFGLA+A  +      
Sbjct: 110 LAQLLLFAQQICEGMAYLHAQHYIHRALAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 169
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY P    L +  +    D+W  G  + E+ T
Sbjct: 170 VREDGDSPVFWYAPE--CLKECKFYYASDVWSFGVTLYELLT 209

>pdb|4ASZ|A Chain A, Crystal Structure Of Apo Trkb Kinase Domain Length = 299

Iteration: 1
 Score = 61.6 bits (148), Expect = 8e-10,   Method: Compositional matrix adjust.
 Identities = 42/173 (24%), Positives = 83/173 (47%), Gaps = 24/173 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL--------- 61
           RE ++L  L+HE++V    +C               +VF++ +H DL   L         
Sbjct: 64  REAELLTNLQHEHIVKFYGVCVEG--------DPLIMVFEYMKHGDLNKFLRAHGPDAVL 115
Query: 62  ---SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
               N   + +  ++  + QQ+  G+ Y+ S   +HRD+   N L+ +  ++K+ DFG++
Sbjct: 116 MAEGNPPTELTQSQMLHIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMS 175
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           R    T   +V  +T  ++ + + PPE ++  R +    D+W  G ++ E++T
Sbjct: 176 RDVYSTDYYRVGGHT--MLPIRWMPPESIM-YRKFTTESDVWSLGVVLWEIFT 225

>pdb|1ZWS|A Chain A, Crystal Structure Of The Catalytic Domain Of Human Drp-1 Kinase Length = 288

Iteration: 1
 Score = 61.6 bits (148), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H NV+ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHHNVITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3V5J|A Chain A, Crystal Structure Of Interleukin-2 Inducible T-Cell Kinase Itk Catalytic Domain With Thienopyrazolylindole Inhibitor 090 Length = 266

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LVF+F EH  L+  L      F+
Sbjct: 50  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRGLFA 101
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 102 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 158
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 159 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 214

>pdb|1QPD|A Chain A, Structural Analysis Of The Lymphocyte-specific Kinase Lck In Complex With Non-selective And Src Family Selective Kinase Inhibitors Length = 279

Iteration: 1
 Score = 61.2 bits (147), Expect = 9e-10,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 48  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 98
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR 
Sbjct: 99  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARL 158
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
               +     R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 159 IEDAE--XTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 211
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 212 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 245

>pdb|4HCT|A Chain A, Crystal Structure Of Itk In Complex With Compound 52 Length = 269

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LVF+F EH  L+  L      F+
Sbjct: 53  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRGLFA 104
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 105 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 161
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 162 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 217

>pdb|2PML|X Chain X, Crystal Structure Of Pfpk7 In Complex With An Atp Analogue Length = 348

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 36/101 (35%), Positives = 53/101 (52%), Gaps = 10/101 (9%)
Query: 73  IKKVIQQLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTK-NGQVN 130
           IK +I+ +LN   YIH+ K I HRD+K +N+L+ K G +KL+DFG +      K  G   
Sbjct: 153 IKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDKKIKGSRG 212
Query: 131 RYTNRVVTLWYRPPELLLGDRNY-GPPVDLWGAGCIMAEMW 170
            Y        + PPE    + +Y G  VD+W  G  +  M+
Sbjct: 213 TYE-------FMPPEFFSNESSYNGAKVDIWSLGICLYVMF 246

>pdb|1SM2|A Chain A, Crystal Structure Of The Phosphorylated Interleukin-2 Tyrosine Kinase Catalytic Domain Length = 264

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LVF+F EH  L+  L      F+
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRGLFA 99
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 100 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 156
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 212

>pdb|2A27|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 8 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H NV+ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHHNVITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|3QGW|A Chain A, Crystal Structure Of Itk Kinase Bound To An Inhibitor Length = 286

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 42/177 (23%), Positives = 78/177 (44%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LVF+F EH  L+  L      F+
Sbjct: 70  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVFEFMEHGCLSDYLRTQRGLFA 121
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 122 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 178
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 179 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 234

>pdb|1Z9X|A Chain A, Human Drp-1 Kinase, W305s S308a D40 Mutant, Crystal Form With 3 Monomers In The Asymmetric Unit Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H NV+ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHHNVITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2A2A|A Chain A, High-resolution Crystallographic Analysis Of The Autoinhibited Conformation Of A Human Death-associated Protein Kinase Length = 321

Iteration: 1
 Score = 61.2 bits (147), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H NV+ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHHNVITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITSVSYDFDEEFFSHTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1WMK|A Chain A, Human Death-Associated Kinase Drp-1, Mutant S308d D40 Length = 321

Iteration: 1
 Score = 60.8 bits (146), Expect = 1e-09,   Method: Compositional matrix adjust.
 Identities = 60/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H NV+ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHHNVITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|1MRV|A Chain A, Crystal Structure Of An Inactive Akt2 Kinase Domain Length = 339

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 116 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKTFC 169
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 170 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 201

>pdb|2DQ7|X Chain X, Crystal Structure Of Fyn Kinase Domain Complexed With Staurosporine Length = 283

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 45/175 (25%), Positives = 78/175 (44%), Gaps = 15/175 (8%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLL 61
           G   P + L E +I++ LKH+ +V L  +   +           Y+V ++  +  L   L
Sbjct: 44  GTMSPESFLEEAQIMKKLKHDKLVQLYAVVSEEP---------IYIVTEYMNKGSLLDFL 94
Query: 62  SNIHVK-FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
            +   +   L  +  +  Q+  G+ YI     +HRD+++AN+L+    I K+ADFGLAR 
Sbjct: 95  KDGEGRALKLPNLVDMAAQVAAGMAYIERMNYIHRDLRSANILVGNGLICKIADFGLARL 154
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI 175
                N    R   +    W  P   L G   +    D+W  G ++ E+ T+  +
Sbjct: 155 IED--NEXTARQGAKFPIKWTAPEAALYG--RFTIKSDVWSFGILLTELVTKGRV 205

>pdb|1GZN|A Chain A, Structure Of Pkb Kinase Domain Length = 335

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKTFC 166
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1O6L|A Chain A, Crystal Structure Of An Activated Akt/protein Kinase B (pkb-pif Chimera) Ternary Complex With Amp-pnp And Gsk3 Peptide Length = 337

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKXFC 166
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|3R1N|A Chain A, Mk3 Kinase Bound To Compound 5b Length = 317

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 10/118 (8%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           F+  E  ++++ +   + ++HS+ I HRD+K  N+L T   K  +LKL DFG A+  +Q 
Sbjct: 106 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 164
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                N       T +Y  PE +LG   Y    D+W  G IM  +    P    NT Q
Sbjct: 165 -----NALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 216

>pdb|3FHR|A Chain A, High Resolution Crystal Structure Of Mitogen-Activated Protein Kinase-Activated Protein Kinase 3 (Mk3)-Inhibitor Complex Length = 336

Iteration: 1
 Score = 60.5 bits (145), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 38/118 (32%), Positives = 57/118 (48%), Gaps = 10/118 (8%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           F+  E  ++++ +   + ++HS+ I HRD+K  N+L T   K  +LKL DFG A+  +Q 
Sbjct: 125 FTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQ- 183
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                N       T +Y  PE +LG   Y    D+W  G IM  +    P    NT Q
Sbjct: 184 -----NALQTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGFPPFYSNTGQ 235

>pdb|2JDO|A Chain A, Structure Of Pkb-Beta (Akt2) Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 342

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 118 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKXFC 171
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 172 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|1GZK|A Chain A, Molecular Mechanism For The Regulation Of Protein Kinase B Akt By Hydrophobic Motif Phosphorylation Length = 315

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKTFC 166
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|1O6K|A Chain A, Structure Of Activated Form Of Pkb Kinase Domain S474d With Gsk3 Peptide And Amp-Pnp Length = 336

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKXFC 166
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|3E87|A Chain A, Crystal Structures Of The Kinase Domain Of Akt2 In Complex With Atp- Competitive Inhibitors Length = 335

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 34/93 (36%), Positives = 53/93 (56%), Gaps = 9/93 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL       K G  +  T +   
Sbjct: 113 EIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLC------KEGISDGATMKXFC 166
Query: 138 -TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 167 GTPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 198

>pdb|2W4O|A Chain A, Crystal Structure Of Human Camk4 In Complex With 4-Amino( Sulfamoyl-Phenylamino)-Triazole-Carbothioic Acid (2,6- Difluoro-Phenyl)-Amide) Length = 349

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 52/158 (32%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L  L H N++ L EI  T         +   LV +        L   I  K  +S 
Sbjct: 98  EIGVLLRLSHPNIIKLKEIFETP--------TEISLVLELVTG--GELFDRIVEKGYYSE 147
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNG 127
            +    ++Q+L  + Y+H N I+HRD+K  N+L         LK+ADFGL++        
Sbjct: 148 RDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEH---- 203
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           QV   T    T  Y  PE+L G   YGP VD+W  G I
Sbjct: 204 QVLMKT-VCGTPGYCAPEILRG-CAYGPEVDMWSVGII 239

>pdb|3MPM|A Chain A, Lck Complexed With A Pyrazolopyrimidine Length = 267

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 53/218 (24%), Positives = 96/218 (44%), Gaps = 26/218 (11%)
Query: 3   GIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL 61
           G   P   L E  +++ L+H+ +V L  +           +   Y++ ++ E+  L   L
Sbjct: 44  GSMSPDAFLAEANLMKQLQHQRLVRLYAVVT---------QEPIYIITEYMENGSLVDFL 94
Query: 62  SNIH-VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                +K ++ ++  +  Q+  G+ +I     +HR+++AAN+L++ T   K+ADFGLAR 
Sbjct: 95  KTPSGIKLTINKLLDMAAQIAEGMAFIEERNYIHRNLRAANILVSDTLSCKIADFGLARL 154
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPI-M 176
                N    R   +    W  P  +     NYG      D+W  G ++ E+ T   I  
Sbjct: 155 IED--NEYTAREGAKFPIKWTAPEAI-----NYGTFTIKSDVWSFGILLTEIVTHGRIPY 207
Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            G T  + I  + +    + P++ P     +LY  M L
Sbjct: 208 PGMTNPEVIQNLERGYRMVRPDNCPE----ELYQLMRL 241

>pdb|1QCF|A Chain A, Crystal Structure Of Hck In Complex With A Src Family- Selective Tyrosine Kinase Inhibitor Length = 454

Iteration: 1
 Score = 60.1 bits (144), Expect = 2e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +           +   Y++ +F      L  L S+   K 
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVVT---------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 281
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ +I     +HRD++AAN+L++ + + K+ADFGLAR      N  
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEY 339
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITL 187
             R   +    W  P  +  G  ++    D+W  G ++ E+ T   I   G +  + I  
Sbjct: 340 TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 397
Query: 188 ISQLCGSITPESWPGVETLDLYNKM 212
           + +      PE+ P     +LYN M
Sbjct: 398 LERGYRMPRPENCPE----ELYNIM 418

>pdb|1U59|A Chain A, Crystal Structure Of The Zap-70 Kinase Domain In Complex With Staurosporine Length = 287

Iteration: 1
 Score = 60.1 bits (144), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 39/159 (24%), Positives = 69/159 (43%), Gaps = 12/159 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           +RE +I+  L +  +V LI +C+ +A           LV +      L   L     +  
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAEA---------LMLVMEMAGGGPLHKFLVGKREEIP 108
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HRD+ A NVL+      K++DFGL++A     +   
Sbjct: 109 VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            R   +    WY P    +  R +    D+W  G  M E
Sbjct: 169 ARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWE 205

>pdb|2JAM|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase I G Length = 304

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 53/178 (29%), Positives = 82/178 (46%), Gaps = 26/178 (14%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRST--FYLVFDFCEHDLAGLLSNIHVK--F 68
           EI +L+ +KHEN+V L +I          Y ST  +YLV          L   I  +  +
Sbjct: 56  EIAVLKKIKHENIVTLEDI----------YESTTHYYLVMQLVSG--GELFDRILERGVY 103
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTK 125
           +  +   VIQQ+L+ + Y+H N I+HRD+K  N+L     +   + + DFGL++     +
Sbjct: 104 TEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSK---MEQ 160
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           NG ++       T  Y  PE +L  + Y   VD W  G I   +    P     TE +
Sbjct: 161 NGIMSTACG---TPGYVAPE-VLAQKPYSKAVDCWSIGVITYILLCGYPPFYEETESK 214

>pdb|2HK5|A Chain A, Hck Kinase In Complex With Lck Targetted Inhibitor Pg- 1009247 Length = 270

Iteration: 1
 Score = 59.7 bits (143), Expect = 3e-09,   Method: Compositional matrix adjust.
 Identities = 51/205 (24%), Positives = 91/205 (44%), Gaps = 20/205 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +           +   Y++ +F      L  L S+   K 
Sbjct: 58  LAEANVMKTLQHDKLVKLHAVVT---------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 108
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ +I     +HRD++AAN+L++ + + K+ADFGLAR      N  
Sbjct: 109 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED--NEY 166
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITL 187
             R   +    W  P  +  G  ++    D+W  G ++ E+ T   I   G +  + I  
Sbjct: 167 TAREGAKFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 224
Query: 188 ISQLCGSITPESWPGVETLDLYNKM 212
           + +      PE+ P     +LYN M
Sbjct: 225 LERGYRMPRPENCPE----ELYNIM 245

>pdb|2V55|A Chain A, Mechanism Of Multi-site Phosphorylation From A Rock-i:rhoe Complex Structure Length = 406

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 36  ANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILH 94
           A Q +RY    Y+V ++    DL  L+SN  V            +++  L  IHS   +H
Sbjct: 142 AFQDDRY---LYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMGFIH 196
Query: 95  RDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDR 151
           RD+K  N+L+ K+G LKLADFG        K G V R    V T  Y  PE+L    GD 
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 152 NYGPPVDLWGAGCIMAEM 169
            YG   D W  G  + EM
Sbjct: 254 YYGRECDWWSVGVFLYEM 271

>pdb|3V8S|A Chain A, Human Rho-Associated Protein Kinase 1 (Rock 1) In Complex With Indazole Derivative (Compound 18) Length = 410

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 36  ANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILH 94
           A Q +RY    Y+V ++    DL  L+SN  V            +++  L  IHS   +H
Sbjct: 137 AFQDDRY---LYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMGFIH 191
Query: 95  RDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDR 151
           RD+K  N+L+ K+G LKLADFG        K G V R    V T  Y  PE+L    GD 
Sbjct: 192 RDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG 248
Query: 152 NYGPPVDLWGAGCIMAEM 169
            YG   D W  G  + EM
Sbjct: 249 YYGRECDWWSVGVFLYEM 266

>pdb|2YA9|A Chain A, Crystal Structure Of The Autoinhibited Form Of Mouse Dapk2 Length = 361

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 59/232 (25%), Positives = 109/232 (46%), Gaps = 32/232 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           RE+ IL+ + H N++ L ++           R+   L+ +        L   +  K SL 
Sbjct: 64  REVSILRQVLHPNIITLHDVYEN--------RTDVVLILELVSG--GELFDFLAQKESLS 113
Query: 72  EIKKV--IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTK 125
           E +    I+Q+L+G+ Y+H+ KI H D+K  N+++    I    +KL DFGLA    + +
Sbjct: 114 EEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAH---EIE 170
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGP---PVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
           +G    + N   T  +  PE++    NY P     D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV--EFKNIFGTPEFVAPEIV----NYEPLGLEADMWSIGVITYILLSGASPFLGDTKQ 224
Query: 183 QQITLISQLCGSITPESWPGVETL--DLYNKMELPKAQKR-KVKERLK-PYV 230
           + +  I+ +      E +     L  D   K+ + + +KR  ++E L+ P++
Sbjct: 225 ETLANITAVSYDFDEEFFSQTSELAKDFIRKLLVKETRKRLTIQEALRHPWI 276

>pdb|2ESM|A Chain A, Crystal Structure Of Rock 1 Bound To Fasudil Length = 415

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 50/138 (36%), Positives = 65/138 (47%), Gaps = 12/138 (8%)
Query: 36  ANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILH 94
           A Q +RY    Y+V ++    DL  L+SN  V            +++  L  IHS   +H
Sbjct: 142 AFQDDRY---LYMVMEYMPGGDLVNLMSNYDVPEKWARF--YTAEVVLALDAIHSMGFIH 196
Query: 95  RDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDR 151
           RD+K  N+L+ K+G LKLADFG        K G V R    V T  Y  PE+L    GD 
Sbjct: 197 RDVKPDNMLLDKSGHLKLADFGT--CMKMNKEGMV-RCDTAVGTPDYISPEVLKSQGGDG 253
Query: 152 NYGPPVDLWGAGCIMAEM 169
            YG   D W  G  + EM
Sbjct: 254 YYGRECDWWSVGVFLYEM 271

>pdb|3V5Q|A Chain A, Discovery Of A Selective Trk Inhibitor With Efficacy In Rodent Cancer Tumor Models Length = 297

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 47/189 (24%), Positives = 87/189 (46%), Gaps = 30/189 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS-------- 62
           RE ++L  L+HE++V    +C               +VF++ +H DL   L         
Sbjct: 66  REAELLTNLQHEHIVKFYGVCGDG--------DPLIMVFEYMKHGDLNKFLRAHGPDAMI 117
Query: 63  -------NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                      +  L ++  +  Q+ +G+ Y+ S   +HRD+   N L+    ++K+ DF
Sbjct: 118 LVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGDF 177
Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RS 173
           G++R    T   +V  +T  ++ + + PPE ++  R +    D+W  G I+ E++T  + 
Sbjct: 178 GMSRDVYSTDYYRVGGHT--MLPIRWMPPESIM-YRKFTTESDVWSFGVILWEIFTYGKQ 234
Query: 174 PIMQ-GNTE 181
           P  Q  NTE
Sbjct: 235 PWFQLSNTE 243

>pdb|3UDB|A Chain A, Crystal Structure Of Snrk2.6 Length = 317

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 75/165 (45%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AG-------RFS 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQL++G+ Y H+ ++ HRD+K  N L+  +    LK+ADFG ++A    SQ 
Sbjct: 114 EDEARFFFQQLISGVSYAHAMQVAHRDLKLENTLLDGSPAPRLKIADFGYSKASVLHSQP 173
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K+         V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 174 KSA--------VGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210

>pdb|3RZF|A Chain A, Crystal Structure Of Inhibitor Of Kappab Kinase Beta (I4122) Length = 677

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL- 70
           EI+I++ L H NVV   E+      Q         L  ++CE  DL   L+       L 
Sbjct: 63  EIQIMKKLNHPNVVSAREV--PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 120
Query: 71  -GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
            G I+ ++  + + L Y+H N+I+HRD+K  N+++    +  I K+ D G A+   Q   
Sbjct: 121 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--- 177
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           G++   T  V TL Y  PE LL  + Y   VD W  G +  E  T
Sbjct: 178 GEL--CTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 219

>pdb|3QA8|A Chain A, Crystal Structure Of Inhibitor Of Kappa B Kinase Beta Length = 676

Iteration: 1
 Score = 59.3 bits (142), Expect = 4e-09,   Method: Compositional matrix adjust.
 Identities = 52/165 (31%), Positives = 78/165 (47%), Gaps = 14/165 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL- 70
           EI+I++ L H NVV   E+      Q         L  ++CE  DL   L+       L 
Sbjct: 62  EIQIMKKLNHPNVVSAREV--PDGLQKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLK 119
Query: 71  -GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKN 126
            G I+ ++  + + L Y+H N+I+HRD+K  N+++    +  I K+ D G A+   Q   
Sbjct: 120 EGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQ--- 176
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           G++   T  V TL Y  PE LL  + Y   VD W  G +  E  T
Sbjct: 177 GEL--CTEFVGTLQYLAPE-LLEQKKYTVTVDYWSFGTLAFECIT 218

>pdb|1Z57|A Chain A, Crystal Structure Of Human Clk1 In Complex With 10z-Hymenialdisine Length = 339

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 35/147 (23%), Positives = 68/147 (46%), Gaps = 27/147 (18%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI------------------ 109
           F L  I+K+  Q+   + ++HSNK+ H D+K  N+L  ++                    
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 110 -LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +K+ DFG     S T + +   ++  V T  YR PE++L    +  P D+W  GCI+ E
Sbjct: 175 DIKVVDFG-----SATYDDE--HHSTLVSTRHYRAPEVILA-LGWSQPCDVWSIGCILIE 226
Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSI 195
            +    +   +  ++ + ++ ++ G +
Sbjct: 227 YYLGFTVFPTHDSKEHLAMMERILGPL 253

>pdb|3NR9|A Chain A, Structure Of Human Cdc2-Like Kinase 2 (Clk2) Length = 368

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 74/166 (44%), Gaps = 34/166 (20%)
Query: 49  VFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---- 104
            FDF       L  N ++ + + +++ +  QL   + ++H NK+ H D+K  N+L     
Sbjct: 122 TFDF-------LKDNNYLPYPIHQVRHMAFQLCQAVKFLHDNKLTHTDLKPENILFVNSD 174
Query: 105 ---------------TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG 149
                           K+  +++ DFG A  F    +  +      V T  YR PE++L 
Sbjct: 175 YELTYNLEKKRDERSVKSTAVRVVDFGSA-TFDHEHHSTI------VSTRHYRAPEVIL- 226
Query: 150 DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSI 195
           +  +  P D+W  GCI+ E +    + Q +  ++ + ++ ++ G I
Sbjct: 227 ELGWSQPCDVWSIGCIIFEYYVGFTLFQTHDNREHLAMMERILGPI 272

>pdb|1K9A|A Chain A, Crystal Structure Analysis Of Full-Length Carboxyl-Terminal Src Kinase At 2.5 A Resolution Length = 450

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVK 67
           L E  ++  L+H N+V L+  I   K   Y    Y +   LV        + L  +  +K
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 293
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FSL         +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +  S T++ 
Sbjct: 294 FSL--------DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 344
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                T ++   W  P  L   ++ +    D+W  G ++ E+++
Sbjct: 345 -----TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYS 381

>pdb|2OZO|A Chain A, Autoinhibited Intact Human Zap-70 Length = 613

Iteration: 1
 Score = 58.9 bits (141), Expect = 5e-09,   Method: Compositional matrix adjust.
 Identities = 38/159 (23%), Positives = 69/159 (43%), Gaps = 12/159 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           +RE +I+  L +  +V LI +C+ +A           LV +      L   L     +  
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQAEA---------LMLVMEMAGGGPLHKFLVGKREEIP 434
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HR++ A NVL+      K++DFGL++A     +   
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            R   +    WY P    +  R +    D+W  G  M E
Sbjct: 495 ARSAGKWPLKWYAPE--CINFRKFSSRSDVWSYGVTMWE 531

>pdb|1BYG|A Chain A, Kinase Domain Of Human C-Terminal Src Kinase (Csk) In Complex With Inhibitor Staurosporine Length = 278

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVK 67
           L E  ++  L+H N+V L+  I   K   Y    Y +   LV        + L  +  +K
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 121
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FSL         +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +  S T++ 
Sbjct: 122 FSL--------DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                T ++   W  P  L   ++ +    D+W  G ++ E+++
Sbjct: 173 -----TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYS 209

>pdb|3CIK|A Chain A, Human Grk2 In Complex With Gbetagamma Subunits Length = 689

Iteration: 1
 Score = 58.9 bits (141), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  +++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 346 KP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 184 Q------ITLISQLCGSITPE 198
                  +T+  +L  S +PE
Sbjct: 400 HEIDRMTLTMAVELPDSFSPE 420

>pdb|3KRW|A Chain A, Human Grk2 In Complex With Gbetgamma Subunits And Balanol (Soak) Length = 688

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  +++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 285 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 344
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 345 KP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 398
Query: 184 Q------ITLISQLCGSITPE 198
                  +T+  +L  S +PE
Sbjct: 399 HEIDRMTLTMAVELPDSFSPE 419

>pdb|1OMW|A Chain A, Crystal Structure Of The Complex Between G Protein-Coupled Receptor Kinase 2 And Heterotrimeric G Protein Beta 1 And Gamma 2 Subunits Length = 689

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  +++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 346 KP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 184 Q------ITLISQLCGSITPE 198
                  +T+  +L  S +PE
Sbjct: 400 HEIDRMTLTMAVELPDSFSPE 420

>pdb|3PSC|A Chain A, Bovine Grk2 In Complex With Gbetagamma Subunits Length = 695

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 39/141 (27%), Positives = 72/141 (51%), Gaps = 13/141 (9%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H  FS  +++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ 
Sbjct: 286 HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK 345
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
           K          V T  Y  PE+L     Y    D +  GC++ ++    SP  Q  T+ +
Sbjct: 346 KP------HASVGTHGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDK 399
Query: 184 Q------ITLISQLCGSITPE 198
                  +T+  +L  S +PE
Sbjct: 400 HEIDRMTLTMAVELPDSFSPE 420

>pdb|3D7U|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 263

Iteration: 1
 Score = 58.5 bits (140), Expect = 6e-09,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 76/164 (46%), Gaps = 19/164 (11%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVK 67
           L E  ++  L+H N+V L+  I   K   Y    Y +   LV        + L  +  +K
Sbjct: 47  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 106
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FSL         +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +  S T++ 
Sbjct: 107 FSL--------DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 157
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                T ++   W  P  L   ++ +    D+W  G ++ E+++
Sbjct: 158 -----TGKLPVKWTAPEALR--EKKFSTKSDVWSFGILLWEIYS 194

>pdb|3I6W|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 443

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 261 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 315
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 316 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 373
Query: 194 ---SITPESWPGV--ETLDLYNKMEL--PKAQKRKVKERLKPYVKDQ 233
              +  PE W  V  + LDL  K+ +  PKA+    +    P+++D+
Sbjct: 374 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 420

>pdb|1LUF|A Chain A, Crystal Structure Of The Musk Tyrosine Kinase: Insights Into Receptor Autoregulation Length = 343

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 54/223 (24%), Positives = 96/223 (43%), Gaps = 30/223 (13%)
Query: 12  REIKILQLLKHENVVHLIEICRTKA--------------NQYNRYRSTFYLVFDFCEHDL 57
           RE  ++    + N+V L+ +C                  N++ R  S  + V      DL
Sbjct: 99  REAALMAEFDNPNIVKLLGVCAVGKPMCLLFEYMAYGDLNEFLRSMSP-HTVCSLSHSDL 157
Query: 58  ---AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
              A + S      S  E   + +Q+  G+ Y+   K +HRD+   N L+ +  ++K+AD
Sbjct: 158 STRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIAD 217
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           FGL+R        + +   N  + + + PPE +  +R Y    D+W  G ++ E+++   
Sbjct: 218 FGLSRNIYSADYYKAD--GNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVLWEIFSYG- 273
Query: 175 IMQ---GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL 214
            +Q   G   ++ I  +        PE+ P    L+LYN M L
Sbjct: 274 -LQPYYGMAHEEVIYYVRDGNILACPENCP----LELYNLMRL 311

>pdb|3I6U|A Chain A, Structure And Activation Mechanism Of The Chk2 Dna-Damage Checkpoint Kinase Length = 419

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 60/235 (25%), Positives = 108/235 (45%), Gaps = 32/235 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKFSL 70
           EI+IL+ L H  ++ +        N ++     +Y+V +  E       ++ N  +K + 
Sbjct: 190 EIEILKKLNHPCIIKI-------KNFFDA--EDYYIVLELMEGGELFDKVVGNKRLKEAT 240
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNG 127
              K    Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G
Sbjct: 241 --CKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----G 293
Query: 128 QVNRYTNRVVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           + +       T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q+
Sbjct: 294 ETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQV 351
Query: 186 TLISQLCG---SITPESWPGV--ETLDLYNKMEL--PKAQKRKVKERLKPYVKDQ 233
           +L  Q+     +  PE W  V  + LDL  K+ +  PKA+    +    P+++D+
Sbjct: 352 SLKDQITSGKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 406

>pdb|3C7Q|A Chain A, Structure Of Vegfr2 Kinase Domain In Complex With Bibf1120 Length = 316

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 46/176 (26%), Positives = 85/176 (48%), Gaps = 25/176 (14%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 80  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 132
Query: 69  -------------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                        +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DF
Sbjct: 133 VPYKPEDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDF 192
Query: 116 GLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           GLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 193 GLARDIXKDPD-XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 245

>pdb|4GV1|A Chain A, Pkb Alpha In Complex With Azd5363 Length = 340

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 116 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF--CG 171
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 172 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 202

>pdb|4FL3|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 635

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 418 LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 468
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 469 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 526
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 527 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 567

>pdb|3CQU|A Chain A, Crystal Structure Of Akt-1 Complexed With Substrate Peptide And Inhibitor Length = 342

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 118 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF--CG 173
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 174 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 204

>pdb|4FL2|A Chain A, Structural And Biophysical Characterization Of The Syk Activation Switch Length = 636

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 419 LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 469
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 470 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 527
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 528 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 568

>pdb|3SLS|A Chain A, Crystal Structure Of Human Mek-1 Kinase In Complex With Ucb1353770 And Amppnp Length = 304

Iteration: 1
 Score = 58.5 bits (140), Expect = 7e-09,   Method: Compositional matrix adjust.
 Identities = 47/153 (30%), Positives = 72/153 (47%), Gaps = 12/153 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 125 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 181
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI  G+       L+  
Sbjct: 182 F---VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIGSGSGSMAIFELLDY 237
Query: 191 LCGSITPESWPGVETL---DLYNKMELPKAQKR 220
           +     P+   GV +L   D  NK  +    +R
Sbjct: 238 IVNEPPPKLPSGVFSLEFQDFVNKCLIKNPAER 270

>pdb|3OCB|A Chain A, Akt1 Kinase Domain With Pyrrolopyrimidine Inhibitor Length = 341

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 117 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMKXF--CG 172
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 173 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 203

>pdb|2P3G|X Chain X, Crystal Structure Of A Pyrrolopyridine Inhibitor Bound To Mapkap Kinase-2 Length = 327

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 72  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 183
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 184 YYVAPE-VLGPEKYDKSCDMWSLGVIM 209

>pdb|3TUB|A Chain A, Crystal Structure Of Syk Kinase Domain With 1-(5-(6,7- Dimethoxyquinolin-4-Yloxy)pyridin-2-Yl)-3-((1r,2s)-2- Phenylcyclopropyl)urea Length = 293

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 126
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 127 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 185 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3VF8|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Syk Catalytic Domain With Pyrazolylbenzimidazole Inhibitor 416 Length = 299

Iteration: 1
 Score = 58.5 bits (140), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 76  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 126
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 127 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 184
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 185 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 225

>pdb|3SRV|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 110
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 111 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENXY 168
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 169 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|2XK9|A Chain A, Structural Analysis Of Checkpoint Kinase 2 (Chk2) In Complex With Inhibitor Pv1533 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 121 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 175
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 176 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 233
Query: 194 ---SITPESWPGV--ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
              +  PE W  V  + LDL  K+                 V D              P 
Sbjct: 234 GKYNFIPEVWAEVSEKALDLVKKL----------------LVVD--------------PK 263
Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
            RF ++ AL H +   + M      +L++  +S
Sbjct: 264 ARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 296

>pdb|3FPM|A Chain A, Crystal Structure Of A Squarate Inhibitor Bound To Mapkap Kinase-2 Length = 325

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 77  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 133
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 134 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 188
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 189 YYVAPE-VLGPEKYDKSCDMWSLGVIM 214

>pdb|3HMN|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With Atp Length = 342

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 213
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 214 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 267
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 268 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 324
Query: 231 KDQ 233
           + Q
Sbjct: 325 QIQ 327

>pdb|2W0J|A Chain A, Crystal Structure Of Chk2 In Complex With Nsc 109555, A Specific Inhibitor Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 176
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 234
Query: 194 ---SITPESWPGV--ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
              +  PE W  V  + LDL  K+                 V D              P 
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKL----------------LVVD--------------PK 264
Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
            RF ++ AL H +   + M      +L++  +S
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297

>pdb|3R2Y|A Chain A, Mk2 Kinase Bound To Compound 1 Length = 319

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 61/243 (25%), Positives = 95/243 (39%), Gaps = 40/243 (16%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 71  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 127
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 128 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 182
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPES 199
           +Y  PE +LG   Y    D+W  G IM  +    P    N        IS          
Sbjct: 183 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAIS---------- 227
Query: 200 WPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPSKRFDSDAALNH 259
            PG++T     + E P  +  +V E +K  +++              P++R      +NH
Sbjct: 228 -PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN---------LLKTEPTQRMTITEFMNH 277
Query: 260 DFF 262
            + 
Sbjct: 278 PWI 280

>pdb|2PZY|A Chain A, Structure Of Mk2 Complexed With Compound 76 Length = 324

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 76  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 132
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 133 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 187
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 188 YYVAPE-VLGPEKYDKSCDMWSLGVIM 213

>pdb|2JBO|A Chain A, Protein Kinase Mk2 In Complex With An Inhibitor (Crystal Form-1, Soaking) Length = 326

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 78  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 134
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 135 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 189
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 190 YYVAPE-VLGPEKYDKSCDMWSLGVIM 215

>pdb|3O96|A Chain A, Crystal Structure Of Human Akt1 With An Allosteric Inhibitor Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 8e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 259 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK--TFCG 314
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 315 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 345

>pdb|3GOK|A Chain A, Binding Site Mapping Of Protein Ligands Length = 334

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/213 (26%), Positives = 87/213 (40%), Gaps = 31/213 (14%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 86  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 142
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 143 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 197
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPES 199
           +Y  PE +LG   Y    D+W  G IM  +    P    N        IS          
Sbjct: 198 YYVAPE-VLGPEKYDKSCDMWSLGVIMYILLCGYPPFYSN----HGLAIS---------- 242
Query: 200 WPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
            PG++T     + E P  +  +V E +K  +++
Sbjct: 243 -PGMKTRIRMGQYEFPNPEWSEVSEEVKMLIRN 274

>pdb|4EJN|A Chain A, Crystal Structure Of Autoinhibited Form Of Akt1 In Complex With N-(4- (5-(3-Acetamidophenyl)-2-(2-Aminopyridin-3-Yl)-3h- Imidazo[4,5- B]pyridin-3-Yl)benzyl)-3-Fluorobenzamide Length = 446

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 34/92 (36%), Positives = 54/92 (58%), Gaps = 6/92 (6%)
Query: 79  QLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           ++++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL +     K+G   +      
Sbjct: 256 EIVSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCK--EGIKDGATMK--TFCG 311
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y  PE +L D +YG  VD WG G +M EM
Sbjct: 312 TPEYLAPE-VLEDNDYGRAVDWWGLGVVMYEM 342

>pdb|2YCF|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv1531 Length = 322

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 176
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 234
Query: 194 ---SITPESWPGV--ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
              +  PE W  V  + LDL  K+                 V D              P 
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKL----------------LVVD--------------PK 264
Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
            RF ++ AL H +   + M      +L++  +S
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297

>pdb|3KA0|A Chain A, Mk2 Complex With Inhibitor 6-(5-(2-Aminopyrimidin-4-Ylamino)-2- Hydroxyphenyl)-N-Methylbenzo[b]thiophene-2-Carboxamide Length = 320

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 70  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTEPCYTP 181
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 182 YYVAPE-VLGPEKYDKSCDMWSLGVIM 207

>pdb|3DB6|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Compound 902 Length = 301

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 5/128 (3%)
Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           Y+V + C       L       +  E +  ++Q + G+ Y+H+N+++HRD+K  N+ +  
Sbjct: 102 YVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 161
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
              +K+ DFGLA       +G+  R  +   T  Y  PE+L   + +   VD+W  GCI+
Sbjct: 162 DMDVKIGDFGLATKIEF--DGE--RKKDLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCIL 216
Query: 167 AEMWTRSP 174
             +    P
Sbjct: 217 YTLLVGKP 224

>pdb|2ONL|C Chain C, Crystal Structure Of The P38a-Mapkap Kinase 2 Heterodimer Length = 406

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 122 HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 178
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 179 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 233
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 234 YYVAPE-VLGPEKYDKSCDMWSLGVIM 259

>pdb|3EMG|A Chain A, Discovery And Sar Of Novel 4-Thiazolyl-2- Phenylaminopyrimidines As Potent Inhibitors Of Spleen Tyrosine Kinase (Syk) Length = 291

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 74  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 124
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 125 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 182
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 183 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 223

>pdb|2OH4|A Chain A, Crystal Structure Of Vegfr2 With A Benzimidazole-Urea Inhibitor Length = 316

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 46/185 (24%), Positives = 82/185 (44%), Gaps = 42/185 (22%)
Query: 11  LREIKIL-QLLKHENVVHLIEIC-----------------------RTKANQYNRYRSTF 46
           + E+KIL  +  H NVV+L+  C                       R+K N++  Y++  
Sbjct: 79  MSELKILIHIGHHLNVVNLLGACTKPGGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTPE 138
Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
            L  DF                +L  +     Q+  G+ ++ S K +HRD+ A N+L+++
Sbjct: 139 DLYKDF---------------LTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSE 183
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             ++K+ DFGLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++
Sbjct: 184 KNVVKICDFGLARDIXKDPD-XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLL 240
Query: 167 AEMWT 171
            E+++
Sbjct: 241 WEIFS 245

>pdb|1KWP|A Chain A, Crystal Structure Of Mapkap2 Length = 400

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 116 HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 172
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 173 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 227
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 228 YYVAPE-VLGPEKYDKSCDMWSLGVIM 253

>pdb|2OZA|A Chain A, Structure Of P38alpha Complex Length = 356

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 72  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 128
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 129 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 183
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 184 YYVAPE-VLGPEKYDKSCDMWSLGVIM 209

>pdb|2YCR|A Chain A, Crystal Structure Of Checkpoint Kinase 2 In Complex With Inhibitor Pv976 Length = 323

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 53/213 (24%), Positives = 88/213 (41%), Gaps = 47/213 (22%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 122 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 176
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 177 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 234
Query: 194 ---SITPESWPGV--ETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCXXXXXXXXXXPS 248
              +  PE W  V  + LDL  K+                 V D              P 
Sbjct: 235 GKYNFIPEVWAEVSEKALDLVKKL----------------LVVD--------------PK 264
Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
            RF ++ AL H +   + M      +L++  +S
Sbjct: 265 ARFTTEEALRHPWLQDEDMKRKFQDLLSEENES 297

>pdb|2ZMC|A Chain A, Crystal Structure Of Human Mitotic Checkpoint Kinase Mps1 Catalytic Domain Apo Form Length = 390

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 213
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 214 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 267
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 268 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 324
Query: 231 KDQ 233
           + Q
Sbjct: 325 QIQ 327

>pdb|3R2B|A Chain A, Mk2 Kinase Bound To Compound 5b Length = 318

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 45/147 (30%), Positives = 65/147 (44%), Gaps = 16/147 (10%)
Query: 27  HLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK----FSLGEIKKVIQQLLN 82
           H++ I     N Y   R    +V +    D   L S I  +    F+  E  ++++ +  
Sbjct: 70  HIVRIVDVYENLYAG-RKCLLIVMECL--DGGELFSRIQDRGDQAFTEREASEIMKSIGE 126
Query: 83  GLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTL 139
            + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +       N  T    T 
Sbjct: 127 AIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTP 181
Query: 140 WYRPPELLLGDRNYGPPVDLWGAGCIM 166
           +Y  PE +LG   Y    D+W  G IM
Sbjct: 182 YYVAPE-VLGPEKYDKSCDMWSLGVIM 207

>pdb|3D5V|A Chain A, Crystal Structure Of An Activated (Thr->asp) Polo-Like Kinase 1 (Plk1) Catalytic Domain. Length = 317

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 62/128 (48%), Gaps = 5/128 (3%)
Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           Y+V + C       L       +  E +  ++Q + G+ Y+H+N+++HRD+K  N+ +  
Sbjct: 118 YVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
              +K+ DFGLA       +G+  R  +   T  Y  PE+L   + +   VD+W  GCI+
Sbjct: 178 DMDVKIGDFGLATKIEF--DGE--RKKDLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCIL 232
Query: 167 AEMWTRSP 174
             +    P
Sbjct: 233 YTLLVGKP 240

>pdb|2CN5|A Chain A, Crystal Structure Of Human Chk2 In Complex With Adp Length = 329

Iteration: 1
 Score = 58.2 bits (139), Expect = 9e-09,   Method: Compositional matrix adjust.
 Identities = 47/167 (28%), Positives = 81/167 (48%), Gaps = 19/167 (11%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++       G+ +     
Sbjct: 128 QMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL-----GETSLMRTL 182
Query: 136 VVTLWYRPPELL--LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCG 193
             T  Y  PE+L  +G   Y   VD W  G I+    +  P    +  + Q++L  Q+  
Sbjct: 183 CGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPF--SEHRTQVSLKDQITS 240
Query: 194 ---SITPESWPGV--ETLDLYNKMEL--PKAQKRKVKERLKPYVKDQ 233
              +  PE W  V  + LDL  K+ +  PKA+    +    P+++D+
Sbjct: 241 GKYNFIPEVWAEVSEKALDLVKKLLVVDPKARFTTEEALRHPWLQDE 287

>pdb|3HNG|A Chain A, Crystal Structure Of Vegfr1 In Complex With N-(4-chlorophenyl)-2- ((pyridin-4-ylmethyl)amino)benzamide Length = 360

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 27/93 (29%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 207 QVARGMEFLSSRKCIHRDLAARNILLSENNVVKICDFGLARDIYKNPD-YVRKGDTRLPL 265
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   D+ Y    D+W  G ++ E+++
Sbjct: 266 KWMAPESIF--DKIYSTKSDVWSYGVLLWEIFS 296

>pdb|3UC3|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.3 Length = 361

Iteration: 1
 Score = 58.2 bits (139), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 53/165 (32%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTPTHLAIIMEYASGGELYERICN---AG-------RFS 114
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQLL+G+ Y HS +I HRD+K  N L+  +    LK+ DFG +++    SQ 
Sbjct: 115 EDEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 174
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K+         V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 175 KST--------VGTPAYIAPEVLLRQEYDGKIADVWSCGVTLYVM 211

>pdb|3T9T|A Chain A, Crystal Structure Of Btk Mutant (F435t,K596r) Complexed With Imidazo[1,5-A]quinoxaline Length = 267

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 41/177 (23%), Positives = 77/177 (43%), Gaps = 13/177 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +A           LV +F EH  L+  L      F+
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVCLEQA--------PICLVTEFMEHGCLSDYLRTQRGLFA 102
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRF---VLDDQY 159
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              T     + +  PE+    R Y    D+W  G +M E+++   I   N    ++ 
Sbjct: 160 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVV 215

>pdb|1Q8Y|A Chain A, The Structure Of The Yeast Sr Protein Kinase, Sky1p, With Bound Adp Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 16/132 (12%)
Query: 48  LVFDFCEHDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLIT 105
           +VF+    +L  L+    H    L  +K++ +QLL GL Y+H    I+H D+K  NVL+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166
Query: 106 KTGI------LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL 159
                     +K+AD G A  + +        YTN + T  YR PE+LLG   +G   D+
Sbjct: 167 IVDSPENLIQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG-APWGCGADI 218
Query: 160 WGAGCIMAEMWT 171
           W   C++ E+ T
Sbjct: 219 WSTACLIFELIT 230

>pdb|1HOW|A Chain A, The X-Ray Crystal Structure Of Sky1p, An Sr Protein Kinase In Yeast Length = 373

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 43/132 (32%), Positives = 66/132 (50%), Gaps = 16/132 (12%)
Query: 48  LVFDFCEHDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLIT 105
           +VF+    +L  L+    H    L  +K++ +QLL GL Y+H    I+H D+K  NVL+ 
Sbjct: 107 MVFEVLGENLLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLME 166
Query: 106 KTGI------LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL 159
                     +K+AD G A  + +        YTN + T  YR PE+LLG   +G   D+
Sbjct: 167 IVDSPENLIQIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG-APWGCGADI 218
Query: 160 WGAGCIMAEMWT 171
           W   C++ E+ T
Sbjct: 219 WSTACLIFELIT 230

>pdb|3A60|A Chain A, Crystal Structure Of Unphosphorylated P70s6k1 (Form I) Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 17/178 (9%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           E  IL+ +KH  +V LI   +T    Y    Y S   L   F + +  G+       F L
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            EI          L ++H   I++RD+K  N+++   G +KL DFGL +      +G V 
Sbjct: 128 AEISMA-------LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVT 178
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
                  T+ Y  PE+L+    +   VD W  G +M +M T +P   G   ++ I  I
Sbjct: 179 H--TFCGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3CEK|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (ttk) Length = 313

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSVVK- 185
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 186 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 239
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 240 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 296
Query: 231 KDQ 233
           + Q
Sbjct: 297 QIQ 299

>pdb|3A62|A Chain A, Crystal Structure Of Phosphorylated P70s6k1 Length = 327

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 51/178 (28%), Positives = 78/178 (43%), Gaps = 17/178 (9%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYN--RYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           E  IL+ +KH  +V LI   +T    Y    Y S   L   F + +  G+       F L
Sbjct: 71  ERNILEEVKHPFIVDLIYAFQTGGKLYLILEYLSGGEL---FMQLEREGIFMEDTACFYL 127
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            EI          L ++H   I++RD+K  N+++   G +KL DFGL +      +G V 
Sbjct: 128 AEISMA-------LGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK--ESIHDGTVT 178
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
                  T+ Y  PE+L+    +   VD W  G +M +M T +P   G   ++ I  I
Sbjct: 179 HXF--CGTIEYMAPEILM-RSGHNRAVDWWSLGALMYDMLTGAPPFTGENRKKTIDKI 233

>pdb|3CJF|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 23/174 (13%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 69  -----------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
                      +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGL
Sbjct: 131 VPYKDLYKDFLTLEHLIXYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKIXDFGL 190
Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           AR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 191 ARDIYKDPD-YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 241

>pdb|2JC6|A Chain A, Crystal Structure Of Human Calmodulin-Dependent Protein Kinase 1d Length = 334

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 45/158 (28%), Positives = 75/158 (47%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L+ +KHEN+V L +I  +  +         YLV          L   I  K  ++ 
Sbjct: 70  EIAVLRKIKHENIVALEDIYESPNH--------LYLVMQLVSG--GELFDRIVEKGFYTE 119
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNG 127
            +   +I+Q+L+ +YY+H   I+HRD+K  N+L     +   + ++DFGL++       G
Sbjct: 120 KDASTLIRQVLDAVYYLHRMGIVHRDLKPENLLYYSQDEESKIMISDFGLSKM-----EG 174
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           + +  +    T  Y  PE +L  + Y   VD W  G I
Sbjct: 175 KGDVMSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVI 211

>pdb|3SRV|B Chain B, Crystal Structure Of Spleen Tyrosine Kinase (Syk) In Complex With A Diaminopyrimidine Carboxamide Inhibitor Length = 277

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 60  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 110
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 111 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 168
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 169 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 209

>pdb|3DBQ|A Chain A, Crystal Structure Of Ttk Kinase Domain Length = 343

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 109 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 166
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 167 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 220
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 221 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 277
Query: 231 KDQ 233
           + Q
Sbjct: 278 QIQ 280

>pdb|1XBA|A Chain A, Crystal Structure Of Apo Syk Tyrosine Kinase Domain Length = 291

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 116
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 117 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 174
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 175 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 215

>pdb|4F4P|A Chain A, Syk In Complex With Ligand Lasw836 Length = 273

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 54  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 104
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 105 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 162
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 163 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 203

>pdb|4DFL|A Chain A, Crystal Structure Of Spleen Tyrosine Kinase Complexed With A Sulfonamidopyrazine Piperidine Inhibitor Length = 274

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/163 (25%), Positives = 74/163 (45%), Gaps = 15/163 (9%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  ++Q L +  +V +I IC  +         ++ LV +  E       L  N HVK 
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 106
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N  
Sbjct: 107 K--NIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENYY 164
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +   +    WY P    +    +    D+W  G +M E ++
Sbjct: 165 KAQTHGKWPVKWYAPE--CINYYKFSSKSDVWSFGVLMWEAFS 205

>pdb|3KB7|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With A Pyrazoloquinazoline Inhibitor Length = 311

Iteration: 1
 Score = 57.8 bits (138), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 67  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 118
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 119 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 174
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 175 KTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 215

>pdb|2YAC|A Chain A, Crystal Structure Of Polo-Like Kinase 1 In Complex With Nms-P937 Length = 311

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 67  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 118
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 119 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 174
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 175 KTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 215

>pdb|3D5U|A Chain A, Crystal Structure Of A Wildtype Polo-Like Kinase 1 (Plk1) Catalytic Domain Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           Y+V + C       L       +  E +  ++Q + G+ Y+H+N+++HRD+K  N+ +  
Sbjct: 118 YVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
              +K+ DFGLA       +G+  R      T  Y  PE+L   + +   VD+W  GCI+
Sbjct: 178 DMDVKIGDFGLATKIEF--DGE--RKKTLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCIL 232
Query: 167 AEMWTRSP 174
             +    P
Sbjct: 233 YTLLVGKP 240

>pdb|2V5Q|A Chain A, Crystal Structure Of Wild-type Plk-1 Kinase Domain In Complex With A Selective Darpin Length = 315

Iteration: 1
 Score = 57.4 bits (137), Expect = 1e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 71  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 122
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 123 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 178
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 179 KTLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 219

>pdb|2X9E|A Chain A, Human Mps1 In Complex With Nms-P715 Length = 317

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 112 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 169
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 170 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 223
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 224 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 280
Query: 231 KDQ 233
           + Q
Sbjct: 281 QIQ 283

>pdb|3VQU|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain In Complex With 4- [(4-Amino-5-Cyano-6-Ethoxypyridin-2- Yl)amino]benzamide Length = 320

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 108 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 165
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 166 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 219
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 220 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 276
Query: 231 KDQ 233
           + Q
Sbjct: 277 QIQ 279

>pdb|2VAG|A Chain A, Crystal Structure Of Di-Phosphorylated Human Clk1 In Complex With A Novel Substituted Indole Inhibitor Length = 339

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 34/147 (23%), Positives = 67/147 (45%), Gaps = 27/147 (18%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI------------------ 109
           F L  I+K+  Q+   + ++HSNK+ H D+K  N+L  ++                    
Sbjct: 115 FRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINP 174
Query: 110 -LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +K+ DFG     S T + +   ++  V    YR PE++L    +  P D+W  GCI+ E
Sbjct: 175 DIKVVDFG-----SATYDDE--HHSTLVXXRHYRAPEVILA-LGWSQPCDVWSIGCILIE 226
Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSI 195
            +    +   +  ++ + ++ ++ G +
Sbjct: 227 YYLGFTVFPTHDSKEHLAMMERILGPL 253

>pdb|1YWN|A Chain A, Vegfr2 In Complex With A Novel 4-amino-furo[2,3-d]pyrimidine Length = 316

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 69  ---------------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           DFGLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 191 DFGLARDIXKDPD-XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3CJG|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 3,4,5-Trimethoxy Aniline Containing Pyrimidine Length = 309

Iteration: 1
 Score = 57.4 bits (137), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 46/174 (26%), Positives = 85/174 (48%), Gaps = 23/174 (13%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 69  -----------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGL 117
                      +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGL
Sbjct: 131 VPYKDLYKDFLTLEHLICYSFQVAKGMEFLASRKXIHRDLAARNILLSEKNVVKICDFGL 190
Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           AR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 191 ARDIYKDPD-YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 241

>pdb|3LCD|A Chain A, Inhibitor Bound To A Dfg-In Structure Of The Kinase Domain Of Csf-1r Length = 329

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKA-----NQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
           + E+KI+  L +HEN+V+L+  C          +Y  Y      +    E DL       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KED 153
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
                L ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DFGLAR     
Sbjct: 154 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 213
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 214 SN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 257

>pdb|3H9F|A Chain A, Crystal Structure Of Human Dual Specificity Protein Kinase (Ttk) In Complex With A Pyrimido-Diazepin Ligand Length = 313

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 57/183 (31%), Positives = 84/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 128 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDXXXVVK- 185
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V T+ Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 186 -DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 239
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 240 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 296
Query: 231 KDQ 233
           + Q
Sbjct: 297 QIQ 299

>pdb|3D5W|A Chain A, Crystal Structure Of A Phosphorylated Polo-Like Kinase 1 (Plk1) Catalytic Domain In Complex With Adp Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/128 (27%), Positives = 61/128 (47%), Gaps = 5/128 (3%)
Query: 47  YLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           Y+V + C       L       +  E +  ++Q + G+ Y+H+N+++HRD+K  N+ +  
Sbjct: 118 YVVLEICRRRSLLELHKRRKAVTEPEARYFMRQTIQGVQYLHNNRVIHRDLKLGNLFLND 177
Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
              +K+ DFGLA       +G+  R      T  Y  PE+L   + +   VD+W  GCI+
Sbjct: 178 DMDVKIGDFGLATKIEF--DGE--RKKXLCGTPNYIAPEVLC-KKGHSFEVDIWSLGCIL 232
Query: 167 AEMWTRSP 174
             +    P
Sbjct: 233 YTLLVGKP 240

>pdb|4AF3|A Chain A, Human Aurora B Kinase In Complex With Incenp And Vx-680 Length = 292

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 48/174 (27%), Positives = 77/174 (44%), Gaps = 19/174 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI+I   L H N++ L          YN +  R   YL+ ++               F 
Sbjct: 72  REIEIQAHLHHPNILRL----------YNYFYDRRRIYLILEYAPRGELYKELQKSCTFD 121
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
                 ++++L + L Y H  K++HRD+K  N+L+   G LK+ADFG       + +   
Sbjct: 122 EQRTATIMEELADALMYCHGKKVIHRDIKPENLLLGLKGELKIADFGW------SVHAPS 175
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            R      TL Y PPE++ G R +   VDLW  G +  E+   +P  +  +  +
Sbjct: 176 LRRKTMCGTLDYLPPEMIEG-RMHNEKVDLWCIGVLCYELLVGNPPFESASHNE 228

>pdb|3D7T|A Chain A, Structural Basis For The Recognition Of C-Src By Its Inactivator Csk Length = 269

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 75/164 (45%), Gaps = 19/164 (11%)
Query: 11  LREIKILQLLKHENVVHLIE-ICRTKANQY--NRYRSTFYLVFDFCEHDLAGLLSNIHVK 67
           L E  ++  L+H N+V L+  I   K   Y    Y +   LV        + L  +  +K
Sbjct: 53  LAEASVMTQLRHSNLVQLLGVIVEEKGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLK 112
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           FSL         +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +  S T++ 
Sbjct: 113 FSL--------DVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQD- 163
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                T ++   W  P  L   +  +    D+W  G ++ E+++
Sbjct: 164 -----TGKLPVKWTAPEALR--EAAFSTKSDVWSFGILLWEIYS 200

>pdb|2OGV|A Chain A, Crystal Structure Of The Autoinhibited Human C-Fms Kinase Domain Length = 317

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/167 (26%), Positives = 74/167 (44%), Gaps = 12/167 (7%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKA-----NQYNRYRSTFYLVFDFCEHDLAGLLSNI 64
           + E+KI+  L +HEN+V+L+  C          +Y  Y      +    E DL       
Sbjct: 89  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEADLD---KED 145
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
                L ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DFGLAR     
Sbjct: 146 GRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMND 205
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 206 SN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 249

>pdb|2P2H|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridinyl-Triazine Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDARLPL 205
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 206 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2P2I|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Nicotinamide Inhibitor Length = 314

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIXKDPD-XVRKGDARLPL 205
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 206 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|2REI|A Chain A, Kinase Domain Of Human Ephrin Type-a Receptor 7 (epha7) Length = 318

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 39/162 (24%), Positives = 71/162 (43%), Gaps = 11/162 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           L E  I+    H NVVHL E   T+            +V +F E+  L   L     +F+
Sbjct: 92  LCEASIMGQFDHPNVVHL-EGVVTRGK-------PVMIVIEFMENGALDAFLRKHDGQFT 143
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A N+L+    + K++DFGL+R          
Sbjct: 144 VIQLVGMLRGIAAGMRYLADMGYVHRDLAARNILVNSNLVCKVSDFGLSRVIEDDPEAVY 203
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W  P  +    R +    D+W  G +M E+ +
Sbjct: 204 TTTGGKIPVRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMS 243

>pdb|3IW4|A Chain A, Crystal Structure Of Pkc Alpha In Complex With Nvp-Aeb071 Length = 360

Iteration: 1
 Score = 57.0 bits (136), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 32/101 (31%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL+++H   I++RD+K  NV++   G +K+ADFG+ +      +G   R      T  Y 
Sbjct: 132 GLFFLHKRGIIYRDLKLDNVMLDSEGHIKIADFGMCK--EHMMDGVTTR--EFCGTPDYI 187
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            PE ++  + YG  VD W  G ++ EM    P   G  E +
Sbjct: 188 APE-IIAYQPYGKSVDWWAYGVLLYEMLAGQPPFDGEDEDE 227

>pdb|1VZO|A Chain A, The Structure Of The N-Terminal Kinase Domain Of Msk1 Reveals A Novel Autoinhibitory Conformation For A Dual Kinase Protein Length = 355

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 35/133 (26%), Positives = 66/133 (49%), Gaps = 5/133 (3%)
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F+  E++  + +++  L ++H   I++RD+K  N+L+   G + L DFGL++ F     
Sbjct: 155 RFTEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVAD-- 212
Query: 127 GQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQ 184
            +  R  +   T+ Y  P+++  GD  +   VD W  G +M E+ T  SP      +  Q
Sbjct: 213 -ETERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQ 271
Query: 185 ITLISQLCGSITP 197
             +  ++  S  P
Sbjct: 272 AEISRRILKSEPP 284

>pdb|3DLS|A Chain A, Crystal Structure Of Human Pas Kinase Bound To Adp Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 41/158 (25%), Positives = 75/158 (47%), Gaps = 20/158 (12%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH----DLAGLLSNIHVKF 68
           EI IL  ++H N++ +++I   +          F LV +  +H    DL   +   H + 
Sbjct: 79  EIAILSRVEHANIIKVLDIFENQG--------FFQLVME--KHGSGLDLFAFIDR-HPRL 127
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
                  + +QL++ + Y+    I+HRD+K  N++I +   +KL DFG A    + K   
Sbjct: 128 DEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK--- 184
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
              +     T+ Y  PE+L+G+   GP +++W  G  +
Sbjct: 185 --LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGVTL 220

>pdb|3P1A|A Chain A, Structure Of Human Membrane-Associated Tyrosine- And Threonine- Specific Cdc2-Inhibitory Kinase Myt1 (Pkmyt1) Length = 311

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 44/174 (25%), Positives = 68/174 (39%), Gaps = 9/174 (5%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           R  K+ ++  HE V      C  +  Q        YL  + C   L              
Sbjct: 100 RARKLAEVGSHEKVGQ--HPCCVRLEQAWEEGGILYLQTELCGPSLQQHCEAWGASLPEA 157
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           ++   ++  L  L ++HS  ++H D+K AN+ +   G  KL DFGL         G+V  
Sbjct: 158 QVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGEVQE 217
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              R     Y  PELL G  +YG   D++  G  + E+     +  G    QQ+
Sbjct: 218 GDPR-----YMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL 264

>pdb|2F2U|A Chain A, Crystal Structure Of The Rho-Kinase Kinase Domain Length = 402

Iteration: 1
 Score = 56.6 bits (135), Expect = 2e-08,   Method: Compositional matrix adjust.
 Identities = 47/128 (36%), Positives = 63/128 (49%), Gaps = 9/128 (7%)
Query: 46  FYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            Y+V ++    DL  L+SN  V       K    +++  L  IHS  ++HRD+K  N+L+
Sbjct: 150 LYMVMEYMPGGDLVNLMSNYDVPEKWA--KFYTAEVVLALDAIHSMGLIHRDVKPDNMLL 207
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDRNYGPPVDLWG 161
            K G LKLADFG      +T  G V+  T  V T  Y  PE+L    GD  YG   D W 
Sbjct: 208 DKHGHLKLADFGTCMKMDET--GMVHCDT-AVGTPDYISPEVLKSQGGDGYYGRECDWWS 264
Query: 162 AGCIMAEM 169
            G  + EM
Sbjct: 265 VGVFLFEM 272

>pdb|1VR2|A Chain A, Human Vascular Endothelial Growth Factor Receptor 2 (Kdr) Kinase Domain Length = 316

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 69  ---------------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           DFGLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 191 DFGLARDIYKDPD-XVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3Q6W|A Chain A, Structure Of Dually-phosphorylated Met Receptor Kinase In Complex With An Mk-2461 Analog With Specificity For The Activated Receptor Length = 307

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 130
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 131 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEXXSV 190
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 191 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 233

>pdb|2RKU|A Chain A, Structure Of Plk1 In Complex With Bi2536 Length = 294

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 65  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 116
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 117 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 172
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 173 KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 213

>pdb|2OU7|A Chain A, Structure Of The Catalytic Domain Of Human Polo-Like Kinase 1 Length = 335

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 91  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 142
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 143 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 198
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 199 KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 239

>pdb|3THB|A Chain A, Structure Of Plk1 Kinase Domain In Complex With A Benzolactam-Derived Inhibitor Length = 333

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGE 72
           EI I + L H++VV          + +       ++V + C       L       +  E
Sbjct: 89  EISIHRSLAHQHVVGF--------HGFFEDNDFVFVVLELCRRRSLLELHKRRKALTEPE 140
Query: 73  IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRY 132
            +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA       +G+  R 
Sbjct: 141 ARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEY--DGE--RK 196
Query: 133 TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                T  Y  PE +L  + +   VD+W  GCIM  +    P
Sbjct: 197 KVLCGTPNYIAPE-VLSKKGHSFEVDVWSIGCIMYTLLVGKP 237

>pdb|2R2P|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 5 (Epha5) Length = 295

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 38/160 (23%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK+           +V ++ E+  L   L     +F+
Sbjct: 71  LGEASIMGQFDHPNIIHL-EGVVTKSK-------PVMIVTEYMENGSLDTFLKKNDGQFT 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 123 VIQLVGMLRGISAGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 182
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G +M E+
Sbjct: 183 TTRGGKIPIRWTAPEAIAF--RKFTSASDVWSYGIVMWEV 220

>pdb|3QD2|B Chain B, Crsytal Structure Of Mouse Perk Kinase Domain Length = 332

Iteration: 1
 Score = 56.6 bits (135), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 51/99 (51%), Gaps = 9/99 (9%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV--------N 130
           Q+   + ++HS  ++HRD+K +N+  T   ++K+ DFGL  A  Q +  Q          
Sbjct: 172 QIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYA 231
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
            +  +V T  Y  PE + G+ NY   VD++  G I+ E+
Sbjct: 232 THXGQVGTKLYMSPEQIHGN-NYSHKVDIFSLGLILFEL 269

>pdb|2ZMD|A Chain A, Crystal Structure Of Human Mps1 Catalytic Domain T686a Mutant In Complex With Sp600125 Inhibitor Length = 390

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 56/183 (30%), Positives = 83/183 (45%), Gaps = 32/183 (17%)
Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          V  
Sbjct: 156 ERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTTSVVK- 213
Query: 132 YTNRVVTLWYRPPEL---LLGDRNYG-------PPVDLWGAGCIMAEM-WTRSPIMQGNT 180
             ++V  + Y PPE    +   R  G       P  D+W  GCI+  M + ++P      
Sbjct: 214 -DSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPF----- 267
Query: 181 EQQQITLISQLCGSITPE---SWPGVETLDLYNKMELPKAQKRKVKERLK-------PYV 230
            QQ I  IS+L   I P     +P +   DL + ++     KR  K+R+        PYV
Sbjct: 268 -QQIINQISKLHAIIDPNHEIEFPDIPEKDLQDVLKC--CLKRDPKQRISIPELLAHPYV 324
Query: 231 KDQ 233
           + Q
Sbjct: 325 QIQ 327

>pdb|2HEL|A Chain A, Crystal Structure Of A Mutant Epha4 Kinase Domain (Y742a) Length = 306

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/162 (21%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK            ++ ++ E+  L   L     +F+
Sbjct: 78  LSEASIMGQFDHPNIIHL-EGVVTKCK-------PVMIITEYMENGSLDAFLRKNDGRFT 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFG++R          
Sbjct: 130 VIQLVGMLRGIGSGMKYLSDMSAVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 189
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W  P  +    R +    D+W  G +M E+ +
Sbjct: 190 TTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 229

>pdb|3TXO|A Chain A, Pkc Eta Kinase In Complex With A Naphthyridine Length = 353

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 35/105 (33%), Positives = 52/105 (49%), Gaps = 9/105 (8%)
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           +F     +    ++++ L ++H   I++RD+K  NVL+   G  KLADFG+       K 
Sbjct: 120 RFDEARARFYAAEIISALMFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMC------KE 173
Query: 127 GQVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           G  N  T      T  Y  PE +L +  YGP VD W  G ++ EM
Sbjct: 174 GICNGVTTATFCGTPDYIAPE-ILQEMLYGPAVDWWAMGVLLYEM 217

>pdb|3BEA|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With A Pyrimidinopyridone Inhibitor Length = 333

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKA-----NQYNRYRSTFYLV---FDFCEHDLAGLL 61
           + E+KI+  L +HEN+V+L+  C          +Y  Y      +       E D A  +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           +N     S  ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DFGLAR  
Sbjct: 157 AN--STLSTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 215 MNDSN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 261

>pdb|1Y6A|A Chain A, Crystal Structure Of Vegfr2 In Complex With A 2-Anilino-5-Aryl-Oxazole Inhibitor Length = 366

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 206 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 264
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 265 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 295

>pdb|2I0V|A Chain A, C-Fms Tyrosine Kinase In Complex With A Quinolone Inhibitor Length = 335

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 44/178 (24%), Positives = 79/178 (44%), Gaps = 28/178 (15%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS------ 62
           + E+KI+  L +HEN+V+L+  C         +     ++ ++C + DL   L       
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACT--------HGGPVLVITEYCCYGDLLNFLRRKRPPG 148
Query: 63  ---------NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                    N   + S  ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ 
Sbjct: 149 LEYSYNPSHNPEEQLSSRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIG 208
Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           DFGLAR      N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 209 DFGLARDIMNDSN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 263

>pdb|2V7A|A Chain A, Crystal Structure Of The T315i Abl Mutant In Complex With The Inhibitor Pha-739358 Length = 286

Iteration: 1
 Score = 56.2 bits (134), Expect = 3e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIIIEFMTY---GNLLDYLRECNR 106
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 107 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 164
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 165 DTXTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 208

>pdb|3DK7|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 277

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIIIEFMTY---GNLLDYLRECNR 103
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 104 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 161
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 162 DTXTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 205

>pdb|3VHK|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Back Pocket Binder Length = 368

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 208 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 266
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 267 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 297

>pdb|3VHE|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With A Novel Pyrrolopyrimidine Inhibitor Length = 359

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 259
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 260 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 290

>pdb|2XIR|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With Pf-00337210 (N,2-Dimethyl-6-(7-(2-Morpholinoethoxy) Quinolin-4-Yloxy)benzofuran-3-Carboxamide) Length = 316

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 130
Query: 69  ---------------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190
Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           DFGLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 191 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 245

>pdb|3VNT|A Chain A, Crystal Structure Of The Kinase Domain Of Human Vegfr2 With A [1, 3]thiazolo[5,4-B]pyridine Derivative Length = 318

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 46/178 (25%), Positives = 85/178 (47%), Gaps = 27/178 (15%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 80  MSELKILIHIGHHLNVVNLLGAC-TKPG------GPLMVIVEFCKFGNLSTYLRSKRNEF 132
Query: 69  ---------------SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 133 VPYKEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 192
Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           DFGLAR   +  +  V +   R+   W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 193 DFGLARDIYKDPD-YVRKGDARLPLKWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 247

>pdb|3VID|A Chain A, Crystal Structure Of Human Vegfr2 Kinase Domain With Compound A Length = 356

Iteration: 1
 Score = 56.2 bits (134), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 199 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 257
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 258 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 288

>pdb|3QRJ|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain T315i Mutant In Complex With Dcc-2036 Length = 277

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIIIEFMTY---GNLLDYLRECNR 110
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 168
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|3U6J|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyrazolone Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 4e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 205
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 206 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3OY3|A Chain A, Crystal Structure Of Abl T315i Mutant Kinase Domain Bound With A Dfg- Out Inhibitor Ap24589 Length = 284

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIIIEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3EWH|A Chain A, Crystal Structure Of The Vegfr2 Kinase Domain In Complex With A Pyridyl-Pyrimidine Benzimidazole Inhibitor Length = 314

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 147 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 205
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 206 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 236

>pdb|3UC4|A Chain A, The Crystal Structure Of Snf1-Related Kinase 2.6 Length = 362

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AG-------RFS 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQL++G+ Y H+ ++ HRD+K  N L+  +    LK+ DFG +++    SQ 
Sbjct: 114 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 173
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K        + V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 174 K--------STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210

>pdb|2Z60|A Chain A, Crystal Structure Of The T315i Mutant Of Abl Kinase Bound With Ppy-A Length = 288

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIIIEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3QFV|A Chain A, Mrck Beta In Complex With Tpca-1 Length = 415

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 46  FYLVFDF-CEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YLV D+    DL  LLS    K      +  I +++  +  IH    +HRD+K  NVL+
Sbjct: 149 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL 208
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLW 160
              G ++LADFG         +G V   +  V T  Y  PE+L     G   YGP  D W
Sbjct: 209 DVNGHIRLADFG--SCLKMNDDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWW 265
Query: 161 GAGCIMAEM 169
             G  M EM
Sbjct: 266 SLGVCMYEM 274

>pdb|3UJG|A Chain A, Crystal Structure Of Snrk2.6 In Complex With Hab1 Length = 361

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 50/165 (30%), Positives = 74/165 (44%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 63  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AG-------RFS 112
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQL++G+ Y H+ ++ HRD+K  N L+  +    LK+ DFG +++    SQ 
Sbjct: 113 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQP 172
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K        + V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 173 K--------STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 209

>pdb|4AGC|A Chain A, Crystal Structure Of Vegfr2 (Juxtamembrane And Kinase Domains) In Complex With Axitinib (Ag-013736) (N-Methyl-2-( 3-((E)-2-Pyridin-2-Yl-Vinyl)-1h-Indazol-6-Ylsulfanyl)- Benzamide) Length = 353

Iteration: 1
 Score = 55.8 bits (133), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 28/93 (30%), Positives = 52/93 (55%), Gaps = 3/93 (3%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +  V +   R+  
Sbjct: 193 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-YVRKGDARLPL 251
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            W  P  +   DR Y    D+W  G ++ E+++
Sbjct: 252 KWMAPETIF--DRVYTIQSDVWSFGVLLWEIFS 282

>pdb|2I1M|A Chain A, Cfms Tyrosine Kinase (Tie2 Kid) In Complex With An Arylamide Inhibitor Length = 333

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 77/170 (45%), Gaps = 14/170 (8%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKA-----NQYNRYRSTFYLV---FDFCEHDLAGLL 61
           + E+KI+  L +HEN+V+L+  C          +Y  Y      +       E D A  +
Sbjct: 97  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAI 156
Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
           +N     S  ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DFGLAR  
Sbjct: 157 ANSTA--STRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDI 214
Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 215 MNDSN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 261

>pdb|2GQG|A Chain A, X-Ray Crystal Structure Of Dasatinib (Bms-354825) Bound To Activated Abl Kinase Domain Length = 278

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 110
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 168
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 169 DTXTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOK|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:s768a Triple Mutant Length = 373

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 37/160 (23%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGLAR          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLARVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|3TKU|A Chain A, Mrck Beta In Complex With Fasudil Length = 433

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 44/129 (34%), Positives = 58/129 (44%), Gaps = 8/129 (6%)
Query: 46  FYLVFDF-CEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI 104
            YLV D+    DL  LLS    K      +  I +++  +  IH    +HRD+K  NVL+
Sbjct: 165 LYLVMDYYVGGDLLTLLSKFEDKLPEDMARFYIGEMVLAIDSIHQLHYVHRDIKPDNVLL 224
Query: 105 TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLW 160
              G ++LADFG         +G V   +  V T  Y  PE+L     G   YGP  D W
Sbjct: 225 DVNGHIRLADFG--SCLKMNDDGTVQS-SVAVGTPDYISPEILQAMEDGMGKYGPECDWW 281
Query: 161 GAGCIMAEM 169
             G  M EM
Sbjct: 282 SLGVCMYEM 290

>pdb|2XYU|A Chain A, Crystal Structure Of Epha4 Kinase Domain In Complex With Vuf 12058 Length = 285

Iteration: 1
 Score = 55.5 bits (132), Expect = 5e-08,   Method: Compositional matrix adjust.
 Identities = 35/160 (21%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK            ++ ++ E+  L   L     +F+
Sbjct: 57  LSEASIMGQFDHPNIIHL-EGVVTKCK-------PVMIITEYMENGSLDAFLRKNDGRFT 108
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFG++R          
Sbjct: 109 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 168
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G +M E+
Sbjct: 169 TTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEV 206

>pdb|2Y6M|A Chain A, Crystal Structure Of Epha4 Kinase Domain Length = 291

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 35/162 (21%), Positives = 72/162 (44%), Gaps = 11/162 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++HL E   TK            ++ ++ E+  L   L     +F+
Sbjct: 63  LSEASIMGQFDHPNIIHL-EGVVTKCK-------PVMIITEYMENGSLDAFLRKNDGRFT 114
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFG++R          
Sbjct: 115 VIQLVGMLRGIGSGMKYLSDMSYVHRDLAARNILVNSNLVCKVSDFGMSRVLEDDPEAAY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W  P  +    R +    D+W  G +M E+ +
Sbjct: 175 TTRGGKIPIRWTAPEAIAY--RKFTSASDVWSYGIVMWEVMS 214

>pdb|3LCO|A Chain A, Inhibitor Bound To A Dfg-Out Structure Of The Kinase Domain Of Csf-1r Length = 324

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 45/177 (25%), Positives = 75/177 (42%), Gaps = 19/177 (10%)
Query: 11  LREIKIL-QLLKHENVVHLIEICRTKA-----NQYNRYRSTFYLVFDFCE---------- 54
           + E+KI+  L +HEN+V+L+  C          +Y  Y      +    E          
Sbjct: 82  MSELKIMSHLGQHENIVNLLGACTHGGPVLVITEYCCYGDLLNFLRRKAEAMLGPSLAPG 141
Query: 55  HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
            D  GL         L ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ D
Sbjct: 142 QDPEGLDKEDGRPLELRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGD 201
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           FGLAR      N  + +   R+   W  P  +   D  Y    D+W  G ++ E+++
Sbjct: 202 FGLARDIMNDSN-YIVKGNARLPVKWMAPESIF--DCVYTVQSDVWSYGILLWEIFS 255

>pdb|3DK6|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 103
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 104 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 161
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 162 DTXTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 205

>pdb|2G15|A Chain A, Structural Characterization Of Autoinhibited C-Met Kinase Length = 318

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 97  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 149
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 150 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 209
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 210 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 252

>pdb|3Q6U|A Chain A, Structure Of The Apo Met Receptor Kinase In The Dually-Phosphorylated, Activated State Length = 308

Iteration: 1
 Score = 55.5 bits (132), Expect = 6e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 132 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 192 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 234

>pdb|1FPU|A Chain A, Crystal Structure Of Abl Kinase Domain In Complex With A Small Molecule Inhibitor Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 110
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 111 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 168
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 212

>pdb|3F66|A Chain A, Human C-Met Kinase In Complex With Quinoxaline Inhibitor Length = 298

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 186
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 187 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 229

>pdb|3I5N|A Chain A, Crystal Structure Of C-Met With Triazolopyridazine Inhibitor 13 Length = 309

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 78  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 130
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 131 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 190
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 191 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 233

>pdb|2RFN|A Chain A, X-ray Structure Of C-met With Inhibitor. Length = 310

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 132 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 191
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 192 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 234

>pdb|3LQ8|A Chain A, Structure Of The Kinase Domain Of C-Met Bound To Xl880 (Gsk1 Length = 302

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 130 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 189
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 190 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 232

>pdb|2WD1|A Chain A, Human C-Met Kinase In Complex With Azaindole Inhibitor Length = 292

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 71  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 123
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 124 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 183
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 184 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 226

>pdb|1AD5|A Chain A, Src Family Kinase Hck-Amp-Pnp Complex Length = 438

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 49/205 (23%), Positives = 90/205 (43%), Gaps = 30/205 (14%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD--LAGLLSNIHVKF 68
           L E  +++ L+H+ +V L  +           +   Y++ +F      L  L S+   K 
Sbjct: 225 LAEANVMKTLQHDKLVKLHAVVT---------KEPIYIITEFMAKGSLLDFLKSDEGSKQ 275
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ +I     +HRD++AAN+L++ + + K+ADFGLAR  +      
Sbjct: 276 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVGA------ 329
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPI-MQGNTEQQQITL 187
                 +    W  P  +  G  ++    D+W  G ++ E+ T   I   G +  + I  
Sbjct: 330 ------KFPIKWTAPEAINFG--SFTIKSDVWSFGILLMEIVTYGRIPYPGMSNPEVIRA 381
Query: 188 ISQLCGSITPESWPGVETLDLYNKM 212
           + +      PE+ P     +LYN M
Sbjct: 382 LERGYRMPRPENCPE----ELYNIM 402

>pdb|2WGJ|A Chain A, X-Ray Structure Of Pf-02341066 Bound To The Kinase Domain Of C-Met Length = 306

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 128
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 129 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 188
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 189 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 231

>pdb|3QRI|A Chain A, The Crystal Structure Of Human Abl1 Kinase Domain In Complex With Dcc- 2036 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 110
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 168
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 212

>pdb|2QOO|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742f Triple Mutant Length = 373

Iteration: 1
 Score = 55.1 bits (131), Expect = 7e-08,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGFVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|4GG5|A Chain A, Crystal Structure Of Cmet In Complex With Novel Inhibitor Length = 319

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/164 (26%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 98  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 150
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 151 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSV 210
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 211 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 253

>pdb|2HIW|A Chain A, Crystal Structure Of Inactive Conformation Abl Kinase Catalytic Domain Complexed With Type Ii Inhibitor Length = 287

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 107
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 108 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 165
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2HZI|A Chain A, Abl Kinase Domain In Complex With Pd180970 Length = 277

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 109
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 110 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 167
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 168 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 211

>pdb|2E2B|A Chain A, Crystal Structure Of The C-Abl Kinase Domain In Complex With Inno-406 Length = 293

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 62  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 110
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 111 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 168
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 169 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 212

>pdb|4G3D|A Chain A, Crystal Structure Of Human Nf-kappab Inducing Kinase (nik) Length = 371

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/135 (31%), Positives = 67/135 (49%), Gaps = 13/135 (9%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNR 135
           + Q L GL Y+HS +ILH D+KA NVL++  G    L DFG A        G+     + 
Sbjct: 191 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGKSLLTGDY 250
Query: 136 VV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM------WT---RSPI-MQGNTEQQQ 184
           +  T  +  PE++LG R+    VD+W + C+M  M      WT   R P+ ++  +E   
Sbjct: 251 IPGTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPPP 309
Query: 185 ITLISQLCGSITPES 199
           +  I   C  +T ++
Sbjct: 310 VREIPPSCAPLTAQA 324

>pdb|3OXZ|A Chain A, Crystal Structure Of Abl Kinase Domain Bound With A Dfg-Out Inhibitor Ap24534 Length = 284

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 207

>pdb|3NYN|A Chain A, Crystal Structure Of G Protein-Coupled Receptor Kinase 6 In Complex With Sangivamycin Length = 576

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++  GL  +H  +I++RD+K  N+L+   G ++++D GLA        GQ  +   RV T
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIK--GRVGT 348
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQ 177
           + Y  PE++  +R    P D W  GC++ EM   +SP  Q
Sbjct: 349 VGYMAPEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQQ 387

>pdb|2QOH|A Chain A, Crystal Structure Of Abl Kinase Bound With Ppy-a Length = 288

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 207

>pdb|2J0K|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains. Length = 656

Iteration: 1
 Score = 55.1 bits (131), Expect = 8e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V KFS
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKFS 487
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++ T  +KL DFGL+R    +   
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY 547
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 548 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 585

>pdb|2ACX|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 6 Bound To Amppnp Length = 576

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 33/100 (33%), Positives = 54/100 (54%), Gaps = 7/100 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++  GL  +H  +I++RD+K  N+L+   G ++++D GLA        GQ  +   RV T
Sbjct: 294 EICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA---VHVPEGQTIK--GRVGT 348
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQ 177
           + Y  PE++  +R    P D W  GC++ EM   +SP  Q
Sbjct: 349 VGYMAPEVVKNERYTFSP-DWWALGCLLYEMIAGQSPFQQ 387

>pdb|2G1T|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 107
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 108 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 165
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 166 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 209

>pdb|2JKK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 54.7 bits (130), Expect = 9e-08,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V KFS
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKFS 107
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++ T  +KL DFGL+R    +   
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSATDCVKLGDFGLSRYMEDSTYY 167
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 168 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 205

>pdb|2HYY|A Chain A, Human Abl Kinase Domain In Complex With Imatinib (Sti571, Glivec) Length = 273

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|3PYY|A Chain A, Discovery And Characterization Of A Cell-Permeable, Small-Molecule C- Abl Kinase Activator That Binds To The Myristoyl Binding Site Length = 298

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 70  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 118
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 119 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 176
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 177 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 220

>pdb|4DN5|A Chain A, Crystal Structure Of Nf-kb-inducing Kinase (nik) Length = 356

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 44/136 (32%), Positives = 68/136 (50%), Gaps = 15/136 (11%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNR 135
           + Q L GL Y+HS +ILH D+KA NVL++  G    L DFG A        G+ +  T  
Sbjct: 172 LGQALEGLEYLHSRRILHGDVKADNVLLSSDGSHAALCDFGHAVCLQPDGLGK-DLLTGD 230
Query: 136 VV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM------WT---RSPI-MQGNTEQQ 183
            +  T  +  PE++LG R+    VD+W + C+M  M      WT   R P+ ++  +E  
Sbjct: 231 YIPGTETHMAPEVVLG-RSCDAKVDVWSSCCMMLHMLNGCHPWTQFFRGPLCLKIASEPP 289
Query: 184 QITLISQLCGSITPES 199
            +  I   C  +T ++
Sbjct: 290 PVREIPPSCAPLTAQA 305

>pdb|1MQB|A Chain A, Crystal Structure Of Ephrin A2 (Epha2) Receptor Protein Kinase Length = 333

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 34/161 (21%), Positives = 68/161 (42%), Gaps = 9/161 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E  I+    H N++ L  +        ++Y+    +        L   L     +FS+
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVI-------SKYKPMMIITEYMENGALDKFLREKDGEFSV 146
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++  +++ +  G+ Y+ +   +HRD+ A N+L+    + K++DFGL+R           
Sbjct: 147 LQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATYT 206
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
               ++   W  P  +    R +    D+W  G +M E+ T
Sbjct: 207 TSGGKIPIRWTAPEAISY--RKFTSASDVWSFGIVMWEVMT 245

>pdb|2GSF|A Chain A, The Human Epha3 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|2QOF|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|2QOD|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y602f Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|3FXX|A Chain A, Human Epha3 Kinase And Juxtamembrane Region Bound To Substrate Kqwdnye[ptyr]iw Length = 371

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 92  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 143
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 144 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 203
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 204 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 241

>pdb|2QOI|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f Double Mutant Length = 373

Iteration: 1
 Score = 54.7 bits (130), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|2RIO|A Chain A, Structure Of The Dual Enzyme Ire1 Reveals The Basis For Catalysis And Regulation Of Non-conventional Splicing Length = 434

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 87/188 (46%), Gaps = 34/188 (18%)
Query: 4   IFFPITALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           I F   AL EIK+L +   H NV+     C    +++       Y+  + C  +L  L+ 
Sbjct: 49  IDFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRF------LYIALELCNLNLQDLVE 100
Query: 63  NIHVKFSLGEIKK------VIQQLLNGLYYIHSNKILHRDMKAANVLIT---------KT 107
           + +V     +++K      +++Q+ +G+ ++HS KI+HRD+K  N+L++         +T
Sbjct: 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 108 GI----LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP------PV 157
           G     + ++DFGL +     ++       N   T  +R PELL    N          +
Sbjct: 161 GAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 158 DLWGAGCI 165
           D++  GC+
Sbjct: 221 DIFSMGCV 228

>pdb|3DK3|A Chain A, Crystal Structure Of Mutant Abl Kinase Domain In Complex With Small Molecule Fragment Length = 293

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 79/166 (47%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 55  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 103
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R  +   
Sbjct: 104 QEVSAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT--- 160
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                 +      + +  PE L  ++ +    D+W  G ++ E+ T
Sbjct: 161 GDTFTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIAT 205

>pdb|3EQC|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Ternary Complex With Compound 1, Atp-Gs And Mg2p Length = 360

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 133 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 189
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 190 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 245
Query: 191 LCG 193
           + G
Sbjct: 246 VEG 248

>pdb|2HZ0|A Chain A, Abl Kinase Domain In Complex With Nvp-Aeg082 Length = 270

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTY---GNLLDYLRECNR 105
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 106 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 163
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 164 DTYTAHAGAKFPIKWTAPESLAYN--KFSIKSDVWAFGVLLWEIAT 207

>pdb|1S9J|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 341

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 162
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 163 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
Query: 191 LCG 193
           + G
Sbjct: 219 VEG 221

>pdb|3MBL|A Chain A, Crystal Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek 1) In Complex With Ligand And Mgadp Length = 328

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 162
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 163 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
Query: 191 LCG 193
           + G
Sbjct: 219 VEG 221

>pdb|3DV3|A Chain A, Mek1 With Pf-04622664 Bound Length = 322

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 162
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 163 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
Query: 191 LCG 193
           + G
Sbjct: 219 VEG 221

>pdb|2Y4I|C Chain C, Ksr2-Mek1 Heterodimer Length = 395

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 168 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 224
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 225 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 280
Query: 191 LCG 193
           + G
Sbjct: 281 VEG 283

>pdb|2G2F|A Chain A, A Src-Like Inactive Conformation In The Abl Tyrosine Kinase Domain Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 59  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 107
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 108 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 165
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 166 DTYTAPAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 209

>pdb|3QTI|A Chain A, C-Met Kinase In Complex With Nvp-Bvu972 Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 192 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 234

>pdb|3GVU|A Chain A, The Crystal Structure Of Human Abl2 In Complex With Gleevec Length = 292

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY+V ++  +   G L +   + + 
Sbjct: 76  LKEAAVMKEIKHPNLVQLLGVCTLE--------PPFYIVTEYMPY---GNLLDYLRECNR 124
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 125 EEVTAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHVVKVADFGLSRLM--TG 182
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 183 DTYTAHAGAKFPIKWTAPESLAY--NTFSIKSDVWAFGVLLWEIAT 226

>pdb|2P55|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In A Complex With Ligand And Mgatp Length = 333

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/123 (31%), Positives = 63/123 (51%), Gaps = 9/123 (7%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 162
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQ 190
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ ++    Q
Sbjct: 163 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKELELMFGCQ 218
Query: 191 LCG 193
           + G
Sbjct: 219 VEG 221

>pdb|2F4J|A Chain A, Structure Of The Kinase Domain Of An Imatinib-Resistant Abl Mutant In Complex With The Aurora Kinase Inhibitor Vx-680 Length = 287

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 39/166 (23%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 58  LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 106
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 107 QEVNAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLM--TG 164
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 165 DTYTAPAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 208

>pdb|2QOL|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596:y602:s768g Triple Mutant Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|3FBV|A Chain A, Crystal Structure Of The Oligomer Formed By The Kinase-Ribonuclease Domain Of Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 30/184 (16%)
Query: 4   IFFPITALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           I F   AL EIK+L +   H NV+     C    +++       Y+  + C  +L  L+ 
Sbjct: 67  IDFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRF------LYIALELCNLNLQDLVE 118
Query: 63  NIHVKFSLGEIKK------VIQQLLNGLYYIHSNKILHRDMKAANVLIT---------KT 107
           + +V     +++K      +++Q+ +G+ ++HS KI+HRD+K  N+L++         +T
Sbjct: 119 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 108 GI----LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL--LGDRNYGPPVDLWG 161
           G     + ++DFGL +     +        N   T  +R PELL     R     +D++ 
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 162 AGCI 165
            GC+
Sbjct: 239 MGCV 242

>pdb|3C1X|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Pyrrolotriazine Based Inhibitor Length = 373

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 250
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 251 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 293

>pdb|2J0L|A Chain A, Crystal Structure Of A The Active Conformation Of The Kinase Domain Of Focal Adhesion Kinase With A Phosphorylated Activation Loop Length = 276

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V KFS
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVI---------TENPVWIIMELC--TLGELRSFLQVRKFS 107
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTXX 167
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 168 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 205

>pdb|3A4P|A Chain A, Human C-Met Kinase Domain Complexed With 6-Benzyloxyquinoline Inhibitor Length = 319

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 84  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 136
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 137 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 196
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 197 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 239

>pdb|2QOC|A Chain A, Human Epha3 Kinase Domain, Phosphorylated, Amp-Pnp Bound Structure Length = 344

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 65  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 116
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 177 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 214

>pdb|3SDJ|A Chain A, Structure Of Rnase-Inactive Point Mutant Of Oligomeric KinaseRNASE Ire1 Length = 448

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 47/184 (25%), Positives = 86/184 (46%), Gaps = 30/184 (16%)
Query: 4   IFFPITALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           I F   AL EIK+L +   H NV+     C    +++       Y+  + C  +L  L+ 
Sbjct: 67  IDFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRF------LYIALELCNLNLQDLVE 118
Query: 63  NIHVKFSLGEIKK------VIQQLLNGLYYIHSNKILHRDMKAANVLIT---------KT 107
           + +V     +++K      +++Q+ +G+ ++HS KI+HRD+K  N+L++         +T
Sbjct: 119 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 178
Query: 108 GI----LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL--LGDRNYGPPVDLWG 161
           G     + ++DFGL +     +        N   T  +R PELL     R     +D++ 
Sbjct: 179 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESTKRRLTRSIDIFS 238
Query: 162 AGCI 165
            GC+
Sbjct: 239 MGCV 242

>pdb|3DKC|A Chain A, Sgx Clone 5698a65kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 192
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 193 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 235

>pdb|3CTH|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With A Aminopyridine Based Inhibitor Length = 314

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 79  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 131
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 132 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 191
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 192 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 234

>pdb|1R0P|A Chain A, Crystal Structure Of The Tyrosine Kinase Domain Of The Hepatocyte Growth Factor Receptor C-Met In Complex With The Microbial Alkaloid K-252a Length = 312

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 77  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 130 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 189
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 190 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 232

>pdb|3DKG|A Chain A, Sgx Clone 5698a109kfg1h1 Length = 317

Iteration: 1
 Score = 54.3 bits (129), Expect = 1e-07,   Method: Compositional matrix adjust.
 Identities = 42/164 (25%), Positives = 77/164 (46%), Gaps = 9/164 (5%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 80  LTEGIIMKDFSHPNVLSLLGICL-------RSEGSPLVVLPYMKHGDLRNFIRNETHNPT 132
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 133 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMLDKEFDSV 192
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           +  T   + + +   E  L  + +    D+W  G ++ E+ TR 
Sbjct: 193 HNKTGAKLPVKWMALE-SLQTQKFTTKSDVWSFGVLLWELMTRG 235

>pdb|3DZQ|A Chain A, Human Epha3 Kinase Domain In Complex With Inhibitor Awl-Ii- 38.3 Length = 361

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 71/160 (44%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V ++ E+  L   L     +F+
Sbjct: 82  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEYMENGSLDSFLRKHDAQFT 133
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 134 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 193
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 194 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 231

>pdb|3KUL|B Chain B, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +         R R    +V ++ E+  L   L     +F+
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVV-------TRGRLAM-IVTEYMENGSLDTFLRTHDGQFT 149
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A NVL+    + K++DFGL+R      +   
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAX 209
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G +M E+
Sbjct: 210 TTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEV 247

>pdb|2IVT|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            ++G++     Q+  G+ Y+   K++HRD+ A N+L+ +   +K++DFGL+R   + ++ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE-EDS 205
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            V R   R+   W     L   D  Y    D+W  G ++ E+ T
Sbjct: 206 XVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1T46|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C-kit Tyrosine Kinase Length = 313

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKA---------------NQYNRYRSTFYLVFDFCE 54
           + E+K+L  L  H N+V+L+  C                   N   R R +F      C 
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-----ICS 128
Query: 55  HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                ++ +  +   L ++     Q+  G+ ++ S   +HRD+ A N+L+T   I K+ D
Sbjct: 129 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 188
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--R 172
           FGLAR      N  V +   R+   W  P  +   +  Y    D+W  G  + E+++   
Sbjct: 189 FGLARDIKNDSN-YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 245
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME 213
           SP      + +   +I +    ++PE  P     ++Y+ M+
Sbjct: 246 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPA----EMYDIMK 282

>pdb|4FR4|A Chain A, Crystal Structure Of Human SerineTHREONINE-Protein Kinase 32a (Yank1) Length = 384

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 54/221 (24%), Positives = 95/221 (42%), Gaps = 28/221 (12%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-----LLSN 63
              +E++I+Q L+H  +V+L    + + +         ++V D     L G     L  N
Sbjct: 61  NVFKELQIMQGLEHPFLVNLWYSFQDEED--------MFMVVDLL---LGGDLRYHLQQN 109
Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
           +H  F    +K  I +L+  L Y+ + +I+HRDMK  N+L+ + G + + DF +A    +
Sbjct: 110 VH--FKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPR 167
Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDR--NYGPPVDLWGAGCIMAEMWT-RSPI-MQGN 179
                  + T    T  Y  PE+    +   Y   VD W  G    E+   R P  ++ +
Sbjct: 168 E-----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYELLRGRRPYHIRSS 222
Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR 220
           T  ++I    +      P +W   E + L  K+  P   +R
Sbjct: 223 TSSKEIVHTFETTVVTYPSAW-SQEMVSLLKKLLEPNPDQR 262

>pdb|3MDY|A Chain A, Crystal Structure Of The Cytoplasmic Domain Of The Bone Morp Protein Receptor Type-1b (Bmpr1b) In Complex With Fkbp12 An 193189 Length = 337

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 52/191 (27%), Positives = 85/191 (44%), Gaps = 23/191 (12%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVK 67
            RE +I Q  L++HEN++  I         + +     YL+ D+  H+   L   +    
Sbjct: 77  FRETEIYQTVLMRHENILGFIAADIKGTGSWTQ----LYLITDY--HENGSLYDYLKSTT 130
Query: 68  FSLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLAR 119
                + K+    ++GL ++H+          I HRD+K+ N+L+ K G   +AD GLA 
Sbjct: 131 LDAKSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAV 190
Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPP---VDLWGAGCIMAEMWTRSP 174
            F    N        RV T  Y PPE+L    +RN+       D++  G I+ E+  R  
Sbjct: 191 KFISDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEV-ARRC 249
Query: 175 IMQGNTEQQQI 185
           +  G  E+ Q+
Sbjct: 250 VSGGIVEEYQL 260

>pdb|3AMA|A Chain A, Protein Kinase A Sixfold Mutant Model Of Aurora B With Inhibitor Jnj- 7706621 Length = 351

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +K+ADFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3KUL|A Chain A, Kinase Domain Of Human Ephrin Type-A Receptor 8 (Epha8) Length = 325

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +         R R    +V ++ E+  L   L     +F+
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVV-------TRGRLAM-IVTEYMENGSLDTFLRTHDGQFT 149
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A NVL+    + K++DFGL+R      +   
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G +M E+
Sbjct: 210 TTTGGKIPIRWTAPEAIAF--RTFSSASDVWSFGVVMWEV 247

>pdb|4AW2|A Chain A, Crystal Structure Of Cdc42 Binding Protein Kinase Alpha (Mrck Alpha) Length = 437

Iteration: 1
 Score = 53.9 bits (128), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 40/131 (30%), Positives = 61/131 (46%), Gaps = 8/131 (6%)
Query: 44  STFYLVFDF-CEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANV 102
           +  YLV D+    DL  LLS    +      +  + +++  +  +H    +HRD+K  N+
Sbjct: 147 NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAIDSVHQLHYVHRDIKPDNI 206
Query: 103 LITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVD 158
           L+   G ++LADFG        ++G V + +  V T  Y  PE+L     G   YGP  D
Sbjct: 207 LMDMNGHIRLADFG--SCLKLMEDGTV-QSSVAVGTPDYISPEILQAMEGGKGRYGPECD 263
Query: 159 LWGAGCIMAEM 169
            W  G  M EM
Sbjct: 264 WWSLGVCMYEM 274

>pdb|2GNF|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase With Y- 27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +K+ADFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GNJ|A Chain A, Pka Three Fold Mutant Model Of Rho-Kinase With Y-27632 Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +K+ADFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2GNG|A Chain A, Protein Kinase A Fivefold Mutant Model Of Rho-Kinase Length = 350

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 35/116 (30%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +K+ADFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIKVADFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3G0E|A Chain A, Kit Kinase Domain In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 50/212 (23%), Positives = 82/212 (38%), Gaps = 30/212 (14%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           + E+K+L  L  H N+V+L+  C            T  +    C  DL   L      F 
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGG-------PTLVITEYCCYGDLLNFLRRKRDSFI 149
Query: 70  LGEIKKVIQ-----------------QLLNGLYYIHSNKILHRDMKAANVLITKTGILKL 112
             +    I                  Q+  G+ ++ S   +HRD+ A N+L+T   I K+
Sbjct: 150 CSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKI 209
Query: 113 ADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT- 171
            DFGLAR      N  V +   R+   W  P  +   +  Y    D+W  G  + E+++ 
Sbjct: 210 CDFGLARDIKNDSN-YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSL 266
Query: 172 -RSPIMQGNTEQQQITLISQLCGSITPESWPG 202
             SP      + +   +I +    ++PE  P 
Sbjct: 267 GSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPA 298

>pdb|1JPA|A Chain A, Crystal Structure Of Unphosphorylated Ephb2 Receptor Tyrosine Kinase And Juxtamembrane Region Length = 312

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/164 (23%), Positives = 75/164 (45%), Gaps = 13/164 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H NV+HL E   TK+       +   ++ +F E+  L   L     +F+
Sbjct: 82  LSEASIMGQFDHPNVIHL-EGVVTKS-------TPVMIITEFMENGSLDSFLRQNDGQFT 133
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ- 128
           + ++  +++ +  G+ Y+     +HRD+ A N+L+    + K++DFGL+R      +   
Sbjct: 134 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 193
Query: 129 -VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             +    ++   W  P  +    R +    D+W  G +M E+ +
Sbjct: 194 YTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEVMS 235

>pdb|1T45|A Chain A, Structural Basis For The Autoinhibition And Sti-571 Inhibition Of C- Kit Tyrosine Kinase Length = 331

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 49/210 (23%), Positives = 86/210 (40%), Gaps = 26/210 (12%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKA---------------NQYNRYRSTFYLVFDFCE 54
           + E+K+L  L  H N+V+L+  C                   N   R R +F      C 
Sbjct: 92  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-----ICS 146
Query: 55  HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                ++ +  +   L ++     Q+  G+ ++ S   +HRD+ A N+L+T   I K+ D
Sbjct: 147 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 206
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--R 172
           FGLAR      N  V +   R+   W  P  +   +  Y    D+W  G  + E+++   
Sbjct: 207 FGLARDIKNDSN-YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 263
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPG 202
           SP      + +   +I +    ++PE  P 
Sbjct: 264 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPA 293

>pdb|4DC2|A Chain A, Structure Of Pkc In Complex With A Substrate Peptide From Par-3 Length = 396

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L Y+H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 154 HARFYSAEISL-------ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGL 204
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + G     +    T  Y  PE+L G+ +YG  VD W  G +M EM   RSP
Sbjct: 205 RPGDTT--STFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP 252

>pdb|2QLU|A Chain A, Crystal Structure Of Activin Receptor Type Ii Kinase Domain From Human Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 61/244 (25%), Positives = 100/244 (40%), Gaps = 51/244 (20%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF-SL 70
           REI     +KHEN++  I   +  +N         +L+  F  HD   L   +     + 
Sbjct: 58  REIFSTPGMKHENLLQFIAAEKRGSN----LEVELWLITAF--HDKGSLTDYLKGNIITW 111
Query: 71  GEIKKVIQQLLNGLYYIHSN-----------KILHRDMKAANVLITKTGILKLADFGLAR 119
            E+  V + +  GL Y+H +            I HRD K+ NVL+       LADFGLA 
Sbjct: 112 NELCHVAETMSRGLSYLHEDVPWCRGEGHKPSIAHRDFKSKNVLLKSDLTAVLADFGLAV 171
Query: 120 AFSQTK-----NGQVNRYTNRVVTLWYRPPELLLGDRNYGPP----VDLWGAGCIMAEMW 170
            F   K     +GQV   T R     Y  PE+L G  N+       +D++  G ++ E+ 
Sbjct: 172 RFEPGKPPGDTHGQVG--TRR-----YMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELV 224
Query: 171 TRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV 230
           +R     G  ++  +    ++         P +E L           Q+  V ++++P +
Sbjct: 225 SRCKAADGPVDEYMLPFEEEIGQH------PSLEEL-----------QEVVVHKKMRPTI 267
Query: 231 KDQY 234
           KD +
Sbjct: 268 KDHW 271

>pdb|3G0F|A Chain A, Kit Kinase Domain Mutant D816h In Complex With Sunitinib Length = 336

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKA---------------NQYNRYRSTFYLVFDFCE 54
           + E+K+L  L  H N+V+L+  C                   N   R R +F      C 
Sbjct: 97  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-----ICS 151
Query: 55  HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                ++ +  +   L ++     Q+  G+ ++ S   +HRD+ A N+L+T   I K+ D
Sbjct: 152 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 211
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--R 172
           FGLAR      N  V +   R+   W  P  +   +  Y    D+W  G  + E+++   
Sbjct: 212 FGLARHIKNDSN-YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 268
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME 213
           SP      + +   +I +    ++PE  P     ++Y+ M+
Sbjct: 269 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPA----EMYDIMK 305

>pdb|2IVS|A Chain A, Crystal Structure Of Non-Phosphorylated Ret Tyrosine Kinase Domain Length = 314

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 29/104 (27%), Positives = 54/104 (51%), Gaps = 3/104 (2%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            ++G++     Q+  G+ Y+   K++HRD+ A N+L+ +   +K++DFGL+R   + ++ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYE-EDS 205
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            V R   R+   W     L   D  Y    D+W  G ++ E+ T
Sbjct: 206 YVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|1PKG|A Chain A, Structure Of A C-kit Kinase Product Complex Length = 329

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 51/221 (23%), Positives = 92/221 (41%), Gaps = 30/221 (13%)
Query: 11  LREIKILQLL-KHENVVHLIEICRTKA---------------NQYNRYRSTFYLVFDFCE 54
           + E+K+L  L  H N+V+L+  C                   N   R R +F      C 
Sbjct: 90  MSELKVLSYLGNHMNIVNLLGACTIGGPTLVITEYCCYGDLLNFLRRKRDSF-----ICS 144
Query: 55  HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                ++ +  +   L ++     Q+  G+ ++ S   +HRD+ A N+L+T   I K+ D
Sbjct: 145 KTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICD 204
Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--R 172
           FGLAR      N  V +   R+   W  P  +   +  Y    D+W  G  + E+++   
Sbjct: 205 FGLARDIKNDSN-YVVKGNARLPVKWMAPESIF--NCVYTFESDVWSYGIFLWELFSLGS 261
Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME 213
           SP      + +   +I +    ++PE  P     ++Y+ M+
Sbjct: 262 SPYPGMPVDSKFYKMIKEGFRMLSPEHAPA----EMYDIMK 298

>pdb|1ZRZ|A Chain A, Crystal Structure Of The Catalytic Domain Of Atypical Protein Kinase C-Iota Length = 364

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L Y+H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 122 HARFYSAEISL-------ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGL 172
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + G     +    T  Y  PE+L G+ +YG  VD W  G +M EM   RSP
Sbjct: 173 RPGDTT--SXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP 220

>pdb|1OPK|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 495

Iteration: 1
 Score = 53.5 bits (127), Expect = 2e-07,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 312
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HR++ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 313 QEVSAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TG 370
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 371 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 414

>pdb|3ZH8|A Chain A, A Novel Small Molecule Apkc Inhibitor Length = 349

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L Y+H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 107 HARFYSAEISL-------ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGL 157
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + G     +    T  Y  PE+L G+ +YG  VD W  G +M EM   RSP
Sbjct: 158 RPGDTT--SXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP 205

>pdb|1OPL|A Chain A, Structural Basis For The Auto-Inhibition Of C-Abl Tyrosine Kinase Length = 537

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/166 (22%), Positives = 76/166 (45%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   G L +   + + 
Sbjct: 303 LKEAAVMKEIKHPNLVQLLGVCTREP--------PFYIITEFMTY---GNLLDYLRECNR 351
Query: 71  GEIKKVI-----QQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            E+  V+      Q+ + + Y+     +HR++ A N L+ +  ++K+ADFGL+R    T 
Sbjct: 352 QEVNAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLM--TG 409
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           +        +    W  P  L      +    D+W  G ++ E+ T
Sbjct: 410 DTYTAHAGAKFPIKWTAPESLAY--NKFSIKSDVWAFGVLLWEIAT 453

>pdb|2QON|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Y596f:y602f:y742a Triple Mutant Length = 373

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V +  E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGAVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|2J0J|A Chain A, Crystal Structure Of A Fragment Of Focal Adhesion Kinase Containing The Ferm And Kinase Domains Length = 656

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 42/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V KFS
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKFS 487
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 488 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 547
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 548 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 585

>pdb|3ZUU|A Chain A, The Structure Of Ost1 (D160a, S175d) Kinase In Complex With Gold Length = 362

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AG-------RFS 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQL++G+ Y H+ ++ HRD+K  N L+  +    LK+  FG +++    SQ 
Sbjct: 114 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP 173
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K        + V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 174 K--------DTVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210

>pdb|1NXK|A Chain A, Crystal Structure Of Staurosporine Bound To Map Kap Kinase 2 Length = 400

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/101 (33%), Positives = 47/101 (46%), Gaps = 9/101 (8%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQT 124
           F+  E  ++ + +   + Y+HS  I HRD+K  N+L T      ILKL DFG A+  +  
Sbjct: 158 FTEREASEIXKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH 217
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
                N  T    T +Y  PE +LG   Y    D W  G I
Sbjct: 218 -----NSLTTPCYTPYYVAPE-VLGPEKYDKSCDXWSLGVI 252

>pdb|3A8W|A Chain A, Crystal Structure Of Pkciota Kinase Domain Length = 345

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 38/111 (34%), Positives = 54/111 (48%), Gaps = 13/111 (11%)
Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H +F   EI          L Y+H   I++RD+K  NVL+   G +KL D+G+ +     
Sbjct: 111 HARFYSAEISL-------ALNYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCK--EGL 161
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSP 174
           + G     +    T  Y  PE+L G+ +YG  VD W  G +M EM   RSP
Sbjct: 162 RPGDTT--SXFCGTPNYIAPEILRGE-DYGFSVDWWALGVLMFEMMAGRSP 209

>pdb|3T8O|A Chain A, Rhodopsin Kinase (grk1) L166k Mutant At 2.5a Resolution Length = 543

Iteration: 1
 Score = 53.1 bits (126), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+++GL ++H   I++RD+K  NVL+   G ++++D GLA    + K GQ  +      T
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQ-TKTKGYAGT 352
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPI 175
             +  PELLLG+  Y   VD +  G  + EM   R P 
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3ZUT|A Chain A, The Structure Of Ost1 (D160a) Kinase Length = 362

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 49/165 (29%), Positives = 73/165 (44%), Gaps = 25/165 (15%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQ--YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           REI   + L+H N+V   E+  T  +      Y S   L    C    AG       +FS
Sbjct: 64  REIINHRSLRHPNIVRFKEVILTPTHLAIVMEYASGGELFERICN---AG-------RFS 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARA---FSQT 124
             E +   QQL++G+ Y H+ ++ HRD+K  N L+  +    LK+  FG +++    SQ 
Sbjct: 114 EDEARFFFQQLISGVSYCHAMQVCHRDLKLENTLLDGSPAPRLKICAFGYSKSSVLHSQP 173
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           K        + V T  Y  PE+LL     G   D+W  G  +  M
Sbjct: 174 K--------STVGTPAYIAPEVLLKKEYDGKVADVWSCGVTLYVM 210

>pdb|3QC9|A Chain A, Crystal Structure Of Cross-Linked Bovine Grk1 T8cN480C DOUBLE MUTANT Complexed With Adp And Mg Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+++GL ++H   I++RD+K  NVL+   G ++++D GLA    + K GQ  +      T
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQ-TKTKGYAGT 352
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPI 175
             +  PELLLG+  Y   VD +  G  + EM   R P 
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3C4X|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.9a Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+++GL ++H   I++RD+K  NVL+   G ++++D GLA    + K GQ  +      T
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQ-TKTKGYAGT 352
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPI 175
             +  PELLLG+  Y   VD +  G  + EM   R P 
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|2QO7|A Chain A, Human Epha3 Kinase And Juxtamembrane Region, Dephosphorylated, Amp-Pnp Bound Length = 373

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V +  E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEXMENGSLDSFLRKHDAQFT 145
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 205
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 206 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 243

>pdb|3H9R|A Chain A, Crystal Structure Of The Kinase Domain Of Type I Activin Receptor (Acvr1) In Complex With Fkbp12 And Dorsomorphin Length = 330

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 19  LLKHENVVHLIEICRTKANQYNRYRST-FYLVFDFCEHDLAGLLSNIHVK-FSLGEIKKV 76
           +L+HEN++  I      ++  +R+ ST  +L+  +  H++  L   + +         ++
Sbjct: 87  MLRHENILGFI-----ASDMTSRHSSTQLWLITHY--HEMGSLYDYLQLTTLDTVSCLRI 139
Query: 77  IQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  + +GL ++H           I HRD+K+ N+L+ K G   +AD GLA   SQ+ N Q
Sbjct: 140 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN-Q 198
Query: 129 VNRYTN-RVVTLWYRPPELL-----LGDRNYGPPVDLWGAGCIMAEMWTR 172
           ++   N RV T  Y  PE+L     +   +    VD+W  G ++ E+  R
Sbjct: 199 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 248

>pdb|3C4W|A Chain A, Crystal Structure Of G Protein Coupled Receptor Kinase 1 Bound To Atp And Magnesium Chloride At 2.7a Length = 543

Iteration: 1
 Score = 52.8 bits (125), Expect = 3e-07,   Method: Compositional matrix adjust.
 Identities = 34/98 (34%), Positives = 53/98 (54%), Gaps = 6/98 (6%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+++GL ++H   I++RD+K  NVL+   G ++++D GLA    + K GQ  +      T
Sbjct: 297 QIVSGLEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLA---VELKAGQ-TKTKGYAGT 352
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPI 175
             +  PELLLG+  Y   VD +  G  + EM   R P 
Sbjct: 353 PGFMAPELLLGE-EYDFSVDYFALGVTLYEMIAARGPF 389

>pdb|3ORN|A Chain A, Mitogen-Activated Protein Kinase Kinase 1 (Mek1) In Complex With Ch4987655 And Mgamp-Pnp Length = 307

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 37/105 (35%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 106 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 162
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPI 175
           +   V T  Y  PE L G  +Y    D+W  G  + EM   R PI
Sbjct: 163 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPI 203

>pdb|3LJ0|A Chain A, Ire1 Complexed With Adp And Quercetin Length = 434

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/188 (25%), Positives = 86/188 (45%), Gaps = 34/188 (18%)
Query: 4   IFFPITALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
           I F   AL EIK+L +   H NV+     C    +++       Y+  + C  +L  L+ 
Sbjct: 49  IDFCDIALMEIKLLTESDDHPNVIRYY--CSETTDRF------LYIALELCNLNLQDLVE 100
Query: 63  NIHVKFSLGEIKK------VIQQLLNGLYYIHSNKILHRDMKAANVLIT---------KT 107
           + +V     +++K      +++Q+ +G+ ++HS KI+HRD+K  N+L++         +T
Sbjct: 101 SKNVSDENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQT 160
Query: 108 GI----LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP------PV 157
           G     + ++DFGL +     +        N   T  +R PELL    N          +
Sbjct: 161 GAENLRILISDFGLCKKLDSGQXXFRXNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSI 220
Query: 158 DLWGAGCI 165
           D++  GC+
Sbjct: 221 DIFSMGCV 228

>pdb|1KOA|A Chain A, Twitchin Kinase Fragment (C.Elegans), Autoregulated Protein Kinase And Immunoglobulin Domains Length = 491

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
           T  +EI+ + +L+H  +V+L +             +   ++++F    +L   +++ H K
Sbjct: 94  TVRKEIQTMSVLRHPTLVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHNK 145
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTK 125
            S  E  + ++Q+  GL ++H N  +H D+K  N++ T  ++  LKL DFGL       +
Sbjct: 146 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 205
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           + +V        T  +  PE+  G +  G   D+W  G +
Sbjct: 206 SVKVT-----TGTAEFAAPEVAEG-KPVGYYTDMWSVGVL 239

>pdb|4DYM|A Chain A, Crystal Structure Of The Acvr1 Kinase Domain In Complex With The Imidazo[1,2-B]pyridazine Inhibitor K00135 Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/171 (27%), Positives = 86/171 (50%), Gaps = 26/171 (15%)
Query: 19  LLKHENVVHLIEICRTKANQYNRYRST-FYLVFDFCEHDLAGLLSNIHVKFSLGEIK--K 75
           +L+HEN++  I      ++  +R+ ST  +L+  +  H++  L   + +  +L  +   +
Sbjct: 58  MLRHENILGFI-----ASDMTSRHSSTQLWLITHY--HEMGSLYDYLQLT-TLDTVSCLR 109
Query: 76  VIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           ++  + +GL ++H           I HRD+K+ N+L+ K G   +AD GLA   SQ+ N 
Sbjct: 110 IVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN- 168
Query: 128 QVNRYTN-RVVTLWYRPPELL-----LGDRNYGPPVDLWGAGCIMAEMWTR 172
           Q++   N RV T  Y  PE+L     +   +    VD+W  G ++ E+  R
Sbjct: 169 QLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|3MTF|A Chain A, Crystal Structure Of The Acvr1 Kinase In Complex With A 2- Aminopyridine Inhibitor Length = 301

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 46/170 (27%), Positives = 83/170 (48%), Gaps = 24/170 (14%)
Query: 19  LLKHENVVHLIEICRTKANQYNRYRST-FYLVFDFCEHDLAGLLSNIHVK-FSLGEIKKV 76
           +L+HEN++  I      ++  +R+ ST  +L+  +  H++  L   + +         ++
Sbjct: 58  MLRHENILGFI-----ASDMTSRHSSTQLWLITHY--HEMGSLYDYLQLTTLDTVSCLRI 110
Query: 77  IQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  + +GL ++H           I HRD+K+ N+L+ K G   +AD GLA   SQ+ N Q
Sbjct: 111 VLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTN-Q 169
Query: 129 VNRYTN-RVVTLWYRPPELL-----LGDRNYGPPVDLWGAGCIMAEMWTR 172
           ++   N RV T  Y  PE+L     +   +    VD+W  G ++ E+  R
Sbjct: 170 LDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARR 219

>pdb|2QOB|A Chain A, Human Epha3 Kinase Domain, Base Structure Length = 344

Iteration: 1
 Score = 52.8 bits (125), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 36/160 (22%), Positives = 70/160 (43%), Gaps = 11/160 (6%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L E   TK+           +V +  E+  L   L     +F+
Sbjct: 65  LGEASIMGQFDHPNIIRL-EGVVTKSKP-------VMIVTEXMENGSLDSFLRKHDAQFT 116
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL+R          
Sbjct: 117 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLSRVLEDDPEAAY 176
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
                ++   W  P  +    R +    D+W  G ++ E+
Sbjct: 177 TTRGGKIPIRWTSPEAIAY--RKFTSASDVWSYGIVLWEV 214

>pdb|4EUT|A Chain A, Structure Of Bx-795 Complexed With Unphosphorylated Human Tbk1 Kinase- Uld Domain Length = 396

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 80/177 (45%), Gaps = 25/177 (14%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFS 69
           +RE ++L+ L H+N+V L  I      ++        L+ +FC    L  +L      + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHK------VLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 70  L--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL--ITKTG--ILKLADFGLARAFSQ 123
           L   E   V++ ++ G+ ++  N I+HR++K  N++  I + G  + KL DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 124 TKNGQVNRYTNRVVTLWYRPPEL-----LLGD--RNYGPPVDLWGAGCIMAEMWTRS 173
            +     ++ +   T  Y  P++     L  D  + YG  VDLW  G       T S
Sbjct: 169 DE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>pdb|1XH9|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 52.4 bits (124), Expect = 4e-07,   Method: Compositional matrix adjust.
 Identities = 34/116 (29%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +K+ DFGLA
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGLA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2IVV|A Chain A, Crystal Structure Of Phosphorylated Ret Tyrosine Kinase Domain Complexed With The Inhibitor Pp1 Length = 314

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 28/104 (26%), Positives = 53/104 (50%), Gaps = 3/104 (2%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            ++G++     Q+  G+ Y+    ++HRD+ A N+L+ +   +K++DFGL+R   + ++ 
Sbjct: 147 LTMGDLISFAWQISQGMQYLAEMSLVHRDLAARNILVAEGRKMKISDFGLSRDVYE-EDS 205
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            V R   R+   W     L   D  Y    D+W  G ++ E+ T
Sbjct: 206 XVKRSQGRIPVKWMAIESLF--DHIYTTQSDVWSFGVLLWEIVT 247

>pdb|3UTO|A Chain A, Twitchin Kinase Region From C.Elegans (Fn31-Nl-Kin-Crd-Ig26) Length = 573

Iteration: 1
 Score = 52.4 bits (124), Expect = 5e-07,   Method: Compositional matrix adjust.
 Identities = 39/160 (24%), Positives = 76/160 (47%), Gaps = 17/160 (10%)
Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
           T  +EI+ + +L+H  +V+L +             +   ++++F    +L   +++ H K
Sbjct: 200 TVRKEIQTMSVLRHPTLVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHNK 251
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTK 125
            S  E  + ++Q+  GL ++H N  +H D+K  N++ T  ++  LKL DFGL       +
Sbjct: 252 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ 311
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           + +V        T  +  PE+  G +  G   D+W  G +
Sbjct: 312 SVKVT-----TGTAEFAAPEVAEG-KPVGYYTDMWSVGVL 345

>pdb|2UZT|A Chain A, Pka Structures Of Akt, Indazole-Pyridine Inhibitors Length = 336

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 23/120 (19%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 122 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 174
Query: 119 RAFSQTKNGQVNRYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R   R  TL     Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 175 K-----------RVKGRTWTLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 222

>pdb|2F7E|E Chain E, Pka Complexed With (S)-2-(1h-Indol-3-Yl)-1-(5-Isoquinolin-6- Yl-Pyridin-3-Yloxymethyl-Etylamine Length = 351

Iteration: 1
 Score = 52.0 bits (123), Expect = 6e-07,   Method: Compositional matrix adjust.
 Identities = 35/120 (29%), Positives = 54/120 (45%), Gaps = 23/120 (19%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R   R  TL     Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 K-----------RVKGRTWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|4EUU|A Chain A, Structure Of Bx-795 Complexed With Human Tbk1 Kinase Domain Phosphorylated On Ser172 Length = 319

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 47/177 (26%), Positives = 79/177 (44%), Gaps = 25/177 (14%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFS 69
           +RE ++L+ L H+N+V L  I      ++        L+ +FC    L  +L      + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRHK------VLIMEFCPCGSLYTVLEEPSNAYG 108
Query: 70  L--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL--ITKTG--ILKLADFGLARAFSQ 123
           L   E   V++ ++ G+ ++  N I+HR++K  N++  I + G  + KL DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168
Query: 124 TKNGQVNRYTNRVVTLWYRPPEL-----LLGD--RNYGPPVDLWGAGCIMAEMWTRS 173
            +     ++     T  Y  P++     L  D  + YG  VDLW  G       T S
Sbjct: 169 DE-----QFVXLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGS 220

>pdb|4F99|A Chain A, Human Cdc7 Kinase In Complex With Dbf4 And Nucleotide Length = 361

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 61/251 (24%), Positives = 100/251 (39%), Gaps = 44/251 (17%)
Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV 66
           PI    E++ L +   ++ V  ++ C  K +          +   + EH+      +I  
Sbjct: 63  PIRIAAELQCLTVAGGQDNVMGVKYCFRKNDH-------VVIAMPYLEHES---FLDILN 112
Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILK---LADFGLARAFSQ 123
             S  E+++ +  L   L  IH   I+HRD+K +N L  +   LK   L DFGLA+    
Sbjct: 113 SLSFQEVREYMLNLFKALKRIHQFGIVHRDVKPSNFLYNRR--LKKYALVDFGLAQGTHD 170
Query: 124 TK---------NGQVNRYTN---------------RVVTLWYRPPELLLGDRNYGPPVDL 159
           TK           Q  R +                R  T  +R PE+L    N    +D+
Sbjct: 171 TKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAGTPGFRAPEVLTKCPNQTTAIDM 230
Query: 160 WGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETL--DLYNKMELPK 216
           W AG I   + + R P  + + +   +  I  + GS   E+    +T    +    E+P 
Sbjct: 231 WSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGS--RETIQAAKTFGKSILCSKEVPA 288
Query: 217 AQKRKVKERLK 227
              RK+ ERL+
Sbjct: 289 QDLRKLCERLR 299

>pdb|4EBW|A Chain A, Structure Of Focal Adhesion Kinase Catalytic Domain In Complex With Novel Allosteric Inhibitor Length = 304

Iteration: 1
 Score = 52.0 bits (123), Expect = 7e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 87  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 135
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 136 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 195
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 196 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 233

>pdb|3PXK|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Pyrrolo[2,3- D]thiazole Length = 282

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 62  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 110
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 111 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 170
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 171 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 208

>pdb|3HGK|A Chain A, Crystal Structure Of Effect Protein Avrptob Complexed With Kinase Pto Length = 327

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 31/96 (32%), Positives = 54/96 (56%), Gaps = 4/96 (4%)
Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL+Y+H+  I+HRD+K+ N+L+ +  + K+ DFG+++    T+ GQ +       TL Y 
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISK--KGTELGQTHLXXVVKGTLGYI 208
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAE-MWTRSPIMQ 177
            PE  +  R      D++  G ++ E +  RS I+Q
Sbjct: 209 DPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQ 243

>pdb|2ETM|A Chain A, Crystal Structure Of Focal Adhesion Kinase Domain Complexed With 7h-Pyrrolo [2,3-D] Pyrimidine Derivative Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 61  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 109
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 110 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 169
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 170 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 207

>pdb|3FHI|A Chain A, Crystal Structure Of A Complex Between The Catalytic And Regulatory (Ri{alpha}) Subunits Of Pka Length = 350

Iteration: 1
 Score = 51.6 bits (122), Expect = 8e-07,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLAGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4AN2|A Chain A, Crystal Structures Of Human Mek1 With Carboxamide-Based Allosteric Inhibitor Xl518 (Gdc-0973), Or Related Analogs. Length = 301

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 36/108 (33%), Positives = 56/108 (51%), Gaps = 12/108 (11%)
Query: 73  IKKVIQQLLNGLYYI-HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 109 LGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDEMANE 165
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM----WTRSPI 175
           +   V T  Y  PE L G  +Y    D+W  G  + EM    + R P+
Sbjct: 166 F---VGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPRPPM 209

>pdb|3DTC|A Chain A, Crystal Structure Of Mixed-Lineage Kinase Mlk1 Complexed With Compound 16 Length = 271

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 46/173 (26%), Positives = 78/173 (45%), Gaps = 31/173 (17%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSL 70
           +E K+  +LKH N++ L  +C  + N          LV +F     L  +LS   +   +
Sbjct: 55  QEAKLFAMLKHPNIIALRGVCLKEPN--------LCLVMEFARGGPLNRVLSGKRIPPDI 106
Query: 71  GEIKKVIQQLLNGLYYIHSNK---ILHRDMKAANVLITK--------TGILKLADFGLAR 119
             +     Q+  G+ Y+H      I+HRD+K++N+LI +          ILK+ DFGLAR
Sbjct: 107 --LVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAR 164
Query: 120 AFSQ-TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            + + TK      Y        +  PE++     +    D+W  G ++ E+ T
Sbjct: 165 EWHRTTKMSAAGAYA-------WMAPEVIRASM-FSKGSDVWSYGVLLWELLT 209

>pdb|2JKM|A Chain A, Focal Adhesion Kinase Catalytic Domain In Complex With Bis- Anilino Pyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 107
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 168 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 205

>pdb|1MP8|A Chain A, Crystal Structure Of Focal Adhesion Kinase (Fak) Length = 281

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 112
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 113 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 173 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 210

>pdb|3BZ3|A Chain A, Crystal Structure Analysis Of Focal Adhesion Kinase With A Methanesulfonamide Diaminopyrimidine Inhibitor Length = 276

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 104
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 105 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 164
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 165 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 202

>pdb|3PLS|A Chain A, Ron In Complex With Ligand Amp-Pnp Length = 298

Iteration: 1
 Score = 51.6 bits (122), Expect = 9e-07,   Method: Compositional matrix adjust.
 Identities = 41/163 (25%), Positives = 76/163 (46%), Gaps = 7/163 (4%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           LRE  +++ L H NV+ LI I        +       L+   C  DL   + +     ++
Sbjct: 70  LREGLLMRGLNHPNVLALIGIMLPPEGLPH------VLLPYMCHGDLLQFIRSPQRNPTV 123
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            ++     Q+  G+ Y+   K +HRD+ A N ++ ++  +K+ADFGLAR     +   V 
Sbjct: 124 KDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQ 183
Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           ++ +  + + +   E L   R +    D+W  G ++ E+ TR 
Sbjct: 184 QHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLLWELLTRG 225

>pdb|1WBP|A Chain A, Srpk1 Bound To 9mer Docking Motif Peptide Length = 397

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 63/245 (25%)
Query: 9   TALREIKILQLLKH--------ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG- 59
           TAL EI++L+ +++        E VV L++  +          +   +VF+   H L   
Sbjct: 79  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN----GTHICMVFEVLGHHLLKW 134
Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLIT------------- 105
           ++ + +    L  +KK+IQQ+L GL Y+H+  +I+H D+K  N+L++             
Sbjct: 135 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 194
Query: 106 ----KTGILKLADFGLARAFSQTKNGQVN-------------------------RYTNRV 136
               ++G    +   ++ A +   N  VN                          +T  +
Sbjct: 195 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 254
Query: 137 VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT------EQQQITLISQ 190
            T  YR  E+L+G   Y  P D+W   C+  E+ T   + + ++      ++  I LI +
Sbjct: 255 QTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 313
Query: 191 LCGSI 195
           L G +
Sbjct: 314 LLGKV 318

>pdb|2J0M|B Chain B, Crystal Structure A Two-Chain Complex Between The Ferm And Kinase Domains Of Focal Adhesion Kinase. Length = 276

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 41/162 (25%), Positives = 74/162 (45%), Gaps = 18/162 (11%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFS 69
           L+E   ++   H ++V LI +            +  +++ + C   L  L S + V K+S
Sbjct: 59  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELC--TLGELRSFLQVRKYS 107
Query: 70  LGEIKKVIQ--QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L     ++   QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +   
Sbjct: 108 LDLASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTYY 167
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           + ++   ++   W  P  +    R +    D+W  G  M E+
Sbjct: 168 KASK--GKLPIKWMAPESINF--RRFTSASDVWMFGVCMWEI 205

>pdb|2JDT|A Chain A, Structure Of Pka-Pkb Chimera Complexed With Isoquinoline-5- Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl) Amide Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +K+ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1S9I|A Chain A, X-Ray Structure Of The Human Mitogen-Activated Protein Kinase Kinase 2 (Mek2)in A Complex With Ligand And Mgatp Length = 354

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/105 (34%), Positives = 55/105 (52%), Gaps = 9/105 (8%)
Query: 73  IKKVIQQLLNGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           + KV   +L GL Y+   ++I+HRD+K +N+L+   G +KL DFG++    Q  +   N 
Sbjct: 116 LGKVSIAVLRGLAYLREKHQIMHRDVKPSNILVNSRGEIKLCDFGVS---GQLIDSMANS 172
Query: 132 YTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPI 175
           +   V T  Y  PE L G  +Y    D+W  G  + E+   R PI
Sbjct: 173 F---VGTRSYMAPERLQGT-HYSVQSDIWSMGLSLVELAVGRYPI 213

>pdb|1J3H|A Chain A, Crystal Structure Of Apoenzyme Camp-Dependent Protein Kinase Catalytic Subunit Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLXGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1Q61|A Chain A, Pka Triple Mutant Model Of Pkb Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +K+ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2VO0|A Chain A, Structure Of Pka-Pkb Chimera Complexed With C-(4-(4- Chlorophenyl)-1-(7h-Pyrrolo(2, 3-D)pyrimidin-4-Yl)piperidin- 4-Yl)methylamine Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +K+ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3L9M|A Chain A, Crystal Structure Of Pkab3 (Pka Triple Mutant V123a, L173m, Q181k) With Compound 18 Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +K+ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SMH|A Chain A, Protein Kinase A Variant Complex With Completely Ordered N- Terminal Helix Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 53/116 (45%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +++ DFGLA
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGLA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QUR|A Chain A, Crystal Structure Of F327aK285P MUTANT OF CAMP-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1YDT|E Chain E, Structure Of Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With H89 Protein Kinase Inhibitor N-[2- (4-Bromocinnamylamino)ethyl]-5-Isoquinoline Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1BKX|A Chain A, A Binary Complex Of The Catalytic Subunit Of Camp-Dependent Protein Kinase And Adenosine Further Defines Conformational Flexibility Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3QAL|E Chain E, Crystal Structure Of Arg280ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2ERZ|E Chain E, Crystal Structure Of C-amp Dependent Kinase (pka) Bound To Hydroxyfasudil Length = 351

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 90  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 146
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 147 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 193
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 194 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1FMO|E Chain E, Crystal Structure Of A Polyhistidine-Tagged Recombinant Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With The Peptide Inhibitor Pki(5-24) And Adenosine Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3LLT|A Chain A, Crystal Structure Of Pf14_0431, Kinase Domain Length = 360

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 36/153 (23%), Positives = 67/153 (43%), Gaps = 33/153 (21%)
Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI----------------------- 104
           F + +IK    ++L  L Y+    + H D+K  N+L+                       
Sbjct: 134 FHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQI 193
Query: 105 --TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA 162
             TK+  +KL DFG A  F    +G +      + T  YR PE++L +  +    D+W  
Sbjct: 194 YRTKSTGIKLIDFGCA-TFKSDYHGSI------INTRQYRAPEVIL-NLGWDVSSDMWSF 245
Query: 163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSI 195
           GC++AE++T S + + +   + + ++  +   I
Sbjct: 246 GCVLAELYTGSLLFRTHEHMEHLAMMESIIQPI 278

>pdb|1JBP|E Chain E, Crystal Structure Of The Catalytic Subunit Of Camp- Dependent Protein Kinase Complexed With A Substrate Peptide, Adp And Detergent Length = 350

Iteration: 1
 Score = 51.2 bits (121), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2I0E|A Chain A, Structure Of Catalytic Domain Of Human Protein Kinase C Beta Ii Complexed With A Bisindolylmaleimide Inhibitor Length = 353

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 30/101 (29%), Positives = 51/101 (50%), Gaps = 5/101 (4%)
Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL+++ S  I++RD+K  NV++   G +K+ADFG+ +      +G   +      T  Y 
Sbjct: 133 GLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF--CGTPDYI 188
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            PE ++  + YG  VD W  G ++ EM       +G  E +
Sbjct: 189 APE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 228

>pdb|3Q4T|A Chain A, Crystal Structure Of Activin Receptor Type-Iia (Acvr2a) Kinase Domain In Complex With Dorsomorphin Length = 322

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 48/186 (25%), Positives = 79/186 (42%), Gaps = 25/186 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           E+  L  +KHEN++  I        +        +L+  F E    G LS+       S 
Sbjct: 68  EVYSLPGMKHENILQFI----GAEKRGTSVDVDLWLITAFHEK---GSLSDFLKANVVSW 120
Query: 71  GEIKKVIQQLLNGLYYIHSN----------KILHRDMKAANVLITKTGILKLADFGLARA 120
            E+  + + +  GL Y+H +           I HRD+K+ NVL+       +ADFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP----VDLWGAGCIMAEMWTRSPIM 176
           F   K+        +V T  Y  PE+L G  N+       +D++  G ++ E+ +R    
Sbjct: 181 FEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238
Query: 177 QGNTEQ 182
            G  ++
Sbjct: 239 DGPVDE 244

>pdb|2GU8|A Chain A, Discovery Of 2-pyrimidyl-5-amidothiophenes As Novel And Potent Inhibitors For Akt: Synthesis And Sar Studies Length = 337

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 44/166 (26%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 76  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 132
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 133 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDEQGYIQVTDFGFAKRVK------ 179
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 180 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 223

>pdb|3BEG|A Chain A, Crystal Structure Of Sr Protein Kinase 1 Complexed To Its Substrate AsfSF2 Length = 381

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 55/245 (22%), Positives = 103/245 (42%), Gaps = 63/245 (25%)
Query: 9   TALREIKILQLLKH--------ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG- 59
           TAL EI++L+ +++        E VV L++  +          +   +VF+   H L   
Sbjct: 63  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVN----GTHICMVFEVLGHHLLKW 118
Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLIT------------- 105
           ++ + +    L  +KK+IQQ+L GL Y+H+  +I+H D+K  N+L++             
Sbjct: 119 IIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEA 178
Query: 106 ----KTGILKLADFGLARAFSQTKNGQVN-------------------------RYTNRV 136
               ++G    +   ++ A +   N  VN                          +T  +
Sbjct: 179 TEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNACWVHKHFTEDI 238
Query: 137 VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT------EQQQITLISQ 190
            T  YR  E+L+G   Y  P D+W   C+  E+ T   + + ++      ++  I LI +
Sbjct: 239 QTRQYRSLEVLIGS-GYNTPADIWSTACMAFELATGDYLFEPHSGEEYTRDEDHIALIIE 297
Query: 191 LCGSI 195
           L G +
Sbjct: 298 LLGKV 302

>pdb|1CMK|E Chain E, Crystal Structures Of The Myristylated Catalytic Subunit Of Camp- Dependent Protein Kinase Reveal Open And Closed Conformations Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3DND|A Chain A, Camp-Dependent Protein Kinase Pka Catalytic Subunit With Pki-5-24 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 1e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4AE6|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit Calpha 2 Length = 343

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 129 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 181
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 182 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|1CDK|A Chain A, Camp-Dependent Protein Kinase Catalytic Subunit (E.C.2.7.1.37) (Protein Kinase A) Complexed With Protein Kinase Inhibitor Peptide Fragment 5-24 (Pki(5-24) Isoelectric Variant Ca) And Mn2+ Adenylyl Imidodiphosphate (Mnamp-Pnp) At Ph 5.6 And 7c And 4c Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3NX8|A Chain A, Human Camp Dependent Protein Kinase In Complex With Phenol Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SVH|A Chain A, Crystal Structure Of Protein Kinase A In Complex With Azepane Derivative 8 Length = 350

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|3AGL|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-1039 Length = 351

Iteration: 1
 Score = 50.8 bits (120), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|3AGM|A Chain A, Complex Of Pka With The Bisubstrate Protein Kinase Inhibitor Arc-670 Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1CTP|E Chain E, Structure Of The Mammalian Catalytic Subunit Of Camp-Dependent Protein Kinase And An Inhibitor Peptide Displays An Open Conformation Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1STC|E Chain E, Camp-Dependent Protein Kinase, Alpha-Catalytic Subunit In Complex With Staurosporine Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2C1A|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With Isoquinoline-5-Sulfonic Acid (2-(2-(4-Chlorobenzyloxy) Ethylamino)ethyl)amide Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 137 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 189
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1B6C|B Chain B, Crystal Structure Of The Cytoplasmic Domain Of The Type I Tgf-Beta Receptor In Complex With Fkbp12 Length = 342

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 82  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 137
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 138 VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 196
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 197 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 256

>pdb|3PFQ|A Chain A, Crystal Structure And Allosteric Activation Of Protein Kinase C Beta Ii Length = 674

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 30/105 (28%), Positives = 53/105 (50%), Gaps = 5/105 (4%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           ++  GL+++ S  I++RD+K  NV++   G +K+ADFG+ +      +G   +      T
Sbjct: 450 EIAIGLFFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCK--ENIWDGVTTKXF--CGT 505
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
             Y  PE ++  + YG  VD W  G ++ EM       +G  E +
Sbjct: 506 PDYIAPE-IIAYQPYGKSVDWWAFGVLLYEMLAGQAPFEGEDEDE 549

>pdb|3MVJ|A Chain A, Human Cyclic Amp-Dependent Protein Kinase Pka Inhibitor Complex Length = 371

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/116 (28%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A
Sbjct: 157 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFA 209
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 210 KRVK-------GRTWXLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|2UVY|A Chain A, Structure Of Pka-pkb Chimera Complexed With Methyl-(4-(9h- Purin-6-yl)-benzyl)-amine Length = 351

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N++I + G +K+ DFG A+           R      T
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------GRTWXLCGT 202
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 203 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SZM|A Chain A, Dual Binding Mode Of Bisindolylmaleimide 2 To Protein Kinase A (Pka) Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N++I + G +K+ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLMIDQQGYIKVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1RDQ|E Chain E, Hydrolysis Of Atp In The Crystal Of Y204a Mutant Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 28/170 (16%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------- 189
Query: 129 VNRYTNRVVTLWYRP----PELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R   R   L   P    PE++L  + Y   VD W  G ++ EM    P
Sbjct: 190 --RVKGRTWXLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2HEN|A Chain A, Crystal Structure Of The Ephb2 Receptor Kinase Domain In Complex With Adp Length = 286

Iteration: 1
 Score = 50.4 bits (119), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 37/162 (22%), Positives = 73/162 (45%), Gaps = 13/162 (8%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H NV+HL E   TK+       +   ++ +F E+  L   L     +F+
Sbjct: 56  LSEASIMGQFDHPNVIHL-EGVVTKS-------TPVMIITEFMENGSLDSFLRQNDGQFT 107
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ- 128
           + ++  +++ +  G+ Y+     +HR + A N+L+    + K++DFGL+R      +   
Sbjct: 108 VIQLVGMLRGIAAGMKYLADMNYVHRALAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 167
Query: 129 -VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             +    ++   W  P  +    R +    D+W  G +M E+
Sbjct: 168 YTSALGGKIPIRWTAPEAIQY--RKFTSASDVWSYGIVMWEV 207

>pdb|3KN5|A Chain A, Crystal Structure Of The C-Terminal Kinase Domain Of Msk1 In With Amp-Pnp Length = 325

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 47/166 (28%), Positives = 74/166 (44%), Gaps = 21/166 (12%)
Query: 12  REIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--F 68
           +EI  L+L + H N+V L E+   + + +        LV +    +   L   I  K  F
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLHTF--------LVMELL--NGGELFERIKKKKHF 103
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTK 125
           S  E   ++++L++ + ++H   ++HRD+K  N+L T       +K+ DFG AR     K
Sbjct: 104 SETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFAR----LK 159
Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                       TL Y  PE LL    Y    DLW  G I+  M +
Sbjct: 160 PPDNQPLKTPCFTLHYAAPE-LLNQNGYDESCDLWSLGVILYTMLS 204

>pdb|1PY5|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Inhibitor Length = 326

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 69  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 124
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 125 VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 183
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 184 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 243

>pdb|2VWU|A Chain A, Ephb4 Kinase Domain Inhibitor Complex Length = 302

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 33/164 (20%), Positives = 73/164 (44%), Gaps = 13/164 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           L E  I+   +H N++ L  +                ++ +F E+  L   L     +F+
Sbjct: 65  LSEASIMGQFEHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFT 116
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG-- 127
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFGL+R   +  +   
Sbjct: 117 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEENSSDPT 176
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           + +    ++   W  P  +    R +    D W  G +M E+ +
Sbjct: 177 ETSSLGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEVMS 218

>pdb|3PVB|A Chain A, Crystal Structure Of (73-244)ria:c Holoenzyme Of Camp-Dependent Protein Kinase Length = 345

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 144 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 196
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 197 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 231

>pdb|1APM|E Chain E, 2.0 Angstrom Refined Crystal Structure Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Complexed With A Peptide Inhibitor And Detergent Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  +  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFAEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4DFX|E Chain E, Crystal Structure Of Myristoylated K7c Catalytic Subunit Of Camp- Dependent Protein Kinase In Complex With Sp20 And Amp-Pnp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 2e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1RW8|A Chain A, Crystal Structure Of Tgf-Beta Receptor I Kinase With Atp Site Inhibitor Length = 301

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 44  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 99
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 100 VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 158
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 159 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 218

>pdb|1L3R|E Chain E, Crystal Structure Of A Transition State Mimic Of The Catalytic Subunit Of Camp-Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QCS|A Chain A, A Complex Structure Between The Catalytic And Regulatory Subunit Of Protein Kinase A That Represents The Inhibited State Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|4AE9|A Chain A, Structure And Function Of The Human Sperm-specific Isoform Of Protein Kinase A (pka) Catalytic Subunit C Alpha 2 Length = 343

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 142 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 194
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 195 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 229

>pdb|4DFY|A Chain A, Crystal Structure Of R194a Mutant Of Camp-Dependent Protein Kinase With Unphosphorylated Activation Loop Length = 371

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 45/170 (26%), Positives = 72/170 (42%), Gaps = 28/170 (16%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 110 LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 166
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 167 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK--------- 210
Query: 129 VNRYTNRVVTLW----YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      TL     Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 211 --RVKGATWTLCGTPEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1Q24|A Chain A, Pka Double Mutant Model Of Pkb In Complex With Mgatp Length = 350

Iteration: 1
 Score = 50.1 bits (118), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 32/116 (27%), Positives = 52/116 (44%), Gaps = 15/116 (12%)
Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLA 118
           G  S  H +F   +I    +       Y+HS  +++RD+K  N++I + G +++ DFG A
Sbjct: 136 GRFSEPHARFYAAQIVLTFE-------YLHSLDLIYRDLKPENLMIDQQGYIQVTDFGFA 188
Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +           R      T  Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 189 KRVK-------GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1VJY|A Chain A, Crystal Structure Of A Naphthyridine Inhibitor Of Human Tgf- Beta Type I Receptor Length = 303

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 43  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 98
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 99  VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 157
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 158 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 217

>pdb|2JDS|A Chain A, Structure Of Camp-Dependent Protein Kinase Complexed With A- 443654 Length = 351

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 150 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 202
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 203 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 237

>pdb|1SYK|A Chain A, Crystal Structure Of E230q Mutant Of Camp-Dependent Protein Kinase Reveals Unexpected Apoenzyme Conformation Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE++L  + Y   VD W  G ++ +M    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIILS-KGYNKAVDWWALGVLIYQMAAGYP 236

>pdb|1Q8W|A Chain A, The Catalytic Subunit Of Camp-Dependent Protein Kinase In Complex With Rho-Kinase Inhibitor Fasudil (Ha-1077) Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2WOT|A Chain A, Alk5 In Complex With 4-((5,6-Dimethyl-2-(2-Pyridyl)-3- Pyridyl)oxy)-N-(3,4,5-Trimethoxyphenyl)pyridin-2-Amine Length = 306

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 46  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 101
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 102 VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 160
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 161 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 220

>pdb|3TZM|A Chain A, Tgf-Beta Receptor Type 1 In Complex With Sb431542 Length = 309

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 50/180 (27%), Positives = 76/180 (42%), Gaps = 20/180 (11%)
Query: 11  LREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            RE +I Q  +L+HEN++  I       N+ N   +  +LV D+ EH       N +   
Sbjct: 49  FREAEIYQTVMLRHENILGFI----AADNKDNGTWTQLWLVSDYHEHGSLFDYLNRYTVT 104
Query: 69  SLGEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARA 120
             G IK  +    +GL ++H           I HRD+K+ N+L+ K G   +AD GLA  
Sbjct: 105 VEGMIKLALSTA-SGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVR 163
Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG-----PPVDLWGAGCIMAEMWTRSPI 175
                +       +RV T  Y  PE+L    N          D++  G +  E+  R  I
Sbjct: 164 HDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSI 223

>pdb|4DG3|E Chain E, Crystal Structure Of R336a Mutant Of Camp-dependent Protein Kinase With Unphosphorylated Turn Motif Length = 371

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 170 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 222
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 223 PEYLAPEIIL-SKGYNKAVDWWALGVLIYEMAAGYP 257

>pdb|1XH7|A Chain A, Crystal Structures Of Protein Kinase B Selective Inhibitors In Complex With Protein Kinase A And Mutants Length = 350

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 29/96 (30%), Positives = 47/96 (48%), Gaps = 8/96 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+           R      T
Sbjct: 149 QIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK-------GRTWXLCGT 201
Query: 139 LWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             Y  PE++L  + Y   VD W  G ++ EM    P
Sbjct: 202 PEYLAPEIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|2QKW|B Chain B, Structural Basis For Activation Of Plant Immunity By Bacterial Effector Protein Avrpto Length = 321

Iteration: 1
 Score = 49.7 bits (117), Expect = 3e-06,   Method: Compositional matrix adjust.
 Identities = 28/96 (29%), Positives = 52/96 (54%), Gaps = 4/96 (4%)
Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
           GL+Y+H+  I+HRD+K+ N+L+ +  + K+ DFG+++  ++     +        TL Y 
Sbjct: 151 GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQTHLXXVVKG--TLGYI 208
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAE-MWTRSPIMQ 177
            PE  +  R      D++  G ++ E +  RS I+Q
Sbjct: 209 DPEYFIKGR-LTEKSDVYSFGVVLFEVLCARSAIVQ 243

>pdb|1YHS|A Chain A, Crystal Structure Of Pim-1 Bound To Staurosporine Length = 273

Iteration: 1
 Score = 49.7 bits (117), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 118 QVLEAVRHCHNXGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 171
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|2ZM3|A Chain A, Complex Structure Of Insulin-Like Growth Factor Receptor And Isoquinolinedione Inhibitor Length = 308

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 189
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 190 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|1YXS|A Chain A, Crystal Structure Of Kinase Pim1 With P123m Mutation Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 175
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 207

>pdb|3O7L|B Chain B, Crystal Structure Of Phospholamban (1-19):pka C-Subunit:amp-Pnp:mg2+ Complex Length = 350

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 42/166 (25%), Positives = 71/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N++I + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLIIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  PE+++  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPEIIIS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1YWV|A Chain A, Crystal Structures Of Proto-Oncogene Kinase Pim1: A Target Of Aberrant Somatic Hypermutations In Diffuse Large Cell Lymphoma Length = 293

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 122 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 175
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 176 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 207

>pdb|4DTK|A Chain A, Novel And Selective Pan-Pim Kinase Inhibitor Length = 276

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 121 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 174
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 175 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 206

>pdb|3C4E|A Chain A, Pim-1 Kinase Domain In Complex With 3-Aminophenyl-7- Azaindole Length = 273

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 171
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|3JXW|A Chain A, Discovery Of 3h-Benzo[4,5]thieno[3,2-D]pyrimidin-4-Ones As Potent, Highly Selective And Orally Bioavailable Pim Kinases Inhibitors Length = 294

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 176
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|4ALU|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 218
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|3UIX|A Chain A, Crystal Structure Of Pim1 Kinase In Complex With Small Molecule Inhibitor Length = 298

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 176
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|1K3A|A Chain A, Structure Of The Insulin-Like Growth Factor 1 Receptor Kinase Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 121 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIXETDXXR 180
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 181 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 220

>pdb|4AW5|A Chain A, Complex Of The Ephb4 Kinase Domain With An Oxindole Inhibitor Length = 291

Iteration: 1
 Score = 49.3 bits (116), Expect = 4e-06,   Method: Compositional matrix adjust.
 Identities = 36/164 (21%), Positives = 73/164 (44%), Gaps = 17/164 (10%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
           L E  I+   +H N++ L  +                ++ +F E+  L   L     +F+
Sbjct: 63  LSEASIMGQFEHPNIIRLEGVVTNSM--------PVMILTEFMENGALDSFLRLNDGQFT 114
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+L+    + K++DFGL+R   +  N   
Sbjct: 115 VIQLVGMLRGIASGMRYLAEMSYVHRDLAARNILVNSNLVCKVSDFGLSRFLEE--NSSD 172
Query: 130 NRYTN----RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
             YT+    ++   W  P  +    R +    D W  G +M E+
Sbjct: 173 PTYTSSLGGKIPIRWTAPEAIAF--RKFTSASDAWSYGIVMWEV 214

>pdb|3R00|A Chain A, The Discovery Of Novel Benzofuran-2-Carboxylic Acids As Potent Pim-1 Inhibitors Length = 299

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 123 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 176
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 177 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 208

>pdb|4G3F|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) Bound To A 2-(aminothiazoly)phenol (cmp2) Length = 336

Iteration: 1
 Score = 49.3 bits (116), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNR 135
           + Q L GL Y+H+ +ILH D+KA NVL++  G    L DFG A        G+     + 
Sbjct: 156 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 215
Query: 136 V-VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           +  T  +  PE+++G +     VD+W + C+M  M
Sbjct: 216 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHM 249

>pdb|4AS0|A Chain A, Cyclometalated Phthalimides As Protein Kinase Inhibitors Length = 273

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 118 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 171
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 172 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 203

>pdb|4G3C|A Chain A, Crystal Structure Of Apo Murine Nf-kappab Inducing Kinase (nik) Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNR 135
           + Q L GL Y+H+ +ILH D+KA NVL++  G    L DFG A        G+     + 
Sbjct: 172 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 231
Query: 136 V-VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           +  T  +  PE+++G +     VD+W + C+M  M
Sbjct: 232 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHM 265

>pdb|1XQZ|A Chain A, Crystal Structure Of Hpim-1 Kinase At 2.1 A Resolution Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 190
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 222

>pdb|4G3G|A Chain A, Crystal Structure Of Murine Nf-kappab Inducing Kinase (nik) V408l Bound To A 2-(aminothiazolyl)phenol (cmp3) Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 32/95 (33%), Positives = 50/95 (52%), Gaps = 3/95 (3%)
Query: 77  IQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNR 135
           + Q L GL Y+H+ +ILH D+KA NVL++  G    L DFG A        G+     + 
Sbjct: 170 LGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDY 229
Query: 136 V-VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           +  T  +  PE+++G +     VD+W + C+M  M
Sbjct: 230 IPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHM 263

>pdb|3F2A|A Chain A, Crystal Structure Of Human Pim-1 In Complex With Dappa Length = 300

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 137 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 190
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 191 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 222

>pdb|2XJ0|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-4 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 191
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|2XIY|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-2 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 191
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|2Y4I|B Chain B, Ksr2-Mek1 Heterodimer Length = 319

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 30/126 (23%), Positives = 63/126 (50%), Gaps = 13/126 (10%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSL 70
           RE+   +  +HENVV  +  C +  +          ++   C+   L  ++ +  +   +
Sbjct: 78  REVMAYRQTRHENVVLFMGACMSPPH--------LAIITSLCKGRTLYSVVRDAKIVLDV 129
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            + +++ Q+++ G+ Y+H+  ILH+D+K+ NV     G + + DFGL   FS +   Q  
Sbjct: 130 NKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYD-NGKVVITDFGL---FSISGVLQAG 185
Query: 131 RYTNRV 136
           R  +++
Sbjct: 186 RREDKL 191

>pdb|1A06|A Chain A, Calmodulin-Dependent Protein Kinase From Rat Length = 332

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L  +KH N+V L +I  +  +         YL+          L   I  K  ++ 
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGH--------LYLIMQLVSG--GELFDRIVEKGFYTE 115
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL---ITKTGILKLADFGLARAFSQTKNG 127
            +  ++I Q+L+ + Y+H   I+HRD+K  N+L   + +   + ++DFGL++       G
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPG 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
            V   +    T  Y  PE +L  + Y   VD W  G I
Sbjct: 173 SV--LSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVI 207

>pdb|4FG7|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-293 In Complex With Atp Length = 293

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L  +KH N+V L +I  +  +         YL+          L   I  K  ++ 
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGH--------LYLIMQLVSG--GELFDRIVEKGFYTE 115
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL---ITKTGILKLADFGLARAFSQTKNG 127
            +  ++I Q+L+ + Y+H   I+HRD+K  N+L   + +   + ++DFGL++       G
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPG 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
            V   +    T  Y  PE +L  + Y   VD W  G I
Sbjct: 173 SV--LSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVI 207

>pdb|1M7N|A Chain A, Crystal Structure Of Unactivated Apo Insulin-Like Growth Factor-1 Receptor Kinase Domain Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 196 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|1XWS|A Chain A, Crystal Structure Of The Human Pim1 Kinase Domain Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 203
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|4A7C|A Chain A, Crystal Structure Of Pim1 Kinase With Etp46546 Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 145 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 198
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 199 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 230

>pdb|4FG8|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-315 In Complex With Atp Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L  +KH N+V L +I  +  +         YL+          L   I  K  ++ 
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGH--------LYLIMQLVSG--GELFDRIVEKGFYTE 115
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL---ITKTGILKLADFGLARAFSQTKNG 127
            +  ++I Q+L+ + Y+H   I+HRD+K  N+L   + +   + ++DFGL++       G
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPG 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
            V   +    T  Y  PE +L  + Y   VD W  G I
Sbjct: 173 SV--LSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVI 207

>pdb|4ALV|A Chain A, Benzofuropyrimidinone Inhibitors Of Pim-1 Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 218
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|3CXW|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Beta Carboline Ligand I Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 204
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|2XIX|A Chain A, Protein Kinase Pim-1 In Complex With Fragment-1 From Crystallographic Fragment Screen Length = 301

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 138 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 191
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 192 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 223

>pdb|1P4O|A Chain A, Structure Of Apo Unactivated Igf-1r Kinase Domain At 1.5a Resolution. Length = 322

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 136 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 195
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 196 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 235

>pdb|3O23|A Chain A, Human Unphosphorylated Igf1-R Kinase Domain In Complex With An Hydantoin Inhibitor Length = 305

Iteration: 1
 Score = 48.9 bits (115), Expect = 5e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 127 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 186
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 187 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 226

>pdb|3JPV|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Pyrrolo[2,3- A]carbazole Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 204
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3DCV|A Chain A, Crystal Structure Of Human Pim1 Kinase Complexed With 4-(4- Hydroxy-3-Methyl-Phenyl)-6-Phenylpyrimidin-2(1h)-One Length = 328

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 165 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 218
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 219 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 250

>pdb|1JQH|A Chain A, Igf-1 Receptor Kinase Domain Length = 308

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 130 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 189
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 190 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 229

>pdb|2BIL|B Chain B, The Human Protein Kinase Pim1 In Complex With Its Consensus Peptide Pimtide Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 203
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|2BIK|B Chain B, Human Pim1 Phosphorylated On Ser261 Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 203
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|3MA3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And A Naphtho-Difuran Ligand Length = 313

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 204
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|3CY3|A Chain A, Crystal Structure Of Human Proto-Oncogene Serine Threonine Kinase (Pim1) In Complex With A Consensus Peptide And The Jnk Inhibitor V Length = 314

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 151 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 204
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 205 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 236

>pdb|2OJ9|A Chain A, Structure Of Igf-1r Kinase Domain Complexed With A Benzimidazole Inhibitor Length = 307

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 189 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|2J2I|B Chain B, Crystal Structure Of The Humab Pim1 In Complex With Ly333531 Length = 312

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 150 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 203
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 204 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 235

>pdb|3A99|A Chain A, Structure Of Pim-1 Kinase Crystallized In The Presence Of P27kip1 Carboxy-Terminal Peptide Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 157 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 210
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 211 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 242

>pdb|3QAM|E Chain E, Crystal Structure Of Glu208ala Mutant Of Catalytic Subunit Of Camp- Dependent Protein Kinase Length = 350

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/166 (25%), Positives = 70/166 (42%), Gaps = 20/166 (12%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFD--FCEHDLAGLLSNIHVKF 68
           L E +ILQ +   N   L+++  +  +  N Y    Y+     F      G  S  H +F
Sbjct: 89  LNEKRILQAV---NFPFLVKLEFSFKDNSNLYMVMEYVAGGEMFSHLRRIGRFSEPHARF 145
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              +I    +       Y+HS  +++RD+K  N+LI + G +++ DFG A+         
Sbjct: 146 YAAQIVLTFE-------YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVK------ 192
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
             R      T  Y  P ++L  + Y   VD W  G ++ EM    P
Sbjct: 193 -GRTWXLCGTPEYLAPAIILS-KGYNKAVDWWALGVLIYEMAAGYP 236

>pdb|1XKK|A Chain A, Egfr Kinase Domain Complexed With A Quinazoline Inhibitor- Gw572016 Length = 352

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 90  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 144
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 145 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 199
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 200 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 257
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 258 EK-GERLPQ--PPICTIDVYMIM 277

>pdb|3I81|A Chain A, Crystal Structure Of Insulin-Like Growth Factor 1 Receptor (Igf-1r-Wt) Complex With Bms-754807 [1-(4-((5-Cyclopropyl- 1h-Pyrazol-3-Yl)amino)pyrrolo[2,1-F][1,2, 4]triazin-2-Yl)-N- (6-Fluoro-3-Pyridinyl)-2-Methyl-L-Prolinamide] Length = 315

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 129 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 188
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 189 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 228

>pdb|4FG9|A Chain A, Crystal Structure Of Human Calcium/calmodulin-dependent Protein Kinase I 1-320 In Complex With Atp Length = 320

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/158 (27%), Positives = 72/158 (45%), Gaps = 21/158 (13%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--FSL 70
           EI +L  +KH N+V L +I  +  +         YL+          L   I  K  ++ 
Sbjct: 66  EIAVLHKIKHPNIVALDDIYESGGH--------LYLIMQLVSG--GELFDRIVEKGFYTE 115
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL---ITKTGILKLADFGLARAFSQTKNG 127
            +  ++I Q+L+ + Y+H   I+HRD+K  N+L   + +   + ++DFGL++       G
Sbjct: 116 RDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSK---MEDPG 172
Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
            V   +    T  Y  PE +L  + Y   VD W  G I
Sbjct: 173 SV--LSTACGTPGYVAPE-VLAQKPYSKAVDCWSIGVI 207

>pdb|3LVP|A Chain A, Crystal Structure Of Bisphosphorylated Igf1-R Kinase Domain (2p) In Complex With A Bis-Azaindole Inhibitor Length = 336

Iteration: 1
 Score = 48.9 bits (115), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 158 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 217
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 218 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 257

>pdb|3LW0|A Chain A, Igf-1rk In Complex With Ligand Msc1609119a-1 Length = 304

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 126 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 185
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 186 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 225

>pdb|2X4F|A Chain A, The Crystal Structure Of The Human Myosin Light Chain Kinase Loc340156. Length = 373

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 43/162 (26%), Positives = 75/162 (46%), Gaps = 29/162 (17%)
Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN--IHVKFSL 70
           EI ++  L H N++ L +   +K +          LV ++ +    G L +  I   ++L
Sbjct: 136 EISVMNQLDHANLIQLYDAFESKND--------IVLVMEYVD---GGELFDRIIDESYNL 184
Query: 71  GEIKKVI--QQLLNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARAFSQTKN 126
            E+  ++  +Q+  G+ ++H   ILH D+K  N+L        +K+ DFGLAR +   + 
Sbjct: 185 TELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPREK 244
Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNY---GPPVDLWGAGCI 165
            +VN  T       +  PE++    NY     P D+W  G I
Sbjct: 245 LKVNFGTPE-----FLAPEVV----NYDFVSFPTDMWSVGVI 277

>pdb|3QQU|A Chain A, Cocrystal Structure Of Unphosphorylated Igf With Pyrimidine 8 Length = 301

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 55/107 (51%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R   +T    
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 183 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 222

>pdb|1M14|A Chain A, Tyrosine Kinase Domain From Epidermal Growth Factor Receptor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 71  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 125
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 126 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 180
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 181 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 238
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 239 EK-GERLPQ--PPICTIDVYMIM 258

>pdb|2OBJ|A Chain A, Crystal Structure Of Human Pim-1 Kinase In Complex With Inhibitor Length = 333

Iteration: 1
 Score = 48.5 bits (114), Expect = 6e-06,   Method: Compositional matrix adjust.
 Identities = 31/92 (33%), Positives = 45/92 (48%), Gaps = 7/92 (7%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVV 137
           Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T       YT+   
Sbjct: 170 QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTV------YTDFDG 223
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM 169
           T  Y PPE +   R +G    +W  G ++ +M
Sbjct: 224 TRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM 255

>pdb|2RFD|A Chain A, Crystal Structure Of The Complex Between The Egfr Kinase Domain And A Mig6 Peptide Length = 324

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 62  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 116
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 117 L----NWCVQIAEGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 171
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 172 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 229
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 230 EK-GERLPQ--PPICTIDVYMIM 249

>pdb|4I23|A Chain A, Crystal Structure Of The Wild-type Egfr Kinase Domain In Complex With Dacomitinib (soaked) Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 121
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 122 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 176
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 177 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 235 EK-GERLPQ--PPICTIDVYMIM 254

>pdb|4HJO|A Chain A, Crystal Structure Of The Inactive Egfr Tyrosine Kinase Domain With Erlotinib Length = 337

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 75  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 129
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 130 LN----WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 184
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 185 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 242
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 243 EK-GERLPQ--PPICTIDVYMIM 262

>pdb|3IKA|A Chain A, Crystal Structure Of Egfr 696-1022 T790m Mutant Covalently Binding To Wz4002 Length = 331

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 69  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 123
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 124 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 178
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 179 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 236
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 237 EK-GERLPQ--PPICTIDVYMIM 256

>pdb|2JIU|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Complex With Aee788 Length = 328

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 120
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 121 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 175
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 176 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 234 EK-GERLPQ--PPICTIDVYMIM 253

>pdb|3BEL|A Chain A, X-Ray Structure Of Egfr In Complex With Oxime Inhibitor Length = 315

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 113
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 114 LN----WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 168
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 169 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 226
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 227 EK-GERLPQ--PPICTIDVYMIM 246

>pdb|1FOT|A Chain A, Structure Of The Unliganded Camp-Dependent Protein Kinase Catalytic Subunit From Saccharomyces Cerevisiae Length = 318

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 30/99 (30%), Positives = 46/99 (46%), Gaps = 9/99 (9%)
Query: 83  GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR 142
            L Y+HS  I++RD+K  N+L+ K G +K+ DFG A+                  T  Y 
Sbjct: 118 ALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVTYXLCG-------TPDYI 170
Query: 143 PPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNT 180
            PE ++  + Y   +D W  G ++ EM    +P    NT
Sbjct: 171 APE-VVSTKPYNKSIDWWSFGILIYEMLAGYTPFYDSNT 208

>pdb|2ITN|A Chain A, Crystal Structure Of Egfr Kinase Domain G719s Mutation In Complex With Amp-Pnp Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 120 LN----WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 233 EK-GERLPQ--PPICTIDVYMIM 252

>pdb|2J5F|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 34-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 120 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 233 EK-GERLPQ--PPICTIDVYMIM 252

>pdb|2GS7|A Chain A, Crystal Structure Of The Inactive Egfr Kinase Domain In Complex With Amp-Pnp Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 123 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 177
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 178 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 236 EK-GERLPQ--PPICTIDVYMIM 255

>pdb|4G5J|A Chain A, Crystal Structure Of Egfr Kinase In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 123 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 177
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 178 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 236 EK-GERLPQ--PPICTIDVYMIM 255

>pdb|4I24|A Chain A, Structure Of T790m Egfr Kinase Domain Co-crystallized With Dacomitinib Length = 329

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 67  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 121
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 122 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 176
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 177 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 234
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 235 EK-GERLPQ--PPICTIDVYMIM 254

>pdb|2JIT|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 120 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 233 EK-GERLPQ--PPICTIDVYMIM 252

>pdb|2GS2|A Chain A, Crystal Structure Of The Active Egfr Kinase Domain Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 7e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 123 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 177
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 178 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 236 EK-GERLPQ--PPICTIDVYMIM 255

>pdb|4G5P|A Chain A, Crystal Structure Of Egfr Kinase T790m In Complex With Bibw2992 Length = 330

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 68  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 122
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 123 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 177
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 178 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 235
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 236 EK-GERLPQ--PPICTIDVYMIM 255

>pdb|2EB2|A Chain A, Crystal Structure Of Mutated Egfr Kinase Domain (G719s) Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 127 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 182 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 240 EK-GERLPQ--PPICTIDVYMIM 259

>pdb|2J5E|A Chain A, Crystal Structure Of Egfr Kinase Domain In Complex With An Irreversible Inhibitor 13-Jab Length = 327

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGXLLDYVREHK-----DNIGSQYL 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 120 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 233 EK-GERLPQ--PPICTIDVYMIM 252

>pdb|3VJO|A Chain A, Crystal Structure Of The Wild-Type Egfr Kinase Domain In Complex With Amppnp Length = 334

Iteration: 1
 Score = 48.5 bits (114), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 127 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 182 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 240 EK-GERLPQ--PPICTIDVYMIM 259

>pdb|3UG1|A Chain A, Crystal Structure Of The Mutated Egfr Kinase Domain (G719sT790M) IN The Apo Form Length = 334

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 72  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGCLLDYVREHK-----DNIGSQYL 126
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 127 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 181
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 182 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 239
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 240 EK-GERLPQ--PPICTIDVYMIM 259

>pdb|2JIV|A Chain A, Crystal Structure Of Egfr Kinase Domain T790m Mutation In Compex With Hki-272 Length = 328

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 66  LDEAYVMASVDNPHVCRLLGICLTSTVQLIMQLMPFGXLLDYVREHK-----DNIGSQYL 120
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 121 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 175
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 176 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 233
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 234 EK-GERLPQ--PPICTIDVYMIM 253

>pdb|2H34|A Chain A, Apoenzyme Crystal Structure Of The Tuberculosis SerineTHREONINE Kinase, Pkne Length = 309

Iteration: 1
 Score = 48.1 bits (113), Expect = 8e-06,   Method: Compositional matrix adjust.
 Identities = 32/104 (30%), Positives = 53/104 (50%), Gaps = 4/104 (3%)
Query: 76  VIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           +++Q+ + L   H+    HRD+K  N+L++      L DFG+A A +  K  Q+    N 
Sbjct: 139 IVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQLG---NT 195
Query: 136 VVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           V TL+Y  PE    + +     D++   C++ E  T SP  QG+
Sbjct: 196 VGTLYYXAPE-RFSESHATYRADIYALTCVLYECLTGSPPYQGD 238

>pdb|2R5T|A Chain A, Crystal Structure Of Inactive Serum And Glucocorticoid- Regulated Kinase 1 In Complex With Amp-Pnp Length = 373

Iteration: 1
 Score = 48.1 bits (113), Expect = 9e-06,   Method: Compositional matrix adjust.
 Identities = 38/123 (30%), Positives = 62/123 (50%), Gaps = 11/123 (8%)
Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV- 137
           ++ + L Y+HS  I++RD+K  N+L+   G + L DFGL +     +N + N  T+    
Sbjct: 147 EIASALGYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCK-----ENIEHNSTTSTFCG 201
Query: 138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-WTRSPIMQGNTEQQQITLIS---QLCG 193
           T  Y  PE +L  + Y   VD W  G ++ EM +   P    NT +    +++   QL  
Sbjct: 202 TPEYLAPE-VLHKQPYDRTVDWWCLGAVLYEMLYGLPPFYSRNTAEMYDNILNKPLQLKP 260
Query: 194 SIT 196
           +IT
Sbjct: 261 NIT 263

>pdb|3LZB|A Chain A, Egfr Kinase Domain Complexed With An Imidazo[2,1-B]thiazole Inhibitor Length = 327

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 119
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 120 L----NWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 174
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 175 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 232
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 233 EK-GERLPQ--PPICTIDVYMIM 252

>pdb|3GOP|A Chain A, Crystal Structure Of The Egf Receptor Juxtamembrane And Kinase Domains Length = 361

Iteration: 1
 Score = 48.1 bits (113), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 50/203 (24%), Positives = 86/203 (42%), Gaps = 16/203 (7%)
Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFC-EHDLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T   Q       F  + D+  EH       NI  ++ 
Sbjct: 99  LDEAYVMASVDNPHVCRLLGICLTSTVQLITQLMPFGCLLDYVREHK-----DNIGSQYL 153
Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L        Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +  + 
Sbjct: 154 LN----WCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG-AEEKEY 208
Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
           +    +V   W     +L   R Y    D+W  G  + E+ T            +I+ I 
Sbjct: 209 HAEGGKVPIKWMALESIL--HRIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSIL 266
Query: 190 QLCGSITPESWPGVETLDLYNKM 212
           +  G   P+  P + T+D+Y  M
Sbjct: 267 EK-GERLPQ--PPICTIDVYMIM 286

>pdb|1TKI|A Chain A, Autoinhibited Serine Kinase Domain Of The Giant Muscle Protein Titin Length = 321

Iteration: 1
 Score = 47.8 bits (112), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 49/224 (21%), Positives = 94/224 (41%), Gaps = 39/224 (17%)
Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           +EI IL + +H N++HL E   +             ++F+F    D+   ++    + + 
Sbjct: 50  KEISILNIARHRNILHLHESFESMEE--------LVMIFEFISGLDIFERINTSAFELNE 101
Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL--ITKTGILKLADFGLARAFSQTKNGQ 128
            EI   + Q+   L ++HS+ I H D++  N++    ++  +K+ +FG AR   Q K G 
Sbjct: 102 REIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQAR---QLKPGD 158
Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPV----------DLWGAGCIMAEMWTRSPIMQG 178
             R       L +  PE       Y P V          D+W  G ++  + +       
Sbjct: 159 NFR-------LLFTAPEY------YAPEVHQHDVVSTATDMWSLGTLVYVLLSGINPFLA 205
Query: 179 NTEQQQITLISQLCGSITPESWP--GVETLDLYNKMELPKAQKR 220
            T QQ I  I     +   E++    +E +D  +++ + + + R
Sbjct: 206 ETNQQIIENIMNAEYTFDEEAFKEISIEAMDFVDRLLVKERKSR 249

>pdb|3D94|A Chain A, Crystal Structure Of The Insulin-Like Growth Factor-1 Receptor Kinase In Complex With Pqip Length = 301

Iteration: 1
 Score = 47.4 bits (111), Expect = 1e-05,   Method: Compositional matrix adjust.
 Identities = 28/107 (26%), Positives = 54/107 (50%), Gaps = 11/107 (10%)
Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT---- 124
           SL ++ ++  ++ +G+ Y+++NK +HRD+ A N  + +   +K+ DFG+ R   +T    
Sbjct: 123 SLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCXVAEDFTVKIGDFGMTRDIYETDYYR 182
Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           K G+       +   W  P    L D  +    D+W  G ++ E+ T
Sbjct: 183 KGGK-----GLLPVRWMSPES--LKDGVFTTYSDVWSFGVVLWEIAT 222
  Database: pdbaa

Structure Templates Detected by RPS-BLAST

Original result of RPS-BLAST against PDB70 database

ID	Length	Definition	E-value
Query	433
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-167
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	1e-24
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	1e-131
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	2e-12
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	1e-130
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	7e-13
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	1e-130
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	4e-13
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	1e-126
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	2e-11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	1e-122
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	7e-11
3niz_A	311	Rhodanese family protein; structural genomics, str	1e-120
3niz_A	311	Rhodanese family protein; structural genomics, str	2e-06
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	1e-119
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	3e-08
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	1e-118
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	3e-09
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	1e-118
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	7e-09
3o0g_A	292	Cell division protein kinase 5; kinase activator c	1e-117
3o0g_A	292	Cell division protein kinase 5; kinase activator c	9e-09
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	1e-117
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	3e-06
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	1e-116
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	4e-08
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-111
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	1e-11
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	9e-76
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	2e-04
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	3e-75
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	4e-68
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	6e-04
3rp9_A	458	Mitogen-activated protein kinase; structural genom	2e-67
3rp9_A	458	Mitogen-activated protein kinase; structural genom	3e-04
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	4e-67
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	6e-04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	7e-67
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	6e-04
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	1e-66
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	7e-04
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	7e-66
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	1e-65
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	9e-04
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	2e-65
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	6e-04
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	2e-65
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	8e-65
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	6e-04
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	9e-65
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	2e-63
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	1e-61
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	6e-04
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	9e-60
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	3e-59
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	3e-46
2a19_B	284	Interferon-induced, double-stranded RNA-activated	1e-44
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	2e-44
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	4e-44
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	2e-42
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	6e-04
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	6e-42
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	8e-42
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	3e-41
4apc_A	350	Serine/threonine-protein kinase NEK1; transferase;	8e-41
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	8e-41
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	5e-40
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	4e-04
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	9e-40
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	9e-39
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	8e-38
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	1e-37
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	7e-05
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	2e-37
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	3e-37
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	6e-37
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	6e-37
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	1e-36
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	2e-36
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	5e-36
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	5e-36
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	9e-36
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	9e-36
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	5e-35
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	4e-04
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	2e-34
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	3e-34
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	3e-34
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	4e-34
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	5e-34
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	8e-34
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	1e-33
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	2e-33
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	1e-04
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	2e-33
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	1e-04
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	3e-33
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	3e-33
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	1e-32
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	1e-32
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	3e-32
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	8e-04
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	3e-32
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	3e-32
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	7e-32
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	1e-31
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	2e-31
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	2e-31
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	3e-31
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	3e-31
3bhy_A	283	Death-associated protein kinase 3; death associate	4e-31
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	5e-31
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	6e-31
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	9e-31
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	1e-30
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	1e-30
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	1e-30
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	2e-30
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	2e-30
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	3e-30
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	6e-30
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	8e-30
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	2e-29
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	3e-29
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	3e-29
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	5e-29
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	5e-29
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	7e-29
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	9e-29
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	2e-28
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	6e-28
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	8e-28
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	9e-28
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	4e-27
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	4e-27
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	6e-27
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	9e-27
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	1e-26
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	1e-26
3q4u_A	301	Activin receptor type-1; structural genomics conso	2e-26
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	3e-26
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	4e-26
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	5e-26
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	6e-26
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	6e-26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	7e-26
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	9e-26
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	1e-25
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	2e-25
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	2e-25
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	4e-25
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	5e-25
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	6e-25
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	6e-25
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	1e-24
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	1e-24
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	3e-24
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	3e-24
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	2e-23
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	4e-23
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	7e-23
1uu3_A	310	HPDK1, 3-phosphoinositide dependent protein kinase	8e-23
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	1e-22
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	2e-22
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	2e-22
3soc_A	322	Activin receptor type-2A; structural genomics cons	2e-22
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	3e-22
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	3e-22
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	3e-22
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	5e-21
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	6e-21
3pvu_A	695	Beta-adrenergic receptor kinase 1; transferase, se	3e-20
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	3e-20
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	6e-20
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	6e-20
3ork_A	311	Serine/threonine protein kinase; structural genomi	8e-20
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	1e-19
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	2e-19
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	3e-19
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	3e-19
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	5e-19
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	8e-19
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	9e-19
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	9e-19
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	4e-18
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	5e-18
3aln_A	327	Dual specificity mitogen-activated protein kinase;	5e-18
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	6e-18
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	1e-17
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	1e-17
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	2e-17
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	2e-17
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	3e-17
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	3e-17
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	3e-17
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	3e-17
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	3e-17
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	3e-17
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	3e-17
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	3e-17
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	4e-17
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	4e-17
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	6e-17
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	8e-17
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	9e-17
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	1e-16
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	1e-16
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	1e-16
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	2e-16
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	2e-16
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	2e-16
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	2e-16
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	3e-16
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	3e-16
3g51_A	325	Ribosomal protein S6 kinase alpha-3; N-terminal ki	6e-16
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	6e-16
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	7e-16
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	8e-16
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	9e-16
3pls_A	298	Macrophage-stimulating protein receptor; protein k	1e-15
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	1e-15
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	2e-15
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	2e-15
2dyl_A	318	Dual specificity mitogen-activated protein kinase	3e-15
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	4e-15
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	4e-15
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	5e-15
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	7e-15
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	9e-15
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	1e-14
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	1e-14
3fme_A	290	Dual specificity mitogen-activated protein kinase;	1e-14
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	2e-14
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	2e-14
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	3e-14
3an0_A	340	Dual specificity mitogen-activated protein kinase;	4e-14
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	6e-14
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	8e-14
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	1e-13
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	1e-13
3v5q_A	297	NT-3 growth factor receptor; kinase domain, kinase	2e-13
4aoj_A	329	High affinity nerve growth factor receptor; transf	2e-13
3zzw_A	289	Tyrosine-protein kinase transmembrane receptor RO;	2e-13
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	2e-13
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	8e-13
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	8e-13
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	1e-12
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	2e-12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	2e-12
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	2e-12
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	3e-12
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	3e-12
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	3e-12
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	5e-12
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	8e-12
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	9e-12
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	3e-11
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	3e-11
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	6e-11
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	7e-11
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	5e-10
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	5e-10
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	2e-09
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	2e-09
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	3e-09
3uqc_A	286	Probable conserved transmembrane protein; structur	1e-08
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	1e-08

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  472 bits (1216), Expect = e-167
 Identities = 233/297 (78%), Positives = 259/297 (87%), Gaps = 4/297 (1%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 59  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 119 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 179 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 238

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 239 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 298

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHH 302
           DP++R DSD ALNHDFFW+DPMPSDL  ML+ H  SMFEYLAPPRR    + HHHHH
Sbjct: 299 DPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRR----KHHHHHH 351

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* Length = 351

 Score =  103 bits (258), Expect = 1e-24
 Identities = 57/96 (59%), Positives = 68/96 (70%), Gaps = 4/96 (4%)

Query: 312 PAAGRATTETGYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP 371
               +     G   +VK+RLK YV+D Y  DL+DKLL+LDP++R DSD ALNHDFFW+DP
Sbjct: 260 ELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDP 319

Query: 372 MPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHH 407
           MPSDL  ML+ H  SMFEYLAPPRR    + HHHHH
Sbjct: 320 MPSDLKGMLSTHLTSMFEYLAPPRR----KHHHHHH 351

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score =  381 bits (980), Expect = e-131
 Identities = 93/275 (33%), Positives = 149/275 (54%), Gaps = 13/275 (4%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
               A+REIK+L+ L+HEN+V+L+E+C+ K          +YLVF+F +H +   L    
Sbjct: 67  VKKIAMREIKLLKQLRHENLVNLLEVCKKKKR--------WYLVFEFVDHTILDDLELFP 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  ++K + Q++NG+ + HS+ I+HRD+K  N+L++++G++KL DFG AR  +   
Sbjct: 119 NGLDYQVVQKYLFQIINGIGFCHSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLA--- 175

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                 Y + V T WYR PELL+GD  YG  VD+W  GC++ EM+   P+  G+++  Q+
Sbjct: 176 -APGEVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVTEMFMGEPLFPGDSDIDQL 234

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I    G++ P          ++  + LP+ ++R+  ER  P +  +   DL  K L +
Sbjct: 235 YHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRYPKL-SEVVIDLAKKCLHI 293

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQ 280
           DP KR      L+HDFF  D      S+ L    Q
Sbjct: 294 DPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQ 328

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} Length = 331

 Score = 67.2 bits (165), Expect = 2e-12
 Identities = 20/57 (35%), Positives = 25/57 (43%), Gaps = 1/57 (1%)

Query: 329 ERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQ 385
           ER  P +  +   DL  K L +DP KR      L+HDFF  D      S+ L    Q
Sbjct: 273 ERRYPKL-SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMDGFAERFSQELQLKVQ 328

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score =  377 bits (971), Expect = e-130
 Identities = 88/279 (31%), Positives = 144/279 (51%), Gaps = 13/279 (4%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
               ALREI++L+ LKH N+V+L+E+ R K           +LVF++C+H +   L    
Sbjct: 45  IKKIALREIRMLKQLKHPNLVNLLEVFRRKRR--------LHLVFEYCDHTVLHELDRYQ 96

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  +K +  Q L  + + H +  +HRD+K  N+LITK  ++KL DFG AR  +   
Sbjct: 97  RGVPEHLVKSITWQTLQAVNFCHKHNCIHRDVKPENILITKHSVIKLCDFGFARLLT--- 153

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G  + Y + V T WYR PELL+GD  YGPPVD+W  GC+ AE+ +  P+  G ++  Q+
Sbjct: 154 -GPSDYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFAELLSGVPLWPGKSDVDQL 212

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LI +  G + P       T   ++ +++P  +  +  E   P +       LL   L +
Sbjct: 213 YLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKFPNI-SYPALGLLKGCLHM 271

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
           DP++R   +  L+H +F       DL+K   +  ++++ 
Sbjct: 272 DPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYF 310

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens} Length = 311

 Score = 68.0 bits (167), Expect = 7e-13
 Identities = 12/53 (22%), Positives = 24/53 (45%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 389
                 LL   L +DP++R   +  L+H +F       DL+K   +  ++++ 
Sbjct: 258 SYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREIEDLAKEHDKPAENLYF 310

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score =  378 bits (972), Expect = e-130
 Identities = 111/303 (36%), Positives = 158/303 (52%), Gaps = 26/303 (8%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+RE+ +L+ LKH N+V L +I  T+         +  LVF++ + DL   L +  
Sbjct: 43  APCTAIREVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDKDLKQYLDDCG 94

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
              ++  +K  + QLL GL Y H  K+LHRD+K  N+LI + G LKLADFGLARA S   
Sbjct: 95  NIINMHNVKLFLFQLLRGLAYCHRQKVLHRDLKPQNLLINERGELKLADFGLARAKS--- 151

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                 Y N VVTLWYRPP++LLG  +Y   +D+WG GCI  EM T  P+  G+T ++Q+
Sbjct: 152 -IPTKTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFYEMATGRPLFPGSTVEEQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I ++ G+ T E+WPG+ + + +     PK +   +         D  G DLL KLL  
Sbjct: 211 HFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSHAPRL--DSDGADLLTKLLQF 268

Query: 246 DPSKRFDSDAALNHDFFWTDP-----MPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHH 300
           +   R  ++ A+ H FF +       +P   S    +  Q   E            AHHH
Sbjct: 269 EGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE-------ASLRSAHHH 321

Query: 301 HHH 303
           HHH
Sbjct: 322 HHH 324

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens} Length = 324

 Score = 69.2 bits (170), Expect = 4e-13
 Identities = 24/77 (31%), Positives = 31/77 (40%), Gaps = 12/77 (15%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP-----MPSDLSKMLAQHTQSMFEYL 391
           D  G DLL KLL  +   R  ++ A+ H FF +       +P   S    +  Q   E  
Sbjct: 255 DSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLGERIHKLPDTTSIFALKEIQLQKE-- 312

Query: 392 APPRRPGHMRAHHHHHH 408
                     AHHHHHH
Sbjct: 313 -----ASLRSAHHHHHH 324

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score =  366 bits (943), Expect = e-126
 Identities = 111/306 (36%), Positives = 157/306 (51%), Gaps = 42/306 (13%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+REI +++ LKHEN+V L ++  T+            LVF+F ++DL   + +  
Sbjct: 46  TPSTAIREISLMKELKHENIVRLYDVIHTENK--------LTLVFEFMDNDLKKYMDSRT 97

Query: 66  VK-----FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
           V        L  +K    QLL GL + H NKILHRD+K  N+LI K G LKL DFGLARA
Sbjct: 98  VGNTPRGLELNLVKYFQWQLLQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARA 157

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
           F       VN +++ VVTLWYR P++L+G R Y   +D+W  GCI+AEM T  P+  G  
Sbjct: 158 FGI----PVNTFSSEVVTLWYRAPDVLMGSRTYSTSIDIWSCGCILAEMITGKPLFPGTN 213

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK---DQYGCD 237
           +++Q+ LI  + G+     WP V  L  Y    + +   R +++ L+P+ K   D    D
Sbjct: 214 DEEQLKLIFDIMGTPNESLWPSVTKLPKY-NPNIQQRPPRDLRQVLQPHTKEPLDGNLMD 272

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRA 297
            L  LL L+P  R  +  AL+H +F      +                       G  R+
Sbjct: 273 FLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS---------------------MGGSRS 311

Query: 298 HHHHHH 303
           HHHHHH
Sbjct: 312 HHHHHH 317

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A* Length = 317

 Score = 63.8 bits (156), Expect = 2e-11
 Identities = 21/86 (24%), Positives = 30/86 (34%), Gaps = 22/86 (25%)

Query: 323 YHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 382
               ++   K  + D    D L  LL L+P  R  +  AL+H +F      +        
Sbjct: 254 LRQVLQPHTKEPL-DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYHHAS------- 305

Query: 383 HTQSMFEYLAPPRRPGHMRAHHHHHH 408
                          G  R+HHHHHH
Sbjct: 306 --------------MGGSRSHHHHHH 317

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score =  357 bits (918), Expect = e-122
 Identities = 95/284 (33%), Positives = 143/284 (50%), Gaps = 18/284 (6%)

Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            P++ +RE+ +L+ L+   H NVV L ++C           +   LVF+  + DL   L 
Sbjct: 54  MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRE---TKLTLVFEHVDQDLTTYLD 110

Query: 63  NI-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            +         IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +
Sbjct: 111 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 170

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T+ VVTLWYR PE+LL    Y  PVDLW  GCI AEM+ R P+ +G+++
Sbjct: 171 SFQM-----ALTSVVVTLWYRAPEVLLQSS-YATPVDLWSVGCIFAEMFRRKPLFRGSSD 224

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
             Q+  I  + G    E WP    L              K    +     D+ G DLL K
Sbjct: 225 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDI-----DELGKDLLLK 279

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEY 285
            L  +P+KR  + +AL+H +F       +        +Q+  E 
Sbjct: 280 CLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSEL 323

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B Length = 326

 Score = 62.2 bits (152), Expect = 7e-11
 Identities = 16/54 (29%), Positives = 26/54 (48%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEY 390
           D+ G DLL K L  +P+KR  + +AL+H +F       +        +Q+  E 
Sbjct: 270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLERCKENLDSHLPPSQNTSEL 323

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score =  353 bits (907), Expect = e-120
 Identities = 101/261 (38%), Positives = 142/261 (54%), Gaps = 14/261 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+REI +L+ L H N+V LI++  ++            LVF+F E DL  +L    
Sbjct: 62  IPSTAIREISLLKELHHPNIVSLIDVIHSERC--------LTLVFEFMEKDLKKVLDENK 113

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                 +IK  + QLL G+ + H ++ILHRD+K  N+LI   G LKLADFGLARAF    
Sbjct: 114 TGLQDSQIKIYLYQLLRGVAHCHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGI-- 171

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V  YT+ VVTLWYR P++L+G + Y   VD+W  GCI AEM T  P+  G T+  Q+
Sbjct: 172 --PVRSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIFAEMITGKPLFPGVTDDDQL 229

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I  + G+  P  WP V+ L L+ +      +K+     +  +   Q G DLL  +L  
Sbjct: 230 PKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSIIPGF--CQEGIDLLSNMLCF 287

Query: 246 DPSKRFDSDAALNHDFFWTDP 266
           DP+KR  +  A+NH +F    
Sbjct: 288 DPNKRISARDAMNHPYFKDLD 308

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} PDB: 2qkr_A* Length = 311

 Score = 48.3 bits (116), Expect = 2e-06
 Identities = 14/35 (40%), Positives = 19/35 (54%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP 371
            Q G DLL  +L  DP+KR  +  A+NH +F    
Sbjct: 274 CQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDLD 308

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score =  348 bits (894), Expect = e-119
 Identities = 95/265 (35%), Positives = 136/265 (51%), Gaps = 18/265 (6%)

Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            PI+ +RE+ +L+ L+   H NVV L+++C T             LVF+  + DL   L 
Sbjct: 54  LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTDR---EIKVTLVFEHVDQDLRTYLD 110

Query: 63  NI-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
                      IK +++Q L GL ++H+N I+HRD+K  N+L+T  G +KLADFGLAR +
Sbjct: 111 KAPPPGLPAETIKDLMRQFLRGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIY 170

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T  VVTLWYR PE+LL    Y  PVD+W  GCI AEM+ R P+  GN+E
Sbjct: 171 SYQM-----ALTPVVVTLWYRAPEVLLQST-YATPVDMWSVGCIFAEMFRRKPLFCGNSE 224

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
             Q+  I  L G    + WP   +L    +   P    R V+  +     ++ G  LL +
Sbjct: 225 ADQLGKIFDLIGLPPEDDWPRDVSL---PRGAFPPRGPRPVQSVVPEM--EESGAQLLLE 279

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDP 266
           +L  +P KR  +  AL H +   D 
Sbjct: 280 MLTFNPHKRISAFRALQHSYLHKDE 304

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens} Length = 308

 Score = 54.1 bits (131), Expect = 3e-08
 Identities = 11/35 (31%), Positives = 18/35 (51%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP 371
           ++ G  LL ++L  +P KR  +  AL H +   D 
Sbjct: 270 EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKDE 304

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score =  349 bits (897), Expect = e-118
 Identities = 97/269 (36%), Positives = 140/269 (52%), Gaps = 16/269 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
              TALREIK+LQ L H N++ L++    K+N          LVFDF E DL  ++ +  
Sbjct: 55  INRTALREIKLLQELSHPNIIGLLDAFGHKSN--------ISLVFDFMETDLEVIIKDNS 106

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           +  +   IK  +   L GL Y+H + ILHRD+K  N+L+ + G+LKLADFGLA++F    
Sbjct: 107 LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGS-- 164

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                 YT++VVT WYR PELL G R YG  VD+W  GCI+AE+  R P + G+++  Q+
Sbjct: 165 --PNRAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 222

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           T I +  G+ T E WP + +L  Y            +              DL+  L L 
Sbjct: 223 TRIFETLGTPTEEQWPDMCSLPDYV--TFKSFPGIPLHHIFSAA--GDDLLDLIQGLFLF 278

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           +P  R  +  AL   +F   P P+   ++
Sbjct: 279 NPCARITATQALKMKYFSNRPGPTPGCQL 307

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7 Length = 346

 Score = 57.2 bits (139), Expect = 3e-09
 Identities = 11/43 (25%), Positives = 18/43 (41%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
                DL+  L L +P  R  +  AL   +F   P P+   ++
Sbjct: 265 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 307

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score =  347 bits (893), Expect = e-118
 Identities = 94/268 (35%), Positives = 150/268 (55%), Gaps = 20/268 (7%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P TA+RE+ +L+ L+H N++ L  +               +L+F++ E+DL   +   +
Sbjct: 76  VPGTAIREVSLLKELQHRNIIELKSVIHHN--------HRLHLIFEYAENDLKKYMDK-N 126

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-----KTGILKLADFGLARA 120
              S+  IK  + QL+NG+ + HS + LHRD+K  N+L++     +T +LK+ DFGLARA
Sbjct: 127 PDVSMRVIKSFLYQLINGVNFCHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARA 186

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
           F       + ++T+ ++TLWYRPPE+LLG R+Y   VD+W   CI AEM  ++P+  G++
Sbjct: 187 FGI----PIRQFTHEIITLWYRPPEILLGSRHYSTSVDIWSIACIWAEMLMKTPLFPGDS 242

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD 240
           E  Q+  I ++ G     +WPGV  L  + K   PK + + +K  L   + D  G DLL 
Sbjct: 243 EIDQLFKIFEVLGLPDDTTWPGVTALPDW-KQSFPKFRGKTLKRVLGALL-DDEGLDLLT 300

Query: 241 KLLLLDPSKRFDSDAALNHDFFWTDPMP 268
            +L +DP KR  +  AL H +F  +   
Sbjct: 301 AMLEMDPVKRISAKNALEHPYFSHNDFD 328

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A* Length = 329

 Score = 56.1 bits (136), Expect = 7e-09
 Identities = 15/45 (33%), Positives = 23/45 (51%)

Query: 329 ERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP 373
           +R+   + D  G DLL  +L +DP KR  +  AL H +F  +   
Sbjct: 284 KRVLGALLDDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHNDFD 328

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score =  344 bits (885), Expect = e-117
 Identities = 98/266 (36%), Positives = 136/266 (51%), Gaps = 20/266 (7%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P +ALREI +L+ LKH+N+V L ++  +             LVF+FC+ DL     + +
Sbjct: 44  VPSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCN 95

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  +K  + QLL GL + HS  +LHRD+K  N+LI + G LKLA+FGLARAF    
Sbjct: 96  GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGI-- 153

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQ 184
              V  Y+  VVTLWYRPP++L G + Y   +D+W AGCI AE+     P+  GN    Q
Sbjct: 154 --PVRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK--DQYGCDLLDKL 242
           +  I +L G+ T E WP +  L  Y                L   V   +  G DLL  L
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPY-----PMYPATTSLVNVVPKLNATGRDLLQNL 266

Query: 243 LLLDPSKRFDSDAALNHDFFWTDPMP 268
           L  +P +R  ++ AL H +F     P
Sbjct: 267 LKCNPVQRISAEEALQHPYFSDFCPP 292

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A Length = 292

 Score = 55.6 bits (135), Expect = 9e-09
 Identities = 15/48 (31%), Positives = 21/48 (43%), Gaps = 2/48 (4%)

Query: 328 KERLKPYVK--DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP 373
              L   V   +  G DLL  LL  +P +R  ++ AL H +F     P
Sbjct: 245 TTSLVNVVPKLNATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score =  342 bits (879), Expect = e-117
 Identities = 99/257 (38%), Positives = 140/257 (54%), Gaps = 15/257 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P T +REI IL+ LKH N+V L ++  TK            LVF+  + DL  LL    
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKR--------LVLVFEHLDQDLKKLLDVCE 94

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   K  + QLLNG+ Y H  ++LHRD+K  N+LI + G LK+ADFGLARAF    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGI-- 152

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V +YT+ +VTLWYR P++L+G + Y   +D+W  GCI AEM   +P+  G +E  Q+
Sbjct: 153 --PVRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I ++ G+   ++WP V  L  Y        +    +  LK    D+ G DLL K+L L
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKY-DPNFTVYEPLPWESFLKGL--DESGIDLLSKMLKL 267

Query: 246 DPSKRFDSDAALNHDFF 262
           DP++R  +  AL H +F
Sbjct: 268 DPNQRITAKQALEHAYF 284

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A Length = 288

 Score = 47.5 bits (114), Expect = 3e-06
 Identities = 15/31 (48%), Positives = 21/31 (67%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           D+ G DLL K+L LDP++R  +  AL H +F
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ... Length = 299

 Score = 53.7 bits (130), Expect = 4e-08
 Identities = 16/43 (37%), Positives = 23/43 (53%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
           D+ G  LL ++L  DP+KR  + AAL H FF     P    ++
Sbjct: 257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPHLRL 299

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score =  331 bits (850), Expect = e-111
 Identities = 97/338 (28%), Positives = 156/338 (46%), Gaps = 37/338 (10%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL---- 61
             ++A REI +L+ LKH NV+ L ++  + A+         +L+FD+ EHDL  ++    
Sbjct: 61  ISMSACREIALLRELKHPNVISLQKVFLSHAD------RKVWLLFDYAEHDLWHIIKFHR 114

Query: 62  ----SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLA 113
               +   V+   G +K ++ Q+L+G++Y+H+N +LHRD+K AN+L+     + G +K+A
Sbjct: 115 ASKANKKPVQLPRGMVKSLLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIA 174

Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           D G AR F+       +     VVT WYR PELLLG R+Y   +D+W  GCI AE+ T  
Sbjct: 175 DMGFARLFNSPLKPLAD-LDPVVVTFWYRAPELLLGARHYTKAIDIWAIGCIFAELLTSE 233

Query: 174 PIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE 224
           PI     E           Q+  I  + G    + W  ++ +  ++ +     +      
Sbjct: 234 PIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYTNC 293

Query: 225 RLKPYVK------DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
            L  Y++      D     LL KLL +DP KR  S+ A+   +F  DP+P+       Q 
Sbjct: 294 SLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQI 353

Query: 279 TQSMFEYLA---PPRRPGHMRAHHHHHHAGAPGAAGPA 313
                E+L    P  +           +    G   P 
Sbjct: 354 PYPKREFLTEEEPDDKGDKKNQQQQQGNNHTNGTGHPG 391

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens} Length = 405

 Score = 64.8 bits (158), Expect = 1e-11
 Identities = 22/85 (25%), Positives = 31/85 (36%), Gaps = 3/85 (3%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLA---P 393
           D     LL KLL +DP KR  S+ A+   +F  DP+P+       Q      E+L    P
Sbjct: 307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTSDVFAGCQIPYPKREFLTEEEP 366

Query: 394 PRRPGHMRAHHHHHHAGAPGAAGPA 418
             +           +    G   P 
Sbjct: 367 DDKGDKKNQQQQQGNNHTNGTGHPG 391

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score =  241 bits (617), Expect = 9e-76
 Identities = 79/329 (24%), Positives = 132/329 (40%), Gaps = 27/329 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL---SNIHVK 67
            RE++I++ L H N+V L     +   + +       LV D+    +  +    S     
Sbjct: 95  NRELQIMRKLDHCNIVRLRYFFYSSGEKKDE--VYLNLVLDYVPETVYRVARHYSRAKQT 152

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKN 126
             +  +K  + QL   L YIHS  I HRD+K  N+L+   T +LKL DFG A+   +   
Sbjct: 153 LPVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG-- 210

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                  + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+ 
Sbjct: 211 ---EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLV 267

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            I ++ G+ T E    +     Y + + P+ +     +  +P         L  +LL   
Sbjct: 268 EIIKVLGTPTREQIREM--NPNYTEFKFPQIKAHPWTKVFRPRT-PPEAIALCSRLLEYT 324

Query: 247 PSKRFDSDAALNHDFF--WTDP---MPS--------DLSKMLAQHTQSMFEYLAPPRRPG 293
           P+ R     A  H FF    DP   +P+        + +         +   L PP    
Sbjct: 325 PTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPPLATILIPPHARI 384

Query: 294 HMRAHHHHHHAGAPGAAGPAAGRATTETG 322
              A    +   A  A     G+      
Sbjct: 385 QAAASTPTNATAASDANTGDRGQTNNAAS 413

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ... Length = 420

 Score = 42.4 bits (100), Expect = 2e-04
 Identities = 19/101 (18%), Positives = 28/101 (27%), Gaps = 13/101 (12%)

Query: 340 GCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP---MPS--------DLSKMLAQHTQS 386
              L  +LL   P+ R     A  H FF    DP   +P+        + +         
Sbjct: 313 AIALCSRLLEYTPTARLTPLEACAHSFFDELRDPNVKLPNGRDTPALFNFTTQELSSNPP 372

Query: 387 MFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETG 427
           +   L PP       A    +   A  A     G+      
Sbjct: 373 LATILIPPHARIQAAASTPTNATAASDANTGDRGQTNNAAS 413

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis} Length = 394

 Score =  239 bits (611), Expect = 3e-75
 Identities = 72/256 (28%), Positives = 121/256 (47%), Gaps = 14/256 (5%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL---SNIHVK 67
            RE++I++++KH NVV L     +  ++ +       LV ++    +       + +   
Sbjct: 80  NRELQIMRIVKHPNVVDLKAFFYSNGDKKDEVF--LNLVLEYVPETVYRASRHYAKLKQT 137

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKN 126
             +  IK  + QLL  L YIHS  I HRD+K  N+L+   +G+LKL DFG A+       
Sbjct: 138 MPMLLIKLYMYQLLRSLAYIHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAG-- 195

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                  + + + +YR PEL+ G  NY   +D+W  GC+MAE+    P+  G +   Q+ 
Sbjct: 196 ---EPNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCVMAELMQGQPLFPGESGIDQLV 252

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            I ++ G+ + E    +     Y + + P+ +     +  +P        DL+ +LL   
Sbjct: 253 EIIKVLGTPSREQIKTM--NPNYMEHKFPQIRPHPFSKVFRPRT-PPDAIDLISRLLEYT 309

Query: 247 PSKRFDSDAALNHDFF 262
           PS R  +  AL H FF
Sbjct: 310 PSARLTAIEALCHPFF 325

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score =  218 bits (557), Expect = 4e-68
 Identities = 86/271 (31%), Positives = 130/271 (47%), Gaps = 24/271 (8%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDL-----A 58
           ALREIKI++ L H+N+V + EI     +Q      +       Y+V ++ E DL      
Sbjct: 55  ALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ 114

Query: 59  GLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGL 117
           G L   H +         + QLL GL YIHS  +LHRD+K AN+ I T+  +LK+ DFGL
Sbjct: 115 GPLLEEHARL-------FMYQLLRGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGL 167

Query: 118 ARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
           AR             +  +VT WYR P LLL   NY   +D+W AGCI AEM T   +  
Sbjct: 168 ARIMD-PHYSHKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMWAAGCIFAEMLTGKTLFA 226

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
           G  E +Q+ LI +    +  E    + ++             + + + L P +  +   D
Sbjct: 227 GAHELEQMQLILESIPVVHEEDRQELLSVIPVYIRNDMTEPHKPLTQLL-PGISRE-AVD 284

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
            L+++L   P  R  ++ AL+H +   ++ P
Sbjct: 285 FLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens} Length = 320

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 9/32 (28%), Positives = 18/32 (56%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           D L+++L   P  R  ++ AL+H +   ++ P
Sbjct: 284 DFLEQILTFSPMDRLTAEEALSHPYMSIYSFP 315

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score =  220 bits (562), Expect = 2e-67
 Identities = 87/324 (26%), Positives = 131/324 (40%), Gaps = 75/324 (23%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL----- 60
                LREI IL  L H++VV +++I   K  +        Y+V +  + D   L     
Sbjct: 95  DCKRILREIAILNRLNHDHVVKVLDIVIPKDVEKFD---ELYVVLEIADSDFKKLFRTPV 151

Query: 61  -LSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
            L+ +H+K        ++  LL G+ Y+HS  ILHRD+K AN L+ +   +K+ DFGLAR
Sbjct: 152 YLTELHIKT-------LLYNLLVGVKYVHSAGILHRDLKPANCLVNQDCSVKVCDFGLAR 204

Query: 120 AFSQTKNGQVNR-----------------------YTNRVVTLWYRPPELLLGDRNYGPP 156
                +NG                            T  VVT WYR PEL+L   NY   
Sbjct: 205 TVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAPELILLQENYTEA 264

Query: 157 VDLWGAGCIMAEM-----------WTRSPIMQGN--------------------TEQQQI 185
           +D+W  GCI AE+             R P+  G+                      + Q+
Sbjct: 265 IDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQL 324

Query: 186 TLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
            +I  + G+ + E    +E  D    +   PK +   + ER  P         LL ++L+
Sbjct: 325 NVIFNILGTPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF-PASSAD-AIHLLKRMLV 382

Query: 245 LDPSKRFDSDAALNHDFF--WTDP 266
            +P+KR   +  L H FF      
Sbjct: 383 FNPNKRITINECLAHPFFKEVRIA 406

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii} Length = 458

 Score = 42.1 bits (99), Expect = 3e-04
 Identities = 10/34 (29%), Positives = 16/34 (47%), Gaps = 2/34 (5%)

Query: 340 GCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
              LL ++L+ +P+KR   +  L H FF      
Sbjct: 373 AIHLLKRMLVFNPNKRITINECLAHPFFKEVRIA 406

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score =  217 bits (554), Expect = 4e-67
 Identities = 80/272 (29%), Positives = 132/272 (48%), Gaps = 27/272 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSNI 64
            LREIKIL+  KHEN++ +  I R   + +  +    Y++ +  + DL       +LS+ 
Sbjct: 56  TLREIKILKHFKHENIITIFNIQR--PDSFENFN-EVYIIQELMQTDLHRVISTQMLSDD 112

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H+++        I Q L  +  +H + ++HRD+K +N+LI     LK+ DFGLAR   ++
Sbjct: 113 HIQY-------FIYQTLRAVKVLHGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDES 165

Query: 125 KNGQVNRY------TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                            V T WYR PE++L    Y   +D+W  GCI+AE++ R PI  G
Sbjct: 166 AADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWSCGCILAELFLRRPIFPG 225

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKM--ELPKAQKRKVKERLKPYVKDQYGC 236
              + Q+ LI  + G+   ++           +    LP      +++   P V  + G 
Sbjct: 226 RDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKMF-PRVNPK-GI 283

Query: 237 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
           DLL ++L+ DP+KR  +  AL H +   + DP
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A* Length = 353

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 13/32 (40%), Positives = 20/32 (62%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DLL ++L+ DP+KR  +  AL H +   + DP
Sbjct: 284 DLLQRMLVFDPAKRITAKEALEHPYLQTYHDP 315

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score =  216 bits (553), Expect = 7e-67
 Identities = 72/268 (26%), Positives = 121/268 (45%), Gaps = 28/268 (10%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLA-------GLLS 62
            LREI++L    H N++ L +I               YLV +    DLA        ++S
Sbjct: 76  VLREIRLLNHFHHPNILGLRDIFVHFEEPAMH---KLYLVTELMRTDLAQVIHDQRIVIS 132

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             H+++        +  +L GL+ +H   ++HRD+   N+L+     + + DF LAR  +
Sbjct: 133 PQHIQY-------FMYHILLGLHVLHEAGVVHRDLHPGNILLADNNDITICDFNLAREDT 185

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
              N      T+ V   WYR PEL++  + +   VD+W AGC+MAEM+ R  + +G+T  
Sbjct: 186 ADAN-----KTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMAEMFNRKALFRGSTFY 240

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKME--LPKAQKRKVKERLKPYVKDQYGCDLLD 240
            Q+  I ++ G+   E      +    + +   L     R     + P        DL+ 
Sbjct: 241 NQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAWTAVV-PTADPV-ALDLIA 298

Query: 241 KLLLLDPSKRFDSDAALNHDFF--WTDP 266
           K+L  +P +R  ++ AL H +F    DP
Sbjct: 299 KMLEFNPQRRISTEQALRHPYFESLFDP 326

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} Length = 362

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 12/32 (37%), Positives = 19/32 (59%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DL+ K+L  +P +R  ++ AL H +F    DP
Sbjct: 295 DLIAKMLEFNPQRRISTEQALRHPYFESLFDP 326

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score =  216 bits (552), Expect = 1e-66
 Identities = 93/265 (35%), Positives = 131/265 (49%), Gaps = 21/265 (7%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSNI 64
            LREIKIL   +HEN++ + +I R  A    + +   Y+V D  E DL        LSN 
Sbjct: 72  TLREIKILLRFRHENIIGINDIIR--APTIEQMK-DVYIVQDLMETDLYKLLKTQHLSND 128

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           H+ +        + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR     
Sbjct: 129 HICY-------FLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADP- 180

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
            +      T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q
Sbjct: 181 DHDHTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQ 240

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           +  I  + GS + E    +  L   N +  LP   K        P    +   DLLDK+L
Sbjct: 241 LNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF-PNADSK-ALDLLDKML 298

Query: 244 LLDPSKRFDSDAALNHDFF--WTDP 266
             +P KR + + AL H +   + DP
Sbjct: 299 TFNPHKRIEVEQALAHPYLEQYYDP 323

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3o71_A 3r63_A 3c9w_A* 2y9q_A* 3sa0_A* 1wzy_A* 2e14_A* 1tvo_A* 2ojg_A* 2oji_A* ... Length = 364

 Score = 40.7 bits (96), Expect = 7e-04
 Identities = 14/32 (43%), Positives = 20/32 (62%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DLLDK+L  +P KR + + AL H +   + DP
Sbjct: 292 DLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP 323

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3mb7_A* 3mb6_A* 3owj_A* 3owk_A* ... Length = 330

 Score =  212 bits (543), Expect = 7e-66
 Identities = 72/264 (27%), Positives = 126/264 (47%), Gaps = 28/264 (10%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
             REIKIL+ L+   N++ L +I +   ++      T  LVF+   + D   L       
Sbjct: 77  IKREIKILENLRGGPNIITLADIVKDPVSR------TPALVFEHVNNTDFKQLYQ----T 126

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKN 126
            +  +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   + 
Sbjct: 127 LTDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ- 185

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQI 185
                Y  RV + +++ PELL+  + Y   +D+W  GC++A M  R  P   G+    Q+
Sbjct: 186 ----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQL 241

Query: 186 TLISQLCGSITPESWPGVETLDL---YNKMELPKAQKRK----VKERLKPYVKDQYGCDL 238
             I+++ G+     +     ++L   +N + L +  +++    V    +  V  +   D 
Sbjct: 242 VRIAKVLGTEDLYDYIDKYNIELDPRFNDI-LGRHSRKRWERFVHSENQHLVSPE-ALDF 299

Query: 239 LDKLLLLDPSKRFDSDAALNHDFF 262
           LDKLL  D   R  +  A+ H +F
Sbjct: 300 LDKLLRYDHQSRLTAREAMEHPYF 323

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score =  213 bits (544), Expect = 1e-65
 Identities = 84/265 (31%), Positives = 134/265 (50%), Gaps = 26/265 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSNI 64
           A RE+++L+ ++HENV+ L+++     ++     + FYLV  F   DL        L   
Sbjct: 71  AYRELRLLKHMRHENVIGLLDVFT--PDETLDDFTDFYLVMPFMGTDLGKLMKHEKLGED 128

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
            ++F       ++ Q+L GL YIH+  I+HRD+K  N+ + +   LK+ DFGLAR     
Sbjct: 129 RIQF-------LVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADSE 181

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                   T  VVT WYR PE++L    Y   VD+W  GCIMAEM T   + +G+    Q
Sbjct: 182 M-------TGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQ 234

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           +  I ++ G+   E    +++ +  N M+ LP+ +K+     L          +LL+K+L
Sbjct: 235 LKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASIL-TNASPL-AVNLLEKML 292

Query: 244 LLDPSKRFDSDAALNHDFF--WTDP 266
           +LD  +R  +  AL H +F    D 
Sbjct: 293 VLDAEQRVTAGEALAHPYFESLHDT 317

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7 Length = 367

 Score = 40.4 bits (95), Expect = 9e-04
 Identities = 12/32 (37%), Positives = 19/32 (59%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           +LL+K+L+LD  +R  +  AL H +F    D 
Sbjct: 286 NLLEKMLVLDAEQRVTAGEALAHPYFESLHDT 317

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score =  212 bits (541), Expect = 2e-65
 Identities = 87/264 (32%), Positives = 132/264 (50%), Gaps = 25/264 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL----LSNIH 65
           A RE+ +L+ ++HENV+ L+++         R    FYLV  F + DL  +     S   
Sbjct: 70  AYRELLLLKHMQHENVIGLLDVFT--PASSLRNFYDFYLVMPFMQTDLQKIMGLKFSEEK 127

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           +++       ++ Q+L GL YIHS  ++HRD+K  N+ + +   LK+ DFGLAR      
Sbjct: 128 IQY-------LVYQMLKGLKYIHSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAEM 180

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                  T  VVT WYR PE++L   +Y   VD+W  GCIMAEM T   + +G     Q+
Sbjct: 181 -------TGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMAEMLTGKTLFKGKDYLDQL 233

Query: 186 TLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           T I ++ G    E    +      + ++ LP+  ++   +   P    Q   DLL+K+L 
Sbjct: 234 TQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQLF-PRASPQ-AADLLEKMLE 291

Query: 245 LDPSKRFDSDAALNHDFF--WTDP 266
           LD  KR  +  AL H FF  + DP
Sbjct: 292 LDVDKRLTAAQALTHPFFEPFRDP 315

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens} Length = 353

 Score = 40.7 bits (96), Expect = 6e-04
 Identities = 16/32 (50%), Positives = 20/32 (62%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DLL+K+L LD  KR  +  AL H FF  + DP
Sbjct: 284 DLLEKMLELDVDKRLTAAQALTHPFFEPFRDP 315

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II} Length = 383

 Score =  213 bits (543), Expect = 2e-65
 Identities = 69/298 (23%), Positives = 120/298 (40%), Gaps = 56/298 (18%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------------------- 46
            P    RE+ I+++L H N++ L++   T  ++  +                        
Sbjct: 43  DPRYKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKS 102

Query: 47  -----------YLVFDFCEHDLAGL----------LSNIHVKFSLGEIKKVIQQLLNGLY 85
                       ++ ++    L  +          +    +          I QL   + 
Sbjct: 103 VIVNPSQNKYLNVIMEYVPDTLHKVLKSFIRSGRSIPMNLISI-------YIYQLFRAVG 155

Query: 86  YIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPP 144
           +IHS  I HRD+K  N+L+ +K   LKL DFG A+    ++          + + +YR P
Sbjct: 156 FIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSEP-----SVAYICSRFYRAP 210

Query: 145 ELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVE 204
           EL+LG   Y P +DLW  GC+  E+    P+  G T   Q+  I Q+ G+ T E    + 
Sbjct: 211 ELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMN 270

Query: 205 TLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
               Y ++  P  + +  ++ L P        DLL+++L  +P  R +   A+ H FF
Sbjct: 271 P--HYTEVRFPTLKAKDWRKIL-PEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFF 325

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score =  211 bits (539), Expect = 8e-65
 Identities = 86/265 (32%), Positives = 130/265 (49%), Gaps = 26/265 (9%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSNI 64
             RE+++L+ +KHENV+ L+++      +     +  YLV      DL        L++ 
Sbjct: 75  TYRELRLLKHMKHENVIGLLDV--FTPARSLEEFNDVYLVTHLMGADLNNIVKCQKLTDD 132

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
           HV+F       +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR  +  
Sbjct: 133 HVQF-------LIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTADE 185

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                   T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q
Sbjct: 186 M-------TGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQ 238

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
           + LI +L G+   E    + +    N ++ L +  K                 DLL+K+L
Sbjct: 239 LKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF-IGANPL-AVDLLEKML 296

Query: 244 LLDPSKRFDSDAALNHDFF--WTDP 266
           +LD  KR  +  AL H +F  + DP
Sbjct: 297 VLDSDKRITAAQALAHAYFAQYHDP 321

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ... Length = 367

 Score = 40.8 bits (96), Expect = 6e-04
 Identities = 15/32 (46%), Positives = 21/32 (65%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DLL+K+L+LD  KR  +  AL H +F  + DP
Sbjct: 290 DLLEKMLVLDSDKRITAAQALAHAYFAQYHDP 321

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II} Length = 388

 Score =  211 bits (540), Expect = 9e-65
 Identities = 89/297 (29%), Positives = 137/297 (46%), Gaps = 53/297 (17%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL-----AGLLSN 63
             REI IL  L  HEN+V+L+ + R   ++        YLVFD+ E DL     A +L  
Sbjct: 55  TFREIMILTELSGHENIVNLLNVLRADNDR------DVYLVFDYMETDLHAVIRANILEP 108

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
           +H ++       V+ QL+  + Y+HS  +LHRDMK +N+L+     +K+ADFGL+R+F  
Sbjct: 109 VHKQY-------VVYQLIKVIKYLHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVN 161

Query: 124 TKNGQVNRY-----------------TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
            +    N                   T+ V T WYR PE+LLG   Y   +D+W  GCI+
Sbjct: 162 IRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLGSTKYTKGIDMWSLGCIL 221

Query: 167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPE---------------SWPGVETLDLYNK 211
            E+    PI  G++   Q+  I  +    + E               S      +   NK
Sbjct: 222 GEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNK 281

Query: 212 MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
            ++    K  + +       ++   DLLDKLL  +P+KR  ++ AL H F   + +P
Sbjct: 282 RDIFTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFHNP 338

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major} Length = 360

 Score =  207 bits (529), Expect = 2e-63
 Identities = 70/262 (26%), Positives = 113/262 (43%), Gaps = 20/262 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNR--YRSTFYLVFDFCEHDLAGLL---SNIH 65
           L+ ++ L +L H N+V L     T   +  R  Y     +V ++    L           
Sbjct: 67  LQIMQDLAVLHHPNIVQLQSYFYTLGERDRRDIY---LNVVMEYVPDTLHRCCRNYYRRQ 123

Query: 66  VKFSLGEIKKVIQQLLNGLYYIH--SNKILHRDMKAANVLI-TKTGILKLADFGLARAFS 122
           V      IK  + QL+  +  +H  S  + HRD+K  NVL+    G LKL DFG A+  S
Sbjct: 124 VAPPPILIKVFLFQLIRSIGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLS 183

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
            ++          + + +YR PEL+ G+++Y   VD+W  GCI AEM    PI +G+   
Sbjct: 184 PSEP-----NVAYICSRYYRAPELIFGNQHYTTAVDIWSVGCIFAEMMLGEPIFRGDNSA 238

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK--DQYGCDLLD 240
            Q+  I ++ G  + E    +     +  ++L  ++          +     +   DLL 
Sbjct: 239 GQLHEIVRVLGCPSREVLRKLNP--SHTDVDLYNSKGIPWSNVFSDHSLKDAKEAYDLLS 296

Query: 241 KLLLLDPSKRFDSDAALNHDFF 262
            LL   P +R     AL H +F
Sbjct: 297 ALLQYLPEERMKPYEALCHPYF 318

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score =  204 bits (522), Expect = 1e-61
 Identities = 80/312 (25%), Positives = 136/312 (43%), Gaps = 67/312 (21%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL------LSN 63
            LREI IL  LK + ++ L ++     +   ++    Y+V +  + DL  L      L+ 
Sbjct: 72  ILREITILNRLKSDYIIRLYDLII--PDDLLKFD-ELYIVLEIADSDLKKLFKTPIFLTE 128

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            H+K        ++  LL G  +IH + I+HRD+K AN L+ +   +K+ DFGLAR  + 
Sbjct: 129 EHIKT-------ILYNLLLGENFIHESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINS 181

Query: 124 TKNGQVNRY------------------TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
            K+  +                     T+ VVT WYR PEL+L   NY   +D+W  GCI
Sbjct: 182 EKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILLQENYTKSIDIWSTGCI 241

Query: 166 MAEM-----------WTRSPIMQGNTEQQ-----------------QITLISQLCGSITP 197
            AE+             R P+  G++                    Q+ +I  + G+ T 
Sbjct: 242 FAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTE 301

Query: 198 ESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAA 256
           +    +   ++   ++  P  +   +K++  P + D  G +LL+ +L  +P+KR   D A
Sbjct: 302 DDLKNINKPEVIKYIKLFPHRKPINLKQKY-PSISDD-GINLLESMLKFNPNKRITIDQA 359

Query: 257 LNHDFF--WTDP 266
           L+H +       
Sbjct: 360 LDHPYLKDVRKK 371

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A* Length = 432

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 10/32 (31%), Positives = 17/32 (53%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           +LL+ +L  +P+KR   D AL+H +       
Sbjct: 340 NLLESMLKFNPNKRITIDQALDHPYLKDVRKK 371

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A* Length = 464

 Score =  200 bits (511), Expect = 9e-60
 Identities = 77/275 (28%), Positives = 125/275 (45%), Gaps = 35/275 (12%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL----LSNIH 65
           A RE+ +++ + H+N++ L+ +      +        YLV +  + +L  +    L +  
Sbjct: 108 AYRELVLMKCVNHKNIISLLNVFT--PQKTLEEFQDVYLVMELMDANLCQVIQMELDHER 165

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           + +       ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR    + 
Sbjct: 166 MSY-------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS- 217

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                  T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q 
Sbjct: 218 ----FMMTPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMVRHKILFPGRDYIDQW 272

Query: 186 TLISQLCGS--------ITPESWPGVETLDLYNKMEL----PKAQKRKVKERLKPYVKDQ 233
             + +  G+        + P     VE    Y  +      P +      E  K   K  
Sbjct: 273 NKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKL--KAS 330

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
              DLL K+L++DP+KR   D AL H +   W DP
Sbjct: 331 QARDLLSKMLVIDPAKRISVDDALQHPYINVWYDP 365

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ... Length = 371

 Score =  197 bits (502), Expect = 3e-59
 Identities = 73/273 (26%), Positives = 123/273 (45%), Gaps = 31/273 (11%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL----LSNIH 65
           A RE+ +++ + H+N++ L+ +      +        Y+V +  + +L  +    L +  
Sbjct: 71  AYRELVLMKCVNHKNIIGLLNVFT--PQKSLEEFQDVYIVMELMDANLCQVIQMELDHER 128

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           + +       ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR    + 
Sbjct: 129 MSY-------LLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF 181

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                  T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q 
Sbjct: 182 MM-----TPYVVTRYYRAPEVILG-MGYKENVDIWSVGCIMGEMIKGGVLFPGTDHIDQW 235

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE----------RLKPYVKDQYG 235
             + +  G+  PE    ++          PK      ++               +K    
Sbjct: 236 NKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQA 295

Query: 236 CDLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 266
            DLL K+L++D SKR   D AL H +   W DP
Sbjct: 296 RDLLSKMLVIDASKRISVDEALQHPYINVWYDP 328

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A Length = 303

 Score =  160 bits (407), Expect = 3e-46
 Identities = 62/285 (21%), Positives = 109/285 (38%), Gaps = 52/285 (18%)

Query: 10  ALREIKILQLLKHENVVHLIEI-----CRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN 63
            L E+ +L  L H+ VV             K     + +ST ++  ++CE   L  L+ +
Sbjct: 49  ILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHS 108

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            ++     E  ++ +Q+L  L YIHS  I+HRD+K  N+ I ++  +K+ DFGLA+   +
Sbjct: 109 ENLNQQRDEYWRLFRQILEALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHR 168

Query: 124 TKNGQVNRYTNRVV----------TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           + +       N             T  Y   E+L G  +Y   +D++  G I  EM    
Sbjct: 169 SLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTGHYNEKIDMYSLGIIFFEM---- 224

Query: 174 PIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ 233
                            +          G+E +++  K+       R V     P   D 
Sbjct: 225 -----------------IYP---FS--TGMERVNILKKL-------RSVSIEFPPDFDDN 255

Query: 234 Y---GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKML 275
                  ++  L+  DP+KR  +   LN  +         + + L
Sbjct: 256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKHQDEVIKEAL 300

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B* Length = 284

 Score =  155 bits (395), Expect = 1e-44
 Identities = 59/264 (22%), Positives = 96/264 (36%), Gaps = 52/264 (19%)

Query: 10  ALREIKILQLLKHENVVHLIE--------ICRTKANQYNRYRSTFYLVFDFCEH-DLAGL 60
           A RE+K L  L H N+VH              +  N         ++  +FC+   L   
Sbjct: 51  AEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQW 110

Query: 61  LSN-IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +      K       ++ +Q+  G+ YIHS K+++RD+K +N+ +  T  +K+ DFGL  
Sbjct: 111 IEKRRGEKLDKVLALELFEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVT 170

Query: 120 AFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           +          + T    TL Y  PE  +  ++YG  VDL+  G I+AE+          
Sbjct: 171 SLKND-----GKRTRSKGTLRYMSPE-QISSQDYGKEVDLYALGLILAELLHVCD----- 219

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
                                   ET   +  +     +   + +      K      LL
Sbjct: 220 ---------------------TAFETSKFFTDL-----RDGIISDIFDKKEK-----TLL 248

Query: 240 DKLLLLDPSKRFDSDAALNHDFFW 263
            KLL   P  R ++   L     W
Sbjct: 249 QKLLSKKPEDRPNTSEILRTLTVW 272

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A* Length = 313

 Score =  156 bits (396), Expect = 2e-44
 Identities = 61/272 (22%), Positives = 90/272 (33%), Gaps = 53/272 (19%)

Query: 11  LREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
             EI  L  L+   + ++ L +   T            Y+V +    DL   L       
Sbjct: 74  RNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKK-KKSI 124

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          
Sbjct: 125 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQPDTTSV 183

Query: 129 VNRYTNRVVTLWYRPPELLLG----------DRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
           V    ++V T+ Y PPE +                 P  D+W  GCI+  M       Q 
Sbjct: 184 VK--DSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQQ 241

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
              Q    L + +  +   E     E             Q                  D+
Sbjct: 242 IINQIS-KLHAIIDPNHEIEFPDIPE----------KDLQ------------------DV 272

Query: 239 LDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 270
           L   L  DP +R      L H +      P +
Sbjct: 273 LKCCLKRDPKQRISIPELLAHPYVQIQTHPVN 304

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens} Length = 343

 Score =  156 bits (396), Expect = 4e-44
 Identities = 63/300 (21%), Positives = 98/300 (32%), Gaps = 56/300 (18%)

Query: 11  LREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
             EI  L  L+   + ++ L +   T            Y+V +    DL   L       
Sbjct: 55  RNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKK-KKSI 105

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          
Sbjct: 106 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ---PDT 161

Query: 129 VNRYTNRVV-TLWYRPPELLLG----------DRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
            +   +  V T+ Y PPE +                 P  D+W  GCI+  M       Q
Sbjct: 162 TSVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 221

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
               Q    L + +  +   E     E             Q                  D
Sbjct: 222 QIINQISK-LHAIIDPNHEIEFPDIPE----------KDLQ------------------D 252

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMP-SDLSKMLAQHTQSMFEYLAPPRRPGHMR 296
           +L   L  DP +R      L H +      P + ++K   +  + +   L     P  + 
Sbjct: 253 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSPNSIL 312

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score =  154 bits (390), Expect = 2e-42
 Identities = 58/264 (21%), Positives = 105/264 (39%), Gaps = 47/264 (17%)

Query: 10  ALREIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
           A RE+++L+   +H NV+      + +           Y+  + C   L   +       
Sbjct: 64  ADREVQLLRESDEHPNVIRYFCTEKDRQF--------QYIAIELCAATLQEYVEQKDFAH 115

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG-----ILKLADFGLARAFSQ 123
              E   ++QQ  +GL ++HS  I+HRD+K  N+LI+           ++DFGL +  + 
Sbjct: 116 LGLEPITLLQQTTSGLAHLHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAV 175

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCIMAEMWTR-SPIMQGNT 180
            ++    R      T  +  PE+L  D   N    VD++ AGC+   + +  S     + 
Sbjct: 176 GRHSFSRRSG-VPGTEGWIAPEMLSEDCKENPTYTVDIFSAGCVFYYVISEGSHPFGKSL 234

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD 240
           ++Q   L+     S+        E            A+                  +L++
Sbjct: 235 QRQANILLGA--CSLDCLHPEKHED---------VIAR------------------ELIE 265

Query: 241 KLLLLDPSKRFDSDAALNHDFFWT 264
           K++ +DP KR  +   L H FFW+
Sbjct: 266 KMIAMDPQKRPSAKHVLKHPFFWS 289

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens} Length = 432

 Score = 40.9 bits (96), Expect = 6e-04
 Identities = 11/28 (39%), Positives = 19/28 (67%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWT 369
           +L++K++ +DP KR  +   L H FFW+
Sbjct: 262 ELIEKMIAMDPQKRPSAKHVLKHPFFWS 289

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A* Length = 390

 Score =  151 bits (384), Expect = 6e-42
 Identities = 62/296 (20%), Positives = 96/296 (32%), Gaps = 56/296 (18%)

Query: 11  LREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
             EI  L  L+   + ++ L +   T            Y+V +    DL   L       
Sbjct: 102 RNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKK-KKSI 152

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              E K   + +L  ++ IH + I+H D+K AN LI   G+LKL DFG+A          
Sbjct: 153 DPWERKSYWKNMLEAVHTIHQHGIVHSDLKPANFLIVD-GMLKLIDFGIANQMQ---PDT 208

Query: 129 VNRYTNRVV-TLWYRPPELLLG----------DRNYGPPVDLWGAGCIMAEMWTRSPIMQ 177
            +   +  V  + Y PPE +                 P  D+W  GCI+  M       Q
Sbjct: 209 TSVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISPKSDVWSLGCILYYMTYGKTPFQ 268

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
               Q    L + +  +   E     E             Q                  D
Sbjct: 269 QIINQISK-LHAIIDPNHEIEFPDIPE----------KDLQ------------------D 299

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMP-SDLSKMLAQHTQSMFEYLAPPRRP 292
           +L   L  DP +R      L H +      P + ++K   +  + +   L     P
Sbjct: 300 VLKCCLKRDPKQRISIPELLAHPYVQIQTHPVNQMAKGTTEEMKYVLGQLVGLNSP 355

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A* Length = 299

 Score =  149 bits (377), Expect = 8e-42
 Identities = 51/275 (18%), Positives = 102/275 (37%), Gaps = 49/275 (17%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKAN----QYNRYRSTFYLVFDFCEH-DLAGLLS-- 62
            +RE+K L  L+H  +V        K      Q +  +   Y+    C   +L   ++  
Sbjct: 50  VMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGR 109

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFS 122
               +        +  Q+   + ++HS  ++HRD+K +N+  T   ++K+ DFGL  A  
Sbjct: 110 CTIEERERSVCLHIFLQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMD 169

Query: 123 QTKN--------GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           Q +             R+T +V T  Y  PE + G  +Y   VD++  G I+ E+    P
Sbjct: 170 QDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHG-NSYSHKVDIFSLGLILFELLY--P 226

Query: 175 IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY 234
               +T+ +++  ++ +     P  +                                +Y
Sbjct: 227 F---STQMERVRTLTDVRNLKFPPLFTQ--------------------------KYPCEY 257

Query: 235 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS 269
              ++  +L   P +R ++   + +  F     P 
Sbjct: 258 --VMVQDMLSPSPMERPEAINIIENAVFEDLDFPG 290

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens} Length = 311

 Score =  147 bits (374), Expect = 3e-41
 Identities = 50/254 (19%), Positives = 83/254 (32%), Gaps = 49/254 (19%)

Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
            L E+    ++ +H   V L +                YL  + C   L           
Sbjct: 103 KLAEVGSHEKVGQHPCCVRLEQAWEEG--------GILYLQTELCGPSLQQHCEAWGASL 154

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              ++   ++  L  L ++HS  ++H D+K AN+ +   G  KL DFGL         G+
Sbjct: 155 PEAQVWGYLRDTLLALAHLHSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAGAGE 214

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           V     +     Y  PELL G  +YG   D++  G  + E+     +  G    QQ+   
Sbjct: 215 V-----QEGDPRYMAPELLQG--SYGTAADVFSLGLTILEVACNMELPHGGEGWQQL--- 264

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
                   P  +    + +L                             +L  +L  DP 
Sbjct: 265 ---RQGYLPPEFTAGLSSEL---------------------------RSVLVMMLEPDPK 294

Query: 249 KRFDSDAALNHDFF 262
            R  ++A L     
Sbjct: 295 LRATAEALLALPVL 308

>4apc_A Serine/threonine-protein kinase NEK1; transferase; 2.10A {Homo sapiens} Length = 350

 Score =  147 bits (373), Expect = 8e-41
 Identities = 62/256 (24%), Positives = 103/256 (40%), Gaps = 48/256 (18%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVK 67
           + RE+ +L  +KH N+V   E              + Y+V D+CE  DL   ++    V 
Sbjct: 70  SRREVAVLANMKHPNIVQYRESFEEN--------GSLYIVMDYCEGGDLFKRINAQKGVL 121

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           F   +I     Q+   L ++H  KILHRD+K+ N+ +TK G ++L DFG+AR  + T   
Sbjct: 122 FQEDQILDWFVQICLALKHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTVE- 180

Query: 128 QVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
                    + T +Y  PE+   ++ Y    D+W  GC++ E+ T     +  + +  + 
Sbjct: 181 ----LARACIGTPYYLSPEICE-NKPYNNKSDIWALGCVLYELCTLKHAFEAGSMKNLVL 235

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            I    GS  P       + DL                             L+ +L   +
Sbjct: 236 KIIS--GSFPP--VSLHYSYDL---------------------------RSLVSQLFKRN 264

Query: 247 PSKRFDSDAALNHDFF 262
           P  R   ++ L   F 
Sbjct: 265 PRDRPSVNSILEKGFI 280

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A* Length = 279

 Score =  145 bits (368), Expect = 8e-41
 Identities = 56/263 (21%), Positives = 101/263 (38%), Gaps = 53/263 (20%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---H 65
            + E+ +L+ LKH N+V   +    + N         Y+V ++CE  DLA +++      
Sbjct: 52  LVSEVNLLRELKHPNIVRYYDRIIDRTNTT------LYIVMEYCEGGDLASVITKGTKER 105

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHS-----NKILHRDMKAANVLITKTGILKLADFGLARA 120
                  + +V+ QL   L   H      + +LHRD+K ANV +     +KL DFGLAR 
Sbjct: 106 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 165

Query: 121 FSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
            +   +     +    V T +Y  PE +    +Y    D+W  GC++ E+    P     
Sbjct: 166 LNHDTS-----FAKTFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAF 219

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
           ++++    I +  G       P   + +L                            +++
Sbjct: 220 SQKELAGKIRE--GKFRR--IPYRYSDEL---------------------------NEII 248

Query: 240 DKLLLLDPSKRFDSDAALNHDFF 262
            ++L L    R   +  L +   
Sbjct: 249 TRMLNLKDYHRPSVEEILENPLI 271

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score =  147 bits (373), Expect = 5e-40
 Identities = 55/284 (19%), Positives = 101/284 (35%), Gaps = 64/284 (22%)

Query: 10  ALREIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLA------GLLS 62
           AL EIK+L     H NV+       T            Y+  + C  +L        +  
Sbjct: 55  ALMEIKLLTESDDHPNVIRYYCSETTDRF--------LYIALELCNLNLQDLVESKNVSD 106

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI------------- 109
                        +++Q+ +G+ ++HS KI+HRD+K  N+L++ +               
Sbjct: 107 ENLKLQKEYNPISLLRQIASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLR 166

Query: 110 LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD------RNYGPPVDLWGAG 163
           + ++DFGL +     ++       N   T  +R PELL         R     +D++  G
Sbjct: 167 ILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELLEESNNLQTKRRLTRSIDIFSMG 226

Query: 164 CIMAEMWT--RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK 221
           C+   + +  + P     + +  I     + G               ++  E+     R 
Sbjct: 227 CVFYYILSKGKHPFGDKYSRESNI-----IRGI--------------FSLDEMKCLHDRS 267

Query: 222 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD 265
           +              DL+ +++  DP KR  +   L H  FW  
Sbjct: 268 LIAEAT---------DLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A* Length = 434

 Score = 41.7 bits (98), Expect = 4e-04
 Identities = 10/29 (34%), Positives = 15/29 (51%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTD 370
           DL+ +++  DP KR  +   L H  FW  
Sbjct: 274 DLISQMIDHDPLKRPTAMKVLRHPLFWPK 302

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* Length = 429

 Score =  146 bits (371), Expect = 9e-40
 Identities = 72/289 (24%), Positives = 125/289 (43%), Gaps = 52/289 (17%)

Query: 10  ALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-S 62
           A  EI+IL+ L+ +      NV+H++E           +R+   + F+    +L  L+  
Sbjct: 140 AAEEIRILEHLRKQDKDNTMNVIHMLE--------NFTFRNHICMTFELLSMNLYELIKK 191

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARA 120
           N    FSL  ++K    +L  L  +H N+I+H D+K  N+L+       +K+ DFG +  
Sbjct: 192 NKFQGFSLPLVRKFAHSILQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCY 251

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
             Q     V  Y   + + +YR PE++LG   YG P+D+W  GCI+AE+ T  P++ G  
Sbjct: 252 EHQR----VYTY---IQSRFYRAPEVILG-ARYGMPIDMWSLGCILAELLTGYPLLPGED 303

Query: 181 EQQQITLISQLCGSI---------------TPESWPGVETLDLYNKMELPKAQKRKVKER 225
           E  Q+  + +L G                 + + +P   T+   +   +     R  + +
Sbjct: 304 EGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRRGK 363

Query: 226 LKPYVKDQYGC------------DLLDKLLLLDPSKRFDSDAALNHDFF 262
           L+   + +               D L + L  DP+ R     AL H + 
Sbjct: 364 LRGPPESREWGNALKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWL 412

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens} Length = 317

 Score =  141 bits (357), Expect = 9e-39
 Identities = 48/271 (17%), Positives = 92/271 (33%), Gaps = 44/271 (16%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK- 67
           A RE  + +L  H N++ L+  C  +    +      +L+  F +   L   +  +  K 
Sbjct: 73  AQREADMHRLFNHPNILRLVAYCLRERGAKHE----AWLLLPFFKRGTLWNEIERLKDKG 128

Query: 68  --FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR-----A 120
              +  +I  ++  +  GL  IH+    HRD+K  N+L+   G   L D G         
Sbjct: 129 NFLTEDQILWLLLGICRGLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHV 188

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIMQG 178
               +   +  +  +  T+ YR PEL     +       D+W  GC++  M         
Sbjct: 189 EGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDERTDVWSLGCVLYAMMFGEGPYDM 248

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
             ++   ++   +   ++    P                   +    L           L
Sbjct: 249 VFQKGD-SVALAVQNQLSIPQSP-------------------RHSSALW---------QL 279

Query: 239 LDKLLLLDPSKRFDSDAALNHDFFWTDPMPS 269
           L+ ++ +DP +R      L+       P P 
Sbjct: 280 LNSMMTVDPHQRPHIPLLLSQLEALQPPAPG 310

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A* Length = 310

 Score =  138 bits (350), Expect = 8e-38
 Identities = 63/280 (22%), Positives = 102/280 (36%), Gaps = 57/280 (20%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---H 65
            ++EI +L+ L H NV+                 +   +V +  +  DL+ ++ +     
Sbjct: 79  CIKEIDLLKQLNHPNVIKYYASFIED--------NELNIVLELADAGDLSRMIKHFKKQK 130

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  + K   QL + L ++HS +++HRD+K ANV IT TG++KL D GL R FS   
Sbjct: 131 RLIPERTVWKYFVQLCSALEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT 190

Query: 126 NGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                   + +V T +Y  PE +     Y    D+W  GC++ EM        G+     
Sbjct: 191 T-----AAHSLVGTPYYMSPERIHE-NGYNFKSDIWSLGCLLYEMAALQSPFYGDKMN-- 242

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY---GCDLLDK 241
              +  LC  I                           +    P   D Y      L++ 
Sbjct: 243 ---LYSLCKKI--------------------------EQCDYPPLPSDHYSEELRQLVNM 273

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
            +  DP KR D     +        M +  +  L  H   
Sbjct: 274 CINPDPEKRPDVTYVYDVAKR----MHACTASSLEHHHHH 309

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score =  139 bits (352), Expect = 1e-37
 Identities = 76/329 (23%), Positives = 128/329 (38%), Gaps = 52/329 (15%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYN--RYRSTFY----------LVFDFCEHD 56
            A  EIK+LQ +   +               +  +    F           +VF+    +
Sbjct: 61  AAEDEIKLLQRVNDADNTK-----EDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGEN 115

Query: 57  LAGLL-SNIHVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLI------TKTG 108
           L  L+    H    L  +K++ +QLL GL Y+H    I+H D+K  NVL+          
Sbjct: 116 LLALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLI 175

Query: 109 ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
            +K+AD G A  + +        YTN + T  YR PE+LLG   +G   D+W   C++ E
Sbjct: 176 QIKIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFE 227

Query: 169 MWTRSPIMQGNT------EQQQITLISQLCGSITPE-SWPGVETLDLYNKMELPKAQKRK 221
           + T   + + +       +   I  I +L G +       G  T   +N   L +   + 
Sbjct: 228 LITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKL 287

Query: 222 VKERLKPYVKDQYGC---------DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLS 272
               L+  + ++Y           D L  +L LDP KR D+   +NH +   D +  +  
Sbjct: 288 KFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEI 346

Query: 273 KMLAQHTQSMFEYLAPPRRPGHMRAHHHH 301
           ++  +        +  P     +R H  H
Sbjct: 347 RVPDRELYGSGSDI--PGWFEEVRDHKRH 373

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A Length = 373

 Score = 43.9 bits (104), Expect = 7e-05
 Identities = 24/148 (16%), Positives = 46/148 (31%), Gaps = 38/148 (25%)

Query: 274 MLAQHTQSMFEYLAPPRRPGHM--RAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKE-- 329
            +AQ    + E L     P ++     +                      G    + +  
Sbjct: 249 HIAQ----IIELLGEL--PSYLLRNGKYTRTFF--------------NSRGLLRNISKLK 288

Query: 330 --RLKPYVKDQYGC---------DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSK 378
              L+  + ++Y           D L  +L LDP KR D+   +NH +   D +  +  +
Sbjct: 289 FWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIR 347

Query: 379 MLAQHTQSMFEYLAPPRRPGHMRAHHHH 406
           +  +        +  P     +R H  H
Sbjct: 348 VPDRELYGSGSDI--PGWFEEVRDHKRH 373

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A* Length = 371

 Score =  139 bits (351), Expect = 2e-37
 Identities = 38/276 (13%), Positives = 68/276 (24%), Gaps = 55/276 (19%)

Query: 12  REIKILQLLKHENVVHLIE------------------ICRTKANQYNRYRSTFYLVFDFC 53
                   L  E+     +                    +    Q +   + + L+    
Sbjct: 111 EATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAA 170

Query: 54  EHDLAGLLSNI------HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKT 107
             DL  L S +           +  +  +  QL+     + S  ++H      N+ I   
Sbjct: 171 SVDLELLFSTLDFVYVFRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPD 230

Query: 108 GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN-YGPPVDLWGAGCIM 166
           G L L D                R     V + Y P E L      +   ++ W  G  +
Sbjct: 231 GRLMLGDVSALWKVGT-------RGPASSVPVTYAPREFLNASTATFTHALNAWQLGLSI 283

Query: 167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL 226
             +W         T   + +           +S                          L
Sbjct: 284 YRVWCLFLPFGLVTPGIKGSWKRPSLRVPGTDSLA------------------FGSCTPL 325

Query: 227 KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
             +VK      L+ + L  D  +R     A+    F
Sbjct: 326 PDFVK-----TLIGRFLNFDRRRRLLPLEAMETPEF 356

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens} Length = 319

 Score =  137 bits (346), Expect = 3e-37
 Identities = 53/267 (19%), Positives = 95/267 (35%), Gaps = 36/267 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE ++L+ L H+N+V L  I      ++        L+ +FC    L  +L      + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRH------KVLIMEFCPCGSLYTVLEEPSNAYG 108

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKT----GILKLADFGLARAFSQ 123
           L E     V++ ++ G+ ++  N I+HR++K  N++         + KL DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGD-------RNYGPPVDLWGAGCIMAEMWTRSP-- 174
            +      + +   T  Y  P++           + YG  VDLW  G       T S   
Sbjct: 169 DEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

Query: 175 --IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
                    ++ +  I     S         E   +    ++P          L   ++ 
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV------SCSLSRGLQV 277

Query: 233 QYGCDLLDKLLLLDPSKRFDSDAALNH 259
                +L  +L  D  K +  D     
Sbjct: 278 L-LTPVLANILEADQEKCWGFDQFFAE 303

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A* Length = 494

 Score =  140 bits (354), Expect = 6e-37
 Identities = 65/259 (25%), Positives = 113/259 (43%), Gaps = 54/259 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HV 66
           L E+ +L+LL H N++ L +    K N        +YLV +  +    G  L   I   +
Sbjct: 84  LEEVAVLKLLDHPNIMKLYDFFEDKRN--------YYLVMECYK----GGELFDEIIHRM 131

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQ 123
           KF+  +   +I+Q+L+G+ Y+H + I+HRD+K  N+L+    K  ++K+ DFGL+  F  
Sbjct: 132 KFNEVDAAVIIKQVLSGVTYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFEN 191

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            K     +   R+ T +Y  PE+L   + Y    D+W  G I+  +    P   G T+Q+
Sbjct: 192 QK-----KMKERLGTAYYIAPEVL--RKKYDEKCDVWSIGVILFILLAGYPPFGGQTDQE 244

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  + +   +     W  V             A+                  DL+ ++L
Sbjct: 245 ILRKVEKGKYTFDSPEWKNVS----------EGAK------------------DLIKQML 276

Query: 244 LLDPSKRFDSDAALNHDFF 262
             D  +R  +  AL H + 
Sbjct: 277 QFDSQRRISAQQALEHPWI 295

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A* Length = 484

 Score =  139 bits (353), Expect = 6e-37
 Identities = 67/259 (25%), Positives = 113/259 (43%), Gaps = 54/259 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HV 66
           LRE+++L+ L H N++ L E    K          FYLV +       G  L   I    
Sbjct: 74  LREVQLLKQLDHPNIMKLYEFFEDKGY--------FYLVGEVYT----GGELFDEIISRK 121

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+L+G+ Y+H NKI+HRD+K  N+L+    K   +++ DFGL+  F  
Sbjct: 122 RFSEVDAARIIRQVLSGITYMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEA 181

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           +K     +  +++ T +Y  PE+L     Y    D+W  G I+  + +  P   G  E  
Sbjct: 182 SK-----KMKDKIGTAYYIAPEVL--HGTYDEKCDVWSTGVILYILLSGCPPFNGANEYD 234

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  + +   +     W  V             A+                  DL+ K+L
Sbjct: 235 ILKKVEKGKYTFELPQWKKVS----------ESAK------------------DLIRKML 266

Query: 244 LLDPSKRFDSDAALNHDFF 262
              PS R  +  AL+H++ 
Sbjct: 267 TYVPSMRISARDALDHEWI 285

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei} Length = 504

 Score =  139 bits (351), Expect = 1e-36
 Identities = 64/256 (25%), Positives = 108/256 (42%), Gaps = 54/256 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HV 66
             EI +L+ L H N++ L ++   K          FYLV +F E    G  L   I    
Sbjct: 94  YNEISLLKSLDHPNIIKLFDVFEDKKY--------FYLVTEFYE----GGELFEQIINRH 141

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQ 123
           KF   +   +++Q+L+G+ Y+H + I+HRD+K  N+L+        +K+ DFGL+  FS+
Sbjct: 142 KFDECDAANIMKQILSGICYLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSK 201

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                  +  +R+ T +Y  PE+L   + Y    D+W  G IM  +    P   G  +Q 
Sbjct: 202 DY-----KLRDRLGTAYYIAPEVL--KKKYNEKCDVWSCGVIMYILLCGYPPFGGQNDQD 254

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            I  + +         W  +            +A+                  +L+  +L
Sbjct: 255 IIKKVEKGKYYFDFNDWKNIS----------DEAK------------------ELIKLML 286

Query: 244 LLDPSKRFDSDAALNH 259
             D +KR  ++ ALN 
Sbjct: 287 TYDYNKRCTAEEALNS 302

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A* Length = 676

 Score =  140 bits (354), Expect = 2e-36
 Identities = 62/287 (21%), Positives = 103/287 (35%), Gaps = 26/287 (9%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            EI+I++ L H NVV   E+      Q         L  ++CE  DL   L+       L
Sbjct: 61  LEIQIMKKLNHPNVVSAREVPDGL--QKLAPNDLPLLAMEYCEGGDLRKYLNQFENCCGL 118

Query: 71  GE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTK 125
            E  I+ ++  + + L Y+H N+I+HRD+K  N+++       I K+ D G A+   Q +
Sbjct: 119 KEGPIRTLLSDISSALRYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE 178

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQ 184
                  T  V TL Y  PELL   + Y   VD W  G +  E  T   P +      Q 
Sbjct: 179 L-----CTEFVGTLQYLAPELLEQ-KKYTVTVDYWSFGTLAFECITGFRPFLPNWQPVQW 232

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
              + +               +   + +  P      +  +L+           L  +L+
Sbjct: 233 HGKVREKSNEHIVVYDDLTGAVKFSSVLPTPNHLSGILAGKLER---------WLQCMLM 283

Query: 245 LDPSKRFDSDAALNHDFF--WTDPMPSDLSKMLAQHTQSMFEYLAPP 289
               +R       N   F      +   L  ++   +  +  Y    
Sbjct: 284 WHQRQRGTDPQNPNVGCFQALDSILSLKLLSVMNMVSGRVHTYPVTE 330

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A* Length = 486

 Score =  137 bits (347), Expect = 5e-36
 Identities = 64/256 (25%), Positives = 109/256 (42%), Gaps = 54/256 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HV 66
           LRE+++L+ L H N++ L EI    ++        FY+V +       G  L   I    
Sbjct: 69  LREVELLKKLDHPNIMKLFEILEDSSS--------FYIVGELYT----GGELFDEIIKRK 116

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQ 123
           +FS  +  ++I+Q+ +G+ Y+H + I+HRD+K  N+L+    K   +K+ DFGL+  F Q
Sbjct: 117 RFSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQ 176

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                  +  +R+ T +Y  PE+L     Y    D+W AG I+  + + +P   G  E  
Sbjct: 177 NT-----KMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYD 229

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  +     +     W  +             A+                  DL+ K+L
Sbjct: 230 ILKRVETGKYAFDLPQWRTIS----------DDAK------------------DLIRKML 261

Query: 244 LLDPSKRFDSDAALNH 259
              PS R  +   L H
Sbjct: 262 TFHPSLRITATQCLEH 277

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A* Length = 382

 Score =  135 bits (341), Expect = 5e-36
 Identities = 72/296 (24%), Positives = 116/296 (39%), Gaps = 59/296 (19%)

Query: 10  ALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-S 62
           A  E+++L+L+          +VHL          +  +R+   LVF+   ++L  LL +
Sbjct: 97  AQIEVRLLELMNKHDTEMKYYIVHLKR--------HFMFRNHLCLVFEMLSYNLYDLLRN 148

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT--KTGILKLADFGLA 118
                 SL   +K  QQ+   L ++ + +  I+H D+K  N+L+   K   +K+ DFG +
Sbjct: 149 TNFRGVSLNLTRKFAQQMCTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSS 208

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
               Q     + +Y   + + +YR PE+LLG   Y   +D+W  GCI+ EM T  P+  G
Sbjct: 209 CQLGQR----IYQY---IQSRFYRSPEVLLGMP-YDLAIDMWSLGCILVEMHTGEPLFSG 260

Query: 179 NTEQQQITLISQLCGSITPE--------------------------------SWPGVETL 206
             E  Q+  I ++ G                                       PG   L
Sbjct: 261 ANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTRKL 320

Query: 207 DLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                +E      R+  E            DL+ ++L  DP  R     AL H FF
Sbjct: 321 HNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFF 376

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A Length = 419

 Score =  135 bits (342), Expect = 9e-36
 Identities = 65/278 (23%), Positives = 108/278 (38%), Gaps = 60/278 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
            EI+IL+ L H  ++ +      +          +Y+V +  E    G  L   +  + +
Sbjct: 189 TEIEILKKLNHPCIIKIKNFFDAE---------DYYIVLELME----GGELFDKVVGNKR 235

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
                 K    Q+L  + Y+H N I+HRD+K  NVL++   +  ++K+ DFG ++     
Sbjct: 236 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKIL--- 292

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTE 181
             G+ +       T  Y  PE+L+      Y   VD W  G I+    +   P  +  T+
Sbjct: 293 --GETSLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILFICLSGYPPFSEHRTQ 350

Query: 182 QQQITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
                 I    G     PE W  V            KA                   DL+
Sbjct: 351 VSLKDQI--TSGKYNFIPEVWAEVS----------EKAL------------------DLV 380

Query: 240 DKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 277
            KLL++DP  RF ++ AL H +   + M      +L++
Sbjct: 381 KKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 418

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II} Length = 345

 Score =  133 bits (337), Expect = 9e-36
 Identities = 57/294 (19%), Positives = 106/294 (36%), Gaps = 79/294 (26%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----------------- 54
            E+++++ L H N+  L E+   +            LV + C                  
Sbjct: 77  TEVRLMKKLHHPNIARLYEVYEDEQY--------ICLVMELCHGGHLLDKLNVFIDDSTG 128

Query: 55  -----------------------HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNK 91
                                    + G   ++        I  +++Q+ + L+Y+H+  
Sbjct: 129 KCAMDVVKTQICPCPECNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQG 188

Query: 92  ILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG 149
           I HRD+K  N L +  K+  +KL DFGL++ F +  NG+    T +  T ++  PE+L  
Sbjct: 189 ICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLNNGEYYGMTTKAGTPYFVAPEVLNT 248

Query: 150 -DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDL 208
            + +YGP  D W AG ++  +   +    G  +   I+ +          ++        
Sbjct: 249 TNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPNYN------- 301

Query: 209 YNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                        +    +         DLL  LL  +  +RFD+  AL H + 
Sbjct: 302 ------------VLSPLAR---------DLLSNLLNRNVDERFDAMRALQHPWI 334

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score =  131 bits (331), Expect = 5e-35
 Identities = 62/280 (22%), Positives = 106/280 (37%), Gaps = 64/280 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
            EI+IL+ L H  ++ +      +          +Y+V +  E    G  L   +  + +
Sbjct: 64  TEIEILKKLNHPCIIKIKNFFDAED---------YYIVLELME----GGELFDKVVGNKR 110

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQT 124
                 K    Q+L  + Y+H N I+HRD+K  NVL++      ++K+ DFG ++   +T
Sbjct: 111 LKEATCKLYFYQMLLAVQYLHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET 170

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                        T  Y  PE+L+      Y   VD W  G I+        I       
Sbjct: 171 S-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSLGVILF-------IC------ 212

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKM-----ELPKAQKRKVKERLKPYVKDQYGCD 237
                   L G   P        + L +++             +V E+           D
Sbjct: 213 --------LSG--YPPFSEHRTQVSLKDQITSGKYNFIPEVWAEVSEKAL---------D 253

Query: 238 LLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 277
           L+ KLL++DP  RF ++ AL H +   + M      +L++
Sbjct: 254 LVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A* Length = 322

 Score = 41.1 bits (97), Expect = 4e-04
 Identities = 14/41 (34%), Positives = 24/41 (58%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 382
           DL+ KLL++DP  RF ++ AL H +   + M      +L++
Sbjct: 253 DLVKKLLVVDPKARFTTEEALRHPWLQDEDMKRKFQDLLSE 293

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens} Length = 396

 Score =  131 bits (331), Expect = 2e-34
 Identities = 53/267 (19%), Positives = 95/267 (35%), Gaps = 36/267 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE ++L+ L H+N+V L  I      ++        L+ +FC    L  +L      + 
Sbjct: 55  MREFEVLKKLNHKNIVKLFAIEEETTTRH------KVLIMEFCPCGSLYTVLEEPSNAYG 108

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKT----GILKLADFGLARAFSQ 123
           L E     V++ ++ G+ ++  N I+HR++K  N++         + KL DFG AR    
Sbjct: 109 LPESEFLIVLRDVVGGMNHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELED 168

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGD-------RNYGPPVDLWGAGCIMAEMWTRSP-- 174
            +      + +   T  Y  P++           + YG  VDLW  G       T S   
Sbjct: 169 DEQ-----FVSLYGTEEYLHPDMYERAVLRKDHQKKYGATVDLWSIGVTFYHAATGSLPF 223

Query: 175 --IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
                    ++ +  I     S         E   +    ++P          L   ++ 
Sbjct: 224 RPFEGPRRNKEVMYKIITGKPSGAISGVQKAENGPIDWSGDMPV------SCSLSRGLQV 277

Query: 233 QYGCDLLDKLLLLDPSKRFDSDAALNH 259
                +L  +L  D  K +  D     
Sbjct: 278 LL-TPVLANILEADQEKCWGFDQFFAE 303

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A* Length = 277

 Score =  128 bits (323), Expect = 3e-34
 Identities = 65/257 (25%), Positives = 101/257 (39%), Gaps = 58/257 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
           +EI+I++ L H N++ L E      +         YLV + C     G  L   +     
Sbjct: 55  QEIEIMKSLDHPNIIRLYETFEDNTD--------IYLVMELCT----GGELFERVVHKRV 102

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           F   +  ++++ +L+ + Y H   + HRD+K  N L         LKL DFGLA  F   
Sbjct: 103 FRESDAARIMKDVLSAVAYCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPG 162

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           K         +V T +Y  P++L  +  YGP  D W AG +M  +    P     T+ + 
Sbjct: 163 K-----MMRTKVGTPYYVSPQVL--EGLYGPECDEWSAGVMMYVLLCGYPPFSAPTDSEV 215

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           +  I    G+ T   + W  V           P+A+                   L+ +L
Sbjct: 216 MLKI--REGTFTFPEKDWLNVS----------PQAE------------------SLIRRL 245

Query: 243 LLLDPSKRFDSDAALNH 259
           L   P +R  S  AL H
Sbjct: 246 LTKSPKQRITSLQALEH 262

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A* Length = 287

 Score =  128 bits (323), Expect = 3e-34
 Identities = 64/257 (24%), Positives = 108/257 (42%), Gaps = 58/257 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
           RE+++L+ L H N++ L EI    ++        FY+V +       G  L   I    +
Sbjct: 70  REVELLKKLDHPNIMKLFEILEDSSS--------FYIVGELYT----GGELFDEIIKRKR 117

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           FS  +  ++I+Q+ +G+ Y+H + I+HRD+K  N+L+    K   +K+ DFGL+  F Q 
Sbjct: 118 FSEHDAARIIKQVFSGITYMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQN 177

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                 +  +R+ T +Y  PE+L     Y    D+W AG I+  + + +P   G  E   
Sbjct: 178 T-----KMKDRIGTAYYIAPEVL--RGTYDEKCDVWSAGVILYILLSGTPPFYGKNEYDI 230

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           +  +    G        W  +             A+                  DL+ K+
Sbjct: 231 LKRV--ETGKYAFDLPQWRTIS----------DDAK------------------DLIRKM 260

Query: 243 LLLDPSKRFDSDAALNH 259
           L   PS R  +   L H
Sbjct: 261 LTFHPSLRITATQCLEH 277

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A* Length = 294

 Score =  128 bits (323), Expect = 4e-34
 Identities = 61/270 (22%), Positives = 105/270 (38%), Gaps = 65/270 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV---KF 68
            EI I + L H++VV                    ++V + C       L  +H      
Sbjct: 64  MEISIHRSLAHQHVVGFHGFFEDNDF--------VFVVLELCRR---RSLLELHKRRKAL 112

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  E +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA         +
Sbjct: 113 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--------TK 164

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           V     R   L     Y  PE+L   + +   VD+W  GCIM  +               
Sbjct: 165 VEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTL--------------- 208

Query: 185 ITLISQLCGSITPESWPGVETLD---LYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
                 L G       P  ET      Y ++       +K +  +  ++       L+ K
Sbjct: 209 ------LVGK------PPFETSCLKETYLRI-------KKNEYSIPKHINPV-AASLIQK 248

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDL 271
           +L  DP+ R   +  LN +FF +  +P+ L
Sbjct: 249 MLQTDPTARPTINELLNDEFFTSGYIPARL 278

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus} Length = 332

 Score =  128 bits (324), Expect = 5e-34
 Identities = 46/261 (17%), Positives = 96/261 (36%), Gaps = 53/261 (20%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS--NIHVKFS 69
           +I+ +     +N V           Q +  +   Y+    C   +L   ++         
Sbjct: 111 KIRRMDPFSTKNTVGQ--------LQPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDRE 162

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ- 128
            G    +  Q+   + ++HS  ++HRD+K +N+  T   ++K+ DFGL  A  Q +  Q 
Sbjct: 163 HGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQT 222

Query: 129 -------VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
                     +T +V T  Y  PE + G  NY   VD++  G I+ E+          T+
Sbjct: 223 VLTPMPAYATHTGQVGTKLYMSPEQIHG-NNYSHKVDIFSLGLILFELLYSFS-----TQ 276

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
            +++ +I+ +     P  +                                ++   ++  
Sbjct: 277 MERVRIITDVRNLKFPLLFT--------------------------QKYPQEH--MMVQD 308

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
           +L   P++R ++   + +  F
Sbjct: 309 MLSPSPTERPEATDIIENAIF 329

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X* Length = 348

 Score =  128 bits (324), Expect = 8e-34
 Identities = 58/275 (21%), Positives = 99/275 (36%), Gaps = 64/275 (23%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE--------HDLAGLLSN 63
            E++I+  +K+E  +    I               Y+++++ E             L  N
Sbjct: 92  NELQIITDIKNEYCLTCEGIITNYDE--------VYIIYEYMENDSILKFDEYFFVLDKN 143

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLARAFS 122
                 +  IK +I+ +LN   YIH+ K I HRD+K +N+L+ K G +KL+DFG +    
Sbjct: 144 YTCFIPIQVIKCIIKSVLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMV 203

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNY-GPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
             K            T  + PPE    + +Y G  VD+W  G  +  M            
Sbjct: 204 DKK-----IKG-SRGTYEFMPPEFFSNESSYNGAKVDIWSLGICLYVM------------ 245

Query: 182 QQQITLISQLCGSITP---ESWPGVETLDLYNK-----MELPKAQKRKVKERLKPYVKDQ 233
                          P   +       ++L+N      +E P  +   +           
Sbjct: 246 ---------FYNV-VPFSLKI----SLVELFNNIRTKNIEYPLDRNHFLYPLTNKKSTCS 291

Query: 234 YG------CDLLDKLLLLDPSKRFDSDAALNHDFF 262
                    D L   L  +P++R  S+ AL H++ 
Sbjct: 292 NNFLSNEDIDFLKLFLRKNPAERITSEDALKHEWL 326

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A* Length = 335

 Score =  127 bits (322), Expect = 1e-33
 Identities = 61/271 (22%), Positives = 105/271 (38%), Gaps = 65/271 (23%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV---KF 68
            EI I + L H++VV                    ++V + C       L  +H      
Sbjct: 90  MEISIHRSLAHQHVVGFHGFFEDNDF--------VFVVLELCRR---RSLLELHKRRKAL 138

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  E +  ++Q++ G  Y+H N+++HRD+K  N+ + +   +K+ DFGLA         +
Sbjct: 139 TEPEARYYLRQIVLGCQYLHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLA--------TK 190

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           V     R   L     Y  PE+L   + +   VD+W  GCIM  +               
Sbjct: 191 VEYDGERKKVLCGTPNYIAPEVLSK-KGHSFEVDVWSIGCIMYTL--------------- 234

Query: 185 ITLISQLCGSITPESWPGVETLD---LYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
                 L G       P  ET      Y ++       +K +  +  ++       L+ K
Sbjct: 235 ------LVGK------PPFETSCLKETYLRI-------KKNEYSIPKHINPV-AASLIQK 274

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLS 272
           +L  DP+ R   +  LN +FF +  +P+ L 
Sbjct: 275 MLQTDPTARPTINELLNDEFFTSGYIPARLP 305

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score =  127 bits (321), Expect = 2e-33
 Identities = 61/291 (20%), Positives = 110/291 (37%), Gaps = 54/291 (18%)

Query: 10  ALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-S 62
           A  EI++L+ L           V ++E        +  +     +VF+         +  
Sbjct: 58  ARSEIQVLEHLNTTDPNSTFRCVQMLE--------WFEHHGHICIVFELLGLSTYDFIKE 109

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----------------- 105
           N  + F L  I+K+  Q+   + ++HSNK+ H D+K  N+L                   
Sbjct: 110 NGFLPFRLDHIRKMAYQICKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDER 169

Query: 106 --KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG 163
                 +K+ DFG     S T + + +  T  V T  YR PE++L    +  P D+W  G
Sbjct: 170 TLINPDIKVVDFG-----SATYDDE-HHST-LVSTRHYRAPEVILALG-WSQPCDVWSIG 221

Query: 164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVK 223
           CI+ E +    +   +  ++ + ++ ++ G +             ++   L   +     
Sbjct: 222 CILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSSAG 281

Query: 224 ERLKPYVK------------DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
             +    K             +   DL+ K+L  DP+KR     AL H FF
Sbjct: 282 RYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A* Length = 339

 Score = 43.0 bits (102), Expect = 1e-04
 Identities = 28/96 (29%), Positives = 38/96 (39%), Gaps = 9/96 (9%)

Query: 277 QHTQSMFEYLAPPRRPGHM----RAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLK 332
           +H   M   L P   P HM    R   + HH         +AGR  +       +KE + 
Sbjct: 241 EHLAMMERILGPL--PKHMIQKTRKRKYFHHDRLDWDEHSSAGRYVSRA--CKPLKEFML 296

Query: 333 PYVKDQYGC-DLLDKLLLLDPSKRFDSDAALNHDFF 367
               +     DL+ K+L  DP+KR     AL H FF
Sbjct: 297 SQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFF 332

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score =  127 bits (322), Expect = 2e-33
 Identities = 63/286 (22%), Positives = 113/286 (39%), Gaps = 44/286 (15%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYN--RYRSTFY------LVFDFCEHDLAGLL 61
           A  EI +L+ +K ++          K N++        F       + F+    +    L
Sbjct: 63  ARLEINVLKKIKEKD----------KENKFLCVLMSDWFNFHGHMCIAFELLGKNTFEFL 112

Query: 62  -SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
             N    + L  ++ +  QL + L ++H N++ H D+K  N+L   +    L +   +  
Sbjct: 113 KENNFQPYPLPHVRHMAYQLCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCE 172

Query: 121 FSQTKNGQV------------NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAE 168
               KN  +              +T  V T  YRPPE++L    +  P D+W  GCI+ E
Sbjct: 173 EKSVKNTSIRVADFGSATFDHEHHTTIVATRHYRPPEVILELG-WAQPCDVWSIGCILFE 231

Query: 169 MWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELP----KAQKRKVKE 224
            +    + Q +  ++ + ++ ++ G I             + K  L      +  R VKE
Sbjct: 232 YYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE 291

Query: 225 RLKP--------YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
             KP         ++     DL+ ++L  DP++R     AL H FF
Sbjct: 292 NCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A* Length = 355

 Score = 43.1 bits (102), Expect = 1e-04
 Identities = 24/96 (25%), Positives = 37/96 (38%), Gaps = 9/96 (9%)

Query: 277 QHTQSMFEYLAPPRRPGHM----RAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLK 332
           +H   M + L P   P HM    R   + +  G       + GR   E      +K  + 
Sbjct: 246 EHLVMMEKILGPI--PSHMIHRTRKQKYFYKGGLVWDENSSDGRYVKE--NCKPLKSYML 301

Query: 333 PYVKDQYGC-DLLDKLLLLDPSKRFDSDAALNHDFF 367
               +     DL+ ++L  DP++R     AL H FF
Sbjct: 302 QDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFF 337

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens} Length = 278

 Score =  125 bits (316), Expect = 3e-33
 Identities = 62/264 (23%), Positives = 106/264 (40%), Gaps = 56/264 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            E+KI   LKH +++ L                  YLV + C + ++   L N    FS 
Sbjct: 60  NEVKIHCQLKHPSILELYNYFEDSNY--------VYLVLEMCHNGEMNRYLKNRVKPFSE 111

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            E +  + Q++ G+ Y+HS+ ILHRD+  +N+L+T+   +K+ADFGLA    +  + +  
Sbjct: 112 NEARHFMHQIITGMLYLHSHGILHRDLTLSNLLLTRNMNIKIADFGLA-TQLKMPHEK-- 168

Query: 131 RYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
            YT   +  T  Y  PE+      +G   D+W  GC+   +                   
Sbjct: 169 HYT---LCGTPNYISPEIATR-SAHGLESDVWSLGCMFYTL------------------- 205

Query: 189 SQLCGSITPESWPGVETLD---LYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             L G       P  +T       NK+             +  ++  +   DL+ +LL  
Sbjct: 206 --LIGR------PPFDTDTVKNTLNKV-------VLADYEMPSFLSIE-AKDLIHQLLRR 249

Query: 246 DPSKRFDSDAALNHDFFWTDPMPS 269
           +P+ R    + L+H F   +    
Sbjct: 250 NPADRLSLSSVLDHPFMSRNSSTK 273

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A* Length = 284

 Score =  125 bits (316), Expect = 3e-33
 Identities = 68/260 (26%), Positives = 101/260 (38%), Gaps = 63/260 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
           RE +I + L+H N+V L +  + ++          YLVFD       G  L  +I     
Sbjct: 54  REARICRKLQHPNIVRLHDSIQEESF--------HYLVFDLVT----GGELFEDIVAREF 101

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           +S  +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA      
Sbjct: 102 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--- 158

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ-- 182
            + +   +     T  Y  PE+L     Y  PVD+W  G I+  +    P      +   
Sbjct: 159 NDSEA--WHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 215

Query: 183 -QQITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
             QI       G+       W  V            K                     L+
Sbjct: 216 YAQI-----KAGAYDYPSPEWDTVT--------PEAK--------------------SLI 242

Query: 240 DKLLLLDPSKRFDSDAALNH 259
           D +L ++P KR  +D AL  
Sbjct: 243 DSMLTVNPKKRITADQALKV 262

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii} Length = 285

 Score =  124 bits (313), Expect = 1e-32
 Identities = 56/255 (21%), Positives = 96/255 (37%), Gaps = 51/255 (20%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIHVK 67
            EI++L+ L H N++ + E+     N         Y+V + CE     +           
Sbjct: 69  AEIEVLKSLDHPNIIKIFEVFEDYHN--------MYIVMETCEGGELLERIVSAQARGKA 120

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
            S G + ++++Q++N L Y HS  ++H+D+K  N+L         +K+ DFGLA  F   
Sbjct: 121 LSEGYVAELMKQMMNALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSD 180

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           +       TN   T  Y  PE+    R+     D+W AG +M  + T      G + ++ 
Sbjct: 181 E-----HSTNAAGTALYMAPEVF--KRDVTFKCDIWSAGVVMYFLLTGCLPFTGTSLEEV 233

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
                                              R +  +           DLL ++L 
Sbjct: 234 QQKA--TYKEPNYAVEC------------------RPLTPQAV---------DLLKQMLT 264

Query: 245 LDPSKRFDSDAALNH 259
            DP +R  +   L+H
Sbjct: 265 KDPERRPSAAQVLHH 279

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens} Length = 295

 Score =  124 bits (313), Expect = 1e-32
 Identities = 54/172 (31%), Positives = 79/172 (45%), Gaps = 25/172 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQY---NRYRSTFYLVFDFCEHD-LAGLLSNIHVK 67
            EI + + LKH+N+V           QY           +  +      L+ LL +    
Sbjct: 68  EEIALHKHLKHKNIV-----------QYLGSFSENGFIKIFMEQVPGGSLSALLRSKWGP 116

Query: 68  FSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLARAFSQT 124
               E  I    +Q+L GL Y+H N+I+HRD+K  NVLI T +G+LK++DFG ++  +  
Sbjct: 117 LKDNEQTIGFYTKQILEGLKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGI 176

Query: 125 KNGQVNRYTNRVV-TLWYRPPELLLGDRN-YGPPVDLWGAGCIMAEMWTRSP 174
                N  T     TL Y  PE++      YG   D+W  GC + EM T  P
Sbjct: 177 -----NPCTETFTGTLQYMAPEIIDKGPRGYGKAADIWSLGCTIIEMATGKP 223

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score =  124 bits (314), Expect = 3e-32
 Identities = 57/298 (19%), Positives = 110/298 (36%), Gaps = 61/298 (20%)

Query: 10  ALREIKILQLLKHE-----NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SN 63
           A  E  IL+ ++++     N+V               Y     L+F+     L  ++  N
Sbjct: 78  AKIEADILKKIQNDDINNNNIVKYHG--------KFMYYDHMCLIFEPLGPSLYEIITRN 129

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT------------------ 105
            +  F + +IK    ++L  L Y+    + H D+K  N+L+                   
Sbjct: 130 NYNGFHIEDIKLYCIEILKALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGK 189

Query: 106 -------KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD 158
                  K+  +KL DFG       T       + + + T  YR PE++L    +    D
Sbjct: 190 KIQIYRTKSTGIKLIDFG-----CATFKSD--YHGSIINTRQYRAPEVILN-LGWDVSSD 241

Query: 159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPE-----SWPGVETLDLYNKME 213
           +W  GC++AE++T S + + +   + + ++  +   I        +          ++++
Sbjct: 242 MWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDELK 301

Query: 214 LPKAQKRKVKERLKPY---------VKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
           L   +       +K           +K +  CD L  +L +DP+ R      L H F 
Sbjct: 302 LAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7} Length = 360

 Score = 40.4 bits (95), Expect = 8e-04
 Identities = 19/96 (19%), Positives = 32/96 (33%), Gaps = 7/96 (7%)

Query: 277 QHTQSMFEYLAPPRRPGHM--RAHHHHHHAGAPGAAGPAAGRATTETGYHDRVKERLKP- 333
           +H   M   + P   P +M   A   +            A      +    +  ++  P 
Sbjct: 266 EHLAMMESIIQPI--PKNMLYEATKTNGSKYVNKDELKLAWPENASSINSIKHVKKCLPL 323

Query: 334 --YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
              +K +  CD L  +L +DP+ R      L H F 
Sbjct: 324 YKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFL 359

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B Length = 362

 Score =  124 bits (314), Expect = 3e-32
 Identities = 67/257 (26%), Positives = 101/257 (39%), Gaps = 57/257 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
           RE +I + L+H N+V L +  + ++          YLVFD       G  L  +I     
Sbjct: 77  REARICRKLQHPNIVRLHDSIQEESF--------HYLVFDLVT----GGELFEDIVAREF 124

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           +S  +    IQQ+L  + Y HSN I+HR++K  N+L+    K   +KLADFGLA      
Sbjct: 125 YSEADASHCIQQILESIAYCHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEV--- 181

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
            + +   +     T  Y  PE+L     Y  PVD+W  G I+  +    P      + + 
Sbjct: 182 NDSEA--WHGFAGTPGYLSPEVLKK-DPYSKPVDIWACGVILYILLVGYPPFWDEDQHRL 238

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
              I    G+       W  V            K                     L+D +
Sbjct: 239 YAQI--KAGAYDYPSPEWDTVT--------PEAK--------------------SLIDSM 268

Query: 243 LLLDPSKRFDSDAALNH 259
           L ++P KR  +D AL  
Sbjct: 269 LTVNPKKRITADQALKV 285

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens} Length = 337

 Score =  124 bits (312), Expect = 3e-32
 Identities = 44/175 (25%), Positives = 77/175 (44%), Gaps = 15/175 (8%)

Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HV 66
            ++E+  + +L  H N+V           + +  ++ F L+ + C+  L   L  +    
Sbjct: 72  IIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRG 131

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLAR----- 119
             S   + K+  Q    + ++H  K  I+HRD+K  N+L++  G +KL DFG A      
Sbjct: 132 PLSCDTVLKIFYQTCRAVQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHY 191

Query: 120 ---AFSQTKNGQVNRYTNRVVTLWYRPPEL--LLGDRNYGPPVDLWGAGCIMAEM 169
              ++S  +   V     R  T  YR PE+  L  +   G   D+W  GCI+  +
Sbjct: 192 PDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNFPIGEKQDIWALGCILYLL 246

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A* Length = 298

 Score =  121 bits (307), Expect = 7e-32
 Identities = 62/275 (22%), Positives = 102/275 (37%), Gaps = 65/275 (23%)

Query: 11  LREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--H 65
           L+E+ IL+ +  H N++ L +   T           F+LVFD  +       L   +   
Sbjct: 71  LKEVDILRKVSGHPNIIQLKDTYETNTF--------FFLVFDLMK----KGELFDYLTEK 118

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           V  S  E +K+++ LL  +  +H   I+HRD+K  N+L+     +KL DFG +       
Sbjct: 119 VTLSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG- 177

Query: 126 NGQVNRYTNRVVTLWYRPPELLLG-----DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
                +      T  Y  PE++          YG  VD+W  G IM  +   SP      
Sbjct: 178 ----EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRK 233

Query: 181 EQ---QQITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG 235
           +    + I     + G+       W            +  K                   
Sbjct: 234 QMLMLRMI-----MSGNYQFGSPEWDDYS--------DTVK------------------- 261

Query: 236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 270
            DL+ + L++ P KR+ ++ AL H FF    +   
Sbjct: 262 -DLVSRFLVVQPQKRYTAEEALAHPFFQQYVVEEV 295

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 3lau_A* 2wtv_A* ... Length = 279

 Score =  121 bits (305), Expect = 1e-31
 Identities = 62/252 (24%), Positives = 98/252 (38%), Gaps = 49/252 (19%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           RE++I   L+H N++ L                  YL+ ++     +   L  +  KF  
Sbjct: 58  REVEIQSHLRHPNILRLYGYFHDATR--------VYLILEYAPLGTVYRELQKLS-KFDE 108

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
                 I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG +            
Sbjct: 109 QRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWS-----VHAPSSR 163

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
           R      TL Y PPE++ G R +   VDLW  G +  E                      
Sbjct: 164 RTD-LCGTLDYLPPEMIEG-RMHDEKVDLWSLGVLCYEF--------------------- 200

Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
           L G   P  +      + Y ++        +V+     +V +    DL+ +LL  +PS+R
Sbjct: 201 LVGK-PP--FEANTYQETYKRI-------SRVEFTFPDFVTEG-ARDLISRLLKHNPSQR 249

Query: 251 FDSDAALNHDFF 262
                 L H + 
Sbjct: 250 PMLREVLEHPWI 261

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A Length = 351

 Score =  122 bits (308), Expect = 2e-31
 Identities = 67/262 (25%), Positives = 106/262 (40%), Gaps = 63/262 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-------SNI 64
           RE  I  +LKH ++V L+E   +            Y+VF+F +      L       ++ 
Sbjct: 75  REASICHMLKHPHIVELLETYSSDGM--------LYMVFEFMD---GADLCFEIVKRADA 123

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAF 121
              +S       ++Q+L  L Y H N I+HRD+K   VL+     +  +KL  FG+A   
Sbjct: 124 GFVYSEAVASHYMRQILEALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQL 183

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
              ++G V     RV T  +  PE++     YG PVD+WG G I+  + +      G  E
Sbjct: 184 G--ESGLV--AGGRVGTPHFMAPEVVKR-EPYGKPVDVWGCGVILFILLSGCLPFYGTKE 238

Query: 182 Q--QQITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
           +  + I     + G     P  W  +                           KD     
Sbjct: 239 RLFEGI-----IKGKYKMNPRQWSHIS-----------------------ESAKD----- 265

Query: 238 LLDKLLLLDPSKRFDSDAALNH 259
           L+ ++L+LDP++R     ALNH
Sbjct: 266 LVRRMLMLDPAERITVYEALNH 287

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A Length = 321

 Score =  121 bits (306), Expect = 2e-31
 Identities = 62/280 (22%), Positives = 111/280 (39%), Gaps = 56/280 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
            RE+ IL+ + H NV+ L ++   + +          L+ +      +G  L   +  K 
Sbjct: 63  EREVSILRQVLHHNVITLHDVYENRTD--------VVLILELV----SGGELFDFLAQKE 110

Query: 69  SLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGLARAFS 122
           SL E      I+Q+L+G+ Y+H+ KI H D+K  N+++         +KL DFGLA    
Sbjct: 111 SLSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIE 170

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                    + N   T  +  PE++  +   G   D+W  G I   + + +    G+T+Q
Sbjct: 171 DGV-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQ 224

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           + +  I+ +      E +            EL K                    D + KL
Sbjct: 225 ETLANITSVSYDFDEEFFSHTS--------ELAK--------------------DFIRKL 256

Query: 243 LLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 282
           L+ +  KR     AL H   W  P+ +  + +  +   ++
Sbjct: 257 LVKETRKRLTIQEALRHP--WITPVDNQQAMVRRESVVNL 294

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7 Length = 321

 Score =  120 bits (304), Expect = 3e-31
 Identities = 50/255 (19%), Positives = 93/255 (36%), Gaps = 53/255 (20%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---HV 66
           +EI IL + +H N++HL E   +             ++F+F      G  +   I     
Sbjct: 50  KEISILNIARHRNILHLHESFESMEE--------LVMIFEFIS----GLDIFERINTSAF 97

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQT 124
           + +  EI   + Q+   L ++HS+ I H D++  N++    ++  +K+ +FG AR     
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                  +        Y  PE+   D       D+W  G ++  + +        T QQ 
Sbjct: 158 D-----NFRLLFTAPEYYAPEVHQHD-VVSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           I  I     +   E++  +            +A                   D +D+LL+
Sbjct: 212 IENIMNAEYTFDEEAFKEIS----------IEAM------------------DFVDRLLV 243

Query: 245 LDPSKRFDSDAALNH 259
            +   R  +  AL H
Sbjct: 244 KERKSRMTASEALQH 258

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A* Length = 336

 Score =  121 bits (305), Expect = 3e-31
 Identities = 58/262 (22%), Positives = 97/262 (37%), Gaps = 57/262 (21%)

Query: 12  REIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---- 64
           +E+    Q     ++V ++++     +     +    ++ +  E    G  L S I    
Sbjct: 70  QEVDHHWQASGGPHIVCILDVYENMHHG----KRCLLIIMECME----GGELFSRIQERG 121

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAF 121
              F+  E  ++++ +   + ++HS+ I HRD+K  N+L T   K  +LKL DFG A+  
Sbjct: 122 DQAFTEREAAEIMRDIGTAIQFLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKET 181

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           +Q      N       T +Y  PE+L     Y    D+W  G IM  +    P    NT 
Sbjct: 182 TQ------NALQTPCYTPYYVAPEVLGP-EKYDKSCDMWSLGVIMYILLCGFPPFYSNTG 234

Query: 182 QQQITLISQ--LCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
           Q     + +    G        W                    +V E  K          
Sbjct: 235 QAISPGMKRRIRLGQYGFPNPEWS-------------------EVSEDAK---------Q 266

Query: 238 LLDKLLLLDPSKRFDSDAALNH 259
           L+  LL  DP++R      +NH
Sbjct: 267 LIRLLLKTDPTERLTITQFMNH 288

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ... Length = 283

 Score =  119 bits (301), Expect = 4e-31
 Identities = 60/256 (23%), Positives = 106/256 (41%), Gaps = 54/256 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ ++H N++ L +I   K +          L+ +      +G  L   +  K S
Sbjct: 57  REVNILREIRHPNIITLHDIFENKTD--------VVLILELV----SGGELFDFLAEKES 104

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGLARAFSQ 123
           L E    + ++Q+L+G++Y+HS +I H D+K  N+++         +KL DFG+A     
Sbjct: 105 LTEDEATQFLKQILDGVHYLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEA 164

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                   + N   T  +  PE++  +   G   D+W  G I   + + +    G T+Q+
Sbjct: 165 GN-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGETKQE 218

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +T IS +      E +            EL K                    D + +LL
Sbjct: 219 TLTNISAVNYDFDEEYFSNTS--------ELAK--------------------DFIRRLL 250

Query: 244 LLDPSKRFDSDAALNH 259
           + DP +R     +L H
Sbjct: 251 VKDPKRRMTIAQSLEH 266

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens} Length = 326

 Score =  120 bits (303), Expect = 5e-31
 Identities = 64/272 (23%), Positives = 109/272 (40%), Gaps = 54/272 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
            RE+ IL+ ++H NV+ L E+   K +          L+ +      AG  L   +  K 
Sbjct: 62  EREVSILKEIQHPNVITLHEVYENKTD--------VILILELV----AGGELFDFLAEKE 109

Query: 69  SLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGLARAFS 122
           SL E    + ++Q+LNG+YY+HS +I H D+K  N+++         +K+ DFGLA    
Sbjct: 110 SLTEEEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKID 169

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                    + N   T  +  PE++  +   G   D+W  G I   + + +    G+T+Q
Sbjct: 170 FGN-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQ 223

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           + +  +S +      E +             L K                    D + +L
Sbjct: 224 ETLANVSAVNYEFEDEYFSNTS--------ALAK--------------------DFIRRL 255

Query: 243 LLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           L+ DP KR     +L H +         LS+ 
Sbjct: 256 LVKDPKKRMTIQDSLQHPWIKPKDTQQALSRK 287

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A* Length = 361

 Score =  120 bits (304), Expect = 6e-31
 Identities = 61/279 (21%), Positives = 111/279 (39%), Gaps = 56/279 (20%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKFS 69
           RE+ IL+ + H N++ L ++   + +          L+ +      +G  L   +  K S
Sbjct: 64  REVSILRQVLHPNIITLHDVYENRTD--------VVLILELV----SGGELFDFLAQKES 111

Query: 70  LGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT----KTGILKLADFGLARAFSQ 123
           L E      I+Q+L+G+ Y+H+ KI H D+K  N+++         +KL DFGLA     
Sbjct: 112 LSEEEATSFIKQILDGVNYLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIED 171

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                   + N   T  +  PE++  +   G   D+W  G I   + + +    G+T+Q+
Sbjct: 172 GV-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWSIGVITYILLSGASPFLGDTKQE 225

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  I+ +      E +            EL K                    D + KLL
Sbjct: 226 TLANITAVSYDFDEEFFSQTS--------ELAK--------------------DFIRKLL 257

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 282
           + +  KR     AL H   W  P+ +  + +  +   ++
Sbjct: 258 VKETRKRLTIQEALRHP--WITPVDTQQAMVRRESVVNL 294

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7 Length = 387

 Score =  120 bits (304), Expect = 9e-31
 Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 53/256 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---H 65
             EI I+  L H  +++L +    K            L+ +F      G  L   I    
Sbjct: 96  KNEISIMNQLHHPKLINLHDAFEDKYE--------MVLILEFLS----GGELFDRIAAED 143

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQ 123
            K S  E+   ++Q   GL ++H + I+H D+K  N++    K   +K+ DFGLA   + 
Sbjct: 144 YKMSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNP 203

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            +            T  +  PE++  +   G   D+W  G +   + +      G  + +
Sbjct: 204 DE-----IVKVTTATAEFAAPEIVDRE-PVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLE 257

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  + +       +++  V           P+A+                  D +  LL
Sbjct: 258 TLQNVKRCDWEFDEDAFSSVS----------PEAK------------------DFIKNLL 289

Query: 244 LLDPSKRFDSDAALNH 259
             +P KR     AL H
Sbjct: 290 QKEPRKRLTVHDALEH 305

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A Length = 573

 Score =  123 bits (310), Expect = 1e-30
 Identities = 52/252 (20%), Positives = 99/252 (39%), Gaps = 45/252 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFS 69
            +EI+ + +L+H  +V+L +                 ++++F    +L   +++ H K S
Sbjct: 202 RKEIQTMSVLRHPTLVNLHDAFEDDNE--------MVMIYEFMSGGELFEKVADEHNKMS 253

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNG 127
             E  + ++Q+  GL ++H N  +H D+K  N++ T  ++  LKL DFGL       +  
Sbjct: 254 EDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-- 311

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
                     T  +  PE+  G +  G   D+W  G +   + +      G  + + +  
Sbjct: 312 ---SVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETLRN 367

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           +     ++   ++ G+         E  K                    D + KLLL DP
Sbjct: 368 VKSCDWNMDDSAFSGIS--------EDGK--------------------DFIRKLLLADP 399

Query: 248 SKRFDSDAALNH 259
           + R     AL H
Sbjct: 400 NTRMTIHQALEH 411

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens} Length = 444

 Score =  121 bits (306), Expect = 1e-30
 Identities = 70/257 (27%), Positives = 105/257 (40%), Gaps = 56/257 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
           RE +I +LLKH N+V L +    + +         YL+FD       G  L  +I     
Sbjct: 59  REARICRLLKHPNIVRLHDSISEEGH--------HYLIFDLVT----GGELFEDIVAREY 106

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           +S  +    IQQ+L  + + H   ++HR++K  N+L+    K   +KLADFGLA      
Sbjct: 107 YSEADASHCIQQILEAVLHCHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEG- 165

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
              Q   +     T  Y  PE+L     YG PVDLW  G I+  +    P      + + 
Sbjct: 166 -EQQA--WFGFAGTPGYLSPEVLRK-DPYGKPVDLWACGVILYILLVGYPPFWDEDQHRL 221

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
              I    G+       W  V           P+A+                  DL++K+
Sbjct: 222 YQQI--KAGAYDFPSPEWDTVT----------PEAK------------------DLINKM 251

Query: 243 LLLDPSKRFDSDAALNH 259
           L ++PSKR  +  AL H
Sbjct: 252 LTINPSKRITAAEALKH 268

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A* Length = 336

 Score =  119 bits (300), Expect = 1e-30
 Identities = 40/174 (22%), Positives = 66/174 (37%), Gaps = 13/174 (7%)

Query: 4   IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLS 62
           +   +  + E+     L    +V L    R              +  +  E   L  L+ 
Sbjct: 91  VRLEVFRVEELVACAGLSSPRIVPLYGAVRE--------GPWVNIFMELLEGGSLGQLIK 142

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGIL-KLADFGLARAF 121
                         + Q L GL Y+H+ +ILH D+KA NVL++  G    L DFG A   
Sbjct: 143 Q-MGCLPEDRALYYLGQALEGLEYLHTRRILHGDVKADNVLLSSDGSRAALCDFGHALCL 201

Query: 122 SQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
                G+     + +  T  +  PE+++G +     VD+W + C+M  M     
Sbjct: 202 QPDGLGKSLLTGDYIPGTETHMAPEVVMG-KPCDAKVDIWSSCCMMLHMLNGCH 254

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens} Length = 305

 Score =  118 bits (297), Expect = 2e-30
 Identities = 60/266 (22%), Positives = 111/266 (41%), Gaps = 50/266 (18%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSL 70
           +EI++L+ L+H+NV+ L+++   +       +   Y+V ++C   +  +L ++   +F +
Sbjct: 55  KEIQLLRRLRHKNVIQLVDVLYNEE------KQKMYMVMEYCVCGMQEMLDSVPEKRFPV 108

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
            +      QL++GL Y+HS  I+H+D+K  N+L+T  G LK++  G+A A          
Sbjct: 109 CQAHGYFCQLIDGLEYLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAADDTC 168

Query: 131 RYT----NRVVTLWYRPPELLLGDRNY-GPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           R +           ++PPE+  G   + G  VD+W AG  +  +                
Sbjct: 169 RTSQGSPA------FQPPEIANGLDTFSGFKVDIWSAGVTLYNI---------------- 206

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
                  G   P  + G     L+  +        K    +          DLL  +L  
Sbjct: 207 -----TTGLY-P--FEGDNIYKLFENI-------GKGSYAIPGDCGPP-LSDLLKGMLEY 250

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDL 271
           +P+KRF       H +F     P++ 
Sbjct: 251 EPAKRFSIRQIRQHSWFRKKHPPAEA 276

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A Length = 304

 Score =  118 bits (297), Expect = 2e-30
 Identities = 62/257 (24%), Positives = 97/257 (37%), Gaps = 58/257 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
            EI +L+ +KHEN+V L +I  +  +        +YLV         G  L   I     
Sbjct: 55  NEIAVLKKIKHENIVTLEDIYESTTH--------YYLVMQLVS----GGELFDRILERGV 102

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQT 124
           ++  +   VIQQ+L+ + Y+H N I+HRD+K  N+L         + + DFGL++     
Sbjct: 103 YTEKDASLVIQQVLSAVKYLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQN- 161

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                   +    T  Y  PE+L   + Y   VD W  G I   +    P     TE + 
Sbjct: 162 -----GIMSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVITYILLCGYPPFYEETESKL 215

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
              I    G        W  +             A+                  D +  L
Sbjct: 216 FEKI--KEGYYEFESPFWDDIS----------ESAK------------------DFICHL 245

Query: 243 LLLDPSKRFDSDAALNH 259
           L  DP++R+  + AL+H
Sbjct: 246 LEKDPNERYTCEKALSH 262

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A* Length = 289

 Score =  117 bits (295), Expect = 3e-30
 Identities = 44/208 (21%), Positives = 77/208 (37%), Gaps = 56/208 (26%)

Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DLAGLL 61
           ALRE+     L +H +VV              RY S +       +  ++C    LA  +
Sbjct: 57  ALREVYAHAVLGQHSHVV--------------RYFSAWAEDDHMLIQNEYCNGGSLADAI 102

Query: 62  SNIHVK---FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGIL-------- 110
           S  +     F   E+K ++ Q+  GL YIHS  ++H D+K +N+ I++T I         
Sbjct: 103 SENYRIMSYFKEAELKDLLLQVGRGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGD 162

Query: 111 -----------KLADFGLARAFS--QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV 157
                      K+ D G     S  Q + G             +   E+L  +  + P  
Sbjct: 163 EDDWASNKVMFKIGDLGHVTRISSPQVEEG----------DSRFLANEVLQENYTHLPKA 212

Query: 158 DLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           D++     +       P+ +   +  +I
Sbjct: 213 DIFALALTVVCAAGAEPLPRNGDQWHEI 240

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A Length = 365

 Score =  118 bits (297), Expect = 6e-30
 Identities = 60/264 (22%), Positives = 103/264 (39%), Gaps = 61/264 (23%)

Query: 12  REIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HV 66
           RE  IL+ +  H +++ LI+   + +          +LVFD          L   +   V
Sbjct: 148 RETHILRQVAGHPHIITLIDSYESSSF--------MFLVFDLMR----KGELFDYLTEKV 195

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
             S  E + +++ LL  + ++H+N I+HRD+K  N+L+     ++L+DFG +      + 
Sbjct: 196 ALSEKETRSIMRSLLEAVSFLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE- 254

Query: 127 GQVNRYTNRVVTLWYRPPELLLGD-----RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
               +      T  Y  PE+L          YG  VDLW  G I+         +     
Sbjct: 255 ----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLWACGVILF-------TL----- 298

Query: 182 QQQITLISQLCGSITP---ESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
                    L GS  P        +  + +  + +    +       +K         DL
Sbjct: 299 ---------LAGS-PPFWHRRQILMLRMIMEGQYQFSSPEWDDRSSTVK---------DL 339

Query: 239 LDKLLLLDPSKRFDSDAALNHDFF 262
           + +LL +DP  R  ++ AL H FF
Sbjct: 340 ISRLLQVDPEARLTAEQALQHPFF 363

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A Length = 325

 Score =  117 bits (294), Expect = 8e-30
 Identities = 62/263 (23%), Positives = 97/263 (36%), Gaps = 60/263 (22%)

Query: 12  REIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVK- 67
           +EI  L+L + H N+V L E+   + +         +LV +       G  L   I  K 
Sbjct: 54  KEITALKLCEGHPNIVKLHEVFHDQLH--------TFLVMELLN----GGELFERIKKKK 101

Query: 68  -FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQ 123
            FS  E   ++++L++ + ++H   ++HRD+K  N+L T       +K+ DFG AR    
Sbjct: 102 HFSETEASYIMRKLVSAVSHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPP 161

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                         TL Y  PELL     Y    DLW  G I+  M +     Q +    
Sbjct: 162 DN----QPLKTPCFTLHYAAPELLNQ-NGYDESCDLWSLGVILYTMLSGQVPFQSHDRSL 216

Query: 184 QITLISQLCGSI-------TPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC 236
             T   ++   I         E+W  V         +  K                    
Sbjct: 217 TCTSAVEIMKKIKKGDFSFEGEAWKNVS--------QEAK-------------------- 248

Query: 237 DLLDKLLLLDPSKRFDSDAALNH 259
           DL+  LL +DP+KR        +
Sbjct: 249 DLIQGLLTVDPNKRLKMSGLRYN 271

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens} Length = 349

 Score =  116 bits (292), Expect = 2e-29
 Identities = 67/257 (26%), Positives = 95/257 (36%), Gaps = 56/257 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI--HVK 67
            EI +L  L H N++ L EI  T             LV +       G  L   I     
Sbjct: 97  TEIGVLLRLSHPNIIKLKEIFETPTE--------ISLVLELVT----GGELFDRIVEKGY 144

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           +S  +    ++Q+L  + Y+H N I+HRD+K  N+L         LK+ADFGL++     
Sbjct: 145 YSERDAADAVKQILEAVAYLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIV--- 201

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           ++  +        T  Y  PE+L G   YGP VD+W  G I   +             Q 
Sbjct: 202 EHQVL--MKTVCGTPGYCAPEILRG-CAYGPEVDMWSVGIITYILLCGFEPFYDERGDQF 258

Query: 185 ITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           +     L          W  V             A             KD     L+ KL
Sbjct: 259 M-FRRILNCEYYFISPWWDEVS----------LNA-------------KD-----LVRKL 289

Query: 243 LLLDPSKRFDSDAALNH 259
           ++LDP KR  +  AL H
Sbjct: 290 IVLDPKKRLTTFQALQH 306

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ... Length = 284

 Score =  114 bits (288), Expect = 3e-29
 Identities = 62/253 (24%), Positives = 102/253 (40%), Gaps = 51/253 (20%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+I   L+H N++ +      +           YL+ +F    +L   L     +F  
Sbjct: 63  REIEIQSHLRHPNILRMYNYFHDRKR--------IYLMLEFAPRGELYKELQKHG-RFDE 113

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
                 +++L + L+Y H  K++HRD+K  N+L+   G LK+ADFG +      +     
Sbjct: 114 QRSATFMEELADALHYCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSLR----- 168

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
           R T    TL Y PPE++ G + +   VDLW AG +  E                      
Sbjct: 169 RRT-MCGTLDYLPPEMIEG-KTHDEKVDLWCAGVLCYEF--------------------- 205

Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC-DLLDKLLLLDPSK 249
           L G   P  +      + + ++         V  +  P++ D  G  DL+ KLL   P +
Sbjct: 206 LVGM-PP--FDSPSHTETHRRI-------VNVDLKFPPFLSD--GSKDLISKLLRYHPPQ 253

Query: 250 RFDSDAALNHDFF 262
           R      + H + 
Sbjct: 254 RLPLKGVMEHPWV 266

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A Length = 377

 Score =  116 bits (292), Expect = 3e-29
 Identities = 31/278 (11%), Positives = 78/278 (28%), Gaps = 60/278 (21%)

Query: 1   MLGIFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGL 60
           + GI     A   ++ +            ++ R + ++ + +  + + ++   + +L   
Sbjct: 130 LRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTF 189

Query: 61  LSNI------HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
              +      H         ++  Q++  L  +H   ++H  ++  ++++ + G + L  
Sbjct: 190 GEVLLSHSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTG 249

Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL----------LGDRNYGPPVDLWGAGC 164
           F            +        V+  + PPEL                     D W  G 
Sbjct: 250 FEHLV--------RDGARVVSSVSRGFEPPELEARRATISYHRDRRTLMTFSFDAWALGL 301

Query: 165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE 224
           ++  +W     +  +        I + C +I                             
Sbjct: 302 VIYWIWCADLPITKDAALGGSEWIFRSCKNIPQP-------------------------- 335

Query: 225 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                V+      LL+  L      R     A+    +
Sbjct: 336 -----VRA-----LLEGFLRYPKEDRLLPLQAMETPEY 363

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A Length = 316

 Score =  114 bits (288), Expect = 5e-29
 Identities = 61/274 (22%), Positives = 102/274 (37%), Gaps = 62/274 (22%)

Query: 12  REIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVK- 67
           RE+++L   + H NV+ LIE    +          FYLVF+       G  +LS+IH + 
Sbjct: 59  REVEMLYQCQGHRNVLELIEFFEEEDR--------FYLVFEKMR----GGSILSHIHKRR 106

Query: 68  -FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAF-- 121
            F+  E   V+Q + + L ++H+  I HRD+K  N+L     +   +K+ DF L      
Sbjct: 107 HFNELEASVVVQDVASALDFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKL 166

Query: 122 -SQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGAGCIMAEMWTRSPIM 176
                            +  Y  PE++         Y    DLW  G I+        I+
Sbjct: 167 NGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYDKRCDLWSLGVILY-------IL 219

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK--------- 227
                         L G   P       +   +++ E   A +  + E ++         
Sbjct: 220 --------------LSGY--PPFVGRCGSDCGWDRGEACPACQNMLFESIQEGKYEFPDK 263

Query: 228 --PYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH 259
              ++      DL+ KLL+ D  +R  +   L H
Sbjct: 264 DWAHISCA-AKDLISKLLVRDAKQRLSAAQVLQH 296

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 3fpq_A Length = 290

 Score =  113 bits (286), Expect = 5e-29
 Identities = 55/261 (21%), Positives = 98/261 (37%), Gaps = 58/261 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI---HVKF 68
            E ++L+ L+H N+V   +   +        +    LV +      +G L          
Sbjct: 74  EEAEMLKGLQHPNIVRFYDSWESTVKG----KKCIVLVTELMT---SGTLKTYLKRFKVM 126

Query: 69  SLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT-KTGILKLADFGLARAFSQTK 125
            +  ++   +Q+L GL ++H+    I+HRD+K  N+ IT  TG +K+ D GLA     + 
Sbjct: 127 KIKVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRASF 186

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V      + T  +  PE  + +  Y   VD++  G  M EM T              
Sbjct: 187 AKAV------IGTPEFMAPE--MYEEKYDESVDVYAFGMCMLEMATSEY----------- 227

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY----VKDQYGCDLLDK 241
                      P           Y++ +      R+V   +KP     V      ++++ 
Sbjct: 228 -----------P-----------YSECQNAAQIYRRVTSGVKPASFDKVAIPEVKEIIEG 265

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
            +  +  +R+     LNH FF
Sbjct: 266 CIRQNKDERYSIKDLLNHAFF 286

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C Length = 400

 Score =  115 bits (291), Expect = 7e-29
 Identities = 63/264 (23%), Positives = 105/264 (39%), Gaps = 60/264 (22%)

Query: 12  REIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---- 64
           RE+++  +  +  ++V ++++           R    +V +  +    G  L S I    
Sbjct: 103 REVELHWRASQCPHIVRIVDVYENLYAG----RKCLLIVMECLD----GGELFSRIQDRG 154

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAF 121
              F+  E  ++++ +   + Y+HS  I HRD+K  N+L T      ILKL DFG A+  
Sbjct: 155 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKET 214

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           +       N  T    T +Y  PE +LG   Y    D+W  G IM        I+     
Sbjct: 215 TSH-----NSLTTPCYTPYYVAPE-VLGPEKYDKSCDMWSLGVIMY-------IL----- 256

Query: 182 QQQITLISQLCG------SITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG 235
                    LCG      +      PG++T     + E P  +  +V E +K        
Sbjct: 257 ---------LCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEWSEVSEEVK-------- 299

Query: 236 CDLLDKLLLLDPSKRFDSDAALNH 259
             L+  LL  +P++R      +NH
Sbjct: 300 -MLIRNLLKTEPTQRMTITEFMNH 322

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens} Length = 298

 Score =  113 bits (285), Expect = 9e-29
 Identities = 60/260 (23%), Positives = 104/260 (40%), Gaps = 57/260 (21%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--HVKFS 69
           +EI IL+ L H NVV L+E+               Y+VF+       G +  +      S
Sbjct: 85  QEIAILKKLDHPNVVKLVEVLDDPN------EDHLYMVFELVNQ---GPVMEVPTLKPLS 135

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             + +   Q L+ G+ Y+H  KI+HRD+K +N+L+ + G +K+ADFG++  F     G  
Sbjct: 136 EDQARFYFQDLIKGIEYLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFK----GSD 191

Query: 130 NRYTNRVVTLWYRPPELLLGD-RNY-GPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
              +N V T  +  PE L    + + G  +D+W  G  +                     
Sbjct: 192 ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMGVTLYCF------------------ 233

Query: 188 ISQLCGSITPESWPGVETLDLYNKM-----ELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
              + G   P  +     + L++K+     E P       +  +   +K     DL+ ++
Sbjct: 234 ---VFGQC-P--FMDERIMCLHSKIKSQALEFPD------QPDIAEDLK-----DLITRM 276

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L  +P  R        H + 
Sbjct: 277 LDKNPESRIVVPEIKLHPWV 296

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens} Length = 373

 Score =  114 bits (287), Expect = 2e-28
 Identities = 55/278 (19%), Positives = 102/278 (36%), Gaps = 53/278 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---H 65
             EI ++  L H N++ L +   +K +          LV ++ +    G  L   I    
Sbjct: 134 KNEISVMNQLDHANLIQLYDAFESKND--------IVLVMEYVD----GGELFDRIIDES 181

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQ 123
              +  +    ++Q+  G+ ++H   ILH D+K  N+L        +K+ DFGLAR +  
Sbjct: 182 YNLTELDTILFMKQICEGIRHMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKP 241

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
            +     +      T  +  PE++  D     P D+W  G I   + +      G+ + +
Sbjct: 242 RE-----KLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVGVIAYMLLSGLSPFLGDNDAE 295

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  I      +  E +  +         E  K                    + + KLL
Sbjct: 296 TLNNILACRWDLEDEEFQDIS--------EEAK--------------------EFISKLL 327

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQS 281
           + + S R  +  AL H +     + S LS    ++  S
Sbjct: 328 IKEKSWRISASEALKHPWLSDHKLHSRLSAQKKKNRGS 365

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A* Length = 327

 Score =  111 bits (281), Expect = 6e-28
 Identities = 60/257 (23%), Positives = 104/257 (40%), Gaps = 52/257 (20%)

Query: 11  LREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIH 65
           L EI +L+L K    V++L E+    +           L+ ++        L   L  + 
Sbjct: 76  LHEIAVLELAKSCPRVINLHEVYENTSE--------IILILEYAAGGEIFSL--CLPELA 125

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFS 122
              S  ++ ++I+Q+L G+YY+H N I+H D+K  N+L+      G +K+ DFG++R   
Sbjct: 126 EMVSENDVIRLIKQILEGVYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKI- 184

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
              +         + T  Y  PE+L  D       D+W  G I   + T +    G   Q
Sbjct: 185 --GHACE--LREIMGTPEYLAPEILNYDP-ITTATDMWNIGIIAYMLLTHTSPFVGEDNQ 239

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           +    ISQ+    + E++  V         +L                      D +  L
Sbjct: 240 ETYLNISQVNVDYSEETFSSVS--------QLAT--------------------DFIQSL 271

Query: 243 LLLDPSKRFDSDAALNH 259
           L+ +P KR  ++  L+H
Sbjct: 272 LVKNPEKRPTAEICLSH 288

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A Length = 342

 Score =  111 bits (281), Expect = 8e-28
 Identities = 53/260 (20%), Positives = 100/260 (38%), Gaps = 57/260 (21%)

Query: 12  REIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVK- 67
            EI+IL +  +H N++ L ++               Y+V +  +    G  LL  I  + 
Sbjct: 64  EEIEILLRYGQHPNIITLKDVYDDGKY--------VYVVTELMK----GGELLDKILRQK 111

Query: 68  -FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVL-ITKTG---ILKLADFGLARAFS 122
            FS  E   V+  +   + Y+H+  ++HRD+K +N+L + ++G    +++ DFG A+   
Sbjct: 112 FFSEREASAVLFTITKTVEYLHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQL- 170

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
                +         T  +  PE+L   + Y    D+W  G ++  M T         + 
Sbjct: 171 ---RAENGLLMTPCYTANFVAPEVLER-QGYDAACDIWSLGVLLYTMLTGYTPFANGPDD 226

Query: 183 QQITLISQ-LCGSI--TPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
               ++++   G    +   W  V         +  K                    DL+
Sbjct: 227 TPEEILARIGSGKFSLSGGYWNSVS--------DTAK--------------------DLV 258

Query: 240 DKLLLLDPSKRFDSDAALNH 259
            K+L +DP +R  +   L H
Sbjct: 259 SKMLHVDPHQRLTAALVLRH 278

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens} Length = 335

 Score =  111 bits (280), Expect = 9e-28
 Identities = 61/326 (18%), Positives = 105/326 (32%), Gaps = 102/326 (31%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLV----------FDFCEHDLAGLL 61
            EI IL  ++H N++ +++I   +          F LV          F F +       
Sbjct: 78  LEIAILSRVEHANIIKVLDIFENQ--------GFFQLVMEKHGSGLDLFAFIDR------ 123

Query: 62  SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
              H +        + +QL++ + Y+    I+HRD+K  N++I +   +KL DFG A   
Sbjct: 124 ---HPRLDEPLASYIFRQLVSAVGYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYL 180

Query: 122 SQ-----TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
            +     T  G +           Y  PE+L+G+   GP +++W  G             
Sbjct: 181 ERGKLFYTFCGTIE----------YCAPEVLMGNPYRGPELEMWSLG------------- 217

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQ 233
                   +TL + +                     E P  +  +  E        V  +
Sbjct: 218 --------VTLYTLVFE-------------------ENPFCELEETVEAAIHPPYLVSKE 250

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF----------------WTDPMPSDLSKMLAQ 277
               L+  LL   P +R   +  +   +                    P    LS    +
Sbjct: 251 -LMSLVSGLLQPVPERRTTLEKLVTDPWVTQPVNLADYTWEEVFRVNKPESGVLSAASLE 309

Query: 278 HTQSMFEYLAPPRRPGHMRAHHHHHH 303
                   +A  +       HHHHHH
Sbjct: 310 MGNRSLSDVAQAQELCGGEGHHHHHH 335

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A* Length = 323

 Score =  109 bits (275), Expect = 4e-27
 Identities = 77/317 (24%), Positives = 118/317 (37%), Gaps = 72/317 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNI--HVKF 68
           +EI I ++L HENVV      R          +  YL  ++C     G L   I   +  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREG--------NIQYLFLEYCSG---GELFDRIEPDIGM 102

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              + ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F       
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY---NN 159

Query: 129 VNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
             R  N++  TL Y  PELL     +  PVD+W  G ++  M                  
Sbjct: 160 RERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM------------------ 201

Query: 188 ISQLCGSITPESWP---GVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC-DLLDKLL 243
              L G +     P     ++   Y+         ++ K  L P+ K       LL K+L
Sbjct: 202 ---LAGEL-----PWDQPSDSCQEYSD-------WKEKKTYLNPWKKIDSAPLALLHKIL 246

Query: 244 LLDPSKRFDSDAALNHDFF----------------WTDPMPSDLSKMLAQHTQSM-FEYL 286
           + +PS R          ++                     PS  SK +  +         
Sbjct: 247 VENPSARITIPDIKKDRWYNKPLKKGAKRPRVTSGGVSESPSGFSKHIQSNLDFSPVNSA 306

Query: 287 APPRRPGHMRAHHHHHH 303
           +     G  + HHHHHH
Sbjct: 307 SRTPGSGWSKEHHHHHH 323

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ... Length = 320

 Score =  109 bits (274), Expect = 4e-27
 Identities = 53/278 (19%), Positives = 92/278 (33%), Gaps = 80/278 (28%)

Query: 12  REIKILQLLKHE--NVVHLIEICRTKANQYNRYRSTFYLV----------FDFCEHDLAG 59
            E+ +L+ +      V+ L++              +F L+          FDF       
Sbjct: 95  MEVVLLKKVSSGFSGVIRLLDWFERP--------DSFVLILERPEPVQDLFDFITE---- 142

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFGLA 118
                         +    Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG  
Sbjct: 143 -----RGALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSG 197

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
              +  K+     YT+   T  Y PPE +   R +G    +W  G ++ +M         
Sbjct: 198 ---ALLKDTV---YTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDM--------- 242

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYG 235
                       +CG                    +P     ++       +  V  +  
Sbjct: 243 ------------VCGD-------------------IPFEHDEEIIRGQVFFRQRVSSE-C 270

Query: 236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSK 273
             L+   L L PS R   +   NH +     +P + ++
Sbjct: 271 QHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAE 308

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B* Length = 389

 Score =  110 bits (276), Expect = 6e-27
 Identities = 58/344 (16%), Positives = 103/344 (29%), Gaps = 64/344 (18%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNI 64
             E+ + +L  H N+V               YR+TF      ++V  F      G   ++
Sbjct: 74  QGELHVSKLFNHPNIV--------------PYRATFIADNELWVVTSFMA---YGSAKDL 116

Query: 65  ---HVKFSLGE--IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
              H    + E  I  ++Q +L  L YIH    +HR +KA+++LI+  G + L+      
Sbjct: 117 ICTHFMDGMNELAIAYILQGVLKALDYIHHMGYVHRSVKASHILISVDGKVYLSGLRSNL 176

Query: 120 AFSQT---KNGQVNRYTNRVVTLWYRPPELLL-GDRNYGPPVDLWGAGCIMA-EMWTRSP 174
           +       +    +     V  L +  PE+L    + Y    D++  G I A E+     
Sbjct: 177 SMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYSVG-ITACELANGHV 235

Query: 175 -------------IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK 221
                         + G      +   S +       S          +        +  
Sbjct: 236 PFKDMPATQMLLEKLNGTVP--CLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPS 293

Query: 222 VKERLKPYVKDQYGC---DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
             +         +       +++ L  +P  R  +   LNH FF          K + + 
Sbjct: 294 NGDSPSHPYHRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFF----------KQIKRR 343

Query: 279 TQSMFEYLAPPRRPGHMRAHHHHHHAGAPGAAGPAAGRATTETG 322
                  L  P  P  +            G  G        E  
Sbjct: 344 ASEALPELLRPVTP--ITNFEGSQSQDHSGIFGLVTNLEELEVD 385

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} Length = 413

 Score =  110 bits (275), Expect = 9e-27
 Identities = 35/323 (10%), Positives = 85/323 (26%), Gaps = 62/323 (19%)

Query: 7   PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-- 64
              A   ++ +            ++ R + ++ + +  + + ++   + +L      +  
Sbjct: 141 QKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLS 200

Query: 65  ----HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
               H         ++  Q++  L  +H   ++H  ++  ++++ + G + L  F     
Sbjct: 201 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVR 260

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDR----NYGPPVDLWGAGCIMAEMWTRSPIM 176
              +    V+               +L   +          D W  G  +  +W      
Sbjct: 261 DGAS---AVSPIGRGFAPPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPN 317

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC 236
             +        I + C +I                                         
Sbjct: 318 TDDAALGGSEWIFRSCKNIPQPVR------------------------------------ 341

Query: 237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMR 296
            LL+  L      R     A+    +  + + ++LS  L  +          P R G   
Sbjct: 342 ALLEGFLRYPKEDRLLPLQAMETPEY--EQLRTELSAALPLYQTD-----GEPTREGGAP 394

Query: 297 AHHHHHHAGAPGAAGPAAGRATT 319
                  +G        A  A T
Sbjct: 395 P------SGTSQPDEAGAAEAVT 411

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A Length = 328

 Score =  108 bits (272), Expect = 1e-26
 Identities = 65/283 (22%), Positives = 114/283 (40%), Gaps = 65/283 (22%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           RE++I+++L H N+V L E+  T+         T YL+ ++    ++   L   H +   
Sbjct: 63  REVRIMKILNHPNIVKLFEVIETE--------KTLYLIMEYASGGEVFDYLVA-HGRMKE 113

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-----TK 125
            E +   +Q+++ + Y H  +I+HRD+KA N+L+     +K+ADFG +  F+        
Sbjct: 114 KEARSKFRQIVSAVQYCHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGGKLDAF 173

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G             Y  PEL  G +  GP VD+W  G I+  +                
Sbjct: 174 CG----------APPYAAPELFQGKKYDGPEVDVWSLGVILYTL---------------- 207

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYGC-DLLDK 241
                + GS+ P         D  N  EL    + +V     R+  Y+     C +LL +
Sbjct: 208 -----VSGSL-P--------FDGQNLKEL----RERVLRGKYRIPFYMST--DCENLLKR 247

Query: 242 LLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
            L+L+P KR   +  +   +        +L   +        +
Sbjct: 248 FLVLNPIKRGTLEQIMKDRWINAGHEEDELKPFVEPELDISDQ 290

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} PDB: 3c4c_A* 3c4d_A* 3idp_A* 3ii5_A* 3d4q_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 2fb8_A* 4dbn_A* 1uwj_A* 1uwh_A* 3q96_A* Length = 289

 Score =  107 bits (270), Expect = 1e-26
 Identities = 36/165 (21%), Positives = 76/165 (46%), Gaps = 14/165 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
             E+ +L+  +H N++  +    T             +V  +CE   L   L     KF 
Sbjct: 68  KNEVGVLRKTRHVNILLFMGYS-TAPQ--------LAIVTQWCEGSSLYHHLHASETKFE 118

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+      
Sbjct: 119 MKKLIDIARQTARGMDYLHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSGS-- 176

Query: 130 NRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTR 172
           +++     ++ +  PE++    +  Y    D++  G ++ E+ T 
Sbjct: 177 HQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGIVLYELMTG 221

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A* Length = 301

 Score =  107 bits (268), Expect = 2e-26
 Identities = 44/187 (23%), Positives = 74/187 (39%), Gaps = 20/187 (10%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            E+    +L+HEN++  I    T  +   +     +L+  + E   L   L         
Sbjct: 51  TELYNTVMLRHENILGFIASDMTSRHSSTQL----WLITHYHEMGSLYDYLQL--TTLDT 104

Query: 71  GEIKKVIQQLLNGLYYIHS--------NKILHRDMKAANVLITKTGILKLADFGLARAFS 122
               +++  + +GL ++H           I HRD+K+ N+L+ K G   +AD GLA   S
Sbjct: 105 VSCLRIVLSIASGLAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHS 164

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP-----VDLWGAGCIMAEMWTRSPIMQ 177
           Q+ N        RV T  Y  PE+L              VD+W  G ++ E+  R     
Sbjct: 165 QSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDCFDSYKRVDIWAFGLVLWEVARRMVSNG 224

Query: 178 GNTEQQQ 184
              + + 
Sbjct: 225 IVEDYKP 231

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A* Length = 348

 Score =  107 bits (270), Expect = 3e-26
 Identities = 66/277 (23%), Positives = 110/277 (39%), Gaps = 50/277 (18%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           +E++ LQ L+H N +            Y R   T +LV ++C    + LL          
Sbjct: 103 KEVRFLQKLRHPNTIQYRG-------CYLR-EHTAWLVMEYCLGSASDLLEVHKKPLQEV 154

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
           EI  V    L GL Y+HS+ ++HRD+KA N+L+++ G++KL DFG A          +  
Sbjct: 155 EIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSA--------SIMAP 206

Query: 132 YTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQQITLI 188
             + V T ++  PE++L      Y   VD+W  G I   E+  R P +        +  I
Sbjct: 207 ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLG-ITCIELAERKPPLFNMNAMSALYHI 265

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
           +                     + E P  Q     E  +         + +D  L   P 
Sbjct: 266 A---------------------QNESPALQSGHWSEYFR---------NFVDSCLQKIPQ 295

Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEY 285
            R  S+  L H F   +  P+ +  ++ +   ++ E 
Sbjct: 296 DRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVREL 332

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A* Length = 297

 Score =  105 bits (265), Expect = 5e-26
 Identities = 69/273 (25%), Positives = 116/273 (42%), Gaps = 53/273 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HV 66
           + EI +++  K+ N+V          N  + Y      ++V ++      G L+++    
Sbjct: 65  INEILVMRENKNPNIV----------NYLDSYLVGDELWVVMEYLA---GGSLTDVVTET 111

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
               G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG     +Q   
Sbjct: 112 CMDEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFC---AQITP 168

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQQI 185
            Q  R T  V T ++  PE++   + YGP VD+W  G IMA EM    P        + +
Sbjct: 169 EQSKRST-MVGTPYWMAPEVVT-RKAYGPKVDIWSLG-IMAIEMIEGEPPYLNENPLRAL 225

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LI+                         P+ Q     E+L    +     D L++ L +
Sbjct: 226 YLIA---------------------TNGTPELQN---PEKLSAIFR-----DFLNRCLEM 256

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
           D  KR  +   L H F       S L+ ++A  
Sbjct: 257 DVEKRGSAKELLQHQFLKIAKPLSSLTPLIAAA 289

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ... Length = 276

 Score =  105 bits (264), Expect = 6e-26
 Identities = 64/258 (24%), Positives = 101/258 (39%), Gaps = 53/258 (20%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNI--HVKF 68
           +EI I ++L HENVV      R          +  YL  ++C     G L   I   +  
Sbjct: 54  KEICINKMLNHENVVKFYGHRREG--------NIQYLFLEYCSG---GELFDRIEPDIGM 102

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
              + ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F      +
Sbjct: 103 PEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNRER 162

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
           +        TL Y  PELL     +  PVD+W  G ++  M                   
Sbjct: 163 LLNKM--CGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAM------------------- 201

Query: 189 SQLCGSITPESWP---GVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC-DLLDKLLL 244
             L G +     P     ++   Y+         ++ K  L P+ K       LL K+L+
Sbjct: 202 --LAGEL-----PWDQPSDSCQEYSD-------WKEKKTYLNPWKKIDSAPLALLHKILV 247

Query: 245 LDPSKRFDSDAALNHDFF 262
            +PS R          ++
Sbjct: 248 ENPSARITIPDIKKDRWY 265

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} Length = 337

 Score =  106 bits (266), Expect = 6e-26
 Identities = 49/187 (26%), Positives = 76/187 (40%), Gaps = 20/187 (10%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            EI    L++HEN++  I         + +     YL+ D+ E+  L   L +       
Sbjct: 80  TEIYQTVLMRHENILGFIAADIKGTGSWTQL----YLITDYHENGSLYDYLKST--TLDA 133

Query: 71  GEIKKVIQQLLNGLYYIHS--------NKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             + K+    ++GL ++H+          I HRD+K+ N+L+ K G   +AD GLA  F 
Sbjct: 134 KSMLKLAYSSVSGLCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFI 193

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSPIMQ 177
              N        RV T  Y PPE+L    N          D++  G I+ E+  R     
Sbjct: 194 SDTNEVDIPPNTRVGTKRYMPPEVLDESLNRNHFQSYIMADMYSFGLILWEVARRCVSGG 253

Query: 178 GNTEQQQ 184
              E Q 
Sbjct: 254 IVEEYQL 260

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens} Length = 312

 Score =  105 bits (265), Expect = 7e-26
 Identities = 52/269 (19%), Positives = 91/269 (33%), Gaps = 82/269 (30%)

Query: 12  REIKILQLL----KHENVVHLIEICRTKANQYNRYRSTFYLV----------FDFCEHDL 57
            E+ +L  +     H  V+ L++   T+          F LV          FD+     
Sbjct: 83  LEVALLWKVGAGGGHPGVIRLLDWFETQ--------EGFMLVLERPLPAQDLFDYITE-- 132

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-TKTGILKLADFG 116
                        G  +    Q++  + + HS  ++HRD+K  N+LI  + G  KL DFG
Sbjct: 133 -------KGPLGEGPSRCFFGQVVAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFG 185

Query: 117 LARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
              A     +     YT+   T  Y PPE +   + +  P  +W  G ++ +M       
Sbjct: 186 SG-AL--LHDEP---YTDFDGTRVYSPPEWISRHQYHALPATVWSLGILLYDM------- 232

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQ 233
                         +CG                   ++P  + +++ E       +V   
Sbjct: 233 --------------VCG-------------------DIPFERDQEILEAELHFPAHVSPD 259

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
             C L+ + L   PS R   +  L   + 
Sbjct: 260 -CCALIRRCLAPKPSSRPSLEEILLDPWM 287

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A* Length = 299

 Score =  105 bits (263), Expect = 1e-25
 Identities = 51/267 (19%), Positives = 84/267 (31%), Gaps = 87/267 (32%)

Query: 12  REIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNI---- 64
           RE+++     +  ++V ++++           R    +V +  +    G  L S I    
Sbjct: 59  REVELHWRASQCPHIVRIVDVYENLYAG----RKCLLIVMECLD----GGELFSRIQDRG 110

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAF 121
              F+  E  ++++ +   + Y+HS  I HRD+K  N+L T      ILKL DFG A   
Sbjct: 111 DQAFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFA--- 167

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEM-------WTRSP 174
                                  E       Y    D+W  G IM  +       ++   
Sbjct: 168 ----------------------KETT--GEKYDKSCDMWSLGVIMYILLCGYPPFYSNHG 203

Query: 175 IMQGNTEQQQITLISQLCGSIT--PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
                      T I    G        W  V                 +VK         
Sbjct: 204 ---LAISPGMKTRI--RMGQYEFPNPEWSEVSE---------------EVK--------- 234

Query: 233 QYGCDLLDKLLLLDPSKRFDSDAALNH 259
                L+  LL  +P++R      +NH
Sbjct: 235 ----MLIRNLLKTEPTQRMTITEFMNH 257

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A* Length = 276

 Score =  103 bits (260), Expect = 2e-25
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 63/260 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+ L+L +H +++ L ++  T         + F++V ++    +L   +   H +   
Sbjct: 60  REIQNLKLFRHPHIIKLYQVISTP--------TDFFMVMEYVSGGELFDYICK-HGRVEE 110

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-----TK 125
            E +++ QQ+L+ + Y H + ++HRD+K  NVL+      K+ADFGL+   S      T 
Sbjct: 111 MEARRLFQQILSAVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 170

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G  N          Y  PE++ G    GP VD+W  G I+  +                
Sbjct: 171 CGSPN----------YAAPEVISGRLYAGPEVDIWSCGVILYAL---------------- 204

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYGCDLLDKL 242
                LCG++ P         D  +   L     +K++     +  Y+       LL  +
Sbjct: 205 -----LCGTL-P--------FDDEHVPTL----FKKIRGGVFYIPEYLNRS-VATLLMHM 245

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L +DP KR        H++F
Sbjct: 246 LQVDPLKRATIKDIREHEWF 265

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A* Length = 321

 Score =  104 bits (262), Expect = 2e-25
 Identities = 64/273 (23%), Positives = 119/273 (43%), Gaps = 53/273 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HV 66
             E+ I++  +H NVV            Y  Y      +++ +F +    G L++I   V
Sbjct: 90  FNEVVIMRDYQHFNVV----------EMYKSYLVGEELWVLMEFLQ---GGALTDIVSQV 136

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
           + +  +I  V + +L  L Y+H+  ++HRD+K+ ++L+T  G +KL+DFG     +Q   
Sbjct: 137 RLNEEQIATVCEAVLQALAYLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFC---AQISK 193

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQQI 185
               R +  V T ++  PE++     Y   VD+W  G IM  EM    P    ++  Q +
Sbjct: 194 DVPKRKS-LVGTPYWMAPEVIS-RSLYATEVDIWSLG-IMVIEMVDGEPPYFSDSPVQAM 250

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             +         +S P             PK +      ++ P ++     D L+++L+ 
Sbjct: 251 KRL--------RDSPP-------------PKLKN---SHKVSPVLR-----DFLERMLVR 281

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
           DP +R  +   L+H F     +P  L  ++  +
Sbjct: 282 DPQERATAQELLDHPFLLQTGLPECLVPLIQLY 314

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens} Length = 365

 Score =  104 bits (261), Expect = 4e-25
 Identities = 34/267 (12%), Positives = 74/267 (27%), Gaps = 63/267 (23%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH----DLAGLLSNIHV 66
            + ++ L+       +               +++   LV +   +    +   L  N   
Sbjct: 115 TQLMERLKPSMQHMFMKFYSAHL--------FQNGSVLVGELYSYGTLLNAINLYKNTPE 166

Query: 67  K-FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI-----------LKLAD 114
           K    G +     ++L  +  +H  +I+H D+K  N ++    +           L L D
Sbjct: 167 KVMPQGLVISFAMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALID 226

Query: 115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
            G +        G +  +T +  T  ++  E+L   + +   +D +G    +  M     
Sbjct: 227 LGQSIDMKLFPKGTI--FTAKCETSGFQCVEMLSN-KPWNYQIDYFGVAATVYCM----- 278

Query: 175 IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY 234
                           L G+       G E                K +   +       
Sbjct: 279 ----------------LFGTYMKVKNEGGEC---------------KPEGLFRRLPHLDM 307

Query: 235 GCDLLDKLLLLDPSKRFDSDAALNHDF 261
             +    +L +       S   L    
Sbjct: 308 WNEFFHVMLNIPDCHHLPSLDLLRQKL 334

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens} Length = 310

 Score =  103 bits (258), Expect = 5e-25
 Identities = 39/185 (21%), Positives = 81/185 (43%), Gaps = 20/185 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E+K+++ L+H NV+  I +                 + ++ +   L G++ ++  ++ 
Sbjct: 55  LKEVKVMRCLEHPNVLKFIGVLYKDKR--------LNFITEYIKGGTLRGIIKSMDSQYP 106

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             +     + + +G+ Y+HS  I+HRD+ + N L+ +   + +ADFGLAR     K    
Sbjct: 107 WSQRVSFAKDIASGMAYLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPE 166

Query: 130 NRYTNRVVTLWYRP----------PELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
              + +      R           PE++ G R+Y   VD++  G ++ E+  R       
Sbjct: 167 GLRSLKKPDRKKRYTVVGNPYWMAPEMING-RSYDEKVDVFSFGIVLCEIIGRVNADPDY 225

Query: 180 TEQQQ 184
             +  
Sbjct: 226 LPRTM 230

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens} Length = 314

 Score =  103 bits (258), Expect = 6e-25
 Identities = 62/271 (22%), Positives = 105/271 (38%), Gaps = 49/271 (18%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           +EI I+Q     +VV            Y  Y   +  ++V ++C    ++ ++   +   
Sbjct: 73  KEISIMQQCDSPHVV----------KYYGSYFKNTDLWIVMEYCGAGSVSDIIRLRNKTL 122

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  EI  ++Q  L GL Y+H  + +HRD+KA N+L+   G  KLADFG+A    Q  +  
Sbjct: 123 TEDEIATILQSTLKGLEYLHFMRKIHRDIKAGNILLNTEGHAKLADFGVA---GQLTDTM 179

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQQITL 187
             R T  + T ++  PE++  +  Y    D+W  G I A EM    P        + I +
Sbjct: 180 AKRNT-VIGTPFWMAPEVIQ-EIGYNCVADIWSLG-ITAIEMAEGKPPYADIHPMRAIFM 236

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I                          P  +K    E            D + + L+  P
Sbjct: 237 IP---------------------TNPPPTFRK---PELWSDNFT-----DFVKQCLVKSP 267

Query: 248 SKRFDSDAALNHDFFWTDPMPSDLSKMLAQH 278
            +R  +   L H F  +    S L  ++ + 
Sbjct: 268 EQRATATQLLQHPFVRSAKGVSILRDLINEA 298

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A* Length = 342

 Score =  103 bits (259), Expect = 6e-25
 Identities = 46/187 (24%), Positives = 76/187 (40%), Gaps = 20/187 (10%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            EI    +L+HEN++  I         + +     +LV D+ EH  L   L+      ++
Sbjct: 85  AEIYQTVMLRHENILGFIAADNKDNGTWTQL----WLVSDYHEHGSLFDYLN--RYTVTV 138

Query: 71  GEIKKVIQQLLNGLYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFS 122
             + K+     +GL ++H           I HRD+K+ N+L+ K G   +AD GLA    
Sbjct: 139 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 198

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP-----VDLWGAGCIMAEMWTRSPIMQ 177
              +       +RV T  Y  PE+L    N          D++  G +  E+  R  I  
Sbjct: 199 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 258

Query: 178 GNTEQQQ 184
            + + Q 
Sbjct: 259 IHEDYQL 265

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe} Length = 336

 Score =  102 bits (257), Expect = 1e-24
 Identities = 57/260 (21%), Positives = 103/260 (39%), Gaps = 64/260 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLG 71
           REI  L+LL+H +++ L ++  T         +   +V ++   +L   +     + +  
Sbjct: 58  REISYLKLLRHPHIIKLYDVITTP--------TDIVMVIEYAGGELFDYIVE-KKRMTED 108

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-----TKN 126
           E ++  QQ++  + Y H +KI+HRD+K  N+L+     +K+ADFGL+   +      T  
Sbjct: 109 EGRRFFQQIICAIEYCHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGNFLKTSC 168

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
           G  N          Y  PE++ G    GP VD+W  G ++  M                 
Sbjct: 169 GSPN----------YAAPEVINGKLYAGPEVDVWSCGIVLYVM----------------- 201

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYGC-DLLDKL 242
               L G + P         D      L     +KV      +  ++    G   L+ ++
Sbjct: 202 ----LVGRL-P--------FDDEFIPNL----FKKVNSCVYVMPDFLSP--GAQSLIRRM 242

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           ++ DP +R          +F
Sbjct: 243 IVADPMQRITIQEIRRDPWF 262

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens} Length = 319

 Score =  101 bits (254), Expect = 3e-24
 Identities = 34/172 (19%), Positives = 75/172 (43%), Gaps = 19/172 (11%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            RE+   +  +HENVV  +  C +  +          ++   C+   L  ++ +  +   
Sbjct: 77  KREVMAYRQTRHENVVLFMGACMSPPH--------LAIITSLCKGRTLYSVVRDAKIVLD 128

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK-NGQ 128
           + + +++ Q+++ G+ Y+H+  ILH+D+K+ NV     G + + DFGL       +   +
Sbjct: 129 VNKTRQIAQEIVKGMGYLHAKGILHKDLKSKNVFYDN-GKVVITDFGLFSISGVLQAGRR 187

Query: 129 VNRYTNRVVTLWYRPPELLLGDRN--------YGPPVDLWGAGCIMAEMWTR 172
            ++   +   L +  PE++             +    D++  G I  E+  R
Sbjct: 188 EDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKHSDVFALGTIWYELHAR 239

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A* Length = 303

 Score =  101 bits (253), Expect = 3e-24
 Identities = 60/271 (22%), Positives = 105/271 (38%), Gaps = 59/271 (21%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEHDLAGLLSNI 64
           L+EI+ +    H N+V               Y ++F      +LV         G + +I
Sbjct: 61  LKEIQAMSQCHHPNIV--------------SYYTSFVVKDELWLVMKLLS---GGSVLDI 103

Query: 65  -----------HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                              I  +++++L GL Y+H N  +HRD+KA N+L+ + G +++A
Sbjct: 104 IKHIVAKGEHKSGVLDESTIATILREVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIA 163

Query: 114 DFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWT 171
           DFG++   +   +   N+     V T  +  PE++   R Y    D+W  G I A E+ T
Sbjct: 164 DFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKADIWSFG-ITAIELAT 222

Query: 172 RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK 231
            +         + + L  Q   +  P       +L+        K   +K  +  +    
Sbjct: 223 GAAPYHKYPPMKVLMLTLQ---NDPP-------SLE---TGVQDKEMLKKYGKSFR---- 265

Query: 232 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                 ++   L  DP KR  +   L H FF
Sbjct: 266 -----KMISLCLQKDPEKRPTAAELLRHKFF 291

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A* Length = 302

 Score = 98.9 bits (247), Expect = 2e-23
 Identities = 62/281 (22%), Positives = 113/281 (40%), Gaps = 50/281 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + EI+IL    H  +V L+         Y       +++ +FC    +  ++  +    +
Sbjct: 64  IVEIEILATCDHPYIVKLLG-------AYYH-DGKLWIMIEFCPGGAVDAIMLELDRGLT 115

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             +I+ V +Q+L  L ++HS +I+HRD+KA NVL+T  G ++LADFG++   ++      
Sbjct: 116 EPQIQVVCRQMLEALNFLHSKRIIHRDLKAGNVLMTLEGDIRLADFGVS---AKNLKTLQ 172

Query: 130 NRYTNRVV-TLWYRPPELLLG----DRNYGPPVDLWGAGCIMA-EMWTRSPIMQGNTEQQ 183
            R +   + T ++  PE+++     D  Y    D+W  G I   EM    P        +
Sbjct: 173 KRDS--FIGTPYWMAPEVVMCETMKDTPYDYKADIWSLG-ITLIEMAQIEPPHHELNPMR 229

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
            +  I++   S  P       TL                  +     +     D L   L
Sbjct: 230 VLLKIAK---SDPP-------TL--------------LTPSKWSVEFR-----DFLKIAL 260

Query: 244 LLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
             +P  R  +   L H F  +      L +++A+    + E
Sbjct: 261 DKNPETRPSAAQLLEHPFVSSITSNKALRELVAEAKAEVME 301

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus} Length = 476

 Score =  100 bits (250), Expect = 4e-23
 Identities = 63/260 (24%), Positives = 109/260 (41%), Gaps = 63/260 (24%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI+ L+L +H +++ L ++  T         S  ++V ++    +L   +   + +   
Sbjct: 65  REIQNLKLFRHPHIIKLYQVISTP--------SDIFMVMEYVSGGELFDYICK-NGRLDE 115

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-----TK 125
            E +++ QQ+L+G+ Y H + ++HRD+K  NVL+      K+ADFGL+   S      T 
Sbjct: 116 KESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEFLRTS 175

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            G  N          Y  PE++ G    GP VD+W +G I+  +                
Sbjct: 176 CGSPN----------YAAPEVISGRLYAGPEVDIWSSGVILYAL---------------- 209

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYGCDLLDKL 242
                LCG++ P         D  +   L     +K+ +       Y+       LL  +
Sbjct: 210 -----LCGTL-P--------FDDDHVPTL----FKKICDGIFYTPQYLNPS-VISLLKHM 250

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L +DP KR        H++F
Sbjct: 251 LQVDPMKRATIKDIREHEWF 270

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} Length = 271

 Score = 96.6 bits (241), Expect = 7e-23
 Identities = 44/174 (25%), Positives = 76/174 (43%), Gaps = 29/174 (16%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            +E K+  +LKH N++ L  +C  + N          LV +F     L  +LS    +  
Sbjct: 54  RQEAKLFAMLKHPNIIALRGVCLKEPN--------LCLVMEFARGGPLNRVLSGK--RIP 103

Query: 70  LGEIKKVIQQLLNGLYYIHSNK---ILHRDMKAANVLITKTG--------ILKLADFGLA 118
              +     Q+  G+ Y+H      I+HRD+K++N+LI +          ILK+ DFGLA
Sbjct: 104 PDILVNWAVQIARGMNYLHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLA 163

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           R + +T         +      +  PE++     +    D+W  G ++ E+ T 
Sbjct: 164 REWHRT------TKMSAAGAYAWMAPEVIRASM-FSKGSDVWSYGVLLWELLTG 210

>1uu3_A HPDK1, 3-phosphoinositide dependent protein kinase-1; PKB, inhibitor, LY333531, diabetes, cancer, transferase, serine/threonine-protein kinase; HET: SEP LY4; 1.7A {Homo sapiens} SCOP: d.144.1.7 PDB: 1okz_A* 1oky_A* 1uu7_A* 1uu8_A* 2biy_A* 3rwp_A* 2xch_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* ... Length = 310

 Score = 96.9 bits (242), Expect = 8e-23
 Identities = 59/269 (21%), Positives = 95/269 (35%), Gaps = 71/269 (26%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL------AGLLSN 63
            RE  ++  L H   V L    +             Y    + ++ +L       G    
Sbjct: 78  TRERDVMSRLDHPFFVKLYFTFQDDEK--------LYFGLSYAKNGELLKYIRKIGSFDE 129

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
              +F   EI       ++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+    
Sbjct: 130 TCTRFYTAEI-------VSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAK---V 179

Query: 124 TKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTE 181
                     N  V T  Y  PELL   ++     DLW  GCI+ ++     P   GN  
Sbjct: 180 LSPESKQARANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEY 238

Query: 182 Q--QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
              Q+I                      +  + + P+        +  P  +     DL+
Sbjct: 239 LIFQKI----------------------IKLEYDFPE--------KFFPKAR-----DLV 263

Query: 240 DKLLLLDPSKRF------DSDAALNHDFF 262
           +KLL+LD +KR              H FF
Sbjct: 264 EKLLVLDATKRLGCEEMEGYGPLKAHPFF 292

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A* Length = 309

 Score = 96.6 bits (241), Expect = 1e-22
 Identities = 40/167 (23%), Positives = 73/167 (43%), Gaps = 18/167 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL--SNIHVK 67
           LRE+ I++ L+H N+V  +       N          +V ++     L  LL  S    +
Sbjct: 82  LREVAIMKRLRHPNIVLFMGAVTQPPN--------LSIVTEYLSRGSLYRLLHKSGAREQ 133

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   +   +  G+ Y+H+    I+HR++K+ N+L+ K   +K+ DFGL+R  + T 
Sbjct: 134 LDERRRLSMAYDVAKGMNYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF 193

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                   +   T  +  PE+L  +       D++  G I+ E+ T 
Sbjct: 194 LSS----KSAAGTPEWMAPEVLRDEP-SNEKSDVYSFGVILWELATL 235

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A* Length = 303

 Score = 96.2 bits (240), Expect = 2e-22
 Identities = 48/168 (28%), Positives = 80/168 (47%), Gaps = 24/168 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNI--HVK 67
           +EI +L       V             Y  Y   +  +++ ++      G   ++     
Sbjct: 69  QEITVLSQCDSPYVTKY----------YGSYLKDTKLWIIMEYLG---GGSALDLLEPGP 115

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
               +I  +++++L GL Y+HS K +HRD+KAANVL+++ G +KLADFG+A    Q  + 
Sbjct: 116 LDETQIATILREILKGLDYLHSEKKIHRDIKAANVLLSEHGEVKLADFGVA---GQLTDT 172

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA-EMWTRSP 174
           Q+ R T  V T ++  PE++     Y    D+W  G I A E+    P
Sbjct: 173 QIKRNT-FVGTPFWMAPEVIK-QSAYDSKADIWSLG-ITAIELARGEP 217

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A Length = 361

 Score = 97.0 bits (242), Expect = 2e-22
 Identities = 56/263 (21%), Positives = 99/263 (37%), Gaps = 61/263 (23%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
           REI   + L+H N+V   E+  T         +   ++ ++    +L   + N   +FS 
Sbjct: 65  REIINHRSLRHPNIVRFKEVILTP--------THLAIIMEYASGGELYERICN-AGRFSE 115

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI--TKTGILKLADFGLARAFSQ----- 123
            E +   QQLL+G+ Y HS +I HRD+K  N L+  +    LK+ DFG +++        
Sbjct: 116 DEARFFFQQLLSGVSYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLHSQPK 175

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
           +  G          T  Y  PE+LL     G   D+W  G  +  M              
Sbjct: 176 STVG----------TPAYIAPEVLLRQEYDGKIADVWSCGVTLYVM-------------- 211

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE---RLKPYVKDQYGC-DLL 239
                  L G+  P         +   +    +   +++      +   ++    C  L+
Sbjct: 212 -------LVGAY-P--------FEDPEEPRDYRKTIQRILSVKYSIPDDIRISPECCHLI 255

Query: 240 DKLLLLDPSKRFDSDAALNHDFF 262
            ++ + DP+ R        H +F
Sbjct: 256 SRIFVADPATRISIPEIKTHSWF 278

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 2qlu_A* Length = 322

 Score = 95.9 bits (239), Expect = 2e-22
 Identities = 47/189 (24%), Positives = 80/189 (42%), Gaps = 23/189 (12%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            E+  L  +KHEN++  I   +   +         +L+  F E   L+  L       S 
Sbjct: 67  YEVYSLPGMKHENILQFIGAEKRGTSVDVDL----WLITAFHEKGSLSDFLKA--NVVSW 120

Query: 71  GEIKKVIQQLLNGLYYIHSN----------KILHRDMKAANVLITKTGILKLADFGLARA 120
            E+  + + +  GL Y+H +           I HRD+K+ NVL+       +ADFGLA  
Sbjct: 121 NELCHIAETMARGLAYLHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALK 180

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP----VDLWGAGCIMAEMWTRSPIM 176
           F   K+        +V T  Y  PE+L G  N+       +D++  G ++ E+ +R    
Sbjct: 181 FEAGKSAGDT--HGQVGTRRYMAPEVLEGAINFQRDAFLRIDMYAMGLVLWELASRCTAA 238

Query: 177 QGNTEQQQI 185
            G  ++  +
Sbjct: 239 DGPVDEYML 247

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens} Length = 307

 Score = 95.5 bits (238), Expect = 3e-22
 Identities = 43/169 (25%), Positives = 69/169 (40%), Gaps = 25/169 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E++ L  + H N+V L   C               LV ++ E   L  +L        
Sbjct: 49  IVELRQLSRVNHPNIVKLYGACLNP----------VCLVMEYAEGGSLYNVLHGAEPLPY 98

Query: 70  LGEIKKVI--QQLLNGLYYIHSNK---ILHRDMKAANVLITKTG-ILKLADFGLARAFSQ 123
                 +    Q   G+ Y+HS +   ++HRD+K  N+L+   G +LK+ DFG A     
Sbjct: 99  YTAAHAMSWCLQCSQGVAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQT 158

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
                    TN   +  +  PE+  G  NY    D++  G I+ E+ TR
Sbjct: 159 HM-------TNNKGSAAWMAPEVFEG-SNYSEKCDVFSWGIILWEVITR 199

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens} Length = 336

 Score = 96.1 bits (239), Expect = 3e-22
 Identities = 44/182 (24%), Positives = 75/182 (41%), Gaps = 27/182 (14%)

Query: 12  REIKILQLLKHENVVHLIEIC-RTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + I  + L++H+N+   I    R  A+    Y     LV ++  +  L   LS       
Sbjct: 56  KNIYRVPLMEHDNIARFIVGDERVTADGRMEY----LLVMEYYPNGSLXKYLSL--HTSD 109

Query: 70  LGEIKKVIQQLLNGLYYIHS---------NKILHRDMKAANVLITKTGILKLADFGLARA 120
                ++   +  GL Y+H+           I HRD+ + NVL+   G   ++DFGL+  
Sbjct: 110 WVSSCRLAHSVTRGLAYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMR 169

Query: 121 FSQTK---NGQVNRYTNRVV-TLWYRPPELLLGDRN------YGPPVDLWGAGCIMAEMW 170
            +  +    G+ +      V T+ Y  PE+L G  N          VD++  G I  E++
Sbjct: 170 LTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAVNLRDXESALKQVDMYALGLIYWEIF 229

Query: 171 TR 172
            R
Sbjct: 230 MR 231

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A* Length = 287

 Score = 95.1 bits (237), Expect = 3e-22
 Identities = 32/171 (18%), Positives = 65/171 (38%), Gaps = 26/171 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            RE+ I+  L H N+V L  +                +V +F    DL   L +      
Sbjct: 71  QREVFIMSNLNHPNIVKLYGLMHNP----------PRMVMEFVPCGDLYHRLLDKAHPIK 120

Query: 70  LGEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLITKTG-----ILKLADFGLARAFS 122
                +++  +  G+ Y+ +    I+HRD+++ N+ +           K+ADFGL++   
Sbjct: 121 WSVKLRLMLDIALGIEYMQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSV 180

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLG-DRNYGPPVDLWGAGCIMAEMWTR 172
            +        +  +    +  PE +   + +Y    D +    I+  + T 
Sbjct: 181 HSV-------SGLLGNFQWMAPETIGAEEESYTEKADTYSFAMILYTILTG 224

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens} Length = 326

 Score = 92.1 bits (229), Expect = 5e-21
 Identities = 49/174 (28%), Positives = 79/174 (45%), Gaps = 21/174 (12%)

Query: 12  REIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIHV 66
           +EI +L +   H N+         K           +LV +FC      DL  + +    
Sbjct: 69  QEINMLKKYSHHRNIATYYGAFIKKNPP--GMDDQLWLVMEFCGAGSVTDL--IKNTKGN 124

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                 I  + +++L GL ++H +K++HRD+K  NVL+T+   +KL DFG++   +Q   
Sbjct: 125 TLKEEWIAYICREILRGLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVS---AQLDR 181

Query: 127 GQVNRYTNRVV-TLWYRPPELLLGDRN----YGPPVDLWGAGCIMA-EMWTRSP 174
               R T   + T ++  PE++  D N    Y    DLW  G I A EM   +P
Sbjct: 182 TVGRRNT--FIGTPYWMAPEVIACDENPDATYDFKSDLWSLG-ITAIEMAEGAP 232

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* Length = 360

 Score = 92.6 bits (230), Expect = 6e-21
 Identities = 58/276 (21%), Positives = 101/276 (36%), Gaps = 50/276 (18%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDL--------AGLLS 62
           +RE+++L       +V                   FY  F + + ++         G L 
Sbjct: 79  IRELQVLHECNSPYIVG------------------FYGAF-YSDGEISICMEHMDGGSLD 119

Query: 63  NI---HVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLA 118
            +     +     + KV   ++ GL Y+    KI+HRD+K +N+L+   G +KL DFG++
Sbjct: 120 QVLKKAGRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVS 179

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQ 177
                +        +  V T  Y  PE L G  +Y    D+W  G  + EM   R PI  
Sbjct: 180 GQLIDSM-----ANSF-VGTRSYMSPERLQGT-HYSVQSDIWSMGLSLVEMAVGRYPIPP 232

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK--------VKERLKPY 229
            + ++ ++    Q+ G                NK  +               V E     
Sbjct: 233 PDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKL 292

Query: 230 VKDQYG---CDLLDKLLLLDPSKRFDSDAALNHDFF 262
               +     D ++K L+ +P++R D    + H F 
Sbjct: 293 PSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFI 328

>3pvu_A Beta-adrenergic receptor kinase 1; transferase, serine/threonine-protein kinase, ATP-binding, I membrane; HET: QRW; 2.48A {Bos taurus} PDB: 3psc_A* 3pvw_A* 1omw_A 1ym7_A 2bcj_A* 3cik_A 3krw_A* 3krx_A* 1bak_A Length = 695

 Score = 92.6 bits (230), Expect = 3e-20
 Identities = 45/223 (20%), Positives = 84/223 (37%), Gaps = 44/223 (19%)

Query: 47  YLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT 105
             + D     DL   LS  H  FS  +++    +++ GL ++H+  +++RD+K AN+L+ 
Sbjct: 268 SFILDLMNGGDLHYHLSQ-HGVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLD 326

Query: 106 KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI 165
           + G ++++D GLA       +    +    V T  Y  PE+L     Y    D +  GC+
Sbjct: 327 EHGHVRISDLGLA------CDFSKKKPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGCM 380

Query: 166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE 224
           + ++    SP  Q  T+ +                       ++             +  
Sbjct: 381 LFKLLRGHSPFRQHKTKDKH----------------------EIDRMT-------LTMAV 411

Query: 225 RLKPYVKDQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFF 262
            L      +    LL+ LL  D ++R       +       FF
Sbjct: 412 ELPDSFSPE-LRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFF 453

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp} Length = 294

 Score = 89.6 bits (223), Expect = 3e-20
 Identities = 48/162 (29%), Positives = 80/162 (49%), Gaps = 16/162 (9%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSL 70
           RE+     L H+N+V +I++              +YLV ++ E   L+  + + H   S+
Sbjct: 60  REVHNSSQLSHQNIVSMIDVDEE--------DDCYYLVMEYIEGPTLSEYIES-HGPLSV 110

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
                   Q+L+G+ + H  +I+HRD+K  N+LI     LK+ DFG+A+A S+T   Q  
Sbjct: 111 DTAINFTNQILDGIKHAHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSLTQ-- 168

Query: 131 RYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             TN V+ T+ Y  PE   G+       D++  G ++ EM  
Sbjct: 169 --TNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVLYEMLV 207

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 3q32_A* 3rvg_A* 3tjc_A* 3tjd_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* 3io7_A* 3kck_A* 3jy9_A* Length = 295

 Score = 88.9 bits (221), Expect = 6e-20
 Identities = 42/199 (21%), Positives = 83/199 (41%), Gaps = 14/199 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +  
Sbjct: 59  EREIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 112

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K    
Sbjct: 113 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEFFK 172

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
            +        WY  PE L  +  +    D+W  G ++ E++T          +       
Sbjct: 173 VKEPGESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFM 225

Query: 190 QLCGSITPESWPGVETLDL 208
           ++ G+           ++L
Sbjct: 226 RMIGNDKQGQMIVFHLIEL 244

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens} Length = 412

 Score = 90.2 bits (224), Expect = 6e-20
 Identities = 57/266 (21%), Positives = 87/266 (32%), Gaps = 61/266 (22%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DLAGLLSNIH 65
           E  +L       +  L                 F      YLV ++    DL  LLS   
Sbjct: 111 ERDVLVNGDRRWITQL--------------HFAFQDENYLYLVMEYYVGGDLLTLLSKFG 156

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            +      +  + +++  +  +H    +HRD+K  N+L+ + G ++LADFG         
Sbjct: 157 ERIPAEMARFYLAEIVMAIDSVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKL--RA 214

Query: 126 NGQVNRYTNRVVTLWYRPPELLLG------DRNYGPPVDLWGAGCIMAEMWTRSPIMQGN 179
           +G V      V T  Y  PE+L          +YGP  D W  G    EM          
Sbjct: 215 DGTVRSLV-AVGTPDYLSPEILQAVGGGPGTGSYGPECDWWALGVFAYEM---------- 263

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
                        G  TP  +    T + Y K+      K  +   L      +   D +
Sbjct: 264 -----------FYG-QTP--FYADSTAETYGKI---VHYKEHLSLPLVDEGVPEEARDFI 306

Query: 240 DKLLLLDPSKRF---DSDAALNHDFF 262
            + LL  P  R     +     H FF
Sbjct: 307 QR-LLCPPETRLGRGGAGDFRTHPFF 331

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A* Length = 311

 Score = 88.5 bits (220), Expect = 8e-20
 Identities = 43/162 (26%), Positives = 73/162 (45%), Gaps = 10/162 (6%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSL 70
           RE +    L H  +V + +    +           Y+V ++ +   L  ++       + 
Sbjct: 61  REAQNAAALNHPAIVAVYDTGEAETPAGPLP----YIVMEYVDGVTLRDIVHT-EGPMTP 115

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
               +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + N    
Sbjct: 116 KRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGNSVTQ 175

Query: 131 RYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             T  V+ T  Y  PE   GD       D++  GC++ E+ T
Sbjct: 176 --TAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLT 214

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} PDB: 3kmw_A* 3rep_A* Length = 271

 Score = 86.9 bits (216), Expect = 1e-19
 Identities = 24/169 (14%), Positives = 58/169 (34%), Gaps = 25/169 (14%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE----HDLAGLLSNIHVK 67
            E   L++  H NV+ ++  C       +       L+  +      +++  L    +  
Sbjct: 56  EECPRLRIFSHPNVLPVLGAC-QSPPAPH-----PTLITHWMPYGSLYNV--LHEGTNFV 107

Query: 68  FSLGEIKKVIQQLLNGLYYIHS--NKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
               +  K    +  G+ ++H+    I    + + +V+I +    +++   +  +F    
Sbjct: 108 VDQSQAVKFALDMARGMAFLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQS-- 165

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTR 172
                    R+    +  PE L            D+W    ++ E+ TR
Sbjct: 166 -------PGRMYAPAWVAPEALQKKPEDTNRRSADMWSFAVLLWELVTR 207

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens} Length = 326

 Score = 87.8 bits (218), Expect = 2e-19
 Identities = 42/199 (21%), Positives = 83/199 (41%), Gaps = 14/199 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            REI+IL+ L+H+N+V    +C      Y+  R    L+ ++  +  L   L     +  
Sbjct: 90  EREIEILKSLQHDNIVKYKGVC------YSAGRRNLKLIMEYLPYGSLRDYLQKHKERID 143

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             ++ +   Q+  G+ Y+ + + +HRD+   N+L+     +K+ DFGL +   Q K    
Sbjct: 144 HIKLLQYTSQICKGMEYLGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEYYK 203

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
            +        WY  PE L  +  +    D+W  G ++ E++T          +       
Sbjct: 204 VKEPGESPIFWY-APESLT-ESKFSVASDVWSFGVVLYELFTY-----IEKSKSPPAEFM 256

Query: 190 QLCGSITPESWPGVETLDL 208
           ++ G+           ++L
Sbjct: 257 RMIGNDKQGQMIVFHLIEL 275

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A* Length = 437

 Score = 88.3 bits (219), Expect = 3e-19
 Identities = 62/353 (17%), Positives = 101/353 (28%), Gaps = 101/353 (28%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLG 71
           E  +L     + +  L    +   N         YLV D+    DL  LLS    +    
Sbjct: 124 ERDVLVNGDSKWITTLHYAFQDDNN--------LYLVMDYYVGGDLLTLLSKFEDRLPEE 175

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
             +  + +++  +  +H    +HRD+K  N+L+   G ++LADFG        ++G V  
Sbjct: 176 MARFYLAEMVIAIDSVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKL--MEDGTVQS 233

Query: 132 YTNRVVTLWYRPPELLL----GDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
               V T  Y  PE+L     G   YGP  D W  G  M EM          +  +    
Sbjct: 234 SV-AVGTPDYISPEILQAMEGGKGRYGPECDWWSLGVCMYEMLYGETPFYAESLVETYGK 292

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I                 ++   + + P       +             DL+ + L+   
Sbjct: 293 I-----------------MNHKERFQFPTQVTDVSEN----------AKDLIRR-LICSR 324

Query: 248 SKRF---DSDAALNHDFF----WTD-------------------------------PMPS 269
             R      +    H FF    W +                                   
Sbjct: 325 EHRLGQNGIEDFKKHPFFSGIDWDNIRNCEAPYIPEVSSPTDTSNFDVDDDCLKNSETMP 384

Query: 270 DLSKMLAQHTQSMFE---YLAP----------------PRRPGHMRAHHHHHH 303
             +          F    Y +                      + ++HHHHHH
Sbjct: 385 PPTHTAFSGHHLPFVGFTYTSSCVLSDRSCLRVTAGPTSAENLYFQSHHHHHH 437

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis} Length = 309

 Score = 86.9 bits (216), Expect = 3e-19
 Identities = 41/173 (23%), Positives = 68/173 (39%), Gaps = 20/173 (11%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNR--YRSTFYLVFDFCE-HDLAGLLSNIHVKF 68
           RE +    L+  +VV +          ++        Y+        DLA +L       
Sbjct: 83  REARTAGRLQEPHVVPI----------HDFGEIDGQLYVDMRLINGVDLAAMLRR-QGPL 131

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +      +++Q+ + L   H+    HRD+K  N+L++      L DFG+A A +  K  Q
Sbjct: 132 APPRAVAIVRQIGSALDAAHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKLTQ 191

Query: 129 VNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
                   V TL+Y  PE            D++   C++ E  T SP  QG+ 
Sbjct: 192 ----LGNTVGTLYYMAPERFSESH-ATYRADIYALTCVLYECLTGSPPYQGDQ 239

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 3eyg_A* 3eyh_A* Length = 302

 Score = 86.2 bits (214), Expect = 5e-19
 Identities = 48/166 (28%), Positives = 73/166 (43%), Gaps = 17/166 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            +EI+IL+ L HEN+V    IC           +   L+ +F     L   L     K +
Sbjct: 71  KKEIEILRNLYHENIVKYKGIC------TEDGGNGIKLIMEFLPSGSLKEYLPKNKNKIN 124

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L +  K   Q+  G+ Y+ S + +HRD+ A NVL+     +K+ DFGL +A    K    
Sbjct: 125 LKQQLKYAVQICKGMDYLGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKEY-- 182

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             YT +        WY  PE L+    +    D+W  G  + E+ T
Sbjct: 183 --YTVKDDRDSPVFWY-APECLM-QSKFYIASDVWSFGVTLHELLT 224

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 3pjc_A* 1yvj_A* Length = 327

 Score = 85.9 bits (213), Expect = 8e-19
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 9/162 (5%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            REI+IL+ L  + +V    +       Y   R +  LV ++     L   L     +  
Sbjct: 72  QREIQILKALHSDFIVKYRGVS------YGPGRQSLRLVMEYLPSGCLRDFLQRHRARLD 125

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +     Q+  G+ Y+ S + +HRD+ A N+L+     +K+ADFGLA+     K+  V
Sbjct: 126 ASRLLLYSSQICKGMEYLGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKDYYV 185

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R   +    WY  PE L  D  +    D+W  G ++ E++T
Sbjct: 186 VREPGQSPIFWY-APESLS-DNIFSRQSDVWSFGVVLYELFT 225

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens} Length = 384

 Score = 86.6 bits (215), Expect = 9e-19
 Identities = 56/264 (21%), Positives = 92/264 (34%), Gaps = 63/264 (23%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DLAGLLSN 63
            +E++I+Q L+H  +V+L                +F      ++V D     DL   L  
Sbjct: 63  FKELQIMQGLEHPFLVNL--------------WYSFQDEEDMFMVVDLLLGGDLRYHLQQ 108

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
            +V F    +K  I +L+  L Y+ + +I+HRDMK  N+L+ + G + + DF +A     
Sbjct: 109 -NVHFKEETVKLFICELVMALDYLQNQRIIHRDMKPDNILLDEHGHVHITDFNIA----- 162

Query: 124 TKNGQVNRYTNRVV-TLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
                       +  T  Y  PE+    +   Y   VD W  G    E+           
Sbjct: 163 -AMLPRETQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLGVTAYEL----------- 210

Query: 181 EQQQITLISQLCGSITP-ESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL 239
                     L G   P        + ++ +       +   V          Q    LL
Sbjct: 211 ----------LRG-RRPYHIRSSTSSKEIVHTF-----ETTVV--TYPSAW-SQEMVSLL 251

Query: 240 DKLLLLDPSKRF-DSDAALNHDFF 262
            KLL  +P +RF       N  + 
Sbjct: 252 KKLLEPNPDQRFSQLSDVQNFPYM 275

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ... Length = 350

 Score = 86.2 bits (214), Expect = 9e-19
 Identities = 60/267 (22%), Positives = 101/267 (37%), Gaps = 77/267 (28%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-----HDL--AGLLSNIH 65
           E +ILQ +    +V L    +  +N         Y+V ++         L   G  S  H
Sbjct: 91  EKRILQAVNFPFLVKLEFSFKDNSN--------LYMVMEYVAGGEMFSHLRRIGRFSEPH 142

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            +F   +I       +    Y+HS  +++RD+K  N+LI + G +++ DFG A+      
Sbjct: 143 ARFYAAQI-------VLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAK------ 189

Query: 126 NGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
             +V   T  +  T     PE++L  + Y   VD W  G ++ EM               
Sbjct: 190 --RVKGRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEM--------------- 231

Query: 185 ITLISQLCGSITPESWP---GVETLDLYNKMELPKAQKRKVKERLK-PYVKDQYGCDLLD 240
                   G      +P     + + +Y K+         V  +++ P        DLL 
Sbjct: 232 ------AAG------YPPFFADQPIQIYEKI---------VSGKVRFPSHFSSDLKDLLR 270

Query: 241 KLLLLDPSKRF-----DSDAALNHDFF 262
            LL +D +KRF       +   NH +F
Sbjct: 271 NLLQVDLTKRFGNLKNGVNDIKNHKWF 297

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* Length = 318

 Score = 83.9 bits (208), Expect = 4e-18
 Identities = 44/162 (27%), Positives = 73/162 (45%), Gaps = 11/162 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            +EI IL+ L HE+++     C       +   ++  LV ++     L   L   H    
Sbjct: 81  KQEIDILRTLYHEHIIKYKGCC------EDAGAASLQLVMEYVPLGSLRDYLPR-H-SIG 132

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L ++    QQ+  G+ Y+H+   +HRD+ A NVL+    ++K+ DFGLA+A  +      
Sbjct: 133 LAQLLLFAQQICEGMAYLHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHEYYR 192

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            R        WY  PE L  +  +    D+W  G  + E+ T
Sbjct: 193 VREDGDSPVFWY-APECLK-EYKFYYASDVWSFGVTLYELLT 232

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7 Length = 318

 Score = 83.4 bits (207), Expect = 5e-18
 Identities = 53/265 (20%), Positives = 90/265 (33%), Gaps = 73/265 (27%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-----HDL--AGLLSNIH 65
           E  +L ++ H  ++ +    +             +++ D+ E       L  +    N  
Sbjct: 56  ERLMLSIVTHPFIIRMWGTFQDAQQ--------IFMIMDYIEGGELFSLLRKSQRFPNPV 107

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            KF   E+          L Y+HS  I++RD+K  N+L+ K G +K+ DFG A+      
Sbjct: 108 AKFYAAEV-------CLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDVT 160

Query: 126 N---GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
               G          T  Y  PE++     Y   +D W  G ++ EM         +   
Sbjct: 161 YTLCG----------TPDYIAPEVVSTKP-YNKSIDWWSFGILIYEMLAGYTPFYDSNTM 209

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
           +    I                   L  ++  P              VK     DLL +L
Sbjct: 210 KTYEKI-------------------LNAELRFPP--------FFNEDVK-----DLLSRL 237

Query: 243 LLLDPSKRF-----DSDAALNHDFF 262
           +  D S+R       ++   NH +F
Sbjct: 238 ITRDLSQRLGNLQNGTEDVKNHPWF 262

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A* Length = 327

 Score = 83.5 bits (207), Expect = 5e-18
 Identities = 55/308 (17%), Positives = 110/308 (35%), Gaps = 64/308 (20%)

Query: 11  LREIKI-LQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVK 67
           L ++ + ++      +V            Y         ++  +            ++  
Sbjct: 68  LMDLDVVMRSSDCPYIVQF----------YGALFREGDCWICMELMSTSFDKFYKYVYSV 117

Query: 68  FS--LGE--IKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFS 122
               + E  + K+    +  L ++  N KI+HRD+K +N+L+ ++G +KL DFG++    
Sbjct: 118 LDDVIPEEILGKITLATVKALNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLV 177

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRN---YGPPVDLWGAGCIMAEMWT-RSPIMQG 178
            +        T       Y  PE +    +   Y    D+W  G  + E+ T R P  + 
Sbjct: 178 DSIAK-----TRDAGCRPYMAPERIDPSASRQGYDVRSDVWSLGITLYELATGRFPYPKW 232

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG--- 235
           N+   Q+T +                      K + P         +L    + ++    
Sbjct: 233 NSVFDQLTQVV---------------------KGDPP---------QLSNSEEREFSPSF 262

Query: 236 CDLLDKLLLLDPSKRFDSDAALNHDFFWT-DPMPSDLSKMLAQHTQSMFEYLAPPRRPGH 294
            + ++  L  D SKR      L H F    +    +++  +    + + +  A P  P +
Sbjct: 263 INFVNLCLTKDESKRPKYKELLKHPFILMYEERAVEVACYV---CKILDQMPATPSSPMY 319

Query: 295 MRAHHHHH 302
           +  HHHHH
Sbjct: 320 VDHHHHHH 327

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B Length = 543

 Score = 84.8 bits (210), Expect = 6e-18
 Identities = 55/276 (19%), Positives = 84/276 (30%), Gaps = 78/276 (28%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFC---------- 53
           A+ E KIL  +    +V L                 F       LV              
Sbjct: 232 AMVEKKILAKVHSRFIVSL--------------AYAFETKTDLCLVMTIMNGGDIRYHIY 277

Query: 54  -EHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKL 112
              +           F   +I       ++GL ++H   I++RD+K  NVL+   G +++
Sbjct: 278 NVDEDNPGFQEPRAIFYTAQI-------VSGLEHLHQRNIIYRDLKPENVLLDDDGNVRI 330

Query: 113 ADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT- 171
           +D GLA      +     +      T  +  PELLLG+  Y   VD +  G  + EM   
Sbjct: 331 SDLGLAVELKAGQ----TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALGVTLYEMIAA 385

Query: 172 RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK 231
           R P      +                     VE  +L  ++        +          
Sbjct: 386 RGPFRARGEK---------------------VENKELKQRV-------LEQAVTYPDKF- 416

Query: 232 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFF 262
                D  + LL  DP KR        D    H  F
Sbjct: 417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLF 452

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A* Length = 410

 Score = 83.6 bits (207), Expect = 1e-17
 Identities = 68/257 (26%), Positives = 95/257 (36%), Gaps = 49/257 (19%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLG 71
           E  I+       VV L       A Q +RY    Y+V ++    DL  L+SN        
Sbjct: 119 ERDIMAFANSPWVVQL-----FYAFQDDRY---LYMVMEYMPGGDLVNLMSN--YDVPEK 168

Query: 72  EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNR 131
             +    +++  L  IHS   +HRD+K  N+L+ K+G LKLADFG        K G V  
Sbjct: 169 WARFYTAEVVLALDAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKM--NKEGMVRC 226

Query: 132 YTNRVVTLWYRPPELLL---GDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
            T  V T  Y  PE+L    GD  YG   D W  G  + EM                   
Sbjct: 227 DT-AVGTPDYISPEVLKSQGGDGYYGRECDWWSVGVFLYEM------------------- 266

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
             L G  TP  +     +  Y+K+      K  +       +  +   +L+    L D  
Sbjct: 267 --LVG-DTP--FYADSLVGTYSKI---MNHKNSLTFPDDNDISKE-AKNLICA-FLTDRE 316

Query: 249 KRF---DSDAALNHDFF 262
            R      +    H FF
Sbjct: 317 VRLGRNGVEEIKRHLFF 333

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A Length = 495

 Score = 84.1 bits (208), Expect = 1e-17
 Identities = 38/167 (22%), Positives = 75/167 (44%), Gaps = 22/167 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  + +L   L      + 
Sbjct: 264 LKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTYGNLLDYLRECNRQEV 315

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           S   +  +  Q+ + + Y+     +HR++ A N L+ +  ++K+ADFGL+R  +      
Sbjct: 316 SAVVLLYMATQISSAMEYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTG----- 370

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            + YT          W  P  L      +    D+W  G ++ E+ T
Sbjct: 371 -DTYTAHAGAKFPIKWTAPESLA--YNKFSIKSDVWAFGVLLWEIAT 414

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens} Length = 325

 Score = 82.0 bits (203), Expect = 2e-17
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 11/162 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +  T+            +V ++ E+  L   L     +F+
Sbjct: 98  LSEASIMGQFDHPNIIRLEGVV-TR-------GRLAMIVTEYMENGSLDTFLRTHDGQFT 149

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+     +HRD+ A NVL+    + K++DFGL+R      +   
Sbjct: 150 IMQLVGMLRGVGAGMRYLSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDAAY 209

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W   PE +   R +    D+W  G +M E+  
Sbjct: 210 TTTGGKIPIRWT-APEAIA-FRTFSSASDVWSFGVVMWEVLA 249

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B* Length = 291

 Score = 81.1 bits (201), Expect = 2e-17
 Identities = 43/167 (25%), Positives = 69/167 (41%), Gaps = 20/167 (11%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE+  +  L H N++ L  +  T             +V +      L   L      F 
Sbjct: 69  IREVNAMHSLDHRNLIRLYGVVLT---------PPMKMVTELAPLGSLLDRLRKHQGHFL 119

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           LG + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q      
Sbjct: 120 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQND---- 175

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           + Y  +        W   PE L   R +    D W  G  + EM+T 
Sbjct: 176 DHYVMQEHRKVPFAWC-APESLK-TRTFSHASDTWMFGVTLWEMFTY 220

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A* Length = 656

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 40/166 (24%), Positives = 67/166 (40%), Gaps = 22/166 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E   ++   H ++V LI +  T+        +  +++ + C   +L   L        
Sbjct: 439 LQEALTMRQFDHPHIVKLIGVI-TE--------NPVWIIMELCTLGELRSFLQVRKFSLD 489

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L  +     QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R    +     
Sbjct: 490 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDST---- 545

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
             Y           W   PE +   R +    D+W  G  M E+  
Sbjct: 546 --YYKASKGKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILM 587

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ... Length = 373

 Score = 82.0 bits (203), Expect = 3e-17
 Identities = 36/162 (22%), Positives = 71/162 (43%), Gaps = 11/162 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +  TK            +V ++ E+  L   L     +F+
Sbjct: 94  LGEASIMGQFDHPNIIRLEGVV-TK-------SKPVMIVTEYMENGSLDSFLRKHDAQFT 145

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ + +G+ Y+     +HRD+ A N+LI    + K++DFGL R          
Sbjct: 146 VIQLVGMLRGIASGMKYLSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEAAY 205

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W   PE +   R +    D+W  G ++ E+ +
Sbjct: 206 TTRGGKIPIRWT-SPEAIA-YRKFTSASDVWSYGIVLWEVMS 245

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis} Length = 681

 Score = 83.4 bits (206), Expect = 3e-17
 Identities = 31/166 (18%), Positives = 65/166 (39%), Gaps = 18/166 (10%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKF 68
           A+ E + L  + H ++V +           +      Y+V ++     L         K 
Sbjct: 126 AMAERQFLAEVVHPSIVQIFNFVEHTDRHGD---PVGYIVMEYVGGQSLKRSKGQ---KL 179

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            + E    + ++L  L Y+HS  +++ D+K  N+++T+  + KL D G     +    G 
Sbjct: 180 PVAEAIAYLLEILPALSYLHSIGLVYNDLKPENIMLTEEQL-KLIDLGAVSRINSF--GY 236

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSP 174
           +        T  ++ PE++          D++  G  +A +    P
Sbjct: 237 L------YGTPGFQAPEIVRTGP--TVATDIYTVGRTLAALTLDLP 274

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A* Length = 281

 Score = 80.7 bits (200), Expect = 3e-17
 Identities = 39/166 (23%), Positives = 66/166 (39%), Gaps = 22/166 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E   ++   H ++V LI +            +  +++ + C   +L   L        
Sbjct: 64  LQEALTMRQFDHPHIVKLIGVIT---------ENPVWIIMELCTLGELRSFLQVRKYSLD 114

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L  +     QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R        + 
Sbjct: 115 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYM------ED 168

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           + Y           W   PE +   R +    D+W  G  M E+  
Sbjct: 169 STYYKASKGKLPIKWM-APESIN-FRRFTSASDVWMFGVCMWEILM 212

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A* Length = 397

 Score = 82.3 bits (203), Expect = 3e-17
 Identities = 69/341 (20%), Positives = 120/341 (35%), Gaps = 111/341 (32%)

Query: 9   TALREIKILQLLK--------HENVVHLIE-----------ICRTKANQYNRYRSTFYLV 49
           TAL EI++L+ ++         E VV L++           IC               +V
Sbjct: 79  TALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGVNGTHIC---------------MV 123

Query: 50  FDFCEHDLAGLL-SNIHVKFSLGEIKKVIQQLLNGLYYIHS-NKILHRDMKAANVLIT-- 105
           F+   H L   +  + +    L  +KK+IQQ+L GL Y+H+  +I+H D+K  N+L++  
Sbjct: 124 FEVLGHHLLKWIIKSNYQGLPLPCVKKIIQQVLQGLDYLHTKCRIIHTDIKPENILLSVN 183

Query: 106 -----------------------------------------------KTGILKLADFGLA 118
                                                          +   +K+AD G A
Sbjct: 184 EQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEKLKVKIADLGNA 243

Query: 119 RAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
               +        +T  + T  YR  E+L+G   Y  P D+W   C+  E+ T   + + 
Sbjct: 244 CWVHKH-------FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEP 295

Query: 179 ------NTEQQQITLISQLCGSITPESWPGVETLDLY-----NKMELPKAQKRKVKERLK 227
                   ++  I LI +L G +  +     +    +     +   + K +   + E L 
Sbjct: 296 HSGEEYTRDEDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLV 355

Query: 228 PYV------KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 262
                       +  D L  +L L P KR  +   L H + 
Sbjct: 356 EKYEWSQEEAAGF-TDFLLPMLELIPEKRATAAECLRHPWL 395

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 287

 Score = 80.8 bits (200), Expect = 3e-17
 Identities = 39/163 (23%), Positives = 70/163 (42%), Gaps = 12/163 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE +I+  L +  +V LI +C+ +            LV +      L   L     +  
Sbjct: 58  MREAQIMHQLDNPYIVRLIGVCQAE---------ALMLVMEMAGGGPLHKFLVGKREEIP 108

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HRD+ A NVL+      K++DFGL++A     +   
Sbjct: 109 VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 168

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
            R   +    WY  PE +   R +    D+W  G  M E  + 
Sbjct: 169 ARSAGKWPLKWY-APECIN-FRKFSSRSDVWSYGVTMWEALSY 209

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} PDB: 3sxr_A* Length = 268

 Score = 80.3 bits (199), Expect = 3e-17
 Identities = 39/187 (20%), Positives = 81/187 (43%), Gaps = 24/187 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
            +E + +  L H  +V    +C +K           Y+V ++  +  L   L +      
Sbjct: 51  FQEAQTMMKLSHPKLVKFYGVC-SK-------EYPIYIVTEYISNGCLLNYLRSHGKGLE 102

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             ++ ++   +  G+ ++ S++ +HRD+ A N L+ +   +K++DFG+ R          
Sbjct: 103 PSQLLEMCYDVCEGMAFLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLD------ 156

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSPIMQGNTEQQ 183
           ++Y + V T     W   PE+      Y    D+W  G +M E+++  + P     T  +
Sbjct: 157 DQYVSSVGTKFPVKWS-APEVFH-YFKYSSKSDVWAFGILMWEVFSLGKMP-YDLYTNSE 213

Query: 184 QITLISQ 190
            +  +SQ
Sbjct: 214 VVLKVSQ 220

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A* Length = 576

 Score = 82.9 bits (205), Expect = 3e-17
 Identities = 54/263 (20%), Positives = 93/263 (35%), Gaps = 55/263 (20%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VK 67
           AL E +IL+ +    VV L     TK            LV       DL   + ++    
Sbjct: 231 ALNEKQILEKVNSRFVVSLAYAYETK--------DALCLVLTLMNGGDLKFHIYHMGQAG 282

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           F          ++  GL  +H  +I++RD+K  N+L+   G ++++D GLA       + 
Sbjct: 283 FPEARAVFYAAEICCGLEDLHRERIVYRDLKPENILLDDHGHIRISDLGLA------VHV 336

Query: 128 QVNRYTN-RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQI 185
              +    RV T+ Y  PE++  +R Y    D W  GC++ EM   +SP           
Sbjct: 337 PEGQTIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGCLLYEMIAGQSP----------- 384

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK-PYVKDQYGCDLLDKLLL 244
                         +   +      ++E     +   +   +           L  +LL 
Sbjct: 385 --------------FQQRKKKIKREEVE-----RLVKEVPEEYSERFSPQARSLCSQLLC 425

Query: 245 LDPSKRF-----DSDAALNHDFF 262
            DP++R       +     H  F
Sbjct: 426 KDPAERLGCRGGSAREVKEHPLF 448

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A* Length = 267

 Score = 79.9 bits (198), Expect = 4e-17
 Identities = 39/166 (23%), Positives = 75/166 (45%), Gaps = 21/166 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +       ++   LV +F EH  L+  L      F+
Sbjct: 51  IEEAEVMMKLSHPKLVQLYGVC-LE-------QAPICLVTEFMEHGCLSDYLRTQRGLFA 102

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R          
Sbjct: 103 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLD------ 156

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           ++YT+   T     W   PE+      Y    D+W  G +M E+++
Sbjct: 157 DQYTSSTGTKFPVKWA-SPEVFS-FSRYSSKSDVWSFGVLMWEVFS 200

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A* Length = 377

 Score = 81.5 bits (202), Expect = 4e-17
 Identities = 30/110 (27%), Positives = 56/110 (50%), Gaps = 9/110 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E +IL+   H N+V LI +C          +   Y+V +  +  D    L     +  
Sbjct: 160 LQEARILKQYSHPNIVRLIGVCTQ--------KQPIYIVMELVQGGDFLTFLRTEGARLR 211

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +  + +++     G+ Y+ S   +HRD+ A N L+T+  +LK++DFG++R
Sbjct: 212 VKTLLQMVGDAAAGMEYLESKCCIHRDLAARNCLVTEKNVLKISDFGMSR 261

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ... Length = 279

 Score = 79.6 bits (197), Expect = 6e-17
 Identities = 45/172 (26%), Positives = 81/172 (47%), Gaps = 25/172 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L E  +++ L+H+ +V L  +  T+           Y++ ++ E+  L   L +   +K 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVV-TQ--------EPIYIITEYMENGSLVDFLKTPSGIKL 106

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR         
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIED----- 161

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
            N YT R        W   PE +     +    D+W  G ++ E+ T  R P
Sbjct: 162 -NEYTAREGAKFPIKWT-APEAIN-YGTFTIKSDVWSFGILLTEIVTHGRIP 210

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ... Length = 452

 Score = 81.0 bits (200), Expect = 8e-17
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 23/167 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L+E ++++ L+HE +V L  +               Y+V ++     L   L        
Sbjct: 227 LQEAQVMKKLRHEKLVQLYAVVS---------EEPIYIVTEYMSKGSLLDFLKGETGKYL 277

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR        +
Sbjct: 278 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI------E 331

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            N YT R        W   PE  L    +    D+W  G ++ E+ T
Sbjct: 332 DNEYTARQGAKFPIKWT-APEAAL-YGRFTIKSDVWSFGILLTELTT 376

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens} Length = 327

 Score = 80.0 bits (198), Expect = 9e-17
 Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 21/167 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T         ST  L+        L   +        
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLT---------STVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +     Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +    
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--- 172

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
               +         W    E +L  R Y    D+W  G  + E+ T 
Sbjct: 173 --EYHAEGGKVPIKWM-ALESIL-HRIYTHQSDVWSYGVTVWELMTF 215

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A Length = 283

 Score = 79.2 bits (196), Expect = 1e-16
 Identities = 42/166 (25%), Positives = 83/166 (50%), Gaps = 21/166 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E K++  L HE +V L  +C TK       +   +++ ++  +  L   L  +  +F 
Sbjct: 67  IEEAKVMMNLSHEKLVQLYGVC-TK-------QRPIFIITEYMANGCLLNYLREMRHRFQ 118

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R          
Sbjct: 119 TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLD------ 172

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           + YT+ V +     W  PPE+L+    +    D+W  G +M E+++
Sbjct: 173 DEYTSSVGSKFPVRWS-PPEVLM-YSKFSSKSDIWAFGVLMWEIYS 216

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7 Length = 333

 Score = 79.7 bits (197), Expect = 1e-16
 Identities = 36/162 (22%), Positives = 72/162 (44%), Gaps = 11/162 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H N++ L  +  +K            ++ ++ E+  L   L     +FS
Sbjct: 94  LGEAGIMGQFSHHNIIRLEGVI-SKYK-------PMMIITEYMENGALDKFLREKDGEFS 145

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+ +   +HRD+ A N+L+    + K++DFGL+R          
Sbjct: 146 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEATY 205

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                ++   W   PE +   R +    D+W  G +M E+ T
Sbjct: 206 TTSGGKIPIRWT-APEAIS-YRKFTSASDVWSFGIVMWEVMT 245

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A* Length = 281

 Score = 78.4 bits (194), Expect = 1e-16
 Identities = 36/167 (21%), Positives = 63/167 (37%), Gaps = 22/167 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E  I++ L H ++V LI I               +++ +   + +L   L        
Sbjct: 61  MSEAVIMKNLDHPHIVKLIGIIE---------EEPTWIIMELYPYGELGHYLERNKNSLK 111

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  +     Q+   + Y+ S   +HRD+   N+L+     +KL DFGL+R          
Sbjct: 112 VLTLVLYSLQICKAMAYLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDED---- 167

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
             Y    VT     W   PE +   R +    D+W     M E+ + 
Sbjct: 168 --YYKASVTRLPIKWM-SPESIN-FRRFTTASDVWMFAVCMWEILSF 210

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A* Length = 278

 Score = 78.0 bits (193), Expect = 2e-16
 Identities = 37/172 (21%), Positives = 71/172 (41%), Gaps = 27/172 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L E  ++  L+H N+V L+ +           +   Y+V ++     L   L S      
Sbjct: 62  LAEASVMTQLRHSNLVQLLGVI-------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 114

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               + K    +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +         
Sbjct: 115 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------- 165

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
               + +        W   PE L  ++ +    D+W  G ++ E+++  R P
Sbjct: 166 -EASSTQDTGKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVP 214

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ... Length = 288

 Score = 78.1 bits (193), Expect = 2e-16
 Identities = 43/172 (25%), Positives = 79/172 (45%), Gaps = 24/172 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAG-LLSNIHVKF 68
           L+E  +++ +KH N+V L+ +C T+          FY++ +F  + +L   L      + 
Sbjct: 57  LKEAAVMKEIKHPNLVQLLGVC-TR-------EPPFYIITEFMTYGNLLDYLRECNRQEV 108

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           S   +  +  Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R  +      
Sbjct: 109 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTG----- 163

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
            + YT          W   PE L     +    D+W  G ++ E+ T   SP
Sbjct: 164 -DTYTAHAGAKFPIKWT-APESLA-YNKFSIKSDVWAFGVLLWEIATYGMSP 212

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens} Length = 613

 Score = 80.4 bits (198), Expect = 2e-16
 Identities = 38/163 (23%), Positives = 69/163 (42%), Gaps = 12/163 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE +I+  L +  +V LI +C+              LV +      L   L     +  
Sbjct: 384 MREAQIMHQLDNPYIVRLIGVCQ---------AEALMLVMEMAGGGPLHKFLVGKREEIP 434

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HR++ A NVL+      K++DFGL++A     +   
Sbjct: 435 VSNVAELLHQVSMGMKYLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 494

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
            R   +    WY  PE +   R +    D+W  G  M E  + 
Sbjct: 495 ARSAGKWPLKWY-APECIN-FRKFSSRSDVWSYGVTMWEALSY 535

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 Length = 535

 Score = 79.9 bits (197), Expect = 2e-16
 Identities = 43/167 (25%), Positives = 75/167 (44%), Gaps = 23/167 (13%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L+E ++++ L+HE +V L  +               Y+V ++     L   L        
Sbjct: 310 LQEAQVMKKLRHEKLVQLYAVVS---------EEPIYIVTEYMSKGSLLDFLKGETGKYL 360

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR        +
Sbjct: 361 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLI------E 414

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
            N YT R        W   PE  L    +    D+W  G ++ E+ T
Sbjct: 415 DNEYTARQGAKFPIKWT-APEAAL-YGRFTIKSDVWSFGILLTELTT 459

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A* Length = 291

 Score = 77.7 bits (192), Expect = 3e-16
 Identities = 41/167 (24%), Positives = 72/167 (43%), Gaps = 21/167 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  ++Q L +  +V +I IC            ++ LV +  E   L   L   +    
Sbjct: 66  LAEANVMQQLDNPYIVRMIGICE---------AESWMLVMEMAELGPLNKYLQQ-NRHVK 115

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N   
Sbjct: 116 DKNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-- 173

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
             Y  +        WY  PE +     +    D+W  G +M E ++ 
Sbjct: 174 --YKAQTHGKWPVKWY-APECIN-YYKFSSKSDVWSFGVLMWEAFSY 216

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B Length = 454

 Score = 79.4 bits (196), Expect = 3e-16
 Identities = 45/172 (26%), Positives = 78/172 (45%), Gaps = 25/172 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L E  +++ L+H+ +V L  +           +   Y++ +F     L   L S+   K 
Sbjct: 231 LAEANVMKTLQHDKLVKLHAVV---------TKEPIYIITEFMAKGSLLDFLKSDEGSKQ 281

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++     Q+  G+ +I     +HRD++AAN+L++ + + K+ADFGLAR         
Sbjct: 282 PLPKLIDFSAQIAEGMAFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIED----- 336

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
            N YT R        W   PE +    ++    D+W  G ++ E+ T  R P
Sbjct: 337 -NEYTAREGAKFPIKWT-APEAIN-FGSFTIKSDVWSFGILLMEIVTYGRIP 385

>3g51_A Ribosomal protein S6 kinase alpha-3; N-terminal kinase domain of P90 ribosomal S6 kinase 2, ATP- binding, nucleotide-binding, phosphoprotein; HET: ANP; 1.80A {Mus musculus} PDB: 2z7q_A* 2z7r_A* 2z7s_A* Length = 325

 Score = 77.6 bits (192), Expect = 6e-16
 Identities = 62/276 (22%), Positives = 100/276 (36%), Gaps = 82/276 (29%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DL------AG 59
           E  IL  + H  +V L                 F      YL+ DF    DL        
Sbjct: 76  ERDILVEVNHPFIVKL--------------HYAFQTEGKLYLILDFLRGGDLFTRLSKEV 121

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           + +   VKF L E+          L ++HS  I++RD+K  N+L+ + G +KL DFGL++
Sbjct: 122 MFTEEDVKFYLAEL-------ALALDHLHSLGIIYRDLKPENILLDEEGHIKLTDFGLSK 174

Query: 120 AFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                ++    +       T+ Y  PE++   R +    D W  G +M EM T +   QG
Sbjct: 175 -----ESIDHEKKAYSFCGTVEYMAPEVVNR-RGHTQSADWWSFGVLMFEMLTGTLPFQG 228

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
              ++ +T+I                   L  K+ +P+    + +              L
Sbjct: 229 KDRKETMTMI-------------------LKAKLGMPQFLSPEAQ-------------SL 256

Query: 239 LDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
           L  L   +P+ R        +    H FF    W  
Sbjct: 257 LRMLFKRNPANRLGAGPDGVEEIKRHSFFSTIDWNK 292

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A Length = 450

 Score = 78.5 bits (194), Expect = 6e-16
 Identities = 37/172 (21%), Positives = 71/172 (41%), Gaps = 27/172 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L E  ++  L+H N+V L+ +           +   Y+V ++     L   L S      
Sbjct: 234 LAEASVMTQLRHSNLVQLLGVI-------VEEKGGLYIVTEYMAKGSLVDYLRSRGRSVL 286

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               + K    +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +         
Sbjct: 287 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTK--------- 337

Query: 129 VNRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT--RSP 174
               + +        W   PE L  ++ +    D+W  G ++ E+++  R P
Sbjct: 338 -EASSTQDTGKLPVKWT-APEALR-EKKFSTKSDVWSFGILLWEIYSFGRVP 386

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A* Length = 325

 Score = 77.4 bits (191), Expect = 7e-16
 Identities = 32/167 (19%), Positives = 61/167 (36%), Gaps = 21/167 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
              +  +  L H ++V L+ +C           S+  LV  +     L   +        
Sbjct: 63  TDHMLAIGSLDHAHIVRLLGLCP---------GSSLQLVTQYLPLGSLLDHVRQHRGALG 113

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +     Q+  G+YY+  + ++HR++ A NVL+     +++ADFG+A           
Sbjct: 114 PQLLLNWGVQIAKGMYYLEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPD----- 168

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
           ++            W    E +     Y    D+W  G  + E+ T 
Sbjct: 169 DKQLLYSEAKTPIKWM-ALESIH-FGKYTHQSDVWSYGVTVWELMTF 213

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A* Length = 327

 Score = 76.8 bits (190), Expect = 8e-16
 Identities = 63/276 (22%), Positives = 101/276 (36%), Gaps = 82/276 (29%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DL------AG 59
           E  IL+ +KH  +V L                 F      YL+ ++    +L       G
Sbjct: 71  ERNILEEVKHPFIVDL--------------IYAFQTGGKLYLILEYLSGGELFMQLEREG 116

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           +       F L EI          L ++H   I++RD+K  N+++   G +KL DFGL +
Sbjct: 117 IFMEDTACFYLAEI-------SMALGHLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCK 169

Query: 120 AFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                ++      T+    T+ Y  PE+L+    +   VD W  G +M +M T +P   G
Sbjct: 170 -----ESIHDGTVTHTFCGTIEYMAPEILMR-SGHNRAVDWWSLGALMYDMLTGAPPFTG 223

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
              ++ I  I                   L  K+ LP    ++ +             DL
Sbjct: 224 ENRKKTIDKI-------------------LKCKLNLPPYLTQEAR-------------DL 251

Query: 239 LDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
           L KLL  + + R      D+     H FF    W +
Sbjct: 252 LKKLLKRNAASRLGAGPGDAGEVQAHPFFRHINWEE 287

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 3q6w_A* 3r7o_A* 3q6u_A* 3cth_A* 3ce3_A* 3ctj_A* ... Length = 298

 Score = 76.5 bits (189), Expect = 9e-16
 Identities = 33/110 (30%), Positives = 56/110 (50%), Gaps = 8/110 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 74  LTEGIIMKDFSHPNVLSLLGIC-------LRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 126

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           + ++     Q+  G+ Y+ S K +HRD+ A N ++ +   +K+ADFGLAR
Sbjct: 127 VKDLIGFGLQVAKGMKYLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 176

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} Length = 298

 Score = 76.2 bits (188), Expect = 1e-15
 Identities = 30/110 (27%), Positives = 55/110 (50%), Gaps = 8/110 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           LRE  +++ L H NV+ LI I               +++  +  H DL   + +     +
Sbjct: 70  LREGLLMRGLNHPNVLALIGIM-------LPPEGLPHVLLPYMCHGDLLQFIRSPQRNPT 122

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           + ++     Q+  G+ Y+   K +HRD+ A N ++ ++  +K+ADFGLAR
Sbjct: 123 VKDLISFGLQVARGMEYLAEQKFVHRDLAARNCMLDESFTVKVADFGLAR 172

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7 Length = 355

 Score = 76.9 bits (190), Expect = 1e-15
 Identities = 55/237 (23%), Positives = 94/237 (39%), Gaps = 57/237 (24%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           +L+ D+    +L          +   V+  +GEI       +  L ++H   I++RD+K 
Sbjct: 135 HLILDYINGGELFTHLSQRERFTEHEVQIYVGEI-------VLALEHLHKLGIIYRDIKL 187

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRN-YGPPV 157
            N+L+   G + L DFGL++ F   +  +          T+ Y  P+++ G  + +   V
Sbjct: 188 ENILLDSNGHVVLTDFGLSKEFVADETER----AYDFCGTIEYMAPDIVRGGDSGHDKAV 243

Query: 158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKA 217
           D W  G +M E+ T +     + E+     IS+    I            L ++   P+ 
Sbjct: 244 DWWSLGVLMYELLTGASPFTVDGEKNSQAEISR---RI------------LKSEPPYPQE 288

Query: 218 QKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
                K             DL+ +LL+ DP KR      D+D    H FF    W D
Sbjct: 289 MSALAK-------------DLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQKINWDD 332

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* 2jiu_A* ... Length = 327

 Score = 76.2 bits (188), Expect = 2e-15
 Identities = 37/167 (22%), Positives = 63/167 (37%), Gaps = 21/167 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  ++  + + +V  L+ IC T         ST  L+        L   +        
Sbjct: 65  LDEAYVMASVDNPHVCRLLGICLT---------STVQLITQLMPFGCLLDYVREHKDNIG 115

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +     Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+     +    
Sbjct: 116 SQYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--- 172

Query: 130 NRYTNRVVTL----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR 172
               +         W    E +L  R Y    D+W  G  + E+ T 
Sbjct: 173 --EYHAEGGKVPIKWM-ALESIL-HRIYTHQSDVWSYGVTVWELMTF 215

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus} Length = 323

 Score = 75.4 bits (186), Expect = 2e-15
 Identities = 26/115 (22%), Positives = 51/115 (44%), Gaps = 8/115 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-----SNI 64
           LRE   ++   H +V  L+ +   + ++         ++  F +H DL   L        
Sbjct: 73  LREAACMKEFDHPHVAKLVGVS-LR-SRAKGRLPIPMVILPFMKHGDLHAFLLASRIGEN 130

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
                L  + + +  +  G+ Y+ S   +HRD+ A N ++ +   + +ADFGL+R
Sbjct: 131 PFNLPLQTLVRFMVDIACGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSR 185

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens} Length = 318

 Score = 75.5 bits (186), Expect = 3e-15
 Identities = 33/189 (17%), Positives = 71/189 (37%), Gaps = 24/189 (12%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVK 67
           L ++ ++ +      +V            +  +   +  ++  +        L   +   
Sbjct: 71  LMDLDVVLKSHDCPYIVQC----------FGTFITNTDVFIAMELMGTCAEKLKKRMQGP 120

Query: 68  FSLGEIKKVIQQLLNGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN 126
                + K+   ++  LYY+   + ++HRD+K +N+L+ + G +KL DFG++      K 
Sbjct: 121 IPERILGKMTVAIVKALYYLKEKHGVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDKA 180

Query: 127 GQVNRYTNRVVTLWYRPPE----LLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTE 181
                         Y  PE          +Y    D+W  G  + E+ T + P     T+
Sbjct: 181 K-----DRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISLVELATGQFPYKNCKTD 235

Query: 182 QQQITLISQ 190
            + +T + Q
Sbjct: 236 FEVLTKVLQ 244

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7 Length = 373

 Score = 75.6 bits (186), Expect = 4e-15
 Identities = 32/110 (29%), Positives = 56/110 (50%), Gaps = 8/110 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC        R   +  +V  + +H DL   + N     +
Sbjct: 138 LTEGIIMKDFSHPNVLSLLGIC-------LRSEGSPLVVLPYMKHGDLRNFIRNETHNPT 190

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR
Sbjct: 191 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLAR 240

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ... Length = 337

 Score = 74.9 bits (185), Expect = 4e-15
 Identities = 59/276 (21%), Positives = 95/276 (34%), Gaps = 82/276 (29%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DL------AG 59
           E ++LQ  +H  +  L              +  F        V ++    +L        
Sbjct: 55  ESRVLQNTRHPFLTAL--------------KYAFQTHDRLCFVMEYANGGELFFHLSRER 100

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
           + +    +F   EI       ++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL +
Sbjct: 101 VFTEERARFYGAEI-------VSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCK 153

Query: 120 AFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQG 178
                              T  Y  PE+L    +YG  VD WG G +M EM         
Sbjct: 154 E-----GISDGATMKTFCGTPEYLAPEVLED-NDYGRAVDWWGLGVVMYEMMCGRLPFYN 207

Query: 179 NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL 238
              ++   LI                   L  ++  P+    + K              L
Sbjct: 208 QDHERLFELI-------------------LMEEIRFPRTLSPEAK-------------SL 235

Query: 239 LDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
           L  LL  DP +R      D+   + H FF    W D
Sbjct: 236 LAGLLKKDPKQRLGGGPSDAKEVMEHRFFLSINWQD 271

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A* Length = 353

 Score = 75.0 bits (185), Expect = 5e-15
 Identities = 51/236 (21%), Positives = 80/236 (33%), Gaps = 62/236 (26%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           Y V ++    DL       G     H  F   EI         GL+++ S  I++RD+K 
Sbjct: 97  YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI-------AIGLFFLQSKGIIYRDLKL 149

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            NV++   G +K+ADFG+ +      N      T     T  Y  PE++   + YG  VD
Sbjct: 150 DNVMLDSEGHIKIADFGMCKE-----NIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSVD 203

Query: 159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ 218
            W  G ++ EM       +G  E +    I                   + + +  PK+ 
Sbjct: 204 WWAFGVLLYEMLAGQAPFEGEDEDELFQSI-------------------MEHNVAYPKSM 244

Query: 219 KRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
            ++                +   L+   P KR             H FF    W  
Sbjct: 245 SKEAV-------------AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 287

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A* Length = 313

 Score = 74.2 bits (183), Expect = 7e-15
 Identities = 26/115 (22%), Positives = 51/115 (44%), Gaps = 9/115 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-----SNI 64
           L E   ++   H NV+ L+ +C  + +   +      ++  F ++ DL   L        
Sbjct: 84  LSEAACMKDFSHPNVIRLLGVC-IEMSS--QGIPKPMVILPFMKYGDLHTYLLYSRLETG 140

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
                L  + K +  +  G+ Y+ +   LHRD+ A N ++     + +ADFGL++
Sbjct: 141 PKHIPLQTLLKFMVDIALGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSK 195

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A* Length = 373

 Score = 74.2 bits (183), Expect = 9e-15
 Identities = 55/235 (23%), Positives = 80/235 (34%), Gaps = 61/235 (25%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           Y V D+    +L               +F   EI        + L Y+HS  I++RD+K 
Sbjct: 115 YFVLDYINGGELFYHLQRERCFLEPRARFYAAEI-------ASALGYLHSLNIVYRDLKP 167

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            N+L+   G + L DFGL +      N + N  T+    T  Y  PE+L   + Y   VD
Sbjct: 168 ENILLDSQGHIVLTDFGLCKE-----NIEHNSTTSTFCGTPEYLAPEVLHK-QPYDRTVD 221

Query: 159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ 218
            W  G ++ EM    P        +    I                   L   ++L    
Sbjct: 222 WWCLGAVLYEMLYGLPPFYSRNTAEMYDNI-------------------LNKPLQLKPNI 262

Query: 219 KRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF----DSDAALNHDFF----WTD 265
               +              LL+ LL  D +KR     D     +H FF    W D
Sbjct: 263 TNSAR-------------HLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSLINWDD 304

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A Length = 674

 Score = 75.1 bits (184), Expect = 1e-14
 Identities = 51/237 (21%), Positives = 81/237 (34%), Gaps = 64/237 (27%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           Y V ++    DL       G     H  F   EI         GL+++ S  I++RD+K 
Sbjct: 418 YFVMEYVNGGDLMYHIQQVGRFKEPHAVFYAAEI-------AIGLFFLQSKGIIYRDLKL 470

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV--TLWYRPPELLLGDRNYGPPV 157
            NV++   G +K+ADFG+       K    +  T +    T  Y  PE++   + YG  V
Sbjct: 471 DNVMLDSEGHIKIADFGMC------KENIWDGVTTKTFCGTPDYIAPEIIAY-QPYGKSV 523

Query: 158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKA 217
           D W  G ++ EM       +G  E +    I                   + + +  PK+
Sbjct: 524 DWWAFGVLLYEMLAGQAPFEGEDEDELFQSI-------------------MEHNVAYPKS 564

Query: 218 QKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFF----WTD 265
             ++                +   L+   P KR             H FF    W  
Sbjct: 565 MSKEAV-------------AICKGLMTKHPGKRLGCGPEGERDIKEHAFFRYIDWEK 608

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ... Length = 322

 Score = 73.5 bits (181), Expect = 1e-14
 Identities = 24/119 (20%), Positives = 56/119 (47%), Gaps = 18/119 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-------- 61
           L E  +++     +VV L+ +  ++            ++ +     DL   L        
Sbjct: 76  LNEASVMKEFNCHHVVRLLGVV-SQGQP-------TLVIMELMTRGDLKSYLRSLRPAMA 127

Query: 62  -SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLAR 119
            + +    SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R
Sbjct: 128 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTR 186

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A Length = 290

 Score = 72.7 bits (179), Expect = 1e-14
 Identities = 39/189 (20%), Positives = 71/189 (37%), Gaps = 26/189 (13%)

Query: 11  LREIKI-LQLLKHENVVHLIEICRTKANQYNRY--RSTFYLVFDFCEHDLAGLLSNIHVK 67
           L ++ I ++ +     V            Y         ++  +  +  L      +  K
Sbjct: 53  LMDLDISMRTVDCPFTVTF----------YGALFREGDVWICMELMDTSLDKFYKQVIDK 102

Query: 68  ---FSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQ 123
                   + K+   ++  L ++HS   ++HRD+K +NVLI   G +K+ DFG++     
Sbjct: 103 GQTIPEDILGKIAVSIVKALEHLHSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVD 162

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRN---YGPPVDLWGAGCIMAEMWT-RSPIMQGN 179
                V +  +      Y  PE +  + N   Y    D+W  G  M E+   R P     
Sbjct: 163 D----VAKDID-AGCKPYMAPERINPELNQKGYSVKSDIWSLGITMIELAILRFPYDSWG 217

Query: 180 TEQQQITLI 188
           T  QQ+  +
Sbjct: 218 TPFQQLKQV 226

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A* Length = 345

 Score = 73.4 bits (181), Expect = 2e-14
 Identities = 55/225 (24%), Positives = 86/225 (38%), Gaps = 54/225 (24%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           + V ++    DL                F   EI       + GL ++HS  I++RD+K 
Sbjct: 94  FFVMEYLNGGDLMYHIQSCHKFDLSRATFYAAEI-------ILGLQFLHSKGIVYRDLKL 146

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            N+L+ K G +K+ADFG+ +     +N   +  TN    T  Y  PE+LLG + Y   VD
Sbjct: 147 DNILLDKDGHIKIADFGMCK-----ENMLGDAKTNTFCGTPDYIAPEILLG-QKYNHSVD 200

Query: 159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ 218
            W  G ++ EM        G  E++    I                     +    P+  
Sbjct: 201 WWSFGVLLYEMLIGQSPFHGQDEEELFHSI-------------------RMDNPFYPRWL 241

Query: 219 KRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL-NHDFF 262
           +++ K             DLL KL + +P KR      +  H  F
Sbjct: 242 EKEAK-------------DLLVKLFVREPEKRLGVRGDIRQHPLF 273

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A Length = 336

 Score = 73.0 bits (178), Expect = 2e-14
 Identities = 43/270 (15%), Positives = 78/270 (28%), Gaps = 43/270 (15%)

Query: 8   ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTF-----YLVFDFCEHDLAGLLS 62
              L  +  +Q      ++   +   +     N     F     ++V +F    +  L  
Sbjct: 94  FIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGGID-LEQ 152

Query: 63  NIHVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAF 121
                 SL   K ++ QL   L    ++ +  HRD+   NVL+ KT + KL      ++ 
Sbjct: 153 MRTKLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSS 212

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           +    G                  L +   +Y           +  ++     +  G+ +
Sbjct: 213 TIPSCG------------------LQVSIIDYTLSRLERDGIVVFCDVSMDEDLFTGDGD 254

Query: 182 QQQITLISQLCGSITPESWPGVETL-------DLYNKMELPKAQKRKVKERLKPYVKDQY 234
            Q    I +L        W              L +KM      K K        +K + 
Sbjct: 255 YQFD--IYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQMTFKTKCNTPAMKQIKRKI 312

Query: 235 GCDLLDKLLLLDPSKRFDS--DAALNHDFF 262
             +    +L       F S  D    H  F
Sbjct: 313 -QEFHRTML------NFSSATDLLCQHSLF 335

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A* Length = 446

 Score = 73.2 bits (180), Expect = 3e-14
 Identities = 63/271 (23%), Positives = 100/271 (36%), Gaps = 81/271 (29%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTF------YLVFDFCEH-DL------AG 59
           E ++LQ  +H  +  L              + +F        V ++    +L        
Sbjct: 198 ENRVLQNSRHPFLTAL--------------KYSFQTHDRLCFVMEYANGGELFFHLSRER 243

Query: 60  LLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNK-ILHRDMKAANVLITKTGILKLADFGLA 118
           + S    +F   EI       ++ L Y+HS K +++RD+K  N+++ K G +K+ DFGL 
Sbjct: 244 VFSEDRARFYGAEI-------VSALDYLHSEKNVVYRDLKLENLMLDKDGHIKITDFGLC 296

Query: 119 RAFSQTKNGQVNRYTNRVV--TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM 176
                 K G  +  T +    T  Y  PE+L  D +YG  VD WG G +M EM       
Sbjct: 297 ------KEGIKDGATMKTFCGTPEYLAPEVLE-DNDYGRAVDWWGLGVVMYEMMCGRLPF 349

Query: 177 QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC 236
                ++   LI                   L  ++  P+    + K             
Sbjct: 350 YNQDHEKLFELI-------------------LMEEIRFPRTLGPEAK------------- 377

Query: 237 DLLDKLLLLDPSKRF-----DSDAALNHDFF 262
            LL  LL  DP +R      D+   + H FF
Sbjct: 378 SLLSGLLKKDPKQRLGGGSEDAKEIMQHRFF 408

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens} Length = 353

 Score = 71.9 bits (177), Expect = 6e-14
 Identities = 49/237 (20%), Positives = 74/237 (31%), Gaps = 63/237 (26%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           + V +F    DL      +        +F   EI       ++ L ++H   I++RD+K 
Sbjct: 100 FFVMEFVNGGDLMFHIQKSRRFDEARARFYAAEI-------ISALMFLHDKGIIYRDLKL 152

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            NVL+   G  KLADFG+ +             T     T  Y  PE+L     YGP VD
Sbjct: 153 DNVLLDHEGHCKLADFGMCKE-----GICNGVTTATFCGTPDYIAPEILQE-MLYGPAVD 206

Query: 159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQ 218
            W  G ++ EM       +   E      I                   L +++  P   
Sbjct: 207 WWAMGVLLYEMLCGHAPFEAENEDDLFEAI-------------------LNDEVVYPTWL 247

Query: 219 KRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF---DSDAAL---NHDFF----WTD 265
                              +L   +  +P+ R              H FF    W  
Sbjct: 248 HEDAT-------------GILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKEIDWAQ 291

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A* Length = 289

 Score = 70.4 bits (173), Expect = 8e-14
 Identities = 32/170 (18%), Positives = 66/170 (38%), Gaps = 25/170 (14%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
                ++  L H+++V    +C    +          LV +F +   L   L       +
Sbjct: 60  FEAASMMSKLSHKHLVLNYGVC-VCGD-------ENILVQEFVKFGSLDTYLKKNKNCIN 111

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG--------ILKLADFGLARAF 121
           +    +V +QL   ++++  N ++H ++ A N+L+ +           +KL+D G++   
Sbjct: 112 ILWKLEVAKQLAAAMHFLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITV 171

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
                 Q      R+   W  PPE +   +N     D W  G  + E+ +
Sbjct: 172 LPKDILQE-----RIP--WV-PPECIENPKNLNLATDKWSFGTTLWEICS 213

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ... Length = 316

 Score = 70.8 bits (174), Expect = 1e-13
 Identities = 34/126 (26%), Positives = 64/126 (50%), Gaps = 24/126 (19%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+KIL  +  H NVV+L+  C TK            ++ +FC+  +L+  L +   +F
Sbjct: 78  MSELKILIHIGHHLNVVNLLGAC-TKPGGP------LMVIVEFCKFGNLSTYLRSKRNEF 130

Query: 69  SLGEIKKV--------IQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
              ++           ++ L+        G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 131 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 190

Query: 114 DFGLAR 119
           DFGLAR
Sbjct: 191 DFGLAR 196

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A* Length = 345

 Score = 70.7 bits (174), Expect = 1e-13
 Identities = 58/246 (23%), Positives = 84/246 (34%), Gaps = 72/246 (29%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           + V ++    DL         L   H +F   EI          L Y+H   I++RD+K 
Sbjct: 86  FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-------SLALNYLHERGIIYRDLKL 138

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            NVL+   G +KL D+G+ +        +    T+    T  Y  PE+L G  +YG  VD
Sbjct: 139 DNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 192

Query: 159 LWGAGCIMAEMWT-RSP--------IMQGNTEQQQITLISQLCGSITPESWPGVETLDLY 209
            W  G +M EM   RSP            NTE     +I                   L 
Sbjct: 193 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------------LE 233

Query: 210 NKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF------DSDAALNHDFF- 262
            ++ +P++   K                +L   L  DP +R              H FF 
Sbjct: 234 KQIRIPRSLSVKAA-------------SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 280

Query: 263 ---WTD 265
              W  
Sbjct: 281 NVDWDM 286

>3v5q_A NT-3 growth factor receptor; kinase domain, kinase, phosphorylation, transferase-transfer inhibitor complex; HET: 0F4; 2.20A {Homo sapiens} Length = 297

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 29/125 (23%), Positives = 56/125 (44%), Gaps = 24/125 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-------- 61
            RE ++L  L+HE++V    +C    +          +VF++ +H DL   L        
Sbjct: 65  QREAELLTNLQHEHIVKFYGVC-GDGDP-------LIMVFEYMKHGDLNKFLRAHGPDAM 116

Query: 62  -------SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                       +  L ++  +  Q+ +G+ Y+ S   +HRD+   N L+    ++K+ D
Sbjct: 117 ILVDGQPRQAKGELGLSQMLHIASQIASGMVYLASQHFVHRDLATRNCLVGANLLVKIGD 176

Query: 115 FGLAR 119
           FG++R
Sbjct: 177 FGMSR 181

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens} Length = 329

 Score = 70.0 bits (172), Expect = 2e-13
 Identities = 30/124 (24%), Positives = 56/124 (45%), Gaps = 23/124 (18%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-------- 61
            RE ++L +L+H+++V    +C T+            +VF++  H DL   L        
Sbjct: 91  QREAELLTMLQHQHIVRFFGVC-TEGRPL-------LMVFEYMRHGDLNRFLRSHGPDAK 142

Query: 62  ------SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                         LG++  V  Q+  G+ Y+     +HRD+   N L+ +  ++K+ DF
Sbjct: 143 LLAGGEDVAPGPLGLGQLLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDF 202

Query: 116 GLAR 119
           G++R
Sbjct: 203 GMSR 206

>3zzw_A Tyrosine-protein kinase transmembrane receptor RO; transferase, neurotrophic tyrosine kinase, receptor-related NTRKR2; 2.90A {Homo sapiens} Length = 289

 Score = 69.2 bits (170), Expect = 2e-13
 Identities = 29/125 (23%), Positives = 52/125 (41%), Gaps = 24/125 (19%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-------- 61
             E  +   L+H NVV L+ +  TK            ++F +C H DL   L        
Sbjct: 60  RHEAMLRARLQHPNVVCLLGVV-TKDQP-------LSMIFSYCSHGDLHEFLVMRSPHSD 111

Query: 62  -------SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD 114
                    +       +   ++ Q+  G+ Y+ S+ ++H+D+   NVL+     +K++D
Sbjct: 112 VGSTDDDRTVKSALEPPDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISD 171

Query: 115 FGLAR 119
            GL R
Sbjct: 172 LGLFR 176

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus} Length = 396

 Score = 70.1 bits (172), Expect = 2e-13
 Identities = 58/246 (23%), Positives = 84/246 (34%), Gaps = 72/246 (29%)

Query: 47  YLVFDFCEH-DL------AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKA 99
           + V ++    DL         L   H +F   EI          L Y+H   I++RD+K 
Sbjct: 129 FFVIEYVNGGDLMFHMQRQRKLPEEHARFYSAEI-------SLALNYLHERGIIYRDLKL 181

Query: 100 ANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVV-TLWYRPPELLLGDRNYGPPVD 158
            NVL+   G +KL D+G+ +        +    T+    T  Y  PE+L G  +YG  VD
Sbjct: 182 DNVLLDSEGHIKLTDYGMCKE-----GLRPGDTTSTFCGTPNYIAPEILRG-EDYGFSVD 235

Query: 159 LWGAGCIMAEMWT-RSP--------IMQGNTEQQQITLISQLCGSITPESWPGVETLDLY 209
            W  G +M EM   RSP            NTE     +I                   L 
Sbjct: 236 WWALGVLMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVI-------------------LE 276

Query: 210 NKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF------DSDAALNHDFF- 262
            ++ +P++   K                +L   L  DP +R              H FF 
Sbjct: 277 KQIRIPRSLSVKAA-------------SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFR 323

Query: 263 ---WTD 265
              W  
Sbjct: 324 NVDWDM 329

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A* Length = 333

 Score = 68.1 bits (167), Expect = 8e-13
 Identities = 33/124 (26%), Positives = 58/124 (46%), Gaps = 23/124 (18%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL----------- 57
           + E+KI+  L +HEN+V+L+  C T             ++ ++C + DL           
Sbjct: 97  MSELKIMSHLGQHENIVNLLGAC-THGGP-------VLVITEYCCYGDLLNFLRRKSRVL 148

Query: 58  --AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADF 115
                 +  +   S  ++     Q+  G+ ++ S   +HRD+ A NVL+T   + K+ DF
Sbjct: 149 ETDPAFAIANSTASTRDLLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDF 208

Query: 116 GLAR 119
           GLAR
Sbjct: 209 GLAR 212

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A* Length = 313

 Score = 68.0 bits (167), Expect = 8e-13
 Identities = 33/128 (25%), Positives = 58/128 (45%), Gaps = 27/128 (21%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL---------AG 59
           + E+K+L  L  H N+V+L+  C T             ++ ++C + DL         + 
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGAC-TI-------GGPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 60  LLSNIHVKFSLGEIKKV-IQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILK 111
           + S         +   + ++ LL        G+ ++ S   +HRD+ A N+L+T   I K
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185

Query: 112 LADFGLAR 119
           + DFGLAR
Sbjct: 186 ICDFGLAR 193

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A* Length = 314

 Score = 67.6 bits (166), Expect = 1e-12
 Identities = 26/133 (19%), Positives = 55/133 (41%), Gaps = 32/133 (24%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL------------ 57
           L E  +L+ + H +V+ L   C ++            L+ ++ ++  L            
Sbjct: 74  LSEFNVLKQVNHPHVIKLYGAC-SQ-------DGPLLLIVEYAKYGSLRGFLRESRKVGP 125

Query: 58  ---AGLLSNIHVKFSLGEIKKV-IQQLL-------NGLYYIHSNKILHRDMKAANVLITK 106
                  S         + + + +  L+        G+ Y+   K++HRD+ A N+L+ +
Sbjct: 126 GYLGSGGSRNSSSLDHPDERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAE 185

Query: 107 TGILKLADFGLAR 119
              +K++DFGL+R
Sbjct: 186 GRKMKISDFGLSR 198

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A* Length = 327

 Score = 67.3 bits (165), Expect = 2e-12
 Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 18/119 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL------SN 63
           L E  I+    H+N+V  I +   ++          +++ +     DL   L       +
Sbjct: 81  LMEALIISKFNHQNIVRCIGVS-LQSLPR-------FILMELMAGGDLKSFLRETRPRPS 132

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLAR 119
                ++ ++  V + +  G  Y+  N  +HRD+ A N L+T  G   + K+ DFG+AR
Sbjct: 133 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 191

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens} Length = 367

 Score = 67.4 bits (165), Expect = 2e-12
 Identities = 28/119 (23%), Positives = 52/119 (43%), Gaps = 18/119 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL------SN 63
           L E  I+    H+N+V  I +   ++          +++ +     DL   L       +
Sbjct: 122 LMEALIISKFNHQNIVRCIGVS-LQSL-------PRFILLELMAGGDLKSFLRETRPRPS 173

Query: 64  IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLAR 119
                ++ ++  V + +  G  Y+  N  +HRD+ A N L+T  G   + K+ DFG+AR
Sbjct: 174 QPSSLAMLDLLHVARDIACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMAR 232

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ... Length = 334

 Score = 66.9 bits (164), Expect = 2e-12
 Identities = 32/126 (25%), Positives = 63/126 (50%), Gaps = 25/126 (19%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL------- 61
           + E++++  + KH+N+++L+  C T+           Y++ ++    +L   L       
Sbjct: 88  VSEMEMMKMIGKHKNIINLLGAC-TQDGP-------LYVIVEYASKGNLREYLRARRPPG 139

Query: 62  -SNIHVKFSLGEIKKVIQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
               +    + E +   + L+        G+ Y+ S K +HRD+ A NVL+T+  ++K+A
Sbjct: 140 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 199

Query: 114 DFGLAR 119
           DFGLAR
Sbjct: 200 DFGLAR 205

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A* Length = 327

 Score = 66.5 bits (163), Expect = 3e-12
 Identities = 33/126 (26%), Positives = 56/126 (44%), Gaps = 25/126 (19%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
             E+++L +L  H N+++L+  C          R   YL  ++  H +L   L    V  
Sbjct: 73  AGELEVLCKLGHHPNIINLLGAC-EH-------RGYLYLAIEYAPHGNLLDFLRKSRVLE 124

Query: 69  SLGEIKKV--------IQQLL-------NGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
           +                QQLL        G+ Y+   + +HRD+ A N+L+ +  + K+A
Sbjct: 125 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 184

Query: 114 DFGLAR 119
           DFGL+R
Sbjct: 185 DFGLSR 190

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A Length = 370

 Score = 66.6 bits (163), Expect = 3e-12
 Identities = 31/126 (24%), Positives = 62/126 (49%), Gaps = 25/126 (19%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL----------- 57
           + E++++  + KH+N+++L+  C T+           Y++ ++    +L           
Sbjct: 134 VSEMEMMKMIGKHKNIINLLGAC-TQ-------DGPLYVIVEYASKGNLREYLRARRPPG 185

Query: 58  ----AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                 +      + +  ++     QL  G+ Y+ S K +HRD+ A NVL+T+  ++K+A
Sbjct: 186 MEYSYDINRVPEEQMTFKDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIA 245

Query: 114 DFGLAR 119
           DFGLAR
Sbjct: 246 DFGLAR 251

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7 Length = 344

 Score = 66.2 bits (162), Expect = 3e-12
 Identities = 41/133 (30%), Positives = 65/133 (48%), Gaps = 32/133 (24%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+K++ QL  HEN+V+L+  C T +          YL+F++C + DL   L +   KF
Sbjct: 96  MSELKMMTQLGSHENIVNLLGAC-TLSGP-------IYLIFEYCCYGDLLNYLRSKREKF 147

Query: 69  SLGEIKKV---------------IQQLL-------NGLYYIHSNKILHRDMKAANVLITK 106
           S  EI+                  + LL        G+ ++     +HRD+ A NVL+T 
Sbjct: 148 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 207

Query: 107 TGILKLADFGLAR 119
             ++K+ DFGLAR
Sbjct: 208 GKVVKICDFGLAR 220

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7 Length = 343

 Score = 65.8 bits (161), Expect = 5e-12
 Identities = 30/133 (22%), Positives = 53/133 (39%), Gaps = 32/133 (24%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-------- 61
            RE  ++    + N+V L+ +C               L+F++  + DL   L        
Sbjct: 98  QREAALMAEFDNPNIVKLLGVC-AVGKP-------MCLLFEYMAYGDLNEFLRSMSPHTV 149

Query: 62  ---------------SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
                          S      S  E   + +Q+  G+ Y+   K +HRD+   N L+ +
Sbjct: 150 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 209

Query: 107 TGILKLADFGLAR 119
             ++K+ADFGL+R
Sbjct: 210 NMVVKIADFGLSR 222

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A* Length = 307

 Score = 64.9 bits (159), Expect = 8e-12
 Identities = 44/143 (30%), Positives = 70/143 (48%), Gaps = 15/143 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFS 69
            +EIK++   +HEN+V L+                  LV+ +  +  L   LS +     
Sbjct: 78  DQEIKVMAKCQHENLVELLGFSSD--------GDDLCLVYVYMPNGSLLDRLSCLDGTPP 129

Query: 70  L--GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           L      K+ Q   NG+ ++H N  +HRD+K+AN+L+ +    K++DFGLARA  +    
Sbjct: 130 LSWHMRCKIAQGAANGINFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQT 189

Query: 128 QVNRYTNRVV-TLWYRPPELLLG 149
            +   T+R+V T  Y  PE L G
Sbjct: 190 VM---TSRIVGTTAYMAPEALRG 209

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens} Length = 382

 Score = 65.1 bits (159), Expect = 9e-12
 Identities = 32/126 (25%), Positives = 62/126 (49%), Gaps = 25/126 (19%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DL----------- 57
           + E++++  + KH+N+++L+  C T+           Y++ ++    +L           
Sbjct: 122 ISEMEMMKMIGKHKNIINLLGAC-TQ-------DGPLYVIVEYASKGNLREYLQARRPPG 173

Query: 58  ----AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                    N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+A
Sbjct: 174 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 233

Query: 114 DFGLAR 119
           DFGLAR
Sbjct: 234 DFGLAR 239

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A* Length = 321

 Score = 63.4 bits (155), Expect = 3e-11
 Identities = 33/146 (22%), Positives = 64/146 (43%), Gaps = 32/146 (21%)

Query: 13  EIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDF-----CEHDLAGLLSNIH-- 65
           EI+ L   +H ++V LI  C  +            L++ +      +  L G        
Sbjct: 85  EIETLSFCRHPHLVSLIGFCDERNEMI--------LIYKYMENGNLKRHLYGSDLPTMSM 136

Query: 66  -----VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                ++  +G  +        GL+Y+H+  I+HRD+K+ N+L+ +  + K+ DFG+++ 
Sbjct: 137 SWEQRLEICIGAAR--------GLHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKK 188

Query: 121 FSQTKNGQVNRYTNRVV-TLWYRPPE 145
            ++     +   +  V  TL Y  PE
Sbjct: 189 GTELDQTHL---STVVKGTLGYIDPE 211

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens} Length = 345

 Score = 63.2 bits (154), Expect = 3e-11
 Identities = 32/141 (22%), Positives = 60/141 (42%), Gaps = 20/141 (14%)

Query: 11  LREIKILQLL-KHENVVHLIEICRTKA-------------NQYNRYRSTFYLVFDFCEHD 56
             E+K  Q + K + +   IE  +                 +   YR   ++V +    D
Sbjct: 81  FSELKFYQRVAKKDCIKKWIERKQLDYLGIPLFYGSGLTEFKGRSYR---FMVMERLGID 137

Query: 57  LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI--TKTGILKLAD 114
           L  +    +  F    + ++  ++L+ L YIH N+ +H D+KAAN+L+       + LAD
Sbjct: 138 LQKIS-GQNGTFKKSTVLQLGIRMLDVLEYIHENEYVHGDIKAANLLLGYKNPDQVYLAD 196

Query: 115 FGLARAFSQTKNGQVNRYTNR 135
           +GL+  +    N +  +   R
Sbjct: 197 YGLSYRYCPNGNHKQYQENPR 217

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A Length = 296

 Score = 62.0 bits (151), Expect = 6e-11
 Identities = 31/126 (24%), Positives = 55/126 (43%), Gaps = 12/126 (9%)

Query: 11  LREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
             E KI ++++    +  +          YN       +V +     L  L +    KFS
Sbjct: 52  HIESKIYKMMQGGVGIPTIRWCGAE--GDYN------VMVMELLGPSLEDLFNFCSRKFS 103

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
           L  +  +  Q+++ + YIHS   +HRD+K  N L+    K  ++ + DFGLA+ +   + 
Sbjct: 104 LKTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDART 163

Query: 127 GQVNRY 132
            Q   Y
Sbjct: 164 HQHIPY 169

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A Length = 364

 Score = 62.5 bits (152), Expect = 7e-11
 Identities = 23/101 (22%), Positives = 46/101 (45%), Gaps = 5/101 (4%)

Query: 37  NQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRD 96
                YR   +++ D    DL  +      +FS   + ++  ++L+ L YIH ++ +H D
Sbjct: 121 KNGKSYR---FMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIHEHEYVHGD 177

Query: 97  MKAANVLI--TKTGILKLADFGLARAFSQTKNGQVNRYTNR 135
           +KA+N+L+       + L D+GLA  +      +      +
Sbjct: 178 IKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPK 218

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3tl8_A* Length = 326

 Score = 59.5 bits (145), Expect = 5e-10
 Identities = 33/145 (22%), Positives = 61/145 (42%), Gaps = 24/145 (16%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
             E++++ +  H N++ L   C T   +         LV+ +  +    + S +  +   
Sbjct: 75  QTEVEMISMAVHRNLLRLRGFCMTPTERL--------LVYPYMANG--SVASCLRERPES 124

Query: 71  GEI------KKVIQQLLNGLYYIH--SN-KILHRDMKAANVLITKTGILKLADFGLARAF 121
                    +++      GL Y+H   + KI+HRD+KAAN+L+ +     + DFGLA+  
Sbjct: 125 QPPLDWPKRQRIALGSARGLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLM 184

Query: 122 SQTKNGQVNRYTNRVV-TLWYRPPE 145
                      T  V  T+ +  PE
Sbjct: 185 DYKDTH----VTTAVRGTIGHIAPE 205

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens} Length = 352

 Score = 59.8 bits (145), Expect = 5e-10
 Identities = 21/118 (17%), Positives = 44/118 (37%), Gaps = 10/118 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK-FS 69
           + + K L       +   +       ++Y       +LV       L   L        S
Sbjct: 105 VNKWKKLYSTPLLAIPTCMG-FGVHQDKYR------FLVLPSLGRSLQSALDVSPKHVLS 157

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI--TKTGILKLADFGLARAFSQTK 125
              + +V  +LL+ L ++H N+ +H ++ A N+ +       + LA +G A  +  + 
Sbjct: 158 ERSVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSG 215

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A* Length = 330

 Score = 57.8 bits (140), Expect = 2e-09
 Identities = 25/123 (20%), Positives = 50/123 (40%), Gaps = 14/123 (11%)

Query: 12  REIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            E +  + L   + +  +         +YN       +V +     L  L       FSL
Sbjct: 53  LEYRFYKQLGSGDGIPQVYYFGPC--GKYN------AMVLELLGPSLEDLFDLCDRTFSL 104

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-----TKTGILKLADFGLARAFSQTK 125
             +  +  QL++ + Y+HS  +++RD+K  N LI         ++ + DF LA+ +   +
Sbjct: 105 KTVLMIAIQLISRMEYVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPE 164

Query: 126 NGQ 128
             +
Sbjct: 165 TKK 167

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A* Length = 298

 Score = 57.4 bits (139), Expect = 2e-09
 Identities = 27/124 (21%), Positives = 49/124 (39%), Gaps = 14/124 (11%)

Query: 11  LREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
             E +  +LL     + ++    +     +N       LV D     L  LL     KFS
Sbjct: 53  RDEYRTYKLLAGCTGIPNVYYFGQE--GLHN------VLVIDLLGPSLEDLLDLCGRKFS 104

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI-----TKTGILKLADFGLARAFSQT 124
           +  +    +Q+L  +  IH   +++RD+K  N LI         ++ + DFG+ + +   
Sbjct: 105 VKTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDP 164

Query: 125 KNGQ 128
              Q
Sbjct: 165 VTKQ 168

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group} Length = 483

 Score = 57.7 bits (139), Expect = 3e-09
 Identities = 34/129 (26%), Positives = 55/129 (42%), Gaps = 12/129 (9%)

Query: 11  LREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           L E KI ++L+    + ++          YN       LV D     L  L +    K S
Sbjct: 50  LYESKIYRILQGGTGIPNVRWFGVE--GDYN------VLVMDLLGPSLEDLFNFCSRKLS 101

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKN 126
           L  +  +  Q++N + ++HS   LHRD+K  N L+    +   + + DFGLA+ +  T  
Sbjct: 102 LKTVLMLADQMINRVEFVHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTST 161

Query: 127 GQVNRYTNR 135
            Q   Y   
Sbjct: 162 HQHIPYREN 170

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A Length = 286

 Score = 55.1 bits (133), Expect = 1e-08
 Identities = 19/182 (10%), Positives = 43/182 (23%), Gaps = 44/182 (24%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKF 68
            L     L  +    V  ++++           R+   +V ++     L  +        
Sbjct: 78  TLSRTLRLSRIDKPGVARVLDVVH--------TRAGGLVVAEWIRGGSLQEVADT---SP 126

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           S     + +Q L       H   +       + V ++  G + LA               
Sbjct: 127 SPVGAIRAMQSLAAAADAAHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------ 174

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
                         P           P  D+ G G  +  +      +     +  +   
Sbjct: 175 ------------TMPDA--------NPQDDIRGIGASLYALLVNRWPLPEAGVRSGLAPA 214

Query: 189 SQ 190
            +
Sbjct: 215 ER 216

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vid_A* 3hng_A* Length = 359

 Score = 55.7 bits (134), Expect = 1e-08
 Identities = 30/111 (27%), Positives = 56/111 (50%), Gaps = 15/111 (13%)

Query: 79  QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVT 138
           Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ DFGLAR   +  +     Y  +   
Sbjct: 201 QVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD-----YVRKGDA 255

Query: 139 L----WYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS----PIMQGNTE 181
                W   PE +  DR Y    D+W  G ++ E+++      P ++ + E
Sbjct: 256 RLPLKWM-APETIF-DRVYTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEE 304

Structure Templates Detected by HHsearch

Original result of HHsearch against PDB70 database

ID	Length	Definition	Probability
Query	433
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	100.0
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	100.0
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	100.0
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	100.0
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	100.0
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	100.0
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	100.0
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	100.0
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	100.0
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	100.0
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	100.0
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3niz_A	311	Rhodanese family protein; structural genomics, str	100.0
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	100.0
4aoj_A	329	High affinity nerve growth factor receptor; transf	100.0
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	100.0
4gt4_A	308	Tyrosine-protein kinase transmembrane receptor RO;	100.0
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	100.0
3o0g_A	292	Cell division protein kinase 5; kinase activator c	100.0
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	100.0
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	100.0
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	100.0
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	100.0
3rp9_A	458	Mitogen-activated protein kinase; structural genom	100.0
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	100.0
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	100.0
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	100.0
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	100.0
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	100.0
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	100.0
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	100.0
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	100.0
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	100.0
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	100.0
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	100.0
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	100.0
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	100.0
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	100.0
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	100.0
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	100.0
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	100.0
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	100.0
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	100.0
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	100.0
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	100.0
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	100.0
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	100.0
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	100.0
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	100.0
3hmm_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	100.0
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	100.0
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	100.0
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	100.0
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	100.0
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	100.0
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	100.0
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	100.0
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	100.0
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	100.0
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	100.0
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	100.0
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	100.0
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	100.0
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	100.0
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	100.0
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	100.0
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	100.0
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	100.0
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	100.0
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	100.0
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	100.0
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	100.0
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	100.0
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	100.0
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	100.0
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	100.0
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	100.0
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	100.0
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	100.0
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	100.0
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	100.0
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	100.0
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	100.0
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	100.0
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	100.0
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	100.0
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	100.0
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	100.0
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	100.0
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	100.0
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	100.0
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	100.0
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	100.0
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	100.0
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	100.0
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	100.0
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	100.0
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	100.0
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	100.0
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	100.0
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	100.0
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	100.0
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	100.0
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	100.0
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	100.0
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	100.0
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	100.0
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	100.0
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	100.0
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	100.0
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	100.0
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	100.0
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	100.0
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	100.0
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	100.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	100.0
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	100.0
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	100.0
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	100.0
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	100.0
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	100.0
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	100.0
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	100.0
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	100.0
3fme_A	290	Dual specificity mitogen-activated protein kinase;	100.0
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	100.0
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	100.0
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	100.0
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	100.0
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	100.0
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	100.0
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	100.0
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	100.0
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	100.0
3bhy_A	283	Death-associated protein kinase 3; death associate	100.0
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	100.0
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	100.0
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	100.0
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	100.0
2psq_A	370	Fibroblast growth factor receptor 2; kinase domain	100.0
3kul_A	325	Ephrin type-A receptor 8; ATP-binding, kinase, nuc	100.0
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	100.0
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	100.0
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	100.0
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	100.0
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	100.0
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	100.0
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	100.0
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	100.0
3an0_A	340	Dual specificity mitogen-activated protein kinase;	100.0
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	100.0
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	100.0
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	100.0
3ork_A	311	Serine/threonine protein kinase; structural genomi	100.0
3s95_A	310	LIMK-1, LIM domain kinase 1; structural genomics,	100.0
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	100.0
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	100.0
3op5_A	364	Serine/threonine-protein kinase VRK1; adenosine tr	100.0
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	100.0
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	100.0
2izr_A	330	Casein kinase I isoform gamma-3; serine/threonine-	100.0
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	100.0
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	100.0
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	100.0
3pls_A	298	Macrophage-stimulating protein receptor; protein k	100.0
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	100.0
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	100.0
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	100.0
3c1x_A	373	Hepatocyte growth factor receptor; receptor tyrosi	100.0
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	100.0
4eqm_A	294	Protein kinase; transferase; HET: ANP; 3.00A {Stap	100.0
2dyl_A	318	Dual specificity mitogen-activated protein kinase	100.0
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	100.0
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	100.0
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	100.0
1luf_A	343	Muscle-specific tyrosine kinase receptor MUSK; pho	100.0
3poz_A	327	Epidermal growth factor receptor; kinase domain, a	100.0
2qol_A	373	Ephrin receptor; receptor tyrosine kinase, juxtame	100.0
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	100.0
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	100.0
3cbl_A	377	C-FES, proto-oncogene tyrosine-protein kinase FES/	100.0
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	100.0
1mqb_A	333	Ephrin type-A receptor 2; tyrosine protein kinase,	100.0
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	100.0
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	100.0
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	100.0
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	100.0
3lzb_A	327	Epidermal growth factor receptor; epidermal growth	100.0
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	100.0
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	100.0
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	100.0
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	100.0
3aln_A	327	Dual specificity mitogen-activated protein kinase;	100.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	100.0
3soc_A	322	Activin receptor type-2A; structural genomics cons	100.0
2pvf_A	334	Fibroblast growth factor receptor 2; kinase domain	100.0
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	100.0
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	100.0
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	100.0
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	100.0
1k9a_A	450	Carboxyl-terminal SRC kinase; COOH-terminal SRC ki	100.0
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	100.0
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	100.0
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	100.0
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	100.0
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	100.0
1opk_A	495	P150, C-ABL, proto-oncogene tyrosine-protein kinas	100.0
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	100.0
1qcf_A	454	Haematopoetic cell kinase (HCK); tyrosine kinase-i	100.0
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	100.0
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	100.0
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	100.0
2ozo_A	613	Tyrosine-protein kinase ZAP-70; inactive ZAP-70, t	100.0
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	100.0
1qpc_A	279	LCK kinase; alpha beta fold, transferase; HET: PTR	100.0
3q4u_A	301	Activin receptor type-1; structural genomics conso	100.0
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	100.0
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	100.0
2a19_B	284	Interferon-induced, double-stranded RNA-activated	100.0
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	100.0
2h34_A	309	Serine/threonine-protein kinase PKNE; apoenzyme, t	100.0
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	100.0
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	100.0
4fl3_A	635	Tyrosine-protein kinase SYK; transferase; HET: ANP	100.0
1fmk_A	452	C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyros	100.0
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	100.0
2y4i_B	319	KSR2, HKSR2, kinase suppressor of RAS 2; transfera	100.0
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	100.0
4eut_A	396	Serine/threonine-protein kinase TBK1; ATP binding,	100.0
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	100.0
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	100.0
2j0j_A	656	Focal adhesion kinase 1; cell migration, FERM, tra	100.0
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	100.0
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	100.0
2h8h_A	535	Proto-oncogene tyrosine-protein kinase SRC; SRC ki	100.0
3sv0_A	483	Casein kinase I-like; typical kinase domain fold,	100.0
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	100.0
3e7e_A	365	HBUB1, BUB1A, mitotic checkpoint serine/threonine-	100.0
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	100.0
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	100.0
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	100.0
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	100.0
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	100.0
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	100.0
2pzi_A	681	Probable serine/threonine-protein kinase PKNG; ATP	99.97
3uqc_A	286	Probable conserved transmembrane protein; structur	99.97
4azs_A	569	Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15	99.96
3en9_A	540	Glycoprotease, O-sialoglycoprotein endopeptidase/p	99.86
1zar_A	282	RIO2 kinase; serine kinase, winged-helix, RIO doma	99.7
1zth_A	258	RIO1 serine protein kinase; ribosome biogenesis, r	99.54
4gyi_A	397	RIO2 kinase; protein kinase, ADP complex, phosphoa	99.12
3tm0_A	263	Aminoglycoside 3'-phosphotransferase; protein kina	98.79
3dxp_A	359	Putative acyl-COA dehydrogenase; protein kinase-li	98.61
1nd4_A	264	Aminoglycoside 3'-phosphotransferase; protein kina	98.57
3sg8_A	304	APH(2'')-ID; antibiotic resistance enzyme, transfe	98.35
4f9c_A	361	Cell division cycle 7-related protein kinase; Ser/	98.19
4b99_A	398	Mitogen-activated protein kinase 7; transferase, i	98.15
3mi9_A	351	Cell division protein kinase 9; P-TEFB, HIV-1, pro	98.14
3rgf_A	405	Cyclin-dependent kinase 8; protein kinase complex,	98.04
3r70_A	320	Aminoglycoside phosphotransferase; structural geno	97.84
3tdw_A	306	Gentamicin resistance protein; kinase, phosphoryl	97.82
4fih_A	346	Serine/threonine-protein kinase PAK 4; kinase doma	97.75
3n9x_A	432	Phosphotransferase; malaria kinase, structural gen	97.7
3rp9_A	458	Mitogen-activated protein kinase; structural genom	97.7
4gkh_A	272	Aminoglycoside 3'-phosphotransferase APHA1-IAB; py	97.67
1cm8_A	367	Phosphorylated MAP kinase P38-gamma; phosphorylati	97.65
3o0g_A	292	Cell division protein kinase 5; kinase activator c	97.65
4fie_A	423	Serine/threonine-protein kinase PAK 4; kinase doma	97.6
3niz_A	311	Rhodanese family protein; structural genomics, str	97.58
3uto_A	573	Twitchin; kinase, muscle sarcomere, transferase; H	97.57
2fst_X	367	Mitogen-activated protein kinase 14; active mutant	97.56
3hyh_A	275	Carbon catabolite-derepressing protein kinase; kin	97.53
3mtl_A	324	Cell division protein kinase 16; pctaire1, indirub	97.53
3fpq_A	290	Serine/threonine-protein kinase WNK1; protein seri	97.53
3g33_A	308	Cell division protein kinase 4; Ser/Thr protein ki	97.52
3oz6_A	388	Mitogen-activated protein kinase 1, serine/threon	97.51
1ob3_A	288	PFPK5, cell division control protein 2 homolog; tr	97.47
2vx3_A	382	Dual specificity tyrosine-phosphorylation- regula	97.47
4agu_A	311	Cyclin-dependent kinase-like 1; transferase, phosp	97.43
3kvw_A	429	DYRK2, dual specificity tyrosine-phosphorylation-r	97.41
3ttj_A	464	Mitogen-activated protein kinase 10; JNK3, protein	97.4
1ua2_A	346	CAK, cell division protein kinase 7; cell cycle, p	97.37
2r3i_A	299	Cell division protein kinase 2; serine/threonine-p	97.37
2yle_A	229	Protein spire homolog 1; actin-binding protein, ac	97.34
3gbz_A	329	Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-	97.33
4b9d_A	350	Serine/threonine-protein kinase NEK1; transferase,	97.33
3nsz_A	330	CK II alpha, casein kinase II subunit alpha; inhib	97.32
3e3p_A	360	Protein kinase, putative glycogen synthase kinase;	97.3
2b9h_A	353	MAP kinase FUS3, mitogen-activated protein kinase	97.28
3qyz_A	364	Mitogen-activated protein kinase 1; transferase, s	97.27
4exu_A	371	Mitogen-activated protein kinase 13; P38 kinase, t	97.25
3ovc_A	362	Hygromycin-B 4-O-kinase; aminoglycoside phosphotra	97.24
2i6l_A	320	Mitogen-activated protein kinase 6; MAPK6, ERK3, e	97.22
3ats_A	357	Putative uncharacterized protein; hypothetical pro	97.21
3gni_B	389	Strad alpha; kinase fold, pseudokinase, alpha heli	97.19
3fe3_A	328	MAP/microtubule affinity-regulating kinase 3; seri	97.18
4g31_A	299	Eukaryotic translation initiation factor 2-alpha;	97.18
2pmi_A	317	Negative RE, cyclin-dependent protein kinase PHO85	97.17
2ac3_A	316	MAP kinase-interacting serine/threonine kinase 2;	97.16
4e7w_A	394	Glycogen synthase kinase 3; GSK3, PTyr195, transfe	97.15
3coi_A	353	Mitogen-activated protein kinase 13; P38D, P38delt	97.13
3llt_A	360	Serine/threonine kinase-1, pflammer; lammer kinase	97.12
2yab_A	361	Death-associated protein kinase 2; apoptosis, tran	97.11
1blx_A	326	Cyclin-dependent kinase 6; inhibitor protein, cycl	97.11
3is5_A	285	Calcium-dependent protein kinase; CDPK, structural	97.11
3q5i_A	504	Protein kinase; CDPK, malaria, phosphotransferase,	97.05
4aw0_A	311	HPDK1, 3-phosphoinositide-dependent protein kinase	97.05
1j1b_A	420	Glycogen synthase kinase-3 beta; complex, TAU, AMP	97.05
1wak_A	397	Serine/threonine-protein kinase SPRK1; SRPK, trans	97.04
3pg1_A	362	Mitogen-activated protein kinase, putative (MAP K	97.04
3fxz_A	297	Serine/threonine-protein kinase PAK 1; transferase	97.01
2c30_A	321	Serine/threonine-protein kinase PAK 6; CRIB domain	96.99
1q8y_A	373	SR protein kinase; transferase; HET: ADP ADE; 2.05	96.99
3p1a_A	311	MYT1 kinase, membrane-associated tyrosine- and thr	96.99
3tki_A	323	Serine/threonine-protein kinase CHK1; cell checkpo	96.99
3eb0_A	383	Putative uncharacterized protein; kinase cryptospo	96.98
2xrw_A	371	Mitogen-activated protein kinase 8; transcription,	96.97
3ubd_A	304	Ribosomal protein S6 kinase alpha-3; kinase-inhibi	96.95
2jam_A	304	Calcium/calmodulin-dependent protein kinase type 1	96.95
3mwu_A	486	Calmodulin-domain protein kinase 1; serine/threoni	96.95
1z57_A	339	Dual specificity protein kinase CLK1; protein tyro	96.95
2eu9_A	355	Dual specificity protein kinase CLK3; kinase domai	96.94
2eue_A	275	Carbon catabolite derepressing protein kinase; kin	96.91
2yex_A	276	Serine/threonine-protein kinase CHK1; transferase,	96.89
3i6u_A	419	CDS1, serine/threonine-protein kinase CHK2; Ser/Th	96.88
1t4h_A	290	Serine/threonine-protein kinase WNK1; protein seri	96.87
2w4o_A	349	Calcium/calmodulin-dependent protein kinase type I	96.86
2y0a_A	326	Death-associated protein kinase 1; transferase, ca	96.85
3kn6_A	325	Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1	96.84
3h4j_B	336	AMPK kdaid, SNF1-like protein kinase SSP2; ATP-bin	96.83
1tki_A	321	Titin; serine kinase, muscle, autoinhibition; 2.00	96.83
3kk8_A	284	Calcium/calmodulin dependent protein kinase II; AT	96.82
3m2w_A	299	MAP kinase-activated protein kinase 2; small molec	96.81
3soa_A	444	Calcium/calmodulin-dependent protein kinase type a	96.8
3uc3_A	361	Serine/threonine-protein kinase SRK2I; SNRK2, ABA	96.8
1x8b_A	289	WEE1HU, WEE1-like protein kinase; cell cycle, tran	96.78
2zv2_A	298	Calcium/calmodulin-dependent protein kinase kinas;	96.78
3lm5_A	327	Serine/threonine-protein kinase 17B; STK17B, serin	96.77
4aaa_A	331	Cyclin-dependent kinase-like 2; transferase, phosp	96.76
3eqc_A	360	Dual specificity mitogen-activated protein kinase;	96.76
3cok_A	278	Serine/threonine-protein kinase PLK4; POLO-like ki	96.76
3qd2_B	332	Eukaryotic translation initiation factor 2-alpha;	96.75
2j7t_A	302	Serine/threonine-protein kinase 10; transferase, A	96.75
1kob_A	387	Twitchin; kinase, intrasteric regulation; 2.30A {A	96.73
2y7j_A	365	Phosphorylase B kinase gamma catalytic chain, test	96.71
2a2a_A	321	Death-associated protein kinase 2; autoinhibition,	96.71
4g3f_A	336	NF-kappa-beta-inducing kinase; non-RD kinase, prot	96.7
2ycf_A	322	Serine/threonine-protein kinase CHK2; transferase,	96.7
3zgw_A	347	Maternal embryonic leucine zipper kinase; transfer	96.7
3q60_A	371	ROP5B; pseudokinase, transferase; HET: ATP; 1.72A	96.69
2x4f_A	373	Myosin light chain kinase family member 4; LUNG, b	96.69
2pml_X	348	PFPK7, Ser/Thr protein kinase; phosphorylati trans	96.68
2qr7_A	342	Ribosomal protein S6 kinase alpha-3; kinase domain	96.68
3p23_A	432	Serine/threonine-protein kinase/endoribonuclease;	96.68
3c0i_A	351	Peripheral plasma membrane protein CASK; neurexin,	96.67
1u5q_A	348	Serine/threonine protein kinase TAO2; transferase;	96.61
3dbq_A	343	Dual specificity protein kinase TTK; MPS1 structur	96.61
3com_A	314	Serine/threonine-protein kinase 4; MST1, STE20-lik	96.6
1phk_A	298	Phosphorylase kinase; glycogen metabolism, transfe	96.6
1zy4_A	303	Serine/threonine-protein kinase GCN2; translation	96.58
2vwi_A	303	Serine/threonine-protein kinase OSR1; STE kinase,	96.58
3fme_A	290	Dual specificity mitogen-activated protein kinase;	96.57
3lij_A	494	Calcium/calmodulin dependent protein kinase with A	96.56
3dls_A	335	PAS domain-containing serine/threonine-protein KI;	96.53
3f3z_A	277	Calcium/calmodulin-dependent protein kinase with d	96.52
3hko_A	345	Calcium/calmodulin-dependent protein kinase with d	96.52
3cek_A	313	Dual specificity protein kinase TTK; HMPS1, PYT, E	96.48
2rio_A	434	Serine/threonine-protein kinase/endoribonuclease I	96.47
2vgo_A	284	Serine/threonine-protein kinase 12-A; nucleotide-b	96.46
3fhr_A	336	MAP kinase-activated protein kinase 3; kinase-inhi	96.46
3byv_A	377	Rhoptry kinase; malaria, transferase, structural g	96.46
2zmd_A	390	Dual specificity protein kinase TTK; MPS1, T686A,	96.45
2clq_A	295	Mitogen-activated protein kinase kinase kinase 5;	96.45
3nyv_A	484	Calmodulin-domain protein kinase 1; serine/threoni	96.44
2x7f_A	326	TRAF2 and NCK-interacting protein kinase; serine/t	96.43
2wtk_C	305	Serine/threonine-protein kinase 11; transferase-me	96.43
2h6d_A	276	5'-AMP-activated protein kinase catalytic subunit	96.36
3fdn_A	279	Serine/threonine-protein kinase 6; aurora kinase i	96.35
2bdw_A	362	Hypothetical protein K11E8.1D; kinase, calmodulin	96.34
3a99_A	320	Proto-oncogene serine/threonine-protein kinase PI;	96.32
4ejn_A	446	RAC-alpha serine/threonine-protein kinase; AKT1, a	96.32
2rku_A	294	Serine/threonine-protein kinase PLK1; structure of	96.27
2y94_A	476	5'-AMP-activated protein kinase catalytic subunit;	96.26
2iwi_A	312	Serine/threonine-protein kinase PIM-2; nucleotide-	96.25
1nxk_A	400	MAP kinase-activated protein kinase 2; MK2, phosph	96.25
4dc2_A	396	Protein kinase C IOTA type; kinase, substrate, cel	96.24
1o6l_A	337	RAC-beta serine/threonine protein kinase; protein	96.2
3a8x_A	345	Protein kinase C IOTA type; transferase; HET: TPO;	96.19
2wei_A	287	Calmodulin-domain protein kinase 1, putative; nucl	96.18
3dxq_A	301	Choline/ethanolamine kinase family protein; NP_106	96.13
3dzo_A	413	Rhoptry kinase domain; parasitic disease, transfer	96.11
3v5w_A	689	G-protein coupled receptor kinase 2; inhibitor com	96.07
3txo_A	353	PKC-L, NPKC-ETA, protein kinase C ETA type; phosph	96.06
1fot_A	318	TPK1 delta, CAMP-dependent protein kinase type 1;	96.06
2owb_A	335	Serine/threonine-protein kinase PLK1; catalytic do	96.05
3bhy_A	283	Death-associated protein kinase 3; death associate	96.02
3an0_A	340	Dual specificity mitogen-activated protein kinase;	95.95
2dyl_A	318	Dual specificity mitogen-activated protein kinase	95.95
3a7i_A	303	MST3 kinase, serine/threonine kinase 24 (STE20 hom	95.93
3a62_A	327	Ribosomal protein S6 kinase beta-1; kinase domain,	95.91
2q83_A	346	YTAA protein; 2635576, structural genomics, joint	95.81
2olc_A	397	MTR kinase, methylthioribose kinase; kinase ADP-2H	95.8
1xjd_A	345	Protein kinase C, theta type; PKC-theta, ATP, AMP,	95.76
3aln_A	327	Dual specificity mitogen-activated protein kinase;	95.69
2w5a_A	279	Serine/threonine-protein kinase NEK2; Ser/Thr prot	95.62
1rdq_E	350	PKA C-alpha, CAMP-dependent protein kinase, alpha-	95.6
1vzo_A	355	Ribosomal protein S6 kinase alpha 5; protein kinas	95.55
2i0e_A	353	Protein kinase C-beta II; serine/threonine protein	95.42
2acx_A	576	G protein-coupled receptor kinase 6; GRK, G transf	95.39
4fr4_A	384	YANK1, serine/threonine-protein kinase 32A; struct	95.0
3pfq_A	674	PKC-B, PKC-beta, protein kinase C beta type; phosp	94.96
3d1u_A	288	Putative fructosamine-3-kinase; YP_290396.1, struc	94.92
3v8s_A	410	RHO-associated protein kinase 1; dimerization, myo	94.84
4aw2_A	437	Serine/threonine-protein kinase MRCK alpha; transf	94.83
3qa8_A	676	MGC80376 protein; kinase ubiquitin-like domain, ph	94.68
2vd5_A	412	DMPK protein; serine/threonine-protein kinase, kin	94.63
3feg_A	379	Choline/ethanolamine kinase; non-protein kinase, c	94.51
3f2s_A	401	CK, chetk-alpha, choline kinase alpha; non-protein	94.5
2r5t_A	373	Serine/threonine-protein kinase SGK1; AGC protein	94.35
2pyw_A	420	Uncharacterized protein; 5-methylthioribose kinase	94.26
4euu_A	319	Serine/threonine-protein kinase TBK1; ATP binding,	94.11
3c4z_A	543	Rhodopsin kinase; Ser/Thr kinase, RGS homology dom	93.96
3jr1_A	312	Putative fructosamine-3-kinase; YP_719053.1, struc	92.47
2ppq_A	322	HSK, HK, homoserine kinase; structural genomics, M	92.05
2vuw_A	336	Serine/threonine-protein kinase haspin; cell cycle	91.82
3csv_A	333	Aminoglycoside phosphotransferase; YP_614837.1, ph	91.12
1zyl_A	328	Hypothetical protein YIHE; putative protein kinase	90.96
3qup_A	323	Tyrosine-protein kinase receptor TYRO3; protein ki	90.69
3i1a_A	339	Spectinomycin phosphotransferase; protein kinase,	89.43
3ork_A	311	Serine/threonine protein kinase; structural genomi	89.13
2a19_B	284	Interferon-induced, double-stranded RNA-activated	88.81
3c5i_A	369	Choline kinase; choline, kinase, malaria, transfer	88.46
4hcu_A	269	Tyrosine-protein kinase ITK/TSK; transferase-trans	87.78
4ase_A	353	Vascular endothelial growth factor receptor 2; tra	87.73
2yfx_A	327	Tyrosine-protein kinase receptor; nucleotide-bindi	87.47
3dtc_A	271	Mitogen-activated protein kinase kinase kinase 9;	87.46
3g2f_A	336	Bone morphogenetic protein receptor type-2; kinase	87.27
3sxs_A	268	Cytoplasmic tyrosine-protein kinase BMX; transfera	86.96
3vhe_A	359	Vascular endothelial growth factor receptor 2; kin	86.75
2buj_A	317	Serine/threonine-protein kinase 16; transferase, A	86.39
1fvr_A	327	Tyrosine-protein kinase TIE-2; tyrosine kinase, tr	86.18
4fvq_A	289	Tyrosine-protein kinase JAK2; janus protein kinase	86.15
3gen_A	283	Tyrosine-protein kinase BTK; bruton'S tyrosine kin	86.11
4e5w_A	302	Tyrosine-protein kinase JAK1; kinase domain, trans	86.07
3mdy_A	337	Bone morphogenetic protein receptor type-1B; compl	85.94
4aoj_A	329	High affinity nerve growth factor receptor; transf	85.88
3kmu_A	271	ILK, integrin-linked kinase; cell adhesion, ANK re	85.87
3soc_A	322	Activin receptor type-2A; structural genomics cons	85.79
3cc6_A	281	Protein tyrosine kinase 2 beta; focal adhesion kin	85.73
2qg7_A	458	Ethanolamine kinase PV091845; malaria, SGC, struct	85.73
4f0f_A	287	Serine/threonine-protein kinase ROCO4; LRRK2, ATP-	85.59
3lb7_A	307	RAF proto-oncogene serine/threonine-protein kinas;	85.36
2ivs_A	314	Proto-oncogene tyrosine-protein kinase receptor RE	85.35
3uim_A	326	Brassinosteroid insensitive 1-associated receptor;	85.34
3omv_A	307	RAF proto-oncogene serine/threonine-protein kinas;	85.25
3lxl_A	327	Tyrosine-protein kinase JAK3; TYK2, inflammation,	85.24
1t46_A	313	HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcom	85.22
2xir_A	316	Vascular endothelial growth factor receptor 2; ang	85.14
3q4u_A	301	Activin receptor type-1; structural genomics conso	85.11
4hgt_A	296	Casein kinase I isoform delta; CK1D, inhibitor, tr	84.78
3t9t_A	267	Tyrosine-protein kinase ITK/TSK; kinase domain, al	84.67
1rjb_A	344	FL cytokine receptor; kinase, structure, autoinhib	84.57
1u59_A	287	Tyrosine-protein kinase ZAP-70; transferase; HET:	84.4
1p4o_A	322	Insulin-like growth factor I receptor protein; IGF	84.37
1nw1_A	429	Choline kinase (49.2 KD); phospholipid synthesis,	84.26
1mp8_A	281	Focal adhesion kinase 1; tyrosine protein kinase,	84.0
3kfa_A	288	Tyrosine-protein kinase ABL1; CML, drug resistance	83.91
3uzp_A	296	CKI-delta, CKID, casein kinase I isoform delta; CK	83.86
3ugc_A	295	Tyrosine-protein kinase JAK2; small molecule inhib	83.43
2qkw_B	321	Protein kinase; three-helix bundle motif, AVRPTO-P	83.38
1u46_A	291	ACK-1, activated CDC42 kinase 1; tyrosine kinase,	83.32
3pls_A	298	Macrophage-stimulating protein receptor; protein k	83.2
1xbb_A	291	Tyrosine-protein kinase SYK; gleevec, STI-571, ima	83.13
3ll6_A	337	Cyclin G-associated kinase; transferase, protein k	83.12
3l9p_A	367	Anaplastic lymphoma kinase; kinase domain, ATP-bin	83.08
3og7_A	289	AKAP9-BRAF fusion protein; proto-oncogene, V600E,	83.03
3brb_A	313	Proto-oncogene tyrosine-protein kinase MER; ATP-bi	82.83
3lxp_A	318	Non-receptor tyrosine-protein kinase TYK2; JAK3, i	82.45
3p86_A	309	Serine/threonine-protein kinase CTR1; ETR1, ERS1,	82.45
2jii_A	352	Serine/threonine-protein kinase VRK3 molecule: VA	82.41
2nru_A	307	Interleukin-1 receptor-associated kinase 4; inhibi	82.24
2wqm_A	310	Serine/threonine-protein kinase NEK7; ATP-binding,	82.19
1b6c_B	342	TGF-B superfamily receptor type I; complex (isomer	81.97
3tt0_A	382	Basic fibroblast growth factor receptor 1; kinase	81.89
2eva_A	307	TAK1 kinase - TAB1 chimera fusion protein; transfe	81.71
3gxj_A	303	TGF-beta receptor type-1; ALK5, kinase, inhibitor,	81.61
2i1m_A	333	Macrophage colony-stimulating factor 1 receptor; k	81.22
1byg_A	278	CSK, protein (C-terminal SRC kinase); protein kina	81.15
2v62_A	345	Serine/threonine-protein kinase VRK2; transferase,	81.06
1csn_A	298	Casein kinase-1; phosphotransferase; HET: ATP; 2.0	80.92
4asz_A	299	BDNF/NT-3 growth factors receptor; transferase, TR	80.77
3kex_A	325	Receptor tyrosine-protein kinase ERBB-3; kinase do	80.73
3f66_A	298	Hepatocyte growth factor receptor; C-Met, protein	80.56
2w1i_A	326	JAK2; chromosomal rearrangement, nucleotide-bindin	80.31

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=100.00  E-value=1.3e-52  Score=401.96  Aligned_cols=221  Identities=26%  Similarity=0.431  Sum_probs=188.6

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+.+|+++|+.++|||||+++++|.+.        +.+|||||||++ +|.+++.+  ..+++.+++.++.||+.||
T Consensus       114 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--------~~~~ivmEy~~gg~L~~~l~~--~~l~e~~~~~~~~qi~~aL  183 (346)
T 4fih_A          114 RRELLFNEVVIMRDYQHENVVEMYNSYLVG--------DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQAL  183 (346)
T ss_dssp             SGGGGHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEECCCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999986        669999999985 78887765  4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+|+.+....    ....+.+||+.|+|||++.+.. |+.++|||||||
T Consensus       184 ~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGv  258 (346)
T 4fih_A          184 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGI  258 (346)
T ss_dssp             HHHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             HHHHHCCcccccCCHHHEEECCCCCEEEecCcCceecCCCC----CcccccccCcCcCCHHHHCCCC-CCcHHHHHHHHH
Confidence            99999999999999999999999999999999998775332    2345679999999999997765 899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+.+..|...... ....                            ....|+++++||.+||.
T Consensus       259 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~----------------------------~~~~s~~~~dli~~~L~  309 (346)
T 4fih_A          259 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKN----------------------------LHKVSPSLKGFLDRLLV  309 (346)
T ss_dssp             HHHHHHHSSCTTTTSCHHHHHHHHHHSSCC-CCSC----------------------------GGGSCHHHHHHHHHHSC
T ss_pred             HHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCCc----------------------------cccCCHHHHHHHHHHcC
Confidence            999999999999999988887777542211 0000                            01257888999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      .||++|||++|+|+||||++...+..
T Consensus       310 ~dP~~R~ta~e~l~Hp~~~~~~~p~~  335 (346)
T 4fih_A          310 RDPAQRATAAELLKHPFLAKAGPPAS  335 (346)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             CChhHCcCHHHHhcCHhhcCCCCCcc
Confidence            99999999999999999987654443

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=100.00  E-value=9.8e-53  Score=412.94  Aligned_cols=256  Identities=32%  Similarity=0.553  Sum_probs=203.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+++|+.|+|||||++++++.....  +.....+|||||||+|+|.+++.+ ...+++..++.++.||+.||+|
T Consensus        97 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~~~--~~~~~~~~ivmE~~~g~L~~~i~~-~~~l~~~~~~~~~~qil~al~y  173 (398)
T 4b99_A           97 AKRTLRELKILKHFKHDNIIAIKDILRPTVP--YGEFKSVYVVLDLMESDLHQIIHS-SQPLTLEHVRYFLYQLLRGLKY  173 (398)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEECCCSSC--TTTCCCEEEEEECCSEEHHHHHTS-SSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcceEeeeeecccc--cccCCEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999999976421  112467999999999999999876 4479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||+|+.+............+.+||++|+|||++.+...|+.++||||+||++
T Consensus       174 lH~~~iiHRDlKP~NIl~~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~Y~APEv~~~~~~~~~~~DiWSlG~il  253 (398)
T 4b99_A          174 MHSAQVIHRDLKPSNLLVNENCELKIGDFGMARGLCTSPAEHQYFMTEYVATRWYRAPELMLSLHEYTQAIDLWSVGCIF  253 (398)
T ss_dssp             HHHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCC-------CCCCCSSCCCCTTCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             HHHCcCcCCCcCccccccCCCCCEEEeecceeeecccCccccccccccceeChHhcCHHHhcCCCCCCChhheehhHHHH
Confidence            99999999999999999999999999999999877544333334456789999999999998877789999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++|.+||.+.+..+++..|....|.++...|...........+. .+...+......+.  ..+.+++|||.+||.+
T Consensus       254 ~ell~G~~pF~g~~~~~~l~~I~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~s~~~~dLl~~mL~~  331 (398)
T 4b99_A          254 GEMLARRQLFPGKNYVHQLQLIMMVLGTPSPAVIQAVGAERVRAYIQSLPPRQPVPWETVYP--GADRQALSLLGRMLRF  331 (398)
T ss_dssp             HHHHHTSCSSCCSSHHHHHHHHHHHHCCCCGGGTC-----CHHHHHHSSCCCCCCCHHHHST--TCCHHHHHHHHHHSCS
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhhhhhhhhhhhhcCCCcCCCCHHHhCC--CCCHHHHHHHHHHCcC
Confidence            99999999999999999999999999998877665544332211110 11111111111111  2578999999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      ||.+|||++|+|+||||++.+.
T Consensus       332 dP~~R~ta~e~L~Hp~f~~~~~  353 (398)
T 4b99_A          332 EPSARISAAAALRHPFLAKYHD  353 (398)
T ss_dssp             STTTSCCHHHHTTSGGGTTTCC
T ss_pred             ChhHCcCHHHHhcCHhhCcCCC
Confidence            9999999999999999977554

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=100.00  E-value=1.2e-52  Score=390.99  Aligned_cols=212  Identities=26%  Similarity=0.463  Sum_probs=176.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++|+.++|||||+++++|.++        +.+|||||||+|+|.+.+.+. ..+++.+++.++.||+.||+|
T Consensus        57 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--------~~~~ivmEy~~g~L~~~l~~~-~~l~e~~~~~~~~qi~~al~y  127 (275)
T 3hyh_A           57 QGRIEREISYLRLLRHPHIIKLYDVIKSK--------DEIIMVIEYAGNELFDYIVQR-DKMSEQEARRFFQQIISAVEY  127 (275)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCEEHHHHHHHS-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCeEEEEEEEC--------CEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999876        669999999999999998764 579999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||+|+.....     ....+.+||+.|+|||++.+...++.++||||+||++
T Consensus       128 lH~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~-----~~~~~~~GT~~Y~APE~~~~~~y~~~~~DiwSlGvil  202 (275)
T 3hyh_A          128 CHRHKIVHRDLKPENLLLDEHLNVKIADFGLSNIMTDG-----NFLKTSCGSPNYAAPEVISGKLYAGPEVDVWSCGVIL  202 (275)
T ss_dssp             HHHTTCCCCCCCTTTEEECTTCCEEECCSSCC--------------------CTTSCHHHHSSSSCCCTHHHHHHHHHHH
T ss_pred             HHHCCcccccCChHHeEECCCCCEEEeecCCCeecCCC-----CccCCeeECcccCChhhhcCCCCCCChhhhHHHHHHH
Confidence            99999999999999999999999999999999876432     2334578999999999998877567899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+.......                                +...|+++++||.+||+.|
T Consensus       203 y~lltg~~PF~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~d  250 (275)
T 3hyh_A          203 YVMLCRRLPFDDESIPVLFKNISNGVYTL--------------------------------PKFLSPGAAGLIKRMLIVN  250 (275)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------------------------CTTSCHHHHHHHHHHSCSS
T ss_pred             HHHHHCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHccCC
Confidence            99999999999988877776665421110                                1125778889999999999


Q ss_pred             CCCCCCHHHhhcCCCccC
Q psy7889         247 PSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~  264 (433)
                      |++|||++|+|+||||+.
T Consensus       251 P~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          251 PLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             GGGSCCHHHHHHCHHHHT
T ss_pred             hhHCcCHHHHHcCccccc
Confidence            999999999999999964

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=100.00  E-value=5.4e-52  Score=392.06  Aligned_cols=214  Identities=26%  Similarity=0.410  Sum_probs=185.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++|+.|+|||||+++++|.++        +.+|||||||.| +|.+++.+. +.+++.+++.++.||+.||+
T Consensus        76 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~~~yivmEy~~gG~L~~~i~~~-~~l~e~~~~~~~~qi~~al~  146 (311)
T 4aw0_A           76 VPYVTRERDVMSRLDHPFFVKLYFTFQDD--------EKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALE  146 (311)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeC--------CEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999986        669999999975 899998764 47999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+.+....  ......+.+||+.|+|||++.+.. |+.++|||||||+
T Consensus       147 ylH~~~IiHRDlKPeNILl~~~g~vKl~DFGla~~~~~~~--~~~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGvi  223 (311)
T 4aw0_A          147 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPES--KQARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCI  223 (311)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTT--TCCCBCCCCSCGGGCCHHHHHHSC-BCHHHHHHHHHHH
T ss_pred             HHHHCCCccCCCCHHHeEEcCCCCEEEEEcCCceecCCCC--CcccccCcccCcccCCHHHHcCCC-CCcHHHHHHHHHH
Confidence            9999999999999999999999999999999998875322  123345679999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+....|.......                                +...|+++++||.+||+.
T Consensus       224 lyeml~G~~PF~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~dli~~lL~~  271 (311)
T 4aw0_A          224 IYQLVAGLPPFRAGNEGLIFAKIIKLEYDF--------------------------------PEKFFPKARDLVEKLLVL  271 (311)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHTCCCC--------------------------------CTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CcccCHHHHHHHHHHccC
Confidence            999999999999999888887776522111                                112577888999999999


Q ss_pred             CCCCCCCHHH------hhcCCCccC
Q psy7889         246 DPSKRFDSDA------ALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e------~L~h~~~~~  264 (433)
                      ||.+|||++|      +++||||+.
T Consensus       272 dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          272 DATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             SGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CHhHCcChHHHcCCHHHHCCCCcCC
Confidence            9999999998      479999965

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=100.00  E-value=2.5e-51  Score=402.63  Aligned_cols=221  Identities=26%  Similarity=0.431  Sum_probs=189.0

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+.+|+.+|+.|+|||||+++++|.+.        +.+|||||||.| +|.+++..  ..+++.+++.|+.||+.||
T Consensus       191 ~~~~~~~Ei~il~~l~HpnIV~l~~~~~~~--------~~~~iVmEy~~gG~L~~~i~~--~~l~e~~~~~~~~qil~aL  260 (423)
T 4fie_A          191 RRELLFNEVVIMRDYQHENVVEMYNSYLVG--------DELWVVMEFLEGGALTDIVTH--TRMNEEQIAAVCLAVLQAL  260 (423)
T ss_dssp             SGGGHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEHHHHHHH--SCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCceEEEEEEC--------CEEEEEEeCCCCCcHHHHHhc--cCCCHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999986        669999999985 78887764  3699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++|||||||||+||||+.+|.+||+|||+|+.+....    ....+.+||+.|+|||++.+.. |+.++|||||||
T Consensus       261 ~ylH~~~IiHRDiKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~GTp~YmAPEvl~~~~-y~~~~DiWSlGv  335 (423)
T 4fie_A          261 SVLHAQGVIHRDIKSDSILLTHDGRVKLSDFGFCAQVSKEV----PRRKSLVGTPYWMAPELISRLP-YGPEVDIWSLGI  335 (423)
T ss_dssp             HHHHHTTEECCCCSTTTEEECTTCCEEECCCTTCEECCSSC----CCBCCCEECTTTCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             HHHHHCCeecccCCHHHEEEcCCCCEEEecCccceECCCCC----ccccccccCcCcCCHHHHCCCC-CCcHHHHHHHHH
Confidence            99999999999999999999999999999999998765332    2345679999999999997765 899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+.+..|...... ....                            ....|+++++||.+||.
T Consensus       336 ilyeml~G~~PF~~~~~~~~~~~i~~~~~~-~~~~----------------------------~~~~s~~~~dli~~~L~  386 (423)
T 4fie_A          336 MVIEMVDGEPPYFNEPPLKAMKMIRDNLPP-RLKN----------------------------LHKVSPSLKGFLDRLLV  386 (423)
T ss_dssp             HHHHHHHSSCTTTTSCHHHHHHHHHHSCCC-CCSC----------------------------TTSSCHHHHHHHHHHSC
T ss_pred             HHHHHHHCCCCCCCcCHHHHHHHHHcCCCC-CCcc----------------------------cccCCHHHHHHHHHHcC
Confidence            999999999999999988887777542211 1011                            11357888999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      .||.+|||++|+|+||||++...+..
T Consensus       387 ~dP~~R~ta~ell~Hp~~~~~~~p~~  412 (423)
T 4fie_A          387 RDPAQRATAAELLKHPFLAKAGPPAS  412 (423)
T ss_dssp             SSTTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             CChhHCcCHHHHhcCHHhcCCCCCcc
Confidence            99999999999999999987655443

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=100.00  E-value=9.6e-52  Score=396.66  Aligned_cols=215  Identities=27%  Similarity=0.427  Sum_probs=185.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+.+|+.|+|||||+++++|.++        +.+|||||||+ |+|.+++.... ..+++..++.|+.||+.||
T Consensus        67 ~~~~~~E~~il~~l~HpnIV~~~~~~~~~--------~~~yiVmEy~~gg~L~~~i~~~~~~~~~e~~~~~~~~qi~~aL  138 (350)
T 4b9d_A           67 REESRREVAVLANMKHPNIVQYRESFEEN--------GSLYIVMDYCEGGDLFKRINAQKGVLFQEDQILDWFVQICLAL  138 (350)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHTTTCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCCCcEEEEEEEC--------CEEEEEEeCCCCCcHHHHHHHcCCCCCCHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999986        66999999997 58999997544 3579999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+|+.+....    ......+||+.|+|||++.+.. |+.++|||||||
T Consensus       139 ~ylH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~GT~~YmAPE~l~~~~-y~~~~DiwSlGv  213 (350)
T 4b9d_A          139 KHVHDRKILHRDIKSQNIFLTKDGTVQLGDFGIARVLNSTV----ELARACIGTPYYLSPEICENKP-YNNKSDIWALGC  213 (350)
T ss_dssp             HHHHHTTCEETTCCGGGEEECTTCCEEECSTTEESCCCHHH----HHHHHHHSCCTTCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             HHHHHCCeeeccCCHHHEEECCCCCEEEcccccceeecCCc----ccccccCCCccccCHHHHCCCC-CCcHHHHHHHHH
Confidence            99999999999999999999999999999999998765321    1234568999999999998765 899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+.+..|......+.                               +...|.++++||.+||+
T Consensus       214 ilyemltG~~PF~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~s~~~~~li~~~L~  262 (350)
T 4b9d_A          214 VLYELCTLKHAFEAGSMKNLVLKIISGSFPPV-------------------------------SLHYSYDLRSLVSQLFK  262 (350)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------------------------------CTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCCcCHHHHHHHHHcCCCCCC-------------------------------CccCCHHHHHHHHHHcc
Confidence            99999999999999998888777755221110                               11257788899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .||.+|||++|+|+||||++.
T Consensus       263 ~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          263 RNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             SSGGGSCCHHHHHTSHHHHTT
T ss_pred             CChhHCcCHHHHhcCHHhhcC
Confidence            999999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=100.00  E-value=6.5e-51  Score=384.52  Aligned_cols=212  Identities=28%  Similarity=0.403  Sum_probs=176.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|++++|||||+++++|.++        +.+|||||||+ |+|.+++.+. ..+++.+++.++.||+.||+|
T Consensus        71 ~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~y  141 (304)
T 3ubd_A           71 VRTKMERDILVEVNHPFIVKLHYAFQTE--------GKLYLILDFLRGGDLFTRLSKE-VMFTEEDVKFYLAELALALDH  141 (304)
T ss_dssp             C------CCCCCCCCTTEECEEEEEEET--------TEEEEEECCCTTCEEHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCeEEEEEEEC--------CEEEEEEEcCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999986        66999999998 5898888764 479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||+|+......    ....+.+||+.|+|||++.+.. |+.++|||||||++
T Consensus       142 lH~~~IiHRDlKp~NILl~~~g~vKl~DFGla~~~~~~~----~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvil  216 (304)
T 3ubd_A          142 LHSLGIIYRDLKPENILLDEEGHIKLTDFGLSKESIDHE----KKAYSFCGTVEYMAPEVVNRRG-HTQSADWWSFGVLM  216 (304)
T ss_dssp             HHHTTCCCSSCCGGGEEECTTSCEEEESSEEEEC---------CCCCSCCCCGGGCCHHHHHTSC-CCTHHHHHHHHHHH
T ss_pred             HHHCCCcCCCCCHHHeEEcCCCCEEecccccceeccCCC----ccccccccCcccCCHHHhccCC-CCCCCcccchHHHH
Confidence            999999999999999999999999999999998754322    2345678999999999998765 89999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |||++|.+||.+.+..+.+..|.+.....                                +...|+++++||.+||+.|
T Consensus       217 yemltG~~PF~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~d  264 (304)
T 3ubd_A          217 FEMLTGTLPFQGKDRKETMTMILKAKLGM--------------------------------PQFLSPEAQSLLRMLFKRN  264 (304)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------------------------------CCcCCHHHHHHHHHHcccC
Confidence            99999999999999888887776521110                                1125778889999999999


Q ss_pred             CCCCCCH-----HHhhcCCCccCC
Q psy7889         247 PSKRFDS-----DAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~-----~e~L~h~~~~~~  265 (433)
                      |++|||+     +|+++||||+.-
T Consensus       265 P~~R~ta~~~~~~eil~Hp~f~~i  288 (304)
T 3ubd_A          265 PANRLGAGPDGVEEIKRHSFFSTI  288 (304)
T ss_dssp             GGGSTTCSTTTHHHHHTSGGGTTC
T ss_pred             HHHCCCCCcCCHHHHHcCccccCC
Confidence            9999984     899999999653

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=100.00  E-value=2.1e-50  Score=392.13  Aligned_cols=249  Identities=26%  Similarity=0.378  Sum_probs=186.5

Q ss_pred             CCchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~   82 (433)
                      .....+.+|+++|+.+ +|||||+++++|.+.        +++|||||||+ ++|.+++.    .+++.+++.++.||+.
T Consensus        61 ~~~~~~~~E~~~l~~~~~h~nIv~l~~~~~~~--------~~~~lvmE~~~g~~L~~~~~----~l~~~~~~~~~~qll~  128 (361)
T 4f9c_A           61 SHPIRIAAELQCLTVAGGQDNVMGVKYCFRKN--------DHVVIAMPYLEHESFLDILN----SLSFQEVREYMLNLFK  128 (361)
T ss_dssp             SCHHHHHHHHHHHHHTCSBTTBCCCSEEEEET--------TEEEEEEECCCCCCHHHHHT----TCCHHHHHHHHHHHHH
T ss_pred             cCHHHHHHHHHHHHHhcCCCCCceEEEEEEEC--------CEEEEEEeCCCcccHHHHHc----CCCHHHHHHHHHHHHH
Confidence            3456789999999998 699999999999886        67999999997 58888773    4899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCC------------------------ccccccCCcc
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNG------------------------QVNRYTNRVV  137 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~------------------------~~~~~~~~~g  137 (433)
                      ||+|||++||+||||||+|||++.+ +.+||+|||+|+........                        ......+.+|
T Consensus       129 al~ylH~~gIiHRDiKPeNiLl~~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~G  208 (361)
T 4f9c_A          129 ALKRIHQFGIVHRDVKPSNFLYNRRLKKYALVDFGLAQGTHDTKIELLKFVQSEAQQERCSQNKCSICLSRRQQVAPRAG  208 (361)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECTTCSCGGGGGC--------------------------CCC
T ss_pred             HHHHHHHCCeEeCcCCHHHeEEeCCCCeEEECcCCCCcccCCcccccccccccccccccccccccccccccccccccccc
Confidence            9999999999999999999999976 79999999999765432110                        1112345689


Q ss_pred             cccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCC-CCCChHHHHHHHHHHhCCCCCCCC--------------Cc
Q psy7889         138 TLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIM-QGNTEQQQITLISQLCGSITPESW--------------PG  202 (433)
Q Consensus       138 t~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~--------------~~  202 (433)
                      |++|+|||++.+...|+.++||||+||++|+|++|++|| .+.++.+++..|..++|.+....+              +.
T Consensus       209 T~~Y~APE~l~~~~~y~~~~DiWSlG~il~ell~G~~Pf~~~~~~~~~l~~I~~~~G~~~~~~~~~~~~~~~~~~~~~p~  288 (361)
T 4f9c_A          209 TPGFRAPEVLTKCPNQTTAIDMWSAGVIFLSLLSGRYPFYKASDDLTALAQIMTIRGSRETIQAAKTFGKSILCSKEVPA  288 (361)
T ss_dssp             CGGGCCHHHHTTCSCCCTHHHHHHHHHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTEEEEESSCCCC
T ss_pred             CccccCHHHHcCCCCCCCccchhhhHHHHHHHHHCCCCCCCCCCHHHHHHHHHHhcCCccchhhhhhccccccccccCcc
Confidence            999999999988777899999999999999999999776 567788899999988885321111              00


Q ss_pred             ccchhhhhccc-----cchHHH---hhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         203 VETLDLYNKME-----LPKAQK---RKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       203 ~~~~~~~~~~~-----~~~~~~---~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .........+.     .+....   ............|++++|||.+||++||++|+|++|+|+||||++-
T Consensus       289 ~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~is~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          289 QDLRKLCERLRGMDSSTPKLTSDIQGHATNLEGWNEVPDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CCHHHHHHHHC----------------------CTTCCHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             hhhhHHHHhhccccccccccccccccccccccccccCCHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            00000000000     000000   0000000112368899999999999999999999999999999763

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=100.00  E-value=5e-50  Score=376.62  Aligned_cols=215  Identities=24%  Similarity=0.343  Sum_probs=175.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+++|+.|+|||||+++++|.+...    ....+|||||||+ |+|.+++.+. ..+++..++.++.||+.||+|
T Consensus        70 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~----~~~~~~lvmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~y  144 (290)
T 3fpq_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVK----GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEEET----TEEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEeeccC----CCcEEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999976421    1366899999998 5898888764 479999999999999999999


Q ss_pred             HHhCC--eeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNK--ILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~--iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++|  |+||||||+|||++. +|.+||+|||+|+....      ....+.+||+.|+|||++.+  .|+.++||||||
T Consensus       145 lH~~~~~IiHRDlKp~NILl~~~~g~vKl~DFGla~~~~~------~~~~~~~GTp~YmAPE~~~~--~y~~~~DiwSlG  216 (290)
T 3fpq_A          145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRA------SFAKAVIGTPEFMAPEMYEE--KYDESVDVYAFG  216 (290)
T ss_dssp             HHTSSSCCCCCCCCGGGEEESSTTSCEEECCTTGGGGCCT------TSBEESCSSCCCCCGGGGGT--CCCTHHHHHHHH
T ss_pred             HHHCCCCEEecccChhheeEECCCCCEEEEeCcCCEeCCC------CccCCcccCccccCHHHcCC--CCCcHHHHHHHH
Confidence            99998  999999999999985 78999999999976432      22345689999999999865  389999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|||++|.+||.+......+....  .....+..                           .+...++++++||.+||
T Consensus       217 vilyelltg~~Pf~~~~~~~~~~~~i--~~~~~~~~---------------------------~~~~~~~~~~~li~~~L  267 (290)
T 3fpq_A          217 MCMLEMATSEYPYSECQNAAQIYRRV--TSGVKPAS---------------------------FDKVAIPEVKEIIEGCI  267 (290)
T ss_dssp             HHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCCCGG---------------------------GGGCCCHHHHHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCCCcHHHHHHHH--HcCCCCCC---------------------------CCccCCHHHHHHHHHHc
Confidence            99999999999998766554433321  11111000                           01124677889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||++|||++|+|+||||++
T Consensus       268 ~~dP~~R~s~~e~l~Hp~~~~  288 (290)
T 3fpq_A          268 RQNKDERYSIKDLLNHAFFQE  288 (290)
T ss_dssp             CSSGGGSCCHHHHHTSGGGC-
T ss_pred             cCChhHCcCHHHHhcCccccC
Confidence            999999999999999999965

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=100.00  E-value=2.3e-49  Score=378.45  Aligned_cols=220  Identities=22%  Similarity=0.257  Sum_probs=177.8

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ..+|+.+|+.|+|||||+++++|.+.        +.+|||||||+ |+|.+++.+. +.+++..++.++.||+.||+|||
T Consensus        97 ~~~E~~il~~l~HpnIV~l~~~~~~~--------~~~~ivmEy~~gg~L~~~l~~~-~~l~e~~~~~~~~qi~~aL~ylH  167 (336)
T 4g3f_A           97 RVEELVACAGLSSPRIVPLYGAVREG--------PWVNIFMELLEGGSLGQLIKQM-GCLPEDRALYYLGQALEGLEYLH  167 (336)
T ss_dssp             CTHHHHTTTTCCCTTBCCEEEEEEET--------TEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHHHH
Confidence            35899999999999999999999986        66999999998 5899988764 47999999999999999999999


Q ss_pred             hCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCc-cccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          89 SNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQ-VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ++||+||||||+|||++.+| .+||+|||+|+.+....... .......+||+.|+|||++.+.. |+.++|||||||++
T Consensus       168 ~~~IiHRDlKp~NILl~~~g~~vKl~DFGla~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-y~~~~DiwSlGvil  246 (336)
T 4g3f_A          168 TRRILHGDVKADNVLLSSDGSRAALCDFGHALCLQPDGLGKSLLTGDYIPGTETHMAPEVVMGKP-CDAKVDIWSSCCMM  246 (336)
T ss_dssp             TTTEECSCCCGGGEEECTTSCCEEECCCTTCEEC------------CCCCCCGGGCCHHHHTTCC-CCTHHHHHHHHHHH
T ss_pred             HCCceecccCHHHEEEeCCCCEEEEeeCCCCeEccCCCcccceecCCccccCccccCHHHHCCCC-CCcHHHHHHHHHHH
Confidence            99999999999999999988 69999999998875432211 11223468999999999998865 89999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |||++|.+||.+.+..+....|...  .++.                           .-.+...++++.+||.+||..|
T Consensus       247 yemltG~~Pf~~~~~~~~~~~i~~~--~~~~---------------------------~~~~~~~s~~~~~li~~~L~~d  297 (336)
T 4g3f_A          247 LHMLNGCHPWTQYFRGPLCLKIASE--PPPI---------------------------REIPPSCAPLTAQAIQEGLRKE  297 (336)
T ss_dssp             HHHHHSSCSSTTTCCSCCHHHHHHS--CCGG---------------------------GGSCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHCcCCCCCCCHHHHHHHHHcC--CCCc---------------------------hhcCccCCHHHHHHHHHHccCC
Confidence            9999999999987766555555431  1000                           0011235788889999999999


Q ss_pred             CCCCCCHHHh-------------hcCCCccCCCCC
Q psy7889         247 PSKRFDSDAA-------------LNHDFFWTDPMP  268 (433)
Q Consensus       247 P~~R~t~~e~-------------L~h~~~~~~~~~  268 (433)
                      |.+|||+.|+             |+|||+.+...|
T Consensus       298 P~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          298 PVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             GGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             HhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            9999999997             689999765544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=100.00  E-value=3.7e-48  Score=376.51  Aligned_cols=290  Identities=79%  Similarity=1.304  Sum_probs=247.3

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .....+++|+.+|+.++||||+++++++......+....+.+|+||||++++|...+......+++..++.++.||+.||
T Consensus        58 ~~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~i~~qi~~~l  137 (351)
T 3mi9_A           58 GFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNGL  137 (351)
T ss_dssp             SSCHHHHHHHHHHHHCCCTTBCCEEEEEEEC--------CEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHH
T ss_pred             cchHHHHHHHHHHHhccCCCcccHhheeeccccccccCCceEEEEEeccCCCHHHHHhhccCCCCHHHHHHHHHHHHHHH
Confidence            34567889999999999999999999999875444444578999999999999999988777899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||++..+...............||+.|+|||++.+...++.++|||||||
T Consensus       138 ~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  217 (351)
T 3mi9_A          138 YYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGC  217 (351)
T ss_dssp             HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCCCSSSSCCCCCSSCSCGGGCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             HHHHHCCeeCCCCCHHHEEEcCCCCEEEccchhcccccccccccccccCCcccccCccCchhhcCCCCCCcHhHHHHHHH
Confidence            99999999999999999999999999999999998776444444445566788999999999987666899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+......+..+....+.++++.|+.......+................+.....++++++||.+||.
T Consensus       218 il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~  297 (351)
T 3mi9_A          218 IMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLV  297 (351)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCGGGTSSCCCSSCCCCHHHHHHHHHCCHHHHHHHHHHSC
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhhccccccchhhcccccccccccCHHHHhhhccCChHHHHHHHHHhc
Confidence            99999999999999999999999999999999999988877766666655544444444444445568889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCCchhHHHHhhhccccccccCCCCCCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGH  294 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (433)
                      .||.+|||++|+|+||||+..+.++.....++.+..++++|..+++....
T Consensus       298 ~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~~~  347 (351)
T 3mi9_A          298 LDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRKHH  347 (351)
T ss_dssp             SSGGGSCCHHHHHTSGGGGSSSCCCCSHHHHHSSCSSHHHHHSCSCC---
T ss_pred             CChhhCCCHHHHhCCCCcCCCCCccccccccCcchHHHHHHhcCCCCCCC
Confidence            99999999999999999999999999999999999999999999876543

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=100.00  E-value=8e-47  Score=388.22  Aligned_cols=220  Identities=24%  Similarity=0.406  Sum_probs=189.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+++|+++|+.|+|||||+++++|.+.        +.+|||||||. |+|.+++.+....+++.+++.++.||+.||+
T Consensus       198 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~--------~~~~iv~E~~~gg~L~~~i~~~~~~l~e~~~~~~~~qi~~al~  269 (573)
T 3uto_A          198 KETVRKEIQTMSVLRHPTLVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC  269 (573)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEECS--------SEEEEEEECCCCCBHHHHHTCTTSCEEHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEEC--------CEEEEEEeecCCCcHHHHHHHhCCCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999876        67999999997 5899999877778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecC--CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKT--GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~--~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.+  +.+||+|||+|+.+...     ......+||+.|+|||++.+.. |+.++||||||
T Consensus       270 ylH~~~iiHRDlKp~Nill~~~~~~~vKl~DFG~a~~~~~~-----~~~~~~~GT~~y~APEv~~~~~-y~~~~DiWSlG  343 (573)
T 3uto_A          270 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK-----QSVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVG  343 (573)
T ss_dssp             HHHHTTEECCCCCGGGEEESSSSCCCEEECCCSSCEECCTT-----SEEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHH
T ss_pred             HHHHCCeeeccCChhhccccCCCCCCEEEeeccceeEccCC-----CceeeeEECccccCHHHhCCCC-CCcHHHHHHHH
Confidence            9999999999999999999854  89999999999887533     2334568999999999998865 89999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+.+..|.......+...|                            ...|.++++||.+||
T Consensus       344 vilyeml~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~dli~~~L  395 (573)
T 3uto_A          344 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----------------------------SGISEDGKDFIRKLL  395 (573)
T ss_dssp             HHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCSGGG----------------------------TTSCHHHHHHHHTTS
T ss_pred             HHHHHHHHCCCCCCCcCHHHHHHHHHhCCCCCCcccc----------------------------cCCCHHHHHHHHHHc
Confidence            9999999999999999998888877654333222111                            125778899999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ..||.+|||++|+|+||||+....+
T Consensus       396 ~~dp~~R~t~~e~l~Hpw~~~~~~~  420 (573)
T 3uto_A          396 LADPNTRMTIHQALEHPWLTPGNAP  420 (573)
T ss_dssp             CSSGGGSCCHHHHHHSTTTSCCCCT
T ss_pred             cCChhHCcCHHHHhcCcCcCCCCCC
Confidence            9999999999999999999865443

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=100.00  E-value=1.8e-46  Score=355.10  Aligned_cols=225  Identities=21%  Similarity=0.369  Sum_probs=162.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccc----cccCceEEEEeecCc-CCHHHHHhccCC--CCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQY----NRYRSTFYLVFDFCE-HDLAGLLSNIHV--KFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~----~~~~~~~~lV~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~ql   80 (433)
                      +.+++|+++|+.|+|||||+++++|.+.....    ......+|||||||. ++|.+++.....  ...+..++.++.||
T Consensus        48 ~~~~~E~~il~~l~HpnIV~~~~~~~~~~~~~~~~~~~~~~~l~ivmE~~~gg~L~~~l~~~~~~~~~~~~~~~~i~~qi  127 (299)
T 4g31_A           48 EKVMREVKALAKLEHPGIVRYFNAWLEKNTTEKLQPSSPKVYLYIQMQLCRKENLKDWMNGRCTIEERERSVCLHIFLQI  127 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEEC----------CEEEEEEEECCCSCCHHHHHHTCCSGGGSCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEecCccccccccCCCcEEEEEEecCCCCcHHHHHHhcCCCChhHHHHHHHHHHHH
Confidence            56889999999999999999999998753210    011345899999997 589888876432  24566789999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc--------cccccCCcccccccCcccccCCCC
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ--------VNRYTNRVVTLWYRPPELLLGDRN  152 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~  152 (433)
                      +.||+|||++||+||||||+|||++.+|.+||+|||+|+.+.......        .....+.+||+.|+|||++.+.. 
T Consensus       128 ~~al~ylH~~~IiHRDlKp~NILl~~~~~vKl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~GT~~YmAPE~~~~~~-  206 (299)
T 4g31_A          128 AEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGDFGLVTAMDQDEEEQTVLTPMPAYARHTGQVGTKLYMSPEQIHGNS-  206 (299)
T ss_dssp             HHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECCCCCC--------------------------CCCTTSCHHHHTTCC-
T ss_pred             HHHHHHHHHCcCccccCcHHHeEECCCCcEEEccCccceecCCCccccccccccccccccCCcccCccccCHHHHcCCC-
Confidence            999999999999999999999999999999999999998875432111        11234568999999999998765 


Q ss_pred             CCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCC
Q psy7889         153 YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD  232 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  232 (433)
                      |+.++|||||||++|||++   ||.+.  .+....+..+....                  ++....          ..+
T Consensus       207 y~~~~DiwSlGvilyell~---Pf~~~--~~~~~~~~~~~~~~------------------~p~~~~----------~~~  253 (299)
T 4g31_A          207 YSHKVDIFSLGLILFELLY---PFSTQ--MERVRTLTDVRNLK------------------FPPLFT----------QKY  253 (299)
T ss_dssp             CCTHHHHHHHHHHHHHHHS---CCSSH--HHHHHHHHHHHTTC------------------CCHHHH----------HHC
T ss_pred             CCCHHHHHHHHHHHHHHcc---CCCCc--cHHHHHHHHHhcCC------------------CCCCCc----------ccC
Confidence            8999999999999999995   66542  23333333322111                  111000          124


Q ss_pred             hhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         233 QYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       233 ~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +...+||.+||+.||.+|||+.|+|+||||++..
T Consensus       254 ~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~  287 (299)
T 4g31_A          254 PCEYVMVQDMLSPSPMERPEAINIIENAVFEDLD  287 (299)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC-
T ss_pred             HHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCC
Confidence            5567999999999999999999999999997643

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=100.00  E-value=6.5e-46  Score=351.16  Aligned_cols=215  Identities=20%  Similarity=0.287  Sum_probs=169.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+|++++|||||++++++..         +.+|||||||+ |+|.+++......+++.++..|+.||+.||+|
T Consensus        77 ~~f~~E~~il~~l~HpNIV~l~g~~~~---------~~~~iVmEy~~gGsL~~~l~~~~~~l~~~~~~~i~~qia~gL~y  147 (307)
T 3omv_A           77 QAFRNEVAVLRKTRHVNILLFMGYMTK---------DNLAIVTQWCEGSSLYKHLHVQETKFQMFQLIDIARQTAQGMDY  147 (307)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS---------SSCEEEEECCSSCBHHHHHHTSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEC---------CeEEEEEEcCCCCCHHHHHhhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999998753         34799999998 58999998777789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv  164 (433)
                      ||++|||||||||+|||++.++.+||+|||+|+.......  .......+||+.|+|||++.+.  ..|+.++|||||||
T Consensus       148 LH~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~GT~~ymAPE~l~~~~~~~y~~ksDVwS~Gv  225 (307)
T 3omv_A          148 LHAKNIIHRDMKSNNIFLHEGLTVKIGDFGLATVKSRWSG--SQQVEQPTGSVLWMAPEVIRMQDNNPFSFQSDVYSYGI  225 (307)
T ss_dssp             HHHTTCBCSCCCSSSEEEETTEEEEECCCSSCBC--------------CCCCTTSCCHHHHHCCSSCCCCHHHHHHHHHH
T ss_pred             HHHCCccCCccCHHHEEECCCCcEEEeeccCceecccCCc--ceeecccccCCCccCHHHhhccCCCCCCcHHHhHhHHH
Confidence            9999999999999999999999999999999987653221  1234456899999999999653  24899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+....+..+... +...+. .+.                        .+...+.++.+||.+||+
T Consensus       226 vl~Elltg~~Pf~~~~~~~~~~~~~~~-~~~~p~-~~~------------------------~~~~~~~~l~~li~~cl~  279 (307)
T 3omv_A          226 VLYELMTGELPYSHINNRDQIIFMVGR-GYASPD-LSK------------------------LYKNCPKAMKRLVADCVK  279 (307)
T ss_dssp             HHHHHHHSSCTTTTCCCHHHHHHHHHT-TCCCCC-STT------------------------SCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhc-CCCCCC-ccc------------------------ccccchHHHHHHHHHHcC
Confidence            999999999999987766655544331 111110 000                        011245677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.|++++
T Consensus       280 ~dP~~RPs~~ei~~~  294 (307)
T 3omv_A          280 KVKEERPLFPQILSS  294 (307)
T ss_dssp             SSSTTSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999988654

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=100.00  E-value=3.5e-45  Score=349.71  Aligned_cols=245  Identities=41%  Similarity=0.711  Sum_probs=204.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        ..+|+||||++++|.+.+......+++..++.++.||+.||+|
T Consensus        63 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  134 (311)
T 3niz_A           63 PSTAIREISLLKELHHPNIVSLIDVIHSE--------RCLTLVFEFMEKDLKKVLDENKTGLQDSQIKIYLYQLLRGVAH  134 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCS--------SCEEEEEECCSEEHHHHHHTCTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCEeeeeeEEccC--------CEEEEEEcCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        5699999999999999998877779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......    .......+|+.|+|||++.+...++.++|||||||++
T Consensus       135 LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  210 (311)
T 3niz_A          135 CHQHRILHRDLKPQNLLINSDGALKLADFGLARAFGIPV----RSYTHEVVTLWYRAPDVLMGSKKYSTSVDIWSIGCIF  210 (311)
T ss_dssp             HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEETTSCC----C---CCCCCCTTCCHHHHTTCCSCCTHHHHHHHHHHH
T ss_pred             HHHCCcccCCCchHhEEECCCCCEEEccCcCceecCCCc----ccccCCcccCCcCCHHHhcCCCCCCchHHhHHHHHHH
Confidence            999999999999999999999999999999998764322    2234457899999999998766689999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+....+.+..+....+.+.+..|+.......+.................  ...+.++++||.+||..|
T Consensus       211 ~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  288 (311)
T 3niz_A          211 AEMITGKPLFPGVTDDDQLPKIFSILGTPNPREWPQVQELPLWKQRTFQVFEKKPWSSII--PGFCQEGIDLLSNMLCFD  288 (311)
T ss_dssp             HHHHHSSCSCCCSSTTTHHHHHHHHHCCCCTTTSGGGTTSHHHHSCCCCCCCCCCHHHHS--TTCCHHHHHHHHHHSCSC
T ss_pred             HHHHhCCCCCCCCChHHHHHHHHHHHCCCChHHhhhhhccchhhhcccccccCCcHHHhC--cccCHHHHHHHHHHcCCC
Confidence            999999999999999999999999999999988877665443332221111111111111  135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|||++|+|+||||++.
T Consensus       289 P~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          289 PNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             TTTSCCHHHHHTSGGGTTS
T ss_pred             hhHCCCHHHHhcCcccccC
Confidence            9999999999999999753

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=100.00  E-value=8.4e-46  Score=350.13  Aligned_cols=211  Identities=21%  Similarity=0.378  Sum_probs=176.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC------------CCCCHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH------------VKFSLGEIK   74 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~------------~~l~~~~~~   74 (433)
                      +.+++|+++|++|+|||||++++++.+.        +.+|||||||+ |+|.+++.+..            ..+++.++.
T Consensus        60 ~~f~~E~~il~~l~HpnIV~l~g~~~~~--------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~l~~~~~~  131 (299)
T 4asz_A           60 KDFHREAELLTNLQHEHIVKFYGVCVEG--------DPLIMVFEYMKHGDLNKFLRAHGPDAVLMAEGNPPTELTQSQML  131 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS--------SSEEEEEECCTTCBHHHHHHHTSHHHHHC----CCCCCCHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEeeC--------CEEEEEEEcCCCCcHHHHHHhcCcccccccccCCCCCCCHHHHH
Confidence            5688999999999999999999999876        55999999997 58999987532            359999999


Q ss_pred             HHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCC
Q psy7889          75 KVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYG  154 (433)
Q Consensus        75 ~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~  154 (433)
                      .++.||+.||+|||+++|+||||||+|||++.++.+||+|||+|+.......  ........||+.|+|||++.+.. |+
T Consensus       132 ~i~~qia~gl~yLH~~~iiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~-~~  208 (299)
T 4asz_A          132 HIAQQIAAGMVYLASQHFVHRDLATRNCLVGENLLVKIGDFGMSRDVYSTDY--YRVGGHTMLPIRWMPPESIMYRK-FT  208 (299)
T ss_dssp             HHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--EEETTTEEECGGGCCHHHHHHCC-CC
T ss_pred             HHHHHHHHHHHHHHhCCcccCccCHhhEEECCCCcEEECCcccceecCCCCc--eeecCceecChhhcCHHHHcCCC-CC
Confidence            9999999999999999999999999999999999999999999987643221  11223356899999999998765 89


Q ss_pred             CcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         155 PPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      .++||||+||++|||+| |++||.+.+..+.+..+........                               |...+.
T Consensus       209 ~k~DVwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~  257 (299)
T 4asz_A          209 TESDVWSLGVVLWEIFTYGKQPWYQLSNNEVIECITQGRVLQR-------------------------------PRTCPQ  257 (299)
T ss_dssp             HHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHHTCCCCC-------------------------------CTTCCH
T ss_pred             chhhHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccchH
Confidence            99999999999999998 8999999988887777654221111                               112456


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      ++.+|+.+||+.||++|||++|++  +|+
T Consensus       258 ~~~~li~~cl~~dP~~RPs~~~i~--~~L  284 (299)
T 4asz_A          258 EVYELMLGCWQREPHMRKNIKGIH--TLL  284 (299)
T ss_dssp             HHHHHHHHHTCSSGGGSCCHHHHH--HHH
T ss_pred             HHHHHHHHHcCCChhHCcCHHHHH--HHH
Confidence            778999999999999999999994  455

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=100.00  E-value=3.3e-45  Score=350.68  Aligned_cols=210  Identities=21%  Similarity=0.386  Sum_probs=169.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC--------------CCCCHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH--------------VKFSLGE   72 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~--------------~~l~~~~   72 (433)
                      +.+++|+++|++|+|||||++++++.+.        +.+|||||||+ |+|.+++.+..              ..+++.+
T Consensus        88 ~~f~~E~~il~~l~HpnIV~l~g~~~~~--------~~~~lV~Ey~~~G~L~~~l~~~~~~~~~~~~~~~~~~~~l~~~~  159 (329)
T 4aoj_A           88 QDFQREAELLTMLQHQHIVRFFGVCTEG--------RPLLMVFEYMRHGDLNRFLRSHGPDAKLLAGGEDVAPGPLGLGQ  159 (329)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS--------SSEEEEEECCTTCBHHHHHHTSSCC-----------CCSCCHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEEcCCCCcHHHHHHhcCcccccccccccccCCCCCHHH
Confidence            5689999999999999999999999875        55999999998 58999887542              3589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC
Q psy7889          73 IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN  152 (433)
Q Consensus        73 ~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (433)
                      +..|+.||+.||+|||+++|+||||||+|||++.++.+||+|||+++.......  .......+||+.|+|||++.+.. 
T Consensus       160 ~~~i~~qia~gl~yLH~~~iiHRDLKp~NILl~~~~~~Ki~DFGla~~~~~~~~--~~~~~~~~gt~~ymAPE~~~~~~-  236 (329)
T 4aoj_A          160 LLAVASQVAAGMVYLAGLHFVHRDLATRNCLVGQGLVVKIGDFGMSRDIYSTDY--YRVGGRTMLPIRWMPPESILYRK-  236 (329)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEEETTTEEEECCCC------------------CCCCGGGCCHHHHTTCC-
T ss_pred             HHHHHHHHHHHHHHHhcCCeecccccHhhEEECCCCcEEEcccccceeccCCCc--ceecCcccccccccChhhhcCCC-
Confidence            999999999999999999999999999999999999999999999987643221  12234467899999999998765 


Q ss_pred             CCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC
Q psy7889         153 YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK  231 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (433)
                      |+.++|||||||++|||+| |++||.+.+..+.+..+........                               |...
T Consensus       237 ~~~~sDvwS~Gvvl~Ellt~G~~Pf~~~~~~~~~~~i~~g~~~~~-------------------------------p~~~  285 (329)
T 4aoj_A          237 FTTESDVWSFGVVLWEIFTYGKQPWYQLSNTEAIDCITQGRELER-------------------------------PRAC  285 (329)
T ss_dssp             CCHHHHHHHHHHHHHHHHTTSCCTTCSSCHHHHHHHHHHTCCCCC-------------------------------CTTC
T ss_pred             CCccccccchHHHHHHHHcCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------cccc
Confidence            8999999999999999998 8999999988887777654221111                               1124


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ++++.+|+.+||+.||++|||++|++++
T Consensus       286 ~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          286 PPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            5677899999999999999999999863

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=100.00  E-value=2e-45  Score=376.66  Aligned_cols=212  Identities=23%  Similarity=0.328  Sum_probs=173.0

Q ss_pred             hHHHH---HHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           9 TALRE---IKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         9 ~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+++|   +.+++.++|||||+++++|.+.        +.+|||||||. |+|..++.+. +.+++..++.|+.||+.||
T Consensus       235 ~~~~E~~~l~ll~~~~HP~IV~l~~~f~~~--------~~lylVmEy~~GGdL~~~l~~~-~~l~E~~a~~y~~qIl~aL  305 (689)
T 3v5w_A          235 LALNERIMLSLVSTGDCPFIVCMSYAFHTP--------DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGL  305 (689)
T ss_dssp             HHHHHHHHHHHHSSSCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-CCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhCCCCCEeEEEEEEEEC--------CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            34455   5666777999999999999986        66999999997 5899888764 5799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++|||||||||+|||++.+|.+||+|||+|+.+...      ...+.+||+.|+|||++.+...|+.++|||||||
T Consensus       306 ~yLH~~gIiHRDLKPeNILld~~G~vKL~DFGlA~~~~~~------~~~t~~GTp~YmAPEvl~~~~~y~~~vDiWSLGv  379 (689)
T 3v5w_A          306 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC  379 (689)
T ss_dssp             HHHHTTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHH
T ss_pred             HHHHHCCccccCCchHHeEEeCCCCEEecccceeeecCCC------CCCCccCCcCccCHHHHhCCCCCCcHHHHHHHHH
Confidence            9999999999999999999999999999999999876532      2345799999999999976556899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+....+....... ..                            .+...|+++++||.+||+
T Consensus       380 ilYEmLtG~~PF~~~~~~~~~~i~~~i~~~~-~~----------------------------~p~~~S~~a~dLI~~lL~  430 (689)
T 3v5w_A          380 MLFKLLRGHSPFRQHKTKDKHEIDRMTLTMA-VE----------------------------LPDSFSPELRSLLEGLLQ  430 (689)
T ss_dssp             HHHHHHHSSCTTCGGGCCCHHHHHHHHHHCC-CC----------------------------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCCCCCCChHHHHHHHHhhcCCC-CC----------------------------CCccCCHHHHHHHHHHcc
Confidence            9999999999998643222111111111100 00                            012357889999999999


Q ss_pred             cCCCCCCC-----HHHhhcCCCccC
Q psy7889         245 LDPSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t-----~~e~L~h~~~~~  264 (433)
                      .||.+|++     ++|+++||||..
T Consensus       431 ~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          431 RDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             SCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             CCHhHCCCCCCCCHHHHhcCccccC
Confidence            99999998     799999999965

>4gt4_A Tyrosine-protein kinase transmembrane receptor RO; ATP binding, phosphorylation, transferase; 2.41A {Homo sapiens} PDB: 3zzw_A

Probab=100.00  E-value=5.2e-45  Score=346.17  Aligned_cols=211  Identities=19%  Similarity=0.319  Sum_probs=176.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---------------CCCCCH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---------------HVKFSL   70 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---------------~~~l~~   70 (433)
                      .+.+++|+.+|++|+|||||++++++.++        +.+|||||||+ |+|.+++...               ...+++
T Consensus        73 ~~~f~~E~~il~~l~HpNIV~l~g~~~~~--------~~~~lV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~  144 (308)
T 4gt4_A           73 REEFRHEAMLRARLQHPNVVCLLGVVTKD--------QPLSMIFSYCSHGDLHEFLVMRSPHSDVGSTDDDRTVKSALEP  144 (308)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCSSCBHHHHHHTTCSSCCCC-----CCEECCCCH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcceEEEEC--------CEEEEEEEcCCCCcHHHHHHhhCccccccccccccccccCCCH
Confidence            46789999999999999999999999876        45899999997 5899998643               235899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+++......  ........+||+.|+|||++.+.
T Consensus       145 ~~~~~i~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~~Ki~DFGlar~~~~~~--~~~~~~~~~gt~~ymAPE~l~~~  222 (308)
T 4gt4_A          145 PDFVHLVAQIAAGMEYLSSHHVVHKDLATRNVLVYDKLNVKISDLGLFREVYAAD--YYKLLGNSLLPIRWMAPEAIMYG  222 (308)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCSCCBCGGGGGG--CBCSSSSSCBCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCCCCCccccceEECCCCCEEECCcccceeccCCC--ceeEecccccCCcccCHHHHhCC
Confidence            9999999999999999999999999999999999999999999999998765322  12234456889999999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . |+.++||||+||++|||+| |.+||.+.+..+.+..+......+.+                               .
T Consensus       223 ~-~s~ksDVwSfGvvl~El~t~g~~Pf~~~~~~~~~~~i~~~~~~~~p-------------------------------~  270 (308)
T 4gt4_A          223 K-FSIDSDIWSYGVVLWEVFSYGLQPYCGYSNQDVVEMIRNRQVLPCP-------------------------------D  270 (308)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTTCCTTTTCCHHHHHHHHHTTCCCCCC-------------------------------T
T ss_pred             C-CCccchhhhHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCCc-------------------------------c
Confidence            5 8999999999999999998 89999999888777666432111111                               1


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+|+.+||+.||.+|||+.|++++
T Consensus       271 ~~~~~~~~li~~C~~~dP~~RPs~~ei~~~  300 (308)
T 4gt4_A          271 DCPAWVYALMIECWNEFPSRRPRFKDIHSR  300 (308)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cchHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            235667799999999999999999999865

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=100.00  E-value=1.5e-43  Score=339.35  Aligned_cols=249  Identities=41%  Similarity=0.702  Sum_probs=203.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-----CCCCHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-----VKFSLGEIKKVIQQL   80 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-----~~l~~~~~~~i~~ql   80 (433)
                      ....+.+|+.+|+.++|||||++++++.+.        +.+|+||||++++|.+++....     ..+++..++.++.||
T Consensus        46 ~~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~qi  117 (317)
T 2pmi_A           46 TPSTAIREISLMKELKHENIVRLYDVIHTE--------NKLTLVFEFMDNDLKKYMDSRTVGNTPRGLELNLVKYFQWQL  117 (317)
T ss_dssp             SCHHHHHHHHHHTTCCBTTBCCEEEEECCT--------TEEEEEEECCCCBHHHHHHHHHSSSCCCCCCHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCcceEEEEEEEC--------CeEEEEEEecCCCHHHHHHhccccccccCCCHHHHHHHHHHH
Confidence            456789999999999999999999999875        6699999999999999886532     358999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.||.|||++||+||||||+|||++.++.+||+|||++.......    .......+|+.|+|||++.+...++.++|||
T Consensus       118 ~~aL~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diw  193 (317)
T 2pmi_A          118 LQGLAFCHENKILHRDLKPQNLLINKRGQLKLGDFGLARAFGIPV----NTFSSEVVTLWYRAPDVLMGSRTYSTSIDIW  193 (317)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEECTTCCEEECCCSSCEETTSCC----CCCCCCCSCCTTCCHHHHTTCCCCCTHHHHH
T ss_pred             HHHHHHHHHCCeeeCCCChHHeEEcCCCCEEECcCccceecCCCc----ccCCCCcccccccCchHhhCCCCCCcHHHHH
Confidence            999999999999999999999999999999999999997764321    2234557899999999998765689999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-c-cchHHHhhHHhhhCCccCChhHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-E-LPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~-~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||||++|+|++|.+||.+.+..+.+..+....|.+....|+.......+... . .+............+...+.++++|
T Consensus       194 slG~il~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~l  273 (317)
T 2pmi_A          194 SCGCILAEMITGKPLFPGTNDEEQLKLIFDIMGTPNESLWPSVTKLPKYNPNIQQRPPRDLRQVLQPHTKEPLDGNLMDF  273 (317)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCSCCTTTCGGGGGCTTCCTTCCCCCCCCSHHHHGGGCSSCCCHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCChhHhhhhhhhhhcccccccccchhHHHhhcccccccCCHHHHHH
Confidence            9999999999999999999999999999999999888888765543322110 0 0000000111111223467889999


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+||+.||.+|||++|+|+||||.+..
T Consensus       274 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~  301 (317)
T 2pmi_A          274 LHGLLQLNPDMRLSAKQALHHPWFAEYY  301 (317)
T ss_dssp             HHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             HHHHCCCCcccCCCHHHHhCChhhhccc
Confidence            9999999999999999999999997644

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=100.00  E-value=1.2e-43  Score=335.77  Aligned_cols=244  Identities=39%  Similarity=0.692  Sum_probs=202.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +.+|+||||+++++...+......+++..++.++.||+.||+|
T Consensus        45 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~l~~~~~~~~~~ql~~~l~~  116 (292)
T 3o0g_A           45 PSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF  116 (292)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHhcCCCCCEeeEEeEEEeC--------CEEEEEEecCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            36788999999999999999999999876        6699999999999999998877789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    .......||+.|+|||++.+...++.++||||+||++
T Consensus       117 lH~~~ivH~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il  192 (292)
T 3o0g_A          117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF  192 (292)
T ss_dssp             HHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCSCC----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             HHhCCeecCCCCHHHEEEcCCCCEEEeecccceecCCcc----ccccCCccccCCcChHHHcCCCCcCchHHHHHHHHHH
Confidence            999999999999999999999999999999998764321    2334567899999999998776689999999999999


Q ss_pred             HHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++| .|+|.+.+..+.+..+....+.+....|+.......+........... .  .......+.++++||.+||+.
T Consensus       193 ~~l~~~~~p~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~--~~~~~~~~~~~~~li~~~L~~  269 (292)
T 3o0g_A          193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTS-L--VNVVPKLNATGRDLLQNLLKC  269 (292)
T ss_dssp             HHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTCC-C--TTTSTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHcCCCCcCCCCHHHHHHHHHHHhCCCChhhhhhhcccccccccccccCCcc-h--hhcccccChHHHHHHHHHhcc
Confidence            999976 556888888999999999999999888877655433221111100000 0  000113578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||.+|||++|+|+||||.+.
T Consensus       270 dP~~R~t~~e~l~hp~f~~~  289 (292)
T 3o0g_A          270 NPVQRISAEEALQHPYFSDF  289 (292)
T ss_dssp             SGGGSCCHHHHHTSGGGTTC
T ss_pred             ChhhCCCHHHHhcCcccccC
Confidence            99999999999999999764

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=100.00  E-value=2.7e-44  Score=345.52  Aligned_cols=244  Identities=41%  Similarity=0.728  Sum_probs=202.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++||||+++++++.+.        +.+|+||||++++|.+++......+++..++.++.||+.||.||
T Consensus        45 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~aL~~L  116 (324)
T 3mtl_A           45 CTAIREVSLLKDLKHANIVTLHDIIHTE--------KSLTLVFEYLDKDLKQYLDDCGNIINMHNVKLFLFQLLRGLAYC  116 (324)
T ss_dssp             CCCCCCHHHHSCCCCTTBCCEEEEEECS--------SCEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhcCCCCCCeeeeEEeeC--------CEEEEEecccccCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3556899999999999999999999875        56999999999999999988777799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++.......    .......+|+.|+|||++.+...++.++|||||||++|
T Consensus       117 H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  192 (324)
T 3mtl_A          117 HRQKVLHRDLKPQNLLINERGELKLADFGLARAKSIPT----KTYDNEVVTLWYRPPDILLGSTDYSTQIDMWGVGCIFY  192 (324)
T ss_dssp             HHTTEEESSCCGGGEEECTTCCEEECSSSEEECC----------------CGGGCCHHHHTTCCCCCTHHHHHHHHHHHH
T ss_pred             HHCCccCCCcCHHHEEECCCCCEEEccCcccccccCCc----cccccccCcccccChhhhcCCCCCCcHHHHHHHHHHHH
Confidence            99999999999999999999999999999997654321    22344577999999999987666899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|.+||.+.+..+.+..+....+.+....|+.......+.....+..........  ....+.++++||.+||+.||
T Consensus       193 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~dP  270 (324)
T 3mtl_A          193 EMATGRPLFPGSTVEEQLHFIFRILGTPTEETWPGILSNEEFKTYNYPKYRAEALLSH--APRLDSDGADLLTKLLQFEG  270 (324)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGCHHHHHTCCCCCCCCCHHHH--CTTSCHHHHHHHHHHSCSSG
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCChHhchhhhcchhhcccccccccchhhhhh--cCCCCHHHHHHHHHHcCcCc
Confidence            9999999999999999999999999999999998776655544443332221111111  12367889999999999999


Q ss_pred             CCCCCHHHhhcCCCccCC
Q psy7889         248 SKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~~~~  265 (433)
                      .+|||++|+|+||||.+.
T Consensus       271 ~~R~t~~e~l~hp~f~~~  288 (324)
T 3mtl_A          271 RNRISAEDAMKHPFFLSL  288 (324)
T ss_dssp             GGSCCHHHHTTSGGGGGG
T ss_pred             ccCCCHHHHhcChhhhhc
Confidence            999999999999999654

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=100.00  E-value=9.1e-44  Score=336.01  Aligned_cols=244  Identities=39%  Similarity=0.706  Sum_probs=198.7

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.+++.++||||+++++++.+.        +.+|+||||++++|.+++......+++..++.++.||+.||+
T Consensus        43 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~  114 (288)
T 1ob3_A           43 IPSTTIREISILKELKHSNIVKLYDVIHTK--------KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGIA  114 (288)
T ss_dssp             CCHHHHHHHHGGGGCCCTTBCCEEEEEECS--------SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHhcCCCCEeeeeeEEccC--------CeEEEEEEecCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHH
Confidence            346788999999999999999999999875        569999999999999999887778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......    .......+|+.|+|||++.+...++.++|||||||+
T Consensus       115 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  190 (288)
T 1ob3_A          115 YCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCI  190 (288)
T ss_dssp             HHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHHH
T ss_pred             HHHHCCeecCCCCHHHEEEcCCCCEEEeECccccccCccc----cccccccccccccCchheeCCCCCCcHHHHHHHHHH
Confidence            9999999999999999999999999999999997654221    223445779999999999876668999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+....+.+....|+.......+... ...........  .....+.++++||.+||..
T Consensus       191 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~  267 (288)
T 1ob3_A          191 FAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN-FTVYEPLPWES--FLKGLDESGIDLLSKMLKL  267 (288)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT-CCCCCCCCGGG--TCCSCCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHHCCCChhhchhhhcccccccc-cccccCccHHH--HhhhcCHHHHHHHHHHcCC
Confidence            99999999999999999999999999999888888765443221100 00000000000  0123578889999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||++|||++|+|+||||.+
T Consensus       268 dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          268 DPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             STTTSCCHHHHHTSGGGGC
T ss_pred             CcccCCCHHHHhcCcchhh
Confidence            9999999999999999965

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1e-43  Score=349.97  Aligned_cols=251  Identities=33%  Similarity=0.529  Sum_probs=194.8

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.+. |||||++++++.....      ..+|+|||||+++|...+..  ..+++..++.++.||+.||+|
T Consensus        53 ~~~~~E~~~l~~l~~h~niv~l~~~~~~~~~------~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~i~~qi~~~L~~  124 (388)
T 3oz6_A           53 QRTFREIMILTELSGHENIVNLLNVLRADND------RDVYLVFDYMETDLHAVIRA--NILEPVHKQYVVYQLIKVIKY  124 (388)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECTTS------SCEEEEEECCSEEHHHHHHH--TCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCCCeeeeEEecCCC------CEEEEEecccCcCHHHHHHc--CCCCHHHHHHHHHHHHHHHHH
Confidence            45789999999997 9999999999986532      56999999999999998876  368999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC-----------------CccccccCCcccccccCcccccC
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN-----------------GQVNRYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-----------------~~~~~~~~~~gt~~y~aPE~~~~  149 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+.....                 .........+||++|+|||++.+
T Consensus       125 LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  204 (388)
T 3oz6_A          125 LHSGGLLHRDMKPSNILLNAECHVKVADFGLSRSFVNIRRVTNNIPLSINENTENFDDDQPILTDYVATRWYRAPEILLG  204 (388)
T ss_dssp             HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEESSSCCCCCCCGGGCCC---------------CCCGGGGCCHHHHTT
T ss_pred             HHhCCEEeCCCCHHHeEEcCCCCEEecCCcccccccccccccccccccccccccccccccccccCCcccCCcCCHHHhcC
Confidence            9999999999999999999999999999999976543110                 01122345689999999999987


Q ss_pred             CCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc------------c---
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME------------L---  214 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~------------~---  214 (433)
                      ...|+.++|||||||++|+|++|.+||.+.+..+++..|...++.+..+.+...........+.            .   
T Consensus       205 ~~~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  284 (388)
T 3oz6_A          205 STKYTKGIDMWSLGCILGEILCGKPIFPGSSTMNQLERIIGVIDFPSNEDVESIQSPFAKTMIESLKEKVEIRQSNKRDI  284 (388)
T ss_dssp             CCCCCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHTSCCSSHHHHHHHHHHHCC-----CCCC
T ss_pred             CCCCCChhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHhccCHHHHHHHHhCcccccccCCCHHHh
Confidence            6668999999999999999999999999999999999999999887654332221110000000            0   


Q ss_pred             chHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         215 PKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       215 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      -..-.............++++++||.+||.+||.+|||++|+|+||||....
T Consensus       285 ~~~~~~~~~~~~~~~~~~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~~  336 (388)
T 3oz6_A          285 FTKWKNLLLKINPKADCNEEALDLLDKLLQFNPNKRISANDALKHPFVSIFH  336 (388)
T ss_dssp             HHHHHHHHHHHCTTCCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTTC
T ss_pred             CcchhhhcccccccccCCHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHhc
Confidence            0000001111112224688999999999999999999999999999996543

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=100.00  E-value=6e-44  Score=344.76  Aligned_cols=211  Identities=22%  Similarity=0.384  Sum_probs=171.5

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+++|+++|++++ |||||+++++|..+       ...+|||||||+ |+|.+++.+..               ..+++
T Consensus       112 ~~~~~E~~il~~l~hhpnIV~l~g~~~~~-------~~~~~iV~Ey~~~G~L~~~L~~~~~~~~~~~~~~~~~~~~~l~~  184 (353)
T 4ase_A          112 RALMSELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL  184 (353)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCT-------TSCCEEEEECCTTEEHHHHHHHTGGGBCCC-------CTTCBCH
T ss_pred             HHHHHHHHHHHHcCCCCcEEEEEEEEEec-------CCEEEEEEEcCCCCCHHHHHHhcccccccccccchhhccccCCH
Confidence            45889999999996 59999999998764       245899999998 58999986532               34899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..+..++.||+.||+|||+++||||||||+|||++.++.+||+|||+|+.+.....  .......+||+.|+|||++.+.
T Consensus       185 ~~~~~~~~qia~gl~yLH~~~iiHRDLK~~NILl~~~~~vKi~DFGlar~~~~~~~--~~~~~~~~gt~~ymAPE~l~~~  262 (353)
T 4ase_A          185 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDR  262 (353)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHhHhhCCeecCccCccceeeCCCCCEEECcchhhhhcccCCC--ceeeccccccccccCHHHHhcC
Confidence            99999999999999999999999999999999999999999999999987653321  1233456789999999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHH-HHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITL-ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP  228 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~-i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (433)
                      . |+.++||||+||++|||+| |.+||.+....+.+.. +........                               |
T Consensus       263 ~-y~~ksDVwS~Gv~l~El~t~G~~Pf~~~~~~~~~~~~i~~g~~~~~-------------------------------p  310 (353)
T 4ase_A          263 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMRA-------------------------------P  310 (353)
T ss_dssp             C-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHHTCCCCC-------------------------------C
T ss_pred             C-CCCcccEeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHHcCCCCCC-------------------------------C
Confidence            5 8999999999999999998 8999998664443333 322111110                               1


Q ss_pred             ccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         229 YVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       229 ~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ...++++.+|+.+||+.||++|||+.|+++|
T Consensus       311 ~~~~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          311 DYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             TTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            1246678899999999999999999999987

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=100.00  E-value=1.8e-43  Score=355.80  Aligned_cols=253  Identities=34%  Similarity=0.611  Sum_probs=190.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++|||||++++++.....   .....+|+||||++++|..++.. ...+++..++.++.||+.||+||
T Consensus        97 ~~~~~E~~~l~~l~h~niv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~~~~qi~~aL~~L  172 (458)
T 3rp9_A           97 KRILREIAILNRLNHDHVVKVLDIVIPKDV---EKFDELYVVLEIADSDFKKLFRT-PVYLTELHIKTLLYNLLVGVKYV  172 (458)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCT---TTCCCEEEEECCCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCceEEEEecCCc---ccCceEEEEEeccccchhhhccc-CCCCCHHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999965421   11366999999999999998876 34699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-----------------------cccccCCcccccccCc
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-----------------------VNRYTNRVVTLWYRPP  144 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-----------------------~~~~~~~~gt~~y~aP  144 (433)
                      |++||+||||||+|||++.++.+||+|||+++.........                       .......+||++|+||
T Consensus       173 H~~~iiHrDlKp~NILl~~~~~~kl~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~aP  252 (458)
T 3rp9_A          173 HSAGILHRDLKPANCLVNQDCSVKVCDFGLARTVDYPENGNSQLPISPREDDMNLVTFPHTKNLKRQLTGHVVTRWYRAP  252 (458)
T ss_dssp             HHTTCBCCCCCGGGEEECTTCCEEECCCTTCBCTTSCTTCCCCCC---------------------------CCCTTCCH
T ss_pred             HhCCcCCCCCChhhEEECCCCCEeecccccchhccCccccccccccCccccccccccccccccccccccCCcccccccCh
Confidence            99999999999999999999999999999998765322110                       0123456889999999


Q ss_pred             ccccCCCCCCCcchhhhHHHHHHHHHh-----------cCCCCCCCC--------------------hHHHHHHHHHHhC
Q psy7889         145 ELLLGDRNYGPPVDLWGAGCIMAEMWT-----------RSPIMQGNT--------------------EQQQITLISQLCG  193 (433)
Q Consensus       145 E~~~~~~~~~~~~DiwSlGvil~ell~-----------g~~pf~~~~--------------------~~~~~~~i~~~~g  193 (433)
                      |++.....|+.++|||||||++|||++           |.++|.+.+                    ..+++..|..++|
T Consensus       253 E~~~~~~~~~~~~DiwSlG~il~elltg~~~~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~~~~~l~~i~~~~g  332 (458)
T 3rp9_A          253 ELILLQENYTEAIDVWSIGCIFAELLNMIKENVAYHADRGPLFPGSSCFPLSPDQKAGNDFKFHTRGNRDQLNVIFNILG  332 (458)
T ss_dssp             HHHTTCCCCCTHHHHHHHHHHHHHHHTTSTTTCSSGGGCCCSCC--------------------CHHHHHHHHHHHHHHC
T ss_pred             HHhhCCCCCCcHhHHHHHHHHHHHHHHhccccccccccccccCCCCccccccccccccccccccccCCHHHHHHHHHHcC
Confidence            988666668999999999999999998           888888765                    3577888888899


Q ss_pred             CCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         194 SITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       194 ~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+..+.+............. .+..........+  -..+.++++||.+||.+||.+|||++|+|+||||....
T Consensus       333 ~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          333 TPSEEDIEALEKEDAKRYIRIFPKREGTDLAERF--PASSADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             CCCHHHHHTSSCHHHHHHHTTSCCCCCCCGGGGS--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CCCHHHHhhcCCHHHHHHHHhcCCCCCCCHHHHC--CCCCHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            87765443332221111100 0000000011111  12478899999999999999999999999999997644

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=100.00  E-value=1.6e-43  Score=356.19  Aligned_cols=248  Identities=28%  Similarity=0.472  Sum_probs=189.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+|+.++|||||++++++.....  ......+||||||+++++...+..   .+++..++.++.||+.||+|
T Consensus       105 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~~~~~~~lv~E~~~~~l~~~~~~---~l~~~~~~~~~~qil~aL~~  179 (464)
T 3ttj_A          105 AKRAYRELVLMKCVNHKNIISLLNVFTPQKT--LEEFQDVYLVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKH  179 (464)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCCSEEECSCCS--TTTCCEEEEEEECCSEEHHHHHTS---CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEccCCc--cccCCeEEEEEeCCCCCHHHHHhh---cCCHHHHHHHHHHHHHHHHH
Confidence            3567899999999999999999999976522  112367899999999998887754   58999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.....     ......+||++|+|||++.+.. |+.++|||||||++
T Consensus       180 lH~~~iiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~il  253 (464)
T 3ttj_A          180 LHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIM  253 (464)
T ss_dssp             HHHTTCCCCCCCGGGEEECTTSCEEECCCCCC-----C-----CCC----CCCTTCCHHHHTTCC-CCTTHHHHHHHHHH
T ss_pred             HHHCCcccCCCChHhEEEeCCCCEEEEEEEeeeecCCC-----cccCCCcccccccCHHHHcCCC-CCHHHHHHHHHHHH
Confidence            99999999999999999999999999999999876432     2344568899999999998865 89999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc----------cCChhHH
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY----------VKDQYGC  236 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----------~~s~~~~  236 (433)
                      |+|++|.+||.+.+..+++..|...+|.+.++.+..............+..........+...          ..+.+++
T Consensus       254 ~ell~g~~pF~g~~~~~~~~~i~~~lg~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  333 (464)
T 3ttj_A          254 GEMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQAR  333 (464)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTSCHHHHHHHTTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHH
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHcchhhhhHhhcccccCCCChHHhCcccccccccccccccCHHHH
Confidence            999999999999999999999999999887665544321100000000000000000111100          1156789


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||.+||.+||.+|||++|+|+||||...
T Consensus       334 dLl~~mL~~dP~~R~ta~e~L~Hp~~~~~  362 (464)
T 3ttj_A          334 DLLSKMLVIDPAKRISVDDALQHPYINVW  362 (464)
T ss_dssp             HHHHHHSCSSTTTSCCHHHHHTSTTTGGG
T ss_pred             HHHHHHcCCChhhCCCHHHHhcChhhhhc
Confidence            99999999999999999999999999653

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=9.5e-43  Score=337.84  Aligned_cols=247  Identities=39%  Similarity=0.671  Sum_probs=205.1

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.+++.++||||+++++++.+.        +.+++||||++++|...+......+++..++.++.|++.||+
T Consensus        55 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~  126 (346)
T 1ua2_A           55 INRTALREIKLLQELSHPNIIGLLDAFGHK--------SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGLE  126 (346)
T ss_dssp             -CTHHHHHHHHHHHCCCTTBCCEEEEECCT--------TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHhhCCCCCCCeEEEEEeeC--------CceEEEEEcCCCCHHHHHHhcCcCCCHHHHHHHHHHHHHHHH
Confidence            346788999999999999999999999865        558999999999999998876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    ......++|+.|+|||++.+...++.++|||||||+
T Consensus       127 ~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~i  202 (346)
T 1ua2_A          127 YLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCI  202 (346)
T ss_dssp             HHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHHH
T ss_pred             HHHHCCEECCCCCHHHEEEcCCCCEEEEecccceeccCCc----ccCCcccccccccCchHhhCCCCCCchhhhHhHHHH
Confidence            9999999999999999999999999999999998764322    233456789999999999776668999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+....+.+..+.|+.......+.......  .......  ....+.++++||.+||..
T Consensus       203 l~ell~g~~~~~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~--~~~~~~~~~~li~~~L~~  278 (346)
T 1ua2_A          203 LAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHI--FSAAGDDLLDLIQGLFLF  278 (346)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHH--CTTCCHHHHHHHHHHHCS
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHHHcCCCChhhhhhhccCcccccccccC--CCChHHh--hccCCHHHHHHHHHHhcc
Confidence            999999999999999999999999999999888887765543221111000  0000000  123578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ||.+|||++|+|+||||...+.+
T Consensus       279 dP~~Rpt~~ell~h~~f~~~~~~  301 (346)
T 1ua2_A          279 NPCARITATQALKMKYFSNRPGP  301 (346)
T ss_dssp             STTTSCCHHHHHTSGGGTSSSCC
T ss_pred             ChhhCCCHHHHhcChhhhcCCCC
Confidence            99999999999999999775543

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.3e-43  Score=347.54  Aligned_cols=258  Identities=34%  Similarity=0.642  Sum_probs=194.5

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc--------CCCCCHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI--------HVKFSLGEIKK   75 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~--------~~~l~~~~~~~   75 (433)
                      .+....+.+|+.+|+.++|||||++++++.....      ..+||||||+.++|.+++...        ...+++..++.
T Consensus        59 ~~~~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~l~~~~~~~  132 (405)
T 3rgf_A           59 TGISMSACREIALLRELKHPNVISLQKVFLSHAD------RKVWLLFDYAEHDLWHIIKFHRASKANKKPVQLPRGMVKS  132 (405)
T ss_dssp             SSCCHHHHHHHHHHHHCCCTTBCCCCEEEEETTT------TEEEEEEECCSEEHHHHHHHHHHHC-------CCHHHHHH
T ss_pred             CCCCHHHHHHHHHHHhcCCCCeeeEeeEEecCCC------CeEEEEEeCCCCCHHHHHHHhccccccccccCCCHHHHHH
Confidence            3456789999999999999999999999976432      679999999999998888632        12489999999


Q ss_pred             HHHHHHHHHHHHHhCCeeccCCCCCcEEE----ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC
Q psy7889          76 VIQQLLNGLYYIHSNKILHRDMKAANVLI----TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        76 i~~qll~aL~~LH~~~iiH~dikp~NIll----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      ++.||+.||+|||++||+||||||+|||+    +.++.+||+|||++........ ........+||+.|+|||++.+..
T Consensus       133 i~~qi~~al~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~  211 (405)
T 3rgf_A          133 LLYQILDGIHYLHANWVLHRDLKPANILVMGEGPERGRVKIADMGFARLFNSPLK-PLADLDPVVVTFWYRAPELLLGAR  211 (405)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCCCGGGEEECCSSTTTTCEEECCTTCCC-----------------CCCTTCCHHHHTTCC
T ss_pred             HHHHHHHHHHHHHhCCEeCCCcCHHHeEEecCCCCCCcEEEEECCCceecCCCCc-ccccCCCceecCcccCchhhcCCC
Confidence            99999999999999999999999999999    6678999999999987653211 112334567899999999998866


Q ss_pred             CCCCcchhhhHHHHHHHHHhcCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCcccchhhhhccc----cchHH
Q psy7889         152 NYGPPVDLWGAGCIMAEMWTRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKME----LPKAQ  218 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~g~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~----~~~~~  218 (433)
                      .++.++|||||||++|+|++|.+||.+...         .+++..|...+|.+....|.............    .....
T Consensus       212 ~~~~~~DiwSlG~il~ell~g~~pf~~~~~~~~~~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (405)
T 3rgf_A          212 HYTKAIDIWAIGCIFAELLTSEPIFHCRQEDIKTSNPYHHDQLDRIFNVMGFPADKDWEDIKKMPEHSTLMKDFRRNTYT  291 (405)
T ss_dssp             SCCHHHHHHHHHHHHHHHHHSSCTTCCCC------CCCCHHHHHHHHHHHCCCCTTTCGGGGGSTTHHHHHHHCCGGGGT
T ss_pred             cccchhhhHHHHHHHHHHHhCCCCCCCccccccccccchHHHHHHHHHhhCCCChhhcchhhcCcchhhhhhhccccCCC
Confidence            689999999999999999999999987665         47889999999999998887665433221110    00000


Q ss_pred             HhhHHhhh--CCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         219 KRKVKERL--KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       219 ~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      .......+  .....+..+++||.+||.+||.+|||++|+|+||||.+.+.+
T Consensus       292 ~~~~~~~~~~~~~~~~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~  343 (405)
T 3rgf_A          292 NCSLIKYMEKHKVKPDSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLP  343 (405)
T ss_dssp             TCCHHHHHHTTTCCTTSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCC
T ss_pred             cchhhhhHhhcCCCCCHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCC
Confidence            00000000  112237789999999999999999999999999999775533

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=100.00  E-value=6.1e-43  Score=349.23  Aligned_cols=253  Identities=31%  Similarity=0.584  Sum_probs=193.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++|||||++++++.....   .....+|+||||++++|.+.+.. ...+++..++.++.||+.||+||
T Consensus        70 ~~~~~E~~~l~~l~h~nIv~l~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~~~~-~~~l~~~~~~~i~~qil~aL~~L  145 (432)
T 3n9x_A           70 KRILREITILNRLKSDYIIRLYDLIIPDDL---LKFDELYIVLEIADSDLKKLFKT-PIFLTEEHIKTILYNLLLGENFI  145 (432)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSCT---TTCCCEEEEEECCSEEHHHHHHS-SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcceEEEEEecCCC---CcCCeEEEEEecCCcCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            568899999999999999999999976521   11256999999999999998876 34699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc------------------cccccCCcccccccCcccccC
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ------------------VNRYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~------------------~~~~~~~~gt~~y~aPE~~~~  149 (433)
                      |++||+||||||+|||++.++.+||+|||+++.........                  .......+||++|+|||++..
T Consensus       146 H~~givHrDlkp~NILl~~~~~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~Y~APE~~~~  225 (432)
T 3n9x_A          146 HESGIIHRDLKPANCLLNQDCSVKVCDFGLARTINSEKDTNIVNDLEENEEPGPHNKNLKKQLTSHVVTRWYRAPELILL  225 (432)
T ss_dssp             HHTTEECCCCCGGGEEECTTCCEEECCCTTCEEC-------------------------------CCCCCTTCCHHHHTT
T ss_pred             HHCCCCCCCCCHHHeEECCCCCEEEccCCCcccccccccccccccccccccccccccchhccccCCCCCccccCHHHHhc
Confidence            99999999999999999999999999999998765332110                  012356788999999999866


Q ss_pred             CCCCCCcchhhhHHHHHHHHHh-----------cCCCCCCCC-----------------hHHHHHHHHHHhCCCCCCCCC
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWT-----------RSPIMQGNT-----------------EQQQITLISQLCGSITPESWP  201 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~-----------g~~pf~~~~-----------------~~~~~~~i~~~~g~~~~~~~~  201 (433)
                      ...|+.++|||||||++|||++           |.++|.+.+                 ..+++..|..++|.++.+.+.
T Consensus       226 ~~~~~~~~DiwSlG~il~ell~g~~p~~~~~~~~~p~f~g~~~~~~~~~~~~~~~~~~~~~~ql~~i~~~~g~p~~~~~~  305 (432)
T 3n9x_A          226 QENYTKSIDIWSTGCIFAELLNMLQSHINDPTNRFPLFPGSSCFPLSPDRNSKKVHEKSNRDQLNIIFNIIGTPTEDDLK  305 (432)
T ss_dssp             CSCCCTHHHHHHHHHHHHHHHTTCTTTCSSGGGCCCSCCCSCSCC----------CHHHHHHHHHHHHHHHCSCCHHHHH
T ss_pred             CCCCCcccccchHHHHHHHHHhcccccccccccccccCCCccccccCcccccccccccchHHHHHHHHHhcCCCCHHHHH
Confidence            6668999999999999999997           677787765                 467888899999988765544


Q ss_pred             cccchhhhhcccc-chHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         202 GVETLDLYNKMEL-PKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       202 ~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+........+.. +..........+  -..++++++||.+||.+||.+|||++|+|+||||....
T Consensus       306 ~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  369 (432)
T 3n9x_A          306 NINKPEVIKYIKLFPHRKPINLKQKY--PSISDDGINLLESMLKFNPNKRITIDQALDHPYLKDVR  369 (432)
T ss_dssp             TCCCHHHHHHHHTSCCCCCCCHHHHS--TTSCHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTC
T ss_pred             hccCHHHHHHHHhCCCCCCCCHHHHC--CCCCHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhcc
Confidence            3333222211110 000000011111  12688999999999999999999999999999997654

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=100.00  E-value=5.4e-42  Score=326.93  Aligned_cols=246  Identities=39%  Similarity=0.692  Sum_probs=199.3

Q ss_pred             CchhHHHHHHHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCC-CCCHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHV-KFSLGEIKKVIQQLL   81 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~-~l~~~~~~~i~~qll   81 (433)
                      ....+.+|+.+++.++   ||||+++++++......   ....+++||||+.++|.+++..... .+++..++.++.||+
T Consensus        54 ~~~~~~~e~~~l~~l~~~~h~niv~~~~~~~~~~~~---~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~  130 (308)
T 3g33_A           54 LPISTVREVALLRRLEAFEHPNVVRLMDVCATSRTD---REIKVTLVFEHVDQDLRTYLDKAPPPGLPAETIKDLMRQFL  130 (308)
T ss_dssp             CCHHHHHHHHHHHHHHHHCCTTBCCEEEEEEECCSS---SEEEEEEEEECCCCBHHHHHHTCCTTCSCHHHHHHHHHHHH
T ss_pred             cchhHHHHHHHHHHHhhcCCCCeEEeeeeeeccCCC---CceeEEEEehhhhcCHHHHHhhccCCCCCHHHHHHHHHHHH
Confidence            3567889999999885   99999999999876321   1236899999999999999977543 389999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||+|||++||+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+.. ++.++||||
T Consensus       131 ~al~~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  204 (308)
T 3g33_A          131 RGLDFLHANCIVHRDLKPENILVTSGGTVKLADFGLARIYSYQM-----ALTPVVVTLWYRAPEVLLQST-YATPVDMWS  204 (308)
T ss_dssp             HHHHHHHHTTCCCSCCCTTTEEECTTSCEEECSCSCTTTSTTCC-----CSGGGGCCCSSCCHHHHHTSC-CCSTHHHHH
T ss_pred             HHHHHHHHCCcccCCCCHHHEEEcCCCCEEEeeCccccccCCCc-----ccCCccccccccCchHHcCCC-CCchHHHHH
Confidence            99999999999999999999999999999999999998764322     234567899999999998765 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||.+.+..+.+..+....+.++...|+.........   ++..........  ....+..+.+||.+
T Consensus       205 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--~~~~~~~~~~li~~  279 (308)
T 3g33_A          205 VGCIFAEMFRRKPLFCGNSEADQLGKIFDLIGLPPEDDWPRDVSLPRGA---FPPRGPRPVQSV--VPEMEESGAQLLLE  279 (308)
T ss_dssp             HHHHHHHTTTSSCSCCCSSHHHHHHHHHHHHCCCCTTTSCSSCSSCGGG---SCCCCCCCHHHH--SCSCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCChhhccchhhccccc---cCCCCCCcHHHh--CccccHHHHHHHHH
Confidence            9999999999999999999999999999999999888886554322111   111111111111  12367888999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||+.||.+|||+.|+|+||||...
T Consensus       280 ~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          280 MLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HTCSSTTTSCCHHHHHTSTTC---
T ss_pred             HhcCCCccCCCHHHHhcCccccCC
Confidence            999999999999999999999764

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=100.00  E-value=1.4e-42  Score=334.36  Aligned_cols=244  Identities=38%  Similarity=0.728  Sum_probs=193.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+.+|+.++||||+++++++.+.        ..+||||||++++|.+++.... .+++..++.++.||+.||+|
T Consensus        77 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~~~~~~-~~~~~~~~~i~~ql~~~l~~  147 (329)
T 3gbz_A           77 PGTAIREVSLLKELQHRNIIELKSVIHHN--------HRLHLIFEYAENDLKKYMDKNP-DVSMRVIKSFLYQLINGVNF  147 (329)
T ss_dssp             ---CHHHHHHGGGCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHCT-TCCHHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHcCCCCcceEEEEEecC--------CEEEEEEecCCCCHHHHHhhcC-CCCHHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999876        6699999999999999987643 68999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEe-----cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          87 IHSNKILHRDMKAANVLIT-----KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~-----~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      ||++||+||||||+|||++     ..+.+||+|||++.......    ......++|+.|+|||++.+...++.++||||
T Consensus       148 LH~~~ivH~Dlkp~NIll~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Diws  223 (329)
T 3gbz_A          148 CHSRRCLHRDLKPQNLLLSVSDASETPVLKIGDFGLARAFGIPI----RQFTHEIITLWYRPPEILLGSRHYSTSVDIWS  223 (329)
T ss_dssp             HHHTTCCCSCCCGGGEEEEC-----CCEEEECCTTHHHHHC---------------CCTTCCHHHHTTCCCCCTHHHHHH
T ss_pred             HHhCCEECCCCCHHHEEEecCCCCccceEEECcCCCccccCCcc----cccCCCcCCccccCHHHhcCCCCCCcHHHHHH
Confidence            9999999999999999995     44569999999997764321    22344577999999999987666899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||.+....+.+..+....+.+....|+.......+.. ..+.......... .+...+.++++||.+
T Consensus       224 lG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~-~~~~~~~~~~~li~~  301 (329)
T 3gbz_A          224 IACIWAEMLMKTPLFPGDSEIDQLFKIFEVLGLPDDTTWPGVTALPDWKQ-SFPKFRGKTLKRV-LGALLDDEGLDLLTA  301 (329)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCT-TCCCCCCCCHHHH-HGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCcCCCCHHHHHHHHHHHhCCCchhhhhhhhhhhhhhh-hhhhhccccHhhh-cccccCHHHHHHHHH
Confidence            99999999999999999999999999999999988888776554332211 1111111111111 122367889999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||..||.+|||++|+|+||||...
T Consensus       302 ~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          302 MLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             HTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             HccCChhhCCCHHHHhCCcccCCC
Confidence            999999999999999999999754

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=100.00  E-value=3.6e-42  Score=331.10  Aligned_cols=212  Identities=26%  Similarity=0.473  Sum_probs=182.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        +.+|+||||++ ++|.+++... ..+++..++.++.||+.||+|
T Consensus        59 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~l~~~~~~~~~~qi~~al~~  129 (328)
T 3fe3_A           59 QKLFREVRIMKILNHPNIVKLFEVIETE--------KTLYLIMEYASGGEVFDYLVAH-GRMKEKEARSKFRQIVSAVQY  129 (328)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC--------CEEEEEEECCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999875        66999999996 5888888664 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+....+.++||||+||++
T Consensus       130 lH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  204 (328)
T 3fe3_A          130 CHQKRIVHRDLKAENLLLDADMNIKIADFGFSNEFTVGG-----KLDAFCGAPPYAAPELFQGKKYDGPEVDVWSLGVIL  204 (328)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTSCEEECSTTCCGGGSSSC-----GGGTTSSSGGGCCHHHHHTCCCCSHHHHHHHHHHHH
T ss_pred             HHHCCEeccCCCHHHEEEcCCCCEEEeeccCceecCCCC-----ccccccCCcceeCcccccCCCcCCchhhhhhhHHHH
Confidence            999999999999999999999999999999997765322     234568899999999998876556899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+.......                                +...+.++.+||.+||..|
T Consensus       205 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~d  252 (328)
T 3fe3_A          205 YTLVSGSLPFDGQNLKELRERVLRGKYRI--------------------------------PFYMSTDCENLLKRFLVLN  252 (328)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHCCSS
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CCCCCHHHHHHHHHHCCCC
Confidence            99999999999988877776665421111                                1235678889999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|||++|+|+||||...
T Consensus       253 P~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          253 PIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             TTTSCCHHHHTTCTTTTTT
T ss_pred             hhHCcCHHHHhcCHhhcCC
Confidence            9999999999999999653

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.3e-42  Score=339.51  Aligned_cols=246  Identities=34%  Similarity=0.576  Sum_probs=196.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++.....  ......+|+||||++++|.+++..  ..+++..++.++.||+.||+||
T Consensus        69 ~~~~~E~~~l~~l~hpnIv~l~~~~~~~~~--~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~~~~qi~~~L~~L  144 (367)
T 1cm8_A           69 KRAYRELRLLKHMRHENVIGLLDVFTPDET--LDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRYI  144 (367)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCCSEEECSCSS--TTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCCceeeEecCCc--cccCceEEEEEecCCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999986532  111255799999998899998876  3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||+++....       .....++|++|+|||++.+...++.++||||+||+++
T Consensus       145 H~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  217 (367)
T 1cm8_A          145 HAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMA  217 (367)
T ss_dssp             HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHHH
T ss_pred             HHCCccccCcCHHHEEEcCCCCEEEEeeeccccccc-------ccCcCcCCCCcCCHHHHhCCCCCChhhhHHHHHHHHH
Confidence            999999999999999999999999999999977542       2345678999999999987556899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+++..|....|.++.+.+..+........+. .+..........  ....++++++||.+||..|
T Consensus       218 ell~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~ll~~mL~~d  295 (367)
T 1cm8_A          218 EMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVLD  295 (367)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCSS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCCHHHHHHhhhHHHHHHHHhCCCCCCCCHHHH--CCCCCHHHHHHHHHHccCC
Confidence            9999999999999999999999999987654433322211100000 000000000000  1135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       296 P~~R~t~~e~l~hp~f~~~~  315 (367)
T 1cm8_A          296 AEQRVTAGEALAHPYFESLH  315 (367)
T ss_dssp             TTTSCCHHHHHHSGGGTTTC
T ss_pred             hhHCCCHHHHhcChHHHhhc
Confidence            99999999999999997654

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.1e-42  Score=328.88  Aligned_cols=248  Identities=33%  Similarity=0.629  Sum_probs=188.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+++||||+++++...+......+++..++.++.|++.||+||
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~i~~~l~~~l~~l  118 (311)
T 4agu_A           47 KIALREIRMLKQLKHPNLVNLLEVFRRK--------RRLHLVFEYCDHTVLHELDRYQRGVPEHLVKSITWQTLQAVNFC  118 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHTSSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCccchhheeecC--------CeEEEEEEeCCCchHHHHHhhhcCCCHHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        66999999999876666655566799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++.......    .......||..|+|||++.+...++.++||||+||+++
T Consensus       119 H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~il~  194 (311)
T 4agu_A          119 HKHNCIHRDVKPENILITKHSVIKLCDFGFARLLTGPS----DYYDDEVATRWYRSPELLVGDTQYGPPVDVWAIGCVFA  194 (311)
T ss_dssp             HHTTEECCCCSGGGEEECTTSCEEECCCTTCEECC----------------GGGCCHHHHHTCSCCCTHHHHHHHHHHHH
T ss_pred             HHCCCcCCCCChhhEEEcCCCCEEEeeCCCchhccCcc----cccCCCcCCccccChHHHhcCCCCCcchhhHHHHHHHH
Confidence            99999999999999999999999999999997765322    12344578999999999987666899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHh-hHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR-KVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+....+....+....+...+...........+.....+..... ......  ...+.++.+||.+||..|
T Consensus       195 ~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  272 (311)
T 4agu_A          195 ELLSGVPLWPGKSDVDQLYLIRKTLGDLIPRHQQVFSTNQYFSGVKIPDPEDMEPLELKF--PNISYPALGLLKGCLHMD  272 (311)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHTCGGGTTCCCCCCSSCCCHHHHC--TTCCHHHHHHHHHHCCSS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhcccccccccccccccccccCcCCCccccchhhhhc--ccccHHHHHHHHHHccCC
Confidence            99999999999999999988888877654432211111111111111110000 000000  135778899999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCc
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |.+|||++|+|+||||++.....
T Consensus       273 P~~Rpt~~ell~hp~f~~~~~~~  295 (311)
T 4agu_A          273 PTERLTCEQLLHHPYFENIREIE  295 (311)
T ss_dssp             TTTSCCHHHHHTSGGGTTCC---
T ss_pred             hhhcCCHHHHhcChHHHhccCHH
Confidence            99999999999999998755433

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=100.00  E-value=4.6e-42  Score=338.79  Aligned_cols=246  Identities=29%  Similarity=0.502  Sum_probs=194.1

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+|+++|+.++|||||+++++|......  .....+|+||||+++++...+..   ....+++..++.++.||+.||+|
T Consensus        79 ~~~E~~il~~l~h~niv~l~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~aL~~  156 (394)
T 4e7w_A           79 KNRELQIMRIVKHPNVVDLKAFFYSNGDK--KDEVFLNLVLEYVPETVYRASRHYAKLKQTMPMLLIKLYMYQLLRSLAY  156 (394)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEESSS--SSCEEEEEEEECCSEEHHHHHHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcceEEEEEEecCCC--CCceEEEEEeeccCccHHHHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            34799999999999999999999765321  12345889999999987766543   34569999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++||+||||||+|||++ .++.+||+|||+++......     ......+|+.|+|||++.+...|+.++||||+||+
T Consensus       157 LH~~~ivHrDlkp~Nill~~~~~~~kL~DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i  231 (394)
T 4e7w_A          157 IHSIGICHRDIKPQNLLLDPPSGVLKLIDFGSAKILIAGE-----PNVSYICSRYYRAPELIFGATNYTTNIDIWSTGCV  231 (394)
T ss_dssp             HHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-----CCCSSCSCGGGCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCCccCCCCCHHHEEEcCCCCcEEEeeCCCcccccCCC-----CCcccccCcCccCHHHHcCCCCCCcHHHHHHHHHH
Confidence            9999999999999999999 78999999999998764332     22345789999999999877668999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+...+|.+..+.+.....  .+....++..........+ +...++++++||.+||.+
T Consensus       232 l~ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~li~~~L~~  308 (394)
T 4e7w_A          232 MAELMQGQPLFPGESGIDQLVEIIKVLGTPSREQIKTMNP--NYMEHKFPQIRPHPFSKVF-RPRTPPDAIDLISRLLEY  308 (394)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCG--GGSSSCCCCCCCCCHHHHS-CTTCCHHHHHHHHHHCCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hhhhhccccccCCcHHHhc-cccCCHHHHHHHHHHhCC
Confidence            9999999999999999999999999999876543322111  0111111111111111111 123678899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||.+|||+.|+|+||||.+.
T Consensus       309 dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          309 TPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             SGGGSCCHHHHHTSGGGSTT
T ss_pred             ChhhCCCHHHHhcChhhhhh
Confidence            99999999999999999754

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=100.00  E-value=5.4e-41  Score=318.54  Aligned_cols=220  Identities=25%  Similarity=0.429  Sum_probs=184.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+|+|||||. ++|.+++...  .+++..++.++.|++.||+
T Consensus        61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~--~~~~~~~~~~~~qi~~~l~  130 (297)
T 3fxz_A           61 KELIINEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTET--CMDEGQIAAVCRECLQALE  130 (297)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHS--CCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCCeEeEEEEEC--------CEEEEEEECCCCCCHHHHHhhc--CCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999876        66999999995 5888888653  5899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||||+
T Consensus       131 ~lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  205 (297)
T 3fxz_A          131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  205 (297)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----CCBCCCCSCGGGCCHHHHHCSC-BCTHHHHHHHHHH
T ss_pred             HHHhCCceeCCCCHHHEEECCCCCEEEeeCCCceecCCcc----cccCCccCCcCccChhhhcCCC-CCcHHHHHHHHHH
Confidence            9999999999999999999999999999999997765322    2234567899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.........+....... ..                            .+...+..+.+||.+||+.
T Consensus       206 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~li~~~l~~  256 (297)
T 3fxz_A          206 AIEMIEGEPPYLNENPLRALYLIATNGTPE-LQ----------------------------NPEKLSAIFRDFLNRCLEM  256 (297)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHHCSCC-CS----------------------------CGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHhCCCCC-CC----------------------------CccccCHHHHHHHHHHccC
Confidence            999999999999988777666554322110 00                            0112567788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      ||.+|||++|+|+||||+.....+.
T Consensus       257 dp~~Rps~~ell~h~~~~~~~~~~~  281 (297)
T 3fxz_A          257 DVEKRGSAKELLQHQFLKIAKPLSS  281 (297)
T ss_dssp             STTTSCCHHHHTTCGGGGGCCCGGG
T ss_pred             ChhHCcCHHHHhhChhhcccCcccc
Confidence            9999999999999999987654443

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=100.00  E-value=1.2e-41  Score=331.56  Aligned_cols=215  Identities=25%  Similarity=0.432  Sum_probs=182.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+|+.++|||||+++++|.+.        ..+|+|||||. ++|.+++.. ...+++..++.++.||+.||.
T Consensus        59 ~~~~~~E~~il~~l~hpnIv~l~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~  129 (361)
T 2yab_A           59 REEIEREVSILRQVLHPNIITLHDVYENR--------TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVN  129 (361)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHTT-CSCCBHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCCCcEEEEEEeC--------CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        66999999996 688888865 446999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.++    .+||+|||++.......     .....+||+.|+|||++.+.. ++.++||||
T Consensus       130 ~LH~~givHrDlkp~NIll~~~~~~~~~vkl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  203 (361)
T 2yab_A          130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWS  203 (361)
T ss_dssp             HHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCSSCEECCTTC-----CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHH
T ss_pred             HHHHCCcccCCCCHHHEEEeCCCCCccCEEEEecCCceEcCCCC-----ccccCCCCccEECchHHcCCC-CCccccHHH
Confidence            99999999999999999998777    79999999998765421     234567899999999997755 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||.+.+..+....|.......+..                   .         ....+.++++||.+
T Consensus       204 lGvil~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~-------------------~---------~~~~s~~~~~li~~  255 (361)
T 2yab_A          204 IGVITYILLSGASPFLGDTKQETLANITAVSYDFDEE-------------------F---------FSQTSELAKDFIRK  255 (361)
T ss_dssp             HHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCCHH-------------------H---------HTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCCch-------------------h---------ccCCCHHHHHHHHH
Confidence            9999999999999999998887777665422211100                   0         01256788899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||..||.+|||++|+|+||||..
T Consensus       256 ~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          256 LLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             HSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             HCCCChhHCcCHHHHhcCcCcCC
Confidence            99999999999999999999964

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=100.00  E-value=2.5e-42  Score=337.30  Aligned_cols=247  Identities=33%  Similarity=0.551  Sum_probs=184.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++.....  ......+|+|||+++++|.+++..  ..+++..++.++.||+.||+||
T Consensus        73 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~L~~~~~~--~~l~~~~~~~i~~qi~~aL~~L  148 (367)
T 2fst_X           73 KRTYRELRLLKHMKHENVIGLLDVFTPARS--LEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI  148 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSS--GGGCCCCEEEEECCCEECC-------CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecCCc--cccCCeEEEEecccCCCHHHHHhc--CCCCHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999976421  111356899999999888887765  4699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||+++....       .....+||++|+|||++.+...++.++|||||||++|
T Consensus       149 H~~givH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  221 (367)
T 2fst_X          149 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTAD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  221 (367)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECC----------------------CCCTTCCHHHHTTCCSCCTTHHHHHHHHHHH
T ss_pred             HHCCeeeCCCCHhhEEECCCCCEEEeeccccccccc-------cCCCcCcCcCccChHHHcCCcCCCchhhHHHHHHHHH
Confidence            999999999999999999999999999999976542       1344578999999999987566899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+++..|....|.+..+.+..+........+. .+..........+  ...++++++||.+||.+|
T Consensus       222 ell~g~~pf~~~~~~~~l~~i~~~~g~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~dLl~~mL~~d  299 (367)
T 2fst_X          222 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVF--IGANPLAVDLLEKMLVLD  299 (367)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHTTCCCHHHHHHHHTSCCCCCCCHHHHT--TTCCHHHHHHHHHHSCSS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHHhccCCCCCCCHHHHC--CCCCHHHHHHHHHhCCCC
Confidence            9999999999999999999999999987765544443321111000 0000000011111  125788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~  267 (433)
                      |.+|||++|+|+||||.....
T Consensus       300 P~~R~t~~e~L~hp~~~~~~~  320 (367)
T 2fst_X          300 SDKRITAAQALAHAYFAQYHD  320 (367)
T ss_dssp             GGGSCCHHHHHTSGGGTTTCC
T ss_pred             cccCcCHHHHhcChhhhhccC
Confidence            999999999999999976543

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=100.00  E-value=6.2e-42  Score=340.65  Aligned_cols=245  Identities=27%  Similarity=0.475  Sum_probs=190.4

Q ss_pred             HHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHH
Q psy7889          10 ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus        10 ~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+|+++|+.++|||||+++++|......  .....+++||||+++++...+..   ....+++..++.++.||+.||+|
T Consensus        94 ~~~E~~il~~l~hpniv~l~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~l~~~~~~~~~~qi~~aL~~  171 (420)
T 1j1b_A           94 KNRELQIMRKLDHCNIVRLRYFFYSSGEK--KDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLAY  171 (420)
T ss_dssp             CCHHHHHHHTCCCTTBCCEEEEEEEEETT--TTEEEEEEEEECCCEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCccceeeEEeccCCC--CcceeEEeehhcccccHHHHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            45799999999999999999999764221  11245789999999988777653   34569999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecC-CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKT-GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~-~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++||+||||||+|||++.+ +.+||+|||+++.+....     .....+||+.|+|||++.+...|+.++|||||||+
T Consensus       172 LH~~~ivHrDlkp~NILl~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlG~i  246 (420)
T 1j1b_A          172 IHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCV  246 (420)
T ss_dssp             HHTTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCTTC-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHHH
T ss_pred             HHHCCccccCCChhhEEEeCCCCeEEeccchhhhhcccCC-----CceeeeeCCCcCCHHHHcCCCCCCchhhhHHHHHH
Confidence            999999999999999999965 678999999998764322     22345789999999999876568999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|||++|.+||.+.+..+++..+.+.+|.+..+.|.....  .+..+.++..........+ +...+.++++||.+||.+
T Consensus       247 l~ell~G~~pf~~~~~~~~l~~i~~~lg~p~~~~~~~~~~--~~~~~~~p~~~~~~~~~~~-~~~~~~~~~~Li~~~L~~  323 (420)
T 1j1b_A          247 LAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNP--NYTEFKFPQIKAHPWTKVF-RPRTPPEAIALCSRLLEY  323 (420)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHHHHCS--CCCCCCCCCCCCCCHHHHS-CTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhCh--hhhhhccCccCCCCHHHhc-CCCCCHHHHHHHHHhccC
Confidence            9999999999999999999999999988775443321110  0111111111111111111 123578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||.+|||+.|+|+||||..
T Consensus       324 dP~~R~t~~e~l~hp~f~~  342 (420)
T 1j1b_A          324 TPTARLTPLEACAHSFFDE  342 (420)
T ss_dssp             SGGGSCCHHHHHTSGGGGG
T ss_pred             ChhHCCCHHHHhCCHhhcc
Confidence            9999999999999999954

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=6.9e-42  Score=328.31  Aligned_cols=217  Identities=22%  Similarity=0.383  Sum_probs=184.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        +.+|+|||||.+ +|.+.+......+++..++.++.||+.||.
T Consensus        45 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~  116 (321)
T 1tki_A           45 QVLVKKEISILNIARHRNILHLHESFESM--------EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ  116 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEET--------TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEeEEEecC--------CEEEEEEEeCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            34578999999999999999999999876        669999999975 899988776667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec--CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITK--TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.  ++.+||+|||++.......     ......||+.|+|||++.+.. ++.++||||||
T Consensus       117 ~lH~~givH~Dlkp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  190 (321)
T 1tki_A          117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLG  190 (321)
T ss_dssp             HHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-----EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHH
T ss_pred             HHHHCCCCcCCCCHHHEEEccCCCCCEEEEECCCCeECCCCC-----ccccccCChhhcCcHHhcCCC-CCchhhHHHHH
Confidence            999999999999999999987  7899999999998765322     233457899999999997764 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+....+.+..+.......+...|                            ...+.++++||.+||
T Consensus       191 ~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~L  242 (321)
T 1tki_A          191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------------------------KEISIEAMDFVDRLL  242 (321)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH----------------------------TTSCHHHHHHHHTTS
T ss_pred             HHHHHHHhCCCCCcCCCHHHHHHHHHcCCCCCChhhh----------------------------ccCCHHHHHHHHHHc
Confidence            9999999999999999888777776553221110000                            125678889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ..||.+|||+.|+|+||||.+.
T Consensus       243 ~~dp~~Rpt~~e~l~hp~~~~~  264 (321)
T 1tki_A          243 VKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CCChhHCcCHHHHhcChhhccC
Confidence            9999999999999999999754

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=100.00  E-value=7.3e-41  Score=323.01  Aligned_cols=212  Identities=26%  Similarity=0.389  Sum_probs=180.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        +.+|+||||+++ +|...+.+. ..+++..++.++.||+.||+
T Consensus        49 ~~~~~~E~~~l~~l~hp~iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~  119 (337)
T 1o6l_A           49 VAHTVTESRVLQNTRHPFLTALKYAFQTH--------DRLCFVMEYANGGELFFHLSRE-RVFTEERARFYGAEIVSALE  119 (337)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcCcceEEEEEeC--------CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        669999999975 788777653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. ++.++|||||||+
T Consensus       120 ~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  194 (337)
T 1o6l_A          120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVV  194 (337)
T ss_dssp             HHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT----CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHH
T ss_pred             HHHHCCeecCcCCHHHEEECCCCCEEEeeccchhhcccCC----CcccccccChhhCChhhhcCCC-CCchhhcccchhH
Confidence            9999999999999999999999999999999997643221    2345568999999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+......                   +             +...+.++++||.+||..
T Consensus       195 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~-------------------~-------------p~~~s~~~~~li~~lL~~  242 (337)
T 1o6l_A          195 MYEMMCGRLPFYNQDHERLFELILMEEIR-------------------F-------------PRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCC-------------------C-------------CTTSCHHHHHHHHHHTCS
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCCCC-------------------C-------------CCCCCHHHHHHHHHHhhc
Confidence            99999999999998877666655431110                   0             113567888999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      ||.+||     +++|+++||||..
T Consensus       243 dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          243 DPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHhcCCCCCCHHHHHcCCCcCC
Confidence            999999     9999999999965

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=100.00  E-value=7e-42  Score=329.63  Aligned_cols=244  Identities=36%  Similarity=0.700  Sum_probs=188.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+++++...+......+++..++.++.||+.||.||
T Consensus        69 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~qi~~~l~~L  140 (331)
T 4aaa_A           69 KIAMREIKLLKQLRHENLVNLLEVCKKK--------KRWYLVFEFVDHTILDDLELFPNGLDYQVVQKYLFQIINGIGFC  140 (331)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHSTTCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCEeeEEEEeecC--------CEEEEEEecCCcchHHHHHhhccCCCHHHHHHHHHHHHHHHHHH
Confidence            3467899999999999999999999875        66999999999887777766666799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++.......    .......||..|+|||++.+...++.++|||||||++|
T Consensus       141 H~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~  216 (331)
T 4aaa_A          141 HSHNIIHRDIKPENILVSQSGVVKLCDFGFARTLAAPG----EVYDDEVATRWYRAPELLVGDVKYGKAVDVWAIGCLVT  216 (331)
T ss_dssp             HHTTCCCCCCCGGGEEECTTSCEEECCCTTC----------------CCCCCTTCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred             HHCCEEccCcChheEEEcCCCcEEEEeCCCceeecCCc----cccCCCcCCccccCcccccCCCCcchHHHHHHHHHHHH
Confidence            99999999999999999999999999999997764322    12344578999999999987656899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhh-HHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK-VKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+.+..+....+...+..+........+.....+...... .....  ...+..+.+||.+||..|
T Consensus       217 ~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~l~~li~~~L~~d  294 (331)
T 4aaa_A          217 EMFMGEPLFPGDSDIDQLYHIMMCLGNLIPRHQELFNKNPVFAGVRLPEIKEREPLERRY--PKLSEVVIDLAKKCLHID  294 (331)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHHHHHCGGGTTCCCCCCSSCCCHHHHS--TTSCHHHHHHHHHHTCSS
T ss_pred             HHHhCCCCCCCCCcHHHHHHHHHHhCCCChhhhhHhhhccccccccCccccccchhhhcc--cchhHHHHHHHHHHhccC
Confidence            999999999999999999888887776543221111111111111111100000 00000  135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|||+.|+|+||||+..
T Consensus       295 P~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          295 PDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             GGGSCCGGGGGGSHHHHGG
T ss_pred             cccCCCHHHHhcCchhccC
Confidence            9999999999999999764

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=100.00  E-value=8.4e-41  Score=333.97  Aligned_cols=215  Identities=30%  Similarity=0.470  Sum_probs=183.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++|||||++++++.+.        +.+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.|
T Consensus        55 ~~~~~E~~il~~l~hpnIv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~i~~~-~~~~e~~~~~i~~qil~aL~~  125 (444)
T 3soa_A           55 QKLEREARICRLLKHPNIVRLHDSISEE--------GHHYLIFDLVTGGELFEDIVAR-EYYSEADASHCIQQILEAVLH  125 (444)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEEEEECS--------SEEEEEECCCBCCBHHHHHHHC-SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEEC--------CEEEEEEEeCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999875        669999999975 888888764 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEe---cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~---~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+|||++   .++.+||+|||++.......    ......+||+.|+|||++.+.. |+.++||||+|
T Consensus       126 lH~~givHrDlKp~NIll~~~~~~~~vkL~DFG~a~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~-~~~~~DIwSlG  200 (444)
T 3soa_A          126 CHQMGVVHRNLKPENLLLASKLKGAAVKLADFGLAIEVEGEQ----QAWFGFAGTPGYLSPEVLRKDP-YGKPVDLWACG  200 (444)
T ss_dssp             HHHTTCBCCCCSSTTEEESBSSTTCCEEECCCSSCBCCCTTC----CBCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHH
T ss_pred             HHHCCccccCCCHHHEEEeccCCCCcEEEccCceeEEecCCC----ceeecccCCcccCCHHHhcCCC-CCCccccHHHH
Confidence            9999999999999999998   45789999999997765322    2234567899999999997765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....+.......+...|.                            ..++++++||.+||
T Consensus       201 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~s~~~~~li~~~L  252 (444)
T 3soa_A          201 VILYILLVGYPPFWDEDQHRLYQQIKAGAYDFPSPEWD----------------------------TVTPEAKDLINKML  252 (444)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCCTTTTT----------------------------TSCHHHHHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCccHHHHHHHHHhCCCCCCccccc----------------------------cCCHHHHHHHHHHc
Confidence            99999999999999999888887776644433333332                            24667889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +.||.+|||+.|+|+||||..
T Consensus       253 ~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          253 TINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             CSSTTTSCCHHHHHHSCTTHH
T ss_pred             CCChhHCCCHHHHhcCccccC
Confidence            999999999999999999953

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=2.5e-41  Score=332.38  Aligned_cols=248  Identities=28%  Similarity=0.518  Sum_probs=192.7

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCcccc------------------------------ccCceEEEEeecCcCCHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYN------------------------------RYRSTFYLVFDFCEHDLA   58 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~------------------------------~~~~~~~lV~e~~~~~L~   58 (433)
                      ...+|+++|+.++|||||+++++|........                              .....+++||||++++|.
T Consensus        46 ~~~~E~~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~  125 (383)
T 3eb0_A           46 YKNRELDIMKVLDHVNIIKLVDYFYTTGDEEPKPPQPPDDHNKLGGKNNGVNNHHKSVIVNPSQNKYLNVIMEYVPDTLH  125 (383)
T ss_dssp             SCCHHHHHHTTCCCTTBCCEEEEEEEC-------------------------------------CCEEEEEECCCSEEHH
T ss_pred             hHHHHHHHHHHcCCCCccchhheeeecCcccccccccccccccccccccccccccccccccCCCceEEEEEEecCCccHH
Confidence            34589999999999999999999976432100                              123568999999999887


Q ss_pred             HHHhc---cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccC
Q psy7889          59 GLLSN---IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTN  134 (433)
Q Consensus        59 ~~l~~---~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~  134 (433)
                      +.+..   ....+++..++.++.||+.||+|||++||+||||||+|||++ .++.+||+|||++..+....     ....
T Consensus       126 ~~l~~~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~gi~H~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~  200 (383)
T 3eb0_A          126 KVLKSFIRSGRSIPMNLISIYIYQLFRAVGFIHSLGICHRDIKPQNLLVNSKDNTLKLCDFGSAKKLIPSE-----PSVA  200 (383)
T ss_dssp             HHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHHHTTTEECSCCCGGGEEEETTTTEEEECCCTTCEECCTTS-----CCCC
T ss_pred             HHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHHHHCcCccCccCHHHEEEcCCCCcEEEEECCCCcccCCCC-----CCcC
Confidence            77753   345699999999999999999999999999999999999998 68899999999998764332     2334


Q ss_pred             CcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcccc
Q psy7889         135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMEL  214 (433)
Q Consensus       135 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~  214 (433)
                      ..+|+.|+|||++.+...++.++||||+||++|+|++|.+||.+.+..+.+..+....|.+..+.+.....  .+....+
T Consensus       201 ~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~i~~~~g~p~~~~~~~~~~--~~~~~~~  278 (383)
T 3eb0_A          201 YICSRFYRAPELMLGATEYTPSIDLWSIGCVFGELILGKPLFSGETSIDQLVRIIQIMGTPTKEQMIRMNP--HYTEVRF  278 (383)
T ss_dssp             CCCCSSCCCHHHHTTCSSCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCT--TC--CCC
T ss_pred             cccCCCccCHHHhcCCCCCCcchhhhhHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhCc--ccccccC
Confidence            57799999999998876689999999999999999999999999999999999999999876543221110  0111111


Q ss_pred             chHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         215 PKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       215 ~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +.......... .+...+.++++||.+||..||.+|||+.|+|+||||.+
T Consensus       279 ~~~~~~~~~~~-~~~~~~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          279 PTLKAKDWRKI-LPEGTPSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CCCCCCCHHHH-SCTTCCHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CccCcccHHhh-CCCCCCHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            11111111111 12236788999999999999999999999999999954

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=100.00  E-value=3.2e-41  Score=329.32  Aligned_cols=250  Identities=36%  Similarity=0.582  Sum_probs=197.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++||||+++++++.....   .....+|+||||++++|.+++...  .+++..++.++.||+.||+||
T Consensus        70 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~---~~~~~~~iv~e~~~~~L~~~l~~~--~~~~~~~~~i~~qi~~aL~~L  144 (364)
T 3qyz_A           70 QRTLREIKILLRFRHENIIGINDIIRAPTI---EQMKDVYIVQDLMETDLYKLLKTQ--HLSNDHICYFLYQILRGLKYI  144 (364)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSST---TTCCCEEEEEECCSEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCccceeEEecCCc---cccceEEEEEcccCcCHHHHHHhC--CCCHHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999999976521   113568999999999999988753  589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++........ ........+||+.|+|||++.+...++.++|||||||++|
T Consensus       145 H~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il~  223 (364)
T 3qyz_A          145 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA  223 (364)
T ss_dssp             HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC-BCCTTCCCCSCGGGCCHHHHHTBCSCSTHHHHHHHHHHHH
T ss_pred             HHCCeecCCCChHhEEECCCCCEEEEeCcceEecCCCCC-ccccccccccccCCCCCHHhcCCCCCCcchhHHHHHHHHH
Confidence            999999999999999999999999999999987653321 1122345688999999999877666899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-ccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+.+..+....|.+..+.+............ ..+...........  ...+.++++||.+||..|
T Consensus       224 ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~li~~~L~~d  301 (364)
T 3qyz_A          224 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF--PNADSKALDLLDKMLTFN  301 (364)
T ss_dssp             HHHHSSCSSCCSSGGGHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC--TTSCHHHHHHHHHHTCSS
T ss_pred             HHHHCCCCCCCCChHHHHHHHHHHhCCCCHHHHHHhhhhhHHHHHHhcCCccCCCHHHhC--CCCCHHHHHHHHHHcCCC
Confidence            999999999999999999999999888765443322221110000 00000000000000  125788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|||++|+|+||||.+.
T Consensus       302 P~~R~t~~e~l~hp~~~~~  320 (364)
T 3qyz_A          302 PHKRIEVEQALAHPYLEQY  320 (364)
T ss_dssp             TTTSCCHHHHHTSGGGTTT
T ss_pred             hhhCCCHHHHhcCcchhhc
Confidence            9999999999999999764

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=100.00  E-value=2.8e-41  Score=328.04  Aligned_cols=213  Identities=25%  Similarity=0.381  Sum_probs=177.5

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+++|+.+|+.+ +|||||++++++.+.        +.+|+|||||.+ +|...+.+. ..+++..++.++.||+.||
T Consensus        67 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  137 (353)
T 3txo_A           67 VECTMTEKRILSLARNHPFLTQLFCCFQTP--------DRLFFVMEFVNGGDLMFHIQKS-RRFDEARARFYAAEIISAL  137 (353)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCceeeEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHH
Confidence            34578999999988 799999999999876        669999999975 788887664 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. |+.++|||||||
T Consensus       138 ~~LH~~givHrDlkp~NILl~~~g~ikL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  212 (353)
T 3txo_A          138 MFLHDKGIIYRDLKLDNVLLDHEGHCKLADFGMCKEGICNG----VTTATFCGTPDYIAPEILQEML-YGPAVDWWAMGV  212 (353)
T ss_dssp             HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCC-------------CCGGGCCHHHHHHHH-CTTHHHHHHHHH
T ss_pred             HHHHHCCCcccCCCHHHEEECCCCCEEEccccceeecccCC----ccccccCCCcCeEChhhcCCCC-cCCccCCCcchH
Confidence            99999999999999999999999999999999997643221    2334568999999999997655 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+....|.......                                +...+.++.+||.+||.
T Consensus       213 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~lL~  260 (353)
T 3txo_A          213 LLYEMLCGHAPFEAENEDDLFEAILNDEVVY--------------------------------PTWLHEDATGILKSFMT  260 (353)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhh
Confidence            9999999999999999888777775521111                                11256778899999999


Q ss_pred             cCCCCCCCH------HHhhcCCCccCC
Q psy7889         245 LDPSKRFDS------DAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~------~e~L~h~~~~~~  265 (433)
                      .||.+||++      +|+++||||...
T Consensus       261 ~dP~~R~~~~~~~~~~~il~hp~f~~~  287 (353)
T 3txo_A          261 KNPTMRLGSLTQGGEHAILRHPFFKEI  287 (353)
T ss_dssp             SSGGGSTTSGGGTCTHHHHTSGGGTTC
T ss_pred             hCHHHccCCcccCCHHHHhhCCcccCC
Confidence            999999999      899999999653

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=100.00  E-value=5.7e-42  Score=330.53  Aligned_cols=212  Identities=23%  Similarity=0.410  Sum_probs=176.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        +.+|+||||++++|.+.+... ..+++..++.++.||+.||.|
T Consensus        53 ~~~~~~E~~~l~~l~hpnIv~l~~~~~~~--------~~~~lv~E~~~g~l~~~l~~~-~~l~~~~~~~i~~qi~~aL~~  123 (336)
T 3h4j_B           53 HMRVEREISYLKLLRHPHIIKLYDVITTP--------TDIVMVIEYAGGELFDYIVEK-KRMTEDEGRRFFQQIICAIEY  123 (336)
T ss_dssp             SHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEeC--------CEEEEEEECCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999876        569999999999999988764 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+....+.++|||||||++
T Consensus       124 LH~~givH~Dlkp~NIll~~~~~~kl~DFG~s~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~il  198 (336)
T 3h4j_B          124 CHRHKIVHRDLKPENLLLDDNLNVKIADFGLSNIMTDGN-----FLKTSCGSPNYAAPEVINGKLYAGPEVDVWSCGIVL  198 (336)
T ss_dssp             HHHHTCCCCCCSTTTEEECTTCCEEECCSSCTBTTTTSB-----TTCCCTTSTTTSCGGGSCCSGGGCHHHHHHHHHHHH
T ss_pred             HHHCCeEecCCchhhEEEcCCCCEEEEEeccceeccCCc-----ccccccCCcCcCCHHHHcCCCCCCCccchhHHHHHH
Confidence            999999999999999999999999999999998765332     234567899999999998776457899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.......               ..+..    ..             ...+...++++.+||.+||..|
T Consensus       199 ~~ll~g~~Pf~~~~~~~~~---------------~~i~~----~~-------------~~~p~~~s~~~~~li~~~L~~d  246 (336)
T 3h4j_B          199 YVMLVGRLPFDDEFIPNLF---------------KKVNS----CV-------------YVMPDFLSPGAQSLIRRMIVAD  246 (336)
T ss_dssp             HHHHHSSCSSBCSSSTTCB---------------CCCCS----SC-------------CCCCTTSCHHHHHHHHTTSCSS
T ss_pred             HHHHhCCCCCCCccHHHHH---------------HHHHc----CC-------------CCCcccCCHHHHHHHHHHcCCC
Confidence            9999999999764321100               00000    00             0012235788899999999999


Q ss_pred             CCCCCCHHHhhcCCCccC
Q psy7889         247 PSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~  264 (433)
                      |.+|||++|+++||||..
T Consensus       247 P~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          247 PMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             GGGSCCHHHHTTCHHHHT
T ss_pred             hhHCcCHHHHHhChhhcc
Confidence            999999999999999964

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=100.00  E-value=2e-41  Score=330.31  Aligned_cols=246  Identities=28%  Similarity=0.483  Sum_probs=189.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++||||+++++++.....   .....+|+||||+.++|.+.+......+++..++.++.||+.||.||
T Consensus        74 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~---~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~l  150 (362)
T 3pg1_A           74 KRVLREIRLLNHFHHPNILGLRDIFVHFEE---PAMHKLYLVTELMRTDLAQVIHDQRIVISPQHIQYFMYHILLGLHVL  150 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEEEECCT---TTCCEEEEEEECCSEEHHHHHHCTTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCccceeeeEEeccC---CCcceEEEEEccCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHHH
Confidence            678999999999999999999999976432   12357999999999999999988777799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++.......     ......+|+.|+|||++.+...++.++|||||||++|
T Consensus       151 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  225 (362)
T 3pg1_A          151 HEAGVVHRDLHPGNILLADNNDITICDFNLAREDTADA-----NKTHYVTHRWYRAPELVMQFKGFTKLVDMWSAGCVMA  225 (362)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECCTTC--------------------CGGGCCHHHHTTCTTCCTHHHHHHHHHHHH
T ss_pred             HHCcCEecCCChHHEEEcCCCCEEEEecCccccccccc-----ccceecccceecCcHHhcCCCCCCcHhHHHhHHHHHH
Confidence            99999999999999999999999999999997544321     2234578999999999987556899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-----ccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-----ELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-----~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      +|++|.+||.+....+.+..+....+.+..+.+............     ..+....   ..  .....++.+.+||.+|
T Consensus       226 ~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~--~~~~~~~~~~~li~~~  300 (362)
T 3pg1_A          226 EMFNRKALFRGSTFYNQLNKIVEVVGTPKIEDVVMFSSPSARDYLRNSLSNVPARAW---TA--VVPTADPVALDLIAKM  300 (362)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHTSCHHHHHHTTTCCCCCCCCCH---HH--HSTTSCHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHcCCCChHHhhhccchhhhHHHHhhcccCChhhH---Hh--hCCCCCHHHHHHHHHH
Confidence            999999999999999999999988887654322111110000000     0000000   00  0113477889999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|||++|+|+||||....
T Consensus       301 L~~dP~~Rpt~~ell~hp~f~~~~  324 (362)
T 3pg1_A          301 LEFNPQRRISTEQALRHPYFESLF  324 (362)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             hcCChhhCCCHHHHHcCchhhhcc
Confidence            999999999999999999997654

>3hmm_A TGF-beta receptor type-1; ALK5, kinase, inhibitor, quinazoline, aortic aneurysm, ATP-binding, craniosynostosis, disease mutation, disulfide bond; HET: 855; 1.70A {Homo sapiens} PDB: 1vjy_A* 3gxl_A* 3tzm_A* 2wot_A* 2wou_A* 1py5_A* 1rw8_A*

Probab=100.00  E-value=5.9e-42  Score=325.42  Aligned_cols=219  Identities=22%  Similarity=0.296  Sum_probs=156.3

Q ss_pred             HHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC
Q psy7889          12 REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN   90 (433)
Q Consensus        12 ~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~   90 (433)
                      .|+..+..++|||||++++++..+..    ....+|||||||+ |+|.+++...  .++++.+..++.|++.||+|||++
T Consensus        46 ~Ei~~~~~l~HpNIv~l~g~~~~~~~----~~~~~~lV~Ey~~~gsL~~~l~~~--~l~~~~~~~i~~~ia~gl~ylH~~  119 (303)
T 3hmm_A           46 AEIYQTVMLRHENILGFIAADNKDNG----TWTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGLAHLHME  119 (303)
T ss_dssp             HHHHTSTTCCCTTBCCEEEEEEEECS----SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHHHHCC
T ss_pred             HHHHHHhcCCCCCCCcEEEEEEecCC----CceEEEEEecCCCCCcHHHHHHhC--CCCHHHHHHHHHHHHHHHHHHHHh
Confidence            34555567899999999999987632    1246899999998 5899988753  589999999999999999999987


Q ss_pred             --------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-----CCCCcc
Q psy7889          91 --------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-----NYGPPV  157 (433)
Q Consensus        91 --------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-----~~~~~~  157 (433)
                              +|+||||||+|||++.++.+||+|||+|+................+||+.|+|||++.+..     .|+.++
T Consensus       120 ~~~~~~~~~IiHRDlKp~NILl~~~~~~Ki~DFGla~~~~~~~~~~~~~~~~~~GT~~ymAPE~l~~~~~~~~~~~~~k~  199 (303)
T 3hmm_A          120 IVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRA  199 (303)
T ss_dssp             BCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEESCC-----CCGGGCCHHHHTTCSCTTCHHHHHHH
T ss_pred             hhhccCCCCEeeccCCcccEEECCCCCEEEEeCCCCccccCCCCceeeecccccccccccCHHHhcccccccCCccChhH
Confidence                    9999999999999999999999999999876543322222334568999999999997642     256799


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHH-----------HHHHHHH-HhCCCCCCCCCcccchhhhhccccchHHHhhHHhh
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQ-----------QITLISQ-LCGSITPESWPGVETLDLYNKMELPKAQKRKVKER  225 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~-----------~~~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (433)
                      ||||+||++|||++|.+||.......           ....+.. +.........+              .        .
T Consensus       200 DVwS~Gvvl~El~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~rp~~p--------------~--------~  257 (303)
T 3hmm_A          200 DIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKVVCEQKLRPNIP--------------N--------R  257 (303)
T ss_dssp             HHHHHHHHHHHHHHTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSCCCCCCC--------------G--------G
T ss_pred             hhhhHHHHHHHHHHCCCCCCccccccccchhcccccchHHHHHHHHhcccCCCCCC--------------c--------c
Confidence            99999999999999988775432110           0000110 00000000000              0        0


Q ss_pred             hCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         226 LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       226 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+......+.+|+.+||+.||++|||+.|+++
T Consensus       258 ~~~~~~~~~l~~li~~cl~~dP~~RPt~~ei~~  290 (303)
T 3hmm_A          258 WQSCEALRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             GGSSHHHHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             ccchHHHHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            000011234568999999999999999999985

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=100.00  E-value=1.7e-40  Score=318.10  Aligned_cols=208  Identities=24%  Similarity=0.363  Sum_probs=179.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        ..+|+||||+.+ +|.+++.+. ..+++..++.++.||+.||+|
T Consensus        51 ~~~~~E~~~l~~l~hp~Iv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~  121 (318)
T 1fot_A           51 EHTNDERLMLSIVTHPFIIRMWGTFQDA--------QQIFMIMDYIEGGELFSLLRKS-QRFPNPVAKFYAAEVCLALEY  121 (318)
T ss_dssp             HHHHHHHHHHHSCCBTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHT-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCceEeEEEEeC--------CEEEEEEeCCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        669999999975 888888763 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||++.....       .....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       122 LH~~~ivHrDlkp~NIll~~~g~~kL~Dfg~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  193 (318)
T 1fot_A          122 LHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPD-------VTYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGILI  193 (318)
T ss_dssp             HHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSS-------CBCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHHH
T ss_pred             HHHCCccccCCChheEEEcCCCCEEEeecCcceecCC-------ccccccCCccccCHhHhcCCC-CCcccchhhhHHHH
Confidence            9999999999999999999999999999999977542       223567899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+.......+.......                                +...+.++.+||.+||..|
T Consensus       194 ~ell~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~lL~~d  241 (318)
T 1fot_A          194 YEMLAGYTPFYDSNTMKTYEKILNAELRF--------------------------------PPFFNEDVKDLLSRLITRD  241 (318)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCSC
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CCCCCHHHHHHHHHHhccC
Confidence            99999999999988877776665421110                                1125677889999999999


Q ss_pred             CCCCC-----CHHHhhcCCCccC
Q psy7889         247 PSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~-----t~~e~L~h~~~~~  264 (433)
                      |.+|+     +++++++||||..
T Consensus       242 p~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          242 LSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             HHHcCCCcCCCHHHHhcCccccC
Confidence            99999     9999999999965

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=100.00  E-value=1.6e-41  Score=332.29  Aligned_cols=248  Identities=28%  Similarity=0.475  Sum_probs=181.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++.....  ......+|+||||+.++|.+.+..   .+++..++.++.||+.||+||
T Consensus        69 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~al~~l  143 (371)
T 2xrw_A           69 KRAYRELVLMKCVNHKNIIGLLNVFTPQKS--LEEFQDVYIVMELMDANLCQVIQM---ELDHERMSYLLYQMLCGIKHL  143 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSCCS--TTTCCEEEEEEECCSEEHHHHHHS---CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCccceEEeeccccc--cccccceEEEEEcCCCCHHHHHhh---ccCHHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999986521  111347899999999999888853   589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++......     ......+||+.|+|||++.+.. ++.++|||||||++|
T Consensus       144 H~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~  217 (371)
T 2xrw_A          144 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMG  217 (371)
T ss_dssp             HHTTCCCSCCCGGGEEECTTSCEEECCCCC---------------------CTTCCHHHHTTCC-CCTTHHHHHHHHHHH
T ss_pred             HHCCeecccCCHHHEEEcCCCCEEEEEeecccccccc-----cccCCceecCCccCHHHhcCCC-CCchHhHHHHHHHHH
Confidence            9999999999999999999999999999999765432     1234467899999999998765 899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhC----C------ccCChhHHH
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK----P------YVKDQYGCD  237 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------~~~s~~~~~  237 (433)
                      +|++|.+||.+.+..+.+..+....|.+.++.+..............+..........+.    +      ...+.++++
T Consensus       218 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  297 (371)
T 2xrw_A          218 EMIKGGVLFPGTDHIDQWNKVIEQLGTPCPEFMKKLQPTVRTYVENRPKYAGYSFEKLFPDVLFPADSEHNKLKASQARD  297 (371)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHC-CCCCCHHHHTTSCHHHHHHHHSSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHhhhHHHHHHhhCccccccchhhhcccccCcccccccccccHHHHH
Confidence            999999999999999988888887776654433322111000000000000000000000    0      012467889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+||..||.+|||++|+|+||||....
T Consensus       298 li~~mL~~dP~~R~t~~e~l~hp~~~~~~  326 (371)
T 2xrw_A          298 LLSKMLVIDASKRISVDEALQHPYINVWY  326 (371)
T ss_dssp             HHHHHSCSSGGGSCCHHHHHHSHHHHTTC
T ss_pred             HHHHHCcCChhhCCCHHHHhCCcchhhhc
Confidence            99999999999999999999999996543

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=100.00  E-value=1.5e-40  Score=324.26  Aligned_cols=214  Identities=29%  Similarity=0.465  Sum_probs=179.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+|+.++|||||++++++.+.        +..|+|||||.+ +|.+.+... ..+++..++.++.||+.||+|
T Consensus        73 ~~~~~E~~il~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~al~~  143 (362)
T 2bdw_A           73 QKLEREARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAY  143 (362)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHTTC-SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEeC--------CEEEEEEecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875        669999999975 888887653 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+|||++.++   .+||+|||++.......     .....+||+.|+|||++.+.. ++.++||||||
T Consensus       144 lH~~~ivH~Dlkp~NIll~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  217 (362)
T 2bdw_A          144 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACG  217 (362)
T ss_dssp             HHHTTCBCCCCSGGGEEESCSSTTCCEEECCCTTCBCCTTCC-----SCCCSCSCTTTCCHHHHTTCC-CCTHHHHHHHH
T ss_pred             HHHCCeEeccCchHHEEEecCCCCCCEEEeecCcceEecCCc-----ccccCCCCccccCHHHHccCC-CCchhhHHHHH
Confidence            9999999999999999998654   59999999998765321     234567899999999997755 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+.......+.......+...|                            ...+.++++||.+||
T Consensus       218 ~il~~ll~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~L  269 (362)
T 2bdw_A          218 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW----------------------------DTVTPEAKSLIDSML  269 (362)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTGG----------------------------GGSCHHHHHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCcccc----------------------------cCCCHHHHHHHHHHc
Confidence            9999999999999998887777766553322221111                            124677889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||.+|||+.|+|+||||..
T Consensus       270 ~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          270 TVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CSSGGGSCCHHHHTTSHHHHT
T ss_pred             CCChhhCcCHHHHhcCcccCC
Confidence            999999999999999999954

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=100.00  E-value=2.2e-40  Score=325.52  Aligned_cols=216  Identities=22%  Similarity=0.364  Sum_probs=182.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++|||||++++++.+.        ..+|+|||||. ++|.+.+......+++..++.++.||+.||+|
T Consensus        93 ~~~~~E~~il~~l~hpnIv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~  164 (387)
T 1kob_A           93 YTVKNEISIMNQLHHPKLINLHDAFEDK--------YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLKH  164 (387)
T ss_dssp             HHHHHHHHHHTTCCSTTBCCEEEEEECS--------SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcCCCeEEEEEEeC--------CEEEEEEEcCCCCcHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875        66999999997 48988887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec--CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITK--TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      ||++||+||||||+|||++.  .+.+||+|||++.......     .....+||+.|+|||++.+.. ++.++|||||||
T Consensus       165 LH~~givHrDlkp~NIll~~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG~  238 (387)
T 1kob_A          165 MHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIGV  238 (387)
T ss_dssp             HHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHHH
T ss_pred             HHhCCeeecccchHHeEEecCCCCceEEEecccceecCCCc-----ceeeeccCCCccCchhccCCC-CCCcccEeeHhH
Confidence            99999999999999999974  4689999999998765321     223447899999999997755 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+.+..+...........+                            ...+.++++||.+||.
T Consensus       239 il~elltg~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~L~  290 (387)
T 1kob_A          239 LGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAF----------------------------SSVSPEAKDFIKNLLQ  290 (387)
T ss_dssp             HHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTT----------------------------TTSCHHHHHHHHTTSC
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc----------------------------ccCCHHHHHHHHHHcC
Confidence            999999999999999888777766553222211111                            1246778899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .||.+|||++|+|+||||...
T Consensus       291 ~dP~~Rpt~~ell~hp~~~~~  311 (387)
T 1kob_A          291 KEPRKRLTVHDALEHPWLKGD  311 (387)
T ss_dssp             SSGGGSCCHHHHHTSTTTSSC
T ss_pred             CChhHCcCHHHHhhCccccCC
Confidence            999999999999999999754

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=100.00  E-value=3.1e-40  Score=320.24  Aligned_cols=219  Identities=28%  Similarity=0.452  Sum_probs=184.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+|+.++|||||++++++...        +..|+||||+.+++.+.+......+++..++.++.|++.||.||
T Consensus        99 ~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~g~l~~~l~~~~~~l~~~~~~~i~~qi~~aL~~L  170 (348)
T 1u5q_A           99 QDIIKEVRFLQKLRHPNTIQYRGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL  170 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC--------CeEEEEEecCCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999875        66999999999999999877677899999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGvi  165 (433)
                      |++||+||||||+|||++.++.+||+|||++.....        .....||+.|+|||++.+  ...++.++|||||||+
T Consensus       171 H~~~ivH~Dlkp~NIll~~~~~~kL~DfG~a~~~~~--------~~~~~gt~~y~aPE~~~~~~~~~~~~~~DiwslG~i  242 (348)
T 1u5q_A          171 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  242 (348)
T ss_dssp             HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------BCCCCSCGGGCCHHHHHTTSSCCBCTHHHHHHHHHH
T ss_pred             HhCCeeeCCCCHHHEEECCCCCEEEeeccCceecCC--------CCcccCCcceeCHhhhccccCCCCCcHHHHHHHHHH
Confidence            999999999999999999999999999999976542        234578999999999853  3347899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||.+.+....+..+.......                              ..+...+..+.+||.+||..
T Consensus       243 l~ell~g~~p~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~l~~li~~~l~~  292 (348)
T 1u5q_A          243 CIELAERKPPLFNMNAMSALYHIAQNESPA------------------------------LQSGHWSEYFRNFVDSCLQK  292 (348)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCCCC------------------------------CCCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCC------------------------------CCCCCCCHHHHHHHHHHccc
Confidence            999999999999888777666554321100                              00112466778999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCchhH
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSDLS  272 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~~~  272 (433)
                      ||.+|||++++|+||||.....+....
T Consensus       293 dP~~Rps~~~ll~h~~~~~~~~~~~~~  319 (348)
T 1u5q_A          293 IPQDRPTSEVLLKHRFVLRERPPTVIM  319 (348)
T ss_dssp             SGGGSCCHHHHTTCHHHHSCCCTTHHH
T ss_pred             ChhhCcCHHHHhhChhhhccCCcchhh
Confidence            999999999999999998766554433

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-40  Score=319.25  Aligned_cols=217  Identities=25%  Similarity=0.441  Sum_probs=181.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||.
T Consensus        58 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~al~  128 (326)
T 2y0a_A           58 REDIEREVSILKEIQHPNVITLHEVYENK--------TDVILILELVAGGELFDFLAE-KESLTEEEATEFLKQILNGVY  128 (326)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHTT-SSCCBHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--------CEEEEEEEcCCCCCHHHHHHh-cCCcCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        66999999996 588888865 446999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.++    .+||+|||++.......     ......||+.|+|||++.+.. ++.++||||
T Consensus       129 ~lH~~~ivH~Dlkp~NIll~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Diws  202 (326)
T 2y0a_A          129 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWS  202 (326)
T ss_dssp             HHHHTTEECCCCCGGGEEESCSSSSSCCEEECCCTTCEECCTTS-----CCCCCCSCTTTCCHHHHTTCC-CCTHHHHHH
T ss_pred             HHHHCCeEcCCCCHHHEEEecCCCCCCCEEEEECCCCeECCCCC-----ccccccCCcCcCCceeecCCC-CCcHHHHHH
Confidence            99999999999999999999877    89999999998765322     234457899999999997655 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||.+....+.+..+........                   ...         ....+..+.+||.+
T Consensus       203 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~~li~~  254 (326)
T 2y0a_A          203 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------DEY---------FSNTSALAKDFIRR  254 (326)
T ss_dssp             HHHHHHHHHHSCCSSCCSSHHHHHHHHHHTCCCCC-------------------HHH---------HTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHCcCCCCCCCHHHHHHHHHhcCCCcC-------------------ccc---------cccCCHHHHHHHHH
Confidence            99999999999999999888877766654322111                   000         01246778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||..||.+|||++|+|+||||....
T Consensus       255 ~L~~dP~~Rpt~~e~l~hp~~~~~~  279 (326)
T 2y0a_A          255 LLVKDPKKRMTIQDSLQHPWIKPKD  279 (326)
T ss_dssp             HSCSSGGGSCCHHHHHHSTTTSCCS
T ss_pred             HccCChhhCCCHHHHhcCCCccCCc
Confidence            9999999999999999999997543

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=100.00  E-value=8.3e-41  Score=333.34  Aligned_cols=241  Identities=29%  Similarity=0.510  Sum_probs=190.0

Q ss_pred             hhHHHHHHHHHhC------CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL------KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l------~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql   80 (433)
                      ..+.+|+.+++.+      +|+||+++++++...        ..+|+||||++++|.+++.... ..+++..++.++.||
T Consensus       138 ~~~~~E~~~l~~l~~~~~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi  209 (429)
T 3kvw_A          138 RQAAEEIRILEHLRKQDKDNTMNVIHMLENFTFR--------NHICMTFELLSMNLYELIKKNKFQGFSLPLVRKFAHSI  209 (429)
T ss_dssp             HHHHHHHHHHHHHHTTCTTSCSCBCCEEEEEEET--------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhccccCCcCEEEEEeecccC--------CeEEEEEeccCCCHHHHHHhccCCCCCHHHHHHHHHHH
Confidence            5677899999888      577999999999876        6799999999999999997754 348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCc--EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~--~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      +.||+|||++||+||||||+|||++.++.  +||+|||++.....       .....+||+.|+|||++.+.. ++.++|
T Consensus       210 ~~aL~~LH~~~ivHrDlKp~NILl~~~~~~~vkL~DFG~a~~~~~-------~~~~~~gt~~y~aPE~~~~~~-~~~~~D  281 (429)
T 3kvw_A          210 LQCLDALHKNRIIHCDLKPENILLKQQGRSGIKVIDFGSSCYEHQ-------RVYTYIQSRFYRAPEVILGAR-YGMPID  281 (429)
T ss_dssp             HHHHHHHHHHTEECSCCSGGGEEESSTTSCCEEECCCTTCEETTC-------CCCSSCSCGGGCCHHHHHTBC-CCTHHH
T ss_pred             HHHHHHHHHCCeecCCCCHHHeEEccCCCcceEEeecccceecCC-------cccccCCCCCccChHHHhCCC-CCchHH
Confidence            99999999999999999999999999887  99999999966432       233567899999999998866 799999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhh-ccccch---------------------
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYN-KMELPK---------------------  216 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~-~~~~~~---------------------  216 (433)
                      ||||||++|+|++|.+||.+.+..+.+..+....|.++...+........+. ....+.                     
T Consensus       282 iwSlG~il~elltG~~pf~~~~~~~~l~~i~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  361 (429)
T 3kvw_A          282 MWSLGCILAELLTGYPLLPGEDEGDQLACMIELLGMPSQKLLDASKRAKNFVSSKGYPRYCTVTTLSDGSVVLNGGRSRR  361 (429)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTBTTHHHHBCTTSCBTTSCEECCCC--CEECCEECTT
T ss_pred             HHhHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCCHHHHHhhhhhhhccCCCCCcccccccccccccccccccccch
Confidence            9999999999999999999999999999999998877654322111111000 000000                     


Q ss_pred             ------HHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         217 ------AQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       217 ------~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                            ......... .+...++++++||.+||++||.+|||++|+|+||||+..
T Consensus       362 ~~~~~~~~~~~~~~~-l~~~~~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          362 GKLRGPPESREWGNA-LKGCDDPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CCEECSTTCSCHHHH-TTTCCCHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             hhccCCccchhhHhh-ccccchHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence                  000000000 111247788999999999999999999999999999764

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=100.00  E-value=1.4e-40  Score=328.94  Aligned_cols=219  Identities=25%  Similarity=0.314  Sum_probs=183.3

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+.+|+.+|+.++|||||+++++|.+.        ..+|||||||+ ++|.+++.+  ..+++..++.++.||+.||
T Consensus       112 ~~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~l~~--~~~~e~~~~~~~~qi~~aL  181 (410)
T 3v8s_A          112 DSAFFWEERDIMAFANSPWVVQLFYAFQDD--------RYLYMVMEYMPGGDLVNLMSN--YDVPEKWARFYTAEVVLAL  181 (410)
T ss_dssp             CCSTHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHH--CCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEEC--------CEEEEEEeCCCCCcHHHHHHc--CCCCHHHHHHHHHHHHHHH
Confidence            345688999999999999999999999875        66999999996 588888865  3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC---CCCcchhhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN---YGPPVDLWG  161 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---~~~~~DiwS  161 (433)
                      +|||++||+||||||+|||++.+|.+||+|||++.......   .......+||+.|+|||++.+...   |+.++||||
T Consensus       182 ~~LH~~givHrDLKp~NILl~~~g~ikL~DFG~a~~~~~~~---~~~~~~~~gt~~Y~APE~l~~~~~~~~~~~~~DiwS  258 (410)
T 3v8s_A          182 DAIHSMGFIHRDVKPDNMLLDKSGHLKLADFGTCMKMNKEG---MVRCDTAVGTPDYISPEVLKSQGGDGYYGRECDWWS  258 (410)
T ss_dssp             HHHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTS---EEECCSCCSCGGGCCHHHHHTTTTTCEEETHHHHHH
T ss_pred             HHHHHCCeEeccCCHHHeeECCCCCEEEeccceeEeeccCC---cccccCCcCCccccCHHHhhccCCCcCCCCcceEec
Confidence            99999999999999999999999999999999998765322   122346789999999999976532   688999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|.+||.+.+..+....|...........                            ....+.++++||.+
T Consensus       259 lGvilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~p~----------------------------~~~~s~~~~~li~~  310 (410)
T 3v8s_A          259 VGVFLYEMLVGDTPFYADSLVGTYSKIMNHKNSLTFPD----------------------------DNDISKEAKNLICA  310 (410)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCT----------------------------TCCCCHHHHHHHHH
T ss_pred             chHHHHHHHhCCCCCCCCChhhHHHHHHhccccccCCC----------------------------cccccHHHHHHHHH
Confidence            99999999999999999998887777754221111000                            01357888999999


Q ss_pred             hcccCCCC--CCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      ||..+|.+  |++++|+++||||+..
T Consensus       311 lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          311 FLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             HSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             HccChhhhCCCCCHHHHhcCccccCC
Confidence            99999988  9999999999999753

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=100.00  E-value=1.7e-40  Score=330.78  Aligned_cols=221  Identities=22%  Similarity=0.288  Sum_probs=184.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|..++|||||+++++|.+.        +.+|||||||. ++|.+++.+....+++..++.++.||+.||+
T Consensus       118 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--------~~~~lV~Ey~~gg~L~~~l~~~~~~l~e~~~~~~~~qi~~aL~  189 (437)
T 4aw2_A          118 TACFREERDVLVNGDSKWITTLHYAFQDD--------NNLYLVMDYYVGGDLLTLLSKFEDRLPEEMARFYLAEMVIAID  189 (437)
T ss_dssp             TCCHHHHHHHHHHSCTTTBCCEEEEEECS--------SEEEEEECCCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEEeeC--------CEEEEEEecCCCCcHHHHHHHccCCCCHHHHHHHHHHHHHHHH
Confidence            34588999999999999999999999876        66999999995 5899999876678999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc----CCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.+|.+||+|||+++.......   ......+||+.|+|||++.    +...|+.++||||
T Consensus       190 ~LH~~giiHrDLKp~NILl~~~g~vkL~DFGla~~~~~~~~---~~~~~~~GT~~Y~APE~l~~~~~~~~~~~~~~DvwS  266 (437)
T 4aw2_A          190 SVHQLHYVHRDIKPDNILMDMNGHIRLADFGSCLKLMEDGT---VQSSVAVGTPDYISPEILQAMEGGKGRYGPECDWWS  266 (437)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC---EECCSCCSCGGGCCHHHHHHHHTSCCEECTHHHHHH
T ss_pred             HHHhCCeEecccCHHHeeEcCCCCEEEcchhhhhhcccCCC---cccccccCCcCeeChHHHhhcccCCCCCCCcCeeHH
Confidence            99999999999999999999999999999999977643221   2234468999999999986    2344899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|||++|.+||.+.+..+....|...........                           .....+.++++||.+
T Consensus       267 lGvil~elltG~~Pf~~~~~~~~~~~i~~~~~~~~~p~---------------------------~~~~~s~~~~dLi~~  319 (437)
T 4aw2_A          267 LGVCMYEMLYGETPFYAESLVETYGKIMNHKERFQFPT---------------------------QVTDVSENAKDLIRR  319 (437)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCCCCS---------------------------SCCCSCHHHHHHHHT
T ss_pred             HHHHHHHHHhCCCCCCCCChhHHHHhhhhccccccCCc---------------------------ccccCCHHHHHHHHH
Confidence            99999999999999999998888777754221110000                           001257888999999


Q ss_pred             hcccCCCC--CCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSK--RFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~--R~t~~e~L~h~~~~~~  265 (433)
                      ||..+|++  |++++|+++||||...
T Consensus       320 lL~~~~~r~~r~~~~eil~Hpff~~i  345 (437)
T 4aw2_A          320 LICSREHRLGQNGIEDFKKHPFFSGI  345 (437)
T ss_dssp             TSSCGGGCTTTTTTHHHHTSGGGTTC
T ss_pred             HhcccccccCCCCHHHHhCCCccCCC
Confidence            99998888  9999999999999653

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=100.00  E-value=1.1e-40  Score=326.44  Aligned_cols=217  Identities=22%  Similarity=0.358  Sum_probs=183.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        +.+||||||+++ +|.+.+......+++..++.++.||+.||+
T Consensus       130 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~E~~~~~~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~  201 (373)
T 2x4f_A          130 KEEVKNEISVMNQLDHANLIQLYDAFESK--------NDIVLVMEYVDGGELFDRIIDESYNLTELDTILFMKQICEGIR  201 (373)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCEEHHHHHHTGGGCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEEC--------CEEEEEEeCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        669999999974 788888766667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEE--ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLI--TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll--~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||+  +.++.+||+|||++..+....     .....+||+.|+|||++.+.. ++.++||||||
T Consensus       202 ~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG  275 (373)
T 2x4f_A          202 HMHQMYILHLDLKPENILCVNRDAKQIKIIDFGLARRYKPRE-----KLKVNFGTPEFLAPEVVNYDF-VSFPTDMWSVG  275 (373)
T ss_dssp             HHHHTTEECCCCCGGGEEEEETTTTEEEECCCSSCEECCTTC-----BCCCCCSSCTTCCHHHHTTCB-CCHHHHHHHHH
T ss_pred             HHHHCCcccccCCHHHEEEecCCCCcEEEEeCCCceecCCcc-----ccccccCCCcEeChhhccCCC-CCcHHhHHHHH
Confidence            9999999999999999999  456789999999998765322     233457899999999987654 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+.+..+...........+                            ...+.++++||.+||
T Consensus       276 ~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~L  327 (373)
T 2x4f_A          276 VIAYMLLSGLSPFLGDNDAETLNNILACRWDLEDEEF----------------------------QDISEEAKEFISKLL  327 (373)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCSCSGGG----------------------------TTSCHHHHHHHHTTS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhccCCCChhhh----------------------------ccCCHHHHHHHHHHc
Confidence            9999999999999999988887777653322211110                            125678889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ..||.+|||++|+|+||||...
T Consensus       328 ~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          328 IKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CCChhhCCCHHHHhcCcCcCCC
Confidence            9999999999999999999764

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=100.00  E-value=3.5e-40  Score=320.05  Aligned_cols=208  Identities=27%  Similarity=0.375  Sum_probs=180.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++.+.        ..+|+||||+. ++|.+.+.+. ..+++..++.++.||+.||+|
T Consensus        86 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~  156 (350)
T 1rdq_E           86 EHTLNEKRILQAVNFPFLVKLEFSFKDN--------SNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFEY  156 (350)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEEcC--------CEEEEEEcCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            5678899999999999999999999875        66999999996 5888888764 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+|||++......       ....+||+.|+|||++.+.. ++.++|||||||++
T Consensus       157 LH~~~ivHrDlkp~NIll~~~g~~kL~DFg~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il  228 (350)
T 1rdq_E          157 LHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVLI  228 (350)
T ss_dssp             HHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHHH
T ss_pred             HHHCCcccccCccceEEECCCCCEEEcccccceeccCC-------cccccCCccccCHHHhcCCC-CCCcCCEecccHhH
Confidence            99999999999999999999999999999999876421       23467899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....|.......                                +...+.++.+||.+||+.|
T Consensus       229 ~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~lL~~d  276 (350)
T 1rdq_E          229 YEMAAGYPPFFADQPIQIYEKIVSGKVRF--------------------------------PSHFSSDLKDLLRNLLQVD  276 (350)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTCCHHHHHHHHHHSCSC
T ss_pred             hHHhhCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhhcC
Confidence            99999999999988877777665421110                                1124677889999999999


Q ss_pred             CCCCCC-----HHHhhcCCCccC
Q psy7889         247 PSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t-----~~e~L~h~~~~~  264 (433)
                      |.+||+     ++++++||||..
T Consensus       277 p~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          277 LTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             TTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             HHhccCCccCCHHHHHhCcCcCC
Confidence            999998     999999999964

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=100.00  E-value=2.1e-40  Score=320.77  Aligned_cols=212  Identities=27%  Similarity=0.450  Sum_probs=180.1

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.+ +||||+++++++.+.        ..+|+|||||. ++|...+.+. ..+++..++.++.||+.||
T Consensus        61 ~~~~~~E~~il~~~~~hp~iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  131 (345)
T 1xjd_A           61 VECTMVEKRVLSLAWEHPFLTHMFCTFQTK--------ENLFFVMEYLNGGDLMYHIQSC-HKFDLSRATFYAAEIILGL  131 (345)
T ss_dssp             HHHHHHHHHHHHHHTTCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCCCcEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHH
Confidence            34578899999987 899999999999876        66999999996 5888888764 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. ++.++|||||||
T Consensus       132 ~~LH~~~ivHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  206 (345)
T 1xjd_A          132 QFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGV  206 (345)
T ss_dssp             HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             HHHHHCCeEeCCCChhhEEECCCCCEEEeEChhhhhcccCC----CcccCCCCCcccCChhhhcCCC-CCChhhhHHHHH
Confidence            99999999999999999999999999999999997643221    2234568999999999998765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+....|....  +.   +                           +...+.++++||.+||.
T Consensus       207 il~ell~g~~Pf~~~~~~~~~~~i~~~~--~~---~---------------------------p~~~s~~~~~li~~lL~  254 (345)
T 1xjd_A          207 LLYEMLIGQSPFHGQDEEELFHSIRMDN--PF---Y---------------------------PRWLEKEAKDLLVKLFV  254 (345)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCC--CC---C---------------------------CTTSCHHHHHHHHHHSC
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHhCC--CC---C---------------------------CcccCHHHHHHHHHHhc
Confidence            9999999999999988877776664311  10   0                           11256778899999999


Q ss_pred             cCCCCCCCHH-HhhcCCCccC
Q psy7889         245 LDPSKRFDSD-AALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~~-e~L~h~~~~~  264 (433)
                      .||.+||++. ++++||||..
T Consensus       255 ~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          255 REPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             SSGGGSBTTBSCGGGSGGGTT
T ss_pred             CCHhHcCCChHHHHcCccccC
Confidence            9999999998 9999999965

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=100.00  E-value=1.6e-40  Score=323.50  Aligned_cols=252  Identities=28%  Similarity=0.434  Sum_probs=193.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+|+..++.++|||||+++++|...... ......+++||||++++|...+..   ....+++..++.++.||+.|
T Consensus        63 ~~~~~~~~~~l~~l~h~niv~~~~~~~~~~~~-~~~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~qi~~a  141 (360)
T 3e3p_A           63 RNRELQIMQDLAVLHHPNIVQLQSYFYTLGER-DRRDIYLNVVMEYVPDTLHRCCRNYYRRQVAPPPILIKVFLFQLIRS  141 (360)
T ss_dssp             CCHHHHHHHHHHHHCCTTBCCEEEEEEEECSS-CTTCEEEEEEEECCSCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHhcCCCCcccHHHhhhccccc-cccceeEEEEeecccccHHHHHHHHhhcccCCCHHHHHHHHHHHHHH
Confidence            45677888888999999999999999765321 112345889999999988776653   34568999999999999999


Q ss_pred             HHHHH--hCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIH--SNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH--~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      |.|||  ++||+||||||+|||++. ++.+||+|||++.......     ......||+.|+|||++.+...++.++|||
T Consensus       142 l~~lH~~~~~ivH~Dlkp~NIll~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~  216 (360)
T 3e3p_A          142 IGCLHLPSVNVCHRDIKPHNVLVNEADGTLKLCDFGSAKKLSPSE-----PNVAYICSRYYRAPELIFGNQHYTTAVDIW  216 (360)
T ss_dssp             HHHHTSTTTCCBCSCCCGGGEEEETTTTEEEECCCTTCBCCCTTS-----CCCSTTSCGGGCCHHHHTTCSSCCTHHHHH
T ss_pred             HHHHhCCCCCeecCcCCHHHEEEeCCCCcEEEeeCCCceecCCCC-----CcccccCCcceeCHHHHcCCCCCCcHHHHH
Confidence            99999  999999999999999996 8999999999998765332     223457799999999997766689999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhh--CCccCChhHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL--KPYVKDQYGCDL  238 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~s~~~~~l  238 (433)
                      ||||++|+|++|.+||.+.+....+..+....+.+..+.+.........  ..............+  .....+.++++|
T Consensus       217 slG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~~l  294 (360)
T 3e3p_A          217 SVGCIFAEMMLGEPIFRGDNSAGQLHEIVRVLGCPSREVLRKLNPSHTD--VDLYNSKGIPWSNVFSDHSLKDAKEAYDL  294 (360)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCTTCCC--GGGGCCCCCCHHHHTTTCCCTTHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCcCCCChHHHHHHHHHHcCCCCHHHHHhcccchhh--ccccccccCCcccccchhhccccHHHHHH
Confidence            9999999999999999999999999999988887654332211110000  000000000000111  112246788999


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+||+.||.+|||+.|+|+||||.+..
T Consensus       295 i~~~L~~dP~~Rpt~~e~l~hp~f~~~~  322 (360)
T 3e3p_A          295 LSALLQYLPEERMKPYEALCHPYFDELH  322 (360)
T ss_dssp             HHHHTCSSGGGSCCHHHHTTSGGGGGGG
T ss_pred             HHHHhccCccccCCHHHHhcCccccccC
Confidence            9999999999999999999999997644

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=100.00  E-value=7.7e-40  Score=318.90  Aligned_cols=240  Identities=24%  Similarity=0.402  Sum_probs=187.6

Q ss_pred             hhHHHHHHHHHhCC-----CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-----HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-----hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.+.     |||||++++++...        +.+|+||||++++|.+++.... ..+++..++.++.||+
T Consensus        76 ~~~~~e~~~l~~l~~~~~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~~i~~qi~  147 (360)
T 3llt_A           76 RSAKIEADILKKIQNDDINNNNIVKYHGKFMYY--------DHMCLIFEPLGPSLYEIITRNNYNGFHIEDIKLYCIEIL  147 (360)
T ss_dssp             HHHHHHHHHHHHTCCCSTTGGGBCCEEEEEEET--------TEEEEEECCCCCBHHHHHHHTTTCCCCHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHhcccCCCCCCeecccceeeEC--------CeeEEEEcCCCCCHHHHHHhcCCCCCCHHHHHHHHHHHH
Confidence            45678999999996     99999999999875        6699999999989999997654 3589999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEec-------------------------CCcEEEeecCCccccccCcCCccccccCCc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITK-------------------------TGILKLADFGLARAFSQTKNGQVNRYTNRV  136 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~-------------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~  136 (433)
                      .||+|||++||+||||||+|||++.                         ++.+||+|||++......       .....
T Consensus       148 ~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~-------~~~~~  220 (360)
T 3llt_A          148 KALNYLRKMSLTHTDLKPENILLDDPYFEKSLITVRRVTDGKKIQIYRTKSTGIKLIDFGCATFKSDY-------HGSII  220 (360)
T ss_dssp             HHHHHHHHTTEECSCCSGGGEEESCTTCCEEEEEEECTTTCCEEEEEEESCCCEEECCCTTCEETTSC-------CCSCC
T ss_pred             HHHHHHHHCCeeeCCCCcccEEEccccccccccchhcccccccccccccCCCCEEEEeccCceecCCC-------CcCcc
Confidence            9999999999999999999999975                         789999999999765422       23457


Q ss_pred             ccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhh------
Q psy7889         137 VTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYN------  210 (433)
Q Consensus       137 gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~------  210 (433)
                      ||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+.+..+....+..+...+..........      
T Consensus       221 gt~~y~aPE~~~~~~-~~~~~DiwslG~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~  299 (360)
T 3llt_A          221 NTRQYRAPEVILNLG-WDVSSDMWSFGCVLAELYTGSLLFRTHEHMEHLAMMESIIQPIPKNMLYEATKTNGSKYVNKDE  299 (360)
T ss_dssp             SCGGGCCHHHHTTCC-CCTTHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHTCCCCHHHHHHHTTSGGGGGEETTT
T ss_pred             CcccccCcHHHcCCC-CCCccchHHHHHHHHHHHHCCCCCCCCcHHHHHHHHHHhcCCCCHHHHhhhhhccCccccCccc
Confidence            899999999998765 8999999999999999999999999999999999998887766542211110000000      


Q ss_pred             -ccccch-----HHHhhHHhhh--CCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         211 -KMELPK-----AQKRKVKERL--KPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       211 -~~~~~~-----~~~~~~~~~~--~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                       ...++.     ..........  .+...+..+.+||.+||+.||.+|||++|+|+||||+
T Consensus       300 ~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          300 LKLAWPENASSINSIKHVKKCLPLYKIIKHELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             TEECTTTTCSCHHHHHHHHTCCCHHHHCCCHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             ceecCcccccchhhhhhhhhcccccccchHHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence             000000     0000000000  0112457788999999999999999999999999994

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=100.00  E-value=3.4e-40  Score=320.38  Aligned_cols=252  Identities=31%  Similarity=0.549  Sum_probs=192.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++....   ......+|+||||+.++|.+.+..  ..+++..++.++.||+.||+||
T Consensus        54 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~---~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~L~~L  128 (353)
T 2b9h_A           54 LRTLREIKILKHFKHENIITIFNIQRPDS---FENFNEVYIIQELMQTDLHRVIST--QMLSDDHIQYFIYQTLRAVKVL  128 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEECCCSC---STTCCCEEEEECCCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCCcCCeeeeecccc---cCccceEEEEEeccCccHHHHHhh--cCCCHHHHHHHHHHHHHHHHHH
Confidence            45679999999999999999999887642   112367899999999999998876  3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc------cccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ------VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |++||+||||||+|||++.++.+||+|||++..........      .......+||+.|+|||++.+...++.++||||
T Consensus       129 H~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~s  208 (353)
T 2b9h_A          129 HGSNVIHRDLKPSNLLINSNCDLKVCDFGLARIIDESAADNSEPTGQQSGMVEFVATRWYRAPEVMLTSAKYSRAMDVWS  208 (353)
T ss_dssp             HHTTEECSCCCGGGEEECTTCCEEECCCTTCEECC----------------CCCCCCGGGCCHHHHHSCCCCCHHHHHHH
T ss_pred             HHCCeecCCCCHHHeEEcCCCcEEEEecccccccccccccccCccccccchhhccccccccCCeeeccCCCccchhhHHH
Confidence            99999999999999999999999999999998765322111      112234578999999999876556899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCc-ccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPG-VETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~-~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||++|+|++|.+||.+.+..+.+..+....|.+....... ........... .+..........  ....+.++++||
T Consensus       209 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li  286 (353)
T 2b9h_A          209 CGCILAELFLRRPIFPGRDYRHQLLLIFGIIGTPHSDNDLRCIESPRAREYIKSLPMYPAAPLEKM--FPRVNPKGIDLL  286 (353)
T ss_dssp             HHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCSTTTTTTCCCHHHHHHHHTSCCCCCCCHHHH--STTSCHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCcHHHHHHHHHHhCCCchhccccccccchhhHHhhcccCCCCcchhhh--cccCCHHHHHHH
Confidence            99999999999999999999999999988888765432211 11110000000 000000000000  113678899999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+||..||.+|||++|+|+||||....
T Consensus       287 ~~~L~~dP~~Rpt~~ell~hp~~~~~~  313 (353)
T 2b9h_A          287 QRMLVFDPAKRITAKEALEHPYLQTYH  313 (353)
T ss_dssp             HHHSCSSGGGSCCHHHHHTSGGGTTTC
T ss_pred             HHhcCcCcccCCCHHHHhcCccccccC
Confidence            999999999999999999999997644

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=100.00  E-value=2e-40  Score=322.16  Aligned_cols=216  Identities=29%  Similarity=0.452  Sum_probs=174.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        +.+|+|||||. ++|...+.+.   ...+++..++.++.||+.
T Consensus        70 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  141 (351)
T 3c0i_A           70 TEDLKREASICHMLKHPHIVELLETYSSD--------GMLYMVFEFMDGADLCFEIVKRADAGFVYSEAVASHYMRQILE  141 (351)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCSSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--------CEEEEEEeCCCCCCHHHHHHHhcccCCCCCHHHHHHHHHHHHH
Confidence            45688999999999999999999999876        66999999998 5787776543   234899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCc---EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~---~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ||+|||++||+||||||+|||++.++.   +||+|||++.......    ......+||+.|+|||++.+.. ++.++||
T Consensus       142 al~~lH~~~ivHrDlkp~NIl~~~~~~~~~vkl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  216 (351)
T 3c0i_A          142 ALRYCHDNNIIHRDVKPHCVLLASKENSAPVKLGGFGVAIQLGESG----LVAGGRVGTPHFMAPEVVKREP-YGKPVDV  216 (351)
T ss_dssp             HHHHHHHTTEECSCCSGGGEEECSSSTTCCEEECCCTTCEECCTTS----CBCCCCCSCGGGCCHHHHTTCC-BCTHHHH
T ss_pred             HHHHHHHCCceeccCChHHeEEecCCCCCcEEEecCcceeEecCCC----eeecCCcCCcCccCHHHHcCCC-CCchHhh
Confidence            999999999999999999999986654   9999999998765322    1234567899999999998765 7999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++|+|++|.+||.+.. ......+.......                   +....         ...+.++++||
T Consensus       217 wslG~il~~ll~g~~pf~~~~-~~~~~~i~~~~~~~-------------------~~~~~---------~~~s~~~~~li  267 (351)
T 3c0i_A          217 WGCGVILFILLSGCLPFYGTK-ERLFEGIIKGKYKM-------------------NPRQW---------SHISESAKDLV  267 (351)
T ss_dssp             HHHHHHHHHHHHSSCSSCSSH-HHHHHHHHHTCCCC-------------------CHHHH---------TTSCHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcH-HHHHHHHHcCCCCC-------------------Ccccc---------ccCCHHHHHHH
Confidence            999999999999999998853 33333332211100                   00000         12567888999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||..||.+|||+.|+|+||||..
T Consensus       268 ~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          268 RRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             HHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhcChhhcC
Confidence            9999999999999999999999964

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=100.00  E-value=4.6e-40  Score=323.55  Aligned_cols=212  Identities=24%  Similarity=0.353  Sum_probs=173.1

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+++ +|||||+++++|.+.        +.+|||||||.+ +|...+.+. ..+++..++.++.||+.||
T Consensus        96 ~~~~~~E~~il~~~~~hp~Iv~l~~~~~~~--------~~~~lV~E~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL  166 (396)
T 4dc2_A           96 IDWVQTEKHVFEQASNHPFLVGLHSCFQTE--------SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLAL  166 (396)
T ss_dssp             CCHHHHHHHHHHHHTTCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCCcCeeEEEEEEC--------CEEEEEEEcCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHH
Confidence            34578999999887 899999999999876        669999999975 788777653 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. |+.++|||||||
T Consensus       167 ~~LH~~givHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~----~~~~~~~gt~~Y~aPE~l~~~~-~~~~~DiwslGv  241 (396)
T 4dc2_A          167 NYLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGV  241 (396)
T ss_dssp             HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----CCBCCCCBCGGGCCHHHHTTCC-BCTHHHHHHHHH
T ss_pred             HHHHHCCEEeccCCHHHEEECCCCCEEEeecceeeecccCC----CccccccCCcccCCchhhcCCC-CChHHHHHHHHH
Confidence            99999999999999999999999999999999997633221    2345678999999999998765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHH---------HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         165 IMAEMWTRSPIMQGNTEQQ---------QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~---------~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|+|++|.+||.+....+         ....+..  +..                              ..+...+.++
T Consensus       242 llyell~G~~Pf~~~~~~~~~~~~~~~~~~~~i~~--~~~------------------------------~~p~~~s~~~  289 (396)
T 4dc2_A          242 LMFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQI------------------------------RIPRSLSVKA  289 (396)
T ss_dssp             HHHHHHHSSCSSTTTTC------CCHHHHHHHHHH--CCC------------------------------CCCTTSCHHH
T ss_pred             HHHHHHhCCCCCcccccccccchhhHHHHHHHHhc--ccc------------------------------CCCCcCCHHH
Confidence            9999999999997532111         1111111  000                              0112357888


Q ss_pred             HHHHHhhcccCCCCCCCH------HHhhcCCCccC
Q psy7889         236 CDLLDKLLLLDPSKRFDS------DAALNHDFFWT  264 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~------~e~L~h~~~~~  264 (433)
                      ++||.+||+.||.+||++      +|+++||||..
T Consensus       290 ~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          290 ASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             HHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             HHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            999999999999999995      79999999965

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=100.00  E-value=1.8e-40  Score=324.83  Aligned_cols=245  Identities=35%  Similarity=0.568  Sum_probs=189.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++......  .....+|+||||+.++|...+..   .+++..++.++.||+.||+||
T Consensus        86 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~~---~~~~~~~~~i~~qi~~aL~~L  160 (371)
T 4exu_A           86 KRAYRELLLLKHMQHENVIGLLDVFTPASSL--RNFYDFYLVMPFMQTDLQKIMGM---EFSEEKIQYLVYQMLKGLKYI  160 (371)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSS--TTCCCCEEEEECCCEEHHHHTTS---CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCchhhhhheeccCCc--ccceeEEEEEccccccHHHHhhc---CCCHHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999999876321  11224599999999998887743   589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++.....       ......||+.|+|||++.+...++.++|||||||++|
T Consensus       161 H~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwslG~il~  233 (371)
T 4exu_A          161 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADA-------EMTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  233 (371)
T ss_dssp             HHTTCCCSCCCGGGEEECTTCCEEECSTTCC---------------CTTCCCTTSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHCCCcCCCcCHHHeEECCCCCEEEEecCccccccc-------CcCCcccCccccCHHHhcCCCCCCcHHhHHHHHHHHH
Confidence            999999999999999999999999999999976542       2234577999999999987556899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+.+..+....+.+..+.+............. .+..........  ....++++++||.+||+.|
T Consensus       234 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~li~~~L~~d  311 (371)
T 4exu_A          234 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQL--FPRASPQAADLLEKMLELD  311 (371)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCSCHHHHHHHHHSCCCCCCCHHHH--STTSCHHHHHHHHHHSCSC
T ss_pred             HHHhCCCCCCCCChHHHHHHHHHHhCCCcHHHHHHhhhhhhhhhhhccCCCcchhHHHh--ccccChHHHHHHHHHCCCC
Confidence            9999999999999999999999988877654333322111100000 000000000000  1135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       312 P~~Rpt~~ell~hp~f~~~~  331 (371)
T 4exu_A          312 VDKRLTAAQALTHPFFEPFR  331 (371)
T ss_dssp             TTTSCCHHHHHTSGGGTTTC
T ss_pred             hhhcCCHHHHhcCcccccCC
Confidence            99999999999999996543

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=100.00  E-value=3.4e-40  Score=313.01  Aligned_cols=215  Identities=25%  Similarity=0.366  Sum_probs=174.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+|+.++||||+++++++.+..      ...+|+||||+++ +|..++.  ...+++..++.++.||+.||+
T Consensus        80 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~------~~~~~lv~e~~~~~~l~~~~~--~~~~~~~~~~~~~~qi~~~l~  151 (298)
T 2zv2_A           80 IEQVYQEIAILKKLDHPNVVKLVEVLDDPN------EDHLYMVFELVNQGPVMEVPT--LKPLSEDQARFYFQDLIKGIE  151 (298)
T ss_dssp             -CHHHHHHHHHHTCCCTTBCCEEEEEECSS------SSEEEEEEECCTTCBSCCSSC--SSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcCC------CCEEEEEEecCCCCcHHHHhh--cCCCCHHHHHHHHHHHHHHHH
Confidence            356899999999999999999999998742      2679999999985 4444322  346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC--CCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......    .......||+.|+|||++.+...  ++.++||||||
T Consensus       152 ~lH~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG  227 (298)
T 2zv2_A          152 YLHYQKIIHRDIKPSNLLVGEDGHIKIADFGVSNEFKGSD----ALLSNTVGTPAFMAPESLSETRKIFSGKALDVWAMG  227 (298)
T ss_dssp             HHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECSSSS----CEECCCCSCGGGCCGGGCCTTCCCEESHHHHHHHHH
T ss_pred             HHHHCCeeccCCCHHHEEECCCCCEEEecCCCcccccccc----ccccCCcCCccccChhhhccCCCCCCCchhhhHhHH
Confidence            9999999999999999999999999999999998765322    12344578999999999876542  36789999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.........+.......+                              .....+.++.+||.+||
T Consensus       228 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l  277 (298)
T 2zv2_A          228 VTLYCFVFGQCPFMDERIMCLHSKIKSQALEFP------------------------------DQPDIAEDLKDLITRML  277 (298)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCC------------------------------SSSCCCHHHHHHHHHHT
T ss_pred             HHHHHHHHCCCCCCCccHHHHHHHHhcccCCCC------------------------------CccccCHHHHHHHHHHh
Confidence            999999999999998876655554433111100                              00124677889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCcc
Q psy7889         244 LLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~  263 (433)
                      ..||.+|||+.|+|+||||.
T Consensus       278 ~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          278 DKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CSCTTTSCCHHHHTTCHHHH
T ss_pred             hcChhhCCCHHHHhcCcccc
Confidence            99999999999999999995

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=100.00  E-value=1.4e-39  Score=319.04  Aligned_cols=216  Identities=25%  Similarity=0.378  Sum_probs=175.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+.+|+.++|||||+++++|.+.        ..+|+||||+.+ +|...+.. ...+++..++.++.||+.||.
T Consensus        59 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~-~~~l~~~~~~~~~~qi~~aL~  129 (384)
T 4fr4_A           59 VRNVFKELQIMQGLEHPFLVNLWYSFQDE--------EDMFMVVDLLLGGDLRYHLQQ-NVHFKEETVKLFICELVMALD  129 (384)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHT-TCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--------CEEEEEEecCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        669999999965 78777765 456999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.+|.+||+|||++..+...     ......+||+.|+|||++.+.  ..|+.++||||||
T Consensus       130 ~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~-----~~~~~~~gt~~Y~aPE~~~~~~~~~~~~~~DiwSlG  204 (384)
T 4fr4_A          130 YLQNQRIIHRDMKPDNILLDEHGHVHITDFNIAAMLPRE-----TQITTMAGTKPYMAPEMFSSRKGAGYSFAVDWWSLG  204 (384)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTT-----CCBCCCCSCGGGCCGGGTCCCSSCCBCTTHHHHHHH
T ss_pred             HHHHCCceeccCcHHHeEECCCCCEEEeccceeeeccCC-----CceeccCCCccccCCeeeccCCCCCCCccceeechH
Confidence            999999999999999999999999999999999876432     234567899999999998753  3478999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.........+........                             ..+...+.++.+||.+||
T Consensus       205 ~il~elltG~~Pf~~~~~~~~~~~~~~~~~~~~-----------------------------~~p~~~s~~~~~li~~lL  255 (384)
T 4fr4_A          205 VTAYELLRGRRPYHIRSSTSSKEIVHTFETTVV-----------------------------TYPSAWSQEMVSLLKKLL  255 (384)
T ss_dssp             HHHHHHHHSSCSSCCCTTSCHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCCCCccHHHHHHHHhhccc-----------------------------CCCCcCCHHHHHHHHHHh
Confidence            999999999999986443222211111111100                             001235678889999999


Q ss_pred             ccCCCCCCC-HHHhhcCCCccCC
Q psy7889         244 LLDPSKRFD-SDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t-~~e~L~h~~~~~~  265 (433)
                      ..||.+||+ ++++++||||...
T Consensus       256 ~~dP~~R~s~~~~l~~hp~f~~~  278 (384)
T 4fr4_A          256 EPNPDQRFSQLSDVQNFPYMNDI  278 (384)
T ss_dssp             CSSGGGSCCSHHHHHTSGGGTTC
T ss_pred             cCCHhHhcccHHHHHcChhhhcC
Confidence            999999998 8999999999653

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=100.00  E-value=8.7e-40  Score=316.69  Aligned_cols=211  Identities=24%  Similarity=0.356  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+.+ +|||||++++++.+.        ..+|+||||+.+ +|...+.+. ..+++..++.++.||+.||+
T Consensus        54 ~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~-~~l~~~~~~~~~~qi~~aL~  124 (345)
T 3a8x_A           54 DWVQTEKHVFEQASNHPFLVGLHSCFQTE--------SRLFFVIEYVNGGDLMFHMQRQ-RKLPEEHARFYSAEISLALN  124 (345)
T ss_dssp             HHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCccCeEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            3478899999988 899999999999875        669999999975 888887653 46999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. ++.++|||||||+
T Consensus       125 ~LH~~~ivHrDlkp~NIll~~~g~~kL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  199 (345)
T 3a8x_A          125 YLHERGIIYRDLKLDNVLLDSEGHIKLTDYGMCKEGLRPG----DTTSTFCGTPNYIAPEILRGED-YGFSVDWWALGVL  199 (345)
T ss_dssp             HHHHTTCBCCCCCGGGEEECTTSCEEECCGGGCBCSCCTT----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             HHHHCCceecCCCHHHEEECCCCCEEEEeccccccccCCC----CcccccCCCccccCccccCCCC-CChHHhHHHHHHH
Confidence            9999999999999999999999999999999997643221    2334568999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCCh---------HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         166 MAEMWTRSPIMQGNTE---------QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       166 l~ell~g~~pf~~~~~---------~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      +|+|++|.+||.....         ......+..  +..                              ..+...+.+++
T Consensus       200 l~ell~g~~pf~~~~~~~~~~~~~~~~~~~~i~~--~~~------------------------------~~p~~~s~~~~  247 (345)
T 3a8x_A          200 MFEMMAGRSPFDIVGSSDNPDQNTEDYLFQVILE--KQI------------------------------RIPRSLSVKAA  247 (345)
T ss_dssp             HHHHHHSSCTTTTTTC-------CHHHHHHHHHH--CCC------------------------------CCCTTSCHHHH
T ss_pred             HHHHHhCCCCcCCcccccccccccHHHHHHHHHc--CCC------------------------------CCCCCCCHHHH
Confidence            9999999999975211         111111111  000                              01123577888


Q ss_pred             HHHHhhcccCCCCCCCH------HHhhcCCCccC
Q psy7889         237 DLLDKLLLLDPSKRFDS------DAALNHDFFWT  264 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~------~e~L~h~~~~~  264 (433)
                      +||.+||..||.+||++      +|+++||||..
T Consensus       248 ~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          248 SVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             HHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             HHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            99999999999999996      89999999964

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=100.00  E-value=2.3e-39  Score=310.96  Aligned_cols=248  Identities=37%  Similarity=0.660  Sum_probs=197.9

Q ss_pred             CCchhHHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQL   80 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql   80 (433)
                      +....+.+|+.+++.+   +||||+++++++.....   .....+++||||+.++|.+++.... ..+++..++.++.||
T Consensus        53 ~~~~~~~~e~~~l~~l~~~~h~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi  129 (326)
T 1blx_A           53 GMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT---DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQL  129 (326)
T ss_dssp             SCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC---SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHHH
T ss_pred             cCCchhhHHHHHHHhhhccCCCCeEeeeeeeeeccc---CCCceEEEEEecCCCCHHHHHHhcccCCCCHHHHHHHHHHH
Confidence            3455788999999887   89999999999974211   1136799999999999999987654 348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      +.||.|||++||+||||||+||+++.++.+||+|||++.......     ......+|..|+|||++.+.. ++.++|||
T Consensus       130 ~~~l~~lH~~gi~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~  203 (326)
T 1blx_A          130 LRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQM-----ALTSVVVTLWYRAPEVLLQSS-YATPVDLW  203 (326)
T ss_dssp             HHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGGG-----GGCCCCCCCTTCCHHHHTTCC-CCTHHHHH
T ss_pred             HHHHHHHHHCCceeccCCHHHeEEcCCCCEEEecCcccccccCCC-----CccccccccceeCHHHHhcCC-CCcchhHH
Confidence            999999999999999999999999999999999999997764321     234567899999999997765 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||.+....+.+..+....+.+....|+...............   ....  ......+..+++||.
T Consensus       204 slG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~--~~~~~~~~~~~~li~  278 (326)
T 1blx_A          204 SVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSA---QPIE--KFVTDIDELGKDLLL  278 (326)
T ss_dssp             HHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCC---CCGG--GTCCSCCHHHHHHHH
T ss_pred             HHHHHHHHHHcCCCCCCCCCHHHHHHHHHHHcCCCCcccCccccccchhhhcccCc---chhh--hccccCCHHHHHHHH
Confidence            99999999999999999999999999999988887776665433221110000000   0000  011235788899999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||..||.+|||+.|+|+||||....
T Consensus       279 ~~L~~dP~~Rpt~~e~l~hp~~~~~~  304 (326)
T 1blx_A          279 KCLTFNPAKRISAYSALSHPYFQDLE  304 (326)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGTTCC
T ss_pred             HHcCCCcccCCCHHHHhcCccccccc
Confidence            99999999999999999999997654

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=100.00  E-value=3.2e-39  Score=309.81  Aligned_cols=225  Identities=24%  Similarity=0.448  Sum_probs=184.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++...        +..|+||||+.+ +|.+++.+  ..+++..++.++.||+.||+
T Consensus        86 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~--~~l~~~~~~~i~~qi~~~L~  155 (321)
T 2c30_A           86 RELLFNEVVIMRDYQHFNVVEMYKSYLVG--------EELWVLMEFLQGGALTDIVSQ--VRLNEEQIATVCEAVLQALA  155 (321)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEECCCCSCBHHHHHTT--CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEEEC--------CEEEEEEecCCCCCHHHHHHh--cCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        669999999975 67777654  36899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||||+
T Consensus       156 ~LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Dv~slG~i  230 (321)
T 2c30_A          156 YLHAQGVIHRDIKSDSILLTLDGRVKLSDFGFCAQISKDV----PKRKSLVGTPYWMAPEVISRSL-YATEVDIWSLGIM  230 (321)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSSS----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             HHHHCCeecCCCCHHHEEECCCCcEEEeeeeeeeecccCc----cccccccCCccccCHhhhcCCC-CCchhhHHHHHHH
Confidence            9999999999999999999999999999999997765322    1234567899999999997755 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.........+.....   +. +.                         .....+.++.+||.+||..
T Consensus       231 l~el~~g~~pf~~~~~~~~~~~~~~~~~---~~-~~-------------------------~~~~~~~~l~~li~~~l~~  281 (321)
T 2c30_A          231 VIEMVDGEPPYFSDSPVQAMKRLRDSPP---PK-LK-------------------------NSHKVSPVLRDFLERMLVR  281 (321)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSSC---CC-CT-------------------------TGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHhcCCC---CC-cC-------------------------ccccCCHHHHHHHHHHccC
Confidence            9999999999998887776655543211   00 00                         0112467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCchhHHHH
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSDLSKML  275 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~  275 (433)
                      ||.+|||++|+|+||||.....+......+
T Consensus       282 dp~~Rps~~ell~hp~~~~~~~~~~~~~~~  311 (321)
T 2c30_A          282 DPQERATAQELLDHPFLLQTGLPECLVPLI  311 (321)
T ss_dssp             STTTSCCHHHHHTSGGGGGCCCGGGGHHHH
T ss_pred             ChhhCcCHHHHhcChhhccCCCcccchHHH
Confidence            999999999999999998776655544433

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=100.00  E-value=9.6e-40  Score=317.09  Aligned_cols=212  Identities=23%  Similarity=0.367  Sum_probs=180.0

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.+ +||||+++++++.+.        +.+|+||||+.+ +|...+.+. ..+++..++.++.||+.||
T Consensus        64 ~~~~~~E~~~l~~~~~hp~iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  134 (353)
T 2i0e_A           64 VECTMVEKRVLALPGKPPFLTQLHSCFQTM--------DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGL  134 (353)
T ss_dssp             HHHHHHHHHHHTCTTCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEEeeEEEEEEcC--------CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            35678899999988 899999999999876        669999999975 888888764 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||
T Consensus       135 ~~LH~~givHrDlkp~NIll~~~g~vkL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  209 (353)
T 2i0e_A          135 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV  209 (353)
T ss_dssp             HHHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----CCBCCCCSCGGGCCHHHHTTCC-BSTHHHHHHHHH
T ss_pred             HHHHHCCEEeccCCHHHEEEcCCCcEEEEeCCcccccccCC----cccccccCCccccChhhhcCCC-cCCcccccchHH
Confidence            99999999999999999999999999999999997643211    2334568999999999997765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+....|.......                                +...+.++++||.+||.
T Consensus       210 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~lL~  257 (353)
T 2i0e_A          210 LLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------------------------------PKSMSKEAVAICKGLMT  257 (353)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CCCCCHHHHHHHHHHhh
Confidence            9999999999999988887777665421110                                11256788899999999


Q ss_pred             cCCCCCCC-----HHHhhcCCCccC
Q psy7889         245 LDPSKRFD-----SDAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t-----~~e~L~h~~~~~  264 (433)
                      .||.+||+     ++++++||||..
T Consensus       258 ~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          258 KHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             SCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             cCHHHcCCCCCCCHHHHhcCccccC
Confidence            99999994     699999999964

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=100.00  E-value=6.5e-40  Score=315.43  Aligned_cols=212  Identities=27%  Similarity=0.389  Sum_probs=172.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        +.+|+||||+. ++|...+... ..+++..++.++.||+.||.
T Consensus        65 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~al~  135 (327)
T 3a62_A           65 TAHTKAERNILEEVKHPFIVDLIYAFQTG--------GKLYLILEYLSGGELFMQLERE-GIFMEDTACFYLAEISMALG  135 (327)
T ss_dssp             ------HHHHHHHCCCTTBCCEEEEEECS--------SCEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCccceeEEEEcC--------CEEEEEEeCCCCCcHHHHHHhC-CCCCHHHHHHHHHHHHHHHH
Confidence            34577899999999999999999999875        56999999997 5888888653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||++.......    ......+||+.|+|||++.+.. ++.++|||||||+
T Consensus       136 ~lH~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  210 (327)
T 3a62_A          136 HLHQKGIIYRDLKPENIMLNHQGHVKLTDFGLCKESIHDG----TVTHTFCGTIEYMAPEILMRSG-HNRAVDWWSLGAL  210 (327)
T ss_dssp             HHHHTTCCCCCCCTTTEEECTTSCEEECCCSCC--------------CTTSSCCTTSCHHHHTTSC-CCTHHHHHHHHHH
T ss_pred             HHHhCCEEcccCCHHHeEECCCCcEEEEeCCcccccccCC----ccccccCCCcCccCHhhCcCCC-CCCcccchhHHHH
Confidence            9999999999999999999999999999999987643221    1234457899999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+.......                                +...+.++++||.+||..
T Consensus       211 l~el~~g~~pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~~L~~  258 (327)
T 3a62_A          211 MYDMLTGAPPFTGENRKKTIDKILKCKLNL--------------------------------PPYLTQEARDLLKKLLKR  258 (327)
T ss_dssp             HHHHHHSSCSCCCSSHHHHHHHHHHTCCCC--------------------------------CTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CCCCCHHHHHHHHHHHhc
Confidence            999999999999988887776665422111                                112467788999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      ||.+||     +++|+++||||..
T Consensus       259 dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          259 NAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             CGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             CHhhccCCCCCCHHHHHcCCcccC
Confidence            999999     8899999999964

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=100.00  E-value=4.7e-40  Score=325.29  Aligned_cols=219  Identities=23%  Similarity=0.334  Sum_probs=181.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|..++|||||+++++|.+.        +.+|||||||. ++|..++.+....+++..++.++.||+.||+
T Consensus       105 ~~~~~~E~~il~~~~hp~Iv~l~~~~~~~--------~~~~lVmE~~~gg~L~~~l~~~~~~l~~~~~~~~~~qi~~aL~  176 (412)
T 2vd5_A          105 VSCFREERDVLVNGDRRWITQLHFAFQDE--------NYLYLVMEYYVGGDLLTLLSKFGERIPAEMARFYLAEIVMAID  176 (412)
T ss_dssp             GCCHHHHHHHHHHSCTTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHHSSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeeEEEEEeeC--------CEEEEEEcCCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            34578999999999999999999999876        66999999995 6899999876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC------CCCCCCcchh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG------DRNYGPPVDL  159 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~------~~~~~~~~Di  159 (433)
                      |||++||+||||||+|||++.+|.+||+|||++........   ......+||+.|+|||++.+      ...|+.++||
T Consensus       177 ~LH~~giiHrDLKp~NILld~~g~vkL~DFGla~~~~~~~~---~~~~~~~Gt~~Y~APE~l~~~~~~~~~~~~~~~~Di  253 (412)
T 2vd5_A          177 SVHRLGYVHRDIKPDNILLDRCGHIRLADFGSCLKLRADGT---VRSLVAVGTPDYLSPEILQAVGGGPGTGSYGPECDW  253 (412)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECCTTSC---EECSSCCSCGGGCCHHHHHHHHTCTTCSEECTHHHH
T ss_pred             HHHHCCeeecccCHHHeeecCCCCEEEeechhheeccCCCc---cccceeccccCcCCHHHHhhcccCcCCCCCChHHhh
Confidence            99999999999999999999999999999999987653221   12234689999999999873      2347999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++|||++|.+||.+.+..+....|........                 .+.          .+...+.++++||
T Consensus       254 wSlGvilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~-----------------~p~----------~~~~~s~~~~dli  306 (412)
T 2vd5_A          254 WALGVFAYEMFYGQTPFYADSTAETYGKIVHYKEHLS-----------------LPL----------VDEGVPEEARDFI  306 (412)
T ss_dssp             HHHHHHHHHHHHSSCTTCCSSHHHHHHHHHTHHHHCC-----------------CC--------------CCCHHHHHHH
T ss_pred             hHHhHHHHHHHhCCCCCCCCCHHHHHHHHHhcccCcC-----------------CCc----------cccCCCHHHHHHH
Confidence            9999999999999999999988877776653211000                 000          0113578889999


Q ss_pred             HhhcccCCCCC---CCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKR---FDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R---~t~~e~L~h~~~~~  264 (433)
                      .+||. +|.+|   ++++|+++||||..
T Consensus       307 ~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          307 QRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             HTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             HHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            99999 99998   59999999999965

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=100.00  E-value=6.7e-40  Score=322.84  Aligned_cols=251  Identities=18%  Similarity=0.209  Sum_probs=177.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+.++|||||++++++.+.        +.+|+|||||. ++|.+++... ...+++..++.++.||+.||+
T Consensus        71 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l~  142 (389)
T 3gni_B           71 TFLQGELHVSKLFNHPNIVPYRATFIAD--------NELWVVTSFMAYGSAKDLICTHFMDGMNELAIAYILQGVLKALD  142 (389)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHTCTTCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEeEEEEEC--------CEEEEEEEccCCCCHHHHHhhhcccCCCHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999876        66999999997 5888888654 345999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC---ccccccCCcccccccCcccccCC-CCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG---QVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.++.+||+|||.+.........   ........+||+.|+|||++.+. ..++.++||||
T Consensus       143 ~LH~~~ivHrDlkp~NIll~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~Diws  222 (389)
T 3gni_B          143 YIHHMGYVHRSVKASHILISVDGKVYLSGLRSNLSMISHGQRQRVVHDFPKYSVKVLPWLSPEVLQQNLQGYDAKSDIYS  222 (389)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTCCEEECCGGGCEECEETTEECSCBCCCCTTCTTTGGGSCHHHHSTTSSCBCTHHHHHH
T ss_pred             HHHhCCeecCCCCHHHEEEcCCCCEEEcccccceeeccccccccccccccccccccccccCHHHHhccCCCCCcHhHHHH
Confidence            999999999999999999999999999999988655322111   11122335789999999999874 34899999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCC-------CCCCC-Cccc----chhhhhcccc--chHHHhhHHhhhC
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSI-------TPESW-PGVE----TLDLYNKMEL--PKAQKRKVKERLK  227 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~-------~~~~~-~~~~----~~~~~~~~~~--~~~~~~~~~~~~~  227 (433)
                      |||++|+|++|.+||.+.+....+..+.......       +.+.+ ....    ..........  +............
T Consensus       223 lG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  302 (389)
T 3gni_B          223 VGITACELANGHVPFKDMPATQMLLEKLNGTVPCLLDTSTIPAEELTMSPSRSVANSGLSDSLTTSTPRPSNGDSPSHPY  302 (389)
T ss_dssp             HHHHHHHHHHSSCTTTTCCSTTHHHHC-----------------------------------------------------
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHhcCCCCccccccccccccccccccccccccccccccccCccccccCCCCCCcc
Confidence            9999999999999999876655544332211000       00000 0000    0000000000  0000000000111


Q ss_pred             CccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         228 PYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       228 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +...+.++++||.+||+.||.+|||++|+|+||||....
T Consensus       303 ~~~~s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~  341 (389)
T 3gni_B          303 HRTFSPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIK  341 (389)
T ss_dssp             ---CCHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC-
T ss_pred             ccccCHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHh
Confidence            234678899999999999999999999999999997654

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=100.00  E-value=5.2e-40  Score=315.53  Aligned_cols=219  Identities=26%  Similarity=0.381  Sum_probs=175.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+++.++|||||++++++.+.        +..|+|||||.+ +|.+++.. ...+++..++.++.||+.||+
T Consensus        49 ~~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~  119 (323)
T 3tki_A           49 PENIKKEICINKMLNHENVVKFYGHRREG--------NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVV  119 (323)
T ss_dssp             --CHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEecC--------CeEEEEEEcCCCCcHHHHHhh-cCCCCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        668999999975 77776654 446999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++..+.....  .......+||+.|+|||++.+...++.++|||||||+
T Consensus       120 ~LH~~givH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~i  197 (323)
T 3tki_A          120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV  197 (323)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--ECCBCSCCSCGGGSCHHHHHCSSBCHHHHHHHHHHHH
T ss_pred             HHHHCCccccccchHHEEEeCCCCEEEEEeeccceeccCCc--ccccCCCccCcCccCcHHhccCCCCCCcccHHHHHHH
Confidence            99999999999999999999999999999999976643221  1223456889999999999877655789999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+................. ..                            .....+..+.+||.+||..
T Consensus       198 l~~ll~g~~pf~~~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~~~~~~~li~~~L~~  248 (323)
T 3tki_A          198 LTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LN----------------------------PWKKIDSAPLALLHKILVE  248 (323)
T ss_dssp             HHHHHHSSCSCSSSCTTSHHHHHHHTTCTT-ST----------------------------TGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCchHHHHHHHHhccccc-CC----------------------------ccccCCHHHHHHHHHHccC
Confidence            999999999998765442222111111000 00                            0012567788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||.+|||++|+++||||...
T Consensus       249 dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          249 NPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             STTTSCCHHHHTTCTTTTCC
T ss_pred             ChhhCcCHHHHhhChhhccc
Confidence            99999999999999999653

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=100.00  E-value=8.4e-40  Score=329.01  Aligned_cols=211  Identities=26%  Similarity=0.435  Sum_probs=180.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        +.+|+|||||. ++|.+++.+ ...+++..++.++.||+.||+|
T Consensus        61 ~~~~~Ei~~l~~l~HpnIv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~-~~~l~~~~~~~i~~qi~~aL~~  131 (476)
T 2y94_A           61 GKIRREIQNLKLFRHPHIIKLYQVISTP--------SDIFMVMEYVSGGELFDYICK-NGRLDEKESRRLFQQILSGVDY  131 (476)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCSSEEHHHHTTS-SSSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEeCCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999876        66999999996 588888865 4569999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+...++.++|||||||++
T Consensus       132 LH~~givHrDLkp~NIll~~~~~vkL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  206 (476)
T 2y94_A          132 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVIL  206 (476)
T ss_dssp             HHTTTEECSCCSGGGEEECTTCCEEECCCSSCEECCTTC-----CBCCCCSCSTTCCHHHHTTCCBCSHHHHHHHHHHHH
T ss_pred             HHHCCCCcccccHHHEEEecCCCeEEEeccchhhccccc-----cccccCCCcCeEChhhccCCCCCCCcceehhhHHHH
Confidence            999999999999999999999999999999998765321     234567899999999998876557899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.........+.......                                +...++++.+||.+||..|
T Consensus       207 ~elltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~Li~~~L~~d  254 (476)
T 2y94_A          207 YALLCGTLPFDDDHVPTLFKKICDGIFYT--------------------------------PQYLNPSVISLLKHMLQVD  254 (476)
T ss_dssp             HHHHHSSCSSCCSSSHHHHHHHHTTCCCC--------------------------------CTTCCHHHHHHHHHHTCSS
T ss_pred             HHHhhCCCCCCCCCHHHHHHHHhcCCcCC--------------------------------CccCCHHHHHHHHHHcCCC
Confidence            99999999999887776666554321110                                1125677889999999999


Q ss_pred             CCCCCCHHHhhcCCCccC
Q psy7889         247 PSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~  264 (433)
                      |.+|||++|+++||||..
T Consensus       255 P~~Rpt~~eil~hp~~~~  272 (476)
T 2y94_A          255 PMKRATIKDIREHEWFKQ  272 (476)
T ss_dssp             TTTSCCHHHHHTCHHHHT
T ss_pred             chhCcCHHHHHhCHHhhh
Confidence            999999999999999965

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=100.00  E-value=6.1e-40  Score=319.85  Aligned_cols=219  Identities=25%  Similarity=0.407  Sum_probs=164.9

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+.+|+.+++.++|||||++++++.+.        +.+|+|||||. ++|.+.+... ..+++..++.++.||+.||
T Consensus        59 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~ql~~~L  129 (361)
T 3uc3_A           59 IDENVQREIINHRSLRHPNIVRFKEVILTP--------THLAIIMEYASGGELYERICNA-GRFSEDEARFFFQQLLSGV  129 (361)
T ss_dssp             SCHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHhCCCCCCCcEEEEEeeC--------CEEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999875        66999999996 5888888663 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCc--EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGI--LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~--~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      +|||++||+||||||+|||++.++.  +||+|||+++.....     ......+||+.|+|||++.+....+.++|||||
T Consensus       130 ~~LH~~~ivH~Dlkp~Nill~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diwsl  204 (361)
T 3uc3_A          130 SYCHSMQICHRDLKLENTLLDGSPAPRLKICDFGYSKSSVLH-----SQPKSTVGTPAYIAPEVLLRQEYDGKIADVWSC  204 (361)
T ss_dssp             HHHHHTTCCSCCCCGGGEEECSSSSCCEEECCCCCC--------------------CTTSCHHHHHCSSCCHHHHHHHHH
T ss_pred             HHHHHCCcccCCCCHHHEEEcCCCCceEEEeecCcccccccc-----CCCCCCcCCCCcCChhhhcCCCCCCCeeeeehh
Confidence            9999999999999999999987665  999999998753321     123345789999999999877644455999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHH-HHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLIS-QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~-~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++|+|++|.+||.+.........+. ........                .+           .....+.++++||.+
T Consensus       205 G~il~ell~g~~Pf~~~~~~~~~~~~~~~~~~~~~~----------------~~-----------~~~~~s~~~~~li~~  257 (361)
T 3uc3_A          205 GVTLYVMLVGAYPFEDPEEPRDYRKTIQRILSVKYS----------------IP-----------DDIRISPECCHLISR  257 (361)
T ss_dssp             HHHHHHHHHSSCSCC----CCCHHHHHHHHHTTCCC----------------CC-----------TTSCCCHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCccHHHHHHHHHHHhcCCCC----------------CC-----------CcCCCCHHHHHHHHH
Confidence            999999999999998754432222221 11111000                00           011356788899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||..||.+|||++|+++||||...
T Consensus       258 ~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          258 IFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             HSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             HccCChhHCcCHHHHHhCcchhcC
Confidence            999999999999999999999653

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=100.00  E-value=3.1e-39  Score=304.56  Aligned_cols=214  Identities=26%  Similarity=0.440  Sum_probs=172.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+++|+.++||||+++++++.+.        ..+|+||||+.+ +|.+.+...   ...+++..++.++.||+.
T Consensus        64 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  135 (285)
T 3is5_A           64 MEQIEAEIEVLKSLDHPNIIKIFEVFEDY--------HNMYIVMETCEGGELLERIVSAQARGKALSEGYVAELMKQMMN  135 (285)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCSCCBHHHHHHHHHHHTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCchHHhHHHheecC--------CeEEEEEEeCCCCcHHHHHHhhhhcccCCCHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        669999999975 888877543   356999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEe---cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          83 GLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~---~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ||+|||++||+||||||+||+++   .++.+||+|||++.......     ......||+.|+|||++.+  .++.++||
T Consensus       136 ~L~~LH~~~ivH~dikp~NIl~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~--~~~~~~Di  208 (285)
T 3is5_A          136 ALAYFHSQHVVHKDLKPENILFQDTSPHSPIKIIDFGLAELFKSDE-----HSTNAAGTALYMAPEVFKR--DVTFKCDI  208 (285)
T ss_dssp             HHHHHHHTTCCCCCCSGGGEEESSSSTTCCEEECCCCCCCC---------------CTTGGGCCHHHHTT--CCCHHHHH
T ss_pred             HHHHHHhCCEEECCCCHHHEEEecCCCCCCEEEEeeecceecCCcc-----cCcCcccccCcCChHHhcc--CCCcccCe
Confidence            99999999999999999999994   45789999999997764322     2234578999999999864  47899999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++++|++|..||.+....+....+..........                             ....++++.+||
T Consensus       209 ~slG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~li  259 (285)
T 3is5_A          209 WSAGVVMYFLLTGCLPFTGTSLEEVQQKATYKEPNYAVE-----------------------------CRPLTPQAVDLL  259 (285)
T ss_dssp             HHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCC-------------------------------CCCCHHHHHHH
T ss_pred             ehHHHHHHHHHhCCCCCCCCCHHHHHhhhccCCcccccc-----------------------------cCcCCHHHHHHH
Confidence            999999999999999999988766555443311111000                             012467788999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||+.||.+|||+.|+|+||||++
T Consensus       260 ~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          260 KQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             HHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             HHHccCChhhCcCHHHHhcCHHhhc
Confidence            9999999999999999999999975

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=100.00  E-value=1.1e-39  Score=315.73  Aligned_cols=223  Identities=26%  Similarity=0.438  Sum_probs=177.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc----------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI----------------------   64 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~----------------------   64 (433)
                      ..+.+|+.+|+.++|||||++++++.+.        ..+|+|||||. ++|.+++...                      
T Consensus        73 ~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  144 (345)
T 3hko_A           73 ERIKTEVRLMKKLHHPNIARLYEVYEDE--------QYICLVMELCHGGHLLDKLNVFIDDSTGKCAMDVVKTQICPCPE  144 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHEEEEEETTTTEEEEEEECCCCCCSHH
T ss_pred             HHHHHHHHHHHhCCCCCcceeehhhccC--------CeEEEEEeCCCCCcHHHHHHHhhccccccccccccccccccccc
Confidence            5688999999999999999999999875        66999999996 5888877421                      


Q ss_pred             -----------------CCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCC--cEEEeecCCccccccCc
Q psy7889          65 -----------------HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG--ILKLADFGLARAFSQTK  125 (433)
Q Consensus        65 -----------------~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~--~~kl~DFg~a~~~~~~~  125 (433)
                                       ...+++..++.++.||+.||+|||++||+||||||+||+++.++  .+||+|||++..+....
T Consensus       145 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIll~~~~~~~~kl~Dfg~a~~~~~~~  224 (345)
T 3hko_A          145 CNEEAINGSIHGFRESLDFVQREKLISNIMRQIFSALHYLHNQGICHRDIKPENFLFSTNKSFEIKLVDFGLSKEFYKLN  224 (345)
T ss_dssp             HHHHHHHSCC--CEEECCHHHHHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEESCSSSCCEEECCCTTCEEGGGTT
T ss_pred             ccccccccccccccccccccccHHHHHHHHHHHHHHHHHHHHCCccccCCChhhEEEecCCCceEEEeeccccccccccC
Confidence                             11246778999999999999999999999999999999998766  89999999998765433


Q ss_pred             CCccccccCCcccccccCcccccCC-CCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCccc
Q psy7889         126 NGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVE  204 (433)
Q Consensus       126 ~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~  204 (433)
                      ...........||+.|+|||++.+. ..++.++|||||||++|+|++|..||.+....+....+...........     
T Consensus       225 ~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-----  299 (345)
T 3hko_A          225 NGEYYGMTTKAGTPYFVAPEVLNTTNESYGPKCDAWSAGVLLHLLLMGAVPFPGVNDADTISQVLNKKLCFENPN-----  299 (345)
T ss_dssp             CC--------CCCGGGCCHHHHTCSSSCCCTHHHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCTTSGG-----
T ss_pred             ccccccccccCCCccccCchhhccCCCCCCcHHHHHHHHHHHHHHHHCCCCCCCCChHHHHHHHHhcccccCCcc-----
Confidence            3332334566789999999998753 4579999999999999999999999999988877776654222111100     


Q ss_pred             chhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         205 TLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       205 ~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                                             ....+.++.+||.+||..||.+|||+.++|+||||.+..
T Consensus       300 -----------------------~~~~~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          300 -----------------------YNVLSPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             -----------------------GGGSCHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             -----------------------cccCCHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence                                   012467788999999999999999999999999996643

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=100.00  E-value=1e-39  Score=327.37  Aligned_cols=212  Identities=27%  Similarity=0.379  Sum_probs=172.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++.+.        +.+||||||+++ +|...+... ..+++..++.++.||+.||+|
T Consensus       193 ~~~~~e~~~l~~l~h~~iv~l~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL~~  263 (446)
T 4ejn_A          193 AHTLTENRVLQNSRHPFLTALKYSFQTH--------DRLCFVMEYANGGELFFHLSRE-RVFSEDRARFYGAEIVSALDY  263 (446)
T ss_dssp             --------CCCCCSCTTSCCEEEEEEET--------TEEEEEECCCSSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCeEeeEEEEEeeC--------CEEEEEEeeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            5677899999999999999999999876        669999999975 787777653 468999999999999999999


Q ss_pred             HHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+ +||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+.. |+.++|||||||+
T Consensus       264 LH~~~giiHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~i  338 (446)
T 4ejn_A          264 LHSEKNVVYRDLKLENLMLDKDGHIKITDFGLCKEGIKDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVV  338 (446)
T ss_dssp             HHHHTCCCCCCCCGGGEEECSSSCEEECCCCCCCTTCC---------CCSSSCGGGCCHHHHHTSC-CCTHHHHHHHHHH
T ss_pred             HhhcCCEEECCCCHHHEEECCCCCEEEccCCCceeccCCC----cccccccCCccccCHhhcCCCC-CCCccchhhhHHH
Confidence            998 999999999999999999999999999997643221    2334578999999999997765 8999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......+.......                                +...++++.+||.+||..
T Consensus       339 l~ell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~~~~~~~li~~~L~~  386 (446)
T 4ejn_A          339 MYEMMCGRLPFYNQDHEKLFELILMEEIRF--------------------------------PRTLGPEAKSLLSGLLKK  386 (446)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CccCCHHHHHHHHHHccc
Confidence            999999999999988877766664321110                                112567788999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||.+||     +++|+|+||||...
T Consensus       387 dP~~R~~~~~~t~~ell~hp~f~~~  411 (446)
T 4ejn_A          387 DPKQRLGGGSEDAKEIMQHRFFAGI  411 (446)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CHHHhCCCCCCCHHHHHhCccccCC
Confidence            999999     99999999999653

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=100.00  E-value=2.2e-39  Score=328.46  Aligned_cols=216  Identities=30%  Similarity=0.547  Sum_probs=180.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        ..+|+|||||.+ +|.+.+... ..+++..++.++.||+.||.
T Consensus        65 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~al~  135 (486)
T 3mwu_A           65 TSTILREVELLKKLDHPNIMKLFEILEDS--------SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGIT  135 (486)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcCeEEEEEEcC--------CEEEEEEEcCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        669999999975 788877664 46999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEe---cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~---~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+|||++   .++.+||+|||++..+....     .....+||+.|+|||++.+  .|+.++||||+
T Consensus       136 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  208 (486)
T 3mwu_A          136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLRG--TYDEKCDVWSA  208 (486)
T ss_dssp             HHHHTTCCCSCCSGGGEEESSSSTTCCEEECSCSCTTTBCCC---------CCTTGGGGCCGGGGGS--CCCHHHHHHHH
T ss_pred             HHHHCCeEeccCchHHEEEecCCCCCCEEEEECCcCeECCCCC-----ccCCCcCCCCCCCHHHhCC--CCCchhhHHHH
Confidence            99999999999999999995   45679999999998765322     2345678999999999976  37999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+..+.+..+...........|                            ...+.++++||.+|
T Consensus       209 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~  260 (486)
T 3mwu_A          209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQW----------------------------RTISDDAKDLIRKM  260 (486)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCSGGG----------------------------GGSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCCccc----------------------------CCCCHHHHHHHHHH
Confidence            99999999999999999988887777653322211111                            12567788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|||+.|+|+||||+...
T Consensus       261 L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          261 LTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             TCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             cCCChhhCcCHHHHhcCHhhccCc
Confidence            999999999999999999997543

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=100.00  E-value=1.1e-39  Score=313.62  Aligned_cols=217  Identities=26%  Similarity=0.398  Sum_probs=156.0

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .....+|+.+++.+. |||||++++++.+.        ..+|+||||+.+ +|.+.+... ..+++..++.++.||+.||
T Consensus        49 ~~~~~~e~~~l~~l~~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l  119 (325)
T 3kn6_A           49 EANTQKEITALKLCEGHPNIVKLHEVFHDQ--------LHTFLVMELLNGGELFERIKKK-KHFSETEASYIMRKLVSAV  119 (325)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHC-SCCCHHHHHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHhcCCCCeeEEEEEEEcC--------CEEEEEEEccCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            456789999999997 99999999999875        669999999975 888888764 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      +|||++||+||||||+|||++.++   .+||+|||++.......    ......+||+.|+|||++.+.. ++.++||||
T Consensus       120 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~~t~~y~aPE~~~~~~-~~~~~Diws  194 (325)
T 3kn6_A          120 SHMHDVGVVHRDLKPENLLFTDENDNLEIKIIDFGFARLKPPDN----QPLKTPCFTLHYAAPELLNQNG-YDESCDLWS  194 (325)
T ss_dssp             HHHHHTTEECCCCCGGGEEEEC----CEEEECCCTTCEECCC--------------------------CC-CCHHHHHHH
T ss_pred             HHHHHCCCeecCCCHHHEEEecCCCcccEEEeccccceecCCCC----CcccccCCCcCccCHHHhcCCC-CCCccchHH
Confidence            999999999999999999998766   89999999997654322    2234557899999999997765 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChH-------HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQ-------QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~-------~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      |||++|+|++|.+||.+....       +....+......                   .+....         ...+.+
T Consensus       195 lG~il~~ll~g~~pf~~~~~~~~~~~~~~~~~~i~~~~~~-------------------~~~~~~---------~~~s~~  246 (325)
T 3kn6_A          195 LGVILYTMLSGQVPFQSHDRSLTCTSAVEIMKKIKKGDFS-------------------FEGEAW---------KNVSQE  246 (325)
T ss_dssp             HHHHHHHHHHSSCTTC-------CCCHHHHHHHHTTTCCC-------------------CCSHHH---------HTSCHH
T ss_pred             HHHHHHHHHhCCCCCCCCccccccccHHHHHHHHHcCCCC-------------------CCcccc---------cCCCHH
Confidence            999999999999999875432       222222110000                   000000         125778


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +++||.+||..||.+|||++|+++||||...
T Consensus       247 ~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          247 AKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             HHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             HHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            8899999999999999999999999999764

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=100.00  E-value=2.1e-39  Score=329.23  Aligned_cols=215  Identities=27%  Similarity=0.539  Sum_probs=182.0

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+++|+.+|+.++|||||++++++.+.        ..+|+|||||.+ +|.+.+... ..+++..++.++.||+.||
T Consensus        79 ~~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~~~~~-~~~~~~~~~~i~~qi~~~l  149 (494)
T 3lij_A           79 SNSKLLEEVAVLKLLDHPNIMKLYDFFEDK--------RNYYLVMECYKGGELFDEIIHR-MKFNEVDAAVIIKQVLSGV  149 (494)
T ss_dssp             TTHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCeEEEEEEeC--------CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999875        669999999975 788877654 4689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecC---CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~---~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .|||++||+||||||+|||++..   +.+||+|||++.......     .....+||+.|+|||++.+  .|+.++||||
T Consensus       150 ~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~--~~~~~~Diws  222 (494)
T 3lij_A          150 TYLHKHNIVHRDLKPENLLLESKEKDALIKIVDFGLSAVFENQK-----KMKERLGTAYYIAPEVLRK--KYDEKCDVWS  222 (494)
T ss_dssp             HHHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEECBTTB-----CBCCCCSCTTTCCHHHHTT--CBCTHHHHHH
T ss_pred             HHHHHCCceeccCChhhEEEeCCCCCCcEEEEECCCCeECCCCc-----cccccCCCcCeeCHHHHcc--cCCCchhHHH
Confidence            99999999999999999999764   459999999998765332     2345678999999999864  3799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|.+||.+.+..+.+..+...........|.                            ..+.++++||.+
T Consensus       223 lG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~s~~~~~li~~  274 (494)
T 3lij_A          223 IGVILFILLAGYPPFGGQTDQEILRKVEKGKYTFDSPEWK----------------------------NVSEGAKDLIKQ  274 (494)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCSGGGT----------------------------TSCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCchhcc----------------------------cCCHHHHHHHHH
Confidence            9999999999999999999888887776644333222221                            246778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||+.||.+|||+.|+|+||||.+
T Consensus       275 ~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          275 MLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             HTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             HCCCChhhCccHHHHhcCccccc
Confidence            99999999999999999999964

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=100.00  E-value=7e-40  Score=318.44  Aligned_cols=245  Identities=35%  Similarity=0.575  Sum_probs=187.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++......  .....+|+||||+.++|.+.+.   ..+++..++.++.||+.||+||
T Consensus        68 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~~~~~lv~e~~~~~l~~~~~---~~~~~~~~~~i~~qi~~al~~L  142 (353)
T 3coi_A           68 KRAYRELLLLKHMQHENVIGLLDVFTPASSL--RNFYDFYLVMPFMQTDLQKIMG---LKFSEEKIQYLVYQMLKGLKYI  142 (353)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSSG--GGCCCCEEEEECCSEEGGGTTT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcccHhheEeccccc--ccceeEEEEeccccCCHHHHhc---CCCCHHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875321  1123469999999988776653   3589999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+||+++.++.+||+|||++......       .....+|+.|+|||++.+...++.++|||||||++|
T Consensus       143 H~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~-------~~~~~~t~~y~aPE~~~~~~~~~~~~Di~slG~il~  215 (353)
T 3coi_A          143 HSAGVVHRDLKPGNLAVNEDCELKILDFGLARHADAE-------MTGYVVTRWYRAPEVILSWMHYNQTVDIWSVGCIMA  215 (353)
T ss_dssp             HHTTCCCSSCCGGGEEECTTCCEEECSTTCTTC---------------CCSBCCSCHHHHSCCSCCCTTHHHHHHHHHHH
T ss_pred             HHCCcccCCCCHHHEeECCCCcEEEeecccccCCCCC-------ccccccCcCcCCHHHHhCcCCCCchhhHHHHHHHHH
Confidence            9999999999999999999999999999999765421       234577999999999987556899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+.+..+....|.+..+.+...........+. .+.........  .....+.++.+||.+||..|
T Consensus       216 el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~~~~li~~~L~~d  293 (353)
T 3coi_A          216 EMLTGKTLFKGKDYLDQLTQILKVTGVPGTEFVQKLNDKAAKSYIQSLPQTPRKDFTQ--LFPRASPQAADLLEKMLELD  293 (353)
T ss_dssp             HHHHSSCSSBSSCHHHHHHHHHHHHCBCCHHHHTTCSCHHHHHHHHTSCBCSSCCTTT--TCTTSCHHHHHHHHHHSCSC
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHHHhhHHHHHHHHhCcCCCCccHHH--hcCCcCHHHHHHHHHHcCCC
Confidence            9999999999999999999998888876554333222211100000 00000000000  01135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       294 p~~Rpt~~e~l~hp~f~~~~  313 (353)
T 3coi_A          294 VDKRLTAAQALTHPFFEPFR  313 (353)
T ss_dssp             TTTSCCHHHHHTSGGGTTTC
T ss_pred             cccCCCHHHHhcCcchhhcc
Confidence            99999999999999996543

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=100.00  E-value=8.4e-39  Score=300.96  Aligned_cols=216  Identities=29%  Similarity=0.457  Sum_probs=180.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +..|+||||+.+ +|.+.+... ..+++..++.++.||+.||.|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~l~~~~~~~-~~~~~~~~~~~~~~i~~~l~~  120 (284)
T 3kk8_A           50 QKLEREARICRKLQHPNIVRLHDSIQEE--------SFHYLVFDLVTGGELFEDIVAR-EFYSEADASHCIQQILESIAY  120 (284)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCcCeEEEEEEcC--------CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4577899999999999999999999875        668999999975 787777654 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCc---EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~---~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++||+||||||+||+++.++.   +||+|||++.......     ......||+.|+|||++.+.. ++.++||||||
T Consensus       121 lH~~~i~H~dikp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG  194 (284)
T 3kk8_A          121 CHSNGIVHRNLKPENLLLASKAKGAAVKLADFGLAIEVNDSE-----AWHGFAGTPGYLSPEVLKKDP-YSKPVDIWACG  194 (284)
T ss_dssp             HHHTTEECSCCCGGGEEESSSSTTCCEEECCCTTCEECCSSC-----BCCCSCSCGGGCCHHHHTTCC-BCTHHHHHHHH
T ss_pred             HHHCCcCcCCCCHHHEEEecCCCCCcEEEeeceeeEEcccCc-----cccCCCCCcCCcCchhhcCCC-CCcccchHHHH
Confidence            99999999999999999986654   9999999997765322     233457899999999998765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++++|++|.+||.+.........+.......+...+                            ...++++.+||.+||
T Consensus       195 ~~l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~l  246 (284)
T 3kk8_A          195 VILYILLVGYPPFWDEDQHRLYAQIKAGAYDYPSPEW----------------------------DTVTPEAKSLIDSML  246 (284)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTT----------------------------TTSCHHHHHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCCchhHHHHHHHhccccCCchhh----------------------------cccCHHHHHHHHHHc
Confidence            9999999999999998888777776554333222211                            124667789999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +.||.+|||++|+|+||||.+..
T Consensus       247 ~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          247 TVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             CSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             ccChhhCCCHHHHhcCccccCCh
Confidence            99999999999999999997643

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=100.00  E-value=3.2e-39  Score=318.98  Aligned_cols=221  Identities=24%  Similarity=0.374  Sum_probs=168.3

Q ss_pred             chhHHHHHHHHHh-CCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQL-LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~-l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.++.+ .+||||++++++|.....    ....+|||||||.+ +|.+++.... ..+++..++.++.||+.|
T Consensus        98 ~~~~~~E~~~~~~~~~hp~iv~l~~~~~~~~~----~~~~~~lv~E~~~gg~L~~~l~~~~~~~l~~~~~~~i~~qi~~a  173 (400)
T 1nxk_A           98 CPKARREVELHWRASQCPHIVRIVDVYENLYA----GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA  173 (400)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TEEEEEEEEECCCSEEHHHHHHCC---CCBHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHhcCCCCcceEeEEEeeccc----CCcEEEEEEEeCCCCcHHHHHHHhCCCCCCHHHHHHHHHHHHHH
Confidence            3567899999854 489999999999976211    13668999999975 8999987643 359999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      |+|||++||+||||||+|||++.   ++.+||+|||++......     ......+||+.|+|||++.+.. |+.++|||
T Consensus       174 L~~LH~~~ivHrDlkp~Nill~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw  247 (400)
T 1nxk_A          174 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSH-----NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMW  247 (400)
T ss_dssp             HHHHHHTTEECCCCCGGGEEESSSSTTCCEEECCCTTCEECC----------------CTTCCGGGSCCCC-SSSHHHHH
T ss_pred             HHHHHHCCccccCcCcceEEEecCCCCccEEEEecccccccCCC-----CccccCCCCCCccCHhhcCCCC-CCCcccHH
Confidence            99999999999999999999997   789999999999865432     1234567899999999987654 89999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHH----HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQ----QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~----~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      ||||++|+|++|.+||.+.....    ....+.......+...|                            ...+.+++
T Consensus       248 slG~il~ell~g~~pf~~~~~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~  299 (400)
T 1nxk_A          248 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRMGQYEFPNPEW----------------------------SEVSEEVK  299 (400)
T ss_dssp             HHHHHHHHHHHSSCSCCCCTTCSSCCSHHHHHHHTCCCCCTTTT----------------------------TTSCHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCccccccHHHHHHHHcCcccCCCccc----------------------------ccCCHHHH
Confidence            99999999999999998754321    12222211111111111                            12567888


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||.+||..||.+|||++|+|+||||...
T Consensus       300 ~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          300 MLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             HHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             HHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            99999999999999999999999999754

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=100.00  E-value=2.1e-39  Score=319.47  Aligned_cols=245  Identities=27%  Similarity=0.428  Sum_probs=185.1

Q ss_pred             chhHHHHHHHHHhCC--------CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHH
Q psy7889           7 PITALREIKILQLLK--------HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVI   77 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~--------hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~   77 (433)
                      ...+.+|+.+|+.++        |+||+++++++.....    ....+|+||||+++++.+.+.... ..+++..++.++
T Consensus        77 ~~~~~~E~~~l~~l~~~~~~~~~~~~iv~~~~~~~~~~~----~~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~i~  152 (397)
T 1wak_A           77 TETALDEIRLLKSVRNSDPNDPNREMVVQLLDDFKISGV----NGTHICMVFEVLGHHLLKWIIKSNYQGLPLPCVKKII  152 (397)
T ss_dssp             HHHHHHHHHHHHHHHHSCTTCGGGGGBCCEEEEEEEEET----TEEEEEEEECCCCCBHHHHHHHTTTSCCCHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHhhcCCCCCCcceeeeeecceeecCC----CCceEEEEEeccCccHHHHHHhcccCCCCHHHHHHHH
Confidence            356789999999995        7889999999985421    136799999999999998887654 469999999999


Q ss_pred             HHHHHHHHHHHhC-CeeccCCCCCcEEEecCC------------------------------------------------
Q psy7889          78 QQLLNGLYYIHSN-KILHRDMKAANVLITKTG------------------------------------------------  108 (433)
Q Consensus        78 ~qll~aL~~LH~~-~iiH~dikp~NIll~~~~------------------------------------------------  108 (433)
                      .||+.||+|||++ ||+||||||+|||++.++                                                
T Consensus       153 ~qi~~aL~~lH~~~givHrDikp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  232 (397)
T 1wak_A          153 QQVLQGLDYLHTKCRIIHTDIKPENILLSVNEQYIRRLAAEATEWQRSGAPPPSGSAVSTAPATAGNFLVNPLEPKNAEK  232 (397)
T ss_dssp             HHHHHHHHHHHHTTCEECCCCSGGGEEECCCHHHHHHHHHHHC---------------------CCTTSCCTTSGGGGGG
T ss_pred             HHHHHHHHHHHHhCCEecCCCCHHHeeEeccchhhhhhhhhhHHHhhcCCCCCCCCccccCCcccccccccccccccccc
Confidence            9999999999998 999999999999998775                                                


Q ss_pred             -cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCC------h
Q psy7889         109 -ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT------E  181 (433)
Q Consensus       109 -~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~------~  181 (433)
                       .+||+|||++......       ....+||+.|+|||++.+.. ++.++|||||||++|+|++|.+||.+.+      .
T Consensus       233 ~~~kl~DfG~a~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~~~~~  304 (397)
T 1wak_A          233 LKVKIADLGNACWVHKH-------FTEDIQTRQYRSLEVLIGSG-YNTPADIWSTACMAFELATGDYLFEPHSGEEYTRD  304 (397)
T ss_dssp             CCEEECCGGGCEETTBC-------SCSCCSCGGGCCHHHHHTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCCCCSSSCHH
T ss_pred             cceEecccccccccccc-------CccCCCCCcccCChhhcCCC-CCcHHHHHHHHHHHHHHhhCCCCCCCCcccccCch
Confidence             7999999999776432       33457899999999998865 7999999999999999999999998755      5


Q ss_pred             HHHHHHHHHHhCCCCCCCCCcccch-hhh---------hccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCC
Q psy7889         182 QQQITLISQLCGSITPESWPGVETL-DLY---------NKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRF  251 (433)
Q Consensus       182 ~~~~~~i~~~~g~~~~~~~~~~~~~-~~~---------~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~  251 (433)
                      .+.+..+....|.++...+...... ..+         ................-.+...+..+++||.+||..||.+||
T Consensus       305 ~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rp  384 (397)
T 1wak_A          305 EDHIALIIELLGKVPRKLIVAGKYSKEFFTKKGDLKHITKLKPWGLFEVLVEKYEWSQEEAAGFTDFLLPMLELIPEKRA  384 (397)
T ss_dssp             HHHHHHHHHHHCSCCHHHHHHCTTGGGTBCTTSSBSSCCCCCCCCHHHHHHHTSCCCHHHHHHHHHHHGGGGCSSGGGSC
T ss_pred             HHHHHHHHHhcCCCChHHhhcccccccccCCccccccccccCCcchhHhhhhhcccchhhHHHHHHHHHHHhccChhhcC
Confidence            6777788888887653221000000 000         000000000000000001112346678999999999999999


Q ss_pred             CHHHhhcCCCcc
Q psy7889         252 DSDAALNHDFFW  263 (433)
Q Consensus       252 t~~e~L~h~~~~  263 (433)
                      |++|+|+||||.
T Consensus       385 t~~e~l~hp~~~  396 (397)
T 1wak_A          385 TAAECLRHPWLN  396 (397)
T ss_dssp             CHHHHHTSGGGG
T ss_pred             CHHHHhhCcccc
Confidence            999999999995

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=100.00  E-value=2.8e-39  Score=303.22  Aligned_cols=214  Identities=29%  Similarity=0.492  Sum_probs=179.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++.+.        ..+|+||||+.+ +|.+.+... ..+++..++.++.|++.||+
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~~i~~~l~  120 (277)
T 3f3z_A           50 VDRFKQEIEIMKSLDHPNIIRLYETFEDN--------TDIYLVMELCTGGELFERVVHK-RVFRESDAARIMKDVLSAVA  120 (277)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecC--------CeEEEEEeccCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        669999999975 788877653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEE---ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll---~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+||++   +.++.++|+|||++.......     ......||+.|+|||++.+.  ++.++|||||
T Consensus       121 ~lH~~~i~H~dlkp~Nil~~~~~~~~~~~l~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~--~~~~~Di~sl  193 (277)
T 3f3z_A          121 YCHKLNVAHRDLKPENFLFLTDSPDSPLKLIDFGLAARFKPGK-----MMRTKVGTPYYVSPQVLEGL--YGPECDEWSA  193 (277)
T ss_dssp             HHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECCTTS-----CBCCCCSCTTTCCHHHHTTC--BCTTHHHHHH
T ss_pred             HHHHCCccCCCCCHHHEEEecCCCCCcEEEEecccceeccCcc-----chhccCCCCCccChHHhccc--CCchhhehhH
Confidence            9999999999999999999   778899999999997765322     23445789999999998653  7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++++|++|..||.+....+....+.......+...|                            ...+.++.+||.+|
T Consensus       194 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~  245 (277)
T 3f3z_A          194 GVMMYVLLCGYPPFSAPTDSEVMLKIREGTFTFPEKDW----------------------------LNVSPQAESLIRRL  245 (277)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH----------------------------TTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCchhh----------------------------hcCCHHHHHHHHHH
Confidence            99999999999999998887777666542221111000                            12467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |..||.+|||+.++|+||||.+
T Consensus       246 l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          246 LTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             TCSSTTTSCCHHHHTTSHHHHH
T ss_pred             ccCChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999954

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=100.00  E-value=1.8e-39  Score=317.34  Aligned_cols=212  Identities=25%  Similarity=0.312  Sum_probs=171.7

Q ss_pred             chhHHHHHHH-HHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKI-LQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+++|..+ ++.++|||||+++++|.+.        +.+|+||||+.+ +|...+.+. ..+++..++.++.||+.||
T Consensus        82 ~~~~~~e~~~ll~~~~hp~Iv~l~~~~~~~--------~~~~lv~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  152 (373)
T 2r5t_A           82 EKHIMSERNVLLKNVKHPFLVGLHFSFQTA--------DKLYFVLDYINGGELFYHLQRE-RCFLEPRARFYAAEIASAL  152 (373)
T ss_dssp             ---------CCBCCCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCEEEEEEeC--------CEEEEEEeCCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            3456777777 5678999999999999876        669999999975 788887663 4689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. ++.++|||||||
T Consensus       153 ~~LH~~givHrDlkp~NIll~~~g~ikL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwslG~  227 (373)
T 2r5t_A          153 GYLHSLNIVYRDLKPENILLDSQGHIVLTDFGLCKENIEHN----STTSTFCGTPEYLAPEVLHKQP-YDRTVDWWCLGA  227 (373)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTSCEEECCCCBCGGGBCCC----CCCCSBSCCCCCCCHHHHTTCC-CCTHHHHHHHHH
T ss_pred             HHHHHCCceecCCCHHHEEECCCCCEEEeeCccccccccCC----CccccccCCccccCHHHhCCCC-CCchhhhHHHHH
Confidence            99999999999999999999999999999999997643221    2345668999999999998765 899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.+..+....|....-..                                +...+.++++||.+||+
T Consensus       228 il~ell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~~~~~li~~lL~  275 (373)
T 2r5t_A          228 VLYEMLYGLPPFYSRNTAEMYDNILNKPLQL--------------------------------KPNITNSARHLLEGLLQ  275 (373)
T ss_dssp             HHHHHHHSSCTTCCSBHHHHHHHHHHSCCCC--------------------------------CSSSCHHHHHHHHHHTC
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhcccCC--------------------------------CCCCCHHHHHHHHHHcc
Confidence            9999999999999988877776665421100                                11256778899999999


Q ss_pred             cCCCCCCCH----HHhhcCCCccC
Q psy7889         245 LDPSKRFDS----DAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~----~e~L~h~~~~~  264 (433)
                      .||.+||++    +++++||||..
T Consensus       276 ~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          276 KDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             SSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             cCHHhCCCCCCCHHHHhCCccccC
Confidence            999999997    69999999964

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=100.00  E-value=4.5e-39  Score=308.62  Aligned_cols=216  Identities=25%  Similarity=0.424  Sum_probs=181.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        ..+|+||||+. ++|.+++.. ...+++..++.++.||+.||+
T Consensus        59 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~aL~  129 (321)
T 2a2a_A           59 REEIEREVSILRQVLHHNVITLHDVYENR--------TDVVLILELVSGGELFDFLAQ-KESLSEEEATSFIKQILDGVN  129 (321)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHT-CSCEEHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEecC--------CEEEEEEEcCCCCcHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        66999999996 588888876 446899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+||+++.++    .+||+|||++.......     ......||+.|+|||++.+.. ++.++||||
T Consensus       130 ~lH~~~ivH~dikp~NIl~~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~s  203 (321)
T 2a2a_A          130 YLHTKKIAHFDLKPENIMLLDKNIPIPHIKLIDFGLAHEIEDGV-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWS  203 (321)
T ss_dssp             HHHHTTEECCCCSGGGEEESCTTSSSCCEEECCCTTCEECCTTC-----CCCCCCSCGGGCCHHHHTTCC-CCTHHHHHH
T ss_pred             HHHhCCeecCCCChHHEEEecCCCCcCCEEEccCccceecCccc-----cccccCCCCCccCcccccCCC-CCCccccHH
Confidence            99999999999999999999887    79999999998765322     234457899999999997755 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|..||.+....+.+..+.......+                   ...         ....+..+.+||.+
T Consensus       204 lG~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------~~~---------~~~~~~~~~~li~~  255 (321)
T 2a2a_A          204 IGVITYILLSGASPFLGDTKQETLANITSVSYDFD-------------------EEF---------FSHTSELAKDFIRK  255 (321)
T ss_dssp             HHHHHHHHHHSCCSSCCSSHHHHHHHHHTTCCCCC-------------------HHH---------HTTCCHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCCCHHHHHHHHHhcccccC-------------------hhh---------hcccCHHHHHHHHH
Confidence            99999999999999999888777666543221110                   000         01256778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||..||.+|||++|+|+||||...
T Consensus       256 ~l~~dp~~Rps~~e~l~hp~~~~~  279 (321)
T 2a2a_A          256 LLVKETRKRLTIQEALRHPWITPV  279 (321)
T ss_dssp             TSCSSTTTSCCHHHHHHSTTTSCS
T ss_pred             HcCCChhhCcCHHHHhcCccccCC
Confidence            999999999999999999999654

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=100.00  E-value=4.6e-39  Score=312.24  Aligned_cols=218  Identities=28%  Similarity=0.415  Sum_probs=163.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        ..+|+||||+. ++|.+.+.. ...+++..++.++.||+.||.
T Consensus        92 ~~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~L~  162 (349)
T 2w4o_A           92 KKIVRTEIGVLLRLSHPNIIKLKEIFETP--------TEISLVLELVTGGELFDRIVE-KGYYSERDAADAVKQILEAVA  162 (349)
T ss_dssp             -------CHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHTT-CSSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCcceeeeEecC--------CeEEEEEEeCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            45678899999999999999999999875        66999999997 588888765 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+|||++.   ++.+||+|||++.......     ......||+.|+|||++.+.. ++.++|||||
T Consensus       163 ~LH~~~ivH~Dikp~NIll~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  236 (349)
T 2w4o_A          163 YLHENGIVHRDLKPENLLYATPAPDAPLKIADFGLSKIVEHQV-----LMKTVCGTPGYCAPEILRGCA-YGPEVDMWSV  236 (349)
T ss_dssp             HHHHTTCCCCCCCGGGEEESSSSTTCCEEECCCC---------------------CGGGSCHHHHTTCC-CCTHHHHHHH
T ss_pred             HHHHCCeEecCCCcccEEEecCCCCCCEEEccCccccccCccc-----ccccccCCCCccCHHHhcCCC-CCcccchHHH
Confidence            999999999999999999975   7899999999997754321     233457899999999998765 7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++|+|++|..||.+..... ....+...........|                            ...+.++.+||.+
T Consensus       237 G~il~ell~g~~pf~~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~~  288 (349)
T 2w4o_A          237 GIITYILLCGFEPFYDERGDQFMFRRILNCEYYFISPWW----------------------------DEVSLNAKDLVRK  288 (349)
T ss_dssp             HHHHHHHHHSSCTTCCTTCHHHHHHHHHTTCCCCCTTTT----------------------------TTSCHHHHHHHHT
T ss_pred             HHHHHHHHhCCCCCCCCcccHHHHHHHHhCCCccCCchh----------------------------hhCCHHHHHHHHH
Confidence            999999999999998766544 33333221111111111                            1246678899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      ||..||++|||+.|+|+||||.....
T Consensus       289 ~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          289 LIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             HccCChhhCcCHHHHhcCcccCCCcc
Confidence            99999999999999999999976543

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=100.00  E-value=2.9e-39  Score=303.50  Aligned_cols=212  Identities=30%  Similarity=0.462  Sum_probs=177.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +.+++||||+++ +|...+.+. ..+++..++.++.||+.||+
T Consensus        53 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~l~~~-~~~~~~~~~~~~~qi~~~l~  123 (279)
T 3fdn_A           53 EHQLRREVEIQSHLRHPNILRLYGYFHDA--------TRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANALS  123 (279)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCcchhheEecC--------CEEEEEEecCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999875        669999999984 788887664 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.++|+|||++......      ......|+..|+|||++.+.. ++.++|||||||+
T Consensus       124 ~LH~~~i~H~dlkp~Nili~~~~~~~l~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  196 (279)
T 3fdn_A          124 YCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS------RRTDLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVL  196 (279)
T ss_dssp             HHHTTTCEECCCCGGGEEECTTSCEEECSCCEESCC--------------CCCCTTCCHHHHTTCC-CCTTHHHHHHHHH
T ss_pred             HHHhCCEecccCChHhEEEcCCCCEEEEeccccccCCcc------cccccCCCCCccCHhHhccCC-CCccchhHhHHHH
Confidence            999999999999999999999999999999988654322      123457799999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+....+....+.......                                +...+..+.+||.+||..
T Consensus       197 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~  244 (279)
T 3fdn_A          197 CYEFLVGKPPFEANTYQETYKRISRVEFTF--------------------------------PDFVTEGARDLISRLLKH  244 (279)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHTCCCC--------------------------------CTTSCHHHHHHHHHHCCS
T ss_pred             HHHHHHCCCCCCCCcHHHHHHHHHhCCCCC--------------------------------CCcCCHHHHHHHHHHhcc
Confidence            999999999999988877776665432211                                112456778999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+|||++|+|+||||....
T Consensus       245 ~p~~Rps~~e~l~h~~~~~~~  265 (279)
T 3fdn_A          245 NPSQRPMLREVLEHPWITANS  265 (279)
T ss_dssp             SGGGSCCHHHHHHCHHHHHHC
T ss_pred             ChhhCCCHHHHhhCccccCCc
Confidence            999999999999999996543

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=100.00  E-value=3.9e-39  Score=307.76  Aligned_cols=208  Identities=24%  Similarity=0.317  Sum_probs=168.2

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..++|+..+..+ +|||||++++++.+.        +.+|+||||++++|.+.+......+++..++.++.||+.||+||
T Consensus       102 ~~~~e~~~~~~~~~h~~iv~l~~~~~~~--------~~~~lv~e~~~~~L~~~~~~~~~~l~~~~~~~i~~qi~~aL~~L  173 (311)
T 3p1a_A          102 RKLAEVGSHEKVGQHPCCVRLEQAWEEG--------GILYLQTELCGPSLQQHCEAWGASLPEAQVWGYLRDTLLALAHL  173 (311)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHHCSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCcEEEEEEEEEeC--------CEEEEEEeccCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            455666666655 899999999999875        67999999999999999988777799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++.......     ......||+.|+|||++.+  .++.++|||||||+++
T Consensus       174 H~~~ivH~Dikp~NIll~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~DiwslG~il~  246 (311)
T 3p1a_A          174 HSQGLVHLDVKPANIFLGPRGRCKLGDFGLLVELGTAG-----AGEVQEGDPRYMAPELLQG--SYGTAADVFSLGLTIL  246 (311)
T ss_dssp             HHTTEECCCCSGGGEEECGGGCEEECCCTTCEECC-----------CCCCCGGGCCGGGGGT--CCSTHHHHHHHHHHHH
T ss_pred             HHCCEecCCCCHHHEEECCCCCEEEccceeeeecccCC-----CCcccCCCccccCHhHhcC--CCCchhhHHHHHHHHH
Confidence            99999999999999999999999999999987764322     2234568999999999876  4799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP  247 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP  247 (433)
                      +|++|..+|.+......   +..  +..                   +..    .     +...+.++.+||.+||..||
T Consensus       247 el~~g~~~~~~~~~~~~---~~~--~~~-------------------~~~----~-----~~~~~~~l~~li~~~L~~dP  293 (311)
T 3p1a_A          247 EVACNMELPHGGEGWQQ---LRQ--GYL-------------------PPE----F-----TAGLSSELRSVLVMMLEPDP  293 (311)
T ss_dssp             HHHHTCCCCSSHHHHHH---HTT--TCC-------------------CHH----H-----HTTSCHHHHHHHHHHSCSST
T ss_pred             HHHhCCCCCCCccHHHH---Hhc--cCC-------------------Ccc----c-----ccCCCHHHHHHHHHHcCCCh
Confidence            99999776665432221   110  000                   000    0     01357788899999999999


Q ss_pred             CCCCCHHHhhcCCCccC
Q psy7889         248 SKRFDSDAALNHDFFWT  264 (433)
Q Consensus       248 ~~R~t~~e~L~h~~~~~  264 (433)
                      .+|||++|+|+||||++
T Consensus       294 ~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          294 KLRATAEALLALPVLRQ  310 (311)
T ss_dssp             TTSCCHHHHHTSGGGSC
T ss_pred             hhCcCHHHHHhCccccC
Confidence            99999999999999965

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=100.00  E-value=1.8e-38  Score=305.29  Aligned_cols=239  Identities=29%  Similarity=0.472  Sum_probs=181.5

Q ss_pred             CchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ....+.+|+.+|+.++ ||||+++++++.+...      ...++||||+.+ +|..++.    .+++..++.++.||+.|
T Consensus        73 ~~~~~~~E~~~l~~l~~~~~i~~~~~~~~~~~~------~~~~lv~e~~~~~~l~~~~~----~~~~~~~~~~~~qi~~~  142 (330)
T 3nsz_A           73 KKKKIKREIKILENLRGGPNIITLADIVKDPVS------RTPALVFEHVNNTDFKQLYQ----TLTDYDIRFYMYEILKA  142 (330)
T ss_dssp             CHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT------CCEEEEEECCCCCCHHHHGG----GCCHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHcCCCCCEEEeeeeeccCCC------CceEEEEeccCchhHHHHHH----hCCHHHHHHHHHHHHHH
Confidence            4567899999999997 9999999999987432      668999999985 6666654    38999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |+|||++||+||||||+|||++.++ .+||+|||++.......     ......+|..|+|||++.+...++.++|||||
T Consensus       143 l~~lH~~~ivH~Dikp~Nil~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Diwsl  217 (330)
T 3nsz_A          143 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  217 (330)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHHhCCeeeCCCCHHHEEEcCCCCEEEEEeCCCceEcCCCC-----ccccccccccccChhhhcCCCcCCchhhHHHH
Confidence            9999999999999999999999777 89999999998765332     23455789999999999875668999999999


Q ss_pred             HHHHHHHHhcCCCC-CCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchH-----------HHhhHHhhhCCcc
Q psy7889         163 GCIMAEMWTRSPIM-QGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKA-----------QKRKVKERLKPYV  230 (433)
Q Consensus       163 Gvil~ell~g~~pf-~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~-----------~~~~~~~~~~~~~  230 (433)
                      ||++|+|++|..|| .+....+.+..+....+......+      ...........           .............
T Consensus       218 G~il~~ll~g~~p~~~~~~~~~~l~~~~~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  291 (330)
T 3nsz_A          218 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDY------IDKYNIELDPRFNDILGRHSRKRWERFVHSENQHL  291 (330)
T ss_dssp             HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHH------HHHTTCCCCTHHHHHHCCCCCCCGGGGCCTTTGGG
T ss_pred             HHHHHHHHhCCCCcccCCchHHHHHHHHHhcCCchhhhH------HHHhccccccchhhhhhhccccchhhhcccccccc
Confidence            99999999999887 456666777666665553210000      00000000000           0000000011123


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+.++++||.+||..||.+|||++|+|+||||+..
T Consensus       292 ~~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~~  326 (330)
T 3nsz_A          292 VSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYTV  326 (330)
T ss_dssp             CCHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTTC
T ss_pred             CCHHHHHHHHHHhcCCcccCCCHHHHhcCccHhhh
Confidence            68889999999999999999999999999999754

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=100.00  E-value=3.3e-39  Score=311.02  Aligned_cols=241  Identities=25%  Similarity=0.462  Sum_probs=187.2

Q ss_pred             hhHHHHHHHHHhCCCC------CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHE------NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hp------nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql   80 (433)
                      ..+.+|+.+++.++|+      +|+++++++...        +.+|+||||++++|.+++.... ..+++..++.++.||
T Consensus        56 ~~~~~e~~~l~~l~~~~~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~~qi  127 (339)
T 1z57_A           56 EAARSEIQVLEHLNTTDPNSTFRCVQMLEWFEHH--------GHICIVFELLGLSTYDFIKENGFLPFRLDHIRKMAYQI  127 (339)
T ss_dssp             HHHHHHHHHHHHHHHHCTTCTTCBCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhhcCCCCceeeEeeecccccC--------CcEEEEEcCCCCCHHHHHHhcCCCCCcHHHHHHHHHHH
Confidence            5678899999999665      499999999876        6799999999999999987654 358999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEec-------------------CCcEEEeecCCccccccCcCCccccccCCcccccc
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITK-------------------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWY  141 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~-------------------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y  141 (433)
                      +.||+|||++||+||||||+|||++.                   ++.+||+|||++......       .....||+.|
T Consensus       128 ~~~l~~lH~~~ivH~Dlkp~Nil~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y  200 (339)
T 1z57_A          128 CKSVNFLHSNKLTHTDLKPENILFVQSDYTEAYNPKIKRDERTLINPDIKVVDFGSATYDDEH-------HSTLVSTRHY  200 (339)
T ss_dssp             HHHHHHHHHTTEECCCCCGGGEEESCCCEEEEEC----CEEEEESCCCEEECCCSSCEETTSC-------CCSSCSCGGG
T ss_pred             HHHHHHHHHCCCcCCCCCHHHEEEeccccccccCCccccccccccCCCceEeeCcccccCccc-------cccccCCccc
Confidence            99999999999999999999999987                   668999999999764321       2345789999


Q ss_pred             cCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhh--ccccch--H
Q psy7889         142 RPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYN--KMELPK--A  217 (433)
Q Consensus       142 ~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~--~~~~~~--~  217 (433)
                      +|||++.+.. ++.++|||||||++|+|++|.+||.+.+..+....+....+..+...+........+.  ...+..  .
T Consensus       201 ~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  279 (339)
T 1z57_A          201 RAPEVILALG-WSQPCDVWSIGCILIEYYLGFTVFPTHDSKEHLAMMERILGPLPKHMIQKTRKRKYFHHDRLDWDEHSS  279 (339)
T ss_dssp             CCHHHHTTSC-CCTHHHHHHHHHHHHHHHHSSCSCCCSCHHHHHHHHHHHHCSCCHHHHHHCSCGGGEETTEECCCTTSH
T ss_pred             cChHHhhCCC-CCcchhhHHHHHHHHHHHhCCCCCCCCChHHHHHHHHHHhCCCCHHHHhhccchhHHhhcccccccccc
Confidence            9999998765 7999999999999999999999999999999888888888866543221111111100  000000  0


Q ss_pred             HHhhHHhh--------hCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         218 QKRKVKER--------LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       218 ~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ........        ......+.++.+||.+||..||.+|||++|+|+||||..
T Consensus       280 ~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          280 AGRYVSRACKPLKEFMLSQDVEHERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             ccchhhhcCcchhhhcccchhhHHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            00000000        111123567889999999999999999999999999965

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=100.00  E-value=1.7e-39  Score=329.16  Aligned_cols=214  Identities=30%  Similarity=0.560  Sum_probs=181.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        +.+|+|||||. ++|.+.+... ..+++..++.++.||+.||.
T Consensus        70 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~-~~~~~~~~~~i~~qi~~~l~  140 (484)
T 3nyv_A           70 KESLLREVQLLKQLDHPNIMKLYEFFEDK--------GYFYLVGEVYTGGELFDEIISR-KRFSEVDAARIIRQVLSGIT  140 (484)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHTC-SCCBHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEeC--------CEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999875        66999999997 5788887663 46999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEE---ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll---~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+|||+   +.++.+||+|||++..+....     .....+||+.|+|||++.+  .|+.++|||||
T Consensus       141 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  213 (484)
T 3nyv_A          141 YMHKNKIVHRDLKPENLLLESKSKDANIRIIDFGLSTHFEASK-----KMKDKIGTAYYIAPEVLHG--TYDEKCDVWST  213 (484)
T ss_dssp             HHHHTTCCCSCCCGGGEEESSSSTTCCEEECCTTHHHHBCCCC-----SHHHHTTGGGTCCHHHHHT--CCCTHHHHHHH
T ss_pred             HHHHCCeeeCCCCHHHEEEecCCCCCcEEEEeeeeeEEccccc-----ccccCCCCccccCceeecC--CCCCcceeHHH
Confidence            9999999999999999999   467899999999997765332     2334578999999999976  37999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+..+.+..+...........|                            ...+.++++||.+|
T Consensus       214 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~  265 (484)
T 3nyv_A          214 GVILYILLSGCPPFNGANEYDILKKVEKGKYTFELPQW----------------------------KKVSESAKDLIRKM  265 (484)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGGG----------------------------GGSCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCCccc----------------------------ccCCHHHHHHHHHH
Confidence            99999999999999999988887777653322211111                            12567788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |..||.+|||+.|+|+||||+.
T Consensus       266 L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          266 LTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             TCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CCCChhHCcCHHHHhhChhhcc
Confidence            9999999999999999999964

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=100.00  E-value=3e-39  Score=312.52  Aligned_cols=214  Identities=23%  Similarity=0.402  Sum_probs=172.5

Q ss_pred             hHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         9 ~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+|+++|.++ +|||||++++++.+.        ..+|+|||||.+ +|.+.+... ..+++..++.++.||+.||+|
T Consensus        61 ~~~~E~~~l~~~~~hp~iv~~~~~~~~~--------~~~~lv~E~~~gg~L~~~i~~~-~~~~~~~~~~~~~qi~~al~~  131 (342)
T 2qr7_A           61 DPTEEIEILLRYGQHPNIITLKDVYDDG--------KYVYVVTELMKGGELLDKILRQ-KFFSEREASAVLFTITKTVEY  131 (342)
T ss_dssp             CCHHHHHHHHHHTTSTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHTC-TTCCHHHHHHHHHHHHHHHHH
T ss_pred             ChHHHHHHHHHhcCCCCcCeEEEEEEcC--------CEEEEEEeCCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            456899999988 799999999999875        679999999974 888888763 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecC----CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKT----GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~----~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||++||+||||||+|||+...    +.+||+|||++.......    ......+||+.|+|||++.+.. |+.++|||||
T Consensus       132 lH~~givHrDlkp~NIl~~~~~~~~~~~kl~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  206 (342)
T 2qr7_A          132 LHAQGVVHRDLKPSNILYVDESGNPESIRICDFGFAKQLRAEN----GLLMTPCYTANFVAPEVLERQG-YDAACDIWSL  206 (342)
T ss_dssp             HHHTTEECSCCCGGGEEESSSSCSGGGEEECCCTTCEECBCTT----CCBCCSSCCSSCCCHHHHHHHH-HHHHHHHHHH
T ss_pred             HHHCCcEeccCCHHHEEEecCCCCcCeEEEEECCCcccCcCCC----CceeccCCCccccCHHHhcCCC-CCCccCeeeH
Confidence            999999999999999998543    359999999998764322    1234567899999999987654 7899999999


Q ss_pred             HHHHHHHHhcCCCCCCC---ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         163 GCIMAEMWTRSPIMQGN---TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~---~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||++|+|++|.+||.+.   ...+....+...........|                            ...+.++++||
T Consensus       207 G~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li  258 (342)
T 2qr7_A          207 GVLLYTMLTGYTPFANGPDDTPEEILARIGSGKFSLSGGYW----------------------------NSVSDTAKDLV  258 (342)
T ss_dssp             HHHHHHHHHSSCSSCSSTTSCHHHHHHHHHHCCCCCCSTTT----------------------------TTSCHHHHHHH
T ss_pred             hHHHHHHhcCCCCCCCCCcCCHHHHHHHHccCCcccCcccc----------------------------ccCCHHHHHHH
Confidence            99999999999999863   334444444332211111111                            12567888999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||..||.+|||+.++|+||||..
T Consensus       259 ~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          259 SKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             HHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             HHHCCCChhHCcCHHHHhcCCeecC
Confidence            9999999999999999999999943

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=100.00  E-value=4.2e-39  Score=302.19  Aligned_cols=215  Identities=27%  Similarity=0.475  Sum_probs=155.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +.+|+||||++ ++|.+++......+++..++.++.||+.||+
T Consensus        55 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~  126 (278)
T 3cok_A           55 VQRVQNEVKIHCQLKHPSILELYNYFEDS--------NYVYLVLEMCHNGEMNRYLKNRVKPFSENEARHFMHQIITGML  126 (278)
T ss_dssp             HHHHHHHHHHHTTBCCTTBCCEEEEEECS--------SEEEEEEECCTTEEHHHHHHTCSSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeEeEEEEEccC--------CeEEEEEecCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        66999999996 4888888876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++........    ......||+.|+|||++.+.. ++.++|||||||+
T Consensus       127 ~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~~----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  201 (278)
T 3cok_A          127 YLHSHGILHRDLTLSNLLLTRNMNIKIADFGLATQLKMPHE----KHYTLCGTPNYISPEIATRSA-HGLESDVWSLGCM  201 (278)
T ss_dssp             HHHHTTEECSSCCGGGEEECTTCCEEECCCTTCEECC---------------------------------CTHHHHHHHH
T ss_pred             HHHHCCeecCCCCHHHEEEcCCCCEEEEeecceeeccCCCC----cceeccCCCCcCCcchhcCCC-CCchhhHHHHHHH
Confidence            99999999999999999999999999999999977643221    223456899999999987655 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...........+..       .            ...             .+...+.++.+||.+||..
T Consensus       202 l~~l~~g~~p~~~~~~~~~~~~~~~-------~------------~~~-------------~~~~~~~~~~~li~~~l~~  249 (278)
T 3cok_A          202 FYTLLIGRPPFDTDTVKNTLNKVVL-------A------------DYE-------------MPSFLSIEAKDLIHQLLRR  249 (278)
T ss_dssp             HHHHHHSSCSSCCCSCC-----CCS-------S------------CCC-------------CCTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCChhHHHHHHHHhh-------c------------ccC-------------CccccCHHHHHHHHHHccc
Confidence            9999999999987553322211100       0            000             1123567788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+|||++++|+||||....
T Consensus       250 dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          250 NPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             SGGGSCCHHHHTTSTTTC---
T ss_pred             CHhhCCCHHHHhcCccccCCC
Confidence            999999999999999997543

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=100.00  E-value=8.5e-39  Score=326.47  Aligned_cols=213  Identities=25%  Similarity=0.388  Sum_probs=176.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+++|+++|+.++|||||++++++.+.        +.+|+||||+. ++|...+.... ..+++..++.++.||+.||
T Consensus       228 ~~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--------~~l~lVmEy~~gg~L~~~l~~~~~~~l~e~~~~~i~~qIl~aL  299 (576)
T 2acx_A          228 EAMALNEKQILEKVNSRFVVSLAYAYETK--------DALCLVLTLMNGGDLKFHIYHMGQAGFPEARAVFYAAEICCGL  299 (576)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHSSSSCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCEeeEEEEEeeC--------CEEEEEEEcCCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        66999999996 58888887643 3499999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||++.......     .....+||+.|+|||++.+.. |+.++|||||||
T Consensus       300 ~yLH~~gIvHrDLKPeNILld~~g~vKL~DFGla~~~~~~~-----~~~~~~GT~~Y~APEvl~~~~-~~~~~DiwSLGv  373 (576)
T 2acx_A          300 EDLHRERIVYRDLKPENILLDDHGHIRISDLGLAVHVPEGQ-----TIKGRVGTVGYMAPEVVKNER-YTFSPDWWALGC  373 (576)
T ss_dssp             HHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC-----CEECCCSCGGGCCHHHHTTCE-ESSHHHHHHHHH
T ss_pred             HHHHHCCEeccCCchheEEEeCCCCeEEEecccceecccCc-----cccccCCCccccCHHHHcCCC-CCccchHHHHHH
Confidence            99999999999999999999999999999999998765322     234458999999999998765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCCh----HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         165 IMAEMWTRSPIMQGNTE----QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       165 il~ell~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ++|+|++|.+||.+...    ......+...    +. .+                           +...+.++++||.
T Consensus       374 ilyeLltG~~PF~~~~~~~~~~~i~~~i~~~----~~-~~---------------------------p~~~s~~~~dLI~  421 (576)
T 2acx_A          374 LLYEMIAGQSPFQQRKKKIKREEVERLVKEV----PE-EY---------------------------SERFSPQARSLCS  421 (576)
T ss_dssp             HHHHHHHSSCSSSCSSSCCCHHHHHHHHHHC----CC-CC---------------------------CTTSCHHHHHHHH
T ss_pred             HHHHHHhCCCCCcccccchhHHHHHHHhhcc----cc-cC---------------------------CccCCHHHHHHHH
Confidence            99999999999987642    2222222110    00 00                           1135778889999


Q ss_pred             hhcccCCCCCC-----CHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      +||..||.+||     +++|+++||||...
T Consensus       422 ~lL~~dP~~R~g~~~~sa~eil~HpfF~~i  451 (576)
T 2acx_A          422 QLLCKDPAERLGCRGGSAREVKEHPLFKKL  451 (576)
T ss_dssp             HHTCSSGGGSTTCSSSHHHHHHTSGGGTTC
T ss_pred             HhccCCHHHcCCCCCCCHHHHHhChhhccC
Confidence            99999999999     89999999999753

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=100.00  E-value=2e-39  Score=310.18  Aligned_cols=251  Identities=33%  Similarity=0.560  Sum_probs=186.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCcc------ccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQ------YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~------~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      ..+++|+.+++.++||||+++++++......      .......+|+||||+.++|.+++.+  ..+++..++.++.||+
T Consensus        53 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~~~~--~~~~~~~~~~~~~qi~  130 (320)
T 2i6l_A           53 KHALREIKIIRRLDHDNIVKVFEILGPSGSQLTDDVGSLTELNSVYIVQEYMETDLANVLEQ--GPLLEEHARLFMYQLL  130 (320)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECTTSCBCCC----CCSCSEEEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEeccccccccccccccccccCceeEEeeccCCCHHHHhhc--CCccHHHHHHHHHHHH
Confidence            4678999999999999999999998654211      1122477999999999999998864  4689999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      .||+|||++||+||||||+||+++ .++.+||+|||++........ .........+|..|+|||++.+...++.++|||
T Consensus       131 ~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~  209 (320)
T 2i6l_A          131 RGLKYIHSANVLHRDLKPANLFINTEDLVLKIGDFGLARIMDPHYS-HKGHLSEGLVTKWYRSPRLLLSPNNYTKAIDMW  209 (320)
T ss_dssp             HHHHHHHHTTCBCCCCSGGGEEEETTTTEEEECCCTTCBCC---------CCCGGGSCCTTCCHHHHHCTTCCCHHHHHH
T ss_pred             HHHHHHHhCCEecCCCCHHHEEEcCCCCeEEEccCccccccCCCcc-cccccccccccccccCcHHhcCcccCCchhhhH
Confidence            999999999999999999999998 567999999999987643211 112234456789999999987755689999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhh-----hCCccCChhH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKER-----LKPYVKDQYG  235 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~s~~~  235 (433)
                      ||||++|+|++|.+||.+....+....+....+....+.+....     ..  .+..........     ......+.++
T Consensus       210 slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~-----~~--~~~~~~~~~~~~~~~~~~~~~~~~~~~  282 (320)
T 2i6l_A          210 AAGCIFAEMLTGKTLFAGAHELEQMQLILESIPVVHEEDRQELL-----SV--IPVYIRNDMTEPHKPLTQLLPGISREA  282 (320)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHSCCCCHHHHHHHH-----TT--SCHHHHHHTTSCCCCHHHHSTTCCHHH
T ss_pred             hHHHHHHHHHhCCCCCCCCCHHHHHHHHHHhcCCCchhhhhhhh-----hc--CcccccccccCCCCChhHhcchhhHHH
Confidence            99999999999999999999888887777655433221110000     00  000000000000     0011367889


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      ++||.+||..||.+|||++|+|+||||.....+
T Consensus       283 ~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p  315 (320)
T 2i6l_A          283 VDFLEQILTFSPMDRLTAEEALSHPYMSIYSFP  315 (320)
T ss_dssp             HHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC-
T ss_pred             HHHHHHHcCCCccccCCHHHHhCCcccccccCc
Confidence            999999999999999999999999999765443

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=100.00  E-value=4.5e-39  Score=327.51  Aligned_cols=216  Identities=29%  Similarity=0.507  Sum_probs=182.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++|||||++++++.+.        ..+|||||||.+ +|.+.+... ..+++..++.++.||+.||+
T Consensus        90 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~gg~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~  160 (504)
T 3q5i_A           90 HEEIYNEISLLKSLDHPNIIKLFDVFEDK--------KYFYLVTEFYEGGELFEQIINR-HKFDECDAANIMKQILSGIC  160 (504)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEcC--------CEEEEEEecCCCCcHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        669999999975 888888664 46999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+|||++.++   .+||+|||++......     ......+||+.|+|||++.+  .++.++||||+
T Consensus       161 ~lH~~~ivH~Dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~--~~~~~~Diwsl  233 (504)
T 3q5i_A          161 YLHKHNIVHRDIKPENILLENKNSLLNIKIVDFGLSSFFSKD-----YKLRDRLGTAYYIAPEVLKK--KYNEKCDVWSC  233 (504)
T ss_dssp             HHHHTTEECSCCSGGGEEESSTTCCSSEEECCCTTCEECCTT-----SCBCCCCSCTTTCCHHHHTT--CBCTHHHHHHH
T ss_pred             HHHHCCeEeCCCcHHHEEEecCCCCccEEEEECCCCEEcCCC-----CccccccCCcCCCCHHHhcc--CCCchHHHHHH
Confidence            99999999999999999998776   6999999999876532     12345678999999999864  37999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+..+.+..+...........|                            ...+.++++||.+|
T Consensus       234 G~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~  285 (504)
T 3q5i_A          234 GVIMYILLCGYPPFGGQNDQDIIKKVEKGKYYFDFNDW----------------------------KNISDEAKELIKLM  285 (504)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCHHHH----------------------------TTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCcccc----------------------------CCCCHHHHHHHHHH
Confidence            99999999999999999988877777652211110000                            12567888999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|||++|+|+||||+...
T Consensus       286 L~~dp~~R~t~~e~l~h~~~~~~~  309 (504)
T 3q5i_A          286 LTYDYNKRCTAEEALNSRWIKKYA  309 (504)
T ss_dssp             TCSSTTTSCCHHHHHTSHHHHHTC
T ss_pred             cCCChhHCCCHHHHhcCHhhhhch
Confidence            999999999999999999997544

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=100.00  E-value=1e-38  Score=313.58  Aligned_cols=242  Identities=30%  Similarity=0.491  Sum_probs=185.7

Q ss_pred             hhHHHHHHHHHhCC-CC-----CccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HE-----NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hp-----nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~ql   80 (433)
                      ..+.+|+.+++.++ |+     +|+++++++...        +.+||||||++++|.+++.... ..+++..++.++.||
T Consensus        95 ~~~~~e~~~l~~l~~~~~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi  166 (382)
T 2vx3_A           95 NQAQIEVRLLELMNKHDTEMKYYIVHLKRHFMFR--------NHLCLVFEMLSYNLYDLLRNTNFRGVSLNLTRKFAQQM  166 (382)
T ss_dssp             HHHHHHHHHHHHHHHCSSGGGGGBCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTSCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcccccceeEEEeeeeeccC--------CceEEEEecCCCCHHHHHhhcCcCCCCHHHHHHHHHHH
Confidence            45678999999885 55     499999999875        6799999999999999998754 458999999999999


Q ss_pred             HHHHHHHH--hCCeeccCCCCCcEEEe--cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCc
Q psy7889          81 LNGLYYIH--SNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        81 l~aL~~LH--~~~iiH~dikp~NIll~--~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +.||.|||  +.||+||||||+|||++  .++.+||+|||++.....       ......||+.|+|||++.+.. ++.+
T Consensus       167 ~~al~~lH~~~~~ivHrDlkp~NIll~~~~~~~~kL~DFG~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~-~~~~  238 (382)
T 2vx3_A          167 CTALLFLATPELSIIHCDLKPENILLCNPKRSAIKIVDFGSSCQLGQ-------RIYQYIQSRFYRSPEVLLGMP-YDLA  238 (382)
T ss_dssp             HHHHHHHTSTTTCEECCCCSGGGEEESSTTSCCEEECCCTTCEETTC-------CCCSSCSCGGGCCHHHHTTCC-CCTH
T ss_pred             HHHHHHhccCCCCEEcCCCCcccEEEecCCCCcEEEEeccCceeccc-------ccccccCCccccChHHHcCCC-CCcH
Confidence            99999999  57999999999999995  477899999999977642       233567899999999998765 8999


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchh-hhhcc---------------ccchHHHh
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLD-LYNKM---------------ELPKAQKR  220 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~-~~~~~---------------~~~~~~~~  220 (433)
                      +|||||||++|+|++|.+||.+.+..+.+..+....+.++...+....... .+..+               ........
T Consensus       239 ~DiwSlG~il~elltg~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  318 (382)
T 2vx3_A          239 IDMWSLGCILVEMHTGEPLFSGANEVDQMNKIVEVLGIPPAHILDQAPKARKFFEKLPDGTWNLKKTKDGKREYKPPGTR  318 (382)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHHHCSCCHHHHTTCTTHHHHEEECTTSCEEECCCCTTCCCSCCTTCS
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHhCCCCHHHHHhhHHHHHHHHhccccccccccccccccccCCcchh
Confidence            999999999999999999999999999999999988876543322111100 00000               00000000


Q ss_pred             hHHhhhCC----------------ccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         221 KVKERLKP----------------YVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       221 ~~~~~~~~----------------~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+...+..                ...+.++++||.+||++||.+|||++|+|+||||.+.
T Consensus       319 ~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          319 KLHNILGVETGGPGGRRAGESGHTVADYLKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             CHHHHHTTTTTSGGGTTTTCTTCCHHHHHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             hHHHHhhccccCCCccccccccccchhhHHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            00000000                0011367899999999999999999999999999764

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=100.00  E-value=1.6e-38  Score=323.55  Aligned_cols=213  Identities=26%  Similarity=0.362  Sum_probs=175.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+++|+.+|+.++|||||+++++|.+.        +.+|+||||+. ++|...+...   ...+++..++.++.||+.|
T Consensus       230 ~~~~~E~~iL~~l~hp~Iv~l~~~~~~~--------~~l~lVmE~~~gg~L~~~l~~~~~~~~~l~e~~~~~~~~qi~~a  301 (543)
T 3c4z_A          230 QGAMVEKKILAKVHSRFIVSLAYAFETK--------TDLCLVMTIMNGGDIRYHIYNVDEDNPGFQEPRAIFYTAQIVSG  301 (543)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCTTCBHHHHHHTSSTTSCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEeeC--------CEEEEEEEeccCCCHHHHHHHhhcccccccHHHHHHHHHHHHHH
Confidence            5678999999999999999999999876        66999999997 5888887654   3359999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.+|.+||+|||++.......    ......+||+.|+|||++.+.. |+.++||||||
T Consensus       302 L~~LH~~gIvHrDLKP~NILl~~~g~vkL~DFGla~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~-~~~~~DiwSlG  376 (543)
T 3c4z_A          302 LEHLHQRNIIYRDLKPENVLLDDDGNVRISDLGLAVELKAGQ----TKTKGYAGTPGFMAPELLLGEE-YDFSVDYFALG  376 (543)
T ss_dssp             HHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCTTC----CCBCCCCSCTTTSCHHHHTTCC-BCTHHHHHHHH
T ss_pred             HHHHHHcCCcccCCChHHEEEeCCCCEEEeecceeeeccCCC----cccccccCCccccChhhhcCCC-CChHHhcCcch
Confidence            999999999999999999999999999999999998765332    1233458999999999998765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCCh----HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         164 CIMAEMWTRSPIMQGNTE----QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |++|+|++|.+||.+...    ......+..  +...                              .+...+.++.+||
T Consensus       377 vilyelltG~~PF~~~~~~~~~~~~~~~i~~--~~~~------------------------------~p~~~s~~~~~li  424 (543)
T 3c4z_A          377 VTLYEMIAARGPFRARGEKVENKELKQRVLE--QAVT------------------------------YPDKFSPASKDFC  424 (543)
T ss_dssp             HHHHHHHHSSCSSCCTTCCCCHHHHHHHHHH--CCCC------------------------------CCTTSCHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCccchhHHHHHHHHhh--cccC------------------------------CCcccCHHHHHHH
Confidence            999999999999987532    222222221  1000                              0123577888999


Q ss_pred             HhhcccCCCCCCC-----HHHhhcCCCccCC
Q psy7889         240 DKLLLLDPSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       240 ~~~L~~dP~~R~t-----~~e~L~h~~~~~~  265 (433)
                      .+||..||.+||+     ++++++||||...
T Consensus       425 ~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~i  455 (543)
T 3c4z_A          425 EALLQKDPEKRLGFRDGSCDGLRTHPLFRDI  455 (543)
T ss_dssp             HHHSCSSGGGSCCCBTTBSHHHHTSGGGTTC
T ss_pred             HHhccCCHhHCCCCcccCHHHHHcCccccCC
Confidence            9999999999996     5899999999653

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=100.00  E-value=4.5e-38  Score=300.43  Aligned_cols=228  Identities=25%  Similarity=0.408  Sum_probs=187.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+|+||||+++ +|.+++......+++..++.++.||+.||.
T Consensus        68 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~~i~~~l~  139 (314)
T 3com_A           68 LQEIIKEISIMQQCDSPHVVKYYGSYFKN--------TDLWIVMEYCGAGSVSDIIRLRNKTLTEDEIATILQSTLKGLE  139 (314)
T ss_dssp             CHHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEHHHHHHHHTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCccEEEEEEeC--------CEEEEEeecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        669999999986 888888766667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++|||||||+
T Consensus       140 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  214 (314)
T 3com_A          140 YLHFMRKIHRDIKAGNILLNTEGHAKLADFGVAGQLTDTM----AKRNTVIGTPFWMAPEVIQEIG-YNCVADIWSLGIT  214 (314)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECBTTB----SCBCCCCSCGGGCCHHHHSSSC-BCTTHHHHHHHHH
T ss_pred             HHHhCCCcCCCcCHHHEEECCCCCEEEeecccchhhhhhc----cccCccCCCCCccChhhcCCCC-CCccccHHHHHHH
Confidence            9999999999999999999999999999999997764321    1233457899999999997765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.........+.....   . .+.                         .+...+..+.+||.+||..
T Consensus       215 l~~l~~g~~p~~~~~~~~~~~~~~~~~~---~-~~~-------------------------~~~~~~~~l~~li~~~l~~  265 (314)
T 3com_A          215 AIEMAEGKPPYADIHPMRAIFMIPTNPP---P-TFR-------------------------KPELWSDNFTDFVKQCLVK  265 (314)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCC---C-CCS-------------------------SGGGSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHhcCCC---c-ccC-------------------------CcccCCHHHHHHHHHHccC
Confidence            9999999999998877665544332110   0 000                         0112467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCchhHHHHh
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLA  276 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~  276 (433)
                      ||.+|||+.++|+||||............+.
T Consensus       266 dp~~Rpt~~~ll~~~~~~~~~~~~~~~~~~~  296 (314)
T 3com_A          266 SPEQRATATQLLQHPFVRSAKGVSILRDLIN  296 (314)
T ss_dssp             CTTTSCCHHHHTTSHHHHTCCCGGGGHHHHH
T ss_pred             ChhhCcCHHHHHhCHHHhcCCcchHHHHHhh
Confidence            9999999999999999987765554444443

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=100.00  E-value=4.9e-39  Score=311.95  Aligned_cols=243  Identities=25%  Similarity=0.451  Sum_probs=188.4

Q ss_pred             chhHHHHHHHHHhCCCCC------ccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHEN------VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIKKVIQQ   79 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpn------Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~~i~~q   79 (433)
                      ...+.+|+.+++.++|++      |+.+++++...        +.+|+||||+++++.+.+.... ..+++..++.++.|
T Consensus        60 ~~~~~~E~~~l~~l~~~~~~~~~~~~~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~i~~q  131 (355)
T 2eu9_A           60 REAARLEINVLKKIKEKDKENKFLCVLMSDWFNFH--------GHMCIAFELLGKNTFEFLKENNFQPYPLPHVRHMAYQ  131 (355)
T ss_dssp             HHHHHHHHHHHHHHHHHCTTSCSCBCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTCCCCHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHHhhcCCCCceeEEEeeeeeeeC--------CeEEEEEeccCCChHHHHHhccCCCCCHHHHHHHHHH
Confidence            356788999999997665      89999999875        6799999999999999887654 46999999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEE-------------------ecCCcEEEeecCCccccccCcCCccccccCCccccc
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLI-------------------TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLW  140 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll-------------------~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~  140 (433)
                      |+.||+|||++||+||||||+|||+                   +.++.+||+|||++.....       ......||+.
T Consensus       132 i~~~L~~lH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~gt~~  204 (355)
T 2eu9_A          132 LCHALRFLHENQLTHTDLKPENILFVNSEFETLYNEHKSCEEKSVKNTSIRVADFGSATFDHE-------HHTTIVATRH  204 (355)
T ss_dssp             HHHHHHHHHTTTEECCCCCGGGEEESCCCEEEEECCC-CCCEEEESCCCEEECCCTTCEETTS-------CCCSSCSCGG
T ss_pred             HHHHHHHHHHCCcccCCCCHHHEEEecccccccccccccccccccCCCcEEEeecCccccccc-------cccCCcCCCc
Confidence            9999999999999999999999999                   6678999999999976432       1234578999


Q ss_pred             ccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhc--cccch--
Q psy7889         141 YRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNK--MELPK--  216 (433)
Q Consensus       141 y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~--~~~~~--  216 (433)
                      |+|||++.+.. ++.++|||||||++|+|++|.+||.+....+.+..+....+..+...+........+..  ..++.  
T Consensus       205 y~aPE~~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~  283 (355)
T 2eu9_A          205 YRPPEVILELG-WAQPCDVWSIGCILFEYYRGFTLFQTHENREHLVMMEKILGPIPSHMIHRTRKQKYFYKGGLVWDENS  283 (355)
T ss_dssp             GCCHHHHTTCC-CCTHHHHHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHHHCSCGGGEETTEECCCTTS
T ss_pred             ccCCeeeecCC-CCCccchHHHHHHHHHHHhCCCCCCCCCHHHHHHHHHHHcCCCcHHHhhhccchhhhccccccccccc
Confidence            99999998765 79999999999999999999999999999999998988888765432211111110000  00000  


Q ss_pred             HHHhhHHhh--------hCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         217 AQKRKVKER--------LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       217 ~~~~~~~~~--------~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .........        ......+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       284 ~~~~~~~~~~~~~~~~~~~~~~~~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~  340 (355)
T 2eu9_A          284 SDGRYVKENCKPLKSYMLQDSLEHVQLFDLMRRMLEFDPAQRITLAEALLHPFFAGL  340 (355)
T ss_dssp             HHHHHHHHHCCCGGGGCSCCSHHHHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGGC
T ss_pred             chhccccccCCcccccccccchhHHHHHHHHHHHhcCChhhCcCHHHHhcChhhcCC
Confidence            000001111        1111234578899999999999999999999999999754

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=100.00  E-value=1.8e-38  Score=298.88  Aligned_cols=210  Identities=27%  Similarity=0.437  Sum_probs=178.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++.+.        +.+|+||||+.+ +|.+.+... ..+++..++.++.||+.||.
T Consensus        58 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~  128 (284)
T 2vgo_A           58 EHQLRREIEIQSHLRHPNILRMYNYFHDR--------KRIYLMLEFAPRGELYKELQKH-GRFDEQRSATFMEELADALH  128 (284)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEEcC--------CEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        669999999975 888888764 36899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++......      ......|+..|+|||++.+.. ++.++|||||||+
T Consensus       129 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  201 (284)
T 2vgo_A          129 YCHERKVIHRDIKPENLLMGYKGELKIADFGWSVHAPSL------RRRTMCGTLDYLPPEMIEGKT-HDEKVDLWCAGVL  201 (284)
T ss_dssp             HHHTTTEECCCCSGGGEEECTTCCEEECCCTTCEECSSS------CBCCCCSCGGGCCHHHHTTCC-BCTTHHHHHHHHH
T ss_pred             HHHHCCceecCCCHHHEEEcCCCCEEEecccccccCccc------ccccccCCCCcCCHHHhccCC-CCcccchhhHHHH
Confidence            999999999999999999999999999999998665422      123457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+....+....+.......                                +...+..+++||.+||..
T Consensus       202 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~  249 (284)
T 2vgo_A          202 CYEFLVGMPPFDSPSHTETHRRIVNVDLKF--------------------------------PPFLSDGSKDLISKLLRY  249 (284)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--------------------------------CTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHHCCCCCCCCCHhHHHHHHhccccCC--------------------------------CCcCCHHHHHHHHHHhhc
Confidence            999999999999888776655543311100                                112467778999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||.+|||++++++||||+.
T Consensus       250 ~p~~Rps~~~ll~h~~~~~  268 (284)
T 2vgo_A          250 HPPQRLPLKGVMEHPWVKA  268 (284)
T ss_dssp             SGGGSCCHHHHHTCHHHHH
T ss_pred             CHhhCCCHHHHhhCHHHHh
Confidence            9999999999999999964

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=100.00  E-value=1.8e-38  Score=306.38  Aligned_cols=215  Identities=27%  Similarity=0.422  Sum_probs=180.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|
T Consensus        86 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~l~~~~~~~i~~qi~~aL~~  156 (335)
T 2owb_A           86 EKMSMEISIHRSLAHQHVVGFHGFFEDN--------DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQY  156 (335)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecC--------CeEEEEEecCCCCCHHHHHhc-cCCCCHHHHHHHHHHHHHHHHH
Confidence            5678899999999999999999999875        66999999998 478777765 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++|||||||++
T Consensus       157 LH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il  231 (335)
T 2owb_A          157 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIM  231 (335)
T ss_dssp             HHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSTT----CCBCCCCSCCSSCCHHHHHTSC-BCTHHHHHHHHHHH
T ss_pred             HHHCCCEecCCCchhEEEcCCCCEEEeeccCceecccCc----ccccccCCCccccCHHHhccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999997764322    1233457899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+....+....+.......                                +...+.++.+||.+||..|
T Consensus       232 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~li~~~l~~d  279 (335)
T 2owb_A          232 YTLLVGKPPFETSCLKETYLRIKKNEYSI--------------------------------PKHINPVAASLIQKMLQTD  279 (335)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHHTCCCC--------------------------------CTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHHCcCCCCCCCHHHHHHHHhcCCCCC--------------------------------CccCCHHHHHHHHHHccCC
Confidence            99999999999887766655554321110                                1124567789999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      |.+|||++|+|+|+||.....+
T Consensus       280 p~~Rps~~ell~~~~~~~~~~~  301 (335)
T 2owb_A          280 PTARPTINELLNDEFFTSGYIP  301 (335)
T ss_dssp             GGGSCCGGGGGGSHHHHTSCCC
T ss_pred             hhHCcCHHHHhcCccccCCCcc
Confidence            9999999999999999776544

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=100.00  E-value=1.5e-38  Score=313.14  Aligned_cols=217  Identities=26%  Similarity=0.377  Sum_probs=170.7

Q ss_pred             hhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+.++  |||||++++++...        ..+|||||+.+++|.+++.... .+++..++.++.||+.||.
T Consensus        99 ~~~~~Ei~~l~~l~~~~~~iv~~~~~~~~~--------~~~~lv~E~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~  169 (390)
T 2zmd_A           99 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKKKK-SIDPWERKSYWKNMLEAVH  169 (390)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEEECCSEEHHHHHHHCS-SCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcccCCCeEEEEEEEEecC--------CEEEEEEecCCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHH
Confidence            56789999999996  59999999999875        5699999988889999987744 7899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----------CCCCC
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----------RNYGP  155 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~  155 (433)
                      |||++||+||||||+|||++ ++.+||+|||++..+.....  .......+||+.|+|||++.+.          ..++.
T Consensus       170 ~lH~~~ivHrDlkp~NIll~-~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~  246 (390)
T 2zmd_A          170 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT--SVVKDSQVGAVNYMPPEAIKDMSSSRENGKSKSKISP  246 (390)
T ss_dssp             HHHTTTCCCCCCCGGGEEES-SSCEEECCCSSSCCC-----------CCSCCCGGGCCHHHHHCC------------CCH
T ss_pred             HHHHCCeeecCCCHHHEEEE-CCeEEEEecCccccccCCCc--cccCCCCCcCCCccChHHhhhccccccccccccCCCC
Confidence            99999999999999999995 58999999999987653221  1123456789999999998652          24788


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChH-HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQ-QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~-~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      ++|||||||++|+|++|.+||.+.... ..+..+   ........+                           +...+.+
T Consensus       247 ~~DiwSlGvil~ell~G~~Pf~~~~~~~~~~~~~---~~~~~~~~~---------------------------~~~~~~~  296 (390)
T 2zmd_A          247 KSDVWSLGCILYYMTYGKTPFQQIINQISKLHAI---IDPNHEIEF---------------------------PDIPEKD  296 (390)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCCCHHHHHHHH---HCTTSCCCC---------------------------CCCSCHH
T ss_pred             hhhHHHHHHHHHHHHHCCCcchhhhHHHHHHHHH---hCccccCCC---------------------------CccchHH
Confidence            999999999999999999999875432 222222   221111111                           1123567


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +.+||.+||..||.+|||+.|+|+||||....
T Consensus       297 ~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~  328 (390)
T 2zmd_A          297 LQDVLKCCLKRDPKQRISIPELLAHPYVQIQT  328 (390)
T ss_dssp             HHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HHHHHHHHcccChhhCCCHHHHhhCcCccccC
Confidence            78999999999999999999999999997543

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=100.00  E-value=2.4e-38  Score=300.99  Aligned_cols=220  Identities=26%  Similarity=0.471  Sum_probs=179.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc-CCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++....      ...+|+||||+.+++.+++... ...+++..++.++.||+.||.
T Consensus        50 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~qi~~al~  123 (305)
T 2wtk_C           50 EANVKKEIQLLRRLRHKNVIQLVDVLYNEE------KQKMYMVMEYCVCGMQEMLDSVPEKRFPVCQAHGYFCQLIDGLE  123 (305)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECC---------CEEEEEECCSEEHHHHHHHSTTCSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEEEcCC------CCeEEEEehhccCCHHHHHHhCcccccCHHHHHHHHHHHHHHHH
Confidence            356889999999999999999999986542      2568999999999888887654 345999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlGv  164 (433)
                      |||++||+||||||+||+++.++.+||+|||++........  ........||..|+|||++.+.. .++.++|||||||
T Consensus       124 ~LH~~~i~H~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~slG~  201 (305)
T 2wtk_C          124 YLHSQGIVHKDIKPGNLLLTTGGTLKISALGVAEALHPFAA--DDTCRTSQGSPAFQPPEIANGLDTFSGFKVDIWSAGV  201 (305)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTCS--SCEECCCCSCGGGCCHHHHTCCSCEESHHHHHHHHHH
T ss_pred             HHHHCCeeecCCCcccEEEcCCCcEEeeccccccccCcccc--ccccccCCCCCCCcChhhccCcccCCcchhhHHHHHH
Confidence            99999999999999999999999999999999977643221  12234556899999999987643 2467999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|..||.+....+....+.......                                +...+..+.+||.+||.
T Consensus       202 il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~--------------------------------~~~~~~~l~~li~~~l~  249 (305)
T 2wtk_C          202 TLYNITTGLYPFEGDNIYKLFENIGKGSYAI--------------------------------PGDCGPPLSDLLKGMLE  249 (305)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHCCCCC--------------------------------CSSSCHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCCCCCchHHHHHHHHhcCCCCC--------------------------------CCccCHHHHHHHHHHcc
Confidence            9999999999999988776665554321100                                11245677799999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .||.+|||++|+++||||....
T Consensus       250 ~dp~~Rps~~~ll~~~~~~~~~  271 (305)
T 2wtk_C          250 YEPAKRFSIRQIRQHSWFRKKH  271 (305)
T ss_dssp             SSTTTSCCHHHHHHSHHHHSCC
T ss_pred             CChhhCCCHHHHhcCcccccCC
Confidence            9999999999999999997654

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=100.00  E-value=1.1e-38  Score=302.83  Aligned_cols=229  Identities=25%  Similarity=0.395  Sum_probs=181.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+|+||||+++ +|..++......+++..++.++.||+.||.|
T Consensus        61 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~l~~  132 (302)
T 2j7t_A           61 EDYIVEIEILATCDHPYIVKLLGAYYHD--------GKLWIMIEFCPGGAVDAIMLELDRGLTEPQIQVVCRQMLEALNF  132 (302)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECC---------CEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeeeeeeeeeC--------CeEEEEEEeCCCCcHHHHHHhhccCCCHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999999875        568999999975 7777777666679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc----CCCCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL----GDRNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~----~~~~~~~~~DiwSl  162 (433)
                      ||++||+|+||||+||+++.++.+||+|||++.......    .......||..|+|||++.    ....++.++|||||
T Consensus       133 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~sl  208 (302)
T 2j7t_A          133 LHSKRIIHRDLKAGNVLMTLEGDIRLADFGVSAKNLKTL----QKRDSFIGTPYWMAPEVVMCETMKDTPYDYKADIWSL  208 (302)
T ss_dssp             HHHTTCCCCCCSGGGEEECTTSCEEECCCHHHHHHHHHH----HC-----CCGGGCCHHHHHHHHTTSTTTTTHHHHHHH
T ss_pred             HhcCCcccCCCCHHHEEECCCCCEEEEECCCCccccccc----cccccccCChhhcCCeeeccccCCCCCCchhhhHHHH
Confidence            999999999999999999999999999999875432211    1123456899999999984    23447899999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+.......+.....  +..                           ..+...+..+.+||.+|
T Consensus       209 G~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~~~---------------------------~~~~~~~~~l~~li~~~  259 (302)
T 2j7t_A          209 GITLIEMAQIEPPHHELNPMRVLLKIAKSDP--PTL---------------------------LTPSKWSVEFRDFLKIA  259 (302)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--CCC---------------------------SSGGGSCHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCCCccCCHHHHHHHHhccCC--ccc---------------------------CCccccCHHHHHHHHHH
Confidence            9999999999999999887766555543211  000                           01112466788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCCCchhHHHHhh
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ  277 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~~~~~~~~~~~  277 (433)
                      |..||.+|||++++++||||............+.+
T Consensus       260 l~~dp~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~  294 (302)
T 2j7t_A          260 LDKNPETRPSAAQLLEHPFVSSITSNKALRELVAE  294 (302)
T ss_dssp             SCSCTTTSCCHHHHTTSTTTTTCCCCHHHHHHHHH
T ss_pred             cccChhhCCCHHHHhcChHHhhhccchhHHHHHHH
Confidence            99999999999999999999877655544444443

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=100.00  E-value=2.5e-38  Score=299.40  Aligned_cols=216  Identities=26%  Similarity=0.413  Sum_probs=179.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+++.++||||+++++++.+.        +.+|+||||+. ++|.+++.. ...+++..++.++.||+.||+|
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~i~~qi~~~l~~  130 (294)
T 2rku_A           60 EKMSMEISIHRSLAHQHVVGFHGFFEDN--------DFVFVVLELCRRRSLLELHKR-RKALTEPEARYYLRQIVLGCQY  130 (294)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHH-HCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeeeccC--------CEEEEEEecCCCCCHHHHHHh-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4678899999999999999999999875        66999999998 577777655 3468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++|||||||++
T Consensus       131 lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  205 (294)
T 2rku_A          131 LHRNRVIHRDLKLGNLFLNEDLEVKIGDFGLATKVEYDG----ERKKVLCGTPNYIAPEVLSKKG-HSFEVDVWSIGCIM  205 (294)
T ss_dssp             HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCSTT----CCBCCCCSCCSSCCHHHHTTSC-BCTHHHHHHHHHHH
T ss_pred             HHHCCccccCCChHhEEEcCCCCEEEEeccCceecccCc----cccccccCCCCcCCcchhccCC-CCchhhHHHHHHHH
Confidence            999999999999999999999999999999997764322    1223456899999999987755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||.+....+....+......                                .+...+..+.++|.+||+.|
T Consensus       206 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~~~~~li~~~l~~~  253 (294)
T 2rku_A          206 YTLLVGKPPFETSCLKETYLRIKKNEYS--------------------------------IPKHINPVAASLIQKMLQTD  253 (294)
T ss_dssp             HHHHHSSCTTCCSSHHHHHHHHHTTCCC--------------------------------CCTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCCCCCHHHHHHHHhhccCC--------------------------------CccccCHHHHHHHHHHcccC
Confidence            9999999999988776655544321100                                01124567789999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCCCCc
Q psy7889         247 PSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |.+|||++|+++||||.....+.
T Consensus       254 p~~Rps~~~ll~~~~~~~~~~~~  276 (294)
T 2rku_A          254 PTARPTINELLNDEFFTSGYIPA  276 (294)
T ss_dssp             GGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             hhhCcCHHHHhhChheecCCcCC
Confidence            99999999999999997765443

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=100.00  E-value=1.6e-38  Score=310.26  Aligned_cols=214  Identities=29%  Similarity=0.512  Sum_probs=178.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.+ +||||+++++++...        +..|+||||+.+ +|.+++... ..+++..++.++.||+.||.
T Consensus       144 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~-~~l~~~~~~~i~~qi~~~L~  214 (365)
T 2y7j_A          144 EATRRETHILRQVAGHPHIITLIDSYESS--------SFMFLVFDLMRKGELFDYLTEK-VALSEKETRSIMRSLLEAVS  214 (365)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEEBS--------SEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeEEEEEEeeC--------CEEEEEEEeCCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999 799999999999875        669999999986 788887653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-----CCCCCcchhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-----RNYGPPVDLW  160 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-----~~~~~~~Diw  160 (433)
                      |||+.||+|+||||+||+++.+|.+||+|||++..+....     .....+||+.|+|||++.+.     ..++.++|||
T Consensus       215 ~LH~~gi~H~Dlkp~NIl~~~~~~ikl~DfG~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~Di~  289 (365)
T 2y7j_A          215 FLHANNIVHRDLKPENILLDDNMQIRLSDFGFSCHLEPGE-----KLRELCGTPGYLAPEILKCSMDETHPGYGKEVDLW  289 (365)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHTTCTTSCCBCTTHHHH
T ss_pred             HHHhCCeecCCCCHHHEEECCCCCEEEEecCcccccCCCc-----ccccCCCCCCccChhhccccccccCcCCCchhhHH
Confidence            9999999999999999999999999999999998765322     23456789999999998632     2478899999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||.+......+..+...........|                            ...+..+.+||.
T Consensus       290 slG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~  341 (365)
T 2y7j_A          290 ACGVILFTLLAGSPPFWHRRQILMLRMIMEGQYQFSSPEW----------------------------DDRSSTVKDLIS  341 (365)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCHHHH----------------------------SSSCHHHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCCCCCHHHHHHHHHhCCCCCCCccc----------------------------ccCCHHHHHHHH
Confidence            9999999999999999988877766665442211100000                            124667889999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCcc
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +||..||.+|||++|+|+||||.
T Consensus       342 ~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          342 RLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             HHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             HHcCCChhHCcCHHHHhcCcccC
Confidence            99999999999999999999995

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=100.00  E-value=1.7e-38  Score=333.00  Aligned_cols=212  Identities=23%  Similarity=0.367  Sum_probs=181.4

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+++|+.+|..+ +||||++++++|.+.        +.+||||||+.+ +|...+... ..+++..++.++.||+.||
T Consensus       385 ~~~~~~E~~~l~~~~~~~~i~~l~~~~~~~--------~~~~lV~E~~~gg~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  455 (674)
T 3pfq_A          385 VECTMVEKRVLALPGKPPFLTQLHSCFQTM--------DRLYFVMEYVNGGDLMYHIQQV-GRFKEPHAVFYAAEIAIGL  455 (674)
T ss_dssp             THHHHHHHHHHTCTTCCTTBCCEEEECBCS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCeEEEEEEEEEeC--------CEEEEEEeCcCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHH
Confidence            45678899999988 799999999999875        669999999974 888888764 4699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. |+.++|||||||
T Consensus       456 ~~LH~~gIiHrDLKp~NILl~~~g~ikL~DFGla~~~~~~~----~~~~~~~GT~~Y~APE~l~~~~-~~~~~DvwSlGv  530 (674)
T 3pfq_A          456 FFLQSKGIIYRDLKLDNVMLDSEGHIKIADFGMCKENIWDG----VTTKTFCGTPDYIAPEIIAYQP-YGKSVDWWAFGV  530 (674)
T ss_dssp             HHHHHTSEECCCCCSTTEEECSSSCEEECCCTTCEECCCTT----CCBCCCCSCSSSCCHHHHTCCC-BSTHHHHHHHHH
T ss_pred             HHHHhCCeEeccCChhhEEEcCCCcEEEeecceeeccccCC----cccccccCCCcccCHhhhcCCC-CCccceEechHH
Confidence            99999999999999999999999999999999997643221    2345678999999999997765 799999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+....|.......                                +...+.++++||.+||+
T Consensus       531 ilyelltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~lL~  578 (674)
T 3pfq_A          531 LLYEMLAGQAPFEGEDEDELFQSIMEHNVAY--------------------------------PKSMSKEAVAICKGLMT  578 (674)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHSSCCCC--------------------------------CTTSCHHHHHHHHHHSC
T ss_pred             HHHHHHcCCCCCCCCCHHHHHHHHHhCCCCC--------------------------------CccCCHHHHHHHHHHcc
Confidence            9999999999999998888777765311110                                11357788899999999


Q ss_pred             cCCCCCCCH-----HHhhcCCCccC
Q psy7889         245 LDPSKRFDS-----DAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~-----~e~L~h~~~~~  264 (433)
                      .||.+|+++     +|+++||||..
T Consensus       579 ~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          579 KHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             SSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CCHHHCCCCCCCcHHHHhcCccccC
Confidence            999999998     99999999965

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=100.00  E-value=2e-38  Score=306.97  Aligned_cols=218  Identities=26%  Similarity=0.376  Sum_probs=169.3

Q ss_pred             hhHHHHHHHHHhCCC--CCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKH--ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~h--pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+.++|  |||+++++++...        ..+|+|||+.+++|.+++... ..+++..++.++.||+.||+
T Consensus        52 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~al~  122 (343)
T 3dbq_A           52 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVH  122 (343)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEECCCSEEHHHHHHHS-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhhhcCCceEEEeeeEeeC--------CEEEEEEeCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            467899999999976  9999999999875        679999998888999999874 47899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----------CCCCCC
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----------DRNYGP  155 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----------~~~~~~  155 (433)
                      |||++||+||||||+|||++ ++.+||+|||++........  .......+||+.|+|||++.+          ...++.
T Consensus       123 ~lH~~~iiHrDikp~NIll~-~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~  199 (343)
T 3dbq_A          123 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP  199 (343)
T ss_dssp             HHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCCC--------------CCCCSSCCHHHHHHCC-----------CCH
T ss_pred             HHHhCCeecCCCCcceEEEE-CCcEEEeecccccccCcccc--cccCCCCcCCcCcCCHHHHhhccccccccccccCCCc
Confidence            99999999999999999997 67899999999987653221  112335678999999999854          234788


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|||||||++|+|++|.+||.+.....  ..+...........+                           +...+.++
T Consensus       200 ~~DiwslG~il~ell~g~~pf~~~~~~~--~~~~~~~~~~~~~~~---------------------------~~~~~~~l  250 (343)
T 3dbq_A          200 KSDVWSLGCILYYMTYGKTPFQQIINQI--SKLHAIIDPNHEIEF---------------------------PDIPEKDL  250 (343)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCCSHH--HHHHHHHCTTSCCCC---------------------------CCCSCHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCcchhhhhHH--HHHHHHhcCCcccCC---------------------------cccCCHHH
Confidence            9999999999999999999998754332  122222221111111                           11235667


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+||.+||..||.+|||+.|+|+||||+...
T Consensus       251 ~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  281 (343)
T 3dbq_A          251 QDVLKCCLKRDPKQRISIPELLAHPYVQIQT  281 (343)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC
T ss_pred             HHHHHHHcCCChhHCCCHHHHHhCccccccC
Confidence            8999999999999999999999999997543

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=100.00  E-value=3e-38  Score=303.80  Aligned_cols=217  Identities=27%  Similarity=0.457  Sum_probs=179.2

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+++|+.+++.+ +||||+++++++.+.        ..+|+||||+.+ +|.+++... ...+++..++.++.||+.|
T Consensus        72 ~~~~~~e~~~l~~l~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~ql~~~  143 (327)
T 3lm5_A           72 RAEILHEIAVLELAKSCPRVINLHEVYENT--------SEIILILEYAAGGEIFSLCLPELAEMVSENDVIRLIKQILEG  143 (327)
T ss_dssp             HHHHHHHHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEEECCTTEEGGGGGSSCC-CCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCEEEEEEEEEeC--------CeEEEEEEecCCCcHHHHHHHhcccCCCHHHHHHHHHHHHHH
Confidence            45788999999999 579999999999875        669999999976 777776543 3468999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      |+|||++||+||||||+|||++.   ++.+||+|||++.......     ......||+.|+|||++.+.. ++.++|||
T Consensus       144 L~~LH~~givH~Dikp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw  217 (327)
T 3lm5_A          144 VYYLHQNNIVHLDLKPQNILLSSIYPLGDIKIVDFGMSRKIGHAC-----ELREIMGTPEYLAPEILNYDP-ITTATDMW  217 (327)
T ss_dssp             HHHHHHTTEECSCCCGGGEEESCBTTBCCEEECCGGGCEEC--------------CCCGGGCCHHHHTTCC-CCTHHHHH
T ss_pred             HHHHHHCCeecCcCChHHEEEecCCCCCcEEEeeCccccccCCcc-----ccccccCCcCccCCeeecCCC-CCchhhHH
Confidence            99999999999999999999987   7899999999998765322     233457899999999997765 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||.+....+....+...........+.                            ..+..+.+||.
T Consensus       218 slG~il~~ll~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~~~~~~~li~  269 (327)
T 3lm5_A          218 NIGIIAYMLLTHTSPFVGEDNQETYLNISQVNVDYSEETFS----------------------------SVSQLATDFIQ  269 (327)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTTT----------------------------TSCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCCCCCchHHHHHHHhcccccCchhhc----------------------------ccCHHHHHHHH
Confidence            99999999999999999998888877776654433332221                            24567789999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||..||.+|||++++|+||||+..
T Consensus       270 ~~L~~dP~~Rpt~~~ll~h~~~~~~  294 (327)
T 3lm5_A          270 SLLVKNPEKRPTAEICLSHSWLQQW  294 (327)
T ss_dssp             HHSCSSGGGSCCHHHHTTCGGGCCC
T ss_pred             HHcCCChhhCcCHHHHhCCHhhccc
Confidence            9999999999999999999999754

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=100.00  E-value=1.3e-38  Score=304.52  Aligned_cols=222  Identities=25%  Similarity=0.388  Sum_probs=167.3

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+++ +||||+++++++.+.        +.+|+||||+. ++|.+++... ..+++..++.++.||+.||
T Consensus        54 ~~~~~~E~~~l~~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l  124 (316)
T 2ac3_A           54 RSRVFREVEMLYQCQGHRNVLELIEFFEEE--------DRFYLVFEKMRGGSILSHIHKR-RHFNELEASVVVQDVASAL  124 (316)
T ss_dssp             HHHHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhcCCCCeeeEEEEEeeC--------CEEEEEEEcCCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHH
Confidence            46789999999985 799999999999875        66999999997 6888888764 4689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCc---EEEeecCCccccccCcCC---ccccccCCcccccccCcccccCC----CCCC
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNG---QVNRYTNRVVTLWYRPPELLLGD----RNYG  154 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~---~kl~DFg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~----~~~~  154 (433)
                      +|||++||+||||||+|||++.++.   +||+|||++.........   ........+||+.|+|||++.+.    ..++
T Consensus       125 ~~lH~~~ivH~dlkp~Nil~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~  204 (316)
T 2ac3_A          125 DFLHNKGIAHRDLKPENILCEHPNQVSPVKICDFDLGSGIKLNGDCSPISTPELLTPCGSAEYMAPEVVEAFSEEASIYD  204 (316)
T ss_dssp             HHHHHTTCCCCCCCGGGEEESCSSSSCSEEECCTTCCC-------------------CCSGGGCCHHHHHHTSHHHHHHT
T ss_pred             HHHHhCCceeCCCCHHHEEEccCCCcCceEEEEccCccccccCCccccccccccccccCCcCccChHHhhcccccccCCC
Confidence            9999999999999999999987765   999999998765422111   11122345689999999998641    2368


Q ss_pred             CcchhhhHHHHHHHHHhcCCCCCCCChHH---------------HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHH
Q psy7889         155 PPVDLWGAGCIMAEMWTRSPIMQGNTEQQ---------------QITLISQLCGSITPESWPGVETLDLYNKMELPKAQK  219 (433)
Q Consensus       155 ~~~DiwSlGvil~ell~g~~pf~~~~~~~---------------~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~  219 (433)
                      .++|||||||++|+|++|.+||.+....+               ....+..  +.                 ...+... 
T Consensus       205 ~~~DiwslG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~i~~--~~-----------------~~~~~~~-  264 (316)
T 2ac3_A          205 KRCDLWSLGVILYILLSGYPPFVGRCGSDCGWDRGEACPACQNMLFESIQE--GK-----------------YEFPDKD-  264 (316)
T ss_dssp             TTHHHHHHHHHHHHHHHSSCSCCCCCCSCSCC----CCHHHHHHHHHHHHH--CC-----------------CCCCHHH-
T ss_pred             cccccHhHHHHHHHHHHCCCCCcccccccccccccccchhHHHHHHHHHhc--cC-----------------cccCchh-
Confidence            89999999999999999999998754211               1111111  00                 0001000 


Q ss_pred             hhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         220 RKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       220 ~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                              ....+.++++||.+||..||.+|||++|+|+||||+..
T Consensus       265 --------~~~~~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          265 --------WAHISCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             --------HTTSCHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             --------cccCCHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence                    01256788899999999999999999999999999753

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=100.00  E-value=9.3e-39  Score=308.34  Aligned_cols=207  Identities=23%  Similarity=0.377  Sum_probs=173.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-C-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-H-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        +.+++||||+. + +|..++.. ...+++..++.++.||+.||
T Consensus        73 ~~~~~~E~~~l~~l~h~~Iv~~~~~~~~~--------~~~~lv~e~~~~g~~l~~~~~~-~~~l~~~~~~~i~~qi~~~L  143 (335)
T 3dls_A           73 LGKVTLEIAILSRVEHANIIKVLDIFENQ--------GFFQLVMEKHGSGLDLFAFIDR-HPRLDEPLASYIFRQLVSAV  143 (335)
T ss_dssp             TEEEEHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCTTSCBHHHHHHT-CCCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEeeC--------CEEEEEEEeCCCCccHHHHHHh-cCCCCHHHHHHHHHHHHHHH
Confidence            34678899999999999999999999875        66999999985 4 78887765 34699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||++.......     .....+||+.|+|||++.+...++.++|||||||
T Consensus       144 ~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwslG~  218 (335)
T 3dls_A          144 GYLRLKDIIHRDIKDENIVIAEDFTIKLIDFGSAAYLERGK-----LFYTFCGTIEYCAPEVLMGNPYRGPELEMWSLGV  218 (335)
T ss_dssp             HHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECCTTC-----CBCEECSCGGGCCHHHHTTCCBCSHHHHHHHHHH
T ss_pred             HHHHhCCeEEeccCHHHEEEcCCCcEEEeecccceECCCCC-----ceeccCCCccccChhhhcCCCCCCCcccchhHHH
Confidence            99999999999999999999999999999999998765332     2334578999999999987765588999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|..||......         ...                             ....+...+.++.+||.+||.
T Consensus       219 il~el~~g~~pf~~~~~~---------~~~-----------------------------~~~~~~~~~~~l~~li~~~L~  260 (335)
T 3dls_A          219 TLYTLVFEENPFCELEET---------VEA-----------------------------AIHPPYLVSKELMSLVSGLLQ  260 (335)
T ss_dssp             HHHHHHHSSCSCSSGGGG---------TTT-----------------------------CCCCSSCCCHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCchhhHHHH---------Hhh-----------------------------ccCCCcccCHHHHHHHHHHcc
Confidence            999999999999752210         000                             001122357788899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .||.+|||++++++||||+..
T Consensus       261 ~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          261 PVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             SSGGGSCCHHHHHHCTTTTCC
T ss_pred             CChhhCcCHHHHhcCccccCC
Confidence            999999999999999999754

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=100.00  E-value=4.1e-38  Score=297.40  Aligned_cols=216  Identities=24%  Similarity=0.344  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.....    ....+|+||||+++ +|.+++... ..+++..++.++.||+.||.|
T Consensus        70 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~  144 (290)
T 1t4h_A           70 QRFKEEAEMLKGLQHPNIVRFYDSWESTVK----GKKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQF  144 (290)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEESS----SCEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeeeccccC----CCceEEEEEEecCCCCHHHHHHHc-cCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999976422    14678999999965 888888664 468999999999999999999


Q ss_pred             HHhCC--eeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNK--ILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~--iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++|  |+|+||||+||+++ .++.+||+|||++......      ......||+.|+|||++.+  .++.++||||||
T Consensus       145 lH~~~~~i~H~dikp~Nil~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~t~~y~aPE~~~~--~~~~~~Di~slG  216 (290)
T 1t4h_A          145 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFG  216 (290)
T ss_dssp             HHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT------SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHH
T ss_pred             HHcCCCCEEECCCCHHHEEEECCCCCEEEeeCCCccccccc------ccccccCCcCcCCHHHHhc--cCCCcchHHHHH
Confidence            99999  99999999999998 7889999999999654322      2234568999999998865  379999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|..||.+............  ....+.                           ..+...++++.+||.+||
T Consensus       217 ~~l~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~~---------------------------~~~~~~~~~l~~li~~~l  267 (290)
T 1t4h_A          217 MCMLEMATSEYPYSECQNAAQIYRRVT--SGVKPA---------------------------SFDKVAIPEVKEIIEGCI  267 (290)
T ss_dssp             HHHHHHHHSSCTTTTCSSHHHHHHHHT--TTCCCG---------------------------GGGGCCCHHHHHHHHHHS
T ss_pred             HHHHHHHhCCCCCCCcCcHHHHHHHHh--ccCCcc---------------------------ccCCCCCHHHHHHHHHHc
Confidence            999999999999988655444332211  100000                           001124567889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ..||.+|||++|+|+||||++.
T Consensus       268 ~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          268 RQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CSSGGGSCCHHHHHTSGGGC--
T ss_pred             cCChhhCCCHHHHhhCcccccC
Confidence            9999999999999999999753

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=100.00  E-value=3.8e-38  Score=299.75  Aligned_cols=216  Identities=27%  Similarity=0.423  Sum_probs=179.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        ..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.
T Consensus        50 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~  120 (304)
T 2jam_A           50 DSSLENEIAVLKKIKHENIVTLEDIYEST--------THYYLVMQLVSGGELFDRILER-GVYTEKDASLVIQQVLSAVK  120 (304)
T ss_dssp             --HHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhCCCCCeeehhhhcccC--------CEEEEEEEcCCCccHHHHHHHc-CCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999875        66999999997 4888888654 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEE---ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll---~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+|+||||+||++   +.++.++|+|||++......      ......||+.|+|||++.+.. ++.++|||||
T Consensus       121 ~lH~~~i~H~dikp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~sl  193 (304)
T 2jam_A          121 YLHENGIVHRDLKPENLLYLTPEENSKIMITDFGLSKMEQNG------IMSTACGTPGYVAPEVLAQKP-YSKAVDCWSI  193 (304)
T ss_dssp             HHHHTTCCCCSCCGGGCEESSSSTTCCEEBCSCSTTCCCCCB------TTHHHHSCCCBCCTTTBSSCS-CCHHHHHHHH
T ss_pred             HHHHCCccccCCCHHHEEEecCCCCCCEEEccCCcceecCCC------ccccccCCCCccChHHhccCC-CCchhhHHHH
Confidence            9999999999999999999   67889999999998654321      123346799999999997754 7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.........+...........+                            ...+.++.+||.+|
T Consensus       194 G~il~~l~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~~~~~~~li~~~  245 (304)
T 2jam_A          194 GVITYILLCGYPPFYEETESKLFEKIKEGYYEFESPFW----------------------------DDISESAKDFICHL  245 (304)
T ss_dssp             HHHHHHHHHSSCTTTTSCHHHHHHHHHHCCCCCCTTTT----------------------------TTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHcCCCCCCcccc----------------------------ccCCHHHHHHHHHH
Confidence            99999999999999998887777666553222111111                            12467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      |..||.+|||++|+|+||||....
T Consensus       246 l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          246 LEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             HCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             cCCChhHCcCHHHHhcCccccCCC
Confidence            999999999999999999997643

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=100.00  E-value=5.1e-39  Score=319.55  Aligned_cols=215  Identities=26%  Similarity=0.444  Sum_probs=163.0

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .+.+|+.+|+.++|||||++++++..         ..+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||+||
T Consensus       186 ~~~~E~~~l~~l~hpniv~l~~~~~~---------~~~~lv~e~~~~g~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~~L  255 (419)
T 3i6u_A          186 NVETEIEILKKLNHPCIIKIKNFFDA---------EDYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQYL  255 (419)
T ss_dssp             CHHHHHHHHHHCCCTTBCCCCEEEES---------SEEEEEEECCTTCBGGGGTSS-SCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCEeeEEEEEec---------CceEEEEEcCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHHH
Confidence            57899999999999999999999854         447999999975 77666654 45699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhH
Q psy7889          88 HSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGA  162 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSl  162 (433)
                      |++||+||||||+|||++.++   .+||+|||++......     ......+||+.|+|||++.+  ...|+.++|||||
T Consensus       256 H~~~ivHrDlkp~NIll~~~~~~~~~kl~DFG~a~~~~~~-----~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Diwsl  330 (419)
T 3i6u_A          256 HENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGET-----SLMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWSL  330 (419)
T ss_dssp             HHTTCCCSCCCGGGEEESSSSSSCCEEECCSSTTTSCC----------------CTTCCTTTTC----CTTHHHHHHHHH
T ss_pred             HHCCccccCCChHhEEEecCCCcceEEEeecccceecCCC-----ccccccCCCCCccCceeeecCCCCCCCchhhhHhH
Confidence            999999999999999997544   5999999999876532     22345678999999999864  3447889999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+......+..... .+..                 ......         ....+..+.+||.+|
T Consensus       331 G~il~~lltg~~pf~~~~~~~~~~~~i~-~~~~-----------------~~~~~~---------~~~~~~~~~~li~~~  383 (419)
T 3i6u_A          331 GVILFICLSGYPPFSEHRTQVSLKDQIT-SGKY-----------------NFIPEV---------WAEVSEKALDLVKKL  383 (419)
T ss_dssp             HHHHHHHHHSSCSSCCCSSSCCHHHHHH-TTCC-----------------CCCHHH---------HTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCcchHHHHHHHh-cCCC-----------------CCCchh---------hcccCHHHHHHHHHH
Confidence            9999999999999986543322211111 0100                 000000         012577888999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |..||.+|||++|+|+||||++.
T Consensus       384 L~~dP~~Rps~~e~l~hp~~~~~  406 (419)
T 3i6u_A          384 LVVDPKARFTTEEALRHPWLQDE  406 (419)
T ss_dssp             SCSSTTTSCCHHHHHHSGGGCCH
T ss_pred             ccCChhHCcCHHHHhCCcccCCh
Confidence            99999999999999999999653

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=100.00  E-value=8.1e-38  Score=292.90  Aligned_cols=219  Identities=26%  Similarity=0.395  Sum_probs=175.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +..|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.
T Consensus        49 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~~~~~i~~~l~  119 (276)
T 2yex_A           49 PENIKKEICINKMLNHENVVKFYGHRREG--------NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVV  119 (276)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhcCCCCceeeeeEEEcC--------CEEEEEEEecCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        668999999975 77776654 346899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++........  ........||..|+|||++.+...++.++|||||||+
T Consensus       120 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~i  197 (276)
T 2yex_A          120 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV  197 (276)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECEETTE--ECCBCCCCSCGGGCCGGGGTCSSBCHHHHHHHHHHHH
T ss_pred             HHHhCCeeccCCChHHEEEccCCCEEEeeCCCccccCCCcc--hhcccCCccccCccChHHHhcCCCCCCcchHHHHHHH
Confidence            99999999999999999999999999999999976643221  1223456789999999999876645789999999999


Q ss_pred             HHHHHhcCCCCCCCChHHH-HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQ-ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~-~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++|..||.+...... ...+..  ......                            .....+..+.+||.+||.
T Consensus       198 l~~l~~g~~p~~~~~~~~~~~~~~~~--~~~~~~----------------------------~~~~~~~~~~~li~~~l~  247 (276)
T 2yex_A          198 LTAMLAGELPWDQPSDSCQEYSDWKE--KKTYLN----------------------------PWKKIDSAPLALLHKILV  247 (276)
T ss_dssp             HHHHHHSSCCCSCSCTTSHHHHHHHT--TCTTST----------------------------TGGGSCHHHHHHHHHHSC
T ss_pred             HHHHHhCCCCCCCCchHHHHHHHhhh--cccccC----------------------------chhhcCHHHHHHHHHHCC
Confidence            9999999999987654322 111111  000000                            001256778899999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .||.+|||++|+++||||....
T Consensus       248 ~~p~~Rps~~~il~~~~~~~~~  269 (276)
T 2yex_A          248 ENPSARITIPDIKKDRWYNKPL  269 (276)
T ss_dssp             SSTTTSCCHHHHTTCTTTTCCC
T ss_pred             CCchhCCCHHHHhcCccccChh
Confidence            9999999999999999997643

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=100.00  E-value=2.8e-38  Score=298.14  Aligned_cols=211  Identities=18%  Similarity=0.229  Sum_probs=159.9

Q ss_pred             HHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc---cCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889          11 LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN---IHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus        11 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~---~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      .++..+++.++||||+++++++.+.        +..|+||||++++|.+++..   ....+++..++.++.||+.||+||
T Consensus        54 ~~~~~~~~~~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~l~~~l~~~~~~~~~~~~~~~~~i~~qi~~~l~~l  125 (290)
T 3fme_A           54 MDLDISMRTVDCPFTVTFYGALFRE--------GDVWICMELMDTSLDKFYKQVIDKGQTIPEDILGKIAVSIVKALEHL  125 (290)
T ss_dssp             HHHHHHHTTCCCTTBCCEEEEEECS--------SSEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCeEEEEeeeeecc--------CCEEEEEehhccchHHHHHHHHhcCCCCCHHHHHHHHHHHHHHHHHH
Confidence            3444557788999999999999875        56899999999988777654   355799999999999999999999


Q ss_pred             HhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc---CCCCCCCcchhhhHH
Q psy7889          88 HSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDRNYGPPVDLWGAG  163 (433)
Q Consensus        88 H~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~DiwSlG  163 (433)
                      |++ ||+||||||+||+++.++.+||+|||++.......     ......||+.|+|||++.   ....++.++||||+|
T Consensus       126 H~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~~~~Di~slG  200 (290)
T 3fme_A          126 HSKLSVIHRDVKPSNVLINALGQVKMCDFGISGYLVDDV-----AKDIDAGCKPYMAPERINPELNQKGYSVKSDIWSLG  200 (290)
T ss_dssp             HHHSCCCCCCCSGGGCEECTTCCEEBCCC--------------------CCCCCCSCHHHHSCCTTC--CCHHHHHHHHH
T ss_pred             hhcCCeecCCCCHHHEEECCCCCEEEeecCCcccccccc-----cccccCCCccccChhhcChhhcCcCCCcHHHHHHHH
Confidence            998 99999999999999999999999999997765322     123346899999999972   334578999999999


Q ss_pred             HHHHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |++++|++|..||... .....+..+.......                              ......+.++.+||.+|
T Consensus       201 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~~~~li~~~  250 (290)
T 3fme_A          201 ITMIELAILRFPYDSWGTPFQQLKQVVEEPSPQ------------------------------LPADKFSAEFVDFTSQC  250 (290)
T ss_dssp             HHHHHHHHTSCSSCCCSCHHHHHHHHHHSCCCC------------------------------CCTTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCccccCchHHHHHHHhccCCCC------------------------------cccccCCHHHHHHHHHH
Confidence            9999999999999863 3333333332211100                              00112467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |+.||.+|||++|+++||||..
T Consensus       251 l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          251 LKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             TCSSGGGSCCHHHHTTSHHHHH
T ss_pred             hhcChhhCcCHHHHHhCccccc
Confidence            9999999999999999999964

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=100.00  E-value=3.9e-38  Score=295.15  Aligned_cols=212  Identities=26%  Similarity=0.427  Sum_probs=170.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+. ++|.+++... ..+++..++.++.||+.||.|
T Consensus        56 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~  126 (276)
T 2h6d_A           56 GKIKREIQNLKLFRHPHIIKLYQVISTP--------TDFFMVMEYVSGGELFDYICKH-GRVEEMEARRLFQQILSAVDY  126 (276)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCEeEEEEEEecC--------CeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875        66999999997 5888888664 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.++|+|||++.......     ......+++.|+|||++.+....+.++|||||||++
T Consensus       127 lH~~~i~H~dl~p~Nil~~~~~~~~l~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~Di~slG~~l  201 (276)
T 2h6d_A          127 CHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGE-----FLRTSCGSPNYAAPEVISGRLYAGPEVDIWSCGVIL  201 (276)
T ss_dssp             HHHHCSSCCCCCGGGEEECTTSCEEECCCCGGGCCCC------------------CCTGGGTTSCCCHHHHHHHHHHHHH
T ss_pred             HHHCCCccCCCChhhEEECCCCCEEEeecccccccCCCc-----ceecccCCccccCHHHHcCCCCCCccchHHHHHHHH
Confidence            999999999999999999999999999999997764321     123456799999999998765446899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||.+.........+.......                                +...+..+.++|.+||+.|
T Consensus       202 ~~l~~g~~p~~~~~~~~~~~~~~~~~~~~--------------------------------~~~~~~~l~~li~~~l~~~  249 (276)
T 2h6d_A          202 YALLCGTLPFDDEHVPTLFKKIRGGVFYI--------------------------------PEYLNRSVATLLMHMLQVD  249 (276)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCCCCcHHHHHHHhhcCcccC--------------------------------chhcCHHHHHHHHHHccCC
Confidence            99999999999877666555544311100                                1124567789999999999


Q ss_pred             CCCCCCHHHhhcCCCccCC
Q psy7889         247 PSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+|||++++++||||++.
T Consensus       250 p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          250 PLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             GGGSCCHHHHHHSHHHHTT
T ss_pred             hhhCCCHHHHHhChhhccC
Confidence            9999999999999999654

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=100.00  E-value=1e-37  Score=299.61  Aligned_cols=230  Identities=24%  Similarity=0.387  Sum_probs=178.1

Q ss_pred             CchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~   82 (433)
                      ....+.+|+.+++.+ +||||+++++++.....  ......+|+||||+++ +|.+++.... ..+++..++.++.||+.
T Consensus        63 ~~~~~~~e~~~l~~l~~h~~i~~~~~~~~~~~~--~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~  140 (326)
T 2x7f_A           63 EEEEIKQEINMLKKYSHHRNIATYYGAFIKKNP--PGMDDQLWLVMEFCGAGSVTDLIKNTKGNTLKEEWIAYICREILR  140 (326)
T ss_dssp             TTHHHHHHHHHHHHHCCSTTBCCEEEEEEECC----CCCCEEEEEEECCTTEEHHHHHHHSGGGCCCHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCCeeeeeeEEeeccC--ccccceEEEEEEcCCCCcHHHHHHhcccCCCCHHHHHHHHHHHHH
Confidence            356789999999999 89999999999987521  1113679999999976 8999887643 46899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcch
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVD  158 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~D  158 (433)
                      ||.|||++||+|+||||+||+++.++.+||+|||++.......    .......||+.|+|||++.+    ...++.++|
T Consensus       141 ~l~~lH~~~ivH~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~D  216 (326)
T 2x7f_A          141 GLSHLHQHKVIHRDIKGQNVLLTENAEVKLVDFGVSAQLDRTV----GRRNTFIGTPYWMAPEVIACDENPDATYDFKSD  216 (326)
T ss_dssp             HHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCTTTC-----------------CCGGGCCHHHHC--------CCTTHH
T ss_pred             HHHHHHHCCccccCCcHHHEEEcCCCCEEEeeCcCceecCcCc----cccccccCCccccChhhhccccccCcCCCccch
Confidence            9999999999999999999999999999999999987764321    12234578999999999863    234789999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||||||++|+|++|.+||.+......+..+.....  + .                           ..+...+..+.+|
T Consensus       217 i~slG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~--~-~---------------------------~~~~~~~~~l~~l  266 (326)
T 2x7f_A          217 LWSLGITAIEMAEGAPPLCDMHPMRALFLIPRNPA--P-R---------------------------LKSKKWSKKFQSF  266 (326)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTSCHHHHHHHHHHSCC--C-C---------------------------CSCSCSCHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCCcHHHHHHHhhcCcc--c-c---------------------------CCccccCHHHHHH
Confidence            99999999999999999998887666554433111  0 0                           0112346778899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCCCCCchh
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDL  271 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~~~~~~~  271 (433)
                      |.+||..||.+|||++++++||||...+.....
T Consensus       267 i~~~l~~dp~~Rps~~~ll~hp~~~~~~~~~~~  299 (326)
T 2x7f_A          267 IESCLVKNHSQRPATEQLMKHPFIRDQPNERQV  299 (326)
T ss_dssp             HHHHCCSSGGGSCCHHHHHTSHHHHCCTTHHHH
T ss_pred             HHHHhccChhhCCCHHHHhhChHHhhCccccce
Confidence            999999999999999999999999877654433

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=100.00  E-value=1.2e-37  Score=295.14  Aligned_cols=217  Identities=28%  Similarity=0.496  Sum_probs=180.0

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+++. ||||+++++++...        ..+|+||||+. ++|.+++... ..+++..++.++.||+.||.
T Consensus        68 ~~~~~e~~~l~~l~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~  138 (298)
T 1phk_A           68 EATLKEVDILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTEK-VTLSEKETRKIMRALLEVIC  138 (298)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeeeeeeccC--------CeEEEEEeccCCCcHHHHHhcc-CCCCHHHHHHHHHHHHHHHH
Confidence            46789999999995 99999999999875        66999999997 5888888763 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc-----CCCCCCCcchhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL-----GDRNYGPPVDLW  160 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~-----~~~~~~~~~Diw  160 (433)
                      |||++||+|+||||+||+++.++.+||+|||++.......     ......++..|+|||++.     ....++.++|||
T Consensus       139 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~~Di~  213 (298)
T 1phk_A          139 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW  213 (298)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred             HHHHCCcccCCCCcceEEEcCCCcEEEecccchhhcCCCc-----ccccccCCccccCHHHhccccccccccCCcccccH
Confidence            9999999999999999999999999999999997765322     234457899999999985     233478899999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++++|++|..||.+.........+...........+                            ...+..+.+||.
T Consensus       214 slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~l~~li~  265 (298)
T 1phk_A          214 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPEW----------------------------DDYSDTVKDLVS  265 (298)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTTG----------------------------GGSCHHHHHHHH
T ss_pred             hHHHHHHHHHHCCCCCcCccHHHHHHHHhcCCcccCcccc----------------------------cccCHHHHHHHH
Confidence            9999999999999999998877766666543222111110                            124667889999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||..||.+|||+.|+|+||||.+..
T Consensus       266 ~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (298)
T 1phk_A          266 RFLVVQPQKRYTAEEALAHPFFQQYV  291 (298)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGCTTC
T ss_pred             HHccCCcccCCCHHHHHhChHhhhcc
Confidence            99999999999999999999997543

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=100.00  E-value=1.2e-38  Score=310.50  Aligned_cols=241  Identities=21%  Similarity=0.294  Sum_probs=175.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++...        +.+|+||||+.+ +|.+++... ..+++..++.++.|++.||.|
T Consensus        76 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~~i~~~l~~  146 (360)
T 3eqc_A           76 NQIIRELQVLHECNSPYIVGFYGAFYSD--------GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKGLTY  146 (360)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEET--------TEEEEEECCCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEEEEeEEEEEC--------CEEEEEEECCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHHHH
Confidence            5688999999999999999999999875        669999999975 888888764 368999999999999999999


Q ss_pred             HHhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||+. ||+||||||+||+++.++.+||+|||++......      ......||+.|+|||++.+.. ++.++|||||||+
T Consensus       147 lh~~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~i  219 (360)
T 3eqc_A          147 LREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSMGLS  219 (360)
T ss_dssp             HHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH------C----CCCCTTCCHHHHTTCC-CSHHHHHHHHHHH
T ss_pred             HHHhCCEEcCCccHHHEEECCCCCEEEEECCCCcccccc------cccCCCCCCCeECHHHHcCCC-CCchhhHHHHHHH
Confidence            9986 9999999999999999999999999998765422      123457899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHH-hCCCCCCCCCcccchhhhhcccc--------chHHHh---hHHhhhCCccCCh
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQL-CGSITPESWPGVETLDLYNKMEL--------PKAQKR---KVKERLKPYVKDQ  233 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~-~g~~~~~~~~~~~~~~~~~~~~~--------~~~~~~---~~~~~~~~~~~s~  233 (433)
                      +|+|++|..||.+....+....+... .+......+..............        ......   ...........+.
T Consensus       220 l~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  299 (360)
T 3eqc_A          220 LVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLNKFGMDSRPPMAIFELLDYIVNEPPPKLPSGVFSL  299 (360)
T ss_dssp             HHHHHHTSCCSSCCCHHHHHHHHC------------------------------CCCHHHHHHHHHHSCCCCCCTTTSCH
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHhcccccccCCCCCCCcccCCCcccccccCCCCcccchhhhhHHhccCCCCCCcccccH
Confidence            99999999999987766544333211 11111111000000000000000        000000   0001111223578


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ++.+||.+||..||.+|||++|+|+||||+.
T Consensus       300 ~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          300 EFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             HHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             HHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence            8999999999999999999999999999964

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=100.00  E-value=2.9e-38  Score=309.00  Aligned_cols=248  Identities=27%  Similarity=0.414  Sum_probs=183.2

Q ss_pred             chhHHHHHHHHHhCC-----------CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccC-CCCCHHHHH
Q psy7889           7 PITALREIKILQLLK-----------HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH-VKFSLGEIK   74 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~-~~l~~~~~~   74 (433)
                      ...+.+|+.++++++           ||||+++++++.....    ....+++||||++++|.+++.... ..+++..++
T Consensus        59 ~~~~~~e~~~l~~l~~~~~~~~~~~~~~~i~~~~~~~~~~~~----~~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~  134 (373)
T 1q8y_A           59 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP----NGVHVVMVFEVLGENLLALIKKYEHRGIPLIYVK  134 (373)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET----TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHHHH
T ss_pred             hhhhhHHHHHHHHhhcccccchhccccchHHHHHHHhhccCC----CCceEEEEEecCCCCHHHHHHHhhccCCcHHHHH
Confidence            356788999999886           8999999999987532    134789999999889999997643 459999999


Q ss_pred             HHHHHHHHHHHHHHhC-CeeccCCCCCcEEEec------CCcEEEeecCCccccccCcCCccccccCCcccccccCcccc
Q psy7889          75 KVIQQLLNGLYYIHSN-KILHRDMKAANVLITK------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL  147 (433)
Q Consensus        75 ~i~~qll~aL~~LH~~-~iiH~dikp~NIll~~------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (433)
                      .++.||+.||+|||++ ||+||||||+|||++.      .+.+||+|||++......       .....||+.|+|||++
T Consensus       135 ~i~~qi~~aL~~lH~~~~ivH~Dikp~NIll~~~~~~~~~~~~kl~Dfg~a~~~~~~-------~~~~~~t~~y~aPE~~  207 (373)
T 1q8y_A          135 QISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDEH-------YTNSIQTREYRSPEVL  207 (373)
T ss_dssp             HHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTBC-------CCSCCSCGGGCCHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCEEecCCChHHeEEeccCCCcCcceEEEcccccccccCCC-------CCCCCCCccccCcHHH
Confidence            9999999999999998 9999999999999953      347999999999776432       2345789999999999


Q ss_pred             cCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCC------hHHHHHHHHHHhCCCCCCCCCcccchhhh----------hc
Q psy7889         148 LGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT------EQQQITLISQLCGSITPESWPGVETLDLY----------NK  211 (433)
Q Consensus       148 ~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~----------~~  211 (433)
                      .+.. ++.++|||||||++|+|++|.+||.+..      ..+.+..+...+|.++...+........+          ..
T Consensus       208 ~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~~~~  286 (373)
T 1q8y_A          208 LGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISK  286 (373)
T ss_dssp             HTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSCCC
T ss_pred             hCCC-CCchHhHHHHHHHHHHHHhCCCCCCCCcccccCChHHHHHHHHHhcCCCCHHHHhccchhhhhcCCcchhccccc
Confidence            8765 7999999999999999999999998754      55677778888887654221111000000          00


Q ss_pred             cccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         212 MELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       212 ~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ................+...+.++.+||.+||+.||.+|||++|+|+||||.+..
T Consensus       287 ~~~~~~~~~~~~~~~~~~~~~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~  341 (373)
T 1q8y_A          287 LKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  341 (373)
T ss_dssp             CCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ccccchhhhhhhcccCCcchHHHHHHHHHHHhccCccccCCHHHHhhChhhhccc
Confidence            0000000000000001122456788999999999999999999999999997643

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=100.00  E-value=1.6e-38  Score=316.73  Aligned_cols=219  Identities=26%  Similarity=0.399  Sum_probs=167.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.+ +|||||++++++.+.        ..+|||||||+++|.+++......+.+..++.++.||+.||+|
T Consensus        62 ~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--------~~~~lv~E~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  133 (432)
T 3p23_A           62 SFADREVQLLRESDEHPNVIRYFCTEKDR--------QFQYIAIELCAATLQEYVEQKDFAHLGLEPITLLQQTTSGLAH  133 (432)
T ss_dssp             EECHHHHHHHHHSCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHSSSCCCCSSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecC--------CEEEEEEECCCCCHHHHHHhcCCCccchhHHHHHHHHHHHHHH
Confidence            4568999999999 799999999999875        6689999999999999998876667777788999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec---C--CcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchh
Q psy7889          87 IHSNKILHRDMKAANVLITK---T--GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDL  159 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~---~--~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~Di  159 (433)
                      ||++||+||||||+|||++.   +  ..+||+|||++........ ........+||+.|+|||++.+  ...++.++||
T Consensus       134 LH~~~ivHrDlKp~NIll~~~~~~~~~~~kL~DFG~a~~~~~~~~-~~~~~~~~~gt~~y~APE~l~~~~~~~~t~~~Di  212 (432)
T 3p23_A          134 LHSLNIVHRDLKPHNILISMPNAHGKIKAMISDFGLCKKLAVGRH-SFSRRSGVPGTEGWIAPEMLSEDCKENPTYTVDI  212 (432)
T ss_dssp             HHHTTCCCCCCSTTSEEECCCBTTTBCCEEECCTTEEECC-------------CCSCTTSCCGGGTSCC---CCCTHHHH
T ss_pred             HHHCcCEeCCCCHHHEEEecCCCCCceeEEEecccceeeccCCCc-ceeeccccCCCcCccChhhhhcccccCCCcHHHH
Confidence            99999999999999999953   2  3688999999987653321 1122345678999999999974  2346889999


Q ss_pred             hhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         160 WGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       160 wSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      |||||++|+|++ |.+||..........    ..+.........                         ....+..+++|
T Consensus       213 wSlG~il~ellt~g~~pf~~~~~~~~~~----~~~~~~~~~~~~-------------------------~~~~~~~~~~l  263 (432)
T 3p23_A          213 FSAGCVFYYVISEGSHPFGKSLQRQANI----LLGACSLDCLHP-------------------------EKHEDVIAREL  263 (432)
T ss_dssp             HHHHHHHHHHHTTSCBTTBSTTTHHHHH----HTTCCCCTTSCT-------------------------TCHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcchhhHHHHHH----HhccCCccccCc-------------------------cccccHHHHHH
Confidence            999999999999 899997654433221    122211111000                         00123446799


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |.+||+.||.+|||++++++||||+.
T Consensus       264 i~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          264 IEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             HHHHHhCCHhhCCCHHHHHhCccccC
Confidence            99999999999999999999999965

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=100.00  E-value=1.2e-38  Score=302.48  Aligned_cols=230  Identities=23%  Similarity=0.326  Sum_probs=165.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc-------cCCCCCHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN-------IHVKFSLGEIKKVIQ   78 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~-------~~~~l~~~~~~~i~~   78 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+|+||||+. ++|.+++..       ....+++..++.++.
T Consensus        57 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~i~~  128 (303)
T 2vwi_A           57 MDELLKEIQAMSQCHHPNIVSYYTSFVVK--------DELWLVMKLLSGGSVLDIIKHIVAKGEHKSGVLDESTIATILR  128 (303)
T ss_dssp             ---------CCCCCCCTTBCCEEEEEESS--------SCEEEEEECCTTCBHHHHHHHHHHTTTTTTCSSCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCEeeEEEEEeec--------CCcEEEehhccCCchHHHHHHHhhccccccCCCCHHHHHHHHH
Confidence            35678999999999999999999999876        55899999996 588888764       234589999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-cccccCCcccccccCcccccCCCCCCCcc
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-VNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      ||+.||.|||++||+|+||||+||+++.++.+||+|||++.......... ........||+.|+|||++.+...++.++
T Consensus       129 qi~~~l~~lH~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~~~~~~~  208 (303)
T 2vwi_A          129 EVLEGLEYLHKNGQIHRDVKAGNILLGEDGSVQIADFGVSAFLATGGDITRNKVRKTFVGTPCWMAPEVMEQVRGYDFKA  208 (303)
T ss_dssp             HHHHHHHHHHHTTCCCCCCSGGGEEECTTCCEEECCCHHHHHCC---------------CCCTTCCHHHHHHHHCCCTHH
T ss_pred             HHHHHHHHHHhCCCCCCCCChhhEEEcCCCCEEEEeccchheeccCCCccchhhhcccCCCccccCHHHhccccCCCchh
Confidence            99999999999999999999999999999999999999987664322111 11223457899999999986544479999


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      |||||||++|+|++|..||.+............  +.... ......                   ........+.++.+
T Consensus       209 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~~~--~~~~~-~~~~~~-------------------~~~~~~~~~~~~~~  266 (303)
T 2vwi_A          209 DIWSFGITAIELATGAAPYHKYPPMKVLMLTLQ--NDPPS-LETGVQ-------------------DKEMLKKYGKSFRK  266 (303)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTSCGGGHHHHHHT--SSCCC-TTC------------------------CCCCCCCHHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCccCchhhHHHHHhc--cCCCc-cccccc-------------------cchhhhhhhHHHHH
Confidence            999999999999999999998776554433221  11110 000000                   00001235677889


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +|.+||..||.+|||+.++++||||....
T Consensus       267 li~~~l~~dp~~Rps~~~ll~h~~~~~~~  295 (303)
T 2vwi_A          267 MISLCLQKDPEKRPTAAELLRHKFFQKAK  295 (303)
T ss_dssp             HHHHHCCSSGGGSCCHHHHHTSTTC----
T ss_pred             HHHHHccCChhhCcCHHHHhhChhhhcCC
Confidence            99999999999999999999999997644

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=100.00  E-value=2.1e-37  Score=294.41  Aligned_cols=217  Identities=24%  Similarity=0.361  Sum_probs=180.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++...        ..+|+||||+++ +|.+++..  ..+++..++.++.||+.||.
T Consensus        64 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~~~~qi~~~l~  133 (303)
T 3a7i_A           64 IEDIQQEITVLSQCDSPYVTKYYGSYLKD--------TKLWIIMEYLGGGSALDLLEP--GPLDETQIATILREILKGLD  133 (303)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEHHHHHTT--SCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecC--------CeEEEEEEeCCCCcHHHHHhc--CCCCHHHHHHHHHHHHHHHH
Confidence            36788999999999999999999999875        669999999985 78887754  46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++.......    .......||..|+|||++.+.. ++.++|||||||+
T Consensus       134 ~lH~~~i~H~dl~p~Nil~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  208 (303)
T 3a7i_A          134 YLHSEKKIHRDIKAANVLLSEHGEVKLADFGVAGQLTDTQ----IKRNTFVGTPFWMAPEVIKQSA-YDSKADIWSLGIT  208 (303)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECBTTB----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             HHHHCCCccCCCChheEEECCCCCEEEeecccceecCccc----cccCccCCCcCccCHHHHhcCC-CCchhhhHHHHHH
Confidence            9999999999999999999999999999999997765322    1234457899999999997765 7899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +++|++|.+||...........+......    .                           .+...+..+.+||.+||..
T Consensus       209 l~~l~~g~~p~~~~~~~~~~~~~~~~~~~----~---------------------------~~~~~~~~l~~li~~~l~~  257 (303)
T 3a7i_A          209 AIELARGEPPHSELHPMKVLFLIPKNNPP----T---------------------------LEGNYSKPLKEFVEACLNK  257 (303)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCCC----C---------------------------CCSSCCHHHHHHHHHHCCS
T ss_pred             HHHHccCCCCCCCcCHHHHHHHhhcCCCC----C---------------------------CccccCHHHHHHHHHHcCC
Confidence            99999999999988776655544331100    0                           0112466778999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      ||.+|||++++++||||.......
T Consensus       258 dp~~Rps~~~ll~~~~~~~~~~~~  281 (303)
T 3a7i_A          258 EPSFRPTAKELLKHKFILRNAKKT  281 (303)
T ss_dssp             SGGGSCCHHHHTTCHHHHHHCCCG
T ss_pred             ChhhCcCHHHHhhChhhhcCCCcc
Confidence            999999999999999997655443

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=100.00  E-value=1.2e-37  Score=293.02  Aligned_cols=209  Identities=24%  Similarity=0.359  Sum_probs=168.4

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll   81 (433)
                      ...+++|+.++..+ +||||+++++++.+.        +.+|+||||+++ +|.+++...   ...+++..++.++.||+
T Consensus        54 ~~~~~~e~~~~~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~  125 (289)
T 1x8b_A           54 EQNALREVYAHAVLGQHSHVVRYFSAWAED--------DHMLIQNEYCNGGSLADAISENYRIMSYFKEAELKDLLLQVG  125 (289)
T ss_dssp             HHHHHHHHHHHHHSCSCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHHHHHTCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCeeeeeeeeecC--------CeEEEEEEecCCCcHHHHHHhhcccccCCCHHHHHHHHHHHH
Confidence            45788999999999 899999999999876        679999999975 899888654   24689999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecC-------------------CcEEEeecCCccccccCcCCccccccCCccccccc
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKT-------------------GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR  142 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~-------------------~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~  142 (433)
                      .||.|||++||+||||||+||+++.+                   ..+||+|||++......        ....||..|+
T Consensus       126 ~al~~lH~~~ivH~Dikp~NIl~~~~~~~~~~~~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~gt~~y~  197 (289)
T 1x8b_A          126 RGLRYIHSMSLVHMDIKPSNIFISRTSIPNAASEEGDEDDWASNKVMFKIGDLGHVTRISSP--------QVEEGDSRFL  197 (289)
T ss_dssp             HHHHHHHHTTEECSCCSGGGEEEC--------------------CCCEEECCCTTCEETTCS--------CCCCCCGGGC
T ss_pred             HHHHHHHhCCEeecCCCHHHEEEcCCCCCcccccccccccccCCceEEEEcccccccccCCc--------cccCCCcccc
Confidence            99999999999999999999999844                   47999999999776432        2235799999


Q ss_pred             CcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         143 PPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       143 aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      |||++.+...++.++|||||||++++|++|.+++.......   .+..  +..+                          
T Consensus       198 aPE~~~~~~~~~~~~Di~slG~il~~l~~~~~~~~~~~~~~---~~~~--~~~~--------------------------  246 (289)
T 1x8b_A          198 ANEVLQENYTHLPKADIFALALTVVCAAGAEPLPRNGDQWH---EIRQ--GRLP--------------------------  246 (289)
T ss_dssp             CHHHHTTCCTTHHHHHHHHHHHHHHHHTTCCCCCSSSHHHH---HHHT--TCCC--------------------------
T ss_pred             ChhHhcCCCCCCchhhHHHHHHHHHHHhcCCCCCcchhHHH---HHHc--CCCC--------------------------
Confidence            99999876556789999999999999999998876543222   1111  1100                          


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                         ..+...+.++.+||.+||..||.+|||+.|+|+||||...
T Consensus       247 ---~~~~~~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          247 ---RIPQVLSQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             ---CCSSCCCHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             ---CCCcccCHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence               0012356778899999999999999999999999999764

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=100.00  E-value=4e-38  Score=296.21  Aligned_cols=215  Identities=25%  Similarity=0.446  Sum_probs=176.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++||||+++++++.+.        ..+++||||+. ++|.+++... ..+++..++.++.||+.||.
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~~i~~~l~  122 (283)
T 3bhy_A           52 REEIEREVNILREIRHPNIITLHDIFENK--------TDVVLILELVSGGELFDFLAEK-ESLTEDEATQFLKQILDGVH  122 (283)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeehhheecCC--------CeEEEEEeecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45688999999999999999999999875        66999999996 6888888653 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++||+|+||||+||+++.++    .+||+|||++.......     ......+++.|+|||++.+.. ++.++||||
T Consensus       123 ~lH~~~i~H~dl~p~Nil~~~~~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  196 (283)
T 3bhy_A          123 YLHSKRIAHFDLKPENIMLLDKNVPNPRIKLIDFGIAHKIEAGN-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWS  196 (283)
T ss_dssp             HHHHTTEECSCCSGGGEEESCSSSSSCCEEECCCTTCEECC-------------CCCGGGCCHHHHTTCC-CCTHHHHHH
T ss_pred             HHHhCCccCCCCChHHEEEecCCCCCCceEEEecccceeccCCC-----cccccCCCcCccCcceecCCC-CCcchhhhh
Confidence            99999999999999999998877    89999999997764322     223456899999999987655 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++++|++|..||.+....+....+........                   ...         ....+..+.+||.+
T Consensus       197 lG~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------~~~---------~~~~~~~~~~li~~  248 (283)
T 3bhy_A          197 IGVITYILLSGASPFLGETKQETLTNISAVNYDFD-------------------EEY---------FSNTSELAKDFIRR  248 (283)
T ss_dssp             HHHHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCCC-------------------HHH---------HTTCCHHHHHHHHT
T ss_pred             HHHHHHHHHHCCCCCCCcchHHHHHHhHhcccCCc-------------------chh---------cccCCHHHHHHHHH
Confidence            99999999999999999887776665543211100                   000         01246778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||..||.+|||+.|+|+||||..
T Consensus       249 ~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          249 LLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             TSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             HccCCHhHCcCHHHHHhCHHHHH
Confidence            99999999999999999999954

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=100.00  E-value=3.5e-38  Score=314.87  Aligned_cols=222  Identities=24%  Similarity=0.394  Sum_probs=162.9

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCC------CCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK------FSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~------l~~~~~~~i~~ql   80 (433)
                      ..+.+|+.+|+++ +|||||++++++.+.        ..+|||||||+++|.+++......      .++..++.++.||
T Consensus        53 ~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--------~~~~lv~E~~~gsL~~~l~~~~~~~~~~~~~~~~~~~~i~~qi  124 (434)
T 2rio_A           53 DIALMEIKLLTESDDHPNVIRYYCSETTD--------RFLYIALELCNLNLQDLVESKNVSDENLKLQKEYNPISLLRQI  124 (434)
T ss_dssp             HHHHHHHHHHHHHTTSTTBCCEEEEEECS--------SEEEEEECCCSEEHHHHHHTC------------CCHHHHHHHH
T ss_pred             HHHHHHHHHHHhccCCCCcCeEEEEEecC--------CeEEEEEecCCCCHHHHHhccCCCchhhhhccchhHHHHHHHH
Confidence            4678999999986 899999999999875        669999999999999998764321      1233467899999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecC-------------CcEEEeecCCccccccCcCCccccccCCcccccccCcccc
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKT-------------GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL  147 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~-------------~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  147 (433)
                      +.||+|||++||+||||||+|||++.+             +.+||+|||++.................+||+.|+|||++
T Consensus       125 ~~aL~~LH~~~ivHrDLkp~NILl~~~~~~~~~~~~~~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~  204 (434)
T 2rio_A          125 ASGVAHLHSLKIIHRDLKPQNILVSTSSRFTADQQTGAENLRILISDFGLCKKLDSGQSSFRTNLNNPSGTSGWRAPELL  204 (434)
T ss_dssp             HHHHHHHHHTTEECCCCSGGGEEEECCHHHHSCCTTCCCSCEEEECCCTTCEECCC--------------CCTTSCHHHH
T ss_pred             HHHHHHHHHCCccccCCChHhEEEecCcccccccccCCCceEEEEcccccceecCCCCccceeeecCCCCCCCccCHHHh
Confidence            999999999999999999999999754             4899999999988754332211223456789999999999


Q ss_pred             cC------CCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHh
Q psy7889         148 LG------DRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR  220 (433)
Q Consensus       148 ~~------~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~  220 (433)
                      .+      ...++.++|||||||++|+|++ |.+||.+.....  ..+..  +...........                
T Consensus       205 ~~~~~~~~~~~~~~~~DiwSlG~il~ellt~g~~Pf~~~~~~~--~~i~~--~~~~~~~~~~~~----------------  264 (434)
T 2rio_A          205 EESNNLQTKRRLTRSIDIFSMGCVFYYILSKGKHPFGDKYSRE--SNIIR--GIFSLDEMKCLH----------------  264 (434)
T ss_dssp             SCCCTTSCCCCCCTHHHHHHHHHHHHHHHTTSCCTTCSTTTHH--HHHHH--TCCCCCCCTTCC----------------
T ss_pred             ccccccccccCcchhhhhHhHHHHHHHHHhCCCCCCCCchhhH--HHHhc--CCCCcccccccc----------------
Confidence            75      2347899999999999999999 999998765443  12222  211111110000                


Q ss_pred             hHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         221 KVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       221 ~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                             ....+.++.+||.+||+.||.+|||+.++++||||+.
T Consensus       265 -------~~~~~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          265 -------DRSLIAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             -------CHHHHHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             -------cccchHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence                   0012456779999999999999999999999999964

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=100.00  E-value=9e-38  Score=300.22  Aligned_cols=224  Identities=21%  Similarity=0.381  Sum_probs=168.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccc-----------------------------------------------
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQY-----------------------------------------------   39 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~-----------------------------------------------   39 (433)
                      .+.+.+|+.+|+.++|||||+++++|.+.....                                               
T Consensus        48 ~~~~~~E~~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  127 (332)
T 3qd2_B           48 REKVMREVKALAKLEHPGIVRYFNAWLETPPEKWQEEMDEIWLKDESTDWPLSSPSPMDAPSVKIRRMDPFSTKNTVGQL  127 (332)
T ss_dssp             HHHHHHHHHHHTSCCCTTBCCEEEEEEECCSCHHHHHHHC----------------------------------------
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEEEeccchhhhhhhhhhhccccccccccCCCcccccccceeeccccCcccccccc
Confidence            467899999999999999999999997653200                                               


Q ss_pred             --cccCceEEEEeecCcC-CHHHHHhccCC--CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEee
Q psy7889          40 --NRYRSTFYLVFDFCEH-DLAGLLSNIHV--KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLAD  114 (433)
Q Consensus        40 --~~~~~~~~lV~e~~~~-~L~~~l~~~~~--~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~D  114 (433)
                        ......+|+|||||.+ +|.+++.....  ..++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|
T Consensus       128 ~~~~~~~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~D  207 (332)
T 3qd2_B          128 QPSSPKVYLYIQMQLCRKENLKDWMNRRCSLEDREHGVCLHIFIQIAEAVEFLHSKGLMHRDLKPSNIFFTMDDVVKVGD  207 (332)
T ss_dssp             ----CCCEEEEEEECCCSSCHHHHHHTCCSGGGSCHHHHHHHHHHHHHHHHHHHHTTEECCCCCGGGEEECTTCCEEECC
T ss_pred             cCCCCCceEEEEEEecCCCCHHHHHhcccCccchhhHHHHHHHHHHHHHHHHHHhCCeeecCCCcccEEEeCCCCEEEee
Confidence              0112358999999975 88888876432  256677999999999999999999999999999999999999999999


Q ss_pred             cCCccccccCcCCc--------cccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHH
Q psy7889         115 FGLARAFSQTKNGQ--------VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT  186 (433)
Q Consensus       115 Fg~a~~~~~~~~~~--------~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~  186 (433)
                      ||++..........        .......+||+.|+|||++.+.. ++.++|||||||++|+|++|..++.     +...
T Consensus       208 fG~a~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~il~el~~~~~~~~-----~~~~  281 (332)
T 3qd2_B          208 FGLVTAMDQDEEEQTVLTPMPAYATHTGQVGTKLYMSPEQIHGNN-YSHKVDIFSLGLILFELLYSFSTQM-----ERVR  281 (332)
T ss_dssp             CTTCEECSCC--------------CCCSCC-CGGGSCHHHHHCCC-CCTHHHHHHHHHHHHHHHSCCCCHH-----HHHH
T ss_pred             cCcccccccchhhccccccccccccccccCCCcCccChHHhcCCC-CcchhhHHHHHHHHHHHHHcCCChh-----HHHH
Confidence            99998775432111        11234467899999999998765 7999999999999999999866542     1112


Q ss_pred             HHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       187 ~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+.......                  .+...          ...++++.+||.+||+.||.+|||++|+|+||||.+
T Consensus       282 ~~~~~~~~~------------------~~~~~----------~~~~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          282 IITDVRNLK------------------FPLLF----------TQKYPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             HHHHHHTTC------------------CCHHH----------HHHCHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             HHHHhhccC------------------CCccc----------ccCChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            222111110                  00000          012456679999999999999999999999999964

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=100.00  E-value=1.2e-37  Score=295.29  Aligned_cols=228  Identities=25%  Similarity=0.423  Sum_probs=167.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCc-----cccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKAN-----QYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~-----~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.++||||+++++++.+..+     ........+|+||||+.+ +|.+++......+++..++.++.||+
T Consensus        47 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~  126 (303)
T 1zy4_A           47 STILSEVMLLASLNHQYVVRYYAAWLERRNFVKPMTAVKKKSTLFIQMEYCENGTLYDLIHSENLNQQRDEYWRLFRQIL  126 (303)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEECCCCCC------CEEEEEEEEECCCSCBHHHHHHHSCGGGCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCchHHHHHHHHHHhhcchhhhhcccccCCceEEEEecCCCCCHHHhhhccccccchHHHHHHHHHHH
Confidence            467899999999999999999999876421     001124678999999974 99999987666688999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC----------CccccccCCcccccccCcccccCCC
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN----------GQVNRYTNRVVTLWYRPPELLLGDR  151 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~----------~~~~~~~~~~gt~~y~aPE~~~~~~  151 (433)
                      .||+|||++||+|+||||+||+++.++.+||+|||++........          ..........||..|+|||++.+..
T Consensus       127 ~~l~~LH~~~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~  206 (303)
T 1zy4_A          127 EALSYIHSQGIIHRDLKPMNIFIDESRNVKIGDFGLAKNVHRSLDILKLDSQNLPGSSDNLTSAIGTAMYVATEVLDGTG  206 (303)
T ss_dssp             HHHHHHHHTTCCCSCCCGGGEEECTTSCEEECCCCCCSCTTC-------------------------CTTSCHHHHTSCS
T ss_pred             HHHHHHHhCCeecccCCHHhEEEcCCCCEEEeeCcchhhcccccchhccccccccccccccccCCCcccccCcccccCCC
Confidence            999999999999999999999999999999999999977643211          0012234457899999999998765


Q ss_pred             CCCCcchhhhHHHHHHHHHhcCCCCCC-CChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCcc
Q psy7889         152 NYGPPVDLWGAGCIMAEMWTRSPIMQG-NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYV  230 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~g~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  230 (433)
                      .++.++|||||||++|+|++   ||.. .........+.......++. +                           +..
T Consensus       207 ~~~~~~Di~slG~il~~l~~---p~~~~~~~~~~~~~~~~~~~~~~~~-~---------------------------~~~  255 (303)
T 1zy4_A          207 HYNEKIDMYSLGIIFFEMIY---PFSTGMERVNILKKLRSVSIEFPPD-F---------------------------DDN  255 (303)
T ss_dssp             CCCTHHHHHHHHHHHHHHHS---CCSSHHHHHHHHHHHHSTTCCCCTT-C---------------------------CTT
T ss_pred             CCcchhhHHHHHHHHHHHHh---ccCCchhHHHHHHhccccccccCcc-c---------------------------ccc
Confidence            68999999999999999998   4432 22222232222211111100 0                           112


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+..+.++|.+||..||.+|||+.++++||||....
T Consensus       256 ~~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~  291 (303)
T 1zy4_A          256 KMKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVKH  291 (303)
T ss_dssp             TSHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCCC
T ss_pred             chHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCCC
Confidence            345677999999999999999999999999996543

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=100.00  E-value=6.9e-38  Score=303.49  Aligned_cols=232  Identities=22%  Similarity=0.358  Sum_probs=179.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHH------Hhcc-CCCCCHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGL------LSNI-HVKFSLGEIKKVIQQ   79 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~------l~~~-~~~l~~~~~~~i~~q   79 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+++ +|.++      +... ...+++..++.++.|
T Consensus        88 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~l~~~~~~~~~~~~~~~i~~q  159 (348)
T 2pml_X           88 DDFKNELQIITDIKNEYCLTCEGIITNY--------DEVYIIYEYMENDSILKFDEYFFVLDKNYTCFIPIQVIKCIIKS  159 (348)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCSEEEESS--------SEEEEEEECCTTCBSSEESSSEESSCSSSCCCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEeeC--------CeEEEEEeccCCCcHHHHHHHhhhhhhccccCCCHHHHHHHHHH
Confidence            7889999999999999999999999875        669999999986 77776      4332 456999999999999


Q ss_pred             HHHHHHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC-cc
Q psy7889          80 LLNGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP-PV  157 (433)
Q Consensus        80 ll~aL~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~-~~  157 (433)
                      |+.||.|||+ +||+|+||||+||+++.++.+||+|||++......      ......||..|+|||++.+...++. ++
T Consensus       160 i~~~l~~lH~~~~i~H~dl~p~Nil~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~~  233 (348)
T 2pml_X          160 VLNSFSYIHNEKNICHRDVKPSNILMDKNGRVKLSDFGESEYMVDK------KIKGSRGTYEFMPPEFFSNESSYNGAKV  233 (348)
T ss_dssp             HHHHHHHHHHTSCEECCCCCGGGEEECTTSCEEECCCTTCEECBTT------EECSSCSCGGGCCGGGGSSCCCEEHHHH
T ss_pred             HHHHHHHHhccCCEeecCCChHhEEEcCCCcEEEeccccccccccc------cccCCCCCcCccCchhhcCCCCCCcchh
Confidence            9999999999 99999999999999999999999999999776432      2344578999999999987644566 99


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++++|++|.+||.+... .+....+.......+.. ....     .....  .     ..........+.++.
T Consensus       234 Di~slG~il~~l~~g~~pf~~~~~~~~~~~~i~~~~~~~~~~-~~~~-----~~~~~--~-----~~~~~~~~~~~~~l~  300 (348)
T 2pml_X          234 DIWSLGICLYVMFYNVVPFSLKISLVELFNNIRTKNIEYPLD-RNHF-----LYPLT--N-----KKSTCSNNFLSNEDI  300 (348)
T ss_dssp             HHHHHHHHHHHHHHSSCSSCCSSCSHHHHHHHTSCCCCCCCS-SSSS-----TTTTC--C-------------CCCHHHH
T ss_pred             hHHHHHHHHHHHHhCCCCCCCCCcHHHHHHHHhccCcCCccc-hhhh-----hcccc--c-----cccccchhhcCHHHH
Confidence            999999999999999999998776 55444443211111100 0000     00000  0     000111134678889


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||.+||..||.+|||++|+|+||||....
T Consensus       301 ~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          301 DFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             HHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             HHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            999999999999999999999999997654

>2psq_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xr0_A

Probab=100.00  E-value=2e-37  Score=303.03  Aligned_cols=210  Identities=24%  Similarity=0.435  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+++|+.+|+.+ +|||||++++++.+.        +.+|+||||+.+ +|.+++....               ..+++
T Consensus       131 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  202 (370)
T 2psq_A          131 SDLVSEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF  202 (370)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHTCCC-----------CCCCCCH
T ss_pred             HHHHHHHHHHHHhcCCCCEeeEEEEEccC--------CCEEEEEEcCCCCCHHHHHHhhCCccccccccccccccccCCH
Confidence            4578999999999 899999999999875        558999999975 8999887643               24889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ........+|+.|+|||++.+.
T Consensus       203 ~~~~~i~~qi~~aL~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~  280 (370)
T 2psq_A          203 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDR  280 (370)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCCSSCEETTCCCT--TCTTTTTTSCGGGCCHHHHHTC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccccchhhEEECCCCCEEEccccCCcccCcccc--eecccCCCcccceECHhHhcCC
Confidence            99999999999999999999999999999999999999999999999987653221  1223345668899999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |.+||.+....+....+.......                               .+.
T Consensus       281 ~-~~~~~DvwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~  328 (370)
T 2psq_A          281 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMD-------------------------------KPA  328 (370)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------------------------CCT
T ss_pred             C-CCcHHHHHHHHHHHHHHHcCCCCCCCCCCHHHHHHHHhcCCCCC-------------------------------CCC
Confidence            5 8999999999999999999 999999877665554443211100                               112


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.++|.+||..||.+|||+.|++++
T Consensus       329 ~~~~~l~~li~~~l~~dP~~Rpt~~ell~~  358 (370)
T 2psq_A          329 NCTNELYMMMRDCWHAVPSQRPTFKQLVED  358 (370)
T ss_dssp             TSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            346678899999999999999999999864

>3kul_A Ephrin type-A receptor 8; ATP-binding, kinase, nucleotide-binding, transfera phosphorylation, transmembrane, tyrosine-protein kinase; HET: PTR; 2.15A {Homo sapiens}

Probab=100.00  E-value=1.4e-37  Score=298.79  Aligned_cols=210  Identities=19%  Similarity=0.296  Sum_probs=172.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++||||+++++++.+.        +.+|+||||+.+ +|.+++......+++..++.++.||+.||+|
T Consensus        95 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~  166 (325)
T 3kul_A           95 RDFLSEASIMGQFDHPNIIRLEGVVTRG--------RLAMIVTEYMENGSLDTFLRTHDGQFTIMQLVGMLRGVGAGMRY  166 (325)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECGG--------GCCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEEeC--------CccEEEeeCCCCCcHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999765        568999999965 8999987776789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++......... ........+|..|+|||++.+.. ++.++|||||||++
T Consensus       167 LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il  244 (325)
T 3kul_A          167 LSDLGYVHRDLAARNVLVDSNLVCKVSDFGLSRVLEDDPDA-AYTTTGGKIPIRWTAPEAIAFRT-FSSASDVWSFGVVM  244 (325)
T ss_dssp             HHHTTEECSCCSGGGEEECTTCCEEECCCSSCEECC----C-CEECC---CCGGGSCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             HHHCCeeCCCCCcceEEECCCCCEEECCCCcccccccCccc-eeeccCCCCcccccCHhHhcCCC-CCcHHHHHHHHHHH
Confidence            99999999999999999999999999999999876543221 11223345578899999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||.+....+....+......+.                               +...+..+.+||.+||..
T Consensus       245 ~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~  293 (325)
T 3kul_A          245 WEVLAYGERPYWNMTNRDVISSVEEGYRLPA-------------------------------PMGCPHALHQLMLDCWHK  293 (325)
T ss_dssp             HHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHcCCCCCC-------------------------------CCCcCHHHHHHHHHHccC
Confidence            99999 9999999888777666543221111                               112466778999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||+.++++
T Consensus       294 dp~~Rps~~eil~  306 (325)
T 3kul_A          294 DRAQRPRFSQIVS  306 (325)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=1.5e-37  Score=290.24  Aligned_cols=210  Identities=21%  Similarity=0.379  Sum_probs=176.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.++++++||||+++++++.+.        +.+|+||||+++ +|.+++......+++..++.++.|++.||+
T Consensus        49 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~~i~~~l~  120 (269)
T 4hcu_A           49 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--------APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA  120 (269)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSEEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecC--------CceEEEEEeCCCCcHHHHHHhcCcccCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        558999999975 799888777777999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......   ........+|..|+|||++.+.. ++.++||||+||+
T Consensus       121 ~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~  196 (269)
T 4hcu_A          121 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVL  196 (269)
T ss_dssp             HHHHTTCCCSCCCGGGEEECGGGCEEECCTTGGGGBCCHH---HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHhCCeecCCcchheEEEcCCCCEEeccccccccccccc---cccccCcccccccCCHHHhcCCC-CCchhhhHHHHHH
Confidence            9999999999999999999999999999999997664321   11223445678899999997655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++|++ |.+||.+....+....+.......                               .+...+..+.++|.+||+
T Consensus       197 l~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~  245 (269)
T 4hcu_A          197 MWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------------------------KPRLASTHVYQIMNHCWR  245 (269)
T ss_dssp             HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------------------------------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHhcCCCCCCCCCCHHHHHHHHhcCccCC-------------------------------CCCcCCHHHHHHHHHHcc
Confidence            999999 999999988877666654321111                               112246678899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.++++|
T Consensus       246 ~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          246 ERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCcccCcCHHHHHHH
Confidence            999999999999975

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=100.00  E-value=4.7e-37  Score=290.54  Aligned_cols=219  Identities=28%  Similarity=0.405  Sum_probs=171.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC--CCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV--KFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.+++.++||||+++++++...        +.+++||||++ ++|.+++.....  .+++..++.++.||+.|
T Consensus        63 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~  134 (295)
T 2clq_A           63 SQPLHEEIALHKHLKHKNIVQYLGSFSEN--------GFIKIFMEQVPGGSLSALLRSKWGPLKDNEQTIGFYTKQILEG  134 (295)
T ss_dssp             -HHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCSEEEHHHHHHHTTCCCTTCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeEEEeC--------CcEEEEEEeCCCCCHHHHHHhhccCCCccHHHHHHHHHHHHHH
Confidence            46688999999999999999999999875        66999999996 588888876533  36789999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWG  161 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwS  161 (433)
                      |.|||++||+|+||||+||+++. ++.+||+|||++.......    .......|++.|+|||++.+. ..++.++||||
T Consensus       135 l~~lH~~~i~H~dl~p~Nil~~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~~~~~~~~Di~s  210 (295)
T 2clq_A          135 LKYLHDNQIVHRDIKGDNVLINTYSGVLKISDFGTSKRLAGIN----PCTETFTGTLQYMAPEIIDKGPRGYGKAADIWS  210 (295)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEETTTCCEEECCTTTCEESCC---------CCCCCCGGGCCHHHHHHGGGGCSHHHHHHH
T ss_pred             HHHHHhCCEEccCCChhhEEEECCCCCEEEeecccccccCCCC----CcccccCCCccccChhhhcCCCCCCCcHHHHHH
Confidence            99999999999999999999997 8999999999997764321    112345689999999998654 23688999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|..||...................+ .                            .+...+.++.+||.+
T Consensus       211 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~~~~li~~  261 (295)
T 2clq_A          211 LGCTIIEMATGKPPFYELGEPQAAMFKVGMFKVHP-E----------------------------IPESMSAEAKAFILK  261 (295)
T ss_dssp             HHHHHHHHHHTSCTTGGGSSHHHHHHHHHHHCCCC-C----------------------------CCTTSCHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCccCCCchhHHHHhhccccccc-c----------------------------ccccCCHHHHHHHHH
Confidence            99999999999999976443322111111111100 0                            011356778899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||..||.+|||++++|+||||....
T Consensus       262 ~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          262 CFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             TTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             HccCChhhCCCHHHHhcChhhhhcc
Confidence            9999999999999999999997543

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=100.00  E-value=9.7e-38  Score=299.03  Aligned_cols=239  Identities=21%  Similarity=0.320  Sum_probs=174.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC--CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV--KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qll~aL   84 (433)
                      ..+++|+++|+.++||||+++++++.....      ..+|+||||+. ++|.+++.....  .+++..++.++.||+.||
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~L  125 (319)
T 4euu_A           52 DVQMREFEVLKKLNHKNIVKLFAIEEETTT------RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM  125 (319)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECTTT------CCEEEEEECCTTCBHHHHHHSGGGTTCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcceEEEEeecCCC------ceEEEEEeCCCCCCHHHHHHHhccccCCCHHHHHHHHHHHHHHH
Confidence            567899999999999999999999987532      56899999997 589888876433  389999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEE----ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC-------CCCC
Q psy7889          85 YYIHSNKILHRDMKAANVLI----TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG-------DRNY  153 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-------~~~~  153 (433)
                      +|||++||+||||||+|||+    +.++.+||+|||++.......     ......||..|+|||++..       ...+
T Consensus       126 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~Dfg~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  200 (319)
T 4euu_A          126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKY  200 (319)
T ss_dssp             HHHHHTTEECSCCSGGGEEEEECTTSCEEEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHTSCCCCCCCB
T ss_pred             HHHHHCCEecCCCCHHHEEEeccCCCCceEEEccCCCceecCCCC-----ceeecccCCCccCHHHhhhccccccccCCC
Confidence            99999999999999999999    677789999999998765432     2334578999999999852       2347


Q ss_pred             CCcchhhhHHHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCC
Q psy7889         154 GPPVDLWGAGCIMAEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD  232 (433)
Q Consensus       154 ~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  232 (433)
                      +.++|||||||++|+|++|.+||..... ......+..+....+...+......... .+.+....+   .....+...+
T Consensus       201 ~~~~DiwslG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~~-~~~~~~~~~---~~~~~~~~~~  276 (319)
T 4euu_A          201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAENG-PIDWSGDMP---VSCSLSRGLQ  276 (319)
T ss_dssp             CTTHHHHHHHHHHHHHHHSSCSEECTTCGGGCHHHHHHHHHHCCTTCCEEEECSTTC-CEEEESSCC---TTCSSCHHHH
T ss_pred             CcHHHHHHHHHHHHHHHhCCCCCCCCCccchhHHHHHHHhcCCCcccchhhhcccCC-ccccCccCC---cccccchhHH
Confidence            9999999999999999999999975432 2222223333333333333322211100 000000000   0000011234


Q ss_pred             hhHHHHHHhhcccCCCCCCCHHHhhcCCC
Q psy7889         233 QYGCDLLDKLLLLDPSKRFDSDAALNHDF  261 (433)
Q Consensus       233 ~~~~~li~~~L~~dP~~R~t~~e~L~h~~  261 (433)
                      ..+.+||.+||+.||.+|||++|+|+||=
T Consensus       277 ~~l~~ll~~~L~~dP~~R~s~~ell~h~~  305 (319)
T 4euu_A          277 VLLTPVLANILEADQEKCWGFDQFFAETS  305 (319)
T ss_dssp             HHHHHHHHHHSCCCTTTSCCHHHHHHHHH
T ss_pred             HHhHHHHHHhccCChhhhccHHHhhhccH
Confidence            56779999999999999999999999974

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=100.00  E-value=9e-38  Score=293.17  Aligned_cols=216  Identities=25%  Similarity=0.410  Sum_probs=176.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc---CCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~---~~~l~~~~~~~i~~qll~a   83 (433)
                      +.+.+|+.+++.++||||+++++++.+..      ...+|+||||+++ +|.+++...   ...+++..++.++.||+.|
T Consensus        50 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~  123 (279)
T 2w5a_A           50 QMLVSEVNLLRELKHPNIVRYYDRIIDRT------NTTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA  123 (279)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEEGG------GTEEEEEEECCTTEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEEEecCC------CceEEEEEeCCCCCCHHHHHHhhcccCCCCCHHHHHHHHHHHHHH
Confidence            45789999999999999999999887542      2679999999975 898888653   2348999999999999999


Q ss_pred             HHHHHhCC-----eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          84 LYYIHSNK-----ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        84 L~~LH~~~-----iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |+|||++|     |+|+||||+||+++.++.+||+|||++.......    .......|+..|+|||++.+.. ++.++|
T Consensus       124 l~~lH~~~~~~~~ivH~dl~p~NIl~~~~~~~kl~dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  198 (279)
T 2w5a_A          124 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT----SFAKTFVGTPYYMSPEQMNRMS-YNEKSD  198 (279)
T ss_dssp             HHHHHHHC------CCCCCSGGGEEECSSSCEEECCCCHHHHC---C----HHHHHHHSCCTTCCHHHHHCC--CCHHHH
T ss_pred             HHHHhcccCCCCeeEEeccchhhEEEcCCCCEEEecCchheeecccc----ccccccCCCccccChHHhccCC-CCchhh
Confidence            99999999     9999999999999999999999999987754321    1122346789999999998765 799999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||||||++|+|++|.+||.+.+..+....+.......                               .+...+.++.++
T Consensus       199 i~slG~il~~l~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~l  247 (279)
T 2w5a_A          199 IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRR-------------------------------IPYRYSDELNEI  247 (279)
T ss_dssp             HHHHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCC-------------------------------CCTTSCHHHHHH
T ss_pred             HHHHHHHHHHHHHCCCCCcccCHHHHHHHHhhccccc-------------------------------CCcccCHHHHHH
Confidence            9999999999999999999988776665554421110                               011256778899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |.+||..||.+|||++|+|+|+|+.+.
T Consensus       248 i~~~l~~~p~~Rps~~~ll~~~~~~~~  274 (279)
T 2w5a_A          248 ITRMLNLKDYHRPSVEEILENPLILEH  274 (279)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSTTCCGG
T ss_pred             HHHHcCCCcccCCCHHHHHhChhhhhh
Confidence            999999999999999999999999654

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.4e-37  Score=302.55  Aligned_cols=217  Identities=26%  Similarity=0.410  Sum_probs=172.1

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.+ +||||+++++++...        ..+||||||+.+ +|.+++... ..+++..++.++.||+.||
T Consensus       102 ~~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi~~aL  172 (355)
T 1vzo_A          102 TEHTRTERQVLEHIRQSPFLVTLHYAFQTE--------TKLHLILDYINGGELFTHLSQR-ERFTEHEVQIYVGEIVLAL  172 (355)
T ss_dssp             GGGCCCHHHHHHHHHTCTTBCCEEEEEEET--------TEEEEEECCCCSCBHHHHHHHH-SCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHccCCCceeEEEEEEeeC--------ceEEEEeecCCCCCHHHHHHHc-CCCCHHHHHHHHHHHHHHH
Confidence            35577899999999 699999999999876        669999999975 888888764 3699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-CCCCCcchhhhHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGAG  163 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSlG  163 (433)
                      .|||++||+||||||+|||++.++.+||+|||++..+.....   ......+||+.|+|||++.+. ..++.++||||||
T Consensus       173 ~~LH~~~ivH~Dlkp~NIll~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~~DvwslG  249 (355)
T 1vzo_A          173 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG  249 (355)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred             HHHHHCCcccCCCCHHHEEECCCCcEEEeeCCCCeecccCCC---CcccCcccCcCccChhhhcCCCCCCCchhhHHHHH
Confidence            999999999999999999999999999999999976643221   223345789999999999763 3478999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHH-HhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQ-LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~-~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |++|+|++|..||...........+.. .....+                             ..+...+..+.+||.+|
T Consensus       250 ~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-----------------------------~~~~~~~~~~~~li~~~  300 (355)
T 1vzo_A          250 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEP-----------------------------PYPQEMSALAKDLIQRL  300 (355)
T ss_dssp             HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCC-----------------------------CCCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHCCCCCccCCccchHHHHHHHHhccCC-----------------------------CCCcccCHHHHHHHHHH
Confidence            999999999999975432211111111 110000                             00123466778999999


Q ss_pred             cccCCCCCC-----CHHHhhcCCCccC
Q psy7889         243 LLLDPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      |..||.+||     +++|+++||||..
T Consensus       301 L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          301 LMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             TCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             hhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            999999999     9999999999965

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=100.00  E-value=1.7e-39  Score=318.59  Aligned_cols=213  Identities=14%  Similarity=0.158  Sum_probs=161.2

Q ss_pred             chhHHHHHHH---HHhCCCCCcccee-------eeEEecCc---------cccccCceEEEEeecCcCCHHHHHhccCCC
Q psy7889           7 PITALREIKI---LQLLKHENVVHLI-------EICRTKAN---------QYNRYRSTFYLVFDFCEHDLAGLLSNIHVK   67 (433)
Q Consensus         7 ~~~~~~Ei~i---l~~l~hpnIv~l~-------~~~~~~~~---------~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~   67 (433)
                      ...+.+|+++   |+.++|||||+++       +++.+...         ....+-...||||||++|+|.+++.... .
T Consensus       117 ~~~~~~E~~~l~~l~~l~hpniv~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~~~lv~E~~~g~L~~~l~~~~-~  195 (377)
T 3byv_A          117 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLL-S  195 (377)
T ss_dssp             HHHHHHHHHGGGGSTTCCSHHHHHHHHCBCCCSEEEECTTSCSEEEC------CEEESEEEEEECCSEEHHHHHHHHH-H
T ss_pred             HHHHHHHHHHHHhccccCCHHHHHHHhhhhhhhhhhhccCCccccccccCCCceEEEEEEEEEeccCCCHHHHHHhcc-c
Confidence            3567899954   4555799999999       66654411         0000001379999999999999997642 2


Q ss_pred             CC-------HHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCccccc
Q psy7889          68 FS-------LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLW  140 (433)
Q Consensus        68 l~-------~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~  140 (433)
                      ++       +..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++.....       .....+| +.
T Consensus       196 ~~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~-------~~~~~~g-~~  267 (377)
T 3byv_A          196 HSSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGA-------RVVSSVS-RG  267 (377)
T ss_dssp             TTTTTHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTC-------EEECCCC-TT
T ss_pred             cccccccccHHHHHHHHHHHHHHHHHHHhCCeecCCCCHHHEEEcCCCCEEEEechhheecCC-------cccCCCC-cC
Confidence            44       478888999999999999999999999999999999999999999999976432       2234566 89


Q ss_pred             ccCcccccCC----------CCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhh
Q psy7889         141 YRPPELLLGD----------RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYN  210 (433)
Q Consensus       141 y~aPE~~~~~----------~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~  210 (433)
                      |+|||++.+.          ..++.++|||||||++|+|++|.+||.+.........+.                    .
T Consensus       268 y~aPE~~~~~~~~~~~~~~~~~~~~~~DvwSlG~il~elltg~~Pf~~~~~~~~~~~~~--------------------~  327 (377)
T 3byv_A          268 FEPPELEARRATISYHRDRRTLMTFSFDAWALGLVIYWIWCADLPITKDAALGGSEWIF--------------------R  327 (377)
T ss_dssp             CCCHHHHHHHTSTHHHHCCEEECCHHHHHHHHHHHHHHHHHSSCCC------CCSGGGG--------------------S
T ss_pred             ccChhhhcccccccccccccccCChhhhHHHHHHHHHHHHHCCCCCcccccccchhhhh--------------------h
Confidence            9999999875          247999999999999999999999997654221111000                    0


Q ss_pred             ccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         211 KMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       211 ~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                                      .....+.++.+||.+||..||.+|||+.|+|+||||.+
T Consensus       328 ----------------~~~~~~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          328 ----------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             ----------------SCCCCCHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             ----------------hccCCCHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence                            00135678889999999999999999999999999954

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=100.00  E-value=3.2e-37  Score=294.24  Aligned_cols=213  Identities=21%  Similarity=0.305  Sum_probs=166.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC--CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV--KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~--~l~~~~~~~i~~qll~aL   84 (433)
                      ..+++|+.+|++++||||+++++++.+.        ..+++||||+.+ +|.+++.....  .+++..++.++.||+.||
T Consensus        79 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~qi~~aL  150 (309)
T 3p86_A           79 NEFLREVAIMKRLRHPNIVLFMGAVTQP--------PNLSIVTEYLSRGSLYRLLHKSGAREQLDERRRLSMAYDVAKGM  150 (309)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECST--------TCCEEEEECCTTCBHHHHHHSTTHHHHSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEEC--------CceEEEEecCCCCcHHHHHhhcCCCCCCCHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999875        558999999975 88888876432  289999999999999999


Q ss_pred             HHHHhCC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          85 YYIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        85 ~~LH~~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      +|||++|  |+||||||+||+++.++.+||+|||++.......    .......||+.|+|||++.+.. ++.++|||||
T Consensus       151 ~~LH~~~~~ivH~Dikp~NIll~~~~~~kL~Dfg~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diwsl  225 (309)
T 3p86_A          151 NYLHNRNPPIVHRNLKSPNLLVDKKYTVKVCDFGLSRLKASTF----LSSKSAAGTPEWMAPEVLRDEP-SNEKSDVYSF  225 (309)
T ss_dssp             HHHHTSSSCCCCTTCCGGGEEECTTCCEEECCCC---------------------CCTTSCHHHHTTCC-CCTTHHHHHH
T ss_pred             HHHHcCCCCEECCCCChhhEEEeCCCcEEECCCCCCccccccc----cccccCCCCccccChhhhcCCC-CCchhhHHHH
Confidence            9999999  9999999999999999999999999997644221    1233457899999999998765 7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|..||.+.+..+....+........                              .+...+.++.+||.+|
T Consensus       226 G~il~elltg~~Pf~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~  275 (309)
T 3p86_A          226 GVILWELATLQQPWGNLNPAQVVAAVGFKCKRLE------------------------------IPRNLNPQVAAIIEGC  275 (309)
T ss_dssp             HHHHHHHHHCCCTTTTSCHHHHHHHHHHSCCCCC------------------------------CCTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHhcCCCCC------------------------------CCccCCHHHHHHHHHH
Confidence            9999999999999999887776655533221110                              0113567788999999


Q ss_pred             cccCCCCCCCHHHhhc--CCCcc
Q psy7889         243 LLLDPSKRFDSDAALN--HDFFW  263 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~--h~~~~  263 (433)
                      |..||.+|||++++++  .+++.
T Consensus       276 l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          276 WTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             TCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             ccCChhhCcCHHHHHHHHHHHHH
Confidence            9999999999999987  34443

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=100.00  E-value=7e-39  Score=313.60  Aligned_cols=226  Identities=15%  Similarity=0.164  Sum_probs=155.2

Q ss_pred             hhHHHHHHHHHhC--CCCCcccee-------eeEEecCcc---------ccccCceEEEEeecCcCCHHHHHhccCCCCC
Q psy7889           8 ITALREIKILQLL--KHENVVHLI-------EICRTKANQ---------YNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS   69 (433)
Q Consensus         8 ~~~~~Ei~il~~l--~hpnIv~l~-------~~~~~~~~~---------~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~   69 (433)
                      ..+.+|+.+++.|  +|||||+++       +++...+..         .......+|||||||+++|.+++......+.
T Consensus       107 ~~~~~E~~~~~~l~~~hp~iv~~~~~~~~p~d~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~L~~~l~~~~~~~~  186 (371)
T 3q60_A          107 ERLHEATFAAARLLGESPEEARDRRRLLLPSDAVAVQSQPPFAQLSPGQDDYAVANYLLLMPAASVDLELLFSTLDFVYV  186 (371)
T ss_dssp             HHHHHHHHHHHHHHC----------CBCCCCEEEEETTSCSSSBCSCC---CCEEEEEEEECCCSEEHHHHHHHHHHSCC
T ss_pred             HHHHHHHHHHHHhcccChhhhhhceeEEeeehheecCCCCCeeeccCCcccceeeeEEEEecCCCCCHHHHHHHhccccc
Confidence            3456775555555  699988866       455443210         0001155899999999999999987544455


Q ss_pred             HHHH------HHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccC
Q psy7889          70 LGEI------KKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRP  143 (433)
Q Consensus        70 ~~~~------~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~a  143 (433)
                      ...+      ..++.||+.||+|||++||+||||||+|||++.+|.+||+|||++......       .....+|+.|+|
T Consensus       187 ~~~~~~~~vk~~i~~qi~~aL~~LH~~~ivHrDikp~NIll~~~~~~kL~DFG~a~~~~~~-------~~~~~~t~~y~a  259 (371)
T 3q60_A          187 FRGDEGILALHILTAQLIRLAANLQSKGLVHGHFTPDNLFIMPDGRLMLGDVSALWKVGTR-------GPASSVPVTYAP  259 (371)
T ss_dssp             CCHHHHHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEECTTSCEEECCGGGEEETTCE-------EEGGGSCGGGCC
T ss_pred             hhhhhhhhhHHHHHHHHHHHHHHHHHCCCccCcCCHHHEEECCCCCEEEEecceeeecCCC-------ccCccCCcCCcC
Confidence            5555      677799999999999999999999999999999999999999999875421       113456799999


Q ss_pred             cccccCC-CCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhh-hhccccchHHHhh
Q psy7889         144 PELLLGD-RNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDL-YNKMELPKAQKRK  221 (433)
Q Consensus       144 PE~~~~~-~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~-~~~~~~~~~~~~~  221 (433)
                      ||++.+. ..++.++|||||||++|+|++|.+||.+.....             ...+........ ......+      
T Consensus       260 PE~~~~~~~~~~~~~DiwSlG~il~elltg~~Pf~~~~~~~-------------~~~~~~~~~~~~~~~~~~~~------  320 (371)
T 3q60_A          260 REFLNASTATFTHALNAWQLGLSIYRVWCLFLPFGLVTPGI-------------KGSWKRPSLRVPGTDSLAFG------  320 (371)
T ss_dssp             HHHHTCSEEECCHHHHHHHHHHHHHHHHHSSCSTTBCCTTC-------------TTCCCBCCTTSCCCCSCCCT------
T ss_pred             hhhccCCCCCcCccccHHHHHHHHHHHHhCCCCCCCcCccc-------------ccchhhhhhhhccccccchh------
Confidence            9999762 347999999999999999999999998764221             000100000000 0000000      


Q ss_pred             HHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         222 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       222 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                           .....+..+.+||.+||..||.+|||+.++|+||||.+
T Consensus       321 -----~~~~~~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          321 -----SCTPLPDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             -----TSSCCCHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             -----hccCCCHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence                 01135788899999999999999999999999999954

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=100.00  E-value=3.2e-37  Score=287.77  Aligned_cols=210  Identities=18%  Similarity=0.292  Sum_probs=175.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        ..+|+||||++ ++|.+++......+++..++.++.|++.||+
T Consensus        47 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~  118 (268)
T 3sxs_A           47 EDEFFQEAQTMMKLSHPKLVKFYGVCSKE--------YPIYIVTEYISNGCLLNYLRSHGKGLEPSQLLEMCYDVCEGMA  118 (268)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccC--------CceEEEEEccCCCcHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999765        55899999996 5799888776666999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.++|+|||++........   .......+|..|+|||++.+.. ++.++|||||||+
T Consensus       119 ~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  194 (268)
T 3sxs_A          119 FLESHQFIHRDLAARNCLVDRDLCVKVSDFGMTRYVLDDQY---VSSVGTKFPVKWSAPEVFHYFK-YSSKSDVWAFGIL  194 (268)
T ss_dssp             HHHHTTEEESSCSGGGEEECTTCCEEECCTTCEEECCTTCE---EECCSCCCCGGGCCHHHHHHSE-EETTHHHHHHHHH
T ss_pred             HHHHCCeecCCcCcceEEECCCCCEEEccCccceecchhhh---hcccCCCcCcccCCHHHHhccC-CchhhhhHHHHHH
Confidence            99999999999999999999999999999999977643321   1223445677899999997655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +++|++ |.+||.+....+....+........                               +...+..+.++|.+||+
T Consensus       195 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~  243 (268)
T 3sxs_A          195 MWEVFSLGKMPYDLYTNSEVVLKVSQGHRLYR-------------------------------PHLASDTIYQIMYSCWH  243 (268)
T ss_dssp             HHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------------------------CTTSCHHHHHHHHHTTC
T ss_pred             HHHHHcCCCCCccccChHHHHHHHHcCCCCCC-------------------------------CCcChHHHHHHHHHHcC
Confidence            999999 9999998887776665543221111                               12245677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.+++++
T Consensus       244 ~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          244 ELPEKRPTFQQLLSS  258 (268)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999975

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=100.00  E-value=8.9e-38  Score=299.70  Aligned_cols=216  Identities=26%  Similarity=0.438  Sum_probs=169.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++...         .+|+||||+.+ +|.+.+.. ...+++..++.++.||+.||.|
T Consensus        60 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------~~~lv~e~~~~~~L~~~~~~-~~~~~~~~~~~~~~qi~~~l~~  129 (322)
T 2ycf_A           60 LNVETEIEILKKLNHPCIIKIKNFFDAE---------DYYIVLELMEGGELFDKVVG-NKRLKEATCKLYFYQMLLAVQY  129 (322)
T ss_dssp             -CHHHHHHHHHHCCCTTBCCEEEEEESS---------SEEEEEECCTTEETHHHHST-TCCCCHHHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHhCCCCCCceEeeEEcCC---------ceEEEEecCCCCcHHHHHhc-cCCCCHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999998653         37999999975 88887765 4479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCc---EEEeecCCccccccCcCCccccccCCcccccccCccccc--CCCCCCCcchhhh
Q psy7889          87 IHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL--GDRNYGPPVDLWG  161 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~---~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~--~~~~~~~~~DiwS  161 (433)
                      ||++||+||||||+||+++.++.   +||+|||++.......     ......||+.|+|||++.  +...++.++||||
T Consensus       130 lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~s  204 (322)
T 2ycf_A          130 LHENGIIHRDLKPENVLLSSQEEDCLIKITDFGHSKILGETS-----LMRTLCGTPTYLAPEVLVSVGTAGYNRAVDCWS  204 (322)
T ss_dssp             HHHTTEECCCCSGGGEEESSSSSSCCEEECCCTTCEECCCCH-----HHHHHHSCCTTCCHHHHHHTTTTTCTTHHHHHH
T ss_pred             HHHCCeeccCCCHHHEEEecCCCCCeEEEccCccceeccccc-----ccccccCCcCccCchhhccCCCCCCCchhhHHH
Confidence            99999999999999999987654   9999999997764321     123346799999999974  2345789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHH-HHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQI-TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~-~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |||++|+|++|.+||.+......+ ..+......                   .....         ....+..+.+||.
T Consensus       205 lG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~-------------------~~~~~---------~~~~~~~~~~li~  256 (322)
T 2ycf_A          205 LGVILFICLSGYPPFSEHRTQVSLKDQITSGKYN-------------------FIPEV---------WAEVSEKALDLVK  256 (322)
T ss_dssp             HHHHHHHHHHSSCSSCSTTCSSCHHHHHHHTCCC-------------------CCHHH---------HTTSCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCcccchHHHHHHHHHhCccc-------------------cCchh---------hhhcCHHHHHHHH
Confidence            999999999999999865432211 222111000                   00000         0125677889999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      +||..||.+|||++++|+||||....
T Consensus       257 ~~l~~dP~~Rps~~~~l~h~~~~~~~  282 (322)
T 2ycf_A          257 KLLVVDPKARFTTEEALRHPWLQDED  282 (322)
T ss_dssp             HHSCSSTTTSCCHHHHHTSGGGCCHH
T ss_pred             HHcccCHhhCCCHHHHhhCcCcCCHH
Confidence            99999999999999999999997643

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=100.00  E-value=3.7e-37  Score=289.68  Aligned_cols=210  Identities=20%  Similarity=0.390  Sum_probs=176.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        ..+|+||||+. ++|.+++......+++..++.++.||+.||+
T Consensus        63 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l~  134 (283)
T 3gen_A           63 EDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--------RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAME  134 (283)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSEEEEECCCTTCBHHHHHHCGGGCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCEeeEEEEEecC--------CCeEEEEeccCCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHH
Confidence            56789999999999999999999999765        55899999996 5899998876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++.......   ........+|+.|+|||++.+.. ++.++|||||||+
T Consensus       135 ~lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG~~  210 (283)
T 3gen_A          135 YLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDE---YTSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVL  210 (283)
T ss_dssp             HHHHTTCCCSSCSGGGEEECTTSCEEECSTTGGGGBCCHH---HHSTTSTTSCGGGCCHHHHHHCC-CSHHHHHHHHHHH
T ss_pred             HHHHCCccCCCCccceEEEcCCCCEEEccccccccccccc---cccccCCccCcccCCHHHhccCC-CCchhhHHHHHHH
Confidence            9999999999999999999999999999999997764321   11223345678899999998665 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+........                               +...+..+.++|.+||.
T Consensus       211 l~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~  259 (283)
T 3gen_A          211 MWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------------------------PHLASEKVYTIMYSCWH  259 (283)
T ss_dssp             HHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHTTC
T ss_pred             HHHHHhCCCCCccccChhHHHHHHhcccCCCC-------------------------------CCcCCHHHHHHHHHHcc
Confidence            999998 9999999888777666654222111                               11245677799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||++++++|
T Consensus       260 ~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          260 EKADERPTFKILLSN  274 (283)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhHCcCHHHHHHH
Confidence            999999999999975

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=100.00  E-value=3.8e-38  Score=300.85  Aligned_cols=221  Identities=23%  Similarity=0.332  Sum_probs=171.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.....    .....|+||||+. ++|.+++... ..+++..++.++.||+.||+|
T Consensus        57 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~----~~~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~  131 (311)
T 3ork_A           57 LRFRREAQNAAALNHPAIVAVYDTGEAETP----AGPLPYIVMEYVDGVTLRDIVHTE-GPMTPKRAIEVIADACQALNF  131 (311)
T ss_dssp             HHHHHHHTTCCCCCCTTBCCEEEEEEEEET----TEEEEEEEEECCCEEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCCcceEEEeeeccCC----CCcccEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            357899999999999999999999987633    1245699999996 5888888654 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++........ .........||+.|+|||++.+.. ++.++|||||||++
T Consensus       132 lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l  209 (311)
T 3ork_A          132 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVL  209 (311)
T ss_dssp             HHHTTCCCCCCCGGGEEEETTSCEEECCCSCC-------------------CCTTCCHHHHHTCC-CCHHHHHHHHHHHH
T ss_pred             HHHCCCCcCCCCHHHEEEcCCCCEEEeeccCccccccccc-ccccccccCcCcccCCHHHhcCCC-CCchHhHHHHHHHH
Confidence            9999999999999999999999999999999987654321 112233457899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.........+......+                    .        .......+.++.+||.+||..|
T Consensus       210 ~~ll~g~~pf~~~~~~~~~~~~~~~~~~~--------------------~--------~~~~~~~~~~l~~li~~~l~~d  261 (311)
T 3ork_A          210 YEVLTGEPPFTGDSPVSVAYQHVREDPIP--------------------P--------SARHEGLSADLDAVVLKALAKN  261 (311)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHCCCCC--------------------H--------HHHSTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCCCCChHHHHHHHhcCCCCC--------------------c--------ccccCCCCHHHHHHHHHHHhcC
Confidence            99999999999988776655443311100                    0        0001125677889999999999


Q ss_pred             CCCCCCHHHhhcCCCcc
Q psy7889         247 PSKRFDSDAALNHDFFW  263 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~  263 (433)
                      |.+||++.++|.|+|+.
T Consensus       262 P~~R~~~~~~l~~~l~~  278 (311)
T 3ork_A          262 PENRYQTAAEMRADLVR  278 (311)
T ss_dssp             GGGSCSSHHHHHHHHHH
T ss_pred             HhhChhhHHHHHHHHHH
Confidence            99999999999999985

>3s95_A LIMK-1, LIM domain kinase 1; structural genomics, structural genomics consortium, SGC, PR kinase, transferase-antibiotic complex; HET: STU GOL; 1.65A {Homo sapiens}

Probab=100.00  E-value=1.4e-36  Score=289.74  Aligned_cols=214  Identities=22%  Similarity=0.380  Sum_probs=169.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++|+.++||||+++++++.+.        +.+++||||+.+ +|.+++......+++..+..++.||+.||+
T Consensus        51 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~  122 (310)
T 3s95_A           51 QRTFLKEVKVMRCLEHPNVLKFIGVLYKD--------KRLNFITEYIKGGTLRGIIKSMDSQYPWSQRVSFAKDIASGMA  122 (310)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHHCCTTSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCcccEEEEEecC--------CeeEEEEEecCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHH
Confidence            35678999999999999999999999876        669999999975 899999887778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcc----------ccccCCcccccccCcccccCCCCCCC
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV----------NRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~----------~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      |||++||+||||||+||+++.++.+||+|||++...........          ......+||+.|+|||++.+.. ++.
T Consensus       123 ~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~  201 (310)
T 3s95_A          123 YLHSMNIIHRDLNSHNCLVRENKNVVVADFGLARLMVDEKTQPEGLRSLKKPDRKKRYTVVGNPYWMAPEMINGRS-YDE  201 (310)
T ss_dssp             HHHHTTEECSCCSTTSEEECTTSCEEECCCTTCEECC--------------------CCCCSCGGGCCHHHHTTCC-CCT
T ss_pred             HHHhCCccCCCCCcCeEEECCCCCEEEeecccceecccccccccccccccccccccccccCCCcceeCHHHhcCCC-CCc
Confidence            99999999999999999999999999999999987653321110          1112457899999999998755 799


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|||||||++|+|++|..||........              .. ..             . .........+...+..+
T Consensus       202 ~~Di~slG~~l~el~~g~~~~~~~~~~~~--------------~~-~~-------------~-~~~~~~~~~~~~~~~~l  252 (310)
T 3s95_A          202 KVDVFSFGIVLCEIIGRVNADPDYLPRTM--------------DF-GL-------------N-VRGFLDRYCPPNCPPSF  252 (310)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSSTTTSCBCT--------------TS-SB-------------C-HHHHHHHTCCTTCCTTH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCcchhhhHH--------------HH-hh-------------h-hhccccccCCCCCCHHH
Confidence            99999999999999999998875321100              00 00             0 00011111223456788


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhc
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .++|.+||..||.+|||+.++++
T Consensus       253 ~~li~~~l~~dP~~Rps~~~l~~  275 (310)
T 3s95_A          253 FPITVRCCDLDPEKRPSFVKLEH  275 (310)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHccCChhhCcCHHHHHH
Confidence            89999999999999999999987

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=100.00  E-value=3.6e-37  Score=290.54  Aligned_cols=214  Identities=29%  Similarity=0.521  Sum_probs=176.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++++.++||||+++++++.+.        ..+|+||||+. ++|.+.+... ..+++..++.++.||+.||.
T Consensus        65 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~  135 (287)
T 2wei_A           65 TSTILREVELLKKLDHPNIMKLFEILEDS--------SSFYIVGELYTGGELFDEIIKR-KRFSEHDAARIIKQVFSGIT  135 (287)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCccEEEEEEeCC--------CeEEEEEEccCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            45788999999999999999999999875        66999999996 5788877654 36899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecC---CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLITKT---GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~---~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+|+||||+||+++.+   +.+||+|||++.......     ......+|+.|+|||++.+.  ++.++|||||
T Consensus       136 ~LH~~~i~H~dl~p~NIlv~~~~~~~~~kL~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~--~~~~~Di~sl  208 (287)
T 2wei_A          136 YMHKHNIVHRDLKPENILLESKEKDCDIKIIDFGLSTCFQQNT-----KMKDRIGTAYYIAPEVLRGT--YDEKCDVWSA  208 (287)
T ss_dssp             HHHHTTCCCSCCCGGGEEESCSSTTCCEEECSTTGGGTBCCCS-----SCSCHHHHHTTCCHHHHTTC--CCTHHHHHHH
T ss_pred             HHHHCCeeccCCChhhEEEecCCCcccEEEeccCcceeecCCC-----ccccccCcccccChHHhcCC--CCCchhhHhH
Confidence            9999999999999999999754   479999999997764322     22344678999999998763  7999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++++|++|.+||.+....+....+...........                            ....+.++.+||.+|
T Consensus       209 G~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~~~~~~li~~~  260 (287)
T 2wei_A          209 GVILYILLSGTPPFYGKNEYDILKRVETGKYAFDLPQ----------------------------WRTISDDAKDLIRKM  260 (287)
T ss_dssp             HHHHHHHHHSSCSSCCSSHHHHHHHHHHCCCCCCSGG----------------------------GTTSCHHHHHHHHHH
T ss_pred             HHHHHHHHhCCCCCCCCCHHHHHHHHHcCCCCCCchh----------------------------hhhcCHHHHHHHHHH
Confidence            9999999999999999887776666544221111000                            012467788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |..||.+|||++|+|+||||.+
T Consensus       261 l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          261 LTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             TCSSGGGSCCHHHHHHSHHHHH
T ss_pred             cccChhhCcCHHHHhcCHHHhc
Confidence            9999999999999999999964

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-37  Score=304.37  Aligned_cols=214  Identities=19%  Similarity=0.337  Sum_probs=175.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC------CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH------VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~------~~l~~~~~~~i~~ql   80 (433)
                      ..+++|+.+|+.++|||||++++++.+.        ...|+|||||. ++|.+++....      ..+++..++.++.||
T Consensus       119 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi  190 (367)
T 3l9p_A          119 LDFLMEALIISKFNHQNIVRCIGVSLQS--------LPRFILLELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI  190 (367)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHHHSCCSSSCCCCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEecC--------CCCEEEEEeCCCCCHHHHHHhhccccCccccccHHHHHHHHHHH
Confidence            3578999999999999999999999875        45799999996 48999987643      348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEecCC---cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~~~---~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      +.||+|||++||+||||||+|||++.+|   .+||+|||+++.......  ........+|+.|+|||++.+.. ++.++
T Consensus       191 ~~aL~~LH~~~ivHrDlkp~NIll~~~~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~  267 (367)
T 3l9p_A          191 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRAGY--YRKGGCAMLPVKWMPPEAFMEGI-FTSKT  267 (367)
T ss_dssp             HHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHHHSS--CTTCCGGGSCGGGCCHHHHHHCC-CCHHH
T ss_pred             HHHHHHHHhCCeeCCCCChhhEEEecCCCCceEEECCCccccccccccc--cccCCCcCCcccEECHHHhcCCC-CCcHH
Confidence            9999999999999999999999999555   599999999976543221  12223456788999999997765 79999


Q ss_pred             hhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++|+|++ |.+||.+....+....+........                               +...+..+.
T Consensus       268 DvwslG~il~ellt~g~~pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~  316 (367)
T 3l9p_A          268 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-------------------------------PKNCPGPVY  316 (367)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccCCHHHH
Confidence            99999999999998 9999999888776666543221111                               112456677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +||.+||+.||.+|||+.+++++.|+.
T Consensus       317 ~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          317 RIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            999999999999999999999998773

>3op5_A Serine/threonine-protein kinase VRK1; adenosine triphosphate, amino acid sequence, binding sites, domain, models, molecular; HET: REB; 2.40A {Homo sapiens} PDB: 2lav_A 2kty_A 2kul_A

Probab=100.00  E-value=8.1e-37  Score=298.16  Aligned_cols=224  Identities=17%  Similarity=0.145  Sum_probs=171.5

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      ...+|+..++.++||||+++++++......    ....|||||||+++|.+++......+++..++.++.||+.||+|||
T Consensus        94 ~~~~e~~~~~~l~h~~iv~~~~~~~~~~~~----~~~~~lv~e~~g~~L~~~~~~~~~~l~~~~~~~i~~qi~~~l~~lH  169 (364)
T 3op5_A           94 EQIQKWIRTRKLKYLGVPKYWGSGLHDKNG----KSYRFMIMDRFGSDLQKIYEANAKRFSRKTVLQLSLRILDILEYIH  169 (364)
T ss_dssp             HHHHHHHHHTTCSCCCSCCEEEEEEEEETT----EEEEEEEEECEEEEHHHHHHHTTSCCCHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHhhccCCCCCeEEeeeeeccCC----cceEEEEEeCCCCCHHHHHHhccCCCCHHHHHHHHHHHHHHHHHHH
Confidence            455666677778899999999999875321    2568999999988999999886678999999999999999999999


Q ss_pred             hCCeeccCCCCCcEEEe--cCCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          89 SNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~--~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ++||+||||||+|||++  .++.+||+|||+++.+........   .......||+.|+|||++.+.. ++.++||||||
T Consensus       170 ~~~iiHrDlkp~Nill~~~~~~~~kl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  248 (364)
T 3op5_A          170 EHEYVHGDIKASNLLLNYKNPDQVYLVDYGLAYRYCPEGVHKAYAADPKRCHDGTIEFTSIDAHNGVA-PSRRGDLEILG  248 (364)
T ss_dssp             HTTEECCCCCGGGEEEESSCTTCEEECCCTTCEESSGGGCCCCSSCCSSCCCCCCTTTCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             HCCeEEecCCHHHEEEecCCCCeEEEEECCcceecccCCcccccccCcccccCCCCCccCHHHhCCCC-CCchhhHHHHH
Confidence            99999999999999999  889999999999987654322111   1123456899999999998765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|..||.+...............                     ...........+.....+.++.+||..||
T Consensus       249 ~~l~el~~g~~Pf~~~~~~~~~~~~~~~~~---------------------~~~~~~~~~~~~~~~~~~~~~~~li~~cl  307 (364)
T 3op5_A          249 YCMIQWLTGHLPWEDNLKDPKYVRDSKIRY---------------------RENIASLMDKCFPAANAPGEIAKYMETVK  307 (364)
T ss_dssp             HHHHHHHHSCCTTGGGTTCHHHHHHHHHHH---------------------HHCHHHHHHHHSCTTCCCHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCccccccCHHHHHHHHHHh---------------------hhhHHHHHHHhcccccCHHHHHHHHHHHh
Confidence            999999999999986433222221111000                     00001111122222345788899999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+||+++++++
T Consensus       308 ~~~p~~RP~~~~l~~  322 (364)
T 3op5_A          308 LLDYTEKPLYENLRD  322 (364)
T ss_dssp             TCCTTCCCCHHHHHH
T ss_pred             cCCCCCCCCHHHHHH
Confidence            999999999999985

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=100.00  E-value=4.9e-37  Score=291.03  Aligned_cols=212  Identities=22%  Similarity=0.296  Sum_probs=172.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.++++++||||+++++++...       .+..|+||||+.+ +|.+++......+++..++.++.||+.||+|
T Consensus        71 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~ql~~~l~~  143 (298)
T 3f66_A           71 SQFLTEGIIMKDFSHPNVLSLLGICLRS-------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKY  143 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCS-------SSCCEEEEECCTTCBHHHHHHCTTCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeeEEEcC-------CCceEEEEeCCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999987654       2568999999986 8999998767779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++..................+|+.|+|||++.+.. ++.++|||||||++
T Consensus       144 lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  222 (298)
T 3f66_A          144 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEYYSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  222 (298)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTCCEEECSCGGGCCCSCGGGCBC-----CCBCGGGSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCccCCCCchheEEECCCCCEEECcccccccccccchhccccccCCCCCccccChHHhcCCC-CChHHHHHHHHHHH
Confidence            99999999999999999999999999999999876543332223334556788999999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++ |.+||.+....+....+........                               +...+..+.++|.+||..
T Consensus       223 ~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~  271 (298)
T 3f66_A          223 WELMTRGAPPYPDVNTFDITVYLLQGRRLLQ-------------------------------PEYCPDPLYEVMLKCWHP  271 (298)
T ss_dssp             HHHHTTSCCSSTTSCTTTHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCccCCHHHHHHHHhcCCCCCC-------------------------------CccCCHHHHHHHHHHcCC
Confidence            99999 7788887766655544433211111                               112456678999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||++++++
T Consensus       272 ~p~~Rps~~ell~  284 (298)
T 3f66_A          272 KAEMRPSFSELVS  284 (298)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=100.00  E-value=3.8e-37  Score=295.27  Aligned_cols=222  Identities=20%  Similarity=0.270  Sum_probs=163.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-----CCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-----VKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-----~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.++||||+++++++......  ......++||||+.+ +|.+++....     ..+++..++.++.||+
T Consensus        70 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~~--~~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  147 (323)
T 3qup_A           70 EEFLREAACMKEFDHPHVAKLVGVSLRSRAK--GRLPIPMVILPFMKHGDLHAFLLASRIGENPFNLPLQTLVRFMVDIA  147 (323)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCCCEEEECC---------CEEEEEECCTTCBHHHHHHHHHC---CCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCceehhhceeeccccc--cCCCccEEEEEeccCCcHHHHHHhhhccccccccCHHHHHHHHHHHH
Confidence            5688999999999999999999999876321  111234999999986 8888875432     2489999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||+|||++||+||||||+|||++.++.+||+|||++........  ........+++.|+|||++.+.. ++.++||||
T Consensus       148 ~al~~LH~~~ivH~Dikp~NIli~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  224 (323)
T 3qup_A          148 CGMEYLSSRNFIHRDLAARNCMLAEDMTVCVADFGLSRKIYSGDY--YRQGCASKLPVKWLALESLADNL-YTVHSDVWA  224 (323)
T ss_dssp             HHHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------------CCGGGCCHHHHHHCC-CCHHHHHHH
T ss_pred             HHHHHHHcCCcccCCCCcceEEEcCCCCEEEeecccccccccccc--ccccccccCcccccCchhhcCCC-CCCccchhh
Confidence            999999999999999999999999999999999999987643221  11222345578899999987765 799999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |||++|+|++ |.+||.+....+....+........                               +...+.++.+||.
T Consensus       225 lG~il~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~  273 (323)
T 3qup_A          225 FGVTMWEIMTRGQTPYAGIENAEIYNYLIGGNRLKQ-------------------------------PPECMEEVYDLMY  273 (323)
T ss_dssp             HHHHHHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCCccccChHHHHHHHhcCCCCCC-------------------------------CCccCHHHHHHHH
Confidence            9999999999 9999998877666555432111100                               1124567889999


Q ss_pred             hhcccCCCCCCC-------HHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFD-------SDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t-------~~e~L~h~~~~~~  265 (433)
                      +||..||.+|||       +++++.|+|+...
T Consensus       274 ~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~~  305 (323)
T 3qup_A          274 QCWSADPKQRPSFTCLRMELENILGHLSVLST  305 (323)
T ss_dssp             HTTCSSGGGSCCHHHHHHHHHHHHHC------
T ss_pred             HHccCChhhCcCHHHHHHHHHHHHHHhhhcCC
Confidence            999999999999       7889999999653

>2izr_A Casein kinase I isoform gamma-3; serine/threonine-protein kinase, transferase, ATP- binding, phosphorylation, nucleotide-binding; HET: BRK; 1.3A {Homo sapiens} PDB: 2izs_A* 2izt_A* 2izu_A* 2chl_A* 2c47_A* 2cmw_A*

Probab=100.00  E-value=1.4e-36  Score=292.49  Aligned_cols=215  Identities=20%  Similarity=0.218  Sum_probs=172.4

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.+ +||||+++++++...        ...|+||||++++|.+++......+++..++.++.||+.||+
T Consensus        48 ~~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~  119 (330)
T 2izr_A           48 APQLHLEYRFYKQLGSGDGIPQVYYFGPCG--------KYNAMVLELLGPSLEDLFDLCDRTFSLKTVLMIAIQLISRME  119 (330)
T ss_dssp             SCCHHHHHHHHHHHCSCTTSCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHhhCCCCCCEEEEEEecC--------CccEEEEEeCCCCHHHHHHHcCCCCCHHHHHHHHHHHHHHHH
Confidence            45789999999999 899999999999875        668999999988999999876678999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCc-----EEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGI-----LKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~-----~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      |||++||+||||||+|||++.++.     +||+|||++..+........   .......||+.|+|||++.+.. ++.++
T Consensus       120 ~LH~~~iiHrDlkp~Nill~~~~~~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~  198 (330)
T 2izr_A          120 YVHSKNLIYRDVKPENFLIGRPGNKTQQVIHIIDFALAKEYIDPETKKHIPYREHKSLTGTARYMSINTHLGKE-QSRRD  198 (330)
T ss_dssp             HHHHTTEECCCCCGGGEEECCGGGTCTTSEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHH
T ss_pred             HHHhCCeeccCCCHHHeeeccCCCCCCceEEEEEcccceeeecCCCCccccccccCCcCCCccccChHHHcCCC-CCchh
Confidence            999999999999999999998887     99999999987654322211   1234568899999999998765 79999


Q ss_pred             hhhhHHHHHHHHHhcCCCCCCCChH---HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         158 DLWGAGCIMAEMWTRSPIMQGNTEQ---QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       158 DiwSlGvil~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      |||||||++|+|++|.+||.+....   +....+.......                   +      . ..+.  ...++
T Consensus       199 Di~slG~il~ell~g~~Pf~~~~~~~~~~~~~~i~~~~~~~-------------------~------~-~~~~--~~~p~  250 (330)
T 2izr_A          199 DLEALGHMFMYFLRGSLPWQGLKADTLKERYQKIGDTKRAT-------------------P------I-EVLC--ENFPE  250 (330)
T ss_dssp             HHHHHHHHHHHHHHSSCTTTTCCCSSHHHHHHHHHHHHHHS-------------------C------H-HHHT--TTCHH
T ss_pred             HHHHHHHHHHHHhcCCCCccccccccHHHHHHHHHhhhccC-------------------C------H-HHHh--ccChH
Confidence            9999999999999999999985433   2222222111000                   0      0 0000  01227


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +.++|.+||..||.+||+++++++
T Consensus       251 ~~~li~~~l~~~p~~RP~~~~l~~  274 (330)
T 2izr_A          251 MATYLRYVRRLDFFEKPDYDYLRK  274 (330)
T ss_dssp             HHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhCCCCCCCCHHHHHH
Confidence            789999999999999999999885

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=100.00  E-value=4.6e-37  Score=288.92  Aligned_cols=208  Identities=23%  Similarity=0.342  Sum_probs=161.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..         +.+|+||||+.+ +|.+++......+++..++.++.|++.||.|
T Consensus        61 ~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  131 (281)
T 1mp8_A           61 EKFLQEALTMRQFDHPHIVKLIGVITE---------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY  131 (281)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS---------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCccceEEEEEcc---------CccEEEEecCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999843         447999999985 8999988766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........   .......+++.|+|||++.+.. ++.++|||||||++
T Consensus       132 lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  207 (281)
T 1mp8_A          132 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  207 (281)
T ss_dssp             HHHTTCCCSCCSGGGEEEEETTEEEECC----------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHH
T ss_pred             HHhCCeecccccHHHEEECCCCCEEECccccccccCcccc---cccccCCCcccccChhhcccCC-CCCccCchHHHHHH
Confidence            9999999999999999999999999999999987653221   1223345678899999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||.+....+....+.......                               .+...+..+.++|.+||..
T Consensus       208 ~ell~~g~~pf~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~  256 (281)
T 1mp8_A          208 WEILMHGVKPFQGVKNNDVIGRIENGERLP-------------------------------MPPNCPPTLYSLMTKCWAY  256 (281)
T ss_dssp             HHHHTTSCCTTTTCCGGGHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhcCCCCCCcCCHHHHHHHHHcCCCCC-------------------------------CCCCCCHHHHHHHHHHccC
Confidence            99996 999999887766655553311100                               0112466778999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||.+|||+.+++++
T Consensus       257 ~p~~Rps~~~l~~~  270 (281)
T 1mp8_A          257 DPSRRPRFTELKAQ  270 (281)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999863

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.2e-36  Score=298.90  Aligned_cols=210  Identities=23%  Similarity=0.421  Sum_probs=174.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+++++.+ +|||||++++++...        +.+|+||||+.+ +|.+++....               ..+++
T Consensus       119 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  190 (382)
T 3tt0_A          119 SDLISEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS  190 (382)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHTCCSSSSSCCCCCSSCCCCCCH
T ss_pred             HHHHHHHHHHHHhcCCchhhhheeeeccC--------CceEEEEEecCCCcHHHHHHHhcccccccccccccccccccCH
Confidence            4578999999999 899999999999875        558999999975 8999987653               34899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ........+|..|+|||++.+.
T Consensus       191 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~DFG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~  268 (382)
T 3tt0_A          191 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDR  268 (382)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECTTCCEEECSCSCCCCSSCCCT--TCCCTTCCCGGGGSCHHHHHSC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCEecCCCCcceEEEcCCCcEEEcccCcccccccccc--cccccCCCCCcceeCHHHhcCC
Confidence            99999999999999999999999999999999999999999999999987653221  1223445678899999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++++|++ |..||.+....+....+........                               +.
T Consensus       269 ~-~~~~~DiwslG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~  316 (382)
T 3tt0_A          269 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK-------------------------------PS  316 (382)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CS
T ss_pred             C-CCchhHHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------Cc
Confidence            5 7999999999999999999 9999999887766555543211100                               11


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.+||.+||..||.+|||++|++++
T Consensus       317 ~~~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          317 NCTNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            246678899999999999999999999975

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=100.00  E-value=5.1e-37  Score=298.70  Aligned_cols=212  Identities=22%  Similarity=0.384  Sum_probs=170.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-------------------
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-------------------   66 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-------------------   66 (433)
                      ..+++|+.+|+.+ +|||||++++++...       ...+++|||||.+ +|.+++.....                   
T Consensus        70 ~~~~~E~~~l~~l~~hpniv~~~~~~~~~-------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  142 (359)
T 3vhe_A           70 RALMSELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKTKGARFRQGKDYV  142 (359)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECST-------TSCCEEEEECCTTEEHHHHHHTTTTSBCSCC-------------
T ss_pred             HHHHHHHHHHHhhcCCcceeeeeeeeecC-------CCceEEEEEecCCCcHHHHHHhccccccccccccchhhcccccc
Confidence            4588999999999 799999999999765       2458999999975 89988876432                   


Q ss_pred             ----------------------------------------------CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCC
Q psy7889          67 ----------------------------------------------KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAA  100 (433)
Q Consensus        67 ----------------------------------------------~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~  100 (433)
                                                                    .+++..++.++.||+.||+|||++||+||||||+
T Consensus       143 ~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~ql~~aL~~LH~~~ivH~Dikp~  222 (359)
T 3vhe_A          143 GAIPVDLKRRLDSITSSQSSASSGFVEEKSLSDVEEEEAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAAR  222 (359)
T ss_dssp             -----------------------------------------CTTTTCBCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGG
T ss_pred             cccchhhhccccccCccccccccccccccccchhhhcccccchhccccCHHHHHHHHHHHHHHHHHHHHCCcccCCCChh
Confidence                                                          1899999999999999999999999999999999


Q ss_pred             cEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCC
Q psy7889         101 NVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGN  179 (433)
Q Consensus       101 NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~  179 (433)
                      |||++.++.+||+|||++........  ........||+.|+|||++.+.. ++.++|||||||++|+|++ |.+||.+.
T Consensus       223 NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~il~ellt~g~~p~~~~  299 (359)
T 3vhe_A          223 NILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDRV-YTIQSDVWSFGVLLWEIFSLGASPYPGV  299 (359)
T ss_dssp             GEEECGGGCEEECCCGGGSCTTSCTT--CEEC--CEECGGGCCHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTC
T ss_pred             hEEEcCCCcEEEEeccceeeeccccc--chhccccCCCceeEChhhhcCCC-CCchhhhhhHHHHHHHHHhcCCCCCCcc
Confidence            99999999999999999987643321  12234456788999999997655 7999999999999999998 99999987


Q ss_pred             ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       180 ~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ...+.+...........                              .+...++++.++|.+||..||.+|||++|+++|
T Consensus       300 ~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          300 KIDEEFCRRLKEGTRMR------------------------------APDYTTPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CCSHHHHHHHHHTCCCC------------------------------CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             chhHHHHHHHHcCCCCC------------------------------CCCCCCHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            65444333322111110                              011246778899999999999999999999976

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.8e-36  Score=286.88  Aligned_cols=212  Identities=21%  Similarity=0.265  Sum_probs=172.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+++.++||||+++++++.+.       ....++||||+. ++|.+++......+++..++.++.|++.||+|
T Consensus        67 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------~~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  139 (298)
T 3pls_A           67 EAFLREGLLMRGLNHPNVLALIGIMLPP-------EGLPHVLLPYMCHGDLLQFIRSPQRNPTVKDLISFGLQVARGMEY  139 (298)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEECCS-------SSCCEEEECCCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEecC-------CCCcEEEEecccCCCHHHHHhccccCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999765       234589999985 68999998767779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++..................++..|+|||++.+.. ++.++|||||||++
T Consensus       140 LH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  218 (298)
T 3pls_A          140 LAEQKFVHRDLAARNCMLDESFTVKVADFGLARDILDREYYSVQQHRHARLPVKWTALESLQTYR-FTTKSDVWSFGVLL  218 (298)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTCCEEECCTTSSCTTTTGGGGCSCCSSCTTCGGGGSCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCcccCCCCcceEEEcCCCcEEeCcCCCcccccCCcccccccCcCCCCCccccChhhhccCC-CChhhchhhHHHHH
Confidence            99999999999999999999999999999999876543322223334556788999999997765 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ +.+||.+.+..+....+........                               +...+..+.++|.+||..
T Consensus       219 ~~l~~g~~~~~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~  267 (298)
T 3pls_A          219 WELLTRGAPPYRHIDPFDLTHFLAQGRRLPQ-------------------------------PEYCPDSLYQVMQQCWEA  267 (298)
T ss_dssp             HHHHHTSCCTTTTSCGGGHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHhhCCCCCCccCCHHHHHHHhhcCCCCCC-------------------------------CccchHHHHHHHHHHccC
Confidence            99999 6677777666555544433221111                               112456778999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||++++++
T Consensus       268 ~p~~Rps~~~ll~  280 (298)
T 3pls_A          268 DPAVRPTFRVLVG  280 (298)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=100.00  E-value=4.7e-37  Score=295.15  Aligned_cols=209  Identities=19%  Similarity=0.271  Sum_probs=170.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+         ..+++||||+. ++|.+.+......+++..++.++.||+.||+|
T Consensus        60 ~~~~~e~~~l~~l~h~~iv~~~~~~~~---------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  130 (325)
T 3kex_A           60 QAVTDHMLAIGSLDHAHIVRLLGLCPG---------SSLQLVTQYLPLGSLLDHVRQHRGALGPQLLLNWGVQIAKGMYY  130 (325)
T ss_dssp             CSCCHHHHHHHTCCCTTBCCEEEEECB---------SSEEEEEECCTTCBSHHHHHSSGGGSCTTHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcCeEEEEEcC---------CccEEEEEeCCCCCHHHHHHHccccCCHHHHHHHHHHHHHHHHH
Confidence            567889999999999999999998853         44899999997 58998888766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++........  ........+|..|+|||++.+.. ++.++|||||||++
T Consensus       131 lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  207 (325)
T 3kex_A          131 LEEHGMVHRNLAARNVLLKSPSQVQVADFGVADLLPPDDK--QLLYSEAKTPIKWMALESIHFGK-YTHQSDVWSYGVTV  207 (325)
T ss_dssp             HHHTTCCCSCCSSTTEEESSSSCEEECSCSGGGGSCCCTT--CCC-----CCTTTSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCCCCCccchheEEECCCCeEEECCCCcccccCcccc--cccccCCCCcccccChHHhccCC-CChhhHhHHhHHHH
Confidence            9999999999999999999999999999999987654322  12234456788999999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||.+....+....+.......                               .+...+.++.++|.+||..
T Consensus       208 ~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~~li~~~l~~  256 (325)
T 3kex_A          208 WELMTFGAEPYAGLRLAEVPDLLEKGERLA-------------------------------QPQICTIDVYMVMVKCWMI  256 (325)
T ss_dssp             HHHHTTSCCTTTTSCTTHHHHHHHTTCBCC-------------------------------CCTTBCTTTTHHHHHHTCS
T ss_pred             HHHHhCCCCCccccCHHHHHHHHHcCCCCC-------------------------------CCCcCcHHHHHHHHHHcCC
Confidence            99999 999999877665554443211110                               0112355667999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||.+|||+.+++++
T Consensus       257 dp~~Rps~~el~~~  270 (325)
T 3kex_A          257 DENIRPTFKELANE  270 (325)
T ss_dssp             CTTTSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999986

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=100.00  E-value=8.8e-37  Score=287.90  Aligned_cols=204  Identities=18%  Similarity=0.272  Sum_probs=167.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+|+.++||||+++++++.+.        +..|+||||+. ++|.+++......+++..++.++.||+.||+
T Consensus        56 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~  127 (289)
T 4fvq_A           56 SESFFEAASMMSKLSHKHLVLNYGVCVCG--------DENILVQEFVKFGSLDTYLKKNKNCINILWKLEVAKQLAAAMH  127 (289)
T ss_dssp             HHHHHHHHHHHHTSCCTTBCCEEEEECCT--------TCCEEEEECCTTCBHHHHHHHTGGGCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEEeC--------CCCEEEEECCCCCCHHHHHHhCCCCCCHHHHHHHHHHHHHHHH
Confidence            46688999999999999999999999875        55799999997 5899999876656999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCc--------EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGI--------LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~--------~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      |||++||+||||||+|||++.++.        +||+|||++......        ....+|..|+|||++.+...++.++
T Consensus       128 ~LH~~~ivH~Dlkp~NIll~~~~~~~~~~~~~~kl~Dfg~~~~~~~~--------~~~~~~~~y~aPE~~~~~~~~~~~~  199 (289)
T 4fvq_A          128 FLEENTLIHGNVCAKNILLIREEDRKTGNPPFIKLSDPGISITVLPK--------DILQERIPWVPPECIENPKNLNLAT  199 (289)
T ss_dssp             HHHHTTCCCCCCCGGGEEEEECCBGGGTBCCEEEECCCCSCTTTSCH--------HHHHHTTTTSCHHHHHCGGGCCHHH
T ss_pred             HHhhCCeECCCcCcceEEEecCCcccccccceeeeccCcccccccCc--------cccCCcCcccCHHHhCCCCCCCchh
Confidence            999999999999999999998886        999999998665321        2235688899999998755589999


Q ss_pred             hhhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++|+|++| .+||.............. ....                                +...+.++.
T Consensus       200 DiwslG~il~el~~g~~~~~~~~~~~~~~~~~~~-~~~~--------------------------------~~~~~~~l~  246 (289)
T 4fvq_A          200 DKWSFGTTLWEICSGGDKPLSALDSQRKLQFYED-RHQL--------------------------------PAPKAAELA  246 (289)
T ss_dssp             HHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHT-TCCC--------------------------------CCCSSCTTH
T ss_pred             HHHHHHHHHHHHHcCCCCCccccchHHHHHHhhc-cCCC--------------------------------CCCCCHHHH
Confidence            999999999999995 566666554443332211 1100                                112356677


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +||.+||+.||.+|||+.++++|
T Consensus       247 ~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          247 NLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHcCCChhHCcCHHHHHHH
Confidence            99999999999999999999976

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=100.00  E-value=6.3e-36  Score=283.20  Aligned_cols=217  Identities=20%  Similarity=0.161  Sum_probs=174.1

Q ss_pred             CchhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+.+|+.+++.+ +|+||+++++++...        ...|+||||++++|.+++......+++..++.++.||+.||
T Consensus        48 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~l  119 (298)
T 1csn_A           48 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--------LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV  119 (298)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHH
T ss_pred             ccHHHHHHHHHHHHHhcCCCCCeEEeecCCC--------ceeEEEEEecCCCHHHHHHHhccCCCHHHHHHHHHHHHHHH
Confidence            456789999999999 799999999999765        66999999998899999987666799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCc-----EEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCc
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGI-----LKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~-----~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +|||++||+||||||+||+++.++.     +||+|||++...........   .......||+.|+|||++.+.. ++.+
T Consensus       120 ~~lH~~~ivH~Dlkp~NIl~~~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~  198 (298)
T 1csn_A          120 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRR  198 (298)
T ss_dssp             HHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHH
T ss_pred             HHHHhCCEecCCCCHHHEEeccCCCCCCCeEEEEECccccccccccccccccccCccCCCCCcccCCchhhcCCC-CChH
Confidence            9999999999999999999987765     99999999987754332211   1234567899999999997765 7999


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCC---hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNT---EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~---~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      +|||||||++|+|++|..||.+..   .......+.......                         .....  ....+.
T Consensus       199 ~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~-------------------------~~~~~--~~~~~~  251 (298)
T 1csn_A          199 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQST-------------------------PLREL--CAGFPE  251 (298)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHHHS-------------------------CHHHH--TTTSCH
T ss_pred             HHHHHHHHHHHHHHcCCCCcchhhccccHHHHHHHHhhccCc-------------------------cHHHH--HhhCcH
Confidence            999999999999999999998843   233333222211000                         00000  113567


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++.++|.+||..||.+||+++++++
T Consensus       252 ~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          252 EFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             HHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHhcCCcccCCCHHHHHH
Confidence            8889999999999999999999985

>3c1x_A Hepatocyte growth factor receptor; receptor tyrosine kinase, signal transduction, GRB2, SHC, ATP-binding, glycoprotein, membrane; HET: CKK; 2.17A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.8e-37  Score=301.25  Aligned_cols=213  Identities=21%  Similarity=0.297  Sum_probs=162.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++|||||++++++...       .+..|+||||+.+ +|.+++.+....+++..++.++.||+.||+|
T Consensus       135 ~~~~~E~~il~~l~hpnIv~~~~~~~~~-------~~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  207 (373)
T 3c1x_A          135 SQFLTEGIIMKDFSHPNVLSLLGICLRS-------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF  207 (373)
T ss_dssp             HHHHHHHTTSTTCCCTTBCCCCEEECCC-------SSCCEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcceEEEEEEcC-------CCCeEEEEECCCCCCHHHHHhhcccCCCHHHHHHHHHHHHHHHHH
Confidence            5688999999999999999999987654       2457999999975 8999998777778999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.................+|..|+|||++.+.. ++.++|||||||++
T Consensus       208 LH~~~ivHrDlkp~NIll~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwSlG~il  286 (373)
T 3c1x_A          208 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  286 (373)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCC---------------------CCGGGSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HHHCCEecCccchheEEECCCCCEEEeeccccccccccccccccccCCCCCcccccChHHhcCCC-CCcHHHHHHHHHHH
Confidence            99999999999999999999999999999999876433222212223445678899999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||.+....+....+.......                               .+...+..+.++|.+||..
T Consensus       287 ~ellt~~~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~p~~~~~~l~~li~~cl~~  335 (373)
T 3c1x_A          287 WELMTRGAPPYPDVNTFDITVYLLQGRRLL-------------------------------QPEYCPDPLYEVMLKCWHP  335 (373)
T ss_dssp             HHHHTTSCCSCTTSCSSCHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhCcCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCCCCHHHHHHHHHHcCC
Confidence            99999 788998766554444332211100                               1112456777999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||.+|||+.+++++
T Consensus       336 dp~~RPs~~ell~~  349 (373)
T 3c1x_A          336 KAEMRPSFSELVSR  349 (373)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=100.00  E-value=1.2e-36  Score=290.24  Aligned_cols=210  Identities=20%  Similarity=0.364  Sum_probs=171.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC--------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV--------------------   66 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~--------------------   66 (433)
                      ..+.+|+++|+.++||||+++++++.+.        +.+|+||||+. ++|.+++.....                    
T Consensus        71 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  142 (314)
T 2ivs_A           71 RDLLSEFNVLKQVNHPHVIKLYGACSQD--------GPLLLIVEYAKYGSLRGFLRESRKVGPGYLGSGGSRNSSSLDHP  142 (314)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHTTTSTTEEC--------------
T ss_pred             HHHHHHHHHHhhCCCCceeeEEEEEecC--------CceEEEEeecCCCCHHHHHHHHhhccCCcccccccccccccccc
Confidence            4678899999999999999999999775        55899999997 689998876432                    


Q ss_pred             ---CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccC
Q psy7889          67 ---KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRP  143 (433)
Q Consensus        67 ---~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~a  143 (433)
                         .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|
T Consensus       143 ~~~~~~~~~~~~i~~qi~~~l~~lH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~a  220 (314)
T 2ivs_A          143 DERALTMGDLISFAWQISQGMQYLAEMKLVHRDLAARNILVAEGRKMKISDFGLSRDVYEEDS--YVKRSQGRIPVKWMA  220 (314)
T ss_dssp             --CEECHHHHHHHHHHHHHHHHHHHHTTEECCCCSGGGEEEETTTEEEECCCTTCEECTTTSC--EECSSCCCSCGGGCC
T ss_pred             cccCcCHHHHHHHHHHHHHHHHHHHHCCCcccccchheEEEcCCCCEEEcccccccccccccc--ceeccCCCCcccccC
Confidence               389999999999999999999999999999999999999999999999999977643221  122334556888999


Q ss_pred             cccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         144 PELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       144 PE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      ||++.+.. ++.++|||||||++|+|++ |.+||.+.........+.......                           
T Consensus       221 PE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------  272 (314)
T 2ivs_A          221 IESLFDHI-YTTQSDVWSFGVLLWEIVTLGGNPYPGIPPERLFNLLKTGHRME---------------------------  272 (314)
T ss_dssp             HHHHHHCE-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC---------------------------
T ss_pred             hhhhcCCC-cCchhhHHHHHHHHHHHHhCCCCCCCCCCHHHHHHHhhcCCcCC---------------------------
Confidence            99997654 7999999999999999999 999999877665544443211100                           


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                          .+...+.++.++|.+||..||.+|||+.+++++
T Consensus       273 ----~~~~~~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          273 ----RPDNCSEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCccCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence                011256778899999999999999999999864

>4eqm_A Protein kinase; transferase; HET: ANP; 3.00A {Staphylococcus aureus subsp}

Probab=100.00  E-value=7.3e-37  Score=289.64  Aligned_cols=215  Identities=25%  Similarity=0.363  Sum_probs=168.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+.+ +|.+++... ..+++..++.++.||+.||+|
T Consensus        56 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~~-~~~~~~~~~~~~~qi~~~l~~  126 (294)
T 4eqm_A           56 KRFEREVHNSSQLSHQNIVSMIDVDEED--------DCYYLVMEYIEGPTLSEYIESH-GPLSVDTAINFTNQILDGIKH  126 (294)
T ss_dssp             HHHHHHHHHHTTCCBTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCceEEEeeeeC--------CeEEEEEeCCCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999875        669999999975 888888664 469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........   .......||+.|+|||++.+.. ++.++|||||||++
T Consensus       127 lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG~~l  202 (294)
T 4eqm_A          127 AHDMRIVHRDIKPQNILIDSNKTLKIFDFGIAKALSETSL---TQTNHVLGTVQYFSPEQAKGEA-TDECTDIYSIGIVL  202 (294)
T ss_dssp             HHHTTCCCCCCCGGGEEECTTSCEEECCCSSSTTC----------------CCSSCCHHHHHTCC-CCTTHHHHHHHHHH
T ss_pred             HHHCCcccCCCCHHHEEECCCCCEEEEeCCCccccccccc---cccCccccCccccCHhHhcCCC-CCchHhHHHHHHHH
Confidence            9999999999999999999999999999999987653221   2233457899999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+............  ...+.     .                    ........+..+.++|.+||..|
T Consensus       203 ~~ll~g~~pf~~~~~~~~~~~~~~--~~~~~-----~--------------------~~~~~~~~~~~l~~li~~~l~~d  255 (294)
T 4eqm_A          203 YEMLVGEPPFNGETAVSIAIKHIQ--DSVPN-----V--------------------TTDVRKDIPQSLSNVILRATEKD  255 (294)
T ss_dssp             HHHHHSSCSSCSSCHHHHHHHHHS--SCCCC-----H--------------------HHHSCTTSCHHHHHHHHHHSCSS
T ss_pred             HHHHhCCCCCCCCChHHHHHHHhh--ccCCC-----c--------------------chhcccCCCHHHHHHHHHHhcCC
Confidence            999999999999877655433321  11100     0                    00001125677889999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||+..+.+.+.|.
T Consensus       256 p~~R~~~~~~l~~~l~  271 (294)
T 4eqm_A          256 KANRYKTIQEMKDDLS  271 (294)
T ss_dssp             GGGSCSSHHHHHHHHH
T ss_pred             HhHccccHHHHHHHHH
Confidence            9999977777666654

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=100.00  E-value=4.1e-36  Score=287.15  Aligned_cols=211  Identities=19%  Similarity=0.274  Sum_probs=160.8

Q ss_pred             HHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHhC-
Q psy7889          12 REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN-   90 (433)
Q Consensus        12 ~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~~-   90 (433)
                      ++..+++.++||||+++++++...        +.+|+||||+++.+..+.......+++..++.++.||+.||.|||++ 
T Consensus        73 ~~~~~~~~~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~~~l~~~~~~~~~~~~~~~~~~~i~~~l~~lH~~~  144 (318)
T 2dyl_A           73 DLDVVLKSHDCPYIVQCFGTFITN--------TDVFIAMELMGTCAEKLKKRMQGPIPERILGKMTVAIVKALYYLKEKH  144 (318)
T ss_dssp             HHHHHHHTTTCTTBCCEEEEEECS--------SEEEEEECCCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHhcCCCceeeEEEEEecC--------CcEEEEEeccCCcHHHHHHHhccCCCHHHHHHHHHHHHHHHHHHHhhC
Confidence            344567788999999999999875        66999999997767666666566799999999999999999999995 


Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhhHHHHH
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwSlGvil  166 (433)
                      ||+|+||||+||+++.++.+||+|||++.......     ......+|+.|+|||++.+    ...++.++|||||||++
T Consensus       145 ~i~H~dlkp~Nil~~~~~~~kl~dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~~~~~~~~~~~Di~slG~il  219 (318)
T 2dyl_A          145 GVIHRDVKPSNILLDERGQIKLCDFGISGRLVDDK-----AKDRSAGCAAYMAPERIDPPDPTKPDYDIRADVWSLGISL  219 (318)
T ss_dssp             CCCCCCCCGGGEEECTTSCEEECCCTTC-------------------CCTTCCHHHHC--------CCTHHHHHHHHHHH
T ss_pred             CEEeCCCCHHHEEECCCCCEEEEECCCchhccCCc-----cccccCCCccccChhhcccccccccCCccccchhhHHHHH
Confidence            99999999999999999999999999997664322     1234568999999999852    33478899999999999


Q ss_pred             HHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|..||... ...+.+..+.......    ++                         .....+.++.+||.+||..
T Consensus       220 ~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~----~~-------------------------~~~~~~~~l~~li~~~l~~  270 (318)
T 2dyl_A          220 VELATGQFPYKNCKTDFEVLTKVLQEEPPL----LP-------------------------GHMGFSGDFQSFVKDCLTK  270 (318)
T ss_dssp             HHHHHSSCTTTTCCSHHHHHHHHHHSCCCC----CC-------------------------SSSCCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCCccHHHHHHHhccCCCC----CC-------------------------ccCCCCHHHHHHHHHHccC
Confidence            9999999999874 4444444443311100    00                         0012467788999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||.+|||++++++||||..
T Consensus       271 dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          271 DHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CTTTSCCHHHHTTSHHHHH
T ss_pred             ChhHCcCHHHHhhCHHHHh
Confidence            9999999999999999964

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=100.00  E-value=3.2e-36  Score=287.66  Aligned_cols=219  Identities=26%  Similarity=0.363  Sum_probs=167.3

Q ss_pred             hhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++  ||||+++++++...        ..+|+|||+.+++|.+++... ..+++..++.++.||+.||.
T Consensus        71 ~~~~~E~~~l~~l~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~aL~  141 (313)
T 3cek_A           71 DSYRNEIAYLNKLQQHSDKIIRLYDYEITD--------QYIYMVMECGNIDLNSWLKKK-KSIDPWERKSYWKNMLEAVH  141 (313)
T ss_dssp             HHHHHHHHHHHHHGGGCTTBCCEEEEEECS--------SEEEEEECCCSEEHHHHHHHC-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhccccCCceEEEEEEeecC--------CEEEEEEecCCCcHHHHHHhc-CCCCHHHHHHHHHHHHHHHH
Confidence            56789999999996  59999999999875        569999998888999998764 46899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC----------CCCCC
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD----------RNYGP  155 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~----------~~~~~  155 (433)
                      |||++||+||||||+||+++ ++.+||+|||++........  ........||+.|+|||++.+.          ..++.
T Consensus       142 ~LH~~~ivH~dlkp~NIl~~-~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~~~~~~  218 (313)
T 3cek_A          142 TIHQHGIVHSDLKPANFLIV-DGMLKLIDFGIANQMQPDTT--SVVKDSQVGTVNYMPPEAIKDMSSSRENGKSKSKISP  218 (313)
T ss_dssp             HHHHTTCCCCCCCGGGEEEE-TTEEEECCCSSSCC----------------CCGGGCCHHHHTTCC----------CCCH
T ss_pred             HHHHCCceecCCCcccEEEE-CCeEEEeeccccccccCccc--cccccCCCCCCCcCCHHHHhhcccccccccccccCCc
Confidence            99999999999999999996 48999999999987653221  1122345789999999998652          24788


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|||||||++|+|++|..||........  .+...........+                           +...+.++
T Consensus       219 ~~Di~slG~il~el~~g~~pf~~~~~~~~--~~~~~~~~~~~~~~---------------------------~~~~~~~l  269 (313)
T 3cek_A          219 KSDVWSLGCILYYMTYGKTPFQQIINQIS--KLHAIIDPNHEIEF---------------------------PDIPEKDL  269 (313)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTTTCCSHHH--HHHHHHCTTSCCCC---------------------------CCCSCHHH
T ss_pred             hHHHHHHHHHHHHHHhCCCchhhHHHHHH--HHHHHHhcccccCC---------------------------cccchHHH
Confidence            99999999999999999999987543321  11122211110000                           11235677


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcCCCccCCCC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  267 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~~  267 (433)
                      .+||.+||..||.+|||+.|+|+||||.....
T Consensus       270 ~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~  301 (313)
T 3cek_A          270 QDVLKCCLKRDPKQRISIPELLAHPYVQIQTH  301 (313)
T ss_dssp             HHHHHHHTCSSTTTSCCHHHHHTSHHHHCC--
T ss_pred             HHHHHHHccCCcccCcCHHHHhcCccccCCCC
Confidence            89999999999999999999999999976543

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=100.00  E-value=5.5e-36  Score=290.14  Aligned_cols=222  Identities=19%  Similarity=0.138  Sum_probs=172.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+.+|+.+++.++||||+++++++.....    ....+|+||||++++|.+++.... .+++..++.++.||+.||+||
T Consensus        93 ~~~~~e~~~~~~l~h~ni~~~~~~~~~~~~----~~~~~~lv~e~~~~~L~~~l~~~~-~~~~~~~~~i~~qi~~aL~~L  167 (345)
T 2v62_A           93 KDCIKKWIERKQLDYLGIPLFYGSGLTEFK----GRSYRFMVMERLGIDLQKISGQNG-TFKKSTVLQLGIRMLDVLEYI  167 (345)
T ss_dssp             HHHHHHHHHHHTCSCCCCCCEEEEEEEESS----SCEEEEEEEECEEEEHHHHCBGGG-BCCHHHHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHhhccccccCcceeecccccccC----CCcEEEEEEeccCCCHHHHHHhcC-CCCHHHHHHHHHHHHHHHHHH
Confidence            456788899999999999999999987421    136799999999889999887644 799999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCC--cEEEeecCCccccccCcCC---ccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          88 HSNKILHRDMKAANVLITKTG--ILKLADFGLARAFSQTKNG---QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~--~~kl~DFg~a~~~~~~~~~---~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |++||+||||||+|||++.++  .+||+|||+++.+......   .........||..|+|||++.+.. ++.++|||||
T Consensus       168 H~~~ivH~Dlkp~NIll~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~sl  246 (345)
T 2v62_A          168 HENEYVHGDIKAANLLLGYKNPDQVYLADYGLSYRYCPNGNHKQYQENPRKGHNGTIEFTSLDAHKGVA-LSRRSDVEIL  246 (345)
T ss_dssp             HHTTEECSCCSGGGEEEESSSTTSEEECCCTTCEESSGGGCCCCCCCCGGGCSCSCTTTCCHHHHHTCC-CCHHHHHHHH
T ss_pred             HhCCeeCCCcCHHHEEEccCCCCcEEEEeCCCceecccccccccchhccccccCCCccccCHHHhcCCC-CCchhhHHHH
Confidence            999999999999999999877  9999999999876533211   111224567899999999998765 7999999999


Q ss_pred             HHHHHHHHhcCCCCCCC--ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         163 GCIMAEMWTRSPIMQGN--TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~--~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||++|+|++|..||.+.  ................                   +    ............+.++.++|.
T Consensus       247 G~il~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~-------------------~----~~~~~~~~~~~~~~~l~~li~  303 (345)
T 2v62_A          247 GYCMLRWLCGKLPWEQNLKDPVAVQTAKTNLLDEL-------------------P----QSVLKWAPSGSSCCEIAQFLV  303 (345)
T ss_dssp             HHHHHHHHHSSCTTGGGTTCHHHHHHHHHHHHHTT-------------------T----HHHHHHSCTTSCCHHHHHHHH
T ss_pred             HHHHHHHHhCCCCccccccccHHHHHHHHhhcccc-------------------c----HHHHhhccccccHHHHHHHHH
Confidence            99999999999999653  2222222111111110                   0    111112222246788999999


Q ss_pred             hhcccCCCCCCCHHHhhc
Q psy7889         241 KLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~  258 (433)
                      +||..||.+||+++++++
T Consensus       304 ~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          304 CAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             HHHTCCTTCCCCHHHHHH
T ss_pred             HHhhcCcccCCCHHHHHH
Confidence            999999999999999985

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=2.1e-36  Score=292.65  Aligned_cols=214  Identities=23%  Similarity=0.373  Sum_probs=172.6

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC------------------
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV------------------   66 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~------------------   66 (433)
                      ...+.+|+.+|+.+ +||||+++++++...        +.+|+||||+++ +|.+++.....                  
T Consensus        92 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  163 (344)
T 1rjb_A           92 REALMSELKMMTQLGSHENIVNLLGACTLS--------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE  163 (344)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHTTTTCC----------------
T ss_pred             HHHHHHHHHHHHhhcCCCCeeeEEEEEeeC--------CccEEEEecCCCCcHHHHHhhccccccccccchhhhcccccc
Confidence            45788999999999 899999999999875        558999999964 99999876543                  


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCccccccc
Q psy7889          67 ----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR  142 (433)
Q Consensus        67 ----~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~  142 (433)
                          .+++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+
T Consensus       164 ~~~~~l~~~~~~~i~~qi~~aL~~LH~~~ivH~Dikp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~  241 (344)
T 1rjb_A          164 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWM  241 (344)
T ss_dssp             -----CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGC
T ss_pred             cccccCCHHHHHHHHHHHHHHHHHHHhCCcccCCCChhhEEEcCCCcEEeCCCccCcccccCcc--ceeccCccCccCcc
Confidence                278999999999999999999999999999999999999999999999999987653321  11223445688899


Q ss_pred             CcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhh
Q psy7889         143 PPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK  221 (433)
Q Consensus       143 aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (433)
                      |||++.+.. ++.++|||||||++|+|++ |.+||.+.........+........                         
T Consensus       242 aPE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------  295 (344)
T 1rjb_A          242 APESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-------------------------  295 (344)
T ss_dssp             CHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-------------------------
T ss_pred             CHHHhccCC-CChhHhHHHHHHHHHHHHcCCCCCcccCCcHHHHHHHHhcCCCCC-------------------------
Confidence            999987655 7999999999999999998 9999988765544433322110000                         


Q ss_pred             HHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCC
Q psy7889         222 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDF  261 (433)
Q Consensus       222 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~  261 (433)
                           .+...+.++.+||.+||..||.+|||+.++++|-.
T Consensus       296 -----~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~~l~  330 (344)
T 1rjb_A          296 -----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSFLG  330 (344)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHHHH
T ss_pred             -----CCCCCCHHHHHHHHHHcCCCchhCcCHHHHHHHHH
Confidence                 01124677889999999999999999999998643

>1luf_A Muscle-specific tyrosine kinase receptor MUSK; phosphorylation, signal transduction, MASS spectrometry, transferase; 2.05A {Rattus norvegicus} SCOP: d.144.1.7

Probab=100.00  E-value=2e-36  Score=292.56  Aligned_cols=210  Identities=21%  Similarity=0.348  Sum_probs=171.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------------   65 (433)
                      ..+.+|+.+|+.++||||+++++++.+.        +.+|+||||+.+ +|.+++....                     
T Consensus        95 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  166 (343)
T 1luf_A           95 ADFQREAALMAEFDNPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP  166 (343)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHTCC--------------------
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEccC--------CceEEEEecCCCCcHHHHHHHhCccccccccccccccccccccc
Confidence            4678999999999999999999999775        558999999975 8999887642                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccC
Q psy7889          66 --VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRP  143 (433)
Q Consensus        66 --~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~a  143 (433)
                        ..+++.+++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|
T Consensus       167 ~~~~l~~~~~~~i~~qi~~~l~~LH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~a  244 (343)
T 1luf_A          167 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSADY--YKADGNDAIPIRWMP  244 (343)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGGC--BC----CCBCGGGCC
T ss_pred             CCCCCCHHHHHHHHHHHHHHHHHHHhCCeecCCCCcceEEECCCCeEEEeecCCCcccccCcc--ccccCCCcccceecC
Confidence              4689999999999999999999999999999999999999999999999999976543211  112234567889999


Q ss_pred             cccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         144 PELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       144 PE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      ||++.+.. ++.++|||||||++|+|++ |..||.+....+....+.......                           
T Consensus       245 PE~~~~~~-~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~---------------------------  296 (343)
T 1luf_A          245 PESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILA---------------------------  296 (343)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCC---------------------------
T ss_pred             hhhhccCC-cCcccccHHHHHHHHHHHhcCCCcCCCCChHHHHHHHhCCCcCC---------------------------
Confidence            99987655 7999999999999999999 999999888776665553311100                           


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                          .+...+.++.++|.+||..||.+|||+.+++++
T Consensus       297 ----~~~~~~~~l~~li~~~l~~~p~~Rps~~~~~~~  329 (343)
T 1luf_A          297 ----CPENCPLELYNLMRLCWSKLPADRPSFCSIHRI  329 (343)
T ss_dssp             ----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ----CCCCCCHHHHHHHHHHcccCcccCCCHHHHHHH
Confidence                011245677899999999999999999999863

>3poz_A Epidermal growth factor receptor; kinase domain, anti-oncogene, ATP-binding, cell cycle, disea mutation, glycoprotein, membrane, nucleotide-binding; HET: 03P; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 2itx_A* 2ity_A* 2j5f_A* 2j6m_A* 2itw_A* 1m14_A 1m17_A* 3vjo_A* 2gs6_A* 2gs2_A* 2rf9_A 4g5j_A* 1xkk_A* 2eb2_A 3gop_A 2eb3_A* 2itn_A* 2ito_A* 2itp_A* 2itq_A* ...

Probab=100.00  E-value=1.9e-36  Score=291.14  Aligned_cols=210  Identities=20%  Similarity=0.271  Sum_probs=170.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+.+|+.++|||||++++++.+.         ..++|++|+. ++|.+++......+++..++.++.||+.||+
T Consensus        61 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~---------~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~  131 (327)
T 3poz_A           61 NKEILDEAYVMASVDNPHVCRLLGICLTS---------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN  131 (327)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCEEEEEESS---------SEEEEEECCTTCBHHHHHHHSTTSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEEEEecC---------CeEEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999863         2678888886 5899999887778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+++.......  ........+|..|+|||++.+.. ++.++|||||||+
T Consensus       132 ~LH~~~ivH~Dikp~NIll~~~~~~kl~Dfg~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i  208 (327)
T 3poz_A          132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  208 (327)
T ss_dssp             HHHHTTCCCSCCCGGGEEEEETTEEEECCTTHHHHHTTTCC---------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHhhCCeeCCCCChheEEECCCCCEEEccCcceeEccCCcc--cccccCCCccccccChHHhccCC-CCchhhhhhhHHH
Confidence            99999999999999999999999999999999987653321  11223445688999999998765 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+........                               +...+.++.+++.+||+
T Consensus       209 l~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~~~li~~~l~  257 (327)
T 3poz_A          209 VWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------------------------PPICTIDVYMIMVKCWM  257 (327)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------------------------CTTBCHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCCccCCCHHHHHHHHHcCCCCCC-------------------------------CccCCHHHHHHHHHHcC
Confidence            999999 9999998776655444432111110                               11245677799999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.+++++
T Consensus       258 ~~p~~Rps~~ell~~  272 (327)
T 3poz_A          258 IDADSRPKFRELIIE  272 (327)
T ss_dssp             SCGGGSCCHHHHHHH
T ss_pred             CChhhCCCHHHHHHH
Confidence            999999999999975

>2qol_A Ephrin receptor; receptor tyrosine kinase, juxtamembrane segment, structural genomics, mutant, structural genomics consortium, SGC, ATP- binding; 1.07A {Homo sapiens} PDB: 2qok_A 2qoi_A 2qoo_A 2qof_A 2qod_A 2qo9_A* 2gsf_A 2qo7_A* 2qo2_A* 2qoq_A* 2qon_A* 3fxx_A* 3fy2_A 2qoc_A* 2qob_A* 3dzq_A* 2r2p_A 2hel_A 2rei_A 3dko_A* ...

Probab=100.00  E-value=1.9e-36  Score=296.43  Aligned_cols=210  Identities=18%  Similarity=0.310  Sum_probs=161.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|++++|||||++++++...        ..+|+||||++ ++|.+++.+....+++..++.++.||+.||+|
T Consensus        91 ~~~~~E~~~l~~l~h~niv~~~~~~~~~--------~~~~lv~e~~~~~sL~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  162 (373)
T 2qol_A           91 RDFLGEASIMGQFDHPNIIRLEGVVTKS--------KPVMIVTEYMENGSLDSFLRKHDAQFTVIQLVGMLRGIASGMKY  162 (373)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHTTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEeeC--------CceEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999765        55899999996 58999998776679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++......... ........++..|+|||++.+.. ++.++|||||||++
T Consensus       163 LH~~~ivH~Dlkp~NIll~~~~~~kl~Dfg~a~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~SlG~il  240 (373)
T 2qol_A          163 LSDMGYVHRDLAARNILINSNLVCKVSDFGLGRVLEDDPEA-AYTTRGGKIPIRWTSPEAIAYRK-FTSASDVWSYGIVL  240 (373)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CTTSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HHHCCeeCCCCCcceEEEcCCCCEEECcCccccccccCCcc-ceeccCCCcCCCccChhhhccCC-cCchhcHHHHHHHH
Confidence            99999999999999999999999999999999876533211 11122234577899999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||.+.+..+....+......+.                               +...+..+.++|.+||+.
T Consensus       241 ~ellt~g~~P~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl~~  289 (373)
T 2qol_A          241 WEVMSYGERPYWEMSNQDVIKAVDEGYRLPP-------------------------------PMDCPAALYQLMLDCWQK  289 (373)
T ss_dssp             HHHHTTC-CTTTTCCHHHHHHHHHTTEECCC-------------------------------CTTCBHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccccHHHHHHHHHHhCc
Confidence            99998 9999998887766555433211110                               112456677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+||++.++++
T Consensus       290 dp~~RPs~~~i~~  302 (373)
T 2qol_A          290 DRNNRPKFEQIVS  302 (373)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhhCcCHHHHHH
Confidence            9999999999986

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=3.2e-36  Score=284.08  Aligned_cols=212  Identities=20%  Similarity=0.297  Sum_probs=174.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++..         +.+++||||+.+ +|.+++......+++..++.++.||+.||.|
T Consensus        55 ~~~~~E~~~l~~l~h~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  125 (287)
T 1u59_A           55 EEMMREAQIMHQLDNPYIVRLIGVCQA---------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY  125 (287)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEES---------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEEEEecC---------CCcEEEEEeCCCCCHHHHHHhCCccCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999943         448999999985 8998887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........ .........+|+.|+|||++.+.. ++.++|||||||++
T Consensus       126 lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  203 (287)
T 1u59_A          126 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTM  203 (287)
T ss_dssp             HHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC-EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             HHHCCEeeCCCchheEEEcCCCCEEECcccceeeeccCcc-eeeccccccccccccCHHHhccCC-CCchhhHHHHHHHH
Confidence            9999999999999999999999999999999987653221 112223445688999999987654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||.+....+....+.......                               .+...+.++.++|.+||..
T Consensus       204 ~ellt~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~~  252 (287)
T 1u59_A          204 WEALSYGQKPYKKMKGPEVMAFIEQGKRME-------------------------------CPPECPPELYALMSDCWIY  252 (287)
T ss_dssp             HHHHTTSCCTTTTCCTHHHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHTTCS
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHhcCCcCC-------------------------------CCCCcCHHHHHHHHHHcCC
Confidence            99998 999999887776655543311000                               0112467788999999999


Q ss_pred             CCCCCCCHHHhhcCCC
Q psy7889         246 DPSKRFDSDAALNHDF  261 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~  261 (433)
                      ||.+||++.+++++.+
T Consensus       253 ~p~~Rps~~~l~~~l~  268 (287)
T 1u59_A          253 KWEDRPDFLTVEQRMR  268 (287)
T ss_dssp             SGGGSCCHHHHHHHHH
T ss_pred             ChhhCcCHHHHHHHHH
Confidence            9999999999998753

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=100.00  E-value=2.6e-36  Score=281.21  Aligned_cols=210  Identities=20%  Similarity=0.353  Sum_probs=174.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+++.++||||+++++++.+.        +.+|+||||++ ++|.+++......+++..++.++.|++.||.
T Consensus        47 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~~~~~~~~~~~~~~~~~i~~~l~  118 (267)
T 3t9t_A           47 EEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--------APICLVTEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGMA  118 (267)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSCEEEECCCTTCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccC--------CCeEEEEeCCCCCcHHHHHhhCcccCCHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        55899999997 5899998876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++.......   ........++..|+|||++.+.. ++.++|||||||+
T Consensus       119 ~lH~~~i~H~dl~p~Nili~~~~~~kl~dfg~~~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  194 (267)
T 3t9t_A          119 YLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQ---YTSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVL  194 (267)
T ss_dssp             HHHHTTCCCSSCCGGGEEECGGGCEEECCTTGGGGBCCHH---HHSTTSTTCCGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHhCCcccCCCchheEEECCCCCEEEccccccccccccc---ccccccccccccccChhhhcCCC-ccchhchhhhHHH
Confidence            9999999999999999999999999999999997654321   11223445678899999987655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+.......                               .+...+..+.++|.+||.
T Consensus       195 l~~l~~~g~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~  243 (267)
T 3t9t_A          195 MWEVFSEGKIPYENRSNSEVVEDISTGFRLY-------------------------------KPRLASTHVYQIMNHCWR  243 (267)
T ss_dssp             HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCC-------------------------------CCTTSCHHHHHHHHHHTC
T ss_pred             HHHHhccCCCCCCCCCHHHHHHHHhcCCcCC-------------------------------CCccCcHHHHHHHHHHcc
Confidence            999999 899999888776665554321110                               111246677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.+++++
T Consensus       244 ~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          244 ERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999864

>3cbl_A C-FES, proto-oncogene tyrosine-protein kinase FES/FPS; V-FES, fujinami, avian sarcoma, viral, feline virus, SGC; HET: STU; 1.75A {Homo sapiens} PDB: 3bkb_A* 3cd3_A* 4e93_A*

Probab=100.00  E-value=1.2e-36  Score=298.44  Aligned_cols=209  Identities=23%  Similarity=0.399  Sum_probs=170.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+|+.++|||||++++++...        ..+|+||||++ ++|.+++......+++..+..++.||+.||+|
T Consensus       157 ~~~~~E~~~l~~l~hpniv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  228 (377)
T 3cbl_A          157 AKFLQEARILKQYSHPNIVRLIGVCTQK--------QPIYIVMELVQGGDFLTFLRTEGARLRVKTLLQMVGDAAAGMEY  228 (377)
T ss_dssp             TTTTHHHHHHTTCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEecC--------CCcEEEEEcCCCCCHHHHHHhcCCCCCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999765        45899999997 68999988766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.......  ........++..|+|||++.+.. ++.++|||||||++
T Consensus       229 LH~~~ivHrDlkp~Nil~~~~~~~kl~DfG~s~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~il  305 (377)
T 3cbl_A          229 LESKCCIHRDLAARNCLVTEKNVLKISDFGMSREEADGVY--AASGGLRQVPVKWTAPEALNYGR-YSSESDVWSFGILL  305 (377)
T ss_dssp             HHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECTTSEE--ECCSSCCEEEGGGSCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHHCCcCCcccCHHHEEEcCCCcEEECcCCCceecCCCce--eecCCCCCCCcCcCCHhHhccCC-CCchhhHHHHHHHH
Confidence            9999999999999999999999999999999976543211  01112234577899999987655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+....+....+......+.                               +...+.++.+||.+||..
T Consensus       306 ~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~cl~~  354 (377)
T 3cbl_A          306 WETFSLGASPYPNLSNQQTREFVEKGGRLPC-------------------------------PELCPDAVFRLMEQCWAY  354 (377)
T ss_dssp             HHHHTTSCCSSTTSCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHcCC
Confidence            99998 9999999887765554432111110                               112356677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||++++++
T Consensus       355 dP~~Rps~~~i~~  367 (377)
T 3cbl_A          355 EPGQRPSFSTIYQ  367 (377)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             CchhCcCHHHHHH
Confidence            9999999999985

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=100.00  E-value=2.8e-36  Score=283.44  Aligned_cols=209  Identities=19%  Similarity=0.258  Sum_probs=169.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.         ..|+||||+. ++|.+++......+++..++.++.||+.||.
T Consensus        57 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~---------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~  127 (281)
T 3cc6_A           57 KEKFMSEAVIMKNLDHPHIVKLIGIIEEE---------PTWIIMELYPYGELGHYLERNKNSLKVLTLVLYSLQICKAMA  127 (281)
T ss_dssp             HHHHHHHHHHHHHHCCTTBCCEEEEECSS---------SCEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCcceEEEEEcCC---------CCEEEEecCCCCCHHHHHHhccccCCHHHHHHHHHHHHHHHH
Confidence            35678899999999999999999998642         3589999998 5899998876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+||+++.++.+||+|||++........   .......++..|+|||++.+.. ++.++|||||||+
T Consensus       128 ~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  203 (281)
T 3cc6_A          128 YLESINCVHRDIAVRNILVASPECVKLGDFGLSRYIEDEDY---YKASVTRLPIKWMSPESINFRR-FTTASDVWMFAVC  203 (281)
T ss_dssp             HHHHTTCCCCCCSGGGEEEEETTEEEECCCCGGGCC------------CCCCCGGGCCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHHCCcccCCCccceEEECCCCcEEeCccCCCcccccccc---cccccCCCCcceeCchhhccCC-CCchhccHHHHHH
Confidence            99999999999999999999999999999999987653221   1223345678899999987654 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |..||......+....+........                               +...++.+.++|.+||.
T Consensus       204 l~~llt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~  252 (281)
T 3cc6_A          204 MWEILSFGKQPFFWLENKDVIGVLEKGDRLPK-------------------------------PDLCPPVLYTLMTRCWD  252 (281)
T ss_dssp             HHHHHTTTCCTTTTSCGGGHHHHHHHTCCCCC-------------------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCcccCChHHHHHHHhcCCCCCC-------------------------------CCCCCHHHHHHHHHHcc
Confidence            999998 9999987766655554443211110                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.|++++
T Consensus       253 ~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          253 YDPSDRPRFTELVCS  267 (281)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCchhCcCHHHHHHH
Confidence            999999999999974

>1mqb_A Ephrin type-A receptor 2; tyrosine protein kinase, transferase; HET: ANP; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=7.1e-36  Score=287.96  Aligned_cols=211  Identities=18%  Similarity=0.310  Sum_probs=167.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+.+++.++||||+++++++...        +.+++||||+.+ +|.+++......+++..++.++.||+.||.|
T Consensus        91 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  162 (333)
T 1mqb_A           91 VDFLGEAGIMGQFSHHNIIRLEGVISKY--------KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY  162 (333)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcEEEEEecC--------CCcEEEEeCCCCCcHHHHHHhCCCCCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999765        568999999976 8999988766779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++......... ........+|..|+|||++.+.. ++.++|||||||++
T Consensus       163 LH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  240 (333)
T 1mqb_A          163 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEA-TYTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVM  240 (333)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCeeCCCCChheEEECCCCcEEECCCCcchhhcccccc-ccccCCCCccccccCchhcccCC-CCchhhhHHHHHHH
Confidence            99999999999999999999999999999999876533211 11122345578899999997655 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |..||.+....+....+......+.                               +...+..+.++|.+||..
T Consensus       241 ~ellt~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~  289 (333)
T 1mqb_A          241 WEVMTYGERPYWELSNHEVMKAINDGFRLPT-------------------------------PMDCPSAIYQLMMQCWQQ  289 (333)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCBHHHHHHHHHHTCS
T ss_pred             HHHHcCCCCCcccCCHHHHHHHHHCCCcCCC-------------------------------cccCCHHHHHHHHHHcCC
Confidence            99998 9999998887766555533211110                               112456677999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||.+||++.+++++
T Consensus       290 ~p~~Rps~~~l~~~  303 (333)
T 1mqb_A          290 ERARRPKFADIVSI  303 (333)
T ss_dssp             STTTSCCHHHHHHH
T ss_pred             ChhhCcCHHHHHHH
Confidence            99999999999864

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=100.00  E-value=4.2e-36  Score=286.38  Aligned_cols=211  Identities=23%  Similarity=0.364  Sum_probs=171.5

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-----------------CC
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-----------------KF   68 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-----------------~l   68 (433)
                      +.+.+|+.+|+++ +||||+++++++.+.        +..++||||+.+ +|.+++.....                 .+
T Consensus        71 ~~~~~E~~~l~~l~~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  142 (313)
T 1t46_A           71 EALMSELKVLSYLGNHMNIVNLLGACTIG--------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL  142 (313)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCC
T ss_pred             HHHHHHHHHHhhcccCCCeeeEEEEEecC--------CCcEEEEecCCCCCHHHHHHhcccccccccccccccccccccC
Confidence            5688999999999 899999999999875        558999999975 89998876543                 38


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc
Q psy7889          69 SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL  148 (433)
Q Consensus        69 ~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (433)
                      ++..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|||++.
T Consensus       143 ~~~~~~~~~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~  220 (313)
T 1t46_A          143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIF  220 (313)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHHCCeecCCCccceEEEcCCCCEEEcccccccccccccc--ceeccCCCCcceeeChHHhc
Confidence            9999999999999999999999999999999999999999999999999987654321  11223445688999999987


Q ss_pred             CCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhC
Q psy7889         149 GDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK  227 (433)
Q Consensus       149 ~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (433)
                      +.. ++.++|||||||++++|++ |.+||.+.........+........                              .
T Consensus       221 ~~~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~  269 (313)
T 1t46_A          221 NCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML------------------------------S  269 (313)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC------------------------------C
T ss_pred             CCC-CChHHHHHHHHHHHHHHHhCCCCCCCcccchhHHHHHhccCCCCC------------------------------C
Confidence            655 7999999999999999998 9999988765444433332111100                              0


Q ss_pred             CccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         228 PYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       228 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +...+..+.++|.+||..||.+|||+.|++++
T Consensus       270 ~~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cccCCHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            11246678899999999999999999999964

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=100.00  E-value=2.4e-36  Score=285.95  Aligned_cols=228  Identities=18%  Similarity=0.306  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.....      ..+++||||+. ++|.+++......+++..++.++.||+.||+|
T Consensus        56 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~qi~~~l~~  129 (295)
T 3ugc_A           56 RDFEREIEILKSLQHDNIVKYKGVCYSAGR------RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY  129 (295)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECHHHH------TSCEEEEECCTTCBHHHHHHHCGGGCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEecCCC------CceEEEEEeCCCCCHHHHHHhcccccCHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999865422      45899999996 59999998766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........ .........++..|+|||++.+.. ++.++|||||||++
T Consensus       130 lH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~~l  207 (295)
T 3ugc_A          130 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKE-FFKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVL  207 (295)
T ss_dssp             HHHTTCCCSCCSGGGEEEEETTEEEECCCCSCC--------------CTTCGGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HhcCCcccCCCCHhhEEEcCCCeEEEccCcccccccCCcc-eeeeccCCCCccceeCcHHhcCCC-CChHHHHHHHHHHH
Confidence            9999999999999999999999999999999987653321 111223345678899999997765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.......     ....+......   ........      . .........+...+.++.+||.+||..|
T Consensus       208 ~~l~~g~~~~~~~~~~~-----~~~~~~~~~~~---~~~~~~~~------~-~~~~~~~~~~~~~~~~l~~li~~~l~~d  272 (295)
T 3ugc_A          208 YELFTYIEKSKSPPAEF-----MRMIGNDKQGQ---MIVFHLIE------L-LKNNGRLPRPDGCPDEIYMIMTECWNNN  272 (295)
T ss_dssp             HHHHHTTCTTCSHHHHH-----HHHHCTTCCTH---HHHHHHHH------H-HHTTCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred             HHHHhcccccCCChHHH-----HhhhcCccccc---hhHHHHHH------H-HhccCcCCCCcCcCHHHHHHHHHHcCCC
Confidence            99999999887543221     11111111000   00000000      0 0000000112235778889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |.+|||+.|+++
T Consensus       273 p~~Rps~~el~~  284 (295)
T 3ugc_A          273 VNQRPSFRDLAL  284 (295)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCCCHHHHHH
Confidence            999999999985

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=100.00  E-value=2.4e-36  Score=291.65  Aligned_cols=221  Identities=23%  Similarity=0.364  Sum_probs=147.0

Q ss_pred             hHHHHHHH-HHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKI-LQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         9 ~~~~Ei~i-l~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+|+.. ++.++||||+++++++.....    ....+|+|||||.+ +|.+++.... ..+++..++.++.||+.||.
T Consensus        67 ~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~----~~~~~~lv~e~~~gg~L~~~l~~~~~~~l~~~~~~~i~~ql~~~l~  142 (336)
T 3fhr_A           67 KARQEVDHHWQASGGPHIVCILDVYENMHH----GKRCLLIIMECMEGGELFSRIQERGDQAFTEREAAEIMRDIGTAIQ  142 (336)
T ss_dssp             HHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TEEEEEEEEECCTTEEHHHHHHTC-CCCCBHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCChHHHHHHHhhccC----CCceEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHHH
Confidence            34455544 566699999999999986422    13568999999976 8999987654 35999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+||+++.   ++.+||+|||++......      ......+|+.|+|||++.+.. ++.++|||||
T Consensus       143 ~LH~~~ivH~dlkp~NIll~~~~~~~~~kl~Dfg~~~~~~~~------~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~sl  215 (336)
T 3fhr_A          143 FLHSHNIAHRDVKPENLLYTSKEKDAVLKLTDFGFAKETTQN------ALQTPCYTPYYVAPEVLGPEK-YDKSCDMWSL  215 (336)
T ss_dssp             HHHHTTEECSCCSGGGEEESCSSTTCCEEECCCTTCEEC----------------------------CH-HHHHHHHHHH
T ss_pred             HHHhCCeecCCCCHHHEEEEecCCCceEEEeccccceecccc------ccccCCCCcCccChhhhCCCC-CCchhhHHHH
Confidence            999999999999999999986   456999999999765432      223456799999999986654 7899999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.........+.......               ....+.         ......+.++++||.+|
T Consensus       216 G~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~---------------~~~~~~---------~~~~~~~~~~~~li~~~  271 (336)
T 3fhr_A          216 GVIMYILLCGFPPFYSNTGQAISPGMKRRIRLG---------------QYGFPN---------PEWSEVSEDAKQLIRLL  271 (336)
T ss_dssp             HHHHHHHHHSSCCC------------------------------------CCCT---------TTSTTCCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCccchhhhhhHHHhhhcc---------------ccccCc---------hhhccCCHHHHHHHHHH
Confidence            999999999999998765443221111100000               000000         00013577888999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      |..||.+|||++|+|+||||.+
T Consensus       272 L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          272 LKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             SCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CCCChhHCcCHHHHhcCccccc
Confidence            9999999999999999999965

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=100.00  E-value=9.6e-36  Score=281.13  Aligned_cols=214  Identities=20%  Similarity=0.321  Sum_probs=159.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||++++++...         ..+++||||+. ++|.+.+......+++..++.++.||+.||.|
T Consensus        65 ~~~~~E~~~l~~l~h~~iv~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~~L~~  135 (289)
T 3og7_A           65 QAFKNEVGVLRKTRHVNILLFMGYSTA---------PQLAIVTQWCEGSSLYHHLHASETKFEMKKLIDIARQTARGMDY  135 (289)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS---------SSCEEEEECCCEEEHHHHHTTC---CCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCcEEEEEeeccC---------CccEEEEEecCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999996532         44799999997 58888887767779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC--CCCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG--DRNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~--~~~~~~~~DiwSlGv  164 (433)
                      ||++||+||||||+||+++.++.+||+|||++........  ........||..|+|||++..  ...++.++|||||||
T Consensus       136 lH~~~i~H~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~~~~Di~slG~  213 (289)
T 3og7_A          136 LHAKSIIHRDLKSNNIFLHEDNTVKIGDFGLATEKSRWSG--SHQFEQLSGSILWMAPEVIRMQDSNPYSFQSDVYAFGI  213 (289)
T ss_dssp             HHHTTCCCSCCCGGGEEEETTTEEEECCCC--------------------CCCTTCCHHHHC----CCSCHHHHHHHHHH
T ss_pred             HHhCCcccccCccceEEECCCCCEEEccceeccccccccc--cccccccCCCccccCchhhcccCCCCCCcccchHHHHH
Confidence            9999999999999999999999999999999976543211  122344578999999999862  234788999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++++|++|..||.+....+.+..+....... +. +...                        ....+..+.+||.+||.
T Consensus       214 il~el~~g~~p~~~~~~~~~~~~~~~~~~~~-~~-~~~~------------------------~~~~~~~l~~li~~~l~  267 (289)
T 3og7_A          214 VLYELMTGQLPYSNINNRDQIIEMVGRGSLS-PD-LSKV------------------------RSNCPKRMKRLMAECLK  267 (289)
T ss_dssp             HHHHHHHSSCTTSSCCCHHHHHHHHHHTSCC-CC-TTSS------------------------CTTSCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCccccchHHHHHHHhcccccC-cc-hhhc------------------------cccCCHHHHHHHHHHcc
Confidence            9999999999999876665554443321111 10 0000                        11245678899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+|||+.++++
T Consensus       268 ~~p~~Rps~~ell~  281 (289)
T 3og7_A          268 KKRDERPSFPRILA  281 (289)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhhCCCHHHHHH
Confidence            99999999999985

>3lzb_A Epidermal growth factor receptor; epidermal growth factor kinase domain, multitargeted small M kinase inhibitor; HET: ITI; 2.70A {Homo sapiens}

Probab=100.00  E-value=5.4e-36  Score=288.06  Aligned_cols=209  Identities=20%  Similarity=0.276  Sum_probs=165.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+.+|+.++||||+++++++...         ..++|++|+. ++|.+++......+++..++.++.||+.||+
T Consensus        61 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~---------~~~~v~~~~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~  131 (327)
T 3lzb_A           61 NKEILDEAYVMASVDNPHVCRLLGICLTS---------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN  131 (327)
T ss_dssp             HHHHHHHHHHHTTCCBTTBCCCCEEEESS---------SEEEEECCCSSCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCeeEEEEEEecC---------CceEEEEecCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            46788999999999999999999999864         2678888886 5899999887778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||++........  ........+|..|+|||++.+.. ++.++|||||||+
T Consensus       132 ~LH~~~ivH~Dikp~NIl~~~~~~~kL~DfG~a~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~~-~~~~~Di~slG~i  208 (327)
T 3lzb_A          132 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  208 (327)
T ss_dssp             HHHHTTCCCSCCCGGGEEEEETTEEEECCTTC------------------CCCGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHhhCCCcCCCCCHHHEEEcCCCCEEEccCcceeEccCccc--cccccCCCccccccCHHHHcCCC-CChHHHHHHHHHH
Confidence            99999999999999999999999999999999987653321  12223345688899999998765 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |.+||.+....+....+........                               +...+.++.+||.+||.
T Consensus       209 l~ell~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~  257 (327)
T 3lzb_A          209 VWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------------------------PPICTIDVYMIMRKCWM  257 (327)
T ss_dssp             HHHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------------------------CTTBCHHHHHHHHHHTC
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccCCHHHHHHHHHHcC
Confidence            999999 9999998876665544432111110                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+|||+.|+++
T Consensus       258 ~dp~~Rps~~ell~  271 (327)
T 3lzb_A          258 IDADSRPKFRELII  271 (327)
T ss_dssp             SSGGGSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999996

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=100.00  E-value=6.4e-36  Score=286.64  Aligned_cols=209  Identities=25%  Similarity=0.354  Sum_probs=173.4

Q ss_pred             hhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCc--CCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE--HDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~--~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++  ||||+++++++...        +.+++|||++.  ++|.+++... ..+++..++.++.||+.|
T Consensus        91 ~~~~~E~~~l~~l~~~~~~i~~~~~~~~~~--------~~~~lv~e~~~~~~~L~~~l~~~-~~l~~~~~~~i~~qi~~~  161 (320)
T 3a99_A           91 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP--------DSFVLILERPEPVQDLFDFITER-GALQEELARSFFWQVLEA  161 (320)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECS--------SEEEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHhhccCCCCceEEEEEEecC--------CcEEEEEEcCCCCccHHHHHhcc-CCCCHHHHHHHHHHHHHH
Confidence            56778999999996  59999999999875        66999999997  6899888763 468999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          84 LYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |+|||++||+||||||+|||++ .++.+||+|||++......      ......||+.|+|||++.+...++.++|||||
T Consensus       162 L~~LH~~~ivH~Dlkp~NIll~~~~~~~kL~Dfg~~~~~~~~------~~~~~~gt~~y~aPE~~~~~~~~~~~~Di~sl  235 (320)
T 3a99_A          162 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  235 (320)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEETTTTEEEECCCTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             HHHHHHCCcEeCCCCHHHEEEeCCCCCEEEeeCccccccccc------cccCCCCCccCCChHHhccCCCCCccchHHhH
Confidence            9999999999999999999999 7889999999999776532      22345689999999998776655788999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|..||.....      +..  +...                              .+...+.++.+||.+|
T Consensus       236 G~il~el~~g~~pf~~~~~------~~~--~~~~------------------------------~~~~~~~~~~~li~~~  277 (320)
T 3a99_A          236 GILLYDMVCGDIPFEHDEE------IIR--GQVF------------------------------FRQRVSSECQHLIRWC  277 (320)
T ss_dssp             HHHHHHHHHSSCSCCSHHH------HHH--CCCC------------------------------CSSCCCHHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCChhh------hhc--cccc------------------------------ccccCCHHHHHHHHHH
Confidence            9999999999999975321      111  1100                              0113567788999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      |..||.+|||++|+++||||.+...+.
T Consensus       278 l~~dp~~Rps~~~ll~hp~~~~~~~~~  304 (320)
T 3a99_A          278 LALRPSDRPTFEEIQNHPWMQDVLLPQ  304 (320)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGSSCCCHH
T ss_pred             ccCChhhCcCHHHHhcCHhhcCccCcc
Confidence            999999999999999999998765443

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=100.00  E-value=5.5e-36  Score=286.97  Aligned_cols=209  Identities=20%  Similarity=0.351  Sum_probs=171.4

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------CCCCHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------VKFSLGEIKKVIQ   78 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------~~l~~~~~~~i~~   78 (433)
                      .+.+|+.+|+.++||||+++++++.+.        ...|+||||+.+ +|.+++....         ..+++..++.++.
T Consensus        74 ~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~i~~  145 (322)
T 1p4o_A           74 EFLNEASVMKEFNCHHVVRLLGVVSQG--------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG  145 (322)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCEeeeEEEEccC--------CccEEEEEeCCCCcHHHHHHHhchhhccCCCCCCcCHHHHHHHHH
Confidence            578999999999999999999999765        558999999974 8988886532         3578999999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      ||+.||.|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|||++.+.. ++.++|
T Consensus       146 qi~~~l~~lH~~~i~H~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~D  222 (322)
T 1p4o_A          146 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGV-FTTYSD  222 (322)
T ss_dssp             HHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCC-CCHHHH
T ss_pred             HHHHHHHHHHHCCCccCCCccceEEEcCCCeEEECcCccccccccccc--cccccCCCCCCCccChhhhccCC-CCchhh
Confidence            999999999999999999999999999999999999999976543221  11223456688999999987655 799999


Q ss_pred             hhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||||++|+|++ |.+||.+.+..+....+....  ...                             .+...+..+.+
T Consensus       223 i~slG~il~el~~~g~~p~~~~~~~~~~~~~~~~~--~~~-----------------------------~~~~~~~~l~~  271 (322)
T 1p4o_A          223 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGG--LLD-----------------------------KPDNCPDMLFE  271 (322)
T ss_dssp             HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTC--CCC-----------------------------CCTTCCHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCccccCCHHHHHHHHHcCC--cCC-----------------------------CCCCCCHHHHH
Confidence            9999999999999 899999888776655543211  000                             01124667789


Q ss_pred             HHHhhcccCCCCCCCHHHhhcC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ||.+||..||.+|||+.|+++|
T Consensus       272 li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          272 LMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHcCCCcccCcCHHHHHHH
Confidence            9999999999999999999986

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=100.00  E-value=5e-36  Score=288.14  Aligned_cols=208  Identities=23%  Similarity=0.339  Sum_probs=169.3

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---------------CCCC
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---------------VKFS   69 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---------------~~l~   69 (433)
                      ...+.+|+.+|+++ +||||+++++++.+.        +.+|+||||+++ +|.+++....               ..++
T Consensus        69 ~~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  140 (327)
T 1fvr_A           69 HRDFAGELEVLCKLGHHPNIINLLGACEHR--------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS  140 (327)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEET--------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSC
T ss_pred             HHHHHHHHHHHHhccCCCchhhhceeeeeC--------CceEEEEecCCCCCHHHHHHhcccccccccccccccccccCC
Confidence            45688999999999 899999999999875        669999999964 8999887643               3689


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC
Q psy7889          70 LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        70 ~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (433)
                      +..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++......     .......++..|+|||++.+
T Consensus       141 ~~~~~~i~~qi~~aL~~LH~~~ivH~dlkp~NIl~~~~~~~kL~Dfg~~~~~~~~-----~~~~~~~~~~~y~aPE~~~~  215 (327)
T 1fvr_A          141 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNY  215 (327)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEE-----CCC----CCTTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHHHHhCCccCCCCccceEEEcCCCeEEEcccCcCcccccc-----ccccCCCCCccccChhhhcc
Confidence            9999999999999999999999999999999999999999999999998754321     11233456788999999876


Q ss_pred             CCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP  228 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (433)
                      .. ++.++|||||||++|+|++ |.+||.+....+....+......                               ..+
T Consensus       216 ~~-~~~~~Di~slG~il~ellt~g~~pf~~~~~~~~~~~~~~~~~~-------------------------------~~~  263 (327)
T 1fvr_A          216 SV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYRL-------------------------------EKP  263 (327)
T ss_dssp             CE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCCC-------------------------------CCC
T ss_pred             cc-CCchhcchHHHHHHHHHHcCCCCCCCCCcHHHHHHHhhcCCCC-------------------------------CCC
Confidence            54 7999999999999999998 99999988876655443221000                               011


Q ss_pred             ccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         229 YVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       229 ~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ...+..+.+||.+||..||.+|||+++++++
T Consensus       264 ~~~~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          264 LNCDDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            2346778899999999999999999999975

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=100.00  E-value=1.8e-35  Score=278.70  Aligned_cols=204  Identities=20%  Similarity=0.296  Sum_probs=165.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.          .++||||+. ++|.+.+......+++..++.++.|++.||+|
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~l~~~l~~  137 (287)
T 4f0f_A           68 QEFQREVFIMSNLNHPNIVKLYGLMHNP----------PRMVMEFVPCGDLYHRLLDKAHPIKWSVKLRLMLDIALGIEY  137 (287)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEETTT----------TEEEEECCTTCBHHHHHHCTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCchhhheeecCC----------CeEEEEecCCCCHHHHHhcccCCccHHHHHHHHHHHHHHHHH
Confidence            5788999999999999999999998654          379999998 68989888777789999999999999999999


Q ss_pred             HHhCC--eeccCCCCCcEEEecCCc-----EEEeecCCccccccCcCCccccccCCcccccccCcccccC-CCCCCCcch
Q psy7889          87 IHSNK--ILHRDMKAANVLITKTGI-----LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG-DRNYGPPVD  158 (433)
Q Consensus        87 LH~~~--iiH~dikp~NIll~~~~~-----~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-~~~~~~~~D  158 (433)
                      ||++|  |+||||||+||+++.++.     +||+|||++.....       ......||+.|+|||++.+ ...++.++|
T Consensus       138 lH~~~~~ivH~dikp~Nil~~~~~~~~~~~~kl~Dfg~~~~~~~-------~~~~~~g~~~y~aPE~~~~~~~~~~~~~D  210 (287)
T 4f0f_A          138 MQNQNPPIVHRDLRSPNIFLQSLDENAPVCAKVADFGLSQQSVH-------SVSGLLGNFQWMAPETIGAEEESYTEKAD  210 (287)
T ss_dssp             HHTSSSCCBCSCCSGGGEEESCCCTTCSCCEEECCCTTCBCCSS-------CEECCCCCCTTSCGGGSSCSSCEECHHHH
T ss_pred             HHhCCCCeecCCCCcceEEEeccCCCCceeEEeCCCCccccccc-------cccccCCCccccCchhhccCCCCcCchhh
Confidence            99999  999999999999988776     99999999875432       2334578999999999843 234688999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHH--HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQ--ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~--~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      ||||||++|+|++|..||.+......  ...+.. .+ ..+.                            .+...++++.
T Consensus       211 i~slG~~l~~l~~g~~pf~~~~~~~~~~~~~~~~-~~-~~~~----------------------------~~~~~~~~l~  260 (287)
T 4f0f_A          211 TYSFAMILYTILTGEGPFDEYSYGKIKFINMIRE-EG-LRPT----------------------------IPEDCPPRLR  260 (287)
T ss_dssp             HHHHHHHHHHHHHSSCTTTTCCCCHHHHHHHHHH-SC-CCCC----------------------------CCTTSCHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCccccccHHHHHHHHhc-cC-CCCC----------------------------CCcccCHHHH
Confidence            99999999999999999987654332  222211 11 1100                            0112467788


Q ss_pred             HHHHhhcccCCCCCCCHHHhhc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++|.+||..||.+|||++++++
T Consensus       261 ~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          261 NVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999985

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=100.00  E-value=4.3e-36  Score=288.50  Aligned_cols=217  Identities=18%  Similarity=0.262  Sum_probs=151.2

Q ss_pred             hHHHHHH-HHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc----cCCCCCHHHHHHHHHHHHHH
Q psy7889           9 TALREIK-ILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN----IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         9 ~~~~Ei~-il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~----~~~~l~~~~~~~i~~qll~a   83 (433)
                      .+.+|+. +++.++||||+++++++...        +..|+||||+.++|.+++..    ....+++..++.++.|++.|
T Consensus        66 ~~~~e~~~~~~~~~h~niv~~~~~~~~~--------~~~~lv~e~~~~~l~~~~~~~~~~~~~~~~~~~~~~i~~~i~~~  137 (327)
T 3aln_A           66 QLLMDLDVVMRSSDCPYIVQFYGALFRE--------GDCWICMELMSTSFDKFYKYVYSVLDDVIPEEILGKITLATVKA  137 (327)
T ss_dssp             HHHHHHHHHHSSCCCTTBCCEEEEEECS--------SEEEEEECCCSEEHHHHHHHHHHTTCCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCcEeeeeeEEEeC--------CceEEEEeecCCChHHHHHHHHhhhcccCcHHHHHHHHHHHHHH
Confidence            4566666 67778999999999999875        56899999999988887753    24568999999999999999


Q ss_pred             HHHHHhC-CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc---CCCCCCCcchh
Q psy7889          84 LYYIHSN-KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL---GDRNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~~-~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~---~~~~~~~~~Di  159 (433)
                      |.|||+. ||+||||||+||+++.++.+||+|||++.......     ......||+.|+|||++.   ....++.++||
T Consensus       138 l~~lH~~~~ivH~dlkp~NIll~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~Di  212 (327)
T 3aln_A          138 LNHLKENLKIIHRDIKPSNILLDRSGNIKLCDFGISGQLVDSI-----AKTRDAGCRPYMAPERIDPSASRQGYDVRSDV  212 (327)
T ss_dssp             HHHHHHHHSCCCSCCCGGGEEEETTTEEEECCCSSSCC-----------------------------------CCSHHHH
T ss_pred             HHHHhccCCEeECCCCHHHEEEcCCCCEEEccCCCceeccccc-----ccccCCCCccccCceeeccccCcCCCCchhhH
Confidence            9999998 99999999999999999999999999997764321     123346899999999984   22347899999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++|+|++|..||.+......  .+.....    ...+...                    .......+..+.+||
T Consensus       213 ~slG~il~~l~~g~~pf~~~~~~~~--~~~~~~~----~~~~~~~--------------------~~~~~~~~~~l~~li  266 (327)
T 3aln_A          213 WSLGITLYELATGRFPYPKWNSVFD--QLTQVVK----GDPPQLS--------------------NSEEREFSPSFINFV  266 (327)
T ss_dssp             HHHHHHHHHHHHSCCCSSCC---------CCCCC----SCCCCCC--------------------CCSSCCCCHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCCcchHHH--HHHHHhc----CCCCCCC--------------------CcccccCCHHHHHHH
Confidence            9999999999999999987543211  1100000    0000000                    000123567788999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .+||..||.+|||+.++++||||..
T Consensus       267 ~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          267 NLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             HHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             HHHhhCChhhCcCHHHHHhChHHHH
Confidence            9999999999999999999999964

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=100.00  E-value=6.3e-36  Score=281.90  Aligned_cols=209  Identities=22%  Similarity=0.354  Sum_probs=172.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+++.++||||+++++++.+.        ..+|+||||+. ++|.+++.... ..+++..++.++.||+.||
T Consensus        53 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~L~~~~~~~~~~~~~~~~~~~i~~~i~~~l  124 (288)
T 3kfa_A           53 VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM  124 (288)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSEEEEEECCTTEEHHHHHHHCCTTTSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEccC--------CCEEEEEEcCCCCcHHHHHHhcccCCccHhHHHHHHHHHHHHH
Confidence            35688999999999999999999999775        55899999998 58999887643 3489999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+|+||||+||+++.++.++|+|||++........   .......+|..|+|||++.+.. ++.++|||||||
T Consensus       125 ~~lH~~~i~H~dikp~Nil~~~~~~~~l~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  200 (288)
T 3kfa_A          125 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGV  200 (288)
T ss_dssp             HHHHHHTCCCSCCSGGGEEECGGGCEEECCCCGGGTSCSSSS---EEETTEEECGGGCCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHHHCCccCCCCCcceEEEcCCCCEEEccCccceeccCCcc---ccccCCccccCcCChhhhccCC-CCchhhHHHHHH
Confidence            999999999999999999999999999999999987653221   2223345678899999997665 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+.+.......+........                               +...+..+.+||.+||
T Consensus       201 il~~ll~~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~~li~~~l  249 (288)
T 3kfa_A          201 LLWEIATYGMSPYPGIDLSQVYELLEKDYRMER-------------------------------PEGCPEKVYELMRACW  249 (288)
T ss_dssp             HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHhccCCCCC-------------------------------CCCCCHHHHHHHHHHh
Confidence            9999999 9999998776655544433211110                               1124567789999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+|||++++++
T Consensus       250 ~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          250 QWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCChhhCcCHHHHHH
Confidence            999999999999986

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=100.00  E-value=6.3e-37  Score=293.89  Aligned_cols=234  Identities=22%  Similarity=0.346  Sum_probs=165.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ....+|+.+|+.++|||||++++++.....    ....+|+|||||.+ +|.+++...  .+++..++.++.||+.||+|
T Consensus        63 ~~~~~E~~~l~~l~hpniv~~~~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~al~~  136 (322)
T 3soc_A           63 WQNEYEVYSLPGMKHENILQFIGAEKRGTS----VDVDLWLITAFHEKGSLSDFLKAN--VVSWNELCHIAETMARGLAY  136 (322)
T ss_dssp             HHHHHHHHTSTTCCCTTBCCEEEEEEEECS----SSEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCchhhcceeccCCC----CCceEEEEEecCCCCCHHHHHHhc--CCCHHHHHHHHHHHHHHHHH
Confidence            345678999999999999999999987532    13568999999975 899988763  48999999999999999999


Q ss_pred             HHhC----------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC----C
Q psy7889          87 IHSN----------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR----N  152 (433)
Q Consensus        87 LH~~----------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~----~  152 (433)
                      ||+.          ||+||||||+|||++.++.+||+|||++........  ........||+.|+|||++.+..    .
T Consensus       137 LH~~~~~l~~~~~~~ivH~Dlkp~Nill~~~~~~kL~DFg~a~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~~~~~~  214 (322)
T 3soc_A          137 LHEDIPGLKDGHKPAISHRDIKSKNVLLKNNLTACIADFGLALKFEAGKS--AGDTHGQVGTRRYMAPEVLEGAINFQRD  214 (322)
T ss_dssp             HTCCEEEETTEEECEEECSCCSGGGEEECTTCCEEECCCTTCEEECTTSC--CCCCTTCCCCGGGCCHHHHTTCCCCCHH
T ss_pred             HHhhccccccccCCCEEeCCCChHhEEECCCCeEEEccCCcccccccccC--ccccccCccCccccCHhhcccccccCcC
Confidence            9999          999999999999999999999999999977654322  12234467899999999997642    2


Q ss_pred             CCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCC
Q psy7889         153 YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD  232 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  232 (433)
                      ++.++|||||||++|+|++|.+||.+................+..      .  ...... ..................+
T Consensus       215 ~~~~~DiwslG~il~el~tg~~pf~~~~~~~~~~~~~~~~~~~~~------~--~~~~~~-~~~~~~~~~~~~~~~~~~~  285 (322)
T 3soc_A          215 AFLRIDMYAMGLVLWELASRCTAADGPVDEYMLPFEEEIGQHPSL------E--DMQEVV-VHKKKRPVLRDYWQKHAGM  285 (322)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTBTTSSSCCCCCCCTTHHHHCSSCCH------H--HHHHHH-TTSCCCCCCCGGGGSSHHH
T ss_pred             CCccchhHHHHHHHHHHHhCCCCCCCCcchhccchhhhhccCCch------h--hhhhhh-hcccCCCCccccccccchH
Confidence            456889999999999999999999875432111000000000000      0  000000 0000000000000011122


Q ss_pred             hhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         233 QYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       233 ~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .++.+||.+||+.||.+|||+.|+++
T Consensus       286 ~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          286 AMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            44779999999999999999999985

>2pvf_A Fibroblast growth factor receptor 2; kinase domain fold consisting of N- and C-lobes, transferase; HET: PTR ACP; 1.80A {Homo sapiens} PDB: 3cly_A* 2pzr_A* 2pzp_A* 2pvy_A* 2pz5_A* 2q0b_A* 2pwl_A* 2py3_A* 3ri1_A* 1gjo_A 1oec_A* 3b2t_A* 3gql_A* 3gqi_A* 1fgk_A 1fgi_A* 1agw_A 2fgi_A* 3js2_A* 3ky2_A ...

Probab=100.00  E-value=1.4e-35  Score=285.81  Aligned_cols=210  Identities=23%  Similarity=0.430  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC---------------CCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV---------------KFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~---------------~l~~   70 (433)
                      ..+.+|+.+|+.+ +||||+++++++...        +.+|+||||+.+ +|.+++.....               .+++
T Consensus        85 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  156 (334)
T 2pvf_A           85 SDLVSEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLRARRPPGMEYSYDINRVPEEQMTF  156 (334)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SCCEEEEECCTTCBHHHHHHTTSCTTCCSCC--------CCCH
T ss_pred             HHHHHHHHHHHHhhcCCCEeeEEEEEccC--------CceEEEEECCCCCcHHHHHHHhccccccccccccccccccCCH
Confidence            3578999999999 899999999999775        568999999975 89999876432               3899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.||+.||+|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|||++.+.
T Consensus       157 ~~~~~i~~qi~~aL~~LH~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~  234 (334)
T 2pvf_A          157 KDLVSCTYQLARGMEYLASQKCIHRDLAARNVLVTENNVMKIADFGLARDINNIDY--YKKTTNGRLPVKWMAPEALFDR  234 (334)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECTTTSS--EECCSCCCCCGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCeeCCCCccceEEEcCCCCEEEcccccccccccccc--ccccCCCCcccceeChHHhcCC
Confidence            99999999999999999999999999999999999999999999999987653221  1122344568889999998765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |..||.+....+....+........                               +.
T Consensus       235 ~-~~~~~Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~  282 (334)
T 2pvf_A          235 V-YTHQSDVWSFGVLMWEIFTLGGSPYPGIPVEELFKLLKEGHRMDK-------------------------------PA  282 (334)
T ss_dssp             E-ECHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------------------------------CT
T ss_pred             C-cChHHHHHHHHHHHHHHHhCCCCCcCcCCHHHHHHHHhcCCCCCC-------------------------------Cc
Confidence            5 7999999999999999999 9999999887766655543211100                               11


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..+.++.++|.+||..||.+|||+.|++++
T Consensus       283 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  312 (334)
T 2pvf_A          283 NCTNELYMMMRDCWHAVPSQRPTFKQLVED  312 (334)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            245677899999999999999999999974

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=100.00  E-value=6.3e-36  Score=288.03  Aligned_cols=210  Identities=22%  Similarity=0.377  Sum_probs=169.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-------------CCCCCHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-------------HVKFSLGE   72 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-------------~~~l~~~~   72 (433)
                      ..+.+|+.+|+.+ +||||+++++++.+.        +.+|+||||+.+ +|.+++...             ...+++..
T Consensus        94 ~~~~~E~~~l~~l~~h~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  165 (333)
T 2i1m_A           94 EALMSELKIMSHLGQHENIVNLLGACTHG--------GPVLVITEYCCYGDLLNFLRRKSRVLETDPAFAIANSTASTRD  165 (333)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHHHHHHHSCC-------CCCCHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEecC--------CceEEEEecCCCCcHHHHHHHhcccccccccccccccccCHHH
Confidence            4578999999999 899999999999775        558999999975 898888653             23589999


Q ss_pred             HHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC
Q psy7889          73 IKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN  152 (433)
Q Consensus        73 ~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~  152 (433)
                      ++.++.||+.||+|||++||+||||||+|||++.++.+||+|||++........  ........+|+.|+|||++.+.. 
T Consensus       166 ~~~~~~qi~~~l~~lH~~~ivH~Dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-  242 (333)
T 2i1m_A          166 LLHFSSQVAQGMAFLASKNCIHRDVAARNVLLTNGHVAKIGDFGLARDIMNDSN--YIVKGNARLPVKWMAPESIFDCV-  242 (333)
T ss_dssp             HHHHHHHHHHHHHHHHHTTEECSCCSGGGCEEEGGGEEEBCCCGGGCCGGGCTT--SEECSSCEECGGGSCHHHHHHCC-
T ss_pred             HHHHHHHHHHHHHHHhcCCcccCCcccceEEECCCCeEEECccccccccccccc--eeecCCCCCCccccCHHHhccCC-
Confidence            999999999999999999999999999999999999999999999987643321  11223445688999999987655 


Q ss_pred             CCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC
Q psy7889         153 YGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK  231 (433)
Q Consensus       153 ~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (433)
                      ++.++|||||||++|+|++ |.+||.+.........+........                              .+...
T Consensus       243 ~~~~~Di~slG~il~el~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~  292 (333)
T 2i1m_A          243 YTVQSDVWSYGILLWEIFSLGLNPYPGILVNSKFYKLVKDGYQMA------------------------------QPAFA  292 (333)
T ss_dssp             CCHHHHHHHHHHHHHHHTTTSCCSSTTCCSSHHHHHHHHHTCCCC------------------------------CCTTC
T ss_pred             CChHHHHHHHHHHHHHHHcCCCCCCcccchhHHHHHHHhcCCCCC------------------------------CCCCC
Confidence            7999999999999999998 9999988765544444332211110                              01124


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +..+.++|.+||..||.+|||+.++++
T Consensus       293 ~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          293 PKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            567789999999999999999999986

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=100.00  E-value=1.7e-35  Score=279.77  Aligned_cols=217  Identities=22%  Similarity=0.223  Sum_probs=170.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+.+++.++|++++..+..+...       .+..++||||++++|.+++......+++..++.++.||+.||+|
T Consensus        48 ~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-------~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~~  120 (296)
T 4hgt_A           48 HPQLHIESKIYKMMQGGVGIPTIRWCGAE-------GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY  120 (296)
T ss_dssp             CCCHHHHHHHHHHHTTSTTCCCEEEEEEE-------TTEEEEEEECCCCBHHHHHHHTTSCCCHHHHHHHHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHhcCCCCCCeeeeecCC-------CCceEEEEEccCCCHHHHHHHhcCCCCHHHHHHHHHHHHHHHHH
Confidence            45789999999999988888777777554       36789999999889999998766779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEE---ecCCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          87 IHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll---~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      ||++||+||||||+|||+   +.++.+||+|||++...........   .......||+.|+|||++.+.. ++.++|||
T Consensus       121 LH~~~ivH~Dlkp~NIl~~~~~~~~~~kL~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~  199 (296)
T 4hgt_A          121 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLE  199 (296)
T ss_dssp             HHHTTEECSCCSGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCGGGCCHHHHTTCC-CCHHHHHH
T ss_pred             HHHCCeecCCCCHHHeeeeccCCCCeEEEecCccceeccCcccCccCCCCcccccCCCccccchHHhcCCC-CCchhHHH
Confidence            999999999999999999   7889999999999987654332111   1233567899999999998765 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHH---HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQ---QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~---~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      ||||++|+|++|.+||.+.....   .+..+.....                   ..+      ..  ......+.++.+
T Consensus       200 slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~--~~~~~~~~~l~~  252 (296)
T 4hgt_A          200 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-------------------STP------IE--VLCKGYPSEFAT  252 (296)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-------------------HSC------HH--HHTTTSCHHHHH
T ss_pred             HHHHHHHHHhcCCCCCcccchhhhhhhhhhhhcccc-------------------cch------hh--hhhccCCHHHHH
Confidence            99999999999999998744221   1111111000                   000      00  001124678889


Q ss_pred             HHHhhcccCCCCCCCHHHhhc
Q psy7889         238 LLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ||.+||..||.+|||++++++
T Consensus       253 li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          253 YLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHhcCCCCCCCHHHHHH
Confidence            999999999999999999986

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=100.00  E-value=6.7e-36  Score=285.41  Aligned_cols=212  Identities=22%  Similarity=0.391  Sum_probs=170.0

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCC---------------CCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK---------------FSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~---------------l~~   70 (433)
                      ..+.+|+.+++.+ +||||+++++++...       ...+|+||||+.+ +|.+++......               +++
T Consensus        75 ~~~~~E~~~l~~l~~hp~iv~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~  147 (316)
T 2xir_A           75 RALMSELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL  147 (316)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECCT-------TSCCEEEEECCTTEEHHHHHHTCTTSEECC-------CTTCEEH
T ss_pred             HHHHHHHHHHHhcccCCCeeeEEEEEecC-------CCceEEEEEcCCCCcHHHHHHhcccccccccccchhhhccccCH
Confidence            3578999999999 799999999998765       3458999999985 899988765432               789


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      ..++.++.||+.||.|||++||+||||||+||+++.++.+||+|||++........  ........+|+.|+|||++.+.
T Consensus       148 ~~~~~~~~qi~~al~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~t~~y~aPE~~~~~  225 (316)
T 2xir_A          148 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDR  225 (316)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCGGGSCTTTCTT--SEEETTEEECGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCcccccCccceEEECCCCCEEECCCccccccccCcc--ceeccCCCcceeecCchhhccc
Confidence            99999999999999999999999999999999999999999999999987643221  1222345678899999999765


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++|||||||++|+|++ |.+||.+..................                              .+.
T Consensus       226 ~-~~~~~Di~slG~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~  274 (316)
T 2xir_A          226 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------------------APD  274 (316)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC------------------------------CCT
T ss_pred             c-ccchhHHHHHHHHHHHHHhCCCCCCcccchhHHHHHHhccCccCC------------------------------CCC
Confidence            5 7999999999999999998 9999988664433322222111100                              011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..++.+.++|.+||..||.+|||+.++++|
T Consensus       275 ~~~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          275 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CCCHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            246677899999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=100.00  E-value=4.4e-36  Score=288.53  Aligned_cols=214  Identities=18%  Similarity=0.324  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC------CCCCHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH------VKFSLGEIKKVIQQL   80 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~------~~l~~~~~~~i~~ql   80 (433)
                      ..+++|+.+++.++||||+++++++...        ...|+||||+. ++|.+++....      ..+++..++.++.||
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~~i~~qi  149 (327)
T 2yfx_A           78 LDFLMEALIISKFNHQNIVRCIGVSLQS--------LPRFILMELMAGGDLKSFLRETRPRPSQPSSLAMLDLLHVARDI  149 (327)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHHTSCCSSSTTSCCHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhCCCCCCCeEEEEEcCC--------CCcEEEEecCCCCcHHHHHHhhcccccccccccHHHHHHHHHHH
Confidence            4678999999999999999999999875        45799999995 68999987654      348999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcc
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPV  157 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  157 (433)
                      +.||.|||++||+||||||+|||++.   +..+||+|||++........  ........+|+.|+|||++.+.. ++.++
T Consensus       150 ~~al~~LH~~~i~H~dlkp~NIli~~~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~  226 (327)
T 2yfx_A          150 ACGCQYLEENHFIHRDIAARNCLLTCPGPGRVAKIGDFGMARDIYRASY--YRKGGCAMLPVKWMPPEAFMEGI-FTSKT  226 (327)
T ss_dssp             HHHHHHHHHTTCCCSCCCGGGEEESCSSTTCCEEECCCHHHHHHHC--------CCGGGSCGGGCCHHHHHHCC-CCHHH
T ss_pred             HHHHHHHhhCCeecCcCCHhHEEEecCCCcceEEECccccccccccccc--cccCCCcCCCcceeCHhHhcCCC-CCchh
Confidence            99999999999999999999999984   44699999999876543211  11223346688999999987655 79999


Q ss_pred             hhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         158 DLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       158 DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||||++|+|++ |.+||.+....+....+........                               +...+..+.
T Consensus       227 Di~slG~il~ellt~g~~p~~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~l~  275 (327)
T 2yfx_A          227 DTWSFGVLLWEIFSLGYMPYPSKSNQEVLEFVTSGGRMDP-------------------------------PKNCPGPVY  275 (327)
T ss_dssp             HHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHH
T ss_pred             hHHHHHHHHHHHHcCCCCCCCCcCHHHHHHHHhcCCCCCC-------------------------------CCCCCHHHH
Confidence            99999999999998 9999998887766555433211100                               112456778


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCcc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      ++|.+||..||.+|||+.++++|.|+.
T Consensus       276 ~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          276 RIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            999999999999999999999998873

>1k9a_A Carboxyl-terminal SRC kinase; COOH-terminal SRC kinase, CSK, SFK, signal transduction, SH2, SH3, SRC homology, tyrosine kinase; 2.50A {Rattus norvegicus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1jeg_A

Probab=100.00  E-value=2e-35  Score=296.39  Aligned_cols=207  Identities=19%  Similarity=0.311  Sum_probs=169.4

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCC-CCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK-FSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~-l~~~~~~~i~~qll~a   83 (433)
                      ..+.+++|+.+|+.++|||||++++++...       ...+|||||||.+ +|.+++...... +++..+..++.||+.|
T Consensus       229 ~~~~~~~E~~~l~~l~h~niv~~~~~~~~~-------~~~~~iv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~  301 (450)
T 1k9a_A          229 TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  301 (450)
T ss_dssp             TSHHHHHHHHHHHTCCCTTBCCEEEEEECT-------TSCEEEEEECCTTCBHHHHHHHHCTTTCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCCEEEEEEEEEcC-------CCceEEEEEecCCCcHHHHHHhcCCCCCCHHHHHHHHHHHHHH
Confidence            456789999999999999999999998765       2458999999975 899998765433 7999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.++.+||+|||+++.....       .....++..|+|||++.+.. ++.++||||||
T Consensus       302 l~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~-------~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG  373 (450)
T 1k9a_A          302 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG  373 (450)
T ss_dssp             HHHHHHTTEECSCCCGGGEEECTTSCEEECCCTTCEECC-------------CCCTTTSCHHHHHSSC-CCHHHHHHHHH
T ss_pred             HHHHHhCCeeCCCCCHhhEEECCCCCEEEeeCCCccccccc-------ccCCCCCcceeCHHHhcCCC-CCcHHHHHHHH
Confidence            99999999999999999999999999999999999754321       12235678899999998765 79999999999


Q ss_pred             HHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |++|||++ |..||.+....+....+.......                               .+...+.++.+||.+|
T Consensus       374 ~~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~-------------------------------~p~~~~~~l~~li~~c  422 (450)
T 1k9a_A          374 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-------------------------------APDGCPPAVYDVMKNC  422 (450)
T ss_dssp             HHHHHHHTTTCCSSTTSCTTTHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCcCCHHHHHHHHHH
Confidence            99999998 999999877665555443211100                               0112456778999999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      |..||.+|||+.++++
T Consensus       423 l~~dp~~Rpt~~~l~~  438 (450)
T 1k9a_A          423 WHLDAATRPTFLQLRE  438 (450)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             cCCChhHCcCHHHHHH
Confidence            9999999999999975

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=100.00  E-value=1.4e-35  Score=277.04  Aligned_cols=205  Identities=24%  Similarity=0.401  Sum_probs=161.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+++++.++||||+++++++.+.        +.+|+||||+. ++|..++..  ..+++..++.++.|++.||+|
T Consensus        51 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~~~~--~~~~~~~~~~i~~~l~~~l~~  120 (271)
T 3dtc_A           51 ENVRQEAKLFAMLKHPNIIALRGVCLKE--------PNLCLVMEFARGGPLNRVLSG--KRIPPDILVNWAVQIARGMNY  120 (271)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECCC----------CEEEEECCTTEEHHHHHTS--SCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeEEEEEecC--------CceEEEEEcCCCCCHHHHhhc--CCCCHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999999875        55899999997 467776643  468999999999999999999


Q ss_pred             HHhCC---eeccCCCCCcEEEec--------CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC
Q psy7889          87 IHSNK---ILHRDMKAANVLITK--------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        87 LH~~~---iiH~dikp~NIll~~--------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      ||++|   |+||||||+||+++.        ++.+||+|||++.......      .....||+.|+|||++.+.. ++.
T Consensus       121 lH~~~~~~i~H~dikp~Nil~~~~~~~~~~~~~~~kl~Dfg~~~~~~~~~------~~~~~~~~~y~aPE~~~~~~-~~~  193 (271)
T 3dtc_A          121 LHDEAIVPIIHRDLKSSNILILQKVENGDLSNKILKITDFGLAREWHRTT------KMSAAGAYAWMAPEVIRASM-FSK  193 (271)
T ss_dssp             HHHSSSSCCCCSCCSGGGEEESSCCSSSCCSSCCEEECCCCC-------------------CCGGGSCHHHHHHCC-CSH
T ss_pred             HHhCCCCceeecCCchHHEEEecccccccccCcceEEccCCccccccccc------ccCCCCccceeCHHHhccCC-CCc
Confidence            99999   999999999999985        6789999999997664322      12346899999999987655 799


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhH
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYG  235 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~  235 (433)
                      ++|||||||++++|++|..||.+.........+........                              .+...+..+
T Consensus       194 ~~Di~slG~~l~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~~  243 (271)
T 3dtc_A          194 GSDVWSYGVLLWELLTGEVPFRGIDGLAVAYGVAMNKLALP------------------------------IPSTCPEPF  243 (271)
T ss_dssp             HHHHHHHHHHHHHHHHCCCTTTTSCHHHHHHHHHTSCCCCC------------------------------CCTTCCHHH
T ss_pred             hhhHHHHHHHHHHHHhCCCCCCCCCHHHHHHhhhcCCCCCC------------------------------CCcccCHHH
Confidence            99999999999999999999998877665544432111000                              011245677


Q ss_pred             HHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         236 CDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       236 ~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .++|.+||..||.+|||+.|++++
T Consensus       244 ~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          244 AKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             HHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHhcCCcccCcCHHHHHHH
Confidence            899999999999999999999874

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=100.00  E-value=5.8e-35  Score=276.27  Aligned_cols=218  Identities=22%  Similarity=0.214  Sum_probs=170.8

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ....+.+|+.+++.++|++++..+..+...       ....++||||++++|.+++......+++..++.++.||+.||+
T Consensus        47 ~~~~~~~e~~~l~~l~~~~~i~~~~~~~~~-------~~~~~lv~e~~~~~L~~~~~~~~~~~~~~~~~~i~~qi~~~l~  119 (296)
T 3uzp_A           47 KHPQLHIESKIYKMMQGGVGIPTIRWCGAE-------GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIE  119 (296)
T ss_dssp             SCCHHHHHHHHHHHHTTSTTCCCEEEEEEE-------TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHH
T ss_pred             chhHHHHHHHHHHHhhcCCCCCccccccCC-------CCceEEEEEecCCCHHHHHHhhccCCCHHHHHHHHHHHHHHHH
Confidence            345789999999999998887777766554       3678999999988999999876678999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEe---cCCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          86 YIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~---~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |||++||+||||||+||+++   .++.+||+|||++...........   .......||+.|+|||++.+.. ++.++||
T Consensus       120 ~lH~~~ivH~dlkp~NIl~~~~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  198 (296)
T 3uzp_A          120 YIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDL  198 (296)
T ss_dssp             HHHHTTEECSCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCSCCCCSCTTTCCHHHHTTCC-CCHHHHH
T ss_pred             HHHhCCeeeCCCCHHHeEEecCCCCCeEEEeeCCCcccccccccccccccccccccccccccCChhhhcCCC-CCcchhh
Confidence            99999999999999999994   788999999999987654332111   1224567899999999998765 7999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChH---HHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQ---QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~---~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      |||||++|+|++|..||.+....   .....+.....                   ..+      .. . .....+.++.
T Consensus       199 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~~~~-------------------~~~------~~-~-~~~~~~~~l~  251 (296)
T 3uzp_A          199 ESLGYVLMYFNLGSLPWQGLKAATKRQKYERISEKKM-------------------STP------IE-V-LCKGYPSEFA  251 (296)
T ss_dssp             HHHHHHHHHHHHSSCTTSSCCCSSSSSHHHHHHHHHH-------------------HSC------HH-H-HTTTSCHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCcCchhhhhhhhhhccccc-------------------CCc------hH-H-HHhhCCHHHH
Confidence            99999999999999999874321   11222111000                   000      00 0 0123567888


Q ss_pred             HHHHhhcccCCCCCCCHHHhhc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +||.+||+.||.+|||++++++
T Consensus       252 ~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          252 TYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             HHHHHHHTSCTTCCCCHHHHHH
T ss_pred             HHHHHHHhcCcCcCCCHHHHHH
Confidence            9999999999999999999985

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=100.00  E-value=9.2e-36  Score=289.33  Aligned_cols=220  Identities=15%  Similarity=0.099  Sum_probs=170.3

Q ss_pred             hhHHHHHHHHHhCCCCCccc---------------eeeeEEecCccccccCceEEEEeecCcCCHHHHHhcc-CCCCCHH
Q psy7889           8 ITALREIKILQLLKHENVVH---------------LIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNI-HVKFSLG   71 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~---------------l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~-~~~l~~~   71 (433)
                      ..+.+|+++++.++|||||+               +++++...       ...+|+||||++++|.+++... ...+++.
T Consensus        87 ~~~~~E~~~l~~l~h~niv~~~~~~~~~~~~~i~~~~~~~~~~-------~~~~~lv~e~~~~~L~~~l~~~~~~~l~~~  159 (352)
T 2jii_A           87 GRLFNEQNFFQRAAKPLQVNKWKKLYSTPLLAIPTCMGFGVHQ-------DKYRFLVLPSLGRSLQSALDVSPKHVLSER  159 (352)
T ss_dssp             STHHHHHHHHHHHCCHHHHHHHHHHTTCTTCSCCCCCEEEEET-------TTEEEEEEECCCEEHHHHHHHSGGGCCCHH
T ss_pred             chHHHHHHHHHHhcccchhhhhhhhccCCccCccchhhccccC-------CcEEEEEecCCCcCHHHHHHhCCcCCCCHH
Confidence            46889999999999999998               45555542       3679999999988999999865 3569999


Q ss_pred             HHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCC--cEEEeecCCccccccCcCCc---cccccCCcccccccCccc
Q psy7889          72 EIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG--ILKLADFGLARAFSQTKNGQ---VNRYTNRVVTLWYRPPEL  146 (433)
Q Consensus        72 ~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~--~~kl~DFg~a~~~~~~~~~~---~~~~~~~~gt~~y~aPE~  146 (433)
                      .++.++.||+.||+|||++||+||||||+|||++.++  .+||+|||++..+.......   ........||+.|+|||+
T Consensus       160 ~~~~i~~qi~~~L~~LH~~~ivH~Dikp~NIl~~~~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~  239 (352)
T 2jii_A          160 SVLQVACRLLDALEFLHENEYVHGNVTAENIFVDPEDQSQVTLAGYGFAFRYCPSGKHVAYVEGSRSPHEGDLEFISMDL  239 (352)
T ss_dssp             HHHHHHHHHHHHHHHHHHTTCBCSCCCGGGEEEETTEEEEEEECCGGGCBCSSGGGCCCCCCTTSSCTTCSCTTTCCHHH
T ss_pred             HHHHHHHHHHHHHHHHHhCCccCCCCCHHHEEEcCCCCceEEEecCcceeeccCCCccccccccccccccCCccccCHHH
Confidence            9999999999999999999999999999999999988  89999999998765432211   112234578999999999


Q ss_pred             ccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCC-hHHHHHHH-HHHhCCCCCCCCCcccchhhhhccccchHHHhhHHh
Q psy7889         147 LLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT-EQQQITLI-SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE  224 (433)
Q Consensus       147 ~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~-~~~~~~~i-~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (433)
                      +.+.. ++.++|||||||++|+|++|..||.+.. ....+... ......... ...                      .
T Consensus       240 ~~~~~-~~~~~Di~slG~il~el~~g~~pf~~~~~~~~~~~~~~~~~~~~~~~-~~~----------------------~  295 (352)
T 2jii_A          240 HKGCG-PSRRSDLQSLGYCMLKWLYGFLPWTNCLPNTEDIMKQKQKFVDKPGP-FVG----------------------P  295 (352)
T ss_dssp             HTTCC-CCHHHHHHHHHHHHHHHHHSCCTTGGGTTCHHHHHHHHHHHHHSCCC-EEC----------------------T
T ss_pred             HccCC-CCchhhHHHHHHHHHHHHhCCCCcccCCcCHHHHHHHHHhccCChhh-hhh----------------------h
Confidence            98765 7999999999999999999999998764 22222222 222211110 000                      0


Q ss_pred             hhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         225 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       225 ~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      .......+.++.+||.+||..||.+|||++++++
T Consensus       296 ~~~~~~~~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          296 CGHWIRPSETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             TSCEECCCHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             ccccCCCcHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            0001124678889999999999999999999986

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=100.00  E-value=1.1e-35  Score=286.23  Aligned_cols=221  Identities=21%  Similarity=0.359  Sum_probs=154.7

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc--cCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN--IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~--~~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.+++++. ||||+++++++.............+++||||+.++|.+++..  ....+++..++.++.||+.|
T Consensus        69 ~~~~~~e~~~l~~l~~h~~iv~~~~~~~~~~~~~~~~~~~~~lv~e~~~g~L~~~l~~~~~~~~~~~~~~~~i~~qi~~~  148 (337)
T 3ll6_A           69 NRAIIQEVCFMKKLSGHPNIVQFCSAASIGKEESDTGQAEFLLLTELCKGQLVEFLKKMESRGPLSCDTVLKIFYQTCRA  148 (337)
T ss_dssp             HHHHHHHHHHHHHHTTSTTBCCEEEEEEECTTTSTTSSEEEEEEEECCSEEHHHHHHHHHTTCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhccCCChhhccccccccccccccCCceEEEEEEecCCCHHHHHHHhhccCCCCHHHHHHHHHHHHHH
Confidence            346789999999995 999999999997654333334577999999999999998865  34469999999999999999


Q ss_pred             HHHHHhCC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCcc--------ccccCCcccccccCccccc--CCC
Q psy7889          84 LYYIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV--------NRYTNRVVTLWYRPPELLL--GDR  151 (433)
Q Consensus        84 L~~LH~~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~--------~~~~~~~gt~~y~aPE~~~--~~~  151 (433)
                      |+|||++|  |+||||||+|||++.++.+||+|||++...........        .......+|+.|+|||++.  ...
T Consensus       149 l~~LH~~~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~~~  228 (337)
T 3ll6_A          149 VQHMHRQKPPIIHRDLKVENLLLSNQGTIKLCDFGSATTISHYPDYSWSAQRRALVEEEITRNTTPMYRTPEIIDLYSNF  228 (337)
T ss_dssp             HHHHHTSSSCCBCCCCCGGGCEECTTSCEEBCCCTTCBCCSSCC-------------------------------CCTTS
T ss_pred             HHHHHhCCCCEEEccCCcccEEECCCCCEEEecCccceeccccCcccccccccccchhhccccCCCCcCChhhhhccccC
Confidence            99999999  99999999999999999999999999987654321110        1112456899999999983  223


Q ss_pred             CCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC
Q psy7889         152 NYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK  231 (433)
Q Consensus       152 ~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (433)
                      .++.++|||||||++|+|++|..||.+.........   .....                               .....
T Consensus       229 ~~~~~~Dv~slG~il~el~~g~~p~~~~~~~~~~~~---~~~~~-------------------------------~~~~~  274 (337)
T 3ll6_A          229 PIGEKQDIWALGCILYLLCFRQHPFEDGAKLRIVNG---KYSIP-------------------------------PHDTQ  274 (337)
T ss_dssp             CSSHHHHHHHHHHHHHHHHHSSCCC---------------CCCC-------------------------------TTCCS
T ss_pred             CCChHHhHHHHHHHHHHHHhCCCCCcchhHHHhhcC---cccCC-------------------------------ccccc
Confidence            478899999999999999999999976543321110   00000                               01123


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhcCCC
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALNHDF  261 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~h~~  261 (433)
                      +..+.+||.+||+.||.+|||+.|+++|-+
T Consensus       275 ~~~~~~li~~~l~~~p~~Rps~~e~l~~l~  304 (337)
T 3ll6_A          275 YTVFHSLIRAMLQVNPEERLSIAEVVHQLQ  304 (337)
T ss_dssp             SGGGHHHHHHHSCSSGGGSCCHHHHHHHHH
T ss_pred             chHHHHHHHHHccCChhhCcCHHHHHHHHH
Confidence            456779999999999999999999998754

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=100.00  E-value=1.9e-36  Score=290.24  Aligned_cols=224  Identities=21%  Similarity=0.294  Sum_probs=166.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC---CCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~---~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|+.++||||+++++++...        +.+|+||||+.+ +|.+++....   ..+++..++.++.||+.|
T Consensus        80 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~~  151 (321)
T 2qkw_B           80 EEFETEIETLSFCRHPHLVSLIGFCDER--------NEMILIYKYMENGNLKRHLYGSDLPTMSMSWEQRLEICIGAARG  151 (321)
T ss_dssp             HHHHHHHHGGGSCCCTTBCCEEEECCCT--------TCCEEEEECCTTCBTGGGSSSSCCCSCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEcCC--------CeEEEEEEcCCCCcHHHHHhccCCCccccCHHHHHHHHHHHHHH
Confidence            4678999999999999999999999765        568999999974 7877775432   248999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+||+++.++.+||+|||++........  ........||+.|+|||++.+.. ++.++||||||
T Consensus       152 l~~lH~~~ivH~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di~slG  228 (321)
T 2qkw_B          152 LHYLHTRAIIHRDVKSINILLDENFVPKITDFGISKKGTELDQ--THLSTVVKGTLGYIDPEYFIKGR-LTEKSDVYSFG  228 (321)
T ss_dssp             HHHHHHTTEECSCCCSTTEEECTTCCEEECCCTTCEECSSSSC--CCCBCCCEEETTTCCHHHHHHCB-CCTHHHHHHHH
T ss_pred             HHHhcCCCeecCCCCHHHEEECCCCCEEEeecccccccccccc--cccccccCCCccccCHHHhcCCC-CCcccchHhHH
Confidence            9999999999999999999999999999999999976543221  11223456899999999987655 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHH---HHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLIS---QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~---~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |++|+|++|..||.+....+....+.   ......   ............  ..             +...+..+.+++.
T Consensus       229 ~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~--~~-------------~~~~~~~l~~li~  290 (321)
T 2qkw_B          229 VVLFEVLCARSAIVQSLPREMVNLAEWAVESHNNG---QLEQIVDPNLAD--KI-------------RPESLRKFGDTAV  290 (321)
T ss_dssp             HHHHHHHHCCTTCSCSSSSSCCCHHHHTHHHHTTT---CCCSSSSSSCTT--CS-------------CHHHHHHHHHHHH
T ss_pred             HHHHHHHhCCCcccccCcHHHHHHHHHhhhccccc---cHHHhcChhhcc--cc-------------CHHHHHHHHHHHH
Confidence            99999999999998654322111110   000000   000000000000  00             0012345679999


Q ss_pred             hhcccCCCCCCCHHHhhcCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHD  260 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~  260 (433)
                      +||..||.+|||+.|++++-
T Consensus       291 ~~l~~dP~~Rps~~ell~~L  310 (321)
T 2qkw_B          291 KCLALSSEDRPSMGDVLWKL  310 (321)
T ss_dssp             HHTCSSGGGSCCHHHHHHHH
T ss_pred             HHcCCCcccCcCHHHHHHHH
Confidence            99999999999999999764

>1opk_A P150, C-ABL, proto-oncogene tyrosine-protein kinase ABL1; transferase; HET: MYR P16; 1.80A {Mus musculus} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1opl_A* 2fo0_A* 2abl_A

Probab=100.00  E-value=1.3e-35  Score=301.13  Aligned_cols=209  Identities=21%  Similarity=0.355  Sum_probs=171.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+++|+.+|+.++|||||++++++...        ..+||||||+. ++|.+++.... ..+++..++.++.||+.||
T Consensus       260 ~~~~~~E~~~l~~l~hpniv~l~~~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~~i~~qi~~~L  331 (495)
T 1opk_A          260 VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM  331 (495)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhcCCCCEeeEEEEEecC--------CcEEEEEEccCCCCHHHHHHhcCcCCCCHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        55899999998 68999987643 4589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+++......   ........++..|+|||++.+.. ++.++|||||||
T Consensus       332 ~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlG~  407 (495)
T 1opk_A          332 EYLEKKNFIHRNLAARNCLVGENHLVKVADFGLSRLMTGDT---YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGV  407 (495)
T ss_dssp             HHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEECCTTCC---EECCTTCCCCGGGCCHHHHHHCE-ECHHHHHHHHHH
T ss_pred             HHHHhCCcccCCCChhhEEECCCCcEEEeecccceeccCCc---eeecCCCcCCcceeCHhHHhcCC-CCcHHhHHhHHH
Confidence            99999999999999999999999999999999998764321   11223345578899999997655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |.+||.+.+..+....+.......                               .+...+.++.+||.+||
T Consensus       408 ~l~el~t~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~cl  456 (495)
T 1opk_A          408 LLWEIATYGMSPYPGIDLSQVYELLEKDYRME-------------------------------RPEGCPEKVYELMRACW  456 (495)
T ss_dssp             HHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCCCCHHHHHHHHHHc
Confidence            9999999 999999877665544443211100                               01124567789999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      +.||.+|||+.++++
T Consensus       457 ~~dP~~RPs~~el~~  471 (495)
T 1opk_A          457 QWNPSDRPSFAEIHQ  471 (495)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CcChhHCcCHHHHHH
Confidence            999999999999986

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=100.00  E-value=7.8e-36  Score=286.76  Aligned_cols=225  Identities=20%  Similarity=0.290  Sum_probs=170.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++++.++||||+++++++....      ...+|+||||++ ++|.+++......+++..++.++.||+.||+|
T Consensus        69 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~~  142 (327)
T 3lxl_A           69 RDFQREIQILKALHSDFIVKYRGVSYGPG------RQSLRLVMEYLPSGCLRDFLQRHRARLDASRLLLYSSQICKGMEY  142 (327)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEECSS------SCEEEEEEECCTTCBHHHHHHHHGGGCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCceeEEEEEEecCC------CceEEEEEeecCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            45789999999999999999999987543      367999999995 58999887766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........ .........+|..|+|||++.+.. ++.++|||||||++
T Consensus       143 lH~~~ivH~Dikp~NIl~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  220 (327)
T 3lxl_A          143 LGSRRCVHRDLAARNILVESEAHVKIADFGLAKLLPLDKD-YYVVREPGQSPIFWYAPESLSDNI-FSRQSDVWSFGVVL  220 (327)
T ss_dssp             HHHTTEECSCCSGGGEEEEETTEEEECCGGGCEECCTTCS-EEECSSCCCSCGGGSCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHhCCccCCCCChhhEEECCCCCEEEcccccceecccCCc-cceeeccCCccccccCHHHhccCC-CChHHhHHHHHHHH
Confidence            9999999999999999999999999999999987653321 112233456788899999987755 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHH---hhhCCccCChhHHHHHHhhc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVK---ERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~s~~~~~li~~~L  243 (433)
                      |+|++|..||..........     ....  .......            .......   ....+...+.++.+||.+||
T Consensus       221 ~~ll~g~~p~~~~~~~~~~~-----~~~~--~~~~~~~------------~~~~~~~~~~~~~~~~~~~~~l~~li~~~l  281 (327)
T 3lxl_A          221 YELFTYCDKSCSPSAEFLRM-----MGCE--RDVPALS------------RLLELLEEGQRLPAPPACPAEVHELMKLCW  281 (327)
T ss_dssp             HHHHTTTCGGGSHHHHHHHH-----CC------CCHHH------------HHHHHHHTTCCCCCCTTCCHHHHHHHHHHT
T ss_pred             HHHHhCCCCCccccchhhhh-----cccc--cccccHH------------HHHHHhhcccCCCCCCcccHHHHHHHHHHc
Confidence            99999999987644321110     0000  0000000            0000000   00012235778899999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      ..||.+|||+++++++
T Consensus       282 ~~dP~~Rps~~ell~~  297 (327)
T 3lxl_A          282 APSPQDRPSFSALGPQ  297 (327)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCChhhCcCHHHHHHH
Confidence            9999999999999754

>1qcf_A Haematopoetic cell kinase (HCK); tyrosine kinase-inhibitor complex, DOWN-regulated kinase, ordered activation loop; HET: PTR PP1; 2.00A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 2c0i_A* 2c0o_A* 2c0t_A* 1ad5_A* 2hck_A* 3nhn_A 3hck_A 1bu1_A 3rea_B 3rbb_B

Probab=100.00  E-value=1.3e-35  Score=298.11  Aligned_cols=208  Identities=20%  Similarity=0.328  Sum_probs=171.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+.+|+.++|||||++++++..         ..+|||||||. ++|.+++.... ..+++..+..++.||+.||
T Consensus       227 ~~~~~~E~~~l~~l~h~~iv~l~~~~~~---------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~qi~~~l  297 (454)
T 1qcf_A          227 VEAFLAEANVMKTLQHDKLVKLHAVVTK---------EPIYIITEFMAKGSLLDFLKSDEGSKQPLPKLIDFSAQIAEGM  297 (454)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEECS---------SSCEEEECCCTTCBHHHHHHSHHHHTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhCCCCCEeeEEEEEeC---------CccEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999862         34799999997 58999887543 3589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+++......   ........++..|+|||++.+.. ++.++|||||||
T Consensus       298 ~~LH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~~DvwslG~  373 (454)
T 1qcf_A          298 AFIEQRNYIHRDLRAANILVSASLVCKIADFGLARVIEDNE---YTAREGAKFPIKWTAPEAINFGS-FTIKSDVWSFGI  373 (454)
T ss_dssp             HHHHHTTCCCSSCSGGGEEECTTCCEEECSTTGGGGBCCHH---HHTTCSSSSCGGGSCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHHhCCccCCCCCHHHEEECCCCcEEEeeCCCceEcCCCc---eeccCCCcccccccCHHHhccCC-CCcHHHHHhHHH
Confidence            99999999999999999999999999999999998764321   11122334577899999997655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |.+||.+.+..+....+......+.                               +...+.++.+||.+||
T Consensus       374 ~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl  422 (454)
T 1qcf_A          374 LLMEIVTYGRIPYPGMSNPEVIRALERGYRMPR-------------------------------PENCPEELYNIMMRCW  422 (454)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHHTCCCCC-------------------------------CTTSCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999999 9999999888777766654221111                               1124567779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+|||++++++
T Consensus       423 ~~dp~~RPt~~~i~~  437 (454)
T 1qcf_A          423 KNRPEERPTFEYIQS  437 (454)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhHCcCHHHHHH
Confidence            999999999999975

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=100.00  E-value=2.9e-35  Score=279.21  Aligned_cols=227  Identities=25%  Similarity=0.375  Sum_probs=169.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.....      ..+++||||+.+ +|.+++......+++..++.++.||+.||+|
T Consensus        68 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~  141 (302)
T 4e5w_A           68 ADLKKEIEILRNLYHENIVKYKGICTEDGG------NGIKLIMEFLPSGSLKEYLPKNKNKINLKQQLKYAVQICKGMDY  141 (302)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEC---------CCEEEEEECCTTCBHHHHHHHHTTTCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeeeeEEecCCC------ceEEEEEEeCCCCcHHHHHHhccccCCHHHHHHHHHHHHHHHHH
Confidence            568899999999999999999999987532      568999999975 8999997767779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........ .........+|..|+|||++.+.. ++.++|||||||++
T Consensus       142 lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  219 (302)
T 4e5w_A          142 LGSRQYVHRDLAARNVLVESEHQVKIGDFGLTKAIETDKE-YYTVKDDRDSPVFWYAPECLMQSK-FYIASDVWSFGVTL  219 (302)
T ss_dssp             HHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCC-EEECCCCTTCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             hhcCCcccCCCchheEEEcCCCCEEECcccccccccCCCc-ceeccCCCCCCccccCCeeecCCC-CCcchhHHHHHHHH
Confidence            9999999999999999999999999999999987654321 112233456788899999987755 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..|+.....     .+....+.....    .........+       ........+...+.++.+||.+||..|
T Consensus       220 ~~l~~g~~p~~~~~~-----~~~~~~~~~~~~----~~~~~~~~~~-------~~~~~~~~~~~~~~~l~~li~~~l~~d  283 (302)
T 4e5w_A          220 HELLTYCDSDSSPMA-----LFLKMIGPTHGQ----MTVTRLVNTL-------KEGKRLPCPPNCPDEVYQLMRKCWEFQ  283 (302)
T ss_dssp             HHHHTTTCGGGSHHH-----HHHHHHCSCCGG----GHHHHHHHHH-------HTTCCCCCCTTCCHHHHHHHHHTTCSS
T ss_pred             HHHHHccCCCcchhh-----HHhhccCCcccc----cCHHHHHHHH-------hccCCCCCCCCCCHHHHHHHHHHcCCC
Confidence            999999887643211     111111111000    0000000000       000000012235778899999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |.+|||+.++++
T Consensus       284 p~~Rps~~~ll~  295 (302)
T 4e5w_A          284 PSNRTSFQNLIE  295 (302)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             CCCCCCHHHHHH
Confidence            999999999985

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=100.00  E-value=1.8e-35  Score=279.14  Aligned_cols=210  Identities=24%  Similarity=0.354  Sum_probs=170.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+.+++.++||||+++++++...         ..++||||+. ++|.+.+......+++..++.++.||+.||.|
T Consensus        66 ~~~~~e~~~l~~l~h~~i~~~~~~~~~~---------~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~i~~~l~~  136 (291)
T 1u46_A           66 DDFIREVNAMHSLDHRNLIRLYGVVLTP---------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY  136 (291)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS---------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCcccEEEEEccC---------CceeeEecccCCCHHHHHHhccCCcCHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999753         2789999997 58999888766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.+||+|||++........ .........+|..|+|||++.+.. ++.++|||||||++
T Consensus       137 lH~~~i~H~dikp~Nili~~~~~~kl~Dfg~~~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  214 (291)
T 1u46_A          137 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDD-HYVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL  214 (291)
T ss_dssp             HHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CC-EEEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHhCCcccCCCchheEEEcCCCCEEEcccccccccccccc-chhhhccCCCCceeeCchhhcCCC-CCchhhHHHHHHHH
Confidence            9999999999999999999999999999999987653321 111223345678899999987654 68999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      ++|++ |.+||.+....+....+.......+                              .+...+.++.++|.+||..
T Consensus       215 ~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~~~~~~l~~li~~~l~~  264 (291)
T 1u46_A          215 WEMFTYGQEPWIGLNGSQILHKIDKEGERLP------------------------------RPEDCPQDIYNVMVQCWAH  264 (291)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTSCCCCC------------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCcccCCHHHHHHHHHccCCCCC------------------------------CCcCcCHHHHHHHHHHccC
Confidence            99999 9999999887766655533111110                              0112467788999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||+.++++
T Consensus       265 ~p~~Rps~~~l~~  277 (291)
T 1u46_A          265 KPEDRPTFVALRD  277 (291)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             CcccCcCHHHHHH
Confidence            9999999999996

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=100.00  E-value=3.3e-35  Score=277.62  Aligned_cols=209  Identities=22%  Similarity=0.323  Sum_probs=168.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++..         +.+|+||||+. ++|.+++.. ...+++..++.++.||+.||.
T Consensus        62 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~---------~~~~lv~e~~~~~~L~~~l~~-~~~~~~~~~~~i~~qi~~~l~  131 (291)
T 1xbb_A           62 KDELLAEANVMQQLDNPYIVRMIGICEA---------ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMK  131 (291)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCEEEEEES---------SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEEEECC---------CCcEEEEEeCCCCCHHHHHHh-CcCCCHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999999932         45899999997 588888876 346999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+|+||||+||+++.++.+||+|||++......... ........++..|+|||++.+.. ++.++|||||||+
T Consensus       132 ~LH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~i  209 (291)
T 1xbb_A          132 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVL  209 (291)
T ss_dssp             HHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHH
T ss_pred             HHHhCCeEcCCCCcceEEEeCCCcEEEccCCcceeeccCCCc-ccccccCCCCceeeChHHhccCC-CChhhhHHHHHHH
Confidence            999999999999999999999999999999999876533211 11222345678899999997655 6889999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|+|++ |..||.+....+....+.......                               .+...+..+.++|.+||.
T Consensus       210 l~~l~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l~  258 (291)
T 1xbb_A          210 MWEAFSYGQKPYRGMKGSEVTAMLEKGERMG-------------------------------CPAGCPREMYDLMNLCWT  258 (291)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCCCCCHHHHHHHHHHcC
Confidence            999999 999999988776555543311000                               011246678899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+||++.++++
T Consensus       259 ~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          259 YDVENRPGFAAVEL  272 (291)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhhCcCHHHHHH
Confidence            99999999999985

>2ozo_A Tyrosine-protein kinase ZAP-70; inactive ZAP-70, tandem SH2, autoinhibition, ITAM, hydrogen bonding network, TCR signaling, transferase; HET: ANP; 2.60A {Homo sapiens}

Probab=100.00  E-value=3.7e-35  Score=304.75  Aligned_cols=210  Identities=20%  Similarity=0.308  Sum_probs=168.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+++|+.++|||||++++++..         +.+|||||||.+ +|.+++......+++..++.++.||+.||+
T Consensus       380 ~~~~~~E~~il~~l~hpniv~l~~~~~~---------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~~L~  450 (613)
T 2ozo_A          380 TEEMMREAQIMHQLDNPYIVRLIGVCQA---------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMK  450 (613)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEES---------SSEEEEEECCTTCBHHHHHTTCTTTSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEecc---------CCeEEEEEeCCCCcHHHHHhhccCCCCHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999975         338999999975 788888776667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+++....... .........+++.|+|||++.+.. ++.++|||||||+
T Consensus       451 ~LH~~~iiHrDlkp~NILl~~~~~vkL~DFGla~~~~~~~~-~~~~~~~~~~~~~y~APE~~~~~~-~~~~sDvwSlGv~  528 (613)
T 2ozo_A          451 YLEEKNFVHRNLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVT  528 (613)
T ss_dssp             HHHHTTCCCSCCSGGGEEEEETTEEEECCCSTTTTCC---------------CCTTSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHHCCEEcCcCCHHHEEEcCCCcEEEeeccCcccccCCCc-eeeeccCCCCccceeCHhhhcCCC-CCcHHHHHHHHHH
Confidence            99999999999999999999999999999999987653221 111122334568899999997655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|||++ |..||.+....+....+........                               +...+.++.+||.+||.
T Consensus       529 l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl~  577 (613)
T 2ozo_A          529 MWEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-------------------------------PPECPPELYALMSDCWI  577 (613)
T ss_dssp             HHHHHTTSCCTTTTCCSHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHTTC
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCcCCHHHHHHHHHHcC
Confidence            999998 9999999887776665543211100                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+||++.++++
T Consensus       578 ~dP~~RPs~~~l~~  591 (613)
T 2ozo_A          578 YKWEDRPDFLTVEQ  591 (613)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CChhHCcCHHHHHH
Confidence            99999999999863

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=100.00  E-value=3.4e-35  Score=274.00  Aligned_cols=206  Identities=16%  Similarity=0.183  Sum_probs=168.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-CCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-KFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+++.++||||+++++++.+...      ..+++||||+.+ +|.+++..... .+++..++.++.||+.||+
T Consensus        52 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l~  125 (271)
T 3kmu_A           52 RDFNEECPRLRIFSHPNVLPVLGACQSPPA------PHPTLITHWMPYGSLYNVLHEGTNFVVDQSQAVKFALDMARGMA  125 (271)
T ss_dssp             HHHHHHGGGGCCCSCTTEECEEEEECTTTS------SSCEEEEECCTTCBHHHHHHSCSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCchhheEEEEccCCC------CCeEeeecccCCCcHHHHHhhcccCCCCHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999976532      568999999984 99999977543 4899999999999999999


Q ss_pred             HHHhCC--eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC--CCCcchhhh
Q psy7889          86 YIHSNK--ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~--iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~--~~~~~DiwS  161 (433)
                      |||++|  |+||||||+||+++.++.++|+|||++....         .....+|+.|+|||++.+...  ++.++||||
T Consensus       126 ~lH~~~~~i~H~dikp~Nil~~~~~~~~l~~~~~~~~~~---------~~~~~~t~~y~aPE~~~~~~~~~~~~~~Di~s  196 (271)
T 3kmu_A          126 FLHTLEPLIPRHALNSRSVMIDEDMTARISMADVKFSFQ---------SPGRMYAPAWVAPEALQKKPEDTNRRSADMWS  196 (271)
T ss_dssp             HHTTSSSCCTTCCCSGGGEEECTTSCEEEEGGGSCCTTS---------CTTCBSCGGGSCHHHHHSCGGGSCHHHHHHHH
T ss_pred             HHhcCCCceecCCCccceEEEcCCcceeEEeccceeeec---------ccCccCCccccChhhhccCCCCCCCchhhHHH
Confidence            999999  9999999999999999999999988765432         123467899999999976542  233799999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |||++|+|++|..||.+....+....+......+  .                            .+...+.++.++|.+
T Consensus       197 lG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~--~----------------------------~~~~~~~~~~~li~~  246 (271)
T 3kmu_A          197 FAVLLWELVTREVPFADLSNMEIGMKVALEGLRP--T----------------------------IPPGISPHVSKLMKI  246 (271)
T ss_dssp             HHHHHHHHHHCSCTTTTSCHHHHHHHHHHSCCCC--C----------------------------CCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHhCCCCccccChHHHHHHHHhcCCCC--C----------------------------CCCCCCHHHHHHHHH
Confidence            9999999999999999888776655543311111  0                            011246678899999


Q ss_pred             hcccCCCCCCCHHHhhc
Q psy7889         242 LLLLDPSKRFDSDAALN  258 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~  258 (433)
                      ||+.||.+|||++++++
T Consensus       247 ~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          247 CMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCcCHHHHHH
Confidence            99999999999999985

>1qpc_A LCK kinase; alpha beta fold, transferase; HET: PTR ANP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1qpe_A* 1qpj_A* 2pl0_A* 3kxz_A* 3ac1_A* 2zm4_A* 2zyb_A* 2zm1_A* 3ac2_A* 3ac3_A* 3ac4_A* 3ac5_A* 3ac8_A* 3acj_A* 3ack_A* 3ad4_A* 3ad5_A* 3ad6_A* 3kmm_A* 1qpd_A* ...

Probab=100.00  E-value=2.7e-35  Score=276.34  Aligned_cols=208  Identities=22%  Similarity=0.372  Sum_probs=170.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+++|+.++||||+++++++..         +..++||||+. ++|.+++.... ..+++..++.++.|++.||
T Consensus        52 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~---------~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~l  122 (279)
T 1qpc_A           52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ---------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM  122 (279)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCcCcceEEEEEcC---------CCcEEEEecCCCCCHHHHHhcCCCCCCCHHHHHHHHHHHHHHH
Confidence            4678899999999999999999998863         34799999996 58988886532 2589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+||+++.++.+||+|||++........   .......++..|+|||++.+.. ++.++|||||||
T Consensus       123 ~~lH~~~i~H~dikp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~  198 (279)
T 1qpc_A          123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNEY---TAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGI  198 (279)
T ss_dssp             HHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSCE---ECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHH
T ss_pred             HHHHHCCeeccCCCHhhEEEcCCCCEEECCCcccccccCccc---ccccCCCCccCccChhhhccCC-CCchhhhHHHHH
Confidence            999999999999999999999999999999999987653221   1223345678899999987654 789999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++++|++ |.+||.+....+....+.......                               .+...+.++.++|.+||
T Consensus       199 il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~~~l  247 (279)
T 1qpc_A          199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMV-------------------------------RPDNCPEELYQLMRLCW  247 (279)
T ss_dssp             HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCC-------------------------------CCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCcccCHHHHHHHHhcccCCC-------------------------------CcccccHHHHHHHHHHh
Confidence            9999999 999999888776655553311100                               01124667889999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+|||++++++
T Consensus       248 ~~~p~~Rps~~~l~~  262 (279)
T 1qpc_A          248 KERPEDRPTFDYLRS  262 (279)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             ccChhhCCCHHHHHH
Confidence            999999999999985

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=100.00  E-value=2.5e-35  Score=279.47  Aligned_cols=222  Identities=23%  Similarity=0.290  Sum_probs=164.8

Q ss_pred             chhHHHHHHHHHh--CCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQL--LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+|.+++..  ++||||+++++++.....    ....+|+||||+.+ +|.+++..  ..+++..++.++.||+.|
T Consensus        44 ~~~~~~e~~~~~~~~l~h~niv~~~~~~~~~~~----~~~~~~lv~e~~~~g~L~~~l~~--~~~~~~~~~~i~~~i~~~  117 (301)
T 3q4u_A           44 EKSWFRETELYNTVMLRHENILGFIASDMTSRH----SSTQLWLITHYHEMGSLYDYLQL--TTLDTVSCLRIVLSIASG  117 (301)
T ss_dssp             HHHHHHHHHHHHHTCCCCTTBCCEEEEEEEEET----TEEEEEEEECCCTTCBHHHHHTT--CCBCHHHHHHHHHHHHHH
T ss_pred             chhhHHHHHHHHHhhccCcCeeeEEEeeccccC----CCceeEEehhhccCCCHHHHHhh--cccCHHHHHHHHHHHHHH
Confidence            3456778888887  789999999999876422    13668999999975 89888854  368999999999999999


Q ss_pred             HHHHH--------hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC---
Q psy7889          84 LYYIH--------SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN---  152 (433)
Q Consensus        84 L~~LH--------~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---  152 (433)
                      |+|||        +.||+||||||+|||++.++.+||+|||++..................||+.|+|||++.+...   
T Consensus       118 l~~lH~~~~~~~~~~~ivH~Dlkp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  197 (301)
T 3q4u_A          118 LAHLHIEIFGTQGKPAIAHRDLKSKNILVKKNGQCCIADLGLAVMHSQSTNQLDVGNNPRVGTKRYMAPEVLDETIQVDC  197 (301)
T ss_dssp             HHHHHSCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEEECCCCCCCCCGGGCCHHHHTTCCCTTC
T ss_pred             HHHHHHhhhhccCCCCeecCCCChHhEEEcCCCCEEEeeCCCeeecccccccccccccccccccceeChhhhcCcCCCCc
Confidence            99999        9999999999999999999999999999997765433322222344578999999999976532   


Q ss_pred             --CCCcchhhhHHHHHHHHHhc----------CCCCCCCCh----HHHHHHHHHHhCCCCCCCCCcccchhhhhccccch
Q psy7889         153 --YGPPVDLWGAGCIMAEMWTR----------SPIMQGNTE----QQQITLISQLCGSITPESWPGVETLDLYNKMELPK  216 (433)
Q Consensus       153 --~~~~~DiwSlGvil~ell~g----------~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  216 (433)
                        ++.++|||||||++|+|++|          .+||.....    ...+..+....+  .....+..             
T Consensus       198 ~~~~~~~DvwslG~il~el~tg~~~~~~~~~~~~pf~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~-------------  262 (301)
T 3q4u_A          198 FDSYKRVDIWAFGLVLWEVARRMVSNGIVEDYKPPFYDVVPNDPSFEDMRKVVCVDQ--QRPNIPNR-------------  262 (301)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC--CCCCCCGG-------------
T ss_pred             ccCCchhhHHHHHHHHHHHHhhhcCccccccccccccccCCCCcchhhhhHHHhccC--CCCCCChh-------------
Confidence              34689999999999999999          778765321    122222111111  00000000             


Q ss_pred             HHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         217 AQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       217 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                               ..+...+.++.+||.+||+.||.+|||+.++++
T Consensus       263 ---------~~~~~~~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          263 ---------WFSDPTLTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             ---------GGGSHHHHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             ---------hccCccHHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence                     000112356779999999999999999999985

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=100.00  E-value=1e-35  Score=285.62  Aligned_cols=225  Identities=20%  Similarity=0.265  Sum_probs=168.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC---CCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV---KFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~---~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +..++||||+.+ +|.+++.....   .+++..++.++.|++.
T Consensus        71 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~~i~~  142 (326)
T 3uim_A           71 ELQFQTEVEMISMAVHRNLLRLRGFCMTP--------TERLLVYPYMANGSVASCLRERPESQPPLDWPKRQRIALGSAR  142 (326)
T ss_dssp             CCHHHHHHHGGGTCCCTTBCCCCEEECCS--------SCCEEEEECCTTCBHHHHHHCCSTTCCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCccceEEEEecC--------CceEEEEEeccCCCHHHHHHhccccCCCCCHHHHHHHHHHHHH
Confidence            34689999999999999999999999875        557999999975 88888876432   3899999999999999


Q ss_pred             HHHHHHhC---CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          83 GLYYIHSN---KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        83 aL~~LH~~---~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      ||+|||++   ||+||||||+|||++.++.+||+|||++........   .......||+.|+|||++.+.. ++.++||
T Consensus       143 ~l~~lH~~~~~~ivH~Dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~~~Di  218 (326)
T 3uim_A          143 GLAYLHDHCDPKIIHRDVKAANILLDEEFEAVVGDFGLAKLMDYKDT---HVTTAVRGTIGHIAPEYLSTGK-SSEKTDV  218 (326)
T ss_dssp             HHHHHHHSSSSCEECCCCSGGGEEECTTCCEEECCCSSCEECCSSSS---CEECCCCSCGGGCCHHHHHHSE-ECHHHHH
T ss_pred             HHHHHHhCCCCCeEeCCCchhhEEECCCCCEEeccCccccccCcccc---cccccccCCcCccCHHHhccCC-CCccccc
Confidence            99999999   999999999999999999999999999987643221   2233456899999999997665 7999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCC-----ChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         160 WGAGCIMAEMWTRSPIMQGN-----TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~-----~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      |||||++|+|++|.+||...     ........+   .+.................  ..+             ...+..
T Consensus       219 ~slG~il~~l~~g~~pf~~~~~~~~~~~~~~~~~---~~~~~~~~~~~~~~~~~~~--~~~-------------~~~~~~  280 (326)
T 3uim_A          219 FGYGVMLLELITGQRAFDLARLANDDDVMLLDWV---KGLLKEKKLEALVDVDLQG--NYK-------------DEEVEQ  280 (326)
T ss_dssp             HHHHHHHHHHHHCCCSBCHHHHTTTSCSBHHHHH---TTTTSSCCSTTSSCTTCTT--SCC-------------HHHHHH
T ss_pred             hhHHHHHHHHHhCCCcccccccccccchhHHHHH---HHHhhchhhhhhcChhhcc--ccC-------------HHHHHH
Confidence            99999999999999999621     111111111   1111111111110000000  000             012356


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHDF  261 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~~  261 (433)
                      +.+++.+||+.||.+|||+.|+++|-+
T Consensus       281 l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          281 LIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            779999999999999999999998754

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=100.00  E-value=4.1e-35  Score=279.83  Aligned_cols=215  Identities=19%  Similarity=0.222  Sum_probs=163.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc-----cCCCCCHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN-----IHVKFSLGEIKKVIQQLL   81 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~-----~~~~l~~~~~~~i~~qll   81 (433)
                      ..+.+|+.+++.++||||+++++++......   .....|+||||+.+ +|.+++..     ....+++..++.++.||+
T Consensus        81 ~~~~~e~~~l~~l~h~~iv~~~~~~~~~~~~---~~~~~~~v~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~qi~  157 (313)
T 3brb_A           81 EEFLSEAACMKDFSHPNVIRLLGVCIEMSSQ---GIPKPMVILPFMKYGDLHTYLLYSRLETGPKHIPLQTLLKFMVDIA  157 (313)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEC----------CEEEEEECCTTCBHHHHHHHTTBTTSCCCCCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCeeeeeEEEeecccc---CCcccEEEEecccCCCHHHHHHHhhhhcCCccCCHHHHHHHHHHHH
Confidence            4578999999999999999999999875321   12357999999985 88888743     234599999999999999


Q ss_pred             HHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          82 NGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        82 ~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      .||.|||++||+||||||+||+++.++.+||+|||++........  ........+++.|+|||++.+.. ++.++||||
T Consensus       158 ~aL~~LH~~~ivH~dikp~NIli~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~s  234 (313)
T 3brb_A          158 LGMEYLSNRNFLHRDLAARNCMLRDDMTVCVADFGLSKKIYSGDY--YRQGRIAKMPVKWIAIESLADRV-YTSKSDVWA  234 (313)
T ss_dssp             HHHHHHHTTTCCCCCCSGGGEEECTTSCEEECSCSCC------------------CCGGGSCHHHHHSSC-CCHHHHHHH
T ss_pred             HHHHHHHhCCcccCCCCcceEEEcCCCcEEEeecCcceecccccc--cCcccccCCCccccCchhhcCCC-ccchhhhHH
Confidence            999999999999999999999999999999999999977643221  11223345678899999997755 799999999


Q ss_pred             HHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         162 AGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       162 lGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |||++|+|++ |.+||.+.........+.......                               .+...+..+.++|.
T Consensus       235 lG~il~el~~~g~~p~~~~~~~~~~~~~~~~~~~~-------------------------------~~~~~~~~l~~li~  283 (313)
T 3brb_A          235 FGVTMWEIATRGMTPYPGVQNHEMYDYLLHGHRLK-------------------------------QPEDCLDELYEIMY  283 (313)
T ss_dssp             HHHHHHHHHTTSCCSSTTCCGGGHHHHHHTTCCCC-------------------------------CBTTCCHHHHHHHH
T ss_pred             HHHHHHHHHhcCCCCCccCCHHHHHHHHHcCCCCC-------------------------------CCccccHHHHHHHH
Confidence            9999999999 899999877665555443211100                               01124567789999


Q ss_pred             hhcccCCCCCCCHHHhhcC
Q psy7889         241 KLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h  259 (433)
                      +||..||.+|||+.+++++
T Consensus       284 ~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          284 SCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             HTTCSSGGGSCCHHHHHHH
T ss_pred             HHcCCChhhCcCHHHHHHH
Confidence            9999999999999999864

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=100.00  E-value=2.3e-35  Score=277.27  Aligned_cols=216  Identities=27%  Similarity=0.416  Sum_probs=171.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCcc--------ccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQ--------YNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKV   76 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~--------~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i   76 (433)
                      ...+.+|+++++.++||||+++++++......        .......+|+||||+++ +|.+++... ...+++..++.+
T Consensus        48 ~~~~~~e~~~l~~l~h~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i  127 (284)
T 2a19_B           48 NEKAEREVKALAKLDHVNIVHYNGCWDGFDYDPETSSKNSSRSKTKCLFIQMEFCDKGTLEQWIEKRRGEKLDKVLALEL  127 (284)
T ss_dssp             SGGGHHHHHHHHHCCCTTBCCEEEEEEEEEEC---------CCEEEEEEEEECCCCSCBHHHHHHHGGGSCCCHHHHHHH
T ss_pred             cHHHHHHHHHHHhCCCCCEEEEeeeEeccccCcccccccccccCcceEEEEEeccCCCCHHHHHhhccCCCCCHHHHHHH
Confidence            35688999999999999999999998652100        00113568999999986 899988654 346899999999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +.||+.||.|||++||+|+||||+||+++.++.+||+|||++.......     ......+|+.|+|||++.+.. ++.+
T Consensus       128 ~~qi~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~kl~Dfg~~~~~~~~~-----~~~~~~~~~~y~aPE~~~~~~-~~~~  201 (284)
T 2a19_B          128 FEQITKGVDYIHSKKLINRDLKPSNIFLVDTKQVKIGDFGLVTSLKNDG-----KRTRSKGTLRYMSPEQISSQD-YGKE  201 (284)
T ss_dssp             HHHHHHHHHHHHHTTEECSCCSGGGEEEEETTEEEECCCTTCEESSCCS-----CCCCCCSCCTTSCHHHHHCSC-CCTH
T ss_pred             HHHHHHHHHHHHhCCeeeccCCHHHEEEcCCCCEEECcchhheeccccc-----cccccCCcccccChhhhccCC-Ccch
Confidence            9999999999999999999999999999999999999999997765322     223456899999999998765 7999


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      +|||||||++|+|++|..||....  ....   .....                               ..+...+..+.
T Consensus       202 ~Di~slG~il~~l~~~~~~~~~~~--~~~~---~~~~~-------------------------------~~~~~~~~~~~  245 (284)
T 2a19_B          202 VDLYALGLILAELLHVCDTAFETS--KFFT---DLRDG-------------------------------IISDIFDKKEK  245 (284)
T ss_dssp             HHHHHHHHHHHHHHSCCSSHHHHH--HHHH---HHHTT-------------------------------CCCTTSCHHHH
T ss_pred             hhhHHHHHHHHHHHhcCCcchhHH--HHHH---Hhhcc-------------------------------cccccCCHHHH
Confidence            999999999999999988764211  1111   11100                               01123566778


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ++|.+||..||.+|||+.|+++|.|...
T Consensus       246 ~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          246 TLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             HHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             HHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            9999999999999999999999988754

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=100.00  E-value=1.3e-35  Score=283.11  Aligned_cols=207  Identities=25%  Similarity=0.387  Sum_probs=165.5

Q ss_pred             chhHHHHHHHHHhC----CCCCccceeeeEEecCccccccCceEEEEeec-Cc-CCHHHHHhccCCCCCHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL----KHENVVHLIEICRTKANQYNRYRSTFYLVFDF-CE-HDLAGLLSNIHVKFSLGEIKKVIQQL   80 (433)
Q Consensus         7 ~~~~~~Ei~il~~l----~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~-~~-~~L~~~l~~~~~~l~~~~~~~i~~ql   80 (433)
                      ...+.+|+.+++++    +||||+++++++...        +..++|||+ +. ++|.+++... ..+++..++.++.||
T Consensus        78 ~~~~~~e~~~l~~l~~~~~h~~i~~~~~~~~~~--------~~~~~v~e~~~~~~~L~~~l~~~-~~~~~~~~~~~~~qi  148 (312)
T 2iwi_A           78 SVTCPLEVALLWKVGAGGGHPGVIRLLDWFETQ--------EGFMLVLERPLPAQDLFDYITEK-GPLGEGPSRCFFGQV  148 (312)
T ss_dssp             -CCCCHHHHHHHHHHSSCCCSSBCCEEEEC-------------CEEEEECCSSEEEHHHHHHHH-CSCCHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhcccCCCCCeeeEEEEEecC--------CeEEEEEEecCCCCCHHHHHHhc-CCCCHHHHHHHHHHH
Confidence            34566899999999    899999999999875        558999998 44 6898888763 468999999999999


Q ss_pred             HHHHHHHHhCCeeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          81 LNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        81 l~aL~~LH~~~iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      +.||.|||++||+||||||+||+++ .++.+||+|||++......      ......|+..|+|||++.+...++.++||
T Consensus       149 ~~~l~~lH~~~i~H~dlkp~Nil~~~~~~~~kl~dfg~~~~~~~~------~~~~~~~~~~y~aPE~~~~~~~~~~~~Di  222 (312)
T 2iwi_A          149 VAAIQHCHSRGVVHRDIKDENILIDLRRGCAKLIDFGSGALLHDE------PYTDFDGTRVYSPPEWISRHQYHALPATV  222 (312)
T ss_dssp             HHHHHHHHHHTEECCCCSGGGEEEETTTTEEEECCCSSCEECCSS------CBCCCCSCTTTSCHHHHHHSCBCHHHHHH
T ss_pred             HHHHHHHHHCCeeecCCChhhEEEeCCCCeEEEEEcchhhhcccC------cccccCCcccccCceeeecCCCCCccchH
Confidence            9999999999999999999999999 8899999999999876532      23445689999999998766544568999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++|+|++|..||.+...      +..  ...                 .             .+...+..+.+||
T Consensus       223 ~slG~il~~l~~g~~pf~~~~~------~~~--~~~-----------------~-------------~~~~~~~~~~~li  264 (312)
T 2iwi_A          223 WSLGILLYDMVCGDIPFERDQE------ILE--AEL-----------------H-------------FPAHVSPDCCALI  264 (312)
T ss_dssp             HHHHHHHHHHHHSSCSCCSHHH------HHH--TCC-----------------C-------------CCTTSCHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCCChHH------Hhh--hcc-----------------C-------------CcccCCHHHHHHH
Confidence            9999999999999999975321      111  000                 0             0112466788999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      .+||..||.+|||++|+++||||....
T Consensus       265 ~~~l~~~p~~Rps~~e~l~~~~~~~~~  291 (312)
T 2iwi_A          265 RRCLAPKPSSRPSLEEILLDPWMQTPA  291 (312)
T ss_dssp             HHHTCSSTTTSCCHHHHHHSTTTCC--
T ss_pred             HHHccCChhhCcCHHHHhcChhhcCch
Confidence            999999999999999999999997643

>2h34_A Serine/threonine-protein kinase PKNE; apoenzyme, transferase; 2.80A {Mycobacterium tuberculosis}

Probab=100.00  E-value=9e-35  Score=277.23  Aligned_cols=209  Identities=22%  Similarity=0.278  Sum_probs=159.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+|+||||+.+ +|.+++... ..+++..++.++.||+.||.|
T Consensus        79 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~-~~~~~~~~~~i~~qi~~~l~~  149 (309)
T 2h34_A           79 TRMQREARTAGRLQEPHVVPIHDFGEID--------GQLYVDMRLINGVDLAAMLRRQ-GPLAPPRAVAIVRQIGSALDA  149 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEEECCCCEEHHHHHHHH-CSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhhcCCCCeeEEEEEEeeC--------CeEEEEEEecCCCCHHHHHHhc-CCCCHHHHHHHHHHHHHHHHH
Confidence            5678999999999999999999999875        669999999985 888888764 468999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+|+||||+||+++.++.+||+|||++........   .......++..|+|||++.+.. ++.++|||||||++
T Consensus       150 lH~~~i~H~dlkp~NIl~~~~~~~kl~Dfg~~~~~~~~~~---~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  225 (309)
T 2h34_A          150 AHAAGATHRDVKPENILVSADDFAYLVDFGIASATTDEKL---TQLGNTVGTLYYMAPERFSESH-ATYRADIYALTCVL  225 (309)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTSCEEECSCCC-------------------CCGGGCCGGGTCC-----CCCHHHHHHHHH
T ss_pred             HHHCcCCcCCCChHHEEEcCCCCEEEecCccCcccccccc---ccccccCCCcCccCHHHHcCCC-CCchHhHHHHHHHH
Confidence            9999999999999999999999999999999977643221   2233457899999999997755 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.........+.   ......                          ...+...+.++.++|.+||..|
T Consensus       226 ~~l~~g~~pf~~~~~~~~~~~~~---~~~~~~--------------------------~~~~~~~~~~l~~li~~~l~~d  276 (309)
T 2h34_A          226 YECLTGSPPYQGDQLSVMGAHIN---QAIPRP--------------------------STVRPGIPVAFDAVIARGMAKN  276 (309)
T ss_dssp             HHHHHSSCSSCSCHHHHHHHHHH---SCCCCG--------------------------GGTSTTCCTHHHHHHHHHTCSS
T ss_pred             HHHHHCCCCCCCchHHHHHHHhc---cCCCCc--------------------------cccCCCCCHHHHHHHHHhccCC
Confidence            99999999998876543222221   111000                          0001235677889999999999


Q ss_pred             CCCCC-CHHHhhc
Q psy7889         247 PSKRF-DSDAALN  258 (433)
Q Consensus       247 P~~R~-t~~e~L~  258 (433)
                      |.+|| +++++++
T Consensus       277 P~~Rp~s~~~l~~  289 (309)
T 2h34_A          277 PEDRYVTCGDLSA  289 (309)
T ss_dssp             GGGSCSSHHHHHH
T ss_pred             HHHHHHhHHHHHH
Confidence            99999 7877774

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=100.00  E-value=1.6e-35  Score=277.93  Aligned_cols=207  Identities=19%  Similarity=0.313  Sum_probs=161.6

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC-CCCHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-KFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~-~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+.+|+.+++.++||||+++++++...       .+.+|+||||+.+ +|.+++..... .+++..++.++.|++.|
T Consensus        57 ~~~~~~~E~~~l~~l~h~~iv~~~~~~~~~-------~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~i~~~  129 (278)
T 1byg_A           57 TAQAFLAEASVMTQLRHSNLVQLLGVIVEE-------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCEA  129 (278)
T ss_dssp             --HHHHHTHHHHTTCCCTTBCCEEEEECCC---------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCEeeEEEEEEcC-------CCceEEEEecCCCCCHHHHHHhcccccCCHHHHHHHHHHHHHH
Confidence            346788999999999999999999987654       2458999999986 89998876432 27899999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+|+||||+||+++.++.+||+|||++......       .....++..|+|||++.+.. ++.++||||||
T Consensus       130 l~~lH~~~i~H~dlkp~Nil~~~~~~~~l~Dfg~~~~~~~~-------~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG  201 (278)
T 1byg_A          130 MEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------QDTGKLPVKWTAPEALREKK-FSTKSDVWSFG  201 (278)
T ss_dssp             HHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------------CCTTTSCHHHHHHCC-CCHHHHHHHHH
T ss_pred             HHHHHhCCccccCCCcceEEEeCCCcEEEeecccccccccc-------ccCCCccccccCHHHhCCCC-CCchhcHHHHH
Confidence            99999999999999999999999999999999998765432       12335678899999987654 79999999999


Q ss_pred             HHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         164 CIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       164 vil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      |++++|++ |.+||.+....+....+......   .                            .+...++.+.++|.+|
T Consensus       202 ~il~~l~t~g~~p~~~~~~~~~~~~~~~~~~~---~----------------------------~~~~~~~~l~~li~~~  250 (278)
T 1byg_A          202 ILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKM---D----------------------------APDGCPPAVYEVMKNC  250 (278)
T ss_dssp             HHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCC---C----------------------------CCTTCCHHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCCCCCCHHHHHHHHhcCCCC---C----------------------------CcccCCHHHHHHHHHH
Confidence            99999998 99999887665544443221000   0                            0112467788999999


Q ss_pred             cccCCCCCCCHHHhhc
Q psy7889         243 LLLDPSKRFDSDAALN  258 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~  258 (433)
                      |..||.+|||+.++++
T Consensus       251 l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          251 WHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             TCSSGGGSCCHHHHHH
T ss_pred             hcCChhhCCCHHHHHH
Confidence            9999999999999985

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=100.00  E-value=7.3e-35  Score=277.61  Aligned_cols=206  Identities=23%  Similarity=0.325  Sum_probs=157.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCC--CCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV--KFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~--~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.+|++++||||+++++++.+.          .|+||||+.+ +|.+++.....  .+++..++.++.|++.|
T Consensus        45 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~~----------~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~~~qi~~~  114 (307)
T 2eva_A           45 RKAFIVELRQLSRVNHPNIVKLYGACLNP----------VCLVMEYAEGGSLYNVLHGAEPLPYYTAAHAMSWCLQCSQG  114 (307)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEBCTTT----------TEEEEECCTTCBHHHHHHCSSSEECCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCcCeEEEEEcCC----------cEEEEEcCCCCCHHHHHhccCCCCccCHHHHHHHHHHHHHH
Confidence            35688999999999999999999987632          7999999974 89988876442  37899999999999999


Q ss_pred             HHHHHh---CCeeccCCCCCcEEEecCCc-EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          84 LYYIHS---NKILHRDMKAANVLITKTGI-LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        84 L~~LH~---~~iiH~dikp~NIll~~~~~-~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |+|||+   +||+||||||+||+++.++. +||+|||++......       .....||+.|+|||++.+.. ++.++||
T Consensus       115 l~~LH~~~~~~ivH~dlkp~NIll~~~~~~~kl~Dfg~~~~~~~~-------~~~~~gt~~y~aPE~~~~~~-~~~~~Di  186 (307)
T 2eva_A          115 VAYLHSMQPKALIHRDLKPPNLLLVAGGTVLKICDFGTACDIQTH-------MTNNKGSAAWMAPEVFEGSN-YSEKCDV  186 (307)
T ss_dssp             HHHHHTCSSSCCCCCCCSGGGEEEETTTTEEEECCCCC-------------------CCTTSSCHHHHTCCC-CCTHHHH
T ss_pred             HHHHHhCCCCCeecCCCChhHEEEeCCCCEEEEcccccccccccc-------cccCCCCCceEChhhhCCCC-CCcHHHH
Confidence            999999   89999999999999998886 799999999765421       22346899999999998765 7999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      |||||++|+|++|..||................+... .                            .....+..+.++|
T Consensus       187 ~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~~~~-~----------------------------~~~~~~~~l~~li  237 (307)
T 2eva_A          187 FSWGIILWEVITRRKPFDEIGGPAFRIMWAVHNGTRP-P----------------------------LIKNLPKPIESLM  237 (307)
T ss_dssp             HHHHHHHHHHHHTCCTTTTTCSSHHHHHHHHHTTCCC-C----------------------------CBTTCCHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCchhhCccHHHHHHHHhcCCCC-C----------------------------cccccCHHHHHHH
Confidence            9999999999999999986433221111111111110 0                            0112456778999


Q ss_pred             HhhcccCCCCCCCHHHhhcC
Q psy7889         240 DKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h  259 (433)
                      .+||..||.+|||+++++++
T Consensus       238 ~~~l~~dp~~Rps~~ell~~  257 (307)
T 2eva_A          238 TRCWSKDPSQRPSMEEIVKI  257 (307)
T ss_dssp             HHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHhcCChhhCcCHHHHHHH
Confidence            99999999999999999873

>4fl3_A Tyrosine-protein kinase SYK; transferase; HET: ANP; 1.90A {Homo sapiens} PDB: 4fl2_A* 1a81_A* 1csy_A* 1csz_A*

Probab=100.00  E-value=4e-35  Score=305.42  Aligned_cols=209  Identities=22%  Similarity=0.329  Sum_probs=168.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+++|+.++|||||++++++..         ..++||||||.+ +|.+++.. ...+++..++.++.||+.||+
T Consensus       414 ~~~~~~E~~il~~l~hpnIv~l~~~~~~---------~~~~lv~E~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~~L~  483 (635)
T 4fl3_A          414 KDELLAEANVMQQLDNPYIVRMIGICEA---------ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMK  483 (635)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEES---------SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEec---------CCEEEEEEccCCCCHHHHHhh-CCCCCHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999864         337999999974 78888865 446899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+++.+..... .........+|..|+|||++.+.. ++.++|||||||+
T Consensus       484 yLH~~~iiHrDLkp~NILl~~~~~~kL~DFGla~~~~~~~~-~~~~~~~~~~t~~y~APE~~~~~~-~~~~sDvwSlGv~  561 (635)
T 4fl3_A          484 YLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVL  561 (635)
T ss_dssp             HHHHTTCCCSCCSGGGEEEEETTEEEECCTTHHHHTTC--------------CGGGSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHHCCEeCCCCChHhEEEeCCCCEEEEEcCCccccccCcc-ccccccCCCCceeeeChhhhcCCC-CCcHHHHHHHHHH
Confidence            99999999999999999999999999999999987653321 112223345678899999997655 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|||++ |..||.+....+....+........                               +...+.++.+||.+||.
T Consensus       562 l~ellt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl~  610 (635)
T 4fl3_A          562 MWEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-------------------------------PAGCPREMYDLMNLCWT  610 (635)
T ss_dssp             HHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHcC
Confidence            999998 9999999888776666543221111                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhc
Q psy7889         245 LDPSKRFDSDAALN  258 (433)
Q Consensus       245 ~dP~~R~t~~e~L~  258 (433)
                      .||.+|||++++++
T Consensus       611 ~dP~~RPs~~~l~~  624 (635)
T 4fl3_A          611 YDVENRPGFAAVEL  624 (635)
T ss_dssp             SSTTTSCCHHHHHH
T ss_pred             CCHhHCcCHHHHHH
Confidence            99999999999974

>1fmk_A C-SRC, P60-SRC, tyrosine-protein kinase SRC; tyrosine kinase, phosphorylation, SH2, SH3, phosphotyrosine, proto-oncogene, phosphotransferase; HET: PTR; 1.50A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7 PDB: 1y57_A* 2src_A* 1ksw_A* 2ptk_A* 1yol_A* 2oiq_A* 3d7t_B* 3dqx_A* 3el7_A* 3el8_A* 3en4_A* 3en5_A* 3en6_A* 3en7_A* 3f6x_A* 3g6g_A* 3uqf_A* 3uqg_A* 4agw_A* 3oez_A* ...

Probab=100.00  E-value=4.2e-35  Score=294.15  Aligned_cols=208  Identities=22%  Similarity=0.362  Sum_probs=166.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+.+|+.++|||||++++++..         ..+||||||+. ++|.+++... ...+++..+..++.||+.||
T Consensus       223 ~~~~~~E~~~l~~l~hp~iv~~~~~~~~---------~~~~iv~e~~~~gsL~~~l~~~~~~~~~~~~~~~i~~qi~~~l  293 (452)
T 1fmk_A          223 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM  293 (452)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEcC---------CceEEEehhhcCCCHHHHHHhcCCCCCCHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999864         33799999997 5899988653 34589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+++......   ........++..|+|||++.+.. ++.++|||||||
T Consensus       294 ~~LH~~~ivHrDlkp~Nill~~~~~~kl~DfG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwslG~  369 (452)
T 1fmk_A          294 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  369 (452)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHHhCCeeCCCCChhhEEECCCCCEEECCCccceecCCCc---eecccCCcccccccCHhHHhcCC-CCccccHHhHHH
Confidence            99999999999999999999999999999999998764321   11122345578899999987655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|+|++ |.+||.+....+....+......+.                               +...+..+.+||.+||
T Consensus       370 ~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl  418 (452)
T 1fmk_A          370 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------------------------------PPECPESLHDLMCQCW  418 (452)
T ss_dssp             HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTSCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999999 9999999887776665543211110                               1124566779999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      ..||.+|||++++++
T Consensus       419 ~~dP~~Rpt~~~l~~  433 (452)
T 1fmk_A          419 RKEPEERPTFEYLQA  433 (452)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             cCChhhCcCHHHHHH
Confidence            999999999999986

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=100.00  E-value=5.6e-35  Score=279.79  Aligned_cols=225  Identities=22%  Similarity=0.333  Sum_probs=167.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++||||+++++++.+...      ..+++||||+.+ +|.+++...  .+++..++.++.||+.||+|
T Consensus        78 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~--~~~~~~~~~i~~~l~~~l~~  149 (318)
T 3lxp_A           78 SGWKQEIDILRTLYHEHIIKYKGCCEDAGA------ASLQLVMEYVPLGSLRDYLPRH--SIGLAQLLLFAQQICEGMAY  149 (318)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEEETTT------TEEEEEECCCTTCBHHHHGGGS--CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCcchhhEEEEEecCCC------ceEEEEEecccCCcHHHHHhhC--CCCHHHHHHHHHHHHHHHHH
Confidence            457899999999999999999999987532      678999999975 888888653  48999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++........ .........+|..|+|||++.+.. ++.++|||||||++
T Consensus       150 LH~~~ivH~Dikp~Nil~~~~~~~kl~Dfg~a~~~~~~~~-~~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  227 (318)
T 3lxp_A          150 LHAQHYIHRDLAARNVLLDNDRLVKIGDFGLAKAVPEGHE-YYRVREDGDSPVFWYAPECLKEYK-FYYASDVWSFGVTL  227 (318)
T ss_dssp             HHHTTEECSCCSGGGEEECTTCCEEECCGGGCEECCTTCS-EEEC---CCCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHhCCccCCCCchheEEEcCCCCEEECCcccccccccccc-ccccccCCCCCceeeChHHhcCCC-CCcHHHHHHHHHHH
Confidence            9999999999999999999999999999999987654321 111223456788899999997755 68999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||.........     ..+... .   .....      ..... .........+...+.++.+||.+||..|
T Consensus       228 ~~ll~g~~p~~~~~~~~~~-----~~~~~~-~---~~~~~------~~~~~-~~~~~~~~~~~~~~~~l~~li~~~l~~d  291 (318)
T 3lxp_A          228 YELLTHCDSSQSPPTKFLE-----LIGIAQ-G---QMTVL------RLTEL-LERGERLPRPDKCPAEVYHLMKNCWETE  291 (318)
T ss_dssp             HHHHTTTCGGGSHHHHHHH-----HHCSCC-H---HHHHH------HHHHH-HHTTCCCCCCTTCCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCcccccchhhhh-----hhcccc-c---chhHH------HHHHH-HhcccCCCCCccccHHHHHHHHHHcCCC
Confidence            9999999998764322100     000000 0   00000      00000 0000000112235778889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |.+|||++|+++
T Consensus       292 P~~Rps~~ell~  303 (318)
T 3lxp_A          292 ASFRPTFENLIP  303 (318)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             cccCcCHHHHHH
Confidence            999999999985

>2y4i_B KSR2, HKSR2, kinase suppressor of RAS 2; transferase, KSR1; HET: ATP; 3.46A {Homo sapiens}

Probab=100.00  E-value=5.1e-35  Score=279.75  Aligned_cols=213  Identities=18%  Similarity=0.300  Sum_probs=167.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +.+++||||+. ++|.+++......+++..++.++.||+.||+
T Consensus        73 ~~~~~~e~~~l~~l~h~~iv~~~~~~~~~--------~~~~iv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~al~  144 (319)
T 2y4i_B           73 LKAFKREVMAYRQTRHENVVLFMGACMSP--------PHLAIITSLCKGRTLYSVVRDAKIVLDVNKTRQIAQEIVKGMG  144 (319)
T ss_dssp             CCCCCTTGGGGTTCCCTTBCCCCEEEECS--------SCEEEECBCCCSEEHHHHTTSSCCCCCSHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCEeEEEEEEecC--------CceEEEeecccCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            35677899999999999999999999876        55999999997 5899888776667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcC-CccccccCCcccccccCcccccC--------CCCCCCc
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKN-GQVNRYTNRVVTLWYRPPELLLG--------DRNYGPP  156 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~-~~~~~~~~~~gt~~y~aPE~~~~--------~~~~~~~  156 (433)
                      |||++||+||||||+||+++ ++.+||+|||++........ ..........||..|+|||++.+        ...++.+
T Consensus       145 ~lH~~~i~H~dlkp~NIl~~-~~~~~l~Dfg~~~~~~~~~~~~~~~~~~~~~g~~~y~aPE~~~~~~~~~~~~~~~~~~~  223 (319)
T 2y4i_B          145 YLHAKGILHKDLKSKNVFYD-NGKVVITDFGLFSISGVLQAGRREDKLRIQNGWLCHLAPEIIRQLSPDTEEDKLPFSKH  223 (319)
T ss_dssp             HHHHTTCCCCCCCSTTEEEC---CCEECCCSCCC----------CCSCBCCSGGGGTSCHHHHSCBSCC--CCCSCCCHH
T ss_pred             HHHhCCccccCCChhhEEEe-CCCEEEeecCCccccccccccccccccccCCCcccccChHHhhhccccccccccCCCch
Confidence            99999999999999999998 67999999999876532111 11122334568999999999875        2346889


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHH
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      +|||||||++|+|++|..||.+.........+.....  +.                            ......+.++.
T Consensus       224 ~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~~~--~~----------------------------~~~~~~~~~l~  273 (319)
T 2y4i_B          224 SDVFALGTIWYELHAREWPFKTQPAEAIIWQMGTGMK--PN----------------------------LSQIGMGKEIS  273 (319)
T ss_dssp             HHHHHHHHHHHHHHHSSCSSSSCCHHHHHHHHHTTCC--CC----------------------------CCCSSCCTTHH
T ss_pred             hhHHHHHHHHHHHHhCCCCCCCCCHHHHHHHhccCCC--CC----------------------------CCcCCCCHHHH
Confidence            9999999999999999999998887766555432111  00                            00112456778


Q ss_pred             HHHHhhcccCCCCCCCHHHhhc
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ++|.+||..||.+|||+.++++
T Consensus       274 ~li~~~l~~~p~~Rpt~~~l~~  295 (319)
T 2y4i_B          274 DILLFCWAFEQEERPTFTKLMD  295 (319)
T ss_dssp             HHHHHHHCSSTTTSCCHHHHHH
T ss_pred             HHHHHHhcCChhhCcCHHHHHH
Confidence            9999999999999999999986

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=100.00  E-value=3.3e-35  Score=279.61  Aligned_cols=224  Identities=25%  Similarity=0.325  Sum_probs=167.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc--CCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI--HVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~--~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.+++.++||||+++++++.+.        +..|+||||++ ++|.+++...  ...+++..++.++.||+.|
T Consensus        74 ~~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~i~~~i~~~  145 (307)
T 2nru_A           74 KQQFDQEIKVMAKCQHENLVELLGFSSDG--------DDLCLVYVYMPNGSLLDRLSCLDGTPPLSWHMRCKIAQGAANG  145 (307)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHTGGGCCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEEEEecC--------CceEEEEEecCCCcHHHHHHhccCCCCCCHHHHHHHHHHHHHH
Confidence            35688999999999999999999999875        55899999996 5888888643  3358999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+||||||+||+++.++.+||+|||++........  ........||+.|+|||++.+.  ++.++||||||
T Consensus       146 l~~lH~~~i~H~dlkp~Nili~~~~~~kl~Dfg~~~~~~~~~~--~~~~~~~~g~~~y~aPE~~~~~--~~~~~Dv~slG  221 (307)
T 2nru_A          146 INFLHENHHIHRDIKSANILLDEAFTAKISDFGLARASEKFAQ--TVMTSRIVGTTAYMAPEALRGE--ITPKSDIYSFG  221 (307)
T ss_dssp             HHHHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECCSCSS--CEECSSCCSCGGGCCHHHHTTE--ECTHHHHHHHH
T ss_pred             HHHHhcCCeecCCCCHHHEEEcCCCcEEEeecccccccccccc--cccccccCCCcCcCChHHhcCC--CCccchhHHHH
Confidence            9999999999999999999999999999999999977643221  1122345789999999998753  68999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+......+..+..........    .  ...... ....          .+...+..+.+++.+||
T Consensus       222 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~~~~~~~----~--~~~~~~-~~~~----------~~~~~~~~l~~li~~cl  284 (307)
T 2nru_A          222 VVLLEIITGLPAVDEHREPQLLLDIKEEIEDEEKT----I--EDYIDK-KMND----------ADSTSVEAMYSVASQCL  284 (307)
T ss_dssp             HHHHHHHHCCCSBCTTBSSSBTTHHHHHHHTTSCC----H--HHHSCS-SCSC----------CCHHHHHHHHHHHHHHT
T ss_pred             HHHHHHHHCCCCcccCcchHHHHHHHHHhhhhhhh----h--hhhccc-cccc----------cchHHHHHHHHHHHHHc
Confidence            99999999999998754433222222211110000    0  000000 0000          00112355679999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      ..||.+|||+.+++++
T Consensus       285 ~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          285 HEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             CSSTTTSCCHHHHHHH
T ss_pred             CCCcccCcCHHHHHHH
Confidence            9999999999999863

>4eut_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: BX7; 2.60A {Homo sapiens}

Probab=100.00  E-value=1.8e-35  Score=291.96  Aligned_cols=236  Identities=21%  Similarity=0.331  Sum_probs=170.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC--CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV--KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+|+++|+.++|||||++++++.....      ..+|+|||||. ++|.+++.....  .+++..++.++.||+.||
T Consensus        52 ~~~~~E~~~l~~l~hpnIv~~~~~~~~~~~------~~~~lv~e~~~~g~L~~~l~~~~~~~~l~~~~~~~i~~qi~~aL  125 (396)
T 4eut_A           52 DVQMREFEVLKKLNHKNIVKLFAIEEETTT------RHKVLIMEFCPCGSLYTVLEEPSNAYGLPESEFLIVLRDVVGGM  125 (396)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEECTTT------CCEEEEECCCTTEEHHHHTTSGGGTTCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCeEEEeeccCCC------CeeEEEEecCCCCCHHHHHHhhhcccCCCHHHHHHHHHHHHHHH
Confidence            567799999999999999999999987532      46899999997 589888876432  389999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEE----ecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC-------CCC
Q psy7889          85 YYIHSNKILHRDMKAANVLI----TKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD-------RNY  153 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll----~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~-------~~~  153 (433)
                      +|||++||+||||||+|||+    +.++.+||+|||++.......     ......||..|+|||++.+.       ..+
T Consensus       126 ~~LH~~~ivH~Dlkp~NIll~~~~~~~~~~kL~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~~~~  200 (396)
T 4eut_A          126 NHLRENGIVHRNIKPGNIMRVIGEDGQSVYKLTDFGAARELEDDE-----QFVSLYGTEEYLHPDMYERAVLRKDHQKKY  200 (396)
T ss_dssp             HHHHHTTEECCCCCGGGEEEEECTTSCEEEEECCGGGCEECCCGG-----GSSCSSSCCTTCCHHHHHHHCC--CHHHHH
T ss_pred             HHHHHCCEEECCcCHHHEEEeecCCCceeEEEecCCCceEccCCC-----ccccccCCccccCHHHhhccccccccccCC
Confidence            99999999999999999999    677789999999998765322     23446789999999998641       236


Q ss_pred             CCcchhhhHHHHHHHHHhcCCCCCCCCh-HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCC
Q psy7889         154 GPPVDLWGAGCIMAEMWTRSPIMQGNTE-QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD  232 (433)
Q Consensus       154 ~~~~DiwSlGvil~ell~g~~pf~~~~~-~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s  232 (433)
                      +.++|||||||++|+|++|..||.+... ......+..+....+...+........ ..+.+....+.   ....+...+
T Consensus       201 ~~~~DiwSlG~il~el~tg~~Pf~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~~-~~~~~~~~~~~---~~~l~~~~~  276 (396)
T 4eut_A          201 GATVDLWSIGVTFYHAATGSLPFRPFEGPRRNKEVMYKIITGKPSGAISGVQKAEN-GPIDWSGDMPV---SCSLSRGLQ  276 (396)
T ss_dssp             HHHHHHHHHHHHHHHHHHSSCSEECTTCTTTCHHHHHHHHHSCCTTCCEEEECSTT-CCEEEESSCCT---TCSSCHHHH
T ss_pred             CcHHHHHHHHHHHHHHHHCCCCCCCCCcccchHHHHHHHhcCCCcccchhheeccC-CCcccCccCCc---ccccchHHH
Confidence            7899999999999999999999975322 112222333333333333322221110 00000000000   000001134


Q ss_pred             hhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         233 QYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       233 ~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..+.++|.+||..||.+||+++|+++
T Consensus       277 ~~l~~ll~~~L~~dP~~R~s~~e~l~  302 (396)
T 4eut_A          277 VLLTPVLANILEADQEKCWGFDQFFA  302 (396)
T ss_dssp             HHHHHHHHHHSCCCTTTSCCHHHHHH
T ss_pred             hhchHHHHHhhccChhhhccHHHHHH
Confidence            56679999999999999999999864

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=100.00  E-value=2.5e-34  Score=274.03  Aligned_cols=208  Identities=28%  Similarity=0.430  Sum_probs=156.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+++.++||||+++++++...        +.+++||||+.+ +|.+++..   ....+++..++.++.||+.|
T Consensus        77 ~~~~~E~~~l~~l~h~~i~~~~~~~~~~--------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~~  148 (310)
T 2wqm_A           77 ADCIKEIDLLKQLNHPNVIKYYASFIED--------NELNIVLELADAGDLSRMIKHFKKQKRLIPERTVWKYFVQLCSA  148 (310)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCCSCBHHHHHHHHHHTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEEcC--------CcEEEEEecCCCCCHHHHHHHhcccccCCCHHHHHHHHHHHHHH
Confidence            4578999999999999999999999875        669999999986 88887754   34568999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+|+||||+||+++.++.+||+|||++.......    .......++..|+|||++.+.. ++.++||||||
T Consensus       149 l~~LH~~~i~H~dl~p~NIl~~~~~~~kl~Dfg~~~~~~~~~----~~~~~~~~~~~y~aPE~~~~~~-~~~~~Dv~slG  223 (310)
T 2wqm_A          149 LEHMHSRRVMHRDIKPANVFITATGVVKLGDLGLGRFFSSKT----TAAHSLVGTPYYMSPERIHENG-YNFKSDIWSLG  223 (310)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECTTSCEEECCC----------------------CCSSCCHHHHTTCC-CCHHHHHHHHH
T ss_pred             HHHHhhCCeeCCCCcHHHEEEcCCCCEEEEeccceeeecCCC----ccccccCCCeeEeChHHhCCCC-CCchhhHHHHH
Confidence            999999999999999999999999999999999987764322    1223456799999999987755 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCCh--HHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         164 CIMAEMWTRSPIMQGNTE--QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~--~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      |++|+|++|..||.+...  ......+..  +..+.                            ......+.++.+||.+
T Consensus       224 ~il~~l~~g~~p~~~~~~~~~~~~~~~~~--~~~~~----------------------------~~~~~~~~~l~~li~~  273 (310)
T 2wqm_A          224 CLLYEMAALQSPFYGDKMNLYSLCKKIEQ--CDYPP----------------------------LPSDHYSEELRQLVNM  273 (310)
T ss_dssp             HHHHHHHHSSCTTC---CCHHHHHHHHHT--TCSCC----------------------------CCTTTSCHHHHHHHHH
T ss_pred             HHHHHHHhCCCCCcccchhHHHHHHHhhc--ccCCC----------------------------CcccccCHHHHHHHHH
Confidence            999999999999976432  122222211  11000                            0011246778899999


Q ss_pred             hcccCCCCCCCHHHhhc
Q psy7889         242 LLLLDPSKRFDSDAALN  258 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~  258 (433)
                      ||..||.+|||+.++++
T Consensus       274 ~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          274 CINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             HTCSSGGGSCCHHHHHH
T ss_pred             HcCCChhhCCCHHHHHH
Confidence            99999999999999996

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=100.00  E-value=4.2e-35  Score=302.36  Aligned_cols=240  Identities=24%  Similarity=0.286  Sum_probs=169.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC--CCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV--KFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~--~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+|+.+|+.++|||||++++++.....  ....+..|+|||||. ++|.+++.....  .+++..++.++.||+.||
T Consensus        57 ~~~~~Ei~iL~~L~HpnIV~l~~v~~~~~~--~~~~~~~~LVmEy~~ggsL~~~L~~~~~~~~lse~~i~~I~~QLl~aL  134 (676)
T 3qa8_A           57 ERWCLEIQIMKKLNHPNVVSAREVPDGLQK--LAPNDLPLLAMEYCEGGDLRKYLNQFENCCGLKEGPIRTLLSDISSAL  134 (676)
T ss_dssp             HHHHHHHHHHHHCCBTTBCCEEECCTTTCC--CCTTSSCCCEEECCSSCBHHHHHHSSSCTTCCCSSHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCceeeeeccccc--ccCCCeEEEEEEeCCCCCHHHHHHhcccCCCCCHHHHHHHHHHHHHHH
Confidence            457889999999999999999999865211  112467899999995 589988876433  589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCc---EEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGI---LKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~---~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      +|||++||+||||||+||+++.++.   +||+|||++.......     ......||..|+|||++.+.. ++.++||||
T Consensus       135 ~yLHs~gIVHrDLKP~NILl~~~g~~~~vKL~DFG~a~~~~~~~-----~~~~~~gt~~Y~APE~l~~~~-~s~ksDIwS  208 (676)
T 3qa8_A          135 RYLHENRIIHRDLKPENIVLQPGPQRLIHKIIDLGYAKELDQGE-----LCTEFVGTLQYLAPELLEQKK-YTVTVDYWS  208 (676)
T ss_dssp             HHHHHTTBCCCCCCSTTEEEECCSSSCEEEECSCCCCCBTTSCC-----CCCCCCSCCTTCSSCSSCCSC-CSTTHHHHH
T ss_pred             HHHHHCCCccCCCCHHHeEeecCCCceeEEEccccccccccccc-----ccccccCCcccCChHHhccCC-CCchhHHHH
Confidence            9999999999999999999997664   9999999998765332     234467899999999997765 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|..||.+..........   .............  .......+.....   .........+..+.+||.+
T Consensus       209 LGviLyeLltG~~Pf~~~~~~~~~~~~---i~~~~~~~~~~~~--~l~g~~~~~~~lp---~p~~l~~~ls~~L~dLI~~  280 (676)
T 3qa8_A          209 FGTLAFECITGFRPFLPNWQPVQWHGK---VREKSNEHIVVYD--DLTGAVKFSSVLP---TPNHLSGILAGKLERWLQC  280 (676)
T ss_dssp             HHHHHHHHHSSCSSCCSSCHHHHSSTT---CC------CCSCC--CCSSSCCCCSSSC---CSCCCCGGGHHHHHHHHHH
T ss_pred             HHHHHHHHHHCCCCCCcccchhhhhhh---hhcccchhhhhhh--hhccccccccccC---CchhhchhhhHHHHHHHHH
Confidence            999999999999999876443221100   0000000000000  0000000000000   0000011245678899999


Q ss_pred             hcccCCCCCCCHHHhhcCCCcc
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~  263 (433)
                      ||.+||.+|||+.|+|+||||.
T Consensus       281 mL~~DP~kRPTa~elL~hp~F~  302 (676)
T 3qa8_A          281 MLMWHQRQRGTDPQNPNVGCFQ  302 (676)
T ss_dssp             HSCSSCC---CCTTCCCCTTHH
T ss_pred             HccCCHhhCcCHHHHhcCHHHH
Confidence            9999999999999999999995

>2j0j_A Focal adhesion kinase 1; cell migration, FERM, transferase, integrin signaling; HET: 4ST; 2.80A {Gallus gallus} PDB: 2j0k_A*

Probab=100.00  E-value=2e-34  Score=301.13  Aligned_cols=207  Identities=23%  Similarity=0.346  Sum_probs=170.1

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+++|+.+|+.++|||||++++++.+         +.+|+||||+. ++|.+++......+++..++.++.||+.||.|
T Consensus       436 ~~~~~E~~~l~~l~HpnIv~l~~~~~~---------~~~~lv~E~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~aL~~  506 (656)
T 2j0j_A          436 EKFLQEALTMRQFDHPHIVKLIGVITE---------NPVWIIMELCTLGELRSFLQVRKFSLDLASLILYAYQLSTALAY  506 (656)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEEECCTTCBHHHHHHHTTTTCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCCeEEEEEec---------CceEEEEEcCCCCcHHHHHHhccCCCCHHHHHHHHHHHHHHHHH
Confidence            568899999999999999999999843         34799999998 58999888766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||++........   .......+|+.|+|||++.+.. ++.++|||||||++
T Consensus       507 LH~~givHrDikp~NILl~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~~~DiwSlG~il  582 (656)
T 2j0j_A          507 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  582 (656)
T ss_dssp             HHHTTCCCSCCSGGGEEEEETTEEEECCCCCCCSCCC-------------CCGGGCCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCccccccchHhEEEeCCCCEEEEecCCCeecCCCcc---eeccCCCCCcceeCHHHhcCCC-CCchhhHHHHHHHH
Confidence            9999999999999999999999999999999987653221   1223345678999999997654 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++ |.+||.+....+.+..+........                               +...+..+.+||.+||..
T Consensus       583 ~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~~l~~  631 (656)
T 2j0j_A          583 WEILMHGVKPFQGVKNNDVIGRIENGERLPM-------------------------------PPNCPPTLYSLMTKCWAY  631 (656)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHHTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHcCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccccHHHHHHHHHHcCC
Confidence            99997 9999999888877766654221111                               112456778999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||.+|||+.++++
T Consensus       632 dP~~RPs~~el~~  644 (656)
T 2j0j_A          632 DPSRRPRFTELKA  644 (656)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999985

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=100.00  E-value=4.6e-35  Score=279.91  Aligned_cols=220  Identities=21%  Similarity=0.329  Sum_probs=166.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhc---cCCCCCHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN---IHVKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~---~~~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+|+.+++.++||||+++++++.....    ....+|+||||+.+ +|.+++..   ....+++..++.++.||+.
T Consensus        70 ~~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~~~i~~qi~~  145 (317)
T 2buj_A           70 REEAQREADMHRLFNHPNILRLVAYCLRERG----AKHEAWLLLPFFKRGTLWNEIERLKDKGNFLTEDQILWLLLGICR  145 (317)
T ss_dssp             HHHHHHHHHHHHTCCCTTBCCCCEEEEEEET----TEEEEEEEEECCTTCBHHHHHHHHHTTTCCCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhhcCCCCeeeEEEEEEeccC----CCceeEEEEEeCCCCcHHHHHHHHHhcCCCCCHHHHHHHHHHHHH
Confidence            3567899999999999999999999975321    13578999999986 88888865   3456999999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-----cccccCCcccccccCcccccCCC--CCCC
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-----VNRYTNRVVTLWYRPPELLLGDR--NYGP  155 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-----~~~~~~~~gt~~y~aPE~~~~~~--~~~~  155 (433)
                      ||.|||++||+||||||+||+++.++.+||+|||++..........     ........||+.|+|||++.+..  .++.
T Consensus       146 ~L~~LH~~~ivH~dlkp~NIl~~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~  225 (317)
T 2buj_A          146 GLEAIHAKGYAHRDLKPTNILLGDEGQPVLMDLGSMNQACIHVEGSRQALTLQDWAAQRCTISYRAPELFSVQSHCVIDE  225 (317)
T ss_dssp             HHHHHHHTTEECCCCCGGGEEECTTSCEEECCCSSCEESCEEEESHHHHHHHHHHHHHHSCGGGCCGGGSSCCSEEEECT
T ss_pred             HHHHHHhCCcccCCCCHHHEEEcCCCCEEEEecCcchhcccccccccccccccccccccCCcccCCHhHhccCCCcCCCc
Confidence            9999999999999999999999999999999999987653211100     00112345689999999987543  2688


Q ss_pred             cchhhhHHHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChh
Q psy7889         156 PVDLWGAGCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQY  234 (433)
Q Consensus       156 ~~DiwSlGvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~  234 (433)
                      ++|||||||++|+|++|..||....... .......  ....                            ...+...+.+
T Consensus       226 ~~Di~slG~il~el~~g~~p~~~~~~~~~~~~~~~~--~~~~----------------------------~~~~~~~~~~  275 (317)
T 2buj_A          226 RTDVWSLGCVLYAMMFGEGPYDMVFQKGDSVALAVQ--NQLS----------------------------IPQSPRHSSA  275 (317)
T ss_dssp             HHHHHHHHHHHHHHHHSSCTTHHHHHTTSCHHHHHH--CC------------------------------CCCCTTSCHH
T ss_pred             hhhHHHHHHHHHHHHhCCCChhhhhcccchhhHHhh--ccCC----------------------------CCccccCCHH
Confidence            9999999999999999999995311000 0000000  0000                            0001135677


Q ss_pred             HHHHHHhhcccCCCCCCCHHHhhcCC
Q psy7889         235 GCDLLDKLLLLDPSKRFDSDAALNHD  260 (433)
Q Consensus       235 ~~~li~~~L~~dP~~R~t~~e~L~h~  260 (433)
                      +.++|.+||..||.+|||+++++++-
T Consensus       276 l~~li~~~l~~dp~~Rps~~~ll~~L  301 (317)
T 2buj_A          276 LWQLLNSMMTVDPHQRPHIPLLLSQL  301 (317)
T ss_dssp             HHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             HHHHHHHHhhcChhhCCCHHHHHHHh
Confidence            88999999999999999999999863

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=100.00  E-value=1.5e-34  Score=278.52  Aligned_cols=222  Identities=24%  Similarity=0.320  Sum_probs=160.2

Q ss_pred             chhHHHHHHHHHhC--CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL--KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l--~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+|.+++..+  +||||+++++++......    ...+|+||||+.+ +|.+++...  .+++..++.++.|++.|
T Consensus        73 ~~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~  146 (337)
T 3mdy_A           73 EASWFRETEIYQTVLMRHENILGFIAADIKGTGS----WTQLYLITDYHENGSLYDYLKST--TLDAKSMLKLAYSSVSG  146 (337)
T ss_dssp             HHHHHHHHHHHTSTTCCCTTBCCEEEEEEESCGG----GCEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHH
T ss_pred             cchhhhHHHHHHHHhhcCCCeeeEEEEEccCCCC----CCceEEEEeccCCCcHHHHhhcc--CCCHHHHHHHHHHHHHH
Confidence            34556777877766  899999999999876321    2678999999975 899988653  58999999999999999


Q ss_pred             HHHHHhC--------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCC
Q psy7889          84 LYYIHSN--------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGP  155 (433)
Q Consensus        84 L~~LH~~--------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  155 (433)
                      |+|||++        ||+||||||+|||++.++.+||+|||++..+...............||+.|+|||++.+.. ++.
T Consensus       147 l~~lH~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kl~Dfg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~  225 (337)
T 3mdy_A          147 LCHLHTEIFSTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVKFISDTNEVDIPPNTRVGTKRYMPPEVLDESL-NRN  225 (337)
T ss_dssp             HHHHHSCBCSTTCBCCEECSCCCGGGEEECTTSCEEECCCTTCEECC---------CCSSCSCGGGCCHHHHTTCC-CTT
T ss_pred             HHHHHHhhhhhccCCCEEecccchHHEEECCCCCEEEEeCCCceeeccccccccCCCCCCccCcceeChhhccccc-CCc
Confidence            9999999        9999999999999999999999999999776543332222234567899999999997755 344


Q ss_pred             c------chhhhHHHHHHHHHhc----------CCCCCCCC----hHHHHHHHHHHhCCCCCCCCCcccchhhhhccccc
Q psy7889         156 P------VDLWGAGCIMAEMWTR----------SPIMQGNT----EQQQITLISQLCGSITPESWPGVETLDLYNKMELP  215 (433)
Q Consensus       156 ~------~DiwSlGvil~ell~g----------~~pf~~~~----~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~  215 (433)
                      .      +|||||||++|+|++|          ..||....    .......+.....  ....++.             
T Consensus       226 ~~~~~~~~DiwslG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~-------------  290 (337)
T 3mdy_A          226 HFQSYIMADMYSFGLILWEVARRCVSGGIVEEYQLPYHDLVPSDPSYEDMREIVCIKK--LRPSFPN-------------  290 (337)
T ss_dssp             CTHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHHHTTSC--CCCCCCG-------------
T ss_pred             cccCccccchHHHHHHHHHHHhccCcccccccccccHhhhcCCCCchhhhHHHHhhhc--cCccccc-------------
Confidence            3      9999999999999999          55554321    1111111111000  0000000             


Q ss_pred             hHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         216 KAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       216 ~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                               ...+...+.++.+||.+||..||.+|||+.++++|
T Consensus       291 ---------~~~~~~~~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          291 ---------RWSSDECLRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             ---------GGGGSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             ---------cchhhHHHHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence                     00001123557799999999999999999999975

>2h8h_A Proto-oncogene tyrosine-protein kinase SRC; SRC kinase, transferase; HET: PTR H8H; 2.20A {Homo sapiens} SCOP: b.34.2.1 d.93.1.1 d.144.1.7

Probab=100.00  E-value=9.5e-35  Score=297.40  Aligned_cols=209  Identities=22%  Similarity=0.364  Sum_probs=171.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+.+|+.++|||||++++++..         ..+||||||+.+ +|.+++... ...+++..++.++.||+.||
T Consensus       306 ~~~~~~E~~~l~~l~hpniv~~~~~~~~---------~~~~lv~e~~~~gsL~~~l~~~~~~~l~~~~~~~i~~qi~~~L  376 (535)
T 2h8h_A          306 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM  376 (535)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEECCCTTEEHHHHHSHHHHTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEee---------ccceEeeehhcCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999864         337999999975 899998653 34589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+++......   ........++..|+|||++.+.. ++.++|||||||
T Consensus       377 ~~LH~~~ivHrDlkp~NIll~~~~~~kl~DFG~a~~~~~~~---~~~~~~~~~~~~y~aPE~~~~~~-~~~~sDvwSlGv  452 (535)
T 2h8h_A          377 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNE---YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  452 (535)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECGGGCEEECCTTSTTTCCCHH---HHTTCSTTSCGGGSCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHHhCCeeCCCCCHhhEEEcCCCcEEEcccccceecCCCc---eecccCCcCcccccCHHHhccCC-CCchhhHHHHHH
Confidence            99999999999999999999999999999999998764321   11122345578899999987655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |..||.+....+.+..+........                               +...+..+.+||.+||
T Consensus       453 ~l~el~t~g~~P~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl  501 (535)
T 2h8h_A          453 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPC-------------------------------PPECPESLHDLMCQCW  501 (535)
T ss_dssp             HHHHHTTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHc
Confidence            9999999 9999999887776665543211110                               1124566779999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      ..||.+|||++++++.
T Consensus       502 ~~dP~~RPt~~~l~~~  517 (535)
T 2h8h_A          502 RKEPEERPTFEYLQAF  517 (535)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             CCChhHCcCHHHHHHH
Confidence            9999999999999863

>3sv0_A Casein kinase I-like; typical kinase domain fold, cytosol, transferase; 2.00A {Oryza sativa japonica group}

Probab=100.00  E-value=1.7e-34  Score=290.84  Aligned_cols=220  Identities=20%  Similarity=0.196  Sum_probs=168.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+++|+++++.|+|++++..+..+...       .+..||||||++++|.+++......+++..++.++.||+.||+|
T Consensus        46 ~~~~~~E~~il~~L~~~~~i~~i~~~~~~-------~~~~~lvme~~g~sL~~ll~~~~~~l~~~~~~~i~~qi~~aL~y  118 (483)
T 3sv0_A           46 HPQLLYESKIYRILQGGTGIPNVRWFGVE-------GDYNVLVMDLLGPSLEDLFNFCSRKLSLKTVLMLADQMINRVEF  118 (483)
T ss_dssp             SCCHHHHHHHHHHTTTSTTCCCEEEEEEE-------TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEee-------CCEEEEEEECCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHHH
Confidence            45789999999999875544444444333       36789999999999999998767789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEE---ecCCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          87 IHSNKILHRDMKAANVLI---TKTGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll---~~~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      ||++||+||||||+||||   +.++.+||+|||++..+........   .......||..|+|||++.+.. ++.++|||
T Consensus       119 LH~~gIvHrDIKP~NILl~~~~~~~~vkL~DFGla~~~~~~~~~~~~~~~~~~~~~gt~~Y~aPE~~~~~~-~s~~sDvw  197 (483)
T 3sv0_A          119 VHSKSFLHRDIKPDNFLMGLGRRANQVYIIDFGLAKKYRDTSTHQHIPYRENKNLTGTARYASVNTHLGIE-QSRRDDLE  197 (483)
T ss_dssp             HHHTTEECCCCCGGGEEECCGGGTTCEEECCCTTCEECBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHHHHHH
T ss_pred             HHHCCEeecccCcceEEEecCCCCCeEEEEeCCcceeccCCccccccccccccccCCCccccCHHHhcCCC-CChHHHHH
Confidence            999999999999999999   5889999999999987764332221   1223567899999999998765 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|..||.+.........+..+...                      ..........  ...+.++.+||.
T Consensus       198 SlGvil~elltG~~Pf~~~~~~~~~~~~~~i~~~----------------------~~~~~~~~l~--~~~p~~l~~li~  253 (483)
T 3sv0_A          198 SLGYVLMYFLRGSLPWQGLKAGTKKQKYEKISEK----------------------KVATSIEALC--RGYPTEFASYFH  253 (483)
T ss_dssp             HHHHHHHHHHHSSCTTSSCCCSSHHHHHHHHHHH----------------------HHHSCHHHHH--TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHhCCCCCccccchhHHHHHHHHhhc----------------------cccccHHHHh--cCCcHHHHHHHH
Confidence            9999999999999999875442222222111100                      0000000000  134678889999


Q ss_pred             hhcccCCCCCCCHHHhhc
Q psy7889         241 KLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~  258 (433)
                      +||..||.+||+++++++
T Consensus       254 ~cl~~dP~~RPs~~el~~  271 (483)
T 3sv0_A          254 YCRSLRFDDKPDYSYLKR  271 (483)
T ss_dssp             HHHTCCTTCCCCHHHHHH
T ss_pred             HHhcCChhhCcCHHHHHH
Confidence            999999999999988764

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=100.00  E-value=1.4e-34  Score=274.55  Aligned_cols=204  Identities=23%  Similarity=0.364  Sum_probs=154.7

Q ss_pred             chhHHHHHHHH-HhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il-~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+.++ +.++||||+++++++.....    ....+|+||||+.+ +|.+++.... ..+++..++.++.||+.|
T Consensus        54 ~~~~~~e~~~~~~~~~h~~i~~~~~~~~~~~~----~~~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~~i~~qi~~~  129 (299)
T 3m2w_A           54 CPKARREVELHWRASQCPHIVRIVDVYENLYA----GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA  129 (299)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TEEEEEEEECCCCSCBHHHHHHHCTTCCCBHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhccCCCchhHHhhhhhhcC----CCceEEEEEeecCCCcHHHHHHhccCCCCCHHHHHHHHHHHHHH
Confidence            35678999998 55689999999999976211    13678999999975 8999987654 359999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      |+|||++||+||||||+||+++.   ++.+||+|||++.....                           ..++.++|||
T Consensus       130 l~~lH~~~i~H~dlkp~Nil~~~~~~~~~~kl~Dfg~a~~~~~---------------------------~~~~~~~Diw  182 (299)
T 3m2w_A          130 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTG---------------------------EKYDKSCDMW  182 (299)
T ss_dssp             HHHHHHTTEECCCCSGGGEEESSSSTTCCEEECCCTTCEECTT---------------------------CGGGGHHHHH
T ss_pred             HHHHHhCCcccCCCCHHHEEEecCCCCCcEEEecccccccccc---------------------------ccCCchhhHH
Confidence            99999999999999999999998   78999999998854321                           2367899999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||.+.........+               ...........+....         ...+.++.+||.
T Consensus       183 slG~il~el~tg~~pf~~~~~~~~~~~~---------------~~~~~~~~~~~~~~~~---------~~~~~~~~~li~  238 (299)
T 3m2w_A          183 SLGVIMYILLCGYPPFYSNHGLAISPGM---------------KTRIRMGQYEFPNPEW---------SEVSEEVKMLIR  238 (299)
T ss_dssp             HHHHHHHHHHHSSCSCCC-------CCS---------------CCSSCTTCCSSCHHHH---------TTSCHHHHHHHH
T ss_pred             HHHHHHHHHHHCCCCCCCCcchhhhHHH---------------HHHHhhccccCCchhc---------ccCCHHHHHHHH
Confidence            9999999999999999876543211100               0000000011111100         135778899999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||..||.+|||++|+|+||||.+.
T Consensus       239 ~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          239 NLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             HHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             HHcccChhhCCCHHHHhcChhhccc
Confidence            9999999999999999999999653

>3e7e_A HBUB1, BUB1A, mitotic checkpoint serine/threonine-protein kinas; spindle assembly checkpoint, mitosis, kinase, activation, KE CDC20, ATP-binding; HET: ATP; 2.31A {Homo sapiens}

Probab=100.00  E-value=8.1e-35  Score=284.09  Aligned_cols=208  Identities=14%  Similarity=0.154  Sum_probs=164.6

Q ss_pred             CCchhHHHHHHHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc----cCCCCCHHHHHHH
Q psy7889           5 FFPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN----IHVKFSLGEIKKV   76 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~----~~~~l~~~~~~~i   76 (433)
                      .....+.+|+.+++.++   |+||+++++++...        +..|||||||. ++|.+++..    ....+++..++.+
T Consensus       106 ~~~~~~~~e~~~~~~l~~~~~~~iv~~~~~~~~~--------~~~~lv~e~~~~g~L~~~l~~~~~~~~~~l~~~~~~~i  177 (365)
T 3e7e_A          106 ANPWEFYIGTQLMERLKPSMQHMFMKFYSAHLFQ--------NGSVLVGELYSYGTLLNAINLYKNTPEKVMPQGLVISF  177 (365)
T ss_dssp             CCHHHHHHHHHHHHHSCGGGGGGBCCEEEEEECS--------SCEEEEECCCCSCBHHHHHHHHHTSTTCSCCHHHHHHH
T ss_pred             CChhHHHHHHHHHHHhhhhhhhhhhhhheeeecC--------CCcEEEEeccCCCcHHHHHHHhhcccccCCCHHHHHHH
Confidence            44567889999999997   99999999999876        55899999997 589988864    2446999999999


Q ss_pred             HHHHHHHHHHHHhCCeeccCCCCCcEEEec-----------CCcEEEeecCCccccccCcCCccccccCCcccccccCcc
Q psy7889          77 IQQLLNGLYYIHSNKILHRDMKAANVLITK-----------TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPE  145 (433)
Q Consensus        77 ~~qll~aL~~LH~~~iiH~dikp~NIll~~-----------~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (433)
                      +.||+.||+|||++||+||||||+|||++.           ++.+||+|||+++.+.....  .......+||+.|+|||
T Consensus       178 ~~qi~~~L~~lH~~~ivHrDiKp~NIll~~~~~~~~~~~~~~~~~kl~DFG~a~~~~~~~~--~~~~~~~~gt~~y~aPE  255 (365)
T 3e7e_A          178 AMRMLYMIEQVHDCEIIHGDIKPDNFILGNGFLEQDDEDDLSAGLALIDLGQSIDMKLFPK--GTIFTAKCETSGFQCVE  255 (365)
T ss_dssp             HHHHHHHHHHHHTTTEECCCCSGGGEEECGGGTCC------CTTEEECCCTTCEEGGGSCT--TEEECCSSCTTSCCCHH
T ss_pred             HHHHHHHHHHHhhCCeecCCCCHHHEEecccccCccccccccCCEEEeeCchhhhhhccCC--CceeeeecCCCCCCChH
Confidence            999999999999999999999999999998           89999999999976542211  12345568999999999


Q ss_pred             cccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhh
Q psy7889         146 LLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKER  225 (433)
Q Consensus       146 ~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  225 (433)
                      ++.+.. |+.++|||||||++|+|++|.+||.......                +.   .                 ...
T Consensus       256 ~~~~~~-~~~~~DiwslG~il~elltg~~pf~~~~~~~----------------~~---~-----------------~~~  298 (365)
T 3e7e_A          256 MLSNKP-WNYQIDYFGVAATVYCMLFGTYMKVKNEGGE----------------CK---P-----------------EGL  298 (365)
T ss_dssp             HHTTCC-BSTHHHHHHHHHHHHHHHHSSCCCEEEETTE----------------EE---E-----------------CSC
T ss_pred             HhcCCC-CCccccHHHHHHHHHHHHhCCCccccCCCCc----------------ee---e-----------------chh
Confidence            998866 8999999999999999999999986532210                00   0                 000


Q ss_pred             hCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         226 LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       226 ~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      +.....+....+++.+||..+|.+|++..+.|.+
T Consensus       299 ~~~~~~~~~~~~~~~~~l~~~p~~r~~~~~~l~~  332 (365)
T 3e7e_A          299 FRRLPHLDMWNEFFHVMLNIPDCHHLPSLDLLRQ  332 (365)
T ss_dssp             CTTCSSHHHHHHHHHHHHCCCCTTCCCCHHHHHH
T ss_pred             ccccCcHHHHHHHHHHHcCCCCCCcchHHHHHHH
Confidence            0111123445689999999999999776555554

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=100.00  E-value=2.7e-34  Score=275.99  Aligned_cols=228  Identities=18%  Similarity=0.303  Sum_probs=167.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++||||+++++++.....      ..+++||||+++ +|.+++......+++..++.++.||+.||.|
T Consensus        87 ~~~~~E~~~l~~l~h~~iv~~~~~~~~~~~------~~~~lv~e~~~~~~L~~~l~~~~~~~~~~~~~~i~~qi~~aL~~  160 (326)
T 2w1i_A           87 RDFEREIEILKSLQHDNIVKYKGVCYSAGR------RNLKLIMEYLPYGSLRDYLQKHKERIDHIKLLQYTSQICKGMEY  160 (326)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECC----------CCEEEECCCTTCBHHHHHHHSTTSSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEEecCC------CceEEEEECCCCCCHHHHHHhcccCCCHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999876522      468999999975 9999998876679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||++......... ........++..|+|||++.+.. ++.++|||||||++
T Consensus       161 LH~~~ivH~dikp~NIli~~~~~~kL~Dfg~~~~~~~~~~~-~~~~~~~~~~~~y~aPE~~~~~~-~~~~~Di~slG~il  238 (326)
T 2w1i_A          161 LGTKRYIHRDLATRNILVENENRVKIGDFGLTKVLPQDKEY-YKVKEPGESPIFWYAPESLTESK-FSVASDVWSFGVVL  238 (326)
T ss_dssp             HHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCSSCSE-EECSSCCSCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHhCCEeccCCCcceEEEcCCCcEEEecCcchhhccccccc-cccccCCCCceeEECchhhcCCC-CCchhhHHHHHHHH
Confidence            99999999999999999999999999999999876543211 11123345678899999987655 78999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|..||......     +....+......+   .......      .... ......+...+.++.++|.+||..|
T Consensus       239 ~el~tg~~~~~~~~~~-----~~~~~~~~~~~~~---~~~~~~~------~~~~-~~~~~~~~~~~~~l~~li~~cl~~d  303 (326)
T 2w1i_A          239 YELFTYIEKSKSPPAE-----FMRMIGNDKQGQM---IVFHLIE------LLKN-NGRLPRPDGCPDEIYMIMTECWNNN  303 (326)
T ss_dssp             HHHHHTTCGGGSHHHH-----HHHHHCTTCCTHH---HHHHHHH------HHHT-TCCCCCCTTCCHHHHHHHHHHSCSS
T ss_pred             HHHHhcCCCCCCCHHH-----HHHhhccccchhh---hHHHHHH------Hhhc-CCCCCCCCcccHHHHHHHHHHcCCC
Confidence            9999999888643211     1111111110000   0000000      0000 0000012235678889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |.+|||+.++++
T Consensus       304 P~~Rps~~el~~  315 (326)
T 2w1i_A          304 VNQRPSFRDLAL  315 (326)
T ss_dssp             GGGSCCHHHHHH
T ss_pred             hhhCcCHHHHHH
Confidence            999999999985

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=100.00  E-value=8.5e-34  Score=273.96  Aligned_cols=223  Identities=22%  Similarity=0.306  Sum_probs=165.2

Q ss_pred             chhHHHHHHHHHh--CCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQL--LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~--l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|+++++.  ++||||+++++++......    ...+|+||||+.+ +|.+++.+.  .+++..++.++.||+.|
T Consensus        78 ~~~~~~e~~~~~~~~l~h~ni~~~~~~~~~~~~~----~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~~i~~~  151 (342)
T 1b6c_B           78 ERSWFREAEIYQTVMLRHENILGFIAADNKDNGT----WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASG  151 (342)
T ss_dssp             HHHHHHHHHHHHHSCCCCTTBCCEEEEEECCCSS----CCCEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCcEEEEEeeecccCCc----cceeEEEEeecCCCcHHHHHhcc--CccHHHHHHHHHHHHHH
Confidence            4567889999998  6899999999999876321    2368999999986 899988753  58999999999999999


Q ss_pred             HHHHH--------hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC---
Q psy7889          84 LYYIH--------SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN---  152 (433)
Q Consensus        84 L~~LH--------~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~---  152 (433)
                      |.|||        +.||+||||||+||+++.++.+||+|||++..................||+.|+|||++.+...   
T Consensus       152 l~~lH~~~~~~~~~~~ivH~Dlkp~NIll~~~~~~kL~Dfg~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~  231 (342)
T 1b6c_B          152 LAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKH  231 (342)
T ss_dssp             HHHHHCCBCSTTCBCEEECSCCSGGGEEECTTSCEEECCCTTCEEEETTTTEEEECCCSCCCCGGGCCHHHHTSCCCTTC
T ss_pred             HHHHHHHHhhhcccCCeeeCCCCHHHEEECCCCCEEEEECCCceeccccccccccccccCCcCcccCCHhhhcccccccc
Confidence            99999        8999999999999999999999999999997765432211112345678999999999876532   


Q ss_pred             --CCCcchhhhHHHHHHHHHhc----------CCCCCCCCh----HHHHHHHHHHhCCCCCCCCCcccchhhhhccccch
Q psy7889         153 --YGPPVDLWGAGCIMAEMWTR----------SPIMQGNTE----QQQITLISQLCGSITPESWPGVETLDLYNKMELPK  216 (433)
Q Consensus       153 --~~~~~DiwSlGvil~ell~g----------~~pf~~~~~----~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~  216 (433)
                        ++.++|||||||++|+|++|          ..||.....    ...+...  +.........+.              
T Consensus       232 ~~~~~~~Di~slG~il~el~tg~~~~~~~~~~~~p~~~~~~~~~~~~~~~~~--~~~~~~~~~~~~--------------  295 (342)
T 1b6c_B          232 FESFKRADIYAMGLVFWEIARRCSIGGIHEDYQLPYYDLVPSDPSVEEMRKV--VCEQKLRPNIPN--------------  295 (342)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTBCBTTBCCCCCCTTTTTSCSSCCHHHHHHH--HTTSCCCCCCCG--------------
T ss_pred             cccCCcccHHHHHHHHHHHHhccCcCCcccccccCccccCcCcccHHHHHHH--HHHHHhCCCCcc--------------
Confidence              23689999999999999999          667765321    1111111  111100000000              


Q ss_pred             HHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         217 AQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       217 ~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                              .......+..+.+||.+||..||.+|||++++++|
T Consensus       296 --------~~~~~~~~~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          296 --------RWQSCEALRVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             --------GGGTSHHHHHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             --------cccchhHHHHHHHHHHHHhccChhhCCCHHHHHHH
Confidence                    00001122456699999999999999999999975

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=100.00  E-value=2.1e-34  Score=277.67  Aligned_cols=245  Identities=21%  Similarity=0.295  Sum_probs=158.3

Q ss_pred             hhHHHHHHHHH--hCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQ--LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il~--~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+..|.+++.  .++||||+++++.+.....   .....+|+|||||+ ++|.+++...  ..++..++.++.||+.||
T Consensus        50 ~~~~~e~~~~~~~~~~h~~i~~~~~~~~~~~~---~~~~~~~lv~e~~~~g~L~~~l~~~--~~~~~~~~~i~~qi~~~L  124 (336)
T 3g2f_A           50 QNFINEKNIYRVPLMEHDNIARFIVGDERVTA---DGRMEYLLVMEYYPNGSLXKYLSLH--TSDWVSSCRLAHSVTRGL  124 (336)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECT---TSCEEEEEEECCCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHH
T ss_pred             hhHHHHHHHHHHHhccCcchhhheeccccccc---CCCceEEEEEecCCCCcHHHHHhhc--ccchhHHHHHHHHHHHHH
Confidence            34555666654  4799999999987654311   11356899999996 5899988654  358899999999999999


Q ss_pred             HHHHhC---------CeeccCCCCCcEEEecCCcEEEeecCCccccccCcCC----ccccccCCcccccccCcccccCC-
Q psy7889          85 YYIHSN---------KILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG----QVNRYTNRVVTLWYRPPELLLGD-  150 (433)
Q Consensus        85 ~~LH~~---------~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~----~~~~~~~~~gt~~y~aPE~~~~~-  150 (433)
                      +|||+.         ||+||||||+|||++.++.+||+|||++..+......    .........||+.|+|||++.+. 
T Consensus       125 ~~LH~~~~~~~~~~~~ivH~Dikp~Nill~~~~~~kL~DFG~a~~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~  204 (336)
T 3g2f_A          125 AYLHTELPRGDHYKPAISHRDLNSRNVLVKNDGTCVISDFGLSMRLTGNRLVRPGEEDNAAISEVGTIRYMAPEVLEGAV  204 (336)
T ss_dssp             HHHHCCBCCGGGCBCCEECSSCSGGGEEECTTSCEEECCCTTCEECSSSSCC---------CCTTSCGGGCCHHHHTTCC
T ss_pred             HHHHhhhccccccccceeecccccceEEEcCCCcEEEeeccceeecccccccCccccccccccCCCccceeCchhhcCCc
Confidence            999999         9999999999999999999999999999876532211    11223345789999999999763 


Q ss_pred             -----CCCCCcchhhhHHHHHHHHHhcCC-CCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHh
Q psy7889         151 -----RNYGPPVDLWGAGCIMAEMWTRSP-IMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKE  224 (433)
Q Consensus       151 -----~~~~~~~DiwSlGvil~ell~g~~-pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  224 (433)
                           ..++.++|||||||++|+|++|.. +|.+.........+....+..+.     .......  ... .........
T Consensus       205 ~~~~~~~~~~~~DiwslG~il~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~-----~~~~~~~--~~~-~~~~~~~~~  276 (336)
T 3g2f_A          205 NLRDXESALKQVDMYALGLIYWEIFMRCTDLFPGESVPEYQMAFQTEVGNHPT-----FEDMQVL--VSR-EKQRPKFPE  276 (336)
T ss_dssp             CGGGHHHHHHHHHHHHHHHHHHHHHTTBGGGSTTSCCCCCCCTTHHHHCSSCC-----HHHHHHH--HTT-SCCCCCCCT
T ss_pred             ccccccccccccchHHHHHHHHHHHhcCCcCCCccchhHHHHhhhcccCCCch-----HHHHHhh--hcc-cccCCCCCc
Confidence                 225678999999999999999954 44443211100000000000000     0000000  000 000000000


Q ss_pred             h-hCCccCChhHHHHHHhhcccCCCCCCCHHHhh------cCCCccCC
Q psy7889         225 R-LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL------NHDFFWTD  265 (433)
Q Consensus       225 ~-~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L------~h~~~~~~  265 (433)
                      . ......+.++.+||.+||..||.+|||++|++      -++|-++.
T Consensus       277 ~~~~~~~~~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~~  324 (336)
T 3g2f_A          277 AWKENSLAVRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERNK  324 (336)
T ss_dssp             TCCCCSHHHHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC--
T ss_pred             ccccccchHHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhcc
Confidence            0 00011234678999999999999999999995      45666443

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=100.00  E-value=7.5e-35  Score=281.05  Aligned_cols=213  Identities=18%  Similarity=0.138  Sum_probs=153.8

Q ss_pred             hhHHHHHHHHHhCC---------CCCccceeeeEEecCc-----------------c-----ccccCceEEEEeecCcC-
Q psy7889           8 ITALREIKILQLLK---------HENVVHLIEICRTKAN-----------------Q-----YNRYRSTFYLVFDFCEH-   55 (433)
Q Consensus         8 ~~~~~Ei~il~~l~---------hpnIv~l~~~~~~~~~-----------------~-----~~~~~~~~~lV~e~~~~-   55 (433)
                      ..+.+|+.+|+.++         |||||++++++...+.                 .     .......+|||||||.+ 
T Consensus        68 ~~~~~E~~~l~~l~~l~~~~~~~h~niv~l~~~~~~~~~~hp~iv~~~~~~~~~~~~~~~~~~~~~~~~~~lv~E~~~~g  147 (336)
T 2vuw_A           68 EEILPEIIISKELSLLSGEVCNRTEGFIGLNSVHCVQGSYPPLLLKAWDHYNSTKGSANDRPDFFKDDQLFIVLEFEFGG  147 (336)
T ss_dssp             HHHHHHHHHHHHHHHGGGCSSSBCCCBCCEEEEEEEESSCCHHHHHHHHHHHHHTCCSSCCSCCCCTTCEEEEEEEECCC
T ss_pred             HHHHHHHHHHHHHHHhhccccccCCchhhhcceeEecCCCcHHHHHHHHHHhhhccccccCccccccCeEEEEEEecCCC
Confidence            67899999999986         7777777666542210                 0     00013679999999965 


Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCcEEEecCC--------------------cEEEee
Q psy7889          56 DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH-SNKILHRDMKAANVLITKTG--------------------ILKLAD  114 (433)
Q Consensus        56 ~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH-~~~iiH~dikp~NIll~~~~--------------------~~kl~D  114 (433)
                      ++.+.+.+  ..+++..++.++.||+.||+||| ++||+||||||+|||++.++                    .+||+|
T Consensus       148 ~ll~~~~~--~~~~~~~~~~i~~qi~~aL~~lH~~~~ivHrDlKp~NILl~~~~~~~~~~~~~~~~~~~~~~~~~vkL~D  225 (336)
T 2vuw_A          148 IDLEQMRT--KLSSLATAKSILHQLTASLAVAEASLRFEHRDLHWGNVLLKKTSLKKLHYTLNGKSSTIPSCGLQVSIID  225 (336)
T ss_dssp             EETGGGTT--TCCCHHHHHHHHHHHHHHHHHHHHHHCCBCSCCCGGGEEEEECSCSEEEEEETTEEEEEECTTEEEEECC
T ss_pred             ccHHHHHh--cCCCHHHHHHHHHHHHHHHHHHHHhCCEeECCCCHHHEEEeccCCcceeeeccCccccccCCCceEEEee
Confidence            35555543  46899999999999999999999 99999999999999999887                    899999


Q ss_pred             cCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH-HHHHHhcCCCCCCCChHH-HHHHHHHHh
Q psy7889         115 FGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI-MAEMWTRSPIMQGNTEQQ-QITLISQLC  192 (433)
Q Consensus       115 Fg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi-l~ell~g~~pf~~~~~~~-~~~~i~~~~  192 (433)
                      ||+|+.....         ..+||+.|+|||++.+..  +.++||||+|++ .+++++|..||.+..... ....+....
T Consensus       226 FG~a~~~~~~---------~~~gt~~y~aPE~~~g~~--~~~~Diwsl~~~~~~~~~~g~~p~~~~~~~~~~~~~~~~~~  294 (336)
T 2vuw_A          226 YTLSRLERDG---------IVVFCDVSMDEDLFTGDG--DYQFDIYRLMKKENNNRWGEYHPYSNVLWLHYLTDKMLKQM  294 (336)
T ss_dssp             CTTCBEEETT---------EEECCCCTTCSGGGCCCS--SHHHHHHHHHHHHHTTCTTSCCTHHHHHHHHHHHHHHHHTC
T ss_pred             ccccEecCCC---------cEEEeecccChhhhcCCC--ccceehhhhhCCCCcccccccCCCcchhhhhHHHHhhhhhh
Confidence            9999876421         347899999999998754  789999998877 677888998885421111 111111110


Q ss_pred             CCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhh-cCCCcc
Q psy7889         193 GSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAAL-NHDFFW  263 (433)
Q Consensus       193 g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L-~h~~~~  263 (433)
                      .... ..     .         .. ..         ...++++++||.+||+.|     |++|+| +||||+
T Consensus       295 ~~~~-~~-----~---------~~-~~---------~~~s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          295 TFKT-KC-----N---------TP-AM---------KQIKRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             CCSS-CC-----C---------SH-HH---------HHHHHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             ccCc-cc-----c---------hh-hh---------hhcCHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            0000 00     0         00 00         013567889999999987     999999 999994

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=100.00  E-value=4.1e-34  Score=283.63  Aligned_cols=214  Identities=13%  Similarity=0.153  Sum_probs=159.3

Q ss_pred             chhHHHHHHHHHhCCC-CCc---------cceeeeEEecCcc---------ccccCceEEEEeecCcCCHHHHHhc----
Q psy7889           7 PITALREIKILQLLKH-ENV---------VHLIEICRTKANQ---------YNRYRSTFYLVFDFCEHDLAGLLSN----   63 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~h-pnI---------v~l~~~~~~~~~~---------~~~~~~~~~lV~e~~~~~L~~~l~~----   63 (433)
                      ...+.+|+.+++.++| +|+         +...+.....+..         .......++++|+++.++|.+++..    
T Consensus       122 ~~~~~~E~~~~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~L~~ll~~l~~~  201 (413)
T 3dzo_A          122 IKQMKEEVLRLRLLRGIKNQKQAKVHLRFIFPFDLVKDPQKKKMIRVRLDERDMWVLSRFFLYPRMQSNLQTFGEVLLSH  201 (413)
T ss_dssp             CHHHHHHHHGGGGSTTCCSHHHHHHHTCBCCCCEEEECCC---------------CCSEEEEEECCSEEHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhhccCCCHHHHHHhcccccchhhcccCCCCccccccCCCccccccceEEEeehhcCCHHHHHHHhhcc
Confidence            4567899999999977 322         2222222211100         0011245789999999999988842    


Q ss_pred             --cCCCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccc
Q psy7889          64 --IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWY  141 (433)
Q Consensus        64 --~~~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y  141 (433)
                        ....+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.....       ....+| +.|
T Consensus       202 ~~~~~~l~~~~~~~i~~qi~~aL~~LH~~~iiHrDiKp~NILl~~~~~~kL~DFG~a~~~~~~-------~~~~~g-~~y  273 (413)
T 3dzo_A          202 SSTHKSLVHHARLQLTLQVIRLLASLHHYGLVHTYLRPVDIVLDQRGGVFLTGFEHLVRDGAS-------AVSPIG-RGF  273 (413)
T ss_dssp             TTTSHHHHHHHHHHHHHHHHHHHHHHHHTTEECSCCCGGGEEECTTCCEEECCGGGCEETTEE-------ECCCCC-TTT
T ss_pred             cccCCCCCHHHHHHHHHHHHHHHHHHHhCCcccCCcccceEEEecCCeEEEEeccceeecCCc-------cccCCC-Cce
Confidence              2334778889999999999999999999999999999999999999999999998765432       344567 899


Q ss_pred             cCccccc---------CCCCCCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc
Q psy7889         142 RPPELLL---------GDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM  212 (433)
Q Consensus       142 ~aPE~~~---------~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~  212 (433)
                      +|||++.         ....++.++|||||||++|+|++|..||.+.........+                    +.  
T Consensus       274 ~aPE~~~~~~~~~~~~~~~~~~~~~DvwSlGvil~elltg~~Pf~~~~~~~~~~~~--------------------~~--  331 (413)
T 3dzo_A          274 APPETTAERMLPFGQHHPTLMTFAFDTWTLGLAIYWIWCADLPNTDDAALGGSEWI--------------------FR--  331 (413)
T ss_dssp             CCHHHHHHHTSTTGGGCCEEECHHHHHHHHHHHHHHHHHSSCCCCTTGGGSCSGGG--------------------GS--
T ss_pred             eCchhhhccccccccccCcCCCchhhHHHHHHHHHHHHHCCCCCCCcchhhhHHHH--------------------Hh--
Confidence            9999983         2334788999999999999999999999875432110000                    00  


Q ss_pred             ccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         213 ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       213 ~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                                    .....+.++.+||.+||..||.+|||+.++++||||..
T Consensus       332 --------------~~~~~~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~~  369 (413)
T 3dzo_A          332 --------------SCKNIPQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  369 (413)
T ss_dssp             --------------SCCCCCHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             --------------hcccCCHHHHHHHHHHccCChhhCcCHHHHHhCHHHHH
Confidence                          01134677889999999999999999999999999954

>2pzi_A Probable serine/threonine-protein kinase PKNG; ATP-recognition, kinase-INH complex, rubredoxin fold, TPR domain, transferase; HET: AXX; 2.40A {Mycobacterium tuberculosis}

Probab=99.97  E-value=9.6e-33  Score=290.64  Aligned_cols=201  Identities=19%  Similarity=0.285  Sum_probs=158.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++|||||++++++......   .....||||||+++ +|.+.+..   .+++..++.++.||+.||.|
T Consensus       124 ~~~~~E~~~l~~l~hp~iv~~~~~~~~~~~~---~~~~~~lv~E~~~g~~L~~~~~~---~l~~~~~~~~~~qi~~aL~~  197 (681)
T 2pzi_A          124 AMAMAERQFLAEVVHPSIVQIFNFVEHTDRH---GDPVGYIVMEYVGGQSLKRSKGQ---KLPVAEAIAYLLEILPALSY  197 (681)
T ss_dssp             HHHHHHHGGGGGCCCTTBCCEEEEEEEECTT---SCEEEEEEEECCCCEECC----C---CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCeEeeeEeecCCC---CCceeEEEEEeCCCCcHHHHHhC---CCCHHHHHHHHHHHHHHHHH
Confidence            3578999999999999999999999876321   11236999999985 66655433   68999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+ .+||+|||++......        ....||+.|+|||++.+.  ++.++|||||||++
T Consensus       198 lH~~giiHrDlkp~NIll~~~-~~kl~DFG~a~~~~~~--------~~~~gt~~y~aPE~~~~~--~~~~sDi~slG~~l  266 (681)
T 2pzi_A          198 LHSIGLVYNDLKPENIMLTEE-QLKLIDLGAVSRINSF--------GYLYGTPGFQAPEIVRTG--PTVATDIYTVGRTL  266 (681)
T ss_dssp             HHHTTEECCCCSGGGEEECSS-CEEECCCTTCEETTCC--------SCCCCCTTTSCTTHHHHC--SCHHHHHHHHHHHH
T ss_pred             HHHCCCeecccChHHeEEeCC-cEEEEecccchhcccC--------CccCCCccccCHHHHcCC--CCCceehhhhHHHH
Confidence            999999999999999999875 8999999999775422        345789999999998764  48899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      ++|++|.+||.+....                ..+..           ..           ....+..+.+||.+||..|
T Consensus       267 ~~l~~g~~~~~~~~~~----------------~~~~~-----------~~-----------~~~~~~~l~~li~~~l~~d  308 (681)
T 2pzi_A          267 AALTLDLPTRNGRYVD----------------GLPED-----------DP-----------VLKTYDSYGRLLRRAIDPD  308 (681)
T ss_dssp             HHHHSCCCEETTEECS----------------SCCTT-----------CH-----------HHHHCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCcccccc----------------ccccc-----------cc-----------ccccCHHHHHHHhhhccCC
Confidence            9999999888752100                00000           00           0012456779999999999


Q ss_pred             CCCCCCHHHhhcCCCcc
Q psy7889         247 PSKRFDSDAALNHDFFW  263 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~  263 (433)
                      |.+||+..+++.|+|+.
T Consensus       309 P~~R~~~~~~l~~~l~~  325 (681)
T 2pzi_A          309 PRQRFTTAEEMSAQLTG  325 (681)
T ss_dssp             GGGSCSSHHHHHHHHHH
T ss_pred             hhhCCCHHHHHHHHHHH
Confidence            99999999999999873

>3uqc_A Probable conserved transmembrane protein; structural genomics, TB structural genomics consortium, TBSG fold, FHAA, transferase; 2.26A {Mycobacterium tuberculosis} PDB: 3oun_B* 3otv_A 3ouk_A

Probab=99.97  E-value=3.7e-31  Score=249.42  Aligned_cols=182  Identities=13%  Similarity=0.070  Sum_probs=141.5

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+++.++||||+++++++.+.        +.+|+||||+. ++|.+++..   .....++..++.||+.||+|
T Consensus        76 ~~~~~e~~~l~~l~hp~iv~~~~~~~~~--------~~~~lv~e~~~g~~L~~~l~~---~~~~~~~~~i~~ql~~aL~~  144 (286)
T 3uqc_A           76 QETLSRTLRLSRIDKPGVARVLDVVHTR--------AGGLVVAEWIRGGSLQEVADT---SPSPVGAIRAMQSLAAAADA  144 (286)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCCEEEHHHHHTT---CCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCcceeeEEEEEC--------CcEEEEEEecCCCCHHHHHhc---CCChHHHHHHHHHHHHHHHH
Confidence            5789999999999999999999999875        66999999997 588888754   24666788999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.+|.+||+++|                        |++        .++.++|||||||++
T Consensus       145 lH~~givH~Dikp~NIll~~~g~~kl~~~~------------------------~~~--------~~~~~~Di~slG~il  192 (286)
T 3uqc_A          145 AHRAGVALSIDHPSRVRVSIDGDVVLAYPA------------------------TMP--------DANPQDDIRGIGASL  192 (286)
T ss_dssp             HHHTTCCCCCCSGGGEEEETTSCEEECSCC------------------------CCT--------TCCHHHHHHHHHHHH
T ss_pred             HHHCCCccCCCCcccEEEcCCCCEEEEecc------------------------ccC--------CCCchhHHHHHHHHH
Confidence            999999999999999999999999998543                        222        268899999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|..||.+.+....+...           .....     .  ..+..  .    . .....+.++.+||.+||..|
T Consensus       193 ~elltg~~Pf~~~~~~~~~~~~-----------~~~~~-----~--~~~~~--~----~-~~~~~~~~l~~li~~~l~~d  247 (286)
T 3uqc_A          193 YALLVNRWPLPEAGVRSGLAPA-----------ERDTA-----G--QPIEP--A----D-IDRDIPFQISAVAARSVQGD  247 (286)
T ss_dssp             HHHHHSEECSCCCSBCCCSEEC-----------CBCTT-----S--CBCCH--H----H-HCTTSCHHHHHHHHHHHCTT
T ss_pred             HHHHHCCCCCCcCCcchhhHHH-----------HHHhc-----c--CCCCh--h----h-cccCCCHHHHHHHHHHcccC
Confidence            9999999999875432100000           00000     0  00000  0    0 01135677889999999999


Q ss_pred             CCCCCCHHHhhc
Q psy7889         247 PSKRFDSDAALN  258 (433)
Q Consensus       247 P~~R~t~~e~L~  258 (433)
                      |.+| |+.|+++
T Consensus       248 P~~R-s~~el~~  258 (286)
T 3uqc_A          248 GGIR-SASTLLN  258 (286)
T ss_dssp             SSCC-CHHHHHH
T ss_pred             CccC-CHHHHHH
Confidence            9999 9999986

>4azs_A Methyltransferase WBDD; kinase; HET: AMP SAM; 2.15A {Escherichia coli} PDB: 4azt_A* 4azv_A* 4azw_A*

Probab=99.96  E-value=2.4e-30  Score=265.76  Aligned_cols=147  Identities=18%  Similarity=0.133  Sum_probs=110.8

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +.+.+|+++|+++ +|+||++++++++++        ..+|||||||+| +|.+.+.. ...+++.   .|+.||+.||+
T Consensus       286 ~~~~~E~~~l~~~~~~~~i~~~~~~~ed~--------~~~yLVMEyv~G~~L~d~i~~-~~~l~~~---~I~~QIl~AL~  353 (569)
T 4azs_A          286 YELHNEIKFLTQPPAGFDAPAVLAHGENA--------QSGWLVMEKLPGRLLSDMLAA-GEEIDRE---KILGSLLRSLA  353 (569)
T ss_dssp             HHHHHHHHHHHSCCTTCCCCCEEEEEECS--------SEEEEEEECCCSEEHHHHHHT-TCCCCHH---HHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeEEEEEEEEC--------CEEEEEEecCCCCcHHHHHHh-CCCCCHH---HHHHHHHHHHH
Confidence            4588999999999 799999999999986        669999999986 88888876 4467665   47899999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++|||||||||+|||++.+|.+||+|||+|+......    ....+.+||+.|+|||++.+.  +..++|+||+|++
T Consensus       354 ylH~~GIIHRDIKPeNILL~~dg~vKL~DFGlAr~~~~~~----~~~~t~vGTp~YmAPE~l~g~--~~~~~d~~s~g~~  427 (569)
T 4azs_A          354 ALEKQGFWHDDVRPWNVMVDARQHARLIDFGSIVTTPQDC----SWPTNLVQSFFVFVNELFAEN--KSWNGFWRSAPVH  427 (569)
T ss_dssp             HHHHTTCEESCCCGGGEEECTTSCEEECCCTTEESCC-------CCSHHHHHHHHHHHHHHC------------------
T ss_pred             HHHHCCceeccCchHhEEECCCCCEEEeecccCeeCCCCC----ccccCceechhhccHHHhCCC--CCCcccccccccc
Confidence            9999999999999999999999999999999998765322    233456899999999999774  5778999999999


Q ss_pred             HHHHHhc
Q psy7889         166 MAEMWTR  172 (433)
Q Consensus       166 l~ell~g  172 (433)
                      +++|.++
T Consensus       428 ~~~l~~~  434 (569)
T 4azs_A          428 PFNLPQP  434 (569)
T ss_dssp             -CCCCTT
T ss_pred             hhhhccc
Confidence            8887655

>3en9_A Glycoprotease, O-sialoglycoprotein endopeptidase/protein kinase; endopeptidase activity, protein kinase activity; HET: TBR; 2.67A {Methanocaldococcus jannaschii} PDB: 3enh_A* 2vwb_A*

Probab=99.86  E-value=3.4e-23  Score=211.39  Aligned_cols=150  Identities=15%  Similarity=0.168  Sum_probs=118.7

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+++|++++||||+++..++...        +..|||||||+ ++|.+++..         +..++.|++.||+|
T Consensus       384 ~~~~~E~~il~~l~h~nIv~~~~~~~~~--------~~~~lVmE~~~ggsL~~~l~~---------~~~i~~qi~~aL~~  446 (540)
T 3en9_A          384 SRTAREARYLALVKDFGIPAPYIFDVDL--------DNKRIMMSYINGKLAKDVIED---------NLDIAYKIGEIVGK  446 (540)
T ss_dssp             HHHHHHHHHHHHGGGGTCCCCCEEEEET--------TTTEEEEECCCSEEHHHHSTT---------CTHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCcCceEEEEEeC--------CccEEEEECCCCCCHHHHHHH---------HHHHHHHHHHHHHH
Confidence            3478999999999999999554444443        34699999997 688888765         56899999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccc---cccCCcccccccCcccccCC-CCCCCcchhhhH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN---RYTNRVVTLWYRPPELLLGD-RNYGPPVDLWGA  162 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~---~~~~~~gt~~y~aPE~~~~~-~~~~~~~DiwSl  162 (433)
                      ||++||+||||||+|||++.  .+||+|||+++...........   .....+||+.|+|||++.+. ..|+..+|+||.
T Consensus       447 LH~~gIiHrDiKp~NILl~~--~~kL~DFGla~~~~~~~~~~~~~~~~~~~~~GT~~y~APEv~~~~~~~Y~~~~d~ws~  524 (540)
T 3en9_A          447 LHKNDVIHNDLTTSNFIFDK--DLYIIDFGLGKISNLDEDKAVDLIVFKKAVLSTHHEKFDEIWERFLEGYKSVYDRWEI  524 (540)
T ss_dssp             HHHTTEECTTCCTTSEEESS--SEEECCCTTCEECCCHHHHHHHHHHHHHHHHHHCGGGHHHHHHHHHHHHHHHCTTHHH
T ss_pred             HHHCcCccCCCCHHHEEECC--eEEEEECccCEECCCccccccchhhhhhhhcCCCCcCCHHHHHHHHHHHHHHHhHHHH
Confidence            99999999999999999998  9999999999887543211000   12356789999999998651 236788999999


Q ss_pred             HHHHHHHHhcCCCC
Q psy7889         163 GCIMAEMWTRSPIM  176 (433)
Q Consensus       163 Gvil~ell~g~~pf  176 (433)
                      ++-..+-+.++..|
T Consensus       525 vl~~l~~v~~r~rY  538 (540)
T 3en9_A          525 ILELMKDVERRARY  538 (540)
T ss_dssp             HHHHHHHHHTCSCC
T ss_pred             HHHHHHHHHhcccc
Confidence            88888877666554

>1zar_A RIO2 kinase; serine kinase, winged-helix, RIO domain, ADP-Mn complex, rRNA processing, transferase; HET: ADP; 1.75A {Archaeoglobus fulgidus} SCOP: a.4.5.56 d.144.1.9 PDB: 1tqi_A* 1tqp_A* 1tqm_A* 1zao_A*

Probab=99.70  E-value=5.3e-18  Score=158.84  Aligned_cols=116  Identities=19%  Similarity=0.226  Sum_probs=89.4

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++  | +++++++..         +..|+||||+++ +|.+ +.       ......++.|++.||.|
T Consensus       149 ~~~~~E~~~l~~l~--~-~~v~~~~~~---------~~~~lvmE~~~g~~L~~-l~-------~~~~~~i~~qi~~~l~~  208 (282)
T 1zar_A          149 RSARNEFRALQKLQ--G-LAVPKVYAW---------EGNAVLMELIDAKELYR-VR-------VENPDEVLDMILEEVAK  208 (282)
T ss_dssp             HHHHHHHHHHHHTT--T-SSSCCEEEE---------ETTEEEEECCCCEEGGG-CC-------CSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcc--C-CCcCeEEec---------cceEEEEEecCCCcHHH-cc-------hhhHHHHHHHHHHHHHH
Confidence            45789999999999  5 666666543         336999999976 6665 31       12455799999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC---------CCCCCcc
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD---------RNYGPPV  157 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~---------~~~~~~~  157 (433)
                      ||++||+||||||+|||++ +|.+||+|||++..                 +..+.|||.+...         ..|+..+
T Consensus       209 lH~~giiHrDlkp~NILl~-~~~vkl~DFG~a~~-----------------~~~~~a~e~l~rdv~~i~~~f~~~~~~~~  270 (282)
T 1zar_A          209 FYHRGIVHGDLSQYNVLVS-EEGIWIIDFPQSVE-----------------VGEEGWREILERDVRNIITYFSRTYRTEK  270 (282)
T ss_dssp             HHHTTEECSCCSTTSEEEE-TTEEEECCCTTCEE-----------------TTSTTHHHHHHHHHHHHHHHHHHHHCCCC
T ss_pred             HHHCCCEeCCCCHHHEEEE-CCcEEEEECCCCeE-----------------CCCCCHHHHHHHHHHHHHHHHHHhcCCCC
Confidence            9999999999999999999 99999999999854                 3346788876421         1245666


Q ss_pred             hhhh
Q psy7889         158 DLWG  161 (433)
Q Consensus       158 DiwS  161 (433)
                      |+|.
T Consensus       271 ~~~~  274 (282)
T 1zar_A          271 DINS  274 (282)
T ss_dssp             CHHH
T ss_pred             ChHH
Confidence            6665

>1zth_A RIO1 serine protein kinase; ribosome biogenesis, rRNA, ADP, manganese, transferase; HET: ADP; 1.89A {Archaeoglobus fulgidus} PDB: 1zp9_A* 1ztf_A*

Probab=99.54  E-value=7.4e-15  Score=135.61  Aligned_cols=95  Identities=15%  Similarity=0.243  Sum_probs=76.3

Q ss_pred             hHHHHHHHHHhCCCCCc--cceeeeEEecCccccccCceEEEEeecCcC------CHHHHHhccCCCCCHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENV--VHLIEICRTKANQYNRYRSTFYLVFDFCEH------DLAGLLSNIHVKFSLGEIKKVIQQL   80 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnI--v~l~~~~~~~~~~~~~~~~~~~lV~e~~~~------~L~~~l~~~~~~l~~~~~~~i~~ql   80 (433)
                      .+.+|+.+|+.++|++|  ..+++.            ...+|||||+++      .|.+....    .++..+..++.||
T Consensus       116 ~~~~E~~~l~~l~~~~i~~p~~~~~------------~~~~lVmE~~g~~g~~~~~L~~~~~~----~~~~~~~~i~~qi  179 (258)
T 1zth_A          116 WTEKEFRNLERAKEAGVSVPQPYTY------------MKNVLLMEFIGEDELPAPTLVELGRE----LKELDVEGIFNDV  179 (258)
T ss_dssp             HHHHHHHHHHHHHHTTCCCCCEEEE------------ETTEEEEECCEETTEECCBHHHHGGG----GGGSCHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCCCeEEEc------------CCCEEEEEecCCCCCccccHHHHhhc----cChHHHHHHHHHH
Confidence            68899999999988865  333331            125899999953      56655432    2355788899999


Q ss_pred             HHHHHHHH-hCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          81 LNGLYYIH-SNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        81 l~aL~~LH-~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      +.||.||| +.||+||||||+|||++.  .++|+|||+|...
T Consensus       180 ~~~l~~lH~~~givHrDlkp~NILl~~--~~~liDFG~a~~~  219 (258)
T 1zth_A          180 VENVKRLYQEAELVHADLSEYNIMYID--KVYFIDMGQAVTL  219 (258)
T ss_dssp             HHHHHHHHHTSCEECSSCSTTSEEESS--SEEECCCTTCEET
T ss_pred             HHHHHHHHHHCCEEeCCCCHHHEEEcC--cEEEEECcccccC
Confidence            99999999 999999999999999988  8999999998654

>4gyi_A RIO2 kinase; protein kinase, ADP complex, phosphoaspartate, acyl-phosphat ribosome biogenesis, Ser/Thr protein kinase; HET: PHD ADP; 2.20A {Chaetomium thermophilum} PDB: 4gyg_A

Probab=99.12  E-value=4.6e-11  Score=115.27  Aligned_cols=93  Identities=14%  Similarity=0.230  Sum_probs=64.8

Q ss_pred             HHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHHHHHHh
Q psy7889          11 LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHS   89 (433)
Q Consensus        11 ~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH~   89 (433)
                      .+|...|.++.+.+|....-+...          ..+|||||++|. |..+       ...+.+..++.||+.+|.+||+
T Consensus       161 ~kE~~nL~rL~~~gv~vp~p~~~~----------~~~LVME~i~G~~L~~l-------~~~~~~~~l~~qll~~l~~lH~  223 (397)
T 4gyi_A          161 IKEFAFMKALYEEGFPVPEPIAQS----------RHTIVMSLVDALPMRQV-------SSVPDPASLYADLIALILRLAK  223 (397)
T ss_dssp             HHHHHHHHHHHHTTCSCCCEEEEE----------TTEEEEECCSCEEGGGC-------CCCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCeeeecc----------CceEEEEecCCccHhhh-------cccHHHHHHHHHHHHHHHHHHH
Confidence            456667777754444322211111          137999999873 3221       1223456788999999999999


Q ss_pred             CCeeccCCCCCcEEEecCC----------cEEEeecCCccc
Q psy7889          90 NKILHRDMKAANVLITKTG----------ILKLADFGLARA  120 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~----------~~kl~DFg~a~~  120 (433)
                      +|||||||||.|||++.+|          .+.|+||+-+..
T Consensus       224 ~gIVHrDLKp~NILl~~dgd~~d~~~~~~~~~iID~~Q~V~  264 (397)
T 4gyi_A          224 HGLIHGDFNEFNILIREEKDAEDPSSITLTPIIIXFPQMVS  264 (397)
T ss_dssp             TTEECSCCSTTSEEEEEEECSSCTTSEEEEEEECCCTTCEE
T ss_pred             CCCcCCCCCHHHEEEeCCCCcccccccccceEEEEeCCccc
Confidence            9999999999999998776          388999986644

>3tm0_A Aminoglycoside 3'-phosphotransferase; protein kinase, phosphorylation, transferase-antibiotic COMP; HET: ANP B31; 2.10A {Enterococcus faecalis} SCOP: d.144.1.6 PDB: 2b0q_A* 1l8t_A* 3q2j_A* 1j7i_A* 1j7u_A* 3h8p_A* 1j7l_A* 2bkk_A*

Probab=98.79  E-value=1.9e-08  Score=92.35  Aligned_cols=99  Identities=15%  Similarity=0.178  Sum_probs=77.8

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.|. +..+.++++++.+.        +..|+||||++| ++...+.      +......++.++..+|
T Consensus        53 ~~~~~~E~~~l~~l~~~~~vP~v~~~~~~~--------~~~~lv~e~i~G~~l~~~~~------~~~~~~~~~~~l~~~l  118 (263)
T 3tm0_A           53 TYDVEREKDMMLWLEGKLPVPKVLHFERHD--------GWSNLLMSEADGVLCSEEYE------DEQSPEKIIELYAECI  118 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--------TEEEEEEECCSSEEHHHHCC------TTTCHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCeEEEEEecC--------CceEEEEEecCCeehhhccC------CcccHHHHHHHHHHHH
Confidence            457899999999994 77788999888764        568999999998 4544321      1223346788999999


Q ss_pred             HHHHh-----------------------------------------------------------CCeeccCCCCCcEEEe
Q psy7889          85 YYIHS-----------------------------------------------------------NKILHRDMKAANVLIT  105 (433)
Q Consensus        85 ~~LH~-----------------------------------------------------------~~iiH~dikp~NIll~  105 (433)
                      ..||+                                                           ..++|+|++|.||+++
T Consensus       119 ~~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~l~~~~~~~~~~l~HgDl~~~Nil~~  198 (263)
T 3tm0_A          119 RLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK  198 (263)
T ss_dssp             HHHHHSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCSGGGGSTTCSSSSHHHHHHHHHHCCCCCCEEEECSSCCTTSEEEE
T ss_pred             HHHhCCCcccCCCcchHHHHHHHHHHHHhccccccccccccccccCCCHHHHHHHHHhcCCCCCceEECCCCCcCcEEEE
Confidence            99998                                                           4589999999999998


Q ss_pred             cCCcEEEeecCCcc
Q psy7889         106 KTGILKLADFGLAR  119 (433)
Q Consensus       106 ~~~~~kl~DFg~a~  119 (433)
                      .++.+.|+||+.+.
T Consensus       199 ~~~~~~lIDwe~a~  212 (263)
T 3tm0_A          199 DGKVSGFIDLGRSG  212 (263)
T ss_dssp             TTEEEEECCCTTCE
T ss_pred             CCcEEEEEEchhcc
Confidence            76666799998663

>3dxp_A Putative acyl-COA dehydrogenase; protein kinase-like fold, structural genomics, joint center structural genomics, JCSG; 2.32A {Ralstonia eutropha JMP134}

Probab=98.61  E-value=7.9e-08  Score=92.61  Aligned_cols=107  Identities=16%  Similarity=0.303  Sum_probs=81.5

Q ss_pred             chhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|+.+|+.|.  +..+.+++.++.+...     .+..|+||||++|....  ......++......++.+++.+|
T Consensus        80 ~~~~~~E~~~l~~L~~~~vpvP~~~~~~~~~~~-----~g~~~~vme~v~G~~l~--~~~~~~l~~~~~~~~~~~l~~~L  152 (359)
T 3dxp_A           80 AHAIEREYRVMDALAGTDVPVAKMYALCEDESV-----IGRAFYIMEFVSGRVLW--DQSLPGMSPAERTAIYDEMNRVI  152 (359)
T ss_dssp             --CHHHHHHHHHHHTTSSSCCCCEEEEECCTTT-----TSSCEEEEECCCCBCCC--CTTCTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhhcCCCCCCcEEEECCCCCc-----cCCeEEEEEecCCeecC--CCccccCCHHHHHHHHHHHHHHH
Confidence            357889999999996  5568888888765421     24578999999973210  01122467888889999999999


Q ss_pred             HHHHh----------------------------------------------------------CCeeccCCCCCcEEEec
Q psy7889          85 YYIHS----------------------------------------------------------NKILHRDMKAANVLITK  106 (433)
Q Consensus        85 ~~LH~----------------------------------------------------------~~iiH~dikp~NIll~~  106 (433)
                      ..||+                                                          .+++|+|++|.||+++.
T Consensus       153 a~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~~~lvHgD~~~~Nil~~~  232 (359)
T 3dxp_A          153 AAMHTVDYQAIGLGDYGKPGNYFQRQIERWTKQYKLSETESIPAMDSLMDWLPQHIPQEDADLTSIVHGDYRLDNLMFHP  232 (359)
T ss_dssp             HHHHHSCTTTTTCTTSSCCSCHHHHHHHHHHHHHHHHCCSCCHHHHHHHHHGGGCCCSTTSSCCEEECSSCSGGGEEECS
T ss_pred             HHHhCCCchhccccccCCCCCchHHHHHHHHHHHHhcCCcCChHHHHHHHHHHhcCCCccCCCceEEeCCCCCCcEEEeC
Confidence            99997                                                          36999999999999997


Q ss_pred             CC--cEEEeecCCccc
Q psy7889         107 TG--ILKLADFGLARA  120 (433)
Q Consensus       107 ~~--~~kl~DFg~a~~  120 (433)
                      ++  .+.|+||+.+..
T Consensus       233 ~~~~v~~viDwe~a~~  248 (359)
T 3dxp_A          233 TEPRVLAVLDWELSTL  248 (359)
T ss_dssp             SSSCEEEECCCTTCEE
T ss_pred             CCCcEEEEECcccccc
Confidence            65  368999998865

>1nd4_A Aminoglycoside 3'-phosphotransferase; protein kinase, ATPase, kanamycin; HET: KAN; 2.10A {Klebsiella pneumoniae} SCOP: d.144.1.6

Probab=98.57  E-value=9.4e-08  Score=87.29  Aligned_cols=97  Identities=11%  Similarity=0.140  Sum_probs=70.2

Q ss_pred             hhHHHHHHHHHhCCCCC--ccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHEN--VVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpn--Iv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|+.+|+.+.+.+  +.+++++....        +..++||||++|.-.. ..    ...   ...++.++...|.
T Consensus        58 ~~~~~E~~~l~~l~~~~~~vP~~~~~~~~~--------~~~~~v~e~i~G~~l~-~~----~~~---~~~~~~~l~~~l~  121 (264)
T 1nd4_A           58 NELQDEAARLSWLATTGVPCAAVLDVVTEA--------GRDWLLLGEVPGQDLL-SS----HLA---PAEKVSIMADAMR  121 (264)
T ss_dssp             SCHHHHHHHHHHHHTTTCCBCCEEEEEECS--------SCEEEEEECCSSEETT-TS----CCC---HHHHHHHHHHHHH
T ss_pred             hhhhHHHHHHHHHHhCCCCCCeEEEeccCC--------CCCEEEEEecCCcccC-cC----cCC---HhHHHHHHHHHHH
Confidence            56789999999995444  55688877654        4589999999873222 11    112   2245677777777


Q ss_pred             HHHhCC----------------------------------------------------------eeccCCCCCcEEEecC
Q psy7889          86 YIHSNK----------------------------------------------------------ILHRDMKAANVLITKT  107 (433)
Q Consensus        86 ~LH~~~----------------------------------------------------------iiH~dikp~NIll~~~  107 (433)
                      .||+..                                                          ++|+|++|.||+++.+
T Consensus       122 ~lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HgDl~~~Nil~~~~  201 (264)
T 1nd4_A          122 RLHTLDPATCPFDHQAKHRIERARTRMEAGLVDQDDLDEEHQGLAPAELFARLKARMPDGEDLVVTHGDACLPNIMVENG  201 (264)
T ss_dssp             HHTTSCGGGCCCBCCHHHHHHHHHHHHHTTCCCTTSCCGGGTTCCHHHHHHHHHHTCCSSCCEEEECSSCCGGGEEEETT
T ss_pred             HHhCCCCCCCCCchHHHHHHHHHHHHHhcCCccchhhhhhccCccHHHHHHHHHHhcCCCCCeEEECCCCCCCcEEEECC
Confidence            777643                                                          9999999999999877


Q ss_pred             CcEEEeecCCccc
Q psy7889         108 GILKLADFGLARA  120 (433)
Q Consensus       108 ~~~kl~DFg~a~~  120 (433)
                      +.+.|+|||.+..
T Consensus       202 ~~~~liD~~~a~~  214 (264)
T 1nd4_A          202 RFSGFIDCGRLGV  214 (264)
T ss_dssp             EEEEECCCTTCEE
T ss_pred             cEEEEEcchhccc
Confidence            6677999997643

>3sg8_A APH(2'')-ID; antibiotic resistance enzyme, transferase, aminoglycoside, phosphorylation, transferase-antibiotic complex; HET: TOY; 1.80A {Enterococcus casseliflavus} PDB: 3sg9_A* 3n4v_A 3n4t_A 3n4u_A 3r81_A* 3r80_A* 3r7z_A* 3r82_A* 3vcq_A* 4dbx_A 4de4_A* 4dfb_A* 4dfu_A* 4dt9_A* 4dt8_A* 4dtb_A* 3sgc_A 4dta_A* 3lzh_A

Probab=98.35  E-value=1.8e-07  Score=87.90  Aligned_cols=156  Identities=15%  Similarity=0.114  Sum_probs=94.2

Q ss_pred             hhHHHHHHHHHhC-CCCCc--cceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLL-KHENV--VHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnI--v~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|+.+ .+..|  .+.+.......     .....|+||++++| ++.....   ..++.++...++.++...
T Consensus        55 ~~~~~E~~~l~~l~~~~~v~vP~~~~~~~~~~-----~~~~~~~vm~~i~G~~l~~~~~---~~l~~~~~~~~~~~l~~~  126 (304)
T 3sg8_A           55 TNLFNEVNILKRIHNKLPLPIPEVVFTGMPSE-----TYQMSFAGFTKIKGVPLTPLLL---NNLPKQSQNQAAKDLARF  126 (304)
T ss_dssp             HHHHHHHHHHHHHTTSSSSCCCCEEEECCCCS-----SCSCSCEEEECCCCEECCHHHH---HTSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCceEeecCCCC-----CCCcceEEEcccCCeECCcccc---ccCCHHHHHHHHHHHHHH
Confidence            4678999999988 44333  34433322211     11345899999997 2322221   246777778888888888


Q ss_pred             HHHHHh----------------------------------------------------------CCeeccCCCCCcEEEe
Q psy7889          84 LYYIHS----------------------------------------------------------NKILHRDMKAANVLIT  105 (433)
Q Consensus        84 L~~LH~----------------------------------------------------------~~iiH~dikp~NIll~  105 (433)
                      +..||+                                                          ..++|+|++|.||+++
T Consensus       127 la~LH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l~~  206 (304)
T 3sg8_A          127 LSELHSINISGFKSNLVLDFREKINEDNKKIKKLLSRELKGPQMKKVDDFYRDILENEIYFKYYPCLIHNDFSSDHILFD  206 (304)
T ss_dssp             HHHHHHSCCTTSCGGGBCCHHHHHHHHHHHHHHHHTTTSCHHHHHHHHHHHHHHHTCGGGTCCCCEEECSCCCGGGEEEE
T ss_pred             HHHHHcCCCCCCCccchhhHHHHHHHHHHHHHHHhcccCCcccHHHHHHHHHHHHhccccccCCceeEeCCCCcccEEEe
Confidence            888885                                                          2479999999999999


Q ss_pred             c--CCcEEEeecCCccccccCcCCccccccCCcccccccCcccc----cCCCC---------CCCcchhhhHHHHHHHHH
Q psy7889         106 K--TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELL----LGDRN---------YGPPVDLWGAGCIMAEMW  170 (433)
Q Consensus       106 ~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~----~~~~~---------~~~~~DiwSlGvil~ell  170 (433)
                      .  .+.+.|+||+.+.......+  ........   .-..|+..    .+...         .....+.|++|.+++.+.
T Consensus       207 ~~~~~~~~~iD~~~~~~~~~~~D--l~~~~~~~---~~~~~~~~~~~l~~Y~~~~~~~~~~r~~~~~~~~~l~~~~~~~~  281 (304)
T 3sg8_A          207 TEKNTICGIIDFGDAAISDPDND--FISLMEDD---EEYGMEFVSKILNHYKHKDIPTVLEKYRMKEKYWSFEKIIYGKE  281 (304)
T ss_dssp             TTTTEEEEECCCTTCEEECTTHH--HHTTCCTT---TSCCHHHHHHHHHHHTCSCHHHHHHHHHHHHHHHHHHHHHHHHH
T ss_pred             CCCCCEEEEEeCCCCccCChHHH--HHHHHhhc---cccCHHHHHHHHHHcCCCCcHHHHHHHHHHHHHHHHHHHHHHHH
Confidence            8  45688999998865322100  00000000   00122211    11000         011258999999999999


Q ss_pred             hcCCCC
Q psy7889         171 TRSPIM  176 (433)
Q Consensus       171 ~g~~pf  176 (433)
                      +|.++|
T Consensus       282 ~g~~~~  287 (304)
T 3sg8_A          282 YGYMDW  287 (304)
T ss_dssp             TTCHHH
T ss_pred             cCCHHH
Confidence            997665

>4f9c_A Cell division cycle 7-related protein kinase; Ser/Thr protein kinase, transferase, phosphorylation, cell C cell division, mitosis, S phase; HET: 0SX; 2.08A {Homo sapiens} PDB: 4f99_A* 4f9b_A* 4f9a_A*

Probab=98.19  E-value=7.2e-07  Score=85.92  Aligned_cols=34  Identities=44%  Similarity=0.616  Sum_probs=32.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++|+|||++||++||.+|+||+|||+||||++-
T Consensus       326 s~~a~DLl~~lL~~dP~~R~ta~eaL~Hp~f~~i  359 (361)
T 4f9c_A          326 PDEAYDLLDKLLDLNPASRITAEEALLHPFFKDM  359 (361)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCC
Confidence            8899999999999999999999999999999763

>4b99_A Mitogen-activated protein kinase 7; transferase, inhibitor; HET: R4L; 2.80A {Homo sapiens}

Probab=98.15  E-value=8.5e-07  Score=86.51  Aligned_cols=44  Identities=30%  Similarity=0.424  Sum_probs=37.7

Q ss_pred             ccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         328 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ...++..  +++++|||.+||.+||.+|+||+|+|+||||+..+.|
T Consensus       311 ~~~~~~~--s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~p  354 (398)
T 4b99_A          311 ETVYPGA--DRQALSLLGRMLRFEPSARISAAAALRHPFLAKYHDP  354 (398)
T ss_dssp             HHHSTTC--CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGTTTCCG
T ss_pred             HHhCCCC--CHHHHHHHHHHCcCChhHCcCHHHHhcCHhhCcCCCC
Confidence            3344555  8999999999999999999999999999999876544

>3mi9_A Cell division protein kinase 9; P-TEFB, HIV-1, protein binding; HET: TPO; 2.10A {Homo sapiens} PDB: 3mia_A* 4ec9_A* 4ec8_A* 3blh_A* 3blq_A* 3blr_A* 3lq5_A* 3my1_A* 3tn8_A* 3tnh_A* 3tni_A* 4bch_A* 4bci_A* 4bcj_A* 4bcf_A*

Probab=98.14  E-value=1.2e-06  Score=83.76  Aligned_cols=61  Identities=72%  Similarity=1.258  Sum_probs=54.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhhhhhhhhhhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRP  397 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  397 (433)
                      ++++++||.+||.+||.+|+|++|+|+||||+..+.|.....+.+....++.+|....++.
T Consensus       285 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~~~~~~~~~~~~~~~~~~e~~~~~~~~  345 (351)
T 3mi9_A          285 DPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDLKGMLSTHLTSMFEYLAPPRRK  345 (351)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGSSSCCCCSHHHHHSSCSSHHHHHSCSCC-
T ss_pred             ChHHHHHHHHHhcCChhhCCCHHHHhCCCCcCCCCCccccccccCcchHHHHHHhcCCCCC
Confidence            7789999999999999999999999999999999999888877888888999998866654

>3rgf_A Cyclin-dependent kinase 8; protein kinase complex, transferase,transcription; HET: BAX; 2.20A {Homo sapiens}

Probab=98.04  E-value=1.4e-06  Score=85.17  Aligned_cols=39  Identities=41%  Similarity=0.771  Sum_probs=35.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD  375 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~  375 (433)
                      ++.+++||.+||.+||.+|+||+|+|+||||...+.+..
T Consensus       307 ~~~~~~Ll~~~L~~dP~~R~ta~e~L~hp~f~~~~~~~~  345 (405)
T 3rgf_A          307 DSKAFHLLQKLLTMDPIKRITSEQAMQDPYFLEDPLPTS  345 (405)
T ss_dssp             TSHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTSSSCCCS
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHhcChhhccCCCCcc
Confidence            678999999999999999999999999999998776643

>3tdw_A Gentamicin resistance protein; kinase, phosphoryl transfer, antibiotic resistance, transfer; HET: GDP; 1.70A {Enterococcus gallinarum} PDB: 3tdv_A*

Probab=97.82  E-value=0.00012  Score=68.71  Aligned_cols=103  Identities=17%  Similarity=0.174  Sum_probs=66.1

Q ss_pred             hhHHHHHHHHHhCCCC---CccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHE---NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hp---nIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|+.|.+.   .|.+.+.+....       .+..|+|||+++|. +......   .++......++.++...
T Consensus        54 ~~~~~E~~~L~~L~~~~~v~VP~~~~~~~~~-------~g~~~~v~e~i~G~~l~~~~~~---~l~~~~~~~~~~~lg~~  123 (306)
T 3tdw_A           54 DELNKEIQLLPLLVGCVKVNIPQYVYIGKRS-------DGNPFVGYRKVQGQILGEDGMA---VLPDDAKDRLALQLAEF  123 (306)
T ss_dssp             HHHHHHHHHHHHHTTTCSSBCCCEEEEEECT-------TSCEEEEEECCCSEECHHHHHT---TSCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCCeEeecccC-------CCceEEEEeccCCeECchhhhh---hCCHHHHHHHHHHHHHH
Confidence            4678999999999642   245555555422       24468999999973 3221111   23444444444555544


Q ss_pred             HHHHHhC------------------------------------------------------------CeeccCCCCCcEE
Q psy7889          84 LYYIHSN------------------------------------------------------------KILHRDMKAANVL  103 (433)
Q Consensus        84 L~~LH~~------------------------------------------------------------~iiH~dikp~NIl  103 (433)
                      |..||+.                                                            .++|+|++|.||+
T Consensus       124 La~LH~~~~~~~~~~g~p~~~w~~~~~~~~~~~~~~~~~~l~~~~~~~l~~~~~~~l~~~~~~~~~~~~~HgD~~~~N~l  203 (306)
T 3tdw_A          124 MNELSAFPVETAISAGVPVTNLKNKILLLSEAVEDQVFPLLDESLRDYLTLRFQSYMTHPVYTRYTPRLIHGDLSPDHFL  203 (306)
T ss_dssp             HHHHHHSCHHHHHHTTCCBCCHHHHHHHHHHHHHHHTGGGSCHHHHHHHHHHHHHHHHCHHHHCCCCEEECSCCSGGGEE
T ss_pred             HHHHhcCCcccccccCCChHHHHHHHHHHHHHHHHhcccccchhhHHHHHHHHHHHHhCcccccCCCeeEeCCCCcccEE
Confidence            4444432                                                            4699999999999


Q ss_pred             Eec---CCc-EEEeecCCccc
Q psy7889         104 ITK---TGI-LKLADFGLARA  120 (433)
Q Consensus       104 l~~---~~~-~kl~DFg~a~~  120 (433)
                      ++.   ++. +.|+||+.+..
T Consensus       204 ~~~~~~~~~~~~~iD~~~a~~  224 (306)
T 3tdw_A          204 TNLNSRQTPLTGIIDFGDAAI  224 (306)
T ss_dssp             ECTTCSSCCEEEECCCTTCEE
T ss_pred             EecCCCCCceEEEEehhhcCC
Confidence            987   455 58999997755

>4fih_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP; 1.97A {Homo sapiens} PDB: 4fig_A* 4fif_A* 4fii_A* 4fij_A*

Probab=97.75  E-value=1.2e-05  Score=76.63  Aligned_cols=37  Identities=30%  Similarity=0.434  Sum_probs=34.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +++++|||.+||..||.+|+||+|+|+||||.....|
T Consensus       297 s~~~~dli~~~L~~dP~~R~ta~e~l~Hp~~~~~~~p  333 (346)
T 4fih_A          297 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  333 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhcCCCCC
Confidence            7899999999999999999999999999999876544

>3n9x_A Phosphotransferase; malaria kinase, structural genomics, structural genomics CON SGC; 2.05A {Plasmodium berghei} PDB: 3nie_A*

Probab=97.70  E-value=2.1e-05  Score=77.53  Aligned_cols=41  Identities=27%  Similarity=0.490  Sum_probs=35.8

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      .++.+  +++++|||++||.+||.+|+||+|+|+||||.....
T Consensus       330 ~~~~~--s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~~  370 (432)
T 3n9x_A          330 KYPSI--SDDGINLLESMLKFNPNKRITIDQALDHPYLKDVRK  370 (432)
T ss_dssp             HSTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHTCGGGTTTCC
T ss_pred             HCCCC--CHHHHHHHHHHhcCCcccCCCHHHHhcChhhhhccC
Confidence            34455  899999999999999999999999999999987543

>3rp9_A Mitogen-activated protein kinase; structural genomics, structural genomics consortium, SGC, TR; 2.40A {Toxoplasma gondii}

Probab=97.70  E-value=2.2e-05  Score=78.06  Aligned_cols=42  Identities=29%  Similarity=0.500  Sum_probs=36.2

Q ss_pred             ccccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         328 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       328 ~~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ...++..  +++++|||++||.+||.+|+||+|+|+||||....
T Consensus       363 ~~~~~~~--s~~~~dLl~~mL~~dP~~R~t~~e~L~Hp~f~~~~  404 (458)
T 3rp9_A          363 AERFPAS--SADAIHLLKRMLVFNPNKRITINECLAHPFFKEVR  404 (458)
T ss_dssp             GGGSTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             HHHCCCC--CHHHHHHHHHHhccCccccCCHHHHhcCHhhhhcC
Confidence            3344455  89999999999999999999999999999998653

>4gkh_A Aminoglycoside 3'-phosphotransferase APHA1-IAB; pyrazolopyrimidine, 1-Na-PP1, bumped kinase inhibitor, BKI, kinase inhibitor; HET: KAN 0J9; 1.86A {Acinetobacter baumannii} PDB: 4feu_A* 4few_A* 4fex_A* 4fev_A* 4gki_A* 4ej7_A* 3r78_A*

Probab=97.67  E-value=0.00025  Score=64.80  Aligned_cols=100  Identities=16%  Similarity=0.158  Sum_probs=67.7

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+.+|..+|+.|. +--+-+++.++.+.        +..|+|||+++| ++.......     ......+..++...|.
T Consensus        64 ~~~~~E~~~l~~l~~~vPVP~v~~~~~~~--------~~~~lvme~l~G~~~~~~~~~~-----~~~~~~~~~~l~~~L~  130 (272)
T 4gkh_A           64 NDVTDEMVRLNWLTAFMPLPTIKHFIRTP--------DDAWLLTTAIPGKTAFQVLEEY-----PDSGENIVDALAVFLR  130 (272)
T ss_dssp             HHHHHHHHHHHHHTTTSCCCCEEEEEEET--------TEEEEEEECCCSEEHHHHHHHC-----GGGHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhccCCCcCeEEEEEEEC--------CeEEEEEEeeCCccccccccCC-----HHHHHHHHHHHHHHHH
Confidence            45778999999884 33467778877765        558999999987 344333221     1122334445555555


Q ss_pred             HHHhC----------------------------------------------------------CeeccCCCCCcEEEecC
Q psy7889          86 YIHSN----------------------------------------------------------KILHRDMKAANVLITKT  107 (433)
Q Consensus        86 ~LH~~----------------------------------------------------------~iiH~dikp~NIll~~~  107 (433)
                      .||+.                                                          .++|+|+.+.||+++.+
T Consensus       131 ~Lh~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~~l~HGDl~~~Nil~~~~  210 (272)
T 4gkh_A          131 RLHSIPVCNCPFNSDRVFRLAQAQSRMNNGLVDASDFDDERNGWPVEQVWKEMHKLLPFSPDSVVTHGDFSLDNLIFDEG  210 (272)
T ss_dssp             HHHTSCGGGCCBBCCHHHHHHHHHHHHHTTCCCGGGCCGGGTTCCHHHHHHHHHTTCCCCCCEEEECSCCCTTSEEEETT
T ss_pred             HhcCCCcccCCcCcccccchhhHHHHHHHhhhhhhhccccccchHHHHHHHHHHhcccccCCcEEEcCCCCCCeEEEECC
Confidence            55531                                                          16899999999999987


Q ss_pred             CcEEEeecCCccc
Q psy7889         108 GILKLADFGLARA  120 (433)
Q Consensus       108 ~~~kl~DFg~a~~  120 (433)
                      +.+-|+||+.+..
T Consensus       211 ~~~~viDwe~a~~  223 (272)
T 4gkh_A          211 KLIGCIDVGRVGI  223 (272)
T ss_dssp             EEEEECCCTTCEE
T ss_pred             eEEEEEECccccc
Confidence            7778999987643

>1cm8_A Phosphorylated MAP kinase P38-gamma; phosphorylation, transferase; HET: TPO PTR ANP; 2.40A {Homo sapiens} SCOP: d.144.1.7

Probab=97.65  E-value=2.8e-05  Score=74.93  Aligned_cols=37  Identities=30%  Similarity=0.496  Sum_probs=33.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +++++|||++||.+||.+|+||+++|+||||.....+
T Consensus       281 ~~~~~~ll~~mL~~dP~~R~t~~e~l~hp~f~~~~~~  317 (367)
T 1cm8_A          281 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDT  317 (367)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC--
T ss_pred             CHHHHHHHHHHccCChhHCCCHHHHhcChHHHhhcCC
Confidence            8899999999999999999999999999999875443

>3o0g_A Cell division protein kinase 5; kinase activator complex, kinase inhibitor complex, transferase-transferase activator complex; HET: 3O0; 1.95A {Homo sapiens} SCOP: d.144.1.7 PDB: 1unh_A* 1ung_A* 1unl_A* 1h4l_A

Probab=97.65  E-value=2.3e-05  Score=72.75  Aligned_cols=36  Identities=33%  Similarity=0.508  Sum_probs=32.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++.+.+||++||..||.+|+||+|+|+||||.+...
T Consensus       256 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~p  291 (292)
T 3o0g_A          256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCP  291 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTC--
T ss_pred             ChHHHHHHHHHhccChhhCCCHHHHhcCcccccCCC
Confidence            788999999999999999999999999999987543

>4fie_A Serine/threonine-protein kinase PAK 4; kinase domain, protein ATP binding, phosphorylation, transferase; HET: SEP ANP; 3.11A {Homo sapiens}

Probab=97.60  E-value=3.4e-05  Score=75.43  Aligned_cols=37  Identities=30%  Similarity=0.434  Sum_probs=34.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +++++|||.+||..||.+|+||+|+|+||||.....|
T Consensus       374 s~~~~dli~~~L~~dP~~R~ta~ell~Hp~~~~~~~p  410 (423)
T 4fie_A          374 SPSLKGFLDRLLVRDPAQRATAAELLKHPFLAKAGPP  410 (423)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCCCG
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHHhcCCCCC
Confidence            7899999999999999999999999999999876544

>3niz_A Rhodanese family protein; structural genomics, structural genomics consortium, SGC, phosphotransferase, cyclin dependent kinase; HET: ADP; 2.40A {Cryptosporidium parvum} SCOP: d.144.1.7 PDB: 2qkr_A*

Probab=97.58  E-value=3.9e-05  Score=72.04  Aligned_cols=34  Identities=41%  Similarity=0.643  Sum_probs=32.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||.+||.+||.+|+||+|+|+||||.+.
T Consensus       274 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  307 (311)
T 3niz_A          274 CQEGIDLLSNMLCFDPNKRISARDAMNHPYFKDL  307 (311)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTS
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcCcccccC
Confidence            7889999999999999999999999999999863

>3uto_A Twitchin; kinase, muscle sarcomere, transferase; HET: FLC P33; 2.40A {Caenorhabditis elegans} PDB: 1koa_A

Probab=97.57  E-value=3.4e-05  Score=78.85  Aligned_cols=39  Identities=33%  Similarity=0.560  Sum_probs=35.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD  375 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~  375 (433)
                      +++++|||.+||..||.+|+||+|+|+||||+....+..
T Consensus       384 s~~~~dli~~~L~~dp~~R~t~~e~l~Hpw~~~~~~~~~  422 (573)
T 3uto_A          384 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGR  422 (573)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTSCCCCTTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcCcCCCCCCCc
Confidence            889999999999999999999999999999987665543

>2fst_X Mitogen-activated protein kinase 14; active mutants, lipids, MAP kinase insertion, autophosphorylation, transferase; HET: BOG; 1.45A {Homo sapiens} PDB: 2fso_X* 2fsl_X* 2fsm_X* 2npq_A* 2bal_A* 2baj_A* 2bak_A* 2baq_A* 2qd9_A* 1ian_A* 2rg5_A* 2rg6_A* 3bv2_A* 3bv3_A* 3bx5_A* 3c5u_A* 3cg2_A* 3l8x_A* 3mvl_A* 3mvm_A* ...

Probab=97.56  E-value=2.4e-05  Score=75.42  Aligned_cols=37  Identities=38%  Similarity=0.629  Sum_probs=34.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++.++|||++||.+||.+|+|+.++|+||||.....+
T Consensus       285 ~~~~~dLl~~mL~~dP~~R~t~~e~L~hp~~~~~~~~  321 (367)
T 2fst_X          285 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDP  321 (367)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             CHHHHHHHHHhCCCCcccCcCHHHHhcChhhhhccCC
Confidence            7889999999999999999999999999999875544

>3hyh_A Carbon catabolite-derepressing protein kinase; kinase domain, transferase, ATP-binding, carbohydrate metabo kinase, membrane; 2.20A {Saccharomyces cerevisiae} PDB: 3dae_A 2fh9_A 3mn3_A

Probab=97.53  E-value=1.5e-05  Score=73.40  Aligned_cols=33  Identities=18%  Similarity=0.476  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+||+|+|+||||+.
T Consensus       236 s~~~~~li~~~L~~dP~~R~s~~eil~hpw~k~  268 (275)
T 3hyh_A          236 SPGAAGLIKRMLIVNPLNRISIHEIMQDDWFKV  268 (275)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHCHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCccccc
Confidence            788999999999999999999999999999974

>3mtl_A Cell division protein kinase 16; pctaire1, indirubin, structural genomics, structural consortium, SGC, transferase; HET: FEF; 2.40A {Homo sapiens}

Probab=97.53  E-value=3.1e-05  Score=73.16  Aligned_cols=35  Identities=37%  Similarity=0.623  Sum_probs=32.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++.+||.+||.+||.+|+||+|+|+||||....
T Consensus       255 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~~  289 (324)
T 3mtl_A          255 DSDGADLLTKLLQFEGRNRISAEDAMKHPFFLSLG  289 (324)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGC
T ss_pred             CHHHHHHHHHHcCcCcccCCCHHHHhcChhhhhcc
Confidence            78899999999999999999999999999997643

>3fpq_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase, ATP-BIND kinase, nucleotide-binding, phosphoprotein; 1.80A {Rattus norvegicus}

Probab=97.53  E-value=2.9e-05  Score=72.17  Aligned_cols=34  Identities=18%  Similarity=0.323  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++.+||.+||..||.+|+|++|+|+||||++.
T Consensus       256 ~~~~~~li~~~L~~dP~~R~s~~e~l~Hp~~~~~  289 (290)
T 3fpq_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccCC
Confidence            6789999999999999999999999999999753

>3g33_A Cell division protein kinase 4; Ser/Thr protein kinase, cell cycle, phosphorylation, ATP-BIN cell division, disease mutation, kinase; 3.00A {Homo sapiens}

Probab=97.52  E-value=5e-05  Score=70.96  Aligned_cols=39  Identities=28%  Similarity=0.525  Sum_probs=32.6

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ..+..  ++.+.+||.+||.+||.+|+||.++|+||||...
T Consensus       265 ~~~~~--~~~~~~li~~~L~~dP~~R~t~~e~l~h~~~~~~  303 (308)
T 3g33_A          265 VVPEM--EESGAQLLLEMLTFNPHKRISAFRALQHSYLHKD  303 (308)
T ss_dssp             HSCSC--CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTC---
T ss_pred             hCccc--cHHHHHHHHHHhcCCCccCCCHHHHhcCccccCC
Confidence            33445  8889999999999999999999999999999864

>3oz6_A Mitogen-activated protein kinase 1, serine/threon protein kinase; structural genomics consortium, SGC, transferase; 2.37A {Cryptosporidium parvum iowa II}

Probab=97.51  E-value=3.4e-05  Score=74.83  Aligned_cols=34  Identities=41%  Similarity=0.623  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||++||.+||.+|+||+|+|+||||...
T Consensus       302 ~~~~~dll~~~L~~dP~~R~t~~e~l~Hp~~~~~  335 (388)
T 3oz6_A          302 NEEALDLLDKLLQFNPNKRISANDALKHPFVSIF  335 (388)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSTTTTTT
T ss_pred             CHHHHHHHHHhhccCcccCCCHHHHhCCHHHHHh
Confidence            7889999999999999999999999999999754

>1ob3_A PFPK5, cell division control protein 2 homolog; transferase, serine/threonine-protein kinase, ATP-binding, phosphorylation, CDK; 1.9A {Plasmodium falciparum} SCOP: d.144.1.7 PDB: 1v0p_A* 1v0o_A* 1v0b_A

Probab=97.47  E-value=7.3e-05  Score=69.15  Aligned_cols=33  Identities=45%  Similarity=0.792  Sum_probs=31.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+|++++|+||||.+
T Consensus       254 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  286 (288)
T 1ob3_A          254 DESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (288)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCcchhh
Confidence            788999999999999999999999999999975

>2vx3_A Dual specificity tyrosine-phosphorylation- regula kinase 1A; serine/threonine-protein kinase, minibrain homolog, nucleotide-binding, transferase; HET: PTR D15 P6G; 2.40A {Homo sapiens} PDB: 2wo6_A* 3anq_A* 3anr_A*

Probab=97.47  E-value=5e-05  Score=73.45  Aligned_cols=33  Identities=33%  Similarity=0.405  Sum_probs=30.2

Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         338 QYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       338 ~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++|||.+||.+||.+||||+|+|+||||...
T Consensus       347 ~~~~dli~~mL~~dP~~Rpta~e~L~hp~f~~~  379 (382)
T 2vx3_A          347 LKFKDLILRMLDYDPKTRIQPYYALQHSFFKKT  379 (382)
T ss_dssp             HHHHHHHHHHTCSCTTTSCCHHHHTTSGGGCC-
T ss_pred             HHHHHHHHHhcCCChhhCCCHHHHhcCcccccC
Confidence            468999999999999999999999999999753

>4agu_A Cyclin-dependent kinase-like 1; transferase, phospho-mimetic; HET: D15; 2.40A {Homo sapiens}

Probab=97.43  E-value=0.00011  Score=68.53  Aligned_cols=41  Identities=22%  Similarity=0.310  Sum_probs=34.7

Q ss_pred             cCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         331 LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       331 ~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++..  +.++.+||.+||..||.+|+|++++|+||||......
T Consensus       254 ~~~~--~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  294 (311)
T 4agu_A          254 FPNI--SYPALGLLKGCLHMDPTERLTCEQLLHHPYFENIREI  294 (311)
T ss_dssp             CTTC--CHHHHHHHHHHCCSSTTTSCCHHHHHTSGGGTTCC--
T ss_pred             cccc--cHHHHHHHHHHccCChhhcCCHHHHhcChHHHhccCH
Confidence            3445  8889999999999999999999999999999875443

>3kvw_A DYRK2, dual specificity tyrosine-phosphorylation-regulat 2; KI-(Y)-phosphorylation REG kinase 2, PSK-H2, kinase, structural genomics consortium; HET: SEP PTR IRB; 2.28A {Homo sapiens} PDB: 3k2l_A* 4azf_A*

Probab=97.41  E-value=7.5e-05  Score=73.53  Aligned_cols=34  Identities=29%  Similarity=0.426  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||++||.+||.+|+||+|+|+||||...
T Consensus       382 ~~~~~dli~~~L~~dP~~Rpta~e~L~Hpw~~~~  415 (429)
T 3kvw_A          382 DPLFLDFLKQCLEWDPAVRMTPGQALRHPWLRRR  415 (429)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSTTTC--
T ss_pred             hHHHHHHHHHHCCCChhhCCCHHHHhCChhhccC
Confidence            6789999999999999999999999999999863

>3ttj_A Mitogen-activated protein kinase 10; JNK3, protein kinase in transferase-transferase inhibitor complex; HET: JBI; 2.10A {Homo sapiens} PDB: 3tti_A* 1jnk_A*

Probab=97.40  E-value=5e-05  Score=75.64  Aligned_cols=33  Identities=39%  Similarity=0.661  Sum_probs=30.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||++||.+||.+|+||+|+|+||||..
T Consensus       329 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~~~~  361 (464)
T 3ttj_A          329 ASQARDLLSKMLVIDPAKRISVDDALQHPYINV  361 (464)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGG
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcChhhhh
Confidence            457999999999999999999999999999975

>1ua2_A CAK, cell division protein kinase 7; cell cycle, phosphorylation, protein-protein interaction, PR kinase, cell cycle, transferase; HET: TPO ATP; 3.02A {Homo sapiens} SCOP: d.144.1.7

Probab=97.37  E-value=0.00012  Score=69.84  Aligned_cols=39  Identities=28%  Similarity=0.510  Sum_probs=35.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD  375 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~  375 (433)
                      +.++++||++||..||.+|+||+|+|+||||...+.+..
T Consensus       265 ~~~~~~li~~~L~~dP~~Rpt~~ell~h~~f~~~~~~~~  303 (346)
T 1ua2_A          265 GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTP  303 (346)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCC
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhcChhhhcCCCCCC
Confidence            788999999999999999999999999999988766544

>2r3i_A Cell division protein kinase 2; serine/threonine-protein kinase, cell cycle, inhibition, cyclin-dependent kinase, cancer, ATP-binding; HET: SCF; 1.28A {Homo sapiens} PDB: 2r3j_A* 2r3k_A* 2r3l_A* 2r3m_A* 2r3n_A* 2r3o_A* 2r3p_A* 2r3q_A* 1jvp_P* 1buh_A 1ckp_A* 1di8_A* 1dm2_A* 1f5q_A 1fin_A* 1fq1_B* 1fvt_A* 1fvv_A* 1g5s_A* 1gih_A* ...

Probab=97.37  E-value=0.00012  Score=67.82  Aligned_cols=38  Identities=42%  Similarity=0.659  Sum_probs=34.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      +++..+||.+||..||.+|+|+.++|+||||.....+.
T Consensus       257 ~~~~~~li~~~L~~dP~~Rpt~~~~l~hp~~~~~~~~~  294 (299)
T 2r3i_A          257 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPV  294 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCCC
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcChhhhcCCCCC
Confidence            78899999999999999999999999999998755543

>2yle_A Protein spire homolog 1; actin-binding protein, actin polymerization; 1.80A {Homo sapiens} PDB: 2ylf_A 3r7g_A 3rbw_A

Probab=97.34  E-value=0.0019  Score=56.38  Aligned_cols=97  Identities=15%  Similarity=0.026  Sum_probs=66.3

Q ss_pred             CHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH-hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccC
Q psy7889          56 DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH-SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTN  134 (433)
Q Consensus        56 ~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH-~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~  134 (433)
                      +|.+.+...+..++|+++|.++.|.+.+|.-+- ...-..+=+.|..|++..+|.|.+.+ +.+.               
T Consensus        34 SL~eIL~~~~~PlsEEqaWALc~Qc~~~L~~~~~~~~~~~~i~~~~~i~l~~dG~V~f~~-~~s~---------------   97 (229)
T 2yle_A           34 SLEEILRLYNQPINEEQAWAVCYQCCGSLRAAARRRQPRHRVRSAAQIRVWRDGAVTLAP-AADD---------------   97 (229)
T ss_dssp             EHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHHHHTTCCCCCCCSGGGEEEETTSCEEECC-C------------------
T ss_pred             cHHHHHHHcCCCcCHHHHHHHHHHHHHHHHhhhhcccCCceecCCcceEEecCCceeccc-cccc---------------
Confidence            799999998989999999999999999887763 22222344567899999999888774 2110               


Q ss_pred             CcccccccCcccccCCCCCCCcchhhhHHHHHHHHHh
Q psy7889         135 RVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT  171 (433)
Q Consensus       135 ~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~ell~  171 (433)
                       .....+.|||...  ...+.+.=|+|||+++|.-+.
T Consensus        98 -~~~~~~~~pe~~~--~~~te~~~IysLG~tLY~ALD  131 (229)
T 2yle_A           98 -AGEPPPVAGKLGY--SQCMETEVIESLGIIIYKALD  131 (229)
T ss_dssp             ----------CCSS--SSSCHHHHHHHHHHHHHHHHT
T ss_pred             -ccccCCCChhhcc--ccchHHHHHHHHHHHHHHHhh
Confidence             0122366888763  223667889999999998765

>3gbz_A Kinase, CMGC CDK; ssgcid, ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; 1.85A {Giardia lamblia} PDB: 3gc0_A*

Probab=97.33  E-value=8.1e-05  Score=70.38  Aligned_cols=34  Identities=41%  Similarity=0.710  Sum_probs=32.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||.+||.+||.+|+||+|+|+||||...
T Consensus       292 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  325 (329)
T 3gbz_A          292 DDEGLDLLTAMLEMDPVKRISAKNALEHPYFSHN  325 (329)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSS
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhCCcccCCC
Confidence            7889999999999999999999999999999864

>4b9d_A Serine/threonine-protein kinase NEK1; transferase, inhibitor; HET: CK7; 1.90A {Homo sapiens} PDB: 4apc_A*

Probab=97.33  E-value=4.2e-05  Score=72.88  Aligned_cols=34  Identities=18%  Similarity=0.219  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||.+||..||.+|+||+|+|+||||...
T Consensus       250 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~~  283 (350)
T 4b9d_A          250 SYDLRSLVSQLFKRNPRDRPSVNSILEKGFIAKR  283 (350)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHHhhcC
Confidence            7889999999999999999999999999999753

>3nsz_A CK II alpha, casein kinase II subunit alpha; inhibitor, transferase-transferase inhibitor CO; HET: ANP; 1.30A {Homo sapiens} SCOP: d.144.1.7 PDB: 2r7i_A 3pe1_A* 1jwh_A* 3pe2_A* 3r0t_A* 3h30_A* 3q9w_A* 3q9x_A* 3q9y_A* 3q9z_A* 3qa0_A 3bqc_A* 2rkp_A* 3c13_A* 3fwq_A 3rps_A* 3u9c_A* 4fbx_A* 3mb7_A* 3mb6_A* ...

Probab=97.32  E-value=7.2e-05  Score=70.53  Aligned_cols=33  Identities=36%  Similarity=0.632  Sum_probs=31.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||.+||.+|+||+++|+||||..
T Consensus       293 ~~~~~~li~~~L~~dP~~Rpta~e~l~hp~f~~  325 (330)
T 3nsz_A          293 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  325 (330)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCcccCCCHHHHhcCccHhh
Confidence            788999999999999999999999999999975

>3e3p_A Protein kinase, putative glycogen synthase kinase; leishmaniasis, transferase; 2.00A {Leishmania major}

Probab=97.30  E-value=4.8e-05  Score=72.72  Aligned_cols=37  Identities=32%  Similarity=0.391  Sum_probs=33.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++++++||.+||.+||.+|+|+.++|+||||.....+
T Consensus       288 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~~  324 (360)
T 3e3p_A          288 AKEAYDLLSALLQYLPEERMKPYEALCHPYFDELHDP  324 (360)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHTTSGGGGGGGCT
T ss_pred             cHHHHHHHHHHhccCccccCCHHHHhcCccccccCCc
Confidence            5789999999999999999999999999999875443

>2b9h_A MAP kinase FUS3, mitogen-activated protein kinase FUS3; transferase; HET: ADP; 1.55A {Saccharomyces cerevisiae} PDB: 2b9i_A* 2b9j_A* 2f49_A 2fa2_A 2b9f_A* 2f9g_A*

Probab=97.28  E-value=0.00014  Score=69.18  Aligned_cols=38  Identities=37%  Similarity=0.678  Sum_probs=34.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||.....+.
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~~~  316 (353)
T 2b9h_A          279 NPKGIDLLQRMLVFDPAKRITAKEALEHPYLQTYHDPN  316 (353)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             CHHHHHHHHHhcCcCcccCCCHHHHhcCccccccCCcc
Confidence            78899999999999999999999999999998755443

>3qyz_A Mitogen-activated protein kinase 1; transferase, serine/threonine-protein kinase, ATP-binding CE phosphorylation; HET: CME Z8B SO4; 1.46A {Rattus norvegicus} PDB: 2fys_B 1erk_A* 3qyi_A* 3erk_A* 3qyw_A* 4erk_A* 4gsb_A* 4gt3_A* 4gva_A* 2z7l_A* 2erk_A* 1gol_A* 2gph_A 3zu7_A 3zuv_A* 3o71_A 3r63_A 3c9w_A* 2y9q_A* 4fmq_A* ...

Probab=97.27  E-value=0.00013  Score=69.91  Aligned_cols=35  Identities=37%  Similarity=0.581  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++++||.+||.+||.+|+|+.++|+||||....
T Consensus       287 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~~~  321 (364)
T 3qyz_A          287 DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYY  321 (364)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTTC
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcchhhcc
Confidence            78899999999999999999999999999998743

>4exu_A Mitogen-activated protein kinase 13; P38 kinase, transferase; 1.70A {Homo sapiens} PDB: 4eyj_A* 4eym_A* 3coi_A

Probab=97.25  E-value=0.00018  Score=69.30  Aligned_cols=36  Identities=39%  Similarity=0.498  Sum_probs=33.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++++.+||.+||.+||.+|+|+.|+|+||||.....
T Consensus       297 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~  332 (371)
T 4exu_A          297 SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  332 (371)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             ChHHHHHHHHHCCCChhhcCCHHHHhcCcccccCCC
Confidence            788999999999999999999999999999986443

>2i6l_A Mitogen-activated protein kinase 6; MAPK6, ERK3, extracellular signal regulated kinase 3, serine phosphorylation, threonine phosphorylation; 2.25A {Homo sapiens}

Probab=97.22  E-value=7.3e-05  Score=69.96  Aligned_cols=39  Identities=26%  Similarity=0.560  Sum_probs=34.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD  375 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~  375 (433)
                      +.+.++||++||..||.+|+|++++|+||||.....|..
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~~p~~  317 (320)
T 2i6l_A          279 SREAVDFLEQILTFSPMDRLTAEEALSHPYMSIYSFPMD  317 (320)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSHHHHTTCC---
T ss_pred             hHHHHHHHHHHcCCCccccCCHHHHhCCcccccccCccC
Confidence            788999999999999999999999999999988766643

>3ats_A Putative uncharacterized protein; hypothetical protein, putative aminoglycoside phosphortransf transferase; 1.67A {Mycobacterium tuberculosis} PDB: 3att_A*

Probab=97.21  E-value=0.00038  Score=66.44  Aligned_cols=31  Identities=19%  Similarity=0.274  Sum_probs=25.9

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      ..++|+|+.+.||++++++.+.|+||+.+..
T Consensus       222 ~~l~HgDl~~~Nil~~~~~~~~vIDwe~a~~  252 (357)
T 3ats_A          222 PVLLWGDARVGNVLYRDFQPVAVLDWEMVAL  252 (357)
T ss_dssp             CEEECSSCSGGGEEEETTEEEEECCGGGCEE
T ss_pred             ceEEeCCCCCCeEEEeCCcEEEEEccccccc
Confidence            4699999999999999644578999987643

>3gni_B Strad alpha; kinase fold, pseudokinase, alpha helical repeat protein, ADA protein, ATP-binding, cell cycle, kinase, nucleotide-bindin nucleus; HET: ATP CIT; 2.35A {Homo sapiens} PDB: 2wtk_B*

Probab=97.19  E-value=0.00015  Score=70.19  Aligned_cols=36  Identities=22%  Similarity=0.277  Sum_probs=32.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++.+++||++||.+||.+|+||+++|+||||.....
T Consensus       307 s~~~~~li~~~L~~dP~~Rpta~ell~hp~f~~~~~  342 (389)
T 3gni_B          307 SPHFHHFVEQCLQRNPDARPSASTLLNHSFFKQIKR  342 (389)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSGGGGGC--
T ss_pred             CHHHHHHHHHHhhcCcccCCCHHHHhcCHHHHHHhh
Confidence            788999999999999999999999999999986543

>3fe3_A MAP/microtubule affinity-regulating kinase 3; serine/threonine protein kinase, MARK;PAR-1, UBA domai TAK1;P78;MARK3, ATP-binding; 1.90A {Homo sapiens} PDB: 2qnj_A 1y8g_A* 1zmw_A 1zmu_A 1zmv_A 2wzj_A 2r0i_A 2hak_A 3iec_A

Probab=97.18  E-value=0.00027  Score=66.80  Aligned_cols=34  Identities=21%  Similarity=0.331  Sum_probs=32.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++.+||++||..||.+|+|++|+|+||||...
T Consensus       238 s~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  271 (328)
T 3fe3_A          238 STDCENLLKRFLVLNPIKRGTLEQIMKDRWINAG  271 (328)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHTTCTTTTTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCHhhcCC
Confidence            7889999999999999999999999999999754

>4g31_A Eukaryotic translation initiation factor 2-alpha; deletion mutant, catalytic domain, synthetic inhibitor, TRAN transferase inhibitor complex; HET: 0WH; 2.28A {Homo sapiens} PDB: 4g34_A*

Probab=97.18  E-value=0.00014  Score=67.83  Aligned_cols=36  Identities=11%  Similarity=0.120  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++.+.+||++||..||.+||||.|+|+||||.+...
T Consensus       253 ~~~~~~li~~~L~~dP~~Rps~~eil~h~~~~~~~~  288 (299)
T 4g31_A          253 YPCEYVMVQDMLSPSPMERPEAINIIENAVFEDLDF  288 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGCCC--
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCCCCC
Confidence            567889999999999999999999999999986543

>2pmi_A Negative RE, cyclin-dependent protein kinase PHO85; cyclin-dependent kinase, signaling protein,transfera cycle complex; HET: MES AGS; 2.90A {Saccharomyces cerevisiae} PDB: 2pk9_A*

Probab=97.17  E-value=0.00012  Score=68.74  Aligned_cols=36  Identities=33%  Similarity=0.441  Sum_probs=33.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +.++++||.+||..||.+|+||.|+|+||||.+...
T Consensus       267 ~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~~~~  302 (317)
T 2pmi_A          267 DGNLMDFLHGLLQLNPDMRLSAKQALHHPWFAEYYH  302 (317)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGGGGCC
T ss_pred             CHHHHHHHHHHCCCCcccCCCHHHHhCChhhhcccc
Confidence            788999999999999999999999999999986443

>2ac3_A MAP kinase-interacting serine/threonine kinase 2; DFD motif, transferase; 2.10A {Homo sapiens} PDB: 2hw7_A* 2ac5_A* 2hw6_A

Probab=97.16  E-value=0.0002  Score=66.99  Aligned_cols=34  Identities=26%  Similarity=0.370  Sum_probs=31.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||++||..||.+|+||.++|+||||...
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~~  302 (316)
T 2ac3_A          269 SCAAKDLISKLLVRDAKQRLSAAQVLQHPWVQGC  302 (316)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSTTCC--
T ss_pred             CHHHHHHHHHHhhCChhhCCCHHHHhcChhhcCC
Confidence            7789999999999999999999999999999863

>4e7w_A Glycogen synthase kinase 3; GSK3, PTyr195, transferase; HET: PTR; 3.30A {Ustilago maydis}

Probab=97.15  E-value=0.00019  Score=69.82  Aligned_cols=34  Identities=35%  Similarity=0.429  Sum_probs=32.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||.+||.+||.+|+|+.++|+||||...
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~~  328 (394)
T 4e7w_A          295 PPDAIDLISRLLEYTPSARLTAIEALCHPFFDEL  328 (394)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGSTT
T ss_pred             CHHHHHHHHHHhCCChhhCCCHHHHhcChhhhhh
Confidence            7899999999999999999999999999999763

>3coi_A Mitogen-activated protein kinase 13; P38D, P38delta, ERK, MAP kinase, PMK, STK26, stress-activated protein kinase, structural genomics, PSI; 2.09A {Homo sapiens}

Probab=97.13  E-value=0.00035  Score=66.54  Aligned_cols=36  Identities=39%  Similarity=0.498  Sum_probs=33.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||.....
T Consensus       279 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~~~~  314 (353)
T 3coi_A          279 SPQAADLLEKMLELDVDKRLTAAQALTHPFFEPFRD  314 (353)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSGGGTTTCC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCcchhhccC
Confidence            788999999999999999999999999999976443

>3llt_A Serine/threonine kinase-1, pflammer; lammer kinase, malaria, structural GE structural genomics consortium, SGC, transferase; HET: ANP; 2.50A {Plasmodium falciparum 3D7}

Probab=97.12  E-value=0.00016  Score=69.18  Aligned_cols=32  Identities=31%  Similarity=0.547  Sum_probs=30.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      ++...+||.+||.+||.+|+||+++|+||||+
T Consensus       329 ~~~l~~li~~~L~~dP~~Rpta~elL~hp~f~  360 (360)
T 3llt_A          329 HELFCDFLYSILQIDPTLRPSPAELLKHKFLE  360 (360)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGC
T ss_pred             HHHHHHHHHHHhcCChhhCCCHHHHhcCcccC
Confidence            57788999999999999999999999999995

>2yab_A Death-associated protein kinase 2; apoptosis, transferase; HET: AMP; 1.90A {Mus musculus} PDB: 2yaa_A* 2ya9_A*

Probab=97.11  E-value=0.00027  Score=67.85  Aligned_cols=33  Identities=27%  Similarity=0.454  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+++||.+||..||.+|+|+.++|+||||..
T Consensus       246 s~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  278 (361)
T 2yab_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (361)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTSC
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcCcCC
Confidence            788999999999999999999999999999974

>1blx_A Cyclin-dependent kinase 6; inhibitor protein, cyclin-dependent kinase, cell cycle control, alpha/beta, complex (inhibitor protein/kinase); 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 1bi7_A 1bi8_A 1g3n_A 2f2c_B* 1jow_B* 2euf_B* 1xo2_B* 3nup_A* 3nux_A* 2w9z_B 2w99_B 2w96_B 2w9f_B

Probab=97.11  E-value=0.00043  Score=64.94  Aligned_cols=36  Identities=39%  Similarity=0.564  Sum_probs=33.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++.+.+||.+||..||.+|+|+.++|+||||.....
T Consensus       270 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  305 (326)
T 1blx_A          270 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDLER  305 (326)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTCCC
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHhcCccccccch
Confidence            788999999999999999999999999999986443

>3is5_A Calcium-dependent protein kinase; CDPK, structural genomics, parasitology, structural genomics consortium, SGC, ATP-binding, nucleotide-binding; HET: ANP; 2.55A {Toxoplasma gondii}

Probab=97.11  E-value=0.00023  Score=65.64  Aligned_cols=33  Identities=30%  Similarity=0.556  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|||+.|+|+||||++
T Consensus       252 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~f~~  284 (285)
T 3is5_A          252 TPQAVDLLKQMLTKDPERRPSAAQVLHHEWFKQ  284 (285)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHhhc
Confidence            788999999999999999999999999999974

>3q5i_A Protein kinase; CDPK, malaria, phosphotransferase, structural genomics, structural genomic consortium, SGC, transferase; HET: ANP; 2.10A {Plasmodium berghei}

Probab=97.05  E-value=0.00024  Score=71.47  Aligned_cols=36  Identities=22%  Similarity=0.274  Sum_probs=33.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++++++||++||.+||.+||||+++|+||||.....
T Consensus       275 s~~~~~li~~~L~~dp~~R~t~~e~l~h~~~~~~~~  310 (504)
T 3q5i_A          275 SDEAKELIKLMLTYDYNKRCTAEEALNSRWIKKYAN  310 (504)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHHTCC
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcCHhhhhchh
Confidence            788999999999999999999999999999976543

>4aw0_A HPDK1, 3-phosphoinositide-dependent protein kinase 1; transferase, allosteric regulation, allosteric site, phosphorylation, AGC protein kinase; HET: SEP ATP MJF; 1.43A {Homo sapiens} PDB: 3hrc_A* 3hrf_A* 4a06_A* 4a07_A* 3rcj_A* 4aw1_A* 3rwq_A* 3sc1_A* 3qd0_A* 2r7b_A* 3ion_A* 3qcq_A* 3qcs_A* 3qcx_A* 3qcy_A* 3iop_A* 3qd3_A* 3qd4_A* 3h9o_A* 1uu3_A* ...

Probab=97.05  E-value=0.00015  Score=67.92  Aligned_cols=33  Identities=36%  Similarity=0.550  Sum_probs=30.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA------LNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~------l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+||+|+      ++||||..
T Consensus       258 s~~~~dli~~lL~~dp~~R~t~~e~~~~~~i~~Hp~F~~  296 (311)
T 4aw0_A          258 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  296 (311)
T ss_dssp             CHHHHHHHHHHSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHccCCHhHCcChHHHcCCHHHHCCCCcCC
Confidence            7899999999999999999999985      88999975

>1j1b_A Glycogen synthase kinase-3 beta; complex, TAU, AMPPNP, transferase; HET: ANP; 1.80A {Homo sapiens} SCOP: d.144.1.7 PDB: 1i09_A* 1j1c_A* 2jld_A* 3m1s_A* 3pup_A* 3du8_A* 1pyx_A* 1q41_A* 1q3w_A* 1q3d_A* 1q4l_A* 3q3b_A* 1q5k_A* 3i4b_A* 3l1s_A* 1r0e_A* 3zrk_A* 3zrl_A* 3zrm_A* 4dit_A* ...

Probab=97.05  E-value=0.00019  Score=70.32  Aligned_cols=34  Identities=26%  Similarity=0.296  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||.+||.+||.+|+|+.++|+||||...
T Consensus       310 ~~~~~~Li~~~L~~dP~~R~t~~e~l~hp~f~~~  343 (420)
T 1j1b_A          310 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDEL  343 (420)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGG
T ss_pred             CHHHHHHHHHhccCChhHCCCHHHHhCCHhhccc
Confidence            7889999999999999999999999999999653

>1wak_A Serine/threonine-protein kinase SPRK1; SRPK, transferase, alternative splicing, ATP-binding, chromosome partition, differentiation, mRNA processing; 1.73A {Homo sapiens} PDB: 1wbp_A* 3beg_A* 2x7g_A*

Probab=97.04  E-value=0.00019  Score=69.32  Aligned_cols=33  Identities=27%  Similarity=0.283  Sum_probs=30.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +..+++||.+||..||.+|+||.|+|+||||.+
T Consensus       365 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~  397 (397)
T 1wak_A          365 AAGFTDFLLPMLELIPEKRATAAECLRHPWLNS  397 (397)
T ss_dssp             HHHHHHHHGGGGCSSGGGSCCHHHHHTSGGGGC
T ss_pred             HHHHHHHHHHHhccChhhcCCHHHHhhCccccC
Confidence            456889999999999999999999999999963

>3pg1_A Mitogen-activated protein kinase, putative (MAP K protein); EPK Ser/Thr protein kinase fold, Ser/Thr protein kinase, TRA; 1.95A {Leishmania major} PDB: 3uib_A*

Probab=97.04  E-value=0.00031  Score=67.14  Aligned_cols=37  Identities=32%  Similarity=0.575  Sum_probs=33.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++.+.+||.+||..||.+|+|+.++|+||||.....+
T Consensus       290 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~~~~  326 (362)
T 3pg1_A          290 DPVALDLIAKMLEFNPQRRISTEQALRHPYFESLFDP  326 (362)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGTTTCCG
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHcCchhhhccCc
Confidence            7889999999999999999999999999999875443

>3fxz_A Serine/threonine-protein kinase PAK 1; transferase, ATP-binding, phosphorylation, allosteric enzyme, alternative splicing, apoptosis, cell junction; HET: TPO FLL; 1.64A {Homo sapiens} SCOP: d.144.1.7 PDB: 3fy0_A* 4daw_A* 3q52_A* 3q53_A* 1yhw_A 1f3m_C 1yhv_A 2hy8_1* 3q4z_A*

Probab=97.01  E-value=0.00039  Score=64.58  Aligned_cols=35  Identities=26%  Similarity=0.312  Sum_probs=32.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +....+||.+||..||.+|+|++++|+||||....
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~ell~h~~~~~~~  277 (297)
T 3fxz_A          243 SAIFRDFLNRCLEMDVEKRGSAKELLQHQFLKIAK  277 (297)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCGGGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhChhhcccC
Confidence            67789999999999999999999999999997643

>2c30_A Serine/threonine-protein kinase PAK 6; CRIB domain, ATP-binding, transferase, nucleotide-binding; HET: SEP; 1.6A {Homo sapiens} PDB: 2f57_A* 2j0i_A* 2cdz_A* 2q0n_A* 2x4z_A* 2bva_A*

Probab=96.99  E-value=0.00041  Score=65.25  Aligned_cols=38  Identities=26%  Similarity=0.534  Sum_probs=34.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      +++..+||.+||..||.+|+|+.++|+||||.....|.
T Consensus       268 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~~~~~~  305 (321)
T 2c30_A          268 SPVLRDFLERMLVRDPQERATAQELLDHPFLLQTGLPE  305 (321)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGGGCCCGG
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhccCCCcc
Confidence            67889999999999999999999999999998765543

>1q8y_A SR protein kinase; transferase; HET: ADP ADE; 2.05A {Saccharomyces cerevisiae} SCOP: d.144.1.7 PDB: 1q8z_A 1q97_A* 1q99_A* 1how_A 2jd5_A

Probab=96.99  E-value=0.00033  Score=67.13  Aligned_cols=34  Identities=32%  Similarity=0.489  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +.+..+||.+||..||.+||||+++|+||||...
T Consensus       307 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  340 (373)
T 1q8y_A          307 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDT  340 (373)
T ss_dssp             HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTC
T ss_pred             HHHHHHHHHHHhccCccccCCHHHHhhChhhhcc
Confidence            4678899999999999999999999999999864

>3p1a_A MYT1 kinase, membrane-associated tyrosine- and threonine-speci inhibitory kinase; structural genomics, structural genomics consortium, SGC; 1.70A {Homo sapiens}

Probab=96.99  E-value=0.00036  Score=65.30  Aligned_cols=33  Identities=21%  Similarity=0.147  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|+|++++|+||||++
T Consensus       278 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~~~~  310 (311)
T 3p1a_A          278 SSELRSVLVMMLEPDPKLRATAEALLALPVLRQ  310 (311)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHhCccccC
Confidence            788999999999999999999999999999975

>3tki_A Serine/threonine-protein kinase CHK1; cell checkpoint, transferase-transferase inhib complex; HET: S25; 1.60A {Homo sapiens} PDB: 2qhm_A* 2r0u_A* 3tkh_A* 2qhn_A* 2hy0_A* 2hog_A* 2hxq_A* 2hxl_A* 3f9n_A*

Probab=96.99  E-value=0.00036  Score=65.72  Aligned_cols=34  Identities=24%  Similarity=0.332  Sum_probs=31.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++.+++||.+||..||.+|+|+.|+|+||||...
T Consensus       235 ~~~~~~li~~~L~~dP~~R~t~~eil~h~~~~~~  268 (323)
T 3tki_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (323)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhhChhhccc
Confidence            7889999999999999999999999999999753

>3eb0_A Putative uncharacterized protein; kinase cryptosporidium parvum, ATP-binding, kinase, nucleoti binding; HET: PTR DRK; 2.65A {Cryptosporidium parvum iowa II}

Probab=96.98  E-value=0.00024  Score=68.61  Aligned_cols=33  Identities=30%  Similarity=0.539  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||.+||.+|+||.|+|+||||..
T Consensus       295 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~f~~  327 (383)
T 3eb0_A          295 PSLAIDLLEQILRYEPDLRINPYEAMAHPFFDH  327 (383)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCHHHHH
Confidence            788999999999999999999999999999964

>2xrw_A Mitogen-activated protein kinase 8; transcription, MAPK signaling pathways, linear binding motif; HET: ANP; 1.33A {Homo sapiens} PDB: 1ukh_A 1uki_A* 2xs0_A* 3elj_A* 2h96_A* 2gmx_A* 2g01_A* 2no3_A* 3o2m_A* 3o17_A* 3pze_A* 3g9l_X* 2p33_A* 3cgf_A* 3cgo_A* 3g90_X* 2ok1_A* 3g9n_A* 1pmn_A* 1pmq_A* ...

Probab=96.97  E-value=0.0001  Score=70.95  Aligned_cols=34  Identities=38%  Similarity=0.533  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +.+++|||.+||.+||.+|+||+++|+||||...
T Consensus       292 ~~~~~~li~~mL~~dP~~R~t~~e~l~hp~~~~~  325 (371)
T 2xrw_A          292 ASQARDLLSKMLVIDASKRISVDEALQHPYINVW  325 (371)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             cHHHHHHHHHHCcCChhhCCCHHHHhCCcchhhh
Confidence            4578999999999999999999999999999754

>3ubd_A Ribosomal protein S6 kinase alpha-3; kinase-inhibitor complex, induced FIT, transferase-transfera inhibitor complex; HET: SL0; 1.53A {Mus musculus} PDB: 4el9_A* 3g51_A* 2z7q_A* 2z7r_A* 2z7s_A*

Probab=96.95  E-value=0.00029  Score=65.74  Aligned_cols=33  Identities=27%  Similarity=0.441  Sum_probs=30.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS-----DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a-----~~~l~~~~~~~  369 (433)
                      +++++|||++||..||.+|+||     +|+++||||+.
T Consensus       250 s~~~~~li~~~L~~dP~~R~ta~~~~~~eil~Hp~f~~  287 (304)
T 3ubd_A          250 SPEAQSLLRMLFKRNPANRLGAGPDGVEEIKRHSFFST  287 (304)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHCCCCCcCCHHHHHcCccccC
Confidence            7899999999999999999985     79999999975

>2jam_A Calcium/calmodulin-dependent protein kinase type 1G; transferase, kinase, membrane, ATP-binding, prenylation, serine/threonine-protein kinase, alternative splicing; HET: J60; 1.7A {Homo sapiens} PDB: 2jc6_A* 1a06_A

Probab=96.95  E-value=0.00039  Score=64.66  Aligned_cols=35  Identities=26%  Similarity=0.456  Sum_probs=32.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++..+||.+||..||.+|+|++++|+||||....
T Consensus       235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (304)
T 2jam_A          235 SESAKDFICHLLEKDPNERYTCEKALSHPWIDGNT  269 (304)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHSSC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCccccCCC
Confidence            78899999999999999999999999999997643

>3mwu_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, bumped kinase inhibitor, BKI; HET: BK3; 1.98A {Cryptosporidium parvum} PDB: 3igo_A* 3ncg_A*

Probab=96.95  E-value=0.00022  Score=71.35  Aligned_cols=35  Identities=26%  Similarity=0.413  Sum_probs=32.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++++||.+||..||.+|+||.++|+||||....
T Consensus       250 s~~~~~li~~~L~~dp~~R~t~~~~l~hp~~~~~~  284 (486)
T 3mwu_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQKYS  284 (486)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHCHHHHHTC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCHhhccCc
Confidence            78899999999999999999999999999997643

>1z57_A Dual specificity protein kinase CLK1; protein tyrosine kinase, splicing, human, 10Z-hymendialdisine, structural genomics; HET: DBQ; 1.70A {Homo sapiens} PDB: 2vag_A*

Probab=96.95  E-value=0.00028  Score=66.48  Aligned_cols=33  Identities=39%  Similarity=0.552  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|+|+.|+|+||||..
T Consensus       302 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~  334 (339)
T 1z57_A          302 HERLFDLIQKMLEYDPAKRITLREALKHPFFDL  334 (339)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHHHHHHHHHhCcCcccccCHHHHhcCHHHHH
Confidence            466889999999999999999999999999975

>2eu9_A Dual specificity protein kinase CLK3; kinase domain, transferase; 1.53A {Homo sapiens} PDB: 2wu6_A* 2wu7_A* 3raw_A* 2exe_A 3nr9_A*

Probab=96.94  E-value=0.00034  Score=66.34  Aligned_cols=33  Identities=33%  Similarity=0.487  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.+..+||.+||..||.+|+|+.++|+||||..
T Consensus       307 ~~~l~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  339 (355)
T 2eu9_A          307 HVQLFDLMRRMLEFDPAQRITLAEALLHPFFAG  339 (355)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHTTSGGGGG
T ss_pred             HHHHHHHHHHHhcCChhhCcCHHHHhcChhhcC
Confidence            457889999999999999999999999999975

>2yex_A Serine/threonine-protein kinase CHK1; transferase, cell cycle; HET: YEX; 1.30A {Homo sapiens} PDB: 2x8e_A* 2ydk_A* 2ydj_A* 2yer_A* 2ydi_A* 1nvq_A* 1nvr_A* 1nvs_A* 2wmq_A* 2wmr_A* 2wms_A* 2wmt_A* 2wmu_A* 2wmv_A* 2wmw_A* 2wmx_A* 2x8d_A* 2x8i_A* 2xey_A* 2xez_A* ...

Probab=96.89  E-value=0.00058  Score=62.32  Aligned_cols=34  Identities=24%  Similarity=0.332  Sum_probs=31.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++...+||.+||..||.+|+|++++++||||...
T Consensus       235 ~~~~~~li~~~l~~~p~~Rps~~~il~~~~~~~~  268 (276)
T 2yex_A          235 DSAPLALLHKILVENPSARITIPDIKKDRWYNKP  268 (276)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTCC
T ss_pred             CHHHHHHHHHHCCCCchhCCCHHHHhcCccccCh
Confidence            7789999999999999999999999999999754

>3i6u_A CDS1, serine/threonine-protein kinase CHK2; Ser/Thr protein kinase, FHA domain, ATP-binding, cell cycle, mutation, LI-fraumeni syndrome, magnesium; 3.00A {Homo sapiens} PDB: 3i6w_A

Probab=96.88  E-value=0.00046  Score=67.59  Aligned_cols=33  Identities=36%  Similarity=0.684  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+++||.+||..||.+|+|++++|+||||+.
T Consensus       373 ~~~~~~li~~~L~~dP~~Rps~~e~l~hp~~~~  405 (419)
T 3i6u_A          373 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  405 (419)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhCCcccCC
Confidence            788999999999999999999999999999974

>1t4h_A Serine/threonine-protein kinase WNK1; protein serine/threonine kinase, transferase; 1.80A {Rattus norvegicus} PDB: 3fpq_A

Probab=96.87  E-value=0.00037  Score=64.31  Aligned_cols=34  Identities=18%  Similarity=0.323  Sum_probs=30.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++..+||.+||..||.+|+|++++|+||||.+.
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~f~~~  289 (290)
T 1t4h_A          256 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQEE  289 (290)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC--
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhhCcccccC
Confidence            5788999999999999999999999999999763

>2w4o_A Calcium/calmodulin-dependent protein kinase type IV; calmodulin-binding, nucleotide-binding, serine/threonine-protein kinase, ATP-binding; HET: DKI; 2.17A {Homo sapiens}

Probab=96.86  E-value=0.00065  Score=64.76  Aligned_cols=36  Identities=33%  Similarity=0.481  Sum_probs=33.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +.++.+||++||..||.+|+|+.++|+||||.....
T Consensus       279 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~~~  314 (349)
T 2w4o_A          279 SLNAKDLVRKLIVLDPKKRLTTFQALQHPWVTGKAA  314 (349)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTTSTTC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCcccCCCcc
Confidence            778999999999999999999999999999986543

>2y0a_A Death-associated protein kinase 1; transferase, calmodulin, esprit; HET: MES; 2.60A {Homo sapiens}

Probab=96.85  E-value=0.00041  Score=65.39  Aligned_cols=34  Identities=26%  Similarity=0.502  Sum_probs=31.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++.+.+||.+||..||.+|||+.++|+||||...
T Consensus       245 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~~~~~  278 (326)
T 2y0a_A          245 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKPK  278 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTSCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCCCccCC
Confidence            7889999999999999999999999999999753

>3kn6_A Ribosomal protein S6 kinase alpha-5; AMP-PNP, MSK1, MSK, ATP-binding, metal-binding, NUCL binding, serine/threonine-protein kinase, transferase; 2.00A {Homo sapiens} PDB: 3kn5_A

Probab=96.84  E-value=0.00042  Score=65.36  Aligned_cols=34  Identities=26%  Similarity=0.426  Sum_probs=32.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||.+||..||.+|+|++++|+||||...
T Consensus       244 s~~~~~li~~~L~~dP~~Rpt~~ell~h~w~~~~  277 (325)
T 3kn6_A          244 SQEAKDLIQGLLTVDPNKRLKMSGLRYNEWLQDG  277 (325)
T ss_dssp             CHHHHHHHHHHHCCCTTTCCCTTTSTTCGGGCTT
T ss_pred             CHHHHHHHHHHCCCChhHCCCHHHHhcChhhccC
Confidence            7889999999999999999999999999999864

>3h4j_B AMPK kdaid, SNF1-like protein kinase SSP2; ATP-binding, nucleotide-binding, phosphoprotei serine/threonine-protein kinase, transferase; 2.80A {Schizosaccharomyces pombe}

Probab=96.83  E-value=0.00042  Score=65.75  Aligned_cols=33  Identities=15%  Similarity=0.320  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|+|++|+++||||..
T Consensus       232 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~  264 (336)
T 3h4j_B          232 SPGAQSLIRRMIVADPMQRITIQEIRRDPWFNV  264 (336)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHTTCHHHHT
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhChhhcc
Confidence            788999999999999999999999999999975

>1tki_A Titin; serine kinase, muscle, autoinhibition; 2.00A {Homo sapiens} SCOP: d.144.1.7

Probab=96.83  E-value=0.00022  Score=67.22  Aligned_cols=35  Identities=23%  Similarity=0.396  Sum_probs=32.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++++||.+||..||.+|+|+.++|+||||....
T Consensus       231 s~~~~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~  265 (321)
T 1tki_A          231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQKI  265 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSCG
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcChhhccCc
Confidence            78899999999999999999999999999997653

>3kk8_A Calcium/calmodulin dependent protein kinase II; ATP-binding, nucleotide-binding, serine/threonine-protein kinase, transferase; HET: TPO; 1.72A {Caenorhabditis elegans} PDB: 3kk9_A* 3kl8_A 2vn9_A* 3bhh_A*

Probab=96.82  E-value=0.00056  Score=62.77  Aligned_cols=35  Identities=26%  Similarity=0.443  Sum_probs=32.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++..+||.+||..||.+|||+.++|+||||....
T Consensus       235 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  269 (284)
T 3kk8_A          235 TPEAKSLIDSMLTVNPKKRITADQALKVPWICNRE  269 (284)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSHHHHSCC
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcCccccCCh
Confidence            78899999999999999999999999999997643

>3m2w_A MAP kinase-activated protein kinase 2; small molecule inhibitor, spiroazetidine-tetracycle, ATP-SIT inhibitor, novartis compound NVP-BXS169; HET: L8I; 2.41A {Homo sapiens} PDB: 3kga_A* 3m42_A*

Probab=96.81  E-value=0.00032  Score=65.18  Aligned_cols=34  Identities=21%  Similarity=0.333  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++..+||.+||..||.+|+|+.++|+||||...
T Consensus       230 ~~~~~~li~~~l~~dP~~Rps~~e~l~hp~~~~~  263 (299)
T 3m2w_A          230 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  263 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHTG
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChhhccc
Confidence            7889999999999999999999999999999754

>3soa_A Calcium/calmodulin-dependent protein kinase type alpha with A beta 7 linker; phosphorylation, cytosolic, transferase-transferase inhibitor complex; HET: DB8; 3.55A {Homo sapiens}

Probab=96.80  E-value=0.00081  Score=66.39  Aligned_cols=33  Identities=33%  Similarity=0.558  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+||.|+|+||||..
T Consensus       241 s~~~~~li~~~L~~dP~~Rpta~e~L~hp~~~~  273 (444)
T 3soa_A          241 TPEAKDLINKMLTINPSKRITAAEALKHPWISH  273 (444)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSCTTHH
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcCccccC
Confidence            788999999999999999999999999999964

>3uc3_A Serine/threonine-protein kinase SRK2I; SNRK2, ABA signaling, transferase; 1.90A {Arabidopsis thaliana} PDB: 3zut_A 3zuu_A 3uc4_A 3ujg_A 3udb_A

Probab=96.80  E-value=0.00044  Score=66.30  Aligned_cols=34  Identities=21%  Similarity=0.554  Sum_probs=31.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||...
T Consensus       248 s~~~~~li~~~L~~dP~~Rps~~ell~hp~f~~~  281 (361)
T 3uc3_A          248 SPECCHLISRIFVADPATRISIPEIKTHSWFLKN  281 (361)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHTSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHhCcchhcC
Confidence            7889999999999999999999999999999653

>1x8b_A WEE1HU, WEE1-like protein kinase; cell cycle, transferase; HET: 824; 1.81A {Homo sapiens} PDB: 3bi6_A* 3biz_A* 3cqe_A* 3cr0_A* 2in6_A* 2io6_A* 2z2w_A*

Probab=96.78  E-value=0.00054  Score=62.74  Aligned_cols=34  Identities=24%  Similarity=0.328  Sum_probs=30.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++..+||.+||..||.+|||+.++|+||||...
T Consensus       253 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  286 (289)
T 1x8b_A          253 SQEFTELLKVMIHPDPERRPSAMALVKHSVLLSA  286 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTCTTC---
T ss_pred             CHHHHHHHHHHhCCCcccCCCHHHHhhChHhhhh
Confidence            7889999999999999999999999999999753

>2zv2_A Calcium/calmodulin-dependent protein kinase kinas; beta, camkk2, E.C.2.7.11.17, phosphorylation, AMPKK, metabolism, binding, calmodulin-binding; HET: 609; 2.40A {Homo sapiens}

Probab=96.78  E-value=0.00038  Score=64.53  Aligned_cols=32  Identities=19%  Similarity=0.180  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +++..+||.+||..||.+|+|+.++|+||||.
T Consensus       266 ~~~l~~li~~~l~~dp~~R~s~~e~l~hp~~~  297 (298)
T 2zv2_A          266 AEDLKDLITRMLDKNPESRIVVPEIKLHPWVT  297 (298)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTCHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHhcCcccc
Confidence            77899999999999999999999999999985

>3lm5_A Serine/threonine-protein kinase 17B; STK17B, serine/threonine kinase 17B, DRAK2, DAP kinase relat apoptosis-inducing protein kinase 2; HET: QUE; 2.29A {Homo sapiens} PDB: 3lm0_A*

Probab=96.77  E-value=0.00083  Score=63.27  Aligned_cols=36  Identities=25%  Similarity=0.455  Sum_probs=32.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++.+.+||.+||..||.+|||++++|+||||.....
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~~ll~h~~~~~~~~  296 (327)
T 3lm5_A          261 SQLATDFIQSLLVKNPEKRPTAEICLSHSWLQQWDF  296 (327)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTCGGGCCCCT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhCCHhhccccc
Confidence            778999999999999999999999999999976443

>4aaa_A Cyclin-dependent kinase-like 2; transferase, phospho-mimetic; HET: DKI; 1.53A {Homo sapiens} PDB: 4bbm_A*

Probab=96.76  E-value=0.00039  Score=65.62  Aligned_cols=34  Identities=41%  Similarity=0.526  Sum_probs=32.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++.++||.+||..||.+|||+.++|+||||+..
T Consensus       280 ~~~l~~li~~~L~~dP~~Rpt~~ell~hp~f~~~  313 (331)
T 4aaa_A          280 SEVVIDLAKKCLHIDPDKRPFCAELLHHDFFQMD  313 (331)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHGG
T ss_pred             hHHHHHHHHHHhccCcccCCCHHHHhcCchhccC
Confidence            8889999999999999999999999999999753

>3eqc_A Dual specificity mitogen-activated protein kinase; MEK1 kinase, ATP-binding, disease mutation, nucleoti binding, phosphoprotein; HET: 3BM AGS; 1.80A {Homo sapiens} PDB: 3eqd_A* 3eqf_A* 3eqg_A* 3eqh_A* 3eqi_A* 2y4i_C* 3eqb_A* 2p55_A* 1s9j_A* 3dy7_A* 3e8n_A* 3v01_A* 3v04_A* 3dv3_A* 3mbl_A* 3pp1_A* 3orn_A* 3os3_A* 3sls_A* 1s9i_A* ...

Probab=96.76  E-value=0.00042  Score=66.18  Aligned_cols=33  Identities=24%  Similarity=0.330  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.+..+||.+||.+||.+|+|++++|+||||..
T Consensus       298 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  330 (360)
T 3eqc_A          298 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  330 (360)
T ss_dssp             CHHHHHHHHHHHCSSTTTSCCHHHHHTSHHHHH
T ss_pred             cHHHHHHHHHHhhcChhhCCCHHHHhhChHhhc
Confidence            678999999999999999999999999999975

>3cok_A Serine/threonine-protein kinase PLK4; POLO-like kinase 4, SAK, STK18, PSI, structural genomics, protein structure initiative; HET: ANP; 2.25A {Homo sapiens}

Probab=96.76  E-value=0.00059  Score=62.44  Aligned_cols=35  Identities=26%  Similarity=0.458  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +.+..+||.+||..||.+|||++++|+||||....
T Consensus       236 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~~~  270 (278)
T 3cok_A          236 SIEAKDLIHQLLRRNPADRLSLSSVLDHPFMSRNS  270 (278)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSTTTC---
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhcCccccCCC
Confidence            77899999999999999999999999999997643

>3qd2_B Eukaryotic translation initiation factor 2-alpha; EIF2A kinase, phosphoryalation, gene regulation; HET: TPO; 2.81A {Mus musculus}

Probab=96.75  E-value=0.00053  Score=64.33  Aligned_cols=33  Identities=12%  Similarity=0.222  Sum_probs=30.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|||+.++|+||||.+
T Consensus       299 ~~~~~~li~~~l~~~p~~Rps~~~~l~~~~f~~  331 (332)
T 3qd2_B          299 YPQEHMMVQDMLSPSPTERPEATDIIENAIFEN  331 (332)
T ss_dssp             CHHHHHHHHHHHCSSGGGSCCHHHHHHSTTCCC
T ss_pred             ChhHHHHHHHHccCCCCcCCCHHHHhhchhhhc
Confidence            567899999999999999999999999999974

>2j7t_A Serine/threonine-protein kinase 10; transferase, ATP-binding, cell cycle progression, phosphorylation, disease mutation, nucleotide- binding; HET: 274; 2.0A {Homo sapiens} PDB: 4aot_A* 3zz2_A* 2j51_A* 2jfl_A* 2jfm_A* 2uv2_A*

Probab=96.75  E-value=0.001  Score=61.55  Aligned_cols=36  Identities=22%  Similarity=0.150  Sum_probs=32.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +....+||.+||..||.+|||+.++++||||.....
T Consensus       249 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~~~  284 (302)
T 2j7t_A          249 SVEFRDFLKIALDKNPETRPSAAQLLEHPFVSSITS  284 (302)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHTTSTTTTTCCC
T ss_pred             CHHHHHHHHHHcccChhhCCCHHHHhcChHHhhhcc
Confidence            677899999999999999999999999999986543

>1kob_A Twitchin; kinase, intrasteric regulation; 2.30A {Aplysia californica} SCOP: d.144.1.7

Probab=96.73  E-value=0.00085  Score=64.98  Aligned_cols=35  Identities=29%  Similarity=0.446  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++++||.+||..||.+|+|+.++|+||||....
T Consensus       278 s~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~~~  312 (387)
T 1kob_A          278 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGDH  312 (387)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSCC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhhCccccCCc
Confidence            78899999999999999999999999999998654

>2y7j_A Phosphorylase B kinase gamma catalytic chain, testis/liver isoform; transferase; HET: B49; 2.50A {Homo sapiens} PDB: 1h0t_A 1lp1_B 1q2n_A 2spz_A 3mzw_B* 1ss1_A 2jwd_A 1bdc_A 1bdd_A 1fc2_C* 2b87_A 2b88_A 1h0t_B 1lp1_A 2b87_B 2b89_A 3s1k_A

Probab=96.71  E-value=0.00071  Score=64.90  Aligned_cols=32  Identities=38%  Similarity=0.627  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +....+||.+||..||.+|+|+.++|+||||.
T Consensus       333 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~f~  364 (365)
T 2y7j_A          333 SSTVKDLISRLLQVDPEARLTAEQALQHPFFE  364 (365)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCcccC
Confidence            67799999999999999999999999999996

>2a2a_A Death-associated protein kinase 2; autoinhibition, transferase; 1.47A {Homo sapiens} PDB: 2cke_A* 1wmk_A 1z9x_A 2a27_A 2x0g_A 2xuu_A* 2w4k_A* 2xzs_A

Probab=96.71  E-value=0.0008  Score=63.12  Aligned_cols=33  Identities=27%  Similarity=0.454  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+.+||.+||..||.+|+|+.++|+||||..
T Consensus       246 ~~~~~~li~~~l~~dp~~Rps~~e~l~hp~~~~  278 (321)
T 2a2a_A          246 SELAKDFIRKLLVKETRKRLTIQEALRHPWITP  278 (321)
T ss_dssp             CHHHHHHHHTTSCSSTTTSCCHHHHHHSTTTSC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCccccC
Confidence            778999999999999999999999999999975

>4g3f_A NF-kappa-beta-inducing kinase; non-RD kinase, protein serine/threonine kinase, S based drug design, MAP3K14, transferase; HET: 0WB; 1.64A {Mus musculus} PDB: 4g3g_A* 4g3c_A 4dn5_A*

Probab=96.70  E-value=0.0012  Score=62.39  Aligned_cols=37  Identities=14%  Similarity=0.100  Sum_probs=32.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH-------------hcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA-------------LNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~-------------l~~~~~~~~~~~  373 (433)
                      ++++.+||.+||..||.+|+||.|+             |+|||+.....|
T Consensus       283 s~~~~~li~~~L~~dP~~R~sa~el~~~l~~~l~~~~~l~hPw~~~~~~P  332 (336)
T 4g3f_A          283 APLTAQAIQEGLRKEPVHRASAMELRRKVGKALQEVGGLKSPWKGEYKEP  332 (336)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHHHTTSSCSCSSSSCCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHHHHHHHhhhhhccCCCcCCCCCC
Confidence            7899999999999999999999995             789999775544

>2ycf_A Serine/threonine-protein kinase CHK2; transferase, anticancer, anticancer drug design; HET: YCF; 1.77A {Homo sapiens} PDB: 2yiq_A* 2w7x_A* 2ycq_A* 2ycs_A* 2w0j_A* 2yir_A* 2yit_A* 2wtj_A* 2cn8_A* 2wtc_A* 2wtd_A* 2wti_A* 2cn5_A* 2xbj_A* 2xm8_A* 2xm9_A* 2xk9_A* 2ycr_A*

Probab=96.70  E-value=0.00083  Score=62.98  Aligned_cols=33  Identities=36%  Similarity=0.684  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+.+||.+||..||.+|+|+.++|+||||..
T Consensus       248 ~~~~~~li~~~l~~dP~~Rps~~~~l~h~~~~~  280 (322)
T 2ycf_A          248 SEKALDLVKKLLVVDPKARFTTEEALRHPWLQD  280 (322)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGCC
T ss_pred             CHHHHHHHHHHcccCHhhCCCHHHHhhCcCcCC
Confidence            788999999999999999999999999999975

>3q60_A ROP5B; pseudokinase, transferase; HET: ATP; 1.72A {Toxoplasma gondii} PDB: 3q5z_A*

Probab=96.69  E-value=0.00061  Score=65.44  Aligned_cols=33  Identities=18%  Similarity=0.271  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||..
T Consensus       326 ~~~~~~li~~~L~~dP~~Rpt~~e~l~hp~f~~  358 (371)
T 3q60_A          326 PDFVKTLIGRFLNFDRRRRLLPLEAMETPEFLQ  358 (371)
T ss_dssp             CHHHHHHHHHHTCSSTTTCCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCHHHHH
Confidence            788999999999999999999999999999964

>2x4f_A Myosin light chain kinase family member 4; LUNG, breast cancer, transferase, serine/threonine-protein kinase, nucleotide-binding; HET: 16X 1PE; 2.67A {Homo sapiens}

Probab=96.69  E-value=0.00035  Score=67.31  Aligned_cols=34  Identities=24%  Similarity=0.402  Sum_probs=32.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||.+||..||.+|+|+.++|+||||...
T Consensus       316 ~~~~~~li~~~L~~dp~~Rps~~e~l~hp~~~~~  349 (373)
T 2x4f_A          316 SEEAKEFISKLLIKEKSWRISASEALKHPWLSDH  349 (373)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHCH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHhcCcCcCCC
Confidence            7899999999999999999999999999999753

>2pml_X PFPK7, Ser/Thr protein kinase; phosphorylati transferase, transferase; HET: ANP; 2.60A {Plasmodium falciparum} PDB: 2pmn_X* 2pmo_X*

Probab=96.68  E-value=0.0007  Score=64.16  Aligned_cols=35  Identities=26%  Similarity=0.455  Sum_probs=32.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +.+..+||.+||..||.+|||+.++|+||||....
T Consensus       296 ~~~l~~li~~~L~~dP~~Rps~~e~l~hp~f~~~~  330 (348)
T 2pml_X          296 SNEDIDFLKLFLRKNPAERITSEDALKHEWLADTN  330 (348)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSGGGTTCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCccccCCC
Confidence            78899999999999999999999999999998643

>2qr7_A Ribosomal protein S6 kinase alpha-3; kinase domain, RSK2, autoinhibitory, ATP-binding, nucleotide phosphorylation, serine/threonine-protein kinase; 2.00A {Mus musculus} PDB: 2qr8_A 4d9t_A* 4d9u_A* 3rny_A 2wnt_A

Probab=96.68  E-value=0.00062  Score=64.73  Aligned_cols=33  Identities=27%  Similarity=0.500  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||++||..||.+|+|+.++|+||||..
T Consensus       251 s~~~~~li~~~L~~dP~~R~t~~~il~hp~~~~  283 (342)
T 2qr7_A          251 SDTAKDLVSKMLHVDPHQRLTAALVLRHPWIVH  283 (342)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCCeecC
Confidence            788999999999999999999999999999954

>3p23_A Serine/threonine-protein kinase/endoribonuclease; kinase domain, kinase and RNAse function, ATP binding ssRNA dephosphorylated, hydrolase; HET: ADP; 2.70A {Homo sapiens}

Probab=96.68  E-value=0.00058  Score=67.20  Aligned_cols=33  Identities=36%  Similarity=0.820  Sum_probs=30.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +..+.+||.+||..||.+|+|++++|+||||+.
T Consensus       257 ~~~~~~li~~~L~~dP~~Rps~~evl~hp~f~~  289 (432)
T 3p23_A          257 DVIARELIEKMIAMDPQKRPSAKHVLKHPFFWS  289 (432)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHTSTTTCC
T ss_pred             cHHHHHHHHHHHhCCHhhCCCHHHHHhCccccC
Confidence            456889999999999999999999999999975

>3c0i_A Peripheral plasma membrane protein CASK; neurexin, Ca2+/calmodulin dependent protein kinase, Mg synaptic plasticity, pseudokinase, maguk; HET: 3AM; 1.85A {Homo sapiens} PDB: 3c0h_A* 3c0g_A* 3mfr_A* 3mfs_A* 3mft_A 3mfu_A* 3tac_A

Probab=96.67  E-value=0.0005  Score=65.56  Aligned_cols=33  Identities=33%  Similarity=0.592  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+|+.++|+||||..
T Consensus       260 s~~~~~li~~~L~~dP~~R~s~~e~l~hp~~~~  292 (351)
T 3c0i_A          260 SESAKDLVRRMLMLDPAERITVYEALNHPWLKE  292 (351)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcChhhcC
Confidence            788999999999999999999999999999975

>1u5q_A Serine/threonine protein kinase TAO2; transferase; HET: SEP; 2.10A {Rattus norvegicus} SCOP: d.144.1.7 PDB: 1u5r_A* 2gcd_A*

Probab=96.61  E-value=0.00062  Score=64.90  Aligned_cols=53  Identities=21%  Similarity=0.355  Sum_probs=40.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhhhhhhhhh
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE  389 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~  389 (433)
                      ++...+||.+||..||.+|||++++|+||||.....+.....+.........+
T Consensus       279 ~~~l~~li~~~l~~dP~~Rps~~~ll~h~~~~~~~~~~~~~~~~~~~~~~~~~  331 (348)
T 1u5q_A          279 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE  331 (348)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChhhhccCCcchhhHHHHHHHHHHhh
Confidence            67789999999999999999999999999998766655444433333333333

>3dbq_A Dual specificity protein kinase TTK; MPS1 structure, kinase activation, phosphorylation, ATP- binding, nucleotide-binding, phosphoprotein; 2.70A {Homo sapiens}

Probab=96.61  E-value=0.00069  Score=64.30  Aligned_cols=37  Identities=24%  Similarity=0.322  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +.+..+||.+||..||.+|||+.++|+||||.....+
T Consensus       247 ~~~l~~li~~~L~~dp~~Rpt~~e~l~hp~~~~~~~~  283 (343)
T 3dbq_A          247 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  283 (343)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCCC-
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHHhCccccccCCc
Confidence            5678999999999999999999999999999865544

>3com_A Serine/threonine-protein kinase 4; MST1, STE20-like kinase, PSI, structural genomics, protein structure initiative; HET: TPO; 2.20A {Homo sapiens}

Probab=96.60  E-value=0.0008  Score=62.73  Aligned_cols=36  Identities=19%  Similarity=0.293  Sum_probs=33.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +....+||.+||..||.+|||+.++|+||||.....
T Consensus       252 ~~~l~~li~~~l~~dp~~Rpt~~~ll~~~~~~~~~~  287 (314)
T 3com_A          252 SDNFTDFVKQCLVKSPEQRATATQLLQHPFVRSAKG  287 (314)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHTCCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHhcCCc
Confidence            678899999999999999999999999999987554

>1phk_A Phosphorylase kinase; glycogen metabolism, transferase, serine/threonine-protein, ATP-binding, calmodulin-binding; HET: ATP; 2.20A {Oryctolagus cuniculus} SCOP: d.144.1.7 PDB: 1ql6_A* 2phk_A*

Probab=96.60  E-value=0.00078  Score=62.25  Aligned_cols=34  Identities=32%  Similarity=0.609  Sum_probs=31.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +....+||.+||..||.+|+|+.++|+||||.+.
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (298)
T 1phk_A          257 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQY  290 (298)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCTT
T ss_pred             CHHHHHHHHHHccCCcccCCCHHHHHhChHhhhc
Confidence            7789999999999999999999999999999753

>1zy4_A Serine/threonine-protein kinase GCN2; translation regulator, signal transduction, acid starvation, starvation stress response; 1.95A {Saccharomyces cerevisiae} PDB: 1zy5_A* 1zyd_A* 1zyc_A* 1zxe_A

Probab=96.58  E-value=0.00095  Score=61.61  Aligned_cols=34  Identities=21%  Similarity=0.245  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +....+||.+||..||.+|||+.++|+||||...
T Consensus       257 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  290 (303)
T 1zy4_A          257 MKVEKKIIRLLIDHDPNKRPGARTLLNSGWLPVK  290 (303)
T ss_dssp             SHHHHHHHHHHTCSSGGGSCCHHHHHHSSCSCCC
T ss_pred             hHHHHHHHHHHHhcCcccCcCHHHHhCCCCcCCC
Confidence            5668999999999999999999999999999753

>2vwi_A Serine/threonine-protein kinase OSR1; STE kinase, hypertension, transferase; HET: ANP; 2.15A {Homo sapiens} PDB: 3dak_A*

Probab=96.58  E-value=0.0011  Score=61.32  Aligned_cols=34  Identities=26%  Similarity=0.332  Sum_probs=30.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +.+..+||.+||..||.+|||+.++|+||||...
T Consensus       261 ~~~~~~li~~~l~~dp~~Rps~~~ll~h~~~~~~  294 (303)
T 2vwi_A          261 GKSFRKMISLCLQKDPEKRPTAAELLRHKFFQKA  294 (303)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSTTC---
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHhhChhhhcC
Confidence            6788999999999999999999999999999753

>3fme_A Dual specificity mitogen-activated protein kinase; active mutant, structural genomics consortium, SCG, binding, nucleotide-binding, phosphoprotein; HET: STU; 2.26A {Homo sapiens} PDB: 3enm_A

Probab=96.57  E-value=0.00052  Score=63.12  Aligned_cols=33  Identities=18%  Similarity=0.175  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|||+.++|+||||..
T Consensus       240 ~~~~~~li~~~l~~~p~~Rpt~~e~l~hp~f~~  272 (290)
T 3fme_A          240 SAEFVDFTSQCLKKNSKERPTYPELMQHPFFTL  272 (290)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCcCHHHHHhCccccc
Confidence            778999999999999999999999999999975

>3lij_A Calcium/calmodulin dependent protein kinase with A kinase domain and 4 calmodulin...; transferase, calcium dependent protein kinase; HET: ANP; 1.90A {Cryptosporidium parvum} PDB: 3hzt_A* 3dxn_A 3l19_A*

Probab=96.56  E-value=0.00082  Score=67.28  Aligned_cols=33  Identities=24%  Similarity=0.468  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+++||++||..||.+|+||.++|+||||..
T Consensus       265 s~~~~~li~~~L~~dp~~R~s~~e~l~hp~~~~  297 (494)
T 3lij_A          265 SEGAKDLIKQMLQFDSQRRISAQQALEHPWIKE  297 (494)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHCCCChhhCccHHHHhcCccccc
Confidence            788999999999999999999999999999964

>3dls_A PAS domain-containing serine/threonine-protein KI; PAS kinase, PASK, protein kinase, drug discovery, ATP-bindin kinase, nucleotide-binding; HET: ADP; 2.30A {Homo sapiens}

Probab=96.53  E-value=0.00098  Score=63.08  Aligned_cols=34  Identities=15%  Similarity=0.143  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++..+||.+||..||.+|+|+.++|+||||...
T Consensus       248 ~~~l~~li~~~L~~dP~~Rps~~ell~hp~~~~~  281 (335)
T 3dls_A          248 SKELMSLVSGLLQPVPERRTTLEKLVTDPWVTQP  281 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHCTTTTCC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCccccCC
Confidence            7889999999999999999999999999999763

>3f3z_A Calcium/calmodulin-dependent protein kinase with domain and 4 calmodulin like EF...; calcium dependent protein kinase; HET: SEP DRK; 1.84A {Cryptosporidium parvum iowa II} PDB: 2qg5_A*

Probab=96.52  E-value=0.00081  Score=61.46  Aligned_cols=33  Identities=30%  Similarity=0.468  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++...+||.+||..||.+|+|+.++|+||||..
T Consensus       235 ~~~~~~li~~~l~~dp~~R~s~~~~l~h~~~~~  267 (277)
T 3f3z_A          235 SPQAESLIRRLLTKSPKQRITSLQALEHEWFEK  267 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHHHhc
Confidence            788999999999999999999999999999964

>3hko_A Calcium/calmodulin-dependent protein kinase with domain and 2 calmodulin-like EF...; structural genomics, protist parasite; HET: ANP; 1.80A {Cryptosporidium parvum iowa II}

Probab=96.52  E-value=0.00073  Score=63.93  Aligned_cols=35  Identities=31%  Similarity=0.392  Sum_probs=32.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||....
T Consensus       304 ~~~~~~li~~~l~~~p~~Rps~~~~l~hp~~~~~~  338 (345)
T 3hko_A          304 SPLARDLLSNLLNRNVDERFDAMRALQHPWISQFS  338 (345)
T ss_dssp             CHHHHHHHHHHSCSCTTTSCCHHHHHHSHHHHTTS
T ss_pred             CHHHHHHHHHHcCCChhHCCCHHHHhcChhhccCh
Confidence            78899999999999999999999999999997643

>3cek_A Dual specificity protein kinase TTK; HMPS1, PYT, ESK, phosphotyros picked threonine kinase, SGC, structural genomics consortiu binding; HET: 7PE; 2.30A {Homo sapiens} PDB: 3gfw_A* 3h9f_A* 2x9e_A* 3hmp_A* 3hmn_A* 3hmo_A*

Probab=96.48  E-value=0.00084  Score=62.63  Aligned_cols=37  Identities=24%  Similarity=0.322  Sum_probs=31.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +.+..+||.+||..||.+|||+.++|+||||.....+
T Consensus       266 ~~~l~~li~~~l~~dp~~Rps~~ell~h~~~~~~~~~  302 (313)
T 3cek_A          266 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  302 (313)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHCC---
T ss_pred             hHHHHHHHHHHccCCcccCcCHHHHhcCccccCCCCc
Confidence            5678999999999999999999999999999876554

>2rio_A Serine/threonine-protein kinase/endoribonuclease IRE1; protein-nucleotide complex, ATP-binding, endoplasmic reticulum, glycoprotein; HET: ADP; 2.40A {Saccharomyces cerevisiae} PDB: 3lj0_A* 3lj1_A* 3lj2_A* 3fbv_A* 3sdm_A* 3sdj_A*

Probab=96.47  E-value=0.00082  Score=66.12  Aligned_cols=33  Identities=30%  Similarity=0.521  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|||+.++|+||||+.
T Consensus       269 ~~~~~~li~~~L~~dP~~Rps~~eil~hp~f~~  301 (434)
T 2rio_A          269 IAEATDLISQMIDHDPLKRPTAMKVLRHPLFWP  301 (434)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSC
T ss_pred             hHHHHHHHHHHhhCChhhCCCHHHHHhCCccCC
Confidence            467899999999999999999999999999974

>2vgo_A Serine/threonine-protein kinase 12-A; nucleotide-binding, serine/threonine-protein kinase, ATP-binding, transferase, coiled coil, cell division, kinase; HET: TPO AD5; 1.7A {Xenopus laevis} PDB: 2bfx_A* 2vgp_A* 3ztx_A* 2vrx_A* 2bfy_A* 4af3_A* 3dj6_A* 3d15_A* 3d2i_A* 3d2k_A* 3d14_A* 3dj5_A* 3dj7_A* 3daj_A* 1ol5_A* 1ol7_A* 2x6d_A* 2x6e_A* 2xng_A* 2dwb_A* ...

Probab=96.46  E-value=0.00049  Score=63.23  Aligned_cols=35  Identities=23%  Similarity=0.414  Sum_probs=32.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +.+..+||.+||..||.+|+|++++|+||||....
T Consensus       236 ~~~~~~li~~~l~~~p~~Rps~~~ll~h~~~~~~~  270 (284)
T 2vgo_A          236 SDGSKDLISKLLRYHPPQRLPLKGVMEHPWVKANS  270 (284)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTCHHHHHHC
T ss_pred             CHHHHHHHHHHhhcCHhhCCCHHHHhhCHHHHhhc
Confidence            67889999999999999999999999999997543

>3fhr_A MAP kinase-activated protein kinase 3; kinase-inhibitor complex, ATP-binding, cytoplasm, nucleotide-binding, nucleus, phosphoprotein, polymorphism; HET: P4O; 1.90A {Homo sapiens} PDB: 3fxw_A* 3r1n_A* 3she_A* 2oza_A 3fyk_X* 3fyj_X* 2p3g_X* 3ka0_A* 3fpm_A* 2pzy_A* 3a2c_A* 3kc3_A* 3gok_A* 2jbo_A* 2jbp_A* 3r2y_A* 3r30_A* 3r2b_A*

Probab=96.46  E-value=0.00052  Score=64.99  Aligned_cols=33  Identities=24%  Similarity=0.378  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+|+.++|+||||..
T Consensus       261 ~~~~~~li~~~L~~dP~~Rpt~~ell~hp~~~~  293 (336)
T 3fhr_A          261 SEDAKQLIRLLLKTDPTERLTITQFMNHPWINQ  293 (336)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCccccc
Confidence            788999999999999999999999999999975

>3byv_A Rhoptry kinase; malaria, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii} PDB: 2w1z_A

Probab=96.46  E-value=0.001  Score=64.00  Aligned_cols=33  Identities=18%  Similarity=0.071  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|+|+.++|+||||..
T Consensus       333 ~~~~~~li~~~L~~dp~~Rpt~~e~l~hp~f~~  365 (377)
T 3byv_A          333 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYEQ  365 (377)
T ss_dssp             CHHHHHHHHHHTCSSGGGCCCHHHHHTSHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCCCHHHHhhChHHHH
Confidence            788999999999999999999999999999963

>2zmd_A Dual specificity protein kinase TTK; MPS1, T686A, ATP-binding, nucleotide-bindi phosphoprotein, serine/threonine-protein kinase; HET: 537 7PE; 2.88A {Homo sapiens} PDB: 2zmc_A*

Probab=96.45  E-value=0.00093  Score=64.73  Aligned_cols=37  Identities=24%  Similarity=0.322  Sum_probs=32.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +.++.+||.+||..||.+|||+.++|+||||.....+
T Consensus       294 ~~~~~~li~~~L~~dP~~Rps~~ell~hp~~~~~~~~  330 (390)
T 2zmd_A          294 EKDLQDVLKCCLKRDPKQRISIPELLAHPYVQIQTHP  330 (390)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHSCC--
T ss_pred             hHHHHHHHHHHcccChhhCCCHHHHhhCcCccccCcc
Confidence            5678999999999999999999999999999865544

>2clq_A Mitogen-activated protein kinase kinase kinase 5; transferase, metal-binding, apoptosis; HET: STU; 2.3A {Homo sapiens}

Probab=96.45  E-value=0.0016  Score=60.04  Aligned_cols=35  Identities=20%  Similarity=0.218  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++..+||.+||..||.+|||+.++|+||||....
T Consensus       252 ~~~~~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~  286 (295)
T 2clq_A          252 SAEAKAFILKCFEPDPDKRACANDLLVDEFLKVSS  286 (295)
T ss_dssp             CHHHHHHHHHTTCSSTTTSCCHHHHHTSGGGCC--
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcChhhhhcc
Confidence            77889999999999999999999999999997543

>3nyv_A Calmodulin-domain protein kinase 1; serine/threonine protein kinase, transferase, calcium-bindin binding, EF hand, bumped kinase inhibitor; HET: MSE DTQ; 1.88A {Toxoplasma gondii} PDB: 3i79_A* 3i7b_A* 3n51_A* 3i7c_A* 3sx9_A* 3sxf_A* 3t3u_A* 3t3v_A* 3upx_A* 3upz_A* 3v51_A* 3v5p_A* 3v5t_A* 3ku2_A* 3hx4_A*

Probab=96.44  E-value=0.00071  Score=67.50  Aligned_cols=33  Identities=33%  Similarity=0.524  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.+++||.+||..||.+|+||.++|+||||..
T Consensus       255 s~~~~~li~~~L~~dp~~R~s~~e~l~h~~~~~  287 (484)
T 3nyv_A          255 SESAKDLIRKMLTYVPSMRISARDALDHEWIQT  287 (484)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSHHHHH
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhhChhhcc
Confidence            788999999999999999999999999999965

>2x7f_A TRAF2 and NCK-interacting protein kinase; serine/threonine-protein kinase, phosphoprotein; HET: 824; 2.80A {Homo sapiens}

Probab=96.43  E-value=0.00067  Score=63.63  Aligned_cols=36  Identities=17%  Similarity=0.302  Sum_probs=33.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +....+||.+||..||.+|||+.++|+||||...+.
T Consensus       260 ~~~l~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~  295 (326)
T 2x7f_A          260 SKKFQSFIESCLVKNHSQRPATEQLMKHPFIRDQPN  295 (326)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHTSHHHHCCTT
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhChHHhhCcc
Confidence            678899999999999999999999999999987654

>2wtk_C Serine/threonine-protein kinase 11; transferase-metal-binding protein complex, transferase metal protein complex, nucleus; HET: ANP; 2.65A {Homo sapiens}

Probab=96.43  E-value=0.00094  Score=61.92  Aligned_cols=36  Identities=28%  Similarity=0.403  Sum_probs=32.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++...+||.+||..||.+|+|+.++++||||.....
T Consensus       237 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  272 (305)
T 2wtk_C          237 GPPLSDLLKGMLEYEPAKRFSIRQIRQHSWFRKKHP  272 (305)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSHHHHSCCC
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHhcCcccccCCC
Confidence            678899999999999999999999999999976544

>2h6d_A 5'-AMP-activated protein kinase catalytic subunit alpha-2; ATP-binding, cholesterol biosynthesis, fatty acid biosynthesis;kinase, lipid synthesis; 1.85A {Homo sapiens} PDB: 3aqv_A* 2yza_A*

Probab=96.36  E-value=0.0007  Score=61.79  Aligned_cols=34  Identities=29%  Similarity=0.434  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +....+||.+||..||.+|||+.++++||||.+.
T Consensus       235 ~~~l~~li~~~l~~~p~~Rps~~~~l~h~~~~~~  268 (276)
T 2h6d_A          235 NRSVATLLMHMLQVDPLKRATIKDIREHEWFKQD  268 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHhChhhccC
Confidence            6778999999999999999999999999999754

>3fdn_A Serine/threonine-protein kinase 6; aurora kinase inhibitors, virtual screening, X-RAY CO- crystal analysis, structure-based drug design (SBDD); HET: MMH; 1.90A {Homo sapiens} SCOP: d.144.1.7 PDB: 3k5u_A* 3m11_A* 2c6e_A* 1muo_A* 2bmc_A* 2j4z_A* 1ol6_A* 3up2_A* 3unz_A* 3uo5_A* 3uo6_A* 3uod_A* 3uoh_A* 3uoj_A* 3uok_A* 3uo4_A* 3uol_A* 3up7_A* 4dea_A* 4deb_A* ...

Probab=96.35  E-value=0.00079  Score=61.64  Aligned_cols=34  Identities=26%  Similarity=0.373  Sum_probs=31.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++...+||.+||..||.+|+|+.++|+||||...
T Consensus       231 ~~~~~~li~~~l~~~p~~Rps~~e~l~h~~~~~~  264 (279)
T 3fdn_A          231 TEGARDLISRLLKHNPSQRPMLREVLEHPWITAN  264 (279)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHCHHHHHH
T ss_pred             CHHHHHHHHHHhccChhhCCCHHHHhhCccccCC
Confidence            6788999999999999999999999999999753

>2bdw_A Hypothetical protein K11E8.1D; kinase, calmodulin activated, transferase; 1.80A {Caenorhabditis elegans} PDB: 2wel_A* 2v7o_A* 2vz6_A* 1cdm_B 1cm1_B 1cm4_B

Probab=96.34  E-value=0.00087  Score=64.23  Aligned_cols=33  Identities=27%  Similarity=0.478  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+|+.++|+||||..
T Consensus       258 ~~~~~~li~~~L~~dP~~R~t~~e~l~hp~~~~  290 (362)
T 2bdw_A          258 TPEAKSLIDSMLTVNPKKRITADQALKVPWICN  290 (362)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSHHHHT
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhcCcccCC
Confidence            788999999999999999999999999999964

>3a99_A Proto-oncogene serine/threonine-protein kinase PI; PIM-1, P27KIP1, peptide drug, prostate cancer, transferase; HET: ANP; 1.60A {Homo sapiens} PDB: 3bgq_A* 3bgp_A* 2obj_A* 3bgz_A* 3t9i_A* 3dcv_A* 1xws_A* 2xj1_A* 2xix_A* 2xiz_A* 2xj0_A* 2xiy_A* 2xj2_A* 3f2a_A* 1xr1_A* 1xqz_A* 3cy2_A* 3cxw_A* 3cy3_A* 2bik_B* ...

Probab=96.32  E-value=0.0014  Score=61.39  Aligned_cols=37  Identities=24%  Similarity=0.250  Sum_probs=33.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +++..+||.+||..||.+|||++++++||||.+...+
T Consensus       267 ~~~~~~li~~~l~~dp~~Rps~~~ll~hp~~~~~~~~  303 (320)
T 3a99_A          267 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLLP  303 (320)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcCHhhcCccCc
Confidence            7789999999999999999999999999999875543

>4ejn_A RAC-alpha serine/threonine-protein kinase; AKT1, autoinhibition, allosteric inhibitor, kinase inhibitor hydrophobic collapase, ATPase; HET: 0R4; 2.19A {Homo sapiens} PDB: 3o96_A*

Probab=96.32  E-value=0.0019  Score=63.68  Aligned_cols=33  Identities=33%  Similarity=0.518  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+     +|+++|+||||..
T Consensus       373 ~~~~~~li~~~L~~dP~~R~~~~~~t~~ell~hp~f~~  410 (446)
T 4ejn_A          373 GPEAKSLLSGLLKKDPKQRLGGGSEDAKEIMQHRFFAG  410 (446)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHhCCCCCCCHHHHHhCccccC
Confidence            78899999999999999999     9999999999975

>2rku_A Serine/threonine-protein kinase PLK1; structure of PLK1, selectivity residues, POLO-like K structure based drug design, ATP-binding; HET: R78 TLA SRT TAR; 1.95A {Homo sapiens} PDB: 2v5q_A 2yac_A* 4a4l_A* 4a4o_A* 3kb7_A* 3d5w_A* 3d5u_A* 3d5v_A 3db8_A* 3dbc_A* 3dbd_A* 3d5x_A* 3db6_A* 3dbe_A* 3dbf_A*

Probab=96.27  E-value=0.00084  Score=61.98  Aligned_cols=39  Identities=28%  Similarity=0.526  Sum_probs=35.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD  375 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~  375 (433)
                      ++...+||.+||..||.+|+|++++|+||||.....|..
T Consensus       239 ~~~~~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~~~~~  277 (294)
T 2rku_A          239 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPAR  277 (294)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCSC
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhhChheecCCcCCC
Confidence            678899999999999999999999999999987766543

>2y94_A 5'-AMP-activated protein kinase catalytic subunit; transferase, nucleotide-binding, staurosporine-binding, serine/threonine-protein kinase; HET: TPO STU AMP; 3.24A {Rattus norvegicus}

Probab=96.26  E-value=0.0013  Score=65.48  Aligned_cols=34  Identities=29%  Similarity=0.448  Sum_probs=31.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||++||..||.+|+|+.++++||||...
T Consensus       240 s~~~~~Li~~~L~~dP~~Rpt~~eil~hp~~~~~  273 (476)
T 2y94_A          240 NPSVISLLKHMLQVDPMKRATIKDIREHEWFKQD  273 (476)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTCHHHHTT
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHhCHHhhhc
Confidence            7889999999999999999999999999999653

>2iwi_A Serine/threonine-protein kinase PIM-2; nucleotide-binding, cancer, leukemia, transferase, ATP-binding, proto- oncogene, phosphorylation; HET: HB1; 2.80A {Homo sapiens}

Probab=96.25  E-value=0.0024  Score=59.44  Aligned_cols=34  Identities=24%  Similarity=0.310  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +....+||.+||..||.+|+|++++|+||||...
T Consensus       257 ~~~~~~li~~~l~~~p~~Rps~~e~l~~~~~~~~  290 (312)
T 2iwi_A          257 SPDCCALIRRCLAPKPSSRPSLEEILLDPWMQTP  290 (312)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHSTTTCC-
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHhcChhhcCc
Confidence            7788999999999999999999999999999764

>1nxk_A MAP kinase-activated protein kinase 2; MK2, phosphorylation, staurosporine, transfe; HET: STU; 2.70A {Homo sapiens} SCOP: d.144.1.7 PDB: 1kwp_A* 1ny3_A* 2onl_C

Probab=96.25  E-value=0.0009  Score=65.09  Aligned_cols=34  Identities=21%  Similarity=0.333  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||++||..||.+|+|+.++|+||||...
T Consensus       295 s~~~~~li~~~L~~dP~~Rpt~~eil~hp~~~~~  328 (400)
T 1nxk_A          295 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQS  328 (400)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHTT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCccccCC
Confidence            7889999999999999999999999999999754

>4dc2_A Protein kinase C IOTA type; kinase, substrate, cell polarity, atypical PKC, trans transferase substrate complex; HET: TPO ADE; 2.40A {Mus musculus}

Probab=96.24  E-value=0.0018  Score=62.79  Aligned_cols=33  Identities=24%  Similarity=0.423  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS------DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a------~~~l~~~~~~~  369 (433)
                      ++++++||++||..||.+|++|      +++++||||..
T Consensus       286 s~~~~~li~~lL~~dP~~R~~~~~~~~~~ei~~Hpff~~  324 (396)
T 4dc2_A          286 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  324 (396)
T ss_dssp             CHHHHHHHHHHTCSCTTTSTTCSTTTHHHHHHHSTTTTT
T ss_pred             CHHHHHHHHHHhcCCHhHcCCCCCCCCHHHHhcCccccC
Confidence            7889999999999999999996      79999999975

>1o6l_A RAC-beta serine/threonine protein kinase; protein kinase, transferase, serine/threonine-protein kinase; HET: TPO ANP; 1.6A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jdo_A* 2jdr_A* 2uw9_A* 2x37_A* 2x39_A* 2xh5_A* 3d0e_A* 3e87_A* 3e88_A* 3e8d_A* 1o6k_A* 1mrv_A 1mry_A 1gzn_A 1gzk_A 1gzo_A 3qkl_A* 3ocb_A* 3ow4_A* 3qkk_A* ...

Probab=96.20  E-value=0.0025  Score=60.41  Aligned_cols=33  Identities=33%  Similarity=0.580  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+     +++++++||||..
T Consensus       229 s~~~~~li~~lL~~dP~~R~g~~~~~~~ei~~h~~f~~  266 (337)
T 1o6l_A          229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhcCHHHhcCCCCCCHHHHHcCCCcCC
Confidence            78899999999999999999     9999999999975

>3a8x_A Protein kinase C IOTA type; transferase; HET: TPO; 2.00A {Homo sapiens} PDB: 3a8w_A* 1zrz_A*

Probab=96.19  E-value=0.0019  Score=61.34  Aligned_cols=33  Identities=24%  Similarity=0.423  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS------DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a------~~~l~~~~~~~  369 (433)
                      +.++.+||++||..||.+|+++      +++++||||..
T Consensus       243 s~~~~~li~~lL~~dP~~R~~~~~~~~~~~i~~hp~f~~  281 (345)
T 3a8x_A          243 SVKAASVLKSFLNKDPKERLGCHPQTGFADIQGHPFFRN  281 (345)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCCTTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHCCCCCCcCCHHHHhcCCccCC
Confidence            7889999999999999999996      79999999975

>2wei_A Calmodulin-domain protein kinase 1, putative; nucleotide-binding, serine/threonine-protein kinase, CGD3_920, transferase; HET: VGG; 1.65A {Cryptosporidium parvum iowa II} PDB: 3dfa_A 3ma6_A*

Probab=96.18  E-value=0.0011  Score=61.03  Aligned_cols=33  Identities=27%  Similarity=0.462  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|||+.++|+||||..
T Consensus       250 ~~~~~~li~~~l~~dp~~Rps~~ell~hp~~~~  282 (287)
T 2wei_A          250 SDDAKDLIRKMLTFHPSLRITATQCLEHPWIQK  282 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHSHHHHH
T ss_pred             CHHHHHHHHHHcccChhhCcCHHHHhcCHHHhc
Confidence            778999999999999999999999999999964

>3dxq_A Choline/ethanolamine kinase family protein; NP_106042.1, STR genomics, joint center for structural genomics, JCSG, prote structure initiative; HET: MSE; 2.55A {Mesorhizobium loti}

Probab=96.13  E-value=0.0096  Score=55.18  Aligned_cols=29  Identities=17%  Similarity=0.170  Sum_probs=24.7

Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      .++|+|+.+.||+ ..++.+.|+||..+..
T Consensus       174 ~l~HgDl~~~Nil-~~~~~~~lID~e~a~~  202 (301)
T 3dxq_A          174 AACHCDPLCENFL-DTGERMWIVDWEYSGM  202 (301)
T ss_dssp             EEECSCCCGGGEE-ECSSCEEECCCTTCEE
T ss_pred             eeeccCCCcCCEE-ECCCCEEEEecccccC
Confidence            4899999999999 5667789999987754

>3dzo_A Rhoptry kinase domain; parasitic disease, transferase, structural genomics, structural genomics consortium, SGC; 1.80A {Toxoplasma gondii}

Probab=96.11  E-value=0.0036  Score=61.02  Aligned_cols=32  Identities=19%  Similarity=0.073  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +++..+||.+||..||.+|+|+.++|+||||.
T Consensus       337 ~~~~~~li~~~l~~dP~~Rpt~~~~l~~~~~~  368 (413)
T 3dzo_A          337 PQPVRALLEGFLRYPKEDRLLPLQAMETPEYE  368 (413)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHhCHHHH
Confidence            78899999999999999999999999999995

>3v5w_A G-protein coupled receptor kinase 2; inhibitor complex, protein kinase, beta propeller, RGS homol domain; HET: 8PR; 2.07A {Homo sapiens} PDB: 3cik_A* 3krw_A* 3krx_A* 1omw_A 1ym7_A 2bcj_A* 3uzs_A 3uzt_A 3pvu_A* 3psc_A* 3pvw_A* 1bak_A

Probab=96.07  E-value=0.0022  Score=66.02  Aligned_cols=33  Identities=24%  Similarity=0.330  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-----SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-----a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|++     |+++++||||..
T Consensus       418 S~~a~dLI~~lL~~dP~~Rl~~~~~ga~ei~~HpfF~~  455 (689)
T 3v5w_A          418 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  455 (689)
T ss_dssp             CHHHHHHHHHHTCSCGGGCTTCSSSTHHHHTTSGGGTT
T ss_pred             CHHHHHHHHHHccCCHhHCCCCCCCCHHHHhcCccccC
Confidence            889999999999999999998     899999999975

>3txo_A PKC-L, NPKC-ETA, protein kinase C ETA type; phosphotransferase, transferase-transferase inhibito; HET: TPO 07U; 2.05A {Homo sapiens}

Probab=96.06  E-value=0.0019  Score=61.72  Aligned_cols=33  Identities=27%  Similarity=0.497  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH------HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS------DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a------~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|+++      +++++||||..
T Consensus       248 ~~~~~~li~~lL~~dP~~R~~~~~~~~~~~il~hp~f~~  286 (353)
T 3txo_A          248 HEDATGILKSFMTKNPTMRLGSLTQGGEHAILRHPFFKE  286 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSGGGTCTHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhhCHHHccCCcccCCHHHHhhCCcccC
Confidence            7889999999999999999999      89999999975

>1fot_A TPK1 delta, CAMP-dependent protein kinase type 1; open conformation, transferase; HET: TPO; 2.80A {Saccharomyces cerevisiae} SCOP: d.144.1.7

Probab=96.06  E-value=0.0029  Score=59.42  Aligned_cols=33  Identities=30%  Similarity=0.457  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|+     +++++++||||..
T Consensus       227 ~~~~~~li~~lL~~dp~~R~~~~~~~~~~i~~hp~f~~  264 (318)
T 1fot_A          227 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  264 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CHHHHHHHHHHhccCHHHcCCCcCCCHHHHhcCccccC
Confidence            78899999999999999999     9999999999975

>2owb_A Serine/threonine-protein kinase PLK1; catalytic domain, POLO-like kinase1, transfera; HET: 626; 2.10A {Homo sapiens} PDB: 2ou7_A* 3fc2_A* 3thb_A*

Probab=96.05  E-value=0.0012  Score=62.25  Aligned_cols=38  Identities=29%  Similarity=0.543  Sum_probs=34.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      ++...+||.+||..||.+|+|+.++|+|+||.....|.
T Consensus       265 ~~~~~~li~~~l~~dp~~Rps~~ell~~~~~~~~~~~~  302 (335)
T 2owb_A          265 NPVAASLIQKMLQTDPTARPTINELLNDEFFTSGYIPA  302 (335)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCGGGGGGSHHHHTSCCCS
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCccccCCCccc
Confidence            67889999999999999999999999999998766553

>3bhy_A Death-associated protein kinase 3; death associated kinase, DAPK3, ZIP kinase, ZIPK, DAP kinase like kinase, DLK, structural genomics consortium; HET: 7CP; 1.24A {Homo sapiens} PDB: 3bqr_A* 2j90_A* 1yrp_A* 2yak_A* 2y4p_A* 3f5u_A* 1jks_A 1jkk_A* 1ig1_A* 1jkl_A 1jkt_A 3eh9_A* 3eha_A* 3f5g_A* 1p4f_A* 1wvw_A 1wvx_A* 1wvy_A* 2w4j_A* 3dgk_A ...

Probab=96.02  E-value=0.0014  Score=60.04  Aligned_cols=33  Identities=24%  Similarity=0.534  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++...+||.+||..||.+|||+.++|+||||..
T Consensus       239 ~~~~~~li~~~l~~dp~~Rps~~~~l~h~~~~~  271 (283)
T 3bhy_A          239 SELAKDFIRRLLVKDPKRRMTIAQSLEHSWIKA  271 (283)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHhCHHHHH
Confidence            778999999999999999999999999999964

>2dyl_A Dual specificity mitogen-activated protein kinase kinase 7; MKK7, activated mutant, ATP-binding, structural genomics, NPPSFA; 2.45A {Homo sapiens}

Probab=95.95  E-value=0.0025  Score=59.35  Aligned_cols=33  Identities=21%  Similarity=0.163  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|||+.++|+||||..
T Consensus       257 ~~~l~~li~~~l~~dp~~Rps~~~ll~h~~~~~  289 (318)
T 2dyl_A          257 SGDFQSFVKDCLTKDHRKRPKYNKLLEHSFIKR  289 (318)
T ss_dssp             CHHHHHHHHHHTCSCTTTSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhhCHHHHh
Confidence            778999999999999999999999999999964

>3a7i_A MST3 kinase, serine/threonine kinase 24 (STE20 homolog, yeast); two-LOBE protein kinase fold, ATP-binding, nucleotid binding, transferase; HET: TPO ADE; 1.45A {Homo sapiens} PDB: 3a7g_A* 3a7h_A* 3a7f_A* 3a7j_A* 3ckw_A 3ckx_A* 3ggf_A* 2xik_A*

Probab=95.93  E-value=0.0021  Score=59.59  Aligned_cols=36  Identities=19%  Similarity=0.260  Sum_probs=32.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +....+||.+||..||.+|||+.++|+||||.....
T Consensus       244 ~~~l~~li~~~l~~dp~~Rps~~~ll~~~~~~~~~~  279 (303)
T 3a7i_A          244 SKPLKEFVEACLNKEPSFRPTAKELLKHKFILRNAK  279 (303)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTCHHHHHHCC
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHhhChhhhcCCC
Confidence            677899999999999999999999999999976544

>3a62_A Ribosomal protein S6 kinase beta-1; kinase domain, inactive, active, ribosomal S6 kinase, activation, alternative initiation, ATP-binding; HET: TPO STU; 2.35A {Homo sapiens} PDB: 3a61_A* 3a60_A*

Probab=95.91  E-value=0.0027  Score=59.69  Aligned_cols=33  Identities=36%  Similarity=0.509  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      +.++.+||.+||..||.+|+     ++.++++||||..
T Consensus       245 ~~~~~~li~~~L~~dp~~R~~~~~~~~~e~l~hp~f~~  282 (327)
T 3a62_A          245 TQEARDLLKKLLKRNAASRLGAGPGDAGEVQAHPFFRH  282 (327)
T ss_dssp             CHHHHHHHHHHSCSCGGGSTTSSTTTHHHHHHSGGGSS
T ss_pred             CHHHHHHHHHHHhcCHhhccCCCCCCHHHHHcCCcccC
Confidence            78899999999999999999     8999999999975

>2q83_A YTAA protein; 2635576, structural genomics, joint center for structu genomics, JCSG, protein structure initiative, PSI-2, transf; HET: ADN CIT UNL; 2.50A {Bacillus subtilis}

Probab=95.81  E-value=0.012  Score=55.25  Aligned_cols=30  Identities=17%  Similarity=0.306  Sum_probs=27.1

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .+++|+|+++.||+++.++.+.|+||+.+.
T Consensus       222 ~~l~HgD~~~~Nil~~~~~~~~lIDfe~a~  251 (346)
T 2q83_A          222 PNLCHQDYGTGNTLLGENEQIWVIDLDTVS  251 (346)
T ss_dssp             CCEECSSCSTTSEEECGGGCEEECCCTTCE
T ss_pred             CceecCCCCcccEEEeCCCcEEEEehhhcc
Confidence            679999999999999888899999999763

>2olc_A MTR kinase, methylthioribose kinase; kinase ADP-2HO complex, transferase; HET: CPS ADP; 2.00A {Bacillus subtilis} SCOP: d.144.1.6 PDB: 2pu8_A* 2pui_A* 2pul_A* 2pun_A* 2pup_A*

Probab=95.80  E-value=0.029  Score=54.14  Aligned_cols=31  Identities=16%  Similarity=0.311  Sum_probs=25.8

Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      ...++|+|+.+.||+++.+ .+.++||..+..
T Consensus       226 ~~~L~HGDl~~~Nil~~~~-~~~lID~e~a~~  256 (397)
T 2olc_A          226 AETLIHGDLHTGSIFASEH-ETKVIDPEFAFY  256 (397)
T ss_dssp             CCEEECSCCSGGGEEECSS-CEEECCCTTCEE
T ss_pred             CCceeeCCCCcCcEEEeCC-CeEEEeCccccc
Confidence            3579999999999999865 489999987643

>1xjd_A Protein kinase C, theta type; PKC-theta, ATP, AMP,, transferase; HET: TPO SEP STU; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 2jed_A*

Probab=95.76  E-value=0.0021  Score=61.18  Aligned_cols=33  Identities=30%  Similarity=0.476  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSD-AALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~-~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+++. ++++||||..
T Consensus       242 s~~~~~li~~lL~~dp~~R~~~~~~i~~hp~f~~  275 (345)
T 1xjd_A          242 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  275 (345)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHcCCChHHHHcCccccC
Confidence            78899999999999999999998 9999999975

>3aln_A Dual specificity mitogen-activated protein kinase; protein AMP-PNP complex, transferase; HET: ANP; 2.30A {Homo sapiens} PDB: 3alo_A*

Probab=95.69  E-value=0.0026  Score=59.60  Aligned_cols=33  Identities=24%  Similarity=0.229  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++...+||.+||..||.+|||+.++|+||||..
T Consensus       259 ~~~l~~li~~~l~~dp~~Rps~~ell~hp~~~~  291 (327)
T 3aln_A          259 SPSFINFVNLCLTKDESKRPKYKELLKHPFILM  291 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTSHHHHH
T ss_pred             CHHHHHHHHHHhhCChhhCcCHHHHHhChHHHH
Confidence            788999999999999999999999999999964

>2w5a_A Serine/threonine-protein kinase NEK2; Ser/Thr protein kinase, nucleus, meiosis, mitosis, cytoplasm, metal-binding, phosphoprotein; HET: ADP; 1.55A {Homo sapiens} PDB: 2wqo_A* 2xk3_A* 2xk4_A* 2xk6_A* 2xk7_A* 2xk8_A* 2xkc_A* 2xkd_A* 2xke_A* 2xkf_A* 2xnm_A* 2xnn_A* 2xno_A* 2xnp_A* 4afe_A* 2jav_A* 2w5b_A* 2w5h_A 4a4x_A*

Probab=95.62  E-value=0.0055  Score=55.79  Aligned_cols=35  Identities=11%  Similarity=0.183  Sum_probs=32.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++..+||.+||..||.+|||+.++|+|+|+....
T Consensus       241 ~~~l~~li~~~l~~~p~~Rps~~~ll~~~~~~~~~  275 (279)
T 2w5a_A          241 SDELNEIITRMLNLKDYHRPSVEEILENPLILEHH  275 (279)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTCCGGG
T ss_pred             CHHHHHHHHHHcCCCcccCCCHHHHHhChhhhhhc
Confidence            67889999999999999999999999999997643

>1rdq_E PKA C-alpha, CAMP-dependent protein kinase, alpha-catalytic SU; CAMP-dependent protein kinase,catalytic mechanism, ATP hydro two nucleotide states; HET: TPO SEP ADP ATP; 1.26A {Mus musculus} SCOP: d.144.1.7 PDB: 2erz_E* 3fjq_E* 1bkx_A* 1atp_E* 1fmo_E* 1j3h_A* 1jlu_E* 1bx6_A* 1re8_A* 1rej_A* 1rek_A* 2cpk_E* 2qcs_A* 2qvs_E* 1l3r_E* 3idb_A* 3idc_A* 3o7l_D* 3ow3_A* 3tnp_C* ...

Probab=95.60  E-value=0.0056  Score=58.26  Aligned_cols=33  Identities=39%  Similarity=0.494  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-----SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-----a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|++     ++++++||||..
T Consensus       262 ~~~~~~li~~lL~~dp~~R~~~~~~~~~ei~~h~~f~~  299 (350)
T 1rdq_E          262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhcCHHhccCCccCCHHHHHhCcCcCC
Confidence            788999999999999999998     999999999975

>1vzo_A Ribosomal protein S6 kinase alpha 5; protein kinase, transferase, phosphorylation, serine/threonine protein kinase; 1.8A {Homo sapiens} SCOP: d.144.1.7

Probab=95.55  E-value=0.005  Score=58.62  Aligned_cols=33  Identities=39%  Similarity=0.667  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      +..+.+||.+||..||.+|+     |++++++||||..
T Consensus       290 ~~~~~~li~~~L~~dP~~R~~~~~~s~~ell~h~~f~~  327 (355)
T 1vzo_A          290 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  327 (355)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhhCHHHhcCCCCCCHHHHHcCcchhc
Confidence            67889999999999999999     9999999999975

>2i0e_A Protein kinase C-beta II; serine/threonine protein kinase, transferase; HET: TPO SEP PDS; 2.60A {Homo sapiens} PDB: 3iw4_A*

Probab=95.42  E-value=0.0066  Score=57.85  Aligned_cols=33  Identities=21%  Similarity=0.363  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+     +++++++||||..
T Consensus       245 s~~~~~li~~lL~~dP~~R~~~~~~~~~~i~~h~~f~~  282 (353)
T 2i0e_A          245 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  282 (353)
T ss_dssp             CHHHHHHHHHHTCSCTTSCTTCSTTHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhcCHHHcCCCCCCCHHHHhcCccccC
Confidence            78899999999999999999     4799999999974

>2acx_A G protein-coupled receptor kinase 6; GRK, G transferase; HET: ANP; 2.60A {Homo sapiens} PDB: 3nyn_A* 3nyo_A*

Probab=95.39  E-value=0.0048  Score=62.78  Aligned_cols=33  Identities=24%  Similarity=0.392  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||.+||..||.+|+     +|+++++||||..
T Consensus       413 s~~~~dLI~~lL~~dP~~R~g~~~~sa~eil~HpfF~~  450 (576)
T 2acx_A          413 SPQARSLCSQLLCKDPAERLGCRGGSAREVKEHPLFKK  450 (576)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTCSSSHHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHHHcCCCCCCCHHHHHhChhhcc
Confidence            78999999999999999999     8999999999975

>4fr4_A YANK1, serine/threonine-protein kinase 32A; structural genomics, structural genomics consortium, SGC, TR; HET: STU; 2.29A {Homo sapiens}

Probab=95.00  E-value=0.0096  Score=57.44  Aligned_cols=33  Identities=30%  Similarity=0.393  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-a~~~l~~~~~~~  369 (433)
                      +.++.+||.+||..||.+|++ ++++++||||..
T Consensus       244 s~~~~~li~~lL~~dP~~R~s~~~~l~~hp~f~~  277 (384)
T 4fr4_A          244 SQEMVSLLKKLLEPNPDQRFSQLSDVQNFPYMND  277 (384)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCSHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcCCHhHhcccHHHHHcChhhhc
Confidence            788999999999999999998 899999999975

>3pfq_A PKC-B, PKC-beta, protein kinase C beta type; phosphorylation, transferase; HET: TPO SEP ANP; 4.00A {Rattus norvegicus} PDB: 1tbn_A 1tbo_A 2e73_A

Probab=94.96  E-value=0.01  Score=61.78  Aligned_cols=33  Identities=21%  Similarity=0.362  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH-----HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS-----DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a-----~~~l~~~~~~~  369 (433)
                      ++++++||++||..||.+|+++     +++++||||..
T Consensus       566 s~~~~~li~~lL~~dP~~R~~~~~~~~~ei~~h~ff~~  603 (674)
T 3pfq_A          566 SKEAVAICKGLMTKHPGKRLGCGPEGERDIKEHAFFRY  603 (674)
T ss_dssp             CHHHHHHHHHHSCSSSTTCTTCSTTHHHHHHSSGGGSS
T ss_pred             CHHHHHHHHHHccCCHHHCCCCCCCcHHHHhcCccccC
Confidence            7889999999999999999997     99999999975

>3v8s_A RHO-associated protein kinase 1; dimerization, myosin, transferase, inhibitor, transf transferase inhibitor complex; HET: 0HD; 2.29A {Homo sapiens} PDB: 3twj_A* 3tv7_A* 2etr_A* 2esm_A* 2eto_A* 2etk_A* 3d9v_A* 3ncz_A* 3ndm_A* 2v55_A* 2f2u_A* 2h9v_A*

Probab=94.84  E-value=0.011  Score=57.51  Aligned_cols=34  Identities=21%  Similarity=0.222  Sum_probs=31.7

Q ss_pred             ChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSK--RFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~--R~~a~~~l~~~~~~~~  370 (433)
                      ++++++||.+||..+|.+  |++++++++||||...
T Consensus       301 s~~~~~li~~lL~~~~~rlgR~~~~ei~~Hp~f~~~  336 (410)
T 3v8s_A          301 SKEAKNLICAFLTDREVRLGRNGVEEIKRHLFFKND  336 (410)
T ss_dssp             CHHHHHHHHHHSSCGGGCTTSSCHHHHHTSGGGCCS
T ss_pred             cHHHHHHHHHHccChhhhCCCCCHHHHhcCccccCC
Confidence            789999999999999988  9999999999999763

>4aw2_A Serine/threonine-protein kinase MRCK alpha; transferase, CDC42BPA; HET: 22E; 1.70A {Rattus norvegicus} PDB: 3tku_A* 3qfv_A*

Probab=94.83  E-value=0.011  Score=58.02  Aligned_cols=33  Identities=18%  Similarity=0.281  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCC--CCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSK--RFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~--R~~a~~~l~~~~~~~  369 (433)
                      +++++|||++||..+|.+  |++++++++||||..
T Consensus       310 s~~~~dLi~~lL~~~~~r~~r~~~~eil~Hpff~~  344 (437)
T 4aw2_A          310 SENAKDLIRRLICSREHRLGQNGIEDFKKHPFFSG  344 (437)
T ss_dssp             CHHHHHHHHTTSSCGGGCTTTTTTHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhcccccccCCCCHHHHhCCCccCC
Confidence            889999999999999998  999999999999975

>3qa8_A MGC80376 protein; kinase ubiquitin-like domain, phosphorylation, kinase domain ubiquitin-like domain, kinase, substrate binding; 3.60A {Xenopus laevis} PDB: 3qad_A* 3rzf_A*

Probab=94.68  E-value=0.0061  Score=62.97  Aligned_cols=33  Identities=15%  Similarity=0.035  Sum_probs=27.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++...+||.+||.+||.+|||++++|+||||..
T Consensus       271 s~~L~dLI~~mL~~DP~kRPTa~elL~hp~F~~  303 (676)
T 3qa8_A          271 AGKLERWLQCMLMWHQRQRGTDPQNPNVGCFQA  303 (676)
T ss_dssp             HHHHHHHHHHHSCSSCC---CCTTCCCCTTHHH
T ss_pred             hHHHHHHHHHHccCCHhhCcCHHHHhcCHHHHH
Confidence            577899999999999999999999999999954

>2vd5_A DMPK protein; serine/threonine-protein kinase, kinase, transferase, ATP-BI nucleotide-binding, cardiac contractility, muscle different; HET: BI8; 2.80A {Homo sapiens}

Probab=94.63  E-value=0.013  Score=57.18  Aligned_cols=32  Identities=25%  Similarity=0.510  Sum_probs=29.8

Q ss_pred             ChHHHHHHHHhcccCCCCCC---CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF---DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~---~a~~~l~~~~~~~  369 (433)
                      ++++++||++||. ||.+|+   +++++++||||..
T Consensus       299 s~~~~dli~~lL~-~p~~Rlgr~~~~ei~~Hpff~~  333 (412)
T 2vd5_A          299 PEEARDFIQRLLC-PPETRLGRGGAGDFRTHPFFFG  333 (412)
T ss_dssp             CHHHHHHHHTTSS-CGGGCTTTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcC-ChhhcCCCCCHHHHhcCCCcCC
Confidence            7899999999999 999995   9999999999965

>3feg_A Choline/ethanolamine kinase; non-protein kinase, choline kinase, structural genomics CONS SGC, hemicholinium-3, phosphorylation; HET: HC7 ADP AMP; 1.30A {Homo sapiens} PDB: 3lq3_A* 2ig7_A*

Probab=94.51  E-value=0.1  Score=50.06  Aligned_cols=30  Identities=27%  Similarity=0.449  Sum_probs=26.2

Q ss_pred             CeeccCCCCCcEEEecC----CcEEEeecCCccc
Q psy7889          91 KILHRDMKAANVLITKT----GILKLADFGLARA  120 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~----~~~kl~DFg~a~~  120 (433)
                      .++|+|+.+.||+++.+    +.+.|+||..+..
T Consensus       221 ~~~H~D~~~~Nil~~~~~~~~~~~~~IDwE~a~~  254 (379)
T 3feg_A          221 VFCHNDIQEGNILLLSEPENADSLMLVDFEYSSY  254 (379)
T ss_dssp             EEECSCCCGGGEEEESCC---CCEEECCCTTCEE
T ss_pred             EEEcCCCCCCeEEEcCCCCccCcEEEEecccCCc
Confidence            59999999999999876    7899999987743

>2r5t_A Serine/threonine-protein kinase SGK1; AGC protein kinase, apoptosis, ATP-binding, cytoplasm, endoplasmic reticulum, nucleotide-binding, nucleus; HET: ANP; 1.90A {Homo sapiens} PDB: 3hdm_A* 3hdn_A*

Probab=94.35  E-value=0.014  Score=55.93  Aligned_cols=33  Identities=30%  Similarity=0.358  Sum_probs=30.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCH----HHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDS----DAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a----~~~l~~~~~~~  369 (433)
                      +.++.+||++||..||.+|+++    .+++.||||..
T Consensus       263 ~~~~~~li~~lL~~dp~~R~~~~~~~~~i~~h~~f~~  299 (373)
T 2r5t_A          263 TNSARHLLEGLLQKDRTKRLGAKDDFMEIKSHVFFSL  299 (373)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTTTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHhCCCCCCCHHHHhCCccccC
Confidence            7889999999999999999987    68999999975

>2pyw_A Uncharacterized protein; 5-methylthioribose kinase, plant methionine recycling, refol transferase; HET: SR1 ADP; 1.90A {Arabidopsis thaliana}

Probab=94.26  E-value=0.033  Score=54.22  Aligned_cols=33  Identities=15%  Similarity=0.307  Sum_probs=28.6

Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCcccc
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAF  121 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~  121 (433)
                      +...++|+|++|.||+++.++ +.|+||+.+...
T Consensus       230 ~~~~liHGDl~~~Nil~~~~~-~~lID~e~a~~G  262 (420)
T 2pyw_A          230 RAQALIHGDLHTGSVMVTQDS-TQVIDPEFSFYG  262 (420)
T ss_dssp             BCCEEECSCCSGGGEEECSSC-EEECCCTTCEEE
T ss_pred             CCCeEEecCCCCCcEEEeCCC-CEEEeCcccccC
Confidence            356899999999999998776 999999988654

>4euu_A Serine/threonine-protein kinase TBK1; ATP binding, phosphorylation, transferase-transferas inhibitor complex; HET: SEP BX7; 1.80A {Homo sapiens}

Probab=94.11  E-value=0.016  Score=53.91  Aligned_cols=29  Identities=17%  Similarity=0.161  Sum_probs=26.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHD  365 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~  365 (433)
                      +....+||++||.+||.+|+|++|+|+||
T Consensus       276 ~~~l~~ll~~~L~~dP~~R~s~~ell~h~  304 (319)
T 4euu_A          276 QVLLTPVLANILEADQEKCWGFDQFFAET  304 (319)
T ss_dssp             HHHHHHHHHHHSCCCTTTSCCHHHHHHHH
T ss_pred             HHHhHHHHHHhccCChhhhccHHHhhhcc
Confidence            46688999999999999999999999985

>3c4z_A Rhodopsin kinase; Ser/Thr kinase, RGS homology domain, G protein coupled recep kinase, GRK, GRK1, P-loop, autophosphoryl ADP, ATP-binding; HET: ADP; 1.84A {Bos taurus} PDB: 3c4x_A* 3c4y_A 3c4w_A* 3c50_A* 3c51_A* 3qc9_A* 2i94_B

Probab=93.96  E-value=0.017  Score=58.42  Aligned_cols=33  Identities=30%  Similarity=0.457  Sum_probs=30.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-----SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-----a~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|++     |+++++||||..
T Consensus       417 s~~~~~li~~lL~~dP~~R~~~~~~~a~ei~~Hpff~~  454 (543)
T 3c4z_A          417 SPASKDFCEALLQKDPEKRLGFRDGSCDGLRTHPLFRD  454 (543)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCCBTTBSHHHHTSGGGTT
T ss_pred             CHHHHHHHHHhccCCHhHCCCCcccCHHHHHcCccccC
Confidence            789999999999999999995     589999999975

>3jr1_A Putative fructosamine-3-kinase; YP_719053.1, structural genomics, joint center for structural genomics, JCSG; HET: MSE UNL; 2.32A {Haemophilus somnus 129PT}

Probab=92.47  E-value=0.28  Score=45.55  Aligned_cols=40  Identities=20%  Similarity=0.186  Sum_probs=30.9

Q ss_pred             hhHHHHHHHHHhCC---CCCccceeeeEEecCccccccCceEEEEeecCcC
Q psy7889           8 ITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH   55 (433)
Q Consensus         8 ~~~~~Ei~il~~l~---hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~   55 (433)
                      ..+.+|...|+.|.   ...+.+++.+....        +..++|||++++
T Consensus        73 ~~~~~E~~~L~~L~~~~~v~VP~vl~~~~~~--------g~~~lvme~l~G  115 (312)
T 3jr1_A           73 SMFRAEADQLALLAKTNSINVPLVYGIGNSQ--------GHSFLLLEALNK  115 (312)
T ss_dssp             HHHHHHHHHHHHHHHTTSSBCCCEEEEEECS--------SEEEEEEECCCC
T ss_pred             HHHHHHHHHHHHHHhhCCCCcceEEEEeecC--------CceEEEEEeccC
Confidence            45788999999883   35678888776553        568999999986

>2ppq_A HSK, HK, homoserine kinase; structural genomics, MCSG, PSI-2, protein structure initiative; 2.00A {Agrobacterium tumefaciens str} SCOP: d.144.1.6

Probab=92.05  E-value=0.077  Score=49.31  Aligned_cols=30  Identities=27%  Similarity=0.371  Sum_probs=25.7

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .+++|+|+.+.||+++.++.+.|+||+.+.
T Consensus       187 ~~liHgDl~~~Nil~~~~~~~~lIDf~~a~  216 (322)
T 2ppq_A          187 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  216 (322)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccCCCCCCccCEEEeCCceEEEecchhcc
Confidence            369999999999999987666899998764

>2vuw_A Serine/threonine-protein kinase haspin; cell cycle, transferase, CAsp8, nucleotide binding; HET: MSE 5ID MPD; 1.80A {Homo sapiens} PDB: 3f2n_A* 3e7v_A* 3dlz_A* 3fmd_A* 3iq7_A* 2wb8_A

Probab=91.82  E-value=0.059  Score=50.48  Aligned_cols=27  Identities=15%  Similarity=0.233  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHh-cCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAAL-NHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l-~~~~~~  368 (433)
                      +++++|||++||.+|     ||+|+| +||||+
T Consensus       309 s~~~~dli~~~L~~d-----sa~e~l~~Hp~f~  336 (336)
T 2vuw_A          309 KRKIQEFHRTMLNFS-----SATDLLCQHSLFK  336 (336)
T ss_dssp             HHHHHHHHHHGGGSS-----SHHHHHHHCGGGC
T ss_pred             CHHHHHHHHHHhccC-----CHHHHHhcCCCcC
Confidence            678999999999988     999999 999995

>3csv_A Aminoglycoside phosphotransferase; YP_614837.1, phosphotransferase enzyme family, structural genomics, JOIN for structural genomics, JCSG; HET: MSE; 2.15A {Silicibacter SP}

Probab=91.12  E-value=0.11  Score=48.68  Aligned_cols=31  Identities=29%  Similarity=0.377  Sum_probs=27.0

Q ss_pred             CCeeccCCCCCcEEEecC----CcEEEeecCCccc
Q psy7889          90 NKILHRDMKAANVLITKT----GILKLADFGLARA  120 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~----~~~kl~DFg~a~~  120 (433)
                      ..++|+|+.+.||+++.+    +.+.|+||+.+..
T Consensus       183 ~~lvHgD~~~~Nil~~~~~~~~~~~~lIDf~~a~~  217 (333)
T 3csv_A          183 MVFVHRDFHAQNLLWLPEREGLARVGVIDFQDAKL  217 (333)
T ss_dssp             CEEECSCCSGGGEEECTTSCGGGGEEECCCTTCEE
T ss_pred             CeeEeCCcCcccEEeccCcCCCCCeEEEeCCCcCc
Confidence            479999999999999874    6899999998754

>1zyl_A Hypothetical protein YIHE; putative protein kinase, structural genomics, PSI, protein structure initiative; 2.80A {Escherichia coli} SCOP: d.144.1.6

Probab=90.96  E-value=0.19  Score=46.81  Aligned_cols=29  Identities=31%  Similarity=0.254  Sum_probs=24.7

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      ..++|+|+++.||+++ + .+.|+||+.+..
T Consensus       195 ~~l~HgD~~~~Nil~~-~-~~~lIDfe~a~~  223 (328)
T 1zyl_A          195 VLRLHGDCHAGNILWR-D-GPMFVDLDDARN  223 (328)
T ss_dssp             CEECCSSCSGGGEEES-S-SEEECCCTTCCE
T ss_pred             eeeeeCCCCcccEeEc-C-CCEEEECCCCCc
Confidence            4589999999999998 4 899999987643

>3qup_A Tyrosine-protein kinase receptor TYRO3; protein kinase inhibitor, receptor tyrosine kinase, spirocyc kinase domain, phosphotransfer, GAS6 ligand; HET: LUN; 1.90A {Mus musculus}

Probab=90.69  E-value=0.096  Score=48.55  Aligned_cols=33  Identities=21%  Similarity=0.166  Sum_probs=25.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-------HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-------SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-------a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|||       .++++.|+|+..
T Consensus       265 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l~~~l~~~~~~~  304 (323)
T 3qup_A          265 MEEVYDLMYQCWSADPKQRPSFTCLRMELENILGHLSVLS  304 (323)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHHC-----
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHHHhhhcC
Confidence            678999999999999999999       677899999965

>3i1a_A Spectinomycin phosphotransferase; protein kinase, aminoglycoside phosphotransferase, antibiotic resistance; HET: MES PG4; 1.70A {Legionella pneumophila} PDB: 3i0q_A* 3i0o_A* 3q2m_A*

Probab=89.43  E-value=0.23  Score=46.68  Aligned_cols=31  Identities=23%  Similarity=0.342  Sum_probs=27.4

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      ..++|+|+.+.||+++.++.+.|+||+.+..
T Consensus       206 ~~~~HgD~~~~N~l~~~~~~~~~iD~e~~~~  236 (339)
T 3i1a_A          206 YVLCHSDIHAGNVLVGNEESIYIIDWDEPML  236 (339)
T ss_dssp             CEEECSCCCGGGEEECGGGCEEECCCSSCEE
T ss_pred             ceeEeCCCCcCCEEEeCCCeEEEEECCCCee
Confidence            3699999999999999888899999987754

>3ork_A Serine/threonine protein kinase; structural genomics, TB structural genomics consortium, TBSG domain, signal transduction; HET: AGS; 1.60A {Mycobacterium tuberculosis} PDB: 3ori_A* 3orl_A* 3oro_A* 3orp_A* 3ort_A* 3f61_A* 1mru_A* 3f69_A* 3orm_A* 1o6y_A* 2fum_A*

Probab=89.13  E-value=0.061  Score=49.76  Aligned_cols=33  Identities=18%  Similarity=0.249  Sum_probs=30.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++..+||.+||..||.+|+++.++|.|+|+..
T Consensus       247 ~~~l~~li~~~l~~dP~~R~~~~~~l~~~l~~~  279 (311)
T 3ork_A          247 SADLDAVVLKALAKNPENRYQTAAEMRADLVRV  279 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHhcCHhhChhhHHHHHHHHHHH
Confidence            788999999999999999999999999999853

>2a19_B Interferon-induced, double-stranded RNA-activated kinase; transferase, protein biosynthesis, protein synthesis transferase complex; HET: TPO ANP; 2.50A {Homo sapiens} PDB: 2a1a_B*

Probab=88.81  E-value=0.085  Score=47.74  Aligned_cols=33  Identities=30%  Similarity=0.422  Sum_probs=29.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +....+||.+||..||.+|||+.++++|.+...
T Consensus       241 ~~~~~~li~~~l~~dp~~Rps~~e~l~~l~~~~  273 (284)
T 2a19_B          241 DKKEKTLLQKLLSKKPEDRPNTSEILRTLTVWK  273 (284)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHT
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHh
Confidence            677899999999999999999999999877643

>3c5i_A Choline kinase; choline, kinase, malaria, transferase, structural genomics, structural genomics consortium; 2.20A {Plasmodium knowlesi} PDB: 3fi8_A*

Probab=88.46  E-value=0.42  Score=45.30  Aligned_cols=29  Identities=28%  Similarity=0.457  Sum_probs=24.3

Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      +++|+|+.+.|||++.++ +.|+||..+..
T Consensus       213 ~l~HgDl~~~Nil~~~~~-~~lID~e~a~~  241 (369)
T 3c5i_A          213 VFCHNDLQENNIINTNKC-LRLIDFEYSGF  241 (369)
T ss_dssp             EEECSCCCGGGEEECC-C-EEECCCTTCEE
T ss_pred             EEEeCCCCcccEEecCCc-EEEEEecCCCC
Confidence            599999999999998655 89999987754

>4hcu_A Tyrosine-protein kinase ITK/TSK; transferase-transferase inhibitor complex; HET: 13L; 1.43A {Homo sapiens} PDB: 4hct_A* 4hcv_A* 3t9t_A* 1sm2_A* 1snu_A* 1snx_A 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=87.78  E-value=0.17  Score=45.48  Aligned_cols=28  Identities=11%  Similarity=0.081  Sum_probs=26.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.++++|
T Consensus       233 ~~~~~~li~~~l~~~p~~Rps~~~ll~~  260 (269)
T 4hcu_A          233 STHVYQIMNHCWRERPEDRPAFSRLLRQ  260 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHHH
Confidence            6788999999999999999999999875

>4ase_A Vascular endothelial growth factor receptor 2; transferase, angiogenesis, signaling protein, phosphorylatio receptor, inhibitor; HET: AV9; 1.83A {Homo sapiens} PDB: 4agd_A* 4asd_A* 4agc_A*

Probab=87.73  E-value=0.17  Score=48.03  Aligned_cols=28  Identities=14%  Similarity=0.045  Sum_probs=26.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.++++|
T Consensus       314 ~~~~~~li~~c~~~dP~~RPt~~eil~~  341 (353)
T 4ase_A          314 TPEMYQTMLDCWHGEPSQRPTFSELVEH  341 (353)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            7789999999999999999999999986

>2yfx_A Tyrosine-protein kinase receptor; nucleotide-binding, transferase; HET: VGH; 1.70A {Homo sapiens} PDB: 2xp2_A* 3aox_A* 2yhv_A 3lcs_A* 3lct_A* 4dce_A* 2xba_A* 2xb7_A*

Probab=87.47  E-value=0.12  Score=48.18  Aligned_cols=32  Identities=9%  Similarity=0.023  Sum_probs=29.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +....+||.+||..||.+|||+.++++|.|+.
T Consensus       271 ~~~l~~li~~~l~~dp~~Rps~~~ll~~l~~~  302 (327)
T 2yfx_A          271 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  302 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHHHHHHH
Confidence            67889999999999999999999999998763

>3dtc_A Mitogen-activated protein kinase kinase kinase 9; mixed-lineage kinase, MLK family, MLK1 and MLK3 subtype selective inhibitors; HET: VIN; 2.60A {Homo sapiens} SCOP: d.144.1.0

Probab=87.46  E-value=0.18  Score=45.25  Aligned_cols=28  Identities=18%  Similarity=0.160  Sum_probs=25.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.+++++
T Consensus       240 ~~~~~~li~~~l~~~p~~Rps~~e~l~~  267 (271)
T 3dtc_A          240 PEPFAKLMEDCWNPDPHSRPSFTNILDQ  267 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhcCCcccCcCHHHHHHH
Confidence            6778999999999999999999999864

>3g2f_A Bone morphogenetic protein receptor type-2; kinase, structural genomics, structural genomics consortium, ATP-binding, disease mutation; HET: ADP; 2.35A {Homo sapiens}

Probab=87.27  E-value=0.2  Score=46.54  Aligned_cols=33  Identities=12%  Similarity=-0.000  Sum_probs=27.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA------LNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~------l~~~~~~~  369 (433)
                      +++..+||.+||..||.+||||.++      |.++|-++
T Consensus       285 ~~~l~~li~~cl~~dP~~Rps~~e~l~~L~~ll~~~~~~  323 (336)
T 3g2f_A          285 VRSLKETIEDCWDQDAEARLTAQXAEERMAELMMIWERN  323 (336)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHHHHHHHHCCCC-
T ss_pred             HHHHHHHHHHHhcCChhhCcchHHHHHHHHHHHHHHHhc
Confidence            3468999999999999999999999      55666554

>3sxs_A Cytoplasmic tyrosine-protein kinase BMX; transferase-transferase inhibitor complex; HET: PP2; 1.89A {Homo sapiens} SCOP: d.144.1.7 PDB: 3sxr_A*

Probab=86.96  E-value=0.2  Score=44.88  Aligned_cols=28  Identities=14%  Similarity=0.011  Sum_probs=25.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (268)
T 3sxs_A          231 SDTIYQIMYSCWHELPEKRPTFQQLLSS  258 (268)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6778999999999999999999999875

>3vhe_A Vascular endothelial growth factor receptor 2; kinase domain, kinase, transferase-transferase inhibitor COM; HET: 42Q; 1.55A {Homo sapiens} PDB: 1y6a_A* 1y6b_A* 3vhk_A* 3vid_A* 3hng_A*

Probab=86.75  E-value=0.2  Score=47.04  Aligned_cols=28  Identities=14%  Similarity=0.045  Sum_probs=26.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.++++|
T Consensus       322 ~~~l~~li~~~l~~dP~~Rps~~ell~~  349 (359)
T 3vhe_A          322 TPEMYQTMLDCWHGEPSQRPTFSELVEH  349 (359)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHHH
Confidence            6789999999999999999999999875

>2buj_A Serine/threonine-protein kinase 16; transferase, ATP-binding, lipoprotein, myristate, PA phosphorylation; HET: STU; 2.6A {Homo sapiens}

Probab=86.39  E-value=0.22  Score=45.87  Aligned_cols=28  Identities=21%  Similarity=0.317  Sum_probs=26.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.+++++
T Consensus       273 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  300 (317)
T 2buj_A          273 SSALWQLLNSMMTVDPHQRPHIPLLLSQ  300 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHhhcChhhCCCHHHHHHH
Confidence            6789999999999999999999999886

>1fvr_A Tyrosine-protein kinase TIE-2; tyrosine kinase, transferase; 2.20A {Homo sapiens} SCOP: d.144.1.7 PDB: 2oo8_X* 2osc_A* 2p4i_A* 3l8p_A* 2wqb_A*

Probab=86.18  E-value=0.23  Score=46.11  Aligned_cols=28  Identities=21%  Similarity=0.132  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+++++++
T Consensus       267 ~~~l~~li~~~l~~dp~~Rps~~ell~~  294 (327)
T 1fvr_A          267 DDEVYDLMRQCWREKPYERPSFAQILVS  294 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6788999999999999999999999874

>4fvq_A Tyrosine-protein kinase JAK2; janus protein kinase, pseudokinase, ATP binding, phosphoryla transferase; HET: ATP; 1.75A {Homo sapiens} PDB: 4fvp_A* 4fvr_A*

Probab=86.15  E-value=0.17  Score=45.89  Aligned_cols=28  Identities=14%  Similarity=0.204  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|+|+.++++|
T Consensus       242 ~~~l~~li~~~l~~dp~~Rps~~~ll~~  269 (289)
T 4fvq_A          242 AAELANLINNCMDYEPDHRPSFRAIIRD  269 (289)
T ss_dssp             SCTTHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            4567899999999999999999999875

>3gen_A Tyrosine-protein kinase BTK; bruton'S tyrosine kinase, 4-amino-5-(4-phenoxyphenyl)-5H- pyrrolo[3, 2-D]pyrimidin-7-YL-cyclopentane, TEC-family; HET: B43; 1.60A {Homo sapiens} PDB: 3k54_A* 3pj2_A* 3piy_A* 3piz_A* 3pj1_A* 3pix_A* 3pj3_A* 3p08_A 3ocs_A* 3oct_A* 1k2p_A

Probab=86.11  E-value=0.24  Score=44.82  Aligned_cols=28  Identities=7%  Similarity=-0.027  Sum_probs=25.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.++++|
T Consensus       247 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  274 (283)
T 3gen_A          247 SEKVYTIMYSCWHEKADERPTFKILLSN  274 (283)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHHH
Confidence            6778999999999999999999999875

>4e5w_A Tyrosine-protein kinase JAK1; kinase domain, transferase-transferase inhibit complex; HET: PTR 0NT; 1.86A {Homo sapiens} PDB: 4e4l_A* 4e4n_A* 4ehz_A* 4ei4_A* 4fk6_A* 3eyg_A* 3eyh_A*

Probab=86.07  E-value=0.29  Score=44.68  Aligned_cols=27  Identities=19%  Similarity=0.201  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       269 ~~~l~~li~~~l~~dp~~Rps~~~ll~  295 (302)
T 4e5w_A          269 PDEVYQLMRKCWEFQPSNRTSFQNLIE  295 (302)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCCCCCCCCHHHHHH
Confidence            678999999999999999999999875

>3mdy_A Bone morphogenetic protein receptor type-1B; complex (isomerase-protein kinase), receptor serine/threonin structural genomics consortium, SGC; HET: LDN; 2.05A {Homo sapiens} SCOP: d.144.1.7

Probab=85.94  E-value=0.23  Score=46.14  Aligned_cols=28  Identities=11%  Similarity=0.076  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.++++|
T Consensus       298 ~~~l~~li~~~l~~dP~~Rps~~ell~~  325 (337)
T 3mdy_A          298 LRQMGKLMTECWAHNPASRLTALRVKKT  325 (337)
T ss_dssp             HHHHHHHHHHHSCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhhhhChhhCCCHHHHHHH
Confidence            3558899999999999999999999874

>4aoj_A High affinity nerve growth factor receptor; transferase, inhibitor; HET: V4Z; 2.75A {Homo sapiens}

Probab=85.88  E-value=0.33  Score=45.44  Aligned_cols=28  Identities=7%  Similarity=0.056  Sum_probs=25.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+|+.+||..||.+|||+++++++
T Consensus       286 ~~~~~~li~~cl~~dP~~RPs~~ei~~~  313 (329)
T 4aoj_A          286 PPEVYAIMRGCWQREPQQRHSIKDVHAR  313 (329)
T ss_dssp             CHHHHHHHHHHCCSSTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCcChhHCcCHHHHHHH
Confidence            6789999999999999999999998763

>3kmu_A ILK, integrin-linked kinase; cell adhesion, ANK repeat, ATP-binding, cell junction, cell membrane, integrin-binding protein, membrane, nucleotide- binding; 1.80A {Homo sapiens} SCOP: d.144.1.0 PDB: 3kmw_A* 3rep_A*

Probab=85.87  E-value=0.3  Score=43.60  Aligned_cols=27  Identities=22%  Similarity=0.192  Sum_probs=25.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       237 ~~~~~~li~~~l~~~p~~Rps~~~il~  263 (271)
T 3kmu_A          237 SPHVSKLMKICMNEDPAKRPKFDMIVP  263 (271)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            778999999999999999999999875

>3soc_A Activin receptor type-2A; structural genomics consortium, SGC, transferase, protein KI; HET: GVD; 1.95A {Homo sapiens} PDB: 3q4t_A* 4asx_A* 2qlu_A*

Probab=85.79  E-value=0.28  Score=45.45  Aligned_cols=26  Identities=12%  Similarity=0.220  Sum_probs=23.8

Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         338 QYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       338 ~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++..+||.+||..||.+|||+.++++
T Consensus       286 ~~l~~li~~cl~~dP~~Rps~~ell~  311 (322)
T 3soc_A          286 AMLCETIEECWDHDAEARLSAGCVGE  311 (322)
T ss_dssp             HHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHccCChhhCcCHHHHHH
Confidence            45889999999999999999999976

>3cc6_A Protein tyrosine kinase 2 beta; focal adhesion kinase, structural genomics, structural genom consortium, SGC, ATP-binding, membrane; 1.60A {Homo sapiens} PDB: 3fzs_A* 3et7_A 3fzo_A* 3fzr_A* 3fzp_A* 3fzt_A* 3h3c_A*

Probab=85.73  E-value=0.25  Score=44.61  Aligned_cols=28  Identities=18%  Similarity=0.095  Sum_probs=25.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.+++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~ell~~  267 (281)
T 3cc6_A          240 PPVLYTLMTRCWDYDPSDRPRFTELVCS  267 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCchhCcCHHHHHHH
Confidence            6788999999999999999999999874

>2qg7_A Ethanolamine kinase PV091845; malaria, SGC, structural genomics consortium, transferase; 2.41A {Plasmodium vivax}

Probab=85.73  E-value=0.62  Score=45.73  Aligned_cols=33  Identities=24%  Similarity=0.265  Sum_probs=23.2

Q ss_pred             HHHHHHHHhCCCCCc-cceeeeEEecCccccccCceEEEEeecCcC
Q psy7889          11 LREIKILQLLKHENV-VHLIEICRTKANQYNRYRSTFYLVFDFCEH   55 (433)
Q Consensus        11 ~~Ei~il~~l~hpnI-v~l~~~~~~~~~~~~~~~~~~~lV~e~~~~   55 (433)
                      .+|..+|+.|...++ .++++++.   +         .+||||++|
T Consensus       152 ~~E~~vl~~L~~~gl~P~ll~~~~---~---------G~v~e~I~G  185 (458)
T 2qg7_A          152 EREKKISCILYNKNIAKKIYVFFT---N---------GRIEEFMDG  185 (458)
T ss_dssp             HHHHHHHHHHTTSSSBCCEEEEET---T---------EEEEECCCS
T ss_pred             HHHHHHHHHHHhcCCCCCEEEEeC---C---------eEEEEeeCC
Confidence            589999999965445 56666552   1         259999875

>4f0f_A Serine/threonine-protein kinase ROCO4; LRRK2, ATP-binding, nucleotide serine/threonine-protein kinase, transferase, signaling Pro; HET: ACP; 1.80A {Dictyostelium discoideum} PDB: 4f0g_A 4f1t_A* 4f1m_A* 4f1o_A*

Probab=85.59  E-value=0.31  Score=44.08  Aligned_cols=27  Identities=15%  Similarity=0.047  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       256 ~~~l~~li~~~l~~dp~~Rps~~~ll~  282 (287)
T 4f0f_A          256 PPRLRNVIELCWSGDPKKRPHFSYIVK  282 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            678899999999999999999999875

>2ivs_A Proto-oncogene tyrosine-protein kinase receptor RET; nucleotide-binding, hirschsprung disease, phosphorylation, disease mutation; HET: ACK; 2.00A {Homo sapiens} PDB: 2ivt_A* 2ivu_A* 2x2k_A* 2x2l_A* 2x2m_A* 2ivv_A*

Probab=85.35  E-value=0.27  Score=45.13  Aligned_cols=28  Identities=14%  Similarity=0.008  Sum_probs=25.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.+++++
T Consensus       278 ~~~~~~li~~~l~~dp~~Rps~~~l~~~  305 (314)
T 2ivs_A          278 SEEMYRLMLQCWKQEPDKRPVFADISKD  305 (314)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            7789999999999999999999999864

>3uim_A Brassinosteroid insensitive 1-associated receptor; kinase, protein kinase, transferase; HET: SEP TPO ANP; 2.20A {Arabidopsis thaliana} PDB: 3ulz_A* 3tl8_A*

Probab=85.34  E-value=0.26  Score=45.65  Aligned_cols=30  Identities=7%  Similarity=-0.198  Sum_probs=26.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDF  366 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~  366 (433)
                      ....++|+.+||..||.+|||+.++++|-.
T Consensus       278 ~~~l~~li~~cl~~dP~~Rps~~ell~~L~  307 (326)
T 3uim_A          278 VEQLIQVALLCTQSSPMERPKMSEVVRMLE  307 (326)
T ss_dssp             HHHHHHHHHHHTCSCGGGSCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCcCCccCCCHHHHHHHhc
Confidence            466889999999999999999999998754

>3omv_A RAF proto-oncogene serine/threonine-protein kinas; serine/threonine-protein kinase, transferase; HET: SM5; 4.00A {Homo sapiens}

Probab=85.25  E-value=0.51  Score=43.68  Aligned_cols=27  Identities=11%  Similarity=-0.129  Sum_probs=24.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+|+.+||..||.+|||+.++++
T Consensus       267 ~~~l~~li~~cl~~dP~~RPs~~ei~~  293 (307)
T 3omv_A          267 PKAMKRLVADCVKKVKEERPLFPQILS  293 (307)
T ss_dssp             CHHHHHHHHHHTCSSSTTSCCHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            678899999999999999999998754

>3lxl_A Tyrosine-protein kinase JAK3; TYK2, inflammation, cancer, PAN inhibitor, ATP-binding mutation, membrane, nucleotide-binding, phosphoprot SCID; HET: IZA; 1.74A {Homo sapiens} PDB: 3lxk_A* 4hvd_A* 4hvg_A* 4hvh_A* 4hvi_A* 3pjc_A* 1yvj_A*

Probab=85.24  E-value=0.27  Score=45.60  Aligned_cols=27  Identities=15%  Similarity=-0.025  Sum_probs=25.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       270 ~~~l~~li~~~l~~dP~~Rps~~ell~  296 (327)
T 3lxl_A          270 PAEVHELMKLCWAPSPQDRPSFSALGP  296 (327)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678899999999999999999999964

>1t46_A HOMO sapiens V-KIT hardy-zuckerman 4 feline sarcoma viral oncogene homolog; kinase, structure, inhibitor, STI-571, gleevec, transferase activator; HET: STI; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1pkg_A* 1t45_A 3g0e_A* 3g0f_A*

Probab=85.22  E-value=0.27  Score=45.05  Aligned_cols=28  Identities=18%  Similarity=0.092  Sum_probs=25.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +....+||.+||..||.+|||+.+++++
T Consensus       274 ~~~l~~li~~~l~~dp~~Rps~~ell~~  301 (313)
T 1t46_A          274 PAEMYDIMKTCWDADPLKRPTFKQIVQL  301 (313)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHH
Confidence            6788999999999999999999999864

>2xir_A Vascular endothelial growth factor receptor 2; angiogenesis, nucleotide-binding, inhibitor, phosphorylation receptor, transferase, transmembrane; HET: 00J; 1.50A {Homo sapiens} PDB: 1vr2_A* 1ywn_A* 3vnt_A* 3c7q_A* 2oh4_A* 3u6j_A* 3efl_A* 2p2i_A* 3cjf_A* 3cjg_A* 3ewh_A* 2qu5_A* 2qu6_A* 2rl5_A* 3b8q_A* 3b8r_A* 2p2h_A* 3cp9_A* 3cpb_A* 3cpc_A* ...

Probab=85.14  E-value=0.28  Score=45.07  Aligned_cols=28  Identities=14%  Similarity=0.045  Sum_probs=26.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.++++|
T Consensus       277 ~~~l~~li~~~l~~dp~~Rps~~ell~~  304 (316)
T 2xir_A          277 TPEMYQTMLDCWHGEPSQRPTFSELVEH  304 (316)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6788999999999999999999999875

>3q4u_A Activin receptor type-1; structural genomics consortium, SGC, protein kinase, transfe; HET: LDN FLC; 1.82A {Homo sapiens} PDB: 3mtf_A* 3oom_A* 4dym_A* 3h9r_A* 3my0_A*

Probab=85.11  E-value=0.32  Score=44.25  Aligned_cols=27  Identities=15%  Similarity=0.102  Sum_probs=24.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +....+||.+||..||.+|||+.++++
T Consensus       269 ~~~l~~li~~cl~~dP~~Rps~~~i~~  295 (301)
T 3q4u_A          269 LTSLAKLMKECWYQNPSARLTALRIKK  295 (301)
T ss_dssp             HHHHHHHHHHHCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcChhhCCCHHHHHH
Confidence            356889999999999999999999875

>4hgt_A Casein kinase I isoform delta; CK1D, inhibitor, transferase-transferase inhibitor C; HET: 15G; 1.80A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 3uzp_A* 4hnf_A* 1cki_A 1ckj_A 4hni_A* 4hok_A

Probab=84.78  E-value=0.49  Score=42.83  Aligned_cols=27  Identities=11%  Similarity=-0.153  Sum_probs=25.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       247 ~~~l~~li~~~l~~~p~~Rpt~~~l~~  273 (296)
T 4hgt_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHHhcCCCCCCCHHHHHH
Confidence            778999999999999999999999876

>3t9t_A Tyrosine-protein kinase ITK/TSK; kinase domain, alpha/beta, ATP binding, phosphorylation, intracellular, transferase-transferase inhibitor complex; HET: IAQ; 1.65A {Homo sapiens} PDB: 3v5l_A* 3v5j_A* 3v8t_A* 3v8w_A* 1sm2_A* 1snu_A* 1snx_A 3qgw_A* 3qgy_A* 3miy_A* 3mj1_A* 3mj2_A*

Probab=84.67  E-value=0.3  Score=43.55  Aligned_cols=28  Identities=11%  Similarity=0.081  Sum_probs=25.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +....+|+.+||..||.+|||+.+++++
T Consensus       231 ~~~l~~li~~~l~~~p~~Rps~~~ll~~  258 (267)
T 3t9t_A          231 STHVYQIMNHCWRERPEDRPAFSRLLRQ  258 (267)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCChhhCcCHHHHHHH
Confidence            6778999999999999999999999863

>1rjb_A FL cytokine receptor; kinase, structure, autoinhibition, juxtamembrane domain, transferase; 2.10A {Homo sapiens} SCOP: d.144.1.7

Probab=84.57  E-value=0.3  Score=45.56  Aligned_cols=29  Identities=10%  Similarity=-0.050  Sum_probs=26.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHD  365 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~  365 (433)
                      +++..+||.+||..||.+|||+.++++|-
T Consensus       301 ~~~l~~li~~~l~~dp~~Rps~~~l~~~l  329 (344)
T 1rjb_A          301 TEEIYIIMQSCWAFDSRKRPSFPNLTSFL  329 (344)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCchhCcCHHHHHHHH
Confidence            67899999999999999999999998753

>1u59_A Tyrosine-protein kinase ZAP-70; transferase; HET: STU; 2.30A {Homo sapiens} SCOP: d.144.1.7

Probab=84.40  E-value=0.32  Score=44.13  Aligned_cols=28  Identities=11%  Similarity=-0.071  Sum_probs=26.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+||++.+++++
T Consensus       239 ~~~l~~li~~~l~~~p~~Rps~~~l~~~  266 (287)
T 1u59_A          239 PPELYALMSDCWIYKWEDRPDFLTVEQR  266 (287)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            7789999999999999999999999875

>1p4o_A Insulin-like growth factor I receptor protein; IGF-1R, kinase domain, hormone-growth factor complex; 1.50A {Homo sapiens} SCOP: d.144.1.7 PDB: 1m7n_A 3lvp_A* 3lw0_A* 1jqh_A* 2zm3_A* 3f5p_A* 3i81_A* 2oj9_A* 3nw5_A* 3nw6_A* 3nw7_A* 3o23_A* 3qqu_A* 3d94_A* 1k3a_A* 2z8c_A* 1ir3_A* 1gag_A* 1irk_A 3bu3_A* ...

Probab=84.37  E-value=0.31  Score=44.92  Aligned_cols=28  Identities=11%  Similarity=0.057  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +....+||.+||..||.+|||+.+++++
T Consensus       266 ~~~l~~li~~~l~~dp~~Rps~~e~l~~  293 (322)
T 1p4o_A          266 PDMLFELMRMCWQYNPKMRPSFLEIISS  293 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            6778999999999999999999999876

>1nw1_A Choline kinase (49.2 KD); phospholipid synthesis, protein kinase fold, transferase; 2.02A {Caenorhabditis elegans} SCOP: d.144.1.8

Probab=84.26  E-value=0.4  Score=46.72  Aligned_cols=30  Identities=33%  Similarity=0.505  Sum_probs=24.0

Q ss_pred             CeeccCCCCCcEEEecC----------------------------CcEEEeecCCccc
Q psy7889          91 KILHRDMKAANVLITKT----------------------------GILKLADFGLARA  120 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~----------------------------~~~kl~DFg~a~~  120 (433)
                      .++|+|+.+.|||++.+                            +.+.|+||..+..
T Consensus       250 v~~H~Dl~~gNiL~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~lIDfEya~~  307 (429)
T 1nw1_A          250 TFCHNDLQEGNILLPKASSGNIRMPSLSDETQALGNSLSAFNPADPRLVLIDFEYASY  307 (429)
T ss_dssp             EEECSCCCGGGEEEEC------------------------------CCEECCCTTCEE
T ss_pred             EEEeCCCCCCeEEeeCCccccccccccccccccccccccccccCCCeEEEEecccCCc
Confidence            48999999999999875                            6788889887644

>1mp8_A Focal adhesion kinase 1; tyrosine protein kinase, transferase; HET: ADP; 1.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 2ijm_A* 2etm_A* 3pxk_A* 2jkq_A* 2j0m_B* 2jkm_A* 2j0l_A* 3bz3_A* 2jko_A* 2jkk_A*

Probab=84.00  E-value=0.34  Score=43.80  Aligned_cols=27  Identities=22%  Similarity=0.135  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       243 ~~~l~~li~~~l~~~p~~Rps~~~l~~  269 (281)
T 1mp8_A          243 PPTLYSLMTKCWAYDPSRRPRFTELKA  269 (281)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            678899999999999999999999876

>3kfa_A Tyrosine-protein kinase ABL1; CML, drug resistance, inhibitor, ATP-binding, nucleotide-binding, oncogene, TRAN; HET: B91; 1.22A {Mus musculus} SCOP: d.144.1.7 PDB: 2qoh_A* 3kf4_A* 3k5v_A* 1fpu_A* 1m52_A* 1iep_A* 2hzn_A* 1opj_A* 3ms9_A* 3mss_A* 3ik3_A* 2z60_A* 2e2b_A* 3pyy_A* 3oxz_A* 2g1t_A* 3ue4_A* 3oy3_A* 2hiw_A* 2v7a_A* ...

Probab=83.91  E-value=0.41  Score=43.23  Aligned_cols=27  Identities=15%  Similarity=0.104  Sum_probs=25.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||+.++++
T Consensus       238 ~~~l~~li~~~l~~dp~~Rps~~~~~~  264 (288)
T 3kfa_A          238 PEKVYELMRACWQWNPSDRPSFAEIHQ  264 (288)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhCCChhhCcCHHHHHH
Confidence            678899999999999999999999976

>3uzp_A CKI-delta, CKID, casein kinase I isoform delta; CK1D, inhibitor, PF670462, transferase-transferase I complex; HET: 0CK; 1.94A {Homo sapiens} PDB: 3uys_A* 3uyt_A* 1cki_A 1ckj_A

Probab=83.86  E-value=0.57  Score=42.44  Aligned_cols=27  Identities=11%  Similarity=-0.153  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       247 ~~~l~~li~~~l~~dp~~Rps~~~l~~  273 (296)
T 3uzp_A          247 PSEFATYLNFCRSLRFDDKPDYSYLRQ  273 (296)
T ss_dssp             CHHHHHHHHHHHTSCTTCCCCHHHHHH
T ss_pred             CHHHHHHHHHHHhcCcCcCCCHHHHHH
Confidence            778999999999999999999999875

>3ugc_A Tyrosine-protein kinase JAK2; small molecule inhibitor, ATP binding, transferase-transfera inhibitor complex; HET: 046; 1.34A {} PDB: 3krr_A* 3lpb_A* 4aqc_A* 4e4m_A* 4f08_A* 4f09_A* 3q32_A* 3rvg_A* 4hge_A* 3tjc_A* 3tjd_A* 4bbe_A* 4bbf_A* 2b7a_A* 3fup_A* 3e64_A* 3e62_A* 3e63_A* 2xa4_A* 3iok_A* ...

Probab=83.43  E-value=0.44  Score=43.28  Aligned_cols=27  Identities=4%  Similarity=-0.200  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       258 ~~~l~~li~~~l~~dp~~Rps~~el~~  284 (295)
T 3ugc_A          258 PDEIYMIMTECWNNNVNQRPSFRDLAL  284 (295)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            678899999999999999999999875

>2qkw_B Protein kinase; three-helix bundle motif, AVRPTO-PTO duplex, layered beta- sheets, transferas; HET: SEP TPO; 3.20A {Solanum pimpinellifolium} PDB: 3hgk_A*

Probab=83.38  E-value=0.35  Score=44.71  Aligned_cols=28  Identities=21%  Similarity=-0.015  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      .....+|+.+||..||.+|||+.+++++
T Consensus       282 ~~~l~~li~~~l~~dP~~Rps~~ell~~  309 (321)
T 2qkw_B          282 LRKFGDTAVKCLALSSEDRPSMGDVLWK  309 (321)
T ss_dssp             HHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            4567899999999999999999999875

>1u46_A ACK-1, activated CDC42 kinase 1; tyrosine kinase, transferase; 2.00A {Homo sapiens} SCOP: d.144.1.7 PDB: 1u4d_A* 1u54_A* 3eqr_A* 3eqp_B*

Probab=83.32  E-value=0.37  Score=43.58  Aligned_cols=27  Identities=15%  Similarity=-0.004  Sum_probs=25.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +.+..+||.+||..||.+|||+.++++
T Consensus       251 ~~~l~~li~~~l~~~p~~Rps~~~l~~  277 (291)
T 1u46_A          251 PQDIYNVMVQCWAHKPEDRPTFVALRD  277 (291)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCCcccCcCHHHHHH
Confidence            678899999999999999999999986

>3pls_A Macrophage-stimulating protein receptor; protein kinase, CIS autophosphorylation conformation, recept tyrosine kinase, AMP-PNP, unphosphorylated; HET: ANP; 2.24A {Homo sapiens} SCOP: d.144.1.7

Probab=83.20  E-value=0.46  Score=43.13  Aligned_cols=27  Identities=11%  Similarity=0.073  Sum_probs=25.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||+.++++
T Consensus       254 ~~~l~~li~~~l~~~p~~Rps~~~ll~  280 (298)
T 3pls_A          254 PDSLYQVMQQCWEADPAVRPTFRVLVG  280 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHccCChhhCcCHHHHHH
Confidence            678899999999999999999999876

>1xbb_A Tyrosine-protein kinase SYK; gleevec, STI-571, imatinib, spleen typrosine kinase, active conformation, structural genomics, structural genomix; HET: STI; 1.57A {Homo sapiens} SCOP: d.144.1.7 PDB: 1xba_A* 1xbc_A* 3fqe_A* 3fqh_A* 3fqs_A* 3emg_A* 3srv_A* 4dfl_A* 4dfn_A* 3vf8_A* 3vf9_A*

Probab=83.13  E-value=0.63  Score=42.15  Aligned_cols=27  Identities=19%  Similarity=0.011  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||+.++++
T Consensus       246 ~~~l~~li~~~l~~dp~~Rps~~~l~~  272 (291)
T 1xbb_A          246 PREMYDLMNLCWTYDVENRPGFAAVEL  272 (291)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678899999999999999999999875

>3ll6_A Cyclin G-associated kinase; transferase, protein kinase, serine/threonine kinase, cyclin clathrine, membrane trafficking, structural genomics; 2.10A {Homo sapiens}

Probab=83.12  E-value=0.33  Score=44.94  Aligned_cols=29  Identities=14%  Similarity=0.229  Sum_probs=26.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHD  365 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~  365 (433)
                      +....+||.+||..||.+|+|+.++++|-
T Consensus       275 ~~~~~~li~~~l~~~p~~Rps~~e~l~~l  303 (337)
T 3ll6_A          275 YTVFHSLIRAMLQVNPEERLSIAEVVHQL  303 (337)
T ss_dssp             SGGGHHHHHHHSCSSGGGSCCHHHHHHHH
T ss_pred             chHHHHHHHHHccCChhhCcCHHHHHHHH
Confidence            45678999999999999999999999874

>3l9p_A Anaplastic lymphoma kinase; kinase domain, ATP-binding, glycoprotein, membrane, nucleotide-binding, phosphoprotein, proto-oncogene; 1.80A {Homo sapiens}

Probab=83.08  E-value=0.25  Score=46.91  Aligned_cols=32  Identities=9%  Similarity=0.023  Sum_probs=29.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      +....+||.+||..||.+|||+.+++++.++.
T Consensus       312 ~~~l~~li~~~l~~dP~~Rps~~eil~~l~~~  343 (367)
T 3l9p_A          312 PGPVYRIMTQCWQHQPEDRPNFAIILERIEYC  343 (367)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHH
Confidence            67789999999999999999999999987763

>3og7_A AKAP9-BRAF fusion protein; proto-oncogene, V600E, kinase, transferase; HET: 032; 2.45A {Homo sapiens} SCOP: d.144.1.7 PDB: 4fk3_A* 3c4c_A* 3c4d_A* 3idp_A* 4g9r_A* 3ii5_A* 4e26_A* 3ppj_A* 3ppk_A* 3prf_A* 3pri_A* 3psb_A* 3psd_A* 3q4c_A* 3skc_A* 3tv4_A* 3tv6_A* 3d4q_A* 4e4x_A* 4g9c_A* ...

Probab=83.03  E-value=0.68  Score=41.95  Aligned_cols=27  Identities=15%  Similarity=0.001  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       255 ~~~l~~li~~~l~~~p~~Rps~~ell~  281 (289)
T 3og7_A          255 PKRMKRLMAECLKKKRDERPSFPRILA  281 (289)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHccCChhhCCCHHHHHH
Confidence            678899999999999999999999875

>3brb_A Proto-oncogene tyrosine-protein kinase MER; ATP-binding, disease mutation, glycoprotein, nucleot binding, phosphorylation, receptor; HET: ADP; 1.90A {Homo sapiens} PDB: 3bpr_A* 2p0c_A*

Probab=82.83  E-value=0.4  Score=44.03  Aligned_cols=28  Identities=11%  Similarity=-0.076  Sum_probs=25.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.+++++
T Consensus       275 ~~~l~~li~~~l~~dp~~Rps~~~l~~~  302 (313)
T 3brb_A          275 LDELYEIMYSCWRTDPLDRPTFSVLRLQ  302 (313)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6788999999999999999999999864

>3lxp_A Non-receptor tyrosine-protein kinase TYK2; JAK3, inflammation, cancer, PAN inhibitor, ATP-binding nucleotide-binding, phosphoprotein, SH2 domain; HET: PTR IZA; 1.65A {Homo sapiens} PDB: 3lxn_A* 3nz0_A* 3nyx_A* 4e20_A* 4e1z_A*

Probab=82.45  E-value=0.51  Score=43.57  Aligned_cols=27  Identities=11%  Similarity=-0.023  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||++||..||.+|||+.++++
T Consensus       277 ~~~l~~li~~~l~~dP~~Rps~~ell~  303 (318)
T 3lxp_A          277 PAEVYHLMKNCWETEASFRPTFENLIP  303 (318)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCCcccCcCHHHHHH
Confidence            678899999999999999999999985

>3p86_A Serine/threonine-protein kinase CTR1; ETR1, ERS1, ETR2, phosphorylation, transferase; HET: STU; 2.50A {Arabidopsis thaliana} PDB: 3ppz_A*

Probab=82.45  E-value=0.51  Score=43.48  Aligned_cols=32  Identities=9%  Similarity=0.113  Sum_probs=27.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN--HDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~--~~~~~  368 (433)
                      +++..+||++||..||.+|||+.++++  .+++.
T Consensus       265 ~~~l~~li~~~l~~dP~~Rps~~~ll~~L~~~~~  298 (309)
T 3p86_A          265 NPQVAAIIEGCWTNEPWKRPSFATIMDLLRPLIK  298 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHC
T ss_pred             CHHHHHHHHHHccCChhhCcCHHHHHHHHHHHHH
Confidence            778999999999999999999999987  44543

>2jii_A Serine/threonine-protein kinase VRK3 molecule: VA related kinase 3; transferase, pseudo kinase domain, vaccinia related kinase, ATP-binding; 2.00A {Homo sapiens}

Probab=82.41  E-value=0.68  Score=43.37  Aligned_cols=27  Identities=11%  Similarity=-0.020  Sum_probs=25.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       303 ~~~l~~li~~~l~~dp~~Rps~~~l~~  329 (352)
T 2jii_A          303 SETLQKYLKVVMALTYEEKPPYAMLRN  329 (352)
T ss_dssp             CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHHHHhCChhhCCCHHHHHH
Confidence            788999999999999999999999875

>2nru_A Interleukin-1 receptor-associated kinase 4; inhibitor, IRAK, transferase; HET: TPO SEP T12; 2.00A {Homo sapiens} PDB: 2nry_A* 2oib_A* 2oic_A* 2oid_A* 2o8y_A*

Probab=82.24  E-value=0.56  Score=42.83  Aligned_cols=28  Identities=14%  Similarity=-0.013  Sum_probs=24.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +....+|+.+||..||.+|||+.+++++
T Consensus       273 ~~~l~~li~~cl~~~p~~Rps~~~l~~~  300 (307)
T 2nru_A          273 VEAMYSVASQCLHEKKNKRPDIKKVQQL  300 (307)
T ss_dssp             HHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCcccCcCHHHHHHH
Confidence            3567899999999999999999998863

>2wqm_A Serine/threonine-protein kinase NEK7; ATP-binding, polymorphism, metal-binding, cell cycle kinase, mitosis, cytoplasm, magnesium, transferase; 2.10A {Homo sapiens} PDB: 2wqn_A*

Probab=82.19  E-value=0.43  Score=43.71  Aligned_cols=27  Identities=22%  Similarity=0.209  Sum_probs=25.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.++++
T Consensus       264 ~~~l~~li~~~l~~dp~~Rps~~~il~  290 (310)
T 2wqm_A          264 SEELRQLVNMCINPDPEKRPDVTYVYD  290 (310)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCCCHHHHHH
Confidence            678999999999999999999999886

>1b6c_B TGF-B superfamily receptor type I; complex (isomerase/protein kinase), receptor serine/threonine kinase; 2.60A {Homo sapiens} SCOP: d.144.1.7 PDB: 1ias_A 2x7o_A* 3faa_A* 3kcf_A*

Probab=81.97  E-value=0.42  Score=44.40  Aligned_cols=27  Identities=4%  Similarity=0.041  Sum_probs=24.3

Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         338 QYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       338 ~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ....+||.+||..||.+|||+.++++|
T Consensus       304 ~~l~~li~~cl~~dp~~Rps~~~i~~~  330 (342)
T 1b6c_B          304 RVMAKIMRECWYANGAARLTALRIKKT  330 (342)
T ss_dssp             HHHHHHHHHHCCSSGGGSCCHHHHHHH
T ss_pred             HHHHHHHHHHhccChhhCCCHHHHHHH
Confidence            457799999999999999999999874

>3tt0_A Basic fibroblast growth factor receptor 1; kinase domain, transferase, transferase-transferase inhibito; HET: 07J; 2.80A {Homo sapiens}

Probab=81.89  E-value=0.45  Score=45.34  Aligned_cols=28  Identities=11%  Similarity=-0.006  Sum_probs=26.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.+++++
T Consensus       319 ~~~l~~li~~~l~~dP~~Rps~~ell~~  346 (382)
T 3tt0_A          319 TNELYMMMRDCWHAVPSQRPTFKQLVED  346 (382)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            6789999999999999999999999874

>2eva_A TAK1 kinase - TAB1 chimera fusion protein; transferase/transferase activator complex; HET: ADN; 2.00A {Homo sapiens}

Probab=81.71  E-value=0.46  Score=43.62  Aligned_cols=27  Identities=19%  Similarity=0.178  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||++++++
T Consensus       230 ~~~l~~li~~~l~~dp~~Rps~~ell~  256 (307)
T 2eva_A          230 PKPIESLMTRCWSKDPSQRPSMEEIVK  256 (307)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCcCHHHHHH
Confidence            678899999999999999999999987

>2i1m_A Macrophage colony-stimulating factor 1 receptor; kinase domain, kinase inhibitor complex, transferase; HET: 5CN; 1.80A {Homo sapiens} PDB: 3bea_A* 3lcd_A* 2i0y_A* 2i0v_A* 3dpk_A* 3krj_A* 3krl_A* 2ogv_A 3lco_A*

Probab=81.22  E-value=0.49  Score=43.85  Aligned_cols=27  Identities=11%  Similarity=0.143  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||+.++++
T Consensus       293 ~~~l~~li~~~l~~~p~~Rps~~~l~~  319 (333)
T 2i1m_A          293 PKNIYSIMQACWALEPTHRPTFQQICS  319 (333)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhccChhhCcCHHHHHH
Confidence            677899999999999999999999986

>1byg_A CSK, protein (C-terminal SRC kinase); protein kinase, phosphorylation, staurosporine, transferase; HET: STU; 2.40A {Homo sapiens} SCOP: d.144.1.7 PDB: 3d7u_A 3d7t_A*

Probab=81.15  E-value=0.61  Score=41.91  Aligned_cols=27  Identities=11%  Similarity=-0.020  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||++||..||.+|||+.++++
T Consensus       240 ~~~l~~li~~~l~~~p~~Rps~~~l~~  266 (278)
T 1byg_A          240 PPAVYEVMKNCWHLDAAMRPSFLQLRE  266 (278)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHhcCChhhCCCHHHHHH
Confidence            678899999999999999999999875

>2v62_A Serine/threonine-protein kinase VRK2; transferase, ATP-binding, membrane, nucleotide-binding, TRAN; 1.7A {Homo sapiens}

Probab=81.06  E-value=0.82  Score=42.71  Aligned_cols=27  Identities=11%  Similarity=-0.170  Sum_probs=25.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       295 ~~~l~~li~~~l~~dp~~Rps~~~l~~  321 (345)
T 2v62_A          295 CCEIAQFLVCAHSLAYDEKPNYQALKK  321 (345)
T ss_dssp             CHHHHHHHHHHHTCCTTCCCCHHHHHH
T ss_pred             HHHHHHHHHHHhhcCcccCCCHHHHHH
Confidence            778999999999999999999999865

>1csn_A Casein kinase-1; phosphotransferase; HET: ATP; 2.00A {Schizosaccharomyces pombe} SCOP: d.144.1.7 PDB: 1eh4_A* 2csn_A*

Probab=80.92  E-value=0.82  Score=41.38  Aligned_cols=27  Identities=11%  Similarity=-0.161  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       250 ~~~l~~li~~~l~~dp~~RP~~~~l~~  276 (298)
T 1csn_A          250 PEEFYKYMHYARNLAFDATPDYDYLQG  276 (298)
T ss_dssp             CHHHHHHHHHHHHCCTTCCCCHHHHHH
T ss_pred             cHHHHHHHHHHhcCCcccCCCHHHHHH
Confidence            778999999999999999999999865

>4asz_A BDNF/NT-3 growth factors receptor; transferase, TRKA, TRKB; 1.70A {Homo sapiens} PDB: 4at3_A* 4at4_A* 4at5_A* 3v5q_A*

Probab=80.77  E-value=0.64  Score=42.82  Aligned_cols=26  Identities=15%  Similarity=0.037  Sum_probs=24.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHh
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAAL  362 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l  362 (433)
                      +++..+|+.+||..||.+|||+++++
T Consensus       256 ~~~~~~li~~cl~~dP~~RPs~~~i~  281 (299)
T 4asz_A          256 PQEVYELMLGCWQREPHMRKNIKGIH  281 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHH
T ss_pred             hHHHHHHHHHHcCCChhHCcCHHHHH
Confidence            67899999999999999999999984

>3kex_A Receptor tyrosine-protein kinase ERBB-3; kinase domain, inactive kinase, HER3, ATP-binding, cell membrane, membrane, nucleotide-binding; HET: ANP; 2.80A {Homo sapiens} PDB: 3lmg_A*

Probab=80.73  E-value=0.48  Score=43.90  Aligned_cols=28  Identities=14%  Similarity=0.005  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +.+..+||.+||..||.+|||+.+++++
T Consensus       243 ~~~~~~li~~~l~~dp~~Rps~~el~~~  270 (325)
T 3kex_A          243 TIDVYMVMVKCWMIDENIRPTFKELANE  270 (325)
T ss_dssp             CTTTTHHHHHHTCSCTTTSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHHH
Confidence            5567799999999999999999999886

>3f66_A Hepatocyte growth factor receptor; C-Met, protein kinase, quinoxaline, alternative splicing, ATP-binding, chromosomal rearrangement; HET: IHX; 1.40A {Homo sapiens} PDB: 3i5n_A* 3u6h_A* 3u6i_A* 4deg_A* 4deh_A* 4dei_A* 3ccn_A* 2rfn_A* 2rfs_A* 3cd8_A* 3efj_A* 3efk_A* 3lq8_A* 3zxz_A* 2wkm_A* 2wgj_A* 3zze_A* 4aoi_A* 4ap7_A* 3q6w_A* ...

Probab=80.56  E-value=0.65  Score=42.16  Aligned_cols=27  Identities=7%  Similarity=-0.090  Sum_probs=25.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +....+||.+||..||.+|||+.++++
T Consensus       258 ~~~l~~li~~~l~~~p~~Rps~~ell~  284 (298)
T 3f66_A          258 PDPLYEVMLKCWHPKAEMRPSFSELVS  284 (298)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            677899999999999999999999876

>2w1i_A JAK2; chromosomal rearrangement, nucleotide-binding, tyrosine-protein kinase, proto-oncogene, phosphoprotein, disease mutation, SH2 domain; HET: PTR L0I; 2.60A {Homo sapiens}

Probab=80.31  E-value=0.67  Score=42.88  Aligned_cols=27  Identities=4%  Similarity=-0.200  Sum_probs=25.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +.+..+||.+||..||.+|||+.++++
T Consensus       289 ~~~l~~li~~cl~~dP~~Rps~~el~~  315 (326)
T 2w1i_A          289 PDEIYMIMTECWNNNVNQRPSFRDLAL  315 (326)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhhCcCHHHHHH
Confidence            678899999999999999999999875

---

Homologous Structure Domains

Structure Domains Detected by RPS-BLAST

Original result of RPS-BLAST against SCOP70(version1.75) database

ID	Length	Definition	E-value
Query	433
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	5e-88
d3blha1	318	d.144.1.7 (A:8-325) Cell division protein kinase 9	2e-12
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	6e-58
d1ua2a_	299	d.144.1.7 (A:) Cell division protein kinase 7, CDK	1e-06
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	3e-54
d1pmea_	345	d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapien	7e-05
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	2e-53
d1s9ja_	322	d.144.1.7 (A:) Dual specificity mitogen-activated	3e-04
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	2e-51
d1ob3a_	286	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmod	0.002
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	5e-50
d1q5ka_	350	d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gs	0.002
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	1e-49
d1gz8a_	298	d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (H	2e-04
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	3e-48
d1u5ra_	309	d.144.1.7 (A:) Serine/threonine protein kinase TAO	1e-04
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	3e-48
d1cm8a_	346	d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo s	5e-04
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	2e-47
d1koaa2	350	d.144.1.7 (A:5915-6264) Twitchin, kinase domain {C	4e-04
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	4e-47
d3bqca1	328	d.144.1.7 (A:3-330) Protein kinase CK2, alpha subu	1e-04
d2jfla1	288	d.144.1.7 (A:21-308) STE20-like serine/threonine-p	6e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	8e-47
d1blxa_	305	d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (H	0.001
d1nvra_	271	d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {	1e-46
d1koba_	352	d.144.1.7 (A:) Twitchin, kinase domain {California	4e-46
d2j4za1	263	d.144.1.7 (A:126-388) Aurora-related kinase 1 (aur	4e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	8e-46
d1unla_	292	d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (H	0.003
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	2e-44
d1yhwa1	293	d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [	0.002
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	9e-44
d2gfsa1	348	d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sa	8e-05
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	2e-43
d1tkia_	321	d.144.1.7 (A:) Titin, kinase domain {Human (Homo s	0.003
d1phka_	277	d.144.1.7 (A:) gamma-subunit of glycogen phosphory	1e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	7e-42
d2b1pa1	355	d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3	1e-05
d2java1	269	d.144.1.7 (A:3-271) Serine/threonine-protein kinas	2e-41
d2ozaa1	335	d.144.1.7 (A:51-385) MAP kinase activated protein	3e-41
d1a06a_	307	d.144.1.7 (A:) Calmodulin-dependent protein kinase	4e-40
d1t4ha_	270	d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sa	9e-40
d1uu3a_	288	d.144.1.7 (A:) 3-phosphoinositide dependent protei	9e-40
d1jksa_	293	d.144.1.7 (A:) Death-associated protein kinase, Da	6e-39
d1uwha_	276	d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens)	2e-38
d1o6ya_	277	d.144.1.7 (A:) Mycobacterial protein kinase PknB,	3e-36
d1omwa3	364	d.144.1.7 (A:186-549) G-protein coupled receptor k	2e-35
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	4e-34
d1xwsa_	273	d.144.1.7 (A:) Proto-oncogene serine/threonine-pro	0.002
d1xjda_	320	d.144.1.7 (A:) Protein kinase C, theta type {Human	5e-34
d1vjya_	303	d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human	4e-33
d1qpca_	272	d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Hom	4e-33
d1fota_	316	d.144.1.7 (A:) cAMP-dependent PK, catalytic subuni	4e-33
d1byga_	262	d.144.1.7 (A:) Carboxyl-terminal src kinase (csk)	1e-32
d1u59a_	285	d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Hum	2e-32
d1xbba_	277	d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human	3e-32
d1fmka3	285	d.144.1.7 (A:249-533) c-src tyrosine kinase {Human	6e-32
d1k2pa_	258	d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Hum	6e-32
d1u46a_	273	d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Hum	1e-31
d1sm2a_	263	d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Hu	3e-31
d1o6la_	337	d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sap	5e-31
d1jpaa_	299	d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mou	1e-30
d1csna_	293	d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast	5e-30
d1rdqe_	350	d.144.1.7 (E:) cAMP-dependent PK, catalytic subuni	1e-29
d1xkka_	317	d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-	2e-29
d1vzoa_	322	d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5	3e-29
d1ckia_	299	d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus n	3e-29
d1mp8a_	273	d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Huma	8e-29
d1rjba_	325	d.144.1.7 (A:) Fl cytokine receptor {Human (Homo s	1e-28
d1opja_	287	d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mou	1e-28
d1lufa_	301	d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus n	1e-28
d1r0pa_	311	d.144.1.7 (A:) Hepatocyte growth factor receptor,	5e-28
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	6e-27
d1q8ya_	362	d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces	0.001
d1mqba_	283	d.144.1.7 (A:) epha2 receptor tyrosine kinase {Hum	2e-26
d1t46a_	311	d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens	1e-24
d1fvra_	309	d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [	3e-24
d1p4oa_	308	d.144.1.7 (A:) Insulin-like growth factor 1 recept	1e-22
d1fgka_	299	d.144.1.7 (A:) Fibroblast growth factor receptor 1	6e-22
d1ywna1	299	d.144.1.7 (A:818-1166) Vascular endothelial growth	3e-21
d1zara2	191	d.144.1.9 (A:91-281) Rio2 serine protein kinase C-	9e-16

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  268 bits (686), Expect = 5e-88
 Identities = 214/266 (80%), Positives = 238/266 (89%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           FPITALREIKILQLLKHENVV+LIEICRTKA+ YNR + + YLVFDFCEHDLAGLLSN+ 
Sbjct: 52  FPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVL 111

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           VKF+L EIK+V+Q LLNGLYYIH NKILHRDMKAANVLIT+ G+LKLADFGLARAFS  K
Sbjct: 112 VKFTLSEIKRVMQMLLNGLYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAK 171

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N Q NRYTNRVVTLWYRPPELLLG+R+YGPP+DLWGAGCIMAEMWTRSPIMQGNTEQ Q+
Sbjct: 172 NSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAGCIMAEMWTRSPIMQGNTEQHQL 231

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            LISQLCGSITPE WP V+  +LY K+EL K QKRKVK+RLK YV+D Y  DL+DKLL+L
Sbjct: 232 ALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLLVL 291

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDL 271
           DP++R DSD ALNHDFFW+DPMPSDL
Sbjct: 292 DPAQRIDSDDALNHDFFWSDPMPSDL 317

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]} Length = 318

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 65.3 bits (158), Expect = 2e-12
 Identities = 38/55 (69%), Positives = 46/55 (83%)

Query: 322 GYHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDL 376
           G   +VK+RLK YV+D Y  DL+DKLL+LDP++R DSD ALNHDFFW+DPMPSDL
Sbjct: 263 GQKRKVKDRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL 317

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  190 bits (483), Expect = 6e-58
 Identities = 99/269 (36%), Positives = 142/269 (52%), Gaps = 16/269 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
              TALREIK+LQ L H N++ L++    K        S   LVFDF E DL  ++ +  
Sbjct: 43  INRTALREIKLLQELSHPNIIGLLDAFGHK--------SNISLVFDFMETDLEVIIKDNS 94

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           +  +   IK  +   L GL Y+H + ILHRD+K  N+L+ + G+LKLADFGLA++F    
Sbjct: 95  LVLTPSHIKAYMLMTLQGLEYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN 154

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                 YT++VVT WYR PELL G R YG  VD+W  GCI+AE+  R P + G+++  Q+
Sbjct: 155 R----AYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGCILAELLLRVPFLPGDSDLDQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
           T I +  G+ T E WP + +L  Y      K+        +     D    DL+  L L 
Sbjct: 211 TRIFETLGTPTEEQWPDMCSLPDYVTF---KSFPGIPLHHIFSAAGDD-LLDLIQGLFLF 266

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           +P  R  +  AL   +F   P P+   ++
Sbjct: 267 NPCARITATQALKMKYFSNRPGPTPGCQL 295

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 47.2 bits (111), Expect = 1e-06
 Identities = 11/38 (28%), Positives = 18/38 (47%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
           DL+  L L +P  R  +  AL   +F   P P+   ++
Sbjct: 258 DLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQL 295

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  181 bits (461), Expect = 3e-54
 Identities = 94/273 (34%), Positives = 130/273 (47%), Gaps = 7/273 (2%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            LREIKIL   +HEN++ + +I R    +  +     YLV      DL  LL   H   S
Sbjct: 53  TLREIKILLRFRHENIIGINDIIRAPTIEQMKD---VYLVTHLMGADLYKLLKTQH--LS 107

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              I   + Q+L GL YIHS  +LHRD+K +N+L+  T  LK+ DFGLAR      +   
Sbjct: 108 NDHICYFLYQILRGLKYIHSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD-HT 166

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L  + Y   +D+W  GCI+AEM +  PI  G     Q+  I 
Sbjct: 167 GFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILAEMLSNRPIFPGKHYLDQLNHIL 226

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
            + GS + E    +  L   N +     + +    RL P    +   DLLDK+L  +P K
Sbjct: 227 GILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLFPNADSK-ALDLLDKMLTFNPHK 285

Query: 250 RFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 282
           R + + AL H +      PSD     A     M
Sbjct: 286 RIEVEQALAHPYLEQYYDPSDEPIAEAPFKFDM 318

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]} Length = 345

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.5 bits (99), Expect = 7e-05
 Identities = 19/65 (29%), Positives = 27/65 (41%)

Query: 323 YHDRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 382
           + ++V         D    DLLDK+L  +P KR + + AL H +      PSD     A 
Sbjct: 254 HKNKVPWNRLFPNADSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDPSDEPIAEAP 313

Query: 383 HTQSM 387
               M
Sbjct: 314 FKFDM 318

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  179 bits (455), Expect = 2e-53
 Identities = 59/286 (20%), Positives = 108/286 (37%), Gaps = 29/286 (10%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
                +RE+++L       +V       +             +  +  +      +    
Sbjct: 47  IRNQIIRELQVLHECNSPYIVGFYGAFYSDGE--------ISICMEHMDGGSLDQVLKKA 98

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
            +     + KV   ++ GL Y+   +KI+HRD+K +N+L+   G +KL DFG++     +
Sbjct: 99  GRIPEQILGKVSIAVIKGLTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS 158

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQ 183
                    + V T  Y  PE L G  +Y    D+W  G  + EM   R PI   + ++ 
Sbjct: 159 ------MANSFVGTRSYMSPERLQG-THYSVQSDIWSMGLSLVEMAVGRYPIPPPDAKEL 211

Query: 184 QITLISQLCGSIT-----------PESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKD 232
           ++    Q+ G              P S  G+++       EL      +   +L   V  
Sbjct: 212 ELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGVFS 271

Query: 233 QYGCDLLDKLLLLDPSKRFDSDAALNHDFF-WTDPMPSDLSKMLAQ 277
               D ++K L+ +P++R D    + H F   +D    D +  L  
Sbjct: 272 LEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 317

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.4 bits (94), Expect = 3e-04
 Identities = 13/54 (24%), Positives = 23/54 (42%), Gaps = 1/54 (1%)

Query: 330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFF-WTDPMPSDLSKMLAQ 382
           +L   V      D ++K L+ +P++R D    + H F   +D    D +  L  
Sbjct: 264 KLPSGVFSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKRSDAEEVDFAGWLCS 317

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score =  172 bits (437), Expect = 2e-51
 Identities = 99/257 (38%), Positives = 141/257 (54%), Gaps = 15/257 (5%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P T +REI IL+ LKH N+V L ++  TK            LVF+  + DL  LL    
Sbjct: 43  IPSTTIREISILKELKHSNIVKLYDVIHTKKR--------LVLVFEHLDQDLKKLLDVCE 94

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                   K  + QLLNG+ Y H  ++LHRD+K  N+LI + G LK+ADFGLARAF    
Sbjct: 95  GGLESVTAKSFLLQLLNGIAYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIP- 153

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
              V +YT+ +VTLWYR P++L+G + Y   +D+W  GCI AEM   +P+  G +E  Q+
Sbjct: 154 ---VRKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGCIFAEMVNGTPLFPGVSEADQL 210

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I ++ G+   ++WP V  L  Y+       +    +  LK    D+ G DLL K+L L
Sbjct: 211 MRIFRILGTPNSKNWPNVTELPKYDP-NFTVYEPLPWESFLKGL--DESGIDLLSKMLKL 267

Query: 246 DPSKRFDSDAALNHDFF 262
           DP++R  +  AL H +F
Sbjct: 268 DPNQRITAKQALEHAYF 284

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]} Length = 286

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

 Score = 37.6 bits (86), Expect = 0.002
 Identities = 15/31 (48%), Positives = 21/31 (67%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
           D+ G DLL K+L LDP++R  +  AL H +F
Sbjct: 254 DESGIDLLSKMLKLDPNQRITAKQALEHAYF 284

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  171 bits (433), Expect = 5e-50
 Identities = 70/255 (27%), Positives = 115/255 (45%), Gaps = 14/255 (5%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL---SNIHVKF 68
           RE++I++ L H N+V L     +   + +       LV D+    +  +    S      
Sbjct: 62  RELQIMRKLDHCNIVRLRYFFYSSGEKKDEVY--LNLVLDYVPETVYRVARHYSRAKQTL 119

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANV-LITKTGILKLADFGLARAFSQTKNG 127
            +  +K  + QL   L YIHS  I HRD+K  N+ L   T +LKL DFG A+   +    
Sbjct: 120 PVIYVKLYMYQLFRSLAYIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRG--- 176

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
                 + + + +YR PEL+ G  +Y   +D+W AGC++AE+    PI  G++   Q+  
Sbjct: 177 --EPNVSYICSRYYRAPELIFGATDYTSSIDVWSAGCVLAELLLGQPIFPGDSGVDQLVE 234

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I ++ G+ T E     E    Y + + P+ +     +  +P    +    L  +LL   P
Sbjct: 235 IIKVLGTPTREQIR--EMNPNYTEFKFPQIKAHPWTKVFRPRTPPE-AIALCSRLLEYTP 291

Query: 248 SKRFDSDAALNHDFF 262
           + R     A  H FF
Sbjct: 292 TARLTPLEACAHSFF 306

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 38.2 bits (88), Expect = 0.002
 Identities = 9/31 (29%), Positives = 11/31 (35%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF 367
                 L  +LL   P+ R     A  H FF
Sbjct: 276 PPEAIALCSRLLEYTPTARLTPLEACAHSFF 306

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  168 bits (427), Expect = 1e-49
 Identities = 109/267 (40%), Positives = 152/267 (56%), Gaps = 18/267 (6%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL-SNI 64
            P TA+REI +L+ L H N+V L+++  T+        +  YLVF+F   DL   + ++ 
Sbjct: 44  VPSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASA 95

Query: 65  HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQT 124
                L  IK  + QLL GL + HS+++LHRD+K  N+LI   G +KLADFGLARAF   
Sbjct: 96  LTGIPLPLIKSYLFQLLQGLAFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVP 155

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
               V  YT+ VVTLWYR PE+LLG + Y   VD+W  GCI AEM TR  +  G++E  Q
Sbjct: 156 ----VRTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGCIFAEMVTRRALFPGDSEIDQ 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I +  G+     WPGV ++  Y K   PK  ++   + + P  +D  G  LL ++L 
Sbjct: 212 LFRIFRTLGTPDEVVWPGVTSMPDY-KPSFPKWARQDFSKVVPPLDED--GRSLLSQMLH 268

Query: 245 LDPSKRFDSDAALNHDFFW--TDPMPS 269
            DP+KR  + AAL H FF   T P+P 
Sbjct: 269 YDPNKRISAKAALAHPFFQDVTKPVPH 295

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]} Length = 298

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 40.6 bits (94), Expect = 2e-04
 Identities = 18/40 (45%), Positives = 24/40 (60%), Gaps = 2/40 (5%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW--TDPMPS 374
           D+ G  LL ++L  DP+KR  + AAL H FF   T P+P 
Sbjct: 256 DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKPVPH 295

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  165 bits (418), Expect = 3e-48
 Identities = 64/277 (23%), Positives = 109/277 (39%), Gaps = 48/277 (17%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            ++E++ LQ L+H N +        +         T +LV ++C    + LL        
Sbjct: 62  IIKEVRFLQKLRHPNTIQYRGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQ 113

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             EI  V    L GL Y+HS+ ++HRD+KA N+L+++ G++KL DFG A   +       
Sbjct: 114 EVEIAAVTHGALQGLAYLHSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAPA----- 168

Query: 130 NRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
               + V T ++  PE++L      Y   VD+W  G    E+  R P +        +  
Sbjct: 169 ---NSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGITCIELAERKPPLFNMNAMSALYH 225

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I+Q                      E P  Q     E  +         + +D  L   P
Sbjct: 226 IAQ---------------------NESPALQSGHWSEYFR---------NFVDSCLQKIP 255

Query: 248 SKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
             R  S+  L H F   +  P+ +  ++ +   ++ E
Sbjct: 256 QDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 292

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score = 41.1 bits (96), Expect = 1e-04
 Identities = 10/48 (20%), Positives = 21/48 (43%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 389
           + +D  L   P  R  S+  L H F   +  P+ +  ++ +   ++ E
Sbjct: 245 NFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRE 292

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  166 bits (420), Expect = 3e-48
 Identities = 84/269 (31%), Positives = 135/269 (50%), Gaps = 12/269 (4%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           F   A RE+++L+ ++HENV+ L+++        +     FYLV  F   DL  L+   H
Sbjct: 60  FAKRAYRELRLLKHMRHENVIGLLDVFTPDETLDDFTD--FYLVMPFMGTDLGKLMK--H 115

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            K     I+ ++ Q+L GL YIH+  I+HRD+K  N+ + +   LK+ DFGLAR      
Sbjct: 116 EKLGEDRIQFLVYQMLKGLRYIHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-- 173

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                  T  VVT WYR PE++L    Y   VD+W  GCIMAEM T   + +G+    Q+
Sbjct: 174 -----EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIMAEMITGKTLFKGSDHLDQL 228

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I ++ G+   E    +++ +  N M+     ++K    +          +LL+K+L+L
Sbjct: 229 KEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASILTNASPL-AVNLLEKMLVL 287

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           D  +R  +  AL H +F +     D  ++
Sbjct: 288 DAEQRVTAGEALAHPYFESLHDTEDEPQV 316

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]} Length = 346

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 39.8 bits (92), Expect = 5e-04
 Identities = 12/43 (27%), Positives = 22/43 (51%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
                +LL+K+L+LD  +R  +  AL H +F +     D  ++
Sbjct: 274 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLHDTEDEPQV 316

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score =  164 bits (416), Expect = 2e-47
 Identities = 54/269 (20%), Positives = 105/269 (39%), Gaps = 45/269 (16%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
           T  +EI+ + +L+H  +V+L +             +   ++++F    +L   +++ H K
Sbjct: 69  TVRKEIQTMSVLRHPTLVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHNK 120

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTK 125
            S  E  + ++Q+  GL ++H N  +H D+K  N++ T  ++  LKL DFGL        
Sbjct: 121 MSEDEAVEYMRQVCKGLCHMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPK- 179

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                       T  +  PE+  G +  G   D+W  G +   + +      G  + + +
Sbjct: 180 ----QSVKVTTGTAEFAAPEVAEG-KPVGYYTDMWSVGVLSYILLSGLSPFGGENDDETL 234

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             +     ++   ++ G+                             + G D + KLLL 
Sbjct: 235 RNVKSCDWNMDDSAFSGI----------------------------SEDGKDFIRKLLLA 266

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           DP+ R     AL H +      P   S++
Sbjct: 267 DPNTRMTIHQALEHPWLTPGNAPGRDSQI 295

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

 Score = 39.7 bits (92), Expect = 4e-04
 Identities = 13/38 (34%), Positives = 18/38 (47%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
           D + KLLL DP+ R     AL H +      P   S++
Sbjct: 258 DFIRKLLLADPNTRMTIHQALEHPWLTPGNAPGRDSQI 295

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score =  162 bits (411), Expect = 4e-47
 Identities = 69/263 (26%), Positives = 122/263 (46%), Gaps = 22/263 (8%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
             REIKIL+ L+   N++ L +I +   ++         LVF+   +        ++   
Sbjct: 76  IKREIKILENLRGGPNIITLADIVKDPVSRT------PALVFEHVNN---TDFKQLYQTL 126

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNG 127
           +  +I+  + ++L  L Y HS  I+HRD+K  NV+I  +   L+L D+GLA  +   +  
Sbjct: 127 TDYDIRFYMYEILKALDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-- 184

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQIT 186
               Y  RV + +++ PELL+  + Y   +D+W  GC++A M   + P   G+    Q+ 
Sbjct: 185 ---EYNVRVASRYFKGPELLVDYQMYDYSLDMWSLGCMLASMIFRKEPFFHGHDNYDQLV 241

Query: 187 LISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQY----GCDLLDK 241
            I+++ G+     +     ++L  +  ++     RK  ER               D LDK
Sbjct: 242 RIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEALDFLDK 301

Query: 242 LLLLDPSKRFDSDAALNHDFFWT 264
           LL  D   R  +  A+ H +F+T
Sbjct: 302 LLRYDHQSRLTAREAMEHPYFYT 324

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]} Length = 328

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

 Score = 41.8 bits (97), Expect = 1e-04
 Identities = 13/45 (28%), Positives = 20/45 (44%)

Query: 325 DRVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT 369
           +R       ++      D LDKLL  D   R  +  A+ H +F+T
Sbjct: 280 ERFVHSENQHLVSPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT 324

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (408), Expect = 6e-47
 Identities = 63/272 (23%), Positives = 114/272 (41%), Gaps = 47/272 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + EI IL    H N+V L++    + N         +++ +FC    +  ++  +    +
Sbjct: 57  MVEIDILASCDHPNIVKLLDAFYYENN--------LWILIEFCAGGAVDAVMLELERPLT 108

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             +I+ V +Q L+ L Y+H NKI+HRD+KA N+L T  G +KLADFG++   ++T    +
Sbjct: 109 ESQIQVVCKQTLDALNYLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRT----I 164

Query: 130 NRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
            R  + + T ++  PE+++     DR Y    D+W  G  + EM    P        + +
Sbjct: 165 QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWSLGITLIEMAEIEPPHHELNPMRVL 224

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             I++                     +  P     +     K         D L K L  
Sbjct: 225 LKIAK----------------SEPPTLAQPS----RWSSNFK---------DFLKKCLEK 255

Query: 246 DPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQ 277
           +   R+ +   L H F  T      + +++A+
Sbjct: 256 NVDARWTTSQLLQHPFV-TVDSNKPIRELIAE 286

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  161 bits (407), Expect = 8e-47
 Identities = 92/261 (35%), Positives = 136/261 (52%), Gaps = 18/261 (6%)

Query: 6   FPITALREIKILQLLK---HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS 62
            P++ +RE+ +L+ L+   H NVV L ++C               LVF+  + DL   L 
Sbjct: 50  MPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRTDRETK---LTLVFEHVDQDLTTYLD 106

Query: 63  NI-HVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAF 121
            +         IK ++ QLL GL ++HS++++HRD+K  N+L+T +G +KLADFGLAR +
Sbjct: 107 KVPEPGVPTETIKDMMFQLLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIY 166

Query: 122 SQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTE 181
           S          T+ VVTLWYR PE+LL   +Y  PVDLW  GCI AEM+ R P+ +G+++
Sbjct: 167 SFQ-----MALTSVVVTLWYRAPEVLLQ-SSYATPVDLWSVGCIFAEMFRRKPLFRGSSD 220

Query: 182 QQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK 241
             Q+  I  + G    E WP    L              K    +    K     DLL K
Sbjct: 221 VDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGK-----DLLLK 275

Query: 242 LLLLDPSKRFDSDAALNHDFF 262
            L  +P+KR  + +AL+H +F
Sbjct: 276 CLTFNPAKRISAYSALSHPYF 296

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]} Length = 305

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.9 bits (87), Expect = 0.001
 Identities = 20/65 (30%), Positives = 33/65 (50%), Gaps = 2/65 (3%)

Query: 305 GAPGAAGPAAGRATTETGYHDRVKERLKPYVK--DQYGCDLLDKLLLLDPSKRFDSDAAL 362
           G PG        A     +H +  + ++ +V   D+ G DLL K L  +P+KR  + +AL
Sbjct: 232 GLPGEEDWPRDVALPRQAFHSKSAQPIEKFVTDIDELGKDLLLKCLTFNPAKRISAYSAL 291

Query: 363 NHDFF 367
           +H +F
Sbjct: 292 SHPYF 296

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 271

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  159 bits (404), Expect = 1e-46
 Identities = 59/263 (22%), Positives = 92/263 (34%), Gaps = 40/263 (15%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P    +EI I ++L HENVV      R          +  YL  ++C            
Sbjct: 46  CPENIKKEICINKMLNHENVVKFYGHRR--------EGNIQYLFLEYCSGGELFDRIEPD 97

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
           +     + ++   QL+ G+ Y+H   I HRD+K  N+L+ +   LK++DFGLA  F    
Sbjct: 98  IGMPEPDAQRFFHQLMAGVVYLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRY-- 155

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N +         TL Y  PELL     +  PVD+W  G ++  M          ++  Q 
Sbjct: 156 NNRERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIVLTAMLAGELPWDQPSDSCQE 215

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
                         W  +                            D     LL K+L+ 
Sbjct: 216 YSD-WKEKKTYLNPWKKI----------------------------DSAPLALLHKILVE 246

Query: 246 DPSKRFDSDAALNHDFFWTDPMP 268
           +PS R          ++   P+ 
Sbjct: 247 NPSARITIPDIKKDRWY-NKPLK 268

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]} Length = 352

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

 Score =  160 bits (406), Expect = 4e-46
 Identities = 53/293 (18%), Positives = 99/293 (33%), Gaps = 51/293 (17%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
           T   EI I+  L H  +++L +    K            L+ +F    +L   ++    K
Sbjct: 72  TVKNEISIMNQLHHPKLINLHDAFEDKYE--------MVLILEFLSGGELFDRIAAEDYK 123

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLI--TKTGILKLADFGLARAFSQTK 125
            S  E+   ++Q   GL ++H + I+H D+K  N++    K   +K+ DFGLA   +   
Sbjct: 124 MSEAEVINYMRQACEGLKHMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPD- 182

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                       T  +  PE++      G   D+W  G +   + +      G  + + +
Sbjct: 183 ----EIVKVTTATAEFAAPEIVDR-EPVGFYTDMWAIGVLGYVLLSGLSPFAGEDDLETL 237

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             + +       +++  V                                 D +  LL  
Sbjct: 238 QNVKRCDWEFDEDAFSSV----------------------------SPEAKDFIKNLLQK 269

Query: 246 DPSKRFDSDAALNHDFFWTD------PMPSDLSKMLAQHTQSMFEYLAPPRRP 292
           +P KR     AL H +   D       +PS     + Q  +  +     P+  
Sbjct: 270 EPRKRLTVHDALEHPWLKGDHSNLTSRIPSSRYNKIRQKIKEKYADWPAPQPA 322

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (400), Expect = 4e-46
 Identities = 62/257 (24%), Positives = 97/257 (37%), Gaps = 47/257 (18%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
                 RE++I   L+H N++ L               +  YL+ ++             
Sbjct: 49  VEHQLRREVEIQSHLRHPNILRLYGYFHDA--------TRVYLILEYAPLGTVYRELQKL 100

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            KF        I +L N L Y HS +++HRD+K  N+L+   G LK+ADFG +     + 
Sbjct: 101 SKFDEQRTATYITELANALSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS- 159

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                R T    TL Y PPE++ G   +   VDLW  G +  E     P  + NT Q+  
Sbjct: 160 -----RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLGVLCYEFLVGKPPFEANTYQETY 213

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
             IS++  +  P+                                  +   DL+ +LL  
Sbjct: 214 KRISRVEFTF-PDFVT-------------------------------EGARDLISRLLKH 241

Query: 246 DPSKRFDSDAALNHDFF 262
           +PS+R      L H + 
Sbjct: 242 NPSQRPMLREVLEHPWI 258

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  158 bits (399), Expect = 8e-46
 Identities = 99/264 (37%), Positives = 139/264 (52%), Gaps = 18/264 (6%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
            P +ALREI +L+ LKH+N+V L ++  +             LVF+FC+ DL     + +
Sbjct: 44  VPSSALREICLLKELKHKNIVRLHDVLHSDKK--------LTLVFEFCDQDLKKYFDSCN 95

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
                  +K  + QLL GL + HS  +LHRD+K  N+LI + G LKLA+FGLARAF    
Sbjct: 96  GDLDPEIVKSFLFQLLKGLGFCHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIP- 154

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQ 184
              V  Y+  VVTLWYRPP++L G + Y   +D+W AGCI AE+     P+  GN    Q
Sbjct: 155 ---VRCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIFAELANAGRPLFPGNDVDDQ 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           +  I +L G+ T E WP +  L  Y    +  A    V    K    +  G DLL  LL 
Sbjct: 212 LKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATTSLVNVVPK---LNATGRDLLQNLLK 268

Query: 245 LDPSKRFDSDAALNHDFF--WTDP 266
            +P +R  ++ AL H +F  +  P
Sbjct: 269 CNPVQRISAEEALQHPYFSDFCPP 292

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]} Length = 292

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.2 bits (85), Expect = 0.003
 Identities = 12/32 (37%), Positives = 18/32 (56%), Gaps = 2/32 (6%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFF--WTDP 371
           DLL  LL  +P +R  ++ AL H +F  +  P
Sbjct: 261 DLLQNLLKCNPVQRISAEEALQHPYFSDFCPP 292

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (391), Expect = 2e-44
 Identities = 57/268 (21%), Positives = 112/268 (41%), Gaps = 47/268 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVK--F 68
           + EI +++  K+ N+V+ ++                ++V ++      G L+++  +   
Sbjct: 65  INEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAG---GSLTDVVTETCM 113

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
             G+I  V ++ L  L ++HSN+++HRD+K+ N+L+   G +KL DFG     +  ++  
Sbjct: 114 DEGQIAAVCRECLQALEFLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQS-- 171

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
             + +  V T ++  PE++     YGP VD+W  G +  EM    P        + + LI
Sbjct: 172 --KRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIMAIEMIEGEPPYLNENPLRALYLI 228

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
           +   G+   ++   +                                 D L++ L +D  
Sbjct: 229 AT-NGTPELQNPEKL----------------------------SAIFRDFLNRCLDMDVE 259

Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLA 276
           KR  +   L H F       S L+ ++A
Sbjct: 260 KRGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.7 bits (87), Expect = 0.002
 Identities = 12/40 (30%), Positives = 19/40 (47%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLA 381
           D L++ L +D  KR  +   L H F       S L+ ++A
Sbjct: 248 DFLNRCLDMDVEKRGSAKELLQHQFLKIAKPLSSLTPLIA 287

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  154 bits (389), Expect = 9e-44
 Identities = 81/261 (31%), Positives = 126/261 (48%), Gaps = 12/261 (4%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
             RE+++L+ +KHENV+ L+++      +     +  YLV      DL  ++     K +
Sbjct: 64  TYRELRLLKHMKHENVIGLLDVFTPA--RSLEEFNDVYLVTHLMGADLNNIVK--CQKLT 119

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              ++ +I Q+L GL YIHS  I+HRD+K +N+ + +   LK+ DFGLAR          
Sbjct: 120 DDHVQFLIYQILRGLKYIHSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDDE----- 174

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  V T WYR PE++L   +Y   VD+W  GCIMAE+ T   +  G     Q+ LI 
Sbjct: 175 --MTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMAELLTGRTLFPGTDHIDQLKLIL 232

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
           +L G+   E    + +    N ++      +     +          DLL+K+L+LD  K
Sbjct: 233 RLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANVFIGANPL-AVDLLEKMLVLDSDK 291

Query: 250 RFDSDAALNHDFFWTDPMPSD 270
           R  +  AL H +F     P D
Sbjct: 292 RITAAQALAHAYFAQYHDPDD 312

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]} Length = 348

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 42.2 bits (98), Expect = 8e-05
 Identities = 15/39 (38%), Positives = 21/39 (53%)

Query: 337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSD 375
           +    DLL+K+L+LD  KR  +  AL H +F     P D
Sbjct: 274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPDD 312

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  152 bits (386), Expect = 2e-43
 Identities = 49/280 (17%), Positives = 101/280 (36%), Gaps = 47/280 (16%)

Query: 8   ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV 66
           +   +EI IL + +H N++HL E   +             ++F+F    D+   ++    
Sbjct: 46  VLVKKEISILNIARHRNILHLHESFESMEE--------LVMIFEFISGLDIFERINTSAF 97

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQT 124
           + +  EI   + Q+   L ++HS+ I H D++  N++    ++  +K+ +FG AR     
Sbjct: 98  ELNEREIVSYVHQVCEALQFLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPG 157

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                + +        Y  PE+   D       D+W  G ++  + +        T QQ 
Sbjct: 158 -----DNFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLGTLVYVLLSGINPFLAETNQQI 211

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
           I  I     +   E++  +                                 D +D+LL+
Sbjct: 212 IENIMNAEYTFDEEAFKEI----------------------------SIEAMDFVDRLLV 243

Query: 245 LDPSKRFDSDAALNHDFFW--TDPMPSDLSKMLAQHTQSM 282
            +   R  +  AL H +     + + + + + L       
Sbjct: 244 KERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]} Length = 321

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 36.9 bits (85), Expect = 0.003
 Identities = 9/48 (18%), Positives = 20/48 (41%), Gaps = 2/48 (4%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFW--TDPMPSDLSKMLAQHTQSM 387
           D +D+LL+ +   R  +  AL H +     + + + + + L       
Sbjct: 236 DFVDRLLVKERKSRMTASEALQHPWLKQKIERVSTKVIRTLKHRRYYH 283

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

 Score =  149 bits (377), Expect = 1e-42
 Identities = 62/260 (23%), Positives = 100/260 (38%), Gaps = 49/260 (18%)

Query: 10  ALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
            L+E+ IL+ +  H N++ L +   T           F+LVFD  +  +L   L+   V 
Sbjct: 56  TLKEVDILRKVSGHPNIIQLKDTYETNTF--------FFLVFDLMKKGELFDYLTE-KVT 106

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
            S  E +K+++ LL  +  +H   I+HRD+K  N+L+     +KL DFG +         
Sbjct: 107 LSEKETRKIMRALLEVICALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPG--- 163

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
              +      T  Y  PE++    N     YG  VD+W  G IM  +   SP      + 
Sbjct: 164 --EKLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMWSTGVIMYTLLAGSPPFWHRKQM 221

Query: 183 QQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL 242
             + +I           W                                    DL+ + 
Sbjct: 222 LMLRMIMSGNYQFGSPEWDDY----------------------------SDTVKDLVSRF 253

Query: 243 LLLDPSKRFDSDAALNHDFF 262
           L++ P KR+ ++ AL H FF
Sbjct: 254 LVVQPQKRYTAEEALAHPFF 273

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  149 bits (377), Expect = 7e-42
 Identities = 76/285 (26%), Positives = 127/285 (44%), Gaps = 21/285 (7%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
           A RE+ +++ + H+N++ L+ +   +  +        YLV +  +     L   I ++  
Sbjct: 63  AYRELVLMKCVNHKNIISLLNVFTPQ--KTLEEFQDVYLVMELMDA---NLCQVIQMELD 117

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  ++ Q+L G+ ++HS  I+HRD+K +N+++     LK+ DFGLAR    +     
Sbjct: 118 HERMSYLLYQMLCGIKHLHSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTSF---- 173

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
              T  VVT +YR PE++LG   Y   VD+W  GCIM EM     +  G     Q   + 
Sbjct: 174 -MMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMGEMVRHKILFPGRDYIDQWNKVI 231

Query: 190 QLCGSITPESWPG--------VETLDLYNKMELPKAQKRKVKERLKPYVK--DQYGCDLL 239
           +  G+  PE            VE    Y  +  PK     +      + K       DLL
Sbjct: 232 EQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARDLL 291

Query: 240 DKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFE 284
            K+L++DP+KR   D AL H +      P+++     Q      +
Sbjct: 292 SKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQLD 336

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]} Length = 355

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 44.9 bits (105), Expect = 1e-05
 Identities = 16/62 (25%), Positives = 27/62 (43%)

Query: 328 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSM 387
            +     +K     DLL K+L++DP+KR   D AL H +      P+++     Q     
Sbjct: 275 ADSEHNKLKASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYDPAEVEAPPPQIYDKQ 334

Query: 388 FE 389
            +
Sbjct: 335 LD 336

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]} Length = 269

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  145 bits (368), Expect = 2e-41
 Identities = 55/261 (21%), Positives = 99/261 (37%), Gaps = 51/261 (19%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI---H 65
            + E+ +L+ LKH N+V   +    + N         Y+V ++CE  DLA +++      
Sbjct: 50  LVSEVNLLRELKHPNIVRYYDRIIDRTNTT------LYIVMEYCEGGDLASVITKGTKER 103

Query: 66  VKFSLGEIKKVIQQLLNGLYYIH-----SNKILHRDMKAANVLITKTGILKLADFGLARA 120
                  + +V+ QL   L   H      + +LHRD+K ANV +     +KL DFGLAR 
Sbjct: 104 QYLDEEFVLRVMTQLTLALKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARI 163

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT 180
            +   +         V T +Y  PE +    +Y    D+W  GC++ E+    P     +
Sbjct: 164 LNHDTS----FAKAFVGTPYYMSPEQMNR-MSYNEKSDIWSLGCLLYELCALMPPFTAFS 218

Query: 181 EQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD 240
           +++    I +      P  +                       + L          +++ 
Sbjct: 219 QKELAGKIREGKFRRIPYRYS----------------------DELN---------EIIT 247

Query: 241 KLLLLDPSKRFDSDAALNHDF 261
           ++L L    R   +  L +  
Sbjct: 248 RMLNLKDYHRPSVEEILENPL 268

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]} Length = 335

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  147 bits (371), Expect = 3e-41
 Identities = 58/259 (22%), Positives = 104/259 (40%), Gaps = 40/259 (15%)

Query: 10  ALREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHV 66
           A RE+++  +  +  ++V ++++           R    +V +  +  +L   +      
Sbjct: 51  ARREVELHWRASQCPHIVRIVDVYENLYAG----RKCLLIVMECLDGGELFSRIQDRGDQ 106

Query: 67  KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQ 123
            F+  E  ++++ +   + Y+HS  I HRD+K  N+L T      ILKL DFG A+  + 
Sbjct: 107 AFTEREASEIMKSIGEAIQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTS 166

Query: 124 TKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQ 183
                 N  T    T +Y  PE+L  ++ Y    D+W  G IM  +    P    N    
Sbjct: 167 H-----NSLTTPCYTPYYVAPEVLGPEK-YDKSCDMWSLGVIMYILLCGYPPFYSNHGLA 220

Query: 184 QITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL 243
                            PG++T     + E P  +  +V E +K          L+  LL
Sbjct: 221 I---------------SPGMKTRIRMGQYEFPNPEWSEVSEEVK---------MLIRNLL 256

Query: 244 LLDPSKRFDSDAALNHDFF 262
             +P++R      +NH + 
Sbjct: 257 KTEPTQRMTITEFMNHPWI 275

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 307

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  143 bits (362), Expect = 4e-40
 Identities = 53/265 (20%), Positives = 93/265 (35%), Gaps = 47/265 (17%)

Query: 9   TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
           +   EI +L  +KH N+V L +I  +            YL+       +L   +      
Sbjct: 53  SMENEIAVLHKIKHPNIVALDDIYESG--------GHLYLIMQLVSGGELFDRIVE-KGF 103

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQT 124
           ++  +  ++I Q+L+ + Y+H   I+HRD+K  N+L     +   + ++DFGL++     
Sbjct: 104 YTERDASRLIFQVLDAVKYLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPG 163

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                +  +    T  Y  PE+L   + Y   VD W  G I   +    P      + + 
Sbjct: 164 -----SVLSTACGTPGYVAPEVLAQ-KPYSKAVDCWSIGVIAYILLCGYPPFYDENDAKL 217

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
              I +         W  +                                 D +  L+ 
Sbjct: 218 FEQILKAEYEFDSPYWDDI----------------------------SDSAKDFIRHLME 249

Query: 245 LDPSKRFDSDAALNHDFFWTDPMPS 269
            DP KRF  + AL H +   D    
Sbjct: 250 KDPEKRFTCEQALQHPWIAGDTALD 274

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 270

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  141 bits (357), Expect = 9e-40
 Identities = 50/255 (19%), Positives = 94/255 (36%), Gaps = 44/255 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
             E ++L+ L+H N+V   +   +      + +    LV +                  +
Sbjct: 56  KEEAEMLKGLQHPNIVRFYDSWES----TVKGKKCIVLVTELMTSGTLKTYLKRFKVMKI 111

Query: 71  GEIKKVIQQLLNGLYYIHSNK--ILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNG 127
             ++   +Q+L GL ++H+    I+HRD+K  N+ IT  TG +K+ D GLA     +   
Sbjct: 112 KVLRSWCRQILKGLQFLHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS--- 168

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
                   + T  +  PE+   +  Y   VD++  G  M EM T            QI  
Sbjct: 169 ---FAKAVIGTPEFMAPEMY--EEKYDESVDVYAFGMCMLEMATSEYPYSECQNAAQI-- 221

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
             ++   + P S+  V   ++                            ++++  +  + 
Sbjct: 222 YRRVTSGVKPASFDKVAIPEVK---------------------------EIIEGCIRQNK 254

Query: 248 SKRFDSDAALNHDFF 262
            +R+     LNH FF
Sbjct: 255 DERYSIKDLLNHAFF 269

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 288

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  142 bits (358), Expect = 9e-40
 Identities = 52/256 (20%), Positives = 90/256 (35%), Gaps = 43/256 (16%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE  ++  L H   V L    +             Y    + ++            F  
Sbjct: 56  TRERDVMSRLDHPFFVKLYFTFQDD--------EKLYFGLSYAKNGELLKYIRKIGSFDE 107

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
              +    ++++ L Y+H   I+HRD+K  N+L+ +   +++ DFG A+  S     +  
Sbjct: 108 TCTRFYTAEIVSALEYLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSP--ESKQA 165

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
           R  + V T  Y  PELL   ++     DLW  GCI+ ++    P  +   E      I +
Sbjct: 166 RANSFVGTAQYVSPELLTE-KSACKSSDLWALGCIIYQLVAGLPPFRAGNEYLIFQKIIK 224

Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
           L      + +P                                   DL++KLL+LD +KR
Sbjct: 225 LEYDFPEKFFPKAR--------------------------------DLVEKLLVLDATKR 252

Query: 251 FDSDAALNHDFFWTDP 266
              +    +      P
Sbjct: 253 LGCEEMEGYGPLKAHP 268

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  139 bits (352), Expect = 6e-39
 Identities = 57/267 (21%), Positives = 101/267 (37%), Gaps = 46/267 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
            RE+ IL+ ++H NV+ L E+   K        +   L+ +                 + 
Sbjct: 61  EREVSILKEIQHPNVITLHEVYENK--------TDVILILELVAGGELFDFLAEKESLTE 112

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGI----LKLADFGLARAFSQTKN 126
            E  + ++Q+LNG+YY+HS +I H D+K  N+++    +    +K+ DFGLA        
Sbjct: 113 EEATEFLKQILNGVYYLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFG-- 170

Query: 127 GQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQIT 186
              N + N   T  +  PE++      G   D+W  G I   + + +    G+T+Q+ + 
Sbjct: 171 ---NEFKNIFGTPEFVAPEIVNY-EPLGLEADMWSIGVITYILLSGASPFLGDTKQETLA 226

Query: 187 LISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD 246
            +S +      E +                                    D + +LL+ D
Sbjct: 227 NVSAVNYEFEDEYFSNT----------------------------SALAKDFIRRLLVKD 258

Query: 247 PSKRFDSDAALNHDFFWTDPMPSDLSK 273
           P KR     +L H +         LS 
Sbjct: 259 PKKRMTIQDSLQHPWIKPKDTQQALSS 285

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 276

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  138 bits (348), Expect = 2e-38
 Identities = 46/252 (18%), Positives = 92/252 (36%), Gaps = 40/252 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
             E+ +L+  +H N++  +                  +V  +CE   L   L  I  KF 
Sbjct: 52  KNEVGVLRKTRHVNILLFMGYSTAP---------QLAIVTQWCEGSSLYHHLHIIETKFE 102

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  + +Q   G+ Y+H+  I+HRD+K+ N+ + +   +K+ DFGLA   S+      
Sbjct: 103 MIKLIDIARQTAQGMDYLHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSGSH- 161

Query: 130 NRYTNRVVTLWYRPPELLLGDRN--YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
            ++     ++ +  PE++       Y    D++  G ++ E+ T          + QI  
Sbjct: 162 -QFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGIVLYELMTGQLPYSNINNRDQIIF 220

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           +                   +      P     KV+      +K      L+ + L    
Sbjct: 221 M-------------------VGRGYLSPDL--SKVRSNCPKAMK-----RLMAECLKKKR 254

Query: 248 SKRFDSDAALNH 259
            +R      L  
Sbjct: 255 DERPLFPQILAS 266

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

 Score =  132 bits (332), Expect = 3e-36
 Identities = 51/256 (19%), Positives = 92/256 (35%), Gaps = 34/256 (13%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
           F +   RE +    L H  +V + +    +           Y+V ++ +      + +  
Sbjct: 50  FYLRFRREAQNAAALNHPAIVAVYDTGEAE----TPAGPLPYIVMEYVDGVTLRDIVHTE 105

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
              +     +VI      L + H N I+HRD+K AN++I+ T  +K+ DFG+ARA + + 
Sbjct: 106 GPMTPKRAIEVIADACQALNFSHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSG 165

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
           N         + T  Y  PE   GD       D++  GC++ E+ T  P   G++     
Sbjct: 166 NSVTQTAA-VIGTAQYLSPEQARGDS-VDARSDVYSLGCVLYEVLTGEPPFTGDSPVSVA 223

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
               +           G+                      L           ++ K L  
Sbjct: 224 YQHVREDPIPPSARHEGLS-------------------ADLD---------AVVLKALAK 255

Query: 246 DPSKRFDSDAALNHDF 261
           +P  R+ + A +  D 
Sbjct: 256 NPENRYQTAAEMRADL 271

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]} Length = 364

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

 Score =  132 bits (332), Expect = 2e-35
 Identities = 41/263 (15%), Positives = 89/263 (33%), Gaps = 48/263 (18%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
             +     + ++       +V +     T              + D           + H
Sbjct: 50  LALNERIMLSLVSTGDCPFIVCMSYAFHTP--------DKLSFILDLMNGGDLHYHLSQH 101

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
             FS  +++    +++ GL ++H+  +++RD+K AN+L+ + G ++++D GLA  FS+ K
Sbjct: 102 GVFSEADMRFYAAEIILGLEHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKKK 161

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQI 185
                       T  Y  PE+L     Y    D +  GC++ ++       + +  + + 
Sbjct: 162 PHASVG------THGYMAPEVLQKGVAYDSSADWFSLGCMLFKLLRGHSPFRQHKTKDKH 215

Query: 186 TLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL 245
            +  ++  ++  E                                       LL+ LL  
Sbjct: 216 EID-RMTLTMAVELPDSF----------------------------SPELRSLLEGLLQR 246

Query: 246 DPSKRF-----DSDAALNHDFFW 263
           D ++R       +       FF 
Sbjct: 247 DVNRRLGCLGRGAQEVKESPFFR 269

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  126 bits (317), Expect = 4e-34
 Identities = 51/270 (18%), Positives = 94/270 (34%), Gaps = 58/270 (21%)

Query: 10  ALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE--HDLAGLLSNIH 65
              E+ +L+ +      V+ L++              +F L+ +  E   DL   ++   
Sbjct: 54  VPMEVVLLKKVSSGFSGVIRLLDWFERP--------DSFVLILERPEPVQDLFDFITE-R 104

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLIT-KTGILKLADFGLARAFSQT 124
                   +    Q+L  + + H+  +LHRD+K  N+LI    G LKL DFG       T
Sbjct: 105 GALQEELARSFFWQVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT 164

Query: 125 KNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
                  YT+   T  Y PPE +   R +G    +W  G ++ +M       + + E  +
Sbjct: 165 ------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIR 218

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
             +                               +++V    +          L+   L 
Sbjct: 219 GQVF-----------------------------FRQRVSSECQ---------HLIRWCLA 240

Query: 245 LDPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
           L PS R   +   NH +     +P + +++
Sbjct: 241 LRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 37.8 bits (87), Expect = 0.002
 Identities = 9/38 (23%), Positives = 17/38 (44%)

Query: 342 DLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
            L+   L L PS R   +   NH +     +P + +++
Sbjct: 233 HLIRWCLALRPSDRPTFEEIQNHPWMQDVLLPQETAEI 270

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]} Length = 320

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  127 bits (320), Expect = 5e-34
 Identities = 62/256 (24%), Positives = 101/256 (39%), Gaps = 49/256 (19%)

Query: 10  ALREIKILQL-LKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVK 67
            + E ++L L  +H  + H+    +TK N         + V ++    DL   + + H K
Sbjct: 49  TMVEKRVLSLAWEHPFLTHMFCTFQTKEN--------LFFVMEYLNGGDLMYHIQSCH-K 99

Query: 68  FSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNG 127
           F L        +++ GL ++HS  I++RD+K  N+L+ K G +K+ADFG+ +        
Sbjct: 100 FDLSRATFYAAEIILGLQFLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD-- 157

Query: 128 QVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITL 187
              +      T  Y  PE+LLG + Y   VD W  G ++ EM        G  E++    
Sbjct: 158 --AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVLLYEMLIGQSPFHGQDEEELFHS 214

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDP 247
           I                     +    P    R +++  K         DLL KL + +P
Sbjct: 215 IRM-------------------DNPFYP----RWLEKEAK---------DLLVKLFVREP 242

Query: 248 SKRFDS-DAALNHDFF 262
            KR         H  F
Sbjct: 243 EKRLGVRGDIRQHPLF 258

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]} Length = 303

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  124 bits (312), Expect = 4e-33
 Identities = 50/253 (19%), Positives = 95/253 (37%), Gaps = 30/253 (11%)

Query: 12  REIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSL 70
            EI    +L+HEN++  I         + +     +LV D+ EH  L   L+      ++
Sbjct: 46  AEIYQTVMLRHENILGFIAADNKDNGTWTQL----WLVSDYHEHGSLFDYLNR--YTVTV 99

Query: 71  GEIKKVIQQLLNGLYYIHS--------NKILHRDMKAANVLITKTGILKLADFGLARAFS 122
             + K+     +GL ++H           I HRD+K+ N+L+ K G   +AD GLA    
Sbjct: 100 EGMIKLALSTASGLAHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHD 159

Query: 123 QTKNGQVNRYTNRVVTLWYRPPELLLGDRN-----YGPPVDLWGAGCIMAEMWTRSPIMQ 177
              +       +RV T  Y  PE+L    N          D++  G +  E+  R  I  
Sbjct: 160 SATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHFESFKRADIYAMGLVFWEIARRCSIGG 219

Query: 178 GNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD 237
            + + Q              +  P   +++   K+   +  +  +  R +     +    
Sbjct: 220 IHEDYQL----------PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEALRVMAK 269

Query: 238 LLDKLLLLDPSKR 250
           ++ +    + + R
Sbjct: 270 IMRECWYANGAAR 282

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]} Length = 272

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  123 bits (310), Expect = 4e-33
 Identities = 45/226 (19%), Positives = 97/226 (42%), Gaps = 21/226 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG--LLSNIHVKF 68
           L E  +++ L+H+ +V L  +   +           Y++ ++ E+      L +   +K 
Sbjct: 56  LAEANLMKQLQHQRLVRLYAVVTQE---------PIYIITEYMENGSLVDFLKTPSGIKL 106

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           ++ ++  +  Q+  G+ +I     +HRD++AAN+L++ T   K+ADFGLAR      + +
Sbjct: 107 TINKLLDMAAQIAEGMAFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIE---DNE 163

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITL 187
                     + +  PE +     +    D+W  G ++ E+ T       G T  + I  
Sbjct: 164 YTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGILLTEIVTHGRIPYPGMTNPEVIQN 222

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPY 229
           + +    + P++ P  E   L       + + R     ++  L+ +
Sbjct: 223 LERGYRMVRPDNCPE-ELYQLMRLCWKERPEDRPTFDYLRSVLEDF 267

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 316

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  124 bits (313), Expect = 4e-33
 Identities = 50/257 (19%), Positives = 90/257 (35%), Gaps = 53/257 (20%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
             E  +L ++ H  ++ +    +             +++ D+ E      L     +F  
Sbjct: 52  NDERLMLSIVTHPFIIRMWGTFQDAQQ--------IFMIMDYIEGGELFSLLRKSQRFPN 103

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
              K    ++   L Y+HS  I++RD+K  N+L+ K G +K+ DFG A+          +
Sbjct: 104 PVAKFYAAEVCLALEYLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVP-------D 156

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQ 190
                  T  Y  PE++   + Y   +D W  G ++ EM         +   +    I  
Sbjct: 157 VTYTLCGTPDYIAPEVVST-KPYNKSIDWWSFGILIYEMLAGYTPFYDSNTMKTYEKI-- 213

Query: 191 LCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKR 250
                            L  ++  P      VK             DLL +L+  D S+R
Sbjct: 214 -----------------LNAELRFPPFFNEDVK-------------DLLSRLITRDLSQR 243

Query: 251 FDS-----DAALNHDFF 262
             +     +   NH +F
Sbjct: 244 LGNLQNGTEDVKNHPWF 260

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]} Length = 262

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (307), Expect = 1e-32
 Identities = 42/224 (18%), Positives = 89/224 (39%), Gaps = 23/224 (10%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL-SNIHVKF 68
           L E  ++  L+H N+V L+ +   +           Y+V ++     L   L S      
Sbjct: 48  LAEASVMTQLRHSNLVQLLGVIVEEKGGL-------YIVTEYMAKGSLVDYLRSRGRSVL 100

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
               + K    +   + Y+  N  +HRD+ A NVL+++  + K++DFGL +  S T+   
Sbjct: 101 GGDCLLKFSLDVCEAMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASSTQ--- 157

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITL 187
                   + + +  PE L   + +    D+W  G ++ E+++           +  +  
Sbjct: 158 ----DTGKLPVKWTAPEALRE-KKFSTKSDVWSFGILLWEIYSFGRVPYPRIPLKDVVPR 212

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLK 227
           + +      P+  P     ++        A  R    +++E+L+
Sbjct: 213 VEKGYKMDAPDGCPP-AVYEVMKNCWHLDAAMRPSFLQLREQLE 255

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  122 bits (306), Expect = 2e-32
 Identities = 54/295 (18%), Positives = 98/295 (33%), Gaps = 68/295 (23%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE +I+  L +  +V LI +C+ +            LV +      L   L     +  
Sbjct: 57  MREAQIMHQLDNPYIVRLIGVCQAE---------ALMLVMEMAGGGPLHKFLVGKREEIP 107

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           +  + +++ Q+  G+ Y+     +HRD+ A NVL+      K++DFGL++A     +   
Sbjct: 108 VSNVAELLHQVSMGMKYLEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDSYYT 167

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
            R +     L +  PE +   R +    D+W  G  M E  +      +     + +  I
Sbjct: 168 AR-SAGKWPLKWYAPECINF-RKFSSRSDVWSYGVTMWEALSYGQKPYKKMKGPEVMAFI 225

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
            Q      P   P                        L           L+    +    
Sbjct: 226 EQGKRMECPPECP----------------------PELY---------ALMSDCWIYKWE 254

Query: 249 KRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYLAPPRRPGHMRAHHHHHH 303
            R               P    + + +    ++ +  LA       +  HHHHHH
Sbjct: 255 DR---------------PDFLTVEQRM----RACYYSLA-----SKVEGHHHHHH 285

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]} Length = 277

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  121 bits (304), Expect = 3e-32
 Identities = 50/228 (21%), Positives = 93/228 (40%), Gaps = 17/228 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E  ++Q L +  +V +I IC  +         ++ LV +  E          +     
Sbjct: 56  LAEANVMQQLDNPYIVRMIGICEAE---------SWMLVMEMAELGPLNKYLQQNRHVKD 106

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             I +++ Q+  G+ Y+  +  +HRD+ A NVL+      K++DFGL++A    +N    
Sbjct: 107 KNIIELVHQVSMGMKYLEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADEN-YYK 165

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLIS 189
             T+    + +  PE +   + +    D+W  G +M E ++      +G    +   ++ 
Sbjct: 166 AQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLMWEAFSYGQKPYRGMKGSEVTAMLE 224

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKDQ 233
           +      P   P  E  DL N       + R     V+ RL+ Y  D 
Sbjct: 225 KGERMGCPAGCPR-EMYDLMNLCWTYDVENRPGFAAVELRLRNYYYDV 271

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 285

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (303), Expect = 6e-32
 Identities = 45/228 (19%), Positives = 94/228 (41%), Gaps = 21/228 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLL--SNIHVKF 68
           L+E ++++ L+HE +V L  +   +           Y+V ++                  
Sbjct: 60  LQEAQVMKKLRHEKLVQLYAVVSEE---------PIYIVTEYMSKGSLLDFLKGETGKYL 110

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
            L ++  +  Q+ +G+ Y+     +HRD++AAN+L+ +  + K+ADFGLAR      + +
Sbjct: 111 RLPQLVDMAAQIASGMAYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIE---DNE 167

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITL 187
                     + +  PE  L  R +    D+W  G ++ E+ T+      G   ++ +  
Sbjct: 168 YTARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGILLTELTTKGRVPYPGMVNREVLDQ 226

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVK 231
           + +      P   P     DL  +    + ++R     ++  L+ Y  
Sbjct: 227 VERGYRMPCPPECPE-SLHDLMCQCWRKEPEERPTFEYLQAFLEDYFT 273

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]} Length = 258

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  120 bits (301), Expect = 6e-32
 Identities = 43/251 (17%), Positives = 96/251 (38%), Gaps = 45/251 (17%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E K++  L HE +V L  +C  +           +++ ++  +  L   L  +  +F 
Sbjct: 47  IEEAKVMMNLSHEKLVQLYGVCTKQ--------RPIFIITEYMANGCLLNYLREMRHRFQ 98

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
             ++ ++ + +   + Y+ S + LHRD+ A N L+   G++K++DFGL+R      + + 
Sbjct: 99  TQQLLEMCKDVCEAMEYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSR---YVLDDEY 155

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
                    + + PPE+L+  + +    D+W  G +M E+++      +  T  +    I
Sbjct: 156 TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGVLMWEIYSLGKMPYERFTNSETAEHI 214

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
           +Q      P                          E++           ++         
Sbjct: 215 AQGLRLYRPHLAS----------------------EKVY---------TIMYSCWHEKAD 243

Query: 249 KRFDSDAALNH 259
           +R      L++
Sbjct: 244 ERPTFKILLSN 254

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 1e-31
 Identities = 50/225 (22%), Positives = 88/225 (39%), Gaps = 21/225 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           +RE+  +  L H N++ L  +  T             +V +      L   L      F 
Sbjct: 59  IREVNAMHSLDHRNLIRLYGVVLTP---------PMKMVTELAPLGSLLDRLRKHQGHFL 109

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           LG + +   Q+  G+ Y+ S + +HRD+ A N+L+    ++K+ DFGL RA  Q  +  V
Sbjct: 110 LGTLSRYAVQVAEGMGYLESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDHYV 169

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
            +  +R V   +  PE L   R +    D W  G  + EM+T       G    Q +  I
Sbjct: 170 MQ-EHRKVPFAWCAPESLKT-RTFSHASDTWMFGVTLWEMFTYGQEPWIGLNGSQILHKI 227

Query: 189 SQLCGSITPESWPGV--ETLDLYNKMELPKAQKR----KVKERLK 227
            +               +  ++  +    K + R     +++ L 
Sbjct: 228 DK--EGERLPRPEDCPQDIYNVMVQCWAHKPEDRPTFVALRDFLL 270

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]} Length = 263

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  118 bits (297), Expect = 3e-31
 Identities = 44/212 (20%), Positives = 86/212 (40%), Gaps = 15/212 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           + E +++  L H  +V L  +C  +        +   LVF+F EH  L+  L      F+
Sbjct: 48  IEEAEVMMKLSHPKLVQLYGVCLEQ--------APICLVFEFMEHGCLSDYLRTQRGLFA 99

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
              +  +   +  G+ Y+    ++HRD+ A N L+ +  ++K++DFG+ R      + Q 
Sbjct: 100 AETLLGMCLDVCEGMAYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVL---DDQY 156

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS-PIMQGNTEQQQITLI 188
              T     + +  PE+    R Y    D+W  G +M E+++      +  +  + +  I
Sbjct: 157 TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGVLMWEVFSEGKIPYENRSNSEVVEDI 215

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKR 220
           S       P          + N     + + R
Sbjct: 216 STGFRLYKPRLAS-THVYQIMNHCWKERPEDR 246

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]} Length = 337

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  119 bits (299), Expect = 5e-31
 Identities = 54/258 (20%), Positives = 92/258 (35%), Gaps = 50/258 (19%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            + E ++LQ  +H  +  L    +T              V ++          +    F+
Sbjct: 52  TVTESRVLQNTRHPFLTALKYAFQTH--------DRLCFVMEYANGGELFFHLSRERVFT 103

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
               +    ++++ L Y+HS  +++RD+K  N+++ K G +K+ DFGL +          
Sbjct: 104 EERARFYGAEIVSALEYLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG---- 159

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
                   T  Y  PE+L  +  YG  VD WG G +M EM            ++   LI 
Sbjct: 160 ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVVMYEMMCGRLPFYNQDHERLFELI- 217

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
                             L  ++  P+     +    K          LL  LL  DP +
Sbjct: 218 ------------------LMEEIRFPR----TLSPEAK---------SLLAGLLKKDPKQ 246

Query: 250 RF-----DSDAALNHDFF 262
           R      D+   + H FF
Sbjct: 247 RLGGGPSDAKEVMEHRFF 264

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  117 bits (295), Expect = 1e-30
 Identities = 46/229 (20%), Positives = 88/229 (38%), Gaps = 17/229 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I+    H NV+HL  +            +   ++ +F E+  L   L     +F+
Sbjct: 75  LSEASIMGQFDHPNVIHLEGVVTKS--------TPVMIITEFMENGSLDSFLRQNDGQFT 126

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQ-TKNGQ 128
           + ++  +++ +  G+ Y+     +HRD+ A N+L+    + K++DFGL+R     T +  
Sbjct: 127 VIQLVGMLRGIAAGMKYLADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPT 186

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITL 187
                   + + +  PE +   R +    D+W  G +M E+ +         T Q  I  
Sbjct: 187 YTSALGGKIPIRWTAPEAIQY-RKFTSASDVWSYGIVMWEVMSYGERPYWDMTNQDVINA 245

Query: 188 ISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKD 232
           I Q      P   P      L           R    ++   L   +++
Sbjct: 246 IEQDYRLPPPMDCPS-ALHQLMLDCWQKDRNHRPKFGQIVNTLDKMIRN 293

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]} Length = 293

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

 Score =  115 bits (289), Expect = 5e-30
 Identities = 38/190 (20%), Positives = 62/190 (32%), Gaps = 16/190 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
             E +  +LL     +  +     +            LV D     L  LL     KFS+
Sbjct: 48  RDEYRTYKLLAGCTGIPNVYYFGQEGLHN-------VLVIDLLGPSLEDLLDLCGRKFSV 100

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK-----TGILKLADFGLARAFSQTK 125
             +    +Q+L  +  IH   +++RD+K  N LI +       ++ + DFG+ + +    
Sbjct: 101 KTVAMAAKQMLARVQSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPV 160

Query: 126 NGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQ 182
             Q        N   T  Y      LG R      DL   G +       S   QG    
Sbjct: 161 TKQHIPYREKKNLSGTARYMSINTHLG-REQSRRDDLEALGHVFMYFLRGSLPWQGLKAA 219

Query: 183 QQITLISQLC 192
                  ++ 
Sbjct: 220 TNKQKYERIG 229

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]} Length = 350

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  116 bits (290), Expect = 1e-29
 Identities = 55/258 (21%), Positives = 91/258 (35%), Gaps = 53/258 (20%)

Query: 10  ALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFS 69
            L E +ILQ +    +V L    +  +N Y        ++      ++   L  I  +FS
Sbjct: 88  TLNEKRILQAVNFPFLVKLEFSFKDNSNLY-------MVMEYVAGGEMFSHLRRIG-RFS 139

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
               +    Q++    Y+HS  +++RD+K  N+LI + G +++ DFG A+          
Sbjct: 140 EPHARFYAAQIVLTFEYLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRV-------K 192

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLIS 189
            R      T     PE++L  + Y   VD W  G ++ EM    P    +   Q    I 
Sbjct: 193 GRTWTLCGTPEALAPEIILS-KGYNKAVDWWALGVLIYEMAAGYPPFFADQPIQIYEKIV 251

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSK 249
                        +                                 DLL  LL +D +K
Sbjct: 252 SGKVRFPSHFSSDL--------------------------------KDLLRNLLQVDLTK 279

Query: 250 RFDS-----DAALNHDFF 262
           RF +     +   NH +F
Sbjct: 280 RFGNLKNGVNDIKNHKWF 297

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]} Length = 317

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (287), Expect = 2e-29
 Identities = 44/257 (17%), Positives = 92/257 (35%), Gaps = 23/257 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
           L E  ++  + + +V  L+ IC T         +   +        L   +         
Sbjct: 59  LDEAYVMASVDNPHVCRLLGICLTS--------TVQLITQLMPFGCLLDYVREHKDNIGS 110

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVN 130
             +     Q+  G+ Y+   +++HRD+ A NVL+     +K+ DFGLA+        +  
Sbjct: 111 QYLLNWCVQIAKGMNYLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLG--AEEKEY 168

Query: 131 RYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLIS 189
                 V + +   E +L  R Y    D+W  G  + E+ T  S    G    +  +++ 
Sbjct: 169 HAEGGKVPIKWMALESILH-RIYTHQSDVWSYGVTVWELMTFGSKPYDGIPASEISSILE 227

Query: 190 QLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKDQYGCDLLDKLLLL 245
           +      P     ++   +  K  +  A  R    ++        +D        + L++
Sbjct: 228 KGERLPQPPICT-IDVYMIMVKCWMIDADSRPKFRELIIEFSKMARD------PQRYLVI 280

Query: 246 DPSKRFDSDAALNHDFF 262
              +R    +  + +F+
Sbjct: 281 QGDERMHLPSPTDSNFY 297

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]} Length = 322

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  114 bits (286), Expect = 3e-29
 Identities = 52/259 (20%), Positives = 98/259 (37%), Gaps = 44/259 (16%)

Query: 10  ALREIKILQLLKHE-NVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKF 68
              E ++L+ ++    +V L    +T+           +L+ D+          +   +F
Sbjct: 75  TRTERQVLEHIRQSPFLVTLHYAFQTETK--------LHLILDYINGGELFTHLSQRERF 126

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           +  E++  + +++  L ++H   I++RD+K  N+L+   G + L DFGL++ F   +  +
Sbjct: 127 TEHEVQIYVGEIVLALEHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADETER 186

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
              Y       +  P  +  GD  +   VD W  G +M E+ T +     + E+     I
Sbjct: 187 --AYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLGVLMYELLTGASPFTVDGEKNSQAEI 244

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPS 248
           S+      P     +                                 DL+ +LL+ DP 
Sbjct: 245 SRRILKSEPPYPQEM----------------------------SALAKDLIQRLLMKDPK 276

Query: 249 KRF-----DSDAALNHDFF 262
           KR      D+D    H FF
Sbjct: 277 KRLGCGPRDADEIKEHLFF 295

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  113 bits (284), Expect = 3e-29
 Identities = 47/261 (18%), Positives = 81/261 (31%), Gaps = 41/261 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSL 70
             E KI ++++    +  I  C  + +          +V +     L  L +    KFSL
Sbjct: 50  HIESKIYKMMQGGVGIPTIRWCGAEGDYN-------VMVMELLGPSLEDLFNFCSRKFSL 102

Query: 71  GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTG---ILKLADFGLARAFSQTKNG 127
             +  +  Q+++ + YIHS   +HRD+K  N L+       ++ + DFGLA+ +   +  
Sbjct: 103 KTVLLLADQMISRIEYIHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTH 162

Query: 128 QVNRY---TNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQ 184
           Q   Y    N   T  Y      LG        DL   G ++      S   QG     +
Sbjct: 163 QHIPYRENKNLTGTARYASINTHLG-IEQSRRDDLESLGYVLMYFNLGSLPWQGLKAATK 221

Query: 185 ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL 244
                ++                      L K    +                 L+    
Sbjct: 222 RQKYERISEKKMSTPIE-----------VLCKGYPSEFA-------------TYLNFCRS 257

Query: 245 LDPSKRFDSDAA---LNHDFF 262
           L    + D         + F 
Sbjct: 258 LRFDDKPDYSYLRQLFRNLFH 278

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]} Length = 273

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (280), Expect = 8e-29
 Identities = 48/229 (20%), Positives = 88/229 (38%), Gaps = 20/229 (8%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L+E   ++   H ++V LI +            +  +++ + C   +L   L        
Sbjct: 56  LQEALTMRQFDHPHIVKLIGVI---------TENPVWIIMELCTLGELRSFLQVRKYSLD 106

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           L  +     QL   L Y+ S + +HRD+ A NVL++    +KL DFGL+R      +   
Sbjct: 107 LASLILYAYQLSTALAYLESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYME---DSTY 163

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
            + +   + + +  PE +   R +    D+W  G  M E+        QG      I  I
Sbjct: 164 YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCMWEILMHGVKPFQGVKNNDVIGRI 222

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKDQ 233
                   P + P      L  K       +R    ++K +L   ++++
Sbjct: 223 ENGERLPMPPNCPP-TLYSLMTKCWAYDPSRRPRFTELKAQLSTILEEE 270

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 325

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  112 bits (282), Expect = 1e-28
 Identities = 53/235 (22%), Positives = 92/235 (39%), Gaps = 36/235 (15%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKF 68
           + E+K++ QL  HEN+V+L+  C              YL+F++C + DL   L +   KF
Sbjct: 88  MSELKMMTQLGSHENIVNLLGACTLS--------GPIYLIFEYCCYGDLLNYLRSKREKF 139

Query: 69  S----------------------LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
           S                        ++     Q+  G+ ++     +HRD+ A NVL+T 
Sbjct: 140 SEDEIEYENQKRLEEEEDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTH 199

Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             ++K+ DFGLAR      N  V    N  + + +  PE L     Y    D+W  G ++
Sbjct: 200 GKVVKICDFGLARDIMSDSNYVV--RGNARLPVKWMAPESLFEGI-YTIKSDVWSYGILL 256

Query: 167 AEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR 220
            E+++       G         + Q    +    +   E   +        ++KR
Sbjct: 257 WEIFSLGVNPYPGIPVDANFYKLIQNGFKMDQPFYATEEIYIIMQSCWAFDSRKR 311

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]} Length = 287

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 45/239 (18%), Positives = 96/239 (40%), Gaps = 22/239 (9%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVKF 68
           L+E  +++ +KH N+V L+ +C  +          FY++ +F  +   L  L      + 
Sbjct: 61  LKEAAVMKEIKHPNLVQLLGVCTREPP--------FYIITEFMTYGNLLDYLRECNRQEV 112

Query: 69  SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ 128
           S   +  +  Q+ + + Y+     +HRD+ A N L+ +  ++K+ADFGL+R  +      
Sbjct: 113 SAVVLLYMATQISSAMEYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMT---GDT 169

Query: 129 VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLI 188
              +      + +  PE L  ++ +    D+W  G ++ E+ T         +  Q+   
Sbjct: 170 YTAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGVLLWEIATYGMSPYPGIDLSQV--Y 226

Query: 189 SQLCGSITPESWPGV--ETLDLYNKMELPKAQKR----KVKERLKPYVKDQYGCDLLDK 241
             L      E   G   +  +L           R    ++ +  +   ++    D ++K
Sbjct: 227 ELLEKDYRMERPEGCPEKVYELMRACWQWNPSDRPSFAEIHQAFETMFQESSISDEVEK 285

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]} Length = 301

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

 Score =  111 bits (279), Expect = 1e-28
 Identities = 47/235 (20%), Positives = 91/235 (38%), Gaps = 37/235 (15%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---- 65
            RE  ++    + N+V L+ +C               L+F++  + DL   L ++     
Sbjct: 64  QREAALMAEFDNPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRSMSPHTV 115

Query: 66  -------------------VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITK 106
                                 S  E   + +Q+  G+ Y+   K +HRD+   N L+ +
Sbjct: 116 CSLSHSDLSTRARVSSPGPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGE 175

Query: 107 TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM 166
             ++K+ADFGL+R        + +   N  + + + PPE +  +R Y    D+W  G ++
Sbjct: 176 NMVVKIADFGLSRNIYSADYYKAD--GNDAIPIRWMPPESIFYNR-YTTESDVWAYGVVL 232

Query: 167 AEMWTRS-PIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR 220
            E+++       G   ++ I  +        PE+ P +E  +L           R
Sbjct: 233 WEIFSYGLQPYYGMAHEEVIYYVRDGNILACPENCP-LELYNLMRLCWSKLPADR 286

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  110 bits (276), Expect = 5e-28
 Identities = 53/236 (22%), Positives = 97/236 (41%), Gaps = 15/236 (6%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFS 69
           L E  I++   H NV+ L+ IC               +V  + +H DL   + N     +
Sbjct: 76  LTEGIIMKDFSHPNVLSLLGICLRSEGSP-------LVVLPYMKHGDLRNFIRNETHNPT 128

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++     Q+  G+ ++ S K +HRD+ A N ++ +   +K+ADFGLAR     +   V
Sbjct: 129 VKDLIGFGLQVAKGMKFLASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSV 188

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
           +  T   + + +   E L   + +    D+W  G ++ E+ TR +P             +
Sbjct: 189 HNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLLWELMTRGAPPYPDVNTFDITVYL 247

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKDQYGCDLLD 240
            Q    + PE  P     ++  K   PKA+ R    ++  R+        G   + 
Sbjct: 248 LQGRRLLQPEYCPD-PLYEVMLKCWHPKAEMRPSFSELVSRISAIFSTFIGEHYVH 302

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score =  108 bits (270), Expect = 6e-27
 Identities = 71/300 (23%), Positives = 124/300 (41%), Gaps = 40/300 (13%)

Query: 6   FPITALREIKILQLLKHENVV--------HLIEICRTKANQYNRYRSTFYLVFDFCEHDL 57
           +   A  EIK+LQ +   +          H++++     ++         +     E+ L
Sbjct: 52  YTEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGPNGVHVVMVFEVLGENLL 111

Query: 58  AGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSN-KILHRDMKAANVLITKTGI------L 110
           A +    H    L  +K++ +QLL GL Y+H    I+H D+K  NVL+           +
Sbjct: 112 ALIKKYEHRGIPLIYVKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQI 171

Query: 111 KLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMW 170
           K+AD G A  + +        YTN + T  YR PE+LLG   +G   D+W   C++ E+ 
Sbjct: 172 KIADLGNACWYDE-------HYTNSIQTREYRSPEVLLG-APWGCGADIWSTACLIFELI 223

Query: 171 TRSPIMQGNT------EQQQITLISQLCGSITPESWP-GVETLDLYNKMELPKAQKRKVK 223
           T   + + +       +   I  I +L G +       G  T   +N   L +   +   
Sbjct: 224 TGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNISKLKF 283

Query: 224 ERLKPYVKDQY---------GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 274
             L+  + ++Y           D L  +L LDP KR D+   +NH +   D +  +  ++
Sbjct: 284 WPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRV 342

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]} Length = 362

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

 Score = 38.5 bits (88), Expect = 0.001
 Identities = 12/40 (30%), Positives = 20/40 (50%), Gaps = 1/40 (2%)

Query: 340 GCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKM 379
             D L  +L LDP KR D+   +NH +   D +  +  ++
Sbjct: 304 ISDFLSPMLQLDPRKRADAGGLVNHPWL-KDTLGMEEIRV 342

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 283

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  105 bits (262), Expect = 2e-26
 Identities = 39/228 (17%), Positives = 86/228 (37%), Gaps = 17/228 (7%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAG-LLSNIHVKFS 69
           L E  I+    H N++ L  +                ++ ++ E+      L     +FS
Sbjct: 57  LGEAGIMGQFSHHNIIRLEGVISKYKP--------MMIITEYMENGALDKFLREKDGEFS 108

Query: 70  LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQV 129
           + ++  +++ +  G+ Y+ +   +HRD+ A N+L+    + K++DFGL+R          
Sbjct: 109 VLQLVGMLRGIAAGMKYLANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPE-AT 167

Query: 130 NRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLI 188
              +   + + +  PE +   +      D+W  G +M E+ T         +  + +  I
Sbjct: 168 YTTSGGKIPIRWTAPEAISYRKFT-SASDVWSFGIVMWEVMTYGERPYWELSNHEVMKAI 226

Query: 189 SQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKPYVKD 232
           +      TP   P      L  +    +  +R     +   L   ++ 
Sbjct: 227 NDGFRLPTPMDCP-SAIYQLMMQCWQQERARRPKFADIVSILDKLIRA 273

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 311

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  101 bits (251), Expect = 1e-24
 Identities = 45/246 (18%), Positives = 92/246 (37%), Gaps = 35/246 (14%)

Query: 11  LREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-------------- 55
           + E+K+L  L  H N+V+L+  C               ++ ++C +              
Sbjct: 74  MSELKVLSYLGNHMNIVNLLGACTIG--------GPTLVITEYCCYGDLLNFLRRKRDSF 125

Query: 56  ----DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILK 111
                   ++ +  +   L ++     Q+  G+ ++ S   +HRD+ A N+L+T   I K
Sbjct: 126 ICSKTSPAIMEDDELALDLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITK 185

Query: 112 LADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT 171
           + DFGLAR      N  V    N  + + +  PE +     Y    D+W  G  + E+++
Sbjct: 186 ICDFGLARDIKNDSNYVV--KGNARLPVKWMAPESIFN-CVYTFESDVWSYGIFLWELFS 242

Query: 172 R-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERL 226
             S    G     +   + +    +        E  D+          KR    ++ + +
Sbjct: 243 LGSSPYPGMPVDSKFYKMIKEGFRMLSPEHAPAEMYDIMKTCWDADPLKRPTFKQIVQLI 302

Query: 227 KPYVKD 232
           +  + +
Sbjct: 303 EKQISE 308

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]} Length = 309

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

 Score =  100 bits (249), Expect = 3e-24
 Identities = 48/245 (19%), Positives = 94/245 (38%), Gaps = 37/245 (15%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHV-- 66
             E+++L +L  H N+++L+  C         +R   YL  ++  H +L   L    V  
Sbjct: 58  AGELEVLCKLGHHPNIINLLGACE--------HRGYLYLAIEYAPHGNLLDFLRKSRVLE 109

Query: 67  -------------KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          S  ++      +  G+ Y+   + +HRD+ A N+L+ +  + K+A
Sbjct: 110 TDPAFAIANSTASTLSSQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIA 169

Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR- 172
           DFGL+R           + T   + + +   E L     Y    D+W  G ++ E+ +  
Sbjct: 170 DFGLSRGQEVY-----VKKTMGRLPVRWMAIESLNYSV-YTTNSDVWSYGVLLWEIVSLG 223

Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR----KVKERLKP 228
                G T  +    + Q      P +    E  DL  +    K  +R    ++   L  
Sbjct: 224 GTPYCGMTCAELYEKLPQGYRLEKPLNCDD-EVYDLMRQCWREKPYERPSFAQILVSLNR 282

Query: 229 YVKDQ 233
            ++++
Sbjct: 283 MLEER 287

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]} Length = 308

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 95.3 bits (236), Expect = 1e-22
 Identities = 43/241 (17%), Positives = 98/241 (40%), Gaps = 31/241 (12%)

Query: 11  LREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH---- 65
           L E  +++     +VV L+ +                ++ +     DL   L ++     
Sbjct: 71  LNEASVMKEFNCHHVVRLLGVVS--------QGQPTLVIMELMTRGDLKSYLRSLRPAMA 122

Query: 66  -----VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARA 120
                   SL ++ ++  ++ +G+ Y+++NK +HRD+ A N ++ +   +K+ DFG+ R 
Sbjct: 123 NNPVLAPPSLSKMIQMAGEIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRD 182

Query: 121 FSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGN 179
             +T      +    ++ + +  PE L     +    D+W  G ++ E+ T      QG 
Sbjct: 183 IYET--DYYRKGGKGLLPVRWMSPESLKDGV-FTTYSDVWSFGVVLWEIATLAEQPYQGL 239

Query: 180 TEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR--------KVKERLKPYVK 231
           + +Q +  + +      P++ P     +L         + R         +KE ++P  +
Sbjct: 240 SNEQVLRFVMEGGLLDKPDNCPD-MLFELMRMCWQYNPKMRPSFLEIISSIKEEMEPGFR 298

Query: 232 D 232
           +
Sbjct: 299 E 299

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 93.4 bits (231), Expect = 6e-22
 Identities = 49/228 (21%), Positives = 94/228 (41%), Gaps = 30/228 (13%)

Query: 11  LREIKIL-QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLL------- 61
           + E++++  + KH+N+++L+  C              Y++ ++    +L   L       
Sbjct: 66  ISEMEMMKMIGKHKNIINLLGACTQDGP--------LYVIVEYASKGNLREYLQARRPPG 117

Query: 62  --------SNIHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                    N   + S  ++     Q+  G+ Y+ S K +HRD+ A NVL+T+  ++K+A
Sbjct: 118 LEYSYNPSHNPEEQLSSKDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIA 177

Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTR- 172
           DFGLAR           + TN  + + +  PE L   R Y    D+W  G ++ E++T  
Sbjct: 178 DFGLARDIHHID--YYKKTTNGRLPVKWMAPEALFD-RIYTHQSDVWSFGVLLWEIFTLG 234

Query: 173 SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKR 220
                G   ++   L+ +      P +    E   +          +R
Sbjct: 235 GSPYPGVPVEELFKLLKEGHRMDKPSNCTN-ELYMMMRDCWHAVPSQR 281

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]} Length = 299

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

 Score = 91.1 bits (225), Expect = 3e-21
 Identities = 54/266 (20%), Positives = 102/266 (38%), Gaps = 56/266 (21%)

Query: 11  LREIKILQLLKHE-NVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSN----- 63
           + E+KIL  + H  NVV+L+  C               ++ +FC+  +L+  L +     
Sbjct: 64  MSELKILIHIGHHLNVVNLLGACTKPGGP-------LMVIVEFCKFGNLSTYLRSKRNEF 116

Query: 64  ----------IHVKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLA 113
                          +L  +     Q+  G+ ++ S K +HRD+ A N+L+++  ++K+ 
Sbjct: 117 VPYKVAPEDLYKDFLTLEHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKIC 176

Query: 114 DFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMAEMWTRS 173
           DFGLAR     K+    R  +  + L +  PE +   R Y    D+W  G ++ E+    
Sbjct: 177 DFGLARDIY--KDPDYVRKGDARLPLKWMAPETIFD-RVYTIQSDVWSFGVLLWEI---- 229

Query: 174 PIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ 233
                                 +P  +PGV+  + + +       K   + R   Y   +
Sbjct: 230 -----------------FSLGASP--YPGVKIDEEFCRR-----LKEGTRMRAPDYTTPE 265

Query: 234 YGCDLLDKLLLLDPSKRFDSDAALNH 259
                +      +PS+R      + H
Sbjct: 266 M-YQTMLDCWHGEPSQRPTFSELVEH 290

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]} Length = 191

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

 Score = 73.3 bits (179), Expect = 9e-16
 Identities = 22/155 (14%), Positives = 51/155 (32%), Gaps = 28/155 (18%)

Query: 6   FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIH 65
              +A  E + LQ L+   V  +                   ++ +  +           
Sbjct: 57  AIRSARNEFRALQKLQGLAVPKVYAWEG------------NAVLMELIDAK-------EL 97

Query: 66  VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTK 125
            +  +    +V+  +L  +   +   I+H D+   NVL+++ GI  + DF  +    +  
Sbjct: 98  YRVRVENPDEVLDMILEEVAKFYHRGIVHGDLSQYNVLVSEEGI-WIIDFPQSVEVGEEG 156

Query: 126 NGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW 160
             ++     R +  ++         R Y    D+ 
Sbjct: 157 WREILERDVRNIITYFS--------RTYRTEKDIN 183

Homologous Domains Detected by HHsearch

Original result of HHsearch against SCOP70(version1.75) database

ID	Length	Definition	Probability
Query	433
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	100.0
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	100.0
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	100.0
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	100.0
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	100.0
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	100.0
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	100.0
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	100.0
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	100.0
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	100.0
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	100.0
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	100.0
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	100.0
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	100.0
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	100.0
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	100.0
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	100.0
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	100.0
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	100.0
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	100.0
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	100.0
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	100.0
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	100.0
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	100.0
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	100.0
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	100.0
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	100.0
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	100.0
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	100.0
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	100.0
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	100.0
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	100.0
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	100.0
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	100.0
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	100.0
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	100.0
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	100.0
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	100.0
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	100.0
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	100.0
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	100.0
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	100.0
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	100.0
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	100.0
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	100.0
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	100.0
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	100.0
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	100.0
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	100.0
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	100.0
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	100.0
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	100.0
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	100.0
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	100.0
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	100.0
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	100.0
d1ckia_	299	Casein kinase-1, CK1 {Rat (Rattus norvegicus) [Tax	100.0
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	100.0
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	100.0
d1csna_	293	Casein kinase-1, CK1 {Fission yeast (Schizosacchar	100.0
d1zara2	191	Rio2 serine protein kinase C-terminal domain {Arch	99.69
d1ua2a_	299	Cell division protein kinase 7, CDK7 {Human (Homo	98.43
d3blha1	318	Cell division protein kinase 9, CDK9 {Human (Homo	98.35
d1unla_	292	Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [T	98.08
d3bqca1	328	Protein kinase CK2, alpha subunit {Rattus norvegic	98.03
d1blxa_	305	Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [T	97.97
d1ob3a_	286	Cyclin-dependent PK, CDK2 {(Plasmodium falciparum)	97.97
d1gz8a_	298	Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [T	97.96
d2gfsa1	348	MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]	97.95
d1cm8a_	346	MAP kinase p38-gamma {Human (Homo sapiens) [TaxId:	97.94
d1q8ya_	362	Sky1p {Baker's yeast (Saccharomyces cerevisiae) [T	97.9
d1a06a_	307	Calmodulin-dependent protein kinase {Rat (Rattus n	97.85
d2b1pa1	355	c-jun N-terminal kinase (jnk3s) {Human (Homo sapie	97.83
d1u5ra_	309	Serine/threonine protein kinase TAO2 {Rat (Rattus	97.79
d1pmea_	345	MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606	97.74
d1q5ka_	350	Glycogen synthase kinase-3 beta (Gsk3b) {Human (Ho	97.72
d1nvra_	271	Cell cycle checkpoint kinase chk1 {Human (Homo sap	97.7
d1koaa2	350	Twitchin, kinase domain {Caenorhabditis elegans, p	97.68
d1s9ja_	322	Dual specificity mitogen-activated protein kinase	97.62
d1xwsa_	273	Proto-oncogene serine/threonine-protein kinase Pim	97.62
d1yhwa1	293	pak1 {Human (Homo sapiens) [TaxId: 9606]}	97.55
d1t4ha_	270	Protein kinase wnk1 {Human (Homo sapiens) [TaxId:	97.5
d2jfla1	288	STE20-like serine/threonine-protein kinase, SLK {H	97.49
d1phka_	277	gamma-subunit of glycogen phosphorylase kinase (Ph	97.47
d1jksa_	293	Death-associated protein kinase, Dap {Human (Homo	97.44
d1koba_	352	Twitchin, kinase domain {California sea hare (Aply	97.42
d2j4za1	263	Aurora-related kinase 1 (aurora-2) {Human (Homo sa	97.35
d1j7la_	263	Type IIIa 3',5"-aminoglycoside phosphotransferase	97.32
d1tkia_	321	Titin, kinase domain {Human (Homo sapiens) [TaxId:	97.26
d2ozaa1	335	MAP kinase activated protein kinase 2, mapkap2 {Hu	97.2
d1omwa3	364	G-protein coupled receptor kinase 2 {Cow (Bos taur	97.1
d2java1	269	Serine/threonine-protein kinase Nek2 {Human (Homo	97.03
d1vzoa_	322	Ribosomal protein S6 kinase alpha 5, Msk1 {Human (	96.97
d1o6la_	337	Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9	96.88
d1rdqe_	350	cAMP-dependent PK, catalytic subunit {Mouse (Mus m	96.8
d1uu3a_	288	3-phosphoinositide dependent protein kinase-1 Pdk1	96.78
d1fota_	316	cAMP-dependent PK, catalytic subunit {Baker's yeas	96.71
d1nd4a_	255	Aminoglycoside 3'-phosphotransferase IIa (Kanamyci	96.7
d1xjda_	320	Protein kinase C, theta type {Human (Homo sapiens)	96.69
d2pula1	392	Methylthioribose kinase MtnK {Bacillus subtilis [T	95.38
d1fmka3	285	c-src tyrosine kinase {Human (Homo sapiens) [TaxId	94.27
d2ppqa1	316	Homoserine kinase ThrB {Agrobacterium tumefaciens	93.79
d1nw1a_	395	Choline kinase {Caenorhabditis elegans [TaxId: 623	93.64
d1ywna1	299	Vascular endothelial growth factor receptor 2 (kdr	92.52
d1qpca_	272	Lymphocyte kinase (lck) {Human (Homo sapiens) [Tax	91.94
d1mp8a_	273	Focal adhesion kinase 1 (fak) {Human (Homo sapiens	91.89
d1xbba_	277	Tyrosine-protein kinase SYK {Human (Homo sapiens)	91.87
d1k2pa_	258	Bruton's tyrosine kinase (Btk) {Human (Homo sapien	91.74
d1rjba_	325	Fl cytokine receptor {Human (Homo sapiens) [TaxId:	91.48
d1fvra_	309	Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}	91.16
d1byga_	262	Carboxyl-terminal src kinase (csk) {Human (Homo sa	90.47
d1sm2a_	263	Tyrosine-protein kinase Itk/Tsk {Human (Homo sapie	90.39
d1o6ya_	277	Mycobacterial protein kinase PknB, catalytic domai	90.06
d1p4oa_	308	Insulin-like growth factor 1 receptor {Human (Homo	89.57
d1fgka_	299	Fibroblast growth factor receptor 1 {Human (Homo s	89.53
d1t46a_	311	c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]	89.26
d1u59a_	285	Tyrosine-protein kinase ZAP-70 {Human (Homo sapien	88.74
d1opja_	287	Abelsone tyrosine kinase (abl) {Mouse (Mus musculu	88.5
d1uwha_	276	B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}	88.39
d1r0pa_	311	Hepatocyte growth factor receptor, c-MET {Human (H	87.85
d1xkka_	317	EGF receptor tyrosine kinase, Erbb-1 {Human (Homo	87.58
d1u46a_	273	Activated CDC42 kinase 1, ACK1 {Human (Homo sapien	86.47
d1jpaa_	299	ephb2 receptor tyrosine kinase {Mouse (Mus musculu	86.36
d1zyla1	325	RdoA {Escherichia coli [TaxId: 562]}	86.03
d1mqba_	283	epha2 receptor tyrosine kinase {Human (Homo sapien	85.33
d1lufa_	301	Musk tyrosine kinase {Rat (Rattus norvegicus) [Tax	85.14
d1vjya_	303	Type I TGF-beta receptor R4 {Human (Homo sapiens)	82.31

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.8e-51  Score=386.54  Aligned_cols=249  Identities=39%  Similarity=0.668  Sum_probs=208.2

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      +....+++|+++|+.++|||||++++++.+.        +.+|||||||.+++...+......+++..++.++.||+.||
T Consensus        42 ~~~~~~~~Ei~il~~l~hpnIv~~~~~~~~~--------~~~~ivmE~~~~~~~~~~~~~~~~l~~~~~~~~~~qil~aL  113 (299)
T d1ua2a_          42 GINRTALREIKLLQELSHPNIIGLLDAFGHK--------SNISLVFDFMETDLEVIIKDNSLVLTPSHIKAYMLMTLQGL  113 (299)
T ss_dssp             --CTHHHHHHHHHHHCCCTTBCCEEEEECCT--------TCCEEEEECCSEEHHHHHTTCCSSCCSSHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeEEEeeeccC--------CceeehhhhhcchHHhhhhhcccCCCHHHHHHHHHHHHHHH
Confidence            3456789999999999999999999999876        56999999999988888877777799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||++.......    ......+||+.|+|||++.+...|+.++||||+||
T Consensus       114 ~~lH~~~iiHrDiKp~NIli~~~~~~KL~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  189 (299)
T d1ua2a_         114 EYLHQHWILHRDLKPNNLLLDENGVLKLADFGLAKSFGSPN----RAYTHQVVTRWYRAPELLFGARMYGVGVDMWAVGC  189 (299)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTCCEEECCCGGGSTTTSCC----CCCCCSCCCCTTCCHHHHTTCSCCCHHHHHHHHHH
T ss_pred             HHhhccceecccCCcceEEecCCCccccccCccccccCCCc----ccccceecChhhccHHHHccCCCCChhhhhhhcch
Confidence            99999999999999999999999999999999997765332    23345688999999999987767899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+.++.+++..|.+..|.+..+.|+...............  ........  ...++++++||.+||+
T Consensus       190 il~el~~g~~pf~~~~~~~~l~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~~~~~--~~~s~~~~dll~~~L~  265 (299)
T d1ua2a_         190 ILAELLLRVPFLPGDSDLDQLTRIFETLGTPTEEQWPDMCSLPDYVTFKSFP--GIPLHHIF--SAAGDDLLDLIQGLFL  265 (299)
T ss_dssp             HHHHHHHSSCSSCCSSHHHHHHHHHHHHCCCCTTTSSSTTSSTTCCCCCCCC--CCCHHHHC--TTCCHHHHHHHHHHHC
T ss_pred             HHHHHHhCcCCCCCCCHHHHHHHHHHhcCCCChhhccchhccchhhhhccCC--CCChHHhc--ccCCHHHHHHHHHHcc
Confidence            9999999999999999999999999999999888887665443322221110  00011111  1357889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCCc
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMPS  269 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~~  269 (433)
                      .||++|||++|+|+||||++.+.+.
T Consensus       266 ~dP~~R~sa~e~L~Hp~f~~~p~p~  290 (299)
T d1ua2a_         266 FNPCARITATQALKMKYFSNRPGPT  290 (299)
T ss_dssp             SSTTTSCCHHHHHTSGGGTSSSCCC
T ss_pred             CChhhCcCHHHHhCCHhhCCCCCCC
Confidence            9999999999999999998877554

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.2e-50  Score=382.71  Aligned_cols=267  Identities=80%  Similarity=1.317  Sum_probs=218.0

Q ss_pred             CCCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      +....++++|+++|+.++||||+++++++......+......+|+|||||.+++..........+++..++.++.||+.|
T Consensus        50 ~~~~~~~~~E~~il~~l~h~nii~~~~~~~~~~~~~~~~~~~~~iv~e~~~~~~~~~~~~~~~~~~~~~~~~i~~qil~~  129 (318)
T d3blha1          50 EGFPITALREIKILQLLKHENVVNLIEICRTKASPYNRCKGSIYLVFDFCEHDLAGLLSNVLVKFTLSEIKRVMQMLLNG  129 (318)
T ss_dssp             TSSCHHHHHHHHHHHHCCCTTBCCEEEEEEC----------CEEEEEECCCEEHHHHHTCTTCCCCHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHHHHHhcCCCccceEeeeecccccccccCceEEEEEeccCCCccchhhhcccccccHHHHHHHHHHHHH
Confidence            34567789999999999999999999999876544444557899999999998888887777789999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |.|||++||+||||||+|||++.++.+||+|||++.................+||+.|+|||++.+...|+.++||||+|
T Consensus       130 l~~lH~~~ivHrDlKp~NILl~~~~~~kl~dfg~~~~~~~~~~~~~~~~~~~~gT~~Y~aPE~~~~~~~~~~k~DiwSlG  209 (318)
T d3blha1         130 LYYIHRNKILHRDMKAANVLITRDGVLKLADFGLARAFSLAKNSQPNRYTNRVVTLWYRPPELLLGERDYGPPIDLWGAG  209 (318)
T ss_dssp             HHHHHHTTEECCCCCGGGEEECTTSCEEECCCTTCEECCC-----CCCCCSCCSCGGGCCHHHHTTCSSCCTHHHHHHHH
T ss_pred             HHHhccCCEEecCcCchheeecCCCcEEeeecceeeecccccccccccccceecCHHHhhHHHHcCCCCCCcHHHcccCC
Confidence            99999999999999999999999999999999999877654443444455678999999999998877789999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.++......+....+.+.++.+...........+.............+.....+++++|||.+||
T Consensus       210 vil~el~~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~dLl~~mL  289 (318)
T d3blha1         210 CIMAEMWTRSPIMQGNTEQHQLALISQLCGSITPEVWPNVDNYELYEKLELVKGQKRKVKDRLKAYVRDPYALDLIDKLL  289 (318)
T ss_dssp             HHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTCCCC-------CCSSCCBCHHHHHHHHHCCHHHHHHHHHHS
T ss_pred             ceeeeHhhCCCCCCCCCHHHHHHHHHHhcCCCChhhccccchhhhhhhhcccccccccchhhhccccCCHHHHHHHHHHC
Confidence            99999999999999999999999999999999988887777666665555444444445555555667889999999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCCCCch
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDPMPSD  270 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~~~~~  270 (433)
                      ++||++|||++|+|+||||++.+.|++
T Consensus       290 ~~dP~~R~sa~elL~Hpff~~~p~p~~  316 (318)
T d3blha1         290 VLDPAQRIDSDDALNHDFFWSDPMPSD  316 (318)
T ss_dssp             CSSTTTSCCHHHHHHSGGGSSSSCCCC
T ss_pred             cCChhHCcCHHHHHcChhhccCCCCCC
Confidence            999999999999999999998877653

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.8e-50  Score=370.86  Aligned_cols=212  Identities=30%  Similarity=0.448  Sum_probs=183.3

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+.+|+++|+.++|||||++++++.++        +.+|||||||+ |+|.+++.+. ..+++..++.++.||+.|
T Consensus        48 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--------~~~~ivmEy~~~g~L~~~l~~~-~~l~e~~~~~i~~qi~~a  118 (263)
T d2j4za1          48 GVEHQLRREVEIQSHLRHPNILRLYGYFHDA--------TRVYLILEYAPLGTVYRELQKL-SKFDEQRTATYITELANA  118 (263)
T ss_dssp             TCHHHHHHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-SSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhcCCCCCCeEEEEEEEC--------CEEEEEEeecCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHH
Confidence            3456789999999999999999999999976        66999999998 4888888764 469999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |+|||++||+||||||+|||++.+|.+||+|||+|......      .....+||+.|+|||++.+.. |+.++||||||
T Consensus       119 l~~lH~~~ivHrDiKp~Nill~~~~~~kl~DFG~a~~~~~~------~~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlG  191 (263)
T d2j4za1         119 LSYCHSKRVIHRDIKPENLLLGSAGELKIADFGWSVHAPSS------RRTTLCGTLDYLPPEMIEGRM-HDEKVDLWSLG  191 (263)
T ss_dssp             HHHHHHTTCCCCCCCGGGEEECTTSCEEECCCCSCSCCCCC------CCEETTEEGGGCCHHHHTTCC-CCTTHHHHHHH
T ss_pred             HHHHHHCCeeeeeeccccceecCCCCEeecccceeeecCCC------cccccCCCCcccCHHHHcCCC-CCchhhhhhHh
Confidence            99999999999999999999999999999999999776532      234567999999999998865 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....+.+.....                                +...++++++||.+||
T Consensus       192 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L  239 (263)
T d2j4za1         192 VLCYEFLVGKPPFEANTYQETYKRISRVEFTF--------------------------------PDFVTEGARDLISRLL  239 (263)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHTTCCCC--------------------------------CTTSCHHHHHHHHHHT
T ss_pred             HHHHHHhcCCCCCCCCCHHHHHHHHHcCCCCC--------------------------------CccCCHHHHHHHHHHc
Confidence            99999999999999998887777664421110                                1125678889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +.||.+|||++|+|+||||+.
T Consensus       240 ~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         240 KHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CSSGGGSCCHHHHHTCHHHHH
T ss_pred             cCCHhHCcCHHHHHcCcCcCC
Confidence            999999999999999999954

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-49  Score=368.70  Aligned_cols=216  Identities=25%  Similarity=0.439  Sum_probs=183.3

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+++|+.++|||||+++++|.++        +.+|||||||.+ +|.+++.+  ..+++.+++.++.||+.||+
T Consensus        61 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~ivmEy~~gg~L~~~~~~--~~l~~~~~~~i~~qi~~aL~  130 (293)
T d1yhwa1          61 KELIINEILVMRENKNPNIVNYLDSYLVG--------DELWVVMEYLAGGSLTDVVTE--TCMDEGQIAAVCRECLQALE  130 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTCBHHHHHHH--SCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeEEEEEC--------CEEEEEEEecCCCcHHHHhhc--cCCCHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999986        669999999985 77776654  36999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+.+....    ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       131 yLH~~~iiHrDiKp~NILl~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~Y~aPE~~~~~~-~~~~~DiwSlGvi  205 (293)
T d1yhwa1         131 FLHSNQVIHRDIKSDNILLGMDGSVKLTDFGFCAQITPEQ----SKRSTMVGTPYWMAPEVVTRKA-YGPKVDIWSLGIM  205 (293)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSTT----CCBCCCCSCGGGCCHHHHSSSC-BCTHHHHHHHHHH
T ss_pred             HHHHCCCcccCCcHHHeEECCCCcEeeccchhheeecccc----ccccccccCCCccChhhhcCCC-CCchhceehHhHH
Confidence            9999999999999999999999999999999998765322    2334568999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+..... +....                            +...+.++++||.+||+.
T Consensus       206 lyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~~----------------------------~~~~s~~~~~li~~~L~~  256 (293)
T d1yhwa1         206 AIEMIEGEPPYLNENPLRALYLIATNGT-PELQN----------------------------PEKLSAIFRDFLNRCLDM  256 (293)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHHCS-CCCSS----------------------------GGGSCHHHHHHHHHHTCS
T ss_pred             HHHHhhCCCCCCCCCHHHHHHHHHhCCC-CCCCC----------------------------cccCCHHHHHHHHHHccC
Confidence            9999999999999888877766654211 11000                            112577888999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+|||++|+|+||||+...
T Consensus       257 dP~~R~s~~eil~Hp~~~~~~  277 (293)
T d1yhwa1         257 DVEKRGSAKELLQHQFLKIAK  277 (293)
T ss_dssp             STTTSCCHHHHTTCGGGGGCC
T ss_pred             ChhHCcCHHHHhcCHhhCCCC
Confidence            999999999999999997543

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-49  Score=369.16  Aligned_cols=218  Identities=26%  Similarity=0.383  Sum_probs=178.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+++|+++|++++|||||++++++.++        +.+|||||||.+ +|.+++.+ ...+++.+++.++.||+.||+
T Consensus        47 ~~~~~~Ei~~l~~l~HpnIv~~~~~~~~~--------~~~~ivmEy~~gg~L~~~l~~-~~~l~e~~~~~i~~qi~~al~  117 (271)
T d1nvra_          47 PENIKKEICINKMLNHENVVKFYGHRREG--------NIQYLFLEYCSGGELFDRIEP-DIGMPEPDAQRFFHQLMAGVV  117 (271)
T ss_dssp             --CHHHHHHHHHTCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEGGGGSBT-TTBCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEeeeeccC--------ceeEEEEeccCCCcHHHHHhc-CCCCCHHHHHHHHHHHHHHHH
Confidence            45789999999999999999999999986        669999999985 88887754 457999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+|+.......  .......+||+.|+|||++.+...++.++||||+||+
T Consensus       118 ylH~~~IiHrDiKp~NILl~~~~~~KL~DFG~a~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~~~~~~~DiwSlGvi  195 (271)
T d1nvra_         118 YLHGIGITHRDIKPENLLLDERDNLKISDFGLATVFRYNNR--ERLLNKMCGTLPYVAPELLKRREFHAEPVDVWSCGIV  195 (271)
T ss_dssp             HHHHTTEECSCCCGGGEEECTTCCEEECCCTTCEECEETTE--ECCBCCCCSCGGGSCTHHHHCSSBCHHHHHHHHHHHH
T ss_pred             HHHHcCCccCcccHHHEEECCCCCEEEccchhheeeccCCc--cccccceeeCcCccCHhHhcCCCCCCCceeeeHhHHH
Confidence            99999999999999999999999999999999987653321  1234567899999999999887656788999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+................. ..                            .....++++++||.+||+.
T Consensus       196 lyeml~G~~pf~~~~~~~~~~~~~~~~~~~-~~----------------------------~~~~~s~~~~~li~~~L~~  246 (271)
T d1nvra_         196 LTAMLAGELPWDQPSDSCQEYSDWKEKKTY-LN----------------------------PWKKIDSAPLALLHKILVE  246 (271)
T ss_dssp             HHHHHHSSCSCSSSSTTSHHHHHHHTTCTT-ST----------------------------TGGGSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCChHHHHHHHHhcCCCC-CC----------------------------ccccCCHHHHHHHHHHcCC
Confidence            999999999998765443332222111100 00                            0012577888999999999


Q ss_pred             CCCCCCCHHHhhcCCCccC
Q psy7889         246 DPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~  264 (433)
                      ||++|||++|+|+||||++
T Consensus       247 dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         247 NPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             STTTSCCHHHHTTCTTTTC
T ss_pred             ChhHCcCHHHHhcCHhhCc
Confidence            9999999999999999965

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-49  Score=368.04  Aligned_cols=218  Identities=28%  Similarity=0.435  Sum_probs=183.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      -+.+++|+++|++++|||||++++++.++        +.+|||||||.+ +|.+++.+....+++..++.++.||+.||.
T Consensus        53 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~~~~lvmEy~~~g~L~~~~~~~~~~l~e~~~~~i~~qi~~gL~  124 (288)
T d2jfla1          53 LEDYMVEIDILASCDHPNIVKLLDAFYYE--------NNLWILIEFCAGGAVDAVMLELERPLTESQIQVVCKQTLDALN  124 (288)
T ss_dssp             GGGTHHHHHHHHHCCCTTBCCEEEEEEET--------TEEEEEEECCTTEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEeeC--------CeEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            35788999999999999999999999986        669999999975 788887766667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC----CCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG----DRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~----~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|.......    ......+||+.|+|||++.+    ...|+.++||||
T Consensus       125 ylH~~~ivHrDiKp~NIll~~~~~~Kl~DFG~a~~~~~~~----~~~~~~~Gt~~y~APE~l~~~~~~~~~y~~k~DiwS  200 (288)
T d2jfla1         125 YLHDNKIIHRDLKAGNILFTLDGDIKLADFGVSAKNTRTI----QRRDSFIGTPYWMAPEVVMCETSKDRPYDYKADVWS  200 (288)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECHHHH----HHHTCCCSCCTTCCHHHHTTCSTTTSSTTTHHHHHH
T ss_pred             HHHHCCEEEeecChhheeECCCCCEEEEechhhhccCCCc----ccccccccccccCCHHHHhhcccCCCCCChhhhHHH
Confidence            9999999999999999999999999999999997654321    12345688999999999853    234789999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|.+||.+.+..+.+..+....  ++..                           ..+...++++++||.+
T Consensus       201 lGvilyemltg~~Pf~~~~~~~~~~~i~~~~--~~~~---------------------------~~~~~~s~~~~~li~~  251 (288)
T d2jfla1         201 LGITLIEMAEIEPPHHELNPMRVLLKIAKSE--PPTL---------------------------AQPSRWSSNFKDFLKK  251 (288)
T ss_dssp             HHHHHHHHHHSSCTTTTSCGGGHHHHHHHSC--CCCC---------------------------SSGGGSCHHHHHHHHH
T ss_pred             HHHHHHHHhhCCCCCCCCCHHHHHHHHHcCC--CCCC---------------------------CccccCCHHHHHHHHH
Confidence            9999999999999999988877766665421  1100                           0112357788999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||+.||.+|||++|+|+||||+..
T Consensus       252 ~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         252 CLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             HSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             HccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999754

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=9.9e-49  Score=370.31  Aligned_cols=219  Identities=27%  Similarity=0.435  Sum_probs=184.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      +.+++|+++|+.++|||||++++++.++        +.+|||||||.+++...+...+..+++..++.++.||+.||.||
T Consensus        60 ~~~~~Ei~il~~l~HpnIv~~~~~~~~~--------~~~~iv~E~~~~g~l~~~~~~~~~l~e~~~~~i~~qi~~aL~yL  131 (309)
T d1u5ra_          60 QDIIKEVRFLQKLRHPNTIQYRGCYLRE--------HTAWLVMEYCLGSASDLLEVHKKPLQEVEIAAVTHGALQGLAYL  131 (309)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHHTSCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEEC--------CEEEEEEEecCCCchHHHHHhCCCCCHHHHHHHHHHHHHHHHHH
Confidence            4578999999999999999999999886        66999999999876666655566899999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGCI  165 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGvi  165 (433)
                      |++||+||||||+|||++.++.+||+|||+|.....        ....+||+.|+|||++.+.  ..|+.++|||||||+
T Consensus       132 H~~~iiHrDiKp~NILl~~~~~~Kl~DFG~a~~~~~--------~~~~~GT~~Y~APE~~~~~~~~~y~~~~DiwSlGvi  203 (309)
T d1u5ra_         132 HSHNMIHRDVKAGNILLSEPGLVKLGDFGSASIMAP--------ANSFVGTPYWMAPEVILAMDEGQYDGKVDVWSLGIT  203 (309)
T ss_dssp             HHTTCBCCCCSGGGEEEETTTEEEECCCTTCBSSSS--------BCCCCSCGGGCCHHHHTTTTSCCBCTHHHHHHHHHH
T ss_pred             HhCCEeccCCCcceEEECCCCCEEEeecccccccCC--------CCccccCccccCHHHHhccCCCCcCchhhhhhHHHH
Confidence            999999999999999999999999999999977542        2345799999999998653  347899999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+.+..+........                              .+...|+++++||.+||+.
T Consensus       204 lyel~~g~~Pf~~~~~~~~~~~i~~~~~~~~------------------------------~~~~~s~~~~~li~~~L~~  253 (309)
T d1u5ra_         204 CIELAERKPPLFNMNAMSALYHIAQNESPAL------------------------------QSGHWSEYFRNFVDSCLQK  253 (309)
T ss_dssp             HHHHHHSSCTTTTSCHHHHHHHHHHSCCCCC------------------------------SCTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHCCCCCCCCCHHHHHHHHHhCCCCCC------------------------------CCCCCCHHHHHHHHHHCcC
Confidence            9999999999999888777666654211100                              1112567888999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCCCCchhH
Q psy7889         246 DPSKRFDSDAALNHDFFWTDPMPSDLS  272 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~~~~~~~  272 (433)
                      ||.+|||++|+|+||||.....+....
T Consensus       254 dP~~Rpt~~ell~Hp~~~~~~~~~~~~  280 (309)
T d1u5ra_         254 IPQDRPTSEVLLKHRFVLRERPPTVIM  280 (309)
T ss_dssp             SGGGSCCHHHHTTCHHHHSCCCTTHHH
T ss_pred             ChhHCcCHHHHHhCHHhcCCCCchhhH
Confidence            999999999999999998765554433

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5e-48  Score=364.73  Aligned_cols=248  Identities=42%  Similarity=0.732  Sum_probs=204.5

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhc-cCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSN-IHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~-~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+++|+++|++++|||||+++++|.+.        +.+|+|||||.+++..++.. ....+++..++.++.||+.||
T Consensus        44 ~~~~~~~Ei~il~~l~Hp~Iv~~~~~~~~~--------~~~~iv~e~~~~~~~~~~~~~~~~~l~e~~~~~~~~qil~~L  115 (298)
T d1gz8a_          44 VPSTAIREISLLKELNHPNIVKLLDVIHTE--------NKLYLVFEFLHQDLKKFMDASALTGIPLPLIKSYLFQLLQGL  115 (298)
T ss_dssp             CCHHHHHHHHHHTTCCCTTBCCEEEEEEET--------TEEEEEEECCSEEHHHHHHHTTTTCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHhCCCCcEEEeccccccc--------cceeEEEeecCCchhhhhhhhcccCCCHHHHHHHHHHHHHHH
Confidence            457889999999999999999999999986        67999999999987777754 345699999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+|+......    .......||+.|+|||++.....++.++||||+||
T Consensus       116 ~yLH~~~IiHrDiKpeNIl~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~gt~~y~apE~~~~~~~~~~~~DiwSlGv  191 (298)
T d1gz8a_         116 AFCHSHRVLHRDLKPQNLLINTEGAIKLADFGLARAFGVPV----RTYTHEVVTLWYRAPEILLGCKYYSTAVDIWSLGC  191 (298)
T ss_dssp             HHHHHTTCCCSCCCGGGEEECTTSCEEECSTTHHHHHCCCS----BCTTCCBCCCTTCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHhhcCCEEccccCchheeecccCcceeccCCcceeccCCc----ccceeecccceeeehhhhccccCCCccccccccch
Confidence            99999999999999999999999999999999997764322    23445688999999999887776789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|++||.+.+..+.+..+....+.+....|............ .+...........  ...|.++++||.+||+
T Consensus       192 ily~m~~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~--~~~s~~~~dll~~mL~  268 (298)
T d1gz8a_         192 IFAEMVTRRALFPGDSEIDQLFRIFRTLGTPDEVVWPGVTSMPDYKPS-FPKWARQDFSKVV--PPLDEDGRSLLSQMLH  268 (298)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT-SCCCCCCCHHHHS--TTCCHHHHHHHHHHTC
T ss_pred             hhhHHhhCCCCCCCCCHHHHHHHHHHhcCCCchhhccccccccccccc-cccccccchhhhc--cCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999998888777665443322111 1111111111111  1367889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      .||.+|||++|+|+||||++.+.|
T Consensus       269 ~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         269 YDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             SSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             CChhHCcCHHHHhCCHhhccCCCC
Confidence            999999999999999999876544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.9e-49  Score=378.30  Aligned_cols=244  Identities=21%  Similarity=0.307  Sum_probs=177.7

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+++|+.+|+.++|||||+++++|.+.        +.+|||||||.+ +|.+++.+. ..+++..++.++.||+.|
T Consensus        46 ~~~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~iVmEy~~gg~L~~~l~~~-~~l~~~~~~~~~~qil~a  116 (322)
T d1s9ja_          46 AIRNQIIRELQVLHECNSPYIVGFYGAFYSD--------GEISICMEHMDGGSLDQVLKKA-GRIPEQILGKVSIAVIKG  116 (322)
T ss_dssp             THHHHHHHHGGGGGGCCCTTBCCEEEEEECS--------SEEEEEEECCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEEcCCCCcHHHHHhhc-CCCCHHHHHHHHHHHHHH
Confidence            3356789999999999999999999999976        669999999985 888888664 469999999999999999


Q ss_pred             HHHHHh-CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          84 LYYIHS-NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        84 L~~LH~-~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |.|||+ +||+||||||+|||++.+|.+||+|||+|..+...      ...+.+||+.|+|||++.+.. |+.++||||+
T Consensus       117 L~yLH~~~~IiHRDiKP~NILl~~~~~vkl~DFGla~~~~~~------~~~~~~GT~~Y~APEvl~~~~-y~~~~DiWSl  189 (322)
T d1s9ja_         117 LTYLREKHKIMHRDVKPSNILVNSRGEIKLCDFGVSGQLIDS------MANSFVGTRSYMSPERLQGTH-YSVQSDIWSM  189 (322)
T ss_dssp             HHHHHHHHCCCCSCCSGGGEEECTTCCEEECCCCCCHHHHHH------TC---CCSSCCCCHHHHHCSC-CCTTHHHHHH
T ss_pred             HHHHHHhCCEEccccCHHHeeECCCCCEEEeeCCCccccCCC------ccccccCCccccCchHHcCCC-CCcHHHHHHH
Confidence            999997 59999999999999999999999999999876432      234568999999999998865 8999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHH-HHHHHHHHhCCCCCCC----CCcccchhhhhccc--cchH-HHhh----HHhhhCCcc
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQ-QITLISQLCGSITPES----WPGVETLDLYNKME--LPKA-QKRK----VKERLKPYV  230 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~-~~~~i~~~~g~~~~~~----~~~~~~~~~~~~~~--~~~~-~~~~----~~~~~~~~~  230 (433)
                      ||++|||++|+.||.+.+... ....+....|......    +.............  .... ....    .........
T Consensus       190 Gvil~ell~G~~Pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  269 (322)
T d1s9ja_         190 GLSLVEMAVGRYPIPPPDAKELELMFGCQVEGDAAETPPRPRTPGRPLSSYGMDSRPPMAIFELLDYIVNEPPPKLPSGV  269 (322)
T ss_dssp             HHHHHHHHHSSCCSSCCCTTHHHHHC------------------------------CCCCHHHHHHHHHTSCCCCCCBTT
T ss_pred             HHHHHHHHHCCCCCCCCCHHHHHHHHHHHhcCCcccCCcccccccccccccccccccchhHHHHHhhhhccCCccCcccc
Confidence            999999999999998765433 2222222232221110    00000000000000  0000 0000    001112234


Q ss_pred             CChhHHHHHHhhcccCCCCCCCHHHhhcCCCccC
Q psy7889         231 KDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       231 ~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      .|.+++|||.+||.+||.+|||++|+|+||||++
T Consensus       270 ~s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         270 FSLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             BCHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CCHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            6889999999999999999999999999999964

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=100.00  E-value=4.4e-48  Score=371.94  Aligned_cols=218  Identities=23%  Similarity=0.402  Sum_probs=186.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+++|+++|++++|||||+++++|.++        +.+|||||||+ |+|.+.+.+....+++..++.++.||+.||+
T Consensus        67 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~ivmE~~~gg~L~~~l~~~~~~l~e~~~~~i~~qi~~aL~  138 (350)
T d1koaa2          67 KETVRKEIQTMSVLRHPTLVNLHDAFEDD--------NEMVMIYEFMSGGELFEKVADEHNKMSEDEAVEYMRQVCKGLC  138 (350)
T ss_dssp             HHHHHHHHHHHHHTCCTTBCCEEEEEEET--------TEEEEEECCCCSCBHHHHHTCTTSCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEEcCCCCCHHHHHHhhcCCCCHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999986        66999999997 5899988776778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEec--CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITK--TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~--~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.  ++.+||+|||+++.+....     ......||+.|+|||++.+.. |+.++||||||
T Consensus       139 ylH~~~iiHrDiKp~NIll~~~~~~~vkL~DFG~a~~~~~~~-----~~~~~~gT~~Y~aPEv~~~~~-~~~~~DiwSlG  212 (350)
T d1koaa2         139 HMHENNYVHLDLKPENIMFTTKRSNELKLIDFGLTAHLDPKQ-----SVKVTTGTAEFAAPEVAEGKP-VGYYTDMWSVG  212 (350)
T ss_dssp             HHHHTTEECCCCCGGGEEESSTTSCCEEECCCTTCEECCTTS-----CEEEECSCTTTCCHHHHHTCC-BCHHHHHHHHH
T ss_pred             HHHhcCCeeeeechhHeeeccCCCCeEEEeecchheeccccc-----ccceecCcccccCHHHHcCCC-CChhHhhhhhh
Confidence            999999999999999999964  5789999999998765322     234568899999999998865 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+.+..|.......+...+                            ...|+++++||.+||
T Consensus       213 vilyell~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~L  264 (350)
T d1koaa2         213 VLSYILLSGLSPFGGENDDETLRNVKSCDWNMDDSAF----------------------------SGISEDGKDFIRKLL  264 (350)
T ss_dssp             HHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCSCCGGG----------------------------GGCCHHHHHHHHHHC
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCcccc----------------------------cCCCHHHHHHHHHHc
Confidence            9999999999999999988888877654332221111                            125678889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ..||++|||++|+|+||||+...
T Consensus       265 ~~dP~~R~t~~eil~hp~~~~~~  287 (350)
T d1koaa2         265 LADPNTRMTIHQALEHPWLTPGN  287 (350)
T ss_dssp             CSSGGGSCCHHHHHHSTTTSCTT
T ss_pred             cCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999997543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=5.7e-48  Score=364.96  Aligned_cols=216  Identities=25%  Similarity=0.400  Sum_probs=169.7

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|+.++|||||++++++.++        +.+|||||||+ ++|.+++.. ...+++.+++.++.||+.||+
T Consensus        51 ~~~~~~Ei~il~~l~HpnIv~l~~~~~~~--------~~~~lvmE~~~gg~L~~~l~~-~~~l~e~~~~~~~~qi~~al~  121 (307)
T d1a06a_          51 EGSMENEIAVLHKIKHPNIVALDDIYESG--------GHLYLIMQLVSGGELFDRIVE-KGFYTERDASRLIFQVLDAVK  121 (307)
T ss_dssp             ----CHHHHHHHTCCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHT-CSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEeccCCCcHHHhhhc-ccCCCHHHHHHHHHHHHHHHH
Confidence            45678999999999999999999999876        66999999998 589998876 447999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEe---cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          86 YIHSNKILHRDMKAANVLIT---KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~---~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |||++||+||||||+|||+.   .++.+||+|||+++......     .....+||+.|+|||++.+.. |+.++||||+
T Consensus       122 ylH~~~iiHrDiKp~Nil~~~~~~~~~vkl~DFG~a~~~~~~~-----~~~~~~GT~~y~APE~~~~~~-~~~~~DiwSl  195 (307)
T d1a06a_         122 YLHDLGIVHRDLKPENLLYYSLDEDSKIMISDFGLSKMEDPGS-----VLSTACGTPGYVAPEVLAQKP-YSKAVDCWSI  195 (307)
T ss_dssp             HHHHTTCCCSCCCGGGEEESSSSTTCCEEECCC-----------------------CTTSCHHHHTTCC-CCTHHHHHHH
T ss_pred             hhhhceeeeEEecccceeecccCCCceEEEeccceeEEccCCC-----eeeeeeeCccccCcHHHcCCC-CCcHHHhhhh
Confidence            99999999999999999995   47899999999998764322     234568999999999998765 8999999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+....+....+.......+...+                            ...|+++++||.+|
T Consensus       196 Gvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~  247 (307)
T d1a06a_         196 GVIAYILLCGYPPFYDENDAKLFEQILKAEYEFDSPYW----------------------------DDISDSAKDFIRHL  247 (307)
T ss_dssp             HHHHHHHHHSSCSCCCSSHHHHHHHHHTTCCCCCTTTT----------------------------TTSCHHHHHHHHHH
T ss_pred             hHHHHHHHhCCCCCCCCCHHHHHHHHhccCCCCCCccc----------------------------cCCCHHHHHHHHHH
Confidence            99999999999999998888777766543222211111                            12567888999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |+.||.+|||++|+|+||||+..
T Consensus       248 L~~dP~~R~s~~eil~hp~~~~~  270 (307)
T d1a06a_         248 MEKDPEKRFTCEQALQHPWIAGD  270 (307)
T ss_dssp             SCSSGGGSCCHHHHHHSTTTTSS
T ss_pred             ccCCHhHCcCHHHHhcCHhhCCC
Confidence            99999999999999999999754

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=100.00  E-value=7.2e-48  Score=370.74  Aligned_cols=217  Identities=22%  Similarity=0.370  Sum_probs=187.4

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+.+|++|+|||||+++++|.++        +.+|||||||+ ++|.+.+......+++.+++.++.||+.||+
T Consensus        70 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--------~~~~ivmE~~~gg~L~~~~~~~~~~l~e~~~~~i~~qi~~aL~  141 (352)
T d1koba_          70 KYTVKNEISIMNQLHHPKLINLHDAFEDK--------YEMVLILEFLSGGELFDRIAAEDYKMSEAEVINYMRQACEGLK  141 (352)
T ss_dssp             HHHHHHHHHHHTTCCSTTBCCEEEEEECS--------SEEEEEEECCCCCBHHHHTTCTTCCBCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEEcCCCChHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999876        66999999998 5888888776767999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEe--cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLIT--KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~--~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++  .++.+||+|||+|..+....     ......||+.|+|||++.+.. |+.++||||||
T Consensus       142 ylH~~~iiHRDiKp~NILl~~~~~~~vkL~DFGla~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlG  215 (352)
T d1koba_         142 HMHEHSIVHLDIKPENIMCETKKASSVKIIDFGLATKLNPDE-----IVKVTTATAEFAAPEIVDREP-VGFYTDMWAIG  215 (352)
T ss_dssp             HHHHTTEECCCCCGGGEEESSTTCCCEEECCCTTCEECCTTS-----CEEEECSSGGGCCHHHHTTCC-BCHHHHHHHHH
T ss_pred             HHHHCCeeecccccccccccccCCCeEEEeecccceecCCCC-----ceeeccCcccccCHHHHcCCC-CCCccchHHHH
Confidence            99999999999999999998  57899999999998875322     234567899999999998765 89999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+.+..|.......+...++                            ..++++++||.+||
T Consensus       216 vilyelltG~~Pf~~~~~~~~~~~i~~~~~~~~~~~~~----------------------------~~s~~~~~li~~~L  267 (352)
T d1koba_         216 VLGYVLLSGLSPFAGEDDLETLQNVKRCDWEFDEDAFS----------------------------SVSPEAKDFIKNLL  267 (352)
T ss_dssp             HHHHHHHHSCCSSCCSSHHHHHHHHHHCCCCCCSSTTT----------------------------TSCHHHHHHHHTTS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCCccccc----------------------------CCCHHHHHHHHHHc
Confidence            99999999999999999988888876644433322221                            25678889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccCC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +.||.+|||++|+|+||||+..
T Consensus       268 ~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         268 QKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CSSGGGSCCHHHHHTSTTTSSC
T ss_pred             cCChhHCcCHHHHhcCHhhCCC
Confidence            9999999999999999999753

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.8e-48  Score=363.59  Aligned_cols=214  Identities=26%  Similarity=0.408  Sum_probs=178.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++|++++|||||+++++|.++        +.+|||||||++ +|.+++... +.+++..++.++.||+.||+
T Consensus        52 ~~~~~~E~~il~~l~HpnIv~l~~~~~~~--------~~~~ivmEy~~gg~L~~~~~~~-~~l~e~~~~~~~~qi~~al~  122 (288)
T d1uu3a_          52 VPYVTRERDVMSRLDHPFFVKLYFTFQDD--------EKLYFGLSYAKNGELLKYIRKI-GSFDETCTRFYTAEIVSALE  122 (288)
T ss_dssp             HHHHHHHHHHHHHCCSTTBCCEEEEEECS--------SEEEEEECCCTTEEHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCCeeEEEEEEEEC--------CEEEEEEEccCCCCHHHhhhcc-CCCCHHHHHHHHHHHHHHHH
Confidence            45689999999999999999999999876        669999999985 888877664 47999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+.+.....  .......+||+.|+|||++.+.. |+.++|||||||+
T Consensus       123 ylH~~~iiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~~--~~~~~~~~GT~~Y~APE~~~~~~-~~~~~DiwSlGvi  199 (288)
T d1uu3a_         123 YLHGKGIIHRDLKPENILLNEDMHIQITDFGTAKVLSPESK--QARANSFVGTAQYVSPELLTEKS-ACKSSDLWALGCI  199 (288)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECC------------CCCCGGGCCHHHHHTCC-CCHHHHHHHHHHH
T ss_pred             hhccccEEcCcCCccccccCCCceEEecccccceecccCCc--ccccccccCCccccCceeeccCC-CCcccceehhhHH
Confidence            99999999999999999999999999999999987753221  12334568999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+....|.......                                +...++++++||.+||+.
T Consensus       200 lyell~g~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~  247 (288)
T d1uu3a_         200 IYQLVAGLPPFRAGNEYLIFQKIIKLEYDF--------------------------------PEKFFPKARDLVEKLLVL  247 (288)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHTTCCCC--------------------------------CTTCCHHHHHHHHTTSCS
T ss_pred             HHHHhhCCCCCCCcCHHHHHHHHHcCCCCC--------------------------------CccCCHHHHHHHHHHccC
Confidence            999999999999998887777664321110                                112567888999999999


Q ss_pred             CCCCCCCHHHh------hcCCCccC
Q psy7889         246 DPSKRFDSDAA------LNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~e~------L~h~~~~~  264 (433)
                      ||++|||++|+      ++||||..
T Consensus       248 dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         248 DATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             SGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CHhHCcCHHHHcCCHHHHcCCccCC
Confidence            99999999984      78999965

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.6e-47  Score=365.89  Aligned_cols=213  Identities=25%  Similarity=0.377  Sum_probs=183.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+.+|+.++|||||+++++|.+.        +.+|+|||||++ +|..++.+ ...+++..++.++.||+.||+
T Consensus        49 ~~~~~~E~~il~~l~hp~Iv~l~~~~~~~--------~~~~iv~ey~~gg~L~~~~~~-~~~~~e~~~~~~~~qil~al~  119 (337)
T d1o6la_          49 VAHTVTESRVLQNTRHPFLTALKYAFQTH--------DRLCFVMEYANGGELFFHLSR-ERVFTEERARFYGAEIVSALE  119 (337)
T ss_dssp             HHHHHHHHHHHHSCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHH-HSCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEEEEEeeeccc--------cccccceeccCCCchhhhhhc-ccCCcHHHHHHHHHHHhhhhh
Confidence            46688999999999999999999999986        669999999985 78777766 447999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+......    ......+||+.|+|||++.+.. |+.++|||||||+
T Consensus       120 ylH~~~iiHRDlKP~NILl~~~g~vkl~DFG~a~~~~~~~----~~~~~~~GT~~Y~aPE~~~~~~-y~~~~DiwSlGvi  194 (337)
T d1o6la_         120 YLHSRDVVYRDIKLENLMLDKDGHIKITDFGLCKEGISDG----ATMKTFCGTPEYLAPEVLEDND-YGRAVDWWGLGVV  194 (337)
T ss_dssp             HHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCSCCTT----CCBCCCEECGGGCCGGGGSSSC-BCTTHHHHHHHHH
T ss_pred             hhhhcCccccccCHHHeEecCCCCEEEeecccccccccCC----cccccceeCHHHhhhhhccCCC-CChhhcccchhhH
Confidence            9999999999999999999999999999999998754322    2345678999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|||++|.+||.+.+..+....+.......                                +...|+++++||.+||++
T Consensus       195 lyeml~G~~pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~dli~~~L~~  242 (337)
T d1o6la_         195 MYEMMCGRLPFYNQDHERLFELILMEEIRF--------------------------------PRTLSPEAKSLLAGLLKK  242 (337)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHHCCCCCCCcCHHHHHHHHhcCCCCC--------------------------------CccCCHHHHHHHHhhccC
Confidence            999999999999999887776665421110                                113578889999999999


Q ss_pred             CCCCCCC-----HHHhhcCCCccCC
Q psy7889         246 DPSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~t-----~~e~L~h~~~~~~  265 (433)
                      ||.+|++     ++|+++||||.+.
T Consensus       243 dP~~R~~~~~~~~~eil~Hp~f~~i  267 (337)
T d1o6la_         243 DPKQRLGGGPSDAKEVMEHRFFLSI  267 (337)
T ss_dssp             STTTSTTCSTTTHHHHHTSGGGTTC
T ss_pred             CchhhcccccccHHHHHcCcccccC
Confidence            9999994     9999999999653

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.6e-48  Score=359.61  Aligned_cols=213  Identities=26%  Similarity=0.426  Sum_probs=168.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhc---cCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSN---IHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~---~~~~l~~~~~~~i~~qll~a   83 (433)
                      +.+.+|+++|++++|||||++++++.+..+      ..+|||||||+ |+|.+++.+   .+..+++..++.++.||+.|
T Consensus        48 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~------~~~~ivmEy~~~g~L~~~i~~~~~~~~~l~e~~~~~i~~qi~~a  121 (269)
T d2java1          48 QMLVSEVNLLRELKHPNIVRYYDRIIDRTN------TTLYIVMEYCEGGDLASVITKGTKERQYLDEEFVLRVMTQLTLA  121 (269)
T ss_dssp             HHHHHHHHHTTSCCCTTBCCEEEEEEC----------CEEEEEECCTTEEHHHHHHHHHHHTCCCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHCCCCCEeeEEEEEEeCCC------CEEEEEEecCCCCcHHHHHHhccccCCCCCHHHHHHHHHHHHHH
Confidence            458899999999999999999999976432      56899999997 488888754   34569999999999999999


Q ss_pred             HHHHHhCC-----eeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          84 LYYIHSNK-----ILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        84 L~~LH~~~-----iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |+|||++|     |+||||||+|||++.++.+||+|||+++.+....    ......+||+.|+|||++.+.. |+.++|
T Consensus       122 l~ylH~~~~~~~~IiHrDiKp~NIll~~~~~vkl~DFG~a~~~~~~~----~~~~~~~gt~~Y~APE~l~~~~-~~~~~D  196 (269)
T d2java1         122 LKECHRRSDGGHTVLHRDLKPANVFLDGKQNVKLGDFGLARILNHDT----SFAKAFVGTPYYMSPEQMNRMS-YNEKSD  196 (269)
T ss_dssp             HHHHHHHCC---------CCGGGEEECTTSCEEECCHHHHHHC---------------CCCSCCCHHHHTTCC-CCHHHH
T ss_pred             HHHHHHhcCCCCCEEeCcCchhhcCcCCCCcEEEeeccceeecccCC----CccccCCCCcccCCHHHHcCCC-CChHHH
Confidence            99999876     9999999999999999999999999998765322    1234568899999999997765 899999


Q ss_pred             hhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHH
Q psy7889         159 LWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDL  238 (433)
Q Consensus       159 iwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~l  238 (433)
                      ||||||++|||++|.+||.+.+..+....+........                               +...|+++.+|
T Consensus       197 IwSlGvilyel~tg~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~s~~l~~l  245 (269)
T d2java1         197 IWSLGCLLYELCALMPPFTAFSQKELAGKIREGKFRRI-------------------------------PYRYSDELNEI  245 (269)
T ss_dssp             HHHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHTCCCCC-------------------------------CTTSCHHHHHH
T ss_pred             HHhhCHHHHHHhhCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CcccCHHHHHH
Confidence            99999999999999999999888877766644211100                               11256788899


Q ss_pred             HHhhcccCCCCCCCHHHhhcCCCc
Q psy7889         239 LDKLLLLDPSKRFDSDAALNHDFF  262 (433)
Q Consensus       239 i~~~L~~dP~~R~t~~e~L~h~~~  262 (433)
                      |.+||+.||.+|||++|+|+|||+
T Consensus       246 i~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         246 ITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             HHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             HHHHcCCChhHCcCHHHHHhCCcC
Confidence            999999999999999999999995

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=9.3e-48  Score=356.84  Aligned_cols=214  Identities=24%  Similarity=0.353  Sum_probs=173.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+.+|+++|++++|||||+++++|.+....    ...+|||||||++ +|.+++.+. ..+++..++.++.||+.||+|
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~~~~~~~~~~----~~~~~ivmE~~~~g~L~~~l~~~-~~~~~~~~~~~~~qi~~gl~y  127 (270)
T d1t4ha_          53 QRFKEEAEMLKGLQHPNIVRFYDSWESTVKG----KKCIVLVTELMTSGTLKTYLKRF-KVMKIKVLRSWCRQILKGLQF  127 (270)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEEEEESSS----CEEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCeeeEEEEEeecccc----CCEEEEEEeCCCCCcHHHHHhcc-ccccHHHHHHHHHHHHHHHHH
Confidence            4678999999999999999999999764221    3678999999975 888888664 469999999999999999999


Q ss_pred             HHhCC--eeccCCCCCcEEEe-cCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          87 IHSNK--ILHRDMKAANVLIT-KTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        87 LH~~~--iiH~dikp~NIll~-~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      ||++|  |+||||||+|||++ .++.+||+|||+++.....      .....+||+.|+|||++.+  .|+.++||||+|
T Consensus       128 LH~~~~~IiHrDiKp~NILl~~~~~~~Kl~DFGla~~~~~~------~~~~~~GT~~Y~aPE~~~~--~~~~~~DIwSlG  199 (270)
T d1t4ha_         128 LHTRTPPIIHRDLKCDNIFITGPTGSVKIGDLGLATLKRAS------FAKAVIGTPEFMAPEMYEE--KYDESVDVYAFG  199 (270)
T ss_dssp             HHTSSSCCCCSCCCGGGEEESSTTSCEEECCTTGGGGCCTT------SBEESCSSCCCCCGGGGGT--CCCTHHHHHHHH
T ss_pred             HHHCCCCEEeCCcChhhceeeCCCCCEEEeecCcceeccCC------ccCCcccCccccCHHHhCC--CCCCcCchhhHH
Confidence            99999  99999999999997 4789999999999764321      2345689999999999875  389999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+......+....  .....+..                           .+...++++.+||.+||
T Consensus       200 vilyel~~g~~Pf~~~~~~~~~~~~i--~~~~~~~~---------------------------~~~~~~~~~~~li~~~l  250 (270)
T d1t4ha_         200 MCMLEMATSEYPYSECQNAAQIYRRV--TSGVKPAS---------------------------FDKVAIPEVKEIIEGCI  250 (270)
T ss_dssp             HHHHHHHHSSCTTTTCSSHHHHHHHH--TTTCCCGG---------------------------GGGCCCHHHHHHHHHHS
T ss_pred             HHHHHHHHCCCCCCCcccHHHHHHHH--HcCCCCcc---------------------------cCccCCHHHHHHHHHHc
Confidence            99999999999998766554433221  11111000                           01125677889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCcc
Q psy7889         244 LLDPSKRFDSDAALNHDFFW  263 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~  263 (433)
                      +.||++|||++|+|+||||+
T Consensus       251 ~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         251 RQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CSSGGGSCCHHHHHTSGGGC
T ss_pred             cCCHhHCcCHHHHhCCcccC
Confidence            99999999999999999995

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=100.00  E-value=2.6e-47  Score=357.83  Aligned_cols=245  Identities=39%  Similarity=0.692  Sum_probs=201.5

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .....+.+|+++|++++|||||+++++|.+.        +.+|+||||+.+++...+......+++..++.++.||+.||
T Consensus        42 ~~~~~~~~E~~il~~l~hpnIv~~~~~~~~~--------~~~~i~~e~~~~~~~~~~~~~~~~l~~~~~~~i~~qi~~~L  113 (286)
T d1ob3a_          42 GIPSTTIREISILKELKHSNIVKLYDVIHTK--------KRLVLVFEHLDQDLKKLLDVCEGGLESVTAKSFLLQLLNGI  113 (286)
T ss_dssp             CCCHHHHHHHHGGGGCCCTTBCCEEEEEECS--------SCEEEEEECCSEEHHHHHHTSTTCCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCcEEeeeeecccC--------CceeEEEEeehhhhHHHHHhhcCCcchhhhHHHHHHHHHHH
Confidence            3457899999999999999999999999986        55999999999988888888778899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||++.......    .......+++.|+|||++.+...++.++||||+||
T Consensus       114 ~~LH~~~IvHrDiKp~NIll~~~~~~kl~DfG~a~~~~~~~----~~~~~~~~~~~y~~pE~~~~~~~~~~~~DiwslGv  189 (286)
T d1ob3a_         114 AYCHDRRVLHRDLKPQNLLINREGELKIADFGLARAFGIPV----RKYTHEIVTLWYRAPDVLMGSKKYSTTIDIWSVGC  189 (286)
T ss_dssp             HHHHHTTCCCSCCCGGGEEECTTSCEEECCTTHHHHHCC-------------CCCTTCCHHHHTTCCSCCTHHHHHHHHH
T ss_pred             HHhccCcEEecCCCCceeeEcCCCCEEecccccceecccCc----cccceecccchhhhHHHHhCCCCCCcceeehhcCc
Confidence            99999999999999999999999999999999997765322    12334567999999999987777899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|++||.+.+..+++..+....|.+....|............ .........  .......++.++|||.+||+
T Consensus       190 ~l~el~~G~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~--~~~~~~~s~~~~dli~~~L~  266 (286)
T d1ob3a_         190 IFAEMVNGTPLFPGVSEADQLMRIFRILGTPNSKNWPNVTELPKYDPN-FTVYEPLPW--ESFLKGLDESGIDLLSKMLK  266 (286)
T ss_dssp             HHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCTTTSTTGGGSTTCCTT-CCCCCCCCG--GGTCCSCCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCChhhccchhhhhhcccc-cccccCcch--hhhcccCCHHHHHHHHHHcc
Confidence            999999999999999999999999999999988888765543322111 000000000  11122357889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccC
Q psy7889         245 LDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +||++|||++|+|+||||++
T Consensus       267 ~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         267 LDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             SSTTTSCCHHHHHTSGGGGC
T ss_pred             CChhHCcCHHHHhcCcccCc
Confidence            99999999999999999964

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.2e-47  Score=358.59  Aligned_cols=248  Identities=37%  Similarity=0.644  Sum_probs=199.6

Q ss_pred             CCCchhHHHHHHHHHhC---CCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHh-ccCCCCCHHHHHHHHHH
Q psy7889           4 IFFPITALREIKILQLL---KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS-NIHVKFSLGEIKKVIQQ   79 (433)
Q Consensus         4 ~~~~~~~~~Ei~il~~l---~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~-~~~~~l~~~~~~~i~~q   79 (433)
                      +.....+++|+++|+.|   +|||||+++++|.....   .....+|++||||.+++..+.. .....+++..++.++.|
T Consensus        48 ~~~~~~~~~E~~~l~~l~~~~HpnIv~~~~~~~~~~~---~~~~~~~~~~e~~~~~~~~~~~~~~~~~~~~~~~~~~~~q  124 (305)
T d1blxa_          48 EGMPLSTIREVAVLRHLETFEHPNVVRLFDVCTVSRT---DRETKLTLVFEHVDQDLTTYLDKVPEPGVPTETIKDMMFQ  124 (305)
T ss_dssp             TSCBCTHHHHHHHHHHHHHTCCTTBCCEEEEEEEEEC---SSEEEEEEEEECCSCBHHHHHHHSCTTCSCHHHHHHHHHH
T ss_pred             chHHHHHHHHHHHHHHHhhcCCCCcceeeeeeccccc---ccCceEEEEEEeccCCchhhhhhccCCCCCHHHHHHHHHH
Confidence            34556788999998877   79999999999975421   1236799999999987766554 34456899999999999


Q ss_pred             HHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchh
Q psy7889          80 LLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDL  159 (433)
Q Consensus        80 ll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Di  159 (433)
                      |+.||+|||++||+||||||+|||++.++.+||+|||++......     ......+||+.|+|||++.+.. |+.++||
T Consensus       125 i~~aL~yLH~~~ivHrDiKp~NILi~~~~~~kl~dfg~~~~~~~~-----~~~~~~~gT~~Y~APE~~~~~~-y~~~~Di  198 (305)
T d1blxa_         125 LLRGLDFLHSHRVVHRDLKPQNILVTSSGQIKLADFGLARIYSFQ-----MALTSVVVTLWYRAPEVLLQSS-YATPVDL  198 (305)
T ss_dssp             HHHHHHHHHHTTCCCCCCCGGGEEECTTCCEEECSCCSCCCCCGG-----GGGCCCCCCCTTCCHHHHTTCC-CCTHHHH
T ss_pred             HHHHHHHHHhCCEEecCCCccEEEEcCCCCeeecchhhhhhhccc-----ccCCCcccChhhcCcchhcCCC-CChhehh
Confidence            999999999999999999999999999999999999998765432     2345678999999999998765 8999999


Q ss_pred             hhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHH
Q psy7889         160 WGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLL  239 (433)
Q Consensus       160 wSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li  239 (433)
                      ||+||++|||++|.+||.+.+..+.+..|....|.+....|+................   ...  -.....++.+++||
T Consensus       199 wSlG~il~ell~g~~pf~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~--~~~~~~s~~~~dli  273 (305)
T d1blxa_         199 WSVGCIFAEMFRRKPLFRGSSDVDQLGKILDVIGLPGEEDWPRDVALPRQAFHSKSAQ---PIE--KFVTDIDELGKDLL  273 (305)
T ss_dssp             HHHHHHHHHHHHSSCSCCCSSHHHHHHHHHHHHCCCCGGGSCTTCSSCGGGSCCCCCC---CGG--GTCCSCCHHHHHHH
T ss_pred             hchHHHHHHHHHCCCCCCCCCHHHHHHHHHHhhCCCchhcccccccchhhhhcccccc---chh--hccccCCHHHHHHH
Confidence            9999999999999999999999999999999999887777655433222111111000   000  01123678899999


Q ss_pred             HhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         240 DKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       240 ~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      .+||++||++|||++|+|+||||++-
T Consensus       274 ~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         274 LKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             HHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             HHHCcCChhHCcCHHHHhcChhhcCc
Confidence            99999999999999999999999753

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=5.2e-47  Score=359.80  Aligned_cols=210  Identities=23%  Similarity=0.358  Sum_probs=180.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+++|+.+|+.++|||||++++++.+.        +.+|+|||||.| ++...+.. ...+++..++.++.||+.||+
T Consensus        48 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~ivmE~~~gg~l~~~~~~-~~~~~~~~~~~~~~qi~~al~  118 (316)
T d1fota_          48 VEHTNDERLMLSIVTHPFIIRMWGTFQDA--------QQIFMIMDYIEGGELFSLLRK-SQRFPNPVAKFYAAEVCLALE  118 (316)
T ss_dssp             HHHHHHHHHHHHSCCBTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHH-TSSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCcChhheeeeEeeC--------CeeeeEeeecCCccccccccc-cccccccHHHHHHHHHHHhhh
Confidence            45688999999999999999999999876        679999999986 45555544 557899999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+.....       ....+||+.|+|||++.+.. |+.++|||||||+
T Consensus       119 ~lH~~~iiHrDiKp~NILl~~~g~vkL~DFG~a~~~~~~-------~~~~~Gt~~Y~APE~l~~~~-y~~~~DiwSlGvi  190 (316)
T d1fota_         119 YLHSKDIIYRDLKPENILLDKNGHIKITDFGFAKYVPDV-------TYTLCGTPDYIAPEVVSTKP-YNKSIDWWSFGIL  190 (316)
T ss_dssp             HHHTTTEECCCCCGGGEEECTTSCEEECCCSSCEECSSC-------BCCCCSCTTTCCHHHHTTCC-BCTTHHHHHHHHH
T ss_pred             hhccCcEEccccCchheeEcCCCCEEEecCccceEeccc-------cccccCcccccCHHHHcCCC-CCchhhccccchh
Confidence            999999999999999999999999999999999876532       24568999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+..+....+.......                                +...+++++++|.+||..
T Consensus       191 lyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~  238 (316)
T d1fota_         191 IYEMLAGYTPFYDSNTMKTYEKILNAELRF--------------------------------PPFFNEDVKDLLSRLITR  238 (316)
T ss_dssp             HHHHHHSSCTTCCSSHHHHHHHHHHCCCCC--------------------------------CTTSCHHHHHHHHHHTCS
T ss_pred             HHHHHhCCCCCCCcCHHHHHHHHHcCCCCC--------------------------------CCCCCHHHHHHHHHHhhh
Confidence            999999999999998888777765422111                                112567788999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||.+|+     |++++|+||||++.
T Consensus       239 dp~~R~~~~r~t~~~il~Hp~f~~i  263 (316)
T d1fota_         239 DLSQRLGNLQNGTEDVKNHPWFKEV  263 (316)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGSSC
T ss_pred             CHHhccccchhhHHHHHcCcccccC
Confidence            999996     99999999999663

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-47  Score=357.19  Aligned_cols=216  Identities=25%  Similarity=0.440  Sum_probs=182.2

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+.+|+.+|++++|||||+++++|.+.        +.+|||||||+ ++|.+++.+. ..+++..++.++.||+.||+
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~iv~E~~~gg~L~~~i~~~-~~l~~~~~~~~~~qi~~al~  127 (293)
T d1jksa_          57 REDIEREVSILKEIQHPNVITLHEVYENK--------TDVILILELVAGGELFDFLAEK-ESLTEEEATEFLKQILNGVY  127 (293)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEECS--------SEEEEEEECCCSCBHHHHHHHH-SSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCcEEEEEEEC--------CEEEEEEEcCCCccccchhccc-cccchhHHHHHHHHHHHHHH
Confidence            35689999999999999999999999886        66999999998 5888888764 47999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC----cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG----ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWG  161 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~----~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwS  161 (433)
                      |||++||+||||||+|||++.++    .+||+|||++.......     ......||+.|+|||++.+.. ++.++||||
T Consensus       128 yLH~~~ivHrDiKp~Nill~~~~~~~~~vkl~DfG~a~~~~~~~-----~~~~~~~t~~y~APE~~~~~~-~~~~~DiwS  201 (293)
T d1jksa_         128 YLHSLQIAHFDLKPENIMLLDRNVPKPRIKIIDFGLAHKIDFGN-----EFKNIFGTPEFVAPEIVNYEP-LGLEADMWS  201 (293)
T ss_dssp             HHHHTTEECCCCSGGGEEESCSSSSSCCEEECCCTTCEECTTSC-----BCSCCCCCGGGCCHHHHTTCC-BCTHHHHHH
T ss_pred             hhhhcceeecccccceEEEecCCCcccceEecchhhhhhcCCCc-----cccccCCCCcccCHHHHcCCC-CCCcccchh
Confidence            99999999999999999998776    59999999998765332     234567899999999998765 799999999


Q ss_pred             HHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         162 AGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       162 lGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      +||++|+|++|.+||.+.+..+.+..+.......+                   ...         +...|.++++||.+
T Consensus       202 lGvilyell~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------~~~---------~~~~s~~~~~li~~  253 (293)
T d1jksa_         202 IGVITYILLSGASPFLGDTKQETLANVSAVNYEFE-------------------DEY---------FSNTSALAKDFIRR  253 (293)
T ss_dssp             HHHHHHHHHHSSCSSCCSSHHHHHHHHHTTCCCCC-------------------HHH---------HTTSCHHHHHHHHT
T ss_pred             hhHHHHHHHcCCCCCCCCCHHHHHHHHHhcCCCCC-------------------chh---------cCCCCHHHHHHHHH
Confidence            99999999999999999998887776654221110                   000         01257788999999


Q ss_pred             hcccCCCCCCCHHHhhcCCCccCC
Q psy7889         242 LLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      ||+.||.+|||++|+|+||||+..
T Consensus       254 ~L~~dP~~R~s~~eil~hp~~~~~  277 (293)
T d1jksa_         254 LLVKDPKKRMTIQDSLQHPWIKPK  277 (293)
T ss_dssp             TSCSSGGGSCCHHHHHHSTTTCC-
T ss_pred             HccCChhHCcCHHHHhcCcccCCC
Confidence            999999999999999999999753

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.8e-46  Score=360.81  Aligned_cols=210  Identities=27%  Similarity=0.367  Sum_probs=181.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      .+.+++|+.+|+.++|||||++++++.+.        ..+|+||||+.+ +|...+.+. ..+++..++.++.||+.||.
T Consensus        85 ~~~~~~E~~il~~l~hpnIv~~~~~~~~~--------~~~~~v~e~~~~g~l~~~l~~~-~~l~e~~~~~i~~qi~~aL~  155 (350)
T d1rdqe_          85 IEHTLNEKRILQAVNFPFLVKLEFSFKDN--------SNLYMVMEYVAGGEMFSHLRRI-GRFSEPHARFYAAQIVLTFE  155 (350)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHHH-CCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHcCCCcEeecccccccc--------cccccccccccccchhhhHhhc-CCCCHHHHHHHHHHHHHHHH
Confidence            35688999999999999999999999876        669999999975 677777653 47999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+|+.....       ....+||+.|+|||++.+.. |+.++|||||||+
T Consensus       156 yLH~~~iiHRDIKP~NILl~~~g~ikL~DFG~a~~~~~~-------~~~~~Gt~~Y~APE~~~~~~-~~~~~DiwSlGvi  227 (350)
T d1rdqe_         156 YLHSLDLIYRDLKPENLLIDQQGYIQVTDFGFAKRVKGR-------TWTLCGTPEALAPEIILSKG-YNKAVDWWALGVL  227 (350)
T ss_dssp             HHHHTTEECCCCSGGGEEECTTSCEEECCCTTCEECSSC-------BCCCEECGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             HHHhCCEecCcCCHHHcccCCCCCEEeeeceeeeecccc-------cccccCccccCCHHHHcCCC-CCccccccchhHH
Confidence            999999999999999999999999999999999876532       34568999999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|.+||.+.+.......|.......                                +...++++.+||.+||..
T Consensus       228 lyemltG~~Pf~~~~~~~~~~~i~~~~~~~--------------------------------p~~~s~~~~~li~~~L~~  275 (350)
T d1rdqe_         228 IYEMAAGYPPFFADQPIQIYEKIVSGKVRF--------------------------------PSHFSSDLKDLLRNLLQV  275 (350)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHHCCCCC--------------------------------CTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCcCHHHHHHHHhcCCCCC--------------------------------CccCCHHHHHHHHHHhhh
Confidence            999999999999998888777775422111                                112567888999999999


Q ss_pred             CCCCCC-----CHHHhhcCCCccCC
Q psy7889         246 DPSKRF-----DSDAALNHDFFWTD  265 (433)
Q Consensus       246 dP~~R~-----t~~e~L~h~~~~~~  265 (433)
                      ||.+|+     |++++++||||+..
T Consensus       276 dP~kR~~~~r~t~~ell~Hp~f~~~  300 (350)
T d1rdqe_         276 DLTKRFGNLKNGVNDIKNHKWFATT  300 (350)
T ss_dssp             CTTTCTTSSTTTTHHHHTSGGGTTC
T ss_pred             CHHhccccccccHHHHHcCccccCC
Confidence            999995     99999999999654

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=100.00  E-value=4.1e-46  Score=346.99  Aligned_cols=215  Identities=28%  Similarity=0.478  Sum_probs=183.0

Q ss_pred             hhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      +.+++|+.+|++++ |||||++++++.+.        +.+|||||||+ ++|.+++.. +..+++..++.++.||+.||+
T Consensus        54 ~~~~~E~~~l~~l~~hpnIv~~~~~~~~~--------~~~~ivmE~~~~g~L~~~l~~-~~~l~e~~~~~~~~qi~~al~  124 (277)
T d1phka_          54 EATLKEVDILRKVSGHPNIIQLKDTYETN--------TFFFLVFDLMKKGELFDYLTE-KVTLSEKETRKIMRALLEVIC  124 (277)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeEEEEeecccC--------cceEEEEEcCCCchHHHHHHh-cCCCCHHHHHHHHHHHHHHHH
Confidence            36889999999997 99999999999876        67999999997 589999876 447999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC-----CCCCCCcchhh
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG-----DRNYGPPVDLW  160 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~-----~~~~~~~~Diw  160 (433)
                      |||++||+||||||+|||++.++.+||+|||++.......     .....+||..|+|||++.+     ...++.++|||
T Consensus       125 ~lH~~~ivHrDlkp~Nill~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~~PE~~~~~~~~~~~~~~~~~Diw  199 (277)
T d1phka_         125 ALHKLNIVHRDLKPENILLDDDMNIKLTDFGFSCQLDPGE-----KLREVCGTPSYLAPEIIECSMNDNHPGYGKEVDMW  199 (277)
T ss_dssp             HHHHTTEECSCCSGGGEEECTTCCEEECCCTTCEECCTTC-----CBCCCCSCGGGCCHHHHHHHHCTTSCCBCTHHHHH
T ss_pred             HHHHcCCcccccccceEEEcCCCCeEEccchheeEccCCC-----ceeeeeccCCCCCHHHhhccccccCCCCCchheEc
Confidence            9999999999999999999999999999999998875432     2345678999999999853     33478899999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      |+||++|+|++|.+||.+.+..+....+.......+...                            ....|+++++||.
T Consensus       200 slGvilyeml~g~~Pf~~~~~~~~~~~i~~~~~~~~~~~----------------------------~~~~s~~~~~li~  251 (277)
T d1phka_         200 STGVIMYTLLAGSPPFWHRKQMLMLRMIMSGNYQFGSPE----------------------------WDDYSDTVKDLVS  251 (277)
T ss_dssp             HHHHHHHHHHHSSCSSCCSSHHHHHHHHHHTCCCCCTTT----------------------------GGGSCHHHHHHHH
T ss_pred             ccchhhhhhccCCCCCCCCCHHHHHHHHHhCCCCCCCcc----------------------------cccCCHHHHHHHH
Confidence            999999999999999999998887777655322111110                            1136788999999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      +||+.||++|||++|+|+||||++
T Consensus       252 ~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         252 RFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             HHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             HHccCChhHCcCHHHHHcCHHHHH
Confidence            999999999999999999999964

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.2e-46  Score=356.39  Aligned_cols=216  Identities=22%  Similarity=0.382  Sum_probs=183.5

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+.+|+++|+.++|||||+++++|.++        +.+|||||||.| +|.+++......+++.+++.++.||+.||+
T Consensus        45 ~~~~~~Ei~il~~l~HpnIv~~~~~~~~~--------~~~~lvmE~~~gg~L~~~i~~~~~~l~e~~~~~i~~qi~~al~  116 (321)
T d1tkia_          45 QVLVKKEISILNIARHRNILHLHESFESM--------EELVMIFEFISGLDIFERINTSAFELNEREIVSYVHQVCEALQ  116 (321)
T ss_dssp             HHHHHHHHHHHHHSCCTTBCCEEEEEEET--------TEEEEEECCCCCCBHHHHHTSSSCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCCCeEEEEEEEC--------CEEEEEEecCCCCcHHHHHHhcCCCCCHHHHHHHHHHHHHHHH
Confidence            34678999999999999999999999986        669999999985 899998876667999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecC--CcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKT--GILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAG  163 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~--~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlG  163 (433)
                      |||++||+||||||+|||++.+  +.+||+|||++.......     .....++|+.|+|||++.+.. |+.++||||+|
T Consensus       117 yLH~~~iiHrDlKp~NIll~~~~~~~ikl~DFG~~~~~~~~~-----~~~~~~~t~~y~ape~~~~~~-~~~~~DiWSlG  190 (321)
T d1tkia_         117 FLHSHNIGHFDIRPENIIYQTRRSSTIKIIEFGQARQLKPGD-----NFRLLFTAPEYYAPEVHQHDV-VSTATDMWSLG  190 (321)
T ss_dssp             HHHHTTEECCCCCGGGEEESSSSCCCEEECCCTTCEECCTTC-----EEEEEESCGGGSCHHHHTTCE-ECHHHHHHHHH
T ss_pred             HHHHcCCCcccccccceeecCCCceEEEEcccchhhccccCC-----cccccccccccccchhccCCC-CCchhhcccHH
Confidence            9999999999999999999854  489999999998764321     234457799999999987765 79999999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....|.......+...|                            ...|+++++||.+||
T Consensus       191 vily~ll~G~~Pf~~~~~~~~~~~i~~~~~~~~~~~~----------------------------~~~s~~~~~li~~~L  242 (321)
T d1tkia_         191 TLVYVLLSGINPFLAETNQQIIENIMNAEYTFDEEAF----------------------------KEISIEAMDFVDRLL  242 (321)
T ss_dssp             HHHHHHHHSSCTTCCSSHHHHHHHHHHTCCCCCHHHH----------------------------TTSCHHHHHHHHTTS
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHhCCCCCChhhc----------------------------cCCCHHHHHHHHHHc
Confidence            9999999999999999988888777653221111000                            125778889999999


Q ss_pred             ccCCCCCCCHHHhhcCCCccC
Q psy7889         244 LLDPSKRFDSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h~~~~~  264 (433)
                      ..||.+|||++|+|+||||.+
T Consensus       243 ~~dp~~R~s~~eil~hp~~~~  263 (321)
T d1tkia_         243 VKERKSRMTASEALQHPWLKQ  263 (321)
T ss_dssp             CSSGGGSCCHHHHHHSHHHHS
T ss_pred             cCChhHCcCHHHHhcCHhhcc
Confidence            999999999999999999964

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.9e-46  Score=357.86  Aligned_cols=247  Identities=27%  Similarity=0.458  Sum_probs=193.0

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHh---ccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLS---NIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~---~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+|+++|++++|||||+++++|.....  .....++|||||||++++...+.   .....+++.+++.++.||+.||+
T Consensus        59 ~~~~Ei~il~~l~h~niv~~~~~~~~~~~--~~~~~~~~lv~Ey~~~~~~~~l~~~~~~~~~l~~~~~~~i~~qil~aL~  136 (350)
T d1q5ka_          59 FKNRELQIMRKLDHCNIVRLRYFFYSSGE--KKDEVYLNLVLDYVPETVYRVARHYSRAKQTLPVIYVKLYMYQLFRSLA  136 (350)
T ss_dssp             SCCHHHHHHHHCCCTTBCCEEEEEEEC----CCSCCEEEEEEECCSEEHHHHHHHHHHTTCCCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHhcCCCCCCcEEEEEEecCc--cCCceEEEEEEeccCCccHHHHHhhhhccCCCCHHHHHHHHHHHHHHHH
Confidence            34589999999999999999999976532  11246789999999988766654   23556999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      |||++||+||||||+|||++.++ .+||+|||++.......     .....+||..|+|||++.+...|+.++||||+||
T Consensus       137 yLH~~~IiHrDiKp~NILl~~~~~~~kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~~~~~~~DIwSlG~  211 (350)
T d1q5ka_         137 YIHSFGICHRDIKPQNLLLDPDTAVLKLCDFGSAKQLVRGE-----PNVSYICSRYYRAPELIFGATDYTSSIDVWSAGC  211 (350)
T ss_dssp             HHHTTTEECCCCCGGGEEECTTTCCEEECCCTTCEECCTTS-----CCCSCCSCTTSCCHHHHTTCSSCCTHHHHHHHHH
T ss_pred             HHHhcCCcccCCCcceEEEecCCCceeEecccchhhccCCc-----ccccccccccccChHHhhcccCCCcceeecccce
Confidence            99999999999999999999775 89999999998765332     3345688999999999887777899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|.+||.+.+..+++..|.+.+|.+..+.|......  +.....+........ .......++++++||.+||.
T Consensus       212 il~el~~g~~pf~~~~~~~~l~~i~~~~g~~~~~~~~~~~~~--~~~~~~~~~~~~~~~-~~~~~~~s~~~~dLl~~mL~  288 (350)
T d1q5ka_         212 VLAELLLGQPIFPGDSGVDQLVEIIKVLGTPTREQIREMNPN--YTEFKFPQIKAHPWT-KVFRPRTPPEAIALCSRLLE  288 (350)
T ss_dssp             HHHHHHHTSCSSCCSSHHHHHHHHHHHHCCCCHHHHHHHCC-----CCCCCCCCCCCGG-GTSCTTSCHHHHHHHHHHSC
T ss_pred             EEEehhhCCCCCCCCCHHHHHHHHHHHhCCChHHhhhhhccc--hhhccccccccCchh-hhcccCCCHHHHHHHHHHcc
Confidence            999999999999999999999999999888765433221111  001111111000000 11122367889999999999


Q ss_pred             cCCCCCCCHHHhhcCCCccCC
Q psy7889         245 LDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||.+|||+.|+|+||||.+.
T Consensus       289 ~dP~~R~ta~e~L~Hp~f~~~  309 (350)
T d1q5ka_         289 YTPTARLTPLEACAHSFFDEL  309 (350)
T ss_dssp             SSGGGSCCHHHHHTSGGGGGG
T ss_pred             CChhHCcCHHHHhcCHhhccc
Confidence            999999999999999999653

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6e-46  Score=357.93  Aligned_cols=247  Identities=34%  Similarity=0.571  Sum_probs=196.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      .+.+++|+++|+.++|||||+++++|.....  .....++|+|||||+.+|......  ..+++..++.++.||+.||+|
T Consensus        61 ~~~~~~Ei~il~~l~hpniv~l~~~~~~~~~--~~~~~~~~lv~e~~~~~l~~~~~~--~~l~~~~~~~~~~qi~~aL~~  136 (346)
T d1cm8a_          61 AKRAYRELRLLKHMRHENVIGLLDVFTPDET--LDDFTDFYLVMPFMGTDLGKLMKH--EKLGEDRIQFLVYQMLKGLRY  136 (346)
T ss_dssp             HHHHHHHHHHHHHCCBTTBCCCSEEECSCSS--TTTCCCCEEEEECCSEEHHHHHHH--CCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCeeEEEEEeccCcc--ccccceEEEEEecccccHHHHHHh--ccccHHHHHHHHHHHHHHHHH
Confidence            3568899999999999999999999987632  112456899999998888877654  369999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+|.....       ......||+.|+|||++.+...++.++||||+||++
T Consensus       137 LH~~~IiHrDiKp~NIL~~~~~~~kl~Dfg~a~~~~~-------~~~~~~~t~~y~aPE~~~~~~~~~~~~DiwSlGvil  209 (346)
T d1cm8a_         137 IHAAGIIHRDLKPGNLAVNEDCELKILDFGLARQADS-------EMTGYVVTRWYRAPEVILNWMRYTQTVDIWSVGCIM  209 (346)
T ss_dssp             HHHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCS-------SCCSSCSCGGGCCTHHHHTTTCCCTTHHHHHHHHHH
T ss_pred             HHhCCCcccccCcchhhcccccccccccccceeccCC-------ccccccccccccCHHHHcCCCCCCccchhhcchHHH
Confidence            9999999999999999999999999999999987643       234567899999999998876689999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhcc-ccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKM-ELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|.+||.+.+..+.+..+....+.++.+.+............ ..+..........  ....++++++||.+||.+
T Consensus       210 ~ell~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~  287 (346)
T d1cm8a_         210 AEMITGKTLFKGSDHLDQLKEIMKVTGTPPAEFVQRLQSDEAKNYMKGLPELEKKDFASI--LTNASPLAVNLLEKMLVL  287 (346)
T ss_dssp             HHHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHHTCSCHHHHHHHHHSCCCCCCCGGGT--CTTCCHHHHHHHHHHSCS
T ss_pred             HHHHHCcCCCCCCChHHHHHHHHhccCCCcHHHHhhhcchhhhhhhccCCcccccchHHh--ccCCCHHHHHHHHHHCcC
Confidence            9999999999999999999999998888765433222211110000 0000000000100  113578899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||++|||++|+|+||||++..
T Consensus       288 dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         288 DAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             STTTSCCHHHHHHSGGGTTTC
T ss_pred             ChhHCcCHHHHhcChhhCcCC
Confidence            999999999999999997643

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=100.00  E-value=2.2e-45  Score=355.10  Aligned_cols=213  Identities=23%  Similarity=0.328  Sum_probs=173.9

Q ss_pred             hHHHH---HHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           9 TALRE---IKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         9 ~~~~E---i~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+++|   +.+++.++|||||+++++|.+.        +.+|||||||. ++|..++.+. ..+++..++.++.||+.||
T Consensus        50 ~~~~e~~~~~~l~~~~hpnIv~l~~~~~~~--------~~~~ivmE~~~gg~L~~~l~~~-~~~~e~~~~~~~~qi~~aL  120 (364)
T d1omwa3          50 LALNERIMLSLVSTGDCPFIVCMSYAFHTP--------DKLSFILDLMNGGDLHYHLSQH-GVFSEADMRFYAAEIILGL  120 (364)
T ss_dssp             HHHHHHHHHHHHSSSCCTTBCCEEEEEECS--------SEEEEEECCCCSCBHHHHHHHH-CSCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCCCCcEEEEEEEEEEC--------CEEEEEEEecCCCcHHHHHHhc-ccccHHHHHHHHHHHHHHH
Confidence            34455   6667777899999999999886        66999999998 5888888663 4689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+|+.+...      .....+||+.|+|||++.+...|+.++|||||||
T Consensus       121 ~ylH~~~iiHrDlKP~NILl~~~g~iKl~DFGla~~~~~~------~~~~~~GT~~y~APE~~~~~~~~~~~~DiwSlGv  194 (364)
T d1omwa3         121 EHMHNRFVVYRDLKPANILLDEHGHVRISDLGLACDFSKK------KPHASVGTHGYMAPEVLQKGVAYDSSADWFSLGC  194 (364)
T ss_dssp             HHHHHTTEECCCCSGGGEEECSSSCEEECCCTTCEECSSS------CCCSCCSCGGGCCHHHHSTTCCCCTHHHHHHHHH
T ss_pred             HHHHHCCccceeeccceeEEcCCCcEEEeeeceeeecCCC------cccccccccccchhHHhhcCCCCCcccchhHHHH
Confidence            9999999999999999999999999999999999876532      2345689999999999976666899999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|+|++|.+||.+....+....+..... ....                            .+...++++++||.+||+
T Consensus       195 ilyemltG~~Pf~~~~~~~~~~~~~~~~~-~~~~----------------------------~~~~~s~~~~~li~~~L~  245 (364)
T d1omwa3         195 MLFKLLRGHSPFRQHKTKDKHEIDRMTLT-MAVE----------------------------LPDSFSPELRSLLEGLLQ  245 (364)
T ss_dssp             HHHHHHHSSCSSCSSCSSCHHHHHHHSSS-CCCC----------------------------CCSSSCHHHHHHHHHHTC
T ss_pred             HHHHHHhCCCCCCCCCHHHHHHHHHhccc-CCCC----------------------------CCCCCCHHHHHHHHHHcc
Confidence            99999999999987654333222222111 1111                            012357788999999999


Q ss_pred             cCCCCCCC-----HHHhhcCCCccCC
Q psy7889         245 LDPSKRFD-----SDAALNHDFFWTD  265 (433)
Q Consensus       245 ~dP~~R~t-----~~e~L~h~~~~~~  265 (433)
                      .||.+|||     ++|+++||||+..
T Consensus       246 ~dP~~R~t~~~~~a~eil~Hp~f~~i  271 (364)
T d1omwa3         246 RDVNRRLGCLGRGAQEVKESPFFRSL  271 (364)
T ss_dssp             SSTTTSTTTSSSTHHHHHTSGGGTTC
T ss_pred             cCHHHhCCCcccCHHHHHcCccccCC
Confidence            99999999     7999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.1e-45  Score=353.35  Aligned_cols=225  Identities=23%  Similarity=0.364  Sum_probs=175.7

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~a   83 (433)
                      ...+.+|++++.++ +|||||+++++|.+...    ....+|||||||+ |+|.+++.+.. ..+++.+++.++.||+.|
T Consensus        48 ~~~~~~E~~~~~~~~~hpnIv~l~~~~~~~~~----~~~~~~ivmEy~~gg~L~~~i~~~~~~~l~e~~~~~i~~qi~~a  123 (335)
T d2ozaa1          48 CPKARREVELHWRASQCPHIVRIVDVYENLYA----GRKCLLIVMECLDGGELFSRIQDRGDQAFTEREASEIMKSIGEA  123 (335)
T ss_dssp             SHHHHHHHHHHHHHTTSTTBCCEEEEEEEEET----TEEEEEEEEECCCSEEHHHHHHSCSCCCEEHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCCCeEEEEEeeccc----CCCEEEEEEECCCCCcHHHHHHhcCCCCcCHHHHHHHHHHHHHH
Confidence            35688999997655 89999999999976311    1367999999997 59999997653 469999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      |+|||++||+||||||+|||++.   .+.+||+|||+|+......     .....+||+.|+|||++.+.. |+.++|||
T Consensus       124 l~ylH~~~iiHRDiKp~NIll~~~~~~~~~Kl~DFG~a~~~~~~~-----~~~~~~gt~~y~aPE~~~~~~-y~~~~Diw  197 (335)
T d2ozaa1         124 IQYLHSINIAHRDVKPENLLYTSKRPNAILKLTDFGFAKETTSHN-----SLTTPCYTPYYVAPEVLGPEK-YDKSCDMW  197 (335)
T ss_dssp             HHHHHHTTEECCCCSGGGEEESCSSTTCCEEECCCTTCEECCCCC-----CCCCCSCCCSSCCCCCCCGGG-GSHHHHHH
T ss_pred             HHHHHHcCCccccccccccccccccccccccccccceeeeccCCC-----ccccccCCcccCCcHHHcCCC-CCHHHHHH
Confidence            99999999999999999999985   5679999999998765332     234568999999999997765 89999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|+|++|.+||.+.+.......+......               ....++....         ...|+++++||.
T Consensus       198 SlGvily~lltg~~Pf~~~~~~~~~~~~~~~i~~---------------~~~~~~~~~~---------~~~s~~~~~li~  253 (335)
T d2ozaa1         198 SLGVIMYILLCGYPPFYSNHGLAISPGMKTRIRM---------------GQYEFPNPEW---------SEVSEEVKMLIR  253 (335)
T ss_dssp             HHHHHHHHHTTSSCSCEETTCC--------CCCS---------------CSSSCCTTHH---------HHSCHHHHHHHH
T ss_pred             hhchhHHHHhhCCCCCCCCCHHHHHHHHHHHHhc---------------CCCCCCCccc---------ccCCHHHHHHHH
Confidence            9999999999999999887655443333221110               0011111110         125788999999


Q ss_pred             hhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         241 KLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      +||+.||++|||++|+|+||||.+.
T Consensus       254 ~~L~~dP~~R~s~~eil~hp~~~~~  278 (335)
T d2ozaa1         254 NLLKTEPTQRMTITEFMNHPWIMQS  278 (335)
T ss_dssp             HHSCSSTTTSCCHHHHHHSHHHHTT
T ss_pred             HHccCChhHCcCHHHHHcCHHhhCC
Confidence            9999999999999999999999654

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.9e-45  Score=346.17  Aligned_cols=211  Identities=27%  Similarity=0.446  Sum_probs=179.5

Q ss_pred             hhHHHHHHHHH-hCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQ-LLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         8 ~~~~~Ei~il~-~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ..+++|+.++. .++|||||++++++.++        +.+|||||||.+ +|..++.. ...+++.+++.++.||+.||+
T Consensus        47 ~~~~~e~~~l~~~~~hp~Iv~~~~~~~~~--------~~~yivmEy~~~g~L~~~i~~-~~~~~e~~~~~~~~qi~~al~  117 (320)
T d1xjda_          47 ECTMVEKRVLSLAWEHPFLTHMFCTFQTK--------ENLFFVMEYLNGGDLMYHIQS-CHKFDLSRATFYAAEIILGLQ  117 (320)
T ss_dssp             HHHHHHHHHHHHHTTCTTBCCEEEEEECS--------SEEEEEEECCTTCBHHHHHHH-HSSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCcEEEEEEEEccC--------CceeEEEeecCCCcHHHHhhc-cCCCCHHHHHHHHHHHHHHHH
Confidence            45677888776 68999999999999986        669999999985 88888765 447999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.+|.+||+|||+++......    ......+||+.|+|||++.+.. |+.++||||+||+
T Consensus       118 ylH~~~iiHrDikp~NiL~~~~~~~kl~DFG~a~~~~~~~----~~~~~~~gt~~y~aPE~~~~~~-~~~~~DiwSlGvi  192 (320)
T d1xjda_         118 FLHSKGIVYRDLKLDNILLDKDGHIKIADFGMCKENMLGD----AKTNTFCGTPDYIAPEILLGQK-YNHSVDWWSFGVL  192 (320)
T ss_dssp             HHHHTTCBCCCCCGGGEEECTTSCEEECCCTTCBCCCCTT----CCBCCCCSCGGGCCHHHHTTCC-BCTHHHHHHHHHH
T ss_pred             HHHhCCeeeccCcccceeecCCCceeccccchhhhccccc----ccccccCCCCCcCCHHHHcCCC-CCchhhhhhhhHH
Confidence            9999999999999999999999999999999998764322    2334568899999999998765 7999999999999


Q ss_pred             HHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         166 MAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       166 l~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      +|+|++|..||.+.+..+....+..  +.+..                              +...|+++.+||.+||..
T Consensus       193 lyemltG~~PF~~~~~~~~~~~i~~--~~~~~------------------------------p~~~s~~~~dli~~~L~~  240 (320)
T d1xjda_         193 LYEMLIGQSPFHGQDEEELFHSIRM--DNPFY------------------------------PRWLEKEAKDLLVKLFVR  240 (320)
T ss_dssp             HHHHHHSSCSSCCSSHHHHHHHHHH--CCCCC------------------------------CTTSCHHHHHHHHHHSCS
T ss_pred             HHHHHhCCCCCCCCCHHHHHHHHHc--CCCCC------------------------------CccCCHHHHHHHHHhccc
Confidence            9999999999999998887776643  21110                              112577888999999999


Q ss_pred             CCCCCCCHH-HhhcCCCccC
Q psy7889         246 DPSKRFDSD-AALNHDFFWT  264 (433)
Q Consensus       246 dP~~R~t~~-e~L~h~~~~~  264 (433)
                      ||.+|||+. ++++||||++
T Consensus       241 dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         241 EPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             SGGGSBTTBSCGGGSGGGTT
T ss_pred             CCCCCcCHHHHHHhCchhcc
Confidence            999999996 8999999965

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2.6e-44  Score=338.32  Aligned_cols=245  Identities=38%  Similarity=0.661  Sum_probs=200.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..++++|+.+|+.++|||||++++++.+.        ..+++|++++.++....+......+++..++.++.|++.||+|
T Consensus        45 ~~~~~~E~~il~~l~h~niv~~~~~~~~~--------~~~~iv~~~~~~~~l~~~~~~~~~~~~~~~~~~~~q~~~aL~~  116 (292)
T d1unla_          45 PSSALREICLLKELKHKNIVRLHDVLHSD--------KKLTLVFEFCDQDLKKYFDSCNGDLDPEIVKSFLFQLLKGLGF  116 (292)
T ss_dssp             HHHHHHHHHHHTTCCCTTBCCEEEEEECS--------SEEEEEEECCSEEHHHHHHHTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcCcCCEEeeccccccc--------cceeEEeeeccccccccccccccccchhHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999886        6689999999987666666667789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||.+.......    .......++..|+|||++.+...++.++||||+||++
T Consensus       117 lH~~~IvHrDiKP~NIli~~~~~~kl~DFG~a~~~~~~~----~~~~~~~~~~~~~~pe~~~~~~~~~~~~DiwSlG~il  192 (292)
T d1unla_         117 CHSRNVLHRDLKPQNLLINRNGELKLANFGLARAFGIPV----RCYSAEVVTLWYRPPDVLFGAKLYSTSIDMWSAGCIF  192 (292)
T ss_dssp             HHHTTEECCCCSGGGEEECTTCCEEECCCTTCEECCSCC----SCCCSCCSCGGGCCHHHHTTCSCCCTHHHHHHHHHHH
T ss_pred             hhcCCEeeecccCcccccccCCceeeeecchhhcccCCC----ccceeeccccchhhhhHhccCCCCCchhhccccchHH
Confidence            999999999999999999999999999999998765432    1233446688999999998777679999999999999


Q ss_pred             HHHHhcCCC-CCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPI-MQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~p-f~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |+|++|..| |.+.+..+.+..+....+.+....|+..................   .........++.+++||.+||+.
T Consensus       193 ~ell~g~~p~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~---~~~~~~~~~s~~~~dll~~mL~~  269 (292)
T d1unla_         193 AELANAGRPLFPGNDVDDQLKRIFRLLGTPTEEQWPSMTKLPDYKPYPMYPATT---SLVNVVPKLNATGRDLLQNLLKC  269 (292)
T ss_dssp             HHHTTTSCCSCCCSSHHHHHHHHHHHHCCCCTTTCTTGGGSTTCCCCCCCCTTC---CCTTTSTTCCHHHHHHHHHHSCS
T ss_pred             HHHhhCCCCCCCCCCHHHHHHHHHhhcCCCChhhhhhhhhcccccccccccccc---hhhhccccCCHHHHHHHHHHccC
Confidence            999998755 77888888899999999998888777665443332222211111   11111224678899999999999


Q ss_pred             CCCCCCCHHHhhcCCCccCCC
Q psy7889         246 DPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       246 dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+|||++|+|+||||++-.
T Consensus       270 dP~~R~sa~e~L~Hp~f~~~~  290 (292)
T d1unla_         270 NPVQRISAEEALQHPYFSDFC  290 (292)
T ss_dssp             SGGGSCCHHHHTTSGGGSSCS
T ss_pred             ChhHCcCHHHHhcChhhcCCC
Confidence            999999999999999997643

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=347.73  Aligned_cols=251  Identities=35%  Similarity=0.566  Sum_probs=193.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+++|+.++|||||++++++.....   .....+|+++++++++|.+++...  .+++..++.++.||+.||+||
T Consensus        51 ~~~~~Ei~il~~l~hp~iv~~~~~~~~~~~---~~~~~~~l~~~~~~g~L~~~l~~~--~l~~~~i~~i~~qil~al~yL  125 (345)
T d1pmea_          51 QRTLREIKILLRFRHENIIGINDIIRAPTI---EQMKDVYLVTHLMGADLYKLLKTQ--HLSNDHICYFLYQILRGLKYI  125 (345)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCCEEECCSST---TTCCCEEEEEECCCEEHHHHHHHC--CCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHcCCCCCCcEEEEEeeccc---cccceEEEEEeecCCchhhhhhcC--CCCHHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999976522   223557888888889999998653  699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+||+|||++........ ........+||+.|+|||++.....++.++||||+||++|
T Consensus       126 H~~~iiHRDIKp~NILl~~~~~~kl~DfG~a~~~~~~~~-~~~~~~~~~gt~~y~aPE~l~~~~~~~~~~DiwSlG~il~  204 (345)
T d1pmea_         126 HSANVLHRDLKPSNLLLNTTCDLKICDFGLARVADPDHD-HTGFLTEYVATRWYRAPEIMLNSKGYTKSIDIWSVGCILA  204 (345)
T ss_dssp             HHTTEECCCCCGGGEEECTTCCEEECCCTTCEECCGGGC-BCCTTCCCCSCGGGCCGGGTTTBCSCSTHHHHHHHHHHHH
T ss_pred             HHCCCcCCCCCcceEEECCCCCEEEcccCceeeccCCCc-cceeeccccccceechHHHhhcCCCCCchhhhhccCceeh
Confidence            999999999999999999999999999999987654322 1223455678999999999977767899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhh-ccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYN-KMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+..+....+....+.+............... ....+...........  ...|+++++||.+||+.|
T Consensus       205 eml~g~~pf~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~s~~~~~li~~~L~~d  282 (345)
T d1pmea_         205 EMLSNRPIFPGKHYLDQLNHILGILGSPSQEDLNCIINLKARNYLLSLPHKNKVPWNRLF--PNADSKALDLLDKMLTFN  282 (345)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCSCCHHHHHTCCCHHHHHHHHTSCCCCCCCHHHHC--TTSCHHHHHHHHHHSCSS
T ss_pred             HHhhCCCCCCCCCHHHHHHHHhhhccCCChhhhhhhhhhhhhcccccCCccCCCCHHHhC--CCCCHHHHHHHHHHccCC
Confidence            9999999999999988888888777765432211111100000 0000000000000111  135788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||....
T Consensus       283 P~~R~ta~e~L~hpf~~~~~  302 (345)
T d1pmea_         283 PHKRIEVEQALAHPYLEQYY  302 (345)
T ss_dssp             TTTSCCHHHHHTSGGGTTTC
T ss_pred             hhHCcCHHHHhcCHhhccCC
Confidence            99999999999999997543

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.6e-45  Score=338.76  Aligned_cols=208  Identities=25%  Similarity=0.352  Sum_probs=172.7

Q ss_pred             hhHHHHHHHHHhCC--CCCccceeeeEEecCccccccCceEEEEeecCcC--CHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLK--HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH--DLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         8 ~~~~~Ei~il~~l~--hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~--~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      ..+.+|+.+|++++  |||||++++++.+.        +.+|+||||+.+  ++..++.+ +..+++++++.++.||+.|
T Consensus        52 ~~~~~E~~il~~l~~~h~nIv~~~~~~~~~--------~~~~lv~e~~~~~~~l~~~~~~-~~~l~e~~~~~~~~qi~~a  122 (273)
T d1xwsa_          52 TRVPMEVVLLKKVSSGFSGVIRLLDWFERP--------DSFVLILERPEPVQDLFDFITE-RGALQEELARSFFWQVLEA  122 (273)
T ss_dssp             CEEEHHHHHHHHHCSSSCSBCCEEEEEECS--------SEEEEEEECCSSEEEHHHHHHH-HCSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCCccEEEEEEeeC--------CeEEEEEEeccCcchHHHHHhc-cCCCCHHHHHHHHHHHHHH
Confidence            44679999999996  89999999999886        669999999964  67776655 4479999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEec-CCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITK-TGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~-~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |+|||++||+||||||+|||++. ++.+||+|||+|......      .....+||+.|+|||++.+...++.++||||+
T Consensus       123 l~~lH~~~iiHrDiKp~NIll~~~~~~vkl~DFG~a~~~~~~------~~~~~~GT~~y~aPE~~~~~~~~~~~~DiwSl  196 (273)
T d1xwsa_         123 VRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDT------VYTDFDGTRVYSPPEWIRYHRYHGRSAAVWSL  196 (273)
T ss_dssp             HHHHHHTTEECSCCSGGGEEEETTTTEEEECCCTTCEECCSS------CBCCCCSCGGGSCHHHHHHSCBCHHHHHHHHH
T ss_pred             HHHHHHCCCccccCcccceEEecCCCeEEECccccceecccc------cccccccCCCcCCHHHHcCCCCCCcccccccc
Confidence            99999999999999999999985 579999999999765432      23456899999999999877656788999999


Q ss_pred             HHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhh
Q psy7889         163 GCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKL  242 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~  242 (433)
                      ||++|+|++|.+||.+.+.      +..  +...                              .+...|+++++||.+|
T Consensus       197 Gvilyell~g~~Pf~~~~~------i~~--~~~~------------------------------~~~~~s~~~~~li~~~  238 (273)
T d1xwsa_         197 GILLYDMVCGDIPFEHDEE------IIR--GQVF------------------------------FRQRVSSECQHLIRWC  238 (273)
T ss_dssp             HHHHHHHHHSSCSCCSHHH------HHH--CCCC------------------------------CSSCCCHHHHHHHHHH
T ss_pred             eeeehhHhhCCCCCCCchH------Hhh--cccC------------------------------CCCCCCHHHHHHHHHH
Confidence            9999999999999976321      111  1100                              0113578889999999


Q ss_pred             cccCCCCCCCHHHhhcCCCccCCCCC
Q psy7889         243 LLLDPSKRFDSDAALNHDFFWTDPMP  268 (433)
Q Consensus       243 L~~dP~~R~t~~e~L~h~~~~~~~~~  268 (433)
                      |+.||.+|||++|+|+||||++...+
T Consensus       239 L~~dp~~R~s~~eil~hp~~~~~~~p  264 (273)
T d1xwsa_         239 LALRPSDRPTFEEIQNHPWMQDVLLP  264 (273)
T ss_dssp             TCSSGGGSCCHHHHHTSGGGSSCCCH
T ss_pred             ccCCHhHCcCHHHHhcCHhhCCCCCC
Confidence            99999999999999999999875543

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-44  Score=335.46  Aligned_cols=215  Identities=20%  Similarity=0.313  Sum_probs=170.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      +.+++|+.+|++++|||||++++++..         +.+|||||||+ |+|.+++......+++..+..++.||+.||+|
T Consensus        49 ~~~~~E~~~l~~l~HpnIv~~~~~~~~---------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~i~~qi~~gl~y  119 (276)
T d1uwha_          49 QAFKNEVGVLRKTRHVNILLFMGYSTA---------PQLAIVTQWCEGSSLYHHLHIIETKFEMIKLIDIARQTAQGMDY  119 (276)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECS---------SSCEEEEECCCEEEHHHHHHTSCCCCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeeeEEEec---------cEEEEEEecCCCCCHHHHHhhccCCCCHHHHHHHHHHHHHHHHH
Confidence            567899999999999999999998643         34799999998 58999998777789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC--CCCCCcchhhhHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD--RNYGPPVDLWGAGC  164 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~--~~~~~~~DiwSlGv  164 (433)
                      ||++||+||||||+|||++.++.+||+|||+|+.......  ........||+.|+|||++.+.  ..|+.++||||+||
T Consensus       120 LH~~~ivHrDlKp~NiLl~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~~~~~~~~sDiwS~Gv  197 (276)
T d1uwha_         120 LHAKSIIHRDLKSNNIFLHEDLTVKIGDFGLATVKSRWSG--SHQFEQLSGSILWMAPEVIRMQDKNPYSFQSDVYAFGI  197 (276)
T ss_dssp             HHHTTCCCSCCCGGGEEEETTSSEEECCCCCSCC--------------CCCCGGGCCHHHHTTCSSCCCCHHHHHHHHHH
T ss_pred             HhcCCEeccccCHHHEEEcCCCCEEEccccceeeccccCC--cccccccccCcccCCHHHHhcccCCCCCchhhhhhhHH
Confidence            9999999999999999999999999999999987653221  1233456789999999998653  23789999999999


Q ss_pred             HHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         165 IMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       165 il~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      ++|||++|..||.+.+....+..+.... ...+. ..                        -.+...++++.+||.+||.
T Consensus       198 ~l~el~tg~~Pf~~~~~~~~~~~~~~~~-~~~p~-~~------------------------~~~~~~~~~l~~li~~cl~  251 (276)
T d1uwha_         198 VLYELMTGQLPYSNINNRDQIIFMVGRG-YLSPD-LS------------------------KVRSNCPKAMKRLMAECLK  251 (276)
T ss_dssp             HHHHHHHSSCTTTTCCCHHHHHHHHHHT-SCCCC-GG------------------------GSCTTCCHHHHHHHHHHTC
T ss_pred             HHHHHHHCCCCCCCCChHHHHHHHHhcC-CCCCc-ch------------------------hccccchHHHHHHHHHHcC
Confidence            9999999999999877666554443321 11110 00                        0011246778899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||++|++++
T Consensus       252 ~dp~~RPt~~~il~~  266 (276)
T d1uwha_         252 KKRDERPLFPQILAS  266 (276)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999999976

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-44  Score=349.10  Aligned_cols=248  Identities=28%  Similarity=0.468  Sum_probs=187.0

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+.+|+.++|||||+++++|.....  .....++|+|||||.+++...+.   ..+++..++.++.||+.||+||
T Consensus        61 ~~~~~Ei~il~~l~hpnIv~~~~~f~~~~~--~~~~~~~~iv~Ey~~~~l~~~~~---~~~~~~~i~~~~~qil~gl~~L  135 (355)
T d2b1pa1          61 KRAYRELVLMKCVNHKNIISLLNVFTPQKT--LEEFQDVYLVMELMDANLCQVIQ---MELDHERMSYLLYQMLCGIKHL  135 (355)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCCS--TTTCCEEEEEEECCSEEHHHHHT---SCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeEEEEEEecccc--cccCceeEEEEeccchHHHHhhh---cCCCHHHHHHHHHHHHHHHHHh
Confidence            457899999999999999999999976522  11247899999999999887764   3689999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.++.+|++|||+++.....     ......++|+.|+|||++.+.. ++.++||||+||+++
T Consensus       136 H~~giiHrDlKP~Nil~~~~~~~kl~df~~~~~~~~~-----~~~~~~~~t~~y~aPE~l~~~~-~~~~~DiwSlG~~l~  209 (355)
T d2b1pa1         136 HSAGIIHRDLKPSNIVVKSDCTLKILDFGLARTAGTS-----FMMTPYVVTRYYRAPEVILGMG-YKENVDIWSVGCIMG  209 (355)
T ss_dssp             HHTTCCCSCCCGGGEEECTTCCEEECCCCC--------------------CCTTCCHHHHTTCC-CCTTHHHHHHHHHHH
T ss_pred             hhcccccccCCccccccccccceeeechhhhhccccc-----cccccccccccccChhhhcCCC-CCCCcccccccchHH
Confidence            9999999999999999999999999999998775532     2334557899999999998865 899999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhh----C------CccCChhHHH
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERL----K------PYVKDQYGCD  237 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~----~------~~~~s~~~~~  237 (433)
                      +|++|++||.+.+.......+....+.+.++.|..............+...........    .      ....++++++
T Consensus       210 ell~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~d  289 (355)
T d2b1pa1         210 EMVRHKILFPGRDYIDQWNKVIEQLGTPCPEFMKKLQPTVRNYVENRPKYAGLTFPKLFPDSLFPADSEHNKLKASQARD  289 (355)
T ss_dssp             HHHHSSCSSCCSSHHHHHHHHHHHHCCCCHHHHTTSCHHHHHHHHTSCCCCCCCHHHHSCGGGSCCSSHHHHHHHHHHHH
T ss_pred             HHhhCCCCCCCCCHHHHHHHHHHhccCCCHHHHHHhhhhHHHHhhcCccccccccccccccccccccccccccCCHHHHH
Confidence            99999999999999999999988888776655544332211000000000000000000    0      0124678899


Q ss_pred             HHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         238 LLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ||.+||.+||++||||+|+|+||||++..
T Consensus       290 ll~~mL~~dP~~R~ta~elL~Hpw~~~~~  318 (355)
T d2b1pa1         290 LLSKMLVIDPAKRISVDDALQHPYINVWY  318 (355)
T ss_dssp             HHHHHSCSSTTTSCCHHHHHTSTTTGGGC
T ss_pred             HHHHHCcCChhHCcCHHHHhcCcccCCCC
Confidence            99999999999999999999999997644

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=5.1e-44  Score=336.78  Aligned_cols=212  Identities=21%  Similarity=0.322  Sum_probs=165.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++.+.        +.+|+|||||++ +|.+++......+++.++..++.||+.||+|
T Consensus        72 ~~~~~E~~~l~~l~HpnIv~l~g~~~~~--------~~~~iv~Ey~~~g~L~~~~~~~~~~l~~~~~~~i~~qia~gl~y  143 (299)
T d1jpaa_          72 RDFLSEASIMGQFDHPNVIHLEGVVTKS--------TPVMIITEFMENGSLDSFLRQNDGQFTVIQLVGMLRGIAAGMKY  143 (299)
T ss_dssp             HHHHHHHHHHTTCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHTTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCccEEEEEeeC--------CEEEEEEEecCCCcceeeeccccCCCCHHHHHHHHHHHHHHHHH
Confidence            4688999999999999999999999775        558999999985 7888887767779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCc-cccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQ-VNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~-~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      ||++||+||||||+|||++.++.+||+|||+++......... ........||+.|+|||++.+.. |+.++|||||||+
T Consensus       144 LH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~~~~~~~~~~~t~~y~aPE~~~~~~-~~~~sDvwS~Gvv  222 (299)
T d1jpaa_         144 LADMNYVHRDLAARNILVNSNLVCKVSDFGLSRFLEDDTSDPTYTSALGGKIPIRWTAPEAIQYRK-FTSASDVWSYGIV  222 (299)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCC-----------------------CGGGSCHHHHHSCC-CCHHHHHHHHHHH
T ss_pred             HhhCCCccCccccceEEECCCCcEEECCcccceEccCCCCcceeeecccccCCccccCHHHHhcCC-CCcccccccchHH
Confidence            999999999999999999999999999999998775432211 11222345789999999998765 7999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|||++ |.+||.+.+..+.+..+......+.                               +...+.++.+||.+||+
T Consensus       223 l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl~  271 (299)
T d1jpaa_         223 MWEVMSYGERPYWDMTNQDVINAIEQDYRLPP-------------------------------PMDCPSALHQLMLDCWQ  271 (299)
T ss_dssp             HHHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTC
T ss_pred             HHHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CccchHHHHHHHHHHcC
Confidence            999998 8999999988877766643211111                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||++|||+.|++++
T Consensus       272 ~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         272 KDRNHRPKFGQIVNT  286 (299)
T ss_dssp             SSTTTSCCHHHHHHH
T ss_pred             CCHhHCcCHHHHHHH
Confidence            999999999999864

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-44  Score=335.22  Aligned_cols=213  Identities=20%  Similarity=0.325  Sum_probs=177.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++.+         +.+|||||||++ +|.+++...+..+++..+..++.||+.||+|
T Consensus        54 ~~~~~E~~il~~l~HpnIv~l~g~~~~---------~~~~lvmE~~~~g~L~~~l~~~~~~l~~~~~~~i~~qi~~gL~y  124 (285)
T d1u59a_          54 EEMMREAQIMHQLDNPYIVRLIGVCQA---------EALMLVMEMAGGGPLHKFLVGKREEIPVSNVAELLHQVSMGMKY  124 (285)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEEES---------SSEEEEEECCTTEEHHHHHTTCTTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEeeeecc---------CeEEEEEEeCCCCcHHHHhhccccCCCHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999864         337999999985 8888887767789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+..... .........||+.|+|||++.+.. ++.++||||+||++
T Consensus       125 lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~-~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDVwS~Gv~l  202 (285)
T d1u59a_         125 LEEKNFVHRDLAARNVLLVNRHYAKISDFGLSKALGADDS-YYTARSAGKWPLKWYAPECINFRK-FSSRSDVWSYGVTM  202 (285)
T ss_dssp             HHHTTEECCCCSGGGEEEEETTEEEECCCTTCEECTTCSC-EECCCCSSCCCGGGCCHHHHHHCE-ECHHHHHHHHHHHH
T ss_pred             HHhCCeecCcCchhheeeccCCceeeccchhhhccccccc-ccccccccccCccccChHHHhCCC-CCccchhhcchHHH
Confidence            9999999999999999999999999999999987754321 122234457899999999997665 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+.+..+....+........                               +...++++.+||.+||..
T Consensus       203 ~E~lt~G~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl~~  251 (285)
T d1u59a_         203 WEALSYGQKPYKKMKGPEVMAFIEQGKRMEC-------------------------------PPECPPELYALMSDCWIY  251 (285)
T ss_dssp             HHHHTTSCCTTTTCCTHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHTTCS
T ss_pred             HHHHhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCcCCHHHHHHHHHHcCC
Confidence            99998 8999999887776666543211110                               112456778999999999


Q ss_pred             CCCCCCCHHHh---hcCCCc
Q psy7889         246 DPSKRFDSDAA---LNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~---L~h~~~  262 (433)
                      ||++|||+.++   |+|.|+
T Consensus       252 ~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         252 KWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             SGGGSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHHHHHHH
Confidence            99999999888   667776

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.7e-44  Score=329.33  Aligned_cols=211  Identities=20%  Similarity=0.356  Sum_probs=168.4

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+++|+++|++++|||||++++++..+        +.+|||||||. |+|.+++......+++..+..++.||+.||
T Consensus        43 ~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~--------~~~~lv~E~~~~g~L~~~l~~~~~~~~~~~~~~i~~qia~gl  114 (263)
T d1sm2a_          43 SEEDFIEEAEVMMKLSHPKLVQLYGVCLEQ--------APICLVFEFMEHGCLSDYLRTQRGLFAAETLLGMCLDVCEGM  114 (263)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHTTTTCCCHHHHHHHHHHHHHHH
T ss_pred             cHHHHHHHHHHHHhcCCCCcccccceeccC--------CceEEEEEecCCCcHHHHhhccccCCCHHHHHHHHHHHHHHH
Confidence            356789999999999999999999999875        55899999997 578888887777799999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||+++|+||||||+|||++.++.+||+|||+++.......   .......||+.|+|||++.+.. |+.++||||+||
T Consensus       115 ~~lH~~~iiHrDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~---~~~~~~~gt~~y~aPE~l~~~~-~~~k~DVwS~Gv  190 (263)
T d1sm2a_         115 AYLEEACVIHRDLAARNCLVGENQVIKVSDFGMTRFVLDDQY---TSSTGTKFPVKWASPEVFSFSR-YSSKSDVWSFGV  190 (263)
T ss_dssp             HHHHHTTCCCTTCSGGGEEECGGGCEEECSCC---------------------CTTSCCHHHHTTCC-CCHHHHHHHHHH
T ss_pred             HhhhccceeecccchhheeecCCCCeEecccchheeccCCCc---eeecceecCcccCChHHhcCCC-CCchhhhcchHH
Confidence            999999999999999999999999999999999987654321   1223457899999999998765 899999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |.+||.+.+..+.+..+........                               +...++++.+||.+||
T Consensus       191 il~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl  239 (263)
T d1sm2a_         191 LMWEVFSEGKIPYENRSNSEVVEDISTGFRLYK-------------------------------PRLASTHVYQIMNHCW  239 (263)
T ss_dssp             HHHHHHTTSCCTTCSCCHHHHHHHHHHTCCCCC-------------------------------CTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHCCCCCCCCCCHHHHHHHHHhcCCCCC-------------------------------ccccCHHHHHHHHHHc
Confidence            9999998 6888888887777766654221111                               1124567789999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      +.||++|||++|+++|
T Consensus       240 ~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         240 KERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHH
Confidence            9999999999999975

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=100.00  E-value=3.7e-44  Score=342.88  Aligned_cols=247  Identities=26%  Similarity=0.414  Sum_probs=182.6

Q ss_pred             CCchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNG   83 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~a   83 (433)
                      .....+.+|+++|+.++ ||||++++++|....+      ..+++|||||.++.+.   .....+++..++.++.||+.|
T Consensus        71 ~~~~~~~~Ei~il~~l~~hpnIv~~~~~~~~~~~------~~~~~v~e~~~~~~L~---~~~~~l~e~~i~~i~~qil~a  141 (328)
T d3bqca1          71 VKKKKIKREIKILENLRGGPNIITLADIVKDPVS------RTPALVFEHVNNTDFK---QLYQTLTDYDIRFYMYEILKA  141 (328)
T ss_dssp             SCHHHHHHHHHHHHHHTTSTTBCCEEEEEECTTT------CSEEEEEECCCSCBGG---GTTTSCCHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhccCCCCCcEEEEEEEecCC------CceeEEEeecCCCcHH---HHhcCCCHHHHHHHHHHHHHH
Confidence            44567899999999995 9999999999986533      5699999999864322   223469999999999999999


Q ss_pred             HHHHHhCCeeccCCCCCcEEEecCC-cEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          84 LYYIHSNKILHRDMKAANVLITKTG-ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        84 L~~LH~~~iiH~dikp~NIll~~~~-~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      |+|||++||+||||||+|||++.++ .+||+|||+|.......     .....++|+.|+|||++.+...++.++||||+
T Consensus       142 L~~LH~~gIvHrDiKp~NILi~~~~~~vkl~DFG~a~~~~~~~-----~~~~~~~t~~y~aPE~~~~~~~~~~~~Diwsl  216 (328)
T d3bqca1         142 LDYCHSMGIMHRDVKPHNVMIDHEHRKLRLIDWGLAEFYHPGQ-----EYNVRVASRYFKGPELLVDYQMYDYSLDMWSL  216 (328)
T ss_dssp             HHHHHHTTEECCCCSGGGEEEETTTTEEEECCGGGCEECCTTC-----CCCSCCSCGGGCCHHHHTTCCCCCTHHHHHHH
T ss_pred             HHHHhhcccccccccccceEEcCCCCeeeecccccceeccCCC-----cccccccCccccCcccccCCCCCCcccchhhh
Confidence            9999999999999999999999765 69999999998765332     23456789999999999887778999999999


Q ss_pred             HHHHHHHHhcCCCCCCC-ChHHHHHHHHHHhCCCCCCCCCccc---chhhhhccc--cchHHHhhHHhhhCCccCChhHH
Q psy7889         163 GCIMAEMWTRSPIMQGN-TEQQQITLISQLCGSITPESWPGVE---TLDLYNKME--LPKAQKRKVKERLKPYVKDQYGC  236 (433)
Q Consensus       163 Gvil~ell~g~~pf~~~-~~~~~~~~i~~~~g~~~~~~~~~~~---~~~~~~~~~--~~~~~~~~~~~~~~~~~~s~~~~  236 (433)
                      ||++++|++|..||... +..++...+...+|.+....+....   ....+....  ..................+++++
T Consensus       217 G~~l~e~~~g~~pf~~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~  296 (328)
T d3bqca1         217 GCMLASMIFRKEPFFHGHDNYDQLVRIAKVLGTEDLYDYIDKYNIELDPRFNDILGRHSRKRWERFVHSENQHLVSPEAL  296 (328)
T ss_dssp             HHHHHHHHHTCSSSSCCSSHHHHHHHHHHHHCHHHHHHHHHHTTCCCCGGGGGTCCCCCCCCGGGGCCTTTGGGCCHHHH
T ss_pred             hhhhHHhccCCCCCCCCchhHHHHHHHHHHHCCchhhhhhhhcccccCcccchhcccccccchhhcccccccccCCHHHH
Confidence            99999999999988754 4555666666666532111110000   000000000  00000000111111234688999


Q ss_pred             HHHHhhcccCCCCCCCHHHhhcCCCccCC
Q psy7889         237 DLLDKLLLLDPSKRFDSDAALNHDFFWTD  265 (433)
Q Consensus       237 ~li~~~L~~dP~~R~t~~e~L~h~~~~~~  265 (433)
                      |||.+||.+||.+|||++|+|+||||++.
T Consensus       297 dli~~mL~~dP~~R~ta~e~L~Hp~F~~v  325 (328)
T d3bqca1         297 DFLDKLLRYDHQSRLTAREAMEHPYFYTV  325 (328)
T ss_dssp             HHHHHHSCSSGGGSCCHHHHHTSGGGTTS
T ss_pred             HHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            99999999999999999999999999764

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-44  Score=339.81  Aligned_cols=212  Identities=23%  Similarity=0.392  Sum_probs=174.6

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCC------------------
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHV------------------   66 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~------------------   66 (433)
                      ...+++|+.+|+++ +|||||++++++.+.        +.+|||||||+ |+|.+++.....                  
T Consensus        84 ~~~~~~E~~~l~~l~~HpnIv~l~~~~~~~--------~~~~lv~Ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~  155 (325)
T d1rjba_          84 REALMSELKMMTQLGSHENIVNLLGACTLS--------GPIYLIFEYCCYGDLLNYLRSKREKFSEDEIEYENQKRLEEE  155 (325)
T ss_dssp             CHHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHTTTTCC----------------
T ss_pred             HHHHHHHHHHHHHhcCCCcEeEEEEEEeeC--------CeEEEEEEcCCCCcHHHHHHhccCCCcchhhhhccccccccc
Confidence            45788999999998 899999999999876        55899999997 589999876432                  


Q ss_pred             ----CCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCccccccc
Q psy7889          67 ----KFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYR  142 (433)
Q Consensus        67 ----~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~  142 (433)
                          .+++..++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......  ........||+.|+
T Consensus       156 ~~~~~l~~~~~~~i~~qi~~gl~yLH~~~IiHRDlKp~Nill~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~  233 (325)
T d1rjba_         156 EDLNVLTFEDLLCFAYQVAKGMEFLEFKSCVHRDLAARNVLVTHGKVVKICDFGLARDIMSDSN--YVVRGNARLPVKWM  233 (325)
T ss_dssp             -----CCHHHHHHHHHHHHHHHHHHHHTTEEETTCSGGGEEEETTTEEEECCCGGGSCGGGCTT--SEEETTEEECGGGC
T ss_pred             cccCCCCHHHHHHHHHHHHHHHHHHHhCCeeeccCchhccccccCCeEEEeeccccccccCCCc--eeeeccccCCCccC
Confidence                378899999999999999999999999999999999999999999999999987654321  12234556799999


Q ss_pred             CcccccCCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhh
Q psy7889         143 PPELLLGDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRK  221 (433)
Q Consensus       143 aPE~~~~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~  221 (433)
                      |||++.+.. |+.++||||+||++|||++ |.+||.+.+....+..+...-..++                         
T Consensus       234 aPE~l~~~~-~~~~~DiwS~Gvil~emlt~g~~Pf~~~~~~~~~~~~~~~~~~~~-------------------------  287 (325)
T d1rjba_         234 APESLFEGI-YTIKSDVWSYGILLWEIFSLGVNPYPGIPVDANFYKLIQNGFKMD-------------------------  287 (325)
T ss_dssp             CHHHHHHCC-CCHHHHHHHHHHHHHHHTTTSCCSSTTCCCSHHHHHHHHTTCCCC-------------------------
T ss_pred             ChHHHcCCC-CCcceeccchhHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-------------------------
Confidence            999998765 8999999999999999997 8999998776655555443111110                         


Q ss_pred             HHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         222 VKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       222 ~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                           .+...++++++||.+||+.||++|||++|+++|
T Consensus       288 -----~p~~~~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         288 -----QPFYATEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             -----CCTTCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             -----CCCcCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence                 112346778899999999999999999999975

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.8e-44  Score=332.66  Aligned_cols=212  Identities=22%  Similarity=0.351  Sum_probs=172.3

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++.+         +..|||||||++ +|.+++.+ ...+++..+..++.||+.||+|
T Consensus        53 ~~~~~E~~il~~l~HpnIv~~~g~~~~---------~~~~lvmE~~~~g~L~~~l~~-~~~l~~~~~~~i~~qi~~gl~y  122 (277)
T d1xbba_          53 DELLAEANVMQQLDNPYIVRMIGICEA---------ESWMLVMEMAELGPLNKYLQQ-NRHVKDKNIIELVHQVSMGMKY  122 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEES---------SSEEEEEECCTTEEHHHHHHH-CTTCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCCceEEEEecc---------CCEEEEEEcCCCCcHHHHHhh-ccCCCHHHHHHHHHHHHHHHhh
Confidence            468999999999999999999999864         237899999985 78887765 4469999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+...... ........||+.|+|||++.+.. ++.++|||||||++
T Consensus       123 lH~~~iiHrDlKp~Nill~~~~~~kl~DFGla~~~~~~~~~-~~~~~~~~gt~~y~APE~l~~~~-~~~~sDiwS~Gv~l  200 (277)
T d1xbba_         123 LEESNFVHRDLAARNVLLVTQHYAKISDFGLSKALRADENY-YKAQTHGKWPVKWYAPECINYYK-FSSKSDVWSFGVLM  200 (277)
T ss_dssp             HHHTTEECSCCSGGGEEEEETTEEEECCCTTCEECCTTCSE-EEC----CCCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             HHhCCcccCCCcchhhcccccCcccccchhhhhhccccccc-cccccccCCCceecCchhhcCCC-CCchhhhccchhhh
Confidence            99999999999999999999999999999999876543221 12233457899999999997765 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+.+..+....+........                               +...+.++.+||.+||+.
T Consensus       201 ~ellt~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~~~~li~~cl~~  249 (277)
T d1xbba_         201 WEAFSYGQKPYRGMKGSEVTAMLEKGERMGC-------------------------------PAGCPREMYDLMNLCWTY  249 (277)
T ss_dssp             HHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             hHHhhCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CcccCHHHHHHHHHHcCC
Confidence            99998 8999999887766665543111100                               112466778999999999


Q ss_pred             CCCCCCCHHHh---hcCCCc
Q psy7889         246 DPSKRFDSDAA---LNHDFF  262 (433)
Q Consensus       246 dP~~R~t~~e~---L~h~~~  262 (433)
                      ||.+|||++++   |+|+|+
T Consensus       250 dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         250 DVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             STTTSCCHHHHHHHHHHHHH
T ss_pred             CHhHCcCHHHHHHHhhCHHh
Confidence            99999999998   466655

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.5e-43  Score=341.47  Aligned_cols=246  Identities=33%  Similarity=0.549  Sum_probs=188.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYI   87 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~L   87 (433)
                      ..+++|+++|+.++|||||++++++.....  ......+++++++++++|.+++..  .++++.+++.++.||+.||+||
T Consensus        62 ~~~~~Ei~il~~l~h~~iv~~~~~~~~~~~--~~~~~~~~i~~~~~gg~L~~~~~~--~~l~e~~~~~i~~qil~aL~~L  137 (348)
T d2gfsa1          62 KRTYRELRLLKHMKHENVIGLLDVFTPARS--LEEFNDVYLVTHLMGADLNNIVKC--QKLTDDHVQFLIYQILRGLKYI  137 (348)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCCSEEECSCSS--TTTCCCCEEEEECCSEEHHHHHTT--CCCCHHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCeeeEEEEEeeccc--cccCceEEEEEeecCCchhhhccc--ccccHHHHHHHHHHHHHHHHHH
Confidence            467899999999999999999999975422  111345677777777899988854  3699999999999999999999


Q ss_pred             HhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHHH
Q psy7889          88 HSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIMA  167 (433)
Q Consensus        88 H~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil~  167 (433)
                      |++||+||||||+|||++.+|.+|++|||++.....       ......||+.|+|||++.+...++.++|||||||++|
T Consensus       138 H~~giiHrDiKp~NILi~~~~~~kl~dfg~a~~~~~-------~~~~~~g~~~y~apE~~~~~~~~~~~~DiwSlGv~l~  210 (348)
T d2gfsa1         138 HSADIIHRDLKPSNLAVNEDCELKILDFGLARHTDD-------EMTGYVATRWYRAPEIMLNWMHYNQTVDIWSVGCIMA  210 (348)
T ss_dssp             HHTTCCCCCCCGGGEEECTTCCEEECCC----CCTG-------GGSSSCHHHHTSCHHHHTTCSCCCTTHHHHHHHHHHH
T ss_pred             HhCCCcccccCCccccccccccccccccchhcccCc-------ccccccccccccCchhhcCCccCCcccchhhhhHHHH
Confidence            999999999999999999999999999999876542       2345678999999999888776799999999999999


Q ss_pred             HHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccc-cchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         168 EMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKME-LPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       168 ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~-~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      +|++|.+||.+.+.......|....+.+..+.+............. ............  ....++++++||.+||..|
T Consensus       211 ~ll~g~~pF~~~~~~~~~~~i~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~--~~~~s~~~~dli~~mL~~d  288 (348)
T d2gfsa1         211 ELLTGRTLFPGTDHIDQLKLILRLVGTPGAELLKKISSESARNYIQSLTQMPKMNFANV--FIGANPLAVDLLEKMLVLD  288 (348)
T ss_dssp             HHHHSSCSCCCSSHHHHHHHHHHHHCCCCHHHHTTCCCHHHHHHHTTSCCCCCCCHHHH--STTCCHHHHHHHHHHSCSS
T ss_pred             HHHhCCCCCCCCCHHHHHHHHHHhcCCCChHHhhhccchhhhhhhhhcccCCCcchhhh--cCCCCHHHHHHHHHHCcCC
Confidence            9999999999999999999998888776543322222111110000 000000000111  1235788999999999999


Q ss_pred             CCCCCCHHHhhcCCCccCCC
Q psy7889         247 PSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~~~~~  266 (433)
                      |.+|||++|+|+||||++..
T Consensus       289 P~~R~ta~elL~Hp~f~~~~  308 (348)
T d2gfsa1         289 SDKRITAAQALAHAYFAQYH  308 (348)
T ss_dssp             GGGSCCHHHHHTSGGGTTTC
T ss_pred             hhhCcCHHHHhcCHhhCCCC
Confidence            99999999999999997654

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.5e-43  Score=323.81  Aligned_cols=211  Identities=20%  Similarity=0.384  Sum_probs=179.6

Q ss_pred             CchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ..+.+++|++++++++|||||++++++.++        +.+++||||+. |++..++......+++..++.++.|+++||
T Consensus        42 ~~~~~~~Ev~~~~~l~HpnIv~~~g~~~~~--------~~~~iv~Ey~~~g~l~~~~~~~~~~~~~~~~~~i~~qi~~gl  113 (258)
T d1k2pa_          42 SEDEFIEEAKVMMNLSHEKLVQLYGVCTKQ--------RPIFIITEYMANGCLLNYLREMRHRFQTQQLLEMCKDVCEAM  113 (258)
T ss_dssp             CHHHHHHHHHHHHTCCCTTBCCEEEEECCS--------SSEEEEEECCTTEEHHHHHHSGGGCCCHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHhcCCCceeeEEEEEeeC--------CceEEEEEccCCCcHHHhhhccccCCcHHHHHHHHHHHHHHH
Confidence            457899999999999999999999999875        55999999997 578888777777899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+++.......   .......+|..|+|||++.+.. ++.++||||+||
T Consensus       114 ~~LH~~~iiH~dlk~~Nill~~~~~~kl~DfG~a~~~~~~~~---~~~~~~~~t~~y~aPE~~~~~~-~~~ksDiwS~G~  189 (258)
T d1k2pa_         114 EYLESKQFLHRDLAARNCLVNDQGVVKVSDFGLSRYVLDDEY---TSSVGSKFPVRWSPPEVLMYSK-FSSKSDIWAFGV  189 (258)
T ss_dssp             HHHHHTTBCCSCCSGGGEEECTTCCEEECCCSSCCBCSSSSC---CCCCCSCCCGGGCCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHhhcCcccccccceeEEEcCCCcEEECcchhheeccCCCc---eeecccCCCCCcCCcHHhcCCC-CCcceeecccch
Confidence            999999999999999999999999999999999987654321   2333467899999999998765 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |+.||.+.+..+....+........                               +...+.++.+||.+||
T Consensus       190 ~l~el~t~g~~Pf~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl  238 (258)
T d1k2pa_         190 LMWEIYSLGKMPYERFTNSETAEHIAQGLRLYR-------------------------------PHLASEKVYTIMYSCW  238 (258)
T ss_dssp             HHHHHHTTSCCTTTTSCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHTT
T ss_pred             hhHhHHhcCCCCCCCCCHHHHHHHHHhCCCCCC-------------------------------cccccHHHHHHHHHHc
Confidence            9999998 8999999998877776654221111                               1224567789999999


Q ss_pred             ccCCCCCCCHHHhhcC
Q psy7889         244 LLDPSKRFDSDAALNH  259 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~h  259 (433)
                      +.||++|||++++|+|
T Consensus       239 ~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         239 HEKADERPTFKILLSN  254 (258)
T ss_dssp             CSSGGGSCCHHHHHHH
T ss_pred             cCCHhHCcCHHHHHHH
Confidence            9999999999999986

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=100.00  E-value=1.6e-43  Score=331.39  Aligned_cols=209  Identities=22%  Similarity=0.367  Sum_probs=169.1

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+++|++++|||||++++++.+.        +.+|||||||+ |+|..++... ...+++..+..++.||+.||
T Consensus        57 ~~~~~~E~~il~~l~HpnIv~~~~~~~~~--------~~~~iv~E~~~~g~l~~~l~~~~~~~~~~~~~~~i~~qi~~gL  128 (287)
T d1opja_          57 VEEFLKEAAVMKEIKHPNLVQLLGVCTRE--------PPFYIITEFMTYGNLLDYLRECNRQEVSAVVLLYMATQISSAM  128 (287)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHSCTTTSCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEecCCccEeeC--------CeeEEEeecccCcchHHHhhhccccchHHHHHHHHHHHHHHHH
Confidence            46789999999999999999999999875        55899999998 5788888653 44689999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+|+.......   .......|++.|+|||++.+.. |+.++||||+||
T Consensus       129 ~yLH~~~iiHrDlKp~NILl~~~~~~Kl~DFG~a~~~~~~~~---~~~~~~~g~~~y~aPE~~~~~~-~~~k~DiwS~Gv  204 (287)
T d1opja_         129 EYLEKKNFIHRDLAARNCLVGENHLVKVADFGLSRLMTGDTY---TAHAGAKFPIKWTAPESLAYNK-FSIKSDVWAFGV  204 (287)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECGGGCEEECCCCCTTTCCSSSS---EEETTEEECGGGCCHHHHHHCC-CSHHHHHHHHHH
T ss_pred             HHHHHCCcccCccccCeEEECCCCcEEEccccceeecCCCCc---eeeccccccccccChHHHcCCC-CCchhhhhhHHH
Confidence            999999999999999999999999999999999987653221   2233446788999999998765 899999999999


Q ss_pred             HHHHHHhcC-CCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWTRS-PIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~g~-~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++|. ++|.+.+.......+.....   ++                            .+...+.++.+||.+||
T Consensus       205 ~l~ell~~~~p~~~~~~~~~~~~~i~~~~~---~~----------------------------~~~~~~~~l~~li~~cl  253 (287)
T d1opja_         205 LLWEIATYGMSPYPGIDLSQVYELLEKDYR---ME----------------------------RPEGCPEKVYELMRACW  253 (287)
T ss_dssp             HHHHHHTTSCCSSTTCCHHHHHHHHHTTCC---CC----------------------------CCTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCcchHHHHHHHHhcCCC---CC----------------------------CCccchHHHHHHHHHHc
Confidence            999999965 55555555444333322110   00                            01124677889999999


Q ss_pred             ccCCCCCCCHHHhhc
Q psy7889         244 LLDPSKRFDSDAALN  258 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~  258 (433)
                      +.||.+|||++|+++
T Consensus       254 ~~dP~~Rps~~ei~~  268 (287)
T d1opja_         254 QWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CSSGGGSCCHHHHHH
T ss_pred             CCCHhHCcCHHHHHH
Confidence            999999999999976

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.4e-43  Score=329.42  Aligned_cols=213  Identities=23%  Similarity=0.388  Sum_probs=173.9

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccC-CCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIH-VKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~-~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+++|++++|||||++++++.+         +.+|||||||++ +|.+.+.... ..+++..+..++.||+.||
T Consensus        52 ~~~~~~E~~~l~~l~HpnIv~~~g~~~~---------~~~~iv~Ey~~~g~L~~~~~~~~~~~l~~~~~~~i~~qi~~gl  122 (272)
T d1qpca_          52 PDAFLAEANLMKQLQHQRLVRLYAVVTQ---------EPIYIITEYMENGSLVDFLKTPSGIKLTINKLLDMAAQIAEGM  122 (272)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEEECCTTCBHHHHTTSHHHHTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeEEEeeecc---------CCeEEEEEeCCCCcHHHHHhhcCCCCCCHHHHHHHHHHHHHHH
Confidence            5678999999999999999999998753         337999999984 7777664432 2589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+|||++.++.+||+|||+|+......   ........||+.|+|||++.+.. ++.++||||+||
T Consensus       123 ~~lH~~~ivHrDiKp~NIll~~~~~~Kl~DFGla~~~~~~~---~~~~~~~~gt~~y~APE~~~~~~-~~~~sDvwS~Gv  198 (272)
T d1qpca_         123 AFIEERNYIHRDLRAANILVSDTLSCKIADFGLARLIEDNE---YTAREGAKFPIKWTAPEAINYGT-FTIKSDVWSFGI  198 (272)
T ss_dssp             HHHHHTTEECSCCSGGGEEECTTSCEEECCCTTCEECSSSC---EECCTTCCCCTTTSCHHHHHHCE-ECHHHHHHHHHH
T ss_pred             HHHHhCCcccCccchhheeeecccceeeccccceEEccCCc---cccccccCCcccccChHHHhCCC-CCchhhhhhhHH
Confidence            99999999999999999999999999999999998775432   12234457899999999997655 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |.+||...+..+.+..+........                               +...+.++.+||.+||
T Consensus       199 vl~ellt~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~li~~cl  247 (272)
T d1qpca_         199 LLTEIVTHGRIPYPGMTNPEVIQNLERGYRMVR-------------------------------PDNCPEELYQLMRLCW  247 (272)
T ss_dssp             HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC-------------------------------cccChHHHHHHHHHHc
Confidence            9999999 5677777777766665543211111                               1124567789999999


Q ss_pred             ccCCCCCCCHHHhhc--CCCcc
Q psy7889         244 LLDPSKRFDSDAALN--HDFFW  263 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~--h~~~~  263 (433)
                      +.||.+|||++|+++  |+||.
T Consensus       248 ~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         248 KERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CCCHhHCcCHHHHHHHhhhhhh
Confidence            999999999999998  78884

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=5.7e-43  Score=325.72  Aligned_cols=208  Identities=23%  Similarity=0.344  Sum_probs=163.9

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++.+         +.+|+|||||. +++..++......+++..++.++.||+.||+|
T Consensus        53 ~~~~~E~~~l~~l~HpnIv~l~~~~~~---------~~~~iv~E~~~~g~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~y  123 (273)
T d1mp8a_          53 EKFLQEALTMRQFDHPHIVKLIGVITE---------NPVWIIMELCTLGELRSFLQVRKYSLDLASLILYAYQLSTALAY  123 (273)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECS---------SSCEEEEECCTTEEHHHHHHHTTTTSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeeEEEEEec---------CeEEEEEEeccCCcHHhhhhccCCCCCHHHHHHHHHHHHHHhhh
Confidence            468899999999999999999999853         44899999998 47888777777789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||+++.......   .......||+.|+|||++.+.. |+.++||||+||++
T Consensus       124 lH~~~iiHrDlKp~NIll~~~~~~Kl~DfG~a~~~~~~~~---~~~~~~~gt~~y~apE~l~~~~-~~~~~DiwSlGvil  199 (273)
T d1mp8a_         124 LESKRFVHRDIAARNVLVSSNDCVKLGDFGLSRYMEDSTY---YKASKGKLPIKWMAPESINFRR-FTSASDVWMFGVCM  199 (273)
T ss_dssp             HHHTTCCCSCCSGGGEEEEETTEEEECC----------------------CCGGGCCHHHHHHCC-CSHHHHHHHHHHHH
T ss_pred             hcccCeeccccchhheeecCCCcEEEccchhheeccCCcc---eeccceecCcccchhhHhccCC-CCCccccccchHHH
Confidence            9999999999999999999999999999999987653221   2234456799999999997665 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+.+..+....+......+.                               +...++++.+||.+||..
T Consensus       200 ~e~lt~g~~P~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~~~~li~~cl~~  248 (273)
T d1mp8a_         200 WEILMHGVKPFQGVKNNDVIGRIENGERLPM-------------------------------PPNCPPTLYSLMTKCWAY  248 (273)
T ss_dssp             HHHHTTSCCTTTTCCGGGHHHHHHTTCCCCC-------------------------------CTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhcCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CCCCCHHHHHHHHHHcCC
Confidence            99998 8999999888777666643211110                               112466788999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||.+|||++|+++|
T Consensus       249 dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         249 DPSRRPRFTELKAQ  262 (273)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CHhHCcCHHHHHHH
Confidence            99999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=100.00  E-value=7.4e-43  Score=325.74  Aligned_cols=220  Identities=23%  Similarity=0.345  Sum_probs=168.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+.+|+.++|||||++++++.....    ....+|||||||++ +|...+.. ...+++.+++.++.||+.||+|
T Consensus        52 ~~~~~E~~~l~~~~hpniv~~~~~~~~~~~----~~~~~~lvmE~~~g~~L~~~~~~-~~~l~~~~~~~i~~qi~~al~~  126 (277)
T d1o6ya_          52 LRFRREAQNAAALNHPAIVAVYDTGEAETP----AGPLPYIVMEYVDGVTLRDIVHT-EGPMTPKRAIEVIADACQALNF  126 (277)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEEEEECS----SSEEEEEEEECCCEEEHHHHHHH-HCSCCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCCCcccceeeeccC----CCceEEEEEECCCCCEehhhhcc-cCCCCHHHHHHHHHHHHHHHHH
Confidence            468899999999999999999999987633    13568999999985 67777655 4479999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.++|+|||.+........ ........+||+.|+|||++.+.. |+.++||||+||++
T Consensus       127 lH~~~iiHrDiKP~NIll~~~~~~~l~d~~~~~~~~~~~~-~~~~~~~~~Gt~~Y~aPE~~~~~~-~~~~~DiwSlGvil  204 (277)
T d1o6ya_         127 SHQNGIIHRDVKPANIMISATNAVKVMDFGIARAIADSGN-SVTQTAAVIGTAQYLSPEQARGDS-VDARSDVYSLGCVL  204 (277)
T ss_dssp             HHHTTEECCCCSGGGEEEETTSCEEECCCTTCEECC-----------------TTCCHHHHTTCC-CCHHHHHHHHHHHH
T ss_pred             HHhCCccCccccCcccccCccccceeehhhhhhhhccccc-cccccccccCcccccCHHHHcCCC-CCcceecccchHHH
Confidence            9999999999999999999999999999999876543322 122345568999999999998765 79999999999999


Q ss_pred             HHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcccC
Q psy7889         167 AEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLD  246 (433)
Q Consensus       167 ~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~d  246 (433)
                      |+|++|.+||.+.+..+....+......++..                            .....|+++.+||.+||+.|
T Consensus       205 yelltG~~Pf~~~~~~~~~~~~~~~~~~~~~~----------------------------~~~~~s~~l~~li~~~L~~d  256 (277)
T d1o6ya_         205 YEVLTGEPPFTGDSPVSVAYQHVREDPIPPSA----------------------------RHEGLSADLDAVVLKALAKN  256 (277)
T ss_dssp             HHHHHSSCSCCCSSHHHHHHHHHHCCCCCGGG----------------------------TSSSCCHHHHHHHHHHTCSS
T ss_pred             HHHHhCCCCCCCcCHHHHHHHHHhcCCCCCch----------------------------hccCCCHHHHHHHHHHccCC
Confidence            99999999999998887766654421111100                            11135778889999999999


Q ss_pred             CCCCCCHHHhhcCCCc
Q psy7889         247 PSKRFDSDAALNHDFF  262 (433)
Q Consensus       247 P~~R~t~~e~L~h~~~  262 (433)
                      |.+||+..+.|.|+|.
T Consensus       257 p~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         257 PENRYQTAAEMRADLV  272 (277)
T ss_dssp             GGGSCSSHHHHHHHHH
T ss_pred             HhHCHhHHHHHHHHHH
Confidence            9999955445556664

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.1e-42  Score=319.81  Aligned_cols=210  Identities=18%  Similarity=0.314  Sum_probs=163.6

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++.+.        ..+++|||||.+ ++...+......+++.++..++.||+.||+|
T Consensus        54 ~~~~~E~~il~~l~H~nIv~~~g~~~~~--------~~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~~i~~gl~~  125 (283)
T d1mqba_          54 VDFLGEAGIMGQFSHHNIIRLEGVISKY--------KPMMIITEYMENGALDKFLREKDGEFSVLQLVGMLRGIAAGMKY  125 (283)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSEEEEEECCTTEEHHHHHHHTTTCSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhcCCCCEeeeeEEEecC--------CceEEEEEecccCcchhhhhcccccccHHHHHHHHHHHHHhhhh
Confidence            3678999999999999999999999875        558999999986 5777777766779999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+|||++.++.+||+|||+++.+....... .......||+.|+|||++.+.. ++.++||||+||++
T Consensus       126 lH~~~iiHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~~~-~~~~~~~gt~~Y~APE~l~~~~-~~~~sDI~S~Gvil  203 (283)
T d1mqba_         126 LANMNYVHRDLAARNILVNSNLVCKVSDFGLSRVLEDDPEAT-YTTSGGKIPIRWTAPEAISYRK-FTSASDVWSFGIVM  203 (283)
T ss_dssp             HHHTTCCCSCCCGGGEEECTTCCEEECCCCC------------------CCCGGGSCHHHHHSCC-CCHHHHHHHHHHHH
T ss_pred             ccccccccCccccceEEECCCCeEEEcccchhhcccCCCccc-eEeccCCCCccccCHHHHccCC-CCCcccccccHHHH
Confidence            999999999999999999999999999999998765432211 1223456799999999998765 89999999999999


Q ss_pred             HHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++| .+++.+.+..+....+......+.                               +...+..+.+||.+||+.
T Consensus       204 ~el~t~~~~~~~~~~~~~~~~~i~~~~~~~~-------------------------------~~~~~~~l~~li~~cl~~  252 (283)
T d1mqba_         204 WEVMTYGERPYWELSNHEVMKAINDGFRLPT-------------------------------PMDCPSAIYQLMMQCWQQ  252 (283)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTTCCCCC-------------------------------CTTCBHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCccccCCHHHHHHHHhccCCCCC-------------------------------chhhHHHHHHHHHHHCcC
Confidence            999985 666766666665555433211111                               112345677999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||++|||+.|+++
T Consensus       253 ~p~~RPt~~eil~  265 (283)
T d1mqba_         253 ERARRPKFADIVS  265 (283)
T ss_dssp             STTTSCCHHHHHH
T ss_pred             CHhHCcCHHHHHH
Confidence            9999999999986

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=6.5e-42  Score=325.30  Aligned_cols=210  Identities=20%  Similarity=0.271  Sum_probs=171.0

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLY   85 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~   85 (433)
                      ...+++|+.+|++++|||||++++++.+.         ..++||||+. ++|.+.+......+++..+..++.||+.||+
T Consensus        55 ~~~~~~E~~~l~~l~HpnIv~l~g~~~~~---------~~~~v~e~~~~~~l~~~~~~~~~~~~~~~~~~i~~qi~~gl~  125 (317)
T d1xkka_          55 NKEILDEAYVMASVDNPHVCRLLGICLTS---------TVQLITQLMPFGCLLDYVREHKDNIGSQYLLNWCVQIAKGMN  125 (317)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEEESS---------SEEEEEECCTTCBHHHHHHHTSSSCCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhCCCCCEeeEEEEEecC---------CeeEEEEeccCCcccccccccccCCCHHHHHHHHHHHHHHHH
Confidence            35689999999999999999999999764         2566677765 6899888887778999999999999999999


Q ss_pred             HHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHH
Q psy7889          86 YIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCI  165 (433)
Q Consensus        86 ~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvi  165 (433)
                      |||++||+||||||+|||++.++.+||+|||+++.......  ........||+.|+|||++.+.. |+.++||||+||+
T Consensus       126 yLH~~~iiHrDlKp~NIll~~~~~~kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~~-~~~~sDvwS~Gvi  202 (317)
T d1xkka_         126 YLEDRRLVHRDLAARNVLVKTPQHVKITDFGLAKLLGAEEK--EYHAEGGKVPIKWMALESILHRI-YTHQSDVWSYGVT  202 (317)
T ss_dssp             HHHHTTCCCSCCCGGGEEEEETTEEEECCCSHHHHTTTTCC----------CCTTTSCHHHHHHCC-CCHHHHHHHHHHH
T ss_pred             HHHHcCcccCcchhhcceeCCCCCeEeeccccceecccccc--cccccccccCccccChHHHhcCC-CChhhhhhhHHHH
Confidence            99999999999999999999999999999999987654322  12233456899999999998765 8999999999999


Q ss_pred             HHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhcc
Q psy7889         166 MAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLL  244 (433)
Q Consensus       166 l~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~  244 (433)
                      +|||++ |.+||.+.+..+....+......+.                               +...+.++.+||.+||.
T Consensus       203 l~el~t~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~~~~li~~cl~  251 (317)
T d1xkka_         203 VWELMTFGSKPYDGIPASEISSILEKGERLPQ-------------------------------PPICTIDVYMIMVKCWM  251 (317)
T ss_dssp             HHHHHTTSCCTTTTSCGGGHHHHHHHTCCCCC-------------------------------CTTBCHHHHHHHHHHTC
T ss_pred             HHHHHHCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------CcccCHHHHHHHHHhCC
Confidence            999998 8999998877665555543211111                               11245677899999999


Q ss_pred             cCCCCCCCHHHhhcC
Q psy7889         245 LDPSKRFDSDAALNH  259 (433)
Q Consensus       245 ~dP~~R~t~~e~L~h  259 (433)
                      .||.+|||+.|+++|
T Consensus       252 ~dP~~RPs~~eil~~  266 (317)
T d1xkka_         252 IDADSRPKFRELIIE  266 (317)
T ss_dssp             SSGGGSCCHHHHHHH
T ss_pred             CChhhCcCHHHHHHH
Confidence            999999999999987

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=8.3e-42  Score=318.89  Aligned_cols=215  Identities=22%  Similarity=0.377  Sum_probs=169.8

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhcc-CCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNI-HVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~-~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+.+|++++|||||++++++.+         +.+++|||||.+ +|..++... ...+++.++..++.||+.||
T Consensus        56 ~~~~~~E~~~l~~l~h~nIv~~~g~~~~---------~~~~lv~Ey~~~g~l~~~~~~~~~~~l~~~~~~~i~~~i~~gl  126 (285)
T d1fmka3          56 PEAFLQEAQVMKKLRHEKLVQLYAVVSE---------EPIYIVTEYMSKGSLLDFLKGETGKYLRLPQLVDMAAQIASGM  126 (285)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECS---------SSCEEEECCCTTCBHHHHHSHHHHTTCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhcccCCEeEEEEEEec---------CCeEEEEEecCCCchhhhhhhcccccchHHHHHHHHHHHHHHH
Confidence            4679999999999999999999999853         337999999985 577666543 34589999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGC  164 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGv  164 (433)
                      +|||++||+||||||+||||+.++.+||+|||+++.......   .......||+.|+|||++.... ++.++||||+||
T Consensus       127 ~~LH~~~ivH~DlKp~NIll~~~~~~kl~DfGla~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~S~Gi  202 (285)
T d1fmka3         127 AYVERMNYVHRDLRAANILVGENLVCKVADFGLARLIEDNEY---TARQGAKFPIKWTAPEAALYGR-FTIKSDVWSFGI  202 (285)
T ss_dssp             HHHHHTTCCCSCCSGGGEEECGGGCEEECCCCTTC-----------------CCGGGSCHHHHHHCC-CCHHHHHHHHHH
T ss_pred             HHHhhhheecccccceEEEECCCCcEEEcccchhhhccCCCc---eeeccccccccccChHHHhCCC-CCcHHhhhcchH
Confidence            999999999999999999999999999999999987653321   2233456899999999997765 799999999999


Q ss_pred             HHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         165 IMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       165 il~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      ++|||++ |.+++.+....+.+..+......+.+                               ...+.++++||.+||
T Consensus       203 il~el~t~~~p~~~~~~~~~~~~~i~~~~~~~~~-------------------------------~~~~~~l~~li~~cl  251 (285)
T d1fmka3         203 LLTELTTKGRVPYPGMVNREVLDQVERGYRMPCP-------------------------------PECPESLHDLMCQCW  251 (285)
T ss_dssp             HHHHHHTTTCCSSTTCCHHHHHHHHHTTCCCCCC-------------------------------TTSCHHHHHHHHHHT
T ss_pred             HHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCCC-------------------------------cccCHHHHHHHHHHc
Confidence            9999999 56777777777776666432211111                               124567789999999


Q ss_pred             ccCCCCCCCHHHhhc--CCCccCC
Q psy7889         244 LLDPSKRFDSDAALN--HDFFWTD  265 (433)
Q Consensus       244 ~~dP~~R~t~~e~L~--h~~~~~~  265 (433)
                      +.||++|||+++++.  ++||...
T Consensus       252 ~~dP~~Rps~~~i~~~L~~~~~~~  275 (285)
T d1fmka3         252 RKEPEERPTFEYLQAFLEDYFTST  275 (285)
T ss_dssp             CSSGGGSCCHHHHHHHHHTTTSCS
T ss_pred             ccCHhHCcCHHHHHHHHhhhhcCC
Confidence            999999999999988  8898653

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-42  Score=326.66  Aligned_cols=218  Identities=26%  Similarity=0.416  Sum_probs=177.0

Q ss_pred             chhHHHHHHHHHhCCC-CCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKH-ENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~h-pnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      .+.+++|+++|++++| |||+++++++.+.        ..+++||||+.+ +|...+.... .+++..++.++.||+.||
T Consensus        72 ~~~~~~E~~il~~l~h~pnIv~~~~~~~~~--------~~~~~v~e~~~~~~L~~~i~~~~-~~~e~~~~~~~~Qi~~al  142 (322)
T d1vzoa_          72 TEHTRTERQVLEHIRQSPFLVTLHYAFQTE--------TKLHLILDYINGGELFTHLSQRE-RFTEHEVQIYVGEIVLAL  142 (322)
T ss_dssp             GGGCCCHHHHHHHHHTCTTBCCEEEEEEET--------TEEEEEECCCCSCBHHHHHHHHS-CCCHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHhccCCCeEEEeeeeeccC--------CceeeeeecccccHHHHHHHhcc-cccHHHHHHHHHHHHHHH
Confidence            4568899999999965 8999999999986        569999999984 7888876644 678999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCC-CCCCcchhhhHH
Q psy7889          85 YYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDR-NYGPPVDLWGAG  163 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~~DiwSlG  163 (433)
                      +|||++||+||||||+|||++.+|.+||+|||+++.+.....   .......|++.|+|||++.+.. .++.++||||||
T Consensus       143 ~~lH~~~ivHrDiKp~Nill~~~~~vkL~DFG~a~~~~~~~~---~~~~~~~g~~~~~~pe~~~~~~~~~~~ksDIWSlG  219 (322)
T d1vzoa_         143 EHLHKLGIIYRDIKLENILLDSNGHVVLTDFGLSKEFVADET---ERAYDFCGTIEYMAPDIVRGGDSGHDKAVDWWSLG  219 (322)
T ss_dssp             HHHHHTTCCCCCCCGGGEEECTTSCEEESCSSEEEECCGGGG---GGGCGGGSCCTTCCHHHHTTCC---CTHHHHHHHH
T ss_pred             HHhhcCCEEeccCCccceeecCCCCEEEeeccchhhhccccc---ccccccccccccchhHHhhcCCcCCCchhhhHHHH
Confidence            999999999999999999999999999999999987653322   2234567899999999997643 468899999999


Q ss_pred             HHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhc
Q psy7889         164 CIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLL  243 (433)
Q Consensus       164 vil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L  243 (433)
                      |++|+|++|.+||.+.+..+....+.+........                            .+...++++++||.+||
T Consensus       220 ~iLyelltG~~PF~~~~~~~~~~~i~~~~~~~~~~----------------------------~~~~~s~~~~~li~~~l  271 (322)
T d1vzoa_         220 VLMYELLTGASPFTVDGEKNSQAEISRRILKSEPP----------------------------YPQEMSALAKDLIQRLL  271 (322)
T ss_dssp             HHHHHHHHSSCTTSCTTSCCCHHHHHHHHHHCCCC----------------------------CCTTSCHHHHHHHHHHT
T ss_pred             HHHHHHHhCCCCCCCCCHHHHHHHHHHhcccCCCC----------------------------CcccCCHHHHHHHHHHc
Confidence            99999999999998876554444443321111000                            11236788999999999


Q ss_pred             ccCCCCCC-----CHHHhhcCCCccC
Q psy7889         244 LLDPSKRF-----DSDAALNHDFFWT  264 (433)
Q Consensus       244 ~~dP~~R~-----t~~e~L~h~~~~~  264 (433)
                      ++||.+||     |++|+|+||||+.
T Consensus       272 ~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         272 MKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             ccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            99999999     5899999999964

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=2e-41  Score=314.73  Aligned_cols=210  Identities=24%  Similarity=0.349  Sum_probs=171.8

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+.+|+++|+.++|||||++++++.++         .+++|||||. +++.+.+......+++..+..++.||+.||.|
T Consensus        56 ~~~~~Ei~~l~~l~H~nIv~~~g~~~~~---------~~~lv~e~~~~~~l~~~~~~~~~~l~~~~~~~~~~qi~~gl~y  126 (273)
T d1u46a_          56 DDFIREVNAMHSLDHRNLIRLYGVVLTP---------PMKMVTELAPLGSLLDRLRKHQGHFLLGTLSRYAVQVAEGMGY  126 (273)
T ss_dssp             HHHHHHHHHHHHCCCTTBCCEEEEECSS---------SCEEEEECCTTCBHHHHHHHHGGGSCHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEEEEEEEEeec---------chheeeeeecCcchhhhhhcccCCCCHHHHHHHHHHHHHHHHH
Confidence            4689999999999999999999999642         3689999997 57888777766679999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||++||+||||||+||+++.++.+||+|||+++........ ........++..|+|||++.+.. ++.++|||||||++
T Consensus       127 lH~~~iiHrDikp~NIll~~~~~vkl~DfGl~~~~~~~~~~-~~~~~~~~~~~~~~aPE~~~~~~-~~~~~Di~S~Gvil  204 (273)
T d1u46a_         127 LESKRFIHRDLAARNLLLATRDLVKIGDFGLMRALPQNDDH-YVMQEHRKVPFAWCAPESLKTRT-FSHASDTWMFGVTL  204 (273)
T ss_dssp             HHHTTEECSCCCGGGEEEEETTEEEECCCTTCEECCC-CCE-EEC-----CCGGGCCHHHHHHCE-EEHHHHHHHHHHHH
T ss_pred             hhhCCEeeeeecHHHhccccccceeeccchhhhhcccCCCc-ceecCccccCcccCCHHHHhCCC-CCcchhhhhhHHHH
Confidence            99999999999999999999999999999999887543221 12233456788999999998765 79999999999999


Q ss_pred             HHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++ |.+||.+.+..+....+......+  +                            .+...+..+.+||.+||..
T Consensus       205 ~emlt~G~~Pf~~~~~~~~~~~i~~~~~~~--~----------------------------~~~~~~~~l~~li~~cl~~  254 (273)
T d1u46a_         205 WEMFTYGQEPWIGLNGSQILHKIDKEGERL--P----------------------------RPEDCPQDIYNVMVQCWAH  254 (273)
T ss_dssp             HHHHTTSCCTTTTCCHHHHHHHHHTSCCCC--C----------------------------CCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHhCCCCCCCCcCHHHHHHHHHhCCCCC--C----------------------------CcccccHHHHHHHHHHcCC
Confidence            99998 899999999888777664321111  0                            0112456778999999999


Q ss_pred             CCCCCCCHHHhhc
Q psy7889         246 DPSKRFDSDAALN  258 (433)
Q Consensus       246 dP~~R~t~~e~L~  258 (433)
                      ||++|||++|+++
T Consensus       255 dp~~RPt~~ei~~  267 (273)
T d1u46a_         255 KPEDRPTFVALRD  267 (273)
T ss_dssp             SGGGSCCHHHHHH
T ss_pred             ChhHCcCHHHHHH
Confidence            9999999999863

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7e-41  Score=315.78  Aligned_cols=212  Identities=22%  Similarity=0.379  Sum_probs=163.5

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+++|+.++.++ +|+|||.+++++...       ...+++|||||+ |+|.+++....               ..+++
T Consensus        61 ~~~~~e~~~l~~~~~h~~iv~~~~~~~~~-------~~~~~iv~E~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~~  133 (299)
T d1ywna1          61 RALMSELKILIHIGHHLNVVNLLGACTKP-------GGPLMVIVEFCKFGNLSTYLRSKRNEFVPYKVAPEDLYKDFLTL  133 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECST-------TSCCEEEEECCTTCBHHHHHHHTGGGBCC-----------CBCH
T ss_pred             HHHHHHHHHHHhhcCCCeEEEeeeeeccC-------CCeEEEEEEecCCCcHHHHHHhccccccccccchhhhhcccCCH
Confidence            4577888888877 699999999988765       356899999998 58888886532               24889


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      .++..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+.......  ........||+.|+|||++.+.
T Consensus       134 ~~~~~~~~qi~~gl~ylH~~~ivHrDlKp~NILl~~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~gt~~y~APE~l~~~  211 (299)
T d1ywna1         134 EHLICYSFQVAKGMEFLASRKCIHRDLAARNILLSEKNVVKICDFGLARDIYKDPD--YVRKGDARLPLKWMAPETIFDR  211 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCCGGGEEECGGGCEEECC------CCSCTT--SCCTTSCCCGGGGCCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHHHhCCCcCCcCCccceeECCCCcEEEccCcchhhcccccc--ccccCceeeCccccchhHhhcC
Confidence            99999999999999999999999999999999999999999999999987653322  2233456789999999999876


Q ss_pred             CCCCCcchhhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . ++.++||||+||++|||++| .+||.+....+.+..+...-..+.                              .+.
T Consensus       212 ~-~~~~sDiwS~Gvil~ellt~~~~p~~~~~~~~~~~~~~~~~~~~~------------------------------~~~  260 (299)
T d1ywna1         212 V-YTIQSDVWSFGVLLWEIFSLGASPYPGVKIDEEFCRRLKEGTRMR------------------------------APD  260 (299)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCCSHHHHHHHHHTCCCC------------------------------CCT
T ss_pred             C-CCcccceeehHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC------------------------------CCc
Confidence            5 79999999999999999986 678887665444433322111110                              011


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ..++++++||.+||+.||.+|||++|+++|
T Consensus       261 ~~~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         261 YTTPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             TCCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            246778899999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.1e-41  Score=311.35  Aligned_cols=209  Identities=19%  Similarity=0.297  Sum_probs=164.6

Q ss_pred             CCchhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-CCCCHHHHHHHHHHHHH
Q psy7889           5 FFPITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-VKFSLGEIKKVIQQLLN   82 (433)
Q Consensus         5 ~~~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-~~l~~~~~~~i~~qll~   82 (433)
                      ...+.+.+|+++|++++|||||++++++.+.       .+.+|+||||++ |+|.+++.+.. ..+++..+..++.||+.
T Consensus        42 ~~~~~~~~E~~~l~~l~HpnIv~~~g~~~~~-------~~~~~lv~ey~~~g~L~~~l~~~~~~~l~~~~~~~i~~~i~~  114 (262)
T d1byga_          42 ATAQAFLAEASVMTQLRHSNLVQLLGVIVEE-------KGGLYIVTEYMAKGSLVDYLRSRGRSVLGGDCLLKFSLDVCE  114 (262)
T ss_dssp             C--HHHHHTHHHHTTCCCTTBCCEEEEECCC---------CCEEEECCCTTEEHHHHHHHHHHHHCCHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHHHHhCCCCCEeeEEEEEEec-------CCcEEEEEeccCCCCHHHHHHhcCCCCCCHHHHHHHHHHHHh
Confidence            4467899999999999999999999998654       245899999997 58998886533 34899999999999999


Q ss_pred             HHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhH
Q psy7889          83 GLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        83 aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSl  162 (433)
                      ||.|||+.+|+||||||+|||++.+|.+||+|||+++.....       .....+|..|+|||++.+.. ++.++|||||
T Consensus       115 al~ylH~~~ivH~dlkp~Nil~~~~~~~kl~dfg~s~~~~~~-------~~~~~~~~~y~aPE~l~~~~-~t~~sDIwSf  186 (262)
T d1byga_         115 AMEYLEGNNFVHRDLAARNVLVSEDNVAKVSDFGLTKEASST-------QDTGKLPVKWTAPEALREKK-FSTKSDVWSF  186 (262)
T ss_dssp             HHHHHHHTTCCCSCCSGGGEEECTTSCEEECCCCC-------------------CCTTTSCHHHHHHCC-CCHHHHHHHH
T ss_pred             hccccccCceeccccchHhheecCCCCEeecccccceecCCC-------CccccccccCCChHHHhCCC-CChHHHHHhH
Confidence            999999999999999999999999999999999999875432       23346688999999998765 7999999999


Q ss_pred             HHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHh
Q psy7889         163 GCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDK  241 (433)
Q Consensus       163 Gvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~  241 (433)
                      ||++|||++ |.+||.+.+..+....+.......                               .+...++++.+||.+
T Consensus       187 G~il~el~t~~~~p~~~~~~~~~~~~i~~~~~~~-------------------------------~~~~~~~~~~~li~~  235 (262)
T d1byga_         187 GILLWEIYSFGRVPYPRIPLKDVVPRVEKGYKMD-------------------------------APDGCPPAVYEVMKN  235 (262)
T ss_dssp             HHHHHHHHTTSCCSCTTSCGGGHHHHHTTTCCCC-------------------------------CCTTCCHHHHHHHHH
T ss_pred             HHHHHHHHHCCCCCCCCCCHHHHHHHHHcCCCCC-------------------------------CCccCCHHHHHHHHH
Confidence            999999998 799999887776655553211000                               011246778899999


Q ss_pred             hcccCCCCCCCHHHhhcC
Q psy7889         242 LLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       242 ~L~~dP~~R~t~~e~L~h  259 (433)
                      ||..||.+|||+.+++++
T Consensus       236 cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         236 CWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             HTCSSGGGSCCHHHHHHH
T ss_pred             HcccCHhHCcCHHHHHHH
Confidence            999999999999999863

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=3.3e-40  Score=312.18  Aligned_cols=213  Identities=22%  Similarity=0.306  Sum_probs=169.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ..+++|+++|++++|||||++++++...       .+.+++|||||++ +|.+++......+++..+..++.|++.||.|
T Consensus        73 ~~~~~E~~~l~~l~HpnIv~~~g~~~~~-------~~~~~lv~E~~~~g~l~~~~~~~~~~~~~~~~~~i~~qia~gL~~  145 (311)
T d1r0pa_          73 SQFLTEGIIMKDFSHPNVLSLLGICLRS-------EGSPLVVLPYMKHGDLRNFIRNETHNPTVKDLIGFGLQVAKGMKF  145 (311)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCCCEEEEET-------TTEEEEEEECCTTCBHHHHHHCTTCCCBHHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHhCCCCCEeEEeEEEEec-------CCceEEEEEEeecCchhhhhccccccchHHHHHHHHHHHHHhhhh
Confidence            5689999999999999999999998764       2568999999985 7777777777678899999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcchhhhHHHHH
Q psy7889          87 IHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVDLWGAGCIM  166 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~DiwSlGvil  166 (433)
                      ||+.||+||||||+|||++.++.+||+|||+++.................||..|+|||++.+.. ++.++|||||||++
T Consensus       146 lH~~~iiHrDLK~~NILl~~~~~~kL~DFG~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~ksDI~SfGivl  224 (311)
T d1r0pa_         146 LASKKFVHRDLAARNCMLDEKFTVKVADFGLARDMYDKEFDSVHNKTGAKLPVKWMALESLQTQK-FTTKSDVWSFGVLL  224 (311)
T ss_dssp             HHHTTCCCSCCSGGGEEECTTCCEEECSSGGGCCTTTTTCCCTTCTTCSSCCGGGSCHHHHHHCC-CCHHHHHHHHHHHH
T ss_pred             hcccCcccCCccHHhEeECCCCCEEEecccchhhccccccccceecccccccccccChHHHhcCC-CCChhHhhhhHHHH
Confidence            99999999999999999999999999999999887654333333344567899999999987765 79999999999999


Q ss_pred             HHHHhcCCCCCC-CChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHHhhccc
Q psy7889         167 AEMWTRSPIMQG-NTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLL  245 (433)
Q Consensus       167 ~ell~g~~pf~~-~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~  245 (433)
                      |||++|..||.. .+..+....+..  |..+                             ..+...++++.+||.+||..
T Consensus       225 ~El~t~~~p~~~~~~~~~~~~~i~~--g~~~-----------------------------~~p~~~~~~l~~li~~cl~~  273 (311)
T d1r0pa_         225 WELMTRGAPPYPDVNTFDITVYLLQ--GRRL-----------------------------LQPEYCPDPLYEVMLKCWHP  273 (311)
T ss_dssp             HHHHTTSCCSCC------CHHHHHT--TCCC-----------------------------CCCTTCCHHHHHHHHHHTCS
T ss_pred             HHHHHCCCCCCCCCCHHHHHHHHHc--CCCC-----------------------------CCcccCcHHHHHHHHHHcCC
Confidence            999996655554 333333333322  1100                             00112456778999999999


Q ss_pred             CCCCCCCHHHhhcC
Q psy7889         246 DPSKRFDSDAALNH  259 (433)
Q Consensus       246 dP~~R~t~~e~L~h  259 (433)
                      ||++||++.|+++|
T Consensus       274 dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         274 KAEMRPSFSELVSR  287 (311)
T ss_dssp             SGGGSCCHHHHHHH
T ss_pred             CHhHCcCHHHHHHH
Confidence            99999999999976

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=7.5e-40  Score=308.43  Aligned_cols=209  Identities=23%  Similarity=0.419  Sum_probs=173.3

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------CCCCH
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------VKFSL   70 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------~~l~~   70 (433)
                      ..+.+|+.++.++ +|||||++++++.++        +.+++|||||. |+|.+++....               ..+++
T Consensus        63 ~~~~~e~~~l~~~~~HpnIv~~~~~~~~~--------~~~~~v~e~~~~g~l~~~i~~~~~~~~~~~~~~~~~~~~~l~~  134 (299)
T d1fgka_          63 SDLISEMEMMKMIGKHKNIINLLGACTQD--------GPLYVIVEYASKGNLREYLQARRPPGLEYSYNPSHNPEEQLSS  134 (299)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEECCCTTCBHHHHHHTTSCC------------CCCCCH
T ss_pred             HHHHHHHHHHHHhcCCCeEEecccccccC--------CeEEEEEEccCCCcHHHHHHhhcCCccccccccccCccccCCH
Confidence            4677899999888 799999999999875        56899999997 57888886543               34899


Q ss_pred             HHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCC
Q psy7889          71 GEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGD  150 (433)
Q Consensus        71 ~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~  150 (433)
                      .+++.++.||+.||+|||++||+||||||+|||++.++.+||+|||+++.......  ........+|+.|+|||++.+.
T Consensus       135 ~~~~~~~~qi~~al~ylH~~~ivHrDiKp~NiLl~~~~~~kl~dfg~~~~~~~~~~--~~~~~~~~~~~~y~aPE~l~~~  212 (299)
T d1fgka_         135 KDLVSCAYQVARGMEYLASKKCIHRDLAARNVLVTEDNVMKIADFGLARDIHHIDY--YKKTTNGRLPVKWMAPEALFDR  212 (299)
T ss_dssp             HHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECTTCCEEECSTTCCCCGGGCCT--TCCCTTSCCGGGGSCHHHHHHC
T ss_pred             HHHHHHHHHHHHHHHHhhhCCEEeeeecccceeecCCCCeEeccchhhcccccccc--ccccccCCCChhhhhhhHhcCC
Confidence            99999999999999999999999999999999999999999999999988764332  2234456789999999999776


Q ss_pred             CCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCc
Q psy7889         151 RNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPY  229 (433)
Q Consensus       151 ~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  229 (433)
                      . |+.++|||||||++|||++ |.+||.+.+..+....+........                               +.
T Consensus       213 ~-y~~k~DiwS~Gvvl~ell~~g~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------p~  260 (299)
T d1fgka_         213 I-YTHQSDVWSFGVLLWEIFTLGGSPYPGVPVEELFKLLKEGHRMDK-------------------------------PS  260 (299)
T ss_dssp             C-CCHHHHHHHHHHHHHHHHTTSCCSSTTCCHHHHHHHHHTTCCCCC-------------------------------CS
T ss_pred             C-CCchhhhHHhHHHHHHhccCCCCCCCCCCHHHHHHHHHcCCCCCC-------------------------------Cc
Confidence            5 8999999999999999998 7999998887766555432111100                               11


Q ss_pred             cCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         230 VKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       230 ~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ..++++.+||.+||+.||++|||+.|+++
T Consensus       261 ~~~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         261 NCTNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             SCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cchHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            24667889999999999999999999986

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=4.6e-40  Score=310.25  Aligned_cols=209  Identities=22%  Similarity=0.356  Sum_probs=171.2

Q ss_pred             hhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------------------
Q psy7889           8 ITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------------------   65 (433)
Q Consensus         8 ~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------------------   65 (433)
                      ..+.+|+++|+.++||||+++++++...        ..+++||||+. ++|.+++....                     
T Consensus        61 ~~~~~E~~il~~l~h~niv~~~~~~~~~--------~~~~~v~e~~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~~~~~  132 (301)
T d1lufa_          61 ADFQREAALMAEFDNPNIVKLLGVCAVG--------KPMCLLFEYMAYGDLNEFLRSMSPHTVCSLSHSDLSTRARVSSP  132 (301)
T ss_dssp             HHHHHHHHHHHTCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHTCC--------------------
T ss_pred             HHHHHHHHHHHhcCCCCcccceeeeccC--------CceEEEEEecCCCcHHHHHHhcCccccccccccccchhhhcccc
Confidence            5689999999999999999999999875        55899999997 58888886432                     


Q ss_pred             --CCCCHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccC
Q psy7889          66 --VKFSLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRP  143 (433)
Q Consensus        66 --~~l~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~a  143 (433)
                        ..+++..+..++.||+.||+|||++||+||||||+|||++.++.+||+|||+|+......  .........+|+.|+|
T Consensus       133 ~~~~l~~~~~~~i~~qi~~gl~ylH~~~ivHrDlKp~NILld~~~~~Kl~DFGls~~~~~~~--~~~~~~~~~~~~~y~a  210 (301)
T d1lufa_         133 GPPPLSCAEQLCIARQVAAGMAYLSERKFVHRDLATRNCLVGENMVVKIADFGLSRNIYSAD--YYKADGNDAIPIRWMP  210 (301)
T ss_dssp             --CCCCHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEECGGGCEEECCCSCHHHHTGGG--CBC----CCBCGGGCC
T ss_pred             CCCCCCHHHHHHHHHHHHHHhhhcccCCeEeeEEcccceEECCCCcEEEccchhheeccCCc--cccccCCCCcCcCcCC
Confidence              237889999999999999999999999999999999999999999999999998664332  1223345678899999


Q ss_pred             cccccCCCCCCCcchhhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhH
Q psy7889         144 PELLLGDRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKV  222 (433)
Q Consensus       144 PE~~~~~~~~~~~~DiwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  222 (433)
                      ||++.+.. |+.++||||+||++|||++| .+||.+.+..+.+..+........                          
T Consensus       211 PE~~~~~~-~t~ksDVwS~Gvvl~ell~~~~~p~~~~~~~e~~~~v~~~~~~~~--------------------------  263 (301)
T d1lufa_         211 PESIFYNR-YTTESDVWAYGVVLWEIFSYGLQPYYGMAHEEVIYYVRDGNILAC--------------------------  263 (301)
T ss_dssp             HHHHHHCC-CCHHHHHHHHHHHHHHHHTTTCCTTTTSCHHHHHHHHHTTCCCCC--------------------------
T ss_pred             HHHHccCC-CChhhhhccchhhHHHHHccCCCCCCCCCHHHHHHHHHcCCCCCC--------------------------
Confidence            99998765 89999999999999999998 578999888877766543211100                          


Q ss_pred             HhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         223 KERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       223 ~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                           +...++++.+||.+||+.||++|||+.|+++
T Consensus       264 -----p~~~~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         264 -----PENCPLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             -----CTTCCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             -----CccchHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence                 1124567789999999999999999999964

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4e-40  Score=311.76  Aligned_cols=208  Identities=23%  Similarity=0.334  Sum_probs=170.6

Q ss_pred             chhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhcc---------------CCCCC
Q psy7889           7 PITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNI---------------HVKFS   69 (433)
Q Consensus         7 ~~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~---------------~~~l~   69 (433)
                      .+.+.+|+++|+++ +|||||++++++.+.        +.+|+|||||+ |+|.+++...               ...++
T Consensus        54 ~~~~~~E~~~l~~l~~HpnIv~~~~~~~~~--------~~~~iV~ey~~~g~L~~~l~~~~~~~~~~~~~~~~~~~~~l~  125 (309)
T d1fvra_          54 HRDFAGELEVLCKLGHHPNIINLLGACEHR--------GYLYLAIEYAPHGNLLDFLRKSRVLETDPAFAIANSTASTLS  125 (309)
T ss_dssp             -CHHHHHHHHHTTCCCCTTBCCEEEEEEET--------TEEEEEECCCTTCBHHHHHHTTCHHHHCHHHHHHTTBSCSSC
T ss_pred             HHHHHHHHHHHHhccCCCCEeeEEEEEecC--------CeeEEEEEecCCCcHHHHHhhccccccchhhhccccccCCCC
Confidence            45689999999999 799999999999876        66999999998 5888888643               34689


Q ss_pred             HHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccC
Q psy7889          70 LGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLG  149 (433)
Q Consensus        70 ~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~  149 (433)
                      +..+..++.||+.||.|||++||+||||||+|||++.++.+||+|||+++......     ......||..|+|||.+.+
T Consensus       126 ~~~~~~~~~qia~gl~~lH~~~iiHrDlkp~NIL~~~~~~~kl~DfG~a~~~~~~~-----~~~~~~gt~~y~aPE~l~~  200 (309)
T d1fvra_         126 SQQLLHFAADVARGMDYLSQKQFIHRDLAARNILVGENYVAKIADFGLSRGQEVYV-----KKTMGRLPVRWMAIESLNY  200 (309)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTTEECSCCSGGGEEECGGGCEEECCTTCEESSCEEC-----CC----CCTTTCCHHHHHH
T ss_pred             HHHHHHHHHHHHHHHHhhhcCCccccccccceEEEcCCCceEEccccccccccccc-----cccceecCCcccchHHhcc
Confidence            99999999999999999999999999999999999999999999999997654321     2234567999999999977


Q ss_pred             CCCCCCcchhhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCC
Q psy7889         150 DRNYGPPVDLWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKP  228 (433)
Q Consensus       150 ~~~~~~~~DiwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  228 (433)
                      .. |+.++|||||||++|||++| .+||.+.+..+....+.+...   ++                            .+
T Consensus       201 ~~-~~~~sDvwSfGvil~ell~~~~~p~~~~~~~~~~~~i~~~~~---~~----------------------------~~  248 (309)
T d1fvra_         201 SV-YTTNSDVWSYGVLLWEIVSLGGTPYCGMTCAELYEKLPQGYR---LE----------------------------KP  248 (309)
T ss_dssp             CE-ECHHHHHHHHHHHHHHHHTTSCCTTTTCCHHHHHHHGGGTCC---CC----------------------------CC
T ss_pred             CC-CCccceeehhHHHHHHHHhcCCCCCCCCCHHHHHHHHHhcCC---CC----------------------------CC
Confidence            65 79999999999999999996 578888887776655432110   00                            01


Q ss_pred             ccCChhHHHHHHhhcccCCCCCCCHHHhhcC
Q psy7889         229 YVKDQYGCDLLDKLLLLDPSKRFDSDAALNH  259 (433)
Q Consensus       229 ~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h  259 (433)
                      ...++++.+||.+||+.||++|||++|+++|
T Consensus       249 ~~~~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         249 LNCDDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             TTBCHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             ccCCHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            1246778899999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.4e-39  Score=304.84  Aligned_cols=210  Identities=23%  Similarity=0.378  Sum_probs=171.7

Q ss_pred             hhHHHHHHHHHhC-CCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC-----------------CCC
Q psy7889           8 ITALREIKILQLL-KHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH-----------------VKF   68 (433)
Q Consensus         8 ~~~~~Ei~il~~l-~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~-----------------~~l   68 (433)
                      ..+++|+.+++.+ +|||||++++++.+.        ..+|||||||+ ++|..++....                 ..+
T Consensus        71 ~~~~~E~~~~~~l~~HpnIv~~~g~~~~~--------~~~~lvmE~~~~g~l~~~l~~~~~~~~~~~~~~~~~~~~~~~l  142 (311)
T d1t46a_          71 EALMSELKVLSYLGNHMNIVNLLGACTIG--------GPTLVITEYCCYGDLLNFLRRKRDSFICSKTSPAIMEDDELAL  142 (311)
T ss_dssp             HHHHHHHHHHHHHCCCTTBCCEEEEECSS--------SSCEEEEECCTTEEHHHHHHHTTTTC--------------CCC
T ss_pred             HHHHHHHHHHHhccCCCCEEEEEEEEeeC--------CEEEEEEEcCCCCCHHHHHHhccccccccccccccccccccCC
Confidence            4578999999999 699999999999875        55899999997 47888876432                 248


Q ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCccccc
Q psy7889          69 SLGEIKKVIQQLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLL  148 (433)
Q Consensus        69 ~~~~~~~i~~qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~  148 (433)
                      ++..+..++.||+.||+|||++||+||||||+||+++.++.+|++|||+++.......  .......+||+.|+|||++.
T Consensus       143 ~~~~~~~~~~qi~~gl~~LH~~~ivHrDLKp~NIl~~~~~~~ki~DfG~~~~~~~~~~--~~~~~~~~gt~~y~aPE~~~  220 (311)
T d1t46a_         143 DLEDLLSFSYQVAKGMAFLASKNCIHRDLAARNILLTHGRITKICDFGLARDIKNDSN--YVVKGNARLPVKWMAPESIF  220 (311)
T ss_dssp             CHHHHHHHHHHHHHHHHHHHHTTCCCSCCSGGGEEEETTTEEEECCCGGGSCTTSCTT--SEECSSSEECGGGCCHHHHH
T ss_pred             CHHHHHHHHHHHHHHHHHHHhCCeeecccccccccccccCcccccccchheeccCCCc--ceEeeecccChHHcCHHHhc
Confidence            9999999999999999999999999999999999999999999999999987754322  12334567899999999997


Q ss_pred             CCCCCCCcchhhhHHHHHHHHHh-cCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhC
Q psy7889         149 GDRNYGPPVDLWGAGCIMAEMWT-RSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLK  227 (433)
Q Consensus       149 ~~~~~~~~~DiwSlGvil~ell~-g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  227 (433)
                      +.. ++.++|||||||++|||++ |.++|.+.+..+.+..+...-..+.                              .
T Consensus       221 ~~~-~~~~~DIwS~G~~l~ellt~g~p~~~~~~~~~~~~~~i~~~~~~~------------------------------~  269 (311)
T d1t46a_         221 NCV-YTFESDVWSYGIFLWELFSLGSSPYPGMPVDSKFYKMIKEGFRML------------------------------S  269 (311)
T ss_dssp             HCC-CCHHHHHHHHHHHHHHHHTTTCCSSTTCCSSHHHHHHHHHTCCCC------------------------------C
T ss_pred             CCC-CCCcccccchHHHHHHHHhCCCCCCCCCCHHHHHHHHHhcCCCCC------------------------------C
Confidence            655 7999999999999999998 7888888776665555433211110                              1


Q ss_pred             CccCChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         228 PYVKDQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       228 ~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +...+..+.+||.+||+.||.+|||++|+++
T Consensus       270 ~~~~~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         270 PEHAPAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CTTSCHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cccccHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            1124677889999999999999999999985

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=4.5e-39  Score=304.25  Aligned_cols=208  Identities=19%  Similarity=0.325  Sum_probs=171.8

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCc-CCHHHHHhccC---------CCCCHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCE-HDLAGLLSNIH---------VKFSLGEIKKVIQ   78 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~-~~L~~~l~~~~---------~~l~~~~~~~i~~   78 (433)
                      .+++|+++|++++|||||++++++...        ..+++|||||. |+|.+++....         ..+++..+..++.
T Consensus        69 ~~~~E~~il~~l~h~nIv~~~~~~~~~--------~~~~lv~e~~~~g~l~~~~~~~~~~~~~~~~~~~~~~~~~~~i~~  140 (308)
T d1p4oa_          69 EFLNEASVMKEFNCHHVVRLLGVVSQG--------QPTLVIMELMTRGDLKSYLRSLRPAMANNPVLAPPSLSKMIQMAG  140 (308)
T ss_dssp             HHHHHHHHGGGCCCTTBCCEEEEECSS--------SSCEEEEECCTTCBHHHHHHHHHHHHHHCTTCCCCCHHHHHHHHH
T ss_pred             HHHHHHHHHHHcCCCCEeeeeeEEecC--------CceeEEEeecCCCCHHHHHHhcccccccccccCCCCHHHHHHHHH
Confidence            478999999999999999999999765        55899999997 57877765421         2368899999999


Q ss_pred             HHHHHHHHHHhCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCCCCCcch
Q psy7889          79 QLLNGLYYIHSNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRNYGPPVD  158 (433)
Q Consensus        79 qll~aL~~LH~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~~D  158 (433)
                      |++.||.|||+++|+||||||+|||++.++.+||+|||+++.......  ........+|+.|+|||.+.+.. ++.++|
T Consensus       141 ~ia~gl~~LH~~~ivHrDlk~~NiLld~~~~~Kl~DFGla~~~~~~~~--~~~~~~~~~t~~y~aPe~l~~~~-~~~~~D  217 (308)
T d1p4oa_         141 EIADGMAYLNANKFVHRDLAARNCMVAEDFTVKIGDFGMTRDIYETDY--YRKGGKGLLPVRWMSPESLKDGV-FTTYSD  217 (308)
T ss_dssp             HHHHHHHHHHHTTCBCSCCSGGGEEECTTCCEEECCTTCCCGGGGGGC--EEGGGSSEECGGGCCHHHHHHCC-CCHHHH
T ss_pred             HHHHHHHHHhhCCeeeceEcCCceeecCCceEEEeecccceeccCCcc--eeeccceecccccCCHHHHccCC-CCcccc
Confidence            999999999999999999999999999999999999999987654322  12234457899999999998765 799999


Q ss_pred             hhhHHHHHHHHHhc-CCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHH
Q psy7889         159 LWGAGCIMAEMWTR-SPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCD  237 (433)
Q Consensus       159 iwSlGvil~ell~g-~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~  237 (433)
                      |||+||++|||++| .+||.+.+..+.+..+........                               +...++.+.+
T Consensus       218 v~S~G~il~El~t~~~~p~~~~~~~~~~~~i~~~~~~~~-------------------------------p~~~~~~l~~  266 (308)
T d1p4oa_         218 VWSFGVVLWEIATLAEQPYQGLSNEQVLRFVMEGGLLDK-------------------------------PDNCPDMLFE  266 (308)
T ss_dssp             HHHHHHHHHHHHHTSCCTTTTSCHHHHHHHHHTTCCCCC-------------------------------CTTCCHHHHH
T ss_pred             cccHHHHHHHHHhCCCCCCCCCCHHHHHHHHHhCCCCCC-------------------------------cccchHHHHH
Confidence            99999999999998 589999888877776643211110                               1124567789


Q ss_pred             HHHhhcccCCCCCCCHHHhhc
Q psy7889         238 LLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       238 li~~~L~~dP~~R~t~~e~L~  258 (433)
                      +|.+||+.||++|||++++++
T Consensus       267 li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         267 LMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             HHHHHTCSSGGGSCCHHHHHH
T ss_pred             HHHHHcCCChhHCcCHHHHHH
Confidence            999999999999999999997

>d1ckia_ d.144.1.7 (A:) Casein kinase-1, CK1 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=100.00  E-value=8.9e-38  Score=294.42  Aligned_cols=225  Identities=20%  Similarity=0.200  Sum_probs=169.6

Q ss_pred             chhHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYY   86 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~   86 (433)
                      ...+.+|+++++.++|+|+|..+..+...       .+..++|||||++++...+......+++..+..++.|++.||+|
T Consensus        46 ~~~~~~E~~i~~~l~~~~~i~~~~~~~~~-------~~~~~ivme~~~~~l~~~~~~~~~~~~~~~~~~~~~qi~~~l~~  118 (299)
T d1ckia_          46 HPQLHIESKIYKMMQGGVGIPTIRWCGAE-------GDYNVMVMELLGPSLEDLFNFCSRKFSLKTVLLLADQMISRIEY  118 (299)
T ss_dssp             SCCHHHHHHHHHHSTTSTTCCCEEEEEEE-------TTEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHHHccCCCcccEEEEEEec-------CCEEEEEEEEcCCchhhhhhhccCCCcHHHHHHHHHHHHHHHHH
Confidence            45789999999999877766555554433       36789999999999988888777789999999999999999999


Q ss_pred             HHhCCeeccCCCCCcEEEec---CCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCcchhh
Q psy7889          87 IHSNKILHRDMKAANVLITK---TGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPPVDLW  160 (433)
Q Consensus        87 LH~~~iiH~dikp~NIll~~---~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~~Diw  160 (433)
                      ||++||+||||||+|||++.   +..+||+|||+|+.+........   ......+||+.|+|||++.+.. ++.++|||
T Consensus       119 lH~~~iiHrDiKp~NIl~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~-~~~~~Diw  197 (299)
T d1ckia_         119 IHSKNFIHRDVKPDNFLMGLGKKGNLVYIIDFGLAKKYRDARTHQHIPYRENKNLTGTARYASINTHLGIE-QSRRDDLE  197 (299)
T ss_dssp             HHHTTEECSCCCGGGEEECCGGGTTCEEECCCSSCEECBCTTTCCBCCCCBCCSCCCCSSSCCHHHHTTBC-CCHHHHHH
T ss_pred             HHHCCeeeccCCHhhccccccCCCceeeeeccCcceeccccccccceeccccCCcCCCccccCHHHHhCCC-CCChhhEE
Confidence            99999999999999999863   45799999999988764432221   2234568999999999998765 79999999


Q ss_pred             hHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCChhHHHHHH
Q psy7889         161 GAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQYGCDLLD  240 (433)
Q Consensus       161 SlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~  240 (433)
                      ||||++|||++|.+||.+.........+......                      .........  ....++++.+||.
T Consensus       198 SlG~~l~el~tg~~P~~~~~~~~~~~~~~~~~~~----------------------~~~~~~~~~--~~~~p~~~~~li~  253 (299)
T d1ckia_         198 SLGYVLMYFNLGSLPWQGLKAATKRQKYERISEK----------------------KMSTPIEVL--CKGYPSEFATYLN  253 (299)
T ss_dssp             HHHHHHHHHHHSSCTTCCCC-------HHHHHHH----------------------HHHSCHHHH--TTTSCHHHHHHHH
T ss_pred             ecCHHHHHHHhCCCcccccchHHHHHHHHHhhcc----------------------cCCCChhHh--ccCCCHHHHHHHH
Confidence            9999999999999999887655443333221100                      000000000  1135678889999


Q ss_pred             hhcccCCCCCCCHHH---hhcCCCcc
Q psy7889         241 KLLLLDPSKRFDSDA---ALNHDFFW  263 (433)
Q Consensus       241 ~~L~~dP~~R~t~~e---~L~h~~~~  263 (433)
                      +||..||++||++++   +|+|+|..
T Consensus       254 ~cl~~~p~~RP~~~~i~~~l~~~~~~  279 (299)
T d1ckia_         254 FCRSLRFDDKPDYSYLRQLFRNLFHR  279 (299)
T ss_dssp             HHHHSCTTCCCCHHHHHHHHHHHHHH
T ss_pred             HHccCChhHCcCHHHHHHHHHHHHHH
Confidence            999999999999874   56777653

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=100.00  E-value=1.2e-38  Score=300.50  Aligned_cols=235  Identities=22%  Similarity=0.279  Sum_probs=159.2

Q ss_pred             hhHHHHHHHH--HhCCCCCccceeeeEEecCccccccCceEEEEeecCcC-CHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           8 ITALREIKIL--QLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH-DLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         8 ~~~~~Ei~il--~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~-~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+|.+++  ..++|||||++++++.+....    ...+|+|||||.+ +|..++.+.  .+++..+..++.|++.||
T Consensus        40 ~~~~~e~ei~~~~~~~HpnIv~~~~~~~~~~~~----~~~~~lv~Ey~~~g~L~~~l~~~--~l~~~~~~~~~~~ia~gl  113 (303)
T d1vjya_          40 RSWFREAEIYQTVMLRHENILGFIAADNKDNGT----WTQLWLVSDYHEHGSLFDYLNRY--TVTVEGMIKLALSTASGL  113 (303)
T ss_dssp             HHHHHHHHHHTSTTCCCTTBCCEEEEEEEECSS----SEEEEEEEECCTTCBHHHHHHHC--CBCHHHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHHhhCCCCcCcceEEEEEeCCCc----ceEEEEEEecccCCCHHHHHhcC--CCCHHHHHHHHHHHHHHH
Confidence            3445555555  467999999999999876331    3478999999974 888888753  589999999999999999


Q ss_pred             HHHHh--------CCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCcccccCCCC----
Q psy7889          85 YYIHS--------NKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPELLLGDRN----  152 (433)
Q Consensus        85 ~~LH~--------~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~----  152 (433)
                      .|||+        +||+||||||+||||+.++.+||+|||++..................||+.|+|||++.+...    
T Consensus       114 ~~lH~~~~~~~~~~~IvHrDlKp~NILl~~~~~~Kl~DFGl~~~~~~~~~~~~~~~~~~~gt~~y~aPE~~~~~~~~~~~  193 (303)
T d1vjya_         114 AHLHMEIVGTQGKPAIAHRDLKSKNILVKKNGTCCIADLGLAVRHDSATDTIDIAPNHRVGTKRYMAPEVLDDSINMKHF  193 (303)
T ss_dssp             HHHHCCBCSTTCBCEEECSCCCGGGEEECTTSCEEECCCTTCEEEETTTTEECC----CCSCGGGCCHHHHTTCSCTTCH
T ss_pred             HHHHHhhhhhccCCCeeccccCccceEEcCCCCeEEEecCccccccCCCcceeccccceecccCcCChhhccccccccCC
Confidence            99996        599999999999999999999999999998876544333334456789999999999865421    


Q ss_pred             -CCCcchhhhHHHHHHHHHhcCCCCCCCChHHHHHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccC
Q psy7889         153 -YGPPVDLWGAGCIMAEMWTRSPIMQGNTEQQQITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVK  231 (433)
Q Consensus       153 -~~~~~DiwSlGvil~ell~g~~pf~~~~~~~~~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  231 (433)
                       ++.++|||||||++|||++|.+||........          +.......................+........+...
T Consensus       194 ~~~~k~Di~S~Gvvl~el~tg~~~~~~~~~~~~----------~~~~~~~~~~~~~~~~~~~~~~~~~p~~~~~~~~~~~  263 (303)
T d1vjya_         194 ESFKRADIYAMGLVFWEIARRCSIGGIHEDYQL----------PYYDLVPSDPSVEEMRKVVCEQKLRPNIPNRWQSCEA  263 (303)
T ss_dssp             HHHHHHHHHHHHHHHHHHHHTBCBTTBCCCCCC----------TTTTTSCSSCCHHHHHHHHTTSCCCCCCCGGGGGCHH
T ss_pred             CcCcchhhhhhHHHHHHHhhCCCCCCccccccc----------chhhcccccchHHHHHHHHhccccCCCCCcccCChHH
Confidence             46689999999999999999888754321100          0000000000000000000000000000000000011


Q ss_pred             ChhHHHHHHhhcccCCCCCCCHHHhhc
Q psy7889         232 DQYGCDLLDKLLLLDPSKRFDSDAALN  258 (433)
Q Consensus       232 s~~~~~li~~~L~~dP~~R~t~~e~L~  258 (433)
                      ...+.+|+.+||+.||.+|||+.|+++
T Consensus       264 ~~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         264 LRVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            234669999999999999999999986

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=100.00  E-value=2e-37  Score=299.83  Aligned_cols=246  Identities=27%  Similarity=0.418  Sum_probs=173.9

Q ss_pred             chhHHHHHHHHHhCC-----------CCCccceeeeEEecCccccccCceEEEEeecCc--CCHHHHH-hccCCCCCHHH
Q psy7889           7 PITALREIKILQLLK-----------HENVVHLIEICRTKANQYNRYRSTFYLVFDFCE--HDLAGLL-SNIHVKFSLGE   72 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-----------hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~--~~L~~~l-~~~~~~l~~~~   72 (433)
                      .+.+.+|+.+|+.++           |+|||++++++.....      ...+++|+++.  ++..... ......+++..
T Consensus        53 ~~~~~~Ei~~l~~l~~~~~~~~~~~~~~~iv~~~~~~~~~~~------~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  126 (362)
T d1q8ya_          53 TEAAEDEIKLLQRVNDADNTKEDSMGANHILKLLDHFNHKGP------NGVHVVMVFEVLGENLLALIKKYEHRGIPLIY  126 (362)
T ss_dssp             HHHHHHHHHHHHHHHHTCCSHHHHHHHTTBCCCCEEEEEEET------TEEEEEEEECCCCEEHHHHHHHTTTSCCCHHH
T ss_pred             hHHHHHHHHHHHHhcchhhhhhhhcCcCceEEEEEEeeeccc------cceeeeeeecccccccccccccccccCCcHHH
Confidence            456788999999885           5789999999876533      44566666654  3333333 33445689999


Q ss_pred             HHHHHHHHHHHHHHHHh-CCeeccCCCCCcEEEecCC------cEEEeecCCccccccCcCCccccccCCcccccccCcc
Q psy7889          73 IKKVIQQLLNGLYYIHS-NKILHRDMKAANVLITKTG------ILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPPE  145 (433)
Q Consensus        73 ~~~i~~qll~aL~~LH~-~~iiH~dikp~NIll~~~~------~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aPE  145 (433)
                      ++.++.||+.||+|||+ +||+||||||+|||++.++      .++++|||.+.....       .....+||+.|+|||
T Consensus       127 i~~i~~qil~al~~lh~~~~IvHrDlKp~NIll~~~~~~~~~~~~kl~dfg~s~~~~~-------~~~~~~gt~~y~aPE  199 (362)
T d1q8ya_         127 VKQISKQLLLGLDYMHRRCGIIHTDIKPENVLMEIVDSPENLIQIKIADLGNACWYDE-------HYTNSIQTREYRSPE  199 (362)
T ss_dssp             HHHHHHHHHHHHHHHHHTTCEECSCCSGGGEEEEEEETTTTEEEEEECCCTTCEETTB-------CCCSCCSCGGGCCHH
T ss_pred             HHHHHHHHHHHHHHHhhhcCcccccCChhHeeeeccCcccccceeeEeeccccccccc-------ccccccccccccChh
Confidence            99999999999999997 8999999999999998665      499999999876542       224567899999999


Q ss_pred             cccCCCCCCCcchhhhHHHHHHHHHhcCCCCCCCC------hHHHHHHHHHHhCCCCCCCCCcccchhhh----------
Q psy7889         146 LLLGDRNYGPPVDLWGAGCIMAEMWTRSPIMQGNT------EQQQITLISQLCGSITPESWPGVETLDLY----------  209 (433)
Q Consensus       146 ~~~~~~~~~~~~DiwSlGvil~ell~g~~pf~~~~------~~~~~~~i~~~~g~~~~~~~~~~~~~~~~----------  209 (433)
                      ++.+.. |+.++||||+||++++|++|++||....      ..+.+..+...+|.++...+........+          
T Consensus       200 ~~~~~~-~~~~~DiwSlG~il~el~~g~~pF~~~~~~~~~~~~~~~~~~~~~lg~~~~~~~~~~~~~~~~~~~~~~~~~~  278 (362)
T d1q8ya_         200 VLLGAP-WGCGADIWSTACLIFELITGDFLFEPDEGHSYTKDDDHIAQIIELLGELPSYLLRNGKYTRTFFNSRGLLRNI  278 (362)
T ss_dssp             HHHTCC-CCTHHHHHHHHHHHHHHHHSSCCC---------CHHHHHHHHHHHHCSCCHHHHHHCTTHHHHBCC--CBSSC
T ss_pred             hccccC-CCccccccchHHHHHHHHHCCCCCCCCccccccchhHHHHHHHHHhCCCCHHHhhcccccccccccchhhhcc
Confidence            998765 7999999999999999999999997543      34566677777776544322111110000          


Q ss_pred             hccccchHHHhhHHhhhCCccCChhHHHHHHhhcccCCCCCCCHHHhhcCCCccCCC
Q psy7889         210 NKMELPKAQKRKVKERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  266 (433)
Q Consensus       210 ~~~~~~~~~~~~~~~~~~~~~~s~~~~~li~~~L~~dP~~R~t~~e~L~h~~~~~~~  266 (433)
                      ................-.....+++++|||.+||.+||.+|||++|+|+||||++..
T Consensus       279 ~~~~~~~~~~~~~~~~~~~~~~~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         279 SKLKFWPLEDVLTEKYKFSKDEAKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             CCCCBCCHHHHHHHTTCCCHHHHHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             ccccCCchhhhcccccccCcccCHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence            000000000000000011122467889999999999999999999999999998543

>d1csna_ d.144.1.7 (A:) Casein kinase-1, CK1 {Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Casein kinase-1, CK1
species: Fission yeast (Schizosaccharomyces pombe) [TaxId: 4896]

Probab=100.00  E-value=1.7e-36  Score=284.58  Aligned_cols=216  Identities=19%  Similarity=0.161  Sum_probs=171.0

Q ss_pred             CchhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           6 FPITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         6 ~~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ....+.+|+++++.|+ |+||+.+++++...        ...|+|||||+++|.+++......+++..+..++.|++.||
T Consensus        43 ~~~~~~~e~~~~~~l~~~~~i~~~~~~~~~~--------~~~~~vme~~~~~l~~~~~~~~~~~~~~~~~~i~~q~~~~l  114 (293)
T d1csna_          43 DAPQLRDEYRTYKLLAGCTGIPNVYYFGQEG--------LHNVLVIDLLGPSLEDLLDLCGRKFSVKTVAMAAKQMLARV  114 (293)
T ss_dssp             TSCCHHHHHHHHHHTTTCTTCCCEEEEEEET--------TEEEEEEECCCCBHHHHHHHTTTCCCHHHHHHHHHHHHHHH
T ss_pred             CcHHHHHHHHHHHHhcCCCCCCEEEEEeecC--------CccEEEEEecCCCHHHHHHhhccchhhHHHHHHHHHHHHHH
Confidence            3567899999999996 58999999999875        66899999999999999988777899999999999999999


Q ss_pred             HHHHhCCeeccCCCCCcEEEec-----CCcEEEeecCCccccccCcCCcc---ccccCCcccccccCcccccCCCCCCCc
Q psy7889          85 YYIHSNKILHRDMKAANVLITK-----TGILKLADFGLARAFSQTKNGQV---NRYTNRVVTLWYRPPELLLGDRNYGPP  156 (433)
Q Consensus        85 ~~LH~~~iiH~dikp~NIll~~-----~~~~kl~DFg~a~~~~~~~~~~~---~~~~~~~gt~~y~aPE~~~~~~~~~~~  156 (433)
                      +|||++||+||||||+|||++.     ++.+||+|||+|+.+........   ......+||+.|+|||++.+.. ++.+
T Consensus       115 ~~lH~~giiHrDiKp~Nili~~~~~~~~~~vkl~DFG~a~~~~~~~~~~~~~~~~~~~~~GT~~y~aPE~~~~~~-~~~~  193 (293)
T d1csna_         115 QSIHEKSLVYRDIKPDNFLIGRPNSKNANMIYVVDFGMVKFYRDPVTKQHIPYREKKNLSGTARYMSINTHLGRE-QSRR  193 (293)
T ss_dssp             HHHHTTTEECCCCCGGGEEECCSSSTTTTCEEECCCTTCEESBCTTTCCBCCCCCCCCCCSCTTTCCHHHHTTCC-CCHH
T ss_pred             HHHHHCCceeccCCccceeecCcccccCCceEEcccceeEEcccCccccceeecccCceEEchhhcCHHHhcCCC-CChH
Confidence            9999999999999999999974     57899999999988754322221   2234568999999999998765 8999


Q ss_pred             chhhhHHHHHHHHHhcCCCCCCCChHHH---HHHHHHHhCCCCCCCCCcccchhhhhccccchHHHhhHHhhhCCccCCh
Q psy7889         157 VDLWGAGCIMAEMWTRSPIMQGNTEQQQ---ITLISQLCGSITPESWPGVETLDLYNKMELPKAQKRKVKERLKPYVKDQ  233 (433)
Q Consensus       157 ~DiwSlGvil~ell~g~~pf~~~~~~~~---~~~i~~~~g~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~s~  233 (433)
                      +|||||||++|+|++|..||.+......   ...+....-                         ........  ...++
T Consensus       194 ~DiwSlG~~l~elltg~~Pf~~~~~~~~~~~~~~i~~~~~-------------------------~~~~~~l~--~~~p~  246 (293)
T d1csna_         194 DDLEALGHVFMYFLRGSLPWQGLKAATNKQKYERIGEKKQ-------------------------STPLRELC--AGFPE  246 (293)
T ss_dssp             HHHHHHHHHHHHHHHSSCTTSSCCSCCHHHHHHHHHHHHH-------------------------HSCHHHHT--TTSCH
T ss_pred             HHHHHhhHHHHHHHhCCCcCCCccchhHHHHHHHHHhccC-------------------------CCChHHhc--CCCCH
Confidence            9999999999999999999986543322   222211100                         00001111  12457


Q ss_pred             hHHHHHHhhcccCCCCCCCHHHhh
Q psy7889         234 YGCDLLDKLLLLDPSKRFDSDAAL  257 (433)
Q Consensus       234 ~~~~li~~~L~~dP~~R~t~~e~L  257 (433)
                      ++.+++..|+..+|++||+.+.+.
T Consensus       247 ~l~~ii~~~~~~~~~~rP~y~~l~  270 (293)
T d1csna_         247 EFYKYMHYARNLAFDATPDYDYLQ  270 (293)
T ss_dssp             HHHHHHHHHHHCCTTCCCCHHHHH
T ss_pred             HHHHHHHHHhcCCcccCcCHHHHH
Confidence            788999999999999999987664

>d1zara2 d.144.1.9 (A:91-281) Rio2 serine protein kinase C-terminal domain {Archaeoglobus fulgidus [TaxId: 2234]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: RIO1-like kinases
domain: Rio2 serine protein kinase C-terminal domain
species: Archaeoglobus fulgidus [TaxId: 2234]

Probab=99.69  E-value=6.8e-18  Score=146.69  Aligned_cols=124  Identities=16%  Similarity=0.162  Sum_probs=91.6

Q ss_pred             hHHHHHHHHHhCCCCCccceeeeEEecCccccccCceEEEEeecCcCCHHHHHhccCCCCCHHHHHHHHHHHHHHHHHHH
Q psy7889           9 TALREIKILQLLKHENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHDLAGLLSNIHVKFSLGEIKKVIQQLLNGLYYIH   88 (433)
Q Consensus         9 ~~~~Ei~il~~l~hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~L~~~l~~~~~~l~~~~~~~i~~qll~aL~~LH   88 (433)
                      .+.+|...|.++.|.+++..+++..            .++||||+++...       ..++...+..++.|++.+|+|||
T Consensus        60 ~~~~e~~~l~~l~~~~v~~~~~~~~------------~~lvme~~~~~~~-------~~l~~~~~~~i~~ql~~~l~~lH  120 (191)
T d1zara2          60 SARNEFRALQKLQGLAVPKVYAWEG------------NAVLMELIDAKEL-------YRVRVENPDEVLDMILEEVAKFY  120 (191)
T ss_dssp             HHHHHHHHHHHTTTSSSCCEEEEET------------TEEEEECCCCEEG-------GGCCCSCHHHHHHHHHHHHHHHH
T ss_pred             HHHHHHHHHHHccCCCcceEEEecC------------CEEEEEeeccccc-------cchhhHHHHHHHHHHHHHHHHHh
Confidence            4567899999999999999886531            2799999997421       12455667889999999999999


Q ss_pred             hCCeeccCCCCCcEEEecCCcEEEeecCCccccccCcCCccccccCCcccccccCc------ccccCCCCCCCcchhhhH
Q psy7889          89 SNKILHRDMKAANVLITKTGILKLADFGLARAFSQTKNGQVNRYTNRVVTLWYRPP------ELLLGDRNYGPPVDLWGA  162 (433)
Q Consensus        89 ~~~iiH~dikp~NIll~~~~~~kl~DFg~a~~~~~~~~~~~~~~~~~~gt~~y~aP------E~~~~~~~~~~~~DiwSl  162 (433)
                      ++||+||||||+|||++.+ .++|+|||.|.....+..            ..|...      +.+ . +.|+..+|+||+
T Consensus       121 ~~giiHrDiKP~NILv~~~-~~~liDFG~a~~~~~~~~------------~~~l~rd~~~~~~~f-~-r~y~~~~d~~s~  185 (191)
T d1zara2         121 HRGIVHGDLSQYNVLVSEE-GIWIIDFPQSVEVGEEGW------------REILERDVRNIITYF-S-RTYRTEKDINSA  185 (191)
T ss_dssp             HTTEECSCCSTTSEEEETT-EEEECCCTTCEETTSTTH------------HHHHHHHHHHHHHHH-H-HHHCCCCCHHHH
T ss_pred             hCCEEEccCChhheeeeCC-CEEEEECCCcccCCCCCc------------HHHHHHHHHHHHHHH-c-CCCCCcccHHHH
Confidence            9999999999999999865 489999999876542211            111111      111 1 237899999997


Q ss_pred             HHHH
Q psy7889         163 GCIM  166 (433)
Q Consensus       163 Gvil  166 (433)
                      .--+
T Consensus       186 ~~~~  189 (191)
T d1zara2         186 IDRI  189 (191)
T ss_dssp             HHHH
T ss_pred             HHHH
Confidence            6444

>d1ua2a_ d.144.1.7 (A:) Cell division protein kinase 7, CDK7 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 7, CDK7
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.43  E-value=3.5e-08  Score=90.44  Aligned_cols=49  Identities=22%  Similarity=0.376  Sum_probs=42.1

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHh
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKML  380 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~  380 (433)
                      .+...  +++++|||.+||.+||++|+||+|+|+||||++.|.|.++..++
T Consensus       248 ~~~~~--s~~~~dll~~~L~~dP~~R~sa~e~L~Hp~f~~~p~p~~~~~~p  296 (299)
T d1ua2a_         248 IFSAA--GDDLLDLIQGLFLFNPCARITATQALKMKYFSNRPGPTPGCQLP  296 (299)
T ss_dssp             HCTTC--CHHHHHHHHHHHCSSTTTSCCHHHHHTSGGGTSSSCCCCSSSSC
T ss_pred             hcccC--CHHHHHHHHHHccCChhhCcCHHHHhCCHhhCCCCCCCCCCCCC
Confidence            33445  88999999999999999999999999999999998887765543

>d3blha1 d.144.1.7 (A:8-325) Cell division protein kinase 9, CDK9 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell division protein kinase 9, CDK9
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.35  E-value=4.8e-08  Score=90.23  Aligned_cols=48  Identities=73%  Similarity=1.324  Sum_probs=40.6

Q ss_pred             cccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCCh
Q psy7889         329 ERLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDL  376 (433)
Q Consensus       329 ~~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~  376 (433)
                      ..+.....+++++|||.+||.+||.+|+||+|+|+||||++.|.|++.
T Consensus       270 ~~~~~~~~~~~~~dLl~~mL~~dP~~R~sa~elL~Hpff~~~p~p~~~  317 (318)
T d3blha1         270 DRLKAYVRDPYALDLIDKLLVLDPAQRIDSDDALNHDFFWSDPMPSDL  317 (318)
T ss_dssp             HHHHHHHCCHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGSSSSCCCCC
T ss_pred             hhhccccCCHHHHHHHHHHCcCChhHCcCHHHHHcChhhccCCCCCCC
Confidence            333333347899999999999999999999999999999998888753

>d1unla_ d.144.1.7 (A:) Cyclin-dependent PK, CDK5 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK5
species: Human (Homo sapiens) [TaxId: 9606]

Probab=98.08  E-value=1e-06  Score=79.81  Aligned_cols=37  Identities=35%  Similarity=0.563  Sum_probs=34.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      ++.++|||++||.+||.+|+||+|+|+||||++...|
T Consensus       256 s~~~~dll~~mL~~dP~~R~sa~e~L~Hp~f~~~~~~  292 (292)
T d1unla_         256 NATGRDLLQNLLKCNPVQRISAEEALQHPYFSDFCPP  292 (292)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHTTSGGGSSCSCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcChhhcCCCCC
Confidence            7899999999999999999999999999999875543

>d3bqca1 d.144.1.7 (A:3-330) Protein kinase CK2, alpha subunit {Rattus norvegicus [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase CK2, alpha subunit
species: Rattus norvegicus [TaxId: 10116]

Probab=98.03  E-value=7.1e-07  Score=82.53  Aligned_cols=33  Identities=36%  Similarity=0.632  Sum_probs=31.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||++||.+||.+|+||+|+|+||||++
T Consensus       292 s~~~~dli~~mL~~dP~~R~ta~e~L~Hp~F~~  324 (328)
T d3bqca1         292 SPEALDFLDKLLRYDHQSRLTAREAMEHPYFYT  324 (328)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            789999999999999999999999999999986

>d1blxa_ d.144.1.7 (A:) Cyclin-dependent PK, CDK6 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK6
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.97  E-value=2.3e-06  Score=78.09  Aligned_cols=34  Identities=41%  Similarity=0.618  Sum_probs=32.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      ++.++|||.+||.+||.+|+||+|+|+||||++-
T Consensus       266 s~~~~dli~~mL~~dP~~R~sa~e~L~Hpff~~i  299 (305)
T d1blxa_         266 DELGKDLLLKCLTFNPAKRISAYSALSHPYFQDL  299 (305)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcChhhcCc
Confidence            8899999999999999999999999999999763

>d1ob3a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {(Plasmodium falciparum) [TaxId: 5833]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: (Plasmodium falciparum) [TaxId: 5833]

Probab=97.97  E-value=2.1e-06  Score=77.65  Aligned_cols=33  Identities=45%  Similarity=0.792  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++.++|||++||++||++|+||+|+|+||||++
T Consensus       254 s~~~~dli~~~L~~dP~~R~s~~ell~Hp~f~~  286 (286)
T d1ob3a_         254 DESGIDLLSKMLKLDPNQRITAKQALEHAYFKE  286 (286)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGGC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCc
Confidence            889999999999999999999999999999974

>d1gz8a_ d.144.1.7 (A:) Cyclin-dependent PK, CDK2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cyclin-dependent PK, CDK2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.96  E-value=2.2e-06  Score=77.96  Aligned_cols=42  Identities=40%  Similarity=0.658  Sum_probs=36.8

Q ss_pred             ccCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         330 RLKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       330 ~~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      .+..+  +++++|||++||..||.+|+||+|+|+||||++-+.|
T Consensus       251 ~~~~~--s~~~~dll~~mL~~dP~~R~t~~ell~H~ff~~~~~p  292 (298)
T d1gz8a_         251 VVPPL--DEDGRSLLSQMLHYDPNKRISAKAALAHPFFQDVTKP  292 (298)
T ss_dssp             HSTTC--CHHHHHHHHHHTCSSTTTSCCHHHHHTSGGGTTCCCC
T ss_pred             hccCC--CHHHHHHHHHHccCChhHCcCHHHHhCCHhhccCCCC
Confidence            33445  8899999999999999999999999999999876665

>d2gfsa1 d.144.1.7 (A:5-352) MAP kinase p38 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.95  E-value=1.6e-06  Score=80.78  Aligned_cols=38  Identities=37%  Similarity=0.617  Sum_probs=34.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPS  374 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~  374 (433)
                      +++++|||++||.+||.+|+||+|+|+||||++...+.
T Consensus       274 s~~~~dli~~mL~~dP~~R~ta~elL~Hp~f~~~~~~~  311 (348)
T d2gfsa1         274 NPLAVDLLEKMLVLDSDKRITAAQALAHAYFAQYHDPD  311 (348)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGTTTCCTT
T ss_pred             CHHHHHHHHHHCcCChhhCcCHHHHhcCHhhCCCCCCc
Confidence            88999999999999999999999999999998755443

>d1cm8a_ d.144.1.7 (A:) MAP kinase p38-gamma {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase p38-gamma
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.94  E-value=2.4e-06  Score=79.50  Aligned_cols=35  Identities=31%  Similarity=0.551  Sum_probs=32.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++++|||.+||.+||.+|+||+|+|+||||+...
T Consensus       274 s~~~~dli~~mL~~dP~~R~ta~eiL~Hp~f~~~~  308 (346)
T d1cm8a_         274 SPLAVNLLEKMLVLDAEQRVTAGEALAHPYFESLH  308 (346)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSGGGTTTC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcChhhCcCC
Confidence            88999999999999999999999999999998644

>d1q8ya_ d.144.1.7 (A:) Sky1p {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Sky1p
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=97.90  E-value=2.2e-06  Score=80.18  Aligned_cols=35  Identities=31%  Similarity=0.453  Sum_probs=32.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++++|||.+||.+||.+||||+|+|+||||++.+
T Consensus       301 ~~~~~dll~~mL~~dP~~Rpta~e~L~Hp~f~~~~  335 (362)
T d1q8ya_         301 AKEISDFLSPMLQLDPRKRADAGGLVNHPWLKDTL  335 (362)
T ss_dssp             HHHHHHHHGGGGCSSTTTCBCHHHHHTCGGGTTCT
T ss_pred             CHHHHHHHHHHCCCChhHCcCHHHHhcCcccCCCC
Confidence            57799999999999999999999999999998543

>d1a06a_ d.144.1.7 (A:) Calmodulin-dependent protein kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Calmodulin-dependent protein kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.85  E-value=8.1e-06  Score=74.45  Aligned_cols=35  Identities=31%  Similarity=0.534  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++++|||.+||..||.+|+||+|+|+||||+...
T Consensus       237 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~~~  271 (307)
T d1a06a_         237 SDSAKDFIRHLMEKDPEKRFTCEQALQHPWIAGDT  271 (307)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHHSTTTTSSC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCC
Confidence            78999999999999999999999999999998644

>d2b1pa1 d.144.1.7 (A:46-400) c-jun N-terminal kinase (jnk3s) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-jun N-terminal kinase (jnk3s)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.83  E-value=2.6e-06  Score=79.59  Aligned_cols=36  Identities=36%  Similarity=0.502  Sum_probs=32.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      +++++|||++||.+||++|+||+|+|+||||+....
T Consensus       284 s~~~~dll~~mL~~dP~~R~ta~elL~Hpw~~~~~~  319 (355)
T d2b1pa1         284 ASQARDLLSKMLVIDPAKRISVDDALQHPYINVWYD  319 (355)
T ss_dssp             HHHHHHHHHHHSCSSTTTSCCHHHHHTSTTTGGGCC
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHhcCcccCCCCC
Confidence            577999999999999999999999999999987543

>d1u5ra_ d.144.1.7 (A:) Serine/threonine protein kinase TAO2 {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine protein kinase TAO2
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=97.79  E-value=4.4e-06  Score=76.32  Aligned_cols=55  Identities=20%  Similarity=0.318  Sum_probs=41.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCCCChhHHhhhhhhhhhhhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMPSDLSKMLAQHTQSMFEYL  391 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~~~~~~~~~~~~~~~~~~~  391 (433)
                      ++++++||.+||..||.+||||+|+|+||||.....+.....+........+++.
T Consensus       240 s~~~~~li~~~L~~dP~~Rpt~~ell~Hp~~~~~~~~~~~~~~~~~~~~~~~~~~  294 (309)
T d1u5ra_         240 SEYFRNFVDSCLQKIPQDRPTSEVLLKHRFVLRERPPTVIMDLIQRTKDAVRELD  294 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHTTCHHHHSCCCTTHHHHHHHHHHHHHHHSS
T ss_pred             CHHHHHHHHHHCcCChhHCcCHHHHHhCHHhcCCCCchhhHHHHHHHHHHHHhhh
Confidence            7889999999999999999999999999999876555443333233333344443

>d1pmea_ d.144.1.7 (A:) MAP kinase Erk2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase Erk2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.74  E-value=8.1e-06  Score=75.75  Aligned_cols=41  Identities=34%  Similarity=0.519  Sum_probs=35.6

Q ss_pred             cCCCCCChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         331 LKPYVKDQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       331 ~~~~~~~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +..+  +++++|||.+||.+||.+|+||+|+|+||||+....+
T Consensus       264 ~~~~--s~~~~~li~~~L~~dP~~R~ta~e~L~hpf~~~~~~~  304 (345)
T d1pmea_         264 FPNA--DSKALDLLDKMLTFNPHKRIEVEQALAHPYLEQYYDP  304 (345)
T ss_dssp             CTTS--CHHHHHHHHHHSCSSTTTSCCHHHHHTSGGGTTTCCG
T ss_pred             CCCC--CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccCCCC
Confidence            3445  7899999999999999999999999999999865443

>d1q5ka_ d.144.1.7 (A:) Glycogen synthase kinase-3 beta (Gsk3b) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Glycogen synthase kinase-3 beta (Gsk3b)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.72  E-value=4.5e-06  Score=77.74  Aligned_cols=35  Identities=26%  Similarity=0.279  Sum_probs=32.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~  371 (433)
                      +++++|||.+||.+||.+|+||.|+|+||||++..
T Consensus       276 s~~~~dLl~~mL~~dP~~R~ta~e~L~Hp~f~~~~  310 (350)
T d1q5ka_         276 PPEAIALCSRLLEYTPTARLTPLEACAHSFFDELR  310 (350)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGGGGG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhcccc
Confidence            88999999999999999999999999999997643

>d1nvra_ d.144.1.7 (A:) Cell cycle checkpoint kinase chk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Cell cycle checkpoint kinase chk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.70  E-value=1e-05  Score=72.42  Aligned_cols=33  Identities=24%  Similarity=0.349  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+||+|+|+||||+.
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~eil~hpwf~~  265 (271)
T d1nvra_         233 DSAPLALLHKILVENPSARITIPDIKKDRWYNK  265 (271)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTCTTTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhcCHhhCc
Confidence            788999999999999999999999999999974

>d1koaa2 d.144.1.7 (A:5915-6264) Twitchin, kinase domain {Caenorhabditis elegans, pjk4 [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: Caenorhabditis elegans, pjk4 [TaxId: 6239]

Probab=97.68  E-value=7.2e-06  Score=76.23  Aligned_cols=37  Identities=35%  Similarity=0.589  Sum_probs=34.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPMP  373 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~~  373 (433)
                      +++++|||.+||..||.+|+||+|+|+||||.....+
T Consensus       253 s~~~~~li~~~L~~dP~~R~t~~eil~hp~~~~~~~~  289 (350)
T d1koaa2         253 SEDGKDFIRKLLLADPNTRMTIHQALEHPWLTPGNAP  289 (350)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHHHSTTTSCTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCCCCC
Confidence            7889999999999999999999999999999876544

>d1s9ja_ d.144.1.7 (A:) Dual specificity mitogen-activated protein kinase kinase 1, Mek1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Dual specificity mitogen-activated protein kinase kinase 1, Mek1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=7.5e-06  Score=75.22  Aligned_cols=33  Identities=24%  Similarity=0.330  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +.+++|||++||.+||.+|+||+|+|+||||+.
T Consensus       271 s~~~~dli~~~L~~dP~~R~ta~e~L~Hpf~~~  303 (322)
T d1s9ja_         271 SLEFQDFVNKCLIKNPAERADLKQLMVHAFIKR  303 (322)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHTSHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHhhCHhhCc
Confidence            788999999999999999999999999999975

>d1xwsa_ d.144.1.7 (A:) Proto-oncogene serine/threonine-protein kinase Pim-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Proto-oncogene serine/threonine-protein kinase Pim-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.62  E-value=7.4e-06  Score=73.36  Aligned_cols=36  Identities=22%  Similarity=0.186  Sum_probs=33.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTDPM  372 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~~~  372 (433)
                      ++++++||++||..||.+|+||+|+|+||||++...
T Consensus       228 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~~~  263 (273)
T d1xwsa_         228 SSECQHLIRWCLALRPSDRPTFEEIQNHPWMQDVLL  263 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSGGGSSCCC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhcCHhhCCCCC
Confidence            789999999999999999999999999999986544

>d1yhwa1 d.144.1.7 (A:249-541) pak1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: pak1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.55  E-value=2e-05  Score=71.28  Aligned_cols=33  Identities=27%  Similarity=0.328  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+||+|+|+||||+.
T Consensus       243 s~~~~~li~~~L~~dP~~R~s~~eil~Hp~~~~  275 (293)
T d1yhwa1         243 SAIFRDFLNRCLDMDVEKRGSAKELLQHQFLKI  275 (293)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHTTCGGGGG
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCC
Confidence            788999999999999999999999999999975

>d1t4ha_ d.144.1.7 (A:) Protein kinase wnk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase wnk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.50  E-value=1.6e-05  Score=71.03  Aligned_cols=32  Identities=19%  Similarity=0.316  Sum_probs=30.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~  368 (433)
                      ++++.+||.+||..||.+|+||+|+|+||||+
T Consensus       239 ~~~~~~li~~~l~~dp~~R~s~~ell~Hp~fk  270 (270)
T d1t4ha_         239 IPEVKEIIEGCIRQNKDERYSIKDLLNHAFFQ  270 (270)
T ss_dssp             CHHHHHHHHHHSCSSGGGSCCHHHHHTSGGGC
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHhCCcccC
Confidence            77899999999999999999999999999995

>d2jfla1 d.144.1.7 (A:21-308) STE20-like serine/threonine-protein kinase, SLK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: STE20-like serine/threonine-protein kinase, SLK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.49  E-value=2.7e-05  Score=70.16  Aligned_cols=34  Identities=26%  Similarity=0.305  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||++||..||.+|+|++|+|+||||+..
T Consensus       242 s~~~~~li~~~L~~dp~~R~t~~ell~hp~~~~~  275 (288)
T d2jfla1         242 SSNFKDFLKKCLEKNVDARWTTSQLLQHPFVTVD  275 (288)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHTTSGGGCCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCCC
Confidence            7889999999999999999999999999999753

>d1phka_ d.144.1.7 (A:) gamma-subunit of glycogen phosphorylase kinase (Phk) {Rabbit (Oryctolagus cuniculus) [TaxId: 9986]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: gamma-subunit of glycogen phosphorylase kinase (Phk)
species: Rabbit (Oryctolagus cuniculus) [TaxId: 9986]

Probab=97.47  E-value=1.9e-05  Score=70.75  Aligned_cols=33  Identities=33%  Similarity=0.656  Sum_probs=31.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+|++|+|+||||+.
T Consensus       243 s~~~~~li~~~L~~~p~~R~s~~eil~h~~~~~  275 (277)
T d1phka_         243 SDTVKDLVSRFLVVQPQKRYTAEEALAHPFFQQ  275 (277)
T ss_dssp             CHHHHHHHHHHCCSSGGGSCCHHHHTTSGGGCT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHHHH
Confidence            889999999999999999999999999999975

>d1jksa_ d.144.1.7 (A:) Death-associated protein kinase, Dap {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Death-associated protein kinase, Dap
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.44  E-value=2.1e-05  Score=71.14  Aligned_cols=33  Identities=27%  Similarity=0.512  Sum_probs=31.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||++||..||.+|+|++|+|+||||+.
T Consensus       244 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  276 (293)
T d1jksa_         244 SALAKDFIRRLLVKDPKKRMTIQDSLQHPWIKP  276 (293)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSTTTCC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCcccCC
Confidence            788999999999999999999999999999975

>d1koba_ d.144.1.7 (A:) Twitchin, kinase domain {California sea hare (Aplysia californica), twk43 [TaxId: 6500]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Twitchin, kinase domain
species: California sea hare (Aplysia californica), twk43 [TaxId: 6500]

Probab=97.42  E-value=6.2e-05  Score=69.75  Aligned_cols=34  Identities=29%  Similarity=0.470  Sum_probs=32.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||.+||..||.+|+|++|+|+||||+..
T Consensus       256 s~~~~~li~~~L~~dp~~R~s~~eil~Hp~~~~~  289 (352)
T d1koba_         256 SPEAKDFIKNLLQKEPRKRLTVHDALEHPWLKGD  289 (352)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHTSTTTSSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhCCC
Confidence            7899999999999999999999999999999764

>d2j4za1 d.144.1.7 (A:126-388) Aurora-related kinase 1 (aurora-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Aurora-related kinase 1 (aurora-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.35  E-value=2e-05  Score=69.98  Aligned_cols=33  Identities=27%  Similarity=0.362  Sum_probs=31.3

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      ++++++||.+||..||.+|+|++|+|+||||+.
T Consensus       228 s~~~~~li~~~L~~dp~~R~t~~eil~hp~~~~  260 (263)
T d2j4za1         228 TEGARDLISRLLKHNPSQRPMLREVLEHPWITA  260 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTCHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHcCcCcCC
Confidence            788999999999999999999999999999964

>d1j7la_ d.144.1.6 (A:) Type IIIa 3',5"-aminoglycoside phosphotransferase {Enterococcus faecalis [TaxId: 1351]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Type IIIa 3',5"-aminoglycoside phosphotransferase
species: Enterococcus faecalis [TaxId: 1351]

Probab=97.32  E-value=0.00041  Score=60.80  Aligned_cols=100  Identities=16%  Similarity=0.198  Sum_probs=63.5

Q ss_pred             chhHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcCC-HHHHHhccCCCCCHHHHHHHHHHHHHHH
Q psy7889           7 PITALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEHD-LAGLLSNIHVKFSLGEIKKVIQQLLNGL   84 (433)
Q Consensus         7 ~~~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~~-L~~~l~~~~~~l~~~~~~~i~~qll~aL   84 (433)
                      ...+.+|..+++.+. +--+.+++++..++        +..++||++++|. +.......   ..   ...++.++...+
T Consensus        53 ~~~~~~E~~~l~~l~~~vpvP~vl~~~~~~--------~~~~lv~~~l~G~~~~~~~~~~---~~---~~~~~~~l~~~l  118 (263)
T d1j7la_          53 TYDVEREKDMMLWLEGKLPVPKVLHFERHD--------GWSNLLMSEADGVLCSEEYEDE---QS---PEKIIELYAECI  118 (263)
T ss_dssp             TTCHHHHHHHHHHHTTTSCCCCEEEEEEET--------TEEEEEEECCSSEEHHHHTTTC---SC---HHHHHHHHHHHH
T ss_pred             hhhHHHHHHHHHHHhccCCCCcEEEEEecC--------CceEEEEEeccccccccccccc---cc---HHHHHHHHHHHH
Confidence            446789999999884 43466777776654        5579999999873 33222110   01   111223333333


Q ss_pred             HHHHh-----------------------------------------------------C------CeeccCCCCCcEEEe
Q psy7889          85 YYIHS-----------------------------------------------------N------KILHRDMKAANVLIT  105 (433)
Q Consensus        85 ~~LH~-----------------------------------------------------~------~iiH~dikp~NIll~  105 (433)
                      ..||+                                                     .      .++|+|+.|.||+++
T Consensus       119 ~~lH~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~~l~~~~~~~~~~l~HgD~~~~Nil~~  198 (263)
T d1j7la_         119 RLFHSIDISDCPYTNSLDSRLAELDYLLNNDLADVDCENWEEDTPFKDPRELYDFLKTEKPEEELVFSHGDLGDSNIFVK  198 (263)
T ss_dssp             HHHHTSCCTTCSCBCCHHHHHHHHHHHHHTTCSCCCGGGGSTTCSCSSHHHHHHHHHHSCCCCCEEEECSCCCTTSEEEE
T ss_pred             HHHhccCccccccCcchhhhhhhHHHHHHHHhhhhhhhcccccccchHHHHHHHHHHhcCCcCCcEEEEeeccCcceeec
Confidence            33332                                                     1      268999999999999


Q ss_pred             cCCcEEEeecCCccc
Q psy7889         106 KTGILKLADFGLARA  120 (433)
Q Consensus       106 ~~~~~kl~DFg~a~~  120 (433)
                      .++.+-|+||+.+..
T Consensus       199 ~~~~~~lIDwe~a~~  213 (263)
T d1j7la_         199 DGKVSGFIDLGRSGR  213 (263)
T ss_dssp             TTEEEEECCCTTCEE
T ss_pred             CCceEEEeechhccc
Confidence            776677999987643

>d1tkia_ d.144.1.7 (A:) Titin, kinase domain {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Titin, kinase domain
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.26  E-value=3e-05  Score=70.97  Aligned_cols=34  Identities=24%  Similarity=0.433  Sum_probs=32.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWTD  370 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~~  370 (433)
                      +++++|||++||..||.+|+|++|+|+||||...
T Consensus       231 s~~~~~li~~~L~~dp~~R~s~~eil~hp~~~~~  264 (321)
T d1tkia_         231 SIEAMDFVDRLLVKERKSRMTASEALQHPWLKQK  264 (321)
T ss_dssp             CHHHHHHHHTTSCSSGGGSCCHHHHHHSHHHHSC
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHhcCHhhccC
Confidence            7889999999999999999999999999999653

>d2ozaa1 d.144.1.7 (A:51-385) MAP kinase activated protein kinase 2, mapkap2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: MAP kinase activated protein kinase 2, mapkap2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.20  E-value=4.2e-05  Score=70.47  Aligned_cols=33  Identities=21%  Similarity=0.338  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+|+.|+|+||||.+
T Consensus       245 s~~~~~li~~~L~~dP~~R~s~~eil~hp~~~~  277 (335)
T d2ozaa1         245 SEEVKMLIRNLLKTEPTQRMTITEFMNHPWIMQ  277 (335)
T ss_dssp             CHHHHHHHHHHSCSSTTTSCCHHHHHHSHHHHT
T ss_pred             CHHHHHHHHHHccCChhHCcCHHHHHcCHHhhC
Confidence            788999999999999999999999999999965

>d1omwa3 d.144.1.7 (A:186-549) G-protein coupled receptor kinase 2 {Cow (Bos taurus) [TaxId: 9913]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: G-protein coupled receptor kinase 2
species: Cow (Bos taurus) [TaxId: 9913]

Probab=97.10  E-value=0.00011  Score=68.33  Aligned_cols=33  Identities=24%  Similarity=0.330  Sum_probs=31.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCC-----HHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFD-----SDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~-----a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+|     |+++++||||+.
T Consensus       233 s~~~~~li~~~L~~dP~~R~t~~~~~a~eil~Hp~f~~  270 (364)
T d1omwa3         233 SPELRSLLEGLLQRDVNRRLGCLGRGAQEVKESPFFRS  270 (364)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTTSSSTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHhCCCcccCHHHHHcCccccC
Confidence            789999999999999999999     899999999975

>d2java1 d.144.1.7 (A:3-271) Serine/threonine-protein kinase Nek2 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Serine/threonine-protein kinase Nek2
species: Human (Homo sapiens) [TaxId: 9606]

Probab=97.03  E-value=0.00012  Score=65.02  Aligned_cols=31  Identities=13%  Similarity=0.222  Sum_probs=29.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      ++++.+||.+||..||.+|||++|+|+|||.
T Consensus       239 s~~l~~li~~~L~~dp~~Rps~~ell~hp~i  269 (269)
T d2java1         239 SDELNEIITRMLNLKDYHRPSVEEILENPLI  269 (269)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHTSTTC
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHhCCcC
Confidence            7889999999999999999999999999995

>d1vzoa_ d.144.1.7 (A:) Ribosomal protein S6 kinase alpha 5, Msk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Ribosomal protein S6 kinase alpha 5, Msk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.97  E-value=0.00013  Score=66.61  Aligned_cols=33  Identities=39%  Similarity=0.667  Sum_probs=31.0

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++++||++||.+||.+|+     ||+|+|+||||+.
T Consensus       260 s~~~~~li~~~l~~dP~~R~s~~~~t~~eil~Hpff~~  297 (322)
T d1vzoa_         260 SALAKDLIQRLLMKDPKKRLGCGPRDADEIKEHLFFQK  297 (322)
T ss_dssp             CHHHHHHHHHHTCSSGGGSTTSSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHcccCHHHcCCCCcccHHHHHcCHhhcC
Confidence            88999999999999999999     5999999999975

>d1o6la_ d.144.1.7 (A:) Pkb kinase (Akt-2) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Pkb kinase (Akt-2)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.88  E-value=0.00023  Score=65.33  Aligned_cols=33  Identities=33%  Similarity=0.580  Sum_probs=31.0

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      +++++|||.+||..||.+|+     +++++++||||..
T Consensus       229 s~~~~dli~~~L~~dP~~R~~~~~~~~~eil~Hp~f~~  266 (337)
T d1o6la_         229 SPEAKSLLAGLLKKDPKQRLGGGPSDAKEVMEHRFFLS  266 (337)
T ss_dssp             CHHHHHHHHHHTCSSTTTSTTCSTTTHHHHHTSGGGTT
T ss_pred             CHHHHHHHHhhccCCchhhcccccccHHHHHcCccccc
Confidence            78999999999999999999     4999999999975

>d1rdqe_ d.144.1.7 (E:) cAMP-dependent PK, catalytic subunit {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=96.80  E-value=0.00025  Score=65.41  Aligned_cols=33  Identities=39%  Similarity=0.494  Sum_probs=31.1

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|+     ||+++|+||||..
T Consensus       262 s~~~~~li~~~L~~dP~kR~~~~r~t~~ell~Hp~f~~  299 (350)
T d1rdqe_         262 SSDLKDLLRNLLQVDLTKRFGNLKNGVNDIKNHKWFAT  299 (350)
T ss_dssp             CHHHHHHHHHHSCSCTTTCTTSSTTTTHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHhhhCHHhccccccccHHHHHcCccccC
Confidence            78899999999999999996     9999999999975

>d1uu3a_ d.144.1.7 (A:) 3-phosphoinositide dependent protein kinase-1 Pdk1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: 3-phosphoinositide dependent protein kinase-1 Pdk1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.78  E-value=0.00016  Score=64.91  Aligned_cols=33  Identities=36%  Similarity=0.550  Sum_probs=30.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH------hcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA------LNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~------l~~~~~~~  369 (433)
                      +++++|||++||..||.+|+||+|+      ++||||..
T Consensus       234 s~~~~~li~~~L~~dP~~R~t~~e~~~~~~i~~Hpff~~  272 (288)
T d1uu3a_         234 FPKARDLVEKLLVLDATKRLGCEEMEGYGPLKAHPFFES  272 (288)
T ss_dssp             CHHHHHHHHTTSCSSGGGSTTSGGGTCHHHHHTSGGGTT
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHcCCHHHHcCCccCC
Confidence            7889999999999999999999985      78999965

>d1fota_ d.144.1.7 (A:) cAMP-dependent PK, catalytic subunit {Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: cAMP-dependent PK, catalytic subunit
species: Baker's yeast (Saccharomyces cerevisiae) [TaxId: 4932]

Probab=96.71  E-value=0.00033  Score=63.59  Aligned_cols=33  Identities=30%  Similarity=0.457  Sum_probs=31.2

Q ss_pred             ChHHHHHHHHhcccCCCCCC-----CHHHHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRF-----DSDAALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~-----~a~~~l~~~~~~~  369 (433)
                      ++++.+||++||..||.+|+     ||+++|+||||+.
T Consensus       225 s~~~~~li~~~L~~dp~~R~~~~r~t~~~il~Hp~f~~  262 (316)
T d1fota_         225 NEDVKDLLSRLITRDLSQRLGNLQNGTEDVKNHPWFKE  262 (316)
T ss_dssp             CHHHHHHHHHHTCSCTTTCTTSSTTTTHHHHTSGGGSS
T ss_pred             CHHHHHHHHHHhhhCHHhccccchhhHHHHHcCccccc
Confidence            78899999999999999997     9999999999975

>d1nd4a_ d.144.1.6 (A:) Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase) {Bacteria (Klebsiella pneumoniae) [TaxId: 573]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Aminoglycoside 3'-phosphotransferase IIa (Kanamycin kinase)
species: Bacteria (Klebsiella pneumoniae) [TaxId: 573]

Probab=96.70  E-value=0.0024  Score=55.38  Aligned_cols=28  Identities=18%  Similarity=0.283  Sum_probs=24.5

Q ss_pred             eeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          92 ILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        92 iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      ++|+|+.|.||+++.++.+-|+||+.+.
T Consensus       177 liHgD~~~~Nvl~~~~~~~~iID~~~~~  204 (255)
T d1nd4a_         177 VTHGDACLPNIMVENGRFSGFIDCGRLG  204 (255)
T ss_dssp             EECSSCCGGGEEEETTEEEEECCCTTCE
T ss_pred             EEeCCCCCcceEEeCCceEEEEEchhcc
Confidence            7999999999999987667899998653

>d1xjda_ d.144.1.7 (A:) Protein kinase C, theta type {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Protein kinase C, theta type
species: Human (Homo sapiens) [TaxId: 9606]

Probab=96.69  E-value=0.00016  Score=65.95  Aligned_cols=33  Identities=30%  Similarity=0.476  Sum_probs=30.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHH-HHhcCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSD-AALNHDFFWT  369 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~-~~l~~~~~~~  369 (433)
                      +++++|||++||..||.+|+|+. ++++||||+.
T Consensus       227 s~~~~dli~~~L~~dP~~R~s~~~~l~~hpff~~  260 (320)
T d1xjda_         227 EKEAKDLLVKLFVREPEKRLGVRGDIRQHPLFRE  260 (320)
T ss_dssp             CHHHHHHHHHHSCSSGGGSBTTBSCGGGSGGGTT
T ss_pred             CHHHHHHHHHhcccCCCCCcCHHHHHHhCchhcc
Confidence            78899999999999999999996 8999999975

>d2pula1 d.144.1.6 (A:5-396) Methylthioribose kinase MtnK {Bacillus subtilis [TaxId: 1423]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Methylthioribose kinase MtnK
species: Bacillus subtilis [TaxId: 1423]

Probab=95.38  E-value=0.0087  Score=55.57  Aligned_cols=29  Identities=17%  Similarity=0.331  Sum_probs=25.1

Q ss_pred             CeeccCCCCCcEEEecCCcEEEeecCCccc
Q psy7889          91 KILHRDMKAANVLITKTGILKLADFGLARA  120 (433)
Q Consensus        91 ~iiH~dikp~NIll~~~~~~kl~DFg~a~~  120 (433)
                      .++|+|+.|.|||++.++ ++|+||..+..
T Consensus       224 ~LiHGDl~~gNIlv~~~~-~~vID~E~a~~  252 (392)
T d2pula1         224 TLIHGDLHTGSIFASEHE-TKVIDPEFAFY  252 (392)
T ss_dssp             EEECSCCCGGGEEECSSC-EEECCCTTCEE
T ss_pred             ceeccCCcCCceeEcCCc-eEEechhhccc
Confidence            599999999999998765 89999987754

>d1fmka3 d.144.1.7 (A:249-533) c-src tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-src tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=94.27  E-value=0.0094  Score=52.70  Aligned_cols=35  Identities=17%  Similarity=0.179  Sum_probs=31.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN--HDFFWTDP  371 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~--~~~~~~~~  371 (433)
                      +++.++||.+||..||.+|||+++++.  ++||....
T Consensus       240 ~~~l~~li~~cl~~dP~~Rps~~~i~~~L~~~~~~~~  276 (285)
T d1fmka3         240 PESLHDLMCQCWRKEPEERPTFEYLQAFLEDYFTSTE  276 (285)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHTTTSCSC
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHHHhhhhcCCC
Confidence            678999999999999999999999877  89997644

>d2ppqa1 d.144.1.6 (A:5-320) Homoserine kinase ThrB {Agrobacterium tumefaciens [TaxId: 358]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: Homoserine kinase ThrB
species: Agrobacterium tumefaciens [TaxId: 358]

Probab=93.79  E-value=0.017  Score=51.60  Aligned_cols=30  Identities=27%  Similarity=0.371  Sum_probs=26.8

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .|+||+|+.++||+++.+..+-|+||+.+.
T Consensus       183 ~giIHgDl~~dNvl~~~~~v~gvIDF~~~~  212 (316)
T d2ppqa1         183 AGVIHADLFQDNVFFLGDELSGLIDFYFAC  212 (316)
T ss_dssp             EEEECSCCCGGGEEEETTEEEEECCCTTCE
T ss_pred             cccccCCcchhhhhcccccceeEecccccc
Confidence            479999999999999988878899999763

>d1nw1a_ d.144.1.8 (A:) Choline kinase {Caenorhabditis elegans [TaxId: 6239]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Choline kinase
domain: Choline kinase
species: Caenorhabditis elegans [TaxId: 6239]

Probab=93.64  E-value=0.032  Score=51.55  Aligned_cols=35  Identities=17%  Similarity=0.093  Sum_probs=24.7

Q ss_pred             hHHHHHHHHHhCC-CCCccceeeeEEecCccccccCceEEEEeecCcC
Q psy7889           9 TALREIKILQLLK-HENVVHLIEICRTKANQYNRYRSTFYLVFDFCEH   55 (433)
Q Consensus         9 ~~~~Ei~il~~l~-hpnIv~l~~~~~~~~~~~~~~~~~~~lV~e~~~~   55 (433)
                      ...+|..+++.+. +.-..++++++.+            .+|+||++|
T Consensus        90 dr~~E~~i~~~ls~~gl~Pkll~~~~~------------g~I~efi~g  125 (395)
T d1nw1a_          90 HLVAESVIFTLLSERHLGPKLYGIFSG------------GRLEEYIPS  125 (395)
T ss_dssp             HHHHHHHHHHHHHHTTSSSCEEEEETT------------EEEECCCCE
T ss_pred             HHHHHHHHHHHHHhCCCCCeEEEEcCC------------ceEEEEecc
Confidence            4568999999985 4334577776632            589999885

>d1ywna1 d.144.1.7 (A:818-1166) Vascular endothelial growth factor receptor 2 (kdr) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Vascular endothelial growth factor receptor 2 (kdr)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=92.52  E-value=0.017  Score=51.16  Aligned_cols=28  Identities=14%  Similarity=0.045  Sum_probs=26.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++++++||.+||..||.+|||++|+++|
T Consensus       263 ~~~l~~li~~cl~~dP~~Rpt~~eil~~  290 (299)
T d1ywna1         263 TPEMYQTMLDCWHGEPSQRPTFSELVEH  290 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6789999999999999999999999986

>d1qpca_ d.144.1.7 (A:) Lymphocyte kinase (lck) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Lymphocyte kinase (lck)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.94  E-value=0.015  Score=50.98  Aligned_cols=32  Identities=22%  Similarity=0.141  Sum_probs=29.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc--CCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN--HDFFW  368 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~--~~~~~  368 (433)
                      +++..+|+.+||..||.+|||++++++  |+||.
T Consensus       236 ~~~l~~li~~cl~~~P~~Rpt~~ei~~~L~~~ft  269 (272)
T d1qpca_         236 PEELYQLMRLCWKERPEDRPTFDYLRSVLEDFFT  269 (272)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHHhhhhhh
Confidence            678899999999999999999999987  77774

>d1mp8a_ d.144.1.7 (A:) Focal adhesion kinase 1 (fak) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Focal adhesion kinase 1 (fak)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.89  E-value=0.023  Score=49.61  Aligned_cols=28  Identities=21%  Similarity=0.145  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++.+.+||.+||..||.+|||++++++|
T Consensus       235 ~~~~~~li~~cl~~dp~~Rps~~ei~~~  262 (273)
T d1mp8a_         235 PPTLYSLMTKCWAYDPSRRPRFTELKAQ  262 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            7889999999999999999999999865

>d1xbba_ d.144.1.7 (A:) Tyrosine-protein kinase SYK {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase SYK
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.87  E-value=0.021  Score=50.13  Aligned_cols=31  Identities=19%  Similarity=0.210  Sum_probs=26.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA---LNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~---l~~~~~  367 (433)
                      +++..+||.+||..||.+|||++++   |+|+|+
T Consensus       236 ~~~~~~li~~cl~~dp~~RPs~~~i~~~L~~~~~  269 (277)
T d1xbba_         236 PREMYDLMNLCWTYDVENRPGFAAVELRLRNYYY  269 (277)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHhhCHHh
Confidence            6789999999999999999999997   455554

>d1k2pa_ d.144.1.7 (A:) Bruton's tyrosine kinase (Btk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Bruton's tyrosine kinase (Btk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.74  E-value=0.025  Score=49.04  Aligned_cols=28  Identities=7%  Similarity=-0.027  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||++++|+|
T Consensus       227 ~~~l~~li~~cl~~dP~~RPt~~eil~~  254 (258)
T d1k2pa_         227 SEKVYTIMYSCWHEKADERPTFKILLSN  254 (258)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            6778999999999999999999999986

>d1rjba_ d.144.1.7 (A:) Fl cytokine receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fl cytokine receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.48  E-value=0.027  Score=50.61  Aligned_cols=28  Identities=11%  Similarity=-0.005  Sum_probs=26.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++++.+||.+||..||.+|||++|+++|
T Consensus       293 ~~~l~~li~~cl~~dP~~RPt~~ei~~~  320 (325)
T d1rjba_         293 TEEIYIIMQSCWAFDSRKRPSFPNLTSF  320 (325)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6789999999999999999999999875

>d1fvra_ d.144.1.7 (A:) Tie2 kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tie2 kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=91.16  E-value=0.03  Score=49.83  Aligned_cols=28  Identities=21%  Similarity=0.132  Sum_probs=26.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||++++|+|
T Consensus       252 ~~~~~~li~~cl~~dP~~RPs~~eil~~  279 (309)
T d1fvra_         252 DDEVYDLMRQCWREKPYERPSFAQILVS  279 (309)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcCCChhHCcCHHHHHHH
Confidence            6789999999999999999999999986

>d1byga_ d.144.1.7 (A:) Carboxyl-terminal src kinase (csk) {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Carboxyl-terminal src kinase (csk)
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.47  E-value=0.039  Score=47.86  Aligned_cols=28  Identities=11%  Similarity=-0.005  Sum_probs=25.7

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      ++...+||.+||..||.+|||+.+++++
T Consensus       226 ~~~~~~li~~cl~~dP~~Rps~~~l~~~  253 (262)
T d1byga_         226 PPAVYEVMKNCWHLDAAMRPSFLQLREQ  253 (262)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHcccCHhHCcCHHHHHHH
Confidence            6789999999999999999999998763

>d1sm2a_ d.144.1.7 (A:) Tyrosine-protein kinase Itk/Tsk {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase Itk/Tsk
species: Human (Homo sapiens) [TaxId: 9606]

Probab=90.39  E-value=0.04  Score=47.74  Aligned_cols=28  Identities=11%  Similarity=0.082  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+|+.+||..||.+|||++++|+|
T Consensus       228 ~~~l~~li~~cl~~~p~~Rps~~~il~~  255 (263)
T d1sm2a_         228 STHVYQIMNHCWKERPEDRPAFSRLLRQ  255 (263)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCcCHHHHHHH
Confidence            6788999999999999999999999875

>d1o6ya_ d.144.1.7 (A:) Mycobacterial protein kinase PknB, catalytic domain {Mycobacterium tuberculosis [TaxId: 1773]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Mycobacterial protein kinase PknB, catalytic domain
species: Mycobacterium tuberculosis [TaxId: 1773]

Probab=90.06  E-value=0.027  Score=49.23  Aligned_cols=31  Identities=19%  Similarity=0.282  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~~~~  367 (433)
                      ++++.+||.+||..||.+|+++.++|.|+|.
T Consensus       242 s~~l~~li~~~L~~dp~~R~~sa~~l~~~l~  272 (277)
T d1o6ya_         242 SADLDAVVLKALAKNPENRYQTAAEMRADLV  272 (277)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCSSHHHHHHHHH
T ss_pred             CHHHHHHHHHHccCCHhHCHhHHHHHHHHHH
Confidence            7889999999999999999955555555554

>d1p4oa_ d.144.1.7 (A:) Insulin-like growth factor 1 receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Insulin-like growth factor 1 receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.57  E-value=0.061  Score=47.69  Aligned_cols=27  Identities=11%  Similarity=0.062  Sum_probs=25.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++...+||.+||..||.+|||++++++
T Consensus       261 ~~~l~~li~~cl~~~P~~RPs~~~il~  287 (308)
T d1p4oa_         261 PDMLFELMRMCWQYNPKMRPSFLEIIS  287 (308)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999987

>d1fgka_ d.144.1.7 (A:) Fibroblast growth factor receptor 1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Fibroblast growth factor receptor 1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.53  E-value=0.061  Score=47.44  Aligned_cols=27  Identities=11%  Similarity=-0.011  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+||||.|+|+
T Consensus       263 ~~~l~~li~~cl~~dP~~Rps~~eil~  289 (299)
T d1fgka_         263 TNELYMMMRDCWHAVPSQRPTFKQLVE  289 (299)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHccCCHhHCcCHHHHHH
Confidence            678899999999999999999999986

>d1t46a_ d.144.1.7 (A:) c-KIT receptor {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: c-KIT receptor
species: Human (Homo sapiens) [TaxId: 9606]

Probab=89.26  E-value=0.066  Score=47.53  Aligned_cols=27  Identities=19%  Similarity=0.118  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ++++.+||.+||..||.+|||++++|+
T Consensus       274 ~~~l~~Li~~cl~~dP~~RPs~~~il~  300 (311)
T d1t46a_         274 PAEMYDIMKTCWDADPLKRPTFKQIVQ  300 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678999999999999999999999885

>d1u59a_ d.144.1.7 (A:) Tyrosine-protein kinase ZAP-70 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Tyrosine-protein kinase ZAP-70
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.74  E-value=0.041  Score=48.36  Aligned_cols=31  Identities=10%  Similarity=0.052  Sum_probs=26.9

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHH---hcCCCC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAA---LNHDFF  367 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~---l~~~~~  367 (433)
                      +++..+||.+||..||.+|||+.++   |+|.|+
T Consensus       238 ~~~l~~li~~cl~~~p~~RPs~~~i~~~L~~~~~  271 (285)
T d1u59a_         238 PPELYALMSDCWIYKWEDRPDFLTVEQRMRACYY  271 (285)
T ss_dssp             CHHHHHHHHHTTCSSGGGSCCHHHHHHHHHHHHH
T ss_pred             CHHHHHHHHHHcCCCHhHCcCHHHHHHHHHHHHH
Confidence            6788999999999999999999887   556665

>d1opja_ d.144.1.7 (A:) Abelsone tyrosine kinase (abl) {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Abelsone tyrosine kinase (abl)
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=88.50  E-value=0.081  Score=46.37  Aligned_cols=27  Identities=15%  Similarity=0.104  Sum_probs=25.4

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||++++++
T Consensus       242 ~~~l~~li~~cl~~dP~~Rps~~ei~~  268 (287)
T d1opja_         242 PEKVYELMRACWQWNPSDRPSFAEIHQ  268 (287)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHH
Confidence            778999999999999999999999976

>d1uwha_ d.144.1.7 (A:) B-Raf kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: B-Raf kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=88.39  E-value=0.1  Score=45.46  Aligned_cols=28  Identities=14%  Similarity=-0.054  Sum_probs=26.1

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+++++++
T Consensus       239 ~~~l~~li~~cl~~dp~~RPt~~~il~~  266 (276)
T d1uwha_         239 PKAMKRLMAECLKKKRDERPLFPQILAS  266 (276)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6789999999999999999999999875

>d1r0pa_ d.144.1.7 (A:) Hepatocyte growth factor receptor, c-MET {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Hepatocyte growth factor receptor, c-MET
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.85  E-value=0.077  Score=47.13  Aligned_cols=28  Identities=7%  Similarity=-0.079  Sum_probs=26.2

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.|+++|
T Consensus       260 ~~~l~~li~~cl~~dP~~RPs~~ei~~~  287 (311)
T d1r0pa_         260 PDPLYEVMLKCWHPKAEMRPSFSELVSR  287 (311)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             cHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6789999999999999999999999876

>d1xkka_ d.144.1.7 (A:) EGF receptor tyrosine kinase, Erbb-1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: EGF receptor tyrosine kinase, Erbb-1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=87.58  E-value=0.081  Score=47.05  Aligned_cols=28  Identities=11%  Similarity=0.013  Sum_probs=26.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+|+.+||..||.+|||+.+++.|
T Consensus       239 ~~~~~~li~~cl~~dP~~RPs~~eil~~  266 (317)
T d1xkka_         239 TIDVYMIMVKCWMIDADSRPKFRELIIE  266 (317)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHHH
T ss_pred             CHHHHHHHHHhCCCChhhCcCHHHHHHH
Confidence            6789999999999999999999999987

>d1u46a_ d.144.1.7 (A:) Activated CDC42 kinase 1, ACK1 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Activated CDC42 kinase 1, ACK1
species: Human (Homo sapiens) [TaxId: 9606]

Probab=86.47  E-value=0.13  Score=44.69  Aligned_cols=27  Identities=15%  Similarity=-0.004  Sum_probs=24.6

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +....+||.+||..||.+|||+.++++
T Consensus       241 ~~~l~~li~~cl~~dp~~RPt~~ei~~  267 (273)
T d1u46a_         241 PQDIYNVMVQCWAHKPEDRPTFVALRD  267 (273)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             cHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678899999999999999999999863

>d1jpaa_ d.144.1.7 (A:) ephb2 receptor tyrosine kinase {Mouse (Mus musculus) [TaxId: 10090]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: ephb2 receptor tyrosine kinase
species: Mouse (Mus musculus) [TaxId: 10090]

Probab=86.36  E-value=0.17  Score=44.38  Aligned_cols=28  Identities=14%  Similarity=-0.019  Sum_probs=25.5

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhcC
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALNH  364 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~~  364 (433)
                      +++..+||.+||..||.+|||+.|++++
T Consensus       259 ~~~l~~li~~cl~~~P~~RPs~~ei~~~  286 (299)
T d1jpaa_         259 PSALHQLMLDCWQKDRNHRPKFGQIVNT  286 (299)
T ss_dssp             CHHHHHHHHHHTCSSTTTSCCHHHHHHH
T ss_pred             hHHHHHHHHHHcCCCHhHCcCHHHHHHH
Confidence            6778999999999999999999998764

>d1zyla1 d.144.1.6 (A:4-328) RdoA {Escherichia coli [TaxId: 562]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: APH phosphotransferases
domain: RdoA
species: Escherichia coli [TaxId: 562]

Probab=86.03  E-value=0.31  Score=43.16  Aligned_cols=28  Identities=36%  Similarity=0.405  Sum_probs=22.7

Q ss_pred             CCeeccCCCCCcEEEecCCcEEEeecCCcc
Q psy7889          90 NKILHRDMKAANVLITKTGILKLADFGLAR  119 (433)
Q Consensus        90 ~~iiH~dikp~NIll~~~~~~kl~DFg~a~  119 (433)
                      .++||+|+.+.|||+++ + ..++||+.+.
T Consensus       192 ~~liHgDlh~~NvL~~~-~-~~~IDFdd~~  219 (325)
T d1zyla1         192 VLRLHGDCHAGNILWRD-G-PMFVDLDDAR  219 (325)
T ss_dssp             CEECCSSCSGGGEEESS-S-EEECCCTTCC
T ss_pred             ceeecCCCCcccEEEeC-C-ceEEechhcc
Confidence            36999999999999964 3 4589999764

>d1mqba_ d.144.1.7 (A:) epha2 receptor tyrosine kinase {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: epha2 receptor tyrosine kinase
species: Human (Homo sapiens) [TaxId: 9606]

Probab=85.33  E-value=0.19  Score=43.62  Aligned_cols=27  Identities=7%  Similarity=-0.015  Sum_probs=25.0

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +.+..+||.+||..||.+|||+.++++
T Consensus       239 ~~~l~~li~~cl~~~p~~RPt~~eil~  265 (283)
T d1mqba_         239 PSAIYQLMMQCWQQERARRPKFADIVS  265 (283)
T ss_dssp             BHHHHHHHHHHTCSSTTTSCCHHHHHH
T ss_pred             HHHHHHHHHHHCcCCHhHCcCHHHHHH
Confidence            577899999999999999999999876

>d1lufa_ d.144.1.7 (A:) Musk tyrosine kinase {Rat (Rattus norvegicus) [TaxId: 10116]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Musk tyrosine kinase
species: Rat (Rattus norvegicus) [TaxId: 10116]

Probab=85.14  E-value=0.16  Score=44.64  Aligned_cols=27  Identities=11%  Similarity=-0.125  Sum_probs=24.8

Q ss_pred             ChHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         337 DQYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       337 ~~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      +++..+||.+||..||.+|||+.|+++
T Consensus       268 ~~~~~~li~~cl~~~P~~RPt~~ev~~  294 (301)
T d1lufa_         268 PLELYNLMRLCWSKLPADRPSFCSIHR  294 (301)
T ss_dssp             CHHHHHHHHHHTCSSGGGSCCHHHHHH
T ss_pred             hHHHHHHHHHHcCCChhHCcCHHHHHH
Confidence            678899999999999999999999864

>d1vjya_ d.144.1.7 (A:) Type I TGF-beta receptor R4 {Human (Homo sapiens) [TaxId: 9606]}

class: Alpha and beta proteins (a+b)
fold: Protein kinase-like (PK-like)
superfamily: Protein kinase-like (PK-like)
family: Protein kinases, catalytic subunit
domain: Type I TGF-beta receptor R4
species: Human (Homo sapiens) [TaxId: 9606]

Probab=82.31  E-value=0.18  Score=44.37  Aligned_cols=26  Identities=4%  Similarity=0.046  Sum_probs=23.3

Q ss_pred             hHHHHHHHHhcccCCCCCCCHHHHhc
Q psy7889         338 QYGCDLLDKLLLLDPSKRFDSDAALN  363 (433)
Q Consensus       338 ~~~~~l~~~~l~~~p~~R~~a~~~l~  363 (433)
                      ....+|+.+||..||.+|||+.|+++
T Consensus       265 ~~l~~li~~cl~~dp~~Rps~~ei~~  290 (303)
T d1vjya_         265 RVMAKIMRECWYANGAARLTALRIKK  290 (303)
T ss_dssp             HHHHHHHHTTCCSSGGGSCCHHHHHH
T ss_pred             HHHHHHHHHHcccCHhHCcCHHHHHH
Confidence            34779999999999999999999876